PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Gole, B; Baumann, C; Mian, E; Ireno, CI; Wiesmuller, L				Gole, B.; Baumann, C.; Mian, E.; Ireno, C. I.; Wiesmueller, L.			Endonuclease G initiates DNA rearrangements at the MLL breakpoint cluster upon replication stress	ONCOGENE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; TOPOISOMERASE-II; HISTONE H2B; CELL-DEATH; HOMOLOGOUS RECOMBINATION; CHROMOSOMAL INSTABILITY; OXIDATIVE STRESS; FRAGILE SITES; STEM-CELLS; APOPTOSIS	MLL (myeloid/lymphoid or mixed-lineage leukemia) rearrangements are frequent in therapy-related and childhood acute leukemia, and are associated with poor prognosis. The majority of the rearrangements fall within a 7.3-kb MLL breakpoint cluster region (MLLbcr), particularly in a 0.4-kb hotspot at the intron11-exon12 boundary. The underlying mechanisms are poorly understood, though multiple pathways including early apoptotic signaling, accompanied by high-order DNA fragmentation, have been implicated. We introduced the MLLbcr hotspot in an EGFP-based recombination reporter system and demonstrated enhancement of both spontaneous and genotoxic treatment-induced DNA recombination by the MLLbcr in various human cell types. We identified Endonuclease G (EndoG), an apoptotic nuclease, as an essential factor for MLLbcr-specific DNA recombination after induction of replication stress. We provide evidence for replication stress-induced nuclear accumulation of EndoG, DNA binding by EndoG as well as cleavage of the chromosomal MLLbcr locus in a manner requiring EndoG. We demonstrate additional dependency of MLLbcr breakage on ATM signaling to histone H2B monoubiquitinase RNF20, involved in chromatin relaxation. Altogether our findings provide a novel mechanism underlying MLLbcr destabilization in the cells of origin of leukemogenesis, with replication stress-activated, EndoG-mediated cleavage at the MLLbcr, which may serve resolution of the stalled forks via recombination repair, however, also permits MLL rearrangements.	[Gole, B.; Baumann, C.; Mian, E.; Ireno, C. I.; Wiesmueller, L.] Univ Ulm, Dept Obstet & Gynecol, Gynecol Oncol, D-89075 Ulm, Baden Wuerttemb, Germany	Ulm University	Gole, B (corresponding author), Univ Ulm, Dept Obstet & Gynecol, Gynecol Oncol, Prittwitzstr 43, D-89075 Ulm, Baden Wuerttemb, Germany.	boris.gole@uniklinik-ulm.de; lisa.wiesmueller@uni-ulm.de	Gole, Boris/GWQ-9292-2022	Gole, Boris/0000-0002-2461-6729	German Research Foundation [WI 3099/7-1, WI 3099/7-2]; European/German Space Agency (ESA/DLR); German Ministry of Economy (BMWi) [A0-10-IBER-2, 50WB1225]	German Research Foundation(German Research Foundation (DFG)); European/German Space Agency (ESA/DLR); German Ministry of Economy (BMWi)(Federal Ministry for Economic Affairs and Energy (BMWi))	We thank Daniela Waldraff, Regina Hafele, Rahel Wiehe (all Department of Obstetrics and Gynecology, University of Ulm, Germany) and Dre van der Merwe (Core facility FACS, Medical Faculty, University of Ulm, Germany) for their contributions to this work. This work was supported by the German Research Foundation (WI 3099/7-1, WI 3099/7-2) and by the European/German Space Agency (ESA/DLR) and German Ministry of Economy (BMWi), A0-10-IBER-2 funding 50WB1225.	Abdulwahab A, 2012, CANCER-AM CANCER SOC, V118, P3962, DOI 10.1002/cncr.26735; Akyuz N, 2002, MOL CELL BIOL, V22, P6306, DOI 10.1128/MCB.22.17.6306-6317.2002; Barlow JH, 2013, CELL, V152, P620, DOI 10.1016/j.cell.2013.01.006; Baumann C, 2006, NUCLEIC ACIDS RES, V34, P1036, DOI 10.1093/nar/gkj509; Betti CJ, 2003, CANCER RES, V63, P1377; Boehden GS, 2004, CARCINOGENESIS, V25, P1305, DOI 10.1093/carcin/bgh092; Bolderson E, 2004, HUM MOL GENET, V13, P2937, DOI 10.1093/hmg/ddh316; Britton S, 2009, CANCER RES, V69, P8120, DOI 10.1158/0008-5472.CAN-08-4400; Buttner S, 2007, MOL CELL, V25, P233, DOI 10.1016/j.molcel.2006.12.021; Carrassa L, 2004, CELL CYCLE, V3, P1177; Chernikova SB, 2012, CANCER RES, V72, P2111, DOI 10.1158/0008-5472.CAN-11-2209; Diener T, 2010, EXP GERONTOL, V45, P638, DOI 10.1016/j.exger.2010.03.002; Ezoe S, 2012, INT J ENV RES PUB HE, V9, P2444, DOI 10.3390/ijerph9072444; Fierz B, 2011, NAT CHEM BIOL, V7, P113, DOI 10.1038/NCHEMBIO.501; Flynn RL, 2011, TRENDS BIOCHEM SCI, V36, P133, DOI 10.1016/j.tibs.2010.09.005; Grabarz A, 2012, AM J CANCER RES, V2, P249; Hars ES, 2006, CANCER RES, V66, P8975, DOI 10.1158/0008-5472.CAN-06-1724; Labi V, 2010, GENE DEV, V24, P1602, DOI 10.1101/gad.1940210; Lee JS, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.181; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Libura J, 2008, EUR J HAEMATOL, V81, P185, DOI 10.1111/j.1600-0609.2008.01103.x; Maddams J, 2011, INT J CANCER, V129, P2885, DOI 10.1002/ijc.26240; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Meyer C, 2013, LEUKEMIA, V27, P2165, DOI 10.1038/leu.2013.135; Milyavsky M, 2010, CELL STEM CELL, V7, P186, DOI 10.1016/j.stem.2010.05.016; Mirault ME, 2006, AM J HUM GENET, V79, P779, DOI 10.1086/507791; Mosad E, 2012, ONCOLOGY-BASEL, V83, P128, DOI 10.1159/000338769; Moyal L, 2011, MOL CELL, V41, P529, DOI 10.1016/j.molcel.2011.02.015; Ousset M, 2010, CELL CYCLE, V9, P2814, DOI 10.4161/cc.9.14.12253; Ozeri-Galai E, 2008, ONCOGENE, V27, P2109, DOI 10.1038/sj.onc.1210849; Ozeri-Galai E, 2011, MOL CELL, V43, P122, DOI 10.1016/j.molcel.2011.05.019; RUIZCARRILLO A, 1987, EMBO J, V6, P401, DOI 10.1002/j.1460-2075.1987.tb04769.x; Saintigny Y, 2001, EMBO J, V20, P3861, DOI 10.1093/emboj/20.14.3861; Samejima K, 2005, NAT REV MOL CELL BIO, V6, P677, DOI 10.1038/nrm1715; Shivakumar R, 2008, ANN ONCOL, V19, P1634, DOI 10.1093/annonc/mdn182; Sim SP, 2001, J BIOL CHEM, V276, P31590, DOI 10.1074/jbc.M103962200; Sordet O, 2004, J BIOL CHEM, V279, P50499, DOI 10.1074/jbc.M410277200; Stam RW, 2006, BRIT J HAEMATOL, V132, P539, DOI 10.1111/j.1365-2141.2005.05909.x; Stanulla M, 1997, MOL CELL BIOL, V17, P4070, DOI 10.1128/MCB.17.7.4070; Stanulla M, 2001, HUM MOL GENET, V10, P2481, DOI 10.1093/hmg/10.22.2481; Strissel PL, 1998, BLOOD, V92, P3793, DOI 10.1182/blood.V92.10.3793.422a24_3793_3803; Sun JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013554; Tichy ED, 2013, STEM CELL RES, V10, P428, DOI 10.1016/j.scr.2013.01.010; Varecha M, 2012, MOL CELL BIOCHEM, V363, P301, DOI 10.1007/s11010-011-1182-x; Wu JX, 2009, MOL CELL BIOL, V29, P849, DOI 10.1128/MCB.01302-08; Yang SH, 2006, EXP MOL MED, V38, P435, DOI 10.1038/emm.2006.51; Zan H, 2011, MOL IMMUNOL, V48, P610, DOI 10.1016/j.molimm.2010.10.023; Zhang F, 2009, TRENDS GENET, V25, P298, DOI 10.1016/j.tig.2009.05.005	48	15	15	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2015	34	26					3391	3401		10.1038/onc.2014.268	http://dx.doi.org/10.1038/onc.2014.268			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CL3SU	25132265				2022-12-25	WOS:000356871700005
J	Heinrichs, D; Berres, ML; Coeuru, M; Knauel, M; Nellen, A; Fischer, P; Philippeit, C; Bucala, R; Trautwein, C; Wasmuth, HE; Bernhagen, J				Heinrichs, Daniel; Berres, Marie-Luise; Coeuru, Melanie; Knauel, Meike; Nellen, Andreas; Fischer, Petra; Philippeit, Claudia; Bucala, Richard; Trautwein, Christian; Wasmuth, Hermann E.; Bernhagen, Juergen			Protective role of macrophage migration inhibitory factor in nonalcoholic steatohepatitis	FASEB JOURNAL			English	Article						cytokines; fatty liver; hepatic fibrosis; hepatocyte; inflammation	FATTY LIVER-DISEASE; ACTIVATED PROTEIN-KINASE; HEPATIC STEATOSIS; ADIPOSE-TISSUE; INSULIN-RESISTANCE; CHRONIC INFLAMMATION; LIPID-ACCUMULATION; MIF; MICE; OBESITY	MIF is an inflammatory cytokine but is hepatoprotective in models of hepatotoxin-induced liver fibrosis. Hepatic fibrosis can also develop from metabolic liver disease, such as nonalcoholic fatty liver disease (NASH). We investigated the role of MIF in high-fat or methionine-and choline-deficient diet mouse models of NASH. Mif-/-mice showed elevated liver triglyceride levels (WT, 53 +/- 14 mg/g liver; Mif(-/-), 103 +/- 7 mg/g liver; P<0.05) and a 2-3-fold increased expression of lipogenic genes. Increased fatty degeneration in the livers of Mif(-/-) mice was associated with increased hepatic inflammatory cells (1.6-fold increase in F4/80(+) macrophages) and proinflammatory cytokines (e.g., 2.3-fold increase in Tnf-alpha and 2-fold increase in Il-6 expression). However, inflammatory cells and cytokines were decreased by 50-90% in white adipose tissue (WAT) of Mif(-/-) mice. Subset analysis showed that macrophage phenotypes in livers of Mif(-/-) mice were skewed toward M2 (e.g., 1.7-fold and 2.5-fold increase in Arg1 and Il-13, respectively, and 2.5-fold decrease in iNos), whereas macrophages were generally reduced in WAT of these mice (70% reduction in mRNA expression of F4/80(+) macrophages). The protective MIF effect was scrutinized in isolated hepatocytes. MIF reversed inflammation-induced triglyceride accumulation in Hepa1-6 cells and primary hepatocytes and also attenuated oleic acid-elicited triglyceride increase in 3T3-L1 adipocytes. Protection from fatty hepatocyte degeneration was paralleled by a 2- to 3-fold reduction by MIF of hepatocyte proinflammatory cytokine production. Blockade of MIF receptor cluster of differentiation 74 (CD74) but not of CXCR2 or CXCR4 fully reverted the protective effect of MIF, comparable to AMPK inhibition. In summary, we demonstrate that MIF mediates hepatoprotection through the CD74/AMPK pathway in hepatocytes in metabolic models of liver injury.	[Heinrichs, Daniel; Coeuru, Melanie; Knauel, Meike; Philippeit, Claudia; Bernhagen, Juergen] Rhein Westfal TH Aachen, Inst Biochem & Mol Cell Biol, D-52074 Aachen, Germany; [Heinrichs, Daniel; Berres, Marie-Luise; Nellen, Andreas; Fischer, Petra; Trautwein, Christian; Wasmuth, Hermann E.] Rhein Westfal TH Aachen, Dept Internal Med 3, D-52074 Aachen, Germany; [Bucala, Richard] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA	RWTH Aachen University; RWTH Aachen University; Yale University	Bernhagen, J (corresponding author), Rhein Westfal TH Aachen, Inst Biochem & Mol Cell Biol, Pauwelsstr 30, D-52074 Aachen, Germany.	jbernhagen@ukaachen.de	Berres, Marie-Luise/AAN-5351-2021		Deutsche Forschungsgemeinschaft [SFB-TRR57]; U.S. National Institutes of Health grant [AI042310]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI042310, R01AI042310] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); U.S. National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank all members of the Q platforms of SFB-TRR57 for their help with the immunohistological stainings and cell isolation procedures. This study was supported by Deutsche Forschungsgemeinschaft grant SFB-TRR57 to J.B., M.B., C.T., and H.E.W., as well as U.S. National Institutes of Health grant AI042310 to R.B.	Agarwal N, 2005, HEPATOL RES, V33, P92, DOI 10.1016/j.hepres.2005.09.012; Asare Y, 2013, THROMB HAEMOSTASIS, V109, P391, DOI 10.1160/TH12-11-0831; Assis DN, 2014, HEPATOLOGY, V59, P580, DOI 10.1002/hep.26664; Bacher M, 1997, AM J PATHOL, V150, P235; Barnes MA, 2013, HEPATOLOGY, V57, P1980, DOI 10.1002/hep.26169; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Berres ML, 2010, J CLIN INVEST, V120, P4129, DOI 10.1172/JCI41732; Bijland S, 2013, CLIN SCI, V124, P491, DOI 10.1042/CS20120536; Borghese F, 2011, EXPERT OPIN THER TAR, V15, P237, DOI 10.1517/14728222.2011.550879; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Chandran M, 2003, DIABETES CARE, V26, P2442, DOI 10.2337/diacare.26.8.2442; Cusi K, 2012, GASTROENTEROLOGY, V142, P711, DOI 10.1053/j.gastro.2012.02.003; Day CA, 2002, AM J GASTROENTEROL, V97, P1872; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI23621; Endo M, 2007, EXP BIOL MED, V232, P614; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Fujii H, 2012, J GASTROENTEROL, V47, P215, DOI 10.1007/s00535-012-0527-x; Heinrichs D, 2011, P NATL ACAD SCI USA, V108, P17444, DOI 10.1073/pnas.1107023108; Hori Y, 2003, EUR J HISTOCHEM, V47, P317; Ikeda D, 2008, ENDOCRINOLOGY, V149, P6037, DOI 10.1210/en.2008-0158; Kabir SM, 2014, ADIPOCYTE, V3, P97, DOI 10.4161/adip.28110; Kim JY, 2010, J MOL BIOL, V397, P917, DOI 10.1016/j.jmb.2010.02.016; Lee Yong-Ho, 2005, Curr Diab Rep, V5, P70; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Miller EJ, 2008, NATURE, V451, P578, DOI 10.1038/nature06504; Miura K, 2010, GASTROENTEROLOGY, V139, P323, DOI 10.1053/j.gastro.2010.03.052; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Morand EF, 2006, NAT REV DRUG DISCOV, V5, P399, DOI 10.1038/nrd2029; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nanji AA, 2001, J INTERF CYTOK RES, V21, P1055, DOI 10.1089/107999001317205187; Ricchi M, 2009, J GASTROEN HEPATOL, V24, P830, DOI 10.1111/j.1440-1746.2008.05733.x; Rinella ME, 2008, J LIPID RES, V49, P1068, DOI 10.1194/jlr.M800042-JLR200; Sahin H, 2010, NAT REV GASTRO HEPAT, V7, P682, DOI 10.1038/nrgastro.2010.168; Schaffler A, 2005, NAT CLIN PRACT GASTR, V2, P273, DOI 10.1038/ncpgasthep0186; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Sozio MS, 2010, SEMIN LIVER DIS, V30, P378, DOI 10.1055/s-0030-1267538; Takahashi Y, 2012, WORLD J GASTROENTERO, V18, P2300, DOI 10.3748/wjg.v18.i19.2300; Tanaka Y, 2008, J PHARMACOL EXP THER, V325, P655, DOI 10.1124/jpet.107.135822; Trayhurn P, 2013, PHYSIOL REV, V93, P1, DOI 10.1152/physrev.00017.2012; Verschuren L, 2009, CIRC RES, V105, P99, DOI 10.1161/CIRCRESAHA.109.199166; Walenbergh SMA, 2013, J HEPATOL, V58, P801, DOI 10.1016/j.jhep.2012.11.014; Xu AM, 2003, J CLIN INVEST, V112, P91, DOI 10.1172/JCI200317797; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yaddanapudi K, 2013, J IMMUNOL, V190, P2984, DOI 10.4049/jimmunol.1201650; Zernecke A, 2008, CIRCULATION, V117, P1594, DOI 10.1161/CIRCULATIONAHA.107.729125	45	39	39	1	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2014	28	12					5136	5147		10.1096/fj.14-256776	http://dx.doi.org/10.1096/fj.14-256776			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AU9EN	25122558	Green Published			2022-12-25	WOS:000345894500010
J	Hanihara-Tatsuzawa, F; Miura, H; Kobayashi, S; Isagawa, T; Okuma, A; Manabe, I; MaruYama, T				Hanihara-Tatsuzawa, Fumito; Miura, Hanae; Kobayashi, Shuhei; Isagawa, Takayuki; Okuma, Atsushi; Manabe, Ichiro; MaruYama, Takashi			Control of Toll-like Receptor-mediated T Cell-independent Type 1 Antibody Responses by the Inducible Nuclear Protein I kappa B-zeta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASS-SWITCH RECOMBINATION; HUMORAL IMMUNE-RESPONSE; VIVO CD40-GP39 INTERACTIONS; CYTIDINE DEAMINASE AID; STREPTOCOCCUS-PNEUMONIAE; DNA RECOMBINATION; MESSENGER-RNA; GENE-EXPRESSION; ACTIVATION; TRANSCRIPTION	Antibody responses have been classified as being either T cell-dependent or T cell-independent (TI). TI antibody responses are further classified as being either type 1 (TI-1) or type 2 (TI-2), depending on their requirement for B cell-mediated antigen receptor signaling. Although the mechanistic basis of antibody responses has been studied extensively, it remains unclear whether different antibody responses share similarities in their transcriptional regulation. Here, we show that mice deficient in I kappa B-zeta, specifically in their B cells, have impaired TI-1 antibody responses but normal T cell-dependent and TI-2 antibody responses. The absence of I kappa B-zeta in B cells also impaired proliferation triggered by Toll-like receptor (TLR) activation, plasma cell differentiation, and class switch recombination (CSR). Mechanistically, I kappa B-zeta-deficient B cells could not induce TLR-mediated induction of activation-induced cytidine deaminase (AID), a class-switch DNA recombinase. Retroviral transduction of AID in I kappa B-zeta-deficient B cells restored CSR activity. Furthermore, acetylation of histone H3 in the vicinity of the transcription start site of the gene that encodes AID was reduced in I kappa B-zeta-deficient B cells relative to I kappa B-zeta-expressing B cells. These results indicate that I kappa B-zeta regulates TLR-mediated CSR by inducing AID. Moreover, I kappa B-zeta defines differences in the transcriptional regulation of different antibody responses.	[Hanihara-Tatsuzawa, Fumito; Miura, Hanae; Kobayashi, Shuhei; Okuma, Atsushi; MaruYama, Takashi] Tohoku Univ, Grad Sch Life Sci, Dept Dev Biol & Neurosci, Lab Cell Recognit & Response, Sendai, Miyagi 9808578, Japan; [Isagawa, Takayuki] Tokyo Med & Dent Univ, Med Res Inst, Dept Genom Pathol, Tokyo 1138510, Japan; [Manabe, Ichiro] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo 38655, Japan; [MaruYama, Takashi] Gifu Univ, Sch Med, Lab Cell Signaling, Gifu 5011194, Japan	Tohoku University; Tokyo Medical & Dental University (TMDU); University of Tokyo; Gifu University	MaruYama, T (corresponding author), Gifu Univ, Sch Med, Lab Cell Signaling, Gifu 5011194, Japan.	ta-maru@umin.ac.jp	Manabe, Ichiro/E-1529-2014; Manabe, Ichiro/AAE-5105-2021; Okuma, Atsushi/V-4675-2019; MaruYama, Takashi/N-5994-2014; Okuma, Atsushi/N-7583-2018	Okuma, Atsushi/0000-0002-9086-1781; MaruYama, Takashi/0000-0003-0820-3219; Okuma, Atsushi/0000-0002-9086-1781	Ministry of Education, Culture, Sports, Science and Technology of Japan [21117004]; Ministry of Education [25118702]; Japan Society for the Promotion of Science [24790458]; Takeda Science Foundation, the Uehara Memorial Foundation [10J06513]; Novartis Foundation; Sumitomo Foundation; Joint Research Program 2024 of the Institute for Molecular and Cellular Regulation, Gunma University	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation, the Uehara Memorial Foundation; Novartis Foundation(Novartis); Sumitomo Foundation; Joint Research Program 2024 of the Institute for Molecular and Cellular Regulation, Gunma University	This work was supported by a Grant-in-aid for Scientific Research on Innovative Areas 21117004 from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to T. M.), Grant-in-aid for Scientific Research on Innovative Areas 25118702 from the Ministry of Education (to T. M. Y.), Grant-in-aid for Young Scientists (B) 24790458 from the Japan Society for the Promotion of Science (to T. M. Y.), Grant-in-aid for JSPS Fellows 10J06513 (to F. H.-T.), grants from the Takeda Science Foundation, the Uehara Memorial Foundation, the Novartis Foundation, and the Sumitomo Foundation (to T. M. Y.), and by Joint Research Program 2024 of the Institute for Molecular and Cellular Regulation, Gunma University.	Allman D, 2008, CURR OPIN IMMUNOL, V20, P149, DOI 10.1016/j.coi.2008.03.014; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bekeredjian-Ding I, 2009, IMMUNOLOGY, V128, P311, DOI 10.1111/j.1365-2567.2009.03173.x; BRILES DE, 1981, J EXP MED, V153, P694, DOI 10.1084/jem.153.3.694; COUTINHO A, 1974, J EXP MED, V139, P74, DOI 10.1084/jem.139.1.74; Crouch EE, 2007, J EXP MED, V204, P1145, DOI 10.1084/jem.20061952; Dhamija S, 2010, J BIOL CHEM, V285, P29165, DOI 10.1074/jbc.M110.146365; FOY TM, 1993, J EXP MED, V178, P1567, DOI 10.1084/jem.178.5.1567; Hanihara F, 2013, INT IMMUNOL, V25, P531, DOI 10.1093/intimm/dxt017; Hobeika E, 2006, P NATL ACAD SCI USA, V103, P13789, DOI 10.1073/pnas.0605944103; Ise W, 2011, NAT IMMUNOL, V12, P536, DOI 10.1038/ni.2037; Khan AQ, 2005, INFECT IMMUN, V73, P298, DOI 10.1128/IAI.73.1.298-307.2005; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; Lafarge S, 2011, CLIN EXP IMMUNOL, V166, P171, DOI 10.1111/j.1365-2249.2011.04465.x; Martin F, 2001, IMMUNITY, V14, P617, DOI 10.1016/S1074-7613(01)00129-7; Miyake T, 2010, P NATL ACAD SCI USA, V107, P17680, DOI 10.1073/pnas.1012977107; MOND JJ, 1995, ANNU REV IMMUNOL, V13, P655, DOI 10.1146/annurev.iy.13.040195.003255; MOSIER DE, 1977, J IMMUNOL, V119, P1874; Motoyama M, 2005, J BIOL CHEM, V280, P7444, DOI 10.1074/jbc.M412738200; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Muto A, 2004, NATURE, V429, P566, DOI 10.1038/nature02596; Nogai H, 2013, BLOOD, V122, P2242, DOI 10.1182/blood-2013-06-508028; Ohba T, 2012, FEBS J, V279, P211, DOI 10.1111/j.1742-4658.2011.08416.x; Okamoto K, 2010, NATURE, V464, P1381, DOI 10.1038/nature08922; Okuma A, 2013, IMMUNITY, V38, P450, DOI 10.1016/j.immuni.2012.11.016; Park SR, 2009, NAT IMMUNOL, V10, P540, DOI 10.1038/ni.1725; Picard C, 2010, MEDICINE, V89, P403, DOI 10.1097/MD.0b013e3181fd8ec3; Pone EJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1769; Pone EJ, 2010, CRIT REV IMMUNOL, V30, P1; Ruan QG, 2011, J EXP MED, V208, P2321, DOI 10.1084/jem.20110462; Sciammas R, 2006, IMMUNITY, V25, P225, DOI 10.1016/j.immuni.2006.07.009; Sen G, 2005, J IMMUNOL, V175, P3084, DOI 10.4049/jimmunol.175.5.3084; Shapiro-Shelef M, 2005, NAT REV IMMUNOL, V5, P230, DOI 10.1038/nri1572; Tatemichi M, 2011, ONCOL REP, V25, P153, DOI 10.3892/or_00001055; Totzke G, 2006, J BIOL CHEM, V281, P12645, DOI 10.1074/jbc.M511956200; Tran TH, 2010, NAT IMMUNOL, V11, P148, DOI 10.1038/ni.1829; VANDENEERTWEGH AJM, 1993, J EXP MED, V178, P1555, DOI 10.1084/jem.178.5.1555; Vasilevsky S, 2008, EUR J IMMUNOL, V38, P3316, DOI 10.1002/eji.200838484; Vos Q, 2000, IMMUNOL REV, V176, P154; Watanabe S, 2007, BIOCHEM BIOPH RES CO, V356, P785, DOI 10.1016/j.bbrc.2007.03.044; Xu ZM, 2012, NAT REV IMMUNOL, V12, P517, DOI 10.1038/nri3216; Yamamoto M, 2004, NATURE, V430, P218, DOI 10.1038/nature02738; Yamazaki S, 2001, J BIOL CHEM, V276, P27657, DOI 10.1074/jbc.M103426200; Yamazaki S, 2005, J BIOL CHEM, V280, P1678, DOI 10.1074/jbc.M409983200	45	17	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					30925	30936		10.1074/jbc.M114.553230	http://dx.doi.org/10.1074/jbc.M114.553230			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25124037	Green Published, hybrid			2022-12-25	WOS:000344549900005
J	Alvarado, JJ; Tarafdar, S; Yeh, JI; Smithgall, TE				Alvarado, John Jeff; Tarafdar, Sreya; Yeh, Joanne I.; Smithgall, Thomas E.			Interaction with the Src Homology (SH3-SH2) Region of the Src-family Kinase Hck Structures the HIV-1 Nef Dimer for Kinase Activation and Effector Recruitment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CRYSTAL-STRUCTURE; TYROSINE KINASE; SH3 DOMAIN; DOWN-REGULATION; TYPE-1 NEF; C-SRC; PROTEIN; BINDING; SURFACE	HIV-1 Nef supports high titer viral replication in vivo and is essential for AIDS progression. Nef function depends on interactions with multiple host cell effectors, including Hck and other Src-family kinases. Here we describe the x-ray crystal structure of Nef in complex with the Hck SH3-SH2 regulatory region to a resolution of 1.86 angstrom. The complex crystallized as a dimer of complexes, with the conserved Nef PXXPXR motif engaging the Hck SH3 domain. Anew intercomplex contact was found between SH3 Glu-93, and Nef Arg-105. Mutagenesis of Hck SH3 Glu-93 interfered with Nef.Hck complex formation and kinase activation in cells. The Hck SH2 domains impinge on the N-terminal region of Nef to stabilize a dimer conformation that exposes Asp-123, a residue critical for Nef function. Our results suggest that in addition to serving as a kinase effector for Nef, Hck binding may reorganize the Nef dimer for functional interaction with other signaling partners.	[Alvarado, John Jeff; Tarafdar, Sreya; Smithgall, Thomas E.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15219 USA; [Alvarado, John Jeff; Yeh, Joanne I.] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15219 USA; [Tarafdar, Sreya] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Infect Dis & Microbiol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Yeh, JI (corresponding author), Univ Pittsburgh, Sch Med, Dept Biol Struct, 1036 BST3,3501 5th Ave, Pittsburgh, PA 15260 USA.	jiyeh@pitt.edu; tsmithga@pitt.edu			National Institutes of Health [AI057083, AI102724]; University of Pittsburgh Center for HIV Protein Interactions (National Institutes of Health) [P50 GM082251]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057083, R01AI102724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082251] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pittsburgh Center for HIV Protein Interactions (National Institutes of Health); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI057083 and AI102724. Initial phases of this work were supported by a pilot grant from the University of Pittsburgh Center for HIV Protein Interactions (National Institutes of Health P50 GM082251).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alvarado JJ, 2010, J BIOL CHEM, V285, P35455, DOI 10.1074/jbc.M110.145102; Arold S, 1997, STRUCTURE, V5, P1361, DOI 10.1016/S0969-2126(97)00286-4; Arold ST, 2001, TRENDS BIOCHEM SCI, V26, P356, DOI 10.1016/S0968-0004(01)01846-1; Arold ST, 2001, J BIOL CHEM, V276, P17199, DOI 10.1074/jbc.M011185200; Briggs SD, 1997, J BIOL CHEM, V272, P17899, DOI 10.1074/jbc.272.29.17899; Choi HJ, 2004, J MOL BIOL, V343, P1255, DOI 10.1016/j.jmb.2004.09.015; Collins KL, 1999, IMMUNOL REV, V168, P65, DOI 10.1111/j.1600-065X.1999.tb01283.x; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988; Dikeakos JD, 2010, MOL BIOL CELL, V21, P3279, DOI 10.1091/mbc.E10-05-0470; ECK MJ, 1994, NATURE, V368, P764, DOI 10.1038/368764a0; Emert-Sedlak L, 2009, ACS CHEM BIOL, V4, P939, DOI 10.1021/cb900195c; Emert-Sedlak LA, 2013, CHEM BIOL, V20, P82, DOI 10.1016/j.chembiol.2012.11.005; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faraldo-Gomez JD, 2007, P NATL ACAD SCI USA, V104, P13643, DOI 10.1073/pnas.0704041104; Fushman D, 1999, BIOCHEMISTRY-US, V38, P10225, DOI 10.1021/bi990897g; Geyer M, 2001, EMBO REP, V2, P580, DOI 10.1093/embo-reports/kve141; Geyer M, 2001, FEBS LETT, V496, P91, DOI 10.1016/S0014-5793(01)02394-8; Grzesiek S, 1996, NAT STRUCT BIOL, V3, P340, DOI 10.1038/nsb0496-340; Hanna Z, 2001, J VIROL, V75, P9378, DOI 10.1128/JVI.75.19.9378-9392.2001; Hanna Z, 1998, CELL, V95, P163, DOI 10.1016/S0092-8674(00)81748-1; Hochrein JM, 2006, PROTEIN SCI, V15, P65, DOI 10.1110/ps.051782206; Hofmann G, 2005, BIOCHEMISTRY-US, V44, P13043, DOI 10.1021/bi050814y; Horenkamp FA, 2011, TRAFFIC, V12, P867, DOI 10.1111/j.1600-0854.2011.01205.x; Hung CH, 2007, CELL HOST MICROBE, V1, P121, DOI 10.1016/j.chom.2007.03.004; Jason-Moller L., 2006, CURR PROTOC PROTEIN, P1, DOI [10.1002/0471140864.ps1913-45, DOI 10.1002/0471140864.PS1913-45, 10.1002/0471142301.ps1914s45]; Jia XF, 2012, NAT STRUCT MOL BIOL, V19, P701, DOI 10.1038/nsmb.2328; Jolicoeur P, 2011, CURR HIV RES, V9, P524, DOI 10.2174/157016211798842062; Jung JW, 2011, PROTEINS, V79, P1609, DOI 10.1002/prot.22986; Kerppola TK, 2008, ANNU REV BIOPHYS, V37, P465, DOI 10.1146/annurev.biophys.37.032807.125842; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; KIRCHHOFF F, 1995, NEW ENGL J MED, V332, P228, DOI 10.1056/NEJM199501263320405; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEE CH, 1995, EMBO J, V14, P5006, DOI 10.1002/j.1460-2075.1995.tb00183.x; Lee CH, 1996, CELL, V85, P931, DOI 10.1016/S0092-8674(00)81276-3; Lerner EC, 2002, NAT STRUCT BIOL, V9, P365, DOI 10.1038/nsb782; Liu LX, 2000, J VIROL, V74, P5310, DOI 10.1128/JVI.74.11.5310-5319.2000; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Meiselbach H, 2011, J MOL MODEL, V17, P1927, DOI 10.1007/s00894-010-0897-z; Michel N, 2005, CURR BIOL, V15, P714, DOI 10.1016/j.cub.2005.02.058; Moarefi I, 1997, NATURE, V385, P650, DOI 10.1038/385650a0; Murphy Michael, 2006, Curr Protoc Protein Sci, VChapter 19, DOI 10.1002/0471142301.ps1914s45; Narute PS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032561; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pene-Dumitrescu Teodora, 2012, BMC Chemical Biology, V12, P1, DOI 10.1186/1472-6769-12-1; Poe JA, 2009, J MOL BIOL, V394, P329, DOI 10.1016/j.jmb.2009.09.047; Rekas A, 2002, J BIOL CHEM, V277, P50573, DOI 10.1074/jbc.M209524200; Ren XF, 2014, ELIFE, V3, DOI 10.7554/eLife.01754; Renkema GH, 2000, FRONT BIOSCI-LANDMRK, V5, pD268, DOI 10.2741/Renkema; SAKSELA K, 1995, EMBO J, V14, P484, DOI 10.1002/j.1460-2075.1995.tb07024.x; Saksela K, 2011, CURR HIV RES, V9, P531, DOI 10.2174/157016211798842107; Schindler T, 1999, MOL CELL, V3, P639, DOI 10.1016/S1097-2765(00)80357-3; SHUGARS DC, 1993, J VIROL, V67, P4639, DOI 10.1128/JVI.67.8.4639-4650.1993; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Trible RP, 2006, J BIOL CHEM, V281, P27029, DOI 10.1074/jbc.M601128200; Trible RP, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-135; Ulmer TS, 2002, STRUCTURE, V10, P901, DOI 10.1016/S0969-2126(02)00781-5; Venzke S, 2006, J VIROL, V80, P11141, DOI 10.1128/JVI.01556-06; Williams JC, 1997, J MOL BIOL, V274, P757, DOI 10.1006/jmbi.1997.1426; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Yang SC, 2010, P NATL ACAD SCI USA, V107, P15757, DOI 10.1073/pnas.1004569107; Young MA, 2001, CELL, V105, P115, DOI 10.1016/S0092-8674(01)00301-4	64	30	31	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28539	28553		10.1074/jbc.M114.600031	http://dx.doi.org/10.1074/jbc.M114.600031			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25122770	Green Published, hybrid			2022-12-25	WOS:000343765400044
J	Furlan, G; Minowa, T; Hanagata, N; Kataoka-Hamai, C; Kaizuka, Y				Furlan, Gabriela; Minowa, Takashi; Hanagata, Nobutaka; Kataoka-Hamai, Chiho; Kaizuka, Yoshihisa			Phosphatase CD45 Both Positively and Negatively Regulates T Cell Receptor Phosphorylation in Reconstituted Membrane Protein Clusters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACULOVIRUS EXPRESSION SYSTEM; TYROSINE-PHOSPHATASE; SIGNAL-TRANSDUCTION; KINASE LCK; ANTIGEN RECEPTOR; ALPHA-SYNUCLEIN; ZETA-CHAIN; LYMPHOCYTE; ACTIVATION; MICROCLUSTERS	T cell receptor (TCR) phosphorylation requires the kinase Lck and phosphatase CD45. CD45 activates Lck by dephosphorylating an inhibitory tyrosine of Lck to relieve autoinhibition. However, CD45 also dephosphorylates the TCR, and the spatial exclusion of CD45 from TCR clustering in the plasma membrane appears to attenuate this negative effect of CD45. To further investigate the role of CD45 in signal initiation, we reconstituted membrane TCR clusters in vitro on supported lipid bilayers. Fluorescence microscopy of single clusters showed that incorporation of CD45 enhanced phosphorylation of TCR clusters, but only when Lck co-clustered with TCR. We found that clustered Lck autophosphorylated the inhibitory tyrosine and thus could be activated by CD45, whereas diffusive Lck molecules did not. In the TCR-Lck clusters and at low CD45 density, we speculate that the effect of Lck activation may overcome dephosphorylation of TCR, resulting in a net positive regulation. The CD45 density in physiological TCR clusters is also low because of the exclusion of CD45. Thus, we propose that the spatial organization of TCR/Lck/CD45 in T cell membranes is important not only for modulating the negative role of CD45 but also for creating conditions in which CD45 has a positive role in signal initiation.	[Furlan, Gabriela; Minowa, Takashi; Hanagata, Nobutaka; Kataoka-Hamai, Chiho; Kaizuka, Yoshihisa] Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton, Tsukuba, Ibaraki 3050047, Japan	National Institute for Materials Science	Kaizuka, Y (corresponding author), Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton, Tsukuba, Ibaraki 3050047, Japan.	KAIZUKA.Yoshihisa@nims.go.jp	KAIZUKA, Yoshihisa/H-2789-2011; Kataoka-Hamai, Chiho/H-2761-2011	Kataoka-Hamai, Chiho/0000-0002-4068-0405; Minowa, Takashi/0000-0003-0046-5230; Hanagata, Nobutaka/0000-0001-6079-3426	Sumitomo foundation	Sumitomo foundation	This work was supported by a grant from the Sumitomo foundation (to Y. K.).	Alexander DR, 2000, SEMIN IMMUNOL, V12, P349, DOI 10.1006/smim.2000.0218; Altan-Bonnet G, 2005, PLOS BIOL, V3, P1925, DOI 10.1371/journal.pbio.0030356; Berry H, 2002, BIOPHYS J, V83, P1891, DOI 10.1016/S0006-3495(02)73953-2; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; Choudhuri K, 2005, NATURE, V436, P578, DOI 10.1038/nature03843; Comellas G, 2012, J AM CHEM SOC, V134, P5090, DOI 10.1021/ja209019s; D'Oro U, 1999, J IMMUNOL, V162, P1879; Davis SJ, 1996, IMMUNOL TODAY, V17, P177, DOI 10.1016/0167-5699(96)80617-7; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; FURUKAWA T, 1994, P NATL ACAD SCI USA, V91, P10928, DOI 10.1073/pnas.91.23.10928; Galush WJ, 2008, BIOPHYS J, V95, P2512, DOI 10.1529/biophysj.108.131540; Housden HR, 2003, EUR J BIOCHEM, V270, P2369, DOI 10.1046/j.1432-1033.2003.03604.x; Hui EF, 2014, NAT STRUCT MOL BIOL, V21, P133, DOI 10.1038/nsmb.2762; Ike H, 2003, CHEMPHYSCHEM, V4, P620, DOI 10.1002/cphc.200300670; Isakov N, 1996, J BIOL CHEM, V271, P15753, DOI 10.1074/jbc.271.26.15753; James JR, 2012, NATURE, V487, P64, DOI 10.1038/nature11220; Kaizuka Y, 2007, P NATL ACAD SCI USA, V104, P20296, DOI 10.1073/pnas.0710258105; KISHIHARA K, 1993, CELL, V74, P143, DOI 10.1016/0092-8674(93)90302-7; KORETZKY GA, 1990, NATURE, V346, P66, DOI 10.1038/346066a0; Lipowsky R., 1995, HDB BIOL PHYS; McConnell HM, 2003, ANNU REV BIOPH BIOM, V32, P469, DOI 10.1146/annurev.biophys.32.110601.141704; McNeill L, 2007, IMMUNITY, V27, P425, DOI 10.1016/j.immuni.2007.07.015; Nika K, 2010, IMMUNITY, V32, P766, DOI 10.1016/j.immuni.2010.05.011; OSUSKY M, 1995, J BIOL CHEM, V270, P25729, DOI 10.1074/jbc.270.43.25729; Pandey AP, 2009, BIOPHYS J, V96, P540, DOI 10.1016/j.bpj.2008.10.011; PINGEL JT, 1989, CELL, V58, P1055, DOI 10.1016/0092-8674(89)90504-7; RAMER SE, 1991, P NATL ACAD SCI USA, V88, P6254, DOI 10.1073/pnas.88.14.6254; Rossy J, 2013, NAT IMMUNOL, V14, P82, DOI 10.1038/ni.2488; Samelson LE, 2002, ANNU REV IMMUNOL, V20, P371, DOI 10.1146/annurev.immunol.20.092601.111357; SOUMPASIS DM, 1983, BIOPHYS J, V41, P95, DOI 10.1016/S0006-3495(83)84410-5; Stirnweiss A, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003607; Straus DB, 1996, J BIOL CHEM, V271, P9976, DOI 10.1074/jbc.271.17.9976; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; VEILLETTE A, 1989, MOL CELL BIOL, V9, P4441, DOI 10.1128/MCB.9.10.4441; WANG D, 1992, BIOPHYS CHEM, V43, P117, DOI 10.1016/0301-4622(92)80027-3; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Williams A.F., 1986, HDB EXPT IMMUNOLOGY; Xu CQ, 2008, CELL, V135, P702, DOI 10.1016/j.cell.2008.09.044; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272; Zikherman J, 2010, IMMUNITY, V32, P342, DOI 10.1016/j.immuni.2010.03.006	41	20	20	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28514	28525		10.1074/jbc.M114.574319	http://dx.doi.org/10.1074/jbc.M114.574319			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25128530	hybrid, Green Published			2022-12-25	WOS:000343765400042
J	Trujillo, JA; Croft, NP; Dudek, NL; Channappanavar, R; Theodossis, A; Webb, AI; Dunstone, MA; Illing, PT; Butler, NS; Fett, C; Tscharke, DC; Rossjohn, J; Perlman, S; Purcell, AW				Trujillo, Jonathan A.; Croft, Nathan P.; Dudek, Nadine L.; Channappanavar, Rudragouda; Theodossis, Alex; Webb, Andrew I.; Dunstone, Michelle A.; Illing, Patricia T.; Butler, Noah S.; Fett, Craig; Tscharke, David C.; Rossjohn, Jamie; Perlman, Stanley; Purcell, Anthony W.			The Cellular Redox Environment Alters Antigen Presentation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antigen Presentation; Antigen Processing; Glutathionylation; Mass Spectrometry (MS); Oxidation-Reduction (Redox); Redox Regulation; T-cell; Viral Immunology	UNFOLDED PROTEIN RESPONSE; CLASS-I; T-CELLS; OXIDATIVE STRESS; GLUTATHIONE DISULFIDE; CYSTEINE RESIDUES; MOLECULAR-BASIS; A-CHAIN; VIRUS; PEPTIDE	Cysteine-containing peptides represent an important class of T cell epitopes, yet their prevalence remains underestimated. We have established and interrogated a database of around 70,000 naturally processed MHC-bound peptides and demonstrate that cysteine-containing peptides are presented on the surface of cells in an MHC allomorph-dependent manner and comprise on average 5-10% of the immunopeptidome. A significant proportion of these peptides are oxidatively modified, most commonly through covalent linkage with the antioxidant glutathione. Unlike some of the previously reported cysteine-based modifications, this represents a true physiological alteration of cysteine residues. Furthermore, our results suggest that alterations in the cellular redox state induced by viral infection are communicated to the immune system through the presentation of S-glutathionylated viral peptides, resulting in altered T cell recognition. Our data provide a structural basis for how the glutathione modification alters recognition by virus-specific T cells. Collectively, these results suggest that oxidative stress represents a mechanism for modulating the virus-specific T cell response.	[Trujillo, Jonathan A.; Channappanavar, Rudragouda; Butler, Noah S.; Fett, Craig; Perlman, Stanley] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; [Trujillo, Jonathan A.; Perlman, Stanley] Univ Iowa, Interdisciplinary Program Immunol, Iowa City, IA 52242 USA; [Croft, Nathan P.; Dudek, Nadine L.; Webb, Andrew I.; Illing, Patricia T.; Purcell, Anthony W.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia; [Croft, Nathan P.; Dudek, Nadine L.; Theodossis, Alex; Dunstone, Michelle A.; Rossjohn, Jamie; Purcell, Anthony W.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Tscharke, David C.; Rossjohn, Jamie] Monash Univ, Australian Res Council Ctr Excellence Adv Mol Ima, Clayton, Vic 3800, Australia; [Butler, Noah S.] Australian Natl Univ, Res Sch Biol, Canberra, ACT 0200, Australia; [Rossjohn, Jamie] Cardiff Univ, Inst Infect & Immun, Sch Med, Cardiff CF14 4XN, S Glam, Wales	University of Iowa; University of Iowa; University of Melbourne; Monash University; Monash University; Australian National University; Cardiff University	Perlman, S (corresponding author), Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA.	Stanley-perlman@uiowa.edu; anthony.purcell@monash.edu	Croft, Nathan/K-3846-2019; Illing, Patricia/AAP-6045-2021; Tscharke, David/C-9133-2009; Rossjohn, Jamie/F-9032-2013; Purcell, Anthony/AAH-1942-2019; Dunstone, Michelle/I-2895-2014	Croft, Nathan/0000-0002-2128-5127; Illing, Patricia/0000-0002-3870-0796; Tscharke, David/0000-0001-6825-9172; Rossjohn, Jamie/0000-0002-2020-7522; Purcell, Anthony/0000-0003-0532-8331; Dunstone, Michelle/0000-0002-6026-648X; Perlman, Stanley/0000-0003-4213-2354; Trujillo, Jonathan/0000-0002-0184-9773; Butler, Noah/0000-0002-1429-0796	National Institutes of Health [R01 NS036592]; Australian Research Council (ARC) [LE100100036]; Juvenile Diabetes Research Foundation [17-2012-134]; National Institutes of Health National Research Service Award [AI093129]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036592] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian Research Council (ARC)(Australian Research Council); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); National Institutes of Health National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 NS036592. This work was also supported by an infrastructure grant (Grant LE100100036) from the Australian Research Council (ARC) and a project grant from the Juvenile Diabetes Research Foundation (17-2012-134).; Supported by National Institutes of Health National Research Service Award AI093129.	Abdalla MY, 2005, J MED VIROL, V76, P489, DOI 10.1002/jmv.20388; Afonine PV, 2005, ACTA CRYSTALLOGR D, V61, P850, DOI 10.1107/S0907444905007894; Ambrose RL, 2011, J VIROL, V85, P2723, DOI 10.1128/JVI.02050-10; ANDERSON ME, 1985, METHOD ENZYMOL, V113, P548; Anderson RP, 2000, NAT MED, V6, P337, DOI 10.1038/73200; Anghelina D, 2006, AM J PATHOL, V169, P209, DOI 10.2353/ajpath.2006.051308; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bergmann CC, 2006, NAT REV MICROBIOL, V4, P121, DOI 10.1038/nrmicro1343; Bowen DG, 2005, J EXP MED, V201, P1709, DOI 10.1084/jem.20050808; Broughton SE, 2012, IMMUNITY, V37, P611, DOI 10.1016/j.immuni.2012.07.013; BUHL R, 1989, LANCET, V2, P1294; Burnett HF, 2012, CELL STRESS CHAPERON, V17, P473, DOI 10.1007/s12192-012-0324-8; Butler NS, 2008, J IMMUNOL, V180, P3926, DOI 10.4049/jimmunol.180.6.3926; Butler NS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000186; Campos-Perez J, 2013, INT J CANCER, V133, P1400, DOI 10.1002/ijc.28156; CASTRO RF, 1995, J VIROL, V69, P8127, DOI 10.1128/JVI.69.12.8127-8131.1995; Chen WS, 1999, J EXP MED, V189, P1757, DOI 10.1084/jem.189.11.1757; Davis DA, 2003, J VIROL, V77, P3319, DOI 10.1128/JVI.77.5.3319-3325.2003; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeDiego ML, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002315; Depontieu FR, 2009, P NATL ACAD SCI USA, V106, P12073, DOI 10.1073/pnas.0903852106; Dudek NL, 2012, DIABETES, V61, P3018, DOI 10.2337/db11-1333; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gelderman KA, 2007, ANTIOXID REDOX SIGN, V9, P1541, DOI 10.1089/ars.2007.1569; Ghezzi P, 2002, MOL IMMUNOL, V38, P773, DOI 10.1016/S0161-5890(01)00114-6; Gong GZ, 2001, P NATL ACAD SCI USA, V98, P9599, DOI 10.1073/pnas.171311298; Gonzalez-Dosal R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002250; Goulder PJR, 2004, NAT REV IMMUNOL, V4, P630, DOI 10.1038/nri1417; GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6; Haque MA, 2001, J IMMUNOL, V166, P4543, DOI 10.4049/jimmunol.166.7.4543; Harada M, 2004, J IMMUNOL, V172, P2659, DOI 10.4049/jimmunol.172.4.2659; Hassan IH, 2012, J BIOL CHEM, V287, P4679, DOI 10.1074/jbc.M111.284695; Henderson KN, 2007, IMMUNITY, V27, P23, DOI 10.1016/j.immuni.2007.05.015; Illing PT, 2012, NATURE, V486, P554, DOI 10.1038/nature11147; Kim KW, 2012, ENVIRON GEOCHEM HLTH, V34, P1, DOI 10.1007/s10653-011-9402-6; Kittlesen DJ, 1998, J IMMUNOL, V160, P2099; La Gruta NL, 2007, IMMUNOL CELL BIOL, V85, P85, DOI 10.1038/sj.icb.7100026; Lassoued S, 2008, MOL CELL BIOCHEM, V313, P179, DOI 10.1007/s11010-008-9755-z; Lawless MW, 2012, CYTOKINE, V59, P195, DOI 10.1016/j.cyto.2012.04.003; Macdonald WA, 2003, J EXP MED, V198, P679, DOI 10.1084/jem.20030066; Mannering SI, 2009, CLIN EXP IMMUNOL, V156, P226, DOI 10.1111/j.1365-2249.2009.03907.x; Mannering SI, 2005, J EXP MED, V202, P1191, DOI 10.1084/jem.20051251; Meadows L, 1997, IMMUNITY, V6, P273, DOI 10.1016/S1074-7613(00)80330-1; Merquiol E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024660; Mieyal JJ, 2008, ANTIOXID REDOX SIGN, V10, P1941, DOI 10.1089/ars.2008.2089; Mieyal JJ, 2012, ANTIOXID REDOX SIGN, V16, P471, DOI 10.1089/ars.2011.4454; Mohammed F, 2008, NAT IMMUNOL, V9, P1236, DOI 10.1038/ni.1660; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perlman S, 2005, NAT REV IMMUNOL, V5, P917, DOI 10.1038/nri1732; Petersen J, 2014, NAT STRUCT MOL BIOL, V21, P480, DOI 10.1038/nsmb.2817; Petersen J, 2009, J MOL MED, V87, P1045, DOI 10.1007/s00109-009-0526-4; Petersen J, 2009, P NATL ACAD SCI USA, V106, P2776, DOI 10.1073/pnas.0812901106; Pewe L, 1999, VIROLOGY, V255, P106, DOI 10.1006/viro.1998.9576; Pewe LL, 2004, J IMMUNOL, V172, P3151, DOI 10.4049/jimmunol.172.5.3151; Pierce RA, 1999, J IMMUNOL, V163, P6360; Purcell AW, 2007, NAT REV DRUG DISCOV, V6, P404, DOI 10.1038/nrd2224; Purcell AW, 2001, J IMMUNOL, V166, P1016, DOI 10.4049/jimmunol.166.2.1016; Qian ZK, 2012, J VIROL, V86, P6712, DOI 10.1128/JVI.00200-12; Qiao SW, 2009, CURR OPIN IMMUNOL, V21, P111, DOI 10.1016/j.coi.2009.03.004; Saeed M, 2011, J BIOL CHEM, V286, P37264, DOI 10.1074/jbc.M111.259085; Sakai J, 2012, IMMUNITY, V37, P1037, DOI 10.1016/j.immuni.2012.08.017; Scally SW, 2013, J EXP MED, V210, P2569, DOI 10.1084/jem.20131241; Scull KE, 2012, MOL IMMUNOL, V51, P136, DOI 10.1016/j.molimm.2012.02.117; Shelton MD, 2008, MOL CELLS, V25, P332; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Suzuki A, 2003, NAT GENET, V34, P395, DOI 10.1038/ng1206; Tan CT, 2011, PROTEOMICS, V11, P2336, DOI 10.1002/pmic.201000531; Theodossis A, 2010, P NATL ACAD SCI USA, V107, P5534, DOI 10.1073/pnas.1000032107; Trujillo JA, 2014, J IMMUNOL, V192, P5245, DOI 10.4049/jimmunol.1400111; Trujillo-Alonso V, 2011, J VIROL, V85, P12594, DOI 10.1128/JVI.05620-11; van Venrooij WJ, 2011, NAT REV RHEUMATOL, V7, P391, DOI 10.1038/nrrheum.2011.76; Viswanathan K, 2005, P NATL ACAD SCI USA, V102, P5808, DOI 10.1073/pnas.0501650102; Webb AI, 2004, J BIOL CHEM, V279, P23438, DOI 10.1074/jbc.M314066200; Webb AI, 2005, J IMMUNOL, V175, P3810, DOI 10.4049/jimmunol.175.6.3810; Wu GF, 2000, J IMMUNOL, V165, P2278, DOI 10.4049/jimmunol.165.4.2278; Zarling AL, 2006, P NATL ACAD SCI USA, V103, P14889, DOI 10.1073/pnas.0604045103; Zhao JX, 2009, J IMMUNOL, V183, P5163, DOI 10.4049/jimmunol.0902164	79	34	34	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27979	27991		10.1074/jbc.M114.573402	http://dx.doi.org/10.1074/jbc.M114.573402			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25135637	hybrid, Green Published, Green Submitted			2022-12-25	WOS:000342852800051
J	McIntyre, KM; Setzkorn, C; Hepworth, PJ; Morand, S; Morse, AP; Baylis, M				McIntyre, K. Marie; Setzkorn, Christian; Hepworth, Philip J.; Morand, Serge; Morse, Andrew P.; Baylis, Matthew			A Quantitative Prioritisation of Human and Domestic Animal Pathogens in Europe	PLOS ONE			English	Article							SYSTEMATIC ANALYSIS; GLOBAL BURDEN; DISEASE; RISK; ZOONOSES; INJURIES; HEALTH	Disease or pathogen risk prioritisations aid understanding of infectious agent impact within surveillance or mitigation and biosecurity work, but take significant development. Previous work has shown the H-(Hirsch-) index as an alternative proxy. We present a weighted risk analysis describing infectious pathogen impact for human health (human pathogens) and wellbeing (domestic animal pathogens) using an objective, evidence-based, repeatable approach; the H-index. This study established the highest H-index European pathogens. Commonalities amongst pathogens not included in previous surveillance or risk analyses were examined. Differences between host types (humans/animals/zoonotic) in pathogen H-indices were explored as a One Health impact indicator. Finally, the acceptability of the H-index proxy for animal pathogen impact was examined by comparison with other measures. 57 pathogens appeared solely in the top 100 highest H-indices (1) human or (2) animal pathogens list, and 43 occurred in both. Of human pathogens, 66 were zoonotic and 67 were emerging, compared to 67 and 57 for animals. There were statistically significant differences between H-indices for host types (humans, animal, zoonotic), and there was limited evidence that H-indices are a reasonable proxy for animal pathogen impact. This work addresses measures outlined by the European Commission to strengthen climate change resilience and biosecurity for infectious diseases. The results include a quantitative evaluation of infectious pathogen impact, and suggest greater impacts of human-only compared to zoonotic pathogens or scientific under-representation of zoonoses. The outputs separate high and low impact pathogens, and should be combined with other risk assessment methods relying on expert opinion or qualitative data for priority setting, or could be used to prioritise diseases for which formal risk assessments are not possible because of data gaps.	[McIntyre, K. Marie; Setzkorn, Christian; Hepworth, Philip J.; Baylis, Matthew] Univ Liverpool, Inst Infect & Global Hlth, Dept Epidemiol & Populat Hlth, Neston, Cheshire, England; [McIntyre, K. Marie; Setzkorn, Christian] Natl Consortium Zoonosis Res, Neston, Cheshire, England; [Morand, Serge] Univ Montpellier 2, CNRS, Inst Sci Evolut, Montpellier, France; [Morand, Serge] Rech Agron Dev Agr Res Dev CIRAD, Unite Rech, Anim & Gest Integree Risques AGIRs, Montpellier, France; [Morse, Andrew P.] Univ Liverpool, Sch Environm Sci, Liverpool L69 3BX, Merseyside, England; [Baylis, Matthew] Univ Liverpool, NIHR Hlth Protect Res Unit Emerging Infect Includ, Liverpool L69 3BX, Merseyside, England	University of Liverpool; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; CIRAD; University of Liverpool; University of Liverpool	McIntyre, KM (corresponding author), Univ Liverpool, Inst Infect & Global Hlth, Dept Epidemiol & Populat Hlth, Leahurst Campus, Neston, Cheshire, England.	k.m.mcintyre@liv.ac.uk	Morand, Serge/M-5433-2018; Baylis, Matthew/S-7694-2019	Morand, Serge/0000-0003-3986-7659; Baylis, Matthew/0000-0003-0335-187X; Morse, Andrew/0000-0002-0413-2065; McIntyre, Kirsty Marie/0000-0003-1360-122X	NERC through the ERA-ENVHEALTH network [NE/G002827/1]; Leverhulme Trust Research Leadership Award [F/0025/AC]; Biotechnology and Biological Sciences Research Council [BB/K003798/1] Funding Source: researchfish; Natural Environment Research Council [NE/G002827/1] Funding Source: researchfish; BBSRC [BB/K003798/1] Funding Source: UKRI; NERC [NE/G002827/1] Funding Source: UKRI	NERC through the ERA-ENVHEALTH network; Leverhulme Trust Research Leadership Award(Leverhulme Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by NERC [NE/G002827/1] through the ERA-ENVHEALTH network, awarded to MB, and a Leverhulme Trust Research Leadership Award [F/0025/AC], awarded to MB. The funders had no role in the writing of the manuscript or decision to submit.	Cardoen S, 2009, FOODBORNE PATHOG DIS, V6, P1083, DOI 10.1089/fpd.2009.0291; Commission of the European Communities, 2009, CISC VIS NETW IND GL; De Mendiburu F, 2009, AGRICOLAE PACKAGE CR; Doherty J A, 2000, Can J Infect Dis, V11, P21; Dufour B, 2008, REV SCI TECH OIE, V27, P541; Havelaar AH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013965; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Lashley Felissa R, 2004, Expert Rev Anti Infect Ther, V2, P299, DOI 10.1586/14787210.2.2.299; Lindgren E, 2012, SCIENCE, V336, P418, DOI 10.1126/science.1215735; Maudlin I, 2009, PHILOS T R SOC B, V364, P2777, DOI 10.1098/rstb.2009.0067; McIntyre KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019558; McIntyre KM, PREV VET MED; Murphy FA, 2008, PREV VET MED, V86, P216, DOI 10.1016/j.prevetmed.2008.02.009; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P429; National Center for Biotechnology Information U.S. National Library of Medicine Bethesda Maryland US, NCBI MED SUBJ HEAD M; National Center for Biotechnology Information U.S. National Library of Medicine Bethesda Maryland US, NCBI NUCL DAT HOM; National Center for Biotechnology Information U.S. National Library of Medicine Bethesda Maryland US, NCBI TAX DAT HOM; OIE, 2013, TROP SPP INF; R Core Team, 2021, R LANG ENV STAT COMP; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Torgerson PR, 2011, VET PARASITOL, V182, P79, DOI 10.1016/j.vetpar.2011.07.017; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Weinberg J, 1999, EUR J PUBLIC HEALTH, V9, P236, DOI 10.1093/eurpub/9.3.236; Woolhouse MEJ, 2005, EMERG INFECT DIS, V11, P1842, DOI 10.3201/eid1112.050997	25	14	14	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e103529	10.1371/journal.pone.0103529	http://dx.doi.org/10.1371/journal.pone.0103529			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136810	Green Published, Green Submitted, gold			2022-12-25	WOS:000340742100009
J	Schoonmaker, AL; Lieffers, VJ; Landhausser, SM				Schoonmaker, Amanda L.; Lieffers, Victor J.; Landhaeusser, Simon M.			Uniform versus Asymmetric Shading Mediates Crown Recession in Conifers	PLOS ONE			English	Article							SCOTS PINE; PHOTOSYNTHETIC CAPACITY; XYLEM VULNERABILITY; CARBON ALLOCATION; SEASONAL-CHANGES; GAS-EXCHANGE; BRANCHES; GROWTH; TREES; TRANSLOCATION	In this study we explore the impact of asymmetrical vs. uniform crown shading on the mortality and growth of upper and lower branches within tree crowns, for two conifer species: shade intolerant lodgepole pine (Pinus contorta) and shade tolerant white spruce (Picea glauca). We also explore xylem hydraulics, foliar nutrition, and carbohydrate status as drivers for growth and expansion of the lower and upper branches in various types of shading. This study was conducted over a two-year period across 10 regenerating forest sites dominated by lodgepole pine and white spruce, in the lower foothills of Alberta, Canada. Trees were assigned to one of four shading treatments: (1), complete uniform shading of the entire tree, (2) light asymmetric shading where the lower 1/4-1/3 of the tree crown was shaded, (3) heavy asymmetric shading as in (2) except with greater light reduction and (4) control in which no artificial shading occurred and most of the entire crown was exposed to full light. Asymmetrical shading of only the lower crown had a larger negative impact on the bud expansion and growth than did uniform shading, and the effect was stronger in pine relative to spruce. In addition, lower branches in pine also had lower carbon reserves, and reduced xylem-area specific conductivity compared to spruce. For both species, but particularly the pine, the needles of lower branches tended to store less C than upper branches in the asymmetric shade, which could suggest a movement of reserves away from the lower branches. The implications of these findings correspond with the inherent shade tolerance and self-pruning behavior of these conifers and supports a carbon based mechanism for branch mortality - mediated by an asymmetry in light exposure of the crown.	[Schoonmaker, Amanda L.] Northern Alberta Inst Technol, Boreal Res Inst, Peace River, AB, Canada; [Lieffers, Victor J.; Landhaeusser, Simon M.] Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada	University of Alberta	Schoonmaker, AL (corresponding author), Northern Alberta Inst Technol, Boreal Res Inst, Peace River, AB, Canada.	aschoonmaker@nait.ca	Landhäusser, Simon M/F-9910-2016	Landhäusser, Simon M/0000-0002-4466-1607; Lieffers, Victor/0000-0001-6939-4093	Weyerhaueser; NSERC (National Science and Engineering Research Council); West Fraser Timber	Weyerhaueser; NSERC (National Science and Engineering Research Council)(Natural Sciences and Engineering Research Council of Canada (NSERC)); West Fraser Timber	This study was supported by Weyerhaueser and West Fraser Timber. NSERC (National Science and Engineering Research Council) also provided support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amponsah IG, 2004, TREE PHYSIOL, V24, P1099, DOI 10.1093/treephys/24.10.1099; Beckingham JD, 1996, FIELD GUIDE ECOSITES, V5; Brockley RP, 1996, 266 FRDA MIN OFR CAN; Burgess SSO, 2006, PLANT CELL ENVIRON, V29, P229, DOI 10.1111/j.1365-3040.2005.01415.x; Chow PS, 2004, TREE PHYSIOL, V24, P1129, DOI 10.1093/treephys/24.10.1129; Cochard H, 1999, PLANT CELL ENVIRON, V22, P101, DOI 10.1046/j.1365-3040.1999.00367.x; COHEN J, 1994, AM PSYCHOL, V49, P997, DOI 10.1037/0003-066X.50.12.1103; Crawley MJ., 2007, R BOOK; CREGG BM, 1993, TREES-STRUCT FUNCT, V7, P208, DOI 10.1007/BF00202075; Cumming G, 2005, AM PSYCHOL, V60, P170, DOI 10.1037/0003-066X.60.2.170; Di Stefano J, 2004, FOREST ECOL MANAG, V187, P173, DOI 10.1016/S0378-1127(03)00331-1; Environment Canada, 2011, NAT CLIM DAT INF ARC; ERICSSON A, 1978, PHYSIOL PLANTARUM, V43, P351, DOI 10.1111/j.1399-3054.1978.tb01593.x; Fraser EC, 2006, TREE PHYSIOL, V26, P1019, DOI 10.1093/treephys/26.8.1019; HANSEN J, 1994, TREES-STRUCT FUNCT, V8, P172, DOI 10.1007/BF00196844; Henriksson J, 2001, OECOLOGIA, V126, P482, DOI 10.1007/s004420000547; Kagawa A, 2006, NEW PHYTOL, V171, P793, DOI 10.1111/j.1469-8137.2006.01780.x; Kellow JT, 1998, AM J EVAL, V19, P123, DOI 10.1016/S1098-2140(99)80186-6; KITAJIMA K, 1994, OECOLOGIA, V98, P419, DOI 10.1007/BF00324232; KOZLOWSKI TT, 1964, AM J BOT, V51, P522, DOI 10.2307/2440281; Kupper P, 2006, TREES-STRUCT FUNCT, V20, P265, DOI 10.1007/s00468-005-0033-3; Lacointe A, 2004, PLANT CELL ENVIRON, V27, P1159, DOI 10.1111/j.1365-3040.2004.01221.x; Landhausser SM, 2012, TREES-STRUCT FUNCT, V26, P653, DOI 10.1007/s00468-011-0633-z; Landhausser SM, 2001, TREE PHYSIOL, V21, P243, DOI 10.1093/treephys/21.4.243; Lieffers VJ, 1999, CAN J FOREST RES, V29, P796, DOI 10.1139/cjfr-29-6-796; Lippu Jukka, 1998, Silva Fennica, V32, P3; Livingston NJ, 1998, PLANT CELL ENVIRON, V21, P795, DOI 10.1046/j.1365-3040.1998.00314.x; Makela A, 1997, FOREST SCI, V43, P7; Meng SX, 2006, J ECOL, V94, P681, DOI 10.1111/j.1365-2745.2006.01121.x; Messier C, 1999, CAN J FOREST RES, V29, P812, DOI 10.1139/cjfr-29-6-812; Myers JA, 2007, J ECOL, V95, P383, DOI 10.1111/j.1365-2745.2006.01207.x; Naidu SL, 1998, CAN J FOREST RES, V28, P1116, DOI 10.1139/cjfr-28-8-1116; Niinemets U, 2010, ECOL RES, V25, P693, DOI 10.1007/s11284-010-0712-4; Pate JS, 2000, AUST J PLANT PHYSIOL, V27, P869, DOI 10.1071/PP99149; PATRICK JW, 1993, PLANT CELL ENVIRON, V16, P1019, DOI 10.1111/j.1365-3040.1996.tb02049.x; Pearcy RW, 2007, FUNCTIONAL PLANT ECO; Plavcova L, 2011, PLANT CELL ENVIRON, V34, P501, DOI 10.1111/j.1365-3040.2010.02258.x; Protz CG, 2000, CAN J FOREST RES, V30, P1088, DOI 10.1139/cjfr-30-7-1088; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Renninger HJ, 2007, TREE PHYSIOL, V27, P33, DOI 10.1093/treephys/27.1.33; SCHIER GA, 1970, FOREST SCI, V16, P1; Schneider A, 1989, TREES-STRUCT FUNCT, V3, P185, DOI 10.1007/BF00225352; SCHOETTLE AW, 1991, TREE PHYSIOL, V9, P245, DOI 10.1093/treephys/9.1-2.245; Schoonmaker AL, 2010, PLANT CELL ENVIRON, V33, P382, DOI 10.1111/j.1365-3040.2009.02088.x; Souza RP, 1999, BIOL PLANTARUM, V42, P631, DOI 10.1023/A:1002656207366; Sprugel DG, 2002, TREE PHYSIOL, V22, P1119, DOI 10.1093/treephys/22.15-16.1119; SPRUGEL DG, 1991, ANNU REV ECOL SYST, V22, P309, DOI 10.1146/annurev.es.22.110191.001521; Takenaka A, 2000, TREE PHYSIOL, V20, P987; Thomas GW, 1996, METHODS SOIL ANAL PA, P475; Valladares F., 2007, FUNCTIONAL PLANT ECO; von Felten S, 2007, TREES-STRUCT FUNCT, V21, P283, DOI 10.1007/s00468-006-0118-7; Witowski J, 1997, TREE PHYSIOL, V17, P757; Yoshimura K, 2010, PLANT CELL ENVIRON, V33, P750, DOI 10.1111/j.1365-3040.2009.02100.x	53	8	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e104187	10.1371/journal.pone.0104187	http://dx.doi.org/10.1371/journal.pone.0104187			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136823	Green Published, Green Submitted, gold			2022-12-25	WOS:000340742100019
J	Zhang, XY; Li, J				Zhang, Xue-yan; Li, Jun			Susceptibility-Weighted Imaging in Heat Stroke	PLOS ONE			English	Article								Objective: To assess the role of susceptibility-weighted imaging in the detection of intracranial hemorrhage after heat stroke and in the prognosis. Materials and Methods: The study group consisted of eight patients after heat stroke, with a score of 3 to 9 in Glasgow Coma Scale. The MR studies were performed with a 1.5 T scanner. Susceptibility-weighted imaging data were collected within 2-5 days after heat stroke. The study was approved by ethics committee, and written informed consents were obtained from family members of the patients. Results: Punctate hemorrhages were detected in brain stem, corona radiata and frontal lobe by susceptibility-weighted imaging for three patients. Among the three cases, two patients came to death in the 5th day and the 25th day after heat stroke respectively. Another patient became a persistent vegetative state and died about 3 months later. Five patients with no hemorrhage detected gradually recovered and cerebellar dysfunction remained to various degrees. Conclusions: Heat stroke is a life-threatening condition characterized by hyperthermia and accompanied by various complications such as disseminated intravascular coagulation. Susceptibility-weighted imaging is a very useful tool for detection of intracranial hemorrhage and may probably evaluate the prognosis after heat stroke.	[Zhang, Xue-yan] Binzhou Med Univ, Coll Nursing, Yantai, Shandong, Peoples R China; [Li, Jun] Binzhou Med Univ, Yantai Affiliated Hosp, Dept Radiol, Yantai, Shandong, Peoples R China	Binzhou Medical University; Binzhou Medical University	Li, J (corresponding author), Binzhou Med Univ, Yantai Affiliated Hosp, Dept Radiol, Yantai, Shandong, Peoples R China.	bzmceducn@sina.com						Albukrek D, 1997, NEURORADIOLOGY, V39, P195, DOI 10.1007/s002340050392; Bazille C, 2005, J NEUROPATH EXP NEUR, V64, P970, DOI 10.1097/01.jnen.0000186924.88333.0d; Bouchama A, 2002, NEW ENGL J MED, V346, P1978, DOI 10.1056/NEJMra011089; Haacke EM, 2006, Z MED PHYS, V16, P237, DOI 10.1078/0939-3889-00321; Lee IS, 2009, AM J NEURORADIOL, V30, P142, DOI [10.3174/ajnr.A1273, 10.3174/ajnr.A1432]; Leon LR, 2010, J APPL PHYSIOL, V109, P1980, DOI 10.1152/japplphysiol.00301.2010; Mahajan Sajan, 2008, Proc (Bayl Univ Med Cent), V21, P433; Muccio CF, 2013, CLIN NEUROL NEUROSUR, V115, P1558, DOI 10.1016/j.clineuro.2013.01.005; Murcia-Gubianas C, 2012, MED INTENSIVA, V36, P526, DOI 10.1016/j.medin.2011.05.003; Ookura R, 2009, INTERNAL MED, V48, P1105, DOI 10.2169/internalmedicine.48.2030; Prasun P, 2012, CLIN DYSMORPHOL, V21, P24, DOI 10.1097/MCD.0b013e32834cef61; Sonkar SK, 2012, BMJ CASE REP, V19, P2012; Sudhakar PJ, 2007, PEDIATR RADIOL, V37, P1289, DOI 10.1007/s00247-007-0612-0; Yeo Theresa Pluth, 2004, AACN Clin Issues, V15, P280, DOI 10.1097/00044067-200404000-00013	14	3	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105247	10.1371/journal.pone.0105247	http://dx.doi.org/10.1371/journal.pone.0105247			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137376	Green Submitted, Green Published, gold			2022-12-25	WOS:000340742100080
J	Bussiere, C; Sicsic, J; Pelletier-Fleury, N				Bussiere, Clemence; Sicsic, Jonathan; Pelletier-Fleury, Nathalie			The Effects of Obesity and Mobility Disability in Access to Breast and Cervical Cancer Screening in France: Results from the National Health and Disability Survey	PLOS ONE			English	Article							UNITED-STATES; SELF-REPORT; INTERVIEW SURVEY; BODY-WEIGHT; WOMEN; MAMMOGRAPHY; OVERWEIGHT; ADULTS; DISPARITIES; SERVICES	Objectives: We aimed to disentangle the effects of obesity and mobility limitation on cervical and breast cancer screening among community dwelling women. Methods: The data source was the French national Health and Disability Survey - Household Section, 2008. The Body Mass Index (BMI) was used to categorize obesity status. We constructed a continuous score of mobility limitations to assess the severity of disability (Cronbach's alpha = 0.84). Logistic regressions were performed to examine the association between obesity, mobility limitations and the use of Pap test (n = 8 133) and the use of mammography (n = 7 561). Adjusted odds ratios were calculated (AOR). Interaction terms between obesity and the disability score were included in models testing for effect modifications. Results: Compared with non-obese women, the odds of having a Pap test in the past 3 years was 24% lower in obese women (AOR = 0.76; 95% CI: 0.65 to 0.89), the odds of having a mammogram in the past 2 years was 23% lower (AOR = 0.77; 95% CI: 0.66 to 0.91). Each time the disability score was 5 points higher, the odds of having a Pap test decreases by 20% (AOR = 0.96; 95% CI: 0.94 to 0.98), the odds of having a mammogram decreases by 25% (AOR = 0.95; 95% CI: 0.94 to 0.97). There was no significant interaction between obesity and disability score. Conclusion: Obesity and mobility limitation are independently associated with a lower likelihood of cervical and breast cancer screening. Protective outreach and follow-up are necessary to reduce inequalities and thus to reduce health disparities in these vulnerable and high-risk populations of obese women with disabilities.	[Bussiere, Clemence; Sicsic, Jonathan; Pelletier-Fleury, Nathalie] INSERM, Cermes3, U988, Villejuif, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Bussiere, C (corresponding author), INSERM, Cermes3, U988, Villejuif, France.	clemence.bussiere@u-psud.fr	SICSIC, Jonathan/M-1549-2018; Pelletier-Fleury, Nathalie/R-4220-2018	SICSIC, Jonathan/0000-0002-5509-4791; Pelletier-Fleury, Nathalie/0000-0002-4821-4863				Aldrich T, 2010, J MIDWIFERY WOM HEAL, V55, P344, DOI 10.1016/j.jmwh.2009.10.001; Amy NK, 2006, INT J OBESITY, V30, P147, DOI 10.1038/sj.ijo.0803105; Angus J, 2012, J CANCER EDUC, V27, P75, DOI 10.1007/s13187-011-0273-4; [Anonymous], CURRENT POPULATION R; Armour BS, 2013, OBESITY, V21, P852, DOI 10.1002/oby.20312; Bannerman E, 2002, PUBLIC HEALTH NUTR, V5, P655, DOI 10.1079/PHN2002336; Barr JK, 2008, AM J HEALTH PROMOT, V22, P381, DOI 10.4278/ajhp.22.6.381; Bigby JA, 2005, CANCER CAUSE CONTROL, V16, P35, DOI 10.1007/s10552-004-1263-1; Blackwell DL, 2008, WOMEN HEALTH ISS, V18, P85, DOI 10.1016/j.whi.2007.10.006; Calle EE, 2004, ONCOGENE, V23, P6365, DOI 10.1038/sj.onc.1207751; Carney CP, 2006, J GEN INTERN MED, V21, P1097, DOI 10.1111/j.1525-1497.2006.00565.x; Cohen SS, 2008, CANCER-AM CANCER SOC, V112, P1892, DOI 10.1002/cncr.23408; Cronin KA, 2009, CANCER EPIDEM BIOMAR, V18, P1699, DOI 10.1158/1055-9965.EPI-09-0020; Diab ME, 2004, ARCH PHYS MED REHAB, V85, P749, DOI 10.1016/j.apmr.2003.06.028; Duport N, 2007, DEPISTAGE ORG CANC C; Elgar FJ, 2008, CAN J PUBLIC HEALTH, V99, P423, DOI 10.1007/BF03405254; Ells LJ, 2006, OBES REV, V7, P341, DOI 10.1111/j.1467-789X.2006.00233.x; European Commission, 2009, ENS ACC NOND PEOPL D; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Fontaine KR, 1998, ARCH FAM MED, V7, P381, DOI 10.1001/archfami.7.4.381; Fontaine KR, 2001, J WOMEN HEALTH GEN-B, V10, P463, DOI 10.1089/152460901300233939; Forhan M, 2013, BEST PRACT RES CL EN, V27, P129, DOI 10.1016/j.beem.2013.01.003; Froehlich-Grobe K, 2013, AM J PREV MED, V45, P83, DOI 10.1016/j.amepre.2013.02.021; Froehlich-Grobe K, 2011, AM J PREV MED, V41, P541, DOI 10.1016/j.amepre.2011.07.015; Gorber SC, 2007, OBES REV, V8, P307, DOI 10.1111/j.1467-789X.2007.00347.x; Hewitt M, 2004, PREV MED, V39, P270, DOI 10.1016/j.ypmed.2004.03.035; Hsia J, 2000, PREV MED, V31, P261, DOI 10.1006/pmed.2000.0697; Iezzoni LI, 2000, AM J PUBLIC HEALTH, V90, P955, DOI 10.2105/AJPH.90.6.955; Lagu T, 2013, ANN INTERN MED, V158, P441, DOI 10.7326/0003-4819-158-6-201303190-00003; Lin SJ, 2008, J R SOC PROMO HEALTH, V128, P327, DOI 10.1177/1466424007092802; Maruthur NM, 2009, OBESITY, V17, P375, DOI 10.1038/oby.2008.480; Maruthur NM, 2009, J GEN INTERN MED, V24, P665, DOI 10.1007/s11606-009-0939-3; Mitchell RS, 2008, AM J PREV MED, V35, P127, DOI 10.1016/j.amepre.2008.03.031; NAGI SZ, 1976, MILBANK FUND Q, V54, P439, DOI 10.2307/3349677; Newmann SJ, 2005, CANCER CAUSE CONTROL, V16, P63, DOI 10.1007/s10552-004-1290-y; Palazzo C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044994; Park JK, 2012, ASIAN PAC J CANCER P, V13, P3271, DOI 10.7314/APJCP.2012.13.7.3271; Ramirez A, 2005, AM J PUBLIC HEALTH, V95, P2057, DOI 10.2105/AJPH.2005.066118; Rasch EK, 2008, ARCH PHYS MED REHAB, V89, P210, DOI 10.1016/j.apmr.2007.08.146; Rimmer JH, 2004, AM J PREV MED, V26, P419, DOI 10.1016/j.amepre.2004.02.002; Schootman M, 2003, CANCER CAUSE CONTROL, V14, P97, DOI 10.1023/A:1023091308625; Selvin E, 2003, AM J PUBLIC HEALTH, V93, P618, DOI 10.2105/AJPH.93.4.618; Tukker A, 2009, PUBLIC HEALTH NUTR, V12, P359, DOI 10.1017/S1368980008002103; U. S Preventive Services Task Force, 2013, REC AD USPSTF CERV C; Vincent HK, 2010, OBES REV, V11, P568, DOI 10.1111/j.1467-789X.2009.00703.x; WHO, 2007, EARL DET CANC; WHO, 2007, BREAST CANC PREV CON; WHO ICF, 2018, DEFINITION; Wisdom JP, 2010, SOC WORK PUBLIC HLTH, V25, P368, DOI 10.1080/19371910903240969	49	27	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e104901	10.1371/journal.pone.0104901	http://dx.doi.org/10.1371/journal.pone.0104901			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO4JF	25133662	gold, Green Published			2022-12-25	WOS:000341302700050
J	Palmer, NA; Saathoff, AJ; Tobias, CM; Twigg, P; Xia, YN; Vogel, KP; Madhavan, S; Sattler, SE; Sarath, G				Palmer, Nathan A.; Saathoff, Aaron J.; Tobias, Christian M.; Twigg, Paul; Xia, Yuannan; Vogel, Kenneth P.; Madhavan, Soundararajan; Sattler, Scott E.; Sarath, Gautam			Contrasting Metabolism in Perenniating Structures of Upland and Lowland Switchgrass Plants Late in the Growing Season	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; ARABIDOPSIS; SENESCENCE; PROTEINS; DORMANCY; ANTIOXIDANT; PEROXIDASES; REGULATORS; TOLERANCE; DISCOVERY	Background: Switchgrass (Panicum virgatum L.) is being developed as a bioenergy crop for many temperate regions of the world. One way to increase biomass yields is to move southern adapted lowland cultivars to more northern latitudes. However, many southerly adapted switchgrass germplasm can suffer significant winter kill in northerly climes. Materials and Methods: Here, we have applied next-generation sequencing in combination with biochemical analyses to query the metabolism of crowns and rhizomes obtained from two contrasting switchgrass cultivars. Crowns and rhizomes from field-grown lowland (cv Kanlow) and upland (cv Summer) switchgrass cultivars were collected from three randomly selected post-flowering plants. Summer plants were senescing, whereas Kanlow plants were not at this harvest date. Results: Principal component analysis (PCA) differentiated between both the Summer and Kanlow transcriptomes and metabolomes. Significant differences in transcript abundances were detected for 8,050 genes, including transcription factors such as WRKYs and those associated with phenylpropanoid biosynthesis. Gene-set enrichment analyses showed that a number of pathways were differentially up-regulated in the two populations. For both populations, protein levels and enzyme activities agreed well with transcript abundances for genes involved in the phenylpropanoid pathway that were up-regulated in Kanlow crowns and rhizomes. The combination of these datasets suggests that dormancy-related mechanisms had been triggered in the crowns and rhizomes of the Summer plants, whereas the crowns and rhizomes of Kanlow plants had yet to enter dormancy. Conclusions: Delayed establishment of dormancy at more northerly latitudes could be one factor that reduces winter-survival in the high-yielding Kanlow plants. Understanding the cellular signatures that accompany the transition to dormancy can be used in the future to select plants with improved winter hardiness.	[Palmer, Nathan A.; Saathoff, Aaron J.; Sattler, Scott E.; Sarath, Gautam] Univ Nebraska, USDA ARS, Forage & Bioenergy Res Unit, Lincoln, NE 68588 USA; [Palmer, Nathan A.; Saathoff, Aaron J.; Sattler, Scott E.; Sarath, Gautam] Univ Nebraska, Dept Agron & Hort, Lincoln, NE USA; [Tobias, Christian M.] USDA ARS, Western Reg Res Ctr, Genom & Gene Discovery Res Unit, Albany, CA 94710 USA; [Twigg, Paul] Univ Nebraska, Dept Biol, Kearney, NE USA; [Xia, Yuannan] Univ Nebraska, Ctr Biotechnol, Lincoln, NE USA; [Vogel, Kenneth P.] USDA ARS, Lincoln, NE 68583 USA; [Madhavan, Soundararajan] Univ Nebraska, Dept Biochem, Lincoln, NE 68583 USA	United States Department of Agriculture (USDA); University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; United States Department of Agriculture (USDA); University of Nebraska System; University of Nebraska System; University of Nebraska Lincoln; United States Department of Agriculture (USDA); University of Nebraska System; University of Nebraska Lincoln	Sarath, G (corresponding author), Univ Nebraska, USDA ARS, Forage & Bioenergy Res Unit, Lincoln, NE 68588 USA.	Gautam.Sarath@ars.usda.gov	Tobias, Christian/B-6602-2009	Tobias, Christian/0000-0002-7881-750X; Sattler, Scott/0000-0002-6814-4073	Office of Science (BER), U. S. Department of Energy [DE-AI02-09ER64829]; USDA-ARS CRIS [5440-21000-030-00D]	Office of Science (BER), U. S. Department of Energy(United States Department of Energy (DOE)); USDA-ARS CRIS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported by the Office of Science (BER), U. S. Department of Energy Grant Number DE-AI02-09ER64829, and by the USDA-ARS CRIS project 5440-21000-030-00D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal P, 2011, MOL BIOL REP, V38, P3883, DOI 10.1007/s11033-010-0504-5; Albaugh BN, 2011, CHEMBIOCHEM, V12, P290, DOI 10.1002/cbic.201000438; Alderson J, 1995, USDA SCS, V170; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Anderson JV, 2010, TOP CURR GENET, V21, P69, DOI 10.1007/978-3-642-12422-8_5; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berr A, 2011, BBA-GENE REGUL MECH, V1809, P567, DOI 10.1016/j.bbagrm.2011.07.001; Besseau S, 2012, J EXP BOT, V63, P2667, DOI 10.1093/jxb/err450; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Campoy JA, 2011, SCI HORTIC-AMSTERDAM, V130, P357, DOI 10.1016/j.scienta.2011.07.011; Casler M, 2012, HDB BIOENERGY CROP P, P563, DOI DOI 10.1201/B11711-25; Casler MD, 2007, CROP SCI, V47, P2249, DOI 10.2135/cropsci2006.12.0780; Chen LG, 2012, BBA-GENE REGUL MECH, V1819, P120, DOI 10.1016/j.bbagrm.2011.09.002; Chi YJ, 2013, MOL PLANT, V6, P287, DOI 10.1093/mp/sst026; Childs KL, PLANT GENOM IN PRESS; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Dogramaci M, 2011, FUNCT INTEGR GENOMIC, V11, P611, DOI 10.1007/s10142-011-0239-y; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Endres S, 2011, PLANTA, V234, P157, DOI 10.1007/s00425-011-1394-z; Ersoz ES, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044112; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Glover JD, 2010, SCIENCE, V328, P1638, DOI 10.1126/science.1188761; Gomez-Vasquez R, 2004, ANN BOT-LONDON, V94, P87, DOI 10.1093/aob/mch107; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Hemming MN, 2011, PLANT SCI, V180, P447, DOI 10.1016/j.plantsci.2010.12.001; Kanehisa M, 2002, NUCLEIC ACIDS RES, V30, P42, DOI 10.1093/nar/30.1.42; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Lai ZB, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-68; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Lu F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003215; MOORE KJ, 1991, AGRON J, V83, P1073, DOI 10.2134/agronj1991.00021962008300060027x; Okada M, 2010, GENETICS, V185, P745, DOI 10.1534/genetics.110.113910; Palmer NA, 2012, BIOENERG RES, V5, P649, DOI 10.1007/s12155-011-9171-1; Palmer NA, 2014, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00549; Palmer NA, 2010, J AGR FOOD CHEM, V58, P5220, DOI 10.1021/jf904445q; Palmer NA, 2008, PLANTA, V229, P115, DOI 10.1007/s00425-008-0814-1; Prouse MB, 2012, BBA-GENE REGUL MECH, V1819, P67, DOI 10.1016/j.bbagrm.2011.10.010; Puranik S, 2012, TRENDS PLANT SCI, V17, P369, DOI 10.1016/j.tplants.2012.02.004; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roessner U, 2006, PLANT PHYSIOL, V142, P1087, DOI 10.1104/pp.106.084053; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Saathoff AJ, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00202; Saathoff AJ, 2010, BIOENERG RES, V4, P1; Sakihama Y, 2002, TOXICOLOGY, V177, P67, DOI 10.1016/S0300-483X(02)00196-8; Sandve SR, 2011, PLANT SCI, V180, P69, DOI 10.1016/j.plantsci.2010.07.011; Sarath G, 2014, PLANT SCI, V217, P140, DOI 10.1016/j.plantsci.2013.12.012; Sattler SE, 2004, PLANT CELL, V16, P1419, DOI 10.1105/tpc.021360; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Team RC, 2011, R LANG ENV STAT COMP; Tripathi P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-270; Ulker B, 2007, PLANTA, V226, P125, DOI 10.1007/s00425-006-0474-y; Vogel KP, 2014, J PLANT REGIST, V8, P242, DOI 10.3198/jpr2013.12.0076crc; Vogel K.P., 2004, WARM SEASON C4 GRASS, P561, DOI DOI 10.2134/AGRONMONOGR45.C16; Vogel KP, 2011, RSC ENERGY ENVIRON S, P341; Vogel KP, 2008, CROP SCI, V48, P2159, DOI 10.2135/cropsci2008.02.0117; Wu X, 2011, PLANT PHYSIOL, V155, P1769, DOI 10.1104/pp.110.165852; Xing SF, 2012, TRENDS PLANT SCI, V17, P423, DOI 10.1016/j.tplants.2012.03.008; Zhang JY, 2013, PLANT J, V74, P160, DOI 10.1111/tpj.12104; Zhao CS, 2008, PLANT J, V53, P425, DOI 10.1111/j.1365-313X.2007.03350.x; Zhao KM, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-135; Zhao Q, 2011, TRENDS PLANT SCI, V16, P227, DOI 10.1016/j.tplants.2010.12.005	65	30	30	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105138	10.1371/journal.pone.0105138	http://dx.doi.org/10.1371/journal.pone.0105138			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133804	gold, Green Submitted, Green Published			2022-12-25	WOS:000341302700076
J	Rahman, KM; Corcoran, DB; Bui, TTT; Jackson, PJM; Thurston, DE				Rahman, Khondaker M.; Corcoran, David B.; Bui, Tam T. T.; Jackson, Paul J. M.; Thurston, David E.			Pyrrolobenzodiazepines (PBDs) Do Not Bind to DNA G-Quadruplexes	PLOS ONE			English	Article							PYRROLO<1,4>BENZODIAZEPINE ANTITUMOR ANTIBIOTICS; CROSS-LINKING ABILITY; BIOLOGICAL EVALUATION; TRANSCRIPTION FACTOR; POLYAMIDE CONJUGATE; STRUCTURAL BASIS; DUPLEX DNA; PHASE-I; SEQUENCE; ANTHRAMYCIN	The pyrrolo[2,1-c][1,4] benzodiazepines (PBDs) are a family of sequence-selective, minor-groove binding DNA-interactive agents that covalently attach to guanine residues. A recent publication in this journal (Raju et al, PloS One, 2012, 7, 4, e35920) reported that two PBD molecules were observed to bind with high affinity to the telomeric quadruplex of Tetrahymena glaucoma based on Electrospray Ionisation Mass Spectrometry (ESI-MS), Circular Dichroism, UV-Visible and Fluorescence spectroscopy data. This was a surprising result given the close 3-dimensional shape match between the structure of all PBD molecules and the minor groove of duplex DNA, and the completely different 3-dimensional structure of quadruplex DNA. Therefore, we evaluated the interaction of eight PBD molecules of diverse structure with a range of parallel, antiparallel and mixed DNA quadruplexes using DNA Thermal Denaturation, Circular Dichroism and Molecular Dynamics Simulations. Those PBD molecules without large C8-substitutents had an insignificant affinity for the eight quadruplex types, although those with large pi-system-containing C8-substituents (as with the compounds evaluated by Raju and co-workers) were found to interact to some extent. Our molecular dynamics simulations support the likelihood that molecules of this type, including those examined by Raju and co-workers, interact with quadruplex DNA through their C8-substituents rather than the PBD moiety itself. It is important for the literature to be clear on this matter, as the mechanism of action of these agents will be under close scrutiny in the near future due to the growing number of PBD-based agents entering the clinic as both single-agents and as components of antibody-drug conjugates (ADCs).	[Rahman, Khondaker M.; Corcoran, David B.; Bui, Tam T. T.; Jackson, Paul J. M.; Thurston, David E.] Kings Coll London, Inst Pharmaceut Sci, Dept Pharm, London, England	University of London; King's College London	Rahman, KM (corresponding author), Kings Coll London, Inst Pharmaceut Sci, Dept Pharm, London, England.	k.miraz.rahman@kcl.ac.uk; david.thurston@kcl.ac.uk	Rahman, Miraz/M-2749-2017	Rahman, Miraz/0000-0001-8566-8648; Bui, Tam Thu Thi/0000-0002-8074-4928; Corcoran, David/0000-0001-6959-8707	King's College London	King's College London	This research was supported by internal funding available within King's College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrus A, 2006, NUCLEIC ACIDS RES, V34, P2723, DOI 10.1093/nar/gkl348; Antonow D, 2011, CHEM REV, V111, P2815, DOI 10.1021/cr100120f; Balasubramanian S, 2011, NAT REV DRUG DISCOV, V10, P261, DOI 10.1038/nrd3428; Baraldi PG, 1999, J MED CHEM, V42, P5131, DOI 10.1021/jm991033w; BARKLEY MD, 1986, BIOCHEMISTRY-US, V25, P3021, DOI 10.1021/bi00358a043; Bates P, 2007, EMBO REP, V8, P1003, DOI 10.1038/sj.embor.7401073; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/NCHEM.1548, 10.1038/nchem.1548]; Brucoli F, 2013, J MED CHEM, V56, P6339, DOI 10.1021/jm4001852; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Campbell NH, 2008, J AM CHEM SOC, V130, P6722, DOI 10.1021/ja8016973; Case D.A., AMBER 11; Case D.A., 2022, AMBER 2020; Cipolla L, 2009, ANTI-CANCER AGENT ME, V9, P1, DOI 10.2174/187152009787047743; Clingen PH, 2005, NUCLEIC ACIDS RES, V33, P3283, DOI 10.1093/nar/gki639; Darby RAJ, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e39; Eddy J, 2008, NUCLEIC ACIDS RES, V36, P1321, DOI 10.1093/nar/gkm1138; FARMER JD, 1988, TETRAHEDRON LETT, V29, P5105, DOI 10.1016/S0040-4039(00)80691-7; Fogolari F, 1999, BIOPHYS J, V76, P1, DOI 10.1016/S0006-3495(99)77173-0; Fotso S, 2010, MINI-REV ORG CHEM, V7, P68; Fotso S, 2009, J NAT PROD, V72, P690, DOI 10.1021/np800827w; Gabelica V, 2007, J AM CHEM SOC, V129, P895, DOI 10.1021/ja065989p; Gerratana B, 2012, MED RES REV, V32, P254, DOI 10.1002/med.20212; Gomez D, 2004, J BIOL CHEM, V279, P41487, DOI 10.1074/jbc.M406123200; Gregson SJ, 2001, J MED CHEM, V44, P737, DOI 10.1021/jm001064n; Hadjivassileva T, 2005, J ANTIMICROB CHEMOTH, V56, P513, DOI 10.1093/jac/dki256; Haider S, 2010, METHODS MOL BIOL, V608, P17, DOI 10.1007/978-1-59745-363-9_2; Hartley JA, 2011, EXPERT OPIN INV DRUG, V20, P733, DOI 10.1517/13543784.2011.573477; Hochhauser D, 2009, CLIN CANCER RES, V15, P2140, DOI 10.1158/1078-0432.CCR-08-1315; Hopton SR, 2011, BIOCHEMISTRY-US, V50, P4720, DOI 10.1021/bi102017e; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; HURLEY LH, 1988, CHEM RES TOXICOL, V1, P258, DOI 10.1021/tx00005a002; Janjigian YY, 2010, CANCER CHEMOTH PHARM, V65, P833, DOI 10.1007/s00280-009-1088-4; Kamal A, 2006, MINI-REV MED CHEM, V6, P53, DOI 10.2174/138955706775197875; Kamal A, 2005, BIOORGAN MED CHEM, V13, P2021, DOI 10.1016/j.bmc.2005.01.010; Kamal A, 2008, BIOORGAN MED CHEM, V16, P7804, DOI 10.1016/j.bmc.2008.06.056; Kamal A, 2010, EUR J MED CHEM, V45, P3870, DOI 10.1016/j.ejmech.2010.05.041; Kamal A, 2009, BIOORGAN MED CHEM, V17, P1557, DOI 10.1016/j.bmc.2008.12.068; KOHN KW, 1970, J MOL BIOL, V51, P551, DOI 10.1016/0022-2836(70)90008-2; KOPKA ML, 1994, BIOCHEMISTRY-US, V33, P13593, DOI 10.1021/bi00250a011; Kotecha M, 2008, MOL CANCER THER, V7, P1319, DOI 10.1158/1535-7163.MCT-07-0475; Kraus GA, 1999, TETRAHEDRON LETT, V40, P2039, DOI 10.1016/S0040-4039(99)00087-8; Lam EYN, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2792; LEIMGRUBER W, 1965, J AM CHEM SOC, V87, P5791, DOI 10.1021/ja00952a050; Mergny JL, 2001, CHEMBIOCHEM, V2, P124, DOI 10.1002/1439-7633(20010202)2:2<124::AID-CBIC124>3.0.CO;2-L; Muller S, 2010, NAT CHEM, V2, P1095, DOI 10.1038/NCHEM.842; OSADA H, 1990, AGR BIOL CHEM TOKYO, V54, P2883, DOI 10.1080/00021369.1990.10870397; Parkinson GN, 2008, J MOL BIOL, V381, P1145, DOI 10.1016/j.jmb.2008.06.022; Parkinson GN, 2007, BIOCHEMISTRY-US, V46, P2390, DOI 10.1021/bi062244n; Perez A, 2007, BIOPHYS J, V92, P3817, DOI 10.1529/biophysj.106.097782; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PUVVADA MS, 1993, NUCLEIC ACIDS RES, V21, P3671, DOI 10.1093/nar/21.16.3671; Puvvada MS, 1997, BIOCHEMISTRY-US, V36, P2478, DOI 10.1021/bi952490r; Puzanov I, 2011, CLIN CANCER RES, V17, P3794, DOI 10.1158/1078-0432.CCR-10-2056; Rahman KM, 2013, J MED CHEM, V56, P2911, DOI 10.1021/jm301882a; Rahman KM, 2012, CHEM COMMUN, V48, P8760, DOI 10.1039/c2cc31277h; Rahman KM, 2012, J ANTIMICROB CHEMOTH, V67, P1683, DOI 10.1093/jac/dks127; Rahman KM, 2011, ORG BIOMOL CHEM, V9, P1632, DOI 10.1039/c0ob00762e; Rahman KM, 2010, ACS MED CHEM LETT, V1, P427, DOI 10.1021/ml100131b; Rahman KM, 2009, J AM CHEM SOC, V131, P13756, DOI 10.1021/ja902986x; Rahman KM, 2009, CHEM COMMUN, P4097, DOI 10.1039/b902359c; Rahman KM, 2009, CHEM COMMUN, P227, DOI 10.1039/b816163a; Rahman KM, 2011, NUCL ACIDS RES; Raju G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035920; Rosado H, 2011, J ANTIMICROB CHEMOTH, V66, P985, DOI 10.1093/jac/dkr044; Seifert J, 2012, ORG BIOMOL CHEM, V10, P6850, DOI 10.1039/c2ob25654a; Smellie M, 2003, BIOCHEMISTRY-US, V42, P8232, DOI 10.1021/bi034313t; Thurston D. E., 1993, MOL ASPECTS ANTICANC, P54; Thurston DE, 2006, CHEM PHARM ANTICANCE, V1, P281; Wells G, 2005, CLIN CANCER RES, V11, p9015S; Wells G, 2006, J MED CHEM, V49, P5442, DOI 10.1021/jm051199z; Yang DZ, 2010, FUTURE MED CHEM, V2, P619, DOI 10.4155/FMC.09.172	71	10	10	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105021	10.1371/journal.pone.0105021	http://dx.doi.org/10.1371/journal.pone.0105021			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133504	Green Published, gold, Green Submitted			2022-12-25	WOS:000341302700062
J	Seitz, AE; Younes, N; Steiner, CA; Prevots, DR				Seitz, Amy E.; Younes, Naji; Steiner, Claudia A.; Prevots, D. Rebecca			Incidence and Trends of Blastomycosis-Associated Hospitalizations in the United States	PLOS ONE			English	Article							ENDEMIC FUNGAL-INFECTIONS; PULMONARY BLASTOMYCOSIS; GEOGRAPHIC-DISTRIBUTION; PRACTICE GUIDELINES; OLDER PERSONS; WISCONSIN; OUTBREAK; DERMATITIDIS; MANAGEMENT; TENNESSEE	We used the State Inpatient Databases from the United States Agency for Healthcare Research and Quality to provide state-specific age-adjusted blastomycosis-associated hospitalization incidence throughout the entire United States. Among the 46 states studied, states within the Mississippi and Ohio River valleys had the highest age-adjusted hospitalization incidence. Specifically, Wisconsin had the highest age-adjusted hospitalization incidence (2.9 hospitalizations per 100,000 person-years). Trends were studied in the five highest hospitalization incidence states. From 2000 to 2011, blastomycosis-associated hospitalizations increased significantly in Illinois and Kentucky with an average annual increase of 4.4% and 8.4%, respectively. Trends varied significantly by state. Overall, 64% of blastomycosis-associated hospitalizations were among men and the median age at hospitalization was 53 years. This analysis provides a complete epidemiologic description of blastomycosis-associated hospitalizations throughout the endemic area in the United States.	[Seitz, Amy E.; Prevots, D. Rebecca] NIAID, Epidemiol Unit, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA; [Seitz, Amy E.; Younes, Naji] George Washington Univ, Sch Publ Hlth, Milken Inst, Dept Epidemiol & Biostat, Washington, DC USA; [Steiner, Claudia A.] US Agcy Healthcare Res & Qual, Healthcare Cost Utilizat Project, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); George Washington University	Seitz, AE (corresponding author), NIAID, Epidemiol Unit, Lab Clin Infect Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	seitza@niaid.nih.gov		Prevots, D Rebecca/0000-0003-0339-9873	Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health	Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This Research was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency for Healthcare Research and Quality, 2014, HCUP SID DAT DOC HEA; American Hospital Association Resource Center, 2012, FAST FACTS US HOSP; Baddley JW, 2012, EMERG INFECT DIS, V18, P361, DOI 10.3201/eid1802.111617; Baddley JW, 2011, EMERG INFECT DIS, V17, P1664, DOI 10.3201/eid1709.101987; Baumgardner Dennis J, 2011, WMJ, V110, P68; Baumgardner DJ, 2011, MED MYCOL, V49, P49, DOI 10.3109/13693786.2010.488658; Bradsher R W, 1997, Semin Respir Infect, V12, P229; Bradsher RW, 2003, INFECT DIS CLIN N AM, V17, P21, DOI 10.1016/S0891-5520(02)00038-7; Brown EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059237; Cano MV, 2003, EPIDEMIOL INFECT, V131, P907, DOI 10.1017/S0950268803008987; Carlos WG, 2010, CHEST, V138, P1377, DOI 10.1378/chest.10-0627; Centers for Disease Control and Prevention (CDC), 1996, MMWR Morb Mortal Wkly Rep, V45, P601; Chapman S W, 1997, Semin Respir Infect, V12, P219; Chapman SW, 2008, CLIN INFECT DIS, V46, P1801, DOI 10.1086/588300; Chapman SW, 2000, CLIN INFECT DIS, V30, P679, DOI 10.1086/313750; Chu JH, 2006, CLIN INFECT DIS, V42, P822, DOI 10.1086/500405; COCKERILL FR, 1984, CHEST, V86, P688, DOI 10.1378/chest.86.5.688; FRYE MD, 1991, MYCOPATHOLOGIA, V116, P15, DOI 10.1007/BF00436085; FURCOLOW ML, 1970, AM J EPIDEMIOL, V92, P121, DOI 10.1093/oxfordjournals.aje.a121184; Goldenberg S, 2008, MEDICINE, V36, P295; Goldman M, 1999, CLIN CHEST MED, V20, P507, DOI 10.1016/S0272-5231(05)70232-X; HAMMERMAN KJ, 1974, SABOURAUDIA, V12, P33; Haselow D, 2012, EMERG INFECT DIS, V18, P360, DOI 10.3201/eid1802.111537; HCUP National Inpatient Sample (NIS), 2012, HEALTHC COST UT PROJ; Herrmann JA, 2011, JAVMA-J AM VET MED A, V239, P335, DOI 10.2460/javma.239.3.335; Illinois Department of Public Health, 2009, REP COMM DIS CAS 200; KLEIN BS, 1987, AM REV RESPIR DIS, V136, P1333, DOI 10.1164/ajrccm/136.6.1333; KLEIN BS, 1987, J INFECT DIS, V155, P262, DOI 10.1093/infdis/155.2.262; Kralt D, 2009, MYCOPATHOLOGIA, V167, P115, DOI 10.1007/s11046-008-9163-7; Light RB, 2008, MED MYCOL, V46, P835, DOI 10.1080/13693780802132763; MacDonald PDM, 2006, EMERG INFECT DIS, V12, P1242, DOI 10.3201/eid1708.050781; Monaco WE, 2013, DIAGN MICR INFEC DIS, V75, P423, DOI 10.1016/j.diagmicrobio.2013.01.010; Nage CA, 2012, RESP MED, V106, P769, DOI 10.1016/j.rmed.2012.02.004; O'Malley KJ, 2005, HEALTH SERV RES, V40, P1620, DOI 10.1111/j.1475-6773.2005.00444.x; PAPPAS PG, 1993, MEDICINE, V72, P311, DOI 10.1097/00005792-199309000-00003; Pfister JR, 2011, CLIN MED RES, V9, P57, DOI 10.3121/cmr.2010.958; Reed KD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002034; Roy M, 2013, CLIN INFECT DIS, V57, P655, DOI 10.1093/cid/cit366; Saccente M, 2010, CLIN MICROBIOL REV, V23, P367, DOI 10.1128/CMR.00056-09; SAROSI GA, 1979, AM REV RESPIR DIS, V120, P911; Vasquez JE, 1998, CHEST, V114, P436, DOI 10.1378/chest.114.2.436; Watts B, 2007, NEW ENGL J MED, V356, P1456, DOI 10.1056/NEJMcps055322; Woodward M., 2013, EPIDEMIOLOGY STUDY D	43	31	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105466	10.1371/journal.pone.0105466	http://dx.doi.org/10.1371/journal.pone.0105466			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126839	Green Published, gold, Green Submitted			2022-12-25	WOS:000340879300112
J	Vasko, MR; Malty, RH; Guo, CL; Duarte, DB; Zhang, YH; Nicol, GD				Vasko, Michael R.; Malty, Ramy Habashy; Guo, Chunlu; Duarte, Djane B.; Zhang, Yihong; Nicol, Grant D.			Nerve Growth Factor Mediates a Switch in Intracellular Signaling for PGE(2)-Induced Sensitization of Sensory Neurons from Protein Kinase A to Epac	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; PROSTAGLANDIN E-2; CYCLIC-AMP; C-EPSILON; PKC-EPSILON; CAPSAICIN RECEPTOR; VANILLOID RECEPTOR; INFLAMMATORY PAIN; EXCHANGE PROTEIN; PHOSPHOLIPASE-C	We examined whether nerve growth factor (NGF), an inflammatory mediator that contributes to chronic hypersensitivity, alters the intracellular signaling that mediates the sensitizing actions of PGE(2) from activation of protein kinase A (PKA) to exchange proteins directly activated by cAMP (Epacs). When isolated sensory neurons are grown in the absence of added NGF, but not in cultures grown with 30 ng/ml NGF, inhibiting protein kinase A (PKA) activity blocks the ability of PGE(2) to augment capsaicin-evoked release of the neuropeptide CGRP and to increase the number of action potentials (APs) evoked by a ramp of current. Growing sensory neurons in culture in the presence of increasing concentrations of NGF increases the expression of Epac2, but not Epac1. An intradermal injection of complete Freund's adjuvant into the rat hindpaw also increases the expression of Epac2, but not Epac1 in the dorsal root ganglia and spinal cord: an effect blocked by intraplantar administration of NGF antibodies. Treating cultures grown in the presence of 30 ng/ml NGF with Epac1siRNA significantly reduced the expression of Epac1, but not Epac2, and did not block the ability of PGE(2) to augment capsaicin-evoked release of CGRP from sensory neurons. Exposing neuronal cultures grown in NGF to Epac2siRNAreduced the expression of Epac2, but not Epac1 and prevented the PGE(2)-induced augmentation of capsaicin and potassium-evoked CGRP release in sensory neurons and the PGE(2)-induced increase in the number of APs generated by a ramp of current. In neurons grown with no added NGF, Epac siRNAs did not attenuate PGE(2)-induced sensitization. These results demonstrate that NGF, through increasing Epac2 expression, alters the signaling cascade that mediates PGE(2)-induced sensitization of sensory neurons, thus providing a novel mechanism for maintaining PGE(2)-induced hypersensitivity during inflammation.	[Vasko, Michael R.; Malty, Ramy Habashy; Guo, Chunlu; Zhang, Yihong; Nicol, Grant D.] Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; [Vasko, Michael R.] Indiana Univ Sch Med, Dept Anesthesia, Indianapolis, IN 46202 USA; [Malty, Ramy Habashy] Ain Shams Univ, Fac Pharm, Dept Pharmacol & Toxicol, Cairo, Egypt; [Duarte, Djane B.] Univ Brasilia, Fac Ciencias Saude FS, Ribeiro Asa Norte, Brazil	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Egyptian Knowledge Bank (EKB); Ain Shams University; Universidade de Brasilia	Vasko, MR (corresponding author), Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA.	vaskom@iupui.edu			National Institute of Neurological Disorders and Stroke of the National Institutes of Health [RO1069915]; Egyptian Government Missions Program; National Center for Research Resources, National Institutes of Health [C06 RR015481-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015481] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Egyptian Government Missions Program; National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Research reported in this publication was supported by National Institute of Neurological Disorders and Stroke of the National Institutes of Health under award RO1069915 M. R. V., and a fellowship grant to RRMH from the Egyptian Government Missions Program. These studies were conducted in a facility constructed with the support from Research Facilities Improvement Program Grant Number C06 RR015481-01 from the National Center for Research Resources, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern GP, 2002, J PHYSIOL-LONDON, V545, P441, DOI 10.1113/jphysiol.2002.029561; Aley KO, 1999, J NEUROSCI, V19, P2181; Aley KO, 2000, J NEUROSCI, V20, P4680, DOI 10.1523/JNEUROSCI.20-12-04680.2000; ALOE L, 1992, ARTHRITIS RHEUM, V35, P351, DOI 10.1002/art.1780350315; Amann R, 1996, PAIN, V64, P323, DOI 10.1016/0304-3959(95)00120-4; Banik RK, 2005, PAIN, V117, P68, DOI 10.1016/j.pain.2005.05.017; Bhave G, 2003, P NATL ACAD SCI USA, V100, P12480, DOI 10.1073/pnas.2032100100; Bolyard LA, 2000, PAIN, V88, P277, DOI 10.1016/S0304-3959(00)00341-9; BOMBARDIERI S, 1981, BRIT J PHARMACOL, V73, P893, DOI 10.1111/j.1476-5381.1981.tb08743.x; Bos JL, 2003, NAT REV MOL CELL BIO, V4, P733, DOI 10.1038/nrm1197; Bos JL, 2006, TRENDS BIOCHEM SCI, V31, P680, DOI 10.1016/j.tibs.2006.10.002; Breyer RM, 2001, ANNU REV PHARMACOL, V41, P661, DOI 10.1146/annurev.pharmtox.41.1.661; Burkey TH, 2004, METH MOLEC MED, P189; Cesare P, 1999, NEURON, V23, P617, DOI 10.1016/S0896-6273(00)80813-2; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Coste B, 2012, NATURE, V483, P176, DOI 10.1038/nature10812; CUI M, 1995, NEUROSCIENCE, V66, P459, DOI 10.1016/0306-4522(94)00567-O; De Jesus ML, 2006, J BIOL CHEM, V281, P21837, DOI 10.1074/jbc.M604156200; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Dmitrieva N, 1996, PAIN, V66, P87, DOI 10.1016/0304-3959(96)02993-4; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; Donaldson LF, 2001, PROSTAG OTH LIPID M, V63, P109, DOI 10.1016/S0090-6980(00)00101-5; DONNERER J, 1992, NEUROSCIENCE, V49, P693, DOI 10.1016/0306-4522(92)90237-V; Eijkelkamp N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2673; Eijkelkamp N, 2010, J NEUROSCI, V30, P12806, DOI 10.1523/JNEUROSCI.3142-10.2010; Evellin S, 2002, J BIOL CHEM, V277, P16805, DOI 10.1074/jbc.M112024200; Fehrenbacher JC, 2005, PAIN, V113, P113, DOI 10.1016/j.pain.2004.09.031; Fehrenbacher JC, 2005, CONTRIBUTION INFLAMM; FERREIRA SH, 1979, PROSTAGLANDINS, V18, P179, DOI 10.1016/0090-6980(79)90103-5; FERREIRA SH, 1973, BRIT J PHARMACOL, V49, P86, DOI 10.1111/j.1476-5381.1973.tb08270.x; FERREIRA SH, 1972, NATURE-NEW BIOL, V240, P200, DOI 10.1038/newbio240200a0; Fujimoto K, 2002, J BIOL CHEM, V277, P50497, DOI 10.1074/jbc.M210146200; Gekel I, 2008, J NEUROSCI, V28, P7991, DOI 10.1523/JNEUROSCI.0268-08.2008; GREAVES MW, 1971, BMJ-BRIT MED J, V2, P258, DOI 10.1136/bmj.2.5756.258; Guo C, 2007, VIEW IT PLANN; Habashy RR, 2010, LONG TERM EXPOSURE N; HINGTGEN CM, 1995, J NEUROSCI, V15, P5411; Hong K, 2008, J BIOL CHEM, V283, P23129, DOI 10.1074/jbc.M800478200; Hucho TB, 2005, J NEUROSCI, V25, P6119, DOI 10.1523/JNEUROSCI.0285-05.2005; Inoue M, 2004, NAT MED, V10, P712, DOI 10.1038/nm1060; Jeske NA, 2008, PAIN, V138, P604, DOI 10.1016/j.pain.2008.02.022; Kang GX, 2008, J PHYSIOL-LONDON, V586, P1307, DOI 10.1113/jphysiol.2007.143818; Kashima Y, 2001, J BIOL CHEM, V276, P46046, DOI 10.1074/jbc.M108378200; Kavelaars A, 2011, BRAIN BEHAV IMMUN, V25, P1055, DOI 10.1016/j.bbi.2011.03.019; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Khasar SG, 1999, NEURON, V24, P253, DOI 10.1016/S0896-6273(00)80837-5; Kim SE, 2012, NATURE, V483, P209, DOI 10.1038/nature10801; LEWIN GR, 1993, J NEUROSCI, V13, P2136; LEWIN GR, 1994, EUR J NEUROSCI, V6, P1903, DOI 10.1111/j.1460-9568.1994.tb00581.x; Lin CR, 2006, J PHARMACOL EXP THER, V319, P1096, DOI 10.1124/jpet.106.105569; Lin SL, 2003, J NEUROCHEM, V87, P1076, DOI 10.1046/j.1471-4159.2003.02076.x; LINDSAY RM, 1989, NATURE, V337, P362, DOI 10.1038/337362a0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopshire JC, 1998, J NEUROSCI, V18, P6081; Malty RRH, 2012, MECH DOWNREGULATIONS; Moriyama T, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-3; Murray AJ, 2008, MOL CELL NEUROSCI, V38, P578, DOI 10.1016/j.mcn.2008.05.006; Nicol GD, 2007, MOL INTERV, V7, P26, DOI 10.1124/mi.7.1.6; Nijholt IM, 2008, CELL SIGNAL, V20, P1715, DOI 10.1016/j.cellsig.2008.05.001; Obata K, 2004, J NEUROSCI, V24, P10211, DOI 10.1523/JNEUROSCI.3388-04.2004; Ozaki N, 2000, NAT CELL BIOL, V2, P805, DOI 10.1038/35041046; Parada CA, 2005, PAIN, V113, P185, DOI 10.1016/j.pain.2004.10.021; Park KA, 2005, TRENDS PHARMACOL SCI, V26, P571, DOI 10.1016/j.tips.2005.09.010; Richardson JD, 2002, J PHARMACOL EXP THER, V302, P839, DOI 10.1124/jpet.102.032797; Roscioni SS, 2008, N-S ARCH PHARMACOL, V377, P345, DOI 10.1007/s00210-007-0246-7; Rueff A, 1996, J NEUROPHYSIOL, V76, P3593, DOI 10.1152/jn.1996.76.5.3593; Sabbatini ME, 2008, J BIOL CHEM, V283, P23884, DOI 10.1074/jbc.M800754200; Sachs D, 2009, BRIT J PHARMACOL, V156, P826, DOI 10.1111/j.1476-5381.2008.00093.x; SCHMID A, 1995, EUR J BIOCHEM, V228, P23, DOI 10.1111/j.1432-1033.1995.tb20223.x; Schmidt M, 2001, NAT CELL BIOL, V3, P1020, DOI 10.1038/ncb1101-1020; Schnizler K, 2008, J NEUROSCI, V28, P4904, DOI 10.1523/JNEUROSCI.0233-08.2008; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Shu XQ, 1999, NEUROSCI LETT, V274, P159, DOI 10.1016/S0304-3940(99)00701-6; Southall MD, 2000, NEUROSCI LETT, V287, P33, DOI 10.1016/S0304-3940(00)01158-7; Southall MD, 2002, PAIN, V96, P285, DOI 10.1016/S0304-3959(01)00458-4; Southall MD, 2001, J BIOL CHEM, V276, P16083, DOI 10.1074/jbc.M011408200; Ster J, 2007, P NATL ACAD SCI USA, V104, P2519, DOI 10.1073/pnas.0611031104; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; Svensson CI, 2002, ANNU REV PHARMACOL, V42, P553, DOI 10.1146/annurev.pharmtox.42.092401.143905; TAIWO YO, 1989, NEUROSCIENCE, V32, P577, DOI 10.1016/0306-4522(89)90280-7; TRANG LE, 1977, SCAND J RHEUMATOL, V6, P151, DOI 10.3109/03009747709095440; Vanegas HN, 2001, PROG NEUROBIOL, V64, P327, DOI 10.1016/S0301-0082(00)00063-0; VASKO MR, 1994, J NEUROSCI, V14, P4987; Vellani V, 2001, J PHYSIOL-LONDON, V534, P813, DOI 10.1111/j.1469-7793.2001.00813.x; Villarreal CF, 2009, BIOCHEM PHARMACOL, V77, P867, DOI 10.1016/j.bcp.2008.11.015; Wang CY, 2007, J PHYSIOL-LONDON, V584, P191, DOI 10.1113/jphysiol.2007.135616; WESKAMP G, 1987, J NEUROCHEM, V48, P1779, DOI 10.1111/j.1471-4159.1987.tb05736.x; WOOLF CJ, 1994, NEUROSCIENCE, V62, P327, DOI 10.1016/0306-4522(94)90366-2; Zhang YH, 2006, J PHYSIOL-LONDON, V575, P101, DOI 10.1113/jphysiol.2006.111575; Zhong N, 2005, J NEUROSCI, V25, P208, DOI 10.1523/JNEUROSCI.3703-04.2005; Zhuang ZY, 2004, J NEUROSCI, V24, P8300, DOI 10.1523/JNEUROSCI.2893-04.2004	91	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104529	10.1371/journal.pone.0104529	http://dx.doi.org/10.1371/journal.pone.0104529			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126967	gold, Green Submitted, Green Published			2022-12-25	WOS:000340879300033
J	Leo, M; Cazzato, D; De Marco, T; Distante, C				Leo, Marco; Cazzato, Dario; De Marco, Tommaso; Distante, Cosimo			Unsupervised Eye Pupil Localization through Differential Geometry and Local Self-Similarity Matching	PLOS ONE			English	Article							FACE-RECOGNITION	The automatic detection and tracking of human eyes and, in particular, the precise localization of their centers (pupils), is a widely debated topic in the international scientific community. In fact, the extracted information can be effectively used in a large number of applications ranging from advanced interfaces to biometrics and including also the estimation of the gaze direction, the control of human attention and the early screening of neurological pathologies. Independently of the application domain, the detection and tracking of the eye centers are, currently, performed mainly using invasive devices. Cheaper and more versatile systems have been only recently introduced: they make use of image processing techniques working on periocular patches which can be specifically acquired or preliminarily cropped from facial images. In the latter cases the involved algorithms must work even in cases of non-ideal acquiring conditions (e.g in presence of noise, low spatial resolution, non-uniform lighting conditions, etc.) and without user's awareness (thus with possible variations of the eye in scale, rotation and/or translation). Getting satisfying results in pupils' localization in such a challenging operating conditions is still an open scientific topic in Computer Vision. Actually, the most performing solutions in the literature are, unfortunately, based on supervised machine learning algorithms which require initial sessions to set the working parameters and to train the embedded learning models of the eye: this way, experienced operators have to work on the system each time it is moved from an operational context to another. It follows that the use of unsupervised approaches is more and more desirable but, unfortunately, their performances are not still satisfactory and more investigations are required. To this end, this paper proposes a new unsupervised approach to automatically detect the center of the eye: its algorithmic core is a representation of the eye's shape that is obtained through a differential analysis of image intensities and the subsequent combination with the local variability of the appearance represented by self-similarity coefficients. The experimental evidence of the effectiveness of the method was demonstrated on challenging databases containing facial images. Moreover, its capabilities to accurately detect the centers of the eyes were also favourably compared with those of the leading state-of-the-art methods.	[Leo, Marco; Cazzato, Dario; De Marco, Tommaso; Distante, Cosimo] Natl Res Council Italy, Inst Opt, Lecce, Italy; [Cazzato, Dario] Univ Salento, Fac Engn, Lecce, Italy	Consiglio Nazionale delle Ricerche (CNR); University of Salento	Leo, M (corresponding author), Natl Res Council Italy, Inst Opt, Lecce, Italy.	marco.leo@cnr.it	Cazzato, Dario/O-4780-2019; Leo, Marco/AAG-6296-2019; Distante, Cosimo/M-7996-2013	Cazzato, Dario/0000-0002-5472-9150; Leo, Marco/0000-0001-5636-6130; Distante, Cosimo/0000-0002-1073-2390				Asteriadis S, 2009, PATTERN RECOGN, V42, P1388, DOI 10.1016/j.patcog.2009.01.009; BioID, 2001, TECHN RES; Campadelli P, 2009, INT J PATTERN RECOGN, V23, P359, DOI 10.1142/S0218001409007259; Chan TF, 2001, IEEE T IMAGE PROCESS, V10, P266, DOI 10.1109/83.902291; Coutinho FL, 2013, INT J COMPUT VISION, V101, P459, DOI 10.1007/s11263-012-0541-8; Cristinacce D., 2004, P BRIT MACH VIS C, P546, DOI DOI 10.5244/C.18.30; DAUGMAN JG, 1993, IEEE T PATTERN ANAL, V15, P1148, DOI 10.1109/34.244676; Georghiades AS, 2001, IEEE T PATTERN ANAL, V23, P643, DOI 10.1109/34.927464; Hansen DW, 2010, IEEE T PATTERN ANAL, V32, P478, DOI 10.1109/TPAMI.2009.30; He ZF, 2009, IEEE T PATTERN ANAL, V31, P1670, DOI 10.1109/TPAMI.2008.183; Jesorsky O, 2001, LECT NOTES COMPUT SC, V2091, P90; KROON B., 2008, P 2008 INT C CONT BA, P379; Leo M, 2013, J ELECTRON IMAGING, V22, DOI 10.1117/1.JEI.22.3.033033; Lichtenauer J, 2005, PROC CVPR IEEE, P649; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Markus N, 2014, PATTERN RECOGN, V47, P578, DOI 10.1016/j.patcog.2013.08.008; Maver J, 2010, IEEE T PATTERN ANAL, V32, P1211, DOI 10.1109/TPAMI.2009.105; Mishra AK, 2011, IEEE T PATTERN ANAL, V33, P310, DOI 10.1109/TPAMI.2010.83; Niu ZH, 2006, INT C PATT RECOG, P1216; Phillips PJ, 1998, IMAGE VISION COMPUT, V16, P295, DOI 10.1016/S0262-8856(97)00070-X; Proenca H, 2010, IEEE T PATTERN ANAL, V32, P1529, DOI 10.1109/TPAMI.2009.66; Shah S, 2009, IEEE T INF FOREN SEC, V4, P824, DOI 10.1109/TIFS.2009.2033225; SMI SensoMotoric Instruments iXH, 2012, MOB HEAD MOUNT EY GA; Timm F, 2011, VISAPP 2011: PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON COMPUTER VISION THEORY AND APPLICATIONS, P125; Valenti R., 2008, P IEEE C COMP VIS PA, P1, DOI DOI 10.1109/CVPR.2008.4587529; Valenti R, 2012, IEEE T PATTERN ANAL, V34, P1785, DOI 10.1109/TPAMI.2011.251; Van Ginkel M, 1999, P SCAND C IM AN, V2, P545; Viola P, 2004, INT J COMPUT VISION, V57, P137, DOI 10.1023/B:VISI.0000013087.49260.fb; Wildes RP, 1997, P IEEE, V85, P1348, DOI 10.1109/5.628669; Zhu ZW, 2005, COMPUT VIS IMAGE UND, V98, P124, DOI 10.1016/j.cviu.2004.07.012	30	39	41	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e102829	10.1371/journal.pone.0102829	http://dx.doi.org/10.1371/journal.pone.0102829			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122452	Green Submitted, Green Published, gold			2022-12-25	WOS:000341017000006
J	He, QY; Wen, D; Jia, QQ; Cui, CL; Wang, J; Palli, SR; Li, S				He, Qianyu; Wen, Di; Jia, Qiangqiang; Cui, Chunlai; Wang, Jian; Palli, Subba R.; Li, Sheng			Heat Shock Protein 83 (Hsp83) Facilitates Methoprene-tolerant (Met) Nuclear Import to Modulate Juvenile Hormone Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Basic Helix-loop-helix Transcription Factor (bHLH); Drosophila; Heat Shock Protein 90 (Hsp90); Hormone Receptor; Insect; bHLH Transcription Factor; Cytoplasm-Nucleus Shuttling; Insect Hormones; Molecular Chaperone	BEETLE TRIBOLIUM-CASTANEUM; BHLH-PAS FAMILY; BOMBYX FAT-BODY; DROSOPHILA-MELANOGASTER; INTRACELLULAR-LOCALIZATION; TRANSCRIPTIONAL REGULATORS; MOLECULAR CHAPERONES; BINDING-PROTEINS; KRUPPEL-HOMOLOG; GENE-EXPRESSION	Background: Methoprene-tolerant (Met) and Germ-cell expressed belonging to the bHLH-PAS family have been identified as juvenile hormone (JH) receptors in Drosophila. Results: Physical interaction with Hsp83 facilitates nuclear import of Met and JH action. Conclusion: Hsp83 modulates JH signaling through mediating the nuclear localization of Met. Significance: Our study helps in understanding the complicated molecular mechanisms of JH signaling. Juvenile hormone (JH) receptors, methoprene-tolerant (Met) and Germ-cell expressed (Gce), transduce JH signals to induce Kr-h1 expression in Drosophila. Dual luciferase assay identified a 120-bp JH response region (JHRR) in the Kr-h1 promoter. Both in vitro and in vivo experiments revealed that Met and Gce transduce JH signals to induce Kr-h1 expression through the JHRR. DNA affinity purification identified chaperone protein Hsp83 as one of the proteins bound to the JHRR in the presence of JH. Interestingly, Hsp83 physically interacts with PAS-B and basic helix-loop-helix domains of Met, and JH induces Met-Hsp83 interaction. As determined by immunohistochemistry, Met is mainly distributed in the cytoplasm of fat body cells of the larval when the JH titer is low and JH induces Met nuclear import. Hsp83 was accumulated in the cytoplasm area adjunct to the nucleus in the presence of JH and Met/Gce. Loss-of-function of Hsp83 attenuated JH binding and JH-induced nuclear import of Met, resulting in a decrease in the JHRR-driven reporter activity leading to reduction of Kr-h1 expression. These data show that Hsp83 facilitates the JH-induced nuclear import of Met that induces Kr-h1 expression through the JHRR.	[He, Qianyu; Wen, Di; Jia, Qiangqiang; Cui, Chunlai; Li, Sheng] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Key Lab Insect Dev & Evolutionary Biol, Shanghai 200032, Peoples R China; [He, Qianyu] Heilongjiang Bayi Agr Univ, Coll Anim Sci & Vet Med, Daqing 163319, Peoples R China; [Wang, Jian] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA; [Palli, Subba R.] Univ Kentucky, Dept Entomol, Coll Agr, Lexington, KY 40546 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Heilongjiang Bayi Agricultural University; University System of Maryland; University of Maryland College Park; University of Kentucky	Li, S (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Key Lab Insect Dev & Evolutionary Biol, Shanghai 200032, Peoples R China.	lisheng01@sibs.ac.cn	PALLI, SUBBA REDDY/AAU-8289-2020	PALLI, SUBBA REDDY/0000-0002-0873-3247; Jia, Qiangqiang/0000-0003-2650-7566	National Science Foundation of China [31330072]; 973 program [2012CB114605]; Outstanding Youth Investigator Award [31125025]; Top Scientific Leadership in Shanghai Award [12XD1406900]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 program(National Basic Research Program of China); Outstanding Youth Investigator Award; Top Scientific Leadership in Shanghai Award	This work was supported in part by the National Science Foundation of China Grant 31330072 and the 973 program Grant 2012CB114605 (to S. L.).; Supported by Outstanding Youth Investigator Award 31125025 and Top Scientific Leadership in Shanghai Award 12XD1406900.	Abdou MA, 2011, INSECT BIOCHEM MOLEC, V41, P938, DOI 10.1016/j.ibmb.2011.09.003; Arbeitman MN, 2000, CELL, V101, P67, DOI 10.1016/S0092-8674(00)80624-8; Ashok M, 1998, P NATL ACAD SCI USA, V95, P2761, DOI 10.1073/pnas.95.6.2761; Baumann A, 2010, GENETICS, V185, P1327, DOI 10.1534/genetics.110.116962; Bedin M, 2004, INT J CANCER, V109, P643, DOI 10.1002/ijc.20010; Cano LQ, 2013, MOL CELL ENDOCRINOL, V369, P52, DOI 10.1016/j.mce.2013.01.023; Charles JP, 2011, P NATL ACAD SCI USA, V108, P21128, DOI 10.1073/pnas.1116123109; Echeverria PC, 2009, MOL CELL BIOL, V29, P4788, DOI 10.1128/MCB.00649-09; Freitas N, 2009, CURR GENOMICS, V10, P550, DOI 10.2174/138920209789503941; Galigniana MD, 2010, NUCLEUS-PHILA, V1, P299, DOI 10.4161/nucl.1.4.11743; Godlewski J, 2006, BIOCHEM BIOPH RES CO, V342, P1305, DOI 10.1016/j.bbrc.2006.02.097; Greb-Markiewicz B, 2011, MOL CELL ENDOCRINOL, V345, P16, DOI 10.1016/j.mce.2011.06.035; Guo EE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053256; Hossain MS, 2013, INSECT BIOCHEM MOLEC, V43, P829, DOI 10.1016/j.ibmb.2013.06.007; Jackson SE, 2013, TOP CURR CHEM, V328, P155, DOI 10.1007/128_2012_356; Jindra M, 2013, ANNU REV ENTOMOL, V58, P181, DOI 10.1146/annurev-ento-120811-153700; Jones D, 2013, GEN COMP ENDOCR, V194, P326, DOI 10.1016/j.ygcen.2013.09.021; KADONAGA JT, 1986, P NATL ACAD SCI USA, V83, P5889, DOI 10.1073/pnas.83.16.5889; Kayukawa T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01570; Kayukawa T, 2012, P NATL ACAD SCI USA, V109, P11729, DOI 10.1073/pnas.1204951109; Kazlauskas A, 2001, MOL CELL BIOL, V21, P2594, DOI 10.1128/MCB.21.7.2594-2607.2001; Kewley RJ, 2004, INT J BIOCHEM CELL B, V36, P189, DOI 10.1016/S1357-2725(03)00211-5; Konopova B, 2007, P NATL ACAD SCI USA, V104, P10488, DOI 10.1073/pnas.0703719104; Li M, 2011, P NATL ACAD SCI USA, V108, P638, DOI 10.1073/pnas.1013914108; Li YP, 2007, J BIOL CHEM, V282, P37605, DOI 10.1074/jbc.M704595200; Liu HH, 2013, INSECT BIOCHEM MOLEC, V43, P1068, DOI 10.1016/j.ibmb.2013.09.001; Liu W, 2013, BBA-GEN SUBJECTS, V1830, P5184, DOI 10.1016/j.bbagen.2013.06.037; Liu Y, 2009, DEVELOPMENT, V136, P2015, DOI 10.1242/dev.033712; Minakuchi C, 2009, DEV BIOL, V325, P341, DOI 10.1016/j.ydbio.2008.10.016; Minakuchi C, 2008, MECH DEVELOP, V125, P91, DOI 10.1016/j.mod.2007.10.002; Miura K, 2005, FEBS J, V272, P1169, DOI 10.1111/j.1742-4658.2005.04552.x; Niwa R, 2008, INSECT BIOCHEM MOLEC, V38, P714, DOI 10.1016/j.ibmb.2008.04.003; Parthasarathy R, 2008, MECH DEVELOP, V125, P601, DOI 10.1016/j.mod.2008.03.004; Pecasse F, 2000, DEV BIOL, V221, P53, DOI 10.1006/dbio.2000.9687; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Pursley S, 2000, INSECT BIOCHEM MOLEC, V30, P839, DOI 10.1016/S0965-1748(00)00056-4; RICHARD DS, 1989, J COMP PHYSIOL B, V159, P383, DOI 10.1007/BF00692410; Riddiford LM, 2010, DEVELOPMENT, V137, P1117, DOI 10.1242/dev.037218; SHEMSHEDINI L, 1990, P NATL ACAD SCI USA, V87, P2072, DOI 10.1073/pnas.87.6.2072; Shin SW, 2012, P NATL ACAD SCI USA, V109, P16576, DOI 10.1073/pnas.1214209109; SLITER TJ, 1987, INSECT BIOCHEM, V17, P161, DOI 10.1016/0020-1790(87)90156-9; Soshilov A, 2011, J BIOL CHEM, V286, P35275, DOI 10.1074/jbc.M111.246439; Tian L, 2013, AUTOPHAGY, V9, P1172, DOI 10.4161/auto.24731; Wang S, 2012, J PROTEOME RES, V11, P6187, DOI 10.1021/pr3008804; WILSON TG, 1986, DEV BIOL, V118, P190, DOI 10.1016/0012-1606(86)90087-4; Zhang ZL, 2011, J BIOL CHEM, V286, P8437, DOI 10.1074/jbc.M110.191684; Zou Z, 2013, P NATL ACAD SCI USA, V110, pE2173, DOI 10.1073/pnas.1305293110	47	55	63	1	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27874	27885		10.1074/jbc.M114.582825	http://dx.doi.org/10.1074/jbc.M114.582825			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25122763	hybrid, Green Published			2022-12-25	WOS:000342852800043
J	Wang, GQ; He, QZ; Feng, C; Liu, Y; Deng, ZQ; Qi, XX; Wu, W; Mei, PC; Chen, ZZ				Wang, Guoqiang; He, Qingzhong; Feng, Chong; Liu, Yang; Deng, Zengqin; Qi, Xiaoxuan; Wu, Wei; Mei, Pinchao; Chen, Zhongzhou			The Atomic Resolution Structure of Human AlkB Homolog 7 (ALKBH7), a Key Protein for Programmed Necrosis and Fat Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Crystal Structure; Dioxygenase; Fatty Acid Metabolism; Necrosis (Necrotic Death); Obesity; X-ray Crystallography; ALKB; ALKBH7; Protein Hydroxylase; Self-Hydroxylation	HYPOXIA-INDUCIBLE FACTOR; REPAIR ENZYME ALKB; CRYSTAL-STRUCTURES; ESCHERICHIA-COLI; TRANSFER-RNA; DNA-DAMAGE; OXIDATIVE DEMETHYLATION; SUBSTRATE RECOGNITION; CYCLOPHILIN-D; CELL-DEATH	Background: Human ALKBH7 is a mitochondrial protein required for alkylation- and oxidation-induced programmed necrosis and short chain fatty acid metabolism. Results: Atomic resolution structures of ALKBH7 in complex with two ligands were determined. Conclusion: Structural analyses and observation of self-hydroxylation demonstrate that ALKBH7 may function as a protein hydroxylase. Significance: ALKBH7 structures provide a foundation for drug design in cell death and metabolic diseases. ALKBH7 is the mitochondrial AlkB family member that is required for alkylation- and oxidation-induced programmed necrosis. In contrast to the protective role of other AlkB family members after suffering alkylation-induced DNA damage, ALKBH7 triggers the collapse of mitochondrial membrane potential and promotes cell death. Moreover, genetic ablation of mouse Alkbh7 dramatically increases body weight and fat mass. Here, we present crystal structures of human ALKBH7 in complex with Mn(II) and -ketoglutarate at 1.35 or N-oxalylglycine at 2.0 resolution. ALKBH7 possesses the conserved double-stranded -helix fold that coordinates a catalytically active iron by a conserved HX(D/E) ... X-n ... H motif. Self-hydroxylation of Leu-110 was observed, indicating that ALKBH7 has the potential to catalyze hydroxylation of its substrate. Unlike other AlkB family members whose substrates are DNA or RNA, ALKBH7 is devoid of the nucleotide recognition lid which is essential for binding nucleobases, and thus exhibits a solvent-exposed active site; two loops between -strands 6 and 7 and between 9 and 10 create a special outer wall of the minor -sheet of the double-stranded -helix and form a negatively charged groove. These distinct features suggest that ALKBH7 may act on protein substrate rather than nucleic acids. Taken together, our findings provide a structural basis for understanding the distinct function of ALKBH7 in the AlkB family and offer a foundation for drug design in treating cell death-related diseases and metabolic diseases.	[Wang, Guoqiang; Feng, Chong; Liu, Yang; Deng, Zengqin; Qi, Xiaoxuan; Wu, Wei; Chen, Zhongzhou] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China; [He, Qingzhong; Mei, Pinchao] Chinese Acad Med Sci, Inst Basic Med Sci, Natl Key Lab Med Mol Biol, Dept Biochem & Mol Biol, Beijing 100005, Peoples R China; [He, Qingzhong; Mei, Pinchao] Peking Union Med Coll, Beijing 100005, Peoples R China	China Agricultural University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Chen, ZZ (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China.	chenzhongzhou@cau.edu.cn	Deng, Zengqin/AAK-5194-2021; chen, zhong/E-3900-2015	chen, zhong/0000-0003-1319-9664; Mei, Pinchao/0000-0002-1564-0372; Liu, Yang/0000-0003-0679-2275; Qi, Xiaoxuan/0000-0001-5191-3713	National Basic Research Program of China 973 Programs [2011CB965304, 2009CB825403]; National Natural Science Foundation of China [31222032, 31300135, 31370720]	National Basic Research Program of China 973 Programs(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China 973 Programs 2011CB965304 and 2009CB825403 and National Natural Science Foundation of China Grants 31222032, 31300135, and 31370720.	Aik W, 2014, NUCLEIC ACIDS RES, V42, P4741, DOI 10.1093/nar/gku085; Aik W, 2012, CURR OPIN STRUC BIOL, V22, P691, DOI 10.1016/j.sbi.2012.10.001; Alano CC, 2010, J NEUROSCI, V30, P2967, DOI 10.1523/JNEUROSCI.5552-09.2010; Bjornstad LG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049045; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Chowdhury R, 2009, STRUCTURE, V17, P981, DOI 10.1016/j.str.2009.06.002; Cipriani G, 2005, J BIOL CHEM, V280, P17227, DOI 10.1074/jbc.M414526200; Dango S, 2011, MOL CELL, V44, P373, DOI 10.1016/j.molcel.2011.08.039; Delaney JC, 2005, NAT STRUCT MOL BIOL, V12, P855, DOI 10.1038/nsmb996; Delaney JC, 2004, P NATL ACAD SCI USA, V101, P14051, DOI 10.1073/pnas.0403489101; Dunai Z, 2011, PATHOL ONCOL RES, V17, P791, DOI 10.1007/s12253-011-9433-4; Duncan T, 2002, P NATL ACAD SCI USA, V99, P16660, DOI 10.1073/pnas.262589799; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Falnes PO, 2002, NATURE, V419, P178, DOI 10.1038/nature01048; Feng C, 2014, J BIOL CHEM, V289, P11571, DOI 10.1074/jbc.M113.546168; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Fu D, 2013, GENE DEV, V27, P1089, DOI 10.1101/gad.215533.113; Fu D, 2010, MOL CELL BIOL, V30, P2449, DOI 10.1128/MCB.01604-09; Fu Y, 2010, ANGEW CHEM INT EDIT, V49, P8885, DOI 10.1002/anie.201001242; Ha HC, 1999, P NATL ACAD SCI USA, V96, P13978, DOI 10.1073/pnas.96.24.13978; Han ZF, 2010, NATURE, V464, P1205, DOI 10.1038/nature08921; Holland PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008680; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Johannessen TCA, 2013, NEURO-ONCOLOGY, V15, P269, DOI 10.1093/neuonc/nos301; Kreuzaler P, 2012, NAT REV CANCER, V12, P411, DOI 10.1038/nrc3264; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Kurowski MA, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-48; Lee DH, 2005, J BIOL CHEM, V280, P39448, DOI 10.1074/jbc.M509881200; Li MM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2863; Loenarz C, 2011, TRENDS BIOCHEM SCI, V36, P7, DOI 10.1016/j.tibs.2010.07.002; Luvisetto S, 2008, NEUROSCIENCE, V155, P585, DOI 10.1016/j.neuroscience.2008.06.030; Mantri M, 2012, FEBS J, V279, P1563, DOI 10.1111/j.1742-4658.2012.08496.x; McDonough MA, 2006, P NATL ACAD SCI USA, V103, P9814, DOI 10.1073/pnas.0601283103; McDonough MA, 2010, CURR OPIN STRUC BIOL, V20, P659, DOI 10.1016/j.sbi.2010.08.006; Monsen VT, 2010, NUCLEIC ACIDS RES, V38, P6447, DOI 10.1093/nar/gkq518; Muller TA, 2010, DNA REPAIR, V9, P58, DOI 10.1016/j.dnarep.2009.10.011; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ougland R, 2012, STEM CELLS, V30, P2672, DOI 10.1002/stem.1228; Pastore C, 2012, J BIOL CHEM, V287, P2130, DOI 10.1074/jbc.M111.286187; Ringvoll J, 2006, EMBO J, V25, P2189, DOI 10.1038/sj.emboj.7601109; Sanchez-Pulido Luis, 2007, BMC Biochemistry, V8, P23, DOI 10.1186/1471-2091-8-23; Schrodinger L., 2020, PYMOL; Solberg A, 2013, J MOL CELL BIOL, V5, P194, DOI 10.1093/jmcb/mjt012; Sundheim O, 2006, EMBO J, V25, P3389, DOI 10.1038/sj.emboj.7601219; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Wang JM, 2005, ACTA CRYSTALLOGR D, V61, P67, DOI 10.1107/S0907444904026721; Westbye MP, 2008, J BIOL CHEM, V283, P25046, DOI 10.1074/jbc.M803776200; Yang CG, 2008, NATURE, V452, P961, DOI 10.1038/nature06889; Yu B, 2006, NATURE, V439, P879, DOI 10.1038/nature04561; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015	54	30	31	2	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27924	27936		10.1074/jbc.M114.590505	http://dx.doi.org/10.1074/jbc.M114.590505			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25122757	Green Published, hybrid			2022-12-25	WOS:000342852800047
J	Liu, LJ; Stockdreher, Y; Koch, T; Sun, ST; Fan, Z; Josten, M; Sahl, HG; Wang, Q; Luo, YM; Liu, SJ; Dahl, C; Jiang, CY				Liu, Li-Jun; Stockdreher, Yvonne; Koch, Tobias; Sun, Shu-Tao; Fan, Zheng; Josten, Michaele; Sahl, Hans-Georg; Wang, Qian; Luo, Yuan-Ming; Liu, Shuang-Jiang; Dahl, Christiane; Jiang, Cheng-Ying			Thiosulfate Transfer Mediated by DsrE/TusA Homologs from Acidothermophilic Sulfur-oxidizing Archaeon Metallosphaera cuprina	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLETE GENOME SEQUENCE; ESCHERICHIA-COLI; THERMOACIDOPHILIC CRENARCHAEON; ALLOCHROMATIUM-VINOSUM; OXIDATION; PROTEINS; ACIDITHIOBACILLUS; REDUCTASE; BACTERIA; INSIGHTS	Conserved clusters of genes encoding DsrE and TusA homologs occur in many archaeal and bacterial sulfur oxidizers. TusA has a well documented function as a sulfurtransferase in tRNA modification and molybdenum cofactor biosynthesis in Escherichia coli, and DsrE is an active site subunit of the DsrEFH complex that is essential for sulfur trafficking in the phototrophic sulfur-oxidizing Allochromatium vinosum. In the acidothermophilic sulfur (S-0)-and tetrathionate (S4O62-)-oxidizing Metallosphaera cuprina Ar-4, a dsrE3A-dsrE2B-tusA arrangement is situated immediately between genes encoding dihydrolipoamide dehydrogenase and a heterodisulfide reductase-like complex. In this study, the biochemical features and sulfur transferring abilities of the DsrE2B, DsrE3A, and TusA proteins were investigated. DsrE3A and TusA proved to react with tetrathionate but not with NaSH, glutathione persulfide, polysulfide, thiosulfate, or sulfite. The products were identified as protein-Cys-S-thiosulfonates. DsrE3A was also able to cleave the thiosulfate group from TusA-Cys(18)-S-thiosulfonate. DsrE2B did not react with any of the sulfur compounds tested. DsrE3A and TusA interacted physically with each other and formed a heterocomplex. The cysteine residue (Cys(18)) of TusA is crucial for this interaction. The single cysteine mutants DsrE3A-(CS)-S-93 and DsrE3A-(CS)-S-101 retained the ability to transfer the thiosulfonate group to TusA. TusA-(CS)-S-18 neither reacted with tetrathionate nor was it loaded with thiosulfate with DsrE3A-Cys-S-thiosulfonate as the donor. The transfer of thiosulfate, mediated by a DsrE-like protein and TusA, is unprecedented not only in M. cuprina but also in other sulfur-oxidizing prokaryotes. The results of this study provide new knowledge on oxidative microbial sulfur metabolism.	[Liu, Li-Jun; Fan, Zheng; Wang, Qian; Luo, Yuan-Ming; Liu, Shuang-Jiang; Jiang, Cheng-Ying] Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing 100101, Peoples R China; [Stockdreher, Yvonne; Koch, Tobias; Dahl, Christiane] Univ Bonn, Inst Mikrobiol & Biotechnol, D-53115 Bonn, Germany; [Sun, Shu-Tao] Chinese Acad Sci, Core Facil, Beijing 100101, Peoples R China; [Liu, Shuang-Jiang; Jiang, Cheng-Ying] Chinese Acad Sci, Environm Microbiol Res Ctr, Inst Microbiol, Beijing 100101, Peoples R China; [Liu, Li-Jun] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Josten, Michaele; Sahl, Hans-Georg] Univ Bonn, Inst Med Mikrobiol Immunol & Parasitol, Abt Pharmazeut Mikrobiol, D-53127 Bonn, Germany	Chinese Academy of Sciences; Institute of Microbiology, CAS; University of Bonn; Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Bonn	Liu, SJ (corresponding author), Chinese Acad Sci, Inst Microbiol, Bei Chen Xi Lu 1, Beijing 100101, Peoples R China.	liusj@im.ac.cn; ChDahl@uni-bonn.de; jiangcy@im.ac.cn	Dahl, Christiane/H-4786-2019; Liu, Shuang-Jiang/E-5756-2013	Dahl, Christiane/0000-0001-8288-7546; 	Ministry of Science and Technology (973 Program) [2010CB630903]; Ministry of Science and Technology (863 Program) [2012AA061501]; National Nature Science Foundation of China [31070042]; open funding project of the State Key Laboratory of Bioreactor Engineering; Deutsche Forschungsgemeinschaft [Da 351/6-1]; German Academic Exchange Service; Chinese Academy of Sciences (DAAD-CAS Joint Program)	Ministry of Science and Technology (973 Program)(National Basic Research Program of China); Ministry of Science and Technology (863 Program); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); open funding project of the State Key Laboratory of Bioreactor Engineering; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); Chinese Academy of Sciences (DAAD-CAS Joint Program)	This work was supported by the Ministry of Science and Technology (973 Program 2010CB630903 and 863 Program 2012AA061501) and the National Nature Science Foundation of China (Grant 31070042) and in part by an open funding project of the State Key Laboratory of Bioreactor Engineering. This work was also supported by Deutsche Forschungsgemeinschaft Grant Da 351/6-1 (to C. D.).; Recipient of a scholarship from the German Academic Exchange Service and the Chinese Academy of Sciences (DAAD-CAS Joint Program).	Auernik KS, 2008, APPL ENVIRON MICROB, V74, P682, DOI 10.1128/AEM.02019-07; Auernik KS, 2008, APPL ENVIRON MICROB, V74, P7723, DOI 10.1128/AEM.01545-08; Berg JS, 2014, APPL ENVIRON MICROB, V80, P629, DOI 10.1128/AEM.02852-13; Brito JA, 2009, BIOCHEMISTRY-US, V48, P5613, DOI 10.1021/bi9003827; BROCK TD, 1972, ARCH MIKROBIOL, V84, P54, DOI 10.1007/BF00408082; Chen ZW, 2007, APPL MICROBIOL BIOT, V74, P688, DOI 10.1007/s00253-006-0691-0; Dahl C, 2005, J BACTERIOL, V187, P1392, DOI 10.1128/JB.187.4.1392-1404.2005; Dahl JU, 2013, J BIOL CHEM, V288, P5426, DOI 10.1074/jbc.M112.431569; Deckert G, 1998, NATURE, V392, P353, DOI 10.1038/32831; Denkmann K, 2012, ENVIRON MICROBIOL, V14, P2673, DOI 10.1111/j.1462-2920.2012.02820.x; Dopson M, 2012, ENVIRON MICROBIOL, V14, P2620, DOI 10.1111/j.1462-2920.2012.02749.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Friedrich CG, 2001, APPL ENVIRON MICROB, V67, P2873, DOI 10.1128/AEM.67.7.2873-2882.2001; Friedrich CG, 2008, MICROBIAL SULFUR METABOLISM, P139, DOI 10.1007/978-3-540-72682-1_12; Ghosh W, 2009, FEMS MICROBIOL REV, V33, P999, DOI 10.1111/j.1574-6976.2009.00187.x; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HIREL PH, 1989, P NATL ACAD SCI USA, V86, P8247, DOI 10.1073/pnas.86.21.8247; HORTON RM, 1995, MOL BIOTECHNOL, V3, P93, DOI 10.1007/BF02789105; HUBER G, 1989, SYST APPL MICROBIOL, V12, P38; Ikeuchi Y, 2006, MOL CELL, V21, P97, DOI 10.1016/j.molcel.2005.11.001; Imhoff JF, 1998, INT J SYST BACTERIOL, V48, P1129, DOI 10.1099/00207713-48-4-1129; Kawarabayasi Y, 2001, DNA RES, V8, P123, DOI 10.1093/dnares/8.4.123; KLETZIN A, 1989, J BACTERIOL, V171, P1638, DOI 10.1128/jb.171.3.1638-1643.1989; Liu LJ, 2011, INT J SYST EVOL MICR, V61, P2395, DOI 10.1099/ijs.0.026591-0; Liu LJ, 2011, J BACTERIOL, V193, P3387, DOI 10.1128/JB.05038-11; Liu YW, 2013, MOL MICROBIOL, V88, P173, DOI 10.1111/mmi.12176; Lubbe YJ, 2006, FEMS MICROBIOL LETT, V261, P194, DOI 10.1111/j.1574-6968.2006.00343.x; Muller FH, 2004, MOL MICROBIOL, V53, P1147, DOI 10.1111/j.1365-2958.2004.04193.x; Muyzer G, 2011, STAND GENOMIC SCI, V5, P341, DOI 10.4056/sigs.2315092; Pott AS, 1998, MICROBIOL-SGM, V144, P1881, DOI 10.1099/00221287-144-7-1881; Protze J, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00068; Quatrini R, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-394; Reysenbach AL, 2009, J BACTERIOL, V191, P1992, DOI 10.1128/JB.01645-08; Rohwerder T, 2007, ENG LIFE SCI, V7, P301, DOI 10.1002/elsc.200720204; Rohwerder T, 2003, MICROBIOL-SGM, V149, P1699, DOI 10.1099/mic.0.26212-0; Sander J, 2006, ARCH MICROBIOL, V186, P357, DOI 10.1007/s00203-006-0156-y; SHERMAN F, 1985, BIOESSAYS, V3, P27, DOI 10.1002/bies.950030108; Sneath P.H.A., 1973, NUMERICAL TAXONOMY P; Stockdreher Y, 2014, J BIOL CHEM, V289, P12390, DOI 10.1074/jbc.M113.536425; Stockdreher Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040785; Sun CW, 2003, EXTREMOPHILES, V7, P131, DOI 10.1007/s00792-002-0304-5; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thome R, 2012, J BIOL CHEM, V287, P4671, DOI 10.1074/jbc.M111.327122; Venceslau SS, 2014, BBA-BIOENERGETICS, V1837, P1148, DOI 10.1016/j.bbabio.2014.03.007; Waksman SA, 1922, J BACTERIOL, V7, P239, DOI 10.1128/JB.7.2.239-256.1922; You XY, 2011, J GENET GENOMICS, V38, P243, DOI 10.1016/j.jgg.2011.04.006; You XY, 2011, EXTREMOPHILES, V15, P487, DOI 10.1007/s00792-011-0379-y; ZHENG LM, 1994, BIOCHEMISTRY-US, V33, P4714, DOI 10.1021/bi00181a031; Zuckerkandl E., 1965, EVOLVING GENES PROTE, P97, DOI DOI 10.1016/B978-1-4832-2734-4.50017-6	49	33	34	0	22	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					26949	26959		10.1074/jbc.M114.591669	http://dx.doi.org/10.1074/jbc.M114.591669			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25122768	hybrid, Green Published			2022-12-25	WOS:000342853900025
J	Pepenella, S; Murphy, KJ; Hayes, JJ				Pepenella, Sharon; Murphy, Kevin J.; Hayes, Jeffrey J.			A Distinct Switch in Interactions of the Histone H4 Tail Domain upon Salt-dependent Folding of Nucleosome Arrays	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							H4-K16 ACETYLATION; SELF-ASSOCIATION; N-TERMINI; MODEL; ORGANIZATION; PROTEIN; DNA; STABILIZATION; STABILITY; ROLES	The core histone tail domains mediate inter-nucleosomal interactions that direct folding and condensation of nucleosome arrays into higher-order chromatin structures. The histone H4 tail domain facilitates inter-array interactions by contacting both the H2A/H2B acidic patch and DNA of neighboring nucleosomes (1, 2). Likewise, H4 tail-H2A contacts stabilize array folding (3). However, whether the H4 tail domains stabilize array folding via inter-nucleosomal interactions with the DNA of neighboring nucleosomes remains unclear. We utilized defined oligonucleosome arrays containing a single specialized nucleosome with a photo-inducible cross-linker in the N terminus of the H4 tail to characterize these interactions. We observed that the H4 tail participates exclusively in intra-array interactions with DNA in unfolded arrays. These interactions are diminished during array folding, yet no inter-nucleosome, intra-array H4 tail-DNA contacts are observed in condensed chromatin. However, we document contacts between the N terminus of the H4 tail and H2A. Installation of acetylation mimics known to disrupt H4-H2A surface interactions did not increase observance of H4-DNA inter-nucleosomal interactions. These results suggest the multiple functions of the H4 tail require targeted distinct interactions within condensed chromatin.	[Pepenella, Sharon; Murphy, Kevin J.; Hayes, Jeffrey J.] Univ Rochester, Dept Biochem & Biophys, Rochester, NY 14642 USA	University of Rochester	Hayes, JJ (corresponding author), Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA.	Jeffrey_Hayes@urmc.rochester.edu			National Institutes of Health [GM R01 52426, 5T32 GM068411]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052426, T32GM068411] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM R01 52426 and 5T32 GM068411.	Allahverdi A, 2011, NUCLEIC ACIDS RES, V39, P1680, DOI 10.1093/nar/gkq900; ALLAN J, 1982, J CELL BIOL, V93, P285, DOI 10.1083/jcb.93.2.285; Arya G, 2009, J PHYS CHEM A, V113, P4045, DOI 10.1021/jp810375d; AUSIO J, 1989, J MOL BIOL, V206, P451, DOI 10.1016/0022-2836(89)90493-2; BELMONT AS, 1994, J CELL BIOL, V127, P287, DOI 10.1083/jcb.127.2.287; Blacketer MJ, 2010, J BIOL CHEM, V285, P34597, DOI 10.1074/jbc.M110.140061; Dorigo B, 2004, SCIENCE, V306, P1571, DOI 10.1126/science.1103124; Dorigo B, 2003, J MOL BIOL, V327, P85, DOI 10.1016/S0022-2836(03)00025-1; Fan JY, 2002, NAT STRUCT BIOL, V9, P172, DOI 10.1038/nsb767; FLETCHER TM, 1995, J BIOL CHEM, V270, P25359, DOI 10.1074/jbc.270.43.25359; GARCIARAMIREZ M, 1992, J BIOL CHEM, V267, P19587; Gritsan NP, 1999, J PHYS CHEM A, V103, P4465, DOI 10.1021/jp990004u; Hansen JC, 1998, BIOCHEMISTRY-US, V37, P17637, DOI 10.1021/bi982409v; HEBBES TR, 1988, EMBO J, V7, P1395, DOI 10.1002/j.1460-2075.1988.tb02956.x; Kalashnikova AA, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.1022; Kan PY, 2007, MOL CELL BIOL, V27, P2084, DOI 10.1128/MCB.02181-06; Kan PY, 2009, MOL CELL BIOL, V29, P538, DOI 10.1128/MCB.01343-08; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Potoyan DA, 2012, P NATL ACAD SCI USA, V109, P17857, DOI 10.1073/pnas.1201805109; Robinson PJJ, 2008, J MOL BIOL, V381, P816, DOI 10.1016/j.jmb.2008.04.050; Schwarz PM, 1996, BIOCHEMISTRY-US, V35, P4009, DOI 10.1021/bi9525684; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Sinha D, 2010, J BIOL CHEM, V285, P16572, DOI 10.1074/jbc.M109.091298; THOMA F, 1979, J CELL BIOL, V83, P403, DOI 10.1083/jcb.83.2.403; Tse C, 1997, BIOCHEMISTRY-US, V36, P11381, DOI 10.1021/bi970801n; Tse C, 1998, MOL CELL BIOL, V18, P4629, DOI 10.1128/MCB.18.8.4629; Wang XD, 2008, MOL CELL BIOL, V28, P227, DOI 10.1128/MCB.01245-07; Wolffe A, 1998, CHROMATIN - STRUCTURE AND FUNCTION, 3RD EDITION, P1, DOI 10.1016/B978-012761914-9/50003-9; Yang DR, 2011, PHYS CHEM CHEM PHYS, V13, P2911, DOI 10.1039/c0cp01487g; Zheng CY, 2005, J BIOL CHEM, V280, P33552, DOI 10.1074/jbc.M507241200; Zheng CY, 2003, J BIOL CHEM, V278, P24217, DOI 10.1074/jbc.M302817200	32	32	32	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					27342	27351		10.1074/jbc.M114.595140	http://dx.doi.org/10.1074/jbc.M114.595140			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25122771	Green Published, hybrid			2022-12-25	WOS:000342853900054
J	Adhikari, K; Hartemink, AE; Minasny, B; Kheir, RB; Greve, MB; Greve, MH				Adhikari, Kabindra; Hartemink, Alfred E.; Minasny, Budiman; Kheir, Rania Bou; Greve, Mette B.; Greve, Mogens H.			Digital Mapping of Soil Organic Carbon Contents and Stocks in Denmark	PLOS ONE			English	Article							TERRAIN ATTRIBUTES; DEPTH FUNCTIONS; PREDICTION; GRASSLANDS; TOPSOIL; MAPS; ECOSYSTEMS; CROPLANDS; PROFILE; STORAGE	Estimation of carbon contents and stocks are important for carbon sequestration, greenhouse gas emissions and national carbon balance inventories. For Denmark, we modeled the vertical distribution of soil organic carbon (SOC) and bulk density, and mapped its spatial distribution at five standard soil depth intervals (0-5, 5-15, 15-30, 30-60 and 60-100 cm) using 18 environmental variables as predictors. SOC distribution was influenced by precipitation, land use, soil type, wetland, elevation, wetness index, and multi-resolution index of valley bottom flatness. The highest average SOC content of 20 g kg(-1) was reported for 0-5 cm soil, whereas there was on average 2.2 g SOC kg(-1) at 60-100 cm depth. For SOC and bulk density prediction precision decreased with soil depth, and a standard error of 2.8 g kg(-1) was found at 60-100 cm soil depth. Average SOC stock for 0-30 cm was 72 t ha(-1) and in the top 1 m there was 120 t SOC ha(-1). In total, the soils stored approximately 570 Tg C within the top 1 m. The soils under agriculture had the highest amount of carbon (444 Tg) followed by forest and semi-natural vegetation that contributed 11% of the total SOC stock. More than 60% of the total SOC stock was present in Podzols and Luvisols. Compared to previous estimates, our approach is more reliable as we adopted a robust quantification technique and mapped the spatial distribution of SOC stock and prediction uncertainty. The estimation was validated using common statistical indices and the data and high-resolution maps could be used for future soil carbon assessment and inventories.	[Adhikari, Kabindra; Hartemink, Alfred E.] Univ Wisconsin, Dept Soil Sci, Madison, WI 53706 USA; [Minasny, Budiman] Univ Sydney, Dept Environm Sci, Sydney, NSW 2006, Australia; [Kheir, Rania Bou; Greve, Mette B.; Greve, Mogens H.] Aarhus Univ, Dept Agroecol, Tjele, Denmark	University of Wisconsin System; University of Wisconsin Madison; University of Sydney; Aarhus University	Adhikari, K (corresponding author), Univ Wisconsin, Dept Soil Sci, Madison, WI 53706 USA.	kadhikari@wisc.edu	Hartemink, Alfred/G-1149-2011; Greve, Mette/AAF-5998-2020; Minasny, Budiman/B-4744-2011; Adhikari, Kabindra/H-3273-2019	Hartemink, Alfred/0000-0002-5797-6798; Minasny, Budiman/0000-0002-1182-2371; Adhikari, Kabindra/0000-0002-1365-7015; Greve, Mette Balslev/0000-0002-9079-6131	Danish Ministry of Climate and Energy through SINKS Project	Danish Ministry of Climate and Energy through SINKS Project	The study was funded by the Danish Ministry of Climate and Energy through SINKS Project (2009-2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari K, 2014, GEODERMA, V214, P101, DOI 10.1016/j.geoderma.2013.09.023; Adhikari K, 2013, SOIL SCI SOC AM J, V77, P860, DOI 10.2136/sssaj2012.0275; [Anonymous], 1985, DAN J GEOGR, DOI DOI 10.1080/; Arrouays D, 2001, SOIL USE MANAGE, V17, P7, DOI 10.1111/j.1475-2743.2001.tb00002.x; Arrouays D, 2014, ADV AGRON, V125, P93, DOI 10.1016/B978-0-12-800137-0.00003-0; Batjes NH, 2014, EUR J SOIL SCI, V65, P10, DOI 10.1111/ejss.12114_2; Beckett PHT, 1971, SOILS FERTILIZERS, V34, P1; Bendix J., 2004, GELANDEKLIMATOLOGIE; Bishop TFA, 1999, GEODERMA, V91, P27, DOI 10.1016/S0016-7061(99)00003-8; Bohner J, 2009, DEV SOIL SCI, V33, P195, DOI 10.1016/S0166-2481(08)00008-1; Bui E, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2009GB003506; Bui EN, 2006, ECOL MODEL, V191, P431, DOI 10.1016/j.ecolmodel.2005.05.021; Chaplot V, 2010, GLOBAL CHANGE BIOL, V16, P1380, DOI 10.1111/j.1365-2486.2009.02013.x; Chapman SJ, 2013, EUR J SOIL SCI, V64, P455, DOI 10.1111/ejss.12041; Danmarks Meteorologiske Institut, 1998, DANM KLIM 1997; Desmet PJJ, 1996, J SOIL WATER CONSERV, V51, P427; Doblas-Miranda E, 2013, BIOGEOSCIENCES, V10, P8353, DOI 10.5194/bg-10-8353-2013; Dorji T, 2014, FOREST ECOL MANAG, V318, P91, DOI 10.1016/j.foreco.2014.01.003; ESRI, 2012, ARCGIS REL 10 1; Gallant JC, 2003, WATER RESOUR RES, V39, DOI 10.1029/2002WR001426; Greve MH, 2014, SOIL SCI IN PRESS; Greve MH, 2007, GEOGR TIDSSKR-DEN, V107, P1; Hartemink A E, 2014, SOIL CARBON; Hartemink A. E., 2014, PEERJ PREPRINTS, V2; Hartemink AE, 2014, GEODERMA, V230, P305, DOI 10.1016/j.geoderma.2014.03.008; Intergovernmental Panel on Climate Change, 2003, GOOD PRACTICE GUIDAN; Janssens IA, 2005, BIOGEOSCIENCES, V2, P15, DOI 10.5194/bg-2-15-2005; JENNY H, 1968, Prib. Sist. Avtom., V32, P5; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; Kempen B, 2011, GEODERMA, V162, P107, DOI 10.1016/j.geoderma.2011.01.010; Kheir RB, 2010, J ENVIRON MANAGE, V91, P1150, DOI 10.1016/j.jenvman.2010.01.001; Krogh L, 2003, AGR ECOSYST ENVIRON, V96, P19, DOI 10.1016/S0167-8809(03)00016-1; Lacoste M, 2014, GEODERMA, V213, P296, DOI 10.1016/j.geoderma.2013.07.002; Lacoste M, 2011, GEOMORPHOLOGY, V133, P90, DOI 10.1016/j.geomorph.2011.06.026; Madsen H.B., 1992, DANISH SOIL CLASSIFI; Malone BP, 2009, GEODERMA, V154, P138, DOI 10.1016/j.geoderma.2009.10.007; Martin MP, 2011, BIOGEOSCIENCES, V8, P1053, DOI 10.5194/bg-8-1053-2011; McBratney AB, 2003, GEODERMA, V117, P3, DOI 10.1016/S0016-7061(03)00223-4; Meersmans J, 2011, GLOBAL CHANGE BIOL, V17, P466, DOI 10.1111/j.1365-2486.2010.02183.x; Mendonca-Santos ML, 2010, PROGR SOIL SCI, V2, P255, DOI 10.1007/978-90-481-8863-5_21; Minasny B, 2006, AUST J SOIL RES, V44, P233, DOI 10.1071/SR05136; Minasny B., 2005, VESPER VERSION 1 62; Minasny B, 2013, ADV AGRON, V118, P1, DOI 10.1016/B978-0-12-405942-9.00001-3; Minasny B, 2008, CHEMOMETR INTELL LAB, V94, P72, DOI 10.1016/j.chemolab.2008.06.003; Mishra U, 2010, SOIL SCI SOC AM J, V74, P906, DOI 10.2136/sssaj2009.0158; Mishra U, 2009, SOIL SCI SOC AM J, V73, P614, DOI 10.2136/sssaj2007.0410; MOORE ID, 1993, SOIL SCI SOC AM J, V57, P443, DOI 10.2136/sssaj1993.03615995005700020026x; Mueller TG, 2003, SOIL SCI SOC AM J, V67, P258, DOI 10.2136/sssaj2003.0258; ODEH IOA, 1995, GEODERMA, V67, P215, DOI 10.1016/0016-7061(95)00007-B; Odgers NP, 2012, GEODERMA, V189, P153, DOI 10.1016/j.geoderma.2012.05.026; Olesen JE, 1991, AJMET NOTAT NO 24 AF; OSTERGAARD HS, 1990, KVADRATNETTET NITRAT; PONCEHERNANDEZ R, 1986, J SOIL SCI, V37, P455, DOI 10.1111/j.1365-2389.1986.tb00377.x; Quinlan J.R, 2014, C4 5 PROGRAMS MACHIN; R Core Team, 2022, R LANG ENV STAT COMP; Razakamanarivo RH, 2011, GEODERMA, V162, P335, DOI 10.1016/j.geoderma.2011.03.006; Ross CW, 2013, SCI TOTAL ENVIRON, V461, P149, DOI 10.1016/j.scitotenv.2013.04.070; Smith J, 2005, GLOBAL CHANGE BIOL, V11, P2141, DOI 10.1111/j.1365-2486.2005.001075.x; Stjernholm M, 2004, CORINE LANDCOVER UPD; Taghizadeh-Toosi A, 2014, EUR J SOIL SCI, V65, P730, DOI 10.1111/ejss.12169; Vasenev VI, 2014, GEODERMA, V226, P103, DOI 10.1016/j.geoderma.2014.03.007; Wiesmeier M, 2012, GLOBAL CHANGE BIOL, V18, P2233, DOI 10.1111/j.1365-2486.2012.02699.x; Wiesmeier M, 2011, PLANT SOIL, V340, P7, DOI 10.1007/s11104-010-0425-z; ZEVENBERGEN LW, 1987, EARTH SURF PROCESSES, V12, P47, DOI 10.1002/esp.3290120107; Zhao YC, 2010, PROGR SOIL SCI, V2, P227, DOI 10.1007/978-90-481-8863-5_19	65	182	187	10	160	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105519	10.1371/journal.pone.0105519	http://dx.doi.org/10.1371/journal.pone.0105519			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137066	Green Published, Green Submitted, gold			2022-12-25	WOS:000340742100104
J	Rauen, J; Kreer, C; Paillard, A; van Duikeren, S; Benckhuijsen, WE; Camps, MG; Valentijn, ARPM; Ossendorp, F; Drijfhout, JW; Arens, R; Burgdorf, S				Rauen, Judith; Kreer, Christoph; Paillard, Arlette; van Duikeren, Suzanne; Benckhuijsen, Willemien E.; Camps, Marcel G.; Valentijn, A. Rob P. M.; Ossendorp, Ferry; Drijfhout, Jan W.; Arens, Ramon; Burgdorf, Sven			Enhanced Cross-Presentation and Improved CD8(+) T Cell Responses after Mannosylation of Synthetic Long Peptides in Mice	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; HUMAN DENDRITIC CELLS; MANNOSE RECEPTOR; ANTIGEN-PRESENTATION; CARBOHYDRATE-RECOGNITION; DC-SIGN; VACCINES; VACCINATION; MECHANISMS; TOLERANCE	The use of synthetic long peptides (SLP) has been proven to be a promising approach to induce adaptive immune responses in vaccination strategies. Here, we analyzed whether the efficiency to activate cytotoxic T cells by SLP-based vaccinations can be increased by conjugating SLPs to mannose residues. We could demonstrate that mannosylation of SLPs results in increased internalization by the mannose receptor (MR) on murine antigen-presenting cells. MR-mediated internalization targeted the mannosylated SLPs into early endosomes, from where they were cross-presented very efficiently compared to non-mannosylated SLPs. The influence of SLP mannosylation was specific for cross-presentation, as no influence on MHC II-restricted presentation was observed. Additionally, we showed that vaccination of mice with mannosylated SLPs containing epitopes from either ovalbumin or HPV E7 resulted in enhanced proliferation and activation of antigen-specific CD8(+) T cells. These findings demonstrate that mannosylation of SLPs augments the induction of a cytotoxic T cell response in vitro and in vivo and might be a promising approach to induce cytotoxic T cell responses in e. g. cancer therapy and anti-viral immunity.	[Rauen, Judith; Kreer, Christoph; Paillard, Arlette; Burgdorf, Sven] Univ Bonn, Life & Med Sci Inst, Bonn, Germany; [van Duikeren, Suzanne; Benckhuijsen, Willemien E.; Camps, Marcel G.; Ossendorp, Ferry; Drijfhout, Jan W.; Arens, Ramon; Burgdorf, Sven] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, Leiden, Netherlands; [Valentijn, A. Rob P. M.] Leiden Univ, Med Ctr, Dept Bioorgan Synth, Leiden, Netherlands	University of Bonn; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Burgdorf, S (corresponding author), Univ Bonn, Life & Med Sci Inst, Bonn, Germany.	burgdorf@uni-bonn.de	Benckhuijsen, Willemina/Y-2490-2018; Arens, Ramon/V-4010-2018; Kreer, Christoph/ABG-7275-2021; Drijfhout, Jan Wouter/ABA-6318-2021	Benckhuijsen, Willemina/0000-0002-8898-5195; Arens, Ramon/0000-0001-5058-4110; Kreer, Christoph/0000-0002-9140-9850; Drijfhout, Jan Wouter/0000-0003-4808-5296	grant C1 of the collaborative research center 645 of the German research Foundation (DFG); LUMC	grant C1 of the collaborative research center 645 of the German research Foundation (DFG); LUMC	This work was supported by grant C1 of the collaborative research center 645 of the German research Foundation (DFG) to SB and by a Gisela Thier grant from LUMC to RA. SB is a member of the DFG Excellence cluster ImmunoSensation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolopoulos V, 1996, VACCINE, V14, P930, DOI 10.1016/0264-410X(95)00258-3; Apostolopoulos V, 2000, EUR J IMMUNOL, V30, P1714, DOI 10.1002/1521-4141(200006)30:6<1714::AID-IMMU1714>3.0.CO;2-C; Arens R, 2013, SEMIN IMMUNOL, V25, P182, DOI 10.1016/j.smim.2013.04.008; Arens R, 2012, ADV IMMUNOL, V114, P217, DOI 10.1016/B978-0-12-396548-6.00009-3; Bijker MS, 2007, J IMMUNOL, V179, P5033, DOI 10.4049/jimmunol.179.8.5033; Burgdorf S, 2008, NAT IMMUNOL, V9, P558, DOI 10.1038/ni.1601; Burgdorf S, 2007, SCIENCE, V316, P612, DOI 10.1126/science.1137971; Burgdorf S, 2006, J IMMUNOL, V176, P6770, DOI 10.4049/jimmunol.176.11.6770; Cebrian I, 2011, CELL, V147, P1355, DOI 10.1016/j.cell.2011.11.021; Chatterjee B, 2012, BLOOD, V120, P2011, DOI 10.1182/blood-2012-01-402370; Chieppa M, 2003, J IMMUNOL, V171, P4552, DOI 10.4049/jimmunol.171.9.4552; De Gregorio E, 2012, MICROB BIOTECHNOL, V5, P149, DOI 10.1111/j.1751-7915.2011.00276.x; Engering A, 2002, J IMMUNOL, V168, P2118, DOI 10.4049/jimmunol.168.5.2118; Engering AJ, 1997, EUR J IMMUNOL, V27, P2417, DOI 10.1002/eji.1830270941; EZEKOWITZ RAB, 1990, J EXP MED, V172, P1785, DOI 10.1084/jem.172.6.1785; Faure F, 2009, EUR J IMMUNOL, V39, P380, DOI 10.1002/eji.200838669; Harvey DJ, 2000, J AM SOC MASS SPECTR, V11, P564, DOI 10.1016/S1044-0305(00)00122-7; He LZ, 2007, J IMMUNOL, V178, P6259, DOI 10.4049/jimmunol.178.10.6259; Herre J, 2004, BLOOD, V104, P4038, DOI 10.1182/blood-2004-03-1140; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kel J, 2007, AM J PATHOL, V170, P272, DOI 10.2353/ajpath.2007.060335; Kel JM, 2008, INT IMMUNOL, V20, P117, DOI 10.1093/intimm/dxm123; Keler T, 2004, EXPERT OPIN BIOL TH, V4, P1953, DOI 10.1517/14712598.4.12.1953; Kenter GG, 2009, NEW ENGL J MED, V361, P1838, DOI 10.1056/NEJMoa0810097; Luca ME, 2005, J NEUROIMMUNOL, V160, P178, DOI 10.1016/j.jneuroim.2004.11.014; McKenzie EJ, 2007, J IMMUNOL, V178, P4975, DOI 10.4049/jimmunol.178.8.4975; Melief CJM, 2008, NAT REV CANCER, V8, P351, DOI 10.1038/nrc2373; Mitchell DA, 2001, J BIOL CHEM, V276, P28939, DOI 10.1074/jbc.M104565200; Mommaas AM, 1999, EUR J IMMUNOL, V29, P571, DOI 10.1002/(SICI)1521-4141(199902)29:02<571::AID-IMMU571>3.0.CO;2-E; Savina A, 2006, CELL, V126, P205, DOI 10.1016/j.cell.2006.05.035; Smith CM, 2011, J IMMUNOL, V187, P1201, DOI 10.4049/jimmunol.1002152; Tan MCAA, 1997, EUR J IMMUNOL, V27, P2426, DOI 10.1002/eji.1830270942; Toes REM, 1996, P NATL ACAD SCI USA, V93, P7855, DOI 10.1073/pnas.93.15.7855; van Duikeren S, 2012, J IMMUNOL, V189, P3397, DOI 10.4049/jimmunol.1201540; van Hall T, 2012, ADV IMMUNOL, V114, P51, DOI 10.1016/B978-0-12-396548-6.00003-2; van Montfoort N, 2009, P NATL ACAD SCI USA, V106, P6730, DOI 10.1073/pnas.0900969106; Wainszelbaum MJ, 2006, EXP CELL RES, V312, P2238, DOI 10.1016/j.yexcr.2006.03.025; Welters MJP, 2007, VACCINE, V25, P1379, DOI 10.1016/j.vaccine.2006.10.049; Zehner M, 2011, P NATL ACAD SCI USA, V108, P9933, DOI 10.1073/pnas.1102397108; Zom GGP, 2012, ADV IMMUNOL, V114, P177, DOI 10.1016/B978-0-12-396548-6.00007-X; Zwaveling S, 2002, J IMMUNOL, V169, P350, DOI 10.4049/jimmunol.169.1.350	41	23	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e103755	10.1371/journal.pone.0103755	http://dx.doi.org/10.1371/journal.pone.0103755			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137039	Green Submitted, Green Published, gold			2022-12-25	WOS:000340742100013
J	Reich, O; Rosemann, T; Rapold, R; Blozik, E; Senn, O				Reich, Oliver; Rosemann, Thomas; Rapold, Roland; Blozik, Eva; Senn, Oliver			Potentially Inappropriate Medication Use in Older Patients in Swiss Managed Care Plans: Prevalence, Determinants and Association with Hospitalization	PLOS ONE			English	Article							BEERS CRITERIA; DRUG-USE; ELDERLY OUTPATIENTS; PHARMACY DATA; OUTCOMES; POPULATION; RISK; PRESCRIPTIONS; EXPENDITURES; POLYPHARMACY	Objectives: To describe the prevalence and determinants of potentially inappropriate medication (PIM) use and association with hospitalizations in an elderly managed care population in Switzerland. Methods: Using health care claims data of four health insurers for a sample of managed care patients 65 years of age and older to compare persons on PIM with persons not on PIM. Beers' 2012 and PRISCUS criteria were used to determine the potential inappropriateness of prescribed medications. The sample included 16'490 elderly patients on PIM and 33'178 patients not on PIM in the time period of January 1, 2008 through December 31, 2012. Prevalence estimates are standardized to the population of Switzerland. Associations between PIM and hospitalizations were examined by multivariate Cox regression analyses controlling for possible confounding variables. Results: The estimated prevalence of PIM use in our managed care sample was 22.5%. Logistic regression analysis showed that number of different medications used in the previous year, total costs in the previous year and hospitalization in the previous year all significantly increased the likelihood of receiving PIM. Multiple Cox regression analysis revealed that those on cumulative levels of PIM use acted significantly as a factor related to greater hospitalization rates: the adjusted HR was 1.13 (95% CI 1.07-1.19) for 1 PIM, 1.27 (95% CI 1.19-1.35) for 2 PIM, 1.35 (95% CI 1.22-1.50) for 3 PIM, and 1.63 (95% CI 1.40-1.90) for more than 3 PIM compared to no PIM use. Conclusions: The prevalence of PIM in managed care health plans are widely found but seem to be much lower than rates of non-managed care plans. Furthermore, our study revealed a significant association with adverse outcomes in terms of hospitalizations. These findings stress the need for further development of interventions to decrease drug-related problems and manage patients with multiple chronic conditions.	[Reich, Oliver; Rapold, Roland] Helsana Grp, Dept Hlth Sci, Zurich, Switzerland; [Rosemann, Thomas; Senn, Oliver] Univ Zurich Hosp, Inst Gen Practice & Hlth Serv Res, CH-8091 Zurich, Switzerland; [Blozik, Eva] Univ Med Ctr Hamburg Eppendorf, Dept Primary Med Care, Hamburg, Germany	University of Zurich; University Zurich Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf	Reich, O (corresponding author), Helsana Grp, Dept Hlth Sci, Zurich, Switzerland.	oliver.reich@helsana.ch		Senn, Oliver/0000-0003-4422-7250; Rapold, Roland/0000-0001-8287-290X	Swiss Academy of Medical Sciences (SAMS), Basel, Switzerland	Swiss Academy of Medical Sciences (SAMS), Basel, Switzerland	This work was supported by an unconditional grant from the Swiss Academy of Medical Sciences (SAMS), Basel, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert SM, 2010, DRUG AGING, V27, P407, DOI 10.2165/11315990-000000000-00000; Aparasu RR, 2000, ANN PHARMACOTHER, V34, P338, DOI 10.1345/aph.19006; Barnett MJ, 2006, J MANAGE CARE PHARM, V12, P362, DOI 10.18553/jmcp.2006.12.5.362; Barry Patrick J, 2008, Curr Psychiatry Rep, V10, P37, DOI 10.1007/s11920-008-0008-3; Blozik E, 2013, DRUG AGING, V30, P561, DOI 10.1007/s40266-013-0073-0; Bodenheimer T, 2008, NEW ENGL J MED, V358, P1064, DOI 10.1056/NEJMhpr0706165; Cahir C, 2010, BRIT J CLIN PHARMACO, V69, P543, DOI 10.1111/j.1365-2125.2010.03628.x; Cannon Katrina T, 2006, Am J Geriatr Pharmacother, V4, P134, DOI 10.1016/j.amjopharm.2006.06.010; Chini F, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-688; Cossman RE, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-25; Dedhiya SD, 2010, AM J GERIATR PHARMAC, V8, P562, DOI 10.1016/S1543-5946(10)80005-4; Federal Office of Public Health FOPH, 2013, STAT ONL KRANK 2012; Federal Statistical Office, 2010, SZEN BEV SCHW 2010 2; Fick D, 2001, J MANAGE CARE PHARM, V7, P407, DOI [10.18553/jmcp.2001.7.5.407, DOI 10.18553/JMCP.2001.7.5.407]; Fick DM, 2003, ARCH INTERN MED, V163, P2716, DOI 10.1001/archinte.163.22.2716; Fick D, 2012, J AM GERIATR SOC, V60, P616, DOI 10.1111/j.1532-5415.2012.03923.x; Fick DM, 2008, RES NURS HEALTH, V31, P42, DOI 10.1002/nur.20232; Fu AZ, 2007, MED CARE, V45, P472, DOI 10.1097/01.mlr.0000254571.05722.34; Galvin R, 2014, EUR J CLIN PHARMACOL, V70, P599, DOI 10.1007/s00228-014-1651-8; Giron MST, 2001, J AM GERIATR SOC, V49, P277, DOI 10.1046/j.1532-5415.2001.4930277.x; Goltz L, 2012, INT J CLIN PHARM TH, V50, P185, DOI 10.5414/CP201441; Hanlon JT, 2002, J AM GERIATR SOC, V50, P26, DOI 10.1046/j.1532-5415.2002.50004.x; Harugeri A, 2010, J POSTGRAD MED, V56, P186, DOI 10.4103/0022-3859.68642; Hilmer SN, 2009, CLIN PHARMACOL THER, V85, P86, DOI 10.1038/clpt.2008.224; Holt S, 2010, DTSCH ARZTEBL INT, V107, P543, DOI 10.3238/arztebl.2010.0543; Huber CA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1030; Huber CA, 2013, J CLIN EPIDEMIOL, V66, P1118, DOI 10.1016/j.jclinepi.2013.04.011; Jano E, 2007, ANN PHARMACOTHER, V41, P438, DOI 10.1345/aph.1H473; Klarin I, 2005, DRUG AGING, V22, P69, DOI 10.2165/00002512-200522010-00005; Lau DT, 2005, ARCH INTERN MED, V165, P68, DOI 10.1001/archinte.165.1.68; Lin HY, 2008, DRUG AGING, V25, P49, DOI 10.2165/00002512-200825010-00006; Liu Gordon G, 2002, J Am Pharm Assoc (Wash), V42, P847; Maio V, 2006, DRUG AGING, V23, P915, DOI 10.2165/00002512-200623110-00006; McLean AJ, 2004, PHARMACOL REV, V56, P163, DOI 10.1124/pr.56.2.4; O'Mahony D, 2010, EUR GERIATR MED, V1, P45, DOI 10.1016/j.eurger.2010.01.007; O'Shea M, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-23; Oliveira MG, 2012, INT J CLIN PHARM-NET, V34, P626, DOI 10.1007/s11096-012-9656-9; Opondo D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043617; Price SD, 2014, ANN PHARMACOTHER, V48, P6, DOI 10.1177/1060028013504904; Reich O, 2012, INT J INTEGR CARE, V12; Rothberg MB, 2008, J HOSP MED, V3, P91, DOI 10.1002/jhm.290; Ruggiero C, 2010, DRUG AGING, V27, P747, DOI 10.2165/11538240-000000000-00000; Schubert I, 2013, PHARMACOEPIDEM DR S, V22, P719, DOI 10.1002/pds.3429; Sichieri K, 2013, ADV PHARMACOL PHARM, V1, P74, DOI 10.13189/app.2013.010205; Siebert S, 2013, Z GERONTOL GERIATR, V46, P35, DOI 10.1007/s00391-012-0324-4; Simon SR, 2005, J AM GERIATR SOC, V53, P227, DOI 10.1111/j.1532-5415.2005.53107.x; Stockl KM, 2010, AM J MANAG CARE, V16, pE1; Swiss Federal Office of Statistics SFOS, 2013, STAND WOHNB NACH GES; Tamura BK, 2012, CLIN GERIATR MED, V28, P217, DOI 10.1016/j.cger.2012.01.005; Tragni E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078827; de Lima TJV, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-52; Zuckerman IH, 2006, MED CARE, V44, P722, DOI 10.1097/01.mlr.0000215849.15769.be	52	84	89	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105425	10.1371/journal.pone.0105425	http://dx.doi.org/10.1371/journal.pone.0105425			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN6XM	25136981	Green Submitted, Green Published, gold			2022-12-25	WOS:000340742100093
J	Geng, YK; Pang, BS; Hao, CY; Tang, SJ; Zhang, XY; Li, T				Geng, Yuke; Pang, Binshuang; Hao, Chenyang; Tang, Saijun; Zhang, Xueyong; Li, Tian			Expression of Wheat High Molecular Weight Glutenin Subunit 1Bx Is Affected by Large Insertions and Deletions Located in the Upstream Flanking Sequences	PLOS ONE			English	Article							ENDOSPERM-SPECIFIC EXPRESSION; TRITICUM-AESTIVUM L; TRANSGENIC RICE; GLUTELIN GENE; ACTIVATES TRANSCRIPTION; QUALITY TRAITS; PROTEIN GENES; BREAD WHEAT; GCN4 MOTIF; IDENTIFICATION	To better understand the transcriptional regulation of high molecular weight glutenin subunit (HMW-GS) expression, we isolated four Glu-1Bx promoters from six wheat cultivars exhibiting diverse protein expression levels. The activities of the diverse Glu-1Bx promoters were tested and compared with beta-glucuronidase (GUS) reporter fusions. Although all the full-length Glu-1Bx promoters showed endosperm-specific activities, the strongest GUS activity was observed with the 1Bx7(OE) promoter in both transient expression assays and stable transgenic rice lines. A 43 bp insertion in the 1Bx7(OE) promoter, which is absent in the 1Bx7 promoter, led to enhanced expression. Analysis of promoter deletion constructs confirmed that a 185 bp MITE (miniature inverted-repeat transposable element) in the 1Bx14 promoter had a weak positive effect on Glu-1Bx expression, and a 54 bp deletion in the 1Bx13 promoter reduced endosperm-specific activity. To investigate the effect of the 43 bp insertion in the 1Bx7(OE) promoter, a functional marker was developed to screen 505 Chinese varieties and 160 European varieties, and only 1Bx7-type varieties harboring the 43 bp insertion in their promoters showed similar overexpression patterns. Hence, the 1Bx7(OE) promoter should be important tool in crop genetic engineering as well as in molecular assisted breeding.	[Geng, Yuke; Hao, Chenyang; Zhang, Xueyong; Li, Tian] Chinese Acad Agr Sci, Inst Crop Sci, Key Lab Crop Gene Resources & Germplasm Enhanceme, Minist Agr, Beijing 100193, Peoples R China; [Geng, Yuke; Tang, Saijun] China Agr Univ, Coll Biol Sci, Beijing 100094, Peoples R China; [Pang, Binshuang] Beijing Acad Agr & Forestry Sci, Beijing Engn & Tech Res Ctr Hybrid Wheat, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Ministry of Agriculture & Rural Affairs; China Agricultural University; Beijing Academy of Agriculture & Forestry	Zhang, XY (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Key Lab Crop Gene Resources & Germplasm Enhanceme, Minist Agr, Beijing 100193, Peoples R China.	zhangxueyong@caas.cn; litian@caas.cn			National Transgenic Research Project [ZX08002-004]; National Natural Science Foundation of China [30671293]	National Transgenic Research Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Transgenic Research Project (ZX08002-004) and National Natural Science Foundation of China (30671293). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON OD, 1989, THEOR APPL GENET, V77, P689, DOI 10.1007/BF00261246; Anderson OD, 2002, GENOME, V45, P367, DOI 10.1139/G01-137; Anderson OD, 1997, P INT WHEAT QUAL C, P205; Bajaj S, 2005, PLANT BIOTECHNOL J, V3, P275, DOI 10.1111/j.1467-7652.2005.00130.x; Barro F, 1997, NAT BIOTECHNOL, V15, P1295, DOI 10.1038/nbt1197-1295; Butaye KMJ, 2005, MOL BREEDING, V16, P79, DOI 10.1007/s11032-005-4929-9; Butow BJ, 2004, THEOR APPL GENET, V109, P1525, DOI 10.1007/s00122-004-1776-8; Cheon BY, 2004, TRANSGENIC RES, V13, P541, DOI 10.1007/s11248-004-2737-3; Cho HJ, 2004, PLANT CELL REP, V23, P104, DOI 10.1007/s00299-004-0789-8; Christensen AH, 1996, TRANSGENIC RES, V5, P213, DOI 10.1007/BF01969712; CLOUTIER S, 2005, P INT C PLANT GEN BI, P40; Cornish GB, 2001, AUST J AGR RES, V52, P1339, DOI 10.1071/AR01060; Dong GQ, 2007, PLANT MOL BIOL, V63, P73, DOI 10.1007/s11103-006-9073-3; FORDE J, 1985, NUCLEIC ACIDS RES, V13, P6817, DOI 10.1093/nar/13.19.6817; FUJIWARA T, 1994, PLANT MOL BIOL, V24, P261, DOI 10.1007/BF00020166; Furtado A, 2008, PLANT BIOTECHNOL J, V6, P679, DOI 10.1111/j.1467-7652.2008.00352.x; GALILI G, 1983, THEOR APPL GENET, V66, P77, DOI 10.1007/BF00281853; GUPTA RB, 1994, J CEREAL SCI, V19, P9, DOI 10.1006/jcrs.1994.1003; HALFORD NG, 1989, PLANT SCI, V62, P207, DOI 10.1016/0168-9452(89)90083-6; HALFORD NG, 1987, THEOR APPL GENET, V75, P117, DOI 10.1007/BF00249151; HARBERD NP, 1987, MOL GEN GENET, V209, P326, DOI 10.1007/BF00329661; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Jiang QT, 2012, GENETICA, V140, P325, DOI 10.1007/s10709-012-9683-4; Juhasz A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029501; KOSUGI S, 1990, PLANT SCI, V70, P133, DOI 10.1016/0168-9452(90)90042-M; Li W, 2004, THEOR APPL GENET, V109, P1093, DOI 10.1007/s00122-004-1726-5; Liu JJ, 2003, EUPHYTICA, V131, P147, DOI 10.1023/A:1023972032592; MARCHYLO BA, 1992, J CEREAL SCI, V15, P29, DOI 10.1016/S0733-5210(09)80054-4; MARKS MD, 1985, J BIOL CHEM, V260, P6445; MULLER M, 1993, PLANT J, V4, P343, DOI 10.1046/j.1365-313X.1993.04020343.x; Onate L, 1999, J BIOL CHEM, V274, P9175, DOI 10.1074/jbc.274.14.9175; Onodera Y, 2001, J BIOL CHEM, V276, P14139, DOI 10.1074/jbc.M007405200; Ortiz Juan Pablo A., 1997, Journal of Applied Genetics, V38, P123; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Qu LQ, 2008, J EXP BOT, V59, P2417, DOI 10.1093/jxb/ern110; Radovanovic N, 2003, MOL BREEDING, V12, P51, DOI 10.1023/A:1025484523771; Ragupathy R, 2008, THEOR APPL GENET, V116, P283, DOI 10.1007/s00122-007-0666-2; Rasmussen R, 2001, RAPID CYCLE REAL TIM, P21, DOI [10.1007/978-3-642-59524-0_3, DOI 10.1007/978-3-642-59524-0_3]; REDDY P, 1993, THEOR APPL GENET, V85, P616, DOI 10.1007/BF00220921; Sambrook J., 2002, MOL CLONING LAB MANU; SanMiguel P, 1996, SCIENCE, V274, P765, DOI 10.1126/science.274.5288.765; Sha S, 1996, BIOSCI BIOTECH BIOCH, V60, P335, DOI 10.1271/bbb.60.335; Shaw LM, 2009, FUNCT INTEGR GENOMIC, V9, P485, DOI 10.1007/s10142-009-0130-2; SHEWRY PR, 1990, BIOCHEM J, V267, P1; Su ZQ, 2011, THEOR APPL GENET, V122, P211, DOI 10.1007/s00122-010-1437-z; Takaiwa F, 1996, PLANT MOL BIOL, V30, P1207, DOI 10.1007/BF00019553; THOMAS MS, 1990, PLANT CELL, V2, P1171, DOI 10.1105/tpc.2.12.1171; Vinces MD, 2009, SCIENCE, V324, P1213, DOI 10.1126/science.1170097; Wessler S R, 1998, Symp Soc Exp Biol, V51, P115; Wieser H, 2000, EUR FOOD RES TECHNOL, V211, P262, DOI 10.1007/s002170000165; Wu CY, 1998, PLANT J, V14, P673, DOI 10.1046/j.1365-313x.1998.00167.x; Yan Y, 2004, THEOR APPL GENET, V108, P1349, DOI 10.1007/s00122-003-1547-y; Yang Zu-Jun, 2006, Acta Genetica Sinica, V33, P929, DOI 10.1016/S0379-4172(06)60127-3; Zhang XB, 2002, J GEN VIROL, V83, P1069, DOI 10.1099/0022-1317-83-5-1069; ZHENG ZW, 1993, PLANT J, V4, P357, DOI 10.1046/j.1365-313X.1993.04020357.x	55	19	20	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105363	10.1371/journal.pone.0105363	http://dx.doi.org/10.1371/journal.pone.0105363			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133580	Green Submitted, gold, Green Published			2022-12-25	WOS:000341302700104
J	Leggatt, RA; Hollo, T; Vandersteen, WE; McFarlane, K; Goh, B; Prevost, J; Devlin, RH				Leggatt, Rosalind A.; Hollo, Tanya; Vandersteen, Wendy E.; McFarlane, Kassandra; Goh, Benjamin; Prevost, Joelle; Devlin, Robert H.			Rearing in Seawater Mesocosms Improves the Spawning Performance of Growth Hormone Transgenic and Wild-Type Coho Salmon	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; POLYMORPHIC MICROSATELLITE MARKERS; TILAPIA OREOCHROMIS-NILOTICUS; REPEAT-ENRICHED LIBRARIES; EXPRESSED SEQUENCE TAGS; RAINBOW-TROUT; ATLANTIC SALMON; REPRODUCTIVE-PERFORMANCE; BREEDING SUCCESS; CHINOOK SALMON	Growth hormone (GH) transgenes can significantly accelerate growth rates in fish and cause associated alterations to their physiology and behaviour. Concern exists regarding potential environmental risks of GH transgenic fish, should they enter natural ecosystems. In particular, whether they can reproduce and generate viable offspring under natural conditions is poorly understood. In previous studies, GH transgenic salmon grown under contained culture conditions had lower spawning behaviour and reproductive success relative to wild-type fish reared in nature. However, wild-type salmon cultured in equal conditions also had limited reproductive success. As such, whether decreased reproductive success of GH transgenic salmon is due to the action of the transgene or to secondary effects of culture (or a combination) has not been fully ascertained. Hence, salmon were reared in large (350,000 L), semi-natural, seawater tanks (termed mesocosms) designed to minimize effects of standard laboratory culture conditions, and the reproductive success of wild-type and GH transgenic coho salmon from mesocosms were compared with that of wild-type fish from nature. Mesocosm rearing partially restored spawning behaviour and success of wild-type fish relative to culture rearing, but remained lower overall than those reared in nature. GH transgenic salmon reared in the mesocosm had similar spawning behaviour and success as wild-type fish reared in the mesocosm when in full competition and without competition, but had lower success in male-only competition experiments. There was evidence of genotype x environmental interactions on spawning success, so that spawning success of transgenic fish, should they escape to natural systems in early life, cannot be predicted with low uncertainty. Under the present conditions, we found no evidence to support enhanced mating capabilities of GH transgenic coho salmon compared to wild-type salmon. However, it is clear that GH transgenic salmon are capable of successful spawning, and can reproduce with wild-type fish from natural systems.	[Leggatt, Rosalind A.; Hollo, Tanya; Vandersteen, Wendy E.; McFarlane, Kassandra; Goh, Benjamin; Prevost, Joelle; Devlin, Robert H.] Fisheries & Oceans Canada, West Vancouver Labs, W Vancouver, BC, Canada	Fisheries & Oceans Canada	Devlin, RH (corresponding author), Fisheries & Oceans Canada, West Vancouver Labs, W Vancouver, BC, Canada.	Robert.devlin@dfo-mpo.gc.ca			Canadian Regulatory System for Biotechnology grant	Canadian Regulatory System for Biotechnology grant	Funding for this project was through a Canadian Regulatory System for Biotechnology grant to RHD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens RNM, 2011, TRANSGENIC RES, V20, P583, DOI 10.1007/s11248-010-9443-0; Aikio S, 2008, OIKOS, V117, P406, DOI 10.1111/j.2007.0030-1299.16061.x; Anderson JH, 2013, EVOL APPL, V6, P165, DOI 10.1111/j.1752-4571.2012.00271.x; [Anonymous], ENV RISK ASSESSMENT; Berejikian BA, 2000, J FISH BIOL, V57, P647, DOI 10.1111/j.1095-8649.2000.tb00266.x; Berejikian BA, 1997, ICES J MAR SCI, V54, P1040, DOI 10.1016/S1054-3139(97)80008-2; Berejikian BA, 2001, N AM J FISH MANAGE, V21, P255, DOI 10.1577/1548-8675(2001)021<0255:RBABSO>2.0.CO;2; Berejikian BA, 2001, CAN J FISH AQUAT SCI, V58, P804, DOI 10.1139/cjfas-58-4-804; Berejikian BA, 2009, CAN J FISH AQUAT SCI, V66, P781, DOI 10.1139/F09-041; Bessey C, 2004, T AM FISH SOC, V133, P1205, DOI 10.1577/T04-010.1; Burner C.J., 1951, FISH B, V52, P95; Cairney M, 2000, MOL ECOL, V9, P2175, DOI 10.1046/j.1365-294X.2000.105312.x; Coulibaly I, 2005, ANIM GENET, V36, P309, DOI 10.1111/j.1365-2052.2005.01305.x; Devlin RH, 1995, AQUACULTURE, V137, P161, DOI 10.1016/0044-8486(95)01090-4; Devlin RH, 1999, AQUAC RES, V30, P479, DOI 10.1046/j.1365-2109.1999.00359.x; Devlin RH, 2004, AQUACULTURE, V236, P607, DOI 10.1016/j.aquaculture.2004.02.026; DEVLIN RH, 1995, CAN J FISH AQUAT SCI, V52, P1376, DOI 10.1139/f95-133; DEVLIN RH, 1994, NATURE, V371, P209, DOI 10.1038/371209a0; Devlin RH, 2001, NATURE, V409, P781, DOI 10.1038/35057314; DFO, 2013, 2013023 DFO; DU SJ, 1992, BIO-TECHNOL, V10, P176, DOI 10.1038/nbt0292-176; DUNHAM RA, 1995, BIOTECHNOLOGY RISK A, P127; Figueiredo MA, 2013, ANIM REPROD SCI, V139, P162, DOI 10.1016/j.anireprosci.2013.03.012; Fitzpatrick JL, 2011, AQUACULTURE, V312, P185, DOI 10.1016/j.aquaculture.2010.11.044; FLEMING IA, 1993, ECOL APPL, V3, P230, DOI 10.2307/1941826; Fleming IA, 1996, J APPL ECOL, V33, P893, DOI 10.2307/2404960; Fleming IA, 1997, BEHAV ECOL, V8, P470, DOI 10.1093/beheco/8.5.470; FLEMING IA, 1989, EVOLUTION, V43, P141, DOI 10.1111/j.1558-5646.1989.tb04213.x; Fleming IA, 2000, P ROY SOC B-BIOL SCI, V267, P1517, DOI 10.1098/rspb.2000.1173; Fleming Ian A., 2001, Nordic Journal of Freshwater Research, V75, P71; Hedrick PW, 2001, CAN J FISH AQUAT SCI, V58, P841, DOI 10.1139/cjfas-58-5-841; Howard RD, 2004, P NATL ACAD SCI USA, V101, P2934, DOI 10.1073/pnas.0306285101; Jhingan E, 2003, J FISH BIOL, V63, P806, DOI 10.1046/j.1095-8649.2003.00194.x; Kim JH, 2013, FISH SHELLFISH IMMUN, V34, P1553, DOI 10.1016/j.fsi.2013.03.365; Kobayashi SI, 2007, AQUACULTURE, V270, P427, DOI 10.1016/j.aquaculture.2007.05.016; Leggatt RA, 2012, AQUACULTURE, V356, P193, DOI 10.1016/j.aquaculture.2012.05.016; Lian H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065506; Maclean N, 2000, FISH FISH, V1, P146, DOI 10.1046/j.1467-2979.2000.00014.x; Moreau DTR, 2011, EVOL APPL, V4, P736, DOI 10.1111/j.1752-4571.2011.00196.x; Muir WM, 2001, AM NAT, V158, P1, DOI 10.1086/320860; Muir WM, 1999, P NATL ACAD SCI USA, V96, P13853, DOI 10.1073/pnas.96.24.13853; Nam YK, 2001, TRANSGENIC RES, V10, P353, DOI 10.1023/A:1016696104185; Olsen JB, 2000, MOL ECOL, V9, P2185, DOI 10.1046/j.1365-294X.2000.105317.x; Ostenfeld TH, 1998, J FISH BIOL, V52, P850, DOI 10.1111/j.1095-8649.1998.tb00825.x; Palti Y, 2002, MOL ECOL NOTES, V2, P449, DOI 10.1046/j.1471-8286.2002.00274.x; Pennington KM, 2011, T AM FISH SOC, V140, P221, DOI 10.1080/00028487.2011.545012; Pennington Kelly M., 2010, Environmental Biosafety Research, V9, DOI 10.1051/ebr/2010005; Rahman MA, 1998, TRANSGENIC RES, V7, P357, DOI 10.1023/A:1008837105299; Rexroad CE, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-54; Rexroad CE, 2002, MAR BIOTECHNOL, V4, P12, DOI 10.1007/s10126-001-0058-6; Rexroad CE, 2003, T AM FISH SOC, V132, P1214, DOI 10.1577/T02-086; Rexroad CE, 2001, ANIM GENET, V32, P317, DOI 10.1046/j.1365-2052.2001.0730b.x; Rodriguez F, 2003, MOL ECOL NOTES, V3, P619, DOI 10.1046/j.1471-8286.2003.00531.x; Small MP, 1998, MOL ECOL, V7, P141, DOI 10.1046/j.1365-294x.1998.00324.x; Sundstrom LF, 2007, P NATL ACAD SCI USA, V104, P3889, DOI 10.1073/pnas.0608767104; Sundstrom LF, 2004, P ROY SOC B-BIOL SCI, V271, pS350, DOI 10.1098/rsbl.2004.0189; Valosaari KR, 2008, EVOL APPL, V1, P608, DOI 10.1111/j.1752-4571.2008.00046.x; Zhu Z, 1985, J APPL ICHTHYOL, V1, P31, DOI DOI 10.1111/J.1439-0426.1985.TB00408.X	58	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105377	10.1371/journal.pone.0105377	http://dx.doi.org/10.1371/journal.pone.0105377			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133780	gold, Green Published, Green Submitted			2022-12-25	WOS:000341302700108
J	Mwebaze, RM; Kibirige, D				Mwebaze, Raymond Mbayo; Kibirige, Davis			Peripheral Arterial Disease among Adult Diabetic Patients Attending a Large Outpatient Diabetic Clinic at a National Referral Hospital in Uganda: A Descriptive Cross Sectional Study	PLOS ONE			English	Article							INTERMITTENT CLAUDICATION; CARDIOVASCULAR-DISEASE; MICROALBUMINURIA; COMPLICATIONS; PREVALENCE; MORTALITY; MELLITUS; AFRICA; RISK	Background: Peripheral arterial disease (PAD) is one of the recognised diabetic macro vascular complications. It is a marker of generalised systemic atherosclerosis and is closely associated with symptomatic coronary and cerebrovascular disease, hence significant morbidity and mortality. Among African adult diabetic populations, screening and diagnosis of PAD is frequently suboptimal. The aim of this study was to determine the prevalence and associated clinical factors of PAD in adult ambulatory diabetic patients attending the outpatient diabetic clinic of Mulago national referral and teaching hospital, Kampala Uganda. Methods: In this descriptive cross sectional study, 146 ambulatory adult diabetic patients were studied. Information about their socio-demographic and clinical characteristics, fasting lipid profile status, blood pressure, glycated haemoglobin (HbA1c) levels and presence of albuminuria was collected using a pre tested questionnaire. Measurement of ankle brachial index (ABI) to assess for PAD, defined as a ratio less than 0.9 was performed using a portable 5-10 MHz Doppler device. Clinical factors associated with PAD were determined by comparing specific selected characteristics in patients with PAD and those without. Results: The mean age/standard deviation of the study participants was 53.9/12.4 years with a male predominance (75, 51.4%). PAD was prevalent in 57 (39%) study participants. Of these, 34 (59.6%) had symptomatic PAD. The noted clinical factors associated with PAD in this study population were presence of symptoms of intermittent claudication and microalbuminuria. Conclusions: This study documents a high prevalence of PAD among adult ambulatory Ugandan diabetic patients. Aggressive screening for PAD using ABI measurement in adult diabetic patients should be emphasised in Uganda especially in the presence of symptoms of intermittent claudication and microalbuminuria.	[Mwebaze, Raymond Mbayo] St Raphael St Francis Hosp Nsambya, Dept Med & Diabet, Endocrine Clin, Kampala, Uganda; [Mwebaze, Raymond Mbayo] Uganda Martyrs Univ, Mother Kevin Postgrad Med Sch, Nkozi, Uganda; [Kibirige, Davis] Uganda Martyrs Hosp Lubaga, Dept Med, Kampala, Uganda	Uganda Martyrs University	Kibirige, D (corresponding author), Uganda Martyrs Hosp Lubaga, Dept Med, Kampala, Uganda.	kibirigedavis@gmail.com		kibirige, Davis/0000-0001-5127-3031				Abdelhafiz AH, 2011, NEPHRON EXP NEPHROL, V119, pE6, DOI 10.1159/000328015; American Diabetes Association Diabetes, 2014, DIABETES CARE, V37, pS14; Criqui MH, 2001, VASC MED, V6, P3, DOI 10.1177/1358836X0100600i102; CRIQUI MH, 1992, NEW ENGL J MED, V326, P381, DOI 10.1056/NEJM199202063260605; DECKERT T, 1992, DIABETES CARE, V15, P1181, DOI 10.2337/diacare.15.9.1181; Gu K, 1998, DIABETES CARE, V21, P1138, DOI 10.2337/diacare.21.7.1138; Gulam-Abbas Z, 2002, DIABETIC MED, V19, P575, DOI 10.1046/j.1464-5491.2002.00740.x; HERTZER NR, 1984, ANN SURG, V199, P223, DOI 10.1097/00000658-198402000-00016; Kengne AP, 2005, CIRCULATION, V112, P3592, DOI 10.1161/CIRCULATIONAHA.105.544312; Kibirige D, 2014, J DIABETES METAB DIS, V13, DOI 10.1186/2251-6581-13-40; LENG GC, 1992, J CLIN EPIDEMIOL, V45, P1101, DOI 10.1016/0895-4356(92)90150-L; Murabito JM, 1997, CIRCULATION, V96, P44; Natha B, 2014, SAMJ S AFR MED J, V104, P148, DOI 10.7196/samj.7919; Oyelade B, 2012, AFR J PRIM HEALTH CA, V4, P354; Paul AK, 2007, SAMJ S AFR MED J, V97, P285; Rabia K, 2007, Med J Malaysia, V62, P130; Rheeder P, 2004, SAMJ S AFR MED J, V94, P379; Singh PP, 2011, DIABETES CARE, V34, P464, DOI 10.2337/dc10-1734; Sobngwi E, 2012, DIABETES RES CLIN PR, V95, P30, DOI 10.1016/j.diabres.2011.10.018; Stehouwer CDA, 2006, J AM SOC NEPHROL, V17, P2106, DOI 10.1681/ASN.2005121288; Uloko Andrew E, 2012, Indian J Endocrinol Metab, V16, P558, DOI 10.4103/2230-8210.98011; White C, 2007, NEW ENGL J MED, V356, P1241, DOI 10.1056/NEJMcp064483	22	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105211	10.1371/journal.pone.0105211	http://dx.doi.org/10.1371/journal.pone.0105211			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133533	Green Published, gold, Green Submitted			2022-12-25	WOS:000341302700087
J	Nunoura, T; Takaki, Y; Kazama, H; Kakuta, J; Shimamura, S; Makita, H; Hirai, M; Miyazaki, M; Takai, K				Nunoura, Takuro; Takaki, Yoshihiro; Kazama, Hiromi; Kakuta, Jungo; Shimamura, Shigeru; Makita, Hiroko; Hirai, Miho; Miyazaki, Masayuki; Takai, Ken			Physiological and Genomic Features of a Novel Sulfur-Oxidizing Gammaproteobacterium Belonging to a Previously Uncultivated Symbiotic Lineage Isolated from a Hydrothermal Vent	PLOS ONE			English	Article							OKINAWENSIS SP NOV.; GEN. NOV.; PHYLOGENETIC DIVERSITY; EPSILON-PROTEOBACTERIA; MICROBIAL COMMUNITIES; MOLECULAR ANALYSIS; RIFTIA-PACHYPTILA; SULFATE-REDUCTION; ESCHERICHIA-COLI; BACTERIUM	Strain Hiromi 1, a sulfur-oxidizing gammaproteobacterium was isolated from a hydrothermal vent chimney in the Okinawa Trough and represents a novel genus that may include a phylogenetic group found as endosymbionts of deep-sea gastropods. The SSU rRNA gene sequence similarity between strain Hiromi 1 and the gastropod endosymbionts was approximately 97%. The strain was shown to grow both chemolithoautotrophically and chemolithoheterotrophically with an energy metabolism of sulfur oxidation and O-2 or nitrate reduction. Under chemolithoheterotrophic growth conditions, the strain utilized organic acids and proteinaceous compounds as the carbon and/or nitrogen sources but not the energy source. Various sugars did not support growth as a sole carbon source. The observation of chemolithoheterotrophy in this strain is in line with metagenomic analyses of endosymbionts suggesting the occurrence of chemolithoheterotrophy in gammaproteobacterial symbionts. Chemolithoheterotrophy and the presence of homologous genes for virulence- and quorum sensing-related functions suggest that the sulfur-oxidizing chomolithotrophic microbes seek animal bodies and microbial biofilm formation to obtain supplemental organic carbons in hydrothermal ecosystems.	[Nunoura, Takuro; Takaki, Yoshihiro; Kazama, Hiromi; Kakuta, Jungo; Shimamura, Shigeru; Makita, Hiroko; Hirai, Miho; Miyazaki, Masayuki; Takai, Ken] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Inst Biogeosci, Extremobiosphere Res Program, Subsurface Geobiol & Adv Res SUGAR Project, Yokosuka, Kanagawa, Japan	Japan Agency for Marine-Earth Science & Technology (JAMSTEC)	Nunoura, T (corresponding author), Japan Agcy Marine Earth Sci & Technol JAMSTEC, Inst Biogeosci, Extremobiosphere Res Program, Subsurface Geobiol & Adv Res SUGAR Project, Yokosuka, Kanagawa, Japan.	takuron@jamstec.go.jp	Makita, Hiroko/U-8718-2017; Nunoura, Takuro/AAL-6266-2020	Makita, Hiroko/0000-0002-9547-8351; Nunoura, Takuro/0000-0003-2323-0880	JAMSTEC;  [18658135]	JAMSTEC; 	The study was partially supported by a Grant-in-Aid for Exploratory Research (no. 18658135 to TN), and was supported mostly by operating expenses of the authors' institute JAMSTEC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anantharaman K, 2013, P NATL ACAD SCI USA, V110, P330, DOI 10.1073/pnas.1215340110; Andrews SC, 1997, MICROBIOL-SGM, V143, P3633, DOI 10.1099/00221287-143-11-3633; Antunes LCM, 2010, MICROBIOL-SGM, V156, P2271, DOI 10.1099/mic.0.038794-0; Besemer J, 2001, NUCLEIC ACIDS RES, V29, P2607, DOI 10.1093/nar/29.12.2607; Caspi R, 2012, NUCLEIC ACIDS RES, V40, pD742, DOI 10.1093/nar/gkr1014; Christie W. W., 1997, ADV LIPID METHODOLOG, V4, P119; Clarke MB, 2006, P NATL ACAD SCI USA, V103, P10420, DOI 10.1073/pnas.0604343103; Dahl Christiane, 2008, V27, P289; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Dubilier N, 2008, NAT REV MICROBIOL, V6, P725, DOI 10.1038/nrmicro1992; Eddy Sean R, 2009, Genome Inform, V23, P205; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Friedrich CG, 2008, MICROBIAL SULFUR METABOLISM, P139, DOI 10.1007/978-3-540-72682-1_12; Frigaard Niels-Ulrik, 2008, V27, P337; Frigaard NU, 2008, MICROBIAL SULFUR METABOLISM, P60, DOI 10.1007/978-3-540-72682-1_6; Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119; Fujiwara Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011808; Gardebrecht A, 2012, ISME J, V6, P766, DOI 10.1038/ismej.2011.137; Ghosh W, 2009, FEMS MICROBIOL REV, V33, P999, DOI 10.1111/j.1574-6976.2009.00187.x; GILLIS M, 2001, BERGEYS MANUAL SYSTE, V1, P43, DOI DOI 10.1007/978-0-387-21609-6_7; Godlewska R, 2009, FEMS MICROBIOL LETT, V298, P1, DOI 10.1111/j.1574-6968.2009.01659.x; Grimm F, 2008, MICROBIAL SULFUR METABOLISM, P101, DOI 10.1007/978-3-540-72682-1_9; Guiral M, 2005, J BIOL CHEM, V280, P42004, DOI 10.1074/jbc.M508034200; Harmer TL, 2008, APPL ENVIRON MICROB, V74, P3895, DOI 10.1128/AEM.02470-07; He YW, 2008, FEMS MICROBIOL REV, V32, P842, DOI 10.1111/j.1574-6976.2008.00120.x; Hickman JW, 2005, P NATL ACAD SCI USA, V102, P14422, DOI 10.1073/pnas.0507170102; HUBER H, 1989, ARCH MICROBIOL, V151, P479, DOI 10.1007/BF00454862; Imhoff JF, 2005, BERGEYS MANUAL SYSTE, V2, P28; Imhoff JF., 2005, BERGEYS MANUAL SYSTE, V2, P12; Imhoff JF, 2005, BERGEYS MANUAL SYSTE, V2, P20; Imhoff JF., 2005, BERGEYS MANUAL SYS B, V2, P3; Jorgensen BB, 2007, NAT REV MICROBIOL, V5, P770, DOI 10.1038/nrmicro1745; KAMPF C, 1980, ARCH MICROBIOL, V127, P125, DOI 10.1007/BF00428016; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kawagucci S, 2013, CHEM GEOL, V339, P213, DOI 10.1016/j.chemgeo.2012.05.003; Kleiner M, 2012, CURR OPIN MICROBIOL, V15, P621, DOI 10.1016/j.mib.2012.09.003; Kleiner M, 2012, P NATL ACAD SCI USA, V109, pE1173, DOI 10.1073/pnas.1121198109; KOMAGATA K, 1987, METHOD MICROBIOL, V19, P161; Kuwahara H, 2007, CURR BIOL, V17, P881, DOI 10.1016/j.cub.2007.04.039; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Markert S, 2007, SCIENCE, V315, P247, DOI 10.1126/science.1132913; Marshall KT, 2013, ISME J, V7, P452, DOI 10.1038/ismej.2012.78; Meyer B, 2007, ENVIRON MICROBIOL, V9, P2957, DOI 10.1111/j.1462-2920.2007.01407.x; Meyer B, 2007, MICROBIOL-SGM, V153, P3478, DOI 10.1099/mic.0.2007/008250-0; Meyer B, 2007, MICROBIOL-SGM, V153, P2026, DOI 10.1099/mic.0.2006/003152-0; MIDI, 1999, SHERL MICR ID SYST O; MINNIKIN DE, 1984, J MICROBIOL METH, V2, P233, DOI 10.1016/0167-7012(84)90018-6; Mori K, 2011, INT J SYST EVOL MICR, V61, P2412, DOI 10.1099/ijs.0.026963-0; Mussmann M, 2007, PLOS BIOL, V5, P1923, DOI 10.1371/journal.pbio.0050230; Nakagawa S, 2005, FEMS MICROBIOL ECOL, V54, P141, DOI 10.1016/j.femsec.2005.03.007; Nakagawa S, 2005, ENVIRON MICROBIOL, V7, P1619, DOI 10.1111/j.1462-2920.2005.00856.x; Nakagawa S, 2008, FEMS MICROBIOL ECOL, V65, P1, DOI 10.1111/j.1574-6941.2008.00502.x; Nakagawa S, 2007, P NATL ACAD SCI USA, V104, P12146, DOI 10.1073/pnas.0700687104; Nakagawa S, 2014, ISME J, V8, P40, DOI 10.1038/ismej.2013.131; Newton ILG, 2007, SCIENCE, V315, P998, DOI 10.1126/science.1138438; Nunoura T, 2008, INT J SYST EVOL MICR, V58, P676, DOI 10.1099/ijs.0.64615-0; Nunoura T, 2009, FEMS MICROBIOL ECOL, V67, P351, DOI 10.1111/j.1574-6941.2008.00636.x; Ohashi Y, 2008, MOL BIOSYST, V4, P135, DOI 10.1039/b714176a; Pires RH, 2003, BBA-BIOENERGETICS, V1605, P67, DOI 10.1016/S0005-2728(03)00065-3; PORTER KG, 1980, LIMNOL OCEANOGR, V25, P943, DOI 10.4319/lo.1980.25.5.0943; Prunetti L, 2010, J BIOL CHEM, V285, P41815, DOI 10.1074/jbc.M110.167841; Ramos AR, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00137; Rashid N, 2002, J BIOL CHEM, V277, P30649, DOI 10.1074/jbc.M202868200; Reading NC, 2009, P NATL ACAD SCI USA, V106, P5889, DOI 10.1073/pnas.0811409106; Reshetnikov AS, 2008, FEMS MICROBIOL LETT, V288, P202, DOI 10.1111/j.1574-6968.2008.01366.x; Robidart JC, 2008, ENVIRON MICROBIOL, V10, P727, DOI 10.1111/j.1462-2920.2007.01496.x; Sato T, 2004, J BACTERIOL, V186, P5799, DOI 10.1128/JB.186.17.5799-5807.2004; Sato T, 2007, SCIENCE, V315, P1003, DOI 10.1126/science.1135999; Say RF, 2010, NATURE, V464, P1077, DOI 10.1038/nature08884; Scott KM, 2006, PLOS BIOL, V4, P2196, DOI 10.1371/journal.pbio.0040383; Shively JM, 1998, ANNU REV MICROBIOL, V52, P191, DOI 10.1146/annurev.micro.52.1.191; Sorokin DY, 2007, ARCH MICROBIOL, V187, P441, DOI 10.1007/s00203-006-0208-3; Sorokin DY, 2010, INT J SYST EVOL MICR, V60, P444, DOI 10.1099/ijs.0.012880-0; Sorokin DY, 2002, INT J SYST EVOL MICR, V52, P657, DOI 10.1099/00207713-52-2-657; Stockdreher Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040785; Sucharita K, 2010, INT J SYST EVOL MICR, V60, P1103, DOI 10.1099/ijs.0.013284-0; Suzuki Y, 2006, APPL ENVIRON MICROB, V72, P1388, DOI 10.1128/AEM.72.2.1388-1393.2006; Suzuki Y, 2006, MAR ECOL PROG SER, V315, P167, DOI 10.3354/meps315167; Szurmant L, 2004, MICROBIOL MOL BIOL R, V68, P301, DOI 10.1128/MMBR.68.2.301-319.2004; Takai K, 2000, INT J SYST EVOL MICR, V50, P489, DOI 10.1099/00207713-50-2-489; Takai K, 2005, INT J SYST EVOL MICR, V55, P183, DOI 10.1099/ijs.0.63330-0; Takai K, 2004, INT J SYST EVOL MICR, V54, P2325, DOI 10.1099/ijs.0.63284-0; Takai K, 2003, FEMS MICROBIOL LETT, V218, P167, DOI 10.1111/j.1574-6968.2003.tb11514.x; Takai K, 2002, INT J SYST EVOL MICR, V52, P1089, DOI 10.1099/00207713-52-4-1089; Takai K, 2009, ENVIRON MICROBIOL, V11, P1983, DOI 10.1111/j.1462-2920.2009.01921.x; Takail K, 2006, GEOPHYS MONOGR SER, V166, P185; TAKAKUWA S, 1977, J GEN APPL MICROBIOL, V23, P163, DOI 10.2323/jgam.23.163; Wadhams GH, 2004, NAT REV MOL CELL BIO, V5, P1024, DOI 10.1038/nrm1524; Welte C, 2009, FEBS LETT, V583, P1281, DOI 10.1016/j.febslet.2009.03.020; Williams P, 2009, CURR OPIN MICROBIOL, V12, P182, DOI 10.1016/j.mib.2009.01.005; Yildiz FH, 2009, TRENDS MICROBIOL, V17, P109, DOI 10.1016/j.tim.2008.12.004; Yoshida-Takashima Y, 2012, APPL ENVIRON MICROB, V78, P1311, DOI 10.1128/AEM.06491-11; Zaar A, 2003, ARCH MICROBIOL, V179, P174, DOI 10.1007/s00203-002-0514-3; Zane GM, 2010, APPL ENVIRON MICROB, V76, P5500, DOI 10.1128/AEM.00691-10; ZILLIG W, 1990, J BACTERIOL, V172, P3959, DOI 10.1128/jb.172.7.3959-3965.1990	98	19	19	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e104959	10.1371/journal.pone.0104959	http://dx.doi.org/10.1371/journal.pone.0104959			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133584	Green Submitted, Green Published, gold			2022-12-25	WOS:000341302700056
J	Watson, CM; El-Asrag, M; Parry, DA; Morgan, JE; Logan, CV; Carr, IM; Sheridan, E; Charlton, R; Johnson, CA; Taylor, G; Toomes, C; McKibbin, M; Inglehearn, CF; Ali, M				Watson, Christopher M.; El-Asrag, Mohammed; Parry, David A.; Morgan, Joanne E.; Logan, Clare V.; Carr, Ian M.; Sheridan, Eamonn; Charlton, Ruth; Johnson, Colin A.; Taylor, Graham; Toomes, Carmel; McKibbin, Martin; Inglehearn, Chris F.; Ali, Manir			Mutation Screening of Retinal Dystrophy Patients by Targeted Capture from Tagged Pooled DNAs and Next Generation Sequencing	PLOS ONE			English	Article							LEBER CONGENITAL AMAUROSIS; CONE-ROD DYSTROPHY; RETINITIS-PIGMENTOSA; MISSENSE MUTATIONS; VISUAL FUNCTION; GENE-THERAPY; ABCA4 GENE; DISEASE; MICE; FREQUENCY	Purpose: Retinal dystrophies are genetically heterogeneous, resulting from mutations in over 200 genes. Prior to the development of massively parallel sequencing, comprehensive genetic screening was unobtainable for most patients. Identifying the causative genetic mutation facilitates genetic counselling, carrier testing and prenatal/pre-implantation diagnosis, and often leads to a clearer prognosis. In addition, in a proportion of cases, when the mutation is known treatment can be optimised and patients are eligible for enrolment into clinical trials for gene-specific therapies. Methods: Patient genomic DNA was sheared, tagged and pooled in batches of four samples, prior to targeted capture and next generation sequencing. The enrichment reagent was designed against genes listed on the RetNet database (July 2010). Sequence data were aligned to the human genome and variants were filtered to identify potential pathogenic mutations. These were confirmed by Sanger sequencing. Results: Molecular analysis of 20 DNAs from retinal dystrophy patients identified likely pathogenic mutations in 12 cases, many of them known and/or confirmed by segregation. These included previously described mutations in ABCA4 (c.6088C> T,p.R2030*; c.5882G>A,p.G1961E), BBS2 (c.1895G>C,p.R632P), GUCY2D (c.2512C>T, p.R838C), PROM1 (c.1117C> T,p.R373C), RDH12 (c.601T. C, p.C201R; c.506G>A, p.R169Q), RPGRIP1 (c.3565C>T, p.R1189*) and SPATA7 (c.253C>T, p.R85*) and new mutations in ABCA4 (c.3328+ 1G>C), CRB1 (c.2832_2842+23del), RP2 (c.884-1G>T) and USH2A (c.12874A. G,p.N4292D). Conclusions: Tagging and pooling DNA prior to targeted capture of known retinal dystrophy genes identified mutations in 60% of cases. This relatively high success rate may reflect enrichment for consanguineous cases in the local Yorkshire population, and the use of multiplex families. Nevertheless this is a promising high throughput approach to retinal dystrophy diagnostics.	[Watson, Christopher M.; Charlton, Ruth; Taylor, Graham] St James Univ Hosp, Yorkshire Reg Genet Serv, Leeds, W Yorkshire, England; [El-Asrag, Mohammed; Logan, Clare V.; Johnson, Colin A.; Toomes, Carmel; McKibbin, Martin; Inglehearn, Chris F.; Ali, Manir] Univ Leeds, Leeds Inst Biomed & Clin Sci, Sect Ophthalmol & Neurosci, Leeds, W Yorkshire, England; [Parry, David A.; Morgan, Joanne E.; Carr, Ian M.; Sheridan, Eamonn] Univ Leeds, Leeds Inst Biomed & Clin Sci, Genet Sect, Leeds, W Yorkshire, England; [McKibbin, Martin] St James Univ Hosp, Dept Ophthalmol, Leeds, W Yorkshire, England	Saint James's University Hospital; University of Leeds; University of Leeds; Saint James's University Hospital	Ali, M (corresponding author), Univ Leeds, Leeds Inst Biomed & Clin Sci, Sect Ophthalmol & Neurosci, Leeds, W Yorkshire, England.	medma@leeds.ac.uk	Ali, Manir/ABE-5251-2020; Elasrag, Mohammed/ABF-5702-2020; Inglehearn, Chris/GYD-9783-2022	Ali, Manir/0000-0003-3204-3788; Elasrag, Mohammed/0000-0003-3750-7414; Johnson, Colin/0000-0002-2979-8234; Toomes, Carmel/0000-0001-8373-9545; Watson, Christopher Mark/0000-0003-2371-1844; Logan, Clare/0000-0003-4323-1602; Parry, David/0000-0003-0376-7736	Leeds Teaching Hospitals NHS Trust Challenge Fund, Yorkshire Eye Research [022]; Sir Jules Thorn Charitable Trust; Egyptian Government; Medical Research Council [MR/K011154/1, MR/L01629X/1] Funding Source: researchfish; The Sir Jules Thorn Charitable Trust [09JTA] Funding Source: researchfish; MRC [MR/L01629X/1, MR/K011154/1] Funding Source: UKRI	Leeds Teaching Hospitals NHS Trust Challenge Fund, Yorkshire Eye Research; Sir Jules Thorn Charitable Trust; Egyptian Government; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Sir Jules Thorn Charitable Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Leeds Teaching Hospitals NHS Trust Challenge Fund, Yorkshire Eye Research (grant number 022) and the Sir Jules Thorn Charitable Trust. ME-A is funded by a Scholarship from the Egyptian Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Safieh L, 2013, GENOME RES, V23, P236, DOI 10.1101/gr.144105.112; Audo I, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-8; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Bowne SJ, 2011, INVEST OPHTH VIS SCI, V52, P494, DOI 10.1167/iovs.10-6180; Bunce C, 2010, EYE, V24, P1692, DOI 10.1038/eye.2010.122; Burke TR, 2012, INVEST OPHTH VIS SCI, V53, P4458, DOI 10.1167/iovs.11-9166; Cella W, 2009, EXP EYE RES, V89, P16, DOI 10.1016/j.exer.2009.02.001; Coppieters F, 2012, GENET MED, V14, P576, DOI 10.1038/gim.2011.51; DARR A, 1988, J MED GENET, V25, P186, DOI 10.1136/jmg.25.3.186; den Hollander AI, 2006, AM J HUM GENET, V79, P556, DOI 10.1086/507318; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Fedick A, 2014, CLIN GENET, V85, P578, DOI 10.1111/cge.12231; Han ZC, 2012, J CLIN INVEST, V122, P3221, DOI 10.1172/JCI64833; Harakalova M, 2011, NAT PROTOC, V6, P1870, DOI 10.1038/nprot.2011.396; Khan MI, 2010, MOL VIS, V16, P2753; Lamba DA, 2009, CELL STEM CELL, V4, P73, DOI 10.1016/j.stem.2008.10.015; Lotery AJ, 2001, ARCH OPHTHALMOL-CHIC, V119, P415, DOI 10.1001/archopht.119.3.415; Mackay DS, 2011, MOL VIS, V17, P2706; Mackay DS, 2011, INVEST OPHTH VIS SCI, V52, P3032, DOI 10.1167/iovs.10-7025; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Michaelides M, 2010, INVEST OPHTH VIS SCI, V51, P4771, DOI 10.1167/iovs.09-4561; Neveling K, 2012, HUM MUTAT, V33, P963, DOI 10.1002/humu.22045; O'Sullivan J, 2012, J MED GENET, V49, P322, DOI 10.1136/jmedgenet-2012-100847; Shanks ME, 2013, EUR J HUM GENET, V21, P274, DOI 10.1038/ejhg.2012.172; Simpson DA, 2011, J MED GENET, V48, P145, DOI 10.1136/jmg.2010.083568; Singh HP, 2006, AM J OPHTHALMOL, V141, P906, DOI 10.1016/j.ajo.2005.12.009; Sun WY, 2007, VISION RES, V47, P2055, DOI 10.1016/j.visres.2007.04.005; Tan MH, 2009, HUM MOL GENET, V18, P2099, DOI 10.1093/hmg/ddp133; Van Ghelue  M, 2000, Ophthalmic Genet, V21, P197, DOI 10.1076/1381-6810(200012)21:4;1-H;FT197; Wilkie SE, 2000, HUM MOL GENET, V9, P3065, DOI 10.1093/hmg/9.20.3065; Willis TA, 2013, BRIT J OPHTHALMOL, V97, P1148, DOI 10.1136/bjophthalmol-2013-303434; Yang ZL, 2008, J CLIN INVEST, V118, P2908, DOI 10.1172/JCI35891	32	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e104281	10.1371/journal.pone.0104281	http://dx.doi.org/10.1371/journal.pone.0104281			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133751	Green Published, gold			2022-12-25	WOS:000341302700027
J	Abbondanzo, SJ; Chang, SL				Abbondanzo, Susan J.; Chang, Sulie L.			HIV-1 Transgenic Rats Display Alterations in Immunophenotype and Cellular Responses Associated with Aging	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; AGE-RELATED DISEASES; MOLECULAR-MECHANISMS; MONOCYTE SUBSETS; HEPATITIS-C; T-CELLS; EXPRESSION; INFECTION; ACTIVATION; RISK	Advances in anti-retroviral therapy over the last two decades have allowed life expectancy in patients infected with the human immunodeficiency virus to approach that of the general population. The process of aging in mammalian species, including rats, results in immune response changes, alterations in immunological phenotypes, and ultimately increased susceptibility to many infectious diseases. In order to investigate the immunological pathologies associated with chronic HIV-1 disease, particularly in aging individuals, the HIV-1 transgenic (HIV-1Tg) rat model was utilized. HIV-1Tg rats were challenged with lipopolysaccharide (LPS) to determine immunological alterations during the aging process. LPS is known to cause an imbalance in cytokine and chemokine release, and provides a method to identify changes in immune responses to bacterial infection in an HIV animal model. An immune profile and accompanying cellular consequences as well as changes in inflammatory cytokine and chemokine release related to age and genotype were assessed in HIV-1Tg rats. The percentage of T cells decreased with age, particularly T cytotoxic cells, whereas T helper cells increased with age. Neutrophils and monocytes increased in HIV-1Tg rats during maturation compared to age-matched F344 control rats. Aging HIV-1Tg rats displayed a significant increase in the pro-inflammatory cytokines, IL-6 and TNF-alpha, along with an increase in the chemokine, KC/GRO, in comparison to age-matched controls. Our data indicate that immunophenotype and immune responses can change during aging in HIV-positive individuals. This information could be important in determining the most beneficial age-dependent therapeutic treatment for HIV patients.	[Chang, Sulie L.] Seton Hall Univ, Inst NeuroImmune Pharmacol, S Orange, NJ 07079 USA; Seton Hall Univ, Dept Biol Sci, S Orange, NJ 07079 USA	Seton Hall University; Seton Hall University	Chang, SL (corresponding author), Seton Hall Univ, Inst NeuroImmune Pharmacol, S Orange, NJ 07079 USA.	sulie.chang@shu.edu			United States National Institutes of Health [AA-019415, DA07058, DA-016149, DA-026356, DA-036175]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [RC2AA019415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA007058, K02DA016149, R01DA026356, R21DA036175] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This project was supported, in part, by United States National Institutes of Health grants AA-019415, DA07058, DA-016149, DA-026356, and DA-036175 to SLC. The funders has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg JA, 2011, TOP ANTIVIR MED, V20, P101; [Anonymous], 2012, HIV UK 2012 REP; [Anonymous], 2012, J AM GERIATR SOC, V60, P974; Barrett L, 2012, AIDS REV, V14, P159; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Cavanagh MM, 2012, CURR OPIN IMMUNOL, V24, P488, DOI 10.1016/j.coi.2012.04.003; Chang SL, 2007, J VIROL, V81, P8406, DOI 10.1128/JVI.00155-07; Chang SL, 2012, J NEUROIMMUNE PHARM, V7, P332, DOI 10.1007/s11481-011-9324-1; Chen R, 2005, J NEUROIMMUNOL, V163, P53, DOI 10.1016/j.jneuroim.2005.02.012; Dawson HD, 1999, J NUTR, V129, P1782, DOI 10.1093/jn/129.10.1782; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016; Freiberg MS, 2011, CIRC-CARDIOVASC QUAL, V4, P425, DOI 10.1161/CIRCOUTCOMES.110.957415; Fujihara M, 2003, PHARMACOL THERAPEUT, V100, P171, DOI 10.1016/j.pharmthera.2003.08.003; Gebo KA, 2006, DRUG AGING, V23, P897, DOI 10.2165/00002512-200623110-00005; Goronzy JJ, 2012, CELL MOL LIFE SCI, V69, P1615, DOI 10.1007/s00018-012-0970-0; Grau V, 2000, IMMUNOBIOLOGY, V202, P94, DOI 10.1016/S0171-2985(00)80056-X; High KP, 2012, JAIDS-J ACQ IMM DEF, V60, pS1, DOI 10.1097/QAI.0b013e31825a3668; Homji NF, 2012, INT J CLIN EXP MED, V5, P105; Homji NF, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-3; Joshi PC, 2008, AM J RESP CELL MOL, V39, P218, DOI 10.1165/rcmb.2007-0344OC; Kogut I, 2012, SEMIN IMMUNOL, V24, P342, DOI 10.1016/j.smim.2012.04.004; Lester RT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005644; Lucas GM, 2007, AIDS, V21, P2435, DOI 10.1097/QAD.0b013e32827038ad; Manfredi R, 2004, Infez Med, V12, P152; Manfredi Roberto, 2004, Expert Rev Anti Infect Ther, V2, P821, DOI 10.1586/14789072.2.6.821; Michaud M, 2013, J AM MED DIR ASSOC, V14, P877, DOI 10.1016/j.jamda.2013.05.009; Mills EJ, 2012, NEW ENGL J MED, V366, P1270, DOI 10.1056/NEJMp1113643; Nath A, 2008, INT REV PSYCHIATR, V20, P25, DOI 10.1080/09540260701861930; Nath A, 2012, J NEUROVIROL, V18, P245, DOI 10.1007/s13365-012-0111-4; Nixon DE, 2010, CURR OPIN HIV AIDS, V5, P498, DOI 10.1097/COH.0b013e32833ed6f4; Pahlavani MA, 2001, FEBS LETT, V491, P114, DOI 10.1016/S0014-5793(01)02184-6; Peng JS, 2010, J NEUROIMMUNOL, V218, P94, DOI 10.1016/j.jneuroim.2009.09.014; Reid W, 2004, VIROLOGY, V321, P111, DOI 10.1016/j.virol.2003.12.010; Reid W, 2001, P NATL ACAD SCI USA, V98, P9271, DOI 10.1073/pnas.161290298; Ropolo A, 2001, EXP GERONTOL, V36, P519, DOI 10.1016/S0531-5565(00)00222-9; Rymkiewicz PD, 2012, IMMUNOL RES, V53, P235, DOI 10.1007/s12026-012-8289-3; Schletter J, 1995, ARCH MICROBIOL, V164, P383, DOI 10.1007/BF02529735; Schmucker DL, 2002, EXP GERONTOL, V37, P1089, DOI 10.1016/S0531-5565(02)00065-7; Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624; Silverberg MJ, 2009, AIDS, V23, P2337, DOI 10.1097/QAD.0b013e3283319184; Smith RL, 2013, FRONT GENET, V3, P328; Strauss-Ayali D, 2007, J LEUKOCYTE BIOL, V82, P244, DOI 10.1189/jlb.0307191; Sulkowski MS, 2003, ANN INTERN MED, V138, P197, DOI 10.7326/0003-4819-138-3-200302040-00012; Tacke F, 2006, IMMUNOBIOLOGY, V211, P609, DOI 10.1016/j.imbio.2006.05.025; Valcour Victor, 2011, Curr HIV/AIDS Rep, V8, P54, DOI 10.1007/s11904-010-0070-4; van Maanen M, 2003, CURR HIV RES, V1, P121; Vasto S, 2007, MECH AGEING DEV, V128, P83, DOI 10.1016/j.mad.2006.11.015; Wolf J, 2012, EXP GERONTOL, V47, P749, DOI 10.1016/j.exger.2012.07.001; Womack JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017217; Wong KL, 2011, BLOOD, V118, pE15, DOI 10.1182/blood-2010-12-326355; Yadav A, 2006, VIROLOGY, V353, P357, DOI 10.1016/j.virol.2006.05.026; Zhou X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074390	53	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105256	10.1371/journal.pone.0105256	http://dx.doi.org/10.1371/journal.pone.0105256			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127062	Green Submitted, gold, Green Published			2022-12-25	WOS:000340879300098
J	Alba, C; Bowers, MD; Blumenthal, D; Hufbauer, RA				Alba, Christina; Bowers, M. Deane; Blumenthal, Dana; Hufbauer, Ruth A.			Chemical and Mechanical Defenses Vary among Maternal Lines and Leaf Ages in Verbascum thapsus L. (Scrophulariaceae) and Reduce Palatability to a Generalist Insect	PLOS ONE			English	Article							BIOLOGICAL-CONTROL AGENT; IRIDOID GLYCOSIDES; NATURAL ENEMIES; COMMON MULLEIN; HERBIVORY; SPECIALIST; PERFORMANCE; RESISTANCE; EVOLUTION; TRICHOMES	Intra-specific variation in host-plant quality affects herbivore foraging decisions and, in turn, herbivore foraging decisions mediate plant fitness. In particular, variation in defenses against herbivores, both among and within plants, shapes herbivore behavior. If variation in defenses is genetically based, it can respond to natural selection by herbivores. We quantified intra-specific variation in iridoid glycosides, trichome length, and leaf strength in common mullein (Verbascum thapsus L, Scrophulariaceae) among maternal lines within a population and among leaves within plants, and related this variation to feeding preferences of a generalist herbivore, Trichopulsia ni Hubner. We found significant variation in all three defenses among maternal lines, with T. ni preferring plants with lower investment in chemical, but not mechanical, defense. Within plants, old leaves had lower levels of all defenses than young leaves, and were strongly preferred by T. ni. Caterpillars also preferred leaves with trichomes removed to leaves with trichomes intact. Differences among maternal lines indicate that phenotypic variation in defenses likely has a genetic basis. Furthermore, these results reveal that the feeding behaviors of T. ni map onto variation in plant defense in a predictable way. This work highlights the importance of variation in host-plant quality in driving interactions between plants and their herbivores.	[Alba, Christina; Hufbauer, Ruth A.] Colorado State Univ, Grad Degree Program Ecol, Ft Collins, CO 80523 USA; [Alba, Christina; Hufbauer, Ruth A.] Colorado State Univ, Dept Bioagr Sci & Pest Management, Ft Collins, CO 80523 USA; [Bowers, M. Deane] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [Blumenthal, Dana] USDA ARS, Ft Collins, CO 80522 USA	Colorado State University; Colorado State University; University of Colorado System; University of Colorado Boulder; United States Department of Agriculture (USDA)	Alba, C (corresponding author), Acad Sci Czech Republ, Inst Bot, CS-25243 Pruhonice, Czech Republic.	christina.alba@ibot.cas.cz	Hufbauer, Ruth/ABA-3984-2020; Alba, Christina/H-1579-2014	Hufbauer, Ruth/0000-0002-8270-0638; Alba, Christina/0000-0001-7040-8480; BOWERS, M/0000-0002-5697-888X	United States Department of Agriculture, Colorado Agricultural Experiment Station [COL00680, COL00222A]; Harold David Harrington Graduate Fellowship; Colorado State University; Academy of Sciences of the Czech Republic [RVO 67985939]	United States Department of Agriculture, Colorado Agricultural Experiment Station; Harold David Harrington Graduate Fellowship; Colorado State University; Academy of Sciences of the Czech Republic(Czech Academy of Sciences)	RH was supported by the United States Department of Agriculture, Colorado Agricultural Experiment Station (grant numbers COL00680 and COL00222A; URL aes.agsci.colostate.edu). CA received support from the Harold David Harrington Graduate Fellowship administered through the Biology Department at Colorado State University. Funding for page charges was provided by the Colorado State University Libraries Open Access Research and Scholarship Fund. CA was funded by long-term research development project no. RVO 67985939 from the Academy of Sciences of the Czech Republic URL http://cas.cz) during the writing of this paper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the of the manuscript.	ADLER LS, 1995, OECOLOGIA, V101, P75, DOI 10.1007/BF00328903; Agrawal AA, 1999, ECOLOGY, V80, P1713, DOI 10.1890/0012-9658(1999)080[1713:IRTHIW]2.0.CO;2; AGREN J, 1994, AM NAT, V143, P1, DOI 10.1086/285593; AIDE TM, 1989, OIKOS, V55, P66, DOI 10.2307/3565873; Alba C, 2013, CHEMOECOLOGY, V23, P83, DOI 10.1007/s00049-012-0121-y; Alba C, 2012, BIOL INVASIONS, V14, P2505, DOI 10.1007/s10530-012-0247-4; Alba C, 2011, BIOL INVASIONS, V13, P2379, DOI 10.1007/s10530-011-0050-7; Aranwela N, 1999, NEW PHYTOL, V144, P369, DOI 10.1046/j.1469-8137.1999.00506.x; Awmack CS, 2002, ANNU REV ENTOMOL, V47, P817, DOI 10.1146/annurev.ento.47.091201.145300; Biere A, 2004, OECOLOGIA, V140, P430, DOI 10.1007/s00442-004-1603-6; Bottrell DG, 1998, ANNU REV ENTOMOL, V43, P347, DOI 10.1146/annurev.ento.43.1.347; BOWERS MD, 1988, J CHEM ECOL, V14, P319, DOI 10.1007/BF01022549; BOWERS MD, 1993, ECOLOGY, V74, P1778, DOI 10.2307/1939936; BOWERS MD, 1984, J CHEM ECOL, V10, P1567, DOI 10.1007/BF00988425; Bowers MD, 1991, HERBIVORES THEIR INT; Choong MF, 1996, FUNCT ECOL, V10, P668, DOI 10.2307/2390178; Chu CC, 2001, ANN ENTOMOL SOC AM, V94, P743, DOI 10.1603/0013-8746(2001)094[0743:SOUCCT]2.0.CO;2; Clapham A. R., 1952, FLORA BRIT ISLES; Clissold FJ, 2009, ECOLOGY, V90, P3393, DOI 10.1890/09-0130.1; COLEY PD, 1983, ECOL MONOGR, V53, P209, DOI 10.2307/1942495; DAMTOFT S, 1994, PHYTOCHEMISTRY, V35, P1187, DOI 10.1016/S0031-9422(00)94819-2; Dobler S, 2011, PHYTOCHEMISTRY, V72, P1593, DOI 10.1016/j.phytochem.2011.04.015; Elle E, 1999, EVOLUTION, V53, P22, DOI [10.2307/2640917, 10.1111/j.1558-5646.1999.tb05330.x]; Facknath S, 2005, ENTOMOL EXP APPL, V115, P79, DOI 10.1111/j.1570-7458.2005.00286.x; FEENY P, 1970, ECOLOGY, V51, P565, DOI 10.2307/1934037; GROSS KL, 1978, CAN J PLANT SCI, V58, P401, DOI 10.4141/cjps78-062; Handley R, 2005, ECOL ENTOMOL, V30, P284, DOI 10.1111/j.0307-6946.2005.00699.x; Hanley ME, 2002, FUNCT ECOL, V16, P216, DOI 10.1046/j.1365-2435.2002.00612.x; Hanson FE, 1983, HERBIVOROUS INSECTS; Hare JD, 1992, PLANT RESISTNAC HERB; HEMMING JDC, 1995, OECOLOGIA, V103, P79, DOI 10.1007/BF00328428; HERMS DA, 1992, Q REV BIOL, V67, P478; Jamieson MA, 2010, J CHEM ECOL, V36, P70, DOI 10.1007/s10886-009-9728-z; Kessler A, 2004, SCIENCE, V306, P2042; Koricheva J, 1998, OIKOS, V83, P212, DOI 10.2307/3546833; Koricheva J, 2002, OIKOS, V98, P537, DOI 10.1034/j.1600-0706.2002.980319.x; LARSSON S, 1988, ECOL ENTOMOL, V13, P19, DOI 10.1111/j.1365-2311.1988.tb00329.x; LEVIN DA, 1973, Q REV BIOL, V48, P3, DOI 10.1086/407484; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; LOWMAN MD, 1983, AUST J ECOL, V8, P17, DOI 10.1111/j.1442-9993.1983.tb01515.x; Lucas PW, 2000, ANN BOT-LONDON, V86, P913, DOI 10.1006/anbo.2000.1261; MADDOX GD, 1990, ECOLOGY, V71, P2115, DOI 10.2307/1938625; Marak HB, 2000, J EVOLUTION BIOL, V13, P985, DOI 10.1046/j.1420-9101.2000.00233.x; Mauricio R, 1998, AM NAT, V151, P20, DOI 10.1086/286099; Mauricio R, 1997, EVOLUTION, V51, P1435, DOI [10.2307/2411196, 10.1111/j.1558-5646.1997.tb01467.x]; McCall AC, 2010, J ECOL, V98, P985, DOI 10.1111/j.1365-2745.2010.01693.x; MCKEY D, 1974, AM NAT, V108, P305, DOI 10.1086/282909; Menken SBJ, 1996, ENTOMOL EXP APPL, V80, P297, DOI 10.1007/BF00194779; MITICH LW, 1989, WEED TECHNOL, V3, P704; Mody K, 2007, ECOLOGY, V88, P1012, DOI 10.1890/06-1338; Moles AT, 2013, NEW PHYTOL, V198, P252, DOI 10.1111/nph.12116; Muller-Scharer H, 2004, TRENDS ECOL EVOL, V19, P417, DOI 10.1016/j.tree.2004.05.010; NICHOLSORIANS CM, 1989, BIOTROPICA, V21, P80, DOI 10.2307/2388446; Ohnmeiss TE, 2000, ECOLOGY, V81, P1765, DOI 10.1890/0012-9658(2000)081[1765:ODTPTO]2.0.CO;2; PUTTICK GM, 1988, J CHEM ECOL, V14, P335, DOI 10.1007/BF01022550; Rasmann S, 2012, PLANT SIGNAL BEHAV, V7, P447, DOI 10.4161/psb.19525; Rhoades D.F., 1976, RECENT ADV PHYTOCHEM, P168, DOI DOI 10.1007/978-1-4684-2646-5_4; Robinson GS, 2010, HOSTS DATABASE WORLD; Salisbury E. J ., 1942, REPROD CAPACITY PLAN; Sanson G, 2001, AUSTRAL ECOL, V26, P535, DOI 10.1046/j.1442-9993.2001.01154.x; STEWARD JL, 1988, OIKOS, V53, P79, DOI 10.2307/3565666; Twigg LE, 1996, OECOLOGIA, V108, P21, DOI 10.1007/BF00333210; Valkama E, 2004, ANN BOT-LONDON, V94, P233, DOI 10.1093/aob/mch131; Valverde PL, 2001, J EVOLUTION BIOL, V14, P424, DOI 10.1046/j.1420-9101.2001.00295.x; van Dam NM, 1999, J HERED, V90, P220, DOI 10.1093/jhered/90.1.220; vanderMeijden E, 1996, ENTOMOL EXP APPL, V80, P307, DOI 10.1007/BF00194780; Wheeler GS, 1996, BIOL CONTROL, V7, P1, DOI 10.1006/bcon.1996.0056; Whitham TG, 2003, ECOLOGY, V84, P559, DOI 10.1890/0012-9658(2003)084[0559:CAEGAC]2.0.CO;2; Wilbur H. D., 2013, NeoBiota, P21; WOODMAN RL, 1991, OIKOS, V60, P11, DOI 10.2307/3544986; Zangerl AR, 1996, AM NAT, V147, P599, DOI 10.1086/285868	71	11	11	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104889	10.1371/journal.pone.0104889	http://dx.doi.org/10.1371/journal.pone.0104889			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127229	Green Published, gold, Green Submitted			2022-12-25	WOS:000340879300060
J	Kobashigawa, LC; Xu, YC; Padbury, JF; Tseng, YT; Yano, N				Kobashigawa, Laura C.; Xu, Yan Chun; Padbury, James F.; Tseng, Yi-Tang; Yano, Naohiro			Metformin Protects Cardiomyocyte from Doxorubicin Induced Cytotoxicity through an AMP-Activated Protein Kinase Dependent Signaling Pathway: An In Vitro Study	PLOS ONE			English	Article							FERRITIN HEAVY-CHAIN; INDUCED CARDIOTOXICITY; INDUCED APOPTOSIS; TYROSINE KINASE; HEART-FAILURE; CELL-DEATH; MECHANISM; GLUCOSE; SYSTEM; TRANSCRIPTION	Doxorubicin (Dox) is one of the most widely used antitumor drugs, but its cumulative cardiotoxicity have been major concerns in cancer therapeutic practice for decades. Recent studies established that metformin (Met), an oral anti-diabetic drug, provides protective effects in Dox-induced cardiotoxicity. Met has been shown to increase fatty acid oxidation, an effect mediated by AMP activated protein kinase (AMPK). Here we delineate the intracellular signaling factors involved in Met mediated protection against Dox-induced cardiotoxicity in the H9c2 cardiomyoblast cell line. Treatment with low dose Met (0.1 mM) increased cell viabilities and Ki-67 expressions while decreasing LDH leakages, ROS generations and [Ca2+](i). The protective effect was reversed by a co-treatment with compound-C, an AMPK specific inhibitor, or by an over expression of a dominant-negative AMPK alpha cDNA. Inhibition of PKA with H89 or a suppression of Src kinase by a small hairpin siRNA also abrogated the protective effect of the low dose Met. Whereas, with a higher dose of Met (1.0 mM), the protective effects were abolished regardless of the enhanced AMPK, PKA/CREB1 and Src kinase activity. In high dose Met treated cells, expression of platelet-derived growth factor receptor (PDGFR) was significantly suppressed. Furthermore, the protective effect of low dose Met was totally reversed by co-treatment with AG1296, a PDGFR specific antagonist. These data provide in vitro evidence supporting a signaling cascade by which low dose Met exerts protective effects against Dox via sequential involvement of AMPK, PKA/CREB1, Src and PDGFR. Whereas high dose Met reverses the effect by suppressing PDGFR expression.	[Kobashigawa, Laura C.; Xu, Yan Chun; Padbury, James F.; Tseng, Yi-Tang; Yano, Naohiro] Brown Univ, Women & Infants Hosp, Dept Pediat, Warren Alpert Med Sch, Providence, RI 02908 USA	Brown University; Women & Infants Hospital Rhode Island	Tseng, YT (corresponding author), Brown Univ, Women & Infants Hosp, Dept Pediat, Warren Alpert Med Sch, Providence, RI 02908 USA.	ytseng@wihri.org; nyano@wihri.org			National Center for Research Resources [SP20RR018728-10]; National Institute of General Medical Science from the National Institute of Health [8 P20 GM103537-10]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103537] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Science from the National Institute of Health; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Center for Research Resources (SP20RR018728-10) and the National Institute of General Medical Science (8 P20 GM103537-10) from the National Institute of Health (to Y-TT and JFP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An D, 2006, DIABETOLOGIA, V49, P2174, DOI 10.1007/s00125-006-0338-9; Asensio-Lopez MC, 2014, FREE RADICAL BIO MED, V67, P19, DOI 10.1016/j.freeradbiomed.2013.11.003; Asensio-Lopez MC, 2013, FREE RADICAL BIO MED, V57, P188, DOI 10.1016/j.freeradbiomed.2012.09.009; Asensio-Lopez MC, 2011, FREE RADICAL BIO MED, V51, P1861, DOI 10.1016/j.freeradbiomed.2011.08.015; Baker MA, 2006, J CELL SCI, V119, P3182, DOI 10.1242/jcs.03055; Betsholtz C, 2001, BIOESSAYS, V23, P494, DOI 10.1002/bies.1069; Bhamra GS, 2008, BASIC RES CARDIOL, V103, P274, DOI [10.1007/s00395-007-0691-y, 10.1007/s00395-008-0736-x]; Bolster DR, 2002, J BIOL CHEM, V277, P23977, DOI 10.1074/jbc.C200171200; Choi IY, 2013, AM J PATHOL, V182, P928, DOI 10.1016/j.ajpath.2012.11.024; Cusi K, 1996, J CLIN ENDOCR METAB, V81, P4059, DOI 10.1210/jc.81.11.4059; Damm E, 2012, MOL ENDOCRINOL, V26, P643, DOI 10.1210/me.2011-1218; Das A, 2005, J BIOL CHEM, V280, P12944, DOI 10.1074/jbc.M404706200; Faure P, 1999, DIABETES, V48, P353, DOI 10.2337/diabetes.48.2.353; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; GOTTLIEB JA, 1973, CANCER RES, V33, P3024; Gundewar S, 2009, CIRC RES, V104, P403, DOI 10.1161/CIRCRESAHA.108.190918; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Iarussi D, 2001, CURR MED CHEM, V8, P1649, DOI 10.2174/0929867013371888; Kalivendi SV, 2001, J BIOL CHEM, V276, P47266, DOI 10.1074/jbc.M106829200; Kalka D, 1998, ARCH GERONTOL GERIAT, V27, P251, DOI 10.1016/S0167-4943(98)00122-8; Kanigur-Sultuybek G, 1995, J Basic Clin Physiol Pharmacol, V6, P271; Kewalramani G, 2009, CARDIOVASC RES, V84, P42, DOI 10.1093/cvr/cvp166; KLIP A, 1990, DIABETES CARE, V13, P696, DOI 10.2337/diacare.13.6.696; Ma YC, 2000, CELL, V102, P635, DOI 10.1016/S0092-8674(00)00086-6; Mahrouf M, 2006, BIOCHEM PHARMACOL, V72, P176, DOI 10.1016/j.bcp.2006.04.027; Nakashima K, 2007, BIOSCI BIOTECH BIOCH, V71, P1650, DOI 10.1271/bbb.70057; Neilan TG, 2007, CIRCULATION, V116, P506, DOI 10.1161/CIRCULATIONAHA.106.652339; Pan QR, 2009, HORM METAB RES, V41, P799, DOI 10.1055/s-0029-1234043; Park H, 2002, J BIOL CHEM, V277, P32571, DOI 10.1074/jbc.M201692200; Sasaki H, 2009, CIRCULATION, V119, P2568, DOI 10.1161/CIRCULATIONAHA.108.798561; Tseng YT, 2005, AM J PHYSIOL-HEART C, V289, pH1834, DOI 10.1152/ajpheart.00435.2005; Wallace KB, 2003, PHARMACOL TOXICOL, V93, P105, DOI 10.1034/j.1600-0773.2003.930301.x; WANG JJ, 1971, CANCER, V28, P837, DOI 10.1002/1097-0142(1971)28:4<837::AID-CNCR2820280406>3.0.CO;2-4; WONG K, 1994, J BIOL CHEM, V269, P28878; Yang J, 2006, ENDOCRINOLOGY, V147, P2728, DOI 10.1210/en.2005-1433; Yano N, 2007, AM J PHYSIOL-HEART C, V293, pH385, DOI 10.1152/ajpheart.01318.2006; Yano N, 2007, J BIOL CHEM, V282, P18819, DOI 10.1074/jbc.M610537200; Yano N, 2009, BIOCHEM J, V423, P129, DOI 10.1042/BJ20082277; Yano N, 2008, ENDOCRINOLOGY, V149, P6449, DOI 10.1210/en.2008-0292; Yuan HD, 2011, BIOSCI BIOTECH BIOCH, V75, P1079, DOI 10.1271/bbb.100881; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	42	71	72	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104888	10.1371/journal.pone.0104888	http://dx.doi.org/10.1371/journal.pone.0104888			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127116	gold, Green Submitted, Green Published			2022-12-25	WOS:000340879300059
J	Lopez-Sanchez, A; Schroeder, J; Roig, S; Sobral, M; Dirzo, R				Lopez-Sanchez, Aida; Schroeder, John; Roig, Sonia; Sobral, Mar; Dirzo, Rodolfo			Effects of Cattle Management on Oak Regeneration in Northern Californian Mediterranean Oak Woodlands	PLOS ONE			English	Article							QUERCUS-DOUGLASII; RECRUITMENT; CONSERVATION; PATTERNS; SYSTEMS; LOBATA; ILEX; BIODIVERSITY; POPULATIONS; ENVIRONMENT	Oak woodlands of Mediterranean ecosystems, a major component of biodiversity hotspots in Europe and North America, have undergone significant land-use change in recent centuries, including an increase in grazing intensity due to the widespread presence of cattle. Simultaneously, a decrease in oak regeneration has been observed, suggesting a link between cattle grazing intensity and limited oak regeneration. In this study we examined the effect of cattle grazing on coast live oak (Quercus agrifolia Nee) regeneration in San Francisco Bay Area, California. We studied seedling, sapling and adult density of coast live oak as well as vertebrate herbivory at 8 independent sites under two grazing conditions: with cattle and wildlife presence (n = 4) and only with wildlife (n = 4). The specific questions we addressed are: i) to what extent cattle management practices affect oak density, and ii) what is the effect of rangeland management on herbivory and size of young oak plants. In areas with cattle present, we found a 50% reduction in young oak density, and plant size was smaller, suggesting that survival and growth young plants in those areas are significantly limited. In addition, the presence of cattle raised the probability and intensity of herbivory (a 1.5 and 1.8-fold difference, respectively). These results strongly suggest that the presence of cattle significantly reduced the success of young Q. agrifolia through elevated herbivory. Given the potential impact of reduced recruitment on adult populations, modifying rangeland management practices to reduce cattle grazing pressure seems to be an important intervention to maintain Mediterranean oak woodlands.	[Lopez-Sanchez, Aida; Roig, Sonia] Univ Politecn Madrid, Dept Silvopascicultura, Madrid, Spain; [Lopez-Sanchez, Aida; Roig, Sonia] Univ Politecn Madrid, Ecol & Gest Forestal Sostenible Res Grp, Madrid, Spain; [Schroeder, John; Sobral, Mar; Dirzo, Rodolfo] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Universidad Politecnica de Madrid; Universidad Politecnica de Madrid; Stanford University	Lopez-Sanchez, A (corresponding author), Univ Politecn Madrid, Dept Silvopascicultura, Madrid, Spain.	aida.lopez.sanchez@gmail.com	López-Sánchez, Aida/AAA-9038-2019; Sobral, Mar/Q-9812-2017; Roig, Sonia/F-8302-2010	López-Sánchez, Aida/0000-0003-3857-2816; Sobral, Mar/0000-0001-6995-0491; Roig, Sonia/0000-0002-2057-3020	(Formacion del Profesorado Universitario) of Spain Ministry of Education, Culture and Sport	(Formacion del Profesorado Universitario) of Spain Ministry of Education, Culture and Sport	This study has been developed thanks to a study abroad fellowship (Formacion del Profesorado Universitario) of Spain Ministry of Education, Culture and Sport to ALS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ramirez JA, 2008, FOREST ECOL MANAG, V255, P1976, DOI 10.1016/j.foreco.2007.12.019; Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Allen-Diaz B. H., 1992, Madrono, V39, P47; Allen-Diaz B, 2007, TERRESTRIAL VEGETATION OF CALIFORNIA, 3RD EDITION, P313; Anderson DR., 2002, PRACTICAL INFORM THE, DOI DOI 10.1007/B97636; Bartolome J.W., 1987, P S MULT US MAN CAL, P26; Bates D, 2012, LME4 LINEAR MIXED EF; Blondel J, 2006, HUM ECOL, V34, P713, DOI 10.1007/s10745-006-9030-4; Bolsinger C. L., 1988, RESOURCE B USDA; Brown RW, 1991, THESIS U CALIFORNIA; Bugalho MN, 2011, FRONT ECOL ENVIRON, V9, P278, DOI 10.1890/100084; Bugalho MN, 2003, FOREST ECOL MANAG, V181, P23, DOI 10.1016/S0378-1127(03)00125-7; Callaway R. M., 1991, Madrono, V38, P158; CALLAWAY RM, 1992, ECOLOGY, V73, P2118, DOI 10.2307/1941460; Callaway RM, 1998, J VEG SCI, V9, P647, DOI 10.2307/3237283; Carmona CP, 2013, BIOL CONSERV, V159, P240, DOI 10.1016/j.biocon.2012.11.015; Clark JS, 1999, AM J BOT, V86, P1, DOI 10.2307/2656950; Dahlgren RA, 1997, BIOGEOCHEMISTRY, V39, P45, DOI 10.1023/A:1005812621312; Danielsen K, 1990, THESIS U CALIFORNIA; DAVIS FW, 1991, US FOR SERV T R PSW, V126, P81; Dufour-Dror JM, 2007, ACTA OECOL, V31, P223, DOI 10.1016/j.actao.2006.11.003; Eichhorn MP, 2006, AGROFOREST SYST, V67, P29, DOI 10.1007/s10457-005-1111-7; Fischer J, 2010, BIOL CONSERV, V143, P1564, DOI 10.1016/j.biocon.2010.03.030; Fox J., 2019, R COMPANION APPL REG, V3rd ed; Garzon-Heydt J, 2004, IALE PUBLICATION SER, P259; Gea-Izquierdo G, 2008, CAN J FOREST RES, V38, P101, DOI 10.1139/X07-142; GORDON DR, 1989, OECOLOGIA, V79, P533, DOI 10.1007/BF00378672; Greenwood G.B., 1993, EXTENT OWNERSHIP CAL; GRIFFIN JR, 1971, ECOLOGY, V52, P862, DOI 10.2307/1936034; GRIFFIN JR, 1976, AM MIDL NAT, V95, P422, DOI 10.2307/2424405; Huntsinger L, 1991, PSW126 USDA FOR SERV; Johnson S, 1985, PAC DISCOV, V38, P4; Mahall BE, 2009, AM J BOT, V96, P751, DOI 10.3732/ajb.0800247; Manning AD, 2006, BIOL CONSERV, V132, P311, DOI 10.1016/j.biocon.2006.04.023; Maranon T., 2009, WEB ECOLOGY, V9, P30, DOI [10.5194/we-9-30-2009, DOI 10.5194/WE-9-30-2009]; Matzner SL, 2003, TREE PHYSIOL, V23, P777, DOI 10.1093/treephys/23.11.777; McClaran M. P., 1989, Madrono, V36, P141; McClaran M. P, 1987, P S MULT US MAN CAL; McCreary DD, 2004, US FOR SERV RMRS-P, V35, P109; Muick P.C., 1987, ASSESSMENT NATURAL R; MUICK PC, 1991, US FOR SERV T R PSW, V126, P21; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Noble IR, 1997, SCIENCE, V277, P522, DOI 10.1126/science.277.5325.522; Papachristou TG, 2005, SMALL RUMINANT RES, V59, P141, DOI 10.1016/j.smallrumres.2005.05.003; Plieninger T, 2004, J ARID ENVIRON, V57, P345, DOI 10.1016/S0140-1963(03)00103-4; Plieninger T, 2010, ECOSYSTEMS, V13, P644, DOI 10.1007/s10021-010-9345-2; PLUMB TR, 1991, US FOR SERV T R PSW, V126, P74; Roche LM, 2012, BIODIVERS CONSERV, V21, P2555, DOI 10.1007/s10531-012-0317-z; Serrada Hierro R., 2004, Investigacion Agraria, Sistemas y Recursos Forestales, P127; Sork VL, 2002, MOL ECOL, V11, P1657, DOI 10.1046/j.1365-294X.2002.01574.x; Standiford R, 2003, P 12 WORLD FOR C QUE, P111; Standiford Richard, 1997, Madrono, V44, P170; Stromberg MR, 1996, ECOL APPL, V6, P1189, DOI 10.2307/2269601; Swiecki TJ, 1997, PROCEEDINGS OF A SYMPOSIUM ON OAK WOODLANDS: ECOLOGY, MANAGEMENT, AND URBAN INTERFACE ISSUES, P147; Swiecki TJ, 1998, FREMONTIA, V26, P19; TRIMBLE SW, 1995, GEOMORPHOLOGY, V13, P233, DOI 10.1016/0169-555X(95)00028-4; Tyler CM, 2008, FOREST ECOL MANAG, V255, P3063, DOI 10.1016/j.foreco.2008.01.073; Tyler CM, 2006, Q REV BIOL, V81, P127, DOI 10.1086/506025; Underwood EC, 2009, DIVERS DISTRIB, V15, P188, DOI 10.1111/j.1472-4642.2008.00518.x; Venables W.N., 2002, MODERN APPL STAT S P, Vfourth, DOI [10.1007/978-0-387-21706-2, DOI 10.1007/978-0-387-21706-2_10]; Welker JM, 1987, P INT C MEAS SOIL PL, P229; WHITE KL, 1966, ECOLOGY, V47, P229, DOI 10.2307/1933769; Zamora R, 2001, FOREST ECOL MANAG, V144, P33, DOI 10.1016/S0378-1127(00)00362-5; Zavaleta ES, 2007, DIVERS DISTRIB, V13, P735, DOI 10.1111/j.1472-4642.2007.00384.x; Zuur Alain F., 2009, P1; [No title captured]	66	26	26	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105472	10.1371/journal.pone.0105472	http://dx.doi.org/10.1371/journal.pone.0105472			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126939	Green Submitted, Green Published, gold			2022-12-25	WOS:000340879300113
J	Weil, MM; Ray, FA; Genik, PC; Yu, YJ; McCarthy, M; Fallgren, CM; Ullrich, RL				Weil, Michael M.; Ray, F. Andrew; Genik, Paula C.; Yu, Yongjia; McCarthy, Maureen; Fallgren, Christina M.; Ullrich, Robert L.			Effects of Si-28 Ions, Fe-56 Ions, and Protons on the Induction of Murine Acute Myeloid Leukemia and Hepatocellular Carcinoma	PLOS ONE			English	Article							MICE; CARCINOGENESIS; INFLAMMATION; NEUTRON; CANCER; RAYS	Estimates of cancer risks posed to space-flight crews by exposure to high atomic number, high-energy (HZE) ions are subject to considerable uncertainty because epidemiological data do not exist for human populations exposed to similar radiation qualities. We assessed the carcinogenic effects of 300 MeV/n Si-28 or 600 MeV/n Fe-56 ions in a mouse model for radiation-induced acute myeloid leukemia and hepatocellular carcinoma. C3H/HeNCrl mice were irradiated with 0.1, 0.2, 0.4, or 1 Gy of 300 MeV/n Si-28 ions, 600 MeV/n Fe-56 ions or 1 or 2 Gy of protons simulating the 1972 solar particle event (1972SPE) at the NASA Space Radiation Laboratory. Additional mice were irradiated with Cs-137 gamma rays at doses of 1, 2, or 3 Gy. All groups were followed until they were moribund or reached 800 days of age. We found that Si-28 or Fe-56 ions do not appear to be substantially more effective than gamma rays for the induction of acute myeloid leukemia. However, Si-28 or Fe-56 ion irradiated mice had a much higher incidence of hepatocellular carcinoma than gamma ray irradiated or proton irradiated mice. These data demonstrate a clear difference in the effects of these HZE ions on the induction of leukemia compared to solid tumors, suggesting potentially different mechanisms of tumorigenesis. Also seen in this study was an increase in metastatic hepatocellular carcinoma in the Si-28 and Fe-56 ion irradiated mice compared with those exposed to gamma rays or 1972SPE protons, a finding with important implications for setting radiation exposure limits for space-flight crew members.	[Weil, Michael M.; Ray, F. Andrew; Genik, Paula C.; Fallgren, Christina M.] Colorado State Univ, Ft Collins, CO 80523 USA; [Yu, Yongjia; McCarthy, Maureen; Ullrich, Robert L.] Univ Texas Med Branch, Galveston, TX 77555 USA	Colorado State University; University of Texas System; University of Texas Medical Branch Galveston	Weil, MM (corresponding author), Colorado State Univ, Ft Collins, CO 80523 USA.	michael.weil@colostate.edu		Genik, Paula C/0000-0003-2149-599X	National Aeronautics and Space Administration [NNX09AM08G]	National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA))	This work was supported by grant NNX09AM08G from the National Aeronautics and Space Administration (www.nasa.gov/exploration/humanresearch/) to RLU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALPEN EL, 1994, ADV SPACE RES, V14, P573, DOI 10.1016/0273-1177(94)90512-6; ALPEN EL, 1993, RADIAT RES, V136, P382, DOI 10.2307/3578551; Alzahrani B, 2014, CANCER LETT, V345, P223, DOI 10.1016/j.canlet.2013.08.036; Bielefeldt-Ohmann H, 2012, HEALTH PHYS, V103, P568, DOI 10.1097/HP.0b013e318265a257; Cheema AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087079; CLAPP NK, 1974, RADIAT RES, V57, P158, DOI 10.2307/3573764; Cucinotta FA, 2011, NASATP2011216155; Cucinotta FA., 2009, HUMAN HLTH PERFORMAN, P119; Cucinotta FA., 2013, TP2013217375 NASA; Cucinotta FA, 2006, LANCET ONCOL, V7, P431, DOI 10.1016/S1470-2045(06)70695-7; Cucinotta FA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096099; Cucinotta FA, 2010, MUTAT RES-FUND MOL M, V687, P49, DOI 10.1016/j.mrfmmm.2010.01.012; Darakhshan F, 2006, CARCINOGENESIS, V27, P311, DOI 10.1093/carcin/bgi207; Datta K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059295; Dicello JF, 2004, PHYS MED BIOL, V49, P3817, DOI 10.1088/0031-9155/49/16/024; Durante M, 2008, NAT REV CANCER, V8, P465, DOI 10.1038/nrc2391; Finney DJ, 1947, PROBIT ANAL STAT TRE; Foumier C, 2012, SCI REP-UK, V2, DOI 10.1038/srep00643; FRY RJM, 1985, RADIAT RES, V104, pS188, DOI 10.2307/3576646; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; ICRP, 2013, ICPR PUBL, V123; Miller RC, 1999, P NATL ACAD SCI USA, V96, P19, DOI 10.1073/pnas.96.1.19; MOLE RH, 1983, BRIT J CANCER, V47, P285, DOI 10.1038/bjc.1983.37; NCRP, 2006, 153 NCRP; Orman ES, 2013, J GASTROEN HEPATOL, V28, P77, DOI 10.1111/jgh.12030; Shlomai A, 2014, SEMIN CANCER BIOL, V26, P78, DOI 10.1016/j.semcancer.2014.01.004; Shuryak I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028559; Smith SM, 2003, BLOOD, V102, P43, DOI 10.1182/blood-2002-11-3343; THESEUS, 2012, CLUSTER 3 SPACE RAD; Turusov VS, 1994, PATHOLOGY TUMOURS LA; ULLRICH RL, 1977, RADIAT RES, V72, P487, DOI 10.2307/3574612; ULLRICH RL, 1983, RADIAT RES, V93, P506, DOI 10.2307/3576029; ULLRICH RL, 1987, RADIAT RES, V109, P165, DOI 10.2307/3576877; Weil MM, 2009, RADIAT RES, V172, P213, DOI 10.1667/RR1648.1	34	62	69	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104819	10.1371/journal.pone.0104819	http://dx.doi.org/10.1371/journal.pone.0104819			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126721	Green Submitted, Green Published, gold			2022-12-25	WOS:000340879300055
J	Bjorner, S; Fitzpatrick, PA; Li, YY; Allred, C; Howell, A; Ringberg, A; Olsson, H; Miller, CJ; Axelson, H; Landberg, G				Bjorner, Sofie; Fitzpatrick, Paul A.; Li, Yaoyong; Allred, Craig; Howell, Anthony; Ringberg, Anita; Olsson, Hakan; Miller, Crispin J.; Axelson, Hakan; Landberg, Goran			Epithelial and Stromal MicroRNA Signatures of Columnar Cell Hyperplasia Linking Let-7c to Precancerous and Cancerous Breast Cancer Cell Proliferation	PLOS ONE			English	Article							PANCREATIC-CANCER; TARGET PREDICTION; EXPRESSION; LESIONS; FIBROBLASTS; GROWTH; CONTRIBUTES; PRECURSORS; MECHANISM; MIR-132	Columnar cell hyperplasia (CCH) is the earliest histologically identifiable breast lesion linked to cancer progression and is characterized by increased proliferation, decreased apoptosis and elevated oestrogen receptor alpha (ER alpha) expression. The mechanisms underlying the initiation of these lesions have not been clarified but might involve early and fundamental changes in cancer progression. MiRNAs are key regulators of several biological processes, acting by influencing the post-transcriptional regulation of numerous targets, thus making miRNAs potential candidates in cancer initiation. Here we have defined novel epithelial as well as stromal miRNA signatures from columnar cell hyperplasia lesions compared to normal terminal duct lobular units by using microdissection and miRNA microarrays. Let-7c were among the identified downregulated epithelial miRNAs and its functions were delineated in unique CCH derived cells and breast cancer cell line MCF-7 suggesting anti-proliferative traits potentially due to effects on Myb and ER alpha. MiR-132 was upregulated in the stroma surrounding CCH compared to stoma surrounding normal terminal duct lobular units (TDLUs), and overexpression of miR-132 in immortalized fibroblasts and in fibroblasts co-cultured with epithelial CCH cells caused substantial expression changes of genes involved in metabolism, DNA damage and cell motility. The miRNA signatures identified in CCH indicate early changes in the epithelial and stromal compartment of CCH and could represent early key alterations in breast cancer progression that potentially could be targeted in novel prevention or treatment schedules.	[Bjorner, Sofie; Landberg, Goran] Lund Univ, Skane Univ Hosp, Ctr Mol Pathol, Dept Lab Med Malmo, Malmo, Sweden; [Bjorner, Sofie; Howell, Anthony; Landberg, Goran] Univ Manchester, Christie Natl Hlth Serv Fdn Trust, Manchester Acad Hlth Sci Ctr, Paterson Inst Canc Res,Inst Canc Sci,Breakthrough, Manchester, Lancs, England; [Bjorner, Sofie; Fitzpatrick, Paul A.; Landberg, Goran] Univ Gothenburg, Sahlgrenska Canc Ctr, Dept Biomed, Gothenburg, Sweden; [Li, Yaoyong; Miller, Crispin J.] Paterson Inst Canc Res, Canc Res UK Appl Computat Biol & Bioinformat Grp, Manchester M20 9BX, Lancs, England; [Allred, Craig] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Ringberg, Anita] Lund Univ, SUS Malmo, Inst Clin Sci Malmo, Dept Plast & Reconstruct Surg, Malmo, Sweden; [Olsson, Hakan] Lund Univ, Skane Univ Hosp, Inst Clin Sci Lund, Dept Oncol, Malmo, Sweden; [Axelson, Hakan] Lund Univ, Dept Lab Med Malmo, Malmo, Sweden	Lund University; Skane University Hospital; Christie NHS Foundation Trust; Paterson Institute for Cancer Research; University of Manchester; University of Gothenburg; Paterson Institute for Cancer Research; Washington University (WUSTL); Lund University; Lund University; Skane University Hospital; Lund University	Landberg, G (corresponding author), Lund Univ, Skane Univ Hosp, Ctr Mol Pathol, Dept Lab Med Malmo, Malmo, Sweden.	goran.landberg@gu.se		Olsson, Hakan/0000-0002-8794-9635; Howell, Anthony/0000-0002-6233-719X; Miller, Crispin/0000-0003-4341-1283; Fitzpatrick, Paul/0000-0002-7590-1546	Swedish Cancer Society; Breakthrough Breast Cancer; Cancer Research UK [15675] Funding Source: researchfish	Swedish Cancer Society(Swedish Cancer Society); Breakthrough Breast Cancer; Cancer Research UK(Cancer Research UK)	This study was supported by grants from the Swedish Cancer Society and Breakthrough Breast Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2012, BRIT J CANCER, V107, P1354, DOI 10.1038/bjc.2012.383; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berglund P, 2005, CANCER RES, V65, P9727, DOI 10.1158/0008-5472.CAN-04-3984; Calin GA, 2006, ONCOGENE, V25, P6202, DOI 10.1038/sj.onc.1209910; Dabbs DJ, 2006, MODERN PATHOL, V19, P344, DOI 10.1038/modpathol.3800538; Drabsch Y, 2007, P NATL ACAD SCI USA, V104, P13762, DOI 10.1073/pnas.0700104104; Egeblad M, 2008, DIS MODEL MECH, V1, P155, DOI 10.1242/dmm.000596; Holm C, 2006, JNCI-J NATL CANCER I, V98, P671, DOI 10.1093/jnci/djj185; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kass L, 2007, INT J BIOCHEM CELL B, V39, P1987, DOI 10.1016/j.biocel.2007.06.025; Kung HN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002229; Lee S, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1367; Lee S, 2007, AM J PATHOL, V171, P252, DOI 10.2353/ajpath.2007.061010; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Madar S, 2009, CARCINOGENESIS, V30, P20, DOI 10.1093/carcin/bgn232; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Maragkakis M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-295; McDermott AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087032; Mishra A, 2009, NEUROBIOL DIS, V36, P26, DOI 10.1016/j.nbd.2009.06.010; Nadiminty N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032832; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Park JK, 2011, BIOCHEM BIOPH RES CO, V406, P518, DOI 10.1016/j.bbrc.2011.02.065; Qin B, 2012, BMB REP, V45, P464, DOI 10.5483/BMBRep.2012.45.8.033; Quintana AM, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-30; Ramsay RG, 2008, NAT REV CANCER, V8, P523, DOI 10.1038/nrc2439; Rasanen K, 2010, EXP CELL RES, V316, P2713, DOI 10.1016/j.yexcr.2010.04.032; Recavarren RA, 2010, INT J CLIN EXP PATHO, V3, P87; Schnitt SJ, 2003, ADV ANAT PATHOL, V10, P113, DOI 10.1097/00125480-200305000-00001; Simpson PT, 2005, AM J SURG PATHOL, V29, P734, DOI 10.1097/01.pas.0000157295.93914.3b; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Storey JD, 2004, J R STAT SOC B, V66, P187, DOI 10.1111/j.1467-9868.2004.00439.x; Ucar A, 2010, NAT GENET, V42, P1101, DOI 10.1038/ng.709; Verissimo F, 2006, ONCOGENE, V25, P4172, DOI 10.1038/sj.onc.1209449; WELLINGS SR, 1975, J NATL CANCER I, V55, P231; Yang D, 2011, ONCOGENE, V30, P4590, DOI [10.1038/onc.2011.541, 10.1038/onc.2011.166]; Yates T, 2008, NUCLEIC ACIDS RES, V36, pD780, DOI 10.1093/nar/gkm779; Zearo S, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-200; Zhang SY, 2011, CARCINOGENESIS, V32, P1183, DOI 10.1093/carcin/bgr105	39	17	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e105099	10.1371/journal.pone.0105099	http://dx.doi.org/10.1371/journal.pone.0105099			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122196	Green Accepted, Green Published, gold			2022-12-25	WOS:000341017000097
J	Burnham, ME; Esnault, S; Roti, ECR; Bates, ME; Bertics, PJ; Denlinger, LC				Burnham, Mandy E.; Esnault, Stephane; Roti, Elon C. Roti; Bates, Mary E.; Bertics, Paul J.; Denlinger, Loren C.			Cholesterol Selectively Regulates IL-5 Induced Mitogen Activated Protein Kinase Signaling in Human Eosinophils	PLOS ONE			English	Article							BLOOD-CELL COUNT; LIPID RAFTS; DIFFERENTIAL REGULATION; FILIPIN-III; FATTY-ACIDS; TNF-ALPHA; P38 MAPK; AIRWAY; EXPRESSION; APOPTOSIS	Eosinophils function contributes to human allergic and autoimmune diseases, many of which currently lack curative treatment. Development of more effective treatments for eosinophil-related diseases requires expanded understanding of eosinophil signaling and biology. Cell signaling requires integration of extracellular signals with intracellular responses, and is organized in part by cholesterol rich membrane microdomains (CRMMs), commonly referred to as lipid rafts. Formation of these organizational membrane domains is in turn dependent upon the amount of available cholesterol, which can fluctuate widely with a variety of disease states. We tested the hypothesis that manipulating membrane cholesterol content in primary human peripheral blood eosinophils (PBEos) would selectively alter signaling pathways that depend upon membrane-anchored signaling proteins localized within CRMMs (e.g., mitogen activated protein kinase [MAPK] pathway), while not affecting pathways that signal through soluble proteins, like the Janus Kinase/Signal Transducer and Activator of Transcription [JAK/STAT] pathway. Cholesterol levels were increased or decreased utilizing cholesterol-chelating methyl-bcyclodextrin (M beta CD), which can either extract membrane cholesterol or add exogenous membrane cholesterol depending on whether M beta CD is preloaded with cholesterol. Human PBEos were pretreated with M beta CD (cholesterol removal) or M beta CD+Cholesterol (M beta CD+Chol; cholesterol delivery); subsequent IL-5-stimulated signaling and physiological endpoints were assessed. M beta CD reduced membrane cholesterol in PBEos, and attenuated an IL-5-stimulated p38 and extracellular-regulated kinase 1/2 phosphorylation (p-p38, p-ERK1/2), and an IL-5-dependent increase in interleukin-1b (IL-1b) mRNA levels. In contrast, M beta CD+Chol treatment elevated PBEos membrane cholesterol levels and basal p-p38, but did not alter IL-5-stimulated phosphorylation of ERK1/2, STAT5, or STAT3. Furthermore, M beta CD+Chol pretreatment attenuated an IL-5-induced increase in cell survival at 48 hours, measured as total cellular metabolism. The reduction in cell survival following cholesterol addition despite unaltered STAT phosphorylation contradicts the current dogma in which JAK/STAT activation is sufficient to promote eosinophil survival, and suggests an additional, unidentified mechanism critically regulates IL-5-mediated human PBEos survival.	[Burnham, Mandy E.; Bates, Mary E.; Bertics, Paul J.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, Madison, WI USA; [Esnault, Stephane; Roti, Elon C. Roti; Denlinger, Loren C.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Denlinger, LC (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Med, Madison, WI 53706 USA.	lcd@medicine.wisc.edu	Esnault, Stephane/AAO-4712-2020; Esnault, Stephane/AAJ-4511-2020	Esnault, Stephane/0000-0001-7238-8671; 	National Institutes of Health [P01HL088594, 5T32DK007665, UL1TR000427]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL088594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007665] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health (grants P01HL088594, 5T32DK007665, and UL1TR000427). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aceves SS, 2008, CURR MOL MED, V8, P350, DOI 10.2174/156652408785161023; Akuthota P, 2012, AM J RESP CELL MOL, V46, P188, DOI 10.1165/rcmb.2010-0335OC; Al-Shawwa B, 2006, J ASTHMA, V43, P231, DOI 10.1080/02770900600567056; Andina N, 2009, J ALLERGY CLIN IMMUN, V123, P603, DOI 10.1016/j.jaci.2008.12.004; Bates ME, 2004, AM J RESP CELL MOL, V30, P736, DOI 10.1165/rcmb.2003-0234OC; Bates ME, 2000, J BIOL CHEM, V275, P10968, DOI 10.1074/jbc.275.15.10968; BITTMAN R, 1972, P NATL ACAD SCI USA, V69, P3795, DOI 10.1073/pnas.69.12.3795; Bochner BS, 2005, J ALLERGY CLIN IMMUN, V115, P953, DOI 10.1016/j.jaci.2005.02.032; Brewer CF, 2002, CURR OPIN STRUC BIOL, V12, P616, DOI 10.1016/S0959-440X(02)00364-0; Brooks AR, 1996, J BIOL CHEM, V271, P9090, DOI 10.1074/jbc.271.15.9090; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Brown DA, 2006, PHYSIOLOGY, V21, P430, DOI 10.1152/physiol.00032.2006; Burnham ME, 2013, J IMMUNOLOG IN PRESS; Busse WW, 2001, NEW ENGL J MED, V344, P350, DOI 10.1056/NEJM200102013440507; Chen YL, 2006, BIOCHEM BIOPH RES CO, V346, P160, DOI 10.1016/j.bbrc.2006.05.093; Cheung PFY, 2008, J IMMUNOL, V180, P5625, DOI 10.4049/jimmunol.180.8.5625; Dendele B, 2014, CHEM-BIOL INTERACT, V207, P41, DOI 10.1016/j.cbi.2013.11.002; Esnault S, 2012, CLIN EXP ALLERGY, V42, P1756, DOI 10.1111/j.1365-2222.2012.04060.x; Esnault S, 2002, BLOOD, V99, P4048, DOI 10.1182/blood.V99.11.4048; Ferreiro I, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-144; Ge BX, 2003, J BIOL CHEM, V278, P2286, DOI 10.1074/jbc.M210918200; Gozgit JM, 2008, J BIOL CHEM, V283, P32334, DOI 10.1074/jbc.M803813200; HASSALL DG, 1992, CYTOMETRY, V13, P381, DOI 10.1002/cyto.990130408; Hooper NM, 1999, MOL MEMBR BIOL, V16, P145, DOI 10.1080/096876899294607; Hou LF, 2013, EUR J EPIDEMIOL, V28, P735, DOI 10.1007/s10654-013-9842-7; Ip WK, 2005, IMMUNOPHARM IMMUNOT, V27, P371, DOI 10.1080/08923970500240925; Janes PW, 1999, J CELL BIOL, V147, P447, DOI 10.1083/jcb.147.2.447; Kankaanranta H, 1999, J PHARMACOL EXP THER, V290, P621; Kranenburg O, 2001, CURR BIOL, V11, P1880, DOI 10.1016/S0960-9822(01)00582-6; Lei JT, 2008, J LEUKOCYTE BIOL, V84, P499, DOI 10.1189/jlb.1207828; Leitinger B, 2002, J CELL SCI, V115, P963; Liu GT, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/421389; Liu LY, 2002, J IMMUNOL, V169, P6452, DOI 10.4049/jimmunol.169.11.6452; Lucero HA, 2004, ARCH BIOCHEM BIOPHYS, V426, P208, DOI 10.1016/j.abb.2004.03.020; McDermott EP, 2002, J BIOL CHEM, V277, P7808, DOI 10.1074/jbc.M108133200; MCGOOKEY DJ, 1983, J CELL BIOL, V96, P1273, DOI 10.1083/jcb.96.5.1273; Mendelsohn AR, 2002, P NATL ACAD SCI USA, V99, P6871, DOI 10.1073/pnas.072290599; MILHAUD J, 1992, BIOCHIM BIOPHYS ACTA, V1105, P307, DOI 10.1016/0005-2736(92)90209-5; Monahan J, 1997, J IMMUNOL, V159, P4024; MULLER CP, 1984, CYTOMETRY, V5, P42, DOI 10.1002/cyto.990050108; Oda E, 2012, HEART VESSELS, V27, P377, DOI 10.1007/s00380-011-0157-x; Pazdrak K, 1998, J EXP MED, V188, P421, DOI 10.1084/jem.188.3.421; Pelicci G, 1996, ONCOGENE, V13, P633; Pike LJ, 2004, BIOCHEM J, V378, P281, DOI 10.1042/BJ20031672; Rockett BD, 2012, J LIPID RES, V53, P674, DOI 10.1194/jlr.M021782; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; Schley PD, 2007, J NUTR, V137, P548, DOI 10.1093/jn/137.3.548; SEDGWICK JB, 1992, J IMMUNOL, V149, P3710; SEDGWICK JB, 1991, AM REV RESPIR DIS, V144, P1274, DOI 10.1164/ajrccm/144.6.1274; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; Shim WS, 2006, DIABETES RES CLIN PR, V73, P284, DOI 10.1016/j.diabres.2006.02.001; Siddiqui S, 2005, AM J KIDNEY DIS, V46, P1065, DOI 10.1053/j.ajkd.2005.09.001; Stout BA, 2004, J IMMUNOL, V173, P6409, DOI 10.4049/jimmunol.173.10.6409; Stulnig TM, 2003, INT ARCH ALLERGY IMM, V132, P310, DOI 10.1159/000074898; Stulnig TM, 2001, J BIOL CHEM, V276, P37335, DOI 10.1074/jbc.M106193200; Szabo G, 2007, J IMMUNOL, V178, P1243, DOI 10.4049/jimmunol.178.3.1243; ten Hove W, 2007, MOL IMMUNOL, V44, P2492, DOI 10.1016/j.molimm.2006.10.009; Tuluc F, 2003, INT IMMUNOPHARMACOL, V3, P1775, DOI 10.1016/j.intimp.2003.08.002; Vidal R, 2011, METHODS MOL BIOL, V793, P241, DOI 10.1007/978-1-61779-328-8_16; Wang WP, 2002, MOL CELL BIOL, V22, P3389, DOI 10.1128/MCB.22.10.3389-3403.2002; Weller PF, 1997, J ALLERGY CLIN IMMUN, V100, P283, DOI 10.1016/S0091-6749(97)70237-9; Wong CK, 2002, CLIN EXP IMMUNOL, V128, P483, DOI 10.1046/j.1365-2249.2002.01880.x; YAMAGUCHI Y, 1991, BLOOD, V78, P2542; Yao XL, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00037; Yao XL, 2012, AM J PHYSIOL-LUNG C, V302, pL206, DOI 10.1152/ajplung.00110.2011; Yao XL, 2011, J IMMUNOL, V186, P576, DOI 10.4049/jimmunol.1001534; Yao XL, 2010, AM J RESP CRIT CARE, V182, P1228, DOI 10.1164/rccm.201002-0308OC; Yiallouros PK, 2012, CLIN EXP ALLERGY, V42, P423, DOI 10.1111/j.1365-2222.2011.03940.x; Zhu XD, 2002, J LEUKOCYTE BIOL, V72, P1046; Zhu YM, 2011, J IMMUNOL, V186, P516, DOI 10.4049/jimmunol.1000955; Zhuang LY, 2005, J CLIN INVEST, V115, P959; Zhuang SG, 2000, J BIOL CHEM, V275, P25939, DOI 10.1074/jbc.M001185200	72	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e103122	10.1371/journal.pone.0103122	http://dx.doi.org/10.1371/journal.pone.0103122			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121926	Green Published, Green Submitted, gold			2022-12-25	WOS:000341017000011
J	Carvalho, N; Noiret, N; Vandel, P; Monnin, J; Chopard, G; Laurent, E				Carvalho, Nicolas; Noiret, Nicolas; Vandel, Pierre; Monnin, Julie; Chopard, Gilles; Laurent, Eric			Saccadic Eye Movements in Depressed Elderly Patients	PLOS ONE			English	Article							COGNITIVE INHIBITION; NEUROPSYCHOLOGICAL DEFICITS; EXECUTIVE FUNCTION; AFFECTIVE-DISORDER; PREFRONTAL CORTEX; MAJOR DEPRESSION; TASK-PERFORMANCE; ANTISACCADE TASK; CORTICAL CONTROL; WORKING-MEMORY	The primary aim of this study was to characterize oculomotor performances in elderly depressed patients. The second aim was to investigate whether cognitive inhibition measured by the antisaccade task was associated with a psychomotor retardation or rather with a more specific cognitive-motor inhibition deficit. Twenty patients with a major depressive disorder and forty-seven healthy subjects performed two eye movement tasks. Saccadic reaction time and error rates were analyzed in the prosaccade task to obtain basic parameters of eye movements. Saccade latency, error rates and correction rates were evaluated in the antisaccade task to investigate inhibition capacities. Performances were impaired in patients, who exhibited a higher reaction time and error rates compared to controls. The higher time cost of inhibition suggested that the reaction time was not related to global psychomotor retardation alone. The higher time cost of inhibition could be explained by a specific alteration of inhibition processes evaluated by the antisaccade task. These changes were associated with the severity of depression. These findings provide a new perspective on cognitive inhibition in elderly depressed patients and could have important clinical implications for our understanding of critical behaviors involving deficits in inhibitory processes in the elderly.	[Carvalho, Nicolas; Noiret, Nicolas; Vandel, Pierre; Monnin, Julie; Chopard, Gilles] Univ Hosp, Dept Clin Psychiat, Besancon, France; [Carvalho, Nicolas; Vandel, Pierre; Monnin, Julie; Chopard, Gilles] Univ Franche Comte, Neurosci Lab, EA 481, F-25030 Besancon, France; [Vandel, Pierre; Monnin, Julie] Besancon Univ Hosp, CIC IT Inserm 808, Besancon, France; [Noiret, Nicolas; Laurent, Eric] Univ Franche Comte, Psychol Lab, EA 3188, F-25030 Besancon, France; [Laurent, Eric] CNRS, UMSR FED MSHE Ledoux 3124 4209, F-25030 Besancon, France; [Laurent, Eric] Univ Franche Comte, F-25030 Besancon, France	Universite de Franche-Comte; CHU Besancon; Universite de Franche-Comte; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Franche-Comte; CHU Besancon; Universite de Franche-Comte; Centre National de la Recherche Scientifique (CNRS); Universite de Franche-Comte; Universite de Franche-Comte	Carvalho, N (corresponding author), Univ Hosp, Dept Clin Psychiat, Besancon, France.	nic.carvalh@gmail.com; eric.laurent@univ-fcomte.fr	carvalho, Nicolas/M-9650-2019; Laurent, Eric/AAM-1161-2020; LAURENT, Éric/AAW-4345-2020	LAURENT, Éric/0000-0002-7112-6765; Vandel, Pierre/0000-0002-0189-8364; CHOPARD, Gilles/0000-0003-2380-1057	French Ministry of Health (Programme Hospitalier de Recherche Clinique: PHRC) [2009-A00942-55]	French Ministry of Health (Programme Hospitalier de Recherche Clinique: PHRC)	This study was supported by a grant from the French Ministry of Health (Programme Hospitalier de Recherche Clinique: PHRC no2009-A00942-55). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexapoulos GS, 2005, LANCET, V365, P1961, DOI 10.1016/S0140-6736(05)66665-2; Alexopoulos GS, 2006, BIOL PSYCHIAT, V60, P1304, DOI 10.1016/j.biopsych.2006.09.006; Alexopoulos GS, 2003, J CLIN PSYCHIAT, V64, P18; APA, 2000, DIAGN STAT MAN MENT, V4th, DOI [DOI 10.1176/APPI.BOOKS.9780890423349, 10.1176/appi.books.9780890423349]; AUSTIN MP, 1992, J AFFECT DISORDERS, V25, P21, DOI 10.1016/0165-0327(92)90089-O; Austin MP, 2001, BRIT J PSYCHIAT, V178, P200, DOI 10.1192/bjp.178.3.200; BALL DM, 1991, PSYCHOPHARMACOLOGY, V105, P361, DOI 10.1007/BF02244431; Basso MR, 1999, NEUROPSYCHOLOGY, V13, P69, DOI 10.1037/0894-4105.13.1.69; Baudic S, 2004, J GERIATR PSYCH NEUR, V17, P195, DOI 10.1177/0891988704269823; Baudic S, 2007, PSYCHOL NEUROPSYCHIA, V5, P65, DOI 10.1684/pnv.2007.0036; BAXTER LR, 1989, ARCH GEN PSYCHIAT, V46, P243; Bonin-Guillaume S, 2008, PSYCHOL NEUROPSYCHIA, V6, P137, DOI 10.1684/pnv.2008.0121; BOONE KB, 1995, NEUROPSYCHOLOGY, V9, P390, DOI 10.1037/0894-4105.9.3.390; Buschke H, 1999, NEUROLOGY, V52, P231, DOI 10.1212/WNL.52.2.231; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Crawford TJ, 2005, BIOL PSYCHIAT, V57, P1052, DOI 10.1016/j.biopsych.2005.01.017; Crevits L, 2005, PSYCHIAT RES, V135, P113, DOI 10.1016/j.psychres.2003.10.008; Currie J, 1991, ARCH NEUROL-CHICAGO, V48, P949, DOI DOI 10.1001/ARCHNEUR.1991.00530180102024; De Lissnyder E, 2011, COGNITION EMOTION, V25, P886, DOI 10.1080/02699931.2010.514711; Dombrovski AY, 2008, AM J GERIAT PSYCHIAT, V16, P109, DOI 10.1097/JGP.0b013e3180f6338d; Eenshuistra RM, 2004, BRAIN COGNITION, V56, P177, DOI 10.1016/j.bandc.2004.02.077; Everling S, 1998, NEUROPSYCHOLOGIA, V36, P885, DOI 10.1016/S0028-3932(98)00020-7; Everling S, 2000, J NEUROSCI, V20, P387, DOI 10.1523/JNEUROSCI.20-01-00387.2000; FAFROWICZ M, 1995, NEUROPSYCHOBIOLOGY, V32, P156, DOI 10.1159/000119316; Ferreira S, 2010, REV NEUROL-FRANCE, V166, P606, DOI 10.1016/j.neurol.2009.12.005; FISCHER B, 1992, EXP BRAIN RES, V89, P415; Fiske A, 2009, ANNU REV CLIN PSYCHO, V5, P363, DOI 10.1146/annurev.clinpsy.032408.153621; Flechtner KM, 2002, EUR ARCH PSY CLIN N, V252, P49, DOI 10.1007/s004060200011; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Foster SM, 2013, PSYCHOL AGING, V28, P179, DOI 10.1037/a0030928; Funahashi S, 2001, NEUROSCI RES, V39, P147, DOI 10.1016/S0168-0102(00)00224-8; Gallagher D, 2012, J AFFECTIVE DISORDER; Gallo JJ, 2000, JAMA-J AM MED ASSOC, V284, P1570, DOI 10.1001/jama.284.12.1570; Gaymard B, 1998, EXP BRAIN RES, V123, P159, DOI 10.1007/s002210050557; Godijn R, 2007, PERCEPT PSYCHOPHYS, V69, P802, DOI 10.3758/BF03193780; Gohier B, 2009, J AFFECT DISORDERS, V116, P100, DOI 10.1016/j.jad.2008.10.028; Goldman WP, 1999, NEUROLOGY, V53, P956, DOI 10.1212/WNL.53.5.956; Gooding DC, 2004, PSYCHOL MED, V34, P921, DOI 10.1017/S003329170300165X; Green JF, 1998, BIOL PSYCHIAT, V44, P709, DOI 10.1016/S0006-3223(97)00452-6; GROBER E, 1987, DEV NEUROPSYCHOL, V3, P13, DOI 10.1080/87565648709540361; Hamilton AC, 2005, COGN AFFECT BEHAV NE, V5, P1; Harnishfeger Katherine Kipp, 1995, P175, DOI 10.1016/B978-012208930-5/50007-6; HARNISHFEGER KK, 1994, LEARN INDIVID DIFFER, V6, P331, DOI 10.1016/1041-6080(94)90021-3; Houghton George, 1994, P53; Hutton SB, 2008, BRAIN COGNITION, V68, P327, DOI 10.1016/j.bandc.2008.08.021; ISAACS B, 1973, BRIT J PSYCHIAT, V123, P467, DOI 10.1192/bjp.123.4.467; Joormann J, 2007, APPL PREV PSYCHOL, V12, P128, DOI 10.1016/j.appsy.2007.09.002; Katsanis J, 1997, J ABNORM PSYCHOL, V106, P468, DOI 10.1037/0021-843X.106.3.468; KRAMER AF, 1994, PSYCHOL AGING, V9, P491, DOI 10.1037/0882-7974.9.4.491; Leigh RJ, 2004, BRAIN, V127, P460, DOI 10.1093/brain/awh035; Liu ZF, 2010, PSYCHIAT RES-NEUROIM, V182, P211, DOI 10.1016/j.pscychresns.2010.03.004; Lockwood KA, 2000, AM J GERIAT PSYCHIAT, V8, P201, DOI 10.1176/appi.ajgp.8.3.201; Mahlberg R, 2001, EUR ARCH PSY CLIN N, V251, P205, DOI 10.1007/s004060170028; Malsert J, 2012, PSYCHIAT RES, V200, P1051, DOI 10.1016/j.psychres.2012.05.007; Marazziti D, 2010, EUR J PHARMACOL, V626, P83, DOI 10.1016/j.ejphar.2009.08.046; Mecocci P, 2004, AGING CLIN EXP RES, V16, P176, DOI 10.1007/BF03327382; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Munoz DP, 2004, NAT REV NEUROSCI, V5, P218, DOI 10.1038/nrn1345; Naismith SL, 2012, PROG NEUROBIOL, V98, P99, DOI 10.1016/j.pneurobio.2012.05.009; Nigg JT, 2000, PSYCHOL BULL, V126, P220, DOI 10.1037/0033-2909.126.2.220; Nijboer T, 2010, NEUROREPORT, V21, P386, DOI 10.1097/WNR.0b013e328337f95f; Palmer BW, 1996, J AFFECT DISORDERS, V41, P17, DOI 10.1016/0165-0327(96)00059-6; Pierrot-Deseilligny C, 2003, BRAIN, V126, P1460, DOI 10.1093/brain/awg148; Pierrot-Deseilligny C, 2004, CURR OPIN NEUROL, V17, P17, DOI 10.1097/00019052-200402000-00005; Pierrot-Deseilligny C, 2003, PROG BRAIN RES, V142, P3; Rafal Robert, 1994, P1; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Richard-Devantoy S, 2012, J AFFECT DISORDERS, V140, P193, DOI 10.1016/j.jad.2012.03.006; Robinson FR, 2001, ANNU REV NEUROSCI, V24, P981, DOI 10.1146/annurev.neuro.24.1.981; Shafiq-Antonacci R, 2003, ARCH NEUROL-CHICAGO, V60, P1272, DOI 10.1001/archneur.60.9.1272; Signoret J. L., 1989, EVALUATION TROUBLES; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Sweeney JA, 1998, BIOL PSYCHIAT, V43, P584, DOI 10.1016/S0006-3223(97)00485-X; Thorpe L, 2001, CAN J NEUROL SCI, V28, pS83, DOI 10.1017/S0317167100001256; Townsend JD, 2013, BIOL PSYCHIAT, V73, P127, DOI 10.1016/j.biopsych.2012.06.030; Unsworth N, 2011, ACTA PSYCHOL, V137, P90, DOI 10.1016/j.actpsy.2011.03.004; Van der Linden M, 2004, EVALUATION TROUBLES, P25; Winograd-Gurvich C, 2006, J AFFECT DISORDERS, V93, P193, DOI 10.1016/j.jad.2006.03.018	79	13	14	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e105355	10.1371/journal.pone.0105355	http://dx.doi.org/10.1371/journal.pone.0105355			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO0QT	25122508	gold, Green Submitted, Green Published			2022-12-25	WOS:000341017000119
J	Luchting, B; Rachinger-Adam, B; Zeitler, J; Egenberger, L; Mohnle, P; Kreth, S; Azad, SC				Luchting, Benjamin; Rachinger-Adam, Banafscheh; Zeitler, Julia; Egenberger, Lisa; Moehnle, Patrick; Kreth, Simone; Azad, Shahnaz Christina			Disrupted TH17/Treg Balance in Patients with Chronic Low Back Pain	PLOS ONE			English	Article							REGULATORY T-CELLS; CHRONIC CONSTRICTION; SELF-TOLERANCE; NERVE INJURY; SPINAL-CORD; DEPRESSION; TH17; INFILTRATION; EXPRESSION; SEVERITY	Chronic low back pain (CLBP) is a leading cause of disability and costs in health care systems worldwide. Despite extensive research, the exact pathogenesis of CLBP, particularly the individual risk of chronification remains unclear. To investigate a possible role of the adaptive immune system in the pathophysiology of CLBP, we analyzed T cell related cytokine profiles, T cell related mRNA expression patterns and the distribution of T cell subsets in 37 patients suffering from nonspecific CLBP before and after multimodal therapy in comparison to 25 healthy controls. Serum patterns of marker cytokines were analyzed by Luminex technology, mRNA expression of cytokines and specific transcription factors was measured by real-time PCR, and distribution of TH1-, TH2-, TH17- and regulatory T cell (Tregs) subsets was determined by multicolor flow cytometry. We found that CLBP patients exhibit an increased number of anti-inflammatory Tregs, while pro-inflammatory TH17 cells are decreased, resulting in an altered TH17/Treg ratio. Accordingly, FoxP3 and TGF-b-mRNA expression was elevated, while expression of IL-23 was reduced. Serum cytokine analyses proved to be unsuitable to monitor the adaptive immune response in CLBP patients. We further show that even after successful therapy with lasting reduction of pain, T cell subset patterns remained altered after a follow-up period of 6 months. These findings suggest an involvement of TH17/Treg cells in the pathogenesis of CLBP and emphasize the importance of these cells in the crosstalk of pain and immune response.	[Luchting, Benjamin; Rachinger-Adam, Banafscheh; Zeitler, Julia; Egenberger, Lisa; Moehnle, Patrick; Kreth, Simone; Azad, Shahnaz Christina] Univ Munich, Dept Anesthesiol & Pain Med, Munich, Germany	University of Munich	Luchting, B (corresponding author), Univ Munich, Dept Anesthesiol & Pain Med, Munich, Germany.	benjamin.luchting@med.uni-muenchen.de	Möhnle, Patrick/C-9243-2018	Möhnle, Patrick/0000-0003-4769-7100; Kreth, Simone/0000-0002-0073-2098; Luchting, Benjamin/0000-0002-8919-9874	Hella-Langer-Stiftung, Germany	Hella-Langer-Stiftung, Germany	This work was supported by grants from the Hella-Langer-Stiftung, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzali B, 2007, CLIN EXP IMMUNOL, V148, P32, DOI 10.1111/j.1365-2249.2007.03356.x; Airaksinen O, 2006, EUR SPINE J, V15, pS192, DOI 10.1007/s00586-006-1072-1; Austin PJ, 2012, PAIN, V153, P1916, DOI 10.1016/j.pain.2012.06.005; Austin PJ, 2010, J NEUROIMMUNOL, V229, P26, DOI 10.1016/j.jneuroim.2010.08.013; Baecher-Allan C, 2001, J IMMUNOL, V167, P1245, DOI 10.4049/jimmunol.167.3.1245; Balague F, 2012, LANCET, V379, P482, DOI 10.1016/S0140-6736(11)60610-7; Becker A, 2012, SPINE, V37, P701, DOI 10.1097/BRS.0b013e31822b01bd; Becker A, 2010, SPINE, V35, P1714, DOI 10.1097/BRS.0b013e3181cd656f; Bozza FA, 2007, CRIT CARE, V11, DOI 10.1186/cc5783; Breen EC, 2011, CLIN VACCINE IMMUNOL, V18, P1229, DOI 10.1128/CVI.05032-11; Brucklacher-Waldert V, 2009, J IMMUNOL, V183, P5494, DOI 10.4049/jimmunol.0901000; Cheng L, 2013, INJURY, V44, P1805, DOI 10.1016/j.injury.2013.04.010; Chouker A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010752; Chowdhury F, 2009, J IMMUNOL METHODS, V340, P55, DOI 10.1016/j.jim.2008.10.002; Costigan M, 2009, J NEUROSCI, V29, P14415, DOI 10.1523/JNEUROSCI.4569-09.2009; DeLeo JA, 2001, PAIN, V90, P1, DOI 10.1016/S0304-3959(00)00490-5; Edit V, 2013, RHEUMATOL INT, V33, P587, DOI 10.1007/s00296-012-2398-0; Fischer CP, 2007, SCAND J MED SCI SPOR, V17, P580, DOI 10.1111/j.1600-0838.2006.00602.x; Hartigan-O'Connor DJ, 2007, J IMMUNOL METHODS, V319, P41, DOI 10.1016/j.jim.2006.10.008; Hirota K, 2007, J EXP MED, V204, P41, DOI 10.1084/jem.20062259; Homey B, 2006, HAUTARZT, V57, P730, DOI 10.1007/s00105-006-1199-3; Hong M, 2013, NEUROIMMUNOMODULAT, V20, P39, DOI 10.1159/000343100; Hu P, 2007, BRAIN BEHAV IMMUN, V21, P599, DOI 10.1016/j.bbi.2006.10.013; Huckans M, 2014, BRAIN BEHAV, V4, P123, DOI 10.1002/brb3.200; Kleinschnitz C, 2006, EXP NEUROL, V200, P480, DOI 10.1016/j.expneurol.2006.03.014; Koch A, 2007, INFLAMM RES, V56, P32, DOI 10.1007/s00011-007-6088-4; Ledderose Carola, 2011, BMC Res Notes, V4, P427, DOI 10.1186/1756-0500-4-427; Lenz M, 2013, PAIN, V154, P2142, DOI 10.1016/j.pain.2013.06.039; Licciardone JC, 2012, J AM OSTEOPATH ASSOC, V112, P783; Liu Hai-hong, 2006, Zhonghua Nan Ke Xue, V12, P330; Liu HH, 2006, ZHONGHUA NAN KE XUE, V12, P336; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; Miller AH, 2010, BRAIN BEHAV IMMUN, V24, P1, DOI 10.1016/j.bbi.2009.09.009; Perkins NM, 2000, NEUROSCIENCE, V101, P745, DOI 10.1016/S0306-4522(00)00396-1; Raison CL, 2011, CURR PSYCHIAT REP, V13, P467, DOI 10.1007/s11920-011-0232-0; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Schinkel C, 2006, CLIN J PAIN, V22, P235, DOI 10.1097/01.ajp.0000169669.70523.f0; Shamji MF, 2010, ARTHRITIS RHEUM-US, V62, P1974, DOI 10.1002/art.27444; SULLIVAN MJL, 1992, PAIN, V50, P5, DOI 10.1016/0304-3959(92)90107-M; Tian Peng, 2009, Orthop Surg, V1, P317, DOI 10.1111/j.1757-7861.2009.00052.x; Torres-Harding Susan, 2008, Bull IACFS ME, V16, P19; Venet F, 2010, J IMMUNOL METHODS, V357, P55, DOI 10.1016/j.jim.2010.02.005; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Wang H, 2008, CLIN J PAIN, V24, P273, DOI 10.1097/AJP.0b013e31816111d3; Whiteside TL, 2012, CANCER IMMUNOL IMMUN, V61, P283, DOI 10.1007/s00262-011-1171-7; Xing Q, 2013, ARCH DERMATOL RES, V305, P715, DOI 10.1007/s00403-013-1367-0	47	26	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104883	10.1371/journal.pone.0104883	http://dx.doi.org/10.1371/journal.pone.0104883			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122126	Green Published, gold, Green Submitted			2022-12-25	WOS:000341017000068
J	Ruder, C; Haase, T; Krost, A; Langwieser, N; Peter, J; Kamann, S; Zohlnhofer, D				Rueder, Constantin; Haase, Tobias; Krost, Annalena; Langwieser, Nicole; Peter, Jan; Kamann, Stefanie; Zohlnhoefer, Dietlind			Combinatorial G-CSF/AMD3100 Treatment in Cardiac Repair after Myocardial Infarction	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; ENDOTHELIAL PROGENITOR CELLS; HEMATOPOIETIC STEM-CELLS; BONE-MARROW-CELLS; ANGIOGENESIS IN-VIVO; G-CSF; PERIPHERAL-BLOOD; MOUSE HEART; RAT MODEL; MOBILIZATION	Aims: Several studies suggest that circulating bone marrow derived stem cells promote the regeneration of ischemic tissues. For hematopoietic stem cell transplantation combinatorial granulocyte-colony stimulating factor (G-CSF)/Plerixafor (AMD3100) administration was shown to enhance mobilization of bone marrow derived stem cells compared to G-CSF monotherapy. Here we tested the hypothesis whether combinatorial G-CSF/AMD3100 therapy has beneficial effects in cardiac recovery in a mouse model of myocardial infarction. Methods: We analyzed the effect of single G-CSF (250 mu g/kg/day) and combinatorial G-CSF/AMD3100 (100 mu g/kg/day) treatment on cardiac morphology, vascularization, and hemodynamics 28 days after permanent ligation of the left anterior descending artery (LAD). G-CSF treatment started directly after induction of myocardial infarction (MI) for 3 consecutive days followed by a single AMD3100 application on day three after MI in the G-CSF/AMD3100 group. Cell mobilization was assessed by flow cytometry of blood samples drawn from tail vein on day 0, 7, and 14. Results: Peripheral blood analysis 7 days after MI showed enhanced mobilization of white blood cells (WBC) and endothelial progenitor cells (EPC) upon G-CSF and combinatorial G-CSF/AMD3100 treatment. However, single or combinatorial treatment showed no improvement in survival, left ventricular function, and infarction size compared to the saline treated control group 28 days after MI. Furthermore, no differences in histology and vascularization of infarcted hearts could be observed. Conclusion: Although the implemented treatment regimen caused no adverse effects, our data show that combinatorial G-CSF/AMD therapy does not promote myocardial regeneration after permanent LAD occlusion.	[Rueder, Constantin; Haase, Tobias; Krost, Annalena; Langwieser, Nicole; Peter, Jan; Kamann, Stefanie; Zohlnhoefer, Dietlind] Berlin Brandenburg Ctr Regenerat Therapies BCRT, Berlin, Germany; [Rueder, Constantin; Haase, Tobias; Zohlnhoefer, Dietlind] Campus Virchow Klinikum, Dept Cardiol, Charite, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Ruder, C (corresponding author), Berlin Brandenburg Ctr Regenerat Therapies BCRT, Berlin, Germany.	constantinrueder@hotmail.com		Haase, Tobias/0000-0002-7220-602X	Berlin-Brandenburg Center for Regenerative Therapies (BCRT)	Berlin-Brandenburg Center for Regenerative Therapies (BCRT)	Work was funded by the Berlin-Brandenburg Center for Regenerative Therapies (BCRT). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott JD, 2004, CIRCULATION, V110, P3300, DOI 10.1161/01.CIR.0000147780.30124.CF; Badorff C, 2003, CIRCULATION, V107, P1024, DOI 10.1161/01.CIR.0000051460.85800.BB; Barron HV, 2000, CIRCULATION, V102, P2329, DOI 10.1161/01.CIR.102.19.2329; Basu S, 2005, BLOOD, V106, P485, DOI 10.1182/blood-2004-10-4145; Bocchi L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017750; Brave M, 2010, ONCOLOGY-BASEL, V78, P282, DOI 10.1159/000315736; Broxmeyer HE, 2005, J EXP MED, V201, P1307, DOI 10.1084/jem.20041385; Calandra G, 2008, BONE MARROW TRANSPL, V41, P331, DOI 10.1038/sj.bmt.1705908; Capoccia BJ, 2006, BLOOD, V108, P2438, DOI 10.1182/blood-2006-04-013755; Cheng ZK, 2008, CARDIOVASC RES, V80, P425, DOI 10.1093/cvr/cvn202; Deten A, 2005, CARDIOVASC RES, V65, P52, DOI 10.1016/j.cardiores.2004.11.009; Dubois C, 2010, J AM COLL CARDIOL, V55, P2232, DOI 10.1016/j.jacc.2009.10.081; England TJ, 2009, BRAIN RES REV, V62, P71, DOI 10.1016/j.brainresrev.2009.09.002; Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5; Gnecchi M, 2005, NAT MED, V11, P367, DOI 10.1038/nm0405-367; Gorog DA, 2003, J MOL CELL CARDIOL, V35, P705, DOI 10.1016/S0022-2828(03)00082-8; Gruh I, 2006, CIRCULATION, V113, P1326, DOI 10.1161/CIRCULATIONAHA.105.559005; Guo Y, 2006, STEM CELLS, V24, P850, DOI 10.1634/stemcells.2005-0457; Guo YR, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0288-y; Harada M, 2005, NAT MED, V11, P305, DOI 10.1038/nm1199; Hasegawa H, 2006, J AM COLL CARDIOL, V47, P842, DOI 10.1016/j.jacc.2005.09.048; Hu J, 2002, HUM GENE THER, V13, P2041, DOI 10.1089/10430340260395893; Huang CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029246; Jujo K, 2010, P NATL ACAD SCI USA, V107, P11008, DOI 10.1073/pnas.0914248107; Lian WS, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-26; Lichtenauer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052101; Maekawa Y, 2004, J AM COLL CARDIOL, V44, P1510, DOI 10.1016/j.jacc.2004.05.083; Miki T, 2004, CLIN EXP PHARMACOL P, V31, P873, DOI 10.1111/j.1440-1681.2004.04130.x; Minatoguchi S, 2004, CIRCULATION, V109, P2572, DOI 10.1161/01.CIR.0000129770.93985.3E; Misao Y, 2006, CARDIOVASC RES, V71, P455, DOI 10.1016/j.cardiores.2006.05.002; Moazzami K., 2013, COCHRANE DB SYST REV, V5; Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446; Ohtsuka M, 2004, FASEB J, V18, P851, DOI 10.1096/fj.03-0637fje; Orlic D, 2001, P NATL ACAD SCI USA, V98, P10344, DOI 10.1073/pnas.181177898; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Pitchford SC, 2009, CELL STEM CELL, V4, P62, DOI 10.1016/j.stem.2008.10.017; Powell TM, 2005, ARTERIOSCL THROM VAS, V25, P296, DOI 10.1161/01.ATV.0000151690.43777.e4; Ripa RS, 2007, CIRCULATION, V116, pI24, DOI 10.1161/CIRCULATIONAHA.106.678649; ROBERTS AW, 1995, STEM CELLS, V13, P512, DOI 10.1002/stem.5530130508; ROBERTS R, 1976, CIRCULATION, V53, P204; Ruder C, 2014, COMBINATORI IN PRESS; Salem HK, 2010, STEM CELLS, V28, P585, DOI 10.1002/stem.269; Sanganalmath SK, 2011, BASIC RES CARDIOL, V106, P709, DOI 10.1007/s00395-011-0183-y; Shepherd RM, 2006, BLOOD, V108, P3662, DOI 10.1182/blood-2006-06-030577; Steendijk P, 2001, AM J PHYSIOL-HEART C, V281, pH755, DOI 10.1152/ajpheart.2001.281.2.H755; Stein A, 2010, THROMB HAEMOSTASIS, V103, P638, DOI 10.1160/TH09-09-0657; Stroncek DF, 1997, TRANSFUSION MED, V7, P19, DOI 10.1046/j.1365-3148.1997.d01-75.x; Sugano Y, 2005, CARDIOVASC RES, V65, P446, DOI 10.1016/j.cardiores.2004.10.008; Takagawa J, 2007, J APPL PHYSIOL, V102, P2104, DOI 10.1152/japplphysiol.00033.2007; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Takamiya M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025265; Theiss HD, 2011, STEM CELL RES, V7, P244, DOI 10.1016/j.scr.2011.05.003; Tura O, 2010, J THROMB HAEMOST, V8, P1614, DOI 10.1111/j.1538-7836.2010.03900.x; Werneck-De-Castro JPS, 2006, BASIC RES CARDIOL, V101, P494, DOI 10.1007/s00395-006-0605-4; Yu RYL, 2005, BLOOD, V105, P1777, DOI 10.1182/blood-2004-08-3171; Zaruba MM, 2008, CARDIOVASC RES, V77, P722, DOI 10.1093/cvr/cvm080; Zohlnhofer D, 2008, CARDIOVASC DRUG THER, V22, P343, DOI 10.1007/s10557-008-6114-y; Zohlnhofer D, 2006, JAMA-J AM MED ASSOC, V295, P1003, DOI 10.1001/jama.295.9.1003	58	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104644	10.1371/journal.pone.0104644	http://dx.doi.org/10.1371/journal.pone.0104644			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121738	Green Submitted, Green Published, gold			2022-12-25	WOS:000341017000052
J	Rutten, B; Tersteeg, C; Vrijenhoek, JEP; van Holten, TC; Elsenberg, EHAM; Mak-Nienhuis, EM; de Borst, GJ; Jukema, JW; Pijls, NHJ; Waltenberger, J; van Zonneveld, AJ; Moll, FL; McClellan, E; Stubbs, A; Pasterkamp, G; Hoefer, I; de Groot, PG; Roest, M				Rutten, Bert; Tersteeg, Claudia; Vrijenhoek, Joyce E. P.; van Holten, Thijs C.; Elsenberg, Ellen H. A. M.; Mak-Nienhuis, Elske M.; de Borst, Gert Jan; Jukema, J. Wouter; Pijls, Nico H. J.; Waltenberger, Johannes; van Zonneveld, Anton Jan; Moll, Frans L.; McClellan, Elizabeth; Stubbs, Andrew; Pasterkamp, Gerard; Hoefer, Imo; de Groot, Philip G.; Roest, Mark			Increased Platelet Reactivity Is Associated with Circulating Platelet-Monocyte Complexes and Macrophages in Human Atherosclerotic Plaques	PLOS ONE			English	Article							P-SELECTIN; EXPRESSION; ENDARTERECTOMY; CLOPIDOGREL; ADHESION; ACTIVATION; DEFICIENT; TRIGGERS; PROTEIN; ARREST	Objective: Platelet reactivity, platelet binding to monocytes and monocyte infiltration play a detrimental role in atherosclerotic plaque progression. We investigated whether platelet reactivity was associated with levels of circulating platelet-monocyte complexes (PMCs) and macrophages in human atherosclerotic carotid plaques. Methods: Platelet reactivity was determined by measuring platelet P-selectin expression after platelet stimulation with increasing concentrations of adenosine diphosphate (ADP), in two independent cohorts: the Circulating Cells cohort (n = 244) and the Athero-Express cohort (n = 91). Levels of PMCs were assessed by flow cytometry in blood samples of patients who were scheduled for percutaneous coronary intervention (Circulating Cells cohort). Monocyte infiltration was semi-quantitatively determined by histological examination of atherosclerotic carotid plaques collected during carotid endarterectomy (Athero-Express cohort). Results: We found increased platelet reactivity in patients with high PMCs as compared to patients with low PMCs (median (interquartile range): 4153 (1585-11267) area under the curve (AUC) vs. 9633 (3580-21565) AUC, P<0.001). Also, we observed increased platelet reactivity in patients with high macrophage levels in atherosclerotic plaques as compared to patients with low macrophage levels in atherosclerotic plaques (mean +/- SD; 8969 +/- 3485 AUC vs. 7020 +/- 3442 AUC, P = 0.02). All associations remained significant after adjustment for age, sex and use of drugs against platelet activation. Conclusion: Platelet reactivity towards ADP is associated with levels of PMCs and macrophages in human atherosclerotic carotid plaques.	[Rutten, Bert; Tersteeg, Claudia; van Holten, Thijs C.; Mak-Nienhuis, Elske M.; de Groot, Philip G.; Roest, Mark] Univ Med Ctr Utrecht, Lab Clin Chem & Hematol, Utrecht, Netherlands; [Tersteeg, Claudia; Vrijenhoek, Joyce E. P.; Elsenberg, Ellen H. A. M.; Mak-Nienhuis, Elske M.; Pasterkamp, Gerard; Hoefer, Imo] Univ Med Ctr Utrecht, Lab Expt Cardiol, Utrecht, Netherlands; [Vrijenhoek, Joyce E. P.; de Borst, Gert Jan; Moll, Frans L.] Univ Med Ctr Utrecht, Dept Vasc Surg, Utrecht, Netherlands; [Vrijenhoek, Joyce E. P.] Interuniv Cardiol Inst Netherlands, Utrecht, Netherlands; [Jukema, J. Wouter] Leiden Univ, Dept Cardiol, Med Ctr, Leiden, Netherlands; [Pijls, Nico H. J.] Catharina Hosp, Dept Cardiol, Eindhoven, Netherlands; [Waltenberger, Johannes] Maastricht Univ, Dept Cardiol, Med Ctr, Maastricht, Netherlands; [van Zonneveld, Anton Jan] Leiden Univ, Med Ctr, Dept Nephrol, Leiden, Netherlands; [van Zonneveld, Anton Jan] Leiden Univ, Med Ctr, Einthoven Lab Expt Vasc Med, Leiden, Netherlands; [McClellan, Elizabeth; Stubbs, Andrew] Erasmus Univ, Med Ctr, Dept Bioinformat, Rotterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Interuniversity Cardiology Institute of the Netherlands; Utrecht University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Catharina Hospital; Maastricht University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC	Roest, M (corresponding author), Univ Med Ctr Utrecht, Lab Clin Chem & Hematol, Utrecht, Netherlands.	M.Roest@umcutrecht.nl	Jukema, J. Wouter/ABD-6503-2021; van Zonneveld, Anton Jan/D-8060-2018; Tersteeg, Claudia/V-3758-2018	Jukema, J. Wouter/0000-0002-3246-8359; van Zonneveld, Anton Jan/0000-0002-1676-7738; Tersteeg, Claudia/0000-0002-6380-6349; Rutten, Bart/0000-0002-9834-6346	project CIRCULATING CELLS [01C-102]; Dutch Heart Foundation	project CIRCULATING CELLS; Dutch Heart Foundation(Netherlands Heart Foundation)	This research was performed within the framework of CTMM, the Center for Translational Molecular Medicine (www.ctmm.nl), project CIRCULATING CELLS (grant 01C-102), and supported by the Dutch Heart Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Bouman HJ, 2010, J THROMB HAEMOST, V8, P482, DOI 10.1111/j.1538-7836.2009.03733.x; Braun OO, 2008, THROMB HAEMOSTASIS, V100, P626, DOI 10.1160/TH08-05-0313; Breet NJ, 2010, JAMA-J AM MED ASSOC, V303, P754, DOI 10.1001/jama.2010.181; Burger PC, 2003, BLOOD, V101, P2661, DOI 10.1182/blood-2002-07-2209; Can MM, 2010, THROMB RES, V125, pE132, DOI 10.1016/j.thromres.2009.11.005; Davies JA, 2009, ACTA HAEMATOL-BASEL, V121, P98, DOI 10.1159/000214848; Dawood BB, 2012, BLOOD, V120, P5041, DOI 10.1182/blood-2012-07-444281; Frenette PS, 2000, J EXP MED, V191, P1413, DOI 10.1084/jem.191.8.1413; Furman MI, 1998, J AM COLL CARDIOL, V31, P352, DOI 10.1016/S0735-1097(97)00510-X; Furman MI, 2001, J AM COLL CARDIOL, V38, P1002, DOI 10.1016/S0735-1097(01)01485-1; Gawaz M, 1998, CIRCULATION, V98, P1164, DOI 10.1161/01.CIR.98.12.1164; GOLDSTEIN MR, 1995, JAMA-J AM MED ASSOC, V274, P1505, DOI 10.1001/jama.1995.03530190019015; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hechler B, 2008, CIRCULATION, V118, P754, DOI 10.1161/CIRCULATIONAHA.108.788927; Hellings WE, 2007, J VASC SURG, V46, P1147, DOI 10.1016/j.jvs.2007.08.018; Henn V, 1998, NATURE, V391, P591, DOI 10.1038/35393; Huo YQ, 2003, NAT MED, V9, P61, DOI 10.1038/nm810; Jones CI, 2007, J THROMB HAEMOST, V5, P1756, DOI 10.1111/j.1538-7836.2007.02632.x; Jukema JW, 2013, CLIN RES CARDIOL; KARANAS YL, 1995, ANN PLAS SURG, V35, P525, DOI 10.1097/00000637-199511000-00015; Klinkhardt U, 2003, CLIN PHARMACOL THER, V73, P232, DOI 10.1067/mcp.2003.13; Leppanen A, 1999, J BIOL CHEM, V274, P24838, DOI 10.1074/jbc.274.35.24838; Li D, 2012, ARTERIOSCL THROM VAS, V32, pE81, DOI 10.1161/ATVBAHA.111.239095; Liu D, 2014, J EXP MED; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Martins PAD, 2006, J LEUKOCYTE BIOL, V79, P499, DOI 10.1189/jlb.0605318; Massberg S, 2002, J EXP MED, V196, P887, DOI 10.1084/jem.20012044; Michelson AD, 2001, CIRCULATION, V104, P1533, DOI 10.1161/hc3801.095588; Rothwell PM, 2004, LANCET, V363, P915, DOI 10.1016/S0140-6736(04)15785-1; Simon DI, 2000, J EXP MED, V192, P193, DOI 10.1084/jem.192.2.193; van Bladel ER, 2014, BLOOD; Van Holten TC, 2012, J THROMB HAEMOST, V10, P1177, DOI 10.1111/j.1538-7836.2012.04703.x; Verhoeven BAN, 2004, EUR J EPIDEMIOL, V19, P1127, DOI 10.1007/s10564-004-2304-6; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262; von Hundelshausen P, 2005, BLOOD, V105, P924, DOI 10.1182/blood-2004-06-2475; von Hundelshausen P, 2001, CIRCULATION, V103, P1772, DOI 10.1161/01.CIR.103.13.1772	38	7	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e105019	10.1371/journal.pone.0105019	http://dx.doi.org/10.1371/journal.pone.0105019			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122139	Green Published, gold, Green Submitted			2022-12-25	WOS:000341017000089
J	Vaisnav, M; Xing, C; Ku, HC; Hwang, D; Stojadinovic, S; Pertsemlidis, A; Abrams, JM				Vaisnav, Mahesh; Xing, Chao; Ku, Hung-Chih; Hwang, Daniel; Stojadinovic, Strahinja; Pertsemlidis, Alexander; Abrams, John M.			Genome-Wide Association Analysis of Radiation Resistance in Drosophila melanogaster	PLOS ONE			English	Article							DNA-REPAIR GENES; IONIZING-RADIATION; HERITABILITY; RADIOTHERAPY; EXPOSURE; CANCER; INSTABILITY; VARIANTS; RISKS	Background: Ionizing radiation is genotoxic to cells. Healthy tissue toxicity in patients and radiation resistance in tumors present common clinical challenges in delivering effective radiation therapies. Radiation response is a complex, polygenic trait with unknown genetic determinants. The Drosophila Genetic Reference Panel (DGRP) provides a model to investigate the genetics of natural variation for sensitivity to radiation. Methods and Findings: Radiation response was quantified in 154 inbred DGRP lines, among which 92 radiosensitive lines and 62 radioresistant lines were classified as controls and cases, respectively. A case-control genome-wide association screen for radioresistance was performed. There are 32 single nucleotide polymorphisms (SNPs) associated with radio resistance at a nominal p<10(-5); all had modest effect sizes and were common variants with the minor allele frequency. 5%. All the genes implicated by those SNP hits were novel, many without a known role in radiation resistance and some with unknown function. Variants in known DNA damage and repair genes associated with radiation response were below the significance threshold of p<10(-5) and were not present among the significant hits. No SNP met the genome-wide significance threshold (p = 1.49x10(-7)), indicating a necessity for a larger sample size. Conclusions: Several genes not previously associated with variation in radiation resistance were identified. These genes, especially the ones with human homologs, form the basis for exploring new pathways involved in radiation resistance in novel functional studies. An improved DGRP model with a sample size of at least 265 lines and ideally up to 793 lines is recommended for future studies of complex traits.	[Vaisnav, Mahesh; Hwang, Daniel; Abrams, John M.] UT Southwestern Med Ctr, Dept Cell Biol, Dallas, TX 75235 USA; [Xing, Chao; Ku, Hung-Chih] UT Southwestren Med Ctr, McDermott Ctr Human Growth & Dev, Dallas, TX USA; [Stojadinovic, Strahinja] UT Southwestren Med Ctr, Dept Radiat Oncol, Dallas, TX USA; [Pertsemlidis, Alexander] UT Southwestren Med Ctr, Greehey Childrens Canc Res Inst, Dept Pediat & Cellular & Struct Biol, Dallas, TX USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Abrams, JM (corresponding author), UT Southwestern Med Ctr, Dept Cell Biol, Dallas, TX 75235 USA.	John.Abrams@UTSouthwestern.edu	Stojadinovic, Strahinja/R-3818-2019; Pertsemlidis, Alexander/Q-7899-2017	Stojadinovic, Strahinja/0000-0002-6840-5747; Pertsemlidis, Alexander/0000-0003-1624-9372; Xing, Chao/0000-0002-1838-0502	NIH [C06 RR30414, R01GM072124]; Cancer Prevention Research Institute of Texas [RP110076]; Ellison Medical Foundation; Welch Foundation [I-1727]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR030414] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072124] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention Research Institute of Texas; Ellison Medical Foundation(Lawrence Ellison Foundation); Welch Foundation(The Welch Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was performed in laboratories constructed with support from NIH grant C06 RR30414, and was funded by NIH R01GM072124, Cancer Prevention Research Institute of Texas RP110076, Ellison Medical Foundation and Welch Foundation (I-1727). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett GC, 2009, NAT REV CANCER, V9, P134, DOI 10.1038/nrc2587; Boice JD, 2012, J RADIOL PROT, V32, pN33, DOI 10.1088/0952-4746/32/1/N33; Chow CY, 2013, P NATL ACAD SCI USA, V110, P9013, DOI 10.1073/pnas.1307125110; Curwen GB, 2010, INT J RADIAT BIOL, V86, P986, DOI 10.3109/09553002.2010.496027; Finnon P, 2008, HUM GENET, V123, P485, DOI 10.1007/s00439-008-0500-1; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gomez FH, 2013, INT J RADIAT BIOL, V89, P583, DOI 10.3109/09553002.2012.711503; Katsnelson A, 2013, NAT MED, V19, P249, DOI 10.1038/nm0313-249; Kerns SL, 2010, INT J RADIAT ONCOL, V78, P1292, DOI 10.1016/j.ijrobp.2010.07.036; Lange SS, 2011, NAT REV CANCER, V11, P96, DOI 10.1038/nrc2998; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; Little MP, 2003, BRIT MED BULL, V68, P259, DOI 10.1093/bmb/ldg031; MACKAY TF, 2008, PROPOSAL SEQUENCE DR; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Marian AJ, 2012, TRANSL RES, V159, P64, DOI 10.1016/j.trsl.2011.08.001; Mettler FA, 2002, NEW ENGL J MED, V346, P1554, DOI 10.1056/NEJMra000365; Morgan WF, 2003, RADIAT RES, V159, P567, DOI 10.1667/0033-7587(2003)159[0567:NADEOE]2.0.CO;2; Pawitan Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007969; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sankaranarayanan K, 2006, J RADIAT RES, V47, pB57, DOI 10.1269/jrr.47.B57; Spencer CCA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000477; Suzuki K, 2003, ONCOGENE, V22, P6988, DOI 10.1038/sj.onc.1206881; Turesson I, 1996, INT J RADIAT ONCOL, V36, P1065, DOI 10.1016/S0360-3016(96)00426-9; Weber AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034745; West CML, 2012, SEMIN RADIAT ONCOL, V22, P91, DOI 10.1016/j.semradonc.2011.12.007; Wood RD, 2005, MUTAT RES-FUND MOL M, V577, P275, DOI 10.1016/j.mrfmmm.2005.03.007; Wood RD, 2001, SCIENCE, V291, P1284, DOI 10.1126/science.1056154; Xing G, 2012, ANN HUM GENET, V76, P168, DOI 10.1111/j.1469-1809.2011.00700.x; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310	32	21	21	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104858	10.1371/journal.pone.0104858	http://dx.doi.org/10.1371/journal.pone.0104858			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121966	Green Submitted, gold, Green Published			2022-12-25	WOS:000341017000067
J	Ennen, M; Keime, C; Kobi, D; Mengus, G; Lipsker, D; Thibault-Carpentier, C; Davidson, I				Ennen, M.; Keime, C.; Kobi, D.; Mengus, G.; Lipsker, D.; Thibault-Carpentier, C.; Davidson, I.			Single-cell gene expression signatures reveal melanoma cell heterogeneity	ONCOGENE			English	Article							MITF TRANSCRIPTION FACTORS; MALIGNANT-MELANOMA; INITIATING CELLS; PHENOTYPE; RESISTANCE; IDENTIFICATION; MELANOGENESIS; PATHWAY; SWITCH; STATES	It is well established that tumours are not homogenous, but comprise cells with differing invasive, proliferative and tumourinitiating potential. A major challenge in cancer research is therefore to develop methods to characterize cell heterogeneity. In melanoma, proliferative and invasive cells are characterized by distinct gene expression profiles and accumulating evidence suggests that cells can alternate between these states through a process called phenotype switching. We have used microfluidic technology to isolate single melanoma cells grown in vitro as monolayers or melanospheres or in vivo as xenografted tumours and analyse the expression profiles of 114 genes that discriminate the proliferative and invasive states by quantitative PCR. Single-cell analysis accurately recapitulates the specific gene expression programmes of melanoma cell lines and defines subpopulations with distinct expression profiles. Cell heterogeneity is augmented when cells are grown as spheres and as xenografted tumours. Correlative analysis identifies gene-regulatory networks and changes in gene expression under different growth conditions. In tumours, subpopulations of cells that express specific invasion and drug resistance markers can be identified amongst which is the pluripotency factor POUF51 (OCT4) whose expression correlates with the tumorigenic potential. We therefore show that single-cell analysis can be used to define and quantify tumour heterogeneity based on detection of cells with specific gene expression profiles.	[Ennen, M.; Keime, C.; Kobi, D.; Mengus, G.; Lipsker, D.; Thibault-Carpentier, C.; Davidson, I.] CNRS INSERM UDS, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France; [Lipsker, D.] Hop Univ Strasbourg, Hop Civil, Fac Med, Strasbourg, France; [Lipsker, D.] Hop Univ Strasbourg, Hop Civil, Serv Dermatol, Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Davidson, I (corresponding author), CNRS INSERM UDS, Inst Genet & Biol Mol & Cellulaire, 1 Rue Laurent Fries, F-67404 Illkirch Graffenstaden, France.	irwin@igbmc.fr		Thibault-Carpentier, Christelle/0000-0003-1562-1451; Lipsker, Dan/0000-0003-4675-0336; Davidson, Irwin/0000-0001-5533-1171; MENGUS, Gabrielle/0000-0002-2844-1778; KEIME, Celine/0000-0001-7604-3814	Centre National de la Recherche Scientifique; Institut National de Sante et de la Recherche Medicale; Universite de Strasbourg; Association pour la Recherche contre le Cancer; Ligue Nationale contre le Cancer; Institut National du Cancer PAIR-melanoma grant; French state fund through the Agence Nationale de la Recherche [ANR-10-LABX-0030-INRT, ANR-10-IDEX-0002-02]	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut National de Sante et de la Recherche Medicale; Universite de Strasbourg; Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Institut National du Cancer PAIR-melanoma grant; French state fund through the Agence Nationale de la Recherche(French National Research Agency (ANR))	We thank D Dembele for help with data analysis, all the staff of the IGBMC common facilities, as well as F Kardouz and the staff of the Strasbourg Hospital Dermatology Clinic, This work was supported by institutional grants from the Centre National de la Recherche Scientifique, the Institut National de Sante et de la Recherche Medicale, the Universite de Strasbourg, the Association pour la Recherche contre le Cancer, the Ligue Nationale contre le Cancer, the Institut National du Cancer PAIR-melanoma grant, the ANR-10-LABX-0030-INRT French state fund through the Agence Nationale de la Recherche under the frame programme Investissements d'Avenir labelled ANR-10-IDEX-0002-02. The IGBMC high throughput sequencing facility is a member of the 'France Genomique' consortium (ANR10-INBS-09-08). ID is an 'equipe labellisee' of the Ligue Nationale contre le Cancer. ME was supported by a fellowship from the Ligue Nationale contre le Cancer.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Caramel J, 2013, CANCER CELL, V24, P466, DOI 10.1016/j.ccr.2013.08.018; Carreira S, 2006, GENE DEV, V20, P3426, DOI 10.1101/gad.406406; Castro FV, 2012, CANCER IMMUNOL IMMUN, V61, P1005, DOI 10.1007/s00262-011-1167-3; Cheli Y, 2011, ONCOGENE, V30, P2307, DOI 10.1038/onc.2010.598; Chen KG, 2009, PIGM CELL MELANOMA R, V22, P740, DOI 10.1111/j.1755-148X.2009.00630.x; Chiaverini C, 2008, J BIOL CHEM, V283, P12635, DOI 10.1074/jbc.M800130200; Dalerba P, 2011, NAT BIOTECHNOL, V29, P1120, DOI 10.1038/nbt.2038; Denecker G, 2014, CELL DEATH DIFFER, V21, P1250, DOI 10.1038/cdd.2014.44; Goodall J, 2008, CANCER RES, V68, P7788, DOI 10.1158/0008-5472.CAN-08-1053; Haass NK, 2014, PIGM CELL MELANOMA R, DOI [10.1111/pcmr.12274, DOI 10.1111/PCMR.12274)]; Herquel B, 2013, NAT STRUCT MOL BIOL, V20, P339, DOI 10.1038/nsmb.2496; Hoek KS, 2008, CANCER RES, V68, P650, DOI 10.1158/0008-5472.CAN-07-2491; Hoek KS, 2010, PIGM CELL MELANOMA R, V23, P746, DOI 10.1111/j.1755-148X.2010.00757.x; Javelaud D, 2011, PIGM CELL MELANOMA R, V24, P932, DOI 10.1111/j.1755-148X.2011.00893.x; Kobi D, 2010, PIGM CELL MELANOMA R, V23, P404, DOI 10.1111/j.1755-148X.2010.00697.x; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Liu SH, 2008, PIGM CELL MELANOMA R, V21, P545, DOI 10.1111/j.1755-148X.2008.00484.x; McDavid A, 2013, BIOINFORMATICS, V29, P461, DOI 10.1093/bioinformatics/bts714; Meacham CE, 2013, NATURE, V501, P328, DOI 10.1038/nature12624; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Ohanna M, 2013, ONCOTARGET, V4, P2212, DOI 10.18632/oncotarget.1143; Perego M, 2010, J INVEST DERMATOL, V130, P1877, DOI 10.1038/jid.2010.69; Perez-Lorenzo R, 2014, J INVEST DERMATOL, V134, P1359, DOI 10.1038/jid.2013.511; Quintana E, 2010, CANCER CELL, V18, P510, DOI 10.1016/j.ccr.2010.10.012; Somasundaram R, 2012, ADV PHARMACOL, V65, P335, DOI 10.1016/B978-0-12-397927-8.00011-7; Strub T, 2011, ONCOGENE, V30, P2319, DOI 10.1038/onc.2010.612; Thies A, 2002, J CLIN ONCOL, V20, P2530, DOI 10.1200/JCO.2002.05.033; Thurber AE, 2011, ONCOGENE, V30, P3036, DOI 10.1038/onc.2011.33; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Widmer DS, 2012, PIGM CELL MELANOMA R, V25, P343, DOI 10.1111/j.1755-148X.2012.00986.x	31	60	60	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2015	34	25					3251	3263		10.1038/onc.2014.262	http://dx.doi.org/10.1038/onc.2014.262			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CK9XH	25132268				2022-12-25	WOS:000356592300004
J	Lechner, M; Hernandez-Rosales, M; Doerr, D; Wieseke, N; Thevenin, A; Stoye, J; Hartmann, RK; Prohaska, SJ; Stadler, PF				Lechner, Marcus; Hernandez-Rosales, Maribel; Doerr, Daniel; Wieseke, Nicolas; Thevenin, Annelyse; Stoye, Jens; Hartmann, Roland K.; Prohaska, Sonja J.; Stadler, Peter F.			Orthology Detection Combining Clustering and Synteny for Very Large Datasets	PLOS ONE			English	Article							GENE ORDER; HOMOLOGY; DUPLICATIONS; PREDICTION; ORTHOMCL; DISTANCE; DATABASE; BROWSER; SEARCH; FATE	The elucidation of orthology relationships is an important step both in gene function prediction as well as towards understanding patterns of sequence evolution. Orthology assignments are usually derived directly from sequence similarities for large data because more exact approaches exhibit too high computational costs. Here we present PoFF, an extension for the standalone tool Proteinortho, which enhances orthology detection by combining clustering, sequence similarity, and synteny. In the course of this work, FFAdj-MCS, a heuristic that assesses pairwise gene order using adjacencies (a similarity measure related to the breakpoint distance) was adapted to support multiple linear chromosomes and extended to detect duplicated regions. PoFF largely reduces the number of false positives and enables more fine-grained predictions than purely similarity-based approaches. The extension maintains the low memory requirements and the efficient concurrency options of its basis Proteinortho, making the software applicable to very large datasets.	[Lechner, Marcus; Hartmann, Roland K.] Univ Marburg, Inst Pharmazeut Chem, D-35032 Marburg, Germany; [Hernandez-Rosales, Maribel; Stadler, Peter F.] Univ Leipzig, Dept Comp Sci, Bioinformat Grp, D-04109 Leipzig, Germany; [Hernandez-Rosales, Maribel; Stadler, Peter F.] Univ Leipzig, Interdisciplinary Ctr Bioinformat, D-04109 Leipzig, Germany; [Hernandez-Rosales, Maribel; Stadler, Peter F.] Max Planck Inst Math Sci, Leipzig, Germany; [Hernandez-Rosales, Maribel] Univ Brasilia, Inst Ciencias Exatas, Dept Ciencia Comp, Brasilia, DF, Brazil; [Doerr, Daniel; Thevenin, Annelyse; Stoye, Jens] Univ Bielefeld, Fac Technol, Genome Informat, D-33615 Bielefeld, Germany; [Doerr, Daniel; Thevenin, Annelyse; Stoye, Jens] Univ Bielefeld, Inst Bioinformat, Ctr Biotechnol, D-33615 Bielefeld, Germany; [Wieseke, Nicolas] Univ Leipzig, Fac Math & Comp Sci, D-04109 Leipzig, Germany; [Prohaska, Sonja J.] Univ Leipzig, Dept Comp Sci, Computat EvoDevo Grp, D-04109 Leipzig, Germany; [Stadler, Peter F.] Univ Vienna, Inst Theoret Chem, Vienna, Austria; [Stadler, Peter F.] Univ Copenhagen, Ctr Noncoding RNA Technol & Hlth, Frederiksberg, Denmark; [Stadler, Peter F.] Santa Fe Inst, Santa Fe, NM 87501 USA; [Stadler, Peter F.] Fraunhofer Inst Cell Therapy & Immunol, RNom Grp, Leipzig, Germany	Philipps University Marburg; Leipzig University; Leipzig University; Max Planck Society; Universidade de Brasilia; University of Bielefeld; University of Bielefeld; Leipzig University; Leipzig University; University of Vienna; University of Copenhagen; The Santa Fe Institute; Fraunhofer Gesellschaft	Lechner, M (corresponding author), Univ Marburg, Inst Pharmazeut Chem, Marbacher Weg 6, D-35032 Marburg, Germany.	lechner@staff.uni-marburg.de	Stadler, Peter F. F/L-7857-2015	Stadler, Peter F. F/0000-0002-5016-5191	German Research Foundation; Open Access Publication Fund of Bielefeld University Library; Deutsche Forschungsgemeinschaft [GRK-1384, MA5082/1-1, MI439/14-1]; CLIB Graduate Cluster Industrial Biotechnology	German Research Foundation(German Research Foundation (DFG)); Open Access Publication Fund of Bielefeld University Library; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); CLIB Graduate Cluster Industrial Biotechnology	We acknowledge support for the Article Processing Charge by the German Research Foundation and the Open Access Publication Fund of Bielefeld University Library. This work was supported in part by the Deutsche Forschungsgemeinschaft grants no. GRK-1384, MA5082/1-1, MI439/14-1. DD receives a scholarship from the CLIB Graduate Cluster Industrial Biotechnology. AT is a research fellow of the Alexander von Humboldt Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenhoff AM, 2011, NUCLEIC ACIDS RES, V39, pD289, DOI 10.1093/nar/gkq1238; Altenhoff AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000262; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arvestad L, 2003, BIOINFORMATICS, V19, pi7, DOI 10.1093/bioinformatics/btg1000; Bergeron A, 2002, LECT NOTES COMPUT SC, V2452, P464; Bergeron A, 2006, J COMPUT BIOL, V13, P1340, DOI 10.1089/cmb.2006.13.1340; Berglund AC, 2008, NUCLEIC ACIDS RES, V36, pD263, DOI 10.1093/nar/gkm1020; Braga MDV, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S9-S8; Byrne KP, 2005, GENOME RES, V15, P1456, DOI 10.1101/gr.3672305; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cao J, 2011, NAT GENET, V43, P956, DOI 10.1038/ng.911; Chang MSS, 2004, J MOL BIOL, V341, P617, DOI 10.1016/j.jmb.2004.05.045; Chen F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000383; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; Creevey CJ, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002269; Dalquen DA, 2012, MOL BIOL EVOL, V29, P1115, DOI 10.1093/molbev/msr268; Dandekar T, 1998, TRENDS BIOCHEM SCI, V23, P324, DOI 10.1016/S0968-0004(98)01274-2; DeLuca TF, 2012, BIOINFORMATICS, V28, P715, DOI 10.1093/bioinformatics/bts006; Dewey CN, 2011, BRIEF BIOINFORM, V12, P401, DOI 10.1093/bib/bbr040; Doerr D, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S19-S3; Ebersberger I, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-157; Fitch WM, 2000, TRENDS GENET, V16, P227, DOI 10.1016/S0168-9525(00)02005-9; FITCH WM, 1970, SYST ZOOL, V19, P99, DOI 10.2307/2412448; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Franzen O, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003000; Grigoriev I. V., 2011, Mycology - An International Journal on Fungal Biology, V2, P192; Haas BJ, 2004, BIOINFORMATICS, V20, P3643, DOI 10.1093/bioinformatics/bth397; Hellmuth M, 2013, J MATH BIOL, V66, P399, DOI 10.1007/s00285-012-0525-x; Hernandez-Rosales M, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S3-A8; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; Jensen LJ, 2008, NUCLEIC ACIDS RES, V36, pD250, DOI 10.1093/nar/gkm796; Keller-Schmidt S, 2010, 10123298V1 ARXIV; Koonin EV, 2005, ANNU REV GENET, V39, P309, DOI 10.1146/annurev.genet.39.073003.114725; Kristensen DM, 2011, BRIEF BIOINFORM, V12, P379, DOI 10.1093/bib/bbr030; Lechner M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-124; Lehmann J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-351; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Liben-Nowell D, 2002, J ALGORITHMS, V43, P264, DOI 10.1016/S0196-6774(02)00006-8; Liu HL, 2013, PLANT CELL REP, V32, P379, DOI 10.1007/s00299-012-1371-4; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Mahmood K, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1261; Ohno S, 1999, SEMIN CELL DEV BIOL, V10, P517, DOI 10.1006/scdb.1999.0332; Proost S, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr955; Rodelsperger C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008861; Rolland T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006515; Schneider A, 2007, BIOINFORMATICS, V23, P2180, DOI 10.1093/bioinformatics/btm295; Shi Guanqun, 2011, PLoS One, V6, pe20892, DOI 10.1371/journal.pone.0020892; Shi GQ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-10; Strope CL, 2009, MOL BIOL EVOL, V26, P2581, DOI 10.1093/molbev/msp174; Suyama M, 2001, TRENDS GENET, V17, P10, DOI 10.1016/S0168-9525(00)02159-4; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Ting C, 2006, J COMB OPTIM, V12, P419, DOI 10.1007/s10878-006-9008-6; Trachana K, 2011, BIOESSAYS, V33, P769, DOI 10.1002/bies.201100062; van der Heijden RTJM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-83; Wang YP, 2012, NUCLEIC ACIDS RES, V40, DOI [10.1093/nar/gkr1293, 10.1093/nar/gkr1132]; Wapinski I, 2007, BIOINFORMATICS, V23, pI549, DOI 10.1093/bioinformatics/btm193; Wapinski I, 2007, NATURE, V449, P54, DOI 10.1038/nature06107; WATTERSON GA, 1982, J THEOR BIOL, V99, P1, DOI 10.1016/0022-5193(82)90384-8; Wheeler DL, 2008, NUCLEIC ACIDS RES, V36, pD13, DOI 10.1093/nar/gkm1000; Xu W, 2007, J COMPUT BIOL, V14, P423, DOI 10.1089/cmb.2007.A004	60	52	53	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105015	10.1371/journal.pone.0105015	http://dx.doi.org/10.1371/journal.pone.0105015			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137074	Green Published, Green Submitted, gold			2022-12-25	WOS:000340742100060
J	Ma, ZR; Zhang, HJ; Shang, WJ; Zhu, FL; Han, WQ; Zhao, XE; Han, DL; Wang, PG; Chen, M				Ma, Zhongrui; Zhang, Huajie; Shang, Wenjing; Zhu, Faliang; Han, Weiqing; Zhao, Xueer; Han, Donglei; Wang, Peng George; Chen, Min			Glycoconjugate Vaccine Containing Escherichia coli O157:H7 O-Antigen Linked with Maltose-Binding Protein Elicits Humoral and Cellular Responses	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; POLYSACCHARIDE; TOXIN; LIPOPOLYSACCHARIDE; GLYCOSYLATION; COLONIZATION; IMMUNIZATION; INFECTION; FUSION; FAILS	Glycoconjugate is one of the most efficacious and safest vaccines against bacterial pathogens. Previous studies of glycoconjugates against pathogen E. coli O157:H7 focused more on the humoral responses they elicited. However, little was known about their cellular responses. In this study, we exploited a novel approach based on bacterial protein N-linked glycosylation system to produce glycoconjugate containing Escherichia coli O157:H7 O-antigen linked with maltose-binding protein and examined its humoral and cellular responses in BALB/c mice. The transfer of E. coli O157:H7 O-antigen to MBP was confirmed by western blot and MALDI-TOF MS. Mice injected with glycoconjugate O-Ag-MBP elicited serum bactericidal antibodies including anti-E. coli O157:H7 O-antigen IgG and IgM. Interestingly, O-Ag-MBP also stimulated the secretion of anti-E. coli O157:H7 O-antigen IgA in intestine. In addition, O-Ag-MBP stimulated cellular responses by recruiting Th1-biased CD4(+) T cells, CD8(+) T cells. Meanwhile, O-Ag-MBP induced the upregulation of Th1-related IFN-gamma and downregulation of Th2-related IL-4, and the upregulation of IFN-gamma was stimulated by MBP in a dose-dependent manner. MBP showed TLR4 agonist-like properties to activate Th1 cells as carrier protein of O-Ag-MBP. Thus, glycoconjugate vaccine E. coli O157:H7-specific O-Ag-MBP produced by bacterial protein N-linked glycosylation system was able to elicit both humoral and Th1-biased cellular responses.	[Ma, Zhongrui; Zhang, Huajie; Zhao, Xueer; Han, Donglei; Wang, Peng George; Chen, Min] Shandong Univ, Natl Glycoengn Res Ctr, Sch Life Sci, Jinan 250100, Shandong, Peoples R China; [Ma, Zhongrui; Zhang, Huajie; Zhao, Xueer; Han, Donglei; Wang, Peng George; Chen, Min] Shandong Univ, Natl Glycoengn Res Ctr, State Key Lab Microbial Technol, Jinan 250100, Shandong, Peoples R China; [Shang, Wenjing] Binzhou Med Univ, Dept Biochem & Mol Biol, YanTai, Shandong, Peoples R China; [Zhu, Faliang] Shandong Univ, Dept Immunol, Sch Med, Jinan 250100, Shandong, Peoples R China; [Han, Weiqing] Nankai Univ, Coll Pharm, Tianjin 300071, Peoples R China; [Han, Weiqing] Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China	Shandong University; Shandong University; Binzhou Medical University; Shandong University; Nankai University; Nankai University	Chen, M (corresponding author), Shandong Univ, Natl Glycoengn Res Ctr, Sch Life Sci, Jinan 250100, Shandong, Peoples R China.	chenmin@sdu.edu.cn	WANG, Peng/GSN-5263-2022		Significant New Drugs Development [2012ZX09502001-005]; 973 Program [2012CB822102]; National Natural Science Foundation [31070824, 31270983]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry	Significant New Drugs Development; 973 Program(National Basic Research Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	This work was supported by Significant New Drugs Development (2012ZX09502001-005 http://www.most.gov.cn), 973 Program (No. 2012CB822102, http://www.most.gov.cn/), National Natural Science Foundation (No. 31070824, 31270983, http://www.nsfc.gov.cn), The Project Sponsored by the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry (http://www.moe.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Conlan JW, 2000, CAN J MICROBIOL, V46, P283; Conlan JW, 1999, CAN J MICROBIOL, V45, P279, DOI 10.1139/cjm-45-4-279; Cuccui J, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130002; Dalziel M, 2014, SCIENCE, V343, P37, DOI 10.1126/science.1235681; Feldman MF, 1999, J BIOL CHEM, V274, P35129, DOI 10.1074/jbc.274.49.35129; Feldman MF, 2005, P NATL ACAD SCI USA, V102, P3016, DOI 10.1073/pnas.0500044102; Fernandez S, 2007, INFECT IMMUN, V75, P1359, DOI 10.1128/IAI.00486-06; Fisher AC, 2011, APPL ENVIRON MICROB, V77, P871, DOI 10.1128/AEM.01901-10; Fox JD, 2001, PROTEIN SCI, V10, P622, DOI 10.1110/ps.45201; Goldwater PN, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-12; Higgins SC, 2006, J IMMUNOL, V177, P7980, DOI 10.4049/jimmunol.177.11.7980; Ihssen J, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-61; Iwashkiw JA, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-13; Karpman D, 1997, J INFECT DIS, V175, P611, DOI 10.1093/infdis/175.3.611; Knuf M, 2011, VACCINE, V29, P4881, DOI 10.1016/j.vaccine.2011.04.053; Konadu E, 1999, INFECT IMMUN, V67, P6191, DOI 10.1128/IAI.67.11.6191-6193.1999; Konadu EY, 1998, J INFECT DIS, V177, P383, DOI 10.1086/514203; Lockhart Stephen, 2003, Expert Rev Vaccines, V2, P633, DOI 10.1586/14760584.2.5.633; MEHL M, 1988, J BASIC MICROB, V28, P437, DOI 10.1002/jobm.3620280704; Pace D, 2013, EXPERT OPIN BIOL TH, V13, P11, DOI 10.1517/14712598.2012.725718; RAGHUPATHY P, 1978, BMJ-BRIT MED J, V1, P1518, DOI 10.1136/bmj.1.6126.1518; Riggs P, 2000, MOL BIOTECHNOL, V15, P51, DOI 10.1385/MB:15:1:51; Rossi GR, 2005, CANCER RES, V65, P10555, DOI 10.1158/0008-5472.CAN-05-0627; Schuurhuis DH, 2002, J IMMUNOL, V168, P2240, DOI 10.4049/jimmunol.168.5.2240; SU CY, 1995, ANN INTERN MED, V123, P698, DOI 10.7326/0003-4819-123-9-199511010-00009; [台桂香 Tai Guixiang], 2003, [中国肿瘤生物治疗杂志, Chinese Journal of Cancer Biotherapy], V10, P202; UNDERDOWN BJ, 1986, ANNU REV IMMUNOL, V4, P389, DOI 10.1146/annurev.iy.04.040186.002133; Wang L, 1998, INFECT IMMUN, V66, P3545, DOI 10.1128/IAI.66.8.3545-3551.1998; Weintraub A, 2003, CARBOHYD RES, V338, P2539, DOI 10.1016/j.carres.2003.07.008; Wetter M, 2013, GLYCOCONJUGATE J, V30, P511, DOI 10.1007/s10719-012-9451-9; Wong CS, 2000, NEW ENGL J MED, V342, P1930, DOI 10.1056/NEJM200006293422601	31	15	18	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105215	10.1371/journal.pone.0105215	http://dx.doi.org/10.1371/journal.pone.0105215			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137044	Green Published, Green Submitted, gold			2022-12-25	WOS:000340742100076
J	Tang, L; Liu, WQ; Fang, X; Sun, Q; Zhu, SL; Wang, CX; Wang, XY; Li, YG; Zhu, DL; Sanderson, KE; Johnston, RN; Liu, GR; Liu, SL				Tang, Le; Liu, Wei-Qiao; Fang, Xin; Sun, Qiang; Zhu, Song-Ling; Wang, Chun-Xiao; Wang, Xiao-Yu; Li, Yong-Guo; Zhu, Da-Ling; Sanderson, Kenneth E.; Johnston, Randal N.; Liu, Gui-Rong; Liu, Shu-Lin			CTAG-Containing Cleavage Site Profiling to Delineate Salmonella into Natural Clusters	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; ESCHERICHIA-COLI; RIBOSOMAL-RNA; BACTERIAL; PARATYPHI; MAP; EVOLUTIONARY; ADAPTATION; BOUNDARIES; DYNAMICS	Background: The bacterial genus Salmonella contains thousands of serotypes that infect humans or other hosts, causing mild gastroenteritis to potentially fatal systemic infections in humans. Pathogenically distinct Salmonella serotypes have been classified as individual species or as serological variants of merely one or two species, causing considerable confusion in both research and clinical settings. This situation reflects a long unanswered question regarding whether the Salmonella serotypes exist as discrete genetic clusters (natural species) of organisms or as phenotypic (e. g. pathogenic) variants of a single (or two) natural species with a continuous spectrum of genetic divergence among them. Our recent work, based on genomic sequence divergence analysis, has demonstrated that genetic boundaries exist among Salmonella serotypes, circumscribing them into clear-cut genetic clusters of bacteria. Methodologies/Principal Findings: To further test the genetic boundary concept for delineating Salmonella into clearly defined natural lineages (e. g., species), we sampled a small subset of conserved genomic DNA sequences, i.e., the endonuclease cleavage sites that contain the highly conserved CTAG sequence such as TCTAGA for XbaI. We found that the CTAG-containing cleavage sequence profiles could be used to resolve the genetic boundaries as reliably and efficiently as whole genome sequence comparisons but with enormously reduced requirements for time and resources. Conclusions: Profiling of CTAG sequence subsets reflects genetic boundaries among Salmonella lineages and can delineate these bacteria into discrete natural clusters.	[Tang, Le; Fang, Xin; Sun, Qiang; Zhu, Song-Ling; Wang, Chun-Xiao; Wang, Xiao-Yu; Liu, Gui-Rong; Liu, Shu-Lin] Harbin Med Univ, Genom Res Ctr, State Prov Key Labs Biomed Pharmaceut China, Harbin, Peoples R China; [Tang, Le; Fang, Xin; Sun, Qiang; Zhu, Song-Ling; Wang, Chun-Xiao; Wang, Xiao-Yu; Zhu, Da-Ling; Liu, Gui-Rong; Liu, Shu-Lin] Harbin Med Univ, Dept Biopharmaceut Sci, Harbin, Peoples R China; [Tang, Le; Fang, Xin; Sun, Qiang; Zhu, Song-Ling; Wang, Chun-Xiao; Wang, Xiao-Yu; Li, Yong-Guo; Liu, Gui-Rong; Liu, Shu-Lin] Harbin Med Univ, HMU UCFM Ctr Infect & Genom, Harbin, Peoples R China; [Liu, Wei-Qiao; Sanderson, Kenneth E.; Liu, Shu-Lin] Univ Calgary, Dept Microbiol & Infect Dis, Calgary, AB, Canada; [Li, Yong-Guo; Liu, Shu-Lin] Harbin Med Univ, Affiliated Hosp 1, Dept Infect Dis, Harbin, Peoples R China; [Zhu, Da-Ling] Harbin Med Univ, Coll Pharm, Daqing, Peoples R China; [Johnston, Randal N.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada	Harbin Medical University; Harbin Medical University; Harbin Medical University; University of Calgary; Harbin Medical University; Harbin Medical University; University of Calgary	Liu, GR (corresponding author), Harbin Med Univ, Genom Res Ctr, State Prov Key Labs Biomed Pharmaceut China, Harbin, Peoples R China.	slliu@ucalgary.ca	Johnston, Randal/B-9247-2009	Sun, Qiang/0000-0002-6703-1587	Heilongjiang Innovation Endowment Award [YJSCX2012-197HLJ]; National Natural Science Foundation of China [NSFC30970078, NSFC30970119, 81030029, 81271786, NSFC-NIH 81161120416]; Natural Science Foundation of Heilongjiang Province of China; Canadian Institutes of Health Research	Heilongjiang Innovation Endowment Award; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Heilongjiang Province of China(Natural Science Foundation of Heilongjiang Province); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a Heilongjiang Innovation Endowment Award for graduate studies (YJSCX2012-197HLJ) to LT; a National Natural Science Foundation of China (NSFC30970078) and a grant of Natural Science Foundation of Heilongjiang Province of China to GRL; a grant of Canadian Institutes of Health Research to RNJ; and grants of the National Natural Science Foundation of China (NSFC30970119, 81030029, 81271786, NSFC-NIH 81161120416) to SLL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrick JE, 2013, NAT REV GENET, V14, P827, DOI 10.1038/nrg3564; BHAGWAT AS, 1992, NUCLEIC ACIDS RES, V20, P1663, DOI 10.1093/nar/20.7.1663; Cohan FM, 2002, ANNU REV MICROBIOL, V56, P457, DOI 10.1146/annurev.micro.56.012302.160634; Cohan FM, 2001, SYST BIOL, V50, P513, DOI 10.1080/10635150118398; Covert AW, 2013, P NATL ACAD SCI USA, V110, pE3171, DOI 10.1073/pnas.1313424110; CROSA JH, 1973, J BACTERIOL, V115, P307, DOI 10.1128/JB.115.1.307-315.1973; EDWARDS PR, 1952, AM J CLIN PATHOL, V22, P692, DOI 10.1093/ajcp/22.7_ts.692; Feng Y, 2012, J BACTERIOL, V194, P744, DOI 10.1128/JB.06507-11; Fraser C, 2009, SCIENCE, V323, P741, DOI 10.1126/science.1159388; Koeppel AF, 2013, ISME J, V7, P1080, DOI 10.1038/ismej.2013.3; LEMINOR L, 1987, INT J SYST BACTERIOL, V37, P465, DOI 10.1099/00207713-37-4-465; LEMINOR L, 1984, BERGEYS MANUAL SYSTE, V1, P427; Liu Shu-Lin, 2007, V394, P39, DOI 10.1007/978-1-59745-512-1_3; LIU SL, 1995, J BACTERIOL, V177, P6585, DOI 10.1128/jb.177.22.6585-6592.1995; LIU SL, 1994, J BACTERIOL, V176, P1014, DOI 10.1128/JB.176.4.1014-1024.1994; LIU SL, 1993, P NATL ACAD SCI USA, V90, P6874, DOI 10.1073/pnas.90.14.6874; LIU SL, 1993, J BACTERIOL, V175, P4104, DOI 10.1128/JB.175.13.4104-4120.1993; LIU SL, 1995, J BACTERIOL, V177, P3355, DOI 10.1128/jb.177.11.3355-3357.1995; Liu SL, 1999, J BACTERIOL, V181, P6747, DOI 10.1128/JB.181.21.6747-6755.1999; LIU SL, 1995, J BACTERIOL, V177, P5099, DOI 10.1128/jb.177.17.5099-5107.1995; Liu WQ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-290; Liu WQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004510; MARSHALL P, 1991, GENE, V104, P241, DOI 10.1016/0378-1119(91)90256-B; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Parry CM, 2002, NEW ENGL J MED, V347, P1770, DOI 10.1056/NEJMra020201; Plucain J, 2014, SCIENCE, V343, P1366, DOI 10.1126/science.1248688; Popoff MY, 2004, RES MICROBIOL, V155, P568, DOI 10.1016/j.resmic.2004.04.005; Popoff MY, 2005, BERGEYS MANUAL SYSTE, V2, P764; REEVES MW, 1989, J CLIN MICROBIOL, V27, P313, DOI 10.1128/JCM.27.2.313-320.1989; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang L, 2013, GENOMICS, V102, P331, DOI 10.1016/j.ygeno.2013.07.014; Tang L, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-489; Tang L, 2012, ANTON LEEUW INT J G, V101, P67, DOI 10.1007/s10482-011-9680-0; Thomson NR, 2008, GENOME RES, V18, P1624, DOI 10.1101/gr.077404.108; Wielgoss S, 2013, P NATL ACAD SCI USA, V110, P222, DOI 10.1073/pnas.1219574110; Wu KY, 2005, J BACTERIOL, V187, P4720, DOI 10.1128/JB.187.14.4720-4727.2005	37	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e103388	10.1371/journal.pone.0103388	http://dx.doi.org/10.1371/journal.pone.0103388			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137186	Green Submitted, Green Published, gold			2022-12-25	WOS:000340742100007
J	Barnes, VM; Kennedy, AD; Panagakos, F; Devizio, W; Trivedi, HM; Jonsson, T; Guo, LN; Cervi, S; Scannapieco, FA				Barnes, Virginia M.; Kennedy, Adam D.; Panagakos, Fotinos; Devizio, William; Trivedi, Harsh M.; Joensson, Thomas; Guo, Lining; Cervi, Shannon; Scannapieco, Frank A.			Global Metabolomic Analysis of Human Saliva and Plasma from Healthy and Diabetic Subjects, with and without Periodontal Disease	PLOS ONE			English	Article							GINGIVAL CREVICULAR FLUID; 2-HYDROXYBUTYRIC ACID; MITOCHONDRIAL GLUTATHIONE; ALPHA-KETOBUTYRATE; OXIDATIVE STRESS; AMYLASE-BINDING; BIOMARKERS; MELLITUS; CERAMIDE; SERUM	Recent studies suggest that periodontal disease and type 2 diabetes mellitus are bi-directionally associated. Identification of a molecular signature for periodontitis using unbiased metabolic profiling could allow identification of biomarkers to assist in the diagnosis and monitoring of both diabetes and periodontal disease. This cross-sectional study identified plasma and salivary metabolic products associated with periodontitis and/or diabetes in order to discover biomarkers that may differentiate or demonstrate an interaction of these diseases. Saliva and plasma samples were analyzed from 161 diabetic and non-diabetic human subjects with a healthy periodontium, gingivitis and periodontitis. Metabolite profiling was performed using Metabolon's platform technology. A total of 772 metabolites were found in plasma and 475 in saliva. Diabetics had significantly higher levels of glucose and alpha-hydroxybutyrate, the established markers of diabetes, for all periodontal groups of subjects. Comparison of healthy, gingivitis and periodontitis saliva samples within the non-diabetic group confirmed findings from previous studies that included increased levels of markers of cellular energetic stress, increased purine degradation and glutathione metabolism through increased levels of oxidized glutathione and cysteine-glutathione disulfide, markers of oxidative stress, including increased purine degradation metabolites (e.g. guanosine and inosine), increased amino acid levels suggesting protein degradation, and increased omega-3 (docosapentaenoate) and omega-6 fatty acid (linoleate and arachidonate) signatures. Differences in saliva between diabetic and non-diabetic cohorts showed altered signatures of carbohydrate, lipid and oxidative stress exist in the diabetic samples. Global untargeted metabolic profiling of human saliva in diabetics replicated the metabolite signature of periodontal disease progression in non-diabetic patients and revealed unique metabolic signatures associated with periodontal disease in diabetics. The metabolites identified in this study that discriminated the periodontal groups may be useful for developing diagnostics and therapeutics tailored to the diabetic population.	[Barnes, Virginia M.; Panagakos, Fotinos; Devizio, William; Trivedi, Harsh M.] Colgate Palmol Technol Ctr, Piscataway, NJ USA; [Cervi, Shannon; Scannapieco, Frank A.] Metabolon, Durham, NC 27713 USA; [Kennedy, Adam D.; Joensson, Thomas; Guo, Lining] SUNY Buffalo, Sch Dent Med, Dept Oral Biol, Buffalo, NY 14260 USA	Metabolon; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Scannapieco, FA (corresponding author), Metabolon, Durham, NC 27713 USA.	fas1@buffalo.edu	Scannapieco, Frank A./AAE-1584-2020	Scannapieco, Frank A./0000-0002-8804-6593	Colgate Palmolive Co.	Colgate Palmolive Co.	This study was funded by a grant from Colgate Palmolive Co. The funder and Metabolon provided support in the form of salaries for authors VMB, FP, WD, HMT, and TJ, LG, ADK respectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Acker-Hewitt TL, 2012, APPL PHYSIOL NUTR ME, V37, P276, DOI [10.1139/h11-160, 10.1139/H11-160]; Akalin FA, 2008, ARCH ORAL BIOL, V53, P44, DOI 10.1016/j.archoralbio.2007.07.009; Akalin FA, 2007, J CLIN PERIODONTOL, V34, P558, DOI 10.1111/j.1600-051X.2007.01091.x; Al-Tarawneh SK, 2011, OMICS, V15, P353, DOI 10.1089/omi.2010.0134; Alpagot T, 2001, J CLIN PERIODONTOL, V28, P353, DOI 10.1034/j.1600-051x.2001.028004353.x; Alpagot T, 2001, J PERIODONTAL RES, V36, P169, DOI 10.1034/j.1600-0765.2001.360305.x; Barnes VM, 2011, J DENT RES, V90, P1293, DOI 10.1177/0022034511416240; Barnes VM, 2009, J DENT RES, V88, P851, DOI 10.1177/0022034509341967; Barnes VM, 2010, J PERIODONTOL, V81, P1273, DOI 10.1902/jop.2010.100070; Barnes Virginia Monsul, 2011, J Clin Dent, V22, P200; BECKER BF, 1993, FREE RADICAL BIO MED, V14, P615, DOI 10.1016/0891-5849(93)90143-I; Bessonneau V, 2013, BIOANALYSIS, V5, P783, DOI [10.4155/BIO.13.35, 10.4155/bio.13.35]; Bieberich E, 2011, J LIPIDS IN PRESS; BRASS EP, 1986, BIOCHIM BIOPHYS ACTA, V888, P18, DOI 10.1016/0167-4889(86)90065-0; Buse John B, 2003, Diabetes Technol Ther, V5, P355, DOI 10.1089/152091503765691839; Calder PC, 2006, AM J CLIN NUTR, V83, p1505S, DOI 10.1093/ajcn/83.6.1505S; Christodoulides N, 2007, ANN NY ACAD SCI, V1098, P411, DOI 10.1196/annals.1384.035; Cobb Jeff, 2013, J Diabetes Sci Technol, V7, P100; DeHaven CD, 2010, J CHEMINFORMATICS, V2, DOI 10.1186/1758-2946-2-9; Demmer RT, 2006, J AM DENT ASSOC, V137, p14S, DOI 10.14219/jada.archive.2006.0402; Dunn W, 2013, NEUROLOGY, V80, pS41, DOI 10.1212/WNL.0b013e3182872c54; Embery G, 1994, Adv Dent Res, V8, P329; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Forman HJ, 2003, BIOFACTORS, V17, P1, DOI 10.1002/biof.5520170101; Fredericks M A, 1971, J Dent Educ, V35, P232; Gall WE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010883; Ganti S, 2011, UROL ONCOL-SEMIN ORI, V29, P551, DOI 10.1016/j.urolonc.2011.05.013; Garcia-German D, 2012, Rev Esp Cir Ortop Traumatol, V56, P422, DOI 10.1016/j.recot.2012.05.002; Garcia- German D, 2012, REV ESP CIR ORTOP TR, V56, P422; GARCIARUIZ C, 1995, MOL PHARMACOL, V48, P825; GARCIARUIZ C, 1995, HEPATOLOGY, V21, P207, DOI 10.1002/hep.1840210133; Genco RJ, 2014, J AM DENT ASSOC, V145, P57, DOI 10.14219/jada.2013.7; Guenther GG, 2008, P NATL ACAD SCI USA, V105, P17402, DOI 10.1073/pnas.0802781105; Gutman DA, 2013, RADIOLOGY, V267, P560, DOI 10.1148/radiol.13120118; Hansen SH, 2013, ADV EXP MED BIOL, V776, P3, DOI 10.1007/978-1-4614-6093-0_1; Hargreaves CE, 2013, J IMMUNOL, V190, P5373, DOI 10.4049/jimmunol.1203412; Judice PB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068936; Kardesler L, 2011, INFLAMM RES, V60, P143, DOI 10.1007/s00011-010-0248-7; Keles GC, 2010, INFLAMM RES, V59, P543, DOI 10.1007/s00011-010-0158-8; Kojer K, 2012, EMBO J, V31, P3169, DOI 10.1038/emboj.2012.165; LANDAAS S, 1975, CLIN CHIM ACTA, V58, P23, DOI 10.1016/0009-8981(75)90481-7; LANDAAS S, 1975, SCAND J CLIN LAB INV, V35, P259, DOI 10.3109/00365517509095738; Leyden JJ, 2004, CUTIS, V73, P11; LOBENE R R, 1986, Clinical Preventive Dentistry, V8, P3; Lobene R R, 1979, Pharmacol Ther Dent, V4, P33; MANDEL ID, 1989, J AM DENT ASSOC, V119, P298, DOI 10.14219/jada.archive.1989.0211; Mao CG, 2008, BBA-MOL CELL BIOL L, V1781, P424, DOI 10.1016/j.bbalip.2008.06.002; Miller CS, 2006, J AM DENT ASSOC, V137, P322, DOI 10.14219/jada.archive.2006.0181; Nerby CL, 2009, CLIN BIOCHEM, V42, P158, DOI 10.1016/j.clinbiochem.2008.08.086; Nichols FC, 2006, ORAL MICROBIOL IMMUN, V21, P84, DOI 10.1111/j.1399-302X.2006.00264.x; Nieman DC, 2013, J PROTEOME RES, V12, P4577, DOI 10.1021/pr400717j; Pastore A, 2003, CLIN CHIM ACTA, V333, P19, DOI 10.1016/S0009-8981(03)00200-6; Peralta ER, 2009, AUTOPHAGY, V5, P407, DOI 10.4161/auto.5.3.7809; PETTERSEN JE, 1973, CLIN CHIM ACTA, V48, P213, DOI 10.1016/0009-8981(73)90367-7; Pradeep AR, 2007, J PERIODONTOL, V78, P2325, DOI 10.1902/jop.2007.070135; Pradeep AR, 2007, J PERIODONTOL, V78, P1962, DOI 10.1902/jop.2007.070096; Pussinen PJ, 2007, CURR MED CHEM, V14, P2402, DOI 10.2174/092986707781745604; Pussinen PJ, 2007, ARTERIOSCL THROM VAS, V27, P1433, DOI 10.1161/ATVBAHA.106.138743; Quick KL, 2000, J NEUROSCI METH, V97, P139, DOI 10.1016/S0165-0270(00)00179-5; Quinlan GJ, 1997, AM J RESP CRIT CARE, V155, P479, DOI 10.1164/ajrccm.155.2.9032182; Rathnayake N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061356; Rathnayake N, 2013, J CLIN PERIODONTOL, V40, P140, DOI 10.1111/jcpe.12038; Salvi GE, 2010, J CLIN PERIODONTOL, V37, P9, DOI 10.1111/j.1600-051X.2009.01500.x; SCANNAPIECO FA, 1994, CRIT REV ORAL BIOL M, V5, P203, DOI 10.1177/10454411940050030201; SCANNAPIECO FA, 1994, J DENT RES, V73, P1627, DOI 10.1177/00220345940730100701; SILNESS J, 1964, Acta Odontol Scand, V22, P121, DOI 10.3109/00016356408993968; Silva AR, 2001, BRAZ J MED BIOL RES, V34, P627, DOI 10.1590/S0100-879X2001000500010; Sima C, 2010, J PERIODONTAL RES, V45, P748, DOI 10.1111/j.1600-0765.2010.01295.x; STUCHELL RN, 1984, OTOLARYNG CLIN N AM, V17, P697; TABAK LA, 1982, J ORAL PATHOL MED, V11, P1, DOI 10.1111/j.1600-0714.1982.tb00138.x; Tonetti MS, 2007, NEW ENGL J MED, V356, P911, DOI 10.1056/NEJMoa063186; Toth BI, 2009, J INVEST DERMATOL, V129, P329, DOI 10.1038/jid.2008.258; Townsend DM, 2003, BIOMED PHARMACOTHER, V57, P145, DOI 10.1016/S0753-3322(03)00043-X; WADDINGTON RJ, 1994, ARCH ORAL BIOL, V39, P361, DOI 10.1016/0003-9969(94)90165-1; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489; Xiang X, 2013, J PERIODONTOL; YANG W, 1985, CLIN CHIM ACTA, V145, P173, DOI 10.1016/0009-8981(85)90284-0; Yoon AJ, 2012, J CLIN PERIODONTOL, V39, P434, DOI 10.1111/j.1600-051X.2012.01866.x; Zhang AH, 2012, APPL BIOCHEM BIOTECH, V168, P1718, DOI 10.1007/s12010-012-9891-5	80	81	83	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105181	10.1371/journal.pone.0105181	http://dx.doi.org/10.1371/journal.pone.0105181			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133529	Green Published, gold, Green Submitted			2022-12-25	WOS:000341302700079
J	Choudhary, S; Kishore, N				Choudhary, Sinjan; Kishore, Nand			Addressing Mechanism of Fibrillization/Aggregation and Its Prevention in Presence of Osmolytes: Spectroscopic and Calorimetric Approach	PLOS ONE			English	Article							THIOFLAVIN T-BINDING; PROTEIN AGGREGATION; AMYLOID FIBRILS; IN-VITRO; ALPHA-SYNUCLEIN; PRION PROTEIN; LYSOZYME; FIBRILLATION; INHIBITION; STABILITY	Understanding the mechanism of protein fibrillization/aggregation and its prevention is the basis of development of therapeutic strategies for amyloidosis. An attempt has been made to understand the nature of interactions of osmolytes L-proline, 4-hydroxy-L-proline, sarcosine and trimethylamine N-oxide with the different stages of fibrillization of hen egg-white lysozyme by using a combination of isothermal titration calorimetry, differential scanning calorimetry, fluorescence spectroscopy, and transmission electron microscopy. Based on thioflavin T fluorescence emission intensities and microscopic images, the nucleation, elongation, and saturation phases of fibrillization have been identified. Isothermal titration calorimetry and differential scanning calorimetry have enabled a quantitative analysis of the nature of interactions of these osmolytes with various conformational states of lysozyme at different stages of fibrillization/aggregation. It is concluded that interaction of the osmolytes with lysozyme fibrils at both the nucleation and elongation stages are important steps in the prevention of fibrillization/aggregation. Identification of the nature of interactions is a key step towards the discovery and synthesis of target oriented potential inhibitors of these associations. This study is a first report in which calorimetry has been used to address interaction of potential inihibitiors with the protein at different stages of fibrillization.	[Choudhary, Sinjan] Univ Mumbai, Bombay, Maharashtra, India; [Choudhary, Sinjan] Ctr Excellence Basic Sci, Dept Atom Energy, Mumbai, Maharashtra, India; [Kishore, Nand] Indian Inst Technol, Dept Chem, Bombay 400076, Maharashtra, India	University of Mumbai; UM-DAE Centre for Excellence in Basic Sciences; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay	Choudhary, S (corresponding author), Univ Mumbai, Bombay, Maharashtra, India.	sinjan.choudhary@cbs.ac.in; nandk@chem.iitb.ac.in			Department of Science and Technology and Council of Scientific and Industrial Research, New Delhi	Department of Science and Technology and Council of Scientific and Industrial Research, New Delhi	The authors are grateful to the Department of Science and Technology and Council of Scientific and Industrial Research, New Delhi for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad FB, 1999, BIOPOLYMERS, V50, P401, DOI 10.1002/(SICI)1097-0282(19991005)50:4&lt;401::AID-BIP6&gt;3.0.CO;2-V; ARAKAWA T, 1982, BIOCHEMISTRY-US, V21, P6536, DOI 10.1021/bi00268a033; ARAKAWA T, 1982, BIOCHEMISTRY-US, V21, P6545, DOI 10.1021/bi00268a034; Auton M, 2005, P NATL ACAD SCI USA, V102, P15065, DOI 10.1073/pnas.0507053102; Borwankar T, 2011, BIOCHEMISTRY-US, V50, P2048, DOI 10.1021/bi1018368; BOYER PM, 1992, CHEM ENG SCI, V47, P241, DOI 10.1016/0009-2509(92)80218-2; Dobson CM, 2004, SEMIN CELL DEV BIOL, V15, P3, DOI 10.1016/j.semcdb.2003.12.008; Dobson CM, 2003, NAT REV DRUG DISCOV, V2, P154, DOI 10.1038/nrd1013; DOBSON CM, 1994, TRENDS BIOCHEM SCI, V19, P31, DOI 10.1016/0968-0004(94)90171-6; Dong XY, 2004, J BIOTECHNOL, V114, P135, DOI 10.1016/j.jbiotec.2004.06.012; Groenning M, 2007, J STRUCT BIOL, V159, P483, DOI 10.1016/j.jsb.2007.06.004; Guo F, 2009, J PHYS CHEM B, V113, P16632, DOI 10.1021/jp9072284; HOBBS JR, 1963, J PATHOL BACTERIOL, V86, P437, DOI 10.1002/path.1700860218; Ignatova Z, 2006, P NATL ACAD SCI USA, V103, P13357, DOI 10.1073/pnas.0603772103; Ivanova MI, 2004, P NATL ACAD SCI USA, V101, P10584, DOI 10.1073/pnas.0403756101; Jain S, 2010, BIOCHEMISTRY-US, V49, P7615, DOI 10.1021/bi100745j; Kar K, 2007, BIOPOLYMERS, V87, P339, DOI 10.1002/bip.20834; KELENYL G, 1967, J HISTOCHEM CYTOCHEM, V15, P172; Kelly JW, 1998, CURR OPIN STRUC BIOL, V8, P101, DOI 10.1016/S0959-440X(98)80016-X; Khurana R, 2005, J STRUCT BIOL, V151, P229, DOI 10.1016/j.jsb.2005.06.006; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kumar TKS, 1998, BIOCHEM MOL BIOL INT, V46, P509; LeVine H, 1997, ARCH BIOCHEM BIOPHYS, V342, P306, DOI 10.1006/abbi.1997.0137; Librizzi F, 2005, PROTEIN SCI, V14, P3129, DOI 10.1110/ps.051692305; Mishra R, 2005, J BIOL CHEM, V280, P15553, DOI 10.1074/jbc.M410947200; Munishkina LA, 2004, BIOCHEMISTRY-US, V43, P3289, DOI 10.1021/bi034938r; Muzaffar M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027906; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; OSSERMAN EF, 1966, J EXP MED, V124, P921, DOI 10.1084/jem.124.5.921; Qi W, 2009, BIOCHEMISTRY-US, V48, P8908, DOI 10.1021/bi9006397; Rousseau F, 2006, CURR OPIN STRUC BIOL, V16, P118, DOI 10.1016/j.sbi.2006.01.011; SAEED SM, 1967, AM J CLIN PATHOL, V47, P588, DOI 10.1093/ajcp/47.5.588; Tanaka M, 2005, J MOL MED, V83, P343, DOI 10.1007/s00109-004-0632-2; Tanaka M, 2004, NAT MED, V10, P148, DOI 10.1038/nm985; Uversky VN, 2004, BBA-PROTEINS PROTEOM, V1698, P131, DOI 10.1016/j.bbapap.2003.12.008; Uversky VN, 2001, FEBS LETT, V509, P31, DOI 10.1016/S0014-5793(01)03121-0; VASSAR PS, 1959, ARCH PATHOL, V68, P487; Wall J, 1999, METHOD ENZYMOL, V309, P204; Yang DS, 1999, J BIOL CHEM, V274, P32970, DOI 10.1074/jbc.274.46.32970; Yeh V, 2010, PROTEIN SCI, V19, P47, DOI 10.1002/pro.281; Yoshimoto N, 2003, BIOMACROMOLECULES, V4, P1530, DOI 10.1021/bm015662a	41	19	19	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e104600	10.1371/journal.pone.0104600	http://dx.doi.org/10.1371/journal.pone.0104600			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133607	Green Submitted, gold, Green Published			2022-12-25	WOS:000341302700033
J	Conde, L; Riby, J; Zhang, JQ; Bracci, PM; Skibola, CF				Conde, Lucia; Riby, Jacques; Zhang, Jianqing; Bracci, Paige M.; Skibola, Christine F.			Copy Number Variation Analysis on a Non-Hodgkin Lymphoma Case-Control Study Identifies an 11q25 Duplication Associated with Diffuse Large B-Cell Lymphoma	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; GENOME-WIDE ASSOCIATION; FOLLICULAR LYMPHOMA; NONCODING RNAS; SUSCEPTIBILITY; SURVIVAL; REVEALS; LOCUS; GENE	Recent GWAS have identified several susceptibility loci for NHL. Despite these successes, much of the heritable variation in NHL risk remains to be explained. Common copy-number variants are important genomic sources of variability, and hence a potential source to explain part of this missing heritability. In this study, we carried out a CNV analysis using GWAS data from 681 NHL cases and 749 controls to explore the relationship between common structural variation and lymphoma susceptibility. Here we found a novel association with diffuse large B-cell lymphoma (DLBCL) risk involving a partial duplication of the C-terminus region of the LOC283177 long non-coding RNA that was further confirmed by quantitative PCR. For chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), known somatic deletions were identified on chromosomes 13q14, 11q22-23, 14q32 and 22q11.22. Our study shows that GWAS data can be used to identify germline CNVs associated with disease risk for DLBCL and somatic CNVs for CLL/SLL.	[Conde, Lucia; Riby, Jacques; Zhang, Jianqing; Skibola, Christine F.] Univ Alabama Birmingham, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35294 USA; [Conde, Lucia; Riby, Jacques; Zhang, Jianqing; Skibola, Christine F.] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA; [Bracci, Paige M.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of California System; University of California San Francisco	Conde, L (corresponding author), Univ Alabama Birmingham, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35294 USA.	lconde@uab.edu; cskibola@uab.edu	Zhang, Jianqing/Q-3161-2019; Conde, Lucia/D-9295-2011	Zhang, Jianqing/0000-0001-5246-3371; Conde, Lucia/0000-0001-5180-543X	National Institutes of Health [CA122663, CA154643-01A1, CA104682, CA087014]; NATIONAL CANCER INSTITUTE [R01CA154643, R01CA104682, R01CA087014, R01CA122663] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grants CA122663, CA154643-01A1 and CA104682 (C.F.S.) and CA087014 (P.M.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bea S, 2005, BLOOD, V106, P3183, DOI 10.1182/blood-2005-04-1399; Berndt SI, 2013, NAT GENET, V45, P868, DOI 10.1038/ng.2652; Cheung KJJ, 2009, BLOOD, V113, P137, DOI 10.1182/blood-2008-02-140616; Conde L, 2010, NAT GENET, V42, P661, DOI 10.1038/ng.626; Dereli-Oz A, 2011, MOL ONCOL, V5, P308, DOI 10.1016/j.molonc.2011.05.002; Dohner H, 2000, NEW ENGL J MED, V343, P1910, DOI 10.1056/NEJM200012283432602; Edsgard Daniel, 2013, Front Endocrinol (Lausanne), V4, P2, DOI 10.3389/fendo.2013.00002; Fernandez-Rozadilla C, 2014, HUM GENET, V133, P525, DOI 10.1007/s00439-013-1390-4; Kuhn MWM, 2012, BLOOD, V119, pE67, DOI 10.1182/blood-2011-09-380444; Kuusisto KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071802; Lenz G, 2008, P NATL ACAD SCI USA, V105, P13520, DOI 10.1073/pnas.0804295105; Marenne G, 2011, HUM MUTAT, V32, P240, DOI 10.1002/humu.21398; Mraz M, 2013, LEUKEMIA RES, V37, P802, DOI 10.1016/j.leukres.2013.03.018; Pasic I, 2010, CANCER RES, V70, P160, DOI 10.1158/0008-5472.CAN-09-1902; Skibola CF, 2009, NAT GENET, V41, P873, DOI 10.1038/ng.419; Smedby KE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001378; Speedy HE, 2014, NAT GENET, V46, P56, DOI 10.1038/ng.2843; Vijai J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003220; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909; Winchester Laura, 2009, Briefings in Functional Genomics & Proteomics, V8, P353, DOI 10.1093/bfgp/elp017	21	13	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105382	10.1371/journal.pone.0105382	http://dx.doi.org/10.1371/journal.pone.0105382			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133503	gold, Green Published, Green Submitted			2022-12-25	WOS:000341302700110
J	Torres, MJ; Dorigny, B; Kuhn, M; Berr, C; Barberger-Gateau, P; Letenneur, L				Torres, Marion J.; Dorigny, Beatrice; Kuhn, Mirjam; Berr, Claudine; Barberger-Gateau, Pascale; Letenneur, Luc			Nutritional Status in Community-Dwelling Elderly in France in Urban and Rural Areas	PLOS ONE			English	Article							COMPREHENSIVE ASSESSMENT; INTERRATER RELIABILITY; MALNUTRITION; RISK; PREVALENCE; HEALTHY; PEOPLE	Malnutrition is a frequent condition in elderly people, especially in nursing homes and geriatric wards. Its frequency is less well known among elderly living at home. The objective of this study was to describe the nutritional status evaluated by the Mini Nutritional Assessment (MNA) of elderly community-dwellers living in rural and urban areas in France and to investigate its associated factors. Methods: Subjects aged 65 years and over from the Approche Multidisciplinaire Integree (AMI) cohort (692 subjects living in a rural area) and the Three-City (3C) cohort (8,691 subjects living in three large urban zones) were included. A proxy version of the MNA was reconstructed using available data from the AMI cohort. Sensitivity and specificity were used to evaluate the agreement between the proxy version and the standard version in AMI. The proxy MNA was computed in both cohorts to evaluate the frequency of poor nutritional status. Factors associated with this state were investigated in each cohort separately. Results: In the rural sample, 38.0% were females and the mean age was 75.5 years. In the urban sample, 60.3% were females and the mean age was 74.1 years. Among subjects in living in the rural sample, 7.4% were in poor nutritional status while the proportion was 18.5% in the urban sample. Female gender, older age, being widowed, a low educational level, low income, low body mass index, being demented, having a depressive symptomatology, a loss of autonomy and an intake of more than 3 drugs appeared to be independently associated with poor nutritional status. Conclusion: Poor nutritional status was commonly observed among elderly people living at home in both rural and urban areas. The associated factors should be further considered for targeting particularly vulnerable individuals.	[Torres, Marion J.; Barberger-Gateau, Pascale; Letenneur, Luc] Univ Bordeaux, ISPED, Ctr INSERM, Epidemiol Biostat U897, F-33000 Bordeaux, France; [Torres, Marion J.; Barberger-Gateau, Pascale; Letenneur, Luc] INSERM, ISPED, Ctr INSERM, Epidemiol Biostat U897, F-33000 Bordeaux, France; [Torres, Marion J.; Dorigny, Beatrice] Danone Res, Nutricia Adv Med Nutr, Saint Ouen, France; [Kuhn, Mirjam] Nutricia Res, Adv Med Nutr, Utrecht, Netherlands; [Berr, Claudine] Univ Montpellier I, Hop La Colombiere, INSERM, U1061, F-34093 Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); Danone Nutricia; Danone Nutricia; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier	Torres, MJ (corresponding author), Univ Bordeaux, ISPED, Ctr INSERM, Epidemiol Biostat U897, F-33000 Bordeaux, France.	Marion.Torres@isped.u-bordeaux2.fr	berr, Claudine/D-5238-2014; LETENNEUR, Luc/T-4424-2019	berr, Claudine/0000-0001-5254-7655; LETENNEUR, Luc/0000-0002-3274-937X; Torres, Marion J/0000-0002-7609-5531	Fondation pour la Recherche Medicale; Caisse Nationale Maladie des Travailleurs Salaries; Direction Generale de la Sante; Conseils Regionaux of Aquitaine; Languedoc-Roussillon and Bourgogne; Fondation de France; Ministry of Research-INSERM Programme 'Cohortes et collections de donnees biologiques'; Mutuelle Generale de l'Education Nationale; Institut de la longevite; Conseil General de la Cote d'or; AGRICA (CAMARCA); la Mutualite Sociale Agricole (MSA) de Gironde; la Caisse Centrale de la Mutualite Sociale Agricole (CCMSA); AGRICA (CRCCA); AGRICA (CCPMA PREVOYANCE); AGRICA (CPCEA); AGRICA (AGRI PREVOYANCE)	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Caisse Nationale Maladie des Travailleurs Salaries; Direction Generale de la Sante(General Electric); Conseils Regionaux of Aquitaine(Region Nouvelle-Aquitaine); Languedoc-Roussillon and Bourgogne(Region Bourgogne-Franche-ComteRegion Occitanie); Fondation de France(Fondation de France); Ministry of Research-INSERM Programme 'Cohortes et collections de donnees biologiques'; Mutuelle Generale de l'Education Nationale; Institut de la longevite; Conseil General de la Cote d'or(Region Bourgogne-Franche-Comte); AGRICA (CAMARCA); la Mutualite Sociale Agricole (MSA) de Gironde; la Caisse Centrale de la Mutualite Sociale Agricole (CCMSA); AGRICA (CRCCA); AGRICA (CCPMA PREVOYANCE); AGRICA (CPCEA); AGRICA (AGRI PREVOYANCE)	The 3C Study is conducted under a partnership agreement between the Institut National de la Sante et de la Recherche Medicale (INSERM), the Victor Segalen - Bordeaux II University and the Sanofi-Synthelabo Company. The Fondation pour la Recherche Medicale funded the preparation and initiation of the study. The 3C Study is also supported by the Caisse Nationale Maladie des Travailleurs Salaries, Direction Generale de la Sante, Conseils Regionaux of Aquitaine, Languedoc-Roussillon and Bourgogne, Fondation de France, Ministry of Research-INSERM Programme 'Cohortes et collections de donnees biologiques', Mutuelle Generale de l'Education Nationale, Institut de la longevite, Conseil General de la Cote d'or. The authors thank the Genopole of Lille, the Laboratory of Biochemistry of the University Hospital of Dijon (Prof. Gambert) and Montpellier (Prof. Descomps), the Neuroradiology Departments of the University Hospitals of Bordeaux (Prof. Caille), Dijon (Prof. Krause) and Montpellier (Prof. Bonafe), the University Hospital Gui de Chauliac in Montpellier, the Council of Dijon and the Conseil General of Cote d'Or. The 3C Study supports are listed on the Study website (www.three-city-study.com). The AMI project was funded by AGRICA (CAMARCA, CRCCA, CCPMA PREVOYANCE, CPCEA, AGRI PREVOYANCE), la Mutualite Sociale Agricole (MSA) de Gironde, la Caisse Centrale de la Mutualite Sociale Agricole (CCMSA). The authors declare that the funders of the cohorts and the commercial company that finance some authors of this paper had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliabadi M, 2008, ASIA PAC J CLIN NUTR, V17, P285; Alperovitch A, 2003, NEUROEPIDEMIOLOGY, V22, P316, DOI 10.1159/000072920; Brownie Sonya, 2006, Int J Nurs Pract, V12, P110, DOI 10.1111/j.1440-172X.2006.00557.x; Chen CCH, 2001, J ADV NURS, V36, P131, DOI 10.1046/j.1365-2648.2001.01950.x; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Cuervo M, 2009, PUBLIC HEALTH NUTR, V12, P82, DOI 10.1017/S136898000800195X; Ferdous T, 2009, PUBLIC HEALTH NUTR, V12, P2270, DOI 10.1017/S1368980009005096; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FUHRER R, 1989, Psychiatrie and Psychobiologie, V4, P163; Guigoz Y, 1996, NUTR REV, V54, pS59; Guigoz Y, 2002, CLIN GERIATR MED, V18, P737, DOI 10.1016/S0749-0690(02)00059-9; Gwet KL, 2008, BRIT J MATH STAT PSY, V61, P29, DOI 10.1348/000711006X126600; Hickson M, 2006, POSTGRAD MED J, V82, P2, DOI 10.1136/pgmj.2005.037564; Iizaka S, 2008, GERIATR GERONTOL INT, V8, P24, DOI 10.1111/j.1447-0594.2008.00443.x; Johansson L, 2009, J NUTR HEALTH AGING, V13, P855, DOI 10.1007/s12603-009-0242-3; Johansson Y, 2009, J CLIN NURS, V18, P1354, DOI 10.1111/j.1365-2702.2008.02552.x; Kaiser MJ, 2010, J AM GERIATR SOC, V58, P1734, DOI 10.1111/j.1532-5415.2010.03016.x; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Larrieu S, 2004, J Nutr Health Aging, V8, P497; Locher JL, 2005, J GERONTOL A-BIOL, V60, P1475, DOI 10.1093/gerona/60.11.1475; Loser C, 2010, DTSCH ARZTEBL INT, V107, P911, DOI 10.3238/arztebl.2010.0911; Morillas J, 2006, NUTR HOSP, V21, P650; *NAT CTR HLTH STAT, 2001, HLTH US 2001 URB RUR; Nykanen I, 2013, EUR J PUBLIC HEALTH, V23, P405, DOI 10.1093/eurpub/cks026; Payette H, 2005, CAN J PUBLIC HEALTH, V96, pS27, DOI 10.1007/BF03405198; Peres K, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-558; Pickering G, 2004, ARCH GERONTOL GERIAT, V38, P174, DOI 10.1016/j.archger.2003.09.004; Raynaud-Simon A, 2011, CLIN NUTR, V30, P312, DOI 10.1016/j.clnu.2010.12.003; ROBERTS RE, 1983, AM J PSYCHIAT, V140, P41; ROGAN WJ, 1978, AM J EPIDEMIOL, V107, P71, DOI 10.1093/oxfordjournals.aje.a112510; Salminen H, 2006, EUR J CLIN NUTR, V60, P486, DOI 10.1038/sj.ejcn.1602341; Soini H, 2005, J NUTR HEALTH AGING, V9, P249; Timpini A, 2011, J NUTR HEALTH AGING, V15, P233, DOI 10.1007/s12603-010-0286-4; Ulger Z, 2010, CLIN NUTR, V29, P507, DOI 10.1016/j.clnu.2010.01.006; United Nations, 2017, WORLD POP AG; Vellas B, 2006, J NUTR HEALTH AGING, V10, P456; Wongpakaran N, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-61	37	32	32	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105137	10.1371/journal.pone.0105137	http://dx.doi.org/10.1371/journal.pone.0105137			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO4JF	25133755	Green Submitted, gold, Green Published			2022-12-25	WOS:000341302700075
J	Chaturvedi, S; Sidana, S; Elson, P; Khorana, AA; McCrae, KR				Chaturvedi, Shruti; Sidana, Surbhi; Elson, Paul; Khorana, Alok A.; McCrae, Keith R.			Symptomatic and Incidental Venous Thromboembolic Disease Are Both Associated with Mortality in Patients with Prostate Cancer	PLOS ONE			English	Article							UNSUSPECTED PULMONARY EMBOLI; TISSUE FACTOR EXPRESSION; DEEP-VEIN THROMBOSIS; ANGIOGENESIS; RISK; CARCINOMA; PREVENTION; MANAGEMENT; SYSTEM; IMPACT	Introduction: The association between malignancy and venous thromboembolic disease (VTE) is well established. The independent impact of VTE, both symptomatic and incidental, on survival in patients with prostate cancer is not known. We conducted a retrospective cohort study to evaluate the effect of VTE of survival in prostate cancer. Methods: Data regarding clinical characteristics, treatment and outcomes of 453 consecutive prostate cancer patients were collected. Fisher exact (categorical variables) and t-test (continuous variables) were utilized to test associations with VTE and mortality. Survival was estimated using the Kaplan Meier method. A Cox regression model was used to model the mortality hazard ratio (HR). Results: At diagnosis, 358 (83%) patients had early stage disease, 43 (10%) had locally advanced disease and 32 (7%) had metastatic disease. During the follow up period, 122 (27%) patients died and 41 (9%) developed VTE (33 deep vein thrombosis, 5 pulmonary embolism, and 3 patients with both DVT and PE). Twenty-five VTE events were symptomatic and 16 were incidentally diagnosed on CT scans obtained for other reasons. VTE was associated with increased mortality [HR 6.89 (4.29-11.08), p < 0.001] in a multivariable analysis adjusted for cancer stage, performance status, treatments and co-morbidities. There was no difference in survival between patients who had symptomatic and incidental VTE. Conclusion: Venous thromboembolic disease, both symptomatic and incidental, is a predictor of poor survival in patients with prostate cancer, especially those with advanced disease. Further studies are needed to evaluate the benefit of prophylactic and therapeutic anticoagulation in this population.	[Chaturvedi, Shruti; Sidana, Surbhi] Cleveland Clin, Dept Internal Med, Cleveland, OH 44106 USA; [Elson, Paul] Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH 44106 USA; [Khorana, Alok A.; McCrae, Keith R.] Cleveland Clin, Dept Cellular & Mol Med, Cleveland, OH 44106 USA; [McCrae, Keith R.] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	McCrae, KR (corresponding author), Cleveland Clin, Dept Cellular & Mol Med, Cleveland, OH 44106 USA.	mccraek@ccf.org		Khorana, Alok/0000-0002-9509-0998; Sidana, Surbhi/0000-0003-3288-7614; Chaturvedi, Shruti/0000-0001-6832-2389	National Institutes of Health [U01HL072033, R01HL089796]; Sondra and Stephen Hardis Chair in Oncology Research; Scott Hamilton CARES initiative; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL072033, R01HL089796] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sondra and Stephen Hardis Chair in Oncology Research; Scott Hamilton CARES initiative; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grants U01HL072033 and R01HL089796 to K. R. McCrae. A. A. Khorana acknowledges the Sondra and Stephen Hardis Chair in Oncology Research and the Scott Hamilton CARES initiative for research support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulkadir SA, 2000, HUM PATHOL, V31, P443, DOI 10.1053/hp.2000.6547; Abe K, 1999, P NATL ACAD SCI USA, V96, P8663, DOI 10.1073/pnas.96.15.8663; Browder T, 2000, J BIOL CHEM, V275, P1521, DOI 10.1074/jbc.275.3.1521; Browne AM, 2010, J THORAC ONCOL, V5, P798, DOI 10.1097/JTO.0b013e3181d6153a; CARSON JL, 1992, NEW ENGL J MED, V326, P1240, DOI 10.1056/NEJM199205073261902; COGO A, 1994, ARCH INTERN MED, V154, P164, DOI 10.1001/archinte.154.2.164; Deitcher SR, 2003, SEMIN THROMB HEMOST, V29, P247; den Exter PL, 2011, J CLIN ONCOL, V29, P2405, DOI 10.1200/JCO.2010.34.0984; Desai SR, 2007, THORAX, V62, P470, DOI 10.1136/thx.2006.067884; Franchini M, 2012, SEMIN THROMB HEMOST, V38, P95, DOI 10.1055/s-0031-1300955; Gross CP, 2007, J GEN INTERN MED, V22, P321, DOI 10.1007/s11606-006-0019-x; Gussoni G, 2013, THROMB RES, V131, P24, DOI 10.1016/j.thromres.2012.10.007; Guyatt GH, 2012, CHEST, V141, p7S, DOI 10.1378/chest.1412S3; Hall IE, 2009, J CANCER EPIDEMIOL, V2009, DOI 10.1155/2009/182521; Han LY, 2006, J CLIN ONCOL, V24, P755, DOI 10.1200/JCO.2005.02.9181; Heit JA, 2006, J THROMB THROMBOLYS, V21, P23, DOI 10.1007/s11239-006-5572-y; Kaushal V, 2008, APPL IMMUNOHISTO M M, V16, P1; Khorana AA, 2003, J THROMB HAEMOST, V1, P2463, DOI 10.1111/j.1538-7836.2003.00501.x; Libertiny G, 1999, BRIT J SURG, V86, P907, DOI 10.1046/j.1365-2168.1999.01129.x; Lindholm PF, 2010, PROSTATE, V70, P1672, DOI 10.1002/pros.21202; Naess IA, 2007, J THROMB HAEMOST, V5, P692, DOI 10.1111/j.1538-7836.2007.02450.x; Nakagawa K, 1998, SEMIN THROMB HEMOST, V24, P207, DOI 10.1055/s-2007-995843; Nitori N, 2005, CLIN CANCER RES, V11, P2531, DOI 10.1158/1078-0432.CCR-04-0866; O'Connell C, 2011, J THROMB HAEMOST, V9, P305, DOI 10.1111/j.1538-7836.2010.04114.x; Ohta S, 2002, ANTICANCER RES, V22, P2991; PRANDONI P, 1992, NEW ENGL J MED, V327, P1128, DOI 10.1056/NEJM199210153271604; Prandoni P, 2007, J INTERN MED, V262, P341, DOI 10.1111/j.1365-2796.2007.01815.x; Prestidge T, 2012, INTERN MED J, V42, P71, DOI 10.1111/j.1445-5994.2010.02401.x; RICKLES FR, 1983, BLOOD, V62, P14; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sorensen HT, 2000, NEW ENGL J MED, V343, P1846, DOI 10.1056/NEJM200012213432504; Vrana JA, 1996, CANCER RES, V56, P5063; Yu YB, 2012, THROMB HAEMOSTASIS, V108, P225, DOI 10.1160/TH12-01-0010; ZHANG YM, 1994, J CLIN INVEST, V94, P1320, DOI 10.1172/JCI117451	34	37	39	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e94048	10.1371/journal.pone.0094048	http://dx.doi.org/10.1371/journal.pone.0094048			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126949	gold, Green Submitted, Green Published			2022-12-25	WOS:000340879300001
J	Jablonsky, J; Schwarz, D; Hagemann, M				Jablonsky, Jiri; Schwarz, Doreen; Hagemann, Martin			Multi-Level Kinetic Model Explaining Diverse Roles of Isozymes in Prokaryotes	PLOS ONE			English	Article							INORGANIC CARBON LIMITATION; SYNECHOCYSTIS SP PCC-6803; LOW CO2; CYANOBACTERIA; METABOLISM; GENE; INACTIVATION; TRANSPORT; BIOLOGY	Current standard methods for kinetic and genomic modeling cannot provide deep insight into metabolic regulation. Here, we developed and evaluated a multi-scale kinetic modeling approach applicable to any prokaryote. Specifically, we highlight the primary metabolism of the cyanobacterium Synechococcus elongatus PCC 7942. The model bridges metabolic data sets from cells grown at different CO2 conditions by integrating transcriptomic data and isozymes. Identification of the regulatory roles of isozymes allowed the calculation and explanation of the absolute metabolic concentration of 3-phosphoglycerate. To demonstrate that this method can characterize any isozyme, we determined the function of two glycolytic glyceraldehyde-3-phosphate dehydrogenases: one co-regulates high concentrations of the 3-phosphoglycerate, the other shifts the bifurcation point in hexose regulation, and both improve biomass production. Moreover, the regulatory roles of multiple phosphoglycolate phosphatases were defined for varying (non-steady) CO2 conditions, suggesting their protective role against toxic photorespiratory intermediates.	[Jablonsky, Jiri] Univ South Bohemia, FFPW, Lab Expt Complex Syst, Ceske Budejovice, Czech Republic; [Schwarz, Doreen; Hagemann, Martin] Univ Rostock, Dept Plant Physiol, D-18055 Rostock, Germany	University of South Bohemia Ceske Budejovice; University of Rostock	Jablonsky, J (corresponding author), Univ South Bohemia, FFPW, Lab Expt Complex Syst, Ceske Budejovice, Czech Republic.	jiri.jablonsky@gmail.com	Jablonsky, Jiri/F-7958-2015	Schwarz, Doreen/0000-0002-1071-5865	Postdok JU [CZ.1.07/2.3.00/30.0006]; CENAKVA [CZ.1.05/2.1.00/01.0024]; German Research Foundation (DFG) as part of the German photorespiration research group PROMICS [FOR 1186]; MEYS under the NPU I program [LO1205]	Postdok JU; CENAKVA; German Research Foundation (DFG) as part of the German photorespiration research group PROMICS(German Research Foundation (DFG)); MEYS under the NPU I program	This work was financially supported by Postdok JU CZ.1.07/2.3.00/30.0006, CENAKVA CZ.1.05/2.1.00/01.0024, and the German Research Foundation (DFG) as part of the German photorespiration research group PROMICS (FOR 1186). The results of the project LO1205 were obtained with a financial support from the MEYS under the NPU I program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alric J, 2010, BBA-BIOENERGETICS, V1797, P44, DOI 10.1016/j.bbabio.2009.07.009; ANDERSON LE, 1971, BIOCHIM BIOPHYS ACTA, V235, P237, DOI 10.1016/0005-2744(71)90051-9; Badger MR, 2006, J EXP BOT, V57, P249, DOI 10.1093/jxb/eri286; Battchikova N, 2010, J PROTEOME RES, V9, P5896, DOI 10.1021/pr100651w; COLMAN B, 1989, AQUAT BOT, V34, P211, DOI 10.1016/0304-3770(89)90057-0; Deng Y, 2003, PLANT CELL PHYSIOL, V44, P534, DOI 10.1093/pcp/pcg067; Ducat DC, 2011, P NATL ACAD SCI USA, V108, P3941, DOI 10.1073/pnas.1016026108; Edwards G., 1983, C3 C4 MECH CELLULAR; Eisenhut M, 2008, P NATL ACAD SCI USA, V105, P17199, DOI 10.1073/pnas.0807043105; Eisenhut M, 2007, PLANT PHYSIOL, V144, P1946, DOI 10.1104/pp.107.103341; Fillinger S, 2000, J BIOL CHEM, V275, P14031, DOI 10.1074/jbc.275.19.14031; Huege J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016278; Jablonsky J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058281; Jablonsky J, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-185; KALLAS T, 1982, J BACTERIOL, V149, P229, DOI 10.1128/JB.149.1.229-236.1982; Knoop H, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003081; Knoop H, 2010, PLANT PHYSIOL, V154, P410, DOI 10.1104/pp.110.157198; Koksharova O, 1998, PLANT MOL BIOL, V36, P183, DOI 10.1023/A:1005925732743; Koksharova OA, 2004, MICROBIOLOGY+, V73, P330, DOI 10.1023/B:MICI.0000032245.17669.72; Lan EI, 2012, P NATL ACAD SCI USA, V109, P6018, DOI 10.1073/pnas.1200074109; Machado D, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003580; Nakashima N, 2014, APPL ENVIRON MICROB, V80, P564, DOI 10.1128/AEM.02376-13; Nogales J, 2012, P NATL ACAD SCI USA, V109, P2678, DOI 10.1073/pnas.1117907109; OGAWA T, 1991, PLANT PHYSIOL, V96, P280, DOI 10.1104/pp.96.1.280; Schwarz D, 2011, PLANT PHYSIOL, V155, P1640, DOI 10.1104/pp.110.170225; Steuer R, 2012, J EXP BOT, V63, P2259, DOI 10.1093/jxb/ers018; Wang H, 2004, J BIOL CHEM, V279, P1468, DOI 10.1074/jbc.M309106200; Westerhoff HV, 2004, NAT BIOTECHNOL, V22, P1249, DOI 10.1038/nbt1020; Wijffels RH, 2013, CURR OPIN BIOTECH, V24, P405, DOI 10.1016/j.copbio.2013.04.004	29	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105292	10.1371/journal.pone.0105292	http://dx.doi.org/10.1371/journal.pone.0105292			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127487	Green Submitted, Green Published, gold			2022-12-25	WOS:000340879300102
J	Lu, X; Zhang, ZD; Guo, XM; Choy, JS; Yang, JR; Svendsen, M; Kassab, G				Lu, Xiao; Zhang, Zhen-Du; Guo, Xiaomei; Choy, Jenny Susana; Yang, Junrong; Svendsen, Mark; Kassab, Ghassan			Response of Various Conduit Arteries in Tachycardia- and Volume Overload-Induced Heart Failure	PLOS ONE			English	Article							NADPH OXIDASE; ENDOTHELIAL-CELLS; ANIMAL-MODELS; HEMODYNAMICS; GENERATION; STRESS	Although hemodynamics changes occur in heart failure (HF) and generally influence vascular function, it is not clear whether various HF models will affect the conduit vessels differentially or whether local hemodynamic forces or systemic factors are more important determinants of vascular response in HF. Here, we studied the hemodynamic changes in tachycardia or volume-overload HF swine model (created by either high rate pacing or distal abdominal aortic-vena cava fistula, respectively) on carotid, femoral, and renal arteries function and molecular expression. The ejection fraction was reduced by 50% or 30% in tachycardia or volume-overload model in four weeks, respectively. The LV end diastolic volume was increased from 65 +/- 22 to 115 +/- 78 ml in tachycardia and 67 +/- 19 to 148 +/- 68 ml in volume-overload model. Flow reversal was observed in diastolic phase in carotid artery of both models and femoral artery in volume-overload model. The endothelial function was also significantly impaired in carotid and renal arteries of tachycardia and volume-overload animals. The endothelial dysfunction was observed in femoral artery of volume-overload animals but not tachycardia animals. The adrenergic receptor-dependent contractility decreased in carotid and femoral arteries of tachycardia animals. The protein expressions of NADPH oxidase subunits increased in the three arteries and both animal models while expression of MnSOD decreased in carotid artery of tachycardia and volume-overload model. In conclusion, different HF models lead to variable arterial hemodynamic changes but similar vascular and molecular expression changes that reflect the role of both local hemodynamics as well as systemic changes in HF.	[Lu, Xiao; Zhang, Zhen-Du; Guo, Xiaomei; Choy, Jenny Susana; Yang, Junrong; Svendsen, Mark; Kassab, Ghassan] Indiana Univ Purdue Univ, Dept Biomed Engn, Indianapolis, IN 46202 USA; [Kassab, Ghassan] Indiana Univ Purdue Univ, Dept Surg, Indianapolis, IN 46202 USA; [Kassab, Ghassan] Indiana Univ Purdue Univ, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Kassab, G (corresponding author), Indiana Univ Purdue Univ, Dept Biomed Engn, Indianapolis, IN 46202 USA.	gkassab@iupui.edu			National Institute of Health-National Heart, Lung, and Blood Institute Grant [R01 HL084529-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084529] Funding Source: NIH RePORTER	National Institute of Health-National Heart, Lung, and Blood Institute Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by the National Institute of Health-National Heart, Lung, and Blood Institute Grant R01 HL084529-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso V, 2007, JOINT BONE SPINE, V74, P324, DOI 10.1016/j.jbspin.2007.02.002; Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; Chiu JJ, 2011, PHYSIOL REV, V91, P327, DOI 10.1152/physrev.00047.2009; CHOW E, 1990, AM J PHYSIOL, V258, pH1603, DOI 10.1152/ajpheart.1990.258.5.H1603; Elkayam U, 1996, J AM COLL CARDIOL, V28, P176, DOI 10.1016/0735-1097(96)00092-7; Godbole AS, 2009, AM J PHYSIOL-HEART C, V296, pH152, DOI 10.1152/ajpheart.01251.2007; Gorlach A, 2000, CIRC RES, V87, P26, DOI 10.1161/01.RES.87.1.26; HENRION D, 1992, EUR J PHARMACOL, V224, P13, DOI 10.1016/0014-2999(92)94812-A; Kawai H, 2000, AM J PHYSIOL-HEART C, V278, pH1708, DOI 10.1152/ajpheart.2000.278.5.H1708; Kostelec M, 2006, J THORAC CARDIOV SUR, V132, P875, DOI 10.1016/j.jtcvs.2006.03.067; Lu X, 2007, ANN BIOMED ENG, V35, P356, DOI 10.1007/s10439-006-9243-0; Paslawska U, 2010, INT J CARDIOL; Patten RD, 2009, CIRC-HEART FAIL, V2, P138, DOI 10.1161/CIRCHEARTFAILURE.108.839761; Power JM, 1999, AUST NZ J MED, V29, P395, DOI 10.1111/j.1445-5994.1999.tb00734.x; REMME WJ, 1994, EUR HEART J, V15, P129, DOI 10.1093/eurheartj/15.suppl_D.129; Schrier RW, 1999, NEW ENGL J MED, V341, P577, DOI 10.1056/NEJM199908193410806; TAYLOR RR, 1968, J CLIN INVEST, V47, P1333, DOI 10.1172/JCI105825; Tsutsui H, 2011, AM J PHYSIOL-HEART C, V301, pH2181, DOI 10.1152/ajpheart.00554.2011; WILSON JR, 1987, CIRCULATION, V75, P857, DOI 10.1161/01.CIR.75.4.857; ZEIGLER DW, 1986, AM J PHYSIOL, V251, pH196, DOI 10.1152/ajpheart.1986.251.1.H196; Zhang H, 1999, CARDIOVASC RES, V44, P215, DOI 10.1016/S0008-6363(99)00183-2; Zhang YH, 2009, CIRC-HEART FAIL, V2, P692, DOI 10.1161/CIRCHEARTFAILURE.109.873968; Zheng H, 2010, J APPL PHYSIOL, V109, P1619, DOI 10.1152/japplphysiol.01356.2009; ZUCKER IH, 1995, PROG CARDIOVASC DIS, V37, P397, DOI 10.1016/S0033-0620(05)80020-9	24	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e101645	10.1371/journal.pone.0101645	http://dx.doi.org/10.1371/journal.pone.0101645			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127035	gold, Green Published, Green Submitted			2022-12-25	WOS:000340879300002
J	Perez-Carbonell, L; Balaguer, F; Toiyama, Y; Egoavil, C; Rojas, E; Guarinos, C; Andreu, M; Llor, X; Castells, A; Jover, R; Boland, CR; Goel, A				Perez-Carbonell, Lucia; Balaguer, Francesc; Toiyama, Yuji; Egoavil, Cecilia; Rojas, Estefania; Guarinos, Carla; Andreu, Montserrat; Llor, Xavier; Castells, Antoni; Jover, Rodrigo; Boland, C. Richard; Goel, Ajay			IGFBP3 Methylation Is a Novel Diagnostic and Predictive Biomarker in Colorectal Cancer	PLOS ONE			English	Article							FACTOR-BINDING PROTEIN-3; CELL LUNG-CANCER; TUMOR MICROSATELLITE-INSTABILITY; ADJUVANT CHEMOTHERAPY; COLON-CANCER; PROMOTER METHYLATION; PHENOTYPE; DNA; EXPRESSION; PROGNOSIS	Background and Aim: Aberrant hypermethylation of cancer-related genes has emerged as a promising strategy for the development of diagnostic, prognostic and predictive biomarkers in human cancer, including colorectal cancer (CRC). The aim of this study was to perform a systematic and comprehensive analysis of a panel of CRC-specific genes as potential diagnostic, prognostic and predictive biomarkers in a large, population-based CRC cohort. Patients and Methods: Methylation status of the SEPT9, TWIST1, IGFBP3, GAS7, ALX4 and miR137 genes was studied by quantitative bisulfite pyrosequencing in a population-based cohort of 425 CRC patients. Results: Methylation levels of all genes analyzed were significantly higher in tumor tissues compared to normal mucosa (p < 0.0001); however, cancer-associated hypermethylation was most frequently observed for miR137 (86.7%) and IGFBP3 (83%) in CRC patients. Methylation analysis using the combination of these two genes demonstrated greatest accuracy for the identification of colonic tumors (sensitivity 95.5%; specificity 90.5%). Low levels of IGFBP3 promoter methylation emerged as an independent risk factor for predicting poor disease free survival in stage II and III CRC patients (HR = 0.49, 95% CI: 0.28-0.85, p = 0.01). Our results also suggest that stage II & III CRC patients with high levels of IGFBP3 methylation do not benefit from adjuvant 5FU-based chemotherapy. Conclusion: By analyzing a large, population-based CRC cohort, we demonstrate the potential clinical significance of miR137 and IGFBP3 hypermethylation as promising diagnostic biomarkers in CRC. Our data also revealed that IGFBP3 hypermethylation may serve as an independent prognostic and predictive biomarker in stage II and III CRC patients.	[Perez-Carbonell, Lucia; Toiyama, Yuji; Boland, C. Richard; Goel, Ajay] Baylor Univ, Med Ctr, Div Gastroenterol, Dept Internal Med,Charles Sammons Canc Ctr, Dallas, TX 75207 USA; [Perez-Carbonell, Lucia; Toiyama, Yuji; Boland, C. Richard; Goel, Ajay] Baylor Univ, Med Ctr, Baylor Res Inst, Dallas, TX USA; [Balaguer, Francesc; Castells, Antoni] Univ Barcelona, Dept Gastroenterol, Hosp Clin, CIBERehd,IDIBAPS, Barcelona, Spain; [Egoavil, Cecilia; Rojas, Estefania] Hosp Gen Univ Alicante, Dept Pathol, Alicante, Spain; [Guarinos, Carla] Hosp Gen Univ Alicante, Res Unit, Alicante, Spain; [Andreu, Montserrat] Hosp Mar, Dept Gastroenterol, Barcelona, Spain; [Llor, Xavier] Univ Illinois, Dept Med, Chicago, IL USA; [Llor, Xavier] Univ Illinois, Ctr Canc, Chicago, IL USA; [Jover, Rodrigo] Hosp Gen Univ Alicante, Unidad Gastroenterol, Alicante, Spain	Baylor University; Baylor University Medical Center; Baylor Scott & White Health; Baylor University; Baylor University Medical Center; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; General University Hospital of Alicante; General University Hospital of Alicante; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; General University Hospital of Alicante	Boland, CR (corresponding author), Baylor Univ, Med Ctr, Div Gastroenterol, Dept Internal Med,Charles Sammons Canc Ctr, Dallas, TX 75207 USA.	rickbo@baylorhealth.edu; ajay.goel@baylorhealth.edu	Castells, Antoni/ABC-1002-2021; Jover, Rodrigo/ABC-3258-2021; BALAGUER, FRANCESC/G-2389-2016; Egoavil, Cecilia/X-5134-2018; Egoavil, Cecilia/ABG-8531-2020; Balaguer, Francesc/GPX-7801-2022	Castells, Antoni/0000-0001-8431-2033; Jover, Rodrigo/0000-0003-3742-3413; Egoavil, Cecilia/0000-0003-0166-4901; Egoavil, Cecilia/0000-0003-0166-4901; Goel, Ajay/0000-0003-1396-6341; Balaguer, Francesc/0000-0002-0206-0539; Rojas Calvente, Estefania/0000-0001-6004-525X	National Cancer Institute, National Institutes of Health [R01 CA72851, CA181572]; Baylor Research Institute; Fundacion Alfonso Martin Escudero; Instituto de Salud Carlos III [PI10/00384]; Generalitat Valenciana [ValI+D Acif/2010/018]; NATIONAL CANCER INSTITUTE [R01CA181572, R01CA072851] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Baylor Research Institute; Fundacion Alfonso Martin Escudero; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The present work was supported by grant R01 CA72851 and CA181572 from the National Cancer Institute, National Institutes of Health and funds from the Baylor Research Institute. Lucia Perez-Carbonell is a recipient of a 2012 post-doctoral grant from Fundacion Alfonso Martin Escudero. Francesc Balaguer is a recipient of a grant from the Instituto de Salud Carlos III (PI10/00384). CIBEREHD is funded by the Instituto de Salud Carlos III. Carla Guarinos is a recipient of a grant from the Generalitat Valenciana (ValI+D Acif/2010/018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balaguer F, 2010, CANCER RES, V70, P6609, DOI 10.1158/0008-5472.CAN-10-0622; Bandres E, 2009, INT J CANCER, V125, P2737, DOI 10.1002/ijc.24638; Benlloch S, 2006, J MOL DIAGN, V8, P540, DOI 10.2353/jmoldx.2006.060070; Borinstein SC, 2010, MOL CARCINOGEN, V49, P94, DOI 10.1002/mc.20581; Chang YS, 2002, CLIN CANCER RES, V8, P3669; Cortes-Sempere M, 2013, ONCOGENE, V32, P1274, DOI 10.1038/onc.2012.146; Ebert MPA, 2006, GASTROENTEROLOGY, V131, P1418, DOI 10.1053/j.gastro.2006.08.034; Gort EH, 2008, CANCER EPIDEM BIOMAR, V17, P3325, DOI 10.1158/1055-9965.EPI-08-0472; Grutzmann R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003759; Gryfe R, 2000, NEW ENGL J MED, V342, P69, DOI 10.1056/NEJM200001133420201; Hanafusa T, 2002, CANCER LETT, V176, P149, DOI 10.1016/S0304-3835(01)00736-4; He QO, 2010, CANCER GENET CYTOGEN, V202, P1, DOI 10.1016/j.cancergencyto.2010.05.018; Ibanez de Caceres I, 2010, ONCOGENE, V29, P1681, DOI 10.1038/onc.2009.454; Ibrahim AEK, 2011, GUT, V60, P499, DOI 10.1136/gut.2010.223602; Issa JP, 2002, J NUTR, V132, p2388S, DOI 10.1093/jn/132.8.2388S; Jass JR, 2007, HISTOPATHOLOGY, V50, P113, DOI 10.1111/j.1365-2559.2006.02549.x; Jover R, 2011, GASTROENTEROLOGY, V140, P1174, DOI 10.1053/j.gastro.2010.12.035; Jover R, 2009, EUR J CANCER, V45, P365, DOI 10.1016/j.ejca.2008.07.016; Kawasaki T, 2007, NEOPLASIA, V9, P1091, DOI 10.1593/neo.07760; Kim YH, 2011, ANN SURG ONCOL, V18, P2338, DOI 10.1245/s10434-011-1573-y; Kondo Y, 2004, CANCER METAST REV, V23, P29, DOI 10.1023/A:1025806911782; Lofton-Day C, 2008, CLIN CHEM, V54, P414, DOI 10.1373/clinchem.2007.095992; Min BH, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-344; Moreira L, 2012, JAMA-J AM MED ASSOC, V308, P1555, DOI 10.1001/jama.2012.13088; Perez-Carbonell L, 2012, GUT, V61, P865, DOI 10.1136/gutjnl-2011-300041; Petko Z, 2005, CLIN CANCER RES, V11, P1203; Pinol V, 2005, JAMA-J AM MED ASSOC, V293, P1986, DOI 10.1001/jama.293.16.1986; Pinol V, 2004, EUR J GASTROEN HEPAT, V16, P39, DOI 10.1097/00042737-200401000-00007; Popat S, 2005, J CLIN ONCOL, V23, P609, DOI 10.1200/JCO.2005.01.086; Regueiro CR, 2005, GASTROENTEROLOGY, V129, P1083, DOI 10.1053/j.gastro.2005.06.012; Ribic CM, 2003, NEW ENGL J MED, V349, P247, DOI 10.1056/NEJMoa022289; Ronneberg JA, 2011, MOL ONCOL, V5, P61, DOI 10.1016/j.molonc.2010.11.004; Samowitz WS, 2005, GASTROENTEROLOGY, V129, P837, DOI 10.1053/j.gastro.2005.06.020; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Smith RA, 2010, CA-CANCER J CLIN, V60, P99, DOI 10.3322/caac.20063; Tanzer M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009061; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Ushijima T, 2005, NAT REV CANCER, V5, P223, DOI 10.1038/nrc1571; Valdes-Mora F, 2009, ANN SURG ONCOL, V16, P78, DOI 10.1245/s10434-008-0166-x; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Wiley A, 2006, INT J GYNECOL CANCER, V16, P210, DOI 10.1111/j.1525-1438.2006.00299.x; Wright CM, 2000, BRIT J SURG, V87, P1197, DOI 10.1046/j.1365-2168.2000.01508.x; Xicola RM, 2007, JNCI-J NATL CANCER I, V99, P244, DOI 10.1093/jnci/djk033; Yi JM, 2011, CLIN CANCER RES, V17, P1535, DOI 10.1158/1078-0432.CCR-10-2509	44	38	40	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104285	10.1371/journal.pone.0104285	http://dx.doi.org/10.1371/journal.pone.0104285			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127039	Green Published, Green Submitted, gold			2022-12-25	WOS:000340879300018
J	Shi, YZ; Forneris, N; Rajora, OP				Shi, Yong-Zhong; Forneris, Natascha; Rajora, Om P.			Highly Informative Single-Copy Nuclear Microsatellite DNA Markers Developed Using an AFLP-SSR Approach in Black Spruce (Picea mariana) and Red Spruce (P. rubens)	PLOS ONE			English	Article							SIMPLE SEQUENCE REPEATS; TRANSMISSION RATIO DISTORTION; GENETIC-LINKAGE MAP; PERSICA L. BATSCH; WHITE SPRUCE; POPULATION-STRUCTURE; CONIFER GENOME; DIVERSITY ASSESSMENT; ARACHIS-HYPOGAEA; SEGREGATION	Background: Microsatellites or simple sequence repeats (SSRs) are highly informative molecular markers for various biological studies in plants. In spruce (Picea) and other conifers, the development of single-copy polymorphic genomic microsatellite markers is quite difficult, owing primarily to the large genome size and predominance of repetitive DNA sequences throughout the genome. We have developed highly informative single-locus genomic microsatellite markers in black spruce (Picea mariana) and red spruce (Picea rubens) using a simple but efficient method based on a combination of AFLP and microsatellite technologies. Principal Findings: A microsatellite-enriched library was constructed from genomic AFLP DNA fragments of black spruce. Sequencing of the 108 putative SSR-containing clones provided 94 unique sequences with microsatellites. Twenty-two of the designed 34 primer pairs yielded scorable amplicons, with single-locus patterns. Fourteen of these microsatellite markers were characterized in 30 black spruce and 30 red spruce individuals drawn from many populations. The number of alleles at a polymorphic locus ranged from 2 to 18, with a mean of 9.3 in black spruce, and from 3 to 15, with a mean of 6.2 alleles in red spruce. The polymorphic information content or expected heterozygosity ranged from 0.340 to 0.909 (mean = 0.67) in black spruce and from 0.161 to 0.851 (mean = 0.62) in red spruce. Ten SSR markers showing inter-parental polymorphism inherited in a single-locus Mendelian mode, with two cases of distorted segregation. Primer pairs for almost all polymorphic SSR loci resolved microsatellites of comparable size in Picea glauca, P. engelmannii, P. sitchensis, and P. abies. Significance: The AFLP-based microsatellite-enriched library appears to be a rapid, cost-effective approach for isolating and developing single-locus informative genomic microsatellite markers in black spruce. The markers developed should be useful in black spruce, red spruce and other Picea species for various genetics, genomics, breeding, forensics, conservation studies and applications.	[Shi, Yong-Zhong; Forneris, Natascha; Rajora, Om P.] Dalhousie Univ, Dept Biol, Forest Genet & Biotechnol Grp, Halifax, NS, Canada; [Rajora, Om P.] Univ New Brunswick, Fac Forestry & Environm Management, Fredericton, NB, Canada	Dalhousie University; University of New Brunswick	Rajora, OP (corresponding author), Dalhousie Univ, Dept Biol, Forest Genet & Biotechnol Grp, Halifax, NS, Canada.	Om.Rajora@unb.ca			Natural Sciences and Engineering Research Council of Canada (NSERC) [STPGP 234783 - 00]; Genome Canada; Stora Enso Port Hawkesbury Ltd (closed) Research Chairs funds; Canada Research Chair Program [CRC950-201869]; NSERC [STPGP 234783 - 00]; Stora Enso Port Hawkesbury Ltd.; Senior Canada Research Chair in Forest and Conservation Genomics and Biotechnology at UNB	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Genome Canada(Genome Canada); Stora Enso Port Hawkesbury Ltd (closed) Research Chairs funds; Canada Research Chair Program(Canada Research Chairs); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Stora Enso Port Hawkesbury Ltd.; Senior Canada Research Chair in Forest and Conservation Genomics and Biotechnology at UNB	This study was funded by a Natural Sciences and Engineering Research Council of Canada (NSERC) Strategic Project grant (STPGP 234783 - 00), http://www.nserc-crsng.gc.ca/index_eng.asp, Genome Canada Large-scale project funds, http://www.genomecanada.ca/, Stora Enso Port Hawkesbury Ltd (closed) Research Chairs funds, and Canada Research Chair Program (CRC950-201869) funds, http://www.chairs-chaires.gc.ca/home-accueil-eng.aspx, to Om P. Rajora. Yongzhong Shi was financially supported by NSERC Strategic Grants funds (STPGP 234783 - 00) to Om P. Rajora and Natascha Forneris was financially supported by Genome Canada funding to Om P. Rajora. Om P. Rajora held the Stora Enso Senior Chair in Forest Genetics and Biotechnology at Dalhousie University, which was supported by Stora Enso Port Hawkesbury Ltd., and the Senior Canada Research Chair in Forest and Conservation Genomics and Biotechnology at UNB, which was supported by the Canada Research Chair Program (CRC950-201869). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Stora Enso Port Hawkesbury Ltd. (closed) has/had no competing interest and no restrictions on sharing of data and/or materials. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Areshchenkova T, 2002, THEOR APPL GENET, V104, P229, DOI 10.1007/s00122-001-0775-2; Bashalkhanov S, 2013, MOL ECOL, V22, P5877, DOI 10.1111/mec.12546; Birol I, 2013, BIOINFORMATICS, V29, P1492, DOI 10.1093/bioinformatics/btt178; BOBOLA MS, 1992, CAN J FOREST RES, V22, P255, DOI 10.1139/x92-033; Bobola MS, 1996, CAN J FOREST RES, V26, P433, DOI 10.1139/x26-049; BRADSHAW HD, 1994, THEOR APPL GENET, V89, P551, DOI 10.1007/BF00222447; CHEN H, 1995, GENOMICS, V25, P1, DOI 10.1016/0888-7543(95)80103-S; Cho YG, 2000, THEOR APPL GENET, V100, P713, DOI 10.1007/s001220051343; Cuc LM, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-55; Dobrzeniecka S, 2009, SILVAE GENET, V58, P168, DOI 10.1515/sg-2009-0022; Donini P, 1998, GENET RESOUR CROP EV, V45, P415, DOI 10.1023/A:1008612917967; Elsik CG, 2001, THEOR APPL GENET, V103, P1189, DOI 10.1007/s001220100725; Fageria MS, 2013, EVOL APPL, V6, P778, DOI 10.1111/eva.12064; Fishman L, 2005, GENETICS, V169, P347, DOI 10.1534/genetics.104.032789; Fishman L, 2008, EVOLUTION, V62, P2958, DOI 10.1111/j.1558-5646.2008.00475.x; Georgi LL, 2002, THEOR APPL GENET, V105, P1151, DOI 10.1007/s00122-002-0967-4; Hamblin MT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001367; HAWLEY GJ, 1994, CAN J BOT, V72, P1778, DOI 10.1139/b94-219; He Guohao, 2003, BMC Plant Biology, V3, P3, DOI 10.1186/1471-2229-3-3; Hodgetts RB, 2001, THEOR APPL GENET, V102, P1252, DOI 10.1007/s00122-001-0546-0; Jenczewski E, 1997, THEOR APPL GENET, V94, P682, DOI 10.1007/s001220050466; Kang BY, 2011, GENOME, V54, P128, DOI 10.1139/G10-099; Kang BY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-515; Kinlaw CS, 1997, TRENDS PLANT SCI, V2, P356, DOI 10.1016/S1360-1385(97)84624-9; Li Y, 2010, AM J BOT, V97, pE39, DOI 10.3732/ajb.1000098; Liewlaksaneeyanawin C, 2004, THEOR APPL GENET, V109, P361, DOI 10.1007/s00122-004-1635-7; Miao YC, 2012, INT J MOL SCI, V13, P11165, DOI 10.3390/ijms130911165; MORGENSTERN EK, 1972, CAN J GENET CYTOL, V14, P443, DOI 10.1139/g72-055; Murray BG, 1998, ANN BOT-LONDON, V82, P3, DOI 10.1006/anbo.1998.0764; Nystedt B, 2013, NATURE, V497, P579, DOI 10.1038/nature12211; Perron M, 2000, P NATL ACAD SCI USA, V97, P11331, DOI 10.1073/pnas.200417097; PERRON M, 1995, THEOR APPL GENET, V91, P142, DOI 10.1007/BF00220871; Pfeiffer A, 1997, GENOME, V40, P411, DOI 10.1139/g97-055; Rabinowicz PD, 2005, GENOME RES, V15, P1431, DOI 10.1101/gr.4100405; Rahman MH, 2002, GENOME, V45, P1083, DOI [10.1139/g02-077, 10.1139/G02-077]; Rahman MH, 2001, PLANT CELL REP, V20, P531, DOI 10.1007/s002990100365; Rajora OP, 2000, CAN J BOT, V78, P941, DOI 10.1139/cjb-78-7-941; Rajora OP, 2000, MOL ECOL, V9, P339, DOI 10.1046/j.1365-294x.2000.00886.x; Rajora OP, 2003, THEOR APPL GENET, V106, P1203, DOI 10.1007/s00122-002-1169-9; Rajora OP, 2003, THEOR APPL GENET, V106, P470, DOI 10.1007/s00122-002-1082-2; Rajora OP, 2001, MOL GEN GENET, V264, P871, DOI 10.1007/s004380000377; Ran JH, 2006, MOL PHYLOGENET EVOL, V41, P405, DOI 10.1016/j.ympev.2006.05.039; Reece KS, 2004, J HERED, V95, P346, DOI 10.1093/jhered/esh058; Rozen S, 2000, Methods Mol Biol, V132, P365; Rungis D, 2004, THEOR APPL GENET, V109, P1283, DOI 10.1007/s00122-004-1742-5; Scott KD, 2000, THEOR APPL GENET, V100, P723, DOI 10.1007/s001220051344; Scotti I, 2002, THEOR APPL GENET, V106, P40, DOI 10.1007/s00122-002-0986-1; Scotti I, 2002, THEOR APPL GENET, V104, P1035, DOI 10.1007/s00122-001-0843-7; Scotti I, 2000, GENOME, V43, P41, DOI 10.1139/gen-43-1-41; Sokal RR, 1995, BIOMETRY; Tang SX, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-48; Taramino G, 1997, THEOR APPL GENET, V95, P66, DOI 10.1007/s001220050533; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Yamamoto T, 2002, MOL ECOL NOTES, V2, P14, DOI 10.1046/j.1471-8286.2002.00128.x; Yamamoto T, 2002, MOL ECOL NOTES, V2, P298, DOI 10.1046/j.1471-8286.2002.00242.x; Yang JB, 2009, HORTSCIENCE, V44, P2043, DOI 10.21273/HORTSCI.44.7.2043; Yazdani R, 2003, HEREDITAS, V138, P219, DOI 10.1034/j.1601-5223.2003.01524.x; ZAMIR D, 1986, BOT GAZ, V147, P355, DOI 10.1086/337602; Zane L, 2002, MOL ECOL, V11, P1, DOI 10.1046/j.0962-1083.2001.01418.x; Zhou Y, 2002, GENOME, V45, P91, DOI 10.1139/g01-119; [No title captured]	61	6	6	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e103789	10.1371/journal.pone.0103789	http://dx.doi.org/10.1371/journal.pone.0103789			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126846	Green Submitted, Green Published, gold			2022-12-25	WOS:000340879300008
J	Al-Barwani, F; Young, SL; Baird, MA; Larsen, DS; Ward, VK				Al-Barwani, Farah; Young, Sarah L.; Baird, Margaret A.; Larsen, David S.; Ward, Vernon K.			Mannosylation of Virus-Like Particles Enhances Internalization by Antigen Presenting Cells	PLOS ONE			English	Article							MACROPHAGE MANNOSE RECEPTOR; HEMORRHAGIC-DISEASE VIRUS; DENDRITIC CELLS; CROSS-PRESENTATION; SELECTIVE RECOGNITION; DOWN-REGULATION; I-TASSER; PROTEIN; EXPRESSION; DELIVERY	Internalization of peptides by antigen presenting cells is crucial for the initiation of the adaptive immune response. Mannosylation has been demonstrated to enhance antigen uptake through mannose receptors, leading to improved immune responses. In this study we test the effect of surface mannosylation of protein-based virus-like particles (VLP) derived from Rabbit hemorrhagic disease virus (RHDV) on uptake by murine and human antigen presenting cells. A monomannoside and a novel dimannoside were synthesized and successfully conjugated to RHDV VLP capsid protein, providing approximately 270 mannose groups on the surface of each virus particle. VLP conjugated to the mannoside or dimannoside exhibited significantly enhanced binding and internalization by murine dendritic cells, macrophages and B cells as well as human dendritic cells and macrophages. This uptake was inhibited by the inclusion of mannan as a specific inhibitor of mannose specific uptake, demonstrating that mannosylation of VLP targets mannose receptor-based uptake. Consistent with mannose receptor-based uptake, partial retargeting of the intracellular processing of RHDV VLP was observed, confirming that mannosylation of VLP provides both enhanced uptake and modified processing of associated antigens.	[Al-Barwani, Farah; Ward, Vernon K.] Univ Otago, Otago Sch Med Sci, Dept Microbiol & Immunol, Dunedin, New Zealand; [Young, Sarah L.; Baird, Margaret A.] Univ Otago, Dunedin Sch Med, Dept Pathol, Dunedin, New Zealand; [Larsen, David S.] Univ Otago, Div Sci, Dept Chem, Dunedin, New Zealand	University of Otago; University of Otago; University of Otago	Ward, VK (corresponding author), Univ Otago, Otago Sch Med Sci, Dept Microbiol & Immunol, Dunedin, New Zealand.	vernon.ward@otago.ac.nz	Larsen, David S/A-6367-2014	Larsen, David S/0000-0002-3563-1086; Ward, Vernon/0000-0001-8692-5116; Young, Sarah/0000-0003-0374-2221	Health Research Council of New Zealand [10/135]; University of Otago, New Zealand	Health Research Council of New Zealand(Health Research Council of New Zealand); University of Otago, New Zealand	This work was supported by Health Research Council of New Zealand grant (10/135) and a Priming Partnership Project from the University of Otago, New Zealand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida SR, 2001, INT IMMUNOL, V13, P1193, DOI 10.1093/intimm/13.9.1193; Apostolopoulos V, 2000, VACCINE, V18, P3174, DOI 10.1016/S0264-410X(00)00090-6; Apostolopoulos V, 2000, EUR J IMMUNOL, V30, P1714, DOI 10.1002/1521-4141(200006)30:6<1714::AID-IMMU1714>3.0.CO;2-C; Apostolopoulos V, 2003, MOL B INT U, P297; Autenrieth SE, 2009, IMMUNOLOGY, V127, P523, DOI 10.1111/j.1365-2567.2008.02960.x; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; BOSONE E, 1983, SYNTHESIS-STUTTGART, P942; Brode S, 2004, IMMUNOLOGY, V112, P345, DOI 10.1111/j.1365-2567.2004.01920.x; Burgdorf S, 2008, NAT IMMUNOL, V9, P558, DOI 10.1038/ni.1601; Engering AJ, 1997, EUR J IMMUNOL, V27, P2417, DOI 10.1002/eji.1830270941; Espuelas S, 2008, BIOCONJUGATE CHEM, V19, P2385, DOI 10.1021/bc8002524; Feinberg H, 2001, SCIENCE, V294, P2163, DOI 10.1126/science.1066371; Fernandez E, 2013, PLOS ONE IN PRESS, V8; Frison N, 2003, J BIOL CHEM, V278, P23922, DOI 10.1074/jbc.M302483200; Furneaux RH, 2002, CAN J CHEM, V80, P964, DOI 10.1139/V02-120; Gazi U, 2009, IMMUNOBIOLOGY, V214, P554, DOI 10.1016/j.imbio.2008.11.004; Ghosh M, 2012, J IMMUNOL, V188, P5489, DOI 10.4049/jimmunol.1103490; HARRIS N, 1992, BLOOD, V80, P2363; Jemon K, 2013, PLOS ONE IN PRESS, V8; Kerscher B, 2013, INT IMMUNOL, V25, P271, DOI 10.1093/intimm/dxt006; KERY V, 1992, ARCH BIOCHEM BIOPHYS, V298, P49, DOI 10.1016/0003-9861(92)90092-B; LAURENT S, 1994, J VIROL, V68, P6794, DOI 10.1128/JVI.68.10.6794-6798.1994; Li KY, 2013, J IMMUNOTHER, V36, P11, DOI 10.1097/CJI.0b013e3182787f5e; Mayer TG, 1999, EUR J ORG CHEM, V1999, P1153; McKee SJ, 2012, J CONTROL RELEASE, V159, P338, DOI 10.1016/j.jconrel.2012.02.015; Noad R, 2003, TRENDS MICROBIOL, V11, P438, DOI 10.1016/S0966-842X(03)00208-7; Peacey M, 2008, VACCINE, V26, P5334, DOI 10.1016/j.vaccine.2008.07.074; Peacey M, 2007, BIOTECHNOL BIOENG, V98, P968, DOI 10.1002/bit.21518; Petrushina I, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-42; PODLASEK CA, 1995, J AM CHEM SOC, V117, P8635, DOI 10.1021/ja00138a020; Ramirez MC, 2002, J IMMUNOL, V169, P6733, DOI 10.4049/jimmunol.169.12.6733; Rodriguez-Limas WA, 2013, CURR OPIN B IN PRESS; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Roy P, 2008, HUM VACCINES, V4, P5, DOI 10.4161/hv.4.1.5559; Ryan EJ, 2002, J IMMUNOL, V169, P5638, DOI 10.4049/jimmunol.169.10.5638; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Sandgren KJ, 2013, J IMMUNOL, V191, P60, DOI 10.4049/jimmunol.1202489; Sheng KC, 2008, EUR J IMMUNOL, V38, P424, DOI 10.1002/eji.200737578; Stahl PD, 1998, CURR OPIN IMMUNOL, V10, P50, DOI 10.1016/S0952-7915(98)80031-9; Tan MCAA, 1997, EUR J IMMUNOL, V27, P2426, DOI 10.1002/eji.1830270942; TAYLOR ME, 1992, J BIOL CHEM, V267, P1719; TROWBRIDGE IS, 1974, J BIOL CHEM, V249, P6004; VINUESA CG, 2003, MOL B INT U, P128; White KL, 2006, J PHARM PHARMACOL, V58, P729, DOI 10.1211/jpp.58.6.0003; Win SJ, 2011, IMMUNOL CELL BIOL, V89, P681, DOI 10.1038/icb.2010.161; WITMERPACK MD, 1995, CELL IMMUNOL, V163, P157, DOI 10.1006/cimm.1995.1110; Young SL, 2006, VACCINE, V24, P5406, DOI 10.1016/j.vaccine.2006.03.052; Zeltins A, 2013, MOL BIOTECHNOL, V53, P92, DOI 10.1007/s12033-012-9598-4; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	49	32	33	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104523	10.1371/journal.pone.0104523	http://dx.doi.org/10.1371/journal.pone.0104523			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122183	Green Submitted, gold, Green Published			2022-12-25	WOS:000341017000041
J	Edagwa, BJ; Guo, DW; Puligujja, P; Chen, H; McMillan, J; Liu, XM; Gendelman, HE; Narayanasamy, P				Edagwa, Benson J.; Guo, Dongwei; Puligujja, Pavan; Chen, Han; McMillan, JoEllyn; Liu, Xinming; Gendelman, Howard E.; Narayanasamy, Prabagaran			Long-acting antituberculous therapeutic nanoparticles target macrophage endosomes	FASEB JOURNAL			English	Article						Mycobacterium tuberculosis; Mycobacterium smegmatis; immunoisolation; MDM; subcellular trafficking	HUMAN-IMMUNODEFICIENCY-VIRUS; MYCOBACTERIUM-TUBERCULOSIS; DRUG-DELIVERY; HIV INFECTION; PATHOGENESIS; PHAGOSOME; NANOTECHNOLOGY; NANOMEDICINE; EPIDEMIOLOGY; PHAGOCYTOSIS	Eradication of Mycobacterium tuberculosis (MTB) infection requires daily administration of combinations of rifampin (RIF), isoniazid [isonicotinylhydrazine (INH)], pyrazinamide, and ethambutol, among other drug therapies. To facilitate and optimize MTB therapeutic selections, a mononuclear phagocyte (MP; monocyte, macrophage, and dendritic cell)-targeted drug delivery strategy was developed. Long-acting nanoformulations of RIF and an INH derivative, pentenyl-INH (INHP), were prepared, and their physicochemical properties were evaluated. This included the evaluation of MP particle uptake and retention, cell viability, and antimicrobial efficacy. Drug levels reached 6 mu g/10(6) cells in human monocyte-derived macrophages (MDMs) for nanoparticle treatments compared with 0.1 mu g/10(6) cells for native drugs. High RIF and INHP levels were retained in MDM for > 15 d following nanoparticle loading. Rapid loss of native drugs was observed in cells and culture fluids within 24 h. Antimicrobial activities were determined against Mycobacterium smegmatis (M. smegmatis). Coadministration of nanoformulated RIF and INHP provided a 6-fold increase in therapeutic efficacy compared with equivalent concentrations of native drugs. Notably, nanoformulated RIF and INHP were found to be localized in recycling and late MDM endosomal compartments. These were the same compartments that contained the pathogen. Our results demonstrate the potential of antimicrobial nanomedicines to simplify MTB drug regimens.	[Edagwa, Benson J.; Puligujja, Pavan; McMillan, JoEllyn; Liu, Xinming; Gendelman, Howard E.; Narayanasamy, Prabagaran] Univ Nebraska, Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE USA; [Guo, Dongwei] Univ Nebraska, Med Ctr, Dept Pharmaceut Sci, Omaha, NE USA; [Chen, Han] Univ Nebraska, Ctr Biotechnol, Lincoln, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Lincoln	Gendelman, HE (corresponding author), Dept Pharmacol & Expt Neurosci, 985880 Nebraska Med Ctr, Omaha, NE 68198 USA.	hegendel@unmc.edu	Guo, Dongwei/E-9024-2018	Narayanasamy, Prabagaran/0000-0002-9617-5555; Guo, Dongwei/0000-0003-3538-4852	U.S. National Institutes of Health [P01-DA-028555, R01-NS-36126, P01-NS-31492, 2R01-NS-034239, P01-MH-64570, P01-NS-43985, R01-A-1097550]; Nebraska Research Initiative; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH064570] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036126, R01NS034239, P01NS043985, P01NS031492] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG043540] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA028555] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nebraska Research Initiative; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors are grateful to Janice Taylor and James R. Talaska (Confocal Laser Scanning Core facility, University of Nebraska Medical Center) for assistance with confocal microscopy. This work was supported by U.S. National Institutes of Health grants P01-DA-028555, R01-NS-36126, P01-NS-31492, 2R01-NS-034239, P01-MH-64570, and P01-NS-43985 (to H.E.G.) and R01-A-1097550 (to P.N.) and by the Nebraska Research Initiative (to H.E.G. and P.N.).	ARMSTRONG JA, 1971, J EXP MED, V134, P713, DOI 10.1084/jem.134.3.713; Balkundi S, 2011, INT J NANOMED, V6, P3393, DOI 10.2147/IJN.S27830; Banyal S, 2013, CURR OPIN PULM MED, V19, P289, DOI 10.1097/MCP.0b013e32835eff08; Batrakova EV, 2011, EXPERT OPIN DRUG DEL, V8, P415, DOI 10.1517/17425247.2011.559457; Bhandari R., 2012, J CHROMATOGR SEP TEC, V03, P128, DOI DOI 10.4172/2157-7064.1000128; Calleja I, 2004, J CHROMATOGR A, V1031, P289, DOI 10.1016/j.chroma.2003.12.041; CLARK SC, 1989, ANN NY ACAD SCI, V557, P438; CLEMENS DL, 1995, J EXP MED, V181, P257, DOI 10.1084/jem.181.1.257; Clift MJD, 2008, TOXICOL APPL PHARM, V232, P418, DOI 10.1016/j.taap.2008.06.009; Cooper AM, 2011, MUCOSAL IMMUNOL, V4, P252, DOI 10.1038/mi.2011.13; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; CROWLE AJ, 1991, INFECT IMMUN, V59, P1823, DOI 10.1128/IAI.59.5.1823-1831.1991; de Faria TJ, 2012, ANTIMICROB AGENTS CH, V56, P2259, DOI 10.1128/AAC.05993-11; Dou H, 2006, BLOOD, V108, P2827, DOI 10.1182/blood-2006-03-012534; Dube D, 2012, DRUG DISCOV TODAY, V17, P760, DOI 10.1016/j.drudis.2012.03.012; Dye C, 2006, LANCET, V367, P938, DOI 10.1016/S0140-6736(06)68384-0; Edagwa B, 2013, BIOORG MED CHEM LETT, V23, P6138, DOI 10.1016/j.bmcl.2013.09.011; Ehlers S, 2009, INFECTION, V37, P87, DOI 10.1007/s15010-009-8450-7; El-Sadr WM, 2001, CLIN INFECT DIS, V32, P623, DOI 10.1086/318706; Eoh H, 2009, CHEM BIOL, V16, P1230, DOI 10.1016/j.chembiol.2009.10.014; GENDELMAN HE, 1989, AIDS, V3, P475, DOI 10.1097/00002030-198908000-00001; GENDELMAN HE, 1988, J EXP MED, V167, P1428, DOI 10.1084/jem.167.4.1428; Getahun H, 2010, CLIN INFECT DIS, V50, pS201, DOI 10.1086/651492; Gupta R, 2001, SCIENCE, V293, P1049, DOI 10.1126/science.1061861; HART PD, 1987, J EXP MED, V166, P933, DOI 10.1084/jem.166.4.933; Hearn MJ, 2009, EUR J MED CHEM, V44, P4169, DOI 10.1016/j.ejmech.2009.05.009; HONEYBOURNE D, 1994, THORAX, V49, P104, DOI 10.1136/thx.49.2.104; Kadiu I, 2011, NANOMEDICINE-UK, V6, P975, DOI [10.2217/NNM.11.27, 10.2217/nnm.11.27]; Kang PB, 2005, J EXP MED, V202, P987, DOI 10.1084/jem.20051239; KUMAR BD, 1992, J TROP MED HYG, V95, P424; Kurosu M, 2007, J MED CHEM, V50, P3973, DOI 10.1021/jm070638m; Lawn SD, 2011, LANCET, V378, P57, DOI 10.1016/S0140-6736(10)62173-3; Lei BF, 2000, J BIOL CHEM, V275, P2520, DOI 10.1074/jbc.275.4.2520; Lenaerts AJ, 2007, ANTIMICROB AGENTS CH, V51, P3338, DOI 10.1128/AAC.00276-07; Lienhardt C, 2012, NAT REV MICROBIOL, V10, P407, DOI 10.1038/nrmicro2797; Lillebaek T, 2003, J INFECT DIS, V188, P1032, DOI 10.1086/378240; MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063; Morgan J R, 1993, Respir Med, V87, P320, DOI 10.1016/0954-6111(93)90040-7; Narayanasamy P, 2010, CHEM BIOL, V17, P117, DOI 10.1016/j.chembiol.2010.01.013; Nowacek Ari, 2013, Methods Mol Biol, V991, P41, DOI 10.1007/978-1-62703-336-7_5; Nowacek AS, 2009, NANOMEDICINE-UK, V4, P903, DOI [10.2217/nnm.09.71, 10.2217/NNM.09.71]; Olakanmi O, 2000, INFECT IMMUN, V68, P5619, DOI 10.1128/IAI.68.10.5619-5627.2000; Pandey R, 2003, TUBERCULOSIS, V83, P373, DOI 10.1016/j.tube.2003.07.001; Pandey R, 2011, NANOMED-NANOTECHNOL, V7, P259, DOI 10.1016/j.nano.2011.01.009; Pawlowski A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002464; Philips JA, 2008, CELL MICROBIOL, V10, P2408, DOI 10.1111/j.1462-5822.2008.01239.x; Russell DG, 2010, SCIENCE, V328, P852, DOI 10.1126/science.1184784; Schaible UE, 2007, PLOS MED, V4, P806, DOI 10.1371/journal.pmed.0040115; SCHLESINGER LS, 1993, J IMMUNOL, V150, P2920; Shive MS, 1997, ADV DRUG DELIV REV, V28, P5; SMALL PLC, 1994, SCIENCE, V263, P637, DOI 10.1126/science.8303269; Smith I, 2003, CLIN MICROBIOL REV, V16, P463, DOI 10.1128/CMR.16.3.463-496.2003; Smith SJ, 1999, ANN PHARMACOTHER, V33, P27, DOI 10.1345/aph.18116; Sosnik A, 2010, ADV DRUG DELIVER REV, V62, P547, DOI 10.1016/j.addr.2009.11.023; STURGILLKOSZYCKI S, 1994, SCIENCE, V263, P678, DOI 10.1126/science.8303277; Venugopal J, 2008, CURR PHARM DESIGN, V14, P2184, DOI 10.2174/138161208785740180; Vilcheze C, 2007, ANNU REV MICROBIOL, V61, P35, DOI 10.1146/annurev.micro.61.111606.122346; Xu PS, 2009, MOL PHARMACEUT, V6, P190, DOI 10.1021/mp800137z; XU SM, 1994, J IMMUNOL, V153, P2568; Yager P, 2008, ANNU REV BIOMED ENG, V10, P107, DOI 10.1146/annurev.bioeng.10.061807.160524; Yu SS, 2012, INT J NANOMED, V7, P799, DOI 10.2147/IJN.S28531	61	28	28	0	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2014	28	12					5071	5082		10.1096/fj.14-255786	http://dx.doi.org/10.1096/fj.14-255786			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AU9EN	25122556	Green Published, Green Submitted			2022-12-25	WOS:000345894500005
J	Crisante, G; Battista, L; Iwaszkiewicz, J; Nesca, V; Merillat, AM; Sergi, C; Zoete, V; Frateschi, S; Hummler, E				Crisante, Giovanna; Battista, Laura; Iwaszkiewicz, Justyna; Nesca, Valeria; Merillat, Anne-Marie; Sergi, Chloe; Zoete, Vincent; Frateschi, Simona; Hummler, Edith			The CAP1/Prss8 catalytic triad is not involved in PAR2 activation and protease nexin-1 (PN-1) inhibition	FASEB JOURNAL			English	Article						serine protease; prostasin; enzymatic activity	THYMIC STROMAL LYMPHOPOIETIN; EPITHELIAL SODIUM-CHANNELS; STATISTICAL-MODEL; SERINE PROTEINASE; SERPIN STRUCTURE; HUMAN PROSTASIN; EXPRESSION; INFLAMMATION; MECHANISM; COMPLEX	Serine proteases, serine protease inhibitors, and protease-activated receptors (PARs) are responsible for several human skin disorders characterized by impaired epidermal permeability barrier function, desquamation, and inflammation. In this study, we addressed the consequences of a catalytically dead serine protease on epidermal homeostasis, the activation of PAR2 and the inhibition by the serine protease inhibitor nexin-1. The catalytically inactive serine protease CAP1/Prss8, when ectopically expressed in the mouse, retained the ability to induce skin disorders as well as its catalytically active counterpart (75%, n=81). Moreover, this phenotype was completely normalized in a PAR2-null background, indicating that the effects mediated by the catalytically inactive CAP1/Prss8 depend on PAR2 (95%, n=131). Finally, nexin-1 displayed analogous inhibitory capacity on both wild-type and inactive mutant CAP1/Prss8 in vitro and in vivo (64% n=151 vs. 89% n=109, respectively), indicating that the catalytic site of CAP1/Prss8 is dispensable for nexin-1 inhibition. Our results demonstrate a novel inhibitory interaction between CAP1/Prss8 and nexin-1, opening the search for specific CAP1/Prss8 antagonists that are independent of its catalytic activity.Crisante, G., Battista, L., Iwaszkiewicz, J., Nesca, V., Merillat, A.-M., Sergi, C., Zoete, V., Frateschi, S., Hummler, E. The CAP1/Prss8 catalytic triad is not involved in PAR2 activation and protease nexin-1 (PN-1) inhibition.	[Crisante, Giovanna; Battista, Laura; Nesca, Valeria; Merillat, Anne-Marie; Sergi, Chloe; Frateschi, Simona; Hummler, Edith] Univ Lausanne, Dept Pharmacol & Toxicol, Lausanne, Switzerland; [Iwaszkiewicz, Justyna; Zoete, Vincent] Univ Lausanne, Swiss Inst Bioinformat, Lausanne, Switzerland	University of Lausanne; Swiss Institute of Bioinformatics; University of Lausanne	Frateschi, S (corresponding author), Dept Pharmacol & Toxicol, Rue Bugnon 27, CH-1005 Lausanne, Switzerland.	simona.frateschi@unil.ch; edith.hummler@unil.ch		Iwaszkiewicz, Justyna/0000-0003-3494-589X; Battista, Laura/0000-0002-9370-6736	Swiss National Foundation [FNRS 31003A-127147/1, 31003A-144198/1]; Swiss National Center of Competence in Research (NCCR Kidney CH)	Swiss National Foundation(Swiss National Science Foundation (SNSF)); Swiss National Center of Competence in Research (NCCR Kidney CH)(Swiss National Science Foundation (SNSF))	The authors thank all of the members of the E.H. laboratory and Bernard Rossier for helpful discussions; Friedric Beermann and Denis Monard for critically reading the manuscript; Denis Monard (Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland) for providing the nexin-1 antibody; Nicole Fowler-Jaeger for excellent technical assistance with the Xenopus oocyte injections and measurements; Olivier Michielin for helpful discussion on bioinformatic approaches; and the facilities of the Mouse Pathology, Protein Analysis, Transgenic Animal, and Cellular Imaging platforms, University of Lausanne. This work was supported by the Swiss National Foundation (grants FNRS 31003A-127147/1 and 31003A-144198/1 to E. H.) and the Swiss National Center of Competence in Research (NCCR Kidney CH). Author contributions: G.C. and S.F. conducted most of the experiments, including phenotypic characterization of the transgenic lines; S.F. designed constructs and analyzed transgenic mice; J.I. and V.Z. performed and analyzed the bioinformatic data; L.B., A.M.M., V.N., and C.S. conducted and assisted in Xenopus oocyte injection, construct preparation, and immunofluorescence experiments; CC., S.F., and E.H. analyzed the data; S.F. and E.H. wrote the manuscript and conceived, designed, and supervised the study.	Adachi M, 2001, J AM SOC NEPHROL, V12, P1114, DOI 10.1681/ASN.V1261114; Andreasen D, 2006, J AM SOC NEPHROL, V17, P968, DOI 10.1681/ASN.2005060637; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Briot A, 2009, J EXP MED, V206, P1135, DOI 10.1084/jem.20082242; Camerer E, 2010, DEV CELL, V18, P25, DOI 10.1016/j.devcel.2009.11.014; Chen LM, 2001, J BIOL CHEM, V276, P21434, DOI 10.1074/jbc.M011423200; Chen LM, 2004, PROSTATE, V59, P1, DOI 10.1002/pros.10346; Chen MQ, 2007, BBA-MOL CELL RES, V1773, P1133, DOI 10.1016/j.bbamcr.2007.04.013; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; de Vries SJ, 2006, PROTEINS, V63, P479, DOI 10.1002/prot.20842; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; del Vescovo CD, 2013, MOL CELL BIOL, V33, P14, DOI 10.1128/MCB.00887-12; Ebner S, 2007, J ALLERGY CLIN IMMUN, V119, P982, DOI 10.1016/j.jaci.2007.01.003; Fayard B, 2009, CANCER RES, V69, P5690, DOI 10.1158/0008-5472.CAN-08-4573; Feutz AC, 2008, J CELL SCI, V121, P1435, DOI 10.1242/jcs.018689; Frateschi S, 2012, AM J PATHOL, V181, P605, DOI 10.1016/j.ajpath.2012.05.007; Frateschi S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1162; Friis S, 2013, J BIOL CHEM, V288, P19028, DOI 10.1074/jbc.M113.469932; GEERING K, 1989, AM J PHYSIOL, V257, pC851, DOI 10.1152/ajpcell.1989.257.5.C851; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Gohlke H, 2003, J MOL BIOL, V330, P891, DOI 10.1016/S0022-2836(03)00610-7; GUENTHER J, 1985, EMBO J, V4, P1963, DOI 10.1002/j.1460-2075.1985.tb03878.x; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Hummler E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055796; Huntington JA, 2011, J THROMB HAEMOST, V9, P26, DOI 10.1111/j.1538-7836.2011.04360.x; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Jensen PJ, 2000, J INVEST DERMATOL, V114, P917, DOI 10.1046/j.1523-1747.2000.00945.x; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Knauer MF, 1997, J BIOL CHEM, V272, P12261, DOI 10.1074/jbc.272.19.12261; Koyama K, 2007, BIOCHEM BIOPH RES CO, V357, P99, DOI 10.1016/j.bbrc.2007.03.081; Leyvraz C, 2005, J CELL BIOL, V170, P487, DOI 10.1083/jcb.200501038; Li W, 2012, BLOOD, V120, P459, DOI 10.1182/blood-2012-03-415869; Lindner JR, 2000, J IMMUNOL, V165, P6504, DOI 10.4049/jimmunol.165.11.6504; List K, 2005, GENE DEV, V19, P1934, DOI 10.1101/gad.1300705; Lopez-Otin C, 2002, NAT REV MOL CELL BIO, V3, P509, DOI 10.1038/nrm858; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Magert HJ, 2005, CURR PROTEIN PEPT SC, V6, P241, DOI 10.2174/1389203054065374; Malsure S, 2014, J AM SOC NEPHROL, V25, P1453, DOI 10.1681/ASN.2013090936; Melo F, 1997, J MOL BIOL, V267, P207, DOI 10.1006/jmbi.1996.0868; Murer V, 2001, P NATL ACAD SCI USA, V98, P3029, DOI 10.1073/pnas.051630698; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Netzel-Arnett S, 2006, J BIOL CHEM, V281, P32941, DOI 10.1074/jbc.C600208200; Peters DE, 2014, J BIOL CHEM, V289, P14740, DOI 10.1074/jbc.M113.541318; Planes C, 2005, AM J PHYSIOL-LUNG C, V288, pL1099, DOI 10.1152/ajplung.00332.2004; Planes C, 2010, EMBO MOL MED, V2, P26, DOI 10.1002/emmm.200900050; Porret Andree, 2006, V337, P185; Ramachandran R, 2012, NAT REV DRUG DISCOV, V11, P69, DOI 10.1038/nrd3615; Rickert KW, 2008, J BIOL CHEM, V283, P34864, DOI 10.1074/jbc.M805262200; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Soumelis V, 2004, SPRINGER SEMIN IMMUN, V25, P325, DOI 10.1007/s00281-003-0152-0; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Stout TJ, 2000, BIOCHEMISTRY-US, V39, P8460, DOI 10.1021/bi000290w; Tully DC, 2008, BIOORG MED CHEM LETT, V18, P5895, DOI 10.1016/j.bmcl.2008.08.029; Vallet V, 1997, NATURE, V389, P607, DOI 10.1038/39329; Verghese GM, 2004, AM J RESP CELL MOL, V30, P519, DOI 10.1165/rcmb.2003-0251OC; Vuagniaux G, 2002, J GEN PHYSIOL, V120, P191, DOI 10.1085/jgp.20028598; Wakida N, 2006, KIDNEY INT, V70, P1432, DOI 10.1038/sj.ki.5001787; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0; Wilson SR, 2013, CELL, V155, P285, DOI 10.1016/j.cell.2013.08.057; Ying S, 2005, J IMMUNOL, V174, P8183, DOI 10.4049/jimmunol.174.12.8183; YU JX, 1995, J BIOL CHEM, V270, P13483, DOI 10.1074/jbc.270.22.13483; YU JX, 1994, J BIOL CHEM, V269, P18843	65	8	8	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2014	28	11					4792	4805		10.1096/fj.14-253781	http://dx.doi.org/10.1096/fj.14-253781			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AS1OU	25138159				2022-12-25	WOS:000344050900018
J	Nielsen, RH; Couppe, C; Jensen, JK; Olsen, MR; Heinemeier, KM; Malfait, F; Symoens, S; De Paepe, A; Schjerling, P; Magnusson, SP; Remvig, L; Kjaer, M				Nielsen, Rie Harboe; Couppe, Christian; Jensen, Jacob Kildevang; Olsen, Morten Raun; Heinemeier, Katja Maria; Malfait, Fransiska; Symoens, Sofie; De Paepe, Anne; Schjerling, Peter; Magnusson, Stig Peter; Remvig, Lars; Kjaer, Michael			Low tendon stiffness and abnormal ultrastructure distinguish classic Ehlers-Danlos syndrome from benign joint hypermobility syndrome in patients	FASEB JOURNAL			English	Article						muscle; cauliflower fibrils; null-allele analysis	MECHANICAL-PROPERTIES; V COLLAGEN; COL5A1 HAPLOINSUFFICIENCY; VISCOELASTIC PROPERTIES; PATELLAR TENDON; PREVALENCE; FEATURES; ALLELES; KNEE; FORM	There is a clinical overlap between classic Ehlers-Danlos syndrome (cEDS) and benign joint hypermobility syndrome (BJHS), with hypermobility as the main symptom. The purpose of this study was to investigate the role of type V collagen mutations and tendon pathology in these 2 syndromes. In patients (cEDS, n=7; BJHS, n=8) and controls (Ctrl, n=8), we measured patellar tendon ultrastructure (transmission electron microscopy), dimensions (magnetic resonance imaging), and biomechanical properties (force and ultrasonographic measurements during a ramped isometric knee extension). Mutation analyses (COL5A1 and COL5A2) were performed in the patients. COL5A1 mutations were found in 3 of 4 of the patients with cEDS. Patellar tendon dimensions were similar between the groups, but large, irregular collagen fibrils were in 4 of 5 patients with cEDS. In the cEDS group, tendon stiffness and Young's modulus were reduced to approximate to 50% of that in BJHS and Ctrl groups (P<0.05). The nonhypermobile, healthy controls were matched with the patients in age, sex, body weight, and physical activity, to compare outcomes. COL5A1 mutations led to structural tendon pathology and low tendon stiffness in cEDS, explaining the patients' hypermobility, whereas no tendon pathology was found that explained the hypermobility in BJHS.Nielsen, R. H., Couppe, C., Jensen, J. K., Olsen, M. R., Heinemeier, K. M., Malfait, F., Symoens, S., De Paepe, A., Schjerling, P., Magnusson, S. P., Remvig, L., Kjaer, M. Low tendon stiffness and abnormal ultrastructure distinguish classic Ehlers-Danlos syndrome from benign joint hypermobility syndrome in patients.	[Nielsen, Rie Harboe; Jensen, Jacob Kildevang; Olsen, Morten Raun; Heinemeier, Katja Maria; Schjerling, Peter; Kjaer, Michael] Bispebjerg Hosp, Inst Sports Med, Dept Orthopaed Surg, DK-2400 Copenhagen NV, Denmark; [Couppe, Christian; Magnusson, Stig Peter] Bispebjerg Hosp, Dept Phys Therapy, Musculoskeletal Rehabil Res Unit, DK-2400 Copenhagen NV, Denmark; [Nielsen, Rie Harboe; Jensen, Jacob Kildevang; Olsen, Morten Raun; Heinemeier, Katja Maria; Schjerling, Peter; Kjaer, Michael] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [Malfait, Fransiska; Symoens, Sofie; De Paepe, Anne] Univ Hosp, Ctr Med Genet, Ghent, Belgium; [Remvig, Lars] Rigshosp, Dept Rheumatol, DK-2100 Copenhagen, Denmark	University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Ghent University; Ghent University Hospital; Rigshospitalet; University of Copenhagen	Nielsen, RH (corresponding author), Bispebjerg Hosp, Inst Sports Med, Bldg 8,Bispebjerg Bakke 23, DK-2400 Copenhagen NV, Denmark.	rieharboenielsen@gmail.com	Schjerling, Peter/F-6194-2011; Magnusson, S. Peter/AAD-5903-2022; Kjaer, Michael/W-6842-2019; Magnusson, Peter/AAN-1631-2020	Schjerling, Peter/0000-0001-7138-3211; Magnusson, S. Peter/0000-0002-4308-5484; Kjaer, Michael/0000-0002-4582-8755; Malfait, Fransiska/0000-0002-5010-0304; Jensen, Jacob Kildevang/0000-0002-5505-5944	Danish Rheumatism Association [R 108-A2458]; Ghent University [08/01M01108]; Fund for Scientific Research FWO, Flanders, Belgium [G.0171.05]; Lundbeck Foundation; Nordea Foundation; Novo Nordic Foundation; Novo Nordisk Fonden [NNF11OC1015388] Funding Source: researchfish	Danish Rheumatism Association; Ghent University(Ghent University); Fund for Scientific Research FWO, Flanders, Belgium(FWO); Lundbeck Foundation(Lundbeckfonden); Nordea Foundation; Novo Nordic Foundation(Novo Nordisk Foundation); Novo Nordisk Fonden(Novo Nordisk Foundation)	The authors thank C. Bojstrup for preparation of samples, and C. E. Hansen for excellent TEM assistance, and the patients and healthy volunteers for their participation in the study. This Work Was supported by the Danish Rheumatism Association (R 108-A2458), a Methusalem grant from Ghent University (grant 08/01M01108), the Fund for Scientific Research FWO, Flanders, Belgium (grant G.0171.05), the Lundbeck Foundation, the Nordea Foundation, and the Novo Nordic Foundation. The authors declare no conflicts of interest.	Beighton P, 1998, AM J MED GENET, V77, P31, DOI 10.1002/(SICI)1096-8628(19980428)77:1<31::AID-AJMG8>3.3.CO;2-P; BEIGHTON P, 1972, Seminars in Arthritis and Rheumatism, V1, P246, DOI 10.1016/0049-0172(72)90004-2; Bojsen-Moller J, 2007, SCAND J MED SCI SPOR, V17, P415, DOI 10.1111/j.1600-0838.2006.00591.x; Castori Marco, 2012, ISRN Dermatol, V2012, P751768, DOI 10.5402/2012/751768; Couppe C, 2009, J APPL PHYSIOL, V107, P880, DOI 10.1152/japplphysiol.00291.2009; Czika W, 2002, AM J HUM GENET, V71, P1235, DOI 10.1086/344290; Dalgleish R, 1998, NUCLEIC ACIDS RES, V26, P253, DOI 10.1093/nar/26.1.253; Decoster LC, 1997, ARCH PEDIAT ADOL MED, V151, P989, DOI 10.1001/archpedi.1997.02170470023005; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Grahame R, 2000, J RHEUMATOL, V27, P1777; Hansen P, 2006, CLIN BIOMECH, V21, P54, DOI 10.1016/j.clinbiomech.2005.07.008; HAUSSER I, 1994, HUM GENET, V93, P394; Iacono V, 2010, KNEE SURG SPORT TR A, V18, P1116, DOI 10.1007/s00167-009-1022-7; Kongsgaard M, 2011, CLIN BIOMECH, V26, P772, DOI 10.1016/j.clinbiomech.2011.02.011; LARSSON LG, 1993, BRIT J RHEUMATOL, V32, P116; Magnusson SP, 2003, ACTA PHYSIOL SCAND, V177, P185, DOI 10.1046/j.1365-201X.2003.01048.x; Magnusson SP, 2001, J RHEUMATOL, V28, P2720; Malfait F, 2005, HUM MUTAT, V25, P28, DOI 10.1002/humu.20107; Moretti Biagio, 2008, Chir Organi Mov, V91, P51, DOI 10.1007/s12306-007-0009-0; PALVOLGYI R, 1979, ARCH ORTHOP TRAUM SU, V95, P173, DOI 10.1007/BF00460115; Pierard GE, 2013, ISRN DERMATOL, V2013; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Reeves ND, 2003, MUSCLE NERVE, V28, P74, DOI 10.1002/mus.10392; Remvig L, 2010, SCAND J RHEUMATOL, V39, P511, DOI 10.3109/03009741003781977; Remvig L, 2009, SCAND J RHEUMATOL, V38, P227, DOI 10.1080/03009740802520714; Rombaut L, 2012, ARTHRIT CARE RES, V64, P766, DOI 10.1002/acr.21592; Schwarze U, 2000, AM J HUM GENET, V66, P1757, DOI 10.1086/302933; Sun M, 2011, J CELL SCI, V124, P4096, DOI 10.1242/jcs.091363; Symoens S, 2012, HUM MUTAT, V33, P1485, DOI 10.1002/humu.22137; Tinkle BT, 2009, AM J MED GENET A, V149A, P2368, DOI 10.1002/ajmg.a.33070; VISSER JJ, 1990, EUR J APPL PHYSIOL O, V61, P453, DOI 10.1007/BF00236067; VOGEL A, 1979, LAB INVEST, V40, P201; Wangkumhang P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-275; Wenstrup RJ, 2011, J BIOL CHEM, V286, P20455, DOI 10.1074/jbc.M111.223693; Wenstrup RJ, 2000, AM J HUM GENET, V66, P1766, DOI 10.1086/302930; Wenstrup RJ, 2006, J BIOL CHEM, V281, P12888, DOI 10.1074/jbc.M511528200; Wenstrup RJ, 2004, J BIOL CHEM, V279, P53331, DOI 10.1074/jbc.M409622200	37	36	36	2	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2014	28	11					4668	4676		10.1096/fj.14-249656	http://dx.doi.org/10.1096/fj.14-249656			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AS1OU	25122555				2022-12-25	WOS:000344050900008
J	Arnott, ER; Early, JB; Wade, CM; McGreevy, PD				Arnott, Elizabeth R.; Early, Jonathan B.; Wade, Claire M.; McGreevy, Paul D.			Environmental Factors Associated with Success Rates of Australian Stock Herding Dogs	PLOS ONE			English	Article							TRAINING METHODS; HOUSING CONDITIONS; CANINE WELFARE; WORKING DOG; BEHAVIOR; PERSONALITY; ABILITY; GUIDE; ENRICHMENT; CORTISOL	This study investigated the current management practices associated with stock herding dogs on Australian farms. A parallel goal was to determine whether these practices and the characteristics of the dog handlers were associated with success rates. Success rate refers to the proportion of dogs acquired by the farmer that were retained as working dogs. Data on a total of 4,027 dogs were obtained through The Farm Dog Survey which gathered information from 812 herding dog owners around Australia. Using logistic regression, significant associations were identified between success rate and seven variables: dog breed, housing method, trial participation, age of the dog at acquisition, electric collar use, hypothetical maximum treatment expenditure and the conscientiousness score of the owner's personality. These findings serve as a guide to direct further research into ways of optimising herding dog performance and welfare. They emphasise the importance of not only examining the genetic predispositions of the working dog but also the impact the handler can have on a dog's success in the workplace.	[Arnott, Elizabeth R.; Early, Jonathan B.; Wade, Claire M.; McGreevy, Paul D.] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia	University of Sydney	Arnott, ER (corresponding author), Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia.	Elizabeth.arnott@sydney.edu.au		McGreevy, Paul/0000-0001-7220-8378; Wade, Claire/0000-0003-3413-4771	Rural Industries Research and Development Corporation [PRJ 007 806]; Meat and Livestock Australia	Rural Industries Research and Development Corporation; Meat and Livestock Australia(Meat and Livestock Australia)	This study was supported by Rural Industries Research and Development Corporation, PRJ 007 806 (http://www.rirdc.gov.au/), to CMW PDM, and by Meat and Livestock Australia, (http://www.mla.com.au/) to CMW PDM. The funders assisted with data collection by promoting the survey to their contacts or on the websites. The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript.	ABS, 2012, AUSTR SOC TRENDS; Allan MF, 2008, MEAT SCI, V80, P79, DOI 10.1016/j.meatsci.2008.05.023; [Anonymous], 2008, WITHDR GUID DOGS; Arhant C, 2010, APPL ANIM BEHAV SCI, V123, P131, DOI 10.1016/j.applanim.2010.01.003; Arnott ER, 2014, ANIM WELFARE, V23, P189, DOI 10.7120/09627286.23.2.189; Arnott ER, 2014, ANIMAL WELF IN PRESS; Arvelius P, 2013, J ANIM BREED GENET, V130, P142, DOI 10.1111/jbg.12026; Arvelius P, 2012, J VET BEHAV CLIN APP; Bakker DM, 2005, AUST J SOIL RES, V43, P575, DOI 10.1071/SR03118; Barnett JL, 1997, AUST J AGR RES, V48, P385, DOI 10.1071/A96102; BARRICK MR, 1991, PERS PSYCHOL, V44, P1, DOI 10.1111/j.1744-6570.1991.tb00688.x; Batt LS, 2008, J VET BEHAV, V3, P143, DOI 10.1016/j.jveb.2008.04.003; Beerda B, 1999, PHYSIOL BEHAV, V66, P233, DOI 10.1016/S0031-9384(98)00289-3; Ben Alexander M, 2011, APPL ANIM BEHAV SCI, V132, P152, DOI 10.1016/j.applanim.2011.04.008; Blackwell EJ, 2012, BMC VET RES, P8; Blackwell EJ, 2008, J VET BEHAV, V3, P207, DOI 10.1016/j.jveb.2007.10.008; Branson N., 2009, AUSTR WORKING DOG SU; Broderick S, 2011, BRIT FOOD J, V113, P1217, DOI 10.1108/00070701111177656; COSTA PT, 1992, J PERS DISORD, V6, P343, DOI 10.1521/pedi.1992.6.4.343; Courreau JF, 2005, APPL ANIM BEHAV SCI, V91, P233, DOI 10.1016/j.applanim.2004.09.003; Evans RI, 2007, JAVMA-J AM VET MED A, V231, P1215, DOI 10.2460/javma.231.8.1215; FAO, 2021, 4081 FAO, P67; FOX MW, 1965, LAB ANIM CARE, V15, P363; Gaines SA, 2008, J FORENSIC SCI, V53, P1400, DOI 10.1111/j.1556-4029.2008.00879.x; Gedye J., 2000, TRAINING NOTES FARME; GODDARD ME, 1982, THEOR APPL GENET, V62, P97, DOI 10.1007/BF00293339; Hampson B. A., 2007, Equine and Comparative Exercise Physiology, V4, P37, DOI 10.1017/S1478061507772006; Haverbeke A, 2008, APPL ANIM BEHAV SCI, V113, P110, DOI 10.1016/j.applanim.2007.11.010; HETTS S, 1992, APPL ANIM BEHAV SCI, V34, P137, DOI 10.1016/S0168-1591(05)80063-2; Hiby EF, 2004, ANIM WELFARE, V13, P63; HOFSTEE WKB, 1992, J PERS SOC PSYCHOL, V63, P146, DOI 10.1037/0022-3514.63.1.146; Horvath Z, 2008, HORM BEHAV, V54, P107, DOI 10.1016/j.yhbeh.2008.02.002; HUBRECHT RC, 1992, APPL ANIM BEHAV SCI, V34, P365, DOI 10.1016/S0168-1591(05)80096-6; Keating BA, 2010, CROP PASTURE SCI, V61, P269, DOI 10.1071/CP09282; Kis A, 2012, INTERACT STUD, V13, P373, DOI 10.1075/is.13.3.03kis; Lefebvre D, 2007, APPL ANIM BEHAV SCI, V104, P49, DOI 10.1016/j.applanim.2006.05.004; Lefebvre D, 2009, J ETHOL, V27, P255, DOI 10.1007/s10164-008-0114-z; Love SB, 2010, COMP EXERC PHYSIOL, V7, P109, DOI 10.1017/S1755254010000310; Maejima M, 2007, APPL ANIM BEHAV SCI, V107, P287, DOI 10.1016/j.applanim.2006.10.005; McGreevy P, 2005, CARROTS STICKS PRINC; McGreevy P.D., 2009, MODERN DOGS LIFE; McNair Ingenuity Research Pty Ltd, 2012, QUANT AGR READ SURV; Morales LE, 2013, MEAT SCI, V94, P239, DOI 10.1016/j.meatsci.2013.02.005; Overall KL, 2012, WHAT DO WE REALLY KN; Parsons AD., 2010, KELPIE; Paulhus DL, 2002, ROLE OF CONSTRUCTS IN PYSCHOLOGICAL AND EDUCATIONAL MEASUREMENT, P49; Phillips CJC, 2005, AUST VET J, V83, P558, DOI 10.1111/j.1751-0813.2005.tb13336.x; Polkinghorne RJ, 2010, MEAT SCI, V86, P227, DOI 10.1016/j.meatsci.2010.05.010; Rammstedt B, 2007, J RES PERS, V41, P203, DOI 10.1016/j.jrp.2006.02.001; Rooney N, 2009, J VET BEHAV, V4, P127, DOI 10.1016/j.jveb.2008.10.037; Rooney NJ, 2007, APPL ANIM BEHAV SCI, V103, P90, DOI 10.1016/j.applanim.2006.03.016; Rooney NJ, 2011, APPL ANIM BEHAV SCI, V132, P169, DOI 10.1016/j.applanim.2011.03.007; Salgirli Y, 2012, REV MED VET-TOULOUSE, V163, P530; Sanders CR, 2006, J CONTEMP ETHNOGR, V35, P148, DOI 10.1177/0891241605283456; Saucier G, 1999, J PERS SOC PSYCHOL, V76, P613, DOI 10.1037/0022-3514.76.4.613; Schmutz SM, 1998, J HERED, V89, P233, DOI 10.1093/jhered/89.3.233; SELIGMAN ME, 1972, ANNU REV MED, V23, P407, DOI 10.1146/annurev.me.23.020172.002203; Shiner RL, 2012, DEV PSYCHOPATHOL, V24, P507, DOI 10.1017/S0954579412000120; Stafford K, 2012, VET J, V192, P257, DOI 10.1016/j.tvjl.2012.02.007; Taylor KD, 2007, ANIM WELFARE, V16, P435; [Victorian Government Department of Environment and Primary Industries Industries DoEaP], 2013, COD PRACT OP BREED R; Vincent IC, 1997, VET J, V153, P179, DOI 10.1016/S1090-0233(97)80038-X; Wells AED, 2011, J AGR ENVIRON ETHIC, V24, P645, DOI 10.1007/s10806-010-9284-0; Wilkie R, 2005, J RURAL STUD, V21, P213, DOI 10.1016/j.jrurstud.2004.10.002; Yeon S. C., 2001, Journal of Applied Animal Welfare Science, V4, P257, DOI 10.1207/S15327604JAWS0404_03	65	21	21	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e104457	10.1371/journal.pone.0104457	http://dx.doi.org/10.1371/journal.pone.0104457			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN6XM	25136828	Green Published, gold			2022-12-25	WOS:000340742100037
J	Fellet, MR; Lorenzo, MG; Elliot, SL; Carrasco, D; Guarneri, AA				Fellet, Maria Raquel; Lorenzo, Marcelo Gustavo; Elliot, Simon Luke; Carrasco, David; Guarneri, Alessandra Aparecida			Effects of Infection by Trypanosoma cruzi and Trypanosoma rangeli on the Reproductive Performance of the Vector Rhodnius prolixus	PLOS ONE			English	Article							TRIATOMA-INFESTANS; FEEDING-BEHAVIOR; BLOOD MEAL; LIPOPHORIN; PARASITE; TRANSMISSION; BRASILIENSIS; HEMIPTERA; PATTERNS; MANIPULATION	The insect Rhodnius prolixus is responsible for the transmission of Trypanosoma cruzi, which is the etiological agent of Chagas disease in areas of Central and South America. Besides this, it can be infected by other trypanosomes such as Trypanosoma rangeli. The effects of these parasites on vectors are poorly understood and are often controversial so here we focussed on possible negative effects of these parasites on the reproductive performance of R. prolixus, specifically comparing infected and uninfected couples. While T. cruzi infection did not delay pre-oviposition time of infected couples at either temperature tested (25 and 30 degrees C) it did, at 25 degrees C, increase the e-value in the second reproductive cycle, as well as hatching rates. Meanwhile, at 30 degrees C, T. cruzi infection decreased the e-value of insects during the first cycle and also the fertility of older insects. When couples were instead infected with T. rangeli, pre-oviposition time was delayed, while reductions in the e-value and hatching rate were observed in the second and third cycles. We conclude that both T. cruzi and T. rangeli can impair reproductive performance of R. prolixus, although for T. cruzi, this is dependent on rearing temperature and insect age. We discuss these reproductive costs in terms of potential consequences on triatomine behavior and survival.	[Fellet, Maria Raquel; Lorenzo, Marcelo Gustavo; Guarneri, Alessandra Aparecida] Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Vector Behav & Pathogen Interact Grp, Belo Horizonte, MG, Brazil; [Elliot, Simon Luke] Univ Fed Vicosa, Dept Entomol, Vicosa, MG, Brazil; [Carrasco, David] Swedish Univ Agr Sci, Dept Plant Protect Biol, Unit Chem Ecol, Alnarp, Sweden	Fundacao Oswaldo Cruz; Universidade Federal de Vicosa; Swedish University of Agricultural Sciences	Guarneri, AA (corresponding author), Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Vector Behav & Pathogen Interact Grp, Belo Horizonte, MG, Brazil.	guarneri@cpqrr.fiocruz.br	Elliot, Simon Luke/A-5557-2013; Lorenzo, Marcelo Gustavo/V-3951-2019; Carrasco, David/G-1883-2017; guarneri, Alessandra A/I-4124-2012; Carvalho, Claudine/J-6347-2014; Lorenzo, Marcelo Gustavo/R-1301-2018	Elliot, Simon Luke/0000-0002-7469-2949; Lorenzo, Marcelo Gustavo/0000-0002-4000-5514; Carrasco, David/0000-0003-1375-2562; Lorenzo, Marcelo Gustavo/0000-0002-4000-5514; Guarneri, Alessandra Aparecida/0000-0002-9162-2731	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Instituto Nacional de Ciencia e Tecnologia em Entomologia Molecular; Fundacao Oswaldo Cruz/Centro de Pesquisas Rene Rachou; Programa Estrategico de Apoio a Pesquisa em Saude	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencia e Tecnologia em Entomologia Molecular; Fundacao Oswaldo Cruz/Centro de Pesquisas Rene Rachou; Programa Estrategico de Apoio a Pesquisa em Saude	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (AAG), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (AAG and MGL), Instituto Nacional de Ciencia e Tecnologia em Entomologia Molecular (AAG and MGL), Fundacao Oswaldo Cruz/Centro de Pesquisas Rene Rachou (MRF, AAG and MGL) and Programa Estrategico de Apoio a Pesquisa em Saude (AAG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFCHAIN D, 1979, J PARASITOL, V65, P507, DOI 10.2307/3280312; ANEZ N, 1984, ACTA TROP, V41, P93; ANEZ N, 1984, Memorias do Instituto Oswaldo Cruz, V79, P249, DOI 10.1590/S0074-02761984000200012; Araujo RV, 2011, J INSECT PHYSIOL, V57, P265, DOI 10.1016/j.jinsphys.2010.11.016; ASIN S, 1992, MEM I OSWALDO CRUZ, V87, P369, DOI 10.1590/S0074-02761992000300006; Atella GC, 2005, AN ACAD BRAS CIENC, V77, P405, DOI 10.1590/S0001-37652005000300005; Bates D., 2015, LINEAR MIXED EFFECTS, V67, P1, DOI 10.18637/jss.v067.i01; Botto-Mahan C, 2008, PHYSIOL ENTOMOL, V33, P25, DOI 10.1111/j.1365-3032.2007.00596.x; Brecher G., 1944, PARASITOLOGY, V35, P220, DOI 10.1017/S0031182000021648; BRENER Z, 1963, Rev Inst Med Trop Sao Paulo, V5, P220; Cheon HM, 2006, J BIOL CHEM, V281, P8426, DOI 10.1074/jbc.M510957200; COPPENS I, 1995, J BIOL CHEM, V270, P5736, DOI 10.1074/jbc.270.11.5736; COPPENS I, 1995, MOL BIOCHEM PARASIT, V73, P179, DOI 10.1016/0166-6851(95)00114-G; d'Alessandro A., 1976, P327; Daflon-Teixeira NF, 2009, MEM I OSWALDO CRUZ, V104, P1031, DOI 10.1590/S0074-02762009000700016; DAVEY K G, 1987, Memorias do Instituto Oswaldo Cruz, V82, P103, DOI 10.1590/S0074-02761987000700020; de Moraes MH, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-20; De Rosario-Martinez H, 2013, PHIA POSTHOC INTERAC; Dettloff M, 2001, CELL TISSUE RES, V306, P449, DOI 10.1007/s00441-001-0468-9; Eichler S, 1998, J INSECT PHYSIOL, V44, P131, DOI 10.1016/S0022-1910(97)00095-4; Eichler S, 2002, EXP PARASITOL, V100, P17, DOI 10.1006/expr.2001.4653; Elliot SL, 2003, ECOLOGY, V84, P2568, DOI 10.1890/02-8013; Ferguson HM, 2002, TRENDS PARASITOL, V18, P256, DOI 10.1016/S1471-4922(02)02281-X; Ferreira LL, 2010, J INVERTEBR PATHOL, V105, P91, DOI 10.1016/j.jip.2010.05.013; Folly E, 2003, BIOCHEM BIOPH RES CO, V310, P555, DOI 10.1016/j.bbrc.2003.09.038; Garcia ES, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-105; GONDIM KC, 1989, J INSECT PHYSIOL, V35, P19, DOI 10.1016/0022-1910(89)90032-2; GREWAL MANOHAR SINGH, 1957, EXPTL PARASITOL, V6, P123, DOI 10.1016/0014-4894(57)90010-3; GRIMSTAD PR, 1980, J MED ENTOMOL, V17, P1, DOI 10.1093/jmedent/17.1.1; Guarneri AA, 2000, J MED ENTOMOL, V37, P373, DOI 10.1603/0022-2585(2000)037[0373:IOTBMS]2.0.CO;2; Guedes RNC, 2014, PEST MANAG SCI, V70, P690, DOI 10.1002/ps.3669; Hashimoto K, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-45; Hurd H., 1990, Advances in Parasitology, V29, P271, DOI 10.1016/S0065-308X(08)60108-6; Hurd H, 2001, TRENDS PARASITOL, V17, P363, DOI 10.1016/S1471-4922(01)01927-4; Kollien AH, 1998, ACTA TROP, V70, P127, DOI 10.1016/S0001-706X(97)00117-4; Kollien AH, 1998, J EUKARYOT MICROBIOL, V45, P59, DOI 10.1111/j.1550-7408.1998.tb05070.x; LAKE P, 1967, P ENTOMOL SOC ONT, V98, P53; Lambrechts L, 2009, P R SOC B, V276, P1369, DOI 10.1098/rspb.2008.1709; LENT H, 1979, B AM MUS NAT HIST, V163, P127; LIMA MM, 1992, ANN ENTOMOL SOC AM, V85, P458, DOI 10.1093/aesa/85.4.458; Lima-Camara TN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017690; Machado EA, 1996, ARCH INSECT BIOCHEM, V31, P185, DOI 10.1002/(SICI)1520-6327(1996)31:2&lt;185::AID-ARCH6&gt;3.0.CO;2-Z; NEVES D P, 1975, Revista Brasileira de Biologia, V35, P317; Nouvellet P, 2011, INFECT GENET EVOL, V11, P1243, DOI 10.1016/j.meegid.2011.04.008; ODALY JA, 1994, ACTA TROP, V56, P265, DOI 10.1016/0001-706X(94)90099-X; Oliveira TG, 2010, MEM I OSWALDO CRUZ, V105, P1057, DOI 10.1590/S0074-02762010000800018; Paul KS, 2003, TRENDS PARASITOL, V8, P381; Pinheiro J, 2016, NLME LINEAR NONLINEA, DOI DOI 10.1016/S0006-3207(01)00201-4; R Core Team, 2021, R LANG ENV STAT COMP; Ramirez-Sierra MJ, 2010, TROP MED INT HEALTH, V15, P77, DOI 10.1111/j.1365-3156.2009.02422.x; Rogers ME, 2007, PLOS PATHOG, V3, P818, DOI 10.1371/journal.ppat.0030091; SCHAUB GA, 1986, ACTA TROP, V43, P349; SCHAUB GA, 1988, T ROY SOC TROP MED H, V82, P94, DOI 10.1016/0035-9203(88)90273-8; Schilman PE, 2004, ACTA TROP, V90, P115, DOI 10.1016/j.actatropica.2003.11.006; SCHLEIN Y, 1992, P NATL ACAD SCI USA, V89, P9944, DOI 10.1073/pnas.89.20.9944; Schofield CJ, 2009, ACTA TROP, V110, P88, DOI 10.1016/j.actatropica.2009.01.010; Schofield CJ, 1994, TRIATOMINAEBIOLOGY C; SCHOTTELIUS J, 1987, TROP MED PARASITOL, V38, P323; Sylvestre G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059933; TOBIE EJ, 1965, J PARASITOL, V51, P837, DOI 10.2307/3276172; TOBIE EJ, 1970, J INVERTEBR PATHOL, V15, P118, DOI 10.1016/0022-2011(70)90106-0; Valle D, 1995, MEM I O CRUZ, V88, P1; VALLEJO GA, 1986, REV BIOL TROP, V34, P75; Vial HJ, 2003, MOL BIOCHEM PARASIT, V126, P143, DOI 10.1016/S0166-6851(02)00281-5; WATKINS R, 1971, J INVERTEBR PATHOL, V17, P59, DOI [10.1016/0022-2011(71)90126-1, 10.1016/0022-2011(71)90127-3]; ZELEDON R, 1970, J MED ENTOMOL, V7, P462, DOI 10.1093/jmedent/7.4.462; Zingales B, 2009, MEM I OSWALDO CRUZ, V104, P1051, DOI 10.1590/S0074-02762009000700021	67	47	48	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105255	10.1371/journal.pone.0105255	http://dx.doi.org/10.1371/journal.pone.0105255			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136800	Green Published, Green Submitted, gold			2022-12-25	WOS:000340742100081
J	Harasti, D; Martin-Smith, K; Gladstone, W				Harasti, David; Martin-Smith, Keith; Gladstone, William			Does a No-Take Marine Protected Area Benefit Seahorses?	PLOS ONE			English	Article							LIFE-HISTORY; FISH ASSEMBLAGES; HIPPOCAMPUS-COMES; ARTISANAL FISHERY; REEF FISH; RESERVES; CONSERVATION; MANAGEMENT; ABUNDANCE; BEHAVIOR	Seahorses are iconic charismatic species that are often used to 'champion' marine conservation causes around the world. As they are threatened in many countries by over-exploitation and habitat loss, marine protected areas (MPAs) could help with their protection and recovery. MPAs may conserve seahorses through protecting essential habitats and removing fishing pressures. Populations of White's seahorse, Hippocampus whitei, a species endemic to New South Wales, Australia, were monitored monthly from 2006 to 2009 using diver surveys at two sites within a no-take marine protected areas established in 1983, and at two control sites outside the no-take MPA sites. Predators of H. whitei were also identified and monitored. Hippocampus whitei were more abundant at the control sites. Seahorse predators (3 species of fish and 2 species of octopus) were more abundant within the no-take MPA sites. Seahorse and predator abundances were negatively correlated. Substantial variability in the seahorse population at one of the control sites reinforced the importance of long-term monitoring and use of multiple control sites to assess the outcomes of MPAs for seahorses. MPAs should be used cautiously to conserve seahorse populations as there is the risk of a negative impact through increased predator abundance.	[Harasti, David] NSW Dept Primary Ind, Nelson Bay, NSW, Australia; [Martin-Smith, Keith] Univ Tasmania, Sch Zool, Hobart, Tas, Australia; [Gladstone, William] Univ Technol Sydney, Sch Environm, Sydney, NSW 2007, Australia	NSW Department of Primary Industries; University of Tasmania; University of Technology Sydney	Harasti, D (corresponding author), NSW Dept Primary Ind, Nelson Bay, NSW, Australia.	david.harasti@dpi.nsw.gov.au	Harasti, David/I-1266-2019	Harasti, David/0000-0002-2851-9838; Gladstone, William/0000-0003-4517-4605				Agardy T, 2003, AQUAT CONSERV, V13, P353, DOI 10.1002/aqc.583; Allison GW, 1998, ECOL APPL, V8, pS79, DOI 10.1890/1051-0761(1998)8[S79:MRANBN]2.0.CO;2; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], 2013, 2013 IUCN RED LIST T; Ashworth JS, 2005, BIOL CONSERV, V121, P333, DOI 10.1016/j.biocon.2004.05.006; Babcock RC, 2010, P NATL ACAD SCI USA, V107, P18256, DOI 10.1073/pnas.0908012107; Babcock RC, 1999, MAR ECOL PROG SER, V189, P125, DOI 10.3354/meps189125; Barrett NS, 2007, J EXP MAR BIOL ECOL, V345, P141, DOI 10.1016/j.jembe.2007.02.007; Bassett DK, 2008, MAR FRESHWATER RES, V59, P1079, DOI 10.1071/MF08036; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Caldwell IR, 2012, AQUAT CONSERV, V22, P427, DOI 10.1002/aqc.2238; Currie JC, 2012, AFR J MAR SCI, V34, P269, DOI 10.2989/1814232X.2012.709963; Curtis JMR, 2007, AQUAT CONSERV, V17, P468, DOI 10.1002/aqc.798; Curtis JMR, 2006, J FISH BIOL, V68, P707, DOI 10.1111/j.0022-1112.2006.00952.x; DPI N, 2013, SPEC COMM RECR SALTW; DPI N, 2005, SEACH THEOR REL; Edgar GJ, 2009, ECOL APPL, V19, P1967, DOI 10.1890/09-0610.1; Edgar GJ, 2009, MAR ECOL PROG SER, V388, P51, DOI 10.3354/meps08149; Foster SJ, 2005, CONSERV BIOL, V19, P1044, DOI 10.1111/j.1523-1739.2005.00192.x; Foster SJ, 2004, J FISH BIOL, V65, P1, DOI 10.1111/j.0022-1112.2004.00429.x; Gotz A, 2009, AFR J MAR SCI, V31, P241, DOI 10.2989/AJMS.2009.31.2.12.884; Graham NAJ, 2003, ENVIRON CONSERV, V30, P200, DOI 10.1017/S0376892903000195; Harasti D, 2014, J FISH BIOL, V85, P1413, DOI 10.1111/jfb.12492; Harasti D, 2013, J FISH BIOL, V83, P1344, DOI 10.1111/jfb.12237; Harasti D, 2012, J FISH BIOL, V81, P1297, DOI 10.1111/j.1095-8649.2012.03406.x; Harasti D, 2010, AQUAT CONSERV, V20, P159, DOI 10.1002/aqc.1066; Hutchings JA, 2010, CAN J FISH AQUAT SCI, V67, P1205, DOI 10.1139/F10-081; Kingsford M., 1998, STUDYING TEMPERATE M; Kleiber D, 2011, REV FISH BIOL FISHER, V21, P205, DOI 10.1007/s11160-010-9167-5; Kramer AM, 2009, POPUL ECOL, V51, P341, DOI 10.1007/s10144-009-0152-6; Kuiter R. H., 2009, SEAHORSES THEIR RELA; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; Marcus JE, 2007, MAR POLLUT BULL, V54, P1483, DOI 10.1016/j.marpolbul.2007.04.011; Martin-Smith KM, 2005, BIOL CONSERV, V123, P533, DOI 10.1016/j.biocon.2005.01.003; Martin-Smith KM, 2004, OCEAN COAST MANAGE, V47, P165, DOI 10.1016/j.ocecoaman.2004.02.002; McClenachan L, 2010, CONSERV LETT, V5, P73; Mislan KAS, 2008, MAR FRESHWATER RES, V59, P246, DOI 10.1071/MF07116; Morgan SK, 2007, J FISH BIOL, V71, P701, DOI 10.1111/j.1095-8649.2007.01535.x; Morgan SK, 2013, MAR FRESHWATER RES, V64, P185, DOI 10.1071/MF12171; Perante NC, 2002, J FISH BIOL, V60, P821, DOI 10.1006/jfbi.2002.1878; Roberts CM, 2001, SCIENCE, V294, P1920, DOI 10.1126/science.294.5548.1920; Samoilys MA, 2007, BIOL CONSERV, V136, P584, DOI 10.1016/j.biocon.2007.01.003; Scales H, 2009, POSEIDONS STEED STOR; Schmid MS, 2002, VIE MILIEU, V52, P201; Shears NT, 2008, ECOL APPL, V18, P1860, DOI 10.1890/07-1776.1; Shokri MR, 2009, AQUAT CONSERV, V19, P588, DOI 10.1002/aqc.1009; Vincent ACJ, 2011, J FISH BIOL, V78, P1681, DOI 10.1111/j.1095-8649.2011.03003.x; Vincent ACJ, 2005, ENVIRON BIOL FISH, V72, P1, DOI 10.1007/s10641-004-4192-7; Vincent ACJ, 2007, FISH RES, V86, P207, DOI 10.1016/j.fishres.2007.06.006; Watson DL, 2007, MAR BIOL, V152, P1197, DOI 10.1007/s00227-007-0767-0; Watson DL, 2009, MAR ECOL PROG SER, V384, P241, DOI 10.3354/meps08009; Williamson DH, 2004, ENVIRON CONSERV, V31, P149, DOI 10.1017/S0376892904001262; Willis TJ, 2003, MAR ECOL PROG SER, V257, P209, DOI 10.3354/meps257209; Willis TJ, 2003, J APPL ECOL, V40, P214, DOI 10.1046/j.1365-2664.2003.00775.x; Yasue M, 2012, ENVIRON CONSERV, V39, P183, DOI 10.1017/S0376892911000622	55	31	33	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105462	10.1371/journal.pone.0105462	http://dx.doi.org/10.1371/journal.pone.0105462			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137253	gold, Green Published, Green Submitted			2022-12-25	WOS:000340742100097
J	Kocsi, S; Demeter, G; Erces, D; Kaszaki, J; Molnar, Z				Kocsi, Szilvia; Demeter, Gabor; Erces, Daniel; Kaszaki, Jozsef; Molnar, Zsolt			Central Venous-To-Arterial CO2-Gap May Increase in Severe Isovolemic Anemia	PLOS ONE			English	Article							OXYGEN-SATURATION; PCO2 DIFFERENCE; TRANSFUSION; LACTATE; INJURY; SHOCK; CO2	Despite blood transfusions are administered to restore adequate tissue oxygenation, transfusion guidelines consider only hemoglobin as trigger value, which gives little information about the balance between oxygen delivery and consumption. Central venous oxygen saturation is an alternative, however its changes reflect systemic metabolism and fail to detect regional hypoxia. A complementary parameter to ScvO(2) may be central venous-to-arterial carbon dioxide difference (CO2-gap). Our aim was to investigate the change of alternative transfusion trigger values in experimental isovolemic anemia. After splenectomy, anesthetized Vietnamese mini pigs (n = 13, weight range: 18-30 kg) underwent controlled bleeding in five stages (T-1-T-5). During each stage approximately 10% of the estimated starting total blood volume was removed and immediately replaced with an equal volume of colloid. Hemodynamic measurements and blood gas analysis were then performed. Each stage of bleeding resulted in a significant fall in hemoglobin, the O-2-extraction increased significantly from T-3 and ScvO(2) showed a similar pattern and dropped below the physiological threshold of 70% at T-4. By T4 CO2-gap increased significantly and well correlated with VO2/DO2 and ScvO(2). To our knowledge, this is the first study to show that anemia caused altered oxygen extraction may have an effect on CO2-gap.	[Kocsi, Szilvia; Demeter, Gabor; Molnar, Zsolt] Univ Szeged, Dept Anaesthesiol & Intens Therapy, Szeged, Hungary; [Kocsi, Szilvia] Hungarian Def Forces Mil Hosp, Dept Anaesthesiol & Intens Therapy, Budapest, Hungary; [Erces, Daniel; Kaszaki, Jozsef] Univ Szeged, Inst Surg Res, Szeged, Hungary	Szeged University; Szeged University	Kocsi, S (corresponding author), Univ Szeged, Dept Anaesthesiol & Intens Therapy, Szeged, Hungary.	kocsi.szilvia@gmail.com						Adamczyk S, 2009, ANN FR ANESTH, V28, P522, DOI 10.1016/j.annfar.2009.03.013; Gallagher CN, 2009, BRAIN, V132, P2839, DOI 10.1093/brain/awp202; Galvin I, 2011, ANN UPD INTENS CARE, P117; Geers C, 2000, PHYSIOL REV, V80, P681, DOI 10.1152/physrev.2000.80.2.681; Guyton AC, 2006, TXB MED PHYSL, P502; Hare GMT, 2007, J APPL PHYSIOL, V103, P1021, DOI 10.1152/japplphysiol.01315.2006; Jalloh I, 2013, J NEUROTRAUM, V30, P2031, DOI 10.1089/neu.2013.2947; Kocsi S, 2012, ACTA ANAESTH SCAND, V56, P291, DOI 10.1111/j.1399-6576.2011.02622.x; Lamia B, 2006, MINERVA ANESTESIOL, V72, P597; Maddirala S, 2010, CRIT CARE CLIN, V26, P323, DOI 10.1016/j.ccc.2009.12.006; Marino PL, 2014, ICU BOOK, P171; Mekontso-Dessap A, 2002, INTENS CARE MED, V28, P272, DOI 10.1007/s00134-002-1215-8; Meletti José Fernando Amaral, 2003, Rev. Bras. Anestesiol., V53, P623, DOI 10.1590/S0034-70942003000500009; Phillips CR, 2009, CRIT CARE, V13, DOI 10.1186/cc7736; Retter A, 2013, BRIT J HAEMATOL, V160, P445, DOI 10.1111/bjh.12143; SCHLICHTIG R, 1994, J APPL PHYSIOL, V76, P2443, DOI 10.1152/jappl.1994.76.6.2443; Vallee F, 2008, INTENS CARE MED, V34, P2218, DOI 10.1007/s00134-008-1199-0; Vallet B, 2000, J APPL PHYSIOL, V89, P1317, DOI 10.1152/jappl.2000.89.4.1317; Vallet B, 2010, CRIT CARE, V14, DOI 10.1186/cc8854; Vincent JL, 2006, CRIT CARE MED, V34, pS96, DOI 10.1097/01.CCM.0000214314.57109.CD; West JB, 1990, RESP PHYSL ESSENTIAL, P69; Westbrook A, 2010, INTENS CARE MED, V36, P1138, DOI 10.1007/s00134-010-1867-8	22	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105148	10.1371/journal.pone.0105148	http://dx.doi.org/10.1371/journal.pone.0105148			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137377	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000340742100071
J	Lindquist, E; Alezzawi, M; Aronsson, H				Lindquist, Emelie; Alezzawi, Mohamed; Aronsson, Henrik			Bioinformatic Indications That COPI- and Clathrin-Based Transport Systems Are Not Present in Chloroplasts: An Arabidopsis Model	PLOS ONE			English	Article							PREDICTING SUBCELLULAR-LOCALIZATION; PEROXIDASE GENE FAMILY; ACETYL-COA CARBOXYLASE; ENDOPLASMIC-RETICULUM; VESICULAR TRANSPORT; REPEAT PROTEINS; MEMBRANE-TRAFFICKING; ENVELOPE MEMBRANE; VESICLE TRANSPORT; SIGNAL PEPTIDES	Coated vesicle transport occurs in the cytosol of yeast, mammals and plants. It consists of three different transport systems, the COPI, COPII and clathrin coated vesicles (CCV), all of which participate in the transfer of proteins and lipids between different cytosolic compartments. There are also indications that chloroplasts have a vesicle transport system. Several putative chloroplast-localized proteins, including CPSAR1 and CPRabA5e with similarities to cytosolic COPII transport-related proteins, were detected in previous experimental and bioinformatics studies. These indications raised the hypothesis that a COPI- and/or CCV-related system may be present in chloroplasts, in addition to a COPII-related system. To test this hypothesis we bioinformatically searched for chloroplast proteins that may have similar functions to known cytosolic COPI and CCV components in the model plants Arabidopsis thaliana and Oryza sativa (subsp. japonica) (rice). We found 29 such proteins, based on domain similarity, in Arabidopsis, and 14 in rice. However, many components could not be identified and among the identified most have assigned roles that are not related to either COPI or CCV transport. We conclude that COPII is probably the only active vesicle system in chloroplasts, at least in the model plants. The evolutionary implications of the findings are discussed.	[Lindquist, Emelie; Alezzawi, Mohamed; Aronsson, Henrik] Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden	University of Gothenburg	Aronsson, H (corresponding author), Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden.	henrik.aronsson@bioenv.gu.se			Olle Engkvist Byggmastare Foundation; Libyan Higher Education	Olle Engkvist Byggmastare Foundation; Libyan Higher Education	This work was supported by Olle Engkvist Byggmastare Foundation (to H.A.), and a PhD student fellowship from the Libyan Higher Education (to M.A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah F, 2000, TRENDS PLANT SCI, V5, P141, DOI 10.1016/S1360-1385(00)01574-0; Andersson MX, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-40; Andersson MX, 2001, PLANT PHYSIOL, V127, P184, DOI 10.1104/pp.127.1.184; Aronsson H, 2008, PLANT CELL MONOGRAPH; Bannai H, 2002, BIOINFORMATICS, V18, P298, DOI 10.1093/bioinformatics/18.2.298; BARLOWE C, 1993, NATURE, V365, P347, DOI 10.1038/365347a0; Bassham DC, 2008, ARABIDOPSIS BOOK, V6, pe0116; Bednarek SY, 1995, CELL, V83, P1183, DOI 10.1016/0092-8674(95)90144-2; Bethune J, 2006, J MEMBRANE BIOL, V211, P65, DOI 10.1007/s00232-006-0859-7; Boden M, 2005, BIOINFORMATICS, V21, P2279, DOI 10.1093/bioinformatics/bti372; Boehm M, 2001, MOL BIOL CELL, V12, P2907, DOI 10.1091/mbc.12.10.2907; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Bonifacino JS, 2003, NAT REV MOL CELL BIO, V4, P409, DOI 10.1038/nrm1099; Cavalier-Smith T, 2000, TRENDS PLANT SCI, V5, P174, DOI 10.1016/S1360-1385(00)01598-3; Cavalier-Smith T, 2009, INT J BIOCHEM CELL B, V41, P307, DOI 10.1016/j.biocel.2008.10.002; Cevher-Keskin B, 2013, INT J MOL SCI, V14, P18181, DOI 10.3390/ijms140918181; Chen X, 2011, CURR OPIN PLANT BIOL, V14, P674, DOI 10.1016/j.pbi.2011.08.006; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Dacks JB, 2007, J CELL SCI, V120, P2977, DOI 10.1242/jcs.013250; Dell'Angelica EC, 2001, TRENDS CELL BIOL, V11, P315, DOI 10.1016/S0962-8924(01)02043-8; DONALDSON JG, 1992, P NATL ACAD SCI USA, V89, P6408, DOI 10.1073/pnas.89.14.6408; Eckhardt U, 2004, PLANT MOL BIOL, V56, P1, DOI 10.1007/s11103-004-2331-3; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Fath S, 2007, CELL, V129, P1325, DOI 10.1016/j.cell.2007.05.036; Fotin A, 2004, NATURE, V432, P573, DOI 10.1038/nature03079; Froehlich JE, 2003, J PROTEOME RES, V2, P413, DOI 10.1021/pr034025j; Fulop K, 2005, CELL CYCLE, V4, P1084; Gao CJ, 2012, PLANT CELL, V24, P2086, DOI 10.1105/tpc.112.096057; Garcia C, 2010, PLANT J, V63, P73, DOI 10.1111/j.1365-313X.2010.04225.x; Gattiker Alexandre, 2002, Appl Bioinformatics, V1, P107; Gothandam KM, 2005, PLANT MOL BIOL, V58, P421, DOI 10.1007/s11103-005-5702-5; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Guda C, 2004, BIOINFORMATICS, V20, P1785, DOI 10.1093/bioinformatics/bth171; Guo JJ, 2009, J EXP BOT, V60, P3819, DOI 10.1093/jxb/erp221; Gutierrez C, 2009, ARABIDOPSIS BOOK, V7; Han XX, 2012, J INTEGR PLANT BIOL, V54, P486, DOI 10.1111/j.1744-7909.2012.01132.x; Heazlewood JL, 2007, NUCLEIC ACIDS RES, V35, pD213, DOI 10.1093/nar/gkl863; Hiller K, 2004, NUCLEIC ACIDS RES, V32, pW375, DOI 10.1093/nar/gkh378; Hirst J, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001170; Hoglund A, 2006, BIOINFORMATICS, V22, P1158, DOI 10.1093/bioinformatics/btl002; Holstein SEH, 2002, TRAFFIC, V3, P614, DOI 10.1034/j.1600-0854.2002.30903.x; Horton P, 2006, SER ADV BIOINFORM, V3, P39, DOI 10.1142/9781860947292_0007; Ito E, 2012, PLANT J, V69, P204, DOI 10.1111/j.1365-313X.2011.04782.x; Jarvis P, 2004, CURR BIOL, V14, pR1064, DOI 10.1016/j.cub.2004.11.049; Jogl G, 2002, EMBO J, V21, P4785, DOI 10.1093/emboj/cdf502; Joyard J, 2010, PROG LIPID RES, V49, P128, DOI 10.1016/j.plipres.2009.10.003; Karim S, 2014, PLANT MOL BIOL, V84, P675, DOI 10.1007/s11103-013-0161-x; Kaya H, 2001, CELL, V104, P131, DOI 10.1016/S0092-8674(01)00197-0; Kelly AA, 2004, CURR OPIN PLANT BIOL, V7, P262, DOI 10.1016/j.pbi.2004.03.009; Khan NZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059898; Kim SY, 2010, PLANT SIGNAL BEHAV, V5, P458, DOI 10.4161/psb.5.4.11342; Kirchhausen T, 2000, ANNU REV BIOCHEM, V69, P699, DOI 10.1146/annurev.biochem.69.1.699; Kirchhausen T, 2000, NAT REV MOL CELL BIO, V1, P187, DOI 10.1038/35043117; Kleffmann T, 2004, CURR BIOL, V14, P354, DOI 10.1016/j.cub.2004.02.039; Kleine-Vehn J, 2006, PLANT CELL, V18, P3171, DOI 10.1105/tpc.106.042770; Kobayashi N, 2007, GENE, V396, P236, DOI 10.1016/j.gene.2007.02.032; Kohler C, 2003, EMBO J, V22, P4804, DOI 10.1093/emboj/cdg444; Kroll D, 2001, P NATL ACAD SCI USA, V98, P4238, DOI 10.1073/pnas.061500998; Kundu N, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.24012; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Larson-Rabin Z, 2009, PLANT PHYSIOL, V149, P874, DOI 10.1104/pp.108.132449; Lee C, 2010, CELL, V142, P123, DOI 10.1016/j.cell.2010.05.030; Lee MCS, 2005, CELL, V122, P605, DOI 10.1016/j.cell.2005.07.025; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Li D, 2001, CELL MOL LIFE SCI, V58, P2085, DOI 10.1007/PL00000838; Lu Y, 2011, PLANT PHYSIOL, V155, P1589, DOI 10.1104/pp.110.170118; Lu Z, 2004, BIOINFORMATICS, V20, P547, DOI 10.1093/bioinformatics/btg447; Mahfouz MM, 2006, PLANT CELL, V18, P477, DOI 10.1105/tpc.105.035931; Masuda T, 2008, PHOTOSYNTH RES, V96, P121, DOI 10.1007/s11120-008-9291-4; Matsuda S, 2005, PROTEIN SCI, V14, P2804, DOI 10.1110/ps.051597405; Maurino VG, 2010, CURR OPIN PLANT BIOL, V13, P249, DOI 10.1016/j.pbi.2010.01.006; McMahon HT, 2004, CURR OPIN CELL BIOL, V16, P379, DOI 10.1016/j.ceb.2004.06.009; Monaghan J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000526; Moore I, 1997, P NATL ACAD SCI USA, V94, P762, DOI 10.1073/pnas.94.2.762; MORRE DJ, 1991, PLANT PHYSIOL, V97, P1558, DOI 10.1104/pp.97.4.1558; Movafeghi A, 1999, PLANT PHYSIOL, V119, P1437, DOI 10.1104/pp.119.4.1437; Nickel W, 2002, J CELL SCI, V115, P3235; Nielsen H, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P122; Nielsen H, 1997, Int J Neural Syst, V8, P581, DOI 10.1142/S0129065797000537; Nielsen H, 1999, PROTEIN ENG, V12, P3, DOI 10.1093/protein/12.1.3; Niihama M, 2009, PLANT CELL PHYSIOL, V50, P2057, DOI 10.1093/pcp/pcp137; Olinares PDB, 2010, MOL CELL PROTEOMICS, V9, P1594, DOI 10.1074/mcp.M000038-MCP201; Ortiz-Zapater E, 2006, PLANT J, V48, P757, DOI 10.1111/j.1365-313X.2006.02909.x; Paleotti O, 2005, J BIOL CHEM, V280, P21661, DOI 10.1074/jbc.m503099200; Papenbrock J, 1997, PLANT J, V12, P981, DOI 10.1046/j.1365-313X.1997.12050981.x; Park CJ, 2013, PLANT SCI, V210, P53, DOI 10.1016/j.plantsci.2013.05.003; Petsalaki Evangelia I., 2006, Genomics Proteomics & Bioinformatics, V4, P48, DOI 10.1016/S1672-0229(06)60016-8; Pierleoni A, 2006, BIOINFORMATICS, V22, pE408, DOI 10.1093/bioinformatics/btl222; Rantfors M, 2000, PHYSIOL PLANTARUM, V110, P262, DOI 10.1034/j.1399-3054.2000.110217.x; Robinson C, 2001, TRAFFIC, V2, P245, DOI 10.1034/j.1600-0854.2001.1r010.x; Robinson DG, 2007, CRIT REV PLANT SCI, V26, P199, DOI 10.1080/07352680701495820; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Rutherford S, 2002, CURR OPIN PLANT BIOL, V5, P518, DOI 10.1016/S1369-5266(02)00307-2; Sasaki Y, 2004, BIOSCI BIOTECH BIOCH, V68, P1175, DOI 10.1271/bbb.68.1175; Schein AI, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.16.e82; Schekman R, 1996, SCIENCE, V271, P1526, DOI 10.1126/science.271.5255.1526; Schmitz-Linneweber C, 2008, TRENDS PLANT SCI, V13, P663, DOI 10.1016/j.tplants.2008.10.001; Schwacke R, 2003, PLANT PHYSIOL, V131, P16, DOI 10.1104/pp.011577; Schwacke R, 2007, MOL GENET GENOMICS, V277, P631, DOI 10.1007/s00438-007-0214-4; Shimojima M, 1997, P NATL ACAD SCI USA, V94, P333, DOI 10.1073/pnas.94.1.333; Slabicki M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000408; Slocum RD, 2005, PLANT PHYSIOL BIOCH, V43, P729, DOI 10.1016/j.plaphy.2005.06.007; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; Small ID, 2000, TRENDS BIOCHEM SCI, V25, P46, DOI 10.1016/S0968-0004(99)01520-0; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Solymosi K., 2013, PLASTID DEV LEAVES G, V36, P39, DOI DOI 10.1007/978-94-007-5724-0_3; Spetea C, 2012, CURRENT CHEM BIOL, V6, P230, DOI DOI 10.2174/2212796811206030006; Stagg SM, 2008, CELL, V134, P474, DOI 10.1016/j.cell.2008.06.024; Teixeira FK, 2006, PLANTA, V224, P300, DOI 10.1007/s00425-005-0214-8; Teixeira FK, 2004, J MOL EVOL, V59, P761, DOI 10.1007/s00239-004-2666-z; ter Haar E, 2000, P NATL ACAD SCI USA, V97, P1096, DOI 10.1073/pnas.97.3.1096; Tewari R, 2010, TRENDS CELL BIOL, V20, P470, DOI 10.1016/j.tcb.2010.05.003; TISDALE EJ, 1992, J CELL BIOL, V119, P749, DOI 10.1083/jcb.119.4.749; Tomaru Koji, 2010, Open Biochem J, V4, P1, DOI 10.2174/1874091X01004010001; Vanhee C, 2011, PLANT CELL, V23, P785, DOI 10.1105/tpc.110.081570; Vernoud V, 2003, PLANT PHYSIOL, V131, P1191, DOI 10.1104/pp.013052; Vothknecht UC, 2001, BBA-MOL CELL RES, V1541, P91, DOI 10.1016/S0167-4889(01)00153-7; Wei Z, 2009, PROTEOMICS, V9, P2798, DOI 10.1002/pmic.200800840; Wen WY, 2006, MOL BIOL CELL, V17, P4282, DOI 10.1091/mbc.E06-02-0128; Westphal S, 2003, PLANT CELL PHYSIOL, V44, P217, DOI 10.1093/pcp/pcg023; Westphal S, 2001, FEBS LETT, V506, P257, DOI 10.1016/S0014-5793(01)02931-3; Wiborg J, 2008, BIOCHEM J, V413, P447, DOI 10.1042/BJ20071568; Wienkoop S, 2004, PHYTOCHEMISTRY, V65, P1641, DOI 10.1016/j.phytochem.2004.03.026; Wilbur JD, 2005, TRAFFIC, V6, P346, DOI 10.1111/j.1600-0854.2005.00277.x; YANAI Y, 1995, PLANT CELL PHYSIOL, V36, P779, DOI 10.1093/oxfordjournals.pcp.a078822; YOSHIHISA T, 1993, SCIENCE, V259, P1466, DOI 10.1126/science.8451644; Zhang HT, 2006, PLANT MOL BIOL, V62, P325, DOI 10.1007/s11103-006-9024-z; Zhu Y, 2012, BBA-GENE REGUL MECH, V1819, P343, DOI 10.1016/j.bbagrm.2011.07.012; Zybailov B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001994	131	8	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e104423	10.1371/journal.pone.0104423	http://dx.doi.org/10.1371/journal.pone.0104423			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137124	Green Submitted, Green Published, gold			2022-12-25	WOS:000340742100033
J	Luo, BB; Li, B; Wang, WK; Liu, XJ; Xia, YF; Zhang, C; Zhang, MX; Zhang, Y; An, FS				Luo, Beibei; Li, Bo; Wang, Wenke; Liu, Xiangjuan; Xia, Yanfei; Zhang, Cheng; Zhang, Mingxiang; Zhang, Yun; An, Fengshuang			NLRP3 Gene Silencing Ameliorates Diabetic Cardiomyopathy in a Type 2 Diabetes Rat Model	PLOS ONE			English	Article							THIOREDOXIN-INTERACTING PROTEIN; NF-KAPPA-B; INFLAMMASOME ACTIVATION; CELL-DEATH; OXIDATIVE STRESS; HIGH GLUCOSE; PYROPTOSIS; HEART; METALLOTHIONEIN; PATHOGENESIS	Background: Nucleotide-binding oligomerization domain-like receptor protein 3 (NLRP3) inflammasome is associated with metabolic disorder and cell death, which are important triggers in diabetic cardiomyopathy (DCM). We aimed to explore whether NLRP3 inflammasome activation contributes to DCM and the mechanism involved. Methods: Type 2 diabetic rat model was induced by high fat diet and low dose streptozotocin. The characteristics of type 2 DCM were evaluated by metabolic tests, echocardiography and histopathology. Gene silencing therapy was used to investigate the role of NLRP3 in the pathogenesis of DCM. High glucose treated H9c2 cardiomyocytes were used to determine the mechanism by which NLRP3 modulated the DCM. The cell death in vitro was detected by TUNEL and EthD-III staining. TXNIP-siRNA and pharmacological inhibitors of ROS and NF-B were used to explore the mechanism of NLRP3 inflammasome activation. Results: Diabetic rats showed severe metabolic disorder, cardiac inflammation, cell death, disorganized ultrastructure, fibrosis and excessive activation of NLRP3, apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC), pro-caspase-1, activated caspase-1 and mature interleukin-1b (IL-1b). Evidence for pyroptosis was found in vivo, and the caspase-1 dependent pyroptosis was found in vitro. Silencing of NLRP3 in vivo did not attenuate systemic metabolic disturbances. However, NLRP3 gene silencing therapy ameliorated cardiac inflammation, pyroptosis, fibrosis and cardiac function. Silencing of NLRP3 in H9c2 cardiomyocytes suppressed pyroptosis under high glucose. ROS inhibition markedly decreased nuclear factor-kB (NF-kB) phosphorylation, thioredoxin interacting/inhibiting protein (TXNIP), NLRP3 inflammasome, and mature IL-1b in high glucose treated H9c2 cells. Inhibition of NF-kB reduced the activation of NLRP3 inflammasome. TXNIP-siRNA decreased the activation of caspase-1 and IL-1b. Conclusion: NLRP3 inflammasome contributed to the development of DCM. NF-kB and TXNIP mediated the ROS-induced caspase-1 and IL-1b activation, which are the effectors of NLRP3 inflammasome. NLRP3 gene silencing may exert a protective effect on DCM.	[An, Fengshuang] Shandong Univ, Qilu Hosp, Chinese Minist Educ, Key Lab Cardiovasc Remodeling & Funct Res, Jinan 250100, Shandong, Peoples R China; Shandong Univ, Qilu Hosp, Chinese Minist Hlth, Jinan 250100, Shandong, Peoples R China	Shandong University; Shandong University	An, FS (corresponding author), Shandong Univ, Qilu Hosp, Chinese Minist Educ, Key Lab Cardiovasc Remodeling & Funct Res, Jinan 250100, Shandong, Peoples R China.	anfengshuang@aliyun.com			National Natural Science Foundation of China [81370325]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (81370325). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asbun J, 2006, J AM COLL CARDIOL, V47, P693, DOI 10.1016/j.jacc.2005.09.050; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Bell David S H, 2008, Endocr Pract, V14, P924; Boudina S, 2010, REV ENDOCR METAB DIS, V11, P31, DOI 10.1007/s11154-010-9131-7; Bryant C, 2009, TRENDS CELL BIOL, V19, P455, DOI 10.1016/j.tcb.2009.06.002; Bujak M, 2009, ARCH IMMUNOL THER EX, V57, P165, DOI 10.1007/s00005-009-0024-y; Cai L, 2006, J AM COLL CARDIOL, V48, P1688, DOI 10.1016/j.jacc.2006.07.022; Cai L, 2006, FREE RADICAL BIO MED, V41, P851, DOI 10.1016/j.freeradbiomed.2006.06.007; Chung SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047299; Coll NS, 2011, CELL DEATH DIFFER, V18, P1247, DOI 10.1038/cdd.2011.37; Corsini E, 2013, FOOD CHEM TOXICOL, V61, P74, DOI 10.1016/j.fct.2013.02.038; Devereux RB, 2000, CIRCULATION, V101, P2271, DOI 10.1161/01.CIR.101.19.2271; Devi TS, 2012, EXP DIABETES RES, DOI 10.1155/2012/438238; Dong Z, 2011, J CELL BIOCHEM, V112, P2097, DOI 10.1002/jcb.23128; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Falcao-Pires I, 2012, HEART FAIL REV, V17, P325, DOI 10.1007/s10741-011-9257-z; Fink SL, 2008, P NATL ACAD SCI USA, V105, P4312, DOI 10.1073/pnas.0707370105; Fink SL, 2006, CELL MICROBIOL, V8, P1812, DOI 10.1111/j.1462-5822.2006.00751.x; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Guarda G, 2010, IMMUNOLOGY, V130, P329, DOI 10.1111/j.1365-2567.2010.03283.x; Lacombe VA, 2007, AM J PHYSIOL-REG I, V293, pR1787, DOI 10.1152/ajpregu.00059.2007; Lamkanfi M, 2010, INT J BIOCHEM CELL B, V42, P792, DOI 10.1016/j.biocel.2010.01.008; Lee HM, 2013, DIABETES, V62, P194, DOI 10.2337/db12-0420; Lian LH, 2012, J INVEST DERMATOL, V132, P1346, DOI 10.1038/jid.2011.482; Liao PC, 2013, INFLAMM RES, V62, P89, DOI 10.1007/s00011-012-0555-2; Lin J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062148; Liu L, 2013, INT J BIOCHEM CELL B, V45, P2027, DOI 10.1016/j.biocel.2013.06.018; Liu XM, 2012, CARDIOVASC DRUG THER, V26, P121, DOI 10.1007/s10557-012-6372-6; Luo BB, 2013, CLIN CHEM LAB MED, V51, P1521, DOI 10.1515/cclm-2012-0600; Maeda H, 2013, BBA-MOL BASIS DIS, V1832, P1159, DOI 10.1016/j.bbadis.2013.02.014; Martinon F, 2010, EUR J IMMUNOL, V40, P616, DOI 10.1002/eji.200940168; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; McCann FJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0049894, 10.1371/journal.pone.0052013]; McCoy AJ, 2010, J IMMUNOL, V185, P7077, DOI 10.4049/jimmunol.1002165; Miao EA, 2011, IMMUNOL REV, V243, P206, DOI 10.1111/j.1600-065X.2011.01044.x; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Mohamed IN, 2014, DIABETOLOGIA, V57, P413, DOI 10.1007/s00125-013-3101-z; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Schroder K, 2010, SCIENCE, V327, P296, DOI 10.1126/science.1184003; Shen X, 2006, DIABETES, V55, P798, DOI 10.2337/diabetes.55.03.06.db05-1039; Simard JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072138; Ti Y, 2011, DIABETES, V60, P2963, DOI 10.2337/db11-0549; Tsai KH, 2012, J CELL PHYSIOL, V227, P1347, DOI 10.1002/jcp.22847; van de Weijer T, 2011, CARDIOVASC RES, V92, P10, DOI 10.1093/cvr/cvr212; Van Linthout S, 2008, CIRCULATION, V117, P1563, DOI 10.1161/CIRCULATIONAHA.107.710830; Wang C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038285; Wree A, 2013, HEPATOLOGY; Yang JR, 2013, AM J PHYSL RENAL PHY; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	49	186	210	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e104771	10.1371/journal.pone.0104771	http://dx.doi.org/10.1371/journal.pone.0104771			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136835	Green Submitted, Green Published, gold			2022-12-25	WOS:000340742100046
J	Dai, L; Deng, CF; Li, YH; Zhu, J; Mu, Y; Deng, Y; Mao, M; Wang, YP; Li, Q; Ma, SG; Ma, XM; Zhang, YW				Dai, Li; Deng, Changfei; Li, Yanhua; Zhu, Jun; Mu, Yi; Deng, Ying; Mao, Meng; Wang, Yanping; Li, Qi; Ma, Shuangge; Ma, Xiaomei; Zhang, Yawei			Birth Weight Reference Percentiles for Chinese	PLOS ONE			English	Article							GESTATIONAL-AGE PATTERNS; FETAL-GROWTH; UNITED-STATES; INTRAUTERINE GROWTH; DIABETES-MELLITUS; RACE; POPULATION; STANDARDS; HYPERTENSION; RETARDATION	Objective: To develop a reference of population-based gestational age-specific birth weight percentiles for contemporary Chinese. Methods: Birth weight data was collected by the China National Population-based Birth Defects Surveillance System. A total of 1,105,214 live singleton births aged >= 28 weeks of gestation without birth defects during 2006-2010 were included. The lambda-mu-sigma method was utilized to generate percentiles and curves. Results: Gestational age-specific birth weight percentiles for male and female infants were constructed separately. Significant differences were observed between the current reference and other references developed for Chinese or non-Chinese infants. Conclusion: There have been moderate increases in birth weight percentiles for Chinese infants of both sexes and most gestational ages since 1980s, suggesting the importance of utilizing an updated national reference for both clinical and research purposes.	[Dai, Li; Deng, Changfei; Zhu, Jun; Mu, Yi; Deng, Ying; Wang, Yanping; Li, Qi] Sichuan Univ, West China Univ Hosp 2, Natl Ctr Birth Defects Monitoring, Chengdu 610064, Peoples R China; [Dai, Li; Zhu, Jun; Deng, Ying; Mao, Meng] Sichuan Univ, West China Univ Hosp 2, Minist Educ, Key Lab Obstet & Gynecol & Pediat Dis & Birth Def, Chengdu 610064, Peoples R China; [Li, Yanhua] Sichuan Univ, West China Univ Hosp 2, Dept Obstet & Gynecol, Chengdu 610064, Peoples R China; [Ma, Shuangge; Ma, Xiaomei; Zhang, Yawei] Yale Univ, Sch Publ Hlth, New Haven, CT USA	Sichuan University; Sichuan University; Sichuan University; Yale University	Dai, L (corresponding author), Sichuan Univ, West China Univ Hosp 2, Natl Ctr Birth Defects Monitoring, Chengdu 610064, Peoples R China.	daili@scu.edu.cn; yawei.zhang@yale.edu			National Natural Science Foundation of China [81072375]; U.S. National Institutes of Health [K02HD070324]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K02HD070324] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by Grant 81072375 from the National Natural Science Foundation of China to LD and Grant K02HD070324 from the U.S. National Institutes of Health to YZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander GR, 1996, OBSTET GYNECOL, V87, P163, DOI 10.1016/0029-7844(95)00386-X; Alshimmiri M. M., 2004, Archives of Gynecology and Obstetrics, V269, P111, DOI 10.1007/s00404-002-0434-0; Bakketeig LS, 1998, EUR J CLIN NUTR, V52, pS1; BARKER DJP, 1993, DIABETOLOGIA, V36, P62, DOI 10.1007/BF00399095; Bonellie Sandra, 2008, BMC Pregnancy Childbirth, V8, P5, DOI 10.1186/1471-2393-8-5; COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005; Coordinating Study Group of Nine Cities on Physical Growth and Development of Children, 2007, Zhonghua Er Ke Za Zhi, V45, P609; Curhan GC, 1996, CIRCULATION, V94, P3246, DOI 10.1161/01.CIR.94.12.3246; da Veiga PV, 2008, MATERN CHILD HLTH J, V12, P194, DOI 10.1007/s10995-007-0238-8; Dai L, 2011, WORLD J PEDIATR, V7, P302, DOI 10.1007/s12519-011-0326-0; Dobbins TA, 2012, MED J AUSTRALIA, V197, P291, DOI 10.5694/mja11.11331; Hutcheon JA, 2008, BJOG-INT J OBSTET GY, V115, P1397, DOI 10.1111/j.1471-0528.2008.01870.x; Hutcheon JA, 2011, PAEDIATR PERINAT EP, V25, P11, DOI 10.1111/j.1365-3016.2010.01155.x; Janssen Patricia A, 2007, Open Med, V1, pe74; Kierans William J, 2008, BMC Pregnancy Childbirth, V8, P1, DOI 10.1186/1471-2393-8-1; Kramer MS, 1998, EUR J CLIN NUTR, V52, pS29; Kramer MS, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.2.e35; Langley-Evans SC, 2010, MED PRIN PRACT, V19, P87, DOI 10.1159/000273066; Larkin JC, 2012, OBSTET GYNECOL, V119, P21, DOI 10.1097/AOG.0b013e31823dc56e; Madan Ashima, 2002, J Perinatol, V22, P230, DOI 10.1038/sj.jp.7210703; McCarton CM, 1996, PEDIATRICS, V98, P1167; Ogunyemi D, 2007, SOUTH MED J, V100, P615, DOI 10.1097/SMJ.0b013e318048798c; Pearl M, 2001, AM J PUBLIC HEALTH, V91, P1808, DOI 10.2105/AJPH.91.11.1808; Pedreira CE, 2011, AN ACAD BRAS CIENC, V83, P619, DOI 10.1590/S0001-37652011005000008; Resnik R, 2007, AM J OBSTET GYNECOL, V197, P221, DOI 10.1016/j.ajog.2007.07.019; Roberts CL, 1999, MED J AUSTRALIA, V170, P114, DOI 10.5694/j.1326-5377.1999.tb127678.x; Shenkin SD, 2004, PSYCHOL BULL, V130, P989, DOI 10.1037/0033-2909.130.6.989; Skjaerven R, 2000, ACTA OBSTET GYN SCAN, V79, P440, DOI 10.1034/j.1600-0412.2000.079006440.x; Swamy GK, 2012, J EPIDEMIOL COMMUN H, V66, P136, DOI 10.1136/jech.2009.088567; Teramoto S, 2006, PEDIATR INT, V48, P274, DOI 10.1111/j.1442-200X.2006.02203.x; Thomas P, 2000, PEDIATRICS, V106, part. no., DOI 10.1542/peds.106.2.e21; Wang Juan, 2007, Zhonghua Liu Xing Bing Xue Za Zhi, V28, P15; WANG XB, 1994, INT J EPIDEMIOL, V23, P119, DOI 10.1093/ije/23.1.119; Wilcox AJ, 2001, INT J EPIDEMIOL, V30, P1233, DOI 10.1093/ije/30.6.1233; Yee TW, 2008, R NEWS, V8, P28; YIP R, 1991, PEDIATRICS, V87, P688; Zhang B., 1992, CHIN J PRACT PEDIAT, V7, P306; Zhang BL, 1997, CHINESE MED J-PEKING, V110, P148; ZHANG J, 1995, OBSTET GYNECOL, V86, P200, DOI 10.1016/0029-7844(95)00142-E; Zheng XY, 2013, EUR J OBSTET GYN R B, V166, P70, DOI 10.1016/j.ejogrb.2012.09.016	40	143	159	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104779	10.1371/journal.pone.0104779	http://dx.doi.org/10.1371/journal.pone.0104779			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127131	gold, Green Published, Green Submitted			2022-12-25	WOS:000340879300051
J	Root, JJ; Bentler, KT; Shriner, SA; Mooers, NL; VanDalen, KK; Sullivan, HJ; Franklin, AB				Root, J. Jeffrey; Bentler, Kevin T.; Shriner, Susan A.; Mooers, Nicole L.; VanDalen, Kaci K.; Sullivan, Heather J.; Franklin, Alan B.			Ecological Routes of Avian Influenza Virus Transmission to a Common Mesopredator: An Experimental Evaluation of Alternatives	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; A VIRUSES; PATHOGENICITY; ANTIBODIES; INFECTION; POPULATIONS; PERSISTENCE; SUBTYPES; WATER; H7N1	Background: Wild raccoons have been shown to be naturally exposed to avian influenza viruses (AIV). However, the mechanisms associated with these natural exposures are not well-understood. Methodology/Principal Findings: We experimentally tested three alternative routes (water, eggs, and scavenged waterfowl carcasses) of AIV transmission that may explain how raccoons in the wild are exposed to AIV. Raccoons were exposed to 1) water and 2) eggs spiked with an AIV (H4N6), as well as 3) mallard carcasses experimentally inoculated with the same virus. Three of four raccoons exposed to the high dose water treatment yielded apparent nasal shedding of >10(2.0) PCR EID50 equivalent/mL. Little to no shedding was observed from the fecal route. The only animals yielding evidence of serologic activity during the study period were three animals associated with the high dose water treatment. Conclusions/Significance: Overall, our results indicate that virus-laden water could provide a natural exposure route of AIV for raccoons and possibly other mammals associated with aquatic environments. However, this association appears to be related to AIV concentration in the water, which would constitute an infective dose. In addition, strong evidence of infection was only detected in three of four animals exposed to a high dose (e.g., 10(5.0) EID50/mL) of AIV in water. As such, water-borne transmission to raccoons may require repeated exposures to water with high concentrations of virus.	[Root, J. Jeffrey; Bentler, Kevin T.; Shriner, Susan A.; Mooers, Nicole L.; VanDalen, Kaci K.; Sullivan, Heather J.; Franklin, Alan B.] USDA, Natl Wildlife Res Ctr, Ft Collins, CO 80526 USA	United States Department of Agriculture (USDA)	Root, JJ (corresponding author), USDA, Natl Wildlife Res Ctr, Ft Collins, CO 80526 USA.	Jeff.root@aphis.usda.gov		Shriner, Susan/0000-0003-0349-7182; Franklin, Alan/0000-0001-9491-795X	United States Department of Agriculture	United States Department of Agriculture(United States Department of Agriculture (USDA))	This study was funded by the United States Department of Agriculture. The manuscript was reviewed for general policy statements committing the USDA to action, but otherwise the findings were independently developed by the authors.	Achenbach JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017643; Bentler KT, 2012, WILDLIFE SOC B, V36, P807, DOI 10.1002/wsb.193; Bertran K, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-24; Britton AP, 2010, EMERG INFECT DIS, V16, P1043, DOI 10.3201/eid1606.100352; Brown JD, 2010, J WILDLIFE DIS, V46, P896, DOI 10.7589/0090-3558-46.3.896; Brown JD, 2009, CLIN VACCINE IMMUNOL, V16, P824, DOI 10.1128/CVI.00084-09; Brown JD, 2009, VET MICROBIOL, V136, P20, DOI 10.1016/j.vetmic.2008.10.027; Busquets N, 2010, J GEN VIROL, V91, P2307, DOI 10.1099/vir.0.021592-0; Ciacci-Zanella JR, 2010, J VET DIAGN INVEST, V22, P3, DOI 10.1177/104063871002200102; Goldman E. A., 1950, N AM FAUNA, V60, P1, DOI [10.3996/nafa.60.0001, DOI 10.3996/NAFA.60.0001]; GREENWOOD RJ, 1979, AM MIDL NAT, V102, P191, DOI 10.2307/2425085; Hall JS, 2008, J WILDLIFE DIS, V44, P362, DOI 10.7589/0090-3558-44.2.362; Hall JS, 2008, EMERG INFECT DIS, V14, P1842, DOI 10.3201/eid1412.071371; Henaux V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031471; Horimoto T, 2011, EMERG INFECT DIS, V17, P714, DOI 10.3201/eid1704.101604; ITO T, 1995, ARCH VIROL, V140, P1163, DOI 10.1007/BF01322743; KAWAOKA Y, 1987, ARCH VIROL, V93, P303, DOI 10.1007/BF01310984; Lyall-Watson M, 1962, P ZOOL SOC LOND, V141, P371; McQuiston JH, 2005, JAVMA-J AM VET MED A, V226, P767, DOI 10.2460/javma.2005.226.767; Pedersen J, 2008, 151004 USDA AVPRO; Pepin KM, 2012, J GEN VIROL, V93, P2575, DOI 10.1099/vir.0.045427-0; Pillai SPS, 2010, AVIAN DIS, V54, P830, DOI 10.1637/9102-101209-Reg.1; Reperant LA, 2009, REV SCI TECH OIE, V28, P137, DOI 10.20506/rst.28.1.1876; Reperant LA, 2008, EMERG INFECT DIS, V14, P1835, DOI 10.3201/eid1412.080470; Rohani P, 2009, P NATL ACAD SCI USA, V106, P10365, DOI 10.1073/pnas.0809026106; Root JJ, 2014, PLOS ONE; Shriner SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039206; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Spickler AR, 2008, AVIAN PATHOL, V37, P555, DOI 10.1080/03079450802499118; STALLKNECHT DE, 1990, AVIAN DIS, V34, P406, DOI 10.2307/1591428; Szretter K. J., 2006, CURRENT PROTOCOLS MI, V15G; TEVIS L, 1947, J MAMMAL, V28, P323, DOI 10.2307/1375355; URBAN D, 1970, J WILDLIFE MANAGE, V34, P372, DOI 10.2307/3799024; VanDalen KK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012851	34	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e102964	10.1371/journal.pone.0102964	http://dx.doi.org/10.1371/journal.pone.0102964			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127468	Green Published, Green Submitted, gold			2022-12-25	WOS:000340879300006
J	Rousseau, C; Beauregard, C; Daignault, K; Petrakos, H; Thombs, BD; Steele, R; Vasiliadis, HM; Hechtman, L				Rousseau, Cecile; Beauregard, Caroline; Daignault, Katherine; Petrakos, Harriet; Thombs, Brett D.; Steele, Russell; Vasiliadis, Helen-Maria; Hechtman, Lily			A Cluster Randomized-Controlled Trial of a Classroom-Based Drama Workshop Program to Improve Mental Health Outcomes among Immigrant and Refugee Youth in Special Classes	PLOS ONE			English	Article							SELF-CONTAINED CLASSROOMS; DIFFICULTIES QUESTIONNAIRE; PSYCHOMETRIC PROPERTIES; ACADEMIC ENGAGEMENT; CHILDREN; INTERVENTION; STRENGTHS; STUDENTS; SCHOOLS; ADOLESCENTS	Objectives: The aim of this cluster randomized trial was to evaluate the effectiveness of a school-based theatre intervention program for immigrant and refugee youth in special classes for improving mental health and academic outcomes. The primary hypothesis was that students in the theatre intervention group would report a greater reduction in impairment from symptoms compared to students in the control and tutoring groups. Methods: Special classrooms in five multiethnic high schools were randomly assigned to theater intervention (n = 10), tutoring (n = 10) or control status (n = 9), for a total of 477 participants. Students and teachers were non-blinded to group assignment. The primary outcome was impairment from emotional and behavioural symptoms assessed by the Impact Supplement of the Strengths and Difficulties Questionnaire (SDQ) completed by the adolescents. The secondary outcomes were the SDQ global scores (teacher and youth reports), impairment assessed by teachers and school performance. The effect of the interventions was assessed through linear mixed effect models which incorporate the correlation between students in the same class, due to the nature of the randomization of the interventions by classroom. Results: The theatre intervention was not associated with a greater reduction in self-reported impairment and symptoms in youth placed in special class because of learning, emotional and behavioural difficulties than a tutoring intervention or a non-active control group. The estimates of the different models show a non-significant decrease in both self-reported and impairment scores in the theatre intervention group for the overall group, but the impairment score decreased significantly for first generation adolescents while it increased for second generation adolescents. Conclusion: The difference between the population of immigrant and refugee youth newcomers studied previously and the sample of this trial may explain some of the differences in the observed impact of the theatre intervention.	[Rousseau, Cecile] McGill Univ, Div Social & Cultural Psychiat, Montreal, PQ, Canada; [Beauregard, Caroline] Univ Montreal, Dept Educ Psychol & Adult Educ, Montreal, PQ, Canada; [Daignault, Katherine; Steele, Russell] McGill Univ, Dept Math & Stat, Montreal, PQ, Canada; [Petrakos, Harriet] Concordia Univ, Dept Educ, Montreal, PQ, Canada; [Thombs, Brett D.] McGill Univ, Dept Psychiat, Lady Davis Inst Med Res, Montreal, PQ, Canada; [Vasiliadis, Helen-Maria] Univ Sherbrooke, Dept Community Hlth Sci, Sherbrooke, PQ J1K 2R1, Canada; [Hechtman, Lily] McGill Univ, Div Child Psychiat, Montreal, PQ, Canada	McGill University; Universite de Montreal; McGill University; Concordia University - Canada; Lady Davis Institute; McGill University; University of Sherbrooke; McGill University	Rousseau, C (corresponding author), McGill Univ, Div Social & Cultural Psychiat, Montreal, PQ, Canada.	cecile.rousseau@mcgill.ca	Steele, Russell J/G-6926-2017		Canadian Institute for Health Research [IRSC-229984]	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR))	This research was funded by a grant from the Canadian Institute for Health Research, No. IRSC-229984. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhundov N, 1999, FORCED MIGRATION DEC, V1999, P20; Anderson JA, 2001, J EMOT BEHAV DISORD, V9, P106, DOI 10.1177/106342660100900205; Bibeau G, 1992, SANTE MENTALE VISAGE; Bourdon KH, 2005, J AM ACAD CHILD PSY, V44, P557, DOI 10.1097/01.chi.0000159157.57075.c8; Danev M., 1998, ART THERAPISTS REFUG; Everitt B. S., 2008, CLIN TRIALS PSYCHIAT; Glick JE, 2003, DEMOGRAPHY, V40, P759, DOI 10.2307/1515207; Goodman A, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-258; Goodman R, 1999, J CHILD PSYCHOL PSYC, V40, P791, DOI 10.1017/S0021963099004096; Goodman R, 2000, EUR CHILD ADOLES PSY, V9, P129, DOI 10.1007/s007870050008; Goodman R, 2001, J AM ACAD CHILD PSY, V40, P1337, DOI 10.1097/00004583-200111000-00015; Hodes M., 2000, CHILD PSYCHOL PSYCHI, V5, P57, DOI [DOI 10.1017/S136064170000215X, 10.1017/S136064170000215X]; Jordans MJD, 2010, J CHILD PSYCHOL PSYC, V51, P818, DOI 10.1111/j.1469-7610.2010.02209.x; Kanoute F., 2002, REV SCI LEDUCATION, V28, P171; Lane KL, 2005, BEHAV DISORDERS, V30, P363; Lane KL, 2005, BEHAV DISORDERS, V30, P349; Layne CM, 2008, J AM ACAD CHILD PSY, V47, P1048, DOI 10.1097/CHI.0b013e31817eecae; Lopez A, 1992, NUESTRO ORIGEN NUEST; Manassis K, 2010, DEPRESSION ANXIETY; MILLER KE, 1994, AM J ORTHOPSYCHIAT, V64, P346, DOI 10.1037/h0079548; Moneta I, 2008, ART PSYCHOTHER, V35, P329, DOI 10.1016/j.aip.2008.07.001; National Collaborating Centre for Mental Health, 2005, POSTTRAUMATIC STRESS; Nylund B. V., 1999, FORCED MIGRATION REV, V6, P16; Rasco LM, 2004, MENTAL HEALTH OF REFUGEES, P375; Reddy LA, 2009, J SCHOOL PSYCHOL, V47, P77, DOI 10.1016/j.jsp.2008.11.001; Rousseau C, 2005, J CHILD PSYCHOL PSYC, V46, P180, DOI 10.1111/j.1469-7610.2004.00344.x; Rousseau C, 1996, AM J ORTHOPSYCHIAT, V66, P239, DOI 10.1037/h0080175; Rousseau C, 2008, CHILD ADOL PSYCH CL, V17, P533, DOI 10.1016/j.chc.2008.02.002; Rousseau Cecile, 2007, Clin Child Psychol Psychiatry, V12, P451; Rousseau C, 2012, CHILD ADOL MENT H-UK, V17, P187, DOI 10.1111/j.1475-3588.2011.00629.x; Rumbaut Ruben, 2001, ETHNICITIES CHILDREN; Stein BD, 2003, JAMA-J AM MED ASSOC, V290, P603, DOI 10.1001/jama.290.5.603; Suarez-Orozco C, 2009, TEACH COLL REC, V111, P712; Tol WA, 2008, JAMA-J AM MED ASSOC, V300, P655, DOI 10.1001/jama.300.6.655; Tol WA, 2012, WORLD PSYCHIATRY, V11, P114, DOI 10.1016/j.wpsyc.2012.05.008; Tucker CM, 2002, PSYCHOL SCHOOLS, V39, P477, DOI 10.1002/pits.10038; Van Hook J, 2002, DEMOGRAPHY, V39, P639, DOI 10.1353/dem.2002.0042; Wilson SJ, 2007, AM J PREV MED, V33, pS130, DOI 10.1016/j.amepre.2007.04.011	38	17	17	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104704	10.1371/journal.pone.0104704	http://dx.doi.org/10.1371/journal.pone.0104704			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN8UD	25127251	Green Published, gold			2022-12-25	WOS:000340879300044
J	Stempler, S; Yizhak, K; Ruppin, E				Stempler, Shiri; Yizhak, Keren; Ruppin, Eytan			Integrating Transcriptomics with Metabolic Modeling Predicts Biomarkers and Drug Targets for Alzheimer's Disease	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; HUMAN BRAIN; AMINO-ACID; EXPRESSION; GENE; PLASMA	Accumulating evidence links numerous abnormalities in cerebral metabolism with the progression of Alzheimer's disease (AD), beginning in its early stages. Here, we integrate transcriptomic data from AD patients with a genome-scale computational human metabolic model to characterize the altered metabolism in AD, and employ state-of-the-art metabolic modelling methods to predict metabolic biomarkers and drug targets in AD. The metabolic descriptions derived are first tested and validated on a large scale versus existing AD proteomics and metabolomics data. Our analysis shows a significant decrease in the activity of several key metabolic pathways, including the carnitine shuttle, folate metabolism and mitochondrial transport. We predict several metabolic biomarkers of AD progression in the blood and the CSF, including succinate and prostaglandin D2. Vitamin D and steroid metabolism pathways are enriched with predicted drug targets that could mitigate the metabolic alterations observed. Taken together, this study provides the first network wide view of the metabolic alterations associated with AD progression. Most importantly, it offers a cohort of new metabolic leads for the diagnosis of AD and its treatment.	[Stempler, Shiri; Ruppin, Eytan] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Yizhak, Keren; Ruppin, Eytan] Tel Aviv Univ, Blavatnik Sch Comp Sci, IL-69978 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University	Stempler, S (corresponding author), Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel.	shirist2@post.tau.ac.il; ruppin@post.tau.ac.il	Ruppin, Eytan/R-9698-2017	Ruppin, Eytan/0000-0002-7862-3940	Israeli Science Foundation (ISF); Israeli Cancer Research Fund (ICRF); I-CORE Program of the Planning and Budgeting Committee; Israel Science Foundation [41/11]; Joseph Sagol Fellowship for brain research at Tel Aviv University; Edmond J. Safra Bioinformatics center at Tel-Aviv University; Azrieli Foundation	Israeli Science Foundation (ISF)(Israel Science Foundation); Israeli Cancer Research Fund (ICRF); I-CORE Program of the Planning and Budgeting Committee; Israel Science Foundation(Israel Science Foundation); Joseph Sagol Fellowship for brain research at Tel Aviv University; Edmond J. Safra Bioinformatics center at Tel-Aviv University; Azrieli Foundation	E.R.'s research is supported by a grant from the Israeli Science Foundation (ISF) and Israeli Cancer Research Fund (ICRF) to E. R. and by the I-CORE Program of the Planning and Budgeting Committee and The Israel Science Foundation (grant No 41/11). S. S. gratefully acknowledges the support of the Joseph Sagol Fellowship for brain research at Tel Aviv University. K.Y. is partially supported by a fellowship from the Edmond J. Safra Bioinformatics center at Tel-Aviv University and is grateful to the Azrieli Foundation for the award of an Azrieli Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreev VP, 2012, J PROTEOME RES; Annweiler C, 2009, EUR J NEUROL, V16, P1083, DOI 10.1111/j.1468-1331.2009.02755.x; BASUN H, 1990, J NEURAL TRANSM-PARK, V2, P295, DOI 10.1007/BF02252924; Becker SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000082; Bjorkhem I, 2006, ACTA NEUROL SCAND, V114, P43, DOI 10.1111/j.1600-0404.2006.00684.x; Blass JP, 2000, ANN NY ACAD SCI, V924, P170; Blazier AS, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00299; Brooks WM, 2007, BRAIN RES, V1127, P127, DOI 10.1016/j.brainres.2006.09.106; Chandrasekaran S, 2010, P NATL ACAD SCI USA, V107, P17845, DOI 10.1073/pnas.1005139107; Chen KD, 2011, NEUROBIOL DIS, V43, P698, DOI 10.1016/j.nbd.2011.05.023; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Faux NG, 2011, J ALZHEIMERS DIS, V27, P909, DOI 10.3233/JAD-2011-110752; Ferrer I, 2009, J BIOENERG BIOMEMBR, V41, P425, DOI 10.1007/s10863-009-9243-5; Folger O, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.35; Fonteh AN, 2007, AMINO ACIDS, V32, P213, DOI 10.1007/s00726-006-0409-8; Francis PT, 2005, CNS SPECTRUMS, V10, P6, DOI 10.1017/S1092852900014164; Henriksen K, 2013, ALZHEIMERS DEMENT; Jones LL, 2010, PROG LIPID RES, V49, P61, DOI 10.1016/j.plipres.2009.08.004; Kaddurah-Daouk R, 2011, ALZHEIMERS DEMENT, V7, P309, DOI 10.1016/j.jalz.2010.06.001; KALARIA RN, 1992, ANN NEUROL, V32, P583, DOI 10.1002/ana.410320417; Kim TY, 2011, CURR OPIN BIOTECHNOL; KISH SJ, 1992, J NEUROCHEM, V59, P776, DOI 10.1111/j.1471-4159.1992.tb09439.x; Lehmann DJ, 2011, NEUROSCI LETT, V504, P79, DOI 10.1016/j.neulet.2011.08.057; Lewis NE, 2010, NAT BIOTECHNOL, V28, P1279, DOI 10.1038/nbt.1711; Liang XB, 2005, J NEUROCHEM, V92, P477, DOI 10.1111/j.1471-4159.2004.02870.x; Mahadevan R, 2003, METAB ENG, V5, P264, DOI 10.1016/j.ymben.2003.09.002; Malaguarnera M, 2012, CURR OPIN GASTROEN, V28, P166, DOI 10.1097/MOG.0b013e3283505a3b; Mardinoglu A, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.5; MASTROGIACOMO F, 1993, J NEUROCHEM, V61, P2007, DOI 10.1111/j.1471-4159.1993.tb07436.x; Matsuzaki T, 2011, NEUROLOGY, V77, P1068, DOI 10.1212/WNL.0b013e31822e145d; Mohler EG, 2011, J NEUROSCI, V31, P5406, DOI 10.1523/JNEUROSCI.4046-10.2011; Molina JA, 2002, J NEURAL TRANSM, V109, P1035, DOI 10.1007/s007020200087; Montine TJ, 1999, NEUROLOGY, V53, P1495, DOI 10.1212/WNL.53.7.1495; Nogales J, 2012, P NATL ACAD SCI USA, V109, P2678, DOI 10.1073/pnas.1117907109; Oberhardt MA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.77; PERRY EK, 1980, NEUROSCI LETT, V18, P105, DOI 10.1016/0304-3940(80)90220-7; Redjems-Bennani N, 1998, GERONTOLOGY, V44, P300, DOI 10.1159/000022031; Riverol Mario, 2011, Front Neurol, V2, P46, DOI 10.3389/fneur.2011.00046; Schumacher M, 2003, PROG NEUROBIOL, V71, P3, DOI 10.1016/j.pneurobio.2003.09.004; Searcy JL, 2012, J ALZHEIMERS DIS, V30, P943, DOI 10.3233/JAD-2012-111661; Serot JM, 2001, J NEURAL TRANSM, V108, P93, DOI 10.1007/s007020170100; Shlomi T, 2008, NAT BIOTECHNOL, V26, P1003, DOI 10.1038/nbt.1487; Stempler S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045879; Stempler S, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2012.04.003; Trushina E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063644; Velayudhan L, 2012, J ALZHEIMERS DIS, V28, P369, DOI 10.3233/JAD-2011-110611; Wang L, 2012, NEUROBIOL AGING, V33; Webster JA, 2009, AM J HUM GENET, V84, P445, DOI 10.1016/j.ajhg.2009.03.011; Yao J, 2011, MOL ASPECTS MED, V32, P247, DOI 10.1016/j.mam.2011.10.005; Yizhak K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3632	50	38	38	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105383	10.1371/journal.pone.0105383	http://dx.doi.org/10.1371/journal.pone.0105383			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127241	Green Published, gold, Green Submitted			2022-12-25	WOS:000340879300108
J	Szuplewska, M; Ludwiczak, M; Lyzwa, K; Czarnecki, J; Bartosik, D				Szuplewska, Magdalena; Ludwiczak, Marta; Lyzwa, Katarzyna; Czarnecki, Jakub; Bartosik, Dariusz			Mobility and Generation of Mosaic Non-Autonomous Transposons by Tn3-Derived Inverted-Repeat Miniature Elements (TIMEs)	PLOS ONE			English	Article							REPABC-TYPE REPLICON; NUCLEOTIDE-SEQUENCE; INSERTION SEQUENCES; SHUTTLE VECTOR; PLASMID PRA2; IDENTIFICATION; ORGANIZATION; OPERON; KUPFERSCHIEFER; CONSTRUCTION	Functional transposable elements (TEs) of several Pseudomonas spp. strains isolated from black shale ore of Lubin mine and from post-flotation tailings of Zelazny Most in Poland, were identified using a positive selection trap plasmid strategy. This approach led to the capture and characterization of (i) 13 insertion sequences from 5 IS families (IS3, IS5, ISL3, IS30 and IS1380), (ii) isoforms of two Tn3-family transposons - Tn5563a and Tn4662a (the latter contains a toxin-antitoxin system), as well as (iii) non-autonomous TEs of diverse structure, ranging in size from 262 to 3892 bp. The non-autonomous elements transposed into AT-rich DNA regions and generated 5- or 6-bp sequence duplications at the target site of transposition. Although these TEs lack a transposase gene, they contain homologous 38-bp-long terminal inverted repeat sequences (IRs), highly conserved in Tn5563a and many other Tn3-family transposons. The simplest elements of this type, designated TIMEs (Tn3 family-derived Inverted-repeat Miniature Elements) (262 bp), were identified within two natural plasmids (pZM1P1 and pLM8P2) of Pseudomonas spp. It was demonstrated that TIMEs are able to mobilize segments of plasmid DNA for transposition, which results in the generation of more complex non-autonomous elements, resembling IS-driven composite transposons in structure. Such transposon-like elements may contain different functional genetic modules in their core regions, including plasmid replication systems. Another non-autonomous element "captured'' with a trap plasmid was a TIME derivative containing a predicted resolvase gene and a res site typical for many Tn3-family transposons. The identification of a portable site-specific recombination system is another intriguing example confirming the important role of non-autonomous TEs of the TIME family in shuffling genetic information in bacterial genomes. Transposition of such mosaic elements may have a significant impact on diversity and evolution, not only of transposons and plasmids, but also of other types of mobile genetic elements.	[Szuplewska, Magdalena; Ludwiczak, Marta; Lyzwa, Katarzyna; Czarnecki, Jakub; Bartosik, Dariusz] Univ Warsaw, Fac Biol, Inst Microbiol, Dept Bacterial Genet, Warsaw, Poland	University of Warsaw	Bartosik, D (corresponding author), Univ Warsaw, Fac Biol, Inst Microbiol, Dept Bacterial Genet, Warsaw, Poland.	bartosik@biol.uw.edu.pl		Czarnecki, Jakub/0000-0003-4372-5143; Bartosik, Dariusz/0000-0002-3589-8864; Szuplewska, Magdalena/0000-0003-1900-4995; Ludwiczak, Marta/0000-0002-5905-4498	National Science Centre, Poland [N N303 579238]	National Science Centre, Poland(National Science Centre, Poland)	This work was supported by the National Science Centre, Poland (grant N N303 579238). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AVILA P, 1988, J BACTERIOL, V170, P1350, DOI 10.1128/jb.170.3.1350-1353.1988; Aziz RK, 2010, NUCLEIC ACIDS RES, V38, P4207, DOI 10.1093/nar/gkq140; Bardaji L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025773; Bartosik D, 2001, J BACTERIOL, V183, P6234, DOI 10.1128/JB.183.21.6234-6243.2001; Bartosik D, 1998, MICROBIOL-UK, V144, P3149, DOI 10.1099/00221287-144-11-3149; Bartosik D, 2008, J BACTERIOL, V190, P3306, DOI 10.1128/JB.01878-07; Bechtel A, 2000, INT J EARTH SCI, V89, P72, DOI 10.1007/s005310050318; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; Chandler M, 2008, MICROBE, V3, P445; Chandler M, 2002, MOBILE DNA, V2, P305; CHEN WP, 1993, NUCLEIC ACIDS RES, V21, P2260, DOI 10.1093/nar/21.9.2260; Chen Y, 2008, GENETICS, V179, P2291, DOI 10.1534/genetics.108.089995; Christie-Oleza JA, 2010, J BACTERIOL, V192, P1423, DOI 10.1128/JB.01336-09; CORREIA FF, 1986, J BACTERIOL, V167, P1009, DOI 10.1128/jb.167.3.1009-1015.1986; CORREIA FF, 1988, J BIOL CHEM, V263, P12194; d'Hugues P, 2008, MINER ENG, V21, P111, DOI 10.1016/j.mineng.2007.10.004; De Gregorio E, 2005, J BACTERIOL, V187, P7945, DOI 10.1128/JB.187.23.7945-7954.2005; De Gregorio E, 2006, J BACTERIOL, V188, P7876, DOI 10.1128/JB.00942-06; De Palmenaer D, 2004, MOL MICROBIOL, V53, P457, DOI 10.1111/j.1365-2958.2004.04146.x; Delihas N, 2008, MOL MICROBIOL, V67, P475, DOI 10.1111/j.1365-2958.2007.06068.x; Delihas N, 2011, GENOME BIOL EVOL, V3, P959, DOI 10.1093/gbe/evr077; Dziewit L, 2007, J BACTERIOL, V189, P1983, DOI 10.1128/JB.01610-06; Dziewit L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032277; FISCHHOFF DA, 1980, J MOL BIOL, V144, P247, DOI 10.1016/0022-2836(80)90089-3; GAY P, 1985, J BACTERIOL, V164, P918, DOI 10.1128/JB.164.2.918-921.1985; Grindley NDF, 2002, MOBILE DNA, P272; Haines AS, 2006, MICROBIOL-SGM, V152, P2689, DOI 10.1099/mic.0.28941-0; Haines AS, 2005, J BACTERIOL, V187, P4728, DOI 10.1128/JB.187.14.4728-4738.2005; ISHIZAKI K, 1985, MOL GEN GENET, V199, P388, DOI 10.1007/BF00330747; Kholodii GY, 1997, MICROBIOL-SGM, V143, P2549, DOI 10.1099/00221287-143-8-2549; Kushner SR, 1978, GENET ENG N Y, P17; Kwong SM, 1998, FEMS MICROBIOL LETT, V158, P159, DOI 10.1111/j.1574-6968.1998.tb12815.x; Lauf U, 1998, MOL GEN GENET, V259, P674, DOI 10.1007/s004380050862; Marx CJ, 2001, MICROBIOL-SGM, V147, P2065, DOI 10.1099/00221287-147-8-2065; Matlakowska R, 2009, J APPL MICROBIOL, V107, P858, DOI 10.1111/j.1365-2672.2009.04261.x; Mikosa M, 2006, MICROBIOL-SGM, V152, P1063, DOI 10.1099/mic.0.28603-0; Nagy Z, 2004, RES MICROBIOL, V155, P387, DOI 10.1016/j.resmic.2004.01.008; NAKATSU C, 1991, P NATL ACAD SCI USA, V88, P8312, DOI 10.1073/pnas.88.19.8312; Oszczepalski S, 1999, MINER DEPOSITA, V34, P599, DOI 10.1007/s001260050222; Peters M, 1997, APPL ENVIRON MICROB, V63, P4899, DOI 10.1128/AEM.63.12.4899-4906.1997; Qin XT, 2001, CURR MICROBIOL, V43, P158, DOI 10.1007/s002840010280; Rodriguez-Herva JJ, 2007, ENVIRON MICROBIOL, V9, P1550, DOI 10.1111/j.1462-2920.2007.01276.x; Sambrook J, 2001, MOL CLONING LAB MANU; Segura A, 2003, EXTREMOPHILES, V7, P371, DOI 10.1007/s00792-003-0331-x; SHERRATT D, 1989, MOBILE DNA, P163; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; Sklodowska A, 2005, GEOMICROBIOL J, V22, P65, DOI 10.1080/01490450590922596; Stavrinides J, 2004, J BACTERIOL, V186, P5101, DOI [10.1128/JB.186.15.5101-5115.2004, 10.1128/jb.186.15.5101-5115.2004]; Szuplewska M, 2009, FEMS MICROBIOL LETT, V292, P216, DOI 10.1111/j.1574-6968.2009.01495.x; Thibodeau SA, 2004, BIOTECHNIQUES, V36, P410, DOI 10.2144/04363BM07; Toleman MA, 2006, MICROBIOL MOL BIOL R, V70, P296, DOI 10.1128/MMBR.00048-05; Woo PCY, 2007, BIOTECHNOL LETT, V29, P1575, DOI 10.1007/s10529-007-9447-x; Yano H, 2010, J BACTERIOL, V192, P4337, DOI 10.1128/JB.00359-10; Yeo CC, 1998, FEMS MICROBIOL LETT, V165, P253, DOI 10.1016/S0378-1097(98)00286-9; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	56	21	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e105010	10.1371/journal.pone.0105010	http://dx.doi.org/10.1371/journal.pone.0105010			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121765	Green Published, Green Submitted, gold			2022-12-25	WOS:000341017000087
J	Han, WJ; Wang, WS; Zhao, M; Sugahara, K; Li, FC				Han, Wenjun; Wang, Wenshuang; Zhao, Mei; Sugahara, Kazuyuki; Li, Fuchuan			A Novel Eliminase from a Marine Bacterium That Degrades Hyaluronan and Chondroitin Sulfate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chondroitin Sulfate; Glycosaminoglycan; Hyaluronan; Hyaluronidase; Proteoglycan; Chondroitinase; Eliminase; Lyase; Marine Bacterium	DERMATAN SULFATE; HYBRID CHAINS; HEXASACCHARIDE SEQUENCES; NEURITOGENIC ACTIVITY; POLYMERIZING FACTOR; BINDING ACTIVITIES; MOLECULAR-CLONING; GROWTH-FACTORS; GENES; PROTEOGLYCANS	Background: Glycosaminoglycan (GAG) lyases have been widely isolated from terrestrial but not marine bacteria. Results: A novel GAG lyase (HCLase) was identified for the first time from a marine bacterium. Conclusion: The HCLase has very low homology to the characterized conventional GAG lyases and possesses very unique biochemical characteristics. Significance: HCLase will be useful for chondroitin sulfate/hyaluronan-related research and applications. Lyases cleave glycosaminoglycans (GAGs) in an eliminative mechanism and are important tools for the structural analysis and oligosaccharide preparation of GAGs. Various GAG lyases have been identified from terrestrial but not marine organisms even though marine animals are rich in GAGs with unique structures and functions. Herein we isolated a novel GAG lyase for the first time from the marine bacterium Vibrio sp. FC509 and then recombinantly expressed and characterized it. It showed strong lyase activity toward hyaluronan (HA) and chondroitin sulfate (CS) and was designated as HA and CS lyase (HCLase). It exhibited the highest activities to both substrates at pH 8.0 and 0.5 m NaCl at 30 degrees C. Its activity toward HA was less sensitive to pH than its CS lyase activity. As with most other marine enzymes, HCLase is a halophilic enzyme and very stable at temperatures from 0 to 40 degrees C for up to 24 h, but its activity is independent of divalent metal ions. The specific activity of HCLase against HA and CS reached a markedly high level of hundreds of thousands units/mg of protein under optimum conditions. The HCLase-resistant tetrasaccharide (4,5)HexUA1-3GalNAc(6-O-sulfate)1-4GlcUA(2-O-sulfate)1-3GalNAc(6-O-sulfate) was isolated from CS-D, the structure of which indicated that HCLase could not cleave the galactosaminidic linkage bound to 2-O-sulfated d-glucuronic acid (GlcUA) in CS chains. Site-directed mutagenesis indicated that HCLase may work via a catalytic mechanism in which Tyr-His acts as the BrOnsted base and acid. Thus, the identification of HCLase provides a useful tool for HA- and CS-related research and applications.	[Han, Wenjun; Wang, Wenshuang; Zhao, Mei; Li, Fuchuan] Shandong Univ, Natl Glycoengn Res Ctr, Jinan 250100, Peoples R China; [Han, Wenjun; Wang, Wenshuang; Zhao, Mei; Li, Fuchuan] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China; [Sugahara, Kazuyuki] Hokkaido Univ, Grad Sch Life Sci, Fac Adv Life Sci, Proteoglycan Signaling & Therapeut Res Grp, Sapporo, Hokkaido 0010021, Japan	Shandong University; Shandong University; Hokkaido University	Li, FC (corresponding author), Shandong Univ, Natl Glycoengn Res Ctr, 27 S Shanda Rd, Jinan 250100, Peoples R China.	fuchuanli@sdu.edu.cn	Han, Wenjun/N-7214-2014		National High Technology Research and Development Program of China [2012AA021504]; Major State Basic Research Development Program of China [2012CB822102]; Shandong Province Science and Technology Development Plan Grant [2013GSF12106]; China Postdoctoral Science Foundation [2013M531588]; Specialized Research Fund for the Doctoral Program of Higher Education [20130131120079]; Japan Society for the Promotion of Science [25670018]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Major State Basic Research Development Program of China(National Basic Research Program of China); Shandong Province Science and Technology Development Plan Grant; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by National High Technology Research and Development Program of China Grant 2012AA021504, Major State Basic Research Development Program of China Grant 2012CB822102, Shandong Province Science and Technology Development Plan Grant 2013GSF12106, General Financial Grant from China Postdoctoral Science Foundation Grant 2013M531588, and Specialized Research Fund for the Doctoral Program of Higher Education Grant 20130131120079 and in part by Grant-in-aid for Challenging Exploratory Research 25670018 from the Japan Society for the Promotion of Science.	Apweiler R, 2001, NUCLEIC ACIDS RES, V29, P37, DOI 10.1093/nar/29.1.37; Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070; Bergefall K, 2005, J BIOL CHEM, V280, P32193, DOI 10.1074/jbc.M503645200; BIGGE JC, 1995, ANAL BIOCHEM, V230, P229, DOI 10.1006/abio.1995.1468; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; BRAMHALL S, 1969, ANAL BIOCHEM, V31, P146, DOI 10.1016/0003-2697(69)90251-6; CHENG F, 1994, GLYCOBIOLOGY, V4, P685, DOI 10.1093/glycob/4.5.685; Claudel-Renard C, 2003, NUCLEIC ACIDS RES, V31, P6633, DOI 10.1093/nar/gkg847; Clement AM, 1998, J BIOL CHEM, V273, P28444, DOI 10.1074/jbc.273.43.28444; ERNST S, 1995, CRIT REV BIOCHEM MOL, V30, P387, DOI 10.3109/10409239509083490; FAISSNER A, 1994, J CELL BIOL, V126, P783, DOI 10.1083/jcb.126.3.783; Garron ML, 2010, GLYCOBIOLOGY, V20, P1547, DOI 10.1093/glycob/cwq122; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guo X., 2014, PLOS ONE, V9; Haft DH, 2003, NUCLEIC ACIDS RES, V31, P371, DOI 10.1093/nar/gkg128; Hashimoto W, 2001, APPL ENVIRON MICROB, V67, P713, DOI 10.1128/AEM.67.2.713-720.2001; HIYAMA K, 1975, J BIOL CHEM, V250, P1824; Hsiao JC, 1999, J VIROL, V73, P8750, DOI 10.1128/JVI.73.10.8750-8761.1999; Hwang HY, 2003, NATURE, V423, P439, DOI 10.1038/nature01634; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Izumikawa T, 2004, J BIOL CHEM, V279, P53755, DOI 10.1074/jbc.M409615200; Izumikawa T, 2007, BIOCHEM J, V403, P545, DOI 10.1042/BJ20061876; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kaneiwa T, 2010, GLYCOBIOLOGY, V20, P300, DOI 10.1093/glycob/cwp174; Kinoshita A, 1999, ANAL BIOCHEM, V269, P367, DOI 10.1006/abio.1999.4027; Kitagawa H, 2003, J BIOL CHEM, V278, P23666, DOI 10.1074/jbc.M302493200; Kluppel M, 2005, DEVELOPMENT, V132, P3989, DOI 10.1242/dev.01948; Kusche-Gullberg M, 2003, CURR OPIN STRUC BIOL, V13, P605, DOI 10.1016/j.sbi.2003.08.002; Kushner D.J., 1988, HALOPHILIC BACTERIA, V1, P109; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lee A, 2010, DERMATOL SURG, V36, P1071, DOI 10.1111/j.1524-4725.2010.01585.x; Li FC, 2007, J BIOL CHEM, V282, P2956, DOI 10.1074/jbc.M609296200; Li FC, 2010, J BIOL CHEM, V285, P27673, DOI 10.1074/jbc.M110.118703; Linhardt RJ, 2006, ADV PHARMACOL, V53, P187, DOI 10.1016/S1054-3589(05)53009-6; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Maccarana M, 2006, J BIOL CHEM, V281, P11560, DOI 10.1074/jbc.M513373200; Marchesi JR, 1998, APPL ENVIRON MICROB, V64, P795; Mizuguchi S, 2003, NATURE, V423, P443, DOI 10.1038/nature01635; Mizumoto S, 2013, J BIOL CHEM, V288, P10953, DOI 10.1074/jbc.R112.437038; Mizumoto S, 2013, GLYCOBIOLOGY, V23, P155, DOI 10.1093/glycob/cws137; Nadanaka S, 1998, J BIOL CHEM, V273, P3296, DOI 10.1074/jbc.273.6.3296; Nandi S, 2006, BLOOD, V107, P786, DOI 10.1182/blood-2005-05-1822; Nandini CD, 2005, J BIOL CHEM, V280, P4058, DOI 10.1074/jbc.M412074200; Nandini CD, 2004, J BIOL CHEM, V279, P50799, DOI 10.1074/jbc.M404746200; Nielsen M, 2010, NUCLEIC ACIDS RES, V38, pW576, DOI 10.1093/nar/gkq535; OHYA T, 1970, BIOCHIM BIOPHYS ACTA, V198, P607, DOI 10.1016/0005-2744(70)90139-7; Pati A, 2010, NAT METHODS, V7, P455, DOI [10.1038/nmeth.1457, 10.1038/NMETH.1457]; Penc SF, 1998, J BIOL CHEM, V273, P28116, DOI 10.1074/jbc.273.43.28116; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; POOLE AR, 1986, BIOCHEM J, V236, P1; Ramachandra R, 2014, GLYCOBIOLOGY, V24, P195, DOI 10.1093/glycob/cwt100; Sambrook J, 2001, MOL CLONING LAB MANU; Sharma K, 2012, EXP NEUROL, V237, P370, DOI 10.1016/j.expneurol.2012.07.009; Silbert JE, 2002, IUBMB LIFE, V54, P177, DOI 10.1080/15216540214923; Stern R, 2006, CHEM REV, V106, P818, DOI 10.1021/cr050247k; Sugahara K, 2003, CURR OPIN STRUC BIOL, V13, P612, DOI 10.1016/j.sbi.2003.09.011; TAM YC, 1985, INFECT IMMUN, V47, P508, DOI 10.1128/IAI.47.2.508-513.1985; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Taylor KR, 2006, FASEB J, V20, P9, DOI 10.1096/fj.05-4682rev; Trowbridge JM, 2002, J BIOL CHEM, V277, P42815, DOI 10.1074/jbc.M204959200; VIEIRA RP, 1991, J BIOL CHEM, V266, P13530; Williams RK, 1997, J VIROL, V71, P1375, DOI 10.1128/JVI.71.2.1375-1380.1997; YAMAGATA T, 1968, J BIOL CHEM, V243, P1523; Yoshida K., 1993, DERMATAN SULFATE PRO, P55	65	38	43	1	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27886	27898		10.1074/jbc.M114.590752	http://dx.doi.org/10.1074/jbc.M114.590752			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25122756	Green Published, hybrid			2022-12-25	WOS:000342852800044
J	Shridas, P; Zahoor, L; Forrest, KJ; Layne, JD; Webb, NR				Shridas, Preetha; Zahoor, Lubna; Forrest, Kathy J.; Layne, Joseph D.; Webb, Nancy R.			Group X Secretory Phospholipase A(2) Regulates Insulin Secretion through a Cyclooxygenase-2-dependent Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cyclooxygenase (COX); Insulin Secretion; Pancreatic Islet; Prostaglandin; Type 2 Diabetes	BETA-CELL FUNCTION; RAT PANCREATIC-ISLETS; PROTEIN-KINASE-C; ARACHIDONIC-ACID; GROUP-V; EXPRESSION; GLUCOSE; INHIBITION; IDENTIFICATION; COX-2	Background: Arachidonic acid and its metabolites regulate pancreatic glucose-stimulated insulin secretion (GSIS) through multiple mechanisms. Results: Group X secretory phospholipase A(2) (GX sPLA(2)) suppresses GSIS; suppression was abolished when COX-2 activity or PGE2-EP3 receptor signaling were inhibited. Conclusion: GX sPLA(2) inhibits GSIS by augmenting PGE2 production. Significance: GX sPLA(2) may be targeted for ameliorating beta cell dysfunction in type 2 diabetes. Group X secretory phospholipase A(2) (GX sPLA(2)) potently hydrolyzes membrane phospholipids to release arachidonic acid (AA). While AA is an activator of glucose-stimulated insulin secretion (GSIS), its metabolite prostaglandin E2 (PGE2) is a known inhibitor. In this study, we determined that GX sPLA(2) is expressed in insulin-producing cells of mouse pancreatic islets and investigated its role in beta cell function. GSIS was measured in vivo in wild-type (WT) and GX sPLA(2)-deficient (GX KO) mice and ex vivo using pancreatic islets isolated from WT and GX KO mice. GSIS was also assessed in vitro using mouse MIN6 pancreatic beta cells with or without GX sPLA(2) overexpression or exogenous addition. GSIS was significantly higher in islets isolated from GX KO mice compared with islets from WT mice. Conversely, GSIS was lower in MIN6 cells overexpressing GX sPLA(2) (MIN6-GX) compared with control (MIN6-C) cells. PGE2 production was significantly higher in MIN6-GX cells compared with MIN6-C cells and this was associated with significantly reduced cellular cAMP. The effect of GX sPLA(2) on GSIS was abolished when cells were treated with NS398 (a COX-2 inhibitor) or L-798,106 (a PGE2-EP3 receptor antagonist). Consistent with enhanced beta cell function, GX KO mice showed significantly increased plasma insulin levels following glucose challenge and were protected from age-related reductions in GSIS and glucose tolerance compared with WT mice. We conclude that GX sPLA(2) plays a previously unrecognized role in negatively regulating pancreatic insulin secretion by augmenting COX-2-dependent PGE2 production.	[Shridas, Preetha; Zahoor, Lubna; Forrest, Kathy J.; Layne, Joseph D.; Webb, Nancy R.] Univ Kentucky, Med Ctr, Saha Cardiovasc Res Ctr, Lexington, KY 40536 USA; [Shridas, Preetha; Zahoor, Lubna; Forrest, Kathy J.] Univ Kentucky, Med Ctr, Dept Internal Med, Lexington, KY 40536 USA; [Layne, Joseph D.; Webb, Nancy R.] Univ Kentucky, Med Ctr, Dept Pharmacol & Nutr Sci, Div Nutr Sci, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky; University of Kentucky	Shridas, P (corresponding author), Dept Internal Med, 537 CT Wethington Bldg,900 S Limestone St, Lexington, KY 40536 USA.	pshri2@uky.edu	Webb, Nancy/AAL-7030-2021		National Institutes of Health [R01 DK082419]; NIGMS [8 P20 GM103527-05]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082419, T32DK007778] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103527] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in whole or in part by National Institutes of Health Grant R01 DK082419 (to N. R. W.) and the NIGMS Grant 8 P20 GM103527-05 (to P. S.).	Bao SZ, 2006, J BIOL CHEM, V281, P20958, DOI 10.1074/jbc.M600075200; BENNETT DL, 1992, J BIOL CHEM, V267, P15229; Chen M, 1996, ENDOCRINOLOGY, V137, P2901, DOI 10.1210/en.137.7.2901; COLEMAN RA, 1994, PHARMACOL REV, V46, P205; Cupillard L, 1997, J BIOL CHEM, V272, P15745, DOI 10.1074/jbc.272.25.15745; Degousee N, 2002, J BIOL CHEM, V277, P5061, DOI 10.1074/jbc.M109083200; Dennis EA, 2011, CHEM REV, V111, P6130, DOI 10.1021/cr200085w; Dubois RN, 1998, FASEB J, V12, P1063, DOI 10.1096/fasebj.12.12.1063; Fryirs M, 2009, CURR OPIN LIPIDOL, V20, P159, DOI 10.1097/MOL.0b013e32832ac180; Fujita H, 2007, BIOCHEM BIOPH RES CO, V363, P37, DOI 10.1016/j.bbrc.2007.08.090; Ishida-Oku M, 2010, ISLETS, V2, P274, DOI 10.4161/isl.2.5.12728; Jemel I, 2011, J BIOL CHEM, V286, P36509, DOI 10.1074/jbc.M111.268540; Jones PM, 2004, DIABETES, V53, pS172, DOI 10.2337/diabetes.53.2007.S172; JONES PM, 1993, J ENDOCRINOL, V137, P7, DOI 10.1677/joe.0.1370007; Juhl K, 2003, AM J PHYSIOL-ENDOC M, V285, pE73, DOI 10.1152/ajpendo.00086.2003; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Keane D, 2008, BIOCHEM SOC T, V36, P955, DOI 10.1042/BST0360955; KENNEDY BP, 1995, J BIOL CHEM, V270, P22378, DOI 10.1074/jbc.270.38.22378; Kimple ME, 2013, DIABETES, V62, P1904, DOI 10.2337/db12-0769; Kruit JK, 2012, DIABETES, V61, P659, DOI 10.2337/db11-1341; Labonte ED, 2006, DIABETES, V55, P935, DOI 10.2337/diabetes.55.04.06.db05-1286; Lambeau G, 2008, ANNU REV BIOCHEM, V77, P495, DOI 10.1146/annurev.biochem.76.062405.154007; LANDT M, 1992, CELL CALCIUM, V13, P163, DOI 10.1016/0143-4160(92)90044-S; Li X, 2010, FASEB J, V24, P4313, DOI 10.1096/fj.10-154716; Luo PC, 2011, PROSTAG OTH LIPID M, V95, P1, DOI 10.1016/j.prostaglandins.2011.06.001; Meng ZX, 2006, DIABETOLOGIA, V49, P2959, DOI 10.1007/s00125-006-0447-5; Meng ZX, 2009, ENDOCRINOLOGY, V150, P5284, DOI 10.1210/en.2009-0671; METZ SA, 1988, DIABETES, V37, P1453, DOI 10.2337/diabetes.37.11.1453; Morioka Y, 2000, FEBS LETT, V487, P262, DOI 10.1016/S0014-5793(00)02350-4; Mounier CM, 2004, J BIOL CHEM, V279, P25024, DOI 10.1074/jbc.M313019200; Murakami M, 2011, PROG LIPID RES, V50, P152, DOI 10.1016/j.plipres.2010.12.001; NEWGARD CB, 1995, ANNU REV BIOCHEM, V64, P689, DOI 10.1146/annurev.biochem.64.1.689; Ohtsuki M, 2006, J BIOL CHEM, V281, P36420, DOI 10.1074/jbc.M607975200; Persaud SJ, 2007, DIABETES, V56, P197, DOI 10.2337/db06-0490; Persaud SJ, 2004, DIABETES, V53, pS190, DOI 10.2337/diabetes.53.2007.S190; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; RAMANADHAM S, 1993, BIOCHEMISTRY-US, V32, P5339, DOI 10.1021/bi00071a009; Ramanadham S, 1998, BBA-LIPID LIPID MET, V1390, P301, DOI 10.1016/S0005-2760(97)00189-6; ROBERTSON RP, 1987, DIABETES, V36, P1047, DOI 10.2337/diabetes.36.9.1047; Shridas P, 2010, ARTERIOSCL THROM VAS, V30, P2014, DOI 10.1161/ATVBAHA.110.210237; Shridas P, 2010, J BIOL CHEM, V285, P20031, DOI 10.1074/jbc.M109.090423; SMEEKENS SP, 1992, P NATL ACAD SCI USA, V89, P8822, DOI 10.1073/pnas.89.18.8822; Smyth EM, 2009, J LIPID RES, V50, pS423, DOI 10.1194/jlr.R800094-JLR200; Song K, 2005, MOL ENDOCRINOL, V19, P504, DOI 10.1210/me.2004-0169; Sorli CH, 1998, P NATL ACAD SCI USA, V95, P1788, DOI 10.1073/pnas.95.4.1788; Tran POT, 2002, DIABETES, V51, P1772, DOI 10.2337/diabetes.51.6.1772; Tran POT, 1999, J BIOL CHEM, V274, P31245, DOI 10.1074/jbc.274.44.31245; Wooton-Kee CR, 2004, ARTERIOSCL THROM VAS, V24, P762, DOI 10.1161/01.ATV.0000122363.02961.c1; Yajima H, 1999, DIABETES, V48, P1006, DOI 10.2337/diabetes.48.5.1006	49	23	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27410	27417		10.1074/jbc.M114.591735	http://dx.doi.org/10.1074/jbc.M114.591735			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25122761	Green Published, hybrid			2022-12-25	WOS:000342852800005
J	Stewart, MD; Cole, TR; Igumenova, TI				Stewart, Mikaela D.; Cole, Taylor R.; Igumenova, Tatyana I.			Interfacial Partitioning of a Loop Hinge Residue Contributes to Diacylglycerol Affinity of Conserved Region 1 Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Diacylglycerol; Lipid Signaling; Nuclear Magnetic Resonance (NMR); Phosphatidylserine; Protein Kinase C (PKC); C1 Domain; Protein-Lipid Interaction	PROTEIN-KINASE-C; PHORBOL ESTER BINDING; CYSTEINE-RICH REGION; MEMBRANE INTERFACES; C1B DOMAIN; ACTIVATION MECHANISMS; LIPID INTERACTION; MIXED MICELLES; SIDE-CHAINS; PKC-DELTA	Background: The activity of protein kinase C isoenzymes (PKCs) is regulated by diacylglycerol (DAG). Results: Aromatic residue that tunes DAG affinity influences the recruitment of the conserved region 1 (C1) regulatory domain to a membrane mimic. Conclusion: Membrane pre-association step contributes to the affinity of C1 to diacylglycerol. Significance: This work offers insight into the origin of differential DAG affinities in PKCs. Conventional and novel isoenzymes of PKC are activated by the membrane-embedded second messenger diacylglycerol (DAG) through its interactions with the C1 regulatory domain. The affinity of C1 domains to DAG varies considerably among PKCs. To gain insight into the origin of differential DAG affinities, we conducted high-resolution NMR studies of C1B domain from PKC (C1B) and its W252Y variant. The W252Y mutation was previously shown to render C1B less responsive to DAG (Dries, D. R., Gallegos, L. L., and Newton, A. C. (2007) A single residue in the C1 domain sensitizes novel protein kinase C isoforms to cellular diacylglycerol production. J. Biol. Chem. 282, 826-830) and thereby emulate the behavior of C1B domains from conventional PKCs that have a conserved Tyr at the equivalent position. Our data revealed that W252Y mutation did not perturb the conformation of C1B in solution but significantly reduced its propensity to partition into a membrane-mimicking environment in the absence of DAG. Using detergent micelles doped with a paramagnetic lipid, we determined that both the residue identity at position 252 and complexation with diacylglycerol influence the geometry of C1B-micelle interactions. In addition, we identified the C-terminal helix 1 of C1B as an interaction site with the head groups of phosphatidylserine, a known activator of PKC. Taken together, our studies (i) reveal the identities of C1B residues involved in interactions with membrane-mimicking environment, DAG, and phosphatidylserine, as well as the affinities associated with each event and (ii) suggest that the initial ligand-independent membrane recruitment of C1B domains, which is greatly facilitated by the interfacial partitioning of Trp-252, is responsible, at least in part, for the differential DAG affinities.	[Stewart, Mikaela D.; Cole, Taylor R.; Igumenova, Tatyana I.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Igumenova, TI (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, 300 Olsen Blvd, College Stn, TX 77843 USA.	tigumenova@tamu.edu	Stewart, Mikaela/GXN-3417-2022	Stewart, Mikaela/0000-0002-0809-9469	Texas AM University; NSF CAREER Award [CHE-1151435]; Welch Foundation [A-1784]; Direct For Mathematical & Physical Scien [1151435] Funding Source: National Science Foundation	Texas AM University; NSF CAREER Award(National Science Foundation (NSF)NSF - Office of the Director (OD)); Welch Foundation(The Welch Foundation); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by the startup funds from Texas A&M University and NSF CAREER Award CHE-1151435 ( to T. I. I.).; Supported by Welch Foundation Grant A-1784 ( to T. I. I.).	Ananthanarayanan B, 2003, J BIOL CHEM, V278, P46886, DOI 10.1074/jbc.M307853200; Balayssac S, 2009, J MAGN RESON, V196, P78, DOI 10.1016/j.jmr.2008.09.022; BELL RM, 1991, J BIOL CHEM, V266, P4661; BELL RM, 1986, CELL, V45, P631, DOI 10.1016/0092-8674(86)90774-9; Bittova L, 2001, J BIOL CHEM, V276, P4218, DOI 10.1074/jbc.M008491200; Bowie JU, 2005, NATURE, V438, P581, DOI 10.1038/nature04395; Choi Y, 2007, J MED CHEM, V50, P3465, DOI 10.1021/jm0702579; Dancea F, 2008, BIOPHYS J, V94, P515, DOI 10.1529/biophysj.107.115923; de Jesus AJ, 2013, BBA-BIOMEMBRANES, V1828, P864, DOI 10.1016/j.bbamem.2012.09.009; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dougherty DA, 2007, J NUTR, V137, p1504S, DOI 10.1093/jn/137.6.1504S; Dries DR, 2008, J BIOL CHEM, V283, P7885, DOI 10.1074/jbc.M709943200; Dries DR, 2007, J BIOL CHEM, V282, P826, DOI 10.1074/jbc.C600268200; Gallegos LL, 2008, IUBMB LIFE, V60, P782, DOI 10.1002/iub.122; Garg R, 2014, ONCOGENE, V33, P5225, DOI 10.1038/onc.2013.524; Giorgione JR, 2006, J BIOL CHEM, V281, P1660, DOI 10.1074/jbc.M510251200; Goddard T. D., 2008, SPARKY 3; HANNUN YA, 1985, J BIOL CHEM, V260, P39; Haynes W. M., 2014, CRC HDB CHEM PHYS, P9; HOMMEL U, 1994, NAT STRUCT BIOL, V1, P383, DOI 10.1038/nsb0694-383; Hurley JH, 1997, PROTEIN SCI, V6, P477; Irie K, 1998, J AM CHEM SOC, V120, P9159, DOI 10.1021/ja981087f; Irie K, 2002, PHARMACOL THERAPEUT, V93, P271, DOI 10.1016/S0163-7258(02)00196-1; Jackson DN, 2004, FASEB J, V18, P627, DOI 10.1096/fj.03-0979rev; Johnson JE, 2000, BIOCHEMISTRY-US, V39, P11360, DOI 10.1021/bi000902c; KAZANIETZ MG, 1995, J BIOL CHEM, V270, P14679, DOI 10.1074/jbc.270.24.14679; KAZANIETZ MG, 1995, J BIOL CHEM, V270, P21852, DOI 10.1074/jbc.270.37.21852; Killian JA, 2000, TRENDS BIOCHEM SCI, V25, P429, DOI 10.1016/S0968-0004(00)01626-1; Kucerka N, 2005, J MEMBRANE BIOL, V208, P193, DOI 10.1007/s00232-005-7006-8; Kucerka N, 2008, BIOPHYS J, V95, P2356, DOI 10.1529/biophysj.108.132662; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAUTERWEIN J, 1979, BIOCHIM BIOPHYS ACTA, V556, P244, DOI 10.1016/0005-2736(79)90046-4; LEE MH, 1989, J BIOL CHEM, V264, P14797; LYONS BA, 1993, J MAGN RESON SER B, V101, P206, DOI 10.1006/jmrb.1993.1034; Medkova M, 1999, J BIOL CHEM, V274, P19852, DOI 10.1074/jbc.274.28.19852; Medkova M, 1998, BIOCHEMISTRY-US, V37, P4892, DOI 10.1021/bi972495j; MORI S, 1995, J MAGN RESON SER B, V108, P94, DOI 10.1006/jmrb.1995.1109; MUHANDIRAM DR, 1994, J MAGN RESON SER B, V103, P203, DOI 10.1006/jmrb.1994.1032; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; NEWTON AC, 1989, J BIOL CHEM, V264, P14909; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; Pogozheva ID, 2013, BBA-BIOMEMBRANES, V1828, P2592, DOI 10.1016/j.bbamem.2013.06.023; Pu YM, 2009, J BIOL CHEM, V284, P1302, DOI 10.1074/jbc.M804796200; QUEST AFG, 1994, J BIOL CHEM, V269, P2953; Rosse C, 2010, NAT REV MOL CELL BIO, V11, P103, DOI 10.1038/nrm2847; Sanchez-Bautista S, 2009, BIOPHYS J, V96, P3638, DOI 10.1016/j.bpj.2009.02.021; Saraiva L, 2004, EUR J PHARMACOL, V491, P101, DOI 10.1016/j.ejphar.2004.03.035; Schramm CA, 2012, STRUCTURE, V20, P924, DOI 10.1016/j.str.2012.03.016; Schumann FH, 2007, J BIOMOL NMR, V39, P275, DOI 10.1007/s10858-007-9197-z; Shanmugasundararaj S, 2012, BIOPHYS J, V103, P2331, DOI 10.1016/j.bpj.2012.10.034; Shen N, 2005, BIOCHEMISTRY-US, V44, P1089, DOI 10.1021/bi0476127; Slater SJ, 1996, J BIOL CHEM, V271, P4627; Stace CL, 2006, BBA-MOL CELL BIOL L, V1761, P913, DOI 10.1016/j.bbalip.2006.03.006; Stahelin RV, 2004, J BIOL CHEM, V279, P29501, DOI 10.1074/jbc.M403191200; Stewart MD, 2011, J MOL BIOL, V408, P949, DOI 10.1016/j.jmb.2011.03.020; Szallasi Z, 1996, J BIOL CHEM, V271, P18299, DOI 10.1074/jbc.271.31.18299; Tristram-Nagle S, 2010, J MOL BIOL, V402, P139, DOI 10.1016/j.jmb.2010.07.026; Ulmschneider MB, 2001, BBA-BIOMEMBRANES, V1512, P1, DOI 10.1016/S0005-2736(01)00299-1; Wang QMJ, 2001, J BIOL CHEM, V276, P19580, DOI 10.1074/jbc.M010089200; White SH, 1998, BBA-REV BIOMEMBRANES, V1376, P339, DOI 10.1016/S0304-4157(98)00021-5; Wilcox C. S., 1991, FRONTIERS SUPRAMOLEC, P123; Wimley WC, 1996, BIOCHEMISTRY-US, V35, P5109, DOI 10.1021/bi9600153; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; Xu RX, 1997, BIOCHEMISTRY-US, V36, P10709, DOI 10.1021/bi970833a; Yau WM, 1998, BIOCHEMISTRY-US, V37, P14713, DOI 10.1021/bi980809c; ZHANG GG, 1995, CELL, V81, P917, DOI 10.1016/0092-8674(95)90011-X; Ziemba BP, 2014, BIOCHEMISTRY-US, V53, P1697, DOI 10.1021/bi4016082	67	12	13	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27653	27664		10.1074/jbc.M114.585570	http://dx.doi.org/10.1074/jbc.M114.585570			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25124034	Green Published, hybrid			2022-12-25	WOS:000342852800025
J	Wolny, M; Batchelor, M; Knight, PJ; Paci, E; Dougan, L; Peckham, M				Wolny, Marcin; Batchelor, Matthew; Knight, Peter J.; Paci, Emanuele; Dougan, Lorna; Peckham, Michelle			Stable Single alpha-Helices Are Constant Force Springs in Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Atomic Force Microscopy (AFM); Circular Dichroism (CD); Cytoskeleton; Molecular Dynamics; Structural Biology; Single -Helices	COILED-COIL; CIRCULAR-DICHROISM; MYOSIN-X; MICROSCOPY; LENGTH; ACTIN; ELASTICITY; STABILITY; FILAMENT; MYOMESIN	Background: Single -helix (SAH) domains bridge two functional domains in proteins. Their force response is poorly understood. Results: Modeling and experiments show that SAH domains unfold non-cooperatively at low forces and maintain an approximately constant force as they unfold. Conclusion: SAH domains act as constant force springs. Significance: SAH domains are important mechanical elements in proteins. Single -helix (SAH) domains are rich in charged residues (Arg, Lys, and Glu) and stable in solution over a wide range of pH and salt concentrations. They are found in many different proteins where they bridge two functional domains. To test the idea that their high stability might enable these proteins to resist unfolding along their length, the properties and unfolding behavior of the predicted SAH domain from myosin-10 were characterized. The expressed and purified SAH domain was highly helical, melted non-cooperatively, and was monomeric as shown by circular dichroism and mass spectrometry as expected for a SAH domain. Single molecule force spectroscopy experiments showed that the SAH domain unfolded at very low forces (<30 pN) without a characteristic unfolding peak. Molecular dynamics simulations showed that the SAH domain unfolds progressively as the length is increased and refolds progressively as the length is reduced. This enables the SAH domain to act as a constant force spring in the mechanically dynamic environment of the cell.	[Wolny, Marcin; Batchelor, Matthew; Knight, Peter J.; Paci, Emanuele; Dougan, Lorna; Peckham, Michelle] Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England	University of Leeds	Peckham, M (corresponding author), Univ Leeds, Sch Mol & Cellular Biol, Fac Biol Sci, Miall Bldg, Leeds LS2 9JT, W Yorkshire, England.	m.peckham@leeds.ac.uk	Paci, Emanuele/B-1893-2010; Peckham, Michelle/J-4991-2015	Paci, Emanuele/0000-0002-4891-2768; Peckham, Michelle/0000-0002-3754-2028; Batchelor, Matthew/0000-0001-6338-5698; Dougan, Lorna/0000-0002-2620-5827; Wolny, Marcin/0000-0003-1030-7607	Biotechnology and Biological Sciences Research Council [BB/I007423/1]; BBSRC [BB/I007423/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council Grant BB/I007423/1.	Baboolal TG, 2009, P NATL ACAD SCI USA, V106, P22193, DOI [10.1073/pnas.0909851106, 10.1073/pnas.09098S1106]; Berg JS, 2000, J CELL SCI, V113, P3439; Berkemeier F, 2011, P NATL ACAD SCI USA, V108, P14139, DOI 10.1073/pnas.1105734108; Borgia MB, 2011, NATURE, V474, P662, DOI 10.1038/nature10099; Brockwell DJ, 2002, BIOPHYS J, V83, P458, DOI 10.1016/S0006-3495(02)75182-5; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P11288, DOI 10.1073/pnas.96.20.11288; FAIRMAN R, 1989, PROTEINS, V5, P1, DOI 10.1002/prot.340050102; FLORY PJ, 1956, J AM CHEM SOC, V78, P5222, DOI 10.1021/ja01601a025; Grati M, 2011, P NATL ACAD SCI USA, V108, P11476, DOI 10.1073/pnas.1104161108; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; Haberthur U, 2008, J COMPUT CHEM, V29, P701, DOI 10.1002/jcc.20832; Hoffmann T, 2013, J PHYS CHEM B, V117, P1819, DOI 10.1021/jp310442s; HUTTER JL, 1993, REV SCI INSTRUM, V64, P1868, DOI 10.1063/1.1143970; Improta S, 1996, STRUCTURE, V4, P323, DOI 10.1016/S0969-2126(96)00036-6; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Knight PJ, 2005, J BIOL CHEM, V280, P34702, DOI 10.1074/jbc.M504887200; Lu H, 2000, BIOPHYS J, V79, P51, DOI 10.1016/S0006-3495(00)76273-4; Lu Q, 2012, P NATL ACAD SCI USA, V109, P17388, DOI 10.1073/pnas.1208642109; Marko JF, 1995, MACROMOLECULES, V28, P8759, DOI 10.1021/ma00130a008; Marszalek PE, 1999, NATURE, V402, P100, DOI 10.1038/47083; Oberhauser AF, 1999, NAT STRUCT BIOL, V6, P1025; Peckham M, 2009, SOFT MATTER, V5, P2493, DOI 10.1039/b822339d; Pinotsis N, 2008, EMBO J, V27, P253, DOI 10.1038/sj.emboj.7601944; Sarkar A, 2005, J BIOL CHEM, V280, P6261, DOI 10.1074/jbc.C400573200; Schwaiger I, 2002, NAT MATER, V1, P232, DOI 10.1038/nmat776; Seeber M, 2007, BIOINFORMATICS, V23, P2625, DOI 10.1093/bioinformatics/btm378; Seeber M, 2011, J COMPUT CHEM, V32, P1183, DOI 10.1002/jcc.21688; Sivaramakrishnan S, 2009, BIOPHYS J, V97, P2993, DOI 10.1016/j.bpj.2009.09.009; Sivaramakrishnan S, 2008, P NATL ACAD SCI USA, V105, P13356, DOI 10.1073/pnas.0806256105; Suveges D, 2009, PROTEINS, V74, P905, DOI 10.1002/prot.22183; Takagi Y, 2014, P NATL ACAD SCI USA, V111, pE1833, DOI 10.1073/pnas.1320122111; Tomatis VM, 2013, J CELL BIOL, V200, P301, DOI 10.1083/jcb.201204092; Wolny M, 2013, J BIOL CHEM, V288, P31952, DOI 10.1074/jbc.M113.513291; Wright CF, 2005, NATURE, V438, P878, DOI 10.1038/nature04195; Zinober RC, 2002, PROTEIN SCI, V11, P2759, DOI 10.1110/ps.0224602; Zocher M, 2012, P NATL ACAD SCI USA, V109, pE3463, DOI 10.1073/pnas.1210373109	37	39	43	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27825	27835		10.1074/jbc.M114.585679	http://dx.doi.org/10.1074/jbc.M114.585679			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25122759	Green Published, hybrid			2022-12-25	WOS:000342852800039
J	Franceschi, V; Jacca, S; Sassu, EL; Stellari, FF; van Santen, VL; Donofrio, G				Franceschi, Valentina; Jacca, Sarah; Sassu, Elena L.; Stellari, Fabio F.; van Santen, Vicky L.; Donofrio, Gaetano			Generation and Characterization of the First Immortalized Alpaca Cell Line Suitable for Diagnostic and Immunization Studies	PLOS ONE			English	Article							HERPESVIRUS-4 BASED VECTOR; LLAMA LAMA-GLAMA; BOVINE HERPESVIRUS-4; VICUGNA-PACOS; NEOSPORA-CANINUM; AOTUS TYPE-2; IN-VITRO; INFECTION; VIRUS; TUBERCULOSIS	Raising of alpacas as exotic livestock for wool and meat production and as companion animals is growing in importance in the United States, Europe and Australia. Furthermore the alpaca, as well as the rest of the camelids, possesses the peculiarity of producing single-chain antibodies from which nanobodies can be generated. Nanobodies, due to their structural simplicity and reduced size, are very versatile in terms of manipulation and bio-therapeutic exploitation. In fact the biotech companies involved in nanobody production and application continue to grow in number and size. Hence, the development of reagents and tools to assist in the further growth of this new scientific and entrepreneurial reality is becoming a necessity. These are needed mainly to address alpaca disease diagnosis and prophylaxis, and to develop alpaca immunization strategies for nanobody generation. For instance an immortalized alpaca cell line would be extremely valuable. In the present work the first stabilized alpaca cell line from alpaca skin stromal cells (ASSCs) was generated and characterized. This cell line was shown to be suitable for replication of viruses bovine herpesvirus-1, bovine viral diarrhea virus and caprine herpesvirus-1 and the endocellular parasite Neospora caninum. Moreover ASSCs were easy to transfect and transduce by several methods. These two latter characteristics are extremely useful when recombinant antigens need to be produced in a host homologous system. This work could be considered as a starting point for the expansion of the biotechnologies linked to alpaca farming and industry.	[Franceschi, Valentina; Jacca, Sarah; Sassu, Elena L.; Stellari, Fabio F.; Donofrio, Gaetano] Univ Parma, Dept Med Vet Sci, I-43100 Parma, Italy; [van Santen, Vicky L.] Auburn Univ, Coll Vet Med, Dept Pathobiol, Auburn, AL 36849 USA	University of Parma; Auburn University System; Auburn University	Donofrio, G (corresponding author), Univ Parma, Dept Med Vet Sci, I-43100 Parma, Italy.	gaetano.donofrio@unipr.it	van Santen, Vicky/A-7098-2018; franceschi, valentina/AAR-5566-2020	van Santen, Vicky/0000-0002-0029-0517; franceschi, valentina/0000-0003-3945-2285; Donofrio, Gaetano/0000-0002-8984-0377	Italian Minister of the Education, University and Research [PRIN 2010LLXR94_004]	Italian Minister of the Education, University and Research	The authors would like to thank the Italian Minister of the Education, University and Research for the financial support (PRIN 2010LLXR94_004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre IM, 2014, VET MICROBIOL, V168, P324, DOI 10.1016/j.vetmic.2013.11.034; AlKurashi M, 2011, VET PARASITOL, V177, P267, DOI 10.1016/j.vetpar.2010.11.053; BARAHONA HH, 1973, J INFECT DIS, V127, P171, DOI 10.1093/infdis/127.2.171; Bedenice D, 2011, J VET INTERN MED, V25, P605, DOI 10.1111/j.1939-1676.2011.0719.x; BUBLOT M, 1991, J GEN VIROL, V72, P715, DOI 10.1099/0022-1317-72-3-715; Chavez-Velasquez A, 2004, J PARASITOL, V90, P864, DOI 10.1645/GE-260R; Donofrio G, 2008, VACCINE, V26, P6031, DOI 10.1016/j.vaccine.2008.09.023; Donofrio G, 2004, J NEUROVIROL, V10, P123, DOI 10.1080/13550280490279780; Donofrio G, 2002, J VIROL METHODS, V101, P49, DOI 10.1016/S0166-0934(01)00419-0; Donofrio G, 2008, J VIROL METHODS, V148, P303, DOI 10.1016/j.jviromet.2007.12.006; Donofrio G, 2006, J VIROL METHODS, V136, P126, DOI 10.1016/j.jviromet.2006.04.008; Donofrio G, 2006, MICROBES INFECT, V8, P898, DOI 10.1016/j.micinf.2005.10.016; Donofrio G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052758; Donofrio G, 2011, VACCINE, V29, P867, DOI 10.1016/j.vaccine.2010.11.048; Donofrio G, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-73; Donofrio G, 2009, CLIN VACCINE IMMUNOL, V16, P1675, DOI 10.1128/CVI.00224-09; Donofrio G, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-68; Egyed L, 1997, VET MICROBIOL, V57, P283, DOI 10.1016/S0378-1135(97)00105-3; Elsheikha HM, 2006, VET PARASITOL, V135, P223, DOI 10.1016/j.vetpar.2005.09.014; Gidlewski T, 2000, VET PATHOL, V37, P77, DOI 10.1354/vp.37-1-77; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Harmsen MM, 2007, APPL MICROBIOL BIOT, V77, P13, DOI 10.1007/s00253-007-1142-2; JAT PS, 1991, P NATL ACAD SCI USA, V88, P5096, DOI 10.1073/pnas.88.12.5096; Kadwell M, 2001, P ROY SOC B-BIOL SCI, V268, P2575, DOI 10.1098/rspb.2001.1774; Lafaye P, 2009, MOL IMMUNOL, V46, P695, DOI 10.1016/j.molimm.2008.09.008; Martignani E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013372; Matrai J, 2010, MOL THER, V18, P477, DOI 10.1038/mt.2009.319; McClenahan SD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068777; MORENOLOPEZ J, 1989, J VET MED B, V36, P481, DOI 10.1111/j.1439-0450.1989.tb00633.x; Muyldermans S, 2009, VET IMMUNOL IMMUNOP, V128, P178, DOI 10.1016/j.vetimm.2008.10.299; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; POVLSEN CO, 1973, INT J CANCER, V11, P30, DOI 10.1002/ijc.2910110105; Rhodes S, 2012, CLIN VACCINE IMMUNOL, V19, P1677, DOI 10.1128/CVI.00405-12; Rogers AD, 2006, J ANIM SCI, V84, P2566, DOI 10.2527/jas.2006-106; Ryan EG, 2008, IRISH VET J, V61, P527, DOI 10.1186/2046-0481-61-8-527; Schrepfer S, 2007, TRANSPL P, V39, P573, DOI 10.1016/j.transproceed.2006.12.019; Sensebe L, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/678063; Serrano-Martinez E, 2007, VET PARASITOL, V150, P39, DOI 10.1016/j.vetpar.2007.08.048; Serrano-Martinez E, 2004, VET REC, V155, P748; Starnes A, 2007, VET REC, V160, P416, DOI 10.1136/vr.160.12.416; Stellari FF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039716; Thys B, 2010, ANTIVIR RES, V87, P257, DOI 10.1016/j.antiviral.2010.05.012; Tibary A, 2006, THERIOGENOLOGY, V66, P633, DOI 10.1016/j.theriogenology.2006.04.008; Vanlandschoot P, 2011, ANTIVIR RES, V92, P389, DOI 10.1016/j.antiviral.2011.09.002; Wommack K. Eric, 2009, V501, P3, DOI 10.1007/978-1-60327-164-6_1; Zimmermann W, 2001, J VIROL, V75, P1186, DOI 10.1128/JVI.75.3.1186-1194.2001	46	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105643	10.1371/journal.pone.0105643	http://dx.doi.org/10.1371/journal.pone.0105643			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140515	gold, Green Submitted, Green Published			2022-12-25	WOS:000342687200117
J	Brown, RM; Weghorst, JA; Olson, KV; Duya, MRM; Barley, AJ; Duya, MV; Shekelle, M; Neri-Arboleda, I; Esselstyn, JA; Dominy, NJ; Ong, PS; Moritz, GL; Luczon, A; Diesmos, MLL; Diesmos, AC; Siler, CD				Brown, Rafe M.; Weghorst, Jennifer A.; Olson, Karen V.; Duya, Mariano R. M.; Barley, Anthony J.; Duya, Melizar V.; Shekelle, Myron; Neri-Arboleda, Irene; Esselstyn, Jacob A.; Dominy, Nathaniel J.; Ong, Perry S.; Moritz, Gillian L.; Luczon, Adrian; Diesmos, Mae Lowe L.; Diesmos, Arvin C.; Siler, Cameron D.			Conservation Genetics of the Philippine Tarsier: Cryptic Genetic Variation Restructures Conservation Priorities for an Island Archipelago Primate	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; POPULATION-STRUCTURE; SPECIES DELIMITATION; INFERENCE; MODEL; BIODIVERSITY; MARKERS; DIVERSIFICATION; INDIVIDUALS; SYSTEMATICS	Establishment of conservation priorities for primates is a particular concern in the island archipelagos of Southeast Asia, where rates of habitat destruction are among the highest in the world. Conservation programs require knowledge of taxonomic diversity to ensure success. The Philippine tarsier is a flagship species that promotes environmental awareness and a thriving ecotourism economy in the Philippines. However, assessment of its conservation status has been impeded by taxonomic uncertainty, a paucity of field studies, and a lack of vouchered specimens and genetic samples available for study in biodiversity repositories. Consequently, conservation priorities are unclear. In this study we use mitochondrial and nuclear DNA to empirically infer geographic partitioning of genetic variation and to identify evolutionarily distinct lineages for conservation action. The distribution of Philippine tarsier genetic diversity is neither congruent with expectations based on biogeographical patterns documented in other Philippine vertebrates, nor does it agree with the most recent Philippine tarsier taxonomic arrangement. We identify three principal evolutionary lineages that do not correspond to the currently recognized subspecies, highlight the discovery of a novel cryptic and range-restricted subcenter of genetic variation in an unanticipated part of the archipelago, and identify additional geographically structured genetic variation that should be the focus of future studies and conservation action. Conservation of this flagship species necessitates establishment of protected areas and targeted conservation programs within the range of each genetically distinct variant of the Philippine tarsier.	[Brown, Rafe M.; Weghorst, Jennifer A.; Olson, Karen V.; Barley, Anthony J.] Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA; [Brown, Rafe M.; Olson, Karen V.; Barley, Anthony J.] Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA; [Duya, Mariano R. M.] Univ Philippines Diliman, Inst Biol, Quezon City, Philippines; [Duya, Melizar V.] Univ Philippines Diliman, Diliman Sci Res Fdn Inc, Quezon City, Philippines; [Shekelle, Myron] Ewha Womans Univ, Res Inst EcoSci, Seoul, South Korea; [Neri-Arboleda, Irene] Thomas Glen Erin Anim Hosp, Mississauga, ON, Canada; [Esselstyn, Jacob A.] Louisiana State Univ, Museum Nat Sci, Baton Rouge, LA 70803 USA; [Esselstyn, Jacob A.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Dominy, Nathaniel J.] Dartmouth Coll, Dept Anthropol, Hanover, NH 03755 USA; [Ong, Perry S.; Luczon, Adrian] Univ Philippines, Inst Biol, Quezon City 1101, Philippines; [Moritz, Gillian L.] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA; [Diesmos, Mae Lowe L.] Univ Santo Tomas, Manila, Philippines; [Diesmos, Arvin C.] Philippine Natl Museum, Div Zool, Herpetol Sect, Manila, Philippines; [Siler, Cameron D.] Univ Oklahoma, Sam Noble Oklahoma Museum Nat Hist, Norman, OK 73019 USA; [Siler, Cameron D.] Univ Oklahoma, Dept Biol, Norman, OK 73019 USA	University of Kansas; University of Kansas; University of the Philippines System; University of the Philippines Diliman; University of the Philippines System; University of the Philippines Diliman; Ewha Womans University; Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University; Dartmouth College; University of the Philippines System; University of the Philippines Diliman; Dartmouth College; University of Santo Tomas; National Museum of the Philippines; University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman	Brown, RM (corresponding author), Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA.	rafe@ku.edu	Diesmos, Arvin C./AGG-8542-2022; Diesmos, Mae Lowe/AGG-8517-2022; Dominy, Nathaniel Jay/A-6151-2013; Duya, Mariano Roy/AFK-6305-2022	Dominy, Nathaniel Jay/0000-0001-5916-418X; Esselstyn, Jacob/0000-0002-1823-4062; Duya, Mariano Roy/0000-0002-7643-293X; Ong, Perry/0000-0002-1597-1921	University of Kansas Biodiversity Institute and Department of Ecology and Evolutionary Biology; National Geographic Society [NGS 8446-08]; Primate Action Fund; Ewha Womans University; David and Lucile Packard Foundation [2007-31754]; U.S. National Science Foundation [DEB 0743491]; Division Of Environmental Biology [0743491] Funding Source: National Science Foundation	University of Kansas Biodiversity Institute and Department of Ecology and Evolutionary Biology; National Geographic Society(National Geographic Society); Primate Action Fund; Ewha Womans University; David and Lucile Packard Foundation(The David & Lucile Packard Foundation); U.S. National Science Foundation(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Support for fieldwork was provided by the University of Kansas Biodiversity Institute and Department of Ecology and Evolutionary Biology (to RMB, CDS, and JAE), the National Geographic Society (NGS 8446-08 to RMB, JAW, MS and INA), funds from the Primate Action Fund (to MS), Ewha Womans University (Ewha Global Top5 Grant 2013 to MS), the David and Lucile Packard Foundation (Fellowship in Science and Engineering no. 2007-31754, to NJD), and U.S. National Science Foundation (DEB 0743491 to RMB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barley AJ, 2013, EVOLUTION, V67, P3556, DOI 10.1111/evo.12219; Bearder SK, 1999, PRIMATES, V40, P267, DOI 10.1007/BF02557715; Brandon-Jones D, 2004, INT J PRIMATOL, V25, P97, DOI 10.1023/B:IJOP.0000014647.18720.32; Brook BW, 2002, CONSERV ECOL, V6; Brown RM, 2013, ANNU REV ECOL EVOL S, V44, P411, DOI 10.1146/annurev-ecolsys-110411-160323; BROWN RM, 2009, ENCY ISLANDS, P723; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Dagosto M, 2003, RUT HUM EVO, P237; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Esselstyn JA, 2008, J MAMMAL, V89, P815, DOI 10.1644/07-MAMM-A-285.1; Esselstyn JA, 2012, P ROY SOC B-BIOL SCI, V279, P3678, DOI 10.1098/rspb.2012.0705; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Evans BJ, 2003, EVOLUTION, V57, P1436; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Funk WC, 2012, TRENDS ECOL EVOL, V27, P489, DOI 10.1016/j.tree.2012.05.012; Groves C, 1998, PRIMATES, V39, P13, DOI 10.1007/BF02557740; Groves C, 2010, INT J PRIMATOL, V31, P1071, DOI 10.1007/s10764-010-9443-1; Groves CP, 2001, PRIMATE TAXONOMY; Hanski I, 1998, NATURE, V396, P41, DOI 10.1038/23876; HILL WCO, 1955, PRIMATES COMP ANATOM, V2; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Mace GM, 2004, PHILOS T R SOC B, V359, P711, DOI 10.1098/rstb.2003.1454; MADDISON D, 2005, MACCLADE ANAL PHYLOG; Melnick DJ, 1999, NATURE HUMAN SOC QUE, P264; Merker S, 2007, MOL ECOL NOTES, V7, P1216, DOI 10.1111/j.1471-8286.2007.01836.x; Merker S, 2008, CONSERV GENET, V9, P1349, DOI 10.1007/s10592-007-9487-8; Mittermeier RA, 1997, MEGADIVERSITY EARTHS; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Myers Norman, 2000, Nature (London), V403, P853, DOI 10.1038/35002501; Niemitz C., 1984, P1; Posa MRC, 2008, BIOSCIENCE, V58, P231, DOI 10.1641/B580309; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pritchard JK, 2000, GENETICS, V155, P945; Rambaut A, 2007, TRACER V 1 4; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; RYDER OA, 1986, TRENDS ECOL EVOL, V1, P9, DOI 10.1016/0169-5347(86)90059-5; Saccheri I, 2006, TRENDS ECOL EVOL, V21, P341, DOI 10.1016/j.tree.2006.03.018; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Shekelle M, 2008, IUCN 2014 IUCN RED L; Shekelle M, 2013, HDB MAMMALS WORLD, V3, P63; Sodhi NS, 2004, TRENDS ECOL EVOL, V19, P654, DOI 10.1016/j.tree.2004.09.006; Spinks PQ, 2010, CONSERV GENET RESOUR, V2, P127, DOI 10.1007/s12686-010-9184-7; Stamatakis A, 2007, J VLSI SIG PROC SYST, V48, P271, DOI 10.1007/s11265-007-0067-4; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Vaha JP, 2006, MOL ECOL, V15, P63, DOI 10.1111/j.1365-294X.2005.02773.x; Welton LJ, 2013, MOL ECOL, V22, P3495, DOI 10.1111/mec.12324	53	23	24	0	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e104340	10.1371/journal.pone.0104340	http://dx.doi.org/10.1371/journal.pone.0104340			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136854	Green Published, gold, Green Submitted			2022-12-25	WOS:000340742100029
J	Tang, T; Li, X; Yang, X; Yu, X; Wang, JH; Liu, FS; Huang, DW				Tang, Ting; Li, Xiang; Yang, Xue; Yu, Xue; Wang, Jianhui; Liu, Fengsong; Huang, Dawei			Transcriptional Response of Musca domestica Larvae to Bacterial Infection	PLOS ONE			English	Article							COMPLEMENT-LIKE PROTEIN; INNATE IMMUNE-SYSTEM; MOLECULAR-CLONING; GENE-EXPRESSION; RECOGNITION PROTEINS; SCAVENGER RECEPTORS; BINDING-PROTEIN; RNA-SEQ; DROSOPHILA; LYSOZYME	The house fly Musca domestica, a cosmopolitan dipteran insect, is a significant vector for human and animal bacterial pathogens, but little is known about its immune response to these pathogens. To address this issue, we inoculated the larvae with a mixture of Escherichia coli and Staphylococcus aureus and profiled the transcriptome 6, 24, and 48 h thereafter. Many genes known to controlling innate immunity in insects were induced following infection, including genes encoding pattern recognition proteins (PGRPs), various components of the Toll and IMD signaling pathways and of the proPO-activating and redox systems, and multiple antimicrobial peptides. Interestingly, we also uncovered a large set of novel immune response genes including two broad-spectrum antimicrobial peptides (muscin and domesticin), which might have evolved to adapt to house-fly's unique ecological environments. Finally, genes mediating oxidative phosphorylation were repressed at 48 h post-infection, suggesting disruption of energy homeostasis and mitochondrial function at the late stages of infection. Collectively, our data reveal dynamic changes in gene expression following bacterial infection in the house fly, paving the way for future in-depth analysis of M. domestica's immune system.	[Tang, Ting; Li, Xiang; Yang, Xue; Yu, Xue; Liu, Fengsong; Huang, Dawei] Hebei Univ, Coll Life Sci, Baoding, Peoples R China; [Wang, Jianhui] Yale Univ, Dept Pathol, New Haven, CT USA; [Huang, Dawei] Chinese Acad Sci, Inst Zool, Beijing, Peoples R China	Hebei University; Yale University; Chinese Academy of Sciences; Institute of Zoology, CAS	Liu, FS (corresponding author), Hebei Univ, Coll Life Sci, Baoding, Peoples R China.	liufengsong@hbu.edu.cn; huangdw@ioz.ac.cn		wang, jianhui/0000-0002-6261-4863	Natural Science Foundation of China [31101669, 31301925]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20101301120005]; Natural Science Foundation of Hebei Province [C2011201027]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Natural Science Foundation of Hebei Province(Natural Science Foundation of Hebei Province)	This work was financially supported by Natural Science Foundation of China (31101669, 31301925), Specialized Research Fund for the Doctoral Program of Higher Education of China (No. 20101301120005), and Natural Science Foundation of Hebei Province (No. C2011201027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoun RB, 2011, J INNATE IMMUN, V3, P52, DOI 10.1159/000321554; Areschoug T, 2009, CELL MICROBIOL, V11, P1160, DOI 10.1111/j.1462-5822.2009.01326.x; Arnoult D, 2011, EMBO REP, V12, P901, DOI 10.1038/embor.2011.157; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bedoya RJU, 2005, INSECT MOL BIOL, V14, P89, DOI 10.1111/j.1365-2583.2004.00534.x; Beresford PJ, 1997, DEV COMP IMMUNOL, V21, P253, DOI 10.1016/S0145-305X(97)00011-6; Bischoff V, 2006, PLOS PATHOG, V2, P139, DOI 10.1371/journal.ppat.0020014; BULET P, 1993, J BIOL CHEM, V268, P14893; CASTEELS P, 1993, J BIOL CHEM, V268, P7044; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Christophides GK, 2002, SCIENCE, V298, P159, DOI 10.1126/science.1077136; Evans JD, 2006, INSECT MOL BIOL, V15, P645, DOI 10.1111/j.1365-2583.2006.00682.x; Freitak D, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-56; Gao Y, 2000, INSECT MOL BIOL, V9, P553, DOI 10.1046/j.1365-2583.2000.00216.x; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Graveley BR, 2004, RNA, V10, P1499, DOI 10.1261/rna.7105504; Guryev V, 2009, FEBS LETT, V583, P1668, DOI 10.1016/j.febslet.2009.04.020; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; ITO Y, 1995, J BIOCHEM-TOKYO, V118, P546, DOI 10.1093/oxfordjournals.jbchem.a124943; Jiang H, 2010, ADV EXP MED BIOL, V708, P181; Jiang HB, 2000, INSECT BIOCHEM MOLEC, V30, P95, DOI 10.1016/S0965-1748(99)00113-7; Kocks C, 2005, CELL, V123, P335, DOI 10.1016/j.cell.2005.08.034; Kurata S, 2006, IMMUNOBIOLOGY, V211, P237, DOI 10.1016/j.imbio.2005.10.016; Lagueux M, 2000, P NATL ACAD SCI USA, V97, P11427, DOI 10.1073/pnas.97.21.11427; Lee WJ, 1996, P NATL ACAD SCI USA, V93, P7888, DOI 10.1073/pnas.93.15.7888; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Levashina EA, 2001, CELL, V104, P709, DOI 10.1016/S0092-8674(01)00267-7; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li SH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058627, 10.1371/journal.pone.0076131]; Liu FS, 2012, MOL BIOL REP, V39, P1927, DOI 10.1007/s11033-011-0939-3; Liu L, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/251364; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Michael J Morgan, 2011, Cell Research, V21, P103; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mukhopadhyay S, 2004, IMMUNOBIOLOGY, V209, P39, DOI 10.1016/j.imbio.2004.02.004; Nayduch D, 2013, J MED ENTOMOL, V50, P847, DOI 10.1603/ME12167; Regel R, 1998, INSECT BIOCHEM MOLEC, V28, P309, DOI 10.1016/S0965-1748(97)00108-2; Ribou AC, 2012, P ROY SOC B-BIOL SCI, V279, P2196, DOI 10.1098/rspb.2011.2422; Robinson MJ, 2006, NAT IMMUNOL, V7, P1258, DOI 10.1038/ni1417; Royet J, 2005, CURR OPIN IMMUNOL, V17, P11, DOI 10.1016/j.coi.2004.12.002; Royet J, 2011, NAT REV IMMUNOL, V11, P837, DOI 10.1038/nri3089; Sackton TB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000797; Scott JG, 2009, J MED ENTOMOL, V46, P175, DOI 10.1603/033.046.0202; Strand Michael R., 2008, Insect Science, V15, P1, DOI 10.1111/j.1744-7917.2008.00183.x; Swift ML, 1997, J CHEM INF COMP SCI, V37, P411, DOI 10.1021/ci960402j; Tanaka H, 2008, INSECT BIOCHEM MOLEC, V38, P1087, DOI 10.1016/j.ibmb.2008.09.001; Tang T, 2012, GENE, V505, P211, DOI 10.1016/j.gene.2012.06.025; Tarazona S, 2011, GENOME RES, V21, P2213, DOI 10.1101/gr.124321.111; Uttenweiler-Joseph S, 1998, P NATL ACAD SCI USA, V95, P11342, DOI 10.1073/pnas.95.19.11342; Wang XW, 2013, FISH SHELLFISH IMMUN, V34, P981, DOI 10.1016/j.fsi.2012.08.008; Wang Z, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000763; Warr E, 2008, INSECT MOL BIOL, V17, P39, DOI 10.1111/j.1365-2583.2008.00778.x; Yoshida H, 1996, J BIOL CHEM, V271, P13854, DOI 10.1074/jbc.271.23.13854; Yu XQ, 2002, INSECT BIOCHEM MOLEC, V32, P1287, DOI 10.1016/S0965-1748(02)00091-7; Zagrobelny M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-574; Zaidman-Remy A, 2006, IMMUNITY, V24, P463, DOI 10.1016/j.immuni.2006.02.012	57	25	30	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e104867	10.1371/journal.pone.0104867	http://dx.doi.org/10.1371/journal.pone.0104867			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137050	gold, Green Published, Green Submitted			2022-12-25	WOS:000340742100049
J	Ali, MB; Ben Ali, Y; Aissa, I; Gargouri, Y				Ali, Madiha Bou; Ben Ali, Yassine; Aissa, Imen; Gargouri, Youssef			Eukaryotic Expression System Pichia pastoris Affects the Lipase Catalytic Properties: A Monolayer Study	PLOS ONE			English	Article							TURKEY PANCREATIC LIPASE; AFFINITY-CHROMATOGRAPHY; PROTEINS; PURIFICATION; CLONING; BINDING	Recombinant DNA methods are being widely used to express proteins in both prokaryotic and eukaryotic cells for both fundamental and applied research purposes. Expressed protein must be well characterized to be sure that it retains the same properties as the native one, especially when expressed protein will be used in the pharmaceutical field. In this aim, interfacial and kinetic properties of native, untagged recombinant and tagged recombinant forms of a pancreatic lipase were compared using the monomolecular film technique. Turkey pancreatic lipase (TPL) was chosen as model. A kinetic study on the dependence of the stereoselectivity of these three forms on the surface pressure was performed using three dicaprin isomers spread in the form of monomolecular films at the air-water interface. The heterologous expression and the N-His-tag extension were found to modify the pressure preference and decrease the catalytic hydrolysis rate of three dicaprin isomers. Besides, the heterologous expression was found to change the TPL regioselectivity without affecting its stereospecificity contrary to the N-tag extension which retained that regioselectivity and changed the stereospecificity at high surface pressures. The study of parameters, termed Recombinant expression Effects on Catalysis (REC), N-Tag Effects on Catalysis (TEC), and N-Tag and Recombinant expression Effects on Catalysis (TREC) showed that the heterologous expression effects on the catalytic properties of the TPL were more deleterious than the presence of an N-terminal tag extension.	[Ali, Madiha Bou; Ben Ali, Yassine; Aissa, Imen; Gargouri, Youssef] Univ Sfax, Natl Engn Sch Sfax ENIS, Biochem Lab, Sfax, Tunisia	Universite de Sfax; Ecole Nationale dIngenieurs de Sfax (ENIS)	Gargouri, Y (corresponding author), Univ Sfax, Natl Engn Sch Sfax ENIS, Biochem Lab, Sfax, Tunisia.	ytgargouri@yahoo.fr						Ali MB, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-24; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CASEY JL, 1995, J IMMUNOL METHODS, V179, P105, DOI 10.1016/0022-1759(94)00278-5; Chaga G, 1999, J CHROMATOGR A, V864, P247; Fendri A, 2006, BIOCHIMIE, V88, P1401, DOI 10.1016/j.biochi.2006.05.022; Gaberc-Porekar V, 1999, J CHROMATOGR A, V852, P117, DOI 10.1016/S0021-9673(99)00374-X; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Hang Q, 1999, J BIOL CHEM, V274, P15305, DOI 10.1074/jbc.274.22.15305; Horchani H, 2010, J COLLOID INTERF SCI, V350, P586, DOI 10.1016/j.jcis.2010.07.021; Jaeger KE, 2002, CURR OPIN BIOTECH, V13, P390, DOI 10.1016/S0958-1669(02)00341-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MARTINELLE M, 1995, BBA-LIPID LIPID MET, V1258, P272, DOI 10.1016/0005-2760(95)00131-U; Nieba L, 1997, ANAL BIOCHEM, V252, P217, DOI 10.1006/abio.1997.2326; Paborsky LR, 1996, ANAL BIOCHEM, V234, P60, DOI 10.1006/abio.1996.0050; Passafiume M, 1998, FEBS LETT, V441, P407, DOI 10.1016/S0014-5793(98)01581-6; PORATH J, 1975, NATURE, V258, P598, DOI 10.1038/258598a0; ROGALSKA E, 1993, CHIRALITY, V5, P24, DOI 10.1002/chir.530050106; Rogalska E, 1995, CHIRALITY IN PRESS; SASSENFELD HM, 1990, TRENDS BIOTECHNOL, V8, P88, DOI 10.1016/0167-7799(90)90145-N; Sayari A, 2000, BIOCHIMIE, V82, P153, DOI 10.1016/S0300-9084(00)00379-5; SHARMA SK, 1991, BIOTECHNOL APPL BIOC, V14, P69; VERGER R, 1973, CHEM PHYS LIPIDS, V10, P127, DOI 10.1016/0009-3084(73)90009-1	22	4	4	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e104221	10.1371/journal.pone.0104221	http://dx.doi.org/10.1371/journal.pone.0104221			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133585	Green Submitted, Green Published, gold			2022-12-25	WOS:000341302700024
J	Amjad, MW; Amin, MCIM; Mahali, SM; Katas, H; Ismail, I; ul Hassan, MN; Chuang, VTG				Amjad, M. Wahab; Amin, Mohd Cairul I. Mohd; Mahali, Shalela M.; Katas, Haliza; Ismail, Ismanizan; ul Hassan, M. Naeem; Chuang, Victor T. Giam			Nanoscale Diblock Copolymer Micelles: Characterizations and Estimation of the Effective Diffusion Coefficients of Biomolecules Release through Cylindrical Diffusion Model	PLOS ONE			English	Article							CONTROLLED DRUG-DELIVERY; BIOMEDICAL APPLICATIONS; CHITOSAN NANOPARTICLES; BIODEGRADABLE POLYMERS; TARGETED DELIVERY; TAT PEPTIDE; BSA; THERAPEUTICS; STABILITY; BIOLOGY	Biomolecules have been widely investigated as potential therapeutics for various diseases. However their use is limited due to rapid degradation and poor cellular uptake in vitro and in vivo. To address this issue, we synthesized a new nano-carrier system comprising of cholic acid-polyethylenimine (CA-PEI) copolymer micelles, via carbodiimide-mediated coupling for the efficient delivery of small interfering ribonucleic acid (siRNA) and bovine serum albumin (BSA) as model protein. The mean particle size of siRNA- or BSA-loaded CA-PEI micelles ranged from 100-150 nm, with zeta potentials of +3-+11 mV, respectively. Atomic force, transmission electron and field emission scanning electron microscopy demonstrated that the micelles exhibited excellent spherical morphology. No significant morphology or size changes were observed in the CA-PEI micelles after siRNA and BSA loading. CA-PEI micelles exhibited sustained release profile, the effective diffusion coefficients were successfully estimated using a mathematically-derived cylindrical diffusion model and the release data of siRNA and BSA closely fitted into this model. High siRNA and BSA binding and loading efficiencies (95% and 70%, respectively) were observed for CA-PEI micelles. Stability studies demonstrated that siRNA and BSA integrity was maintained after loading and release. The CA-PEI micelles were non cytotoxic to V79 and DLD-1 cells, as shown by alamarBlue and LIVE/DEAD cell viability assays. RT-PCR study revealed that siRNA-loaded CA-PEI micelles suppressed the mRNA for ABCB1 gene. These results revealed the promising potential of CA-PEI micelles as a stable, safe, and versatile nano-carrier for siRNA and the model protein delivery.	[Amjad, M. Wahab; Amin, Mohd Cairul I. Mohd; Katas, Haliza] Univ Kebangsaan Malaysia, Fac Pharm, Ctr Drug Delivery Res, Kuala Lumpur, Fed Territory, Malaysia; [Mahali, Shalela M.] Univ Malaysia Terengganu, Sch Informat & Appl Math, Kuala Terengganu, Terengganu, Malaysia; [Ismail, Ismanizan; ul Hassan, M. Naeem] Univ Kebangsaan Malaysia, Inst Syst Biol, Bangi 43600, Selangor, Malaysia; [Chuang, Victor T. Giam] Curtin Univ, Fac Hlth Sci, Curtin Hlth Innovat Res Inst, Sch Pharm, Perth, WA 6845, Australia	Universiti Kebangsaan Malaysia; Universiti Malaysia Terengganu; Universiti Kebangsaan Malaysia; Curtin University	Mahali, SM (corresponding author), Univ Kebangsaan Malaysia, Fac Pharm, Ctr Drug Delivery Res, Kuala Lumpur, Fed Territory, Malaysia.	mciamin@pharmacy.ukm.my	Naeem-ul-Hassan, Muhammad/K-8886-2019; Mohd Mahali, Shalela Mohd/AAX-7558-2021; Chuang, Victor/A-3644-2011; KATAS, HALIZA/I-6417-2016; Amjad, Muhammad Wahab/AHA-5553-2022	Naeem-ul-Hassan, Muhammad/0000-0003-3709-6248; Chuang, Victor/0000-0002-2141-630X; KATAS, HALIZA/0000-0001-7249-1628; MAHALI, SHALELA/0000-0003-3458-991X; Amjad, Muhammad Wahab/0000-0002-5832-8602	Universiti Kebangsaan Malaysia (UKM) [UKM-GUP-SK-07-23-045]; Ministry of Science, Technology and Innovation, Malaysia [02-01-02-SF0738]	Universiti Kebangsaan Malaysia (UKM); Ministry of Science, Technology and Innovation, Malaysia(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia)	This project was funded by a Research University Grant (UKM-GUP-SK-07-23-045) from Universiti Kebangsaan Malaysia (UKM) and Science Fund (02-01-02-SF0738) from the Ministry of Science, Technology and Innovation, Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali-Boucetta H, 2008, CHEM COMMUN, P459, DOI 10.1039/b712350g; Amjad MW, 2012, NANOSCALE RES LETT, V7, DOI 10.1186/1556-276X-7-687; Bowman K, 2006, INT J NANOMED, V1, P117, DOI 10.2147/nano.2006.1.2.117; Butt AM, 2012, J NANOMATER, V2012, DOI 10.1155/2012/916573; Chappelow AV, 2008, DRUGS, V68, P1029, DOI 10.2165/00003495-200868080-00002; Chaudhuri P, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/2/025102; Check E, 2005, NAT MED, V11, P243, DOI 10.1038/nm0305-243; Dash S, 2010, ACTA POL PHARM, V67, P217; Davis ME, 2008, NAT REV DRUG DISCOV, V7, P771, DOI 10.1038/nrd2614; De M, 2008, ADV MATER, V20, P4225, DOI 10.1002/adma.200703183; Devalapally H, 2007, J PHARM SCI-US, V96, P2547, DOI 10.1002/jps.20875; DeVincenzo J, 2008, ANTIVIR RES, V77, P225, DOI 10.1016/j.antiviral.2007.11.009; Han XL, 2012, J PHOTOCH PHOTOBIO B, V109, P1, DOI 10.1016/j.jphotobiol.2011.12.010; Katas H, 2006, J CONTROL RELEASE, V115, P216, DOI 10.1016/j.jconrel.2006.07.021; Kirchhoff F, 2008, CELL, V134, P566, DOI 10.1016/j.cell.2008.08.004; Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388; Larsericsdotter H, 2005, J COLLOID INTERF SCI, V289, P26, DOI 10.1016/j.jcis.2005.03.064; Li YL, 2012, CHEM SOC REV, V41, P2193, DOI 10.1039/c1cs15203c; Liu HA, 2011, INVEST OPHTH VIS SCI, V52, P4789, DOI 10.1167/iovs.10-5891; Liu TY, 2005, J CONTROL RELEASE, V107, P112, DOI 10.1016/j.jconrel.2005.05.025; Luckachan GE, 2011, J POLYM ENVIRON, V19, P637, DOI 10.1007/s10924-011-0317-1; Maeda H, 2001, J CONTROL RELEASE, V74, P47, DOI 10.1016/S0168-3659(01)00309-1; Maeda H, 2000, J CONTROL RELEASE, V65, P271, DOI 10.1016/S0168-3659(99)00248-5; Manosroi J, 2013, DRUG DEV IND PHARM, V39, P520, DOI 10.3109/03639045.2012.684388; Mora-Huertas CE, 2010, INT J PHARMACEUT, V385, P113, DOI 10.1016/j.ijpharm.2009.10.018; Narla SN, 2014, BIOCHEM BIOPH RES CO, V443, P562, DOI 10.1016/j.bbrc.2013.12.006; Sakai-Kato K, 2003, J PHARMACEUT BIOMED, V31, P299, DOI 10.1016/S0731-7085(02)00638-6; Torchilin VP, 2008, ADV DRUG DELIVER REV, V60, P548, DOI 10.1016/j.addr.2007.10.008; Ulery BD, 2011, J POLYM SCI POL PHYS, V49, P832, DOI 10.1002/polb.22259; Wang S, 2009, J IND MANAG OPTIM, V5, P127, DOI 10.3934/jimo.2009.5.127	30	2	2	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105234	10.1371/journal.pone.0105234	http://dx.doi.org/10.1371/journal.pone.0105234			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133390	Green Published, Green Submitted, gold			2022-12-25	WOS:000341302700093
J	Davanco, MG; Aguiar, ACC; dos Santos, LA; Padilha, EC; Campos, ML; de Andrade, CR; da Fonseca, LM; dos Santos, JL; Chin, CM; Krettli, AU; Peccinini, RG				Davanco, Marcelo Gomes; Campos Aguiar, Anna Caroline; dos Santos, Leandro Alves; Padilha, Elias Carvalho; Campos, Michel Leandro; de Andrade, Cleverton Roberto; da Fonseca, Luiz Marcos; dos Santos, Jean Leandro; Chin, Chung Man; Krettli, Antoniana Ursine; Peccinini, Rosangela Goncalves			Evaluation of Antimalarial Activity and Toxicity of a New Primaquine Prodrug	PLOS ONE			English	Article							PLASMODIUM-GALLINACEUM; DIPEPTIDE DERIVATIVES; IN-VITRO; DRUGS; ERYTHROCYTES; DISCOVERY; MEMBRANE; SCREEN; RAT	Plasmodium vivax is the most prevalent of the five species causing malaria in humans. The current available treatment for P. vivax malaria is limited and unsatisfactory due to at least two drawbacks: the undesirable side effects of primaquine (PQ) and drug resistance to chloroquine. Phenylalanine-alanine-PQ (Phe-Ala-PQ) is a PQ prodrug with a more favorable pharmacokinetic profile compared to PQ. The toxicity of this prodrug was evaluated in in vitro assays using a human hepatoma cell line (HepG2), a monkey kidney cell line (BGM), and human red blood cells deficient in the enzyme glucose-6-phosphate-dehydrogenase (G6PD). In addition, in vivo toxicity assays were performed with rats that received multiple doses of Phe-Ala-PQ to evaluate biochemical, hematological, and histopathological parameters. The activity was assessed by the inhibition of the sporogonic cycle using a chicken malaria parasite. Phe-Ala-PQ blocked malaria transmission in Aedes mosquitoes. When compared with PQ, it was less cytotoxic to BGM and HepG2 cells and caused less hemolysis of G6PD-deficient red blood cells at similar concentrations. The prodrug caused less alteration in the biochemical parameters than did PQ. Histopathological analysis of the liver and kidney did show differences between the control and Phe-Ala-PQ-treated groups, but they were not statistically significant. Taken together, the results highlight the prodrug as a novel lead compound candidate for the treatment of P. vivax malaria and as a blocker of malaria transmission.	[Davanco, Marcelo Gomes; Padilha, Elias Carvalho; Campos, Michel Leandro; Peccinini, Rosangela Goncalves] Univ Estadual Paulista UNESP, Fac Ciencias Farm, Dept Principios Ativos Nat & Toxicol, Sao Paulo, Brazil; [Campos Aguiar, Anna Caroline; Krettli, Antoniana Ursine] Fiocruz MS, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil; [dos Santos, Leandro Alves; de Andrade, Cleverton Roberto] Univ Estadual Paulista UNESP, Fac Odontol Araraquara, Dept Fisiol & Patol, Sao Paulo, Brazil; [da Fonseca, Luiz Marcos] Univ Estadual Paulista UNESP, Fac Ciencias Farm, Dept Anal Clin, Sao Paulo, Brazil; [dos Santos, Jean Leandro; Chin, Chung Man] Univ Estadual Paulista UNESP, Fac Ciencias Farm, Lab Pesquisa & Desenvolvimento Farmacos Lapdesf, Sao Paulo, Brazil	Universidade Estadual Paulista; Fundacao Oswaldo Cruz; Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual Paulista	Peccinini, RG (corresponding author), Univ Estadual Paulista UNESP, Fac Ciencias Farm, Dept Principios Ativos Nat & Toxicol, Sao Paulo, Brazil.	peccinin@fcfar.unesp.br	Dos Santos, Jean Leandro/O-9111-2019; Chin, Chung Man/W-2762-2019; Davanço, Marcelo Gomes/A-7196-2015; de Campos, Michel Leandro/G-2855-2014; Santos, Jean Leandro dos/E-8753-2016; de+Andrade, Cleverton Roberto/AAA-6683-2019; de Andrade, Cleverton Roberto Roberto/D-9138-2012; Padilha, Elias Carvalho/J-5671-2015; Chung/AAP-8459-2021; Peccinini, Rosangela/G-6068-2015; Aguiar, Anna Caroline/J-6970-2015; Man Chin, Chung/C-2259-2013	de Campos, Michel Leandro/0000-0002-7147-7637; Santos, Jean Leandro dos/0000-0002-2460-2829; de+Andrade, Cleverton Roberto/0000-0001-7015-7175; de Andrade, Cleverton Roberto Roberto/0000-0001-7015-7175; Padilha, Elias Carvalho/0000-0002-3794-9389; Peccinini, Rosangela/0000-0002-2692-8101; Aguiar, Anna Caroline/0000-0003-0139-8279; Man Chin, Chung/0000-0003-4141-0455; Alves dos Santos, Leandro/0000-0001-8088-5790	Sao Paulo Research Foundation - FAPESP [09/51075-5, 11/11239-9]; National Institute of Science and Technology - Pharmaceutical Innovation (INCT-if); Coordination for the Improvement of Higher Education Personnel - CAPES; National Council for Scientific and Technological Development - CNPq (Neglected Diseases); Minas Gerais State Research Foundation - FAPEMIG	Sao Paulo Research Foundation - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Institute of Science and Technology - Pharmaceutical Innovation (INCT-if); Coordination for the Improvement of Higher Education Personnel - CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Council for Scientific and Technological Development - CNPq (Neglected Diseases)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Minas Gerais State Research Foundation - FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This work was supported by Sao Paulo Research Foundation - FAPESP (process 09/51075-5 and process 11/11239-9, http://www.bv.fapesp.br/5394 and http://www.bv.fapesp.br/5395); National Institute of Science and Technology - Pharmaceutical Innovation (INCT-if); Coordination for the Improvement of Higher Education Personnel - CAPES; National Council for Scientific and Technological Development - CNPq (Neglected Diseases, Project 2012-14); and Minas Gerais State Research Foundation - FAPEMIG. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ALVING A S, 1960, Bull World Health Organ, V22, P621; Baird JK, 2004, CLIN INFECT DIS, V39, P1336, DOI 10.1086/424663; Bell A, 2005, FEMS MICROBIOL LETT, V253, P171, DOI 10.1016/j.femsle.2005.09.035; BREWER GJ, 1962, JAMA-J AM MED ASSOC, V180, P386, DOI 10.1001/jama.1962.03050180032008; CARVALHO LH, 1992, BRAZ J MED BIOL RES, V25, P247; Charman SA, 2011, P NATL ACAD SCI USA, V108, P4400, DOI 10.1073/pnas.1015762108; Chung MC, 1997, J PHARM SCI, V86, P1127, DOI 10.1021/js970006v; Cushion MT, 2009, CURR MED CHEM, V16, P2514, DOI 10.2174/092986709788682038; Davanco MG, 2012, BIOPHARM DRUG DISPOS, V33, P437, DOI 10.1002/bdd.1807; de Madureira MD, 2002, J ETHNOPHARMACOL, V81, P23, DOI 10.1016/S0378-8741(02)00005-3; Dembele L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018162; Deye GA, 2012, AM J TROP MED HYG, V86, P931, DOI 10.4269/ajtmh.2012.11-0552; FERRANTE A, 1984, PARASITE IMMUNOL, V6, P571, DOI 10.1111/j.1365-3024.1984.tb00826.x; FRASER IM, 1968, ANN NY ACAD SCI, V151, P777, DOI 10.1111/j.1749-6632.1968.tb48261.x; GINSBURG H, 1988, BIOCHEM PHARMACOL, V37, P2013, DOI 10.1016/0006-2952(88)90549-7; GWADZ RW, 1983, EXP PARASITOL, V55, P188, DOI 10.1016/0014-4894(83)90013-9; Heurtault B, 2001, ANN TROP MED PARASIT, V95, P529, DOI 10.1080/00034980120067226; Katsuragawa Tony H., 2004, Rev. Bras. Hematol. Hemoter., V26, P268, DOI 10.1590/S1516-84842004000400007; Kaur K, 2011, BIOORGAN MED CHEM, V19, P197, DOI 10.1016/j.bmc.2010.11.036; Kim T, 2009, J INFECT CHEMOTHER, V15, P343, DOI 10.1007/s10156-009-0710-z; LORKE D, 1983, ARCH TOXICOL, V54, P275, DOI 10.1007/BF01234480; Luzzatto L, 2014, BRIT J HAEMATOL, V164, P469, DOI 10.1111/bjh.12665; Mata G, 2012, BIOORGAN MED CHEM, V20, P886, DOI 10.1016/j.bmc.2011.11.059; MIHALY GW, 1984, BRIT J CLIN PHARMACO, V17, P441, DOI 10.1111/j.1365-2125.1984.tb02369.x; Na-Bangchang K, 2009, FUND CLIN PHARMACOL, V23, P387, DOI 10.1111/j.1472-8206.2009.00709.x; Naoum Paulo Cesar, 2004, Rev. Bras. Hematol. Hemoter., V26, P19, DOI 10.1590/S1516-84842004000100004; Noel S, 2007, TOXICOLOGY, V239, P96, DOI 10.1016/j.tox.2007.06.098; PHILIP A, 1988, J MED CHEM, V31, P870, DOI 10.1021/jm00399a032; Portela MJ, 1999, PHARM RES-DORDR, V16, P949, DOI 10.1023/A:1018922425551; Schiff U, 1866, CLIN TESTS HISTOPATH, P100; SCHLESINGER PH, 1988, ANTIMICROB AGENTS CH, V32, P793, DOI 10.1128/AAC.32.6.793; SCHMIDT LH, 1986, AM J TROP MED HYG, V35, P1077, DOI 10.4269/ajtmh.1986.35.1077; Sticova E, 2013, WORLD J GASTROENTERO, V19, P6398, DOI 10.3748/wjg.v19.i38.6398; Tekwani BL, 2006, CURR OPIN INFECT DIS, V19, P623, DOI 10.1097/QCO.0b013e328010b848; Thoolen B, 2010, TOXICOL PATHOL, V38, p5S, DOI 10.1177/0192623310386499; TROUET A, 1981, B WORLD HEALTH ORGAN, V59, P449; Vale N, 2009, J MED CHEM, V52, P7800, DOI 10.1021/jm900738c; Vale N, 2009, EUR J MED CHEM, V44, P2506, DOI 10.1016/j.ejmech.2009.01.018; Vale N, 2009, EUR J MED CHEM, V44, P937, DOI 10.1016/j.ejmech.2008.08.011; Vale-Costa S, 2012, ANTIMICROB AGENTS CH, V56, P5774, DOI 10.1128/AAC.00873-12; Walsh JJ, 2009, CURR PHARM DESIGN, V15, P2970, DOI 10.2174/138161209789058183; Wang C, 2010, BIOCHEM BIOPH RES CO, V402, P773, DOI 10.1016/j.bbrc.2010.10.108; Weerasinghe K. L., 2002, Ceylon Medical Journal, V47, P83; White NJ, 2014, LANCET, V383, P723, DOI 10.1016/S0140-6736(13)60024-0; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Williams HD, 2013, PHARMACOL REV, V65, P315, DOI 10.1124/pr.112.005660; Yardley V, 2010, ANTIMICROB AGENTS CH, V54, P5356, DOI 10.1128/AAC.00985-10; Zeeman AM, 2014, ANTIMICROB AGENTS CH, V58, P1586, DOI 10.1128/AAC.01927-13	48	17	18	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105217	10.1371/journal.pone.0105217	http://dx.doi.org/10.1371/journal.pone.0105217			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133630	gold, Green Published, Green Submitted			2022-12-25	WOS:000341302700089
J	Emukule, GO; Khagayi, S; McMorrow, ML; Ochola, R; Otieno, N; Widdowson, MA; Ochieng, M; Feikin, DR; Katz, MA; Mott, JA				Emukule, Gideon O.; Khagayi, Sammy; McMorrow, Meredith L.; Ochola, Rachel; Otieno, Nancy; Widdowson, Marc-Alain; Ochieng, Melvin; Feikin, Daniel R.; Katz, Mark A.; Mott, Joshua A.			The Burden of Influenza and RSV among Inpatients and Outpatients in Rural Western Kenya, 2009-2012	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; UNITED-STATES; YOUNG-CHILDREN; MORTALITY; ILLNESS; INFECTIONS; HOSPITALIZATION; IMMUNIZATION; METAANALYSIS; SEASONALITY	Background: In Kenya, detailed data on the age-specific burden of influenza and RSV are essential to inform use of limited vaccination and treatment resources. Methods: We analyzed surveillance data from August 2009 to July 2012 for hospitalized severe acute respiratory illness (SARI) and outpatient influenza-like illness (ILI) at two health facilities in western Kenya to estimate the burden of influenza and respiratory syncytial virus (RSV). Incidence rates were estimated by dividing the number of cases with laboratory-confirmed virus infections by the mid-year population. Rates were adjusted for healthcare-seeking behavior, and to account for patients who met the SARI/ILI case definitions but were not tested. Results: The average annual incidence of influenza-associated SARI hospitalization per 1,000 persons was 2.7 (95% CI 1.8-3.9) among children <5 years and 0.3 (95% CI 0.2-0.4) among persons >= 5 years; for RSV-associated SARI hospitalization, it was 5.2 (95% CI 4.0-6.8) among children <5 years and 0.1 (95% CI 0.0-0.2) among persons >= 5 years. The incidence of influenza-associated medically-attended ILI per 1,000 was 24.0 (95% CI 16.6-34.7) among children <5 years and 3.8 (95% CI 2.6-5.7) among persons >= 5 years. The incidence of RSV-associated medically-attended ILI was 24.6 (95% CI 17.0-35.4) among children <5 years and 0.8 (95% CI 0.3-1.9) among persons >= 5 years. Conclusions: Influenza and RSV both exact an important burden in children. This highlights the possible value of influenza vaccines, and future RSV vaccines, for Kenyan children.	[Emukule, Gideon O.; Katz, Mark A.; Mott, Joshua A.] Kenya Country Off, Ctr Dis Control & Prevent CDC, Nairobi, Kenya; [Khagayi, Sammy; Ochola, Rachel; Otieno, Nancy; Ochieng, Melvin] Kenya Med Res Inst KEMRI, Nairobi, Kenya; [Khagayi, Sammy; Ochola, Rachel; Otieno, Nancy; Ochieng, Melvin] Kenya Med Res Inst KEMRI, Kisumu, Kenya; [McMorrow, Meredith L.; Widdowson, Marc-Alain; Mott, Joshua A.] US Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Influenza Div, Atlanta, GA USA; [Feikin, Daniel R.] Ctr Dis Control & Prevent, Div Preparedness & Emerging Infect, Atlanta, GA USA; [Katz, Mark A.] Ctr Dis Control & Prevent, Port Au Prince, Haiti; [McMorrow, Meredith L.; Mott, Joshua A.] US PHS, Rockville, MD USA	Kenya Medical Research Institute; Kenya Medical Research Institute; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; United States Public Health Service	Emukule, GO (corresponding author), Kenya Country Off, Ctr Dis Control & Prevent CDC, Nairobi, Kenya.	uyr9@cdc.gov	McMorrow, Meredith/M-1274-2019	McMorrow, Meredith/0000-0001-6363-4033; Otieno, Nancy Awuor/0000-0002-7083-4735	Global Disease Detection Division of CDC	Global Disease Detection Division of CDC	The funding for this project is from Core Funding of the Global Disease Detection Division of CDC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azziz-Baumgartner E, 2012, B WORLD HEALTH ORGAN, V90, P12, DOI 10.2471/BLT.11.090209; Breese C, 2013, PEDIATRICS, V132, pE341, DOI 10.1542/peds.2013-0303; Burton DC, 2011, J HEALTH POPUL NUTR, V29, P61, DOI 10.3329/jhpn.v29i1.7567; Dalal W, 2012, J ACQUIR IMMUNE DEFI; Dalal W, 2013, JAIDS-J ACQ IMM DEF, V62, pE47, DOI 10.1097/QAI.0b013e318276bea0; Dawood FS, 2012, LANCET INFECT DIS, V12, P687, DOI 10.1016/S1473-3099(12)70121-4; Feikin DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043656; Feikin DR, 2012, B WORLD HEALTH ORGAN, V90, P256, DOI 10.2471/BLT.11.094326; Feikin DR, 2013, PEDIAT INFECT DIS J, V32; Fuller JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056882; Ganatra Rahul, 2012, Morbidity and Mortality Weekly Report, V61, P414; Hamel MJ, 2011, AM J TROP MED HYG, V85, P597, DOI 10.4269/ajtmh.2011.10-0678; Katz MA, 2012, J INFECT DIS, V206, pS53, DOI 10.1093/infdis/jis530; Keitel W, 2013, MMWR-MORBID MORTAL W, V62, P356; Kim SR, 2009, J VIROL METHODS, V156, P111, DOI 10.1016/j.jviromet.2008.11.007; Nair H, 2011, LANCET, V378, P1917, DOI 10.1016/S0140-6736(11)61051-9; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Nascimento-Carvalho C M, 2001, Braz J Infect Dis, V5, P87; Nicholson KG, 2006, VACCINE, V24, P102, DOI 10.1016/j.vaccine.2005.02.004; Nokes DJ, 2009, CLIN INFECT DIS, V49, P1341, DOI 10.1086/606055; Odhiambo FO, 2012, INT J EPIDEMIOL, V41, P977, DOI 10.1093/ije/dys108; Okiro EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052520; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Paget WJ, 2010, EUR J PEDIATR, V169, P997, DOI 10.1007/s00431-010-1164-0; Rowlinson E, 2013, J INFECT DIS, V208, pS189, DOI 10.1093/infdis/jit457; Schickli JH, 2012, VIRUS RES, V169, P38, DOI 10.1016/j.virusres.2012.06.027; Simmerman JM, 2009, PLOS ONE, V4, pA107, DOI 10.1371/journal.pone.0007776; Simoes EAF, 2001, LANCET, V358, P1382, DOI 10.1016/S0140-6736(01)06488-1; Siston AM, 2010, JAMA-J AM MED ASSOC, V303, P1517, DOI 10.1001/jama.2010.479; ULM K, 1990, AM J EPIDEMIOL, V131, P373, DOI 10.1093/oxfordjournals.aje.a115507; WHO, 2013, GLOB EP SURV STAND I; Williams BG, 2002, LANCET INFECT DIS, V2, P25, DOI 10.1016/S1473-3099(01)00170-0; World Health Organization, 2011, 2 M SAG WORK GROUP I; World Health Organization, 2012, BACKGR PAP INFL VACC; Zaman K, 2008, NEW ENGL J MED, V359, P1555, DOI 10.1056/NEJMoa0708630; Zambon MC, 2001, LANCET, V358, P1410, DOI 10.1016/S0140-6736(01)06528-X; Zhou H, 2012, CLIN INFECT DIS, V54, P1427, DOI 10.1093/cid/cis211	37	60	63	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105543	10.1371/journal.pone.0105543	http://dx.doi.org/10.1371/journal.pone.0105543			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133576	Green Published, gold			2022-12-25	WOS:000341302700120
J	Hu, SX; Rotschafer, JH; Lokensgard, JR; Cheeran, MCJ				Hu, Shuxian; Rotschafer, Jessica H.; Lokensgard, James R.; Cheeran, Maxim C-J.			Activated CD8(+) T Lymphocytes Inhibit Neural Stem/Progenitor Cell Proliferation: Role of Interferon-Gamma	PLOS ONE			English	Article							EXPERIMENTAL HERPES-ENCEPHALITIS; STEM-CELLS; ADULT BRAIN; IMMUNE CELLS; NEURONAL DIFFERENTIATION; PROGENITOR CELLS; NEUROGENESIS; INJURY; EXPRESSION; STROKE	The ability of neural stem/progenitor cells (NSCs) to self-renew, migrate to damaged sites, and differentiate into neurons has renewed interest in using them in therapies for neurodegenerative disorders. Neurological diseases, including viral infections of the brain, are often accompanied by chronic inflammation, whose impact on NSC function remains unexplored. We have previously shown that chronic neuroinflammation, a hallmark of experimental herpes simplex encephalitis (HSE) in mice, is dominated by brain-infiltrating activated CD8 T-cells. In the present study, activated CD8 lymphocytes were found to suppress NSC proliferation profoundly. Luciferase positive (luc(+)) NSCs co-cultured with activated, MHC-matched, CD8(+) lymphocytes (luc(-)) showed two-to five-fold lower luminescence than co-cultures with unstimulated lymphocytes. On the other hand, similarly activated CD4(+) lymphocytes did not suppress NSC growth. This differential lymphocyte effect on proliferation was confirmed by decreased BrdU uptake by NSC cultured with activated CD8 T-cells. Interestingly, neutralizing antibodies to interferon-gamma (IFN-gamma) reversed the impact of CD8 lymphocytes on NSCs. Antibodies specific to the IFN-gamma receptor-1 subunit complex abrogated the inhibitory effects of both CD8 lymphocytes and IFN-gamma, indicating that the inhibitory effect of these cells was mediated by IFN-gamma in a receptor-specific manner. In addition, activated CD8 lymphocytes decreased levels of nestin and Sox2 expression in NSCs while increasing GFAP expression, suggesting possible induction of an altered differentiation state. Furthermore, NSCs obtained from IFN-gamma receptor-1 knock-out embryos were refractory to the inhibitory effects of activated CD8(+) T lymphocytes on cell proliferation and Sox2 expression. Taken together, the studies presented here demonstrate a role for activated CD8 T-cells in regulating NSC function mediated through the production of IFN-gamma. This cytokine may influence neuro-restorative processes and ultimately contribute to the long-term sequelae commonly seen following herpes encephalitis.	[Hu, Shuxian; Lokensgard, James R.; Cheeran, Maxim C-J.] Univ Minnesota, Sch Med, Dept Med, Ctr Infect Dis & Microbiol Translat Res, Minneapolis, MN 55455 USA; [Rotschafer, Jessica H.; Cheeran, Maxim C-J.] Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Cheeran, MCJ (corresponding author), Univ Minnesota, Sch Med, Dept Med, Ctr Infect Dis & Microbiol Translat Res, Minneapolis, MN 55455 USA.	cheeran@umn.edu	Cheeran, Maxim C-J/C-2135-2009	Cheeran, Maxim C-J/0000-0002-5331-4746	National Institutes of Health (NIH) [RO1 NS065817, RO1 MH066703, RO1 NS038836, T32 DA007097]; AHC Faculty Development Grant, University of Minnesota; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038836, R01NS065817] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007097] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHC Faculty Development Grant, University of Minnesota; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	These studies were funded in part by National Institutes of Health (NIH) grants RO1 NS065817, RO1 MH066703, RO1 NS038836, and T32 DA007097, and the AHC Faculty Development Grant, University of Minnesota. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Armien AG, 2010, BRAIN PATHOL, V20, P738, DOI 10.1111/j.1750-3639.2009.00354.x; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Bach EA, 1997, ANNU REV IMMUNOL, V15, P563, DOI 10.1146/annurev.immunol.15.1.563; Brynskikh A, 2008, BRAIN BEHAV IMMUN, V22, P861, DOI 10.1016/j.bbi.2007.12.008; Chaitanya GV, 2010, NEUROSCIENCE, V165, P1203, DOI 10.1016/j.neuroscience.2009.10.067; Cheeran MCJ, 2008, J NEUROVIROL, V14, P437, DOI 10.1080/13550280802356845; Cheeran MCJ, 2005, J NEUROSCI RES, V82, P839, DOI 10.1002/jnr.20682; Cimadamore F, 2013, P NATL ACAD SCI USA, V110, pE3017, DOI 10.1073/pnas.1220176110; Das S, 2008, J NEUROCHEM, V106, P1624, DOI 10.1111/j.1471-4159.2008.05511.x; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gonzalez-Perez O, 2012, NEUROSCIENCE, V226, P270, DOI 10.1016/j.neuroscience.2012.08.053; Gonzalez-Perez Oscar, 2010, J Stem Cells, V5, P23, DOI jsc.2010.5.1.23; Gonzalez-Perez Oscar, 2010, Current Immunology Reviews, V6, P167; Gu LJ, 2012, STROKE, V43, P1941, DOI 10.1161/STROKEAHA.112.656611; Hurn PD, 2007, J CEREBR BLOOD F MET, V27, P1798, DOI 10.1038/sj.jcbfm.9600482; Johansson S, 2008, STEM CELLS, V26, P2444, DOI 10.1634/stemcells.2008-0116; Julian LM, 2013, CELL STEM CELL, V12, P440, DOI 10.1016/j.stem.2013.02.001; Kaneko N, 2009, NEUROSCI RES, V63, P155, DOI 10.1016/j.neures.2008.12.001; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kempermann G., 2011, ADULT NEUROGENESIS, V2nd ed.; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Kim SJ, 2007, NEUROCHEM RES, V32, P1399, DOI 10.1007/s11064-007-9323-z; Kipnis J, 2004, P NATL ACAD SCI USA, V101, P8180, DOI 10.1073/pnas.0402268101; Kleinschnitz C, 2010, BLOOD, V115, P3835, DOI 10.1182/blood-2009-10-249078; Kokaia Z, 2012, NAT NEUROSCI, V15, P1078, DOI 10.1038/nn.3163; Li L, 2010, J NEUROSCI, V30, P9038, DOI 10.1523/JNEUROSCI.5691-09.2010; Ling CY, 2006, J NEUROSCI, V26, P731, DOI 10.1523/JNEUROSCI.3502-05.2006; Ling CY, 2003, J NEUROIMMUNOL, V141, P90, DOI 10.1016/S0165-5728(03)00249-2; Lum M, 2009, J NEUROIMMUNOL, V206, P32, DOI 10.1016/j.jneuroim.2008.10.009; Lynch MA, 2012, BRAIN BEHAV IMMUN, V26, P1, DOI 10.1016/j.bbi.2011.05.013; Marques CP, 2008, J IMMUNOL, V181, P6417, DOI 10.4049/jimmunol.181.9.6417; McGowan PO, 2011, BRAIN RES, V1383, P187, DOI 10.1016/j.brainres.2011.02.054; Merkle FT, 2007, SCIENCE, V317, P381, DOI 10.1126/science.1144914; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Mutnal MB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033143; Mutnal MB, 2011, J NEUROVIROL, V17, P424, DOI 10.1007/s13365-011-0042-5; Ni HT, 2004, DEV BRAIN RES, V152, P159, DOI 10.1016/j.devbrainres.2004.06.015; Pluchino S, 2008, BRAIN, V131, P2564, DOI 10.1093/brain/awn198; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Ricci-Vitiani L, 2006, NEUROL RES, V28, P488, DOI 10.1179/016164106X115134; Rotschafer JH, 2013, NEUROBIOL DIS, V58, P144, DOI 10.1016/j.nbd.2013.05.018; Russo I, 2011, J NEUROCHEM, V116, P947, DOI 10.1111/j.1471-4159.2010.07168.x; Saino O, 2010, J NEUROSCI RES, V88, P2385, DOI 10.1002/jnr.22410; Sekeljic V, 2012, BRAIN STRUCT FUNCT, V217, P411, DOI 10.1007/s00429-011-0336-7; Shichita T, 2009, NAT MED, V15, P946, DOI 10.1038/nm.1999; Thiel Gerald, 2013, Biochem J, V450, pe1, DOI 10.1042/BJ20130176; Tompkins DH, 2011, AM J RESP CELL MOL, V45, P101, DOI 10.1165/rcmb.2010-0149OC; Walter J, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00052; Walter J, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-18; Wang TG, 2010, J NEUROSCI, V30, P5020, DOI 10.1523/JNEUROSCI.0311-10.2010; Wang XW, 2001, J EXP MED, V194, P1069, DOI 10.1084/jem.194.8.1069; Wang Y, 2008, ANN NEUROL, V64, P417, DOI 10.1002/ana.21457; Wei Y, 2011, ANN NEUROL, V69, P119, DOI 10.1002/ana.22186; Whitney NP, 2009, J NEUROCHEM, V108, P1343, DOI 10.1111/j.1471-4159.2009.05886.x; Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108; Wong G, 2004, EXP NEUROL, V187, P171, DOI 10.1016/j.expneurol.2004.01.009; Yang L, 2004, EUR J IMMUNOL, V34, P1617, DOI 10.1002/eji.200424939; Yirmiya R, 2011, BRAIN BEHAV IMMUN, V25, P181, DOI 10.1016/j.bbi.2010.10.015; Ziv Y, 2006, NAT NEUROSCI, V9, P268, DOI 10.1038/nn1629	60	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105219	10.1371/journal.pone.0105219	http://dx.doi.org/10.1371/journal.pone.0105219			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133679	Green Submitted, Green Published, gold			2022-12-25	WOS:000341302700090
J	Jin, L; Bhuiya, MW; Li, MM; Liu, XQ; Han, JX; Deng, WW; Wang, M; Yu, O; Zhang, ZZ				Jin, Lu; Bhuiya, Mohammad Wadud; Li, Mengmeng; Liu, XiangQi; Han, Jixiang; Deng, WeiWei; Wang, Min; Yu, Oliver; Zhang, Zhengzhu			Metabolic Engineering of Saccharomyces cerevisiae for Caffeine and Theobromine Production	PLOS ONE			English	Article							PURINE ALKALOIDS; N-METHYLTRANSFERASES; SYNTHASE GENE; BIOSYNTHESIS; CAMELLIA; PURIFICATION; LEAVES; PLANTS; 7-METHYLXANTHINE; XANTHOSINE	Caffeine (1, 3, 7-trimethylxanthine) and theobromine (3, 7-dimethylxanthine) are the major purine alkaloids in plants, e. g. tea (Camellia sinensis) and coffee (Coffea arabica). Caffeine is a major component of coffee and is used widely in food and beverage industries. Most of the enzymes involved in the caffeine biosynthetic pathway have been reported previously. Here, we demonstrated the biosynthesis of caffeine (0.38 mg/L) by co-expression of Coffea arabica xanthosine methyltransferase (CaXMT) and Camellia sinensis caffeine synthase (TCS) in Saccharomyces cerevisiae. Furthermore, we endeavored to develop this production platform for making other purine-based alkaloids. To increase the catalytic activity of TCS in an effort to increase theobromine production, we identified four amino acid residues based on structural analyses of 3D-model of TCS. Two TCS1 mutants (Val317Met and Phe217Trp) slightly increased in theobromine accumulation and simultaneously decreased in caffeine production. The application and further optimization of this biosynthetic platform are discussed.	[Jin, Lu; Li, Mengmeng; Liu, XiangQi; Deng, WeiWei; Wang, Min; Zhang, Zhengzhu] Anhui Agr Univ, Key Lab Tea Biochem & Biotechnol, Minist Educ, Hefei, Peoples R China; [Bhuiya, Mohammad Wadud; Han, Jixiang] Conagen Inc, St Louis, MO USA; [Yu, Oliver] Donald Danforth Plant Sci Ctr, St Louis, MO USA	Anhui Agricultural University; Donald Danforth Plant Science Center	Zhang, ZZ (corresponding author), Anhui Agr Univ, Key Lab Tea Biochem & Biotechnol, Minist Educ, Hefei, Peoples R China.	zzz@ahau.edu.cn		Zhang, Zhengzhu/0000-0003-1564-1428; Deng, Wei-Wei/0000-0003-0732-7076	Natural Science Foundation of China (NSFC) [31170649]; Program for Changjiang Scholars, and the Innovative Research Team in University [IRT1101]; US National Science Foundation (NSF) [MCB-0923779]; US Department of Energy (DOE) [DE-SC0001295]; NSF-MRI [DBI-0521250]	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars, and the Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); US National Science Foundation (NSF)(National Science Foundation (NSF)); US Department of Energy (DOE)(United States Department of Energy (DOE)); NSF-MRI(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported by grants from the Natural Science Foundation of China (NSFC No. 31170649), the Program for Changjiang Scholars, and the Innovative Research Team in University (No. IRT1101). This work was also supported in part by grants from US National Science Foundation (NSF) (MCB-0923779) and US Department of Energy (DOE) (DE-SC0001295) to O. Yu. Funding for the 4000QTRAP mass spectrometer was provided through an NSF-MRI grant (DBI-0521250). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashihara H, 1996, PLANT PHYSIOL, V111, P747, DOI 10.1104/pp.111.3.747; Ashihara H, 1997, PLANT CELL PHYSIOL, V38, P413, DOI 10.1093/oxfordjournals.pcp.a029184; Ashihara H, 2008, PHYTOCHEMISTRY, V69, P841, DOI 10.1016/j.phytochem.2007.10.029; Cornell KA, 2009, J ANTIMICROB CHEMOTH, V63, P1163, DOI 10.1093/jac/dkp129; Facchini PJ, 2001, ANNU REV PLANT PHYS, V52, P29, DOI 10.1146/annurev.arplant.52.1.29; Grosdidier A, 2011, NUCLEIC ACIDS RES, V39, pW270, DOI 10.1093/nar/gkr366; Haferkamp I, 2013, J BACTERIOL, V195, P3183, DOI 10.1128/JB.00195-13; Hansen MR, 2005, BBA-GEN SUBJECTS, V1723, P55, DOI 10.1016/j.bbagen.2005.01.012; Hughes EH, 2002, METAB ENG, V4, P41, DOI 10.1006/mben.2001.0205; Ito E, 1999, J PLANT PHYSIOL, V154, P145, DOI 10.1016/S0176-1617(99)80202-8; Kato M, 2000, NATURE, V406, P956, DOI 10.1038/35023072; Kato M, 1996, PHYSIOL PLANTARUM, V98, P629, DOI [10.1111/j.1399-3054.1996.tb05720.x, 10.1034/j.1399-3054.1996.980325.x]; Kato M, 1999, PLANT PHYSIOL, V120, P579, DOI 10.1104/pp.120.2.579; Kim HS, 2006, MICROBIOL-SGM, V152, P1169, DOI 10.1099/mic.0.28703-0; Koshiishi C, 2001, FEBS LETT, V499, P50, DOI 10.1016/S0014-5793(01)02512-1; Kutchan TM, 2008, ADV PL BIOCH MOL BIO, V1, P283, DOI 10.1016/S1755-0408(07)01010-7; Lee JH, 2010, P NATL ACAD SCI USA, V107, P17557, DOI 10.1073/pnas.1006848107; MAGNI G, 1982, ARCH BIOCHEM BIOPHYS, V213, P426, DOI 10.1016/0003-9861(82)90568-9; McCarthy AA, 2007, PLANT PHYSIOL, V144, P879, DOI 10.1104/pp.106.094854; Mizuno K, 2003, FEBS LETT, V534, P75, DOI 10.1016/S0014-5793(02)03781-X; Ogawa M, 2001, J BIOL CHEM, V276, P8213, DOI 10.1074/jbc.M009480200; Osamu N, 1988, AGR BIOL CHEM TOKYO, V52, P169; Pasquali G, 2006, J BIOSCI BIOENG, V101, P287, DOI 10.1263/jbb.101.287; Ralston L, 2005, PLANT PHYSIOL, V137, P1375, DOI 10.1104/pp.104.054502; Sato F, 2001, P NATL ACAD SCI USA, V98, P367, DOI 10.1073/pnas.011526398; Shi CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-131; SUZUKI T, 1992, PHYTOCHEMISTRY, V31, P2575, DOI 10.1016/0031-9422(92)83590-U; Uefuji H, 2003, PLANT PHYSIOL, V132, P372, DOI 10.1104/pp.102.019679; Verpoorte R, 2002, CURR OPIN BIOTECH, V13, P181, DOI 10.1016/S0958-1669(02)00308-7; Verpoorte R., 1998, ALKALOIDS, V50, P453; Wang YC, 2011, METAB ENG, V13, P455, DOI 10.1016/j.ymben.2011.04.005; Yoneyama N, 2006, MOL GENET GENOMICS, V275, P125, DOI 10.1007/s00438-005-0070-z; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	33	14	16	3	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105368	10.1371/journal.pone.0105368	http://dx.doi.org/10.1371/journal.pone.0105368			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133732	Green Published, Green Submitted, gold			2022-12-25	WOS:000341302700107
J	Mineshita, M; Kida, H; Nishine, H; Handa, H; Inoue, T; Miyazawa, T				Mineshita, Masamichi; Kida, Hirotaka; Nishine, Hiroki; Handa, Hiroshi; Inoue, Takeo; Miyazawa, Teruomi			Left and Right Lung Asynchrony as a Physiological Indicator for Unilateral Bronchial Obstruction in Interventional Bronchoscopy	PLOS ONE			English	Article							CENTRAL AIRWAY-OBSTRUCTION; PULMONARY-DISEASE; TRACHEOBRONCHIAL STENOSIS; REGIONAL VENTILATION; BREATH SOUNDS; STENTS; DIAGNOSIS; CT	Background: In patients with bronchial obstruction, pulmonary function tests may not change significantly after intervention. The airflow asynchrony in both lungs due to unilateral bronchial obstruction may be applicable as a physiological indicator. The airflow asynchrony is reflected by the difference in the left and right lung sound development at tidal breathing. Objectives: To investigate the usefulness of left and right lung asynchrony due to unilateral bronchial obstruction as a physiological indicator for interventional bronchoscopy. Methods: Fifty cases with central airway obstruction were classified into three groups: tracheal, bronchial and extensive obstruction. The gap index was defined as the absolute value of the average of gaps between the left and right lung sound intensity peaks for a 12-second duration. Results: Before interventional bronchoscopy, the gap index was significantly higher in the bronchial (p < 0.05) and extensive obstruction groups (p < 0.05) than in the tracheal group. The gap index in cases with unilateral bronchial obstruction of at least 80% (0.18=0.04 seconds) was significantly higher than in cases with less than 80% obstruction (0.02=0.01 seconds, p < 0.05). After intervention for bronchial obstruction, the dyspnea scale (p < 0.001) and gap index significantly improved (p < 0.05), although no significant improvements were found in spirometric assessments. The responder rates for dyspnea were 79.3% for gap indexes over 0.06 seconds and 55.6% for gap indexes of 0.06 seconds or under. Conclusions: Assessment of left and right lung asynchrony in central airway obstruction with bronchial involvement may provide useful physiological information for interventional bronchoscopy.	[Mineshita, Masamichi; Kida, Hirotaka; Nishine, Hiroki; Handa, Hiroshi; Inoue, Takeo; Miyazawa, Teruomi] St Marianna Univ, Sch Med, Dept Internal Med, Div Resp & Infect Dis, Kawasaki, Kanagawa, Japan	Saint Marianna University	Mineshita, M (corresponding author), St Marianna Univ, Sch Med, Dept Internal Med, Div Resp & Infect Dis, Kawasaki, Kanagawa, Japan.	m-mine@marianna-u.ac.jp			Japan Society for the Promotion of Science [24591143]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research (C) Grant number (24591143). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker HD, 2009, RESPIRATION, V77, P179, DOI 10.1159/000182972; Dellinger RP, 2008, RESPIRATION, V75, P60, DOI 10.1159/000103558; Dellinger RP, 2007, CRIT CARE, V11, DOI 10.1186/cc5706; Doi M, 1999, J BRONCHOL, V6, P155; DUMON JF, 1990, CHEST, V97, P328, DOI 10.1378/chest.97.2.328; Ernst A, 2004, AM J RESP CRIT CARE, V169, P1278, DOI 10.1164/rccm.200210-1181SO; Fain S, 2010, J MAGN RESON IMAGING, V32, P1398, DOI 10.1002/jmri.22375; Handa H, 2014, RESP CARE, V59, P231, DOI 10.4187/respcare.02094; Handa H, 2012, RESP CARE, V57, P634, DOI 10.4187/respcare.01363; Herth F, 2001, CHEST, V119, P1910, DOI 10.1378/chest.119.6.1910; Maher TM, 2008, THORAX, V63, P542, DOI 10.1136/thx.2007.086405; Matsuoka S, 2008, RADIOLOGY, V248, P1042, DOI 10.1148/radiol.2491071650; Matsuoka S, 2008, AM J ROENTGENOL, V190, P762, DOI 10.2214/AJR.07.2820; Mineshita M, 2014, RESPIR INVESTIG, V52, P28, DOI 10.1016/j.resinv.2013.05.008; Mineshita M, 2014, RESPIRATION, V87, P45, DOI 10.1159/000350228; Miyazawa T, 1998, Respirology, V3, P229, DOI 10.1111/j.1440-1843.1998.tb00127.x; Miyazawa T, 2000, CHEST, V118, P959, DOI 10.1378/chest.118.4.959; Miyazawa T, 2004, AM J RESP CRIT CARE, V169, P1096, DOI 10.1164/rccm.200311-1784OC; Miyazu Y, 2003, CHEST, V124, P2393, DOI 10.1378/chest.124.6.2393; Nishine H, 2012, AM J RESP CRIT CARE, V185, P24, DOI 10.1164/rccm.201104-0701OC; Oki M, 2012, EUR RESPIR J, V40, P1483, DOI 10.1183/09031936.00015012; Park EA, 2010, RADIOLOGY, V256, P985, DOI 10.1148/radiol.10091502; PLOYSONGSANG Y, 1978, AM REV RESPIR DIS, V117, P657; PLOYSONGSANG Y, 1977, AM REV RESPIR DIS, V116, P187; Ryu YJ, 2006, EUR RESPIR J, V28, P1029, DOI 10.1183/09031936.00020906; Saad CP, 2003, CHEST, V124, P1993, DOI 10.1378/chest.124.5.1993; Seijo LM, 2001, NEW ENGL J MED, V344, P740, DOI 10.1056/NEJM200103083441007; Shi C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086638; Wang Z, 2008, J ASTHMA, V45, P575, DOI 10.1080/02770900802017744; Wang Z, 2009, RESPIRATION, V77, P134, DOI 10.1159/000178023; Yigla M, 2008, AM J ROENTGENOL, V191, P845, DOI 10.2214/AJR.07.3151	31	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105327	10.1371/journal.pone.0105327	http://dx.doi.org/10.1371/journal.pone.0105327			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133760	gold, Green Published, Green Submitted			2022-12-25	WOS:000341302700100
J	Shiba, D; Hatou, S; Ono, T; Hosoda, S; Tanabe, S; Ozeki, N; Yuki, K; Shimoyama, M; Fukagawa, K; Shimmura, S; Tsubota, K				Shiba, Daisuke; Hatou, Shin; Ono, Takeshi; Hosoda, Shingo; Tanabe, Sachiko; Ozeki, Naoki; Yuki, Kenya; Shimoyama, Masaru; Fukagawa, Kazumi; Shimmura, Shigeto; Tsubota, Kazuo			Multivariable Logistic Regression Model: A Novel Mathematical Model that Predicts Visual Field Sensitivity from Macular Ganglion Cell Complex Thickness in Glaucoma	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; RETINAL NERVE-FIBER; LAYER THICKNESS; LINEAR-MODEL; DOMAIN OCT; PERIMETRY; DAMAGE; EYES	Purpose: To design a mathematical model that can predict the relationship between the ganglion cell complex (GCC) thickness and visual field sensitivity (VFS) in glaucoma patients. Design: Retrospective cross-sectional case series. Method: Within 3 months from VFS measurements by the Humphrey field analyzer 10-2 program, 83 eyes underwent macular GCC thickness measurements by spectral-domain optical coherence tomography (SD-OCT). Data were used to construct a multiple logistic model that depicted the relationship between the explanatory variables (GCC thickness, age, sex, and spherical equivalent of refractive errors) determined by a regression analysis and the mean VFS corresponding to the SD-OCT scanned area. Analyses were performed in half or 8 segmented local areas as well as in whole scanned areas. A simple logistic model that included GCC thickness as the single explanatory variable was also constructed. The ability of the logistic models to depict the real GCC thickness/VFS in SAP distribution was analyzed by the chi(2) test of goodness-of-fit. The significance of the model effect was analyzed by analysis of variance (ANOVA). Results: Scatter plots between the GCC thickness and the mean VFS showed sigmoid curves. The chi(2) test of goodness-of-fit revealed that the multiple logistic models showed a good fit for the real GCC thickness/VFS distribution in all areas except the nasal-inferior-outer area. ANOVA revealed that all of the multiple logistic models significantly predicted the VFS based on the explanatory variables. Although simple logistic models also exhibited significant VFS predictability based on the GCC thickness, the model effect was less than that observed for the multiple logistic models. Conclusions: The currently proposed logistic models are useful methods for depicting relationships between the explanatory variables, including the GCC thickness, and the mean VFS in glaucoma patients.	[Shiba, Daisuke; Hatou, Shin; Ono, Takeshi; Hosoda, Shingo; Tanabe, Sachiko; Ozeki, Naoki; Yuki, Kenya; Shimoyama, Masaru; Fukagawa, Kazumi; Shimmura, Shigeto; Tsubota, Kazuo] Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan; [Shiba, Daisuke; Ozeki, Naoki; Yuki, Kenya; Fukagawa, Kazumi] Keisho Kai Iidabashi Eye Clin, Tokyo, Japan; [Tanabe, Sachiko] Tanabe Eye Clin, Kai, Yamanashi, Japan; [Shimoyama, Masaru] Shimoyama Eye Clin, Shizuoka, Japan	Keio University	Shiba, D (corresponding author), Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan.	shiba@personal.email.ne.jp		Hatou, Shin/0000-0001-9273-5909				Drasdo N, 2007, VISION RES, V47, P2901, DOI 10.1016/j.visres.2007.01.007; Glantz S, 2001, REGRESSION QUALITATI, P607; Harwerth RS, 2007, INVEST OPHTH VIS SCI, V48, P763, DOI 10.1167/iovs.06-0688; Hood DC, 2007, PROG RETIN EYE RES, V26, P688, DOI 10.1016/j.preteyeres.2007.08.001; Hood DC, 2007, INVEST OPHTH VIS SCI, V48, P3662, DOI 10.1167/iovs.06-1401; Hood DC, 2009, INVEST OPHTH VIS SCI, V50, P4254, DOI 10.1167/iovs.08-2697; Ishikawa H, 2005, INVEST OPHTH VIS SCI, V46, P2012, DOI 10.1167/iovs.04-0335; Kanamori A, 2013, ACTA OPHTHALMOL, V91, pE196, DOI 10.1111/aos.12028; Kerrigan-Baumrind LA, 2000, INVEST OPHTH VIS SCI, V41, P741; Kim NR, 2010, INVEST OPHTH VIS SCI, V51, P4646, DOI 10.1167/iovs.09-5053; Nilforushan N, 2012, INVEST OPHTH VIS SCI, V53, P2740, DOI 10.1167/iovs.11-8320; QUIGLEY HA, 1989, AM J OPHTHALMOL, V107, P453, DOI 10.1016/0002-9394(89)90488-1; Rao HL, 2011, ARCH OPHTHALMOL-CHIC, V129, P864, DOI 10.1001/archophthalmol.2011.145; Raza AS, 2011, ARCH OPHTHALMOL-CHIC, V129, P1529, DOI 10.1001/archophthalmol.2011.352; Sato S, 2013, INVEST OPHTH VIS SCI, V54, P3046, DOI 10.1167/iovs.12-11173; Shin HY, 2013, INVEST OPHTHALMOL VI; Takahashi M, 2013, CURR EYE RES, V38, P1133, DOI 10.3109/02713683.2013.807932; Tan O, 2008, OPHTHALMOLOGY, V115, P949, DOI 10.1016/j.ophtha.2007.08.011; Tan O, 2009, OPHTHALMOLOGY, V116, P2305, DOI 10.1016/j.ophtha.2009.05.025; Zeimer R, 1998, OPHTHALMOLOGY, V105, P224, DOI 10.1016/S0161-6420(98)92743-9	20	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e104126	10.1371/journal.pone.0104126	http://dx.doi.org/10.1371/journal.pone.0104126			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133512	Green Published, gold, Green Submitted			2022-12-25	WOS:000341302700022
J	Bluteau, G; Zhuang, L; Amann, R; Trueb, B				Bluteau, Gilles; Zhuang, Lei; Amann, Ruth; Trueb, Beat			Targeted Disruption of the Intracellular Domain of Receptor FgfrL1 in Mice	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; FIBROBLAST; CARTILAGE; PROTEINS; SIGNALS	FgfrL1 is the fifth member of the fibroblast growth factor receptor (Fgfr) family. Studies with FgfrL1 deficient mice have demonstrated that the gene plays an important role during embryonic development. FgfrL1 knock-out mice die at birth as they have a malformed diaphragm and lack metanephric kidneys. Similar to the classical Fgfrs, the FgfrL1 protein contains an extracellular part composed of three Ig-like domains that interact with Fgf ligands and heparin. However, the intracellular part of FgfrL1 is not related to the classical receptors and does not possess any tyrosine kinase activity. Curiously enough, the amino acid sequence of this domain is barely conserved among different species, with the exception of three motifs, namely a dileucine peptide, a tandem tyrosine-based motif YXX Phi and a histidine-rich sequence. To investigate the function of the intracellular domain of FgfrL1, we have prepared genetically modified mice that lack the three conserved sequence motifs, but instead contain a GFP cassette (FgfrL1 Delta C-GFP). To our surprise, homozygous FgfrL1 Delta C-GFP knock-in mice are viable, fertile and phenotypically normal. They do not exhibit any alterations in the diaphragm or the kidney, except for a slight reduction in the number of glomeruli that does not appear to affect life expectancy. In addition, the pancreas of both FgfrL1 Delta C-GFP knock-in and FgfrL1 knock-out mice do not show any disturbances in the production of insulin, in contrast to what has been suggested by recent studies. Thus, the conserved motifs of the intracellular FgfrL1 domain are dispensable for organogenesis and normal life. We conclude that the extracellular domain of the protein must conduct the vital functions of FgfrL1.	[Bluteau, Gilles; Zhuang, Lei; Amann, Ruth; Trueb, Beat] Univ Bern, Dept Clin Res, Bern, Switzerland; [Trueb, Beat] Univ Hosp Bern, Dept Rheumatol, CH-3010 Bern, Switzerland	University of Bern; University of Bern; University Hospital of Bern	Trueb, B (corresponding author), Univ Bern, Dept Clin Res, Bern, Switzerland.	beat.trueb@dkf.unibe.ch	Trueb, Beat/AAL-9621-2020	Trueb, Beat/0000-0001-8684-6856	Swiss National Science Foundation [31003A-143350]; Helmut Horten Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Helmut Horten Foundation	This work was supported by grants from the Swiss National Science Foundation (grant 31003A-143350) and the Helmut Horten Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann R, 2013, INT J MOL MED, V32, P983, DOI 10.3892/ijmm.2013.1484; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; Baertschi S, 2007, FEBS J, V274, P6241, DOI 10.1111/j.1742-4658.2007.06143.x; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Catela C, 2009, DIS MODEL MECH, V2, P283, DOI 10.1242/dmm.002287; di Martino E, 2013, GENE CHROMOSOME CANC, V52, P860, DOI 10.1002/gcc.22082; Dingemann J, 2011, EUR J PEDIATR SURG, V21, P46, DOI 10.1055/s-0030-1262853; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; Gerber SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033457; Gerber SD, 2009, DEV BIOL, V335, P106, DOI 10.1016/j.ydbio.2009.08.019; Kim I, 2001, BBA-GENE STRUCT EXPR, V1518, P152, DOI 10.1016/S0167-4781(00)00282-7; Kim MS, 2014, NATURE, V509, P575, DOI 10.1038/nature13302; MCLEOD MJ, 1980, TERATOLOGY, V22, P299, DOI 10.1002/tera.1420220306; Rieckmann T, 2008, EXP CELL RES, V314, P1071, DOI 10.1016/j.yexcr.2007.10.029; Rieckmann T, 2009, BBA-MOL BASIS DIS, V1792, P112, DOI 10.1016/j.bbadis.2008.11.006; Silva PN, 2013, J BIOL CHEM, V2013, P2; SIPOS L, 1993, EUR J BIOCHEM, V213, P1333, DOI 10.1111/j.1432-1033.1993.tb17885.x; Sleeman M, 2001, GENE, V271, P171, DOI 10.1016/S0378-1119(01)00518-2; Steinberg F, 2010, J BIOL CHEM, V285, P37704, DOI 10.1074/jbc.M110.140517; Steinberg F, 2010, J BIOL CHEM, V285, P2193, DOI 10.1074/jbc.M109.058248; Trueb B, 2003, J BIOL CHEM, V278, P33857, DOI 10.1074/jbc.M300281200; Trueb B, 2013, CELL MOL LIFE SCI, V70, P2505, DOI 10.1007/s00018-012-1189-9; Trueb B, 2011, CELL MOL LIFE SCI, V68, P951, DOI 10.1007/s00018-010-0576-3; Tsuchiya S, 2011, J BIOL CHEM, V286, P420, DOI 10.1074/jbc.M110.170852; Wiedemann M, 2000, GENOMICS, V69, P275, DOI 10.1006/geno.2000.6332; Wiedemann M, 2001, BBA-GENE STRUCT EXPR, V1520, P247, DOI 10.1016/S0167-4781(01)00267-6; Zhuang L, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-33	27	11	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105210	10.1371/journal.pone.0105210	http://dx.doi.org/10.1371/journal.pone.0105210			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126760	Green Submitted, gold, Green Published			2022-12-25	WOS:000340879300095
J	Chen, YW; Huang, HS; Shieh, YS; Ma, KH; Huang, SH; Hueng, DY; Sytwu, HK; Lin, GJ				Chen, Yuan-Wu; Huang, Hsu-Shan; Shieh, Yi-Shing; Ma, Kuo-Hsing; Huang, Shing-Hwa; Hueng, Dueng-Yuan; Sytwu, Huey-Kang; Lin, Gu-Jiun			A Novel Compound NSC745885 Exerts an Anti-Tumor Effect on Tongue Cancer SAS Cells In Vitro and In Vivo	PLOS ONE			English	Article							ANTHRACYCLINE ANTIBIOTICS; APOPTOSIS; ADRIAMYCIN; CARCINOMA; DAMAGE; IAP; MECHANISMS; EXPRESSION; INHIBITOR; P53	Objective: Oral squamous cell carcinoma (OSCC) is a prevalent cancer, especially in developing countries. Anthracyclines and their anthraquinone derivatives, such as doxorubicin, exhibit a cell growth inhibitory effect and have been used as anticancer drugs for many years. However, the cardiotoxicity of anthracycline antibiotics is a major concern in their clinical application. NSC745885 is a novel compound synthesized from 1,2-diaminoanthraquinone, which subsequently reacts with thionyl chloride and triethylamine. The present study aimed to investigate the anti-oral cancer potential and the safety of NSC745885. Methods: We investigated the anti-cancer potential of NSC745885 in oral squamous carcinoma cell lines and in an in vivo oral cancer xenograft mouse model. The expression of apoptotic related genes were evaluated by real-time RT-PCR and western bloting, and the in vivo assessment of apoptotic marker were measured by immunohistochemical staining. The anti-tumor efficiency and safety between doxorubicin and NSC745885 were also compared. Results: Our results demonstrated that NSC745885 exhibits anti-oral cancer activity through the induction of apoptosis in cancer cells and in tumor-bearing mice, and this treatment did not induce marked toxicity in experimental mice. This compound also exhibits a comparable anti-tumor efficiency and a higher safety in experimental mice when compared to doxorubicin. Conclusions: The data of this study provide evidence for NSC745885 as a potential novel therapeutic drug for the treatment of human OSCC.	[Chen, Yuan-Wu; Shieh, Yi-Shing] Natl Def Med Ctr, Sch Dent, Taipei, Taiwan; [Chen, Yuan-Wu] Triserv Gen Hosp, Dept Oral & Maxillofacial Surg, Taipei, Taiwan; [Huang, Hsu-Shan] Natl Def Med Ctr, Sch Pharm, Taipei, Taiwan; [Huang, Hsu-Shan] Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Canc Biol & Drug Discovery, Taipei, Taiwan; [Ma, Kuo-Hsing; Huang, Shing-Hwa; Lin, Gu-Jiun] Natl Def Med Ctr, Dept Biol & Anat, Taipei, Taiwan; [Huang, Shing-Hwa] Triserv Gen Hosp, Dept Gen Surg, Taipei, Taiwan; [Hueng, Dueng-Yuan] Triserv Gen Hosp, Dept Neurol Surg, Taipei, Taiwan; [Sytwu, Huey-Kang] Natl Def Med Ctr, Dept Microbiol & Immunol, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Taipei Medical University; National Defense Medical Center; Tri-Service General Hospital; Tri-Service General Hospital; National Defense Medical Center	Lin, GJ (corresponding author), Natl Def Med Ctr, Dept Biol & Anat, Taipei, Taiwan.	lingujiun@mail.ndmctsgh.edu.tw	Hueng, Dueng-Yuan/AAM-7807-2021	Hueng, Dueng-Yuan/0000-0001-7868-3161; Huang, Hsu-Shan/0000-0001-8162-5608; Lin, Gu-Jiun/0000-0003-4302-8196	National Science Council, Taiwan, R.O.C. [NSC101-2320-B-016-016, NSC102-2314-B-016-018-MY3]; Tri-Service General Hospital, Republic of China [TSGH-C102-019, TSGH-C100-034, TSGH-C101-009-S06]; C.Y. Foundation for Advancement of Education, Science and Medicine	National Science Council, Taiwan, R.O.C.(Ministry of Science and Technology, Taiwan); Tri-Service General Hospital, Republic of China; C.Y. Foundation for Advancement of Education, Science and Medicine	This study was supported by research grants from the National Science Council, Taiwan, R.O.C. (NSC101-2320-B-016-016 to G.-J. Lin and NSC102-2314-B-016-018-MY3 to Y.-W. Chen), Tri-Service General Hospital, Republic of China (Grant No. TSGH-C102-019, TSGH-C100-034 and TSGH-C101-009-S06) and in part by the C.Y. Foundation for Advancement of Education, Science and Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiko Y, 1997, CANCER LETT, V118, P101, DOI 10.1016/S0304-3835(97)00234-6; Bugger H, 2011, CANCER CHEMOTH PHARM, V67, P1381, DOI 10.1007/s00280-010-1441-7; Chang YL, 2011, INT J BIOCHEM CELL B, V43, P1720, DOI 10.1016/j.biocel.2011.08.006; Chen YJ, 2004, J PATHOL, V204, P326, DOI 10.1002/path.1640; Daley Tom, 2003, J Can Dent Assoc, V69, P577; de Almagro M. C., 2012, Experimental Oncology, V34, P200; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Elmore LW, 2002, J BIOL CHEM, V277, P35509, DOI 10.1074/jbc.M205477200; Gewirtz DA, 1999, BIOCHEM PHARMACOL, V57, P727, DOI 10.1016/S0006-2952(98)00307-4; Greider CW, 1996, ANNU REV BIOCHEM, V65, P337, DOI 10.1146/annurev.bi.65.070196.002005; Holcik M, 2001, APOPTOSIS, V6, P253, DOI 10.1023/A:1011379307472; Huang HS, 2009, BIOORGAN MED CHEM, V17, P7418, DOI 10.1016/j.bmc.2009.09.033; JACOBS JP, 1970, NATURE, V227, P168, DOI 10.1038/227168a0; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Lee YT, 2005, CANCER LETT, V223, P19, DOI 10.1016/j.canlet.2004.09.048; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; LING YH, 1993, CANCER RES, V53, P1845; Liston P, 1996, NATURE, V379, P349, DOI 10.1038/379349a0; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Martschick A, 2009, ANTICANCER RES, V29, P2307; Meissner K, 2002, J HISTOCHEM CYTOCHEM, V50, P1351, DOI 10.1177/002215540205001008; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Pentenero M, 2005, HEAD NECK-J SCI SPEC, V27, P1080, DOI 10.1002/hed.20275; SKLADANOWSKI A, 1993, BIOCHEM PHARMACOL, V46, P375, DOI 10.1016/0006-2952(93)90512-U; STEINHERZ LJ, 1991, JAMA-J AM MED ASSOC, V266, P1672, DOI 10.1001/jama.266.12.1672; TEWEY KM, 1984, SCIENCE, V226, P466, DOI 10.1126/science.6093249; van Almen GC, 2011, J MOL CELL CARDIOL, V51, P318, DOI 10.1016/j.yjmcc.2011.05.010; VasquezVivar J, 1997, BIOCHEMISTRY-US, V36, P11293, DOI 10.1021/bi971475e; Xu Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028335; Yang XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031601; Yoon KA, 2003, INT J MOL MED, V11, P343; Zucchi Riccardo, 2003, Current Medicinal Chemistry - Anti-Cancer Agents, V3, P151, DOI 10.2174/1568011033353434	32	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104703	10.1371/journal.pone.0104703	http://dx.doi.org/10.1371/journal.pone.0104703			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127132	gold, Green Published, Green Submitted			2022-12-25	WOS:000340879300043
J	Gharib, SA; Pippin, JW; Ohse, T; Pickering, SG; Krofft, RD; Shankland, SJ				Gharib, Sina A.; Pippin, Jeffrey W.; Ohse, Takamoto; Pickering, Scott G.; Krofft, Ronald D.; Shankland, Stuart J.			Transcriptional Landscape of Glomerular Parietal Epithelial Cells	PLOS ONE			English	Article							DE-NOVO EXPRESSION; PODOCYTE PROTEINS; RETINOIC ACID; IN-VITRO; KIDNEY; REGENERATION; PAX8; DIFFERENTIATION; NEPHROPATHY; MICROARRAY	Very little is known about the function of glomerular parietal epithelial cells (PECs). In this study, we performed genome-wide expression analysis on PEC-enriched capsulated vs. PEC-deprived decapsulated rat glomeruli to determine the transcriptional state of PECs under normal conditions. We identified hundreds of differentially expressed genes that mapped to distinct biologic modules including development, tight junction, ion transport, and metabolic processes. Since developmental programs were highly enriched in PECs, we characterized several of their candidate members at the protein level. Collectively, our findings confirm that PECs are multifaceted cells and help define their diverse functional repertoire.	[Gharib, Sina A.] Univ Washington, Ctr Lung Biol, Computat Med Core, Div Pulm & Crit Care Med, Seattle, WA 98195 USA; [Pippin, Jeffrey W.; Pickering, Scott G.; Krofft, Ronald D.; Shankland, Stuart J.] Univ Washington, Div Nephrol, Seattle, WA 98195 USA; [Ohse, Takamoto] Univ Tokyo, Div Nephrol, Tokyo, Japan	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Tokyo	Gharib, SA (corresponding author), Univ Washington, Ctr Lung Biol, Computat Med Core, Div Pulm & Crit Care Med, Seattle, WA 98195 USA.	sagharib@u.washington.edu		GHARIB, SINA A./0000-0002-2480-4367	National Institutes of Health (NIH) [DK056799, DK083391]; American Heart Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056799, R01DK083391] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by National Institutes of Health (NIH) grants DK056799, DK083391, and the American Heart Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appel D, 2009, J AM SOC NEPHROL, V20, P333, DOI 10.1681/ASN.2008070795; Arakawa M, 1977, Contrib Nephrol, V6, P73; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bouchard M, 2002, GENE DEV, V16, P2958, DOI 10.1101/gad.240102; Chen P, 2013, AM J PATHOL, V183, P1405, DOI 10.1016/j.ajpath.2013.07.007; GAUTHIER VJ, 1988, KIDNEY INT, V33, P897, DOI 10.1038/ki.1988.82; Gharib SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037669; Gudas LJ, 2012, BBA-MOL CELL BIOL L, V1821, P213, DOI 10.1016/j.bbalip.2011.08.002; Guhr SSO, 2013, KIDNEY INT, V84, P532, DOI 10.1038/ki.2013.115; Hauser PV, 2009, NEPHRON EXP NEPHROL, V112, pE43, DOI 10.1159/000213505; Jia LW, 2011, MOL BIOL CELL, V22, P2031, DOI 10.1091/mbc.E11-01-0038; Kabgani N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034907; Kayala MA, 2012, NUCLEIC ACIDS RES, V40, pW553, DOI 10.1093/nar/gks420; Marlier A, 2004, GENE EXPR PATTERNS, V5, P179, DOI 10.1016/j.modgep.2004.08.005; Narlis M, 2007, J AM SOC NEPHROL, V18, P1121, DOI 10.1681/ASN.2006070739; Ohse T, 2008, J AM SOC NEPHROL, V19, P1879, DOI 10.1681/ASN.2007101087; Ohse T, 2010, AM J PHYSIOL-RENAL, V298, pF702, DOI 10.1152/ajprenal.00428.2009; Ohse T, 2009, AM J PHYSIOL-RENAL, V297, pF1566, DOI 10.1152/ajprenal.00214.2009; Ohse T, 2009, KIDNEY INT, V76, P1225, DOI 10.1038/ki.2009.386; Paul R, 1997, CANCER RES, V57, P2741; Peired A, 2013, J AM SOC NEPHROL, V24, P1756, DOI 10.1681/ASN.2012090950; Petermann AT, 2002, KIDNEY INT, V61, P40, DOI 10.1046/j.1523-1755.2002.00102.x; Pitera JE, 2008, HUM MOL GENET, V17, P3953, DOI 10.1093/hmg/ddn297; Ronconi E, 2009, J AM SOC NEPHROL, V20, P322, DOI 10.1681/ASN.2008070709; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sagrinati C, 2006, J AM SOC NEPHROL, V17, P2443, DOI 10.1681/ASN.2006010089; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shankland SJ, 2007, KIDNEY INT, V72, P26, DOI 10.1038/sj.ki.5002291; Shankland SJ, 2013, CURR OPIN NEPHROL HY; Smeets B, 2009, J AM SOC NEPHROL, V20, P2593, DOI 10.1681/ASN.2009020132; Swetha G, 2011, J CELL MOL MED, V15, P396, DOI 10.1111/j.1582-4934.2009.00937.x; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; Tong GX, 2009, MODERN PATHOL, V22, P1218, DOI 10.1038/modpathol.2009.88; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; XIANG YY, 1994, CANCER RES, V54, P3034; Zhang J, 2012, AM J PHYSIOL-RENAL, V302, pF571, DOI 10.1152/ajprenal.00516.2011	39	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105289	10.1371/journal.pone.0105289	http://dx.doi.org/10.1371/journal.pone.0105289			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127402	Green Submitted, Green Published, gold			2022-12-25	WOS:000340879300101
J	Nayak, MK; Dash, A; Singh, N; Dash, D				Nayak, Manasa K.; Dash, Ayusman; Singh, Nitesh; Dash, Debabrata			Aspirin Delimits Platelet Life Span by Proteasomal Inhibition	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; PRIMARY PREVENTION; CELL-CYCLE; SUBUNIT INTERACTIONS; INDUCED APOPTOSIS; INDUCE APOPTOSIS; CYTOCHROME-C; CANCER CELLS; ACTIVATION; RISK	Aspirin is widely used in clinical settings as an anti-inflammatory and anti-platelet drug due its inhibitory effect on cyclooxygenase activity. Although the drug has long been considered to be an effective and safe therapeutic regime against inflammatory and cardiovascular disorders, consequences of its cyclooxygenase-independent attributes on platelets, the key players in thrombogenesis, beg serious investigation. In this report we explored the effect of aspirin on platelet lifespan in murine model and its possible cytotoxicity against human platelets in vitro. Aspirin administration in mice led to significant reduction in half-life of circulating platelets, indicative of enhanced rate of platelet clearance. Aspirin-treated human platelets were found to be phagocytosed more efficiently by macrophages, associated with attenuation in platelet proteasomal activity and upregulation of conformationally active Bax, which were consistent with enhanced platelet apoptosis. Although the dosage of aspirin administered in mice was higher than the therapeutic regimen against cardiovascular events, it is comparable with the recommended anti-inflammatory prescription. Thus, above observations provide cautionary framework to critically re-evaluate prophylactic and therapeutic dosage regime of aspirin in systemic inflammatory as well as cardiovascular ailments.	[Nayak, Manasa K.; Singh, Nitesh; Dash, Debabrata] Banaras Hindu Univ, Inst Med Sci, Dept Biochem, Varanasi 221005, Uttar Pradesh, India; [Dash, Ayusman] Indian Inst Sci Educ & Res, Kolkata, India	Banaras Hindu University (BHU); Indian Institute of Science Education & Research (IISER) - Kolkata	Dash, D (corresponding author), Banaras Hindu Univ, Inst Med Sci, Dept Biochem, Varanasi 221005, Uttar Pradesh, India.	ddash.biochem@gmail.com	DASH, DEBABRATA/AAF-1837-2020; Dash, Ayusman/GLV-4745-2022; Nayak, Manasa/AAZ-9439-2021; SINGH, NITESH/GRS-3129-2022	Dash, Ayusman/0000-0003-1394-3174; SINGH, NITESH/0000-0002-1345-1148; Nayak, Manasa/0000-0001-6461-0543	Department of Biotechnology (DBT); Department of Science and Technology (DST), Government of India; Council of Scientific and Industrial Research (CSIR); Indian Council of Medical Research (ICMR); DBT	Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); Department of Science and Technology (DST), Government of India(Department of Science & Technology (India)); Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR)); DBT(Department of Biotechnology (DBT) India)	This research was supported by grants received by D. Dash from the Department of Biotechnology (DBT)(http://dbtindia.nic.in/index.asp) and the Department of Science and Technology (DST)(http://www.dst.gov.in), Government of India, the Council of Scientific and Industrial Research (CSIR)(http://www.csir.res.in/), and the Indian Council of Medical Research (ICMR)(http://www.icmr.nic.in). D. Dash thankfully acknowledges Tata Innovation Fellowship grant received from DBT for carrying out this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktas B, 2005, J BIOL CHEM, V280, P39716, DOI 10.1074/jbc.M507762200; Algra A, 2009, LANCET, V373, P1821, DOI 10.1016/S0140-6736(09)61003-5; [Anonymous], 1988, BRIT MED J, V296, P316; Arendt CS, 1997, P NATL ACAD SCI USA, V94, P7156, DOI 10.1073/pnas.94.14.7156; Bellosillo B, 1998, BLOOD, V92, P1406, DOI 10.1182/blood.V92.4.1406.416k17_1406_1414; Brown SB, 2000, J BIOL CHEM, V275, P5987, DOI 10.1074/jbc.275.8.5987; Cho MS, 2012, BLOOD, V120, P4869, DOI 10.1182/blood-2012-06-438598; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Dikshit P, 2006, J BIOL CHEM, V281, P29228, DOI 10.1074/jbc.M602629200; Dreser M. H., 1970, PFLUGERS ARCH, V76, P306, DOI [10.1007/bf01662127, DOI 10.1007/BF01662127]; Er E, 2006, BBA-BIOENERGETICS, V1757, P1301, DOI 10.1016/j.bbabio.2006.05.032; Ferrell K, 2000, TRENDS BIOCHEM SCI, V25, P83, DOI 10.1016/S0968-0004(99)01529-7; FITZGERALD GA, 1991, AM J CARDIOL, V68, pB11, DOI 10.1016/0002-9149(91)90379-Y; Fu NY, 2009, MOL CELL, V33, P15, DOI 10.1016/j.molcel.2008.11.025; Gao JJ, 2005, P NATL ACAD SCI USA, V102, P17207, DOI 10.1073/pnas.0506893102; GIOVANNUCCI E, 1995, NEW ENGL J MED, V333, P609, DOI 10.1056/NEJM199509073331001; Glickman MH, 2000, SEMIN CELL DEV BIOL, V11, P149, DOI 10.1006/scdb.2000.0161; GREENBERG ER, 1993, JNCI-J NATL CANCER I, V85, P912, DOI 10.1093/jnci/85.11.912; Gu Q, 2005, CARCINOGENESIS, V26, P541, DOI 10.1093/carcin/bgh345; Gupta RA, 1998, GASTROENTEROLOGY, V114, P1095, DOI 10.1016/S0016-5085(98)70330-0; HAMBERG M, 1975, P NATL ACAD SCI USA, V72, P2994, DOI 10.1073/pnas.72.8.2994; Ho CC, 2003, EUR J CLIN INVEST, V33, P875, DOI 10.1046/j.1365-2362.2003.01240.x; Hu YZ, 2013, INT J CLIN PHARM TH, V51, P228, DOI 10.5414/CP201808; Kodama T, 2011, J BIOL CHEM, V286, P13905, DOI 10.1074/jbc.M110.195370; Kuku I, 2012, J HEMATOL, V1, P44, DOI 10.4021/jh28w; Leytin V, 2009, LAB INVEST, V89, P374, DOI 10.1038/labinvest.2009.13; Li BY, 2000, P NATL ACAD SCI USA, V97, P3850, DOI 10.1073/pnas.070047997; Lopez JJ, 2007, J THROMB HAEMOST, V5, P1283, DOI 10.1111/j.1538-7836.2007.02505.x; Mason KD, 2007, CELL, V128, P1173, DOI 10.1016/j.cell.2007.01.037; Medicines and Healthcare Products Regulatory Agency Commission on Human Medicines, 2009, DRUG SAFETY UPDATE, V3, P3; Nayak MK, 2013, J BIOL CHEM, V288, P6826, DOI 10.1074/jbc.M112.403154; Nayak MK, 2011, THROMB HAEMOSTASIS, V106, P624, DOI 10.1160/TH11-03-0178; Nayak MK, 2011, CELL CALCIUM, V49, P226, DOI 10.1016/j.ceca.2011.02.005; NORRVING B, 1991, LANCET, V338, P1345; Park K, 2013, CLEV CLIN J MED, V80, P318, DOI 10.3949/ccjm.80a.12146; Pereira J, 1999, THROMB HAEMOSTASIS, V82, P1318; Piazza GA, 1997, CANCER RES, V57, P2452; Pignone M, 2010, DIABETES CARE, V33, P1395, DOI 10.2337/dc10-0555; Pique M, 2000, FEBS LETT, V480, P193, DOI 10.1016/S0014-5793(00)01922-0; Rao CV, 2004, CURR CANCER DRUG TAR, V4, P29, DOI 10.2174/1568009043481632; RODERICK PJ, 1993, BRIT J CLIN PHARMACO, V35, P219, DOI 10.1111/j.1365-2125.1993.tb05689.x; Rosenzweig R, 2008, BIOCHEM SOC T, V36, P807, DOI 10.1042/BST0360807; ROTH S, 1989, ARCH INTERN MED, V149, P775, DOI 10.1001/archinte.149.4.775; Rothwell PM, 2012, LANCET, V379, P1602, DOI 10.1016/S0140-6736(11)61720-0; Sanmuganathan PS, 2001, HEART, V85, P265, DOI 10.1136/heart.85.3.265; Shiff SJ, 1996, EXP CELL RES, V222, P179, DOI 10.1006/excr.1996.0023; SHIFF SJ, 1995, J CLIN INVEST, V96, P491, DOI 10.1172/JCI118060; The Swedish Cooperative Study Group, 1986, STROKE, V18, P325; Thun MJ, 2002, JNCI-J NATL CANCER I, V94, P252, DOI 10.1093/jnci/94.4.252; Tsutsumi S, 2004, CELL DEATH DIFFER, V11, P1009, DOI 10.1038/sj.cdd.4401436; Vanags DM, 1997, BRIT J HAEMATOL, V99, P824, DOI 10.1046/j.1365-2141.1997.4813284.x; Warner TD, 2002, P NATL ACAD SCI USA, V99, P13371, DOI 10.1073/pnas.222543099; WEISS HJ, 1967, LANCET, V2, P495; Zhang H, 2007, CELL DEATH DIFFER, V14, P943, DOI 10.1038/sj.cdd.4402081; Zhang L, 2000, SCIENCE, V290, P989, DOI 10.1126/science.290.5493.989; Zhao LL, 2013, PLATELETS, V24, P637, DOI 10.3109/09537104.2012.754417; Zhou XM, 2001, CARCINOGENESIS, V22, P1393, DOI 10.1093/carcin/22.9.1393; Zimmermann KC, 2000, NEOPLASIA, V2, P505, DOI 10.1038/sj.neo.7900120	58	16	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105049	10.1371/journal.pone.0105049	http://dx.doi.org/10.1371/journal.pone.0105049			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126950	Green Published, Green Submitted, gold			2022-12-25	WOS:000340879300073
J	Pritchard, RE; Prassinos, AJ; Osborne, JD; Raviv, Z; Balish, MF				Pritchard, Rachel E.; Prassinos, Alexandre J.; Osborne, John D.; Raviv, Ziv; Balish, Mitchell F.			Reduction of Hydrogen Peroxide Accumulation and Toxicity by a Catalase from Mycoplasma iowae	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; VIRULENCE DETERMINANT; AVIAN MYCOPLASMA; MYCOIDES SC; PNEUMONIAE; GLYCEROL; METABOLISM; GALLISEPTICUM; CYTOTOXICITY; INFECTION	Mycoplasma iowae is a well-established avian pathogen that can infect and damage many sites throughout the body. One potential mediator of cellular damage by mycoplasmas is the production of H2O2 via a glycerol catabolic pathway whose genes are widespread amongst many mycoplasma species. Previous sequencing of M. iowae serovar I strain 695 revealed the presence of not only genes for H2O2 production through glycerol catabolism but also the first documented mycoplasma gene for catalase, which degrades H2O2. To test the activity of M. iowae catalase in degrading H2O2, we studied catalase activity and H2O2 accumulation by both M. iowae serovar K strain DK-CPA, whose genome we sequenced, and strains of the H2O2-producing species Mycoplasma gallisepticum engineered to produce M. iowae catalase by transformation with the M. iowae putative catalase gene, katE. H2O2-mediated virulence by M. iowae serovar K and catalase-producing M. gallisepticum transformants were also analyzed using a Caenorhabditis elegans toxicity assay, which has never previously been used in conjunction with mycoplasmas. We found that M. iowae katE encodes an active catalase that, when expressed in M. gallisepticum, reduces both the amount of H2O2 produced and the amount of damage to C. elegans in the presence of glycerol. Therefore, the correlation between the presence of glycerol catabolism genes and the use of H2O2 as a virulence factor by mycoplasmas might not be absolute.	[Pritchard, Rachel E.; Prassinos, Alexandre J.; Balish, Mitchell F.] Miami Univ, Dept Microbiol, Oxford, OH 45056 USA; [Osborne, John D.] Univ Alabama Birmingham, Ctr Clin & Translat Sci, Birmingham, AL USA; [Raviv, Ziv] Ohio State Univ, Dept Vet Prevent Med, Columbus, OH 43210 USA	Miami University; University of Alabama System; University of Alabama Birmingham; Ohio State University	Balish, MF (corresponding author), Miami Univ, Dept Microbiol, Oxford, OH 45056 USA.	balishmf@miamioh.edu	Osborne, John/F-3445-2016	Osborne, John/0000-0002-0851-1150	National Institutes of Health Public Service Grant [R15 AI073994]; Hybrid Turkeys, Kitchener, Ontario, Canada; Miami University Doctoral-Undergraduate Opportunities in Scholarship Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI073994] Funding Source: NIH RePORTER	National Institutes of Health Public Service Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hybrid Turkeys, Kitchener, Ontario, Canada; Miami University Doctoral-Undergraduate Opportunities in Scholarship Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (www.nih.gov) Public Service Grant R15 AI073994 to MFB, by funding from Hybrid Turkeys (www.hybridturkeys.com), Kitchener, Ontario, Canada to ZR, and by the Miami University Doctoral-Undergraduate Opportunities in Scholarship Program (miamioh.edu) to REP and AJP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo EM, 1998, VET MICROBIOL, V59, P109, DOI 10.1016/S0378-1135(97)00184-3; AlAnkari ARS, 1996, AVIAN PATHOL, V25, P205, DOI 10.1080/03079459608419137; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; BANAI M, 1978, INFECT IMMUN, V21, P365, DOI 10.1128/IAI.21.2.365-372.1978; BARBER TL, 1971, APPL MICROBIOL, V21, P594, DOI 10.1128/AEM.21.4.594-599.1971; Berent LM, 2003, INFECT IMMUN, V71, P3657, DOI 10.1128/IAI.71.6.3657-3662.2003; BRADBURY JM, 1988, AVIAN PATHOL, V17, P149, DOI 10.1080/03079458808436435; BRADBURY JM, 1983, YALE J BIOL MED, V56, P912; BRENNAN PC, 1969, J BACTERIOL, V98, P1036, DOI 10.1128/JB.98.3.1036-1040.1969; Couillault C, 2002, INFECT IMMUN, V70, P4705, DOI 10.1128/IAI.70.8.4705-4707.2002; Couronne O, 2003, GENOME RES, V13, P73, DOI 10.1101/gr.762503; Dhandayuthapani S, 2001, J BACTERIOL, V183, P5645, DOI 10.1128/JB.183.19.5645-5650.2001; do Nascimento NC, 2012, J BACTERIOL, V194, P1605, DOI 10.1128/JB.06781-11; Ewbank JJ, 2002, MICROBES INFECT, V4, P247, DOI 10.1016/S1286-4579(01)01531-3; French CT, 2008, MOL MICROBIOL, V69, P67, DOI 10.1111/j.1365-2958.2008.06262.x; GEOURJON C, 1995, COMPUT APPL BIOSCI, V13, P209; Grosshennig S, 2013, INFECT IMMUN, V81, P896, DOI [10.1128/IAI.01212, 10.1128/IAI.01212-12]; Hakansson KO, 2004, ACTA CRYSTALLOGR D, V60, P1374, DOI 10.1107/S0907444904012004; Hames C, 2009, J BACTERIOL, V191, P747, DOI 10.1128/JB.01103-08; HEDREYDA CT, 1993, PLASMID, V30, P170, DOI 10.1006/plas.1993.1047; Hong Y, 2005, J CLIN MICROBIOL, V43, P909, DOI 10.1128/JCM.43.2.909-912.2005; Houshaymi BM, 1997, VET REC, V140, P182, DOI 10.1136/vr.140.7.182; Jansen WTM, 2002, INFECT IMMUN, V70, P5202, DOI 10.1128/IAI.70.9.5202-5207.2002; Johansson K.E., 2002, MOL BIOL PATHOGENICI; Jurkovic DA, 2012, J BACTERIOL, V194, P2877, DOI 10.1128/JB.00060-12; Kannan TR, 2006, P NATL ACAD SCI USA, V103, P6724, DOI 10.1073/pnas.0510644103; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lewis JA, 1995, METHOD CELL BIOL, V48, P3; Ley DH, 2010, AVIAN PATHOL, V39, P87, DOI 10.1080/03079451003599276; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Martinez MA, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-44; MIRSALIMI SM, 1989, AVIAN DIS, V33, P310, DOI 10.2307/1590849; Moy TI, 2004, INFECT IMMUN, V72, P4512, DOI 10.1128/IAI.72.8.4512-4520.2004; Papazisi L, 2003, MICROBIOL-SGM, V149, P2307, DOI 10.1099/mic.0.26427-0; Perriere G, 1996, BIOCHIMIE, V78, P364, DOI 10.1016/0300-9084(96)84768-7; Pilo P, 2005, J BACTERIOL, V187, P6824, DOI 10.1128/JB.187.19.6824-6831.2005; Schmidl SR, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002263; SHAHMAJID M, 1987, AVIAN DIS, V31, P365, DOI 10.2307/1590887; Shima S, 2001, APPL ENVIRON MICROB, V67, P3041, DOI 10.1128/AEM.67.7.3041-3045.2001; Simmons WL, 2013, MICROBIOL-SGM, V159, P737, DOI 10.1099/mic.0.064782-0; Taylor RR, 1996, VET MICROBIOL, V51, P291, DOI 10.1016/0378-1135(96)00039-9; TRAMPEL DW, 1994, AVIAN DIS, V38, P905, DOI 10.2307/1592133; TULLY JG, 1979, J INFECT DIS, V139, P478, DOI 10.1093/infdis/139.4.478; Vilei EM, 2001, CLIN DIAGN LAB IMMUN, V8, P85, DOI 10.1128/CDLI.8.1.85-92.2001; Wei S, 2012, J BACTERIOL, V194, P547, DOI 10.1128/JB.06297-11; Yus E, 2009, SCIENCE, V326, P1263, DOI 10.1126/science.1177263; Zhang WB, 2014, J BACTERIOL, V196, P1012, DOI 10.1128/JB.00954-13	48	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105188	10.1371/journal.pone.0105188	http://dx.doi.org/10.1371/journal.pone.0105188			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127127	Green Submitted, Green Published, gold			2022-12-25	WOS:000340879300091
J	Silva-Flores, R; Perez-Verdin, G; Wehenkel, C				Silva-Flores, Ramon; Perez-Verdin, Gustavo; Wehenkel, Christian			Patterns of Tree Species Diversity in Relation to Climatic Factors on the Sierra Madre Occidental, Mexico	PLOS ONE			English	Article							RICHNESS; SCALE; BIODIVERSITY; ENERGY; WATER; TEMPERATURE; REGRESSION; VEGETATION; GRADIENTS; FORESTS	Biological diversity can be defined as variability among living organisms from all sources, including terrestrial organisms, marine and other aquatic ecosystems, and the ecological complexes which they are part of. This includes diversity within species, between species, and of ecosystems. Numerous diversity indices combine richness and evenness in a single expression, and several climate-based explanations have been proposed to explain broad-scale diversity patterns. However, climate-based water-energy dynamics appears to be an essential factor that determines patterns of diversity. The Mexican Sierra Madre Occidental occupies an area of about 29 million hectares and is located between the Neotropical and Holarctic ecozones. It shelters a high diversity of flora, including 24 different species of Pinus (ca. 22% on the whole), 54 species of Quercus (ca. 9-14%), 7 species of Arbutus (ca. 50%) and many other trees species. The objectives of this study were to model how tree species diversity is related to climatic and geographic factors and stand density and to test the Metabolic Theory, Productivity-Diversity Hypothesis, Physiological Tolerance Hypothesis, Mid-Domain Effect, and the Water-Energy Dynamic Theory on the Sierra Madre Occidental, Durango. The results supported the Productivity-Diversity Hypothesis, Physiological Tolerance Hypothesis and Water-Energy Dynamic Theory, but not the Mid-Domain Effect or Metabolic Theory. The annual aridity index was the variable most closely related to the diversity indices analyzed. Contemporary climate was found to have moderate to strong effects on the minimum, median and maximum tree species diversity. Because water-energy dynamics provided a satisfactory explanation for the patterns of minimum, median and maximum diversity, an understanding of this factor is critical to future biodiversity research. Quantile regression of the data showed that the three diversity parameters of tree species are generally higher in cold, humid temperate climates than in dry, hot climates.	[Silva-Flores, Ramon] Univ Juarez Estado Durango, Durango, Mexico; [Perez-Verdin, Gustavo] Inst Politecn Nacl, CIIDIR, Durango, Mexico; [Wehenkel, Christian] Univ Juarez Estado Durango, Inst Silvicultura & Ind Madera, Durango, Mexico	Universidad Juarez del Estado de Durango; Instituto Politecnico Nacional - Mexico; Universidad Juarez del Estado de Durango	Wehenkel, C (corresponding author), Univ Juarez Estado Durango, Inst Silvicultura & Ind Madera, Ciudad Univ, Durango, Mexico.	wehenkel@ujed.mx	PEREZ-VERDIN, GUSTAVO/A-4248-2011	PEREZ-VERDIN, GUSTAVO/0000-0001-6788-2763	Consejo Nacional de Ciencia y Tecnologia (CONACYT)	Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	We are grateful to the Comision Nacional Forestal (CONAFOR) for sharing the National Forest and Soil Inventory data and to the Consejo Nacional de Ciencia y Tecnologia (CONACYT) for the support awarded for a doctoral research project. We also thank Maria del Socorro Gonzalez-Elizondo and Daniel Moya-Navarro, for their helpful suggestions in an early manuscript.	Aitken SN, 2008, EVOL APPL, V1, P95, DOI 10.1111/j.1752-4571.2007.00013.x; Alkemade R, 2011, REG ENVIRON CHANGE, V11, pS143, DOI 10.1007/s10113-010-0161-1; Allen AP, 2002, SCIENCE, V297, P1545, DOI 10.1126/science.1072380; ARROYO MTK, 1988, ANN MO BOT GARD, V75, P55, DOI 10.2307/2399466; Badii MH, 2008, DAENA INT J GOOD CON, V3, P632; Begon M., 1996, ECOLOGY; Bharali S, 2011, NATURE SCI, V9, P125; Brooker RW, 2006, NEW PHYTOL, V171, P271, DOI 10.1111/j.1469-8137.2006.01752.x; Cade BS, 2003, FRONT ECOL ENVIRON, V1, P412, DOI 10.1890/1540-9295(2003)001[0412:AGITQR]2.0.CO;2; CBD (Convention on Biological Diversity), 2011, HDB CONV BIOL DIV; Chen XW, 2003, CHEMOSPHERE, V51, P215, DOI 10.1016/S0045-6535(02)00809-3; COLWELL RK, 1994, AM NAT, V144, P570, DOI 10.1086/285695; CONAFOR (Comision Nacional Forestal), 2004, INV NACL FOR SUEL; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Currie DJ, 2004, ECOL LETT, V7, P1121, DOI 10.1111/j.1461-0248.2004.00671.x; CURRIE DJ, 1987, NATURE, V329, P326, DOI 10.1038/329326a0; Eiserhardt WL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027027; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Gregorius HR, 2008, ECOL MODEL, V211, P90, DOI 10.1016/j.ecolmodel.2007.08.026; Gregorius Hans-Rolf, 2010, Diversity, V2, P370; GREGORIUS HR, 1978, MATH BIOSCI, V41, P253, DOI 10.1016/0025-5564(78)90040-8; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Hawkins BA, 2007, ECOLOGY, V88, P1877, DOI 10.1890/06-1444.1; Hebda RJ, 1994, BIODIVERSITY BRIT CO, P343; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Hutchinson M.F., 2004, ANUSPLIN VERSION 4 3; Hutchinson MF, 1991, DATA ASSIMILATION SY, P104; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Karger DN, 2011, J BIOGEOGR, V38, P1177, DOI 10.1111/j.1365-2699.2010.02468.x; KOENKER R, 1978, ECONOMETRICA, V46, P33, DOI 10.2307/1913643; Koenker R, 2011, QUANTILE REGRESSION; Lennon JJ, 2011, ECOGRAPHY, V34, P529, DOI 10.1111/j.1600-0587.2010.06669.x; McNeely J. A., 1988, EC BIOL DIVERSITY DE; Norse EA, 1988, CONSERVING BIOSCIENC; NOSS RF, 1990, CONSERV BIOL, V4, P355, DOI 10.1111/j.1523-1739.1990.tb00309.x; O'Brien EM, 2006, J BIOGEOGR, V33, P1868, DOI 10.1111/j.1365-2699.2006.01534.x; O'Brien EM, 1998, J BIOGEOGR, V25, P379, DOI 10.1046/j.1365-2699.1998.252166.x; Rehfeldt GE, 2006, RMRSGTR165; Rehfeldt GE, 2006, INT J PLANT SCI, V167, P1123, DOI 10.1086/507711; Rehfeldt GE, 2012, ECOL APPL, V22, P119, DOI 10.1890/11-0495.1; Richardson BA, 2009, INT J PLANT SCI, V170, P1120, DOI 10.1086/605870; Rzedowski J., 1978, VEGETACION MEXICO; Saenz-Romero C, 2010, CLIMATIC CHANGE, V102, P595, DOI 10.1007/s10584-009-9753-5; Sanders NJ, 2007, GLOBAL ECOL BIOGEOGR, V16, P640, DOI 10.1111/j.1466-8238.2007.00316.x; Sang Weiguo, 2009, Ecological Research, V24, P303, DOI 10.1007/s11284-008-0507-z; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Sharma CM, 2009, J AM SCI, V5, P119, DOI DOI 10.7537/MARSJAS050509.15; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Gonzalez-Elizondo MS, 2012, ACTA BOT MEX, V100, P351, DOI 10.21829/abm100.2012.40; SRNyMA (Secretaria de Recursos Naturales y Medio Ambiente), 2006, PROGR ESTR FOR 2030; Statistical Analysis System SAS Institute Inc, 2004, SAS ETS 9 1 US GUID; Tabachnick B. G., 2001, USING MULTIVARIATE S; Ter Steege H, 2003, BIODIVERS CONSERV, V12, P2255, DOI 10.1023/A:1024593414624; Traill LW, 2007, BIOL CONSERV, V139, P159, DOI 10.1016/j.biocon.2007.06.011; Wang ZH, 2009, P NATL ACAD SCI USA, V106, P13388, DOI 10.1073/pnas.0905030106; Wehenkel C, 2014, FOREST ECOL MANAG, V316, P117, DOI 10.1016/j.foreco.2013.05.056; Wehenkel C, 2012, TREE GENET GENOMES, V8, P1085, DOI 10.1007/s11295-012-0488-5; Wehenkel C, 2011, ANN FOREST SCI, V68, P385, DOI 10.1007/s13595-011-0027-9; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190; Wolfgang KH, 2012, APPL MULTIVARIATE ST; Woodward F.I., 1987, CLIMATE PLANT DISTRI; Wright David H., 1993, P66; ZEIDE B, 1991, FOREST SCI, V37, P517; Zyczkowski K, 2003, OPEN SYST INF DYN, V10, P297, DOI 10.1023/A:1025128024427	65	38	41	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105034	10.1371/journal.pone.0105034	http://dx.doi.org/10.1371/journal.pone.0105034			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127455	Green Published, Green Submitted, gold			2022-12-25	WOS:000340879300070
J	Brown, S; Reid, D; Rogan, E				Brown, Susie; Reid, David; Rogan, Emer			Characteristics of Fishing Operations, Environment and Life History Contributing to Small Cetacean Bycatch in the Northeast Atlantic	PLOS ONE			English	Article							DOLPHINS DELPHINUS-DELPHIS; PORPOISE PHOCOENA-PHOCOENA; COMMON DOLPHIN; MARINE-MAMMALS; BY-CATCH; INCIDENTAL CATCHES; GILLNET FISHERIES; SEA-TURTLES; BEHAVIOR; IMPACTS	Fisheries bycatch is a key threat to cetacean species globally. Managing the impact requires an understanding of the conditions under which animals are caught and the sections of the population affected. We used observer data collected on an albacore tuna gillnet fishery in the northeast Atlantic, to assess operational and environmental factors contributing to bycatch of common and striped dolphins, using generalised linear models and model averaging. Life history demographics of the captured animals were also investigated. In both species, young males dominated the catch. The age ratio of common dolphins was significantly different from that estimated for the population in the region, based on life tables (G = 17.1, d.f. = 2, p = 0.002). Skewed age and sex ratios may reflect varying vulnerability to capture, through differences in behaviour or segregation in populations. Adult females constituted the second largest portion of the bycatch for both species, with potential consequences for population sustainability. Depth was the most important parameter influencing bycatch of both species and reflected what is known about common and striped dolphin habitat use in the region as the probability of catching common dolphins decreased, and striped dolphins increased, with increasing depth. Striped dolphin capture was similarly influenced by the extent to which operations were conducted in daylight, with the probability of capture increasing with increased operations in the pre-sunset and post-sunrise period, potentially driven by increased ability of observers to record animals during daylight operations, or by diurnal movements increasing contact with the fishery. Effort, based on net length and soak time, had little influence on the probability of capturing either species. Our results illustrate the importance of assessing the demographic of the animals captured during observer programmes and, perhaps more importantly, suggest that effort restrictions alone may not be sufficient to eradicate bycatch in areas where driftnets and small cetaceans co-occur.	[Brown, Susie; Rogan, Emer] Natl Univ Ireland Univ Coll Cork, Cork Enterprise Ctr, Sch Biol Earth & Environm Sci, Distillery Fields North Mall, Cork, Ireland; [Reid, David] Marine Inst Headquarters, Galway, Ireland	University College Cork; Marine Institute Ireland	Brown, S (corresponding author), Natl Univ Ireland Univ Coll Cork, Cork Enterprise Ctr, Sch Biol Earth & Environm Sci, Distillery Fields North Mall, Cork, Ireland.	s.brown@ucc.ie	Reid, David/ABC-5916-2021	Reid, Dave/0000-0002-8494-0918	Beaufort Ecosystem Approach, Irish Government's National Development Plan (NDP); Department of Communications, Energy and Natural Resources (DCENR); Department of Agriculture, Fisheries and Food (DAFF) under the Strategy for Science Technology and Innovation (SSTI); Sea Change StrategyEuropean Commission [FAIR-CT95-0523]	Beaufort Ecosystem Approach, Irish Government's National Development Plan (NDP); Department of Communications, Energy and Natural Resources (DCENR); Department of Agriculture, Fisheries and Food (DAFF) under the Strategy for Science Technology and Innovation (SSTI); Sea Change StrategyEuropean Commission	This analysis is funded under the Beaufort Ecosystem Approach to Fisheries Management award, as part of the Irish Government's National Development Plan (NDP), the Beaufort Marine Research Award is grant aided by the Department of Communications, Energy and Natural Resources (DCENR) and the Department of Agriculture, Fisheries and Food (DAFF) under the Strategy for Science Technology and Innovation (SSTI) and the Sea Change Strategy. This analysis was based on data collected under the European Commission funded EC-FAIR contract FAIR-CT95-0523: Assessment and Reduction of the By-catch of Small Cetaceans (BY-CARE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson Orea R. J., 2011, Endangered Species Research, V14, P91, DOI 10.3354/esr00347; Atkins S, 2013, BIOL CONSERV, V159, P442, DOI 10.1016/j.biocon.2012.10.007; AU WWL, 1991, MAR MAMMAL SCI, V7, P258, DOI 10.1111/j.1748-7692.1991.tb00101.x; Barton K., 2013, MUMIN MULTIMODEL INF; BERKELEY SA, 1988, MAR FISH REV, V50, P9; Bjorge A, 2013, BIOL CONSERV, V161, P164, DOI 10.1016/j.biocon.2013.03.009; Booth GD, 1994, INT470 SU DEP AGR FO; Brostrom G., 2011, GLMMML GEN LINEAR MO; Brown SL, 2013, BIOL CONSERV, V168, P78, DOI 10.1016/j.biocon.2013.09.019; Burnham K.P., 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.2307/3802723, DOI 10.2307/3802723]; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Carbonell A, 2003, FISH RES, V61, P7, DOI 10.1016/S0165-7836(02)00242-4; Carretta JV, 2012, NMFSSWFSC488; Caurant F, 2009, USE ECOLOGICAL TRCER; Cox TM, 2004, BIOL CONSERV, V115, P203, DOI 10.1016/S0006-3207(03)00108-3; Cury PM, 2008, TRENDS ECOL EVOL, V23, P338, DOI 10.1016/j.tree.2008.02.005; de Boer MN., 2012, INT J BIODIVERS CONS, V4, P481, DOI DOI 10.5897/IJBC12.016; Di-Meglio Nathalie, 1996, Aquatic Mammals, V22, P11; Fernandez-Contreras MM, 2010, ICES J MAR SCI, V67, P1732, DOI 10.1093/icesjms/fsq077; FERRERO RC, 1995, FISH B-NOAA, V93, P483; Fiedler FN, 2012, BIODIVERS CONSERV, V21, P915, DOI 10.1007/s10531-012-0227-0; Filby NE, 2013, AUST J ZOOL, V61, P291, DOI 10.1071/ZO12033; Gannier Alexandre, 1999, Aquatic Mammals, V25, P123; Goldsworthy SD, 2006, MARINE MAMMALS FISHE, P62; Halekoh U, 2006, J STAT SOFTW, V15, P1, DOI 10.18637/jss.v015.i02; Hall MA, 2000, MAR POLLUT BULL, V41, P204, DOI 10.1016/S0025-326X(00)00111-9; Hamer DJ, 2006, BIOL CONSERV, V130, P517, DOI 10.1016/j.biocon.2006.01.014; Hammond P.S., 2009, CETACEAN OFFSHORE DI; Hammond PS, 2013, BIOL CONSERV, V164, P107, DOI 10.1016/j.biocon.2013.04.010; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Kastelein RA, 2006, MAR ENVIRON RES, V61, P363, DOI 10.1016/j.marenvres.2005.11.005; Kastelein RA, 2007, MAR ENVIRON RES, V64, P160, DOI 10.1016/j.marenvres.2006.12.012; Lahaye V, 2005, MAR ECOL PROG SER, V305, P275, DOI 10.3354/meps305275; Leung ES, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045389; Levin PS, 2010, FISH FISH, V11, P307, DOI 10.1111/j.1467-2979.2010.00355.x; Lewison RL, 2007, CONSERV BIOL, V21, P79, DOI 10.1111/j.1523-1739.2006.00592.x; Lewison RL, 2004, TRENDS ECOL EVOL, V19, P598, DOI 10.1016/j.tree.2004.09.004; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Lopez A, 2003, BIOL CONSERV, V111, P25, DOI 10.1016/S0006-3207(02)00244-6; Macri S, 2002, ANIM BEHAV, V64, P541, DOI 10.1006/anbe.2002.4004; Mannocci L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032615; McAuley RB, 2007, ICES J MAR SCI, V64, P1702, DOI 10.1093/icesjms/fsm136; Mirimin L, 2009, MAR BIOL, V156, P821, DOI 10.1007/s00227-008-1120-y; Mooney TA, 2007, ICES J MAR SCI, V64, P1324, DOI 10.1093/icesjms/fsm135; Moore CH, 2009, ICES J MAR SCI, V66, P2068, DOI 10.1093/icesjms/fsp205; Morizur Y, 1999, FISH RES, V41, P297, DOI 10.1016/S0165-7836(99)00013-2; Murphy S, 2005, J MAMMAL, V86, P1247, DOI 10.1644/1545-1542(2005)86[1247:MSITMC]2.0.CO;2; Murphy S, 2006, ACTA ZOOL-STOCKHOLM, V87, P315, DOI 10.1111/j.1463-6395.2006.00245.x; Murphy S, 2009, MAR ECOL PROG SER, V388, P273, DOI 10.3354/meps08129; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Neumann Dirk R., 2001, Aquatic Mammals, V27, P121; Northridge S, 2006, PETRACET PELAGIC FIS; Northridge S, 2007, 2 ANN REPORT UK CETA; Northridge S.P., 1991, 320 FAO; O Cadhla O, 2002, CETACEANS SEABIRDS I, VII; Orphanides CD, 2009, J NW ATL FISH SCI, V42, P55, DOI DOI 10.2960/J.V42.M647; Owens IPF, 2002, SCIENCE, V297, P2008, DOI 10.1126/science.1076813; Palka D., 2009, NMFSNE212 NOAA; Perrin W.F., 1984, Reports of the International Whaling Commission Special Issue, P97; Perry RI, 2010, J MARINE SYST, V79, P427, DOI 10.1016/j.jmarsys.2008.12.017; Pusineri C, 2007, MAR MAMMAL SCI, V23, P30, DOI 10.1111/j.1748-7692.2006.00088.x; R Core Team, 2021, R LANG ENV STAT COMP; Read AJ, 2006, CONSERV BIOL, V20, P163, DOI 10.1111/j.1523-1739.2006.00338.x; Rogan E, 2007, FISH RES, V86, P6, DOI 10.1016/j.fishres.2007.02.013; Rossman MC, 2010, J NW ATL FISH SCI, V42, P77, DOI DOI 10.2960/J.V42.M650; Silvani L, 1999, BIOL CONSERV, V90, P79, DOI 10.1016/S0006-3207(98)00079-2; Stockin KA, 2009, MAR MAMMAL SCI, V25, P283, DOI 10.1111/j.1748-7692.2008.00262.x; Svane I, 2009, ESTUAR COAST SHELF S, V82, P621, DOI 10.1016/j.ecss.2009.03.009; Thompson FN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064438; Travers M, 2010, J MARINE SYST, V79, P101, DOI 10.1016/j.jmarsys.2009.07.005; Tregenza N.J.C., 1997, Report of the International Whaling Commission, V47, P835; Tudela S, 2005, BIOL CONSERV, V121, P65, DOI 10.1016/j.biocon.2004.04.010; Van der Hoop JM, 2013, CONSERV BIOL, V27, P121, DOI 10.1111/j.1523-1739.2012.01934.x; Wade P.R., 2012, J MAR BIOL, V2012, P1, DOI [10.1155/2012/567276, DOI 10.1155/2012/567276]; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Yan J, 2004, STAT MED, V23, P859, DOI 10.1002/sim.1650; Yan J., 2002, R NEWS, V2, P12; Yates KL, 2013, MAR POLICY, V38, P140, DOI 10.1016/j.marpol.2012.05.030	78	9	9	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104468	10.1371/journal.pone.0104468	http://dx.doi.org/10.1371/journal.pone.0104468			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121802	Green Published, gold, Green Submitted			2022-12-25	WOS:000341017000039
J	Carrillo-Sepulveda, MA; Keen, HL; Davis, DR; Grobe, JL; Sigmund, CD				Carrillo-Sepulveda, Maria Alicia; Keen, Henry L.; Davis, Deborah R.; Grobe, Justin L.; Sigmund, Curt D.			Role of Vascular Smooth Muscle PPAR gamma in Regulating AT(1) Receptor Signaling and Angiotensin II-Dependent Hypertension	PLOS ONE			English	Article							INSULIN-RESISTANCE; TYPE-1 RECEPTOR; DOWN-REGULATION; BLOOD-PRESSURE; INTERFERENCE; DYSFUNCTION; ACTIVATION; CELLS; ATHEROSCLEROSIS; ROSIGLITAZONE	Peroxisome proliferator activated receptor gamma (PPAR gamma) has been reported to play a protective role in the vasculature; however, the underlying mechanisms involved are not entirely known. We previously showed that vascular smooth muscle-specific overexpression of a dominant negative human PPAR gamma mutation in mice (S-P467L) leads to enhanced myogenic tone and increased angiotensin-II-dependent vasoconstriction. S-P467L mice also exhibit increased arterial blood pressure. Here we tested the hypotheses that a) mesenteric smooth muscle cells isolated from S-P467L mice exhibit enhanced angiotensinII AT(1) receptor signaling, and b) the increased arterial pressure of S-P467L mice is angiotensin-II AT(1) receptor dependent. Phosphorylation of mitogen-activated protein/extracellular signal-regulated kinase (ERK1/2) was robustly increased in mesenteric artery smooth muscle cell cultures from S-P467L in response to angiotensin-II. The increase in ERK1/2 activation by angiotensin-II was blocked by losartan, a blocker of AT(1) receptors. Angiotensin-II-induced ERK1/2 activation was also blocked by Tempol, a scavenger of reactive oxygen species, and correlated with increased Nox4 protein expression. To investigate whether endogenous renin-angiotensin system activity contributes to the elevated arterial pressure in S-P467L, non-transgenic and S-P467L mice were treated with the AT(1) receptor blocker, losartan (30 mg/kg per day), for 14-days and arterial pressure was assessed by radiotelemetry. At baseline S-P467L mice showed a significant increase of systolic arterial pressure (142.0 +/- 10.2 vs 129.1 +/- 3.0 mmHg, p<0.05). Treatment with losartan lowered systolic arterial pressure in S-P467L (132.2 +/- 6.9 mmHg) to a level similar to untreated non-transgenic mice. Losartan also lowered arterial pressure in non-transgenic (113.0 +/- 3.9 mmHg) mice, such that there was no difference in the losartan-induced depressor response between groups (-13.53 +/- 1.39 in S-P467L vs -16.16 +/- 3.14 mmHg in non-transgenic). Our results suggest that interference with PPAR gamma in smooth muscle: a) causes enhanced angiotensin-II AT(1) receptor-mediated ERK1/2 activation in resistance vessels, b) and may elevate arterial pressure through both angiotensin-II AT(1) receptor-dependent and -independent mechanisms.	[Carrillo-Sepulveda, Maria Alicia; Keen, Henry L.; Davis, Deborah R.; Grobe, Justin L.; Sigmund, Curt D.] Univ Iowa, Roy J & Lucille Carver Coll Med, Dept Pharmacol, Iowa City, IA 52242 USA	University of Iowa	Sigmund, CD (corresponding author), Univ Iowa, Roy J & Lucille Carver Coll Med, Dept Pharmacol, Iowa City, IA 52242 USA.	curt-sigmund@uiowa.edu	Sigmund, Curt D./W-1611-2019	Sigmund, Curt D./0000-0002-1453-0921; Grobe, Justin/0000-0001-9737-0873	National Institutes of Health [HL048058, HL061446, HL062984, HL084207, HL098276]; Roy J. Carver Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048058, R37HL048058, R00HL098276, P01HL062984, R01HL061446, K99HL098276, P01HL084207] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Roy J. Carver Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported through research grants from the National Institutes of Health to CDS (HL048058, HL061446, HL062984), to CDS and JLG (HL084207), and to JLG (HL098276). The authors also gratefully acknowledge the generous research support of the Roy J. Carver Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159; Barroso I, 1999, NATURE, V402, P880, DOI 10.1038/47254; Beyer AM, 2008, CIRC RES, V103, P654, DOI 10.1161/CIRCRESAHA.108.176339; Beyer AM, 2008, HYPERTENSION, V51, P867, DOI 10.1161/HYPERTENSIONAHA.107.103648; Blanquicett C, 2010, FREE RADICAL BIO MED, V48, P1618, DOI 10.1016/j.freeradbiomed.2010.03.007; Borges GR, 2014, HYPERTENSION; Caron-Debarle M, 2013, ARTERIOSCLER THROMB, V33, P829; Carrillo-Sepulveda MA, 2010, CARDIOVASC RES, V85, P560, DOI 10.1093/cvr/cvp304; Cat AND, 2013, ANTIOXID REDOX SIGN, V19, P1110, DOI 10.1089/ars.2012.4641; Diep QN, 2002, CIRCULATION, V105, P2296, DOI 10.1161/01.CIR.0000016049.86468.23; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Gray SL, 2006, DIABETES, V55, P2669, DOI 10.2337/db06-0389; Green DE, 2012, AM J RESP CELL MOL, V47, P718, DOI 10.1165/rcmb.2011-0418OC; GRIENDLING KK, 1994, CIRC RES, V74, P1141, DOI 10.1161/01.RES.74.6.1141; Grobe JL, 2010, CELL METAB, V12, P431, DOI 10.1016/j.cmet.2010.09.011; Halabi CM, 2008, CELL METAB, V7, P215, DOI 10.1016/j.cmet.2007.12.008; Hilzendeger AM, 2013, HYPERTENSION, V61, P716, DOI 10.1161/HYPERTENSIONAHA.111.00356; Ji YY, 2009, LAB INVEST, V89, P887, DOI 10.1038/labinvest.2009.45; Kanda T, 2009, J CLIN INVEST, V119, P110, DOI 10.1172/JCI36233; Keen HL, 2010, ARTERIOSCL THROM VAS, V30, P518, DOI 10.1161/ATVBAHA.109.200733; Keen HL, 2004, PHYSIOL GENOMICS, V18, P33, DOI 10.1152/physiolgenomics.00027.2004; Ketsawatsomkron P, 2012, CIRC RES, V111, P1446, DOI 10.1161/CIRCRESAHA.112.271577; Kleinhenz JM, 2009, AM J PHYSIOL-HEART C, V297, pH1647, DOI 10.1152/ajpheart.00148.2009; Marchesi C, 2013, CARDIOVASC RES, V97, P562, DOI 10.1093/cvr/cvs362; Meredith D, 2009, ARTERIOSCL THROM VAS, V29, P465, DOI 10.1161/ATVBAHA.109.184234; Nicol CJ, 2005, AM J HYPERTENS, V18, P549, DOI 10.1016/j.amjhyper.2004.10.032; Nisbet RE, 2010, AM J RESP CELL MOL, V42, P482, DOI 10.1165/rcmb.2008-0132OC; Pelham CJ, 2013, AM J PHYSIOL-REG I, V304, pR690, DOI 10.1152/ajpregu.00607.2012; Pelham CJ, 2012, CELL METAB, V16, P462, DOI 10.1016/j.cmet.2012.08.011; Ryan MJ, 2004, HYPERTENSION, V43, P661, DOI 10.1161/01.HYP.0000116303.71408.c2; Sigmund CD, 2013, ARTERIOSCL THROM VAS, V33, P676, DOI 10.1161/ATVBAHA.112.301125; Sigmund CD, 2010, HYPERTENSION, V55, P437, DOI 10.1161/HYPERTENSIONAHA.109.144170; Subramanian V, 2010, CIRC RES, V107, P953, DOI 10.1161/CIRCRESAHA.110.219089; Takeda K, 2000, CIRCULATION, V102, P1834; Tham DM, 2002, PHYSIOL GENOMICS, V11, P21, DOI 10.1152/physiolgenomics.00062.2002; Tsai YS, 2004, J CLIN INVEST, V114, P240, DOI 10.1172/JCI200420964; Xiao J, 2009, CLIN IMMUNOL, V132, P266, DOI 10.1016/j.clim.2009.04.004; Yang HM, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.112; Zhang LL, 2010, J BIOL CHEM, V285, P13666, DOI 10.1074/jbc.M109.087718; Zhao SM, 2008, CHINESE J PHYSIOL, V51, P357	40	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e103786	10.1371/journal.pone.0103786	http://dx.doi.org/10.1371/journal.pone.0103786			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122005	gold, Green Published, Green Submitted			2022-12-25	WOS:000341017000019
J	Mazuc, E; Guglielmi, L; Bec, N; Parez, V; Hahn, CS; Mollevi, C; Parrinello, H; Desvignes, JP; Larroque, C; Jupp, R; Dariavach, P; Martineau, P				Mazuc, Elsa; Guglielmi, Laurence; Bec, Nicole; Parez, Vincent; Hahn, Chang S.; Mollevi, Caroline; Parrinello, Hugues; Desvignes, Jean-Pierre; Larroque, Christian; Jupp, Ray; Dariavach, Piona; Martineau, Pierre			In-Cell Intrabody Selection from a Diverse Human Library Identifies C12orf4 Protein as a New Player in Rodent Mast Cell Degranulation	PLOS ONE			English	Article							ANTIBODY FRAGMENT; INTRACELLULAR ANTIBODIES; SINGLE; IMMUNOGLOBULIN; TARGETS; KINASE; TRANSLOCATION; REPERTOIRE; PREVENTION; INHIBITION	The high specificity of antibodies for their antigen allows a fine discrimination of target conformations and post-translational modifications, making antibodies the first choice tool to interrogate the proteome. We describe here an approach based on a large-scale intracellular expression and selection of antibody fragments in eukaryotic cells, so-called intrabodies, and the subsequent identification of their natural target within living cell. Starting from a phenotypic trait, this integrated system allows the identification of new therapeutic targets together with their companion inhibitory intrabody. We applied this system in a model of allergy and inflammation. We first cloned a large and highly diverse intrabody library both in a plasmid and a retroviral eukaryotic expression vector. After transfection in the RBL-2H3 rat basophilic leukemia cell line, we performed seven rounds of selection to isolate cells displaying a defect in Fc epsilon RI-induced degranulation. We used high throughput sequencing to identify intrabody sequences enriched during the course of selection. Only one intrabody was common to both plasmid and retroviral selections, and was used to capture and identify its target from cell extracts. Mass spectrometry analysis identified protein RGD1311164 (C12orf4), with no previously described function. Our data demonstrate that RGD1311164 is a cytoplasmic protein implicated in the early signaling events following Fc epsilon RI-induced cell activation. This work illustrates the strength of the intrabody-based in-cell selection, which allowed the identification of a new player in mast cell activation together with its specific inhibitor intrabody.	[Mazuc, Elsa; Guglielmi, Laurence; Bec, Nicole; Parez, Vincent; Larroque, Christian; Dariavach, Piona; Martineau, Pierre] Inst Rech Cancerol Montpellier, IRCM, Montpellier, France; [Mazuc, Elsa; Guglielmi, Laurence; Bec, Nicole; Parez, Vincent; Larroque, Christian; Dariavach, Piona; Martineau, Pierre] INSERM, U896, Montpellier, France; [Mazuc, Elsa; Guglielmi, Laurence; Bec, Nicole; Parez, Vincent; Larroque, Christian; Dariavach, Piona; Martineau, Pierre] Univ Montpellier I, Montpellier, France; [Mazuc, Elsa; Guglielmi, Laurence; Bec, Nicole; Parez, Vincent; Larroque, Christian; Dariavach, Piona; Martineau, Pierre] Inst Reg Canc Montpellier, ICM, Montpellier, France; [Hahn, Chang S.; Jupp, Ray] Sanofi Aventis, Bridgewater, NJ USA; [Parrinello, Hugues; Desvignes, Jean-Pierre] MGX Montpellier GenomiX, Inst Genom Fonct, Montpellier, France; [Dariavach, Piona] Univ Montpellier 2, Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UNICANCER; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); Sanofi-Aventis; Universite de Montpellier; Universite de Montpellier	Dariavach, P (corresponding author), Inst Rech Cancerol Montpellier, IRCM, Montpellier, France.	piona.dariavach@inserm.fr; pierre.martineau@inserm.fr	Desvignes, Jean-Pierre/I-2858-2016; Mollevi, Caroline/AAA-6839-2019; Martineau, Pierre/N-4386-2017	Desvignes, Jean-Pierre/0000-0003-3142-1994; Mollevi, Caroline/0000-0003-4827-3684; Martineau, Pierre/0000-0002-7993-7183; bec, nicole/0000-0001-7608-2434; Guglielmi, Laurence/0000-0003-2517-4616	Sanofi-Aventis [L07053]; Labex MabImprove	Sanofi-Aventis(Sanofi-Aventis); Labex MabImprove	This work was supported by the Sanofi-Aventis collaboration agreement No L07053, and Labex MabImprove. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez RD, 2000, CLIN CANCER RES, V6, P3081; Asai K, 2001, IMMUNITY, V14, P791, DOI 10.1016/S1074-7613(01)00157-1; Beronja S, 2013, NATURE, V501, P185, DOI 10.1038/nature12464; Boldicke T, 2007, J CELL MOL MED, V11, P54, DOI 10.1111/j.1582-4934.2007.00002.x; Bounab Y, 2013, CURR OPIN IMMUNOL, V25, P313, DOI 10.1016/j.coi.2013.04.001; Butler DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029199; Cassimeris L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059812; Cattaneo A, 1999, TRENDS BIOTECHNOL, V17, P115, DOI 10.1016/S0167-7799(98)01268-2; Caussinus E, 2012, NAT STRUCT MOL BIOL, V19, P117, DOI 10.1038/nsmb.2180; Cohen PA, 1998, ONCOGENE, V17, P2445, DOI 10.1038/sj.onc.1202190; D'Cruz OJ, 2012, J PHARM DRUG DELIV R, V1, DOI [10.4172/2325-9604.1000107, DOI 10.4172/2325-9604.1000107]; DAGOSTINO RB, 1990, AM STAT, V44, P316, DOI 10.2307/2684359; Dauvillier S, 2002, J IMMUNOL, V169, P2274, DOI 10.4049/jimmunol.169.5.2274; Demo SD, 1999, CYTOMETRY, V36, P340, DOI 10.1002/(SICI)1097-0320(19990801)36:4<340::AID-CYTO9>3.0.CO;2-C; Fisher AC, 2009, J MOL BIOL, V385, P299, DOI 10.1016/j.jmb.2008.10.051; Freund G, 2013, MABS-AUSTIN, V5, P518, DOI 10.4161/mabs.25084; Galli SJ, 2005, ANNU REV IMMUNOL, V23, P749, DOI 10.1146/annurev.immunol.21.120601.141025; Gargano N, 1997, J GEN VIROL, V78, P2591, DOI 10.1099/0022-1317-78-10-2591; Gargano N, 1997, FEBS LETT, V414, P537, DOI 10.1016/S0014-5793(97)01065-X; Genini S, 2006, ANIM GENET, V37, P239, DOI 10.1111/j.1365-2052.2006.01447.x; Giudicelli V, 2006, NUCLEIC ACIDS RES, V34, pD781, DOI 10.1093/nar/gkj088; Griffin H, 2006, J MOL BIOL, V355, P360, DOI 10.1016/j.jmb.2005.10.077; Guglielmi L, 2011, PROTEIN ENG DES SEL, V24, P873, DOI 10.1093/protein/gzr049; Huang SD, 2012, CELL, V151, P937, DOI 10.1016/j.cell.2012.10.035; Kalesnikoff J, 2001, IMMUNITY, V14, P801, DOI 10.1016/S1074-7613(01)00159-5; Kalesnikoff J, 2008, NAT IMMUNOL, V9, P1215, DOI 10.1038/ni.f.216; Kontermann RE, 2004, METHODS, V34, P163, DOI 10.1016/j.ymeth.2004.04.002; Li J, 2011, COMPUT MATH METHOD M, V2011, DOI 10.1155/2011/527610; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Marschall ALJ, 2011, MABS-AUSTIN, V3, P3, DOI 10.4161/mabs.3.1.14110; Martineau P, 1998, J MOL BIOL, V280, P117, DOI 10.1006/jmbi.1998.1840; Mazuc E, 2008, J ALLERGY CLIN IMMUN, V122, P188, DOI 10.1016/j.jaci.2008.04.026; Meltzer EO, 2005, J ALLERGY CLIN IMMUN, V115, P791, DOI 10.1016/j.jaci.2005.01.040; Miller TW, 2005, NEUROBIOL DIS, V19, P47, DOI 10.1016/j.nbd.2004.11.003; Norman P, 2009, EXPERT OPIN THER PAT, V19, P1469, DOI 10.1517/13543770903059281; Paz K, 2005, MOL CANCER THER, V4, P1801, DOI 10.1158/1535-7163.MCT-05-0174; Philibert P, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-81; Quintana FJ, 2012, J NEUROIMMUNOL, V248, P53, DOI 10.1016/j.jneuroim.2012.01.002; Rabu C, 2012, FUTURE ONCOL, V8, P943, DOI [10.2217/FON.12.88, 10.2217/fon.12.88]; Ravn U, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq789; Riccaboni M, 2010, DRUG DISCOV TODAY, V15, P517, DOI 10.1016/j.drudis.2010.05.001; Schneider P, 2000, METHOD ENZYMOL, V322, P325; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Sibler AP, 2003, EXP CELL RES, V286, P276, DOI 10.1016/S0014-4827(03)00093-4; Su C, 2002, MOL BIOL EVOL, V19, P205, DOI 10.1093/oxfordjournals.molbev.a004073; Swaminathan J, 2012, EXPERT OPIN DRUG DEL, V9, P1489, DOI 10.1517/17425247.2012.735658; Tanaka T, 2003, J MOL BIOL, V331, P1109, DOI 10.1016/S0022-2836(03)00836-2; Tanaka T, 2007, EMBO J, V26, P3250, DOI 10.1038/sj.emboj.7601744; Villoutreix BO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021117; WARD ES, 1989, NATURE, V341, P544, DOI 10.1038/341544a0; Xie J, 2014, CHEM BIOL, V21, P274, DOI 10.1016/j.chembiol.2013.12.006; Yea K, 2013, P NATL ACAD SCI USA, V110, P14966, DOI 10.1073/pnas.1313671110	52	11	13	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104998	10.1371/journal.pone.0104998	http://dx.doi.org/10.1371/journal.pone.0104998			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122211	Green Submitted, Green Published, gold			2022-12-25	WOS:000341017000083
J	Zhang, P; Goodrich, C; Fu, CL; Dong, C				Zhang, Pu; Goodrich, Chris; Fu, Changliang; Dong, Cheng			Melanoma upregulates ICAM-1 expression on endothelial cells through engagement of tumor CD44 with endothelial E-selectin and activation of a PKC alpha-p38-SP-1 pathway	FASEB JOURNAL			English	Article						flow coculture; intracellular signaling; adhesion; cross-linkingcytokine	INTERCELLULAR-ADHESION MOLECULE-1; PROTEIN-KINASE-C; NF-KAPPA-B; COLON-CARCINOMA CELLS; TYROSINE PHOSPHORYLATION; FLOW CONDITIONS; CELLULAR MECHANOTRANSDUCTION; VARIANT ISOFORMS; BINDING-KINETICS; GENE-EXPRESSION	Cancer metastasis involves multistep adhesive interactions between tumor cells (TCs) and endothelial cells (ECs), but the molecular mechanisms of intercellular communication in the tumor microenvironment remain elusive. Using static and flow coculture systems in conjunction with flow cytometry, we discovered that certain receptors on the ECs are upregulated on melanoma cell adhesion. Direct contact but not separate coculture between human umbilical endothelial cells (HUVECs) and a human melanoma cell line (Lu1205) increased intercellular adhesion molecule 1 (ICAM-1) and E-selectin expression on HUVECs by 3- and 1.5-fold, respectively, compared with HUVECs alone. The nonmetastatic cell line WM35 failed to promote ICAM-1 expression changes in HUVECs on contact. Enzyme-linked immunosorbent assay (ELISA) revealed that EC-TC contact has a synergistic effect on the expression of the cytokines interleukin (IL)-8, IL-6, and growth-related oncogene (Gro-). By using E-selectin cross-linking and beads coated with CD44 immunopurified from Lu1205 cells, we showed that CD44/selectin ligation was responsible for the ICAM-1 up-regulation on HUVECs. Protein kinase C (PKC-) activation was found to be the downstream target of the CD44/selectin-initiated signaling, as ICAM-1 elevation was inhibited by siRNA targeting PKC or a dominant negative form of PKC (PKC DN). Western blot analysis and electrophoretic mobility shift assays (EMSAs) showed that TC-EC contact mediated p38 phosphorylation and binding of the transcription factor SP-1 to its regulation site. In conclusion, CD44/selectin binding signals ICAM-1 up-regulation on the EC surface through a PKC-p38-SP-1 pathway, which further enhances melanoma cell adhesion to ECs during metastasis.Zhang, P., Goodrich, C., Fu, C., Dong, C. Melanoma upregulates ICAM-1 expression on ECs through engagement of tumor CD44 with endothelial E-selectin and activation of a PKC-p38-SP-1 pathway.	[Zhang, Pu; Goodrich, Chris; Fu, Changliang; Dong, Cheng] Penn State Univ, Dept Biomed Engn, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Dong, C (corresponding author), Penn State Univ, 233 Hallowell Bldg, University Pk, PA 16802 USA.	cxd23@psu.edu			U.S. National Institutes of Health [CA-125707]; National Science Foundation [CBET-0729091, CBET-1330663]; NATIONAL CANCER INSTITUTE [R01CA125707] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank Dr. J. Brown (Department of Biomedical Engineering, Pennsylvania State University) and Dr. E. Gomez (Department of Chemical Engineering, Pennsylvania State University) for their helpful discussions and critical proofreading of the manuscript; Dr. D. Welch (University of Kansas, Lawrence, KS, USA), Dr. G. Roberson (Penn State Hershey Medical Center, Hershey, PA, USA), and Dr. M. Herlyn (Wistar Institute, Philadelphia, PA, USA) for providing C8161, 1205Lu, and WM35 melanoma cells, respectively; and Addgene (Cambridge, MA, USA) for providing the PKC alpha DN, PKC alpha CAT, PKC epsilon DN, and CKAR plasmids. This study was supported in part by U.S. National Institutes of Health grant CA-125707 and National Science Foundation grants CBET-0729091 and CBET-1330663.	Alves CS, 2009, J BIOL CHEM, V284, P1177, DOI 10.1074/jbc.M805144200; Bijli KM, 2008, J BIOL CHEM, V283, P14674, DOI 10.1074/jbc.M802094200; Blaheta RA, 2009, NEOPLASIA, V11, P1054, DOI 10.1593/neo.09762; Chen CC, 2000, MOL PHARMACOL, V58, P1479, DOI 10.1124/mol.58.6.1479; Chen CC, 2001, CELL SIGNAL, V13, P543, DOI 10.1016/S0898-6568(01)00171-1; Chen CS, 2008, J CELL SCI, V121, P3285, DOI 10.1242/jcs.023507; Chen JX, 2001, AM J PHYSIOL-CELL PH, V280, pC1475, DOI 10.1152/ajpcell.2001.280.6.C1475; Chen SQ, 2001, P NATL ACAD SCI USA, V98, P950, DOI 10.1073/pnas.98.3.950; Chesla SE, 1998, BIOPHYS J, V75, P1553, DOI 10.1016/S0006-3495(98)74074-3; Chiu JJ, 2007, BLOOD, V110, P519, DOI 10.1182/blood-2006-08-040097; COLLINS T, 1995, FASEB J, V9, P899, DOI 10.1096/fasebj.9.10.7542214; Coward J, 2011, CLIN CANCER RES, V17, P6083, DOI 10.1158/1078-0432.CCR-11-0945; Dimitroff CJ, 2001, J CELL BIOL, V153, P1277, DOI 10.1083/jcb.153.6.1277; Dong C, 2005, FRONT BIOSCI-LANDMRK, V10, P379, DOI 10.2741/1535; Dong C, 2000, J BIOMECH, V33, P35, DOI 10.1016/S0021-9290(99)00174-8; Fagerholm SC, 2005, J CELL BIOL, V171, P705, DOI 10.1083/jcb.200504016; Fan ZZ, 2013, SCI REP-UK, V3, DOI 10.1038/srep02176; Feigelson S, 2001, J BIOL CHEM, V276, P13891, DOI 10.1074/jbc.M004939200; Fu CL, 2011, J BIOL CHEM, V286, P34777, DOI 10.1074/jbc.M111.281642; Fujisaki T, 1999, CANCER RES, V59, P4427; Hanley WD, 2005, CANCER RES, V65, P5812, DOI 10.1158/0008-5472.CAN-04-4557; Hanley WD, 2006, FASEB J, V20, P337, DOI 10.1096/fj.05-4574fje; Haraldsen G, 1996, J IMMUNOL, V156, P2558; Hoffman BD, 2011, NATURE, V475, P316, DOI 10.1038/nature10316; Homeister JW, 1998, BLOOD, V92, P2345, DOI 10.1182/blood.V92.7.2345.2345_2345_2352; Hu YY, 2001, J BIOL CHEM, V276, P48549, DOI 10.1074/jbc.M105513200; Hu YY, 2000, J IMMUNOL, V165, P2142, DOI 10.4049/jimmunol.165.4.2142; Huang HD, 2004, AM J PHYSIOL-CELL PH, V287, pC1, DOI 10.1152/ajpcell.00559.2003; Huang WC, 2003, J BIOL CHEM, V278, P9944, DOI 10.1074/jbc.M208521200; Huh SJ, 2010, CANCER RES, V70, P6071, DOI 10.1158/0008-5472.CAN-09-4442; Ingber DE, 1997, ANNU REV PHYSIOL, V59, P575, DOI 10.1146/annurev.physiol.59.1.575; Javaid K, 2003, CIRC RES, V92, P1089, DOI 10.1161/01.RES.0000072971.88704.CB; Katayama Y, 2005, J EXP MED, V201, P1183, DOI 10.1084/jem.20042014; Kaur J, 2003, AM J PHYSIOL-HEART C, V284, pH1095, DOI 10.1152/ajpheart.00016.2002; Khanna P, 2010, AM J PHYSIOL-CELL PH, V298, pC1140, DOI 10.1152/ajpcell.00242.2009; Kiely JM, 2003, J IMMUNOL, V171, P3216, DOI 10.4049/jimmunol.171.6.3216; Klemke M, 2007, J CELL PHYSIOL, V212, P368, DOI 10.1002/jcp.21029; Konstantopoulos K, 2011, ADV EXP MED BIOL, V705, P601, DOI 10.1007/978-1-4419-7877-6_32; Konstantopoulos K, 2009, ANNU REV BIOMED ENG, V11, P177, DOI 10.1146/annurev-bioeng-061008-124949; Kronschnabl M, 2003, J GEN VIROL, V84, P61, DOI 10.1099/vir.0.18703-0; Legg JW, 2002, NAT CELL BIOL, V4, P399, DOI 10.1038/ncb797; Liang S, 2005, EXP CELL RES, V310, P282, DOI 10.1016/j.yexcr.2005.07.028; Liang S, 2008, AM J PHYSIOL-CELL PH, V295, pC701, DOI 10.1152/ajpcell.00245.2008; Liang SL, 2008, AM J PHYSIOL-CELL PH, V294, pC743, DOI 10.1152/ajpcell.00250.2007; Liang SL, 2007, CANCER RES, V67, P5814, DOI 10.1158/0008-5472.CAN-06-4233; Lorenzon P, 1998, J CELL BIOL, V142, P1381, DOI 10.1083/jcb.142.5.1381; Mauro A, 2002, J CELL SCI, V115, P3587, DOI 10.1242/jcs.00037; Miho N, 2005, CARDIOVASC RES, V68, P289, DOI 10.1016/j.cardiores.2005.05.029; Min JK, 2005, J IMMUNOL, V175, P531, DOI 10.4049/jimmunol.175.1.531; Na S, 2008, P NATL ACAD SCI USA, V105, P6626, DOI 10.1073/pnas.0711704105; Nakano T, 1996, ANTICANCER RES, V16, P3577; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; Ozdemir T, 2012, AM J PHYSIOL-CELL PH, V302, pC1189, DOI 10.1152/ajpcell.00346.2011; Peng HH, 2005, FRONT BIOSCI-LANDMRK, V10, P1597, DOI 10.2741/1643; Peng HH, 2007, EXP CELL RES, V313, P551, DOI 10.1016/j.yexcr.2006.10.030; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Rahman A, 2001, MOL CELL BIOL, V21, P5554, DOI 10.1128/MCB.21.16.5554-5565.2001; Schmidt C, 1998, J BIOL CHEM, V273, P5081, DOI 10.1074/jbc.273.9.5081; Slattery MJ, 2005, AM J PHYSIOL-CELL PH, V288, pC831, DOI 10.1152/ajpcell.00439.2004; Slattery MJ, 2003, INT J CANCER, V106, P713, DOI 10.1002/ijc.11297; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Tremblay PL, 2006, ONCOGENE, V25, P6563, DOI 10.1038/sj.onc.1209664; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125; Wang YX, 2005, NATURE, V434, P1040, DOI 10.1038/nature03469; Williams TE, 2000, BIOPHYS J, V79, P1858, DOI 10.1016/S0006-3495(00)76435-6; Wirtz D, 2011, NAT REV CANCER, V11, P512, DOI 10.1038/nrc3080; Yago T, 2004, J CELL BIOL, V166, P913, DOI 10.1083/jcb.200403144; Yasuda M, 2001, INT IMMUNOL, V13, P1309, DOI 10.1093/intimm/13.10.1309; Yoshida M, 1996, J CELL BIOL, V133, P445, DOI 10.1083/jcb.133.2.445; Zhang P, 2011, J IMMUNOL, V186, P242, DOI 10.4049/jimmunol.1000494; Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023	72	37	38	0	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2014	28	11					4591	4609		10.1096/fj.11-202747	http://dx.doi.org/10.1096/fj.11-202747			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AS1OU	25138157	Green Published			2022-12-25	WOS:000344050900002
J	Kosami, K; Ohki, I; Nagano, M; Furuita, K; Sugiki, T; Kawano, Y; Kawasaki, T; Fujiwara, T; Nakagawa, A; Shimamoto, K; Kojima, C				Kosami, Ken-ichi; Ohki, Izuru; Nagano, Minoru; Furuita, Kyoko; Sugiki, Toshihiko; Kawano, Yoji; Kawasaki, Tsutomu; Fujiwara, Toshimichi; Nakagawa, Atsushi; Shimamoto, Ko; Kojima, Chojiro			The Crystal Structure of the Plant Small GTPase OsRac1 Reveals Its Mode of Binding to NADPH Oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISEASE RESISTANCE; ROP GTPASE; RAC GTPASE; ARABIDOPSIS ROOTS; RAC/ROP GTPASES; RICE; ACTIVATION; P67(PHOX); RHO; IMMUNITY	Rac/Rop proteins are Rho-type small GTPases that act as molecular switches in plants. Recent studies have identified these proteins as key components in many major plant signaling pathways, such as innate immunity, pollen tube growth, and root hair formation. In rice, the Rac/Rop protein OsRac1 plays an important role in regulating the production of reactive oxygen species (ROS) by the NADPH oxidase OsRbohB during innate immunity. However, the molecular mechanism by which OsRac1 regulates OsRbohB remains unknown. Here, we report the crystal structure of OsRac1 complexed with the non-hydrolyzable GTP analog guanosine 5'-(beta,gamma-imido) triphosphate at 1.9 angstrom resolution; this represents the first active-form structure of a plant small GTPase. To elucidate the ROS production in rice cells, structural information was used to design OsRac1 mutants that displayed reduced binding to OsRbohB. Only mutations in the OsRac1 Switch I region showed attenuated interactions with OsRbohB in vitro. In particular, Tyr(39) and Asp(45) substitutions suppressed ROS production in rice cells, indicating that these residues are critical for interaction with and activation of OsRbohB. Structural comparison of active-form OsRac1 with AtRop9 in its GDP-bound inactive form showed a large conformational difference in the vicinity of these residues. Our results provide new insights into the molecular mechanism of the immune response through OsRac1 and the various cellular responses associated with plant Rac/Rop proteins.	[Kosami, Ken-ichi; Furuita, Kyoko; Sugiki, Toshihiko; Fujiwara, Toshimichi; Nakagawa, Atsushi; Kojima, Chojiro] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; [Ohki, Izuru; Kojima, Chojiro] Nara Inst Sci & Technol, Biophys Lab, Nara 6300192, Japan; [Ohki, Izuru; Nagano, Minoru; Kawano, Yoji; Kawasaki, Tsutomu; Shimamoto, Ko] Nara Inst Sci & Technol, Plant Mol Genet Lab, Nara 6300192, Japan; [Ohki, Izuru] Kyoto Univ, Grad Sch Sci, Dept Biophys, Sakyo Ku, Kyoto 6068502, Japan; [Kawasaki, Tsutomu] Kinki Univ, Dept Adv Biosci, Nara 6318505, Japan	Osaka University; Nara Institute of Science & Technology; Nara Institute of Science & Technology; Kyoto University; Kindai University (Kinki University)	Ohki, I (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Biophys, Sakyo Ku, Kyoto 6068502, Japan.	ohki.izuru.4a@kyoto-u.ac.jp; kojima@protein.osaka-u.ac.jp	Kosami, Ken-Ichi/U-4649-2019; Kawano, Yoji/C-7484-2011; Nakagawa, Atsushi/D-4329-2009; Ohki, Izuru/O-4816-2019; Kojima, Chojiro/AFV-4592-2022	Kawano, Yoji/0000-0003-0687-2777; Nakagawa, Atsushi/0000-0002-1700-7861; Ohki, Izuru/0000-0002-0667-5936; Furuita, Kyoko/0000-0002-9272-0026; Kojima, Chojiro/0000-0003-2723-8249	Targeted Proteins Research Program; Ministry of Agriculture, Forestry and Fisheries Genomics for Agricultural Innovation; Ministry of Education, Culture, Sports, Science and Technology, Japan; Grants-in-Aid for Scientific Research [26850232, 26291029] Funding Source: KAKEN	Targeted Proteins Research Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Agriculture, Forestry and Fisheries Genomics for Agricultural Innovation(Ministry of Agriculture Forestry & Fisheries - Japan); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-aid for science research (to I. O., Y. K., C. K., and K. S.), the Targeted Proteins Research Program (to C. K. and K. S.), a Ministry of Agriculture, Forestry and Fisheries Genomics for Agricultural Innovation grant (to K. S.), Grants-in-aid for JSPS Fellows (to K. K. and M. N.), and the Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Akamatsu A, 2013, CELL HOST MICROBE, V13, P465, DOI 10.1016/j.chom.2013.03.007; Al-Mulla F, 1999, J PATHOL, V187, P433, DOI 10.1002/(SICI)1096-9896(199903)187:4<433::AID-PATH273>3.0.CO;2-E; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen X, 2012, CURR BIOL, V22, P1326, DOI 10.1016/j.cub.2012.05.020; Craddock C, 2012, TRENDS CELL BIOL, V22, P492, DOI 10.1016/j.tcb.2012.05.002; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DIEKMANN D, 1994, SCIENCE, V265, P531, DOI 10.1126/science.8036496; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fujiwara M, 2006, PLANT PHYSIOL, V140, P734, DOI 10.1104/pp.105.068395; Han CH, 1998, J BIOL CHEM, V273, P16663, DOI 10.1074/jbc.273.27.16663; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Hirshberg M, 1997, NAT STRUCT BIOL, V4, P147, DOI 10.1038/nsb0297-147; Ihara K, 1998, J BIOL CHEM, V273, P9656, DOI 10.1074/jbc.273.16.9656; Jones MA, 2007, J EXP BOT, V58, P1261, DOI 10.1093/jxb/erl279; Kawano Y, 2013, CURR OPIN PLANT BIOL, V16, P496, DOI 10.1016/j.pbi.2013.07.004; Kawano Y, 2010, RICE, V3, P112, DOI 10.1007/s12284-010-9049-4; Kawano Y, 2010, CELL HOST MICROBE, V7, P362, DOI 10.1016/j.chom.2010.04.010; Kawasaki T, 1999, P NATL ACAD SCI USA, V96, P10922, DOI 10.1073/pnas.96.19.10922; Koga H, 1999, J BIOL CHEM, V274, P25051, DOI 10.1074/jbc.274.35.25051; Kosami K, 2014, ACTA CRYSTALLOGR F, V70, P113, DOI 10.1107/S2053230X13033645; Lapouge K, 2000, MOL CELL, V6, P899, DOI 10.1016/S1097-2765(00)00087-3; Li ZX, 2012, J INTEGR PLANT BIOL, V54, P180, DOI 10.1111/j.1744-7909.2012.01101.x; Lin DS, 2012, CURR BIOL, V22, P1319, DOI 10.1016/j.cub.2012.05.019; Longenecker K, 2003, ACTA CRYSTALLOGR D, V59, P876, DOI 10.1107/S0907444903005390; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagawa S, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001299; Nibau C, 2006, TRENDS PLANT SCI, V11, P309, DOI 10.1016/j.tplants.2006.04.003; Nibau C, 2013, J EXP BOT, V64, P3425, DOI 10.1093/jxb/ert179; Oda T, 2008, ACTA CRYSTALLOGR F, V64, P867, DOI 10.1107/S1744309108026535; Oda T, 2010, J BIOL CHEM, V285, P1435, DOI 10.1074/jbc.M109.058909; Oda Y, 2012, SCIENCE, V337, P1333, DOI 10.1126/science.1222597; Ono E, 2001, P NATL ACAD SCI USA, V98, P759, DOI 10.1073/pnas.021273498; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Potocky M, 2012, J PLANT PHYSIOL, V169, P1654, DOI 10.1016/j.jplph.2012.05.014; Sormo CG, 2006, PHYTOCHEMISTRY, V67, P2332, DOI 10.1016/j.phytochem.2006.08.011; Suharsono U, 2002, P NATL ACAD SCI USA, V99, P13307, DOI 10.1073/pnas.192244099; Thomas C, 2007, MOL CELL, V25, P141, DOI 10.1016/j.molcel.2006.11.023; Thomas C, 2009, BIOL CHEM, V390, P427, DOI 10.1515/BC.2009.049; Wong HL, 2007, PLANT CELL, V19, P4022, DOI 10.1105/tpc.107.055624; Xu TD, 2010, CELL, V143, P99, DOI 10.1016/j.cell.2010.09.003; XU XM, 1994, J BIOL CHEM, V269, P23569; Yamaguchi K, 2012, PLANT J, V70, P389, DOI 10.1111/j.1365-313X.2011.04874.x; Yang ZB, 2002, PLANT CELL, V14, pS375, DOI 10.1105/tpc.001065; Yang Z, 2007, CURR OPIN PLANT BIOL, V10, P490, DOI 10.1016/j.pbi.2007.07.005; Zheng ZL, 2000, PLANT MOL BIOL, V44, P1, DOI 10.1023/A:1006402628948; Zheng ZL, 2002, PLANT CELL, V14, P2787, DOI 10.1105/tpc.005611	49	24	24	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28569	28578		10.1074/jbc.M114.603282	http://dx.doi.org/10.1074/jbc.M114.603282			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25128531	Green Published, hybrid			2022-12-25	WOS:000343765400046
J	Kowalewski, B; Lubke, T; Kollmann, K; Braulke, T; Reinheckel, T; Dierks, T; Damme, M				Kowalewski, Bjoern; Luebke, Torben; Kollmann, Katrin; Braulke, Thomas; Reinheckel, Thomas; Dierks, Thomas; Damme, Markus			Molecular Characterization of Arylsulfatase G EXPRESSION, PROCESSING, GLYCOSYLATION, TRANSPORT, AND ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Processing; Heparan Sulfate; Lysosomal Glycoprotein; Lysosomal Storage Disease; Lysosome; Arylsulfatase G; Mannose 6-Phosphate; Mucopolysaccharidosis; Proteolytic Processing; Sulfatase	MANNOSE 6-PHOSPHATE RECEPTORS; CATHEPSIN-D; LYSOSOMAL SULFATASE; HUMAN-FIBROBLASTS; ACID SPHINGOMYELINASE; ENDOPLASMIC-RETICULUM; MICE DEFICIENT; HEPG2 CELLS; IN-VITRO; G ARSG	Arylsulfatase G (ARSG) is a recently identified lysosomal sulfatase that was shown to be responsible for the degradation of 3-O-sulfated N-sulfoglucosamine residues of heparan sulfate glycosaminoglycans. Deficiency of ARSG leads to a new type of mucopolysaccharidosis, as described in a mouse model. Here, we provide a detailed molecular characterization of the endogenous murine enzyme. ARSG is expressed and proteolytically processed in a tissue-specific manner. The 63-kDa single-chain precursor protein localizes to pre-lysosomal compartments and tightly associates with organelle membranes, most likely the endoplasmic reticulum. In contrast, proteolytically processed ARSG fragments of 34-, 18-, and 10-kDa were found in lysosomal fractions and lost their membrane association. The processing sites and a disulfide bridge between the 18- and 10-kDa chains could be roughly mapped. Proteases participating in the processing were identified as cathepsins B and L. Proteolytic processing is dispensable for hydrolytic sulfatase activity in vitro. Lysosomal transport of ARSG in the liver is independent of mannose 6-phosphate, sortilin, and Limp2. However, mutation of glycosylation site N-497 abrogates transport of ARSG to lysosomes in human fibrosarcoma cells, due to impaired mannose 6-phosphate modification.	[Kowalewski, Bjoern; Luebke, Torben; Dierks, Thomas; Damme, Markus] Univ Bielefeld, Dept Chem, D-33615 Bielefeld, Germany; [Kollmann, Katrin; Braulke, Thomas] Univ Med Ctr Hamburg Eppendorf, Childrens Hosp, Dept Biochem, D-20246 Hamburg, Germany; [Reinheckel, Thomas] Univ Freiburg, Inst Mol Med & Cell Res, D-79104 Freiburg, Germany; [Braulke, Thomas] Univ Freiburg, BIOSS Ctr Biol Signalling, D-79104 Freiburg, Germany	University of Bielefeld; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Freiburg; University of Freiburg	Dierks, T (corresponding author), Univ Bielefeld, Dept Chem, D-33615 Bielefeld, Germany.	thomas.dierks@uni-bielefeld.de; mdamme@biochem.uni-kiel.de	Reinheckel, Thomas/AAL-9761-2021; Braulke, Thomas/AAV-9121-2020; Dierks, Thomas/A-3596-2012	Reinheckel, Thomas/0000-0001-9866-9105; Braulke, Thomas/0000-0002-2336-8532; Dierks, Thomas/0000-0001-6426-1339; Lubke, Torben/0000-0002-3342-0090	Deutsche Forschungsgemeinschaft [DI 575/6]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant DI 575/6 (to T. D.).	Abitbol M, 2010, P NATL ACAD SCI USA, V107, P14775, DOI 10.1073/pnas.0914206107; Aebi M, 2013, BBA-MOL CELL RES, V1833, P2430, DOI 10.1016/j.bbamcr.2013.04.001; Bielicki J, 1998, BIOCHEM J, V329, P145, DOI 10.1042/bj3290145; Bond CS, 1997, STRUCTURE, V5, P277, DOI 10.1016/S0969-2126(97)00185-8; BRAULKE T, 1987, EUR J CELL BIOL, V43, P316; Buhling F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026247; Claussen M, 1997, ENDOCRINOLOGY, V138, P3797, DOI 10.1210/en.138.9.3797; Cohen E, 2005, FEBS LETT, V579, P2334, DOI 10.1016/j.febslet.2005.03.030; Deuschl F, 2006, FEBS LETT, V580, P5747, DOI 10.1016/j.febslet.2006.09.029; Diez-Roux G, 2005, ANNU REV GENOM HUM G, V6, P355, DOI 10.1146/annurev.genom.6.080604.162334; DIMENT S, 1988, J BIOL CHEM, V263, P6901; Dittmer F, 1998, TRANSGENIC RES, V7, P473, DOI 10.1023/A:1008823315416; Durand S, 2010, J BIOL CHEM, V285, P31233, DOI 10.1074/jbc.M110.141150; Ferrante P, 2002, EUR J HUM GENET, V10, P813, DOI 10.1038/sj.ejhg.5200887; FREEMAN C, 1987, BIOCHEM J, V246, P347, DOI 10.1042/bj2460347; FREEMAN C, 1986, BIOCHEM J, V234, P83, DOI 10.1042/bj2340083; Frese MA, 2008, J BIOL CHEM, V283, P11388, DOI 10.1074/jbc.M709917200; FROISSART R, 1995, BIOCHEM J, V309, P425, DOI 10.1042/bj3090425; FUJII T, 1992, BIOCHIM BIOPHYS ACTA, V1122, P93, DOI 10.1016/0167-4838(92)90132-W; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Gamp AC, 2003, HUM MOL GENET, V12, P631, DOI 10.1093/hmg/ddg062; GIESELMANN V, 1983, J CELL BIOL, V97, P1, DOI 10.1083/jcb.97.1.1; Golabek AA, 2004, J BIOL CHEM, V279, P31058, DOI 10.1074/jbc.M400700200; Halangk W, 2000, J CLIN INVEST, V106, P773, DOI 10.1172/JCI9411; Huang RT, 2009, FEBS J, V276, P1891, DOI 10.1111/j.1742-4658.2009.06915.x; Kollmann K, 2012, BRAIN, V135, P2661, DOI 10.1093/brain/aws209; Kollmann K, 2010, EUR J CELL BIOL, V89, P117, DOI 10.1016/j.ejcb.2009.10.008; Kollmann K, 2009, FEBS J, V276, P1356, DOI 10.1111/j.1742-4658.2009.06877.x; Kowalewski B, 2012, P NATL ACAD SCI USA, V109, P10310, DOI 10.1073/pnas.1202071109; Lefrancois S, 2003, EMBO J, V22, P6430, DOI 10.1093/emboj/cdg629; LEMANSKY P, 1984, J BIOL CHEM, V259, P129; Ljusberg J, 2005, J BIOL CHEM, V280, P28370, DOI 10.1074/jbc.M502469200; MASUE M, 1991, J BIOCHEM-TOKYO, V110, P965, DOI 10.1093/oxfordjournals.jbchem.a123697; Matthews SP, 2010, J IMMUNOL, V184, P2423, DOI 10.4049/jimmunol.0901486; MEHL E, 1968, BIOCHIM BIOPHYS ACTA, V151, P619, DOI 10.1016/0005-2744(68)90008-9; MERION M, 1983, J CELL BIOL, V96, P644, DOI 10.1083/jcb.96.3.644; Muenzer J, 2004, J PEDIATR-US, V144, pS27, DOI 10.1016/j.jpeds.2004.01.052; Ni X, 2006, HISTOL HISTOPATHOL, V21, P899, DOI 10.14670/HH-21.899; Ni XY, 2006, TRAFFIC, V7, P889, DOI 10.1111/j.1600-0854.2006.00429.x; NISHIMURA Y, 1988, ARCH BIOCHEM BIOPHYS, V261, P64, DOI 10.1016/0003-9861(88)90104-X; NISHIMURA Y, 1995, BIOL PHARM BULL, V18, P1340; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; Ong WY, 2004, NEUROSCIENCE, V128, P561, DOI 10.1016/j.neuroscience.2004.07.001; POHLMANN R, 1995, J BIOL CHEM, V270, P27311, DOI 10.1074/jbc.270.45.27311; Reczek D, 2007, CELL, V131, P770, DOI 10.1016/j.cell.2007.10.018; RIJNBOUTT S, 1991, J BIOL CHEM, V266, P4862; RIJNBOUTT S, 1991, J BIOL CHEM, V266, P23586; Roth W, 2000, FASEB J, V14, P2075, DOI 10.1096/fj.99-0970com; Saarela J, 1998, J BIOL CHEM, V273, P25320, DOI 10.1074/jbc.273.39.25320; SAFTIG P, 1995, EMBO J, V14, P3599, DOI 10.1002/j.1460-2075.1995.tb00029.x; Sardiello M, 2005, HUM MOL GENET, V14, P3203, DOI 10.1093/hmg/ddi351; SCHUERMANN M, 1990, NUCLEIC ACIDS RES, V18, P4945, DOI 10.1093/nar/18.16.4945; Sleat DE, 2006, MOL CELL PROTEOMICS, V5, P686, DOI 10.1074/mcp.M500343-MCP200; STORRIE B, 1984, J CELL BIOL, V98, P108, DOI 10.1083/jcb.98.1.108; VONMOLLARD GF, 1994, EUR J CELL BIOL, V65, P319; Wahe A, 2010, J CELL SCI, V123, P2502, DOI 10.1242/jcs.067686; WATTIAUX R, 1963, ARCH INT PHYS BIOCH, V71, P140; Wiegmann EM, 2013, J BIOL CHEM, V288, P30019, DOI 10.1074/jbc.M113.499541; Zhao LY, 2007, BBA-MOL CELL BIOL L, V1771, P1397, DOI 10.1016/j.bbalip.2007.10.002; ZHU Y, 1994, J BIOL CHEM, V269, P3846	60	21	21	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27992	28005		10.1074/jbc.M114.584144	http://dx.doi.org/10.1074/jbc.M114.584144			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25135642	Green Published, hybrid			2022-12-25	WOS:000342852800052
J	Magliozzi, R; Kim, J; Low, TY; Heck, AJR; Guardavaccaro, D				Magliozzi, Roberto; Kim, Jihoon; Low, Teck Yew; Heck, Albert J. R.; Guardavaccaro, Daniele			Degradation of Tiam1 by Casein Kinase 1 and the SCF beta TrCP Ubiquitin Ligase Controls the Duration of mTOR-S6K Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						E3 Ubiquitin Ligase; Proteasome; Proteolysis; Signal Transduction; Ubiquitin; Tiam1; betaTrCP; mTOR-S6K Signaling	I-KAPPA-B; DEPENDENT DEGRADATION; GENOTOXIC STRESS; DNA-DAMAGE; S6 KINASE; PROTEIN; COMPLEX; RAC; PHOSPHORYLATION; DESTRUCTION	Background: The guanine nucleotide exchange factor Tiam1 regulates the activity of the small GTPase Rac1, a crucial regulator of cell adhesion, proliferation, and survival. Results: The SCFTrCP ubiquitin ligase in cooperation with CK1 targets Tiam1 for proteasome-dependent degradation. Conclusion: Tiam1 degradation is required to terminate the mTOR-S6K signaling pathway. Significance: Tiam1 degradation controls the duration of mTOR-S6K signaling in response to mitogens. Tiam1 (T-cell lymphoma invasion and metastasis 1) is a guanine nucleotide exchange factor that specifically controls the activity of the small GTPase Rac, a key regulator of cell adhesion, proliferation, and survival. Here, we report that in response to mitogens, Tiam1 is degraded by the ubiquitin-proteasome system via the SCFTrCP ubiquitin ligase. Mitogenic stimulation triggers the binding of Tiam1 to the F-box protein TrCP via its degron sequence and subsequent Tiam1 ubiquitylation and proteasomal degradation. The proteolysis of Tiam1 is prevented by TrCP silencing, inhibition of CK1 and MEK, or mutation of the Tiam1 degron site. Expression of a stable Tiam1 mutant that is unable to interact with TrCP results in sustained activation of the mTOR/S6K signaling and increased apoptotic cell death. We propose that the SCFTrCP-mediated degradation of Tiam1 controls the duration of the mTOR-S6K signaling pathway in response to mitogenic stimuli.	[Magliozzi, Roberto; Kim, Jihoon; Guardavaccaro, Daniele] Hubrecht Inst KNAW, NL-3584 CT Utrecht, Netherlands; [Magliozzi, Roberto; Kim, Jihoon; Guardavaccaro, Daniele] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Low, Teck Yew; Heck, Albert J. R.] Univ Utrecht, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands; [Low, Teck Yew; Heck, Albert J. R.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, NL-3584 CH Utrecht, Netherlands; [Low, Teck Yew; Heck, Albert J. R.] Netherlands Prote Ctr, NL-3584 CH Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University	Guardavaccaro, D (corresponding author), Hubrecht Inst, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	d.guardavaccaro@hubrecht.eu	Low, Teck Yew/Q-5946-2019; Heck, Albert/D-7098-2011	Low, Teck Yew/0000-0001-7878-7534; Heck, Albert/0000-0002-2405-4404; Guardavaccaro, Daniele/0000-0002-4517-1765	Royal Dutch Academy of Arts and Sciences (KNAW); Dutch Cancer Society (KWF); Cancer Genomics Centre; European Union under Marie Curie Actions; Netherlands Proteomics Center	Royal Dutch Academy of Arts and Sciences (KNAW); Dutch Cancer Society (KWF)(KWF Kankerbestrijding); Cancer Genomics Centre; European Union under Marie Curie Actions; Netherlands Proteomics Center	This work was supported by funds from the Royal Dutch Academy of Arts and Sciences (KNAW), the Dutch Cancer Society (KWF), the Cancer Genomics Centre, and the European Union under Marie Curie Actions (to D. G.) and from the Netherlands Proteomics Center (to T. Y. L. and A. J. R. H.).	Buchsbaum RJ, 2003, J BIOL CHEM, V278, P18833, DOI 10.1074/jbc.M207876200; Busino L, 2003, NATURE, V426, P87, DOI 10.1038/nature02082; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Chou MM, 1996, CELL, V85, P573, DOI 10.1016/S0092-8674(00)81257-X; D'Annibale S, 2014, J BIOL CHEM, V289, P7730, DOI 10.1074/jbc.M114.549535; Dehan E, 2009, MOL CELL, V33, P109, DOI 10.1016/j.molcel.2008.12.020; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Duan SS, 2011, MOL CELL, V44, P317, DOI 10.1016/j.molcel.2011.09.005; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Fuchs SY, 1999, ONCOGENE, V18, P2039, DOI 10.1038/sj.onc.1202760; Guardavaccaro D, 2008, NATURE, V452, P365, DOI 10.1038/nature06641; HABETS GGM, 1994, CELL, V77, P537, DOI 10.1016/0092-8674(94)90216-X; Hordijk PL, 1997, SCIENCE, V278, P1464, DOI 10.1126/science.278.5342.1464; Jin JP, 2003, GENE DEV, V17, P3062, DOI 10.1101/gad.1157503; Kruiswijk F, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002718; Lambert JM, 2002, NAT CELL BIOL, V4, P621, DOI 10.1038/ncb833; Lee CH, 2007, EMBO J, V26, P4812, DOI 10.1038/sj.emboj.7601900; Magliozzi R, 2013, DEV CELL, V27, P574, DOI 10.1016/j.devcel.2013.10.023; Mailand N, 2006, MOL CELL, V23, P307, DOI 10.1016/j.molcel.2006.06.016; Malliri A, 2004, J BIOL CHEM, V279, P30092, DOI 10.1074/jbc.M401192200; Malliri A, 2003, CURR OPIN CELL BIOL, V15, P583, DOI 10.1016/S0955-0674(03)00098-X; Mantovani F, 2003, J BIOL CHEM, V278, P42477, DOI 10.1074/jbc.M302799200; Margottin-Goguet F, 2003, DEV CELL, V4, P813, DOI 10.1016/S1534-5807(03)00153-9; Melixetian M, 2009, NAT CELL BIOL, V11, P1247, DOI 10.1038/ncb1969; Mertens AE, 2003, FEBS LETT, V546, P11, DOI 10.1016/S0014-5793(03)00435-6; MICHIELS F, 1995, NATURE, V375, P338, DOI 10.1038/375338a0; Raijmakers R, 2008, MOL CELL PROTEOMICS, V7, P1755, DOI 10.1074/mcp.M800093-MCP200; Saci A, 2011, MOL CELL, V42, P50, DOI 10.1016/j.molcel.2011.03.017; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Spencer E, 1999, GENE DEV, V13, P284, DOI 10.1101/gad.13.3.284; Taus T, 2011, J PROTEOME RES, V10, P5354, DOI 10.1021/pr200611n; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Woodcock SA, 2009, MOL CELL, V33, P639, DOI 10.1016/j.molcel.2009.02.012; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Wu K, 2000, MOL CELL BIOL, V20, P1382, DOI 10.1128/MCB.20.4.1382-1393.2000; Yaron A, 1998, NATURE, V396, P590, DOI 10.1038/25159; Zhu GX, 2014, J BIOL CHEM, V289, P15482, DOI 10.1074/jbc.M114.553388	37	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27400	27409		10.1074/jbc.M114.575571	http://dx.doi.org/10.1074/jbc.M114.575571			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25124033	hybrid, Green Published			2022-12-25	WOS:000342852800004
J	Wang, Z; Yang, X; Guo, S; Yang, Y; Su, XC; Shen, YQ; Long, JF				Wang, Zheng; Yang, Xue; Guo, Shuang; Yang, Yin; Su, Xun-Cheng; Shen, Yuequan; Long, Jiafu			Crystal Structure of the Ubiquitin-like Domain-CUT Repeat-like Tandem of Special AT-rich Sequence Binding Protein 1 (SATB1) Reveals a Coordinating DNA-binding Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chromatin Regulation; Crystal Structure; DNA-binding Protein; Gene Regulation; Scaffold Protein; CUTL Domain; DNA Binding; SATB1; Coordination Mechanism; Global Gene Regulation	MATRIX ATTACHMENT REGION; MEDIATED DIMERIZATION; GENE-EXPRESSION; MULTIPLE GENES; TUMOR-GROWTH; CHROMATIN; TRANSCRIPTION; ARCHITECTURE; RECOGNITION; HOMEODOMAIN	Background: SATB1 is a multidomain protein that acts as a global gene organizer. Results: The newly identified CUTL domain contributes to the DNA binding ability of SATB1. Conclusion: The DNA binding ability of SATB1 requires the contribution of the CUTL domain and the other DNA-binding domains. Significance: These findings reveal a multiple-domain-coordinated mechanism whereby SATB1 recognizes DNA targets. SATB1 is essential for T-cell development and growth and metastasis of multitype tumors and acts as a global chromatin organizer and gene expression regulator. The DNA binding ability of SATB1 plays vital roles in its various biological functions. We report the crystal structure of the N-terminal module of SATB1. Interestingly, this module contains a ubiquitin-like domain (ULD) and a CUT repeat-like (CUTL) domain (ULD-CUTL tandem). Detailed biochemical experiments indicate that the N terminus of SATB1 (residues 1-248, SATB1((1-248))), including the extreme 70 N-terminal amino acids, and the ULD-CUTL tandem bind specifically to DNA targets. Our results show that the DNA binding ability of full-length SATB1 requires the contribution of the CUTL domain, as well as the CUT1-CUT2 tandem domain and the homeodomain. These findings may reveal a multiple-domain-coordinated mechanism whereby SATB1 recognizes DNA targets.	[Wang, Zheng; Yang, Xue; Guo, Shuang; Shen, Yuequan; Long, Jiafu] Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Wang, Zheng; Yang, Xue; Shen, Yuequan; Long, Jiafu] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Yang, Yin; Su, Xun-Cheng] Nankai Univ, State Key Lab Elementoorgan Chem, Tianjin 300071, Peoples R China; [Shen, Yuequan] Synerget Innovat Ctr Chem Sci & Engn, Tianjin 300071, Peoples R China	Nankai University; Nankai University; Nankai University	Shen, YQ (corresponding author), Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China.	shenyuequan@gmail.com; jflong@nankai.edu.cn	Long, Jiafu/B-7420-2012	Long, Jiafu/0000-0002-6625-0147; , Xun-Cheng/0000-0003-3051-0047	973 Program [2014CB910201, 2012CB917201]; National Natural Science Foundation of China [31270815, 31100527]	973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by 973 Program Grants 2014CB910201 (to J. L.) and 2012CB917201 (to Y. S.) and National Natural Science Foundation of China Grants 31270815 (to J. L.) and 31100527 (to H. Z.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahlfors H, 2010, BLOOD, V116, P1443, DOI 10.1182/blood-2009-11-252205; Alvarez JD, 2000, GENE DEV, V14, P521; BODE J, 1992, SCIENCE, V255, P195, DOI 10.1126/science.1553545; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Cai ST, 2003, NAT GENET, V34, P42, DOI 10.1038/ng1146; Dickinson LA, 1997, J BIOL CHEM, V272, P11463; DICKINSON LA, 1992, CELL, V70, P631, DOI 10.1016/0092-8674(92)90432-C; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Galande S, 2001, MOL CELL BIOL, V21, P5591, DOI 10.1128/MCB.21.16.5591-5604.2001; Galande S, 2007, CURR OPIN GENET DEV, V17, P408, DOI 10.1016/j.gde.2007.08.003; Gong FR, 2011, NUCLEIC ACIDS RES, V39, P4640, DOI 10.1093/nar/gkr023; Gotzmann J, 2000, CELL DEATH DIFFER, V7, P425, DOI 10.1038/sj.cdd.4400668; Han B, 2013, TUMOR BIOL, V34, P2943, DOI 10.1007/s13277-013-0857-1; Han HJ, 2008, NATURE, V452, P187, DOI 10.1038/nature06781; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Klemm JD, 1996, GENE DEV, V10, P27, DOI 10.1101/gad.10.1.27; Kumar P, 2007, NAT CELL BIOL, V9, P45, DOI 10.1038/ncb1516; Kumar PP, 2005, MOL CELL BIOL, V25, P1620, DOI 10.1128/MCB.25.5.1620-1633.2005; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; NAKAGOMI K, 1994, MOL CELL BIOL, V14, P1852, DOI 10.1128/MCB.14.3.1852; Notani D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000296; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pavan KP, 2006, MOL CELL, V22, P231, DOI 10.1016/j.molcel.2006.03.010; Purbey PK, 2008, NUCLEIC ACIDS RES, V36, P2107, DOI 10.1093/nar/gkm1151; Purbey PK, 2009, MOL CELL BIOL, V29, P1321, DOI 10.1128/MCB.00822-08; Razin SV, 2013, FEBS LETT, V587, P1840, DOI 10.1016/j.febslet.2013.04.027; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Serrano L, 2013, EXP BIOL MED, V238, P259, DOI 10.1177/1535370213480718; Sun YJ, 2006, CELL BIOL INT, V30, P244, DOI 10.1016/j.cellbi.2005.10.025; Suva ML, 2013, SCIENCE, V339, P1567, DOI 10.1126/science.1230184; Tan JAT, 2008, J BIOL CHEM, V283, P18124, DOI 10.1074/jbc.M800512200; Tan JAT, 2010, MOL CELL BIOL, V30, P2823, DOI 10.1128/MCB.01603-09; Tu W, 2012, LIVER INT, V32, P1064, DOI 10.1111/j.1478-3231.2012.02815.x; Wang Z, 2012, NUCLEIC ACIDS RES, V40, P4193, DOI 10.1093/nar/gkr1284; Xue Z, 2012, NUCLEIC ACIDS RES, V40, P4804, DOI 10.1093/nar/gks064; Yamasaki K, 2007, NUCLEIC ACIDS RES, V35, P5073, DOI 10.1093/nar/gkm504; Yasui D, 2002, NATURE, V419, P641, DOI 10.1038/nature01084	40	10	10	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27376	27385		10.1074/jbc.M114.562314	http://dx.doi.org/10.1074/jbc.M114.562314			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25124042	Green Published, hybrid			2022-12-25	WOS:000342852800002
J	Schniepp, R; Wuehr, M; Huth, S; Pradhan, C; Schlick, C; Brandt, T; Jahn, K				Schniepp, Roman; Wuehr, Max; Huth, Sabrina; Pradhan, Cauchy; Schlick, Cornelia; Brandt, Thomas; Jahn, Klaus			The Gait Disorder in Downbeat Nystagmus Syndrome	PLOS ONE			English	Article							OLDER-ADULTS; CEREBELLAR; LOCOMOTION; VARIABILITY; GRAVITY; VISION	Background: Downbeat nystagmus (DBN) is a common form of acquired fixation nystagmus with key symptoms of oscillopsia and gait disturbance. Gait disturbance could be a result of impaired visual feedback due to the involuntary ocular oscillations. Alternatively, a malfunction of cerebellar locomotor control might be involved, since DBN is considered a vestibulocerebellar disorder. Methods: Investigation of walking in 50 DBN patients (age 72 +/- 11 years, 23 females) and 50 healthy controls (HS) (age 70 +/- 11 years, 23 females) using a pressure sensitive carpet (GAITRite). The patient cohort comprised subjects with only ocular motor signs (DBN) and subjects with an additional limb ataxia (DBNCA). Gait investigation comprised different walking speeds and walking with eyes closed. Results: In DBN, gait velocity was reduced (p<0.001) with a reduced stride length (p<0.001), increased base of support (p<0.050), and increased double support (p<0.001). Walking with eyes closed led to significant gait changes in both HS and DBN. These changes were more pronounced in DBN patients (p<0.001). Speed-dependency of gait variability revealed significant differences between the subgroups of DBN and DBNCA (p<0.050). Conclusions: (I) Impaired visual control caused by involuntary ocular oscillations cannot sufficiently explain the gait disorder. (II) The gait of patients with DBN is impaired in a speed dependent manner. (III) Analysis of gait variability allows distinguishing DBN from DBNCA: Patients with pure DBN show a speed dependency of gait variability similar to that of patients with afferent vestibular deficits. In DBNCA, gait variability resembles the pattern found in cerebellar ataxia.	[Schniepp, Roman; Huth, Sabrina; Jahn, Klaus] Univ Munich, Dept Neurol, D-80539 Munich, Germany; [Schniepp, Roman; Wuehr, Max; Huth, Sabrina; Pradhan, Cauchy; Schlick, Cornelia; Brandt, Thomas; Jahn, Klaus] Univ Munich, German Ctr Vertigo & Balance Disorders DSGZ, Munich, Germany; [Brandt, Thomas] Univ Munich, Inst Clin Neurosci, Munich, Germany	University of Munich; University of Munich; University of Munich	Schniepp, R (corresponding author), Univ Munich, Dept Neurol, D-80539 Munich, Germany.	roman.schniepp@med.uni-muenchen.de	Jahn, Klaus/F-9902-2010; Jahn, Klaus/AAC-4969-2021	Jahn, Klaus/0000-0002-1669-3652; Wuhr, Max/0000-0001-5115-3777	German research foundation (Deutsche Forschungsgemeinschaft) [DFG JA 1087/1-1]; German Hertie Foundation; Federal Ministry for Education and Science (BMBF) of Germany [80121000-49]	German research foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); German Hertie Foundation; Federal Ministry for Education and Science (BMBF) of Germany(Federal Ministry of Education & Research (BMBF))	The work was supported by the German research foundation (Deutsche Forschungsgemeinschaft, DFG JA 1087/1-1), the German Hertie Foundation and the Federal Ministry for Education and Science (BMBF, Nr. 80121000-49) of Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG DM, 1988, J PHYSIOL-LONDON, V405, P1, DOI 10.1113/jphysiol.1988.sp017319; Brandt T, 1999, LANCET, V354, P746, DOI 10.1016/S0140-6736(99)03179-7; Buchele W, 1983, Adv Otorhinolaryngol, V30, P291; Cromwell RL, 2002, J GERONTOL A-BIOL, V57, pM442, DOI 10.1093/gerona/57.7.M442; Crowdy KA, 2000, EXP BRAIN RES, V135, P437, DOI 10.1007/s002210000539; Gagey P M, 1999, POSTUROLOGIE REGULAT, P45; Glasauer S, 2005, NEUROLOGY, V65, P1291, DOI 10.1212/01.wnl.0000175132.01370.fc; Hallemans A, 2010, GAIT POSTURE, V32, P547, DOI 10.1016/j.gaitpost.2010.07.018; HALMAGYI GM, 1988, ARCH NEUROL-CHICAGO, V45, P737, DOI 10.1001/archneur.1988.00520310043015; Hausdorff JM, 2005, J NEUROENG REHABIL, V2, P19, DOI [DOI 10.1186/1743-0003-2-19, 10.1186/1743-0003-2-19]; Hufner K, 2007, NEUROLOGY, V69, P1128, DOI 10.1212/01.wnl.0000276953.00969.48; ITO M, 1977, J PHYSIOL-LONDON, V265, P833, DOI 10.1113/jphysiol.1977.sp011747; Jahn K, 2008, NEUROIMAGE, V39, P786, DOI 10.1016/j.neuroimage.2007.09.047; Jahn K, 2010, RESTOR NEUROL NEUROS, V28, P105, DOI 10.3233/RNN-2010-0506; Kalla R, 2006, NEUROLOGY, V66, P281, DOI 10.1212/01.wnl.0000194242.28018.d9; Leigh RJ, 2006, CONT NEUROLOGY SERIE, V70; Lord S, 2013, J GERONTOL A-BIOL, V68, P820, DOI 10.1093/gerona/gls255; Marti S, 2002, ANN NEUROL, V52, P712, DOI 10.1002/ana.10370; Marti S, 2008, EXP BRAIN RES, V188, P613, DOI 10.1007/s00221-008-1396-7; Miles FA, 1999, ANN NY ACAD SCI, V871, P260, DOI 10.1111/j.1749-6632.1999.tb09190.x; Mori S, 1998, ANN NY ACAD SCI, V860, P94, DOI 10.1111/j.1749-6632.1998.tb09041.x; Mori S, 2001, ADV NEUROL, V87, P25; NELSON AJ, 1974, PHYS THER, V54, P1059, DOI 10.1093/ptj/54.10.1059; Palliyath S, 1998, MOVEMENT DISORD, V13, P958, DOI 10.1002/mds.870130616; Pierrot-Deseilligny C, 2009, ANN NY ACAD SCI, V1164, P155, DOI 10.1111/j.1749-6632.2009.03864.x; Pradhan C, 2013, J NEUROSCIENCE NEURO, V2, P542; Schniepp R, 2014, J NEUROL, V261, P213, DOI 10.1007/s00415-013-7189-3; Schniepp R, 2012, MOVEMENT DISORD, V27, P125, DOI 10.1002/mds.23978; Spiegel R, 2010, NEUROLOGY, V75, P1928, DOI 10.1212/WNL.0b013e3181feb22f; Stolze H, 2002, J NEUROL NEUROSUR PS, V73, P310, DOI 10.1136/jnnp.73.3.310; WAESPE W, 1989, PROG BRAIN RES, V80, P225; Wagner JN, 2008, J NEUROL NEUROSUR PS, V79, P672, DOI 10.1136/jnnp.2007.126284; Wuehr M, 2013, GAIT POSTURE, V37, P214, DOI 10.1016/j.gaitpost.2012.07.003; Wuehr M, 2013, EXP BRAIN RES, V224, P287, DOI 10.1007/s00221-012-3310-6	34	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105463	10.1371/journal.pone.0105463	http://dx.doi.org/10.1371/journal.pone.0105463			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140517	Green Published, gold, Green Submitted			2022-12-25	WOS:000342687200090
J	Chiarovano, E; Darlington, C; Vidal, PP; Lamas, G; de Waele, C				Chiarovano, Elodie; Darlington, Cynthia; Vidal, Pierre-Paul; Lamas, Georges; de Waele, Catherine			The Role of Cervical and Ocular Vestibular Evoked Myogenic Potentials in the Assessment of Patients with Vestibular Schwannomas	PLOS ONE			English	Article							BONE-CONDUCTED VIBRATION; CLINICAL-APPLICATIONS; UTRICULAR FUNCTION; SOUND; FOREHEAD; OVEMP; NERVE	Objectives: To investigate the clinical utility of VEMPs in patients suffering from unilateral vestibular schwannoma (VS) and to determine the optimal stimulation parameter (air conducted sound, bone conducted vibration) for evaluating the function of the vestibular nerve. Methods: Data were obtained in 63 patients with non-operated VS, and 20 patients operated on VS. Vestibular function was assessed by caloric, cervical and ocular VEMP testing. 37/63 patients with conclusive ACS ocular VEMPs responses were studied separately. Results: In the 63 non-operated VS patients, cVEMPs were abnormal in 65.1% of patients in response to AC STB and in 49.2% of patients to AC clicks. In the 37/63 patients with positive responses from the unaffected side, oVEMPs were abnormal in 75.7% of patients with ACS, in 67.6% with AFz and in 56.8% with mastoid BCV stimulation. In 16% of the patients, VEMPs were the only abnormal test (normal caloric and normal hearing). Among the 26 patients who did not show oVEMP responses on either side with ACS, oVEMPs responses could be obtained with AFz (50%) and with mastoid stimulation (89%). Conclusions: The VEMP test demonstrated significant clinical value as it yielded the only abnormal test results in some patients suffering from a unilateral vestibular schwannoma. For oVEMPs, we suggest that ACS stimulation should be the initial test. In patients who responded to ACS and who had normal responses, BCV was not required. In patients with abnormal responses on the affected side using ACS, BCV at AFz should be used to confirm abnormal function of the superior vestibular nerve. In patients who exhibited no responses on either side to ACS, BCV was the only approach allowing assessment of the function of the superior vestibular nerve. We favor using AFz stimulation first because it is easier to perform in clinical practice than mastoid stimulation.	[Chiarovano, Elodie; Vidal, Pierre-Paul; de Waele, Catherine] Univ Paris 05, Ctr Univ St Peres, CESEM, CNRS UMR 8194, Paris, France; [Darlington, Cynthia] Univ Otago, Sch Med, Dept Pharmacol & Toxicol, Dunedin, New Zealand; [Lamas, Georges] Salpetriere Hosp, ENT Dept, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; University of Otago; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	de Waele, C (corresponding author), Univ Paris 05, Ctr Univ St Peres, CESEM, CNRS UMR 8194, Paris, France.	catherine.de-waele@parisdescartes.fr		Chiarovano, Elodie/0000-0002-3738-0700				Chiarovano E, 2011, CLIN NEUROPHYSIOL, V122, P1650, DOI 10.1016/j.clinph.2011.01.006; Chihara Y, 2007, CLIN NEUROPHYSIOL, V118, P2745, DOI 10.1016/j.clinph.2007.08.005; COLEBATCH JG, 1994, J NEUROL NEUROSUR PS, V57, P190, DOI 10.1136/jnnp.57.2.190; Curthoys IS, 2012, ACTA OTORHINOLARYNGO, V32, P41; Curthoys IS, 2009, ACTA OTORHINOLARYNGO, V29, P179; Curthoys IS, 2011, CLIN NEUROPHYSIOL, V122, P611, DOI 10.1016/j.clinph.2010.07.018; De Waele C, 1999, ANN NY ACAD SCI, V871, P392; Iwasaki S, 2005, OTOL NEUROTOL, V26, P1196, DOI 10.1097/01.mao.0000194890.44023.e6; Iwasaki S, 2009, CLIN NEUROPHYSIOL, V120, P588, DOI 10.1016/j.clinph.2008.12.036; Janky KL, 2013, OTOL NEUROTOL, V34, P127, DOI 10.1097/MAO.0b013e318271c32a; JONGKEES L B, 1962, Pract Otorhinolaryngol (Basel), V24, P65; Kantner C, 2012, HEARING RES, V294, P55, DOI 10.1016/j.heares.2012.10.008; Kinoshita M, 2013, OTOL NEUROTOL, V34, P1342, DOI 10.1097/MAO.0b013e31828d6539; Lin MC, 2013, IEEE T VIS COMPUT GR, V19, P177, DOI 10.1109/TVCG.2013.6; Manzari L, 2010, ACTA OTORHINOLARYNGO, V30, P175; Murofushi T, 1998, ARCH OTOLARYNGOL, V124, P509, DOI 10.1001/archotol.124.5.509; Murofushi T, 1999, ARCH OTOLARYNGOL, V125, P660, DOI 10.1001/archotol.125.6.660; Murofushi T, 2011, ACTA OTO-LARYNGOL, V131, P945, DOI 10.3109/00016489.2011.580003; Nguyen KD, 2010, OTOL NEUROTOL, V31, P793, DOI 10.1097/MAO.0b013e3181e3d60e; OKADA Y, 1991, ACTA OTO-LARYNGOL, P150; Patko T, 2003, CLIN NEUROPHYSIOL, V114, P1344, DOI 10.1016/S1388-2457(03)00119-6; Piras G, 2013, EUR ARCH OTO-RHINO-L, V270, P497, DOI 10.1007/s00405-012-2018-3; Rosengren SM, 2010, CLIN NEUROPHYSIOL, V121, P636, DOI 10.1016/j.clinph.2009.10.016; Rosengren SM, 2011, CLIN NEUROPHYSIOL, V122, P2282, DOI 10.1016/j.clinph.2011.04.001; Rosengren SM, 2009, J VESTIBUL RES-EQUIL, V19, P33, DOI 10.3233/VES-2009-0345; Tseng CC, 2012, OTOLARYNG HEAD NECK, V146, P289, DOI 10.1177/0194599811425884; Ushio M, 2009, CLIN NEUROPHYSIOL, V120, P1149, DOI 10.1016/j.clinph.2009.01.017; Viciana D, 2012, EUR ARCH OTO-RHINO-L, V269, P1857, DOI 10.1007/s00405-011-1912-4; Weber KP, 2009, ANN NY ACAD SCI, V1164, P486, DOI 10.1111/j.1749-6632.2008.03730.x; Welgampola MS, 2005, NEUROLOGY, V64, P1682, DOI 10.1212/01.WNL.0000161876.20552.AA; Welgampola MS, 2001, CLIN NEUROPHYSIOL, V112, P1971, DOI 10.1016/S1388-2457(01)00645-9	31	29	31	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105026	10.1371/journal.pone.0105026	http://dx.doi.org/10.1371/journal.pone.0105026			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137289	Green Submitted, gold, Green Published			2022-12-25	WOS:000340742100062
J	Howes, PD; Wongsriruksa, S; Laughlin, Z; Witchel, HJ; Miodownik, M				Howes, Philip D.; Wongsriruksa, Supinya; Laughlin, Zoe; Witchel, Harry J.; Miodownik, Mark			The Perception of Materials through Oral Sensation	PLOS ONE			English	Article							HAPTIC PERCEPTION; TACTILE PERCEPTION; TOUCH PERCEPTION; FINGER FRICTION; TASTE; ROUGHNESS; TEXTURE; DISCRIMINATION; DIMENSIONS; PREDICT	This paper presents the results of a multimodal study of oral perception conducted with a set of material samples made from metals, polymers and woods, in which both the somatosensory and taste factors were examined. A multidimensional scaling analysis coupled with subjective attribute ratings was performed to assess these factors both qualitatively and quantitatively. The perceptual somatosensory factors of warmth, hardness and roughness dominated over the basic taste factors, and roughness was observed to be a less significant sensation compared to touch-only experiments. The perceptual somatosensory ratings were compared directly with physical property data in order to assess the correlation between the perceived properties and measured physical properties. In each case, a strong correlation was observed, suggesting that physical properties may be useful in industrial design for predicting oral perception.	[Howes, Philip D.] Univ London Imperial Coll Sci Technol & Med, Dept Mat, London, England; [Wongsriruksa, Supinya] Kings Coll London, Dept Phys, London WC2R 2LS, England; [Laughlin, Zoe; Miodownik, Mark] UCL, Inst Making, London, England; [Witchel, Harry J.] Univ Sussex, Brighton & Sussex Med Sch, Brighton, E Sussex, England	Imperial College London; University of London; King's College London; University of London; University College London; University of Brighton; University of Sussex	Miodownik, M (corresponding author), UCL, Inst Making, London, England.	m.miodownik@ucl.ac.uk	Howes, Philip D./U-8901-2017	Howes, Philip D./0000-0002-1862-8395	Leverhulme Trust [f/07 040/AF]; EPSRC [EP/I00159X/2, EP/I00159X/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I00159X/2, EP/I00159X/1] Funding Source: researchfish	Leverhulme Trust(Leverhulme Trust); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The study was funded by the Leverhulme Trust, grant number: f/07 040/AF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blake DT, 1997, J NEUROSCI, V17, P7480; Boliek CA, 2007, J ORAL REHABIL, V34, P433, DOI 10.1111/j.1365-2842.2007.01735.x; Chen XJ, 2009, INT J DES, V3, P67; CONNOR CE, 1990, J NEUROSCI, V10, P3823, DOI 10.1523/JNEUROSCI.10-12-03823.1990; Engelen L, 2008, J TEXTURE STUD, V39, P83, DOI 10.1111/j.1745-4603.2007.00132.x; Epke EM, 2007, PHYSIOL BEHAV, V92, P487, DOI 10.1016/j.physbeh.2007.04.022; Erickson RP, 2008, BEHAV BRAIN SCI, V31, P59, DOI 10.1017/S0140525X08003348; Green BG, 2003, FOOD QUAL PREFER, V14, P99, DOI 10.1016/S0950-3293(02)00071-X; Ho HN, 2006, PERCEPT PSYCHOPHYS, V68, P118, DOI 10.3758/BF03193662; Hollins M, 2000, PERCEPT PSYCHOPHYS, V62, P1534, DOI 10.3758/BF03212154; HOLLINS M, 1993, PERCEPT PSYCHOPHYS, V54, P697, DOI 10.3758/BF03211795; Hollins M, 2001, SOMATOSENS MOT RES, V18, P253; Hollins M, 2007, CAN J EXP PSYCHOL, V61, P184, DOI 10.1037/cjep2007020; Hollins M, 2010, ANNU REV PSYCHOL, V61, P243, DOI 10.1146/annurev.psych.093008.100419; Jacobs R, 1998, Clin Oral Investig, V2, P3, DOI 10.1007/s007840050035; Kawagishi S, 2009, J ORAL REHABIL, V36, P872, DOI 10.1111/j.1365-2842.2009.02005.x; Klocker A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079085; KRUSKAL J.B., 1978, MULTIDIMENSIONAL SCA; Laughlin Z, 2011, FOOD QUAL PREFER, V22, P628, DOI 10.1016/j.foodqual.2011.03.012; Lawless HT, 2005, CHEM SENSES, V30, P185, DOI 10.1093/chemse/bji014; Lederman SJ, 2009, ATTEN PERCEPT PSYCHO, V71, P1439, DOI 10.3758/APP.71.7.1439; Miodownik MA, 2007, PURE APPL CHEM, V79, P1635, DOI 10.1351/pac200779101635; Picard D, 2003, ACTA PSYCHOL, V114, P165, DOI 10.1016/j.actpsy.2003.08.001; Piqueras-Fiszman B, 2012, FOOD QUAL PREFER, V24, P24, DOI 10.1016/j.foodqual.2011.08.005; Rolls ET, 2011, J TEXTURE STUD, V42, P137, DOI 10.1111/j.1745-4603.2011.00296.x; Schiffman SS, 2009, ANN NY ACAD SCI, V1170, P725, DOI 10.1111/j.1749-6632.2009.03924.x; Skedung L, 2011, TRIBOL INT, V44, P505, DOI 10.1016/j.triboint.2010.04.010; Skedung L, 2010, TRIBOL LETT, V37, P389, DOI 10.1007/s11249-009-9538-z; Spence C, 2011, PSYCHOL MARKET, V28, P267, DOI 10.1002/mar.20392; Stevens DA, 2006, PHYSIOL BEHAV, V87, P272, DOI 10.1016/j.physbeh.2005.10.013; Stevens DA, 2008, CHEM SENSES, V33, P405, DOI 10.1093/chemse/bjn002; Stevens SS, 1975, PSYCHOPHYSICS INTRO, pxiv; Tiest WMB, 2006, ACTA PSYCHOL, V121, P1, DOI 10.1016/j.actpsy.2005.04.005; Tiest WMB, 2010, VISION RES, V50, P2775, DOI 10.1016/j.visres.2010.10.005; Tiest WMB, 2009, IEEE T HAPTICS, V2, P189, DOI [10.1109/TOH.2009.16, 10.1109/ToH.2009.16]; Tiest WMB, 2009, ATTEN PERCEPT PSYCHO, V71, P481, DOI 10.3758/APP.71.3.481; Wongsriruksa S, 2012, MATER DESIGN, V42, P238, DOI 10.1016/j.matdes.2012.05.054	37	14	14	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105035	10.1371/journal.pone.0105035	http://dx.doi.org/10.1371/journal.pone.0105035			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136793	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000340742100063
J	Li, Q; Liu, M; Ma, F; Luo, Y; Cai, RG; Wang, LM; Xu, NZ; Xu, BH				Li, Qian; Liu, Mei; Ma, Fei; Luo, Yang; Cai, Ruigang; Wang, Liming; Xu, Ningzhi; Xu, Binghe			Circulating miR-19a and miR-205 in Serum May Predict the Sensitivity of Luminal A Subtype of Breast Cancer Patients to Neoadjuvant Chemotherapy with Epirubicin Plus Paclitaxel	PLOS ONE			English	Article							MICRORNA EXPRESSION; PROGNOSTIC-SIGNIFICANCE; ADJUVANT CHEMOTHERAPY; IDENTIFICATION; RESISTANCE; CELLS; GENE; TRASTUZUMAB; PATHWAY; MARKERS	Background: The luminal A subtype of breast cancer has a good prognosis and is sensitive to endocrine therapy but is less sensitive to chemotherapy. It is necessary to identify biomarkers to predict chemosensitivity and avoid over-treatment. We hypothesized that miRNAs in the serum might be associated with chemosensitivity. Methods: Sixty-eight breast cancer patients received neoadjuvant chemotherapy with epirubicin plus paclitaxel. The serum of the patients was collected before chemotherapy and stored at -80 degrees C. The samples were classified into two groups in term of the chemosensitivity. We identified the differential expression patterns of miRNAs between the chemotherapy sensitive and resistant groups using microRNA profiling. Four miRNAs that were differentially expressed between the two groups were further validated in another 56 samples. We created a model fitting formula and a receiver operating characteristics (ROC) curve using logistic regression analysis to evaluate the prediction potency. Results: We identified 8 miRNAs differentially expressed between the two groups: 6 miRNAs were up-regulated, and 2 miRNAs were down-regulated in the resistant group compared with the sensitive group. The expression of miR-19a and miR-205 were determined to have significant differences between the two groups (P<0.05). A predictive model of these two miRNAs was created by the logistic regression analysis. The probability of this model was 89.71%. Based on the ROC curve, the specificity was 75.00%, and the sensitivity was 81.25%. Conclusions: The combination of miR-19a and miR-205 in the serum may predict the chemosensitivity of luminal A subtype of breast cancer to epirubicin plus paclitaxel neoadjuvant chemotherapy.	[Li, Qian; Ma, Fei; Luo, Yang; Cai, Ruigang; Xu, Binghe] Chinese Acad Med Sci, Inst Canc, Dept Med Oncol, Beijing 100021, Peoples R China; [Li, Qian; Liu, Mei; Ma, Fei; Luo, Yang; Cai, Ruigang; Wang, Liming; Xu, Ningzhi; Xu, Binghe] Chinese Acad Med Sci, Canc Hosp, Beijing 100021, Peoples R China; [Li, Qian; Liu, Mei; Ma, Fei; Luo, Yang; Cai, Ruigang; Wang, Liming; Xu, Ningzhi; Xu, Binghe] Peking Union Med Coll, Beijing 100021, Peoples R China; [Liu, Mei; Xu, Ningzhi] Chinese Acad Med Sci, Inst Canc, Lab Cell & Mol Biol, Beijing 100021, Peoples R China; [Liu, Mei; Xu, Ningzhi] Chinese Acad Med Sci, Inst Canc, State Key Lab Mol Oncol, Beijing 100021, Peoples R China; [Wang, Liming] Chinese Acad Med Sci, Inst Canc, Dept Abdominal Surg, Beijing 100021, Peoples R China; [Li, Qian] Peking Univ, Hosp 3, Dept Tumor Chemotherapy & Radiat Sickness, Beijing 100871, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking University	Xu, BH (corresponding author), Chinese Acad Med Sci, Inst Canc, Dept Med Oncol, Beijing 100021, Peoples R China.	bhxu@hotmail.com	Wang, Liming/AAD-7697-2020; Cai, Rui/GRO-1869-2022	Ma, Fei/0000-0001-9432-1902; li, qian/0000-0002-7204-0429	National Natural Science Foundation [81372830]; Beijing Hope Run Special Fund [LC2013L09]; Capital Clinical Feature Applied Research Fund [Z141107002514010]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Beijing Hope Run Special Fund; Capital Clinical Feature Applied Research Fund	This work was supported by National Natural Science Foundation grant (81372830), Beijing Hope Run Special Fund (LC2013L09) and Capital Clinical Feature Applied Research Fund (Z141107002514010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhargava R, 2010, CANCER-AM CANCER SOC, V116, P1431, DOI 10.1002/cncr.24876; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Choi BH, 2008, CANCER LETT, V259, P111, DOI 10.1016/j.canlet.2007.10.003; Coates AS, 2012, J CLIN ONCOL, V30, P1260, DOI 10.1200/JCO.2011.37.7879; Farazi TA, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r9; Godfrey AC, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3428; Hayes DF, 2012, J CLIN ONCOL, V30, P1264, DOI 10.1200/JCO.2011.38.4529; Healy NA, 2012, INT J CANCER, V131, P2215, DOI 10.1002/ijc.27642; Hu XW, 2013, MOL CANCER RES, V11, P240, DOI 10.1158/1541-7786.MCR-12-0432; Hu ZB, 2012, CARCINOGENESIS, V33, P828, DOI 10.1093/carcin/bgs030; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jung EJ, 2012, CANCER-AM CANCER SOC, V118, P2603, DOI 10.1002/cncr.26565; Kutanzi KR, 2011, CLIN EPIGENETICS, V2, P171, DOI 10.1007/s13148-011-0040-8; Le Quesne J, 2012, J PATHOL, V227, P306, DOI 10.1002/path.3983; Lee JT, 2004, CANCER RES, V64, P8397, DOI 10.1158/0008-5472.CAN-04-1612; Liang ZX, 2011, PHARM RES-DORDR, V28, P3091, DOI 10.1007/s11095-011-0570-y; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Markou A, 2014, CLIN CHEM, V60, P197, DOI 10.1373/clinchem.2013.210542; Mo WC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054775; Ogston KN, 2003, BREAST, V12, P320, DOI 10.1016/S0960-9776(03)00106-1; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Qi RQ, 2012, HEPATOLOGY, V55, P1640, DOI 10.1002/hep.25558; Sempere LF, 2007, CANCER RES, V67, P11612, DOI 10.1158/0008-5472.CAN-07-5019; Sochor M, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-448; Sun Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032115, 10.1371/journal.pone.0047003]; Takada T, 2005, DRUG METAB DISPOS, V33, P905, DOI 10.1124/dmd.104.003228; von Minckwitz G, 2013, CURR OPIN OBSTET GYN, V25, P66, DOI 10.1097/GCO.0b013e32835c0889; von Minckwitz G, 2011, BREAST, V20, pS142, DOI 10.1016/S0960-9776(11)70312-5; Wang HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034210; Wu HL, 2009, CELL RES, V19, P439, DOI 10.1038/cr.2009.18; Yao YS, 2014, ONCOL LETT, V7, P541, DOI 10.3892/ol.2013.1697; Ye XM, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-134	32	50	53	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e104870	10.1371/journal.pone.0104870	http://dx.doi.org/10.1371/journal.pone.0104870			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137071	gold, Green Published, Green Submitted			2022-12-25	WOS:000340742100050
J	Viluksela, M; Heikkinen, P; van der Ven, LTM; Rendel, F; Roos, R; Esteban, J; Korkalainen, M; Lensu, S; Miettinen, HM; Savolainen, K; Sankari, S; Lilienthal, H; Adamsson, A; Toppari, J; Herlin, M; Finnila, M; Tuukkanen, J; Leslie, HA; Hamers, T; Hamscher, G; Al-Anati, L; Stenius, U; Dervola, KS; Bogen, IL; Fonnum, F; Andersson, PL; Schrenk, D; Halldin, K; Hakansson, H				Viluksela, Matti; Heikkinen, Paivi; van der Ven, Leo T. M.; Rendel, Filip; Roos, Robert; Esteban, Javier; Korkalainen, Merja; Lensu, Sanna; Miettinen, Hanna M.; Savolainen, Kari; Sankari, Satu; Lilienthal, Hellmuth; Adamsson, Annika; Toppari, Jorma; Herlin, Maria; Finnila, Mikko; Tuukkanen, Juha; Leslie, Heather A.; Hamers, Timo; Hamscher, Gerd; Al-Anati, Lauy; Stenius, Ulla; Dervola, Kine-Susann; Bogen, Inger-Lise; Fonnum, Frode; Andersson, Patrik L.; Schrenk, Dieter; Halldin, Krister; Hakansson, Helen			Toxicological Profile of Ultrapure 2,2 ',3,4,4 ',5,5 '-Heptachlorbiphenyl (PCB 180) in Adult Rats	PLOS ONE			English	Article							DIOXIN-LIKE-PCBS; ARYL-HYDROCARBON RECEPTOR; DIBENZO-P-DIOXINS; POLYCHLORINATED-BIPHENYLS PCBS; THYROID-HORMONE; POSTNATAL EXPOSURE; IN-VITRO; DEVELOPMENTAL EXPOSURE; SUBCHRONIC TOXICITY; RETINOIC ACID	PCB 180 is a persistent non-dioxin-like polychlorinated biphenyl (NDL-PCB) abundantly present in food and the environment. Risk characterization of NDL-PCBs is confounded by the presence of highly potent dioxin-like impurities. We used ultrapure PCB 180 to characterize its toxicity profile in a 28-day repeat dose toxicity study in young adult rats extended to cover endocrine and behavioral effects. Using a loading dose/maintenance dose regimen, groups of 5 males and 5 females were given total doses of 0, 3, 10, 30, 100, 300, 1000 or 1700 mg PCB 180/kg body weight by gavage. Dose-responses were analyzed using benchmark dose modeling based on dose and adipose tissue PCB concentrations. Body weight gain was retarded at 1700 mg/kg during loading dosing, but recovered thereafter. The most sensitive endpoint of toxicity that was used for risk characterization was altered open field behavior in females; i.e. increased activity and distance moved in the inner zone of an open field suggesting altered emotional responses to unfamiliar environment and impaired behavioral inhibition. Other dose-dependent changes included decreased serum thyroid hormones with associated histopathological changes, altered tissue retinoid levels, decreased hematocrit and hemoglobin, decreased follicle stimulating hormone and luteinizing hormone levels in males and increased expression of DNA damage markers in liver of females. Dose-dependent hypertrophy of zona fasciculata cells was observed in adrenals suggesting activation of cortex. There were gender differences in sensitivity and toxicity profiles were partly different in males and females. PCB 180 adipose tissue concentrations were clearly above the general human population levels, but close to the levels in highly exposed populations. The results demonstrate a distinct toxicological profile of PCB 180 with lack of dioxin-like properties required for assignment of WHO toxic equivalency factor. However, PCB 180 shares several toxicological targets with dioxin-like compounds emphasizing the potential for interactions.	[Viluksela, Matti; Heikkinen, Paivi; Korkalainen, Merja; Lensu, Sanna; Miettinen, Hanna M.] Natl Inst Hlth & Welf, Dept Environm Hlth, Kuopio, Finland; [Viluksela, Matti] Univ Eastern Finland, Dept Environm Sci, Kuopio, Finland; [van der Ven, Leo T. M.] Natl Inst Publ Hlth & Environm, Ctr Hlth Protect, NL-3720 BA Bilthoven, Netherlands; [Rendel, Filip; Roos, Robert; Esteban, Javier; Herlin, Maria; Al-Anati, Lauy; Stenius, Ulla; Halldin, Krister; Hakansson, Helen] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Esteban, Javier] Univ Miguel Hernandez Elche, Inst Bioingn, Elche, Alicante, Spain; [Lensu, Sanna] Univ Jyvaskyla, Dept Biol Phys Act, SF-40100 Jyvaskyla, Finland; [Savolainen, Kari] ISLAB Lab Ctr, Kuopio, Finland; [Sankari, Satu] Univ Helsinki, Dept Equine & Small Anim Med, Helsinki, Finland; [Lilienthal, Hellmuth] Ruhr Univ Bochum, German Social Accid Insurance, IPA Inst Prevent & Occupat Med, Ctr Toxicol, Bochum, Germany; [Adamsson, Annika; Toppari, Jorma] Univ Turku, Dept Physiol, Turku, Finland; [Toppari, Jorma] Univ Turku, Dept Paediat, Turku, Finland; [Finnila, Mikko; Tuukkanen, Juha] Univ Oulu, Dept Anat & Cell Biol, Oulu, Finland; [Leslie, Heather A.; Hamers, Timo] Vrije Univ Amsterdam, Inst Environm Studies, Amsterdam, Netherlands; [Hamscher, Gerd] Univ Giessen, Inst Food Chem & Food Biotechnol, D-35390 Giessen, Germany; [Dervola, Kine-Susann; Bogen, Inger-Lise; Fonnum, Frode] Univ Oslo, Inst Basic Med Sci, Dept Biochem, Oslo, Norway; [Andersson, Patrik L.] Umea Univ, Dept Chem, Umea, Sweden; [Schrenk, Dieter] Univ Kaiserslautern, D-67663 Kaiserslautern, Germany	Finland National Institute for Health & Welfare; University of Eastern Finland; Netherlands National Institute for Public Health & the Environment; Karolinska Institutet; Universidad Miguel Hernandez de Elche; University of Jyvaskyla; University of Helsinki; Ruhr University Bochum; University of Turku; University of Turku; University of Oulu; Vrije Universiteit Amsterdam; Justus Liebig University Giessen; University of Oslo; Umea University; University of Kaiserslautern	Viluksela, M (corresponding author), Natl Inst Hlth & Welf, Dept Environm Hlth, Kuopio, Finland.	matti.viluksela@thl.fi	Esteban, Javier/A-5640-2019; Fonnum, Frode/S-4387-2019; Finnila, Mikko/X-6492-2019; Hamscher, Gerd/B-2100-2012; Hamers, Timo HM/L-2999-2013; Tuukkanen, Juha/R-3728-2018	Esteban, Javier/0000-0003-3760-8223; Hamers, Timo HM/0000-0002-5733-3290; Tuukkanen, Juha/0000-0002-1723-6461; Hakansson, Helen/0000-0002-7524-8209; Halldin, Krister/0000-0002-9838-4983; Finnila, Mikko/0000-0002-3348-5759; Noren Dervola, Kine Susann/0000-0002-0941-6948; Bogen, Inger Lise/0000-0003-2877-0624	European Commission (ATHON (Assessing the toxicity and hazards of NDL-PCBs present in food) [FOOD-CT-2005-022923]; National Fund Research, Luxembourg (FNR); Marie Curie Actions of the European Commission; Academy of Finland; Sigrid Juselius Foundation; Formas [2007-1524]	European Commission (ATHON (Assessing the toxicity and hazards of NDL-PCBs present in food); National Fund Research, Luxembourg (FNR)(Luxembourg National Research Fund); Marie Curie Actions of the European Commission(European Commission); Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Formas(Swedish Research Council Formas)	This study was funded by the European Commission (ATHON (Assessing the toxicity and hazards of NDL-PCBs present in food), FOOD-CT-2005-022923). The authors are solely responsible for the contents of this paper, which does not necessarily represent the opinion of the European Community. RR was also supported by the National Fund Research, Luxembourg (FNR) and co-funded under the Marie Curie Actions of the European Commission (FP7-COFUND), J. Toppari by the Academy of Finland and the Sigrid Juselius Foundation and KH by Formas (2007-1524). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Anati L, 2009, CHEM-BIOL INTERACT, V182, P191, DOI 10.1016/j.cbi.2009.09.004; ALLAIN CC, 1974, CLIN CHEM, V20, P470; Andreola F, 1997, CANCER RES, V57, P2835; BAUER PJ, 1981, ANAL BIOCHEM, V110, P61, DOI 10.1016/0003-2697(81)90112-3; BERGMEYER HU, 1974, METHOD ENZYMAT AN, P1794; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bloom MS, 2009, INT J HYG ENVIR HEAL, V212, P599, DOI 10.1016/j.ijheh.2009.04.005; Boas M, 2006, EUR J ENDOCRINOL, V154, P599, DOI 10.1530/eje.1.02128; Boix J, 2010, NEUROSCIENCE, V167, P994, DOI 10.1016/j.neuroscience.2010.02.068; Brouwer A, 1998, TOXICOL IND HEALTH, V14, P59, DOI 10.1177/074823379801400107; Brtko J, 2011, CURR DRUG METAB, V12, P71, DOI 10.2174/138920011795016881; Carreira SC, 2011, PLACENTA, V32, P283, DOI 10.1016/j.placenta.2010.12.024; Chauhan KR, 2000, TOXICOL APPL PHARM, V162, P10, DOI 10.1006/taap.1999.8826; CHU I, 1995, FUND APPL TOXICOL, V26, P282, DOI 10.1006/faat.1995.1099; Chu I, 1998, J APPL TOXICOL, V18, P285; Chu I, 1996, J APPL TOXICOL, V16, P121, DOI 10.1002/(SICI)1099-1263(199603)16:2<121::AID-JAT320>3.0.CO;2-G; Chu I, 1996, J TOXICOL ENV HEALTH, V49, P301, DOI 10.1080/009841096160844; CHU I, 1994, FUND APPL TOXICOL, V22, P457, DOI 10.1006/faat.1994.1051; Crofton KM, 2008, INT J ANDROL, V31, P209, DOI 10.1111/j.1365-2605.2007.00857.x; Crofton KM, 2005, ENVIRON HEALTH PERSP, V113, P1549, DOI 10.1289/ehp.8195; Danielsson C., 2008, ORGANOHALOGEN COMP, V70, P1201; EFSA, 2005, EFSA J, V263, P1, DOI DOI 10.2903/J.EFSA.2005.284; Esteban J, 2014, TOXICOL LETT, V229, P41, DOI 10.1016/j.toxlet.2014.04.021; FABINY DL, 1971, CLIN CHEM, V17, P696; FELASA, 1996, Lab Anim. (NY)., V30, P193; Fernandez MF, 2008, CHEMOSPHERE, V71, P1196, DOI 10.1016/j.chemosphere.2007.09.064; Fletcher N, 2005, TOXICOL SCI, V86, P264, DOI 10.1093/toxsci/kfi183; Gahrs M, 2013, TOXICOL APPL PHARM, V272, P77, DOI 10.1016/j.taap.2013.05.034; Gibaldi M, 1975, PHARMACOKINETICS; Gutleb AC, 2010, TOXICOL LETT, V192, P126, DOI 10.1016/j.toxlet.2009.10.008; HAAVISTO AM, 1993, ENDOCRINOLOGY, V132, P1687, DOI 10.1210/en.132.4.1687; Hallgren S, 2001, ARCH TOXICOL, V75, P200, DOI 10.1007/s002040000208; Hamers T, 2011, TOXICOL SCI, V121, P88, DOI 10.1093/toxsci/kfr043; Hany J, 1999, NEUROTOXICOL TERATOL, V21, P147, DOI 10.1016/S0892-0362(98)00038-5; Hassel B, 1997, J CEREBR BLOOD F MET, V17, P1230, DOI 10.1097/00004647-199711000-00012; Herlin M, 2010, TOXICOLOGY, V273, P1, DOI 10.1016/j.tox.2010.04.006; IPCS, 1994, ASS HUM HLTH RISKS C, P170; Jamsa T, 2001, J BONE MINER RES, V16, P1812, DOI 10.1359/jbmr.2001.16.10.1812; Jamsa T, 1998, BONE, V23, P155, DOI 10.1016/S8756-3282(98)00076-3; Jamsa T, 1999, J BONE MINER RES, V14, P1708, DOI 10.1359/jbmr.1999.14.10.1708; Johannessen CU, 2001, EPILEPSY RES, V47, P247, DOI 10.1016/S0920-1211(01)00308-4; Johansen EB, 2011, BEHAV BRAIN FUNCT, V7, DOI 10.1186/1744-9081-7-18; Kiviranta H, 2002, ENVIRON HEALTH PERSP, V110, P355, DOI 10.1289/ehp.02110355; Kiviranta H, 2005, CHEMOSPHERE, V60, P854, DOI 10.1016/j.chemosphere.2005.01.064; Knerr S, 2006, CRIT REV TOXICOL, V36, P663, DOI 10.1080/10408440600845304; KONTUR PJ, 1994, J NEUROCHEM, V62, P282; LANS MC, 1993, CHEM-BIOL INTERACT, V88, P7, DOI 10.1016/0009-2797(93)90081-9; Lecavalier P, 1997, J TOXICOL ENV HEALTH, V51, P265, DOI 10.1080/00984109708984026; Lee DW, 2012, TOXICOL SCI, V125, P496, DOI 10.1093/toxsci/kfr313; Lilienthal H, 2013, TOXICOLOGY, V311, P52, DOI 10.1016/j.tox.2013.01.025; Linden J, 2010, FRONT NEUROENDOCRIN, V31, P452, DOI 10.1016/j.yfrne.2010.07.002; Lundberg R, 2006, TOXICOLOGY, V228, P33, DOI 10.1016/j.tox.2006.08.016; Mariussen E, 2002, TOXICOL APPL PHARM, V179, P137, DOI 10.1006/taap.2002.9353; Miller MD, 2009, ENVIRON HEALTH PERSP, V117, P1033, DOI 10.1289/ehp.0800247; Minzenberg MJ, 2012, NEUROTHERAPEUTICS, V9, P610, DOI 10.1007/s13311-012-0128-7; MORSE DC, 1995, CHEM-BIOL INTERACT, V95, P41, DOI 10.1016/0009-2797(94)03347-1; Morse DC, 1996, TOXICOL APPL PHARM, V136, P269, DOI 10.1006/taap.1996.0034; Nishimura N, 2005, ARCH TOXICOL, V79, P260, DOI 10.1007/s00204-004-0626-4; Novak J, 2008, ENVIRON INT, V34, P898, DOI 10.1016/j.envint.2007.12.024; NTP (National Toxicology Programe), 2006, NIH PUBL; Oberg M, 2002, TOXICOL SCI, V70, P171, DOI 10.1093/toxsci/70.2.171; OECD, 2006, OECD SER TEST ASS, V57; Park HY, 2009, ENVIRON HEALTH PERSP, V117, P1600, DOI 10.1289/ehp.0900611; Rice DC, 1998, NEUROTOXICOL TERATOL, V20, P391, DOI 10.1016/S0892-0362(97)00134-7; Rice DC, 2005, EFSA J, V284, P1; Ritter R, 2011, ENVIRON HEALTH PERSP, V119, P225, DOI 10.1289/ehp.1002211; Roegge CS, 2006, NEUROTOXICOL TERATOL, V28, P260, DOI 10.1016/j.ntt.2005.12.009; Roos R, 2011, TOXICOLOGY, V284, P42, DOI 10.1016/j.tox.2011.03.013; Sable HJK, 2009, NEUROTOXICOL TERATOL, V31, P149, DOI 10.1016/j.ntt.2008.12.006; Sagiv SK, 2012, ENVIRON HEALTH PERSP, V120, P904, DOI 10.1289/ehp.1104372; Sagiv SK, 2010, AM J EPIDEMIOL, V171, P593, DOI 10.1093/aje/kwp427; Schmidt CK, 2003, ARCH TOXICOL, V77, P371, DOI 10.1007/s00204-003-0457-8; Schuchardt JP, 2009, FEBS J, V276, P3043, DOI 10.1111/j.1742-4658.2009.07023.x; Simon E, 2013, ENVIRON SCI TECHNOL, V47, P8902, DOI 10.1021/es401696u; Simon E, 2011, ENVIRON SCI TECHNOL, V45, P7936, DOI 10.1021/es2016389; Slob W, 2002, TOXICOL SCI, V66, P298, DOI 10.1093/toxsci/66.2.298; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Stenberg M, 2008, CHEMOSPHERE, V71, P1909, DOI 10.1016/j.chemosphere.2008.01.007; Stenberg M, 2011, CHEMOSPHERE, V85, P1423, DOI 10.1016/j.chemosphere.2011.08.019; Stewart P, 2003, ENVIRON HEALTH PERSP, V111, P1670, DOI 10.1289/ehp.6173; Tanabe S, 2002, MAR POLLUT BULL, V45, P69, DOI 10.1016/S0025-326X(02)00175-3; Theodosiou M, 2010, CELL MOL LIFE SCI, V67, P1423, DOI 10.1007/s00018-010-0268-z; Tian YH, 2011, SYNAPSE, V65, P1032, DOI 10.1002/syn.20934; TRINDER P., 1969, Journal of Clinical Pathology, V22, P158, DOI 10.1136/jcp.22.2.158; Tripp G, 2012, NEUROTHERAPEUTICS, V9, P622, DOI 10.1007/s13311-012-0132-y; US EPA, 2012, EPA600R10038F, V1; van Casteren JIJ, 2000, BIOL REPROD, V62, P886, DOI 10.1095/biolreprod62.4.886; Van den Berg M, 2006, TOXICOL SCI, V93, P223, DOI 10.1093/toxsci/kfl055; VANLEEUWEN FXR, 2002, ORGANOHALOGEN COMPD, V56, P311; Viluksela M, 1997, TOXICOL APPL PHARM, V146, P207, DOI 10.1006/taap.1997.8239; Viluksela M, 1998, TOXICOL APPL PHARM, V151, P57, DOI 10.1006/taap.1998.8384; Virtanen HE, 2012, INT J ANDROL, V35, P283, DOI 10.1111/j.1365-2605.2011.01233.x; VONEULER G, 1991, BRAIN RES, V561, P93, DOI 10.1016/0006-8993(91)90753-I; Wahlefeld A.W., 1974, DETERMINATION SERUM, P1831; Wimmerova S, 2011, CHEMOSPHERE, V82, P687, DOI 10.1016/j.chemosphere.2010.10.099; Yoshinari K, 2001, MOL PHARMACOL, V59, P278, DOI 10.1124/mol.59.2.278	96	22	22	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e104639	10.1371/journal.pone.0104639	http://dx.doi.org/10.1371/journal.pone.0104639			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137063	Green Published, gold, Green Submitted			2022-12-25	WOS:000340742100041
J	Watson, M; Hawkes, E; Meyer, P				Watson, Michael; Hawkes, Emily; Meyer, Peter			Transmission of Epi-Alleles with MET1-Dependent Dense Methylation in Arabidopsis thaliana	PLOS ONE			English	Article							DNA METHYLATION; EPIGENETIC VARIATION; CPG METHYLATION; INHERITANCE; STABILITY; PATTERNS; MUTATION; METHYLTRANSFERASES; IMMOBILIZATION; EPIGENOME	DNA methylation in plants targets cytosines in three sequence contexts, CG, CHG and CHH (H representing A, C or T). Each of these patterns has traditionally been associated with distinct DNA methylation pathways with CHH methylation being controlled by the RNA dependent DNA methylation (RdDM) pathway employing small RNAs as a guide for the de novo DOMAINS REARRANGED METHYLTRANSFERASE (DRM2), and maintenance DNA METHYLTRANSFERASE1 (MET1) being responsible for faithful propagation of CG methylation. Here we report an unusual 'dense methylation' pattern under the control of MET1, with methylation in all three sequence contexts. We identified epi-alleles of dense methylation at a non coding RNA locus (At4g15242) in Arabidopsis ecotypes, with distinct dense methylation and expression characteristics, which are stably maintained and transmitted in genetic crosses and which can be heritably altered by depletion of MET1. This suggests that, in addition to its classical CG maintenance function, at certain loci MET1 plays a role in creating transcriptional diversity based on the generation of independent epi-alleles. Database inspection identified several other loci with MET1-dependent dense methylation patterns. Arabidopsis ecotypes contain distinct epi-alleles of these loci with expression patterns that inversely correlate with methylation density, predominantly within the transcribed region. In Arabidopsis, dense methylation appears to be an exception as it is only found at a small number of loci. Its presence does, however, highlight the potential for MET1 as a contributor to epigenetic diversity, and it will be interesting to investigate the representation of dense methylation in other plant species.	[Watson, Michael; Hawkes, Emily; Meyer, Peter] Univ Leeds, Ctr Plant Sci, Leeds, W Yorkshire, England	University of Leeds	Meyer, P (corresponding author), Univ Leeds, Ctr Plant Sci, Leeds, W Yorkshire, England.	p.meyer@leeds.ac.uk			BBSRC Case studentship	BBSRC Case studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	MW was supported by a BBSRC Case studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker C, 2011, NATURE, V480, P245, DOI 10.1038/nature10555; Boyko A, 2007, NUCLEIC ACIDS RES, V35, P1714, DOI 10.1093/nar/gkm029; Cao XF, 2003, CURR BIOL, V13, P2212, DOI 10.1016/j.cub.2003.11.052; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Cubas P, 1999, NATURE, V401, P157, DOI 10.1038/43657; DAS OP, 1994, GENETICS, V136, P1121; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; Finnegan EJ, 2002, CURR OPIN PLANT BIOL, V5, P101, DOI 10.1016/S1369-5266(02)00233-9; Finnegan EJ, 1996, P NATL ACAD SCI USA, V93, P8449, DOI 10.1073/pnas.93.16.8449; Greaves IK, 2014, P NATL ACAD SCI USA, V111, P2017, DOI 10.1073/pnas.1323656111; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Hetzl J, 2007, PLANT J, V51, P526, DOI 10.1111/j.1365-313X.2007.03152.x; Huettel B, 2007, BBA-GENE STRUCT EXPR, V1769, P358, DOI 10.1016/j.bbaexp.2007.03.001; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jullien PE, 2008, PLOS BIOL, V6, P1693, DOI 10.1371/journal.pbio.0060194; Kakutani T, 1999, GENETICS, V151, P831; Kato M, 2003, CURR BIOL, V13, P421, DOI 10.1016/S0960-9822(03)00106-4; Kinoshita Y, 2007, PLANT J, V49, P38, DOI 10.1111/j.1365-313X.2006.02936.x; Kou HP, 2011, J PLANT PHYSIOL, V168, P1685, DOI 10.1016/j.jplph.2011.03.017; Kovarik A, 1997, THEOR APPL GENET, V95, P301, DOI 10.1007/s001220050563; Lira-Medeiros CF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010326; Lopez-Maury L, 2008, NAT REV GENET, V9, P583, DOI 10.1038/nrg2398; Manning K, 2006, NAT GENET, V38, P948, DOI 10.1038/ng1841; Mathieu O, 2007, CELL, V130, P851, DOI 10.1016/j.cell.2007.07.007; Matzke M, 2009, CURR OPIN CELL BIOL, V21, P367, DOI 10.1016/j.ceb.2009.01.025; Mirouze M, 2012, P NATL ACAD SCI USA, V109, P5880, DOI 10.1073/pnas.1120841109; Miura K, 2009, P NATL ACAD SCI USA, V106, P11218, DOI 10.1073/pnas.0901942106; O'Malley R C, 2012, Cold Spring Harb Symp Quant Biol, V77, P135, DOI 10.1101/sqb.2012.77.014571; Reinders J, 2009, GENE DEV, V23, P939, DOI 10.1101/gad.524609; Rhee SY, 2003, NUCLEIC ACIDS RES, V31, P224, DOI 10.1093/nar/gkg076; Richards EJ, 2006, NAT REV GENET, V7, P395, DOI 10.1038/nrg1834; Saze H, 2003, NAT GENET, V34, P65, DOI 10.1038/ng1138; Schmitz RJ, 2013, GENOME RES, V23, P1663, DOI 10.1101/gr.152538.112; Schmitz RJ, 2013, NATURE, V495, P193, DOI 10.1038/nature11968; Silveira AB, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003437; Stam M, 2000, PLANT J, V21, P27, DOI 10.1046/j.1365-313x.2000.00650.x; Stroud H, 2013, CELL, V152, P352, DOI 10.1016/j.cell.2012.10.054; Tariq M, 2003, P NATL ACAD SCI USA, V100, P8823, DOI 10.1073/pnas.1432939100; Teixeira FK, 2009, SCIENCE, V323, P1600, DOI 10.1126/science.1165313; Vejlupkova Z., 2003, Maize Genetics Cooperation Newsletter, P24; Yao YL, 2012, PLANT CELL REP, V31, P1549, DOI 10.1007/s00299-012-1269-1; You WH, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-51; Zemach A, 2013, CELL, V153, P193, DOI 10.1016/j.cell.2013.02.033	43	13	13	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105338	10.1371/journal.pone.0105338	http://dx.doi.org/10.1371/journal.pone.0105338			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137154	Green Published, gold			2022-12-25	WOS:000340742100087
J	Zhang, J; Carnduff, L; Norman, G; Josey, T; Wang, YS; Sawyer, TW; Martyniuk, CJ; Langlois, VS				Zhang, Jing; Carnduff, Lisa; Norman, Grant; Josey, Tyson; Wang, Yushan; Sawyer, Thomas W.; Martyniuk, Christopher J.; Langlois, Valerie S.			Transcriptional Profiling in Rat Hair Follicles following Simulated Blast Insult: A New Diagnostic Tool for Traumatic Brain Injury	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; GENE-EXPRESSION; INFLAMMATORY RESPONSE; CEREBROSPINAL-FLUID; ENRICHMENT ANALYSIS; CEREBRAL-ISCHEMIA; GENOMIC PROFILE; HEAD-INJURY; APOPTOSIS; CALCIUM	With wide adoption of explosive-dependent weaponry during military activities, Blast-induced neurotrauma (BINT)-induced traumatic brain injury (TBI) has become a significant medical issue. Therefore, a robust and accessible biomarker system is in demand for effective and efficient TBI diagnosis. Such systems will also be beneficial to studies of TBI pathology. Here we propose the mammalian hair follicles as a potential candidate. An Advanced Blast Simulator (ABS) was developed to generate shock waves simulating traumatic conditions on brains of rat model. Microarray analysis was performed in hair follicles to identify the gene expression profiles that are associated with shock waves. Gene set enrichment analysis (GSEA) and sub-network enrichment analysis (SNEA) were used to identify cell processes and molecular signaling cascades affected by simulated bomb blasts. Enrichment analyses indicated that genes with altered expression levels were involved in central nervous system (CNS)/peripheral nervous system (PNS) responses as well as signal transduction including Ca2+, K+-transportation-dependent signaling, Toll-Like Receptor (TLR) signaling and Mitogen Activated Protein Kinase (MAPK) signaling cascades. Many of the pathways identified as affected by shock waves in the hair follicles have been previously reported to be TBI responsive in other organs such as brain and blood. The results suggest that the hair follicle has some common TBI responsive molecular signatures to other tissues. Moreover, various TBI-associated diseases were identified as preferentially affected using a gene network approach, indicating that the hair follicle may be capable of reflecting comprehensive responses to TBI conditions. Accordingly, the present study demonstrates that the hair follicle is a potentially viable system for rapid and non-invasive TBI diagnosis.	[Zhang, Jing; Carnduff, Lisa; Norman, Grant; Langlois, Valerie S.] Royal Mil Coll Canada, Dept Chem & Chem Engn, Kingston, ON, Canada; [Josey, Tyson; Wang, Yushan; Sawyer, Thomas W.] Def Res & Dev Canada Suffield, Medicine Hat, AB, Canada; [Martyniuk, Christopher J.] Univ New Brunswick, Fredericton, NB, Canada; [Martyniuk, Christopher J.] Canadian River Inst, Fredericton, NB, Canada	Royal Military College - Canada; University of New Brunswick	Langlois, VS (corresponding author), Royal Mil Coll Canada, Dept Chem & Chem Engn, Kingston, ON, Canada.	valerie.langlois@rmc.ca	Zhang, Jing/F-4468-2017	Zhang, Jing/0000-0002-6076-7321; Langlois, Valerie S./0000-0003-4031-6838; Martyniuk, Christopher J./0000-0003-0921-4796	Defence Research and Development Canada (DRDC) Technology Investment Fund (TIF)	Defence Research and Development Canada (DRDC) Technology Investment Fund (TIF)	This research was supported by the Defence Research and Development Canada (DRDC) Technology Investment Fund (TIF), http://www.drdc-rddc.gc.ca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054657; Akins PT, 1996, STROKE, V27, P1682, DOI 10.1161/01.STR.27.9.1682; [Anonymous], 2004, SCI STKE; Arck PC, 2003, AM J PATHOL, V162, P803, DOI 10.1016/S0002-9440(10)63877-1; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergad PL, 2000, AM J PHYSIOL-CELL PH, V279, pC1906, DOI 10.1152/ajpcell.2000.279.6.C1906; Berger RP, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e31; Botchkarev VA, 2003, J EXP ZOOL PART B, V298B, P164, DOI 10.1002/jez.b.00033; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Brea D, 2011, J CEREBR BLOOD F MET, V31, P1424, DOI 10.1038/jcbfm.2010.231; Cao R, 2006, NEUROSCI LETT, V401, P136, DOI 10.1016/j.neulet.2006.03.005; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chen Y, 2013, J NEUROPSYCH CLIN N, V25, P103, DOI 10.1176/appi.neuropsych.12030058; Chen Y, 2011, BRAIN INJURY, V25, P641, DOI 10.3109/02699052.2011.580313; Chishti YZ, 2013, GEN COMP ENDOCR, V192, P115, DOI 10.1016/j.ygcen.2013.04.033; Choi HI, 2011, BRIT J DERMATOL, V165, P1183, DOI 10.1111/j.1365-2133.2011.10625.x; Crack P, 2009, J NEURAL TRANSM, V116, P1, DOI 10.1007/s00702-008-0145-1; De Preter K, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn114; Defense and Veterans Brain Injury Center (DVBIC), 2013, DOD WORLDW NUMB TBI; Defense Manpower Data Center (DMDC), 2008, GLOB WAR TERR CAUS R; Denninger JW, 1999, BBA-BIOENERGETICS, V1411, P334, DOI 10.1016/S0005-2728(99)00024-9; DIXON CE, 1995, BEHAV BRAIN RES, V70, P125, DOI 10.1016/0166-4328(95)80002-6; Doggrell SA, 1998, CARDIOVASC RES, V39, P89, DOI 10.1016/S0008-6363(98)00076-5; DRAGUNOW M, 1995, BRAIN RES REV, V21, P1, DOI 10.1016/0165-0173(95)00003-L; Elsayed NM, 1996, EXP LUNG RES, V22, P179, DOI 10.3109/01902149609050846; Ermak G, 2002, MOL IMMUNOL, V38, P713, DOI 10.1016/S0161-5890(01)00108-0; Foley LM, 2013, J CEREBR BLOOD F MET, V33, P129, DOI 10.1038/jcbfm.2012.145; Garrett MR, 2003, MAMM GENOME, V14, P268, DOI 10.1007/s00335-002-2245-9; Gilibert S, 2009, J HYPERTENS, V27, P1186, DOI 10.1097/HJH.0b013e328329e4c0; Goldsmith ZG, 2007, ONCOGENE, V26, P3122, DOI 10.1038/sj.onc.1210407; He M, 2013, CHIN J TRAUMATOL, V16, P136, DOI 10.3760/cma.j.issn.1008-1275.2013.03.002; Heim MH, 1999, J RECEPT SIGNAL TR R, V19, P75, DOI 10.3109/10799899909036638; Hnasko TS, 2012, ANNU REV PHYSIOL, V74, P225, DOI 10.1146/annurev-physiol-020911-153315; Hua F, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-42; Kim SJ, 2006, ANN CLIN LAB SCI, V36, P115; Langlois VS, 2013, MECH DEVELOP, V130, P304, DOI 10.1016/j.mod.2012.12.002; Laurer HL, 1999, CURR OPIN NEUROL, V12, P715, DOI 10.1097/00019052-199912000-00010; Leist M, 1998, EXP CELL RES, V239, P183, DOI 10.1006/excr.1997.4026; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Lozada A, 2005, NEUROPATH APPL NEURO, V31, P150, DOI 10.1111/j.1365-2990.2004.00622.x; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI [10.2735/3489, 10.2741/3489]; Maejima D, 2011, MICROCIRCULATION, V18, P474, DOI 10.1111/j.1549-8719.2011.00108.x; Magnuson J, 2012, CURR NEUROL NEUROSCI, V12, P570, DOI 10.1007/s11910-012-0303-6; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; McMahon CG, 2008, CRIT CARE MED, V36, P216, DOI 10.1097/01.CCM.0000295425.41831.85; Mishra A, 2010, INT J CANCER, V126, P819, DOI 10.1002/ijc.24807; Moreno C, 2011, AM J PHYSIOL-HEART C, V300, pH1530, DOI 10.1152/ajpheart.01026.2010; Mori T, 2002, J CEREBR BLOOD F MET, V22, P444, DOI 10.1097/00004647-200204000-00008; Mott FW, 1916, LANCET, V1, P331; Naor Z, 2000, TRENDS ENDOCRIN MET, V11, P91, DOI 10.1016/S1043-2760(99)00232-5; Oliva AA, 2012, J NEUROCHEM, V120, P710, DOI 10.1111/j.1471-4159.2011.07610.x; Olson N Eric, 2006, NeuroRx, V3, P373; Pages G, 2005, CARDIOVASC RES, V65, P564, DOI 10.1016/j.cardiores.2004.09.032; Paus R, 1999, NEW ENGL J MED, V341, P491, DOI 10.1056/NEJM199908123410706; Pelletier S, 2003, MOL CELL BIOL, V23, P1316, DOI 10.1128/MCB.23.4.1316-1333.2003; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; Reed J. C., 2004, SCI STKE, V2004, pre9, DOI DOI 10.1126/STKE.2392004RE9; Reinert M, 2000, J NEUROSURG, V93, P800, DOI 10.3171/jns.2000.93.5.0800; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; Ritzel D, 2011, MIL VET HLTH RES FOR; Sabroe I, 2008, J PATHOL, V214, P126, DOI 10.1002/path.2264; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Shively SB, 2012, J HEAD TRAUMA REHAB, V27, P234, DOI 10.1097/HTR.0b013e318250e9dd; Simard JM, 2010, J NEUROSURG, V113, P622, DOI 10.3171/2009.11.JNS081052; Sivachenko AY, 2007, J BIOINF COMPUT BIOL, V5, P429, DOI 10.1142/S0219720007002795; STENN KS, 1994, J INVEST DERMATOL, V103, P107, DOI 10.1111/1523-1747.ep12391844; Stenn KS, 2001, PHYSIOL REV, V81, P449, DOI 10.1152/physrev.2001.81.1.449; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sullivan PG, 1998, J NEUROTRAUM, V15, P789, DOI 10.1089/neu.1998.15.789; Sun DA, 2008, EUR J NEUROSCI, V27, P1659, DOI 10.1111/j.1460-9568.2008.06156.x; Svetlov SI, 2009, J NEUROTRAUM, V26, P913, DOI 10.1089/neu.2008.0609; Truettner JS, 2007, J NEUROTRAUM, V24, P599, DOI 10.1089/neu.2006.0186; Vassart G, 2011, NAT REV ENDOCRINOL, V7, P362, DOI 10.1038/nrendo.2011.20; Wang SJ, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat046; Wang YF, 2012, J NEUROSCI, V32, P713, DOI 10.1523/JNEUROSCI.3872-11.2012; Weber JT, 2004, CURR NEUROVASC RES, V1, P151, DOI 10.2174/1567202043480134; White TE, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-282; Wong J, 2005, NEUROCRIT CARE, V3, P177, DOI 10.1385/NCC:3:2:177; Yamada T, 2010, UROLOGY, V76, DOI 10.1016/j.urology.2010.03.029; Yeh DD, 2012, WORLD J SURG, V36, P966, DOI 10.1007/s00268-012-1500-9; Yeoh S, 2013, ANN BIOMED ENG, V41, P2206, DOI 10.1007/s10439-013-0805-7; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9	83	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e104518	10.1371/journal.pone.0104518	http://dx.doi.org/10.1371/journal.pone.0104518			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136963	Green Submitted, Green Published, gold			2022-12-25	WOS:000340742100039
J	Chen, QR; Hu, Y; Yan, CH; Buetow, K; Meerzaman, D				Chen, Qing-Rong; Hu, Ying; Yan, Chunhua; Buetow, Kenneth; Meerzaman, Daoud			Systematic Genetic Analysis Identifies Cis-eQTL Target Genes Associated with Glioblastoma Patient Survival	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; EXPRESSION; SUSCEPTIBILITY; POLYMORPHISMS; GLIOMA; CELLS; RISK	Prior expression quantitative trait locus (eQTL) studies have demonstrated heritable variation determining differences in gene expression. The majority of eQTL studies were based on cell lines and normal tissues. We performed cis-eQTL analysis using glioblastoma multiforme (GBM) data sets obtained from The Cancer Genome Atlas (TCGA) to systematically investigate germline variation's contribution to tumor gene expression levels. We identified 985 significant cis-eQTL associations (FDR<0.05) mapped to 978 SNP loci and 159 unique genes. Approximately 57% of these eQTLs have been previously linked to the gene expression in cell lines and normal tissues; 43% of these share cis associations known to be associated with functional annotations. About 25% of these cis-eQTL associations are also common to those identified in Breast Cancer from a recent study. Further investigation of the relationship between gene expression and patient clinical information identified 13 eQTL genes whose expression level significantly correlates with GBM patient survival (p<0.05). Most of these genes are also differentially expressed in tumor samples and organ-specific controls (p<0.05). Our results demonstrated a significant relationship of germline variation with gene expression levels in GBM. The identification of eQTLs-based expression associated survival might be important to the understanding of genetic contribution to GBM cancer prognosis.	[Chen, Qing-Rong; Hu, Ying; Yan, Chunhua; Buetow, Kenneth; Meerzaman, Daoud] NIH, Natl Canc Inst, Ctr Biomed Informat & Informat Technol, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Chen, QR (corresponding author), NIH, Natl Canc Inst, Ctr Biomed Informat & Informat Technol, Bldg 10, Bethesda, MD 20892 USA.	chenqi@mail.nih.gov						Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Boyle LH, 2013, P NATL ACAD SCI USA, V110, P3465, DOI 10.1073/pnas.1222342110; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Cheung VG, 2003, NAT GENET, V33, P422, DOI 10.1038/ng1094; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Coutinho P, 2010, GENET MOL RES, V9, P539, DOI 10.4238/vol9-1gmr753; Cunningham TD, 2007, CELL IMMUNOL, V245, P32, DOI 10.1016/j.cellimm.2007.03.004; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; ELEXPURUCAMIRUAGA J, 1995, CANCER RES, V55, P4237; Grisanzio C, 2012, P NATL ACAD SCI USA, V109, P11252, DOI 10.1073/pnas.1200853109; Gunes C, 2013, CELL, V152, P390, DOI 10.1016/j.cell.2013.01.010; Kappei D, 2013, EMBO J, V32, P1681, DOI 10.1038/emboj.2013.105; Kim YA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001095; Lai R, 2005, CANCER EPIDEM BIOMAR, V14, P1784, DOI 10.1158/1055-9965.EPI-05-0105; Li QY, 2013, CELL, V152, P633, DOI 10.1016/j.cell.2012.12.034; Loo LWM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030477; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Quigley DA, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r5; Rajaraman P, 2012, HUM GENET, V131, P1877, DOI 10.1007/s00439-012-1212-0; Rousalova I, 2010, INT J ONCOL, V36, P275, DOI 10.3892/ijo_00000498; Saraiva N, 2013, J CELL BIOL, V202, P699, DOI 10.1083/jcb.201301016; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; Shpak M, 2014, GENOMICS, V103, P252, DOI 10.1016/j.ygeno.2014.02.005; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Wuchty S, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-11; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693	34	38	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105393	10.1371/journal.pone.0105393	http://dx.doi.org/10.1371/journal.pone.0105393			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133526	Green Published, Green Submitted, gold			2022-12-25	WOS:000341302700111
J	Durand, MT; Becari, C; de Oliveira, M; do Carmo, JM; Silva, CAA; Prado, CM; Fazan, R; Salgado, HC				Durand, Marina T.; Becari, Christiane; de Oliveira, Mauro; do Carmo, Jussara M.; Aguiar Silva, Carlos Alberto; Prado, Cibele M.; Fazan, Rubens, Jr.; Salgado, Helio C.			Pyridostigmine Restores Cardiac Autonomic Balance after Small Myocardial Infarction in Mice	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; CHOLINERGIC STIMULATION; VENTRICULAR-FUNCTION; ACETYLCHOLINESTERASE INHIBITION; PARASYMPATHETIC CONTROL; VAGAL-STIMULATION; MAXIMAL EXERCISE; FAILURE; IMPROVES; MODULATION	The effect of pyridostigmine (PYR) - an acetylcholinesterase inhibitor - on hemodynamics and cardiac autonomic control, was never studied in conscious myocardial infarcted mice. Telemetry transmitters were implanted into the carotid artery under isoflurane anesthesia. Seven to ten days after recovery from the surgery, basal arterial pressure and heart rate were recorded, while parasympathetic and sympathetic tone (Delta HR) was evaluated by means of methyl atropine and propranolol. After the basal hemodynamic recording the mice were subjected to left coronary artery ligation for producing myocardial infarction (MI), or sham operation, and implantation of minipumps filled with PYR or saline. Separate groups of anesthetized (isoflurane) mice previously (4 weeks) subjected to MI, or sham coronary artery ligation, were submitted to cardiac function examination. The mice exhibited an infarct length of approximately 12%, no change in arterial pressure and increased heart rate only in the 1st week after MI. Vagal tone decreased in the 1 st week, while the sympathetic tone was increased in the 1 st and 4 th week after MI. PYR prevented the increase in heart rate but did not affect the arterial pressure. Moreover, PYR prevented the increase in sympathetic tone throughout the 4 weeks. Concerning the parasympathetic tone, PYR not only impaired its attenuation in the 1 st week, but enhanced it in the 4 th week. MI decreased ejection fraction and increased diastolic and systolic volume. Therefore, the pharmacological increase of peripheral acetylcholine availability by means of PYR prevented tachycardia, increased parasympathetic and decreased sympathetic tone after MI in mice.	[Durand, Marina T.; Becari, Christiane; de Oliveira, Mauro; Aguiar Silva, Carlos Alberto; Fazan, Rubens, Jr.; Salgado, Helio C.] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Physiol, Ribeirao Preto, SP, Brazil; [Prado, Cibele M.] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Pathol, Ribeirao Preto, SP, Brazil; [do Carmo, Jussara M.] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Jackson, MS 39216 USA	Universidade de Sao Paulo; Universidade de Sao Paulo; University of Mississippi; University of Mississippi Medical Center	Salgado, HC (corresponding author), Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Physiol, Ribeirao Preto, SP, Brazil.	hcsalgado@fmrp.usp.br	Becari, Christiane/ABE-7066-2021; Junior, Rubens Fazan/V-3114-2019; Durand, Marina/AAH-2846-2020; Becari, Christiane/J-6895-2015; Prado, Cibele M/P-5773-2016	Becari, Christiane/0000-0001-8548-9674; Junior, Rubens Fazan/0000-0002-6200-6008; Durand, Marina/0000-0002-5625-4662; Prado, Cibele M/0000-0003-4321-0879	Fapesp [2012/03349-1]; NAP-NIC-USP [12.1.24345.01.0]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104357] Funding Source: NIH RePORTER	Fapesp(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NAP-NIC-USP; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding for this work came from Fapesp (2012/03349-1), NAP-NIC-USP (12.1.24345.01.0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn D, 2004, AM J PHYSIOL-HEART C, V286, pH1201, DOI 10.1152/ajpheart.00862.2003; Androne AS, 2003, HEART, V89, P854, DOI 10.1136/heart.89.8.854; Arenja N, 2013, AM J MED, V126, P515, DOI 10.1016/j.amjmed.2012.11.028; Azevedo ER, 1999, CIRCULATION, V100, P274, DOI 10.1161/01.CIR.100.3.274; Behling A, 2003, AM HEART J, V146, P494, DOI 10.1016/S0002-8703(03)00319-3; Bernatova I, 2003, PHARMACOL BIOCHEM BE, V74, P901, DOI 10.1016/S0091-3057(03)00012-1; Bibevski S, 2011, HEART FAIL REV, V16, P129, DOI 10.1007/s10741-010-9190-6; BINKLEY PF, 1991, J AM COLL CARDIOL, V18, P464, DOI 10.1016/0735-1097(91)90602-6; Bridgman P, 2005, AM J PHYSIOL-HEART C, V289, pH586, DOI 10.1152/ajpheart.00474.2004; Butz GM, 2001, PHYSIOL GENOMICS, V5, P89, DOI 10.1152/physiolgenomics.2001.5.2.89; Carlson SH, 2000, HYPERTENSION, V35, pE1, DOI 10.1161/01.HYP.35.2.e1; Castro RRT, 2006, INT J CARDIOL, V107, P138, DOI 10.1016/j.ijcard.2005.01.035; Castro RRT, 2004, HEART, V90, P1119, DOI 10.1136/hrt.2003.028167; De Ferrari GM, 2011, HEART FAIL REV, V16, P195, DOI 10.1007/s10741-010-9216-0; de La Fuente RN, 2013, CLIN EXP PHARMACOL P, V40, P610, DOI 10.1111/1440-1681.12121; Desai MY, 2011, HEART FAIL REV, V16, P179, DOI 10.1007/s10741-010-9195-1; Dewland TA, 2007, AM J PHYSIOL-HEART C, V293, pH86, DOI 10.1152/ajpheart.01339.2006; Dunlap ME, 2003, AM J PHYSIOL-HEART C, V285, pH1632, DOI 10.1152/ajpheart.01051.2002; ECKBERG DL, 1971, NEW ENGL J MED, V285, P877, DOI 10.1056/NEJM197110142851602; Handa T, 2009, J CARD FAIL, V15, P805, DOI 10.1016/j.cardfail.2009.05.008; Hauptman PJ, 2012, AM HEART J, V163, P954, DOI 10.1016/j.ahj.2012.03.021; Higuchi MD, 1999, J CARDIAC SURG, V14, P401; Infanger DW, 2010, CIRC RES, V106, P1763, DOI 10.1161/CIRCRESAHA.109.213025; Ishise H, 1998, J APPL PHYSIOL, V84, P1234, DOI 10.1152/jappl.1998.84.4.1234; Katare RG, 2010, J MOL CELL CARDIOL, V49, P234, DOI 10.1016/j.yjmcc.2010.03.007; Kumashiro H, 1999, BASIC RES CARDIOL, V94, P78, DOI 10.1007/s003950050129; LaCroix C, 2008, AM J PHYSIOL-HEART C, V294, pH810, DOI 10.1152/ajpheart.00724.2007; Lara A, 2010, MOL CELL BIOL, V30, P1746, DOI 10.1128/MCB.00996-09; Lataro RM, 2013, AM J PHYSIOL-REG I, V305, pR908, DOI 10.1152/ajpregu.00102.2013; LEVY MN, 1971, CIRC RES, V29, P437, DOI 10.1161/01.RES.29.5.437; LEVY MN, 1969, J APPL PHYSIOL, V27, P465, DOI 10.1152/jappl.1969.27.4.465; Li M, 2004, CIRCULATION, V109, P120, DOI 10.1161/01.CIR.0000105721.71640.DA; MANABE N, 1991, J AUTONOM NERV SYST, V32, P233, DOI 10.1016/0165-1838(91)90117-L; MUSCHOLL E, 1980, AM J PHYSIOL, V239, pH713, DOI 10.1152/ajpheart.1980.239.6.H713; Nobrega ACL, 2001, CLIN AUTON RES, V11, P11, DOI 10.1007/BF02317797; Nobrega ACL, 2008, INT J CARDIOL, V125, P418, DOI 10.1016/j.ijcard.2007.01.043; Okazaki Y, 2010, J PHYSIOL SCI, V60, P67, DOI 10.1007/s12576-009-0071-5; Olshansky B, 2008, CIRCULATION, V118, P863, DOI 10.1161/CIRCULATIONAHA.107.760405; Pacher P, 2008, NAT PROTOC, V3, P1422, DOI 10.1038/nprot.2008.138; Patten RD, 1998, AM J PHYSIOL-HEART C, V274, pH1812, DOI 10.1152/ajpheart.1998.274.5.H1812; PORTER TR, 1990, J CLIN INVEST, V85, P1362, DOI 10.1172/JCI114580; Sabino JPJ, 2013, AUTON NEUROSCI-BASIC, V173, P58, DOI 10.1016/j.autneu.2012.11.007; Salto-Tellez M, 2004, CARDIOVASC PATHOL, V13, P91, DOI 10.1016/s1054-8807(03)00129-7; Sam F, 2000, AM J PHYSIOL-HEART C, V279, pH422, DOI 10.1152/ajpheart.2000.279.1.H422; Schwartz PJ, 2013, NETH HEART J, V21, P82, DOI 10.1007/s12471-012-0368-5; Schwartz PJ, 2011, HEART FAIL REV, V16, P101, DOI 10.1007/s10741-010-9179-1; Serra SM, 2009, J CARD FAIL, V15, P124, DOI 10.1016/j.cardfail.2008.10.018; Soares PPDA, 2004, AUTON NEUROSCI-BASIC, V113, P24, DOI 10.1016/j.autneu.2004.05.002; Takagawa J, 2007, J APPL PHYSIOL, V102, P2104, DOI 10.1152/japplphysiol.00033.2007; VANHOUTTE PM, 1980, AM J PHYSIOL, V238, pH275, DOI 10.1152/ajpheart.1980.238.3.H275; WATANABE AM, 1984, FED PROC, V43, P2618; Yutzey KE, 2007, CIRCULATION, V115, P792, DOI 10.1161/CIRCULATIONAHA.106.682534; Zhang YH, 2009, CIRC-HEART FAIL, V2, P692, DOI 10.1161/CIRCHEARTFAILURE.109.873968; Zheng C, 2005, P ANN INT IEEE EMBS, P7072; Zimerman LI, 2010, BRAZ J MED BIOL RES, V43, P211, DOI 10.1590/S0100-879X2010005000001	55	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e104476	10.1371/journal.pone.0104476	http://dx.doi.org/10.1371/journal.pone.0104476			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133392	Green Published, gold, Green Submitted			2022-12-25	WOS:000341302700029
J	Kiss, T; Kovacs, K; Komocsi, A; Tornyos, A; Zalan, P; Sumegi, B; Gallyas, F; Kovacs, K				Kiss, Tamas; Kovacs, Krisztina; Komocsi, Andras; Tornyos, Adrienn; Zalan, Petra; Sumegi, Balazs; Gallyas, Ferenc, Jr.; Kovacs, Krisztina			Novel Mechanisms of Sildenafil in Pulmonary Hypertension Involving Cytokines/Chemokines, MAP Kinases and Akt	PLOS ONE			English	Article							NF-KAPPA-B; ACTIVATED PROTEIN-KINASE; ARTERIAL-HYPERTENSION; SIGNALING PATHWAYS; RODENT MODEL; TNF-ALPHA; INFLAMMATION; INHIBITION; EXPRESSION; SORAFENIB	Pulmonary arterial hypertension (PH) is associated with high mortality due to right ventricular failure and hypoxia, therefore to understand the mechanism by which pulmonary vascular remodeling initiates these processes is very important. We used a well-characterized monocrotaline (MCT)-induced rat PH model, and analyzed lung morphology, expression of cytokines, mitogen-activated protein kinase (MAPK) phosphorylation, and phosphatidylinositol 3-kinase-Akt (PI-3k-Akt) pathway and nuclear factor (NF)-kappa B activation in order to elucidate the mechanisms by which sildenafil's protective effect in PH is exerted. Besides its protective effect on lung morphology, sildenafil suppressed multiple cytokines involved in neutrophil and mononuclear cells recruitment including cytokine-induced neutrophil chemoattractant (CINC)-1, CINC-2 alpha/beta, tissue inhibitor of metalloproteinase (TIMP)-1, interleukin (IL)-1 alpha, lipopolysaccharide induced CXC chemokine (LIX), monokine induced by gamma interferon (MIG), macrophage inflammatory protein (MIP)-1 alpha, and MIP-3 alpha. NF-kappa B activation and phosphorylation were also attenuated by sildenafil. Furthermore, sildenafil reduced extracellular signal-regulated kinase (ERK) 1/ 2 and p38 MAPK activation while enhanced activation of the cytoprotective Akt pathway in PH. These data suggest a beneficial effect of sildenafil on inflammatory and kinase signaling mechanisms that substantially contribute to its protective effects, and may have potential implications in designing future therapeutic strategies in the treatment of pulmonary hypertension.	[Kiss, Tamas] Univ Pecs, Dept Anaesthesiol & Intens Therapy, Pecs, Hungary; [Kovacs, Krisztina] Univ Pecs, Dept Pathol, Pecs, Hungary; [Komocsi, Andras; Tornyos, Adrienn] Univ Pecs, Inst Heart, Pecs, Hungary; [Zalan, Petra; Sumegi, Balazs; Gallyas, Ferenc, Jr.; Kovacs, Krisztina] Univ Pecs, Dept Biochem & Med Chem, Pecs, Hungary; [Sumegi, Balazs] MTA PTE, Nucl Mitochondrial Res Grp, Pecs, Hungary; [Sumegi, Balazs] Univ Pecs, Szentagothai Res Ctr, Pecs, Hungary	University of Pecs; University of Pecs; University of Pecs; University of Pecs; University of Pecs; University of Pecs	Kovacs, K (corresponding author), Univ Pecs, Dept Biochem & Med Chem, Pecs, Hungary.	krisztina.kovacs@aok.pte.hu	Gallyas, Ferenc/AAY-5343-2020; Kovacs, Krisztina/E-9712-2010; Gallyas, Ferenc/C-2272-2012	Gallyas, Ferenc/0000-0002-1906-4333	"National Excellence Program - Elaborating and operating an inland student and researcher personal support system" [TAMOP 4.2.4. A/2-11-1-2012-0001]; European Union; European Social Fund; Bolyai Scholarship [PTE-AOK-KA-2013/3]; OTKA [NN109841]	"National Excellence Program - Elaborating and operating an inland student and researcher personal support system"; European Union(European Commission); European Social Fund(European Social Fund (ESF)); Bolyai Scholarship(Hungarian Academy of Sciences); OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This research was realized in the frames of TAMOP 4.2.4. A/2-11-1-2012-0001 "National Excellence Program - Elaborating and operating an inland student and researcher personal support system." The project was subsidized by the European Union and co-financed by the European Social Fund. This work was also supported by Bolyai Scholarship, PTE-AOK-KA-2013/3 and OTKA NN109841. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mousawi AM, 2010, SHOCK, V34, P261, DOI 10.1097/SHK.0b013e3181d8e2a6; Alexandru B, 2001, Pneumologia, V50, P85; Badesch DB, 2007, J RHEUMATOL, V34, P2417; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Balabanian K, 2002, AM J RESP CRIT CARE, V165, P1419, DOI 10.1164/rccm.2106007; Chan SY, 2008, J MOL CELL CARDIOL, V44, P14, DOI 10.1016/j.yjmcc.2007.09.006; Clayton RA, 2004, RESP RES, V5, DOI 10.1186/1465-9921-5-4; de Visser YP, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-30; Dorfmuller P, 2003, EUR RESPIR J, V22, P358, DOI 10.1183/09031936.03.00038903; Dumitrascu Rio, 2008, BMC Pulm Med, V8, P25, DOI 10.1186/1471-2466-8-25; Ebina M, 2004, AM J RESP CRIT CARE, V169, P1203, DOI 10.1164/rccm.200308-1111OC; Fan ZY, 2014, DNA CELL BIOL, V33, P12, DOI 10.1089/dna.2013.2022; Fartoukh M, 1988, CHEST S, V114, p50S; Firth AL, 2010, DIS MODEL MECH, V3, P268, DOI 10.1242/dmm.003616; Fukudome EY, 2012, SURGERY, V152, P254, DOI 10.1016/j.surg.2012.03.013; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Gomez-Arroyo JG, 2012, AM J PHYSIOL-LUNG C, V302, pL363, DOI 10.1152/ajplung.00212.2011; Guo YL, 2013, J HUAZHONG U SCI-MED, V33, P470, DOI 10.1007/s11596-013-1144-5; Hosokawa S, 2013, CARDIOVASC RES, V99, P35, DOI 10.1093/cvr/cvt105; Humbert M, 2004, J AM COLL CARDIOL, V43, p13S, DOI 10.1016/j.jacc.2004.02.029; HUMBERT M, 1995, AM J RESP CRIT CARE, V151, P1628, DOI 10.1164/ajrccm.151.5.7735624; Jeyaseelan S, 2004, INFECT IMMUN, V72, P7247, DOI 10.1128/IAI.72.12.7247-7256.2004; KAY JM, 1967, THORAX, V22, P176, DOI 10.1136/thx.22.2.176; Kim TJ, 2007, VASC PHARMACOL, V46, P43, DOI 10.1016/j.vph.2006.06.007; Klein M, 2008, CIRCULATION, V118, P2081, DOI 10.1161/CIRCULATIONAHA.108.779751; Lagente V, 2004, J PHARMACOL EXP THER, V310, P367, DOI 10.1124/jpet.103.061739; LALICH JJ, 1977, ARCH PATHOL LAB MED, V101, P69; Lepetit H, 2005, EUR RESPIR J, V25, P834, DOI 10.1183/09031936.05.00072504; Li B, 2007, ANESTH ANALG, V105, P1034, DOI 10.1213/01.ane.0000278736.81133.26; Liu JW, 2009, SHOCK, V32, P317, DOI 10.1097/SHK.0b013e31819c374c; Lu J, 2004, J THORAC CARDIOV SUR, V128, P850, DOI 10.1016/j.jtcvs.2004.03.003; Marathe N, 2012, J BIOL CHEM, V287, P978, DOI 10.1074/jbc.M111.294959; Miura T, 2010, CARDIOVASC DRUG THER, V24, P255, DOI 10.1007/s10557-010-6234-z; Moreno-Vinasco L, 2008, PHYSIOL GENOMICS, V33, P278, DOI 10.1152/physiolgenomics.00169.2007; Mortimer HJ, 2007, PULM PHARMACOL THER, V20, P718, DOI 10.1016/j.pupt.2006.08.007; Nedvig K, 2012, J MOL NEUROSCI, V48, P788, DOI 10.1007/s12031-012-9870-x; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Rabinovitch M, 2012, J CLIN INVEST, V122, P4306, DOI 10.1172/JCI60658; Raychaudhuri B, 1999, AM J RESP CELL MOL, V21, P311, DOI 10.1165/ajrcmb.21.3.3611; Rondelet B, 2012, EUR HEART J, V33, P1017, DOI 10.1093/eurheartj/ehr111; ROSENBERG HC, 1988, AM J PHYSIOL, V255, pH1484, DOI 10.1152/ajpheart.1988.255.6.H1484; Ross DJ, 2012, J HEART LUNG TRANSPL, V31, P865, DOI 10.1016/j.healun.2012.04.008; Rossi F, 2006, REGUL PEPTIDES, V133, P155, DOI 10.1016/j.regpep.2005.09.029; Rubin LJ, 2011, CHEST, V140, P1274, DOI 10.1378/chest.10-0969; Sanchez O, 2007, AM J RESP CRIT CARE, V176, P1041, DOI 10.1164/rccm.200610-1559OC; Schermuly RT, 2004, AM J RESP CRIT CARE, V169, P39, DOI 10.1164/rccm.200302-282OC; Suwara MI, 2013, MUCOSAL IMMUNOL; THANOS D, 1995, CELL, V80, P529, DOI 10.1016/0092-8674(95)90506-5; Thorley AJ, 2007, J IMMUNOL, V178, P463, DOI 10.4049/jimmunol.178.1.463; Wang Q, 2013, VASC PHARMACOL, V58, P71, DOI 10.1016/j.vph.2012.07.006; Wang T, 2009, EUR RESPIR J, V33, P1122, DOI 10.1183/09031936.00055908; WILSON DW, 1989, MICROVASC RES, V38, P57; Yanagisawa R, 2012, CIRC J, V76, P1245, DOI 10.1253/circj.CJ-11-1192; Zeng Z, 2010, CARDIOVASC THER, V28, P23, DOI 10.1111/j.1755-5922.2009.00115.x	55	32	34	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e104890	10.1371/journal.pone.0104890	http://dx.doi.org/10.1371/journal.pone.0104890			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133539	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000341302700047
J	Nenseth, HZ; Dezitter, X; Tesikova, M; Mueller, F; Klokk, TI; Hager, GL; Saatcioglu, F				Nenseth, Hatice Z.; Dezitter, Xavier; Tesikova, Martina; Mueller, Florian; Klokk, Tove I.; Hager, Gordon L.; Saatcioglu, Fahri			Distinctly Different Dynamics and Kinetics of Two Steroid Receptors at the Same Response Elements in Living Cells	PLOS ONE			English	Article							LIGAND-SPECIFIC DYNAMICS; LONG TERMINAL REPEAT; ANDROGEN-RECEPTOR; GLUCOCORTICOID-RECEPTOR; DNA-BINDING; ACTINOMYCIN-D; TRANSCRIPTIONAL ELONGATION; IN-VITRO; P-TEFB; PROMOTER	Closely related transcription factors (TFs) can bind to the same response elements (REs) with similar affinities and activate transcription. However, it is unknown whether transcription is similarly orchestrated by different TFs bound at the same RE. Here we have compared the recovery half time (t(1/2)), binding site occupancy and the resulting temporal changes in transcription upon binding of two closely related steroid receptors, the androgen and glucocorticoid receptors (AR and GR), to their common hormone REs (HREs). We show that there are significant differences at all of these levels between AR and GR at the MMTV HRE when activated by their ligands. These data show that two TFs bound at the same RE can have significantly different modes of action that can affect their responses to environmental cues.	[Nenseth, Hatice Z.; Dezitter, Xavier; Tesikova, Martina; Klokk, Tove I.; Saatcioglu, Fahri] Univ Oslo, Dept Biosci, Oslo, Norway; [Mueller, Florian] Inst Pasteur, Computat Imaging & Modeling Unit, Paris, France; [Hager, Gordon L.] Natl Inst Hlth, Natl Canc Inst, Lab Receptor Biol & Gene Express, Bethesda, MD USA; [Saatcioglu, Fahri] Oslo Univ Hosp, Inst Canc Genet & Informat, Oslo, Norway	University of Oslo; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Oslo	Saatcioglu, F (corresponding author), Univ Oslo, Dept Biosci, Oslo, Norway.	fahris@ibv.uio.no	Dezitter, Xavier/H-6923-2018; Mueller, Florian/C-9075-2012	Dezitter, Xavier/0000-0001-6932-6947; Mueller, Florian/0000-0002-9622-4396; Nenseth, Hatice Zeynep/0000-0002-8385-3476	Norwegian Research Council; Norwegian Cancer Society; University of Oslo	Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Cancer Society(Norwegian Cancer Society); University of Oslo	This work was supported by funds from the Norwegian Research Council (www.forskningsradet.no), Norwegian Cancer Society (www.kreftforeningen.no), and University of Oslo (www.uio.no). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARCHER TK, 1994, MOL ENDOCRINOL, V8, P568, DOI 10.1210/me.8.5.568; BEATO M, 1989, J STEROID BIOCHEM, V32, P737, DOI 10.1016/0022-4731(89)90521-9; Becker M, 2002, EMBO REP, V3, P1188, DOI 10.1093/embo-reports/kvf244; Callewaert L, 2004, MOL ENDOCRINOL, V18, P1438, DOI 10.1210/me.2003-0313; Casse C, 1999, J BIOL CHEM, V274, P16097, DOI 10.1074/jbc.274.23.16097; CATO ACB, 1987, EMBO J, V6, P363, DOI 10.1002/j.1460-2075.1987.tb04763.x; CHODOSH LA, 1989, J BIOL CHEM, V264, P2250; Conway-Campbell BL, 2011, MOL ENDOCRINOL, V25, P944, DOI 10.1210/me.2010-0073; Czyz M, 1998, ACTA BIOCHIM POL, V45, P67, DOI 10.18388/abp.1998_4319; Dezitter X, 2011, J STEROID BIOCHEM, V126, P104, DOI 10.1016/j.jsbmb.2011.04.008; ELBI C, 2004, SCI STKE, pPL10; Fragoso G, 1998, MOL CELL BIOL, V18, P3633, DOI 10.1128/MCB.18.6.3633; FRAGOSO G, 1995, GENE DEV, V9, P1933, DOI 10.1101/gad.9.15.1933; Fu MF, 2003, MOL CELL BIOL, V23, P8563, DOI 10.1128/MCB.23.23.8563-8575.2003; FUNDER JW, 1993, SCIENCE, V259, P1132, DOI 10.1126/science.8382375; Gao WQ, 2005, CHEM REV, V105, P3352, DOI 10.1021/cr020456u; Gaughan L, 2011, NUCLEIC ACIDS RES, V39, P1266, DOI 10.1093/nar/gkq861; Haelens A, 2001, BIOCHEM J, V353, P611, DOI 10.1042/0264-6021:3530611; Hager GL, 2009, MOL CELL, V35, P741, DOI 10.1016/j.molcel.2009.09.005; John S, 2009, ENDOCRINOLOGY, V150, P1766, DOI 10.1210/en.2008-0863; Kang ZG, 2002, J BIOL CHEM, V277, P48366, DOI 10.1074/jbc.M209074200; Kinyamu HK, 2007, MOL CELL BIOL, V27, P4891, DOI 10.1128/MCB.02162-06; Klokk TI, 2007, MOL CELL BIOL, V27, P1823, DOI 10.1128/MCB.01297-06; Lee DK, 2001, J BIOL CHEM, V276, P9978, DOI 10.1074/jbc.M002285200; Lee JW, 2001, CELL MOL LIFE SCI, V58, P289, DOI 10.1007/PL00000856; Lee YF, 1999, P NATL ACAD SCI USA, V96, P14724, DOI 10.1073/pnas.96.26.14724; Lickwar CR, 2012, NATURE, V484, P251, DOI 10.1038/nature10985; Lonard DM, 2007, MOL CELL, V27, P691, DOI 10.1016/j.molcel.2007.08.012; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; MARSCHKE KB, 1995, ENDOCRINE, V3, P819, DOI 10.1007/BF02935687; MARSHALL NF, 1992, MOL CELL BIOL, V12, P2078, DOI 10.1128/MCB.12.5.2078; McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321; McKenna NJ, 1998, P NATL ACAD SCI USA, V95, P11697, DOI 10.1073/pnas.95.20.11697; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; PUVIONDUTILLEUL F, 1992, EUR J CELL BIOL, V58, P149; Rayasam GV, 2005, MOL CELL BIOL, V25, P2406, DOI 10.1128/MCB.25.6.2406-2418.2005; Reddy TE, 2009, GENOME RES, V19, P2163, DOI 10.1101/gr.097022.109; RICHARDFOY H, 1987, EMBO J, V6, P2321, DOI 10.1002/j.1460-2075.1987.tb02507.x; RUNDLETT SE, 1995, MOL CELL ENDOCRINOL, V109, P1, DOI 10.1016/0303-7207(95)03477-O; Shaffer PL, 2004, P NATL ACAD SCI USA, V101, P4758, DOI 10.1073/pnas.0401123101; Stavreva DA, 2004, MOL CELL BIOL, V24, P2682, DOI 10.1128/MCB.24.7.2682-2697.2004; STRAHLE U, 1987, P NATL ACAD SCI USA, V84, P7871, DOI 10.1073/pnas.84.22.7871; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.biochem.63.1.451; Verrijdt G, 2002, BIOCHEM J, V361, P97, DOI 10.1042/0264-6021:3610097; Wang LG, 1999, BIOCHEM BIOPH RES CO, V259, P21, DOI 10.1006/bbrc.1999.0655; Whitacre DC, 2001, ENDOCRINE, V15, P111, DOI 10.1385/ENDO:15:1:111; Wilson VS, 2002, TOXICOL SCI, V66, P69, DOI 10.1093/toxsci/66.1.69; Xu L, 1999, CURR OPIN GENET DEV, V9, P140, DOI 10.1016/S0959-437X(99)80021-5; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029	49	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105204	10.1371/journal.pone.0105204	http://dx.doi.org/10.1371/journal.pone.0105204			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133404	Green Published, gold, Green Submitted			2022-12-25	WOS:000341302700085
J	Ponsuwanna, P; Kumpornsin, K; Chookajorn, T				Ponsuwanna, Patrath; Kuempornsin, Krittikorn; Chookajorn, Thanat			Genome-Wide Prediction of the Polymorphic Ser Gene Family in Tetrahymena thermophila Based on Motif Analysis	PLOS ONE			English	Article							IMMOBILIZATION ANTIGEN LOCUS; MOLECULAR CHARACTERIZATION; SURFACE PROTEIN; EXPRESSION; SEQUENCE; MALARIA; CELL; STABILITY; SELECTION; BIOLOGY	Even though antigenic variation is employed among parasitic protozoa for host immune evasion, Tetrahymena thermophila, a free-living ciliate, can also change its surface protein antigens. These cysteine-rich glycosylphosphatidylinositol (GPI)-linked surface proteins are encoded by a family of polymorphic Ser genes. Despite the availability of T. thermophila genome, a comprehensive analysis of the Ser family is limited by its high degree of polymorphism. In order to overcome this problem, a new approach was adopted by searching for Ser candidates with common motif sequences, namely length-specific repetitive cysteine pattern and GPI anchor site. The candidate genes were phylogenetically compared with the previously identified Ser genes and classified into subtypes. Ser candidates were often found to be located as tandem arrays of the same subtypes on several chromosomal scaffolds. Certain Ser candidates located in the same chromosomal arrays were transcriptionally expressed at specific T. thermophila developmental stages. These Ser candidates selected by the motif analysis approach can form the foundation for a systematic identification of the entire Ser gene family, which will contribute to the understanding of their function and the basis of T. thermophila antigenic variation.	[Ponsuwanna, Patrath; Kuempornsin, Krittikorn] Mahidol Univ, Fac Sci, Dept Biochem, Bangkok 10700, Thailand; [Chookajorn, Thanat] Mahidol Univ, Fac Trop Med, Ctr Excellence Malaria, Bangkok 10700, Thailand	Mahidol University; Mahidol University	Chookajorn, T (corresponding author), Mahidol Univ, Fac Trop Med, Ctr Excellence Malaria, Bangkok 10700, Thailand.	thanat.cho@mahidol.edu			Commission of Higher Education-Thailand Research Fund-Mahidol University [RMU5380054]; CPMO-National Science and Technology Development Agency; Thailand Research Fund through the Royal Golden Jubilee PhD Program [PHD/0044/2554]	Commission of Higher Education-Thailand Research Fund-Mahidol University; CPMO-National Science and Technology Development Agency; Thailand Research Fund through the Royal Golden Jubilee PhD Program(Thailand Research Fund (TRF))	This work was supported by the Commission of Higher Education-Thailand Research Fund-Mahidol University (RMU5380054) and the CPMO-National Science and Technology Development Agency. KK was supported by The Thailand Research Fund through the Royal Golden Jubilee PhD Program (PHD/0044/2554). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Chang JY, 2011, BIOCHEMISTRY-US, V50, P3414, DOI 10.1021/bi200131j; Chookajorn T, 2004, P NATL ACAD SCI USA, V101, P911, DOI 10.1073/pnas.2637116100; Chookajorn T, 2008, TRENDS PARASITOL, V24, P455, DOI 10.1016/j.pt.2008.07.005; Chookajorn T, 2007, TRENDS PARASITOL, V23, P563, DOI 10.1016/j.pt.2007.08.022; Collins K, 2005, CURR BIOL, V15, pR317, DOI 10.1016/j.cub.2005.04.039; Coyne RS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-562; DEAK JC, 1995, GENE, V164, P163, DOI 10.1016/0378-1119(95)00446-D; DOERDER FP, 1985, GENETICS, V111, P273; Doerder FP, 2000, BIOCHEM BIOPH RES CO, V278, P621, DOI 10.1006/bbrc.2000.3857; Doerder FP, 2000, GENE, V257, P319, DOI 10.1016/S0378-1119(00)00380-2; Eisen JA, 2006, PLOS BIOL, V4, P1620, DOI 10.1371/journal.pbio.0040286; Eisenhaber B, 1998, PROTEIN ENG, V11, P1155, DOI 10.1093/protein/11.12.1155; Eisenhaber B, 1999, J MOL BIOL, V292, P741, DOI 10.1006/jmbi.1999.3069; ELLIOTT AM, 1959, ANNU REV MICROBIOL, V13, P79, DOI 10.1146/annurev.mi.13.100159.000455; Gerber CA, 2002, GENETICS, V160, P1469; HALLBERG RL, 1984, MOL CELL BIOL, V4, P2170, DOI 10.1128/MCB.4.10.2170; HARRISON GS, 1985, NUCLEIC ACIDS RES, V13, P73, DOI 10.1093/nar/13.1.73; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Karrer KM, 2000, METHOD CELL BIOL, V62, P127; KO YG, 1992, J PROTOZOOL, V39, P719, DOI 10.1111/j.1550-7408.1992.tb04454.x; Kusch J, 2001, J MEMBRANE BIOL, V180, P101, DOI 10.1007/s002320010062; LOVE HD, 1988, MOL CELL BIOL, V8, P427, DOI 10.1128/MCB.8.1.427; Lujan HD, 2011, ESSAYS BIOCHEM, V51, P177, DOI [10.1042/BSE0510177, 10.1042/bse0510177]; MARGOLIN P, 1959, J PROTOZOOL, V6, P207, DOI 10.1111/j.1550-7408.1959.tb04359.x; MCMILLAN PJ, 1995, NUCLEIC ACIDS RES, V23, P942, DOI 10.1093/nar/23.6.942; Miao W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004429; Miller LH, 2013, NAT MED, V19, P156, DOI 10.1038/nm.3073; Miller M. A., 2010, GAT COMP ENV WORKSH, P1, DOI DOI 10.1109/GCE.2010.5676129; PHILLIPS RB, 1967, GENETICS, V56, P667; Poisson Guylaine, 2007, Genomics Proteomics & Bioinformatics, V5, P121, DOI 10.1016/S1672-0229(07)60022-9; Rivero FD, 2010, NAT MED, V16, P551, DOI 10.1038/nm.2141; RON A, 1992, J PROTOZOOL, V39, P508, DOI 10.1111/j.1550-7408.1992.tb04840.x; Simon EM, 2008, BIODIVERS CONSERV, V17, P365, DOI 10.1007/s10531-007-9255-6; Simon MC, 2007, J EUKARYOT MICROBIOL, V54, P1, DOI 10.1111/j.1550-7408.2006.00226.x; SMITH DL, 1992, J PROTOZOOL, V39, P420, DOI 10.1111/j.1550-7408.1992.tb01475.x; SMITH DL, 1992, J PROTOZOOL, V39, P628, DOI 10.1111/j.1550-7408.1992.tb04862.x; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; STARGELL LA, 1990, NUCLEIC ACIDS RES, V18, P6637, DOI 10.1093/nar/18.22.6637; Swanson WJ, 2003, CURR OPIN GENET DEV, V13, P617, DOI 10.1016/j.gde.2003.10.007; Taylor JE, 2006, TRENDS GENET, V22, P614, DOI 10.1016/j.tig.2006.08.003; Templeton TJ, 2007, TRENDS PARASITOL, V23, P205, DOI 10.1016/j.pt.2007.03.001; TONDRAVI MM, 1990, MOL CELL BIOL, V10, P6091, DOI 10.1128/MCB.10.11.6091; UDENFRIEND S, 1995, ANNU REV BIOCHEM, V64, P563, DOI 10.1146/annurev.bi.64.070195.003023; WILLIAMS NE, 1985, MOL CELL BIOL, V5, P1925, DOI 10.1128/MCB.5.8.1925	46	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105201	10.1371/journal.pone.0105201	http://dx.doi.org/10.1371/journal.pone.0105201			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133747	Green Published, gold, Green Submitted			2022-12-25	WOS:000341302700083
J	Xiao, XY; Ou, B; Yang, HY; Wu, H; Luo, BM				Xiao, Xiaoyun; Ou, Bing; Yang, Haiyun; Wu, Huan; Luo, Baoming			Breast Contrast-Enhanced Ultrasound: Is a Scoring System Feasible? -A Preliminary Study in China	PLOS ONE			English	Article							POWER DOPPLER US; CANCER TUMOR SIZE; PREOPERATIVE ASSESSMENT; BI-RADS; LESIONS; ELASTOGRAPHY; MICROBUBBLE; AGENT; MAMMOGRAPHY; SONOGRAPHY	Objectives: Although many studies about breast contrast-enhanced ultrasound had been conducted, clear diagnostic criteria for evaluating enhancement patterns are still lacking. This study aims to identify significant indicators for breast contrast-enhanced ultrasound and to establish an initial scoring system. Materials and Methods: Totally 839 patients were included in the study. This study was divided into two parts. 364 patients were included in part 1 while 475 in part 2. Conventional ultrasound and contrast-enhanced ultrasound were used to examine each lesion. Only the cases in part 2 were also examined by elastography. In part 1, Logistic regression analysis was performed to predict significant variables. A 5-point scoring system was developed based on the results. In part 2, the scoring system was used to evaluate all the breast lesions. To evaluate the diagnostic efficacy of the new scoring system, it was compared with the system established for elastography and conventional ultrasound (BI-RADS). Results: Three independent variables, namely, lesion scope, margin, and shape were selected in the final step of the logistic regression analysis in part 1. In part 2, the area under the ROC (receiver operating characteristic) curve for the contrast-enhanced scoring system was 0.912. The difference in the diagnostic capabilities of the contrast-enhanced scoring system and elastography was not statistically significant (P = 0.17). The difference in the diagnostic capabilities of the contrast-enhanced scoring system and BI-RADS was statistically significant (P<0.001). Conclusions: The contrast-enhanced patterns of benign and malignant breast tumors are different. The application of a 5-point scoring system for contrast-enhanced ultrasound is clinically promising.	[Xiao, Xiaoyun; Ou, Bing; Yang, Haiyun; Wu, Huan; Luo, Baoming] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Ultrasound, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Xiao, XY (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Ultrasound, Guangzhou 510275, Guangdong, Peoples R China.	papayaxxy@163.com						Algul Ali, 2003, Tani Girisim Radyol, V9, P199; American College of Radiology, 2003, BREAST IM REP DAT SY; Are C, 2013, J SURG ONCOL, V107, P221, DOI 10.1002/jso.23248; Balleyguier C, 2009, EUR J RADIOL, V69, P14, DOI 10.1016/j.ejrad.2008.07.037; Berg WA, 2000, RADIOLOGY, V214, P59, DOI 10.1148/radiology.214.1.r00ja2559; Berg WA, 2005, AM J ROENTGENOL, V185, P952, DOI 10.2214/AJR.04.0929; Berg WA, 2004, RADIOLOGY, V233, P830, DOI 10.1148/radiol.2333031484; BROWN LF, 1995, HUM PATHOL, V26, P86, DOI 10.1016/0046-8177(95)90119-1; Caproni N, 2010, EUR RADIOL, V20, P1384, DOI 10.1007/s00330-009-1690-1; Cho N, 2008, KOREAN J RADIOL, V9, P111, DOI 10.3348/kjr.2008.9.2.111; del Carmen MG, 2003, CANCER-AM CANCER SOC, V98, P590, DOI 10.1002/cncr.11517; Du J, 2008, J ULTRAS MED, V27, P844; Du J, 2008, J ULTRAS MED, V27, P833, DOI 10.7863/jum.2008.27.6.833; Golshan M, 2004, BREAST, V13, P265, DOI 10.1016/j.breast.2004.05.005; Heusinger K, 2005, BREAST CANCER RES TR, V94, P17, DOI 10.1007/s10549-005-6653-x; Hlawatsch A, 2002, AM J ROENTGENOL, V179, P1493, DOI 10.2214/ajr.179.6.1791493; Huber S, 2001, ULTRASOUND MED BIOL, V27, P3, DOI 10.1016/S0301-5629(00)00282-9; Itoh A, 2006, RADIOLOGY, V239, P341, DOI 10.1148/radiol.2391041676; Jiang YX, 2007, ULTRASOUND MED BIOL, V33, P1873, DOI 10.1016/j.ultrasmedbio.2007.06.002; Kedar RP, 1996, RADIOLOGY, V198, P679, DOI 10.1148/radiology.198.3.8628854; Kettenbach J, 2005, EUR J RADIOL, V53, P238, DOI 10.1016/j.ejrad.2004.04.017; Kook SH, 2003, J CLIN ULTRASOUND, V31, P227, DOI 10.1002/jcu.10172; Liberman L, 2003, AM J ROENTGENOL, V181, P519, DOI 10.2214/ajr.181.2.1810519; Lichtenbeld HC, 1998, INT J CANCER, V77, P455, DOI 10.1002/(SICI)1097-0215(19980729)77:3<455::AID-IJC23>3.3.CO;2-C; Liu H, 2008, BREAST, V17, P532, DOI 10.1016/j.breast.2008.04.004; Metz S, 2003, ACAD RADIOL, V10, P484, DOI 10.1016/S1076-6332(03)80056-9; Moon WK, 2000, RADIOLOGY, V217, P240, DOI 10.1148/radiology.217.1.r00oc03240; Ozdemir A, 2004, J ULTRAS MED, V23, P183; Quaia E, 2011, EUR RADIOL, V21, P604, DOI 10.1007/s00330-010-1965-6; Reinikainen H, 2001, ACTA RADIOL, V42, P106, DOI 10.1080/028418501127346341; Ricci P, 2007, ULTRASCHALL MED, V28, P57, DOI 10.1055/s-2006-927226; Saracco A, 2009, ACTA RADIOL, V50, P854, DOI 10.1080/02841850903085576; Satake H, 2000, EUR RADIOL, V10, P1726, DOI 10.1007/s003300000465; Schroder RJ, 2002, ROFO-FORTSCHR RONTG, V174, P1132, DOI 10.1055/s-2002-33940; Sedgwick E, 2011, SEMIN ROENTGENOL, V46, P245, DOI 10.1053/j.ro.2011.04.001; Shoma A, 2006, BREAST J, V12, P252, DOI 10.1111/j.1075-122X.2006.00249.x; Suzuki Tomoyoshi, 2006, Int J Clin Oncol, V11, P108, DOI 10.1007/s10147-006-0564-7; Svensson W.E, 1997, EUR J ULTRASOUND, V6, P77; Szabo BK, 2003, ACTA RADIOL, V44, P379, DOI 10.1034/j.1600-0455.2003.00084.x; Tan SM, 2008, BREAST, V17, P252, DOI 10.1016/j.breast.2007.10.015; Taskin F, 2012, J CLIN ULTRASOUND, V40, P261, DOI 10.1002/jcu.21923; Thomas A, 2006, ULTRASOUND OBST GYN, V28, P335, DOI 10.1002/uog.2823; van Esser S, 2007, Cancer Imaging, V7, P63, DOI 10.1102/1470-7330.2007.0012; Wan CF, 2012, RADIOLOGY, V262, P450, DOI 10.1148/radiol.11110789; Xu HX, 2009, WORLD J RADIOL, V1, P15, DOI 10.4329/wjr.v1.i1.15; Yang WT, 2001, RADIOLOGY, V220, P795, DOI 10.1148/radiol.2203001545; Yang WT, 1997, J ULTRAS MED, V16, P791; Zeggelink WFAK, 2003, MED PHYS, V30, P2919, DOI 10.1118/1.1621136; Zhao HJ, 2010, EUR J RADIOL, V73, P288, DOI 10.1016/j.ejrad.2009.05.043; Zhi H, 2007, J ULTRAS MED, V26, P807, DOI 10.7863/jum.2007.26.6.807; Zhu QL, 2008, ULTRASOUND MED BIOL, V34, P1232, DOI 10.1016/j.ultrasmedbio.2008.01.004	51	36	50	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105517	10.1371/journal.pone.0105517	http://dx.doi.org/10.1371/journal.pone.0105517			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133534	gold, Green Published, Green Submitted			2022-12-25	WOS:000341302700119
J	Castanho, CD; Prado, PI				Castanho, Camila de Toledo; Prado, Paulo Inacio			Benefit of Shading by Nurse Plant Does Not Change along a Stress Gradient in a Coastal Dune	PLOS ONE			English	Article							POSITIVE INTERACTIONS; ENVIRONMENTAL GRADIENTS; PRIMARY SUCCESSION; SEEDLING ESTABLISHMENT; FACILITATION; SHRUB; RESTORATION; VEGETATION; COMPETITION; HYPOTHESIS	The proximity of adult neighbors often increases the performance of woody seedlings under harsh environmental conditions but this nurse plant effect becomes less intense when abiotic stress is alleviated, as predicted by the stress gradient hypothesis (SGH). Although some studies have tested how the net nurse effect is changed by stress, few studies have tested how the mechanism that drives the facilitative effect of nurse responds to changes in stress. We conducted field experiments in a subtropical coastal dune to test if shading drives the known nurse effect of adults of the tree Guapira opposita on seedling performance of another tree species, Ternstroemia brasiliensis. We transplanted T. brasiliensis seedlings to three neighbor environments: under a G. opposita crown, under artificial shade and without neighbor as a control. Furthermore, assuming that proximity to the seashore correlates with stress intensity, we tested if the potential shade-driven facilitation became less intense as stress decreased. Regardless of the proximity to the seashore, after a year, the survival of T. brasiliensis seedlings was twice as high when the seedlings were under G. opposita or under artificial shade compared to the control, indicating that the nurse effect is driven by shade and that this facilitation mechanism is constant along the stress gradient. However, G. opposita and artificial shade had a negative effect on seedlings growth. Overall, our results showed that the facilitation mechanism behind the nurse effect did not wane as the stress was reduced. Furthermore, in spite of the potential costs in terms of biomass production, our study highlights the potential of nurse plants and artificial shade as techniques to improve the survival of transplanted seedlings used in the restoration of degraded shrubland coastal dunes.	[Castanho, Camila de Toledo; Prado, Paulo Inacio] Univ Sao Paulo, Inst Biociencias, Dept Ecol, Sao Paulo, Brazil	Universidade de Sao Paulo	Castanho, CD (corresponding author), Univ Fed Sao Paulo, Dept Ciencias Biol, Diadema, Brazil.	ctcastanho@gmail.com	Prado, Paulo I/G-3353-2012; Prado, Paulo Inácio/AAN-6512-2021; Castanho, Camila T/D-4583-2012	Prado, Paulo Inácio/0000-0002-7174-5005; Castanho, Camila T/0000-0002-0198-3200	CAPES - Improvement of Higher Education Personnel; FAPESP - Sao Paulo Research Foundation [2012/09794-7]; CNPq - Brazilian National Council for Scientific and Technological Development	CAPES - Improvement of Higher Education Personnel(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP - Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq - Brazilian National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was financially supported by CAPES - Improvement of Higher Education Personnel - http://www.capes.gov.br - that provided a PhD scholarship for CTC; FAPESP - Sao Paulo Research Foundation (project No 2012/09794-7) - http://www.fapesp.br - with a posdoctoral fellowship for CTC; CNPq - Brazilian National Council for Scientific and Technological Development - http://www.cnpq.br - with a grant for PIP; and Petrobras - http://www.petrobras.com.br - that provided support for field work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, BOT SISTEMATICA GUIA; Armas C, 2011, J VEG SCI, V22, P818, DOI 10.1111/j.1654-1103.2011.01301.x; Armas C, 2009, J VEG SCI, V20, P535, DOI 10.1111/j.1654-1103.2009.01055.x; Baumeister D, 2006, ECOLOGY, V87, P1816, DOI 10.1890/0012-9658(2006)87[1816:FBPFDS]2.0.CO;2; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Bonanomi G, 2011, PLANT ECOL, V212, P1777, DOI 10.1007/s11258-011-9948-5; Correia Cristiane Maria Brandão, 2010, Braz. J. Bot., V33, P607, DOI 10.1590/S0100-84042010000400009; Brooker RW, 1998, OIKOS, V81, P196, DOI 10.2307/3546481; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Butterfield BJ, 2013, FUNCT ECOL, V27, P907, DOI 10.1111/1365-2435.12019; Callaway RM, 1998, OIKOS, V82, P202, DOI 10.2307/3546931; Callaway RM, 1995, BOT REV, V61, P306, DOI 10.1007/BF02912621; Callaway RM, 2002, NATURE, V417, P844, DOI 10.1038/nature00812; CALLAWAY RM, 1992, ECOLOGY, V73, P2118, DOI 10.2307/1941460; Carboni M, 2011, J VEG SCI, V22, P751, DOI 10.1111/j.1654-1103.2011.01303.x; Castanho CT, 2012, J VEG SCI, V23, P952, DOI 10.1111/j.1654-1103.2012.01414.x; Cavieres LA, 2009, J ECOL, V97, P1181, DOI 10.1111/j.1365-2745.2009.01579.x; CHAPIN FS, 1994, ECOL MONOGR, V64, P149, DOI 10.2307/2937039; Cushman JH, 2010, J VEG SCI, V21, P821, DOI 10.1111/j.1654-1103.2010.01196.x; Flores J, 2003, J VEG SCI, V14, P911, DOI 10.1111/j.1654-1103.2003.tb02225.x; Franks SJ, 2003, PLANT ECOL, V168, P1, DOI 10.1023/A:1024426608966; Gomez-Aparicio L, 2005, J VEG SCI, V16, P191, DOI 10.1111/j.1654-1103.2005.tb02355.x; Gomez-Aparicio L, 2004, ECOL APPL, V14, P1128, DOI 10.1890/03-5084; Gomez-Aparicio L, 2009, J ECOL, V97, P1202, DOI 10.1111/j.1365-2745.2009.01573.x; Hastwell GT, 2003, J ECOL, V91, P941, DOI 10.1046/j.1365-2745.2003.00832.x; Hobbs NT, 2006, ECOL APPL, V16, P5, DOI 10.1890/04-0645; Holmgren M, 2001, ECOSYSTEMS, V4, P151, DOI 10.1007/s100210000065; Joy DA, 2002, PLANT ECOL, V160, P125, DOI 10.1023/A:1015812923216; Kawai T, 2007, P R SOC B, V274, P2503, DOI 10.1098/rspb.2007.0871; KELLMAN M, 1992, J VEG SCI, V3, P679, DOI 10.2307/3235836; Kennedy PG, 2006, OECOLOGIA, V148, P464, DOI 10.1007/s00442-006-0382-7; King EG, 2008, RESTOR ECOL, V16, P464, DOI 10.1111/j.1526-100X.2007.00310.x; Kitzberger T, 2000, ECOLOGY, V81, P1914, DOI 10.1890/0012-9658(2000)081[1914:EOCVOF]2.0.CO;2; Kunstler G, 2006, J VEG SCI, V17, P379, DOI 10.1111/j.1654-1103.2006.tb02458.x; Lacerda L.D., 1993, DRY COASTAL ECOSYSTE, P477; Lane C, 2008, J COASTAL RES, V24, P213, DOI 10.2112/07-0853.1; Larcher W, 1995, PHYSL PLANT ECOLOGY, P213; Lichter J, 2000, J ECOL, V88, P825, DOI 10.1046/j.1365-2745.2000.00503.x; Lubke RA, 2004, ECOL STU AN, V171, P67; Maestre FT, 2003, ECOLOGY, V84, P3186, DOI 10.1890/02-0635; Martinez ML, 2003, PLANT ECOL, V168, P333, DOI 10.1023/A:1024406707115; MAUN MA, 1994, VEGETATIO, V111, P59; Maun MA, 1999, ECOL LETT, V2, P14, DOI 10.1046/j.1461-0248.1999.21048.x; Ogura A, 2008, ECOL RES, V23, P107, DOI 10.1007/s11284-007-0347-2; Padilla FM, 2006, FRONT ECOL ENVIRON, V4, P196, DOI 10.1890/1540-9295(2006)004[0196:TRONPI]2.0.CO;2; Pakeman RJ, 2009, BIOL LETTERS, V5, P577, DOI 10.1098/rsbl.2009.0384; Sa CFC (n.d.), NYCT LIST ESP FLOR B; Scarano FR, 2002, ANN BOT-LONDON, V90, P517, DOI 10.1093/aob/mcf189; Shumway SW, 2000, OECOLOGIA, V124, P138, DOI 10.1007/s004420050033; Smit C, 2006, J APPL ECOL, V43, P305, DOI 10.1111/j.1365-2664.2006.01147.x; Smit C, 2006, FOREST ECOL MANAG, V237, P471, DOI 10.1016/j.foreco.2006.09.069; Suding KN, 2004, TRENDS ECOL EVOL, V19, P46, DOI 10.1016/j.tree.2003.10.005; Taiz L., 2002, PLANT PHYSIOL, V9, P172; van Zonneveld MJ, 2012, J VEG SCI, V23, P541, DOI 10.1111/j.1654-1103.2011.01379.x; Wilson JB, 2001, ECOL LETT, V2, P233; Yang L, 2010, J VEG SCI, V21, P262, DOI 10.1111/j.1654-1103.2009.01140.x; YARRANTON GA, 1974, J ECOL, V62, P417, DOI 10.2307/2258988; Zuur Alain F., 2009, P1	58	10	10	4	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105082	10.1371/journal.pone.0105082	http://dx.doi.org/10.1371/journal.pone.0105082			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127399	Green Published, gold, Green Submitted			2022-12-25	WOS:000340879300077
J	Li, XL; Rendon, JL; Choudhry, MA				Li, Xiaoling; Rendon, Juan L.; Choudhry, Mashkoor A.			T Cell IFN-gamma Suppression Following Alcohol and Burn Injury Is Independent of miRNA155	PLOS ONE			English	Article							NF-KAPPA-B; BACTERIAL TRANSLOCATION; DOWN-REGULATION; THERMAL-INJURY; RODENT MODEL; INTOXICATION; MICRORNA-155; ACTIVATION; MECHANISMS; DAMAGE	miRNA155 has been implicated in normal T cell function and their differentiations into the Th1 subtype. We have shown that acute alcohol (ethanol) intoxication combined with burn injury suppresses T cell IFN-gamma release. Herein, we examined whether the decrease in IFN-gamma is resulted from altered expression of miRNA155 and transcription factors -NFAT, Tbx21, Jun and Fos - in T cells following ethanol and burn injury. Mice received ethanol (similar to 3 g/Kg) 4 hours prior to similar to 12.5% total body surface area sham or burn injury and were sacrificed one day after injury. Splenic T cells were harvested and cultured with anti-CD3 (2 mu g/ml) in the presence or absence of rIL-12 (10 ng/ml) or PMA (10 ng/ml) plus ionomycin (50 ng/ml) for 48 hours. We observed a significant decrease in miRNA155, NFAT, Tbx21, Jun and Fos expression as well as IFN-gamma release in T cells cultured with anti-CD3 following ethanol and burn injury compared with shams. The co-treatment of T cells with rIL-12 prevented the decrease in IFN-gamma and NFAT, Tbx21, Jun and Fos, but not miRNA155. In contrast, the co-treatment with PMA plus ionomycin normalized the expression of NFAT. It did not prevent the decrease in IFN-gamma, Tbx21, Jun, Fos and miRNA155. Finally, results obtained in miRNA155(-/-) mice did not show any change in T cell release of IFN-gamma or expression of nuclear factors compared to wildtype mice. Together, these findings suggest that while ethanol and burn injury decreases the expression of miRNA155, it may not be involved in decreased IFN-gamma under those conditions.	[Li, Xiaoling; Rendon, Juan L.; Choudhry, Mashkoor A.] Loyola Univ, Chicago Hlth Sci Div, Alcohol Res Program, Maywood, IL 60153 USA; [Li, Xiaoling; Rendon, Juan L.; Choudhry, Mashkoor A.] Loyola Univ, Chicago Hlth Sci Div, Burn & Shock Trauma Res Inst, Maywood, IL 60153 USA; [Li, Xiaoling; Choudhry, Mashkoor A.] Loyola Univ, Chicago Hlth Sci Div, Dept Surg, Maywood, IL 60153 USA; [Choudhry, Mashkoor A.] Loyola Univ, Chicago Hlth Sci Div, Dept Microbiol & Immunol, Maywood, IL 60153 USA	Loyola University Chicago; Loyola University Chicago; Loyola University Chicago; Loyola University Chicago	Choudhry, MA (corresponding author), Loyola Univ, Chicago Hlth Sci Div, Alcohol Res Program, Maywood, IL 60153 USA.	mchoudhry@luc.edu			National Institutes of Health [R01AA015731, F30AA020167]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [F30AA020167, R01AA015731] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Support was provided by the National Institutes of Health - R01AA015731 (MAC) and F30AA020167 (JLR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Banerjee A, 2010, EUR J IMMUNOL, V40, P225, DOI 10.1002/eji.200939381; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; CHATILA T, 1989, J IMMUNOL, V143, P1283; Choudhry MA, 2004, ALCOHOL, V33, P199, DOI 10.1016/j.alcohol.2004.05.004; Choudhry MA, 2001, SHOCK, V16, P183, DOI 10.1097/00024382-200116030-00003; Choudhry MA, 1998, J IMMUNOL, V160, P929; Choudhry MA, 2002, AM J PHYSIOL-GASTR L, V282, pG937, DOI 10.1152/ajpgi.00235.2001; Cook RT, 1998, ALCOHOL CLIN EXP RES, V22, P1927, DOI 10.1097/00000374-199812000-00007; Dong C, 2006, NAT REV IMMUNOL, V6, P329, DOI 10.1038/nri1807; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Fazal N, 2005, BBA-MOL BASIS DIS, V1741, P113, DOI 10.1016/j.bbadis.2004.10.006; Gatto G, 2008, NUCLEIC ACIDS RES, V36, P6608, DOI 10.1093/nar/gkn666; Grobmyer S. R., 1996, Journal of Burn Care and Rehabilitation, V17, P532, DOI 10.1097/00004630-199611000-00010; Huang YP, 2004, J BIOL CHEM, V279, P28827, DOI 10.1074/jbc.R400012200; Humar M, 2004, J PHARMACOL EXP THER, V311, P1232, DOI 10.1124/jpet.104.071332; Inatsu A, 2011, J IMMUNOL, V187, P2155, DOI 10.4049/jimmunol.1003235; Jeker LT, 2013, IMMUNOL REV, V253, P65, DOI 10.1111/imr.12061; Kelly JL, 1999, SHOCK, V12, P39, DOI 10.1097/00024382-199907000-00006; Keshavarzian A, 1999, AM J GASTROENTEROL, V94, P200; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kluiver J, 2007, ONCOGENE, V26, P3769, DOI 10.1038/sj.onc.1210147; Koralov SB, 2008, CELL, V132, P860, DOI 10.1016/j.cell.2008.02.020; Lederer JA, 1999, SHOCK, V11, P153, DOI 10.1097/00024382-199903000-00001; Li XL, 2008, J IMMUNOL, V180, P6933, DOI 10.4049/jimmunol.180.10.6933; Li XL, 2008, SHOCK, V29, P377, DOI 10.1097/shk.0b013e31815abe80; Li XL, 2012, MOL MED, V18, P982, DOI 10.2119/molmed.2011.00513; Li XL, 2011, J BURN CARE RES, V32, P489, DOI 10.1097/BCR.0b013e3182223c9e; Li XL, 2009, J IMMUNOL, V183, P3955, DOI 10.4049/jimmunol.0804103; Li XL, 2006, J LEUKOCYTE BIOL, V79, P453, DOI 10.1189/jlb.0705369; Li XL, 2005, AM J PHYSIOL-REG I, V289, pR37, DOI 10.1152/ajpregu.00782.2004; Macian F, 2002, CELL, V109, P719, DOI 10.1016/S0092-8674(02)00767-5; MCGILL V, 1995, J TRAUMA, V38, P931, DOI 10.1097/00005373-199506000-00019; Messingham KAN, 2002, ALCOHOL, V28, P137, DOI 10.1016/S0741-8329(02)00278-1; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; O'Connell RM, 2009, P NATL ACAD SCI USA, V106, P7113, DOI 10.1073/pnas.0902636106; O'Suilleabhain CB, 2001, SHOCK, V15, P432, DOI 10.1097/00024382-200115060-00004; Oertli M, 2011, J IMMUNOL, V187, P3578, DOI 10.4049/jimmunol.1101772; Purohit V, 2008, ALCOHOL, V42, P349, DOI 10.1016/j.alcohol.2008.03.131; Rendon JL, 2014, ANN SURG, V259, P582, DOI 10.1097/SLA.0b013e3182a626f2; Rendon JL, 2012, J LEUKOCYTE BIOL, V92, P529, DOI 10.1189/jlb.0212083; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Russ Brendan E., 2013, Frontiers in Genetics, V4, P218, DOI 10.3389/fgene.2013.00218; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schwacha MG, 2002, INT J MOL MED, V10, P239; Silver GM, 2008, J BURN CARE RES, V29, P784, DOI 10.1097/BCR.0b013e31818481bc; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; Tarasenko T, 2007, P NATL ACAD SCI USA, V104, P11382, DOI 10.1073/pnas.0704853104; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Trinchieri G, 2003, IMMUNITY, V19, P641, DOI 10.1016/S1074-7613(03)00296-6; Trotta R, 2012, BLOOD, V119, P3478, DOI 10.1182/blood-2011-12-398099; Venkatesh N, 2004, P NATL ACAD SCI USA, V101, P8969, DOI 10.1073/pnas.0402803101; Yin QY, 2008, J VIROL, V82, P5295, DOI 10.1128/JVI.02380-07; Yin QY, 2008, J BIOL CHEM, V283, P2654, DOI 10.1074/jbc.M708218200	55	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105314	10.1371/journal.pone.0105314	http://dx.doi.org/10.1371/journal.pone.0105314			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126745	Green Submitted, gold, Green Published			2022-12-25	WOS:000340879300103
J	Shiota, S; Suzuki, R; Matsuo, Y; Miftahussurur, M; Tran, TTH; Binh, TT; Yamaoka, Y				Shiota, Seiji; Suzuki, Rumiko; Matsuo, Yuichi; Miftahussurur, Muhammad; Trang Thu Huyen Tran; Tran Thanh Binh; Yamaoka, Yoshio			Helicobacter pylori from Gastric Cancer and Duodenal Ulcer Show Same Phylogeographic Origin in the Andean Region in Colombia	PLOS ONE			English	Article							VIRULENCE FACTORS; INCREASED RISK; CYTOTOXIN PRODUCTION; PEPTIC-ULCER; ASSOCIATION; POLYMORPHISMS; GENE; EPIDEMIOLOGY; INFECTION; PACIFIC	Background: A recent report has shown that the phylogenetic origin of Helicobacter pylori based on multi-locus sequence typing (MLST) was significantly associated with the severity of gastritis in Colombia. However, the potential relationship between phylogenetic origin and clinical outcomes was not examined in that study. If the phylogenetic origin rather than virulence factors were truly associated with clinical outcomes, identifying a population at high risk for gastric cancer in Colombia would be relatively straightforward. In this study, we examined the phylogenetic origins of strains from gastric cancer and duodenal ulcer patients living in Bogota, Colombia. Methods: We included 35 gastric cancer patients and 31 duodenal ulcer patients, which are considered the variant outcomes. The genotypes of cagA and vacA were determined by polymerase chain reaction. The genealogy of these Colombian strains was analyzed by MLST. Bacterial population structure was analyzed using STRUCTURE software. Results: H. pylori strains from gastric cancer and duodenal ulcer patients were scattered in the phylogenetic tree; thus, we did not detect any difference in phylogenetic distribution between gastric cancer and duodenal ulcer strains in the hpEurope group in Colombia. Sixty-six strains, with one exception, were classified as hpEurope irrespective of the cagA and vacA genotypes, and type of disease. STRUCTURE analysis revealed that Colombian hpEurope strains have a phylogenetic connection to Spanish strains. Conclusions: Our study showed that a phylogeographic origin determined by MLST was insufficient for distinguishing between gastric cancer and duodenal ulcer risk among hpEurope strains in the Andean region in Colombia. Our analysis also suggests that hpEurope strains in Colombia were primarily introduced by Spanish immigrants.	[Shiota, Seiji; Suzuki, Rumiko; Matsuo, Yuichi; Miftahussurur, Muhammad; Trang Thu Huyen Tran; Tran Thanh Binh; Yamaoka, Yoshio] Oita Univ, Fac Med, Dept Environm & Prevent Med, Yufu, Japan; [Yamaoka, Yoshio] Michael E DeBakey VA Med Ctr, Dept Medicine Gastroenterol, Houston, TX USA; [Yamaoka, Yoshio] Baylor Coll Med, Houston, TX 77030 USA	Oita University; Baylor College of Medicine; Baylor College of Medicine	Yamaoka, Y (corresponding author), Oita Univ, Fac Med, Dept Environm & Prevent Med, Yufu, Japan.	yyamaoka@oita-u.ac.jp	Matsuo, Yuichi/AAG-4137-2019; Miftahussurur, Muhammad/AAB-6151-2021	Shiota, Seiji/0000-0001-9811-218X; Matsuo, Yuichi/0000-0001-6942-3202; Miftahussurur, Muhammad/0000-0003-1415-6033; Yamaoka, Yoshio/0000-0002-1222-5819	National Institutes of Health [DK62813]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [22390085, 22659087, 24406015, 24659200, 23790798]; Special Coordination Funds for Promoting Science and Technology from the Japan Science and Technology Agency (JST); Grants-in-Aid for Scientific Research [25860544] Funding Source: KAKEN; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062813, P30DK056338] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Special Coordination Funds for Promoting Science and Technology from the Japan Science and Technology Agency (JST); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This report is based on work supported in part by grants from the National Institutes of Health (DK62813) (YY), and grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (22390085, 22659087, 24406015 and 24659200) (YY), (23790798) (SS) and Special Coordination Funds for Promoting Science and Technology from the Japan Science and Technology Agency (JST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 1999, MOL MICROBIOL, V32, P459, DOI 10.1046/j.1365-2958.1999.01382.x; Akopyants NS, 1998, MOL MICROBIOL, V28, P37, DOI 10.1046/j.1365-2958.1998.00770.x; ATHERTON JC, 1995, J BIOL CHEM, V270, P17771, DOI 10.1074/jbc.270.30.17771; CORREA P, 1976, JNCI-J NATL CANCER I, V57, P1027, DOI 10.1093/jnci/57.5.1027; CUELLO C, 1976, JNCI-J NATL CANCER I, V57, P1015, DOI 10.1093/jnci/57.5.1015; de Sablet T, 2011, GUT, V60, P1189, DOI 10.1136/gut.2010.234468; Dominguez-Bello MG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003307; El-Omar EM, 2003, GASTROENTEROLOGY, V124, P1193, DOI 10.1016/S0016-5085(03)00157-4; El-Omar EM, 2000, NATURE, V404, P398, DOI 10.1038/35006081; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; Fock KM, 2009, J GASTROEN HEPATOL, V24, P1587, DOI 10.1111/j.1440-1746.2009.05982.x; Goh KL, 2011, HELICOBACTER, V16, P1, DOI 10.1111/j.1523-5378.2011.00874.x; Kersulyte D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015076; Kodaman N, 2014, P NATL ACAD SCI USA, V111, P1455, DOI 10.1073/pnas.1318093111; Kusters JG, 2006, CLIN MICROBIOL REV, V19, P449, DOI 10.1128/CMR.00054-05; LI WH, 1991, GENETICS, V129, P513; Linz B, 2007, NATURE, V445, P915, DOI 10.1038/nature05562; Lu H, 2005, GASTROENTEROLOGY, V128, P833, DOI 10.1053/j.gastro.2005.01.009; Machado JC, 2001, GASTROENTEROLOGY, V121, P823, DOI 10.1053/gast.2001.28000; Machado JC, 2003, GASTROENTEROLOGY, V125, P364, DOI 10.1016/S0016-5085(03)00899-0; Matsunari O, 2012, J CLIN MICROBIOL, V50, P876, DOI 10.1128/JCM.05562-11; Moodley Y, 2009, SCIENCE, V323, P527, DOI 10.1126/science.1166083; Olbermann P, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001069; Rugge M, 2000, AM J SURG PATHOL, V24, P167, DOI 10.1097/00000478-200002000-00001; Salas A, 2008, AM J HUM BIOL, V20, P584, DOI 10.1002/ajhb.20783; Shiota S, 2013, J DIGEST DIS, V14, P341, DOI 10.1111/1751-2980.12054; Shiota S, 2012, GUT, V61, P469, DOI 10.1136/gutjnl-2011-300317; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Suerbaum S, 2007, NAT REV MICROBIOL, V5, P441, DOI 10.1038/nrmicro1658; Sugimoto M, 2007, J GASTROEN HEPATOL, V22, P1443, DOI 10.1111/j.1440-1746.2006.04613.x; Sugimoto M, 2007, J GASTROEN HEPATOL, V22, P51, DOI 10.1111/j.1440-1746.2006.04442.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Ubukata H, 2011, GASTRIC CANCER, V14, P4, DOI 10.1007/s10120-011-0005-9; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Watada M, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-141; Yamaoka Y, 2000, EPIDEMIOL INFECT, V124, P91, DOI 10.1017/S0950268899003209; Yamaoka Y, 1999, GASTROENTEROLOGY, V117, P342, DOI 10.1053/gast.1999.0029900342; Yamaoka Y, 1998, HELICOBACTER, V3, P241, DOI 10.1046/j.1523-5378.1998.08056.x; Yamaoka Y, 2002, FEBS LETT, V517, P180, DOI 10.1016/S0014-5793(02)02617-0; Yamaoka Y, 2002, GASTROENTEROLOGY, V123, P414, DOI 10.1053/gast.2002.34781; Yamaoka Y, 2009, CLIN MICROBIOL INFEC, V15, P829, DOI 10.1111/j.1469-0691.2009.02967.x; Yamaoka Y, 2010, NAT REV GASTRO HEPAT, V7, P629, DOI 10.1038/nrgastro.2010.154; Yamaoka Y, 2008, INTERNAL MED, V47, P1077, DOI 10.2169/internalmedicine.47.0975	44	9	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e105392	10.1371/journal.pone.0105392	http://dx.doi.org/10.1371/journal.pone.0105392			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121764	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000341017000122
J	Zhu, B; Yan, K; Li, L; Lin, M; Zhang, S; He, Q; Zheng, D; Yang, H; Shao, G				Zhu, B.; Yan, K.; Li, L.; Lin, M.; Zhang, S.; He, Q.; Zheng, D.; Yang, H.; Shao, G.			K63-linked ubiquitination of FANCG is required for its association with the Rap80-BRCA1 complex to modulate homologous recombination repair of DNA interstand crosslinks	ONCOGENE			English	Article							DOUBLE-STRAND BREAKS; BINDING PROTEIN; DAMAGE RESPONSE; DEUBIQUITINATING ENZYME; CANCER SUSCEPTIBILITY; TARGETS BRCA1; ANEMIA; PATHWAY; REPLICATION; GENE	DNA interstrand crosslinks (ICLs) are extremely deleterious lesions that are repaired by homologous recombination (HR) through coordination of Fanconi anemia (FA) proteins and breast cancer susceptibility gene 1 (BRCA1) product, but the exact role these proteins have remains unclear. Here we report that FANCG was modified by the addition of lysine63-linked polyubiquitin chains (K63Ub) in response to DNA damage. We show that FANCG K63Ub was dispensable for monoubiquitination of FANCD2, but was required for FANCG to interact with the Rap80-BRCA1 (receptor-associated protein 80-BRCA1) complex for subsequent modulation of HR repair of ICLs induced by mitomycin C. Mutation of three lysine residues within FANCG to arginine (K182, K258 and K347, 3KR) reduced FANCG K63Ub modification, as well as its interaction with the Rap80-BRCA1 complex, and therefore impeded HR repair. In addition, we demonstrated that K63Ub-modified FANCG was deubiquitinated by BRCC36 complex in vitro and in vivo. Inhibition of BRCC36 resulted in increased K63Ub modification of FANCG. Taken together, our results identify a new role of FANCG in HR repair of ICL through K63Ub-mediated interaction with the Rap80-BRCA1 complex.	[Zhu, B.; Yan, K.; Li, L.; Lin, M.; Zhang, S.; Yang, H.; Shao, G.] Peking Univ, Sch Basic Med Sci, Dept fo Cell Biol, Beijing 100191, Peoples R China; [Zhu, B.; Shao, G.] Peking Univ, Inst Syst Biol, Beijing 100191, Peoples R China; [He, Q.] Peking Univ, Ctr Med & Hlth Anal, Beijing 100191, Peoples R China; [Zheng, D.] Shenzhen Univ, Sch Med, Shenzhen, Guangdong, Peoples R China	Peking University; Peking University; Peking University; Shenzhen University	Yang, H (corresponding author), Peking Univ, Sch Basic Med Sci, Dept fo Cell Biol, 38 Xueyuan Rd, Beijing 100191, Peoples R China.	yanghua@bjmu.edu.cn; gzshao@bjmu.edu.cn	Li, Li/B-8842-2019	Li, Li/0000-0002-8630-3699	Beijing Natural Science Foundation [7122099]; Natural Science Foundation of China [81272915]; Research Fund for the Doctoral Program of Higher Education [20110001110013]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry [JWSL44-8]; 985 Program, Ministry of Education of China	Beijing Natural Science Foundation(Beijing Natural Science Foundation); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education(Research Fund for the Doctoral Program of Higher Education of China (RFDP)); Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars); 985 Program, Ministry of Education of China(Ministry of Education, China)	This work was supported by Beijing Natural Science Foundation (Grant 7122099); Natural Science Foundation of China (Grant 81272915); the Research Fund for the Doctoral Program of Higher Education (20110001110013); the Project Sponsored by the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry (JWSL44-8); 985 Program, Ministry of Education of China.	Akkari YMN, 2000, MOL CELL BIOL, V20, P8283, DOI 10.1128/MCB.20.21.8283-8289.2000; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Clague MJ, 2006, TRENDS CELL BIOL, V16, P551, DOI 10.1016/j.tcb.2006.09.002; Coleman KA, 2011, J BIOL CHEM, V286, P13669, DOI 10.1074/jbc.M110.213728; Cooper EM, 2010, J BIOL CHEM, V285, P10344, DOI 10.1074/jbc.M109.059667; Cooper EM, 2009, EMBO J, V28, P621, DOI 10.1038/emboj.2009.27; D'Andrea AD, 2003, NAT REV CANCER, V3, P23, DOI 10.1038/nrc970; Davies AA, 2001, MOL CELL, V7, P273, DOI 10.1016/S1097-2765(01)00175-7; Deans AJ, 2011, NAT REV CANCER, V11, P467, DOI 10.1038/nrc3088; Deans AJ, 2009, MOL CELL, V36, P943, DOI 10.1016/j.molcel.2009.12.006; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Dronkert MLG, 2001, MUTAT RES-DNA REPAIR, V486, P217, DOI 10.1016/S0921-8777(01)00092-1; Enoiu M, 2012, NUCLEIC ACIDS RES, V40, P8953, DOI 10.1093/nar/gks670; Feng L, 2012, NAT STRUCT MOL BIOL, V19, P201, DOI 10.1038/nsmb.2211; Feng L, 2010, J BIOL CHEM, V285, P30982, DOI 10.1074/jbc.M110.135392; Feng L, 2009, GENE DEV, V23, P719, DOI 10.1101/gad.1770609; Folias A, 2002, HUM MOL GENET, V11, P2591, DOI 10.1093/hmg/11.21.2591; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Greenberg RA, 2006, GENE DEV, V20, P34, DOI 10.1101/gad.1381306; Hofmann K, 2009, DNA REPAIR, V8, P544, DOI 10.1016/j.dnarep.2009.01.003; Hu YD, 2011, GENE DEV, V25, P685, DOI 10.1101/gad.2011011; Huang TT, 2006, NAT REV MOL CELL BIO, V7, P323, DOI 10.1038/nrm1908; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Hussain S, 2003, HUM MOL GENET, V12, P2503, DOI 10.1093/hmg/ddg266; Joenje H, 2001, NAT REV GENET, V2, P446, DOI 10.1038/35076590; Karran P, 2000, CURR OPIN GENET DEV, V10, P144, DOI 10.1016/S0959-437X(00)00069-1; Kim H, 2007, NAT STRUCT MOL BIOL, V14, P710, DOI 10.1038/nsmb1277; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; Kim Y, 2011, NAT GENET, V43, P142, DOI 10.1038/ng.750; Knipscheer P, 2009, SCIENCE, V326, P1698, DOI 10.1126/science.1182372; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Kratz K, 2010, CELL, V142, P77, DOI 10.1016/j.cell.2010.06.022; Liu ZX, 2007, NAT STRUCT MOL BIOL, V14, P716, DOI 10.1038/nsmb1279; Long DT, 2011, SCIENCE, V333, P84, DOI 10.1126/science.1204258; MacKay C, 2010, CELL, V142, P65, DOI 10.1016/j.cell.2010.06.021; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Moldovan GL, 2009, ANNU REV GENET, V43, P223, DOI 10.1146/annurev-genet-102108-134222; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; Nakanishi K, 2005, P NATL ACAD SCI USA, V102, P1110, DOI 10.1073/pnas.0407796102; Nakanishi K, 2011, NAT STRUCT MOL BIOL, V18, P500, DOI 10.1038/nsmb.2029; Narod SA, 2004, NAT REV CANCER, V4, P665, DOI 10.1038/nrc1431; Niedzwiedz W, 2004, MOL CELL, V15, P607, DOI 10.1016/j.molcel.2004.08.009; Raschle M, 2008, CELL, V134, P969, DOI 10.1016/j.cell.2008.08.030; Rahman N, 2007, NAT GENET, V39, P165, DOI 10.1038/ng1959; Rothfuss A, 2004, MOL CELL BIOL, V24, P123, DOI 10.1128/MCB.24.1.123-134.2004; Roy R, 2012, NAT REV CANCER, V12, P68, DOI 10.1038/nrc3181; Sato Y, 2009, EMBO J, V28, P2461, DOI 10.1038/emboj.2009.160; Shao G, P NATL ACAD SCI; Shao G, 2009, GENE DEV, V23, P740, DOI 10.1101/gad.1739609; Sims JJ, 2009, MOL CELL, V33, P775, DOI 10.1016/j.molcel.2009.02.011; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Smogorzewska A, 2010, MOL CELL, V39, P36, DOI 10.1016/j.molcel.2010.06.023; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Stoepker C, 2011, NAT GENET, V43, P138, DOI 10.1038/ng.751; Thompson LH, 2009, MUTAT RES-FUND MOL M, V668, P54, DOI 10.1016/j.mrfmmm.2009.02.003; Tischkowitz MD, 2003, J MED GENET, V40, P1, DOI 10.1136/jmg.40.1.1; Vaz F, 2010, NAT GENET, V42, P406, DOI 10.1038/ng.570; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Wang B, 2009, GENE DEV, V23, P729, DOI 10.1101/gad.1770309; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159; Wang X, 2001, MOL CELL BIOL, V21, P713, DOI 10.1128/MCB.21.3.713-720.2001; Ward IM, 2004, J CELL BIOL, V165, P459, DOI 10.1083/jcb.200403021; Weake VM, 2008, MOL CELL, V29, P653, DOI 10.1016/j.molcel.2008.02.014; Wilson JB, 2008, ONCOGENE, V27, P3641, DOI 10.1038/sj.onc.1211034; Yamamoto K, 2003, MOL CELL BIOL, V23, P5421, DOI 10.1128/MCB.23.15.5421-5430.2003; Yan ZJ, 2012, MOL CELL, V47, P61, DOI 10.1016/j.molcel.2012.05.026; Yang YG, 2005, CARCINOGENESIS, V26, P1731, DOI 10.1093/carcin/bgi134; Yu XC, 2004, MOL CELL BIOL, V24, P9478, DOI 10.1128/MCB.24.21.9478-9486.2004; Zhang NX, 2007, DNA REPAIR, V6, P1670, DOI 10.1016/j.dnarep.2007.06.002; Zhao GY, 2007, MOL CELL, V25, P663, DOI 10.1016/j.molcel.2007.01.029	72	15	16	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 28	2015	34	22					2867	2878		10.1038/onc.2014.229	http://dx.doi.org/10.1038/onc.2014.229			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CJ2OM	25132264				2022-12-25	WOS:000355324300006
J	Zhang, SP; Liu, H; Chuang, CL; Li, XL; Au, MG; Zhang, L; Phillips, ARJ; Scott, DW; Cooper, GJS				Zhang, Shaoping; Liu, Hong; Chuang, Chia Lin; Li, Xiaoling; Au, Maggie; Zhang, Lin; Phillips, Anthony R. J.; Scott, David W.; Cooper, Garth J. S.			The pathogenic mechanism of diabetes varies with the degree of overexpression and oligomerization of human amylin in the pancreatic islet beta cells	FASEB JOURNAL			English	Article						gene-dosage effect; apoptosis; peptide aggregation; transgenic mice; insulin resistance	AMYLOID POLYPEPTIDE; TRANSGENIC MICE; MOUSE MODEL; APOPTOSIS; CYTOTOXICITY; EXPRESSION; INSULIN; ACTIVATION; IAPP; GENE	The aggregation of human amylin (hA) to form cytotoxic structures has been closely associated with the causation of type 2 diabetes. We sought to advance understanding of how altered expression and aggregation of hA might link beta-cell degeneration with diabetes onset and progression, by comparing phenotypes between homozygous and hemizygous hA-transgenic mice. The homozygous mice displayed elevated islet hA that correlated positively with measures of oligomer formation (r = 0.91; P<0.0001). They also developed hyperinsulinemia with transient insulin resistance during the prediabetes stage and then underwent rapid beta-cell loss, culminating in severe juvenile-onset diabetes. The prediabetes stage was prolonged in the hemizygous mice, wherein beta-cell dysfunction and extensive oligomer formation occurred in adulthood at a much later stage, when hA levels were lower (r=-0.60; P<0.0001). This is the first report to show that hAevoked diabetes is associated with age, insulin resistance, progressive islet dysfunction, and beta-cell apoptosis, which interact variably to cause the different diabetes syndromes. The various levels of hA elevation cause different extents of oligomer formation in the disease stages, thus eliciting early-or adult-onset diabetes syndromes, reminiscent of type 1 and 2 diabetes, respectively. Thus, the hA-evoked diabetes phenotypes differ substantively according to degree of amylin overproduction. These findings are relevant to the understanding of the pathogenesis and the development of experimental therapeutics for diabetes.	[Zhang, Shaoping; Liu, Hong; Chuang, Chia Lin; Li, Xiaoling; Au, Maggie; Zhang, Lin; Phillips, Anthony R. J.; Scott, David W.; Cooper, Garth J. S.] Univ Auckland, Sch Biol Sci, Auckland 1010, New Zealand; [Zhang, Shaoping; Phillips, Anthony R. J.; Cooper, Garth J. S.] Univ Auckland, Fac Sci, Maurice Wilkins Ctr Mol BioDiscovery, Auckland 1010, New Zealand; [Cooper, Garth J. S.] Cent Manchester Univ Hosp, NHS Fdn Trust, Ctr Adv Discovery & Expt Therapeut, Manchester, Lancs, England; [Cooper, Garth J. S.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Med & Human Sci, Ctr Endocrinol & Diabet,Inst Human Dev, Manchester, Lancs, England	University of Auckland; University of Auckland; Oxford University Hospitals NHS Foundation Trust; University of Manchester	Cooper, GJS (corresponding author), Univ Auckland, Sch Biol Sci, 3 Symonds St, Auckland 1010, New Zealand.	g.cooper@auckland.ac.nz	Cooper, Garth JS/I-3201-2015	Cooper, Garth JS/0000-0001-5241-3163; Zhang, Shaoping/0000-0003-2969-7043	Endocore Research Associates; Maurice and Phyllis Paykel Trust; Lottery Health (New Zealand); Auckland Medical Research Foundation; University of Auckland; Department of Education (New Zealand) through the Maurice Wilkins Centre of Excellence for Molecular BioDiscovery; Ministry for Business, Innovation, and Employment, New Zealand; Health Research Council of New Zealand	Endocore Research Associates; Maurice and Phyllis Paykel Trust; Lottery Health (New Zealand); Auckland Medical Research Foundation; University of Auckland; Department of Education (New Zealand) through the Maurice Wilkins Centre of Excellence for Molecular BioDiscovery; Ministry for Business, Innovation, and Employment, New Zealand(New Zealand Ministry of Business, Innovation and Employment (MBIE)); Health Research Council of New Zealand(Health Research Council of New Zealand)	The authors thank C. A. Tse (School of Biological Sciences, University of Auckland, Auckland, New Zealand) for outstanding management, administrative assistance, and critical reading of the manuscript; A. Petzer, S. Johnson, Dr. J. Aitken, and C. C. H. Cheung for technical assistance; and the two anonymous reviewers for comprehensive analysis of the manuscript and for numerous insightful comments and suggestions that substantively strengthened the work. This work was funded by grants from Endocore Research Associates; the Maurice and Phyllis Paykel Trust; Lottery Health (New Zealand); the Auckland Medical Research Foundation; the University of Auckland; the Department of Education (New Zealand), through a grant to the Maurice Wilkins Centre of Excellence for Molecular BioDiscovery; by program grants from the Ministry for Business, Innovation, and Employment, New Zealand, and the Health Research Council of New Zealand. The study was facilitated by the Manchester Biomedical Research Centre and the UK National Institute for Health Research Greater Manchester Comprehensive Local Research Network.	Aitken JF, 2010, DIABETES, V59, P161, DOI 10.2337/db09-0548; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc12-s064, 10.2337/dc10-S062, 10.2337/dc13-S067, 10.2337/dc11-S062]; Bonner-Weir S, 2001, DIABETES, V50, pS20, DOI 10.2337/diabetes.50.2007.S20; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Butler AE, 2003, DIABETES, V52, P2304, DOI 10.2337/diabetes.52.9.2304; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Butler AE, 2004, DIABETES, V53, P1509, DOI 10.2337/diabetes.53.6.1509; Cooper GJS, 2010, DIABETOLOGIA, V53, P1011, DOI 10.1007/s00125-010-1715-y; COOPER GJS, 1989, BIOCHIM BIOPHYS ACTA, V1014, P247, DOI 10.1016/0167-4889(89)90220-6; COOPER GJS, 1994, ENDOCR REV, V15, P163, DOI 10.1210/er.15.2.163; COOPER GJS, 1987, P NATL ACAD SCI USA, V84, P8628, DOI 10.1073/pnas.84.23.8628; Couce M, 1996, DIABETES, V45, P1094, DOI 10.2337/diabetes.45.8.1094; DALESSIO DA, 1994, DIABETES, V43, P1457, DOI 10.2337/diabetes.43.12.1457; Despa S, 2012, CIRC RES, V110, P598, DOI [10.1161/CIRCRESAHA.111.258285, 10.1161/circresaha.111.258285]; FOX N, 1993, FEBS LETT, V323, P40, DOI 10.1016/0014-5793(93)81444-5; Goldsbury CS, 1997, J STRUCT BIOL, V119, P17, DOI 10.1006/jsbi.1997.3858; Gong W, 2007, KIDNEY INT, V72, P213, DOI 10.1038/sj.ki.5002305; Green JD, 2004, J BIOL CHEM, V279, P12206, DOI 10.1074/jbc.M312452200; HOPPENER JWM, 1993, DIABETOLOGIA, V36, P1258, DOI 10.1007/BF00400803; Hull RL, 2004, J CLIN ENDOCR METAB, V89, P3629, DOI 10.1210/jc.2004-0405; Hull RL, 2003, DIABETES, V52, P372, DOI 10.2337/diabetes.52.2.372; In't Veld P, 2011, ISLETS, V3, P131, DOI 10.4161/isl.3.4.15728; Janciauskiene S, 2000, BIOCHEM BIOPH RES CO, V267, P619, DOI 10.1006/bbrc.1999.1989; Janson J, 1996, P NATL ACAD SCI USA, V93, P7283, DOI 10.1073/pnas.93.14.7283; Janson J, 1999, DIABETES, V48, P491, DOI 10.2337/diabetes.48.3.491; Kahn SE, 1999, DIABETES, V48, P241, DOI 10.2337/diabetes.48.2.241; Kapurniotu A, 2001, BIOPOLYMERS, V60, P438, DOI 10.1002/1097-0282(2001)60:6<438::AID-BIP10182>3.0.CO;2-A; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2006, METHOD ENZYMOL, V413, P326, DOI 10.1016/S0076-6879(06)13017-7; Konarkowska B, 2006, FEBS J, V273, P3614, DOI 10.1111/j.1742-4658.2006.05367.x; Lin CY, 2007, DIABETES, V56, P1324, DOI 10.2337/db06-1579; LORENZO A, 1994, NATURE, V368, P756, DOI 10.1038/368756a0; LUKINIUS A, 1989, DIABETOLOGIA, V32, P240, DOI 10.1007/BF00285291; Maedler K, 2004, HORM RES, V62, P67, DOI 10.1159/000080503; Meier JJ, 2006, AM J PHYSIOL-ENDOC M, V291, pE1317, DOI 10.1152/ajpendo.00082.2006; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Ritzel RA, 2007, DIABETES, V56, P65, DOI 10.2337/db06-0734; Rumora L, 2002, BIOL CHEM, V383, P1751, DOI 10.1515/BC.2002.196; Soeller WC, 1998, DIABETES, V47, P743, DOI 10.2337/diabetes.47.5.743; Verchere CB, 1996, P NATL ACAD SCI USA, V93, P3492, DOI 10.1073/pnas.93.8.3492; Westermark GT, 2000, MOL MED, V6, P998, DOI 10.1007/BF03402051; WESTERMARK P, 1987, P NATL ACAD SCI USA, V84, P3881, DOI 10.1073/pnas.84.11.3881; WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P5036, DOI 10.1073/pnas.87.13.5036; Wong WPS, 2008, DIABETES, V57, P2737, DOI 10.2337/db06-1755; Zhang SP, 2008, DIABETES, V57, P348, DOI 10.2337/db07-0849; Zhang SP, 2003, J BIOL CHEM, V278, P52810, DOI 10.1074/jbc.M308244200; Zhang SP, 2002, J MOL BIOL, V324, P271, DOI 10.1016/S0022-2836(02)01044-6; Zhang SP, 1999, FEBS LETT, V455, P315, DOI 10.1016/S0014-5793(99)00894-7; Zhao HL, 2009, TRANSL RES, V153, P24, DOI 10.1016/j.trsl.2008.10.009; Zraika S, 2010, DIABETOLOGIA, V53, P1046, DOI 10.1007/s00125-010-1671-6; Zraika S, 2009, DIABETOLOGIA, V52, P626, DOI 10.1007/s00125-008-1255-x	51	33	33	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2014	28	12					5083	5096		10.1096/fj.14-251744	http://dx.doi.org/10.1096/fj.14-251744			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AU9EN	25138158	Green Submitted			2022-12-25	WOS:000345894500006
J	Modica, S; Cariello, M; Morgano, A; Gross, I; Vegliante, MC; Murzilli, S; Salvatore, L; Freund, JN; Sabba, C; Moschetta, A				Modica, Salvatore; Cariello, Marica; Morgano, Annalisa; Gross, Isabelle; Vegliante, Maria Carmela; Murzilli, Stefania; Salvatore, Lorena; Freund, Jean-Noel; Sabba, Carlo; Moschetta, Antonio			Transcriptional Regulation of the Intestinal Nuclear Bile Acid Farnesoid X Receptor (FXR) by the caudal-related Homeobox 2 (CDX2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLUTE TRANSPORTER-ALPHA; ACTIVATED PROTEIN-KINASE; COLON-CANCER CELLS; COLORECTAL-CANCER; MUTANT MICE; GENE CDX2; CHROMOSOMAL INSTABILITY; EXPRESSION; DIFFERENTIATION; BETA	Farnesoid X receptor (FXR, NR1H4) is a bile acid-activated transcription factor that belongs to the nuclear receptor superfamily. It is highly expressed in the enterohepatic system, where it senses bile acid levels to consequently reduce their synthesis while inducing their detoxification. Bile acids are intestinal tumor promoters and their concentrations have to be tightly regulated. Indeed, reduced expression of FXR in the intestine increases colorectal cancer susceptibility in mice, whereas its activation can promote apoptosis in genetically modified cells. Notably, despite the broad knowledge of the FXR enterohepatic transcriptional activity, the molecular mechanisms regulating FXR expression in the intestine are still unknown. Herein, by combining both gain and loss of function approaches and FXR promoter activity studies, we identified caudal-related homeobox 2 (CDX2) transcription factor as a positive regulator of FXR expression in the enterocytes. Our results provide a putative novel tool for modulating FXR expression against bile acid-related colorectal cancer progression.	[Modica, Salvatore; Sabba, Carlo; Moschetta, Antonio] Univ Bari, Dept Interdisciplinary Med, I-70124 Bari, Italy; [Modica, Salvatore; Cariello, Marica; Vegliante, Maria Carmela; Moschetta, Antonio] IRCCS Oncol Giovanni Paolo II, Natl Canc Res Ctr, I-70124 Bari, Italy; [Morgano, Annalisa; Murzilli, Stefania; Salvatore, Lorena] Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, Lab Lipid Metab & Canc, I-66030 Santa Maria Imbaro, Chieti, Italy; [Gross, Isabelle; Freund, Jean-Noel] INSERM, UMR S1113, F-67200 Strasbourg, France; [Gross, Isabelle; Freund, Jean-Noel] Univ Strasbourg, F-67081 Strasbourg, France	Universita degli Studi di Bari Aldo Moro; IRCCS Istituto Tumori Bari Giovanni Paolo II; Consorzio Mario Negri Sud; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Moschetta, A (corresponding author), Univ Bari Aldo Moro, Dept Interdisciplinary Med, Clin Med Cesare Frugoni, Piazza Giulio Cesare 11, I-70124 Bari, Italy.	antonio.moschetta@uniba.it	Cariello, Marica/K-4064-2018; Vegliante, Maria Carmela/K-1732-2018; Gross, Isabelle/I-4972-2016; Vegliante, Maria Carmela/AAC-5888-2022; Moschetta, Antonio/K-6211-2016; Freund, Jean-Noel/R-4383-2016; Moschetta, Antonio/AAC-5295-2022; Gross, Isabelle/P-9859-2019	Vegliante, Maria Carmela/0000-0002-3165-1768; Gross, Isabelle/0000-0002-2783-8773; Vegliante, Maria Carmela/0000-0002-3165-1768; Freund, Jean-Noel/0000-0002-0971-3774; Gross, Isabelle/0000-0002-2783-8773; Sabba', Carlo/0000-0002-9874-8740; Moschetta, Antonio/0000-0003-2123-6074	Italian Association for Cancer Research (AIRC; Milan, Italy) [IG 14732]; Italian Ministry of University and Education (Finanziamenti per la Ricerca di Base IDEAS) [RBID08C9N7]; Italian Ministry of University and Education (Programma Operativo Nazionale) [PON01_01958]; Italian Ministry of University and Education (PRIN) [2010FHH32M_002]; Italian Ministry of Health [GR-2008-1143546, GR-2010-2314703]; Italian Ministry of Health (NR-Net Marie Curie ITN); University of Bari, Italy [ORBA 08WEZJ, 07X7Q1, 06BXVC, IDEA GRBA0802SJ]; CariSPAQ (L'Aquila, Italy)	Italian Association for Cancer Research (AIRC; Milan, Italy)(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of University and Education (Finanziamenti per la Ricerca di Base IDEAS); Italian Ministry of University and Education (Programma Operativo Nazionale); Italian Ministry of University and Education (PRIN)(Ministry of Education, Universities and Research (MIUR)); Italian Ministry of Health(Ministry of Health, Italy); Italian Ministry of Health (NR-Net Marie Curie ITN); University of Bari, Italy; CariSPAQ (L'Aquila, Italy)	This work was supported by Italian Association for Cancer Research (AIRC; Milan, Italy) Grant IG 14732 (to A. M.); the Italian Ministry of University and Education (Finanziamenti per la Ricerca di Base IDEAS RBID08C9N7 (to A. M., Programma Operativo Nazionale PON01_01958 (to A. M.), and PRIN 2010FHH32M_002 to (to A. M.)); Italian Ministry of Health Grants GR-2008-1143546 and GR-2010-2314703 (to A. M.); NR-Net Marie Curie ITN (to A. M.)); University of Bari, Italy, Grants ORBA 08WEZJ, 07X7Q1, 06BXVC, and IDEA GRBA0802SJ (to A. M.); and CariSPAQ (L'Aquila, Italy).	Aoki K, 2003, NAT GENET, V35, P323, DOI 10.1038/ng1265; Baba Y, 2009, CLIN CANCER RES, V15, P4665, DOI 10.1158/1078-0432.CCR-09-0401; Bai YQ, 2003, ONCOGENE, V22, P7942, DOI 10.1038/sj.onc.1206634; Beck F, 1999, P NATL ACAD SCI USA, V96, P7318, DOI 10.1073/pnas.96.13.7318; Bonhomme C, 2003, GUT, V52, P1465, DOI 10.1136/gut.52.10.1465; Brabletz T, 2004, CANCER RES, V64, P6973, DOI 10.1158/0008-5472.CAN-04-1132; CAMA A, 1995, HUM MUTAT, V5, P144, DOI 10.1002/humu.1380050208; Chawengsaksophak K, 1997, NATURE, V386, P84, DOI 10.1038/386084a0; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; da Costa LT, 1999, ONCOGENE, V18, P5010, DOI 10.1038/sj.onc.1202872; Dang DT, 2001, ONCOGENE, V20, P4884, DOI 10.1038/sj.onc.1204645; De Sousa E Melo F, 2013, NAT MED, V19, P614, DOI 10.1038/nm.3174; Degirolamo C, 2011, TRENDS MOL MED, V17, P564, DOI 10.1016/j.molmed.2011.05.010; EE HC, 1995, AM J PATHOL, V147, P586; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Gao N, 2009, DEV CELL, V16, P588, DOI 10.1016/j.devcel.2009.02.010; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Grober J, 1999, J BIOL CHEM, V274, P29749, DOI 10.1074/jbc.274.42.29749; Gross I, 2008, ONCOGENE, V27, P107, DOI 10.1038/sj.onc.1210601; Hinkel I, 2012, GASTROENTEROLOGY, V142, P875, DOI 10.1053/j.gastro.2011.12.037; Holt JA, 2003, GENE DEV, V17, P1581, DOI 10.1101/gad.1083503; Houde M, 2001, J BIOL CHEM, V276, P21885, DOI 10.1074/jbc.M100236200; Huber RM, 2002, GENE, V290, P35, DOI 10.1016/S0378-1119(02)00557-7; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Kazumori H, 2006, GUT, V55, P16, DOI 10.1136/gut.2005.066209; Kim I, 2007, CARCINOGENESIS, V28, P940, DOI 10.1093/carcin/bgl249; Landrier JF, 2006, AM J PHYSIOL-GASTR L, V290, pG476, DOI 10.1152/ajpgi.00430.2005; Lee H, 2006, J LIPID RES, V47, P201, DOI 10.1194/jlr.M500417-JLR200; Lorentz O, 1997, J CELL BIOL, V139, P1553, DOI 10.1083/jcb.139.6.1553; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Mallo GV, 1998, J BIOL CHEM, V273, P14030, DOI 10.1074/jbc.273.22.14030; Maran RRM, 2009, J PHARMACOL EXP THER, V328, P469, DOI 10.1124/jpet.108.145409; Modica S, 2010, GASTROENTEROLOGY, V138, P636, DOI 10.1053/j.gastro.2009.09.060; Modica S, 2009, FRONT BIOSCI-LANDMRK, V14, P4719, DOI 10.2741/3563; Modica S, 2008, CANCER RES, V68, P9589, DOI 10.1158/0008-5472.CAN-08-1791; Otte K, 2003, MOL CELL BIOL, V23, P864, DOI 10.1128/MCB.23.3.864-872.2003; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Rings EHHM, 2001, GASTROENTEROLOGY, V121, P1437, DOI 10.1053/gast.2001.29618; Scholl C, 2007, J CLIN INVEST, V117, P1037, DOI 10.1172/JCI30182; Silberg DG, 2000, GASTROENTEROLOGY, V119, P961, DOI 10.1053/gast.2000.18142; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; Stringer EJ, 2012, DEVELOPMENT, V139, P465, DOI 10.1242/dev.070722; Subtil C, 2007, CANCER LETT, V247, P197, DOI 10.1016/j.canlet.2006.04.004; Suh E, 1996, MOL CELL BIOL, V16, P619; Taupin D, 1999, GASTROENTEROLOGY, V116, P1072, DOI 10.1016/S0016-5085(99)70010-7; Thomas Maria A, 2007, Methods Mol Med, V130, P185; Verzi MP, 2010, DEV CELL, V19, P713, DOI 10.1016/j.devcel.2010.10.006; Wang HB, 1999, MOL CELL, V3, P543, DOI 10.1016/S1097-2765(00)80348-2; Yang F, 2007, CANCER RES, V67, P863, DOI 10.1158/0008-5472.CAN-06-1078; Zhang YQ, 2003, J BIOL CHEM, V278, P104, DOI 10.1074/jbc.M209505200	50	10	10	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28421	28432		10.1074/jbc.M114.571513	http://dx.doi.org/10.1074/jbc.M114.571513			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25138215	Green Published, hybrid			2022-12-25	WOS:000343765400035
J	Verhamme, IM; Bock, PE				Verhamme, Ingrid M.; Bock, Paul E.			Rapid Binding of Plasminogen to Streptokinase in a Catalytic Complex Reveals a Three-step Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Pathogenesis; Fibrinolysis; Fluorescence; Kinetics; Plasmin; Streptokinase	DYSGALACTIAE SUBSP EQUISIMILIS; BLOOD-COAGULATION PROTEINASES; PEPTIDE CHLOROMETHYL KETONES; GLOBAL KINETIC EXPLORER; GROUP-A STREPTOCOCCI; ACTIVE-SITE; HIGH-AFFINITY; FLUORESCENCE PROBES; CONFORMATIONAL ACTIVATION; EQUIMOLAR COMPLEXES	Rapid kinetics demonstrate a three-step pathway of streptokinase (SK) binding to plasminogen (Pg), the zymogen of plasmin (Pm). Formation of a fluorescently silent encounter complex is followed by two conformational tightening steps reported by fluorescence quenches. Forward reactions were defined by time courses of biphasic quenching during complex formation between SK or its COOH-terminal Lys(414) deletion mutant (SKK414) and active site-labeled [Lys]Pg ([5-(acetamido)fluorescein]-d-Phe-Phe-Arg-[Lys]Pg ([5F]FFR-[Lys]Pg)) and by the SK dependences of the quench rates. Active site-blocked Pm rapidly displaced [5F]FFR-[Lys]Pg from the complex. The encounter and final SK[5F]FFR-[Lys]Pg complexes were weakened similarly by SK Lys(414) deletion and blocking of lysine-binding sites (LBSs) on Pg kringles with 6-aminohexanoic acid or benzamidine. Forward and reverse rates for both tightening steps were unaffected by 6-aminohexanoic acid, whereas benzamidine released constraints on the first conformational tightening. This indicated that binding of SK Lys(414) to Pg kringle 4 plays a role in recognition of Pg by SK. The substantially lower affinity of the final SKPg complex compared with SKPm is characterized by a approximate to 25-fold weaker encounter complex and approximate to 40-fold faster off-rates for the second conformational step. The results suggest that effective Pg encounter requires SK Lys(414) engagement and significant non-LBS interactions with the protease domain, whereas Pm binding additionally requires contributions of other lysines. This difference may be responsible for the lower affinity of the SKPg complex and the expression of a weaker pro-exosite for binding of a second Pg in the substrate mode compared with SKPm.	[Verhamme, Ingrid M.; Bock, Paul E.] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA	Vanderbilt University	Bock, PE (corresponding author), Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Med Ctr North C3321A, Nashville, TN 37232 USA.	paul.bock@vanderbilt.edu			National Institutes of Health from the NHLBI [R01 HL056181]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056181] Funding Source: NIH RePORTER	National Institutes of Health from the NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL056181 from the NHLBI (to P. E. B.).	BAJAJ AP, 1977, J BIOL CHEM, V252, P492; Bean RR, 2005, J BIOL CHEM, V280, P7504, DOI 10.1074/jbc.M411637200; Bock PE, 1996, J BIOL CHEM, V271, P1072, DOI 10.1074/jbc.271.2.1072; BOCK PE, 1992, J BIOL CHEM, V267, P14963; BOCK PE, 1992, J BIOL CHEM, V267, P14974; BOCK PE, 1989, ARCH BIOCHEM BIOPHYS, V273, P375, DOI 10.1016/0003-9861(89)90496-7; BODE W, 1976, FEBS LETT, V68, P231, DOI 10.1016/0014-5793(76)80443-7; BOK RA, 1985, BIOCHEMISTRY-US, V24, P3279, DOI 10.1021/bi00334a031; Boxrud PD, 2000, J BIOL CHEM, V275, P14579, DOI 10.1074/jbc.275.19.14579; Boxrud PD, 2000, BIOCHEMISTRY-US, V39, P13974, DOI 10.1021/bi000594i; Boxrud PD, 2004, J BIOL CHEM, V279, P36633, DOI 10.1074/jbc.M405264200; Boxrud PD, 2004, J BIOL CHEM, V279, P36642, DOI 10.1074/jbc.M405265200; Boxrud PD, 2001, J BIOL CHEM, V276, P26084, DOI 10.1074/jbc.M101966200; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; CASTELLINO FJ, 1981, METHOD ENZYMOL, V80, P365; Castellino FJ, 1997, CIBA F SYMP, V212, P46; Chang Y, 1998, BIOCHEMISTRY-US, V37, P3258, DOI 10.1021/bi972284e; CHRISTENSEN U, 1985, FEBS LETT, V182, P43, DOI 10.1016/0014-5793(85)81150-9; CHRISTENSEN U, 1992, BIOCHEM J, V285, P419, DOI 10.1042/bj2850419; CHRISTENSEN U, 1984, BIOCHEM J, V223, P413, DOI 10.1042/bj2230413; CLEMMENSEN I, 1986, EUR J BIOCHEM, V156, P327, DOI 10.1111/j.1432-1033.1986.tb09586.x; Cockell CS, 1998, BIOCHEM J, V333, P99, DOI 10.1042/bj3330099; COLLEN D, 1995, THROMB HAEMOSTASIS, V74, P167; Cook SM, 2014, BIOCHEM J, V458, P23, DOI 10.1042/BJ20131305; Cook SM, 2012, MOL MICROBIOL, V86, P1052, DOI 10.1111/mmi.12037; DAMASCHUN G, 1992, EUR BIOPHYS J BIOPHY, V20, P355; DAVIDSON DJ, 1990, BIOCHEMISTRY-US, V29, P3585, DOI 10.1021/bi00466a023; Deryugina EI, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/564259; DEUTSCH DG, 1970, SCIENCE, V170, P1095, DOI 10.1126/science.170.3962.1095; Friedrich R, 2003, NATURE, V425, P535, DOI 10.1038/nature01962; HENKIN J, 1991, PROG CARDIOVASC DIS, V34, P135, DOI 10.1016/0033-0620(91)90010-J; Ho-Tin-Noe B, 2005, FEBS J, V272, P3387, DOI 10.1111/j.1742-4658.2005.04754.x; HOYLAERTS M, 1982, J BIOL CHEM, V257, P2912; JACKSON KW, 1982, BIOCHEMISTRY-US, V21, P6620, DOI 10.1021/bi00269a001; Johnson KA, 2009, METHOD ENZYMOL, V467, P601, DOI 10.1016/S0076-6879(09)67023-3; Johnson KA, 2009, ANAL BIOCHEM, V387, P30, DOI 10.1016/j.ab.2008.12.025; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Kalia A, 2004, J BACTERIOL, V186, P110, DOI 10.1128/JB.186.1.110-121.2004; Khil J, 2003, J INFECT DIS, V188, P497, DOI 10.1086/377100; Kroh HK, 2012, J BIOL CHEM, V287, P39149, DOI 10.1074/jbc.M112.415562; Laha M, 2011, ANAL BIOCHEM, V415, P105, DOI 10.1016/j.ab.2011.04.025; Law RHP, 2012, CELL REP, V1, P185, DOI 10.1016/j.celrep.2012.02.012; LERCH PG, 1980, EUR J BIOCHEM, V107, P7, DOI 10.1111/j.1432-1033.1980.tb04617.x; Lopardo HA, 2005, J CLIN MICROBIOL, V43, P802, DOI 10.1128/JCM.43.2.802-807.2005; LUCAS MA, 1983, J BIOL CHEM, V258, P4249; Malke H, 2004, INDIAN J MED RES, V119, P48; MANGEL WF, 1990, SCIENCE, V248, P69, DOI 10.1126/science.2108500; MARKUS G, 1978, J BIOL CHEM, V253, P727; MARSHALL JM, 1994, BIOCHEMISTRY-US, V33, P3599, DOI 10.1021/bi00178a017; Marti DN, 1997, BIOCHEMISTRY-US, V36, P11591, DOI 10.1021/bi971316v; MCCANCE SG, 1995, BIOCHEMISTRY-US, V34, P9581, DOI 10.1021/bi00029a035; MCCLINTOCK DK, 1971, BIOCHEM BIOPH RES CO, V43, P694, DOI 10.1016/0006-291X(71)90670-X; Nolan M, 2013, J BIOL CHEM, V288, P29482, DOI 10.1074/jbc.M113.477935; Panizzi P, 2006, J BIOL CHEM, V281, P1169, DOI 10.1074/jbc.M507955200; Panizzi P, 2006, J BIOL CHEM, V281, P26774, DOI 10.1074/jbc.C600171200; PONTING CP, 1992, BIOCHIM BIOPHYS ACTA, V1159, P155, DOI 10.1016/0167-4838(92)90020-E; PONTING CP, 1992, BLOOD COAGUL FIBRIN, V3, P605, DOI 10.1097/00001721-199210000-00012; Preziuso S, 2010, J VET SCI, V11, P67, DOI 10.4142/jvs.2010.11.1.67; REDDY KNN, 1972, J BIOL CHEM, V247, P1683; Sanderson-Smith ML, 2006, J BIOL CHEM, V281, P25965, DOI 10.1074/jbc.M603846200; SCHICK LA, 1974, BIOCHEM BIOPH RES CO, V57, P47, DOI 10.1016/S0006-291X(74)80355-4; SJOHOLM I, 1973, EUR J BIOCHEM, V39, P471, DOI 10.1111/j.1432-1033.1973.tb03146.x; Sun HM, 2004, SCIENCE, V305, P1283, DOI 10.1126/science.1101245; TAYLOR FB, 1968, BIOCHEMISTRY-US, V7, P232, DOI 10.1021/bi00841a028; THEWES T, 1990, J BIOL CHEM, V265, P3906; Tsodikov OV, 1999, BIOPHYS J, V76, P1320, DOI 10.1016/S0006-3495(99)77294-2; VALI Z, 1982, J BIOL CHEM, V257, P2104; VARADI A, 1981, BIOCHEM BIOPH RES CO, V103, P97, DOI 10.1016/0006-291X(81)91665-X; Verhamme IM, 2002, J BIOL CHEM, V277, P6788, DOI 10.1074/jbc.M110257200; Verhamme IM, 2008, J BIOL CHEM, V283, P26137, DOI 10.1074/jbc.M804038200; VIOLAND BN, 1976, J BIOL CHEM, V251, P3906; VIOLAND BN, 1978, J BIOL CHEM, V253, P5395; Walker MJ, 2005, TRENDS MICROBIOL, V13, P308, DOI 10.1016/j.tim.2005.05.006; Wang SG, 1999, BIOCHEMISTRY-US, V38, P5232, DOI 10.1021/bi981915h; Wang SG, 2000, EUR J BIOCHEM, V267, P3994, DOI 10.1046/j.1432-1327.2000.01434.x; Wang XQ, 1998, SCIENCE, V281, P1662, DOI 10.1126/science.281.5383.1662; WEISEL JW, 1994, J MOL BIOL, V235, P1117, DOI 10.1006/jmbi.1994.1061; WIMAN B, 1979, BIOCHIM BIOPHYS ACTA, V579, P142, DOI 10.1016/0005-2795(79)90094-1; WOHL RC, 1980, J BIOL CHEM, V255, P2005; WOHL RC, 1978, J BIOL CHEM, V253, P1402; Zhang YL, 2012, J BIOL CHEM, V287, P42093, DOI 10.1074/jbc.M112.417808	81	14	14	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					28006	28018		10.1074/jbc.M114.589077	http://dx.doi.org/10.1074/jbc.M114.589077			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25138220	Green Published, hybrid			2022-12-25	WOS:000342852800053
J	Park, SH; Kim, J; Do, KH; Park, J; Oh, CG; Choi, HJ; Song, BG; Lee, SJ; Kim, YS; Moon, Y				Park, Seong-Hwan; Kim, Juil; Do, Kee Hun; Park, Jiyeon; Oh, Chang Gyu; Choi, Hye Jin; Song, Bo Gyoung; Lee, Seung Joon; Kim, Yong Sik; Moon, Yuseok			Activating Transcription Factor 3-mediated Chemo-intervention with Cancer Chemokines in a Noncanonical Pathway under Endoplasmic Reticulum Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; MESSENGER-RNA STABILITY; TNF-ALPHA; GENE-EXPRESSION; DOWN-REGULATION; PROTEIN-KINASE; RESPONSE GENE; UP-REGULATION; COLON-CANCER; CELLS	The cell-protective features of the endoplasmic reticulum (ER) stress response are chronically activated in vigorously growing malignant tumor cells, which provide cellular growth advantages over the adverse microenvironment including chemotherapy. As an intervention with ER stress responses in the intestinal cancer cells, preventive exposure to flavone apigenin potentiated superinduction of a regulatory transcription factor, activating transcription factor 3 (ATF3), which is also known to be an integral player coordinating ER stress response-related gene expression. ATF3 superinduction was due to increased turnover of ATF3 transcript via stabilization with HuR protein in the cancer cells under ER stress. Moreover, enhanced ATF3 caused inhibitory action against ER stress-induced cancer chemokines that are potent mediators determining the survival and metastatic potential of epithelial cancer cells. Although enhanced ATF3 was a negative regulator of the well known proinflammatory transcription factor NF-kappa B, blocking of NF-kappa B signaling did not affect ER stress-induced chemokine expression. Instead, immediately expressed transcription factor early growth response protein 1 (EGR-1) was positively involved in cancer chemokine induction by ER stressors. ER stress-induced EGR-1 and subsequent chemokine production were repressed by ATF3. Mechanistically, ATF3 directly interacted with and recruited HDAC1 protein, which led to epigenetic suppression of EGR-1 expression and subsequent chemokine production. Conclusively, super-induced ATF3 attenuated ER stress-induced cancer chemokine expression by epigenetically interfering with induction of EGR-1, a transcriptional modulator crucial to cancer chemokine production. Thus, these results suggest a potent therapeutic intervention of ER stress response-related cancer-favoring events by ATF3.	[Park, Seong-Hwan; Kim, Juil; Do, Kee Hun; Park, Jiyeon; Oh, Chang Gyu; Choi, Hye Jin; Song, Bo Gyoung; Lee, Seung Joon; Moon, Yuseok] Pusan Natl Univ, Sch Med, Dept Biomed Sci, Lab Mucosal Exposome & Biomodulat, Yangsan 626870, South Korea; [Park, Seong-Hwan; Moon, Yuseok] Pusan Natl Univ, Res Inst Basic Sci, Pusan 609735, South Korea; [Park, Seong-Hwan; Moon, Yuseok] Pusan Natl Univ, Med Res Inst, Pusan 609735, South Korea; [Kim, Yong Sik] Seoul Natl Univ, Dept Pharmacol, Coll Med, Seoul 110799, South Korea; [Moon, Yuseok] Immunoregulatory Therapeut Grp Brain Busan 21 Pro, Pusan 609735, South Korea	Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University; Seoul National University (SNU)	Moon, Y (corresponding author), Pusan Natl Univ, Sch Med, Dept Biomed Sci, Yangsan 626870, South Korea.	moon@pnu.edu	Yuseok Moon, ATS/AAE-4364-2020; KIM, Yong Sik/J-5418-2012	KIM, Yong Sik/0000-0003-3763-4544; MOON, YUSEOK/0000-0001-8686-8166	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science and Technology [2012R1A1A2005837]; Korean Health Technology Research and Development Project, Ministry of Health and Welfare, Republic of Korea [HI13C0259]	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science and Technology; Korean Health Technology Research and Development Project, Ministry of Health and Welfare, Republic of Korea	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea, funded by Ministry of Education, Science and Technology Grant 2012R1A1A2005837, and Grant HI13C0259 from the Korean Health Technology Research and Development Project, Ministry of Health and Welfare, Republic of Korea.	Ahmed MM, 1997, J BIOL CHEM, V272, P33056, DOI 10.1074/jbc.272.52.33056; Bertin J, 1999, J BIOL CHEM, V274, P12955, DOI 10.1074/jbc.274.19.12955; Bethel-Brown C, 2011, J IMMUNOL, V186, P4119, DOI 10.4049/jimmunol.1002235; Bowie A, 2000, J LEUKOCYTE BIOL, V67, P508, DOI 10.1002/jlb.67.4.508; BROCKMAN JA, 1995, MOL CELL BIOL, V15, P2809; COLEMAN DL, 1992, J IMMUNOL, V149, P3045; Coope A, 2012, J BIOL CHEM, V287, P15580, DOI 10.1074/jbc.M111.315218; Cui MZ, 1996, J BIOL CHEM, V271, P2731, DOI 10.1074/jbc.271.5.2731; Decker EL, 2003, NUCLEIC ACIDS RES, V31, P911, DOI 10.1093/nar/gkg186; Dieckgraefe BK, 1999, AM J PHYSIOL-GASTR L, V276, pG322, DOI 10.1152/ajpgi.1999.276.2.G322; Do KH, 2012, BIOCHEM PHARMACOL, V84, P513, DOI 10.1016/j.bcp.2012.05.015; Egan LJ, 2003, AM J PHYSIOL-CELL PH, V285, pC1028, DOI 10.1152/ajpcell.00167.2003; Garg AD, 2012, TRENDS MOL MED, V18, P589, DOI 10.1016/j.molmed.2012.06.010; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Goldberg JE, 2010, CURR DRUG TARGETS, V11, P1133; Hackl C, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-668; Hershko DD, 2004, J CELL BIOCHEM, V91, P951, DOI 10.1002/jcb.20014; Hoetzenecker W, 2012, NAT MED, V18, P128, DOI 10.1038/nm.2557; Hollman PCH, 1999, FREE RADICAL RES, V31, pS75, DOI 10.1080/10715769900301351; Hua B, 2006, J BIOL CHEM, V281, P1620, DOI 10.1074/jbc.M508471200; Hung JH, 2004, J BIOL CHEM, V279, P46384, DOI 10.1074/jbc.M403568200; Jeong SH, 2010, EXP DERMATOL, V19, pE206, DOI 10.1111/j.1600-0625.2009.01050.x; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; Jiang QQ, 2000, J IMMUNOL, V165, P3541, DOI 10.4049/jimmunol.165.7.3541; Kawauchi J, 2002, J BIOL CHEM, V277, P39025, DOI 10.1074/jbc.M202974200; Koh IU, 2010, FEBS J, V277, P2304, DOI 10.1111/j.1742-4658.2010.07646.x; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Lefort EC, 2013, MOL NUTR FOOD RES, V57, P126, DOI 10.1002/mnfr.201200424; Li SG, 1997, TOXICOL APPL PHARM, V147, P331, DOI 10.1006/taap.1997.8279; Liang GS, 1996, J BIOL CHEM, V271, P1695, DOI 10.1074/jbc.271.3.1695; Litvak V, 2009, NAT IMMUNOL, V10, P437, DOI 10.1038/ni.1721; Liu GB, 2012, J CELL MOL MED, V16, P1618, DOI 10.1111/j.1582-4934.2011.01401.x; Lu D, 2006, J BIOL CHEM, V281, P10473, DOI 10.1074/jbc.M509278200; Luo JL, 2004, CANCER CELL, V6, P297, DOI 10.1016/j.ccr.2004.08.012; Luo SZ, 2003, J BIOL CHEM, V278, P37375, DOI 10.1074/jbc.M303619200; Martineti V, 2005, ENDOCR-RELAT CANCER, V12, P455, DOI 10.1677/erc.1.00861; Maru Yoshiro, 2011, Clin Calcium, V21, P364, DOI CliCa1103364371; Marwarha G, 2012, CELL SIGNAL, V24, P484, DOI 10.1016/j.cellsig.2011.09.029; Miean KH, 2001, J AGR FOOD CHEM, V49, P3106, DOI 10.1021/jf000892m; MILBRANDT J, 1987, SCIENCE, V238, P797, DOI 10.1126/science.3672127; Moenner M, 2007, CANCER RES, V67, P10631, DOI 10.1158/0008-5472.CAN-07-1705; Moon Y, 2007, BIOL PHARM BULL, V30, P1808, DOI 10.1248/bpb.30.1808; Niknejad N, 2014, INT J CANCER, V134, P268, DOI 10.1002/ijc.28369; Pan YX, 2005, J BIOL CHEM, V280, P34609, DOI 10.1074/jbc.M507802200; Park SH, 2013, J IMMUNOL, V191, P5170, DOI 10.4049/jimmunol.1301145; Patel D, 2007, INT J ONCOL, V30, P233; Qin J, 2011, HEPATO-GASTROENTEROL, V58, P1951, DOI 10.5754/hge11352; Roger T, 1998, BBA-GENE STRUCT EXPR, V1398, P275, DOI 10.1016/S0167-4781(98)00075-X; Savidge TC, 2006, PEDIATR RES, V59, P89, DOI 10.1203/01.pdr.0000195101.74184.e3; Schonthal AH, 2013, BIOCHEM PHARMACOL, V85, P653, DOI 10.1016/j.bcp.2012.09.012; Schonthal Axel H, 2012, Front Biosci (Schol Ed), V4, P412; Seijffers R, 2007, J NEUROSCI, V27, P7911, DOI 10.1523/JNEUROSCI.5313-06.2007; Suganami T, 2009, CIRC RES, V105, P25, DOI 10.1161/CIRCRESAHA.109.196261; Verfaillie T, 2013, CANCER LETT, V332, P249, DOI 10.1016/j.canlet.2010.07.016; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Whitmore MM, 2007, J IMMUNOL, V179, P3622, DOI 10.4049/jimmunol.179.6.3622; Whitney ML, 2009, BIOCHEM BIOPH RES CO, V379, P451, DOI 10.1016/j.bbrc.2008.12.079; Xie YB, 2009, NUCLEIC ACIDS RES, V37, P4100, DOI 10.1093/nar/gkp333; Xu ZJ, 2001, J IMMUNOL, V167, P6975, DOI 10.4049/jimmunol.167.12.6975; Yang H, 2009, BIOCHEM PHARMACOL, V77, P1105, DOI 10.1016/j.bcp.2008.11.028; Yao J, 1997, J BIOL CHEM, V272, P17795, DOI 10.1074/jbc.272.28.17795; Yin X, 2008, ONCOGENE, V27, P2118, DOI 10.1038/sj.onc.1210861; Yuan XL, 2013, CANCER RES, V73, P3625, DOI 10.1158/0008-5472.CAN-12-3879	63	19	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					27118	27133		10.1074/jbc.M114.568717	http://dx.doi.org/10.1074/jbc.M114.568717			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25122760	Green Published, hybrid			2022-12-25	WOS:000342853900038
J	Bumke-Vogt, C; Osterhoff, MA; Borchert, A; Guzman-Perez, V; Sarem, Z; Birkenfeld, AL; Bahr, V; Pfeiffer, AFH				Bumke-Vogt, Christiane; Osterhoff, Martin A.; Borchert, Andrea; Guzman-Perez, Valentina; Sarem, Zeinab; Birkenfeld, Andreas L.; Baehr, Volker; Pfeiffer, Andreas F. H.			The Flavones Apigenin and Luteolin Induce FOXO1 Translocation but Inhibit Gluconeogenic and Lipogenic Gene Expression in Human Cells	PLOS ONE			English	Article							RESVERATROL SUPPLEMENTATION; INSULIN SENSITIVITY; TRANSCRIPTION; PREVENTION; PHOSPHORYLATION; METABOLISM; PROTEINS; DIETS	The flavones apigenin (4',5,7,-trihydroxyflavone) and luteolin (3',4',5,7,-tetrahydroxyflavone) are plant secondary metabolites with antioxidant, antiinflammatory, and anticancer activities. We evaluated their impact on cell signaling pathways related to insulin-resistance and type 2 diabetes. Apigenin and luteolin were identified in our U-2 OS (human osteosarcoma) cell screening assay for micronutrients triggering rapid intracellular translocation of the forkhead box transcription factor O1 (FOXO1), an important mediator of insulin signal transduction. Insulin reversed the translocation of FOXO1 as shown by live cell imaging. The impact on the expression of target genes was evaluated in HepG2 (human hepatoma) cells. The mRNA-expression of the gluconeogenic enzymes phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase (G6Pc), the lipogenic enzymes fatty-acid synthase (FASN) and acetyl-CoA-carboxylase (ACC) were down-regulated by both flavones with smaller effective dosages of apigenin than for luteolin. PKB/AKT-, PRAS40-, p70S6K-, and S6-phosphorylation was reduced by apigenin and luteolin but not that of the insulin-like growth factor receptor IGF-1R by apigenin indicating a direct inhibition of the PKB/AKT-signaling pathway distal to the IGF-1 receptor. N-acetyl-L-cysteine did not prevent FOXO1 nuclear translocation induced by apigenin and luteolin, suggesting that these flavones do not act via oxidative stress. The roles of FOXO1, FOXO3a, AKT, sirtuin1 (SIRT1), and nuclear factor (erythroid-derived2)-like2 (NRF2), investigated by siRNA knockdown, showed differential patterns of signal pathways involved and a role of NRF2 in the inhibition of gluconeogenic enzyme expression. We conclude that these flavones show an antidiabetic potential due to reduction of gluconeogenic and lipogenic capacity despite inhibition of the PKB/AKT pathway which justifies detailed investigation in vivo.	[Bumke-Vogt, Christiane; Osterhoff, Martin A.; Borchert, Andrea; Guzman-Perez, Valentina; Sarem, Zeinab; Pfeiffer, Andreas F. H.] German Inst Human Nutr, Dept Clin Nutr, Nuthetal, Germany; [Bumke-Vogt, Christiane; Osterhoff, Martin A.; Birkenfeld, Andreas L.; Baehr, Volker; Pfeiffer, Andreas F. H.] Charite, Dept Endocrinol Diabetol & Nutr, D-13353 Berlin, Germany; [Guzman-Perez, Valentina] Pontificia Univ Javeriana, Fac Sci, Dept Biochem & Nutr, Bogota, Colombia	Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Pontificia Universidad Javeriana	Osterhoff, MA (corresponding author), German Inst Human Nutr, Dept Clin Nutr, Nuthetal, Germany.	martino@dife.de	Pfeiffer, Andreas F.H./AAJ-2311-2020; Guzmán-Pérez, Valentina/AAB-5471-2020; Birkenfeld, Andreas L./U-3954-2019	Pfeiffer, Andreas F.H./0000-0002-6887-0016; Birkenfeld, Andreas L./0000-0003-1407-9023; Guzman-Perez, Valentina/0000-0002-6668-3161	"Investitionsbank Berlin" (IBB) [10140311]; "German Academic Exchange Service" (DAAD) [A/09/72490]	"Investitionsbank Berlin" (IBB); "German Academic Exchange Service" (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	MAO was in part funded by "Investitionsbank Berlin" (IBB): http://www.ibb.de/Foerderangebote.aspx. Project Title: "Entwicklung einer biotechnologischen Methode zur Identifikation gesundheitlich vorteilhafter Pflanzeninhaltsstoffe zur Pravention von Diabetes Typ 2" (Ref-No: 10140311). VG was funded by the "German Academic Exchange Service" (DAAD): https://www.daad.de/de/index.html. (Ref-No: A/09/72490). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arafat AM, 2009, J CLIN ENDOCR METAB, V94, P5093, DOI 10.1210/jc.2009-0875; Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Besse-Patin Aurele, 2014, Int J Cell Biol, V2014, P519153, DOI 10.1155/2014/519153; Brasnyo P, 2011, BRIT J NUTR, V106, P383, DOI 10.1017/S0007114511000316; Cooper AJ, 2012, DIABETES CARE, V35, P1293, DOI 10.2337/dc11-2388; Crandall JP, 2008, NAT CLIN PRACT ENDOC, V4, P382, DOI 10.1038/ncpendmet0843; Crandall JP, 2012, J GERONTOL A-BIOL, V67, P1307, DOI 10.1093/gerona/glr235; Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101; Daitoku H, 2011, BBA-MOL CELL RES, V1813, P1954, DOI 10.1016/j.bbamcr.2011.03.001; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Eijkelenboom A, 2013, NAT REV MOL CELL BIO, V14, P83, DOI 10.1038/nrm3507; Jang S, 2008, P NATL ACAD SCI USA, V105, P7534, DOI 10.1073/pnas.0802865105; Lien EJ, 1999, FREE RADICAL BIO MED, V26, P285, DOI 10.1016/S0891-5849(98)00190-7; Lopez-Lazaro M, 2009, MINI-REV MED CHEM, V9, P31, DOI 10.2174/138955709787001712; Marniemi J, 2005, NUTR METAB CARDIOVAS, V15, P188, DOI 10.1016/j.numecd.2005.01.001; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Okada K, 2013, J GASTROENTEROL, V48, P620, DOI 10.1007/s00535-012-0659-z; Park JM, 2010, BIOCHEM BIOPH RES CO, V403, P329, DOI 10.1016/j.bbrc.2010.11.028; Paulweber B, 2010, HORM METAB RES, V42, pS3, DOI 10.1055/s-0029-1240928; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; Poulsen MM, 2013, DIABETES, V62, P1186, DOI 10.2337/db12-0975; Ruela-de-Sousa RR, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.18; Salas-Salvado J, 2014, ANN INTERN MED, V160, P1, DOI 10.7326/M13-1725; Shukla S, 2010, PHARM RES-DORDR, V27, P962, DOI 10.1007/s11095-010-0089-7; Timmers S, 2011, CELL METAB, V14, P612, DOI 10.1016/j.cmet.2011.10.002; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190; van der Horst A, 2006, NAT CELL BIOL, V8, P1064, DOI 10.1038/ncb1469; Weickert MO, 2011, AM J CLIN NUTR, V94, P459, DOI 10.3945/ajcn.110.004374; Xiong SQ, 2011, J BIOL CHEM, V286, P5289, DOI 10.1074/jbc.M110.163667; Zhang XH, 2002, J BIOL CHEM, V277, P45276, DOI 10.1074/jbc.M208063200	30	46	51	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e104321	10.1371/journal.pone.0104321	http://dx.doi.org/10.1371/journal.pone.0104321			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136826	Green Published, Green Submitted, gold			2022-12-25	WOS:000340742100028
J	Falcao, ASC; Kataoka, MSD; Ribeiro, NAB; Diniz, JAP; Alves, SM; Ribeiro, ALR; de Siqueira, AS; da Silva, AL; Ramos, RTJ; Freitas, VM; Jaeger, RG; Pinheiro, JJV				Carreira Falcao, Aline Semblano; da Silva Kataoka, Maria Sueli; Bailao Ribeiro, Nelson Antonio; Picanco Diniz, Jose Antonio, Jr.; Alves, Sergio Melo, Jr.; Ribeiro Ribeiro, Andre L.; de Siqueira, Adriane Sousa; da Silva, Artur Luiz; Juca Ramos, Rommel Thiago; Freitas, Vanessa M.; Jaeger, Ruy G.; Pinheiro, Joao J. V.			A Novel Cell Line Derived from Pleomorphic Adenoma Expresses MMP2, MMP9, TIMP1, TIMP2, and Shows Numeric Chromosomal Anomalies	PLOS ONE			English	Article							BURROWS-WHEELER TRANSFORM; SALIVARY-GLAND; MATRIX METALLOPROTEINASES; TISSUE INHIBITORS; BASEMENT-MEMBRANE; READ ALIGNMENT; CANCER; GENE; AMELOBLASTOMA; MICROSCOPY	Pleomorphic adenoma is the most common salivary gland neoplasm, and it can be locally invasive, despite its slow growth. This study aimed to establish a novel cell line (AP-1) derived from a human pleomorphic adenoma sample to better understand local invasiveness of this tumor. AP-1 cell line was characterized by cell growth analysis, expression of epithelial and myoepithelial markers by immunofluorescence, electron microscopy, 3D cell culture assays, cytogenetic features and transcriptomic study. Expression of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs)was also analyzed by immunofluorescence and zymography. Furthermore, epithelial and myoepithelial markers, MMPs and TIMPs were studied in the tumor that originated the cell line. AP-1 cells showed neoplastic epithelial and myoepithelial markers, such as cytokeratins, vimentin, S100 protein and smooth-muscle actin. These molecules were also found in vivo, in the tumor that originated the cell line. MMPs and TIMPs were observed in vivo and in AP-1 cells. Growth curve showed that AP-1 exhibited a doubling time of 3.342 days. AP-1 cells grown inside Matrigel recapitulated tumor architecture. Different numerical and structural chromosomal anomalies were visualized in cytogenetic analysis. Transcriptomic analysis addressed expression of 7 target genes (VIM, TIMP2, MMP2, MMP9, TIMP1, ACTA2 e PLAG1). Results were compared to transcriptomic profile of nonneoplastic salivary gland cells (HSG). Only MMP9 was not expressed in both libraries, and VIM was expressed solely in AP-1 library. The major difference regarding gene expression level between AP-1 and HSG samples occurred for MMP2. This gene was 184 times more expressed in AP-1 cells. Our findings suggest that AP-1 cell line could be a useful model for further studies on pleomorphic adenoma biology.	[Carreira Falcao, Aline Semblano; da Silva Kataoka, Maria Sueli; Alves, Sergio Melo, Jr.; Ribeiro Ribeiro, Andre L.; Pinheiro, Joao J. V.] Fed Univ Para UFPA, Sch Dent, Dept Oral & Maxillofacial Pathol, Belem, Para, Brazil; [Bailao Ribeiro, Nelson Antonio] Evandro Chagas Inst, Mol Biol Lab, Belem, Para, Brazil; [Picanco Diniz, Jose Antonio, Jr.] Evandro Chagas Inst, Electron Microscopy Lab, Belem, Para, Brazil; [Alves, Sergio Melo, Jr.; Ribeiro Ribeiro, Andre L.] Univ Ctr Para CESUPA, Sch Dent, Dept Oral & Maxillofacial Surg, Belem, Para, Brazil; [de Siqueira, Adriane Sousa; Freitas, Vanessa M.; Jaeger, Ruy G.; Pinheiro, Joao J. V.] Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, Sao Paulo, Brazil; [da Silva, Artur Luiz; Juca Ramos, Rommel Thiago] Univ Fed Para UFPA, Fed Univ Para, Inst Biol Sci, Belem, Para, Brazil	Universidade Federal do Para; Instituto Evandro Chagas; Instituto Evandro Chagas; Centro Universitario do Estado do Para (CESUPA); Universidade de Sao Paulo; Universidade Federal do Para	Pinheiro, JJV (corresponding author), Fed Univ Para UFPA, Sch Dent, Dept Oral & Maxillofacial Pathol, Belem, Para, Brazil.	joaopinheiro@ufpa.br	Pinheiro, João/AAR-1577-2020; Ramos, Rommel Thiago Juca/L-9329-2013; Freitas, Vanessa M/D-7897-2012; Ribeiro, Andre Luis/K-2558-2013; Luiz Silva, Artur da Costa da/AAI-3516-2021; Ribeiro, Andre/C-9338-2019; Jaeger, Ruy G/G-8230-2011; Alves, Sergio/AAE-9583-2019; Siqueira, Adriane S/D-8352-2013; da Silva Kataoka, Maria Sueli/GON-5256-2022; Pinheiro, João JV/H-2653-2012	Pinheiro, João/0000-0002-6914-6441; Ramos, Rommel Thiago Juca/0000-0002-8032-1474; Freitas, Vanessa M/0000-0001-9613-8626; Ribeiro, Andre Luis/0000-0001-8124-2156; Luiz Silva, Artur da Costa da/0000-0002-4082-1132; Ribeiro, Andre/0000-0001-8124-2156; Jaeger, Ruy G/0000-0002-1564-0356; Alves, Sergio/0000-0003-0272-9279; Pinheiro, João JV/0000-0002-6914-6441	Para State Research Foundation (FAPESPA) [060/2007]; Rede Paraense de Genomica e Protemica; Brazilian National Council for Scientific and Technological Development (CNPq) [480752/2010-9]; State of Sao Paulo Research Foundation (FAPESP) [2009/17336-6]; CNPq [504667/2008-4]	Para State Research Foundation (FAPESPA)(Fundacao Amazonia de Amparo a Estudos e Pesquisas (FAPESPA)); Rede Paraense de Genomica e Protemica; Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); State of Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was supported by Para State Research Foundation (FAPESPA, grant 060/2007), Rede Paraense de Genomica e Proteomica, and Brazilian National Council for Scientific and Technological Development (CNPq, grant 480752/2010-9). Adriane S. Siqueira is recipient of Graduate fellowship from the State of Sao Paulo Research Foundation (FAPESP, grant 2009/17336-6). Joao J. V. Pinheiro is recipient of a Post Doctoral fellowship from CNPq (504667/2008-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antony J, 2012, HEAD NECK PATHOL, V6, P1, DOI 10.1007/s12105-011-0281-z; Bahrami A, 2012, HEAD NECK PATHOL, V6, P377, DOI 10.1007/s12105-012-0330-2; Bahrami A, 2012, HEAD NECK PATHOL, V6, P328, DOI 10.1007/s12105-012-0353-8; Blankenberg D, 2010, BIOINFORMATICS, V26, P1783, DOI 10.1093/bioinformatics/btq281; BULLERDIEK J, 1993, CYTOGENETIC SUBTYPIN; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; DeRoche TC, 2008, ARCH PATHOL LAB MED, V132, P1907, DOI 10.1043/1543-2165-132.12.1907; Duffy MJ, 2008, J PATHOL, V214, P283, DOI 10.1002/path.2282; Ellis GL, 1996, TUMORS SALIVARY GLAN; Freitas VM, 2004, ORAL ONCOL, V40, P483, DOI 10.1016/j.oraloncology.2003.10.002; Friedrich RE, 2005, ANTICANCER RES, V25, P1703; HURET JL, 2010, ATLAS GENETICS CYTOG; Ito FA, 2009, MED ORAL PATOL ORAL, V14, pE57; Jaeger MMM, 1997, VIRCHOWS ARCH, V430, P467, DOI 10.1007/s004280050057; Jiang YF, 2002, ONCOGENE, V21, P2245, DOI 10.1038/sj.onc.1205291; Kas K, 1998, J BIOL CHEM, V273, P23026, DOI 10.1074/jbc.273.36.23026; Kas K, 1997, GENOMICS, V43, P349, DOI 10.1006/geno.1997.4819; Kitagawa M, 2007, INT J ONCOL, V31, P339; KLIGERMAN AD, 1977, J FISH RES BOARD CAN, V34, P266, DOI 10.1139/f77-039; KONDO T, 1971, CANCER-AM CANCER SOC, V27, P403, DOI 10.1002/1097-0142(197102)27:2<403::AID-CNCR2820270225>3.0.CO;2-B; Li H, 2012, BIOINFORMATICS, V28, P1838, DOI 10.1093/bioinformatics/bts280; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Maruyama S, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-247; Mendenhall WM, 2008, AM J CLIN ONCOL-CANC, V31, P95, DOI 10.1097/COC.0b013e3181595ae0; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Pereira Antonio L.A., 2005, Rev. Bras. Otorrinolaringol., V71, P81, DOI 10.1590/S0034-72992005000100014; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Riad MA, 2011, LARYNGOSCOPE, V121, P1467, DOI 10.1002/lary.21830; Rosa LEB, 1997, ORAL ONCOL, V33, P209, DOI 10.1016/S0964-1955(96)00070-X; Sandberg AA, 2010, CANCER GENET CYTOGEN, V203, P102, DOI 10.1016/j.cancergencyto.2010.10.004; SANDROS J, 1990, CANCER GENET CYTOGEN, V44, P153, DOI 10.1016/0165-4608(90)90042-9; SEABRIGH.M, 1971, LANCET, V2, P971; Siqueira AS, 2010, HISTOPATHOLOGY, V57, P128, DOI 10.1111/j.1365-2559.2010.03596.x; Stetler-Stevenson WG, 2008, CANCER METAST REV, V27, P57, DOI 10.1007/s10555-007-9105-8; Stetler-Stevenson WG, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.127re6; Thomas GT, 1999, ORAL ONCOL, V35, P227, DOI 10.1016/S1368-8375(99)00004-4; Thompson MW, 1991, THOMPSON THOMPSON GE; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Yurchenco PD, 2004, MATRIX BIOL, V22, P521, DOI 10.1016/j.matbio.2003.10.006; Zhang XJ, 2009, HISTOPATHOLOGY, V55, P250, DOI 10.1111/j.1365-2559.2009.03355.x	43	7	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105231	10.1371/journal.pone.0105231	http://dx.doi.org/10.1371/journal.pone.0105231			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137137	Green Submitted, Green Published, gold			2022-12-25	WOS:000340742100078
J	Fournier, P; Dumont, A; Tourigny, C; Philibert, A; Coulibaly, A; Traore, M				Fournier, Pierre; Dumont, Alexandre; Tourigny, Caroline; Philibert, Aline; Coulibaly, Aliou; Traore, Mamadou			The Free Caesareans Policy in Low-Income Settings: An Interrupted Time Series Analysis in Mali (2003-2012)	PLOS ONE			English	Article							EMERGENCY OBSTETRIC CARE; CESAREAN DELIVERY; MATERNAL MORTALITY; HEALTH; OUTCOMES; QUALITY; ACCESS; TRENDS; BIRTH; RATES	Introduction: Several countries have instituted fee exemptions for caesareans to reduce maternal and newborn mortality. Objectives: To evaluate the effect of fee exemptions for caesareans on population caesarean rates taking into account different levels of accessibility. Methods: The observation period was from January 2003 to May 2012 in one Region and covered 11.7 million person-years. Exemption fees for caesareans were adopted on June 26, 2005. Data were obtained from a registration system implemented in 2003 that tracks all obstetrical emergencies and interventions including caesareans. The pre-intervention period was 30 months and the post-intervention period was 83 months. We used an interrupted time series to evaluate the trend before and after the policy adoption and the overall tendency. Findings: During the study period, the caesarean rate increased from 0.25 to 1.5% for the entire population. For women living in cities with district hospitals that provided caesareans, the rate increased from 1.7% before the policy was enforced to 5.7% 83 months later. No significant change in trends was observed among women living in villages with a healthcare centre or those in villages with no healthcare facility. For the latter, the caesarean rate increased from 0.4 to 1%. Conclusions: After nine years of implementation policy in Mali, the caesarean rate achieved in cities with a district hospital reached the full beneficial effect of this measure, whereas for women living elsewhere this policy did not increase the caesarean rate to a level that could contribute effectively to reduce their risk of maternal death. Only universal access to this essential intervention could reduce the inequities and increase the effectiveness of this policy.	[Fournier, Pierre; Tourigny, Caroline; Philibert, Aline; Coulibaly, Aliou] Res Ctr Univ Montreal Hosp CR CHUM, Montreal, PQ, Canada; [Fournier, Pierre] Univ Montreal, Sch Publ Hlth, Montreal, PQ, Canada; [Dumont, Alexandre] Univ Paris 05, Sorbonne Paris Cite, UMR 216, Inst Dev Res, Paris, France; [Traore, Mamadou] Referral Hlth Ctr Commune V, Unite Rech & Format Sante Mere & Enfant URFOSAME, Bamako, Mali	Universite de Montreal; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite	Fournier, P (corresponding author), Res Ctr Univ Montreal Hosp CR CHUM, Montreal, PQ, Canada.	pierre.fournier@umontreal.ca	Dumont, Alexandre/I-9429-2016	Dumont, Alexandre/0000-0003-3826-0193	Governance, Equity and Health Initiative of the International Development Research Centre (IDRC) in Ottawa (Canada); Teasdale-Corti Global Health Research Partnership Program of the Global Health Research Initiative (Canadian Institutes of Health Research, Canadian International Development Agency, Health Canada, IDRC and Public Health Agency of Canada)	Governance, Equity and Health Initiative of the International Development Research Centre (IDRC) in Ottawa (Canada); Teasdale-Corti Global Health Research Partnership Program of the Global Health Research Initiative (Canadian Institutes of Health Research, Canadian International Development Agency, Health Canada, IDRC and Public Health Agency of Canada)	This research was supported by the Governance, Equity and Health Initiative of the International Development Research Centre (IDRC) in Ottawa (Canada) and by the Teasdale-Corti Global Health Research Partnership Program of the Global Health Research Initiative (Canadian Institutes of Health Research, Canadian International Development Agency, Health Canada, IDRC and Public Health Agency of Canada). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arsenault C, 2013, B WORLD HEALTH ORGAN, V91, P207, DOI 10.2471/BLT.12.108969; Borghi J, 2003, HEALTH POLICY PLANN, V18, P383, DOI 10.1093/heapol/czg046; Borghi J, 2006, LANCET, V368, P1457, DOI 10.1016/S0140-6736(06)69383-5; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Cavallaro FL, 2013, B WORLD HEALTH ORGAN, V91, P914, DOI 10.2471/BLT.13.117598; Craig P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1655; De Brouwere V, 2002, LANCET, V359, P974, DOI 10.1016/S0140-6736(02)07993-X; Dumont A, 2001, LANCET, V358, P1328, DOI 10.1016/S0140-6736(01)06414-5; El-Khoury M, 2011, AMELIORER ACCES SERI; El-Khoury M, 2012, INT J EQUITY HEALTH, V11, DOI 10.1186/1475-9276-11-49; Fournier P, 2012, APPROACHES PRATIQUES, P325; Fournier P, 2009, B WORLD HEALTH ORGAN, V87, P30, DOI 10.2471/BLT.07.047076; Gibbons L, 2010, 30 WHO; Group CEPaOoC, 1998, INCL INT TIM SER ITS; Gustafsson NKJ, 2011, INT J EPIDEMIOL, V40, P432, DOI 10.1093/ije/dyq153; Gwatkin DR, 2004, LANCET, V364, P1273, DOI 10.1016/S0140-6736(04)17145-6; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Holtz SA, 2007, STUD FAMILY PLANN, V38, P47, DOI 10.1111/j.1728-4465.2007.00115.x; MAIGA Z, 1999, STUDIES HLTH SERVICE; McCulloch P, 2009, LANCET, V374, P1105, DOI 10.1016/S0140-6736(09)61116-8; Ministere de l'E conomie et des Finances Institut National de la Statistique Bureau central de recensement, 2011, RES DEF, V1; Paxton A, 2011, NEW ENGL J MED, V364, P1990, DOI 10.1056/NEJMp1012860; Pirkle CM, 2011, MATERN CHILD HLTH J, V15, P1081, DOI 10.1007/s10995-010-0655-y; Ramsay CR, 2003, INT J TECHNOL ASSESS, V19, P613, DOI 10.1017/S0266462303000576; Richard F, 2008, INT J GYNECOL OBSTET, V103, P283, DOI 10.1016/j.ijgo.2008.08.008; Richard F, 2010, AM J PUBLIC HEALTH, V100, P1845, DOI 10.2105/AJPH.2009.179689; Ronsmans C, 2006, LANCET, V368, P1516, DOI 10.1016/S0140-6736(06)69639-6; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Serumaga B, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d108; Shadish WR, 2009, ANNU REV PSYCHOL, V60, P607, DOI 10.1146/annurev.psych.60.110707.163544; Stanton CK, 2006, STUD FAMILY PLANN, V37, P41, DOI 10.1111/j.1728-4465.2006.00082.x; StataCorp, 2019, STATA STAT SOFTWARE; UNDP, 2013, HUMAN DEV REPORT; Victora CG, 2011, LANCET, V377, P85, DOI 10.1016/S0140-6736(10)60810-0; Villar J, 2006, LANCET, V367, P1819, DOI 10.1016/S0140-6736(06)68704-7; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; West SG, 2008, AM J PUBLIC HEALTH, V98, P1359, DOI 10.2105/AJPH.2007.124446; WHO UNICEF UNFPA Bank W & UNDP, 2014, TRENDS MAT MORT 1990; Witter S, 2010, HEALTH POLICY PLANN, V25, P384, DOI 10.1093/heapol/czq013; World Health Organization (WHO); UNFPA; UNICEF; Columbia University. Mailman School of Public Health, 2009, MON EM OBST CAR HDB; Zhang F, 2009, J CLIN EPIDEMIOL, V62, P143, DOI 10.1016/j.jclinepi.2008.08.007; [No title captured]	42	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105130	10.1371/journal.pone.0105130	http://dx.doi.org/10.1371/journal.pone.0105130			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN6XM	25137072	Green Published, Green Submitted, gold			2022-12-25	WOS:000340742100068
J	Guo, P; Xu, XJ; Huang, BL; Sun, D; Zhang, J; Chen, XJ; Zhang, Q; Huo, X; Hao, YT				Guo, Pi; Xu, Xijin; Huang, Binliang; Sun, Di; Zhang, Jian; Chen, Xiaojuan; Zhang, Qin; Huo, Xia; Hao, Yuantao			Blood Lead Levels and Associated Factors among Children in Guiyu of China: A Population-Based Study	PLOS ONE			English	Article							WASTE RECYCLING TOWN; PORT-PIRIE COHORT; ELECTRONIC WASTE; INTELLECTUAL IMPAIRMENT; EXPOSURE; CHILDHOOD; REGRESSION; SELECTION; HEALTH; LASSO	Objectives: Children's health problems caused by the electronic waste (e-waste) lead exposure in China remains. To assess children's blood lead levels (BLLs) in Guiyu of China and investigate risk factors of children's elevated BLLs in Guiyu. Material and Methods: 842 children under 11 years of age from Guiyu and Haojiang were enrolled in this population-based study during 2011-2013. Participants completed a lifestyle and residential environment questionnaire and their physical growth indices were measured, and blood samples taken. Blood samples were tested to assess BLLs. Children's BLLs between the two groups were compared and factors associated with elevated BLLs among Guiyu children were analyzed by group Lasso logistic regression model. Results: Children living in Guiyu had significant higher BLLs (7.06 mu g/dL) than the quantity (5.89 mu g/dL) of Haojiang children (P<0.05). Subgroup analyses of BLLs exceeding 10 mu g/dL showed the proportion (24.80%) of high-level BLLs for Guiyu children was greater than that (12.84%) in Haojiang (P<0.05). Boys had greater BLLs than girls, irrespectively of areas (P<0.05). The number of e-waste piles or recycling workshops around the house (odds ratio, 2.28; 95% confidence interval [CI], 1.37 to 3.87) significantly contributed to the elevated BLLs of children in Guiyu, and girls had less risk (odds ratio, 0.51; 95% CI, 0.31 to 0.83) of e-waste lead exposure than boys. Conclusions: This analysis reinforces the importance of shifting e-waste recycling piles or workshops to non-populated areas as part of a comprehensive response to e-waste lead exposure control in Guiyu. To correct the problem of lead poisoning in children in Guiyu should be a long-term mission.	[Guo, Pi; Hao, Yuantao] Sun Yat Sen Univ, Sch Publ Hlth, Dept Med Stat & Epidemiol, Guangzhou 510275, Guangdong, Peoples R China; [Xu, Xijin; Huang, Binliang; Sun, Di; Zhang, Jian; Chen, Xiaojuan; Huo, Xia] Shantou Univ, Coll Med, Lab Environm Med & Dev Toxicol, Shantou, Peoples R China; [Xu, Xijin; Huang, Binliang; Sun, Di; Zhang, Jian; Chen, Xiaojuan; Huo, Xia] Shantou Univ, Coll Med, Guangdong Prov Key Lab Infect Dis & Mol Immunopat, Shantou, Peoples R China; [Zhang, Qin] Shantou Univ, Good Clin Practice Off, Canc Hosp, Coll Med, Shantou, Peoples R China	Sun Yat Sen University; Shantou University; Shantou University; Shantou University	Huo, X (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, Dept Med Stat & Epidemiol, Guangzhou 510275, Guangdong, Peoples R China.	xhuo@stu.edu.cn; haoyt@mail.sysu.edu.cn		Huo, Xia/0000-0002-2102-4840	Natural Science Foundation of China, NSFC [21177080, 21377077]; Natural Science Foundation of Guangdong province [S2011020002399]	Natural Science Foundation of China, NSFC(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong province(National Natural Science Foundation of Guangdong Province)	This work was supported by the Natural Science Foundation of China, NSFC (21177080, 21377077) and Natural Science Foundation of Guangdong province (S2011020002399). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELLINGER D, 1987, NEW ENGL J MED, V316, P1037, DOI 10.1056/NEJM198704233161701; Binns HJ, 2007, PEDIATRICS, V120, pE1285, DOI 10.1542/peds.2005-1770; Canfield RL, 2003, NEW ENGL J MED, V348, P1517, DOI 10.1056/NEJMoa022848; Duarte M. F., 2011, TR201010 DUK U DEP C; Gavaghan H, 2002, B WORLD HEALTH ORGAN, V80, P82; Grigg J, 2004, ARCH DIS CHILD, V89, P244, DOI 10.1136/adc.2002.022202; Huang J, 2012, STAT SCI, V27, P481, DOI 10.1214/12-STS392; Huo X, 2007, ENVIRON HEALTH PERSP, V115, P1113, DOI 10.1289/ehp.9697; Jain NB, 2006, ENVIRON HEALTH PERSP, V114, P466, DOI 10.1289/ehp.8399; Koller K, 2004, ENVIRON HEALTH PERSP, V112, P987, DOI 10.1289/ehp.6941; Lanphear BP, 2005, ENVIRON HEALTH PERSP, V113, P894, DOI 10.1289/ehp.7688; Li Y, 2008, J ENVIRON MONITOR, V10, P1233, DOI 10.1039/b804959a; Li Y, 2013, J APPL STAT, V40, P699, DOI 10.1080/02664763.2012.724660; Liu JX, 2011, NEUROTOXICOLOGY, V32, P458, DOI 10.1016/j.neuro.2011.03.012; Lundgren K., 2012, GLOBAL IMPACT E WAST; MCMICHAEL AJ, 1988, NEW ENGL J MED, V319, P468, DOI 10.1056/NEJM198808253190803; Meier L, 2008, J R STAT SOC B, V70, P53, DOI 10.1111/j.1467-9868.2007.00627.x; Needleman H, 2004, ANNU REV MED, V55, P209, DOI 10.1146/annurev.med.55.091902.103653; Noel-Brune M, 2013, LANCET GLOB HEALTH, V1, pE70, DOI 10.1016/S2214-109X(13)70020-2; Peng ML, 2011, ZHONG GUO ER TONG BA, V19, P740; Qi Qiping, 2002, Zhonghua Liu Xing Bing Xue Za Zhi, V23, P162; SCHWARTZ J, 1986, PEDIATRICS, V77, P281; Team RDC, 2005, R LANG ENV STAT COMP; Tibshirani R, 2011, J R STAT SOC B, V73, P273, DOI 10.1111/j.1467-9868.2011.00771.x; Tong S, 1998, JAMA-J AM MED ASSOC, V280, P1915, DOI 10.1001/jama.280.22.1915; UE P, 2007, E WAST; Wong CSC, 2007, ENVIRON POLLUT, V145, P434, DOI 10.1016/j.envpol.2006.05.017; Woolston A, 2010, J EPIDEMIOL COMMUN H, V64, pA59, DOI 10.1136/jech.2010.120477.65; Wu KS, 2012, ENVIRON INT, V48, P1, DOI 10.1016/j.envint.2012.06.018; Xu XJ, 2014, ENVIRON SCI POLLUT R, V21, P3540, DOI 10.1007/s11356-013-2289-2; Xu XJ, 2012, REPROD TOXICOL, V33, P94, DOI 10.1016/j.reprotox.2011.12.006; Yan CH, 2013, ENVIRON HEALTH PERSP, V121, pA294, DOI 10.1289/ehp.1307558; Yang H, 2013, ENVIRON SCI POLLUT R, V20, P4441, DOI 10.1007/s11356-012-1366-2; Yuan M, 2006, J R STAT SOC B, V68, P49, DOI 10.1111/j.1467-9868.2005.00532.x; Zhang Shuai-ming, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P651; Zheng GN, 2013, J EXPO SCI ENV EPID, V23, P67, DOI 10.1038/jes.2012.84; Zheng LK, 2008, ENVIRON RES, V108, P15, DOI 10.1016/j.envres.2008.04.002; Zhou H, 2011, BIOCOMPUT-PAC SYM, P106	39	30	32	4	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105470	10.1371/journal.pone.0105470	http://dx.doi.org/10.1371/journal.pone.0105470			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136795	gold, Green Published, Green Submitted			2022-12-25	WOS:000340742100099
J	Koivisto, E; Acosta, AJ; Moilanen, AM; Tokola, H; Aro, J; Pennanen, H; Sakkinen, H; Kaikkonen, L; Ruskoaho, H; Rysa, J				Koivisto, Elina; Acosta, Alicia Jurado; Moilanen, Anne-Mari; Tokola, Heikki; Aro, Jani; Pennanen, Harri; Sakkinen, Hanna; Kaikkonen, Leena; Ruskoaho, Heikki; Rysa, Jaana			Characterization of the Regulatory Mechanisms of Activating Transcription Factor 3 by Hypertrophic Stimuli in Rat Cardiomyocytes	PLOS ONE			English	Article							INDUCED CARDIAC-HYPERTROPHY; ATF3 GENE-EXPRESSION; PROTEIN-KINASE; HEART-FAILURE; GATA-4; PATHWAYS; DISEASE; ALPHA; ENDOTHELIN-1; APOPTOSIS	Aims: Activating transcription factor 3 (ATF3) is a stress-activated immediate early gene suggested to have both detrimental and cardioprotective role in the heart. Here we studied the mechanisms of ATF3 activation by hypertrophic stimuli and ATF3 downstream targets in rat cardiomyocytes. Methods and Results: When neonatal rat cardiomyocytes were exposed to endothelin-1 (ET-1, 100 nM) and mechanical stretching in vitro, maximal increase in ATF3 expression occurred at 1 hour. Inhibition of extracellular signal-regulated kinase (ERK) by PD98059 decreased ET-1- and stretch-induced increase of ATF3 protein but not ATF3 mRNA levels, whereas protein kinase A (PKA) inhibitor H89 attenuated both ATF3 mRNA transcription and protein expression in response to ET-1 and stretch. To characterize further the regulatory mechanisms upstream of ATF3, p38 mitogen-activated protein kinase (MAPK) signaling was investigated using a gain-of-function approach. Adenoviral overexpression of p38 alpha, but not p38 beta, increased ATF3 mRNA and protein levels as well as DNA binding activity. To investigate the role of ATF3 in hypertrophic process, we overexpressed ATF3 by adenovirus-mediated gene transfer. In vitro, ATF3 gene delivery attenuated the mRNA transcription of interleukin-6 (IL-6) and plasminogen activator inhibitor-1 (PAI-1), and enhanced nuclear factor-kappa B (NF-kappa B) and Nkx-2.5 DNA binding activities. Reduced PAI-1 expression was also detected in vivo in adult rat heart by direct intramyocardial adenovirus-mediated ATF3 gene delivery. Conclusions: These data demonstrate that ATF3 activation by ET-1 and mechanical stretch is partly mediated through ERK and cAMP-PKA pathways, whereas p38 MAPK pathway is involved in ATF3 activation exclusively through p38 alpha isoform. ATF3 activation caused induction of modulators of the inflammatory response NF-kappa B and Nkx-2.5, as well as attenuation of pro-fibrotic and pro-inflammatory proteins IL-6 and PAI-1, suggesting cardioprotective role for ATF3 in the heart.	[Koivisto, Elina; Acosta, Alicia Jurado; Moilanen, Anne-Mari; Tokola, Heikki; Aro, Jani; Pennanen, Harri; Sakkinen, Hanna; Kaikkonen, Leena; Ruskoaho, Heikki; Rysa, Jaana] Univ Oulu, Dept Pharmacol & Toxicol, Inst Biomed, Oulu, Finland; [Moilanen, Anne-Mari; Tokola, Heikki] Univ Oulu, Dept Pathol, Inst Diagnost, Oulu, Finland; [Ruskoaho, Heikki] Univ Helsinki, Div Pharmacol & Pharmacotherapy, Fac Pharm, Helsinki, Finland; [Rysa, Jaana] Univ Eastern Finland, Sch Pharm, Kuopio, Finland	University of Oulu; University of Oulu; University of Helsinki; University of Eastern Finland	Ruskoaho, H (corresponding author), Univ Oulu, Dept Pharmacol & Toxicol, Inst Biomed, Oulu, Finland.	heikki.ruskoaho@helsinki.fi		Rysa, Jaana/0000-0003-2205-6323	Academy of Finland - Center of Excellence; Sigrid Juselius Foundation; Finnish Foundation for Cardiovascular Research; Emil Aaltonen Foundation; Ida Montin Foundation; Finnish Cultural Foundation	Academy of Finland - Center of Excellence(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Foundation for Cardiovascular Research; Emil Aaltonen Foundation; Ida Montin Foundation; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science)	This work was supported by grants from the Academy of Finland - Center of Excellence (HR), Sigrid Juselius Foundation (HR), Finnish Foundation for Cardiovascular Research (EK, AJA, A-MM, HT, HP, HS, LK, HR, JR), Emil Aaltonen Foundation (EK), Ida Montin Foundation(EK) and Finnish Cultural Foundation (EK, JR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal R, 2010, PHARMACOL RES, V61, P269, DOI 10.1016/j.phrs.2009.11.012; Bottone FG, 2005, J PHARMACOL EXP THER, V315, P668, DOI 10.1124/jpet.105.089607; Brasier AR, 2010, CARDIOVASC RES, V86, P211, DOI 10.1093/cvr/cvq076; Cai Y, 2000, BLOOD, V96, P2140, DOI 10.1182/blood.V96.6.2140.h8002140_2140_2148; Chakraborti S, 2007, MOL CELL BIOCHEM, V298, P1, DOI 10.1007/s11010-006-9355-8; Chen BPC, 1996, MOL CELL BIOL, V16, P1157, DOI 10.1128/mcb.16.3.1157; Chu WF, 2012, CARDIOVASC RES, V96, P90, DOI 10.1093/cvr/cvs230; Clerk A, 2007, PHYSIOL GENOMICS, V29, P118, DOI 10.1152/physiolgenomics.00168.2006; Clerk A, 2009, ADV ENZYME REGUL, V49, P30, DOI 10.1016/j.advenzreg.2008.12.007; Cullingford TE, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r32; Erbel C, 2011, BASIC RES CARDIOL, V106, P125, DOI 10.1007/s00395-010-0135-y; Fischer P, 2007, BASIC RES CARDIOL, V102, P279, DOI 10.1007/s00395-007-0658-z; Freire G, 2007, J MOL CELL CARDIOL, V43, P465, DOI 10.1016/j.yjmcc.2007.07.046; Freund C, 2005, CIRCULATION, V111, P2319, DOI 10.1161/01.CIR.0000164237.58200.5A; Gao MH, 2004, J BIOL CHEM, V279, P38797, DOI 10.1074/jbc.M405701200; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Giraldo A, 2012, BIOCHEM J, V444, P343, DOI 10.1042/BJ20120125; Hai T, 2001, GENE, V273, P1, DOI 10.1016/S0378-1119(01)00551-0; HAI TW, 1989, GENE DEV, V3, P2083, DOI 10.1101/gad.3.12b.2083; Hasin T, 2011, BASIC RES CARDIOL, V106, P175, DOI 10.1007/s00395-010-0145-9; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Herzig TC, 1997, P NATL ACAD SCI USA, V94, P7543, DOI 10.1073/pnas.94.14.7543; Hill JA, 2008, NEW ENGL J MED, V358, P1370, DOI 10.1056/NEJMra072139; Inoue K, 2004, GENES CELLS, V9, P59, DOI 10.1111/j.1356-9597.2004.00707.x; Jessup M, 2003, NEW ENGL J MED, V348, P2007, DOI 10.1056/NEJMra021498; Keesler GA, 1998, PROTEIN EXPRES PURIF, V14, P221, DOI 10.1006/prep.1998.0947; Kehat I, 2006, CARDIOVASC RES, V70, P543, DOI 10.1016/j.cardiores.2006.02.018; Kerkela R, 2002, J BIOL CHEM, V277, P13752, DOI 10.1074/jbc.M105736200; Kim MY, 2010, CARDIOVASC RES, V87, P119, DOI 10.1093/cvr/cvq048; Koivisto E, 2011, MOL CELL ENDOCRINOL, V338, P18, DOI 10.1016/j.mce.2011.02.015; Koren L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068396; Kuhn M, 2004, BASIC RES CARDIOL, V99, P76, DOI 10.1007/s00395-004-0460-0; LIN YS, 1988, P NATL ACAD SCI USA, V85, P3396, DOI 10.1073/pnas.85.10.3396; Lochner A, 2006, CARDIOVASC DRUG REV, V24, P261, DOI 10.1111/j.1527-3466.2006.00261.x; Lu D, 2007, BIOCHEM J, V401, P559, DOI 10.1042/BJ20061081; Luosujarvi H, 2010, BLOOD PRESSURE, V19, P54, DOI 10.3109/08037050903464519; Murray AJ, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.122re4; Nobori K, 2002, J MOL CELL CARDIOL, V34, P1387, DOI 10.1006/jmcc.2002.2091; Oka T, 2007, SEMIN CELL DEV BIOL, V18, P117, DOI 10.1016/j.semcdb.2006.11.012; Okamoto Y, 2001, AM J PATHOL, V159, P639, DOI 10.1016/S0002-9440(10)61735-X; Pikkarainen S, 2003, J BIOL CHEM, V278, P23807, DOI 10.1074/jbc.M302719200; Pohjolainen V, 2008, HUM PATHOL, V39, P1695, DOI 10.1016/j.humpath.2008.04.015; Rose BA, 2010, PHYSIOL REV, V90, P1507, DOI 10.1152/physrev.00054.2009; Ruskoaho H, 2003, ENDOCR REV, V24, P341, DOI 10.1210/er.2003-0006; Rysa J, 2006, BLOOD PRESSURE, V15, P375, DOI 10.1080/08037050601037851; Saadane N, 1999, BRIT J PHARMACOL, V127, P1165, DOI 10.1038/sj.bjp.0702676; Sugden PH, 1998, J MOL MED, V76, P725, DOI 10.1007/s001090050275; Tavi P, 2001, TRENDS PHARMACOL SCI, V22, P254, DOI 10.1016/S0165-6147(00)01679-5; Tenhunen O, 2006, FASEB J, V20, P1907, DOI 10.1096/fj.05-5618fje; Tenhunen O, 2006, CIRC RES, V99, P485, DOI 10.1161/01.RES.0000238387.85144.92; Thompson MR, 2009, J MOL MED, V87, P1053, DOI 10.1007/s00109-009-0520-x; Yamazaki T, 1996, J BIOL CHEM, V271, P3221, DOI 10.1074/jbc.271.6.3221; Yang CJ, 2013, CARDIOVASC RES, V97, P33, DOI 10.1093/cvr/cvs287; Yin TG, 1997, J BIOL CHEM, V272, P19943, DOI 10.1074/jbc.272.32.19943; Zhou H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026744	55	17	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105168	10.1371/journal.pone.0105168	http://dx.doi.org/10.1371/journal.pone.0105168			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136830	Green Submitted, Green Published, gold			2022-12-25	WOS:000340742100073
J	Pastuszak-Lewandoska, D; Domanska, D; Czarnecka, KH; Kordiak, J; Migdalska-Sek, M; Nawrot, E; Kiszalkiewicz, J; Antczak, A; Gorski, P; Brzezianska, E				Pastuszak-Lewandoska, Dorota; Domanska, Daria; Czarnecka, Karolina H.; Kordiak, Jacek; Migdalska-Sek, Monika; Nawrot, Ewa; Kiszalkiewicz, Justyna; Antczak, Adam; Gorski, Pawel; Brzezianska, Ewa			Expression of STAT5, COX-2 and PIAS3 in Correlation with NSCLC Histhopathological Features	PLOS ONE			English	Article							CELL LUNG-CANCER; HUMAN PROSTATE-CANCER; HUMAN BREAST-CANCER; SIGNAL TRANSDUCER; TRANSCRIPTION FACTORS; CYCLOOXYGENASE-2 EXPRESSION; PROTEIN INHIBITOR; ACTIVATED STAT3; POOR-PROGNOSIS; IN-VIVO	Signal transducers and activators of transcription (STATs), their inhibitors and cyclooxygenase-2 (COX-2) participate in transformations of many various types of cancers. The aim of the present study was to evaluate the relationship between STAT5A/B, COX-2, and PIAS3 mRNA expression and tumor staging, metastasis status, and histopathological subtype in 71 patients with confirmed non-small cell lung cancer (NSCLC) diagnosis. Total RNA was isolated from NSCLC tissue samples and the expression of the studied genes was assessed using TaqMan probes in real-time PCR assay. The expression levels of STAT5A, STAT5B, and COX-2 genes were increased in 69%, 79%, and 71% NSCLC samples respectively, while PIAS3 expression was decreased in the majority (69%) of the studied tissues. Statistically significant differences were observed between STAT5 isoforms (P = 0.0008), with higher expression of STAT5B. We found statistically significant positive correlation between STAT5B and COX-2 (rho = 0.045), and significant negative correlation between STAT5B and PIAS3 (rho = -0.049). The negative correlation between STAT5B and PIAS3 (rho = -0.43) was also observed in T2a+T2b tumor group. Additionally, STAT5B and COX-2 expression levels were significantly different between T1a+T1b and T2a+T2b tumors (P = 0.002 and P = 0.041, respectively), with higher expression of both genes in T2 tumor stage. PIAS3 expression was significantly lower in NSCC subtype as compared with SCC subtype (P = 0.017). Also, STAT5A and STAT5B immunoexpression was assessed, and the results indicated significantly higher protein levels in NSCLC patients as compared with controls (P = 0.048 and P = 0.034, respectively). High STAT5B immunoexpression was positively correlated with STAT5B gene expression in tumors (rho = 0.755). STAT5B protein level was also significantly higher in T2a+T2b tumors, reflecting high STAT5B gene expression in this group. There was no statistically significant association between mRNA and protein expression levels of the studied genes and patients' characteristics: age, gender, smoking. The obtained results highlight the importance of the genes STAT5B and COX-2 in lung cancer progression.	[Pastuszak-Lewandoska, Dorota; Domanska, Daria; Czarnecka, Karolina H.; Migdalska-Sek, Monika; Nawrot, Ewa; Kiszalkiewicz, Justyna; Brzezianska, Ewa] Med Univ Lodz, Dept Mol Bases Med, Lodz, Poland; [Kordiak, Jacek] Med Univ Lodz, Dept Chest Surg Gen & Oncol Surg, Univ Hosp 2, Lodz, Poland; [Antczak, Adam] Med Univ Lodz, Dept Gen & Oncol Pulmonol, Lodz, Poland; [Gorski, Pawel] Med Univ Lodz, Dept Pneumol & Allergol, Lodz, Poland	Medical University Lodz; Medical University Lodz; Medical University Lodz; Medical University Lodz	Brzezianska, E (corresponding author), Med Univ Lodz, Dept Mol Bases Med, Lodz, Poland.	ewa.brzezianska@umed.lodz.pl	Pastuszak-Lewandoska, Dorota/S-9465-2016; Czarnecka, Karolina H./C-8609-2011	Pastuszak-Lewandoska, Dorota/0000-0001-7602-9203; Czarnecka, Karolina H./0000-0003-4013-513X; Kordiak, Jacek/0000-0002-9991-9070	Medical University of Lodz, Poland [502/03-1-151/04/502-14-069]	Medical University of Lodz, Poland	The study was supported by the Medical University of Lodz, Poland (grant no 502/03-1-151/04/502-14-069). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barash I, 2012, CARCINOGENESIS, V33, P2320, DOI 10.1093/carcin/bgs362; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Brantley EC, 2008, CLIN CANCER RES, V14, P4694, DOI 10.1158/1078-0432.CCR-08-0618; Bromberg J, 2000, ONCOGENE, V19, P2468, DOI 10.1038/sj.onc.1203476; Buettner R, 2002, CLIN CANCER RES, V8, P945; Cao SQ, 2011, INT J ONCOL, V39, P383, DOI 10.3892/ijo.2011.1053; Chung CD, 1997, SCIENCE, V278, P1803, DOI 10.1126/science.278.5344.1803; Clevenger CV, 2004, AM J PATHOL, V165, P1449, DOI 10.1016/S0002-9440(10)63403-7; Creamer BA, 2010, MOL CELL BIOL, V30, P2957, DOI 10.1128/MCB.00851-09; Dabir S, 2011, CANCER BIOL THER, V12, P139, DOI 10.4161/cbt.12.2.15732; de Groot Rolf P., 2000, Molecular Cell Biology Research Communications, V3, P299, DOI 10.1006/mcbr.2000.0231; Dohadwala M, 2001, J BIOL CHEM, V276, P20809, DOI 10.1074/jbc.C100140200; Du W, 2012, J CELL PHYSIOL, V227, P2421, DOI 10.1002/jcp.22977; Furth PA, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2921; Greenhough A, 2009, CARCINOGENESIS, V30, P377, DOI 10.1093/carcin/bgp014; Grimley PM, 1999, CYTOKINE GROWTH F R, V10, P131, DOI 10.1016/S1359-6101(99)00011-8; Groen HJM, 2011, J CLIN ONCOL, V29, P4320, DOI 10.1200/JCO.2011.35.5214; Gu L, 2010, ENDOCR-RELAT CANCER, V17, P481, DOI 10.1677/ERC-09-0328; Harris SG, 2002, TRENDS IMMUNOL, V23, P144, DOI 10.1016/S1471-4906(01)02154-8; Hennighausen L, 2008, GENE DEV, V22, P711, DOI 10.1101/gad.1643908; Hida T, 1998, CANCER RES, V58, P3761; Hosomi Y, 2000, LUNG CANCER, V30, P73, DOI 10.1016/S0169-5002(00)00132-X; Ihle JN, 2001, CURR OPIN CELL BIOL, V13, P211, DOI 10.1016/S0955-0674(00)00199-X; Jiang H, 2013, CLIN CHIM ACTA, V419, P26, DOI 10.1016/j.cca.2013.01.012; Khuri FR, 2001, CLIN CANCER RES, V7, P861; Kim DY, 2009, J GASTROEN HEPATOL, V24, P646, DOI 10.1111/j.1440-1746.2008.05671.x; Kluge A, 2011, MOL ONCOL, V5, P256, DOI 10.1016/j.molonc.2011.03.004; Leahy KM, 2000, CURR MED CHEM, V7, P1163, DOI 10.2174/0929867003374336; Li F, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-27; Li HZ, 2005, CLIN CANCER RES, V11, P5863, DOI 10.1158/1078-0432.CCR-05-0562; Li HZ, 2004, CANCER RES, V64, P4774, DOI 10.1158/0008-5472.CAN-03-3499; Lin JX, 1996, J BIOL CHEM, V271, P10738, DOI 10.1074/jbc.271.18.10738; Lin JX, 2000, ONCOGENE, V19, P2566, DOI 10.1038/sj.onc.1203523; Liu Jun-Ru, 2007, Ai Zheng, V26, P458; Mascaux C, 2006, BRIT J CANCER, V95, P139, DOI 10.1038/sj.bjc.6603226; Nevalainen MT, 2004, J CLIN ONCOL, V22, P2053, DOI 10.1200/JCO.2004.11.046; Ogata Y, 2006, NEOPLASIA, V8, P817, DOI 10.1593/neo.06409; Pold M, 2004, CANCER RES, V64, P1853, DOI 10.1158/0008-5472.CAN-03-3262; Rycyzyn MA, 2002, P NATL ACAD SCI USA, V99, P6790, DOI 10.1073/pnas.092160699; Sanchez-Ceja SG, 2006, LUNG CANCER, V54, P163, DOI 10.1016/j.lungcan.2006.07.012; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Soslow RA, 2000, CANCER, V89, P2637, DOI 10.1002/1097-0142(20001215)89:12<2637::AID-CNCR17>3.0.CO;2-B; Spira A, 2004, NEW ENGL J MED, V350, P379, DOI 10.1056/NEJMra035536; Sultan AS, 2005, ONCOGENE, V24, P746, DOI 10.1038/sj.onc.1208203; Sung YH, 2005, MECH AGEING DEV, V126, P732, DOI 10.1016/j.mad.2005.01.007; Tan SH, 2008, ENDOCR-RELAT CANCER, V15, P367, DOI 10.1677/ERC-08-0013; Tang JZ, 2010, ENDOCRINOLOGY, V151, P43, DOI 10.1210/en.2009-0651; Wagner KU, 2008, J MAMMARY GLAND BIOL, V13, P93, DOI 10.1007/s10911-008-9062-z; Xi SC, 2003, CANCER RES, V63, P6763; Zhang Q, 2007, NAT MED, V13, P1341, DOI 10.1038/nm1659	50	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e104265	10.1371/journal.pone.0104265	http://dx.doi.org/10.1371/journal.pone.0104265			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137041	Green Submitted, Green Published, gold			2022-12-25	WOS:000340742100022
J	Guzzo, CM; Ringel, A; Cox, E; Uzoma, I; Zhu, H; Blackshaw, S; Wolberger, C; Matunis, MJ				Guzzo, Catherine M.; Ringel, Alison; Cox, Eric; Uzoma, Ijeoma; Zhu, Heng; Blackshaw, Seth; Wolberger, Cynthia; Matunis, Michael J.			Characterization of the SUMO-Binding Activity of the Myeloproliferative and Mental Retardation (MYM)-Type Zinc Fingers in ZNF261 and ZNF198	PLOS ONE			English	Article							PROTEIN MODIFICATION; NUCLEAR-BODIES; UBIQUITIN; MOTIF; GENE; PML; RECOGNITION; SUMOYLATION; CLONING; DISEASE	SUMO-binding proteins interact with SUMO modified proteins to mediate a wide range of functional consequences. Here, we report the identification of a new SUMO-binding protein, ZNF261. Four human proteins including ZNF261, ZNF198, ZNF262, and ZNF258 contain a stretch of tandem zinc fingers called myeloproliferative and mental retardation (MYM)-type zinc fingers. We demonstrated that MYM-type zinc fingers from ZNF261 and ZNF198 are necessary and sufficient for SUMO-binding and that individual MYM-type zinc fingers function as SUMO-interacting motifs (SIMs). Our binding studies revealed that the MYM-type zinc fingers from ZNF261 and ZNF198 interact with the same surface on SUMO-2 recognized by the archetypal consensus SIM. We also present evidence that MYM-type zinc fingers in ZNF261 contain zinc, but that zinc is not required for SUMO-binding. Immunofluorescence microscopy studies using truncated fragments of ZNF198 revealed that MYM-type zinc fingers of ZNF198 are necessary for localization to PML-nuclear bodies (PML-NBs). In summary, our studies have identified and characterized the SUMO-binding activity of the MYM-type zinc fingers in ZNF261 and ZNF198.	[Guzzo, Catherine M.; Matunis, Michael J.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21218 USA; [Ringel, Alison; Wolberger, Cynthia] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; [Cox, Eric; Blackshaw, Seth] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD USA; [Uzoma, Ijeoma; Zhu, Heng] Johns Hopkins Univ, Dept Pharmacol & Mol Sci, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Matunis, MJ (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21218 USA.	mmatuni1@jhu.edu		Wolberger, Cynthia/0000-0001-8578-2969; Ringel, Alison/0000-0002-6451-9376; Cox, Eric/0000-0001-7691-4835; Matunis, Michael/0000-0002-9350-6611	AACR [08-40-02-GUZZ]; National Institutes of Health (NIH) [GMO60980, U54RR020839]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060980, T32GM007445] Funding Source: NIH RePORTER	AACR; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by AACR postdoctoral fellowship 08-40-02-GUZZ to CMG and National Institutes of Health (NIH) grants GMO60980 and U54RR020839 to MJM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong AA, 2012, NATURE, V483, P59, DOI 10.1038/nature10883; Baba D, 2005, NATURE, V435, P979, DOI 10.1038/nature03634; Banecki B, 1996, J BIOL CHEM, V271, P14840, DOI 10.1074/jbc.271.25.14840; Chang CC, 2011, MOL CELL, V42, P62, DOI 10.1016/j.molcel.2011.02.022; Danielsen JR, 2012, J CELL BIOL, V197, P179, DOI 10.1083/jcb.201106152; Dudev T, 2003, CHEM REV, V103, P773, DOI 10.1021/cr020467n; Flotho A, 2013, ANNU REV BIOCHEM, V82, P357, DOI 10.1146/annurev-biochem-061909-093311; Gocke CB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003255; Gregory SG, 2006, NATURE, V441, P315, DOI 10.1038/nature04727; Hakimi MA, 2003, J BIOL CHEM, V278, P7234, DOI 10.1074/jbc.M208992200; Hakli M, 2005, EXP CELL RES, V304, P224, DOI 10.1016/j.yexcr.2004.10.029; Hannich JT, 2005, J BIOL CHEM, V280, P4102, DOI 10.1074/jbc.M413209200; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Jian Ouyang, 2009, V497, P141, DOI 10.1007/978-1-59745-566-4_9; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kerscher O, 2007, EMBO REP, V8, P550, DOI 10.1038/sj.embor.7400980; Keusekotten K, 2014, BIOCHEM J, V457, P207, DOI 10.1042/BJ20130753; Kunapuli P, 2003, ONCOGENE, V22, P3417, DOI 10.1038/sj.onc.1206408; Kunapuli P, 2006, EXP CELL RES, V312, P3739, DOI 10.1016/j.yexcr.2006.06.037; Kung CC, 2014, BIOCH J; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Laue T.M., 1992, ANAL ULTRACENTRIFUGA; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; Lin YY, 2009, CELL, V136, P1073, DOI 10.1016/j.cell.2009.01.033; Lu CY, 2010, NUCLEIC ACIDS RES, V38, P488, DOI 10.1093/nar/gkp1008; Makhnevych T, 2009, MOL CELL, V33, P124, DOI 10.1016/j.molcel.2008.12.025; Minty A, 2000, J BIOL CHEM, V275, P36316, DOI 10.1074/jbc.M004293200; QIU HW, 1994, J BIOL CHEM, V269, P2773; Raffa GD, 2005, MOL CELL, V20, P821, DOI 10.1016/j.molcel.2005.12.003; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sekiyama N, 2008, J BIOL CHEM, V283, P35966, DOI 10.1074/jbc.M802528200; Shen TH, 2006, MOL CELL, V24, P331, DOI 10.1016/j.molcel.2006.09.013; Smedley D, 1999, GENOMICS, V60, P244, DOI 10.1006/geno.1999.5918; Smedley D, 1998, HUM MOL GENET, V7, P637, DOI 10.1093/hmg/7.4.637; Sohal J, 2000, CYTOGENET CELL GENET, V89, P24, DOI 10.1159/000015584; Song J, 2005, J BIOL CHEM, V280, P40122, DOI 10.1074/jbc.M507059200; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Sousa SF, 2009, DALTON T, P7946, DOI 10.1039/b904404c; Sung KS, 2011, EXP CELL RES, V317, P1060, DOI 10.1016/j.yexcr.2010.12.016; Takahashi H, 2005, J BIOL CHEM, V280, P5611, DOI 10.1074/jbc.M408130200; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; vanderMaarel SM, 1996, HUM MOL GENET, V5, P887, DOI 10.1093/hmg/5.7.887; Vogt B, 2012, METHODS MOL BIOL, V832, P249, DOI 10.1007/978-1-61779-474-2_18; Xhemalce B, 2007, P NATL ACAD SCI USA, V104, P893, DOI 10.1073/pnas.0605442104; Xiao S, 1998, NAT GENET, V18, P84, DOI 10.1038/ng0198-84; Zhu JM, 2008, J BIOL CHEM, V283, P29405, DOI 10.1074/jbc.M803632200	49	21	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105271	10.1371/journal.pone.0105271	http://dx.doi.org/10.1371/journal.pone.0105271			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133527	Green Submitted, Green Published, gold			2022-12-25	WOS:000341302700095
J	Ramanarayanan, V; Lammert, A; Goldstein, L; Narayanan, S				Ramanarayanan, Vikram; Lammert, Adam; Goldstein, Louis; Narayanan, Shrikanth			Are Articulatory Settings Mechanically Advantageous for Speech Motor Control?	PLOS ONE			English	Article								We address the hypothesis that postures adopted during grammatical pauses in speech production are more "mechanically advantageous'' than absolute rest positions for facilitating efficient postural motor control of vocal tract articulators. We quantify vocal tract posture corresponding to inter-speech pauses, absolute rest intervals as well as vowel and consonant intervals using automated analysis of video captured with real-time magnetic resonance imaging during production of read and spontaneous speech by 5 healthy speakers of American English. We then use locally-weighted linear regression to estimate the articulatory forward map from low-level articulator variables to high-level task/goal variables for these postures. We quantify the overall magnitude of the first derivative of the forward map as a measure of mechanical advantage. We find that postures assumed during grammatical pauses in speech as well as speech-ready postures are significantly more mechanically advantageous than postures assumed during absolute rest. Further, these postures represent empirical extremes of mechanical advantage, between which lie the postures assumed during various vowels and consonants. Relative mechanical advantage of different postures might be an important physical constraint influencing planning and control of speech production.	[Ramanarayanan, Vikram; Lammert, Adam; Narayanan, Shrikanth] Univ So Calif, Viterbi Sch Engn, Signal Anal & Interpretat Lab, Los Angeles, CA 90089 USA; [Goldstein, Louis; Narayanan, Shrikanth] Univ So Calif, Dept Linguist, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California	Ramanarayanan, V (corresponding author), Univ So Calif, Viterbi Sch Engn, Signal Anal & Interpretat Lab, Los Angeles, CA 90089 USA.	vikram.ramanarayanan@gmail.com	Narayanan, Shrikanth S/D-5676-2012		NIH [DC007124, 5T32DC009975]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003172, T32DC009975, R01DC007124] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by NIH Grant DC007124 and a graduate traineeship NIH 5T32DC009975. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonsson E.K., 2005, FORMAL ENG DESIGN SY; Bresch E, 2006, J ACOUST SOC AM, V120, P1791, DOI 10.1121/1.2335423; Browman C., 1995, MIND MOTION EXPLORAT, P175; Chung W., 2008, SPRINGER HDB ROBOTIC; ESLING JH, 1983, TESOL QUART, V17, P89, DOI 10.2307/3586426; Fujimura O, 1979, FRONTIERS SPEECH COM, P17; Gick B, 2004, PHONETICA, V61, P220, DOI 10.1159/000084159; Honikman Beatrice, 1964, HONOUR D JONES, P73; Joos MA., 1948, LANGUAGE, V24, P5, DOI [10.2307/522229, DOI 10.2307/522229]; Lammert A, 2014, J SPEECH CO IN PRESS; Laver J, 1978, HISTORIOGRAPHIA LING, V5, P1; Laver J., 1980, PHONETIC DESCRIPTION; Mennen I, 2010, SECOND LANG RES, V26, P13, DOI 10.1177/0267658309337617; Narayanan S, 2004, J ACOUST SOC AM, V115, P1771, DOI 10.1121/1.1652588; Ohman S, 1967, PERIPHERAL MOTOR COM, P30; PELLOM B, 2001, TRCSLR200101 U COL; Perkell J, 1997, SPEECH COMMUN, V22, P227, DOI 10.1016/S0167-6393(97)00026-5; Ramanarayanan V, 2013, J ACOUST SOC AM, V134, P510, DOI 10.1121/1.4807639; Ramanarayanan V, 2009, J ACOUST SOC AM, V126, pEL160, DOI 10.1121/1.3213452; Rosenbaum DA, 2001, PSYCHOL REV, V108, P709, DOI 10.1037//0033-295X.108.4.709; Saltzman E., 1989, ECOL PSYCHOL, V1, P333, DOI [10.1207/s15326969eco0104_2, DOI 10.1207/S15326969EC00104_]; Sweet H, 1890, PRIMER PHONETICS; Wilson I, 2006, J ACOUST SOC AM, V120, P3295; Wrench A., 2000, WORKSH PHON PHON ASR	24	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e104168	10.1371/journal.pone.0104168	http://dx.doi.org/10.1371/journal.pone.0104168			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO4JF	25133544	Green Published, Green Submitted, gold			2022-12-25	WOS:000341302700023
J	Alaimo, JT; Hahn, NH; Mullegama, SV; Elsea, SH				Alaimo, Joseph T.; Hahn, Natalie H.; Mullegama, Sureni V.; Elsea, Sarah H.			Dietary Regimens Modify Early Onset of Obesity in Mice Haploinsufficient for Rai1	PLOS ONE			English	Article							SMITH-MAGENIS-SYNDROME; MOUSE MODELS; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; FAT DISTRIBUTION; ADIPOSE-TISSUE; METHYLATION; OVEREXPRESSION; PHENOTYPES; GENOTYPE	Smith-Magenis syndrome is a complex genomic disorder in which a majority of individuals are obese by adolescence. While an interstitial deletion of chromosome 17p11.2 is the leading cause, mutation or deletion of the RAI1 gene alone results in most features of the disorder. Previous studies have shown that heterozygous knockout of Rai1 results in an obese phenotype in mice and that Smith-Magenis syndrome mouse models have a significantly reduced fecundity and an altered transmission pattern of the mutant Rai1 allele, complicating large, extended studies in these models. In this study, we show that breeding C57Bl/6J Rai1(+/-) mice with FVB/NJ to create F1 Rai1(+/-) offspring in a mixed genetic background ameliorates both fecundity and Rai1 allele transmission phenotypes. These findings suggest that the mixed background provides a more robust platform for breeding and larger phenotypic studies. We also characterized the effect of dietary intake on Rai1(+/-) mouse growth during adolescent and early adulthood developmental stages. Animals fed a high carbohydrate or a high fat diet gained weight at a significantly faster rate than their wild type littermates. Both high fat and high carbohydrate fed Rai1(+/-) mice also had an increase in body fat and altered fat distribution patterns. Interestingly, Rai1(+/-) mice fed different diets did not display altered fasting blood glucose levels. These results suggest that dietary regimens are extremely important for individuals with Smith-Magenis syndrome and that food high in fat and carbohydrates may exacerbate obesity outcomes.	[Alaimo, Joseph T.; Mullegama, Sureni V.; Elsea, Sarah H.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Hahn, Natalie H.; Elsea, Sarah H.] Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA USA	Baylor College of Medicine; Virginia Commonwealth University	Elsea, SH (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	elsea@bcm.edu	Alaimo, Joseph/AHC-1981-2022	Elsea, Sarah/0000-0002-1400-8519	Smith-Magenis Syndrome Research Foundation	Smith-Magenis Syndrome Research Foundation	This work was supported by Smith-Magenis Syndrome Research Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnlov J, 2010, CIRCULATION, V121, P230, DOI 10.1161/CIRCULATIONAHA.109.887521; Bi WM, 2007, HUM MOL GENET, V16, P1802, DOI 10.1093/hmg/ddm128; Bi WM, 2005, HUM MOL GENET, V14, P983, DOI 10.1093/hmg/ddi085; Bucan M, 2002, NAT REV GENET, V3, P114, DOI 10.1038/nrg728; Burns B, 2010, HUM MOL GENET, V19, P4026, DOI 10.1093/hmg/ddq317; Chen N, 2005, DIABETES, V54, P3379, DOI 10.2337/diabetes.54.12.3379; Darvekar S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078907; Dobkin C, 2000, NEUROSCIENCE, V100, P423, DOI 10.1016/S0306-4522(00)00292-X; Edelman EA, 2007, CLIN GENET, V71, P540, DOI 10.1111/j.1399-0004.2007.00815.x; Elsea SH, 2008, EUR J HUM GENET, V16, P412, DOI 10.1038/sj.ejhg.5202009; Girirajan S, 2008, EUR J HUM GENET, V16, P941, DOI 10.1038/ejhg.2008.21; Girirajan S, 2006, GENET MED, V8, P417, DOI 10.1097/01.gim.0000228215.32110.89; Girirajan S, 2009, EUR J MED GENET, V52, P224, DOI 10.1016/j.ejmg.2008.12.002; Haluzik M, 2004, ENDOCRINOLOGY, V145, P3258, DOI 10.1210/en.2004-0219; Herrera BM, 2011, MATURITAS, V69, P41, DOI 10.1016/j.maturitas.2011.02.018; Kim DH, 2013, INT J OBESITY, V37, P853, DOI 10.1038/ijo.2012.141; Kuk JL, 2009, DIABETES CARE, V32, P2297, DOI 10.2337/dc09-0574; Lacaria M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002713; Milagro FI, 2009, J PHYSIOL BIOCHEM, V65, P1, DOI 10.1007/BF03165964; Nan C, 2012, EUR J EPIDEMIOL, V27, P247, DOI 10.1007/s10654-012-9678-6; Patel PS, 2013, J OBES, V2013, DOI 10.1155/2013/616193; Plagemann A, 2009, J PHYSIOL-LONDON, V587, P4963, DOI 10.1113/jphysiol.2009.176156; Poirier P, 2006, CIRCULATION, V113, P898, DOI 10.1161/CIRCULATIONAHA.106.171016; Potocki L, 2007, AM J HUM GENET, V80, P633, DOI 10.1086/512864; Slager RE, 2003, NAT GENET, V33, P466, DOI 10.1038/ng1126; Smith ACM, 2002, GENET MED, V4, P118, DOI 10.1097/00125817-200205000-00004; Staiger H, 2003, OBES RES, V11, P368, DOI 10.1038/oby.2003.48; Tanabe LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032245; Vlangos CN, 2003, MOL GENET METAB, V79, P134, DOI 10.1016/S1096-7192(03)00048-9; Walz K, 2004, HUM MOL GENET, V13, P367, DOI 10.1093/hmg/ddh044; Walz K, 2006, J CLIN INVEST, V116, P3035, DOI 10.1172/JCI28953; Widiker S, 2010, J APPL GENET, V51, P193, DOI 10.1007/BF03195727; Williams SR, 2012, AM J HUM GENET, V90, P941, DOI 10.1016/j.ajhg.2012.04.013; Wolfer DP, 2002, TRENDS NEUROSCI, V25, P336, DOI 10.1016/S0166-2236(02)02192-6; Yan J, 2007, AM J HUM GENET, V80, P518, DOI 10.1086/512043	35	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105077	10.1371/journal.pone.0105077	http://dx.doi.org/10.1371/journal.pone.0105077			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127133	Green Published, gold, Green Submitted			2022-12-25	WOS:000340879300075
J	Cao, MH; You, H; Hermonat, PL				Cao, Maohua; You, Hong; Hermonat, Paul L.			The X Gene of Adeno-Associated Virus 2 (AAV2) Is Involved in Viral DNA Replication	PLOS ONE			English	Article							ADENO-ASSOCIATED VIRUS; HUMAN-PAPILLOMAVIRUS; INFECTION; TYPE-2; CELLS; MUTANTS	Adeno-associated virus (AAV) (type 2) is a popular human gene therapy vector with a long active transgene expression period and no reported vector-induced adverse reactions. Yet the basic molecular biology of this virus has not been fully addressed. One potential gene at the far 3' end of the AAV2 genome, previously referred to as X (nt 3929 to 4393), overlapping the 3' end of the cap gene, has never been characterized, although we did previously identify a promoter just up-stream (p81). Computer analysis suggested that X was involved in replication and transcription. The X protein was identified during active AAV2 replication using a polyclonal antibody against a peptide starting at amino acid 98. Reagents for the study of X included an AAV2 deletion mutant (dl78-91), a triple nucleotide substitution mutant that destroys all three 5' AUG-initiation products of X, with no effect on the cap coding sequence, and X-positive-293 cell lines. Here, we found that X up-regulated AAV2 DNA replication in differentiating keratinocytes (without helper virus, autonomous replication) and in various forms of 293 cell-based assays with help from wild type adenovirus type 5 (wt Ad5) or Ad5 helper plasmid (pHelper). The strongest contribution by X was seen in increasing wt AAV2 DNA replication in keratinocytes and dl78-91 in Ad5-infected X-positive-293 cell lines (both having multi-fold effects). Mutating the X gene in pAAV-RC (pAAV-RC-3Xneg) yielded approximately a similar to 33% reduction in recombinant AAV vector DNA replication and virion production, but a larger effect was seen when using this same X-knockout AAV helper plasmid in X-positive-293 cell lines versus normal 293 cells (again, multi-fold). Taken together these data strongly suggest that AAV2 X encodes a protein involved in the AAV life cycle, particularly in increasing AAV2 DNA replication, and suggests that further studies are warranted.	[Cao, Maohua; Hermonat, Paul L.] Cent Arkansas Vet Healthcare Syst, Little Rock, AR 72205 USA; [You, Hong; Hermonat, Paul L.] Univ Arkansas Med Sci, Dept Obstet & Gynecol, Little Rock, AR 72205 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System; University of Arkansas System; University of Arkansas Medical Sciences	Hermonat, PL (corresponding author), Cent Arkansas Vet Healthcare Syst, Little Rock, AR 72205 USA.	Paul.Hermonat@va.gov	You, Hong/G-6686-2011		VA Merit Review; NIH [R56 AI093695]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI093695] Funding Source: NIH RePORTER	VA Merit Review(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by VA Merit Review and NIH R56 AI093695 grants to PLH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLACKLOW NR, 1971, AM J EPIDEMIOL, V94, P359, DOI 10.1093/oxfordjournals.aje.a121331; BLACKLOW NR, 1968, J NATL CANCER I, V40, P319; Buchlis G, 2012, BLOOD, V119, P3038, DOI 10.1182/blood-2011-09-382317; BULLER RML, 1978, J VIROL, V25, P331, DOI 10.1128/JVI.25.1.331-338.1978; Chirmule N, 1999, GENE THER, V6, P1574, DOI 10.1038/sj.gt.3300994; Hemonat PL, 1999, J HUMAN VIROL, V2, P359; Hermonat P.L., 1984, THESIS U FL; HERMONAT PL, 1984, P NATL ACAD SCI-BIOL, V81, P6466, DOI 10.1073/pnas.81.20.6466; HERMONAT PL, 1984, J VIROL, V51, P329, DOI 10.1128/JVI.51.2.329-339.1984; Hermonat PL, 2014, HUMAN GENE IN PRESS; Kang BY, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-79; Meyers C, 2001, VIROLOGY, V287, P30, DOI 10.1006/viro.2001.0968; Meyers C, 2000, VIROLOGY, V272, P338, DOI 10.1006/viro.2000.0385; Nagy V, 2006, NATURE METHODS, V3; Sonntag F, 2010, P NATL ACAD SCI USA, V107, P10220, DOI 10.1073/pnas.1001673107; SRIVASTAVA A, 1983, J VIROL, V45, P555, DOI 10.1128/JVI.45.2.555-564.1983; TRATSCHIN JD, 1984, J VIROL, V51, P611, DOI 10.1128/JVI.51.3.611-619.1984; You CX, 2012, ONCOIMMUNOLOGY, V1, P847, DOI 10.4161/onci.20504; You H, 2006, VIROLOGY, V344, P532, DOI 10.1016/j.virol.2005.08.039; Zhu H, 2013, J GENET SYNDR GENE T, V4, P135	20	25	32	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104596	10.1371/journal.pone.0104596	http://dx.doi.org/10.1371/journal.pone.0104596			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127256	Green Published, gold, Green Submitted			2022-12-25	WOS:000340879300036
J	Eto, K; Nishimura, W; Oishi, H; Udagawa, H; Kawaguchi, M; Hiramoto, M; Fujiwara, T; Takahashi, S; Yasuda, K				Eto, Koki; Nishimura, Wataru; Oishi, Hisashi; Udagawa, Haruhide; Kawaguchi, Miho; Hiramoto, Masaki; Fujiwara, Toshiyoshi; Takahashi, Satoru; Yasuda, Kazuki			MafA Is Required for Postnatal Proliferation of Pancreatic beta-Cells	PLOS ONE			English	Article							GROWTH-HORMONE; PLACENTAL-LACTOGEN; INSULIN-SECRETION; SIGNAL TRANSDUCER; TRANSCRIPTION FACTOR; GLUCOSE-HOMEOSTASIS; PROLACTIN RECEPTOR; CYCLIN D2; EXPRESSION; ISLETS	The postnatal proliferation and maturation of insulin-secreting pancreatic beta-cells are critical for glucose metabolism and disease development in adults. Elucidation of the molecular mechanisms underlying these events will be beneficial to direct the differentiation of stem cells into functional beta-cells. Maturation of beta-cells is accompanied by increased expression of MafA, an insulin gene transcription factor. Transcriptome analysis of MafA knockout islets revealed MafA is required for the expression of several molecules critical for beta-cell function, including Glut2, ZnT8, Granuphilin, Vdr, Pcsk1 and Urocortin 3, as well as Prolactin receptor (Prlr) and its downstream target Cyclin D2 (Ccnd2). Inhibition of MafA expression in mouse islets or beta-cell lines resulted in reduced expression of Prlr and Ccnd2, and MafA transactivated the Prlr promoter. Stimulation of beta-cells by prolactin resulted in the phosphorylation and translocation of Stat5B and an increased nuclear pool of Ccnd2 via Prlr and Jak2. Consistent with these results, the loss of MafA resulted in impaired proliferation of beta-cells at 4 weeks of age. These results suggest that MafA regulates the postnatal proliferation of beta-cells via prolactin signaling.	[Eto, Koki; Nishimura, Wataru; Udagawa, Haruhide; Kawaguchi, Miho; Hiramoto, Masaki; Yasuda, Kazuki] Natl Ctr Global Hlth & Med, Res Inst, Dept Metab Disorders, Diabet Res Ctr, Tokyo, Japan; [Eto, Koki; Fujiwara, Toshiyoshi] Okayama Univ, Dept Surg Gastroenterol, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan; [Oishi, Hisashi; Takahashi, Satoru] Univ Tsukuba, Fac Med, Dept Anat & Embryol, Tsukuba, Ibaraki, Japan	National Center for Global Health & Medicine - Japan; Okayama University; University of Tsukuba	Nishimura, W (corresponding author), Natl Ctr Global Hlth & Med, Res Inst, Dept Metab Disorders, Diabet Res Ctr, Tokyo, Japan.	wnishimura@ri.ncgm.go.jp; kyasuda@ri.ncgm.go.jp	Nishimura, Wataru/R-9215-2019	Nishimura, Wataru/0000-0002-8068-1277	JSPS KAKENHI [22591022, 21390283]; National Center for Global Health and Medicine [22-103, 25-102]; Takeda Science Foundation; Japan Diabetes Foundation	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); National Center for Global Health and Medicine(National Center for Global Health & Medicine - Japan); Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Diabetes Foundation	This study was supported by JSPS KAKENHI (22591022), a grant from the National Center for Global Health and Medicine (22-103), the Takeda Science Foundation, and the Japan Diabetes Foundation to WN, JSPS KAKENHI (21390283) and a grant from the National Center for Global Health and Medicine (25-102) to KY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artner I, 2007, P NATL ACAD SCI USA, V104, P3853, DOI 10.1073/pnas.0700013104; Artner I, 2010, DIABETES, V59, P2530, DOI 10.2337/db10-0190; Arumugam R, 2011, ENDOCRINOLOGY, V152, P856, DOI 10.1210/en.2010-1258; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Bonner-Weir S, 2000, ENDOCRINOLOGY, V141, P1926, DOI 10.1210/en.141.6.1926; BRELJE TC, 1993, ENDOCRINOLOGY, V132, P879, DOI 10.1210/en.132.2.879; Brelje TC, 2004, ENDOCRINOLOGY, V145, P4162, DOI 10.1210/en.2004-0201; Brelje TC, 2002, J HISTOCHEM CYTOCHEM, V50, P365, DOI 10.1177/002215540205000308; Fleenor D, 2000, PEDIATR RES, V47, P136, DOI 10.1203/00006450-200001000-00023; Freemark M, 1997, J CLIN INVEST, V99, P1107, DOI 10.1172/JCI119239; Freemark M, 2002, ENDOCRINOLOGY, V143, P1378, DOI 10.1210/en.143.4.1378; Friedrichsen BN, 2001, MOL ENDOCRINOL, V15, P136, DOI 10.1210/me.15.1.136; Friedrichsen BN, 2003, MOL ENDOCRINOL, V17, P945, DOI 10.1210/me.2002-0356; Georgia S, 2010, DIABETES, V59, P987, DOI 10.2337/db09-0838; Guo SL, 2013, J CLIN INVEST, V123, P3305, DOI 10.1172/JCI65390; Hang Y, 2014, DIABETES, V63, P1994, DOI 10.2337/db13-1001; Heit JJ, 2006, ANNU REV CELL DEV BI, V22, P311, DOI 10.1146/annurev.cellbio.22.010305.104425; HOSOKAWA Y, 1994, GENE, V147, P249, DOI 10.1016/0378-1119(94)90075-2; Huang C, 2009, ENDOCRINOLOGY, V150, P1618, DOI 10.1210/en.2008-1003; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hughes E, 2011, ENDOCRINOLOGY, V152, P847, DOI 10.1210/en.2010-1250; Hurt EM, 2004, CANCER CELL, V5, P191, DOI 10.1016/S1535-6108(04)00019-4; JOHNSTON DG, 1980, CLIN ENDOCRINOL, V13, P361, DOI 10.1111/j.1365-2265.1980.tb03397.x; Kato T, 2006, CELL METAB, V4, P143, DOI 10.1016/j.cmet.2006.06.009; Kim H, 2010, NAT MED, V16, P804, DOI 10.1038/nm.2173; Kulkarni RN, 2005, REV ENDOCR METAB DIS, V6, P199, DOI 10.1007/s11154-005-3051-y; Kushner JA, 2005, MOL CELL BIOL, V25, P3752, DOI 10.1128/MCB.25.9.3752-3762.2005; Maccario M, 1996, EUR J ENDOCRINOL, V135, P205, DOI 10.1530/eje.0.1350205; Meier JJ, 2008, DIABETES, V57, P1584, DOI 10.2337/db07-1369; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; MOLDRUP A, 1993, ENDOCRINOLOGY, V133, P1165, DOI 10.1210/en.133.3.1165; NIELSEN JH, 1982, ENDOCRINOLOGY, V110, P600, DOI 10.1210/endo-110-2-600; Nishimura W, 2002, J NEUROSCI, V22, P757, DOI 10.1523/JNEUROSCI.22-03-00757.2002; Nishimura W, 2013, ENDOCRINOLOGY, V154, P4388, DOI 10.1210/en.2012-2248; Nishimura W, 2006, DEV BIOL, V293, P526, DOI 10.1016/j.ydbio.2006.02.028; Olbrot M, 2002, P NATL ACAD SCI USA, V99, P6737, DOI 10.1073/pnas.102168499; Picard F, 2002, P NATL ACAD SCI USA, V99, P15644, DOI 10.1073/pnas.202612199; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; Schraenen A, 2010, DIABETOLOGIA, V53, P2589, DOI 10.1007/s00125-010-1913-7; SORENSON RL, 1993, ENDOCRINOLOGY, V133, P2227, DOI 10.1210/en.133.5.2227; Vasavada RC, 2000, J BIOL CHEM, V275, P15399, DOI 10.1074/jbc.275.20.15399; Warner MJ, 2010, BIOCHEM J, V427, P333, DOI 10.1042/BJ20091861; Weinhaus AJ, 2007, J ENDOCRINOL, V193, P367, DOI 10.1677/JOE-07-0043; Yokouchi H, 2013, ACTA OPHTHALMOL, V91, pE289, DOI 10.1111/aos.12097; Zhang C, 2005, MOL CELL BIOL, V25, P4969, DOI 10.1128/MCB.25.12.4969-4976.2005; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	46	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104184	10.1371/journal.pone.0104184	http://dx.doi.org/10.1371/journal.pone.0104184			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126749	gold, Green Published, Green Submitted			2022-12-25	WOS:000340879300015
J	Felix-Silva, J; Souza, T; Menezes, YAS; Cabral, B; Camara, RBG; Silva, AA; Rocha, HAO; Rebecchi, IMM; Zucolotto, SM; Fernandes-Pedrosa, MF				Felix-Silva, Juliana; Souza, Thiago; Menezes, Yamara A. S.; Cabral, Barbara; Camara, Rafael B. G.; Silva-Junior, Arnobio A.; Rocha, Hugo A. O.; Rebecchi, Ivanise M. M.; Zucolotto, Silvana M.; Fernandes-Pedrosa, Matheus F.			Aqueous Leaf Extract of Jatropha gossypiifolia L. (Euphorbiaceae) Inhibits Enzymatic and Biological Actions of Bothrops jararaca Snake Venom	PLOS ONE			English	Article							ANTIINFLAMMATORY ACTIVITY; PHOSPHOLIPASE A(2); ETHANOLIC EXTRACT; GOSSYPIFOLIA L.; PAW EDEMA; METALLOPROTEINASES; CONSTITUENTS; LEAVES; ANTICOAGULANT; QUANTITATION	Snakebites are a serious public health problem due their high morbi-mortality. The main available specific treatment is the antivenom serum therapy, which has some disadvantages, such as poor neutralization of local effects, risk of immunological reactions, high cost and difficult access in some regions. In this context, the search for alternative therapies is relevant. Therefore, the aim of this study was to evaluate the antiophidic properties of Jatropha gossypiifolia, a medicinal plant used in folk medicine to treat snakebites. The aqueous leaf extract of the plant was prepared by decoction and phytochemical analysis revealed the presence of sugars, alkaloids, flavonoids, tannins, terpenes and/or steroids and proteins. The extract was able to inhibit enzymatic and biologic activities induced by Bothrops jararaca snake venom in vitro and in vivo. The blood incoagulability was efficiently inhibited by the extract by oral route. The hemorrhagic and edematogenic local effects were also inhibited, the former by up to 56% and the latter by 100%, in animals treated with extract by oral and intraperitoneal routes, respectively. The inhibition of myotoxic action of B. jararaca reached almost 100%. According to enzymatic tests performed, it is possible to suggest that the antiophidic activity may be due an inhibitory action upon snake venom metalloproteinases (SVMPs) and/or serine proteinases (SVSPs), including fibrinogenolytic enzymes, clotting factors activators and thrombin like enzymes (SVTLEs), as well upon catalytically inactive phospholipases A(2) (Lys49 PLA(2)). Anti-inflammatory activity, at least partially, could also be related to the inhibition of local effects. Additionally, protein precipitating and antioxidant activities may also be important features contributing to the activity presented. In conclusion, the results demonstrate the potential antiophidic activity of J. gossypiifolia extract, including its significant action upon local effects, suggesting that it may be used as a new source of bioactive molecules against bothropic venom.	[Felix-Silva, Juliana; Souza, Thiago; Menezes, Yamara A. S.; Silva-Junior, Arnobio A.; Fernandes-Pedrosa, Matheus F.] Univ Fed Rio Grande do Norte, Lab Tecnol & Biotecnol Farmaceut TecBioFar, Programa Posgrad Ciencias Farmaceut PPgCF, BR-59072970 Natal, RN, Brazil; [Cabral, Barbara; Zucolotto, Silvana M.] Univ Fed Rio Grande do Norte, Dept Farm, Lab Farmacognosia, BR-59072970 Natal, RN, Brazil; [Camara, Rafael B. G.; Rocha, Hugo A. O.] Univ Fed Rio Grande do Norte, Programa Posgrad Bioquim, Lab Biotecnol Polimeros Nat BIOPOL, BR-59072970 Natal, RN, Brazil; [Rebecchi, Ivanise M. M.] Univ Fed Rio Grande do Norte, Dept Anal Clin & Toxicol, Lab Hematol Clin, BR-59072970 Natal, RN, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte	Fernandes-Pedrosa, MF (corresponding author), Univ Fed Rio Grande do Norte, Lab Tecnol & Biotecnol Farmaceut TecBioFar, Programa Posgrad Ciencias Farmaceut PPgCF, BR-59072970 Natal, RN, Brazil.	mpedrosa@ufrnet.br	Félix-Silva, Juliana/K-7066-2012; Menezes, Yamara/K-1783-2016; Zucolotto, Silvana Maria/A-8557-2014; Câmara, Rafael Barros Gomes da/X-7416-2019; Rocha, Hugo Alexandre Oliveira/X-6411-2019; da Silva, Arnobio A/L-4252-2013; Félix-Silva, Juliana/AAA-1737-2019; Fernandes-Pedrosa, Matheus/C-6398-2014; Silva, André/HHN-2071-2022; de Oliveira Rocha, Hugo Alexandre/I-5130-2019; Rocha, Hugo Alexandre Oliveira/X-6410-2019	Félix-Silva, Juliana/0000-0003-3131-9025; Menezes, Yamara/0000-0002-3532-5273; Zucolotto, Silvana Maria/0000-0002-2768-0793; da Silva, Arnobio A/0000-0002-7516-1787; Félix-Silva, Juliana/0000-0003-3131-9025; Fernandes-Pedrosa, Matheus/0000-0003-4221-9580; Rocha, Hugo Alexandre Oliveira/0000-0003-2252-1221	CAPES [23038000814/2011-83]; CNPq [483842/2010-9]; BNB [ETENE/2010]; FAPERN [PRONEM/2011]	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); BNB; FAPERN(Fundacao de Apoio a Pesquisa do Estado do Rio Grande do Norte (FAPERN))	This research was supported by grants from CAPES (23038000814/2011-83), CNPq (483842/2010-9), BNB (ETENE/2010) and FAPERN (PRONEM/2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambikabothy J, 2011, J ETHNOPHARMACOL, V137, P257, DOI 10.1016/j.jep.2011.05.013; Pereanez JA, 2013, TOXICON, V71, P41, DOI 10.1016/j.toxicon.2013.05.013; [Anonymous], 2014, INT J PHARM PHARM SC; Araujo SD, 2007, INFLAMM RES, V56, P409, DOI 10.1007/s00011-007-7054-x; Arni RK, 1996, TOXICON, V34, P827, DOI 10.1016/0041-0101(96)00036-0; Bhagat R, 2011, J SCI IND RES INDIA, V70, P289; BJARNASON JB, 1994, PHARMACOL THERAPEUT, V62, P325, DOI 10.1016/0163-7258(94)90049-3; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Brasil, 2011, REN REL NCAL PLANT M; CURY Y, 1994, TOXICON, V32, P1425, DOI 10.1016/0041-0101(94)90414-6; Dantas Jose Oliveira, 2006, Biologia Geral e Experimental, V6, P32; de Albuquerque UP, 2007, J ETHNOPHARMACOL, V110, P76, DOI 10.1016/j.jep.2006.09.010; De PRC, 2010, J VENOM ANIM TOXINS, V16, P311, DOI 10.1590/S1678-91992010000200012; de Paula RC, 2009, PROTEIN PEPTIDE LETT, V16, P899, DOI 10.2174/092986609788923365; de Roodt AR, 2000, TOXICON, V38, P865, DOI 10.1016/S0041-0101(99)00205-6; Devappa RK, 2010, J TOXICOL ENV HEAL B, V13, P476, DOI 10.1080/10937404.2010.499736; Dey A, 2012, INT J PHARMACOL, V8, P62, DOI 10.3923/ijp.2012.62.79; Di Stasi L.C., 2002, PLANTAS MED AMAZONIA; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Escalante T, 2011, J PROTEOMICS, V74, P1781, DOI 10.1016/j.jprot.2011.03.026; Feitosa L, 1998, TOXICON, V36, P1039, DOI 10.1016/S0041-0101(97)00083-4; Felix-Silva J, 2014, EVID-BASED COMPL ALT, V2014, P1; Franke K, 2004, BIOCHEM SYST ECOL, V32, P219, DOI 10.1016/S0305-1978(03)00140-6; Fuly, 2011, BIOMED PREV NUTR, V1, P61, DOI [10.1016/j.bionut.2010.09.003, DOI 10.1016/J.BIONUT.2010.09.003]; Gomes A, 2010, INDIAN J EXP BIOL, V48, P865; GUTIERREZ J M, 1989, Memorias do Instituto Butantan (Sao Paulo), V51, P211; GUTIERREZ JM, 1995, TOXICON, V33, P1405, DOI 10.1016/0041-0101(95)00085-Z; Gutierrez JM, 2000, BIOCHIMIE, V82, P841, DOI 10.1016/S0300-9084(00)01163-9; Gutierrez JM, 2006, PLOS MED, V3, P727, DOI 10.1371/journal.pmed.0030150; Gutierrez JM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002162; HABERMANN E, 1972, ANAL BIOCHEM, V50, P163, DOI 10.1016/0003-2697(72)90495-2; Kang TS, 2011, FEBS J, V278, P4544, DOI 10.1111/j.1742-4658.2011.08115.x; Kasturiratne A, 2008, PLOS MED, V5, P1591, DOI 10.1371/journal.pmed.0050218; KORNALIK F, 1985, PHARMACOL THERAPEUT, V29, P353, DOI 10.1016/0163-7258(85)90008-7; KUPPUSAMY UR, 1993, PHARMACOL TOXICOL, V72, P290, DOI 10.1111/j.1600-0773.1993.tb01652.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Maiorano VA, 2005, J ETHNOPHARMACOL, V102, P364, DOI 10.1016/j.jep.2005.06.039; Mao WJ, 2009, INT J BIOL MACROMOL, V44, P70, DOI 10.1016/j.ijbiomac.2008.10.003; Gutierrez JM, 2011, BIOLOGICALS, V39, P129, DOI 10.1016/j.biologicals.2011.02.005; Mariz SR, 2012, REV BRAS FARMACOGN, V22, P663, DOI 10.1590/S0102-695X2012005000024; MEBS D, 1983, TOXICON, V21, P393, DOI 10.1016/0041-0101(83)90096-X; Melo-Silveira RF, 2012, INT J MOL SCI, V13, P409, DOI 10.3390/ijms13010409; Ministerio da Saude, 2009, CADERNO 14; Mors WB, 2000, PHYTOCHEMISTRY, V55, P627, DOI 10.1016/S0031-9422(00)00229-6; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nagaharika Y, 2013, J ACUTE DIS, V2, P156, DOI 10.1016/S2221-6189(13)60118-3; Nunez V, 2004, BRAZ J MED BIOL RES, V37, P969, DOI 10.1590/S0100-879X2004000700005; Ode O.J., 2010, INT J APPL BIOL PHAR, V1, P1330; Panda BB, 2009, GLOBAL J PHARM, V3, P1; Pilon AC, 2013, PHYTOCHEM ANALYSIS, V24, P401, DOI 10.1002/pca.2423; Ramos OHP, 2006, COMP BIOCHEM PHYS C, V142, P328, DOI 10.1016/j.cbpc.2005.11.005; Robert S, 2010, J ETHNOPHARMACOL, V128, P641, DOI 10.1016/j.jep.2010.02.007; Rodrigues VM, 2000, ARCH BIOCHEM BIOPHYS, V381, P213, DOI 10.1006/abbi.2000.1958; Sabandar CW, 2013, PHYTOCHEMISTRY, V85, P7, DOI 10.1016/j.phytochem.2012.10.009; Sajevic T, 2011, TOXICON, V57, P627, DOI 10.1016/j.toxicon.2011.01.006; Santhosh MS, 2013, MINI-REV MED CHEM, V13, P106; Shenoy PA, 2013, J ETHNOPHARMACOL, V147, P373, DOI 10.1016/j.jep.2013.03.022; STOCKER K, 1982, TOXICON, V20, P265, DOI 10.1016/0041-0101(82)90225-2; SUBRAMAN.SS, 1971, PHYTOCHEMISTRY, V10, P1690, DOI 10.1016/0031-9422(71)85055-0; Swenson S, 2005, TOXICON, V45, P1021, DOI 10.1016/j.toxicon.2005.02.027; Teixeira CFP, 2003, TOXICON, V42, P947, DOI 10.1016/j.toxicon.2003.11.006; Melo KRT, 2013, MOLECULES, V18, P14543, DOI 10.3390/molecules181214543; THEAKSTON RDG, 1983, B WORLD HEALTH ORGAN, V61, P949; TREBIEN HA, 1989, AGENTS ACTIONS, V26, P292, DOI 10.1007/BF01967293; Wagner H., 2001, PLANT DRUG ANAL, VVolume 1, P195; Zhang XP, 2009, CHEM BIODIVERS, V6, P2166, DOI 10.1002/cbdv.200700461	67	33	34	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104952	10.1371/journal.pone.0104952	http://dx.doi.org/10.1371/journal.pone.0104952			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126759	Green Submitted, Green Published, gold			2022-12-25	WOS:000340879300063
J	Kang, MJ; Hansen, TJ; Mickiewicz, M; Kaczynski, TJ; Fye, S; Gunawardena, S				Kang, Min Jung; Hansen, Timothy J.; Mickiewicz, Monique; Kaczynski, Tadeusz J.; Fye, Samantha; Gunawardena, Shermali			Disruption of Axonal Transport Perturbs Bone Morphogenetic Protein (BMP) - Signaling and Contributes to Synaptic Abnormalities in Two Neurodegenerative Diseases	PLOS ONE			English	Article							PRESYNAPTIC ACTIVE ZONES; MOUSE MODEL; KINESIN MUTATIONS; II RECEPTOR; DROSOPHILA; GROWTH; MOTOR; SYNAPTOTAGMIN; EXPRESSION; PLASTICITY	Formation of new synapses or maintenance of existing synapses requires the delivery of synaptic components from the soma to the nerve termini via axonal transport. One pathway that is important in synapse formation, maintenance and function of the Drosophila neuromuscular junction (NMJ) is the bone morphogenetic protein (BMP)-signaling pathway. Here we show that perturbations in axonal transport directly disrupt BMP signaling, as measured by its downstream signal, phospho Mad (p-Mad). We found that components of the BMP pathway genetically interact with both kinesin-1 and dynein motor proteins. Thick vein (TKV) vesicle motility was also perturbed by reductions in kinesin-1 or dynein motors. Interestingly, dynein mutations severely disrupted p-Mad signaling while kinesin-1 mutants showed a mild reduction in p-Mad signal intensity. Similar to mutants in components of the BMP pathway, both kinesin-1 and dynein motor protein mutants also showed synaptic morphological defects. Strikingly TKV motility and p-Mad signaling were disrupted in larvae expressing two human disease proteins; expansions of glutamine repeats (polyQ77) and human amyloid precursor protein (APP) with a familial Alzheimer's disease (AD) mutation (APPswe). Consistent with axonal transport defects, larvae expressing these disease proteins showed accumulations of synaptic proteins along axons and synaptic abnormalities. Taken together our results suggest that similar to the NGF-TrkA signaling endosome, a BMP signaling endosome that directly interacts with molecular motors likely exist. Thus problems in axonal transport occurs early, perturbs BMP signaling, and likely contributes to the synaptic abnormalities observed in these two diseases.	[Kang, Min Jung; Hansen, Timothy J.; Mickiewicz, Monique; Kaczynski, Tadeusz J.; Fye, Samantha; Gunawardena, Shermali] SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Gunawardena, S (corresponding author), SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA.	sg99@buffalo.edu		gunawardena, shermali/0000-0001-8776-9397	John R. Oishei Foundation; National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS) [R03-NS084386-01]; University at Buffalo (UB) Center for Undergraduate Research and Creative Activities (CURCA); Honors College Research and Creative Activities Fund; Department of Biological Sciences McCroskey Endowment Scholarship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R03NS084386] Funding Source: NIH RePORTER	John R. Oishei Foundation; National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); University at Buffalo (UB) Center for Undergraduate Research and Creative Activities (CURCA); Honors College Research and Creative Activities Fund; Department of Biological Sciences McCroskey Endowment Scholarship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by funds from the John R. Oishei Foundation and National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS) (R03-NS084386-01) to SG. TJH was supported by fellowships from the University at Buffalo (UB) Center for Undergraduate Research and Creative Activities (CURCA), the Honors College Research and Creative Activities Fund, and the Department of Biological Sciences McCroskey Endowment Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Allan DW, 2003, CELL, V113, P73, DOI 10.1016/S0092-8674(03)00204-6; Ball RW, 2010, NEURON, V66, P536, DOI 10.1016/j.neuron.2010.04.011; Bayat V, 2011, CURR OPIN NEUROBIOL, V21, P182, DOI 10.1016/j.conb.2010.08.014; Bilsland LG, 2010, P NATL ACAD SCI USA, V107, P20523, DOI 10.1073/pnas.1006869107; Bowman AB, 1999, J CELL BIOL, V146, P165; Budnik V, 1996, NEURON, V17, P627, DOI 10.1016/S0896-6273(00)80196-8; Cai Q, 2009, NEUROSCIENTIST, V15, P78, DOI 10.1177/1073858408329511; Chang HCH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003209; Chia PH, 2013, J CELL BIOL, V203, P11, DOI 10.1083/jcb.201307020; Cosker KE, 2008, CURR OPIN NEUROBIOL, V18, P270, DOI 10.1016/j.conb.2008.08.005; Crews L, 2010, J NEUROSCI, V30, P12252, DOI 10.1523/JNEUROSCI.1305-10.2010; Cummings DM, 2006, HUM MOL GENET, V15, P2856, DOI 10.1093/hmg/ddl224; Davis GW, 2006, ANNU REV NEUROSCI, V29, P307, DOI 10.1146/annurev.neuro.28.061604.135751; DIANTONIO A, 1994, NEURON, V12, P909, DOI 10.1016/0896-6273(94)90342-5; DIANTONIO A, 1993, CELL, V73, P1281, DOI 10.1016/0092-8674(93)90356-U; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Dolma K, 2014, HUM MOL GENET, V23, P1121, DOI 10.1093/hmg/ddt505; Eaton BA, 2005, NEURON, V47, P695, DOI 10.1016/j.neuron.2005.08.010; Fiorillo C, 2014, HUM MUTAT, V35, P298, DOI 10.1002/humu.22491; Fitzsimonds RM, 1998, PHYSIOL REV, V78, P143, DOI 10.1152/physrev.1998.78.1.143; Franker MAM, 2013, J CELL SCI, V126, P2319, DOI 10.1242/jcs.115030; Fuger P, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003066; Fuentes-Medel Y, 2010, NEURON, V66, P473, DOI 10.1016/j.neuron.2010.05.016; Fye Samantha, 2010, J Vis Exp, DOI 10.3791/2128; GHO M, 1992, SCIENCE, V258, P313, DOI 10.1126/science.1384131; Gindhart JG, 1998, J CELL BIOL, V141, P443, DOI 10.1083/jcb.141.2.443; Gunawardena S, 2001, NEURON, V32, P389, DOI 10.1016/S0896-6273(01)00496-2; Gunawardena S, 2004, J NEUROBIOL, V58, P258, DOI 10.1002/neu.10319; Gunawardena S, 2003, NEURON, V40, P25, DOI 10.1016/S0896-6273(03)00594-4; Gunawardena S, 2013, HUM MOL GENET, V22, P3828, DOI 10.1093/hmg/ddt237; Gunawardena S, 2013, PHARM RES-DORDR, V30, P2459, DOI 10.1007/s11095-013-1037-0; Heerssen HM, 2004, NAT NEUROSCI, V7, P596, DOI 10.1038/nn1242; Hoerndli FJ, 2013, NEURON, V80, P1421, DOI 10.1016/j.neuron.2013.10.050; Holbert S, 2003, P NATL ACAD SCI USA, V100, P2712, DOI 10.1073/pnas.0437967100; Hurd DD, 1996, GENETICS, V144, P1075; Kaczynski TJ, 2010, JOVE-J VIS EXP, V46, P2150; Keshishian H, 2002, NEURON, V33, P491, DOI 10.1016/S0896-6273(02)00597-4; Keshishian H, 2004, TRENDS NEUROSCI, V27, P143, DOI 10.1016/j.tins.2004.01.004; Kim NC, 2010, DEV DYNAM, V239, P2413, DOI 10.1002/dvdy.22368; Kuznicki Michelle L, 2010, J Vis Exp, DOI 10.3791/2151; LAHEY T, 1994, NEURON, V13, P823, DOI 10.1016/0896-6273(94)90249-6; LAMPERT PW, 1971, ACTA NEUROPATHOL B S, V5, P49; Lee S, 2011, AUTOPHAGY, V7, P1562, DOI 10.4161/auto.7.12.17956; Li H, 2001, J NEUROSCI, V21, P8473, DOI 10.1523/JNEUROSCI.21-21-08473.2001; Lione LA, 1999, J NEUROSCI, V19, P10428; LITTLETON JT, 1993, DEVELOPMENT, V118, P1077; LITTLETON JT, 1993, CELL, V74, P1125, DOI 10.1016/0092-8674(93)90733-7; Liu F, 1996, NATURE, V381, P620, DOI 10.1038/381620a0; Lloyd TE, 2012, NEURON, V74, P344, DOI 10.1016/j.neuron.2012.02.026; Loewen CA, 2001, GENESIS, V31, P30, DOI 10.1002/gene.10002; Machado RD, 2003, HUM MOL GENET, V12, P3277, DOI 10.1093/hmg/ddg365; Marques G, 2003, DEVELOPMENT, V130, P5457, DOI 10.1242/dev.00772; Marques G, 2002, NEURON, V33, P529, DOI 10.1016/S0896-6273(02)00595-0; Mazarakis NK, 2005, J NEUROSCI, V25, P3059, DOI 10.1523/JNEUROSCI.4320-04.2005; McCabe BD, 2004, NEURON, V41, P891, DOI 10.1016/S0896-6273(04)00073-X; McCabe BD, 2003, NEURON, V39, P241, DOI 10.1016/S0896-6273(03)00426-4; Merino C, 2009, J CELL BIOL, V185, P713, DOI 10.1083/jcb.200809127; Meyer-Luehmann M, 2008, NATURE, V451, P720, DOI 10.1038/nature06616; Morel M, 2012, ACTA NEUROPATHOL, V123, P71, DOI 10.1007/s00401-011-0901-4; Nahm M, 2013, NEURON, V77, P680, DOI 10.1016/j.neuron.2012.12.015; O'Connor-Giles KM, 2008, NEURON, V58, P507, DOI 10.1016/j.neuron.2008.03.007; OKADA Y, 1995, CELL, V81, P769, DOI 10.1016/0092-8674(95)90538-3; Orth M, 2010, J NEUROL NEUROSUR PS, V81, P267, DOI 10.1136/jnnp.2009.171926; Paulsen JS, 2008, J NEUROL NEUROSUR PS, V79, P874, DOI 10.1136/jnnp.2007.128728; PERIN MS, 1991, J BIOL CHEM, V266, P615; Ratnaparkhi A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002334; Rawson JM, 2003, J NEUROBIOL, V55, P134, DOI 10.1002/neu.10189; Rodal AA, 2011, J CELL BIOL, V193, P201, DOI 10.1083/jcb.201009052; Salehi A, 2006, NEURON, V51, P29, DOI 10.1016/j.neuron.2006.05.022; Sampo B, 2003, NEURON, V37, P611, DOI 10.1016/S0896-6273(03)00058-8; Sanchez-Varo R, 2012, ACTA NEUROPATHOL, V123, P53, DOI 10.1007/s00401-011-0896-x; Sapp E, 1997, ANN NEUROL, V42, P604, DOI 10.1002/ana.410420411; Scheff SW, 2011, J ALZHEIMERS DIS, V24, P547, DOI 10.3233/JAD-2011-101782; Schippling S, 2009, BIOL PSYCHIAT, V65, P959, DOI 10.1016/j.biopsych.2008.12.026; Schuster CM, 1996, NEURON, V17, P655, DOI 10.1016/S0896-6273(00)80198-1; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shapira M, 2003, NEURON, V38, P237, DOI 10.1016/S0896-6273(03)00207-1; Smith RB, 2012, J CELL SCI, V125, P3752, DOI 10.1242/jcs.094292; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Stokin GB, 2008, HUM MOL GENET, V17, P3474, DOI 10.1093/hmg/ddn240; Stokin GB, 2006, ANNU REV BIOCHEM, V75, P607, DOI 10.1146/annurev.biochem.75.103004.142637; Sweeney ST, 2002, NEURON, V36, P403, DOI 10.1016/S0896-6273(02)01014-0; Torres Manuel, 2012, Mol Neurodegener, V7, P59, DOI 10.1186/1750-1326-7-59; Torroja L, 1999, J NEUROSCI, V19, P7793; Tsang HTH, 2009, HUM MOL GENET, V18, P3805, DOI 10.1093/hmg/ddp324; Van Raamsdonk JM, 2005, J NEUROSCI, V25, P4169, DOI 10.1523/JNEUROSCI.0590-05.2005; Vanlandingham PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065997; Wang XN, 2007, NAT NEUROSCI, V10, P177, DOI 10.1038/nn1841; Watson FL, 2001, NAT NEUROSCI, V4, P981, DOI 10.1038/nn720; Ye X, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.11.004; Zhao JL, 2013, MOL CELL NEUROSCI, V52, P87, DOI 10.1016/j.mcn.2012.10.005; Zito K, 1999, NEURON, V22, P719, DOI 10.1016/S0896-6273(00)80731-X	94	22	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104617	10.1371/journal.pone.0104617	http://dx.doi.org/10.1371/journal.pone.0104617			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127478	Green Published, Green Submitted, gold			2022-12-25	WOS:000340879300038
J	Nehls, J; Koppensteiner, H; Brack-Werner, R; Floss, T; Schindler, M				Nehls, Julia; Koppensteiner, Herwig; Brack-Werner, Ruth; Floss, Thomas; Schindler, Michael			HIV-1 Replication in Human Immune Cells Is Independent of TAR DNA Binding Protein 43 (TDP-43) Expression	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; T-CELLS; RESTRICTION FACTORS; NUCLEAR FACTOR; NEF; RELEASE; RNA; VPU; TRANSCRIPTION; MACROPHAGES	The TAR DNA binding protein (TDP-43) was originally identified as a host cell factor binding to the HIV-1 LTR and thereby suppressing HIV-1 transcription and gene expression (Ou et al., J. Virol. 1995, 69(6): 3584). TDP-43 is a global regulator of transcription, can influence RNA metabolism in many different ways and is ubiquitously expressed. Thus, TDP-43 could be a major factor restricting HIV-1 replication at the level of LTR transcription and gene expression. These facts prompted us to revisit the role of TDP-43 for HIV-1 replication. We utilized established HIV-1 cell culture systems as well as primary cell models and performed a comprehensive analysis of TDP-43 function and investigated its putative impact on HIV-1 gene expression. In HIV-1 infected cells TDP-43 was neither degraded nor sequestered from the nucleus. Furthermore, TDP-43 overexpression as well as siRNA mediated knockdown did not affect HIV-1 gene expression and virus production in T cells and macrophages. In summary, our experiments argue against a restricting role of TDP-43 during HIV-1 replication in immune cells.	[Nehls, Julia; Koppensteiner, Herwig; Brack-Werner, Ruth; Schindler, Michael] German Res Ctr Environm Hlth, Helmholtz Zentrum Munich, Inst Virol, Neuherberg, Germany; [Floss, Thomas] German Res Ctr Environm Hlth, Helmholtz Zentrum Munich, Inst Dev Genet, Neuherberg, Germany; [Schindler, Michael] Univ Clin Tubingen, Inst Med Virol & Epidemiol Viral Dis, Tubingen, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Schindler, M (corresponding author), German Res Ctr Environm Hlth, Helmholtz Zentrum Munich, Inst Virol, Neuherberg, Germany.	michael.schindler@helmholtz-muenchen.de	Schindler, Michael/C-1647-2015; Brack-Werner, Ruth/M-4615-2014	Schindler, Michael/0000-0001-8989-5813; Brack-Werner, Ruth/0000-0002-8651-9318	Helmholtz Zentrum Munchen; German Research Foundation [DFG SCHI1073/4-1]; Else Kroner-Fresenius Stiftung; KNDD2 [FKZ 01 GI 1005D]	Helmholtz Zentrum Munchen(Helmholtz Association); German Research Foundation(German Research Foundation (DFG)); Else Kroner-Fresenius Stiftung; KNDD2	Financial support for this study was provided by intramural funding of the Helmholtz Zentrum Munchen. JN and MS received funding from the German Research Foundation (DFG SCHI1073/4-1) and the Else Kroner-Fresenius Stiftung. TF was supported by the KNDD2 grants FKZ 01 GI 1005D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayala YM, 2005, J MOL BIOL, V348, P575, DOI 10.1016/j.jmb.2005.02.038; Ayala YM, 2011, EMBO J, V30, P277, DOI 10.1038/emboj.2010.310; Baldauf HM, 2012, NAT MED, V18, P1682, DOI 10.1038/nm.2964; Banning C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009344; Boutwell CL, 2010, J INFECT DIS, V202, pS309, DOI 10.1086/655653; Budini M, 2011, J MOL NEUROSCI, V45, P473, DOI 10.1007/s12031-011-9573-8; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; Buratti E, 2010, RNA BIOL, V7, P420, DOI 10.4161/rna.7.4.12205; Bushman FD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000437; Chen-Plotkin AS, 2010, NAT REV NEUROL, V6, P211, DOI 10.1038/nrneurol.2010.18; Clifford DB, 2013, LANCET INFECT DIS, V13, P976, DOI 10.1016/S1473-3099(13)70269-X; Cohen TJ, 2011, TRENDS MOL MED, V17, P659, DOI 10.1016/j.molmed.2011.06.004; Descours B, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-87; Freibaum BD, 2010, J PROTEOME RES, V9, P1104, DOI 10.1021/pr901076y; Gaudin R, 2012, J CELL BIOL, V199, P467, DOI 10.1083/jcb.201201144; Gitler AD, 2011, PRION, V5, P179, DOI 10.4161/pri.5.3.17230; Gramberg T, 2010, J VIROL, V84, P1387, DOI 10.1128/JVI.01437-09; Harris RS, 2012, J BIOL CHEM, V287, P40875, DOI 10.1074/jbc.R112.416925; Harris RS, 2004, NAT REV IMMUNOL, V4, P868, DOI 10.1038/nri1489; IGNATIUS SH, 1995, J VIROL, V69, P3584, DOI 10.1128/JVI.69.6.3584-3596.1995; Kirchhoff F, 2008, CELL MOL LIFE SCI, V65, P2621, DOI 10.1007/s00018-008-8094-2; Koppensteiner H, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-1; Koppensteiner H, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-82; Koppensteiner H, 2012, J VIROL, V86, P2826, DOI 10.1128/JVI.05915-11; Lalmansingh AS, 2011, J BIOL CHEM, V286, P10970, DOI 10.1074/jbc.M110.166587; Le Tortorec A, 2011, VIRUSES-BASEL, V3, P520, DOI 10.3390/v3050520; Ling SC, 2013, NEURON, V79, P416, DOI 10.1016/j.neuron.2013.07.033; Liu L, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-94; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Martin-Serrano J, 2011, NAT REV MICROBIOL, V9, P519, DOI 10.1038/nrmicro2596; Meggendorfer M, 2010, CHROMOSOME RES, V18, P401, DOI 10.1007/s10577-010-9133-z; Munch J, 2007, J VIROL, V81, P13852, DOI 10.1128/JVI.00904-07; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; NORTHROP JP, 1993, J BIOL CHEM, V268, P2917; Schindler M, 2006, CELL, V125, P1055, DOI 10.1016/j.cell.2006.04.033; Schwartz O, 1996, NAT MED, V2, P338, DOI 10.1038/nm0396-338; Sephton CF, 2012, BIOL CHEM, V393, P589, DOI 10.1515/hsz-2012-0115; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Van Lint C, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-67; Wildurn S, 2006, J VIROL, V80, P8047, DOI 10.1128/JVI.00252-06	40	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105478	10.1371/journal.pone.0105478	http://dx.doi.org/10.1371/journal.pone.0105478			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127017	Green Submitted, Green Published, gold			2022-12-25	WOS:000340879300114
J	von Drygalski, A; Bhat, V; Gale, AJ; Burnier, L; Cramer, TJ; Griffin, JH; Mosnier, LO				von Drygalski, Annette; Bhat, Vikas; Gale, Andrew J.; Burnier, Laurent; Cramer, Thomas J.; Griffin, John H.; Mosnier, Laurent O.			An Engineered Factor Va Prevents Bleeding Induced by Anticoagulant wt Activated Protein C	PLOS ONE			English	Article							ACUTE TRAUMATIC COAGULOPATHY; IN-VIVO; SEVERE SEPSIS; INACTIVATION; SAFETY; MUTANT; HEMOSTASIS; HEMORRHAGE; THROMBIN; MICE	Objective: An increased risk of bleeding is observed in patients receiving activated protein C (APC), which may be a limiting factor for the application of novel APC therapies. Since APC's therapeutic effects often require its cytoprotective activities on cells but not APC's anticoagulant activities, an agent that specifically antagonizes APC's anticoagulant effects but not its cytoprotective effects could provide an effective means to control concerns for risk of bleeding. We hypothesized that (super)FVa, an engineered activated FVa-variant that restores hemostasis in hemophilia could reduce APC-induced bleeding. Approach and Results: (Super)FVa was engineered with mutations of the APC cleavage sites (Arg506/306/679Gln) and a disulfide bond (Cys609-Cys1691) between the A2 and A3 domains, which augment its biological activity and cause high resistance to APC. (Super)FVa normalized APC-prolonged clotting times and restored APC-suppressed thrombin generation in human and murine plasma at concentrations where wild-type (wt) FVa did not show effects. Following intravenous injection of APC into BALB/c mice, addition to whole blood ex vivo of (super)FVa but not wt-FVa significantly normalized whole blood clotting. Blood loss following tail clip or liver laceration was significantly reduced when (super)FVa was administered intravenously to BALB/c mice prior to intravenous APC-treatment. Furthermore, (super)FVa abolished mortality (similar to 50%) associated with excessive bleeding following liver laceration in mice treated with APC. Conclusions: Our results provide proof of concept that (super)FVa is effective in preventing APC-induced bleeding and may provide therapeutic benefits as a prohemostatic agent in various situations where bleeding is a serious risk.	[von Drygalski, Annette; Bhat, Vikas; Gale, Andrew J.; Burnier, Laurent; Griffin, John H.; Mosnier, Laurent O.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [von Drygalski, Annette; Bhat, Vikas; Cramer, Thomas J.; Griffin, John H.] Univ Calif San Diego, Dept Med, Div Hematol Oncol, San Diego, CA 92103 USA	Scripps Research Institute; University of California System; University of California San Diego	von Drygalski, A (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	avondrygalski@ucsd.edu	Burnier, Laurent P/E-5807-2011	Burnier, Laurent P/0000-0001-7767-0334; Griffin, John/0000-0002-4302-2547	American Society of Hematology; Bayer Early Career Investigator Award; Swiss National Science Foundation; Fondation Suisse pour les Bourses en Medecine et Biologie (FSBMB); Novartis [PBGEP3-134242, PASMP3_140065]; National Institutes of Health [R01HL021544, PO1HL031950, R01HL052246, R01HL104165]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL104165, R01HL021544, P01HL031950, R01HL052246] Funding Source: NIH RePORTER	American Society of Hematology; Bayer Early Career Investigator Award; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Fondation Suisse pour les Bourses en Medecine et Biologie (FSBMB); Novartis(Novartis); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	These studies were supported by a Research Training Award for Fellows from the American Society of Hematology (A. v. D.), a Bayer Early Career Investigator Award (A. v. D.), postdoctoral fellowships from the Swiss National Science Foundation, the Fondation Suisse pour les Bourses en Medecine et Biologie (FSBMB) and Novartis PBGEP3-134242 and PASMP3_140065 (L. B.), and National Institutes of Health grants R01HL021544, PO1HL031950, and R01HL052246 (J. H. G.) and R01HL104165 (L. O. M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajaj MS, 2011, J BIOL CHEM, V286, P4329, DOI 10.1074/jbc.M110.191163; Bernard GR, 2003, CRIT CARE, V7, P155, DOI 10.1186/cc2167; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Burnier L, 2013, BLOOD CELL MOL DIS, V50, P252, DOI 10.1016/j.bcmd.2013.01.002; Charbonneau S, 2012, J TRAUMA ACUTE CARE, V72, P136, DOI 10.1097/TA.0b013e31823183b4; Chesebro BB, 2009, SHOCK, V32, P659, DOI 10.1097/SHK.0b013e3181a5a632; Christiaans SC, 2014, SHOCK; Cramer TJ, 2009, PATHOPHYSIOL HAEMO T, V37, P17, DOI 10.1159/000315141; Davenport R, 2013, TRANSFUSION, V53, p23S, DOI 10.1111/trf.12032; Fernandez JA, 2009, HAEMATOL-HEMATOL J, V94, P1721, DOI 10.3324/haematol.2009.009233; Franchini M, 2010, THROMB RES, V125, P119, DOI 10.1016/j.thromres.2009.11.003; Gale AJ, 1997, PROTEIN SCI, V6, P132; Gale AJ, 2002, PROTEIN SCI, V11, P2091, DOI 10.1110/ps.0210002; Geiger H, 2012, NAT MED, V18, P1123, DOI 10.1038/nm.2813; HEEB MJ, 1988, THROMB RES, V52, P33, DOI 10.1016/0049-3848(88)90038-2; Hemker HC, 2002, PATHOPHYSIOL HAEMO T, V32, P249, DOI 10.1159/000073575; Jasuja GK, 2013, THROMB RES, V131, P31, DOI 10.1016/j.thromres.2012.10.010; KALAFATIS M, 1994, J BIOL CHEM, V269, P31869; Karakaya K, 2009, J INVEST SURG, V22, P201, DOI 10.1080/08941930902866246; Kerschen EJ, 2007, J EXP MED, V204, P2439, DOI 10.1084/jem.20070404; Lu GM, 2013, NAT MED, V19, P446, DOI 10.1038/nm.3102; Lyden P, 2013, CURR PHARM DESIGN, V19, P7479; MANN KG, 1988, ANNU REV BIOCHEM, V57, P915, DOI 10.1146/annurev.bi.57.070188.004411; Mosnier LO, 2007, J BIOL CHEM, V282, P33022, DOI 10.1074/jbc.M705824200; Mosnier LO, 2011, J BIOL CHEM, V286, P502, DOI 10.1074/jbc.M110.147959; Mosnier LO, 2004, BLOOD, V104, P1740, DOI 10.1182/blood-2004-01-0110; NESHEIM ME, 1979, J BIOL CHEM, V254, P952; NICOLAES GAF, 1995, J BIOL CHEM, V270, P21158, DOI 10.1074/jbc.270.36.21158; Schlachterman A, 2005, J THROMB HAEMOST, V3, P2730, DOI 10.1111/j.1538-7836.2005.01639.x; Shibata M, 2001, CIRCULATION, V103, P1799, DOI 10.1161/01.CIR.103.13.1799; von Drygalski A, 2014, J THROMB HAEMOST, V12, P363, DOI 10.1111/jth.12489	31	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104304	10.1371/journal.pone.0104304	http://dx.doi.org/10.1371/journal.pone.0104304			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127130	gold, Green Published, Green Submitted			2022-12-25	WOS:000340879300019
J	Chang, MC; Chang, HH; Wang, TM; Chan, CP; Lin, BR; Yeung, SY; Yeh, CY; Cheng, RH; Jeng, JH				Chang, Mei-Chi; Chang, Hsiao-Hua; Wang, Tong-Mei; Chan, Chiu-Po; Lin, Bor-Ru; Yeung, Sin-Yuet; Yeh, Chien-Yang; Cheng, Ru-Hsiu; Jeng, Jiiang-Huei			Antiplatelet Effect of Catechol Is Related to Inhibition of Cyclooxygenase, Reactive Oxygen Species, ERK/p38 Signaling and Thromboxane A(2) Production	PLOS ONE			English	Article							IN-VITRO; PLATELET-AGGREGATION; ANTIOXIDANT ACTIVITY; HYDROQUINONE; ACTIVATION; CELLS; CYTOTOXICITY; ANTAGONIST; MODULATION; FLAVONOIDS	Catechol (benzenediol) is present in plant-derived products, such as vegetables, fruits, coffee, tea, wine, areca nut and cigarette smoke. Because platelet dysfunction is a risk factor of cardiovascular diseases, including stroke, atherosclerosis and myocardial infarction, the purpose of this study was to evaluate the anti-platelet and anti-inflammatory effect of catechol and its mechanisms. The effects of catechol on cyclooxygenase (COX) activity, arachidonic acid (AA)-induced aggregation, thromboxane B-2 (TXB2) production, lactate dehydrogenase (LDH) release, reactive oxygen species (ROS) production and extracellular signal-regulated kinase (ERK)/p38 phosphorylation were determined in rabbit platelets. In addition, its effect on IL-1b-induced prostaglandin E-2 (PGE(2)) production by fibroblasts was determined. The ex vivo effect of catechol on platelet aggregation was also measured. Catechol (5-25 mu M) suppressed AA-induced platelet aggregation and inhibited TXB2 production at concentrations of 0.5-5 mu M; however, it showed little cytotoxicity and did not alter U46619-induced platelet aggregation. Catechol (10-50 mu M) suppressed COX-1 activity by 29-44% and COX-2 activity by 29-50%. It also inhibited IL-1b- induced PGE2 production, but not COX-2 expression of fibroblasts. Moreover, catechol (1-10 mu M) attenuated AA-induced ROS production in platelets and phorbol myristate acetate (PMA)-induced ROS production in human polymorphonuclear leukocytes. Exposure of platelets to catechol decreased AA-induced ERK and p38 phosphorylation. Finally, intravenous administration of catechol (2.5-5 mu mole/mouse) attenuated ex vivo AA-induced platelet aggregation. These results suggest that catechol exhibited anti-platelet and anti-inflammatory effects, which were mediated by inhibition of COX, ROS and TXA(2) production as well as ERK/p38 phosphorylation. The anti-platelet effect of catechol was confirmed by ex vivo analysis. Exposure to catechol may affect platelet function and thus cardiovascular health.	[Chang, Mei-Chi; Cheng, Ru-Hsiu] Chang Gung Univ Sci & Technol, Biomed Sci Team, Taoyuan, Taiwan; [Chang, Hsiao-Hua; Wang, Tong-Mei; Yeh, Chien-Yang; Jeng, Jiiang-Huei] Natl Taiwan Univ Hosp, Grad Inst Clin Dent, Lab Pharmacol & Toxicol, Taipei, Taiwan; [Chang, Hsiao-Hua; Wang, Tong-Mei; Yeh, Chien-Yang; Jeng, Jiiang-Huei] Natl Taiwan Univ Hosp, Dept Dent, Taipei, Taiwan; [Chang, Hsiao-Hua; Wang, Tong-Mei; Yeh, Chien-Yang; Jeng, Jiiang-Huei] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Chan, Chiu-Po; Yeung, Sin-Yuet] Chang Gung Mem Hosp, Dept Dent, Taipei 10591, Taiwan; [Chan, Chiu-Po; Yeung, Sin-Yuet] Chang Gung Univ, Taipei, Taiwan; [Lin, Bor-Ru] Natl Taiwan Univ Hosp, Dept Diagnotherapeut, Taipei, Taiwan	Chang Gung University of Science & Technology; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Chang Gung Memorial Hospital; Chang Gung University; National Taiwan University; National Taiwan University Hospital	Jeng, JH (corresponding author), Natl Taiwan Univ Hosp, Grad Inst Clin Dent, Lab Pharmacol & Toxicol, Taipei, Taiwan.	jhjeng@ntu.edu.tw		CHANG, HSIAO-HUA/0000-0002-8417-8847; WANG, TONG-MEI/0000-0002-9885-6899; LIN, BOR-RU/0000-0001-9545-7393; Jeng, Jiiang-Huei/0000-0002-2068-5380	National Science Council [NSC102-2314-B-255-003-MY2, NSC102-2628-B-255-001-MY3, NSC101-2320-B-255-002, NSC-100-2314-B-002-094, NSC-101-2320-B-255-002]; Chang Gung Memorial Hospital [CMRPF1C0011, CMRPF1C0012, NMRPF3C0091, NMRPF3C0061]	National Science Council(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	The authors would like to thank Miss HF Jeng for her technical assistance. This study is supported by grants from National Science Council (NSC102-2314-B-255-003-MY2, NSC102-2628-B-255-001-MY3, NSC101-2320-B-255-002, NSC-100-2314-B-002-094 and NSC-101-2320-B-255-002) and Chang Gung Memorial Hospital (CMRPF1C0011, CMRPF1C0012, NMRPF3C0091, NMRPF3C0061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Ghouleh I, 2011, FREE RADICAL BIO MED, V51, P1271, DOI 10.1016/j.freeradbiomed.2011.06.011; ALANKO J, 1995, PROSTAG LEUKOTR ESS, V52, P299, DOI 10.1016/0952-3278(95)90030-6; Alexandru N, 2012, THROMB RES, V129, P116, DOI 10.1016/j.thromres.2011.09.026; [Anonymous], 1985, IARC MON EV CARC RIS, V37, P141; Beck J, 1996, J PERIODONTOL, V67, P1123, DOI 10.1902/jop.1996.67.10s.1123; BORN GVR, 1963, J PHYSIOL-LONDON, V168, P178, DOI 10.1113/jphysiol.1963.sp007185; Chang MC, 2007, BRIT J PHARMACOL, V152, P73, DOI 10.1038/sj.bjp.0707367; Chang MC, 2006, INT ENDOD J, V39, P819, DOI 10.1111/j.1365-2591.2006.01156.x; Chang MC, 1998, BLOOD, V91, P1582, DOI 10.1182/blood.V91.5.1582.1582_1582_1589; Chang MC, 2012, TOXICOL APPL PHARM, V263, P287, DOI 10.1016/j.taap.2012.06.021; Chang MC, 2009, J ORAL PATHOL MED, V38, P434, DOI 10.1111/j.1600-0714.2008.00701.x; De Martino L, 2012, INT J MOL SCI, V13, P5406, DOI 10.3390/ijms13055406; de Oliveira DM, 2010, HUM EXP TOXICOL, V29, P199, DOI 10.1177/0960327109360364; DeCaprio AP, 1999, CRIT REV TOXICOL, V29, P283, DOI 10.1080/10408449991349221; Dileep KV, 2012, CHEM BIOL DRUG DES, V79, P143, DOI 10.1111/j.1747-0285.2011.01258.x; Essex DW, 2009, ANTIOXID REDOX SIGN, V11, P1191, DOI [10.1089/ars.2008.2322, 10.1089/ARS.2008.2322]; Flevaris P, 2009, BLOOD, V113, P893, DOI 10.1182/blood-2008-05-155978; Hsiao G, 2007, CARDIOVASC RES, V75, P782, DOI 10.1016/j.cardiores.2007.05.005; IULIANO L, 1994, EUR J BIOCHEM, V221, P695, DOI 10.1111/j.1432-1033.1994.tb18782.x; Jeng JH, 2002, FREE RADICAL BIO MED, V32, P860, DOI 10.1016/S0891-5849(02)00749-9; Jung CT, 2003, FOOD CHEM TOXICOL, V41, P885, DOI 10.1016/S0278-6915(03)00040-1; Kim SD, 2008, EUR J PHARMACOL, V584, P361, DOI 10.1016/j.ejphar.2008.02.008; KITAGAWA S, 1991, CHEM PHARM BULL, V39, P1062; LAUGHTON MJ, 1991, BIOCHEM PHARMACOL, V42, P1673, DOI 10.1016/0006-2952(91)90501-U; Lee Shern-Fwu, 1994, Journal of Biomedical Science, V1, P125, DOI 10.1007/BF02257986; Lee YM, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-45; Lopez-Farre A, 2001, NEPHROL DIAL TRANSPL, V16, P45, DOI 10.1093/ndt/16.suppl_1.45; Mansoor S, 2010, TOXICOLOGY, V271, P107, DOI 10.1016/j.tox.2010.03.013; Martinho FC, 2012, J ENDODONT, V38, P740, DOI 10.1016/j.joen.2012.02.021; McGregor D, 2007, CRIT REV TOXICOL, V37, P887, DOI 10.1080/10408440701638970; McNicol A, 2003, BIOCHEM PHARMACOL, V65, P1243, DOI 10.1016/S0006-2952(03)00069-8; Myburg RB, 2002, ENVIRON HEALTH PERSP, V110, P813, DOI 10.1289/ehp.02110813; Ostertag LM, 2011, MOL NUTR FOOD RES, V55, P1624, DOI 10.1002/mnfr.201100135; Ribeiro D, 2013, EUR J MED CHEM, V67, P280, DOI 10.1016/j.ejmech.2013.06.019; SCHAEFER D, 1995, INT J CANCER, V60, P520, DOI 10.1002/ijc.2910600416; SUBRAHMANYAM VV, 1991, ARCH BIOCHEM BIOPHYS, V286, P76, DOI 10.1016/0003-9861(91)90010-G; Sun L, 2004, ANN BIOMED ENG, V32, P1193, DOI 10.1114/B:ABME.0000039353.97347.28; TENG CM, 1988, THROMB HAEMOSTASIS, V59, P304; Thavasi V, 2009, J PHYS CHEM A, V113, P3068, DOI 10.1021/jp806679v; Tsoumani ME, 2012, CURR VASC PHARMACOL, V10, P539; Wang M, 2008, J INTERN MED, V263, P500, DOI 10.1111/j.1365-2796.2008.01938.x; Willoughby Scott, 2002, Eur J Cardiovasc Nurs, V1, P273; Wright B, 2013, J FOOD SCI, V78, pN1921, DOI 10.1111/1750-3841.12293; WROBLEWSKI F, 1955, P SOC EXP BIOL MED, V90, P210; Yacoub D, 2006, J BIOL CHEM, V281, P30024, DOI 10.1074/jbc.M604504200; Yamada K, 1999, IN VITRO CELL DEV-AN, V35, P169; Zinkevich NS, 2011, AM J PHYSIOL-HEART C, V301, pH647, DOI 10.1152/ajpheart.01271.2010	47	13	14	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104310	10.1371/journal.pone.0104310	http://dx.doi.org/10.1371/journal.pone.0104310			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122505	Green Published, gold, Green Submitted			2022-12-25	WOS:000341017000035
J	Li, C; Wang, Y; Qiu, Q; Shi, TJ; Wu, Y; Han, J; Chai, XY; Wang, W				Li, Chun; Wang, Yong; Qiu, Qi; Shi, Tianjiao; Wu, Yan; Han, Jing; Chai, Xingyun; Wang, Wei			Qishenyiqi Protects Ligation-Induced Left Ventricular Remodeling by Attenuating Inflammation and Fibrosis via STAT3 and NF-kappa B Signaling Pathway	PLOS ONE			English	Article							CHRONIC HEART-FAILURE; INHIBITION; BIOMARKERS; CYTOKINES	Aim: Qi-shen-yi-qi (QSYQ), a formula used for the routine treatment of heart failure (HF) in China, has been demonstrated to improve cardiac function through down-regulating the activation of the Renin-Angiotensin-Aldosterone System (RAAS). However, the mechanisms governing its therapeutic effects are largely unknown. The present study aims to demonstrate that QSYQ treatment can prevent left ventricular remodeling in heart failure by attenuating oxidative stress and inhabiting inflammation. Methods: Sprague-Dawley (SD) rats were randomly divided into 6 groups: sham group, model group (LAD coronary artery ligation), QSYQ group with high dosage, middle dosage and low dosage (LAD ligation and treated with QSYQ), and captopril group (LAD ligation and treated with captopril as the positive drug). Indicators of fibrosis (Masson, MMPs, and collagens) and inflammation factors were detected 28 days after surgery. Results: Results of hemodynamic alterations (dp/dt value) in the model group as well as other ventricular remodeling (VR) markers, such as MMP-2, MMP-9, collagen I and III elevated compared with sham group. VR was accompanied by activation of RAAS (angiotensin II and NADPHoxidase). Levels of pro-inflammatory cytokines (TNF-alpha, IL-6) in myocardial tissue were also up-regulated. Treatment of QSYQ improved cardiac remodeling through counter-acting the aforementioned events. The improvement of QSYQ was accompanied with a restoration of angiotensin II-NADPHoxidase-ROS-MMPs pathways. In addition, "therapeutic'' QSYQ administration can reduce both TNF-alpha-NF-B and IL-6-STAT3 pathways, respectively, which further proves the beneficial effects of QSYQ. Conclusions: Our study demonstrated that QSYQ protected LAD ligation-induced left VR via attenuating AngII -NADPH oxidase pathway and inhabiting inflammation. These findings provide evidence as to the cardiac protective efficacy of QSYQ to HF and explain the beneficial effects of QSYQ in the clinical application for HF.	[Li, Chun; Chai, Xingyun] Beijing Univ Chinese Med, Modern Res Ctr Tradit Chinese Med, Beijing, Peoples R China; [Wang, Yong; Shi, Tianjiao; Wu, Yan; Han, Jing; Wang, Wei] Beijing Univ Chinese Med, Basic Med Coll, Beijing, Peoples R China; [Qiu, Qi] Capital Med Univ, Anzhen Hosp, Beijing, Peoples R China	Beijing University of Chinese Medicine; Beijing University of Chinese Medicine; Capital Medical University	Wang, W (corresponding author), Beijing Univ Chinese Med, Basic Med Coll, Beijing, Peoples R China.	wangwei26960@126.com			National Natural Science Foundation of China [81202788, 81302908]; National Science & Technology Pillar Program [2012BAI29B07]; Beijing Natural Science Foundation [7142099]; Creation for Significant New Drugs Project of China [2012ZX09103-201-011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science & Technology Pillar Program; Beijing Natural Science Foundation(Beijing Natural Science Foundation); Creation for Significant New Drugs Project of China	This study was financially supported, in part, by the Grants from the National Natural Science Foundation of China (No. 81202788 and 81302908), the National Science & Technology Pillar Program (No. 2012BAI29B07), Beijing Natural Science Foundation (7142099), and Creation for Significant New Drugs Project of China (No. 2012ZX09103-201-011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal R, 2010, PHARMACOL RES, V61, P269, DOI 10.1016/j.phrs.2009.11.012; Ahmad T, 2012, NAT REV CARDIOL, V9, P347, DOI 10.1038/nrcardio.2012.37; Armstrong PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020062; Bartunek J, 2012, BIOMARK MED, V6, P1, DOI [10.2217/BMM.12.3, 10.2217/bmm.12.3]; Dai Guo-hua, 2007, Zhongguo Zhong Xi Yi Jie He Za Zhi, V27, P653; Ferreira AS, 2011, CHIN J INTEGR MED, V17, P818, DOI 10.1007/s11655-011-0892-y; Fertin M, 2012, AM J CARDIOL, V110, P277, DOI 10.1016/j.amjcard.2012.02.069; Gullestad L, 2012, CARDIOLOGY, V122, P23, DOI 10.1159/000338166; Hamid T, 2009, CIRCULATION, V119, P1386, DOI 10.1161/CIRCULATIONAHA.108.802918; Hohensinner PJ, 2011, CURR OPIN INFECT DIS, V24, P259, DOI 10.1097/QCO.0b013e328344f50f; Hong Chengtao, 2009, Zhongguo Zhong Yao Za Zhi, V34, P1018; Houser SR, 2012, CIRC RES, V111, P131, DOI 10.1161/RES.0b013e3182582523; Kairouz V, 2012, ANN NY ACAD SCI, V1254, P42, DOI 10.1111/j.1749-6632.2012.06520.x; Khatib R, 2012, INT J CARDIOLOGY; Kirkpatrick James N, 2012, Curr Heart Fail Rep, V9, P328, DOI 10.1007/s11897-012-0116-6; Kurdi Mazen, 2010, Congest Heart Fail, V16, P234, DOI 10.1111/j.1751-7133.2010.00175.x; Lecour S, 2011, EUR HEART J, V32, P680, DOI 10.1093/eurheartj/ehq484; Li YW, 2006, CARDIOVASC RES, V71, P684, DOI 10.1016/j.cardiores.2006.06.003; Lin Yang, 2012, China Journal of Traditional Chinese Medicine and Pharmacy, V27, P1280; Mir SA, 2012, J BIOL CHEM, V287, P2666, DOI 10.1074/jbc.M111.246173; Mukhopadhyay P, 2007, J AM COLL CARDIOL, V50, P528, DOI 10.1016/j.jacc.2007.03.057; Pacher P, 2008, NAT PROTOC, V3, P1422, DOI 10.1038/nprot.2008.138; Rajesh M, 2010, J AM COLL CARDIOL, V56, P2115, DOI 10.1016/j.jacc.2010.07.033; Schroder K, 2012, CIRC RES, V110, P1217, DOI 10.1161/CIRCRESAHA.112.267054; Wang MJ, 2007, AM J PHYSIOL-HEART C, V293, pH2101, DOI 10.1152/ajpheart.00125.2007; Wang Y., 2012, EVIDENCE BASED COMPL; Wang Y, 2013, EVIDENCE BASED COMPL, V2013; Wysong A, 2011, AM J PATHOL, V178, P1059, DOI 10.1016/j.ajpath.2010.12.009; Zhang M, 2013, ANTIOXID REDOX SIGN, V18, P1024, DOI 10.1089/ars.2012.4550	29	52	58	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104255	10.1371/journal.pone.0104255	http://dx.doi.org/10.1371/journal.pone.0104255			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122164	Green Published, Green Submitted, gold			2022-12-25	WOS:000341017000033
J	Long, ZJ; Hu, YA; Li, XD; He, Y; Xiao, RZ; Fang, ZG; Wang, DN; Liu, JJ; Yan, JS; Huang, RW; Lin, DJ; Liu, QT				Long, Zi-Jie; Hu, Yuan; Li, Xu-Dong; He, Yi; Xiao, Ruo-Zhi; Fang, Zhi-Gang; Wang, Dong-Ning; Liu, Jia-Jun; Yan, Jin-Song; Huang, Ren-Wei; Lin, Dong-Jun; Liu, Quentin			ATO/ATRA/Anthracycline-Chemotherapy Sequential Consolidation Achieves Long-Term Efficacy in Primary Acute Promyelocytic Leukemia	PLOS ONE			English	Article							TRANS-RETINOIC ACID; ARSENIC TRIOXIDE AS2O3; REMISSION INDUCTION; INITIAL THERAPY; COMBINATION; SURVIVAL; DIFFERENTIATION; ANTHRACYCLINE; INTERGROUP; SAFETY	The combination of all-trans retinoic acid (ATRA) and arsenic trioxide (As2O3, ATO) has been effective in obtaining high clinical complete remission (CR) rates in acute promyelocytic leukemia (APL), but the long-term efficacy and safety among newly diagnosed APL patients are unclear. In this retrospective study, total 45 newly diagnosed APL patients received ATRA/chemotherapy combination regimen to induce remission. Among them, 43 patients (95.6%) achieved complete remission (CR) after induction therapy, followed by ATO/ATRA/anthracycline-based chemotherapy sequential consolidation treatment with a median follow-up of 55 months. In these patients, the estimated overall survival (OS) and the relapse-free survival (RFS) were 94.4%+/- 3.9% and 94.6 +/- 3.7%, respectively. The toxicity profile was mild and reversible. No secondary carcinoma was observed. These results demonstrated the high efficacy and minimal toxicity of ATO/ATRA/anthracycline-based chemotherapy sequential consolidation treatment for newly diagnosed APL in long-term follow-up, suggesting a potential frontline therapy for APL.	[Long, Zi-Jie; Hu, Yuan; Li, Xu-Dong; He, Yi; Xiao, Ruo-Zhi; Fang, Zhi-Gang; Wang, Dong-Ning; Liu, Jia-Jun; Huang, Ren-Wei; Lin, Dong-Jun; Liu, Quentin] Sun Yat Sen Univ, Sun Yat Sen Inst Hematol, Affiliated Hosp 3, Dept Hematol, Guangzhou, Guangdong, Peoples R China; [Liu, Quentin] Dalian Med Univ, Inst Canc Stem Cell, Dalian, Peoples R China; [Yan, Jin-Song] Dalian Med Univ, Affiliated Hosp 2, Dept Hematol, Dalian, Peoples R China	Sun Yat Sen University; Dalian Medical University; Dalian Medical University	Huang, RW (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Inst Hematol, Affiliated Hosp 3, Dept Hematol, Guangzhou, Guangdong, Peoples R China.	huangrw56@163.com; lindj@mail.sysu.edu.cn; liuq9@mail.sysu.edu.cn	Yan, Jinsong/ABC-6784-2020; liu, xiaoyun/GXV-0330-2022	Yan, Jinsong/0000-0003-4109-2602; liu, xiaoyun/0000-0002-5425-7456				Aribi A, 2007, CANCER, V109, P1355, DOI 10.1002/cncr.22524; Asou N, 2007, BLOOD, V110, P59, DOI 10.1182/blood-2006-08-043992; Au WY, 2002, BRIT J HAEMATOL, V117, P130, DOI 10.1046/j.1365-2141.2002.03409.x; Avvisati G, 2011, BLOOD, V117, P4716, DOI 10.1182/blood-2010-08-302950; Chen GQ, 1997, BLOOD, V89, P3345; Coutre SE, 2014, BRIT J HAEMATOL, V165, P497, DOI 10.1111/bjh.12775; CUNNINGHAM I, 1989, BLOOD, V73, P1116; Dai CW, 2009, ACTA HAEMATOL-BASEL, V121, P1, DOI 10.1159/000204472; dos Santos GA, 2013, J EXP MED, V210, P2793, DOI 10.1084/jem.20131121; Estey E, 2006, BLOOD, V107, P3469, DOI 10.1182/blood-2005-10-4006; Galimberti S, 1999, BONE MARROW TRANSPL, V24, P345, DOI 10.1038/sj.bmt.1701875; Ghavamzadeh A, 2006, ANN ONCOL, V17, P131, DOI 10.1093/annonc/mdj019; Gianni M, 1998, BLOOD, V91, P4300, DOI 10.1182/blood.V91.11.4300.411k41_4300_4310; Gore SD, 2010, J CLIN ONCOL, V28, P1047, DOI 10.1200/JCO.2009.25.5158; Grigg A, 2003, LEUKEMIA, V17, P1916, DOI 10.1038/sj.leu.2403050; Hu J, 2009, P NATL ACAD SCI USA, V106, P3342, DOI 10.1073/pnas.0813280106; HUANG ME, 1988, BLOOD, V72, P567, DOI 10.1182/blood.V72.2.567.567; Iland HJ, 2012, BLOOD, V120, P1570, DOI 10.1182/blood-2012-02-410746; Jing YK, 2001, BLOOD, V97, P264, DOI 10.1182/blood.V97.1.264; Lallemand-Breitenbach V, 1999, J EXP MED, V189, P1043, DOI 10.1084/jem.189.7.1043; Lengfelder E, 2009, LEUKEMIA, V23, P2248, DOI 10.1038/leu.2009.183; Li X, 2007, LEUKEMIA RES, V31, P765, DOI 10.1016/j.leukres.2006.07.028; Lo-Coco F, 2013, NEW ENGL J MED, V369, P111, DOI 10.1056/NEJMoa1300874; Mathews V, 2006, BLOOD, V107, P2627, DOI 10.1182/blood-2005-08-3532; Niu C, 1999, BLOOD, V94, P3315, DOI 10.1182/blood.V94.10.3315.422k16_3315_3324; Powell BL, 2010, BLOOD, V116, P3751, DOI 10.1182/blood-2010-02-269621; Quezada G, 2008, PEDIATR BLOOD CANCER, V51, P133, DOI 10.1002/pbc.21529; Raffoux E, 2003, J CLIN ONCOL, V21, P2326, DOI 10.1200/JCO.2003.01.149; Rock N, 2014, PEDIATR HEMAT ONCOL, V31, P143, DOI 10.3109/08880018.2013.876470; SANZ MA, 1988, CANCER, V61, P7, DOI 10.1002/1097-0142(19880101)61:1<7::AID-CNCR2820610103>3.0.CO;2-6; Sanz MA, 2010, BLOOD, V115, P5137, DOI 10.1182/blood-2010-01-266007; Shen ZX, 2004, P NATL ACAD SCI USA, V101, P5328, DOI 10.1073/pnas.0400053101; Shen ZX, 1997, BLOOD, V89, P3354, DOI 10.1182/blood.V89.9.3354; Shigeno K, 2005, INT J HEMATOL, V82, P224, DOI 10.1532/IJH97.05044; Soignet SL, 2001, J CLIN ONCOL, V19, P3852, DOI 10.1200/JCO.2001.19.18.3852; Sun H. D., 1992, CHIN J INTEGRAT CHIN, V12, P170; Tallman MS, 2007, BEST PRACT RES CL HA, V20, P57, DOI 10.1016/j.beha.2006.11.002; Tallman MS, 2002, BLOOD, V100, P4298, DOI 10.1182/blood-2002-02-0632; Wang GJ, 2004, HEMATOL ONCOL, V22, P63, DOI 10.1002/hon.728; Wang ZY, 2008, BLOOD, V111, P2505, DOI 10.1182/blood-2007-07-102798; ZHANG P, 1996, CHIN J HEMATOL, V17, P58; Zhang YM, 2013, CANCER-AM CANCER SOC, V119, P115, DOI 10.1002/cncr.27650; Zheng PZ, 2005, P NATL ACAD SCI USA, V102, P7653, DOI 10.1073/pnas.0502825102	43	12	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104610	10.1371/journal.pone.0104610	http://dx.doi.org/10.1371/journal.pone.0104610			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122165	Green Published, Green Submitted, gold			2022-12-25	WOS:000341017000047
J	Noguchi, F; Nakajima, T; Inui, S; Reddy, JK; Itami, S				Noguchi, Fumihito; Nakajima, Takeshi; Inui, Shigeki; Reddy, Janardan K.; Itami, Satoshi			Alteration of Skin Wound Healing in Keratinocyte-Specific Mediator Complex Subunit 1 Null Mice	PLOS ONE			English	Article							FOLLICLE STEM-CELLS; PROLIFERATOR-ACTIVATED RECEPTOR; VITAMIN-D-RECEPTOR; HAIR FOLLICLE; HUMAN FOLLISTATIN; EPIDERMAL ALTERATIONS; PORCINE FOLLISTATIN; ACTIVIN-BINDING; REPAIR; REGENERATION	MED1 (Mediator complex subunit 1) is a co-activator of various transcription factors that function in multiple transcriptional pathways. We have already established keratinocyte-specific MED1 null mice (Med1(epi-/-)) that develop epidermal hyperplasia. Herein, to investigate the function(s) of MED1 in skin wound healing, full-thickness skin wounds were generated in Med1(epi-/-) and age-matched wild-type mice and the healing process was analyzed. Macroscopic wound closure and the re-epithelialization rate were accelerated in 8-week-old Med1(epi-/-) mice compared with age-matched wildtype mice. Increased lengths of migrating epithelial tongues and numbers of Ki67-positive cells at the wounded epidermis were observed in 8-week-old Med1(epi-/-) mice, whereas wound contraction and the area of alpha-SMA-positive myofibroblasts in the granulation tissue were unaffected. Migration was enhanced in Med1(epi-/-) keratinocytes compared with wild-type keratinocytes in vitro. Immunoblotting revealed that the expression of follistatin was significantly decreased in Med1(epi-/-) keratinocytes. Moreover, the mitogen-activated protein kinase pathway was enhanced before and after treatment of Med1(epi-/-) keratinocytes with activin A in vitro. Cell-cycle analysis showed an increased ratio of S phase cells after activin A treatment of Med1(epi-/-) keratinocytes compared with wild-type keratinocytes. These findings indicate that the activinfollistatin system is involved in this acceleration of skin wound healing in 8-week-old Med1(epi-/-) mice. On the other hand, skin wound healing in 6-month-old Med1(epi-/-) mice was significantly delayed with decreased numbers of Ki67-positive cells at the wounded epidermis as well as BrdU-positive label retaining cells in hair follicles compared with age-matched wildtype mice. These results agree with our previous observation that hair follicle bulge stem cells are reduced in older Med1(epi-/-) mice, indicating a decreased contribution of hair follicle stem cells to epidermal regeneration after wounding in 6-month-old Med1(epi-/-) mice. This study sheds light on the novel function of MED1 in keratinocytes and suggests a possible new therapeutic approach for skin wound healing and aging.	[Noguchi, Fumihito; Inui, Shigeki; Itami, Satoshi] Osaka Univ, Grad Sch Med, Dept Regenerat Dermatol, Osaka, Japan; [Nakajima, Takeshi] Osaka Gen Med Ctr, Dept Dermatol, Osaka, Japan; [Reddy, Janardan K.] Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA	Osaka University; Northwestern University; Feinberg School of Medicine	Noguchi, F (corresponding author), Osaka Univ, Grad Sch Med, Dept Regenerat Dermatol, Osaka, Japan.	noguchi@r-derma.med.osaka-u.ac.jp			Ministry of Education, Science, Sports and Culture of Japan [19790784, 21791075, 23591644]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097249] Funding Source: NIH RePORTER	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by grants-in-aid from the Ministry of Education, Science, Sports and Culture of Japan (19790784, 21791075 and 23591644). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antsiferova M, 2009, LAB INVEST, V89, P131, DOI 10.1038/labinvest.2008.120; Arwert EN, 2012, NAT REV CANCER, V12, P170, DOI 10.1038/nrc3217; Bikle DD, 2006, J CELL PHYSIOL, V207, P340, DOI 10.1002/jcp.20578; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Blanpain C, 2010, NATURE, V464, P686, DOI 10.1038/464686a; Brownell I, 2011, CELL STEM CELL, V8, P552, DOI 10.1016/j.stem.2011.02.021; Castilho RM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010503; Chen YG, 2006, EXP BIOL MED, V231, P534; Cianferotti L, 2007, P NATL ACAD SCI USA, V104, P9428, DOI 10.1073/pnas.0702884104; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; deWinter JP, 1996, MOL CELL ENDOCRINOL, V116, P105, DOI 10.1016/0303-7207(95)03705-5; Frye M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000763; Fuchs E, 2008, GENE DEV, V22, P976, DOI 10.1101/gad.1645908; Garza LA, 2011, J CLIN INVEST, V121, P613, DOI 10.1172/JCI44478; Gazel A, 2006, J BIOL CHEM, V281, P20530, DOI 10.1074/jbc.M602712200; Ge K, 2002, NATURE, V417, P563, DOI 10.1038/417563a; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Horsley V, 2008, CELL, V132, P299, DOI 10.1016/j.cell.2007.11.047; Hubner G, 1996, DEV BIOL, V173, P490, DOI 10.1006/dbio.1996.0042; INOUYE S, 1991, ENDOCRINOLOGY, V129, P815, DOI 10.1210/endo-129-2-815; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Ito M, 2002, J INVEST DERMATOL, V119, P1310, DOI 10.1046/j.1523-1747.2002.19644.x; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Jensen KB, 2009, CELL STEM CELL, V4, P427, DOI 10.1016/j.stem.2009.04.014; Jensen UB, 2008, J CELL SCI, V121, P609, DOI 10.1242/jcs.025502; Lau K, 2009, EXP DERMATOL, V18, P921, DOI 10.1111/j.1600-0625.2009.00942.x; Levy V, 2007, FASEB J, V21, P1358, DOI 10.1096/fj.06-6926com; Li M, 2001, DEVELOPMENT, V128, P675; Mardaryev AN, 2011, DEVELOPMENT, V138, P4843, DOI 10.1242/dev.070284; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Matsumoto K, 2007, J BIOL CHEM, V282, P17053, DOI 10.1074/jbc.M701956200; McDowall A, 2008, CYTOKINE GROWTH F R, V19, P415, DOI [10.1016/j.cytogfr.2009.08.005, 10.1016/j.cytogfr.2008.08.005]; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Munz B, 1999, EMBO J, V18, P5205, DOI 10.1093/emboj/18.19.5205; Munz B, 2001, MOL CELL ENDOCRINOL, V180, P169, DOI 10.1016/S0303-7207(01)00514-7; Nakajima T, 2012, J INVEST DE IN PRESS; Necela BM, 2008, J BIOL CHEM, V283, P29784, DOI 10.1074/jbc.M804481200; Nguyen H, 2009, NAT GENET, V41, P1068, DOI 10.1038/ng.431; Nowak JA, 2008, CELL STEM CELL, V3, P33, DOI 10.1016/j.stem.2008.05.009; Oda Y, 2012, J INVEST DERMATOL, V132, P1075, DOI 10.1038/jid.2011.430; Peters JM, 2000, MOL CELL BIOL, V20, P5119, DOI 10.1128/MCB.20.14.5119-5128.2000; Rhee H, 2006, SCIENCE, V312, P1946, DOI 10.1126/science.1128004; Santoro MM, 2005, EXP CELL RES, V304, P274, DOI 10.1016/j.yexcr.2004.10.033; SHIMASAKI S, 1988, BIOCHEM BIOPH RES CO, V152, P717, DOI 10.1016/S0006-291X(88)80097-4; SHIMASAKI S, 1988, P NATL ACAD SCI USA, V85, P4218, DOI 10.1073/pnas.85.12.4218; SHIMONAKA M, 1991, ENDOCRINOLOGY, V128, P3313, DOI 10.1210/endo-128-6-3313; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Snippert HJ, 2010, SCIENCE, V327, P1385, DOI 10.1126/science.1184733; Trempus CS, 2003, J INVEST DERMATOL, V120, P501, DOI 10.1046/j.1523-1747.2003.12088.x; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Uchugonova A, 2011, J CELL BIOCHEM, V112, P2046, DOI 10.1002/jcb.23122; Vidal VPI, 2005, CURR BIOL, V15, P1340, DOI 10.1016/j.cub.2005.06.064; Wang QF, 2000, ENDOCRINOLOGY, V141, P3183, DOI 10.1210/en.141.9.3183; Wankell M, 2003, ANN NY ACAD SCI, V995, P48, DOI 10.1111/j.1749-6632.2003.tb03209.x; Wankell M, 2001, EMBO J, V20, P5361, DOI 10.1093/emboj/20.19.5361; Zhang L, 2003, EMBO J, V22, P4443, DOI 10.1093/emboj/cdg440; Zhang L, 2005, MOL CELL BIOL, V25, P60, DOI 10.1128/MCB.25.1.60-65.2005; Zhang M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025143; Zhu YJ, 1997, J BIOL CHEM, V272, P25500, DOI 10.1074/jbc.272.41.25500	59	19	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e102271	10.1371/journal.pone.0102271	http://dx.doi.org/10.1371/journal.pone.0102271			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122137	Green Submitted, Green Published, gold			2022-12-25	WOS:000341017000005
J	Chen, ZX; Wang, YN; Liu, W; Zhao, GN; Lee, S; Balogh, A; Zou, YN; Guo, YQ; Zhang, Z; Gu, WW; Li, CY; Tigyi, G; Yue, JM				Chen, Zixuan; Wang, Yinan; Liu, Wen; Zhao, Guannan; Lee, Suechin; Balogh, Andrea; Zou, Yanan; Guo, Yuqi; Zhang, Zhan; Gu, Weiwang; Li, Chengyao; Tigyi, Gabor; Yue, Junming			Doxycycline Inducible Kruppel-Like Factor 4 Lentiviral Vector Mediates Mesenchymal to Epithelial Transition in Ovarian Cancer Cells	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; BREAST-CANCER; STEM-CELLS; KLF4; GROWTH; CARCINOMA; GENE; EMT; METASTASIS; INVASION	Ovarian cancer presents therapeutic challenges due to its typically late detection, aggressive metastasis, and therapeutic resistance. The transcription factor Kruppel-like factor 4 (KLF4) has been implicated in human cancers as a tumor suppressor or oncogene, although its role depends greatly on the cellular context. The role of KLF4 in ovarian cancer has not been elucidated in mechanistic detail. In this study, we investigated the role of KLF4 in ovarian cancer cells by transducing the ovarian cancer cell lines SKOV3 and OVCAR3 with a doxycycline-inducible KLF4 lentiviral vector. Overexpression of KLF4 reduced cell proliferation, migration, and invasion. The epithelial cell marker gene E-cadherin was significantly upregulated, whereas the mesenchymal cell marker genes vimentin, twist1 and snail2 (slug) were downregulated in both KLF4-expressing SKOV3 and OVCAR3 cells. KLF4 inhibited the transforming growth factor beta (TGF beta)-induced epithelial to mesenchymal transition (EMT) in ovarian cancer cells. Taken together, our data demonstrate that KLF4 functions as a tumor suppressor gene in ovarian cancer cells by inhibiting TGF beta-induced EMT.	[Chen, Zixuan; Wang, Yinan; Liu, Wen; Zhao, Guannan; Yue, Junming] Univ Tennessee, Hlth Sci Ctr, Dept Pathol & Lab Med, Memphis, TN USA; [Chen, Zixuan; Wang, Yinan; Liu, Wen; Zhao, Guannan; Yue, Junming] Univ Tennessee, Hlth Sci Ctr, Ctr Canc Res, Memphis, TN USA; [Wang, Yinan; Liu, Wen; Lee, Suechin; Balogh, Andrea; Gu, Weiwang; Tigyi, Gabor] Univ Tennessee, Hlth Sci Ctr, Dept Physiol, Memphis, TN USA; [Chen, Zixuan; Li, Chengyao] Southern Med Univ, Guangzhou, Guangdong, Peoples R China; [Zhao, Guannan; Guo, Yuqi; Zhang, Zhan] Zhengzhou Univ, Affiliated Hosp 3, Zhengzhou 450052, Peoples R China; [Zou, Yanan] Harbin Med Univ, Affiliated Hosp 2, Harbin, Peoples R China	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Southern Medical University - China; Zhengzhou University; Harbin Medical University	Li, CY (corresponding author), Southern Med Univ, Guangzhou, Guangdong, Peoples R China.	chengyaoli@hotmail.com; jyue@uthsc.edu		Zhao, Guannan/0000-0003-3155-8528	National Institute of Health [HL095957, HD061420, CA092160]; UTHSC; Western clinic Cancer Center; Chinese Government [2010CB530204, 112102310110]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD061420] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL095957] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UTHSC; Western clinic Cancer Center; Chinese Government; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This project was partially supported by National Institute of Health (HL095957, HD061420 to J.Y., and CA092160 to G.T.) and UTHSC startup funding, Western clinic Cancer Center (J.Y.) and Chinese Government (2010CB530204 to C.L., 112102310110 to Y.G., 2011DFA33290 to W.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaogi K, 2009, ONCOGENE, V28, P2894, DOI 10.1038/onc.2009.151; Brosh R, 2013, CELL DEATH DIFFER, V20, P312, DOI 10.1038/cdd.2012.125; Cheng JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042436; Chou JL, 2010, LAB INVEST, V90, P414, DOI 10.1038/labinvest.2009.138; Deng YF, 2012, STEM CELLS DEV, V21, P2485, DOI 10.1089/scd.2012.0018; Dong PX, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-99; Guan HF, 2010, BLOOD, V116, P1469, DOI 10.1182/blood-2009-12-256446; Guo Y, 2013, PHARM RES; Hoffmeyer K, 2012, SCIENCE, V336, P1549, DOI 10.1126/science.1218370; Le Magnen C, 2013, EUR J CANCER, V49, P955, DOI 10.1016/j.ejca.2012.09.023; Leng ZW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056082; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Li Y, 2013, CURR CANC DRUG TARGE; Lin ZS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043593; Liu YN, 2012, MOL CELL BIOL, V32, P941, DOI 10.1128/MCB.06306-11; LIU Z, 2013, HISTOPATHOLOGY; Lowe KA, 2013, GYNECOL ONCOL, V130, P107, DOI 10.1016/j.ygyno.2013.03.026; Miyamoto S, 2013, CARCINOGENESIS; Mohan N, 2013, MOL ONCOL, V7, P464, DOI 10.1016/j.molonc.2012.12.002; Pinho AV, 2011, CELL CYCLE, V10, P1312, DOI 10.4161/cc.10.8.15363; Radisky DC, 2007, NAT CELL BIOL, V9, P361, DOI 10.1038/ncb0407-361; Reichl P, 2012, CURR PHARM DESIGN, V18, P4135, DOI 10.2174/138161212802430477; Ren DY, 2011, GENES CELLS, V16, P304, DOI 10.1111/j.1365-2443.2011.01487.x; Su ZL, 2013, CLIN CHIM ACTA, V415, P341, DOI 10.1016/j.cca.2012.10.058; Tiwari N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057329; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Yang WT, 2012, CANCER-AM CANCER SOC, V118, P3691, DOI 10.1002/cncr.26698; Yoon O, 2012, ONCOL LETT, V4, P1033, DOI 10.3892/ol.2012.834; Yori JL, 2011, NEOPLASIA, V13, P601, DOI 10.1593/neo.11260; Yori JL, 2010, J BIOL CHEM, V285, P16854, DOI 10.1074/jbc.M110.114546; Yu F, 2011, ONCOGENE, V30, P2161, DOI 10.1038/onc.2010.591; Yu F, 2013, INT J CANC; Yue JM, 2010, BIOCHEM BIOPH RES CO, V394, P667, DOI 10.1016/j.bbrc.2010.03.047; Yue P, 2012, ONCOGENE, V31, P2309, DOI 10.1038/onc.2011.409; Zammarchi F, 2011, AM J PATHOL, V178, P361, DOI 10.1016/j.ajpath.2010.11.021; Zhou YB, 2010, CANCER BIOL THER, V9, P507, DOI 10.4161/cbt.9.7.11106; Zhu YH, 2010, ENDOCRINOLOGY, V151, P5497, DOI 10.1210/en.2010-0486	37	29	32	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105331	10.1371/journal.pone.0105331	http://dx.doi.org/10.1371/journal.pone.0105331			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137052	gold, Green Published, Green Submitted			2022-12-25	WOS:000340742100085
J	Hang, HL; Yu, YB; Wu, N; Huang, QF; Xia, Q; Bian, JM				Hang, Hualian; Yu, Yabin; Wu, Ning; Huang, Qingfeng; Xia, Qiang; Bian, Jianmin			Induction of Highly Functional Hepatocytes from Human Umbilical Cord Mesenchymal Stem Cells by HNF4 alpha Transduction	PLOS ONE			English	Article							TRANSCRIPTION FACTOR HNF-4; OF-THE-ART; HEPATIC DIFFERENTIATION; GENE-EXPRESSION; BONE-MARROW; LIVER DEVELOPMENT; IN-VITRO; TRANSPLANTATION; SPECIFICATION; ENDODERM	Aim: To investigate the differentiation potential of human umbilical mesenchymal stem cells (HuMSCs) and the key factors that facilitate hepatic differentiation. Methods: HuMSCs were induced to become hepatocyte-like cells according to a previously published protocol. The differentiation status of the hepatocyte-like cells was examined by observing the morphological changes under an inverted microscope and by immunofluorescence analysis. Hepatocyte nuclear factor 4 alpha (HNF4 alpha) overexpression was achieved by plasmid transfection of the hepatocyte-like cells. The expression of proteins and genes of interest was then examined by Western blotting and reverse transcription-polymerase chain reaction (RT-PCR) or real-time RT-PCR methods. Results: Our results demonstrated that HuMSCs can easily be induced into hepatocyte-like cells using a published differentiation protocol. The overexpression of HNF4 alpha in the induced HuMSCs significantly enhanced the expression levels of hepatic-specific proteins and genes. HNF4 alpha overexpression may be associated with liver-enriched transcription factor networks and the Wnt/beta-Catenin pathway. Conclusion: The overexpression of HNF4 alpha improves the hepatic differentiation of HuMSCs and is a simple way to improve cellular sources for clinical applications.	[Hang, Hualian; Xia, Qiang] Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Liver Surg, Shanghai 200030, Peoples R China; [Hang, Hualian; Yu, Yabin; Wu, Ning; Huang, Qingfeng; Bian, Jianmin] NanJing Med Univ, Dept Gen Surg, Nanjing Hosp, Nanjing, Jiangsu, Peoples R China	Shanghai Jiao Tong University; Nanjing Medical University	Xia, Q (corresponding author), Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Liver Surg, Shanghai 200030, Peoples R China.	xiaqiang@shsmu.edu.cn; jianminbian@163.com			National Natural Science Foundation of China [81100306]; Science and Technology Commission Medical Foundation of Shanghai [134119a9501]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission Medical Foundation of Shanghai	Project supported by the National Natural Science Foundation of China (No 81100306) and the Science and Technology Commission Medical Foundation of Shanghai (No. 134119a9501). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cereghini S, 1996, FASEB J, V10, P267, DOI 10.1096/fasebj.10.2.8641560; Chen ML, 2010, WORLD J GASTROENTERO, V16, P5092, DOI 10.3748/wjg.v16.i40.5092; CHEN WS, 1994, GENE DEV, V8, P2466, DOI 10.1101/gad.8.20.2466; Costa RH, 2003, HEPATOLOGY, V38, P1331, DOI 10.1016/j.hep.2003.09.034; DUNCAN SA, 1994, P NATL ACAD SCI USA, V91, P7598, DOI 10.1073/pnas.91.16.7598; Ek M, 2007, BIOCHEM PHARMACOL, V74, P496, DOI 10.1016/j.bcp.2007.05.009; Fu YS, 2006, STEM CELLS, V24, P115, DOI 10.1634/stemcells.2005-0053; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Ke ZF, 2008, BIOCHEM BIOPH RES CO, V367, P342, DOI 10.1016/j.bbrc.2007.12.134; KUO CJ, 1992, NATURE, V355, P457, DOI 10.1038/355457a0; Kyrmizi I, 2006, GENE DEV, V20, P2293, DOI 10.1101/gad.390906; Laudes M, 2011, J MOL ENDOCRINOL, V46, pR65, DOI 10.1530/JME-10-0169; Lee KD, 2004, HEPATOLOGY, V40, P1275, DOI 10.1002/hep.20469; Medicetty S, 2004, EXP NEUROL, V190, P32, DOI 10.1016/j.expneurol.2004.06.023; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Parviz F, 2003, NAT GENET, V34, P292, DOI 10.1038/ng1175; Shimomura T, 2007, HEPATOL RES, V37, P1068, DOI 10.1111/j.1872-034X.2007.00162.x; SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353; Strain AJ, 2002, SCIENCE, V295, P1005, DOI 10.1126/science.1068660; Takayama K, 2012, MOL THER, V20, P127, DOI 10.1038/mt.2011.234; Tang N, 2009, J CELL MOL MED, V13, P2448, DOI 10.1111/j.1582-4934.2008.00569.x; TARAVIRAS S, 1994, MECH DEVELOP, V48, P67, DOI 10.1016/0925-4773(94)90017-5; Terry C, 2006, CRYOBIOLOGY, V53, P149, DOI 10.1016/j.cryobiol.2006.05.004; Wang HS, 2004, STEM CELLS, V22, P1330, DOI 10.1634/stemcells.2004-0013; Wang HS, 2011, CELL TRANSPLANT, V20, P455, DOI 10.3727/096368910X522270; Watt AJ, 2003, HEPATOLOGY, V37, P1249, DOI 10.1053/jhep.2003.50273; Weiss ML, 2006, STEM CELLS, V24, P781, DOI 10.1634/stemcells.2005-0330; Yoshida Y, 2007, AM J PHYSIOL-GASTR L, V293, pG1089, DOI 10.1152/ajpgi.00187.2007	28	23	23	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e104133	10.1371/journal.pone.0104133	http://dx.doi.org/10.1371/journal.pone.0104133			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137413	Green Published, Green Submitted, gold			2022-12-25	WOS:000340742100017
J	Hopfenmuller, S; Steffan-Dewenter, I; Holzschuh, A				Hopfenmueller, Sebastian; Steffan-Dewenter, Ingolf; Holzschuh, Andrea			Trait-Specific Responses of Wild Bee Communities to Landscape Composition, Configuration and Local Factors	PLOS ONE			English	Article							HABITAT AREA; AGRICULTURAL LANDSCAPES; CLIMATE-CHANGE; FRUIT-SET; CONNECTIVITY; DIVERSITY; CONSERVATION; POLLINATORS; RESOURCES; RICHNESS	Land-use intensification and loss of semi-natural habitats have induced a severe decline of bee diversity in agricultural landscapes. Semi-natural habitats like calcareous grasslands are among the most important bee habitats in central Europe, but they are threatened by decreasing habitat area and quality, and by homogenization of the surrounding landscape affecting both landscape composition and configuration. In this study we tested the importance of habitat area, quality and connectivity as well as landscape composition and configuration on wild bees in calcareous grasslands. We made detailed trait-specific analyses as bees with different traits might differ in their response to the tested factors. Species richness and abundance of wild bees were surveyed on 23 calcareous grassland patches in Southern Germany with independent gradients in local and landscape factors. Total wild bee richness was positively affected by complex landscape configuration, large habitat area and high habitat quality (i.e. steep slopes). Cuckoo bee richness was positively affected by complex landscape configuration and large habitat area whereas habitat specialists were only affected by the local factors habitat area and habitat quality. Small social generalists were positively influenced by habitat area whereas large social generalists (bumblebees) were positively affected by landscape composition (high percentage of semi-natural habitats). Our results emphasize a strong dependence of habitat specialists on local habitat characteristics, whereas cuckoo bees and bumblebees are more likely affected by the surrounding landscape. We conclude that a combination of large high-quality patches and heterogeneous landscapes maintains high bee species richness and communities with diverse trait composition. Such diverse communities might stabilize pollination services provided to crops and wild plants on local and landscape scales.	[Hopfenmueller, Sebastian; Steffan-Dewenter, Ingolf; Holzschuh, Andrea] Univ Wurzburg, Dept Anim Ecol & Trop Biol, Bioctr, D-97070 Wurzburg, Germany	University of Wurzburg	Hopfenmuller, S (corresponding author), Univ Wurzburg, Dept Anim Ecol & Trop Biol, Bioctr, D-97070 Wurzburg, Germany.	sebastian.hopfenmueller@uni-wuerzburg.de	Holzschuh, Andrea/X-8989-2018	Holzschuh, Andrea/0000-0002-5235-4746	European Community's Seventh Framework Programme [244090]; German Research Foundation (DFG); University of Wuerzburg	European Community's Seventh Framework Programme(European Commission); German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg	This research received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 244090, STEP Project (Status and Trends of European Pollinators: www.step-project.net). This publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BayLfU, 2003, ROT LIST GEF TIER BA; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Bluthgen N, 2011, BASIC APPL ECOL, V12, P282, DOI 10.1016/j.baae.2010.11.001; Bommarco R, 2010, P ROY SOC B-BIOL SCI, V277, P2075, DOI 10.1098/rspb.2009.2221; Bruckmann SV, 2010, J APPL ECOL, V47, P799, DOI 10.1111/j.1365-2664.2010.01828.x; Colwell RK, 2013, ESTIMATES STAT ESTIM; Dias ATC, 2013, J ECOL, V101, P29, DOI 10.1111/1365-2745.12024; Diekotter T, 2006, BIODIVERS CONSERV, V15, P57, DOI 10.1007/s10531-004-2932-9; Doerr VAJ, 2011, J APPL ECOL, V48, P143, DOI 10.1111/j.1365-2664.2010.01899.x; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Ehrlich PR, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2845; Ekroos J, 2013, LANDSCAPE ECOL, V28, P1283, DOI 10.1007/s10980-013-9864-2; Environmental Systems Research Institute (ESRI), 2008, ARCGIS 9 3; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Fahrig L, 2011, ECOL LETT, V14, P101, DOI 10.1111/j.1461-0248.2010.01559.x; Flick T, 2012, AGR ECOSYST ENVIRON, V156, P123, DOI 10.1016/j.agee.2012.05.006; Franzen M, 2010, P ROY SOC B-BIOL SCI, V277, P79, DOI 10.1098/rspb.2009.1584; Franzen M, 2009, J INSECT CONSERV, V13, P89, DOI 10.1007/s10841-007-9123-4; Frund J, 2013, ECOLOGY, V94, P2042, DOI 10.1890/12-1620.1; Garibaldi LA, 2013, SCIENCE, V339, P1608, DOI 10.1126/science.1230200; Garibaldi LA, 2011, ECOL LETT, V14, P1062, DOI 10.1111/j.1461-0248.2011.01669.x; Garibaldi LA, 2011, P NATL ACAD SCI USA, V108, P5909, DOI 10.1073/pnas.1012431108; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Gonzalez-Varo JP, 2013, TRENDS ECOL EVOL, V28, P524, DOI 10.1016/j.tree.2013.05.008; Goulson D, 2008, ANNU REV ENTOMOL, V53, P191, DOI 10.1146/annurev.ento.53.103106.093454; Greenleaf SS, 2007, OECOLOGIA, V153, P589, DOI 10.1007/s00442-007-0752-9; Hadley AS, 2012, BIOL REV, V87, P526, DOI 10.1111/j.1469-185X.2011.00205.x; HANSKI I, 1994, J ANIM ECOL, V63, P151, DOI 10.2307/5591; Hodgson JA, 2011, J APPL ECOL, V48, P148, DOI 10.1111/j.1365-2664.2010.01919.x; Hodgson JA, 2009, J APPL ECOL, V46, P964, DOI 10.1111/j.1365-2664.2009.01695.x; Hoiss B, 2012, P ROY SOC B-BIOL SCI, V279, P4447, DOI 10.1098/rspb.2012.1581; Holzschuh A, 2009, ECOL APPL, V19, P123, DOI 10.1890/08-0384.1; Holzschuh A, 2012, BIOL CONSERV, V153, P101, DOI 10.1016/j.biocon.2012.04.032; Holzschuh A, 2010, J ANIM ECOL, V79, P491, DOI 10.1111/j.1365-2656.2009.01642.x; Jauker B, 2013, LANDSCAPE ECOL, V28, P107, DOI 10.1007/s10980-012-9820-6; Kennedy CM, 2013, ECOL LETT, V16, P584, DOI 10.1111/ele.12082; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Krauss J, 2009, J APPL ECOL, V46, P194, DOI 10.1111/j.1365-2664.2008.01582.x; Krewenka KM, 2011, BIOL CONSERV, V144, P1816, DOI 10.1016/j.biocon.2011.03.014; Le Feon V, 2010, AGR ECOSYST ENVIRON, V137, P143, DOI 10.1016/j.agee.2010.01.015; Lepais O, 2010, MOL ECOL, V19, P819, DOI 10.1111/j.1365-294X.2009.04500.x; MAC ARTHUR ROBERT H., 1967; Mandery K, 2001, BIENEN WESPEN FRANKE; Marshall EJP, 2006, AGR ECOSYST ENVIRON, V113, P36, DOI 10.1016/j.agee.2005.08.036; Calvillo LM, 2010, J INSECT CONSERV, V14, P323, DOI 10.1007/s10841-010-9262-x; Moilanen A, 2002, ECOLOGY, V83, P1131, DOI 10.1890/0012-9658(2002)083[1131:SCMISE]2.0.CO;2; Ockinger E, 2012, ECOGRAPHY, V35, P259, DOI 10.1111/j.1600-0587.2011.06870.x; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; Poschlod P, 2002, BIOL CONSERV, V104, P361, DOI 10.1016/S0006-3207(01)00201-4; Potts SG, 2005, ECOL ENTOMOL, V30, P78, DOI 10.1111/j.0307-6946.2005.00662.x; Potts SG, 1997, ECOL ENTOMOL, V22, P319, DOI 10.1046/j.1365-2311.1997.00071.x; Raatikainen KM, 2009, BIODIVERS CONSERV, V18, P1067, DOI 10.1007/s10531-008-9462-9; Rands SA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025971; Ricotta C, 2011, OECOLOGIA, V167, P181, DOI 10.1007/s00442-011-1965-5; ROOT RB, 1973, ECOL MONOGR, V43, P95, DOI 10.2307/1942161; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Roulston TH, 2011, ANNU REV ENTOMOL, V56, P293, DOI 10.1146/annurev-ento-120709-144802; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Sardinas HS, 2014, BASIC APPL ECOL, V15, P161, DOI 10.1016/j.baae.2014.02.004; Sokal RR, 2003, BIOMETRY; Steffan-Dewenter I, 2002, ECOLOGY, V83, P1421, DOI 10.1890/0012-9658(2002)083[1421:SDEOLC]2.0.CO;2; Steffan-Dewenter I, 2003, CONSERV BIOL, V17, P1036, DOI 10.1046/j.1523-1739.2003.01575.x; Steffan-Dewenter I, 2000, ECOL LETT, V3, P449, DOI 10.1046/j.1461-0248.2000.00175.x; Thomas JA, 2011, J INSECT CONSERV, V15, P241, DOI 10.1007/s10841-010-9341-z; Thomas JA, 2001, P ROY SOC B-BIOL SCI, V268, P1791, DOI 10.1098/rspb.2001.1693; Tscharntke T, 2012, BIOL REV, V87, P661, DOI 10.1111/j.1469-185X.2011.00216.x; Violle C, 2007, OIKOS, V116, P882, DOI 10.1111/j.2007.0030-1299.15559.x; Westphal C, 2003, ECOL LETT, V6, P961, DOI 10.1046/j.1461-0248.2003.00523.x; Westphal C, 2008, ECOL MONOGR, V78, P653, DOI 10.1890/07-1292.1; Westrich P., 1990, WILDBIENEN BADEN WUR; Westrich P., 1996, CONSERVATION BEES; Williams NM, 2012, ECOLOGY, V93, P1049, DOI 10.1890/11-1006.1; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	73	73	74	3	164	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e104439	10.1371/journal.pone.0104439	http://dx.doi.org/10.1371/journal.pone.0104439			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137311	gold, Green Submitted, Green Published			2022-12-25	WOS:000340742100035
J	Oliveira, MT; Matzek, V; Medeiros, CD; Rivas, R; Falcao, HM; Santos, MG				Oliveira, Marciel Teixeira; Matzek, Virginia; Medeiros, Camila Dias; Rivas, Rebeca; Falcao, Hiram Marinho; Santos, Mauro Guida			Stress Tolerance and Ecophysiological Ability of an Invader and a Native Species in a Seasonally Dry Tropical Forest	PLOS ONE			English	Article							LIPID-PEROXIDATION; CATALASE; CAATINGA; PLANTS; NORTHEASTERN; CONSERVATION; ATTRIBUTES; PROLINE; TRAITS; GROWTH	Ecophysiological traits of Prosopis juliflora (Sw.) DC. and a phylogenetically and ecologically similar native species, Anadenanthera colubrina (Vell.) Brenan, were studied to understand the invasive species' success in caatinga, a seasonally dry tropical forest ecosystem of the Brazilian Northeast. To determine if the invader exhibited a superior resource-capture or a resource-conservative strategy, we measured biophysical and biochemical parameters in both species during dry and wet months over the course of two years. The results show that P. juliflora benefits from a flexible strategy in which it frequently outperforms the native species in resource capture traits under favorable conditions (e.g., photosynthesis), while also showing better stress tolerance (e.g., antioxidant activity) and water-use efficiency in unfavorable conditions. In addition, across both seasons the invasive has the advantage over the native with higher chlorophyll/carotenoids and chlorophyll a/b ratios, percent N, and leaf protein. We conclude that Prosopis juliflora utilizes light, water and nutrients more efficiently than Anadenanthera colubrina, and suffers lower intensity oxidative stress in environments with reduced water availability and high light radiation.	[Oliveira, Marciel Teixeira; Medeiros, Camila Dias; Rivas, Rebeca; Falcao, Hiram Marinho; Santos, Mauro Guida] Univ Fed Pernambuco, Dept Bot, Recife, PE, Brazil; [Matzek, Virginia] Santa Clara Univ, Dept Environm Studies & Sci, Santa Clara, CA 95053 USA	Universidade Federal de Pernambuco; Santa Clara University	Santos, MG (corresponding author), Univ Fed Pernambuco, Dept Bot, Recife, PE, Brazil.	mauro.gsantos@ufpe.br	OLIVEIRA, MARCIEL/A-9995-2015; Falcão, Hiram/AAO-1891-2020; Santos, Mauro/D-7026-2012; Medeiros, Camila/S-3957-2018	OLIVEIRA, MARCIEL/0000-0001-9706-5625; Falcão, Hiram/0000-0003-3198-1801; Santos, Mauro/0000-0001-5146-4591; Medeiros, Camila/0000-0002-5822-5603	Brazilian Fundacao de Amparo a Pesquisa e Tecnologia de Pernambuco (FACEPE) [PBPG-0525-2.05/09]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [9906/11-8]; Brazilian Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	Brazilian Fundacao de Amparo a Pesquisa e Tecnologia de Pernambuco (FACEPE); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	MTO was funded by the Brazilian Fundacao de Amparo a Pesquisa e Tecnologia de Pernambuco (FACEPE), scholarship #PBPG-0525-2.05/09, and by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, scholarship #9906/11-8. MGS was supported by a fellowship from the Brazilian Conselho Nacional de Desenvolvimento Cientifico e Tecnologico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexieva V, 2001, PLANT CELL ENVIRON, V24, P1337, DOI 10.1046/j.1365-3040.2001.00778.x; Altschul S.V.R., 1964, CONTRIB GRAY HERB HA, V193, P3; Andrade L.A., 2008, NAT CONSERVACAO, V6, P61; Andrade LA, 2010, ACTA SCI-BIOL SCI, V32, P249, DOI DOI 10.4025/ACTASCIBIOLSCI.V32I3.4535; Barker DH, 2006, NEW PHYTOL, V169, P799, DOI 10.1111/j.1469-8137.2006.01628.x; Baruch Z, 1999, OECOLOGIA, V121, P183, DOI 10.1007/s004420050920; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURKART A, 1976, J ARNOLD ARBORETUM, V57, P219; CAKMAK I, 1991, PHYSIOL PLANTARUM, V83, P463, DOI 10.1111/j.1399-3054.1991.tb00121.x; Chen LS, 2003, J EXP BOT, V54, P2165, DOI 10.1093/jxb/erg220; da Costa RC, 2007, J ARID ENVIRON, V68, P237, DOI 10.1016/j.jaridenv.2006.06.003; Dabrowska G, 2007, ACTA BIOL CRACOV BOT, V49, P7; Daehler CC, 2003, ANNU REV ECOL EVOL S, V34, P183, DOI 10.1146/annurev.ecolsys.34.011802.132403; Davis MA, 2000, J ECOL, V88, P528, DOI 10.1046/j.1365-2745.2000.00473.x; De Gara Laura, 2004, Phytochemistry Reviews, V3, P195, DOI 10.1023/B:PHYT.0000047795.82713.99; Dolatabadian A, 2008, J AGRON CROP SCI, V194, P206, DOI 10.1111/j.1439-037X.2008.00301.x; Drenovsky RE, 2012, AM J BOT, V99, P629, DOI 10.3732/ajb.1100417; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Dudley BD, 2014, ECOLOGICAL IN PRESS; Feng YL, 2008, PHYSIOL PLANTARUM, V132, P350, DOI 10.1111/j.1399-3054.2007.01019.x; Freitas ADS, 2008, FERTILIDADE SOLO PRO, P27; Frosi G, 2013, ACTA PHYSIOL PLANT, V35, P335, DOI 10.1007/s11738-012-1076-x; Funk JL, 2007, NATURE, V446, P1079, DOI 10.1038/nature05719; Funk JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064502; Funk JL, 2013, PHYSIOLOGY, V1; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P315, DOI 10.1104/pp.59.2.309; HAVIR EA, 1987, PLANT PHYSIOL, V84, P450, DOI 10.1104/pp.84.2.450; James JJ, 2005, OECOLOGIA, V145, P113, DOI 10.1007/s00442-005-0109-1; KAR M, 1976, PLANT PHYSIOL, V57, P315, DOI 10.1104/pp.57.2.315; Keunen E, 2013, PLANT CELL ENVIRON, V36, P1242, DOI 10.1111/pce.12061; KLOEPPEL BD, 1995, TREE PHYSIOL, V15, P739, DOI 10.1093/treephys/15.11.739; Leal IR, 2005, CONSERV BIOL, V19, P701, DOI 10.1111/j.1523-1739.2005.00703.x; Lichtenthaler H. K., 2001, CURRENT PROTOCOLS F, V1, DOI [10.1002/0471142913.faf0403s01, DOI 10.1002/0471142913.FAF0403S01]; Lima GPP, 2002, REV BRASILEIRA AGROC, V8, P107; Lima Michele Soares de, 2010, Braz. J. Bot., V33, P437, DOI 10.1590/S0100-84042010000300007; Matzek V, 2011, BIOL INVASIONS, V13, P3005, DOI 10.1007/s10530-011-9985-y; McDowell SCL, 2002, AM J BOT, V89, P1431, DOI 10.3732/ajb.89.9.1431; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; MOORE S, 1948, J BIOL CHEM, V176, P367; Nagel JM, 2004, BIOL INVASIONS, V6, P101, DOI 10.1023/B:BINV.0000010125.93370.32; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Pasiecznik NM, 2001, PROSOPIS JULIFLORA P; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Pegado Cláudia Maria Alves, 2006, Acta Bot. Bras., V20, P887, DOI 10.1590/S0102-33062006000400013; Pinheiro EAR, 2013, J ARID ENVIRON, V89, P1, DOI 10.1016/j.jaridenv.2012.10.003; Piza I. M. T., 2003, Revista Brasileira de Agrociencia, V9, P361; Pysek Petr, 2007, V193, P97; Rejmanek M, 1996, ECOLOGY, V77, P1655, DOI 10.2307/2265768; Rivas R, 2013, PLANT PHYSIOL BIOCH, V63, P200, DOI 10.1016/j.plaphy.2012.11.026; Santos MG, 2014, THEOR EXP PLANT PHYS, V26, P83, DOI 10.1007/s40626-014-0008-0; Schulten JR, 2014, PAC SCI, V68, P267, DOI 10.2984/68.2.7; THOMAS RL, 1967, AGRON J, V59, P240, DOI 10.2134/agronj1967.00021962005900030010x; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Wright IJ, 2002, NEW PHYTOL, V155, P403, DOI 10.1046/j.1469-8137.2002.00479.x	56	19	20	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105514	10.1371/journal.pone.0105514	http://dx.doi.org/10.1371/journal.pone.0105514			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137048	Green Published, gold, Green Submitted			2022-12-25	WOS:000340742100103
J	Pena-Gomez, FT; Guerrero, PC; Bizama, G; Duarte, M; Bustamante, RO				Pena-Gomez, Francisco T.; Guerrero, Pablo C.; Bizama, Gustavo; Duarte, Milen; Bustamante, Ramiro O.			Climatic Niche Conservatism and Biogeographical Non-Equilibrium in Eschscholzia californica (Papaveraceae), an Invasive Plant in the Chilean Mediterranean Region	PLOS ONE			English	Article							SPECIES DISTRIBUTIONS; RANGE MARGINS; EVOLUTION; SHIFTS; POPULATIONS; ADAPTATION; COMMUNITIES; DIVERSITY; INSIGHTS; ECOLOGY	Species climate requirements are useful for predicting their geographic distribution. It is often assumed that the niche requirements for invasive plants are conserved during invasion, especially when the invaded regions share similar climate conditions. California and central Chile have a remarkable degree of convergence in their vegetation structure, and a similar Mediterranean climate. Such similarities make these geographic areas an interesting natural experiment for testing climatic niche dynamics and the equilibrium of invasive species in a new environment. We tested to see if the climatic niche of Eschscholzia californica is conserved in the invaded range (central Chile), and we assessed whether the invasion process has reached a biogeographical equilibrium, i.e., occupy all the suitable geographic locations that have suitable conditions under native niche requirements. We compared the climatic niche in the native and invaded ranges as well as the projected potential geographic distribution in the invaded range. In order to compare climatic niches, we conducted a Principal Component Analysis (PCA) and Species Distribution Models (SDMs), to estimate E. californica's potential geographic distribution. We also used SDMs to predict altitudinal distribution limits in central Chile. Our results indicated that the climatic niche occupied by E. californica in the invaded range is firmly conserved, occupying a subset of the native climatic niche but leaving a substantial fraction of it unfilled. Comparisons of projected SDMs for central Chile indicate a similarity, yet the projection from native range predicted a larger geographic distribution in central Chile compared to the prediction of the model constructed for central Chile. The projected niche occupancy profile from California predicted a higher mean elevation than that projected from central Chile. We concluded that the invasion process of E. californica in central Chile is consistent with climatic niche conservatism but there is potential for further expansion in Chile.	[Pena-Gomez, Francisco T.; Guerrero, Pablo C.; Bizama, Gustavo; Duarte, Milen; Bustamante, Ramiro O.] Univ Chile, Fac Ciencias, Inst Ecol & Biodiversidad, Santiago, Chile; [Pena-Gomez, Francisco T.; Bizama, Gustavo; Duarte, Milen; Bustamante, Ramiro O.] Univ Chile, Fac Ciencias, Dept Cs Ecol, Santiago, Chile; [Guerrero, Pablo C.] Univ Concepcion, Fac Ciencias Nat & Oceanog, Dept Bot, Concepcion, Chile	Universidad de Chile; Universidad de Chile; Universidad de Concepcion	Bustamante, RO (corresponding author), Univ Chile, Fac Ciencias, Inst Ecol & Biodiversidad, Santiago, Chile.	rbustama@uchile.cl	Peña-Gomez, Francisco Tomas/H-1404-2019; BUSTAMANTE, RAMIRO/I-7353-2019; Guerrero, Pablo/J-4296-2012	Guerrero, Pablo/0000-0003-1034-1899; Duarte, Milen/0000-0003-4784-9880	Fondecyt [1100072, 3130456]; Instituto de Ecologia y Biodiversidad (IEB) [ICM-02-005, PBF-23]	Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Instituto de Ecologia y Biodiversidad (IEB)	This study was financed by Fondecyt 1100072 to Ramiro O. Bustamante (URL: http://www.conicyt.cl/fondecyt/). The authors acknowledge partial support from projects ICM-02-005 and PBF-23 of Instituto de Ecologia y Biodiversidad (IEB) (URL: http://www.ieb-chile.cl/). Pablo. C. Guerrero is funded by the Fondecyt 3130456 (URL: http://www.conicyt.cl/fondecyt/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander JM, 2010, OIKOS, V119, P1377, DOI 10.1111/j.1600-0706.2009.17977.x; Alexander JM, 2009, ECOGRAPHY, V32, P334, DOI 10.1111/j.1600-0587.2008.05605.x; Alexander JM, 2009, ECOLOGY, V90, P612, DOI 10.1890/08-0453.1; [Anonymous], 2011, ECOLOGICAL NICHES GE; Araujo MB, 2005, ECOGRAPHY, V28, P693, DOI 10.1111/j.2005.0906-7590.04253.x; Arroyo Mary T. Kalin, 2000, P385; Arroyo MTK, 1995, ECOL STU AN, P43, DOI DOI 10.1007/978-1-4612-2490-7_; Barbosa FG, 2012, AUSTRAL ECOL, V10, P1442; Beaumont LJ, 2009, DIVERS DISTRIB, V15, P409, DOI 10.1111/j.1472-4642.2008.00547.x; Beaumont LJ, 2005, ECOL MODEL, V186, P250, DOI 10.1016/j.ecolmodel.2005.01.030; Becker T, 2005, PERSPECT PLANT ECOL, V7, P173, DOI 10.1016/j.ppees.2005.09.006; Bridle JR, 2007, TRENDS ECOL EVOL, V22, P140, DOI 10.1016/j.tree.2006.11.002; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; Broennimann O, 2012, GLOBAL ECOL BIOGEOGR, V21, P481, DOI 10.1111/j.1466-8238.2011.00698.x; California Climate and Agricultural Network, 2021, INV CAL AGR CLIM SOL; CLARK C, 1978, SYST BOT, V3, P374, DOI 10.2307/2418748; Colwell RK, 2009, P NATL ACAD SCI USA, V106, P19651, DOI 10.1073/pnas.0901650106; Cowling RM, 1996, TRENDS ECOL EVOL, V11, P362, DOI 10.1016/0169-5347(96)10044-6; COWLING RM, 1980, VEGETATIO, V43, P191, DOI 10.1007/BF00158749; Development Core Team, 2006, R LANG ENV STAT COMP; di Castri F., 1973, MEDITERRANEAN TYPE E, P21; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; ESRI, 2011, ARCGIS DESKT REL 9 3; Evans MEK, 2009, AM NAT, V173, P225, DOI 10.1086/595757; FRIASL D, 1975, PLANT SYST EVOL, V123, P185, DOI 10.1007/BF00989403; Gallagher RV, 2010, J ECOL, V98, P790, DOI 10.1111/j.1365-2745.2010.01677.x; Geber MA, 2005, EVOLUTION, V59, P521; Graham CH, 2008, J APPL ECOL, V45, P239, DOI 10.1111/j.1365-2664.2007.01408.x; Guisan A, 2014, TRENDS ECOL EVOL, V29, P260, DOI 10.1016/j.tree.2014.02.009; Hickman J. C., 1993, JEPSON MANUAL HIGHER; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hutchinson G.E., 1978, INTRO POPULATION ECO; Jimenez A, 2008, J BIOGEOGR, V35, P614, DOI 10.1111/j.1365-2699.2007.01799.x; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; Le Maitre DC, 2008, GLOBAL ECOL BIOGEOGR, V17, P569, DOI 10.1111/j.1466-8238.2008.00407.x; Leger EA, 2007, J EVOLUTION BIOL, V20, P1090, DOI 10.1111/j.1420-9101.2006.01292.x; Leger EA, 2005, DIVERS DISTRIB, V11, P311, DOI 10.1111/j.1366-9516.2005.00165.x; Leger EA, 2003, ECOL LETT, V6, P257, DOI 10.1046/j.1461-0248.2003.00423.x; Medley KA, 2010, GLOBAL ECOL BIOGEOGR, V19, P122, DOI 10.1111/j.1466-8238.2009.00497.x; Monty A, 2009, OECOLOGIA, V159, P305, DOI 10.1007/s00442-008-1228-2; MOONEY H A, 1970, Flora (Jena), V159, P480; Ortega-Huerta MA, 2008, REV MEX BIODIVERS, V79, P205; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Pena-Gomez FT, 2012, GAYANA BOT, V69, P113, DOI 10.4067/S0717-66432012000100011; Peterson AT, 2003, WEED SCI, V51, P863, DOI 10.1614/P2002-081; Petitpierre B, 2012, SCIENCE, V335, P1344, DOI 10.1126/science.1215933; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; RUNDEL PW, 1982, OECOLOGIA, V55, P409, DOI 10.1007/BF00376930; Sax DF, 2002, DIVERS DISTRIB, V8, P193, DOI 10.1046/j.1472-4642.2002.00147.x; Sax DF, 2007, TRENDS ECOL EVOL, V22, P465, DOI 10.1016/j.tree.2007.06.009; Sexton JP, 2009, ANNU REV ECOL EVOL S, V40, P415, DOI 10.1146/annurev.ecolsys.110308.120317; Soberon J, 2009, P NATL ACAD SCI USA, V106, P19644, DOI 10.1073/pnas.0901637106; Theoharides KA, 2007, NEW PHYTOL, V176, P256, DOI 10.1111/j.1469-8137.2007.02207.x; Vaclavik T, 2012, DIVERS DISTRIB, V18, P73, DOI 10.1111/j.1472-4642.2011.00854.x; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Webber BL, 2012, SCIENCE, V338, DOI 10.1126/science.1225980; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; Wilson JRU, 2007, DIVERS DISTRIB, V13, P11, DOI 10.1111/j.1366-9516.2006.00302.x	59	18	19	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105025	10.1371/journal.pone.0105025	http://dx.doi.org/10.1371/journal.pone.0105025			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137175	Green Submitted, gold, Green Published			2022-12-25	WOS:000340742100061
J	Chen, X; Sheng, XI; Liu, XX; Li, HP; Liu, Y; Rong, WN; Ha, SP; Liu, WZ; Kang, XL; Zhao, KX; Zhao, C				Chen, Xue; Sheng, Xuniun; Liu, Xiaoxing; Li, Huiping; Liu, Yani; Rong, Weining; Ha, Shaoping; Liu, Wenzhou; Kang, Xiaoli; Zhao, Kanxing; Zhao, Chen			Targeted Next-Generation Sequencing Reveals Novel USH2A Mutations Associated with Diverse Disease Phenotypes: Implications for Clinical and Molecular Diagnosis	PLOS ONE			English	Article							USHER-SYNDROME GENES; PRE-MESSENGER-RNA; RETINITIS-PIGMENTOSA; JAPANESE PATIENTS; CHINESE FAMILIES; LONG ISOFORM; IDENTIFICATION; PROTEIN; EXPRESSION; PREDICTION	USH2A mutations have been implicated in the disease etiology of several inherited diseases, including Usher syndrome type 2 (USH2), nonsyndromic retinitis pigmentosa (RP), and nonsyndromic deafness. The complex genetic and phenotypic spectrums relevant to USH2A defects make it difficult to manage patients with such mutations. In the present study, we aim to determine the genetic etiology and to characterize the correlated clinical phenotypes for three Chinese pedigrees with nonsyndromic RP, one with RP sine pigmento (RPSP), and one with USH2. Family histories and clinical details for all included patients were reviewed. Ophthalmic examinations included best corrected visual acuities, visual field measurements, funduscopy, and electroretinography. Targeted next-generation sequencing (NGS) was applied using two sequence capture arrays to reveal the disease causative mutations for each family. Genotype-phenotype correlations were also annotated. Seven USH2A mutations, including four missense substitutions (p.P2762A, p.G3320C, p.R3719H, and p.G4763R), two splice site variants (c.8223+1G>A and c.8559-2T>C), and a nonsense mutation (p.Y3745*), were identified as disease causative in the five investigated families, of which three reported to have consanguineous marriage. Among all seven mutations, six were novel, and one was recurrent. Two homozygous missense mutations (p.P2762A and p.G3320C) were found in one individual family suggesting a potential double hit effect. Significant phenotypic divergences were revealed among the five families. Three families of the five families were affected with early, moderated, or late onset RP, one with RPSP, and the other one with USH2. Our study expands the genotypic and phenotypic variability relevant to USH2A mutations, which would help with a clear insight into the complex genetic and phenotypic spectrums relevant to USH2A defects, and is complementary for a better management of patients with such mutations. We have also demonstrated that a targeted NGS approach is a valuable tool for the genetic diagnosis of USH2 and RP.	[Chen, Xue; Liu, Xiaoxing; Zhao, Chen] Nanjing Med Univ, Affiliated Hosp 1, Dept Ophthalmol, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Sheng, Xuniun; Li, Huiping; Liu, Yani; Rong, Weining; Ha, Shaoping; Liu, Wenzhou] Ningxia Peoples Hosp, Ningxia Eye Hosp, Ningxia, Peoples R China; [Kang, Xiaoli] Shanghai Jiao Tong Univ, Xinhua Hosp, Sch Med, Dept Ophthalmol, Shanghai 200030, Peoples R China; [Zhao, Kanxing] Tianjin Med Univ, Tianjin Eye Hosp, Tianjin Key Lab Ophthalmol & Visual Sci, Tianjin, Peoples R China; [Zhao, Chen] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China	Nanjing Medical University; Shanghai Jiao Tong University; Tianjin Medical University; Sun Yat Sen University	Zhao, C (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Ophthalmol, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China.	dr.zhaochen@gmail.com			National Key Basic Research Program of China (973 Program) [2013CB967500]; National Natural Science Foundation of China [81222009, 81170856, 81160124, 81260154, 81170867]; Thousand Youth Talents Program of China; Jiangsu Outstanding Young Investigator Program [BK2012046]; Jiangsu Province's Key Provincial Talents Program [RC201149]; Fundamental Research Funds of the State Key Laboratory of Ophthalmology; Jiangsu Province's Scientific Research Innovation Program for Postgraduates [CXZZ13_0590]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Key Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Thousand Youth Talents Program of China; Jiangsu Outstanding Young Investigator Program; Jiangsu Province's Key Provincial Talents Program; Fundamental Research Funds of the State Key Laboratory of Ophthalmology; Jiangsu Province's Scientific Research Innovation Program for Postgraduates; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by National Key Basic Research Program of China (973 Program, 2013CB967500); National Natural Science Foundation of China (81222009, 81170856, 81160124, 81260154, and 81170867); Thousand Youth Talents Program of China (to C. Z.); Jiangsu Outstanding Young Investigator Program (BK2012046); Jiangsu Province's Key Provincial Talents Program (RC201149); the Fundamental Research Funds of the State Key Laboratory of Ophthalmology (to C. Z.); Jiangsu Province's Scientific Research Innovation Program for Postgraduates (CXZZ13_0590 to X. C.); and A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Bernal S, 2003, J Med Genet, V40, pe8, DOI 10.1136/jmg.40.1.e8; Bhattacharya G, 2002, HEARING RES, V163, P1, DOI 10.1016/S0378-5955(01)00344-6; BJELLQVIST B, 1994, ELECTROPHORESIS, V15, P529, DOI 10.1002/elps.1150150171; Bonnet C, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-21; BRUNAK S, 1991, J MOL BIOL, V220, P49, DOI 10.1016/0022-2836(91)90380-O; Chen X, 2014, HUM MOL GENET, V23, P2926, DOI 10.1093/hmg/ddu005; Chen XJ, 2013, INVEST OPHTH VIS SCI, V54, P2186, DOI 10.1167/iovs.12-10967; Choi YH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039927, 10.1371/journal.pone.0046688]; Dai HJ, 2008, MOL VIS, V14, P2067; Davies WIL, 2014, PERS MED, V11, P99, DOI [10.2217/PME.13.95, 10.2217/pme.13.95]; Davies WIL, 2012, GENET MED, V14, P891, DOI 10.1038/gim.2012.73; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Dogan RI, 2007, NUCLEIC ACIDS RES, V35, pW285, DOI 10.1093/nar/gkm407; Eudy JD, 1998, SCIENCE, V280, P1753, DOI 10.1126/science.280.5370.1753; Gonzalez-Perez A, 2011, AM J HUM GENET, V88, P440, DOI 10.1016/j.ajhg.2011.03.004; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hebsgaard SM, 1996, NUCLEIC ACIDS RES, V24, P3439, DOI 10.1093/nar/24.17.3439; Kaiserman N, 2007, ARCH OPHTHALMOL-CHIC, V125, P219, DOI 10.1001/archopht.125.2.219; KAJIWARA K, 1994, SCIENCE, V264, P1604, DOI 10.1126/science.8202715; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Liu XQ, 2007, P NATL ACAD SCI USA, V104, P4413, DOI 10.1073/pnas.0610950104; McGee TL, 2010, J MED GENET, V47, P499, DOI 10.1136/jmg.2009.075143; Mendez-Vidal C, 2013, MOL VIS, V19, P2187; Mutai H, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-172; Nakanishi H, 2009, CLIN GENET, V76, P383, DOI 10.1111/j.1399-0004.2009.01257.x; Nakanishi H, 2011, J HUM GENET, V56, P484, DOI 10.1038/jhg.2011.45; Nakanishi H, 2010, J HUM GENET, V55, P701, DOI 10.1038/jhg.2010.83; Pan XY, 2014, MOL VIS, V20, P770; Pearsall N, 2002, HEARING RES, V174, P55, DOI 10.1016/S0378-5955(02)00635-4; Rong WN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097808; Stabej PL, 2012, J MED GENET, V49, P27, DOI 10.1136/jmedgenet-2011-100468; van Wijk E, 2004, AM J HUM GENET, V74, P738, DOI 10.1086/383096; Weston MD, 2000, AM J HUM GENET, V66, P1199, DOI 10.1086/302855; Zhao C, 2006, HUM GENET, V119, P617, DOI 10.1007/s00439-006-0168-3	37	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105439	10.1371/journal.pone.0105439	http://dx.doi.org/10.1371/journal.pone.0105439			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133613	Green Submitted, Green Published, gold			2022-12-25	WOS:000341302700113
J	Kim, KH; Kang, YM; Im, CH; Ali, A; Kim, SY; Je, HJ; Kim, MK; Rho, HS; Lee, HS; Kong, WS; Ryu, JS				Kim, Kyung-Hee; Kang, Young Min; Im, Chak Han; Ali, Asjad; Kim, Sun Young; Je, Hee-Jeong; Kim, Min-Keun; Rho, Hyun Su; Lee, Hyun Sook; Kong, Won-Sik; Ryu, Jae-San			Identification and Functional Analysis of Pheromone and Receptor Genes in the B3 Mating Locus of Pleurotus eryngii	PLOS ONE			English	Article							SCHIZOPHYLLUM-COMMUNE; MUSHROOM; COPRINUS; SPECIFICITIES; GROWTH; TRANSFORMATION; TRICHOGYNES; RECOGNITION; FERTILITY; EVOLUTION	Pleurotus eryngii has recently become a major cultivated mushroom; it uses tetrapolar heterothallism as a part of its reproductive process. Sexual development progresses only when the A and B mating types are compatible. Such mating incompatibility occasionally limits the efficiency of breeding programs in which crossing within loci-shared strains or backcrossing strategies are employed. Therefore, understanding the mating system in edible mushroom fungi will help provide a short cut in the development of new strains. We isolated and identified pheromone and receptor genes in the B3 locus of P. eryngii and performed a functional analysis of the genes in the mating process by transformation. A genomic DNA library was constructed to map the entire mating-type locus. The B3 locus was found to contain four pheromone precursor genes and four receptor genes. Remarkably, receptor PESTE3.3.1 has just 34 amino acid residues in its C-terminal cytoplasmic region; therefore, it seems likely to be a receptor-like gene. Real-time quantitative RT-PCR (real-time qRT-PCR) revealed that most pheromone and receptor genes showed significantly higher expression in monokaryotic cells than dikaryotic cells. The pheromone genes PEphb3.1 and PEphb3.3 and the receptor gene PESTE3.3.1 were transformed into P5 (A3B4). The transformants were mated with a tester strain (A4B4), and the progeny showed clamp connections and a normal fruiting body, which indicates the proposed role of these genes in mating and fruiting processes. This result also confirms that PESTE3.3.1 is a receptor gene. In this study, we identified pheromone and receptor genes in the B3 locus of P. eryngii and found that some of those genes appear to play a role in the mating and fruiting processes. These results might help elucidate the mechanism of fruiting differentiation and improve breeding efficiency.	[Kim, Kyung-Hee; Kang, Young Min; Im, Chak Han; Ali, Asjad; Kim, Sun Young; Je, Hee-Jeong; Kim, Min-Keun; Ryu, Jae-San] Gyeongsangnam Do Agr Res & Extens Serv, Environm Friendly Res Div, Jinju, South Korea; [Kang, Young Min] KIOM, Herbal Med Res Div, Taejon, South Korea; [Rho, Hyun Su; Lee, Hyun Sook] Gyeongsang Natl Univ, Dept Microbiol, Jinju, South Korea; [Kong, Won-Sik] Rural Dev Adm, Natl Inst Hort & Herbal Sci, Mushroom Res Div, Eumsung, South Korea	Korea Institute of Oriental Medicine (KIOM); Gyeongsang National University; National Institute of Horticultural & Herbal Science (NIHHS), Republic of Korea; Rural Development Administration (RDA), Republic of Korea	Ryu, JS (corresponding author), Gyeongsangnam Do Agr Res & Extens Serv, Environm Friendly Res Div, Jinju, South Korea.	coolmush88@gmail.com		Ali, Asjad/0000-0002-0415-4598; Kong, Won-Sik/0000-0001-6800-2545; Ryu, Jae-San/0000-0002-8541-3079	Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea [PJ00821602014]	Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea	This work was supported by a grant from the Next-Generation BioGreen 21 Program (No. PJ00821602014), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study was designed and started by the corresponding author who is an employee of the GNARES. GNARES is a non-profit organization by the Gyeongnam government.	CALDWELL GA, 1995, MICROBIOL REV, V59, P406, DOI 10.1128/MMBR.59.3.406-422.1995; Chen X, 2000, APPL ENVIRON MICROB, V66, P4510, DOI 10.1128/AEM.66.10.4510-4513.2000; Erdmann S, 2012, EUKARYOT CELL, V11, P571, DOI 10.1128/EC.05214-11; Fowler TJ, 2001, GENETICS, V158, P1491; GIASSON L, 1989, MOL GEN GENET, V218, P72, DOI 10.1007/BF00330567; Gola S, 2000, FUNGAL GENET BIOL, V30, P191, DOI 10.1006/fgbi.2000.1222; Gola S, 2003, CURR GENET, V42, P276, DOI 10.1007/s00294-002-0353-4; Halsall JR, 2000, GENETICS, V154, P1115; Hegner J, 1999, FUNGAL GENET BIOL, V26, P190, DOI 10.1006/fgbi.1999.1119; Im CH, 2014, P 2014 C MICR BIOT T, P33; Irie T, 2001, APPL MICROBIOL BIOT, V55, P563, DOI 10.1007/s002530000535; James TY, 2004, FUNGAL GENET BIOL, V41, P813, DOI 10.1016/j.fgb.2004.04.005; Kim H, 2006, EUKARYOT CELL, V5, P544, DOI 10.1128/EC.5.3.544-554.2006; Kim H, 2004, MOL MICROBIOL, V52, P1781, DOI 10.1111/j.1365-2958.2004.04096.x; KOLTIN Y, 1967, P NATL ACAD SCI USA, V57, P55, DOI 10.1073/pnas.57.1.55; KURJAN J, 1993, ANNU REV GENET, V27, P147; Larraya LM, 2001, APPL ENVIRON MICROB, V67, P3385, DOI 10.1128/AEM.67.8.3385-3390.2001; Niculita-Hirzel H, 2008, NEW PHYTOL, V180, P329, DOI 10.1111/j.1469-8137.2008.02525.x; Nieuwenhuis BP, 2013, HEREDITY, P1; O'Shea SF, 1998, GENETICS, V148, P1081; Ohm RA, 2010, NAT BIOTECHNOL, V28, P957, DOI 10.1038/nbt.1643; Olesnicky NS, 2000, GENETICS, V156, P1025; 박순영, 2010, [The Korean Journal of Mycology, 한국균학회지], V38, P48; Raudaskoski M, 2010, EUKARYOT CELL, V9, P847, DOI 10.1128/EC.00319-09; RICHARDSON WVJ, 1993, MOL GEN GENET, V238, P304, DOI 10.1007/BF00279559; Riquelme M, 2005, GENETICS, V170, P1105, DOI 10.1534/genetics.105.040774; Ryu JS, 2012, J MICROBIOL BIOTECHN, V22, P1177, DOI 10.4014/jmb.1108.08085; Shi L, 2014, MICROBIOL RES, V51, P303; SPECHT CA, 1995, CURR GENET, V28, P374, DOI 10.1007/BF00326436; Stajich JE, 2010, P NATL ACAD SCI USA, V107, P11889, DOI 10.1073/pnas.1003391107; van Peer AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022249; WENDLAND J, 1995, EMBO J, V14, P5271, DOI 10.1002/j.1460-2075.1995.tb00211.x; YEADON PJ, 1995, CURR GENET, V28, P155, DOI 10.1007/BF00315782; Zadrazil F., 2004, SCI CULTIVATION EDIB; Zervakis GI, 2001, MICROBIOL-SGM, V147, P3183, DOI 10.1099/00221287-147-11-3183	35	18	22	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e104693	10.1371/journal.pone.0104693	http://dx.doi.org/10.1371/journal.pone.0104693			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133513	Green Published, Green Submitted, gold			2022-12-25	WOS:000341302700038
J	Masia, M; Robledano, C; de la Tabla, VO; Antequera, P; Lumbreras, B; Hernandez, I; Gutierrez, F				Masia, Mar; Robledano, Catalina; de la Tabla, Victoria Ortiz; Antequera, Pedro; Lumbreras, Blanca; Hernandez, Ildefonso; Gutierrez, Felix			Coinfection with Human Herpesvirus 8 Is Associated with Persistent Inflammation and Immune Activation in Virologically Suppressed HIV-Infected Patients	PLOS ONE			English	Article							MULTICENTRIC CASTLEMAN DISEASE; INTIMA-MEDIA THICKNESS; C-REACTIVE PROTEIN; T-CELL-ACTIVATION; NON-AIDS EVENTS; ANTIRETROVIRAL THERAPY; MICROBIAL TRANSLOCATION; KAPOSIS-SARCOMA; RISK-FACTORS; MARKERS	Objectives: Infection with co-pathogens is one of the postulated factors contributing to persistent inflammation and non-AIDS events in virologically-suppressed HIV-infected patients. We aimed to investigate the relationship of human herpesvirus-8 (HHV-8), a vasculotropic virus implicated in the pathogenesis of Kaposi's sarcoma, with inflammation and subclinical atherosclerosis in HIV-infected patients. Methods: Prospective study including virologically suppressed HIV-infected patients. Several blood biomarkers (highly-sensitive C-reactive protein [hsCRP], tumour necrosis factor-alpha, interleukin-6, monocyte chemoattractant protein-1, vascular cell adhesion molecule-1, intercellular cell adhesion molecule-1, malondialdehyde, plasminogen activator inhibitor [PAI-1], D-dimer, sCD14, sCD163, CD4/CD38/HLA-DR, and CD8/CD38/HLA-DR), serological tests for HHV-8 and the majority of herpesviruses, carotid intima-media thickness, and endothelial function through flow-mediated dilatation of the brachial artery were measured. Results: A total of 136 patients were included, 34.6% of them infected with HHV-8. HHV-8-infected patients were more frequently co-infected with herpes simplex virus type 2 (HSV-2) (P<0.001), and less frequently with hepatitis C virus (HCV) (P = 0.045), and tended to be older (P = 0.086). HHV-8-infected patients had higher levels of hsCRP (median [interquartile range], 3.63 [1.32-7.54] vs 2.08 [0.89-4.11] mg/L, P = 0.009), CD4/CD38/HLA-DR (7.67% [4.10-11.86]% vs 3.86% [2.51-7.42]%, P = 0.035) and CD8/CD38/HLA-DR (8.02% [4.98-14.09]% vs 5.02% [3.66-6.96]%, P = 0.018). After adjustment for the traditional cardiovascular risk factors, HCV and HSV-2 infection, the associations remained significant: adjusted difference between HHV-8 positive and negative patients (95% confidence interval) for hsCRP, 74.19% (16.65-160.13)%; for CD4/CD38/HLA-DR, 89.65% (14.34-214.87)%; and for CD8/CD38/HLA-DR, 58.41% (12.30-123.22)%. Flow-mediated dilatation and total carotid intima-media thickness were not different according to HHV-8 serostatus. Conclusion: In virologically suppressed HIV-infected patients, coinfection with HHV-8 is associated with increased inflammation and immune activation. This might contribute to increase the risk of non-AIDS events, including accelerated atherosclerotic disease.	[Masia, Mar; Robledano, Catalina; Gutierrez, Felix] Univ Miguel Hernandez, Hosp Gen Univ Elche, Infect Dis Unit, Alicante, Spain; [de la Tabla, Victoria Ortiz; Antequera, Pedro] Hosp Univ San Juan, Microbiol Serv, Alicante, Spain; [Lumbreras, Blanca; Hernandez, Ildefonso] Univ Miguel Hernandez, Dept Publ Hlth, Alicante, Spain	Universidad Miguel Hernandez de Elche; Universidad Miguel Hernandez de Elche	Masia, M (corresponding author), Univ Miguel Hernandez, Hosp Gen Univ Elche, Infect Dis Unit, Alicante, Spain.	marmasiac@gmail.com	Hernández-Aguado, Ildefonso/I-2634-2015; Masiá, Mar/U-7510-2017; Rodero, Félix Gutiérrez/Q-7880-2018	Hernández-Aguado, Ildefonso/0000-0003-1911-5759; Masiá, Mar/0000-0001-9878-2458; Rodero, Félix Gutiérrez/0000-0002-9485-6867; Lumbreras, Blanca/0000-0003-1665-0860	Plan Nacional R+D+I [RD12/0017/0023]; ISCIII- Subdireccion General de Evaluacion y el Fondo Europeo de Desarrollo Regional (FEDER) [FIBELX10/11, FIBELX10/12]; Instituto de Salud Carlos III-FIS [PI081893, PI13/002256]	Plan Nacional R+D+I; ISCIII- Subdireccion General de Evaluacion y el Fondo Europeo de Desarrollo Regional (FEDER); Instituto de Salud Carlos III-FIS(Instituto de Salud Carlos IIIEuropean Commission)	This work has been partially funded by the RD12/0017/0023 project as part of the Plan Nacional R+D+I, and co-financed by ISCIII- Subdireccion General de Evaluacion y el Fondo Europeo de Desarrollo Regional (FEDER), FIBELX10/11, FIBELX10/12, and Instituto de Salud Carlos III-FIS [PI081893, PI13/002256]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaide ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063804; Aldaz P, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-300; Cassol E, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-203; Crabtree KL, 2014, CANCER EPIDEM BIOMAR, V23, P300, DOI 10.1158/1055-9965.EPI-13-0730; Deeks SG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3172; Giuliani M, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-143; Grahame-Clarke C, 2001, AIDS, V15, P1902, DOI 10.1097/00002030-200109280-00029; Gutierrez F, 2006, J CLIN VIROL, V37, P79, DOI 10.1016/j.jcv.2006.05.011; Gutierrez F, 2008, AIDS, V22, P1369, DOI 10.1097/QAD.0b013e3282f7cb88; Hannachi N, 2012, PATHOL BIOL, V60, P282, DOI 10.1016/j.patbio.2011.10.008; Hechter RC, 2012, ATHEROSCLEROSIS, V223, P433, DOI 10.1016/j.atherosclerosis.2012.03.002; Hsue PY, 2006, AIDS, V20, P2275, DOI 10.1097/QAD.0b013e3280108704; Hunt PW, 2008, J INFECT DIS, V197, P126, DOI 10.1086/524143; Kaplan RC, 2011, J INFECT DIS, V203, P452, DOI 10.1093/infdis/jiq071; Macy EM, 1997, CLIN CHEM, V43, P52; Marchetti G, 2008, AIDS, V22, P2035, DOI 10.1097/QAD.0b013e3283112d29; Martinez E, 2012, AIDS, V26, P2315, DOI 10.1097/QAD.0b013e328359f29c; Masia M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064327; Masia M, 2013, AIDS, V27, P181, DOI 10.1097/QAD.0b013e32835a1156; Masia M, 2010, ANTIVIR THER, V15, P101, DOI 10.3851/IMP1491; McComsey GA, 2014, JAIDS-J ACQ IMM DEF, V65, P167, DOI 10.1097/01.qai.0000437171.00504.41; Miller CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095061; Neuhaus J, 2010, J INFECT DIS, V201, P1788, DOI 10.1086/652749; Neuhaus J, 2010, AIDS, V24, P697, DOI 10.1097/QAD.0b013e3283365356; Polizzotto MN, 2013, BLOOD, V122, P4189, DOI 10.1182/blood-2013-08-519959; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Spira TJ, 2000, J CLIN MICROBIOL, V38, P2174; Uldrick TS, 2010, CLIN INFECT DIS, V51, P350, DOI 10.1086/654798	28	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105442	10.1371/journal.pone.0105442	http://dx.doi.org/10.1371/journal.pone.0105442			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133669	Green Submitted, Green Published, gold			2022-12-25	WOS:000341302700114
J	Mafficini, A; Amato, E; Fassan, M; Simbolo, M; Antonello, D; Vicentini, C; Scardoni, M; Bersani, S; Gottardi, M; Rusev, B; Malpeli, G; Corbo, V; Barbi, S; Sikora, KO; Lawlor, RT; Tortora, G; Scarpa, A				Mafficini, Andrea; Amato, Eliana; Fassan, Matteo; Simbolo, Michele; Antonello, Davide; Vicentini, Caterina; Scardoni, Maria; Bersani, Samantha; Gottardi, Marisa; Rusev, Borislav; Malpeli, Giorgio; Corbo, Vincenzo; Barbi, Stefano; Sikora, Katarzyna O.; Lawlor, Rita T.; Tortora, Giampaolo; Scarpa, Aldo			Reporting Tumor Molecular Heterogeneity in Histopathological Diagnosis	PLOS ONE			English	Article							SEQUENCING PLATFORMS; SOMATIC MUTATIONS; CANCER; ADENOCARCINOMA; LANDSCAPE; EVOLUTION; CARCINOMA; TISSUES; GENOME; GENES	Background: Detection of molecular tumor heterogeneity has become of paramount importance with the advent of targeted therapies. Analysis for detection should be comprehensive, timely and based on routinely available tumor samples. Aim: To evaluate the diagnostic potential of targeted multigene next-generation sequencing (TM-NGS) in characterizing gastrointestinal cancer molecular heterogeneity. Methods: 35 gastrointestinal tract tumors, five of each intestinal type gastric carcinomas, pancreatic ductal adenocarcinomas, pancreatic intraductal papillary mucinous neoplasms, ampulla of Vater carcinomas, hepatocellular carcinomas, cholangiocarcinomas, pancreatic solid pseudopapillary tumors were assessed for mutations in 46 cancer-associated genes, using Ion Torrent semiconductor-based TM-NGS. One ampulla of Vater carcinoma cell line and one hepatic carcinosarcoma served to assess assay sensitivity. TP53, PIK3CA, KRAS, and BRAF mutations were validated by conventional Sanger sequencing. Results: TM-NGS yielded overlapping results on matched fresh-frozen and formalin-fixed paraffin-embedded (FFPE) tissues, with a mutation detection limit of 1% for fresh-frozen high molecular weight DNA and 2% for FFPE partially degraded DNA. At least one somatic mutation was observed in all tumors tested; multiple alterations were detected in 20/35 (57%) tumors. Seven cancers displayed significant differences in allelic frequencies for distinct mutations, indicating the presence of intratumor molecular heterogeneity; this was confirmed on selected samples by immunohistochemistry of p53 and Smad4, showing concordance with mutational analysis. Conclusions: TM-NGS is able to detect and quantitate multiple gene alterations from limited amounts of DNA, moving one step closer to a next-generation histopathologic diagnosis that integrates morphologic, immunophenotypic, and multigene mutational analysis on routinely processed tissues, essential for personalized cancer therapy.	[Mafficini, Andrea; Amato, Eliana; Fassan, Matteo; Simbolo, Michele; Antonello, Davide; Vicentini, Caterina; Scardoni, Maria; Bersani, Samantha; Gottardi, Marisa; Rusev, Borislav; Malpeli, Giorgio; Corbo, Vincenzo; Barbi, Stefano; Sikora, Katarzyna O.; Lawlor, Rita T.; Scarpa, Aldo] Univ & Hosp Trust Verona, Appl Res Canc Network ARC NET, Verona, Italy; [Mafficini, Andrea; Amato, Eliana; Fassan, Matteo; Simbolo, Michele; Antonello, Davide; Vicentini, Caterina; Scardoni, Maria; Bersani, Samantha; Gottardi, Marisa; Rusev, Borislav; Malpeli, Giorgio; Corbo, Vincenzo; Barbi, Stefano; Sikora, Katarzyna O.; Lawlor, Rita T.; Scarpa, Aldo] Univ & Hosp Trust Verona, Dept Pathol & Diagnost, Verona, Italy; [Antonello, Davide; Malpeli, Giorgio] Univ & Hosp Trust Verona, Dept Surg, Verona, Italy; [Tortora, Giampaolo] Univ & Hosp Trust Verona, Oncol Unit, Dept Med, Verona, Italy	University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona	Scarpa, A (corresponding author), Univ & Hosp Trust Verona, Appl Res Canc Network ARC NET, Verona, Italy.	aldo.scarpa@univr.it	scarpa, aldo/K-6832-2016; Tortora, Giampaolo/HGB-6261-2022; Corbo, Vincenzo/J-7754-2016; Tortora, Giampaolo/AAA-1252-2019; Mafficini, Andrea/AAK-8158-2020; Simbolo, Michele/AAB-1851-2019; Fassan, Matteo/F-5152-2012	scarpa, aldo/0000-0003-1678-739X; Corbo, Vincenzo/0000-0002-6340-8009; Mafficini, Andrea/0000-0002-7471-3121; Simbolo, Michele/0000-0002-0866-4499; Malpeli, Giorgio/0000-0002-2996-2903; Fassan, Matteo/0000-0001-6515-5482; Tortora, Giampaolo/0000-0002-1378-4962; lawlor, Rita/0000-0003-3160-0634	AIRC [12182, 6421]; Italian Cancer Genome Project grant from the Italian Ministry of Research [FIRB - RBAP10AHJB]; Ministry of Health [CUP_J33G13000210001]; FP7 European Community CAM-PAC [602783]	AIRC(Fondazione AIRC per la ricerca sul cancro); Italian Cancer Genome Project grant from the Italian Ministry of Research; Ministry of Health; FP7 European Community CAM-PAC	This work has been supported by AIRC grant n. 12182 and n. 6421; Italian Cancer Genome Project grant from the Italian Ministry of Research (FIRB - RBAP10AHJB) and Ministry of Health (CUP_J33G13000210001), FP7 European Community CAM-PAC (Grant no: 602783). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham SC, 2002, AM J PATHOL, V160, P1361, DOI 10.1016/S0002-9440(10)62563-1; Allegra CJ, 2009, J CLIN ONCOL, V27, P2091, DOI 10.1200/JCO.2009.21.9170; Amato E, 2014, J PATHOL; Balschun K, 2011, J MOL DIAGN, V13, P436, DOI 10.1016/j.jmoldx.2011.03.002; Barbi S, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-32; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Ciriello G, 2013, NAT GENET, V45, P1127, DOI 10.1038/ng.2762; Ellison DW, 2011, J CLIN ONCOL, V29, P1400, DOI 10.1200/JCO.2010.30.2810; Fassan M, 2013, GASTRIC CANC; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Hadd AG, 2013, J MOL DIAGN, V15, P234, DOI 10.1016/j.jmoldx.2012.11.006; Jiao YC, 2013, NAT GENET, V45, P1470, DOI 10.1038/ng.2813; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Jorgensen JT, 2013, EXPERT REV MOL DIAGN, V13, P667, DOI 10.1586/14737159.2013.834799; Kerick M, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-68; Kipp BR, 2012, HUM PATHOL, V43, P1552, DOI 10.1016/j.humpath.2011.12.007; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Liu L, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/251364; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; Luchini C, 2014, J CLIN ONCOL; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Ow TJ, 2013, CANCER; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Rivenbark AG, 2013, AM J PATHOL, V183, P1113, DOI 10.1016/j.ajpath.2013.08.002; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Scarpa A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080478; Schweiger MR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005548; Simbolo M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062692; Sorio C, 2004, VIRCHOWS ARCH, V444, P269, DOI 10.1007/s00428-003-0936-6; Ulivi P, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-87; Voss JS, 2013, HUM PATHOL IN PRESS; Wang P, 2012, ONCOGENE; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Zamo A, 2012, J MOL DIAGN, V14, P30, DOI 10.1016/j.jmoldx.2011.07.007; Zang ZJ, 2012, NAT GENET, V44, P570, DOI 10.1038/ng.2246	37	36	37	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104979	10.1371/journal.pone.0104979	http://dx.doi.org/10.1371/journal.pone.0104979			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127237	Green Published, Green Submitted, gold			2022-12-25	WOS:000340879300068
J	Majtan, T; Pey, AL; Fernandez, R; Fernandez, JA; Martinez-Cruz, LA; Kraus, JP				Majtan, Tomas; Pey, Angel L.; Fernandez, Roberto; Fernandez, Jose A.; Martinez-Cruz, Luis A.; Kraus, Jan P.			Domain Organization, Catalysis and Regulation of Eukaryotic Cystathionine Beta-Synthases	PLOS ONE			English	Article							CYSTEINE BIOSYNTHESIS; HYDROGEN-SULFIDE; SACCHAROMYCES-CEREVISIAE; TRANS-SULFURATION; REDOX REGULATION; STRUCTURAL BASIS; WILD-TYPE; HEME; TRANSSULFURATION; ADENOSYLMETHIONINE	Cystathionine beta-synthase (CBS) is a key regulator of sulfur amino acid metabolism diverting homocysteine, a toxic intermediate of the methionine cycle, via the transsulfuration pathway to the biosynthesis of cysteine. Although the pathway itself is well conserved among eukaryotes, properties of eukaryotic CBS enzymes vary greatly. Here we present a side-by-side biochemical and biophysical comparison of human (hCBS), fruit fly (dCBS) and yeast (yCBS) enzymes. Preparation and characterization of the full-length and truncated enzymes, lacking the regulatory domains, suggested that eukaryotic CBS exists in one of at least two significantly different conformations impacting the enzyme's catalytic activity, oligomeric status and regulation. Truncation of hCBS and yCBS, but not dCBS, resulted in enzyme activation and formation of dimers compared to native tetramers. The dCBS and yCBS are not regulated by the allosteric activator of hCBS, S-adenosylmethionine (AdoMet); however, they have significantly higher specific activities in the canonical as well as alternative reactions compared to hCBS. Unlike yCBS, the heme-containing dCBS and hCBS showed increased thermal stability and retention of the enzyme's catalytic activity. The mass-spectrometry analysis and isothermal titration calorimetry showed clear presence and binding of AdoMet to yCBS and hCBS, but not dCBS. However, the role of AdoMet binding to yCBS remains unclear, unlike its role in hCBS. This study provides valuable information for understanding the complexity of the domain organization, catalytic specificity and regulation among eukaryotic CBS enzymes.	[Majtan, Tomas; Kraus, Jan P.] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO 80045 USA; [Pey, Angel L.] Univ Granada, Fac Sci, Dept Phys Chem, Granada, Spain; [Fernandez, Roberto; Fernandez, Jose A.] Univ,Basque Country UPV EHU, Fac Sci & Technol, Dept Phys Chem, Leioa, Spain; [Martinez-Cruz, Luis A.] CIC bioGUNE, Struct Biol Unit, Derio, Bizkaia, Spain	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Granada; University of Basque Country; CIC bioGUNE	Kraus, JP (corresponding author), Univ Colorado, Sch Med, Dept Pediat, Aurora, CO 80045 USA.	jan.kraus@ucdenver.edu	Fernandez, Jose Andres/E-8565-2011; Majtan, Tomas/AAE-8426-2021; Martinez-Cruz, Luis Alfonso/G-2285-2011	Fernandez, Jose Andres/0000-0002-7315-2326; Majtan, Tomas/0000-0002-2751-2124; Fernandez, Roberto Antonio/0000-0002-3424-9758; Martinez-Cruz, Luis Alfonso/0000-0002-5856-9377; Pey, Angel Luis/0000-0001-7706-3243	American Heart Association [0920079G, 09GRNT2110159]; National Institutes of Health [HL065217]; Jerome Lejeune Foundation;  [RYC2009-04147];  [P11-CTS-07187];  [CSD2009-00088];  [BIO2012-34937]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065217] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jerome Lejeune Foundation; ; ; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Postdoctoral Fellowship 0920079G from the American Heart Association (to TM), by National Institutes of Health Grant HL065217, by American Heart Association Grant In-Aid 09GRNT2110159, by a grant from the Jerome Lejeune Foundation (all to JPK) and by a research contract RYC2009-04147 (to ALP). In addition, grant support (P11-CTS-07187, CSD2009-00088 and BIO2012-34937) to Dr. Jose M. Sanchez-Ruiz (University of Granada) and SGIker technical and human support (UPV/EHU, MICINN, GV/EJ, ESF) are gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee R, 2005, ARCH BIOCHEM BIOPHYS, V433, P144, DOI 10.1016/j.abb.2004.08.037; Banerjee R, 2012, J BIOL CHEM, V287, P4397, DOI 10.1074/jbc.R111.287995; Baykov AA, 2011, ACS CHEM BIOL, V6, P1156, DOI 10.1021/cb200231c; CHEREST H, 1993, J BACTERIOL, V175, P5366, DOI 10.1128/JB.175.17.5366-5374.1993; Christen P, 2001, CHEM REC, V1, P436, DOI 10.1002/tcr.10005; COOPER AJL, 1983, ANNU REV BIOCHEM, V52, P187, DOI 10.1146/annurev.bi.52.070183.001155; Ereno-Orbea J, 2013, P NATL ACAD SCI USA, V110, pE3790, DOI 10.1073/pnas.1313683110; Finkelstein JD, 2006, J NUTR, V136, p1750S, DOI 10.1093/jn/136.6.1750S; FINKELSTEIN JD, 1975, BIOCHEM BIOPH RES CO, V66, P81, DOI 10.1016/S0006-291X(75)80297-X; Frank N, 2008, ARCH BIOCHEM BIOPHYS, V470, P64, DOI 10.1016/j.abb.2007.11.006; GAITONDE MK, 1967, BIOCHEM J, V104, P627, DOI 10.1042/bj1040627; Hebert A, 2011, FEMS YEAST RES, V11, P366, DOI 10.1111/j.1567-1364.2011.00725.x; Janosik M, 2001, AM J HUM GENET, V68, P1506, DOI 10.1086/320597; Janosik M, 2001, BIOCHEMISTRY-US, V40, P10625, DOI 10.1021/bi010711p; Jhee KH, 2000, BIOCHEMISTRY-US, V39, P10548, DOI 10.1021/bi001020g; Kabil H, 2011, P NATL ACAD SCI USA, V108, P16831, DOI 10.1073/pnas.1102008108; KAYASTHA AM, 1991, ANAL BIOCHEM, V193, P200, DOI 10.1016/0003-2697(91)90009-I; Kery V, 1998, ARCH BIOCHEM BIOPHYS, V355, P222, DOI 10.1006/abbi.1998.0723; KERY V, 1994, J BIOL CHEM, V269, P25283; Koutmos M, 2010, P NATL ACAD SCI USA, V107, P20958, DOI 10.1073/pnas.1011448107; KRAUS JP, 1987, METHOD ENZYMOL, V143, P388; Li L, 2011, ANNU REV PHARMACOL, V51, P169, DOI 10.1146/annurev-pharmtox-010510-100505; Lloyd D, 2006, TRENDS MICROBIOL, V14, P456, DOI 10.1016/j.tim.2006.08.003; Lucas M, 2010, J MOL BIOL, V396, P800, DOI 10.1016/j.jmb.2009.12.012; Maclean KN, 2000, J INORG BIOCHEM, V81, P161, DOI 10.1016/S0162-0134(00)00100-8; Maclean KN, 2002, HUM MUTAT, V19, P641, DOI 10.1002/humu.10089; Majtan T, 2012, PROTEIN EXPRES PURIF, V82, P317, DOI 10.1016/j.pep.2012.01.019; Majtan T, 2010, J BIOL CHEM, V285, P15866, DOI 10.1074/jbc.M110.107722; Majtan T, 2008, J BIOL CHEM, V283, P34588, DOI 10.1074/jbc.M805928200; Marciano D, 2012, MOL BIOCHEM PARASIT, V185, P114, DOI [10.10, 10.1016/j.molbiopara.2012.07.009]; Meier M, 2001, EMBO J, V20, P3910, DOI 10.1093/emboj/20.15.3910; Miles EW, 2004, J BIOL CHEM, V279, P29871, DOI 10.1074/jbc.R400005200; Mudd S., 2001, METABOLIC MOL BASES, P2007; Nozaki T, 2001, J BIOL CHEM, V276, P6516, DOI 10.1074/jbc.M009774200; Pey AL, 2013, BIOCHEM J, V449, P109, DOI 10.1042/BJ20120731; Prudova A, 2006, P NATL ACAD SCI USA, V103, P6489, DOI 10.1073/pnas.0509531103; Robertson AD, 1997, CHEM REV, V97, P1251, DOI 10.1021/cr960383c; Rodriguez-Larrea D, 2006, J MOL BIOL, V360, P715, DOI 10.1016/j.jmb.2006.05.009; SANCHEZRUIZ JM, 1988, BIOCHEMISTRY-US, V27, P3338, DOI 10.1021/bi00409a033; Singh S, 2011, BBA-PROTEINS PROTEOM, V1814, P1518, DOI 10.1016/j.bbapap.2011.02.004; Singh S, 2009, J BIOL CHEM, V284, P22457, DOI 10.1074/jbc.M109.010868; Su Y, 2013, BIOCHEMISTRY-US, V52, P741, DOI 10.1021/bi300615c; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P917, DOI 10.1038/nrd2425; Taoka S, 1999, BIOCHEMISTRY-US, V38, P7406, DOI 10.1021/bi995077i; Taoka S, 1998, J BIOL CHEM, V273, P25179, DOI 10.1074/jbc.273.39.25179; Taoka S, 2002, J BIOL CHEM, V10, P10; Uthus EO, 2006, MECH AGEING DEV, V127, P444, DOI 10.1016/j.mad.2006.01.001; Vozdek R, 2012, BIOCHEM J, V443, P535, DOI 10.1042/BJ20111478; Williams RAM, 2009, BIOCHEM J, V420, P451, DOI 10.1042/BJ20082441; Zuin A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002842	50	36	37	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e105290	10.1371/journal.pone.0105290	http://dx.doi.org/10.1371/journal.pone.0105290			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122507	Green Published, gold, Green Submitted			2022-12-25	WOS:000341017000112
J	Sarangi, M; Ganguly, P; Zenia; Arvind, C; Lakshman, A; Vidya, TNC				Sarangi, Manaswini; Ganguly, Payel; Zenia; Arvind, Chiti; Lakshman, Abhilash; Vidya, T. N. C.			Common Myna Roosts Are Not Recruitment Centres	PLOS ONE			English	Article							INFORMATION-CENTER HYPOTHESIS; COMMUNAL ROOSTS; ACRIDOTHERES-TRISTIS; GROUP-SIZE; FOOD; BEHAVIOR; STRATEGIES; VIGILANCE; COLONIES; BIRDS	We studied communal roosting in the Common Myna (Acridotheres tristis) in the light of the recruitment centre hypothesis and predation at the roost. The number and sizes of flocks departing from and arriving at focal roosts were recorded over a two year period. We also recorded the sizes and behaviour of foraging flocks. We found that flock sizes of birds departing from roosts at sunrise were larger than those at the feeding site, suggesting that there was no recruitment from the roosts. Flocks entering the roosts during sunset were larger on average than those leaving the following sunrise, suggesting no consolidation of flocks in the morning. Flocks entering the roosts at sunset were also larger on average than those that had left that sunrise, although there was no recruitment at the feeding site. There was no effect of group size on the proportion of time spent feeding. Contrary to expectation, single birds showed lower apparent vigilance than birds that foraged in pairs or groups, possibly due to scrounging tactics being used in the presence of feeding companions. Thus, the recruitment centre hypothesis did not hold in our study population of mynas. Predation at dawn and dusk were also not important to communal roosting: predators near the roosts did not result in larger flocks, and resulted in larger durations of arrival/departure contrary to expectation. Since flock sizes were smallest at the feeding site and larger in the evening than in the morning, but did not coincide with predator activity, information transfer unrelated to food (such as breeding opportunities) may possibly give rise to the evening aggregations.	[Sarangi, Manaswini; Ganguly, Payel; Zenia; Arvind, Chiti; Lakshman, Abhilash; Vidya, T. N. C.] Indian Inst Sci, Jawaharlal Nehru Ctr Adv Sci Res, Evolutionary & Organismal Biol Unit, Bangalore 560012, Karnataka, India	Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Indian Institute of Science (IISC) - Bangalore	Vidya, TNC (corresponding author), Indian Inst Sci, Jawaharlal Nehru Ctr Adv Sci Res, Evolutionary & Organismal Biol Unit, Bangalore 560012, Karnataka, India.	tncvidya@jncasr.ac.in	Arvind, Chiti/ACN-1394-2022	Arvind, Chiti/0000-0003-0727-9465; T.N.C., Vidya/0000-0002-7143-9008; Abhilash, Lakshman/0000-0002-9933-8989	Department of Science and Technology's (Government of India) Ramanujan Fellowship; JNCASR's Project Oriented Biological Education (POBE) programme	Department of Science and Technology's (Government of India) Ramanujan Fellowship; JNCASR's Project Oriented Biological Education (POBE) programme	This project was carried out through the Department of Science and Technology's (Government of India) Ramanujan Fellowship to TNCV. Zenia and Chiti Arvind were supported by JNCASR's Project Oriented Biological Education (POBE) programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S., 1996, BOOK INDIAN BIRDS; BAYER RD, 1982, AUK, V99, P31, DOI 10.2307/4086019; Beauchamp G, 1999, BEHAV ECOL, V10, P675, DOI 10.1093/beheco/10.6.675; Beauchamp G, 2001, BEHAV ECOL SOCIOBIOL, V51, P47, DOI 10.1007/s002650100413; Bijleveld AI, 2010, OIKOS, V119, P277, DOI 10.1111/j.1600-0706.2009.17892.x; BROWN CR, 1986, SCIENCE, V234, P83, DOI 10.1126/science.234.4772.83; Buckley NJ, 1996, AUK, V113, P473, DOI 10.2307/4088913; Caccamise DF, 1997, AUK, V114, P628, DOI 10.2307/4089282; CACCAMISE DF, 1986, AM NAT, V128, P191, DOI 10.1086/284553; CARACO T, 1980, NATURE, V285, P400, DOI 10.1038/285400a0; COUNSILMAN J J, 1974, Emu, V74, P135; DUPLESSIS MA, 1994, CONDOR, V96, P631, DOI 10.2307/1369466; EISERER LA, 1984, BIRD BEHAV, V5, P61; EVANS RM, 1982, AUK, V99, P24, DOI 10.2307/4086018; Fernandez-Juricic E, 2004, BEHAV ECOL, V15, P371, DOI 10.1093/beheco/arh017; GADGIL M, 1975, Journal of the Bombay Natural History Society, V72, P716; GADGIL M, 1972, IBIS, V114, P531, DOI 10.1111/j.1474-919X.1972.tb00853.x; Hansen H, 2000, CAN J ZOOL, V78, P1813, DOI 10.1139/cjz-78-10-1813; HEINRICH B, 1988, BEHAV ECOL SOCIOBIOL, V23, P141, DOI 10.1007/BF00300349; HEINRICH B, 1991, BEHAV ECOL SOCIOBIOL, V28, P13; Joern A., 1990, P415; KREBS JR, 1974, BEHAVIOUR, V51, P99, DOI 10.1163/156853974X00165; Kulkarni S, 2007, BEHAV PROCESS, V74, P88, DOI 10.1016/j.beproc.2006.10.005; Lack D., 1968, pvii; MAHABAL A, 1989, P INDIAN AS-ANIM SCI, V98, P199, DOI 10.1007/BF03179646; Mahabal Anil, 1993, Biovigyanam, V19, P55; Mahabal Anil, 1991, Pavo, V29, P23; Marzluff JM, 1996, ANIM BEHAV, V51, P89, DOI 10.1006/anbe.1996.0008; McGiffin A, 2013, EMU, V113, P154, DOI 10.1071/MU12107; MOCK DW, 1988, ORNIS SCAND, V19, P231, DOI 10.2307/3676564; MOORE J, 1988, AM NAT, V131, P22, DOI 10.1086/284771; Moore JE, 1998, CAN J ZOOL, V76, P508, DOI 10.1139/cjz-76-3-508; Newey P, 2007, EMU, V107, P315, DOI 10.1071/MU06054; Ni SX, 2003, AGR ECOSYST ENVIRON, V95, P61, DOI 10.1016/S0167-8809(02)00165-2; RABENOLD PP, 1987, ANIM BEHAV, V35, P1775, DOI 10.1016/S0003-3472(87)80070-2; Richner H, 1996, BEHAV ECOL, V7, P115, DOI 10.1093/beheco/7.1.115; RICHNER H, 1995, ADV STUD BEHAV, V24, P1, DOI 10.1016/S0065-3454(08)60391-5; Roberts G, 1996, ANIM BEHAV, V51, P1077, DOI 10.1006/anbe.1996.0109; SENGUPTA S, 1976, Proceedings of the Indian National Science Academy Part B Biological Sciences, V42, P338; Sonerud GA, 2002, BEHAV ECOL SOCIOBIOL, V51, P309, DOI 10.1007/s00265-001-0440-4; Sonerud GA, 2001, P ROY SOC B-BIOL SCI, V268, P827, DOI 10.1098/rspb.2001.1586; StatSoft, 2007, STATISTICA 8; WAGNER RH, 1993, J THEOR BIOL, V163, P333, DOI 10.1006/jtbi.1993.1123; WALTZ EC, 1987, ANIM BEHAV, V35, P48, DOI 10.1016/S0003-3472(87)80209-9; WARD P., 1965, IBIS, V107, P173, DOI 10.1111/j.1474-919X.1965.tb07296.x; WARD P, 1973, IBIS, V115, P517, DOI 10.1111/j.1474-919X.1973.tb01990.x; Warton DI, 2011, ECOLOGY, V92, P3, DOI 10.1890/10-0340.1; WEATHERHEAD PJ, 1983, AM NAT, V121, P237, DOI 10.1086/284053; WEATHERHEAD PJ, 1987, ANIM BEHAV, V35, P614, DOI 10.1016/S0003-3472(87)80295-6; Wright J, 2003, J ANIM ECOL, V72, P1003, DOI 10.1046/j.1365-2656.2003.00771.x; YOMTOV Y, 1979, IBIS, V121, P331, DOI 10.1111/j.1474-919X.1979.tb06852.x; ZAHAVI A, 1971, IBIS, V113, P106, DOI 10.1111/j.1474-919X.1971.tb05131.x; Zahavi A, 1996, BEHAV ECOL, V7, P118, DOI 10.1093/beheco/7.1.118	53	0	0	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e103406	10.1371/journal.pone.0103406	http://dx.doi.org/10.1371/journal.pone.0103406			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122467	Green Published, Green Submitted, gold			2022-12-25	WOS:000341017000014
J	Traini, C; Faussone-Pellegrini, MS; Evangelista, S; Mazzaferro, K; Cipriani, G; Santicioli, P; Vannucchi, MG				Traini, Chiara; Faussone-Pellegrini, Maria Simonetta; Evangelista, Stefano; Mazzaferro, Katia; Cipriani, Gianluca; Santicioli, Paolo; Vannucchi, Maria Giuliana			Inner and Outer Portions of Colonic Circular Muscle: Ultrastructural and Immunohistochemical Changes in Rat Chronically Treated with Otilonium Bromide	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; IRRITABLE-BOWEL-SYNDROME; SMOOTH-MUSCLE; INTERSTITIAL-CELLS; CALCIUM-CHANNELS; EXPRESSION; CAJAL	Rat colonic circular muscle, main target of otilonium bromide (OB) spasmolytic activity, is subdivided in an inner and outer portion. Since the inner one is particularly rich in organelles involved in calcium availability (caveolae, smooth endoplasmic reticulum, mitochondria), the expression of specific markers (Caveolin-1, eNOS, calreticulin, calsequestrin) in comparison with the outer portion was investigated. The possible changes of these organelles and related markers, and of muscarinic receptors (Mr2) were then studied after OB chronic exposition. Rats were treated with 2-20 mg/kg/OB for 10 or 30 days. Proximal colon was processed by electron microscopy, immunohistochemistry, and western blot. In colon strips the stimulated contractility response to muscarinic agonist was investigated. The inner portion showed a higher expression of Caveolin-1 and Mr2, but not of eNOS, calreticulin and calsequestrin, compared to the outer portion. Chronic OB treatment caused similar ultrastructural and immunohistochemical changes in both portions. Organelles and some related markers were increased at 10 days; Mr2 expression and muscle contractility induced by methacholine was increased at 30 days. The present findings: 1) provide new information on the immunohistochemical properties of the inner portion of the circular layer that are in favour of a role it might play in colonic motility distinct from that of the outer portion; 2) demonstrate that chronically administered OB interferes with cell structures and molecules responsible for calcium handling and storage, and modifies cholinergic transmission. In conclusion, chronic OB administration in the colonic circular muscle layer directly interacts with the organelles and molecules calcium-related and with the Mr2.	[Traini, Chiara; Faussone-Pellegrini, Maria Simonetta; Mazzaferro, Katia; Santicioli, Paolo; Vannucchi, Maria Giuliana] Dept Expt & Clin Med, Histol & Embryol Res Unit, Florence, Italy; [Evangelista, Stefano] Menarini Ric SpA, Preclin Dev, Florence, Italy; [Cipriani, Gianluca] Mayo Clin, Dept Physiol & Biomed Engn, Div Gastroenterol, Enter Neurosci Program, Rochester, MN USA	Menarini Group; Mayo Clinic	Vannucchi, MG (corresponding author), Dept Expt & Clin Med, Histol & Embryol Res Unit, Florence, Italy.	mariagiuliana.vannucchi@unifi.it		Evangelista, Stefano/0000-0001-6025-2400	Menarini IFR grant	Menarini IFR grant(Menarini Group)	There were no financial, professional, or personal disclosures from any of the authors. This work was supported by a Menarini IFR grant. The funder was involved in the decision to publish the manuscript.	Boeckxstaens G, 2013, INT J COLORECTAL DIS, V28, P295, DOI 10.1007/s00384-012-1598-0; Cho WJ, 2005, AM J PHYSIOL-GASTR L, V288, pG571, DOI 10.1152/ajpgi.00222.2004; Cipriani G, 2011, J CELL MOL MED, V15, P2411, DOI 10.1111/j.1582-4934.2011.01333.x; Cipriani G, 2013, GASTROENTEROLOGY, V144, pS369; Clave P, 2011, ALIMENT PHARM THER, V34, P432, DOI 10.1111/j.1365-2036.2011.04730.x; Colasanti M, 2000, TRENDS PHARMACOL SCI, V21, P249, DOI 10.1016/S0165-6147(00)01499-1; Copray JCVM, 1996, J CHEM NEUROANAT, V11, P57, DOI 10.1016/0891-0618(96)00125-1; Evangelista S, 2004, CURR PHARM DESIGN, V10, P3561, DOI 10.2174/1381612043382972; Evangelista S, 2000, DRUG METAB DISPOS, V28, P643; Evangelista S, 2012, GASTROENT RES PRACT, V2012, DOI 10.1155/2012/936960; Faussone Pellegrini M S, 1984, Acta Anat (Basel), V120, P185; Faussone-Pellegrini MS, 1985, ARCH IT J ANAT EMBRI, V88, P25; FAUSSONEPELLEGRINI MS, 1990, CAN J PHYSIOL PHARM, V68, P1437, DOI 10.1139/y90-218; Gallego D, 2010, NEUROGASTROENT MOTIL, V22, pe180, DOI 10.1111/j.1365-2982.2010.01495.x; Huber A, 1998, AM J PHYSIOL-GASTR L, V275, pG1146, DOI 10.1152/ajpgi.1998.275.5.G1146; Martin MT, 2004, NEUROGASTROENT MOTIL, V16, P175, DOI 10.1111/j.1365-2982.2004.00518.x; Martinez-Cutillas M, 2013, NEUROGASTROENT MOTIL, V25, pE803, DOI 10.1111/nmo.12206; NARDUCCI F, 1986, DIGEST DIS SCI, V31, P241, DOI 10.1007/BF01318114; Santicioli P, 1999, N-S ARCH PHARMACOL, V359, P420, DOI 10.1007/PL00005370; Strege PR, 2004, NEUROGASTROENT MOTIL, V16, P167, DOI 10.1111/j.1365-2982.2004.00517.x; Sutton JA, 1997, EUR J CLIN PHARMACOL, V52, P365, DOI 10.1007/s002280050302; Teng BQ, 1998, AM J PHYSIOL-GASTR L, V275, pG342, DOI 10.1152/ajpgi.1998.275.2.G342; Traini C, 2013, NEUROGASTROENT MOTIL, V25, pE728, DOI 10.1111/nmo.12197; Triantafillidis JK, 2014, CLIN EXP GASTROENTER, V7, P75, DOI 10.2147/CEG.S46291; Vannucchi MG, 2002, NEUROSCI LETT, V326, P191, DOI 10.1016/S0304-3940(02)00338-5	25	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e103237	10.1371/journal.pone.0103237	http://dx.doi.org/10.1371/journal.pone.0103237			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122192	Green Published, gold, Green Submitted			2022-12-25	WOS:000341017000013
J	Wang, CL; Zhuang, Y; Guo, WW; Cao, LL; Zhang, H; Xu, LZ; Fan, YM; Zhang, DP; Wang, YP				Wang, Chunli; Zhuang, Yi; Guo, Wenwen; Cao, Lili; Zhang, Huan; Xu, Lizhi; Fan, Yimei; Zhang, Deping; Wang, Yaping			Mucin 5B Promoter Polymorphism Is Associated with Susceptibility to Interstitial Lung Diseases in Chinese Males	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; SYSTEMIC-SCLEROSIS; REVISED CRITERIA; EXPRESSION; MUC5B; GENE; CLASSIFICATION; PNEUMONIA; DERMATOMYOSITIS; POLYMYOSITIS	The variation of G>T in the MUC5B promoter (rs35705950) has been associated with idiopathic pulmonary fibrosis (IPF) and familial interstitial pneumonia (FIP) in Caucasians, but no information is available regarding this variant in the Chinese population. We recruited 405 patients with interstitial lung diseases (ILD), including 165 IPF patients and 2043 healthy controls, for genotyping the MUC5B gene in the Chinese population. One hundred three patients with pneumonia and 360 patients with autoimmune diseases (ADs) were recruited as disease controls. Our results indicated that the prevalence of the minor allele (T) of the polymorphism rs35705950 in healthy Chinese subjects was approximately 0.66%, which was lower than that described in the Caucasian population. The frequencies of the T allele were 3.33% and 2.22% in IPF and ILD patients, respectively, and these values were significantly higher than those of healthy controls (P = 0.001, OR = 4.332 for IPF, and P = 0.002, OR = 2.855 for ILD). A stratified analysis showed that this variant in MUC5B associated with the risk for ILD mainly in older male Chinese subjects. No difference was observed between patients with pneumonia, AD patients, and healthy controls.	[Wang, Chunli; Zhuang, Yi; Guo, Wenwen; Cao, Lili; Zhang, Huan; Xu, Lizhi; Fan, Yimei; Wang, Yaping] Nanjing Univ, Sch Med, Dept Med Genet, Nanjing 210008, Jiangsu, Peoples R China; [Zhuang, Yi; Zhang, Deping] Nanjing Univ, Sch Med, Jiangsu Key Lab Mol Med, Nanjing 210008, Jiangsu, Peoples R China; [Zhuang, Yi; Zhang, Deping] Nanjing Univ, Affiliated Drum Tower Hosp, Sch Med, Dept Respirol, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University; Nanjing University; Nanjing University	Wang, YP (corresponding author), Nanjing Univ, Sch Med, Dept Med Genet, Nanjing 210008, Jiangsu, Peoples R China.	wangyap@nju.edu.cn		Guo, Wenwen/0000-0001-8563-0359	National Natural Science Foundation of China [81270152, 81070273]; Open Foundation of the State Key Laboratory of Pharmaceutical Biotechnology [KF-GN-201201]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Foundation of the State Key Laboratory of Pharmaceutical Biotechnology	This work was partly supported by the National Natural Science Foundation of China (grant number: 81270152,81070273) and the Open Foundation of the State Key Laboratory of Pharmaceutical Biotechnology (grant number: KF-GN-201201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Thoracic Society, 2002, AM J RESP CRIT CARE, V165, P277, DOI DOI 10.1164/ajrccm.165.2.ats01; Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; BOHAN A, 1975, NEW ENGL J MED, V292, P344, DOI 10.1056/NEJM197502132920706; Borie R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070621; Chinese Society of Respiratory Diseases, 2004, 6 NAT RESP DIS AC M, V27, P857; Choi WI, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-172; Cui Y, 2014, MOL MED, V20, P120, DOI 10.2119/molmed.2013.00123; Devine MS, 2012, CLIN CHEST MED, V33, P95, DOI 10.1016/j.ccm.2011.11.001; Ding M, 2013, CELL BIOCHEM BIOPHYS, V67, P905, DOI 10.1007/s12013-013-9580-1; Ekstrom M, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004018; Ferri C, 2002, MEDICINE, V81, P139, DOI 10.1097/00005792-200203000-00004; Fingerlin TE, 2013, NAT GENET, V45, P613, DOI 10.1038/ng.2609; Gorini G, 2013, CANCER CAUSE CONTROL, V24, P1385, DOI 10.1007/s10552-013-0218-9; Gutsche M, 2012, CURR PULMONOL REP, V1, P224, DOI 10.1007/s13665-012-0028-7; Hermalin AI, 2012, POPUL RES POLICY REV, V31, P545, DOI 10.1007/s11113-012-9239-4; Hubbard R, 1998, AM J RESP CRIT CARE, V157, P743, DOI 10.1164/ajrccm.157.3.9701093; Hubbard R, 1996, LANCET, V347, P284, DOI 10.1016/S0140-6736(96)90465-1; Hutyrova B, 2002, AM J RESP CRIT CARE, V165, P148, DOI 10.1164/ajrccm.165.2.2106004; Kamio K, 2005, AM J RESP CRIT CARE, V171, P949, DOI 10.1164/rccm.200409-1168OC; Kim EA, 2002, RADIOGRAPHICS, V22, pS151, DOI 10.1148/radiographics.22.suppl_1.g02oc04s151; Kirkham S, 2008, AM J RESP CRIT CARE, V178, P1033, DOI 10.1164/rccm.200803-391OC; Lai CC, 2012, RESP MED, V106, P1566, DOI 10.1016/j.rmed.2012.07.012; Leikauf GD, 2002, CHEST, V121, p166S, DOI 10.1378/chest.121.5_suppl.166S; Ley Brett, 2013, Clin Epidemiol, V5, P483, DOI 10.2147/CLEP.S54815; Macneal Ken, 2012, Proc Am Thorac Soc, V9, P120, DOI 10.1513/pats.201112-055AW; Marie I, 2002, ARTHRIT RHEUM-ARTHR, V47, P614, DOI 10.1002/art.10794; Noth I, 2013, LANCET RESP MED, V1, P309, DOI 10.1016/S2213-2600(13)70045-6; O'Donnell RA, 2004, THORAX, V59, P1032, DOI 10.1136/thx.2004.028043; Park JH, 2007, AM J RESP CRIT CARE, V175, P705, DOI 10.1164/rccm.200607-912OC; Peljto AL, 2012, CHEST, V142, P1584, DOI 10.1378/chest.12-0110; Plantier L, 2011, THORAX, V66, P651, DOI 10.1136/thx.2010.151555; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Schwartz David A, 2008, Proc Am Thorac Soc, V5, P343, DOI 10.1513/pats.200710-158DR; Seibold MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058658; Seibold MA, 2011, NEW ENGL J MED, V364, P1503, DOI 10.1056/NEJMoa1013660; Sepper R, 2012, J LEUKOCYTE BIOL, V92, P319, DOI 10.1189/jlb.0111047; Solomon JJ, 2013, EUR RESPIR REV, V22, P6, DOI 10.1183/09059180.00005512; Son JY, 2013, LUNG, V191, P199, DOI 10.1007/s00408-012-9447-z; Stock CJ, 2013, THORAX, V68, P436, DOI 10.1136/thoraxjnl-2012-201786; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; THORNTON DJ, 1994, AM J RESP CRIT CARE, V150, P823, DOI 10.1164/ajrccm.150.3.8087358; Tsakiri KD, 2007, P NATL ACAD SCI USA, V104, P7552, DOI 10.1073/pnas.0701009104; Vitali C, 1996, ANN RHEUM DIS, V55, P116, DOI 10.1136/ard.55.2.116; World Health Organization (WHO), 2012, TOB CONTR PRACT; Zhang J, 2012, RESP MED, V106, P1456, DOI 10.1016/j.rmed.2012.06.015; Zhang X, 2012, CHINESE MED J-PEKING, V125, P1945, DOI 10.3760/cma.j.issn.0366-6999.2012.11.020; Zhang YZ, 2011, NEW ENGL J MED, V364, P1576, DOI 10.1056/NEJMc1013504	48	37	39	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104919	10.1371/journal.pone.0104919	http://dx.doi.org/10.1371/journal.pone.0104919			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121989	gold, Green Published, Green Submitted			2022-12-25	WOS:000341017000074
J	Lee, HK; Lee, DS; Park, SJ; Cho, KH; Bae, HS; Park, JC				Lee, Hye-Kyung; Lee, Dong-Seol; Park, Su-Jin; Cho, Kwang-Hee; Bae, Hyun-Sook; Park, Joo-Cheol			Nuclear Factor I-C (NFIC) Regulates Dentin Sialophosphoprotein (DSPP) and E-cadherin via Control of Kruppel-like Factor 4 (KLF4) During Dentinogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TOOTH ROOT DEVELOPMENT; MATRIX PROTEIN-1 DMP1; ODONTOBLAST DIFFERENTIATION; PULP CELLS; EXPRESSION; CANCER; ROLES; OVEREXPRESSION; ODONTOGENESIS	Odontoblasts are a type of terminally differentiated matrix-secreting cells. A number of molecular mechanisms are involved in the differentiation of odontoblasts. Several studies demonstrated that Kruppel-like factor 4 (KLF4) promotes odontoblast differentiation via control of dentin sialophosphoprotein (DSPP). Because nuclear factor I-C (NFIC) is also known to control DSPP, we investigated the relationship between NFIC and KLF4 during odontoblast differentiation. Klf4 mRNA expression was significantly decreased in Nfic(-/-) pulp cells compared with wild type cells. In immunohistochemistry assays, dentin matrix protein 1 (Dmp1), and DSP protein expression was barely observed in Nfic(-/-) odontoblasts and dentin matrix. Nfic bound directly to the Klf4 promoter and stimulated Klf4 transcriptional activity, thereby regulating Dmp1 and DSPP expression during odontoblast differentiation. Nfic or Klf4 overexpression promoted mineralized nodule formation in MDPC-23 cells. In addition, Nfic overexpression also decreased Slug luciferase activity but augmented E-cadherin promoter activity via up-regulation of Klf4 in odontoblasts. Our study reveals important signaling pathways during dentinogenesis: the Nfic-Klf4-Dmp1-Dspp and the Nfic-Klf4-E-cadherin pathways in odontoblasts. Our results indicate the important role of NFIC in regulating KLF4 during dentinogenesis.	[Lee, Hye-Kyung; Lee, Dong-Seol; Park, Su-Jin; Park, Joo-Cheol] Seoul Natl Univ, Sch Dent, Dept Oral Histol Dev Biol, Seoul 110749, South Korea; [Lee, Hye-Kyung; Lee, Dong-Seol; Park, Su-Jin; Park, Joo-Cheol] Seoul Natl Univ, Sch Dent, Dent Res Inst, Seoul 110749, South Korea; [Cho, Kwang-Hee; Bae, Hyun-Sook] Namseoul Univ, Dept Dent Hyg, Cheonan 331707, Chung Nam, South Korea	Seoul National University (SNU); Seoul National University (SNU); Namseoul University	Park, JC (corresponding author), Seoul Natl Univ, Sch Dent, Dept Oral Histol Dev Biol, 101 Daehagro, Seoul 110749, South Korea.	jcapark@snu.ac.kr	Park, Joo Cheol/D-6437-2012; Lee, Dong-Seol/GLN-3829-2022	Park, Joo Cheol/0000-0002-3162-7557; LEE, HYE KYUNG/0000-0002-7785-5942	National Research Foundation of Korea [NRF-2013R1A2A2A01010911, NRF-2013037491, NRF-2013M3A9B2076480]	National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by National Research Foundation of Korea Grants NRF-2013R1A2A2A01010911, NRF-2013037491, and NRF-2013M3A9B2076480.	Abe S, 2012, CELL BIOL INT, V36, P927, DOI 10.1042/CBI20110506; Arana-Chavez VE, 2004, INT J BIOCHEM CELL B, V36, P1367, DOI 10.1016/j.biocel.2004.01.006; AranaChavez VE, 1997, ANAT REC, V248, P332, DOI 10.1002/(SICI)1097-0185(199707)248:3<332::AID-AR5>3.0.CO;2-R; Bandyopadhyay S, 1998, J BIOL CHEM, V273, P392, DOI 10.1074/jbc.273.1.392; Chaudhry AZ, 1999, J BIOL CHEM, V274, P7072, DOI 10.1074/jbc.274.11.7072; Chaudhry AZ, 1998, J BIOL CHEM, V273, P18538, DOI 10.1074/jbc.273.29.18538; Chen Z, 2009, ARCH ORAL BIOL, V54, P403, DOI 10.1016/j.archoralbio.2009.02.003; Couble ML, 2000, CALCIFIED TISSUE INT, V66, P129, DOI 10.1007/PL00005833; del Barrio MG, 2002, DEVELOPMENT, V129, P1583; Diekwisch T, 1989, Acta Histochem Suppl, V37, P209; DSouza RN, 1997, J BONE MINER RES, V12, P2040, DOI 10.1359/jbmr.1997.12.12.2040; Evans PM, 2008, ACTA BIOCH BIOPH SIN, V40, P554, DOI 10.1111/j.1745-7270.2008.00439.x; Gibson MP, 2013, J BIOL CHEM, V288, P7204, DOI 10.1074/jbc.M112.445775; Gronostajski RM, 2000, GENE, V249, P31, DOI 10.1016/S0378-1119(00)00140-2; Gumireddy K, 2009, NAT CELL BIOL, V11, P1297, DOI 10.1038/ncb1974; Heymann R, 2002, AM J PATHOL, V160, P2123, DOI 10.1016/S0002-9440(10)61161-3; Hosoya A, 2006, J HISTOCHEM CYTOCHEM, V54, P1371, DOI 10.1369/jhc.6A6980.2006; Iida K, 2013, J DENT RES, V92, P905, DOI 10.1177/0022034513502204; Kwon A, 2012, J DENT RES, V91, P506, DOI 10.1177/0022034512443367; Lee DS, 2014, STEM CELLS, V32, P2467, DOI 10.1002/stem.1733; Lee DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029160; Lee DS, 2009, J BIOL CHEM, V284, P17293, DOI 10.1074/jbc.M109.009084; LESOT H, 1982, DIFFERENTIATION, V21, P133, DOI 10.1111/j.1432-0436.1982.tb01206.x; Lin H, 2013, J CELL PHYSIOL, V228, P2076, DOI 10.1002/jcp.24377; Lin H, 2011, J ENDODONT, V37, P948, DOI 10.1016/j.joen.2011.03.030; Liu H, 2013, J BIOL CHEM, V288, P9261, DOI 10.1074/jbc.M112.433730; Liu YN, 2012, MOL CELL BIOL, V32, P941, DOI 10.1128/MCB.06306-11; MINA M, 1987, ARCH ORAL BIOL, V32, P123, DOI 10.1016/0003-9969(87)90055-0; Narayanan K, 2001, P NATL ACAD SCI USA, V98, P4516, DOI 10.1073/pnas.081075198; Nilsson J, 2010, CANCER RES, V70, P2020, DOI 10.1158/0008-5472.CAN-09-1677; Oh HJ, 2012, J CELL BIOCHEM, V113, P877, DOI 10.1002/jcb.23421; Park JC, 2007, J PERIODONTOL, V78, P1795, DOI 10.1902/jop.2007.060363; Qin C, 2007, J DENT RES, V86, P1134, DOI 10.1177/154405910708601202; SLAVKIN HC, 1976, DEV BIOL, V50, P428, DOI 10.1016/0012-1606(76)90163-9; Steele-Perkins G, 2003, MOL CELL BIOL, V23, P1075, DOI 10.1128/MCB.23.3.1075-1084.2003; ten Cate JM, 1998, CARIES RES, V32, P141, DOI 10.1159/000016444; Tiwari N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057329; Wang X, 2011, ONCOGENE, V30, P1901, DOI 10.1038/onc.2010.563; Yori JL, 2010, J BIOL CHEM, V285, P16854, DOI 10.1074/jbc.M110.114546	39	30	33	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28225	28236		10.1074/jbc.M114.568691	http://dx.doi.org/10.1074/jbc.M114.568691			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25138274	Green Published, hybrid			2022-12-25	WOS:000343765400019
J	Brumshtein, B; Esswein, SR; Landau, M; Ryan, CM; Whitelegge, JP; Phillips, ML; Cascio, D; Sawaya, MR; Eisenberg, DS				Brumshtein, Boris; Esswein, Shannon R.; Landau, Meytal; Ryan, Christopher M.; Whitelegge, Julian P.; Phillips, Martin L.; Cascio, Duilio; Sawaya, Michael R.; Eisenberg, David S.			Formation of Amyloid Fibers by Monomeric Light Chain Variable Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amyloid; Antibody; Multiple Myeloma; Protein Aggregation; X-ray Crystallography; Bence-Jones Proteins; Light Chain Amyloidosis; Light Chain Variable Domains; Systemic Amyloidosis	BENCE-JONES PROTEIN; IN-VITRO; 3-DIMENSIONAL STRUCTURE; SYSTEMIC AMYLOIDOSES; MOLECULAR-STRUCTURE; FIBRIL FORMATION; DIMER INTERFACE; IMMUNOGLOBULIN; CRYSTAL; TRANSTHYRETIN	Background: Amyloid fibers are protein aggregates associated with numerous pathologies. Results: Mcg light chain variable domains form amyloid fibers through monomers. Conclusion: This light chain variable domain monomer is the fundamental unit required to form amyloid fibers. Significance: Understanding the molecular mechanism of Mcg light chain amyloid fiber formation has implications for treating systemic amyloidosis. Systemic light chain amyloidosis is a lethal disease characterized by excess immunoglobulin light chains and light chain fragments composed of variable domains, which aggregate into amyloid fibers. These fibers accumulate and damage organs. Some light chains induce formation of amyloid fibers, whereas others do not, making it unclear what distinguishes amyloid formers from non-formers. One mechanism by which sequence variation may reduce propensity to form amyloid fibers is by shifting the equilibrium toward an amyloid-resistant quaternary structure. Here we identify the monomeric form of the Mcg immunoglobulin light chain variable domain as the quaternary unit required for amyloid fiber assembly. Dimers of Mcg variable domains remain stable and soluble, yet become prone to assemble into amyloid fibers upon disassociation into monomers.	[Brumshtein, Boris; Esswein, Shannon R.; Landau, Meytal; Phillips, Martin L.; Cascio, Duilio; Sawaya, Michael R.; Eisenberg, David S.] UCLA, Howard Hughes Med Inst, Inst Genom & Prote, Dept Biol Chem,DOE, Los Angeles, CA 90095 USA; [Brumshtein, Boris; Esswein, Shannon R.; Landau, Meytal; Phillips, Martin L.; Cascio, Duilio; Sawaya, Michael R.; Eisenberg, David S.] UCLA, Howard Hughes Med Inst, Inst Genom & Prote, Dept Chem & Biochem,DOE, Los Angeles, CA 90095 USA; [Ryan, Christopher M.; Whitelegge, Julian P.] UCLA, David Geffen Sch Med, Pasarow Mass Spectrometry Lab, NPI,Semel Inst, Los Angeles, CA 90025 USA	Howard Hughes Medical Institute; United States Department of Energy (DOE); University of California System; University of California Los Angeles; Howard Hughes Medical Institute; United States Department of Energy (DOE); University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Eisenberg, DS (corresponding author), UCLA, Howard Hughes Med Inst, Inst Genom & Prote, Dept Biol Chem,DOE, Los Angeles, CA 90095 USA.	david@mbi.ucla.edu	Landau, Meytal/AAF-3479-2021; Landau, Meytal/J-3075-2012	Landau, Meytal/0000-0002-1743-3430; Landau, Meytal/0000-0002-1743-3430; Sawaya, Michael/0000-0003-0874-9043; Esswein, Shannon/0000-0002-5142-0190	National Institutes of Health [AG-029430]; National Science Foundation [MCB-0958111]; Amyloidosis Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS049134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RF1AG048120, R01AG029430, R01AG048120] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Amyloidosis Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG-029430 (to D. S. E.). This work was also supported by National Science Foundation Grant MCB-0958111.; Recipient of a fellowship from the Amyloidosis Foundation.	Baden EM, 2008, J BIOL CHEM, V283, P15853, DOI 10.1074/jbc.M705347200; Baden EM, 2009, CURR PROTEIN PEPT SC, V10, P500, DOI 10.2174/138920309789351949; Bennett MJ, 2006, STRUCTURE, V14, P811, DOI 10.1016/j.str.2006.03.011; BENNETT MJ, 1994, P NATL ACAD SCI USA, V91, P3127, DOI 10.1073/pnas.91.8.3127; BERNIER GM, 1963, NATURE, V200, P223, DOI 10.1038/200223b0; Blancas-Mejia LM, 2013, ANNU REV BIOCHEM, V82, P745, DOI 10.1146/annurev-biochem-072611-130030; Bodi K, 2009, AMYLOID, V16, P1, DOI 10.1080/13506120802676781; Booth DR, 1997, NATURE, V385, P787, DOI 10.1038/385787a0; Bourne PC, 2002, ACTA CRYSTALLOGR D, V58, P815, DOI 10.1107/S0907444902004183; BUXBAUM J, 1992, HEMATOL ONCOL CLIN N, V6, P323, DOI 10.1016/S0889-8588(18)30347-2; BUXBAUM J, 1986, J CLIN INVEST, V78, P798, DOI 10.1172/JCI112643; Cohn E. J., 1943, PROTEINS AMINO ACIDS, P370; COLMAN PM, 1977, J MOL BIOL, V116, P73, DOI 10.1016/0022-2836(77)90119-X; COLON W, 1992, BIOCHEMISTRY-US, V31, P8654, DOI 10.1021/bi00151a036; DAHLIN DC, 1950, AM J PATHOL, V26, P581; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Edmundson A B, 1969, ANL Rep, P283; EDMUNDSON AB, 1993, PROTEINS, V16, P246, DOI 10.1002/prot.340160304; EDMUNDSON AB, 1984, MOL IMMUNOL, V21, P561, DOI 10.1016/0161-5890(84)90041-5; EDMUNDSON AB, 1976, FED PROC, V35, P2119; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; ELY KR, 1989, J MOL BIOL, V210, P601, DOI 10.1016/0022-2836(89)90135-6; EPP O, 1975, BIOCHEMISTRY-US, V14, P4943, DOI 10.1021/bi00693a025; Falk RH, 1997, NEW ENGL J MED, V337, P898, DOI 10.1056/NEJM199709253371306; Fink AL, 1998, FOLD DES, V3, pR9, DOI 10.1016/S1359-0278(98)00002-9; FIRCA JR, 1978, BIOCHEMISTRY-US, V17, P148, DOI 10.1021/bi00594a022; GEDDES AJ, 1968, J MOL BIOL, V32, P343, DOI 10.1016/0022-2836(68)90014-4; GLENNER GG, 1970, BIOCHEM BIOPH RES CO, V41, P1287, DOI 10.1016/0006-291X(70)90227-5; GLENNER GG, 1973, BRIT J HAEMATOL, V24, P533, DOI 10.1111/j.1365-2141.1973.tb01679.x; GLENNER GG, 1971, SCIENCE, V174, P712, DOI 10.1126/science.174.4010.712; Guo ZF, 2006, P NATL ACAD SCI USA, V103, P8042, DOI 10.1073/pnas.0602607103; Hanson BL, 2002, J MOL RECOGNIT, V15, P297, DOI 10.1002/jmr.591; Hernandez-Santoyo A, 2010, J MOL BIOL, V396, P280, DOI 10.1016/j.jmb.2009.11.038; HOBBS JR, 1973, P ROY SOC MED, V66, P705, DOI 10.1177/003591577306600751; HURLE MR, 1994, P NATL ACAD SCI USA, V91, P5446, DOI 10.1073/pnas.91.12.5446; Jones H. B., 1848, PHILOS T R SOC LOND, V138, P55; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Khurana R, 2001, BIOCHEMISTRY-US, V40, P3525, DOI 10.1021/bi001782b; KISHIDA F, 1975, J BIOCHEM, V77, P481, DOI 10.1093/oxfordjournals.jbchem.a130749; Lai ZH, 1996, BIOCHEMISTRY-US, V35, P6470, DOI 10.1021/bi952501g; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lavatelli F, 2008, MOL CELL PROTEOMICS, V7, P1570, DOI 10.1074/mcp.M700545-MCP200; Lefranc MP, 1999, NUCLEIC ACIDS RES, V27, P209, DOI 10.1093/nar/27.1.209; Liu C, 2011, NAT STRUCT MOL BIOL, V18, P49, DOI 10.1038/nsmb.1948; Makino DL, 2007, ACTA CRYSTALLOGR D, V63, P780, DOI 10.1107/S0907444907021981; MARCHALONIS JJ, 1989, FASEB J, V3, P2469, DOI 10.1096/fasebj.3.13.2509274; Miroy GJ, 1996, P NATL ACAD SCI USA, V93, P15051, DOI 10.1073/pnas.93.26.15051; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Olsen KE, 1998, BIOCHEM BIOPH RES CO, V251, P642, DOI 10.1006/bbrc.1998.9508; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pace C N, 1986, Methods Enzymol, V131, P266; Peterson FC, 2010, STRUCTURE, V18, P563, DOI 10.1016/j.str.2010.02.012; Qin ZJ, 2007, BIOCHEMISTRY-US, V46, P3521, DOI 10.1021/bi061716v; RICHARDSON JS, 1977, NATURE, V268, P495, DOI 10.1038/268495a0; SAKANO H, 1979, NATURE, V280, P288, DOI 10.1038/280288a0; Sawaya MR, 1999, CELL, V99, P167, DOI 10.1016/S0092-8674(00)81648-7; Sipe JD, 2000, J STRUCT BIOL, V130, P88, DOI 10.1006/jsbi.2000.4221; STEVENS FJ, 1995, BIOCHEMISTRY-US, V34, P10697, DOI 10.1021/bi00034a001; STEVENS FJ, 1980, P NATL ACAD SCI-BIOL, V77, P1144, DOI 10.1073/pnas.77.2.1144; Terzyan SS, 2003, J MOL RECOGNIT, V16, P83, DOI 10.1002/jmr.610; Vrana JA, 2009, BLOOD, V114, P4957, DOI 10.1182/blood-2009-07-230722; Wall J, 1999, METHOD ENZYMOL, V309, P204	63	29	29	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27513	27525		10.1074/jbc.M114.585638	http://dx.doi.org/10.1074/jbc.M114.585638			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25138218	Green Published, hybrid			2022-12-25	WOS:000342852800014
J	Kim, Y; Kim, H; Park, H; Park, D; Lee, H; Lee, YS; Choe, J; Kim, YM; Jeoung, D				Kim, Youngmi; Kim, Hyuna; Park, Hyunmi; Park, Deokbum; Lee, Hansoo; Lee, Yun Sil; Choe, Jongseon; Kim, Young Myeong; Jeoung, Dooil			miR-326-Histone Deacetylase-3 Feedback Loop Regulates the Invasion and Tumorigenic and Angiogenic Response to Anti-cancer Drugs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Angiogenesis; Gene Expression; Histone Deacetylase 3 (HDAC3); MicroRNA (miRNA); Tumor Metastases; Anti-cancer Drug Resistance; Feedback Loop; miR-326	CANCER/TESTIS ANTIGEN CAGE; HISTONE DEACETYLASE; CELL-PROLIFERATION; COLORECTAL-CANCER; TUMOR-SUPPRESSOR; GENE-EXPRESSION; LUNG-CANCER; HDAC3; RESISTANCE; PACLITAXEL	Histone modification is known to be associated with multidrug resistance phenotypes. Cancer cell lines that are resistant or have been made resistant to anti-cancer drugs showed lower expression levels of histone deacetylase-3 (HDAC3), among the histone deacetylase(s), than cancer cell lines that were sensitive to anti-cancer drugs. Celastrol and Taxol decreased the expression of HDAC3 in cancer cell lines sensitive to anti-cancer drugs. HDAC3 negatively regulated the invasion, migration, and anchorage-independent growth of cancer cells. HDAC3 conferred sensitivity to anti-cancer drugs in vitro and in vivo. TargetScan analysis predicted miR-326 as a negative regulator of HDAC3. ChIP assays and luciferase assays showed a negative feedback loop between HDAC3 and miR-326. miR-326 decreased the apoptotic effect of anti-cancer drugs, and the miR-326 inhibitor increased the apoptotic effect of anti-cancer drugs. miR-326 enhanced the invasion and migration potential of cancer cells. The miR-326 inhibitor negatively regulated the tumorigenic, metastatic, and angiogenic potential of anti-cancer drug-resistant cancer cells. HDAC3 showed a positive feedback loop with miRNAs such as miR-200b, miR-217, and miR-335. miR-200b, miR-217, and miR-335 negatively regulated the expression of miR-326 and the invasion and migration potential of cancer cells while enhancing the apoptotic effect of anti-cancer drugs. TargetScan analysis predicted miR-200b and miR-217 as negative regulators of cancer-associated gene, a cancer/testis antigen, which is known to regulate the response to anti-cancer drugs. HDAC3 and miR-326 acted upstream of the cancer-associated gene. Thus, we show that the miR-326-HDAC3 feedback loop can be employed as a target for the development of anti-cancer therapeutics.	[Kim, Youngmi; Kim, Hyuna; Park, Hyunmi; Park, Deokbum; Jeoung, Dooil] Kangwon Natl Univ, Dept Biochem, Coll Nat Sci, Chunchon 200701, South Korea; [Lee, Hansoo] Kangwon Natl Univ, Dept Biol Sci, Coll Nat Sci, Chunchon 200701, South Korea; [Choe, Jongseon; Kim, Young Myeong] Kangwon Natl Univ, Grad Sch Med, Chunchon 200701, South Korea; [Lee, Yun Sil] Ewha Womans Univ, Coll Pharm, Seoul 120750, South Korea	Kangwon National University; Kangwon National University; Kangwon National University; Ewha Womans University	Jeoung, D (corresponding author), Kangwon Natl Univ, Dept Biochem, Coll Nat Sci, Chunchon 200701, South Korea.	jeoungd@kangwon.ac.kr	Lee, Yun-Sil/AAP-1378-2020	Lee, Yun-Sil/0000-0002-7538-8850	National Research Foundation from the BK21 Plus Program [2012H1B8A2025495, 2014R1A2A2A01002448, 2012R1A1A3009993]; National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea [1320160]	National Research Foundation from the BK21 Plus Program; National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea	This work was supported by National Research Foundation Grants 2012H1B8A2025495, 2014R1A2A2A01002448, and 2012R1A1A3009993, a grant from the BK21 Plus Program, and by National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea Grant 1320160.	Aghdassi A, 2012, GUT, V61, P439, DOI 10.1136/gutjnl-2011-300060; Bar N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010859; Bardai FH, 2011, J NEUROSCI, V31, P1746, DOI 10.1523/JNEUROSCI.5704-10.2011; Bitarte N, 2011, STEM CELLS, V29, P1661, DOI 10.1002/stem.741; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chae S, 2012, AM J PHYSIOL-GASTR L, V302, pG1016, DOI 10.1152/ajpgi.00449.2011; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Chen ZL, 2013, CELL SIGNAL, V25, P2693, DOI 10.1016/j.cellsig.2013.08.032; Cheng WW, 2012, FEBS J, V279, P2047, DOI 10.1111/j.1742-4658.2012.08589.x; El-Khoury V, 2007, BRIT J CANCER, V97, P562, DOI 10.1038/sj.bjc.6603914; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Hummel R, 2010, EUR J CANCER, V46, P298, DOI 10.1016/j.ejca.2009.10.027; Jin W, 2010, BREAST CANCER RES TR, V124, P39, DOI 10.1007/s10549-009-0683-8; Kannaiyan R, 2011, APOPTOSIS, V16, P1028, DOI 10.1007/s10495-011-0629-6; Kefas B, 2009, J NEUROSCI, V29, P15161, DOI 10.1523/JNEUROSCI.4966-09.2009; Kim HC, 2010, CELL MOL LIFE SCI, V67, P3499, DOI 10.1007/s00018-010-0388-5; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Kim Y, 2013, J BIOL CHEM, V288, P36502, DOI 10.1074/jbc.M113.502047; Kim Y, 2010, J BIOL CHEM, V285, P25957, DOI 10.1074/jbc.M109.095950; Li JW, 2000, EMBO J, V19, P4342, DOI 10.1093/emboj/19.16.4342; Li YG, 2013, CARCINOGENESIS, V34, P1601, DOI 10.1093/carcin/bgt065; Li YH, 2013, BLOOD, V121, P499, DOI 10.1182/blood-2012-07-444729; Liang ZX, 2010, BIOCHEM PHARMACOL, V79, P817, DOI 10.1016/j.bcp.2009.10.017; Liu CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051436; Liu ZX, 2013, J BIOL CHEM, V288, P4334, DOI 10.1074/jbc.M112.419168; Mahlknecht U, 2004, J IMMUNOL, V173, P3979, DOI 10.4049/jimmunol.173.6.3979; Mahlknecht U, 1999, GENOMICS, V56, P197, DOI 10.1006/geno.1998.5645; Noh JH, 2013, CANCER LETT, V335, P455, DOI 10.1016/j.canlet.2013.03.003; Ott PA, 2013, CANCER CHEMOTH PHARM, V71, P183, DOI 10.1007/s00280-012-1995-7; Park D, 2014, BMB REP, V47, P227, DOI 10.5483/BMBRep.2014.47.4.128; Por E, 2010, J BIOL CHEM, V285, P14475, DOI 10.1074/jbc.M109.084400; Sankar N, 2008, ONCOGENE, V27, P5717, DOI 10.1038/onc.2008.181; Scarola M, 2010, CANCER RES, V70, P6925, DOI 10.1158/0008-5472.CAN-10-0141; Scott GK, 2006, CANCER RES, V66, P1277, DOI 10.1158/0008-5472.CAN-05-3632; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Tan ZQ, 2014, MOL CELL BIOCHEM, V386, P223, DOI 10.1007/s11010-013-1860-y; To KKW, 2008, MOL CANCER RES, V6, P151, DOI 10.1158/1541-7786.MCR-07-0175; Uo T, 2009, J NEUROSCI, V29, P2824, DOI 10.1523/JNEUROSCI.6186-08.2009; Wang HQ, 2013, TUMOR BIOL, V34, P3101, DOI 10.1007/s13277-013-0878-9; Williams LV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083991; Xu R, 2011, CANCER LETT, V306, P151, DOI 10.1016/j.canlet.2011.02.042; Xu R, 2009, ANTICANCER RES, V29, P261; Yang HJ, 2006, CANCER RES, V66, P4758, DOI 10.1158/0008-5472.CAN-05-4529; Zhang JS, 2002, MOL CELL, V9, P611, DOI 10.1016/S1097-2765(02)00468-9; Zhang XN, 2011, MOL CELL, V41, P371, DOI 10.1016/j.molcel.2011.01.020; Zhang XW, 2012, CANCER CELL, V22, P506, DOI 10.1016/j.ccr.2012.09.003; Zhao JJ, 2010, BLOOD, V115, P2630, DOI 10.1182/blood-2009-09-243147; Zhao WG, 2010, CARCINOGENESIS, V31, P1726, DOI 10.1093/carcin/bgq160; Zhou JX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068469	49	34	34	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					28019	28039		10.1074/jbc.M114.578229	http://dx.doi.org/10.1074/jbc.M114.578229			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25138213	hybrid, Green Published			2022-12-25	WOS:000342852800054
J	Coelho, DS; Gaspar, CJ; Domingos, PM				Coelho, Dina S.; Gaspar, Catarina J.; Domingos, Pedro M.			Ire1 Mediated mRNA Splicing in a C-Terminus Deletion Mutant of Drosophila Xbp1	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; ER STRESS; RETINAL DEGENERATION; TRANSCRIPTION FACTOR; MAMMALIAN-CELLS; MECHANISM; NUCLEUS; PATHWAY; KINASE	The Unfolded Protein Response is a homeostatic mechanism that permits eukaryotic cells to cope with Endoplasmic Reticulum (ER) stress caused by excessive accumulation of misfolded proteins in the ER lumen. The more conserved branch of the UPR relies on an ER transmembrane enzyme, Ire1, which, upon ER stress, promotes the unconventional splicing of a small intron from the mRNA encoding the transcription factor Xbp1. In mammals, two specific regions (the hydrophobic region 2 - HR2 - and the C-terminal translational pausing site) present in the Xbp1(unspliced) protein mediate the recruitment of the Xbp1 mRNA-ribosome-nascent chain complex to the ER membrane, so that Xbp1 mRNA can be spliced by Ire1. Here, we generated a Drosophila Xbp1 deletion mutant (Excision101) lacking both HR2 and C-terminal region, but not the Ire1 splicing site. We show that Ire1-dependent splicing of Xbp1 mRNA is reduced, but not abolished in Excision101. Our results suggest the existence of additional mechanisms for ER membrane targeting of Xbp1 mRNA that are independent of the C-terminal domain of Drosophila Xbp1(unspliced).	[Coelho, Dina S.; Gaspar, Catarina J.; Domingos, Pedro M.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal	Universidade Nova de Lisboa	Domingos, PM (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal.	domingp@itqb.unl.pt	Domingos, Pedro/F-5557-2011	Domingos, Pedro/0000-0003-4523-5631; Gaspar, Catarina/0000-0002-5295-6165; Coelho, Dina/0000-0002-4929-8990	Fundacao para a Ciencia e a Tecnologia, Portugal [PEst-OE/EQB/LA0004/2011, PTDC/BIA-BCM/105217/2008, PTDC/SAU-OBD/104399/2008, FCT-ANR/NEU-NMC/0006/2013]; Marie Curie International Reintegration [PIRG03-GA-2008-230935]; Gulbenkian Foundation	Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology); Marie Curie International Reintegration(European Commission); Gulbenkian Foundation	This work was supported by Fundacao para a Ciencia e a Tecnologia, Portugal, through grants PEst-OE/EQB/LA0004/2011, PTDC/BIA-BCM/105217/2008, PTDC/SAU-OBD/104399/2008 and FCT-ANR/NEU-NMC/0006/2013, by a Marie Curie International Reintegration grant (PIRG03-GA-2008-230935). D. S. C. was supported by a doctoral fellowship from the Gulbenkian Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragon T, 2009, NATURE, V457, P736, DOI 10.1038/nature07641; BRAND AH, 1993, DEVELOPMENT, V118, P401; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Casas-Tinto S, 2011, HUM MOL GENET, V20, P2144, DOI 10.1093/hmg/ddr100; Coelho DS, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00076; Coelho DS, 2013, CELL REP, V5, P791, DOI 10.1016/j.celrep.2013.09.046; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Credle JJ, 2005, P NATL ACAD SCI USA, V102, P18773, DOI 10.1073/pnas.0509487102; Cross BCS, 2012, P NATL ACAD SCI USA, V109, pE869, DOI 10.1073/pnas.1115623109; Gaddam D, 2013, MOL BIOL CELL, V24, P14, DOI 10.1091/mbc.E12-06-0491; Gardner BM, 2011, SCIENCE, V333, P1891, DOI 10.1126/science.1209126; Griciuc A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001075; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Hollien J, 2013, BBA-MOL CELL RES, V1833, P2458, DOI 10.1016/j.bbamcr.2013.01.016; Hollien J, 2009, J CELL BIOL, V186, P323, DOI 10.1083/jcb.200903014; Kang MJ, 2009, P NATL ACAD SCI USA, V106, P17043, DOI 10.1073/pnas.0905566106; Kimmig P, 2012, ELIFE, V1, DOI 10.7554/eLife.00048; Lee AH, 2003, P NATL ACAD SCI USA, V100, P9946, DOI 10.1073/pnas.1334037100; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Liu CY, 2002, J BIOL CHEM, V277, P18346, DOI 10.1074/jbc.M112454200; Maurel M, 2014, TRENDS BIOCHEM SCI, V39, P245, DOI 10.1016/j.tibs.2014.02.008; Mendes CS, 2009, EMBO J, V28, P1296, DOI 10.1038/emboj.2009.76; Moore KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075723; Moore KA, 2012, ANNU REV GENET, V46, P165, DOI 10.1146/annurev-genet-110711-155644; Plongthongkum N, 2007, BIOCHEM BIOPH RES CO, V354, P789, DOI 10.1016/j.bbrc.2007.01.056; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Ryoo HD, 2007, CELL CYCLE, V6, P830, DOI 10.4161/cc.6.7.4064; Ryoo HD, 2007, EMBO J, V26, P242, DOI 10.1038/sj.emboj.7601477; Shamu CE, 1996, EMBO J, V15, P3028, DOI 10.1002/j.1460-2075.1996.tb00666.x; Shen XH, 2001, CELL, V107, P893, DOI 10.1016/S0092-8674(01)00612-2; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Sone M, 2013, CELL STRESS CHAPERON, V18, P307, DOI 10.1007/s12192-012-0383-x; Souid S, 2007, DEV GENES EVOL, V217, P159, DOI 10.1007/s00427-006-0124-1; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Yanagitani K, 2011, SCIENCE, V331, P586, DOI 10.1126/science.1197142; Yanagitani K, 2009, MOL CELL, V34, P191, DOI 10.1016/j.molcel.2009.02.033; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2006, J CELL BIOL, V172, P565, DOI 10.1083/jcb.200508145	40	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105588	10.1371/journal.pone.0105588	http://dx.doi.org/10.1371/journal.pone.0105588			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136861	Green Published, gold, Green Submitted			2022-12-25	WOS:000340742100110
J	Du, XY; Li, BZ; Liu, H; Yang, D; Yu, W; Liao, JK; Huang, ZC; Xia, KC				Du, Xiuyuan; Li, Baizhan; Liu, Hong; Yang, Dong; Yu, Wei; Liao, Jianke; Huang, Zhichao; Xia, Kechao			The Response of Human Thermal Sensation and Its Prediction to Temperature Step-Change (Cool-Neutral-Cool)	PLOS ONE			English	Article							COMFORT; PERCEPTION; ENVIRONMENTS	This paper reports on studies of the effect of temperature step-change (between a cool and a neutral environment) on human thermal sensation and skin temperature. Experiments with three temperature conditions were carried out in a climate chamber during the period in winter. Twelve subjects participated in the experiments simulating moving inside and outside of rooms or cabins with air conditioning. Skin temperatures and thermal sensation were recorded. Results showed overshoot and asymmetry of TSV due to the step-change. Skin temperature changed immediately when subjects entered a new environment. When moving into a neutral environment from cool, dynamic thermal sensation was in the thermal comfort zone and overshoot was not obvious. Air-conditioning in a transitional area should be considered to limit temperature difference to not more than 5 degrees C to decrease the unacceptability of temperature step-change. The linear relationship between thermal sensation and skin temperature or gradient of skin temperature does not apply in a step-change environment. There is a significant linear correlation between TSV and Q(loss) in the transient environment. Heat loss from the human skin surface can be used to predict dynamic thermal sensation instead of the heat transfer of the whole human body.	[Du, Xiuyuan; Li, Baizhan; Liu, Hong; Yang, Dong; Yu, Wei; Liao, Jianke; Huang, Zhichao; Xia, Kechao] Chongqing Univ, Key Lab Gorges Reservoir Reg Ecoenvironm 3, Minist Educ, Chongqing 630044, Peoples R China; [Du, Xiuyuan; Li, Baizhan; Liu, Hong; Yang, Dong; Yu, Wei; Liao, Jianke; Huang, Zhichao; Xia, Kechao] Chongqing Univ, Natl Ctr Int Res Low Carbon & Green Bldg, Chongqing 630044, Peoples R China	Chongqing University; Chongqing University	Li, BZ (corresponding author), Chongqing Univ, Key Lab Gorges Reservoir Reg Ecoenvironm 3, Minist Educ, Chongqing 630044, Peoples R China.	baizhanli@163.com	li, bz/GVR-7133-2022; li, bing/GWQ-9617-2022	Li, Baizhan/0000-0001-7526-1748	National Key Basic Research Program of China (The 973 Program) [2012CB720100]; National Key Technology R&D Program of China [2012BAJ02B00]; 111 Project [B13041]	National Key Basic Research Program of China (The 973 Program); National Key Technology R&D Program of China(National Key Technology R&D Program); 111 Project(Ministry of Education, China - 111 Project)	This research is supported by the National Key Basic Research Program of China (The 973 Program) (Grant No. 2012CB720100), the National Key Technology R&D Program of China (Grant No. 2012BAJ02B00) and the 111 Project (Grant No. B13041). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, WINDS P C AD CHANG N; [Anonymous], 2012, GBT507852012; [Anonymous], 2011, 552010 ASHRAE VENT A; Arens E, 2006, J THERM BIOL, V31, P60, DOI 10.1016/j.jtherbio.2005.11.027; BELL CR, 1971, BRIT J IND MED, V28, P259; CABANAC M, 1971, SCIENCE, V173, P1103, DOI 10.1126/science.173.4002.1103; Chen CP, 2011, BUILD ENVIRON, V46, P2387, DOI 10.1016/j.buildenv.2011.05.021; Choi J, 2010, BUILD ENVIRON, V45, P1529, DOI 10.1016/j.buildenv.2010.01.004; Chun C, 2005, BUILD ENVIRON, V40, P633, DOI 10.1016/j.buildenv.2004.08.001; Chun C, 2004, BUILD ENVIRON, V39, P1187, DOI 10.1016/j.buildenv.2004.02.003; Chun C, 2008, BUILD ENVIRON, V43, P877, DOI 10.1016/j.buildenv.2007.01.031; Chun CY, 1998, BUILD ENVIRON, V33, P151, DOI 10.1016/S0360-1323(97)00047-4; de Dear RJ, 2013, INDOOR AIR, V23, P442, DOI 10.1111/ina.12046; de Dear R.J., 1993, INDOOR AIR, V3, P181, DOI [10.1111/j.1600-0668.1993.t01-1-00004.x, DOI 10.1111/J.1600-0668.1993.T01-1-00004.X]; de Dear R, 2011, BUILD RES INF, V39, P108, DOI 10.1080/09613218.2011.552269; De dear RJ., 1994, ASHRAE T, V100, P457; Dedear R.J., 1985, ASHRAE T, V91, P452; Fanger PO., 1970, THERMAL COMFORT; Fiala D., 2003, ASHRAE T, P179, DOI 10.1590/S1517-838220080002000021; Gagge A.P., 2011, HEAT EXCHANGE HUMAN, P69, DOI [DOI 10.1002/CPHY.CP090105, 10.1002/cphy.cp090105]; GAGGE AP, 1967, ENVIRON RES, V1, P1, DOI 10.1016/0013-9351(67)90002-3; Hashiguchi N, 2010, EUR J APPL PHYSIOL, V109, P41, DOI 10.1007/s00421-009-1158-7; Humphreys MA, 2002, ENERG BUILDINGS, V34, P667, DOI 10.1016/S0378-7788(02)00018-X; IBM, 2012, IBMSPSS STAT 20 REL; Indraganti M, 2010, ENERG BUILDINGS, V42, P273, DOI 10.1016/j.enbuild.2009.09.003; ISO, 2005, 7730 ISO; Jin Q, 2011, BUILD ENVIRON, V51, P330; Jing SL, 2013, INDOOR BUILT ENVIRON, V22, P598, DOI 10.1177/1420326X12447614; Kaynakli O, 2003, INT COMMUN HEAT MASS, V30, P1179, DOI 10.1016/S0735-1933(03)00183-0; Kim J, 2013, BUILD ENVIRON, V70, P245, DOI 10.1016/j.buildenv.2013.08.022; Liu H, 2007, J CENT SOUTH UNIV T, V14, P43, DOI 10.1007/s11771-007-0362-z; Liu H, 2014, BUILD ENVIRON, V73, P232, DOI 10.1016/j.buildenv.2013.12.007; Ma XL, 2011, THESIS CHONGQING U; MOHURD, 2012, GB507362012 MOHURD; Nagano K, 2005, INT J BIOMETEOROL, V50, P33, DOI 10.1007/s00484-005-0265-3; Nakano J, 2006, WINDS P COMPF EN US; Nevins R.G., 1966, ASHRAE T, V72, P283; Ring J.W., 1991, INDOOR AIR, V1, P448, DOI [10.1111/j.1600-0668.1991.00009.x, DOI 10.1111/J.1600-0668.1991.00009.X, DOI 10.1111/INA.1991.1.ISSUE-4]; Schiller G.E., 1988, ASHRAE T, V94, P280; Zhang H, 2004, EUR J APPL PHYSIOL, V92, P728, DOI 10.1007/s00421-004-1137-y; Zhang H., 2003, THESIS U CALIFORNIA; Zhang H, 2013, THERMAL COMFORT STUD; Zhang YF, 2010, HEATING VENTILATING, V40, P26; Zhao RY, 2007, BUILD ENVIRON, V42, P3926, DOI 10.1016/j.buildenv.2006.06.030; Zhu Y.X., 2005, BUILT ENV	45	44	44	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e104320	10.1371/journal.pone.0104320	http://dx.doi.org/10.1371/journal.pone.0104320			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136808	Green Published, Green Submitted, gold			2022-12-25	WOS:000340742100027
J	Kanan, Y; Siefert, JC; Kinter, M; Al-Ubaidi, MR				Kanan, Yogita; Siefert, Joseph C.; Kinter, Michael; Al-Ubaidi, Muayyad R.			Complement Factor H, Vitronectin, and Opticin Are Tyrosine-Sulfated Proteins of the Retinal Pigment Epithelium	PLOS ONE			English	Article							MACULAR DEGENERATION; O-SULFATION; TYROSYLPROTEIN SULFOTRANSFERASE-2; P-SELECTIN; S-PROTEIN; BINDING; GENE; IDENTIFICATION; CELLS; SITE	Lack of tyrosine sulfation of ocular proteins results in disorganized photoreceptor structure and drastically reduced visual function, demonstrating the importance of this post-translational modification to vision. To understand the role that tyrosine sulfation plays in the function of ocular proteins, we identified some tyrosine-sulfated proteins in the retinal pigment epithelium using two independent methods, immuno-affinity column purification with an anti-sulfotyrosine specific antibody and computer-based sequence analysis of retinal pigment epithelium secretome by means of the prediction program Sulfinator. Radioactive labeling followed by thin layer electrophoresis revealed that three proteins, vitronectin, opticin, and complement factor H (CFH), were post-translationally modified by tyrosine sulfation. The identification of vitronectin and CFH as tyrosine-sulfated proteins is significant, since both are deposited in drusen in the eyes of patients with age-related macular degeneration (AMD). Furthermore, mutations in CFH have been determined to be a major risk factor in the development of AMD. Future studies that seek to understand the role of CFH in the development of AMD should take into account the role that tyrosine sulfation plays in the interaction of this protein with its partners, and examine whether modulating sulfation provides a potential therapeutic target.	[Kanan, Yogita; Siefert, Joseph C.; Al-Ubaidi, Muayyad R.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73106 USA; [Kinter, Michael] Univ Oklahoma, Hlth Sci Ctr, Dept Geriatr Med, Oklahoma City, OK USA; [Kinter, Michael] Oklahoma Med Res Fdn, Free Rad Biol & Aging Res Program, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Oklahoma Medical Research Foundation	Kanan, Y (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73106 USA.	ykanan@ouhsc.edu; muayyad-al-ubaidi@ouhsc.edu		Siefert, Joseph/0000-0001-5584-8672; Kinter, Michael/0000-0001-7409-8918	National Eye Institute; Oklahoma Center for the Advancement of Science and Technology; Foundation Fighting Blindness	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Oklahoma Center for the Advancement of Science and Technology; Foundation Fighting Blindness(European Commission)	This study was supported by the National Eye Institute to MRA, Oklahoma Center for the Advancement of Science and Technology to YK, and Foundation Fighting Blindness to MRA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of NIH or any of its institutes.	An E, 2006, J PROTEOME RES, V5, P2599, DOI 10.1021/pr060121j; Annunen S, 1999, AM J HUM GENET, V65, P974, DOI 10.1086/302585; BAEUERLE PA, 1988, J BIOL CHEM, V263, P14925; BAEUERLE PA, 1987, J CELL BIOL, V105, P2655, DOI 10.1083/jcb.105.6.2655; Bhattacharjee A, 2010, MOL IMMUNOL, V47, P1686, DOI 10.1016/j.molimm.2010.03.007; Boon CJE, 2008, AM J HUM GENET, V82, P516, DOI 10.1016/j.ajhg.2007.11.007; Borghei A, 2006, J BIOL CHEM, V281, P9423, DOI 10.1074/jbc.M513768200; Bradley DT, 2011, EYE, V25, P683, DOI 10.1038/eye.2011.37; BUDARF ML, 1982, J BIOL CHEM, V257, P128; Caraci F, 2008, NEUROCHEM RES, V33, P2401, DOI 10.1007/s11064-008-9710-0; Chen M, 2007, EXP EYE RES, V84, P635, DOI 10.1016/j.exer.2006.11.015; Choe H, 2009, METHOD ENZYMOL, V461, P147, DOI 10.1016/S0076-6879(09)05407-X; Choi Y, 2010, PROTEOMICS, V10, P72, DOI 10.1002/pmic.200900146; Costagliola S, 2002, EMBO J, V21, P504, DOI 10.1093/emboj/21.4.504; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; FARRELL DH, 1991, BIOCHEMISTRY-US, V30, P9414, DOI 10.1021/bi00103a004; Fenaille F, 2007, GLYCOBIOLOGY, V17, P932, DOI 10.1093/glycob/cwm060; Fernando AN, 2007, J MOL BIOL, V368, P564, DOI 10.1016/j.jmb.2007.02.038; Hageman GS, 1999, FASEB J, V13, P477, DOI 10.1096/fasebj.13.3.477; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; HINTNER H, 1991, J INVEST DERMATOL, V96, P747, DOI 10.1111/1523-1747.ep12470980; HIROSE S, 1988, J BIOL CHEM, V263, P7426; Hoffhines AJ, 2006, J BIOL CHEM, V281, P37877, DOI 10.1074/jbc.M609398200; Hoffhines AJ, 2009, J BIOL CHEM, V284, P3096, DOI 10.1074/jbc.M808434200; HORTIN G, 1986, J BIOL CHEM, V261, P1786; HORTIN G, 1986, J BIOL CHEM, V261, P5827; HUTTNER WB, 1984, METHOD ENZYMOL, V107, P200; HUTTNER WB, 1988, ANNU REV PHYSIOL, V50, P363, DOI 10.1146/annurev.ph.50.030188.002051; JENNE D, 1989, EUR J BIOCHEM, V185, P391, DOI 10.1111/j.1432-1033.1989.tb15127.x; Kanan Y., 2014, J BIOL CHEM IN PRESS; Kanan Y, 2012, ADV EXP MED BIOL, V723, P835, DOI 10.1007/978-1-4614-0631-0_107; Kanan Y, 2010, J NEUROCHEM, V113, P477, DOI 10.1111/j.1471-4159.2010.06609.x; Kanan Y, 2009, EXP EYE RES, V89, P559, DOI 10.1016/j.exer.2009.05.010; Karagianni N, 2010, ADV EXP MED BIOL, V703, P1, DOI 10.1007/978-1-4419-5635-4_1; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; KRAJEWSKI T, 1968, ACTA CHEM SCAND, V22, P1339, DOI 10.3891/acta.chem.scand.22-1339; Le Goff MM, 2012, J BIOL CHEM, V287, P28027, DOI 10.1074/jbc.M111.331157; Le Goff MM, 2012, INVEST OPHTH VIS SCI, V53, P228, DOI 10.1167/iovs.11-8514; Le Goff MM, 2003, J BIOL CHEM, V278, P45280, DOI 10.1074/jbc.M303117200; Liu ZJ, 2011, ACTA PHARMACOL SIN, V32, P1038, DOI 10.1038/aps.2011.53; Lueck K, 2011, EYE, V25, P1074, DOI 10.1038/eye.2011.109; Ma J, 2012, CYTOKINE, V59, P100, DOI 10.1016/j.cyto.2012.03.025; Monfort J, 2008, OSTEOARTHR CARTILAGE, V16, P749, DOI 10.1016/j.joca.2007.11.007; Monigatti F, 2002, BIOINFORMATICS, V18, P769, DOI 10.1093/bioinformatics/18.5.769; Moore KL, 2003, J BIOL CHEM, V278, P24243, DOI 10.1074/jbc.R300008200; MORRIS KM, 1982, J CLIN INVEST, V70, P906, DOI 10.1172/JCI110687; Morse E E, 1971, Ann Clin Lab Sci, V1, P155; Muthana SM, 2012, ACS CHEM BIOL, V7, P31, DOI 10.1021/cb2004466; Nicholas HB, 1999, ENDOCRINE, V11, P285, DOI 10.1385/ENDO:11:3:285; Nishimura Y, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001174; Okemefuna AI, 2008, J MOL BIOL, V375, P80, DOI 10.1016/j.jmb.2007.09.026; Okemefuna AI, 2010, J BIOL CHEM, V285, P1053, DOI 10.1074/jbc.M109.044529; Onnerfjord P, 2004, J BIOL CHEM, V279, P26, DOI 10.1074/jbc.M308689200; Ouyang YB, 2002, J BIOL CHEM, V277, P23781, DOI 10.1074/jbc.M202420200; Pauleikhoff D, 1992, Ophthalmologe, V89, P39; Pechtl IC, 2011, J BIOL CHEM, V286, P11082, DOI 10.1074/jbc.M110.211839; PEPPERBERG DR, 1993, MOL NEUROBIOL, V7, P61, DOI 10.1007/BF02780609; Perkins SJ, 2010, BIOCHEM SOC T, V38, P894, DOI 10.1042/BST0380894; PIERSCHBACHER MD, 1987, J BIOL CHEM, V262, P17294; PODACK ER, 1984, ACTA PATH MICRO IM C, V92, P89; POHL WR, 1991, AM REV RESPIR DIS, V143, P1369, DOI 10.1164/ajrccm/143.6.1369; Ramachandran V, 1999, P NATL ACAD SCI USA, V96, P13771, DOI 10.1073/pnas.96.24.13771; Ramesh S, 2004, BRIT J OPHTHALMOL, V88, P697, DOI 10.1136/bjo.2003.031989; Richards AJ, 1996, HUM MOL GENET, V5, P1339, DOI 10.1093/hmg/5.9.1339; Rodgers SD, 2001, BIOPHYS J, V81, P2001, DOI 10.1016/S0006-3495(01)75850-X; ROSE JK, 1988, ANNU REV CELL BIOL, V4, P257, DOI 10.1146/annurev.cellbio.4.1.257; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Sanders EJ, 2003, INVEST OPHTH VIS SCI, V44, P5404, DOI 10.1167/iovs.03-0500; Schmidt C, 2008, REV ECON POLIT, V118, P3; SCHWAEBLE W, 1987, EUR J IMMUNOL, V17, P1485, DOI 10.1002/eji.1830171015; Seger D, 2000, FEBS LETT, V480, P169, DOI 10.1016/S0014-5793(00)01917-7; Sherry DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039702; Sherry DM, 2010, EUR J NEUROSCI, V32, P1461, DOI 10.1111/j.1460-9568.2010.07431.x; Sparrow JR, 2012, MOL ASPECTS MED, V33, P436, DOI 10.1016/j.mam.2012.03.007; Stone MJ, 2009, NEW BIOTECHNOL, V25, P299, DOI 10.1016/j.nbt.2009.03.011; VOGEL BE, 1993, J CELL BIOL, V121, P461, DOI 10.1083/jcb.121.2.461; Wasmuth S, 2009, INVEST OPHTH VIS SCI, V50, P5304, DOI 10.1167/iovs.08-3326; Westmuckett AD, 2008, GEN COMP ENDOCR, V156, P145, DOI 10.1016/j.ygcen.2007.12.006; Wyatt MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068088; Yu YH, 2007, NAT METHODS, V4, P583, DOI 10.1038/NMETH1056; Zhu JZ, 2011, BIOCHEMISTRY-US, V50, P1524, DOI 10.1021/bi101240v	82	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105409	10.1371/journal.pone.0105409	http://dx.doi.org/10.1371/journal.pone.0105409			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136834	Green Submitted, Green Published, gold			2022-12-25	WOS:000340742100091
J	Rifat, M; Milton, AH; Hall, J; Oldmeadow, C; Islam, MA; Husain, A; Akhanda, MW; Siddiquea, BN				Rifat, Mahfuza; Milton, Abul Hasnat; Hall, John; Oldmeadow, Christopher; Islam, Md. Akramul; Husain, Ashaque; Akhanda, Md. Wahiduzzaman; Siddiquea, Bodrun Naher			Development of Multidrug Resistant Tuberculosis in Bangladesh: A Case-Control Study on Risk Factors	PLOS ONE			English	Article							DRUG-RESISTANCE; PREVALENCE; PAKISTAN	Objective: To determine the risk factors for developing multidrug resistant tuberculosis in Bangladesh. Methods: This case-control study was set in central, district and sub-district level hospitals of rural and urban Bangladesh. Included were 250 multidrug resistant tuberculosis (MDR-TB) patients as cases and 750 drug susceptible tuberculosis patients as controls. We recruited cases from all three government hospitals treating MDR-TB in Bangladesh during the study period. Controls were selected randomly from those local treatment units that had referred the cases. Information was collected through face-to-face interviews and record reviews. Unadjusted and multivariable logistic regression were used to analyse the data. Results: Previous treatment history was shown to be the major contributing factor to MDR-TB in univariate analysis. After adjusting for other factors in multivariable analysis, age group "18-25'' (OR 1.77, CI 1.07-2.93) and "26-45'' (OR 1.72, CI 1.12-2.66), some level of education (OR 1.94, CI 1.32-2.85), service and business as occupation (OR 2.88, CI 1.29-6.44; OR 3.71, CI 1.59-8.66, respectively), smoking history (OR 1.58, CI 0.99-2.5), and type 2 diabetes (OR 2.56 CI 1.51-4.34) were associated with MDR-TB. Previous treatment was not included in the multivariable analysis as it was correlated with multiple predictors. Conclusion: Previous tuberculosis treatment was found to be the major risk factor for MDR-TB. This study also identified age 18 to 45 years, some education up to secondary level, service and business as occupation, past smoking status, and type 2 diabetes as comorbid illness as risk factors. National Tuberculosis programme should address these risk factors in MDR-TB control strategy. The integration of MDR-TB control activities with diabetes and tobacco control programmes is needed in Bangladesh.	[Rifat, Mahfuza; Milton, Abul Hasnat; Hall, John; Oldmeadow, Christopher] Univ Newcastle, Newcastle, NSW 2300, Australia; [Rifat, Mahfuza; Islam, Md. Akramul; Siddiquea, Bodrun Naher] BRAC, Dhaka, Bangladesh; [Husain, Ashaque] Directorate Gen Hlth Serv, Natl TB Control Programme, Dhaka, Bangladesh; [Akhanda, Md. Wahiduzzaman] Natl Inst Dis Chest & Hosp, Dhaka, Bangladesh	University of Newcastle; Bangladesh Rural Advancement Committee BRAC	Rifat, M (corresponding author), Univ Newcastle, Newcastle, NSW 2300, Australia.	mahfuza.rifat@uon.edu.au		Hall, John/0000-0001-9839-5626; Oldmeadow, Christopher/0000-0001-6104-1322; Atun, Rifat/0000-0002-1531-5983	Australian Respiratory Council; University of Newcastle, Australia; BRAC Bangladesh	Australian Respiratory Council; University of Newcastle, Australia; BRAC Bangladesh	This research was supported by the Australian Respiratory Council, the University of Newcastle, Australia, and BRAC Bangladesh. The funders had no role in study design, data collection and analysis or decision to publish or preparation of manuscript.	Andrews JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015735; [Anonymous], 2008, 4 WHO; [Anonymous], 2012, ANN REPORT; [Anonymous], 2013, UNAIDS REP GLOB AIDS; Bhowmik B, 2013, DIABETES METAB J, V37, P46, DOI 10.4093/dmj.2013.37.1.46; Brewer TF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025861; Caminero JA, 2010, INT J TUBERC LUNG D, V14, P382; Casal M, 2005, MICROB DRUG RESIST, V11, P62, DOI 10.1089/mdr.2005.11.62; Diande S, 2009, MICROB DRUG RESIST, V15, P217, DOI 10.1089/mdr.2009.0906; Dooley KE, 2009, LANCET INFECT DIS, V9, P737, DOI 10.1016/S1473-3099(09)70282-8; Ejaz M, 2010, T ROY SOC TROP MED H, V104, P511, DOI 10.1016/j.trstmh.2010.03.005; Espinal MA, 2001, INT J TUBERC LUNG D, V5, P887; Farmer P, 2001, INT J TUBERC LUNG D, V5, P885; Faustini A, 2006, THORAX, V61, P158, DOI 10.1136/thx.2005.045963; Fisher-Hoch SP, 2008, SCAND J INFECT DIS, V40, P888, DOI 10.1080/00365540802342372; Flora M S, 2013, Bangladesh Med Res Counc Bull, V39, P34; Government of India, 2018, GUIDELINES CLIN OPER; Kim HR, 2011, J HOSP INFECT, V77, P134, DOI 10.1016/j.jhin.2010.07.004; Law WS, 2008, INT J TUBERC LUNG D, V12, P1065; Lomtadze N, 2009, INT J TUBERC LUNG D, V13, P68; Magee MJ, 2013, INT J INFECT DIS, V17, pE404, DOI 10.1016/j.ijid.2012.12.029; National Institute of Population Research and Training (NIPORT) Mitra and Associates ICF International, 2012, BANGL DEM HLTH SURV; National TB Control Programme DGoHS Bangladesh, 2012, OP MAN MAN MULT TB M; National TB Control Programme DGoHS Bangladesh, 2013, 1 BANGL NAT TUB DRUG; Qazi F, 2011, INT J TUBERC LUNG D, V15, P1556, DOI 10.5588/ijtld.10.0679; Sharma SK, 2003, INFECT GENET EVOL, V3, P183, DOI 10.1016/S1567-1348(03)00086-8; Shen X, 2009, INT J TUBERC LUNG D, V13, P253; Siddiquea BN, 2013, PUBLIC HEALTH ACTION, V3, P243, DOI 10.5588/pha.13.0051; Suarez-Garcia I, 2009, EUR J CLIN MICROBIOL, V28, P325, DOI 10.1007/s10096-008-0627-y; Suchindran S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005561; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; World Health Organization, 2007, WHO UN MON TB TOB CO; World Health Organization, 2011, GLOB PLAN STOP TB TR; World Health Organization, 2011, WHO PROGRESS REPORT; World Health Organization International Union against Tuberculosis and Lung Disease, 2011, COLL FRAM CAR CONTR; Zaman K, 2005, SCAND J INFECT DIS, V37, P21, DOI 10.1080/00365540410026095	36	41	46	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105214	10.1371/journal.pone.0105214	http://dx.doi.org/10.1371/journal.pone.0105214			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136966	Green Published, Green Submitted, gold			2022-12-25	WOS:000340742100075
J	Sharma, M; Wilton, J; Senn, H; Fowler, S; Tan, DHS				Sharma, Malika; Wilton, James; Senn, Heather; Fowler, Shawn; Tan, Darrell H. S.			Preparing for PrEP: Perceptions and Readiness of Canadian Physicians for the Implementation of HIV Pre-Exposure Prophylaxis	PLOS ONE			English	Article							ANTIRETROVIRAL PROPHYLAXIS; COST-EFFECTIVENESS; LIMITED KNOWLEDGE; PREVENTION; INFECTION; MEN; PROVIDERS; ATTITUDES; SEX; WILLINGNESS	Recent evidence has demonstrated the efficacy of pre-exposure prophylaxis (PrEP) for HIV prevention, but concerns persist around its use. Little is known about Canadian physicians' knowledge of and willingness to prescribe PrEP. We disseminated an online survey to Canadian family, infectious disease, internal medicine, and public health physicians between September 2012-June 2013 to determine willingness to prescribe PrEP. Criteria for analysis were met by 86 surveys. 45.9% of participants felt "very familiar" with PrEP, 49.4% felt that PrEP should be approved by Health Canada, and 45.4% of respondents were willing to prescribe PrEP. Self-identifying as an HIV expert (odds ratio, OR=4.1, 95% confidence interval, CI=1.6-10.2), familiarity with PrEP (OR=5.0, 95%CI=1.3-19.0) and having been asked by patients about PrEP (OR=4.0, 95%CI=1.5-10.5) were positively associated with willingness to prescribe PrEP on univariable analysis. The latter two were the strongest predictors on multivariate analysis. Participants cited cost and efficacy as major concerns. 75.3% did not feel that information had been adequately disseminated among physicians. In summary, Canadian physicians demonstrate varying levels of support for PrEP and express concerns about its implementation. Further research on real-world effectiveness, continuing medical education, and clinical support is needed to prepare physicians for this prevention strategy.	[Sharma, Malika; Tan, Darrell H. S.] Univ Toronto, Div Infect Dis, Toronto, ON, Canada; [Wilton, James] Canadian AIDS Treatment Informat Exchange, Toronto, ON, Canada; [Senn, Heather; Tan, Darrell H. S.] Univ Toronto, Fac Med, Toronto, ON, Canada; [Fowler, Shawn; Tan, Darrell H. S.] Hassle Free Clin, Toronto, ON, Canada; [Tan, Darrell H. S.] St Michaels Hosp, Div Infect Dis, Toronto, ON M5B 1W8, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Tan, DHS (corresponding author), Univ Toronto, Div Infect Dis, 100 Coll St, Toronto, ON, Canada.	darrell.tan@gmail.com		Wilton, James/0000-0002-2295-7511; Sharma, Malika/0000-0002-3729-4554	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	DHST is supported by a Randomized Controlled Trials Mentoring Grant from the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson PL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004006; [Anonymous], 2013, AV INT PROPH PREEXP; Arnold EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040603; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Baeten JM, 2013, JAIDS-J ACQ IMM DEF, V63, pS122, DOI 10.1097/QAI.0b013e3182986f69; Barash EA, 2010, AIDS PATIENT CARE ST, V24, P689, DOI 10.1089/apc.2010.0173; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Cohen SE, 2014, TOP ANTIVIR MED, V22, P500; Eisingerich AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028238; Feinberg J, 2012, ANN INTERN MED, V157, P521, DOI 10.7326/0003-4819-157-7-201210020-00513; Golub SA, 2010, JAIDS-J ACQ IMM DEF, V54, P548, DOI 10.1097/QAI.0b013e3181e19a54; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Guest G, 2008, SEX TRANSM DIS, V35, P1002, DOI 10.1097/OLQ.0b013e3181812939; Hurt CB, 2011, CLIN INFECT DIS, V53, P1265, DOI 10.1093/cid/cir684; Karris MY, 2014, CLIN INFECT DIS, V58, P704, DOI 10.1093/cid/cit796; Koppenhaver RT, 2011, JAIDS-J ACQ IMM DEF, V58, pE51, DOI 10.1097/QAI.0b013e31822b74fe; Krakower D, 2012, ANN INTERN MED, V157, P490, DOI 10.7326/0003-4819-157-7-201210020-00510; Leonardi M, 2011, INT J STD AIDS, V22, P738, DOI 10.1258/ijsa.2011.011057; Liu A, 2013, 8 INT C HIV TREATM P; Liu AY, 2008, JAIDS-J ACQ IMM DEF, V47, P241, DOI 10.1097/QAI.0b013e31815e4041; Mayer KH, 2014, TOP ANTIVIR MED, V22, P499; Mimiaga MJ, 2009, JAIDS-J ACQ IMM DEF, V50, P77, DOI 10.1097/QAI.0b013e31818d5a27; Nair G, 2013, 20 C RETR OPP INF; Puro V, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-217; Senn H, 2013, AIDS RES HUM RETROV, V29, P1183, DOI [10.1089/aid.2013.0090, 10.1089/AID.2013.0090]; Smith D. K., 2011, Morbidity and Mortality Weekly Report, V60, P65; Smith D. K., 2012, Morbidity and Mortality Weekly Report, V61, P586; Supervie V, 2010, P NATL ACAD SCI USA, V107, P12381, DOI 10.1073/pnas.1006061107; Tellalian D, 2013, AIDS PATIENT CARE ST, V27, P553, DOI 10.1089/apc.2013.0173; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Tripathi A, 2012, SOUTH MED J, V105, P199, DOI 10.1097/SMJ.0b013e31824f1a1b; Underhill K, 2010, JAIDS-J ACQ IMM DEF, V55, P8, DOI 10.1097/QAI.0b013e3181e8efe4; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; van der Straten A, 2012, AIDS, V26, pF13, DOI 10.1097/QAD.0b013e3283522272; Walensky RP, 2012, CLIN INFECT DIS, V54, P1504, DOI 10.1093/cid/cis225; White JM, 2012, AIDS PATIENT CARE ST, V26, P395, DOI 10.1089/apc.2012.0030; Wood LV, 2012, ANN INTERN MED, V157, P519, DOI 10.7326/0003-4819-157-7-201210020-00511; Yoong DM, 2013, PREPARING PREP ASSES	38	44	44	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105283	10.1371/journal.pone.0105283	http://dx.doi.org/10.1371/journal.pone.0105283			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133648	gold, Green Submitted, Green Published			2022-12-25	WOS:000341302700098
J	Chung, CJ; Chang, CH; Liu, CS; Huang, CP; Chang, YH; Chien, SN; Tsai, PH; Hsieh, HA				Chung, Chi-Jung; Chang, Chao-Hsiang; Liu, Chiu-Shong; Huang, Chi-Ping; Chang, Yi-Huei; Chien, Ssu-Ning; Tsai, Ping-Huan; Hsieh, Hui-An			Association of DNA Methyltransferases 3A and 3B Polymorphisms, and Plasma Folate Levels with the Risk of Urothelial Carcinoma	PLOS ONE			English	Article							DNMT3B PROMOTER POLYMORPHISMS; CANCER RISK; COLORECTAL-CANCER; BLADDER-CANCER; GASTRIC-CANCER; BREAST-CANCER; SERUM FOLATE; COLON-CANCER; POPULATION; METHYLATION	Background: Interindividual genetic variations of human DNA methyltransferases (DNMTs), which involve the methyl donor from the folate-related one-carbon metabolism pathway, are hypothesized as a risk factor for urothelial carcinoma (UC). Therefore, we evaluated the role of gene-environment interaction in UC carcinogenesis. Methods: A hospital-based case-control study was conducted by recruiting 192 patients with UC and 381 controls. Their plasma folate levels were measured using a competitive immunoassay kit. In addition, DNMT3A -448A>G and DNMT3B - -579G>T genotyping was evaluated using a polymerase chain reaction-restriction fragment length polymorphism technique. Multivariate logistic regression and 95% confidence intervals (CIs) were applied to estimate the UC risk. Results: We observed that patients with UC exhibited a higher prevalence rate of folate insufficiency (folate levels <= 6 ng/mL) compared with the controls (35.94% and 18.37%, respectively). Furthermore, folate levels were higher in the prevalent UC patients than in the incident UC patients. However, folate insufficiency was similarly associated with a nearly two-fold increase in the risk of UC regardless of the UC patient group. In addition, the frequencies of the variant alleles for DNMT3A and DNMT3B were 0.80 and 0.92, respectively, and no association was observed with UC risk. However, participants with a variant homozygous genotype of DNMT3B -579G>T and folate insufficiency or with high cumulative cigarette smoking exhibited an increased risk of UC. Conclusion: Overall, environmental factors may contribute more significantly to UC carcinogenesis compared with genetic susceptibility. Future studies should investigate other polymorphisms of DNMT3A and DNMT3B to determine genetic susceptibility.	[Chung, Chi-Jung; Chien, Ssu-Ning; Tsai, Ping-Huan; Hsieh, Hui-An] China Med Univ, Coll Publ Hlth, Dept Hlth Risk Management, Taichung, Taiwan; [Chung, Chi-Jung] China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Chang, Chao-Hsiang; Huang, Chi-Ping; Chang, Yi-Huei] China Med Univ & Hosp, Dept Urol, Taichung, Taiwan; [Chang, Chao-Hsiang; Liu, Chiu-Shong] China Med Univ & Hosp, Coll Med, Dept Med, Taichung, Taiwan; [Liu, Chiu-Shong] China Med Univ, Dept Family Med, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan	Chung, CJ (corresponding author), China Med Univ, Coll Publ Hlth, Dept Hlth Risk Management, Taichung, Taiwan.	cjchung@mail.cmu.edu.tw	Chung, Chi-Jung/G-4755-2013		National Science Council of the ROC [NSC 100-2314-B-039-035, NSC 101-2314-B-039-025-MY3]; China Medical University Hospital [DMR-CS-001-100, DMR-100-163]; China Medical University [CMU101-N1-02]	National Science Council of the ROC(Ministry of Science and Technology, Taiwan); China Medical University Hospital; China Medical University(China Medical University)	This study was supported by grants from the National Science Council of the ROC (NSC 100-2314-B-039-035 and NSC 101-2314-B-039-025-MY3), the China Medical University Hospital (DMR-CS-001-100 and DMR-100-163), and China Medical University (CMU101-N1-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao XY, 2013, ASIAN PAC J CANCER P, V14, P5713, DOI 10.7314/APJCP.2013.14.10.5713; Chang KP, 2008, ONCOL REP, V19, P217; Chen KJ, 2011, ASIA PAC J CLIN NUTR, V20, P275; Chung CJ, 2011, SCI TOTAL ENVIRON, V409, P1638, DOI 10.1016/j.scitotenv.2011.01.046; Chung CJ, 2010, CANCER CAUSE CONTROL, V21, P1605, DOI 10.1007/s10552-010-9589-3; Coppede F, 2013, HUM REPROD, V28, P545, DOI 10.1093/humrep/des376; Coppede F, 2012, CURR ALZHEIMER RES, V9, P550, DOI 10.2174/156720512800618062; Daraei A, 2011, J RES MED SCI, V16, P807; de Vogel S, 2013, INT J EPIDEMIOL, V42, P201, DOI 10.1093/ije/dys199; Di YP, 2012, J BIOL CHEM, V287, P27948, DOI 10.1074/jbc.M111.334375; Duncan TM, 2013, NUTRIENTS, V5, P2457, DOI 10.3390/nu5072457; Duthie SJ, 2002, J NUTR, V132, p2444S, DOI 10.1093/jn/132.8.2444S; Ericson U, 2010, J NUTR, V140, P1661, DOI 10.3945/jn.110.124313; Eussen SJPM, 2010, CANCER EPIDEM BIOMAR, V19, P1328, DOI 10.1158/1055-9965.EPI-09-0841; Fan H, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-12; Fuchs CS, 2002, CANCER EPIDEM BIOMAR, V11, P227; Gonzalo S, 2006, NAT CELL BIOL, V8, P416, DOI 10.1038/ncb1386; GORROD JW, 1974, JNCI-J NATL CANCER I, V52, P1421, DOI 10.1093/jnci/52.5.1421; He H, 2013, INT J FOOD SCI NUTR; Jin BL, 2013, ADV EXP MED BIOL, V754, P3, DOI 10.1007/978-1-4419-9967-2_1; Johansson SL, 1997, SEMIN SURG ONCOL, V13, P291; Khorshied MM, 2012, GENE, V511, P34, DOI 10.1016/j.gene.2012.09.024; Kile ML, 2008, NUTR REV, V66, P349, DOI 10.1111/j.1753-4887.2008.00043.x; Kim YI, 2005, J NUTR, V135, P2703, DOI 10.1093/jn/135.11.2703; Larsson SC, 2006, CANCER EPIDEM BIOMAR, V15, P1409, DOI 10.1158/1055-9965.EPI-05-0830; Mercer BA, 2009, AM J RESP CELL MOL, V40, P4, DOI 10.1165/rcmb.2007-0310OC; Mostowska A, 2013, MOL BIOL REP, V40, P4893, DOI 10.1007/s11033-013-2589-0; Nazki FH, 2014, GENE, V533, P11, DOI 10.1016/j.gene.2013.09.063; Obeid R, 2013, NUTRIENTS, V5, P3481, DOI 10.3390/nu5093481; Ohnishi S, 2002, JPN J CANCER RES, V93, P736, DOI 10.1111/j.1349-7006.2002.tb01314.x; Pufulete M, 2005, BRIT J CANCER, V92, P838, DOI 10.1038/sj.bjc.6602439; Robertson KD, 2001, ONCOGENE, V20, P3139, DOI 10.1038/sj.onc.1204341; Saad AA, 2006, CANCER EPIDEM BIOMAR, V15, P740, DOI 10.1158/1055-9965.EPI-05-0813; Satta R, 2008, P NATL ACAD SCI USA, V105, P16356, DOI 10.1073/pnas.0808699105; Strope SA, 2008, J UROLOGY, V180, P31, DOI 10.1016/j.juro.2008.03.045; Sun MY, 2012, GENET MOL RES, V11, P4330, DOI 10.4238/2012.September.26.1; Szczepanska M, 2013, EUR J OBSTET GYN R B, V166, P81, DOI 10.1016/j.ejogrb.2012.09.003; Tan W, 2005, CARCINOGENESIS, V26, P1430, DOI 10.1093/carcin/bgi090; Xu F, 2010, CURR MED CHEM, V17, P4052, DOI 10.2174/092986710793205372; Yang XX, 2012, INT J MOL SCI, V13, P8364, DOI 10.3390/ijms13078364; Zhang SL, 2009, J HUAZHONG U SCI-MED, V29, P215, DOI 10.1007/s11596-009-0216-z; Zheng Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074626	42	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104968	10.1371/journal.pone.0104968	http://dx.doi.org/10.1371/journal.pone.0104968			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126948	Green Published, Green Submitted, gold			2022-12-25	WOS:000340879300065
J	Diaz, A; Zarouri, B; Fergany, M; Eduardo, I; Alvarez, JM; Pico, B; Monforte, AJ				Diaz, Aurora; Zarouri, Belkacem; Fergany, Mohamed; Eduardo, Iban; Alvarez, Jose M.; Pico, Belen; Monforte, Antonio J.			Mapping and Introgression of QTL Involved in Fruit Shape Transgressive Segregation into 'Piel de Sapo' Melon (Cucucumis melo L.)	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCUS; CUCUMIS-SATIVUS L.; RECOMBINANT INBRED LINES; TOMATO SUGAR CONTENT; NEAR-ISOGENIC LINES; FLOWERING-TIME; PHOTOPERIOD SENSITIVITY; ETHYLENE BIOSYNTHESIS; GENOMIC LIBRARY; GENETIC-CONTROL	A mapping F-2 population from the cross 'Piel de Sapo' x PI124112 was selectively genotyped to study the genetic control of morphological fruit traits by QTL (Quantitative Trait Loci) analysis. Ten QTL were identified, five for FL (Fruit Length), two for FD (Fruit Diameter) and three for FS (Fruit Shape). At least one robust QTL per character was found, flqs8.1 (LOD = 16.85, R-2 = 34%), fdqs12.1 (LOD = 3.47, R-2 = 11%) and fsqs8.1 (LOD = 14.85, R-2 = 41%). flqs2.1 and fsqs2.1 cosegregate with gene a (andromonoecious), responsible for flower sex determination and with pleiotropic effects on FS. They display a positive additive effect (a) value, so the PI124112 allele causes an increase in FL and FS, producing more elongated fruits. Conversely, the negative a value for flqs8.1 and fsqs8.1 indicates a decrease in FL and FS, what results in rounder fruits, even if PI124112 produces very elongated melons. This is explained by a significant epistatic interaction between fsqs2.1 and fsqs8.1, where the effects of the alleles at locus a are attenuated by the additive PI124112 allele at fsqs8.1. Roundest fruits are produced by homozygous for PI124112 at fsqs8.1 that do not carry any dominant A allele at locus a (PiPiaa). A significant interaction between fsqs8.1 and fsqs12.1 was also detected, with the alleles at fsqs12.1 producing more elongated fruits. fsqs8.1 seems to be allelic to QTL discovered in other populations where the exotic alleles produce elongated fruits. This model has been validated in assays with backcross lines along 3 years and ultimately obtaining a fsqs8.1-NIL (Near Isogenic Line) in 'Piel de Sapo' background which yields round melons.	[Diaz, Aurora; Monforte, Antonio J.] Univ Politecn Valencia, Inst Biol Mol & Celular Plantas, CSIC, E-46071 Valencia, Spain; [Zarouri, Belkacem] Inst Madrileno Invest & Desarrollo Rural Agr & Al, Dept Invest Agroalimentaria, Mol Biol Lab, Madrid, Spain; [Fergany, Mohamed; Eduardo, Iban] IRTA CSIC UAB, Ctr Recerca Agrigenom CRAG, Barcelona, Spain; [Alvarez, Jose M.] Ctr Invest & Tecnol Agroalimentaria Aragon CITA, Zaragoza, Spain; [Pico, Belen] Univ Politecn Valencia, Inst Conservat & Breeding Agr Biodivers, COMAV UPV, E-46071 Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP); Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); IRTA; University of Barcelona; Universitat Politecnica de Valencia	Diaz, A (corresponding author), Univ Politecn Valencia, Inst Biol Mol & Celular Plantas, CSIC, E-46071 Valencia, Spain.	audiaber@ibmcp.upv.es; amonforte@ibmcp.upv.es	Bermúdez, Aurora Díaz/AFB-9080-2022; MONFORTE, Antonio José/B-4784-2009; Eduardo, Iban/J-9383-2015; PICO, BELEN/K-6517-2014; Díaz, Aurora/AGY-7093-2022	MONFORTE, Antonio José/0000-0003-3461-3094; Eduardo, Iban/0000-0002-9963-2934; PICO, BELEN/0000-0001-7761-990X; Díaz, Aurora/0000-0001-7297-1699; Zarouri, Belkacem/0000-0002-4816-2266	Spanish Ministry of Economy and Competitiveness [AGL2009-12698-C02-02, AGL2012-40130-C02-02]; CSIC; GRAG; Spanish Ministry of Education; Instituto Agronomico Mediterraneo de Zaragoza (IAMZ), Spain	Spanish Ministry of Economy and Competitiveness(Spanish Government); CSIC; GRAG; Spanish Ministry of Education(Spanish Government); Instituto Agronomico Mediterraneo de Zaragoza (IAMZ), Spain	This work was supported by grants AGL2009-12698-C02-02 and AGL2012-40130-C02-02 from the Spanish Ministry of Economy and Competitiveness to AJM. AD was supported by a JAE-Doc contract from CSIC, MF by a Postdoctoral contract from GRAG, IE by a fellowship from the former Spanish Ministry of Education and BZ by a fellowship from Instituto Agronomico Mediterraneo de Zaragoza (IAMZ), Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Blanco C, 2009, PLANT CELL, V21, P1877, DOI 10.1105/tpc.109.068114; Boualem A, 2008, SCIENCE, V321, P836, DOI 10.1126/science.1159023; Butelli E, 2008, NAT BIOTECHNOL, V26, P1301, DOI 10.1038/nbt.1506; Chen KY, 2004, GENETICS, V168, P1563, DOI 10.1534/genetics.103.022558; Cong B, 2008, NAT GENET, V40, P800, DOI 10.1038/ng.144; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Deleu W, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-90; Dhillon N. P. S., 2012, Plant Breeding Reviews, V35, P85; Diaz A, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-111; Doebley J, 1997, NATURE, V386, P485, DOI 10.1038/386485a0; Doi K, 2004, GENE DEV, V18, P926, DOI 10.1101/gad.1189604; Doyle J.J., 1990, FOCUS, V12, P13, DOI DOI 10.2307/2419362; Eduardo I, 2005, THEOR APPL GENET, V112, P139, DOI 10.1007/s00122-005-0116-y; Eduardo I, 2007, J AM SOC HORTIC SCI, V132, P80, DOI 10.21273/JASHS.132.1.80; Essafi A, 2009, THEOR APPL GENET, V118, P275, DOI 10.1007/s00122-008-0897-x; Esteras C, 2013, THEOR APPL GENET, V126, P1285, DOI 10.1007/s00122-013-2053-5; Esteras C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-80; Fazio G, 2003, THEOR APPL GENET, V107, P864, DOI 10.1007/s00122-003-1277-1; Ferguson AR, 1999, ACTA HORTIC, P43, DOI 10.17660/ActaHortic.1999.498.4; Fernandez-Silva I, 2009, J HERED, V100, P229, DOI 10.1093/jhered/esn075; Fernandez-Silva I, 2010, THEOR APPL GENET, V121, P931, DOI 10.1007/s00122-010-1361-2; Frary A, 2000, SCIENCE, V289, P85, DOI 10.1126/science.289.5476.85; Fridman E, 2000, P NATL ACAD SCI USA, V97, P4718, DOI 10.1073/pnas.97.9.4718; Fridman E, 2002, MOL GENET GENOMICS, V266, P821, DOI 10.1007/s00438-001-0599-4; Garcia-Mas J, 2012, P NATL ACAD SCI USA, V109, P11872, DOI 10.1073/pnas.1205415109; Harel-Beja R, 2010, THEOR APPL GENET, V121, P511, DOI 10.1007/s00122-010-1327-4; Hayden MJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-80; KENIGSBUCH D, 1990, GENOME, V33, P317, DOI 10.1139/g90-049; Khavkin E, 1997, THEOR APPL GENET, V95, P343, DOI 10.1007/s001220050569; Kojima S, 2002, PLANT CELL PHYSIOL, V43, P1096, DOI 10.1093/pcp/pcf156; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LANDER ES, 1989, GENETICS, V121, P185; Li CB, 2006, SCIENCE, V311, P1936, DOI 10.1126/science.1123604; Li DW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-396; Liu JP, 2002, P NATL ACAD SCI USA, V99, P13302, DOI 10.1073/pnas.162485999; Marguerit E, 2009, THEOR APPL GENET, V118, P1261, DOI 10.1007/s00122-009-0979-4; Monforte AJ, 2003, PLANT BREEDING, V122, P153, DOI 10.1046/j.1439-0523.2003.00848.x; Monforte AJ, 2005, EUPHYTICA, V144, P31, DOI 10.1007/s10681-005-0201-y; Monforte AJ, 2004, THEOR APPL GENET, V108, P750, DOI 10.1007/s00122-003-1483-x; Monforte AJ, 2014, J EXP BOT; Noguera FJ, 2005, THEOR APPL GENET, V110, P714, DOI 10.1007/s00122-004-1897-0; Paris MK, 2008, MOL BREEDING, V22, P405, DOI 10.1007/s11032-008-9185-3; Perin C, 2002, MOL GENET GENOMICS, V266, P933, DOI 10.1007/s00438-001-0612-y; Pitrat Michel, 2008, V1, P283; Roy A, 2012, GENET RESOUR CROP EV, V59, P755, DOI 10.1007/s10722-011-9716-3; SALVI S, 2007, GENOMICS ASSISTED CR, V1, P207; Salvi S, 2007, P NATL ACAD SCI USA, V104, P11376, DOI 10.1073/pnas.0704145104; Stepansky A, 1999, PLANT SYST EVOL, V217, P313, DOI 10.1007/BF00984373; Syvanen AC, 2001, NAT REV GENET, V2, P930, DOI 10.1038/35103535; Takahashi Y, 2001, P NATL ACAD SCI USA, V98, P7922, DOI 10.1073/pnas.111136798; Thornsberry JM, 2001, NAT GENET, V28, P286, DOI 10.1038/90135; Tomason Y, 2013, MOL BREEDING, V31, P829, DOI 10.1007/s11032-013-9837-9; Tuberosa R, 2002, ANN BOT-LONDON, V89, P941, DOI 10.1093/aob/mcf134; van der Knaap E, 2003, THEOR APPL GENET, V107, P139, DOI 10.1007/s00122-003-1224-1; van der Knaap E, 2002, THEOR APPL GENET, V104, P241, DOI 10.1007/s00122-001-0776-1; Vegas J, 2013, THEOR APPL GENET, V126, P1531, DOI 10.1007/s00122-013-2071-3; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang S., 2007, WINDOWS QTL CARTOGRA; Xiao H, 2008, SCIENCE, V319, P1527, DOI 10.1126/science.1153040; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Yuan XJ, 2008, EUPHYTICA, V164, P473, DOI 10.1007/s10681-008-9722-5; ZENG ZB, 1993, P NATL ACAD SCI USA, V90, P10972, DOI 10.1073/pnas.90.23.10972	63	34	40	3	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104188	10.1371/journal.pone.0104188	http://dx.doi.org/10.1371/journal.pone.0104188			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126852	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000340879300016
J	Huang, Y; Mao, Y; Buczek-Thomas, JA; Nugent, MA; Zaia, J				Huang, Yu; Mao, Yang; Buczek-Thomas, Jo Ann; Nugent, Matthew A.; Zaia, Joseph			Oligosaccharide Substrate Preferences of Human Extracellular Sulfatase Sulf2 Using Liquid Chromatography-Mass Spectrometry Based Glycomics Approaches	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; UP-REGULATES GLYPICAN-3; HEPARAN-SULFATE; CELL-SURFACE; 6-O-ENDOSULFATASES SULF1; SIGNALING PATHWAYS; DECREASES SURVIVAL; PROTEOGLYCANS; BINDING; ENDOSULFATASE	Sulfs are extracellular endosulfatases that selectively remove the 6-O-sulfate groups from cell surface heparan sulfate (HS) chain. By altering the sulfation at these particular sites, Sulfs function to remodel HS chains. As a result of the remodeling activity, HSulf2 regulates a multitude of cell-signaling events that depend on interactions between proteins and HS. Previous efforts to characterize the substrate specificity of human Sulfs (HSulfs) focused on the analysis of HS disaccharides and synthetic repeating units. In this study, we characterized the substrate preferences of human HSulf2 using HS oligosaccharides with various lengths and sulfation degrees from several naturally occurring HS sources by applying liquid chromatography mass spectrometry based glycomics methods. The results showed that HSulf2 preferentially digests highly sulfated HS oligosaccharides with zero acetyl groups and this preference is length dependent. In terms of length of oligosaccharides, HSulf2 digestion induced more sulfation decrease on DP6 (DP: degree of polymerization) compared to DP2, DP4 and DP8. In addition, the HSulf2 preferentially digests the oligosaccharide domain located at the non-reducing end (NRE) of the HS and heparin chain. In addition, the HSulf2 digestion products were altered only for specific isomers. HSulf2 treated NRE oligosaccharides also showed greater decrease in cell proliferation than those from internal domains of the HS chain. After further chromatographic separation, we identified the three most preferred unsaturated hexasaccharide for HSulf2.	[Huang, Yu; Mao, Yang; Zaia, Joseph] Boston Univ, Sch Med, Dept Biochem, Ctr Biomed Mass Spectrometry, Boston, MA 02118 USA; [Buczek-Thomas, Jo Ann; Nugent, Matthew A.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA	Boston University; Boston University	Zaia, J (corresponding author), Boston Univ, Sch Med, Dept Biochem, Ctr Biomed Mass Spectrometry, Boston, MA 02118 USA.	jzaia@bu.edu	Zaia, Joseph/U-7850-2019	Zaia, Joseph/0000-0001-9497-8701; Mao, Yang/0000-0002-9674-1158	NIH [P41GN104603, R01HL098950]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL131554, R01HL098950] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by NIH grants P41GN104603 and R01HL098950. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai XB, 2006, J BIOL CHEM, V281, P4969, DOI 10.1074/jbc.M511902200; Ai XB, 2003, J CELL BIOL, V162, P341, DOI 10.1083/jcb.200212083; Ai XB, 2007, DEVELOPMENT, V134, P3327, DOI 10.1242/dev.007674; Alaoui HL, 2009, J THORAC ONCOL, V4, pS557; Alhasan SF, 2012, GUT, V61, pA111, DOI 10.1136/gutjnl-2012-302514b.94; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Buresh-Stiemke RA, 2012, DEV DYNAM, V241, P2005, DOI 10.1002/dvdy.23886; Frese MA, 2009, J BIOL CHEM, V284, P28033, DOI 10.1074/jbc.M109.035808; Fujita K, 2010, MECH DEVELOP, V127, P235, DOI 10.1016/j.mod.2009.12.001; Fux L, 2009, TRENDS BIOCHEM SCI, V34, P511, DOI 10.1016/j.tibs.2009.06.005; Gill RBS, 2011, BIOCHEM BIOPH RES CO, V414, P468, DOI 10.1016/j.bbrc.2011.09.088; Guiral EC, 2010, DEV BIOL, V341, P375, DOI 10.1016/j.ydbio.2010.02.034; Hayano S, 2012, J BIOL CHEM, V287, P12217, DOI 10.1074/jbc.M111.332924; Higginson JR, 2012, J NEUROSCI, V32, P15902, DOI 10.1523/JNEUROSCI.6340-11.2012; Holst CR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000575; Hossain MM, 2010, GLYCOBIOLOGY, V20, P175, DOI 10.1093/glycob/cwp159; Huang Y, 2011, ANAL CHEM, V83, P8222, DOI 10.1021/ac201964n; Hur K, 2012, J PATHOL, V228, P88, DOI 10.1002/path.4055; Kalus I, 2009, J CELL MOL MED, V13, P4505, DOI 10.1111/j.1582-4934.2008.00558.x; KRAEMER PM, 1970, J CELL BIOL, V47, pA110; Lai JP, 2008, GASTROENTEROLOGY, V134, pA762; Lai JP, 2008, HEPATOLOGY, V47, P1211, DOI 10.1002/hep.22202; Lai JP, 2008, FUTURE ONCOL, V4, P803, DOI 10.2217/14796694.4.6.803; Lai JP, 2004, ONCOGENE, V23, P1439, DOI 10.1038/sj.onc.1207258; Lai JP, 2004, GASTROENTEROLOGY, V126, P231, DOI 10.1053/j.gastro.2003.09.043; Lai JP, 2003, J BIOL CHEM, V278, P23107, DOI 10.1074/jbc.M302203200; Lamanna WC, 2008, J BIOL CHEM, V283, P27724, DOI 10.1074/jbc.M802130200; Lamanna WC, 2006, BIOCHEM J, V400, P63, DOI 10.1042/BJ20060848; Langsdorf A, 2007, DEV BIOL, V311, P464, DOI 10.1016/j.ydbio.2007.08.053; Lemjabbar-Alaoui H, 2010, ONCOGENE, V29, P635, DOI 10.1038/onc.2009.365; LINDAHL U, 1977, UPSALA J MED SCI, V82, P78, DOI 10.3109/03009737709179069; Nagamine S, 2012, J BIOL CHEM, V287, P9579, DOI 10.1074/jbc.M111.290262; Naimy H, 2011, J BIOL CHEM, V286, P19311, DOI 10.1074/jbc.M110.204693; Naimy H, 2010, GLYCOBIOLOGY, V20, P1472; ORNITZ DM, 1992, MOL CELL BIOL, V12, P240, DOI 10.1128/MCB.12.1.240; Otsuki S, 2010, P NATL ACAD SCI USA, V107, P10202, DOI 10.1073/pnas.0913897107; Pempe EH, 2012, GLYCOBIOLOGY, V22, P1353, DOI 10.1093/glycob/cws092; Phillips JJ, 2012, J CLIN INVEST, V122, P911, DOI 10.1172/JCI58215; Ratzka A, 2008, DEV DYNAM, V237, P339, DOI 10.1002/dvdy.21423; Rosen SD, 2010, EXPERT OPIN THER TAR, V14, P935, DOI 10.1517/14728222.2010.504718; Saad OM, 2005, GLYCOBIOLOGY, V15, P818, DOI 10.1093/glycob/cwi064; Shi XF, 2009, J BIOL CHEM, V284, P11806, DOI 10.1074/jbc.M809637200; Staples GO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016689; Staples GO, 2010, ANAL CHEM, V82, P516, DOI 10.1021/ac901706f; Sugahara K, 2000, CURR OPIN STRUC BIOL, V10, P518, DOI 10.1016/S0959-440X(00)00125-1; Sugahara K, 2002, IUBMB LIFE, V54, P163, DOI 10.1080/15216540214928; Tatrai P, 2010, J HISTOCHEM CYTOCHEM, V58, P429, DOI 10.1369/jhc.2010.955161; Tran TH, 2012, J BIOL CHEM, V287, P32651, DOI 10.1074/jbc.M112.353243; Tumova S, 2000, INT J BIOCHEM CELL B, V32, P269, DOI 10.1016/S1357-2725(99)00116-8; Turnbull J, 2001, TRENDS CELL BIOL, V11, P75, DOI 10.1016/S0962-8924(00)01897-3; Vlodavsky I, 2008, CONNECT TISSUE RES, V49, P207, DOI 10.1080/03008200802143281; Wittstock U, 2000, IUBMB LIFE, V49, P71, DOI 10.1080/152165400306395; Yang JD, 2011, GENE CHROMOSOME CANC, V50, P122, DOI 10.1002/gcc.20838; Zhao W, 2007, FEBS LETT, V581, P4960, DOI 10.1016/j.febslet.2007.09.033	55	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105143	10.1371/journal.pone.0105143	http://dx.doi.org/10.1371/journal.pone.0105143			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127119	Green Published, gold, Green Submitted			2022-12-25	WOS:000340879300083
J	Reale, M; Kamal, MA; Patruno, A; Costantini, E; D'Angelo, C; Pesce, M; Greig, NH				Reale, Marcella; Kamal, Mohammad A.; Patruno, Antonia; Costantini, Erica; D'Angelo, Chiara; Pesce, Miko; Greig, Nigel H.			Neuronal Cellular Responses to Extremely Low Frequency Electromagnetic Field Exposure: Implications Regarding Oxidative Stress and Neurodegeneration	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; AMYOTROPHIC-LATERAL-SCLEROSIS; REMITTING MULTIPLE-SCLEROSIS; PRO-INFLAMMATORY CYTOKINES; ALZHEIMERS-DISEASE; HUNTINGTONS-DISEASE; NEUROBLASTOMA-CELLS; PARKINSONS-DISEASE; LEARN MODEL; NEUROGENESIS	Neurodegenerative diseases comprise both hereditary and sporadic conditions characterized by an identifying progressive nervous system dysfunction and distinctive neuopathophysiology. The majority are of non-familial etiology and hence environmental factors and lifestyle play key roles in their pathogenesis. The extensive use of and ever increasing worldwide demand for electricity has stimulated societal and scientific interest on the environmental exposure to low frequency electromagnetic fields (EMFs) on human health. Epidemiological studies suggest a positive association between 50/60-Hz power transmission fields and leukemia or lymphoma development. Consequent to the association between EMFs and induction of oxidative stress, concerns relating to development of neurodegenerative diseases, such as Alzheimer disease (AD), have been voiced as the brain consumes the greatest fraction of oxygen and is particularly vulnerable to oxidative stress. Exposure to extremely low frequency (ELF)-EMFs are reported to alter animal behavior and modulate biological variables, including gene expression, regulation of cell survival, promotion of cellular differentiation, and changes in cerebral blood flow in aged AD transgenic mice. Alterations in inflammatory responses have also been reported, but how these actions impact human health remains unknown. We hence evaluated the effects of an electromagnetic wave (magnetic field intensity 1mT; frequency, 50-Hz) on a well-characterized immortalized neuronal cell model, human SH-SY5Y cells. ELF-EMF exposure elevated the expession of NOS and O-2(-), which were countered by compensatory changes in antioxidant catylase (CAT) activity and enzymatic kinetic parameters related to CYP-450 and CAT activity. Actions of ELF-EMFs on cytokine gene expression were additionally evaluated and found rapidly modified. Confronted with co-exposure to H2O2-induced oxidative stress, ELF-EMF proved not as well counteracted and resulted in a decline in CAT activity and a rise in O-2(-) levels. Together these studies support the further evaluation of ELF-EMF exposure in cellular and in vivo preclinical models to define mechanisms potentially impacted in humans.	[Reale, Marcella; Costantini, Erica; D'Angelo, Chiara] Univ G dAnnunzio, Dept Expt & Clin Sci, Chieti, Italy; [Kamal, Mohammad A.] King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah 21413, Saudi Arabia; [Patruno, Antonia; Pesce, Miko] Univ G dAnnunzio, Dept Med & Aging Sci, Chieti, Italy; [Greig, Nigel H.] NIA, Drug Design & Dev Sect, Translat Gerontol Branch, Intramural Res Program,NIH, Baltimore, MD 21224 USA	G d'Annunzio University of Chieti-Pescara; King Abdulaziz University; G d'Annunzio University of Chieti-Pescara; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Reale, M (corresponding author), Univ G dAnnunzio, Dept Expt & Clin Sci, Chieti, Italy.	mreale@unich.it; greign@grc.nia.nih.gov	Costantini, erica/AAD-9167-2020; Kamal, Mohammad Amjad/J-2918-2014; D'Angelo, Chiara/AAH-5200-2019; Reale, Marcella/G-4299-2013; Patruno, Alessandro/T-6621-2019	Costantini, erica/0000-0003-2175-4226; Kamal, Mohammad Amjad/0000-0003-0088-0565; D'Angelo, Chiara/0000-0002-1477-0706; Reale, Marcella/0000-0002-4164-8781; Pesce, Mirko/0000-0001-8836-2564; Patruno, Alessandro/0000-0002-6459-0674	Italian MIUR; King Fahd Medical Research Center, King Abdulaziz University; National Institute on Aging, National Institutes of Health; NATIONAL INSTITUTE ON AGING [ZIAAG000311] Funding Source: NIH RePORTER	Italian MIUR(Ministry of Education, Universities and Research (MIUR)); King Fahd Medical Research Center, King Abdulaziz University; National Institute on Aging, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the Italian MIUR to M. R. and A. P., the King Fahd Medical Research Center, King Abdulaziz University for M. A. K., and the Intramural Research Program, National Institute on Aging, National Institutes of Health for N. H. G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H., 1974, METHOD ENZYMAT AN, P673; Antonini RA, 2006, TOXICOL LETT, V164, P268, DOI 10.1016/j.toxlet.2006.01.006; Arendash GW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035751; Arias-Carrion O, 2004, J NEUROSCI RES, V78, P16, DOI 10.1002/jnr.20235; Azizi G, 2014, AM J ALZHEIMERS DIS; Barja G, 1998, ANN NY ACAD SCI, V854, P224, DOI 10.1111/j.1749-6632.1998.tb09905.x; Battista D, 2006, EUR J NEUROSCI, V23, P83, DOI 10.1111/j.1460-9568.2005.04539.x; Becker RE, 2014, NAT REV DRUG DISCOV, V13, P157, DOI 10.1038/nrd3842-c2; Bertram L, 2005, J CLIN INVEST, V115, P1449, DOI 10.1172/JCI24761; Blandini F, 2013, J NEUROIMMUNE PHARM, V8, P189, DOI 10.1007/s11481-013-9435-y; Bonda DJ, 2011, CURR ALZHEIMER RES, V8, P639; Bonda DJ, 2010, NEUROPHARMACOLOGY, V59, P290, DOI 10.1016/j.neuropharm.2010.04.005; Bose S, 2013, ARCH PHARM RES, V36, P1039, DOI 10.1007/s12272-013-0161-z; Bossu P, 2010, CURR PHARM DESIGN, V16, P4213, DOI 10.2174/138161210794519147; Bossy-Wetzel E, 2004, NAT MED, V10, pS2, DOI 10.1038/nm1067; Brown RC, 2005, ENVIRON HEALTH PERSP, V113, P1250, DOI 10.1289/ehp.7567; Cannon JR, 2011, TOXICOL SCI, V124, P225, DOI 10.1093/toxsci/kfr239; Consales C., 2012, INT J CELL BIOL, V2012; Del Vecchio G, 2009, BIOELECTROMAGNETICS, V30, P564, DOI 10.1002/bem.20507; Dinarello CA, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00289; Eleuteri AM, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/834239; Falone S, 2007, INT J BIOCHEM CELL B, V39, P2093, DOI 10.1016/j.biocel.2007.06.001; Feychting M, 2005, ANNU REV PUBL HEALTH, V26, P165, DOI 10.1146/annurev.publhealth.26.021304.144445; Ortiz GG, 2009, DIS MARKERS, V26, P35, DOI [10.1155/2009/325847, 10.3233/DMA-2009-0602]; Gerard C, 2001, NAT IMMUNOL, V2, P108, DOI 10.1038/84209; International Programme On Chemical Safety, 1984, ENV HLTH CRI; Jack CR, 2013, LANCET NEUROL, V12, P207, DOI 10.1016/S1474-4422(12)70291-0; Korhonen Riku, 2005, Current Drug Targets - Inflammation and Allergy, V4, P471, DOI 10.2174/1568010054526359; Kraft AD, 2011, INT J ENV RES PUB HE, V8, P2980, DOI 10.3390/ijerph8072980; Lacy-Hulbert A, 1998, FASEB J, V12, P395, DOI 10.1096/fasebj.12.6.395; Lahiri DK, 2009, MOL PSYCHIATR, V14, P992, DOI 10.1038/mp.2009.82; Lahiri DK, 2007, CURR ALZHEIMER RES, V4, P219, DOI 10.2174/156720507780362164; Lisi A, 2006, BIOELECTROMAGNETICS, V27, P641, DOI 10.1002/bem.20255; Luukkonen J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018021; Martinez-Samano J, 2012, ARCH MED RES, V43, P183, DOI 10.1016/j.arcmed.2012.04.003; Moreau C, 2005, NEUROLOGY, V65, P1958, DOI 10.1212/01.wnl.0000188907.97339.76; Moreno-Gonzalez I, 2012, CURR PHARM DESIGN, V18, P1148, DOI 10.2174/138161212799315768; Moreno-Gonzalez I, 2011, SEMIN CELL DEV BIOL, V22, P482, DOI 10.1016/j.semcdb.2011.04.002; Mullard A, 2012, NAT REV DRUG DISCOV, V11, P657, DOI 10.1038/nrd3842; Patruno A, 2011, CNS NEUROL DISORD-DR, V10, P936, DOI 10.2174/187152711799219325; Patruno A, 2010, BRIT J DERMATOL, V162, P258, DOI 10.1111/j.1365-2133.2009.09527.x; Piacentini R, 2008, J CELL PHYSIOL, V215, P129, DOI 10.1002/jcp.21293; Poloni M, 2000, NEUROSCI LETT, V287, P211, DOI 10.1016/S0304-3940(00)01177-0; PRITCHARD KA, 1995, CIRC RES, V77, P510, DOI 10.1161/01.RES.77.3.510; Reale M, 2012, CURR ALZHEIMER RES, V9, P447, DOI 10.2174/156720512800492549; Reale M, 2009, MINI-REV MED CHEM, V9, P1229, DOI 10.2174/138955709789055199; Reale M, 2009, BRAIN BEHAV IMMUN, V23, P55, DOI 10.1016/j.bbi.2008.07.003; Reale M, 2008, J ALZHEIMERS DIS, V14, P147; Reale M, 2006, NITRIC OXIDE-BIOL CH, V15, P50, DOI 10.1016/j.niox.2005.11.010; Reale M, 2012, INT J MOL SCI, V13, P12656, DOI 10.3390/ijms131012656; Ren RF, 1997, MOL BRAIN RES, V48, P315, DOI 10.1016/S0169-328X(97)00108-3; Saracchi E, 2014, AGING DIS, V5, P27, DOI 10.14366/AD.2014.050027; Simko M, 2004, J CELL BIOCHEM, V93, P83, DOI 10.1002/jcb.20198; Sonnier H, 2003, NEUROSCI LETT, V337, P163, DOI 10.1016/S0304-3940(02)01329-0; Stefani IC, 2012, CURR ALZHEIMER RES, V9, P373; Su B, 2008, CURR ALZHEIMER RES, V5, P525, DOI 10.2174/156720508786898451; Sunkari VG, 2011, ELECTROMAGN BIOL MED, V30, P80, DOI 10.3109/15368378.2011.566774; Sutinen EM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-199; Taskiran D, 2000, INT J NEUROSCI, V101, P65, DOI 10.3109/00207450008986493; Tasset I, 2012, NEUROSCIENCE, V209, P54, DOI 10.1016/j.neuroscience.2012.02.034; Tasset I, 2013, BRAIN STIMUL, V6, P84, DOI 10.1016/j.brs.2012.03.015; Tesseur I, 2006, J CLIN INVEST, V116, P3060, DOI 10.1172/JCI27341; Tunez I, 2006, J NEUROCHEM, V97, P619, DOI 10.1111/j.1471-4159.2006.03724.x; Tunez I, 2009, REV NEUROLOGIA, V48, P430, DOI 10.33588/rn.4808.2008678; Tweedie D, 2007, CURR ALZHEIMER RES, V4, P378, DOI 10.2174/156720507781788873; Vaz AR, 2011, EXP NEUROL, V229, P381, DOI 10.1016/j.expneurol.2011.03.004; Vianale G, 2008, BRIT J DERMATOL, V158, P1189, DOI 10.1111/j.1365-2133.2008.08540.x; von Bernhardi R, 2012, ANTIOXID REDOX SIGN, V16, P974, DOI 10.1089/ars.2011.4082; WHO, 2007, EX LOW FREQU FIELD, V35	69	53	56	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104973	10.1371/journal.pone.0104973	http://dx.doi.org/10.1371/journal.pone.0104973			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127118	Green Submitted, gold, Green Published			2022-12-25	WOS:000340879300067
J	Tiano, L; Garcia-Robledo, E; Revsbech, NP				Tiano, Laura; Garcia-Robledo, Emilio; Revsbech, Niels Peter			A New Highly Sensitive Method to Assess Respiration Rates and Kinetics of Natural Planktonic Communities by Use of the Switchable Trace Oxygen Sensor and Reduced Oxygen Concentrations	PLOS ONE			English	Article							ELECTRON-TRANSPORT ACTIVITY; ATTACHED BACTERIA; MINIMUM ZONES; FECAL PELLETS; SOUTH-PACIFIC; WATER-COLUMN; CARBON-CYCLE; MARINE SNOW; LOW O-2; OCEAN	Oxygen respiration rates in pelagic environments are often difficult to quantify as the resolutions of our methods for O-2 concentration determination are marginal for observing significant decreases during bottle incubations of less than 24 hours. Here we present the assessment of a new highly sensitive method, that combine Switchable Trace Oxygen (STOX) sensors and all-glass bottle incubations, where the O-2 concentration was artificially lowered. The detection limit of respiration rate by this method is inversely proportional to the O-2 concentration, down to <2 nmol L-1 h(-1) for water with an initial O-2 concentration of 500 nmol L-1. The method was tested in Danish coastal waters and in oceanic hypoxic waters. It proved to give precise measurements also with low oxygen consumption rates (similar to 7 nmol L-1 h(-1)), and to significantly decrease the time required for incubations (<= 14 hours) compared to traditional methods. This method provides continuous real time measurements, allowing for a number of diverse possibilities, such as modeling the rate of oxygen decrease to obtain kinetic parameters. Our data revealed apparent half-saturation concentrations (K-m values) one order of magnitude lower than previously reported for marine bacteria, varying between 66 and 234 nmol L-1 O-2. Km values vary between different microbial planktonic communities, but our data show that it is possible to measure reliable respiration rates at concentrations similar to 0.5-1 mu mol L-1 O-2 that are comparable to the ones measured at full air saturation.	[Tiano, Laura; Garcia-Robledo, Emilio; Revsbech, Niels Peter] Aarhus Univ, Dept Biosci, Microbiol Sect, Aarhus, Denmark	Aarhus University	Tiano, L (corresponding author), Aarhus Univ, Dept Biosci, Microbiol Sect, Aarhus, Denmark.	tiano.laura@gmail.com	Revsbech, Niels P/I-8040-2013; Garcia-Robledo, Emilio/B-3781-2017	Garcia-Robledo, Emilio/0000-0002-4337-6433; Revsbech, Niels Peter/0000-0002-2193-262X	Danish Natural Science Research Council [10-083140]; European Research Council [267233]; Ramon Areces Foundation (Spain)	Danish Natural Science Research Council(Danish Natural Science Research Council); European Research Council(European Research Council (ERC)European Commission); Ramon Areces Foundation (Spain)	Financial support was given by the Danish Natural Science Research Council, grant no. 10-083140, and European Research Council, grant no. 267233. E. Garcia-Robledo was funded by Ramon Areces Foundation (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLDREDGE AL, 1987, SCIENCE, V235, P689, DOI 10.1126/science.235.4789.689; Andersson JH, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018756; Aristegui J, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016227; ARISTEGUI J, 1995, J PLANKTON RES, V17, P1563, DOI 10.1093/plankt/17.7.1563; Aristegui Javier, 2005, P181; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Baughn AD, 2004, NATURE, V427, P441, DOI 10.1038/nature02285; Buesseler KO, 2007, J MAR RES, V65, P345, DOI 10.1357/002224007781567621; Burd AB, 2010, DEEP-SEA RES PT II, V57, P1557, DOI 10.1016/j.dsr2.2010.02.022; Dalsgaard T, 2013, GEOCHIM COSMOCHIM AC, V106, P247, DOI 10.1016/j.gca.2012.12.038; Dalsgaard T, 2012, LIMNOL OCEANOGR, V57, P1331, DOI 10.4319/lo.2012.57.5.1331; Nguyen D, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007343; De Brabandere L, 2012, J MICROBIOL METH, V88, P147, DOI 10.1016/j.mimet.2011.11.001; del Giorgio PA, 2002, NATURE, V420, P379, DOI 10.1038/nature01165; delGiorgio PA, 1997, NATURE, V385, P148, DOI 10.1038/385148a0; DEVOL AH, 1978, DEEP-SEA RES, V25, P137, DOI 10.1016/0146-6291(78)90001-2; DOWD JE, 1965, J BIOL CHEM, V240, P863; Duarte CM, 1998, SCIENCE, V281, P234, DOI 10.1126/science.281.5374.234; Gattuso JP, 2002, J PLANKTON RES, V24, P1197, DOI 10.1093/plankt/24.11.1197; Han HZ, 2011, P NATL ACAD SCI USA, V108, P14109, DOI 10.1073/pnas.1018958108; HARREMOES P, 1977, Vatten, V33, P122; HARRISON WG, 1986, POLAR BIOL, V6, P145, DOI 10.1007/BF00274877; Holtappels M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089369; JAHNKE RA, 1995, LIMNOL OCEANOGR, V40, P436, DOI 10.4319/lo.1995.40.2.0436; JASSBY AD, 1976, LIMNOL OCEANOGR, V21, P540, DOI 10.4319/lo.1976.21.4.0540; JESPERSEN AM, 1987, ARCH HYDROBIOL, V109, P445; JOHNSON MJ, 1967, J BACTERIOL, V94, P101, DOI 10.1128/JB.94.1.101-108.1967; Jorgensen B.B., 2006, MARINE GEOCHEMISTRY, P169, DOI DOI 10.1007/3-540-32144-6_5; Kalvelage T, 2013, NAT GEOSCI, V6, P228, DOI [10.1038/NGEO1739, 10.1038/ngeo1739]; Kemmer G, 2010, NAT PROTOC, V5, P267, DOI 10.1038/nprot.2009.182; Kirchman DL, 1997, NATURE, V385, P121, DOI 10.1038/385121a0; KOCH AL, 1990, ADV MICROB ECOL, V11, P37; KUZMA MM, 1993, PLANT PHYSIOL, V101, P161, DOI 10.1104/pp.101.1.161; Labasque T, 2004, MAR CHEM, V88, P53, DOI 10.1016/j.marchem.2004.03.004; Longmuir IS, 1949, OPTICAL CONFIGURATIO, V57, P81; LORENZEN CJ, 1967, LIMNOL OCEANOGR, V12, P343, DOI 10.4319/lo.1967.12.2.0343; Maldonado F, 2012, J EXP MAR BIOL ECOL, V434, P110, DOI 10.1016/j.jembe.2012.08.010; Martinez-Garcia S, 2009, LIMNOL OCEANOGR-METH, V7, P459, DOI 10.4319/lom.2009.7.459; Morris RL, 2013, NAT REV MICROBIOL, V11, P205, DOI 10.1038/nrmicro2970; Nielsen K, 2003, AMBIO, V32, P287, DOI 10.1639/0044-7447(2003)032[0287:ARCATT]2.0.CO;2; PACKARD TT, 1971, J MAR RES, V29, P235; Ploug H, 2001, LIMNOL OCEANOGR, V46, P1624, DOI 10.4319/lo.2001.46.7.1624; Ploug H, 2008, LIMNOL OCEANOGR, V53, P1878, DOI 10.4319/lo.2008.53.5.1878; POMEROY LR, 1994, APPL ENVIRON MICROB, V60, P328, DOI 10.1128/AEM.60.1.328-332.1994; Revsbech NP, 2011, METHOD ENZYMOL, V486, P325, DOI [10.1016/S0076-6879(11)86014-3, 10.1016/B978-0-12-381294-0.00014-6]; Revsbech NP, 2009, LIMNOL OCEANOGR-METH, V7, P371, DOI 10.4319/lom.2009.7.371; REVSBECH NP, 1989, LIMNOL OCEANOGR, V34, P474, DOI 10.4319/lo.1989.34.2.0474; Rice CW, 1978, CULTURE, V134, P115; Robinson C, 2005, RESPIRATION IN AQUATIC ECOSYSTEMS, P147, DOI 10.1093/acprof:oso/9780198527084.003.0009; Robinson C, 2002, DEEP-SEA RES PT I, V49, P787, DOI 10.1016/S0967-0637(01)00083-8; Robinson C., 2008, MICROB ECOL OCEAN, p299, DOI DOI 10.1002/9780470281840.CH9; Sherr EB, 1999, AQUAT MICROB ECOL, V20, P213, DOI 10.3354/ame020213; Stolper DA, 2010, P NATL ACAD SCI USA, V107, P18755, DOI 10.1073/pnas.1013435107; SUESS E, 1980, NATURE, V288, P260, DOI 10.1038/288260a0; Tang KW, 2005, AQUAT MICROB ECOL, V38, P31, DOI 10.3354/ame038031; Tarpgaard IH, 2011, GEOCHIM COSMOCHIM AC, V75, P2997, DOI 10.1016/j.gca.2011.03.028; Taylor GT, 1996, CAN J MICROBIOL, V42, P911, DOI 10.1139/m96-117; Tiano L, 2013, MICROBIAL RESP GENE, P200; Ulloa O, 2012, P NATL ACAD SCI; Williams P.J. le B., 1984, NATO Conference Series IV Marine Sciences, V15, P357; WILLIAMS PJ, 1973, LIMNOL OCEANOGR, V18, P159, DOI 10.4319/lo.1973.18.1.0159; Williams PJL, 1998, NATURE, V394, P55; WILLIAMS PJL, 1981, OCEANOL ACTA, V4, P359	63	19	19	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105399	10.1371/journal.pone.0105399	http://dx.doi.org/10.1371/journal.pone.0105399			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127458	gold, Green Published, Green Submitted			2022-12-25	WOS:000340879300110
J	Rajan, R; Osterman, AK; Gast, AT; Mondragon, A				Rajan, Rakhi; Osterman, Amy K.; Gast, Alexandra T.; Mondragon, Alfonso			Biochemical Characterization of the Topoisomerase Domain of Methanopyrus kandleri Topoisomerase V	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI DNA TOPOISOMERASE; VACCINIA TOPOISOMERASE; COVALENT CATALYSIS; HYPERTHERMOPHILIC PROKARYOTE; MUTATIONAL ANALYSIS; REPAIR ACTIVITIES; CRYSTAL-STRUCTURE; MECHANISM; IB; RESIDUES	Topoisomerases are ubiquitous enzymes that modify the topological state of DNA inside the cell and are essential for several cellular processes. Topoisomerase V is the sole member of the type IC topoisomerase subtype. The topoisomerase domain has a unique fold among topoisomerases, and the putative active site residues show a distinct arrangement. The present study was aimed at identifying the roles of the putative active site residues in the DNA cleavage/religation process. Residues Arg-131, Arg144, His-200, Glu-215, Lys-218, and Tyr-226 were mutated individually to a series of conservative and non-conservative amino acids, and the DNA relaxation activity at different pH values, times, and enzyme concentrations was compared with wild-type activity. The results suggest that Arg-144 is essential for protein stability because any substitution at this position was deleterious and that Arg-131 and His-200 are involved in transition state stabilization. Glu-215 reduces the DNA binding ability of topoisomerase V, especially in shorter fragments with fewer helix-hairpin-helix DNA binding motifs. Finally, Lys-218 appears to play a direct role in catalysis but not in charge stabilization of the protein-DNA intermediate complex. The results suggest that although catalytically important residues are oriented in different fashions in the active sites of type IB and type IC topoisomerases, similar amino acids play equivalent roles in both of these subtypes of enzymes, showing convergent evolution of the catalytic mechanism.	[Rajan, Rakhi; Osterman, Amy K.; Gast, Alexandra T.; Mondragon, Alfonso] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA	Northwestern University	Mondragon, A (corresponding author), Northwestern Univ, Dept Mol Biosci, 2205 Tech Dr, Evanston, IL 60208 USA.	a-mondragon@northwestern.edu	Rajan, Rakhi/K-2477-2016	Tarabochia-Gast, Alexandra/0000-0001-7691-179X	National Institutes of Health [R01GM51350]; American Heart Association [10POST2600325]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051350] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM51350 (to A. M.). This work was also supported by American Heart Association Grant 10POST2600325 (to R. R.).	Baker NM, 2009, NUCLEIC ACIDS RES, V37, P693, DOI 10.1093/nar/gkn1009; Belova GI, 2002, J BIOL CHEM, V277, P4959, DOI 10.1074/jbc.M110131200; Belova GI, 2001, P NATL ACAD SCI USA, V98, P6015, DOI 10.1073/pnas.111040498; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Changela A, 2001, NATURE, V411, P1077, DOI 10.1038/35082615; Changela A, 2007, J MOL BIOL, V368, P105, DOI 10.1016/j.jmb.2007.01.065; Cheng CH, 1997, J BIOL CHEM, V272, P8263, DOI 10.1074/jbc.272.13.8263; DOMANICO PL, 1991, J INORG BIOCHEM, V42, P87, DOI 10.1016/0162-0134(91)80035-G; Forterre P, 2006, TRENDS BIOTECHNOL, V24, P245, DOI 10.1016/j.tibtech.2006.04.006; Koster DA, 2005, NATURE, V434, P671, DOI 10.1038/nature03395; Koster DA, 2008, NUCLEIC ACIDS RES, V36, P2301, DOI 10.1093/nar/gkn035; Krogh BO, 2000, MOL CELL, V5, P1035, DOI 10.1016/S1097-2765(00)80268-3; Krogh BO, 2002, J BIOL CHEM, V277, P5711, DOI 10.1074/jbc.C100681200; Perry K, 2002, J BIOL CHEM, V277, P13237, DOI 10.1074/jbc.M112019200; Perry K, 2006, MOL CELL, V23, P343, DOI 10.1016/j.molcel.2006.06.015; Perry K, 2010, STRUCTURE, V18, P127, DOI 10.1016/j.str.2009.10.020; Petersen BO, 1996, J MOL BIOL, V263, P181, DOI 10.1006/jmbi.1996.0568; Petersen BO, 1997, J BIOL CHEM, V272, P3891, DOI 10.1074/jbc.272.7.3891; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; Rajan R, 2013, NUCLEIC ACIDS RES, V41, P657, DOI 10.1093/nar/gks1017; Rajan R, 2010, STRUCTURE, V18, P829, DOI 10.1016/j.str.2010.03.006; Redinbo MR, 1998, SCIENCE, V279, P1504, DOI 10.1126/science.279.5356.1504; Schoeffler AJ, 2008, Q REV BIOPHYS, V41, P41, DOI 10.1017/S003358350800468X; Seol Y, 2012, P NATL ACAD SCI USA, V109, P16125, DOI 10.1073/pnas.1206480109; SLESAREV AI, 1994, J BIOL CHEM, V269, P3295; SLESAREV AI, 1993, NATURE, V364, P735, DOI 10.1038/364735a0; Stewart L, 1998, SCIENCE, V279, P1534, DOI 10.1126/science.279.5356.1534; STIVERS JT, 1994, BIOCHEMISTRY-US, V33, P15449, DOI 10.1021/bi00255a027; STIVERS JT, 1994, BIOCHEMISTRY-US, V33, P327, DOI 10.1021/bi00167a043; Taneja B, 2006, EMBO J, V25, P398, DOI 10.1038/sj.emboj.7600922; Taneja B, 2007, P NATL ACAD SCI USA, V104, P14670, DOI 10.1073/pnas.0701989104; Tian LG, 2005, STRUCTURE, V13, P513, DOI 10.1016/j.str.2005.02.001; Vos SM, 2011, NAT REV MOL CELL BIO, V12, P827, DOI 10.1038/nrm3228; Wang JC, 2009, ANNU REV BIOCHEM, V78, P31, DOI 10.1146/annurev.biochem.78.030107.090101; WITTSCHIEBEN J, 1994, J BIOL CHEM, V269, P29978; Wittschieben J, 1997, NUCLEIC ACIDS RES, V25, P3001, DOI 10.1093/nar/25.15.3001; Yang Z, 2001, J BIOL CHEM, V276, P677, DOI 10.1074/jbc.M007593200; Zhang ZT, 2011, P NATL ACAD SCI USA, V108, P6939, DOI 10.1073/pnas.1100300108; Zhu CX, 1997, J BIOL CHEM, V272, P16206, DOI 10.1074/jbc.272.26.16206; Zhu CX, 2000, J BIOL CHEM, V275, P5318, DOI 10.1074/jbc.275.8.5318; Zhu CX, 1998, J BIOL CHEM, V273, P8783, DOI 10.1074/jbc.273.15.8783	41	4	4	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					28898	28909		10.1074/jbc.M114.590711	http://dx.doi.org/10.1074/jbc.M114.590711			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25135643	Green Published, hybrid			2022-12-25	WOS:000344141000013
J	Kasim, M; Benko, E; Winkelmann, A; Mrowka, R; Staudacher, JJ; Persson, PB; Scholz, H; Meier, JC; Fahling, M				Kasim, Mumtaz; Benko, Edgar; Winkelmann, Aline; Mrowka, Ralf; Staudacher, Jonas J.; Persson, Pontus B.; Scholz, Holger; Meier, Jochen C.; Faehling, Michael			Shutdown of Achaete-scute Homolog-1 Expression by Heterogeneous Nuclear Ribonucleoprotein (hnRNP)-A2/B1 in Hypoxia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENOME-WIDE CHARACTERIZATION; MESSENGER-RNA; LUNG-CANCER; HNRNP A2/B1; HIPPOCAMPAL-NEURONS; PRONEURAL GENES; NEUROBLASTOMA; TRANSCRIPTION; DIFFERENTIATION; PROTEIN	The basic helix-loop-helix transcription factor hASH1, encoded by the ASCL1 gene, plays an important role in neurogenesis and tumor development. Recent findings indicate that local oxygen tension is a critical determinant for the progression of neuroblastomas. Here we investigated the molecular mechanisms underlying the oxygen-dependent expression of hASH1 in neuroblastoma cells. Exposure of human neuroblastoma-derived Kelly cells to 1% O-2 significantly decreased ASCL1 mRNA and hASH1 protein levels. Using reporter gene assays, we show that the response of hASH1 to hypoxia is mediated mainly by post-transcriptional inhibition via the ASCL1 mRNA 5'- and 3'-UTRs, whereas additional inhibition of the ASCL1 promoter was observed under prolonged hypoxia. By RNA pulldown experiments followed by MALDI/TOF-MS analysis, we identified heterogeneous nuclear ribonucleoprotein (hnRNP)-A2/B1 and hnRNP-R as interactors binding directly to the ASCL1 mRNA 5'- and 3'-UTRs and influencing its expression. We further demonstrate that hnRNP-A2/B1 is a key positive regulator of ASCL1, findings that were also confirmed by analysis of a large compilation of gene expression data. Our data suggest that a prominent down-regulation of hnRNP-A2/B1 during hypoxia is associated with the post-transcriptional suppression of hASH1 synthesis. This novel post-transcriptional mechanism for regulating hASH1 levels will have important implications in neural cell fate development and disease.	[Kasim, Mumtaz; Benko, Edgar; Staudacher, Jonas J.; Persson, Pontus B.; Scholz, Holger; Faehling, Michael] Charite, Inst Vegetat Physiol, D-10117 Berlin, Germany; [Winkelmann, Aline; Meier, Jochen C.] Max Delbruck Ctr Mol Med, RNA Editing & Hyperexcitabil Disorders Helmholtz, D-13125 Berlin, Germany; [Mrowka, Ralf] Univ Klinikum Jena, Klin Innere Med 3, AG Expt Nephrol, D-07743 Jena, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Friedrich Schiller University of Jena	Fahling, M (corresponding author), Charite, Inst Vegetat Physiol, D-10117 Berlin, Germany.	michael.faehling@charite.de	Mrowka, Ralf/AAW-1480-2021; Fähling, Michael/E-5018-2011; Staudacher, Jonas Jaromir/AAM-6134-2020	Mrowka, Ralf/0000-0002-0991-3418; Staudacher, Jonas Jaromir/0000-0001-5697-2798; Fahling, Michael/0000-0003-1079-5049; Meier, Jochen/0000-0001-5574-3336; Persson, Pontus/0000-0003-0926-2878	Deutsche Forschungsgemeinschaft [FA845/2-2]; Bundesministerium fur Bildung und Forschung BMBF ERA-Net NEURON II project CIPRESS	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung BMBF ERA-Net NEURON II project CIPRESS	This work was supported by Deutsche Forschungsgemeinschaft Grant FA845/2-2 (to M. F.) and the Bundesministerium fur Bildung und Forschung BMBF ERA-Net NEURON II project CIPRESS (to J. C. M.).	Agostini F, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks968; Axelson H, 2004, CANCER LETT, V204, P171, DOI 10.1016/S0304-3835(03)00453-1; BALL DW, 1993, P NATL ACAD SCI USA, V90, P5648, DOI 10.1073/pnas.90.12.5648; Bannai H, 2004, J BIOL CHEM, V279, P53427, DOI 10.1074/jbc.M409732200; Bellucci M, 2011, NAT METHODS, V8, P444, DOI 10.1038/nmeth.1611; Benko E, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00001; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Bhattacharjee RB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053036; BREWER GJ, 1989, BRAIN RES, V494, P65, DOI 10.1016/0006-8993(89)90144-3; Castro DS, 2011, CELL CYCLE, V10, P4026, DOI 10.4161/cc.10.23.18578; Castro DS, 2011, GENE DEV, V25, P930, DOI 10.1101/gad.627811; Cau E, 2002, DEVELOPMENT, V129, P1871; Chen H, 1997, P NATL ACAD SCI USA, V94, P5355, DOI 10.1073/pnas.94.10.5355; DeGregori J, 2006, CURR MOL MED, V6, P739; Demeter J, 2007, NUCLEIC ACIDS RES, V35, pD766, DOI 10.1093/nar/gkl1019; Edlund T, 1999, CELL, V96, P211, DOI 10.1016/S0092-8674(00)80561-9; Eichler SA, 2009, EUR J NEUROSCI, V30, P1077, DOI 10.1111/j.1460-9568.2009.06903.x; Elmi M, 2010, MOL CELL NEUROSCI, V45, P121, DOI 10.1016/j.mcn.2010.06.003; Fahling M, 2006, J BIOL CHEM, V281, P26089, DOI 10.1074/jbc.M604939200; Fahling M, 2009, J CELL MOL MED, V13, P2770, DOI 10.1111/j.1582-4934.2009.00875.x; Fahling M, 2009, J BIOL CHEM, V284, P4255, DOI 10.1074/jbc.M807354200; Fahling M, 2006, J BIOL CHEM, V281, P9279, DOI 10.1074/jbc.M510925200; Forstera B, 2010, BRAIN, V133, P3778, DOI 10.1093/brain/awq298; Fukuda A, 2009, J BIOL CHEM, V284, P23472, DOI 10.1074/jbc.M109.013656; Garayoa M, 2003, AM J RESP CELL MOL, V28, P80, DOI 10.1165/rcmb.4880; Gestblom C, 1999, LAB INVEST, V79, P67; Goodarzi H, 2012, NATURE, V485, P264, DOI 10.1038/nature11013; GUILLEMOT F, 1993, MECH DEVELOP, V42, P171, DOI 10.1016/0925-4773(93)90006-J; GUILLEMOT F, 1993, CELL, V75, P463, DOI 10.1016/0092-8674(93)90381-Y; Holmquist L, 2006, ADV EXP MED BIOL, V587, P179; Horton S, 1999, MOL CELL NEUROSCI, V14, P355, DOI 10.1006/mcne.1999.0791; Huang J, 2008, CELL MOL BIOL LETT, V13, P303, DOI 10.2478/s11658-008-0002-0; Isogai E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019297; Jogi A, 2002, P NATL ACAD SCI USA, V99, P7021, DOI 10.1073/pnas.102660199; JOHNSON JE, 1992, P NATL ACAD SCI USA, V89, P3596, DOI 10.1073/pnas.89.8.3596; JURASKA JM, 1982, J COMP NEUROL, V212, P208, DOI 10.1002/cne.902120210; Kageyama R, 2005, EXP CELL RES, V306, P343, DOI 10.1016/j.yexcr.2005.03.015; Khazipov R, 2001, J NEUROSCI, V21, P9770, DOI 10.1523/JNEUROSCI.21-24-09770.2001; Kosari F, 2014, ONCOGENE, V33, P3776, DOI 10.1038/onc.2013.359; Liu J, 2010, INT J GYNECOL CANCER, V20, P1109, DOI 10.1111/IGC.0b013e3181ea74ad; Liu YC, 2010, J HISTOCHEM CYTOCHEM, V58, P695, DOI 10.1369/jhc.2010.955021; LO LC, 1991, GENE DEV, V5, P1524, DOI 10.1101/gad.5.9.1524; Lo LC, 1998, DEVELOPMENT, V125, P609; Marin O, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001834; Nakagawara A, 2004, CANCER LETT, V204, P213, DOI 10.1016/S0304-3835(03)00457-9; Petanjek Z, 2011, P NATL ACAD SCI USA, V108, P13281, DOI 10.1073/pnas.1105108108; Powell LM, 2008, CURR OPIN GENET DEV, V18, P411, DOI 10.1016/j.gde.2008.07.012; RAKIC P, 1994, PROG BRAIN RES, V102, P227; Salama-Cohen P, 2005, MOL BIOL CELL, V16, P339, DOI 10.1091/mbc.e04-05-0438; Shi YH, 2004, NATURE, V427, P78, DOI 10.1038/nature02211; Soderholm H, 1999, BIOCHEM BIOPH RES CO, V256, P557, DOI 10.1006/bbrc.1999.0314; Sriuranpong V, 2002, MOL CELL BIOL, V22, P3129, DOI 10.1128/MCB.22.9.3129-3139.2002; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Tauler J, 2010, CANCER RES, V70, P7137, DOI 10.1158/0008-5472.CAN-10-0860; Teicher BA, 2014, BIOCHEM PHARMACOL, V87, P211, DOI 10.1016/j.bcp.2013.09.014; Torii MA, 1999, DEVELOPMENT, V126, P443; Wang L, 2011, WORLD J GASTROENTERO, V17, P1434, DOI 10.3748/wjg.v17.i11.1434; Wilkinson G, 2013, NEUROSCIENCE, V253, P256, DOI 10.1016/j.neuroscience.2013.08.029; Winkelmann A, 2014, J CLIN INVEST, V124, P696, DOI 10.1172/JCI71472; Yao LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078439; Zhou J, 2001, BREAST CANCER RES TR, V66, P217, DOI 10.1023/A:1010631915831	61	5	6	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					26973	26988		10.1074/jbc.M114.579391	http://dx.doi.org/10.1074/jbc.M114.579391			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25124043	hybrid, Green Published, Green Accepted			2022-12-25	WOS:000342853900027
J	Sharp, T; Wang, JB; Li, X; Cao, HJ; Gao, S; Moreno, M; Gao, ACS				Sharp, Thad; Wang, Jianbo; Li, Xiao; Cao, Huojun; Gao, Shan; Moreno, Myriam; Amendt, Brad A.			A Pituitary Homeobox 2 (Pitx2):microRNA-200a-3p: beta-catenin Pathway Converts Mesenchymal Cells to Amelogenin-expressing Dental Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMELOBLAST-LINEAGE CELLS; STEM-CELLS; TOOTH MORPHOGENESIS; IN-VITRO; GENE-EXPRESSION; MIR-200 FAMILY; DIFFERENTIAL REGULATION; PROGENITOR CELLS; LEF-1 PROMOTER; CUTTING-EDGE	Pitx2, Wnt/beta-catenin signaling, and microRNAs (miRs) play a critical role in the regulation of dental stem cells during embryonic development. In this report, we have identified a Pitx2: beta-catenin regulatory pathway involved in epithelial cell differentiation and conversion of mesenchymal cells to amelogenin expressing epithelial cells via miR-200a. Pitx2 and beta-catenin are expressed in the labial incisor cervical loop or epithelial stem cell niche, with decreased expression in the differentiating ameloblast cells of the mouse lower incisor. Bioinformatics analyses reveal that miR-200a-3p expression is activated in the pre-ameloblast cells to enhance epithelial cell differentiation. We demonstrate that Pitx2 activates miR-200a-3p expression and miR-200a-3p reciprocally represses Pitx2 and beta-catenin expression. Pitx2 and beta-catenin interact to synergistically activate gene expression during odontogenesis and miR-200a-3p attenuates their expression and directs differentiation. To understand how this mechanism controls cell differentiation and cell fate, oral epithelial and odontoblast mesenchymal cells were reprogrammed by a two-step induction method using Pitx2 and miR-200a-3p. Conversion to amelogenin expressing dental epithelial cells involved an up-regulation of the stem cell marker Sox2 and proliferation genes and decreased expression of mesenchymal markers. E-cadherin expression was increased as well as ameloblast specific factors. The combination of Pitx2, a regulator of dental stem cells and miR-200a converts mesenchymal cells to a fully differentiated dental epithelial cell type. This pathway and reprogramming can be used to reprogram mesenchymal or oral epithelial cells to dental epithelial (ameloblast) cells, which can be used in tissue repair and regeneration studies.	[Sharp, Thad; Li, Xiao; Moreno, Myriam; Amendt, Brad A.] Univ Iowa, Carver Coll Med, Dept Anat & Cell Biol, Iowa City, IA 52242 USA; [Wang, Jianbo; Cao, Huojun; Gao, Shan] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX 77030 USA; [Amendt, Brad A.] Univ Iowa, Carver Coll Med, Craniofacial Anomalies Res Ctr, Iowa City, IA 52242 USA	University of Iowa; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Iowa	Gao, ACS (corresponding author), Univ Iowa, Carver Coll Med, Craniofacial Anomalies Res Ctr, 1-675 BSB,51 Newton Rd, Iowa City, IA 52242 USA.	brad-amendt@uiowa.edu	cao, huojun/M-5431-2017; Li, Xiao/X-3429-2019	Li, Xiao/0000-0001-8527-4438; Amendt, Brad A./0000-0001-6524-1006; Cao, Huojun/0000-0003-4428-8686	University of Iowa College of Dentistry; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013941] Funding Source: NIH RePORTER	University of Iowa College of Dentistry; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank the University of Iowa College of Dentistry for support and preclinical studies, the University of Iowa Carver College of Medicine Bioinformatics and RNA sequencing core. We thank Steven Eliason (University of Iowa, Carver College of Medicine) and Dr. Liu Hong (University of Iowa, College of Dentistry) for technical support.	Amen M, 2008, NUCLEIC ACIDS RES, V36, P462, DOI 10.1093/nar/gkm1047; Amen M, 2007, MOL CELL BIOL, V27, P7560, DOI 10.1128/MCB.00315-07; Amendt BA, 1999, MOL CELL BIOL, V19, P7001; Amendt BA, 1998, J BIOL CHEM, V273, P20066, DOI 10.1074/jbc.273.32.20066; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bei M, 2009, CURR OPIN GENET DEV, V19, P504, DOI 10.1016/j.gde.2009.09.002; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Brabletz S, 2011, EMBO J, V30, P770, DOI 10.1038/emboj.2010.349; Brabletz S, 2010, EMBO REP, V11, P670, DOI 10.1038/embor.2010.117; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Cao H, 2010, J DENT RES, V89, P779, DOI 10.1177/0022034510369304; Cao HJ, 2013, DEVELOPMENT, V140, P3348, DOI 10.1242/dev.089193; Cao HJ, 2010, DEV BIOL, V347, P289, DOI 10.1016/j.ydbio.2010.08.031; Cha KB, 2004, MECH DEVELOP, V121, P183, DOI 10.1016/j.mod.2003.12.002; Chavez MG, 2014, JOVE-J VIS EXP, DOI 10.3791/51266; Chavez MG, 2013, TISSUE ENG PART C-ME, V19, DOI [10.1089/ten.TEC.2012.0232, 10.1089/ten.tec.2012.0232]; CHEN LS, 1992, ARCH ORAL BIOL, V37, P771, DOI 10.1016/0003-9969(92)90110-T; Chen SY, 2013, DEVELOPMENT, V140, P255, DOI 10.1242/dev.083139; Cox CJ, 2002, J BIOL CHEM, V277, P25001, DOI 10.1074/jbc.M201737200; Cui L, 2013, J CLIN INVEST, V123, P1647, DOI 10.1172/JCI65048; Cui XM, 2005, DEV BIOL, V278, P193, DOI 10.1016/j.ydbio.2004.10.023; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; DenBesten PK, 2005, ARCH ORAL BIOL, V50, P689, DOI 10.1016/j.archoralbio.2004.12.008; FARGES JC, 1991, ARCH ORAL BIOL, V36, P737, DOI 10.1016/0003-9969(91)90040-2; Filali M, 2002, J BIOL CHEM, V277, P33398, DOI 10.1074/jbc.M107977200; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Gay I, 2014, J PERIODONTAL RES, V49, P110, DOI 10.1111/jre.12086; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Gronthos S, 2011, METHODS MOL BIOL, V698, P107, DOI 10.1007/978-1-60761-999-4_9; Hanks CT, 1998, EUR J ORAL SCI, V106, P260, DOI 10.1111/j.1600-0722.1998.tb02185.x; Harada H, 1999, J CELL BIOL, V147, P105, DOI 10.1083/jcb.147.1.105; Harada H, 2004, ARCH HISTOL CYTOL, V67, P1, DOI 10.1679/aohc.67.1; Harada H, 2002, DEVELOPMENT, V129, P1533; Hjalt TA, 2000, DEV DYNAM, V218, P195, DOI 10.1002/(SICI)1097-0177(200005)218:1<195::AID-DVDY17>3.0.CO;2-C; Hogan BLM, 1999, CELL, V96, P225, DOI 10.1016/S0092-8674(00)80562-0; Hu JKH, 2014, GENESIS, V52, P79, DOI 10.1002/dvg.22732; Hynes K, 2014, STEM CELLS DEV, V23, P1084, DOI 10.1089/scd.2013.0111; Ikeda E, 2009, P NATL ACAD SCI USA, V106, P13475, DOI 10.1073/pnas.0902944106; Ivey KN, 2010, CELL STEM CELL, V7, P36, DOI 10.1016/j.stem.2010.06.012; Jarvinen E, 2006, P NATL ACAD SCI USA, V103, P18627, DOI 10.1073/pnas.0607289103; Jernvall J, 2000, MECH DEVELOP, V92, P19, DOI 10.1016/S0925-4773(99)00322-6; Jheon AH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024536; Karpowicz P, 2009, J NEUROSCI, V29, P3885, DOI 10.1523/JNEUROSCI.0037-09.2009; Kawano S, 2004, J DENT RES, V83, P129, DOI 10.1177/154405910408300209; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Kratochwil K, 1996, GENE DEV, V10, P1382, DOI 10.1101/gad.10.11.1382; Li CY, 2012, DEV BIOL, V366, P357, DOI 10.1016/j.ydbio.2012.03.012; LIMEBACK H, 1987, BIOCHEM CELL BIOL, V65, P698, DOI 10.1139/o87-092; Lin CR, 1999, NATURE, V401, P279, DOI 10.1038/45803; Liu F, 2010, J DENT RES, V89, P318, DOI 10.1177/0022034510363373; Liu F, 2008, DEV BIOL, V313, P210, DOI 10.1016/j.ydbio.2007.10.016; Liu W, 2003, DEVELOPMENT, V130, P6375, DOI 10.1242/dev.00849; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Maas R, 1997, CRIT REV ORAL BIOL M, V8, P4, DOI 10.1177/10454411970080010101; Martinez NJ, 2010, CELL STEM CELL, V7, P31, DOI 10.1016/j.stem.2010.06.011; Matsumura T, 1998, INT J DEV BIOL, V42, P1137; Menicanin D, 2014, STEM CELLS DEV, V23, P1001, DOI 10.1089/scd.2013.0490; Menicanin D, 2010, STEM CELLS DEV, V19, P1501, DOI 10.1089/scd.2009.0492; Michon F, 2010, DEV BIOL, V340, P355, DOI 10.1016/j.ydbio.2010.01.019; Mongroo Perry S, 2010, Cancer Biol Ther, V10, P219; Morotomi T, 2005, ARCH ORAL BIOL, V50, P695, DOI 10.1016/j.archoralbio.2004.12.006; Mucchielli ML, 1997, DEV BIOL, V189, P275, DOI 10.1006/dbio.1997.8672; Mustonen T, 2002, DEV BIOL, V248, P281, DOI 10.1006/dbio.2002.0734; NAKAHORI Y, 1991, GENOMICS, V9, P264, DOI 10.1016/0888-7543(91)90251-9; Neubuser A, 1997, CELL, V90, P247, DOI 10.1016/S0092-8674(00)80333-5; Noramly S, 1999, DEVELOPMENT, V126, P3509; Peters H, 1999, TRENDS GENET, V15, P59, DOI 10.1016/S0168-9525(98)01662-X; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Sasaki T, 2005, DEV BIOL, V278, P130, DOI 10.1016/j.ydbio.2004.10.021; Sharpe PT, 2005, SCI AM, V293, P34, DOI 10.1038/scientificamerican0805-34; Shi S, 2005, Orthod Craniofac Res, V8, P191, DOI 10.1111/j.1601-6343.2005.00331.x; SNEAD ML, 1985, BIOCHEM BIOPH RES CO, V129, P812, DOI 10.1016/0006-291X(85)91964-3; St Amand TR, 2000, DEV BIOL, V217, P323, DOI 10.1006/dbio.1999.9547; Stockinger A, 2001, J CELL BIOL, V154, P1185, DOI 10.1083/jcb.200104036; Tabata MJ, 1996, ARCH ORAL BIOL, V41, P1019, DOI 10.1016/S0003-9969(96)00087-8; Tabata MJ, 2003, J HISTOCHEM CYTOCHEM, V51, P1673, DOI 10.1177/002215540305101211; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thesleff I, 1996, CURR OPIN CELL BIOL, V8, P844, DOI 10.1016/S0955-0674(96)80086-X; Thesleff I., 2009, TOOTH ORGANOGENESIS; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tucker A, 2004, NAT REV GENET, V5, P499, DOI 10.1038/nrg1380; Tummers M, 2003, DEVELOPMENT, V130, P1049, DOI 10.1242/dev.00332; Tummers M, 2008, EVOL DEV, V10, P187, DOI 10.1111/j.1525-142X.2008.00226.x; Vadlamudi U, 2005, J CELL SCI, V118, P1129, DOI 10.1242/jcs.01706; Venugopalan SR, 2008, HUM MOL GENET, V17, P3643, DOI 10.1093/hmg/ddn258; Wang XP, 2007, PLOS BIOL, V5, P1324, DOI 10.1371/journal.pbio.0050159; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Xia HP, 2010, J BIOL CHEM, V285, P36995, DOI 10.1074/jbc.M110.133744; Yen AHH, 2006, EXPERT OPIN BIOL TH, V6, P9, DOI 10.1517/14712598.6.1.9; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323; ZEICHNERDAVID M, 1995, INT J DEV BIOL, V39, P69; Zhang YD, 2005, CELL RES, V15, P301, DOI 10.1038/sj.cr.7290299; Zhang ZC, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0024608, 10.1371/journal.pone.0028817]; Zhang ZC, 2010, J BIOL CHEM, V285, P34718, DOI 10.1074/jbc.M110.126441	96	33	37	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					27327	27341		10.1074/jbc.M114.575654	http://dx.doi.org/10.1074/jbc.M114.575654			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25122764	Green Published, hybrid			2022-12-25	WOS:000342853900053
J	Koshiar, RL; Somajo, S; Norstrom, E; Dahlback, B				Koshiar, Ruzica Livaja; Somajo, Sofia; Norstrom, Eva; Dahlback, Bjorn			Erythrocyte-Derived Microparticles Supporting Activated Protein C-Mediated Regulation of Blood Coagulation	PLOS ONE			English	Article							FACTOR PATHWAY INHIBITOR; TISSUE FACTOR PATHWAY; SICKLE-CELL-DISEASE; FACTOR VA; THROMBIN GENERATION; VITAMIN-K; FLOW-CYTOMETRY; TFPI-ALPHA; FACTOR-IXA; FACTOR XA	Elevated levels of erythrocyte-derived microparticles are present in the circulation in medical conditions affecting the red blood cells. Erythrocyte-derived microparticles expose phosphatidylserine thus providing a suitable surface for procoagulant reactions leading to thrombin formation via the tenase and prothrombinase complexes. Patients with elevated levels of circulating erythrocyte-derived microparticles have increased thrombin generation in vivo. The aim of the present study was to investigate whether erythrocyte-derived microparticles are able to support the anticoagulant reactions of the protein C system. Erythrocyte-derived microparticles were isolated using ultracentrifugation after incubation of freshly prepared erythrocytes with the ionophore A23187 or from outdated erythrocyte concentrates, the different microparticles preparations yielding similar results. According to flow cytometry analysis, the microparticles exposed phoshatidylserine and bound lactadherin, annexin V, and protein S, which is a cofactor to activated protein C. The microparticles were able to assemble the tenase and prothrombinase complexes and to stimulate the formation of thrombin in plasma-based thrombin generation assay both in presence and absence of added tissue factor. The addition of activated protein C in the thrombin generation assay inhibited thrombin generation in a dose-dependent fashion. The anticoagulant effect of activated protein C in the thrombin generation assay was inhibited by a monoclonal antibody that prevents binding of protein S to microparticles and also attenuated by anti-TFPI antibodies. In the presence of erythrocyte-derived microparticles, activated protein C inhibited tenase and prothrombinase by degrading the cofactors FVIIIa and FVa, respectively. Protein S stimulated the Arg306-cleavage in FVa, whereas efficient inhibition of FVIIIa depended on the synergistic cofactor activity of protein S and FV. In summary, the erythrocyte-derived microparticle surface is suitable for the anticoagulant reactions of the protein C system, which may be important to balance the initiation and propagation of coagulation in vivo.	[Koshiar, Ruzica Livaja; Somajo, Sofia; Norstrom, Eva; Dahlback, Bjorn] Lund Univ, Dept Lab Med, Div Clin Chem, Skane Univ Hosp, Malmo, Sweden	Lund University; Skane University Hospital	Dahlback, B (corresponding author), Lund Univ, Dept Lab Med, Div Clin Chem, Skane Univ Hosp, Malmo, Sweden.	Bjorn.Dahlback@med.lu.se	Somajo, Sofia/ABB-8170-2021	Somajo, Sofia/0000-0003-0433-8079; Dahlback, Bjorn/0000-0003-1546-0328	Swedish Research Council [71430]; Heart and Lung Foundation [20110251]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Heart and Lung Foundation(Swedish Heart-Lung Foundation)	This work was supported by Swedish Research Council #71430 (http://www.vr.se), and Heart and Lung Foundation #20110251 (http://www.hjartlungfonden.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad SS, 2003, J THROMB HAEMOST, V1, P2348, DOI 10.1046/j.1538-7836.2003.00428.x; Ahnstrom J, 2012, BLOOD, V120, P5059, DOI 10.1182/blood-2012-05-432005; Ahnstrom J, 2011, BLOOD, V117, P6685, DOI 10.1182/blood-2010-11-317099; ALLAN D, 1980, BIOCHEM J, V188, P881, DOI 10.1042/bj1880881; Ataga KI, 2003, AM J MED, V115, P721, DOI 10.1016/j.amjmed.2003.07.011; Berckmans RJ, 2001, THROMB HAEMOSTASIS, V85, P639; Bezeaud A, 2002, BRIT J HAEMATOL, V117, P409, DOI 10.1046/j.1365-2141.2002.03445.x; Burnier L, 2009, THROMB HAEMOSTASIS, V101, P439, DOI 10.1160/TH08-08-0521; Canellini G, 2012, BLOOD TRANSFUS-ITALY, V10, pS39, DOI 10.2450/2012.007S; Castoldi E, 2010, J THROMB HAEMOST, V8, P294, DOI 10.1111/j.1538-7836.2009.03712.x; Dahlback B, 2005, ARTERIOSCL THROM VAS, V25, P1311, DOI 10.1161/01.ATV.0000168421.13467.82; DAHLBACK B, 1980, J CLIN INVEST, V66, P583, DOI 10.1172/JCI109890; DAHLBACK B, 1990, J BIOL CHEM, V265, P8127; Duckers C, 2008, BLOOD, V112, P3615, DOI 10.1182/blood-2008-06-162453; Eldor A, 2002, BLOOD, V99, P36, DOI 10.1182/blood.V99.1.36; FUJIKAWA K, 1972, BIOCHEMISTRY-US, V11, P4882, DOI 10.1021/bi00776a002; Gerotziafas GT, 2012, THROMB HAEMOSTASIS, V107, P1044, DOI 10.1160/TH11-10-0689; GILBERT GE, 1991, J BIOL CHEM, V266, P17261; Hackeng TM, 2006, P NATL ACAD SCI USA, V103, P3106, DOI 10.1073/pnas.0504240103; HOFFMAN M, 1992, THROMB HAEMOSTASIS, V68, P74; Horstman LL, 1999, CRIT REV ONCOL HEMAT, V30, P111, DOI 10.1016/S1040-8428(98)00044-4; Hou J, 2011, VOX SANG, V100, P187, DOI 10.1111/j.1423-0410.2010.01375.x; Hugel B, 1999, BLOOD, V93, P3451, DOI 10.1182/blood.V93.10.3451.410k27_3451_3456; Inal JM, 2012, ARCH IMMUNOL THER EX, V60, P107, DOI 10.1007/s00005-012-0165-2; Joop K, 2001, THROMB HAEMOSTASIS, V85, P810; Koch CG, 2013, ANN THORAC SURG, V96, P1894, DOI 10.1016/j.athoracsur.2013.05.116; LANE PA, 1994, AM J HEMATOL, V47, P295, DOI 10.1002/ajh.2830470409; LUNDBLAD RL, 1975, BIOCHEM BIOPH RES CO, V66, P482, DOI 10.1016/0006-291X(75)90536-7; MALM J, 1990, EUR J BIOCHEM, V187, P737, DOI 10.1111/j.1432-1033.1990.tb15361.x; Maroney SA, 2007, BLOOD, V109, P1931, DOI 10.1182/blood-2006-07-037283; Nantakomol D, 2011, J INFECT DIS, V203, P700, DOI 10.1093/infdis/jiq104; Ndonwi M, 2010, BLOOD, V116, P1344, DOI 10.1182/blood-2009-10-246686; NELSESTUEN GL, 1973, P NATL ACAD SCI USA, V70, P3366, DOI 10.1073/pnas.70.12.3366; NICOLAES GAF, 1995, J BIOL CHEM, V270, P21158, DOI 10.1074/jbc.270.36.21158; Norstrom E, 2002, BLOOD, V100, P524, DOI 10.1182/blood-2002-02-0343; Norstrom EA, 2003, J BIOL CHEM, V278, P24904, DOI 10.1074/jbc.M303829200; Norstrom EA, 2006, J BIOL CHEM, V281, P31486, DOI 10.1074/jbc.M606441200; NOVOTNY WF, 1988, BLOOD, V72, P2020; Pattanapanyasat K, 2004, CYTOM PART B-CLIN CY, V57B, P23, DOI 10.1002/cyto.b.10064; Piccin A, 2012, ANN HEMATOL, V91, P1669, DOI 10.1007/s00277-012-1447-9; Rubin O, 2008, VOX SANG, V95, P288, DOI 10.1111/j.1423-0410.2008.01101.x; Rubin O, 2013, TRANSFUSION, V53, P1744, DOI 10.1111/trf.12008; Salzer U, 2008, TRANSFUSION, V48, P451, DOI 10.1111/j.1537-2995.2007.01549.x; Shen L, 1997, BIOCHEMISTRY-US, V36, P16025, DOI 10.1021/bi971730v; SIMS PJ, 1989, J BIOL CHEM, V264, P17049; Somajo S, 2014, THROMBOSIS RES; Spinella PC, 2009, CRIT CARE, V13, DOI 10.1186/cc8050; Sun YH, 2004, J BIOL CHEM, V279, P47528, DOI 10.1074/jbc.M407366200; TANS G, 1991, BLOOD, V77, P2641; TRACY PB, 1982, BLOOD, V60, P59; van Beers EJ, 2009, HAEMATOL-HEMATOL J, V94, P1513, DOI 10.3324/haematol.2009.008938; van der Meijden PEJ, 2012, J THROMB HAEMOST, V10, P1355, DOI 10.1111/j.1538-7836.2012.04758.x; Vincent LM, 2013, J CLIN INVEST, V123, P3777, DOI 10.1172/JCI69091; Wood JP, 2014, ARTERIOSCL THROM VAS, V34, P169, DOI 10.1161/ATVBAHA.113.302655	54	58	59	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e104200	10.1371/journal.pone.0104200	http://dx.doi.org/10.1371/journal.pone.0104200			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136857	Green Published, gold, Green Submitted			2022-12-25	WOS:000340742100020
J	Zander, MA; Cancino, GI; Gridley, T; Kaplan, DR; Miller, FD				Zander, Mark A.; Cancino, Gonzalo I.; Gridley, Thomas; Kaplan, David R.; Miller, Freda D.			The Snail Transcription Factor Regulates the Numbers of Neural Precursor Cells and Newborn Neurons throughout Mammalian Life	PLOS ONE			English	Article							SELF-RENEWAL; STEM; PROTEIN; EXPRESSION; SURVIVAL; FAMILY; MOUSE; GENE; P53; DIFFERENTIATION	The Snail transcription factor regulates diverse aspects of stem cell biology in organisms ranging from Drosophila to mammals. Here we have asked whether it regulates the biology of neural precursor cells (NPCs) in the forebrain of postnatal and adult mice, taking advantage of a mouse containing a floxed Snail allele (Snail(fl/fl) mice). We show that when Snail is inducibly ablated in the embryonic cortex, this has long-term consequences for cortical organization. In particular, when Snail(fl/fl) mice are crossed to Nestin-cre mice that express Cre recombinase in embryonic neural precursors, this causes inducible ablation of Snail expression throughout the postnatal cortex. This loss of Snail causes a decrease in proliferation of neonatal cortical neural precursors and mislocalization and misspecification of cortical neurons. Moreover, these precursor phenotypes persist into adulthood. Adult neural precursor cell proliferation is decreased in the forebrain subventricular zone and in the hippocampal dentate gyrus, and this is coincident with a decrease in the number of adult-born olfactory and hippocampal neurons. Thus, Snail is a key regulator of the numbers of neural precursors and newborn neurons throughout life.	[Zander, Mark A.; Cancino, Gonzalo I.; Kaplan, David R.; Miller, Freda D.] Hosp Sick Children, Program Neurosci & Mental Hlth, Toronto, ON M5G 1X8, Canada; [Zander, Mark A.; Kaplan, David R.; Miller, Freda D.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Kaplan, David R.; Miller, Freda D.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Miller, Freda D.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Gridley, Thomas] Univ Maine, Maine Med Ctr, Res Inst, Scarborough, ME USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto; Maine Medical Center; University of Maine System; University of Maine Orono	Miller, FD (corresponding author), Hosp Sick Children, Program Neurosci & Mental Hlth, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	fredam@sickkids.ca	Cancino, Gonzalo/ABF-6049-2021	Cancino, Gonzalo/0000-0001-8697-7282	Canadian Institute of Health Research [MOP-38021, MOP-13958]; Howard Hughes Medical Institute Senior International Research Scholar; Heart and Stroke Foundation of Canada; Becas Chile postdoctoral fellowship	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Howard Hughes Medical Institute Senior International Research Scholar; Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Becas Chile postdoctoral fellowship	This work was funded by Canadian Institute of Health Research grants MOP-38021 and MOP-13958 to FDM and DRK (http://www.cihr-irsc.gc.ca/). FDM is a Howard Hughes Medical Institute Senior International Research Scholar, and FDM and DRK hold Canada Research Chairs. GIC was funded by a Heart and Stroke Foundation of Canada (www.heartandstroke.com) and Becas Chile postdoctoral fellowship (www.becaschile.cl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acloque H, 2009, J CLIN INVEST, V119, P1438, DOI 10.1172/JCI38019; Ashraf SI, 2001, DEVELOPMENT, V128, P4757; BARBE MF, 1991, J NEUROSCI, V11, P519; Barnabe-Heider F, 2005, NEURON, V48, P253, DOI 10.1016/j.neuron.2005.08.037; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Cai Y, 2001, EMBO J, V20, P1704, DOI 10.1093/emboj/20.7.1704; Cancino GI, 2013, J NEUROSCI, V33, P12569, DOI 10.1523/JNEUROSCI.1251-13.2013; Dugani CB, 2009, J NEUROSCI, V29, P6710, DOI 10.1523/JNEUROSCI.5878-08.2009; Fatt MP, 2014, CELL DEATH DIFFER, V21, P1546, DOI 10.1038/cdd.2014.61; Fujitani M, 2010, CURR BIOL, V20, P2058, DOI 10.1016/j.cub.2010.10.029; Gallagher D, 2013, CELL STEM CELL, V13, P564, DOI 10.1016/j.stem.2013.10.002; Gauthier AS, 2007, NEURON, V54, P245, DOI 10.1016/j.neuron.2007.03.027; Gauthier-Fisher A, 2009, NAT NEUROSCI, V12, P735, DOI 10.1038/nn.2339; Gil-Perotin S, 2006, J NEUROSCI, V26, P1107, DOI 10.1523/JNEUROSCI.3970-05.2006; Hatzold J, 2008, PLOS BIOL, V6, P771, DOI 10.1371/journal.pbio.0060084; Inoue A, 2002, CANCER CELL, V2, P279, DOI 10.1016/S1535-6108(02)00155-1; Itoh Y, 2013, NAT NEUROSCI, V16, P416, DOI 10.1038/nn.3336; Kriegstein A, 2006, NAT REV NEUROSCI, V7, P883, DOI 10.1038/nrn2008; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Kusek G, 2012, CELL STEM CELL, V11, P505, DOI 10.1016/j.stem.2012.06.006; Lai SL, 2012, DEV CELL, V23, P849, DOI 10.1016/j.devcel.2012.09.007; Liang HX, 2012, BIOL OPEN, V1, P1200, DOI 10.1242/bio.20122287; Meletis K, 2006, DEVELOPMENT, V133, P363, DOI 10.1242/dev.02208; Miller FD, 2009, CELL STEM CELL, V4, P507, DOI 10.1016/j.stem.2009.05.008; Murray SA, 2006, GENESIS, V44, P7, DOI 10.1002/gene.20178; Okamoto SI, 2007, CELL STEM CELL, V1, P230, DOI 10.1016/j.stem.2007.07.010; OLEARY DDM, 1992, EXP NEUROL, V115, P121, DOI 10.1016/0014-4886(92)90234-H; Pacary E, 2011, NEURON, V69, P1069, DOI 10.1016/j.neuron.2011.02.018; Postiglione MP, 2011, NEURON, V72, P269, DOI 10.1016/j.neuron.2011.09.022; Radakovits R, 2009, J NEUROSCI, V29, P7694, DOI 10.1523/JNEUROSCI.5537-08.2009; Rembold M, 2014, GENE DEV, V28, P167, DOI 10.1101/gad.230953.113; Schwamborn JC, 2009, CELL, V136, P913, DOI 10.1016/j.cell.2008.12.024; Thellmann M, 2003, DEVELOPMENT, V130, P4057, DOI 10.1242/dev.00597; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Tsui D, 2014, DEV BIOL, V385, P230, DOI 10.1016/j.ydbio.2013.11.005; Tsui D, 2013, J NEUROSCI, V33, P244, DOI 10.1523/JNEUROSCI.1665-12.2013; Vessey JP, 2012, CELL STEM CELL, V11, P517, DOI 10.1016/j.stem.2012.06.010; Wang J, 2012, CELL STEM CELL, V11, P23, DOI 10.1016/j.stem.2012.03.016; Wang J, 2010, DEV CELL, V18, P114, DOI 10.1016/j.devcel.2009.10.023; Wu WS, 2005, CELL, V123, P641, DOI 10.1016/j.cell.2005.09.029; Zander MA, 2014, J NEUROSCI, V34, P5164, DOI 10.1523/JNEUROSCI.0370-14.2014	41	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e104767	10.1371/journal.pone.0104767	http://dx.doi.org/10.1371/journal.pone.0104767			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136812	Green Submitted, gold, Green Published			2022-12-25	WOS:000340742100045
J	Kansiime, C; Rutebemberwa, E; Mugisha, A; Mugisha, S; Asiimwe, BB; Rwego, IB; Kiwanuka, SN				Kansiime, Catherine; Rutebemberwa, Elizeus; Mugisha, Anthony; Mugisha, Samuel; Asiimwe, Benon B.; Rwego, Innocent B.; Kiwanuka, Suzanne N.			Determinants of Patients' Choice of Provider in Accessing Brucellosis Care among Pastoral Communities Adjacent to Lake Mburo National Park in Kiruhura District, Uganda	PLOS ONE			English	Article							HEALTH-SEEKING BEHAVIOR; SUB-SAHARAN AFRICA; SERVICES; POOR; CHILDREN; EQUITY	Background: Brucellosis is the commonest zoonotic infection worldwide with symptoms similar to other febrile syndromes such as malaria and typhoid fever. It is often easily misdiagnosed, resulting in underreporting and misdirected treatments. Understanding of the factors that influence brucellosis care seeking is essential in enhancing its effective management. Our study sought to determine the factors associated with choice of provider in accessing care for brucellosis among pastoral communities in Uganda. Methods: This was a cross-sectional survey involving 245 randomly selected respondents previously diagnosed and treated for brucellosis, two months before the study. They were enrolled from three sub-counties neighboring Lake Mburo National Park between December 2012 to April 2013. Data on socio-demographics, availability, accessibility, affordability and acceptability of health services were collected. A multivariable logistic regression model was fitted to determine association between independent and outcome variables using odds ratios and 95% confidence intervals with p-value <= 0.05 considered statistically significant. Results: Of the 245 respondents, 127(51.8%) sought health care at government facilities and the rest at private. Respondents who were less likely to choose a government facility were either single (OR: 0.50, CI: 0.26-0.97), had general weakness (OR: 0.09, CI: 0.01-0.72) or whom family took a decision (OR: 0.52, CI: 0.28-0.97). At multivariable analysis, choice of government facility was influenced by primary education (aOR: 0.46, CI: 0.22-0.97), having six to ten household members (aOR: 3.71, CI: 1.84-7.49), family advice (aOR: 0.64, CI: 0.23-0.91), distance >= 10 kms (aOR: 0.44, CI: 0.21-0.92), high costs at private clinics (aOR: 0.01, CI: 0.02-0.15) and no diagnosis at government facility (aOR: 0.11, CI: 0.01-0.97). Females were more likely to seek health care at government facilities, while those with tertiary education were less likely, after the first provider. Conclusions: Females and households with six to ten members were more likely to choose government facilities. Government facilities need to be equipped to attract more patients.	[Kansiime, Catherine; Rutebemberwa, Elizeus; Kiwanuka, Suzanne N.] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Hlth Policy Planning & Management, Kampala, Uganda; [Mugisha, Anthony] Makerere Univ, Sch Vet Med & Anim Resources, Kampala, Uganda; [Mugisha, Samuel; Rwego, Innocent B.] Makerere Univ, Coll Nat Sci, Dept Biol Sci, Kampala, Uganda; [Asiimwe, Benon B.] Makerere Univ, Coll Hlth Sci, Dept Med Microbiol, Kampala, Uganda; [Rwego, Innocent B.] Univ Minnesota, Coll Vet Med, Ecosyst Hlth Initiat, St Paul, MN 55108 USA	Makerere University; Makerere University; Makerere University; Makerere University; University of Minnesota System; University of Minnesota Twin Cities	Kansiime, C (corresponding author), Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Hlth Policy Planning & Management, Kampala, Uganda.	cathie.kansiime@gmail.com	; Rwego, Innocent Bidason/I-5049-2013	Rutebemberwa, Elizeus/0000-0001-8363-7928; Rwego, Innocent Bidason/0000-0003-1274-7788	International Development Research Council (IDRC), Canada	International Development Research Council (IDRC), Canada	CK, SM, BBA, IBR received funding from the International Development Research Council (IDRC), Canada. http://www.idrc.ca/EN/Page/default.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amone Joseph, 2005, Int J Equity Health, V4, P6, DOI 10.1186/1475-9276-4-6; [Anonymous], UG MOH ANN HLTH SECT; Aye M, 2002, SOC SCI MED, V55, P1929, DOI 10.1016/S0277-9536(01)00322-7; Bakeera SK, 2009, INT J EQUITY HEALTH, V8, DOI 10.1186/1475-9276-8-25; Bax HI, 2007, NETH J MED, V65, P352; Dean AS, 2012, PLOS NEGLECT TROP D, V6, DOI [10.1371/journal.pntd.0001929, 10.1371/journal.pntd.0001865]; Ensor T, 2004, HEALTH POLICY PLANN, V19, P69, DOI 10.1093/heapol/czh009; Government of Uganda, 2005, HLTH SECT PERF REP; Kangwana BB, 2009, AM J TROP MED HYG, V80, P737, DOI 10.4269/ajtmh.2009.80.737; Kish L, 1965, SURVEY SAMPLING; Kiwanuka SN, 2008, T ROY SOC TROP MED H, V102, P1067, DOI 10.1016/j.trstmh.2008.04.023; Kunda J, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-315; Makita K, 2008, ANN NY ACAD SCI, V1149, P309, DOI 10.1196/annals.1428.015; Mamdani M, 2004, REPROD HEALTH MATTER, V12, P138, DOI 10.1016/S0968-8080(04)24135-0; MCPAKE B, 2002, HLTH EC INT PERSPECT; Merle V, 2009, J HOSP INFECT, V71, P263, DOI 10.1016/j.jhin.2008.11.025; Mukanga D, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-121; O'Donnell O, 2007, CAD SAUDE PUBLICA, V23, P2820, DOI 10.1590/S0102-311X2007001200003; Obrist B, 2007, PLOS MED, V4, P1584, DOI 10.1371/journal.pmed.0040308; Odaga J, 2004, HLTH POLICY DEV, V2, P192; Oliver A, 2004, J EPIDEMIOL COMMUN H, V58, P655, DOI 10.1136/jech.2003.017731; Pappas G, 2006, LANCET INFECT DIS, V6, P91, DOI 10.1016/S1473-3099(06)70382-6; Pappas G, 2005, NEW ENGL J MED, V352, P2325, DOI 10.1056/NEJMra050570; Pariyo GW, 2009, INT J EQUITY HEALTH, V8, DOI 10.1186/1475-9276-8-39; Peters DH, 2008, ANN NY ACAD SCI, V1136, P161, DOI 10.1196/annals.1425.011; Robertson R, 2011, J HEALTH SERV RES PO, V16, P22, DOI 10.1258/jhsrp.2010.010084; Rutebemberwa E, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-45; Rutherford ME, 2010, TROP MED INT HEALTH, V15, P508, DOI 10.1111/j.1365-3156.2010.02497.x; Smits LH, 2004, AFR J BIOTECHNOL, V3, P631; Tai WTC, 2004, HEALTH SERV RES, V39, P1903, DOI 10.1111/j.1475-6773.2004.00324.x; Thorson A, 2000, LANCET, V356, P1823, DOI 10.1016/S0140-6736(00)03241-4; WHO, 2006, ZOON FOOD SAF; Williams HA, 2004, SOC SCI MED, V59, P501, DOI 10.1016/j.socscimed.2003.11.010; Yimer S, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-454	34	8	8	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105276	10.1371/journal.pone.0105276	http://dx.doi.org/10.1371/journal.pone.0105276			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO4JF	25133548	Green Submitted, gold, Green Published			2022-12-25	WOS:000341302700096
J	Raicevich, S; Minute, F; Finoia, MG; Caranfa, F; Di Muro, P; Scapolan, L; Beltramini, M				Raicevich, Sasa; Minute, Fabrizio; Finoia, Maria Grazia; Caranfa, Francesca; Di Muro, Paolo; Scapolan, Lucia; Beltramini, Mariano			Synergistic and Antagonistic Effects of Thermal Shock, Air Exposure, and Fishing Capture on the Physiological Stress of Squilla mantis (Stomatopoda)	PLOS ONE			English	Article							CRUSTACEAN HYPERGLYCEMIC HORMONE; ACID-BASE-BALANCE; DECAPOD CRUSTACEANS; ION-TRANSPORT; MORTALITY; AMMONIUM; L.; RESPIRATION; TEMPERATURE; EXCRETION	This study is aimed at assessing the effects of multiple stressors (thermal shock, fishing capture, and exposure to air) on the benthic stomatopod Squilla mantis, a burrowing crustacean quite widespread in the Mediterranean Sea. Laboratory analyses were carried out to explore the physiological impairment onset over time, based on emersion and thermal shocks, on farmed individuals. Parallel field-based studies were carried out to also investigate the role of fishing (i.e., otter trawling) in inducing physiological imbalance in different seasonal conditions. The dynamics of physiological recovery from physiological disruption were also studied. Physiological stress was assessed by analysing hemolymph metabolites (L-Lactate, D-glucose, ammonia, and H+), as well as glycogen concentration in muscle tissues. The experiments were carried out according to a factorial scheme considering the three factors (thermal shock, fishing capture, and exposure to air) at two fixed levels in order to explore possible synergistic, additive, or antagonistic effects among factors. Additive effects on physiological parameters were mainly detected when the three factors interacted together while synergistic effects were found as effect of the combination of two factors. This finding highlights that the physiological adaptive and maladaptive processes induced by the stressors result in a dynamic response that may encounter physiological limits when high stress levels are sustained. Thus, a further increase in the physiological parameters due to synergies cannot be reached. Moreover, when critical limits are encountered, mortality occurs and physiological parameters reflect the response of the last survivors. In the light of our mortality studies, thermal shock and exposure to air have the main effect on the survival of S. mantis only on trawled individuals, while lab-farmed individuals did not show any mortality during exposure to air until after 2 hours.	[Raicevich, Sasa] ISPRA, Natl Inst Environm Protect & Res, Chioggia, Italy; [Minute, Fabrizio; Caranfa, Francesca; Di Muro, Paolo; Scapolan, Lucia; Beltramini, Mariano] Univ Padua, Dept Biol, Padua, Italy; [Finoia, Maria Grazia] ISPRA, Natl Inst Environm Protect & Res, Rome, Italy	Italian Institute for Environmental Protection & Research (ISPRA); University of Padua; Italian Institute for Environmental Protection & Research (ISPRA)	Beltramini, M (corresponding author), Univ Padua, Dept Biol, Padua, Italy.	mariano.beltramini@unipd.it		Raicevich, Sasa/0000-0002-9323-031X	Regione Veneto "Progetto Clodia", MURST; FP7 EU project GAP2 (Bridging the gap between science, stakeholders and policy makers) [266544]; ISPRA	Regione Veneto "Progetto Clodia", MURST; FP7 EU project GAP2 (Bridging the gap between science, stakeholders and policy makers); ISPRA	This work was financially supported by Regione Veneto "Progetto Clodia", MURST (ex-60%), Co-funded by the FP7 EU project GAP2 (Bridging the gap between science, stakeholders and policy makers), Grant agreement no.: 266544, and ISPRA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson RJA, 1997, MAR ECOL-P S Z N I, V18, P337, DOI 10.1111/j.1439-0485.1997.tb00446.x; Bergmann M, 2001, J EXP MAR BIOL ECOL, V259, P215, DOI 10.1016/S0022-0981(01)00231-3; Bergmann M, 2001, ICES J MAR SCI, V58, P163, DOI 10.1006/jmsc.2000.0999; Box GE., 1978, STAT EXPT; Bridges CR, 2001, J EXP BIOL, V204, P1021; CARROLL NV, 1956, J BIOL CHEM, V220, P583; Chung JS, 2010, GEN COMP ENDOCR, V166, P447, DOI 10.1016/j.ygcen.2009.12.011; Crain CM, 2008, ECOL LETT, V11, P1304, DOI 10.1111/j.1461-0248.2008.01253.x; da Silva-Castiglioni D, 2010, COMP BIOCHEM PHYS A, V156, P436, DOI 10.1016/j.cbpa.2010.03.025; Darling ES, 2008, ECOL LETT, V11, P1278, DOI 10.1111/j.1461-0248.2008.01243.x; Darling ES, 2010, CONSERV LETT, V3, P122, DOI 10.1111/j.1755-263X.2009.00089.x; Davis MW, 2002, CAN J FISH AQUAT SCI, V59, P1834, DOI 10.1139/F02-139; Gaitan-Espitia JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070662; Durand F, 2000, COMP BIOCHEM PHYS A, V127, P259, DOI 10.1016/S1095-6433(00)00253-1; Fanjul-Moles ML, 2006, COMP BIOCHEM PHYS C, V142, P390, DOI 10.1016/j.cbpc.2005.11.021; Folt CL, 1999, LIMNOL OCEANOGR, V44, P864, DOI 10.4319/lo.1999.44.3_part_2.0864; Froglia C., 1989, Collana U.Z.I. Selected Symposia and Monographs, P221; Froglia C, 1996, 14MED93016 EU DG; Gamito R, 2003, FISH RES, V63, P423, DOI 10.1016/S0165-7836(03)00108-5; Gehan EA, 1975, SURVIVAL DISTRIBUTIO, P120; Giomi F, 2008, HYDROBIOLOGIA, V606, P195, DOI 10.1007/s10750-008-9336-x; Glazier DS, 2005, BIOL REV, V80, P611, DOI 10.1017/S1464793105006834; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Harris RR, 2004, ICES J MAR SCI, V61, P127, DOI 10.1016/j.icesjms.2003.08.002; HENRY RP, 1992, AM ZOOL, V32, P407; IVLEVA IV, 1980, INT REV GES HYDROBIO, V65, P1, DOI 10.1002/iroh.19800650102; KAISER MJ, 1995, MAR ECOL PROG SER, V126, P31, DOI 10.3354/meps126031; Lorenzon S, 2004, J EXP ZOOL PART A, V301A, P727, DOI 10.1002/jez.a.59; Lorenzon S, 2013, FISH RES, V137, P9, DOI 10.1016/j.fishres.2012.08.015; MANGUM CP, 1985, J CRUSTACEAN BIOL, V5, P185, DOI 10.2307/1547865; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Maynou F, 2004, CRUSTACEANA, V77, P1081, DOI 10.1163/1568540042900295; McMahon BR, 2001, RESP PHYSIOL, V128, P349, DOI 10.1016/S0034-5687(01)00311-5; Narayanaswamy BE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058909; Portner HO, 2010, J EXP BIOL, V213, P881, DOI 10.1242/jeb.037523; Portner HO, 2006, PHYSIOL BIOCHEM ZOOL, V79, P295, DOI 10.1086/499986; Pranovi F, 2001, MAR BIOL, V139, P863; PRESSLEY TA, 1981, AM J PHYSIOL, V241, pR370, DOI 10.1152/ajpregu.1981.241.5.R370; Qadri SA, 2007, J EXP BIOL, V210, P1245, DOI 10.1242/jeb.02709; Raicevich S, 2011, HYDROBIOLOGIA, V664, P107, DOI 10.1007/s10750-010-0590-3; SANTOS EA, 1993, COMP BIOCHEM PHYS A, V106, P343, DOI 10.1016/0300-9629(93)90523-7; SANTOS EA, 1993, J COMP PHYSIOL B, V163, P374; Stillman JH, 2002, INTEGR COMP BIOL, V42, P790, DOI 10.1093/icb/42.4.790; Stoner AW, 2012, REV FISH SCI, V20, P111, DOI 10.1080/10641262.2012.689025; Sunday JM, 2012, NAT CLIM CHANGE, V2, P686, DOI 10.1038/NCLIMATE1539; Thioulouse J, 1997, STAT COMPUT, V7, P75, DOI 10.1023/A:1018513530268; Todgham AE, 2013, INTEGR COMP BIOL, V53, P539, DOI 10.1093/icb/ict086; TOWLE DW, 1987, AM J PHYSIOL, V252, pR479, DOI 10.1152/ajpregu.1987.252.3.R479; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; Weihrauch D, 2001, AM ZOOL, V41, P1621; Weihrauch D, 2002, J EXP BIOL, V205, P2765	51	9	9	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105060	10.1371/journal.pone.0105060	http://dx.doi.org/10.1371/journal.pone.0105060			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133593	Green Published, gold, Green Submitted			2022-12-25	WOS:000341302700064
J	Stotz, M; Szkandera, J; Seidel, J; Stojakovic, T; Samonigg, H; Reitz, D; Gary, T; Kornprat, P; Schaberl-Moser, R; Hoefler, G; Gerger, A; Pichler, M				Stotz, Michael; Szkandera, Joanna; Seidel, Julia; Stojakovic, Tatjana; Samonigg, Hellmut; Reitz, Daniel; Gary, Thomas; Kornprat, Peter; Schaberl-Moser, Renate; Hoefler, Gerald; Gerger, Armin; Pichler, Martin			Evaluation of Uric Acid as a Prognostic Blood-Based Marker in a Large Cohort of Pancreatic Cancer Patients	PLOS ONE			English	Article							REACTIVE PROTEIN-LEVELS; NEOADJUVANT FOLFIRINOX; DUCTAL ADENOCARCINOMA; LYMPHOCYTE RATIO; SURVIVAL; PANCREATICODUODENECTOMY; INFLAMMATION; GEMCITABINE; PROGRESSION; NEUTROPHIL	Background: Recently, chemical blood parameters gain more attraction as potential prognostic parameters in pancreatic cancer (PC). In the present study we investigated the prognostic relevance of the uric acid (UA) level in blood plasma at the time of diagnosis for overall survival (OS) in a large cohort of patients with PC. Patients and Methods: Data from 466 consecutive patients with ductal adenocarcinoma of the pancreas were evaluated retrospectively. Overall survival (OS) was analysed using the Kaplan-Meier method. To further evaluate the prognostic significance of the UA level, univariate and multivariate Cox regression models were calculated. Results: None of the clinicopathological parameters (tumour grade, clinical stage, age, CA19-9 level, Karnofski Index (KI) or surgical resection) except gender was associated with UA level. In univariate analysis we observed the elevated UA level (<5.1 versus >= 5.1 mg/dl, p = 0.017) as poor prognostic factor for OS. In the multivariate analysis that included age, gender, tumour grade, tumour stage, surgical resection, CA19-9 level, the KI and UA level we confirmed the UA level as independent prognostic factor for OS (HR = 1.373%; CI = 1.077-1.751; p = 0.011). Conclusion: In conclusion, we identified the UA level at time of diagnosis as an independent prognostic factor in PC patients. Our results indicate that the UA level might represent a novel and useful marker for patient stratification in PC management.	[Stotz, Michael; Szkandera, Joanna; Seidel, Julia; Samonigg, Hellmut; Reitz, Daniel; Schaberl-Moser, Renate; Gerger, Armin; Pichler, Martin] Med Univ Graz, Dept Med, Div Clin Oncol, Graz, Austria; [Stojakovic, Tatjana] Med Univ Graz, Inst Clin Med, Graz, Austria; [Stojakovic, Tatjana] Med Univ Graz, Chem Lab Diagnost, Graz, Austria; [Gary, Thomas] Med Univ Graz, Dept Med, Div Angiol, Graz, Austria; [Kornprat, Peter] Med Univ Graz, Dept Surg, Div Gen Surg, Graz, Austria; [Hoefler, Gerald] Med Univ Graz, Inst Pathol, Graz, Austria; [Stotz, Michael; Szkandera, Joanna; Gerger, Armin] Med Univ Graz, Dept Med, Div Clin Oncol, Res Unit Genet Epidemiol & Pharmacogenet, Graz, Austria; [Pichler, Martin] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA	Medical University of Graz; Medical University of Graz; Medical University of Graz; Medical University of Graz; Medical University of Graz; Medical University of Graz; Medical University of Graz; University of Texas System; UTMD Anderson Cancer Center	Stotz, M (corresponding author), Med Univ Graz, Dept Med, Div Clin Oncol, Graz, Austria.	michael.stotz@medunigraz.at	, Kornprat/AAH-6353-2019; Hoefler, Gerald/H-1796-2016	Reitz, Daniel/0000-0003-0539-9092; Hoefler, Gerald/0000-0002-9056-3063; Pichler, Martin/0000-0002-8701-9462; Szkandera, Joanna/0000-0002-2217-893X				Absenger G, 2013, BRIT J CANCER, V109, P395, DOI 10.1038/bjc.2013.346; AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; Baldwin W, 2011, DIABETES, V60, P1258, DOI 10.2337/db10-0916; Benckert C, 2012, SURG TODAY, V42, P169, DOI 10.1007/s00595-011-0045-0; Christians KK, 2014, ONCOLOGIST, V19, P266, DOI 10.1634/theoncologist.2013-0273; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Dhankhar R, 2011, CLIN LAB, V57, P795; Dziaman T, 2013, INT J CANC; Fabbrini E, 2013, DIABETES; Fini MA, 2012, CLIN TRANSL MED, V1, DOI 10.1186/2001-1326-1-16; Fortner JG, 1996, ANN SURG, V223, P147, DOI 10.1097/00000658-199602000-00006; Heinemann V, 2013, ANN ONCOL, V24, P2484, DOI 10.1093/annonc/mdt239; Heinig M, 2006, CLEV CLIN J MED, V73, P1059, DOI 10.3949/ccjm.73.12.1059; Hochberg J, 2007, HAEMATOLOGICA, V93, P9, DOI 10.3324/haematol.12327; Jackson AL, 2001, MUTAT RES-FUND MOL M, V477, P7, DOI 10.1016/S0027-5107(01)00091-4; Kang DH, 2005, AM J NEPHROL, V25, P425, DOI 10.1159/000087713; Lin H, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-121; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; NIEDERHUBER JE, 1995, CANCER, V76, P1671, DOI 10.1002/1097-0142(19951101)76:9<1671::AID-CNCR2820760926>3.0.CO;2-R; Ozaki H, 1999, SURG TODAY, V29, P16; Raut CP, 2007, ANN SURG, V246, P52, DOI 10.1097/01.sla.0000259391.84304.2b; Richter A, 2003, WORLD J SURG, V27, P324, DOI 10.1007/s00268-002-6659-z; Sautin YY, 2007, AM J PHYSIOL-CELL PH, V293, pC584, DOI 10.1152/ajpcell.00600.2006; Shi Y, 2000, P NATL ACAD SCI USA, V97, P14590, DOI 10.1073/pnas.260497597; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; Shin HS, 2006, J PAIN SYMPTOM MANAG, V31, P493, DOI 10.1016/j.jpainsymman.2005.11.014; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Storz P, 2005, FRONT BIOSCI-LANDMRK, V10, P1881, DOI 10.2741/1667; Stotz M, 2013, BRIT J CANCER, V109, P416, DOI 10.1038/bjc.2013.332; Stotz M, 2013, J CLIN PATHOL, V66, P753, DOI 10.1136/jclinpath-2012-201394; Szkandera J, 2014, BRIT J CANCER, V110, P183, DOI 10.1038/bjc.2013.701; Szkandera J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078225; Szkandera J, 2013, TUMOR BIOL, V34, P2183, DOI 10.1007/s13277-013-0754-7; Tinchon C, 2013, ACTA ONCOL, V52, P1231, DOI 10.3109/0284186X.2013.771821; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Wiseman H, 1996, BIOCHEM J, V313, P17, DOI 10.1042/bj3130017; Xu XL, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-194	37	21	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e104730	10.1371/journal.pone.0104730	http://dx.doi.org/10.1371/journal.pone.0104730			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133546	gold, Green Submitted, Green Published			2022-12-25	WOS:000341302700039
J	Bachstetter, AD; Webster, SJ; Tu, T; Goulding, DS; Haiech, J; Watterson, DM; Van Eldik, LJ				Bachstetter, Adam D.; Webster, Scott J.; Tu, Tao; Goulding, Danielle S.; Haiech, Jacques; Watterson, D. Martin; Van Eldik, Linda J.			Generation and Behavior Characterization of CaMKII beta Knockout Mice	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; ALPHA-CAMKII; MOUSE MODEL; BRAIN; PLASTICITY; SYNAPSES; STAGE	The calcium/calmodulin-dependent protein kinase II (CaMKII) is abundant in the brain, where it makes important contributions to synaptic organization and homeostasis, including playing an essential role in synaptic plasticity and memory. Four genes encode isoforms of CaMKII (alpha, beta, delta, gamma), with CaMKII alpha and CaMKII beta highly expressed in the brain. Decades of molecular and cellular research, as well as the use of a large number of CaMKII alpha mutant mouse lines, have provided insight into the pivotal roles of CaMKII alpha in brain plasticity and cognition. However, less is known about the CaMKII beta isoform. We report the development and extensive behavioral and phenotypic characterization of a CaMKII beta knockout (KO) mouse. The CaMKII beta KO mouse was found to be smaller at weaning, with an altered body mass composition. The CaMKII beta KO mouse showed ataxia, impaired forelimb grip strength, and deficits in the rotorod, balance beam and running wheel tasks. Interestingly, the CaMKII beta KO mouse exhibited reduced anxiety in the elevated plus maze and open field tests. The CaMKII beta KO mouse also showed cognitive impairment in the novel object recognition task. Our results provide a comprehensive behavioral characterization of mice deficient in the beta isoform of CaMKII. The neurologic phenotypes and the construction of the genotype suggest the utility of this KO mouse strain for future studies of CaMKII beta in brain structure, function and development.	[Bachstetter, Adam D.; Webster, Scott J.; Goulding, Danielle S.; Van Eldik, Linda J.] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; [Van Eldik, Linda J.] Univ Kentucky, Dept Anat & Neurobiol, Lexington, KY 40536 USA; [Tu, Tao; Watterson, D. Martin] Northwestern Univ, Feinberg Sch Med, Dept Biol Chem & Mol Pharmacol, Chicago, IL 60611 USA; [Haiech, Jacques] Univ Strasbourg, Lab Innovat Therapeut, Strasbourg, France	University of Kentucky; University of Kentucky; Northwestern University; Feinberg School of Medicine; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Van Eldik, LJ (corresponding author), Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA.	linda.vaneldik@uky.edu	haiech, jacques J/F-2890-2010	Bachstetter, Adam/0000-0003-4646-6757; Watterson, Daniel/0000-0001-7605-5866; haiech, jacques/0000-0003-2908-8053	National Institute on Aging [F32 AG037280, K99 AG044445]; National Institute of Neurological Disorders and Stroke [F32 NS084605]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103527] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS084605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F32AG037280, K99AG044445] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	ADB was supported by National Institute on Aging F32 AG037280 and K99 AG044445. SJW was supported by National Institute of Neurological Disorders and Stroke F32 NS084605. Metabolic measurements were supported by National Institutes of Health P20 RR021954 and P20 GM103527. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachstetter AD, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-146; Bachstetter AD, 2013, J NEUROSCI, V33, P6143, DOI 10.1523/JNEUROSCI.5399-12.2013; Bachstetter AD, 2012, J NEUROSCI, V32, P10201, DOI 10.1523/JNEUROSCI.1496-12.2012; BARNETT SA, 1981, BEHAV NEURAL BIOL, V31, P73, DOI 10.1016/S0163-1047(81)91098-0; Baucum AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031554; Borgesius NZ, 2011, J NEUROSCI, V31, P10141, DOI 10.1523/JNEUROSCI.5105-10.2011; Cervia D, 2011, GEN PHYSIOL BIOPHYS, V30, P251, DOI 10.4149/gpb_2011_03_251; Coultrap SJ, 2012, TRENDS NEUROSCI, V35, P607, DOI 10.1016/j.tins.2012.05.003; Deacon RMJ, 2006, NAT PROTOC, V1, P1117, DOI 10.1038/nprot.2006.170; Fink CC, 2003, NEURON, V39, P283, DOI 10.1016/S0896-6273(03)00428-8; FOX MW, 1965, ANIM BEHAV, V13, P232, DOI 10.1016/0003-3472(65)90040-0; Gaskill BN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032799; Hell JW, 2014, NEURON, V81, P249, DOI 10.1016/j.neuron.2013.12.024; Kamata A, 2006, J NEUROCHEM, V96, P195, DOI 10.1111/j.1471-4159.2005.03531.x; Li K, 2013, SCIENCE, V341, P1016, DOI 10.1126/science.1240729; Lin YC, 2008, P NATL ACAD SCI USA, V105, P15791, DOI 10.1073/pnas.0804399105; Lisman J, 2012, NAT REV NEUROSCI, V13, P169, DOI 10.1038/nrn3192; Okamoto KI, 2007, P NATL ACAD SCI USA, V104, P6418, DOI 10.1073/pnas.0701656104; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Puram SV, 2011, NAT NEUROSCI, V14, P973, DOI 10.1038/nn.2857; Sik A, 2003, BEHAV BRAIN RES, V147, P49, DOI 10.1016/S0166-4328(03)00117-7; Swulius MT, 2008, CELL MOL LIFE SCI, V65, P2637, DOI 10.1007/s00018-008-8086-2; Thiagarajan TC, 2002, NEURON, V36, P1103, DOI 10.1016/S0896-6273(02)01049-8; Tinsley FC, 2004, OBES RES, V12, P150, DOI 10.1038/oby.2004.20; Vallano ML, 2000, GLIA, V30, P154, DOI 10.1002/(SICI)1098-1136(200004)30:2<154::AID-GLIA5>3.0.CO;2-S; van Woerden GM, 2009, NAT NEUROSCI, V12, P823, DOI 10.1038/nn.2329; Waggener CT, 2013, J NEUROSCI, V33, P10453, DOI 10.1523/JNEUROSCI.5875-12.2013; Webster SJ, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt182	28	29	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105191	10.1371/journal.pone.0105191	http://dx.doi.org/10.1371/journal.pone.0105191			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127391	Green Published, Green Submitted, gold			2022-12-25	WOS:000340879300093
J	Kang, DH; Lee, JY; Hah, YS; Chung, DY; Lee, DH; Cho, KS				Kang, Dong Hyuk; Lee, Joo Yong; Hah, Yoon Soo; Chung, Doo Yong; Lee, Dae Hun; Cho, Kang Su			Correlation of Prostatic Urethral Angle with the Severity of Urinary Symptom and Peak Flow Rate in Men with Small Prostate Volume	PLOS ONE			English	Article							BLADDER OUTLET OBSTRUCTION; TRANSITION ZONE INDEX; TRACT SYMPTOMS; NATURAL-HISTORY; HYPERPLASIA; SCORE; UROFLOWMETRY; ANGULATION; ETIOLOGY	Purpose: To evaluate the effects of prostatic anatomical factors on male lower urinary tract symptoms (LUTS) and the peak flow rate (Qmax) in patients with small prostate volume (PV). Materials and Methods: Records were obtained from a prospectively maintained database of first-visit men with LUTS. Patients whose total PV (TPV) was greater than 30 mL were excluded; 444 patients were enrolled in the study. The TPV, transitional zone volume (TZV), transitional zone index (TZI), intravesical prostatic protrusion (IPP), and prostatic urethral angle (PUA) were measured by transrectal ultrasonography. LUTS were evaluated using the International Prostate Symptom Score (IPSS) and the Overactive Bladder Symptom Score (OABSS) questionnaires. Uroflowmetric measurements were also made. Results: PUA (r = 0.269, P < 0.001), TZV (r = 0.160, P < 0.001), and TZI (r = 0.109, P = 0.022) significantly correlated with the IPSS. Qmax (r = -0.334, P < 0.001) and OABSS (r = 0.211, P < 0.001) correlated only with PUA. In a multivariate regression analysis, PUA and age were independently associated with IPSS, OABSS, and Qmax. For IPSS of 20 or greater, the area under the ROC curve (AUC) of PUA was 0.667 and the cut-off value was 43.7 degrees. When Qmax was 10 mL/s or less, the AUC of PUA was 0.664 and the cut-off value was 43.5 degrees. Conclusions: PUA has a significant association with symptom severity and Qmax among prostatic anatomical factors analyzed in men with LUTS and small PV. PUA should be considered as an important clinical factor in male LUTS management. Furthermore, the impact of PUA on response to medical treatment and disease progression needs to be investigated.	[Kang, Dong Hyuk] Yangpyeong Hlth Ctr, Dept Urol, Yangpyeong, South Korea; [Lee, Joo Yong; Hah, Yoon Soo; Chung, Doo Yong] Yonsei Univ, Coll Med, Dept Urol, Severance Hosp,Urol Sci Inst, Seoul, South Korea; [Lee, Dae Hun] Yonsei Univ Hlth Syst, Dept Urol, Seoul, South Korea; [Cho, Kang Su] Yonsei Univ, Coll Med, Dept Urol, Gangnam Severance Hosp,Urol Sci Inst, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Cho, KS (corresponding author), Yonsei Univ, Coll Med, Dept Urol, Gangnam Severance Hosp,Urol Sci Inst, Seoul, South Korea.	kscho99@yuhs.ac	Lee, Joo Yong/C-3851-2013	Lee, Joo Yong/0000-0002-3470-1767; Cho, Kang Su/0000-0002-3500-8833; Hah, Yoon Soo/0000-0001-6424-4619				Bang WJ, 2012, UROLOGY, V80, P1333, DOI 10.1016/j.urology.2012.08.058; Bushman W, 2009, UROL CLIN N AM, V36, P403, DOI 10.1016/j.ucl.2009.07.003; Chia SJ, 2003, BJU INT, V91, P371, DOI 10.1046/j.1464-410X.2003.04088.x; Cho KS, 2008, UROLOGY, V71, P858, DOI 10.1016/j.urology.2008.01.019; Cho KS, 2008, MED HYPOTHESES, V70, P532, DOI 10.1016/j.mehy.2007.07.012; Choi J, 2002, EUR UROL, V42, P7, DOI 10.1016/S0302-2838(02)00222-1; elDin KE, 1996, UROLOGY, V48, P393; Franciosi M, 2007, INT UROL NEPHROL, V39, P871, DOI 10.1007/s11255-006-9148-8; GIRMAN CJ, 1995, J UROLOGY, V153, P1510, DOI 10.1016/S0022-5347(01)67448-2; Homma Y, 1997, Int J Urol, V4, P40, DOI 10.1111/j.1442-2042.1997.tb00138.x; KAPLAN SA, 1995, J UROLOGY, V154, P1764, DOI 10.1016/S0022-5347(01)66779-X; Ku JH, 2010, UROLOGY, V75, P1467, DOI 10.1016/j.urology.2009.08.049; Kuo HC, 1999, UROLOGY, V54, P90, DOI 10.1016/S0090-4295(99)00092-8; Kurita Y, 1998, UROLOGY, V51, P595, DOI 10.1016/S0090-4295(97)00685-7; Lee HH, 2013, UROLOGY, V81, P915, DOI 10.1016/j.urology.2012.12.020; MCNEAL J, 1990, UROL CLIN N AM, V17, P477; Oelke M, 2013, EUR UROL, V64, P118, DOI 10.1016/j.eururo.2013.03.004; Park YJ, 2012, KOREAN J UROL, V53, P410, DOI 10.4111/kju.2012.53.6.410; Rodriguez-Nieves JA, 2013, NAT REV UROL, V10, P546, DOI 10.1038/nrurol.2013.149; Sciarra A, 1998, PROSTATE, V34, P121; Soler R, 2013, EUR UROL, V64, P610, DOI 10.1016/j.eururo.2013.04.042; Zhang KQ, 2007, UROLOGY, V70, P1096, DOI 10.1016/j.urology.2007.08.008	22	12	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104395	10.1371/journal.pone.0104395	http://dx.doi.org/10.1371/journal.pone.0104395			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127394	gold, Green Published, Green Submitted			2022-12-25	WOS:000340879300021
J	Rosa, RG; Joazeiro, PP; Bianco, J; Kunz, M; Weber, JF; Waldman, SD				Rosa, Renata G.; Joazeiro, Paulo P.; Bianco, Juares; Kunz, Manuela; Weber, Joanna F.; Waldman, Stephen D.			Growth Factor Stimulation Improves the Structure and Properties of Scaffold-Free Engineered Auricular Cartilage Constructs	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; ARTICULAR-CARTILAGE; IN-VITRO; ELASTIC CARTILAGE; GENE-EXPRESSION; TISSUE; CHONDROCYTES; INSULIN; RECONSTRUCTION; CULTURE	The reconstruction of the external ear to correct congenital deformities or repair following trauma remains a significant challenge in reconstructive surgery. Previously, we have developed a novel approach to create scaffold-free, tissue engineering elastic cartilage constructs directly from a small population of donor cells. Although the developed constructs appeared to adopt the structural appearance of native auricular cartilage, the constructs displayed limited expression and poor localization of elastin. In the present study, the effect of growth factor supplementation (insulin, IGF-1, or TGF-beta 1) was investigated to stimulate elastogenesis as well as to improve overall tissue formation. Using rabbit auricular chondrocytes, bioreactor-cultivated constructs supplemented with either insulin or IGF-1 displayed increased deposition of cartilaginous ECM, improved mechanical properties, and thicknesses comparable to native auricular cartilage after 4 weeks of growth. Similarly, growth factor supplementation resulted in increased expression and improved localization of elastin, primarily restricted within the cartilaginous region of the tissue construct. Additional studies were conducted to determine whether scaffold-free engineered auricular cartilage constructs could be developed in the 3D shape of the external ear. Isolated auricular chondrocytes were grown in rapid-prototyped tissue culture molds with additional insulin or IGF-1 supplementation during bioreactor cultivation. Using this approach, the developed tissue constructs were flexible and had a 3D shape in very good agreement to the culture mold (average error <400 mu m). While scaffold-free, engineered auricular cartilage constructs can be created with both the appropriate tissue structure and 3D shape of the external ear, future studies will be aimed assessing potential changes in construct shape and properties after subcutaneous implantation.	[Rosa, Renata G.; Bianco, Juares; Kunz, Manuela; Weber, Joanna F.; Waldman, Stephen D.] Kingston Gen Hosp, Human Mobil Res Ctr, Kingston, ON K7L 2V7, Canada; [Rosa, Renata G.; Bianco, Juares; Kunz, Manuela; Weber, Joanna F.; Waldman, Stephen D.] Queens Univ, Kingston, ON, Canada; [Rosa, Renata G.; Joazeiro, Paulo P.; Bianco, Juares] Univ Estadual Campinas, UNICAMP, Inst Biol, Dept Histol & Embryol, Campinas, SP, Brazil; [Kunz, Manuela] Queens Univ, Sch Comp, Kingston, ON, Canada; [Weber, Joanna F.] Queens Univ, Dept Mech & Mat Engn, Kingston, ON, Canada; [Waldman, Stephen D.] Ryerson Univ, Dept Chem Engn, Toronto, ON, Canada; [Waldman, Stephen D.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON M5B 1W8, Canada	Queens University - Canada; Queens University - Canada; Universidade de Sao Paulo; Universidade Estadual de Campinas; Queens University - Canada; Queens University - Canada; Toronto Metropolitan University; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto	Waldman, SD (corresponding author), Kingston Gen Hosp, Human Mobil Res Ctr, Kingston, ON K7L 2V7, Canada.	swaldman@ryerson.ca	Bianco, Juares/G-7543-2012					Arevalo-Silva CA, 2001, TISSUE ENG, V7, P81, DOI 10.1089/107632700300003314; BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; Bos PK, 2001, OSTEOARTHR CARTILAGE, V9, P382, DOI 10.1053/joca.2000.0399; Brenner JM, 2013, BIOTECHNOL PROGR, V29, P213, DOI 10.1002/btpr.1670; BRENT B, 1977, PLAST RECONSTR SURG, V59, P475, DOI 10.1097/00006534-197759040-00001; Cao YL, 1997, PLAST RECONSTR SURG, V100, P297, DOI 10.1097/00006534-199708000-00001; Cigan AD, 2013, TISSUE ENG PT A, V19, P1941, DOI [10.1089/ten.tea.2012.0596, 10.1089/ten.TEA.2012.0596]; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; FOSTER J, 1987, COLLAGEN REL RES, V7, P161; Fujisawa T, 2008, OSTEOARTHR CARTILAGE, V16, P787, DOI 10.1016/j.joca.2007.11.001; Gaissmaier C, 2008, INJURY, V39, pS88, DOI 10.1016/j.injury.2008.01.035; Giardini-Rosa R, 2014, TISSUE ENG PT A, V20, P1012, DOI [10.1089/ten.TEA.2013.0159, 10.1089/ten.tea.2013.0159]; GOLDBERG RL, 1990, CONNECT TISSUE RES, V24, P265, DOI 10.3109/03008209009152154; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; HAYES WC, 1972, J BIOMECH, V5, P541, DOI 10.1016/0021-9290(72)90010-3; Heinegard D, 1998, OSTEOARTHRITIS, P74; Hellingman CA, 2011, CELL TRANSPLANT, V20, P925, DOI 10.3727/096368910X539119; Hinton RJ, 2009, ORTHOD CRANIOFAC RES, V12, P168, DOI 10.1111/j.1601-6343.2009.01450.x; Isogai N, 2004, TISSUE ENG, V10, P673, DOI 10.1089/1076327041348527; JENSEN DE, 1995, J BIOL CHEM, V270, P6555, DOI 10.1074/jbc.270.12.6555; Jin H, 2004, J BIOMECH ENG-T ASME, V126, P138, DOI 10.1115/1.1688772; JURVELIN JS, 1995, J BIOMECH, V28, P231, DOI 10.1016/0021-9290(94)00060-H; Kamil SH, 2004, LARYNGOSCOPE, V114, P867, DOI 10.1097/00005537-200405000-00015; Kelly TAN, 2008, ANN BIOMED ENG, V36, P769, DOI 10.1007/s10439-008-9476-1; Khan AA, 2009, BIOTECHNOL PROGR, V25, P508, DOI 10.1002/btpr.108; KIM YJ, 1988, ANAL BIOCHEM, V174, P168, DOI 10.1016/0003-2697(88)90532-5; Kisiday JD, 2005, TISSUE ENG, V11, P141, DOI 10.1089/ten.2005.11.141; Lammi PE, 2002, BONE, V31, P690, DOI 10.1016/S8756-3282(02)00904-3; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Long JL, 2003, MATRIX BIOL, V22, P339, DOI 10.1016/S0945-053X(03)00052-0; MADSEN K, 1983, DEV BIOL, V96, P63, DOI 10.1016/0012-1606(83)90311-1; MAOR G, 1993, CALCIFIED TISSUE INT, V52, P291, DOI 10.1007/BF00296654; MISHELL RI, 1980, IMMUNOPHARMACOLOGY, V2, P233, DOI 10.1016/0162-3109(80)90052-1; MOSKALEWSKI S, 1979, AM J ANAT, V155, P339, DOI 10.1002/aja.1001550305; MOSKALEWSKI S, 1977, ACTA ANAT, V97, P231; MOSKALEWSKI S, 1981, CONNECT TISSUE RES, V8, P171, DOI 10.3109/03008208109152369; NAGATA S, 1993, PLAST RECONSTR SURG, V92, P187, DOI 10.1097/00006534-199308000-00001; Naumann A, 2004, TISSUE ENG, V10, P1695, DOI 10.1089/ten.2004.10.1695; Ng KW, 2011, ANN BIOMED ENG, V39, P2491, DOI 10.1007/s10439-011-0356-8; Nimeskern L, 2014, TISSUE ENG PART B-RE, V20, P17, DOI 10.1089/ten.TEB.2013.0117; Nimeskern L, 2013, J MECH BEHAV BIOMED, V22, P12, DOI 10.1016/j.jmbbm.2013.03.005; Pelttari K, 2008, INJURY, V39, pS58, DOI 10.1016/j.injury.2008.01.038; Reiffel AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056506; Shi JY, 2012, AM J PATHOL, V180, P715, DOI 10.1016/j.ajpath.2011.10.022; Shibata S, 2012, EUR J HISTOCHEM, V56, pe23; Shieh SJ, 2004, BIOMATERIALS, V25, P1545, DOI 10.1016/S0142-9612(03)00501-5; TANZER R C, 1959, Plast Reconstr Surg Transplant Bull, V23, P1; Togo T, 2006, LAB INVEST, V86, P445, DOI 10.1038/labinvest.3700409; van der Kraan PM, 2002, OSTEOARTHR CARTILAGE, V10, P631, DOI 10.1053/joca.2002.0806; van Osch GJVM, 2000, TISSUE ENG, V6, P321, DOI 10.1089/107632700418047; von Bomhard A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071667; Walton RL, 2002, PLAST RECONSTR SURG, V110, P234, DOI 10.1097/00006534-200207000-00041; Wang J, 1999, FASEB J, V13, P1985, DOI 10.1096/fasebj.13.14.1985; WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0; Yanaga H, 2012, TISSUE ENG PT A, V18, P2020, DOI [10.1089/ten.tea.2011.0370, 10.1089/ten.TEA.2011.0370]; Yanaga H, 2009, AESTHET PLAST SURG, V33, P795, DOI 10.1007/s00266-009-9399-8; Yoon DM, 2006, ADV EXP MED BIOL, V585, P67; Yotsuyanagi T, 1999, PLAST RECONSTR SURG, V103, P1120, DOI 10.1097/00006534-199904040-00002	58	20	20	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105170	10.1371/journal.pone.0105170	http://dx.doi.org/10.1371/journal.pone.0105170			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126941	Green Published, Green Submitted, gold			2022-12-25	WOS:000340879300089
J	Godfrey, KB; Swindale, NV				Godfrey, Keith B.; Swindale, Nicholas V.			Modeling Development in Retinal Afferents: Retinotopy, Segregation, and EphrinA/EphA Mutants	PLOS ONE			English	Article							LATERAL GENICULATE-NUCLEUS; NICOTINIC ACETYLCHOLINE-RECEPTOR; DENDRITIC SPINE MORPHOLOGY; OCULAR DOMINANCE COLUMNS; AXONS IN-VIVO; SUPERIOR COLLICULUS; INSTRUCTIVE ROLE; GANGLION-CELLS; SYNAPTIC CONNECTIVITY; PRENATAL DEVELOPMENT	During neural development, neurons extend axons to target areas of the brain. Through processes of growth, branching and retraction these axons establish stereotypic patterns of connectivity. In the visual system, these patterns include retinotopic organization and the segregation of individual axons onto different subsets of target neurons based on the eye of origin (ocular dominance) or receptive field type (ON or OFF). Characteristic disruptions to these patterns occur when neural activity or guidance molecule expression is perturbed. In this paper we present a model that explains how these developmental patterns might emerge as a result of the coordinated growth and retraction of individual axons and synapses responding to position-specific markers, trophic factors and spontaneous neural activity. This model derives from one presented earlier (Godfrey et al., 2009) but which is here extended to account for a wider range of phenomena than previously described. These include ocular dominance and ON-OFF segregation and the results of altered ephrinA and EphA guidance molecule expression. The model takes into account molecular guidance factors, realistic patterns of spontaneous retinal wave activity, trophic molecules, homeostatic mechanisms, axon branching and retraction rules and intra-axonal signaling mechanisms that contribute to the survival of nearby synapses on an axon. We show that, collectively, these mechanisms can account for a wider range of phenomena than previous models of retino-tectal development.	[Godfrey, Keith B.] NERF, Leuven, Belgium; [Godfrey, Keith B.] IMEC, Leuven, Belgium; [Godfrey, Keith B.] Univ Lethbridge, Canadian Ctr Behav Neurosci, Lethbridge, AB T1K 3M4, Canada; [Godfrey, Keith B.] Univ Cambridge, Dept Appl Math & Theoret Phys, Cambridge, England; [Godfrey, Keith B.; Swindale, Nicholas V.] Univ British Columbia, Dept Ophthalmol & Visual Sci, Vancouver, BC V5Z 1M9, Canada	IMEC; University of Lethbridge; University of Cambridge; University of British Columbia	Godfrey, KB (corresponding author), NERF, Leuven, Belgium.	keith@aquilonis.net			CIHR [15360]; NSERC [178702-05]; Alberta Heritage Foundation for Medical Research Polaris Award; NERF; imec; VIB; KU Leuven	CIHR(Canadian Institutes of Health Research (CIHR)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Heritage Foundation for Medical Research Polaris Award; NERF; imec; VIB; KU Leuven(KU Leuven)	This work was funded by CIHR 15360; NSERC 178702-05; Alberta Heritage Foundation for Medical Research Polaris Award; NERF, a joint research initiative between imec, VIB and KU Leuven (nerf.be). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsina B, 2001, NAT NEUROSCI, V4, P1093, DOI 10.1038/nn735; Aoto J, 2007, BRAIN RES, V1184, P72, DOI 10.1016/j.brainres.2006.11.033; Brown A, 2000, CELL, V102, P77, DOI 10.1016/S0092-8674(00)00012-X; Carvalho RF, 2006, NAT NEUROSCI, V9, P322, DOI 10.1038/nn1655; Chandrasekaran AR, 2009, J PHYSIOL-LONDON, V587, P953, DOI 10.1113/jphysiol.2008.160952; Chandrasekaran AR, 2005, J NEUROSCI, V25, P6929, DOI 10.1523/JNEUROSCI.1470-05.2005; Chen Y, 2012, J NEUROSCI, V32, P8263, DOI 10.1523/JNEUROSCI.1264-12.2012; CLINE HT, 1989, NEURON, V3, P413, DOI 10.1016/0896-6273(89)90201-8; Cohen-Cory S, 2004, INT J DEV BIOL, V48, P947, DOI 10.1387/ijdb.041883sc; Crair MC, 1999, CURR OPIN NEUROBIOL, V9, P88, DOI 10.1016/S0959-4388(99)80011-7; Dhande OS, 2011, J NEUROSCI, V31, P3384, DOI 10.1523/JNEUROSCI.4899-10.2011; DUBIN MW, 1986, J NEUROSCI, V6, P1021; Feldheim DA, 2004, J NEUROSCI, V24, P2542, DOI 10.1523/JNEUROSCI.0239-03.2004; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Feller MB, 1999, NEURON, V22, P653, DOI 10.1016/S0896-6273(00)80724-2; Fitzgerald M, 2008, BIOCHEM BIOPH RES CO, V374, P625, DOI 10.1016/j.bbrc.2008.07.110; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Frisen J, 1998, NEURON, V20, P235, DOI 10.1016/S0896-6273(00)80452-3; FROST DO, 1979, NEUROSCIENCE, V4, P1649, DOI 10.1016/0306-4522(79)90026-5; Fu WY, 2007, NAT NEUROSCI, V10, P67, DOI 10.1038/nn1811; FUKUDA Y, 1978, JPN J PHYSIOL, V28, P385; Gjorgjieva J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000618; Godfrey KB, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000600; Godfrey KB, 2007, PLOS COMPUT BIOL, V3, P2408, DOI 10.1371/journal.pcbi.0030245; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; Grubb MS, 2003, NEURON, V40, P1161, DOI 10.1016/S0896-6273(03)00789-X; Hindges R, 2002, NEURON, V35, P475, DOI 10.1016/S0896-6273(02)00799-7; Hu B, 2005, DEVELOPMENT, V132, P4285, DOI 10.1242/dev.02017; HUBEL DH, 1977, PHILOS T ROY SOC B, V278, P377, DOI 10.1098/rstb.1977.0050; Huberman AD, 2005, NAT NEUROSCI, V8, P1013, DOI 10.1038/nn1505; Ibata K, 2008, NEURON, V57, P819, DOI 10.1016/j.neuron.2008.02.031; Juttner R, 2001, INT J DEV NEUROSCI, V19, P255, DOI 10.1016/S0736-5748(01)00009-0; Kerschensteiner D, 2008, NEURON, V58, P851, DOI 10.1016/j.neuron.2008.04.025; Lemke G, 2005, ANNU REV CELL DEV BI, V21, P551, DOI 10.1146/annurev.cellbio.20.022403.093702; LEVAY S, 1980, J COMP NEUROL, V191, P1, DOI 10.1002/cne.901910102; Lim YS, 2008, NEURON, V59, P746, DOI 10.1016/j.neuron.2008.07.032; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; MAFFEI L, 1990, P NATL ACAD SCI USA, V87, P2861, DOI 10.1073/pnas.87.7.2861; Marler KJM, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-30; Marler KJM, 2008, J NEUROSCI, V28, P12700, DOI 10.1523/JNEUROSCI.1915-08.2008; Marshak S, 2007, J NEUROSCI, V27, P2444, DOI 10.1523/JNEUROSCI.4434-06.2007; McLaughlin T, 2003, NEURON, V40, P1147, DOI 10.1016/S0896-6273(03)00790-6; McLaughlin T, 2005, ANNU REV NEUROSCI, V28, P327, DOI 10.1146/annurev.neuro.28.061604.135714; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; Murai KK, 2003, NAT NEUROSCI, V6, P153, DOI 10.1038/nn994; Pfeiffenberger C, 2005, NAT NEUROSCI, V8, P1022, DOI 10.1038/nn1508; Pfeiffenberger C, 2006, J NEUROSCI, V26, P12873, DOI 10.1523/JNEUROSCI.3595-06.2006; Plas DT, 2008, J NEUROSCI, V28, P7057, DOI 10.1523/JNEUROSCI.3598-06.2008; Reber M, 2004, NATURE, V431, P847, DOI 10.1038/nature02957; Ruthazer ES, 2004, J NEUROBIOL, V59, P134, DOI 10.1002/neu.10344; Singh KK, 2008, NAT NEUROSCI, V11, P649, DOI 10.1038/nn.2114; Snider WD, 1996, MOL CELL NEUROSCI, V7, P433, DOI 10.1006/mcne.1996.0031; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; SRETAVAN D, 1984, NATURE, V308, P845, DOI 10.1038/308845a0; SRETAVAN DW, 1986, J NEUROSCI, V6, P234; Stafford BK, 2009, NEURON, V64, P200, DOI 10.1016/j.neuron.2009.09.021; Staras K, 2007, TRENDS NEUROSCI, V30, P292, DOI 10.1016/j.tins.2007.04.005; Stellwagen D, 2002, NEURON, V33, P357, DOI 10.1016/S0896-6273(02)00577-9; STRYKER MP, 1983, J NEUROSCI, V3, P1943; Sun C, 2008, P NATL ACAD SCI USA, V105, P13638, DOI 10.1073/pnas.0807178105; Swindale NV, 1996, NETWORK-COMP NEURAL, V7, P161, DOI 10.1088/0954-898X/7/2/002; THOMPSON I, 1989, J COMP NEUROL, V282, P371; Tomita K, 2012, CEREBRAL CORTEX; Willshaw D, 2006, DEVELOPMENT, V133, P2705, DOI 10.1242/dev.02430; WILLSHAW DJ, 1979, PHILOS T ROY SOC B, V287, P203, DOI 10.1098/rstb.1979.0056; Wu YJ, 2004, J NEUROSCI RES, V75, P825, DOI 10.1002/jnr.20048; Xu HP, 2011, NEURON, V70, P1115, DOI 10.1016/j.neuron.2011.04.028; Yates PA, 2001, J NEUROSCI, V21, P8548, DOI 10.1523/JNEUROSCI.21-21-08548.2001; Zhang JY, 2012, NAT NEUROSCI, V15, P298, DOI 10.1038/nn.3007; Zhou L, 2007, J NEUROSCI, V27, P5127, DOI 10.1523/JNEUROSCI.1170-07.2007	70	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104670	10.1371/journal.pone.0104670	http://dx.doi.org/10.1371/journal.pone.0104670			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122119	Green Published, gold, Green Submitted			2022-12-25	WOS:000341017000054
J	Nowinski, WL; Gupta, V; Qian, GY; Ambrosius, W; Kazmierski, R				Nowinski, Wieslaw L.; Gupta, Varsha; Qian, Guoyu; Ambrosius, Wojciech; Kazmierski, Radoslaw			Population-Based Stroke Atlas for Outcome Prediction: Method and Preliminary Results for Ischemic Stroke from CT	PLOS ONE			English	Article							SCALE; THROMBOLYSIS; VOLUME; LOCALIZATION; VALIDATION; INSTRUMENT; HEMORRHAGE; SCORES; IMAGES; INDEX	Background and Purpose: Knowledge of outcome prediction is important in stroke management. We propose a lesion size and location-driven method for stroke outcome prediction using a Population-based Stroke Atlas (PSA) linking neurological parameters with neuroimaging in population. The PSA aggregates data from previously treated patients and applies them to currently treated patients. The PSA parameter distribution in the infarct region of a treated patient enables prediction. We introduce a method for PSA calculation, quantify its performance, and use it to illustrate ischemic stroke outcome prediction of modified Rankin Scale (mRS) and Barthel Index (BI). Methods: The preliminary PSA was constructed from 128 ischemic stroke cases calculated for 8 variants (various data aggregation schemes) and 3 case selection variables (infarct volume, NIHSS at admission, and NIHSS at day 7), each in 4 ranges. Outcome prediction for 9 parameters (mRS at 7th, and mRS and BI at 30th, 90th, 180th, 360th day) was studied using a leave-one-out approach, requiring 589,824 PSA maps to be analyzed. Results: Outcomes predicted for different PSA variants are statistically equivalent, so the simplest and most efficient variant aiming at parameter averaging is employed. This variant allows the PSA to be pre-calculated before prediction. The PSA constrained by infarct volume and NIHSS reduces the average prediction error (absolute difference between the predicted and actual values) by a fraction of 0.796; the use of 3 patient-specific variables further lowers it by 0.538. The PSA-based prediction error for mild and severe outcomes (mRS = [2-5]) is (0.5-0.7). Prediction takes about 8 seconds. Conclusions: PSA-based prediction of individual and group mRS and BI scores over time is feasible, fast and simple, but its clinical usefulness requires further studies. The case selection operation improves PSA predictability. A multiplicity of PSAs can be computed independently for different datasets at various centers and easily merged, which enables building powerful PSAs over the community.	[Nowinski, Wieslaw L.; Gupta, Varsha; Qian, Guoyu; Ambrosius, Wojciech] Agcy Sci Technol & Res, Singapore Bioimaging Consortium, Biomed Imaging Lab, Singapore, Singapore; [Ambrosius, Wojciech] Poznan Univ Med Sci, Dept Neurol, Poznan, Poland; [Kazmierski, Radoslaw] Poznan Univ Med Sci, L Bierkowski Hosp, Dept Neurol & Cerebrovasc Disorders, Poznan, Poland	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Singapore Bioimaging Consortium (SBIC); Poznan University of Medical Sciences; Poznan University of Medical Sciences	Nowinski, WL (corresponding author), Agcy Sci Technol & Res, Singapore Bioimaging Consortium, Biomed Imaging Lab, Singapore, Singapore.	wieslaw@sbic.a-star.edu.sg	Ambrosius, Wojciech/AGL-7764-2022; Nowinski, Wieslaw/AFR-8393-2022	Nowinski, Wieslaw/0000-0003-2869-0608; Gupta, Varsha/0000-0002-6634-5111	Biomedical Research Council, Agency for Science, Technology and Research ASTAR, Singapore [62/N-Singapur/2007/0, 072-1340049]; Ministry of Science and Higher Education, Poland	Biomedical Research Council, Agency for Science, Technology and Research ASTAR, Singapore(Agency for Science Technology & Research (A*STAR)); Ministry of Science and Higher Education, Poland(Ministry of Science and Higher Education, Poland)	This research was funded by Biomedical Research Council, Agency for Science, Technology and Research ASTAR, Singapore. The data contribution to this study was a part of a joined Polish-Singaporean project funded by the Ministry of Science and Higher Education, Poland and ASTAR, Singapore (project No. 62/N-Singapur/2007/0 and 072-1340049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosius W, 2011, EXP CLIN ENDOCR DIAB, V119, P139, DOI 10.1055/s-0030-1267918; Asadi H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088225; Balucani C, 2012, NEUROLOGY, V78, P755, DOI 10.1212/WNL.0b013e318248e558; Beswick A. D., 2008, SYSTEMATIC REV RISK; Bilello M, 2006, NEUROINFORMATICS, V4, P234, DOI 10.1385/NI:4:3:235; Counsell C, 2002, STROKE, V33, P1041, DOI 10.1161/hs0402.105909; Counsell C, 2001, CEREBROVASC DIS, V12, P159, DOI 10.1159/000047699; Cucchiara Brett, 2008, J Stroke Cerebrovasc Dis, V17, P331, DOI 10.1016/j.jstrokecerebrovasdis.2008.03.012; Fink JN, 2002, STROKE, V33, P954, DOI 10.1161/01.STR.0000013069.24300.1D; Hacke W, 2006, NEW ENGL J MED, V359, P1317; Kazmierski R, 2006, EXPERT REV NEUROTHER, V6, P1349, DOI 10.1586/14737175.6.9.1349; Kazmierski R, 2012, NEUROLOGY, V79, P1677, DOI 10.1212/WNL.0b013e31826e9a83; Kent DM, 2006, STROKE, V37, P2957, DOI 10.1161/01.STR.0000249054.96644.c6; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Koenig IR, 2008, STROKE, V39, P1821, DOI 10.1161/STROKEAHA.107.505867; Kwakkel G, 2013, INT J STROKE, V8, P25, DOI 10.1111/j.1747-4949.2012.00967.x; Lou M, 2008, NEUROLOGY, V71, P1417, DOI 10.1212/01.wnl.0000330297.58334.dd; Mazya M, 2012, STROKE, V43, P1524, DOI 10.1161/STROKEAHA.111.644815; Menezes NM, 2007, STROKE, V38, P194, DOI 10.1161/01.STR.0000251792.76080.45; Navi BB, 2011, STROKE, V42, P3392, DOI 10.1161/STROKEAHA.111.620336; Nogueira RG, 2012, LANCET, V380, P1231, DOI 10.1016/S0140-6736(12)61299-9; Nowinski WL, 2013, NEURORADIOL J, V26, P56, DOI 10.1177/197140091302600110; Nowinski WL, 2012, J NEUROSCI METH, V204, P44, DOI 10.1016/j.jneumeth.2011.10.021; Nowinski WL, 2006, ACAD RADIOL, V13, P1025, DOI 10.1016/j.acra.2006.05.009; Nowinski WL, 2013, INVEST RADIOL, V48, P661, DOI 10.1097/RLI.0b013e31828d8403; Nowinski WL, 2001, ACTA NEUROCHIR, V143, P1045, DOI 10.1007/s007010170011; Nowinski WL, 2012, STROK INT STROK C 20; Ntaios G, 2012, NEUROLOGY, V78, P1916, DOI 10.1212/WNL.0b013e318259e221; O'Donnell MJ, 2012, ARCH INTERN MED, V15, P1; Qiao Q, 2012, INT J STROKE, V7, P662, DOI 10.1111/j.1747-4949.2011.00692.x; Richards A, 2013, STROKE, V44, P564, DOI 10.1161/STROKEAHA.111.649798; Saposnik G, 2013, NEUROLOGY, V80, P21, DOI 10.1212/WNL.0b013e31827b1ace; Saposnik G, 2011, STROKE, V42, P3421, DOI 10.1161/STROKEAHA.111.623116; Saposnik G, 2011, CIRCULATION, V123, P739, DOI 10.1161/CIRCULATIONAHA.110.983353; Saver JL, 2012, LANCET, V380, P1241, DOI 10.1016/S0140-6736(12)61384-1; Schlegel D, 2003, STROKE, V34, P134, DOI 10.1161/01.STR.0000048217.44714.02; Stinear CM, 2013, INT J STROKE, V8, P33, DOI 10.1111/j.1747-4949.2012.00970.x; Strbian D, 2012, NEUROLOGY, V78, P427, DOI 10.1212/WNL.0b013e318245d2a9; Strbian D, 2012, ANN NEUROL, V71, P634, DOI 10.1002/ana.23546; Talairach I., 1988, COPLANAR STEREOTACTI; Uyttenboogaart M, 2005, STROKE, V36, P1984, DOI 10.1161/01.STR.0000177872.87960.61; Vogt G, 2012, STROKE, V43, P1266, DOI 10.1161/STROKEAHA.111.646570; Volkau I, 2012, NEURORADIOL J, V25, P98, DOI 10.1177/197140091202500114; Volkau I, 2006, MED IMAGE ANAL, V10, P863, DOI 10.1016/j.media.2006.07.005; Weimar C, 2002, J NEUROL, V249, P888, DOI 10.1007/s00415-002-0755-8	45	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e102048	10.1371/journal.pone.0102048	http://dx.doi.org/10.1371/journal.pone.0102048			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121979	gold, Green Published, Green Submitted			2022-12-25	WOS:000341017000004
J	Haque, I; Banerjee, S; De, A; Maity, G; Sarkar, S; Majumdar, M; Jha, SS; McGragor, D; Banerjee, SK				Haque, I.; Banerjee, S.; De, A.; Maity, G.; Sarkar, S.; Majumdar, M.; Jha, S. S.; McGragor, D.; Banerjee, S. K.			CCN5/WISP-2 promotes growth arrest of triple-negative breast cancer cells through accumulation and trafficking of p27(Kip1) via Skp2 and FOXO3a regulation	ONCOGENE			English	Article							DEPENDENT KINASE INHIBITOR; CDK INHIBITOR; INVASIVE PHENOTYPES; ONCOGENIC FUNCTION; TUMOR-CELLS; P27; EXPRESSION; CYCLE; ESTROGEN; DEGRADATION	The matricellular protein CCN5/WISP-2 represents a promising target in triple-negative breast cancer (TNBC) because treatment or induced activation of CCN5 in TNBC cells promotes cell growth arrest at the G0/G1 phase, reduces cell proliferation and delays tumor growth in the xenograft model. Our studies found that the p27(Kip1) tumor suppressor protein is upregulated and relocalized to the nucleus from cytoplasm by CCN5 in these cells and that these two events (upregulation and relocalization of p27(Kip1)) are critical for CCN5-induced growth inhibition of TNBC cells. In the absence of CCN5, p27(Kip1) resides mostly in the cytoplasm, which is associated with the aggressive nature of cancer cells. Mechanistically, CCN5 inhibits Skp2 expression, which seems to stabilize the p27(Kip1) protein in these cells. On the other hand, CCN5 also recruits FOXO3a to mediate the transcriptional regulation of p27(Kip1). The recruitment of FOXO3a is achieved by the induction of its expression and activity through shifting from cytoplasm to the nucleus. Our data indicate that CCN5 blocks PI3K/AKT signaling to dephosphorylate at S318, S253 and Thr32 in FOXO3a for nuclear relocalization and activation of FOXO3a. Moreover, inhibition of alpha 6 beta 1 receptors diminishes CCN5 action on p27(Kip1) in TNBC cells. Collectively, these data suggest that CCN5 effectively inhibits TNBC growth through the accumulation and trafficking of p27(Kip1) via Skp2 and FOXO3a regulation, and thus, activation of CCN5 may have the therapeutic potential to kill TNBC.	[Haque, I.; Banerjee, S.; De, A.; Maity, G.; Sarkar, S.; Majumdar, M.; Jha, S. S.; McGragor, D.; Banerjee, S. K.] Vet Adm Med Ctr, Canc Res Unit, Kansas City, MO 64128 USA; [Haque, I.; Banerjee, S.; Maity, G.; Banerjee, S. K.] Univ Kansas, Med Ctr, Dept Med, Div Hematol & Oncol, Kansas City, MO USA; [Sarkar, S.; Banerjee, S. K.] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, MO USA; [Sarkar, S.; Banerjee, S. K.] Univ Kansas, Med Ctr, Dept Pathol, Kansas City, MO USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Kansas; University of Kansas; University of Kansas	Banerjee, SK (corresponding author), Vet Adm Med Ctr, Canc Res Unit, Res Div 151, 4801 Linwood Blvd, Kansas City, MO 64128 USA.	sbanerjee2@kumc.edu	Banerjee, Sushanta/AAG-6534-2021; Haque, Inamul/I-2482-2019	Banerjee, Sushanta/0000-0002-7698-0717; Haque, Inamul/0000-0002-1307-9446	VA Merit Award; Veterans Affairs [I01BX001989] Funding Source: NIH RePORTER	VA Merit Award(US Department of Veterans Affairs); Veterans Affairs(US Department of Veterans Affairs)	These studies were supported by VA Merit Award grants (SKB and SB).	Alkarain A, 2004, J MAMMARY GLAND BIOL, V9, P67, DOI 10.1023/B:JOMG.0000023589.00994.5e; Asada M, 1999, EMBO J, V18, P1223, DOI 10.1093/emboj/18.5.1223; Baldassarre G, 1999, J CLIN INVEST, V104, P865, DOI 10.1172/JCI6443; Banerjee S, 2005, MOL CANCER RES, V3, P151, DOI 10.1158/1541-7786.MCR-04-0130; Banerjee S, 2003, NEOPLASIA, V5, P63, DOI 10.1016/S1476-5586(03)80018-0; Banerjee S, 2008, CANCER RES, V68, P7606, DOI 10.1158/0008-5472.CAN-08-1461; Banerjee S, 2006, MOL CARCINOGEN, V45, P871, DOI 10.1002/mc.20248; Banerjee SK, 2012, J CELL COMMUN SIGNAL, V6, P63, DOI 10.1007/s12079-012-0158-2; Barbareschi M, 2000, INT J CANCER, V89, P236, DOI 10.1002/1097-0215(20000520)89:3<236::AID-IJC5>3.3.CO;2-Q; Besson A, 2004, NAT REV CANCER, V4, P948, DOI 10.1038/nrc1501; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Blagosklonny MV, 2002, CELL CYCLE, V1, P391, DOI 10.4161/cc.1.6.262; Bloom J, 2003, SEMIN CANCER BIOL, V13, P41, DOI 10.1016/S1044-579X(02)00098-6; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Chen Y, 1996, CELL GROWTH DIFFER, V7, P1571; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Coqueret O, 2003, TRENDS CELL BIOL, V13, P65, DOI 10.1016/S0962-8924(02)00043-0; De Paola F, 2002, J PATHOL, V196, P26, DOI 10.1002/path.1011; Dhar G, 2008, CANCER RES, V68, P4580, DOI 10.1158/0008-5472.CAN-08-0316; Dhar G, 2007, CANCER LETT, V254, P63, DOI 10.1016/j.canlet.2007.02.012; Dhar K, 2007, CANCER RES, V67, P1520, DOI 10.1158/0008-5472.CAN-06-3753; Fritah A, 2008, MOL CELL BIOL, V28, P1114, DOI 10.1128/MCB.01335-07; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Haque I, 2012, J BIOL CHEM, V287, P38569, DOI 10.1074/jbc.M112.389064; Haque I, 2011, J BIOL CHEM, V286, P43475, DOI 10.1074/jbc.M111.284158; Jiang YH, 2000, P NATL ACAD SCI USA, V97, P10538, DOI 10.1073/pnas.190104497; Jun JI, 2011, NAT REV DRUG DISCOV, V10, P945, DOI 10.1038/nrd3599; Kossatz U, 2004, GENE DEV, V18, P2602, DOI 10.1101/gad.321004; LEVENSON AS, 1994, J STEROID BIOCHEM, V51, P229, DOI 10.1016/0960-0760(94)90035-3; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Mineta H, 1999, CANCER-AM CANCER SOC, V85, P1011, DOI 10.1002/(SICI)1097-0142(19990301)85:5<1011::AID-CNCR1>3.0.CO;2-0; Moller MB, 2000, LEUKEMIA LYMPHOMA, V39, P19, DOI 10.3109/10428190009053535; Motti ML, 2005, AM J PATHOL, V166, P737, DOI 10.1016/S0002-9440(10)62295-X; Nakao T, 2008, CELL CYCLE, V7, P257, DOI 10.4161/cc.7.2.5148; Nakayama K, 2000, EMBO J, V19, P2069, DOI 10.1093/emboj/19.9.2069; Nakayama K, 2004, DEV CELL, V6, P661, DOI 10.1016/S1534-5807(04)00131-5; Nakayama KI, 2005, SEMIN CELL DEV BIOL, V16, P323, DOI 10.1016/j.semcdb.2005.02.010; NOURSE J, 1994, NATURE, V372, P570, DOI 10.1038/372570a0; Oliveira LR, 2010, HISTOL HISTOPATHOL, V25, P371, DOI 10.14670/HH-25.371; POLYAK K, 1994, GENE DEV, V8, P9, DOI 10.1101/gad.8.1.9; Reed W, 1999, VIRCHOWS ARCH, V435, P116, DOI 10.1007/s004280050408; Russo JW, 2010, J CELL COMMUN SIGNAL, V4, P119, DOI 10.1007/s12079-010-0098-7; Sabbah M, 2011, MOL CELL BIOL, V31, P1459, DOI 10.1128/MCB.01316-10; Sgambato A, 2000, J CELL PHYSIOL, V183, P18, DOI 10.1002/(SICI)1097-4652(200004)183:1<18::AID-JCP3>3.0.CO;2-S; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Simpson PT, 2005, AM J SURG PATHOL, V29, P734, DOI 10.1097/01.pas.0000157295.93914.3b; Slingerland J, 2000, J CELL PHYSIOL, V183, P10, DOI 10.1002/(SICI)1097-4652(200004)183:1<10::AID-JCP2>3.0.CO;2-I; Spruck C, 2001, MOL CELL, V7, P639, DOI 10.1016/S1097-2765(01)00210-6; Tan P, 1997, CANCER RES, V57, P1259; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; Troncone G, 2004, DIAGN CYTOPATHOL, V30, P375, DOI 10.1002/dc.20059; Viglietto G, 2002, NAT MED, V8, P1136, DOI 10.1038/nm762; Wander SA, 2011, CLIN CANCER RES, V17, P12, DOI 10.1158/1078-0432.CCR-10-0752; Wei SO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047298; Zhang SW, 2013, J CELL BIOCHEM, V114, P354, DOI 10.1002/jcb.24371	55	28	30	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 11	2015	34	24					3152	3163		10.1038/onc.2014.250	http://dx.doi.org/10.1038/onc.2014.250			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CK3FD	25132260	Bronze			2022-12-25	WOS:000356101100007
J	Belardinelli, JM; Larrouy-Maumus, G; Jones, V; de Carvalho, LPS; McNeil, MR; Jackson, M				Belardinelli, Juan Manuel; Larrouy-Maumus, Gerald; Jones, Victoria; de Carvalho, Luiz Pedro Sorio; McNeil, Michael R.; Jackson, Mary			Biosynthesis and Translocation of Unsulfated Acyltrehaloses in Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Glycolipid; Mycobacteria; Polyketide; Transporter; Tuberculosis; Chp2; MmpL10; Acyltransferase; Acyltrehalose	SULFOLIPID-1 BIOSYNTHESIS; OUTER-MEMBRANE; LIPID-BILAYER; FATTY-ACIDS; T-CELLS; VIRULENCE; INHIBITION; SULFATIDE; ANTIGEN; PROTEIN	Background: The biogenesis of 2,3-diacyltrehaloses (DAT) and penta-acyltrehaloses (PAT) found in the outer membrane of Mycobacterium tuberculosis is ill defined. Results: DAT synthesis is cytosolic. Chp2-mediated transesterification reactions between DAT substrates yield PAT on the periplasmic face of the membrane. Conclusion: DAT and PAT biosynthesis is topologically split across the membrane. Significance: DAT and PAT biosynthesis and transport are coupled and dependent on the MmpL10 transporter. A number of species-specific polymethyl-branched fatty acid-containing trehalose esters populate the outer membrane of Mycobacterium tuberculosis. Among them, 2,3-diacyltrehaloses (DAT) and penta-acyltrehaloses (PAT) not only play a structural role in the cell envelope but also contribute to the ability of M. tuberculosis to multiply and persist in the infected host, promoting the intracellular survival of the bacterium and modulating host immune responses. The nature of the machinery, topology, and sequential order of the reactions leading to the biosynthesis, assembly, and export of these complex glycolipids to the cell surface are the object of the present study. Our genetic and biochemical evidence corroborates a model wherein the biosynthesis and translocation of DAT and PAT to the periplasmic space are coupled and topologically split across the plasma membrane. The formation of DAT occurs on the cytosolic face of the plasma membrane through the action of PapA3, FadD21, and Pks3/4; that of PAT occurs on the periplasmic face via transesterification reactions between DAT substrates catalyzed by the acyltransferase Chp2 (Rv1184c). The integral membrane transporter MmpL10 is essential for DAT to reach the cell surface, and its presence in the membrane is required for Chp2 to be active. Disruption of mmpL10 or chp2 leads to an important build-up of DAT inside the cells and to the formation of a novel form of unsulfated acyltrehalose esterified with polymethyl-branched fatty acids normally found in sulfolipids that is translocated to the cell surface.	[Belardinelli, Juan Manuel; Jones, Victoria; McNeil, Michael R.; Jackson, Mary] Colorado State Univ, Dept Microbiol Immunol & Pathol, Mycobacteria Res Labs, Ft Collins, CO 80523 USA; [Larrouy-Maumus, Gerald; de Carvalho, Luiz Pedro Sorio] Natl Inst Med Res, MRC, Div Mycobacterial Res, London NW7 1AA, England	Colorado State University; MRC National Institute for Medical Research	Jackson, M (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	Mary.Jackson@colostate.edu	Belardinelli, Juan Manuel/N-7335-2019; Jackson, Mary/D-5345-2017; McNeil, Michael/G-3325-2019	Belardinelli, Juan Manuel/0000-0003-1336-9141; Jackson, Mary/0000-0002-9212-0258; Sorio de Carvalho, Luiz Pedro/0000-0003-2875-4552; Larrouy-Maumus, Gerald/0000-0001-6614-8698	National Institutes of Health, NIAID [AI063054]; Medical Research Council (MRC) [MC_UP_A253_1111]; MRC [U117533887]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063054] Funding Source: NIH RePORTER; Medical Research Council [MC_UP_A253_1111] Funding Source: researchfish; MRC [MC_UP_A253_1111, MR/J006874/1] Funding Source: UKRI	National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported, in whole or in part, by National Institutes of Health, NIAID, Grant AI063054. This work was supported by funds from the Medical Research Council (MRC) to L.P.S.d.C. (MC_UP_A253_1111). The MRC Biomedical NMR Centre, NIMR, Mill Hill, is funded by MRC Grant-in-aid U117533887.	Alexeyev MF, 1999, J MOL BIOL, V285, P1503, DOI 10.1006/jmbi.1998.2412; Asensio JG, 2006, J BIOL CHEM, V281, P1313, DOI 10.1074/jbc.C500388200; Bansal-Mutalik R, 2014, P NATL ACAD SCI USA, V111, P4958, DOI 10.1073/pnas.1403078111; Belisle JT, 1997, SCIENCE, V276, P1420, DOI 10.1126/science.276.5317.1420; Berg S, 2005, J BIOL CHEM, V280, P5651, DOI 10.1074/jbc.M411418200; Brodin P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001100; BROZNA JP, 1991, INFECT IMMUN, V59, P2542, DOI 10.1128/IAI.59.8.2542-2548.1991; Camacho LR, 2001, J BIOL CHEM, V276, P19845, DOI 10.1074/jbc.M100662200; Chesne-Seck ML, 2008, J BACTERIOL, V190, P1329, DOI 10.1128/JB.01465-07; Converse SE, 2003, P NATL ACAD SCI USA, V100, P6121, DOI 10.1073/pnas.1030024100; Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131; Daffe M, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.MGM2-0021-2013; Deshayes C, 2010, MOL MICROBIOL, V78, P989, DOI 10.1111/j.1365-2958.2010.07385.x; Domenech P, 2005, INFECT IMMUN, V73, P3492, DOI 10.1128/IAI.73.6.3492-3501.2005; Domenech P, 2004, J BIOL CHEM, V279, P21257, DOI 10.1074/jbc.M400324200; Dubey VS, 2002, MOL MICROBIOL, V45, P1451, DOI 10.1046/j.1365-2958.2002.03119.x; Gilleron M, 2004, J EXP MED, V199, P649, DOI 10.1084/jem.20031097; Gilmore SA, 2012, ACS CHEM BIOL, V7, P863, DOI 10.1021/cb200311s; GOREN MB, 1976, P NATL ACAD SCI USA, V73, P2510, DOI 10.1073/pnas.73.7.2510; GOREN MB, 1990, HDB LIPID RES, V6, P363; Grzegorzewicz AE, 2012, NAT CHEM BIOL, V8, P334, DOI [10.1038/NCHEMBIO.794, 10.1038/nchembio.794]; Guerin ME, 2009, J BIOL CHEM, V284, P21613, DOI 10.1074/jbc.M109.003947; Hatzios SK, 2009, J BIOL CHEM, V284, P12745, DOI 10.1074/jbc.M809088200; Hoffmann C, 2008, P NATL ACAD SCI USA, V105, P3963, DOI 10.1073/pnas.0709530105; Hsieh JM, 2010, PROTEIN SCI, V19, P868, DOI 10.1002/pro.365; HUSSEINI H, 1952, AM REV TUBERC PULM, V65, P655; Jackson M, 2001, Methods Mol Med, V54, P59, DOI 10.1385/1-59259-147-7:059; Jain M, 2005, PLOS PATHOG, V1, P12, DOI 10.1371/journal.ppat.0010002; KATO M, 1974, INFECT IMMUN, V10, P733, DOI 10.1128/IAI.10.4.733-741.1974; Kumar P, 2007, P NATL ACAD SCI USA, V104, P11221, DOI 10.1073/pnas.0611649104; Lamichhane G, 2005, INFECT IMMUN, V73, P2533, DOI 10.1128/IAI.73.4.2533-2540.2005; Layre E, 2011, J LIPID RES, V52, P1098, DOI 10.1194/jlr.M013482; Lee KS, 2007, FEMS MICROBIOL LETT, V267, P121, DOI 10.1111/j.1574-6968.2006.00553.x; Lee W, 2013, J BIOL CHEM, V288, P6788, DOI 10.1074/jbc.M112.445056; Lynett J, 2007, MICROBIOL-SGM, V153, P3133, DOI 10.1099/mic.0.2007/007864-0; Mederle I, 2002, INFECT IMMUN, V70, P303, DOI 10.1128/IAI.70.1.303-314.2002; Murakami S, 2008, CURR OPIN STRUC BIOL, V18, P459, DOI 10.1016/j.sbi.2008.06.007; PABST MJ, 1988, J IMMUNOL, V140, P634; Passemar C, 2014, CELL MICROBIOL, V16, P195, DOI 10.1111/cmi.12214; Rezwan M, 2007, J MICROBIOL METH, V68, P32, DOI 10.1016/j.mimet.2006.05.016; Rousseau C, 2003, INFECT IMMUN, V71, P4684, DOI 10.1128/IAI.71.8.4684-4690.2003; Rousseau C, 2003, CELL MICROBIOL, V5, P405, DOI 10.1046/j.1462-5822.2003.00289.x; Saavedra R, 2001, CLIN DIAGN LAB IMMUN, V8, P1081, DOI 10.1128/CDLI.8.6.1-91-1088.2001; Seeliger JC, 2012, J BIOL CHEM, V287, P7990, DOI 10.1074/jbc.M111.315473; Seidel M, 2007, GLYCOBIOLOGY, V17, P210, DOI 10.1093/glycob/cwl066; Singh A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000545; Sonden B, 2005, MOL MICROBIOL, V58, P426, DOI 10.1111/j.1365-2958.2005.04847.x; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Sulzenbacher G, 2006, EMBO J, V25, P1436, DOI 10.1038/sj.emboj.7601048; Trivedi OA, 2004, NATURE, V428, P441, DOI 10.1038/nature02384; Zgurskaya HI, 1999, P NATL ACAD SCI USA, V96, P7190, DOI 10.1073/pnas.96.13.7190; ZHANG L, 1991, J IMMUNOL, V146, P2730; ZHANG L, 1988, INFECT IMMUN, V56, P2876, DOI 10.1128/IAI.56.11.2876-2883.1988; Zuber B, 2008, J BACTERIOL, V190, P5672, DOI 10.1128/JB.01919-07	55	51	53	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27952	27965		10.1074/jbc.M114.581199	http://dx.doi.org/10.1074/jbc.M114.581199			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25124040	Green Published, hybrid			2022-12-25	WOS:000342852800049
J	Hassinen, A; Kellokumpu, S				Hassinen, Antti; Kellokumpu, Sakari			Organizational Interplay of Golgi N-Glycosyltransferases Involves Organelle Microenvironment-Dependent Transitions between Enzyme Homo-and Heteromers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEX-FORMATION; KIN RECOGNITION; MEDIAL-GOLGI; GLYCOSYLATION; RETENTION; DOMAIN; FORM; OLIGOSACCHARIDES; OLIGOMERIZATION; LOCALIZATION	Glycosylation of proteins and lipids takes place in the Golgi apparatus by the consecutive actions of functionally distinct glycosidases and glycosyltransferases. Current evidence indicates that they function as enzyme homomers and/or heteromers in the living cell. Here we investigate their organizational interplay and show that glycosyltransferase homomers are assembled in the endoplasmic reticulum. Upon transport to the Golgi, the majority of homomers are disassembled to allow the formation of enzyme heteromers between sequentially acting medial Golgi enzymes GnT-I and GnT-II or trans-Golgi enzymes GalT-I and ST6Gal-I. This transition is driven by the acidic Golgi environment, as it was markedly inhibited by raising Golgi luminal pH with chloroquine. Our FRAP ( fluorescence recovery after photobleaching) measurements showed that the complexes remain mobile Golgi membrane constituents that can relocate to the endoplasmic reticulum or to the scattered Golgi mini-stacks upon brefeldin A or nocodazole treatment, respectively. During this relocation, heteromers undergo a reverse transition back to enzyme homomers. These data unveil an unprecedented organizational interplay between Golgi N-glycosyltransferases that involves dynamic and organelle microenvironment-driven transitions between enzyme homomers and heteromers during their trafficking within the early secretory compartments.	[Hassinen, Antti; Kellokumpu, Sakari] Univ Oulu, Fac Biochem & Mol Med, FI-90220 Oulu, Finland	University of Oulu	Kellokumpu, S (corresponding author), Univ Oulu, Fac Biochem & Mol Med, Aapistie 7, FI-90220 Oulu, Finland.	sakari.kellokumpu@oulu.fi		Hassinen, Antti/0000-0001-9491-2868	Finnish Glycoscience Graduate School; University of Oulu; Magnus Ehrnrooth Foundation; Emil Aaltonen Foundation; Finnish Cultural Foundation	Finnish Glycoscience Graduate School; University of Oulu; Magnus Ehrnrooth Foundation; Emil Aaltonen Foundation; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science)	This work was supported by the Finnish Glycoscience Graduate School, The University of Oulu, Magnus Ehrnrooth Foundation, Emil Aaltonen Foundation, and the Finnish Cultural Foundation.	Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; Banfield DK, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005264; Brockhausen I, 1999, BBA-GEN SUBJECTS, V1473, P67, DOI 10.1016/S0304-4165(99)00170-1; Burchell J, 1999, GLYCOBIOLOGY, V9, P1307, DOI 10.1093/glycob/9.12.1307; Cole NB, 1996, MOL BIOL CELL, V7, P631, DOI 10.1091/mbc.7.4.631; Cole NB, 1996, SCIENCE, V273, P797, DOI 10.1126/science.273.5276.797; Cummings R.D., 2009, PRINCIPLES GLYCAN RE, P387; Dayhoff JE, 2010, J MOL BIOL, V395, P860, DOI 10.1016/j.jmb.2009.10.052; de Graffenried CL, 2004, CURR OPIN CELL BIOL, V16, P356, DOI 10.1016/j.ceb.2004.06.007; DUNPHY WG, 1985, CELL, V40, P463, DOI 10.1016/0092-8674(85)90161-8; Emr S, 2009, J CELL BIOL, V187, P449, DOI 10.1083/jcb.200909011; Flugel D, 2012, BLOOD, V119, P1292, DOI 10.1182/blood-2011-08-375014; Freeze HH, 2006, NAT REV GENET, V7, P537, DOI 10.1038/nrg1894; Giraudo CG, 2003, J BIOL CHEM, V278, P40262, DOI 10.1074/jbc.M305455200; Giraudo CG, 2003, MOL BIOL CELL, V14, P3753, DOI 10.1091/mbc.E03-02-0101; Gleeson PA, 1998, HISTOCHEM CELL BIOL, V109, P517, DOI 10.1007/s004180050252; Glick BS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005215; Hart Gerald W., 1992, Current Opinion in Cell Biology, V4, P1017, DOI 10.1016/0955-0674(92)90134-X; Hashimoto K, 2010, J MOL BIOL, V399, P196, DOI 10.1016/j.jmb.2010.03.059; Hassinen A, 2011, J BIOL CHEM, V286, P38329, DOI 10.1074/jbc.M111.277681; Hassinen A, 2010, J BIOL CHEM, V285, P17771, DOI 10.1074/jbc.M110.103184; Jackson CL, 2009, J CELL SCI, V122, P443, DOI 10.1242/jcs.032581; Jungmann J, 1998, EMBO J, V17, P423, DOI 10.1093/emboj/17.2.423; Kerppola TK, 2008, ANNU REV BIOPHYS, V37, P465, DOI 10.1146/annurev.biophys.37.032807.125842; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; LIPPINCOTTSCHWARTZ J, 1991, CELL, V67, P601, DOI 10.1016/0092-8674(91)90534-6; Losev E, 2006, NATURE, V441, P1002, DOI 10.1038/nature04717; Maccioni HJF, 2011, J NEUROCHEM, V117, P589, DOI 10.1111/j.1471-4159.2011.07232.x; Matsuura-Tokita K, 2006, NATURE, V441, P1007, DOI 10.1038/nature04737; McCormick C, 2000, P NATL ACAD SCI USA, V97, P668, DOI 10.1073/pnas.97.2.668; NILSSON T, 1994, EMBO J, V13, P562, DOI 10.1002/j.1460-2075.1994.tb06294.x; NILSSON T, 1993, FEBS LETT, V330, P1, DOI 10.1016/0014-5793(93)80906-B; Nilsson T, 2009, FEBS LETT, V583, P3764, DOI 10.1016/j.febslet.2009.10.064; Ohtsubo K, 2011, NAT MED, V17, P1067, DOI 10.1038/nm.2414; Opat AS, 2000, J BIOL CHEM, V275, P11836, DOI 10.1074/jbc.275.16.11836; Ouzzine M, 2000, J BIOL CHEM, V275, P28254; Patterson GH, 2008, CELL, V133, P1055, DOI 10.1016/j.cell.2008.04.044; Rabouille C, 2005, NAT REV MOL CELL BIO, V6, P812, DOI 10.1038/nrm1735; RABOUILLE C, 1995, J CELL SCI, V108, P1617; Rivinoja A, 2006, J CELL PHYSIOL, V208, P167, DOI 10.1002/jcp.20653; Sasai K, 2001, J BIOL CHEM, V276, P759, DOI 10.1074/jbc.M004972200; Schoberer J, 2013, PLANT PHYSIOL, V161, P1737, DOI 10.1104/pp.112.210757; Storrie B, 1998, J CELL BIOL, V143, P1505, DOI 10.1083/jcb.143.6.1505; Tu LN, 2010, CELL MOL LIFE SCI, V67, P29, DOI 10.1007/s00018-009-0126-z; Ungar D, 2009, SEMIN CELL DEV BIOL, V20, P762, DOI 10.1016/j.semcdb.2009.03.004; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Varki A, 2008, TRENDS MOL MED, V14, P351, DOI 10.1016/j.molmed.2008.06.002; WEISZ OA, 1993, J CELL BIOL, V122, P1185, DOI 10.1083/jcb.122.6.1185; YAMAGUCHI N, 1995, J BIOL CHEM, V270, P12170, DOI 10.1074/jbc.270.20.12170; Yang W, 1997, CELL BIOL INT, V21, P223, DOI 10.1006/cbir.1997.0138; Yen TY, 2003, J BIOL CHEM, V278, P45864, DOI 10.1074/jbc.M303851200	51	35	37	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					26937	26948		10.1074/jbc.M114.595058	http://dx.doi.org/10.1074/jbc.M114.595058			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25135644	Green Published, hybrid			2022-12-25	WOS:000342853900024
J	Choi, YS; Lee, SK; Bae, WJ; Kim, SJ; Cho, HJ; Hong, SH; Lee, JY; Hwang, TK; Kim, SW				Choi, Yong Sun; Lee, Sang Kuon; Bae, Woong Jin; Kim, Su Jin; Cho, Hyuk Jin; Hong, Sung-Hoo; Lee, Ji Youl; Hwang, Tae-Kon; Kim, Sae Woong			Bariatric Surgery Improves the Cavernosal Neuronal, Vasorelaxation, and Contraction Mechanisms for Erectile Dysfunction As Result of Amelioration of Glucose Homeostasis in a Diabetic Rat Model	PLOS ONE			English	Article							CORPUS CAVERNOSUM; PENILE ERECTION; MICE LACKING; WEIGHT-LOSS; BODY-IMAGE; OBESE; PREVALENCE	Background: Bariatric surgery is an effective treatment option for both obesity and obesity-related type 2 diabetes mellitus (T2DM). However, little is known regarding the effects of bariatric surgery on erectile dysfunction among patients with T2DM. Therefore, we investigated whether bariatric surgery would lead to structural and biochemical changes in the corpus cavernosum. Material and Method: Twenty-five male Otsuka Long-Evans Tokushima Fatty rats were assigned to either a control group (sham operation, n = 10) or a bariatric surgery group (gastric bypass surgery, n = 15). Four weeks after the operation, each group of rats was evaluated with an oral glucose tolerance test (OGTT). The penile intracavernous pressure was measured for erectile functional analysis. Histologic evaluation of the tissue was performed with Masson's trichrome staining. Endothelial nitric oxide synthase (eNOS), neuronal nitric oxide synthase (nNOS), Rho kinase, and 8-hydroxy-2-deoxyguanosine (8-OHdG) levels in the corpus cavernosum were assayed by using western blot and ELISA. Results: The mean body weight of the bariatric surgery group was lower than the control group (p = 0.002). The postoperative OGTT result was lower in the bariatric surgery group than in the control group (p = 0.014), and this was lower than the preoperative value (p = 0.037). The intracavernous pressure/mean arterial pressure ratio was higher in the bariatric surgery group compared to the control group (p = 0.021), and a higher cavernosum smooth muscle/collagen ratio was observed in the bariatric surgery group compared to the control group (p = 0.025). Likewise, the expression of eNOS and nNOS was higher in bariatric surgery group than in the control group (p = 0.027 and p = 0.008, respectively). Decreased expression of Rho kinase and levels of 8-OHdG were observed in the bariatric surgery group (p = 0.032). Conclusion: In this animal model, bariatric surgery appears to ameliorate T2DM-related metabolic dysfunction leading to structural and biochemical changes in the corpus cavernosum, and thus, results in improvement of erectile dysfunction associated with T2DM.	[Choi, Yong Sun; Bae, Woong Jin; Kim, Su Jin; Cho, Hyuk Jin; Hong, Sung-Hoo; Lee, Ji Youl; Hwang, Tae-Kon; Kim, Sae Woong] Catholic Univ Korea, Dept Urol, Coll Med, Seoul, South Korea; [Lee, Sang Kuon] Catholic Univ Korea, Dept Surg, Coll Med, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea	Kim, SW (corresponding author), Catholic Univ Korea, Dept Urol, Coll Med, Seoul, South Korea.	ksw1227@catholic.ac.kr	Cho, Hyuk Jin/AAU-7753-2020	Cho, Hyuk Jin/0000-0003-2599-2950				Buchwald H, 2004, JAMA-J AM MED ASSOC, V292, P1724, DOI 10.1001/jama.292.14.1724; Burnett AL, 2002, J ANDROL, V23, P92, DOI 10.1002/j.1939-4640.2002.tb02601.x; Burnett AL, 1996, MOL MED, V2, P288, DOI 10.1007/BF03401627; Chitaley K, 2001, INT J IMPOT RES, V13, P67, DOI 10.1038/sj.ijir.3900647; Chitaley K, 2009, J UROLOGY, V182, pS45, DOI 10.1016/j.juro.2009.07.089; Dallal RM, 2008, J AM COLL SURGEONS, V207, P859, DOI 10.1016/j.jamcollsurg.2008.08.006; DETEJADA IS, 1988, AM J PHYSIOL, V254, pH459, DOI 10.1152/ajpheart.1988.254.3.H459; Dixon JB, 2002, OBES SURG, V12, P65, DOI 10.1381/096089202321144612; Hidalgo-Tamola J, 2009, J SEX MED, V6, P916, DOI 10.1111/j.1743-6109.2008.01116.x; Jang H, 2012, REPROD FERT DEVELOP, V24, P649, DOI 10.1071/RD11174; Jesmin S, 2003, J MOL ENDOCRINOL, V31, P401, DOI 10.1677/jme.0.0310401; Karra E, 2010, TRENDS ENDOCRIN MET, V21, P337, DOI 10.1016/j.tem.2010.01.006; Kolotkin RL, 2006, OBESITY, V14, P472, DOI 10.1038/oby.2006.62; KREMEN AJ, 1954, ANN SURG, V140, P439, DOI 10.1097/00000658-195409000-00018; Lee YS, 2013, UROLOGY, V81, P873, DOI 10.1016/j.urology.2012.09.064; MCCULLOCH DK, 1980, DIABETOLOGIA, V18, P279; Ranasinghe WKB, 2011, BJU INT, V107, P88, DOI 10.1111/j.1464-410X.2010.09509.x; Rubino F, 2006, ANN SURG, V244, P741, DOI 10.1097/01.sla.0000224726.61448.1b; Saigal CS, 2006, ARCH INTERN MED, V166, P207, DOI 10.1001/archinte.166.2.207; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; Takahashi R, 2003, J UROLOGY, V169, P2412, DOI 10.1097/01.ju.0000065808.45445.a1; Varela JE, 2011, CURR OPIN CLIN NUTR, V14, P396, DOI 10.1097/MCO.0b013e3283468e50; Werlinger K, 1997, J SEX MARITAL THER, V23, P74; Wessells H, 2006, BJU INT, V97, P1047, DOI 10.1111/j.1464-410X.2006.06059.X; Wolf AM, 1998, OBES RES, V6, P97, DOI 10.1002/j.1550-8528.1998.tb00322.x	25	8	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e104042	10.1371/journal.pone.0104042	http://dx.doi.org/10.1371/journal.pone.0104042			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137300	gold, Green Submitted, Green Published			2022-12-25	WOS:000340742100016
J	Kim, JG; Bae, JH; Kim, JA; Heo, K; Yang, K; Yi, JM				Kim, Joong-Gook; Bae, Jin-Han; Kim, Jin-Ah; Heo, Kyu; Yang, Kwangmo; Yi, Joo Mi			Combination Effect of Epigenetic Regulation and Ionizing Radiation in Colorectal Cancer Cells	PLOS ONE			English	Article							DNA METHYLTRANSFERASE; INDUCED APOPTOSIS; POLY(ADP-RIBOSE) POLYMERASE; 5-AZA-2'-DEOXYCYTIDINE; RADIOSENSITIVITY; METHYLATION; INHIBITOR; P53; ENHANCEMENT; ACTIVATION	Exposure of cells to ionizing radiation (IR) induces, not only, activation of multiple signaling pathways that play critical roles in cell fate determination, but also alteration of molecular pathways involved in cell death or survival. Recently, DNA methylation has been established as a critical epigenetic process involved in the regulation of gene expression in cancer cells, suggesting that DNA methylation inhibition may be an effective cancer treatment strategy. Because alterations of gene expression by DNA methylation have been considered to influence radioresponsiveness, we investigated the effect of a DNA methyltransferase inhibitor, 5-aza-2'-deoxycytidine (5-aza-dC), on radiosensitivity. In addition, we investigated the underlying cellular mechanisms of combination treatments of ionizing irradiation (IR) and 5-aza-dC in human colon cancer cells. Colon cancer cell lines were initially tested for radiation sensitivity by IR in vitro and were treated with two different doses of 5-aza-dC. Survival of these cell lines was measured using MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) and clonogenic assays. The effects of 5-aza-dC along with irradiation on cell growth, cell cycle distribution, apoptosis, and apoptosis-related gene expression were examined. Combination irradiation treatment with 5-aza-dC significantly decreased growth activity compared with irradiation treatment alone or with 5-aza-dC treatment alone. The percentage of HCT116 cells in the sub-G1 phase and their apoptotic rate was increased when cells were treated with irradiation in combination with 5-aza-dC compared with either treatment alone. These observations were strongly supported by increased caspase activity, increased comet tails using comet assays, and increased protein levels of apoptosis-associated molecules (caspase 3/9, cleaved PARP). Our data demonstrated that 5-aza-dC enhanced radiosensitivity in colon cancer cells, and the combination effects of 5-aza-dC with radiation showed greater cellular effects than that of single treatment, suggesting that the combination of 5-aza-dC and radiation has the potential to become a clinical strategy for the treatment of cancer.	[Kim, Joong-Gook; Bae, Jin-Han; Kim, Jin-Ah; Heo, Kyu; Yang, Kwangmo; Yi, Joo Mi] Dongnam Inst Radiol & Med Sci DIRAMS, Res Ctr, Pusan, South Korea; [Yang, Kwangmo] Korea Inst Radiol & Med Sci, Dept Radiat Oncol, Seoul, South Korea	Korea Institute of Radiological & Medical Sciences; Korea Institute of Radiological & Medical Sciences	Yang, K (corresponding author), Dongnam Inst Radiol & Med Sci DIRAMS, Res Ctr, Pusan, South Korea.	kmyang@dirams.re.kr; jmyi@dirams.re.kr		Heo, Kyu/0000-0001-8833-4731	National R&D Program through the Dongnam Institute of Radiological & Medical Sciences - Korean Ministry of Education, Science, and Technology [50596-2014]; National Research Foundation (NRF); Ministry of Science, ICT and Future Planning (MSIP), Korean government through its National Nuclear Technology Program [2013M2A2A7043665]	National R&D Program through the Dongnam Institute of Radiological & Medical Sciences - Korean Ministry of Education, Science, and Technology; National Research Foundation (NRF); Ministry of Science, ICT and Future Planning (MSIP), Korean government through its National Nuclear Technology Program	This study was supported by a National R&D Program (50596-2014) through the Dongnam Institute of Radiological & Medical Sciences funded by the Korean Ministry of Education, Science, and Technology. This work was also supported by the National Research Foundation (NRF) and Ministry of Science, ICT and Future Planning (MSIP), Korean government, through its National Nuclear Technology Program (2013M2A2A7043665). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELE R, 1987, EUR J CANCER CLIN ON, V23, P1921, DOI 10.1016/0277-5379(87)90060-5; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Camphausen K, 2007, J CLIN ONCOL, V25, P4051, DOI 10.1200/JCO.2007.11.6202; De Schutter H, 2009, INT J RADIAT ONCOL, V73, P904, DOI 10.1016/j.ijrobp.2008.10.032; Dote H, 2005, CLIN CANCER RES, V11, P4571, DOI 10.1158/1078-0432.CCR-05-0050; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; GOODHEAD DT, 1994, INT J RADIAT BIOL, V65, P7, DOI 10.1080/09553009414550021; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Hofstetter B, 2010, INT J RADIAT ONCOL, V76, P1512, DOI 10.1016/j.ijrobp.2009.10.037; Jones PA, 1999, NAT GENET, V21, P163, DOI 10.1038/5947; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kaminskas E, 2005, CLIN CANCER RES, V11, P3604, DOI 10.1158/1078-0432.CCR-04-2135; Karpf AR, 2001, MOL PHARMACOL, V59, P751, DOI 10.1124/mol.59.4.751; KAUFMANN SH, 1993, CANCER RES, V53, P3976; Kelly TK, 2010, NAT BIOTECHNOL, V28, P1069, DOI 10.1038/nbt.1678; Kim HJ, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-39; Kristensen LS, 2009, EUR J PHARMACOL, V625, P131, DOI 10.1016/j.ejphar.2009.10.011; KUERBITZ SJ, 1992, P NATL ACAD SCI USA, V89, P7491, DOI 10.1073/pnas.89.16.7491; Kulis M, 2010, ADV GENET, V70, P27, DOI [10.1016/S0065-2660(10)70002-X, 10.1016/B978-0-12-380866-0.60002-2]; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Li J, 2008, ONCOGENE, V27, P6194, DOI 10.1038/onc.2008.297; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; Plimack ER, 2007, J CLIN ONCOL, V25, P4519, DOI 10.1200/JCO.2007.12.6029; Pulukuri SMK, 2005, INT J ONCOL, V26, P863; Qiu H, 2009, CANCER SCI, V100, P181, DOI 10.1111/j.1349-7006.2008.01004.x; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Schuebel KE, 2007, PLOS GENET, V3, P1709, DOI 10.1371/journal.pgen.0030157; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; VANGROENINGEN CJ, 1986, CANCER RES, V46, P4831; Wang L, 2013, CANCER BIOTHER RADIO, V28, P34, DOI 10.1089/cbr.2012.1170; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930; Zhang Y, 2001, J BIOL CHEM, V276, P28842, DOI 10.1074/jbc.M010525200	32	9	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105405	10.1371/journal.pone.0105405	http://dx.doi.org/10.1371/journal.pone.0105405			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136811	gold, Green Published, Green Submitted			2022-12-25	WOS:000340742100090
J	Bahaji, A; Baroja-Fernandez, E; Sanchez-Lopez, AM; Munoz, FJ; Li, J; Almagro, G; Montero, M; Pujol, P; Galarza, R; Kaneko, K; Oikawa, K; Wada, K; Mitsui, T; Pozueta-Romero, J				Bahaji, Abdellatif; Baroja-Fernandez, Edurne; Maria Sanchez-Lopez, Angela; Jose Munoz, Francisco; Li, Jun; Almagro, Goizeder; Montero, Manuel; Pujol, Pablo; Galarza, Regina; Kaneko, Kentaro; Oikawa, Kazusato; Wada, Kaede; Mitsui, Toshiaki; Pozueta-Romero, Javier			HPLC-MS/MS Analyses Show That the Near-Starchless aps1 and pgm Leaves Accumulate Wild Type Levels of ADPglucose: Further Evidence for the Occurrence of Important ADPglucose Biosynthetic Pathway(s) Alternative to the pPGI-pPGM-AGP Pathway	PLOS ONE			English	Article							ADP-GLUCOSE PYROPHOSPHORYLASE; ADENOSINE-DIPHOSPHATE GLUCOSE; SUCROSE SYNTHASE ACTIVITY; IN-SOURCE LEAVES; ARABIDOPSIS-THALIANA; ESCHERICHIA-COLI; GLYCOGEN BIOSYNTHESIS; TRANSITORY STARCH; LEAF STARCH; MOLECULAR CHARACTERIZATION	In leaves, it is widely assumed that starch is the end-product of a metabolic pathway exclusively taking place in the chloroplast that (a) involves plastidic phosphoglucomutase (pPGM), ADPglucose (ADPG) pyrophosphorylase (AGP) and starch synthase (SS), and (b) is linked to the Calvin-Benson cycle by means of the plastidic phosphoglucose isomerase (pPGI). This view also implies that AGP is the sole enzyme producing the starch precursor molecule, ADPG. However, mounting evidence has been compiled pointing to the occurrence of important sources, other than the pPGI-pPGM-AGP pathway, of ADPG. To further explore this possibility, in this work two independent laboratories have carried out HPLC-MS/MS analyses of ADPG content in leaves of the near-starchless pgm and aps1 mutants impaired in pPGM and AGP, respectively, and in leaves of double aps1/pgm mutants grown under two different culture conditions. We also measured the ADPG content in wild type (WT) and aps1 leaves expressing in the plastid two different ADPG cleaving enzymes, and in aps1 leaves expressing in the plastid GlgC, a bacterial AGP. Furthermore, we measured the ADPG content in ss3/ss4/aps1 mutants impaired in starch granule initiation and chloroplastic ADPG synthesis. We found that, irrespective of their starch contents, pgm and aps1 leaves, WT and aps1 leaves expressing in the plastid ADPG cleaving enzymes, and aps1 leaves expressing in the plastid GlgC accumulate WT ADPG content. In clear contrast, ss3/ss4/aps1 leaves accumulated ca. 300 fold-more ADPG than WT leaves. The overall data showed that, in Arabidopsis leaves, (a) there are important ADPG biosynthetic pathways, other than the pPGI-pPGM-AGP pathway, (b) pPGM and AGP are not major determinants of intracellular ADPG content, and (c) the contribution of the chloroplastic ADPG pool to the total ADPG pool is low.	[Bahaji, Abdellatif; Baroja-Fernandez, Edurne; Maria Sanchez-Lopez, Angela; Jose Munoz, Francisco; Li, Jun; Almagro, Goizeder; Montero, Manuel; Pozueta-Romero, Javier] Univ Publ Navarra, Inst Agrobiotecnol, CSIC, Nafarroa, Spain; [Pujol, Pablo; Galarza, Regina] Univ Publ Navarra, Serv Apoyo Invest, Nafarroa, Spain; [Kaneko, Kentaro; Oikawa, Kazusato; Wada, Kaede; Mitsui, Toshiaki] Niigata Univ, Dept Appl Biol Chem, Niigata, Japan	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-GN-UPNA - Instituto de Agrobiotecnologia (IDAB); Universidad Publica de Navarra; Universidad Publica de Navarra; Niigata University	Pozueta-Romero, J (corresponding author), Univ Publ Navarra, Inst Agrobiotecnol, CSIC, Nafarroa, Spain.	javier.pozueta@unavarra.es	Pozueta-Romero, Javier/AAP-9341-2021; Muñoz, Francisco/I-3547-2012; Mitsui, Toshikai/N-9773-2017; Bahaji, Abdellatif/C-4105-2015; Montero, Manuel/K-7166-2013; Pozueta-Romero, Javier/G-3766-2011; Sánchez-López, Ángela María/Y-9884-2019; Almagro, Goizeder/Y-9900-2019; Edurne, Baroja-Fernandez/I-4037-2012	Pozueta-Romero, Javier/0000-0002-0335-9663; Muñoz, Francisco/0000-0002-0426-2118; Mitsui, Toshikai/0000-0002-9165-8830; Bahaji, Abdellatif/0000-0002-5270-497X; Montero, Manuel/0000-0002-8036-8758; Pozueta-Romero, Javier/0000-0002-0335-9663; Sánchez-López, Ángela María/0000-0001-9620-0258; Almagro, Goizeder/0000-0001-7035-9965; Edurne, Baroja-Fernandez/0000-0003-0049-6045; Oikawa, Kazusato/0000-0002-1033-9089	Comision Interministerial de Ciencia y Tecnologia [BIO2010-18239]; Fondo Europeo de Desarrollo Regional (Spain); Government of Navarra [IIM010491.RI1]; Iden Biotechnology; Ministry of Education, Culture, Sports, Science and Technology, Japan [22114507, 22380186]	Comision Interministerial de Ciencia y Tecnologia(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); Fondo Europeo de Desarrollo Regional (Spain)(European Commission); Government of Navarra; Iden Biotechnology; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was partially supported by the grants [BIO2010-18239] from the Comision Interministerial de Ciencia y Tecnologia and Fondo Europeo de Desarrollo Regional (Spain) and [IIM010491.RI1] from the Government of Navarra, and by Iden Biotechnology. This research was also supported by Scientific Research on Innovative Areas [22114507] and Grants-in-Aid for Scientific Research (B) [22380186] from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asatsuma S, 2005, PLANT CELL PHYSIOL, V46, P858, DOI 10.1093/pcp/pci091; Bahaji A, 2014, 12 PLANT MOL BIOL M; Bahaji A, 2013, 13 SPAIN PORT C PLAN; Bahaji A, 2014, BIOTECHNOL ADV, V32, P87, DOI 10.1016/j.biotechadv.2013.06.006; Bahaji A, 2011, PLANT CELL PHYSIOL, V52, P1162, DOI 10.1093/pcp/pcr067; Baroja-Fernandez E, 2005, TRENDS PLANT SCI, V10, P156, DOI 10.1016/j.tplants.2005.02.003; Baroja-Fernandez E, 2004, P NATL ACAD SCI USA, V101, P13080, DOI 10.1073/pnas.0402883101; Baroja-Fernandez E, 2003, PLANT CELL PHYSIOL, V44, P500, DOI 10.1093/pcp/pcg062; Baroja-Fernandez E, 2001, PLANT CELL PHYSIOL, V42, P1311, DOI 10.1093/pcp/pce175; Baroja-Fernandez E, 2012, P NATL ACAD SCI USA, V109, pE777, DOI 10.1073/pnas.1201538109; Baroja-Fernandez E, 2012, P NATL ACAD SCI USA, V109, P321, DOI 10.1073/pnas.1117099109; Barratt DHP, 2009, P NATL ACAD SCI USA, V106, P13124, DOI 10.1073/pnas.0900689106; Belanger AE, 1999, J BACTERIOL, V181, P6670, DOI 10.1128/JB.181.21.6670-6678.1999; Bollen M, 1998, BIOCHEM J, V336, P19, DOI 10.1042/bj3360019; CASPAR T, 1991, PLANT PHYSIOL, V95, P1181, DOI 10.1104/pp.95.4.1181; CASPAR T, 1985, PLANT PHYSIOL, V79, P11, DOI 10.1104/pp.79.1.11; Chen MJ, 2011, PLANT CELL, V23, P2991, DOI 10.1105/tpc.111.085829; Cho MH, 2011, NEW PHYTOL, V190, P101, DOI 10.1111/j.1469-8137.2010.03580.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Crevillen P, 2005, J BIOL CHEM, V280, P8143, DOI 10.1074/jbc.M411713200; Crumpton-Taylor M, 2013, NEW PHYTOL, V200, P1064, DOI 10.1111/nph.12455; DANKERT M, 1964, BIOCHIM BIOPHYS ACTA, V81, P78, DOI 10.1016/0926-6569(64)90337-2; DAVID M, 1990, J CLIN INVEST, V86, P612, DOI 10.1172/JCI114752; DELMER DP, 1972, J BIOL CHEM, V247, P3822; Eydallin G, 2007, FEBS LETT, V581, P4417, DOI 10.1016/j.febslet.2007.08.016; Eydallin G, 2007, FEBS LETT, V581, P2947, DOI 10.1016/j.febslet.2007.05.044; Fettke J, 2011, PLANT PHYSIOL, V155, P1723, DOI 10.1104/pp.110.168716; FOX TC, 1984, PLANT PHYSIOL, V76, P763, DOI 10.1104/pp.76.3.763; FU HY, 1995, PLANT CELL, V7, P1395, DOI 10.1105/tpc.7.9.1395; Fulton DC, 2008, PLANT CELL, V20, P1040, DOI 10.1105/tpc.107.056507; GAUDET G, 1992, EUR J BIOCHEM, V207, P155, DOI 10.1111/j.1432-1033.1992.tb17032.x; Geigenberger P, 2011, PLANT PHYSIOL, V155, P1566, DOI 10.1104/pp.110.170399; Giese JO, 2005, FEBS LETT, V579, P827, DOI 10.1016/j.febslet.2004.12.071; Guedon E, 2000, J BACTERIOL, V182, P2010, DOI 10.1128/JB.182.7.2010-2017.2000; Guerra LT, 2013, J BIOTECHNOL, V166, P65, DOI 10.1016/j.jbiotec.2013.04.005; Kaneko K, 2014, PLANT CELL PHYSIOL, V55, P320, DOI 10.1093/pcp/pct139; KIEL JAKW, 1994, MOL MICROBIOL, V11, P203, DOI 10.1111/j.1365-2958.1994.tb00301.x; Kleczkowski LA, 2000, BBA-PROTEIN STRUCT M, V1476, P103, DOI 10.1016/S0167-4838(99)00229-0; Kleczkowski LA, 1999, FEBS LETT, V448, P153, DOI 10.1016/S0014-5793(99)00346-4; Kofler H, 2000, MOL GEN GENET, V263, P978, DOI 10.1007/PL00008698; Kunz HH, 2010, PLANT BIOLOGY, V12, P115, DOI 10.1111/j.1438-8677.2010.00349.x; LEHMANN M, 1976, ARCH MICROBIOL, V111, P93, DOI 10.1007/BF00446554; Lepek VC, 2002, MOL PLANT MICROBE IN, V15, P368, DOI 10.1094/MPMI.2002.15.4.368; LIN TP, 1988, PLANT PHYSIOL, V86, P1131, DOI 10.1104/pp.86.4.1131; Lozovaya VV, 1996, PLANT PHYSIOL, V111, P921, DOI 10.1104/pp.111.3.921; Lunn JE, 2006, BIOCHEM J, V397, P139, DOI 10.1042/BJ20060083; Marroqui S, 2001, J BACTERIOL, V183, P854, DOI 10.1128/JB.183.3.854-864.2001; Martin MC, 1997, J BACTERIOL, V179, P7784, DOI 10.1128/jb.179.24.7784-7789.1997; Martins MCM, 2013, PLANT PHYSIOL, V163, P1142, DOI 10.1104/pp.113.226787; MASSILLON D, 1995, J BIOL CHEM, V270, P19351, DOI 10.1074/jbc.270.33.19351; McCoy JG, 2006, BIOCHEMISTRY-US, V45, P3154, DOI 10.1021/bi052232m; Montero M, 2011, BIOCHEM J, V433, P107, DOI 10.1042/BJ20101186; Montero M, 2009, BIOCHEM J, V424, P129, DOI 10.1042/BJ20090980; Moran-Zorzano MT, 2007, FEBS LETT, V581, P4423, DOI 10.1016/j.febslet.2007.08.017; Moreno-Bruna B, 2001, P NATL ACAD SCI USA, V98, P8128, DOI 10.1073/pnas.131214098; Munoz FJ, 2005, PLANT CELL PHYSIOL, V46, P1366, DOI 10.1093/pcp/pci148; Munoz FJ, 2006, BIOCATAL BIOTRANSFOR, V24, P63, DOI 10.1080/10242420500518839; MURATA T, 1966, ARCH BIOCHEM BIOPHYS, V113, P34, DOI 10.1016/0003-9861(66)90153-6; MURATA T, 1977, AGR BIOL CHEM TOKYO, V41, P1995, DOI 10.1080/00021369.1977.10862796; NEIJSSEL OM, 1990, BIOCHIM BIOPHYS ACTA, V1018, P252, DOI 10.1016/0005-2728(90)90260-B; Neuhaus HE, 2005, TRENDS PLANT SCI, V10, P154, DOI 10.1016/j.tplants.2005.02.002; NEWSHOLME EA, 1984, TRENDS BIOCHEM SCI, V9, P277, DOI 10.1016/0968-0004(84)90165-8; Okazaki Y, 2009, PLANT CELL, V21, P892, DOI 10.1105/tpc.108.063925; OKITA TW, 1992, PLANT PHYSIOL, V100, P560, DOI 10.1104/pp.100.2.560; Olsson T, 2003, J BIOL CHEM, V278, P44439, DOI 10.1074/jbc.M306265200; Pedro CN, 2003, J BIOL CHEM, V278, P28508, DOI 10.1074/jbc.M304280200; POZUETAROMERO J, 1991, PLANT PHYSIOL, V97, P1565, DOI 10.1104/pp.97.4.1565; Ragel P, 2013, PLANT PHYSIOL, V163, P75, DOI 10.1104/pp.113.223420; Rao M, 1995, PLANT PHYSIOL, V107, P195; Rodriguez-Lopez M, 2000, P NATL ACAD SCI USA, V97, P8705, DOI 10.1073/pnas.120168097; Sambou T, 2008, MOL MICROBIOL, V70, P762, DOI 10.1111/j.1365-2958.2008.06445.x; SCOTT P, 1995, PLANT PHYSIOL, V108, P1569, DOI 10.1104/pp.108.4.1569; SILVIUS JE, 1979, PLANT PHYSIOL, V64, P1070, DOI 10.1104/pp.64.6.1070; Smith AM, 2012, P NATL ACAD SCI USA, V109, pE776, DOI 10.1073/pnas.1200878109; Sokolov LN, 1998, BIOCHEM J, V336, P681, DOI 10.1042/bj3360681; STITT M, 1989, PHYSIOL PLANTARUM, V77, P633, DOI 10.1111/j.1399-3054.1989.tb05402.x; STITT M, 1981, BIOCHIM BIOPHYS ACTA, V638, P1, DOI 10.1016/0005-2728(81)90179-1; Stitt M, 2012, CURR OPIN PLANT BIOL, V15, P282, DOI 10.1016/j.pbi.2012.03.016; Streb Sebastian, 2012, Arabidopsis Book, V10, pe0160, DOI 10.1199/tab.0160; Streb S, 2012, J BIOL CHEM, V287, P41745, DOI 10.1074/jbc.M112.395244; Streb S, 2009, PLANT PHYSIOL, V151, P1769, DOI 10.1104/pp.109.144931; Sulpice R, 2009, P NATL ACAD SCI USA, V106, P10348, DOI 10.1073/pnas.0903478106; Szecowka M, 2013, PLANT CELL, V25, P694, DOI 10.1105/tpc.112.106989; Szydlowski N, 2009, PLANT CELL, V21, P2443, DOI 10.1105/tpc.109.066522; TACKE M, 1991, PLANTA, V185, P220, DOI 10.1007/BF00194064; Tanase K, 2000, PLANT CELL PHYSIOL, V41, P408, DOI 10.1093/pcp/41.4.408; Ugalde JE, 1998, J BACTERIOL, V180, P6557, DOI 10.1128/JB.180.24.6557-6564.1998; Ventriglia T, 2008, PLANT PHYSIOL, V148, P65, DOI 10.1104/pp.108.122846; Walters RG, 2004, PLANT PHYSIOL, V135, P891, DOI 10.1104/pp.104.040469; Wang AY, 1999, PLANT CELL PHYSIOL, V40, P800, DOI 10.1093/oxfordjournals.pcp.a029608; Wang SM, 1998, PLANT J, V13, P63, DOI 10.1046/j.1365-313X.1998.00009.x; Wilson WA, 2010, FEMS MICROBIOL REV, V34, P952, DOI 10.1111/j.1574-6976.2010.00220.x; Yamada K, 2003, SCIENCE, V302, P842, DOI 10.1126/science.1088305; Yu TS, 2000, PLANT PHYSIOL, V123, P319, DOI 10.1104/pp.123.1.319; Zeeman SC, 2007, BIOCHEM J, V401, P13, DOI 10.1042/BJ20061393; Zeeman SC, 2004, PLANT PHYSIOL, V135, P849, DOI 10.1104/pp.103.032631; Zervosen A, 1998, J MOL CATAL B-ENZYM, V5, P25, DOI 10.1016/S1381-1177(98)00040-X; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8	98	17	18	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e104997	10.1371/journal.pone.0104997	http://dx.doi.org/10.1371/journal.pone.0104997			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133777	Green Published, gold, Green Submitted			2022-12-25	WOS:000341302700060
J	Dahl, M; Maturi, V; Lonn, P; Papoutsoglou, P; Zieba, A; Vanlandewijck, M; van der Heide, LP; Watanabe, Y; Soderberg, O; Hottiger, MO; Heldin, CH; Moustakas, A				Dahl, Markus; Maturi, Varun; Lonn, Peter; Papoutsoglou, Panagiotis; Zieba, Agata; Vanlandewijck, Michael; van der Heide, Lars P.; Watanabe, Yukihide; Soderberg, Ola; Hottiger, Michael O.; Heldin, Carl-Henrik; Moustakas, Aristidis			Fine-Tuning of Smad Protein Function by Poly(ADP-Ribose) Polymerases and Poly(ADP-Ribose) Glycohydrolase during Transforming Growth Factor beta Signaling	PLOS ONE			English	Article							ADP-RIBOSYLATION; PARP-1; TRANSCRIPTION; BINDING; ACETYLATION; EXPRESSION; RECEPTORS; LYSINE-36; PROGRESS; OUTCOMES	Background: Initiation, amplitude, duration and termination of transforming growth factor beta (TGF beta) signaling via Smad proteins is regulated by post-translational modifications, including phosphorylation, ubiquitination and acetylation. We previously reported that ADP-ribosylation of Smads by poly(ADP-ribose) polymerase 1 (PARP-1) negatively influences Smad-mediated transcription. PARP-1 is known to functionally interact with PARP-2 in the nucleus and the enzyme poly(ADP-ribose) glycohydrolase (PARG) can remove poly(ADP-ribose) chains from target proteins. Here we aimed at analyzing possible cooperation between PARP-1, PARP-2 and PARG in regulation of TGF beta signaling. Methods: A robust cell model of TGF beta signaling, i.e. human HaCaT keratinocytes, was used. Endogenous Smad3 ADP-ribosylation and protein complexes between Smads and PARPs were studied using proximity ligation assays and co-immunoprecipitation assays, which were complemented by in vitro ADP-ribosylation assays using recombinant proteins. Real-time RT-PCR analysis of mRNA levels and promoter-reporter assays provided quantitative analysis of gene expression in response to TGF beta stimulation and after genetic perturbations of PARP-1/-2 and PARG based on RNA interference. Results: TGF beta signaling rapidly induces nuclear ADP-ribosylation of Smad3 that coincides with a relative enhancement of nuclear complexes of Smads with PARP-1 and PARP-2. Inversely, PARG interacts with Smads and can de-ADP-ribosylate Smad3 in vitro. PARP-1 and PARP-2 also form complexes with each other, and Smads interact and activate auto-ADP-ribosylation of both PARP-1 and PARP-2. PARP-2, similar to PARP-1, negatively regulates specific TGF beta target genes (fibronectin, Smad7) and Smad transcriptional responses, and PARG positively regulates these genes. Accordingly, inhibition of TGF beta-mediated transcription caused by silencing endogenous PARG expression could be relieved after simultaneous depletion of PARP-1. Conclusion: Nuclear Smad function is negatively regulated by PARP-1 that is assisted by PARP-2 and positively regulated by PARG during the course of TGF beta signaling.	[Dahl, Markus; Maturi, Varun; Lonn, Peter; Papoutsoglou, Panagiotis; Vanlandewijck, Michael; van der Heide, Lars P.; Watanabe, Yukihide; Heldin, Carl-Henrik; Moustakas, Aristidis] Uppsala Univ, Ludwig Inst Canc Res, Sci Life Lab, Uppsala, Sweden; [Zieba, Agata; Soderberg, Ola] Uppsala Univ, Dept Immunol Genet & Pathol, Sci Life Lab, Uppsala, Sweden; [Hottiger, Michael O.] Univ Zurich, Inst Vet Biochem & Mol Biol, Zurich, Switzerland; [Moustakas, Aristidis] Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, Uppsala, Sweden	Ludwig Institute for Cancer Research; Uppsala University; Uppsala University; University of Zurich; Uppsala University	Moustakas, A (corresponding author), Uppsala Univ, Ludwig Inst Canc Res, Sci Life Lab, Uppsala, Sweden.	aris.moustakas@imbim.uu.se	Söderberg, Ola/O-5130-2017; Hottiger, Michael O./J-7747-2013; Papoutsoglou, Panagiotis/AAF-8898-2019; Maturi, Varun/K-1837-2019	Söderberg, Ola/0000-0003-2883-1925; Hottiger, Michael O./0000-0002-7323-2270; Papoutsoglou, Panagiotis/0000-0003-2115-3500; Maturi, Varun/0000-0003-1177-0839; Vanlandewijck, Michael/0000-0002-0709-7808; van der Heide, Lars P./0000-0003-1779-425X	Ludwig Cancer Research; Swedish Research Council [K2007-66X-14936-04-3, K2010-67X-14936-07-3, K2013-66X-14936-10-5, K2012-77PK-21931-01-2]; Bodossaki Foundation, Greece	Ludwig Cancer Research; Swedish Research Council(Swedish Research CouncilEuropean Commission); Bodossaki Foundation, Greece	This work was supported by Ludwig Cancer Research grants to A. M. and C.-H. H., the Swedish Research Council grants K2007-66X-14936-04-3, K2010-67X-14936-07-3 and K2013-66X-14936-10-5 to A. M., the Swedish Research Council grant K2012-77PK-21931-01-2 to P. L., and the Bodossaki Foundation, Greece to P. P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai P, 2011, CELL METAB, V13, P450, DOI 10.1016/j.cmet.2011.03.013; Frizzell KM, 2009, J BIOL CHEM, V284, P33926, DOI 10.1074/jbc.M109.023879; Gagne JP, 2006, CURR OPIN CELL BIOL, V18, P145, DOI 10.1016/j.ceb.2006.02.013; Gordon KJ, 2008, BBA-MOL BASIS DIS, V1782, P197, DOI 10.1016/j.bbadis.2008.01.006; Haenni SS, 2008, INT J BIOCHEM CELL B, V40, P2274, DOI 10.1016/j.biocel.2008.03.008; Haenni SS, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-39; Hassa PO, 2005, J BIOL CHEM, V280, P40450, DOI 10.1074/jbc.M507553200; Hottiger MO, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001645; Huang D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027123; Ikushima H, 2010, CANCER SCI, V101, P306, DOI 10.1111/j.1349-7006.2009.01441.x; Itoh S, 2011, GROWTH FACTORS, V29, P163, DOI 10.3109/08977194.2011.614236; Kang JS, 2009, TRENDS CELL BIOL, V19, P385, DOI 10.1016/j.tcb.2009.05.008; Kim MY, 2004, CELL, V119, P803, DOI 10.1016/j.cell.2004.11.002; Kowanetz M, 2004, MOL CELL BIOL, V24, P4241, DOI 10.1128/MCB.24.10.4241-4254.2004; Kowanetz M, 2008, J CELL BIOL, V182, P655, DOI 10.1083/jcb.200804107; Kraus WL, 2013, MOL ASPECTS MED, V34, P1109, DOI 10.1016/j.mam.2013.01.005; Krishnakumar R, 2008, SCIENCE, V319, P819, DOI 10.1126/science.1149250; Krishnakumar R, 2010, MOL CELL, V39, P8, DOI 10.1016/j.molcel.2010.06.017; Kurisaki A, 2001, MOL BIOL CELL, V12, P1079, DOI 10.1091/mbc.12.4.1079; Lonn P, 2010, MOL CELL, V40, P521, DOI 10.1016/j.molcel.2010.10.029; Lonn P, 2009, CELL RES, V19, P21, DOI 10.1038/cr.2008.308; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Miwa M, 2007, CANCER SCI, V98, P1528, DOI 10.1111/j.1349-7006.2007.00567.x; Moren A, 2003, J BIOL CHEM, V278, P33571, DOI 10.1074/jbc.M300159200; Rosenthal F, 2013, NAT STRUCT MOL BIOL, V20, P502, DOI 10.1038/nsmb.2521; Schreiber V, 2002, J BIOL CHEM, V277, P23028, DOI 10.1074/jbc.M202390200; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Yelamos J, 2011, AM J CANCER RES, V1, P328; Zampieri M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004717; Zhang P, 2013, BLOOD, V122, P2224, DOI 10.1182/blood-2013-05-503250	33	19	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e103651	10.1371/journal.pone.0103651	http://dx.doi.org/10.1371/journal.pone.0103651			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133494	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000341302700014
J	Czarnecka, M; Trinh, E; Lu, C; Kuan-Celarier, A; Galli, S; Hong, SH; Tilan, JU; Talisman, N; Izycka-Swieszewska, E; Tsuei, J; Yang, C; Martin, S; Horton, M; Christian, D; Everhart, L; Maheswaran, I; Kitlinska, J				Czarnecka, M.; Trinh, E.; Lu, C.; Kuan-Celarier, A.; Galli, S.; Hong, S-H; Tilan, J. U.; Talisman, N.; Izycka-Swieszewska, E.; Tsuei, J.; Yang, C.; Martin, S.; Horton, M.; Christian, D.; Everhart, L.; Maheswaran, I.; Kitlinska, J.			Neuropeptide Y receptor Y5 as an inducible pro-survival factor in neuroblastoma: implications for tumor chemoresistance	ONCOGENE			English	Article							NEUROTROPHIC FACTOR ACTIVATION; G-PROTEIN; MEDIATED NEUROPROTECTION; TYROSINE KINASES; EWING SARCOMA; IN-VIVO; BRAIN; EXPRESSION; CELLS; TRKB	Neuroblastoma (NB) is a pediatric tumor of neural crest origin with heterogeneous phenotypes. Although low-stage tumors carry a favorable prognosis, >50% of high-risk NB relapses after treatment with a fatal outcome. Thus developing therapies targeting refractory NB remains an unsolved clinical problem. Brain-derived neurotrophic factor (BDNF) and its TrkB receptor are known to protect NB cells from chemotherapy-induced cell death, while neuropeptide Y (NPY), acting via its Y2 receptor (Y2R), is an autocrine proliferative and angiogenic factor crucial for maintaining NB tumor growth. Here we show that in NB cells, BDNF stimulates the synthesis of NPY and induces expression of another one of its receptors, Y5R. In human NB tissues, the expression of NPY and Y5R positively correlated with the expression of BDNF and TrkB. Functionally, BDNF triggered Y5R internalization in NB cells, whereas Y5R antagonist inhibited BDNF-induced p44/42 mitogen-activated protein kinase activation and its pro-survival activity. These observations suggested TrkB-Y5R transactivation that resulted in cross-talk between their signaling pathways. Additionally, NPY and Y5R were upregulated in a BDNF-independent manner in NB cells under pro-apoptotic conditions, such as serum deprivation and chemotherapy, as well as in cell lines and tissues derived from posttreatment NB tumors. Blocking Y5R in chemoresistant NB cells rich in this receptor sensitized them to chemotherapy-induced apoptosis and inhibited their growth in vivo by augmenting cell death. In summary, the NPY/Y5R axis is an inducible survival pathway activated in NB by BDNF or cellular stress. Upon such activation, Y5R augments the pro-survival effect of BDNF via its interactions with TrkB receptor and exerts an additional BDNF-independent anti-apoptotic effect, both of which contribute to NB chemoresistance. Therefore, the NPY/Y5R pathway may become a novel therapeutic target for patients with refractory NB, thus far an incurable form of this disease.	[Czarnecka, M.; Trinh, E.; Kuan-Celarier, A.; Galli, S.; Talisman, N.; Tsuei, J.; Yang, C.; Everhart, L.; Maheswaran, I.; Kitlinska, J.] Georgetown Univ, Med Ctr, Dept Biochem & Mol & Cellular Biol, Washington, DC 20057 USA; [Lu, C.] MIT, McGovern Inst, Boston, MA USA; [Hong, S-H] Georgetown Univ, Med Ctr, Dept Oncol, Lombardi Comprehens Canc Ctr, Washington, DC 20057 USA; [Tilan, J. U.] Georgetown Univ, Dept Nursing, Sch Nursing & Hlth Studies, Washington, DC 20057 USA; [Tilan, J. U.; Martin, S.; Horton, M.; Christian, D.] Georgetown Univ, Dept Human Sci, Sch Nursing & Hlth Studies, Washington, DC 20057 USA; [Izycka-Swieszewska, E.] Med Univ Gdansk, Dept Pathol & Neuropathol, Gdansk, Poland	Georgetown University; Massachusetts Institute of Technology (MIT); Georgetown University; Georgetown University; Georgetown University; Fahrenheit Universities; Medical University Gdansk	Kitlinska, J (corresponding author), Georgetown Univ, Med Ctr, Dept Biochem & Mol & Cellular Biol, 3900 Reservoir,Basic Sci Bldg,Room 231A, Washington, DC 20057 USA.	jbk4@georgetown.edu	Izycka-Swieszewska, Ewa/AAX-5191-2020	izycka-swieszewska, ewa/0000-0001-7550-1326	National Institutes of Health grants from National Center for Advancing Translational Sciences (NCATS) through the Clinical and Translational Science Awards Program (CTSA) [UL1RR031975, 1R01CA123211, 1R03CA178809, UL1TR000101]; Children's Cancer Foundation (Baltimore, MD, USA); NIH/NCI grant [P30-CA051008]; Georgetown Undergraduate Research Opportunities Program; NATIONAL CANCER INSTITUTE [P30CA051008, R01CA123211, R03CA178809] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000101] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR031975] Funding Source: NIH RePORTER	National Institutes of Health grants from National Center for Advancing Translational Sciences (NCATS) through the Clinical and Translational Science Awards Program (CTSA); Children's Cancer Foundation (Baltimore, MD, USA); NIH/NCI grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgetown Undergraduate Research Opportunities Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Human NB samples at diagnosis were provided by the Children's Oncology Group. We thank Dr Garret Brodeur for providing SY5Y/TrkB transfectants. This work was supported by the National Institutes of Health grants: UL1TR000101 (previously UL1RR031975) from the National Center for Advancing Translational Sciences (NCATS), through the Clinical and Translational Science Awards Program (CTSA), 1R01CA123211 and 1R03CA178809 to JK, as well as funding from Children's Cancer Foundation (Baltimore, MD, USA) to JK, and Georgetown Undergraduate Research Opportunities Program to MH and DC. Experiments were performed with use of the Lombardi Comprehensive Cancer Center Shared Resources (Histopathology and Tissue, Biostatistics and Bioinformatics, Microscopy and Imaging, Animal Model and Tissue Culture) partially supported by the NIH/NCI grant P30-CA051008. We thank Dr Aykut Oren, Dr Ruijun Han and Dr Kristi Graves for their critical reading of the manuscript.	Garcia-Sainz JA, 2010, EUR J PHARMACOL, V648, P1, DOI 10.1016/j.ejphar.2010.08.049; Barnea A, 2001, BRAIN RES, V919, P57, DOI 10.1016/S0006-8993(01)02999-7; Borroto-Escuela DO, 2011, IUBMB LIFE, V63, P463, DOI 10.1002/iub.473; Brodeur GM, 2009, CLIN CANCER RES, V15, P3244, DOI 10.1158/1078-0432.CCR-08-1815; Brodeur GM, 1997, J NEURO-ONCOL, V31, P49, DOI 10.1023/A:1005729329526; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; COHEN PS, 1990, CANCER RES, V50, P6055; Decressac M, 2012, NEUROBIOL AGING, V33, P2125, DOI 10.1016/j.neurobiolaging.2011.06.018; Delcourt N, 2007, TRENDS PHARMACOL SCI, V28, P602, DOI 10.1016/j.tips.2007.09.007; Dotsch J, 1998, REGUL PEPTIDES, V75-6, P185, DOI 10.1016/S0167-0115(98)00067-6; Dudas J, 2011, ORAL ONCOL, V47, P98, DOI 10.1016/j.oraloncology.2010.11.002; Erondu N, 2006, CELL METAB, V4, P275, DOI 10.1016/j.cmet.2006.08.002; Erondu N, 2007, OBESITY, V15, P895, DOI 10.1038/oby.2007.620; Flajolet M, 2008, NAT NEUROSCI, V11, P1402, DOI 10.1038/nn.2216; Gehlert DR, 2007, BIOCHEM PHARMACOL, V74, P1652, DOI 10.1016/j.bcp.2007.08.017; Han BH, 2000, J NEUROSCI, V20, P5775, DOI 10.1523/jneurosci.20-15-05775.2000; Hansel DE, 2001, NATURE, V410, P940, DOI 10.1038/35073601; Ho R, 2002, CANCER RES, V62, P6462; Jaboin J, 2003, CANCER LETT, V193, P109, DOI 10.1016/S0304-3835(02)00723-1; Jaboin J, 2002, CANCER RES, V62, P6756; Keshelava N, 1998, CANCER RES, V58, P5396; Kitlinska J, 2005, CANCER RES, V65, P1719, DOI 10.1158/0008-5472.CAN-04-2192; Klocker N, 2000, J NEUROSCI, V20, P6962, DOI 10.1523/JNEUROSCI.20-18-06962.2000; KOGNER P, 1994, ACTA PAEDIATR, V83, P423, DOI 10.1111/j.1651-2227.1994.tb18134.x; Lee EW, 2003, J CLIN INVEST, V111, P1853, DOI 10.1172/JCI200316929; Lee FS, 2002, CYTOKINE GROWTH F R, V13, P11, DOI 10.1016/S1359-6101(01)00024-7; Li Z, 2007, CELL DEATH DIFFER, V14, P318, DOI 10.1038/sj.cdd.4401983; Lou XJ, 2001, MOL BIOL CELL, V12, P615, DOI 10.1091/mbc.12.3.615; Lu C, 2010, ONCOGENE, V29, P5630, DOI 10.1038/onc.2010.301; Lu CY, 2011, J BIOL CHEM, V286, P27494, DOI 10.1074/jbc.M111.224089; Malva JO, 2012, NEUROPEPTIDES, V46, P299, DOI 10.1016/j.npep.2012.09.001; Maris JM, 2005, CURR OPIN PEDIATR, V17, P7, DOI 10.1097/01.mop.0000150631.60571.89; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Movafagh S, 2006, FASEB J, V20, P1924, DOI 10.1096/fj.05-4770fje; NAKAGAWARA A, 1994, MOL CELL BIOL, V14, P759, DOI 10.1128/MCB.14.1.759; Nakagawara A, 2001, CANCER LETT, V169, P107, DOI 10.1016/S0304-3835(01)00530-4; Nakagawara A, 1997, EUR J CANCER, V33, P2050, DOI 10.1016/S0959-8049(97)00280-3; Pandey SC, 2003, TRENDS PHARMACOL SCI, V24, P456, DOI 10.1016/S0165-6147(03)00226-8; Pedrazzini T, 2003, CELL MOL LIFE SCI, V60, P350, DOI 10.1007/s000180300029; Pellieux C, 2000, P NATL ACAD SCI USA, V97, P1595, DOI 10.1073/pnas.030533197; Pfeiffer M, 2001, J BIOL CHEM, V276, P14027, DOI 10.1074/jbc.M006084200; Pons J, 2003, CAN J PHYSIOL PHARM, V81, P177, DOI 10.1139/Y02-166; Pons J, 2008, CAN J PHYSIOL PHARM, V86, P438, DOI [10.1139/Y08-054, 10.1139/y08-054]; Pyne NJ, 2003, BIOCHEM SOC T, V31, P1220; Rajagopal R, 2004, J NEUROSCI, V24, P6650, DOI 10.1523/JNEUROSCI.0010-04.2004; Rakhit S, 2001, MOL PHARMACOL, V60, P63, DOI 10.1124/mol.60.1.63; Reibel S, 2000, EUR J NEUROSCI, V12, P595, DOI 10.1046/j.1460-9568.2000.00941.x; Schramm A, 2005, CANCER LETT, V228, P143, DOI 10.1016/j.canlet.2005.02.051; Sheriff' S, 1998, REGUL PEPTIDES, V75-6, P309, DOI 10.1016/S0167-0115(98)00083-4; Sheriff S, 2010, MOL CANCER RES, V8, P604, DOI 10.1158/1541-7786.MCR-09-0301; Skaper SD, 1998, J NEUROCHEM, V70, P1859, DOI 10.1046/j.1471-4159.1998.70051859.x; Takei N, 1996, MOL BRAIN RES, V37, P283; Thiele CJ, 2009, CLIN CANCER RES, V15, P5962, DOI 10.1158/1078-0432.CCR-08-0651; Tilan JU, 2013, ONCOTARGET, V4, P2487, DOI 10.18632/oncotarget.1604; Tilan JU, 2013, FASEB J, V27, P2244, DOI 10.1096/fj.12-213546; Waters CM, 2005, CELL SIGNAL, V17, P263, DOI 10.1016/j.cellsig.2004.07.011; Wilhelm JC, 2012, J NEUROSCI, V32, P5002, DOI 10.1523/JNEUROSCI.1411-11.2012; Williams AG, 1998, BIOCHEM J, V333, P505, DOI 10.1042/bj3330505; Wirth MJ, 2005, P NATL ACAD SCI USA, V102, P3064, DOI 10.1073/pnas.0404712102; Xapelli S, 2008, EUR J NEUROSCI, V27, P2089, DOI 10.1111/j.1460-9568.2008.06172.x; Yoshimura R, 2009, NEUROSCI LETT, V450, P262, DOI 10.1016/j.neulet.2008.12.010; Zeine R, 2009, MODERN PATHOL, V22, P950, DOI 10.1038/modpathol.2009.52	64	14	15	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 11	2015	34	24					3131	3143		10.1038/onc.2014.253	http://dx.doi.org/10.1038/onc.2014.253			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CK3FD	25132261	Green Accepted			2022-12-25	WOS:000356101100005
J	Jia, N; Barclay, WS; Roberts, K; Yen, HL; Chan, RWY; Lam, AKY; Air, G; Peiris, JSM; Dell, A; Nicholls, JM; Haslam, SM				Jia, Nan; Barclay, Wendy S.; Roberts, Kim; Yen, Hui-Ling; Chan, Renee W. Y.; Lam, Alfred K. Y.; Air, Gillian; Peiris, J. S. Malik; Dell, Anne; Nicholls, John M.; Haslam, Stuart M.			Glycomic Characterization of Respiratory Tract Tissues of Ferrets IMPLICATIONS FOR ITS USE IN INFLUENZA VIRUS INFECTION STUDIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A H7N9 VIRUS; RECEPTOR SPECIFICITY; AVIAN INFLUENZA; MASS-SPECTROMETRY; SIALIC-ACID; GUINEA-PIG; TRANSMISSION; HEMAGGLUTININ; GLYCAN; MODEL	The initial recognition between influenza virus and the host cell is mediated by interactions between the viral surface protein hemagglutinin and sialic acid-terminated glycoconjugates on the host cell surface. The sialic acid residues can be linked to the adjacent monosaccharide by alpha 2-3- or alpha 2-6-type glycosidic bonds. It is this linkage difference that primarily defines the species barrier of the influenza virus infection with alpha 2-3 binding being associated with avian influenza viruses and alpha 2-6 binding being associated with human strains. The ferret has been extensively used as an animal model to study the transmission of influenza. To better understand the validity of this model system, we undertook glycomic characterization of respiratory tissues of ferret, which allows a comparison of potential viral receptors to be made between humans and ferrets. To complement the structural analysis, lectin staining experiments were performed to characterize the regional distributions of glycans along the respiratory tract of ferrets. Finally, the binding between the glycans identified and the hemagglutinins of different strains of influenza viruses was assessed by glycan array experiments. Our data indicated that the respiratory tissues of ferret heterogeneously express both alpha 2-3- and alpha 2-6-linked sialic acids. However, the respiratory tissues of ferret also expressed the Sda epitope (NeuAc alpha 2-3( GalNAc beta 1-4) Gal beta 1-4GlcNAc) and sialylated N,N'-diacetyllactosamine(NeuAc alpha 2-6GalNAc beta 1-4GlcNAc), which have not been observed in the human respiratory tract surface epithelium. The presence of the Sda epitope reduces potential binding sites for avian viruses and thus may have implications for the usefulness of the ferret in the study of influenza virus infection.	[Jia, Nan; Dell, Anne; Haslam, Stuart M.] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London SW7 2AZ, England; [Barclay, Wendy S.; Roberts, Kim] Univ London Imperial Coll Sci Technol & Med, Fac Med, Div Infect Dis, London W2 1PG, England; [Yen, Hui-Ling; Chan, Renee W. Y.; Peiris, J. S. Malik] Univ Hong Kong, Sch Publ Hlth, Pokfulam, Hong Kong, Peoples R China; [Lam, Alfred K. Y.] Griffith Univ, Dept Pathol, Nathan, Qld 4111, Australia; [Air, Gillian] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73126 USA; [Nicholls, John M.] Univ Hong Kong, Dept Pathol, Pokfulam, Hong Kong, Peoples R China	Imperial College London; Imperial College London; University of Hong Kong; Griffith University; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Hong Kong	Nicholls, JM (corresponding author), Univ Hong Kong, Dept Pathol, Pokfulam, Hong Kong, Peoples R China.	nicholls@pathology.hku.hk; s.haslam@imperial.ac.uk	Chan, Renee Wan Yi/AAA-6598-2020; Yen, Hui-Ling/GNH-5083-2022; Jia, Nan/AAG-2775-2020; Yen, Hui-Ling/C-4501-2009; Lam, Alfred/C-1652-2008; Nicholls, John Malcolm/C-4375-2009; Peiris, Joseph Sriyal Malik/C-4380-2009	Chan, Renee Wan Yi/0000-0001-6485-0926; Jia, Nan/0000-0002-6317-269X; Yen, Hui-Ling/0000-0003-2493-3609; Lam, Alfred/0000-0003-2771-564X; Air, Gillian/0000-0001-5724-3108; Barclay, Wendy/0000-0002-3948-0895; Nicholls, John Malcolm/0000-0001-7217-7444; Peiris, Joseph Sriyal Malik/0000-0001-8217-5995; Dell, Anne/0000-0003-1380-2347	Wellcome Trust [082098]; Biotechnology and Biological Sciences Research Council [BB/K016164/1, BB/F008309/1]; University Grants Committee from Government of the Hong Kong Special Administrative Region [AoE/M-12/96]; BBSRC [BB/K016164/1, BB/F008309/1] Funding Source: UKRI; National Centre for the Replacement [G1000033/1] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050933] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University Grants Committee from Government of the Hong Kong Special Administrative Region; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Centre for the Replacement; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Grant 082098 from the Wellcome Trust (to S. M. H., A. D., and J. N.), Grants BB/K016164/1 and BB/F008309/1 from the Biotechnology and Biological Sciences Research Council (to A. D. and S. M. H.), and Area of Excellence Scheme of the University Grants Committee Grant AoE/M-12/96 from the Government of the Hong Kong Special Administrative Region.	Air GM, 2012, INFLUENZA OTHER RESP, V6, P245, DOI 10.1111/j.1750-2659.2011.00304.x; BASARAB O, 1969, BRIT J EXP PATHOL, V50, P612; Bateman AC, 2010, J BIOL CHEM, V285, P34016, DOI 10.1074/jbc.M110.115998; Belser JA, 2013, NATURE, V501, P556, DOI 10.1038/nature12391; Belser JA, 2011, DIS MODEL MECH, V4, P575, DOI 10.1242/dmm.007823; Belser JA, 2009, ADV VIRUS RES, V73, P55, DOI 10.1016/S0065-3527(09)73002-7; Bern M, 2013, MOL CELL PROTEOMICS, V12, P996, DOI 10.1074/mcp.O112.026377; Chan MCW, 2013, LANCET RESP MED, V1, P534, DOI 10.1016/S2213-2600(13)70138-3; Childs RA, 2009, NAT BIOTECHNOL, V27, P797, DOI 10.1038/nbt0909-797; Chou HH, 1998, P NATL ACAD SCI USA, V95, P11751, DOI 10.1073/pnas.95.20.11751; Cohen J, 2012, SCIENCE, V335, P512, DOI 10.1126/science.335.6068.512; Crusat M, 2013, VIROLOGY, V447, P326, DOI 10.1016/j.virol.2013.08.010; de Vries RP, 2014, J VIROL, V88, P768, DOI 10.1128/JVI.02690-13; DELL A, 1991, CARBOHYD RES, V209, P33, DOI 10.1016/0008-6215(91)80143-B; DRZENIEK R, 1966, BIOCHIM BIOPHYS ACTA, V128, P547, DOI 10.1016/0926-6593(66)90015-4; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Francis T, 1938, J EXP MED, V68, P789, DOI 10.1084/jem.68.6.789; GALILI U, 1991, P NATL ACAD SCI USA, V88, P7401, DOI 10.1073/pnas.88.16.7401; Gambaryan A, 2005, VIROLOGY, V334, P276, DOI 10.1016/j.virol.2005.02.003; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Jang-Lee J, 2006, METHOD ENZYMOL, V415, P59, DOI 10.1016/S0076-6879(06)15005-3; Klisch K, 2008, GLYCOBIOLOGY, V18, P42, DOI 10.1093/glycob/cwm113; Kolarich D, 2013, MOL CELL PROTEOMICS, V12, P991, DOI 10.1074/mcp.O112.026492; Kreijtz JHCM, 2013, VACCINE, V31, P4995, DOI 10.1016/j.vaccine.2013.06.071; Lee CL, 2009, J BIOL CHEM, V284, P15084, DOI 10.1074/jbc.M807960200; LEIGH MW, 1989, BIOCHEMISTRY-US, V28, P9440, DOI 10.1021/bi00450a029; LEIGH MW, 1995, VACCINE, V13, P1468, DOI 10.1016/0264-410X(95)00004-K; Lowen AC, 2006, P NATL ACAD SCI USA, V103, P9988, DOI 10.1073/pnas.0604157103; MALAGOLINI N, 1994, GLYCOCONJUGATE J, V11, P89, DOI 10.1007/BF00731148; MANNING DD, 1990, J AM VET MED ASSOC, V197, P84; Munster VJ, 2009, SCIENCE, V325, P481, DOI 10.1126/science.1177127; North SJ, 2010, METHOD ENZYMOL, V478, P27, DOI 10.1016/S0076-6879(10)78002-2; POTTER CW, 1972, BRIT J EXP PATHOL, V53, P153; Richard M, 2013, NATURE, V501, P560, DOI 10.1038/nature12476; Roberts KL, 2011, J GEN VIROL, V92, P1822, DOI 10.1099/vir.0.031203-0; SERAFINICESSI F, 1983, BIOCHEM J, V215, P483, DOI 10.1042/bj2150483; Shelton H, 2013, J GEN VIROL, V94, P1220, DOI 10.1099/vir.0.050526-0; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Stevens J, 2006, J MOL BIOL, V355, P1143, DOI 10.1016/j.jmb.2005.11.002; Van Poucke S, 2013, INFLUENZA OTHER RESP, V7, P151, DOI 10.1111/j.1750-2659.2012.00376.x; Walther T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003223; Xu LL, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-253; Xu R, 2013, SCIENCE, V342, P1230, DOI 10.1126/science.1243761; Yen HL, 2007, J VIROL, V81, P6890, DOI 10.1128/JVI.00170-07; Yen HL, 2011, P NATL ACAD SCI USA, V108, P14264, DOI 10.1073/pnas.1111000108	45	64	64	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28489	28504		10.1074/jbc.M114.588541	http://dx.doi.org/10.1074/jbc.M114.588541			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25135641	hybrid, Green Published			2022-12-25	WOS:000343765400040
J	Byun, K; Bayarsaikhan, D; Bayarsaikhan, E; Son, M; Oh, S; Lee, J; Son, HI; Won, MH; Kim, SU; Song, BJ; Lee, B				Byun, Kyunghee; Bayarsaikhan, Delger; Bayarsaikhan, Enkhjargal; Son, Myeongjoo; Oh, Seyeon; Lee, Jaesuk; Son, Hye-in; Won, Moo-Ho; Kim, Seung U.; Song, Byoung-Joon; Lee, Bonghee			Microglial AGE-Albumin Is Critical in Promoting Alcohol-Induced Neurodegeneration in Rats and Humans	PLOS ONE			English	Article							INDUCED OXIDATIVE STRESS; BINGE ETHANOL EXPOSURE; INCREASED MCP-1; BRAIN; ACTIVATION; NEUROINFLAMMATION; REGIONS; NEUROGENESIS; EXPRESSION; MECHANISM	Alcohol is a neurotoxic agent, since long-term heavy ingestion of alcohol can cause various neural diseases including fetal alcohol syndrome, cerebellar degeneracy and alcoholic dementia. However, the molecular mechanisms of alcohol-induced neurotoxicity are still poorly understood despite numerous studies. Thus, we hypothesized that activated microglial cells with elevated AGE-albumin levels play an important role in promoting alcohol-induced neurodegeneration. Our results revealed that microglial activation and neuronal damage were found in the hippocampus and entorhinal cortex following alcohol treatment in a rat model. Increased AGE-albumin synthesis and secretion were also observed in activated microglial cells after alcohol exposure. The expressed levels of receptor for AGE (RAGE)-positive neurons and RAGE-dependent neuronal death were markedly elevated by AGE-albumin through the mitogen activated protein kinase pathway. Treatment with soluble RAGE or AGE inhibitors significantly diminished neuronal damage in the animal model. Furthermore, the levels of activated microglial cells, AGE-albumin and neuronal loss were significantly elevated in human brains from alcoholic indivisuals compared to normal controls. Taken together, our data suggest that increased AGE-albumin from activated microglial cells induces neuronal death, and that efficient regulation of its synthesis and secretion is a therapeutic target for preventing alcohol-induced neurodegeneration.	[Byun, Kyunghee; Bayarsaikhan, Delger; Bayarsaikhan, Enkhjargal; Son, Myeongjoo; Oh, Seyeon; Lee, Jaesuk; Lee, Bonghee] Gachon Univ, Lee Gil Ya Canc & Diabet Inst, Ctr Genom & Prote, Inchon, South Korea; [Byun, Kyunghee; Lee, Bonghee] Gachon Univ, Grad Sch Med, Dept Anat & Cell Biol, Inchon, South Korea; [Son, Hye-in] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Won, Moo-Ho] Kangwon Natl Univ, Coll Med, Dept Anat & Neurobiol, Chunchon, South Korea; [Won, Moo-Ho] Kangwon Natl Univ, Coll Med, Inst Neurodegenerat & Neuroregenerat, Chunchon, South Korea; [Kim, Seung U.] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Song, Byoung-Joon] NIAAA, Lab Membrane Biochem & Biophys, NIH, Bethesda, MD 20892 USA	Gachon University; Gachon University; University of California System; University of California Berkeley; Kangwon National University; Kangwon National University; University of British Columbia; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Song, BJ (corresponding author), NIAAA, Lab Membrane Biochem & Biophys, NIH, Bethesda, MD 20892 USA.	bj.song@nih.gov; bhlee@gachon.ac.kr	Son, myeongjoo/GWQ-6808-2022		National Research Foundation - Korean government [20120002979]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000036] Funding Source: NIH RePORTER	National Research Foundation - Korean government(Korean Government); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the National Research Foundation grant funded by the Korean government (K. B.) (20120002979). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002829; Boyadjieva NI, 2013, ALCOHOL CLIN EXP RES, V37, P252, DOI 10.1111/j.1530-0277.2012.01889.x; Boyadjieva NI, 2010, ALCOHOL CLIN EXP RES, V34, P1835, DOI 10.1111/j.1530-0277.2010.01271.x; Brown GC, 2010, MOL NEUROBIOL, V41, P242, DOI 10.1007/s12035-010-8105-9; Byun K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037917; Crew FT, 2011, BRAIN BEHAV IMMUN, V25, P4; Crews FT, 2006, ALCOHOL CLIN EXP RES, V30, P720, DOI 10.1111/j.1530-0277.2006.00084.x; Crews FT, 2006, NEUROSCIENCE, V137, P437, DOI 10.1016/j.neuroscience.2005.08.090; Crews F, 2006, ALCOHOL CLIN EXP RES, V30, P1938, DOI 10.1111/j.1530-0277.2006.00239.x; Fernandez-Lizarbe S, 2009, J IMMUNOL, V183, P4733, DOI 10.4049/jimmunol.0803590; Goodman MD, 2013, J SURG RES, V184, P1053, DOI 10.1016/j.jss.2013.04.058; Haorah J, 2008, FREE RADICAL BIO MED, V45, P1542, DOI 10.1016/j.freeradbiomed.2008.08.030; Harper C, 2005, CURR OPIN PHARMACOL, V5, P73, DOI 10.1016/j.coph.2004.06.011; Hayes DM, 2013, ALCOHOL CLIN EXP RES, V37, P425, DOI 10.1111/j.1530-0277.2012.01955.x; He J, 2008, EXP NEUROL, V210, P349, DOI 10.1016/j.expneurol.2007.11.017; Hinojosa AE, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-77; Jeanblanc J, 2013, EUR J NEUROSCI, V37, P607, DOI 10.1111/ejn.12067; Jin M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.78; Lee H, 2004, J NEUROIMMUNOL, V156, P88, DOI 10.1016/j.jneuroim.2004.07.008; Marshall SA, 2013, NEUROBIOL DIS, V54, P239, DOI 10.1016/j.nbd.2012.12.016; Matsumoto I, 2009, ALCOHOL ALCOHOLISM, V44, P171, DOI 10.1093/alcalc/agn104; McClain JA, 2011, BRAIN BEHAV IMMUN, V25, pS120, DOI 10.1016/j.bbi.2011.01.006; MONTOLIU C, 1995, J NEUROCHEM, V65, P2561; Nagai A, 2001, NEUROBIOL DIS, V8, P1057, DOI 10.1006/nbdi.2001.0437; Nelson S, 2012, NAT REV IMMUNO, V2, P205; Nixon K, 2008, NEUROBIOL DIS, V31, P218, DOI 10.1016/j.nbd.2008.04.009; Nixon K, 2002, J NEUROCHEM, V83, P1087, DOI 10.1046/j.1471-4159.2002.01214.x; Nowoslawski L, 2005, J NEUROPATH EXP NEUR, V64, P490, DOI 10.1093/jnen/64.6.490; Obernier JA, 2002, ALCOHOL CLIN EXP RES, V26, P547, DOI 10.1097/00000374-200204000-00016; Qin LY, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-10; Qin LY, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-5; Ramasamy R, 2005, GLYCOBIOLOGY, V15, p16R, DOI 10.1093/glycob/cwi053; Shi L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066781; Sullivan EV, 2008, EXP NEUROL, V213, P10, DOI 10.1016/j.expneurol.2008.05.016; Tateno M, 2008, PSYCHIAT INVEST, V5, P21, DOI 10.4306/pi.2008.5.1.21; Vetreno RP, 2013, NEUROBIOL DIS, V59, P52, DOI 10.1016/j.nbd.2013.07.002; Vilpoux C, 2009, ALCOHOL CLIN EXP RES, V33, P945, DOI 10.1111/j.1530-0277.2009.00916.x; Yan SF, 2009, ANN MED, V41, P408, DOI 10.1080/07853890902806576; Zhao YN, 2013, BEHAV BRAIN RES, V236, P270, DOI 10.1016/j.bbr.2012.08.052	39	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e104699	10.1371/journal.pone.0104699	http://dx.doi.org/10.1371/journal.pone.0104699			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140518	gold, Green Submitted, Green Published			2022-12-25	WOS:000342687200027
J	Beydoun, MA; Gamaldo, AA; Canas, JA; Beydoun, HA; Shah, MT; McNeely, JM; Zonderman, AB				Beydoun, May A.; Gamaldo, Alyssa A.; Canas, Jose A.; Beydoun, Hind A.; Shah, Mauli T.; McNeely, Jessica M.; Zonderman, Alan B.			Serum Nutritional Biomarkers and Their Associations with Sleep among US Adults in Recent National Surveys	PLOS ONE			English	Article							PLASMA HOMOCYSTEINE LEVELS; RESTLESS LEGS SYNDROME; VITAMIN-D; DEPRESSIVE SYMPTOMS; OLDER-ADULTS; COGNITIVE IMPAIRMENT; ANTIOXIDANT STATUS; METABOLIC SYNDROME; SAMPLE SELECTION; CHRONIC DISEASE	Background: The associations between nutritional biomarkers and measures of sleep quantity and quality remain unclear. Methods: Cross-sectional data from the National Health and Nutrition Examination Surveys (NHANES) 2005-2006 were used. We selected 2,459 adults aged 20-85, with complete data on key variables. Five sleep measures were constructed as primary outcomes: (A) Sleep duration; (B) Sleep disorder; (C) Three factors obtained from factor analysis of 15 items and labeled as "Poor sleep-related daytime dysfunction'' (Factor 1), "Sleepiness'' (Factor 2) and "Sleep disturbance'' (Factor 3). Main exposures were serum concentrations of key nutrients, namely retinol, retinyl esters, carotenoids (alpha-carotene, beta-carotene, beta-cryptoxanthin, lutein+zeaxanthin, lycopene), folate, vitamin B-12, total homocysteine (tHcy), vitamin C, 25-hydroxyvitamin D (25(OH) D) and vitamin E. Main analyses consisted of multiple linear, logistic and multinomial logit models. Results: Among key findings, independent inverse associations were found between serum vitamin B-12 and sleep duration, 25(OH) D and sleepiness (as well as insomnia), and between folate and sleep disturbance. Serum total carotenoids concentration was linked to higher odds of short sleep duration (i.e. 5-6 h per night) compared to normal sleep duration (7-8 h per night). Conclusions: A few of the selected serum nutritional biomarkers were associated with sleep quantity and quality. Longitudinal studies are needed to ascertain temporality and assess putative causal relationships.	[Beydoun, May A.; Gamaldo, Alyssa A.; Shah, Mauli T.; McNeely, Jessica M.; Zonderman, Alan B.] NIA, NIH, IRP, Baltimore, MD 21224 USA; [Canas, Jose A.] Nemours Childrens Clin, Jacksonville, FL USA; [Beydoun, Hind A.] Eastern Virginia Med Sch, Grad Program Publ Hlth, Norfolk, VA 23501 USA; [Shah, Mauli T.; McNeely, Jessica M.] Univ Maryland Baltimore Cty, Dept Psychol, Baltimore, MD 21228 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Eastern Virginia Medical School; University System of Maryland; University of Maryland Baltimore County	Beydoun, MA (corresponding author), NIA, NIH, IRP, Baltimore, MD 21224 USA.	baydounm@mail.nih.gov	Zonderman, Alan B/A-5807-2013; Canas, Jose Atilio/Y-8500-2019	Zonderman, Alan B/0000-0003-3530-2319; Canas, Jose Atilio/0000-0003-4788-8820; Zonderman, Alan B/0000-0002-6523-4778	National Institute on Aging; Intramural Research Program (NIA/NIH/IRP); NATIONAL INSTITUTE ON AGING [ZIAAG000199] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Intramural Research Program (NIA/NIH/IRP); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was entirely supported by the National Institute on Aging, Intramural Research Program (NIA/NIH/IRP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acock A. C., 2013, DISCOVERING STRUCTUR, DOI DOI 10.1080/10538712.2011.607753; Annweiler C, 2009, EUR J NEUROL, V16, P1083, DOI 10.1111/j.1468-1331.2009.02755.x; [Anonymous], 2002, Mayo Clin Health Lett, V20, P6; [Anonymous], ARS MYPYRAMID EQ DAT; [Anonymous], CFDCAP NAT HLTH NUTR; [Anonymous], 2009, NAT HLTH NUTR EX SUR; [Anonymous], ASS PACK INS IMX AN; Balaban H, 2012, SLEEP MED, V13, P953, DOI 10.1016/j.sleep.2012.04.009; Beydoun MA, 2013, BRIT J NUTR, V109, P1714, DOI 10.1017/S0007114512003467; Beydoun MA, 2012, AM J CLIN NUTR, V95, P163, DOI 10.3945/ajcn.111.017137; Beydoun MA, 2011, J NUTR, V141, P903, DOI 10.3945/jn.110.136580; Beydoun MA, 2010, PSYCHOSOM MED, V72, P862, DOI 10.1097/PSY.0b013e3181f61863; Beydoun MA, 2010, J NUTR, V140, P338, DOI 10.3945/jn.109.113878; Blackwell T, 2011, SLEEP, V34, P1347, DOI 10.5665/SLEEP.1276; Bottiglieri T, 2005, PROG NEURO-PSYCHOPH, V29, P1103, DOI 10.1016/j.pnpbp.2005.06.021; Bozkurt NC, 2012, ENDOCRINE, V41, P518, DOI 10.1007/s12020-012-9595-1; Cannell JJ, 2006, EPIDEMIOL INFECT, V134, P1129, DOI 10.1017/S0950268806007175; Cappuccio FP, 2008, SLEEP, V31, P619, DOI 10.1093/sleep/31.5.619; Centers for Disease Control and Prevention, 2020, ADOLESCENT HEALTH; Centers for Disease Control and Prevention. National Center for Health Statistics, 2010, NAT HLTH NUTR EX SUR; Challet E, 2013, NEUROBIOL AGING, V34, P1589, DOI 10.1016/j.neurobiolaging.2012.11.021; Chen MG, 2011, J CLIN NEUROSCI, V18, P1454, DOI 10.1016/j.jocn.2011.01.037; Cheng YJ, 2007, DIABETES CARE, V30, P2264, DOI 10.2337/dc07-0372; Cherubini A, 2005, NEUROBIOL AGING, V26, P987, DOI 10.1016/j.neurobiolaging.2004.09.002; Clarke R, 2007, AM J CLIN NUTR, V86, P1384, DOI 10.1093/ajcn/86.5.1384; Day RM, 2009, RESPIROLOGY, V14, P1134, DOI 10.1111/j.1440-1843.2009.01623.x; Dunn JE, 2007, NEUROLOGY, V68, P670, DOI 10.1212/01.wnl.0000255940.13116.86; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Foley D, 2004, J PSYCHOSOM RES, V56, P497, DOI 10.1016/j.jpsychores.2004.02.010; Garland CF, 2007, J STEROID BIOCHEM, V103, P708, DOI 10.1016/j.jsbmb.2006.12.007; Giovannucci E, 2008, ARCH INTERN MED, V168, P1174, DOI 10.1001/archinte.168.11.1174; Golombek DA, 2010, PHYSIOL REV, V90, P1063, DOI 10.1152/physrev.00009.2009; Gominak SC, 2012, MED HYPOTHESES, V79, P132, DOI 10.1016/j.mehy.2012.03.031; Gottlieb DJ, 2006, SLEEP, V29, P1009, DOI 10.1093/sleep/29.8.1009; Gottlieb DJ, 2005, ARCH INTERN MED, V165, P863, DOI 10.1001/archinte.165.8.863; Grandner MA, 2013, J SLEEP RES; Grandner MA, 2013, APPETITE, V64, P71, DOI 10.1016/j.appet.2013.01.004; Grandner MA, 2010, SLEEP MED, V11, P180, DOI 10.1016/j.sleep.2009.07.014; Grebe M, 2006, AM J RESP CRIT CARE, V173, P897, DOI 10.1164/rccm.200508-1223OC; Haghighatdoost F, 2012, NUTRITION, V28, P1146, DOI 10.1016/j.nut.2012.04.015; HECKMAN JJ, 1979, ECONOMETRICA, V47, P153, DOI 10.2307/1912352; Hochberg Y, 1987, MULTIPLE COMP PROCED; Huang W, 2013, CLIN J PAIN, V29, P341, DOI 10.1097/AJP.0b013e318255655d; Imaki Masahide, 2002, Journal of Physiological Anthropology and Applied Human Science, V21, P115, DOI 10.2114/jpa.21.115; Kang JH, 2009, CIRCULATION, V119, P2772, DOI 10.1161/CIRCULATIONAHA.108.816900; Kim S, 2011, PUBLIC HEALTH NUTR, V14, P889, DOI 10.1017/S136898001000296X; Kitaoka K, 2011, BRAIN RES, V1423, P10, DOI 10.1016/j.brainres.2011.09.023; KRINSKY NI, 1993, ANNU REV NUTR, V13, P561, DOI 10.1146/annurev.nutr.13.1.561; Laaksi I, 2007, AM J CLIN NUTR, V86, P714, DOI 10.1093/ajcn/86.3.714; Lagerros YT, 2007, EUR J EPIDEMIOL, V22, P353, DOI 10.1007/s10654-007-9154-x; Lavie L, 2001, CHEST, V120, P900, DOI 10.1378/chest.120.3.900; Lee KA, 2001, J WOMEN HEALTH GEN-B, V10, P335, DOI 10.1089/152460901750269652; Lichstein KL, 2007, SLEEP MED, V9, P27, DOI 10.1016/j.sleep.2006.12.009; Lin J, 2007, ARCH INTERN MED, V167, P1050, DOI 10.1001/archinte.167.10.1050; Lohr S.L., 2010, SAMPLING DESIGN ANAL, Vsecond; Maret S, 2005, SCIENCE, V310, P111, DOI 10.1126/science.1117623; Mayer G, 1996, NEUROPSYCHOPHARMACOL, V15, P456, DOI 10.1016/S0893-133X(96)00055-3; McCarty DE, 2012, J CLIN SLEEP MED, V8, P693, DOI 10.5664/jcsm.2266; McCullough ML, 2000, AM J CLIN NUTR, V72, P1223; Mey J, 2004, NEUROSCIENTIST, V10, P409, DOI 10.1177/1073858404263520; Milaneschi Y., 2013, MOL PSYCHIAT; MUSIOL IM, 1992, NEUROSCIENCE, V48, P841, DOI 10.1016/0306-4522(92)90272-4; Ohayon MM, 2005, SLEEP, V28, P981; OHTA T, 1991, SLEEP, V14, P414; Oishi J, 2009, ACTA MED OKAYAMA, V63, P9; Patel SR, 2008, OBESITY, V16, P643, DOI 10.1038/oby.2007.118; Pernet P, 2000, CLIN CHEM, V46, P1440; Peuhkuri K, 2012, NUTR RES, V32, P309, DOI 10.1016/j.nutres.2012.03.009; Poole KES, 2006, STROKE, V37, P243, DOI 10.1161/01.STR.0000195184.24297.c1; Puhani PA, 2000, J ECON SURV, V14, P53, DOI 10.1111/1467-6419.00104; Ravaglia G, 2008, AM J CLIN NUTR, V87, P1306, DOI 10.1093/ajcn/87.5.1306; Ripperger JA, 2011, FEBS LETT, V585, P1406, DOI 10.1016/j.febslet.2011.04.047; Ryan S, 2007, THORAX, V62, P509, DOI 10.1136/thx.2006.066720; Schmidt R, 1998, J AM GERIATR SOC, V46, P1407, DOI 10.1111/j.1532-5415.1998.tb06008.x; Schmutte Timothy, 2007, Behav Sleep Med, V5, P39; Selhub J, 1999, ANNU REV NUTR, V19, P217, DOI 10.1146/annurev.nutr.19.1.217; Seshadri S, 2002, NEW ENGL J MED, V346, P476, DOI 10.1056/NEJMoa011613; Singh T D, 2009, Indian J Chest Dis Allied Sci, V51, P217; Soni M, 2012, SCAND J CLIN LAB INV, V72, P79, DOI 10.3109/00365513.2012.681969; Soory Mena, 2009, Infectious Disorders - Drug Targets, V9, P400; Spiegel K, 2004, J CLIN ENDOCR METAB, V89, P5762, DOI 10.1210/jc.2004-1003; STATA, 2009, STAT DAT AN REL 11 0; Thakre Tushar P, 2012, Sleep Disord, V2012, P634920, DOI 10.1155/2012/634920; USDA, FOOD NUTR DAT DIET S; Van Cauter E, 2008, SLEEP MED, V9, pS23, DOI 10.1016/S1389-9457(08)70013-3; Voutilainen S, 2006, AM J CLIN NUTR, V83, P1265; Watanabe M, 2010, SLEEP, V33, P161, DOI 10.1093/sleep/33.2.161; Weaver TE, 1997, SLEEP, V20, P835; Zadeh SS, 2011, NUTR RES PRACT, V5, P230, DOI 10.4162/nrp.2011.5.3.230	89	53	55	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e103490	10.1371/journal.pone.0103490	http://dx.doi.org/10.1371/journal.pone.0103490			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137304	Green Submitted, Green Published, gold			2022-12-25	WOS:000340742100008
J	Ambrosio, L; Morriss, S; Riaz, A; Bailey, R; Ding, J; MacIntosh, GC				Ambrosio, Linda; Morriss, Stephanie; Riaz, Ayesha; Bailey, Ryan; Ding, Jian; MacIntosh, Gustavo C.			Phylogenetic Analyses and Characterization of RNase X25 from Drosophila melanogaster Suggest a Conserved Housekeeping Role and Additional Functions for RNase T2 Enzymes in Protostomes	PLOS ONE			English	Article							GENE-EXPRESSION; CYSTIC LEUKOENCEPHALOPATHY; SECRETORY RIBONUCLEASES; OXIDATIVE STRESS; E-RNS; FAMILY; GENOME; STARVATION; AUTOPHAGY; MEMBER	Ribonucleases belonging to the RNase T2 family are enzymes associated with the secretory pathway that are almost absolutely conserved in all eukaryotes. Studies in plants and vertebrates suggest they have an important housekeeping function in rRNA recycling. However, little is known about this family of enzymes in protostomes. We characterized RNase X25, the only RNase T2 enzyme in Drosophila melanogaster. We found that RNase X25 is the major contributor of ribonuclease activity in flies as detected by in gel assays, and has an acidic pH preference. Gene expression analyses showed that the RNase X25 transcript is present in all adult tissues and developmental stages. RNase X25 expression is elevated in response to nutritional stresses; consistent with the hypothesis that this enzyme has a housekeeping role in recycling RNA. A correlation between induction of RNase X25 expression and autophagy was observed. Moreover, induction of gene expression was triggered by oxidative stress suggesting that RNase X25 may have additional roles in stress responses. Phylogenetic analyses of this family in protostomes showed that RNase T2 genes have undergone duplication events followed by divergence in several phyla, including the loss of catalytic residues, and suggest that RNase T2 proteins have acquired novel functions. Among those, it is likely that a role in host immunosuppression evolved independently in several groups, including parasitic Platyhelminthes and parasitoid wasps. The presence of only one RNase T2 gene in the D. melanogaster genome, without any other evident secretory RNase activity detected, makes this organism an ideal system to study the cellular functions of RNase T2 proteins associated with RNA recycling and maintenance of cellular homeostasis. On the other hand, the discovery of gene duplications in several protostome genomes also presents interesting new avenues to study additional biological functions of this ancient family of proteins.	[Ambrosio, Linda; Morriss, Stephanie; Bailey, Ryan; MacIntosh, Gustavo C.] Iowa State Univ, Roy J Carver Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA; [Riaz, Ayesha] Iowa State Univ, Interdept Genet Grad Program, Ames, IA USA; [Ding, Jian] Harvard Univ, Sch Med, Childrens Hosp Boston, Boston, MA USA	Iowa State University; Iowa State University; Harvard University; Boston Children's Hospital; Harvard Medical School	Ambrosio, L (corresponding author), Iowa State Univ, Roy J Carver Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA.	lima@iastate.edu; gustavo@iastate.edu	Ding, Jian/F-6996-2015	Ding, Jian/0000-0002-5578-5410; MacIntosh, Gustavo/0000-0003-1350-1229; Riaz, Ayesha/0000-0002-4627-4133	Fulbright Fellowship; United States National Science Foundation [MBC-1051818]	Fulbright Fellowship; United States National Science Foundation(National Science Foundation (NSF))	A.R. is the recipient of a Fulbright Fellowship. This work was supported by grant No. MBC-1051818 from the United States National Science Foundation to G.C.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquati F, 2005, INT J ONCOL, V26, P1159; Ali MR, 2012, J INVERTEBR PATHOL, V110, P389, DOI 10.1016/j.jip.2012.05.003; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersen KL, 2012, MOL BIOL CELL, V23, P36, DOI 10.1091/mbc.E11-08-0689; Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Ashburner M., 2004, DROSOPHILA LAB HDB; Barth JMI, 2011, CELL DEATH DIFFER, V18, P915, DOI 10.1038/cdd.2010.157; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Burke Gaelen R., 2012, Insects, V3, P91, DOI 10.3390/insects3010091; Campomenosi P, 2006, ARCH BIOCHEM BIOPHYS, V449, P17, DOI 10.1016/j.abb.2006.02.022; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; Chang YY, 2010, FEBS LETT, V584, P1342, DOI 10.1016/j.febslet.2010.01.006; Deshpande RA, 2002, CRIT REV MICROBIOL, V28, P79, DOI 10.1080/1040-840291046704; Everts B, 2012, J EXP MED, V209, P1753, DOI 10.1084/jem.20111381; Fitzsimmons CM, 2005, MOL BIOCHEM PARASIT, V144, P123, DOI 10.1016/j.molbiopara.2005.08.003; Grigoriev IV, 2012, NUCLEIC ACIDS RES, V40, pD26, DOI 10.1093/nar/gkr947; Haud N, 2011, P NATL ACAD SCI USA, V108, P1099, DOI 10.1073/pnas.1009811107; Henneke M, 2009, NAT GENET, V41, P773, DOI 10.1038/ng.398; Hillwig MS, 2011, P NATL ACAD SCI USA, V108, P1093, DOI 10.1073/pnas.1009809108; Hillwig MS, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-170; HIME G, 1995, GENE, V158, P203, DOI 10.1016/0378-1119(94)00896-Z; Hulst MM, 1998, J VIROL, V72, P151, DOI 10.1128/JVI.72.1.151-157.1998; Igic B, 2001, P NATL ACAD SCI USA, V98, P13167, DOI 10.1073/pnas.231386798; Iqbal M, 2004, J VIROL, V78, P136, DOI 10.1128/JVI.78.1.136-145.2004; Irie M, 1999, PHARMACOL THERAPEUT, V81, P77, DOI 10.1016/S0163-7258(98)00035-7; Jimenez-Sanchez M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2212; Juhasz Gabor, 2008, V445, P125, DOI 10.1007/978-1-59745-157-4_8; Kersey PJ, 2012, NUCLEIC ACIDS RES, V40, pD91, DOI 10.1093/nar/gkr895; Kim HS, 2010, NUCLEIC ACIDS RES, V38, pD437, DOI 10.1093/nar/gkp807; Kraft C, 2008, NAT CELL BIOL, V10, P602, DOI 10.1038/ncb1723; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Legeai F, 2010, INSECT MOL BIOL, V19, P5, DOI 10.1111/j.1365-2583.2009.00930.x; Li HM, 2009, INSECT MOL BIOL, V18, P21, DOI 10.1111/j.1365-2583.2008.00844.x; Logan-Klumpler FJ, 2012, NUCLEIC ACIDS RES, V40, pD98, DOI 10.1093/nar/gkr1032; Luhtala N, 2010, TRENDS BIOCHEM SCI, V35, P253, DOI 10.1016/j.tibs.2010.02.002; MacIntosh GC, 2001, P NATL ACAD SCI USA, V98, P1018, DOI 10.1073/pnas.98.3.1018; MacIntosh GC, 2011, NUCLEIC ACIDS MOL BI, V26, P89, DOI 10.1007/978-3-642-21078-5_4; MacIntosh GC, 2011, AUTOPHAGY, V7, P662, DOI 10.4161/auto.7.6.15447; MacIntosh GC, 2010, MOL GENET GENOMICS, V283, P381, DOI 10.1007/s00438-010-0524-9; Megy K, 2012, NUCLEIC ACIDS RES, V40, pD729, DOI 10.1093/nar/gkr1089; Miao W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004429; Munoz-Torres MC, 2011, NUCLEIC ACIDS RES, V39, pD658, DOI 10.1093/nar/gkq1145; Park B, 2012, INSECT SCI, V19, P47, DOI 10.1111/j.1744-7917.2011.01421.x; Park B, 2010, J INVERTEBR PATHOL, V105, P156, DOI 10.1016/j.jip.2010.06.003; Pearce EJ, 2005, PARASITE IMMUNOL, V27, P265, DOI 10.1111/j.1365-3024.2005.00765.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Python S, 2013, PLOS PATHOG, V9, DOI [10.1371/journal.ppat.1003412, 10.1371/annotation/4290dfee-64fd-4157-89e3-8edbba912420]; Robb SMC, 2008, NUCLEIC ACIDS RES, V36, pD599, DOI 10.1093/nar/Gkm684; Robinson SW, 2013, NUCLEIC ACIDS RES, V41, pD744, DOI 10.1093/nar/gks1141; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Tanaka N, 2000, J MOL BIOL, V298, P859, DOI 10.1006/jmbi.2000.3707; Thompson DM, 2008, RNA, V14, P2095, DOI 10.1261/rna.1232808; Thompson DM, 2009, J CELL BIOL, V185, P43, DOI 10.1083/jcb.200811119; Wang J, 2005, NUCLEIC ACIDS RES, V33, pD399, DOI 10.1093/nar/gki116; Wang XY, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r107; Yamasaki S, 2009, J CELL BIOL, V185, P35, DOI 10.1083/jcb.200811106; YEN Y, 1991, PLANT PHYSIOL, V97, P1487, DOI 10.1104/pp.97.4.1487; Zinke I, 2002, EMBO J, V21, P6162, DOI 10.1093/emboj/cdf600	59	10	10	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105444	10.1371/journal.pone.0105444	http://dx.doi.org/10.1371/journal.pone.0105444			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133712	Green Published, Green Submitted, gold			2022-12-25	WOS:000341302700115
J	Cai, J; Wu, GZ; Tan, XR; Han, Y; Chen, CY; Li, CW; Wang, N; Zou, X; Chen, XJ; Zhou, FY; He, DF; Zhou, L; Jose, PA; Zeng, CY				Cai, Jin; Wu, Gengze; Tan, Xiaorong; Han, Yu; Chen, Caiyu; Li, Chuanwei; Wang, Na; Zou, Xue; Chen, Xinjian; Zhou, Faying; He, Duofen; Zhou, Lin; Jose, Pedro A.; Zeng, Chunyu			Transferred BCR/ABL DNA from K562 Extracellular Vesicles Causes Chronic Myeloid Leukemia in Immunodeficient Mice	PLOS ONE			English	Article							CELLS; COMMUNICATION; EXOSOMES	Our previous study showed that besides mRNAs and microRNAs, there are DNA fragments within extracellular vesicles (EVs). The BCR/ABL hybrid gene, involved in the pathogenesis of chronic myeloid leukemia (CML), could be transferred from K562 EVs to neutrophils and decrease their phagocytic activity in vitro. Our present study provides evidence that BCR/ABL DNAs transferred from EVs have pathophysiological significance in vivo. Two months after injection of K562 EVs into the tail vein of Sprague-Dawley (SD) rats, they showed some characteristics of CML, e.g., feeble, febrile, and thin, with splenomegaly and neutrophilia but with reduced neutrophil phagocytic activity. These findings were also observed in immunodeficient NOD/SCID mice treated with K562 EVs; BCR/ABL mRNA and protein were found in their neutrophils. The administration of actinomycin D, an inhibitor of de novo mRNA synthesis, prevented the abnormalities caused by K562 EVs in NOD/SCID mice related to CML, including neutrophilia and bone marrow hyperplasia. As a specific inhibitor of tyrosine kinases, imatinib blocked the activity of tyrosine kinases and the expression of phospho-Crkl, induced by the de novo BCR/ABL protein caused by K562 EVs bearing BCR/ABL DNA. Our current study shows the pathophysiological significance of transferred tumor gene from EVs in vivo, which may represent an important mechanism for tumorigenesis, tumor progression, and metastasis.	[Cai, Jin; Wu, Gengze; Tan, Xiaorong; Han, Yu; Chen, Caiyu; Li, Chuanwei; Wang, Na; Zou, Xue; Chen, Xinjian; Zhou, Faying; He, Duofen; Zhou, Lin; Zeng, Chunyu] Third Mil Med Univ, Daping Hosp, Dept Cardiol, Chongqing, Peoples R China; [Cai, Jin] Air Force Nanjing Area Command, Logist Dept, Clin Hlth Serv, Nanjing, Jiangsu, Peoples R China; [Jose, Pedro A.] Univ Maryland, Sch Med, Dept Med, Div Nephrol, Baltimore, MD 21201 USA; [Jose, Pedro A.] Univ Maryland, Sch Med, Dept Physiol, Div Nephrol, Baltimore, MD 21201 USA	Army Medical University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Zeng, CY (corresponding author), Third Mil Med Univ, Daping Hosp, Dept Cardiol, Chongqing, Peoples R China.	chunyuzeng01@163.com			National Natural Science Foundation of China [31130029]; National Basic Research Program of China [2012CB517801]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1216]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092196] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	These studies were supported, in part, by grants from the National Natural Science Foundation of China (31130029), the National Basic Research Program of China (2012CB517801), and the Program for Changjiang Scholars and Innovative Research Team in University (IRT1216). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balaj L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1180; Belting M, 2008, J CELL BIOL, V183, P1187, DOI 10.1083/jcb.200810038; Cai J, 2013, J MOL CELL BIOL, V5, P227, DOI 10.1093/jmcb/mjt011; Cai J, 2011, SENSOR ACTUAT B-CHEM, V155, P500, DOI 10.1016/j.snb.2010.12.053; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Gerdes HH, 2008, CURR OPIN CELL BIOL, V20, P470, DOI 10.1016/j.ceb.2008.03.005; Gross JC, 2012, NAT CELL BIOL, V14, P1036, DOI 10.1038/ncb2574; Hergenreider E, 2012, NAT CELL BIOL, V14, P249, DOI 10.1038/ncb2441; Higginbotham JN, 2011, CURR BIOL, V21, P779, DOI 10.1016/j.cub.2011.03.043; Kasimir-Bauer S, 1998, LEUKEMIA RES, V22, P115, DOI 10.1016/S0145-2126(97)00185-9; Mineo M, 2012, ANGIOGENESIS, V15, P33, DOI 10.1007/s10456-011-9241-1; Miranda KC, 2010, KIDNEY INT, V78, P191, DOI 10.1038/ki.2010.106; Pap E, 2009, INFLAMM RES, V58, P1, DOI 10.1007/s00011-008-8210-7; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Pisetsky DS, 2011, IMMUNOL RES, V49, P227, DOI 10.1007/s12026-010-8184-8; Pluk H, 2002, CELL, V108, P247, DOI 10.1016/S0092-8674(02)00623-2; Puissant A, 2012, J MOL CELL BIOL, V4, P207, DOI 10.1093/jmcb/mjs010; RAM Z, 1993, J NEUROSURG, V79, P400, DOI 10.3171/jns.1993.79.3.0400; Regev-Rudzki N, 2013, CELL, V153, P1120, DOI 10.1016/j.cell.2013.04.029; Shibata Y, 2010, GENOME MED, V2, DOI 10.1186/gm191; Wang H, 2012, MOL MED, V18, P159, DOI 10.2119/molmed.2011.00295; Zen K, 2012, MED RES REV, V32, P326, DOI 10.1002/med.20215; Zhang YJ, 2010, MOL CELL, V39, P133, DOI 10.1016/j.molcel.2010.06.010	23	53	55	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105200	10.1371/journal.pone.0105200	http://dx.doi.org/10.1371/journal.pone.0105200			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133686	gold, Green Published, Green Submitted			2022-12-25	WOS:000341302700082
J	Perevozchikova, SA; Trikin, RM; Heinze, RJ; Romanova, EA; Oretskaya, TS; Friedhoff, P; Kubareva, EA				Perevozchikova, Svetlana A.; Trikin, Roman M.; Heinze, Roger J.; Romanova, Elena A.; Oretskaya, Tatiana S.; Friedhoff, Peter; Kubareva, Elena A.			Is Thymidine Glycol Containing DNA a Substrate of E. coli DNA Mismatch Repair System?	PLOS ONE			English	Article							UV-LIGHT PHOTOPRODUCTS; ESCHERICHIA-COLI; THYMINE GLYCOL; PROTEIN MUTS; EXCISION-REPAIR; FUNCTIONAL INTERACTIONS; RECOGNITION COMPLEX; MOLECULAR SWITCH; BASE-PAIRS; BINDING	The DNA mismatch repair (MMR) system plays a crucial role in the prevention of replication errors and in the correction of some oxidative damages of DNA bases. In the present work the most abundant oxidized pyrimidine lesion, 5,6-dihydro-5,6-dihydroxythymidine (thymidine glycol, Tg) was tested for being recognized and processed by the E. coli MMR system, namely complex of MutS, MutL and MutH proteins. In a partially reconstituted MMR system with MutS-MutL-MutH proteins, G/Tg and A/Tg containing plasmids failed to provoke the incision of DNA. Tg residue in the 30-mer DNA duplex destabilized double helix due to stacking disruption with neighboring bases. However, such local structural changes are not important for E. coli MMR system to recognize this lesion. A lack of repair of Tg containing DNA could be due to a failure of MutS (a first acting protein of MMR system) to interact with modified DNA in a proper way. It was shown that Tg in DNA does not affect on ATPase activity of MutS. On the other hand, MutS binding affinities to DNA containing Tg in G/Tg and A/Tg pairs are lower than to DNA with a G/T mismatch and similar to canonical DNA. Peculiarities of MutS interaction with DNA was monitored by Forster resonance energy transfer (FRET) and fluorescence anisotropy. Binding of MutS to Tg containing DNAs did not result in the formation of characteristic DNA kink. Nevertheless, MutS homodimer orientation on Tg-DNA is similar to that in the case of G/T-DNA. In contrast to G/T-DNA, neither G/Tg- nor A/Tg-DNA was able to stimulate ADP release from MutS better than canonical DNA. Thus, Tg residue in DNA is unlikely to be recognized or processed by the E. coli MMR system. Probably, the MutS transformation to active "sliding clamp" conformation on Tg-DNA is problematic.	[Perevozchikova, Svetlana A.; Romanova, Elena A.; Oretskaya, Tatiana S.; Kubareva, Elena A.] Lomonosov Moscow State Univ, Dept Chem, Moscow, Russia; [Perevozchikova, Svetlana A.; Romanova, Elena A.; Oretskaya, Tatiana S.; Kubareva, Elena A.] Lomonosov Moscow State Univ, Belozersky Inst Phys Chem Biol, Moscow, Russia; [Trikin, Roman M.] Univ Bern, Inst Cell Biol, Bern, Switzerland; [Heinze, Roger J.; Friedhoff, Peter] Univ Giessen, Inst Biochem, D-35390 Giessen, Germany	Lomonosov Moscow State University; Lomonosov Moscow State University; University of Bern; Justus Liebig University Giessen	Kubareva, EA (corresponding author), Lomonosov Moscow State Univ, Dept Chem, Moscow, Russia.	kubareva@belozersky.msu.ru	Romanova, Elena/D-5856-2013; Friedhoff, Peter/G-7905-2012; Kubareva, Elena A/I-3184-2012; Oretskaya, Tatiana S/E-2556-2012	Friedhoff, Peter/0000-0003-1946-1117	European Community [HEALTHF4-2008-223545]; Deutsche Forschungsgemeinschaft [GRK 1384]; Russian Foundation for Basic Research [RFBR-DFG 14-04-91343]; RFBR [13-04-00615]	European Community(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); RFBR(Russian Foundation for Basic Research (RFBR))	This research was supported by the European Community Seventh Framework Program FP7/2007-2013 under Grant HEALTHF4-2008-223545 (to P. F. and R.J.H.), Deutsche Forschungsgemeinschaft Grant GRK 1384 (to P. F. and R.J.H.) and Russian Foundation for Basic Research Grant RFBR-DFG 14-04-91343 (to T.O. and S. P.) and RFBR Grant 13-04-00615 (to E. K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya S, 2003, MOL CELL, V12, P233, DOI 10.1016/S1097-2765(03)00219-3; Aller P, 2007, P NATL ACAD SCI USA, V104, P814, DOI 10.1073/pnas.0606648104; Bellacosa A, 2001, CELL DEATH DIFFER, V8, P1076, DOI 10.1038/sj.cdd.4400948; Bellon S, 2009, NUCLEIC ACIDS RES, V37, P4430, DOI 10.1093/nar/gkp422; BRANCH P, 1993, NATURE, V362, P652, DOI 10.1038/362652a0; Brown J, 2001, BIOCHEM J, V354, P627, DOI 10.1042/0264-6021:3540627; Brown KL, 2008, J AM CHEM SOC, V130, P11701, DOI 10.1021/ja8016544; Brown KL, 2010, NUCLEIC ACIDS RES, V38, P428, DOI 10.1093/nar/gkp844; Brown KL, 2009, BIOCHEMISTRY-US, V48, P9722, DOI 10.1021/bi900695e; Cristovao M, 2012, NUCLEIC ACIDS RES, V40, P5448, DOI 10.1093/nar/gks138; Dizdaroglu M, 2005, MUTAT RES-FUND MOL M, V591, P45, DOI 10.1016/j.mrfmmm.2005.01.033; Dolinnaya NG, 2013, BIOCHIMIE, V95, P134, DOI 10.1016/j.biochi.2012.09.008; Duckett DR, 1996, P NATL ACAD SCI USA, V93, P6443, DOI 10.1073/pnas.93.13.6443; Fedotova E A, 2008, Bioorg Khim, V34, P236; FENG G, 1995, BIOTECHNIQUES, V19, P956; FENG WY, 1991, GENETICS, V129, P1007; Goodrich J., 2007, BINDING KINETICS MOL; Gorman J, 2012, P NATL ACAD SCI USA, V109, pE3074, DOI 10.1073/pnas.1211364109; Gradia S, 1997, CELL, V91, P995, DOI 10.1016/S0092-8674(00)80490-0; HARE D, 1986, BIOCHEMISTRY-US, V25, P7445, DOI 10.1021/bi00371a029; Heinze RJ, 2009, NUCLEIC ACIDS RES, V37, P4453, DOI 10.1093/nar/gkp380; Heo SD, 2007, BIOCHEM BIOPH RES CO, V364, P264, DOI 10.1016/j.bbrc.2007.09.130; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Jeong C, 2011, NAT STRUCT MOL BIOL, V18, P379, DOI 10.1038/nsmb.2009; Junop MS, 2001, MOL CELL, V7, P1, DOI 10.1016/S1097-2765(01)00149-6; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Lamers MH, 2000, NATURE, V407, P711, DOI 10.1038/35037523; Lebbink JHG, 2010, J BIOL CHEM, V285, P13131, DOI 10.1074/jbc.M109.066001; Li GM, 1996, J BIOL CHEM, V271, P24084, DOI 10.1074/jbc.271.39.24084; Lieb M, 2001, J BACTERIOL, V183, P6487, DOI 10.1128/JB.183.21.6487-6490.2001; Manelyte L, 2006, NUCLEIC ACIDS RES, V34, P5270, DOI 10.1093/nar/gkl489; Mazurek A, 2002, J BIOL CHEM, V277, P8260, DOI 10.1074/jbc.M111269200; McTigue MM, 2004, DNA REPAIR, V3, P313, DOI 10.1016/j.dnarep.2003.11.009; Mello JA, 1996, CHEM BIOL, V3, P579, DOI 10.1016/S1074-5521(96)90149-0; Monti MC, 2011, NUCLEIC ACIDS RES, V39, P8052, DOI 10.1093/nar/gkr498; Mu D, 1997, MOL CELL BIOL, V17, P760, DOI 10.1128/MCB.17.2.760; Mukherjee S, 2009, BIOPHYS J, V96, P1707, DOI 10.1016/j.bpj.2008.10.071; Natrajan G, 2003, NUCLEIC ACIDS RES, V31, P4814, DOI 10.1093/nar/gkg677; Ni TT, 1999, MOL CELL, V4, P439, DOI 10.1016/S1097-2765(00)80346-9; Obmolova G, 2000, NATURE, V407, P703, DOI 10.1038/35037509; Peyret N, 1999, BIOCHEMISTRY-US, V38, P3468, DOI 10.1021/bi9825091; Qiu RY, 2012, EMBO J, V31, P2528, DOI 10.1038/emboj.2012.95; Sass LE, 2010, BIOCHEMISTRY-US, V49, P3174, DOI 10.1021/bi901871u; Scatchard G, 1949, SCIENCE, V51, P660; Snowden T, 2004, MOL CELL, V15, P437, DOI 10.1016/j.molcel.2004.06.040; Wang H, 2003, P NATL ACAD SCI USA, V100, P14822, DOI 10.1073/pnas.2433654100; Wang HX, 1999, J BIOL CHEM, V274, P16894, DOI 10.1074/jbc.274.24.16894; Warren JJ, 2007, MOL CELL, V26, P579, DOI 10.1016/j.molcel.2007.04.018; Winkler I, 2011, J BIOL CHEM, V286, P17326, DOI 10.1074/jbc.M110.187641; Yang W, 2006, DNA REPAIR, V5, P654, DOI 10.1016/j.dnarep.2006.02.004; Yoon JH, 2003, NUCLEIC ACIDS RES, V31, P5399, DOI 10.1093/nar/gkg730; Young LC, 2003, J INVEST DERMATOL, V121, P435, DOI 10.1046/j.1523-1747.2003.12450.x; ZUO SJ, 1995, NUCLEIC ACIDS RES, V23, P3239, DOI 10.1093/nar/23.16.3239	53	4	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e104963	10.1371/journal.pone.0104963	http://dx.doi.org/10.1371/journal.pone.0104963			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133614	Green Submitted, gold, Green Published			2022-12-25	WOS:000341302700057
J	Brun, P; Pathak, S; Castagliuolo, I; Palu, G; Brun, P; Zuin, M; Cavazzana, R; Martines, E				Brun, Paola; Pathak, Surajit; Castagliuolo, Ignazio; Palu, Giorgio; Brun, Paola; Zuin, Matteo; Cavazzana, Roberto; Martines, Emilio			Helium Generated Cold Plasma Finely Regulates Activation of Human Fibroblast-Like Primary Cells	PLOS ONE			English	Article							ATMOSPHERIC-PRESSURE PLASMA; OXIDATIVE STRESS; HACAT-KERATINOCYTES; NONTHERMAL PLASMA; ELECTRIC-FIELDS; RECEPTOR-GAMMA; PPAR-GAMMA; MYOFIBROBLASTS; APOPTOSIS; RESPONSES	Non-thermal atmospheric pressure plasmas are being developed for a wide range of health care applications, including wound healing. However in order to exploit the potential of plasma for clinical applications, the understanding of the mechanisms involved in plasma-induced activation of fibroblasts, the cells active in the healing process, is mandatory. In this study, the role of helium generated plasma in the tissue repairing process was investigated in cultured human fibroblast-like primary cells, and specifically in hepatic stellate cells and intestinal subepithelial myofibroblasts. Five minutes after treatment, plasma induced formation of reactive oxygen species (ROS) in cultured cells, as assessed by flow cytometric analysis of fluorescence-activated 2',7'-dichlorofluorescein diacetate probe. Plasma-induced intracellular ROS were characterized by lower concentrations and shorter half-lives with respect to hydrogen peroxide-induced ROS. Moreover ROS generated by plasma treatment increased the expression of peroxisome proliferator activated receptor (PPAR)-gamma, nuclear receptor that modulates the inflammatory responses. Plasma exposure promoted wound healing in an in vitro model and induced fibroblast migration and proliferation, as demonstrated, respectively, by trans-well assay and partitioning between daughter cells of carboxyfluorescein diacetate succinimidyl ester fluorescent dye. Plasma-induced fibroblast migration and proliferation were found to be ROS-dependent as cellular incubation with antioxidant agents (e.g. N-acetyl L-cysteine) cancelled the biological effects. This study provides evidence that helium generated plasma promotes proliferation and migration in liver and intestinal fibroblast-like primary cells mainly by increasing intracellular ROS levels. Since plasma-evoked ROS are time-restricted and elicit the PPAR-gamma anti-inflammatory molecular pathway, this strategy ensures precise regulation of human fibroblast activation and can be considered a valid therapeutic approach for liver and gut lesions.	[Brun, Paola; Pathak, Surajit; Castagliuolo, Ignazio; Palu, Giorgio] Univ Padua, Microbiol Unit, Dept Mol Med, Padua, Italy; [Pathak, Surajit] Univ Padua, Dept Surg Oncol & Gastroenterol Sci, Padua, Italy; [Brun, Paola] Univ Padua, Unit Histol, Dept Mol Med, Padua, Italy; [Zuin, Matteo; Cavazzana, Roberto; Martines, Emilio] Consorzio RFX, Padua, Italy; [Zuin, Matteo; Martines, Emilio] Ist Gas Ionizzati CNR, Padua, Italy	University of Padua; University of Padua; University of Padua; Consiglio Nazionale delle Ricerche (CNR); Istituto Gas Ionizzati (IGI-CNR)	Brun, P (corresponding author), Univ Padua, Microbiol Unit, Dept Mol Med, Padua, Italy.	paola.brun.1@unipd.it	castagliuolo, ignazio/K-9963-2016; zuin, matteo/AAX-8015-2020; ZUIN, Matteo/G-5540-2018; Martines, Emilio/B-1418-2009; Pathak, Surajit/AAH-4022-2020; Brun, Paola/K-5729-2016; Brun, Paola/A-3380-2016	castagliuolo, ignazio/0000-0001-9888-7030; ZUIN, Matteo/0000-0002-0282-2978; Martines, Emilio/0000-0002-4181-2959; Pathak, Surajit/0000-0002-7306-1272; Brun, Paola/0000-0002-3279-9000; Brun, Paola/0000-0002-4204-3549	European Society of Clinical Microbiology and Infectious Diseases (ESCMID-Research Grant); Italian Ministry of University and Research [2009HLNNRL_002]	European Society of Clinical Microbiology and Infectious Diseases (ESCMID-Research Grant); Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR))	This work was supported by grants from the European Society of Clinical Microbiology and Infectious Diseases (ESCMID-Research Grant 2011) to PB and from Italian Ministry of University and Research (2009HLNNRL_002) to IC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086173; Andoh A, 2007, PHARMACOL THERAPEUT, V114, P94, DOI 10.1016/j.pharmthera.2006.12.004; Arndt S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079325; Badid C, 2000, HISTOL HISTOPATHOL, V15, P269, DOI 10.14670/HH-15.269; Blackert S, 2013, J DERMATOL SCI, V70, P173, DOI 10.1016/j.jdermsci.2013.01.012; Brun P, 2005, AM J PHYSIOL-GASTR L, V289, pG571, DOI 10.1152/ajpgi.00537.2004; Brun P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033245; Cataldi A, 2010, CURR PHARM DESIGN, V16, P1387, DOI 10.2174/138161210791033969; Chen ACH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022453; de Valence S, 2013, EUR J PHARM BIOPHARM, V85, P78, DOI 10.1016/j.ejpb.2013.06.012; Di Mari JF, 2003, GASTROENTEROLOGY, V124, P1855, DOI 10.1016/S0016-5085(03)00399-8; Dubuquoy L, 2006, GUT, V55, P1341, DOI 10.1136/gut.2006.093484; Fridman G, 2008, PLASMA PROCESS POLYM, V5, P503, DOI 10.1002/ppap.200700154; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Garcia-Alcantara E, 2013, ARCH MED RES, V44, P169, DOI 10.1016/j.arcmed.2013.02.001; Giro G, 2013, J BIOMED MATER RES A, V101, P98, DOI 10.1002/jbm.a.34304; Grahn JC, 2003, WOUND REPAIR REGEN, V11, P64, DOI 10.1046/j.1524-475X.2003.11110.x; Graves DB, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/26/263001; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Haertel B, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/761451; Haertel B, 2011, EXP DERMATOL, V20, P282, DOI 10.1111/j.1600-0625.2010.01159.x; Heinlin J, 2013, WOUND REPAIR REGEN, V21, P800, DOI 10.1111/wrr.12078; Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246; Ikehara Y, 2013, J PHOTOPOLYM SCI TEC, V26, P555; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Joshi SG, 2011, ANTIMICROB AGENTS CH, V55, P1053, DOI 10.1128/AAC.01002-10; Kagan VE, 2002, J IMMUNOL, V169, P487, DOI 10.4049/jimmunol.169.1.487; Kalghatgi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016270; Kalghatgi S, 2010, ANN BIOMED ENG, V38, P748, DOI 10.1007/s10439-009-9868-x; Kong MG, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115012; Lerouge S, 2000, J BIOMED MATER RES, V51, P128, DOI 10.1002/(SICI)1097-4636(200007)51:1<128::AID-JBM17>3.3.CO;2-R; Maisch T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034610; Martines E, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115014; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; Nandi D, 2010, IMMUNOBIOLOGY, V215, P443, DOI 10.1016/j.imbio.2009.08.003; Nishimura KY, 1996, J CELL SCI, V109, P199; Novo E, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S4; Plewa JM, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/4/043027; Ralph SJ, 2010, MOL ASPECTS MED, V31, P145, DOI 10.1016/j.mam.2010.02.008; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Rojkind M, 2002, CELL MOL LIFE SCI, V59, P1872, DOI 10.1007/PL00012511; Saeidnia S, 2013, TOXICOL APPL PHARM, V273, P442, DOI 10.1016/j.taap.2013.09.031; Salvioli S, 1997, FEBS LETT, V411, P77, DOI 10.1016/S0014-5793(97)00669-8; Sanz Alberto, 2008, Curr Aging Sci, V1, P10; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Vandamme M, 2012, INT J CANCER, V130, P2185, DOI 10.1002/ijc.26252; VANZANDWIJK N, 1995, J CELL BIOCHEM, P24; Volotskova O, 2011, PLASMA MED, V1, P85, DOI [DOI 10.1615/PlasmaMed.v1.i1.70, DOI 10.1615/PLASMAMED.V1.I1.70]; Voltan S, 2008, GASTROENTEROLOGY, V135, P1216, DOI 10.1053/j.gastro.2008.07.007; Wende K, 2014, CELL BIOL INT, V38, P412, DOI 10.1002/cbin.10200; Whitney JD, 2005, NURS CLIN N AM, V40, P191, DOI 10.1016/j.cnur.2004.09.002; Xu JY, 2003, AM J PHYSIOL-GASTR L, V285, pG20, DOI 10.1152/ajpgi.00474.2002	52	57	61	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104397	10.1371/journal.pone.0104397	http://dx.doi.org/10.1371/journal.pone.0104397			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127477	gold, Green Published, Green Submitted			2022-12-25	WOS:000340879300022
J	Figueiredo, LB; Sakamoto, T; Coelho, LFL; Rocha, ESD; Cota, MMG; Ferreira, GP; de Oliveira, JG; Kroon, EG				Figueiredo, Leandra Barcelos; Sakamoto, Tetsu; Leomil Coelho, Luiz Felipe; de Oliveira Rocha, Eliseu Soares; Gomes Cota, Marcela Menezes; Ferreira, Gustavo Portela; de Oliveira, Jaquelline Germano; Kroon, Erna Geessien			Dengue Virus 2 American-Asian Genotype Identified during the 2006/2007 Outbreak in Piaui, Brazil Reveals a Caribbean Route of Introduction and Dissemination of Dengue Virus in Brazil	PLOS ONE			English	Article							RIO-DE-JANEIRO; CO-CIRCULATION; TYPE-2; EVOLUTION; EMERGENCE; PROTEIN; STATE	Dengue virus (DENV) is the most widespread arthropod-borne virus, and the number and severity of outbreaks has increased worldwide in recent decades. Dengue is caused by DENV-1, DENV-2, DENV-3 and DENV-4 which are genetically distant. The species has been subdivided into genotypes based on phylogenetic studies. DENV-2, which was isolated from dengue fever patients during an outbreak in Piaui, Brazil in 2006/2007 was analyzed by sequencing the envelope (E) gene. The results indicated a high similarity among the isolated viruses, as well as to other DENV-2 from Brazil, Central America and South America. A phylogenetic and phylogeographic analysis based on DENV-2E gene sequences revealed that these viruses are grouped together with viruses of the American-Asian genotype in two distinct lineages. Our results demonstrate the co-circulation of two American-Asian genotype lineages in northeast Brazil. Moreover, we reveal that DENV-2 lineage 2 was detected in Piaui before it disseminated to other Brazilian states and South American countries, indicating the existence of a new dissemination route that has not been previously described.	[Figueiredo, Leandra Barcelos] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, Belo Horizonte, MG, Brazil; [Sakamoto, Tetsu] Univ Fed Minas Gerais, Lab Biodados, Belo Horizonte, MG, Brazil; [Leomil Coelho, Luiz Felipe] Univ Fed Alfenas, Lab Vacinas, Alfenas, MG, Brazil; [de Oliveira Rocha, Eliseu Soares; Gomes Cota, Marcela Menezes] Univ Fed Minas Gerais, Virus Lab, Belo Horizonte, MG, Brazil; [Ferreira, Gustavo Portela] Univ Fed Piaui, Lab Biotecnol, Parnaiba, Piaui, Brazil; [de Oliveira, Jaquelline Germano] Fundacao Oswaldo Cruz, Lab Imunol Celular & Mol, Belo Horizonte, MG, Brazil; [Kroon, Erna Geessien] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Alfenas; Universidade Federal de Minas Gerais; Universidade Federal do Piaui; Fundacao Oswaldo Cruz; Universidade Federal de Minas Gerais	Kroon, EG (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, Belo Horizonte, MG, Brazil.	ernagkroon@gmail.cozm	Coelho, Luiz FL/G-5853-2012; Kroon, Erna Geessien/B-3631-2015; Sakamoto, Tetsu/N-7951-2014; Kroon, Erna/V-5444-2019; De Oliveira, Jaquelline/ABE-3725-2021	Kroon, Erna Geessien/0000-0003-2721-3826; Sakamoto, Tetsu/0000-0003-3023-0117; Rocha, Eliseu/0000-0002-2854-0768; Coelho, Luiz Felipe/0000-0003-4289-384X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); INCT; PRONEX-Dengue, Departamento de Ciencia e Tecnologia do Ministerio da Saude (DECIT/MS)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); INCT; PRONEX-Dengue, Departamento de Ciencia e Tecnologia do Ministerio da Saude (DECIT/MS)	This study was funded by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), INCT and PRONEX-Dengue, Departamento de Ciencia e Tecnologia do Ministerio da Saude (DECIT/MS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amarilla AA, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-113; Anez G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027459; Carrillo-Valenzo E, 2010, ARCH VIROL, V155, P1401, DOI 10.1007/s00705-010-0721-1; Clyde K, 2006, J VIROL, V80, P11418, DOI 10.1128/JVI.01257-06; Costa RL, 2012, INFECT GENET EVOL, V12, P309, DOI 10.1016/j.meegid.2011.12.011; de Castro JAF, 2003, MEM I OSWALDO CRUZ, V98, P1021, DOI 10.1590/S0074-02762003000800007; De Simone TS, 2004, T ROY SOC TROP MED H, V98, P553, DOI 10.1016/j.trstmh.2003.09.003; DESOUZA RV, 1995, MEM I OSWALDO CRUZ, V90, P345, DOI 10.1590/S0074-02761995000300006; Drummond A., 2002, BEAUTI BAYESIAN EVOL; Drummond A.J., 2002, BEAST BAYESIAN EVOLU; Drumond BP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059422; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Figueiredo LB, 2008, EMERG INFECT DIS, V14, P314, DOI 10.3201/eid1402.070278; Gardella-Garcia CE, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-117; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0; IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531; Klungthong C, 2008, J VIROL METHODS, V154, P175, DOI 10.1016/j.jviromet.2008.07.021; LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992; Leitmeyer KC, 1999, J VIROL, V73, P4738, DOI 10.1128/JVI.73.6.4738-4747.1999; Mendez JA, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-64; Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165; NOGUEIRA RMR, 1990, MEM I OSWALDO CRUZ, V85, P253, DOI 10.1590/S0074-02761990000200022; NOGUEIRA RMR, 1993, EPIDEMIOL INFECT, V111, P163, DOI 10.1017/S0950268800056788; Oliveira MF, 2010, EMERG INFECT DIS, V16, P576, DOI 10.3201/eid1603.090996; Posada D, 2011, JMODELTEST PHYLOGENE; Rambaut A, 2002, TREEANOTATOR V1 6 1; Rambaut A., 2006, TREE FIGURE DRAWING; Rambaut A., 2003, TRACER MCMC TRACE AN; Rambaut A, 2013, PATH O GEN SOFTWARE; Rico-Hesse R, 2003, ADV VIRUS RES, V59, P315, DOI 10.1016/S0065-3527(03)59009-1; RICOHESSE R, 1990, VIROLOGY, V174, P479, DOI 10.1016/0042-6822(90)90102-W; RicoHesse R, 1997, VIROLOGY, V230, P244, DOI 10.1006/viro.1997.8504; Romano CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011811; Thiel HJ, 2007, FIELDS VIROLOGY, P810; Twiddy SS, 2003, INFECT GENET EVOL, V3, P87, DOI 10.1016/S1567-1348(02)00153-3; Twiddy SS, 2002, J GEN VIROL, V83, P1679, DOI 10.1099/0022-1317-83-7-1679; Vasconcelos Pedro F. Da C., 1995, Revista do Instituto de Medicina Tropical de Sao Paulo, V37, P253; Wang EY, 2000, J VIROL, V74, P3227, DOI 10.1128/JVI.74.7.3227-3234.2000; Wang WK, 2000, J CLIN MICROBIOL, V38, P3306, DOI 10.1128/JCM.38.9.3306-3310.2000; Wittke V, 2002, VIROLOGY, V301, P148, DOI 10.1006/viro.2002.1549; World Health Organization, 2009, DENGUE GUIDELINES DI; Zhang CL, 2006, J GEN VIROL, V87, P873, DOI 10.1099/vir.0.81486-0	47	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104516	10.1371/journal.pone.0104516	http://dx.doi.org/10.1371/journal.pone.0104516			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127366	gold, Green Published, Green Submitted			2022-12-25	WOS:000340879300029
J	Tseng, WN; Lo, MH; Guo, MMH; Hsieh, KS; Chang, WC; Kuo, HC				Tseng, Wan-Ning; Lo, Mao-Hung; Guo, Mindy Ming-Huey; Hsieh, Kai-Sheng; Chang, Wei-Chiao; Kuo, Ho-Chang			IL-31 Associated with Coronary Artery Lesion Formation in Kawasaki Disease	PLOS ONE			English	Article							ATOPIC-DERMATITIS; T-CELLS; EOSINOPHILIA; SUSCEPTIBILITY; POLYMORPHISMS; INFLAMMATION; DIAGNOSIS; ANEURYSMS; COUNTS	Background: Kawasaki disease (KD) is known to be associated with T help (Th) 2 reaction and subsequently allergic diseases. Interleukin-31 (IL-31) has also been reported to be involved in Th2 mediated diseases such as allergic diseases. However, the role of IL-31 in KD has not been previously reported. The aim of this study is to investigate whether IL-31 is associated with KD and its clinical outcome. Material: A total of 78 KD patients who met the criteria of KD were enrolled in this study as well as 20 age-matched controls. Plasma samples were conducted to measure IL-31 before intravenous immunoglobulin (IVIG) treatment (KD1), within 3 days after IVIG treatment (KD2) and at least 3 weeks after IVIG treatment (KD3) by utilizing enzyme-linked immunosorbent assay (ELISA). Result: Our findings showed that IL-31 expression was higher in KD patients after IVIG treatment significantly (KD2>KD1: 1265.0 +/- 199.3 vs. 840.2 +/- 152.5 pg/ml, p<0.0001). Further analysis revealed that IL-31 level was significantly higher in KD patients with coronary artery lesion (CAL) (656.6 +/- 139.5 vs. 1373.0 +/- 422.0 pg/ml, p = 0.04) before IVIG treatment (KD1). There were no significant differences between the IVIG resistance and IVIG responsiveness groups. Conclusion: IL-31 was increased after IVIG treatment in patients with KD and was significantly associated with CAL formation. The results from this study may help to identify a novel risk factor for predicting KD and CAL formation.	[Tseng, Wan-Ning; Lo, Mao-Hung; Guo, Mindy Ming-Huey; Hsieh, Kai-Sheng; Kuo, Ho-Chang] Chang Gung Univ, Kaohsiung Chang Gung Mem Hosp, Coll Med, Dept Pediat, Kaohsiung, Taiwan; [Tseng, Wan-Ning; Lo, Mao-Hung; Guo, Mindy Ming-Huey; Hsieh, Kai-Sheng; Kuo, Ho-Chang] Kaohsiung Chang Gung Mem Hosp, Kawasaki Dis Ctr, Kaohsiung, Taiwan; [Chang, Wei-Chiao] Taipei Med Univ, Sch Pharm, Dept Clin Pharm, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Taipei Medical University	Chang, WC (corresponding author), Taipei Med Univ, Sch Pharm, Dept Clin Pharm, Taipei, Taiwan.	wcc@tmu.edu.tw; dr.hckuo@gmail.com	Kuo, Ho-Chang/AAQ-6644-2020	Kuo, Ho-Chang/0000-0002-3295-2984; Hsieh, Kai-Sheng/0000-0002-0294-9872; Chang, Wei-Chiao/0000-0002-8573-5924	National Science Council, Taiwan [NSC 102-2314-B-182-053-MY3]; Chang Gung Memorial Hospital [CMRPG8C1081, CMRPG8B0211]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This study was supported by a grant from the National Science Council, Taiwan (NSC 102-2314-B-182-053-MY3) and a grant from the Chang Gung Memorial Hospital (CMRPG8C1081 and CMRPG8B0211). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAGI T, 1992, J PEDIATR-US, V121, P689, DOI 10.1016/S0022-3476(05)81894-3; Beiser AS, 1998, AM J CARDIOL, V81, P1116, DOI 10.1016/S0002-9149(98)00116-7; BROSIUS CL, 1988, PEDIATR INFECT DIS J, V7, P863; Cheung PFY, 2010, INT IMMUNOL, V22, P453, DOI 10.1093/intimm/dxq027; Chu MP, 2012, MOL MED REP, V5, P1237, DOI 10.3892/mmr.2012.799; Dillon SR, 2004, NAT IMMUNOL, V5, P752, DOI 10.1038/ni1084; Hospers JJ, 1999, AM J EPIDEMIOL, V150, P482; KAWASAKI T, 1974, PEDIATRICS, V54, P271; Kobayashi T, 2006, CIRCULATION, V113, P2606, DOI 10.1161/CIRCULATIONAHA.105.592865; Kuo HC, 2007, PEDIAT ALLERG IMM-UK, V18, P354, DOI 10.1111/j.1399-3038.2007.00516.x; Kuo HC, 2012, PEDIATR NEONATOL, V53, P4, DOI 10.1016/j.pedneo.2011.11.003; Lee CP, 2013, PEDIATR RES, V74, P545, DOI 10.1038/pr.2013.134; Liew WK, 2011, PEDIAT ALLERG IMM-UK, V22, P488, DOI 10.1111/j.1399-3038.2011.01149.x; Lin IC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038635; Lin LY, 2012, PEDIAT CARDIOL; Matsuoka S, 1997, EUR J PEDIATR, V156, P30; Mori K, 2000, EUR J PEDIATR, V159, P509, DOI 10.1007/s004310051321; Newburger JW, 2004, CIRCULATION, V110, P2747, DOI 10.1161/01.CIR.0000145143.19711.78; Okano M, 2011, J ALLERGY CLIN IMMUN, V127, P277, DOI 10.1016/j.jaci.2010.09.029; Ouyang H, 2014, EUR ARCH OTORHINOLAR; PRENTICE RL, 1982, AM J EPIDEMIOL, V116, P496, DOI 10.1093/oxfordjournals.aje.a113434; Raap U, 2008, J ALLERGY CLIN IMMUN, V122, P421, DOI 10.1016/j.jaci.2008.05.047; SHULMAN ST, 1995, PEDIATR CLIN N AM, V42, P1205; Sonkoly E, 2006, J ALLERGY CLIN IMMUN, V117, P411, DOI 10.1016/j.jaci.2005.10.033; Stott B, 2013, J ALLERGY CLIN IMMUN, V132, P446, DOI 10.1016/j.jaci.2013.03.050; Terai M, 2002, PEDIATR INFECT DIS J, V21, P777, DOI 10.1097/00006454-200208000-00015; Ting EC, 1998, PEDIATR INFECT DIS J, V17, P431, DOI 10.1097/00006454-199805000-00020; Wang YJ, 2013, ARTHRITIS RHEUM-US, V65, P805, DOI 10.1002/art.37815; Webster RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028004; Yu JI, 2012, KOREAN J PATHOL, V46, P162, DOI 10.4132/KoreanJPathol.2012.46.2.162	30	19	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e105195	10.1371/journal.pone.0105195	http://dx.doi.org/10.1371/journal.pone.0105195			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122210	Green Published, gold, Green Submitted			2022-12-25	WOS:000341017000104
J	Sarmento, LM; Povoa, V; Nascimento, R; Real, G; Antunes, I; Martins, LR; Moita, C; Alves, PM; Abecasis, M; Moita, LF; Parkhouse, RME; Meijerink, JPP; Barata, JT				Sarmento, L. M.; Povoa, V.; Nascimento, R.; Real, G.; Antunes, I.; Martins, L. R.; Moita, C.; Alves, P. M.; Abecasis, M.; Moita, L. F.; Parkhouse, R. M. E.; Meijerink, J. P. P.; Barata, J. T.			CHK1 overexpression in T-cell acute lymphoblastic leukemia is essential for proliferation and survival by preventing excessive replication stress	ONCOGENE			English	Article							DNA-DAMAGE; CROSS-TALK; CHECKPOINT; ATR; KINASE; PROGRESSION; ACTIVATION; INHIBITOR; MUTATIONS; PHOSPHORYLATION	Checkpoint kinase 1 (CHK1) is a key component of the ATR (ataxia telangiectasia-mutated and Rad3-related)-dependent DNA damage response pathway that protect cells from replication stress, a cell intrinsic phenomenon enhanced by oncogenic transformation. Here, we show that CHK1 is overexpressed and hyperactivated in T-cell acute lymphoblastic leukemia (T-ALL). CHEK1 mRNA is highly abundant in patients of the proliferative T-ALL subgroup and leukemia cells exhibit constitutively elevated levels of the replication stress marker phospho-RPA32 and the DNA damage marker gamma H2AX. Importantly, pharmacologic inhibition of CHK1 using PF-004777736 or CHK1 short hairpin RNA-mediated silencing impairs T-ALL cell proliferation and viability. CHK1 inactivation results in the accumulation of cells with incompletely replicated DNA, ensuing DNA damage, ATM/CHK2 activation and subsequent ATM-and caspase-3-dependent apoptosis. In contrast to normal thymocytes, primary T-ALL cells are sensitive to therapeutic doses of PF-004777736, even in the presence of stromal or interleukin-7 survival signals. Moreover, CHK1 inhibition significantly delays in vivo growth of xenotransplanted T-ALL tumors. We conclude that CHK1 is critical for T-ALL proliferation and viability by downmodulating replication stress and preventing ATM/caspase-3-dependent cell death. Pharmacologic inhibition of CHK1 may be a promising therapeutic alternative for T-ALL treatment.	[Sarmento, L. M.; Povoa, V.; Antunes, I.; Martins, L. R.; Moita, C.; Moita, L. F.; Barata, J. T.] Univ Lisbon, Inst Med Mol, Fac Med, P-1649028 Lisbon, Portugal; [Nascimento, R.; Parkhouse, R. M. E.] Inst Gulbenkian Ciencias, Infect & Immun Lab, Oeiras, Portugal; [Real, G.; Alves, P. M.] Inst Biol Expt & Tecnol, iBET, Oeiras, Portugal; [Real, G.; Alves, P. M.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal; [Abecasis, M.] Hosp Sta Cruz, Cardiol Pediat Med Cirurg, Lisbon, Portugal; [Meijerink, J. P. P.] Erasmus MC Sophia Childrens Hosp, Dept Pediat Oncol Hematol, Rotterdam, Netherlands	Universidade de Lisboa; Instituto Gulbenkian de Ciencia; Universidade Nova de Lisboa; Erasmus University Rotterdam; Erasmus MC	Barata, JT (corresponding author), Univ Lisbon, Inst Med Mol, Fac Med, Av Prof Egas Moniz, P-1649028 Lisbon, Portugal.	joao_barata@medicina.ulisboa.pt	Barata, João T./D-9181-2015; Alves, Paula M/C-1070-2008; Moita, Luis F./L-1296-2013; Meijerink, Jules P/D-4393-2017; Moita, Luis/HCI-2793-2022	Barata, João T./0000-0002-4826-8976; Alves, Paula M/0000-0003-1445-3556; Moita, Luis F./0000-0003-0707-315X; Meijerink, Jules P/0000-0002-6860-798X; Moita, Luis/0000-0003-0707-315X; Parkhouse, Michael/0000-0001-5967-3291; Afonso, Rute/0000-0002-4531-6581; Martins, Leila/0000-0002-5887-4734; Real, Goncalo/0000-0003-3157-4341; Ferreira Moita, Catarina/0000-0002-9910-2343	Fundacao para a Ciencia e a Tecnologia (FCT), Portugal [PTDC/SAU-ONC/113202/2009]; FCT	Fundacao para a Ciencia e a Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by the grant PTDC/SAU-ONC/113202/2009 from Fundacao para a Ciencia e a Tecnologia (FCT), Portugal. LMS, RN, IA, LRM and CM had postdoctoral fellowships, and VP a BI fellowship, all from FCT. We thank Dr J Ferreira for fruitful discussions and reagents. We also thank Dr O Fernandez-Capetillo and Centro Nacional de Investigaciones Oncologicas for providing the ATR inhibitor. We especially thank the generosity of patients and their families, and the collaboration of all the team from the Pediatrics Service of Instituto Portugues de Oncologia de Lisboa.	Aifantis I, 2008, NAT REV IMMUNOL, V8, P380, DOI 10.1038/nri2304; Bains T, 2012, LEUKEMIA, V26, P2144, DOI 10.1038/leu.2012.74; Barata JT, 2004, BLOOD, V103, P1891, DOI 10.1182/blood-2002-12-3861; Barata JT, 2001, BLOOD, V98, P1524, DOI 10.1182/blood.V98.5.1524; Barde I, 2010, CURR PROTOC NEUROSCI, V53, P4211; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Brooks K, 2013, ONCOGENE, V32, P788, DOI 10.1038/onc.2012.72; Brown EJ, 2000, GENE DEV, V14, P397; Carrassa L, 2011, CELL CYCLE, V10, P2121, DOI 10.4161/cc.10.13.16398; Castedo M, 2004, ONCOGENE, V23, P2825, DOI 10.1038/sj.onc.1207528; Cole KA, 2011, P NATL ACAD SCI USA, V108, P3336, DOI 10.1073/pnas.1012351108; Dai Y, 2005, BLOOD, V105, P1706, DOI 10.1182/blood-2004-07-2767; Dohda T, 2007, EXP CELL RES, V313, P3141, DOI 10.1016/j.yexcr.2007.04.027; Ferrando AA, 2002, CANCER CELL, V1, P75, DOI 10.1016/S1535-6108(02)00018-1; Flex E, 2008, J EXP MED, V205, P751, DOI 10.1084/jem.20072182; Forment JV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023517; Gagou ME, 2010, MOL BIOL CELL, V21, P739, DOI 10.1091/mbc.E09-07-0618; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Homminga I, 2011, CANCER CELL, V19, P484, DOI 10.1016/j.ccr.2011.02.008; Indraccolo S, 2009, CANCER RES, V69, P1314, DOI 10.1158/0008-5472.CAN-08-2791; Katsuno Y, 2009, P NATL ACAD SCI USA, V106, P3184, DOI 10.1073/pnas.0809350106; King B, 2013, CELL, V153, P1552, DOI 10.1016/j.cell.2013.05.041; Lam MH, 2004, CANCER CELL, V6, P45, DOI 10.1016/j.ccr.2004.06.015; Liu QH, 2000, GENE DEV, V14, P1448; Liu SQ, 2012, NUCLEIC ACIDS RES, V40, P10780, DOI 10.1093/nar/gks849; Lonetti A, 2014, LEUKEMIA, V28, P1196, DOI 10.1038/leu.2013.369; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; Lopez-Contreras AJ, 2012, J EXP MED, V209, P455, DOI 10.1084/jem.20112147; Ma CX, 2011, TRENDS MOL MED, V17, P88, DOI 10.1016/j.molmed.2010.10.009; Mailand N, 2000, SCIENCE, V288, P1425, DOI 10.1126/science.288.5470.1425; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Murga M, 2011, NAT STRUCT MOL BIOL, V18, P1331, DOI 10.1038/nsmb.2189; Myers K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000324; Niida H, 2005, J BIOL CHEM, V280, P39246, DOI 10.1074/jbc.M505009200; Petermann E, 2010, P NATL ACAD SCI USA, V107, P16090, DOI 10.1073/pnas.1005031107; Pui CH, 2008, LANCET, V371, P1030, DOI 10.1016/S0140-6736(08)60457-2; Real G, 2011, APPL MICROBIOL BIOT, V91, P1581, DOI 10.1007/s00253-011-3392-2; Ribeiro Daniel, 2013, Adv Biol Regul, V53, P211, DOI 10.1016/j.jbior.2012.10.005; Sarmento LM, 2011, EXPERT REV ANTICANC, V11, P1403, DOI [10.1586/ERA.11.73, 10.1586/era.11.73]; Sarmento LM, 2005, J EXP MED, V202, P157, DOI 10.1084/jem.20050559; Scupoli MT, 2007, HAEMATOLOGICA, V92, P264, DOI 10.3324/haematol.10356; Sidi S, 2008, CELL, V133, P864, DOI 10.1016/j.cell.2008.03.037; Silva A, 2008, J CLIN INVEST, V118, P3762, DOI 10.1172/JCI34616; Silva A, 2011, CANCER RES, V71, P4780, DOI 10.1158/0008-5472.CAN-10-3606; Smith J, 2010, ADV CANCER RES, V108, P73, DOI 10.1016/S0065.230X(10)08002.4; Sorensen CS, 2005, NAT CELL BIOL, V7, P195, DOI 10.1038/ncb1212; Sugimoto K, 2008, ONCOGENE, V27, P3091, DOI 10.1038/sj.onc.1210978; Syljuasen RG, 2005, MOL CELL BIOL, V25, P3553, DOI 10.1128/MCB.25.9.3553-3562.2005; Toledo LI, 2011, MOL ONCOL, V5, P368, DOI 10.1016/j.molonc.2011.07.002; Toledo LI, 2011, NAT STRUCT MOL BIOL, V18, P721, DOI 10.1038/nsmb.2076; Verlinden L, 2007, CANCER RES, V67, P6574, DOI 10.1158/0008-5472.CAN-06-3545; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Xu J, 2013, ONCOGENE, V32, P976, DOI 10.1038/onc.2012.121; Zaugg K, 2007, P NATL ACAD SCI USA, V104, P3805, DOI 10.1073/pnas.0611584104; Zenatti PP, 2011, NAT GENET, V43, P932, DOI 10.1038/ng.924; Zhang C, 2009, CLIN CANCER RES, V15, P4630, DOI 10.1158/1078-0432.CCR-08-3272; Zhang YW, 2009, MOL CELL, V35, P442, DOI 10.1016/j.molcel.2009.06.030; Zhang YW, 2014, INT J CANCER, V134, P1013, DOI 10.1002/ijc.28226; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	60	44	47	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 4	2015	34	23					2978	2990		10.1038/onc.2014.248	http://dx.doi.org/10.1038/onc.2014.248			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CK3EX	25132270	Bronze			2022-12-25	WOS:000356100500004
J	Lauer, ME; Hascall, VC; Green, DE; DeAngelis, PL; Calabro, A				Lauer, Mark E.; Hascall, Vincent C.; Green, Dixy E.; DeAngelis, Paul L.; Calabro, Anthony			Irreversible Heavy Chain Transfer to Chondroitin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESENCHYMAL STEM-CELLS; FACTOR-STIMULATED GENE-6; ALPHA-TRYPSIN INHIBITOR; SMOOTH-MUSCLE-CELLS; CHEMOENZYMATIC SYNTHESIS; EXTRACELLULAR-MATRIX; OOCYTE COMPLEXES; PROTEIN TSG-6; HYALURONAN; TNF	We have recently demonstrated that the transfer of heavy chains (HCs) from inter-alpha-inhibitor, via the enzyme TSG-6 (tumor necrosis factor-stimulated gene 6), to hyaluronan (HA) oligosaccharides is an irreversible event in which subsequent swapping of HCs between HA molecules does not occur. We now describe our results of HC transfer experiments to chondroitin sulfate A, chemically desulfated chondroitin, chemoenzymatically synthesized chondroitin, unsulfated heparosan, heparan sulfate, and alginate. Of these potential HC acceptors, only chemically desulfated chondroitin and chemoenzymatically synthesized chondroitin were HC acceptors. The kinetics of HC transfer to chondroitin was similar to HA. At earlier time points, HCs were more widely distributed among the different sizes of chondroitin chains. As time progressed, the HCs migrated to lower molecular weight chains of chondroitin. Our interpretation is that TSG-6 swaps the HCs from the larger, reversible sites on chondroitin chains, which function as HC acceptors, onto smaller chondroitin chains, which function as irreversible HC acceptors. HCs transferred to smaller chondroitin chains were unable to be swapped off the smaller chondroitin chains and transferred to HA. HCs transferred to high molecular weight HA were unable to be swapped onto chondroitin. We also present data that although chondroitin was a HC acceptor, HA was the preferred acceptor when chondroitin and HA were in the same reaction mixture.	[Lauer, Mark E.; Hascall, Vincent C.; Calabro, Anthony] Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44195 USA; [Green, Dixy E.; DeAngelis, Paul L.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma Ctr Med Glycobiol, Oklahoma City, OK 73126 USA	Cleveland Clinic Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center	Lauer, ME (corresponding author), Cleveland Clin, Dept Biomed Engn ND20, Cleveland, OH 44195 USA.	lauerm1@ccf.org			National Institutes of Health, NHLBI [P01HL107147, 1RO1HL113325-01A1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107147, R01HL113325] Funding Source: NIH RePORTER	National Institutes of Health, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health, NHLBI Awards P01HL107147 and 1RO1HL113325-01A1.	Calabro A, 2000, GLYCOBIOLOGY, V10, P273, DOI 10.1093/glycob/10.3.273; Chi LL, 2008, J AM CHEM SOC, V130, P2617, DOI 10.1021/ja0778500; Choi H, 2011, BLOOD, V118, P330, DOI 10.1182/blood-2010-12-327353; Evanko SP, 2009, J HISTOCHEM CYTOCHEM, V57, P1041, DOI 10.1369/jhc.2009.953802; Fulop C, 1997, GENE, V202, P95, DOI 10.1016/S0378-1119(97)00459-9; Jing W, 2004, J BIOL CHEM, V279, P42345, DOI 10.1074/jbc.M402744200; Kota DJ, 2013, DIABETES, V62, P2048, DOI 10.2337/db12-0931; Lauer ME, 2013, J BIOL CHEM, V288, P205, DOI 10.1074/jbc.M112.403998; Lauer ME, 2013, J BIOL CHEM, V288, P423, DOI 10.1074/jbc.M112.389882; Lauer ME, 2009, J BIOL CHEM, V284, P5299, DOI 10.1074/jbc.M807965200; LEE TH, 1992, J CELL BIOL, V116, P545, DOI 10.1083/jcb.116.2.545; Lin QM, 2013, ACTA PHARMACOL SIN, V34, P784, DOI 10.1038/aps.2012.199; Ly M, 2011, NAT CHEM BIOL, V7, P827, DOI 10.1038/nchembio.673; Mukhopadhyay D, 2004, J BIOL CHEM, V279, P11119, DOI 10.1074/jbc.M313471200; Mukhopadhyay D, 2001, ARCH BIOCHEM BIOPHYS, V394, P173, DOI 10.1006/abbi.2001.2552; Qi Y, 2014, J INVEST DERMATOL, V134, P526, DOI 10.1038/jid.2013.328; Roddy GW, 2011, STEM CELLS, V29, P1572, DOI 10.1002/stem.708; Rugg MS, 2005, J BIOL CHEM, V280, P25674, DOI 10.1074/jbc.M501332200; Sanggaard KW, 2010, J BIOL CHEM, V285, P21988, DOI 10.1074/jbc.M109.041046; Scarchilli L, 2007, J BIOL CHEM, V282, P30161, DOI 10.1074/jbc.M703738200; Sismey-Ragatz AE, 2007, J BIOL CHEM, V282, P28321, DOI 10.1074/jbc.M701599200; Swaidani S, 2013, J BIOL CHEM, V288, P412, DOI 10.1074/jbc.M112.389874; Szanto S, 2004, ARTHRITIS RHEUM-US, V50, P3012, DOI 10.1002/art.20655; Tracy BS, 2007, J BIOL CHEM, V282, P337, DOI 10.1074/jbc.M607569200; Tsukahara S, 2006, BIOCHEM J, V398, P595, DOI 10.1042/BJ20060027; Wang AM, 2011, FEBS J, V278, P1412, DOI 10.1111/j.1742-4658.2011.08069.x; Wang N, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt142; Wang N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043768; WISNIEWSKI HG, 1993, J IMMUNOL, V151, P6593; Yang H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100285	30	4	4	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					29171	29179		10.1074/jbc.M114.600809	http://dx.doi.org/10.1074/jbc.M114.600809			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25135638	Green Published, hybrid			2022-12-25	WOS:000344141000033
J	Chen, C; Tao, T; Wen, C; He, WQ; Qiao, YN; Gao, YQ; Chen, X; Wang, P; Chen, CP; Zhao, W; Chen, HQ; Ye, AP; Peng, YJ; Zhu, MS				Chen, Chen; Tao, Tao; Wen, Cheng; He, Wei-Qi; Qiao, Yan-Ning; Gao, Yun-Qian; Chen, Xin; Wang, Pei; Chen, Cai-Ping; Zhao, Wei; Chen, Hua-Qun; Ye, An-Pei; Peng, Ya-Jing; Zhu, Min-Sheng			Myosin Light Chain Kinase (MLCK) Regulates Cell Migration in a Myosin Regulatory Light Chain Phosphorylation-independent Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE CONTRACTION; MEMBRANE TENSION; RHO-KINASE; EXTRACELLULAR-MATRIX; ADHESION DYNAMICS; ACTIN CONNECTION; CA2+ SENSITIVITY; DISTINCT ROLES; IN-VIVO; MOTILITY	Myosin light chain kinase (MLCK) has long been implicated in the myosin phosphorylation and force generation required for cell migration. Here, we surprisingly found that the deletion of MLCK resulted in fast cell migration, enhanced protrusion formation, and no alteration of myosin light chain phosphorylation. The mutant cells showed reduced membrane tether force and fewer membrane F-actin filaments. This phenotype was rescued by either kinase-dead MLCK or five-DFRXXL motif, a MLCK fragment with potent F-actin-binding activity. Pull-down and co-immunoprecipitation assays showed that the absence of MLCK led to attenuated formation of transmembrane complexes, including myosin II, integrins and fibronectin. We suggest that MLCK is not required for myosin phosphorylation in a migrating cell. A critical role of MLCK in cell migration involves regulating the cell membrane tension and protrusion necessary for migration, thereby stabilizing the membrane skeleton through F-actin-binding activity. This finding sheds light on a novel regulatory mechanism of protrusion during cell migration.	[Chen, Chen; Tao, Tao; He, Wei-Qi; Qiao, Yan-Ning; Gao, Yun-Qian; Chen, Xin; Wang, Pei; Chen, Cai-Ping; Zhao, Wei; Peng, Ya-Jing; Zhu, Min-Sheng] Nanjing Univ, Model Anim Res Ctr, Key Lab Model Anim Dis Study, Minist Educ, Nanjing 210061, Jiangsu, Peoples R China; [Wen, Cheng; Ye, An-Pei] Peking Univ, Sch Elect Engn & Comp Sci, Key Lab Phys & Chem Nanodevices, Minist Educ, Beijing 100871, Peoples R China; [Chen, Hua-Qun; Zhu, Min-Sheng] Nanjing Normal Univ, Sch Life Sci, Nanjing 210009, Jiangsu, Peoples R China	Nanjing University; Peking University; Nanjing Normal University	Peng, YJ (corresponding author), Nanjing Univ, Model Anim Res Ctr, Key Lab Model Anim Dis Study, Minist Educ, 12 Xue Fu Rd, Nanjing 210061, Jiangsu, Peoples R China.	pengyj@nicemice.cn; zhums@nju.edu.cn	Chen, Caiping/HII-8998-2022; He, Weiqi/I-7935-2013; Ye, Anpei/E-2765-2016; He, Weiqi/L-2502-2019	He, Weiqi/0000-0003-3137-8420; He, Weiqi/0000-0003-3137-8420; Chen, Chen/0000-0001-7075-8501; Chen, Xin/0000-0003-3304-8943; Qiao, Yanning/0000-0002-8092-4662	National Basic Research Program of China (973 Program) [2014CB964701]; National Natural Science Foundation of China [31371356, 31200824, 31330034]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (973 Program, 2014CB964701) and the National Natural Science Foundation of China (31371356, 31200824, and 31330034).	Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Batchelder EL, 2011, P NATL ACAD SCI USA, V108, P11429, DOI 10.1073/pnas.1010481108; Betapudi V, 2006, CANCER RES, V66, P4725, DOI 10.1158/0008-5472.CAN-05-4236; Betapudi V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008560; Blue EK, 2002, AM J PHYSIOL-CELL PH, V282, pC451, DOI 10.1152/ajpcell.00333.2001; Brakebusch C, 2003, EMBO J, V22, P2324, DOI 10.1093/emboj/cdg245; Burnette DT, 2011, NAT CELL BIOL, V13, P371, DOI 10.1038/ncb2205; Chew TL, 2002, J CELL BIOL, V156, P543, DOI 10.1083/jcb.200110161; Connell LE, 2006, J CELL SCI, V119, P2269, DOI 10.1242/jcs.02926; Cramer LP, 2013, CURR OPIN CELL BIOL, V25, P591, DOI 10.1016/j.ceb.2013.05.001; Dai JW, 1999, BIOPHYS J, V77, P3363, DOI 10.1016/S0006-3495(99)77168-7; Dai JW, 1998, J NEUROSCI, V18, P6681; Davidson LA, 2006, CURR BIOL, V16, P833, DOI 10.1016/j.cub.2006.03.038; Deng JT, 2001, J BIOL CHEM, V276, P16365, DOI 10.1074/jbc.M011634200; Diz-Munoz A, 2013, TRENDS CELL BIOL, V23, P47, DOI 10.1016/j.tcb.2012.09.006; Diz-Munoz A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000544; Doherty GJ, 2008, ANNU REV BIOPHYS, V37, P65, DOI 10.1146/annurev.biophys.37.032807.125912; Even-Ram S, 2007, NAT CELL BIOL, V9, P299, DOI 10.1038/ncb1540; Friedland JC, 2009, SCIENCE, V323, P642, DOI 10.1126/science.1168441; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3; Glynn MW, 2006, NAT PROTOC, V1, P1287, DOI 10.1038/nprot.2006.220; He WQ, 2008, GASTROENTEROLOGY, V135, P610, DOI 10.1053/j.gastro.2008.05.032; HOLZAPFEL G, 1983, EXP CELL RES, V148, P117, DOI 10.1016/0014-4827(83)90192-1; Hu K, 2007, SCIENCE, V315, P111, DOI 10.1126/science.1135085; KAMM KE, 1985, ANNU REV PHARMACOL, V25, P593, DOI 10.1146/annurev.pharmtox.25.1.593; Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200; Katoh K, 2001, AM J PHYSIOL-CELL PH, V280, pC1669, DOI 10.1152/ajpcell.2001.280.6.C1669; Kenagy RD, 1997, CIRCULATION, V96, P3555; Komatsu S, 2004, J CELL BIOL, V165, P243, DOI 10.1083/jcb.200309056; Kudryashov DS, 1999, FEBS LETT, V463, P67, DOI 10.1016/S0014-5793(99)01591-4; Larsen M, 2003, NAT REV MOL CELL BIO, V4, P700, DOI 10.1038/nrm1199; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Leung T, 1998, MOL CELL BIOL, V18, P130, DOI 10.1128/MCB.18.1.130; Li YJ, 2009, COLLOID SURFACE B, V70, P169, DOI 10.1016/j.colsurfb.2008.11.012; Lieber AD, 2013, CURR BIOL, V23, P1409, DOI 10.1016/j.cub.2013.05.063; Lin PJ, 1999, J BIOL CHEM, V274, P5987, DOI 10.1074/jbc.274.9.5987; Liu SC, 2000, J CELL SCI, V113, P3563; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; Mizuno Y, 2008, AM J PHYSIOL-CELL PH, V295, pC358, DOI 10.1152/ajpcell.90645.2007; Niggli V, 2006, BIOCHEM BIOPH RES CO, V343, P602, DOI 10.1016/j.bbrc.2006.03.022; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Okeyo KO, 2009, J BIOMECH, V42, P2540, DOI 10.1016/j.jbiomech.2009.07.002; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Raucher D, 1999, BIOPHYS J, V77, P1992, DOI 10.1016/S0006-3495(99)77040-2; Raucher D, 2000, J CELL BIOL, V148, P127, DOI 10.1083/jcb.148.1.127; Renkawitz J, 2009, NAT CELL BIOL, V11, P1438, DOI 10.1038/ncb1992; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rozario T, 2010, DEV BIOL, V341, P126, DOI 10.1016/j.ydbio.2009.10.026; Schiller HB, 2013, EMBO REP, V14, P509, DOI 10.1038/embor.2013.49; Sellers JR, 1991, CURR OPIN CELL BIOL, V3, P98, DOI 10.1016/0955-0674(91)90171-T; SELLERS JR, 1981, J BIOL CHEM, V256, P3137; Sheetz MP, 1996, TRENDS CELL BIOL, V6, P85, DOI 10.1016/0962-8924(96)80993-7; Sheetz MP, 2001, NAT REV MOL CELL BIO, V2, P392, DOI 10.1038/35073095; Smith AF, 1998, AM J PHYSIOL-CELL PH, V274, pC1188, DOI 10.1152/ajpcell.1998.274.5.C1188; Smith L, 1999, J BIOL CHEM, V274, P29433, DOI 10.1074/jbc.274.41.29433; Smith L, 2002, J BIOL CHEM, V277, P35597, DOI 10.1074/jbc.M206483200; SOMLYO AP, 1994, NATURE, V372, P231, DOI 10.1038/372231a0; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; TANSEY MG, 1994, J BIOL CHEM, V269, P9912; Tinevez JY, 2009, P NATL ACAD SCI USA, V106, P18581, DOI 10.1073/pnas.0903353106; Totsukawa G, 2004, J CELL BIOL, V164, P427, DOI 10.1083/jcb.200306172; Traynor D, 2007, J CELL SCI, V120, P2318, DOI 10.1242/jcs.007732; Verkhovsky AB, 1999, CURR BIOL, V9, P11, DOI 10.1016/S0960-9822(99)80042-6; Vicente-Manzanares M, 2007, J CELL BIOL, V176, P573, DOI 10.1083/jcb.200612043; Vicente-Manzanares M, 2009, J CELL SCI, V122, P199, DOI 10.1242/jcs.018564; WORD RA, 1991, AM J PHYSIOL, V260, pC861, DOI 10.1152/ajpcell.1991.260.4.C861; Yang CX, 2006, CELL RES, V16, P367, DOI 10.1038/sj.cr.7310047; Zhang WC, 2008, FEBS J, V275, P2489, DOI 10.1111/j.1742-4658.2008.06393.x; Zhang WC, 2010, J BIOL CHEM, V285, P5522, DOI 10.1074/jbc.M109.062836	73	38	41	1	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28478	28488		10.1074/jbc.M114.567446	http://dx.doi.org/10.1074/jbc.M114.567446			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25122766	Green Published, hybrid			2022-12-25	WOS:000343765400039
J	Ishikawa, M; Ito, H; Kitaori, T; Murata, K; Shibuya, H; Furu, M; Yoshitomi, H; Fujii, T; Yamamoto, K; Matsuda, S				Ishikawa, Masahiro; Ito, Hiromu; Kitaori, Toshiyuki; Murata, Koichi; Shibuya, Hideyuki; Furu, Moritoshi; Yoshitomi, Hiroyuki; Fujii, Takayuki; Yamamoto, Koji; Matsuda, Shuichi			MCP/CCR2 Signaling Is Essential for Recruitment of Mesenchymal Progenitor Cells during the Early Phase of Fracture Healing	PLOS ONE			English	Article							BONE-MARROW-CELLS; STEM-CELLS; REPAIR; GROWTH; MORTALITY; CCR2	Objective: The purpose of this study was to investigate chemokine profiles and their functional roles in the early phase of fracture healing in mouse models. Methods: The expression profiles of chemokines were examined during fracture healing in wild-type (WT) mice using a polymerase chain reaction array and histological staining. The functional effect of monocyte chemotactic protein-1 (MCP-1) on primary mouse bone marrow stromal cells (mBMSCs) was evaluated using an in vitro migration assay. MCP-1(-/-) and C-C chemokine receptor 2 (CCR2)(-/-) mice were fractured and evaluated by histological staining and micro-computed tomography (micro-CT). RS102895, an antagonist of CCR2, was continuously administered in WT mice before or after rib fracture and evaluated by histological staining and micro-CT. Bone graft exchange models were created in WT and MCP-1(-/-) mice and were evaluated by histological staining and micro-CT. Results: MCP-1 and MCP-3 expression in the early phase of fracture healing were up-regulated, and high levels of MCP-1 and MCP-3 protein expression observed in the periosteum and endosteum in the same period. MCP-1, but not MCP-3, increased migration of mBMSCs in a dose-dependent manner. Fracture healing in MCP-1(-/-) and CCR2(-/-) mice was delayed compared with WT mice on day 21. Administration of RS102895 in the early, but not in the late phase, caused delayed fracture healing. Transplantation of WT-derived graft into host MCP-1(-/-) mice significantly increased new bone formation in the bone graft exchange models. Furthermore, marked induction of MCP-1 expression in the periosteum and endosteum was observed around the WT-derived graft in the host MCP-1(-/-) mouse. Conversely, transplantation of MCP-1(-/-) mouse-derived grafts into host WT mice markedly decreased new bone formation. Conclusions: MCP-1/CCR2 signaling in the periosteum and endosteum is essential for the recruitment of mesenchymal progenitor cells in the early phase of fracture healing.	[Ishikawa, Masahiro; Ito, Hiromu; Kitaori, Toshiyuki; Murata, Koichi; Shibuya, Hideyuki; Furu, Moritoshi; Fujii, Takayuki; Matsuda, Shuichi] Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Kyoto, Japan; [Ishikawa, Masahiro; Furu, Moritoshi] Kyoto Univ, Grad Sch Med, Dept Control Rheumat Dis, Kyoto, Japan; [Yoshitomi, Hiroyuki] Kyoto Univ, Grad Sch Med, Ctr Innovat Immunoregulat Technol & Therapeut, Kyoto, Japan; [Yamamoto, Koji] Kyoto Univ, Ctr Promot Interdisciplinary Educ & Res, Kyoto, Japan	Kyoto University; Kyoto University; Kyoto University; Kyoto University	Ito, H (corresponding author), Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Kyoto, Japan.	hiromu@kuhp.kyoto-u.ac.jp		Murata, Koichi/0000-0002-7896-3937; Matsuda, Shuichi/0000-0003-0802-1255; , Hiroyuki/0000-0001-7339-9030	Ministry of Education of Japan [19591756, 21591942]	Ministry of Education of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-Aids from the Ministry of Education of Japan (No. 19591756, 21591942). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augello A, 2010, EUR CELLS MATER, V20, P121; Belema-Bedada F, 2008, CELL STEM CELL, V2, P566, DOI 10.1016/j.stem.2008.03.003; Bielby R, 2007, INJURY, V38, pS26, DOI 10.1016/j.injury.2007.02.007; Bliuc D, 2009, JAMA-J AM MED ASSOC, V301, P513, DOI 10.1001/jama.2009.50; Caplan A, 2009, J PATHOL, V217, P318, DOI 10.1002/path.2469; Claes L, 2012, NAT REV RHEUMATOL, V8, P133, DOI 10.1038/nrrheum.2012.1; Colnot C, 2009, J BONE MINER RES, V24, P274, DOI 10.1359/JBMR.081003; Dimitriou R, 2005, INJURY, V36, P1392, DOI 10.1016/j.injury.2005.07.019; Docheva D, 2008, CURR RHEUMATOL REV, V4, P155, DOI 10.2174/157339708785133479; Glass GE, 2011, P NATL ACAD SCI USA, V108, P1585, DOI 10.1073/pnas.1018501108; Granero-Molto F, 2009, STEM CELLS, V27, P1887, DOI 10.1002/stem.103; Griffin M, 2011, J BONE JOINT SURG BR, V93B, P427, DOI 10.1302/0301-620X.93B4.25249; Hernigou P, 2005, J BONE JOINT SURG BR, V87B, P896, DOI 10.1302/0301-620X.87B7.16289; Ito H, 1999, BIOCHEM BIOPH RES CO, V262, P443, DOI 10.1006/bbrc.1999.1197; Ito H, 2005, NAT MED, V11, P291, DOI 10.1038/nm1190; Ito H, 2011, MOD RHEUMATOL, V21, P113, DOI 10.1007/s10165-010-0357-8; Jones E, 2011, INJURY, V42, P562, DOI 10.1016/j.injury.2011.03.030; Khosla S, 2010, STEM CELLS, V28, P2124, DOI 10.1002/stem.546; Kitaori T, 2009, ARTHRITIS RHEUM-US, V60, P813, DOI 10.1002/art.24330; Kumar S, 2010, MOL THER, V18, P1026, DOI 10.1038/mt.2009.315; Lange J, 2010, J ORTHOP RES, V28, P778, DOI 10.1002/jor.21061; Lu HY, 2011, FASEB J, V25, P358, DOI 10.1096/fj.10-171579; Mountziaris PM, 2008, TISSUE ENG PART B-RE, V14, P179, DOI 10.1089/ten.teb.2008.0038; Murao H, 2013, J BONE MINER METAB, V31, P390, DOI 10.1007/s00774-013-0429-x; Murata K, 2014, J BONE MINER RES, V29, P316, DOI 10.1002/jbmr.2040; Murata K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037163; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Sasaki M, 2008, J IMMUNOL, V180, P2581, DOI 10.4049/jimmunol.180.4.2581; Schenk S, 2007, STEM CELLS, V25, P245, DOI 10.1634/stemcells.2006-0293; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Shireman PK, 2006, J SURG RES, V134, P145, DOI 10.1016/j.jss.2005.12.003; Shirernan PK, 2007, J LEUKOCYTE BIOL, V81, P775, DOI 10.1189/jlb.0506356; Si Y, 2010, J CLIN INVEST, V120, P1192, DOI 10.1172/JCI40310; Tsou C, 2007, J CLIN INVEST, V117, P2; Tsuboi M, 2007, J BONE JOINT SURG BR, V89B, P461, DOI [10.1302/0301-620X.89B4.18552, 10.1302/0301-620X.89B4]; Utvag SE, 1996, J ORTHOP TRAUMA, V10, P279, DOI 10.1097/00005131-199605000-00009; Van Linthout S, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/757154; Vortkamp A, 1998, MECH DEVELOP, V71, P65, DOI 10.1016/S0925-4773(97)00203-7; Xing ZQ, 2010, DIS MODEL MECH, V3, P451, DOI 10.1242/dmm.003186; Zhang F, 2009, J BIOL CHEM, V284, P17564, DOI 10.1074/jbc.M109.013987	40	48	48	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e104954	10.1371/journal.pone.0104954	http://dx.doi.org/10.1371/journal.pone.0104954			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133509	Green Submitted, Green Published, gold			2022-12-25	WOS:000341302700054
J	Kim, JW; Seung, H; Kwon, KJ; Ko, MJ; Lee, EJ; Oh, HA; Choi, CS; Kim, KC; Gonzales, EL; You, JS; Choi, DH; Lee, J; Han, SH; Yang, SM; Cheong, JH; Shin, CY; Bahn, GH				Kim, Ji-Woon; Seung, Hana; Kwon, Kyung Ja; Ko, Mee Jung; Lee, Eun Joo; Oh, Hyun Ah; Choi, Chang Soon; Kim, Ki Chan; Gonzales, Edson Luck; You, Jueng Soo; Choi, Dong-Hee; Lee, Jongmin; Han, Seol-Heui; Yang, Sung Min; Cheong, Jae Hoon; Shin, Chan Young; Bahn, Geon Ho			Subchronic Treatment of Donepezil Rescues Impaired Social, Hyperactive, and Stereotypic Behavior in Valproic Acid-Induced Animal Model of Autism	PLOS ONE			English	Article							BTBR-T+TF/J MICE; MOUSE MODEL; SPECTRUM DISORDERS; ALZHEIMERS-DISEASE; NICOTINIC RECEPTORS; TRANSGENIC MICE; RATS; ACETYLCHOLINE; DEFICITS; MEMORY	Autism spectrum disorder (ASD) is a group of pervasive developmental disorders with core symptoms such as sociability deficit, language impairment, and repetitive/restricted behaviors. Although worldwide prevalence of ASD has been increased continuously, therapeutic agents to ameliorate the core symptoms especially social deficits, are very limited. In this study, we investigated therapeutic potential of donepezil for ASD using valproic acid-induced autistic animal model (VPA animal model). We found that prenatal exposure of valproic acid (VPA) induced dysregulation of cholinergic neuronal development, most notably the up-regulation of acetylcholinesterase (AChE) in the prefrontal cortex of affected rat and mouse offspring. Similarly, differentiating cortical neural progenitor cell in culture treated with VPA showed increased expression of AChE in vitro. Chromatin precipitation experiments revealed that acetylation of histone H3 bound to AChE promoter region was increased by VPA. In addition, other histone deacetyalse inhibitors (HDACIs) such as trichostatin A and sodium butyrate also increased the expression of AChE in differentiating neural progenitor cells suggesting the essential role of HDACIs in the regulation of AChE expression. For behavioral analysis, we injected PBS or donepezil (0.3 mg/kg) intraperitoneally to control and VPA mice once daily from postnatal day 14 all throughout the experiment. Subchronic treatment of donepezil improved sociability and prevented repetitive behavior and hyperactivity of VPA-treated mice offspring. Taken together, these results provide evidence that dysregulation of ACh system represented by the up-regulation of AChE may serve as an effective pharmacological therapeutic target against autistic behaviors in VPA animal model of ASD, which should be subjected for further investigation to verify the clinical relevance.	[Kim, Ji-Woon; Seung, Hana; Ko, Mee Jung; Lee, Eun Joo; Oh, Hyun Ah; Choi, Chang Soon; Kim, Ki Chan; Gonzales, Edson Luck; You, Jueng Soo; Choi, Dong-Hee; Lee, Jongmin; Han, Seol-Heui; Yang, Sung Min; Shin, Chan Young] Konkuk Univ, Sch Med, Dept Neurosci, Seoul, South Korea; [Kwon, Kyung Ja] Konkuk Univ, Ctr Res Neurosci, Inst Biomed Sci & Technol, Seoul, South Korea; [Cheong, Jae Hoon] Sahmyook Univ, Coll Pharm, Dept Pharmacol, Seoul, South Korea; [Bahn, Geon Ho] Kyung Hee Univ, Sch Med, Dept Neuropsychiat, Seoul, South Korea	Konkuk University; Konkuk University Medical Center; Konkuk University; Sahmyook University; Kyung Hee University	Shin, CY (corresponding author), Konkuk Univ, Sch Med, Dept Neurosci, Seoul, South Korea.	chanyshin@kku.ac.k; mompeian@khu.ac.kr	Bahn, Geon Ho/Q-4424-2019; bahn, geon ho/AAT-3577-2021; Kim, Ji-Woon/GXV-6752-2022	bahn, geon ho/0000-0002-3550-0422; Lee, Jongmin/0000-0001-8718-0099; Kim, Ki Chan/0000-0002-4899-1929; Kim, Ji-Woon/0000-0003-3890-0592; Ko, Mee Jung/0000-0003-0169-1387	Korean Health Technology R&D Project, Ministry of health & welfare, Republic of Korea [A120029]	Korean Health Technology R&D Project, Ministry of health & welfare, Republic of Korea	This work was supported by a grant of the Korean Health Technology R&D Project, Ministry of health & welfare, Republic of Korea (No. A120029). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes CA, 2000, NEUROSCIENCE, V99, P17, DOI 10.1016/S0306-4522(00)00180-9; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; Bohnen NI, 2011, BEHAV BRAIN RES, V221, P564, DOI 10.1016/j.bbr.2009.12.048; Chez MG, 2004, J CHILD NEUROL, V19, P165; Chilian B, 2013, CLIN GENET; CLAYTONSMITH J, 1995, J MED GENET, V32, P724, DOI 10.1136/jmg.32.9.724; Cohen O, 2002, MOL PSYCHIATR, V7, P874, DOI 10.1038/sj.mp.4001103; Cutuli D, 2009, J ALZHEIMERS DIS, V17, P161, DOI 10.3233/JAD-2009-1040; de la Monte SM, 2006, J ALZHEIMERS DIS, V10, P89; Deacon R, 2012, JOVE-J VIS EXP, DOI 10.3791/2607; Deacon RMJ, 2006, NAT PROTOC, V1, P122, DOI 10.1038/nprot.2006.20; Delorme R, 2013, NAT MED, V19, P685, DOI 10.1038/nm.3193; Erb C, 2001, J NEUROCHEM, V77, P638, DOI 10.1046/j.1471-4159.2001.00287.x; Francis PT, 1999, J NEUROL NEUROSUR PS, V66, P137, DOI 10.1136/jnnp.66.2.137; Friedman SD, 2006, ARCH GEN PSYCHIAT, V63, P786, DOI 10.1001/archpsyc.63.7.786; Ghosh A, 2013, NAT REV DRUG DISCOV, V12, P777, DOI 10.1038/nrd4102; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Hardan AY, 2002, J CHILD ADOL PSYCHOP, V12, P237, DOI 10.1089/104454602760386923; Hertzman M, 2003, INT J PSYCHIAT MED, V33, P395, DOI 10.2190/JE5Q-1NFT-FL40-7PMW; Holmes A, 2002, J MOL NEUROSCI, V18, P151, DOI 10.1385/JMN:18:1-2:151; Huguet G, 2013, ANNU REV GENOM HUM G, V14, P191, DOI 10.1146/annurev-genom-091212-153431; Iwasaki E, 2012, DIGEST DIS SCI, V57, P858, DOI 10.1007/s10620-011-1953-y; Karvat G, 2014, NEUROPSYCHOPHARMACOL, V39, P831, DOI 10.1038/npp.2013.274; Kim KC, 2014, MOL NEUROBIOL, V49, P512, DOI 10.1007/s12035-013-8535-2; Kim KC, 2011, TOXICOL LETT, V201, P137, DOI 10.1016/j.toxlet.2010.12.018; Lee M, 2002, BRAIN, V125, P1483, DOI 10.1093/brain/awf160; LINDHOUT D, 1992, EPILEPSIA, V33, pS41; LINDHOUT D, 1986, LANCET, V1, P1392; Markram H, 2007, FRONT NEUROSCI-SWITZ, V1, P77, DOI 10.3389/neuro.01.1.1.006.2007; Markram K, 2008, NEUROPSYCHOPHARMACOL, V33, P901, DOI 10.1038/sj.npp.1301453; Martin-Ruiz CM, 2004, MOL BRAIN RES, V123, P81, DOI 10.1016/j.molbrainres.2004.01.003; McFarlane HG, 2008, GENES BRAIN BEHAV, V7, P152, DOI 10.1111/j.1601-183X.2007.00330.x; McTighe SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062189; Mikhail FM, 2011, AM J MED GENET A, V155A, P2386, DOI 10.1002/ajmg.a.34177; Moriguchi S, 2005, J PHARMACOL EXP THER, V315, P125, DOI 10.1124/jpet.105.087908; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Nicolson R, 2006, J CHILD ADOL PSYCHOP, V16, P621, DOI 10.1089/cap.2006.16.621; Penagarikano O, 2011, CELL, V147, P235, DOI 10.1016/j.cell.2011.08.040; Perry EK, 2001, AM J PSYCHIAT, V158, P1058, DOI 10.1176/appi.ajp.158.7.1058; Petersen AK, 2013, EUR J MED GENET, V56, P118, DOI 10.1016/j.ejmg.2012.11.003; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; Picciotto MR, 2012, NEURON, V76, P116, DOI 10.1016/j.neuron.2012.08.036; Politte L. C., 2013, PSYCHOPHARMACOLOGY B; Ray MA, 2005, NEUROBIOL DIS, V19, P366, DOI 10.1016/j.nbd.2005.01.017; Riedel G, 2009, BEHAV BRAIN RES, V204, P217, DOI 10.1016/j.bbr.2009.06.012; Rinaldi T, 2007, P NATL ACAD SCI USA, V104, P13501, DOI 10.1073/pnas.0704391104; Romberg C, 2011, J NEUROSCI, V31, P3500, DOI 10.1523/JNEUROSCI.5242-10.2011; Sailaja BS, 2012, P NATL ACAD SCI USA, V109, pE3687, DOI 10.1073/pnas.1209990110; Sarter M, 2004, NEUROBIOL AGING, V25, P1127, DOI 10.1016/j.neurobiolaging.2003.11.011; Sarter M, 2012, NEUROPHARMACOLOGY, V62, P1544, DOI 10.1016/j.neuropharm.2010.12.001; Sarter M, 2011, BEHAV NEUROSCI, V125, P825, DOI 10.1037/a0026227; Scattoni ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003067; Schneider T, 2005, NEUROPSYCHOPHARMACOL, V30, P80, DOI 10.1038/sj.npp.1300518; Shen H, 2010, BRIT J PHARMACOL, V161, P127, DOI 10.1111/j.1476-5381.2010.00894.x; Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851; Silverman JL, 2010, NEUROPSYCHOPHARMACOL, V35, P976, DOI 10.1038/npp.2009.201; Silverman JL, 2013, DRUG DISCOV TODAY; Sokol DK, 2002, J CHILD NEUROL, V17, P245, DOI 10.1177/088307380201700401; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Thomas A, 2009, PSYCHOPHARMACOLOGY, V204, P361, DOI 10.1007/s00213-009-1466-y; Ueno K, 2002, BEHAV PHARMACOL, V13, P1, DOI 10.1097/00008877-200202000-00001; Williams G, 2001, DEV MED CHILD NEUROL, V43, P202, DOI 10.1017/S001216220100038X; Won H, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00019; Yang M, 2007, INT J DEV NEUROSCI, V25, P515, DOI 10.1016/j.ijdevneu.2007.09.008; Yang YL, 2009, PSYCHIAT RES-NEUROIM, V174, P81, DOI 10.1016/j.pscychresns.2009.03.012; Yuan E, 2012, HUM MOL GENET, V21, P4286, DOI 10.1093/hmg/dds262	67	67	71	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e104927	10.1371/journal.pone.0104927	http://dx.doi.org/10.1371/journal.pone.0104927			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133713	gold, Green Submitted, Green Published			2022-12-25	WOS:000341302700051
J	Schaefer, ST; Gessner, S; Scherag, A; Rump, K; Frey, UH; Siffert, W; Westendorf, AM; Steinmann, J; Peters, J; Adamzik, M				Schaefer, Simon T.; Gessner, Sophia; Scherag, Andre; Rump, Katharina; Frey, Ulrich H.; Siffert, Winfried; Westendorf, Astrid M.; Steinmann, Joerg; Peters, Juergen; Adamzik, Michael			Hydrocortisone Fails to Abolish NF-kappa B1 Protein Nuclear Translocation in Deletion Allele Carriers of the NFKB1 Promoter Polymorphism (-94ins/delATTG) and Is Associated with Increased 30-Day Mortality in Septic Shock	PLOS ONE			English	Article							NEGATIVE REGULATION; ORGAN FAILURE; SEPSIS; SCORE; GUIDELINES; MONOCYTES; THERAPY	Background: Previous investigations and meta-analyses on the effect of glucocorticoids on mortality in septic shock revealed mixed results. This heterogeneity might be evoked by genetic variations. Such candidate is a promoter polymorphism (-94ins/delATTG) of the gene encoding the ubiquitous transcription-factor nuclear-factor-kappa B (NF-kappa B) which binds to recognition elements in the promoter of several genes encoding for the innate immune-system. In turn, hydrocortisone inhibits NF-kappa B nuclear translocation and thus transcription of key immune-response regulators. Accordingly, we tested the hypotheses that hydrocortisone has a NFKB1 genotype dependent effect on 1) NF-kappa B1 nuclear translocation evoked by lipopolysaccharide (LPS) in monocytes in vitro, and 2) mortality in septic shock. Methods: Monocytes of volunteers with the homozygous insertion (II; n = 5) or deletion (DD; n = 6) NFKB1 genotype were incubated with 10 mu gml(-1) LPS +/- hydrocortisone (10(-5) M), and NF-kappa B1 nuclear translocation was assessed (immunofluorescence). Furthermore, we analyzed 30-day-mortality in 160 patients with septic shock stratified for both genotype and hydrocortisone therapy. Results: Hydrocortisone inhibited LPS induced nuclear translocation of NF-kappa B1 in II (25% +/- 11; p = 0.0001) but not in DD genotypes (51% +/- 15; p = n.s.). Onehundredandfour of 160 patients with septic shock received hydrocortisone, at the discretion of the intensivist. NFKB1 deletion allele carriers (ID/DD) receiving hydrocortisone had a much greater 30-day-mortality (57.6%) than II genotypes (24.4%; HR:3.18, 95%-CI:1.61-6.28; p = 0.001). In contrast, 30-day mortality was 22.2% in ID/DD and 25.0% in II genotypes without hydrocortisone therapy. Results were similar when using propensity score matching to account for possible bias in the intensivists' decision to administer hydrocortisone. Conclusion: Hydrocortisone fails to inhibit LPS induced nuclear NF-kappa B1 translocation in deletion allele carriers of the NFKB1 promoter polymorphism (-94ins/delATTG). In septic shock, hydrocortisone treatment is associated with markedly increased 30-day-mortality only in such carriers. Accordingly, previous heterogeneous results regarding the benefit of hydrocortisone in septic shock may be reconciled by genetic variation of the NFKB1 promoter polymorphism.	[Schaefer, Simon T.; Gessner, Sophia; Rump, Katharina; Frey, Ulrich H.; Peters, Juergen; Adamzik, Michael] Univ Duisburg Essen, Klin Anasthesiol & Intens Med, Essen, Germany; [Schaefer, Simon T.; Gessner, Sophia; Rump, Katharina; Frey, Ulrich H.; Peters, Juergen; Adamzik, Michael] Univ Klinikum Essen, Essen, Germany; [Scherag, Andre] Univ Klinikum Jena, Klin Epidemiol, Integriertes Forschungs & Behandlungszent IFB, Sepsis & Sepsisfolgen Ctr Sepsis Control & Care C, Jena, Germany; [Rump, Katharina; Adamzik, Michael] Univ Duisburg Essen, Essen, Germany; [Rump, Katharina; Siffert, Winfried; Adamzik, Michael] Univ Klinikum Essen, Essen, Germany; [Rump, Katharina; Adamzik, Michael] Knappschaftskrankenhaus Bochum, Klin Anasthesiol & Intensivmed, Bochum, Germany; [Rump, Katharina; Adamzik, Michael] Ruhr Univ Bochum, Bochum, Germany; [Siffert, Winfried] Univ Duisburg Essen, Inst Pharmakogenet, Essen, Germany; [Westendorf, Astrid M.; Steinmann, Joerg] Inst Med Mikrobiol, Zurich, Switzerland	University of Duisburg Essen; University of Duisburg Essen; Friedrich Schiller University of Jena; University of Duisburg Essen; University of Duisburg Essen; Ruhr University Bochum; Ruhr University Bochum; University of Duisburg Essen	Schaefer, ST (corresponding author), Univ Duisburg Essen, Klin Anasthesiol & Intens Med, Essen, Germany.	simon.schaefer@uk-essen.de	Rump, Katharina/AAJ-9090-2020; Adamzik, Michael/HGE-9286-2022; Schaefer, Simon Thomas/AAA-8869-2021; Westendorf, Astrid M./AAX-1937-2020; Frey, Ulrich H/C-2752-2019	Rump, Katharina/0000-0003-2220-519X; Schaefer, Simon Thomas/0000-0001-7289-6000; Scherag, Andre/0000-0002-9406-4704; Frey, Ulrich/0000-0003-2961-6629	Federal Ministry of Education and Research (BMBF), Germany [FKZ: 01EO1002]; IFORES Research Grant of the medical faculty of the University Duisburg-Essen [D/D107-40240]	Federal Ministry of Education and Research (BMBF), Germany(Federal Ministry of Education & Research (BMBF)); IFORES Research Grant of the medical faculty of the University Duisburg-Essen	A. S. was supported by the Federal Ministry of Education and Research (BMBF), Germany, FKZ: 01EO1002. S. S. was supported by an IFORES Research Grant of the medical faculty of the University Duisburg-Essen (No.: D/D107-40240). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamzik M, 2008, BASIC RES CARDIOL, V103, P598, DOI 10.1007/s00395-008-0750-z; Adamzik M, 2007, INTENS CARE MED, V33, P1199, DOI 10.1007/s00134-007-0649-4; Adamzik M, 2013, ANESTHESIOLOGY, V118, P123, DOI 10.1097/ALN.0b013e318277a652; Aegerter P, 2005, INTENS CARE MED, V31, P416, DOI 10.1007/s00134-005-2557-9; AKERBLOM IE, 1988, SCIENCE, V241, P350, DOI 10.1126/science.2838908; Annane D, 2002, JAMA-J AM MED ASSOC, V288, P862, DOI 10.1001/jama.288.7.862; [Anonymous], 2010, SER EV SOFA SCOR PRE, P1; Austin PC, 2014, STAT MED, V33, P1242, DOI 10.1002/sim.5984; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; Berchner-Pfannschmidt U, 2007, J BIOL CHEM, V282, P1788, DOI 10.1074/jbc.M607065200; Billing AM, 2011, INNATE IMMUN-LONDON, V17, P302, DOI 10.1177/1753425910369269; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Bota DP, 2002, INTENS CARE MED, V28, P1619, DOI 10.1007/s00134-002-1491-3; Casserly B, 2012, INTENS CARE MED, V38, P1946, DOI 10.1007/s00134-012-2720-z; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Engel C, 2007, INTENS CARE MED, V33, P606, DOI 10.1007/s00134-006-0517-7; Karban AS, 2004, HUM MOL GENET, V13, P35, DOI 10.1093/hmg/ddh008; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Luca F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061654; Matot I, 2001, INTENS CARE MED, V27, pS3, DOI 10.1007/PL00003795; Minne L, 2008, CRIT CARE, V12, DOI 10.1186/cc7160; Ovstebo R, 2008, INFECT IMMUN, V76, P2685, DOI 10.1128/IAI.01625-07; Pekalski J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078887; Shiramizo SCPL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026790; Schafer ST, 2013, ANESTHESIOLOGY, V118, P1426, DOI 10.1097/ALN.0b013e31828baa67; Sprung CL, 2008, NEW ENGL J MED, V358, P111, DOI 10.1056/NEJMoa071366; UNLAP T, 1995, MOL BRAIN RES, V28, P193, DOI 10.1016/0169-328X(94)00202-P; Wang CS, 2014, ANESTH ANALG, V118, P346, DOI 10.1213/ANE.0000000000000050; Xiao WZ, 2011, J EXP MED, V208, P2581, DOI 10.1084/jem.20111354	30	38	39	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e104953	10.1371/journal.pone.0104953	http://dx.doi.org/10.1371/journal.pone.0104953			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133403	Green Published, gold, Green Submitted			2022-12-25	WOS:000341302700053
J	Ackaert, C; Kofler, S; Horejs-Hoeck, J; Zulehner, N; Asam, C; von Grafenstein, S; Fuchs, JE; Briza, P; Liedl, KR; Bohle, B; Ferreira, F; Brandstetter, H; Oostingh, GJ; Duschl, A				Ackaert, Chloe; Kofler, Stefan; Horejs-Hoeck, Jutta; Zulehner, Nora; Asam, Claudia; von Grafenstein, Susanne; Fuchs, Julian E.; Briza, Peter; Liedl, Klaus R.; Bohle, Barbara; Ferreira, Fatima; Brandstetter, Hans; Oostingh, Gertie J.; Duschl, Albert			The Impact of Nitration on the Structure and Immunogenicity of the Major Birch Pollen Allergen Bet v 1.0101	PLOS ONE			English	Article							AIR-POLLUTION; PROTEIN STRUCTURES; ASTHMA; IGE; RECOGNITION; REACTIVITY; PARAMETERS; RESPONSES; BET-V-1; ANTIGEN	Allergy prevalence has increased in industrialized countries. One contributing factor could be pollution, which can cause nitration of allergens exogenously (in the air) or endogenously (in inflamed lung tissue). We investigated the impact of nitration on both the structural and immunological behavior of the major birch pollen allergen Bet v 1.0101 to determine whether nitration might be a factor in the increased incidence of allergy. Bet v 1.0101 was nitrated with tetranitromethane. Immune effects were assessed by measuring the proliferation of specific T-cell lines (TCLs) upon stimulation with different concentrations of nitrated and unmodified allergen, and by measurement of cytokine release of monocyte-derived dendritic cells (moDCs) and primary DCs (primDCs) stimulated with nitrated versus unmodified allergen. HPLC-MS, crystallography, gel electrophoresis, amino acid analysis, size exclusion chromatography and molecular dynamics simulation were performed to characterize structural changes after nitration of the allergen. The proliferation of specific TCLs was higher upon stimulation with the nitrated allergen in comparison to the unmodified allergen. An important structural consequence of nitration was oligomerization. Moreover, analysis of the crystal structure of nitrated Bet v 1.0101 showed that amino acid residue Y83, located in the hydrophobic cavity, was nitrated to 100%. Both moDCs and primDCs showed decreased production of T(H)1-priming cytokines, thus favoring a T(H)2 response. These results implicate that nitration of Bet v 1.0101 might be a contributing factor to the observed increase in birch pollen allergy, and emphasize the importance of protein modifications in understanding the molecular basis of allergenicity.	[Ackaert, Chloe; Kofler, Stefan; Horejs-Hoeck, Jutta; Briza, Peter; Brandstetter, Hans; Oostingh, Gertie J.; Duschl, Albert] Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria; [Zulehner, Nora; Bohle, Barbara] Med Univ Vienna, Dept Pathophysiol & Allergy Res, Vienna, Austria; [Zulehner, Nora; Bohle, Barbara] Med Univ Vienna, Christian Doppler Lab Immunomodulat, Vienna, Austria; [Asam, Claudia; Ferreira, Fatima] Salzburg Univ, Dept Mol Biol, Christian Doppler Lab Allergy Diag & Therapy, A-5020 Salzburg, Austria; [von Grafenstein, Susanne; Fuchs, Julian E.; Liedl, Klaus R.] Univ Innsbruck, Inst Gen Inorgan & Theoret Chem Theoret Chem, A-6020 Innsbruck, Austria; [von Grafenstein, Susanne; Fuchs, Julian E.; Liedl, Klaus R.] Univ Innsbruck, Ctr Mol Biosci Innsbruck, A-6020 Innsbruck, Austria	Salzburg University; Medical University of Vienna; Medical University of Vienna; Salzburg University; University of Innsbruck; University of Innsbruck	Duschl, A (corresponding author), Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria.	albert.duschl@sbg.ac.at	Horejs-Hoeck, Jutta/AAF-1735-2019; Liedl, Klaus/ABB-4725-2021; Brandstetter, Hans/E-6754-2011; Ferreira, Fatima/AAB-4321-2019; Horejs-Hoeck, Jutta/E-5010-2011; Liedl, Klaus R/F-3099-2015; Briza, Peter/D-7309-2012; Oostingh, Gertie Janneke/HHC-1098-2022; Ferreira, Fatima/E-4889-2011; Duschl, Albert/E-5872-2011	Horejs-Hoeck, Jutta/0000-0002-0984-204X; Liedl, Klaus/0000-0002-0985-2299; Brandstetter, Hans/0000-0002-6089-3045; Ferreira, Fatima/0000-0003-0989-2335; Horejs-Hoeck, Jutta/0000-0002-0984-204X; Liedl, Klaus R/0000-0002-0985-2299; Briza, Peter/0000-0002-4941-6782; Ferreira, Fatima/0000-0003-0989-2335; Duschl, Albert/0000-0002-7034-9860; Bohle, Barbara/0000-0002-5105-7985; Oostingh, Gertie Janneke/0000-0001-5083-217X	Austrian Science Fund; Austrian Academy of Sciences at University of Innsbruck;  [P22236_B13]; Austrian Science Fund (FWF) [P 22236] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Academy of Sciences at University of Innsbruck; ; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was funded by the Austrian Science Fund. The grant number is P22236_B13 and the URL is http://www.fwf.ac.at. JEF is a recipient of a DOC fellowship of the Austrian Academy of Sciences at University of Innsbruck. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez B, 2003, AMINO ACIDS, V25, P295, DOI 10.1007/s00726-003-0018-8; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bergfors T, 2003, J STRUCT BIOL, V142, P66, DOI 10.1016/S1047-8477(03)00039-X; Bernstein JA, 2004, J ALLERGY CLIN IMMUN, V114, P1116, DOI 10.1016/j.jaci.2004.08.030; Case D., 2010, AMBER11 AMBERTOOLS V; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; D'Amato G, 2010, J INVEST ALLERG CLIN, V20, P95; Delamarre L, 2006, J EXP MED, V203, P2049, DOI 10.1084/jem.20052442; DeLano WL, 2005, DRUG DISCOV TODAY, V10, P213, DOI 10.1016/S1359-6446(04)03363-X; Egger M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017278; Eiwegger T, 2008, CLIN EXP ALLERGY, V38, P1627, DOI 10.1111/j.1365-2222.2008.03080.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Franze T, 2005, ENVIRON SCI TECHNOL, V39, P1673, DOI 10.1021/es0488737; Franze T, 2003, ANALYST, V128, P824, DOI 10.1039/b303132b; Ghosh S, 2006, J IMMUNOL, V176, P5587, DOI 10.4049/jimmunol.176.9.5587; Ghosh S, 2011, BBA-GEN SUBJECTS, V1810, P1008, DOI 10.1016/j.bbagen.2011.06.009; Gruijthuijsen YK, 2006, INT ARCH ALLERGY IMM, V141, P265, DOI 10.1159/000095296; HoffmannSommergruber K, 1997, PROTEIN EXPRES PURIF, V9, P33, DOI 10.1006/prep.1996.0671; Holgate ST, 1999, NATURE, V402, pB2, DOI 10.1038/35037000; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Ilyinskii PO, 2008, VACCINE, V26, P3223, DOI 10.1016/j.vaccine.2008.03.078; Jahn-Schmid B, 2005, J ALLERGY CLIN IMMUN, V116, P213, DOI 10.1016/j.jaci.2005.04.019; JAROLIM E, 1989, ALLERGY, V44, P385, DOI 10.1111/j.1398-9995.1989.tb04169.x; Karle AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031483; Kiese S, 2008, J PHARM SCI-US, V97, P4347, DOI 10.1002/jps.21328; Kofler S, 2014, J BIOL CHEM, V289, P540, DOI 10.1074/jbc.M113.518795; Koide S, 2009, ACS CHEM BIOL, V4, P325, DOI 10.1021/cb800314v; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Mahler HC, 2009, J PHARM SCI-US, V98, P2909, DOI 10.1002/jps.21566; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Myung Y, 2010, B KOREAN CHEM SOC, V31, P2581, DOI 10.5012/bkcs.2010.31.9.2581; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; Radi R, 2013, ACCOUNTS CHEM RES, V46, P550, DOI 10.1021/ar300234c; Ring J, 2001, CURR OPIN IMMUNOL, V13, P701, DOI 10.1016/S0952-7915(01)00282-5; RIORDAN JF, 1967, BIOCHEMISTRY-US, V6, P358, DOI 10.1021/bi00853a053; Rosenberg AS, 2006, AAPS J, V8, pE501, DOI 10.1208/aapsj080359; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Saxon A, 2005, NAT IMMUNOL, V6, P223, DOI 10.1038/ni0305-223; Scholl I, 2005, J IMMUNOL, V175, P6645, DOI 10.4049/jimmunol.175.10.6645; Shiraiwa M, 2012, ENVIRON SCI TECHNOL, V46, P6630, DOI 10.1021/es300677a; Vrtala S, 2001, FASEB J; Wallnoefer HG, 2010, J AM CHEM SOC, V132, P10330, DOI 10.1021/ja909908y; Weichenberger CX, 2007, NUCLEIC ACIDS RES, V35, pW403, DOI 10.1093/nar/gkm263; Zaborsky N, 2010, J IMMUNOL, V184, P725, DOI 10.4049/jimmunol.0902080	46	48	48	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104520	10.1371/journal.pone.0104520	http://dx.doi.org/10.1371/journal.pone.0104520			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126882	Green Published, gold, Green Submitted			2022-12-25	WOS:000340879300032
J	Camero, S; Benitez, MJ; Cuadros, R; Hernandez, F; Avila, J; Jimenez, JS				Camero, Sergio; Benitez, Maria J.; Cuadros, Raquel; Hernandez, Felix; Avila, Jesus; Jimenez, Juan S.			Thermodynamics of the Interaction between Alzheimer's Disease Related Tau Protein and DNA	PLOS ONE			English	Article							SURFACE-PLASMON RESONANCE; CYCLE-DEPENDENT PHOSPHORYLATION; NUCLEAR TAU; MICROTUBULE-BINDING; IN-VITRO; AGGREGATION; CELLS; HYPERPHOSPHORYLATION; MECHANISM; ISOFORMS	Tau hyperphosphorylation can be considered as one of the hallmarks of Alzheimer's disease and other tauophaties. Besides its well-known role as a microtubule associated protein, Tau displays a key function as a protector of genomic integrity in stress situations. Phosphorylation has been proven to regulate multiple processes including nuclear translocation of Tau. In this contribution, we are addressing the physicochemical nature of DNA-Tau interaction including the plausible influence of phosphorylation. By means of surface plasmon resonance (SPR) we measured the equilibrium constant and the free energy, enthalpy and entropy changes associated to the Tau-DNA complex formation. Our results show that unphosphorylated Tau binding to DNA is reversible. This fact is in agreement with the protective role attributed to nuclear Tau, which stops binding to DNA once the insult is over. According to our thermodynamic data, oscillations in the concentration of dephosphorylated Tau available to DNA must be the variable determining the extent of Tau binding and DNA protection. In addition, thermodynamics of the interaction suggest that hydrophobicity must represent an important contribution to the stability of the Tau-DNA complex. SPR results together with those from Tau expression in HEK cells show that phosphorylation induces changes in Tau protein which prevent it from binding to DNA. The phosphorylation-dependent regulation of DNA binding is analogous to the Tau-microtubules binding inhibition induced by phosphorylation. Our results suggest that hydrophobicity may control Tau location and DNA interaction and that impairment of this Tau-DNA interaction, due to Tau hyperphosphorylation, could contribute to Alzheimer's pathogenesis.	[Camero, Sergio; Benitez, Maria J.; Jimenez, Juan S.] Univ Autonoma Madrid, Dept Quim Fis Aplicada, E-28049 Madrid, Spain; [Camero, Sergio; Benitez, Maria J.; Cuadros, Raquel; Hernandez, Felix; Avila, Jesus] Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain; Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain	Autonomous University of Madrid; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); CIBERNED	Jimenez, JS (corresponding author), Univ Autonoma Madrid, Dept Quim Fis Aplicada, E-28049 Madrid, Spain.	juans.jimenez@uam.es	Benitez, María José/G-4404-2015; Avila, Jesus/I-2610-2015; Hernandez, Felix/L-2114-2015; Benitez Moreno, Maria Jose/ABE-8245-2021	Benitez, María José/0000-0002-6034-8557; Avila, Jesus/0000-0002-6288-0571; Hernandez, Felix/0000-0001-8753-8249; Benitez Moreno, Maria Jose/0000-0002-6034-8557; Cuadros Catalan, Raquel/0000-0001-6962-1110; Jimenez Martinez, Juan Salvador/0000-0001-5454-7827; Camero Gigante, Sergio/0000-0001-5283-6510	Spanish Government [SAF2006-02424, P2009/TIC-1476]; Comunidad de Madrid	Spanish Government(Spanish GovernmentEuropean Commission); Comunidad de Madrid(Comunidad de Madrid)	Financial support has been provided by grants SAF2006-02424 and P2009/TIC-1476 from the Spanish Government and Comunidad de Madrid. Sergio Camero belonged to CIBERNED (Centro de Investigacion Biomedica en Red de Enfermedades Neurodegenerativas) while writing this contribution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackmann M, 2000, J BIOL CHEM, V275, P30335, DOI 10.1074/jbc.M002590200; ALONSO AD, 1994, P NATL ACAD SCI USA, V91, P5562, DOI 10.1073/pnas.91.12.5562; Alonso AD, 2001, P NATL ACAD SCI USA, V98, P6923, DOI 10.1073/pnas.121119298; Avila J, 2006, FEBS LETT, V580, P2922, DOI 10.1016/j.febslet.2006.02.067; Avila Jesus, 2012, Int J Alzheimers Dis, V2012, P578373, DOI 10.1155/2012/578373; Barrantes A, 2007, J ALZHEIMERS DIS, V12, P345; Barrantes A, 2012, CURR ALZHEIMER RES, V9, P924, DOI 10.2174/156720512803251101; Benitez MJ, 2002, ANAL BIOCHEM, V302, P161, DOI 10.1006/abio.2001.5547; Bergen M, 2000, PROC NATL ACAD; Biernat J, 1999, MOL BIOL CELL, V10, P727, DOI 10.1091/mbc.10.3.727; BRADY RM, 1995, NEUROBIOL AGING, V16, P479; BRANDT R, 1995, J CELL BIOL, V131, P1327, DOI 10.1083/jcb.131.5.1327; Camero S, 2014, J ALZHEIMERS DIS, V39, P649, DOI 10.3233/JAD-131415; CORCES VG, 1980, EUR J BIOCHEM, V105, P7; Cross DC, 2000, J CELL BIOCHEM, V78, P305, DOI 10.1002/(SICI)1097-4644(20000801)78:2<305::AID-JCB12>3.3.CO;2-N; Cuchillo-Ibanez I, 2008, FASEB J, V22, P3186, DOI 10.1096/fj.08-109181; Devred F, 2004, BIOCHEMISTRY-US, V43, P10520, DOI 10.1021/bi0493160; DRECHSEL DN, 1992, MOL BIOL CELL, V3, P1141, DOI 10.1091/mbc.3.10.1141; DRUBIN DG, 1986, J CELL BIOL, V103, P2739, DOI 10.1083/jcb.103.6.2739; Ebneth A, 1998, J CELL BIOL, V143, P777, DOI 10.1083/jcb.143.3.777; Feinstein SC, 2005, BBA-MOL BASIS DIS, V1739, P268, DOI 10.1016/j.bbadis.2004.07.002; Gomez-Ramos A, 2004, BRAIN RES, V1007, P57, DOI 10.1016/j.brainres.2004.01.071; Grundke-Iqbal I, 2006, Bratisl Lek Listy, V107, P359; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; Hao N, 2013, SCIENCE, V339, P460, DOI 10.1126/science.1227299; Hernandez F, 2007, CELL MOL LIFE SCI, V64, P2219, DOI 10.1007/s00018-007-7220-x; Hernandez F, EXPT NEUROLOGY, V223, P322; HIMMLER A, 1989, MOL CELL BIOL, V9, P1381, DOI 10.1128/MCB.9.4.1381; Hua Q, 2003, CELL MOL LIFE SCI, V60, P413, DOI 10.1007/s000180300034; Hua Q, 2003, BBA-PROTEINS PROTEOM, V1645, P205, DOI 10.1016/S1570-9639(02)00538-1; Hua Q, 2002, PROTEIN PEPTIDE LETT, V9, P349, DOI 10.2174/0929866023408652; Illenberger S, 1998, MOL BIOL CELL, V9, P1495, DOI 10.1091/mbc.9.6.1495; Iqbal K, 2010, CURR ALZHEIMER RES, V7, P656, DOI 10.2174/156720510793611592; Jeganathan S, 2008, BIOCHEMISTRY-US, V47, P10526, DOI 10.1021/bi800783d; KRETSCHM.E, 1968, Z NATURFORSCH PT A, VA 23, P2135, DOI 10.1515/zna-1968-1247; Krylova SM, 2005, FEBS LETT, V579, P1371, DOI 10.1016/j.febslet.2005.01.032; Kuret J, 2005, MICROSC RES TECHNIQ, V67, P141, DOI 10.1002/jemt.20187; LAMBERT MP, 1995, NEUROBIOL AGING, V16, P583, DOI 10.1016/0197-4580(95)00042-D; LIEDBERG B, 1983, SENSOR ACTUATOR, V4, P299, DOI 10.1016/0250-6874(83)85036-7; LINDWALL G, 1984, J BIOL CHEM, V259, P2241; LOOMIS PA, 1990, P NATL ACAD SCI USA, V87, P8422, DOI 10.1073/pnas.87.21.8422; Lu Y, 2013, J ALZHEIMERS DIS, V37, P551, DOI 10.3233/JAD-130602; Mandelkow E, 2007, BRAIN PATHOL, V17, P83, DOI 10.1111/j.1750-3639.2007.00053.x; Mandelkow EM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006247; PAPASOZOMENOS SC, 1995, CLIN NEUROPATHOL, V14, P100; PAPASOZOMENOS SC, 1991, P NATL ACAD SCI USA, V88, P4543, DOI 10.1073/pnas.88.10.4543; Perez M, 1996, J NEUROCHEM, V67, P1183; Polyansky AA, 2012, J PHYS CHEM LETT, V3, P973, DOI 10.1021/jz300103p; Pooler AM, 2014, NEUROPHARMACOLOGY, V76, P1, DOI 10.1016/j.neuropharm.2013.09.018; POPE WB, 1994, EXP NEUROL, V126, P185, DOI 10.1006/exnr.1994.1057; PREUSS U, 1995, MOL BIOL CELL, V6, P1397, DOI 10.1091/mbc.6.10.1397; Qu MH, 2004, NEUROREPORT, V15, P2723; Ramachandran G, 2013, BIOCHEMISTRY-US, V52, P4107, DOI 10.1021/bi400209z; Rossi G, 2008, CELL CYCLE, V7, P1788, DOI 10.4161/cc.7.12.6012; Sjoberg MK, 2006, J CELL SCI, V119, P2025, DOI 10.1242/jcs.02907; Spillantini MG, 2013, LANCET NEUROL, V12, P609, DOI 10.1016/S1474-4422(13)70090-5; STENBERG E, 1991, J COLLOID INTERF SCI, V143, P513, DOI 10.1016/0021-9797(91)90284-F; Sultan A, 2011, J BIOL CHEM, V286, P4566, DOI 10.1074/jbc.M110.199976; Tatebayashi Y, 2004, J CELL SCI, V117, P1653, DOI 10.1242/jcs.01018; Thurston VC, 1996, CHROMOSOMA, V105, P20, DOI 10.1007/BF02510035; Thurston VC, 1997, CELL MOTIL CYTOSKEL, V38, P100, DOI 10.1002/(SICI)1097-0169(1997)38:1<100::AID-CM9>3.0.CO;2-C; von Bergen M, 2005, BBA-MOL BASIS DIS, V1739, P158, DOI 10.1016/j.bbadis.2004.09.010; Wang JZ, 2013, J ALZHEIMERS DIS, V33, pS123, DOI 10.3233/JAD-2012-129031; WANG Y, 1993, J CELL BIOL, V121, P257, DOI 10.1083/jcb.121.2.257; Wegmann S, 2010, J BIOL CHEM, V285, P27302, DOI 10.1074/jbc.M110.145318; Wei Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002600	67	29	29	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104690	10.1371/journal.pone.0104690	http://dx.doi.org/10.1371/journal.pone.0104690			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126942	Green Published, gold			2022-12-25	WOS:000340879300041
J	De Sarkar, N; Roy, R; Mitra, JK; Ghose, S; Chakraborty, A; Paul, RR; Mukhopadhyay, I; Roy, B				De Sarkar, Navonil; Roy, Roshni; Mitra, Jit Kumar; Ghose, Sandip; Chakraborty, Arnab; Paul, Ranjan Rashmi; Mukhopadhyay, Indranil; Roy, Bidyut			A Quest for miRNA Bio-Marker: A Track Back Approach from Gingivo Buccal Cancer to Two Different Types of Precancers	PLOS ONE			English	Article							CELL-PROLIFERATION; MICRORNA; GENE; HEAD; EXPRESSION; DATABASE; TARGETS; PROTEIN; FAMILY; MIR-1	Deregulation of miRNA expression may contribute to tumorigenesis and other patho-physiology associated with cancer. Using TLDA, expression of 762 miRNAs was checked in 18 pairs of gingivo buccal cancer-adjacent control tissues. Expression of significantly deregulated miRNAs was further validated in cancer and examined in two types of precancer (leukoplakia and lichen planus) tissues by primer-specific TaqMan assays. Biological implications of these miRNAs were assessed bioinformatically. Expression of hsa-miR-1293, hsa-miR-31, hsa-miR-31* and hsa-miR-7 were significantly up-regulated and those of hsa-miR-206, hsa-miR-204 and hsa-miR-133a were significantly down-regulated in all cancer samples. Expression of only hsa-miR-31 was significantly up-regulated in leukoplakia but none in lichen planus samples. Analysis of expression heterogeneity divided 18 cancer samples into clusters of 13 and 5 samples and revealed that expression of 30 miRNAs (including the above-mentioned 7 miRNAs), was significantly deregulated in the cluster of 13 samples. From database mining and pathway analysis it was observed that these miRNAs can significantly target many of the genes present in different cancer related pathways such as "proteoglycans in cancer", PI3K-AKT etc. which play important roles in expression of different molecular features of cancer. Expression of hsa-miR-31 was significantly up-regulated in both cancer and leukoplakia tissues and, thus, may be one of the molecular markers of leukoplakia which may progress to gingivo-buccal cancer.	[De Sarkar, Navonil; Roy, Roshni; Mitra, Jit Kumar; Chakraborty, Arnab; Mukhopadhyay, Indranil; Roy, Bidyut] Indian Stat Inst, Human Genet Unit, Kolkata, India; [Ghose, Sandip; Paul, Ranjan Rashmi] Guru Nanak Inst Dent Sci & Res, Dept Oral Pathol, Panihati, Kokata, India	Indian Statistical Institute; Indian Statistical Institute Kolkata	Roy, B (corresponding author), Indian Stat Inst, Human Genet Unit, Kolkata, India.	broy@isical.ac.in	Paul, R R/AAS-3560-2021	Paul, R R/0000-0001-6221-6446; Chakraborty, Arnab/0000-0002-1763-7249; De Sarkar, Navonil/0000-0003-2139-7951	Department of Biotechnolgy, Government of India; Indian Statistical Institute	Department of Biotechnolgy, Government of India(Department of Biotechnology (DBT) India); Indian Statistical Institute	All funding came from Department of Biotechnolgy, Government of India, and Indian Statistical Institute to Prof. Bidyut Roy. The funder has no role in study design, data collection, analysis, decision to publish and manuscript preparation.	*AM CANC SOC, 2007, CANC FACTS FIG 2007; Anderson C, 2006, NUCLEIC ACIDS RES, V34, P5863, DOI 10.1093/nar/gkl743; Arai E, 2014, INT J CANCER, V135, P1330, DOI 10.1002/ijc.28768; Benjamini Y, 1996, J ROYAL STAT SOC B, V58, P289; Boya Xie, 2010, International Society for Computers and Their Applications. 2nd International Conference on Bioinformatics and Computational Biology (BICoB-2010), P159; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Cai CX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029750; Chang KW, 2013, ORAL ONCOL, V49, P27, DOI 10.1016/j.oraloncology.2012.07.003; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen Dan, 2013, J Oral Maxillofac Res, V4, pe2, DOI 10.5037/jomr.2013.4102; Chen ZJ, 2012, ORAL ONCOL, V48, P686, DOI 10.1016/j.oraloncology.2012.02.020; Childs G, 2009, AM J PATHOL, V174, P736, DOI 10.2353/ajpath.2009.080731; Cuellar TL, 2005, J ENDOCRINOL, V187, P327, DOI 10.1677/joe.1.06426; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Jung HM, 2012, J BIOL CHEM, V287, P29261, DOI 10.1074/jbc.M112.366518; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kinoshita T, 2012, BIOCHEM BIOPH RES CO, V418, P378, DOI 10.1016/j.bbrc.2012.01.030; Kojima S, 2012, BRIT J CANCER, V106, P405, DOI 10.1038/bjc.2011.462; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Lajer CB, 2011, BRIT J CANCER, V104, P830, DOI 10.1038/bjc.2011.29; Lee Y, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000730; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu CJ, 2010, CANCER RES, V70, P1635, DOI 10.1158/0008-5472.CAN-09-2291; Lu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003420; Nagel R, 2008, CANCER RES, V68, P5795, DOI 10.1158/0008-5472.CAN-08-0951; Nohata N, 2011, ONCOTARGET, V2, P29; Planchard D, 2012, CANCER-AM CANCER SOC, V118, P5015, DOI 10.1002/cncr.27510; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Schooneveld EV, 2010, MOL CELL, V40, P841; Song GS, 2009, J BIOL CHEM, V284, P31921, DOI 10.1074/jbc.M109.046862; Tu HF, 2013, CURR OPIN OTOLARYNGO, V21, P104, DOI 10.1097/MOO.0b013e32835e1d6e; Wang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017167; Wilfred BR, 2007, MOL GENET METAB, V91, P209, DOI 10.1016/j.ymgme.2007.03.011; Wilson N, 2004, NAT REV GENET, V5, P244, DOI 10.1038/nrg1334; Wu CD, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-80; Xie BY, 2013, BIOINFORMATICS, V29, P638, DOI 10.1093/bioinformatics/btt014; Yang JH, 2011, NUCLEIC ACIDS RES, V39, pD202, DOI 10.1093/nar/gkq1056	43	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104839	10.1371/journal.pone.0104839	http://dx.doi.org/10.1371/journal.pone.0104839			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126847	Green Submitted, gold, Green Published			2022-12-25	WOS:000340879300056
J	Granville, K; Fan, ZZ				Granville, Kevin; Fan, Zhaozhi			Buckley-James Estimator of AFT Models with Auxiliary Covariates	PLOS ONE			English	Article							FAILURE TIME REGRESSION; CENSORED-DATA; MEASUREMENT ERROR; LINEAR-REGRESSION	In this paper we study the Buckley-James estimator of accelerated failure time models with auxiliary covariates. Instead of postulating distributional assumptions on the auxiliary covariates, we use a local polynomial approximation method to accommodate them into the Buckley-James estimating equations. The regression parameters are obtained iteratively by minimizing a consecutive distance of the estimates. Asymptotic properties of the proposed estimator are investigated. Simulation studies show that the efficiency gain of using auxiliary information is remarkable when compared to just using the validation sample. The method is applied to the PBC data from the Mayo Clinic trial in primary biliary cirrhosis as an illustration.	[Granville, Kevin] Univ Waterloo, Dept Stat & Actuarial Sci, Waterloo, ON N2L 3G1, Canada; [Fan, Zhaozhi] Mem Univ Newfoundland, Dept Math & Stat, St John, NF A1C 5S7, Canada	University of Waterloo; Memorial University Newfoundland	Fan, ZZ (corresponding author), Mem Univ Newfoundland, Dept Math & Stat, St John, NF A1C 5S7, Canada.	zhaozhi@mun.ca		Granville, Kevin/0000-0003-3912-015X	USRA from the National Sciences and Engineering Research Council of Canada; National Sciences and Engineering Research Council of Canada	USRA from the National Sciences and Engineering Research Council of Canada; National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	The research of Kevin Granville was partially supported by USRA from the National Sciences and Engineering Research Council of Canada. The research of Zhaozhi Fan was partially supported by a Discovery Grant from the National Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, PRIM BIL CIRRH PBC; BUCKLEY J, 1979, BIOMETRIKA, V66, P429; CARROL RJ, 1995, MEASUREMENT ERROR NO; Cox D. R., 1984, ANAL SURVIVAL DATA; COX DR, 1972, J R STAT SOC B, V34, P187; Fan ZZ, 2009, J NONPARAMETR STAT, V21, P771, DOI 10.1080/10485250902915903; FLEMING TR, 1991, COUNTING PROCESSES S; Fuller W.A., 2009, MEASUREMENT ERROR MO; Granville K, 2012, J BIOM BIOSTAT, V3, P152, DOI [10.4172/2155-6180.1000152., DOI 10.4172/2155-6180.1000152]; He WQ, 2007, STAT MED, V26, P4817, DOI 10.1002/sim.2892; Hu CC, 2002, SCAND J STAT, V29, P637, DOI 10.1111/1467-9469.00310; Hu P, 1998, BIOMETRICS, V54, P1407, DOI 10.2307/2533667; JAMES IR, 1984, ANN STAT, V12, P590, DOI 10.1214/aos/1176346507; Jin ZZ, 2006, BIOMETRIKA, V93, P147, DOI 10.1093/biomet/93.1.147; Kalbfleisch J.D., 2002, STAT ANAL FAILURE TI; LAI TL, 1991, ANN STAT, V19, P1370, DOI 10.1214/aos/1176348253; Liu YY, 2010, J MULTIVARIATE ANAL, V101, P679, DOI 10.1016/j.jmva.2009.09.008; Liu YY, 2009, BIOMETRICS, V65, P1184, DOI 10.1111/j.1541-0420.2009.01198.x; Nadaraya TA, 1964, THEOR PROBAB APPL, V10, P186; National Institutes of Health, 2011, PRIM BILL CIRRH; PRENTICE RL, 1982, BIOMETRIKA, V69, P331, DOI 10.1093/biomet/69.2.331; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.2307/2335739; Wand M. P., 1994, KERNEL SMOOTHING; Wang NY, 1998, J AM STAT ASSOC, V93, P249, DOI 10.2307/2669621; Watson GS, 1964, INDIAN J STAT A, V26, P359; Yu MG, 2010, BIOMETRICS, V66, P405, DOI 10.1111/j.1541-0420.2009.01295.x; Zhou H, 2000, J ROY STAT SOC B, V62, P657, DOI 10.1111/1467-9868.00255; ZHOU HB, 1995, BIOMETRIKA, V82, P139	28	1	1	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104817	10.1371/journal.pone.0104817	http://dx.doi.org/10.1371/journal.pone.0104817			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127479	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000340879300054
J	Shanley, CS; Albert, DM				Shanley, Colin S.; Albert, David M.			Climate Change Sensitivity Index for Pacific Salmon Habitat in Southeast Alaska	PLOS ONE			English	Article							FRESH-WATER ECOSYSTEMS; POPULATION DIVERSITY; SOCKEYE-SALMON; PINK SALMON; CONSERVATION; PATTERNS; TEMPERATURE; PERFORMANCE; RESILIENCE; STRATEGY	Global climate change may become one of the most pressing challenges to Pacific Salmon conservation and management for southeast Alaska in the 21 st Century. Predicted hydrologic change associated with climate change will likely challenge the ability of specific stocks to adapt to new flow regimes and resulting shifts in spawning and rearing habitats. Current research suggests egg-to-fry survival may be one of the most important freshwater limiting factors in Pacific Salmon's northern range due to more frequent flooding events predicted to scour eggs from mobile spawning substrates. A watershed-scale hydroclimatic sensitivity index was developed to map this hypothesis with an historical stream gauge station dataset and monthly multiple regression-based discharge models. The relative change from present to future watershed conditions predicted for the spawning and incubation period (September to March) was quantified using an ensemble global climate model average (ECHAM5, HadCM3, and CGCM3.1) and three global greenhouse gas emission scenarios (B1, A1B, and A2) projected to the year 2080. The models showed the region's diverse physiography and climatology resulted in a relatively predictable pattern of change: northern mainland and steeper, snow-fed mountainous watersheds exhibited the greatest increases in discharge, an earlier spring melt, and a transition into rain-fed hydrologic patterns. Predicted streamflow increases for all watersheds ranged from approximately 1-fold to 3-fold for the spawning and incubation period, with increased peak flows in the spring and fall. The hydroclimatic sensitivity index was then combined with an index of currently mapped salmon habitat and species diversity to develop a research and conservation priority matrix, highlighting potentially vulnerable to resilient high-value watersheds. The resulting matrix and observed trends are put forth as a framework to prioritize long-term monitoring plans, mitigation experiments, and finer-scale climate impact and adaptation studies.	[Shanley, Colin S.; Albert, David M.] Nature Conservancy, Juneau, AK 99801 USA	Nature Conservancy	Shanley, CS (corresponding author), Nature Conservancy, Juneau, AK 99801 USA.	cshanley@tnc.org			Alaska Sustainable Salmon Fund [44550]; Gordon and Betty Moore Foundation	Alaska Sustainable Salmon Fund; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	This project was funded by the Alaska Sustainable Salmon Fund (www.akssf.org; project #44550) and the Gordon and Betty Moore Foundation (www.moore.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkison MD, 2003, ALASKA FISHERY RES B, V10, P83; Albert DM, 2013, CONSERV BIOL, V27, P774, DOI 10.1111/cobi.12109; Anderson D.R., 2008, MODEL BASED INFERENC; Araki H, 2007, SCIENCE, V318, P100, DOI 10.1126/science.1145621; Battin J, 2007, P NATL ACAD SCI USA, V104, P6720, DOI 10.1073/pnas.0701685104; Beechie T, 2006, BIOL CONSERV, V130, P560, DOI 10.1016/j.biocon.2006.01.019; Bisson PA, 2009, ECOL SOC, V14; Bottom DL, 2009, ECOL SOC, V14; Bryant MD, 2009, CLIMATIC CHANGE, V95, P169, DOI 10.1007/s10584-008-9530-x; Buhle ER, 2009, BIOL CONSERV, V142, P2449, DOI 10.1016/j.biocon.2009.05.013; Clark John H., 2006, ALASKA FISHERY RESEARCH BULLETIN, V12, P1; Daly C, 2002, CLIM RES, V22, P99, DOI 10.3354/cr022099; Dorava JM, 2000, HYDROL PROCESS, V14, P3149, DOI 10.1002/1099-1085(200011/12)14:16/17<3149::AID-HYP139>3.3.CO;2-P; Edwards RT, 2013, NORTH PACIFIC TEMPERATE RAINFORESTS: ECOLOGY & CONSERVATION, P43; Elsner MM, 2010, CLIMATIC CHANGE, DOI [10.1007/s10584-10010-19855-10580, DOI 10.1007/S10584-10010-19855-10580]; Fellman JB, 2014, HYDROL PROCESS, V28, P2062, DOI 10.1002/hyp.9742; Fussel HM, 2009, CLIMATIC CHANGE, V97, P469, DOI 10.1007/s10584-009-9648-5; Gende SM, 2002, BIOSCIENCE, V52, P917, DOI 10.1641/0006-3568(2002)052[0917:PSIAAT]2.0.CO;2; Gustafson RG, 2007, CONSERV BIOL, V21, P1009, DOI 10.1111/j.1523-1739.2007.00693.x; Halupka KC, 2003, N AM J FISH MANAGE, V23, P1057, DOI 10.1577/M02-152; Hamann A, 2005, AGR FOREST METEOROL, V128, P211, DOI 10.1016/j.agrformet.2004.10.004; Hennon PE, 2012, BIOSCIENCE, V62, P147, DOI 10.1525/bio.2012.62.2.8; Hodgson S, 2002, CAN J ZOOL, V80, P542, DOI 10.1139/Z02-030; Hood E, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2009JG000971; Jonsson B, 2012, CAN J FISH AQUAT SCI, V69, P1817, DOI 10.1139/f2012-108; Koski KV, 2009, ECOL SOC, V14; Kovach RP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053807; Kovach RP, 2012, P ROY SOC B-BIOL SCI, V279, P3870, DOI 10.1098/rspb.2012.1158; Larsen CF, 2005, EARTH PLANET SC LETT, V237, P548, DOI 10.1016/j.epsl.2005.06.032; Mantua N, 2010, CLIMATIC CHANGE, DOI [10.1007/s10584-10010-19845-10582, DOI 10.1007/S10584-10010-19845-10582]; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; McGarigal K., 2000, MULTIVARIATE STAT WI; Meehl GA, 2004, CLIM DYNAM, V23, P495, DOI 10.1007/s00382-004-0442-9; Milner AM, 2013, NAT CLIM CHANGE, V3, P137, DOI [10.1038/nclimate1665, 10.1038/NCLIMATE1665]; Milner AM, 2009, HYDROL PROCESS, V23, P62, DOI 10.1002/hyp.7197; Montgomery DR, 1999, CAN J FISH AQUAT SCI, V56, P377, DOI 10.1139/cjfas-56-3-377; Mote PW, 2010, CLIMATIC CHANGE, V102, P29, DOI 10.1007/s10584-010-9848-z; Mote PW, 2003, CLIMATIC CHANGE, V61, P45, DOI 10.1023/A:1026302914358; Neal EG, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL042385; Neal EG, 2002, J HYDROL, V263, P188, DOI 10.1016/S0022-1694(02)00058-6; Nolin AW, 2010, WATER RESOUR RES, V46, DOI 10.1029/2009WR008968; Pinsky ML, 2009, CONSERV BIOL, V23, P680, DOI 10.1111/j.1523-1739.2008.01156.x; Quinn T. P, 2018, BEHAV ECOLOGY PACIFI; Radic V, 2011, J CLIMATE, V24, P5257, DOI 10.1175/JCLI-D-11-00011.1; Ruggerone GT, 2010, MAR COAST FISH, V2, P306, DOI 10.1577/C09-054.1; Schindler DE, 2010, NATURE, V465, P609, DOI 10.1038/nature09060; Schoch GM, 2013, ESTUAR COAST, DOI [10.1007/s12237-12013-19622-12233, DOI 10.1007/S12237-12013-19622-12233]; Schwarz TC, 2010, THESIS CORNELL U ITH; Simpson JJ, 2005, ARCTIC, V58, P137; Stewart IT, 2004, CLIMATIC CHANGE, V62, P217, DOI 10.1023/B:CLIM.0000013702.22656.e8; Taylor SG, 2008, GLOBAL CHANGE BIOL, V14, P229, DOI 10.1111/j.1365-2486.2007.01494.x; USFS, 2012, R10 PR 028; Walsh JE, 2008, J CLIMATE, V21, P6156, DOI 10.1175/2008JCLI2163.1; Wang T, 2006, INT J CLIMATOL, V26, P383, DOI 10.1002/joc.1247; Wang TL, 2012, J APPL METEOROL CLIM, V51, P16, DOI 10.1175/JAMC-D-11-043.1; Wipfli MS, 2010, FISHERIES, V35, P373, DOI 10.1577/1548-8446-35.8.373; [No title captured]	57	25	29	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104799	10.1371/journal.pone.0104799	http://dx.doi.org/10.1371/journal.pone.0104799			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127398	gold, Green Published			2022-12-25	WOS:000340879300053
J	Uceyler, N; Valet, M; Kafke, W; Tolle, TR; Sommer, C				Ueceyler, Nurcan; Valet, Michael; Kafke, Waldemar; Toelle, Thomas R.; Sommer, Claudia			Local and Systemic Cytokine Expression in Patients with Postherpetic Neuralgia	PLOS ONE			English	Article							REGIONAL PAIN SYNDROME; GERMAN RESEARCH NETWORK; HERPES-ZOSTER; DIFFERENTIAL EXPRESSION; NATURAL-HISTORY; SKIN; NEUROPATHY; DIAGNOSIS; RESPONSES; IMMUNE	Background: Postherpetic neuralgia (PHN) is the painful complication of a varicella zoster virus reactivation. We investigated the systemic and local gene expression of pro-and anti-inflammatory cytokine expression in patients with PHN. Methods: Thirteen patients with PHN at the torso (Th4-S1) were recruited. Skin punch biopsies were obtained from the painful and the contralateral painless body area for intraepidermal nerve fiber density (IENFD) and cytokine profiling. Additionally, blood was withdrawn for systemic cytokine expression and compared to blood values of healthy controls. We analyzed the gene expression of selected pro-and anti-inflammatory cytokines (tumor necrosis factor-alpha [TNF] and interleukins [IL]-1 beta, IL-2, and IL-8). Results: IENFD was lower in affected skin compared to unaffected skin (p<0.05), while local gene expression of pro-and anti-inflammatory cytokines did not differ except for two patients who had 7fold higher IL-6 and 10fold higher IL-10 gene expression in the affected skin compared to the contralateral unaffected skin sample. Also, the systemic expression of cytokines in patients with PHN and in healthy controls was similar. Conclusion: While the systemic and local expression of the investigated pro- and anti-inflammatory cytokines was not different from controls, this may have been influenced by study limitations like the low number of patients and different disease durations. Furthermore, other cytokines or pain mediators need to be considered.	[Ueceyler, Nurcan; Kafke, Waldemar; Sommer, Claudia] Univ Wurzburg, Dept Neurol, Wurzburg, Germany; [Valet, Michael; Toelle, Thomas R.] Tech Univ Munich, Klinikum Rechts Isar, Dept Neurol, D-80290 Munich, Germany	University of Wurzburg; Technical University of Munich	Uceyler, N (corresponding author), Univ Wurzburg, Dept Neurol, Josef Schneider Str 11, Wurzburg, Germany.	ueceyler_n@ukw.de	Sommer, Claudia/A-9820-2010	Sommer, Claudia/0000-0002-7064-5002; Uceyler, Nurcan/0000-0001-6973-6428; Valet, Michael/0000-0003-3828-9164	Bundesministerium fur Bildung und Forschung (BMBF), Deutscher Forschungsverbund Neuropathischer Schmerz (DFNS); German Research Foundation (DFG); University of Wurzburg	Bundesministerium fur Bildung und Forschung (BMBF), Deutscher Forschungsverbund Neuropathischer Schmerz (DFNS); German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wurzburg	The study was supported by Bundesministerium fur Bildung und Forschung (BMBF), Deutscher Forschungsverbund Neuropathischer Schmerz (DFNS). The publication of the authors' study was funded by the German Research Foundation (DFG) and the University of Wurzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander GM, 2012, J PAIN, V13, P10, DOI 10.1016/j.jpain.2011.10.003; Austin PJ, 2010, J NEUROIMMUNOL, V229, P26, DOI 10.1016/j.jneuroim.2010.08.013; Buonocore M, 2012, J CELL PHYSIOL, V227, P934, DOI 10.1002/jcp.22804; Dworkin RH, 2008, J PAIN, V9, pS37, DOI 10.1016/j.jpain.2007.10.008; Failla V, 2011, EUR J DERMATOL, V21, P782, DOI 10.1684/ejd.2011.1424; Gnann JW, 2002, NEW ENGL J MED, V347, P340, DOI 10.1056/NEJMcp1302674; Javed S, 2011, J MED VIROL, V83, P2051, DOI 10.1002/jmv.22182; Kennedy WR. W-CG, 2005, PERIPHERAL NEUROPATH, V4th, P869, DOI [10.1016/B978-0-7216-9491-7.50037-5, DOI 10.1016/B978-0-7216-9491-7.50037-5]; Knapp DJ, 2013, CLIN J PAIN, V29, pE6, DOI 10.1097/AJP.0b013e31828b8ef8; Kotani N, 2004, AM J MED, V116, P318, DOI 10.1016/j.amjmed.2003.10.027; Lauria G, 2005, EUR J NEUROL, V12, P747, DOI 10.1111/j.1468-1331.2005.01260.x; Lenz M, 2013, PAIN, V154, P2142, DOI 10.1016/j.pain.2013.06.039; Oaklander AL, 2008, J PAIN, V9, pS10, DOI 10.1016/j.jpain.2007.10.003; Petersen KL, 2007, PAIN, V131, P214, DOI 10.1016/j.pain.2007.03.004; Petersen KL, 2010, PAIN, V150, P75, DOI 10.1016/j.pain.2010.04.002; Pfau DB, 2014, PAIN, V155, P1002, DOI 10.1016/j.pain.2014.02.004; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rijsdijk M, 2013, EUR J PAIN, V17, P714, DOI 10.1002/j.1532-2149.2012.00233.x; Rolke R, 2006, PAIN, V123, P231, DOI 10.1016/j.pain.2006.01.041; Rotty J, 2006, CLIN INFECT DIS, V43, pE109, DOI 10.1086/509639; Strangfeld A, 2009, JAMA-J AM MED ASSOC, V301, P737, DOI 10.1001/jama.2009.146; Thyregod HG, 2007, PAIN, V128, P148, DOI 10.1016/j.pain.2006.09.021; Uceyler N, 2007, NEUROLOGY, V69, P42, DOI 10.1212/01.wnl.0000265062.92340.a5; Uceyler N, 2010, NEUROLOGY, V74, P1806, DOI 10.1212/WNL.0b013e3181e0f7b3; Uceyler N, 2007, PAIN, V132, P195, DOI 10.1016/j.pain.2007.07.031; Uceyler N, 2009, EXP BRAIN RES, V196, P67, DOI 10.1007/s00221-009-1755-z; Zak-Prelich M, 2003, CLIN EXP IMMUNOL, V131, P318, DOI 10.1046/j.1365-2249.2003.02061.x; Zhu SM, 2009, J ZHEJIANG UNIV-SC B, V10, P625, DOI 10.1631/jzus.B0920049	28	10	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105269	10.1371/journal.pone.0105269	http://dx.doi.org/10.1371/journal.pone.0105269			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127283	gold, Green Submitted, Green Published			2022-12-25	WOS:000340879300100
J	Wei, J; Chamberlain, JR				Wei, Jessica; Chamberlain, Joel R.			Systemic RNAi Delivery to the Muscles of ROSA26 Mice Reduces lacZ Expression	PLOS ONE			English	Article							RECOMBINANT ADENOASSOCIATED VIRUS; DOUBLE-STRANDED-RNA; MESSENGER-RNA; GENE-TRANSFER; INTERFERENCE; TRANSDUCTION; SHRNA; PERSISTENCE; THERAPY; VECTORS	RNAi has potential for therapeutically downregulating the expression of dominantly inherited genes in a variety of human genetic disorders. Here we used the ROSA26 mouse, which constitutively expresses the bacterial lacZ gene in tissues body wide, as a model to test the ability to downregulate gene expression in striated muscles. Recombinant adeno-associated viral vectors (rAAVs) were generated that express short hairpin RNAs (shRNAs) able to target the lacZ mRNA. Systemic delivery of these rAAV6 vectors led to a decrease of beta-galactosidase expression of 30-50-fold in the striated muscles of ROSA26 mice. However, high doses of vectors expressing 21 nucleotide shRNA sequences were associated with significant toxicity in both liver and cardiac muscle. This toxicity was reduced in cardiac muscle using lower vector doses. Furthermore, improved knockdown in the absence of toxicity was obtained by using a shorter (19 nucleotide) shRNA guide sequence. These results support the possibility of using rAAV vectors to deliver RNAi sequences systemically to treat dominantly inherited disorders of striated muscle.	[Wei, Jessica; Chamberlain, Joel R.] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Chamberlain, JR (corresponding author), Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA.	Jrcham@uw.edu			NIH [AR56107, AR44533]; Muscular Dystrophy Association Research Grant; Pacific Northwest Friends of FSH Dystrophy Research Grant; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044533, R03AR056107] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association Research Grant; Pacific Northwest Friends of FSH Dystrophy Research Grant; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	NIH AR56107 and AR44533, Muscular Dystrophy Association Research Grant, Pacific Northwest Friends of FSH Dystrophy Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnett A, 2012, MUSCLE FUNDAMENTAL B, P1045; Asokan A, 2010, NAT BIOTECHNOL, V28, P79, DOI 10.1038/nbt.1599; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Blankinship MJ, 2004, MOL THER, V10, P671, DOI 10.1016/j.ymthe.2004.07.016; Borel F, 2014, MOL THER, V22, P692, DOI 10.1038/mt.2013.285; Bortolanza S, 2011, MOL THER, V19, P2055, DOI 10.1038/mt.2011.153; Boudreau RL, 2009, MOL THER, V17, P169, DOI 10.1038/mt.2008.231; Chen JF, 2008, P NATL ACAD SCI USA, V105, P2111, DOI 10.1073/pnas.0710228105; Davis ME, 2010, NATURE, V464, P1067, DOI 10.1038/nature08956; Duan DS, 1998, J VIROL, V72, P8568, DOI 10.1128/JVI.72.11.8568-8577.1998; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fitzgerald K, 2014, LANCET, V383, P60, DOI 10.1016/S0140-6736(13)61914-5; Gao GP, 2004, J VIROL, V78, P6381, DOI 10.1128/JVI.78.12.6381-6388.2004; Gao GP, 2002, P NATL ACAD SCI USA, V99, P11854, DOI 10.1073/pnas.182412299; Giering JC, 2008, MOL THER, V16, P1630, DOI 10.1038/mt.2008.144; Gregorevic P, 2004, NAT MED, V10, P828, DOI 10.1038/nm1085; Gregorevic P, 2008, MUSCLE NERVE, V37, P104, DOI 10.1002/mus.20877; Gregorevic P, 2006, NAT MED, V12, P787, DOI 10.1038/nm1439; Grimm D, 2007, J CLIN INVEST, V117, P3633, DOI 10.1172/JCI34129; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Grimm D, 2010, J CLIN INVEST, V120, P3106, DOI 10.1172/JCI43565; Halbert CL, 1997, J VIROL, V71, P5932, DOI 10.1128/JVI.71.8.5932-5941.1997; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Harper SQ, 2005, METH MOL B, V309, P219; Koornneef A, 2011, MOL THER, V19, P731, DOI 10.1038/mt.2011.6; Lambeth Luke S, 2013, Methods Mol Biol, V942, P205, DOI 10.1007/978-1-62703-119-6_12; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; McBride JL, 2008, P NATL ACAD SCI USA, V105, P5868, DOI 10.1073/pnas.0801775105; Odom GL, 2007, BBA-MOL BASIS DIS, V1772, P243, DOI 10.1016/j.bbadis.2006.09.007; Odom GL, 2011, MOL THER, V19, P36, DOI 10.1038/mt.2010.205; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; Paul CP, 2002, NAT BIOTECHNOL, V20, P505, DOI 10.1038/nbt0502-505; Rao PK, 2009, CIRC RES, V105, P585, DOI 10.1161/CIRCRESAHA.109.200451; Salva MZ, 2007, MOL THER, V15, P320, DOI 10.1038/sj.mt.6300027; Schultz BR, 2008, MOL THER, V16, P1189, DOI 10.1038/mt.2008.103; Sharp PA, 1999, GENE DEV, V13, P139, DOI 10.1101/gad.13.2.139; Vickers TA, 2007, NUCLEIC ACIDS RES, V35, P6598, DOI 10.1093/nar/gkm663; Wallace LM, 2012, MOL THER, V20, P1417, DOI 10.1038/mt.2012.68; Wallace LM, 2011, MOL THER, V19, P2048, DOI 10.1038/mt.2011.118; Wang HY, 2014, HUM MOL GENET, V23, P668, DOI 10.1093/hmg/ddt454; Xiao XA, 1996, J VIROL, V70, P8098, DOI 10.1128/JVI.70.11.8098-8108.1996; Yang WQ, 2012, EXPERT OPIN BIOL TH, V12, P1495, DOI 10.1517/14712598.2012.712107; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; Zeng Y, 2002, RNA, V8, P855, DOI 10.1017/S1355838202020071	47	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e102053	10.1371/journal.pone.0102053	http://dx.doi.org/10.1371/journal.pone.0102053			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127128	Green Submitted, Green Published, gold			2022-12-25	WOS:000340879300003
J	Chen, CH; Hsieh, JT; Huang, KH; Pu, YS; Chang, HC				Chen, Chien-Hua; Hsieh, Ju-Ton; Huang, Kuo-How; Pu, Yeong-Shiau; Chang, Hong-Chiang			Predictive Clinical Indicators of Biochemical Progression in Advanced Prostate Cancer Patients Receiving Leuplin Depot as Androgen Deprivation Therapy	PLOS ONE			English	Article							LEUPRORELIN ACETATE DEPOT; ANTIGEN PSA NADIR; PROGNOSTIC-FACTORS; RADIATION-THERAPY; SURVIVAL; TRIAL; TIME; MEN; ORCHIECTOMY; SUPPRESSION	Therapeutic planning and counseling for advanced prostate cancer patients receiving androgen deprivation therapy (ADT) is complicated because the prognoses are highly variable. The purpose of this study is to identify predictive clinical indicators of biochemical progression (BCP). In this retrospective analysis, data from 107 newly diagnosed patients (from November 1995 to April 2008) with advanced prostate adenocarcinoma receiving Leuprorelin acetate depot were analyzed. Data was collected from the computerized registry of two collaborating medical centers in Taiwan. Cox regression and Kaplan-Meier analyses were used to evaluate the relationship between potential predictive parameters and BCP. Univariate analysis revealed that predictors of BCP included (1) initial serum prostate-specific antigen (PSA) (hazard ratio [HR], 1.00; 95% confidence interval [CI] 1.00-1.00); (2) log of initial PSA (HR, 1.35; 95% CI 1.17-1.56); (3) PSA density at diagnosis (HR, 1.00; 95% CI 1.00-1.01), and (4) pathological bone fracture (HR, 2.22; 95% CI 1.20-4.11). Age (HR, 0.94; 95% CI 0.91-0.98) and hemoglobin levels (HR, 0.86; 95% CI 0.76-0.97) were also associated with greater risk of BCP. After adjusting for age, pathologic fracture, and hemoglobin level, the initial PSA and PSA density were no longer significantly associated with BCP. However, age and hemoglobin levels continued to be associated with greater risk of BCP (P <= 0.007). Using Kaplan-Meier analysis, patients with higher initial PSA concentration, pathological bone fracture, and low hemoglobin had a greater probability of BCP. Thus, low hemoglobin and age are predictive indicators of BCP and therefore early indicators of BCP despite ADT therapy.	[Chen, Chien-Hua] En Chu Kong Hosp, Dept Urol, Taipei, Taiwan; [Hsieh, Ju-Ton; Huang, Kuo-How; Pu, Yeong-Shiau; Chang, Hong-Chiang] Natl Taiwan Univ Hosp, Dept Urol, Taipei, Taiwan; [Hsieh, Ju-Ton; Huang, Kuo-How; Pu, Yeong-Shiau; Chang, Hong-Chiang] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University	Chang, HC (corresponding author), En Chu Kong Hosp, Dept Urol, Taipei, Taiwan.	changhong@ntu.edu.tw		CHANG, HONG-CHIANG/0000-0001-5411-6680; HSIEH, JU-TON/0000-0001-7545-8487; Huang, Kuo-How/0000-0002-0989-0578; PU, YEONG-SHIAU/0000-0002-2859-3966				Adib RS, 1997, BRIT J UROL, V79, P235; AKAZA H, 1990, J INT MED RES, V18, P90, DOI 10.1177/03000605900180S114; BERRY WR, 1979, CANCER, V44, P763, DOI 10.1002/1097-0142(197908)44:2<763::AID-CNCR2820440251>3.0.CO;2-5; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen CH, 2008, UROLOGY, V72, P1287, DOI 10.1016/j.urology.2008.01.026; Cho D, 2003, UROL ONCOL-SEMIN ORI, V21, P282, DOI 10.1016/S1078-1439(03)00057-7; Choueiri TK, 2009, CANCER, V115, P981, DOI 10.1002/cncr.24064; de Crevoisier R, 2010, ANN ONCOL, V21, P808, DOI 10.1093/annonc/mdp365; Denis LJ, 1998, EUR UROL, V33, P144, DOI 10.1159/000019546; Eisenberger MA, 1998, NEW ENGL J MED, V339, P1036, DOI 10.1056/NEJM199810083391504; EMRICH LJ, 1985, CANCER RES, V45, P5173; Glass TR, 2003, J UROLOGY, V169, P164, DOI 10.1016/S0022-5347(05)64059-1; GLEASON DF, 1974, J UROLOGY, V111, P58, DOI 10.1016/S0022-5347(17)59889-4; Graff JN, 2007, J UROLOGY, V177, P1307, DOI 10.1016/j.juro.2006.11.054; Hori S, 2011, J CANCER RES CLIN, V137, P235, DOI 10.1007/s00432-010-0877-9; Howlader N, 2012, SEER CANC STAT REV; Huang SP, 2012, AGING MALE, V15, P34, DOI 10.3109/13685538.2011.580398; Huang SP, 2011, PROSTATE, V71, P1189, DOI 10.1002/pros.21334; JANKNEGT RA, 1993, J UROLOGY, V149, P77, DOI 10.1016/S0022-5347(17)36003-2; Jorgensen T, 1997, J UROLOGY, V158, P164, DOI 10.1097/00005392-199707000-00052; Kachroo N, 2013, J CANCER RES CLIN, V139, P1, DOI 10.1007/s00432-012-1351-7; Kattan MW, 2008, CANCER, V112, P69, DOI 10.1002/cncr.23106; Keating NL, 2006, J CLIN ONCOL, V24, P4448, DOI 10.1200/JCO.2006.06.2497; Keto CJ, 2012, EUR UROL; McGuire SE, 2013, INT J RADIAT ONCOL, V85, pE39, DOI 10.1016/j.ijrobp.2012.08.036; National Cancer Registry, 2009, NAT CANC REG ANN REP; Oefelein MG, 2002, UROLOGY, V60, P120, DOI 10.1016/S0090-4295(02)01633-3; Radwan MH, 2007, UROLOGY, V69, P1121, DOI 10.1016/j.urology.2007.01.087; RIZZO M, 1990, J INT MED RES, V18, P114, DOI 10.1177/03000605900180S116; Robson M, 1996, HEMATOL ONCOL CLIN N, V10, P727, DOI 10.1016/S0889-8588(05)70364-6; Ross RW, 2008, J CLIN ONCOL, V26, P842, DOI 10.1200/JCO.2007.13.6804; Ross RW, 2008, CANCER-AM CANCER SOC, V112, P1247, DOI 10.1002/cncr.23304; Sasaki T, 2011, PROSTATE CANCER P D, V14, P248, DOI 10.1038/pcan.2011.14; Seidenfeld J, 2000, ANN INTERN MED, V132, P566, DOI 10.7326/0003-4819-132-7-200004040-00009; Sharifi N, 2005, JAMA-J AM MED ASSOC, V294, P238, DOI 10.1001/jama.294.2.238; Stephenson AJ, 2006, J CLIN ONCOL, V24, P3973, DOI 10.1200/JCO.2005.04.0756; Takizawa I, 2010, PROSTATE, V70, P1395, DOI 10.1002/pros.21174; Thomas BM, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0719-0; 1997, INT J RAD ONCOL BIOL, V37, P1035	39	2	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e105091	10.1371/journal.pone.0105091	http://dx.doi.org/10.1371/journal.pone.0105091			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121948	gold, Green Submitted, Green Published			2022-12-25	WOS:000341017000095
J	Hanisch, FG; Bonar, D; Schloerer, N; Schroten, H				Hanisch, Franz-Georg; Bonar, David; Schloerer, Nils; Schroten, Horst			Human Trefoil Factor 2 Is a Lectin That Binds alpha-GlcNAc-capped Mucin Glycans with Antibiotic Activity against Helicobacter pylori	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Glycomics; Glycosylation; Helicobacter pylori; Lectin; Mucin; Mucin-type O-Glycans; Trefoil Factor Family 2 (TFF2)	PANCREATIC SPASMOLYTIC POLYPEPTIDE; DAMAGED GASTRIC-MUCOSA; O-LINKED GLYCANS; N-ACETYLGLUCOSAMINE; FAMILY FACTOR-2; HUMAN STOMACH; CELL MUCIN; EXPRESSION; TFF2; PEPTIDES	Background: Trefoil factor 2 (TFF2) forms complexes with MUC6 and is concertedly secreted by deep gastric glands. Results: TFF2 is a lectin that binds to -GlcNAc-capped MUC6 O-glycans with antibiotic activity against Helicobacter pylori. Conclusion: There may be a functional link between mucin glycans and TFF2 in H. pylori defense. Significance: The findings impact in development of defense strategies against H. pylori and in TFF2 receptor-mediated cell signaling. Helicobacter pylori infection is the major cause of gastric cancer and remains an important health care challenge. The trefoil factor peptides are a family of small highly conserved proteins that are claimed to play essential roles in cytoprotection and epithelial repair within the gastrointestinal tract. H. pylori colocalizes with MUC5AC at the gastric surface epithelium, but not with MUC6 secreted in concert with TFF2 by deep gastric glands. Both components of the gastric gland secretome associate non-covalently and show increased expression upon H. pylori infection. Although blood group active O-glycans of the Lewis-type form the basis of H. pylori adhesion to the surface mucin layer and to epithelial cells, 1,4-GlcNAc-capped O-glycans on gastric mucins were proposed to inhibit H. pylori growth as a natural antibiotic. We show here that the gastric glycoform of TFF2 is a calcium-independent lectin, which binds with high specificity to O-linked 1,4-GlcNAc-capped hexasaccharides on human and porcine stomach mucin. The structural assignments of two hexasaccharide isomers and the binding active glycotope were based on mass spectrometry, linkage analysis, H-1 nuclear magnetic resonance spectroscopy, glycan inhibition, and lectin competition of TFF2-mucin binding. Neoglycolipids derived from the C3/C6-linked branches of the two isomers revealed highly specific TFF2 binding to the 6-linked trisaccharide in GlcNAc1-4Gal1-4GlcNAc1-6(Fuc1-2Gal1-3)GalNAc-ol(Structure 1). Supposedly, lectin TFF2 is involved in protection of gastric epithelia via a functional relationship to defense against H. pylori launched by antibiotic 1,4-GlcNAc-capped mucin glycans. Lectin-carbohydrate interaction may have also an impact on more general functional aspects of TFF members by mediating their binding to cell signaling receptors.	[Hanisch, Franz-Georg; Bonar, David] Univ Cologne, Inst Biochem 2, Fac Med, D-50931 Cologne, Germany; [Hanisch, Franz-Georg] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Schloerer, Nils] Univ Cologne, Inst Organ Chem, D-50939 Cologne, Germany; [Schroten, Horst] Heidelberg Univ, Univ Childrens Hosp, D-68167 Mannheim, Germany	University of Cologne; University of Cologne; University of Cologne; Ruprecht Karls University Heidelberg; University of Hamburg; University Medical Center Hamburg-Eppendorf	Hanisch, FG (corresponding author), Univ Cologne, Inst Biochem 2, Fac Med, Joseph Stelzmann Str 52, D-50931 Cologne, Germany.	franz.hanisch@uni-koeln.de	Schloerer, Nils E/C-3868-2013; Schloerer, Nils/AAA-5176-2021	Schloerer, Nils E/0000-0002-0990-9582; Schloerer, Nils/0000-0002-0990-9582	Deutsche Forschungsgemeinschaft [HA 2092/21-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant HA 2092/21-1 (to F. G. H.).	ALBERSHEIM PETER, 1967, CARBOHYD RES, V5, P340, DOI 10.1016/S0008-6215(00)80510-8; Breloy I, 2012, J BIOL CHEM, V287, P18275, DOI 10.1074/jbc.M111.280297; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; Colomb F, 2014, SPR CARB CH, V40, P596, DOI 10.1039/9781849739986-00596; Ding SZ, 2012, GUT PATHOG, V4, DOI 10.1186/1757-4749-4-18; Ferreira B, 2006, J HISTOCHEM CYTOCHEM, V54, P585, DOI 10.1369/jhc.5A6836.2006; Fox JG, 2007, AM J PATHOL, V171, P1520, DOI 10.2353/ajpath.2007.070249; GAJHEDE M, 1993, STRUCTURE, V1, P253, DOI 10.1016/0969-2126(93)90014-8; Gott P, 1996, EUR J HUM GENET, V4, P308; HANBY AM, 1993, GASTROENTEROLOGY, V105, P1110, DOI 10.1016/0016-5085(93)90956-D; HANISCH FG, 1992, EUR J BIOCHEM, V205, P527, DOI 10.1111/j.1432-1033.1992.tb16809.x; HANISCH FG, 1993, EUR J BIOCHEM, V217, P645, DOI 10.1111/j.1432-1033.1993.tb18288.x; Hanisch FG, 2013, GLYCOBIOLOGY, V23, P2, DOI 10.1093/glycob/cws131; Hanisch Franz-Georg, 2009, V534, P107, DOI 10.1007/978-1-59745-022-5_8; Hoffmann W, 2002, INT REV CYTOL, V213, P147; Jiang P, 2014, ONCOL LETT, V7, P1525, DOI 10.3892/ol.2014.1904; JORGENSEN KH, 1982, REGUL PEPTIDES, V3, P207, DOI 10.1016/0167-0115(82)90126-4; Karasawa F, 2012, J CLIN INVEST, V122, P923, DOI 10.1172/JCI59087; Kawakubo M, 2004, SCIENCE, V305, P1003, DOI 10.1126/science.1099250; Kobayashi M, 2009, GLYCOBIOLOGY, V19, P453, DOI 10.1093/glycob/cwp004; Kouznetsova I, 2007, CELL PHYSIOL BIOCHEM, V20, P899, DOI 10.1159/000110450; Kurt-Jones EA, 2007, INFECT IMMUN, V75, P471, DOI 10.1128/IAI.02039-05; May FEB, 2000, GUT, V46, P454, DOI 10.1136/gut.46.4.454; Muller S, 2002, J BIOL CHEM, V277, P26103, DOI 10.1074/jbc.M202921200; Nakayama J, 1999, P NATL ACAD SCI USA, V96, P8991, DOI 10.1073/pnas.96.16.8991; Ota H, 2006, HISTOCHEM CELL BIOL, V126, P617, DOI 10.1007/s00418-006-0197-y; Otto W, 2005, CELL MOL LIFE SCI, V62, P2939, DOI 10.1007/s00018-005-5482-8; Phillipson M, 2008, AM J PHYSIOL-GASTR L, V295, pG806, DOI 10.1152/ajpgi.90252.2008; PLAYFORD RJ, 1995, GASTROENTEROLOGY, V108, P108, DOI 10.1016/0016-5085(95)90014-4; Rossez Y, 2012, GLYCOBIOLOGY, V22, P1193, DOI 10.1093/glycob/cws072; STOLL MS, 1990, EUR J BIOCHEM, V189, P499, DOI 10.1111/j.1432-1033.1990.tb15515.x; Sturmer R, 2014, CELL PHYSIOL BIOCHEM, V33, P895, DOI 10.1159/000358662; Suzuki K, 2006, SCAND J GASTROENTERO, V41, P1390, DOI 10.1080/00365520600792077; Thim L, 2002, EUR J CLIN INVEST, V32, P519, DOI 10.1046/j.1365-2362.2002.01014.x; TOMASETTO C, 1990, EMBO J, V9, P407, DOI 10.1002/j.1460-2075.1990.tb08125.x; Van den Brink GR, 2000, GUT, V46, P601, DOI 10.1136/gut.46.5.601; Xia HHX, 2004, J CLIN PATHOL, V57, P861, DOI 10.1136/jcp.2003.015487	37	42	43	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27363	27375		10.1074/jbc.M114.597757	http://dx.doi.org/10.1074/jbc.M114.597757			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25124036	hybrid, Green Published			2022-12-25	WOS:000342852800001
J	Yadav, T; Carrasco, B; Serrano, E; Alonso, JC				Yadav, Tribhuwan; Carrasco, Begona; Serrano, Ester; Alonso, Juan C.			Roles of Bacillus subtilis DprA and SsbA in RecA-mediated Genetic Recombination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA-binding Protein; DNA Recombination; DNA Transformation; DNA-Protein Interaction; Protein-DNA Interaction	SINGLE-STRANDED-DNA; HELICOBACTER-PYLORI DPRA; HOMOLOGOUS RECOMBINATION; ESCHERICHIA-COLI; INCOMING DNA; PROTEIN; TRANSFORMATION; EXCHANGE; BINDING; MECHANISM	Background: ATP-bound RecA cannot catalyze DNA recombination without crucial accessory factors. Results: DprA facilitates RecA assembly onto SsbA- or SsbB-coated single-stranded DNA, but only DprA and SsbA enable RecAATP to mediate strand exchange. Conclusion: RecAATP transition to an active state requires DprA and SsbA. Significance: DprA and SsbA may serve as a two-component mediator during chromosomal transformation. Bacillus subtilis competence-induced RecA, SsbA, SsbB, and DprA are required to internalize and to recombine single-stranded (ss) DNA with homologous resident duplex. RecA, in the ATPMg(2+)-bound form (RecAATP), can nucleate and form filament onto ssDNA but is inactive to catalyze DNA recombination. We report that SsbA or SsbB bound to ssDNA blocks the RecA filament formation and fails to activate recombination. DprA facilitates RecA filamentation; however, the filaments cannot engage in DNA recombination. When ssDNA was preincubated with SsbA, but not SsbB, DprA was able to activate DNA strand exchange dependent on RecAATP. This work demonstrates that RecAATP, in concert with SsbA and DprA, catalyzes DNA strand exchange, and SsbB is an accessory factor in the reaction. In contrast, RecAdATP efficiently catalyzes strand exchange even in the absence of single-stranded binding proteins or DprA, and addition of the accessory factors marginally improved it. We proposed that the RecA-bound nucleotide (ATP and to a lesser extent dATP) might dictate the requirement for accessory factors.	[Yadav, Tribhuwan; Carrasco, Begona; Serrano, Ester; Alonso, Juan C.] CSIC, Ctr Nacl Biotecnol, Dept Microbial Biotechnol, Madrid 28049, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Alonso, JC (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Microbial Biotechnol, Darwin Str 3, Madrid 28049, Spain.	jcalonso@cnb.csic.es	Serrano, Ester/Q-1730-2018; Alonso, Juan Carlos/D-2595-2009	Serrano, Ester/0000-0001-5075-2954; Alonso, Juan Carlos/0000-0002-5178-7179; Carrasco, Begona/0000-0002-5671-1296; Yadav, Tribhuwan/0000-0003-3571-9907	Ministerio de Economia y Competitividad, Direccion General de Investigacion [FU2012-39879-C02-01]; Comunidad de Madrid [S2009MAT-1507]; International Fellowship Programme of La Caixa Foundation (La Caixa/Centro Nacional de Biotecnologia)	Ministerio de Economia y Competitividad, Direccion General de Investigacion; Comunidad de Madrid(Comunidad de Madrid); International Fellowship Programme of La Caixa Foundation (La Caixa/Centro Nacional de Biotecnologia)	This work was supported in part by the Ministerio de Economia y Competitividad, Direccion General de Investigacion FU2012-39879-C02-01 and by Comunidad de Madrid Grant S2009MAT-1507 (to J. C. A.).; Supported by the International Fellowship Programme of La Caixa Foundation (La Caixa/Centro Nacional de Biotecnologia). Present address: Dept. of Molecular Biophysics and Biochemistry, School of Medicine, Yale University, New Haven, CT 06510.	Attaiech L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002156; Ayora S, 2002, J BIOL CHEM, V277, P35969, DOI 10.1074/jbc.M204467200; Ayora S, 2002, J MOL BIOL, V316, P35, DOI 10.1006/jmbi.2001.5336; Bazemore LR, 1997, J BIOL CHEM, V272, P14672, DOI 10.1074/jbc.272.23.14672; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Berge M, 2003, MOL MICROBIOL, V50, P527, DOI 10.1046/j.1365-2958.2003.03702.x; Brimacombe CA, 2014, MOL MICROBIOL, V92, P1260, DOI 10.1111/mmi.12628; Carrasco B, 2005, NUCLEIC ACIDS RES, V33, P3942, DOI 10.1093/nar/gki713; Carrasco B, 2008, DNA REPAIR, V7, P990, DOI 10.1016/j.dnarep.2008.03.019; Chen I, 2005, SCIENCE, V310, P1456, DOI 10.1126/science.1114021; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; Chiesa M, 2012, NANO LETT, V12, P1275, DOI 10.1021/nl2037547; Claverys JP, 2009, FEMS MICROBIOL REV, V33, P643, DOI 10.1111/j.1574-6976.2009.00164.x; Cox MM, 2007, NAT REV MOL CELL BIO, V8, P127, DOI 10.1038/nrm2099; Dwivedi GR, 2013, NUCLEIC ACIDS RES, V41, P3274, DOI 10.1093/nar/gkt024; Grove DE, 2012, BIOCHEM BIOPH RES CO, V424, P40, DOI 10.1016/j.bbrc.2012.06.059; Ha T, 2012, ANNU REV BIOPHYS, V41, P295, DOI 10.1146/annurev-biophys-042910-155351; Hobbs MD, 2007, J BIOL CHEM, V282, P11058, DOI 10.1074/jbc.M611007200; Kidane D, 2012, CRIT REV BIOCHEM MOL, V47, P531, DOI 10.3109/10409238.2012.729562; KOWALCZYKOWSKI SC, 1994, ANNU REV BIOCHEM, V63, P991, DOI 10.1146/annurev.biochem.63.1.991; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; Kramer N, 2007, MOL MICROBIOL, V65, P454, DOI 10.1111/j.1365-2958.2007.05799.x; Lioy VS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030282; Lisboa J, 2014, NUCLEIC ACIDS RES, V42, P7395, DOI 10.1093/nar/gku349; LOVETT CM, 1985, J BIOL CHEM, V260, P3305; Manfredi C, 2008, J BIOL CHEM, V283, P24837, DOI 10.1074/jbc.M802002200; Mortier-Barriere I, 2007, CELL, V130, P824, DOI 10.1016/j.cell.2007.07.038; Ngo KV, 2013, J BIOL CHEM, V288, P21351, DOI 10.1074/jbc.M113.459230; Quevillon-Cheruel S, 2012, P NATL ACAD SCI USA, V109, pE2466, DOI 10.1073/pnas.1205638109; RADDING CM, 1991, J BIOL CHEM, V266, P5355; Shereda RD, 2008, CRIT REV BIOCHEM MOL, V43, P289, DOI [10.1080/10409230802341296, 10.1080/10409230802341296 ]; Sinha S, 2012, J BACTERIOL, V194, P5245, DOI 10.1128/JB.00671-12; Steffen SE, 2002, J BIOL CHEM, V277, P14493, DOI 10.1074/jbc.M112444200; Steffen SE, 1999, J BIOL CHEM, V274, P25990, DOI 10.1074/jbc.274.37.25990; Takeuchi N, 2014, G3-GENES GENOM GENET, V4, P325, DOI 10.1534/g3.113.009845; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; VLAI I, 2014, NUCLEIC ACIDS RES, V42, P2295; Voloshin ON, 2004, MOL CELL, V15, P846, DOI 10.1016/j.molcel.2004.09.010; Wang W, 2014, NUCLEIC ACIDS RES, V42, P3478, DOI 10.1093/nar/gkt1334; Yadav T, 2013, J BIOL CHEM, V288, P22437, DOI 10.1074/jbc.M113.478347; Yadav T, 2012, NUCLEIC ACIDS RES, V40, P5546, DOI 10.1093/nar/gks173; YANCEYWRONA JE, 1995, CURR BIOL, V5, P1149, DOI 10.1016/S0960-9822(95)00231-4	42	31	36	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27640	27652		10.1074/jbc.M114.577924	http://dx.doi.org/10.1074/jbc.M114.577924			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25138221	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000342852800024
J	Artigas, N; Urena, C; Rodriguez-Carballo, E; Rosa, JL; Ventura, F				Artigas, Natalia; Urena, Carlos; Rodriguez-Carballo, Edgardo; Luis Rosa, Jose; Ventura, Francesc			Mitogen-activated Protein Kinase (MAPK)-regulated Interactions between Osterix and Runx2 Are Critical for the Transcriptional Osteogenic Program	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OSTEOBLAST-SPECIFIC EXPRESSION; CLEIDOCRANIAL DYSPLASIA; OSTEOCALCIN GENE; BONE-FORMATION; CELL-DIFFERENTIATION; SIGNALING PATHWAYS; PROXIMAL PROMOTER; FACTOR OSF2/CBFA1; P38; PHOSPHORYLATION	The transcription factors Runx2 and Osx (Osterix) are required for osteoblast differentiation and bone formation. Runx2 expression occurs at early stages of osteochondroprogenitor determination, followed by Osx induction during osteoblast maturation. We demonstrate that coexpression of Osx and Runx2 leads to cooperative induction of expression of the osteogenic genes Col1a1, Fmod, and Ibsp. Functional interaction of Osx and Runx2 in the regulation of these promoters is mediated by enhancer regions with adjacent Sp1 and Runx2 DNA-binding sites. These enhancers allow formation of a cooperative transcriptional complex, mediated by the binding of Osx and Runx2 to their specific DNA promoter sequences and by the protein-protein interactions between them. We also identified the domains involved in the interaction between Osx and Runx2. These regions contain the amino acids in Osx and Runx2 known to be phosphorylated by p38 and ERK MAPKs. Inhibition of p38 and ERK kinase activities or mutation of their known phosphorylation sites in Osx or Runx2 strongly disrupts their physical interaction and cooperative transcriptional effects. Altogether, our results provide a molecular description of a mechanism for Osx and Runx2 transcriptional cooperation that is subject to further regulation by MAPK-activating signals during osteogenesis.	[Artigas, Natalia; Urena, Carlos; Rodriguez-Carballo, Edgardo; Luis Rosa, Jose; Ventura, Francesc] Univ Barcelona, Inst Invest Biomed Bellvitge IDIBELL, Dept Ciencies Fisiol 2, E-08907 Lhospitalet De Llobregat, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona	Ventura, F (corresponding author), Univ Barcelona, IDIBELL, Dept Ciencies Fisiol 2, C Feixa Llarga S-N, E-08907 Lhospitalet De Llobregat, Spain.	fventura@ub.edu	Ventura, Francesc/ABG-2285-2020; Ventura, Francesc/K-9700-2014; Rosa, Jose Luis/K-6685-2014	Ventura, Francesc/0000-0001-9673-9405; Ventura, Francesc/0000-0001-9673-9405; Rosa, Jose Luis/0000-0002-6161-5688; Artigas, Natalia/0000-0003-3290-2052; Urena Martin, Carlos/0000-0002-7130-9705; Rodriguez-Carballo, Eddie/0000-0003-4321-508X	Ministry of Education, Spain [BFU2011-24254]; La Marato de TV3; Instituto de Salud Carlos III [RETIC RD06/0020]; University of Barcelona	Ministry of Education, Spain(Spanish Government); La Marato de TV3; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); University of Barcelona	This work was supported in part by Ministry of Education, Spain Grant BFU2011-24254, La Marato de TV3, and Instituto de Salud Carlos III Grant RETIC RD06/0020.; Recipient of a fellowship from the University of Barcelona.	Baek WY, 2010, BONE, V46, P920, DOI 10.1016/j.bone.2009.12.007; Bialek P, 2004, DEV CELL, V6, P423, DOI 10.1016/S1534-5807(04)00058-9; Celil AB, 2005, J BIOL CHEM, V280, P31353, DOI 10.1074/jbc.M503845200; Chen F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024638; Cheng AX, 2010, J BONE MINER RES, V25, P2404, DOI 10.1002/jbmr.174; Choi YH, 2011, BIOCHEM BIOPH RES CO, V415, P472, DOI 10.1016/j.bbrc.2011.10.097; DUCY P, 1995, MOL CELL BIOL, V15, P1858; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Franceschi RT, 2003, CONNECT TISSUE RES, V44, P109, DOI 10.1080/03008200390152188; Ge CX, 2012, J BONE MINER RES, V27, P538, DOI 10.1002/jbmr.561; Greenblatt MB, 2013, ANNU REV CELL DEV BI, V29, P63, DOI 10.1146/annurev-cellbio-101512-122347; Greenblatt MB, 2010, J CLIN INVEST, V120, P2457, DOI 10.1172/JCI42285; Guicheux J, 2003, J BONE MINER RES, V18, P2060, DOI 10.1359/jbmr.2003.18.11.2060; Hinoi E, 2006, J BIOL CHEM, V281, P18015, DOI 10.1074/jbc.M600603200; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Javed A, 2008, J BIOL CHEM, V283, P8412, DOI 10.1074/jbc.M705578200; Jin HL, 2009, HUM MOL GENET, V18, P2729, DOI 10.1093/hmg/ddp205; Ortuno MJ, 2013, BONE, V52, P548, DOI 10.1016/j.bone.2012.11.007; Ortuno MJ, 2010, J BIOL CHEM, V285, P31985, DOI 10.1074/jbc.M110.123612; Karsenty G, 2009, ANNU REV CELL DEV BI, V25, P629, DOI 10.1146/annurev.cellbio.042308.113308; Kawate H, 2007, J STEROID BIOCHEM, V105, P46, DOI 10.1016/j.jsbmb.2006.11.020; Kern B, 2001, J BIOL CHEM, V276, P7101, DOI 10.1074/jbc.M006215200; Kim S, 2003, GENE DEV, V17, P1979, DOI 10.1101/gad.1119303; Kim Y, 2007, J CELL PHYSIOL, V211, P253, DOI 10.1002/jcp.20933; Koga T, 2005, NAT MED, V11, P880, DOI 10.1038/nm1270; Lapunzina P, 2010, AM J HUM GENET, V87, P110, DOI 10.1016/j.ajhg.2010.05.016; Lee B, 1997, NAT GENET, V16, P307, DOI 10.1038/ng0797-307; Lee HW, 2008, J BONE MINER RES, V23, P1227, DOI 10.1359/JBMR.080325; Lee KE, 2013, GENET MOL RES, V12, P4567, DOI 10.4238/2013.October.15.5; Lee KN, 2012, J BIOL CHEM, V287, P18888, DOI 10.1074/jbc.M111.311878; Lee MH, 2003, BIOCHEM BIOPH RES CO, V309, P689, DOI 10.1016/j.bbrc.2003.08.058; Liu TJ, 2007, J CELL PHYSIOL, V211, P728, DOI 10.1002/jcp.20988; Liu TM, 2013, TISSUE ENG PART B-RE, V19, P254, DOI [10.1089/ten.TEB.2012.0527, 10.1089/ten.teb.2012.0527]; Matsubara T, 2008, J BIOL CHEM, V283, P29119, DOI 10.1074/jbc.M801774200; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Niger C, 2011, BONE, V49, P683, DOI 10.1016/j.bone.2011.07.027; Nishimura R, 2012, J BIOL CHEM, V287, P33179, DOI 10.1074/jbc.M111.337063; Nishio Y, 2006, GENE, V372, P62, DOI 10.1016/j.gene.2005.12.022; Paredes R, 2004, MOL CELL BIOL, V24, P8847, DOI 10.1128/MCB.24.20.8847-8861.2004; Pelletier N, 2002, ONCOGENE, V21, P2729, DOI 10.1038/sj.onc.1205367; Roca H, 2005, J BIOL CHEM, V280, P30845, DOI 10.1074/jbc.M503942200; Shimoyama A, 2007, MOL BIOL CELL, V18, P2411, DOI 10.1091/mbc.E06-08-0743; Sierra J, 2003, MOL CELL BIOL, V23, P3339, DOI 10.1128/MCB.23.9.3339-3351.2003; Sinha KM, 2014, J BONE MINER RES, V29, P855, DOI 10.1002/jbmr.2103; Thirunavukkarasu K, 1998, MOL CELL BIOL, V18, P4197, DOI 10.1128/MCB.18.7.4197; Timpson NJ, 2009, HUM MOL GENET, V18, P1510, DOI 10.1093/hmg/ddp052; Ulsamer A, 2008, J BIOL CHEM, V283, P3816, DOI 10.1074/jbc.M704724200; Xiao GZ, 2000, J BIOL CHEM, V275, P4453, DOI 10.1074/jbc.275.6.4453; Xiao GZ, 2002, J BIOL CHEM, V277, P36181, DOI 10.1074/JBC.m206057200; Zhang YW, 2000, P NATL ACAD SCI USA, V97, P10549, DOI 10.1073/pnas.180309597; Zhou G, 2006, P NATL ACAD SCI USA, V103, P19004, DOI 10.1073/pnas.0605170103; Zhou X, 2010, P NATL ACAD SCI USA, V107, P12919, DOI 10.1073/pnas.0912855107	53	87	89	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					27105	27117		10.1074/jbc.M114.576793	http://dx.doi.org/10.1074/jbc.M114.576793			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25122769	Green Published, hybrid			2022-12-25	WOS:000342853900037
J	Entin-Meer, M; Levy, R; Goryainov, P; Landa, N; Barshack, I; Avivi, C; Semo, J; Keren, G				Entin-Meer, Michal; Levy, Ran; Goryainov, Pavel; Landa, Natalie; Barshack, Iris; Avivi, Camila; Semo, Jonathan; Keren, Gad			The Transient Receptor Potential Vanilloid 2 Cation Channel Is Abundant in Macrophages Accumulating at the Peri-Infarct Zone and May Enhance Their Migration Capacity towards Injured Cardiomyocytes following Myocardial Infarction	PLOS ONE			English	Article							TRP CHANNELS; TRANSLOCATION	Purpose: A novel family of transient receptor potential (TRP) channels, that may hold a role in calcium homeostasis, has recently been described. By employing a GeneChip array analysis we have demonstrated a clear and specific upregulation of the TRP vanilloid 2 (TRPV2) mRNA in the left ventricles (LV) 3-5 days post-acute myocardial infarction (MI) compared to sham-operated controls, both in rats and in mice. We sought to characterize the cardiac cellular subpopulations in which TRPV2 is overexpressed upon acute MI. Methods: Lewis rats underwent an acute MI by ligation of the left anterior descending artery or chest opening only (sham). The animals were terminated at various time points and an immunohistochemical (IHC) and immunofloerescent (IFC) staining of the LV sections as well as a flow cytometry analysis of LV-derived cells were carried out, using anti-TRPV2 and anti-monocyte/macrophage antibodies. Rat alveolar macrophage cells, NR8383, transiently transfected with TRPV2 siRNA were allowed to migrate towards hypoxic conditioned media of the rat cardiac myoblast line H9C2 using a trans-well migration assay. The macrophage cells migrating to the bottom side of the inserts were counted. Results: The IHC and IFC staining as well as the flow cytometry data demonstrated a substantial expression of TRPV2 in infiltrating macrophages in the peri-infarct region 3-5 days post-acute MI. The in vitro migration assay data demonstrated that following inhibition of the TRPV2 channel, the number of migrating macrophages towards conditioned medium of hypoxic cardiomyocytes was significantly reduced. Conclusions: TRPV2 is highly expressed on the peri-infarct infiltrating macrophages and may play an important role in post-MI phagocytosis. Better characterization of this channel may pave the way for identifying a new target for modulating the dramatic post-MI immune reactions.	[Entin-Meer, Michal; Levy, Ran; Goryainov, Pavel; Semo, Jonathan; Keren, Gad] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Cardiol, Cardiovasc Res Lab, IL-69978 Tel Aviv, Israel; [Entin-Meer, Michal; Semo, Jonathan; Keren, Gad] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Landa, Natalie] Chaim Sheba Med Ctr, Neufeld Cardiac Res Inst, Ramat Gan, Israel; [Barshack, Iris; Avivi, Camila] Chaim Sheba Med Ctr, Dept Pathol, Ramat Gan, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; Chaim Sheba Medical Center	Keren, G (corresponding author), Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Cardiol, Cardiovasc Res Lab, IL-69978 Tel Aviv, Israel.	kereng@tlvmc.gov.il			Israel Science Foundation; Alsa And Leo Abramson Research fund	Israel Science Foundation(Israel Science Foundation); Alsa And Leo Abramson Research fund	Funding provided by Israel Science Foundation; Alsa And Leo Abramson Research fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anversa P, 1995, EUR HEART J, V16, P37, DOI 10.1093/eurheartj/16.suppl_N.37; Barzelay A, 2010, THROMB HAEMOSTASIS, V103, P188, DOI 10.1160/TH09-07-0433; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Di A, 2010, CURR OPIN PHARMACOL, V10, P127, DOI 10.1016/j.coph.2009.11.010; Dong XP, 2010, J NEUROCHEM, V113, P313, DOI 10.1111/j.1471-4159.2010.06626.x; Huang W, 2009, HYPERTENSION, V53, P243, DOI 10.1161/HYPERTENSIONAHA.108.118349; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Iwata Y, 2013, CARDIOVASC RES, V99, P760, DOI 10.1093/cvr/cvt163; Katanosaka Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4932; Koch SE, 2012, J MOL CELL CARDIOL, V53, P134, DOI 10.1016/j.yjmcc.2012.04.011; Kojima Itaru, 2007, P105; Lehen'kyi V, 2011, ADV EXP MED BIOL, V704, P929, DOI 10.1007/978-94-007-0265-3_48; Link TM, 2010, NAT IMMUNOL, V11, P232, DOI 10.1038/ni.1842; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Matthews KG, 1999, J ENDOCRINOL, V163, P433, DOI 10.1677/joe.0.1630433; Minke B, 2006, CELL CALCIUM, V40, P261, DOI 10.1016/j.ceca.2006.05.002; Montange D, 2012, EXP CLIN CARDIOL, V17, P131; Nagasawa M, 2007, J CELL PHYSIOL, V210, P692, DOI 10.1002/jcp.20883; Nagasawa M, 2012, CELL CALCIUM, V51, P186, DOI 10.1016/j.ceca.2011.12.012; Peralvarez-Marin A, 2013, FEBS J, V280, P5471, DOI 10.1111/febs.12302; Rowell J, 2010, J CARDIOVASC TRANSL, V3, P516, DOI 10.1007/s12265-010-9208-4; Santoni Giorgio, 2011, Endocrine Metabolic & Immune Disorders-Drug Targets, V11, P54; Solem ML, 1998, BIOCHEM BIOPH RES CO, V252, P151, DOI 10.1006/bbrc.1998.9626; Sopel M, 2010, J INVEST SURG, V23, P79, DOI 10.3109/08941930903469425; Tang MS, 2012, GROWTH HORM IGF RES, V22, P206, DOI 10.1016/j.ghir.2012.09.002; Vennekens R, 2011, J PHYSIOL-LONDON, V589, P1527, DOI 10.1113/jphysiol.2010.202077; Yan XX, 2013, J MOL CELL CARDIOL, V62, P24, DOI 10.1016/j.yjmcc.2013.04.023	27	26	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105055	10.1371/journal.pone.0105055	http://dx.doi.org/10.1371/journal.pone.0105055			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136832	gold, Green Published, Green Submitted			2022-12-25	WOS:000340742100064
J	Kang, S; Kim, JE; Song, NR; Jung, SK; Lee, MH; Park, JS; Yeom, MH; Bode, AM; Dong, ZG; Lee, KW				Kang, Soouk; Kim, Jong-Eun; Song, Nu Ry; Jung, Sung Keun; Lee, Mee Hyun; Park, Jun Seong; Yeom, Myeong-Hun; Bode, Ann M.; Dong, Zigang; Lee, Ki Won			The Ginsenoside 20-O-beta-D-Glucopyranosyl-20(S)-Protopanaxadiol Induces Autophagy and Apoptosis in Human Melanoma via AMPK/JNK Phosphorylation	PLOS ONE			English	Article							HUMAN COLORECTAL-CANCER; COMPOUND-K; CELL-DEATH; B-RAF; ACTIVATION; MUTATIONS; NECROSIS; SURVIVAL; BRAF; RB1	Studies have shown that a major metabolite of the red ginseng ginsenoside Rb1, called 20-O-beta-D-glucopyranosyl-20(S)-protopanaxadiol (GPD), exhibits anticancer properties. However, the chemotherapeutic effects and molecular mechanisms behind GPD action in human melanoma have not been previously investigated. Here we report the anticancer activity of GPD and its mechanism of action in melanoma cells. GPD, but not its parent compound Rb1, inhibited melanoma cell proliferation in a dose-dependent manner. Further investigation revealed that GPD treatment achieved this inhibition through the induction of autophagy and apoptosis, while Rb1 failed to show significant effect at the same concentrations. The inhibitory effect of GPD appears to be mediated through the induction of AMPK and the subsequent attenuation of mTOR phosphorylation. In addition, GPD activated c-Jun by inducing JNK phosphorylation. Our findings suggest that GPD suppresses melanoma growth by inducing autophagic cell death and apoptosis via AMPK/JNK pathway activation. GPD therefore has the potential to be developed as a chemotherapeutic agent for the treatment of human melanoma.	[Kang, Soouk; Kim, Jong-Eun; Song, Nu Ry; Jung, Sung Keun; Lee, Ki Won] Seoul Natl Univ, Dept Agr Biotechnol, WCU Biomodulat Major, Seoul, South Korea; [Kang, Soouk; Kim, Jong-Eun; Song, Nu Ry; Jung, Sung Keun; Lee, Ki Won] Seoul Natl Univ, Ctr Food & Bioconvergence, Seoul, South Korea; [Kang, Soouk; Kim, Jong-Eun; Jung, Sung Keun; Lee, Mee Hyun; Bode, Ann M.; Dong, Zigang] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA; [Song, Nu Ry; Lee, Ki Won] Seoul Natl Univ, Adv Inst Convergence Technol, Suwon, South Korea; [Jung, Sung Keun] Korea Food Res Inst, Funct Food Resources Res Grp, Songnam, South Korea; [Park, Jun Seong; Yeom, Myeong-Hun] Amorepacif Corp R&D Ctr, Skin Res Inst, Yongin, South Korea; [Lee, Ki Won] Seoul Natl Univ, Inst Green Bio Sci & Technol, Res Inst Bio Food Ind, Pyeongchang, South Korea	Seoul National University (SNU); Seoul National University (SNU); University of Minnesota System; Seoul National University (SNU); Korea Food Research Institute (KFRI); Seoul National University (SNU)	Dong, ZG (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.	zgdong@hi.umn.edu; kiwon@snu.ac.kr	Lee, Ki Won/M-4114-2018; kim, jong-eun/B-3550-2017	kim, jong-eun/0000-0002-5030-6126	World Class Institute Program [WCI2009-002]; Leap Research Program Grant through the National Research Foundation, Ministry of Science, ICT and Future Planning, Republic of Korea [2010-0029233]	World Class Institute Program; Leap Research Program Grant through the National Research Foundation, Ministry of Science, ICT and Future Planning, Republic of Korea	This work was supported by the World Class Institute Program (WCI2009-002) and the Leap Research Program Grant (2010-0029233) through the National Research Foundation, Ministry of Science, ICT and Future Planning, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attele AS, 1999, BIOCHEM PHARMACOL, V58, P1685, DOI 10.1016/S0006-2952(99)00212-9; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Carling D, 2011, NAT CHEM BIOL, V7, P512, DOI [10.1038/nchembio.610, 10.1038/NCHEMBIO.610]; Choi K, 2007, NEUROSCI LETT, V421, P37, DOI 10.1016/j.neulet.2007.05.017; Cuong TT, 2009, LIFE SCI, V85, P625, DOI 10.1016/j.lfs.2009.08.014; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Goydos JS, 2005, J AM COLL SURGEONS, V200, P362, DOI 10.1016/j.jamcollsurg.2004.10.032; Ha YW, 2010, ANAL BIOANAL CHEM, V396, P3017, DOI 10.1007/s00216-010-3515-0; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jia L, 2009, CURR MED CHEM, V16, P2924, DOI 10.2174/092986709788803204; Jung IH, 2012, BIOL PHARM BULL, V35, P573, DOI 10.1248/bpb.35.573; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Karantza-Wadsworth V, 2007, GENE DEV, V21, P1621, DOI 10.1101/gad.1565707; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kim K, 2010, CELL BIOL INT, V34, P75, DOI 10.1042/CBI20090020; Lee DCW, 2011, MOLECULES, V16, P2802, DOI 10.3390/molecules16042802; Leung KW, 2007, BRIT J PHARMACOL, V152, P207, DOI 10.1038/sj.bjp.0707359; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Li W, 2012, FITOTERAPIA, V83, P192, DOI 10.1016/j.fitote.2011.10.011; Lopez-Bergami P, 2007, CANCER CELL, V11, P447, DOI 10.1016/j.ccr.2007.03.009; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; Martin MJ, 2009, CANCER CELL, V15, P163, DOI 10.1016/j.ccr.2009.02.006; Mathew R, 2007, GENE DEV, V21, P1367, DOI 10.1101/gad.1545107; Miki H, 2012, INT J ONCOL, V40, P1020, DOI 10.3892/ijo.2012.1325; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Nikoletopoulou V, 2013, BBA-MOL CELL RES, V1833, P3448, DOI 10.1016/j.bbamcr.2013.06.001; Park JS, 2009, J NEUROIMMUNOL, V209, P40, DOI 10.1016/j.jneuroim.2009.01.020; Park S, 2011, FOOD CHEM TOXICOL, V49, P1367, DOI 10.1016/j.fct.2011.03.021; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; Puissant A, 2010, CANCER RES, V70, P1042, DOI 10.1158/0008-5472.CAN-09-3537; Rozenblat S, 2008, BIOCHEM PHARMACOL, V75, P369, DOI 10.1016/j.bcp.2007.08.024; Si L, 2012, EUR J CANCER, V48, P94, DOI 10.1016/j.ejca.2011.06.056; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Steeves MA, 2010, CURR OPIN CELL BIOL, V22, P218, DOI 10.1016/j.ceb.2009.12.013; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Tomic T, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.86; Vakana E, 2012, J CELL BIOCHEM, V113, P404, DOI 10.1002/jcb.23369; Wakabayashi C, 1998, BIOCHEM BIOPH RES CO, V246, P725, DOI 10.1006/bbrc.1998.8690; Wang CZ, 2007, INT J ONCOL, V31, P1149; Wang CZ, 2012, INT J ONCOL, V40, P1970, DOI 10.3892/ijo.2012.1399; Wong CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009996; Yamada E, 2012, DIABETES, V61, P272, DOI 10.2337/db11-1199; Yoon SH, 2007, BIOL PHARM BULL, V30, P2196, DOI 10.1248/bpb.30.2196; Yun TK, 2001, J KOREAN MED SCI S, V16, P3; Zheng B, 2009, MOL CELL, V33, P237, DOI 10.1016/j.molcel.2008.12.026	47	24	25	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e104305	10.1371/journal.pone.0104305	http://dx.doi.org/10.1371/journal.pone.0104305			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137374	Green Published, Green Submitted, gold			2022-12-25	WOS:000340742100026
J	Miyazaki, Y; Li, R; Rezk, A; Misirliyan, H; Moore, C; Farooqi, N; Solis, M; Goiry, LG; de Faria, O; Dang, VD; Colman, D; Dhaunchak, AS; Antel, J; Gommerman, J; Prat, A; Fillatreau, S; Bar-Or, A				Miyazaki, Yusei; Li, Rui; Rezk, Ayman; Misirliyan, Hetoum; Moore, Craig; Farooqi, Nasr; Solis, Mayra; Goiry, Lorna Galleguillos; de Faria, Omar, Jr.; Van Duc Dang; Colman, David; Dhaunchak, Ajit Singh; Antel, Jack; Gommerman, Jennifer; Prat, Alexandre; Fillatreau, Simon; Bar-Or, Amit		CIHR MSSC New Emerging Team Grant; MSSRF Canadian B Cells MS Team	A Novel MicroRNA-132-Surtuin-1 Axis Underlies Aberrant B-cell Cytokine Regulation in Patients with Relapsing-Remitting Multiple Sclerosis	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; MICRORNA EXPRESSION; T-CELLS; DISEASE; ACTIVATION; ENCEPHALOMYELITIS; AUTOIMMUNITY; LYMPHOCYTES; GENERATION; INDUCTION	Clinical trial results demonstrating that B-cell depletion substantially reduces new relapses in patients with multiple sclerosis (MS) have established that B cells play a role in the pathophysiology of MS relapses. The same treatment appears not to impact antibodies directed against the central nervous system, which underscores the contribution of antibody-independent functions of B cells to disease activity. One mechanism by which B cells are now thought to contribute to MS activity is by over-activating T cells, including through aberrant expression of B cell pro-inflammatory cytokines. However, the mechanisms underlying the observed B cell cytokine dysregulation in MS remain unknown. We hypothesized that aberrant expression of particular microRNAs might be involved in the dysregulated pro-inflammatory cytokine responses of B cells of patients with MS. Through screening candidate microRNAs in activated B cells of MS patients and matched healthy subjects, we discovered that abnormally increased secretion of lymphotoxin and tumor necrosis factor alpha by MS B cells is associated with abnormally increased expression of miR-132. Over-expression of miR-132 in normal B cells significantly enhanced their production of lymphotoxin and tumor necrosis factor alpha. The over-expression of miR-132 also suppressed the miR-132 target, sirtuin-1. We confirmed that pharmacological inhibition of sirtuin-1 in normal B cells induces exaggerated lymphotoxin and tumor necrosis factor alpha production, while the abnormal production of these cytokines by MS B cells can be normalized by resveratrol, a sirtuin-1 activator. These results define a novel miR-132-sirtuin-1 axis that controls pro-inflammatory cytokine secretion by human B cells, and demonstrate that a dysregulation of this axis underlies abnormal pro-inflammatory B cell cytokine responses in patients with MS.	[Miyazaki, Yusei; Li, Rui; Rezk, Ayman; Misirliyan, Hetoum; Moore, Craig; Farooqi, Nasr; Goiry, Lorna Galleguillos; de Faria, Omar, Jr.; Colman, David; Dhaunchak, Ajit Singh; Antel, Jack; Bar-Or, Amit] McGill Univ, Montreal Neurol Inst & Hosp, Neuroimmunol Unit, Montreal, PQ, Canada; [Miyazaki, Yusei; Li, Rui; Rezk, Ayman; Misirliyan, Hetoum; Moore, Craig; Farooqi, Nasr; Goiry, Lorna Galleguillos; de Faria, Omar, Jr.; Colman, David; Dhaunchak, Ajit Singh; Antel, Jack; Bar-Or, Amit] McGill Univ, Montreal Neurol Inst & Hosp, Dept Neurol & Neurosurg, Montreal, PQ, Canada; [Solis, Mayra; Bar-Or, Amit] McGill Univ, Montreal Neurol Inst & Hosp, Clin Res Unit, Montreal, PQ, Canada; [Van Duc Dang; Fillatreau, Simon] Deutsch Rheuma Forschungszentrum, Leibniz Inst, Berlin, Germany; [Gommerman, Jennifer] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Prat, Alexandre] Univ Montreal, Neuroimmunol Res Unit, Ctr Hosp, Ctr Rech, Montreal, PQ, Canada; [Bar-Or, Amit] McGill Univ, Montreal Neurol Inst & Hosp, Expt Therapeut Program, Montreal, PQ, Canada	McGill University; McGill University; McGill University; Deutsches Rheuma-Forschungszentrum (DRFZ); University of Toronto; Universite de Montreal; McGill University	Bar-Or, A (corresponding author), McGill Univ, Montreal Neurol Inst & Hosp, Neuroimmunol Unit, Montreal, PQ, Canada.	amit.bar-or@mcgill.ca	Li, Rui/O-7397-2016; Bar-Or, Amit/AIC-1416-2022; Moore, Craig/AGF-9555-2022	Li, Rui/0000-0002-7210-8358; Moore, Craig/0000-0003-3333-435X; Prat, Alexandre/0000-0001-6188-0580; Fillatreau, Simon/0000-0002-7730-9917; Dang, Van Duc/0000-0002-0403-6479; antel, jack/0000-0002-5148-0636; Gommerman, Jennifer/0000-0003-4576-6168	Canadian Institutes of Health Research (CIHR); Multiple Sclerosis Society of Canada (MSSC), CIHR/MSSC NET Grant in Clinical Autoimmunity; Research Foundation of the MSSC (MSSRF), Canadian B cells in MS Team; Canadian Bureau for International Education (CBIE)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Multiple Sclerosis Society of Canada (MSSC), CIHR/MSSC NET Grant in Clinical Autoimmunity; Research Foundation of the MSSC (MSSRF), Canadian B cells in MS Team; Canadian Bureau for International Education (CBIE)	This work was supported by the Canadian Institutes of Health Research (CIHR) and the Multiple Sclerosis Society of Canada (MSSC) as part of the CIHR/MSSC NET Grant in Clinical Autoimmunity, and the Research Foundation of the MSSC (MSSRF) as part of the 'Canadian B cells in MS Team'. Y.M. was also supported in part by an award from the Canadian Bureau for International Education (CBIE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-Or A, 2008, ANN NEUROL, V63, P395, DOI 10.1002/ana.21363; Bar-Or A, 2010, ANN NEUROL, V67, P452, DOI 10.1002/ana.21939; Barr TA, 2012, J EXP MED, V209, P1001, DOI 10.1084/jem.20111675; Basso K, 2009, IMMUNITY, V30, P744, DOI 10.1016/j.immuni.2009.03.017; Belver L, 2010, IMMUNITY, V33, P713, DOI 10.1016/j.immuni.2010.11.010; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Choi SR, 2012, BRAIN, V135, P2925, DOI 10.1093/brain/aws189; Correale J, 2008, ANN NEUROL, V64, P187, DOI 10.1002/ana.21438; Dorsett Y, 2008, IMMUNITY, V28, P630, DOI 10.1016/j.immuni.2008.04.002; Du CS, 2009, NAT IMMUNOL, V10, P1252, DOI 10.1038/ni.1798; Duddy M, 2007, J IMMUNOL, V178, P6092, DOI 10.4049/jimmunol.178.10.6092; Fillatreau S, 2002, NAT IMMUNOL, V3, P944, DOI 10.1038/ni833; GARRONE P, 1995, J EXP MED, V182, P1265, DOI 10.1084/jem.182.5.1265; Guerau-de-Arellano M, 2011, BRAIN, V134, P3575, DOI 10.1093/brain/awr262; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Hauser SL, 2008, NEW ENGL J MED, V358, P676, DOI 10.1056/NEJMoa0706383; HE L, 2004, NAT REV GENET, V5, P522; Imler TJ, 2009, INT IMMUNOPHARMACOL, V9, P134, DOI 10.1016/j.intimp.2008.10.015; Junker A, 2011, FEBS LETT, V585, P3738, DOI 10.1016/j.febslet.2011.03.052; Kappos L, 2011, LANCET, V378, P1779, DOI 10.1016/S0140-6736(11)61649-8; Lucchinetti CF, 2011, NEW ENGL J MED, V365, P2188, DOI 10.1056/NEJMoa1100648; Magliozzi R, 2007, BRAIN, V130, P1089, DOI 10.1093/brain/awm038; Malumbres R, 2009, BLOOD, V113, P3754, DOI 10.1182/blood-2008-10-184077; Matsushita T, 2008, J CLIN INVEST, V118, P3420, DOI 10.1172/JCI36030; Moore CS, 2013, ANN NEUROL, V74, P709, DOI 10.1002/ana.23967; Nakahama T, 2013, P NATL ACAD SCI USA, V110, P11964, DOI 10.1073/pnas.1311087110; Nimmagadda VK, 2013, J IMMUNOL, V190, P4595, DOI 10.4049/jimmunol.1202584; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Sequeira J, 2008, EXP CELL RES, V314, P3069, DOI 10.1016/j.yexcr.2008.07.011; Shindler KS, 2010, J NEURO-OPHTHALMOL, V30, P328, DOI 10.1097/WNO.0b013e3181f7f833; Sievers C, 2012, CLIN IMMUNOL, V144, P70, DOI 10.1016/j.clim.2012.04.002; Singh NP, 2007, MOL PHARMACOL, V72, P1508, DOI 10.1124/mol.107.038984; Smith KM, 2012, J IMMUNOL, V189, P1567, DOI 10.4049/jimmunol.1103171; Tan LP, 2009, LAB INVEST, V89, P708, DOI 10.1038/labinvest.2009.26; Tang FC, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj009; Tegla CA, 2013, EXP MOL PATHOL, V96, P139; van Loosdregt J, 2010, BLOOD, V115, P965, DOI 10.1182/blood-2009-02-207118; Vigorito E, 2007, IMMUNITY, V27, P847, DOI 10.1016/j.immuni.2007.10.009; von Budingen HC, 2011, CURR OPIN IMMUNOL, V23, P713, DOI 10.1016/j.coi.2011.09.003; Wanet A, 2012, NUCLEIC ACIDS RES, V40, P4742, DOI 10.1093/nar/gks151; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Yoshizaki A, 2012, NATURE, V491, P264, DOI 10.1038/nature11501; Zhang J, 2009, BLOOD, V113, P4586, DOI 10.1182/blood-2008-09-178186; Zhang JN, 2009, J CLIN INVEST, V119, P3048, DOI 10.1172/JCI38902; Zhou BY, 2007, P NATL ACAD SCI USA, V104, P7080, DOI 10.1073/pnas.0702409104	46	64	66	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105421	10.1371/journal.pone.0105421	http://dx.doi.org/10.1371/journal.pone.0105421			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136908	Green Submitted, Green Published, gold			2022-12-25	WOS:000340742100092
J	Paprotny, D; Andrzejewski, P; Terefenko, P; Furmanczyk, K				Paprotny, Dominik; Andrzejewski, Pawel; Terefenko, Pawel; Furmanczyk, Kazimierz			Application of Empirical Wave Run-Up Formulas to the Polish Baltic Sea Coast	PLOS ONE			English	Article							LEVEL; STORM; HINDCAST; PROJECT; EVENTS	Advanced, multidimensional models are typically applied when researching processes occurring in the nearshore. Relatively simple, empirical equations are commonly used in coastal engineering practice in order to estimate extreme wave run-up on beaches and coastal structures. However, they were mostly calibrated to the characteristics of oceanic coasts, which have different wave regime than a semi-enclosed basin like the Baltic Sea. In this paper we apply the formulas to the Polish Baltic Sea coast. The equations were adjusted to match local conditions in two test sites in Miedzyzdroje and Dziwnowek, where beaches are under continuous video surveillance. Data from WAM wave model and coastal gauge stations were used, as well as precise measurements of the beaches' cross-sections. More than 600 run-up events spanning from June to December 2013 were analysed, including surges causing dune erosion. Extreme wave run-up R-2% was calculated and presented as a percentage value indicating what part of the beach was inundated. The method had a root-mean-square error of 6.1 and 6.5 percentage points depending on the test site. We consider it is a fast and computationally undemanding alternative to morphodynamic models. It will constitute a part of the SatBaltyk Operating System-Shores, delivering forecasts of wave run-up on the beaches for the entire Polish coastline.	[Paprotny, Dominik; Andrzejewski, Pawel; Terefenko, Pawel; Furmanczyk, Kazimierz] Univ Szczecin, Fac Geosci, Szczecin, Poland	University of Szczecin	Paprotny, D (corresponding author), Univ Szczecin, Fac Geosci, Szczecin, Poland.	dominikpaprotny@op.pl	Terefenko, Paweł/J-1907-2019	Terefenko, Paweł/0000-0002-5081-8615; Furmanczyk, Kazimierz/0000-0003-2397-4433; Paprotny, Dominik/0000-0001-5090-8402	European Union [POIG.01.01.02-22-011/09-00]	European Union(European Commission)	This work was supported by the European Union through the Innovative Economy Operational Programme - project No. POIG.01.01.02-22-011/09-00 "The Satellite Monitoring of the Baltic Sea Environment (SatBaltyk)". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAGAARD T, 1989, J COASTAL RES, V5, P547; [Anonymous], [No title captured]; Battjes J.A., 1974, P 14 INT C COAST ENG, P466, DOI DOI 10.9753/ICCE.V14; Bugajny N, 2013, J COASTAL RES, P672, DOI 10.2112/SI65-114.1; Ciavola P, 2011, ENVIRON SCI POLICY, V14, P924, DOI 10.1016/j.envsci.2011.05.009; Cieslikiewicz W, 2008, COAST ENG, V55, P894, DOI 10.1016/j.coastaleng.2008.02.017; Davidson M, 2007, COAST ENG, V54, P463, DOI 10.1016/j.coastaleng.2007.01.007; Diaz-Sanchez R, 2014, J COASTAL RES, P1, DOI 10.2112/SI70-001.1; DOUGLASS SL, 1992, J WATERW PORT C-ASCE, V118, P220, DOI 10.1061/(ASCE)0733-950X(1992)118:2(220); Dyke PPG, 1985, OFFSHORE COASTAL MOD; Ferreira O, 2009, J COASTAL RES, P1632; Furmanczyk K, 2014, J COASTAL RES, P338, DOI 10.2112/SI70-057.1; GUZA RT, 1981, J GEOPHYS RES-OCEANS, V86, P4133, DOI 10.1029/JC086iC05p04133; Haerens P, 2012, COASTAL ENG P, V1, P1; Hanson H, 2008, J HYDRAUL RES, V46, P292, DOI 10.1080/00221686.2008.9521962; Haslett SK, 2009, ROUTL INTROD ENVIRON, P1; HASSELMANN S, 1988, J PHYS OCEANOGR, V18, P1775; Holland KT, 1997, IEEE J OCEANIC ENG, V22, P81, DOI 10.1109/48.557542; HOLMAN RA, 1986, COAST ENG, V9, P527, DOI 10.1016/0378-3839(86)90002-5; HOLMAN RA, 1984, J GEOPHYS RES-OCEANS, V89, P6446, DOI 10.1029/JC089iC04p06446; Hughes SA, 2004, COAST ENG, V51, P1085, DOI 10.1016/j.coastaleng.2004.07.026; Hunt IA., 1959, J WATERW HARB DIV, V85, P123, DOI DOI 10.1061/JWHEAU.0000129; Institute of Meteorology and Water Management, 2014, MON BLAT; Interdisciplinary Centre for Mathematical and Computational Modelling, 2014, NUM WEATH FOR; Jedrasik J, 2008, COAST ENG, V55, P849, DOI 10.1016/j.coastaleng.2008.02.026; Johansson M, 2001, BOREAL ENVIRON RES, V6, P159; KOBAYASHI N, 1991, J COASTAL RES, V7, P127; Kont A, 2008, J COASTAL RES, V24, P423, DOI 10.2112/07A-0015.1; Kowalewski M, 2011, BOREAL ENVIRON RES, V16, P27; Lakhan VC, 1989, APPL COASTAL MODELLI, P1; LIPPMANN TC, 1989, J GEOPHYS RES-OCEANS, V94, P995, DOI 10.1029/JC094iC01p00995; MASE H, 1989, J WATERW PORT C-ASCE, V115, P649, DOI 10.1061/(ASCE)0733-950X(1989)115:5(649); Massel SR, 2001, OCEANOLOGIA, V43, P61; Mayer R., 1994, P 24 COAST ENG C ASC, P2325; Melby JA, 2012, TR1224 ERDCCHL; NIELSEN P, 1991, J COASTAL RES, V7, P1139; Powell Helen, 2013, P COSTS PORTS 2013 1, P1; Pullen T., 2007, WAVE OVERTOPPING SEA; Remote Sensing and Marine Cartography Unit, 2014, KAM ZTIKM DZIWN ZACH; Roelvink D, 2009, COAST ENG, V56, P1133, DOI 10.1016/j.coastaleng.2009.08.006; Santos F, 2012, PROC SPIE, V8538, DOI 10.1117/12.974679; Schwarzer K, 2003, MAR GEOL, V194, P79, DOI 10.1016/S0025-3227(02)00700-4; Stockdon HF, 2006, COAST ENG, V53, P573, DOI 10.1016/j.coastaleng.2005.12.005; Suursaar U, 2006, BOREAL ENVIRON RES, V11, P143; Suursaar U, 2003, J SEA RES, V49, P295, DOI 10.1016/S1385-1101(03)00022-4; Trenhaile AS, 1997, COASTAL DYNAMICS LAN; U.S. Army Corps of Engineers, 1984, US ARM ENG WAT EXP S; Vousdoukas MI, 2012, OCEAN DYNAM, V62, P123, DOI 10.1007/s10236-011-0480-x; Wozniak B, 2011, OCEANOLOGIA, V53, P897, DOI 10.5697/oc.53-4.897	49	14	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105437	10.1371/journal.pone.0105437	http://dx.doi.org/10.1371/journal.pone.0105437			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137155	gold, Green Submitted, Green Published			2022-12-25	WOS:000340742100096
J	Phinyomark, A; Hettinga, BA; Osis, ST; Ferber, R				Phinyomark, Angkoon; Hettinga, Blayne A.; Osis, Sean T.; Ferber, Reed			Gender and Age-Related Differences in Bilateral Lower Extremity Mechanics during Treadmill Running	PLOS ONE			English	Article							PRINCIPAL COMPONENT ANALYSIS; KINEMATICS; SELECTION; INJURIES; PATTERNS	Female runners have a two-fold risk of sustaining certain running-related injuries as compared to their male counterparts. Thus, a comprehensive understanding of the sex-related differences in running kinematics is necessary. However, previous studies have either used discrete time point variables and inferential statistics and/or relatively small subject numbers. Therefore, the first purpose of this study was to use a principal component analysis (PCA) method along with a support vector machine (SVM) classifier to examine the differences in running gait kinematics between female and male runners across a large sample of the running population as well as between two age-specific sub-groups. Bilateral 3-dimensional lower extremity gait kinematic data were collected during treadmill running. Data were analysed on the complete sample (n = 483: female 263, male 220), a younger subject group (n = 56), and an older subject group (n = 51). The PC scores were first sorted by the percentage of variance explained and we also employed a novel approach wherein PCs were sorted based on between-gender statistical effect sizes. An SVM was used to determine if the sex and age conditions were separable and classifiable based on the PCA. Forty PCs explained 84.74% of the variance in the data and an SVM classification accuracy of 86.34% was found between female and male runners. Classification accuracies between genders for younger subjects were higher than a subgroup of older runners. The observed interactions between age and gender suggest these factors must be considered together when trying to create homogenous sub-groups for research purposes.	[Phinyomark, Angkoon; Hettinga, Blayne A.; Osis, Sean T.; Ferber, Reed] Univ Calgary, Fac Kinesiol, Calgary, AB, Canada; [Ferber, Reed] Univ Calgary, Fac Nursing, Calgary, AB, Canada; [Hettinga, Blayne A.; Osis, Sean T.; Ferber, Reed] Running Injury Clin, Calgary, AB, Canada	University of Calgary; University of Calgary	Ferber, R (corresponding author), Univ Calgary, Fac Kinesiol, Calgary, AB, Canada.	rferber@ucalgary.ca	Phinyomark, Angkoon/C-7680-2015; Ferber, Reed/AAT-3140-2020	Phinyomark, Angkoon/0000-0003-0170-3245; Ferber, Reed/0000-0002-6154-9115	Alberta Innovates: Health Solutions - Alberta Heritage Foundation; SOLE, Inc.; University of Calgary Eyes High Postdoctoral Research Award program	Alberta Innovates: Health Solutions - Alberta Heritage Foundation; SOLE, Inc.; University of Calgary Eyes High Postdoctoral Research Award program	This work was supported in part by research grants from the Alberta Innovates: Health Solutions (funded by the Alberta Heritage Foundation for Medical Research endowment fund), a charitable donation from SOLE, Inc., and the University of Calgary Eyes High Postdoctoral Research Award program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astephen JL, 2005, CLIN BIOMECH, V20, P209, DOI 10.1016/j.clinbiomech.2004.09.007; Bus SA, 2003, MED SCI SPORT EXER, V35, P1167, DOI 10.1249/01.MSS.0000074441.55707.D1; Chumanov ES, 2008, CLIN BIOMECH, V23, P1260, DOI 10.1016/j.clinbiomech.2008.07.011; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Duda R.O., 2006, PATTERN CLASSIFICATI; Eskofier BM, 2013, COMPUT METHOD BIOMEC, V16, P435, DOI 10.1080/10255842.2011.624515; Eskofier BM, 2012, COMPUT METHOD BIOMEC, V15, P467, DOI 10.1080/10255842.2010.542153; Federolf P, 2013, J BIOMECH, V46, P2626, DOI 10.1016/j.jbiomech.2013.08.008; Fellin RE, 2010, J SCI MED SPORT, V13, P646, DOI 10.1016/j.jsams.2010.03.006; Ferber R, 2003, CLIN BIOMECH, V18, P350, DOI 10.1016/S0268-0033(03)00025-1; Ferber R, 2009, SPORTS HEALTH, V1, P242, DOI 10.1177/1941738109334272; FERRE L, 1995, COMPUT STAT DATA AN, V19, P669, DOI 10.1016/0167-9473(94)00020-J; Foch E, 2014, J BIOMECH, V47, P81, DOI 10.1016/j.jbiomech.2013.10.008; Fukuchi R, 2008, J SPORT SCI, V26, P1447, DOI 10.1080/02640410802209018; Fukuchi RK, 2014, CLIN BIOMECH, V29, P304, DOI 10.1016/j.clinbiomech.2013.12.007; Fukuchi RK, 2011, J BIOMECH, V44, P540, DOI 10.1016/j.jbiomech.2010.09.031; Hedges L. V., 1981, J ED STAT, V6, P107, DOI [10.3102/10769986006002107, DOI 10.3102/10769986006002107]; Labbe DR, 2010, J BIOMECH, V43, P3080, DOI 10.1016/j.jbiomech.2010.08.011; Lilley K, 2011, GAIT POSTURE, V33, P496, DOI 10.1016/j.gaitpost.2011.01.002; Malinzak RA, 2001, CLIN BIOMECH, V16, P438, DOI 10.1016/S0268-0033(01)00019-5; Maurer C, 2012, GAIT POSTURE, V36, P40, DOI 10.1016/j.gaitpost.2011.12.023; McGibbon CA, 2003, EXERC SPORT SCI REV, V31, P102, DOI 10.1097/00003677-200304000-00009; McKean KA, 2007, J BIOMECH, V40, pS616; Nigg BM, 2012, J BIOMECH, V45, P1692, DOI 10.1016/j.jbiomech.2012.03.027; NIGG BM, 1994, GAIT POSTURE, V2, P213, DOI DOI 10.1016/0966-6362(94)90106-6; Olney SJ, 1998, PHYS THER, V78, P814, DOI 10.1093/ptj/78.8.814; Pohl MB, 2010, GAIT POSTURE, V32, P559, DOI 10.1016/j.gaitpost.2010.07.020; Taunton JE, 2002, BRIT J SPORT MED, V36, P95, DOI 10.1136/bjsm.36.2.95; TAYLOR R, 1990, J DIAGN MED SONOG, V6, P35, DOI 10.1177/875647939000600106; Vardaxis VG, 2006, J BIOMECH, V39, pS112; von Tscharner V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065063	31	55	56	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105246	10.1371/journal.pone.0105246	http://dx.doi.org/10.1371/journal.pone.0105246			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137240	Green Submitted, Green Published, gold			2022-12-25	WOS:000340742100079
J	Sawall, Y; Al-Sofyani, A; Banguera-Hinestroza, E; Voolstra, CR				Sawall, Yvonne; Al-Sofyani, Abdulmohsin; Banguera-Hinestroza, Eulalia; Voolstra, Christian R.			Spatio-Temporal Analyses of Symbiodinium Physiology of the Coral Pocillopora verrucosa along Large-Scale Nutrient and Temperature Gradients in the Red Sea	PLOS ONE			English	Article							GREAT-BARRIER-REEF; STYLOPHORA-PISTILLATA; THERMAL TOLERANCE; CHLOROPHYLL; DIVERSITY; PHOTOACCLIMATION; EUTROPHICATION; ENDOSYMBIONTS; ZOOXANTHELLAE; FLUCTUATIONS	Algal symbionts (zooxanthellae, genus Symbiodinium) of scleractinian corals respond strongly to temperature, nutrient and light changes. These factors vary greatly along the north-south gradient in the Red Sea and include conditions, which are outside of those typically considered optimal for coral growth. Nevertheless, coral communities thrive throughout the Red Sea, suggesting that zooxanthellae have successfully acclimatized or adapted to the harsh conditions they experience particularly in the south (high temperatures and high nutrient supply). As such, the Red Sea is a region, which may help to better understand how zooxanthellae and their coral hosts successfully acclimatize or adapt to environmental change (e. g. increased temperatures and localized eutrophication). To gain further insight into the physiology of coral symbionts in the Red Sea, we examined the abundance of dominant Symbiodinium types associated with the coral Pocillopora verrucosa, and measured Symbiodinium physiological characteristics (i.e. photosynthetic processes, cell density, pigmentation, and protein composition) along the latitudinal gradient of the Red Sea in summer and winter. Despite the strong environmental gradients from north to south, our results demonstrate that Symbiodinium microadriaticum (type A1) was the predominant species in P. verrucosa along the latitudinal gradient. Furthermore, measured physiological characteristics were found to vary more with prevailing seasonal environmental conditions than with region-specific differences, although the measured environmental parameters displayed much higher spatial than temporal variability. We conclude that our findings might present the result of long-term acclimatization or adaptation of S. microadriaticum to regionally specific conditions within the Red Sea. Of additional note, high nutrients in the South correlated with high zooxanthellae density indicating a compensation for a temperature-driven loss of photosynthetic performance, which may prove promising for the resilience of these corals under increase of temperature increase and eutrophication.	[Sawall, Yvonne] Helmholtz Ctr Ocean Res GEOMAR, Benth Ecol Grp, Kiel, Germany; [Al-Sofyani, Abdulmohsin] King Abdulaziz Univ, Fac Marine Sci, Dept Marine Biol, Jeddah 21413, Saudi Arabia; [Banguera-Hinestroza, Eulalia; Voolstra, Christian R.] King Abdullah Univ Sci & Technol, Red Sea Res Ctr, Thuwal, Saudi Arabia	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; King Abdulaziz University; King Abdullah University of Science & Technology	Sawall, Y (corresponding author), Helmholtz Ctr Ocean Res GEOMAR, Benth Ecol Grp, Kiel, Germany.	ysawall@geomar.de	Voolstra, Christian R/H-7158-2014	Voolstra, Christian R/0000-0003-4555-3795; Banguera-Hinestroza, Eulalia/0000-0002-1798-8911	KAU, Jeddah, Saudi Arabia [T-065/430-DSR]; GEOMAR and King Abdullah University for Science and Technology (KAUST), Thuwal, Saudi Arabia; Academic Excellence Alliance (AEA) Award [1000000533]	KAU, Jeddah, Saudi Arabia; GEOMAR and King Abdullah University for Science and Technology (KAUST), Thuwal, Saudi Arabia; Academic Excellence Alliance (AEA) Award	This collaboration of the Jeddah Transect Project between King Abdulaziz University (KAU) and Helmholtz-Center for Ocean Research GEOMAR was funded by KAU, Jeddah, Saudi Arabia, under grant no. T-065/430-DSR. Further support was given by GEOMAR and King Abdullah University for Science and Technology (KAUST), Thuwal, Saudi Arabia for laboratory analyses. This project was partially funded by an Academic Excellence Alliance (AEA) Award (Award Number 1000000533) to CRV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acker J, 2008, J MARINE SYST, V69, P191, DOI 10.1016/j.jmarsys.2005.12.006; Al-Sofyani AA, 2013, OCEANOLOGIA, V55, P917, DOI 10.5697/oc.55-4.917; Ambarsari I, 1997, MAR ECOL PROG SER, V159, P303, DOI 10.3354/meps159303; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Baker AC, 2004, NATURE, V430, P741, DOI 10.1038/430741a; BELL PRF, 1992, WATER RES, V26, P553, DOI 10.1016/0043-1354(92)90228-V; Berkelmans R, 2006, P ROY SOC B-BIOL SCI, V273, P2305, DOI 10.1098/rspb.2006.3567; Borell EM, 2008, OECOLOGIA, V157, P593, DOI 10.1007/s00442-008-1102-2; Brown BE, 2002, MAR ECOL PROG SER, V242, P119, DOI 10.3354/meps242119; Brown BE, 1999, MAR ECOL PROG SER, V191, P53, DOI 10.3354/meps191053; Coles SL, 2003, ADV MAR BIOL, V46, P183, DOI 10.1016/S0065-2881(03)46004-5; DENNISON WC, 1993, BIOSCIENCE, V43, P86, DOI 10.2307/1311969; DeVantier L, 2000, CORAL BLEACHING CENT; DUBINSKY Z, 1990, PROC R SOC SER B-BIO, V239, P231, DOI 10.1098/rspb.1990.0015; Dubinsky Z., 1994, Pacific Science, V48, P313; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Enriquez S, 2010, DEVEL APPL PHYCOL, V4, P187, DOI 10.1007/978-90-481-9268-7_9; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Fabricius KE, 2004, MOL ECOL, V13, P2445, DOI 10.1111/j.1365-294X.2004.02230.x; Ferrier-Pages C, 2010, J EXP MAR BIOL ECOL, V390, P118, DOI 10.1016/j.jembe.2010.05.007; Fitt WK, 2001, CORAL REEFS, V20, P51, DOI 10.1007/s003380100146; Frade PR, 2008, MOL ECOL, V17, P691, DOI 10.1111/j.1365-294X.2007.03612.x; Franklin EC, 2012, MOL ECOL RESOUR, V12, P369, DOI 10.1111/j.1755-0998.2011.03081.x; Glynn PW, 1996, GLOBAL CHANGE BIOL, V2, P495, DOI 10.1111/j.1365-2486.1996.tb00063.x; Goulet TL, 2006, MAR ECOL PROG SER, V321, P1, DOI 10.3354/meps321001; Grottoli AG, 2006, NATURE, V440, P1186, DOI 10.1038/nature04565; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Houlbreque F, 2009, BIOL REV, V84, P1, DOI 10.1111/j.1469-185X.2008.00058.x; Iglesias-Prieto R, 2004, P ROY SOC B-BIOL SCI, V271, P1757, DOI 10.1098/rspb.2004.2757; Jessen C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062091; JOKIEL PL, 1993, MAR ECOL PROG SER, V93, P175, DOI 10.3354/meps093175; Jones RJ, 1998, PLANT CELL ENVIRON, V21, P1219, DOI 10.1046/j.1365-3040.1998.00345.x; Karako-Lampert S, 2004, J EXP MAR BIOL ECOL, V311, P301, DOI 10.1016/j.jembe.2004.05.015; Kleypas JA, 1999, AM ZOOL, V39, P146; LaJeunesse TC, 2003, LIMNOL OCEANOGR, V48, P2046, DOI 10.4319/lo.2003.48.5.2046; LaJeunesse TC, 2002, MAR BIOL, V141, P387, DOI 10.1007/s00227-002-0829-2; LaJeunesse TC, 2001, J PHYCOL, V37, P866, DOI 10.1046/j.1529-8817.2001.01031.x; LaJeunesse TC, 2000, BIOL BULL, V199, P126, DOI 10.2307/1542872; LaJeunesse TC, 2010, J BIOGEOGR, V37, P785, DOI 10.1111/j.1365-2699.2010.02273.x; Loisel H, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003367; Mass T, 2007, MAR ECOL PROG SER, V334, P93, DOI 10.3354/meps334093; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; McGinley MP, 2012, MAR ECOL PROG SER, V462, P1, DOI 10.3354/meps09914; Naumann MS, 2009, CORAL REEFS, V28, P109, DOI 10.1007/s00338-008-0459-3; PORTER JW, 1984, PROC R SOC SER B-BIO, V222, P161, DOI 10.1098/rspb.1984.0057; Rabalais NN, 2009, ICES J MAR SCI, V66, P1528, DOI 10.1093/icesjms/fsp047; Ralph PJ, 2005, AQUAT BOT, V82, P222, DOI 10.1016/j.aquabot.2005.02.006; Reynolds JM, 2008, P NATL ACAD SCI USA, V105, P13674, DOI 10.1073/pnas.0805187105; Robison JD, 2006, J PHYCOL, V42, P568, DOI 10.1111/j.1529-8817.2006.00232.x; Sampayo EM, 2009, MOL ECOL, V18, P500, DOI 10.1111/j.1365-294X.2008.04037.x; Sawall Y, 2011, CORAL REEFS, V30, P841, DOI 10.1007/s00338-011-0764-0; Sawall Y., 2014, J ECOL ECOGR, VS4, P003, DOI DOI 10.4172/2157-7625.S4-003; Sheppard C.R.C., 1991, Fauna of Saudi Arabia, V12, P3; SOUVERMEZOGLOU E, 1989, J MAR RES, V47, P441, DOI 10.1357/002224089785076244; Stimson J, 2002, CORAL REEFS, V21, P409, DOI 10.1007/s00338-002-0264-3; Stott PA, 2000, SCIENCE, V290, P2133, DOI 10.1126/science.290.5499.2133; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Titlyanov EA, 2001, J EXP MAR BIOL ECOL, V257, P163, DOI 10.1016/S0022-0981(00)00308-7; TRENCH RK, 1987, J PHYCOL, V23, P469, DOI 10.1111/j.1529-8817.1987.tb02534.x; Ulstrup KE, 2006, MAR ECOL PROG SER, V314, P135, DOI 10.3354/meps314135; Veron JEN, 2000, CORALS WORLD AUSTR I; Weis VM, 2008, J EXP BIOL, V211, P3059, DOI 10.1242/jeb.009597; Wiedenmann J, 2013, NAT CLIM CHANGE, V3, P160, DOI 10.1038/NCLIMATE1661	63	68	70	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e103179	10.1371/journal.pone.0103179	http://dx.doi.org/10.1371/journal.pone.0103179			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137123	Green Published, gold, Green Accepted			2022-12-25	WOS:000340742100006
J	Liang, ZC; Cheng, LL; Zhong, GY; Liu, RH				Liang, Zhenchang; Cheng, Lailiang; Zhong, Gan-Yuan; Liu, Rui Hai			Antioxidant and Antiproliferative Activities of Twenty-Four Vitis vinifera Grapes	PLOS ONE			English	Article							ANTI PROLIFERATIVE ACTIVITIES; WOODCHUCK HEPATITIS-VIRUS; KAPPA-B ACTIVATION; CANCER MCF-7 CELLS; COMMON FRUITS; RED WINES; POLYPHENOLS; ASSAY; PHYTOCHEMICALS; PROFILES	Grapes are rich in phytochemicals with many proven health benefits. Phenolic profiles, antioxidant and antiproliferative activities of twenty-four selected Vitis vinifera grape cultivars were investigated in this study. Large ranges of variation were found in these cultivars for the contents of total phenolics (95.3 to 686.5 mg/100 g) and flavonoids (94.7 to 1055 mg/100 g) and antioxidant activities (oxygen radical absorbance capacity 378.7 to 3386.0 mg of Trolox equivalents/100 g and peroxylradical scavenging capacity14.2 to 557 mg of vitamin C equivalents/100 g), cellular antioxidant activities (3.9 to 139.9 mu mol of quercetin equivalents/100 g without PBS wash and 1.4 to 95.8 mu mol of quercetin equivalents/100 g with PBS wash) and antiproliferative activities (25 to 82% at the concentrations of 100 mg/mL extracts). The total antioxidant activities were significantly correlated with the total phenolics and flavonoids. However, no significant correlations were found between antiproliferative activities and total phenolics or total flavonoids content. Wine grapes and color grapes showed much higher levels of phytochemicals and antioxidant activities than table grapes and green/yellow grapes. Several germplasm accessions with much high contents of phenolics and flavonoids, and total antioxidant activity were identified. These germplasm can be valuable sources of genes for breeding grape cultivars with better nutritional qualities of wine and table grapes in the future.	[Liang, Zhenchang] Chinese Acad Sci, Inst Bot, Beijing, Peoples R China; [Liang, Zhenchang; Liu, Rui Hai] Cornell Univ, Dept Food Sci, Ithaca, NY 14853 USA; [Cheng, Lailiang] Cornell Univ, Dept Hort, Ithaca, NY USA; [Zhong, Gan-Yuan] USDA ARS, Grape Genet Res Unit, Geneva, NY 14456 USA	Chinese Academy of Sciences; Institute of Botany, CAS; Cornell University; Cornell University; United States Department of Agriculture (USDA)	Zhong, GY (corresponding author), USDA ARS, Grape Genet Res Unit, Geneva, NY 14456 USA.	ganyuan.zhong@ars.usda.gov; rl23@cornell.edu	Liu, Rui Hai/AAE-4865-2019; Liu, Rui Hai/C-2865-2008	Liu, Rui Hai/0000-0002-7018-7929; 	USDA-ARS; Cornell University; United States Department of Agriculture-Agricultural Research Service [1910-21220-004-00D]	USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Cornell University; United States Department of Agriculture-Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	The authors are grateful to Mr. Bernard Prins of the USDA-ARS National Clonal Germplasm Repository for Fruit and Nut Crops in Davis, California and Dr. Christopher Owens of the USDA-ARS Grape Genetics Research Unit in Geneva, New York for providing V. vinifera berry samples. This work was supported by a Special Cooperative Agreement between USDA-ARS and Cornell University. USDA-ARS is an equal opportunity provider and employer. This project was supported by the United States Department of Agriculture-Agricultural Research Service Project 1910-21220-004-00D through a Specific Cooperative Agreement with Cornell University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adom KK, 2005, J AGR FOOD CHEM, V53, P6572, DOI 10.1021/jf048318o; Arnous A, 2002, J FOOD COMPOS ANAL, V15, P655, DOI 10.1006/jfca.2002.1070; Bitsch R, 2004, J BIOMED BIOTECHNOL, P293, DOI 10.1155/S1110724304403106; Bub A, 2003, J NUTR BIOCHEM, V14, P90, DOI 10.1016/S0955-2863(02)00255-3; Chu YF, 2002, J AGR FOOD CHEM, V50, P6910, DOI 10.1021/jf020665f; Del Caro A, 2010, ACTA ALIMENT HUNG, V39, P192, DOI 10.1556/AAlim.39.2010.2.11; Eberhardt MV, 2005, J AGR FOOD CHEM, V53, P7421, DOI 10.1021/jf051495k; Felice DL, 2009, J FUNCT FOODS, V1, P109, DOI 10.1016/j.jff.2008.09.014; Garcia-Alonso M, 2009, J NUTR BIOCHEM, V20, P521, DOI 10.1016/j.jnutbio.2008.05.011; He X, 2008, J AGR FOOD CHEM, V56, P9905, DOI 10.1021/jf8015255; He XJ, 2008, J AGR FOOD CHEM, V56, P9337, DOI 10.1021/jf070954+; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Jia Z, 1999, FOOD CHEM, V64, P555, DOI 10.1016/S0308-8146(98)00102-2; Kallithraka S, 2009, INT J FOOD SCI TECH, V44, P2385, DOI 10.1111/j.1365-2621.2008.01869.x; Liang ZC, 2008, FOOD CHEM, V111, P837, DOI 10.1016/j.foodchem.2008.04.069; Liang ZC, 2011, FOOD CHEM, V129, P940, DOI 10.1016/j.foodchem.2011.05.050; Liu RH, 2003, AM J CLIN NUTR, V78, p517S, DOI 10.1093/ajcn/78.3.517S; Liu RH, 2004, J NUTR, V134, p3479S, DOI 10.1093/jn/134.12.3479S; LIU RH, 1992, CANCER RES, V52, P4139; LIU RH, 1994, CARCINOGENESIS, V15, P2875, DOI 10.1093/carcin/15.12.2875; Nikfardjam MSP, 2006, FOOD CHEM, V98, P453, DOI 10.1016/j.foodchem.2005.06.014; Okarter N, 2010, FOOD CHEM, V119, P249, DOI 10.1016/j.foodchem.2009.06.021; Ou BX, 2001, J AGR FOOD CHEM, V49, P4619, DOI 10.1021/jf010586o; Pirniyazov AZ, 2003, CHEM NAT COMPD+, V39, P349, DOI 10.1023/B:CONC.0000003414.46129.15; Shin Y, 2008, POSTHARVEST BIOL TEC, V49, P201, DOI 10.1016/j.postharvbio.2008.02.008; Singleton VL, 1999, METHOD ENZYMOL, V299, P152; Sun J, 2002, J AGR FOOD CHEM, V50, P7449, DOI 10.1021/jf0207530; Tagliazucchi D, 2010, FOOD CHEM, V120, P599, DOI 10.1016/j.foodchem.2009.10.030; USDA, 2010, DIET GUID AM, DOI DOI 10.HTTP://WWW.CNPP.USDA.G0V/PUBLICATI0NS/DIETARYGUIDELINES/2010/P0LICYD0C/P0LICYD0C.PDF; Valdez LB, 2004, BIOL RES, V37, P279, DOI 10.4067/S0716-97602004000200014; Vita JA, 2005, AM J CLIN NUTR, V81, p292S, DOI 10.1093/ajcn/81.1.292S; Wolfe KL, 2008, J AGR FOOD CHEM, V56, P8404, DOI 10.1021/jf8013074; Wolfe KL, 2008, J AGR FOOD CHEM, V56, P8418, DOI 10.1021/jf801381y; Wolfe KL, 2007, J AGR FOOD CHEM, V55, P8896, DOI 10.1021/jf0715166; Xia EQ, 2010, INT J MOL SCI, V11, P622, DOI 10.3390/ijms11020622; Yang J, 2009, FOOD CHEM, V116, P332, DOI 10.1016/j.foodchem.2009.02.021; Yoon H, 2008, J AGR FOOD CHEM, V56, P8412, DOI 10.1021/jf8012844; Yoon H, 2007, J AGR FOOD CHEM, V55, P3167, DOI 10.1021/jf0632379; Zhang MW, 2010, J AGR FOOD CHEM, V58, P7580, DOI 10.1021/jf1007665	39	47	49	3	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105146	10.1371/journal.pone.0105146	http://dx.doi.org/10.1371/journal.pone.0105146			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133401	gold, Green Published, Green Submitted			2022-12-25	WOS:000341302700077
J	Nagib, S; Rau, J; Sammra, O; Lammler, C; Schlez, K; Zschock, M; Prenger-Berninghoff, E; Klein, G; Abdulmawjood, A				Nagib, Samy; Rau, Joerg; Sammra, Osama; Laemmler, Christoph; Schlez, Karen; Zschoeck, Michael; Prenger-Berninghoff, Ellen; Klein, Guenter; Abdulmawjood, Amir			Identification of Trueperella pyogenes Isolated from Bovine Mastitis by Fourier Transform Infrared Spectroscopy	PLOS ONE			English	Article							ARCANOBACTERIUM-PYOGENES; CLASSIFICATION; BACTERIA; FOOD	The present study was designed to investigate the potential of Fourier transform infrared (FT-IR) spectroscopy to identify Trueperella (T.) pyogenes isolated from bovine clinical mastitis. FT-IR spectroscopy was applied to 57 isolates obtained from 55 cows in a period from 2009 to 2012. Prior to FT-IR spectroscopy these isolates were identified by phenotypic and genotypic properties, also including the determination of seven potential virulence factor encoding genes. The FT-IR analysis revealed a reliable identification of all 57 isolates as T. pyogenes and a clear separation of this species from the other species of genus Trueperella and from species of genus Arcanobacterium and Actinomyces. The results showed that all 57 isolates were assigned to the correct species indicating that FT-IR spectroscopy could also be efficiently used for identification of this bacterial pathogen.	[Nagib, Samy; Sammra, Osama; Laemmler, Christoph] Univ Giessen, Inst Pharmakol & Toxikol, D-35390 Giessen, Germany; [Rau, Joerg] CVUAS, Fellbach, Germany; [Schlez, Karen; Zschoeck, Michael] Landesbetrieb Hess Landeslabor, Giessen, Germany; [Prenger-Berninghoff, Ellen] Univ Giessen, Inst Hyg & Infekt Krankheiten Tiere, Giessen, Germany; [Klein, Guenter; Abdulmawjood, Amir] Univ Vet Med Hannover, Inst Lebensmittelqual & Sicherheit, Hannover, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen; University of Veterinary Medicine Hannover, Foundation	Abdulmawjood, A (corresponding author), Univ Vet Med Hannover, Inst Lebensmittelqual & Sicherheit, Hannover, Germany.	amir.abdulmawjood@tiho-hannover.de	Abdulmawjood, Amir/C-6083-2015; Abdulmawjood, Amir/AAL-5523-2020; Klein, Günter/G-5321-2013	Abdulmawjood, Amir/0000-0001-5189-8381; Klein, Günter/0000-0003-1931-2701				Al-Tarazi Y., 2012, Journal of Camelid Science, V5, P99; Contzen M, 2011, ZOONOSES PUBLIC HLTH, V58, P479, DOI 10.1111/j.1863-2378.2011.01396.x; Fricker M, 2011, INT J FOOD MICROBIOL, V145, pS24, DOI 10.1016/j.ijfoodmicro.2010.08.025; GAHRNHANSEN B, 1992, DIAGN MICR INFEC DIS, V15, P349, DOI 10.1016/0732-8893(92)90022-L; Grunert T, 2013, J CLIN MICROBIOL, V51, P2261, DOI 10.1128/JCM.00581-13; HARTWIGK H, 1962, ZBL BAKT PARASIT, V186, P544; HARTWIGK H., 1960, ZENTRALBL BAKT PARASITENK INFEKTIONSKRANKH U HYG, V179, P499; Hijazin M, 2012, VET MICROBIOL, V157, P243, DOI 10.1016/j.vetmic.2011.12.022; Hijazin M, 2011, J DAIRY SCI, V94, P1813, DOI 10.3168/jds.2010-3678; Horlacher S, 2009, AMTSTIERARZTLICHER D; Janbu AO, 2008, FEMS MICROBIOL LETT, V278, P164, DOI 10.1111/j.1574-6968.2007.00995.x; Johler S, 2013, FOODBORNE PATHOG DIS, V10, P777, DOI 10.1089/fpd.2013.1503; Jost BH, 2005, ANTON LEEUW INT J G, V88, P87, DOI 10.1007/s10482-005-2316-5; Kavitha K, 2010, J MED MICROBIOL, V59, P736, DOI 10.1099/jmm.0.016485-0; Kuhm AE, 2009, APPL ENVIRON MICROB, V75, P5809, DOI 10.1128/AEM.00206-09; Lammler C, 1995, HDB BAKTERIELLEN INF, VII/3, P196; Lasch P., 2015, ENCY ANAL CHEM, P1, DOI DOI 10.1002/9780470027318.A0117.PUB2; Moore R., 2010, CORYNEBACTERIUM ARCA, V4th, P133, DOI [10.1002/9780470958209.CH8, DOI 10.1002/9780470958209.CH8]; Oberreuter H, 2002, INT J SYST EVOL MICR, V52, P91, DOI 10.1099/00207713-52-1-91; Prunner I., 2013, XIII Middle European Buiatrics Congress, Belgrade, Serbia, 5-8 June, 2013., P168; Rau J, 2009, BERL MUNCH TIERARZTL, V122, P25, DOI 10.2376/0005-9366-122-25; Samuels AC, 2009, APPL SPECTROSC, V63, P14, DOI 10.1366/000370209787169867; Schabauer L, 2011, FT IR SPECTR MICR ME; Spohr M, 2011, ZOONOSES PUBLIC HLTH, V58, P252, DOI 10.1111/j.1863-2378.2010.01344.x; Udelhoven T, 2003, CHEMOMETR INTELL LAB, V66, P219, DOI 10.1016/S0169-7439(02)00161-2; Udelhoven T, 2000, APPL SPECTROSC, V54, P1471, DOI 10.1366/0003702001948619; Ulbegi-Mohyla H, 2010, J VET SCI, V11, P265, DOI 10.4142/jvs.2010.11.3.265; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Wenning M, 2013, APPL MICROBIOL BIOT, V97, P7111, DOI 10.1007/s00253-013-5087-3; Wortberg F, 2012, J FISH DIS, V35, P1, DOI 10.1111/j.1365-2761.2011.01317.x; Yassin AF, 2011, INT J SYST EVOL MICR, V61, P1265, DOI 10.1099/ijs.0.020032-0	31	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e104654	10.1371/journal.pone.0104654	http://dx.doi.org/10.1371/journal.pone.0104654			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133407	Green Submitted, gold, Green Published			2022-12-25	WOS:000341302700037
J	Zorin, B; Grundman, O; Khozin-Goldberg, I; Leu, S; Shapira, M; Kaye, Y; Tourasse, N; Vallon, O; Boussiba, S				Zorin, Boris; Grundman, Omer; Khozin-Goldberg, Inna; Leu, Stefan; Shapira, Michal; Kaye, Yuval; Tourasse, Nicolas; Vallon, Olivier; Boussiba, Sammy			Development of a Nuclear Transformation System for Oleaginous Green Alga Lobosphaera (Parietochloris) incisa and Genetic Complementation of a Mutant Strain, Deficient in Arachidonic Acid Biosynthesis	PLOS ONE			English	Article							CHLAMYDOMONAS-REINHARDTII; PHAEODACTYLUM-TRICORNUTUM; NITROGEN STARVATION; NANNOCHLOROPSIS SP; ACCUMULATION; EXPRESSION; PROMOTER; TRIACYLGLYCEROLS; TREBUXIOPHYCEAE; CHLOROPHYTA	Microalgae are considered a promising source for various high value products, such as carotenoids, omega-3 and omega-6 polyunsaturated fatty acids (PUFA). The unicellular green alga Lobosphaera (Parietochloris) incisa is an outstanding candidate for the efficient phototrophic production of arachidonic acid (AA), an essential omega-6 PUFA for infant brain development and a widely used ingredient in the baby formula industry. Although phototrophic production of such algal products has not yet been established, estimated costs are considered to be 2-5 times higher than competing heterotrophic production costs. This alga accumulates unprecedented amounts of AA within triacylglycerols and the molecular pathway of AA biosynthesis in L. incisa has been previously elucidated. Thus, progress in transformation and metabolic engineering of this high value alga could be exploited for increasing the efficient production of AA at competitive prices. We describe here the first successful transformation of L. incisa using the ble gene as a selection marker, under the control of the endogenous RBCS promoter. Furthermore, we have succeeded in the functional complementation of the L. incisa mutant strain P127, containing a mutated, inactive version of the delta-5 (Delta 5) fatty acid desaturase gene. A copy of the functional Delta 5 desaturase gene, linked to the ble selection marker, was transformed into the P127 mutant. The resulting transformants selected for zeocine resistant, had AA biosynthesis partially restored, indicating the functional complementation of the mutant strain with the wild-type gene. The results of this study present a platform for the successful genetic engineering of L. incisa and its long-chain PUFA metabolism.	[Zorin, Boris; Grundman, Omer; Khozin-Goldberg, Inna; Leu, Stefan; Kaye, Yuval; Boussiba, Sammy] Ben Gurion Univ Negev, J Blaustein Inst Desert Res, French Associates Inst Agr & Biotechnol Drylands, Microalgal Biotechnol Lab, Midreshet Ben Gurion, Israel; [Shapira, Michal] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Tourasse, Nicolas; Vallon, Olivier] Univ Paris 06, CNRS, Inst Biol Physicochim, UMR 7141, Paris, France	Ben Gurion University; Ben Gurion University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite	Khozin-Goldberg, I (corresponding author), Ben Gurion Univ Negev, J Blaustein Inst Desert Res, French Associates Inst Agr & Biotechnol Drylands, Microalgal Biotechnol Lab, Midreshet Ben Gurion, Israel.	khozin@bgu.ac.il	Khozin-Goldberg, Inna/F-2300-2012; VALLON, Olivier/AAM-7737-2021; Zorin, Boris/AAW-9130-2021	Khozin-Goldberg, Inna/0000-0001-8618-0687; Zorin, Boris/0000-0002-5558-6438; Boussiba, Sammy/0000-0001-9707-0811; Shapira, Michal/0000-0002-6164-7874	European Commission [266401]; Kreitman School of Advanced Graduate Studies at Ben-Gurion University; French state "Initiative d'Excellence" program (Grant "DYNAMO") [ANR-11-LABX-0011-01]	European Commission(European CommissionEuropean Commission Joint Research Centre); Kreitman School of Advanced Graduate Studies at Ben-Gurion University; French state "Initiative d'Excellence" program (Grant "DYNAMO")	This research was financially supported by the European Commission's Seventh Framework Program for Research and Technology Development (FP7), project GIAVAP, Grant No. 266401. BZ, OG and YK acknowledge support from the Kreitman School of Advanced Graduate Studies at Ben-Gurion University. OV acknowledges support from the French state "Initiative d'Excellence" program (Grant "DYNAMO", ANR-11-LABX-0011-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apt KE, 1996, MOL GEN GENET, V252, P572, DOI 10.1007/s004380050264; Bigogno C, 2002, PHYTOCHEMISTRY, V60, P135, DOI 10.1016/S0031-9422(02)00037-7; Bigogno C, 2002, PHYTOCHEMISTRY, V60, P497, DOI 10.1016/S0031-9422(02)00100-0; Cohen Z., 2010, Single cell oils: microbial and algal oils, P201; Cohen Z, 2009, Parietochloris incisa, Patent No. [WO/2009/022323, 2009022323]; DOWER WJ, 1988, NUCLEIC ACIDS RES, V16, P6127, DOI 10.1093/nar/16.13.6127; Fischer N, 2001, MOL GENET GENOMICS, V265, P888, DOI 10.1007/s004380100485; Guo SL, 2013, J BIOTECHNOL, V163, P61, DOI 10.1016/j.jbiotec.2012.10.020; Hamilton ML, 2014, METAB ENG, V22, P3, DOI 10.1016/j.ymben.2013.12.003; Harris E. H., 1989, CHLAMYDOMONAS SOURCE; Imamura S, 2012, J GEN APPL MICROBIOL, V58, P1; Ishida K, 2007, EUKARYOT CELL, V6, P2157, DOI 10.1128/EC.00304-07; Iskandarov U, 2011, APPL MICROBIOL BIOT, V90, P249, DOI 10.1007/s00253-010-3005-5; Karsten U, 2005, J PHYCOL, V41, P557, DOI 10.1111/j.1529-8817.2005.00081.x; Khozin-Goldberg I, 2005, BBA-MOL CELL BIOL L, V1738, P63, DOI 10.1016/j.bbalip.2005.09.005; Khozin-Goldberg I, 2002, J PHYCOL, V38, P991, DOI 10.1046/j.1529-8817.2002.01160.x; Kilian O, 2011, P NATL ACAD SCI USA, V108, P21265, DOI 10.1073/pnas.1105861108; KINDLE KL, 1990, P NATL ACAD SCI USA, V87, P1228, DOI 10.1073/pnas.87.3.1228; Lerche K, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-11; Leu S., 2014, Industrial Biotechnology, V10, P169; Lumbreras V, 1998, PLANT J, V14, P441, DOI 10.1046/j.1365-313X.1998.00145.x; Meslet-Cladiere L, 2011, EUKARYOT CELL, V10, P1670, DOI 10.1128/EC.05043-11; Mussgnug JH, 2007, PLANT BIOTECHNOL J, V5, P802, DOI 10.1111/j.1467-7652.2007.00285.x; Neupert J, 2009, PLANT J, V57, P1140, DOI 10.1111/j.1365-313X.2008.03746.x; Pal D, 2011, APPL MICROBIOL BIOT, V90, P1429, DOI 10.1007/s00253-011-3170-1; Qin S, 2012, BIOTECHNOL ADV, V30, P1602, DOI 10.1016/j.biotechadv.2012.05.004; Schroda M, 2002, PLANT J, V31, P445, DOI 10.1046/j.1365-313X.2002.01371.x; Schroda M, 2000, PLANT J, V21, P121, DOI 10.1046/j.1365-313x.2000.00652.x; STANIER RY, 1971, BACTERIOL REV, V35, P171, DOI 10.1128/MMBR.35.2.171-205.1971; Stevens DR, 1996, MOL GEN GENET, V251, P23; Talebi AF, 2013, MOL BIOL REP, V40, P4421, DOI 10.1007/s11033-013-2532-4; Trentacoste EM, 2013, P NATL ACAD SCI USA, V110, P19748, DOI 10.1073/pnas.1309299110; van Ooijen G, 2012, JOVE-J VIS EXP, DOI 10.3791/4074; Vieler A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003064; von Gromoff ED, 2006, NUCLEIC ACIDS RES, V34, P4767, DOI 10.1093/nar/gkl602; Watanabe Shin, 1996, Phycological Research, V44, P107, DOI 10.1111/j.1440-1835.1996.tb00383.x; Zhang C., 2013, MAR GENOMICS	37	25	25	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105223	10.1371/journal.pone.0105223	http://dx.doi.org/10.1371/journal.pone.0105223			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133787	Green Published, gold, Green Submitted			2022-12-25	WOS:000341302700092
J	Ananthasubramaniam, B; Herzel, H				Ananthasubramaniam, Bharath; Herzel, Hanspeter			Positive Feedback Promotes Oscillations in Negative Feedback Loops	PLOS ONE			English	Article							CIRCADIAN-RHYTHMS; MODEL; ULTRASENSITIVITY; MOTIFS	A simple three-component negative feedback loop is a recurring motif in biochemical oscillators. This motif oscillates as it has the three necessary ingredients for oscillations: a three-step delay, negative feedback, and nonlinearity in the loop. However, to oscillate, this motif under the common Goodwin formulation requires a high degree of cooperativity (a measure of nonlinearity) in the feedback that is biologically "unlikely.'' Moreover, this recurring negative feedback motif is commonly observed augmented by positive feedback interactions. Here we show that these positive feedback interactions promote oscillation at lower degrees of cooperativity, and we can thus unify several common kinetic mechanisms that facilitate oscillations, such as self-activation and Michaelis-Menten degradation. The positive feedback loops are most beneficial when acting on the shortest lived component, where they function by balancing the lifetimes of the different components. The benefits of multiple positive feedback interactions are cumulative for a majority of situations considered, when benefits are measured by the reduction in the cooperativity required to oscillate. These positive feedback motifs also allow oscillations with longer periods than that determined by the lifetimes of the components alone. We can therefore conjecture that these positive feedback loops have evolved to facilitate oscillations at lower, kinetically achievable, degrees of cooperativity. Finally, we discuss the implications of our conclusions on the mammalian molecular clock, a system modeled extensively based on the three-component negative feedback loop.	[Ananthasubramaniam, Bharath; Herzel, Hanspeter] Charite & Humboldt Univ Berlin, Inst Theoret Biol, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Ananthasubramaniam, B (corresponding author), Charite & Humboldt Univ Berlin, Inst Theoret Biol, Berlin, Germany.	bharath.ananthasubramaniam@biologie.hu-berlin.de	Ananthasubramaniam, Bharath/L-7777-2013; Ananthasubramaniam, Bharath/AAT-3641-2021	Ananthasubramaniam, Bharath/0000-0003-4467-1546; Ananthasubramaniam, Bharath/0000-0003-4467-1546	Alexander von Humboldt Foundation; BMBF (T-Sys) [0316164G]; DFG (SPP InKomBio); Bernstein Center for Computational Neuroscience Berlin [01GQ1001C]	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); BMBF (T-Sys)(Federal Ministry of Education & Research (BMBF)); DFG (SPP InKomBio)(German Research Foundation (DFG)); Bernstein Center for Computational Neuroscience Berlin	BA was supported by a fellowship from the Alexander von Humboldt Foundation. The authors acknowledge support from BMBF (T-Sys, 0316164G), DFG (SPP InKomBio) and Bernstein Center for Computational Neuroscience Berlin (grant 01GQ1001C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Becker-Weimann S, 2004, BIOPHYS J, V87, P3023, DOI 10.1529/biophysj.104.040824; Bernard S, 2007, PLOS COMPUT BIOL, V3, P667, DOI 10.1371/journal.pcbi.0030068; Bier M, 2000, BIOPHYS J, V78, P1087, DOI 10.1016/S0006-3495(00)76667-7; BLISS RD, 1982, J THEOR BIOL, V97, P177, DOI 10.1016/0022-5193(82)90098-4; Bluthgen N, 2006, FEBS J, V273, P895, DOI 10.1111/j.1742-4658.2006.05105.x; Bohr C, 1904, SKAND ARCH PHYSIOL, V16, P402, DOI 10.1111/j.1748-1716.1904.tb01382.x; Buchler NE, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.30; Cheong R, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.30; EDSALL JT, 1980, FED PROC, V39, P226; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; GOLDBETER A, 1990, BIOPHYS CHEM, V37, P341, DOI 10.1016/0301-4622(90)88033-O; GOLDBETER A, 1972, BIOPHYS J, V12, P1302, DOI 10.1016/S0006-3495(72)86164-2; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Goldbeter A, 1997, BIOCH OSCILLATIONS C; Gonze D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069573; GOODWIN BRIAN C., 1965, ADVANCE ENZYME REGULAT, V3, P425, DOI 10.1016/0065-2571(65)90067-1; GRIFFITH JS, 1968, J THEOR BIOL, V20, P202, DOI 10.1016/0022-5193(68)90189-6; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; Kholodenko BN, 2000, EUR J BIOCHEM, V267, P1583, DOI 10.1046/j.1432-1327.2000.01197.x; Kim JK, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.62; Korencic A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046835; Krishna S, 2006, P NATL ACAD SCI USA, V103, P10840, DOI 10.1073/pnas.0604085103; Kurosawa G, 2002, J THEOR BIOL, V216, P193, DOI 10.1006/jtbi.2002.2546; Kurosawa G, 2002, J BIOL RHYTHM, V17, P568, DOI 10.1177/0748730402238239; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Legewie S, 2005, PLOS COMPUT BIOL, V1, P405, DOI 10.1371/journal.pcbi.0010054; Leloup JC, 2003, P NATL ACAD SCI USA, V100, P7051, DOI 10.1073/pnas.1132112100; Leloup JC, 1998, J BIOL RHYTHM, V13, P70, DOI 10.1177/074873098128999934; Lewis J, 2003, CURR BIOL, V13, P1398, DOI 10.1016/S0960-9822(03)00534-7; MARTIEL JL, 1987, BIOPHYS J, V52, P807, DOI 10.1016/S0006-3495(87)83275-7; Meinhardt H., 1982, MODELS BIOL PATTERN; Michaelis L, 1913, BIOCHEM Z, V49, P333; Novak B, 2008, NAT REV MOL CELL BIO, V9, P981, DOI 10.1038/nrm2530; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Ruoff P, 1996, J THEOR BIOL, V179, P275, DOI 10.1006/jtbi.1996.0067; Salazar C, 2009, FEBS J, V276, P3177, DOI 10.1111/j.1742-4658.2009.07027.x; Steuer R, 2006, P NATL ACAD SCI USA, V103, P11868, DOI 10.1073/pnas.0600013103; THOMAS R, 1995, B MATH BIOL, V57, P247, DOI 10.1007/BF02460618; THRON CD, 1991, B MATH BIOL, V53, P403; Tsai TYC, 2008, SCIENCE, V321, P126, DOI 10.1126/science.1156951; Tyson J., 1978, PROG THEOR BIOL, V5, P1; Tyson JJ, 1999, BIOPHYS J, V77, P2411, DOI 10.1016/S0006-3495(99)77078-5; Tyson JJ, 2010, ANNU REV PHYS CHEM, V61, P219, DOI 10.1146/annurev.physchem.012809.103457; Wolf J, 2005, SYSTEMS BIOL, V2, P35, DOI 10.1049/sb:20045035	45	46	46	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104761	10.1371/journal.pone.0104761	http://dx.doi.org/10.1371/journal.pone.0104761			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126951	Green Submitted, Green Published, gold			2022-12-25	WOS:000340879300049
J	Hammer, N; Huster, D; Fritsch, S; Hadrich, C; Koch, H; Schmidt, P; Sichting, F; Wagner, MFX; Boldt, A				Hammer, Niels; Huster, Daniel; Fritsch, Sebastian; Haedrich, Carsten; Koch, Holger; Schmidt, Peter; Sichting, Freddy; Wagner, Martin Franz-Xaver; Boldt, Andreas			Do Cells Contribute to Tendon and Ligament Biomechanics?	PLOS ONE			English	Article							ACELLULAR DERMAL MATRIX; ROTATOR CUFF REPAIR; ACHILLES-TENDON; MECHANICAL-PROPERTIES; EXTRACELLULAR-MATRIX; BOVINE PERICARDIUM; ILIOTIBIAL TRACT; FLEXOR TENDONS; DECELLULARIZATION; GRAFT	Introduction: Acellular scaffolds are increasingly used for the surgical repair of tendon injury and ligament tears. Despite this increased use, very little data exist directly comparing acellular scaffolds and their native counterparts. Such a comparison would help establish the effectiveness of the acellularization procedure of human tissues. Furthermore, such a comparison would help estimate the influence of cells in ligament and tendon stability and give insight into the effects of acellularization on collagen. Material and Methods: Eighteen human iliotibial tract samples were obtained from nine body donors. Nine samples were acellularized with sodium dodecyl sulphate (SDS), while nine counterparts from the same donors remained in the native condition. The ends of all samples were plastinated to minimize material slippage. Their water content was adjusted to 69%, using the osmotic stress technique to exclude water content-related alterations of the mechanical properties. Uniaxial tensile testing was performed to obtain the elastic modulus, ultimate stress and maximum strain. The effectiveness of the acellularization procedure was histologically verified by means of a DNA assay. Results: The histology samples showed a complete removal of the cells, an extensive, yet incomplete removal of the DNA content and alterations to the extracellular collagen. Tensile properties of the tract samples such as elastic modulus and ultimate stress were unaffected by acellularization with the exception of maximum strain. Discussion: The data indicate that cells influence the mechanical properties of ligaments and tendons in vitro to a negligible extent. Moreover, acellularization with SDS alters material properties to a minor extent, indicating that this method provides a biomechanical match in ligament and tendon reconstruction. However, the given protocol insufficiently removes DNA. This may increase the potential for transplant rejection when acellular tract scaffolds are used in soft tissue repair. Further research will help optimize the SDS-protocol for clinical application.	[Hammer, Niels] Univ Leipzig, Fac Med, Inst Anat, D-04109 Leipzig, Germany; [Huster, Daniel; Schmidt, Peter] Univ Leipzig, Fac Med, Inst Med Phys & Biophys, D-04109 Leipzig, Germany; [Fritsch, Sebastian; Wagner, Martin Franz-Xaver] Tech Univ Chemnitz, Inst Mat Sci & Engn, Chemnitz, Germany; [Haedrich, Carsten] Univ Leipzig, Fac Med, Inst Forens Med, D-04109 Leipzig, Germany; [Koch, Holger; Boldt, Andreas] Univ Leipzig, Fac Med, Translat Ctr Regenerat Med, D-04109 Leipzig, Germany; [Sichting, Freddy] Tech Univ Chemnitz, Dept Human Locomot, Inst Sport Sci, Chemnitz, Germany; [Boldt, Andreas] Univ Leipzig, Fac Med, Inst Clin Immunol, D-04109 Leipzig, Germany	Leipzig University; Leipzig University; Technische Universitat Chemnitz; Leipzig University; Leipzig University; Technische Universitat Chemnitz; Leipzig University	Hammer, N (corresponding author), Univ Leipzig, Fac Med, Inst Anat, D-04109 Leipzig, Germany.	niels.hammer@medizin.uni-leipzig.de	Wagner, Martin/M-9684-2019; Wagner, Martin FX/A-6880-2008	Wagner, Martin/0000-0003-4082-2618; Hammer, Niels/0000-0001-8230-9383	German Federal Ministry of Education and Research (BMBF) [1315883]; German Federal Ministry of Education and Research; Institute of Anatomy, University of Leipzig; German Research Foundation (DFG); Leipzig University	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Institute of Anatomy, University of Leipzig; German Research Foundation (DFG)(German Research Foundation (DFG)); Leipzig University	Parts of the work presented in this paper were supported by the German Federal Ministry of Education and Research (BMBF number 1315883, www.bmbf.de). The authors Holger Koch and Andreas Boldt were financed via the German Federal Ministry of Education and Research. In both, they were involved in data collection, analysis and in the preparation of the manuscript. This work was furthermore made possible by the budgetary resources of the Institute of Anatomy, University of Leipzig. The authors declare that there are no competing interests. They acknowledge support from the German Research Foundation (DFG) and Leipzig University within the program of Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JE, 2006, ARTHROSCOPY, V22, P700, DOI 10.1016/j.arthro.2006.03.016; Adeeb S, 2004, COMPUT METHOD BIOMEC, V7, P33, DOI 10.1080/10255840310001637266; ARNOLD G, 1974, Z ANAT ENTWICKLUNGS, V143, P263, DOI 10.1007/BF00519870; Asundi KR, 2008, ANN BIOMED ENG, V36, P237, DOI 10.1007/s10439-007-9427-2; Badylak SE, 2008, SEMIN IMMUNOL, V20, P109, DOI 10.1016/j.smim.2007.11.003; Barber FA, 2009, ARTHROSCOPY, V25, P1233, DOI 10.1016/j.arthro.2009.05.012; Birnbaum K, 2004, SURG RADIOL ANAT, V26, P433, DOI 10.1007/s00276-004-0265-8; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bos I, 2008, PATHOLOGE, V29, P280, DOI 10.1007/s00292-007-0921-y; Branch JP, 2011, J FOOT ANKLE SURG, V50, P257, DOI 10.1053/j.jfas.2010.12.015; Burk J, 2013, TISSUE ENG C; Oliveira AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066538; Chen JM, 2009, EXPERT REV MED DEVIC, V6, P61, DOI 10.1586/17434440.6.1.61; Chiquet M, 2003, MATRIX BIOL, V22, P73, DOI 10.1016/S0945-053X(03)00004-0; Chung S, 2003, PLAST RECONSTR SURG, V111, P225, DOI 10.1097/01.PRS.0000034934.05304.ED; Connizzo BK, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4023234; Ehsan A, 2012, J HAND SURG-AM, V37A, P1538, DOI 10.1016/j.jhsa.2012.04.043; ELDEN HR, 1964, BIOCHIM BIOPHYS ACTA, V79, P592, DOI 10.1016/0926-6577(64)90225-6; Ellis CV, 2012, PLAST RECONSTR SURG, V130, p256S, DOI 10.1097/PRS.0b013e318265a5cf; Ernstberger M, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.6.060506; Farnebo S, 2014, PLAST RECONSTR SURG, V133, P79, DOI 10.1097/01.prs.0000436823.64827.a0; Gawrisch K, 1988, ELECTROMAGNETIC FIEL, P9; Gilbert TW, 2009, J SURG RES, V152, P135, DOI 10.1016/j.jss.2008.02.013; Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014; Gratz CM, 1931, J BONE JOINT SURG, V13, P334; Hammer N, 2012, J MECH BEHAV BIOMED, V16, P81, DOI 10.1016/j.jmbbm.2012.04.025; Hulsmann J, 2012, XENOTRANSPLANTATION, V19, P286, DOI 10.1111/j.1399-3089.2012.00719.x; Hwang K, 2007, J CRANIOFAC SURG, V18, P551, DOI 10.1097/scs.0b013e3180534421; Igarza E, 2014, MATER DESIGN, V55, P85, DOI 10.1016/j.matdes.2013.09.055; Keane TJ, 2012, BIOMATERIALS, V33, P1771, DOI 10.1016/j.biomaterials.2011.10.054; Kjaer M, 2008, DISABIL REHABIL, V30, P1514, DOI 10.1080/09638280701785403; Klatte-Schulz F, 2012, EUR CELLS MATER, V24, P74, DOI 10.22203/eCM.v024a06; Klatte-Schulz F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067209; Koch H, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/948320; KOSTROMINOVA TY, 2013, AGE DORDR, P15253; Lang R, 2011, BIOMATERIALS, V32, P7042, DOI 10.1016/j.biomaterials.2011.06.005; Lee DK, 2008, J FOOT ANKLE SURG, V47, P8, DOI 10.1053/j.jfas.2007.08.015; Ma S Z, 2006, Hernia, V10, P229, DOI 10.1007/s10029-006-0071-9; McLaughlin P, 2013, J BIOMECH, V46, P2757, DOI 10.1016/j.jbiomech.2013.08.015; Ozasa Y, 2014, TISSUE ENG PT A, V20, P566, DOI 10.1089/ten.TEA.2013.0284; Parsegian VA, 1995, METHOD ENZYMOL, V259, P43; Pridgen BC, 2011, TISSUE ENG PART C-ME, V17, P819, DOI 10.1089/ten.tec.2010.0457; Rao BM, 2012, INT ORTHOP, V36, P2049, DOI 10.1007/s00264-012-1630-6; Robayo LM, 2011, WOUND REPAIR REGEN, V19, P38, DOI 10.1111/j.1524-475X.2010.00640.x; Romeis B., 1989, ROMEIS MIKROSKOPISCH; Rubin L, 2005, CLIN PODIATR MED SUR, V22, pvi; Rubin Laurence, 2005, Clin Podiatr Med Surg, V22, P533, DOI 10.1016/j.cpm.2005.08.002; Sahoo S, 2012, J SHOULDER ELB SURG, V21, P1413, DOI 10.1016/j.jse.2011.10.028; Schulze-Tanzil G, 2012, CELLS, V1, P1011; Seitz AM, 2012, J MECH BEHAV BIOMED, V10, P120, DOI 10.1016/j.jmbbm.2012.02.027; Song L, 2010, J FOOT ANKLE SURG, V49, P438, DOI 10.1053/j.jfas.2010.06.009; Steinke H, 2012, MED ENG PHYS, V34, P1221, DOI 10.1016/j.medengphy.2011.12.009; Svensson RB, 2011, CONNECT TISSUE RES, V52, P415, DOI 10.3109/03008207.2010.551569; Thorpe CT, 2013, INT J EXP; Tischer T, 2010, TISSUE ENG PT A, V16, P1031, DOI [10.1089/ten.tea.2009.0043, 10.1089/ten.TEA.2009.0043]; Waggett AD, 2006, EUR J CELL BIOL, V85, P1145, DOI 10.1016/j.ejcb.2006.06.002; Yoeruek E, 2012, ACTA OPHTHALMOL, V90, pe125, DOI 10.1111/j.1755-3768.2011.02261.x; Zernia G, 2006, NMR BIOMED, V19, P1010, DOI 10.1002/nbm.1061; Zheng MH, 2005, J BIOMED MATER RES B, V73B, P61, DOI 10.1002/jbm.b.30170	59	30	30	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105037	10.1371/journal.pone.0105037	http://dx.doi.org/10.1371/journal.pone.0105037			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126746	Green Published, gold, Green Submitted			2022-12-25	WOS:000340879300071
J	Kim, GJ; Rhee, H; Yoo, JE; Ko, JE; Lee, JS; Kim, H; Choi, JS; Park, YN				Kim, Gi Jeong; Rhee, Hyungjin; Yoo, Jeong Eun; Ko, Jung Eun; Lee, Jee San; Kim, Hyunki; Choi, Jin Sub; Park, Young Nyun			Increased Expression of CCN2, Epithelial Membrane Antigen, and Fibroblast Activation Protein in Hepatocellular Carcinoma with Fibrous Stroma Showing Aggressive Behavior	PLOS ONE			English	Article							TISSUE GROWTH-FACTOR; CANCER-ASSOCIATED FIBROBLASTS; MESENCHYMAL TRANSITION; COLON-CANCER; STEM-CELLS; CROSS-TALK; MUC1; MICROENVIRONMENT; PROGRESSION; FAP	Tumor behavior is affected by the tumor microenvironment, composed of cancer-associated fibroblasts (CAFs). Meanwhile, hepatocellular carcinomas (HCC) with fibrous stroma reportedly exhibit aggressive behavior suggestive of tumor-stroma interaction. However, evidence of the crosstalk remains unclear. In this study, CCN2, epithelial membrane antigen (EMA), fibroblast activation protein (FAP), and keratin 19 (K19) expression was studied in 314 HCCs (cohort 1), 42 scirrhous HCCs (cohort 2), and 36 chronic hepatitis/cirrhosis specimens by immunohistochemistry. Clinicopathological parameters were analyzed according to the expressions of these markers. In tumor epithelial cells from cohort 1, CCN2 and EMA were expressed in 15.3% and 17.2%, respectively, and their expressions were more frequent in HCCs with fibrous stroma (>= 5% of tumor area) than those without (P<0.05 for all); CCN2 expression was well correlated with K19 and EMA expression. In tumor stromal cells, FAP expression was found in 6.7%. In cohort 2, CCN2, EMA, and FAP expression was noted in 40.5%, 40.5%, and 66.7%, respectively, which was more frequent than that in cohort 1 (P<0.05 for all). Additionally, EMA expression was associated with the expression of K19, CCN2, and FAP (P<0.05 for all); EMA expressing tumor epithelial cells showed a topographic closeness to FAP-expressing CAFs. Analysis of disease-free survival revealed CCN2 expression to be a worse prognostic factor in both cohort 1 (P = 0.005) and cohort 2 (P = 0.023), as well as EMA as a worse prognostic factor in cohort 2 (P = 0.048). In conclusion, expression of CCN2, EMA, and FAP may be involved in the activation of CAFs in HCC, giving rise to aggressive behavior. Significant correlation between EMA-expressing tumor cells and FAP-expressing CAFs and their topographic closeness suggests possible cross-talk between tumor epithelial cells and stromal cells in the tumor microenvironment of HCC.	[Kim, Gi Jeong; Rhee, Hyungjin; Yoo, Jeong Eun; Ko, Jung Eun; Lee, Jee San; Kim, Hyunki; Park, Young Nyun] Yonsei Univ, Coll Med, Dept Pathol, Seoul, South Korea; [Rhee, Hyungjin; Ko, Jung Eun; Lee, Jee San] Yonsei Univ, Coll Med, PLUS Project Med Sci BK21, Seoul, South Korea; [Choi, Jin Sub] Yonsei Univ, Coll Med, Dept Surg, Seoul, South Korea; [Park, Young Nyun] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul, South Korea; [Park, Young Nyun] Yonsei Univ, Coll Med, Integrated Genom Res Ctr Metab Regulat, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Park, YN (corresponding author), Yonsei Univ, Coll Med, Dept Pathol, Seoul, South Korea.	young0608@yuhs.ac	Rhee, Hyungjin/T-7619-2019	Rhee, Hyungjin/0000-0001-7759-4458; Park, Young Nyun/0000-0003-0357-7967; Kim, Hyunki/0000-0003-2292-5584	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI12C0555]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI12C0555). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboussekhra A, 2011, INT J DEV BIOL, V55, P841, DOI 10.1387/ijdb.113362aa; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Brigstock DR, 2010, J CELL COMMUN SIGNAL, V4, P1, DOI 10.1007/s12079-009-0071-5; Campbell NE, 2010, J ONCOL, V2010, DOI 10.1155/2010/586905; Chen CM, 2007, PEDIATR RES, V62, P128, DOI 10.1203/PDR.0b013e3180987202; Coulouarn C, 2012, CANCER RES, V72, P2533, DOI 10.1158/0008-5472.CAN-11-3317; di Mola FF, 1999, ANN SURG, V230, P63, DOI 10.1097/00000658-199907000-00010; Gao YB, 2013, J CANCER RES CLIN, V139, P669, DOI 10.1007/s00432-012-1370-4; Giannoni E, 2010, CANCER RES, V70, P6945, DOI 10.1158/0008-5472.CAN-10-0785; Gupta S, 2000, KIDNEY INT, V58, P1389, DOI 10.1046/j.1523-1755.2000.00301.x; Hafner C, 2005, CURR CANCER DRUG TAR, V5, P393, DOI 10.2174/1568009054863591; Henriksson ML, 2011, AM J PATHOL, V178, P1387, DOI 10.1016/j.ajpath.2010.12.008; Henry LR, 2007, CLIN CANCER RES, V13, P1736, DOI 10.1158/1078-0432.CCR-06-1746; Ichikawa T, 2006, J HEPATO-BILIARY-PAN, V13, P245, DOI 10.1007/s00534-005-1070-4; Jing YY, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-29; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094; Kim H, 2011, HEPATOLOGY, V54, P1707, DOI 10.1002/hep.24559; Kim SM, 2012, KOREAN J PATHOL, V46, P429, DOI 10.4132/KoreanJPathol.2012.46.5.429; Kwon S, 2007, INT J ONCOL, V31, P693; Liu SL, 2011, CANCER RES, V71, P614, DOI 10.1158/0008-5472.CAN-10-0538; MATHEW S, 1995, GENOMICS, V25, P335, DOI 10.1016/0888-7543(95)80157-H; Mazzocca A, 2010, HEPATOLOGY, V51, P523, DOI 10.1002/hep.23285; Nakasone ES, 2012, CANCER CELL, V21, P488, DOI 10.1016/j.ccr.2012.02.017; Niedermeyer J, 2000, MOL CELL BIOL, V20, P1089, DOI 10.1128/MCB.20.3.1089-1094.2000; Rachfal AW, 2003, HEPATOL RES, V26, P1, DOI 10.1016/S1386-6346(03)00115-3; Rasanen K, 2010, EXP CELL RES, V316, P2713, DOI 10.1016/j.yexcr.2010.04.032; Seok JY, 2012, HEPATOLOGY, V55, P1776, DOI 10.1002/hep.25570; Shi M, 2012, WORLD J GASTROENTERO, V18, P840, DOI 10.3748/wjg.v18.i8.840; Tanaka K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0027922; Vermeulen L, 2012, LANCET ONCOL, V13, pE83, DOI 10.1016/S1470-2045(11)70257-1; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; von Mensdorff-Pouilly S, 2000, INT J BIOL MARKER, V15, P343, DOI 10.1177/172460080001500413; Wikberg ML, 2013, TUMOR BIOL, V34, P1013, DOI 10.1007/s13277-012-0638-2; Woenckhaus M, 2008, HUM PATHOL, V39, P126, DOI 10.1016/j.humpath.2007.05.027; Xiang ZL, 2011, ONCOLOGIST, V16, P1028, DOI 10.1634/theoncologist.2010-0358; Xiu M, 2012, WORLD J GASTROENTERO, V18, P7070, DOI 10.3748/wjg.v18.i47.7070; Yang JD, 2011, SEMIN CANCER BIOL, V21, P35, DOI 10.1016/j.semcancer.2010.10.007; Yang JD, 2010, NAT REV GASTRO HEPAT, V7, P448, DOI 10.1038/nrgastro.2010.100; Yuan SF, 2005, WORLD J GASTROENTERO, V11, P4661, DOI 10.3748/wjg.v11.i30.4661	40	41	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105094	10.1371/journal.pone.0105094	http://dx.doi.org/10.1371/journal.pone.0105094			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126747	gold, Green Submitted, Green Published			2022-12-25	WOS:000340879300079
J	Ma, ZY; Zhong, ZG; Zheng, ZY; Shi, XM; Zhang, WX				Ma, Zhenyu; Zhong, Zhigang; Zheng, Zhenyang; Shi, Xing-Ming; Zhang, Weixi			Inhibition of Glycogen Synthase Kinase-3 beta Attenuates Glucocorticoid-Induced Suppression of Myogenic Differentiation In Vitro	PLOS ONE			English	Article							SKELETAL-MUSCLE; GENE-EXPRESSION; SATELLITE CELLS; MYOBLAST FUSION; GSK-3-BETA; PATHWAYS; RECEPTOR; PHOSPHORYLATION; INACTIVATION; ACTIVATION	Glucocorticoids are the only therapy that has been demonstrated to alter the progress of Duchenne muscular dystrophy (DMD), the most common muscular dystrophy in children. However, glucocorticoids disturb skeletal muscle metabolism and hamper myogenesis and muscle regeneration. The mechanisms involved in the glucocorticoid-mediated suppression of myogenic differentiation are not fully understood. Glycogen synthase kinase-3 beta (GSK-3 beta) is considered to play a central role as a negative regulator in myogenic differentiation. Here, we showed that glucocorticoid treatment during the first 48 h in differentiation medium decreased the level of phosphorylated Ser9-GSK-3 beta, an inactive form of GSK-3 beta, suggesting that glucocorticoids affect GSK-3 beta activity. We then investigated whether GSK-3 beta inhibition could regulate glucocorticoid-mediated suppression of myogenic differentiation in vitro. Two methods were employed to inhibit GSK-3 beta: pharmacological inhibition with LiCl and GSK-3 beta gene knockdown. We found that both methods resulted in enhanced myotube formation and increased levels of muscle regulatory factors and muscle-specific protein expression. Importantly, GSK-3 beta inhibition attenuated glucocorticoid-induced suppression of myogenic differentiation. Collectively, these data suggest the involvement of GSK-3 beta in the glucocorticoid-mediated impairment of myogenic differentiation. Therefore, the inhibition of GSK-3 beta may be a strategy for preventing glucocorticoid-induced muscle degeneration.	[Ma, Zhenyu; Zhong, Zhigang; Zheng, Zhenyang; Zhang, Weixi] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou 510275, Guangdong, Peoples R China; [Shi, Xing-Ming] Georgia Regents Univ, Inst Mol Med & Genet, Augusta, GA USA	Sun Yat Sen University; University System of Georgia; Augusta University	Zhang, WX (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou 510275, Guangdong, Peoples R China.	weixizhang@qq.com			National Natural Science Foundation of China [81371260, 30971026]; Guangdong Natural Science Foundation [S2013010015600]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province)	This study was supported by the National Natural Science Foundation of China (Grant Nos. 81371260 and 30971026) and Guangdong Natural Science Foundation (Grant No. S2013010015600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beiner JM, 1999, AM J SPORT MED, V27, P2, DOI 10.1177/03635465990270011101; Betters JL, 2008, MUSCLE NERVE, V37, P203, DOI 10.1002/mus.20915; Brack AS, 2008, CELL STEM CELL, V2, P50, DOI 10.1016/j.stem.2007.10.006; Bruscoli S, 2010, J BIOL CHEM, V285, P10385, DOI 10.1074/jbc.M109.070136; Bushby K, 2010, LANCET NEUROL, V9, P77, DOI 10.1016/S1474-4422(09)70271-6; Dong YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058554; Du WJ, 2009, CELLS TISSUES ORGANS, V190, P11, DOI 10.1159/000167699; Evenson AR, 2005, INT J BIOCHEM CELL B, V37, P2226, DOI 10.1016/j.biocel.2005.06.002; French RL, 2009, P NATL ACAD SCI USA, V106, P20924, DOI 10.1073/pnas.0910813106; Galliher-Beckley AJ, 2008, MOL CELL BIOL, V28, P7309, DOI 10.1128/MCB.00808-08; Garza JC, 2012, MOL PSYCHIATR, V17, P790, DOI 10.1038/mp.2011.161; Kitamura T, 2007, J CLIN INVEST, V117, P2477, DOI 10.1172/JCI32054; Koivisto L, 2004, EXP CELL RES, V293, P68, DOI 10.1016/j.yexcr.2003.09.026; Kuang S, 2008, TRENDS MOL MED, V14, P82, DOI 10.1016/j.molmed.2007.12.004; Kuo T, 2013, MOL CELL ENDOCRINOL, V380, P79, DOI 10.1016/j.mce.2013.03.003; Manzur AY, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003725.pub3; Martinez A, 2008, MED RES REV, V28, P773, DOI 10.1002/med.20119; OLSON EN, 1993, MOL ENDOCRINOL, V7, P1369, DOI 10.1210/me.7.11.1369; Pansters NAM, 2011, CELL MOL LIFE SCI, V68, P523, DOI 10.1007/s00018-010-0467-7; Ridgeway AG, 2000, J BIOL CHEM, V275, P32398, DOI 10.1074/jbc.M004349200; Rochat A, 2004, MOL BIOL CELL, V15, P4544, DOI 10.1091/mbc.E03-11-0816; Schakman O, 2008, J ENDOCRINOL, V197, P1, DOI 10.1677/JOE-07-0606; Serrano AL, 2011, CURR TOP DEV BIOL, V96, P167, DOI 10.1016/B978-0-12-385940-2.00007-3; te Pas MFW, 2000, MOL BIOL REP, V27, P87, DOI 10.1023/A:1007120921064; Tran TH, 2012, J BIOL CHEM, V287, P32651, DOI 10.1074/jbc.M112.353243; van der Velden JLJ, 2006, AM J PHYSIOL-CELL PH, V290, pC453, DOI 10.1152/ajpcell.00068.2005; van der Velden JLJ, 2008, J BIOL CHEM, V283, P358, DOI 10.1074/jbc.M707812200; Velica P, 2010, MOL CELL ENDOCRINOL, V319, P71, DOI 10.1016/j.mce.2010.01.023; Verhees KJP, 2011, AM J PHYSIOL-CELL PH, V301, pC995, DOI 10.1152/ajpcell.00520.2010; Wang FS, 2009, LIFE SCI, V85, P685, DOI 10.1016/j.lfs.2009.09.009; Wang Y, 2011, J CELL SCI, V124, P3835, DOI 10.1242/jcs.086686; Wu RW, 2011, BONE, V49, P1255, DOI 10.1016/j.bone.2011.08.022; Zhang CP, 2012, AGING CELL, V11, P14, DOI 10.1111/j.1474-9726.2011.00753.x; Zhang F, 2003, J BIOL CHEM, V278, P33067, DOI 10.1074/jbc.M212635200; Zhang LP, 2010, J AM SOC NEPHROL, V21, P419, DOI 10.1681/ASN.2009060571	35	14	14	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105528	10.1371/journal.pone.0105528	http://dx.doi.org/10.1371/journal.pone.0105528			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127359	Green Published, gold, Green Submitted			2022-12-25	WOS:000340879300117
J	Pan, XN; Chen, JJ; Wang, LX; Xiao, RZ; Liu, LL; Fang, ZG; Liu, QT; Long, ZJ; Lin, DJ				Pan, Xiao-Na; Chen, Jia-Jie; Wang, Le-Xun; Xiao, Ruo-Zhi; Liu, Ling-Ling; Fang, Zhi-Gang; Liu, Quentin; Long, Zi-Jie; Lin, Dong-Jun			Inhibition of c-Myc Overcomes Cytotoxic Drug Resistance in Acute Myeloid Leukemia Cells by Promoting Differentiation	PLOS ONE			English	Article							ARGININE DEIMINASE RESISTANCE; ANTISENSE OLIGODEOXYNUCLEOTIDES; IN-VIVO; CISPLATIN; MECHANISMS; APOPTOSIS; 10058-F4; COMPLEX; GENES; CYCLE	Nowadays, drug resistance still represents a major obstacle to successful acute myeloid leukemia (AML) treatment and the underlying mechanism is not fully elucidated. Here, we found that high expression of c-Myc was one of the cytogenetic characteristics in the drug-resistant leukemic cells. c-Myc over-expression in leukemic cells induced resistance to chemotherapeutic drugs, enhanced colony formation capacity and inhibited cell differentiation induced by all-trans retinoic acid (ATRA). Meanwhile, inhibition of c-Myc by shRNA or specific c-Myc inhibitor 10058-F4 rescued the sensitivity to cytotoxic drugs, restrained the colony formation ability and promoted differentiation. RT-PCR and western blotting analysis showed that down-regulation of C/EBP beta contributed to the poor differentiation state of leukemic cells induced by c-Myc over-expression. Importantly, over-expression of C/EBP beta could reverse c-Myc induced drug resistance. In primary AML cells, the c-Myc expression was negatively correlated with C/EBP beta. 10058-F4, displayed anti-proliferative activity and increased cellular differentiation with up-regulation of C/EBP beta in primary AML cells. Thus, our study indicated that c-Myc could be a novel target to overcome drug resistance, providing a new approach in AML therapy.	[Pan, Xiao-Na; Chen, Jia-Jie; Wang, Le-Xun; Xiao, Ruo-Zhi; Liu, Ling-Ling; Fang, Zhi-Gang; Liu, Quentin; Long, Zi-Jie; Lin, Dong-Jun] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Hematol, Guangzhou 510275, Guangdong, Peoples R China; [Pan, Xiao-Na; Chen, Jia-Jie; Wang, Le-Xun; Xiao, Ruo-Zhi; Liu, Ling-Ling; Fang, Zhi-Gang; Liu, Quentin; Long, Zi-Jie; Lin, Dong-Jun] Sun Yat Sen Univ, Sun Yat Sen Inst Hematol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Long, ZJ (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Dept Hematol, Guangzhou 510275, Guangdong, Peoples R China.	longzij@mail.sysu.edu.cn; lindj@mail.sysu.edu.cn	liu, xiaoyun/GXV-0330-2022	liu, xiaoyun/0000-0002-5425-7456	Science and Technology Project of Guangzhou [2012J2200077]; Fundamental Research Funds for the Central Universities [11ykpy37]	Science and Technology Project of Guangzhou; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the Science and Technology Project of Guangzhou (No. 2012J2200077 to Z.-J. Long), and the Fundamental Research Funds for the Central Universities (No. 11ykpy37 to Z.-J. Long). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Citro G, 1998, CANCER RES, V58, P283; Civenni G, 2013, CANCER RES, V73, P6816, DOI 10.1158/0008-5472.CAN-13-0615; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Delgado MD, 2013, CLIN TRANSL ONCOL, V15, P87, DOI 10.1007/s12094-012-0926-8; Estey EH, 2013, AM J HEMATOL, V88, P317, DOI 10.1002/ajh.23404; FIELD JK, 1990, ANTICANCER RES, V10, P1; Follis AV, 2009, BIOORG MED CHEM LETT, V19, P807, DOI 10.1016/j.bmcl.2008.12.025; Frank SR, 2003, EMBO REP, V4, P575, DOI 10.1038/sj.embor.embor861; Fredlund E, 2008, P NATL ACAD SCI USA, V105, P14094, DOI 10.1073/pnas.0804455105; Funato T, 2004, EXPERT REV MOL DIAGN, V4, P705, DOI 10.1586/14737159.4.5.705; Gomez-Casares MT, 2013, ONCOGENE, V32, P2239, DOI 10.1038/onc.2012.246; Haggerty TJ, 2003, P NATL ACAD SCI USA, V100, P5313, DOI 10.1073/pnas.0931346100; Hoffman B, 2002, ONCOGENE, V21, P3414, DOI 10.1038/sj.onc.1205400; Huang MJ, 2006, EXP HEMATOL, V34, P1480, DOI 10.1016/j.exphem.2006.06.019; Knapp DC, 2003, ANTI-CANCER DRUG, V14, P39, DOI 10.1097/00001813-200301000-00006; Leonetti C, 1999, CLIN CANCER RES, V5, P2588; LI LH, 1994, EMBO J, V13, P4070, DOI 10.1002/j.1460-2075.1994.tb06724.x; Lin CP, 2007, ANTI-CANCER DRUG, V18, P161, DOI 10.1097/CAD.0b013e3280109424; Liu L, 2012, BIOCHEM BIOPH RES CO, V425, P368, DOI 10.1016/j.bbrc.2012.07.098; Liu LL, 2013, MOL CANCER RES, V11, P1326, DOI 10.1158/1541-7786.MCR-13-0172; Long Y, 2013, MOL CANCER THER, V12, P2581, DOI 10.1158/1535-7163.MCT-13-0302; Magri L., 2014, NEUROSCIENCE; Masui K, 2013, CELL METAB, V18, P726, DOI 10.1016/j.cmet.2013.09.013; Mink S, 1996, P NATL ACAD SCI USA, V93, P6635, DOI 10.1073/pnas.93.13.6635; Nair R, 2013, ONCOGENE; Negoro E, 2011, INT J ONCOL, V38, P911, DOI 10.3892/ijo.2011.933; Nielsen DL, 2004, DAN MED BULL, V51, P393; Porro A, 2011, MOL CANCER RES, V9, P1054, DOI 10.1158/1541-7786.MCR-10-0510; Roderick JE, 2014, BLOOD, V123, P1040, DOI 10.1182/blood-2013-08-522698; Sheth A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.112; Si JL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-92; Singh AM, 2009, CELL STEM CELL, V5, P141, DOI 10.1016/j.stem.2009.07.003; Soucek L, 2010, CURR OPIN GENET DEV, V20, P91, DOI 10.1016/j.gde.2009.11.001; Tsai WB, 2012, CANCER RES, V72, P2622, DOI 10.1158/0008-5472.CAN-11-3605; Walker TL, 1996, BRIT J CANCER, V73, P610, DOI 10.1038/bjc.1996.105; Wong Rebecca S Y, 2012, Malays J Pathol, V34, P77; Yu L, 2013, ASIAN PAC J TROP MED, V6, P473, DOI 10.1016/S1995-7645(13)60077-2; Zeng DF, 2014, EUR REV MED PHARMACO, V18, P537	38	65	69	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105381	10.1371/journal.pone.0105381	http://dx.doi.org/10.1371/journal.pone.0105381			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127121	Green Submitted, Green Published, gold			2022-12-25	WOS:000340879300107
J	Leal, MF; Belangero, PS; Cohen, C; Figueiredo, EA; Loyola, LC; Pochini, AC; Smith, MC; Andreoli, CV; Belangero, SI; Ejnisman, B; Cohen, M				Leal, Mariana Ferreira; Belangero, Paulo Santoro; Cohen, Carina; Figueiredo, Eduardo Antonio; Loyola, Leonor Casilla; Pochini, Alberto Castro; Smith, Marilia Cardoso; Andreoli, Carlos Vicente; Belangero, Sintia Iole; Ejnisman, Benno; Cohen, Moises			Identification of Suitable Reference Genes for Gene Expression Studies of Shoulder Instability	PLOS ONE			English	Article							MESSENGER-RNA LEVELS; REAL-TIME PCR; HOUSEKEEPING GENES; MATRIX MOLECULES; ROTATOR CUFF; NORMALIZATION; DISLOCATION; MANAGEMENT; LIGAMENTS; COLLAGEN	Shoulder instability is a common shoulder injury, and patients present with plastic deformation of the glenohumeral capsule. Gene expression analysis may be a useful tool for increasing the general understanding of capsule deformation, and reverse-transcription quantitative polymerase chain reaction (RT-qPCR) has become an effective method for such studies. Although RT-qPCR is highly sensitive and specific, it requires the use of suitable reference genes for data normalization to guarantee meaningful and reproducible results. In the present study, we evaluated the suitability of a set of reference genes using samples from the glenohumeral capsules of individuals with and without shoulder instability. We analyzed the expression of six commonly used reference genes (ACTB, B2M, GAPDH, HPRT1, TBP and TFRC) in the antero-inferior, antero-superior and posterior portions of the glenohumeral capsules of cases and controls. The stability of the candidate reference gene expression was determined using four software packages: NormFinder, geNorm, BestKeeper and DataAssist. Overall, HPRT1 was the best single reference gene, and HPRT1 and B2M composed the best pair of reference genes from different analysis groups, including simultaneous analysis of all tissue samples. GenEx software was used to identify the optimal number of reference genes to be used for normalization and demonstrated that the accumulated standard deviation resulting from the use of 2 reference genes was similar to that resulting from the use of 3 or more reference genes. To identify the optimal combination of reference genes, we evaluated the expression of COL1A1. Although the use of different reference gene combinations yielded variable normalized quantities, the relative quantities within sample groups were similar and confirmed that no obvious differences were observed when using 2, 3 or 4 reference genes. Consequently, the use of 2 stable reference genes for normalization, especially HPRT1 and B2M, is a reliable method for evaluating gene expression by RT-qPCR.	[Leal, Mariana Ferreira; Belangero, Paulo Santoro; Cohen, Carina; Figueiredo, Eduardo Antonio; Loyola, Leonor Casilla; Pochini, Alberto Castro; Andreoli, Carlos Vicente; Ejnisman, Benno; Cohen, Moises] Univ Fed Sao Paulo, Sao Paulo, Brazil; [Leal, Mariana Ferreira; Loyola, Leonor Casilla; Smith, Marilia Cardoso; Belangero, Sintia Iole] Univ Fed Sao Paulo, Dept Morfol & Genet, Disciplina Genet, Sao Paulo, Brazil; [Belangero, Sintia Iole] Univ Fed Sao Paulo, Dept Psiquiatria, Lab Interdisciplinar Neurociencia Clin, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Leal, MF (corresponding author), Univ Fed Sao Paulo, Sao Paulo, Brazil.	mariana.morf@epm.br	Andreoli, Carlos Vicente/AAW-1228-2021; de A. C. Smith, Marilia/C-4397-2012; Belangero, Paulo/AAD-8299-2021; Belangero, Sintia I/A-6818-2009; Leal, Mariana/C-4010-2012; Ejnisman, Benno/J-1556-2015	de A. C. Smith, Marilia/0000-0002-1441-1033; Belangero, Sintia I/0000-0002-2419-4351; Leal, Mariana/0000-0003-4375-2563; Ejnisman, Benno/0000-0002-3301-1457	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; MC and MACS) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP; MFL, and MC) as grants and fellowship awards. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bramono DS, 2005, CONNECT TISSUE RES, V46, P53, DOI 10.1080/03008200590935556; Burkart AC, 2002, CLIN ORTHOP RELAT R, P32; Buss DD, 2004, AM J SPORT MED, V32, P1430, DOI 10.1177/0363546503262069; Bustin SA, 2005, CLIN SCI, V109, P365, DOI 10.1042/CS20050086; Bustin SA, 2010, METHODS, V50, P217, DOI 10.1016/j.ymeth.2009.12.006; Clements DN, 2008, OSTEOARTHR CARTILAGE, V16, P195, DOI 10.1016/j.joca.2007.06.013; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Derveaux S, 2010, METHODS, V50, P227, DOI 10.1016/j.ymeth.2009.11.001; Eriksen HA, 2002, J ORTHOPAED RES, V20, P1352, DOI 10.1016/S0736-0266(02)00064-5; Fu J, 2010, ACTA BIOCH BIOPH SIN, V42, P568, DOI 10.1093/abbs/gmq062; Gohlke F, 1994, J Shoulder Elbow Surg, V3, P111, DOI 10.1016/S1058-2746(09)80090-6; Hayes K, 2002, J ORTHOP SPORT PHYS, V32, P497, DOI 10.2519/jospt.2002.32.10.497; HOVELIUS L, 1983, J BONE JOINT SURG AM, V65, P343, DOI 10.2106/00004623-198365030-00008; Hruz T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-156; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; KALTSAS DS, 1983, CLIN ORTHOP RELAT R, P20; KAZAR, 1969, ACTA ORTHOP SCAND, V40, P216, DOI 10.3109/17453676908989501; Kozera B, 2013, J APPL GENET, V54, P391, DOI 10.1007/s13353-013-0173-x; Larrain MV, 2001, ARTHROSCOPY, V17, P373, DOI 10.1053/jars.2001.23226; Li YL, 2009, ANAL BIOCHEM, V394, P110, DOI 10.1016/j.ab.2009.07.022; Lo IKY, 2003, CLIN ORTHOP RELAT R, P249, DOI 10.1097/01.blo.0000037442.23683.35; Lo IKY, 2005, ARTHROSCOPY, V21, P645, DOI 10.1016/j.arthro.2005.03.008; Lo IKY, 1998, J ORTHOPAED RES, V16, P421, DOI 10.1002/jor.1100160405; Lyng MB, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-20; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pombo-Suarez M, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-17; Rubie C, 2005, MOL CELL PROBE, V19, P101, DOI 10.1016/j.mcp.2004.10.001; Shirachi I, 2011, ARTHROSCOPY, V27, P1173, DOI 10.1016/j.arthro.2011.03.078; te Slaa RL, 2004, J BONE JOINT SURG BR, V86B, P58, DOI 10.1302/0301-620X.86B1.13695; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang Q, 2012, INT J LEGAL MED, V126, P943, DOI 10.1007/s00414-012-0774-7; Wang VM, 2005, J SHOULDER ELB SURG, V14, p2S, DOI 10.1016/j.jse.2004.10.002; Wisnieski F, 2013, WORLD J GASTROENTERO, V19, P7121, DOI 10.3748/wjg.v19.i41.7121; Xu YH, 2008, CLIN ORTHOP RELAT R, V466, P1528, DOI 10.1007/s11999-008-0286-4; Yuzbasioglu A, 2010, EXP MOL PATHOL, V88, P326, DOI 10.1016/j.yexmp.2009.12.007; Zhou ZJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088892	37	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e105002	10.1371/journal.pone.0105002	http://dx.doi.org/10.1371/journal.pone.0105002			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122470	Green Submitted, Green Published, gold			2022-12-25	WOS:000341017000084
J	Cai, Q; Yan, L; Xu, Y				Cai, Q.; Yan, L.; Xu, Y.			Anoikis resistance is a critical feature of highly aggressive ovarian cancer cells	ONCOGENE			English	Article							MOUSE MODEL; CARCINOMA; GROWTH; TUMOR	High-grade serous ovarian cancer is an aggressive form of epithelial ovarian cancer (EOC), and accounts for the majority of deaths due to EOC. The critical cellular processes and underlying molecular mechanisms that define this malignancy remain poorly understood. Using a syngeneic murine model, we investigated the changes that accompanied the progression to increased aggressiveness induced by in vivo passage of mouse EOC cells. We found that enhanced anoikis resistance was a key cellular process associated with greater aggressiveness and tumorigenicity in vivo. Biochemical studies revealed that the enhanced anoikis resistance was associated with the activation of the Src/Akt/Erk signaling pathway. A higher rate of metabolism and autophagy were also associated with increased anoikis resistance. Blocking these pathways with specific inhibitors and/or genetic modifications significantly increased anoikis in vitro and inhibited tumor development in vivo. In addition, we demonstrated that similar signaling pathways were also involved in a human EOC cell line model. Collectively, our data suggest that anoikis resistance represents a critical and a distinguishing feature underlying the aggressiveness of ovarian cancer cells.	[Cai, Q.; Yan, L.; Xu, Y.] Indiana Univ Sch Med, Dept Obstet & Gynecol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington	Xu, Y (corresponding author), Indiana Univ Sch Med, Dept Obstet & Gynecol, 975 W Walnut St IB355A, Indianapolis, IN 46202 USA.	xu2@iupui.edu			National Institutes of Health [RO1 155145]; Mary Fendrich-Hulman Charitable Trust Fund; NATIONAL CANCER INSTITUTE [R01CA155145] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mary Fendrich-Hulman Charitable Trust Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Caryl Antalis and Christy A Tidwell for their critical reading and editing of this manuscript. This work is supported in part by the National Institutes of Health (RO1 155145 to YX) and the Mary Fendrich-Hulman Charitable Trust Fund to YX.	Ahmed N, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00256; BAUMAL R, 1986, CANCER RES, V46, P3994; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Chiarugi P, 2008, BIOCHEM PHARMACOL, V76, P1352, DOI 10.1016/j.bcp.2008.07.023; Guadamillas MC, 2011, J CELL SCI, V124, P3189, DOI 10.1242/jcs.072165; Janat-Amsbury MM, 2006, ANTICANCER RES, V26, P3223; Li H, 2009, MOL CANCER THER, V8, P1692, DOI 10.1158/1535-7163.MCT-08-1106; Miskimins WK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085576; Roby KF, 2000, CARCINOGENESIS, V21, P585, DOI 10.1093/carcin/21.4.585; Said NA, 2007, NEOPLASIA, V9, P23, DOI 10.1593/neo.06658; Schafer ZT, 2009, NATURE, V461, P109, DOI 10.1038/nature08268; Sher I, 2009, INT J CANCER, V124, P553, DOI 10.1002/ijc.23963; Ward KK, 2013, CLIN EXP METASTAS, V30, P579, DOI 10.1007/s10585-012-9562-5; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; YU DH, 1993, CANCER RES, V53, P891	15	65	68	3	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2015	34	25					3315	3324		10.1038/onc.2014.264	http://dx.doi.org/10.1038/onc.2014.264			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CK9XH	25132267	Green Submitted, Green Accepted			2022-12-25	WOS:000356592300010
J	Orticello, M; Fiore, M; Totta, P; Desideri, M; Barisic, M; Passeri, D; Lenzi, J; Rosa, A; Orlandi, A; Maiato, H; Del Bufalo, D; Degrassi, F				Orticello, M.; Fiore, M.; Totta, P.; Desideri, M.; Barisic, M.; Passeri, D.; Lenzi, J.; Rosa, A.; Orlandi, A.; Maiato, H.; Del Bufalo, D.; Degrassi, F.			N-terminus-modified Hec1 suppresses tumour growth by interfering with kinetochore-microtubule dynamics	ONCOGENE			English	Article							CANCER-CELLS; CHROMOSOME SEGREGATION; MITOTIC PROGRESSION; GENE DELIVERY; IN-VIVO; CHECKPOINT; PROTEIN; EXPRESSION; INSTABILITY; ATTACHMENT	Mitotic proteins are attractive targets to develop molecular cancer therapeutics due to the intimate interdependence between cell proliferation and mitosis. In this work, we have explored the therapeutic potential of the kinetochore (KT) protein Hec1 (Highly Expressed in Cancer protein 1) as a molecular target to produce massive chromosome missegregation and cell death in cancer cells. Hec1 is a constituent of the Ndc80 complex, which mediates KT-microtubule (MT) attachments at mitosis and is upregulated in various cancer types. We expressed Hec1 fused with enhanced green fluorescent protein (EGFP) at its N-terminus MT-interaction domain in HeLa cells and showed that expression of this modified Hec1, which localized at KTs, blocked cell proliferation and promoted apoptosis in tumour cells. EGFP-Hec1 was extremely potent in tumour cell killing and more efficient than siRNA-induced Hec1 depletion. In striking contrast, normal cells showed no apparent cell proliferation defects or cell death following EGFP-Hec1 expression. Live-cell imaging demonstrated that cancer cell death was associated with massive chromosome missegregation within multipolar spindles after a prolonged mitotic arrest. Moreover, EGFP-Hec1 expression was found to increase KT-MT attachment stability, providing a molecular explanation for the abnormal spindle architecture and the cytotoxic activity of this modified protein. Consistent with cell culture data, EGFP-Hec1 expression was found to strongly inhibit tumour growth in a mouse xenograft model by disrupting mitosis and inducing multipolar spindles. Taken together, these findings demonstrate that stimulation of massive chromosome segregation defects can be used as an anti-cancer strategy through the activation of mitotic catastrophe after a multipolar mitosis. Importantly, this study represents a clear proof of concept that targeting KT proteins required for proper KT-MT attachment dynamics constitutes a powerful approach in cancer therapy.	[Orticello, M.; Fiore, M.; Totta, P.; Degrassi, F.] CNR, Inst Biol Mol Med & Nanobiotechnol, Rome, Italy; [Desideri, M.; Del Bufalo, D.] Regina Elena Inst Canc Res, Expt Chemotherapy Lab, Rome, Italy; [Barisic, M.; Maiato, H.] Univ Porto, Inst Biol Mol & Celular, Chromosome Instabil & Dynam Lab, P-4100 Oporto, Portugal; [Passeri, D.; Orlandi, A.] Univ Roma Tor Vergata, Anat Pathol Inst, Rome, Italy; [Lenzi, J.; Rosa, A.] Univ Roma La Sapienza, Dept Biol & Biotechnol Charles Darwin, I-00185 Rome, Italy; [Maiato, H.] Univ Porto, Fac Med, Dept Expt Biol, Cell Div Unit, P-4100 Oporto, Portugal	Consiglio Nazionale delle Ricerche (CNR); IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; Universidade do Porto; University of Rome Tor Vergata; Sapienza University Rome; Universidade do Porto	Degrassi, F (corresponding author), CNR, Inst Biol Mol Med & Nanobiotechnol, Rome, Italy.	francesca.degrassi@uniroma1.it	desideri, marianna/K-5771-2016; Alessandro, Rosa/A-3860-2012; Totta, Pierangela/I-3251-2018; Del Bufalo, Donatella/K-8673-2016; Del Bufalo, Donatella/AAC-1594-2021; Orlandi, Augusto/AHE-8753-2022; Maiato, Helder/J-9466-2013; Barisic, Marin/K-2301-2013	desideri, marianna/0000-0002-4311-9656; Alessandro, Rosa/0000-0001-9999-7223; Totta, Pierangela/0000-0001-7826-4733; Del Bufalo, Donatella/0000-0002-3148-6096; Del Bufalo, Donatella/0000-0002-3148-6096; orlandi, augusto/0000-0001-7202-5854; Maiato, Helder/0000-0002-6200-9997; Barisic, Marin/0000-0001-7587-3867	Italian Association for Cancer Research [IG 14100]; COMPETE [FCOMP-01-0124-FEDER-015941 (PTDC/SAU-ONC/112917/2009)]; Fundacao para a Ciencia e a Tecnologia of Portugal, Human Frontier Science Program; European Research Council	Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); COMPETE; Fundacao para a Ciencia e a Tecnologia of Portugal, Human Frontier Science Program; European Research Council(European Research Council (ERC)European Commission)	Live-cell imaging experiments were performed at the Nikon Reference Centre, CNR Institute of Biology, Molecular Medicine and Nanobiotechnology. We thank Giulia Guarguaglini and Patrizia Lavia for advice and support with live cell analysis. We also thank Giulia Vargiu for her contribution in the initial phases of the work, Enrico Cundari for helpful comments and suggestions, Antonio Pereira for expert advice and software update in the statistical analysis of MT dynamics data and Stephan Geley for mEOS-tubulin vector. This work was partially supported by a grant from the Italian Association for Cancer Research to DDB (IG 14100). Work in HM's laboratory is funded by FCOMP-01-0124-FEDER-015941 (PTDC/SAU-ONC/112917/2009) through COMPETE and Fundacao para a Ciencia e a Tecnologia of Portugal, the Human Frontier Science Program and PRECISE grant from the European Research Council.	Bakhoum SF, 2009, CURR BIOL, V19, P1937, DOI 10.1016/j.cub.2009.09.055; Bakhoum SF, 2009, NAT CELL BIOL, V11, P27, DOI 10.1038/ncb1809; Bieche I, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-23; Brito DA, 2006, CURR BIOL, V16, P1194, DOI 10.1016/j.cub.2006.04.043; Chen YM, 1997, MOL CELL BIOL, V17, P6049, DOI 10.1128/MCB.17.10.6049; Ciferri C, 2008, CELL, V133, P427, DOI 10.1016/j.cell.2008.03.020; Cimini D, 2006, CURR BIOL, V16, P1711, DOI 10.1016/j.cub.2006.07.022; Daum JR, 2011, CURR BIOL, V21, P1018, DOI 10.1016/j.cub.2011.05.032; Davis ME, 2010, NATURE, V464, P1067, DOI 10.1038/nature08956; Degenhardt Y, 2010, CLIN CANCER RES, V16, P384, DOI 10.1158/1078-0432.CCR-09-1380; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; DeLuca JG, 2012, CURR OPIN CELL BIOL, V24, P48, DOI 10.1016/j.ceb.2011.11.003; DeLuca JG, 2003, CURR BIOL, V13, P2103, DOI 10.1016/j.cub.2003.10.056; Diaz-Rodriguez E, 2008, P NATL ACAD SCI USA, V105, P16719, DOI 10.1073/pnas.0803504105; Duijf PHG, 2013, ONCOGENE, V32, P4727, DOI 10.1038/onc.2012.616; Ferretti C, 2010, CELL CYCLE, V9, P4174, DOI 10.4161/cc.9.20.13457; Frecha C, 2008, CURR GENE THER, V8, P449, DOI 10.2174/156652308786848003; Galimberti F, 2010, CLIN CANCER RES, V16, P109, DOI 10.1158/1078-0432.CCR-09-2151; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; Glinsky GV, 2005, J CLIN INVEST, V115, P1503, DOI 10.1172/JCI23412; Guimaraes GJ, 2008, CURR BIOL, V18, P1778, DOI 10.1016/j.cub.2008.08.012; Gurzov EN, 2006, GENE THER, V13, P1, DOI 10.1038/sj.gt.3302595; Hayama S, 2006, CANCER RES, V66, P10339, DOI 10.1158/0008-5472.CAN-06-2137; Huang HC, 2009, CANCER CELL, V16, P347, DOI 10.1016/j.ccr.2009.08.020; Janssen A, 2013, ONCOGENE, V32, P4459, DOI 10.1038/onc.2012.576; Janssen A, 2009, P NATL ACAD SCI USA, V106, P19108, DOI 10.1073/pnas.0904343106; Kabeche L, 2013, NATURE, V502, P110, DOI 10.1038/nature12507; Kaneko N, 2009, BIOCHEM BIOPH RES CO, V390, P1235, DOI 10.1016/j.bbrc.2009.10.127; Kwon M, 2008, GENE DEV, V22, P2189, DOI 10.1101/gad.1700908; Lacoste A, 2009, CELL STEM CELL, V5, P332, DOI 10.1016/j.stem.2009.07.011; Lan WJ, 2004, CURR BIOL, V14, P273, DOI 10.1016/j.cub.2004.01.055; Li L, 2007, GENE THER, V14, P814, DOI 10.1038/sj.gt.3302933; Logarinho E, 2012, NAT CELL BIOL, V14, P295, DOI 10.1038/ncb2423; Maiato H, 2014, NAT CELL BIOL, V16, P386, DOI 10.1038/ncb2958; Manning AL, 2007, CURR BIOL, V17, P260, DOI 10.1016/j.cub.2006.11.071; Manning AL, 2010, EMBO J, V29, P3531, DOI 10.1038/emboj.2010.230; Martin-Lluesma S, 2002, SCIENCE, V297, P2267, DOI 10.1126/science.1075596; Mattiuzzo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016307; McKinney SA, 2009, NAT METHODS, V6, P131, DOI [10.1038/NMETH.1296, 10.1038/nmeth.1296]; Meraldi P, 2004, DEV CELL, V7, P45, DOI 10.1016/j.devcel.2004.06.006; Miller SA, 2008, CURR BIOL, V18, P1785, DOI 10.1016/j.cub.2008.11.007; Morlando M, 2012, EMBO J, V31, P4502, DOI 10.1038/emboj.2012.319; O'Connor MJ, 2007, ONCOGENE, V26, P7816, DOI 10.1038/sj.onc.1210879; Orlandi A, 2006, MODERN PATHOL, V19, P797, DOI 10.1038/modpathol.3800586; Rosa A, 2011, EMBO J, V30, P237, DOI 10.1038/emboj.2010.319; Schafer J, 2010, BIOMATERIALS, V31, P6892, DOI 10.1016/j.biomaterials.2010.05.043; Senzer N, 2013, MOL THER, V21, P1096, DOI 10.1038/mt.2013.32; Sethi G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047086; Singh J, 2012, J NANOBIOTECHNOL, V10, DOI 10.1186/1477-3155-10-7; Stevens D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022969; Vitale I, 2011, NAT REV MOL CELL BIO, V12, P384, DOI 10.1038/nrm3115; Wandke C, 2012, J CELL BIOL, V198, P847, DOI 10.1083/jcb.201110060; Wang YQ, 2012, INT J NANOMED, V7, P693, DOI 10.2147/IJN.S27849; Welburn JPI, 2010, MOL CELL, V38, P383, DOI 10.1016/j.molcel.2010.02.034; Zasadil LM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007965; ZHAI Y, 1995, J CELL BIOL, V131, P721, DOI 10.1083/jcb.131.3.721; Zhou Q, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.22566	57	8	8	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2015	34	25					3325	3335		10.1038/onc.2014.265	http://dx.doi.org/10.1038/onc.2014.265			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CK9XH	25132262				2022-12-25	WOS:000356592300011
J	Messenger, SW; Falkowski, MA; Thomas, DDH; Jones, EK; Hong, WJ; Gaisano, HY; Boulis, NM; Groblewski, GE				Messenger, Scott W.; Falkowski, Michelle A.; Thomas, Diana D. H.; Jones, Elaina K.; Hong, Wanjin; Gaisano, Herbert Y.; Boulis, Nicholas M.; Groblewski, Guy E.			Vesicle Associated Membrane Protein 8 (VAMP8)-mediated Zymogen Granule Exocytosis Is Dependent on Endosomal Trafficking via the Constitutive-Like Secretory Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endosome; Exocytosis; Intracellular Trafficking; Pancreas; SNARE Proteins	REGULATED EXOCYTOSIS; NEUROTRANSMITTER RELEASE; AMYLASE SECRETION; FUNCTIONAL-ROLE; ACINAR-CELLS; SNARE; IDENTIFICATION; VAMP8; EXPRESSION; DISTINCT	Acinar cell zymogen granules (ZG) express 2 isoforms of the vesicle-associated membrane protein family (VAMP2 and -8) thought to regulate exocytosis. Expression of tetanus toxin to cleave VAMP2 in VAMP8 knock-out (-/-) acini confirmed that VAMP2 and -8 are the primary VAMPs for regulated exocytosis, each contributing approximate to 50% of the response. Analysis of VAMP8(-/-) acini indicated that although stimulated secretion was significantly reduced, a compensatory increase in constitutive secretion maintained total secretion equivalent to wild type (WT). Using a perifusion system to follow secretion over time revealed VAMP2 mediates an early rapid phase peaking and falling within 2-3 min, whereas VAMP8 controls a second prolonged phase that peaks at 4 min and slowly declines over 20 min to support the protracted secretory response. VAMP8(-/-) acini show increased expression of the endosomal proteins Ti-VAMP7 (2-fold) and Rab11a (4-fold) and their redistribution from endosomes to ZGs. Expression of GDP-trapped Rab11a-S25N inhibited secretion exclusively from the VAMP8 but not the VAMP2 pathway. VAMP8(-/-) acini also showed a >90% decrease in the early endosomal proteins Rab5/D52/EEA1, which control anterograde trafficking in the constitutive-like secretory pathway. In WT acini, short term (14-16 h) culture also results in a >90% decrease in Rab5/D52/EEA1 and a complete loss of the VAMP8 pathway, whereas VAMP2-secretion remains intact. Remarkably, rescue of Rab5/D52/EEA1 expression restored the VAMP8 pathway. Expressed D52 shows extensive colocalization with Rab11a and VAMP8 and partially copurifies with ZG fractions. These results indicate that robust trafficking within the constitutive-like secretory pathway is required for VAMP8- but not VAMP2-mediated ZG exocytosis.	[Messenger, Scott W.; Falkowski, Michelle A.; Thomas, Diana D. H.; Jones, Elaina K.; Groblewski, Guy E.] Univ Wisconsin, Dept Nutr Sci, 1415 Linden Dr, Madison, WI 53706 USA; [Hong, Wanjin] Natl Univ Singapore, Inst Mol & Cellular Biol, Singapore 138673, Singapore; [Gaisano, Herbert Y.] Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada; [Gaisano, Herbert Y.] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; [Boulis, Nicholas M.] Georgia Inst Technol, Dept Neurosurg, Atlanta, GA 30322 USA	University of Wisconsin System; University of Wisconsin Madison; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; University of Toronto; University of Toronto; University System of Georgia; Georgia Institute of Technology	Groblewski, GE (corresponding author), Univ Wisconsin, Dept Nutr Sci, 1415 Linden Dr, Madison, WI 53706 USA.	groby@nutrisci.wisc.edu		Jones, Elaina/0000-0002-0691-4933	National Institutes of Health [DK07088]; United States Department of Agriculture/HATCH Grant [WIS01583]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK098108, R01DK070888, T32DK007665] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Agriculture/HATCH Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK07088 (to G. E. G.). This work was also supported by United States Department of Agriculture/HATCH Grant WIS01583 (to G. E. G.).	Aikawa Y, 2006, MOL BIOL CELL, V17, P2113, DOI 10.1091/mbc.E06-01-0074; Antonin W, 2000, MOL BIOL CELL, V11, P3289, DOI 10.1091/mbc.11.10.3289; ARVAN P, 1991, J BIOL CHEM, V266, P14171; Arvan P, 1998, BIOCHEM J, V332, P593, DOI 10.1042/bj3320593; Azouz NP, 2014, J IMMUNOL, V192, P4043, DOI 10.4049/jimmunol.1302196; Baetz NW, 2013, MOL BIOL CELL, V24, P643, DOI 10.1091/mbc.E12-09-0659; Baumler MD, 2010, AM J PHYSIOL-GASTR L, V299, pG338, DOI 10.1152/ajpgi.00165.2010; Behrendorff N, 2011, J BIOL CHEM, V286, P29627, DOI 10.1074/jbc.M111.265199; Castle AM, 2002, J CELL SCI, V115, P2963; Castle JD, 1996, J CELL SCI, V109, P2591; Chaudhuri A, 2007, AM J PHYSIOL-GASTR L, V292, pG1403, DOI 10.1152/ajpgi.00478.2005; Chen XQ, 2003, J BIOL CHEM, V278, P50053, DOI 10.1074/jbc.M309910200; Chen XQ, 2008, MOL CELL PROTEOMICS, V7, P2323, DOI 10.1074/mcp.M700575-MCP200; Chen Y, 2005, AM J PHYSIOL-CELL PH, V289, pC1209, DOI 10.1152/ajpcell.00159.2005; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; Cosen-Binker LI, 2008, J CLIN INVEST, V118, P2535, DOI 10.1172/JCI34672; Falkowski MA, 2011, AM J PHYSIOL-GASTR L, V301, pG306, DOI 10.1152/ajpgi.00108.2011; FujitaYoshigaki J, 1996, J BIOL CHEM, V271, P13130, DOI 10.1074/jbc.271.22.13130; Gaisano HY, 2009, GASTROENTEROLOGY, V136, P2040, DOI 10.1053/j.gastro.2009.04.023; GAISANO HY, 1994, J BIOL CHEM, V269, P17062; Groblewski GE, 1998, J BIOL CHEM, V273, P22738, DOI 10.1074/jbc.273.35.22738; Groblewski GE, 1999, AM J PHYSIOL-GASTR L, V276, pG219, DOI 10.1152/ajpgi.1999.276.1.G219; Hoekstra D, 2004, J CELL SCI, V117, P2183, DOI 10.1242/jcs.01217; Huang AY, 2001, J BIOL CHEM, V276, P22296, DOI 10.1074/jbc.M100211200; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jones LC, 2012, J PHYSIOL-LONDON, V590, P545, DOI 10.1113/jphysiol.2011.222091; KAWABATA SI, 1988, EUR J BIOCHEM, V172, P17, DOI 10.1111/j.1432-1033.1988.tb13849.x; Loo LS, 2009, EUR J IMMUNOL, V39, P3520, DOI 10.1002/eji.200939378; LOWE ME, 1992, J BIOL CHEM, V267, P17069; Mallard F, 2002, J CELL BIOL, V156, P653, DOI 10.1083/jcb.200110081; Masedunskas A, 2008, TRAFFIC, V9, P1801, DOI 10.1111/j.1600-0854.2008.00798.x; MCMAHON HT, 1993, NATURE, V364, P346, DOI 10.1038/364346a0; Messenger SW, 2014, CELL CALCIUM, V55, P369, DOI 10.1016/j.ceca.2014.03.003; Messenger SW, 2013, AM J PHYSIOL-GASTR L, V305, pG439, DOI 10.1152/ajpgi.00143.2013; Mullock BM, 2000, MOL BIOL CELL, V11, P3137, DOI 10.1091/mbc.11.9.3137; Nemoto T, 2001, NAT CELL BIOL, V3, P253, DOI 10.1038/35060042; Oishi Y, 2006, HISTOCHEM CELL BIOL, V125, P273, DOI 10.1007/s00418-005-0068-y; PADFIELD PJ, 1995, AM J PHYSIOL-GASTR L, V269, pG647, DOI 10.1152/ajpgi.1995.269.5.G647; PALADE G, 1975, SCIENCE, V189, P347, DOI 10.1126/science.1096303; Paumet F, 2000, J IMMUNOL, V164, P5850, DOI 10.4049/jimmunol.164.11.5850; Pickett JA, 2007, BIOCHEM BIOPH RES CO, V359, P599, DOI 10.1016/j.bbrc.2007.05.128; Pocard T, 2007, J CELL SCI, V120, P3309, DOI 10.1242/jcs.007948; Polgar J, 2002, BLOOD, V100, P1081, DOI 10.1182/blood.V100.3.1081; Rao SK, 2004, J BIOL CHEM, V279, P20471, DOI 10.1074/jbc.M400798200; Rodriguez-Pineiro AM, 2012, J PROTEOME RES, V11, P1879, DOI 10.1021/pr2010988; Sabbatini ME, 2008, J BIOL CHEM, V283, P23884, DOI 10.1074/jbc.M800754200; Scheuber A, 2006, P NATL ACAD SCI USA, V103, P16562, DOI 10.1073/pnas.0603511103; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Sengupta D, 1996, EUR J CELL BIOL, V70, P306; Shahheydari H, 2014, MOL BIOL REP, V41, P4565, DOI 10.1007/s11033-014-3327-y; Sudhof TC, 2013, NEURON, V80, P675, DOI 10.1016/j.neuron.2013.10.022; Teng Q, 2005, GENE THER, V12, P108, DOI 10.1038/sj.gt.3302400; Thomas DDH, 2004, AM J PHYSIOL-GASTR L, V287, pG253, DOI 10.1152/ajpgi.00033.2004; Thomas DDH, 2001, J BIOL CHEM, V276, P28866, DOI 10.1074/jbc.M102214200; Thomas DDH, 2010, AM J PHYSIOL-CELL PH, V298, pC725, DOI 10.1152/ajpcell.00455.2009; Thorn Peter, 2012, Commun Integr Biol, V5, P61; Wang CC, 2004, DEV CELL, V7, P359, DOI 10.1016/j.devcel.2004.08.002; Wang CC, 2007, MOL BIOL CELL, V18, P1056, DOI 10.1091/mbc.E06-10-0974; Weng N, 2007, J BIOL CHEM, V282, P9635, DOI 10.1074/jbc.M611108200; Williams JA, 2008, CURR OPIN GASTROEN, V24, P573, DOI 10.1097/MOG.0b013e32830b110c; Yoshimura K, 1998, EUR J MORPHOL, V36, P198; YOSHIMURA K, 1991, JPN J PHYSIOL, V41, P443, DOI 10.2170/jjphysiol.41.443; Zeigerer A, 2012, NATURE, V485, P465, DOI 10.1038/nature11133; Zhang Z, 2013, J NEUROSCI, V33, P9169, DOI 10.1523/JNEUROSCI.0301-13.2013; Zhu D, 2012, CELL METAB, V16, P238, DOI 10.1016/j.cmet.2012.07.001	65	15	16	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					28040	28053		10.1074/jbc.M114.593913	http://dx.doi.org/10.1074/jbc.M114.593913			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25138214	hybrid, Green Published			2022-12-25	WOS:000342852800055
J	Zhu, L; Yang, K; Wang, XE; Wang, X; Wang, CC				Zhu, Li; Yang, Kai; Wang, Xi'e; Wang, Xi; Wang, Chih-chen			A Novel Reaction of Peroxiredoxin 4 towards Substrates in Oxidative Protein Folding	PLOS ONE			English	Article							DISULFIDE BOND FORMATION; ENDOPLASMIC-RETICULUM; REDOX HOMEOSTASIS; ISOMERASE; PEROXIDE; IV; REDUCTASE; DOMAINS; PATHWAY; CELLS	Peroxiredoxin 4 (Prx4) is the only endoplasmic reticulum localized peroxiredoxin. It functions not only to eliminate peroxide but also to promote oxidative protein folding via oxidizing protein disulfide isomerase (PDI). In Prx4-mediated oxidative protein folding we discovered a new reaction that the sulfenic acid form of Prx4 can directly react with thiols in folding substrates, resulting in non-native disulfide cross-linking and aggregation. We also found that PDI can inhibit this reaction by exerting its reductase and chaperone activities. This discovery discloses an off-pathway reaction in the Prx4-mediated oxidative protein folding and the quality control role of PDI.	[Zhu, Li; Yang, Kai; Wang, Xi'e; Wang, Xi; Wang, Chih-chen] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China; [Zhu, Li; Yang, Kai] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, X (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China.	wangxi@moon.ibp.ac.cn; chihwang@sun5.ibp.ac.cn	Yang, Kai S./AAC-9906-2021	Yang, Kai S./0000-0002-1890-4169	Chinese Ministry of Science and Technology [2011CB910303, 2012CB911002]; National Natural Science Foundation of China [31370758]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Chinese Ministry of Science and Technology (2011CB910303 and 2012CB911002, http://www.most.gov.cn) and the National Natural Science Foundation of China (31370758, http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appenzeller-Herzog C, 2010, EMBO J, V29, P3318, DOI 10.1038/emboj.2010.203; Chng SS, 2012, MOL MICROBIOL, V85, P996, DOI 10.1111/j.1365-2958.2012.08157.x; Cohen TJ, 2012, EMBO J, V31, P1241, DOI 10.1038/emboj.2011.471; Freedman RB, 2002, EMBO REP, V3, P136, DOI 10.1093/embo-reports/kvf035; Gross E, 2006, P NATL ACAD SCI USA, V103, P299, DOI 10.1073/pnas.0506448103; Hall A, 2009, FEBS J, V276, P2469, DOI 10.1111/j.1742-4658.2009.06985.x; Kakihana T, 2012, ANTIOXID REDOX SIGN, V16, P763, DOI 10.1089/ars.2011.4238; Karch CM, 2009, P NATL ACAD SCI USA, V106, P7774, DOI 10.1073/pnas.0902505106; LUNDSTROM J, 1990, J BIOL CHEM, V265, P9114; LYLES MM, 1991, BIOCHEMISTRY-US, V30, P613, DOI 10.1021/bi00217a004; Nguyen VD, 2011, J MOL BIOL, V406, P503, DOI 10.1016/j.jmb.2010.12.039; Park B, 2006, CELL, V127, P369, DOI 10.1016/j.cell.2006.08.041; Poole LB, 2004, ANNU REV PHARMACOL, V44, P325, DOI 10.1146/annurev.pharmtox.44.101802.121735; Rutkevich LA, 2012, MOL BIOL CELL, V23, P2017, DOI 10.1091/mbc.E12-02-0102; Sato Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep02456; Tavender TJ, 2008, BIOCHEM J, V411, P191, DOI 10.1042/BJ20071428; Tavender TJ, 2010, EMBO J, V29, P4185, DOI 10.1038/emboj.2010.273; Tavender TJ, 2010, J CELL SCI, V123, P2672, DOI 10.1242/jcs.067843; Tu BP, 2000, SCIENCE, V290, P1571, DOI 10.1126/science.290.5496.1571; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Wang C, 2012, J BIOL CHEM, V287, P1139, DOI 10.1074/jbc.M111.303149; Wang L, 2014, ANTIOXID REDOX SIGN, V20, P545, DOI 10.1089/ars.2013.5236; Wang L, 2009, J BIOL CHEM, V284, P199, DOI 10.1074/jbc.M806645200; Wang X, 2012, BIOCHEM J, V441, P113, DOI 10.1042/BJ20110380; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Yao Y, 1997, EMBO J, V16, P651, DOI 10.1093/emboj/16.3.651; ZAPUN A, 1992, PROTEINS, V14, P10, DOI 10.1002/prot.340140104; Zito E, 2012, MOL CELL, V48, P39, DOI 10.1016/j.molcel.2012.08.010; Zito E, 2010, MOL CELL, V40, P787, DOI 10.1016/j.molcel.2010.11.010	30	19	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105529	10.1371/journal.pone.0105529	http://dx.doi.org/10.1371/journal.pone.0105529			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137134	Green Published, gold, Green Submitted			2022-12-25	WOS:000340742100105
J	Pena, EJ; Ferriol, I; Sambade, A; Buschmann, H; Niehl, A; Elena, SF; Rubio, L; Heinlein, M				Pena, Eduardo Jose; Ferriol, Inmaculada; Sambade, Adrian; Buschmann, Henrik; Niehl, Annette; Elena, Santiago F.; Rubio, Luis; Heinlein, Manfred			Experimental Virus Evolution Reveals a Role of Plant Microtubule Dynamics and TORTIFOLIA1/SPIRAL2 in RNA Trafficking	PLOS ONE			English	Article							TOBACCO-MOSAIC-VIRUS; ARABIDOPSIS CORTICAL MICROTUBULES; MOVEMENT PROTEIN; CELL-WALLS; TRANSGENIC PLANTS; HELICAL GROWTH; COAT PROTEIN; ORGANIZATION; COMPLEXES; INFECTION	The cytoskeleton is a dynamic network composed of filamentous polymers and regulatory proteins that provide a flexible structural scaffold to the cell and plays a fundamental role in developmental processes. Mutations that alter the spatial orientation of the cortical microtubule (MT) array of plants are known to cause important changes in the pattern of cell wall synthesis and developmental phenotypes; however, the consequences of such alterations on other MT-network-associated functions in the cytoplasm are not known. In vivo observations suggested a role of cortical MTs in the formation and movement of Tobacco mosaic virus (TMV) RNA complexes along the endoplasmic reticulum (ER). Thus, to probe the significance of dynamic MT behavior in the coordination of MT-network-associated functions related to TMV infection and, thus, in the formation and transport of RNA complexes in the cytoplasm, we performed an evolution experiment with TMV in Arabidopsis thaliana tor1/spr2 and tor2 mutants with specific defects in MT dynamics and asked whether TMV is sensitive to these changes. We show that the altered cytoskeleton induced genetic changes in TMV that were correlated with efficient spread of infection in the mutant hosts. These observations demonstrate a role of dynamic MT rearrangements and of the MT-associated protein TORTIFOLIA1/SPIRAL2 in cellular functions related to virus spread and indicate that MT dynamics and MT-associated proteins represent constraints for virus evolution and adaptation. The results highlight the importance of the dynamic plasticity of the MT network in directing cytoplasmic functions in macromolecular assembly and trafficking and illustrate the value of experimental virus evolution for addressing the cellular functions of dynamic, long-range order systems in multicellular organisms.	[Pena, Eduardo Jose; Heinlein, Manfred] CNRS, Inst Biol Mol Plantes, UPR2357, F-67084 Strasbourg, France; [Ferriol, Inmaculada; Rubio, Luis] Inst Valenciano Invest Agr, Moncada, Spain; [Sambade, Adrian] Univ Valencia, CIBERNED, Inst Cavanilles Biodiversitat & Biol Evolut, Dept Comparat Neurobiol, Valencia, Spain; [Buschmann, Henrik] Univ Osnabruck, Inst Bot, Osnabruck, Germany; [Niehl, Annette; Heinlein, Manfred] Univ Basel, Dept Environm Sci Plant Physiol, Basel, Switzerland; [Elena, Santiago F.] CSIC UPV, Inst Biol Mol & Celular Plantas, Valencia, Spain; [Elena, Santiago F.] Santa Fe Inst, Santa Fe, NM 87501 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Instituto Valenciano de Investigaciones Agrarias (IVIA); CIBERNED; University of Valencia; University Osnabruck; University of Basel; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP); The Santa Fe Institute	Rubio, L (corresponding author), Inst Valenciano Invest Agr, Moncada, Spain.	lrubio@ivia.es; manfred.heinlein@ibmp-cnrs.unistra.fr	Ferriol, Inmaculada/T-3950-2017; Rubio, Luis/H-7810-2012; Elena, Santiago F./A-4191-2011	Ferriol, Inmaculada/0000-0003-0111-7537; Rubio, Luis/0000-0002-7964-3062; Elena, Santiago F./0000-0001-8249-5593	Agence National de la Recherche (ANR) [ANR-08-BLAN-244]; Swiss National Science Foundation (SNF) [310031A_140694]; EMBO; Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA) from Spain; Spanish Ministry of Science and Education [AGL2005-07754]; Spanish Secretaria de Estado de Investigacion, Desarrollo e Innovacion [BFU2012-30805]	Agence National de la Recherche (ANR)(French National Research Agency (ANR)); Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); EMBO(European Molecular Biology Organization (EMBO)); Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA) from Spain; Spanish Ministry of Science and Education(Spanish Government); Spanish Secretaria de Estado de Investigacion, Desarrollo e Innovacion	Work of E.P. and of A.N. was supported by grants from the Agence National de la Recherche (ANR, grant ANR-08-BLAN-244) and the Swiss National Science Foundation (SNF, grant 310031A_140694) to M. H. We also acknowledge the funding of an EMBO short-term fellowship to H. B. I. F. was supported by a pre-doctoral fellowship from the Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA) from Spain. L. R. was supported by grant AGL2005-07754 from the Spanish Ministry of Science and Education and S. F. E. by grant BFU2012-30805 from the Spanish Secretaria de Estado de Investigacion, Desarrollo e Innovacion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose C, 2013, DEV CELL, V24, P649, DOI 10.1016/j.devcel.2013.02.007; Ashby J, 2006, J VIROL, V80, P8329, DOI 10.1128/JVI.00540-06; Asurmendi S, 2004, P NATL ACAD SCI USA, V101, P1415, DOI 10.1073/pnas.0307778101; Baskin TI, 2005, ANNU REV CELL DEV BI, V21, P203, DOI 10.1146/annurev.cellbio.20.082503.103053; Bonfield JK, 2010, BIOINFORMATICS, V26, P1699, DOI 10.1093/bioinformatics/btq268; Boyko V, 2000, NAT CELL BIOL, V2, P826, DOI 10.1038/35041072; Boyko V, 2007, PLANT J, V51, P589, DOI 10.1111/j.1365-313X.2007.03163.x; Brandner K, 2008, PLANT PHYSIOL, V147, P611, DOI 10.1104/pp.108.117481; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; Buschmann H, 2004, CURR BIOL, V14, P1515, DOI 10.1016/j.cub.2004.08.033; Buschmann H, 2009, PLANT CELL, V21, P2090, DOI 10.1105/tpc.108.061242; Buschmann H, 2008, MOL PLANT, V1, P888, DOI 10.1093/mp/ssn060; Chan J, 2010, J CELL SCI, V123, P3490, DOI 10.1242/jcs.074641; Chan J, 2009, PLANT CELL, V21, P2298, DOI 10.1105/tpc.109.069716; Crowell EF, 2009, PLANT CELL, V21, P1141, DOI 10.1105/tpc.108.065334; Debreczeni DE, 2011, J VIROL METHODS, V176, P32, DOI 10.1016/j.jviromet.2011.05.027; DEOM CM, 1987, SCIENCE, V237, P389, DOI 10.1126/science.237.4813.389; DEOM CM, 1990, P NATL ACAD SCI USA, V87, P3284, DOI 10.1073/pnas.87.9.3284; Dohner K, 2005, TRENDS MICROBIOL, V13, P320, DOI 10.1016/j.tim.2005.05.010; Elena SF, 2007, ANNU REV ECOL EVOL S, V38, P27, DOI 10.1146/annurev.ecolsys.38.091206.095637; Ferralli J, 2006, J VIROL, V80, P5807, DOI 10.1128/JVI.00254-06; Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908; Greber UF, 2006, CELL, V124, P741, DOI 10.1016/j.cell.2006.02.018; Gutierrez R, 2009, NAT CELL BIOL, V11, P797, DOI 10.1038/ncb1886; Heinlein M, 1998, PLANT CELL, V10, P1107, DOI 10.1105/tpc.10.7.1107; HEINLEIN M, 1995, SCIENCE, V270, P1983, DOI 10.1126/science.270.5244.1983; Herzog E, 1998, VIROLOGY, V248, P312, DOI 10.1006/viro.1998.9287; Hirashima K, 2001, J VIROL, V75, P8831, DOI 10.1128/JVI.75.18.8831-8836.2001; HOLT CA, 1991, VIROLOGY, V181, P109, DOI 10.1016/0042-6822(91)90475-Q; Ketelaar T, 2004, FEBS LETT, V567, P302, DOI 10.1016/j.febslet.2004.04.088; Liu JZ, 2005, PLANT PHYSIOL, V138, P1853, DOI 10.1104/pp.105.065722; Lloyd C, 2011, INT REV CEL MOL BIO, V287, P287, DOI 10.1016/B978-0-12-386043-9.00007-4; Mansilla C, 2009, MOL PLANT PATHOL, V10, P59, DOI 10.1111/j.1364-3703.2008.00506.x; Murata T, 2005, NAT CELL BIOL, V7, P961, DOI 10.1038/ncb1306; NAGATA T, 1992, INT REV CYTOL, V132, P1, DOI 10.1016/S0074-7696(08)62452-3; Nakamura M, 2010, NAT CELL BIOL, V12, P1064, DOI 10.1038/ncb2110; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Niehl A, 2013, PLANT J, V75, P290, DOI 10.1111/tpj.12134; Niehl A, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.22865; Niehl A, 2012, PLANT PHYSIOL, V160, P2093, DOI 10.1104/pp.112.207399; Oda Y, 2013, CURR OPIN PLANT BIOL, V16, P743, DOI 10.1016/j.pbi.2013.10.010; OSBOURN JK, 1990, VIROLOGY, V179, P921, DOI 10.1016/0042-6822(90)90169-R; Paredez AR, 2006, SCIENCE, V312, P1491, DOI 10.1126/science.1126551; Pena EJ, 2013, CURR OPIN PLANT BIOL, V16, P764, DOI 10.1016/j.pbi.2013.10.002; Sambade A, 2008, TRAFFIC, V9, P2073, DOI 10.1111/j.1600-0854.2008.00824.x; Shaw SL, 2003, SCIENCE, V300, P1715, DOI 10.1126/science.1083529; Wightman R, 2013, CURR BIOL, V23, P1902, DOI 10.1016/j.cub.2013.07.061; Wu S, 2013, PLANT J, V74, P148, DOI 10.1111/tpj.12112; Yao M, 2008, J CELL SCI, V121, P2372, DOI 10.1242/jcs.030221	49	8	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105364	10.1371/journal.pone.0105364	http://dx.doi.org/10.1371/journal.pone.0105364			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133612	Green Published, gold, Green Submitted			2022-12-25	WOS:000341302700105
J	Arnold, T; Freundlich, G; Weilnau, T; Verdi, A; Tibbetts, IR				Arnold, Thomas; Freundlich, Grace; Weilnau, Taylor; Verdi, Arielle; Tibbetts, Ian R.			Impacts of Groundwater Discharge at Myora Springs (North Stradbroke Island, Australia) on the Phenolic Metabolism of Eelgrass, Zostera muelleri, and Grazing by the Juvenile Rabbitfish, Siganus fuscescens	PLOS ONE			English	Article							CO2 ENRICHMENT FACE; WASTING DISEASE; ELEVATED CO2; MORETON BAY; LIGHT-INTENSITY; CARBON-DIOXIDE; CAFFEIC ACID; GROWTH; CHEMISTRY; LEAVES	Myora Springs is one of many groundwater discharge sites on North Stradbroke Island (Queensland, Australia). Here spring waters emerge from wetland forests to join Moreton Bay, mixing with seawater over seagrass meadows dominated by eelgrass, Zostera muelleri. We sought to determine how low pH /high CO2 conditions near the spring affect these plants and their interactions with the black rabbitfish (Siganus fuscescens), a co-occurring grazer. In paired-choice feeding trials S. fuscescens preferentially consumed Z. muelleri shoots collected nearest to Myora Springs. Proximity to the spring did not significantly alter the carbon and nitrogen contents of seagrass tissues but did result in the extraordinary loss of soluble phenolics, including Folin-reactive phenolics, condensed tannins, and phenolic acids by >= 87%. Conversely, seagrass lignin contents were, in this and related experiments, unaffected or increased, suggesting a shift in secondary metabolism away from the production of soluble, but not insoluble, (poly)phenolics. We suggest that groundwater discharge sites such as Myora Springs, and other sites characterized by low pH, are likely to be popular feeding grounds for seagrass grazers seeking to reduce their exposure to soluble phenolics.	[Arnold, Thomas; Freundlich, Grace; Weilnau, Taylor; Verdi, Arielle] Dickinson Coll, Biochem & Mol Biol Program, Carlisle, PA 17013 USA; [Tibbetts, Ian R.] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia	Dickinson College; University of Queensland	Arnold, T (corresponding author), Dickinson Coll, Biochem & Mol Biol Program, Carlisle, PA 17013 USA.	arnoldt@dickinson.edu	Tibbetts, Ian/K-6191-2013	Tibbetts, Ian/0000-0002-1481-238X; Freundlich, Grace/0000-0002-1784-4416	Dickinson College's Research and Development Committee and Center for Sustainability Education [NASA 09-GCCE-0139]; Smithsonian Institution	Dickinson College's Research and Development Committee and Center for Sustainability Education; Smithsonian Institution(Smithsonian Institution)	Support was provided by grants from Dickinson College's Research and Development Committee and Center for Sustainability Education (NASA 09-GCCE-0139) and by a Smithsonian Institution senior postdoctoral fellowship to TA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIN DE, 1995, ANIM FEED SCI TECH, V53, P29, DOI 10.1016/0377-8401(94)00736-S; Arnold T, 2004, NEW PHYTOL, V164, P157, DOI 10.1111/j.1469-8137.2004.01157.x; Arnold T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035107; Arnold TM, 2002, J CHEM ECOL, V28, P1919, DOI 10.1023/A:1020737609151; ARNOLD TM, 1995, MAR ECOL PROG SER, V123, P177, DOI 10.3354/meps123177; Beer S, 1996, MAR ECOL PROG SER, V141, P199, DOI 10.3354/meps141199; Beer S, 1997, AQUAT BOT, V56, P277, DOI 10.1016/S0304-3770(96)01109-6; Bidart-Bouzat MG, 2008, J INTEGR PLANT BIOL, V50, P1339, DOI 10.1111/j.1744-7909.2008.00751.x; Brand-Gardner SJ, 1999, AUST J ZOOL, V47, P181, DOI 10.1071/ZO98065; BRYANT JP, 1983, OIKOS, V40, P357, DOI 10.2307/3544308; Cai WJ, 1998, LIMNOL OCEANOGR, V43, P657, DOI 10.4319/lo.1998.43.4.0657; Coley PD, 2002, OECOLOGIA, V133, P62, DOI 10.1007/s00442-002-1005-6; Cosgrove DJ, 1999, ANNU REV PLANT PHYS, V50, P391, DOI 10.1146/annurev.arplant.50.1.391; Cseke LJ, 2009, NEW PHYTOL, V182, P891, DOI 10.1111/j.1469-8137.2009.02812.x; Cuttriss AK, 2013, AQUAT BOT, V108, P41, DOI 10.1016/j.aquabot.2013.03.003; de los Santos CB, 2012, MAR ECOL PROG SER, V458, P89, DOI 10.3354/meps09757; Den Hartog C., 1996, SEAGRASS BIOL, P307; Dickson A. G., 2007, PICES SPECIAL PUBLIC, DOI DOI 10.1159/000331784; Dixon RA, 2002, MOL PLANT PATHOL, V3, P371, DOI 10.1046/j.1364-3703.2002.00131.x; Flamarique IN, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2490; Goecker ME, 2005, MAR ECOL PROG SER, V286, P239, DOI 10.3354/meps286239; Grabber JH, 2003, J AGR FOOD CHEM, V51, P4984, DOI 10.1021/jf030027c; Grice AM, 1996, J EXP MAR BIOL ECOL, V195, P91, DOI 10.1016/0022-0981(95)00096-8; Hagerman AE, 1986, PLANT FLAVONOIDS BIO, P67; Hagihara R, 2014, MAR MAMMAL SCI, V30, P348, DOI 10.1111/mms.12041; HARRISON PG, 1982, MAR BIOL, V67, P225, DOI 10.1007/BF00401288; HARRISON PG, 1985, MAR BIOL, V90, P117, DOI 10.1007/BF00428222; HARRISON PG, 1980, MAR BIOL, V61, P21, DOI 10.1007/BF00410338; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; Lager I, 2010, PLANT CELL ENVIRON, V33, P1513, DOI 10.1111/j.1365-3040.2010.02161.x; Lanyon J.M., 1989, BIOL SEAGRASSES TREA, P610; Laylock JT, 1975, N STRADBROKE ISLAND; Leach L. M., 2011, Proceedings of the Royal Society of Queensland, V117, P21; Limpus Colin J., 1994, Memoirs of the Queensland Museum, V35, P139; Lindroth RL, 2010, J CHEM ECOL, V36, P2, DOI 10.1007/s10886-009-9731-4; Losey GS, 1999, J FISH BIOL, V54, P921, DOI 10.1111/j.1095-8649.1999.tb00848.x; Luo ZB, 2008, PLANT SOIL, V304, P45, DOI 10.1007/s11104-007-9518-8; Luo ZB, 2009, GLOBAL CHANGE BIOL, V15, P38, DOI 10.1111/j.1365-2486.2008.01768.x; Mariani S, 1999, MAR ECOL PROG SER, V189, P295, DOI 10.3354/meps189295; Martin S, 2008, BIOL LETTERS, V4, P689, DOI 10.1098/rsbl.2008.0412; Mathger LM, 2007, COPEIA, P169; Mattson WJ, 2005, OIKOS, V111, P337, DOI 10.1111/j.0030-1299.2005.13634.x; MCMILLAN C, 1984, AQUAT BOT, V20, P351, DOI 10.1016/0304-3770(84)90099-8; Meehan TD, 2010, SOIL BIOL BIOCHEM, V42, P1132, DOI 10.1016/j.soilbio.2010.03.019; Migliore L, 2012, MEDITERRANEAN SEAGRA; Moss P., 2011, Proceedings of the Royal Society of Queensland, V117, P133; MUEHLSTEIN LK, 1992, CAN J BOT, V70, P2081, DOI 10.1139/b92-258; Natural Resources and Water, 2006, HYDR N STARDBR ISL; Pauly M., 2010, JOVE-J VIS EXP, V37, P1745, DOI [10.3791/1745, DOI 10.3791/1745]; Penuelas J, 1997, PHOTOSYNTHETICA, V33, P313, DOI 10.1023/A:1022120431279; Penuelas J, 1998, TRENDS ECOL EVOL, V13, P20, DOI 10.1016/S0169-5347(97)01235-4; PETERSON CH, 1989, OECOLOGIA, V80, P82, DOI 10.1007/BF00789935; Pierrot D., 2006, ORNLCDIAC105A US DEP, DOI [10.3334/CDIAC/otg.CO2SYS_XLS_CDIAC105a, DOI 10.3334/CDIAC/OTG.CO2SYS_XLS_CDIAC105A]; Prado P, 2011, MAR ECOL PROG SER, V429, P45, DOI 10.3354/meps09076; PREEN A, 1995, MAR ECOL PROG SER, V124, P201, DOI 10.3354/meps124201; QUACKENBUSH RC, 1986, AQUAT BOT, V24, P83, DOI 10.1016/0304-3770(86)90119-1; RAVN H, 1989, BIOCHEM SYST ECOL, V17, P175, DOI 10.1016/0305-1978(89)90076-8; RAVN H, 1994, OPHELIA, V40, P51, DOI 10.1080/00785326.1994.10429550; Steele L, 2005, MAR ECOL PROG SER, V303, P123, DOI 10.3354/meps303123; Stiling P, 2007, GLOBAL CHANGE BIOL, V13, P1823, DOI 10.1111/j.1365-2486.2007.01392.x; Tomas F, 2011, ECOLOGY, V92, P1807, DOI 10.1890/10-2095.1; Udy JW, 1997, MAR FRESHWATER RES, V48, P605, DOI 10.1071/MF97001; VALIELA I, 1979, NATURE, V280, P55, DOI 10.1038/280055a0; Valkama E, 2007, GLOBAL CHANGE BIOL, V13, P184, DOI 10.1111/j.1365-2486.2006.01284.x; VERGEER LHT, 1995, AQUAT BOT, V52, P35, DOI 10.1016/0304-3770(95)00480-N; Vergeer LHT, 1997, AQUAT BOT, V58, P65, DOI 10.1016/S0304-3770(96)01115-1; Verges A, 2007, MAR ECOL PROG SER, V343, P107, DOI 10.3354/meps06885; Vizzini S, 2010, J ECOL, V98, P1284, DOI 10.1111/j.1365-2745.2010.01730.x; Vogt T, 2010, MOL PLANT, V3, P2, DOI 10.1093/mp/ssp106; WENG HT, 1990, ESTUAR COAST SHELF S, V30, P569, DOI 10.1016/0272-7714(90)90093-7; YOUNG P C, 1975, Aquatic Botany, V1, P191, DOI 10.1016/0304-3770(75)90022-4; ZAPATA O, 1979, AQUAT BOT, V7, P307, DOI 10.1016/0304-3770(79)90032-9; [No title captured]	73	17	17	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104738	10.1371/journal.pone.0104738	http://dx.doi.org/10.1371/journal.pone.0104738			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127379	Green Published, Green Submitted, gold			2022-12-25	WOS:000340879300045
J	da Hora, BT; de Macedo, DM; Barreto, RW; Evans, HC; Mattos, CRR; Maffia, LA; Mizubuti, ESG				da Hora Junior, Braz Tavares; de Macedo, Davi Mesquita; Barreto, Robert Weingart; Evans, Harry C.; Reis Mattos, Carlos Raimundo; Maffia, Luiz Antonio; Mizubuti, Eduardo S. G.			Erasing the Past: A New Identity for the Damoclean Pathogen Causing South American Leaf Blight of Rubber	PLOS ONE			English	Article							RIBOSOMAL DNA; MYCOSPHAERELLA; PHYLOGENY; MICROCYCLUS; SEQUENCE; TREE; PLANISTROMELLACEAE; MORPHOLOGY; BIOLOGY; SPOT	Background: South American leaf blight (SALB) of rubber has been the main constraint to production in its neotropical centre of origin since commercial plantations were first established. The fungal causal agent was identified and described more than a century ago but its precise placement within the Ascomycota still remains uncertain. Indeed, such is the ambiguity surrounding the pathogen that each of the spore morphs would, according to their present classification, be placed in different ascomycete families: the Microcyclus sexual morph in the Planistromellaceae and the two purported asexual morphs - Fusicladium and Aposphaeria - in the Venturiaceae and Lophiostomataceae, respectively. Given the historical importance of the fungus and the ever-menacing threat that it poses to rubber production in the Palaeotropics and, thus to the rubber industry and to the global economy - its phylogeny, as well as its biology, should be resolved as a matter of urgency. Methods and Results: Here, six genomic regions (LSU rRNA, mtSSU, MCM7, EF-1 alpha, Act and ITS) were used for reconstructing the molecular phylogeny of the SALB fungus based on material collected throughout Brazil. The analyses support the classification of the fungus in the family Mycosphaerellaceae s. str. (Capnodiales, Dothideomycetes) and place it firmly within the clade Pseudocercospora s. str., now accepted as one of the distinct genera within Mycosphaerellaceae. The new combination Pseudocercospora ulei is proposed and the life cycle of the fungus is confirmed, based on both experimental and phylogenetic evidence, with the Aposphaeria morph shown to have a spermatial rather than an infective-dispersal function. Conclusions: Because the phylogeny of the SALB fungus has now been clarified, new insights of its epidemiology and genomics can be gained following comparison with closely-related, better-researched crop pathogens.	[da Hora Junior, Braz Tavares; de Macedo, Davi Mesquita; Barreto, Robert Weingart; Evans, Harry C.; Maffia, Luiz Antonio; Mizubuti, Eduardo S. G.] Univ Fed Vicosa, Dept Fitopatol, BR-36570 Vicosa, MG, Brazil; [Evans, Harry C.] CAB Int, E UK Ctr, Egham, Surrey, England; [Reis Mattos, Carlos Raimundo] Plantacoes Michelin Bahia, Itubera, Bahia, Brazil	Universidade Federal de Vicosa; Michelin	Mizubuti, ESG (corresponding author), Univ Fed Vicosa, Dept Fitopatol, BR-36570 Vicosa, MG, Brazil.	mizubuti@ufv.br	Mizubuti, Eduardo/C-3578-2013	Mizubuti, Eduardo/0000-0001-9612-5155	Plantacoes Michelin da Bahia	Plantacoes Michelin da Bahia	The work was funded by Plantacoes Michelin da Bahia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, FUNGAL DATABASES; Barr ME, 1996, MYCOTAXON, V60, P433; Beck Andreas, 2005, Mycological Progress, V4, P111, DOI 10.1007/s11557-006-0114-8; Bonorden HF, 1851, HDB ALLGEMEINEN MYKO; Braun Uwe, 2002, Mycological Progress, V1, P19, DOI 10.1007/s11557-006-0002-2; CANNON PF, 1995, MYCOL RES, V99, P353, DOI 10.1016/S0953-7562(09)80912-X; Carbone I, 1999, MYCOLOGIA, V91, P553, DOI 10.2307/3761358; CHEE KH, 1986, MALAYSIAN RUBBER RES, V13; Churchill ACL, 2011, MOL PLANT PATHOL, V12, P307, DOI 10.1111/j.1364-3703.2010.00672.x; Crous PW, 2007, STUD MYCOL, P1, DOI 10.3114/sim.2007.58.01; Crous PW, 2013, STUD MYCOL, P37, DOI 10.3114/sim0005; Crous PW, 2009, STUD MYCOL, P17, DOI 10.3114/sim.2009.64.02; Crous PW, 2009, PERSOONIA, V23, P99, DOI 10.3767/003158509X479487; Crous PW, 2006, STUD MYCOL, P163, DOI 10.3114/sim.55.1.163; Crous PW, 2004, STUD MYCOL, P19; Crous PW, 2001, MYCOLOGIA, V93, P1081, DOI 10.2307/3761670; Crous PW, 2003, CBS BIODIVERSITY SER, V1, P1; Davis W, 1997, ONE RIVER SCI ADVENT; Doyle J.J., 1990, FOCUS, V12, P13, DOI DOI 10.2307/2419362; DRING D. M., 1961, TRANS BRIT MYCOL SOC, V44, P253; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eriksson Ove E., 1993, Systema Ascomycetum, V12, P51; Evans H. C., 2002, Tropical mycology: volume 2, micromycetes, P83, DOI 10.1079/9780851995434.0083; Evans HC, 1984, MYCOL PAP, V153, P1; Ferraris T, 1912, FLORA ITALICA CRYPTO, V6, P195; Gasparotto L, 1997, DOENCAS SERINGUERIA; Grandin Greg, 2009, FORDLANDIA RISE FALL; Grigoriev IV, 2012, NUCLEIC ACIDS RES, V40, pD26, DOI 10.1093/nar/gkr947; Guyot J, 2014, PLANT PATHOL, V63, P510, DOI 10.1111/ppa.12126; Guyot J, 2010, J PLANT PATHOL, V92, P765; Halle F., 1968, Adansonia, V8, P475; Hennings P, 1904, NOTIZBL BOT GART MUS, V4, P133; Higgins BB, 1920, AM J BOT, V7, P435, DOI 10.2307/2440939; HOLLIDAY P., 1970, Phytopathological Papers; HUGHES SJ, 1953, CAN J BOT, V31, P560, DOI 10.1139/b53-045; INMAN AJ, 1991, MYCOL RES, V95, P1334, DOI 10.1016/S0953-7562(09)80586-8; JUNQUEIRA NTV, 1988, PESQUI AGROPECU BRAS, V23, P877; Junqueira NTV., 1984, REV CERES, V31, P322; Kirk PM, 2008, DICT FUNGI; Langford Michael, 1945, TECHNICAL B USDA, V882, P1; LI KN, 1994, APPL ENVIRON MICROB, V60, P4324, DOI 10.1128/AEM.60.12.4324-4331.1994; LIBERATO JR, 2009, BLACK SIGATOKA BANAN; Lieberei R, 2007, ANN BOT-LONDON, V100, P1125, DOI 10.1093/aob/mcm133; Lindau G, 1907, RABENSHORSTS KRYPTOG; Lumbsch H. Thorsten, 2010, Fieldiana-Life and Earth Sciences, V1, P1, DOI 10.3158/1557.1; Minnis AM, 2012, PERSOONIA, V29, P11, DOI 10.3767/003158512X658766; Money N.P., 2007, TRIUMPH FUNG ROTT; Mugambi GK, 2009, STUD MYCOL, P103, DOI 10.3114/sim.2009.64.05; Muller E, 1962, FLORA SCHWEIZ, V11, P1; Nylander JAA., 2004, MRMODELTEST V 2 2 PR; Rambaut A., 2007, TRACER V1 4; REHNER SA, 1994, MYCOL RES, V98, P625, DOI 10.1016/S0953-7562(09)80409-7; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SACCARDO PA, 1897, SYLLOGE FUNGORUM, V12; Schmitt I, 2009, PERSOONIA, V23, P35, DOI 10.3767/003158509X470602; Schoch CL, 2009, SYST BIOL, V58, P224, DOI 10.1093/sysbio/syp020; Schubert K., 2003, SCHLECHTENDALIA, V9, P1; SNYDER WC, 1946, PHYTOPATHOLOGY, V36, P481; Staden R, 1996, MOL BIOTECHNOL, V5, P233, DOI 10.1007/BF02900361; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; van Beilen JB, 2007, TRENDS BIOTECHNOL, V25, P522, DOI 10.1016/j.tibtech.2007.08.009; Verkley GJM, 2004, MYCOLOGIA, V96, P558, DOI 10.2307/3762175; Verkley GJM, 2004, MYCOL RES, V108, P1271, DOI 10.1017/S0953756204001054; VILGALYS R, 1990, J BACTERIOL, V172, P4238, DOI 10.1128/jb.172.8.4238-4246.1990; von Arx J.A., 1975, STUD MYCOL, V9, P1, DOI DOI 10.2307/3758851; VONARX JA, 1983, P K NED AKAD C BIOL, V86, P15; White T., 1990, PCR PROTOCOLS GUIDE, P315; Wingfield MJ, 2012, MOL PLANT PATHOL, V13, P604, DOI 10.1111/j.1364-3703.2011.00768.x; Zhang Y, 2012, FUNGAL DIVERS, V53, P1, DOI 10.1007/s13225-011-0117-x; Zhang Y, 2011, FUNGAL DIVERS, V51, P249, DOI 10.1007/s13225-011-0141-x	70	34	34	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104750	10.1371/journal.pone.0104750	http://dx.doi.org/10.1371/journal.pone.0104750			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126853	Green Published, Green Submitted, gold			2022-12-25	WOS:000340879300048
J	Kumar, JD; Holmberg, C; Kandola, S; Steele, I; Hegyi, P; Tiszlavicz, L; Jenkins, R; Beynon, RJ; Peeney, D; Giger, OT; Alqahtani, A; Wang, TC; Charvat, TT; Penfold, M; Dockray, GJ; Varro, A				Kumar, J. Dinesh; Holmberg, Chris; Kandola, Sandhir; Steele, Islay; Hegyi, Peter; Tiszlavicz, Laszlo; Jenkins, Rosalind; Beynon, Robert J.; Peeney, David; Giger, Olivier T.; Alqahtani, Ahlam; Wang, Timothy C.; Charvat, Trevor T.; Penfold, Mark; Dockray, Graham J.; Varro, Andrea			Increased Expression of Chemerin in Squamous Esophageal Cancer Myofibroblasts and Role in Recruitment of Mesenchymal Stromal Cells	PLOS ONE			English	Article							GASTRIC EPITHELIAL-CELLS; STEM-CELLS; MATRIX METALLOPROTEINASE-7; HELICOBACTER-PYLORI; TUMOR PROGRESSION; DENDRITIC CELLS; FIBROBLASTS; GROWTH; MIGRATION; MICROENVIRONMENT	Stromal cells such as myofibroblasts influence tumor progression. The mechanisms are unclear but may involve effects on both tumor cells and recruitment of bone marrow-derived mesenchymal stromal cells (MSCs) which then colonize tumors. Using iTRAQ and LC-MS/MS we identified the adipokine, chemerin, as overexpressed in esophageal squamous cancer associated myofibroblasts (CAMs) compared with adjacent tissue myofibroblasts (ATMs). The chemerin receptor, ChemR23, is expressed by MSCs. Conditioned media (CM) from CAMs significantly increased MSC cell migration compared to ATM-CM; the action of CAM-CM was significantly reduced by chemerin-neutralising antibody, pretreatment of CAMs with chemerin siRNA, pretreatment of MSCs with ChemR23 siRNA, and by a ChemR23 receptor antagonist, CCX832. Stimulation of MSCs by chemerin increased phosphorylation of p42/44, p38 and JNK-II kinases and inhibitors of these kinases and PKC reversed chemerin-stimulated MSC migration. Chemerin stimulation of MSCs also induced expression and secretion of macrophage inhibitory factor (MIF) that tended to restrict migratory responses to low concentrations of chemerin but not higher concentrations. In a xenograft model consisting of OE21 esophageal cancer cells and CAMs, homing of MSCs administered i.v. was inhibited by CCX832. Thus, chemerin secreted from esophageal cancer myofibroblasts is a potential chemoattractant for MSCs and its inhibition may delay tumor progression.	[Kumar, J. Dinesh; Holmberg, Chris; Kandola, Sandhir; Steele, Islay; Peeney, David; Giger, Olivier T.; Alqahtani, Ahlam; Dockray, Graham J.; Varro, Andrea] Univ Liverpool, Dept Cell & Mol Physiol, Liverpool L69 3BX, Merseyside, England; [Hegyi, Peter] Univ Szeged, Dept Med & Surg, Szeged, Hungary; [Jenkins, Rosalind] Univ Liverpool, Inst Translat Med, Dept Pharmacol, Liverpool L69 3BX, Merseyside, England; [Tiszlavicz, Laszlo] Univ Szeged, Dept Pathol, Szeged, Hungary; [Beynon, Robert J.] Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England; [Charvat, Trevor T.; Penfold, Mark] ChemoCentryx, Mountain View, CA USA; [Wang, Timothy C.] Columbia Univ, Med Ctr, Dept Med, New York, NY USA	University of Liverpool; Szeged University; University of Liverpool; Szeged University; University of Liverpool; Columbia University	Varro, A (corresponding author), Univ Liverpool, Dept Cell & Mol Physiol, Liverpool L69 3BX, Merseyside, England.	avarro@liverpool.ac.uk	Kumar, Jothi Dinesh/I-6168-2019; Varro, Andras/M-2647-2016; Peeney, David/AAG-7448-2021; Beynon, Robert/K-1408-2014	Kumar, Jothi Dinesh/0000-0003-1086-0509; Wang, Timothy/0000-0001-5730-3019; Beynon, Robert/0000-0003-0857-495X; Peeney, David/0000-0002-9126-9923	Cancer Research UK; NIHR; National Institute of Health/NCI [5U54CA126513]; Hungarian Scientific Research Fund [NF100677]; Wellcome Trust; NATIONAL CANCER INSTITUTE [U54CA126513] Funding Source: NIH RePORTER	Cancer Research UK(Cancer Research UK); NIHR(National Institute for Health Research (NIHR)); National Institute of Health/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Wellcome Trust(Wellcome Trust); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Cancer Research UK (AV), NIHR (AV), National Institute of Health/NCI (5U54CA126513, TCW, AV) and Hungarian Scientific Research Fund (NF100677, PH), Wellcome Trust (AV, CH, SK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnea G, 2008, P NATL ACAD SCI USA, V105, P64, DOI 10.1073/pnas.0710487105; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Bremnes RM, 2011, J THORAC ONCOL, V6, P209, DOI 10.1097/JTO.0b013e3181f8a1bd; Chamberlain G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025663; De Becker A, 2007, HAEMATOLOGICA, V92, P440, DOI 10.3324/haematol.10475; De Boeck A, 2013, PROTEOMICS, V13, P379, DOI 10.1002/pmic.201200179; De Wever O, 2008, INT J CANCER, V123, P2229, DOI 10.1002/ijc.23925; Farmer P, 2009, NAT MED, V15, P68, DOI 10.1038/nm.1908; Fischer-Valuck BW, 2010, BIOTECHNOL LETT, V32, P19, DOI 10.1007/s10529-009-0110-6; Goralski KB, 2007, J BIOL CHEM, V282, P28175, DOI 10.1074/jbc.M700793200; Grugan KD, 2010, P NATL ACAD SCI USA, V107, P11026, DOI 10.1073/pnas.0914295107; Hemers E, 2005, CANCER RES, V65, P7363, DOI 10.1158/0008-5472.CAN-05-0157; Ho IAW, 2013, HISTOL HISTOPATHOL, V28, P1427, DOI 10.14670/HH-28.1427; Holmberg C, 2012, CARCINOGENESIS, V33, P1553, DOI 10.1093/carcin/bgs180; Holmberg C, 2013, J PROTEOME RES, V12, P3413, DOI 10.1021/pr400270q; Honczarenko M, 2006, STEM CELLS, V24, P1030, DOI 10.1634/stemcells.2005-0319; Houghton J, 2004, SCIENCE, V306, P1568, DOI 10.1126/science.1099513; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jiang L, 2008, CANCER RES, V68, P9900, DOI 10.1158/0008-5472.CAN-08-1319; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Lin W, 2011, CLIN LAB, V57, P879; Lozito TP, 2011, J CELL PHYSIOL, V226, P385, DOI 10.1002/jcp.22344; McCaig C, 2006, GASTROENTEROLOGY, V130, P1754, DOI 10.1053/j.gastro.2006.02.031; Meder W, 2003, FEBS LETT, V555, P495, DOI 10.1016/S0014-5793(03)01312-7; Muruganandan S, 2011, J BIOL CHEM, V286, P23982, DOI 10.1074/jbc.M111.220491; Noble PJM, 2003, AM J PHYSIOL-GASTR L, V284, pG75, DOI 10.1152/ajpgi.00300.2002; Noma K, 2008, GASTROENTEROLOGY, V134, P1981, DOI 10.1053/j.gastro.2008.02.061; Olumi AF, 1999, CANCER RES, V59, P5002; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Ozaki Y, 2007, STEM CELLS DEV, V16, P119, DOI 10.1089/scd.2006.0032; Pachynski RK, 2012, J EXP MED, V209, P1427, DOI 10.1084/jem.20112124; Parolini S, 2007, BLOOD, V109, P3625, DOI 10.1182/blood-2006-08-038844; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Quante M, 2011, CANCER CELL, V19, P257, DOI 10.1016/j.ccr.2011.01.020; Quante M, 2009, NAT REV GASTRO HEPAT, V6, P724, DOI 10.1038/nrgastro.2009.195; Satija NK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055769; Skalnikova H, 2011, PROTEOMICS, V11, P691, DOI 10.1002/pmic.201000402; Smith H, 2012, STEM CELLS DEV, V21, P476, DOI 10.1089/scd.2011.0025; Somja J, 2013, AM J PATHOL, V182, P2168, DOI 10.1016/j.ajpath.2013.02.036; Sordi V, 2005, BLOOD, V106, P419, DOI 10.1182/blood-2004-09-3507; Studeny M, 2004, JNCI-J NATL CANCER I, V96, P1593, DOI 10.1093/jnci/djh299; Teo GSL, 2012, STEM CELLS, V30, P2472, DOI 10.1002/stem.1198; Varro A, 2004, CANCER RES, V64, P1695, DOI 10.1158/0008-5472.CAN-03-2399; Wang CH, 2014, PEPTIDES, V51, P131, DOI 10.1016/j.peptides.2013.10.009; Watts SW, 2013, ARTERIOSCL THROM VAS, V33, P1320, DOI 10.1161/ATVBAHA.113.301476; Wittamer V, 2003, J EXP MED, V198, P977, DOI 10.1084/jem.20030382; Wroblewski LE, 2003, J CELL SCI, V116, P3017, DOI 10.1242/jcs.00518; Wu KC, 1999, GUT, V44, P323, DOI 10.1136/gut.44.3.323; Zabel BA, 2005, J BIOL CHEM, V280, P34661, DOI 10.1074/jbc.M504868200; Zheng Y, 2008, EUR J DERMATOL, V18, P638, DOI 10.1684/ejd.2008.0511	50	37	39	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104877	10.1371/journal.pone.0104877	http://dx.doi.org/10.1371/journal.pone.0104877			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127029	Green Published, Green Submitted, gold			2022-12-25	WOS:000340879300058
J	Matsui, H; Fujimoto, N; Sasakawa, N; Ohinata, Y; Shima, M; Yamanaka, S; Sugimoto, M; Hotta, A				Matsui, Hideto; Fujimoto, Naoko; Sasakawa, Noriko; Ohinata, Yasuhide; Shima, Midori; Yamanaka, Shinya; Sugimoto, Mitsuhiko; Hotta, Akitsu			Delivery of Full-Length Factor VIII Using a piggyBac Transposon Vector to Correct a Mouse Model of Hemophilia A	PLOS ONE			English	Article							MEDIATED GENE-TRANSFER; LONG-TERM EXPRESSION; SLEEPING-BEAUTY; THERAPY; FVIII; MICE; CELLS	Viral vectors have been used for hemophilia A gene therapy. However, due to its large size, full-length Factor VIII ( FVIII) cDNA has not been successfully delivered using conventional viral vectors. Moreover, viral vectors may pose safety risks, e. g., adverse immunological reactions or virus-mediated cytotoxicity. Here, we took advantages of the non-viral vector gene delivery system based on piggyBac DNA transposon to transfer the full-length FVIII cDNA, for the purpose of treating hemophilia A. We tested the efficiency of this new vector system in human 293T cells and iPS cells, and confirmed the expression of the full-length FVIII in culture media using activity-sensitive coagulation assays. Hydrodynamic injection of the piggyBac vectors into hemophilia A mice temporally treated with an immunosuppressant resulted in stable production of circulating FVIII for over 300 days without development of anti-FVIII antibodies. Furthermore, tail-clip assay revealed significant improvement of blood coagulation time in the treated mice. piggyBac transposon vectors can facilitate the long-term expression of therapeutic transgenes in vitro and in vivo. This novel gene transfer strategy should provide safe and efficient delivery of FVIII.	[Matsui, Hideto; Sugimoto, Mitsuhiko] Nara Med Univ, Dept Regulatory Med Thrombosis, Kashihara, Nara 634, Japan; [Fujimoto, Naoko; Sasakawa, Noriko; Yamanaka, Shinya; Hotta, Akitsu] Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Dept Reprogramming Sci, Sakyo Ku, Kyoto, Japan; [Fujimoto, Naoko; Yamanaka, Shinya; Hotta, Akitsu] Kyoto Univ, iCeMS, Kyoto, Japan; [Ohinata, Yasuhide] Univ Yamanashi, Fac Life & Environm Sci, Dept Biotechnol, Life Sci Expt Facil, Kofu, Yamanashi, Japan; [Ohinata, Yasuhide; Hotta, Akitsu] Japan Sci & Technol Agcy JST, PRESTO, Saitama, Japan; [Shima, Midori] Nara Med Univ, Kashihara, Nara 634, Japan; [Yamanaka, Shinya] Gladstone Inst Cardiovasc Dis, San Francisco, CA USA	Nara Medical University; Kyoto University; Kyoto University; University of Yamanashi; Japan Science & Technology Agency (JST); Nara Medical University; University of California System; University of California San Francisco; The J David Gladstone Institutes	Matsui, H (corresponding author), Nara Med Univ, Dept Regulatory Med Thrombosis, Kashihara, Nara 634, Japan.	hide-ped@naramed-u.ac.jp; akitsu.hotta@cira.kyoto-u.ac.jp	Wilson, Matthew H/K-3193-2013	Hotta, Akitsu/0000-0002-2619-7441	JSPS KAKENHI [25293237, 24591559, 22890088]; Bayer Hemophilia Awards Program; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Uehara Memorial Foundation; Baxter Coagulation Research Fund; Grants-in-Aid for Scientific Research [25293237] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Bayer Hemophilia Awards Program; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Uehara Memorial Foundation(Uehara Memorial Foundation); Baxter Coagulation Research Fund; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI (No. 25293237 for HM, M. Shima, and AH, No. 24591559 for HM, No. 22890088 for AH), research grants from the Bayer Hemophilia Awards Program (http://www.bayer-hemophilia-awards.com/) (HM), the Mochida Memorial Foundation for Medical and Pharmaceutical Research (http://www.mochida.co.jp/zaidan/) (HM), the Uehara Memorial Foundation (http://www.ueharazaidan.or.jp/) (AH), and the Baxter Coagulation Research Fund (http://baxter.co.jp/medical/grant/bhf/index.html) (AH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrow RT, 2001, BLOOD, V97, P169, DOI 10.1182/blood.V97.1.169; Brown BD, 2004, BLOOD, V103, P804, DOI 10.1182/blood-2003-05-1426; Cesana D, 2014, MOL THER; Chavez CL, 2012, HUM GENE THER, V23, P390, DOI 10.1089/hum.2011.110; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Doherty JE, 2012, HUM GENE THER, V23, P311, DOI 10.1089/hum.2011.138; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hackett PB, 2011, CURR GENE THER, V11, P341; Hotta A, 2009, NAT METHODS, V6, P370, DOI [10.1038/NMETH.1325, 10.1038/nmeth.1325]; Hu CH, 2011, P NATL ACAD SCI USA, V108, P2082, DOI 10.1073/pnas.1015571108; Huang X, 2010, MOL THER, V18, P1803, DOI 10.1038/mt.2010.141; Jiang HY, 2006, BLOOD, V108, P107, DOI 10.1182/blood-2005-12-5115; Kamimura K, 2009, MOL THER, V17, P491, DOI 10.1038/mt.2008.294; KAMISUE S, 1994, BRIT J HAEMATOL, V86, P106, DOI 10.1111/j.1365-2141.1994.tb03259.x; Kang YB, 2005, BLOOD, V106, P1552, DOI 10.1182/blood-2004-11-4358; Kootstra NA, 2003, MOL THER, V7, P623, DOI 10.1016/S1525-0016(03)00073-X; Li HJ, 2011, NATURE, V475, P217, DOI 10.1038/nature10177; Li MA, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr764; LIND P, 1995, EUR J BIOCHEM, V232, P19, DOI 10.1111/j.1432-1033.1995.tb20776.x; Liras A, 2009, HAEMOPHILIA, V15, P811, DOI 10.1111/j.1365-2516.2009.02010.x; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Lu H, 2008, HUM GENE THER, V19, P648, DOI 10.1089/hum.2007.0182; Matrai J, 2010, CURR OPIN HEMATOL, V17, P387, DOI 10.1097/MOH.0b013e32833cd4bd; Matsui H, 2007, STEM CELLS, V25, P2660, DOI 10.1634/stemcells.2006-0699; Matsui H, 2011, MOL THER, V19, P723, DOI 10.1038/mt.2010.290; Nakanishi H, 2010, MOL THER, V18, P707, DOI 10.1038/mt.2009.302; Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Ohlfest JR, 2005, BLOOD, V105, P2691, DOI 10.1182/blood-2004-09-3496; Ott MG, 2006, NAT MED, V12, P401, DOI 10.1038/nm1393; Petrus I, 2010, J GENE MED, V12, P797, DOI 10.1002/jgm.1500; Pipe SW, 2009, HAEMOPHILIA, V15, P1187, DOI 10.1111/j.1365-2516.2009.02026.x; Powell JS, 2003, BLOOD, V102, P2038, DOI 10.1182/blood-2003-01-0167; Reddy LH, 2011, J HEPATOL, V55, P1461, DOI 10.1016/j.jhep.2011.05.039; Sarkar R, 2004, BLOOD, V103, P1253, DOI 10.1182/blood-2003-08-2954; Suda T, 2008, MOL THER, V16, P1098, DOI 10.1038/mt.2008.66; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tatsumi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083280; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Thomas CE, 2001, MOL THER, V3, P36, DOI 10.1006/mthe.2000.0224; Wilson MH, 2007, MOL THER, V15, P139, DOI 10.1038/sj.mt.6300028; Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034; Yusa K, 2011, P NATL ACAD SCI USA, V108, P1531, DOI 10.1073/pnas.1008322108	43	36	46	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104957	10.1371/journal.pone.0104957	http://dx.doi.org/10.1371/journal.pone.0104957			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126862	gold, Green Submitted, Green Published			2022-12-25	WOS:000340879300064
J	Jung, KM; Folkvord, A; Kjesbu, OS; Sundby, S				Jung, Kyung-Mi; Folkvord, Arild; Kjesbu, Olav Sigurd; Sundby, Svein			Experimental Parameterisation of Principal Physics in Buoyancy Variations of Marine Teleost Eggs	PLOS ONE			English	Article							COD GADUS-MORHUA; MACKEREL SCOMBER-SCOMBRUS; SPAWNING ATLANTIC COD; PELAGIC FISH EGGS; VERTICAL-DISTRIBUTION; BALTIC-SEA; LARVAE; DENSITY; AQUAPORINS; SURVIVAL	It is generally accepted that the high buoyancy of pelagic marine eggs is due to substantial influx of water across the cell membrane just before ovulation. Here we further develop the theoretical basis by applying laboratory observations of the various components of the fertilized egg in first-principle equations for egg specific gravity (rho(egg)) followed by statistical validation. We selected Atlantic cod as a model animal due to the affluent amount of literature on this species, but also undertook additional dedicated experimental works. We found that specific gravity of yolk plus embryo is central in influencing regg and thereby the buoyancy. However, our established framework documents the effect on regg of the initial deposition of the heavy chorion material in the gonad prior to spawning. Thereafter, we describe the temporal changes in regg during incubation: Generally, the eggs showed a slight rise in regg from fertilization to mid-gastrulation followed by a gradual decrease until full development of main embryonic organs just before hatching. Ontogenetic changes in rho(egg) were significantly associated with volume and mass changes of yolk plus embryo. The initial rho(egg) at fertilization appeared significantly influenced by the chorion volume fraction which is determined by the combination of the final chorion volume of the oocyte and of the degree of swelling (hydrolyzation) prior to spawning. The outlined principles and algorithms are universal in nature and should therefore be applicable to fish eggs in general.	[Jung, Kyung-Mi; Folkvord, Arild; Kjesbu, Olav Sigurd; Sundby, Svein] IMR, Bergen, Norway; [Jung, Kyung-Mi; Folkvord, Arild; Kjesbu, Olav Sigurd; Sundby, Svein] Hjort Ctr Marine Ecosyst Dynam, Bergen, Norway; [Jung, Kyung-Mi; Folkvord, Arild] Univ Bergen, Dept Biol, Bergen, Norway; [Kjesbu, Olav Sigurd] Univ Oslo, Dept Biol, CEES, Oslo, Norway	Institute of Marine Research - Norway; University of Bergen; University of Oslo	Jung, KM (corresponding author), IMR, Bergen, Norway.	kyungmi-toy@hanmail.net	Kjesbu, Olav Sigurd/M-3551-2015; Folkvord, Arild/A-5311-2012	Folkvord, Arild/0000-0002-4763-0590; Sundby, Svein/0000-0002-0815-9740	project "Population differentiation of Atlantic cod'' under the Programme on Biological mechanisms; Programme on Climate and Fish at the Institute of Marine Research in Norway	project "Population differentiation of Atlantic cod'' under the Programme on Biological mechanisms; Programme on Climate and Fish at the Institute of Marine Research in Norway	This study was funded by the project "Population differentiation of Atlantic cod'' under the Programme on Biological mechanisms and by the Programme on Climate and Fish at the Institute of Marine Research in Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adoff GR, 1986, FISH LARVAL PHYSL AN, P51; ANDERSON JT, 1994, ICES MAR SC, V198, P654; [Anonymous], 2010, R LANG ENV STAT COMP; Cerda J, 2009, J FISH BIOL, V75, P2175, DOI 10.1111/j.1095-8649.2009.02397.x; Cerda J, 2010, J EXP ZOOL PART A, V313A, P623, DOI 10.1002/jez.634; COOMBS SH, 1981, MAR BIOL, V63, P101, DOI 10.1007/BF00394667; Coombs SH, 2001, FISH RES, V50, P27, DOI 10.1016/S0165-7836(00)00240-X; CRAIK JCA, 1987, J MAR BIOL ASSOC UK, V67, P169, DOI 10.1017/S0025315400026436; DAVENPORT J, 1981, J FISH BIOL, V19, P317, DOI 10.1111/j.1095-8649.1981.tb05835.x; dlandsvik B, 2001, FISH RES, V50, P59; Finn RN, 1995, MAR BIOL, V124, P355, DOI 10.1007/BF00363909; FRIDGEIRSSON E, 1978, Rit Fiskideildar, V5, P1; FYHN HJ, 1987, MAR BIOL, V96, P335, DOI 10.1007/BF00412514; Govoni John J., 2008, P495; Jung KM, 2012, J SEA RES, V73, P63, DOI 10.1016/j.seares.2012.06.007; Jung KM, 2012, MAR BIOL, V159, P1969, DOI 10.1007/s00227-012-1984-8; Kjesbu OS, 1996, J FISH BIOL, V49, P1197, DOI 10.1111/j.1095-8649.1996.tb01789.x; KJESBU OS, 1992, J FISH BIOL, V41, P581, DOI 10.1111/j.1095-8649.1992.tb02685.x; KJORSVIK E, 1983, J FISH BIOL, V23, P1, DOI 10.1111/j.1095-8649.1983.tb02877.x; LONNING S, 1988, SARSIA, V73, P49, DOI 10.1080/00364827.1988.10420671; Mangor-Jensen A, 1986, FISH LARVAL PHYSL AN, P117; MANGORJENSEN A, 1987, FISH PHYSIOL BIOCHEM, V3, P17, DOI 10.1007/BF02183990; MANGORJENSEN A, 1991, J FISH BIOL, V39, P133, DOI 10.1111/j.1095-8649.1991.tb04349.x; Nissling A, 1996, J FISH BIOL, V48, P217; NISSLING A, 1994, MAR ECOL PROG SER, V110, P67, DOI 10.3354/meps110067; OPPENBERNTSEN DO, 1990, DEV BIOL, V137, P258, DOI 10.1016/0012-1606(90)90252-E; Ospina-Alvarez A, 2012, FISH RES, V117, P86, DOI 10.1016/j.fishres.2011.01.030; Riis-Vestergaard J, 2002, J FISH BIOL, V60, P1511, DOI 10.1006/jfbi.2002.2004; Riis-Vestergaard J, 1984, PROPAGATION COD, V1, P87; Skjaerven KH, 2003, BIG FISH BANG, P193; SOLEMDAL P, 1981, INT COUNC EXPLOR S G, V77, P1; StatSoft Inc, 2013, STATISTICA DAT AN SO; Sundby S, 1997, SCI MAR, V61, P159; SUNDBY S, 1983, DEEP-SEA RES, V30, P645, DOI 10.1016/0198-0149(83)90042-0; Sundby S, 2001, S AFR J MARINE SCI, V23, P317; SUNDBY S, 1991, ICES MAR SC, V192, P33; Thorsen A, 1996, J FISH BIOL, V48, P457, DOI 10.1111/j.1095-8649.1996.tb01440.x; WESTIN L, 1991, MAR BIOL, V108, P5, DOI 10.1007/BF01313465	38	14	14	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104089	10.1371/journal.pone.0104089	http://dx.doi.org/10.1371/journal.pone.0104089			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122447	gold, Green Published, Green Submitted			2022-12-25	WOS:000341017000027
J	Morris, SM; Carter, KT; Baek, JY; Koszarek, A; Yeh, MM; Knoblaugh, SE; Grady, WM				Morris, S. M.; Carter, K. T.; Baek, J. Y.; Koszarek, A.; Yeh, M. M.; Knoblaugh, S. E.; Grady, W. M.			TGF-beta signaling alters the pattern of liver tumorigenesis induced by Pten inactivation	ONCOGENE			English	Article							GROWTH-FACTOR-BETA; EMBRYONIC STEM-CELLS; RECEPTOR C-KIT; CYCLIN D1; CARCINOMA; EXPRESSION; CANCER; DIFFERENTIATION; ROLES; MOUSE	Hepatocarcinogenesis results from the accumulation of genetic and epigenetic changes in liver cells. A common mechanism through which these alterations induce liver cancer is by deregulating signaling pathways. A number of signaling pathways, including the PI3K/PTEN/AKT and transforming growth factor beta (TGF-beta) pathways have been implicated in normal liver development as well as in cancer formation. In this study, we assessed the effect of the TGF-beta signaling pathway on liver tumors induced by phosphatase and tensin homolog (Pten) loss. Inactivation of only the TGF-beta receptor type II, Tgfbr2, in the mouse liver (Tgfbr2(LKO)) had no overt phenotype, while inactivation of Pten alone (Pten(LKO)), resulted in the formation of both hepatocellular carcinomas and cholangiocarcinomas (CC). Interestingly, deletion of both Pten and Tgfbr2 (Pten(LKO); Tgfbr2(LKO)) in the mouse liver resulted in a dramatic shift in tumor type to predominantly CC. Assessment of the PI3K/PTEN/AKT pathway revealed increased phosphorylation of AKT and glycogen synthase kinase 3 beta (GSK-3 beta) in both the Pten(LKO) and Pten(LKO); Tgfbr2(LKO) mice, suggesting that this pathway is constitutively active regardless of the status of the TGF-beta signaling pathway. However, phosphorylation of p70 S6 kinase was observed in the liver of all three phenotypes (Tgfbr2(LKO), Pten(LKO), Pten(LKO); Tgfbr2(LKO)) indicating that the loss of Tgfbr2 and/or Pten leads to an increase in this signaling pathway. Analysis of markers of liver progenitor/stem cells revealed that the loss of TGF-beta signaling resulted in increased expression of c-Kit and CD133. Furthermore, in addition to increased c-Kit and CD133, Scf and EpCam expression were also increased in the double knock-out mice. These results suggest that the alteration in tumor types between the Pten(LKO) mice and Pten(LKO); Tgfbr2(LKO) mice is secondary to the altered regulation of stem-cell features induced by the loss of TGF-beta signaling.	[Morris, S. M.; Carter, K. T.; Koszarek, A.; Grady, W. M.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA; [Baek, J. Y.] Natl Canc Ctr, Res Inst & Hosp, Ctr Colorectal Canc, Goyang, South Korea; [Yeh, M. M.] Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA; [Knoblaugh, S. E.] Fred Hutchinson Canc Res Ctr, Comparat Med, Seattle, WA 98109 USA; [Grady, W. M.] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; National Cancer Center - Korea (NCC); University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Grady, WM (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, 1100 Fairview Ave N,Mailstop D4-100, Seattle, WA 98109 USA.	wgrady@fhcrc.org			Burroughs Wellcome Fund; National Institutes of Health [RO1 DK60669-01, P30 CA015704]; National Institutes of Health Interdisciplinary Training Grant [T32 CA080416]; Experimental Histopathology, Scientific Imaging and Comparative Medicine Cores at the Fred Hutchinson Cancer Research Center; NATIONAL CANCER INSTITUTE [T32CA080416, P30CA015704] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060669] Funding Source: NIH RePORTER	Burroughs Wellcome Fund(Burroughs Wellcome Fund); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Interdisciplinary Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Experimental Histopathology, Scientific Imaging and Comparative Medicine Cores at the Fred Hutchinson Cancer Research Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is supported in part by funding from Burroughs Wellcome Fund, the National Institutes of Health (RO1 DK60669-01 and P30 CA015704, WMG) and by the National Institutes of Health Interdisciplinary Training Grant (T32 CA080416, SMM). The authors thank Jean Campbell and members of the Grady laboratory for helpful suggestions. We also wish to acknowledge support from the Experimental Histopathology, Scientific Imaging and Comparative Medicine Cores at the Fred Hutchinson Cancer Research Center.	Amin Rupen, 2008, Gastrointest Cancer Res, V2, pS27; Attisano Liliana, 2013, F1000Prime Rep, V5, P17, DOI 10.12703/P5-17; Bierie B, 2006, CYTOKINE GROWTH F R, V17, P29, DOI 10.1016/j.cytogfr.2005.09.006; Breuhahn K, 2006, ONCOGENE, V25, P3787, DOI 10.1038/sj.onc.1209556; Cai J, 2007, HEPATOLOGY, V45, P1229, DOI 10.1002/hep.21582; Carracedo A, 2008, ONCOGENE, V27, P5527, DOI 10.1038/onc.2008.247; Chalhoub N, 2009, ANNU REV PATHOL-MECH, V4, P127, DOI 10.1146/annurev.pathol.4.110807.092311; Chen CL, 2013, J CLIN INVEST, V123, P2832, DOI 10.1172/JCI65859; Chytil A, 2002, GENESIS, V32, P73, DOI 10.1002/gene.10046; Clotman F, 2005, GENE DEV, V19, P1849, DOI 10.1101/gad.340305; Deschl U, 2001, INT CLASSIFICATION R, P59; Fabregat I, 2009, WORLD J GASTROENTERO, V15, P513, DOI 10.3748/wjg.15.513; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Galicia VA, 2010, GASTROENTEROLOGY, V139, P2170, DOI 10.1053/j.gastro.2010.09.002; Herrera B, 2012, CURR PHARM DESIGN, V18, P4114, DOI 10.2174/138161212802430503; Hollander MC, 2011, NAT REV CANCER, V11, P289, DOI 10.1038/nrc3037; Horie Y, 2004, J CLIN INVEST, V113, P1774, DOI 10.1172/JCI200420513; Hu TH, 2003, CANCER, V97, P1929, DOI 10.1002/cncr.11266; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kim H, 2004, J HEPATOL, V40, P298, DOI 10.1016/j.jhep.2003.10.023; Kitisin K, 2007, ONCOGENE, V26, P7103, DOI 10.1038/sj.onc.1210513; Knobbe CB, 2008, ONCOGENE, V27, P5398, DOI 10.1038/onc.2008.238; Lesche R, 2002, GENESIS, V32, P148, DOI 10.1002/gene.10036; Luo SM, 2005, WORLD J GASTROENTERO, V11, P4272; Majumdar A, 2012, NAT REV GASTRO HEPAT, V9, P530, DOI 10.1038/nrgastro.2012.114; Mansuroglu T, 2009, EUR J GASTROEN HEPAT, V21, P1206, DOI 10.1097/MEG.0b013e328317f4ef; Mansuroglu T, 2009, LAB INVEST, V89, P562, DOI 10.1038/labinvest.2009.15; Mittal S, 2013, J CLIN GASTROENTEROL, V47, pS2, DOI 10.1097/MCG.0b013e3182872f29; Morris SM, 2012, HEPATOLOGY, V55, P121, DOI 10.1002/hep.24653; Petritsch C, 2000, GENE DEV, V14, P3093, DOI 10.1101/gad.854200; Peyrou M, 2010, WORLD J GASTROENTERO, V16, P4627, DOI 10.3748/wjg.v16.i37.4627; Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Romero-Gallo J, 2005, ONCOGENE, V24, P3028, DOI 10.1038/sj.onc.1208475; Rountree CB, 2009, STEM CELLS, V27, P290, DOI 10.1634/stemcells.2008-0332; Shi YJ, 2012, J CELL SCI, V125, P4687, DOI 10.1242/jcs.093765; Shiraki N, 2008, GENES CELLS, V13, P731, DOI 10.1111/j.1365-2443.2008.01201.x; Singal AK, 2011, J CANCER RES CLIN, V137, P1071, DOI 10.1007/s00432-010-0971-z; Stiles B, 2004, P NATL ACAD SCI USA, V101, P2082, DOI 10.1073/pnas.0308617100; Sugimachi K, 2001, J HEPATOL, V35, P74, DOI 10.1016/S0168-8278(01)00079-4; Thoolen B, 2010, TOXICOL PATHOL, V38, p5S, DOI 10.1177/0192623310386499; Wakefield LM, 2013, NAT REV CANCER, V13, P328, DOI 10.1038/nrc3500; WENNERBERG AE, 1993, AM J PATHOL, V143, P1050; Whittaker S, 2010, ONCOGENE, V29, P4989, DOI 10.1038/onc.2010.236; Wu K, 2012, HEPATOLOGY, V56, P2255, DOI 10.1002/hep.26007; Wu X, 2012, LIVER TUMORS, P37; Xu XL, 2006, J CLIN INVEST, V116, P1843, DOI 10.1172/JCI27282; Yamashita T, 2013, J CLIN INVEST, V123, P1911, DOI 10.1172/JCI66024; Yao YJ, 1999, ONCOGENE, V18, P3181, DOI 10.1038/sj.onc.1202659; Yeh MM, 2010, J GASTROEN HEPATOL, V25, P1485, DOI 10.1111/j.1440-1746.2010.06430.x; Zaret KS, 2001, CURR OPIN GENET DEV, V11, P568, DOI 10.1016/S0959-437X(00)00234-3; Zhou L, 2006, WORLD J GASTROENTERO, V12, P1175, DOI 10.3748/wjg.v12.i8.1175	52	17	18	0	14	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2015	34	25					3273	3282		10.1038/onc.2014.258	http://dx.doi.org/10.1038/onc.2014.258			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CK9XH	25132272	Green Accepted			2022-12-25	WOS:000356592300006
J	Sturzenegger, A; Burdova, K; Kanagaraj, R; Levikova, M; Pinto, C; Cejka, P; Janscak, P				Sturzenegger, Andreas; Burdova, Kamila; Kanagaraj, Radhakrishnan; Levikova, Maryna; Pinto, Cosimo; Cejka, Petr; Janscak, Pavel			DNA2 Cooperates with the WRN and BLM RecQ Helicases to Mediate Long-range DNA End Resection in Human Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WERNER-SYNDROME PROTEIN; DOUBLE-STRAND BREAKS; HOMOLOGOUS RECOMBINATION; REPAIR; EXO1; PROMOTES; MECHANISM; COMPLEX; SGS1; MRE11-RAD50-XRS2	The 5'-3' resection of DNA ends is a prerequisite for the repair of DNA double strand breaks by homologous recombination, microhomology-mediated end joining, and single strand annealing. Recent studies in yeast have shown that, following initial DNA end processing by the Mre11-Rad50-Xrs2 complex and Sae2, the extension of resection tracts is mediated either by exonuclease 1 or by combined activities of the RecQ family DNA helicase Sgs1 and the helicase/endonuclease Dna2. Although human DNA2 has been shown to cooperate with the BLM helicase to catalyze the resection of DNA ends, it remains a matter of debate whether another human RecQ helicase, WRN, can substitute for BLM in DNA2-catalyzed resection. Here we present evidence that WRN and BLM act epistatically with DNA2 to promote the long-range resection of double strand break ends in human cells. Our biochemical experiments show that WRN and DNA2 interact physically and coordinate their enzymatic activities to mediate 5'-3' DNA end resection in a reaction dependent on RPA. In addition, we present in vitro and in vivo data suggesting that BLM promotes DNA end resection as part of the BLM-TOPOIII alpha-RMI1-RMI2 complex. Our study provides new mechanistic insights into the process of DNA end resection in mammalian cells.	[Sturzenegger, Andreas; Kanagaraj, Radhakrishnan; Levikova, Maryna; Pinto, Cosimo; Cejka, Petr; Janscak, Pavel] Univ Zurich, Inst Mol Canc Res, CH-8057 Zurich, Switzerland; [Burdova, Kamila; Janscak, Pavel] Acad Sci Czech Republ, Inst Mol Genet, Prague 14300, Czech Republic	University of Zurich; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences	Janscak, P (corresponding author), Univ Zurich, Inst Mol Canc Res, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	pjanscak@imcr.uzh.ch	Janscak, Pavel/Q-3795-2018; Kanagaraj, Raj R./O-3205-2016	Janscak, Pavel/0000-0002-1748-7789; Radhakrishnan, Kanagaraj/0000-0003-0906-5399; Levikova, Maryna/0000-0003-1076-5181; Cejka, Petr/0000-0002-9087-032X; Burdova, Kamila/0000-0003-4402-3688	Swiss National Science Foundation [31003A-129747, 31003A_146206, PP00P3 133636]; Czech Science Foundation [GAP305/10/0281]; Stiftung zur Krebsbekampfung; Forschungskredit of the University of Zurich [FK-13-098]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Czech Science Foundation(Grant Agency of the Czech Republic); Stiftung zur Krebsbekampfung; Forschungskredit of the University of Zurich	This work was supported by Swiss National Science Foundation Grants 31003A-129747 and 31003A_146206, by Czech Science Foundation Grant GAP305/10/0281, and by the Stiftung zur Krebsbekampfung. This work was also supported by Swiss National Science Foundation Grant PP00P3 133636 (to P.C.) and by Forschungskredit of the University of Zurich Grant FK-13-098 (to A.S.).	Adams KE, 2006, ONCOGENE, V25, P3894, DOI 10.1038/sj.onc.1209426; AVEMANN K, 1988, MOL CELL BIOL, V8, P3026, DOI 10.1128/MCB.8.8.3026; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; Bernstein KA, 2010, ANNU REV GENET, V44, P393, DOI 10.1146/annurev-genet-102209-163602; Brosh RM, 2002, J BIOL CHEM, V277, P23236, DOI 10.1074/jbc.M111446200; Bunting SF, 2013, NAT REV CANCER, V13, P443, DOI 10.1038/nrc3537; Bussen W, 2007, J BIOL CHEM, V282, P31484, DOI 10.1074/jbc.M706116200; Cannavo E, 2013, P NATL ACAD SCI USA, V110, pE1661, DOI 10.1073/pnas.1305166110; Cejka P, 2010, NATURE, V467, P112, DOI 10.1038/nature09355; Chen LS, 2003, AGING CELL, V2, P191, DOI 10.1046/j.1474-9728.2003.00052.x; Cheng WH, 2004, J BIOL CHEM, V279, P21169, DOI 10.1074/jbc.M312770200; El-Shemerly M, 2005, CANCER RES, V65, P3604, DOI 10.1158/0008-5472.CAN-04-4069; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; FUKUCHI K, 1989, P NATL ACAD SCI USA, V86, P5893, DOI 10.1073/pnas.86.15.5893; Gravel S, 2008, GENE DEV, V22, P2767, DOI 10.1101/gad.503108; Gunn Amanda, 2012, Methods Mol Biol, V920, P379, DOI 10.1007/978-1-61779-998-3_27; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; Heyer WD, 2010, ANNU REV GENET, V44, P113, DOI 10.1146/annurev-genet-051710-150955; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Kamath-Loeb AS, 1998, J BIOL CHEM, V273, P34145, DOI 10.1074/jbc.273.51.34145; Kanagaraj R, 2006, NUCLEIC ACIDS RES, V34, P5217, DOI 10.1093/nar/gkl677; Kanagaraj R, 2012, NUCLEIC ACIDS RES, V40, P8449, DOI 10.1093/nar/gks648; Karanja KK, 2012, CELL CYCLE, V11, P3983, DOI 10.4161/cc.22215; Karow JK, 1997, J BIOL CHEM, V272, P30611, DOI 10.1074/jbc.272.49.30611; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kim JH, 2006, NUCLEIC ACIDS RES, V34, P1854, DOI 10.1093/nar/gkl102; Lan L, 2005, J CELL SCI, V118, P4153, DOI 10.1242/jcs.02544; Lee JW, 2005, MECH AGEING DEV, V126, P79, DOI 10.1016/j.mad.2004.09.011; Liao SR, 2008, NUCLEIC ACIDS RES, V36, P6091, DOI 10.1093/nar/gkn616; Liao SR, 2012, NUCLEIC ACIDS RES, V40, P4496, DOI 10.1093/nar/gks044; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Longhese MP, 2009, DNA REPAIR, V8, P1127, DOI 10.1016/j.dnarep.2009.04.005; Masuda-Sasa T, 2006, NUCLEIC ACIDS RES, V34, P1865, DOI 10.1093/nar/gkl070; Melcher R, 2000, CYTOGENET CELL GENET, V91, P180, DOI 10.1159/000056841; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Nicolette ML, 2010, NAT STRUCT MOL BIOL, V17, P1478, DOI 10.1038/nsmb.1957; Nimonkar AV, 2011, GENE DEV, V25, P350, DOI 10.1101/gad.2003811; Niu HY, 2010, NATURE, V467, P108, DOI 10.1038/nature09318; Orren DK, 1999, NUCLEIC ACIDS RES, V27, P3557, DOI 10.1093/nar/27.17.3557; Perry JJP, 2006, NAT STRUCT MOL BIOL, V13, P414, DOI 10.1038/nsmb1088; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Raynard S, 2006, J BIOL CHEM, V281, P13861, DOI 10.1074/jbc.C600051200; Richardson C, 1998, GENE DEV, V12, P3831, DOI 10.1101/gad.12.24.3831; Saintigny Y, 2002, MOL CELL BIOL, V22, P6971, DOI 10.1128/MCB.22.20.6971-6978.2002; SALK D, 1981, CYTOGENET CELL GENET, V30, P92, DOI 10.1159/000131596; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Saydam N, 2007, NUCLEIC ACIDS RES, V35, P5706, DOI 10.1093/nar/gkm500; Shen JC, 1998, J BIOL CHEM, V273, P34139, DOI 10.1074/jbc.273.51.34139; Shibata A, 2014, MOL CELL, V53, P7, DOI 10.1016/j.molcel.2013.11.003; Shim EY, 2010, EMBO J, V29, P3370, DOI 10.1038/emboj.2010.219; Soulas-Sprauel P, 2007, ONCOGENE, V26, P7780, DOI 10.1038/sj.onc.1210875; Stark JM, 2004, MOL CELL BIOL, V24, P9305, DOI 10.1128/MCB.24.21.9305-9316.2004; Swanson C, 2004, DNA REPAIR, V3, P475, DOI 10.1016/j.dnarep.2004.01.002; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Tomimatsu N, 2012, DNA REPAIR, V11, P441, DOI 10.1016/j.dnarep.2012.01.006; Truong LN, 2013, P NATL ACAD SCI USA, V110, P7720, DOI 10.1073/pnas.1213431110; Wu L, 2006, P NATL ACAD SCI USA, V103, P4068, DOI 10.1073/pnas.0508295103; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; Xu DY, 2008, GENE DEV, V22, P2843, DOI 10.1101/gad.1708608; Xue XY, 2013, J BIOL CHEM, V288, P14221, DOI 10.1074/jbc.M113.465609; Yan H, 2005, J CELL BIOL, V171, P217, DOI 10.1083/jcb.200502077; Yang J, 2012, MOL CELL BIOL, V32, P3054, DOI 10.1128/MCB.00255-12; Yin JH, 2005, EMBO J, V24, P1465, DOI 10.1038/sj.emboj.7600622; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	65	128	131	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					27314	27326		10.1074/jbc.M114.578823	http://dx.doi.org/10.1074/jbc.M114.578823			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25122754	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000342853900052
J	Kalikaki, A; Politaki, H; Souglakos, J; Apostolaki, S; Papadimitraki, E; Georgoulia, N; Tzardi, M; Mavroudis, D; Georgoulias, V; Voutsina, A				Kalikaki, Aristea; Politaki, Helen; Souglakos, John; Apostolaki, Stella; Papadimitraki, Elisavet; Georgoulia, Nefeli; Tzardi, Maria; Mavroudis, Dimitris; Georgoulias, Vassilis; Voutsina, Alexandra			KRAS Genotypic Changes of Circulating Tumor Cells during Treatment of Patients with Metastatic Colorectal Cancer	PLOS ONE			English	Article							ACQUIRED-RESISTANCE; PROGRESSION-FREE; MUTATIONS; EGFR; DNA; HETEROGENEITY; SURVIVAL; THERAPY; PREDICT; BRAF	Introduction: Circulating tumor cells (CTCs) could represent a non-invasive source of cancer cells used for longitudinal monitoring of the tumoral mutation status throughout the course of the disease. The aims of the present study were to investigate the detection of KRAS mutations in CTCs from patients with metastatic colorectal cancer (mCRC) and to compare their mutation status during treatment or disease progression with that of the corresponding primary tumors. Materials and Methods: Identification of the seven most common KRAS mutations on codons 12 and 13 was performed by Peptide Nucleic Acid (PNA)-based qPCR method. The sensitivity of the assay was determined after isolation of KRAS mutant cancer cells spiked into healthy donors' blood, using the CellSearch Epithelial Cell kit. Consistent detection of KRAS mutations was achieved in samples containing at least 10 tumor cells/7.5 ml of blood. Results: The clinical utility of the assay was assessed in 48 blood samples drawn from 31 patients with mCRC. All patients had PIK3CA and BRAF wild type primary tumors and 14 KRAS mutant tumors. CTCs were detected in 65% of specimens obtained from 74% of patients. KRAS mutation analysis in CTC-enriched specimens showed that 45% and 16.7% of patients with mutant and wild type primary tumors, respectively, had detectable mutations in their CTCs. Assessing KRAS mutations in serial blood samples revealed that individual patient's CTCs exhibited different mutational status of KRAS during treatment. Conclusions: The current findings support the rationale for using the CTCs as a dynamic source of tumor cells which, by re-evaluating their KRAS mutation status, could predict, perhaps more accurately, the response of mCRC patients to targeted therapy.	[Kalikaki, Aristea; Politaki, Helen; Souglakos, John; Apostolaki, Stella; Georgoulia, Nefeli; Mavroudis, Dimitris; Georgoulias, Vassilis; Voutsina, Alexandra] Univ Crete, Sch Med, Tumor Cell Biol Lab, Iraklion, Crete, Greece; [Souglakos, John; Papadimitraki, Elisavet; Mavroudis, Dimitris; Georgoulias, Vassilis] Univ Gen Hosp Heraklion, Dept Med Oncol, Iraklion, Crete, Greece; [Tzardi, Maria] Univ Gen Hosp Heraklion, Dept Pathol, Iraklion, Crete, Greece	University of Crete; University Hospital of Heraklion; University Hospital of Heraklion	Voutsina, A (corresponding author), Univ Crete, Sch Med, Tumor Cell Biol Lab, Iraklion, Crete, Greece.	voutsina@med.uoc.gr			Cretan Association for Biomedical Research (CABR); Hellenic Society of Medical Oncology (HeSMO); Operational Programme "Competitiveness & Entrepreneurship", National Strategic Reference Framework; National Action: "Cooperation", OncoSeed Diagnostics: Biology of Circulating Tumour Cells, Distant Metastasis & Development of Liquid Biopsy Methods; General Secretariat of Research and Technology of Greece	Cretan Association for Biomedical Research (CABR); Hellenic Society of Medical Oncology (HeSMO); Operational Programme "Competitiveness & Entrepreneurship", National Strategic Reference Framework; National Action: "Cooperation", OncoSeed Diagnostics: Biology of Circulating Tumour Cells, Distant Metastasis & Development of Liquid Biopsy Methods; General Secretariat of Research and Technology of Greece	This work was supported by research grants from the Cretan Association for Biomedical Research (CABR), the Hellenic Society of Medical Oncology (HeSMO) and the Operational Programme "Competitiveness & Entrepreneurship", National Strategic Reference Framework 2007-2013, National Action: "Cooperation", OncoSeed Diagnostics: Biology of Circulating Tumour Cells, Distant Metastasis & Development of Liquid Biopsy Methods; General Secretariat of Research and Technology of Greece. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal C, 2013, ANN ONCOL, V24, P420, DOI 10.1093/annonc/mds336; Allen JE, 2010, CURR COLORECT CANC R, V6, P212, DOI 10.1007/s11888-010-0069-7; Baldus SE, 2010, CLIN CANCER RES, V16, P790, DOI 10.1158/1078-0432.CCR-09-2446; Cohen SJ, 2008, J CLIN ONCOL, V26, P3213, DOI 10.1200/JCO.2007.15.8923; Coumans FAW, 2010, ANN ONCOL, V21, P1851, DOI 10.1093/annonc/mdq030; Danila DC, 2011, CLIN CANCER RES, V17, P3903, DOI 10.1158/1078-0432.CCR-10-2650; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Di Fiore F, 2008, BRIT J CANCER, V99, P551, DOI 10.1038/sj.bjc.6604451; Diaz LA, 2012, NATURE, V486, P537, DOI 10.1038/nature11219; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Flores LM, 2010, BRIT J CANCER, V102, P1495, DOI 10.1038/sj.bjc.6605676; Garrigos N, 2010, CLIN TRANSL ONCOL, V12, P142, DOI 10.1007/S12094-010-0479-7; Gasch C, 2013, CLIN CHEM, V59, P252, DOI 10.1373/clinchem.2012.188557; Harb W, 2013, TRANSL ONCOL, V6, P528, DOI 10.1593/tlo.13367; Hayes DF, 2006, CLIN CANCER RES, V12, P4218, DOI 10.1158/1078-0432.CCR-05-2821; Heitzer E, 2013, CANCER RES, V73, P2965, DOI 10.1158/0008-5472.CAN-12-4140; Hodgkinson CL, 2014, NAT MED; Jiang YQ, 2010, CLIN CHEM, V56, P1492, DOI 10.1373/clinchem.2010.143297; Jonker DJ, 2007, NEW ENGL J MED, V357, P2040, DOI 10.1056/NEJMoa071834; Krebs MG, 2011, J CLIN ONCOL, V29, P1556, DOI 10.1200/JCO.2010.28.7045; Luo JD, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj008; Magbanua MJM, 2013, CANCER RES, V73, P30, DOI 10.1158/0008-5472.CAN-11-3017; Magbanua MJM, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-78; Maheswaran S, 2008, NEW ENGL J MED, V359, P366, DOI 10.1056/NEJMoa0800668; McShane LM, 2005, J CLIN ONCOL, V23, P9067, DOI 10.1200/JCO.2004.01.0454; Misale S, 2012, NATURE, V486, P532, DOI 10.1038/nature11156; Mostert B, 2013, INT J CANCER, V133, P130, DOI 10.1002/ijc.27987; Ni XH, 2013, P NATL ACAD SCI USA, V110, P21083, DOI 10.1073/pnas.1320659110; Parkinson DR, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-138; Punnoose EA, 2012, CLIN CANCER RES, V18, P2391, DOI 10.1158/1078-0432.CCR-11-3148; Sastre J, 2012, ONCOLOGIST, V17, P947, DOI 10.1634/theoncologist.2012-0048; Schneck H, 2013, MOL ONCOL; Fernandez MJS, 2009, CLIN TRANSL ONCOL, V11, P659, DOI 10.1007/s12094-009-0421-z; Sieuwerts AM, 2009, BREAST CANCER RES TR, V118, P455, DOI 10.1007/s10549-008-0290-0; Skvortsova TE, 2006, BRIT J CANCER, V94, P1492, DOI 10.1038/sj.bjc.6603117; Stoecklein NH, 2010, INT J CANCER, V126, P589, DOI 10.1002/ijc.24916; Stott SL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000403; Tol J, 2009, ANN ONCOL, V20, P24; Vermaat JS, 2012, CLIN CANCER RES, V18, P688, DOI 10.1158/1078-0432.CCR-11-1965; Voutsina A, 2012, MOD PATHOL; Voutsina A, 2013, MODERN PATHOL, V26, P302, DOI 10.1038/modpathol.2012.150; Watanabe T, 2011, DIS COLON RECTUM, V54, P1170, DOI 10.1097/DCR.0b013e31821d37a3	42	36	37	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e104902	10.1371/journal.pone.0104902	http://dx.doi.org/10.1371/journal.pone.0104902			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137394	gold, Green Submitted, Green Published			2022-12-25	WOS:000340742100053
J	Leotta, CG; Federico, C; Brundo, MV; Tosi, S; Saccone, S				Leotta, Claudia Giovanna; Federico, Concetta; Brundo, Maria Violetta; Tosi, Sabrina; Saccone, Salvatore			HLXB9 Gene Expression, and Nuclear Location during In Vitro Neuronal Differentiation in the SK-N-BE Neuroblastoma Cell Line	PLOS ONE			English	Article							CHROMOSOME TERRITORIES; INTERPHASE NUCLEI; LOCALIZATION; INDUCTION; COMPARTMENTALIZATION; ARRANGEMENTS; ORGANIZATION; ARCHITECTURE; TOPOGRAPHY; MNR2	Different parts of the genome occupy specific compartments of the cell nucleus based on the gene content and the transcriptional activity. An example of this is the altered nuclear positioning of the HLXB9 gene in leukaemia cells observed in association with its over-expression. This phenomenon was attributed to the presence of a chromosomal translocation with breakpoint proximal to the HLXB9 gene. Before becoming an interesting gene in cancer biology, HLXB9 was studied as a developmental gene. This homeobox gene is also known as MNX1 (motor neuron and pancreas homeobox 1) and it is relevant for both motor neuronal and pancreatic beta cells development. A spectrum of mutations in this gene are causative of sacral agenesis and more broadly, of what is known as the Currarino Syndrome, a constitutional autosomal dominant disorder. Experimental work on animal models has shown that HLXB9 has an essential role in motor neuronal differentiation. Here we present data to show that, upon treatment with retinoic acid, the HLXB9 gene becomes over-expressed during the early stages of neuronal differentiation and that this corresponds to a reposition of the gene in the nucleus. More precisely, we used the SK-N-BE human neuroblastoma cell line as an in vitro model and we demonstrated a transient transcription of HLXB9 at the 4th and 5th days of differentiation that corresponded to the presence, predominantly in the cell nuclei, of the encoded protein HB9. The nuclear positioning of the HLXB9 gene was monitored at different stages: a peripheral location was noted in the proliferating cells whereas a more internal position was noted during differentiation, that is while HLXB9 was transcriptionally active. Our findings suggest that HLXB9 can be considered a marker of early neuronal differentiation, possibly involving chromatin remodeling pathways.	[Leotta, Claudia Giovanna; Federico, Concetta; Brundo, Maria Violetta; Saccone, Salvatore] Univ Catania, Sez Biol Anim, Dipartimento Sci Biol Geol & Ambientali, Catania, Italy; [Tosi, Sabrina] Brunel Univ, Div Biosci, Leukaemia & Chromosome Res Lab, London, England	University of Catania; Brunel University	Saccone, S (corresponding author), Univ Catania, Sez Biol Anim, Dipartimento Sci Biol Geol & Ambientali, Catania, Italy.	saccosal@unict.it	Federico, Concetta/M-5553-2015; Saccone, Salvatore/H-1548-2012; Tosi, Sabrina/AAA-7199-2022; Brundo, Maria Violetta/Q-4354-2016	Federico, Concetta/0000-0002-0160-9040; Saccone, Salvatore/0000-0001-7568-5823; Tosi, Sabrina/0000-0002-0036-0191; Brundo, Maria Violetta/0000-0001-5146-3564	University of Catania	University of Catania	The work was supported by PRA from the University of Catania to SS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abemayor E, 1999, ENV HLTH PERSPECT, V80, P3; Andres D, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-49; Andrulis ED, 1998, NATURE, V394, P592, DOI 10.1038/29100; Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Arkhipova V, 2012, DEV BIOL, V365, P290, DOI 10.1016/j.ydbio.2012.03.001; Ballabio E, 2009, LEUKEMIA, V23, P1179, DOI 10.1038/leu.2009.15; Bartova E, 2005, LEUKEMIA RES, V29, P901, DOI 10.1016/j.leukres.2005.01.011; Bartova E, 2000, GENE, V244, P1, DOI 10.1016/S0378-1119(99)00572-7; Bartova E, 2008, DIFFERENTIATION, V76, P24, DOI 10.1111/j.1432-0436.2007.00192.x; BIEDLER JL, 1978, CANCER RES, V38, P3751; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; Bunone G, 1997, ONCOGENE, V14, P1463, DOI 10.1038/sj.onc.1200972; Cockell M, 1999, CURR OPIN GENET DEV, V9, P199, DOI 10.1016/S0959-437X(99)80030-6; Constantinescu R, 2007, J NEURAL TRANSM-SUPP, P17; Cremer M, 2003, J CELL BIOL, V162, P809, DOI 10.1083/jcb.200304096; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Croft JA, 1999, J CELL BIOL, V145, P1119, DOI 10.1083/jcb.145.6.1119; DALESSIO A, 1995, CELL GROWTH DIFFER, V6, P1387; Fagerstrom S, 1996, CELL GROWTH DIFFER, V7, P775; Federico C, 2006, CHROMOSOMA, V115, P123, DOI 10.1007/s00412-005-0039-z; Federico C, 2008, CHROMOSOMA, V117, P399, DOI 10.1007/s00412-008-0160-x; Ferrier DEK, 2001, DEV GENES EVOL, V211, P103, DOI 10.1007/s004270000124; Foster HA, 2005, CHROMOSOMA, V114, P212, DOI 10.1007/s00412-005-0016-6; Garcia-Barcelo MM, 2009, J PEDIATR SURG, V44, P1892, DOI 10.1016/j.jpedsurg.2009.03.039; Grossi MR, 2014, TOXICOL LETT, V224, P240, DOI 10.1016/j.toxlet.2013.10.012; Hagan DM, 2000, AM J HUM GENET, V66, P1504, DOI 10.1086/302899; Harnicarova A, 2006, EXP CELL RES, V312, P4019, DOI 10.1016/j.yexcr.2006.09.007; HARRISON KA, 1994, J BIOL CHEM, V269, P19968; Holland PWH, 2001, J ANAT, V199, P13; KNOWLES BB, 1980, SCIENCE, V209, P497, DOI 10.1126/science.6248960; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; Kuroda M, 2004, J CELL SCI, V117, P5897, DOI 10.1242/jcs.01508; Li H, 1999, NAT GENET, V23, P67; Lin YC, 2012, NAT IMMUNOL, V13, P1196, DOI 10.1038/ni.2432; Lukasova E, 2002, CHROMOSOME RES, V10, P535, DOI 10.1023/A:1020958517788; Mahmoud MS, 1998, BLOOD, V92, P3887, DOI 10.1182/blood.V92.10.3887.422a48_3887_3897; Melino G, 1997, J NEURO-ONCOL, V31, P65, DOI 10.1023/A:1005733430435; Murata S, 2007, THYROID, V17, P489, DOI 10.1089/thy.2006.0328; Nagel S, 2005, GENE CHROMOSOME CANC, V42, P170, DOI 10.1002/gcc.20113; NILSSON K, 1970, CLIN EXP IMMUNOL, V7, P477; Patel NS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003614; Saccone S, 2002, GENE, V300, P169, DOI 10.1016/S0378-1119(02)01038-7; Sadoni N, 1999, J CELL BIOL, V146, P1211, DOI 10.1083/jcb.146.6.1211; Shin S, 2005, STEM CELLS DEV, V14, P266, DOI 10.1089/scd.2005.14.266; Shiohira H, 2012, BIOMED RES-TOKYO, V33, P291, DOI 10.2220/biomedres.33.291; Skok JA, 2001, NAT IMMUNOL, V2, P848, DOI 10.1038/ni0901-848; Solovei I, 2002, EXP CELL RES, V276, P10, DOI 10.1006/excr.2002.5513; Strouboulis J, 1996, J CELL SCI, V109, P1991; Szczerbal I, 2009, CHROMOSOMA, V118, P647, DOI 10.1007/s00412-009-0225-5; Takizawa T, 2008, GENE DEV, V22, P489, DOI 10.1101/gad.1634608; Tanabe Y, 1998, CELL, V95, P67, DOI 10.1016/S0092-8674(00)81783-3; Tibullo D, 2012, BLOOD, V120, DOI 10.1182/blood.V120.21.5005.5005; Williams RRE, 2006, J CELL SCI, V119, P132, DOI 10.1242/jcs.02727; Xie HR, 2010, CHINESE MED J-PEKING, V123, P1086, DOI 10.3760/cma.j.issn.0366-6999.2010.08.021	54	23	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105481	10.1371/journal.pone.0105481	http://dx.doi.org/10.1371/journal.pone.0105481			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136833	Green Published, Green Submitted, gold			2022-12-25	WOS:000340742100100
J	Manyema, M; Veerman, LJ; Chola, L; Tugendhaft, A; Sartorius, B; Labadarios, D; Hofman, KJ				Manyema, Mercy; Veerman, Lennert J.; Chola, Lumbwe; Tugendhaft, Aviva; Sartorius, Benn; Labadarios, Demetre; Hofman, Karen J.			The Potential Impact of a 20% Tax on Sugar-Sweetened Beverages on Obesity in South African Adults: A Mathematical Model	PLOS ONE			English	Article							BODY-WEIGHT; DENTAL-CARIES; RISK; CONSUMPTION; PREVALENCE; CHILDREN; HEALTH; OVERWEIGHT; COUNTRIES; TRIAL	Background/Objectives: The prevalence of obesity in South Africa has risen sharply, as has the consumption of sugar-sweetened beverages (SSBs). Research shows that consumption of SSBs leads to weight gain in both adults and children, and reducing SSBs will significantly impact the prevalence of obesity and its related diseases. We estimated the effect of a 20% tax on SSBs on the prevalence of and obesity among adults in South Africa. Methods: A mathematical simulation model was constructed to estimate the effect of a 20% SSB tax on the prevalence of obesity. We used consumption data from the 2012 SA National Health and Nutrition Examination Survey and a previous meta-analysis of studies on own-and cross-price elasticities of SSBs to estimate the shift in daily energy consumption expected of increased prices of SSBs, and energy balance equations to estimate shifts in body mass index. The population distribution of BMI by age and sex was modelled by fitting measured data from the SA National Income Dynamics Survey 2012 to the lognormal distribution and shifting the mean values. Uncertainty was assessed with Monte Carlo simulations. Results: A 20% tax is predicted to reduce energy intake by about 36kJ per day (95% CI: 9-68kJ). Obesity is projected to reduce by 3.8% (95% CI: 0.6%-7.1%) in men and 2.4% (95% CI: 0.4%-4.4%) in women. The number of obese adults would decrease by over 220 000 (95% CI: 24 197-411 759). Conclusions: Taxing SSBs could impact the burden of obesity in South Africa particularly in young adults, as one component of a multi-faceted effort to prevent obesity.	[Manyema, Mercy; Chola, Lumbwe; Tugendhaft, Aviva; Sartorius, Benn; Hofman, Karen J.] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Johannesburg, South Africa; [Manyema, Mercy; Chola, Lumbwe; Tugendhaft, Aviva; Hofman, Karen J.] Univ Witwatersrand, Fac Hlth Sci, PRICELESS SA, MRC Wits Rural Publ Hlth & Hlth Transit Res Unit, Johannesburg, South Africa; [Veerman, Lennert J.] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [Sartorius, Benn] Univ KwaZulu Natal, Sch Nursing & Publ Hlth, Discipline Publ Hlth Med, Durban, South Africa; [Labadarios, Demetre] Human Sci Res Council, Cape Town, South Africa; [Hofman, Karen J.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA	University of Witwatersrand; University of Witwatersrand; University of Queensland; University of Kwazulu Natal; Human Sciences Research Council-South Africa; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Manyema, M (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Johannesburg, South Africa.	Mercy.Manyema@wits.ac.za	Chola, Lumbwe/AFX-3377-2022; Veerman, Lennert/A-9973-2011	Veerman, Lennert/0000-0002-3206-8232; Chola, Lumbwe/0000-0001-6488-2813; HOFMAN, KAREN/0000-0001-9512-7220; , bennsartorius/0000-0001-6761-2325	International Development Research Center, Canada [PROP020911E]	International Development Research Center, Canada	This research was supported by grant PROP020911E from the International Development Research Center, Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. URL: http://www.idrc.ca/EN/Pages/default.aspx	Adami N, 2012, Q DIVISIONAL SEMINAR; Andreyeva T, 2011, PREV MED, V52, P413, DOI 10.1016/j.ypmed.2011.03.013; Armfield JM, 2013, AM J PUBLIC HEALTH, V103, P494, DOI 10.2105/AJPH.2012.300889; Basu S, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001582; Berardi N, 2012, 415 BANK FRANC; Bertram Melanie Y, 2013, Int J Stroke, V8 Suppl A100, P76, DOI 10.1111/j.1747-4949.2012.00955.x; Bertram MY, 2013, GLOBAL HEALTH ACTION, V6, P206, DOI 10.3402/gha.v6i0.19244; Briggs AD, 2013, BMC PUBLIC HEALTH, V13; Briggs ADM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-860; Briggs ADM, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6189; Brown M., 2012, NATL INCOME DYNAMICS; Brownell KD, 2005, J HEALTH POLIT POLIC, V30, P955, DOI 10.1215/03616878-30-5-955; Brownell KD, 2009, NEW ENGL J MED, V361, P1599, DOI 10.1056/NEJMhpr0905723; Cabrera-Escobar MA, 2013, BMC PUBLIC HEALTH, V13; Cawley J, 2012, J HEALTH ECON, V31, P219, DOI 10.1016/j.jhealeco.2011.10.003; Chattan N, 2013, MEX C PASS TAX BILL; Chen LW, 2009, AM J CLIN NUTR, V89, P1299, DOI 10.3945/ajcn.2008.27240; Cheney C, 2011, BATTL COUCH POT HUNG; Claro RM, 2012, AM J PUBLIC HEALTH, V102, P178, DOI 10.2105/AJPH.2011.300313; de Ruyter JC, 2012, NEW ENGL J MED, V367, P1397, DOI 10.1056/NEJMoa1203034; De Villiers L, 2013, NATK INCOME DYNAMICS; De Wet P, 2011, DAY HEART ATTACK FAT; Department of Health, 2007, S AFR DEM HLTH SURV, P258; Dodds C, 2013, MINSTER HLTH GOES SO; Ebbeling CB, 2006, PEDIATRICS, V117, P673, DOI 10.1542/peds.2005-0983; Escobar MAC, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1072; EU Food Law, 2013, DENM DROPS DEC OLD S; Euromonitor International, 2013, SOFT DRINKS S AFR IN; Finkelstein EA, 2010, ARCH INTERN MED, V170, P2028, DOI 10.1001/archinternmed.2010.449; Finkelstein EA, 2013, J HEALTH ECON, V32, P219, DOI 10.1016/j.jhealeco.2012.10.005; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Friedman Roberta R, 2012, SUGAR SWEETENED BEVE, P1; Godfray HCJ, 2010, PHILOS T R SOC B, V365, P2769, DOI 10.1098/rstb.2010.0180; Goris JM, 2010, PUBLIC HEALTH NUTR, V13, P1003, DOI 10.1017/S1368980009992850; Hall KD, 2011, LANCET, V378, P826, DOI 10.1016/S0140-6736(11)60812-X; Holmes T, 2013, SALT SELLIERS SHAKEN; Hu FB, 2010, PHYSIOL BEHAV, V100, P47, DOI 10.1016/j.physbeh.2010.01.036; Joubert J, 2007, SAMJ S AFR MED J, V97, P683; Kenkel DS, 2005, AM ECON REV, V95, P273, DOI 10.1257/000282805774670284; Leibbtandt M, 2009, METHODOLOGY REPORT N; Lobstein T, 2011, MEDICINE, V39, P11; Malaza A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047761; Malik VS, 2006, AM J CLIN NUTR, V84, P274; Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079; Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185; Mayosi BM, 2009, LANCET, V374, P934, DOI 10.1016/S0140-6736(09)61087-4; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Ng M., 2014, LANCET; NIDS, 2013, WAVE 3 SALDRU; NIDS, 2012, INTRO NIDS DAT; NIDS, 2008, FILDW MAN WAV 1; Parmalat, 2011, EV MILK NUTR INF PER; Popkin BM, 2013, OBES REV, V14, P11, DOI 10.1111/obr.12102; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; Powell LM, 2014, AM J PUBLIC HEALTH, V104, P672, DOI 10.2105/AJPH.2013.301630; ROSE G, 1990, BRIT MED J, V301, P1031, DOI 10.1136/bmj.301.6759.1031; Sacks G, 2011, INT J OBESITY, V35, P1001, DOI 10.1038/ijo.2010.228; Shisana O, 2013, S AFRICAN NATL HLTH, P135; Southern Africa Labour and Development Research Unit, 2014, S AFR NATL INC DYN S; Spiegel, 2011, FRENCH COL TAX APPR; STATA, 2011, STAT STAT SOFTW REL; StatsSA, 2013, MID POP EST 2013; Sturm R, 2013, SAMJ S AFR MED J, V103, P840, DOI [10.7196/SAMJ.7260, 10.7196/samj.7260]; Swinburn BA, 2009, AM J CLIN NUTR, V89, P1723, DOI 10.3945/ajcn.2008.27061; UNESDA, 2010, WHY DISCR TEX DONT W; van Walbeek C., 2003, TOBACCO EXCISE TAXAT; Veerman JL, 2007, OBESITY, V15, P2365, DOI 10.1038/oby.2007.280; Veerman JL, 2009, EUR J PUBLIC HEALTH, V19, P365, DOI 10.1093/eurpub/ckp039; von Lengerke T, 2011, MATURITAS, V69, P220, DOI 10.1016/j.maturitas.2011.04.005; Warren JJ, 2009, COMMUNITY DENT ORAL, V37, P116, DOI 10.1111/j.1600-0528.2008.00447.x; World Health Organization, 2009, GLOB HLTH RISKS MORT	71	64	66	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105287	10.1371/journal.pone.0105287	http://dx.doi.org/10.1371/journal.pone.0105287			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN6XM	25136987	Green Submitted, Green Published, gold			2022-12-25	WOS:000340742100084
J	Banville, N; Burgess, JK; Jaffar, J; Tjin, G; Richeldi, L; Cerri, S; Persiani, E; Black, JL; Oliver, BG				Banville, Nessa; Burgess, Janette K.; Jaffar, Jade; Tjin, Gavin; Richeldi, Luca; Cerri, Stefania; Persiani, Elisa; Black, Judith L.; Oliver, Brian G.			A Quantitative Proteomic Approach to Identify Significantly Altered Protein Networks in the Serum of Patients with Lymphangioleiomyomatosis (LAM)	PLOS ONE			English	Article							TUBEROUS SCLEROSIS COMPLEX; VON-WILLEBRAND-FACTOR; PULMONARY LYMPHANGIOLEIOMYOMATOSIS; CANCER-CELLS; DISEASE; GROWTH; FIBRONECTIN; EXPRESSION; GUIDELINES; SIROLIMUS	Lymphangioleiomyomatosis (LAM) is a rare and progressive cystic lung condition affecting approximately 3.4-7.5/million women, with an average lag time between symptom onset and diagnosis of upwards of 4 years. The aim of this work was to identify altered proteins in LAM serum which may be potential biomarkers of disease. Serum from LAM patient volunteers and healthy control volunteers were pooled and analysis carried out using quantitative 4-plex iTRAQ technology. Differentially expressed proteins were validated using ELISAs and pathway analysis was carried out using Ingenuity Pathway Analysis. Fourteen proteins were differentially expressed in LAM serum compared to control serum (p < 0.05). Further screening validated the observed differences in extracellular matrix remodelling proteins including fibronectin (30% decrease in LAM, p = 0.03), von Willebrand Factor (40% reduction in LAM, p = 0.03) and Kallikrein III (25% increase in LAM, p = 0.03). Pathway networks elucidated the relationships between the ECM and cell trafficking in LAM. This study was the first to highlight an imbalance in networks important for remodelling in LAM, providing a set of novel potential biomarkers. These understandings may lead to a new effective treatment for LAM in the future.	[Banville, Nessa; Burgess, Janette K.; Jaffar, Jade; Tjin, Gavin; Black, Judith L.; Oliver, Brian G.] Univ Sydney, Woolcock Inst Med Res, Sydney, NSW 2006, Australia; [Burgess, Janette K.] Univ Sydney, Woolcock Inst Med Res, Discipline Pharmacol, Sydney, NSW 2006, Australia; [Richeldi, Luca] Univ Southampton, Southampton, Hants, England; [Cerri, Stefania; Persiani, Elisa] Univ Modena & Reggio Emilia, Ctr Rare Lung Dis, Modena, Italy; [Oliver, Brian G.] Univ Technol, Sch Med & Mol Biosci, Sydney, NSW, Australia	University of Sydney; Woolcock Institute of Medical Research; University of Sydney; Woolcock Institute of Medical Research; University of Southampton; Universita di Modena e Reggio Emilia; University of Technology Sydney	Oliver, BG (corresponding author), Univ Sydney, Woolcock Inst Med Res, Sydney, NSW 2006, Australia.	brian.oliver@sydney.edu.au	Richeldi, Luca/ABF-2486-2020; Cerri, Stefania/N-9701-2016; Burgess, Janette K/A-3597-2010; Burgess, Janette/M-7117-2019; Richeldi, Luca/B-6243-2019; Oliver, Brian/E-7939-2010	Richeldi, Luca/0000-0001-8594-1448; Cerri, Stefania/0000-0003-4612-1580; Oliver, Brian/0000-0002-7122-9262; Burgess, Janette/0000-0001-9868-9966; Tjin, Gavin/0000-0002-7235-6909	LAM Australia Research Alliance; National Health and Medical Research Council (NHMRC) [1009156]; NHMRC Career Development Fellowship [1032695, 1026880]; NHMRC Senior Principal Research Fellowship [571098]; Rebecca L. Cooper PhD scholarship	LAM Australia Research Alliance; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Senior Principal Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Rebecca L. Cooper PhD scholarship	This work was supported by LAM Australia Research Alliance and the National Health and Medical Research Council (NHMRC, 1009156), JKB was supported by a NHMRC Career Development Fellowship #1032695. JLB was supported by a NHMRC Senior Principal Research Fellowship #571098. BGO was supported by a NHMRC Career Development Fellowship #1026880. JJ was supported by a Rebecca L. Cooper PhD scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaensen MEAPM, 2011, CLIN RADIOL, V66, P625, DOI 10.1016/j.crad.2011.02.009; Borgono CA, 2004, NAT REV CANCER, V4, P876, DOI 10.1038/nrc1474; Burgess JK, 2009, PHARMACOL THERAPEUT, V122, P19, DOI 10.1016/j.pharmthera.2008.12.002; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Cook-Mills JM, 2006, CELL MOL BIOL, V52, P8, DOI 10.1170/T721; Costello LC, 2000, MAYO CLIN PROC, V75, P591, DOI 10.4065/75.6.591; Davis JM, 2013, J HISTOCHEM CYTOCHEM, V61, P580, DOI 10.1369/0022155413489311; Evans SE, 2004, CHEST, V125, P1063, DOI 10.1378/chest.125.3.1063; Furlan M, 1996, ANN HEMATOL, V72, P341, DOI 10.1007/s002770050184; Glasgow CG, 2009, CHEST, V135, P1293, DOI 10.1378/chest.08-1160; Hammes SR, 2013, HORM CANCER-US, V4, P70, DOI 10.1007/s12672-012-0128-4; Henske EP, 2012, J CLIN INVEST, V122, P3807, DOI 10.1172/JCI58709; Jajic I, 1990, Reumatizam, V37, P39; Jawad H, 2012, CLIN CHEST MED, V33, P11, DOI 10.1016/j.ccm.2012.01.002; Johnson SR, 2010, EUR RESPIR J, V35, P14, DOI 10.1183/09031936.00076209; Johnson SR, 2010, RESP MED, V104, pS33, DOI 10.1016/j.rmed.2010.03.015; Johnson SR, 2004, THORAX, V59, P800, DOI 10.1136/thx.2004.023283; Kollara A, 2003, J STEROID BIOCHEM, V84, P493, DOI 10.1016/S0960-0760(03)00069-4; Koumandou VL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068074; Labat-Robert J, 2012, PATHOL BIOL, V60, P15, DOI 10.1016/j.patbio.2011.10.003; Lawless MW, 2009, J CELL MOL MED, V13, P2800, DOI 10.1111/j.1582-4934.2009.00845.x; Lee EH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055827; Matsui K, 2000, ARCH PATHOL LAB MED, V124, P1642; McCormack FX, 2012, AM J RESP CRIT CARE, V186, P1210, DOI 10.1164/rccm.201205-0848OE; McCormack FX, 2011, NEW ENGL J MED, V364, P1595, DOI 10.1056/NEJMoa1100391; Mount DL, 2009, CLIN TRIALS, V6, P416, DOI 10.1177/1740774509344440; Ortea I, 2012, J PROTEOMICS, V77, P372, DOI 10.1016/j.jprot.2012.09.011; Polatli M, 2008, J THROMB THROMBOLYS, V26, P97, DOI 10.1007/s11239-007-0073-1; Schiavina M, 2007, AM J RESP CRIT CARE, V176, P96, DOI 10.1164/rccm.200610-1408CR; Sehestedt T, 2011, ATHEROSCLEROSIS, V216, P237, DOI 10.1016/j.atherosclerosis.2011.01.049; Tailleux A, 2002, ATHEROSCLEROSIS, V164, P1, DOI 10.1016/S0021-9150(01)00751-1; Taveira-DaSilva AM, 2012, EXPERT REV RESP MED, V6, P267, DOI [10.1586/ers.12.26, 10.1586/ERS.12.26]; Taveira-DaSilva AM, 2011, ANN INTERN MED, V154, P797, DOI 10.7326/0003-4819-154-12-201106210-00007; Tu CJ, 2010, J PROTEOME RES, V9, P4982, DOI 10.1021/pr100646w; Valencia JC, 2001, J INVEST MED, V49, P421, DOI 10.2310/6650.2001.33787; Wang DX, 2013, CHINESE MED J-PEKING, V126, P3656, DOI 10.3760/cma.j.issn.0366-6999.20130400; Young LR, 2013, LANCET RESP MED, V1, P445, DOI 10.1016/S2213-2600(13)70090-0; Zhe XN, 2005, AM J RESP CELL MOL, V32, P28, DOI 10.1165/rcmb.2004-0289OC; Zuo L, 2013, MOL IMMUNOL, V56, P57, DOI 10.1016/j.molimm.2013.04.002	39	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105365	10.1371/journal.pone.0105365	http://dx.doi.org/10.1371/journal.pone.0105365			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133674	Green Submitted, Green Published, gold			2022-12-25	WOS:000341302700106
J	Li, ZR; Zhao, CQ; Zha, Y; Wan, C; Si, SL; Liu, F; Zhang, R; Li, FC; Yu, B; Yi, ZL; Xu, N; Peng, LC; Li, Q				Li, Zhengru; Zhao, Chunqiao; Zha, Yi; Wan, Can; Si, Shengli; Liu, Fei; Zhang, Rui; Li, Fengcheng; Yu, Bin; Yi, Zili; Xu, Ning; Peng, Liangcai; Li, Qing			The Minor Wall-Networks between Monolignols and Interlinked-Phenolics Predominantly Affect Biomass Enzymatic Digestibility in Miscanthus	PLOS ONE			English	Article							FERMENTABLE SUGAR YIELDS; H2SO4 PRETREATMENTS; ETHANOL-PRODUCTION; POLYMER FEATURES; LIGNIN CONTENT; 4-COUMARATE/COENZYME; RECALCITRANCE; HYDROLYSIS; BIOFUELS; LIGASE	Plant lignin is one of the major wall components that greatly contribute to biomass recalcitrance for biofuel production. In this study, total 79 representative Miscanthus germplasms were determined with wide biomass digestibility and diverse monolignol composition. Integrative analyses indicated that three major monolignols (S, G, H) and S/G ratio could account for lignin negative influence on biomass digestibility upon NaOH and H2SO4 pretreatments. Notably, the biomass enzymatic digestions were predominately affected by the non-KOH-extractable lignin and interlinked-phenolics, other than the KOH-extractable ones that cover 80% of total lignin. Furthermore, a positive correlation was found between the monolignols and phenolics at p < 0.05 level in the non-KOH-extractable only, suggesting their tight association to form the minor wall-networks against cellulases accessibility. The results indicated that the non-KOH-extractable lignin-complex should be the target either for cost-effective biomass pretreatments or for relatively simply genetic modification of plant cell walls in Miscanthus.	[Li, Zhengru; Zhao, Chunqiao; Liu, Fei; Li, Fengcheng; Xu, Ning; Peng, Liangcai] Huazhong Agr Univ, Coll Plant Sci & Technol, Biomass & Bioenergy Res Ctr, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China; [Zha, Yi; Wan, Can; Si, Shengli; Zhang, Rui; Yu, Bin; Peng, Liangcai] Huazhong Agr Univ, Coll Life Sci & Technol, Biomass & Bioenergy Res Ctr, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China; [Yi, Zili] Hunan Agr Univ, Dept Biotechnol, Changsha, Hunan, Peoples R China; [Xu, Ning] Huaiyin Normal Univ, Jiangsu Key Lab Biomass Based Energy & Enzyme Tec, Huaian, Peoples R China; [Li, Qing] Huazhong Agr Univ, Coll Sci, Biomass & Bioenergy Res Ctr, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University; Hunan Agricultural University; Huaiyin Normal University; Huazhong Agricultural University	Li, Q (corresponding author), Huazhong Agr Univ, Coll Sci, Biomass & Bioenergy Res Ctr, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China.	liqing@mail.hzau.edu.cn			111 Project [B08032]; Open Project of Jiangsu Key Laboratory for Biomass-based Energy and Enzyme Technology [JSBEET1204]; 973 Specific Pre-project [2010CB134401]; Fundamental Research Funds for the Central Universities [2013PY061]	111 Project(Ministry of Education, China - 111 Project); Open Project of Jiangsu Key Laboratory for Biomass-based Energy and Enzyme Technology; 973 Specific Pre-project(National Basic Research Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported in part by grants from 111 Project (B08032), the Open Project of Jiangsu Key Laboratory for Biomass-based Energy and Enzyme Technology (JSBEET1204), the 973 Specific Pre-project (2010CB134401) and the Fundamental Research Funds for the Central Universities (No2013PY061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achyuthan KE, 2010, MOLECULES, V15, P8641, DOI 10.3390/molecules15118641; Chang VS, 2000, APPL BIOCHEM BIOTECH, V84-6, P5, DOI 10.1385/ABAB:84-86:1-9:5; Chen F, 2007, NAT BIOTECHNOL, V25, P759, DOI 10.1038/nbt1316; Chen P, 2013, BIOL CONVERSION BIOM, P83; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Dische Z., 1962, METHODS CARBOHYDRATE, P477; Fry S. C, 1988, GROWING PLANT CELL W, DOI DOI 10.1016/0031-9422(88)83079-6; Fu CX, 2011, P NATL ACAD SCI USA, V108, P3803, DOI 10.1073/pnas.1100310108; Grabber JH, 2005, CROP SCI, V45, P820, DOI 10.2135/cropsci2004.0191; Himmel ME, 1999, CURR OPIN BIOTECH, V10, P358, DOI 10.1016/S0958-1669(99)80065-2; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Huang JF, 2012, BIORESOURCE TECHNOL, V121, P274, DOI 10.1016/j.biortech.2012.06.015; IIYAMA K, 1994, PLANT PHYSIOL, V104, P315, DOI 10.1104/pp.104.2.315; Jung HJG, 2012, BIOENERG RES, V5, P319, DOI 10.1007/s12155-011-9131-9; Keegstra K, 2010, PLANT PHYSIOL, V154, P483, DOI 10.1104/pp.110.161240; Li FC, 2013, BIORESOURCE TECHNOL, V130, P629, DOI 10.1016/j.biortech.2012.12.107; Li M, 2014, BIORESOURCE TECHNOL, V167, P14, DOI 10.1016/j.biortech.2014.04.086; Lygin AV, 2011, GCB BIOENERGY, V3, P333, DOI 10.1111/j.1757-1707.2011.01091.x; Pauly M, 2008, PLANT J, V54, P559, DOI 10.1111/j.1365-313X.2008.03463.x; Peng LC, 2000, PLANTA, V211, P406, DOI 10.1007/s004250000301; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Ralph John, 2004, Phytochemistry Reviews, V3, P29, DOI 10.1023/B:PHYT.0000047809.65444.a4; Saha BC, 2007, J CHEM TECHNOL BIOT, V82, P913, DOI 10.1002/jctb.1760; Sang T, 2011, GCB BIOENERGY, V3, P79, DOI 10.1111/j.1757-1707.2010.01064.x; Somerville C, 2004, SCIENCE, V306, P2206, DOI 10.1126/science.1102765; Somerville C, 2010, SCIENCE, V329, P790, DOI 10.1126/science.1189268; Studer MH, 2011, P NATL ACAD SCI USA, V108, P6300, DOI 10.1073/pnas.1009252108; Sun HY, 2013, BIOCHEM BIOPH RES CO, V430, P1151, DOI 10.1016/j.bbrc.2012.12.019; Sun Y, 2002, BIORESOURCE TECHNOL, V83, P1, DOI 10.1016/S0960-8524(01)00212-7; Wu ZL, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-183; Xie GS, 2011, J INTEGR PLANT BIOL, V53, P143, DOI 10.1111/j.1744-7909.2010.01022.x; Xu B, 2011, NEW PHYTOL, V192, P611, DOI 10.1111/j.1469-8137.2011.03830.x; Xu N, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-58; Zhang W, 2013, BIORESOURCE TECHNOL, V130, P30, DOI 10.1016/j.biortech.2012.12.029	34	28	29	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105115	10.1371/journal.pone.0105115	http://dx.doi.org/10.1371/journal.pone.0105115			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133694	Green Submitted, Green Published, gold			2022-12-25	WOS:000341302700074
J	Rochette, PA; Laliberte, M; Bertrand-Grenier, A; Houle, MA; Blache, MC; Legare, F; Pearson, A				Rochette, Pierre-Alexandre; Laliberte, Mathieu; Bertrand-Grenier, Antony; Houle, Marie-Andree; Blache, Marie-Claire; Legare, Francois; Pearson, Angela			Visualization of Mouse Neuronal Ganglia Infected by Herpes Simplex Virus 1 (HSV-1) Using Multimodal Non-Linear Optical Microscopy	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; RAMAN SCATTERING MICROSCOPY; IN-VIVO REACTIVATION; 2ND-HARMONIC GENERATION; ZOSTERIFORM SPREAD; NERVOUS-SYSTEM; TYPE-1; CARS; TISSUE; MICE	Herpes simplex virus 1 (HSV-1) is a neurotropic virus that causes skin lesions and goes on to enter a latent state in neurons of the trigeminal ganglia. Following stress, the virus may reactivate from latency leading to recurrent lesions. The in situ study of neuronal infections by HSV-1 is critical to understanding the mechanisms involved in the biology of this virus and how it causes disease; however, this normally requires fixation and sectioning of the target tissues followed by treatment with contrast agents to visualize key structures, which can lead to artifacts. To further our ability to study HSV-1 neuropathogenesis, we have generated a recombinant virus expressing a second generation red fluorescent protein (mCherry), which behaves like the parental virus in vivo. By optimizing the application of a multimodal non-linear optical microscopy platform, we have successfully visualized in unsectioned trigeminal ganglia of mice both infected cells by two-photon fluorescence microscopy, and myelinated axons of uninfected surrounding cells by coherent anti-Stokes Raman scattering (CARS) microscopy. These results represent the first report of CARS microscopy being combined with 2-photon fluorescence microscopy to visualize virus-infected cells deep within unsectioned explanted tissue, and demonstrate the application of multimodal non-linear optical microscopy for high spatial resolution biological imaging of tissues without the use of stains or fixatives.	[Rochette, Pierre-Alexandre; Pearson, Angela] INRS, Inst Armand Frappier, Laval, PQ, Canada; [Laliberte, Mathieu; Bertrand-Grenier, Antony; Houle, Marie-Andree; Blache, Marie-Claire; Legare, Francois] INRS, Ctr Energie Mat Telecommun, Varennes, PQ, Canada	University of Quebec; Institut national de la recherche scientifique (INRS); University of Quebec; Institut national de la recherche scientifique (INRS)	Pearson, A (corresponding author), INRS, Inst Armand Frappier, Laval, PQ, Canada.	angela.pearson@iaf.inrs.ca		Pearson, Angela/0000-0002-5997-2846	Fondation Armand-Frappier (FAF); INRS-EMT; Natural Sciences and Engineering Research Council of Canada; Fonds de recherche du Quebec - Nature et technologies; Fonds quebecois de la recherche sur la nature et les technologies [125806]; Canada Foundation for Innovation [9991]; Canadian Institute for Photonic Innovations; Canadian Institutes of Health Research [82924]	Fondation Armand-Frappier (FAF); INRS-EMT; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Fonds de recherche du Quebec - Nature et technologies; Fonds quebecois de la recherche sur la nature et les technologies(FQRNT); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canadian Institute for Photonic Innovations; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	PAR was the recipient of a scholarship from the Fondation Armand-Frappier (FAF). ML and ABG received financial support from INRS-EMT. MAH received scholarships from the Natural Sciences and Engineering Research Council of Canada and the Fonds de recherche du Quebec - Nature et technologies. This project was supported by a team grant from the Fonds quebecois de la recherche sur la nature et les technologies (125806), to FL and AP, as well as separate infrastructure grants from the Canada Foundation for Innovation to AP (9991) and to FL, and operating funds from the Natural Sciences and Engineering Research Council of Canada, and the Canadian Institute for Photonic Innovations to FL, and from the Canadian Institutes of Health Research (82924) to AP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antinone SE, 2010, J VIROL, V84, P13019, DOI 10.1128/JVI.01296-10; Balliet JW, 2007, VIROLOGY, V361, P372, DOI 10.1016/j.virol.2006.11.022; BARINGER JR, 1973, NEW ENGL J MED, V288, P648, DOI 10.1056/NEJM197303292881303; BLYTH WA, 1980, INFECT IMMUN, V29, P902; BLYTH WA, 1984, J GEN VIROL, V65, P1477, DOI 10.1099/0022-1317-65-9-1477; Brown CP, 2012, J MECH BEHAV BIOMED, V5, P62, DOI 10.1016/j.jmbbm.2011.08.004; Cheng JX, 2002, J OPT SOC AM B, V19, P1363, DOI 10.1364/JOSAB.19.001363; Cheng JX, 2001, J PHYS CHEM B, V105, P1277, DOI 10.1021/jp003774a; COEN DM, 1985, J VIROL, V53, P477, DOI 10.1128/JVI.53.2.477-488.1985; COEN DM, 1989, P NATL ACAD SCI USA, V86, P4736, DOI 10.1073/pnas.86.12.4736; COOK ML, 1973, INFECT IMMUN, V7, P272, DOI 10.1128/IAI.7.2.272-288.1973; de Oliveira AP, 2008, J VIROL, V82, P4974, DOI 10.1128/JVI.02431-07; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; DYSON H, 1987, J GEN VIROL, V68, P2989, DOI 10.1099/0022-1317-68-12-2989; Evans CL, 2005, P NATL ACAD SCI USA, V102, P16807, DOI 10.1073/pnas.0508282102; Folick A, 2011, CURR OPIN GENET DEV, V21, P585, DOI 10.1016/j.gde.2011.09.003; Foster TP, 1999, J VIROL, V73, P8457, DOI 10.1128/JVI.73.10.8457-8468.1999; Fu Y, 2007, J NEUROSCI RES, V85, P2870, DOI 10.1002/jnr.21403; Griffiths A, 2003, J VIROL, V77, P2282, DOI 10.1128/JVI.77.3.2282-2286.2003; Gusachenko I, 2012, BIOPHYS J, V102, P2220, DOI 10.1016/j.bpj.2012.03.068; Hellerer T, 2007, P NATL ACAD SCI USA, V104, P14658, DOI 10.1073/pnas.0703594104; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; HILL TJ, 1983, PROG BRAIN RES, V59, P173; Kimberlin David, 2004, Herpes, V11 Suppl 2, p65A; LEIB DA, 1989, J VIROL, V63, P759, DOI 10.1128/JVI.63.2.759-768.1989; Lim RS, 2011, J LIPID RES, V52, P2177, DOI 10.1194/jlr.M018077; Lin CY, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2981817; Luker GD, 2003, J VIROL, V77, P11082, DOI 10.1128/JVI.77.20.11082-11093.2003; Luker GD, 2002, J VIROL, V76, P12149, DOI 10.1128/JVI.76.23.12149-12161.2002; Lyn RK, 2009, VIROLOGY, V394, P130, DOI 10.1016/j.virol.2009.08.022; MOCHIZUKI Y, 1995, ZOOL SCI, V12, P283, DOI 10.2108/zsj.12.283; Monici M, 2005, BIOTECHNOL ANN REV, V11, P227, DOI 10.1016/S1387-2656(05)11007-2; Mostaco-Guidolin LB, 2010, BIOMED OPT EXPRESS, V1, P59, DOI 10.1364/BOE.1.000059; Nagel CH, 2008, J VIROL, V82, P3109, DOI 10.1128/JVI.02124-07; Nagel CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044177; Neumann DM, 2007, J VIROL, V81, P6106, DOI 10.1128/JVI.00070-07; Ouyang H, 2010, J NEUROTRAUM, V27, P1109, DOI 10.1089/neu.2010.1271; Potel C, 2002, J VIROL METHODS, V105, P13, DOI 10.1016/S0166-0934(02)00027-7; POTTAGE JC, 1995, INFECT AGENT DIS, V4, P115; Ramachandran S, 2008, VIROLOGY, V378, P254, DOI 10.1016/j.virol.2008.05.034; Reichelt M, 2008, J VIROL, V82, P3971, DOI 10.1128/JVI.02592-07; Robinson I, 2010, J BIOPHOTONICS, V3, P138, DOI 10.1002/jbio.200910054; Roizman B, 1974, COMPREHENSIVE VIROLO, V3, P175; Roizman B, 2007, FIELDS VIROLOGY, P3177; Sawtell NM, 2003, J VIROL, V77, P4127, DOI 10.1128/JVI.77.7.4127-4138.2003; SAWTELL NM, 1992, J VIROL, V66, P2150, DOI 10.1128/JVI.66.4.2150-2156.1992; Schurmann S, 2010, BIOPHYS J, V99, P1842, DOI 10.1016/j.bpj.2010.07.005; Shaner NC, 2004, NAT BIOTECHNOL, V22, P6; SMITT PAES, 1993, ACTA HISTOCHEM, V95, P13, DOI 10.1016/S0065-1281(11)80381-8; Snyder A, 2007, J VIROL, V81, P8337, DOI 10.1128/JVI.00520-07; Stoothoff WH, 2008, J BIOMED OPT, V13, DOI 10.1117/1.3050422; Summers BC, 2001, J VIROL, V75, P5069, DOI 10.1128/JVI.75.11.5069-5075.2001; Tanaka M, 2004, MICROBES INFECT, V6, P485, DOI 10.1016/j.micinf.2004.01.011; Teng SW, 2006, INVEST OPHTH VIS SCI, V47, P1216, DOI 10.1167/iovs.04-1520; Volkmer A, 2005, J PHYS D APPL PHYS, V38, pR59, DOI 10.1088/0022-3727/38/5/R01; Volkmer A, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.023901; von Messling V, 2003, J VIROL, V77, P12579, DOI 10.1128/JVI.77.23.12579-12591.2003; Wang HF, 2005, BIOPHYS J, V89, P581, DOI 10.1529/biophysj.105.061911; Winnard PT, 2006, NEOPLASIA, V8, P796, DOI 10.1593/neo.06304	59	3	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105103	10.1371/journal.pone.0105103	http://dx.doi.org/10.1371/journal.pone.0105103			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133579	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000341302700072
J	Zhang, P; Xi, M; Zhao, L; Shen, JX; Li, QQ; He, LR; Liu, SL; Liu, MZ				Zhang, Peng; Xi, Mian; Zhao, Lei; Shen, Jing-Xian; Li, Qiao-Qiao; He, Li-Ru; Liu, Shi-Liang; Liu, Meng-Zhong			Is There a Benefit in Receiving Concurrent Chemoradiotherapy for Elderly Patients with Inoperable Thoracic Esophageal Squamous Cell Carcinoma?	PLOS ONE			English	Article							DEFINITIVE CHEMORADIOTHERAPY; PROGNOSTIC-FACTORS; CANCER; CHEMORADIATION; OLDER; OUTCOMES; ADENOCARCINOMA; COMPLICATIONS; CHEMOTHERAPY; RADIOTHERAPY	Background and purpose: The benefit of concurrent chemoradiotherapy (CCRT) in elderly patients with inoperable esophageal squamous cell carcinoma (SCC) is controversial. This study aimed to assess the efficiency and safety of CCRT in elderly thoracic esophageal cancer patients. Methods and materials: Between January 2002 and December 2011, 128 patients aged 65 years or older treated with CCRT or radiotherapy (RT) alone for inoperable thoracic esophageal SCC were analyzed retrospectively (RT alone, n = 55; CCRT, n = 73). Results: No treatment-related deaths occurred and no patients experienced any acute grade 4 non-hematologic toxicities. Patients treated with CCRT developed more severe acute toxicities than patients who received RT alone. The 3-year overall survival (OS) rate was 36.1% for CCRT compared with 28.5% following RT alone (p = 0.008). Multivariate analysis identified T stage and treatment modality as independent prognostic factors for survival. Further analysis revealed that survival was significantly better in the CCRT group than in the RT alone group for patients <= 72 years. Nevertheless, the CCRT group had a similar OS to the RT group for patients > 72 years. Conclusion: Our results suggest that elderly patients with inoperable thoracic esophageal SCC could benefit from CCRT, without major toxicities. However, for patients older than 72 years, CCRT is not superior to RT alone in terms of survival benefit.	[Zhang, Peng; Xi, Mian; Zhao, Lei; Li, Qiao-Qiao; He, Li-Ru; Liu, Shi-Liang; Liu, Meng-Zhong] Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, Dept Radiat Oncol,State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China; [Shen, Jing-Xian] Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, Imaging Diag & Intervent Ctr,State Key Lab Oncol, Guangzhou 510275, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University	Liu, MZ (corresponding author), Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, Dept Radiat Oncol,State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China.	liumengzhong@126.com			Sci-Tech Project Foundation of Guangdong Province [42012B031800287]	Sci-Tech Project Foundation of Guangdong Province	This work was supported by the grant from the Sci-Tech Project Foundation of Guangdong Province (No.42012B031800287). Website: http://www.gdstc.gov.cn. PZ and MX received the funding. The funders provided help in data collection and analysis.	Anderson SE, 2007, BRIT J CANCER, V96, P1823, DOI 10.1038/sj.bjc.6603821; Eloubeidi MA, 2002, CANCER-AM CANCER SOC, V95, P1434, DOI 10.1002/cncr.10868; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Go SI, 2012, TUMORI, V98, P225, DOI 10.1700/1088.11934; Gockel I, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-114; HERSKOVIC A, 1992, NEW ENGL J MED, V326, P1593, DOI 10.1056/NEJM199206113262403; HISHIKAWA Y, 1991, INT J RADIAT ONCOL, V20, P685, DOI 10.1016/0360-3016(91)90009-S; Hsu FM, 2008, J SURG ONCOL, V98, P34, DOI 10.1002/jso.21063; Kinugasa S, 2001, ANN THORAC SURG, V71, P414, DOI 10.1016/S0003-4975(00)02333-X; Lagarde SM, 2006, J CLIN ONCOL, V24, P4347, DOI 10.1200/JCO.2005.04.9445; Law S, 2004, ANN SURG, V240, P791, DOI 10.1097/01.sla.0000143123.24556.1c; Li QQ, 2010, DIS ESOPHAGUS, V23, P253, DOI 10.1111/j.1442-2050.2009.01003.x; Liu H, 2011, RADIOTHER ONCOL, V99, P181, DOI 10.1016/j.radonc.2011.05.011; Mak RH, 2010, DIS ESOPHAGUS, V23, P316, DOI 10.1111/j.1442-2050.2009.01014.x; Morota M, 2009, INT J RADIAT ONCOL, V75, P122, DOI 10.1016/j.ijrobp.2008.10.075; Nallapareddy S, 2005, ANTICANCER RES, V25, P3055; Reid BC, 2001, CANCER, V92, P2109, DOI 10.1002/1097-0142(20011015)92:8<2109::AID-CNCR1552>3.0.CO;2-M; Sabel MS, 2002, ANN SURG ONCOL, V9, P210, DOI 10.1007/BF02557376; Semrau R, 2012, STRAHLENTHER ONKOL, V188, P226, DOI 10.1007/s00066-011-0039-2; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Steyerberg EW, 2007, J CLIN ONCOL, V25, P2389, DOI 10.1200/JCO.2006.09.7931; Takeuchi S, 2007, AM J CLIN ONCOL-CANC, V30, P607, DOI 10.1097/COC.0b013e3180ca7c84; Tougeron D, 2008, BRIT J CANCER, V99, P1586, DOI 10.1038/sj.bjc.6604749; Tougeron D, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-510; Trumper M, 2006, EUR J CANCER, V42, P827, DOI 10.1016/j.ejca.2005.08.044; Wu Sen, 2012, Zhonghua Zhong Liu Za Zhi, V34, P873, DOI 10.3760/cma.j.issn.0253-3766.2012.11.017; Xu HY, 2014, ONCOL LETT, V7, P260, DOI 10.3892/ol.2013.1694; YAMAKAWA M, 1994, INT J RADIAT ONCOL, V30, P1225, DOI 10.1016/0360-3016(94)90333-6	28	25	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105270	10.1371/journal.pone.0105270	http://dx.doi.org/10.1371/journal.pone.0105270			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133495	Green Submitted, gold, Green Published			2022-12-25	WOS:000341302700094
J	Farrell, JD; Byrne, S; Paina, C; Asp, T				Farrell, Jacqueline D.; Byrne, Stephen; Paina, Cristiana; Asp, Torben			De Novo Assembly of the Perennial Ryegrass Transcriptome Using an RNA-Seq Strategy	PLOS ONE			English	Article							HKT TRANSPORTERS; SIGNALING PEPTIDES; KEY DETERMINANTS; SALT TOLERANCE; WEB SERVER; ALIGNMENT; ROOT; DISCOVERY; REVEALS; GENES	Background: Perennial ryegrass is a highly heterozygous outbreeding grass species used for turf and forage production. Heterozygosity can affect de-Bruijn graph assembly making de novo transcriptome assembly of species such as perennial ryegrass challenging. Creating a reference transcriptome from a homozygous perennial ryegrass genotype can circumvent the challenge of heterozygosity. The goals of this study were to perform RNA-sequencing on multiple tissues from a highly inbred genotype to develop a reference transcriptome. This was complemented with RNA-sequencing of a highly heterozygous genotype for SNP calling. Result: De novo transcriptome assembly of the inbred genotype created 185,833 transcripts with an average length of 830 base pairs. Within the inbred reference transcriptome 78,560 predicted open reading frames were found of which 24,434 were predicted as complete. Functional annotation found 50,890 transcripts with a BLASTp hit from the Swiss-Prot non-redundant database, 58,941 transcripts with a Pfam protein domain and 1,151 transcripts encoding putative secreted peptides. To evaluate the reference transcriptome we targeted the high-affinity K+ transporter gene family and found multiple orthologs. Using the longest unique open reading frames as the reference sequence, 64,242 single nucleotide polymorphisms were found. One thousand sixty one open reading frames from the inbred genotype contained heterozygous sites, confirming the high degree of homozygosity. Conclusion: Our study has developed an annotated, comprehensive transcriptome reference for perennial ryegrass that can aid in determining genetic variation, expression analysis, genome annotation, and gene mapping.	[Farrell, Jacqueline D.; Byrne, Stephen; Paina, Cristiana; Asp, Torben] Aarhus Univ, Res Ctr Flakkebjerg, Dept Mol Biol & Genet, Slagelse, Denmark	Aarhus University	Asp, T (corresponding author), Aarhus Univ, Res Ctr Flakkebjerg, Dept Mol Biol & Genet, Slagelse, Denmark.	Torben.Asp@agrsci.dk	Byrne, Stephen/L-3572-2019	Byrne, Stephen/0000-0002-1179-2272; Campbell, Jacqueline D/0000-0003-2787-3955; Paina, Cristiana/0000-0001-7124-1280	The Danish Council for Independent Research [09-070323]	The Danish Council for Independent Research	The research was supported by a grant from The Danish Council for Independent Research, grant number 09-070323. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amrutha RN, 2007, PLANT SCI, V172, P708, DOI 10.1016/j.plantsci.2006.11.019; Annadurai RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056217; Ashraf M, 2013, PLANT BREEDING, V132, P10, DOI 10.1111/pbr.12000; Bafeel S. O., 2013, International Journal of Biology, V5, P64; Bao H, 2009, BIOINFORMATICS, V25, P1554, DOI 10.1093/bioinformatics/btp255; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Chen WH, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-320; CORNISH MA, 1979, HEREDITY, V43, P95, DOI 10.1038/hdy.1979.63; Corratge-Faillie C, 2010, CELL MOL LIFE SCI, V67, P2511, DOI 10.1007/s00018-010-0317-7; Crawford JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014202; de Carvalho JF, 2013, HEREDITY, V110, P181, DOI 10.1038/hdy.2012.76; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Fernandez A, 2013, PLANT PHYSIOL, V161, P954, DOI 10.1104/pp.112.206029; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Fu N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057686; Garciadeblas B, 2003, PLANT J, V34, P788, DOI 10.1046/j.1365-313X.2003.01764.x; Gil P, 2001, GENE DEV, V15, P1985, DOI 10.1101/gad.905201; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Gordo SMC, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-168; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guo XL, 2013, PLANTA, V237, P1135, DOI 10.1007/s00425-012-1834-4; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hansey CN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033071; Haro R, 2010, PLANT CELL PHYSIOL, V51, P68, DOI 10.1093/pcp/pcp168; Henry RJ, 2012, J BIOSCIENCES, V37, P829, DOI 10.1007/s12038-012-9253-z; Higashiyama T, 2010, PLANT CELL PHYSIOL, V51, P177, DOI 10.1093/pcp/pcq008; Horie T, 2001, PLANT J, V27, P129, DOI 10.1046/j.1365-313x.2001.01077.x; Hu ZL, 2008, ONLINE J BIOINFORMAT, V9, P108, DOI DOI 10.1186/1471-2105-13-134; Huang LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038653; Huang S, 2008, J EXP BOT, V59, P927, DOI 10.1093/jxb/ern033; Jensen LB, 2005, THEOR APPL GENET, V110, P527, DOI 10.1007/s00122-004-1865-8; Katsir L, 2011, CURR BIOL, V21, pR356, DOI 10.1016/j.cub.2011.03.012; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lease KA, 2006, PLANT PHYSIOL, V142, P831, DOI 10.1104/pp.106.086041; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li D, 2012, BMC GENOMICS, V13, P1; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lv HX, 2013, GENOMICS, V101, P229, DOI 10.1016/j.ygeno.2013.01.004; Maser P, 2002, P NATL ACAD SCI USA, V99, P6428, DOI 10.1073/pnas.082123799; Matsuzaki Y, 2010, SCIENCE, V329, P1065, DOI 10.1126/science.1191132; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; McNally KL, 2009, P NATL ACAD SCI USA, V106, P12273, DOI 10.1073/pnas.0900992106; Meng L, 2012, PLANT SCI, V183, P106, DOI 10.1016/j.plantsci.2011.10.020; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; Mizrachi E, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-681; Munns R, 2005, NEW PHYTOL, V167, P645, DOI 10.1111/j.1469-8137.2005.01487.x; Murphy E, 2012, PLANT CELL, V24, P3198, DOI 10.1105/tpc.112.099010; Penn O, 2010, NUCLEIC ACIDS RES, V38, pW23, DOI 10.1093/nar/gkq443; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Platten JD, 2006, TRENDS PLANT SCI, V11, P372, DOI 10.1016/j.tplants.2006.06.001; Rafalski A, 2002, CURR OPIN PLANT BIOL, V5, P94, DOI 10.1016/S1369-5266(02)00240-6; Rengasamy P, 2006, J EXP BOT, V57, P1017, DOI 10.1093/jxb/erj108; Rismani-Yazdi H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-148; Ruttink T, 2013, PLANT BIOTECHNOL J, V11, P605, DOI 10.1111/pbi.12051; Schejbel B, 2008, PLANT BREEDING, V127, P368, DOI 10.1111/j.1439-0523.2007.01477.x; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Seeb JE, 2011, MOL ECOL RESOUR, V11, P1, DOI 10.1111/j.1755-0998.2010.02979.x; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Sparks E, 2013, NAT REV GENET, V14, P631, DOI 10.1038/nrg3541; Studer B, 2008, THEOR APPL GENET, V117, P781, DOI 10.1007/s00122-008-0819-y; Studer B, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-140; Studer B, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-177; Studer B, 2009, MOL BREEDING, V24, P191, DOI 10.1007/s11032-009-9291-x; Treangen TJ, 2012, NAT REV GENET, V13, P36, DOI 10.1038/nrg3117; Uozumi N, 2000, PLANT PHYSL; Van Belleghem SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042605; Van Verk MC, 2013, TRENDS PLANT SCI, V18, P175, DOI 10.1016/j.tplants.2013.02.001; Waters S, 2013, INT J MOL SCI, V14, P7660, DOI 10.3390/ijms14047660; WILKINS PW, 1991, EUPHYTICA, V52, P201, DOI 10.1007/BF00029397; Wu ZQ, 2012, MOL PHYLOGENET EVOL, V62, P573, DOI 10.1016/j.ympev.2011.10.019; Yamada M, 2013, CURR OPIN PLANT BIOL, V16, P56, DOI 10.1016/j.pbi.2012.11.004; Yazawa T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062460; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zerbino DR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008407; Zhang JA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-90; Zhao SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0078644; Zhu S, 2013, GENE, V519, P238, DOI 10.1016/j.gene.2013.02.023	79	41	43	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e103567	10.1371/journal.pone.0103567	http://dx.doi.org/10.1371/journal.pone.0103567			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126744	Green Published, Green Submitted, gold			2022-12-25	WOS:000340879300007
J	Chang, ML; Tsou, YK; Hu, TH; Lin, CH; Lin, WR; Sung, CM; Chen, TH; Cheng, ML; Chang, KC; Chiu, CT; Yeh, CT; Pang, JHS; Shiao, MS				Chang, Ming-Ling; Tsou, Yung-Kuan; Hu, Tsung-Hui; Lin, Cheng-Hui; Lin, Wey-Ran; Sung, Chang-Mu; Chen, Tsung-Hsing; Cheng, Mei-Ling; Chang, Kuo-Chin; Chiu, Cheng-Tang; Yeh, Chau-Ting; Pang, Jong-Hwei Su; Shiao, Ming-Shi			Distinct Patterns of the Lipid Alterations between Genotype 1 and 2 Chronic Hepatitis C Patients after Viral Clearance	PLOS ONE			English	Article							SUSTAINED VIROLOGICAL RESPONSE; INSULIN-RESISTANCE; METABOLIC SYNDROME; VIRUS-INFECTION; GLUCOSE ABNORMALITIES; INTERFERON THERAPY; RIBAVIRIN THERAPY; CHOLESTEROL; PEGINTERFERON; ASSOCIATIONS	Background: The hepatitis C virus (HCV) genotype-specific impacts on the host metabolic alterations remained inconclusive. Methods: A prospective study including 229 (118 genotype 1 (G1) and 111 G2) consecutive chronic HCV patients who had completed a course of anti-HCV treatment and underwent pre- and 24 weeks post-treatment surveys of metabolic profiles was conducted. Patients were stratified according to the therapeutic response, viral genotype and baseline insulin resistance (IR: homeostasis model assessments of IR (HOMA-IR) >= 2.5). Paired t-tests were used to compare the pre- and post-treatment variables. Results: Significant post-therapeutic increases in cholesterol, triglyceride, HDL, LDL, apolipoprotein A1 and apolipoprotein B were observed in patients with sustained virological response (SVR) but not in those without. Among those with SVR, post-therapeutic increases in HDL (p < 0.001) and apolipoprotein A1 (p = 0.012) were only found in G2, whereas increased triglyceride/HDL (p = 0.01) ratios were only found in G1 patients. When stratified by baseline IR among those with SVR, a significant increase in post-treatment HDL (p = 0.019) and apolipoprotein A1 (p = 0.012) but a decrease in HOMA-IR (p = 0.04), C-peptide (p = 0.019) and hemoglobin A1c (p = 0.047) were found in patients with baseline IR; a significant increase in HOMA-IR (p = 0.002) was found in patients without baseline IR. The latter change was observed only in G1 (p = 0.01) but not G2 patients. Although the pre-treatment metabolic profiles of G1 and G2 patients were indifferent, G1 had higher post-treatment triglyceride/HDL ratios (p = 0.041) and triglyceride (p = 0.044) levels than G2 patients. Conclusions: G2 benefit more than G1 patients from viral clearance in metabolic alterations, particularly in those without baseline IR.	[Chang, Ming-Ling; Tsou, Yung-Kuan; Lin, Cheng-Hui; Lin, Wey-Ran; Sung, Chang-Mu; Chen, Tsung-Hsing; Chiu, Cheng-Tang; Yeh, Chau-Ting] Chang Gung Mem Hosp, Dept Gastroenterol & Hepatol, Div Hepatol, Liver Res Ctr, Taoyuan, Taiwan; [Chang, Ming-Ling; Pang, Jong-Hwei Su] Chang Gung Univ, Grad Inst Clin Med Sci, Taoyuan, Taiwan; [Hu, Tsung-Hui; Chang, Kuo-Chin] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Hepatogastroenterol, Kaohsiung, Taiwan; [Hu, Tsung-Hui; Chang, Kuo-Chin] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Cheng, Mei-Ling; Shiao, Ming-Shi] Chang Gung Mem Hosp, Dept Lab Med, Linkou, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital	Chang, ML (corresponding author), Chang Gung Mem Hosp, Dept Gastroenterol & Hepatol, Div Hepatol, Liver Res Ctr, Taoyuan, Taiwan.	mlchang8210@gmail.com	Tsou, Yung-Kuan/AAE-8049-2022	PANG, JONG-HWEI/0000-0003-3432-0208	Chang Gung Medical Research Program [CMRPG380353, CMRPG3B1251, CMRPG3B1252, CMRPG 3B0401, CMRPG3B1741, XMRPG3A0521]; National Science Council, Taiwan [100-2314-B-182-069-, 101-2314-B-182-083-, 102-2628-B-182 -021 -MY3]; Investigator Initiated Studies Program of Merck Sharp Dohme Corp	Chang Gung Medical Research Program; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Investigator Initiated Studies Program of Merck Sharp Dohme Corp	This work was funded by grants from the Chang Gung Medical Research Program (CMRPG380353, CMRPG3B1251, CMRPG3B1252, CMRPG 3B0401, CMRPG3B1741 and XMRPG3A0521), the National Science Council, Taiwan (100-2314-B-182-069-, 101-2314-B-182-083- and 102-2628-B-182 -021 -MY3), and in part by a research grant from the Investigator Initiated Studies Program of Merck Sharp & Dohme Corp to M.L.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The opinions expressed in this paper are those of the authors and do not necessarily represent those of Merck Sharp & Dohme Corp.	Aghemo A, 2012, HEPATOLOGY, V56, P1681, DOI 10.1002/hep.25867; Andre P, 2005, SEMIN LIVER DIS, V25, P93, DOI 10.1055/s-2005-864785; Arase Y, 2009, HEPATOLOGY, V49, P739, DOI 10.1002/hep.22703; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Corey KE, 2009, HEPATOLOGY, V50, P1030, DOI 10.1002/hep.23219; Dai CY, 2008, J HEPATOL, V49, P9, DOI 10.1016/j.jhep.2008.03.016; Guiltinan AM, 2008, AM J EPIDEMIOL, V167, P743, DOI 10.1093/aje/kwm370; Hamamoto S, 2005, J GASTROEN HEPATOL, V20, P204, DOI 10.1111/j.1440-1746.2004.03526.x; Hamer OW, 2006, RADIOGRAPHICS, V26, P1637, DOI 10.1148/rg.266065004; Harrison SA, 2010, HEPATOLOGY, V52, P864, DOI 10.1002/hep.23787; Hsu CS, 2013, ALIMENT PHARM THER, V38, P415, DOI 10.1111/apt.12391; Hsu CS, 2009, AM J GASTROENTEROL, V104, P598, DOI 10.1038/ajg.2008.125; Hsu YC, 2014, HEPATOLOGY, V59, P1293, DOI 10.1002/hep.26892; Huang CF, 2012, ANTIVIR RES, V93, P239, DOI 10.1016/j.antiviral.2011.12.002; Huang JF, 2013, KAOHSIUNG J MED SCI, V29, P61, DOI 10.1016/j.kjms.2012.11.001; Huang JF, 2012, LIVER INT, V32, P962, DOI 10.1111/j.1478-3231.2012.02771.x; Jan CF, 2006, INT J OBESITY, V30, P794, DOI 10.1038/sj.ijo.0803204; Kang GH, 2011, J MAGN RESON IMAGING, V34, P928, DOI 10.1002/jmri.22701; Kawamoto R, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-79; Kocelak P, 2012, MINERVA ENDOCRINOL, V32, P247; Kono Y, 2003, J MED VIROL, V70, P42, DOI 10.1002/jmv.10372; Kuo YH, 2011, J FORMOS MED ASSOC, V110, P363, DOI 10.1016/S0929-6646(11)60054-5; Lee MH, 2011, GUT, V60, P688, DOI 10.1136/gut.2010.220889; LIAW YF, 1988, HEPATOLOGY, V8, P493, DOI 10.1002/hep.1840080310; Lin CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018322; Lin ZH, 2011, HEPATOLOGY, V53, P726, DOI 10.1002/hep.24105; Negro F, 2006, J HEPATOL, V45, P514, DOI 10.1016/j.jhep.2006.07.011; Negro F, 2010, GUT, V59, P1279, DOI 10.1136/gut.2009.192732; Nissen SE, 2005, NEW ENGL J MED, V352, P29, DOI 10.1056/NEJMoa042000; Petta S, 2013, CLIN GASTROENTEROL H, V11, P311, DOI 10.1016/j.cgh.2012.11.022; Prasad H, 2012, POSTGRAD MED, V124, P21, DOI 10.3810/pgm.2012.01.2514; Prati D, 2006, J HEPATOL, V44, P679, DOI 10.1016/j.jhep.2006.01.004; Ramcharran D, 2010, HEPATOLOGY, V52, P854, DOI 10.1002/hep.23796; Rashid S, 2002, J DIABETES COMPLICAT, V16, P24, DOI 10.1016/S1056-8727(01)00191-X; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Su TH, 2013, P NATL ACAD SCI USA, V110, P7844, DOI 10.1073/pnas.1306138110; Syed GH, 2010, TRENDS ENDOCRIN MET, V21, P33, DOI 10.1016/j.tem.2009.07.005; Thompson AJ, 2012, GUT, V61, P128, DOI 10.1136/gut.2010.236158; Tillmann HL, 2011, J HEPATOL, V55, P1195, DOI 10.1016/j.jhep.2011.03.015; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Yu ML, 2001, J MED VIROL, V65, P58, DOI 10.1002/jmv.2001	42	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104783	10.1371/journal.pone.0104783	http://dx.doi.org/10.1371/journal.pone.0104783			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122116	gold, Green Submitted, Green Published			2022-12-25	WOS:000341017000061
J	Kawagoshi, T; Uno, Y; Nishida, C; Matsuda, Y				Kawagoshi, Taiki; Uno, Yoshinobu; Nishida, Chizuko; Matsuda, Yoichi			The Staurotypus Turtles and Aves Share the Same Origin of Sex Chromosomes but Evolved Different Types of Heterogametic Sex Determination	PLOS ONE			English	Article							MICROCHROMOSOME SYSTEM; GENE DMRT1; EVOLUTION; BIRD; TESTUDINES; HOMOLOGY; INSIGHTS; OSTRICH	Reptiles have a wide diversity of sex-determining mechanisms and types of sex chromosomes. Turtles exhibit temperature-dependent sex determination and genotypic sex determination, with male heterogametic (XX/XY) and female heterogametic (ZZ/ZW) sex chromosomes. Identification of sex chromosomes in many turtle species and their comparative genomic analysis are of great significance to understand the evolutionary processes of sex determination and sex chromosome differentiation in Testudines. The Mexican giant musk turtle (Staurotypus triporcatus, Kinosternidae, Testudines) and the giant musk turtle (Staurotypus salvinii) have heteromorphic XY sex chromosomes with a low degree of morphological differentiation; however, their origin and linkage group are still unknown. Cross-species chromosome painting with chromosome-specific DNA from Chinese soft-shelled turtle (Pelodiscus sinensis) revealed that the X and Y chromosomes of S. triporcatus have homology with P. sinensis chromosome 6, which corresponds to the chicken Z chromosome. We cloned cDNA fragments of S. triporcatus homologs of 16 chicken Z-linked genes and mapped them to S. triporcatus and S. salvinii chromosomes using fluorescence in situ hybridization. Sixteen genes were localized to the X and Y long arms in the same order in both species. The orders were also almost the same as those of the ostrich (Struthio camelus) Z chromosome, which retains the primitive state of the avian ancestral Z chromosome. These results strongly suggest that the X and Y chromosomes of Staurotypus turtles are at a very early stage of sex chromosome differentiation, and that these chromosomes and the avian ZW chromosomes share the same origin. Nonetheless, the turtles and birds acquired different systems of heterogametic sex determination during their evolution.	[Kawagoshi, Taiki; Uno, Yoshinobu; Matsuda, Yoichi] Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Lab Anim Genet, Nagoya, Aichi 4648601, Japan; [Nishida, Chizuko] Hokkaido Univ, Fac Sci, Dept Nat Hist Sci, Sapporo, Hokkaido 060, Japan; [Matsuda, Yoichi] Nagoya Univ, Grad Sch Bioagr Sci, Avian Biosci Res Ctr, Nagoya, Aichi 4648601, Japan	Nagoya University; Hokkaido University; Nagoya University	Matsuda, Y (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Lab Anim Genet, Nagoya, Aichi 4648601, Japan.	yoimatsu@agr.nagoya-u.ac.jp		Uno, Yoshinobu/0000-0001-9609-1186	Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan [23113004, 22370081]	Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by Grants-in-Aid for Scientific Research on Innovative Areas (No. 23113004) and Scientific Research (B) ( No. 22370081) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfoldi J, 2011, NATURE, V477, P587, DOI 10.1038/nature10390; Badenhorst D, 2013, CHROMOSOME RES, V21, P137, DOI 10.1007/s10577-013-9343-2; BULL JJ, 1974, CYTOGENET CELL GENET, V13, P419, DOI 10.1159/000130295; Ezaz T, 2006, CHROMOSOME RES, V14, P139, DOI 10.1007/s10577-006-1029-6; Ezaz T, 2009, CYTOGENET GENOME RES, V127, P249, DOI 10.1159/000300507; HOWELL WM, 1980, EXPERIENTIA, V36, P1014, DOI 10.1007/BF01953855; Ishijima J, 2014, CYTOGENET GENOME RES, V142, P255, DOI 10.1159/000362479; Iverson JB, 2013, MOL PHYLOGENET EVOL, V69, P929, DOI 10.1016/j.ympev.2013.06.011; Janzen FJ, 2006, J EVOLUTION BIOL, V19, P1775, DOI 10.1111/j.1420-9101.2006.01138.x; Kasai F, 2012, CYTOGENET GENOME RES, V136, P303, DOI 10.1159/000338111; Kawagoshi T, 2009, CYTOGENET GENOME RES, V125, P125, DOI 10.1159/000227837; Kawagoshi T, 2012, CHROMOSOME RES, V20, P95, DOI 10.1007/s10577-011-9267-7; Kawai A, 2007, CYTOGENET GENOME RES, V117, P92, DOI 10.1159/000103169; Kawai A, 2009, CHROMOSOMA, V118, P43, DOI 10.1007/s00412-008-0176-2; Kumazawa Y, 1999, MOL BIOL EVOL, V16, P784, DOI 10.1093/oxfordjournals.molbev.a026163; Martinez PA, 2008, CHROMOSOME RES, V16, P815, DOI 10.1007/s10577-008-1228-4; Matsubara K, 2003, CHROMOSOME RES, V11, P57, DOI 10.1023/A:1022010116287; Matsubara K, 2006, P NATL ACAD SCI USA, V103, P18190, DOI 10.1073/pnas.0605274103; MATSUDA Y, 1995, ELECTROPHORESIS, V16, P261, DOI 10.1002/elps.1150160142; Matsuda Y, 2005, CHROMOSOME RES, V13, P601, DOI 10.1007/s10577-005-0986-5; Nanda I, 2000, CYTOGENET CELL GENET, V89, P67, DOI 10.1159/000015567; Nishida-Umehara C, 2007, CHROMOSOME RES, V15, P721, DOI 10.1007/s10577-007-1157-7; O'Meally D, 2012, CHROMOSOME RES, V20, P7, DOI 10.1007/s10577-011-9266-8; Ogawa A, 1998, P NATL ACAD SCI USA, V95, P4415, DOI 10.1073/pnas.95.8.4415; Organ CL, 2008, INTEGR COMP BIOL, V48, P512, DOI 10.1093/icb/icn041; Pokorna M, 2009, ZOOL J LINN SOC-LOND, V156, P168, DOI 10.1111/j.1096-3642.2008.00481.x; Rest JS, 2003, MOL PHYLOGENET EVOL, V29, P289, DOI 10.1016/S1055-7903(03)00108-8; Shetty S, 2002, CYTOGENET GENOME RES, V99, P245, DOI 10.1159/000071600; SITES JW, 1979, SCIENCE, V206, P1410, DOI 10.1126/science.92052; Smith CA, 2009, NATURE, V461, P267, DOI 10.1038/nature08298; SUMNER AT, 1972, EXP CELL RES, V75, P304, DOI 10.1016/0014-4827(72)90558-7; Tsuda Y, 2007, CHROMOSOMA, V116, P159, DOI 10.1007/s00412-006-0088-y; Uno Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053027; Valenzuela N., 2004, TEMPERATURE DEPENDEN; Valenzuela N, 2011, EVOLUTION, V65, P1808, DOI 10.1111/j.1558-5646.2011.01258.x; Vitt LJ, 2013, HERPETOLOGY INTRO BI; VOGT RC, 1992, HERPETOLOGICA, V48, P265; Wang Z, 2013, NAT GENET, V45, P701, DOI 10.1038/ng.2615; Yoshimoto S, 2008, P NATL ACAD SCI USA, V105, P2469, DOI 10.1073/pnas.0712244105; Young MJ, 2013, CHROMOSOME RES, V21, P361, DOI 10.1007/s10577-013-9362-z	40	32	33	0	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e105315	10.1371/journal.pone.0105315	http://dx.doi.org/10.1371/journal.pone.0105315			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121779	Green Submitted, Green Published, gold			2022-12-25	WOS:000341017000115
J	McDowell, IC; Nikapitiya, C; Aguiar, D; Lane, CE; Istrail, S; Gomez-Chiarri, M				McDowell, Ian C.; Nikapitiya, Chamilani; Aguiar, Derek; Lane, Christopher E.; Istrail, Sorin; Gomez-Chiarri, Marta			Transcriptome of American Oysters, Crassostrea virginica, in Response to Bacterial Challenge: Insights into Potential Mechanisms of Disease Resistance	PLOS ONE			English	Article							RNA-SEQ DATA; EASTERN OYSTERS; ROSEOVARIUS-CRASSOSTREAE; DIFFERENTIAL EXPRESSION; STAPHYLOCOCCUS-AUREUS; BIOMPHALARIA-GLABRATA; IMMUNE-RESPONSE; INNATE IMMUNITY; VIBRIO-TAPETIS; SHELL MATRIX	The American oyster Crassostrea virginica, an ecologically and economically important estuarine organism, can suffer high mortalities in areas in the Northeast United States due to Roseovarius Oyster Disease ( ROD), caused by the gram-negative bacterial pathogen Roseovarius crassostreae. The goals of this research were to provide insights into: 1) the responses of American oysters to R. crassostreae, and 2) potential mechanisms of resistance or susceptibility to ROD. The responses of oysters to bacterial challenge were characterized by exposing oysters from ROD-resistant and susceptible families to R. crassostreae, followed by high-throughput sequencing of cDNA samples from various timepoints after disease challenge. Sequence data was assembled into a reference transcriptome and analyzed through differential gene expression and functional enrichment to uncover genes and processes potentially involved in responses to ROD in the American oyster. While susceptible oysters experienced constant levels of mortality when challenged with R. crassostreae, resistant oysters showed levels of mortality similar to non-challenged oysters. Oysters exposed to R. crassostreae showed differential expression of transcripts involved in immune recognition, signaling, protease inhibition, detoxification, and apoptosis. Transcripts involved in metabolism were enriched in susceptible oysters, suggesting that bacterial infection places a large metabolic demand on these oysters. Transcripts differentially expressed in resistant oysters in response to infection included the immune modulators IL-17 and arginase, as well as several genes involved in extracellular matrix remodeling. The identification of potential genes and processes responsible for defense against R. crassostreae in the American oyster provides insights into potential mechanisms of disease resistance.	[McDowell, Ian C.; Nikapitiya, Chamilani; Lane, Christopher E.; Gomez-Chiarri, Marta] Univ Rhode Isl, Coll Environm & Life Sci, Kingston, RI 02881 USA; [Aguiar, Derek; Istrail, Sorin] Brown Univ, Dept Comp Sci, Providence, RI 02912 USA; [Aguiar, Derek; Istrail, Sorin] Brown Univ, Ctr Computat Mol Biol, Providence, RI 02912 USA	University of Rhode Island; Brown University; Brown University	Gomez-Chiarri, M (corresponding author), Univ Rhode Isl, Coll Environm & Life Sci, Kingston, RI 02881 USA.	gomezchi@mail.uri.edu	Aguiar, Derek/AAT-6242-2020	Aguiar, Derek/0000-0001-9166-8783; Nikapitiya, Chamilani/0000-0001-6273-9271; Gomez-Chiarri, Marta/0000-0002-2576-9612	USDA NIFA AFRI [2009-38925-19971]; Rhode Island Agricultural Experiment Station [Hatch13 901-INT]; RI-NSF EPSCoR [0554548]; NSF [1048831, 1321000]	USDA NIFA AFRI(United States Department of Agriculture (USDA)); Rhode Island Agricultural Experiment Station; RI-NSF EPSCoR; NSF(National Science Foundation (NSF))	This research has been funded by USDA NIFA AFRI award 2009-38925-19971 to MGC, CEL, and DP, Rhode Island Agricultural Experiment Station Hatch13 901-INT to MGC, CEL, and RR, and RI-NSF EPSCoR grant no. 0554548. Work by DA and SI was funded by NSF awards 1048831 and 1321000 to SI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adema CM, 2010, MOL IMMUNOL, V47, P849, DOI 10.1016/j.molimm.2009.10.019; Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Allam B, 2006, FISH SHELLFISH IMMUN, V20, P374, DOI 10.1016/j.fsi.2005.05.012; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barber BJ, 1998, J SHELLFISH RES, V17, P1171; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boardman CL, 2008, J INVERTEBR PATHOL, V97, P150, DOI 10.1016/j.jip.2007.08.007; Boettcher KJ, 2000, APPL ENVIRON MICROB, V66, P3924, DOI 10.1128/AEM.66.9.3924-3930.2000; Boettcher KJ, 2005, INT J SYST EVOL MICR, V55, P1531, DOI 10.1099/ijs.0.63620-0; Borrego JJ, 1996, AQUAT LIVING RESOUR, V9, P125, DOI 10.1051/alr:1996016; Bricelj V. Monica, 1992, Journal of Shellfish Research, V11, P331; Brulle F, 2012, DEV COMP IMMUNOL, V38, P368, DOI 10.1016/j.dci.2012.03.003; Cancela ML, 2010, INTRODUCTION TO MARINE GENOMICS, P213, DOI 10.1007/978-90-481-8639-6_7; Canton J, 2013, NAT REV IMMUNOL, V13, P621, DOI 10.1038/nri3515; Carland TM, 2010, DEV COMP IMMUNOL, V34, P785, DOI 10.1016/j.dci.2010.02.014; Chang CI, 1998, AM J PHYSIOL-HEART C, V274, pH342, DOI 10.1152/ajpheart.1998.274.1.H342; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; David E, 2005, FEBS J, V272, P5635, DOI 10.1111/j.1742-4658.2005.04960.x; Davis CV, 1999, AQUACULTURE, V178, P253, DOI 10.1016/S0044-8486(99)00135-0; de Lorgeril J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023142; Dheilly NM, 2011, J INVERTEBR PATHOL, V106, P223, DOI 10.1016/j.jip.2010.09.008; Donaghy L, 2009, AQUACULTURE, V297, P10, DOI 10.1016/j.aquaculture.2009.09.003; Dower K, 2008, J IMMUNOL, V180, P3520, DOI 10.4049/jimmunol.180.5.3520; Dunn JR, 2006, BRIT J CANCER, V94, P1186, DOI 10.1038/sj.bjc.6603006; Egging D, 2007, ARCH DERMATOL RES, V298, P389, DOI 10.1007/s00403-006-0706-9; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Fleury E, 2010, MAR BIOTECHNOL, V12, P326, DOI 10.1007/s10126-009-9227-9; Ford SE, 2001, J INVERTEBR PATHOL, V78, P141, DOI 10.1006/jipa.2001.5052; FORD SE, 1987, J PARASITOL, V73, P368, DOI 10.2307/3282092; Ford Susan E., 1996, P581; Gaffen SL, 2011, CURR OPIN IMMUNOL, V23, P613, DOI 10.1016/j.coi.2011.07.006; Ghosh J, 2011, DEV COMP IMMUNOL, V35, P959, DOI 10.1016/j.dci.2010.12.009; Gomez-Leon J, 2008, DIS AQUAT ORGAN, V79, P95, DOI 10.3354/dao01902; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guo Ximing, 2008, V2, P163, DOI 10.1007/978-3-540-73837-4_8; Gutierrez JL, 2003, OIKOS, V101, P79, DOI 10.1034/j.1600-0706.2003.12322.x; Haag ES, 1999, DEV BIOL, V211, P77, DOI 10.1006/dbio.1999.9283; Hanington PC, 2011, J INNATE IMMUN, V3, P17, DOI 10.1159/000321882; Hertel LA, 2005, DEV COMP IMMUNOL, V29, P295, DOI 10.1016/j.dci.2004.08.003; Huang GH, 2007, DEV COMP IMMUNOL, V31, P1013, DOI 10.1016/j.dci.2007.01.003; Hughes FM, 2010, FISH SHELLFISH IMMUN, V29, P247, DOI 10.1016/j.fsi.2010.03.003; Huvet A, 2004, GENE, V343, P211, DOI 10.1016/j.gene.2004.09.008; Infante RE, 2008, P NATL ACAD SCI USA, V105, P15287, DOI 10.1073/pnas.0807328105; Ivanina AV, 2008, J EXP BIOL, V211, P577, DOI 10.1242/jeb.011262; Khokha R, 2013, NAT REV IMMUNOL, V13, P649, DOI 10.1038/nri3499; Kong PF, 2010, DEV COMP IMMUNOL, V34, P837, DOI 10.1016/j.dci.2010.03.006; Kong Y, 2011, GENOMICS, V98, P152, DOI 10.1016/j.ygeno.2011.05.009; La Peyre JF, 2010, DEV COMP IMMUNOL, V34, P84, DOI 10.1016/j.dci.2009.08.007; Lacoste A, 2001, GEN COMP ENDOCR, V122, P252, DOI 10.1006/gcen.2001.7643; LANDE R, 1990, GENETICS, V124, P743; Lang RP, 2009, MAR BIOTECHNOL, V11, P650, DOI 10.1007/s10126-009-9181-6; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lettre G, 2006, NAT REV MOL CELL BIO, V7, P97, DOI 10.1038/nrm1836; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liu L, 2011, DEV COMP IMMUNOL, V35, P227, DOI 10.1016/j.dci.2010.09.010; Loker ES, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00025; Lopez J, 2010, CURR OPIN CELL BIOL, V22, P872, DOI 10.1016/j.ceb.2010.08.025; Maloy AP, 2005, DIS AQUAT ORGAN, V67, P155, DOI 10.3354/dao067155; Manoury B, 1998, NATURE, V396, P695, DOI 10.1038/25379; Marxen JC, 2003, BBA-PROTEINS PROTEOM, V1650, P92, DOI 10.1016/S1570-9639(03)00203-6; Matussek A, 2005, SCAND J IMMUNOL, V61, P536, DOI 10.1111/j.1365-3083.2005.01597.x; Messier-Solek C, 2010, SEMIN IMMUNOL, V22, P39, DOI 10.1016/j.smim.2009.11.007; MOHANDAS A, 1985, J INVERTEBR PATHOL, V46, P189, DOI 10.1016/0022-2011(85)90148-X; Morga B, 2011, DEV COMP IMMUNOL, V35, P323, DOI 10.1016/j.dci.2010.10.005; Morita Y, 2007, FEBS LETT, V581, P1417, DOI 10.1016/j.febslet.2007.02.064; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mullner D, 2013, FASTCLUSTER FAST HIE; National Marine Fisheries Service (NMFS), 2012, ANN COMM LAND STAT F; Newell RIE, 2004, J SHELLFISH RES, V23, P51; Nitta T, 2007, TRENDS IMMUNOL, V28, P58, DOI 10.1016/j.it.2006.12.002; Ordas MC, 2000, FISH SHELLFISH IMMUN, V10, P597, DOI 10.1006/fsim.2000.0274; Ottaviani E, 1996, PROG NEUROBIOL, V48, P421, DOI 10.1016/0301-0082(95)00049-6; Quintana FJ, 2011, TRENDS IMMUNOL, V32, P89, DOI 10.1016/j.it.2010.11.001; R Core Team, 2021, R LANG ENV STAT COMP; Roberts S, 2008, DEV COMP IMMUNOL, V32, P1099, DOI 10.1016/j.dci.2008.02.006; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rosado CJ, 2008, CELL MICROBIOL, V10, P1765, DOI 10.1111/j.1462-5822.2008.01191.x; Sarashina I, 2006, J MOL EVOL, V62, P307, DOI 10.1007/s00239-005-0095-2; Sayers EW, 2012, NUCLEIC ACIDS RES, V40, pD13, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Schlicker A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-302; SHIMOYAMA Y, 1989, CANCER RES, V49, P2128; Smit A.F.A., 1996, REPEATMASTER OPEN 3 REPEATMASTER OPEN 3; Snyder MJ, 2000, AQUAT TOXICOL, V48, P529, DOI 10.1016/S0166-445X(00)00085-0; Sokolova IM, 2009, ISJ-INVERT SURVIV J, V6, P49; Sunila I, 2003, DIS AQUAT ORGAN, V56, P163, DOI 10.3354/dao056163; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Villamil L, 2007, DEV COMP IMMUNOL, V31, P968, DOI 10.1016/j.dci.2007.01.006; Wang LL, 2012, FISH SHELLFISH IMMUN, V33, P427, DOI 10.1016/j.fsi.2012.05.032; Warnes GR, 2013, GPLOTS VARIOUS R PRO; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Yang JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017089; Yu HY, 2011, FISH SHELLFISH IMMUN, V30, P757, DOI 10.1016/j.fsi.2010.12.015; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413; Zhang H, 2009, FISH SHELLFISH IMMUN, V26, P56, DOI 10.1016/j.fsi.2008.07.019; Zhang LL, 2014, MAR BIOTECHNOL, V16, P17, DOI 10.1007/s10126-013-9526-z; Zhang LL, 2011, DEV COMP IMMUNOL, V35, P603, DOI 10.1016/j.dci.2011.01.005; Zhao ZG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0045675, 10.1371/journal.pone.0046244]; Zhou Z, 2012, FISH SHELLFISH IMMUN, V33, P67, DOI 10.1016/j.fsi.2012.04.002; Zhou Z, 2011, FISH SHELLFISH IMMUN, V31, P1065, DOI 10.1016/j.fsi.2011.09.009	102	56	56	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e105097	10.1371/journal.pone.0105097	http://dx.doi.org/10.1371/journal.pone.0105097			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122115	Green Published, Green Submitted, gold			2022-12-25	WOS:000341017000096
J	An, PNT; Yamaguchi, M; Bamba, T; Fukusaki, E				Phan Nguyen Thuy An; Yamaguchi, Masamitsu; Bamba, Takeshi; Fukusaki, Eiichiro			Metabolome Analysis of Drosophila melanogaster during Embryogenesis	PLOS ONE			English	Article							MASS-SPECTROMETRY; SYSTEMATIC PREDICTION; ZEBRAFISH; CHROMATOGRAPHY; TREHALOSE; HYPOXIA; EMBRYO; GENOME	The Drosophila melanogaster embryo has been widely utilized as a model for genetics and developmental biology due to its small size, short generation time, and large brood size. Information on embryonic metabolism during developmental progression is important for further understanding the mechanisms of Drosophila embryogenesis. Therefore, the aim of this study is to assess the changes in embryos' metabolome that occur at different stages of the Drosophila embryonic development. Time course samples of Drosophila embryos were subjected to GC/MS-based metabolome analysis for profiling of low molecular weight hydrophilic metabolites, including sugars, amino acids, and organic acids. The results showed that the metabolic profiles of Drosophila embryo varied during the course of development and there was a strong correlation between the metabolome and different embryonic stages. Using the metabolome information, we were able to establish a prediction model for developmental stages of embryos starting from their high-resolution quantitative metabolite composition. Among the important metabolites revealed from our model, we suggest that different amino acids appear to play distinct roles in different developmental stages and an appropriate balance in trehalose-glucose ratio is crucial to supply the carbohydrate source for the development of Drosophila embryo.	[Phan Nguyen Thuy An; Bamba, Takeshi; Fukusaki, Eiichiro] Osaka Univ, Grad Sch Engn, Dept Biotechnol, Suita, Osaka, Japan; [Yamaguchi, Masamitsu] Kyoto Inst Technol, Insect Biomed Res Ctr, Dept Appl Biol, Sakyo Ku, Kyoto 606, Japan	Osaka University; Kyoto Institute of Technology	Fukusaki, E (corresponding author), Osaka Univ, Grad Sch Engn, Dept Biotechnol, Suita, Osaka, Japan.	fukusaki@bio.eng.osaka-u.ac.jp		THUY AN, PHAN NGUYEN/0000-0002-1438-416X; Yamaguchi, Masamitsu/0000-0002-6321-9750				Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Al Bratty M, 2011, METABOLOMICS, V7, P542, DOI 10.1007/s11306-011-0275-6; [Anonymous], 1993, 3D QSAR DRUG DESIGN; Bakovic M, 2007, BIOCHEM CELL BIOL, V85, P283, DOI 10.1139/O07-006; Bender D.A, 2012, AMINO ACID METABIS, P1; Brosnan JT, 2003, J NUTR, V133, p2068S, DOI 10.1093/jn/133.6.2068S; Chambers MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050679; Chen QF, 2004, J EXP BIOL, V207, P3125, DOI 10.1242/jeb.01133; Colinet H, 2012, FUNCT ECOL, V26, P711, DOI 10.1111/j.1365-2435.2012.01985.x; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; Everaerts C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009607; Feala JD, 2008, PROG BIOPHYS MOL BIO, V96, P209, DOI 10.1016/j.pbiomolbio.2007.07.014; Fortini ME, 2000, J CELL BIOL, V150, pF23, DOI 10.1083/jcb.150.2.F23; Gilbert S, 2000, EARLY DROSOPHILA DEV; Hammad LA, 2011, RAPID COMMUN MASS SP, V25, P2959, DOI 10.1002/rcm.5187; Hayashi S, 2011, Z NATURFORSCH C, V66, P191, DOI 10.5560/ZNC.2011.66c0191; Hayashi S, 2009, BIOCHEM BIOPH RES CO, V386, P268, DOI 10.1016/j.bbrc.2009.06.041; Heinrichsen ET, MOL METABOLISM; Howe E, 2010, BIOMEDICAL INFORMATICS FOR CANCER RESEARCH, P267, DOI 10.1007/978-1-4419-5714-6_15; Huang SM, 2013, MOL BIOSYST, V9, P1372, DOI 10.1039/c3mb25450j; Kamleh MA, 2008, FEBS LETT, V582, P2916, DOI 10.1016/j.febslet.2008.07.029; Kamleh MA, 2009, FEBS J, V276, P6798, DOI 10.1111/j.1742-4658.2009.07397.x; Kanamori Y, 2010, INSECT BIOCHEM MOLEC, V40, P30, DOI 10.1016/j.ibmb.2009.12.006; Knee JM, 2013, J CHROMATOGR B, V936, P63, DOI 10.1016/j.jchromb.2013.07.027; Kostal V, 2012, P NATL ACAD SCI USA, V109, P3270, DOI 10.1073/pnas.1119986109; Kostal V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025025; Leptin M, 1999, EMBO J, V18, P3187, DOI 10.1093/emboj/18.12.3187; Lommen A, 2007, ANAL CHIM ACTA, V584, P43, DOI 10.1016/j.aca.2006.11.018; Lommen A, 2009, ANAL CHEM, V81, P3079, DOI 10.1021/ac900036d; Malmendal A, 2006, AM J PHYSIOL-REG I, V291, pR205, DOI 10.1152/ajpregu.00867.2005; MERRILL PT, 1988, DEVELOPMENT, V104, P495; Overgaard J, 2007, J INSECT PHYSIOL, V53, P1218, DOI 10.1016/j.jinsphys.2007.06.012; Papan C, 2009, OMICS, V13, P397, DOI 10.1089/omi.2009.0023; Pedersen KS, 2008, GENETICS, V180, P1233, DOI 10.1534/genetics.108.089144; Rockstein M., 2012, BIOCH INSECTS; Sarup P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047461; Soanes KH, 2011, J PROTEOME RES, V10, P5102, DOI 10.1021/pr2005549; Tennessen JM, 2014, COORDINATED METABOLI, pG3; Tram U., 2001, CLEAVAGE GASTRULATIO; Tsugawa H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-131; Turner A., 1986, BIOCH MOL BIOL ED, V14, P46; Vastag Livia, 2011, PLoS One, V6, pe16881, DOI 10.1371/journal.pone.0016881; YAMAGUCHI M, 1991, MOL CELL BIOL, V11, P4909, DOI 10.1128/MCB.11.10.4909; YAMAGUCHI M, 1991, J CELL SCI, V100, P729; Yang B, 2012, J PHARMACEUT BIOMED, V58, P113, DOI 10.1016/j.jpba.2011.09.033; Yoshida R, 2010, AGING CELL, V9, P616, DOI 10.1111/j.1474-9726.2010.00590.x	46	22	22	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e99519	10.1371/journal.pone.0099519	http://dx.doi.org/10.1371/journal.pone.0099519			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121768	Green Published, Green Submitted, gold			2022-12-25	WOS:000341017000003
J	Mediero, A; Perez-Aso, M; Cronstein, BN				Mediero, Aranzazu; Perez-Aso, Miguel; Cronstein, Bruce N.			Activation of EPAC1/2 is essential for osteoclast formation by modulating NF kappa B nuclear translocation and actin cytoskeleton rearrangements	FASEB JOURNAL			English	Article						RhoA; cdc42; Rac1; FAK	BONE-RESORPTION; MOLECULAR-MECHANISM; RECEPTOR; DIFFERENTIATION; OSTEOPROTEGERIN; EXPRESSION; PROTEINS; CELLS; RANK; OSTEOPETROSIS	Bisphosphonates inhibit osteoclast differentiation/function via inhibition of Rap1A isoprenylation. As Rap1 is the effector of exchange protein directly activated by cAMP (EPAC) proteins, we determined the role of EPAC in osteoclast differentiation. We examined osteoclast differentiation as the number of primary murine/human bone-marrow precursors that differentiated into multinucleated TRAP-positive cells in the presence of EPAC-selective stimulus (8-pCTP-2-O-Me-cAMP, 100 M; 8-pCTP-2-O-Me-cAMP-AM, 1 M) or inhibitor brefeldin A (BFA), ESI-05, and ESI-09 (10 M each). Rap1 activity was assessed, and signaling events, as well as differentiation in EPAC1/2-knockdown RAW264.7 cells, were studied. Direct EPAC1/2 stimulation significantly increased osteoclast differentiation, whereas EPAC1/2 inhibition diminished differentiation (113 +/- 6%, P<0.05, and 42 +/- 10%, P<0.001, of basal, respectively). Rap1 activation was maximal 15 min after RANKL stimulation (147 +/- 9% of basal, P<0.001), whereas silencing of EPAC1/2 diminished activated Rap1 (43 +/- 13 and 20 +/- 15% of control, P<0.001) and NFkB nuclear translocation. TRAP-staining revealed no osteoclast differentiation in EPAC1/2-KO cells. Cathepsin K, NFATc1, and osteopontin mRNA expression decreased in EPAC1/2-KO cells when compared to control. RhoA, cdc42, Rac1, and FAK were activated in an EPAC1/2-dependent manner, and there was diminished cytoskeletal assembly in EPAC1/2-KO cells. In summary, EPAC1 and EPAC2 are critical signaling intermediates in osteoclast differentiation that permit RANKL-stimulated NFkB nuclear translocation and actin rearrangements. Targeting this signaling intermediate may diminish bone destruction in inflammatory arthritis.Mediero, A., Perez-Aso, M., Cronstein, B. N. Activation of EPAC1/2 is essential for osteoclast formation by modulating NFB nuclear translocation and actin cytoskeleton rearrangements.	[Mediero, Aranzazu; Perez-Aso, Miguel; Cronstein, Bruce N.] NYU, Sch Med, Dept Med, Div Translat Med, 550 First Ave,MSB251, New York, NY 10016 USA	New York University	Cronstein, BN (corresponding author), NYU, Sch Med, Dept Med, Div Translat Med, 550 First Ave,MSB251, New York, NY 10016 USA.	bruce.cronstein@nyumc.org	Mediero, Aranzazu/AAA-8362-2020	Cronstein, Bruce/0000-0002-4295-7383	U.S. National Institutes of Health [AR56672, AR56672S1, AR54897, AR046121]; New York University-Health and Hospitals Corp. Clinical and Translational Science Institute [UL1TR000038]; New York University Caregiver Intervention Center Support grant [9NIH/NCI 5 P30CA16087-310]; OSI (Melville, NY, USA); Takeda (Deerfield, IL, USA); Gilead Pharmaceuticals (Foster City, CA, USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056672, R56AR056672, P30AR046121] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York University-Health and Hospitals Corp. Clinical and Translational Science Institute; New York University Caregiver Intervention Center Support grant; OSI (Melville, NY, USA); Takeda (Deerfield, IL, USA)(Takeda Pharmaceutical Company Ltd); Gilead Pharmaceuticals (Foster City, CA, USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grants from the U.S. National Institutes of Health (AR56672, AR56672S1, AR54897, AR046121), the New York University-Health and Hospitals Corp. Clinical and Translational Science Institute (UL1TR000038), a New York University Caregiver Intervention Center Support grant (9NIH/NCI 5 P30CA16087-310), and grants from OSI (Melville, NY, USA), Takeda (Deerfield, IL, USA), and Gilead Pharmaceuticals (Foster City, CA, USA). A.M. and B.N.C. have filed a patent on use of adenosine A<INF>2A</INF>R agonists to prevent prosthesis loosening (U.S. patent 8,183,225), and have filed a patent on use of antinetrin-1 antibodies for the treatment of bone disease (pending). M.P-A. declares no conflicts of interest. B.N.C. holds U.S. patents 5,932,558; 6,020,321; 6,555,545; 7,795,427; adenosine A<INF>1</INF>R and A<INF>2B</INF>R antagonists to treat fatty liver (pending); adenosine A<INF>2A</INF>R agonists to prevent prosthesis loosening (pending). B.N.C. is a consultant for Bristol-Myers Squibb New York, NY, USA), Novartis (New York, NY, USA), CanFite Biopharmaceuticals (Petah-Tikva, Israel), Cypress Laboratories (Allen, TX, USA), Regeneron (Westat, DSMB; Tarrytown, NY, USA), Endocyte (West Lafayette, IN, USA), Protalex (Florham Park, NJ, USA), Allos, Inc. (Westminster, CO, USA), Savient (East Brunswick Township, NJ, USA), Gismo Therapeutics (Howard Beach NY, USA), Antares Pharmaceutical (Ewing, NJ, USA), Medivector (Boston, MA, USA), King Pharmaceutical (Bristol, TN, USA), Celizome (St. Petersburg, FL, USA), Tap Pharmaceuticals (Lake Forest, IL, USA), Prometheus Laboratories (Lake Forest, IL, USA), Sepracor (Basel, Switzerland), Amgen (Thousand Oaks, CA, USA), Combinatorx (Boston, MA, USA), Kyowa Hakka (Tokyo, Japan), Hoffman-LaRoche (Basel, Switzerland), and Avidimer Therapeutics (Ann Arbor, MI, USA). B.N.C. has stock in CanFite Biopharmaceuticals. Author contributions: B. C. and A.M. designed most of the experiments; A.M. was the primary person responsible for carrying out all experimental procedures; and M.P.A. helped with Western blot experiments.	Blair HC, 2005, BIOCHEM BIOPH RES CO, V328, P728, DOI 10.1016/j.bbrc.2004.11.077; Breckler M, 2011, CELL SIGNAL, V23, P1257, DOI 10.1016/j.cellsig.2011.03.007; Chen HJ, 2014, J MED CHEM, V57, P3651, DOI 10.1021/jm401425e; Chitu V, 2005, MOL BIOL CELL, V16, P2947, DOI 10.1091/mbc.e04-10-0914; Croke M, 2011, J CELL SCI, V124, P3811, DOI 10.1242/jcs.086280; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; Frith JC, 2001, ARTHRITIS RHEUM, V44, P2201, DOI 10.1002/1529-0131(200109)44:9<2201::AID-ART374>3.0.CO;2-E; Gloerich M, 2010, ANNU REV PHARMACOL, V50, P355, DOI 10.1146/annurev.pharmtox.010909.105714; Grandoch M, 2010, BRIT J PHARMACOL, V159, P265, DOI 10.1111/j.1476-5381.2009.00458.x; Granholm S, 2007, J ENDOCRINOL, V195, P415, DOI 10.1677/JOE-07-0338; Guerrini MM, 2008, AM J HUM GENET, V83, P64, DOI 10.1016/j.ajhg.2008.06.015; Kondo H, 2002, J BONE MINER RES, V17, P1667, DOI 10.1359/jbmr.2002.17.9.1667; Lee YJ, 2012, BBA-MOL CELL RES, V1823, P971, DOI 10.1016/j.bbamcr.2011.12.011; Li J, 2000, P NATL ACAD SCI USA, V97, P1566, DOI 10.1073/pnas.97.4.1566; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; McHugh KP, 2007, ADV EXP MED BIOL, V602, P107; Mediero A, 2013, BRIT J PHARMACOL, V169, P1372, DOI 10.1111/bph.12227; Mediero A, 2012, AM J PATHOL, V180, P775, DOI 10.1016/j.ajpath.2011.10.017; Ory S, 2000, J CELL SCI, V113, P1177; Park YG, 2006, INT IMMUNOPHARMACOL, V6, P947, DOI 10.1016/j.intimp.2006.01.005; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ray BJ, 2012, J LEUKOCYTE BIOL, V92, P1021, DOI 10.1189/jlb.0512259; Roelofs AJ, 2010, J BONE MINER RES, V25, P606, DOI 10.1359/jbmr.091009; Saltel F, 2008, EUR J CELL BIOL, V87, P459, DOI 10.1016/j.ejcb.2008.01.001; Shahrara S, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2318; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Soysa NS, 2009, BIOCHEM BIOPH RES CO, V378, P1, DOI 10.1016/j.bbrc.2008.10.146; Soysa NS, 2009, J BONE MINER METAB, V27, P131, DOI 10.1007/s00774-008-0026-6; Ster J, 2007, P NATL ACAD SCI USA, V104, P2519, DOI 10.1073/pnas.0611031104; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Sugimoto N, 2011, NEUROSCI LETT, V497, P55, DOI 10.1016/j.neulet.2011.04.028; Takada K, 2004, J BONE MINER METAB, V22, P12, DOI 10.1007/s00774-003-0441-7; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Yamamoto Yohei, 2005, Clin Calcium, V15, P147; Yasuda H, 1999, BONE, V25, P109, DOI 10.1016/S8756-3282(99)00121-0; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Yoon SH, 2011, J BONE MINER RES, V26, P1217, DOI 10.1002/jbmr.310; YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0; Yu MJ, 2011, J IMMUNOL, V187, P1797, DOI 10.4049/jimmunol.1002628; Zou W, 2013, MOL CELL BIOL, V33, P830, DOI 10.1128/MCB.00790-12	43	35	36	2	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2014	28	11					4901	4913		10.1096/fj.14-255703	http://dx.doi.org/10.1096/fj.14-255703			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AS1OU	25122553	Green Published			2022-12-25	WOS:000344050900027
J	Mehmeti, I; Lortz, S; Elsner, M; Lenzen, S				Mehmeti, Ilir; Lortz, Stephan; Elsner, Matthias; Lenzen, Sigurd			Peroxiredoxin 4 Improves Insulin Biosynthesis and Glucose-induced Insulin Secretion in Insulin-secreting INS-1E Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; PANCREATIC BETA-CELLS; ANTIOXIDATIVE DEFENSE STATUS; UNFOLDED PROTEIN RESPONSE; ENZYME GENE-EXPRESSION; OXIDATIVE STRESS; LOCALIZED PEROXIREDOXIN; DISULFIDE FORMATION; DIABETES-MELLITUS; HYDROGEN-PEROXIDE	Oxidative folding of (pro) insulin is crucial for its assembly and biological function. This process takes place in the endoplasmic reticulum (ER) and is accomplished by protein disulfide isomerase and ER oxidoreductin 1 beta, generating stoichiometric amounts of hydrogen peroxide (H2O2) as byproduct. During insulin resistance in the prediabetic state, increased insulin biosynthesis can overwhelm the ER antioxidative and folding capacity, causing an imbalance in the ER redox homeostasis and oxidative stress. Peroxiredoxin 4 (Prdx4), an ER-specific antioxidative peroxidase can utilize luminal H2O2 as driving force for reoxidizing protein disulfide isomerase family members, thus efficiently contributing to disulfide bond formation. Here, we examined the functional significance of Prdx4 on beta-cell function with emphasis on insulin content and secretion during stimulation with nutrient secretagogues. Overexpression of Prdx4 in glucose-responsive insulin-secreting INS-1E cells significantly metabolized luminal H2O2 and improved the glucose-induced insulin secretion, which was accompanied by the enhanced proinsulin mRNA transcription and insulin content. This beta-cell beneficial effect was also observed upon stimulation with the nutrient insulin secretagogue combination of leucine plus glutamine, indicating that the effect is not restricted to glucose. However, knockdown of Prdx4 had no impact on H2O2 metabolism or beta-cell function due to the fact that Prdx4 expression is negligibly low in pancreatic beta-cells. Moreover, we provide evidence that the constitutively low expression of Prdx4 is highly susceptible to hyperoxidation in the presence of high glucose. Overall, these data suggest an important role of Prdx4 in maintaining insulin levels and improving the ER folding capacity also under conditions of a high insulin requirement.	[Mehmeti, Ilir; Lortz, Stephan; Elsner, Matthias; Lenzen, Sigurd] Hannover Med Sch, Inst Clin Biochem, D-30623 Hannover, Germany	Hannover Medical School	Lenzen, S (corresponding author), Hannover Med Sch, Inst Clin Biochem, D-30623 Hannover, Germany.	lenzen.sigurd@mh-hannover.de	Elsner, Matthias/Q-1229-2017	Mehmeti, Ilir/0000-0003-1923-0837; Lortz, Stephan/0000-0002-3392-8978	European Union (BetaBAT) [277713]	European Union (BetaBAT)	This work was supported by a grant from the European Union (BetaBAT, Grant 277713) in the Framework Programme 7.	Appenzeller-Herzog C., 2008, EMBO J, V27, P2977; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Awazawa M, 2014, MOL CELL BIOL, V34, P1290, DOI 10.1128/MCB.01647-13; Back SH, 2012, ANNU REV BIOCHEM, V81, P767, DOI 10.1146/annurev-biochem-072909-095555; Bast A, 2002, DIABETOLOGIA, V45, P867, DOI 10.1007/s00125-002-0846-1; Cao ZB, 2011, J BIOL CHEM, V286, P42257, DOI 10.1074/jbc.M111.298810; Ding Y, 2010, ANTIOXID REDOX SIGN, V13, P1477, DOI 10.1089/ars.2010.3137; Goodge KA, 2000, SEMIN CELL DEV BIOL, V11, P235, DOI 10.1006/scdb.2000.0172; Gross E, 2006, P NATL ACAD SCI USA, V103, P299, DOI 10.1073/pnas.0506448103; Gurgul-Convey E, 2011, J MOL MED, V89, P785, DOI 10.1007/s00109-011-0747-1; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Iuchi Y, 2009, BIOCHEM J, V419, P149, DOI 10.1042/BJ20081526; Kakihana T, 2012, ANTIOXID REDOX SIGN, V16, P763, DOI 10.1089/ars.2011.4238; Karala AR, 2009, ANTIOXID REDOX SIGN, V11, P963, DOI 10.1089/ARS.2008.2326; Khoo C, 2011, ENDOCRINOLOGY, V152, P2599, DOI 10.1210/en.2010-1420; Lenzen S, 1996, FREE RADICAL BIO MED, V20, P463, DOI 10.1016/0891-5849(96)02051-5; Liu M, 2005, J BIOL CHEM, V280, P13209, DOI 10.1074/jbc.C400475200; Liu M, 2007, P NATL ACAD SCI USA, V104, P15841, DOI 10.1073/pnas.0702697104; Malhotra JD, 2007, ANTIOXID REDOX SIGN, V9, P2277, DOI 10.1089/ars.2007.1782; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Mehmeti I, 2012, FREE RADICAL BIO MED, V53, P1451, DOI 10.1016/j.freeradbiomed.2012.08.010; Mehmeti I, 2011, MOL CELL ENDOCRINOL, V332, P88, DOI 10.1016/j.mce.2010.09.017; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nabeshima A, 2013, ANTIOXID REDOX SIGN, V19, P1983, DOI 10.1089/ars.2012.4946; Nguyen VD, 2011, J MOL BIOL, V406, P503, DOI 10.1016/j.jmb.2010.12.039; Oka OBV, 2013, BBA-MOL CELL RES, V1833, P2425, DOI 10.1016/j.bbamcr.2013.02.007; Pagani M, 2000, J BIOL CHEM, V275, P23685, DOI 10.1074/jbc.M003061200; Paula FMM, 2013, MOL CELL ENDOCRINOL, V374, P56, DOI 10.1016/j.mce.2013.04.009; Ramming Thomas, 2013, Int J Cell Biol, V2013, P180906, DOI 10.1155/2013/180906; Ramming T, 2014, FREE RADICAL BIO MED, V70, P106, DOI 10.1016/j.freeradbiomed.2014.01.018; Rhee SG, 2012, J BIOL CHEM, V287, P4403, DOI 10.1074/jbc.R111.283432; Rhee SG, 2010, MOL CELLS, V29, P539, DOI 10.1007/s10059-010-0082-3; Ron D, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013177; Saaranen MJ, 2010, ANTIOXID REDOX SIGN, V12, P15, DOI 10.1089/ars.2009.2674; Sato Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep02456; Scheuner D, 2008, ENDOCR REV, V29, P317, DOI 10.1210/er.2007-0039; SCHUIT FC, 1991, BIOCHEM BIOPH RES CO, V178, P1182, DOI 10.1016/0006-291X(91)91017-7; Tavender TJ, 2008, BIOCHEM J, V411, P191, DOI 10.1042/BJ20071428; Tavender TJ, 2010, EMBO J, V29, P4185, DOI 10.1038/emboj.2010.273; Tavender TJ, 2010, J CELL SCI, V123, P2672, DOI 10.1242/jcs.067843; Tiedge M, 1997, DIABETES, V46, P1733, DOI 10.2337/diabetes.46.11.1733; Tu BP, 2004, J CELL BIOL, V164, P341, DOI 10.1083/jcb.200311055; Van Lommel L, 2006, DIABETES, V55, P3214, DOI 10.2337/db06-0774; Wang L, 2014, ANTIOXID REDOX SIGN, V20, P545, DOI 10.1089/ars.2013.5236; Wang X, 2012, BIOCHEM J, V441, P113, DOI 10.1042/BJ20110380; Wolf G, 2010, J ENDOCRINOL, V207, P163, DOI 10.1677/JOE-09-0455; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Zito E, 2013, ANTIOXID REDOX SIGN, V18, P1666, DOI 10.1089/ars.2012.4966; Zito E, 2012, MOL CELL, V48, P39, DOI 10.1016/j.molcel.2012.08.010; Zito E, 2010, MOL CELL, V40, P787, DOI 10.1016/j.molcel.2010.11.010; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998	51	39	41	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					26904	26913		10.1074/jbc.M114.568329	http://dx.doi.org/10.1074/jbc.M114.568329			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25122762	Green Published, hybrid			2022-12-25	WOS:000342853900021
J	Shigeto, J; Nagano, M; Fujita, K; Tsutsumi, Y				Shigeto, Jun; Nagano, Mariko; Fujita, Koki; Tsutsumi, Yuji			Catalytic Profile of Arabidopsis Peroxidases, AtPrx-2, 25 and 71, Contributing to Stem Lignification	PLOS ONE			English	Article							SITE-DIRECTED MUTAGENESIS; SUBSTRATE OXIDATION SITES; WALL-BOUND PEROXIDASE; DEHYDROGENATIVE POLYMER; VERSATILE PEROXIDASE; SINAPYL ALCOHOL; VASCULAR TISSUE; DOWN-REGULATION; LIGNIN; ENVIRONMENT	Lignins are aromatic heteropolymers that arise from oxidative coupling of lignin precursors, including lignin monomers (p-coumaryl, coniferyl, and sinapyl alcohols), oligomers, and polymers. Whereas plant peroxidases have been shown to catalyze oxidative coupling of monolignols, the oxidation activity of well-studied plant peroxidases, such as horseradish peroxidase C (HRP-C) and AtPrx53, are quite low for sinapyl alcohol. This characteristic difference has led to controversy regarding the oxidation mechanism of sinapyl alcohol and lignin oligomers and polymers by plant peroxidases. The present study explored the oxidation activities of three plant peroxidases, AtPrx2, AtPrx25, and AtPrx71, which have been already shown to be involved in lignification in the Arabidopsis stem. Recombinant proteins of these peroxidases (rAtPrxs) were produced in Escherichia coli as inclusion bodies and successfully refolded to yield their active forms. rAtPrx2, rAtPrx25, and rAtPrx71 were found to oxidize two syringyl compounds (2,6-dimethoxyphenol and syringaldazine), which were employed here as model monolignol compounds, with higher specific activities than HRP-C and rAtPrx53. Interestingly, rAtPrx2 and rAtPrx71 oxidized syringyl compounds more efficiently than guaiacol. Moreover, assays with ferrocytochrome c as a substrate showed that AtPrx2, AtPrx25, and AtPrx71 possessed the ability to oxidize large molecules. This characteristic may originate in a protein radical. These results suggest that the plant peroxidases responsible for lignin polymerization are able to directly oxidize all lignin precursors.	[Shigeto, Jun; Nagano, Mariko; Fujita, Koki; Tsutsumi, Yuji] Kyushu Univ, Fac Agr, Fukuoka 812, Japan	Kyushu University	Tsutsumi, Y (corresponding author), Kyushu Univ, Fac Agr, Fukuoka 812, Japan.	y-tsutsu@agr.kyushu-u.ac.jp	Fujita, Koki/G-2702-2013; Shigeto, Jun/ABF-4131-2020	Fujita, Koki/0000-0002-3821-8393; , Jun/0000-0003-2170-8895	Japan Society for the Promotion of Science (JSPS) KAKENHI [23380102]; JSPS KAKENHI Young Scientists [25850123]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS KAKENHI Young Scientists	This work was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI (B) Grant Number 23380102 (Y.T.) and JSPS KAKENHI Young Scientists (B) Grant Number 25850123 (J.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almagro L, 2009, J EXP BOT, V60, P377, DOI 10.1093/jxb/ern277; Aoyama W, 2002, J WOOD SCI, V48, P497, DOI 10.1007/BF00766646; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Barcelo AR, 2007, TRENDS PLANT SCI, V12, P486, DOI 10.1016/j.tplants.2007.09.002; Blee KA, 2003, PHYTOCHEMISTRY, V64, P163, DOI 10.1016/S0031-9422(03)00212-7; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Doyle WA, 1998, BIOCHEMISTRY-US, V37, P15097, DOI 10.1021/bi981633h; El Mansouri I, 1999, PHYSIOL PLANTARUM, V106, P355, DOI 10.1034/j.1399-3054.1999.106401.x; Gabaldon C, 2005, PLANT PHYSIOL, V139, P1138, DOI 10.1104/pp.105.069674; HARKIN JM, 1973, SCIENCE, V180, P296, DOI 10.1126/science.180.4083.296; Herrero J, 2013, PLANTA, V237, P1599, DOI 10.1007/s00425-013-1865-5; Kavousi B, 2010, PHYTOCHEMISTRY, V71, P531, DOI 10.1016/j.phytochem.2010.01.008; Kobayashi T, 2005, J WOOD SCI, V51, P607, DOI 10.1007/s10086-005-0702-2; Li YH, 2003, J PLANT RES, V116, P175, DOI 10.1007/s10265-003-0087-5; Marjamaa K, 2006, TREE PHYSIOL, V26, P605, DOI 10.1093/treephys/26.5.605; Miki Y, 2011, J BIOL CHEM, V286, P15525, DOI 10.1074/jbc.M111.220996; Miki Y, 2009, PROTEIN EXPRES PURIF, V68, P208, DOI 10.1016/j.pep.2009.06.003; Nielsen KL, 2001, BIOCHEMISTRY-US, V40, P11013, DOI 10.1021/bi010661o; Novo-Uzal E, 2013, J EXP BOT, V64, P3499, DOI 10.1093/jxb/ert221; Ostergaard L, 2000, PLANT MOL BIOL, V44, P231, DOI 10.1023/A:1006442618860; Perez-Boada M, 2005, J MOL BIOL, V354, P385, DOI 10.1016/j.jmb.2005.09.047; Pham LTM, 2014, APPL BIOCHEM BIOTECH, V172, P792, DOI 10.1007/s12010-013-0534-2; Ruiz-Duenas FJ, 2008, BIOCHEMISTRY-US, V47, P1685, DOI 10.1021/bi7020298; Ruiz-Duenas FJ, 2009, J EXP BOT, V60, P441, DOI 10.1093/jxb/ern261; Sarkanen KV., 1971, LIGNINS OCCURRENCE F; Sasaki S, 2004, FEBS LETT, V562, P197, DOI 10.1016/S0014-5793(04)00224-8; Sasaki S, 2008, PHYTOCHEMISTRY, V69, P348, DOI 10.1016/j.phytochem.2007.08.020; Shigeto J, 2013, J AGR FOOD CHEM, V61, P3781, DOI 10.1021/jf400426g; Shigeto J, 2012, FEBS J, V279, P348, DOI 10.1111/j.1742-4658.2011.08429.x; SMITH AT, 1990, J BIOL CHEM, V265, P13335; Takahama U, 1996, PLANT CELL PHYSIOL, V37, P499, DOI 10.1093/oxfordjournals.pcp.a028972; Xu F, 1996, BBA-PROTEIN STRUCT M, V1292, P303, DOI 10.1016/0167-4838(95)00210-3	32	40	41	6	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105332	10.1371/journal.pone.0105332	http://dx.doi.org/10.1371/journal.pone.0105332			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137070	Green Published, Green Submitted, gold			2022-12-25	WOS:000340742100086
J	Fang, JY; Tan, SJ; Yang, Z; Tayag, C; Han, B				Fang, Josephine Y.; Tan, Shih-Jye; Yang, Zhi; Tayag, Charisse; Han, Bo			Tumor Bioengineering Using a Transglutaminase Crosslinked Hydrogel	PLOS ONE			English	Article							BREAST-CANCER CELLS; EXTRACELLULAR-MATRIX; DRUG-SENSITIVITY; CULTURE MODELS; 3D MATRICES; STEM-CELLS; MICROENVIRONMENT; GROWTH; TISSUE; ANGIOGENESIS	Development of a physiologically relevant 3D model system for cancer research and drug development is a current challenge. We have adopted a 3D culture system based on a transglutaminase-crosslinked gelatin gel (Col-Tgel) to mimic the tumor 3D microenvironment. The system has several unique advantages over other alternatives including presenting cell-matrix interaction sites from collagen-derived peptides, geometry-initiated multicellular tumor spheroids, and metabolic gradients in the tumor microenvironment. Also it provides a controllable wide spectrum of gel stiffness for mechanical signals, and technical compatibility with imaging based screening due to its transparent properties. In addition, the Col-Tgel provides a cure-in-situ delivery vehicle for tumor xenograft formation in animals enhancing tumor cell uptake rate. Overall, this distinctive 3D system could offer a platform to more accurately mimic in vivo situations to study tumor formation and progression both in vitro and in vivo.	[Han, Bo] Univ So Calif, Keck Sch Med, Dept Surg, Div Plast & Reconstruct Surg,Nimni Cordoba Tissue, Los Angeles, CA 90033 USA; Univ So Calif, Keck Sch Med, Dept Biomed Engn, Div Plast & Reconstruct Surg,Nimni Cordoba Tissue, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California	Han, B (corresponding author), Univ So Calif, Keck Sch Med, Dept Surg, Div Plast & Reconstruct Surg,Nimni Cordoba Tissue, Los Angeles, CA 90033 USA.	bohan@usc.edu	Fang, Josephine/AAS-5996-2020					Agastin S, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3596530; Ahearne M, 2008, TOP TISSUE ENG, V4, P1; ALBINI A, 1987, CANCER RES, V47, P3239; Allavena P, 2008, CRIT REV ONCOL HEMAT, V66, P1, DOI 10.1016/j.critrevonc.2007.07.004; Ananthanarayanan B, 2011, BIOMATERIALS, V32, P7913, DOI 10.1016/j.biomaterials.2011.07.005; Baker BM, 2012, J CELL SCI, V125, P3015, DOI 10.1242/jcs.079509; Baker EL, 2010, BIOPHYS J, V99, P2048, DOI 10.1016/j.bpj.2010.07.051; Barcus CE, 2013, J BIOL CHEM, V288, P12722, DOI 10.1074/jbc.M112.447631; Bissell MJ, 2005, CANCER CELL, V7, P17, DOI 10.1016/j.ccr.2004.12.013; Bradbury P, 2012, CELL ADHES MIGR, V6, P424, DOI 10.4161/cam.21559; BRAMMER I, 1979, EUR J CANCER, V15, P1329, DOI 10.1016/0014-2964(79)90109-9; Buchler P, 2004, J SURG RES, V120, P295, DOI 10.1016/j.jss.2004.02.014; Chau DYS, 2005, BIOMATERIALS, V26, P6518, DOI 10.1016/j.biomaterials.2005.04.017; Chekenya M, 2002, FASEB J, V16, P586, DOI 10.1096/fj.01-0632fje; Constantinou AI, 1998, AM J CLIN NUTR, V68, p1426S, DOI 10.1093/ajcn/68.6.1426S; Crescenzi V, 2002, BIOMACROMOLECULES, V3, P1384, DOI 10.1021/bm025657m; Davis GE, 2000, AM J PATHOL, V156, P1489, DOI 10.1016/S0002-9440(10)65020-1; Doillon CJ, 2004, ANTICANCER RES, V24, P2169; Evans CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023434; Fang J, 2014, REGEN MED, V9, P41, DOI [10.2217/RME.13.76, 10.2217/rme.13.76]; Fischbach C, 2007, NAT METHODS, V4, P855, DOI 10.1038/NMETH1085; Fischbach C, 2009, P NATL ACAD SCI USA, V106, P399, DOI 10.1073/pnas.0808932106; Fraley SI, 2010, NAT CELL BIOL, V12, P598, DOI 10.1038/ncb2062; Ghajar CM, 2010, TISSUE ENG PT A, V16, P2153, DOI 10.1089/ten.TEA.2010.0135; Gordon EM, 1997, HUM GENE THER, V8, P1385, DOI 10.1089/hum.1997.8.11-1385; Gurski LA, 2009, BIOMATERIALS, V30, P6076, DOI 10.1016/j.biomaterials.2009.07.054; Hakkinen KM, 2011, TISSUE ENG PT A, V17, P713, DOI 10.1089/ten.TEA.2010.0273; Hendriks J, 2005, CELL DEATH DIFFER, V12, P637, DOI 10.1038/sj.cdd.4401647; Ivascu A, 2007, INT J ONCOL, V31, P1403; Ivascu A, 2006, J BIOMOL SCREEN, V11, P922, DOI 10.1177/1087057106292763; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; KIBBEY MC, 1992, J NATL CANCER I, V84, P1633, DOI 10.1093/jnci/84.21.1633; Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107; Kim JB, 2005, SEMIN CANCER BIOL, V15, P365, DOI 10.1016/j.semcancer.2005.05.002; Kuwahara K, 2010, TISSUE ENG PART C-ME, V16, P609, DOI 10.1089/ten.TEC.2009.0406; Kuwahara K, 2011, TISSUE ENG PT A, V17, P2955, DOI 10.1089/ten.tea.2011.0290; Langley RR, 2011, INT J CANCER, V128, P2527, DOI 10.1002/ijc.26031; Loessner D, 2010, BIOMATERIALS, V31, P8494, DOI 10.1016/j.biomaterials.2010.07.064; Ma LA, 2010, BIOMED MICRODEVICES, V12, P753, DOI 10.1007/s10544-010-9429-y; Iglesias JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077281; Mao Y, 2005, J CELL SCI, V118, P4427, DOI 10.1242/jcs.02566; Masood R, 2006, INT J CANCER, V119, P1236, DOI 10.1002/ijc.21926; MILLER BE, 1985, CANCER RES, V45, P4200; Nyga A, 2011, J CELL COMMUN SIGNAL, V5, P239, DOI 10.1007/s12079-011-0132-4; Ong SM, 2010, BIOMATERIALS, V31, P1180, DOI 10.1016/j.biomaterials.2009.10.049; PASSANITI A, 1992, INT J CANCER, V51, P318, DOI 10.1002/ijc.2910510224; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pirazzoli V, 2013, BLOOD, V121, P2316, DOI 10.1182/blood-2012-08-451187; Rajendran JG, 2005, RADIOL CLIN N AM, V43, P169, DOI 10.1016/j.rcl.2004.08.004; Saverio B, 2000, CANCER RES, V60, P28; Stroock AD, 2010, TISSUE ENG PT A, V16, P2143, DOI [10.1089/ten.tea.2009.0689, 10.1089/ten.TEA.2009.0689]; Su S.F., 2012, ONCOGENE; Sung SY, 2007, CURR PROB CANCER, V31, P36, DOI 10.1016/j.currproblcancer.2006.12.002; Szot CS, 2011, BIOMATERIALS, V32, P7905, DOI 10.1016/j.biomaterials.2011.07.001; Talukdar S, 2011, BIOMATERIALS, V32, P2149, DOI 10.1016/j.biomaterials.2010.11.052; Tilghman RW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037231; Timmins Nicholas E., 2007, V140, P141; Tredan O, 2007, J NATL CANCER I, V99, P1441, DOI 10.1093/jnci/djm135; Ungefroren H, 2011, CURR CANCER DRUG TAR, V11, P524, DOI 10.2174/156800911795538075; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Whiteside TL, 2008, ONCOGENE, V27, P5904, DOI 10.1038/onc.2008.271; WULF E, 1979, P NATL ACAD SCI USA, V76, P4498, DOI 10.1073/pnas.76.9.4498; Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006; Yang Y, 2007, J R SOC INTERFACE, V4, P1169, DOI 10.1098/rsif.2007.1044; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995; Zahir N, 2003, J CELL BIOL, V163, P1397, DOI 10.1083/jcb.200302023; Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103	67	29	29	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105616	10.1371/journal.pone.0105616	http://dx.doi.org/10.1371/journal.pone.0105616			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133673	Green Published, gold, Green Submitted			2022-12-25	WOS:000341302700122
J	Greger, L; Su, J; Rung, J; Ferreira, PG; Lappalainen, T; Dermitzakis, ET; Brazma, A				Greger, Liliana; Su, Jing; Rung, Johan; Ferreira, Pedro G.; Lappalainen, Tuuli; Dermitzakis, Emmanouil T.; Brazma, Alvis		Geuvadis Consortium	Tandem RNA Chimeras Contribute to Transcriptome Diversity in Human Population and Are Associated with Intronic Genetic Variants	PLOS ONE			English	Article							MESSENGER-RNA; POSTTRANSCRIPTIONAL CONTROL; FUSION TRANSCRIPTS; IN-VITRO; EXPRESSION; PROTEINS; POLYADENYLATION; TRANSLOCATIONS; ALIGNMENT; ACCURATE	Chimeric RNAs originating from two or more different genes are known to exist not only in cancer, but also in normal tissues, where they can play a role in human evolution. However, the exact mechanism of their formation is unknown. Here, we use RNA sequencing data from 462 healthy individuals representing 5 human populations to systematically identify and in depth characterize 81 RNA tandem chimeric transcripts, 13 of which are novel. We observe that 6 out of these 81 chimeras have been regarded as cancer-specific. Moreover, we show that a prevalence of long introns at the fusion breakpoint is associated with the chimeric transcripts formation. We also find that tandem RNA chimeras have lower abundances as compared to their partner genes. Finally, by combining our results with genomic data from the same individuals we uncover intronic genetic variants associated with the chimeric RNA formation. Taken together our findings provide an important insight into the chimeric transcripts formation and open new avenues of research into the role of intronic genetic variants in post-transcriptional processing events.	[Greger, Liliana; Su, Jing; Rung, Johan; Brazma, Alvis] EBI, EMBL, Hinxton, England; [Ferreira, Pedro G.; Dermitzakis, Emmanouil T.] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Ferreira, Pedro G.; Dermitzakis, Emmanouil T.] Univ Geneva, Inst Genet & Genom Geneva IG3, Geneva, Switzerland; [Ferreira, Pedro G.; Dermitzakis, Emmanouil T.] Swiss Inst Bioinformat, Geneva, Switzerland; [Lappalainen, Tuuli] New York Genome Ctr, New York, NY USA	European Molecular Biology Laboratory (EMBL); University of Geneva; University of Geneva; Swiss Institute of Bioinformatics	Greger, L (corresponding author), EBI, EMBL, Hinxton, England.	lgreger@ebi.ac.uk	Ferreira, Pedro/HDO-1346-2022; Ferreira, Pedro G/J-6379-2013; Häsler, Robert/A-4908-2009; Esser, Daniela/ABB-9383-2020; Antonarakis, Stylianos E/N-8866-2014; Meitinger, Thomas/O-1318-2015; Estivill, Xavier/A-3125-2013; Lappalainen, Tuuli/AAE-6532-2020; Beltran, Sergi/I-3408-2015	Ferreira, Pedro G/0000-0003-3838-8664; Häsler, Robert/0000-0003-4174-8229; Antonarakis, Stylianos E/0000-0001-8907-5823; Estivill, Xavier/0000-0002-0723-2256; Lappalainen, Tuuli/0000-0002-7746-8109; Beltran, Sergi/0000-0002-2810-3445; Carracedo, Angel/0000-0003-1085-8986; Friedlander, Marc/0000-0001-6577-4363; Ongen, Halit/0000-0002-4197-5790; MacArthur, Daniel/0000-0002-5771-2290; Meitinger, Thomas/0000-0002-8838-8403; Rung, Johan/0000-0001-5875-8429; Brazma, Alvis/0000-0001-5988-7409	European Commission [GEUVADIS 261123]; EurocanPlatform [260791]	European Commission(European CommissionEuropean Commission Joint Research Centre); EurocanPlatform	This work was supported by grants: the European Commission 7th Framework Programs (FP7) (GEUVADIS 261123) and EurocanPlatform (260791). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiva P, 2006, GENOME RES, V16, P30, DOI 10.1101/gr.4137606; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Asmann YW, 2012, CANCER RES, V72, P1921, DOI 10.1158/0008-5472.CAN-11-3142; Bag J, 2010, RNA BIOL, V7, P5, DOI 10.4161/rna.7.1.10256; Behm-Ansmant I, 2007, EMBO J, V26, P1591, DOI 10.1038/sj.emboj.7601588; Brooks YS, 2009, J BIOL CHEM, V284, P18033, DOI 10.1074/jbc.M109.006999; Carrara M, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S7-S2; Chase A, 2010, HAEMATOL-HEMATOL J, V95, P20, DOI 10.3324/haematol.2009.011536; Cingolani Pablo, 2012, Frontiers in Genetics, V3, P35, DOI 10.3389/fgene.2012.00035; Courseaux A, 2003, GENOME RES, V13, P369, DOI 10.1101/gr.490303; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Denoeud F, 2007, GENOME RES, V17, P746, DOI 10.1101/gr.5660607; Duc C, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003867; Ferreira PG, 1914, PLOS GENET UNPUB; Francis RW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039987; Frenkel-Morgenstern M, 2012, GENOME RES, V22, P1231, DOI 10.1101/gr.130062.111; Ge HY, 2011, BIOINFORMATICS, V27, P1922, DOI 10.1093/bioinformatics/btr310; Gingeras TR, 2009, NATURE, V461, P206, DOI 10.1038/nature08452; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hernandez-Sanchez C, 2006, NUCLEIC ACIDS RES, V34, P3455, DOI 10.1093/nar/gkl436; Holt R, 2012, EUR J HUM GENET, V20, P1141, DOI 10.1038/ejhg.2012.73; Jain R, 2011, METHODS MOL BIOL, V703, P247, DOI 10.1007/978-1-59745-248-9_17; Kandul NP, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-67; Kapranov P, 2005, GENOME RES, V15, P987, DOI 10.1101/gr.3455305; Kawase T, 2007, BLOOD, V110, P1055, DOI 10.1182/blood-2007-02-075911; Kim DS, 2012, GENOMICS, V100, P14, DOI 10.1016/j.ygeno.2012.05.005; Kim RN, 2012, FUNCT INTEGR GENOMIC, V12, P45, DOI 10.1007/s10142-011-0260-1; Kinsella M, 2011, BIOINFORMATICS, V27, P1068, DOI 10.1093/bioinformatics/btr085; Kunarso G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-155; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Lee Y, 2006, P NATL ACAD SCI USA, V103, P17885, DOI 10.1073/pnas.0608344103; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Magrangeas F, 1998, J BIOL CHEM, V273, P16005, DOI 10.1074/jbc.273.26.16005; Mangus DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-223; Marco-Sola S, 2012, NAT METHODS, V9, P1185, DOI [10.1038/NMETH.2221, 10.1038/nmeth.2221]; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Nacu S, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-11; NIWA M, 1990, GENE DEV, V4, P1552, DOI 10.1101/gad.4.9.1552; NIWA M, 1991, GENE DEV, V5, P2086, DOI 10.1101/gad.5.11.2086; Parra G, 2006, GENOME RES, V16, P37, DOI 10.1101/gr.4145906; Plebani R, 2012, NEOPLASIA, V14, P1087, DOI 10.1593/neo.121342; Prakash T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013284; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Qu HQ, 2007, DIABETES, V56, P270, DOI 10.2337/db06-0865; Quinlan AR, 2010, GENOME RES, V20, P623, DOI 10.1101/gr.102970.109; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rigo F, 2008, MOL CELL BIOL, V28, P849, DOI 10.1128/MCB.01410-07; Rosenbloom KR, 2013, NUCLEIC ACIDS RES, V41, pD56, DOI 10.1093/nar/gks1172; Salzman J, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001156; Seeler JS, 1998, P NATL ACAD SCI USA, V95, P7316, DOI 10.1073/pnas.95.13.7316; Takahara T, 2005, MOL CELL, V18, P245, DOI 10.1016/j.molcel.2005.03.018; Thierry-Mieg D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s12; Wang K, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-348; Wang Y, 2014, METHODS, V65, P350, DOI 10.1016/j.ymeth.2013.08.019; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Zhang YM, 2012, CANCER DISCOV, V2, P598, DOI 10.1158/2159-8290.CD-12-0042	58	24	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e104567	10.1371/journal.pone.0104567	http://dx.doi.org/10.1371/journal.pone.0104567			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133550	Green Published, Green Submitted, gold			2022-12-25	WOS:000341302700032
J	Zgheel, F; Alhosin, M; Rashid, S; Burban, M; Auger, C; Schini-Kerth, VB				Zgheel, Faraj; Alhosin, Mahmoud; Rashid, Sherzad; Burban, Melanie; Auger, Cyril; Schini-Kerth, Valerie B.			Redox-Sensitive Induction of Src/PI3-kinase/Akt and MAPKs Pathways Activate eNOS in Response to EPA:DHA 6:1	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; PORCINE CORONARY-ARTERIES; ENDOTHELIUM-DEPENDENT RELAXATION; POLYUNSATURATED FATTY-ACIDS; EDHF-MEDIATED RELAXATIONS; EICOSAPENTAENOIC ACID; DOCOSAHEXAENOIC ACID; DIETARY SUPPLEMENTATION; OXIDATIVE STRESS; HEART-DISEASE	Aims: Omega-3 fatty acid products containing eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) have vasoprotective effects, in part, by stimulating the endothelial formation of nitric oxide (NO). This study determined the role of the EPA: DHA ratio and amount, and characterized the mechanism leading to endothelial NO synthase (eNOS) activation. Methods and Results: EPA:DHA 6:1 and 9:1 caused significantly greater endothelium-dependent relaxations in porcine coronary artery rings than EPA: DHA 3:1, 1:1, 1:3, 1:6, 1:9, EPA and DHA alone, and EPA:DHA 6:1 with a reduced EPA + DHA amount, which were inhibited by an eNOS inhibitor. Relaxations to EPA:DHA 6:1 were insensitive to cyclooxygenase inhibition, and reduced by inhibitors of either oxidative stress, Src kinase, PI3-kinase, p38 MAPK, MEK, or JNK. EPA:DHA 6:1 induced phosphorylation of Src, Akt, p38 MAPK, ERK, JNK and eNOS; these effects were inhibited by MnTMPyP. EPA:DHA 6:1 induced the endothelial formation of ROS in coronary artery sections as assessed by dihydroethidium, and of superoxide anions and hydrogen peroxide in cultured endothelial cells as assessed by electron spin resonance with the spin probe CMH, and the Amplex Red based assay, respectively. Conclusion: Omega-3 fatty acids cause endothelium-dependent NO-mediated relaxations in coronary artery rings, which are dependent on the EPA:DHA ratio and amount, and involve an intracellular activation of the redox-sensitive PI3-kinase/Akt and MAPKs pathways to activate eNOS.	[Zgheel, Faraj; Alhosin, Mahmoud; Rashid, Sherzad; Burban, Melanie; Auger, Cyril; Schini-Kerth, Valerie B.] Univ Strasbourg, Fac Pharm, CNRS, Lab Biophoton & Pharmacol,UMR 7213, Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Schini-Kerth, VB (corresponding author), Univ Strasbourg, Fac Pharm, CNRS, Lab Biophoton & Pharmacol,UMR 7213, Illkirch Graffenstaden, France.	valerie.schini-kerth@unistra.fr	Alhosin, Mahmoud/AAD-5782-2020; Auger, Cyril/N-4702-2016; Alhosin, Mahmoud/H-8101-2017	Alhosin, Mahmoud/0000-0003-2147-1445; 	Pivotal Therapeutics Inc., Toronto, Canada; Higher Education Ministry, Libya; Higher Education Ministry, KRG, Iraq	Pivotal Therapeutics Inc., Toronto, Canada; Higher Education Ministry, Libya; Higher Education Ministry, KRG, Iraq	This work was supported, in part, by an unrestricted research grant from Pivotal Therapeutics Inc., Toronto, Canada. Faraj Zgheel is supported by a fellowship from the Higher Education Ministry, Libya, and Sherzad Rashid by a fellowship from the Higher Education Ministry, KRG, Iraq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anselm E, 2007, CARDIOVASC RES, V73, P404, DOI 10.1016/j.cardiores.2006.08.004; Auger C, 2010, BIOCHEM BIOPH RES CO, V393, P162, DOI 10.1016/j.bbrc.2010.01.112; BOULANGER C, 1990, BRIT J PHARMACOL, V99, P176, DOI 10.1111/j.1476-5381.1990.tb14673.x; Crnkovic S, 2012, FREE RADICAL BIO MED, V52, P1786, DOI 10.1016/j.freeradbiomed.2012.02.036; de Berrazueta JR, 2009, EUR J CLIN INVEST, V39, P165, DOI 10.1111/j.1365-2362.2008.02072.x; ELLIS EF, 1990, AM J PHYSIOL, V258, pH1780, DOI 10.1152/ajpheart.1990.258.6.H1780; Fisslthaler B, 2000, ACTA PHYSIOL SCAND, V168, P81; Madeira SVF, 2009, J VASC RES, V46, P406, DOI 10.1159/000194271; Galan P, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6273; Ganster F, 2010, CRIT CARE, V14, DOI 10.1186/cc9257; Haynes MP, 2000, CIRC RES, V87, P677, DOI 10.1161/01.RES.87.8.677; He K, 2004, CIRCULATION, V109, P2705, DOI 10.1161/01.CIR.0000132503.19410.6B; Hu FB, 2002, JAMA-J AM MED ASSOC, V287, P1815, DOI 10.1001/jama.287.14.1815; Kang KS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010296; Kim JA, 2007, J BIOL CHEM, V282, P13736, DOI 10.1074/jbc.M609725200; Kromhout D, 2012, EUR HEART J, V33, P436, DOI 10.1093/eurheartj/ehr362; Kromhout D, 2010, NEW ENGL J MED, V363, P2015, DOI 10.1056/NEJMoa1003603; Li QR, 2007, ARCH BIOCHEM BIOPHYS, V466, P250, DOI 10.1016/j.abb.2007.06.023; Li QR, 2007, BIOCHIMIE, V89, P169, DOI 10.1016/j.biochi.2006.10.009; Michel JB, 1997, J BIOL CHEM, V272, P25907, DOI 10.1074/jbc.272.41.25907; Mori TA, 2000, CIRCULATION, V102, P1264, DOI 10.1161/01.CIR.102.11.1264; Ndiaye M, 2004, FASEB J, V18, DOI 10.1096/fj.04-2146fje; Ndiaye M, 2004, BRIT J PHARMACOL, V142, P1131, DOI 10.1038/sj.bjp.0705774; Ndiaye M, 2003, BIOCHEM BIOPH RES CO, V310, P371, DOI 10.1016/j.bbrc.2003.09.028; Omura M, 2001, FEBS LETT, V487, P361, DOI 10.1016/S0014-5793(00)02351-6; SHIMOKAWA H, 1987, CIRCULATION, V76, P898, DOI 10.1161/01.CIR.76.4.898; SHIMOKAWA H, 1988, BRIT J PHARMACOL, V95, P1191, DOI 10.1111/j.1476-5381.1988.tb11755.x; SHIMOKAWA H, 1989, AM J PHYSIOL, V256, pH968, DOI 10.1152/ajpheart.1989.256.4.H968; Singh TU, 2010, EUR J PHARMACOL, V636, P108, DOI 10.1016/j.ejphar.2010.02.041; Stirban A, 2010, AM J CLIN NUTR, V91, P808, DOI 10.3945/ajcn.2009.28374; Tagawa H, 1999, J CARDIOVASC PHARM, V33, P633, DOI 10.1097/00005344-199904000-00017; Valagussa F, 1999, LANCET, V354, P447, DOI 10.1016/S0140-6736(99)07072-5; Wang QQ, 2012, ATHEROSCLEROSIS, V221, P536, DOI 10.1016/j.atherosclerosis.2012.01.006	33	31	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105102	10.1371/journal.pone.0105102	http://dx.doi.org/10.1371/journal.pone.0105102			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133540	Green Published, gold, Green Submitted			2022-12-25	WOS:000341302700071
J	Chen, JX; Shao, LY; Gong, L; Luo, F; Wang, JE; Shi, Y; Tan, Y; Chen, QL; Zhang, Y; Hui, RT; Wang, YB				Chen, Jinxing; Shao, Liying; Gong, Ling; Luo, Fang; Wang, Jin'e; Shi, Yi; Tan, Yu; Chen, Qianlong; Zhang, Yu; Hui, Rutai; Wang, Yibo			A Pharmacogenetics-Based Warfarin Maintenance Dosing Algorithm from Northern Chinese Patients	PLOS ONE			English	Article							VITAMIN-K EPOXIDE; REDUCTASE COMPLEX SUBUNIT-1; GENOME-WIDE ASSOCIATION; VKORC1 HAPLOTYPES; DOSE REQUIREMENTS; GENETIC-VARIANTS; INTERINDIVIDUAL VARIABILITY; ORAL ANTICOAGULATION; AFRICAN-AMERICANS; VALVE-REPLACEMENT	Inconsistent associations with warfarin dose were observed in genetic variants except VKORC1 haplotype and CYP2C9*3 in Chinese people, and few studies on warfarin dose algorithm was performed in a large Chinese Han population lived in Northern China. Of 787 consenting patients with heart-valve replacements who were receiving long-term warfarin maintenance therapy, 20 related Single nucleotide polymorphisms were genotyped. Only VKORC1 and CYP2C9 SNPs were observed to be significantly associated with warfarin dose. In the derivation cohort (n = 551), warfarin dose variability was influenced, in decreasing order, by VKORC1 rs7294 (27.3%), CYP2C9*3(7.0%), body surface area(4.2%), age(2.7%), target INR(1.4%), CYP4F2 rs2108622 (0.7%), amiodarone use(0.6%), diabetes mellitus(0.6%), and digoxin use(0.5%), which account for 45.1% of the warfarin dose variability. In the validation cohort (n = 236), the actual maintenance dose was significantly correlated with predicted dose (r = 0.609, P<0.001). Our algorithm could improve the personalized management of warfarin use in Northern Chinese patients.	[Chen, Jinxing; Shao, Liying; Gong, Ling; Wang, Jin'e; Tan, Yu; Chen, Qianlong; Zhang, Yu; Hui, Rutai; Wang, Yibo] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Sino German Lab Mol Med, State Key Lab Cardiovasc Dis,Fuwai Hosp, Beijing 100730, Peoples R China; [Chen, Jinxing; Shao, Liying; Gong, Ling; Luo, Fang; Wang, Jin'e; Shi, Yi; Tan, Yu; Chen, Qianlong; Zhang, Yu; Hui, Rutai; Wang, Yibo] Peking Union Med Coll, Beijing 100021, Peoples R China; [Gong, Ling; Luo, Fang; Hui, Rutai] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Fuwai Hosp, Dept Cardiol, Beijing 100730, Peoples R China; [Shi, Yi] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Fuwai Hosp, Dept Cardiovasc Surg, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS	Wang, YB (corresponding author), Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Sino German Lab Mol Med, State Key Lab Cardiovasc Dis,Fuwai Hosp, Beijing 100730, Peoples R China.	yibowang@hotmail.com		Wang, Yibo/0000-0001-9984-581X	National Natural Science Foundation of China [81322002, 31171220, 81270333]; Fundamental Research Funds for the Central Universities [2013-GZ15-YP]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The study was supported by National Natural Science Foundation of China with grants 81322002, 31171220, and 81270333, and the Fundamental Research Funds for the Central Universities with grant 2013-GZ15-YP to Dr. Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aquilante CL, 2006, CLIN PHARMACOL THER, V79, P291, DOI 10.1016/j.clpt.2005.11.011; Aso Y, 2002, METABOLISM, V51, P471, DOI 10.1053/meta.2002.31334; Borgiani P, 2007, PHARMACOGENOMICS, V8, P1545, DOI 10.2217/14622416.8.11.1545; Caldwell MD, 2008, BLOOD, V111, P4106, DOI 10.1182/blood-2007-11-122010; Carlquist JF, 2006, J THROMB THROMBOLYS, V22, P191, DOI 10.1007/s11239-006-9030-7; Cha PC, 2007, J HUM GENET, V52, P856, DOI 10.1007/s10038-007-0183-9; Cha PC, 2010, HUM MOL GENET, V19, P4735, DOI 10.1093/hmg/ddq389; Chan SL, 2011, THROMB HAEMOSTASIS, V105, P1100, DOI 10.1160/TH11-01-0018; Chern HD, 2006, CLIN CHIM ACTA, V367, P108, DOI 10.1016/j.cca.2005.11.026; Choi JR, 2011, J HUM GENET, V56, P290, DOI 10.1038/jhg.2011.4; Cooper GM, 2008, BLOOD, V112, P1022, DOI 10.1182/blood-2008-01-134247; Costea I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015672; D'Andrea G, 2005, BLOOD, V105, P645, DOI 10.1182/blood-2004-06-2111; Garcia D, 2005, CHEST, V127, P2049, DOI 10.1378/chest.127.6.2049; Geisen C, 2005, THROMB HAEMOSTASIS, V94, P773, DOI 10.1160/TH05-04-0290; Gong IY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027808; Gu QA, 2010, EUR J CLIN PHARMACOL, V66, P1217, DOI 10.1007/s00228-010-0863-9; Hillman MA, 2004, PHARMACOGENETICS, V14, P539, DOI 10.1097/01.fpc.0000114760.08559.dc; Huang SW, 2011, THROMB RES, V127, P131, DOI 10.1016/j.thromres.2010.10.027; Huang SW, 2009, PHARMACOGENET GENOM, V19, P226, DOI 10.1097/FPC.0b013e328326e0c7; Imperatore G, 2004, AM J EPIDEMIOL, V160, P531, DOI 10.1093/aje/kwh232; Kamali F, 2000, THROMB HAEMOSTASIS, V84, P39; KNOBL P, 1993, DIABETOLOGIA, V36, P1045, DOI 10.1007/BF02374497; Lenzini P, 2010, CLIN PHARMACOL THER, V87, P572, DOI 10.1038/clpt.2010.13; Liang RJ, 2012, J THROMB THROMBOLYS, V34, P120, DOI 10.1007/s11239-012-0725-7; Liu H, 2008, J AM SOC NEPHROL, V19, P714, DOI 10.1681/ASN.2007060713; Liu Yuan, 2011, Zhonghua Xin Xue Guan Bing Za Zhi, V39, P929; Luxembourg B, 2011, THROMB HAEMOSTASIS, V105, P169, DOI 10.1160/TH10-03-0194; Mazzaccara C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071505; McDonald MG, 2009, MOL PHARMACOL, V75, P1337, DOI 10.1124/mol.109.054833; Oldenburg J, 2007, THROMB HAEMOSTASIS, V98, P570, DOI 10.1160/TH07-07-0454; Pautas E, 2010, CLIN PHARMACOL THER, V87, P57, DOI 10.1038/clpt.2009.178; Ramirez AH, 2012, PHARMACOGENOMICS, V13, P407, DOI [10.2217/PGS.11.164, 10.2217/pgs.11.164]; Rieder MJ, 2005, NEW ENGL J MED, V352, P2285, DOI 10.1056/NEJMoa044503; Rusdiana T, 2013, EUR J CLIN PHARMACOL, V69, P395, DOI 10.1007/s00228-012-1356-9; Sconce EA, 2005, BLOOD, V106, P2329, DOI 10.1182/blood-2005-03-1108; Suriapranata IM, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-80; Takeuchi F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000433; Tan SL, 2012, PHARMAZIE, V67, P930, DOI 10.1691/ph.2012.2633; Teichert M, 2009, CLIN PHARMACOL THER, V85, P379, DOI 10.1038/clpt.2008.294; Teichert M, 2009, HUM MOL GENET, V18, P3758, DOI 10.1093/hmg/ddp309; Trujillo TC, 2000, DRUG SAFETY, V23, P509, DOI 10.2165/00002018-200023060-00003; Vinik AI, 2001, DIABETES CARE, V24, P1476, DOI 10.2337/diacare.24.8.1476; Voora D, 2010, CLIN PHARMACOL THER, V87, P445, DOI 10.1038/clpt.2009.291; Wadelius M, 2007, HUM GENET, V121, P23, DOI 10.1007/s00439-006-0260-8; Wang MS, 2012, INT J MED SCI, V9, P472, DOI 10.7150/ijms.4637; Wang TL, 2008, CLIN CHIM ACTA, V396, P76, DOI 10.1016/j.cca.2008.07.005; Wang YB, 2006, CIRCULATION, V113, P1615, DOI 10.1161/CIRCULATIONAHA.105.580167; Wei M, 2012, THROMB HAEMOSTASIS, V107, P1083, DOI 10.1160/TH11-12-0848; Xu Q, 2012, THROMB HAEMOSTASIS, V108, P1132, DOI 10.1160/TH12-05-0362; Yazbek N, 2003, CORONARY ARTERY DIS, V14, P365, DOI 10.1097/01.mca.0000085138.16622.9e; You JHS, 2011, J THROMB THROMBOLYS, V31, P113, DOI 10.1007/s11239-010-0497-x; Zhang W, 2012, PHARMACOGENOMICS, V13, P309, DOI [10.2217/PGS.11.147, 10.2217/pgs.11.147]; Zhong SL, 2012, PHARMACOGENET GENOM, V22, P176, DOI 10.1097/FPC.0b013e32834f45f9	54	28	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105250	10.1371/journal.pone.0105250	http://dx.doi.org/10.1371/journal.pone.0105250			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126975	Green Published, Green Submitted, gold			2022-12-25	WOS:000340879300097
J	Golo, PS; Gardner, DR; Grilley, MM; Takemoto, JY; Krasnoff, SB; Pires, MS; Fernandes, EKK; Bittencourt, VREP; Roberts, DW				Golo, Patricia S.; Gardner, Dale R.; Grilley, Michelle M.; Takemoto, Jon Y.; Krasnoff, Stuart B.; Pires, Marcus S.; Fernandes, Everton K. K.; Bittencourt, Vania R. E. P.; Roberts, Donald W.			Production of Destruxins from Metarhizium spp. Fungi in Artificial Medium and in Endophytically Colonized Cowpea Plants	PLOS ONE			English	Article							ANISOPLIAE; PATHOGENICITY; INHIBITION; INSECTS	Destruxins (DTXs) are cyclic depsipeptides produced by many Metarhizium isolates that have long been assumed to contribute to virulence of these entomopathogenic fungi. We evaluated the virulence of 20 Metarhizium isolates against insect larvae and measured the concentration of DTXs A, B, and E produced by these same isolates in submerged (shaken) cultures. Eight of the isolates (ARSEF 324, 724, 760, 1448, 1882, 1883, 3479, and 3918) did not produce DTXs A, B, or E during the five days of submerged culture. DTXs were first detected in culture medium at 2-3 days in submerged culture. Galleria mellonella and Tenebrio molitor showed considerable variation in their susceptibility to the Metarhizium isolates. The concentration of DTXs produced in vitro did not correlate with percent or speed of insect kill. We established endophytic associations of M. robertsii and M. acridum isolates in Vigna unguiculata (cowpeas) and Cucumis sativus (cucumber) plants. DTXs were detected in cowpeas colonized by M. robertsii ARSEF 2575 12 days after fungal inoculation, but DTXs were not detected in cucumber. This is the first instance of DTXs detected in plants endophytically colonized by M. robertsii. This finding has implications for new approaches to fungus-based biological control of pest arthropods.	[Golo, Patricia S.; Pires, Marcus S.; Bittencourt, Vania R. E. P.] Univ Fed Rural Rio de Janeiro, Inst Vet, Dept Parasitol Anim, Seropedica, RJ, Brazil; [Golo, Patricia S.; Grilley, Michelle M.; Takemoto, Jon Y.; Roberts, Donald W.] Utah State Univ, Dept Biol, Logan, UT 84322 USA; [Gardner, Dale R.] ARS, USDA, Poisonous Plants Res Lab, Logan, UT USA; [Krasnoff, Stuart B.] USDA ARS, Biol Integrated Pest Management Res Unit, Robert W Holley Ctr Agr & Hlth, Ithaca, NY 14853 USA; [Fernandes, Everton K. K.] Univ Fed Goias, Inst Patol Trop & Saude Publ, Goiania, Go, Brazil	Universidade Federal Rural do Rio de Janeiro (UFRRJ); Utah System of Higher Education; Utah State University; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Universidade Federal de Goias	Golo, PS (corresponding author), Univ Fed Rural Rio de Janeiro, Inst Vet, Dept Parasitol Anim, Seropedica, RJ, Brazil.	patriciagolo@gmail.com	Golo, Patricia/AAQ-2227-2020; Takemoto, Jon/A-5309-2011; Golo, Patricia/E-6469-2015; , Fernandes/I-4890-2012; Bittencourt, Vania Rita Elias Pinheiro/D-3219-2013	Golo, Patricia/0000-0003-1854-7488; Takemoto, Jon/0000-0001-9919-9168; Golo, Patricia/0000-0003-1854-7488; , Fernandes/0000-0001-7062-3295; Bittencourt, Vania Rita Elias Pinheiro/0000-0001-8473-8501	United States Department of Agriculture (USDA)/Animal Plant Health and Inspection Service (APHIS) [13-8130-0114-CA]; ARS [ARS-0424163] Funding Source: Federal RePORTER	United States Department of Agriculture (USDA)/Animal Plant Health and Inspection Service (APHIS); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This research was supported in part by grants from the United States Department of Agriculture (USDA)/Animal Plant Health and Inspection Service (APHIS); Cooperative agreement (CA) #13-8130-0114-CA. The financial support was received by DWR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiri B, 1999, BIOCONTROL SCI TECHN, V9, P487, DOI 10.1080/09583159929451; Ayres M., 2007, BIOESTAT 5 0 APLICA; Behie SW, 2012, SCIENCE, V336, P1576, DOI 10.1126/science.1222289; BILLS GF, 1991, CAN J BOT, V69, P1477, DOI 10.1139/b91-191; BING LA, 1991, ENVIRON ENTOMOL, V20, P1207, DOI 10.1093/ee/20.4.1207; Bischoff JF, 2009, MYCOLOGIA, V101, P512, DOI 10.3852/07-202; Bittencourt V. R. E. P., 1992, Arquivos da Universidade Federal Rural do Rio de Janeiro, V15, P197; CERENIUS L, 1990, J INSECT PHYSIOL, V36, P785, DOI 10.1016/0022-1910(90)90052-H; Donzelli BGG, 2012, CURR GENET, V58, P105, DOI 10.1007/s00294-012-0368-4; Fernandes EKK, 2008, EXP APPL ACAROL, V46, P71, DOI 10.1007/s10493-008-9161-y; Gurulingappa P, 2010, BIOL CONTROL, V55, P34, DOI 10.1016/j.biocontrol.2010.06.011; Han P, 2013, PLOS ONE, V8; HUXHAM IM, 1989, J INSECT PHYSIOL, V35, P97, DOI 10.1016/0022-1910(89)90042-5; JAMES PJ, 1993, J INSECT PHYSIOL, V39, P797, DOI 10.1016/0022-1910(93)90056-W; Kershaw MJ, 1999, J INVERTEBR PATHOL, V74, P213, DOI 10.1006/jipa.1999.4884; Krasnoff SB, 2006, J AGR FOOD CHEM, V54, P7083, DOI 10.1021/jf061405r; Leger RJS, 2008, J INVERTEBR PATHOL, V98, P271, DOI 10.1016/j.jip.2008.01.007; Moon YS, 2008, APPL ENVIRON MICROB, V74, P4366, DOI 10.1128/AEM.00285-08; MUROI M, 1994, BIOCHEM BIOPH RES CO, V205, P1358, DOI 10.1006/bbrc.1994.2815; O'Brien TR, 2008, THESIS; Parsa Soroush, 2013, J Vis Exp, DOI 10.3791/50360; Pava-Ripoll M, 2011, MICROBIOL-SGM, V157, P47, DOI 10.1099/mic.0.042200-0; Pedras MSC, 2002, PHYTOCHEMISTRY, V59, P579, DOI 10.1016/S0031-9422(02)00016-X; Pedras MSC, 2001, P NATL ACAD SCI USA, V98, P747, DOI 10.1073/pnas.021394998; PETRINI O, 1981, Sydowia, V34, P135; Quiot J.M., 1985, ADV CELL CULT, V4, P199, DOI [10.1016/B978-0-12-007904-9.50013-7, DOI 10.1016/B978-0-12-007904-9.50013-7]; Rangel DEN, 2011, FEMS MICROBIOL LETT, V315, P81, DOI 10.1111/j.1574-6968.2010.02168.x; Roberts DW, 2004, ADV APPL MICROBIOL, V54, P1, DOI 10.1016/S0065-2164(04)54001-7; Samish M, 2004, PARASITOLOGY, V129, pS389, DOI 10.1017/S0031182004005219; Sampaio IBM, 2002, ESTATISTICA APLICADA; SAMUELS RI, 1988, COMP BIOCHEM PHYS C, V90, P403, DOI 10.1016/0742-8413(88)90018-7; SAMUELS RI, 1988, MYCOPATHOLOGIA, V104, P51, DOI 10.1007/BF00437924; Sasan RK, 2012, AM J BOT, V99, P101, DOI 10.3732/ajb.1100136; Skrobek A, 2008, BIOCONTROL, V53, P361, DOI 10.1007/s10526-007-9077-1; SUZUKI A, 1971, AGR BIOL CHEM TOKYO, V35, P1641, DOI 10.1080/00021369.1971.10860127; Thomsen L., 1996, Bulletin OILB/SROP, V19, P190; TULLOCH M, 1976, T BRIT MYCOL SOC, V66, P407, DOI 10.1016/S0007-1536(76)80209-4; Vega FE, 2008, BIOL CONTROL, V46, P72, DOI 10.1016/j.biocontrol.2008.01.008; Vey A, 2002, J INVERTEBR PATHOL, V80, P177, DOI 10.1016/S0022-2011(02)00104-0; Vilcinskas A, 1997, J INSECT PHYSIOL, V43, P475, DOI 10.1016/S0022-1910(96)00120-5; Wang B, 2012, P NATL ACAD SCI USA, V109, P1287, DOI 10.1073/pnas.1115983109; Wyrebek M, 2011, MICROBIOL-SGM, V157, P2904, DOI 10.1099/mic.0.051102-0	42	31	31	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104946	10.1371/journal.pone.0104946	http://dx.doi.org/10.1371/journal.pone.0104946			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127450	gold, Green Submitted, Green Published			2022-12-25	WOS:000340879300062
J	Hu, J; Jiang, L; Low, MJ; Rui, LY				Hu, Jun; Jiang, Lin; Low, Malcolm J.; Rui, Liangyou			Glucose Rapidly Induces Different Forms of Excitatory Synaptic Plasticity in Hypothalamic POMC Neurons	PLOS ONE			English	Article							ARCUATE PROOPIOMELANOCORTIN NEURONS; ACTIVATED PROTEIN-KINASE; NEUROPEPTIDE-Y; TRPC CHANNELS; BODY-WEIGHT; NUCLEUS; LEPTIN; INSULIN; EXPRESSION; OBESITY	Hypothalamic POMC neurons are required for glucose and energy homeostasis. POMC neurons have a wide synaptic connection with neurons both within and outside the hypothalamus, and their activity is controlled by a balance between excitatory and inhibitory synaptic inputs. Brain glucose-sensing plays an essential role in the maintenance of normal body weight and metabolism; however, the effect of glucose on synaptic transmission in POMC neurons is largely unknown. Here we identified three types of POMC neurons (EPSC(+), EPSC(-), and EPSC(+/-)) based on their glucose-regulated spontaneous excitatory postsynaptic currents (sEPSCs), using whole-cell patch-clamp recordings. Lowering extracellular glucose decreased the frequency of sEPSCs in EPSC(+) neurons, but increased it in EPSC(-) neurons. Unlike EPSC(+) and EPSC(-) neurons, EPSC(+/-) neurons displayed a bi-phasic sEPSC response to glucoprivation. In the first phase of glucoprivation, both the frequency and the amplitude of sEPSCs decreased, whereas in the second phase, they increased progressively to the levels above the baseline values. Accordingly, lowering glucose exerted a bi-phasic effect on spontaneous action potentials in EPSC(+/-) neurons. Glucoprivation decreased firing rates in the first phase, but increased them in the second phase. These data indicate that glucose induces distinct excitatory synaptic plasticity in different subpopulations of POMC neurons. This synaptic remodeling is likely to regulate the sensitivity of the melanocortin system to neuronal and hormonal signals.	[Hu, Jun; Jiang, Lin; Low, Malcolm J.; Rui, Liangyou] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Hu, Jun] Nanjing Med Univ, Affiliated Hosp 1, Dept Orthoped, Nanjing, Jiangsu, Peoples R China	University of Michigan System; University of Michigan; Nanjing Medical University	Rui, LY (corresponding author), Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA.	ruily@umich.edu		Low, Malcolm/0000-0002-9900-3708	National Institutes of Health [DK065122, DK091591, DK094014, NIH R01 DK066604]; Michigan Diabetes Research and Training Center [NIH DK20572]; University of Michigan's Cancer Center [NIH CA46592]; University of Michigan Nathan Shock Center [NIH P30AG013283]; University of Michigan Gut Peptide Research Center [NIH DK34933]; National Natural Science Foundation of China [81373397]; State Scholarship Funds [201208320286]; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572, P30DK034933, P60DK020572, R01DK091591, R01DK094014, R01DK065122, R01DK066604] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG013283] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michigan Diabetes Research and Training Center; University of Michigan's Cancer Center(University of Michigan System); University of Michigan Nathan Shock Center; University of Michigan Gut Peptide Research Center; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Scholarship Funds; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants DK065122, DK091591, DK094014 and NIH R01 DK066604 (MJL) from the National Institutes of Health. This work utilized the cores supported by the Michigan Diabetes Research and Training Center (NIH DK20572), the University of Michigan's Cancer Center (NIH CA46592), the University of Michigan Nathan Shock Center (NIH P30AG013283), and the University of Michigan Gut Peptide Research Center (NIH DK34933). HJ was supported by the grants from the National Natural Science Foundation of China (No. 81373397) and the State Scholarship Funds (No. 201208320286). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Campfield LA, 2003, PHYSIOL REV, V83, P25, DOI 10.1152/physrev.00019.2002; Claret M, 2007, J CLIN INVEST, V117, P2325, DOI 10.1172/JCI31516; Collin M, 2003, EUR J NEUROSCI, V18, P1265, DOI 10.1046/j.1460-9568.2003.02840.x; Elias CF, 1998, NEURON, V21, P1375, DOI 10.1016/S0896-6273(00)80656-X; Fioramonti X, 2007, DIABETES, V56, P1219, DOI 10.2337/db06-0567; Fioramonti X, 2010, DIABETES, V59, P519, DOI 10.2337/db09-0421; Heisler LK, 2002, SCIENCE, V297, P609, DOI 10.1126/science.1072327; Hentges ST, 2009, J NEUROSCI, V29, P13684, DOI 10.1523/JNEUROSCI.3770-09.2009; Hentges ST, 2005, J NEUROSCI, V25, P9746, DOI 10.1523/JNEUROSCI.2769-05.2005; Hentges ST, 2004, J NEUROSCI, V24, P1578, DOI 10.1523/JNEUROSCI.3952-03.2004; Hill JW, 2008, J CLIN INVEST, V118, P1796, DOI 10.1172/JCI32964; Ibrahim N, 2003, ENDOCRINOLOGY, V144, P1331, DOI 10.1210/en.2002-221033; Jarvie BC, 2012, J COMP NEUROL, V520, P3863, DOI 10.1002/cne.23127; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Karnani M, 2011, AM J PHYSIOL-REG I, V300, pR47, DOI 10.1152/ajpregu.00527.2010; KELLY MJ, 1990, NEUROENDOCRINOLOGY, V52, P268, DOI 10.1159/000125597; Kiss J, 2005, EUR J NEUROSCI, V21, P2111, DOI 10.1111/j.1460-9568.2005.04012.x; Lam TKT, 2007, NAT MED, V13, P171, DOI 10.1038/nm1540; Meister B, 2006, EUR J NEUROSCI, V24, P2731, DOI 10.1111/j.1460-9568.2006.05157.x; Mercer AJ, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00019; Newton AJ, 2013, ENDOCRINOLOGY, V154, P172, DOI 10.1210/en.2012-1643; Parton LE, 2007, NATURE, V449, P228, DOI 10.1038/nature06098; Pennock RL, 2011, J NEUROSCI, V31, P281, DOI 10.1523/JNEUROSCI.4654-10.2011; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Plum L, 2006, J CLIN INVEST, V116, P1886, DOI 10.1172/JCI27123; Qiu J, 2010, J NEUROSCI, V30, P1560, DOI 10.1523/JNEUROSCI.4816-09.2010; Rother E, 2012, P NATL ACAD SCI USA, V109, P18132, DOI 10.1073/pnas.1206147109; Routh VH, 2010, SENSORS-BASEL, V10, P9002, DOI 10.3390/s101009002; Ruderman NB, 2006, OBESITY, V14, p25S, DOI 10.1038/oby.2006.279; Rui LY, 2013, REV ENDOCR METAB DIS, V14, P387, DOI 10.1007/s11154-013-9261-9; Sohn JW, 2011, NEURON, V71, P488, DOI 10.1016/j.neuron.2011.06.012; Song ZT, 2001, DIABETES, V50, P2673, DOI 10.2337/diabetes.50.12.2673; Spanswick D, 2000, NAT NEUROSCI, V3, P757, DOI 10.1038/77660; Sternson SM, 2005, NAT NEUROSCI, V8, P1356, DOI 10.1038/nn1550; Thorens B, 2011, DIABETES OBES METAB, V13, P82, DOI 10.1111/j.1463-1326.2011.01453.x; Vong L, 2011, NEURON, V71, P142, DOI 10.1016/j.neuron.2011.05.028; Wang R, 2004, DIABETES, V53, P1959, DOI 10.2337/diabetes.53.8.1959; Williams KW, 2010, J NEUROSCI, V30, P2472, DOI 10.1523/JNEUROSCI.3118-09.2010; Wittmann G, 2013, J COMP NEUROL, V521, P3287, DOI 10.1002/cne.23350; Xu Y, 2010, NAT NEUROSCI, V13, P1457, DOI 10.1038/nn.2664; Zhan C, 2013, J NEUROSCI, V33, P3624, DOI 10.1523/JNEUROSCI.2742-12.2013; Zhang XB, 2013, J PHYSIOL-LONDON, V591, P1731, DOI 10.1113/jphysiol.2012.248385	43	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105080	10.1371/journal.pone.0105080	http://dx.doi.org/10.1371/journal.pone.0105080			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127258	Green Submitted, gold, Green Published			2022-12-25	WOS:000340879300076
J	Rezouki, C; Dozieres, A; Le Coeur, C; Thibault, S; Pisanu, B; Chapuis, JL; Baudry, E				Rezouki, Celia; Dozieres, Anne; Le Coeur, Christie; Thibault, Sophie; Pisanu, Benoit; Chapuis, Jean-Louis; Baudry, Emmanuelle			A Viable Population of the European Red Squirrel in an Urban Park	PLOS ONE			English	Article							SCIURUS-VULGARIS; GREY SQUIRRELS; HABITAT FRAGMENTATION; REPRODUCTIVE SUCCESS; VIABILITY ANALYSIS; GENETIC-STRUCTURE; SPACE USE; DYNAMICS; CAROLINENSIS; CONSERVATION	Whether urban parks can maintain viable and self-sustaining populations over the long term is questionable. In highly urbanized landscapes, urban parks could play a role in biodiversity conservation by providing habitat and resources to native species. However, populations inhabiting urban parks are usually small and isolated, leading to increased demographic stochasticity and genetic drift, with expected negative consequences on their viability. Here, we investigated a European red squirrel population located in an urban park close to Paris, France (Parc de Sceaux; 184 ha) to assess its viability. Using mitochondrial D-loop sequences and 13 microsatellite loci, we showed that the population presented high levels of genetic variation and no evidence of inbreeding. The size of the population was estimated at 100-120 individuals based on the comparison of two census techniques, Distance Sampling and Capture-Mark-Recapture. The estimated heterozygosity level and population size were integrated in a Population Viability Analysis to project the likelihood of the population's persistence over time. Results indicate that the red squirrel population of this urban park can be viable on the long term (i.e. 20 years) for a range of realistic demographic parameters (juvenile survival at least >40%) and immigration rates (at least one immigration event every two years). This study highlights that urban parks can be potential suitable refuges for the red squirrel, a locally threatened species across western European countries, provided that ecological corridors are maintained.	[Rezouki, Celia; Dozieres, Anne; Le Coeur, Christie; Pisanu, Benoit; Chapuis, Jean-Louis] Museum Natl Hist Nat, Ctr Ecol & Sci Conservat, F-75231 Paris, France; [Thibault, Sophie; Baudry, Emmanuelle] Univ Paris 11, Lab Ecol Systemat & Evolut, Orsay, France	Museum National d'Histoire Naturelle (MNHN); AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay	Chapuis, JL (corresponding author), Museum Natl Hist Nat, Ctr Ecol & Sci Conservat, F-75231 Paris, France.	chapuis@mnhn.fr	Baudry, Emmanuelle/G-4005-2010		Conseil General des Hauts-de-Seine (Parc de Sceaux); Ministere de l'Ecologie, du Developpement Durable et de l'Energie (MEDDE); Office National des Forets (ONF)	Conseil General des Hauts-de-Seine (Parc de Sceaux); Ministere de l'Ecologie, du Developpement Durable et de l'Energie (MEDDE); Office National des Forets (ONF)	This work was funded by the Conseil General des Hauts-de-Seine (Parc de Sceaux), the Ministere de l'Ecologie, du Developpement Durable et de l'Energie (MEDDE) and the Office National des Forets (ONF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf FW, 2002, POPULATION VIABILITY ANALYSIS, P50; Alvey Alexis A., 2006, Urban Forestry & Urban Greening, V5, P195, DOI 10.1016/j.ufug.2006.09.003; Babinska-Werka J, 2008, ANN ZOOL FENN, V45, P270, DOI 10.5735/086.045.0405; Beissinger S. R., 2002, POPULATION VIABILITY; Brook BW, 2000, NATURE, V404, P385, DOI 10.1038/35006050; Broquet T, 2007, CONSERV GENET, V8, P249, DOI 10.1007/s10592-006-9146-5; Buckland S. T., 1993, Distance sampling: estimating abundance of biological populations.; Burnham K. P., 1980, WILDLIFE MONOGR, V72, P1; Chapuis J.-L., 2012, ECUREUILS FRANCE; Cornelis J, 2004, LANDSCAPE URBAN PLAN, V69, P385, DOI 10.1016/j.landurbplan.2003.10.038; Coulson T, 2001, TRENDS ECOL EVOL, V16, P219, DOI 10.1016/S0169-5347(01)02137-1; Czech B, 2000, BIOSCIENCE, V50, P593, DOI 10.1641/0006-3568(2000)050[0593:EAACOS]2.0.CO;2; Delin AE, 1999, LANDSCAPE ECOL, V14, P67, DOI 10.1023/A:1008040001801; Dozieres A, 2012, THESIS MUSEUM NATL H; Dozieres A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047607; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Filatov DA, 2009, BIOINFORMATICS, V25, P3189, DOI 10.1093/bioinformatics/btp572; GOUDET J, 2002, FSTAT SOFTWARE ESTIM; Gurnell J, 2004, MAMMAL REV, V34, P51, DOI 10.1046/j.0305-1838.2003.00028.x; GURNELL J, 1983, MAMMAL REV, V13, P133, DOI 10.1111/j.1365-2907.1983.tb00274.x; Gurnell J, 2004, J ANIM ECOL, V73, P26, DOI 10.1111/j.1365-2656.2004.00791.x; Gurnell J, 1987, NATURAL HIST SQUIRRE; Gurnell J., 2001, 11 FOR COMM; Kendall WL, 1997, ECOLOGY, V78, P563; Kenward RE, 1998, J ZOOL, V244, P23; Koprowski JL, 2005, ANIM CONSERV, V8, P369, DOI 10.1017/S1367943005002416; Lacy R.C., 2009, VORTEX STOCHASTIC SI; Laguet S, 2012, ECUREUIL ROUX SCIURU; LaRose JP, 2010, VET REC, V167, P297, DOI 10.1136/vr.c4196; Lurz Peter W. W., 2005, Mammalian Species, P1; LYNCH M, 1995, AM NAT, V146, P489, DOI 10.1086/285812; MACE GM, 1991, CONSERV BIOL, V5, P148, DOI 10.1111/j.1523-1739.1991.tb00119.x; Magris L, 2002, J ZOOL, V256, P99, DOI 10.1017/S0952836902000134; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; Ogden R, 2005, CONSERV GENET, V6, P511, DOI 10.1007/s10592-005-9006-8; Pritchard JK, 2000, GENETICS, V155, P945; Robert A, 2011, AM NAT, V177, P99, DOI 10.1086/657434; Shar S., 2008, SCIURUS VULGARIS IUC; Shochat E, 2006, TRENDS ECOL EVOL, V21, P186, DOI 10.1016/j.tree.2005.11.019; Shuttleworth CM, 2000, WILDLIFE BIOL, V6, P149, DOI 10.2981/wlb.2000.010; Shuttleworth Craig M., 2003, Urban Ecosystems, V5, P109, DOI 10.1023/A:1022387620713; Simpson S, 2013, ECOL EVOL, V3, P614, DOI 10.1002/ece3.486; STACEY PB, 1992, ECOL APPL, V2, P18, DOI 10.2307/1941886; Trizio I, 2005, MOL ECOL, V14, P469, DOI 10.1111/j.1365-294X.2005.02428.x; Verbeylen G, 2003, ECOGRAPHY, V26, P118, DOI 10.1034/j.1600-0587.2003.03236.x; Verbeylen G, 2003, LANDSCAPE ECOL, V18, P791, DOI 10.1023/B:LAND.0000014492.50765.05; WAUTERS L, 1994, OIKOS, V69, P140, DOI 10.2307/3545294; WAUTERS L, 1989, J ANIM ECOL, V58, P637, DOI 10.2307/4853; Wauters LA, 2000, ECOL RES, V15, P271, DOI 10.1046/j.1440-1703.2000.00354.x; WAUTERS LA, 1994, P ROY SOC B-BIOL SCI, V255, P107, DOI 10.1098/rspb.1994.0015; Wauters LA, 2004, J ANIM ECOL, V73, P11, DOI 10.1111/j.1365-2656.2004.00792.x; Wauters LA, 1997, BIOL CONSERV, V82, P101, DOI 10.1016/S0006-3207(97)00007-4; WAUTERS LA, 1995, OIKOS, V72, P402, DOI 10.2307/3546126; WAUTERS LA, 1995, ECOLOGY, V76, P2460, DOI 10.2307/2265820; Wauters LA, 2008, ECOGRAPHY, V31, P104, DOI 10.1111/j.2007.0906-7590.05251.x; Wauters LA, 2011, MAMM BIOL, V76, P369, DOI 10.1016/j.mambio.2010.04.003; Wauters LA, 2010, POPUL ECOL, V52, P527, DOI 10.1007/s10144-010-0203-z	57	22	25	3	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105111	10.1371/journal.pone.0105111	http://dx.doi.org/10.1371/journal.pone.0105111			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126848	gold, Green Published, Green Submitted			2022-12-25	WOS:000340879300080
J	Jha, V; Workman, CJ; McGaha, TL; Li, LP; Vas, J; Vignali, DAA; Monestier, M				Jha, Vibha; Workman, Creg J.; McGaha, Tracy L.; Li, Liping; Vas, Jaya; Vignali, Dario A. A.; Monestier, Marc			Lymphocyte Activation Gene-3 (LAG-3) Negatively Regulates Environmentally-Induced Autoimmunity	PLOS ONE			English	Article							MERCURY-INDUCED AUTOIMMUNITY; DENDRITIC CELLS; T-CELLS; ANTINUCLEOLAR ANTIBODIES; TRYPTOPHAN CATABOLISM; MOLECULAR ANALYSIS; EFFECTOR FUNCTION; PROTEIN; MICE; PROLIFERATION	Environmental factors including drugs, mineral oils and heavy metals such as lead, gold and mercury are triggers of autoimmune diseases in animal models or even in occupationally exposed humans. After exposure to subtoxic levels of mercury (Hg), genetically susceptible strains of mice develop an autoimmune disease characterized by the production of highly specific anti-nucleolar autoantibodies, hyperglobulinemia and nephritis. However, mice can be tolerized to the disease by a single low dose administration of Hg. Lymphocyte Activation Gene-3 (LAG-3) is a CD4-related, MHC-class II binding molecule expressed on activated T cells and NK cells which maintains lymphocyte homeostatic balance via various inhibitory mechanisms. In our model, administration of anti-LAG-3 monoclonal antibody broke tolerance to Hg resulting in autoantibody production and an increase in serum IgE level. In addition, LAG-3-deficient B6.SJL mice not only had increased susceptibility to Hg-induced autoimmunity but were also unresponsive to tolerance induction. Conversely, adoptive transfer of wild-type CD4(+) T cells was able to partially rescue LAG-3-deficient mice from the autoimmune disease. Further, in LAG-3-deficient mice, mercury elicited higher amounts of IL-6, IL-4 and IFN-gamma, cytokines known to play a critical role in mercury-induced autoimmunity. Therefore, we conclude that LAG-3 exerts an important regulatory effect on autoimmunity elicited by a common environmental pollutant.	[Jha, Vibha; Li, Liping; Vas, Jaya; Monestier, Marc] Temple Univ, Sch Med, Temple Autoimmun Ctr, Philadelphia, PA 19122 USA; [Jha, Vibha; Li, Liping; Vas, Jaya; Monestier, Marc] Temple Univ, Sch Med, Dept Microbiol & Immunol, Philadelphia, PA 19122 USA; [McGaha, Tracy L.] Temple Univ, Sch Med, Rheumatol Sect, Dept Med, Philadelphia, PA 19122 USA; [Workman, Creg J.; Vignali, Dario A. A.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; St Jude Children's Research Hospital	Monestier, M (corresponding author), Temple Univ, Sch Med, Temple Autoimmun Ctr, Philadelphia, PA 19122 USA.	marcm@temple.edu	li, liping/G-3163-2010	li, liping/0000-0001-6407-2589; McGaha, Tracy/0000-0003-4721-9301	National Institutes of Health [ES-12646]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R13ES012646] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	National Institutes of Health Grant ES-12646. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedi-Valugerdi M, 2001, SCAND J IMMUNOL, V54, P190, DOI 10.1046/j.1365-3083.2001.00932.x; Arnett FC, 1996, ARTHRITIS RHEUM-US, V39, P1151, DOI 10.1002/art.1780390712; Bagenstose LM, 1998, CLIN EXP IMMUNOL, V114, P9; Bagenstose LM, 1998, J IMMUNOL, V160, P1612; BAIXERAS E, 1992, J EXP MED, V176, P327, DOI 10.1084/jem.176.2.327; Bertrand H, 1995, EUR J IMMUNOL, V25, P2718; Bilsborough J, 2003, IMMUNOLOGY, V108, P481, DOI 10.1046/j.1365-2567.2003.01606.x; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Bruniquel D, 1997, IMMUNOGENETICS, V47, P96, DOI 10.1007/s002510050332; Fallarino F, 2003, NAT IMMUNOL, V4, P1206, DOI 10.1038/ni1003; Fallarino F, 2004, J IMMUNOL, V173, P3748, DOI 10.4049/jimmunol.173.6.3748; Grosso JF, 2007, J CLIN INVEST, V117, P3383, DOI 10.1172/JCI31184; Haggqvist B, 2003, CLIN EXP IMMUNOL, V134, P202, DOI 10.1046/j.1365-2249.2003.02303.x; Hanley GA, 1997, CLIN IMMUNOL IMMUNOP, V84, P328, DOI 10.1006/clin.1997.4405; Hanley GA, 1998, J IMMUNOL, V161, P1778; Havarinasab S, 2009, CLIN EXP IMMUNOL, V155, P567, DOI 10.1111/j.1365-2249.2008.03831.x; Houot R, 2006, J IMMUNOL, V176, P5293, DOI 10.4049/jimmunol.176.9.5293; Huang CT, 2004, IMMUNITY, V21, P503, DOI 10.1016/j.immuni.2004.08.010; HUARD B, 1994, IMMUNOGENETICS, V39, P213; HULTMAN P, 1992, CLIN IMMUNOL IMMUNOP, V65, P98, DOI 10.1016/0090-1229(92)90212-7; Johansson U, 1997, J AUTOIMMUN, V10, P347, DOI 10.1006/jaut.1997.0149; Kisielow M, 2005, EUR J IMMUNOL, V35, P2081, DOI 10.1002/eji.200526090; Kono DH, 1998, J IMMUNOL, V161, P234; LAUWERYS R, 1983, TOXICOL LETT, V17, P113, DOI 10.1016/0378-4274(83)90045-0; Li NY, 2007, EMBO J, V26, P494, DOI 10.1038/sj.emboj.7601520; Li NY, 2004, J IMMUNOL, V173, P6806, DOI 10.4049/jimmunol.173.11.6806; Liang BT, 2008, J IMMUNOL, V180, P5916, DOI 10.4049/jimmunol.180.9.5916; Martin P, 2002, BLOOD, V100, P383, DOI 10.1182/blood.V100.2.383; McGaha TL, 2008, J IMMUNOL, V180, P5670, DOI 10.4049/jimmunol.180.8.5670; Miyazaki T, 1996, SCIENCE, V272, P405, DOI 10.1126/science.272.5260.405; MONESTIER M, 1994, J IMMUNOL, V152, P667; Moszczynski P, 1995, Int J Occup Med Environ Health, V8, P49; OCHEL M, 1991, J IMMUNOL, V146, P3006; Pollard KM, 2005, AUTOIMMUN REV, V4, P282, DOI 10.1016/j.autrev.2004.12.005; Pollard KM, 2003, ANN NY ACAD SCI, V987, P236, DOI 10.1111/j.1749-6632.2003.tb06053.x; Pollard KM, 2001, INT IMMUNOPHARMACOL, V1, P581, DOI 10.1016/S1567-5769(00)00034-5; Pollard KM, 2001, ENVIRON HEALTH PERSP, V109, P27, DOI 10.2307/3434917; Richter K, 2010, INT IMMUNOL, V22, P13, DOI 10.1093/intimm/dxp107; Robinson CJG, 1997, CLIN IMMUNOL IMMUNOP, V83, P127, DOI 10.1006/clin.1997.4336; Schiraldi M, 2009, TRENDS IMMUNOL, V30, P502, DOI 10.1016/j.it.2009.07.005; Serra P, 2003, IMMUNITY, V19, P877, DOI 10.1016/S1074-7613(03)00327-3; Shin H, 2007, CURR OPIN IMMUNOL, V19, P408, DOI 10.1016/j.coi.2007.06.004; Silbergeld Ellen K, 2005, Toxicol Appl Pharmacol, V207, P282, DOI 10.1016/j.taap.2004.11.035; TRIEBEL F, 1990, J EXP MED, V171, P1393, DOI 10.1084/jem.171.5.1393; Vas J, 2008, J IMMUNOL, V181, P6779, DOI 10.4049/jimmunol.181.10.6779; Vas J, 2008, ANN NY ACAD SCI, V1143, P240, DOI 10.1196/annals.1443.022; Via CS, 2003, ENVIRON HEALTH PERSP, V111, P1273, DOI 10.1289/ehp.6064; Workman CJ, 2005, J IMMUNOL, V174, P688, DOI 10.4049/jimmunol.174.2.688; Workman CJ, 2003, EUR J IMMUNOL, V33, P970, DOI 10.1002/eji.200323382; Workman CJ, 2002, EUR J IMMUNOL, V32, P2255, DOI 10.1002/1521-4141(200208)32:8<2255::AID-IMMU2255>3.0.CO;2-A; Workman CJ, 2002, J IMMUNOL, V169, P5392, DOI 10.4049/jimmunol.169.10.5392; Workman CJ, 2009, J IMMUNOL, V182, P1885, DOI 10.4049/jimmunol.0800185; Zarek PE, 2008, BLOOD, V111, P251, DOI 10.1182/blood-2007-03-081646; Zhu XF, 2007, GRAEF ARCH CLIN EXP, V245, P1549, DOI 10.1007/s00417-007-0591-8; Ziemba SE, 2009, FASEB J, V23, P1663, DOI 10.1096/fj.08-117283	55	28	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104484	10.1371/journal.pone.0104484	http://dx.doi.org/10.1371/journal.pone.0104484			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122007	Green Published, gold, Green Submitted			2022-12-25	WOS:000341017000040
J	Li, Y; Ma, X; Zhao, ML; Qi, P; Zhong, JG				Li, Ying; Ma, Xiao; Zhao, Minglu; Qi, Pan; Zhong, Jingang			Quick and Label-Free Detection for Coumaphos by Using Surface Plasmon Resonance Biochip	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; ORGANOPHOSPHORUS INSECTICIDE FENTHION; LINKED-IMMUNOSORBENT-ASSAY; THIN-LAYER-CHROMATOGRAPHY; LIQUID-CHROMATOGRAPHY; PESTICIDE-RESIDUES; GAS-CHROMATOGRAPHY; APIS-MELLIFERA; HONEY SAMPLES; IMMUNOASSAY	Coumaphos is a common organophosphorus pesticide used in agricultural products. It is harmful to human health and has a strictly stipulated maximum residue limit (MRL) on fruits and vegetables. Currently existing methods for detection are complex in execution, require expensive tools and are time consuming and labor intensive. The surface plasmon resonance method has been widely used in biomedicine and many other fields. This study discusses a detection method based on surface plasmon resonance in organophosphorus pesticide residues. As an alternative solution, this study proposes a method to detect Coumaphos. The method, which is based on surface plasmon resonance (SPR) and immune reaction, belongs to the suppression method. A group of samples of Coumaphos was detected by this method. The concentrations of Coumaphos in the samples were 0 mu g/L, 50 mu g/L, 100 mu g/L, 300 mu g/L, 500 mu g/L, 1000 mu g/L, 3000 mu g/L and 5000 mu g/L, respectively. Through detecting a group of samples, the process of kinetic reactions was analyzed and the corresponding standard curve was obtained. The sensibility is less than 25 mu g/L, conforming to the standard of the MRL of Coumaphos stipulated by China. This method is label- free, using an unpurified single antibody only and can continuously test at least 80 groups of samples continuously. It has high sensitivity and specificity. The required equipments are simple, environmental friendly and easy to control. So this method is promised for a large number of samples quick detection on spot and for application prospects.	[Li, Ying; Zhong, Jingang] Jinan Univ, Guangdong Higher Educ Inst, Key Lab Optoelect Informat & Sensing Technol, Guangzhou, Guangdong, Peoples R China; [Li, Ying] Jinan Univ, Preuniv Dept, Guangzhou, Guangdong, Peoples R China; [Ma, Xiao; Zhao, Minglu; Zhong, Jingang] Jinan Univ, Dept Optoelect Engn, Guangzhou, Guangdong, Peoples R China; [Qi, Pan] Guangdong Commun Polytech, Dept Elect Engn, Guangzhou, Guangdong, Peoples R China	Jinan University; Jinan University; Jinan University	Zhong, JG (corresponding author), Jinan Univ, Guangdong Higher Educ Inst, Key Lab Optoelect Informat & Sensing Technol, Guangzhou, Guangdong, Peoples R China.	tzjg@jnu.edu.cn			National Natural Science Foundation of China (NSFC) [41206081]; Key Laboratory of Integrated Marine Monitoring, Guangdong Natural Science Foundation [8451063201000076]; Applied Technologies for Harmful Algal Blooms [MATHAB20120208]; breakthroughs in key areas of Guangdong and Hong Kong [2005A20501001]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Key Laboratory of Integrated Marine Monitoring, Guangdong Natural Science Foundation; Applied Technologies for Harmful Algal Blooms; breakthroughs in key areas of Guangdong and Hong Kong	This work was supported by National Natural Science Foundation of China (NSFC) under the Grant No. 41206081, Key Laboratory of Integrated Marine Monitoring, Guangdong Natural Science Foundation under the Grant No. 8451063201000076, and Applied Technologies for Harmful Algal Blooms under the Grant No. MATHAB20120208, and breakthroughs in key areas of Guangdong and Hong Kong tender No. 2005A20501001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albero B, 2004, J AGR FOOD CHEM, V52, P5828, DOI 10.1021/jf049470t; Balayiannis G, 2008, ARCH ENVIRON CON TOX, V55, P462, DOI 10.1007/s00244-007-9126-x; Brun EM, 2004, J IMMUNOL METHODS, V295, P21, DOI 10.1016/j.jim.2004.08.014; BUTZ S, 1995, ANAL CHEM, V67, P620, DOI 10.1021/ac00099a021; Choudhary A, 2008, B ENVIRON CONTAM TOX, V80, P417, DOI 10.1007/s00128-008-9426-5; Dai Z, 2012, ANAL CHEM, V84, P8157, DOI 10.1021/ac301217s; Das YK, 2009, B ENVIRON CONTAM TOX, V83, P378, DOI 10.1007/s00128-009-9778-5; Eddleston M, 2002, QJM-INT J MED, V95, P275, DOI 10.1093/qjmed/95.5.275; EVERSOLE JW, 1965, J ECON ENTOMOL, V58, P709, DOI 10.1093/jee/58.4.709; Famiglini G, 2009, ANAL CHEM, V81, P7373, DOI 10.1021/ac9008995; Grimalt S, 2006, J AGR FOOD CHEM, V54, P1188, DOI 10.1021/jf052737j; HILL E F, 1982, Environmental Toxicology and Chemistry, V1, P27, DOI 10.1897/1552-8618(1982)1[27:APOBFM]2.0.CO;2; Huang Z, 2001, AM BEE J, V141, P730; Janotta M, 2003, ANAL CHIM ACTA, V496, P339, DOI 10.1016/S0003-2670(03)01011-0; Jimenez JJ, 1998, J CHROMATOGR A, V829, P269, DOI 10.1016/S0021-9673(98)00826-7; Johnson RM, 2009, J ECON ENTOMOL, V102, P474, DOI 10.1603/029.102.0202; Kim YJ, 2003, ANAL CHIM ACTA, V494, P29, DOI 10.1016/j.aca.2003.07.003; Kuo YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022382; LAWRENCE JF, 1976, J CHROMATOGR, V121, P343, DOI 10.1016/S0021-9673(00)85032-3; Li Y, 2014, EUR FOOD RES TECHNOL, V239, P195, DOI 10.1007/s00217-014-2201-4; MARRS TC, 1993, PHARMACOL THERAPEUT, V58, P51, DOI 10.1016/0163-7258(93)90066-M; Ministry of Health PR China Standardization Administration of the PR China, 2012, 27632012 GB MIN HLTH; Moeller N, 2007, EUR FOOD RES TECHNOL, V224, P285, DOI 10.1007/s00217-006-0392-z; Nogues C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012152; Pang GF, 2006, FOOD ADDIT CONTAM A, V23, P777, DOI 10.1080/02652030600657997; Pardio VT, 2007, J ENVIRON SCI HEAL B, V42, P359, DOI 10.1080/03601230701310500; POPENDORF WJ, 1982, RESIDUE REV, V82, P125; Rissato SR, 2007, FOOD CHEM, V101, P1719, DOI 10.1016/j.foodchem.2005.10.034; Sannino A, 2004, J CHROMATOGR A, V1036, P161, DOI 10.1016/j.chroma.2004.02.078; SAVAGE EP, 1988, ARCH ENVIRON HEALTH, V43, P38, DOI 10.1080/00039896.1988.9934372; Skerl MIS, 2009, B ENVIRON CONTAM TOX, V83, P374, DOI 10.1007/s00128-009-9762-0; Tanner PA, 1996, APPL SPECTROSC, V50, P565, DOI 10.1366/0003702963905781; Viveros L, 2006, SENSOR ACTUAT B-CHEM, V115, P150, DOI 10.1016/j.snb.2005.08.032; Weick J, 2002, J ECON ENTOMOL, V95, P227, DOI 10.1603/0022-0493-95.2.227; Xu ZL, 2011, ANAL CHIM ACTA, V708, P123, DOI 10.1016/j.aca.2011.09.040; Yavuz H, 2010, ENVIRON MONIT ASSESS, V168, P277, DOI 10.1007/s10661-009-1111-6; Yin GH, 2009, APPL MICROBIOL BIOT, V84, P323, DOI 10.1007/s00253-009-1967-y	37	2	3	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104689	10.1371/journal.pone.0104689	http://dx.doi.org/10.1371/journal.pone.0104689			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122502	Green Published, Green Submitted, gold			2022-12-25	WOS:000341017000056
J	Park, SA; Raghunathan, VK; Shah, NM; Teixeira, L; Motta, MJ; Covert, J; Dubielzig, R; Schurr, M; Isseroff, RR; Abbott, NL; McAnulty, J; Murphy, CJ				Park, Shin Ae; Raghunathan, Vijay Krishna; Shah, Nihar M.; Teixeira, Leandro; Motta, Monica J.; Covert, Jill; Dubielzig, Richard; Schurr, Michael; Isseroff, Roslyn Rivkah; Abbott, Nicholas L.; McAnulty, Jonathan; Murphy, Christopher J.			PDGF-BB Does Not Accelerate Healing in Diabetic Mice with Splinted Skin Wounds	PLOS ONE			English	Article							GROWTH FACTOR-BB; IN-VITRO; CELL-PROLIFERATION; KERATINOCYTES; BETA; FGF; DIFFERENTIATION; ANGIOGENESIS; EXPRESSION; MIGRATION	Topical application of platelet-derived growth factor-BB (PDGF-BB) is considered to accelerate tissue repair of impaired chronic wounds. However, the vast literature is plagued with conflicting reports of its efficacy in animal models and this is often influenced by a wide array of experimental variables making it difficult to compare the results across the studies. To mitigate the confounding variables that influence the efficacy of topically applied PDGF-BB, we used a controlled full thickness splinted excisional wound model in db/db mice (type 2 diabetic mouse model) for our investigations. A carefully-defined silicone-splinted wound model, with reduced wound contraction, controlled splint and bandage maintenance, allowing for healing primarily by reepithelialization was employed. Two splinted 8 mm dorsal full thickness wounds were made in db/db mice. Wounds were topically treated once daily with either 3 mu g PDGF-BB in 30 mu l of 5% PEG-PBS vehicle or an equal volume of vehicle for 10 days. Body weights, wound contraction, wound closure, reepithelialization, collagen content, and wound bed inflammation were evaluated clinically and histopathologically. The bioactivity of PDGF-BB was confirmed by in vitro proliferation assay. PDGF-BB, although bioactive in vitro, failed to accelerate wound healing in vivo in the db/db mice using the splinted wound model. Considering that the predominant mechanism of wound healing in humans is by re-epeithelialization, the most appropriate model for evaluating therapeutics is one that uses splints to prevent excessive wound contraction. Here, we report that PDGF-BB does not promote wound closure by reepithelialization in a murine splinted wound model. Our results highlight that the effects of cytoactive factors reported in vivo ought to be carefully interpreted with critical consideration of the wound model used.	[Park, Shin Ae; Raghunathan, Vijay Krishna; Shah, Nihar M.; Motta, Monica J.; Covert, Jill; Murphy, Christopher J.] Univ Calif Davis, Sch Vet Med, Dept Surg & Radiol Sci, Davis, CA 95616 USA; [Teixeira, Leandro; Dubielzig, Richard] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA; [Schurr, Michael] Univ Colorado, Dept Surg, Denver, CO 80202 USA; [Isseroff, Roslyn Rivkah] Univ Calif Davis, Sch Med, Dept Dermatol, Davis, CA 95616 USA; [Isseroff, Roslyn Rivkah] VA Northern Calif Hlth Care Syst, Mather, CA USA; [Abbott, Nicholas L.] Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI USA; [McAnulty, Jonathan] Univ Wisconsin, Sch Vet Med, Dept Surg Sci, Madison, WI 53706 USA; [Murphy, Christopher J.] Univ Calif Davis, Sch Med, Davis, CA 95616 USA	University of California System; University of California Davis; University of Wisconsin System; University of Wisconsin Madison; University of Colorado System; University of Colorado Denver; University of California System; University of California Davis; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Davis	Murphy, CJ (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Surg & Radiol Sci, Davis, CA 95616 USA.	murphyc@corl.vetmed.wisc.edu	Isseroff, Roslyn Rivkah/AAD-8478-2021; Raghunathan, Vijaykrishna/D-2911-2015; Teixeira, Leandro/AAU-6094-2021; Teixeira, Leandro B C/H-9272-2015	Isseroff, Roslyn Rivkah/0000-0001-7813-0858; Raghunathan, Vijaykrishna/0000-0003-1702-591X; Teixeira, Leandro/0000-0001-9960-678X; Teixeira, Leandro B C/0000-0001-9960-678X	National Institutes of Health [RC2AR058971]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [RC2AR058971] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The project described was supported by National Institutes of Health grant number RC2AR058971. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTSON S, 1993, SURGERY, V114, P368; Andl CD, 2003, J BIOL CHEM, V278, P1824, DOI 10.1074/jbc.M209148200; Beer HD, 1997, J INVEST DERMATOL, V109, P132, DOI 10.1111/1523-1747.ep12319188; Blakytny R, 2006, DIABETIC MED, V23, P594, DOI 10.1111/j.1464-5491.2006.01773.x; Blom IE, 2001, NEPHROL DIAL TRANSPL, V16, P1139, DOI 10.1093/ndt/16.6.1139; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Brown KRS, 2001, AM J PHYSIOL-LUNG C, V281, pL1001, DOI 10.1152/ajplung.2001.281.4.L1001; BROWN RL, 1994, J SURG RES, V56, P562, DOI 10.1006/jsre.1994.1090; BROWNLEE M, 1995, ANNU REV MED, V46, P223, DOI 10.1146/annurev.med.46.1.223; Cantarella G, 2002, FASEB J, V16, P1307, DOI 10.1096/fj.01-1000fje; Cantero AV, 2007, FASEB J, V21, P3096, DOI 10.1096/fj.06-7536com; Chan RK, 2006, J BURN CARE RES, V27, P202, DOI 10.1097/01.BCR.0000202898.11277.58; Fan BS, 2011, GENE; Fang RC, 2008, J BIOMAT SCI-POLYM E, V19, P989, DOI 10.1163/156856208784909327; Galiano RD, 2004, WOUND REPAIR REGEN, V12, P485, DOI 10.1111/j.1067-1927.2004.12404.x; Galiano RD, 2004, AM J PATHOL, V164, P1935, DOI 10.1016/S0002-9440(10)63754-6; Greenhalgh David G., 1993, Wound Repair and Regeneration, V1, P69; Greenhalgh DG, 2003, METH MOLEC MED, V78, P181; GREENHALGH DG, 1990, AM J PATHOL, V136, P1235; Guo S, 2010, J DENT RES, V89, P219, DOI 10.1177/0022034509359125; Hardwicke J, 2011, BRIT J SURG, V98, pE11; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Judith R, 2010, LIFE SCI, V87, P1, DOI 10.1016/j.lfs.2010.05.003; Kim SJ, 2007, GROWTH FACTORS, V25, P77, DOI 10.1080/08977190701398977; Koria P, 2012, BIODRUGS, V26, P163, DOI 10.2165/11631850-000000000-00000; Lindblad WJ, 2008, J BIOMAT SCI-POLYM E, V19, P1087, DOI 10.1163/156856208784909390; Lobmann R, 2002, DIABETOLOGIA, V45, P1011, DOI 10.1007/s00125-002-0868-8; Mast Bruce A., 1996, Wound Repair and Regeneration, V4, P411, DOI 10.1046/j.1524-475X.1996.40404.x; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Muangman P, 2004, WOUND REPAIR REGEN, V12, P44, DOI 10.1111/j.1067-1927.2004.012110.x-1; Nass N, 2010, INT J BIOCHEM CELL B, V42, P749, DOI 10.1016/j.biocel.2010.01.012; Portero-Otin M, 2002, DIABETES, V51, P1535, DOI 10.2337/diabetes.51.5.1535; Raghunathan VK, 2013, BIOMATERIALS, V34, P3559, DOI 10.1016/j.biomaterials.2013.01.085; RANKIN S, 1994, J BIOL CHEM, V269, P704; Rende M, 2000, INT J DEV NEUROSCI, V18, P869, DOI 10.1016/S0736-5748(00)00041-1; Robson MC, 2005, WOUND HEALING, P491; Saaristo A, 2006, AM J PATHOL, V169, P1080, DOI 10.2353/ajpath.2006.051251; Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217; Schoop VM, 1999, J INVEST DERMATOL, V112, P343, DOI 10.1046/j.1523-1747.1999.00524.x; Schultz GS, 2009, WOUND REPAIR REGEN, V17, P153, DOI 10.1111/j.1524-475X.2009.00466.x; Senter Lucy H., 1995, Wound Repair and Regeneration, V3, P351, DOI 10.1046/j.1524-475X.1995.30316.x; Skobe M, 1998, P NATL ACAD SCI USA, V95, P1050, DOI 10.1073/pnas.95.3.1050; Smiell JM, 1999, WOUND REPAIR REGEN, V7, P335, DOI 10.1046/j.1524-475X.1999.00335.x; SPRUGEL KH, 1987, AM J PATHOL, V129, P601; Tkalcevic VI, 2009, TOXICOL PATHOL, V37, P183, DOI 10.1177/0192623308329280; Trengove NJ, 1999, WOUND REPAIR REGEN, V7, P442, DOI 10.1046/j.1524-475X.1999.00442.x; TSUBOI R, 1995, J INVEST DERMATOL, V104, P199, DOI 10.1111/1523-1747.ep12612755; Uhl E, 2003, WOUND REPAIR REGEN, V11, P361, DOI 10.1046/j.1524-475X.2003.11508.x; Wong V, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/969618; Yang SY, 2002, FEBS LETT, V522, P156, DOI 10.1016/S0014-5793(02)02918-6; Yoshikawa Y, 2001, ACTA ORTHOP SCAND, V72, P287, DOI 10.1080/00016470152846646; Yu JH, 2001, BIOCHEM BIOPH RES CO, V282, P697, DOI 10.1006/bbrc.2001.4622	52	35	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104447	10.1371/journal.pone.0104447	http://dx.doi.org/10.1371/journal.pone.0104447			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121729	Green Published, gold, Green Submitted			2022-12-25	WOS:000341017000038
J	Campeotto, I; Percy, MG; MacDonald, JT; Forster, A; Freemont, PS; Grundling, A				Campeotto, Ivan; Percy, Matthew G.; MacDonald, James T.; Foerster, Andreas; Freemont, Paul S.; Gruendling, Angelika			Structural and Mechanistic Insight into the Listeria monocytogenes Two-enzyme Lipoteichoic Acid Synthesis System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOSYNTHESIS; SYNTHASE; MODEL	Lipoteichoic acid (LTA) is an important cell wall component required for proper cell growth in many Gram-positive bacteria. In Listeria monocytogenes, two enzymes are required for the synthesis of this polyglycerolphosphate polymer. The LTA primase LtaP(Lm) initiates LTA synthesis by transferring the first glycerolphosphate (GroP) subunit onto the glycolipid anchor and the LTA synthase LtaS(Lm) extends the polymer by the repeated addition of GroP subunits to the tip of the growing chain. Here, we present the crystal structures of the enzymatic domains of LtaP(Lm) and LtaS(Lm). Although the enzymes share the same fold, substantial differences in the cavity of the catalytic site and surface charge distribution contribute to enzyme specialization. The eLtaS(Lm) structure was also determined in complex with GroP revealing a second GroP binding site. Mutational analysis confirmed an essential function for this binding site and allowed us to propose a model for the binding of the growing chain.	[Campeotto, Ivan; Percy, Matthew G.; Gruendling, Angelika] Univ London Imperial Coll Sci Technol & Med, Microbiol Sect, London SW7 2AZ, England; [Campeotto, Ivan; Percy, Matthew G.; Gruendling, Angelika] Univ London Imperial Coll Sci Technol & Med, MRC Ctr Mol Bacteriol & Infect, London SW7 2AZ, England; [MacDonald, James T.; Foerster, Andreas; Freemont, Paul S.] Univ London Imperial Coll Sci Technol & Med, Struct Biol Ctr, London SW7 2AZ, England	Imperial College London; Imperial College London; Imperial College London	Freemont, PS (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Med, South Kensington Campus,Sir Ernst Chain Bldg, London SW7 2AZ, England.	p.freemont@imperial.ac.uk; a.grundling@imperial.ac.uk		MacDonald, James/0000-0001-9675-4429; Grundling, Angelika/0000-0002-6235-8687; Freemont, Paul/0000-0002-5658-8486; Campeotto, Ivan/0000-0002-0814-619X; Forster, Andreas/0000-0003-1472-3990	European Research Council [260371]; MRC [MR/J006874/1, G0800777] Funding Source: UKRI; Medical Research Council [G0800777] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by European Research Council Grant 260371 (to A. G.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Antelmann H, 2005, PROTEOMICS, V5, P3684, DOI 10.1002/pmic.200401218; Bergfors T, 2003, J STRUCT BIOL, V142, P66, DOI 10.1016/S1047-8477(03)00039-X; BISHOP DK, 1987, J IMMUNOL, V139, P2005; Bond CS, 1997, STRUCTURE, V5, P277, DOI 10.1016/S0969-2126(97)00185-8; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fisher W, 1990, BACTERIAL PHOSPHOGLY; Grundling A, 2004, P NATL ACAD SCI USA, V101, P12318, DOI 10.1073/pnas.0404924101; Grundling A, 2007, P NATL ACAD SCI USA, V104, P8478, DOI 10.1073/pnas.0701821104; HETHER NW, 1983, J BACTERIOL, V156, P809, DOI 10.1128/JB.156.2.809-817.1983; Jones DT, 2012, BIOINFORMATICS, V28, P184, DOI 10.1093/bioinformatics/btr638; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karatsa-Dodgson M, 2010, J BACTERIOL, V192, P5341, DOI 10.1128/JB.00453-10; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; KOCH HU, 1984, EUR J BIOCHEM, V138, P357, DOI 10.1111/j.1432-1033.1984.tb07923.x; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lauer P, 2002, J BACTERIOL, V184, P4177, DOI 10.1128/JB.184.15.4177-4186.2002; Lebedev AA, 2012, ACTA CRYSTALLOGR D, V68, P431, DOI 10.1107/S090744491200251X; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Lu D, 2009, P NATL ACAD SCI USA, V106, P1584, DOI 10.1073/pnas.0809020106; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Oku Y, 2009, J BACTERIOL, V191, P141, DOI 10.1128/JB.01221-08; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Percy MG, 2014, ANNU REV MICROBIOL, V68, P81, DOI 10.1146/annurev-micro-091213-112949; Powers ME, 2011, J BACTERIOL, V193, P340, DOI 10.1128/JB.01052-10; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Reichmann NT, 2011, FEMS MICROBIOL LETT, V319, P97, DOI 10.1111/j.1574-6968.2011.02260.x; Richter SG, 2013, P NATL ACAD SCI USA, V110, P3531, DOI 10.1073/pnas.1217337110; Schirner K, 2009, EMBO J, V28, P830, DOI 10.1038/emboj.2009.25; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; TARON DJ, 1983, J BACTERIOL, V154, P1110, DOI 10.1128/JB.154.3.1110-1116.1983; UCHIKAWA KI, 1986, J BACTERIOL, V168, P115, DOI 10.1128/jb.168.1.115-122.1986; Walter TS, 2006, STRUCTURE, V14, P1617, DOI 10.1016/j.str.2006.09.005; Webb AJ, 2009, MOL MICROBIOL, V74, P299, DOI 10.1111/j.1365-2958.2009.06829.x; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wormann ME, 2011, J BACTERIOL, V193, P5279, DOI 10.1128/JB.00369-11; Wormann ME, 2011, MOL MICROBIOL, V79, P566, DOI 10.1111/j.1365-2958.2010.07472.x	43	17	17	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28054	28069		10.1074/jbc.M114.590570	http://dx.doi.org/10.1074/jbc.M114.590570			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25128528	hybrid, Green Published			2022-12-25	WOS:000343765400001
J	Meneses, E; Mittermaier, A				Meneses, Erick; Mittermaier, Anthony			Electrostatic Interactions in the Binding Pathway of a Transient Protein Complex Studied by NMR and Isothermal Titration Calorimetry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Isothermal Titration Calorimetry (ITC); Ligand-binding Protein; Nuclear Magnetic Resonance; Protein Dynamic; Src Homology 3 Domain (SH3 Domain); Carr-Purcell-Meiboom-Gill (CPMG) Relaxation Dispersion	NUCLEAR-MAGNETIC-RESONANCE; RECEPTOR-ALPHA CHAIN; SH3 DOMAIN; BIMOLECULAR KINETICS; ENCOUNTER COMPLEXES; HYDROPHOBIC CORE; EXCITED-STATES; TIME-SCALE; ASSOCIATION; BARSTAR	Background: Electrostatic interactions are known accelerate binding in protein complexes with long lifetimes (minutes to hours). Results: NMR and calorimetry were used to characterize binding kinetics in short lived (approximate to 1 ms) protein-peptide complexes. Conclusion: Electrostatic enhancement is much less and basal (electrostatic-free) association rates are greater than previously observed. Significance: Electrostatics may play different roles in short lived and long lived protein complexes. Much of our knowledge of protein binding pathways is derived from extremely stable complexes that interact very tightly, with lifetimes of hours to days. Much less is known about weaker interactions and transient complexes because these are challenging to characterize experimentally. Nevertheless, these types of interactions are ubiquitous in living systems. The combination of NMR relaxation dispersion Carr-Purcell-Meiboom-Gill (CPMG) experiments and isothermal titration calorimetry allows the quantification of rapid binding kinetics for complexes with submillisecond lifetimes that are difficult to study using conventional techniques. We have used this approach to investigate the binding pathway of the Src homology 3 (SH3) domain from the Fyn tyrosine kinase, which forms complexes with peptide targets whose lifetimes are on the order of about a millisecond. Long range electrostatic interactions have been shown to play a critical role in the binding pathways of tightly binding complexes. The role of electrostatics in the binding pathways of transient complexes is less well understood. Similarly to previously studied tight complexes, we find that SH3 domain association rates are enhanced by long range electrostatics, whereas short range interactions are formed late in the docking process. However, the extent of electrostatic association rate enhancement is several orders of magnitudes less, whereas the electrostatic-free basal association rate is significantly greater. Thus, the SH3 domain is far less reliant on electrostatic enhancement to achieve rapid association kinetics than are previously studied systems. This suggests that there may be overall differences in the role played by electrostatics in the binding pathways of extremely stable versus transient complexes.	[Meneses, Erick; Mittermaier, Anthony] McGill Univ, Dept Chem, Montreal, PQ H3A 0B8, Canada	McGill University	Mittermaier, A (corresponding author), McGill Univ, Dept Chem, 801 Sherbrooke St W,Rm 322, Montreal, PQ H3A 0B8, Canada.	anthony.mittermaier@mcgill.ca	Mittermaier, Anthony/R-3210-2017	Mittermaier, Anthony/0000-0002-3767-1225	McGill University; Groupe de Recherche Axe sur la Structure des Proteines (GRASP)	McGill University; Groupe de Recherche Axe sur la Structure des Proteines (GRASP)	NMR experiments were recorded at the Quebec/Eastern Canada High Field NMR Facility, supported by McGill University and Groupe de Recherche Axe sur la Structure des Proteines (GRASP).	ALBERTY RA, 1958, J PHYS CHEM-US, V62, P154, DOI 10.1021/j150560a005; Alsallaq R, 2008, PROTEINS, V71, P320, DOI 10.1002/prot.21679; Alsallaq R, 2007, STRUCTURE, V15, P215, DOI 10.1016/j.str.2007.01.005; ALTSCHUH D, 1992, BIOCHEMISTRY-US, V31, P6298, DOI 10.1021/bi00142a019; BENNAIM A, 1974, J PHYS CHEM-US, V78, P170, DOI 10.1021/j100595a600; BERG OG, 1985, ANNU REV BIOPHYS BIO, V14, P131, DOI 10.1146/annurev.biophys.14.1.131; BOLZANI R, 1979, Bollettino Societa Italiana Biologia Sperimentale, V55, P1618; BUCKLE AM, 1994, BIOCHEMISTRY-US, V33, P8878, DOI 10.1021/bi00196a004; Camacho CJ, 2000, BIOPHYS J, V78, P1094, DOI 10.1016/S0006-3495(00)76668-9; Camacho CJ, 1999, BIOPHYS J, V76, P1166, DOI 10.1016/S0006-3495(99)77281-4; Cantor C., 1980, BIOPHYSICAL CHEM 3, P892; CARVER JP, 1972, J MAGN RESON, V6, P89, DOI 10.1016/0022-2364(72)90090-X; Demers JP, 2009, J AM CHEM SOC, V131, P4355, DOI 10.1021/ja808255d; Di Nardo AA, 2003, J MOL BIOL, V333, P641, DOI 10.1016/j.jmb.2003.08.035; Docherty H, 2007, J PHYS CHEM B, V111, P8993, DOI 10.1021/jp0678249; Efron B, 1986, STAT SCI, V1, P54, DOI DOI 10.1214/SS/1177013815; England P, 1997, BIOCHEMISTRY-US, V36, P164, DOI 10.1021/bi961419y; ESCOBAR L, 1993, BIOCHEMISTRY-US, V32, P6982, DOI 10.1021/bi00078a024; Eyring H, 1935, J CHEM PHYS, V3, P107, DOI 10.1063/1.1749604; Feng SB, 1995, P NATL ACAD SCI USA, V92, P12408, DOI 10.1073/pnas.92.26.12408; FOOTE J, 1991, NATURE, V352, P530, DOI 10.1038/352530a0; Gabdoulline RR, 2002, CURR OPIN STRUC BIOL, V12, P204, DOI 10.1016/S0959-440X(02)00311-1; Hansen DF, 2008, J PHYS CHEM B, V112, P5898, DOI 10.1021/jp074793o; Hansen DF, 2008, J AM CHEM SOC, V130, P2667, DOI 10.1021/ja078337p; Ishima R, 2005, J BIOMOL NMR, V32, P41, DOI 10.1007/s10858-005-3593-z; Janin J, 1997, PROTEINS, V28, P153, DOI 10.1002/(SICI)1097-0134(199706)28:2<153::AID-PROT4>3.0.CO;2-G; Jucovic M, 1996, P NATL ACAD SCI USA, V93, P2343, DOI 10.1073/pnas.93.6.2343; LUZ Z, 1963, J CHEM PHYS, V39, P366, DOI 10.1063/1.1734254; MACOMBER RS, 1992, J CHEM EDUC, V69, P375, DOI 10.1021/ed069p375; Mayer BJ, 2001, J CELL SCI, V114, P1253; MELANDER W, 1977, ARCH BIOCHEM BIOPHYS, V183, P200, DOI 10.1016/0003-9861(77)90434-9; Millet O, 2000, J AM CHEM SOC, V122, P2867, DOI 10.1021/ja993511y; Mittermaier A, 2004, PROTEIN SCI, V13, P1088, DOI 10.1110/ps.03502504; Mittermaier AK, 2009, TRENDS BIOCHEM SCI, V34, P601, DOI 10.1016/j.tibs.2009.07.004; Mulder FAA, 2001, NAT STRUCT BIOL, V8, P932, DOI 10.1038/nsb1101-932; NORTHRUP SH, 1993, BIOCHEMISTRY-US, V32, P6613, DOI 10.1021/bi00077a014; NORTHRUP SH, 1992, P NATL ACAD SCI USA, V89, P3338, DOI 10.1073/pnas.89.8.3338; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Palmer AG, 2001, METHOD ENZYMOL, V339, P204, DOI 10.1016/S0076-6879(01)39315-1; Pilling M., 1995, REACTION KINETICS, P146; Radic Z, 1997, J BIOL CHEM, V272, P23265, DOI 10.1074/jbc.272.37.23265; SCHREIBER G, 1993, BIOCHEMISTRY-US, V32, P5145, DOI 10.1021/bi00070a025; Schreiber G, 1996, NAT STRUCT BIOL, V3, P427, DOI 10.1038/nsb0596-427; Schreiber G, 2002, CURR OPIN STRUC BIOL, V12, P41, DOI 10.1016/S0959-440X(02)00287-7; SEGUR JB, 1951, IND ENG CHEM, V43, P2117, DOI 10.1021/ie50501a040; Shen BJ, 1996, EUR J BIOCHEM, V240, P252, DOI 10.1111/j.1432-1033.1996.0252h.x; Smith AJ, 1997, METHOD ENZYMOL, V289, P419; SOMMER J, 1982, J MOL BIOL, V159, P721, DOI 10.1016/0022-2836(82)90110-3; STONE SR, 1989, BIOCHEMISTRY-US, V28, P6857, DOI 10.1021/bi00443a012; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Sydor JR, 1998, BIOCHEMISTRY-US, V37, P14292, DOI 10.1021/bi980764f; SZABO A, 1982, J CHEM PHYS, V77, P4484, DOI 10.1063/1.444397; Tang C, 2006, NATURE, V444, P383, DOI 10.1038/nature05201; Taylor MG, 1998, PROTEIN SCI, V7, P1857, DOI 10.1002/pro.5560070902; Vallurupalli P, 2007, P NATL ACAD SCI USA, V104, P18473, DOI 10.1073/pnas.0708296104; Vijayakumar M, 1998, J MOL BIOL, V278, P1015, DOI 10.1006/jmbi.1998.1747; Volkov AN, 2010, J BIOMOL NMR, V48, P225, DOI 10.1007/s10858-010-9452-6; WALLIS R, 1995, BIOCHEMISTRY-US, V34, P13751, DOI 10.1021/bi00042a005; WALLIS R, 1995, BIOCHEMISTRY-US, V34, P13743, DOI 10.1021/bi00042a004; Wang YH, 1997, P NATL ACAD SCI USA, V94, P1657, DOI 10.1073/pnas.94.5.1657; Wendt H, 1997, BIOCHEMISTRY-US, V36, P204, DOI 10.1021/bi961672y; WHERLAND S, 1976, P NATL ACAD SCI USA, V73, P2950, DOI 10.1073/pnas.73.9.2950; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Xu D, 1997, J MOL BIOL, V265, P68, DOI 10.1006/jmbi.1996.0712; YU HT, 1994, CELL, V76, P933, DOI 10.1016/0092-8674(94)90367-0; Zarrine-Afsar A, 2006, PROTEIN SCI, V15, P162, DOI 10.1110/ps.051829106; Zhou HX, 1997, BIOPHYS J, V73, P2441, DOI 10.1016/S0006-3495(97)78272-9; Zhou HX, 2001, BIOPOLYMERS, V59, P427, DOI 10.1002/1097-0282(200111)59:6<427::AID-BIP1047>3.0.CO;2-7	68	17	17	0	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27911	27923		10.1074/jbc.M114.553354	http://dx.doi.org/10.1074/jbc.M114.553354			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25122758	hybrid, Green Published			2022-12-25	WOS:000342852800046
J	Lopes, AM; Machado, JAT				Lopes, Antonio M.; Machado, J. A. Tenreiro			Dynamic Analysis and Pattern Visualization of Forest Fires	PLOS ONE			English	Article							MUTUAL INFORMATION; MODEL	This paper analyses forest fires in the perspective of dynamical systems. Forest fires exhibit complex correlations in size, space and time, revealing features often present in complex systems, such as the absence of a characteristic length-scale, or the emergence of long range correlations and persistent memory. This study addresses a public domain forest fires catalogue, containing information of events for Portugal, during the period from 1980 up to 2012. The data is analysed in an annual basis, modelling the occurrences as sequences of Dirac impulses with amplitude proportional to the burnt area. First, we consider mutual information to correlate annual patterns. We use visualization trees, generated by hierarchical clustering algorithms, in order to compare and to extract relationships among the data. Second, we adopt the Multidimensional Scaling (MDS) visualization tool. MDS generates maps where each object corresponds to a point. Objects that are perceived to be similar to each other are placed on the map forming clusters. The results are analysed in order to extract relationships among the data and to identify forest fire patterns.	[Lopes, Antonio M.] Univ Porto, Inst Engn Mech, Fac Engn, P-4100 Oporto, Portugal; [Machado, J. A. Tenreiro] Polytech Porto, Inst Engn, Oporto, Portugal	Universidade do Porto; Polytechnic Institute of Porto	Lopes, AM (corresponding author), Univ Porto, Inst Engn Mech, Fac Engn, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	aml@fe.up.pt	Machado, J. A. Tenreiro/M-2173-2013; Lopes, António M./A-2740-2016	Machado, J. A. Tenreiro/0000-0003-4274-4879; Lopes, António M./0000-0001-7359-4370				Alvarado E., 1998, NORTHWEST SCI, V72, P66; [Anonymous], 2005, EXPLORATORY DATA ANA; BAK P, 1990, PHYS LETT A, V147, P297, DOI 10.1016/0375-9601(90)90451-S; Barabasi AL, 2005, NATURE, V435, P207, DOI 10.1038/nature03459; Barford P., 1999, World Wide Web, V2, P15, DOI 10.1023/A:1019236319752; Bradstock RA, 2008, INT J WILDLAND FIRE, V17, P809, DOI 10.1071/WF07153; Costa AM, 2011, BIOINFORMATICS, V27, P1207, DOI 10.1093/bioinformatics/btr131; Cox T.F., 2001, MULTIDIMENSIONAL SCA, V2nd; Di Bella CM, 2006, GLOBAL ECOL BIOGEOGR, V15, P192, DOI [10.1111/j.1466-822x.2006.00225.x, 10.1111/j.1466-822X.2006.00225.x]; DROSSEL B, 1992, PHYS REV LETT, V69, P1629, DOI 10.1103/PhysRevLett.69.1629; Flannigan MD, 2009, INT J WILDLAND FIRE, V18, P483, DOI 10.1071/WF08187; Fletcher I. N., 2013, BIOGEOSCIENCES DISCU, V10, P14141; Hanson CT, 2014, INT J WILDLAND FIRE, V23, P1, DOI 10.1071/WF13016; HERZEL H, 1994, CHAOS SOLITON FRACT, V4, P97, DOI 10.1016/0960-0779(94)90020-5; Jain AK., 1988, TECHNOMETRICS; JOHNSON SC, 1967, PSYCHOMETRIKA, V32, P241, DOI 10.1007/BF02289588; KRUSKAL J.B., 1978, MULTIDIMENSIONAL SCA; KVALSETH TO, 1987, IEEE T SYST MAN CYB, V17, P517, DOI 10.1109/TSMC.1987.4309069; Malamud BD, 1998, SCIENCE, V281, P1840, DOI 10.1126/science.281.5384.1840; Marques S, 2011, EUR J FOREST RES, V130, P775, DOI 10.1007/s10342-010-0470-4; Matsuda H, 2000, PHYS REV E, V62, P3096, DOI 10.1103/PhysRevE.62.3096; Mohajeri N, 2012, ENTROPY-SWITZ, V14, P800, DOI 10.3390/e14040800; Mori T, 1998, PHYSICA D, V116, P275, DOI 10.1016/S0167-2789(97)00302-3; Pinto CMA, 2012, COMMUN NONLINEAR SCI, V17, P3558, DOI 10.1016/j.cnsns.2012.01.013; Posadas A, 2000, PHYS EARTH PLANET IN, V122, P269, DOI 10.1016/S0031-9201(00)00181-3; Preisler HK, 2011, INT J WILDLAND FIRE, V20, P508, DOI 10.1071/WF09087; Prentice IC, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2010GB003906; Reed WJ, 2002, ECOL MODEL, V150, P239, DOI 10.1016/S0304-3800(01)00483-5; Ricotta C, 1999, ECOL MODEL, V119, P73, DOI 10.1016/S0304-3800(99)00057-5; Silva FRY, 2010, INT J WILDLAND FIRE, V19, P927, DOI 10.1071/WF09015; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHEPARD RN, 1962, PSYCHOMETRIKA, V27, P219, DOI 10.1007/BF02289621; Telesca L, 2005, ECOL MODEL, V185, P531, DOI 10.1016/j.ecolmodel.2005.01.009; Telesca L, 2011, ENTROPY-SWITZ, V13, P1267, DOI 10.3390/e13071267; Telesca L, 2007, COMMUN NONLINEAR SCI, V12, P1326, DOI 10.1016/j.cnsns.2005.12.003; Machado JAT, 2013, ENTROPY-SWITZ, V15, P3892, DOI 10.3390/e15093892; Tzagarakis C, 2009, EXP BRAIN RES, V194, P369, DOI 10.1007/s00221-009-1709-5; Zamora R, 2010, ECOL MODEL, V221, P19, DOI 10.1016/j.ecolmodel.2009.07.010; Zumbrunnen T, 2011, FOREST ECOL MANAG, V261, P2188, DOI 10.1016/j.foreco.2010.10.009	39	4	4	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105465	10.1371/journal.pone.0105465	http://dx.doi.org/10.1371/journal.pone.0105465			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137393	Green Published, gold			2022-12-25	WOS:000340742100098
J	Yang, MY; Wu, H; Lian, Y; Li, XF; Lai, FR; Zhao, GL				Yang, Meiyan; Wu, Hui; Lian, Yan; Li, Xiaofeng; Lai, Furao; Zhao, Guanglei			Influence of Organic Solvents on Catalytic Behaviors and Cell Morphology of Whole-Cell Biocatalysts for Synthesis of 5 '-Arabinocytosine Laurate	PLOS ONE			English	Article							REGIOSELECTIVE ENZYMATIC ACYLATION; 1-BETA-D-ARABINOFURANOSYLCYTOSINE; TOXICITY; ENZYMES	A whole-cell based method was developed for the regioselective synthesis of arabinocytosine laurate. Among the seven kinds of bacteria strains tested in the acylation reaction, Pseudomonas fluorescens gave the highest productivity and a higher 5'-regioselectivity than 99%. Compared with pure organic solvents, the use of organic solvent mixtures greatly promoted the yield of the whole-cell catalyzed reaction, but showed little influence on the 5'-regioselectivity. Of all the tested solvent mixtures, the best reaction result was found in isopropyl ether/pyridine followed by isopentanol/pyridine. However, the whole-cells showed much lower thermostability in isopropyl ether/pyridine than in THF-pyridine. To better understand the toxic effects of the organic solvents on P. fluorescens whole-cells and growing cells were further examined. Significant influences of organic solvents on the biomass of the cells were found, which differed depending on the type of solvents used. SEM analysis visually revealed the changes in the surface morphology of whole-cells and growing cells cultured in media containing various organic solvents, in terms of surface smoothness, bulges and changed cell sizes. Results demonstrated that organic toxicity to cell structure played an important role in whole-cell mediated catalysis.	[Yang, Meiyan; Li, Xiaofeng; Zhao, Guanglei] S China Univ Technol, State Key Lab Pulp & Paper Making Engn, Guangzhou, Guangdong, Peoples R China; [Yang, Meiyan; Wu, Hui; Lian, Yan; Lai, Furao] S China Univ Technol, Coll Light Ind & Food Sci, Guangzhou, Guangdong, Peoples R China	South China University of Technology; South China University of Technology	Li, XF (corresponding author), S China Univ Technol, State Key Lab Pulp & Paper Making Engn, Guangzhou, Guangdong, Peoples R China.	xflibio@scut.edu.cn; zhaoguanglei@gmail.com			National Natural Science Foundation of China [31270636]; Foundation for Natural Science Foundation of Guangdong Province [S2013010012486]; Project of Department of Education of Guangdong Province [2012KJCX0006]; Program for New Century Excellent Talents in University [NCET-12-0192]; self determined research funds of SCUT from the college basic research and operation of MOE [2013ZM0044, 2013ZZ0068, 2013ZM0065]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Project of Department of Education of Guangdong Province; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); self determined research funds of SCUT from the college basic research and operation of MOE	The National Natural Science Foundation of China (No. 31270636), a Foundation for Natural Science Foundation of Guangdong Province (No. S2013010012486), the Project of Department of Education of Guangdong Province (No. 2012KJCX0006), Program for New Century Excellent Talents in University (NCET-12-0192) and self determined research funds of SCUT from the college basic research and operation of MOE (Nos. 2013ZM0044, 2013ZZ0068 and 2013ZM0065) supported the study design, data collection and analysis, decision to publish.	Baumgarten T, 2012, APPL MICROBIOL BIOT, V93, P837, DOI 10.1007/s00253-011-3442-9; Bommarius A.S., 2004, BIOCATALYSIS; Bornscheuer UT, 2002, TRENDS BIOTECHNOL, V20, P433, DOI 10.1016/S0167-7799(02)02046-2; Bornscheuer UT, 2002, FEMS MICROBIOL REV, V26, P73, DOI 10.1016/S0168-6445(01)00075-4; de Bont JAM, 1998, TRENDS BIOTECHNOL, V16, P493, DOI 10.1016/S0167-7799(98)01234-7; de Carvalho CCCR, 2011, BIOTECHNOL ADV, V29, P75, DOI 10.1016/j.biotechadv.2010.09.001; Ferrero M, 2000, MONATSH CHEM, V131, P585, DOI 10.1007/s007060070088; Gonzalez-Sabin J, 2011, CHEM SOC REV, V40, P5321, DOI 10.1039/c1cs15081b; INOUE A, 1989, NATURE, V338, P264, DOI 10.1038/338264a0; Kalscheuer R, 2006, MICROBIOL-SGM, V152, P2529, DOI 10.1099/mic.0.29028-0; Kieboom J, 1998, J BACTERIOL, V180, P6769, DOI 10.1128/JB.180.24.6769-6772.1998; Klibanov AM, 2001, NATURE, V409, P241, DOI 10.1038/35051719; Li XF, 2006, J BIOTECHNOL, V124, P552, DOI 10.1016/j.jbiotec.2006.01.013; Li XF, 2012, PROCESS BIOCHEM, V47, P1826, DOI 10.1016/j.procbio.2012.06.009; Li XF, 2012, BIORESOURCE TECHNOL, V114, P6, DOI 10.1016/j.biortech.2012.03.056; Li XF, 2010, APPL MICROBIOL BIOT, V88, P57, DOI 10.1007/s00253-010-2705-1; Li XF, 2010, BIOORG MED CHEM LETT, V20, P4125, DOI 10.1016/j.bmcl.2010.05.077; Matsuda A, 2004, CANCER SCI, V95, P105, DOI 10.1111/j.1349-7006.2004.tb03189.x; Matsumoto M, 2004, J BIOSCI BIOENG, V98, P344, DOI 10.1016/S1389-1723(04)00293-2; Matsumoto M, 2002, J BIOSCI BIOENG, V94, P45; NAKAJIMA H, 1995, APPL ENVIRON MICROB, V61, P2302, DOI 10.1128/AEM.61.6.2302-2307.1995; Riva S, 2001, CURR OPIN CHEM BIOL, V5, P106, DOI 10.1016/S1367-5931(00)00178-2; Schwarz H, 1995, MICROBIOL-UK, V141, P3161, DOI 10.1099/13500872-141-12-3161; Serdakowski AL, 2008, TRENDS BIOTECHNOL, V26, P48, DOI 10.1016/j.tibtech.2007.10.007; SIKKEMA J, 1995, MICROBIOL REV, V59, P201, DOI 10.1128/MMBR.59.2.201-222.1995; Torres S, 2009, BIORESOURCE TECHNOL, V100, P896, DOI 10.1016/j.biortech.2008.07.009; Wagner CR, 2000, MED RES REV, V20, P417, DOI 10.1002/1098-1128(200011)20:6<417::AID-MED1>3.0.CO;2-Z	27	4	4	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e104847	10.1371/journal.pone.0104847	http://dx.doi.org/10.1371/journal.pone.0104847			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136983	Green Submitted, Green Published, gold			2022-12-25	WOS:000340742100048
J	Chen, J; Lv, FJ; Liu, JR; Ma, Y; Wang, YH; Chen, BL; Meng, YL; Zhou, ZG; Oosterhuis, DM				Chen, Ji; Lv, Fengjuan; Liu, Jingran; Ma, Yina; Wang, Youhua; Chen, Binglin; Meng, Yali; Zhou, Zhiguo; Oosterhuis, Derrick M.			Effect of Late Planting and Shading on Cellulose Synthesis during Cotton Fiber Secondary Wall Development	PLOS ONE			English	Article							SUCROSE-PHOSPHATE SYNTHASE; COOL TEMPERATURE; CELL-WALL; IN-VITRO; ELONGATION; METABOLISM; YIELD; LOCALIZATION; INVERTASE; RESPONSES	Cotton-rapeseed or cotton-wheat double cropping systems are popular in the Yangtze River Valley and Yellow River Valley of China. Due to the competition of temperature and light resources during the growing season of double cropping system, cotton is generally late-germinating and late-maturing and has to suffer from the coupling of declining temperature and low light especially in the late growth stage. In this study, late planting (LP) and shading were used to fit the coupling stress, and the coupling effect on fiber cellulose synthesis was investigated. Two cotton (Gossypium hirsutum L.) cultivars were grown in the field in 2010 and 2011 at three planting dates (25 April, 25 May and 10 June) each with three shading levels (normal light, declined 20% and 40% PAR). Mean daily minimum temperature was the primary environmental factor affected by LP. The coupling of LP and shading (decreased cellulose content by 7.8%-25.5%) produced more severe impacts on cellulose synthesis than either stress alone, and the effect of LP (decreased cellulose content by 6.7%-20.9%) was greater than shading (decreased cellulose content by 0.7%-5.6%). The coupling of LP and shading hindered the flux from sucrose to cellulose by affecting the activities of related cellulose synthesis enzymes. Fiber cellulose synthase genes expression were delayed under not only LP but shading, and the coupling of LP and shading markedly postponed and even restrained its expression. The decline of sucrose-phosphate synthase activity and its peak delay may cause cellulose synthesis being more sensitive to the coupling stress during the later stage of fiber secondary wall development (38-45 days post-anthesis). The sensitive difference of cellulose synthesis between two cultivars in response to the coupling of LP and shading may be mainly determined by the sensitiveness of invertase, sucrose-phosphate synthase and cellulose synthase.	[Chen, Ji; Lv, Fengjuan; Liu, Jingran; Ma, Yina; Wang, Youhua; Chen, Binglin; Meng, Yali; Zhou, Zhiguo] Nanjing Agr Univ, Key Lab Crop Physiol & Ecol, Minist Agr, Nanjing, Jiangsu, Peoples R China; [Oosterhuis, Derrick M.] Univ Arkansas, Dept Crop & Soil Environm Sci, Fayetteville, AR 72701 USA	Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University; University of Arkansas System; University of Arkansas Fayetteville	Zhou, ZG (corresponding author), Nanjing Agr Univ, Key Lab Crop Physiol & Ecol, Minist Agr, Nanjing, Jiangsu, Peoples R China.	giscott@njau.edu.cn			National Natural Science Foundation of China [30971735]; China Agriculture Research System [CARS-18-20]; Special Fund for Agro-scientific Research in the Public Interest (Impact of climate change on agriculture production of China) [200903003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Agriculture Research System; Special Fund for Agro-scientific Research in the Public Interest (Impact of climate change on agriculture production of China)	This work was funded by the National Natural Science Foundation of China (30971735), China Agriculture Research System (CARS-18-20), and the Special Fund for Agro-scientific Research in the Public Interest (Impact of climate change on agriculture production of China, 200903003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMOR Y, 1995, P NATL ACAD SCI USA, V92, P9353, DOI 10.1073/pnas.92.20.9353; Babb VM, 2001, PLANT PHYSIOL, V127, P1234, DOI 10.1104/pp.010424; Bian HaiYun, 2008, Scientia Agricultura Sinica, V41, P1235; Bradow JM, 2010, PHYSIOLOGY OF COTTON, P229, DOI 10.1007/978-90-481-3195-2_21; Dai JL, 2014, FIELD CROP RES, V155, P99, DOI 10.1016/j.fcr.2013.09.017; DELMER DP, 1995, PLANT CELL, V7, P987, DOI 10.1105/tpc.7.7.987; Dong HZ, 2006, FIELD CROP RES, V98, P106, DOI 10.1016/j.fcr.2005.12.008; EATON FM, 1954, PLANT PHYSIOL, V29, P39, DOI 10.1104/pp.29.1.39; Fujii S, 2010, PLANT CELL PHYSIOL, V51, P294, DOI 10.1093/pcp/pcp190; Haigler Candace H., 2007, P147, DOI 10.1007/978-1-4020-5380-1_9; HAIGLER CH, 1991, PLANT PHYSIOL, V95, P88, DOI 10.1104/pp.95.1.88; Haigler CH, 2001, PLANT MOL BIOL, V47, P29, DOI 10.1023/A:1010615027986; HENDRIX DL, 1993, CROP SCI, V33, P1306, DOI 10.2135/cropsci1993.0011183X003300060037x; [蒋建雄 Jiang Jianxiong], 2003, [棉花学报, Cotton Science], V15, P166; KHAYAT E, 1987, PLANT PHYSIOL, V84, P447, DOI 10.1104/pp.84.2.447; Kim HJ, 2001, PLANT PHYSIOL, V127, P1361, DOI 10.1104/pp.010724; King SP, 1997, PLANT PHYSIOL, V114, P153, DOI 10.1104/pp.114.1.153; KOHLE H, 1985, PLANT PHYSIOL, V77, P544, DOI 10.1104/pp.77.3.544; Lee JJ, 2007, ANN BOT-LONDON, V100, P1391, DOI 10.1093/aob/mcm232; Li Tian, 2006, Acta Agronomica Sinica, V32, P943; Liakatas A, 1998, J AGR SCI-CAMBRIDGE, V130, P463, DOI 10.1017/S0021859698005413; Liu JR, 2013, FIELD CROP RES, V144, P200, DOI 10.1016/j.fcr.2013.02.003; MALTBY D, 1979, PLANT PHYSIOL, V63, P1158, DOI 10.1104/pp.63.6.1158; Martin LK, 2004, CELLULOSE, V11, P339, DOI 10.1023/B:CELL.0000046420.10403.15; MEINERT MC, 1977, PLANT PHYSIOL, V59, P1088, DOI 10.1104/pp.59.6.1088; PETTIGREW WT, 1995, AGRON J, V87, P947, DOI 10.2134/agronj1995.00021962008700050029x; Pettigrew WT, 2001, CROP SCI, V41, P1108, DOI 10.2135/cropsci2001.4141108x; Ren WanJun, 2003, Acta Agronomica Sinica, V29, P785; ROBERTS EM, 1992, PLANT PHYSIOL, V100, P979, DOI 10.1104/pp.100.2.979; Roussopoulos D, 1998, J AGR SCI-CAMBRIDGE, V131, P277, DOI 10.1017/S0021859698005735; Ruan YL, 2003, PLANT CELL, V15, P952, DOI 10.1105/tpc.010108; Ruan YL, 2007, FUNCT PLANT BIOL, V34, P1, DOI 10.1071/FP06234; Salnikov VV, 2003, PROTOPLASMA, V221, P175, DOI 10.1007/s00709-002-0079-7; Shu HM, 2009, EUR J AGRON, V31, P61, DOI 10.1016/j.eja.2009.03.004; Tang GQ, 1999, PLANT CELL, V11, P177, DOI 10.1105/tpc.11.2.177; UPDEGRAFF DM, 1969, ANAL BIOCHEM, V32, P420, DOI 10.1016/S0003-2697(69)80009-6; WAFLER U, 1994, PLANT PHYSIOL BIOCH, V32, P697; Wang L, 2010, PLANT PHYSIOL, V154, P744, DOI 10.1104/pp.110.162487; Wang Qingcai, 2005, Yingyong Shengtai Xuebao, V16, P1465; Wang QingCai, 2006, Acta Agronomica Sinica, V32, P671; Wang YouHua, 2008, Scientia Agricultura Sinica, V41, P3865; Wang YH, 2009, PLANT GROWTH REGUL, V57, P203, DOI 10.1007/s10725-008-9337-9; Winter H, 2000, CRIT REV PLANT SCI, V19, P31, DOI 10.1016/S0735-2689(01)80002-2; XIE WZ, 1993, CROP SCI, V33, P1258, DOI 10.2135/cropsci1993.0011183X003300060029x; Yeates SJ, 2010, FIELD CROP RES, V116, P300, DOI 10.1016/j.fcr.2010.01.006; Zhang JiWang, 2008, Acta Agronomica Sinica, V34, P1470, DOI 10.3724/SP.J.1006.2008.01470; Zhao D, 2000, EXP AGR, V36, P27, DOI 10.1017/S0014479700361014; Zhao D, 1998, J PLANT GROWTH REGUL, V17, P47, DOI 10.1007/PL00007011; Zhao WenQing, 2012, American Journal of Experimental Agriculture, V2, P133	49	26	27	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105088	10.1371/journal.pone.0105088	http://dx.doi.org/10.1371/journal.pone.0105088			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133819	Green Published, gold, Green Submitted			2022-12-25	WOS:000341302700068
J	Hodgin, JB; Berthier, CC; John, R; Grone, E; Porubsky, S; Grone, HJ; Herzenberg, AM; Scholey, JW; Hladunewich, M; Cattran, DC; Kretzler, M; Reich, HN				Hodgin, Jeffrey B.; Berthier, Celine C.; John, Rohan; Grone, Elisabeth; Porubsky, Stefan; Groene, Hermann-Josef; Herzenberg, Andrew M.; Scholey, James W.; Hladunewich, Michelle; Cattran, Daniel C.; Kretzler, Matthias; Reich, Heather N.			The Molecular Phenotype of Endocapillary Proliferation: Novel Therapeutic Targets for IgA Nephropathy	PLOS ONE			English	Article							OXFORD CLASSIFICATION; VALIDATION; IMMUNOSUPPRESSION; RESVERATROL; INHIBITION; ACTIVATION	IgA nephropathy (IgAN) is a clinically and pathologically heterogeneous disease. Endocapillary proliferation is associated with higher risk of progressive disease, and clinical studies suggest that corticosteroids mitigate this risk. However, corticosteroids are associated with protean cellular effects and significant toxicity. Furthermore the precise mechanism by which they modulate kidney injury in IgAN is not well delineated. To better understand molecular pathways involved in the development of endocapillary proliferation and to identify novel specific therapeutic targets, we evaluated the glomerular transcriptome of microdissected kidney biopsies from 22 patients with IgAN. Endocapillary proliferation was defined according to the Oxford scoring system independently by 3 nephropathologists. We analyzed mRNA expression using microarrays and identified transcripts differentially expressed in patients with endocapillary proliferation compared to IgAN without endocapillary lesions. Next, we employed both transcription factor analysis and in silico drug screening and confirmed that the endocapillary proliferation transcriptome is significantly enriched with pathways that can be impacted by corticosteroids. With this approach we also identified novel therapeutic targets and bioactive small molecules that may be considered for therapeutic trials for the treatment of IgAN, including resveratrol and hydroquinine. In summary, we have defined the distinct molecular profile of a pathologic phenotype associated with progressive renal insufficiency in IgAN. Exploration of the pathways associated with endocapillary proliferation confirms a molecular basis for the clinical effectiveness of corticosteroids in this subgroup of IgAN, and elucidates new therapeutic strategies for IgAN.	[Hodgin, Jeffrey B.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Berthier, Celine C.] Univ Michigan, Dept Internal Med Nephrol & Computat Med & Bioinf, Ann Arbor, MI 48109 USA; [John, Rohan; Herzenberg, Andrew M.] Univ Hlth Network, Dept Lab Med & Pathol, Toronto, ON, Canada; [John, Rohan; Herzenberg, Andrew M.; Scholey, James W.; Hladunewich, Michelle; Cattran, Daniel C.; Reich, Heather N.] Univ Toronto, Toronto, ON M5S 1A1, Canada; [Grone, Elisabeth; Porubsky, Stefan; Groene, Hermann-Josef] German Canc Res Ctr, Dept Cellular & Mol Pathol, Heidelberg, Germany; [Porubsky, Stefan] Heidelberg Univ, Univ Med Ctr Mannheim, Inst Pathol, Mannheim, Germany; [Hladunewich, Michelle] Sunnybrook Hlth Sci Ctr, Dept Nephrol, Toronto, ON M4N 3M5, Canada; [Herzenberg, Andrew M.] Univ Hlth Network, Dept Lab Med & Pathol, Toronto, ON, Canada; [Scholey, James W.; Hladunewich, Michelle; Cattran, Daniel C.; Reich, Heather N.] Univ Hlth Network, Dept Med, Toronto, ON, Canada; [Scholey, James W.; Hladunewich, Michelle; Cattran, Daniel C.; Reich, Heather N.] Toronto Glomerulonephritis Registry, Toronto, ON, Canada	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Reich, HN (corresponding author), Univ Hlth Network, Dept Med, Toronto, ON, Canada.	heather.reich@uhn.ca	Porubsky, Stefan/AAX-9682-2021; Porubsky, Stefan/J-5738-2015	Porubsky, Stefan/0000-0002-7647-7265; Porubsky, Stefan/0000-0002-7647-7265; John, Rohan/0000-0001-7946-3013	NIH [RO1- DK085241, 5-K08-DK088944]; Physicians Services Incorporated Foundation; Amgen Inc.; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085241, K08DK088944, P30DK081943] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Physicians Services Incorporated Foundation; Amgen Inc.(Amgen); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work of CCB was supported by a grant from the NIH (RO1- DK085241). The work of AH and HNR was supported by an initial grant from the Physicians Services Incorporated Foundation and unrestricted investigator-initiated funds from Amgen Inc. The work of JBH was supported by a grant from the NIH (5-K08-DK088944). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUPHAN N, 1995, SCIENCE, V270, P286, DOI 10.1126/science.270.5234.286; Barratt J, 2005, J AM SOC NEPHROL, V16, P2088, DOI 10.1681/ASN.2005020134; Bartosik LP, 2001, AM J KIDNEY DIS, V38, P728, DOI 10.1053/ajkd.2001.27689; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brown VA, 2010, CANCER RES, V70, P9003, DOI 10.1158/0008-5472.CAN-10-2364; Butte AJ, 2012, CLIN PHARMACOL THER, V91, P949, DOI 10.1038/clpt.2012.55; Cattran DC, 2009, KIDNEY INT; Cohen CD, 2002, KIDNEY INT, V61, P133, DOI 10.1046/j.1523-1755.2002.00113.x; COPPO R, 1984, CLIN EXP IMMUNOL, V57, P583; Coppo R, 2010, J NEPHROL, V23, P626; El Karoui K, 2011, KIDNEY INT, V79, P643, DOI 10.1038/ki.2010.460; GESUALDO L, 1990, J IMMUNOL, V145, P3684; Giovannini L, 2001, J CARDIOVASC PHARM, V37, P262, DOI 10.1097/00005344-200103000-00004; Halling SE, 2012, NEPHROL DIAL TRANSPL, V27, P715, DOI 10.1093/ndt/gfr339; Herzenberg AM, 2011, KIDNEY INT, V80, P310, DOI 10.1038/ki.2011.126; Hotta O, 2002, AM J KIDNEY DIS, V39, P493, DOI 10.1053/ajkd.2002.31399; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lee H, 2012, KOREAN J INTERN MED, V27, P293, DOI 10.3904/kjim.2012.27.3.293; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lv JC, 2012, J AM SOC NEPHROL, V23, P1108, DOI 10.1681/ASN.2011111112; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Roberts ISD, 2013, CURR OPIN NEPHROL HY, V22, P281, DOI 10.1097/MNH.0b013e32835fe65c; Roberts IS, 2009, KIDNEY INT; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; SCHEINMAN RI, 1995, SCIENCE, V270, P283, DOI 10.1126/science.270.5234.283; Schmid H, 2006, CURR OPIN NEPHROL HY, V15, P123, DOI 10.1097/01.mnh.0000214770.11609.fb; Shi SF, 2011, CLIN J AM SOC NEPHRO, V6, P2175, DOI 10.2215/CJN.11521210; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Wen DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082336; Zeng CH, 2012, AM J KIDNEY DIS, V60, P812, DOI 10.1053/j.ajkd.2012.06.011; Zhong YF, 2013, J AM SOC NEPHROL, V24, P801, DOI 10.1681/ASN.2012060590	32	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e103413	10.1371/journal.pone.0103413	http://dx.doi.org/10.1371/journal.pone.0103413			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133636	Green Submitted, gold, Green Published			2022-12-25	WOS:000341302700009
J	Mishiro, K; Imai, T; Sugitani, S; Kitashoji, A; Suzuki, Y; Takagi, T; Chen, H; Oumi, Y; Tsuruma, K; Shimazawa, M; Hara, H				Mishiro, Keisuke; Imai, Takahiko; Sugitani, Sou; Kitashoji, Akira; Suzuki, Yukiya; Takagi, Toshinori; Chen, Huayue; Oumi, Yasunori; Tsuruma, Kazuhiro; Shimazawa, Masamitsu; Hara, Hideaki			Diabetes Mellitus Aggravates Hemorrhagic Transformation after Ischemic Stroke via Mitochondrial Defects Leading to Endothelial Apoptosis	PLOS ONE			English	Article							HIGH GLUCOSE; CEREBRAL-ISCHEMIA; UP-REGULATION; RISK-FACTOR; HYPERGLYCEMIA; CELLS; INFLAMMATION; PREVALENCE; SYNTHASE; DAMAGE	Diabetes is a crucial risk factor for stroke and is associated with increased frequency and poor prognosis. Although endothelial dysfunction is a known contributor of stroke, the underlying mechanisms have not been elucidated. The aim of this study was to elucidate the mechanism by which chronic hyperglycemia may contribute to the worsened prognosis following stroke, especially focusing on mitochondrial alterations. We examined the effect of hyperglycemia on hemorrhagic transformation at 24 hours after middle cerebral artery occlusion (MCAO) in streptozotocin (STZ)-induced diabetic mice. We also examined the effects of high-glucose exposure for 6 days on cell death, mitochondrial functions and morphology in human brain microvascular endothelial cells (HBMVECs) or human endothelial cells derived from induced pluripotent stem cells (iCell endothelial cells). Hyperglycemia aggravated hemorrhagic transformation, but not infarction following stroke. High-glucose exposure increased apoptosis, capase-3 activity, and release of apoptosis inducing factor (AIF) and cytochrome c in HBMVECs as well as affected mitochondrial functions (decreased cell proliferation, ATP contents, mitochondrial membrane potential, and increased matrix metalloproteinase (MMP)-9 activity, but not reactive oxygen species production). Furthermore, morphological aberration of mitochondria was observed in diabetic cells (a great deal of fragmentation, vacuolation, and cristae disruption). A similar phenomena were seen also in iCell endothelial cells. In conclusion, chronic hyperglycemia aggravated hemorrhagic transformation after stroke through mitochondrial dysfunction and morphological alteration, partially via MMP-9 activation, leading to caspase-dependent apoptosis of endothelial cells of diabetic mice. Mitochondria-targeting therapy may be a clinically innovative therapeutic strategy for diabetic complications in the future.	[Mishiro, Keisuke; Imai, Takahiko; Sugitani, Sou; Kitashoji, Akira; Suzuki, Yukiya; Takagi, Toshinori; Tsuruma, Kazuhiro; Shimazawa, Masamitsu; Hara, Hideaki] Gifu Pharmaceut Univ, Dept Biofunct Evaluat, Gifu, Japan; [Takagi, Toshinori] Gifu Univ, Grad Sch Med, Dept Neurosurg, Gifu, Japan; [Chen, Huayue] Gifu Univ, Grad Sch Med, Dept Anat, Gifu, Japan; [Oumi, Yasunori] Gifu Univ, Life Sci Res Ctr, Div Instrument Anal, Gifu, Japan	Gifu Pharmaceutical University; Gifu University; Gifu University; Gifu University	Hara, H (corresponding author), Gifu Pharmaceut Univ, Dept Biofunct Evaluat, Gifu, Japan.	hidehara@gifu-pu.ac.jp	Imai, Takahiko/ABF-6143-2020; Oumi, Yasunori/E-5964-2017	Imai, Takahiko/0000-0002-4422-2946; Oumi, Yasunori/0000-0001-9987-0417; Hara, Hideaki/0000-0003-2046-9001				Abraham NG, 2003, CIRC RES, V93, P507, DOI 10.1161/01.RES.0000091828.36599.34; Bach D, 2003, J BIOL CHEM, V278, P17190, DOI 10.1074/jbc.M212754200; Capes SE, 2001, STROKE, V32, P2426, DOI 10.1161/hs1001.096194; Chiu CD, 2013, STROKE, V44, P1682, DOI 10.1161/STROKEAHA.113.675983; Contreras L, 2010, BBA-BIOENERGETICS, V1797, P607, DOI 10.1016/j.bbabio.2010.05.005; Copin JC, 2005, EUR J NEUROSCI, V22, P1597, DOI 10.1111/j.1460-9568.2005.04367.x; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Ergul A, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-33; Folsom AR, 1999, DIABETES CARE, V22, P1077, DOI 10.2337/diacare.22.7.1077; Gong L, 2011, BBA-MOL CELL RES, V1813, P1211, DOI 10.1016/j.bbamcr.2011.03.011; Hamasaki M, 2013, NATURE, V495, P389, DOI 10.1038/nature11910; Hara H, 1997, P NATL ACAD SCI USA, V94, P2007, DOI 10.1073/pnas.94.5.2007; Hara H, 1996, J CEREBR BLOOD F MET, V16, P605, DOI 10.1097/00004647-199607000-00010; Hawkins BT, 2007, DIABETOLOGIA, V50, P202, DOI 10.1007/s00125-006-0485-z; Kageyama S, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-73; Kawai N, 1997, STROKE, V28, P149, DOI 10.1161/01.STR.28.1.149; Kissela BM, 2005, DIABETES CARE, V28, P355, DOI 10.2337/diacare.28.2.355; Kumari R, 2011, J NEUROCHEM, V119, P1029, DOI 10.1111/j.1471-4159.2011.07487.x; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Luan HY, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-28; Makino A, 2010, DIABETOLOGIA, V53, P1783, DOI 10.1007/s00125-010-1770-4; Martini SR, 2007, J CEREBR BLOOD F MET, V27, P435, DOI 10.1038/sj.jcbfm.9600355; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; Molina AJA, 2009, DIABETES, V58, P2303, DOI 10.2337/db07-1781; Morigi M, 1998, J CLIN INVEST, V101, P1905, DOI 10.1172/JCI656; Mukhopadhyay P, 2007, BIOCHEM BIOPH RES CO, V358, P203, DOI 10.1016/j.bbrc.2007.04.106; Murase S, 2012, J BIOL CHEM, V287, P12184, DOI 10.1074/jbc.M111.297671; Ning HX, 2012, UROLOGY, V80, DOI 10.1016/j.urology.2012.04.071; Ning R, 2012, NEUROSCIENCE, V222, P326, DOI 10.1016/j.neuroscience.2012.07.018; Piconi L, 2006, DIABETES-METAB RES, V22, P198, DOI 10.1002/dmrr.613; Prakash R, 2012, DIABETES, V61, P1533, DOI 10.2337/db11-1528; PULSINELLI WA, 1983, AM J MED, V74, P540, DOI 10.1016/0002-9343(83)91007-0; Putaala J, 2011, NEUROLOGY, V76, P1742, DOI 10.1212/WNL.0b013e31821a44ad; Qiu JH, 2010, STROKE, V41, P2077, DOI 10.1161/STROKEAHA.110.590463; Quast MJ, 1997, J CEREBR BLOOD F MET, V17, P553, DOI 10.1097/00004647-199705000-00009; Saita S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2400; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Smith CJ, 2013, J NEUROIMMUNE PHARM, V8, P867, DOI 10.1007/s11481-013-9469-1; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; STEGMAYR B, 1995, DIABETOLOGIA, V38, P1061, DOI 10.1007/BF00402176; Trudeau K, 2010, AM J PATHOL, V177, P447, DOI 10.2353/ajpath.2010.091029; Tureyen K, 2011, J NEUROCHEM, V116, P499, DOI 10.1111/j.1471-4159.2010.07127.x; Twig G, 2008, BBA-BIOENERGETICS, V1777, P1092, DOI 10.1016/j.bbabio.2008.05.001; Widlansky ME, 2010, TRANSL RES, V156, P15, DOI 10.1016/j.trsl.2010.04.001; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Won SJ, 2011, ANN NEUROL, V70, P583, DOI 10.1002/ana.22538; Yan JQ, 2012, CELL MOL LIFE SCI, V69, P115, DOI 10.1007/s00018-011-0731-5; Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103; Zorzano A, 2009, INT J BIOCHEM CELL B, V41, P1846, DOI 10.1016/j.biocel.2009.02.004; Zou MH, 2002, DIABETES, V51, P198, DOI 10.2337/diabetes.51.1.198	50	36	41	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e103818	10.1371/journal.pone.0103818	http://dx.doi.org/10.1371/journal.pone.0103818			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133692	Green Submitted, Green Published, gold			2022-12-25	WOS:000341302700018
J	Pinto, MP; Sousa e Silva, JD; de Lima, AA; Grelle, CEV				Pinto, Miriam Plaza; Sousa e Silva-Junior, Jose de; de Lima, Adriana Almeida; Viveiros Grelle, Carlos Eduardo			Multi-Scales Analysis of Primate Diversity and Protected Areas at a Megadiverse Region	PLOS ONE			English	Article							RESERVE SELECTION; SPECIES RICHNESS; CONSERVATION; BIODIVERSITY; EXTINCTION; FIRE; DEFORESTATION; BIOGEOGRAPHY; HOTSPOTS; FORESTS	In this paper, we address the question of what proportion of biodiversity is represented within protected areas. We assessed the effectiveness of different protected area types at multiple scales in representing primate biodiversity in the Brazilian Legal Amazon. We used point locality data and distribution data for primate species within 1 degrees, 0.5 degrees, and 0.25 degrees spatial resolution grids, and computed the area of reserves within each cell. Four different approaches were used - no reserves (A), exclusively strict use reserves (B), strict and sustainable use reserves (C), and strict and sustainable use reserves and indigenous lands (D). We used the complementarity concept to select reserve networks. The proportions of cells that were classified as reserves at a grid resolution of 1 degrees were 37%, 64%, and 88% for approaches B, C and D, respectively. Our comparison of these approaches clearly showed the effect of an increase in area on species representation. Representation was consistently higher at coarser resolutions, indicating the effect of grain size. The high number of irreplaceable cells for selected networks identified based on approach A could be attributed to the use of point locality occurrence data. Although the limited number of point occurrences for some species may have been due to a Wallacean shortfall, in some cases it may also be the result of an actual restricted geographic distribution. The existing reserve system cannot be ignored, as it has an established structure, legal protection status, and societal recognition, and undoubtedly represents important elements of biodiversity. However, we found that strict use reserves (which are exclusively dedicated to biodiversity conservation) did not effectively represent primate species. This finding may be related to historical criteria for selecting reserves based on political, economic, or social motives.	[Pinto, Miriam Plaza] Univ Fed Rio de Janeiro, Programa Posgrad Ecol, Rio De Janeiro, RJ, Brazil; [Sousa e Silva-Junior, Jose de] Museu Paraense Emilio Goeldi, Belem, Para, Brazil; [de Lima, Adriana Almeida] Univ Fed Rio Grande do Norte, Dept Ecol, BR-59072970 Natal, RN, Brazil; [Viveiros Grelle, Carlos Eduardo] Univ Fed Rio de Janeiro, Dept Ecol, Rio De Janeiro, RJ, Brazil; [Viveiros Grelle, Carlos Eduardo] Univ Fed Rio de Janeiro, Lab Vertebrados, Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro; Museu Paraense Emilio Goeldi; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Pinto, MP (corresponding author), Univ Fed Rio Grande do Norte, Dept Ecol, BR-59072970 Natal, RN, Brazil.	miriamplazapinto@yahoo.com.br	Grelle, Carlos EV/A-9687-2017; Pinto, Míriam Plaza/B-8000-2013	Pinto, Míriam Plaza/0000-0002-4030-5015	FAPERJ [proc. E-26/111.829/2010]; CNPq [PDJ 150721/2010-2]; Carlos Eduardo Viveiros Grelle by CNPq	FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Carlos Eduardo Viveiros Grelle by CNPq	Miriam Plaza Pinto was supported by FAPERJ doctoral scholarship (http://www.faperj.br/) and CNPq pos-doctoral scholarship (PDJ 150721/2010-2; http://www.cnpq.br/) and Carlos Eduardo Viveiros Grelle by CNPq productivity fellowship. This study was supported by grants from CNPq and FAPERJ (Auxilio Instalacao - proc. E-26/111.829/2010 and Jovem Cientista do Estado). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard F, 2002, SCIENCE, V297, P999, DOI 10.1126/science.1070656; [Anonymous], 2012, OCCASIONAL PAPERS CO; Araujo MB, 2007, CONSERV BIOL, V21, P1423, DOI 10.1111/j.1523-1739.2007.00827.x; Asner GP, 2005, SCIENCE, V310, P480, DOI 10.1126/science.1118051; Asner GP, 2009, CONSERV BIOL, V23, P1386, DOI 10.1111/j.1523-1739.2009.01333.x; AYRES JM, 1992, AM NAT, V140, P531, DOI 10.1086/285427; Ball I, 2000, MARXAN V1 8 2 USER M; Ball I. R., 2009, SPATIAL CONSERVATION, P185, DOI DOI 10.1111/EVA.12631; Bicca-Marques JC, 2006, MAMIFEROS BRASIL; Bini LM, 2006, DIVERS DISTRIB, V12, P475, DOI 10.1111/j.1366-9516.2006.00286.x; Bird JP, 2012, DIVERS DISTRIB, V18, P273, DOI 10.1111/j.1472-4642.2011.00843.x; Brito D, 2006, BIODIVERS CONSERV, V15, P4197, DOI 10.1007/s10531-005-3575-1; Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; Brooks TM, 2009, CONSERV BIOL, V23, P1448, DOI 10.1111/j.1523-1739.2009.01334.x; Chapman CA, 2001, EVOL ANTHROPOL, V10, P16, DOI 10.1002/1520-6505(2001)10:1<16::AID-EVAN1010>3.0.CO;2-O; Cochrane MA, 2001, ENVIRONMENT, V43, P28, DOI 10.1080/00139150109604505; Da Silva JMC, 2005, CONSERV BIOL SER, V8, P337; Fa JE, 2002, CONSERV BIOL, V16, P232, DOI 10.1046/j.1523-1739.2002.00275.x; Fuller HL, 2009, J TROP ECOL, V25, P387, DOI 10.1017/S0266467409006063; Game ET, 2008, QUANTITATIVE METHODS; Goldani A., 2006, Braz. J. Biol., V66, P61, DOI 10.1590/S1519-69842006000100009; Grelle CED, 1999, ANIM CONSERV, V2, P149, DOI 10.1111/j.1469-1795.1999.tb00060.x; Grelle CEV, 2005, ORYX, V39, P347, DOI 10.1017/S0030605305000700; Harcourt AH, 2006, J BIOGEOGR, V33, P2077, DOI 10.1111/j.1365-2699.2006.01557.x; Harcourt AH, 2000, BIOL CONSERV, V93, P163, DOI 10.1016/S0006-3207(99)00145-7; Hurlbert AH, 2007, P NATL ACAD SCI USA, V104, P13384, DOI 10.1073/pnas.0704469104; IUCN, 2022, IUCN RED LIST THREAT; Jantke K, 2011, BIODIVERS CONSERV, V20, P581, DOI 10.1007/s10531-010-9968-9; Jenkins CN, 2009, BIOL CONSERV, V142, P2166, DOI 10.1016/j.biocon.2009.04.016; Jennings MD, 2000, LANDSCAPE ECOL, V15, P5, DOI 10.1023/A:1008184408300; Joppa LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008273; Klink CA, 2005, CONSERV BIOL, V19, P707, DOI 10.1111/j.1523-1739.2005.00702.x; Laurance William F., 2009, Oecologia Brasiliensis, V13, P434; Laurance WF, 2009, CONSERV BIOL, V23, P1427, DOI 10.1111/j.1523-1739.2009.01336.x; Machado ABM, 2008, LIVRO VERMELHO FAUNA; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Marini MA, 2009, BIOL CONSERV, V142, P3039, DOI 10.1016/j.biocon.2009.08.002; Nepstad D, 1998, CONSERV BIOL, V12, P951, DOI 10.1046/j.1523-1739.1998.012005951.x; Nepstad D, 2006, CONSERV BIOL, V20, P65, DOI 10.1111/j.1523-1739.2006.00351.x; Nepstad DC, 1999, NATURE, V398, P505, DOI 10.1038/19066; O'Dea N, 2006, DIVERS DISTRIB, V12, P205, DOI 10.1111/j.1366-9516.2006.00235.x; Peres CA, 2006, BIODIVERS CONSERV, V15, P2627, DOI 10.1007/s10531-005-5406-9; Pinto MP, 2009, BIODIVERS CONSERV, V18, P957, DOI 10.1007/s10531-008-9513-2; Possingham H, 1998, QUANTITATIVE METHODS FOR CONSERVATION BIOLOGY, P291; Pressey RL, 2001, CONSERV BIOL, V15, P275, DOI 10.1046/j.1523-1739.2001.99541.x; Pressey RL, 2002, BIOL CONSERV, V106, P57, DOI 10.1016/S0006-3207(01)00229-4; R Development Core Team, 2012, R LANG ENV STAT COMP; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Rondinini C, 2006, ECOL LETT, V9, P1136, DOI 10.1111/j.1461-0248.2006.00970.x; Schmitt CB, 2009, BIOL CONSERV, V142, P2122, DOI 10.1016/j.biocon.2009.04.012; Schulman L, 2007, BIODIVERS CONSERV, V16, P3011, DOI 10.1007/s10531-007-9158-6; SCOTT JM, 1993, WILDLIFE MONOGR, P1; Sebastiao H, 2009, ECOL INDIC, V9, P160, DOI 10.1016/j.ecolind.2008.03.002; Soule ME, 1987, VIABLE POPULATIONS C, P101; Strayer DL, 2006, TRENDS ECOL EVOL, V21, P645, DOI 10.1016/j.tree.2006.07.007; Tognelli MF, 2008, DIVERS DISTRIB, V14, P148, DOI 10.1111/j.1472-4642.2007.00437.x; Wearn OR, 2012, SCIENCE, V337, P228, DOI 10.1126/science.1219013; Whittaker RJ, 2005, DIVERS DISTRIB, V11, P3, DOI 10.1111/j.1366-9516.2005.00143.x	58	5	5	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105205	10.1371/journal.pone.0105205	http://dx.doi.org/10.1371/journal.pone.0105205			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133497	Green Published, Green Submitted, gold			2022-12-25	WOS:000341302700086
J	van der Linden, ML; Hooper, JE; Cowan, P; Weller, BB; Mercer, TH				van der Linden, Marietta L.; Hooper, Julie E.; Cowan, Paula; Weller, Belinda B.; Mercer, Thomas H.			Habitual Functional Electrical Stimulation Therapy Improves Gait Kinematics and Walking Performance, but Not Patient-Reported Functional Outcomes, of People with Multiple Sclerosis who Present with Foot-Drop	PLOS ONE			English	Article							FATIGUE SEVERITY SCALE; RELIABILITY; IMPACT; INVESTIGATE; EXERCISE; QUALITY; ABILITY; DEVICE; STROKE; COST	Background: People with Multiple Sclerosis (pwMS) often experience a disturbed gait function such as foot-drop. The objective of this pilot study was to investigate the medium term effects of using Functional Electrical Stimulation (FES) to treat foot-drop over a period 12 weeks on gait and patient reported outcomes of pwMS. Methods and Findings: Nine pwMS aged 35 to 64 (2 males, 7 females) were assessed on four occasions; four weeks before baseline, at baseline and after six weeks and twelve weeks of FES use. Joint kinematics and performance on the 10 meter and 2 minute walk tests (10WT, 2 minWT) were assessed with and without FES. Participants also completed the MS walking Scale (MSWS), MS impact scale (MSIS29), Fatigue Severity Score (FSS) and wore an activity monitor for seven days after each assessment. Compared to unassisted walking, FES resulted in statistically significant improvements in peak dorsiflexion in swing (p = 0.006), 10MWT (p = 0.006) and 2 minWT (p = 0.002). Effect sizes for the training effect, defined as the change from unassisted walking at baseline to that at 12 weeks, indicated improved ankle angle at initial contact (2.6 degrees, 95% CI -1 degrees to 4 degrees, d = 0.78), and a decrease in perceived exertion over the 2 min walking tests (-1.2 points, 95% CI -5.7 to 3.4, d = -0.86). Five participants exceeded the Minimally Detectable Change (MDC) for a training effect on the 10mWT, but only two did so for the 2 minWT. No effects of the use of FES for 12 weeks were found for MSWS, MSIS29, FSS or step count. Conclusion: Although FES to treat foot-drop appears to offer the potential for a medium term training effect on ankle kinematics and walking speed, this was not reflected in the patient reported outcomes. This observed lack of relationship between objective walking performance and patient reported outcomes warrants further investigation.	[van der Linden, Marietta L.; Mercer, Thomas H.] Queen Margaret Univ, Musselburgh, Scotland; [Hooper, Julie E.] NHS Lothian, Slateford Physiotherapy Clin, Edinburgh, Midlothian, Scotland; [Cowan, Paula] NHS Lothian, Kenilworth Med Ctr, Edinburgh, Midlothian, Scotland; [Weller, Belinda B.] Anne Rowling Regenerat Neurol Clin, Edinburgh, Midlothian, Scotland	Queen Margaret University	van der Linden, ML (corresponding author), Queen Margaret Univ, Musselburgh, Scotland.	mvanderlinden@qmu.ac.uk		van der Linden, Marietta/0000-0003-2256-6673	Multiple Sclerosis Society [873/07]	Multiple Sclerosis Society(National Multiple Sclerosis Society)	This study was carried out as part of a Multiple Sclerosis Society PhD studentship award funded by the Multiple Sclerosis Society [grant number 873/07]. TM was the PI and budget holder. MvdL, JH and PC were co-applicants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett CL, 2009, MULT SCLER J, V15, P493, DOI 10.1177/1352458508101320; Barrett C, 2010, NEUROMODULATION, V13, P58, DOI 10.1111/j.1525-1403.2009.00250.x; Benedetti MG, 1999, MULT SCLER J, V5, P363, DOI 10.1191/135245899678846393; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Bulley C, 2011, PHYSIOTHERAPY, V97, P226, DOI 10.1016/j.physio.2010.11.001; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Crayton HJ, 2006, CLIN THER, V28, P445, DOI 10.1016/j.clinthera.2006.04.005; Dahlgren G, 2010, GAIT POSTURE, V32, P386, DOI 10.1016/j.gaitpost.2010.06.022; Esnouf JE, 2010, MULT SCLER J, V16, P1141, DOI 10.1177/1352458510366013; Feys P, 2014, J NEUROL SCI, V338, P183, DOI 10.1016/j.jns.2014.01.001; FREAL JE, 1984, ARCH PHYS MED REHAB, V65, P135; Gijbels D, 2011, MULT SCLER J, V17, P1269, DOI 10.1177/1352458511408475; Gunn H, 2014, ARCH PHYS MED REHAB, V95, P538, DOI 10.1016/j.apmr.2013.08.244; Heesen C, 2008, MULT SCLER, V14, P988, DOI 10.1177/1352458508088916; Hobart J, 2001, BRAIN, V124, P962, DOI 10.1093/brain/124.5.962; Hobart JC, 2003, NEUROLOGY, V60, P31, DOI 10.1212/WNL.60.1.31; Horsley W, 2012, ORTHOTIC FUNCTIONAL; KADABA MP, 1990, J ORTHOP RES, V8, P383, DOI 10.1002/jor.1100080310; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Learmonth YC, 2013, J NEUROL SCI, V331, P102, DOI 10.1016/j.jns.2013.05.023; Martin CL, 2006, MULT SCLER J, V12, P620, DOI 10.1177/1352458506070658; McGinley JL, 2009, GAIT POSTURE, V29, P360, DOI 10.1016/j.gaitpost.2008.09.003; Paul L, 2008, MULT SCLER J, V14, P954, DOI 10.1177/1352458508090667; PERRY J, 1995, STROKE, V26, P982, DOI 10.1161/01.STR.26.6.982; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Rossier P, 2001, ARCH PHYS MED REHAB, V82, P9, DOI 10.1053/apmr.2001.9396; Scott SM, 2013, J REHABIL MED, V45, P364, DOI 10.2340/16501977-1109; Sheffler LR, 2009, ARCH PHYS MED REHAB, V90, P362, DOI 10.1016/j.apmr.2008.10.010; Stein RB, 2010, NEUROREHAB NEURAL RE, V24, P152, DOI 10.1177/1545968309347681; Taylor P, 2014, NEUROMODULATION, V17, P75, DOI 10.1111/ner.12048; Taylor P, 2013, J REHABIL MED, V45, P154, DOI 10.2340/16501977-1090; Taylor PN, 1999, ARCH PHYS MED REHAB, V80, P1577, DOI 10.1016/S0003-9993(99)90333-7; van der Linden Marietta L, 2008, Pediatr Phys Ther, V20, P23, DOI 10.1097/PEP.0b013e31815f39c9; WINTER DA, 1992, PHYS THER, V72, P45, DOI 10.1093/ptj/72.1.45	34	24	25	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e103368	10.1371/journal.pone.0103368	http://dx.doi.org/10.1371/journal.pone.0103368			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133535	Green Published, Green Submitted, gold			2022-12-25	WOS:000341302700007
J	Chugh, PE; Damania, BA; Dittmer, DP				Chugh, Pauline E.; Damania, Blossom A.; Dittmer, Dirk P.			Toll-Like Receptor-3 Is Dispensable for the Innate MicroRNA Response to West Nile Virus (WNV)	PLOS ONE			English	Article							METHYLENE-BLUE PHOTOINACTIVATION; INTERFERON REGULATORY FACTOR-3; PRIMARY EFFUSION LYMPHOMA; BLOOD-BRAIN-BARRIER; PROTEIN-KINASE PKR; COMPLEX CLASS-I; SENSORS RIG-I; IMMUNE-RESPONSE; RNA VIRUSES; ENCEPHALITIS-VIRUS	The innate immune response to West Nile virus (WNV) infection involves recognition through toll-like receptors (TLRs) and RIG-I-like receptors (RLRs), leading to establishment of an antiviral state. MiRNAs (miRNAs) have been shown to be reliable biomarkers of TLR activation. Here, we sought to evaluate the contribution of TLR3 and miRNAs to the host response to WNV infection. We first analyzed HEK293-NULL and HEK293-TLR3 cells for changes in the innate immune response to infection. The presence of TLR3 did not seem to affect WNV load, infectivity or phosphorylation of IRF3. Analysis of experimentally validated NFkB-responsive genes revealed a WNV-induced signature largely independent of TLR3. Since miRNAs are involved in viral pathogenesis and the innate response to infection, we sought to identify changes in miRNA expression upon infection in the presence or absence of TLR3. MiRNA profiling revealed 70 miRNAs induced following WNV infection in a TLR3-independent manner. Further analysis of predicted gene targets of WNV signature miRNAs revealed genes highly associated with pathways regulating cell death, viral pathogenesis and immune cell trafficking.	[Chugh, Pauline E.; Damania, Blossom A.; Dittmer, Dirk P.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Ctr AIDS Res, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Dittmer, DP (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Ctr AIDS Res, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.	ddittmer@med.unc.edu	Dittmer, Dirk/AAH-3535-2021; Dittmer, Dirk/GPW-7423-2022	Dittmer, Dirk/0000-0003-4968-5656; 	NIH [DE018304, DE018281];  [R01 CA109232-08S1]; NATIONAL CANCER INSTITUTE [R01CA109232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018281, R01DE018304] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by NIH grants DE018304 and DE018281. PC is supported by a minority supplement to R01 CA109232-08S1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, MMWR MORB MORTAL WKL, V62, P513; Arjona A, 2007, J IMMUNOL, V179, P8403, DOI 10.4049/jimmunol.179.12.8403; Backes S, 2014, CELL REP; Baronti C, 2010, VIROLOGY, V404, P319, DOI 10.1016/j.virol.2010.05.020; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bi YJ, 2009, J CELL PHYSIOL, V218, P467, DOI 10.1002/jcp.21639; Bogerd HP, 2014, J VIROL, V88, P8065, DOI 10.1128/JVI.00985-14; Brien JD, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002230; Chen G, 2006, J BIOL CHEM, V281, P15909, DOI 10.1074/jbc.M600612200; Cheng Y, 2004, J INFECT DIS, V189, P658, DOI 10.1086/381501; Chugh P, 2010, J VIS EXP; Chugh P, 2012, WIRES RNA, V3, P601, DOI 10.1002/wrna.1120; Crook KR, 2014, VIROLOGY, V458, P172, DOI 10.1016/j.virol.2014.04.036; Daffis S, 2008, J VIROL, V82, P10349, DOI 10.1128/JVI.00935-08; Daffis S, 2007, PLOS PATHOG, V3, P1005, DOI 10.1371/journal.ppat.0030106; Daffis S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000607; Diamond MS, 2012, TRENDS IMMUNOL, V33, P522, DOI 10.1016/j.it.2012.05.008; Diamond MS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000452; Diamond MS, 2009, FRONT BIOSCI-LANDMRK, V14, P3024, DOI 10.2741/3432; Diao FC, 2007, P NATL ACAD SCI USA, V104, P11706, DOI 10.1073/pnas.0700544104; Elbarbary RA, 2013, GENE DEV, V27, P1495, DOI 10.1101/gad.220962.113; Errett JS, 2013, J VIROL, V87, P11416, DOI 10.1128/JVI.01488-13; Floyd RA, 2004, ANTIVIR RES, V61, P141, DOI 10.1016/j.antiviral.2003.11.004; Fredericksen BL, 2006, J VIROL, V80, P2913, DOI 10.1128/JVI.80.6.2913-2923.2006; Fredericksen BL, 2004, J VIROL, V78, P7737, DOI 10.1128/JVI.78.14.7737-7747.2004; Fredericksen BL, 2008, J VIROL, V82, P609, DOI 10.1128/JVI.01305-07; Galli R, 2013, P NATL ACAD SCI USA, V110, P9812, DOI 10.1073/pnas.1304610110; Gantier MP, 2011, NUCLEIC ACIDS RES, V39, P5692, DOI 10.1093/nar/gkr148; Getts DR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-246; Gilfoy FD, 2007, J VIROL, V81, P11148, DOI 10.1128/JVI.00446-07; Gusev Y, 2008, METHODS, V44, P61, DOI 10.1016/j.ymeth.2007.10.005; Hayes EB, 2005, EMERG INFECT DIS, V11, P1174, DOI 10.3201/eid1108.050289b; Hussain M, 2012, NUCLEIC ACIDS RES, V40, P2210, DOI 10.1093/nar/gkr848; Jeon SH, 2012, FEBS LETT, V586, P3477, DOI 10.1016/j.febslet.2012.07.076; Jiang XM, 2012, IMMUNITY, V36, P959, DOI 10.1016/j.immuni.2012.03.022; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Ke N, 2011, METHODS MOL BIOL, V740, P33, DOI 10.1007/978-1-61779-108-6_6; Kesson AM, 2001, J INFECT DIS, V184, P947, DOI 10.1086/323603; Kong KF, 2008, J VIROL, V82, P7613, DOI 10.1128/JVI.00618-08; Kumar M, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-73; Lazear HM, 2013, J VIROL, V87, P11401, DOI 10.1128/JVI.01403-13; Lindsey NP, 2014, MMWR-MORBID MORTAL W, V63, P521; Liu G, 2009, P NATL ACAD SCI USA, V106, P15819, DOI 10.1073/pnas.0901216106; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; Marfin AA, 2001, EMERG INFECT DIS, V7, P730; Mashimo T, 2002, P NATL ACAD SCI USA, V99, P11311, DOI 10.1073/pnas.172195399; Medigeshi GR, 2007, J VIROL, V81, P10849, DOI 10.1128/JVI.01151-07; MMWR, 2008, MMWR MORB MORTAL WKL, V57, P720; O'Hara AJ, 2008, BLOOD, V111, P2347, DOI 10.1182/blood-2007-08-104463; O'Hara AJ, 2009, BLOOD, V113, P5938, DOI 10.1182/blood-2008-09-179168; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Ostermann E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043744; Papin JF, 2005, ANTIVIR RES, V68, P84, DOI 10.1016/j.antiviral.2005.07.001; Papin JF, 2004, J CLIN MICROBIOL, V42, P1511, DOI 10.1128/JCM.42.4.1511-1518.2004; Parameswaran P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000764; Pare JM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003865; Perelygin AA, 2002, P NATL ACAD SCI USA, V99, P9322, DOI 10.1073/pnas.142287799; Ramos JC, 2012, INT J CANCER, V130, P2728, DOI 10.1002/ijc.26302; Roe K, 2012, J GEN VIROL, V93, P1193, DOI 10.1099/vir.0.040899-0; Rudd BD, 2005, J VIROL, V79, P3350, DOI 10.1128/JVI.79.6.3350-3357.2005; Samuel MA, 2006, J VIROL, V80, P7009, DOI 10.1128/JVI.00489-06; Scherbik S.V., 2013, J VIROL; Scherbik SV, 2006, J VIROL, V80, P2987, DOI 10.1128/JVI.80.6.2987-2999.2006; Scherbik SV, 2007, VIROLOGY, V368, P232, DOI 10.1016/j.virol.2007.08.017; Scholle F, 2005, VIROLOGY, V342, P77, DOI 10.1016/j.virol.2005.07.021; Schumann M, 2009, J VIROL, V83, P8993, DOI 10.1128/JVI.00523-09; Seo GJ, 2013, CELL HOST MICROBE, V14, P435, DOI 10.1016/j.chom.2013.09.002; Shapiro JS, 2012, RNA, V18, P1338, DOI 10.1261/rna.032268.112; Skalsky RL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-119; Slonchak A, 2014, J VIROL, V88, P8457, DOI 10.1128/JVI.00317-14; Smith JL, 2012, J VIROL, V86, P5278, DOI 10.1128/JVI.06883-11; Storey John D, 2003, Methods Mol Biol, V224, P149; Sullivan CS, 2008, NAT REV GENET, V9, P503, DOI 10.1038/nrg2349; Suthar MS, 2013, NAT REV MICROBIOL, V11, P115, DOI 10.1038/nrmicro2950; Suthar MS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000757; Suthar MS, 2009, CELL MICROBIOL, V11, P880, DOI 10.1111/j.1462-5822.2009.01311.x; Suthar MS, 2012, IMMUNITY; Town T, 2009, IMMUNITY, V30, P242, DOI 10.1016/j.immuni.2008.11.012; Tu YC, 2012, J VIROL, V86, P10347, DOI 10.1128/JVI.00525-12; Verma S, 2009, VIROLOGY, V385, P425, DOI 10.1016/j.virol.2008.11.047; Wang N, 2009, J VIROL, V83, P9824, DOI 10.1128/JVI.01125-09; Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140; West J, 2008, J VIROL, V82, P5440, DOI 10.1128/JVI.02590-07; Wies E, 2013, IMMUNITY, V38, P437, DOI 10.1016/j.immuni.2012.11.018; Wilson JR, 2008, J VIROL, V82, P8262, DOI 10.1128/JVI.00226-08; Wolf RF, 2006, VIROLOGY, V355, P44, DOI 10.1016/j.virol.2006.06.033; Ye J, 2013, VACCINE, V31, P461, DOI 10.1016/j.vaccine.2012.11.015; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoon CH, 2010, EMBO REP, V11, P393, DOI 10.1038/embor.2010.45	89	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104770	10.1371/journal.pone.0104770	http://dx.doi.org/10.1371/journal.pone.0104770			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127040	Green Published, gold, Green Submitted			2022-12-25	WOS:000340879300050
J	Grdisa, M; Liber, Z; Radosavljevic, I; Carovic-Stanko, K; Kolak, I; Satovic, Z				Grdisa, Martina; Liber, Zlatko; Radosavljevic, Ivan; Carovic-Stanko, Klaudija; Kolak, Ivan; Satovic, Zlatko			Genetic Diversity and Structure of Dalmatian Pyrethrum (Tanacetum cinerariifolium Trevir./Sch./Bip., Asteraceae) within the Balkan Refugium	PLOS ONE			English	Article							POPULATION-STRUCTURE; REMNANT POPULATIONS; PHYLOGEOGRAPHY; RANGE; AFLP; DIFFERENTIATION; CONSERVATION; CONSEQUENCES; DIVERGENCE; DISTANCE	Dalmatian pyrethrum (Tanacetum cinerariifolium Trevir. /Sch./ Bip.) is an outcrossing, perennial insecticidal plant, restricted to the eastern Adriatic coast (Mediterranean). Amplified fragment-length polymorphisms (AFLP) were used to investigate the genetic diversity and structure within and among 20 natural plant populations. The highest level of gene diversity, the number of private alleles and the frequency down-weighted marker values (DW) were found in northern Adriatic populations and gradually decreased towards the southern boundary of the species range. Genetic impoverishment of these southern populations is most likely the result of human-related activities. An analysis of molecular variance (AMOVA) indicated that most of the genetic diversity was attributed to differences among individuals within populations (85.78%), which are expected due to the outcrossing nature of the species. A Bayesian analysis of the population structure identified two dominant genetic clusters. A spatial analysis of the genetic diversity indicated that 5.6% of the genetic differentiation resulted from isolation by distance (IBD), while 12.3% of the genetic differentiation among populations followed the pattern of isolation by environmental distance (IBED). Knowledge of the genetic diversity patterns of the natural populations and the mechanism behind these patterns is required for the exploitation and possible conservation management of this endemic and economically important species.	[Grdisa, Martina; Carovic-Stanko, Klaudija; Kolak, Ivan; Satovic, Zlatko] Univ Zagreb, Fac Agr, Dept Seed Sci & Technol, Zagreb 41000, Croatia; [Liber, Zlatko; Radosavljevic, Ivan] Univ Zagreb, Fac Sci, Div Biol, Dept Biol, Zagreb 41000, Croatia	University of Zagreb; University of Zagreb	Grdisa, M (corresponding author), Univ Zagreb, Fac Agr, Dept Seed Sci & Technol, Zagreb 41000, Croatia.	mgrdisa@agr.hr	Liber, Zlatko/D-3342-2016; Šatović, Zlatko/AAA-9626-2020	Šatović, Zlatko/0000-0002-9848-1601; Liber, Zlatko/0000-0002-2370-6650	Ministry of Science, Education and Sports of the Republic of Croatia [178-1191193-0212, 178-0000000-3595, 119-1191193-1232]	Ministry of Science, Education and Sports of the Republic of Croatia(Ministry of Science, Education and Sports, Republic of Croatia)	This study was supported by the Ministry of Science, Education and Sports of the Republic of Croatia (public.mzos.hr), within the framework of Project No. 178-1191193-0212 (ZS), Project No. 178-0000000-3595 (IK) and Project No. 119-1191193-1232 (ZL). The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	AEgisdottir HH, 2009, ANN BOT-LONDON, V104, P1313, DOI 10.1093/aob/mcp242; Bakaric P, 2005, GOSPOD LIST, V17, P41; Baldoni L, 2006, ANN BOT-LONDON, V98, P935, DOI 10.1093/aob/mcl178; Bonin A, 2004, MOL ECOL, V13, P3261, DOI 10.1111/j.1365-294X.2004.02346.x; Bourguiba H, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-49; Campillo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020986; Canestrelli D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041754; Canestrelli D, 2010, MOL ECOL, V19, P5432, DOI 10.1111/j.1365-294X.2010.04900.x; Carovic-Stanko K, 2011, PLANT SYST EVOL, V294, P253, DOI 10.1007/s00606-011-0471-x; Corander J, 2003, GENETICS, V163, P367; Corander J, 2006, MOL ECOL, V15, P2833, DOI 10.1111/j.1365-294X.2006.02994.x; Corander J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-539; Cruse-Sanders JM, 2004, AM J BOT, V91, P540, DOI 10.3732/ajb.91.4.540; Dahlgren JP, 2007, AM J BOT, V94, P1570, DOI 10.3732/ajb.94.9.1570; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Eckert CG, 2008, MOL ECOL, V17, P1170, DOI 10.1111/j.1365-294X.2007.03659.x; Ehrich D, 2007, MOL ECOL, V16, P2542, DOI 10.1111/j.1365-294X.2007.03299.x; Ehrich D, 2006, MOL ECOL NOTES, V6, P603, DOI 10.1111/j.1471-8286.2006.01380.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; FELSENSTEIN J, 1993, PHYLOGENY INFERENCE; Ferrarese S, 2008, J MARINE SYST, V74, P659, DOI 10.1016/j.jmarsys.2008.07.003; Fitter AH, 2002, SCIENCE, V296, P1689, DOI 10.1126/science.1071617; Gomez A, 2007, PHYLOGEOGRAPHY OF SOUTHERN EUROPEAN REFUGIA, P155, DOI 10.1007/1-4020-4904-8_5; Hampe A, 2005, ECOL LETT, V8, P461, DOI 10.1111/j.1461-0248.2005.00739.x; Hamrick JL, 1996, PHILOS T ROY SOC B, V351, P1291, DOI 10.1098/rstb.1996.0112; Head S.W., 1973, PYRETHRUM, P25; Herrmann D, 2010, GENOME, V53, P302, DOI [10.1139/G10-006, 10.1139/g10-006]; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hewitt GM, 2001, MOL ECOL, V10, P537, DOI 10.1046/j.1365-294x.2001.01202.x; Heywood V. H., 1976, FLORA EUROPAEA PLANT, VIV, P169; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hofreiter M, 2009, CURR BIOL, V19, pR584, DOI 10.1016/j.cub.2009.06.030; Hou Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024497; HUA Y, 2010, BIOCH SYST ECOL, V38, P264; Huff DR, 1997, CROP SCI, V37, P557, DOI 10.2135/cropsci1997.0011183X003700020041x; Kozak KH, 2006, EVOLUTION, V60, P2604, DOI 10.1111/j.0014-3820.2006.tb01893.x; Krystufek B, 2007, MOL ECOL, V16, P1221, DOI 10.1111/j.1365-294X.2007.03235.x; Kucera J, 2008, PLANT SYST EVOL, V275, P193, DOI 10.1007/s00606-008-0061-8; Kukla GJ, 2002, QUATERNARY RES, V58, P2, DOI 10.1006/qres.2001.2316; Lakusic Dmitar, 2006, Willdenowia, V36, P177, DOI 10.3372/wi.36.36115; Lakusic D, 2013, TAXON, V62, P505, DOI 10.12705/623.1; Lambeck K, 2002, QUATERNARY SCI REV, V21, P343, DOI 10.1016/S0277-3791(01)00071-3; LESICA P, 1995, CONSERV BIOL, V9, P753, DOI 10.1046/j.1523-1739.1995.09040753.x; Lewontin R.C., 1972, EVOLUTIONARY BIOL, V14, P381, DOI DOI 10.1007/978-1-4684-9063-3_14; Li Q, 2005, BIOCHEM GENET, V43, P445, DOI 10.1007/s10528-005-6782-2; LYNCH M, 1994, MOL ECOL, V3, P91, DOI 10.1111/j.1365-294X.1994.tb00109.x; MacDonald William L., 1995, P55; Manel S, 2003, TRENDS ECOL EVOL, V18, P189, DOI 10.1016/S0169-5347(03)00008-9; MANTEL N, 1967, CANCER RES, V27, P209; Mendez M, 2010, MOL ECOL, V19, P2212, DOI 10.1111/j.1365-294X.2010.04647.x; Muhs DR, 2001, QUATERNARY SCI REV, V20, P41, DOI 10.1016/S0277-3791(00)00132-3; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Nikolic T, 2014, FLORA CROATICA DATAB; Oanic S, 1955, POLJOPRIVREDA DALMAC; Olden JD, 2004, TRENDS ECOL EVOL, V19, P18, DOI 10.1016/j.tree.2003.09.010; OZANIC S, 1930, BUHAC PYRETHRUM CINE; Parisod C, 2008, NEW PHYTOL, V178, P436, DOI 10.1111/j.1469-8137.2007.02361.x; Parlevliet J. E., 1975, Pyrethrum Post, V13, P47; Paun O, 2008, MOL ECOL, V17, P4263, DOI 10.1111/j.1365-294X.2008.03908.x; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; Pikelj K, 2009, GEOL CROAT, V62, P95, DOI 10.4154/gc.2009.08; Pilot M, 2006, MOL ECOL, V15, P4533, DOI 10.1111/j.1365-294X.2006.03110.x; Podnar M, 2004, ORG DIVERS EVOL, V4, P307, DOI 10.1016/j.ode.2004.04.004; Pope LC, 2006, MOL ECOL, V15, P371, DOI 10.1111/j.1365-294X.2005.02815.x; Previsic A, 2009, MOL ECOL, V18, P634, DOI 10.1111/j.1365-294X.2008.04046.x; Pritchard JK, 2000, GENETICS, V155, P945; Rivera-Ocasio E, 2002, MOL ECOL, V11, P675, DOI 10.1046/j.1365-294X.2002.01476.x; ROHLF F, 2000, NTSYS NUMERICAL TAXO; Rossignol-Strick M, 1999, QUATERNARY SCI REV, V18, P515, DOI 10.1016/S0277-3791(98)00093-6; Rousset F, 1997, GENETICS, V145, P1219; Savic I.R., 2008, ADV ARACHNOLOGY DEV, P57; Schmidt K, 2000, AM J BOT, V87, P678, DOI 10.2307/2656854; Schmitt T, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-11; SCHNEIDER S., 2000, ARLEQUIN VERSION 2 0; Schonswetter P, 2005, TAXON, V54, P725, DOI 10.2307/25065429; Shannon C., 1964, MATH THEORY COMMUNIC; Shim SI, 2000, THEOR APPL GENET, V101, P227, DOI 10.1007/s001220051473; Suric M, 2009, MAR GEOL, V262, P62, DOI 10.1016/j.margeo.2009.03.005; Surina B, 2011, J BIOGEOGR, V38, P1381, DOI 10.1111/j.1365-2699.2011.02493.x; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; Temunovic M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042764; Ursenbacher S, 2008, MOL PHYLOGENET EVOL, V46, P1116, DOI 10.1016/j.ympev.2007.11.002; Vega R, 2010, BIOL J LINN SOC, V100, P774, DOI 10.1111/j.1095-8312.2010.01454.x; Vekemans X, 2002, MOL ECOL, V11, P139, DOI 10.1046/j.0962-1083.2001.01415.x; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Vucetich JA, 2003, CONSERV GENET, V4, P639, DOI 10.1023/A:1025671831349; Wang IJ, 2013, ECOL LETT, V16, P175, DOI 10.1111/ele.12025; Wang T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041310; Warren RJ, 2011, GLOBAL CHANGE BIOL, V17, P2444, DOI 10.1111/j.1365-2486.2010.02386.x; Wielstra B, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-13; Wiersum KF, 2006, WAG UR FRON, V17, P43; Wright S, 1943, GENETICS, V28, P114; Yamagishi M, 2010, LANDSC ECOL ENG, V6, P75, DOI 10.1007/s11355-009-0084-5; Yang DF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029678; Yao XH, 2012, CONSERV GENET, V13, P1499, DOI 10.1007/s10592-012-0393-3; Yuan QJ, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-29; Zaghloul MS, 2012, CONSERV GENET, V13, P9, DOI 10.1007/s10592-011-0260-7; Zhivotovsky LA, 1999, MOL ECOL, V8, P907, DOI 10.1046/j.1365-294x.1999.00620.x	102	24	25	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e105265	10.1371/journal.pone.0105265	http://dx.doi.org/10.1371/journal.pone.0105265			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121763	Green Published, gold			2022-12-25	WOS:000341017000108
J	Ji, D; Shao, Q; Han, P; Li, F; Li, B; Zang, H; Niu, XX; Li, ZB; Xin, SJ; Chen, GF				Ji, Dong; Shao, Qing; Han, Ping; Li, Fan; Li, Bing; Zang, Hong; Niu, Xiaoxia; Li, Zhongbin; Xin, Shaojie; Chen, Guofeng			The Frequency and Determinants of Liver Stiffness Measurement Failure: A Retrospective Study of "Real-Life'' 38,464 Examinations	PLOS ONE			English	Article							HEPATITIS-C VIRUS; TRANSIENT ELASTOGRAPHY; DIAGNOSTIC PERFORMANCE; NONINVASIVE MARKERS; XL PROBE; FIBROSIS; CIRRHOSIS; FIBROSCAN(R); FEASIBILITY; DISEASE	Objective: To investigate the frequency and determinants of liver stiffness measurement (LSM) failure by means of FibroScan in "real-life'' Chinese patients. Methods: A total of 38,464 "real-life'' Chinese patients in 302 military hospital of China through the whole year of 2013, including asymptomatic carrier, chronic hepatitis B, chronic hepatitis C, liver cirrhosis (LC), alcoholic liver disease, autoimmune liver disease, hepatocellular carcinoma (HCC) and other, were enrolled, their clinical and biological parameters were retrospectively investigated. Liver fibrosis was evaluated by FibroScan detection. S probe (for children with height less than 1.20 m) and M probe (for adults) were used. LSM failure defined as zero valid shots (unsuccessful LSM), or the ratio of the interquartile range to the median of 10 measurements (IQR/M) greater than 0.30 plus median LSM greater or equal to 7.1 kPa (unreliable LSM). Results: LSM failure occurred in 3.34% of all examinations (1286 patients out of 38,464), among them, there were 958 cases (2.49%) with unsuccessful LSM, and 328 patients (0.85%) with unreliable LSM. Statistical analyses showed that LSM failure was independently associated with body mass index (BMI) greater than 30 kg/m(2), female sex, age greater than 50 years, intercostal spaces (IS) less than 9 mm, decompensated liver cirrhosis and HCC patients. There were no significant differences among other diseases. By changing another skilled operator, success was achieved on 301 cases out of 1286, which reduced the failure rate to 2.56%, the decrease was significant (P<0.0001). Conclusions: The principal reasons of LSM failure are ascites, obesity and narrow of IS. The failure rates of HCC, decompensated LC, elder or female patients are higher. These results emphasize the need for adequate operator training, technological improvements and optimal criteria for specific patient subpopulations.	[Ji, Dong; Shao, Qing; Li, Fan; Li, Bing; Niu, Xiaoxia; Li, Zhongbin; Chen, Guofeng] 302 Mil Hosp China, Liver Fibrosis Diag & Treatment Ctr, Beijing, Peoples R China; [Han, Ping] 302 Mil Hosp China, Tumor Radiotherapy Ctr, Beijing, Peoples R China; [Zang, Hong; Xin, Shaojie] 302 Mil Hosp China, Liver Failure Diag & Treatment Ctr, Beijing, Peoples R China	Fifth Medical Center of Chinese PLA General Hospital; Fifth Medical Center of Chinese PLA General Hospital; Fifth Medical Center of Chinese PLA General Hospital	Xin, SJ (corresponding author), 302 Mil Hosp China, Liver Failure Diag & Treatment Ctr, Beijing, Peoples R China.	XinShaojie302@163.com; bjchen302@aliyun.com	ji, dong/AAF-6364-2019	ji, dong/0000-0001-8214-462X	Beijing Natural Science Foundation [7122177]; National Natural Science Foundation of China [81371799]	Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Beijing Natural Science Foundation (7122177, http://www.bjnsf.org/) and National Natural Science Foundation of China (81371799, http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afdhal Nezam H, 2012, Gastroenterol Hepatol (N Y), V8, P605; Buster EHCJ, 2009, GASTROENTEROLOGY, V137, P2002, DOI 10.1053/j.gastro.2009.08.061; Calvaruso V, 2012, LIVER INT, V32, P2, DOI 10.1111/j.1478-3231.2011.02703.x; Castera L, 2008, J HEPATOL, V48, P835, DOI 10.1016/j.jhep.2008.02.008; Castera L, 2012, GASTROENTEROLOGY, V142, P1293, DOI 10.1053/j.gastro.2012.02.017; Corpechot C, 2006, HEPATOLOGY, V43, P1118, DOI 10.1002/hep.21151; Crespo G, 2012, J HEPATOL, V57, P281, DOI 10.1016/j.jhep.2012.03.016; de Ledinghen V, 2010, LIVER INT, V30, P1043, DOI 10.1111/j.1478-3231.2010.02258.x; Duarte-Rojo A, 2012, ANN HEPATOL, V11, P426, DOI 10.1016/S1665-2681(19)31456-5; Ferraioli G, 2013, WORLD J GASTROENTERO, V19, P49, DOI 10.3748/wjg.v19.i1.49; Forestier J, 2010, EUR J GASTROEN HEPAT, V22, P532, DOI 10.1097/MEG.0b013e3283343f58; Fraquelli M, 2007, HEPATOLOGY, V46, P282, DOI 10.1002/hep.21653; Fraquelli M, 2007, GUT, V56, P968, DOI 10.1136/gut.2006.111302; Friedrich-Rust M, 2010, EUR RADIOL, V20, P2390, DOI 10.1007/s00330-010-1820-9; Janssens F, 2010, ACTA GASTRO-ENT BELG, V73, P52; Kim BK, 2010, LIVER INT, V30, P1073, DOI 10.1111/j.1478-3231.2010.02269.x; Kim SU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036676; Kim SU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032233; Kim SU, 2010, J CLIN GASTROENTEROL, V44, P66, DOI 10.1097/MCG.0b013e3181a95c7f; Kim SU, 2009, J CLIN GASTROENTEROL, V43, P267, DOI 10.1097/MCG.0b013e31816f212e; Kirk GD, 2009, CLIN INFECT DIS, V48, P963, DOI 10.1086/597350; Kumar R, 2013, DIGEST DIS SCI, V58, P265, DOI 10.1007/s10620-012-2306-1; Lemoine M, 2008, ALIMENT PHARM THER, V28, P1102, DOI 10.1111/j.1365-2036.2008.03825.x; Liaw YF, 2012, HEPATOL INT, V6, P531, DOI 10.1007/s12072-012-9365-4; Marcellin P, 2009, LIVER INT, V29, P242, DOI 10.1111/j.1478-3231.2008.01802.x; Millonig G, 2008, HEPATOLOGY, V48, P1718, DOI 10.1002/hep.22577; Myers RP, 2012, HEPATOLOGY, V55, P199, DOI 10.1002/hep.24624; Nahon P, 2008, J HEPATOL, V49, P1062, DOI 10.1016/j.jhep.2008.08.011; Osaki A, 2010, WORLD J GASTROENTERO, V16, P2918, DOI 10.3748/wjg.v16.i23.2918; Povero D, 2010, HISTOL HISTOPATHOL, V25, P1075, DOI 10.14670/HH-25.1075; Saad Y, 2013, J CLIN DIAGN RES, V7, P2253, DOI 10.7860/JCDR/2013/6026.3484; Sanchez-Conde M, 2010, J VIRAL HEPATITIS, V17, P280, DOI 10.1111/j.1365-2893.2009.01180.x; Singh S, 2013, CLIN GASTROENTEROL H, V11, P1573, DOI 10.1016/j.cgh.2013.07.034; Sporea I, 2011, HEPAT MON, V11, P182; Wong GLH, 2011, J GASTROEN HEPATOL, V26, P300, DOI 10.1111/j.1440-1746.2010.06510.x; Wong GLH, 2013, WORLD J HEPATOL, V5, P264, DOI 10.4254/wjh.v5.i5.264; Wong VWS, 2012, AM J GASTROENTEROL, V107, P1862, DOI 10.1038/ajg.2012.331	37	7	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e105183	10.1371/journal.pone.0105183	http://dx.doi.org/10.1371/journal.pone.0105183			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122123	Green Published, Green Submitted, gold			2022-12-25	WOS:000341017000103
J	Lin, CH; Shih, CH; Tseng, CC; Yu, CC; Tsai, YJ; Bien, MY; Chen, BC				Lin, Chien-Huang; Shih, Chung-Huang; Tseng, Chih-Chieh; Yu, Chung-Chi; Tsai, Yuan-Jhih; Bien, Mauo-Ying; Chen, Bing-Chang			CXCL12 Induces Connective Tissue Growth Factor Expression in Human Lung Fibroblasts through the Rac1/ERK, JNK, and AP-1 Pathways	PLOS ONE			English	Article							NF-KAPPA-B; IDIOPATHIC PULMONARY-FIBROSIS; FACTOR-I; CIRCULATING FIBROCYTES; CANCER CELLS; REGULATED KINASE; EPITHELIAL-CELLS; FOCAL ADHESIONS; GENE-REGULATION; SIGNALING AXIS	CXCL12 (stromal cell-derived factor-1, SDF-1) is a potent chemokine for homing of CXCR4(+) fibrocytes to injury sites of lung tissue, which contributes to pulmonary fibrosis. Overexpression of connective tissue growth factor (CTGF) plays a critical role in pulmonary fibrosis. In this study, we investigated the roles of Rac1, extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and activator protein-1 (AP-1) in CXCL12-induced CTGF expression in human lung fibroblasts. CXCL12 caused concentration- and time-dependent increases in CTGF expression and CTGF-luciferase activity. CXCL12-induced CTGF expression was inhibited by a CXCR4 antagonist (AMD3100), small interfering RNA of CXCR4 (CXCR4 siRNA), a dominant negative mutant of Rac1 (RacN17), a mitogen-activated protein kinase (MAPK) kinase (MEK) inhibitor (PD98059), a JNK inhibitor (SP600125), a p21-activated kinase inhibitor (PAK18), c-Jun siRNA, and an AP-1 inhibitor (curcumin). Treatment of cells with CXCL12 caused activations of Rac1, Rho, ERK, and c-Jun. The CXCL12-induced increase in ERK phosphorylation was inhibited by RacN17. Treatment of cells with PD98059 and SP600125 both inhibited CXCL12-induced c-Jun phosphorylation. CXCL12 caused the recruitment of c-Jun and c-Fos binding to the CTGF promoter. Furthermore, CXCL12 induced an increase in alpha-smooth muscle actin (alpha-SMA) expression, a myofibroblastic phenotype, and actin stress fiber formation. CXCL12-induced actin stress fiber formation and alpha-SMA expression were respectively inhibited by AMD3100 and CTGF siRNA. Taken together, our results suggest that CXCL12, acting through CXCR4, activates the Rac/ERK and JNK signaling pathways, which in turn initiates c-Jun phosphorylation, and recruits c-Jun and c-Fos to the CTGF promoter and ultimately induces CTGF expression in human lung fibroblasts. Moreover, overexpression of CTGF mediates CXCL12-induced alpha-SMA expression.	[Lin, Chien-Huang; Tseng, Chih-Chieh; Yu, Chung-Chi; Tsai, Yuan-Jhih] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan; [Shih, Chung-Huang; Bien, Mauo-Ying; Chen, Bing-Chang] Taipei Med Univ, Coll Med, Sch Resp Therapy, Taipei, Taiwan; [Shih, Chung-Huang; Bien, Mauo-Ying] Taipei Med Univ Hosp, Dept Internal Med, Div Pulm Med, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital	Chen, BC (corresponding author), Taipei Med Univ, Coll Med, Sch Resp Therapy, Taipei, Taiwan.	bcchen@tmu.edu.tw		Lin, Chien-Huang/0000-0002-0916-8737	Taipei Medical University Hospital [101TMU-TMUH-06, 103-TMU-TMUH-04]; National Science Council of Taiwan [NSC100-2320-B-038-022MY2, NSC102-2320-B-038-049]	Taipei Medical University Hospital; National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants (101TMU-TMUH-06 and 103-TMU-TMUH-04) from Taipei Medical University Hospital and (NSC100-2320-B-038-022MY2 and NSC102-2320-B-038-049) from the National Science Council of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksamitiene E, 2011, CELL SIGNAL, V23, P1794, DOI 10.1016/j.cellsig.2011.06.014; Albiges-Rizo C, 2009, J CELL SCI, V122, P3037, DOI 10.1242/jcs.052704; Antoniou KM, 2013, EUR RESPIR REV, V22, P281, DOI 10.1183/09059180.00002113; Arai A, 2006, CELL SIGNAL, V18, P2162, DOI 10.1016/j.cellsig.2006.05.001; Baggiolini M, 1997, ANNU REV IMMUNOL, V15, P675, DOI 10.1146/annurev.immunol.15.1.675; Beei C, 2013, J TOXICOL SCI, V38, P793; Blom IE, 2001, J CLIN PATHOL-MOL PA, V54, P192, DOI 10.1136/mp.54.3.192; Blom IE, 2002, MATRIX BIOL, V21, P473, DOI 10.1016/S0945-053X(02)00055-0; Chen G, 2013, J CELL SCI, V126, P3697, DOI 10.1242/jcs.126714; Chen M, 2008, CELL PROLIFERAT, V41, P336, DOI 10.1111/j.1365-2184.2008.00519.x; Crean JKG, 2002, J BIOL CHEM, V277, P44187, DOI 10.1074/jbc.M203715200; Engers R, 2006, FEBS J, V273, P4754, DOI 10.1111/j.1742-4658.2006.05476.x; Frazier K, 1996, J INVEST DERMATOL, V107, P404, DOI 10.1111/1523-1747.ep12363389; Fuhler GM, 2008, BLOOD, V111, P359, DOI 10.1182/blood-2006-11-060632; Gassmann P, 2009, NEOPLASIA, V11, P651, DOI 10.1593/neo.09272; Gross TJ, 2001, NEW ENGL J MED, V345, P517, DOI 10.1056/NEJMra003200; Grotendorst GR, 1996, CELL GROWTH DIFFER, V7, P469; Hashimoto N, 2004, J CLIN INVEST, V113, P243, DOI 10.1172/JCI200418847; Jin S, 2006, AM J PHYSIOL-GASTR L, V291, pG1137, DOI 10.1152/ajpgi.00031.2006; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Kim K, 2007, J LEUKOCYTE BIOL, V82, P1332, DOI 10.1189/jlb.1106697; Kojima Y, 2010, P NATL ACAD SCI USA, V107, P20009, DOI 10.1073/pnas.1013805107; Lama Vibha N, 2006, Proc Am Thorac Soc, V3, P373, DOI 10.1513/pats.200512-133TK; Leask A, 2003, J BIOL CHEM, V278, P13008, DOI 10.1074/jbc.M210366200; Libura J, 2002, BLOOD, V100, P2597, DOI 10.1182/blood-2002-01-0031; Lin CH, 2006, J IMMUNOL, V177, P3427, DOI 10.4049/jimmunol.177.5.3427; Lin CH, 2013, CELL SIGNAL, V25, P1166, DOI 10.1016/j.cellsig.2013.01.018; Lin CH, 2011, J BIOL CHEM, V286, P10483, DOI 10.1074/jbc.M110.112433; Lin Q, 2010, EXP LUNG RES, V36, P120, DOI 10.3109/01902140903214659; Liu Y, 2013, J BIOL CHEM, V288, P30708, DOI 10.1074/jbc.M113.478685; Makino H, 2013, J MED INVESTIG, V60, P127, DOI 10.2152/jmi.60.127; Moeller A, 2009, AM J RESP CRIT CARE, V179, P588, DOI 10.1164/rccm.200810-1534OC; Murthy S, 2012, BIOCHEM J, V445, P229, DOI 10.1042/BJ20120053; Nakerakanti SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021911; Nasser MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023901; Oglesby IK, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-148; Oubrahim H, 2013, CELL SIGNAL, V25, P1136, DOI 10.1016/j.cellsig.2013.01.026; Perbal B, 2004, LANCET, V363, P62, DOI 10.1016/S0140-6736(03)15172-0; Phillips RJ, 2004, J CLIN INVEST, V114, P438, DOI 10.1172/jci200420997; Ping YF, 2011, J PATHOL, V224, P344, DOI 10.1002/path.2908; Ponticos M, 2009, ARTHRITIS RHEUM-US, V60, P2142, DOI 10.1002/art.24620; Recchia AG, 2009, J MOL CELL CARDIOL, V46, P352, DOI 10.1016/j.yjmcc.2008.11.017; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; ROCHE WR, 1989, LANCET, V1, P520; Rosin NL, 2013, AM J PATHOL, V182, P714, DOI 10.1016/j.ajpath.2012.11.014; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; Salvucci O, 2002, BLOOD, V99, P2703, DOI 10.1182/blood.V99.8.2703; Schmidt M, 2003, J IMMUNOL, V171, P380, DOI 10.4049/jimmunol.171.1.380; Scupoli MT, 2008, HAEMATOLOGICA, V93, P524, DOI 10.3324/haematol.12098; Shi-wen X, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007438; Singh AP, 2012, J BIOL CHEM, V287, P39115, DOI 10.1074/jbc.M112.409581; Tan CT, 2008, CARCINOGENESIS, V29, P1519, DOI 10.1093/carcin/bgn108; Tan WF, 2006, J BIOL CHEM, V281, P39542, DOI 10.1074/jbc.M609062200; Tung SY, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-91; Van Beek JP, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1890; Wang XH, 2011, RESPIROLOGY, V16, P500, DOI 10.1111/j.1440-1843.2011.01938.x; Wang Z, 2010, ONCOGENE, V29, P3362, DOI 10.1038/onc.2010.95; Weng CM, 2013, AM J RESP CRIT CARE, V188, P298, DOI 10.1164/rccm.201301-0132OC; Williams LA, 2008, MOL IMMUNOL, V45, P2446, DOI 10.1016/j.molimm.2007.12.011; Worrall JAR, 2011, FEBS J, V278, P663, DOI 10.1111/j.1742-4658.2010.07988.x; Xia W, 2007, ANN SURG, V246, P886, DOI 10.1097/SLA.0b013e318070d54f; Yu CC, 2009, J IMMUNOL, V182, P7916, DOI 10.4049/jimmunol.0801582; Zhang J, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/492901	63	23	32	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104746	10.1371/journal.pone.0104746	http://dx.doi.org/10.1371/journal.pone.0104746			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121739	Green Submitted, Green Published, gold			2022-12-25	WOS:000341017000059
J	Zhang, YH; Meng, XZ; Chen, L; Li, D; Zhao, LF; Zhao, Y; Li, LX; Shi, HJ				Zhang, Yunhui; Meng, Xiangzhou; Chen, Li; Li, Dan; Zhao, Lifang; Zhao, Yan; Li, Luxi; Shi, Huijing			Age and Sex-Specific Relationships between Phthalate Exposures and Obesity in Chinese Children at Puberty	PLOS ONE			English	Article							WAIST CIRCUMFERENCE; BODY-MASS; ASSOCIATIONS; OVERWEIGHT; ACTIVATION; EXPRESSION; MONOESTERS; PATTERN; TISSUES; GIRLS	Objective: To examine the age and sex-specific associations of urine levels of six mono-phthalates with body size and fat distribution in Chinese children at puberty. Materials and Methods: Four hundred and ninety-three school-aged children (247 boys, 246 girls) were recruited. Obesity related anthropometric indices were measured and body fat proportion (BF%) was calculated. Spot urine samples were collected and phthalate monoesters were detected by an API 2000 electrospray triple quadrupole mass spectrometer (ESIMS/MS). Associations between phthalate exposure and overweight/obesity measures and their trends were examined by multiple linear regression and Logistic regression analyses, respectively. Results: Di-2-ethylhexyl phthalate (DEHP) metabolites and monobutyl phthalate (MBP) were found to be the most detectable chemicals. In 8-10 years (yrs) group, concentrations of MEHP and MBP were significantly higher in girls than those in boys. However, concentrations of all phthalate monoesters, except for MEP and MEHP, in 11-13 yrs boys were significantly higher than those in girls. After adjusting for confounders including puberty onset, urinary concentrations of MBP and sum of low molecular-weight phthalate metabolites (Sigma LMP) were positively associated with boys' obesity in a concentration-effect manner, while concentrations of MEHP, MEHHP and sum of DEHP metabolites (Sigma MEHP) were negatively associated with girls' obesity. Associations between phthalate exposure levels and BMI z-score changes were age-and sex-specific in school-age children. Conclusion: There are age and sex-specific concentration-effect associations between phthalate exposure and fat distribution in Chinese children. Urinary phthalate levels in 11-13 yrs boys were about 30 percent higher than those in girls, and Sigma MEHP levels in younger boys (<10 yrs) were significantly higher than those in elder boys (>10 yrs). Associations were positive for MBP and Sigma LMP with both BMI z-score and fat distribution in boys >10 years of age, and negative for Sigma MEHP with fat distribution in girls <10 years of age.	[Zhang, Yunhui; Chen, Li; Zhao, Yan; Li, Luxi] Fudan Univ, Sch Publ Hlth, Dept Environm Hlth, Key Lab Publ Hlth Safety,Chinese Minist Educ, Shanghai 200433, Peoples R China; [Meng, Xiangzhou; Zhao, Lifang] Tongji Univ, Coll Environm Sci & Engn, State Key Lab Pollut Control & Resources Reuse, Shanghai 200092, Peoples R China; [Li, Dan; Shi, Huijing] Fudan Univ, Sch Publ Hlth, Dept Maternal Child & Adolescent Hlth, Key Lab Publ Hlth Safety,Chinese Minist Educ, Shanghai 200433, Peoples R China	Fudan University; Tongji University; Fudan University	Shi, HJ (corresponding author), Fudan Univ, Sch Publ Hlth, Dept Maternal Child & Adolescent Hlth, Key Lab Publ Hlth Safety,Chinese Minist Educ, Shanghai 200433, Peoples R China.	hjshi@fudan.edu.cn	Shi, Huijing/GRR-8564-2022		Natural Science Foundation of China [81072263, 81172684]; Shanghai Municipal Health Bureau [12GWZX0301]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Health Bureau	This research was supported by grants from the Natural Science Foundation of China (Grant 81072263, to Y. Z.; Grant 81172684, to H. S.), and by an award from the Shanghai Municipal Health Bureau (Grant 12GWZX0301, to X. Q.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlow SE, 2007, PEDIATRICS, V120, pS164, DOI 10.1542/peds.2007-2329C; Bility MT, 2004, TOXICOL SCI, V82, P170, DOI 10.1093/toxsci/kfh253; Boas M, 2010, ENVIRON HEALTH PERSP, V118, P1458, DOI 10.1289/ehp.0901331; de Onis Mercedes, 2004, Food Nutr Bull, V25, pS27; de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786; Feige JN, 2010, ENVIRON HEALTH PERSP, V118, P234, DOI 10.1289/ehp.0901217; Goran MI, 1999, AM J CLIN NUTR, V70, p149S; Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88; Guo Y, 2011, ENVIRON SCI TECHNOL, V45, P3138, DOI 10.1021/es103879m; Hao CJ, 2012, BIOSCIENCE REP, V32, P619, DOI 10.1042/BSR20120042; Hatch EE, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-27; Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212; HAYCOCK GB, 1978, J PEDIATR-US, V93, P62, DOI 10.1016/S0022-3476(78)80601-5; Hurst CH, 2003, TOXICOL SCI, V74, P297, DOI 10.1093/toxsci/kfg145; Itsuki-Yoneda A, 2007, BIOSCI BIOTECH BIOCH, V71, P414, DOI 10.1271/bbb.60478; Jiang Y, 2007, SHANGHAI J PREVEN ME, V19, P544; Li De-Bing, 2013, Journal of Fisheries International, V8, P1; Lind PM, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-21; Ma HM, 2011, INT J ANDROL, V34, pE435, DOI 10.1111/j.1365-2605.2011.01173.x; Maffeis C, 2003, EUR J CLIN NUTR, V57, P566, DOI 10.1038/sj.ejcn.1601573; Marinelli R, 2010, OBESITY SILVER SPRIN, V18, P2170; MARSHALL WA, 1969, ARCH DIS CHILD, V44, P291, DOI 10.1136/adc.44.235.291; MARSHALL WA, 1970, ARCH DIS CHILD, V45, P13, DOI 10.1136/adc.45.239.13; Prader A, 1966, Triangle, V7, P240; Silva MJ, 2004, ENV HLTH PERSPECT, V112, P685; Stahlhut RW, 2007, ENVIRON HEALTH PERSP, V115, P876, DOI 10.1289/ehp.9882; Teitelbaum SL, 2012, ENVIRON RES, V112, P186, DOI 10.1016/j.envres.2011.12.006; Trasande L, 2013, ENVIRON HEALTH PERSP, V121, P501, DOI 10.1289/ehp.1205526; Wang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074508; Wang J, 2012, INT J OBESITY, V36, P542, DOI 10.1038/ijo.2011.218; World Health Organization, 2009, GLOB HLTH RISKS MORT; Wu YF, 2006, BMJ-BRIT MED J, V333, P362, DOI 10.1136/bmj.333.7564.362; Yao Xing-Jia, 1994, Zhonghua Yufang Yixue Zazhi, V28, P213	33	54	57	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104852	10.1371/journal.pone.0104852	http://dx.doi.org/10.1371/journal.pone.0104852			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121758	Green Published, Green Submitted, gold			2022-12-25	WOS:000341017000066
J	Thomas, A; Perry, T; Berhane, S; Oldreive, C; Zlatanou, A; Williams, LR; Weston, VJ; Stankovic, T; Kearns, P; Pors, K; Grand, RJ; Stewart, GS				Thomas, A.; Perry, T.; Berhane, S.; Oldreive, C.; Zlatanou, A.; Williams, L. R.; Weston, V. J.; Stankovic, T.; Kearns, P.; Pors, K.; Grand, R. J.; Stewart, G. S.			The dual-acting chemotherapeutic agent Alchemix induces cell death independently of ATM and p53	ONCOGENE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; INDUCED REPLICATION STRESS; DEPENDENT PROTEIN-KINASE; RESISTANT OVARIAN-CANCER; DNA TOPOISOMERASE-II; GENE; REPAIR; INACTIVATION; DEFICIENCY; MECHANISMS	Topoisomerase inhibitors are in common use as chemotherapeutic agents although they can display reduced efficacy in chemotherapy-resistant tumours, which have inactivated DNA damage response (DDR) genes, such as ATM and TP53. Here, we characterise the cellular response to the dual-acting agent, Alchemix (ALX), which is a modified anthraquinone that functions as a topoisomerase inhibitor as well as an alkylating agent. We show that ALX induces a robust DDR at nano-molar concentrations and this is mediated primarily through ATR- and DNA-PK- but not ATM-dependent pathways, despite DNA double strand breaks being generated after prolonged exposure to the drug. Interestingly, exposure of epithelial tumour cell lines to ALX in vitro resulted in potent activation of the G2/M checkpoint, which after a prolonged arrest, was bypassed allowing cells to progress into mitosis where they ultimately died by mitotic catastrophe. We also observed effective killing of lymphoid tumour cell lines in vitro following exposure to ALX, although, in contrast, this tended to occur via activation of a p53-independent apoptotic pathway. Lastly, we validate the effectiveness of ALX as a chemotherapeutic agent in vivo by demonstrating its ability to cause a significant reduction in tumour cell growth, irrespective of TP53 status, using a mouse leukaemia xenograft model. Taken together, these data demonstrate that ALX, through its dual action as an alkylating agent and topoisomerase inhibitor, represents a novel anti-cancer agent that could be potentially used clinically to treat refractory or relapsed tumours, particularly those harbouring mutations in DDR genes.	[Thomas, A.; Perry, T.; Berhane, S.; Oldreive, C.; Zlatanou, A.; Williams, L. R.; Weston, V. J.; Stankovic, T.; Kearns, P.; Grand, R. J.; Stewart, G. S.] Univ Birmingham, Coll Med & Dent, Sch Canc Sci, IBR West Extens, Birmingham B15 2TT, W Midlands, England; [Pors, K.] Univ Bradford, Sch Life Sci, Inst Canc Therapeut, Bradford BD7 1DP, W Yorkshire, England	University of Birmingham; University of Bradford	Stewart, GS (corresponding author), Univ Birmingham, Coll Med & Dent, Sch Canc Sci, IBR West Extens, Vincent Dr, Birmingham B15 2TT, W Midlands, England.	k.pors1@bradford.ac.uk; R.J.A.Grand@bham.ac.uk; G.S.Stewart@bham.ac.uk	Kearns, Pamela/AAD-6011-2021	Stankovic, Tatjana/0000-0002-3780-274X; Stewart, Grant/0000-0002-0960-3241; Berhane, Sarah/0000-0002-1437-0411; Pors, Klaus/0000-0002-0837-5208; Kearns, Pamela/0000-0003-2756-5813	University of Birmingham; MRC [G0900088]; Cancer Research UK [C17183/A13030]; Leukaemia Lymphoma Research [11045]; Lister Institute; Yorkshire Cancer Research; Cancer Research UK [13030] Funding Source: researchfish; Medical Research Council [G0900088] Funding Source: researchfish	University of Birmingham; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Leukaemia Lymphoma Research; Lister Institute; Yorkshire Cancer Research; Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are most grateful to Fred Bunz, Alan D'Andrea, Eva Petermann, Panagiotis Kotsantis and Jiri Lukas for the gift of cell lines, and Philip Byrd, Arnold Levine and David Lane for antibodies. We would especially like to thank Cyrus Vaziri for providing cell lines and a recombinant adenovirus expressing Cyclin E, Rebbeca Jones for helping us with PFGE and Malcolm Taylor for helpful discussions. Last, we would also thank the University of Birmingham (AT-PhD studentship), MRC (GSS, RJG-Project grant: G0900088), the Cancer Research UK (GSS-Senior Fellowship: C17183/A13030), the Leukaemia Lymphoma Research (TS, GSS-Programme grant: 11045), the Lister Institute (GSS, AZ-Research Prize) and the Yorkshire Cancer Research (KP) for funding this study.	Abdallah QMA, 2012, BIOCHEM PHARMACOL, V83, P1514, DOI 10.1016/j.bcp.2012.02.017; Al-Ejeh F, 2010, ONCOGENE, V29, P6085, DOI 10.1038/onc.2010.407; Beeharry N, 2013, CELL CYCLE, V12, P1588, DOI 10.4161/cc.24740; Bester AC, 2011, CELL, V145, P435, DOI 10.1016/j.cell.2011.03.044; Bhojwani D, 2013, LANCET ONCOL, V14, pE205, DOI 10.1016/S1470-2045(12)70580-6; CALDECOTT K, 1990, CANCER RES, V50, P5778; Chan EYW, 2007, J BIOL CHEM, V282, P25464, DOI 10.1074/jbc.M703663200; Forrest RA, 2013, CANCER CHEMOTH PHARM, V71, P809, DOI 10.1007/s00280-012-2049-x; Greaves M, 2013, BRIT J CANCER, V109, P1391, DOI 10.1038/bjc.2013.490; Hof J, 2011, J CLIN ONCOL, V29, P3185, DOI 10.1200/JCO.2011.34.8144; Holmfeldt L, 2013, NAT GENET, V45, P242, DOI 10.1038/ng.2532; Inaba H, 2013, LANCET, V381, P1943, DOI 10.1016/S0140-6736(12)62187-4; Jones RM, 2013, ONCOGENE, V32, P3744, DOI 10.1038/onc.2012.387; Larsen AK, 2003, PHARMACOL THERAPEUT, V99, P167, DOI 10.1016/S0163-7258(03)00058-5; Longley DB, 2005, J PATHOL, V205, P275, DOI 10.1002/path.1706; McNeely S, 2010, CELL CYCLE, V9, P995, DOI 10.4161/cc.9.5.10935; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Nitiss JL, 2009, NAT REV CANCER, V9, P327, DOI 10.1038/nrc2608; Orth JD, 2012, MOL BIOL CELL, V23, P567, DOI 10.1091/mbc.E11-09-0781; Pabla N, 2011, J BIOL CHEM, V286, P10411, DOI 10.1074/jbc.M110.210989; Petermann E, 2010, MOL CELL, V37, P492, DOI 10.1016/j.molcel.2010.01.021; Pommier Y, 2013, ACS CHEM BIOL, V8, P82, DOI 10.1021/cb300648v; Pors K, 2005, J MED CHEM, V48, P6690, DOI 10.1021/jm050438f; Pors K, 2004, J MED CHEM, V47, P1856, DOI 10.1021/jm031070u; Pors K, 2003, MOL CANCER THER, V2, P607; Pors K, 2005, CURR TOP MED CHEM, V5, P1133, DOI 10.2174/156802605774370883; Redmond KM, 2008, FRONT BIOSCI-LANDMRK, V13, P5138, DOI 10.2741/3070; Schaffner C, 2000, P NATL ACAD SCI USA, V97, P2773, DOI 10.1073/pnas.050400997; Stankovic T, 1999, LANCET, V353, P26, DOI 10.1016/S0140-6736(98)10117-4; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Sy SMH, 2011, J BIOL CHEM, V286, P22355, DOI 10.1074/jbc.M111.232041; Vorechovsky I, 1997, NAT GENET, V17, P96, DOI 10.1038/ng0997-96; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Wang Y, 2003, P NATL ACAD SCI USA, V100, P15387, DOI 10.1073/pnas.2536810100; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Yajima H, 2006, MOL CELL BIOL, V26, P7520, DOI 10.1128/MCB.00048-06; Yajima H, 2009, J MOL BIOL, V385, P800, DOI 10.1016/j.jmb.2008.11.036	37	2	2	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2015	34	25					3336	3348		10.1038/onc.2014.266	http://dx.doi.org/10.1038/onc.2014.266			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CK9XH	25132271	Green Accepted			2022-12-25	WOS:000356592300012
J	Gupta, S; Yeeles, JTP; Marians, KJ				Gupta, Sankalp; Yeeles, Joseph T. P.; Marians, Kenneth J.			Regression of Replication Forks Stalled by Leading-strand Template Damage I-BOTH RecG AND RuvAB CATALYZE REGRESSION, BUT RuvC CLEAVES THE HOLLIDAY JUNCTIONS FORMED BY RecG PREFERENTIALLY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE-III; ESCHERICHIA-COLI; BRANCH MIGRATION; GENETIC-RECOMBINATION; MAMMALIAN-CELLS; PROTEIN; VITRO; RESOLUTION; REPAIR; HELICASE	The orderly progression of replication forks formed at the origin of replication in Escherichia coli is challenged by encounters with template damage, slow moving RNA polymerases, and frozen DNA-protein complexes that stall the fork. These stalled forks are foci for genomic instability and must be reactivated. Many models of replication fork reactivation invoke nascent strand regression as an intermediate in the processing of the stalled fork. We have investigated the replication fork regression activity of RecG and RuvAB, two proteins commonly thought to be involved in the process, using a reconstituted DNA replication system where the replisome is stalled by collision with leading-strand template damage. We find that both RecG and RuvAB can regress the stalled fork in the presence of the replisome and SSB; however, RuvAB generates a completely unwound product consisting of the paired nascent leading and lagging strands, whereas RuvC cleaves the Holliday junction generated by RecG-catalyzed fork regression. We also find that RecG stimulates RuvAB-catalyzed regression, presumably because it is more efficient at generating the initial Holliday junction from the stalled fork.	[Gupta, Sankalp; Yeeles, Joseph T. P.; Marians, Kenneth J.] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Marians, KJ (corresponding author), Mem Sloan Kettering Canc Ctr, Program Mol Biol, 1275 York Ave, New York, NY 10065 USA.	kmarians@sloankettering.edu	Gupta, Sankalp/M-1907-2014	Yeeles, Joseph/0000-0002-2255-2119	National Institutes of Health [GM34557]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM034557, R01GM034557] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM34557 (to K. J. M.).	Abd Wahab S, 2013, J BIOL CHEM, V288, P26397, DOI 10.1074/jbc.M113.500223; Atkinson J, 2009, NUCLEIC ACIDS RES, V37, P3475, DOI 10.1093/nar/gkp244; Baharoglu Z, 2006, EMBO J, V25, P596, DOI 10.1038/sj.emboj.7600941; Baharoglu Z, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000012; BENNETT RJ, 1993, CELL, V74, P1021, DOI 10.1016/0092-8674(93)90724-5; BENSON FE, 1994, J BIOL CHEM, V269, P5195; Bradley AS, 2011, J BIOL CHEM, V286, P22372, DOI 10.1074/jbc.M111.233908; CASSUTO E, 1980, P NATL ACAD SCI-BIOL, V77, P3962, DOI 10.1073/pnas.77.7.3962; CONNOLLY B, 1991, P NATL ACAD SCI USA, V88, P6063, DOI 10.1073/pnas.88.14.6063; Courcelle J, 2003, SCIENCE, V299, P1064, DOI 10.1126/science.1081328; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Dickman MJ, 2002, EUR J BIOCHEM, V269, P5492, DOI 10.1046/j.1432-1033.2002.03250.x; DUNDERDALE HJ, 1991, NATURE, V354, P506, DOI 10.1038/354506a0; DUNDERDALE HJ, 1994, J BIOL CHEM, V269, P5187; Eggleston AK, 2000, J BIOL CHEM, V275, P26467, DOI 10.1074/jbc.M001496200; Eggleston AK, 1997, CELL, V89, P607, DOI 10.1016/S0092-8674(00)80242-1; FUJIWARA Y, 1976, MUTAT RES, V37, P91, DOI 10.1016/0027-5107(76)90058-0; Gabbai CB, 2010, DNA REPAIR, V9, P202, DOI 10.1016/j.dnarep.2009.12.009; Gregg AV, 2002, MOL CELL, V9, P241, DOI 10.1016/S1097-2765(02)00455-0; GRIEP MA, 1990, BIOCHEMISTRY-US, V29, P9006, DOI 10.1021/bi00490a018; Gupta S, 2014, J BIOL CHEM, V289, P28388, DOI 10.1074/jbc.M114.587907; Guy CP, 2009, MOL CELL, V36, P654, DOI 10.1016/j.molcel.2009.11.009; Hanawalt P C, 1966, Photochem Photobiol, V5, P1, DOI 10.1111/j.1751-1097.1966.tb05756.x; HIGGINS NP, 1976, J MOL BIOL, V101, P417, DOI 10.1016/0022-2836(76)90156-X; HILL TM, 1990, P NATL ACAD SCI USA, V87, P2481, DOI 10.1073/pnas.87.7.2481; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Kim SS, 1996, CELL, V84, P643, DOI 10.1016/S0092-8674(00)81039-9; LANE HED, 1975, J MOL BIOL, V97, P99; LEBOWITZ JH, 1986, J BIOL CHEM, V261, P4738; LLOYD RG, 1984, MOL GEN GENET, V194, P303, DOI 10.1007/BF00383532; Manosas M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3368; MARIANS KJ, 1992, ANNU REV BIOCHEM, V61, P673, DOI 10.1146/annurev.bi.61.070192.003325; MCENTEE K, 1979, P NATL ACAD SCI USA, V76, P2615, DOI 10.1073/pnas.76.6.2615; McGlynn P, 2000, NUCLEIC ACIDS RES, V28, P2324, DOI 10.1093/nar/28.12.2324; McGlynn P, 2000, CELL, V101, P35, DOI 10.1016/S0092-8674(00)80621-2; McGlynn P, 2002, NAT REV MOL CELL BIO, V3, P859, DOI 10.1038/nrm951; McGlynn P, 2001, P NATL ACAD SCI USA, V98, P8227, DOI 10.1073/pnas.111008698; McGlynn P, 2001, P NATL ACAD SCI USA, V98, P8235, DOI 10.1073/pnas.121007798; McGlynn P, 2001, J BIOL CHEM, V276, P41938, DOI 10.1074/jbc.M107945200; McInerney P, 2007, J BIOL CHEM, V282, P25903, DOI 10.1074/jbc.M703777200; Michel B, 2004, P NATL ACAD SCI USA, V101, P12783, DOI 10.1073/pnas.0401586101; Michel B, 2007, DNA REPAIR, V6, P967, DOI 10.1016/j.dnarep.2007.02.016; MINDEN JS, 1985, J BIOL CHEM, V260, P9316; NURSE P, 1991, J BACTERIOL, V173, P6686, DOI 10.1128/jb.173.21.6686-6693.1991; ODONNELL M, 1990, J BIOL CHEM, V265, P1179; Postow L, 2001, J BIOL CHEM, V276, P2790, DOI 10.1074/jbc.M006736200; Robu ME, 2004, J BIOL CHEM, V279, P10973, DOI 10.1074/jbc.M312184200; Robu ME, 2001, P NATL ACAD SCI USA, V98, P8211, DOI 10.1073/pnas.131022698; Seigneur M, 2000, MOL MICROBIOL, V38, P565, DOI 10.1046/j.1365-2958.2000.02152.x; SHAH R, 1994, CELL, V79, P853, DOI 10.1016/0092-8674(94)90074-4; SHARPLES GJ, 1990, MOL GEN GENET, V221, P219, DOI 10.1007/BF00261724; SHIBATA T, 1979, P NATL ACAD SCI USA, V76, P5100, DOI 10.1073/pnas.76.10.5100; Singleton MR, 2001, CELL, V107, P79, DOI 10.1016/S0092-8674(01)00501-3; Skalka A., 1974, MECH RECOMBINATION, P421, DOI [10.1007/978-1-4684-2133-0_37, DOI 10.1007/978-1-4684-2133-0_37]; Suski C, 2008, MOL CELL, V30, P779, DOI 10.1016/j.molcel.2008.04.020; TSANEVA IR, 1992, CELL, V69, P1171, DOI 10.1016/0092-8674(92)90638-S; van Gool AJ, 1998, EMBO J, V17, P1838, DOI 10.1093/emboj/17.6.1838; Whitby MC, 1998, J BIOL CHEM, V273, P19729, DOI 10.1074/jbc.273.31.19729; WHITBY MC, 1993, CELL, V75, P341, DOI 10.1016/0092-8674(93)80075-P; WHITBY MC, 1994, EMBO J, V13, P5220, DOI 10.1002/j.1460-2075.1994.tb06853.x; Whitby MC, 1996, J MOL BIOL, V264, P878, DOI 10.1006/jmbi.1996.0684; WICKNER W, 1973, P NATL ACAD SCI USA, V70, P1764, DOI 10.1073/pnas.70.6.1764; Yeeles JTP, 2013, MOL CELL, V52, P855, DOI 10.1016/j.molcel.2013.10.020; Yeeles JTP, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012815; Yeeles JTP, 2011, SCIENCE, V334, P235, DOI 10.1126/science.1209111; ZAVITZ KH, 1991, MOL MICROBIOL, V5, P2869, DOI 10.1111/j.1365-2958.1991.tb01846.x; Zerbib D, 1998, J MOL BIOL, V281, P621, DOI 10.1006/jmbi.1998.1959; Zhang J, 2010, GENETICS, V185, P23, DOI 10.1534/genetics.110.114413	68	32	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28376	28387		10.1074/jbc.M114.587881	http://dx.doi.org/10.1074/jbc.M114.587881			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25138216	Green Published, hybrid			2022-12-25	WOS:000343765400031
J	Albracht, CD; Rank, KC; Obrzut, S; Rayment, I; Gilbert, SP				Albracht, Clayton D.; Rank, Katherine C.; Obrzut, Steven; Rayment, Ivan; Gilbert, Susan P.			Kinesin-2 KIF3AB Exhibits Novel ATPase Characteristics*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPase; Intracellular Trafficking; Kinesin; Microtubule; Presteady-state Kinetics; Intraflagellar Transport; Processivity	LEFT-RIGHT ASYMMETRY; SUPERFAMILY PROTEIN; STRUCTURAL MODEL; DIMERIC KINESIN; IFT PARTICLES; MOTOR PROTEIN; NECK LINKER; PATHWAY; TRANSPORT; HYDROLYSIS	Background: KIF3AB is a heterotrimeric plus-end-directed kinesin-2 motor, implicated in intraflagellar transport. Results: KIF3AB shows rate-limiting ADP release upon microtubule collision and an unusual apparent weak ATP affinity observed at microtubuleKIF3AB dissociation. Conclusion: The presteady-state kinetics suggest a novel ATPase mechanism for KIF3AB stepping. Significance: The KIF3AB kinetics reveal the mechanistic diversity that kinesin motors exhibit for cargo transport. KIF3AB is an N-terminal processive kinesin-2 family member best known for its role in intraflagellar transport. There has been significant interest in KIF3AB in defining the key principles that underlie the processivity of KIF3AB in comparison with homodimeric processive kinesins. To define the ATPase mechanism and coordination of KIF3A and KIF3B stepping, a presteady-state kinetic analysis was pursued. For these studies, a truncated murine KIF3AB was generated. The results presented show that microtubule association was fast at 5.7 m(-1) s(-1), followed by rate-limiting ADP release at 12.8 s(-1). ATP binding at 7.5 m(-1) s(-1) was followed by an ATP-promoted isomerization at 84 s(-1) to form the intermediate poised for ATP hydrolysis, which then occurred at 33 s(-1). ATP hydrolysis was required for dissociation of the microtubuleKIF3AB complex, which was observed at 22 s(-1). The dissociation step showed an apparent affinity for ATP that was very weak (K-1/2,K-ATP at 133 m). Moreover, the linear fit of the initial ATP concentration dependence of the dissociation kinetics revealed an apparent second-order rate constant at 0.09 m(-1) s(-1), which is inconsistent with fast ATP binding at 7.5 m(-1) s(-1) and a K-d,K-ATP at 6.1 m. These results suggest that ATP binding per se cannot account for the apparent weak K-1/2,K-ATP at 133 m. The steady-state ATPase K-m,K-ATP, as well as the dissociation kinetics, reveal an unusual property of KIF3AB that is not yet well understood and also suggests that the mechanochemistry of KIF3AB is tuned somewhat differently from homodimeric processive kinesins.	[Gilbert, Susan P.] Rensselaer Polytech Inst, Dept Biol Sci, Troy, NY 12180 USA; Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA; [Rank, Katherine C.; Rayment, Ivan] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; University of Wisconsin System; University of Wisconsin Madison	Rayment, I (corresponding author), Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA.	ivan_rayment@biochem.wisc.edu; sgilbert@rpi.edu	rayment, ivan/A-2720-2008	rayment, ivan/0000-0001-9279-7835	National Institutes of Health [R37-GM54141, R01-GM086351]; National Institutes of Health Training Grant [T32-GM07215]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007215, R01GM086351, R37GM054141] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R37-GM54141 (to S. P. G) and R01-GM086351 (to I. R.).; Supported by National Institutes of Health Training Grant T32-GM07215.	AIZAWA H, 1992, J CELL BIOL, V119, P1287, DOI 10.1083/jcb.119.5.1287; Auerbach SD, 2005, J BIOL CHEM, V280, P37048, DOI 10.1074/jbc.M502984200; Behnke-Parks WM, 2011, J BIOL CHEM, V286, P5242, DOI 10.1074/jbc.M110.192930; Brunnbauer M, 2012, MOL CELL, V46, P147, DOI 10.1016/j.molcel.2012.04.005; Brunnbauer M, 2010, P NATL ACAD SCI USA, V107, P10460, DOI 10.1073/pnas.1005177107; Chen CJ, 2012, J BIOL CHEM, V287, P36673, DOI 10.1074/jbc.M112.395590; Chen CJ, 2011, J BIOL CHEM, V286, P29261, DOI 10.1074/jbc.M111.255554; Clancy BE, 2011, NAT STRUCT MOL BIOL, V18, P1020, DOI 10.1038/nsmb.2104; Cochran JC, 2006, BIOCHEMISTRY-US, V45, P12334, DOI 10.1021/bi0608562; COLE DG, 1992, J CELL SCI, V101, P291; Cole DG, 1998, J CELL BIOL, V141, P993, DOI 10.1083/jcb.141.4.993; COLE DG, 1993, NATURE, V366, P268, DOI 10.1038/366268a0; Foster KA, 2001, J BIOL CHEM, V276, P19259, DOI 10.1074/jbc.M008347200; GILBERT SP, 1995, NATURE, V373, P671, DOI 10.1038/373671a0; GILBERT SP, 1994, BIOCHEMISTRY-US, V33, P1951, DOI 10.1021/bi00173a044; Gilbert SP, 2000, METHODS, V22, P337, DOI 10.1006/meth.2000.1086; Goulet A, 2014, P NATL ACAD SCI USA, V111, P1837, DOI 10.1073/pnas.1319848111; Gumy LF, 2013, J NEUROSCI, V33, P11329, DOI 10.1523/JNEUROSCI.5221-12.2013; HACKNEY DD, 1994, P NATL ACAD SCI USA, V91, P6865, DOI 10.1073/pnas.91.15.6865; HENSON JH, 1995, DEV BIOL, V171, P182, DOI 10.1006/dbio.1995.1270; Ishikawa H, 2011, NAT REV MOL CELL BIO, V12, P222, DOI 10.1038/nrm3085; Klenchin VA, 2011, J BIOL CHEM, V286, P18240, DOI 10.1074/jbc.M111.227371; Klumpp LM, 2004, BIOCHEMISTRY-US, V43, P2792, DOI 10.1021/bi035830e; Klumpp LM, 2004, P NATL ACAD SCI USA, V101, P3444, DOI 10.1073/pnas.0307691101; KONDO S, 1994, J CELL BIOL, V125, P1095, DOI 10.1083/jcb.125.5.1095; Krzysiak TC, 2008, J BIOL CHEM, V283, P2078, DOI 10.1074/jbc.M708354200; Krzysiak TC, 2006, EMBO J, V25, P2263, DOI 10.1038/sj.emboj.7601108; Krzysiak TC, 2006, J BIOL CHEM, V281, P39444, DOI 10.1074/jbc.M608056200; Lindhout DA, 2004, BIOPOLYMERS, V75, P367, DOI 10.1002/bip.20150; Ma YZ, 1997, J BIOL CHEM, V272, P724, DOI 10.1074/jbc.272.2.724; MA YZ, 1995, BIOCHEMISTRY-US, V34, P13242, DOI 10.1021/bi00040a040; Marszalek JR, 1999, P NATL ACAD SCI USA, V96, P5043, DOI 10.1073/pnas.96.9.5043; Marszalek JR, 2000, CELL, V102, P175, DOI 10.1016/S0092-8674(00)00023-4; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; Moyer ML, 1998, BIOCHEMISTRY-US, V37, P800, DOI 10.1021/bi9711184; Muthukrishnan G, 2009, CURR BIOL, V19, P442, DOI 10.1016/j.cub.2009.01.058; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Pan XY, 2006, J CELL BIOL, V174, P1035, DOI 10.1083/jcb.200606003; PATEL SS, 1993, J BIOL CHEM, V268, P10668; PESAVENTO PA, 1994, J CELL BIOL, V127, P1041, DOI 10.1083/jcb.127.4.1041; Rank KC, 2012, J CELL BIOL, V197, P957, DOI 10.1083/jcb.201201132; Rogers SL, 1997, P NATL ACAD SCI USA, V94, P3720, DOI 10.1073/pnas.94.8.3720; Rosenfeld SS, 2003, J BIOL CHEM, V278, P18550, DOI 10.1074/jbc.M300849200; Rosenfeld SS, 2002, J BIOL CHEM, V277, P36731, DOI 10.1074/jbc.M205261200; Rosenfeld SS, 2001, J BIOL CHEM, V276, P40167, DOI 10.1074/jbc.M103899200; Rosenfeld SS, 2005, J BIOL CHEM, V280, P35684, DOI 10.1074/jbc.M506561200; Rosenfeld SS, 2009, J BIOL CHEM, V284, P32858, DOI 10.1074/jbc.M109.041210; Sardar HS, 2012, J BIOL CHEM, V287, P24894, DOI 10.1074/jbc.M112.376830; Sardar HS, 2010, CURR BIOL, V20, P1648, DOI 10.1016/j.cub.2010.08.001; Scholey JM, 2013, ANNU REV CELL DEV BI, V29, P443, DOI 10.1146/annurev-cellbio-101512-122335; Schroeder HW, 2012, BIOPHYS J, V103, P48, DOI 10.1016/j.bpj.2012.05.037; SHAKIR MA, 1993, NEUROREPORT, V4, P891, DOI 10.1097/00001756-199307000-00013; Shastry S, 2010, CURR BIOL, V20, P939, DOI 10.1016/j.cub.2010.03.065; Skiniotis G, 2004, EMBO J, V23, P989, DOI 10.1038/sj.emboj.7600118; STEWART RJ, 1991, P NATL ACAD SCI USA, V88, P8470, DOI 10.1073/pnas.88.19.8470; Takeda S, 2000, J CELL BIOL, V148, P1255, DOI 10.1083/jcb.148.6.1255; Takeda S, 1999, J CELL BIOL, V145, P825, DOI 10.1083/jcb.145.4.825; Tuma MC, 1998, J CELL BIOL, V143, P1547, DOI 10.1083/jcb.143.6.1547; Verhey KJ, 2011, ANNU REV BIOPHYS, V40, P267, DOI 10.1146/annurev-biophys-042910-155310; VERNOS I, 1993, DEV BIOL, V157, P232, DOI 10.1006/dbio.1993.1127; Wedaman KP, 1996, J CELL BIOL, V132, P371, DOI 10.1083/jcb.132.3.371; YAMAZAKI H, 1995, J CELL BIOL, V130, P1387, DOI 10.1083/jcb.130.6.1387; Yang ZH, 1998, MOL BIOL CELL, V9, P249, DOI 10.1091/mbc.9.2.249; Zhang YR, 2004, BIOPHYS J, V87, P1795, DOI 10.1529/biophysj.104.039842	64	15	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27836	27848		10.1074/jbc.M114.583914	http://dx.doi.org/10.1074/jbc.M114.583914			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25122755	Green Published, hybrid			2022-12-25	WOS:000342852800040
J	Moretti, DM; Ahuja, LG; Nunes, RD; Cudischevitch, CO; Daumas, CRO; Medeiros-Castro, P; Ventura-Martins, G; Jablonka, W; Gazos-Lopes, F; Senna, R; Sorgine, MHF; Hartfelder, K; Capurro, M; Atella, GC; Mesquita, RD; Silva-Neto, MAC				Moretti, Debora Monteiro; Ahuja, Lalima Gagan; Nunes, Rodrigo Dutra; Cudischevitch, Cecilia Oliveira; Oliveira Daumas-Filho, Carlos Renato; Medeiros-Castro, Priscilla; Ventura-Martins, Guilherme; Jablonka, Willy; Gazos-Lopes, Felipe; Senna, Raquel; Ferreira Sorgine, Marcos Henrique; Hartfelder, Klaus; Capurro, Margareth; Atella, Georgia Correa; Mesquita, Rafael Dias; Cardoso Silva-Neto, Mario Alberto			Molecular Analysis of Aedes aegypti Classical Protein Tyrosine Phosphatases Uncovers an Ortholog of Mammalian PTP-1B Implicated in the Control of Egg Production in Mosquitoes	PLOS ONE			English	Article							YELLOW-FEVER MOSQUITO; FUNCTIONAL ANNOTATION; STRUCTURE PREDICTION; GENE-EXPRESSION; LOCALIZATION; KINASE; IDENTIFICATION; MECHANISM; SIGNAL; SITES	Background: Protein Tyrosine Phosphatases (PTPs) are enzymes that catalyze phosphotyrosine dephosphorylation and modulate cell differentiation, growth and metabolism. In mammals, PTPs play a key role in the modulation of canonical pathways involved in metabolism and immunity. PTP1B is the prototype member of classical PTPs and a major target for treating human diseases, such as cancer, obesity and diabetes. These signaling enzymes are, hence, targets of a wide array of inhibitors. Anautogenous mosquitoes rely on blood meals to lay eggs and are vectors of the most prevalent human diseases. Identifying the mosquito ortholog of PTP1B and determining its involvement in egg production is, therefore, important in the search for a novel and crucial target for vector control. Methodology/Principal Findings: We conducted an analysis to identify the ortholog of mammalian PTP1B in the Aedes aegypti genome. We identified eight genes coding for classical PTPs. In silico structural and functional analyses of proteins coded by such genes revealed that four of these code for catalytically active enzymes. Among the four genes coding for active PTPs, AAEL001919 exhibits the greatest degree of homology with the mammalian PTP1B. Next, we evaluated the role of this enzyme in egg formation. Blood feeding largely affects AAEL001919 expression, especially in the fat body and ovaries. These tissues are critically involved in the synthesis and storage of vitellogenin, the major yolk protein. Including the classical PTP inhibitor sodium orthovanadate or the PTP substrate DiFMUP in the blood meal decreased vitellogenin synthesis and egg production. Similarly, silencing AAEL001919 using RNA interference (RNAi) assays resulted in 30% suppression of egg production. Conclusions/Significance: The data reported herein implicate, for the first time, a gene that codes for a classical PTP in mosquito egg formation. These findings raise the possibility that this class of enzymes may be used as novel targets to block egg formation in mosquitoes.	[Moretti, Debora Monteiro; Ahuja, Lalima Gagan; Nunes, Rodrigo Dutra; Cudischevitch, Cecilia Oliveira; Oliveira Daumas-Filho, Carlos Renato; Medeiros-Castro, Priscilla; Ventura-Martins, Guilherme; Jablonka, Willy; Gazos-Lopes, Felipe; Senna, Raquel; Ferreira Sorgine, Marcos Henrique; Atella, Georgia Correa; Cardoso Silva-Neto, Mario Alberto] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, Lab Sinalizacao Celular LabSiCel, Rio De Janeiro, RJ, Brazil; [Ahuja, Lalima Gagan] Univ Calif San Diego, Dept Pharmacol, San Diego, CA 92103 USA; [Hartfelder, Klaus] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biol Celular & Mol & Bioagentes Patogen, BR-14049 Ribeirao Preto, Brazil; [Capurro, Margareth] Univ Sao Paulo, Dept Parasitol, Inst Ciencias Biomed, Sao Paulo, Brazil; [Mesquita, Rafael Dias] Univ Fed Rio de Janeiro, Inst Quim, Dept Bioquim, Rio De Janeiro, RJ, Brazil; [Moretti, Debora Monteiro; Nunes, Rodrigo Dutra; Cudischevitch, Cecilia Oliveira; Oliveira Daumas-Filho, Carlos Renato; Medeiros-Castro, Priscilla; Ventura-Martins, Guilherme; Jablonka, Willy; Gazos-Lopes, Felipe; Senna, Raquel; Ferreira Sorgine, Marcos Henrique; Atella, Georgia Correa; Mesquita, Rafael Dias; Cardoso Silva-Neto, Mario Alberto] Inst Nacl Ciecncia & Tecnol Entomol Mol, Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro; University of California System; University of California San Diego; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal do Rio de Janeiro	Silva-Neto, MAC (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, Lab Sinalizacao Celular LabSiCel, Rio De Janeiro, RJ, Brazil.	maneto@bioqmed.ufrj.br	Atella, Georgia/AAK-7897-2020; Capurro, Margareth L/F-8679-2012; Nunes, Rodrigo/J-6859-2012; Hartfelder, Klaus/L-2300-2019; Mesquita, Rafael Dias/AFP-3693-2022; Jablonka, Willy/D-2333-2017; Hartfelder, Klaus/A-4293-2009; Mesquita, Rafael Dias/AAH-4352-2022; Capurro, Margareth/M-5286-2019	Capurro, Margareth L/0000-0002-7480-2116; Nunes, Rodrigo/0000-0003-1346-291X; Hartfelder, Klaus/0000-0001-7981-8427; Mesquita, Rafael Dias/0000-0002-2882-3362; Hartfelder, Klaus/0000-0001-7981-8427; Mesquita, Rafael Dias/0000-0002-2882-3362; Daumas, Carlos/0000-0002-5753-2812; Jablonka, Willy/0000-0001-5380-7797	FAPERJ (Fundacao Carlos Chagas Filho de Apoio a Pesquisa do Estado do Rio de Janeiro); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); INCT-EM (Instituto Nacional de Ciencia e Tecnologia em Entomologia Molecular)	FAPERJ (Fundacao Carlos Chagas Filho de Apoio a Pesquisa do Estado do Rio de Janeiro)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); INCT-EM (Instituto Nacional de Ciencia e Tecnologia em Entomologia Molecular)	This work was supported by FAPERJ (Fundacao Carlos Chagas Filho de Apoio a Pesquisa do Estado do Rio de Janeiro), CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) and INCT-EM (Instituto Nacional de Ciencia e Tecnologia em Entomologia Molecular). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; Arik Anam J., 2009, BMC Physiology, V9, P15, DOI 10.1186/1472-6793-9-15; Asthagiri D, 2002, J AM CHEM SOC, V124, P10225, DOI 10.1021/ja020046n; Baeg GH, 2005, GENE DEV, V19, P1861, DOI 10.1101/gad.1320705; Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; Bauler TJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004014; Bonizzoni M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-82; Brown MR, 2008, P NATL ACAD SCI USA, V105, P5716, DOI 10.1073/pnas.0800478105; Brown MR, 1998, J BIOL CHEM, V273, P3967, DOI 10.1074/jbc.273.7.3967; Buszard BJ, 2013, MOL CELL BIOL, V33, P1345, DOI 10.1128/MCB.01411-12; Castillo J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002274; Chang YC, 2008, J PROTEOME RES, V7, P1055, DOI 10.1021/pr700801p; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Ferrari E, 2011, J BIOL CHEM, V286, P4173, DOI 10.1074/jbc.M110.157420; Fialho E, 2002, INSECT BIOCHEM MOLEC, V32, P871, DOI 10.1016/S0965-1748(01)00175-8; Franz AWE, 2006, P NATL ACAD SCI USA, V103, P4198, DOI 10.1073/pnas.0600479103; Gazos-Lopes F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047285; Gulia-Nuss M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020401; Hansen IA, 2005, J BIOL CHEM, V280, P20565, DOI 10.1074/jbc.M500712200; Hansen IA, 2007, INSECT BIOCHEM MOLEC, V37, P985, DOI 10.1016/j.ibmb.2007.05.008; Hatzihristidis T, 2014, METHODS, V65, P156, DOI 10.1016/j.ymeth.2013.07.031; Hauck ES, 2013, MICROBES INFECT, V15, P775, DOI 10.1016/j.micinf.2013.05.006; Helbling P, 1998, J INSECT PHYSIOL, V44, P1127, DOI 10.1016/S0022-1910(97)00039-5; Hilger M, 2009, MOL CELL PROTEOMICS, V8, P1908, DOI 10.1074/mcp.M800559-MCP200; Huang CH, 2007, J BIOL CHEM, V282, P32442, DOI 10.1074/jbc.M702583200; Innis CA, 2007, NUCLEIC ACIDS RES, V35, pW489, DOI 10.1093/nar/gkm422; Jablonka W, 2011, MEM I OSWALDO CRUZ, V106, P546, DOI 10.1590/S0074-02762011000500005; Karim FD, 1999, MOL CELL, V3, P741, DOI 10.1016/S1097-2765(01)80006-X; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kokoza V, 2000, P NATL ACAD SCI USA, V97, P9144, DOI 10.1073/pnas.160258197; Kokoza VA, 2011, INSECT BIOCHEM MOLEC, V41, P637, DOI 10.1016/j.ibmb.2011.04.004; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lim WA, 2010, CELL, V142, P661, DOI 10.1016/j.cell.2010.08.023; Madan LL, 2011, BIOCHEMISTRY-US, V50, P10114, DOI 10.1021/bi201092q; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; MCLAUGHLIN S, 1993, J BIOL CHEM, V268, P6839; Mertins P, 2008, MOL CELL PROTEOMICS, V7, P1763, DOI 10.1074/mcp.M800196-MCP200; Mesquita R.D., 2011, FAT FUNCTIONAL ANAL, V11083-6; Oishi K, 2009, HUM MOL GENET, V18, P193, DOI 10.1093/hmg/ddn336; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Pakpour N, 2012, INFECT IMMUN, V80, P2141, DOI 10.1128/IAI.00024-12; PERKINS LA, 1992, CELL, V70, P225, DOI 10.1016/0092-8674(92)90098-W; Porter CT, 2004, NUCLEIC ACIDS RES, V32, pD129, DOI 10.1093/nar/gkh028; Riehle MA, 1999, INSECT BIOCHEM MOLEC, V29, P855, DOI 10.1016/S0965-1748(99)00084-3; Riehle MA, 2006, PEPTIDES, V27, P2547, DOI 10.1016/j.peptides.2006.07.016; Roy SG, 2011, INSECT BIOCHEM MOLEC, V41, P62, DOI 10.1016/j.ibmb.2010.10.001; Sacco F, 2012, FEBS LETT, V586, P2732, DOI 10.1016/j.febslet.2012.05.008; Shimizu S, 2003, J BIOL CHEM, V278, P43095, DOI 10.1074/jbc.M306880200; Silveira AB, 2006, INSECT BIOCHEM MOLEC, V36, P200, DOI 10.1016/j.ibmb.2006.01.015; Tiganis T, 2013, FEBS J, V280, P445, DOI 10.1111/j.1742-4658.2012.08563.x; Tonks NK, 2009, CELL, V139, P464, DOI 10.1016/j.cell.2009.10.008; Ugi S, 2009, J BIOCHEM, V146, P541, DOI 10.1093/jb/mvp104; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wass MN, 2008, BIOINFORMATICS, V24, P798, DOI 10.1093/bioinformatics/btn037; Whited JL, 2007, DEVELOPMENT, V134, P43, DOI 10.1242/dev.02718; Wood TC, 1999, J MOL BIOL, V291, P977, DOI 10.1006/jmbi.1999.2972; Wu CL, 2011, BIOCHEM J, V439, P151, DOI 10.1042/BJ20110799; Zhang ZY, 1998, CRIT REV BIOCHEM MOL, V33, P1, DOI 10.1080/10409239891204161	61	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e104878	10.1371/journal.pone.0104878	http://dx.doi.org/10.1371/journal.pone.0104878			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137153	Green Published, Green Submitted, gold			2022-12-25	WOS:000340742100051
J	Corte, L; Valente, F; Serrano, M; Gomes, CM; Moran, CP; Henriques, AO				Corte, Luisa; Valente, Filipa; Serrano, Monica; Gomes, Claudio M.; Moran, Charles P., Jr.; Henriques, Adriano O.			A Conserved Cysteine Residue of Bacillus subtilis SpoIIIJ Is Important for Endospore Development	PLOS ONE			English	Article							ZETA-CHAIN DIMERIZATION; PERIPLASMIC DOMAIN; MEMBRANE-PROTEINS; CRYSTAL-STRUCTURE; MOTHER-CELL; SPORULATION; YIDC; GENE; TRANSLOCASE; EXPRESSION	During sporulation in Bacillus subtilis, the onset of activity of the late forespore-specific sigma factor sigma(G) coincides with completion of forespore engulfment by the mother cell. At this stage, the forespore becomes a free protoplast, surrounded by the mother cell cytoplasm and separated from it by two membranes that derive from the asymmetric division septum. Continued gene expression in the forespore, isolated from the surrounding medium, relies on the SpoIIIA-SpoIIQ secretion system assembled from proteins synthesised both in the mother cell and in the forespore. The membrane protein insertase SpoIIIJ, of the YidC/Oxa1/Alb3 family, is involved in the assembly of the SpoIIIA-SpoIIQ complex. Here we show that SpoIIIJ exists as a mixture of monomers and dimers stabilised by a disulphide bond. We show that residue Cys134 within transmembrane segment 2 (TM2) of SpoIIIJ is important to stabilise the protein in the dimeric form. Labelling of Cys134 with a Cys-reactive reagent could only be achieved under stringent conditions, suggesting a tight association at least in part through TM2, between monomers in the membrane. Substitution of Cys134 by an Ala results in accumulation of the monomer, and reduces SpoIIIJ function in vivo. Therefore, SpoIIIJ activity in vivo appears to require dimer formation.	[Corte, Luisa; Valente, Filipa; Serrano, Monica; Gomes, Claudio M.; Henriques, Adriano O.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, P-2780156 Oeiras, Portugal; [Moran, Charles P., Jr.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA	Universidade Nova de Lisboa; Emory University	Henriques, AO (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, P-2780156 Oeiras, Portugal.	aoh@itqb.unl.pt	Serrano, Mónica/H-8726-2013; Gomes, Cláudio M./A-8152-2008	Serrano, Mónica/0000-0003-3335-3219; Gomes, Cláudio M./0000-0003-4662-6933; Henriques, Adriano/0000-0003-4292-4802	"Fundacao para a Ciencia e a Tecnologia" (FCT) [POCTI/BIA-BCM/60855/2004, PEst-OE/EQB/LA0004/2011]; National Institute of General and Medical Sciences Public Health Services [GM54395-29]; FCT [SFRH/BD/6489/2001, SFRH/BPD/36328/2007, SFRH/BPD/26470/2006]	"Fundacao para a Ciencia e a Tecnologia" (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); National Institute of General and Medical Sciences Public Health Services; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by grants POCTI/BIA-BCM/60855/2004 and PEst-OE/EQB/LA0004/2011 from "Fundacao para a Ciencia e a Tecnologia" (FCT) to A.O.H., and by National Institute of General and Medical Sciences Public Health Services R01 Grant GM54395-29 to C. P. M. LC (SFRH/BD/6489/2001) and M. S (SFRH/BPD/36328/2007) and F. V. (SFRH/BPD/26470/2006) were the recipients of a PhD (LC) and post doctoral fellowships (MS and FV) from the FCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MH, 2005, BIOORGAN MED CHEM, V13, P5013, DOI 10.1016/j.bmc.2005.05.037; Arien H, 2003, J BIOL CHEM, V278, P29231, DOI 10.1074/jbc.M301401200; Bolliger L, 1999, J IMMUNOL, V163, P3867; Bowie JU, 1997, J MOL BIOL, V272, P780, DOI 10.1006/jmbi.1997.1279; Boy D, 2009, MOL BIOL CELL, V20, P1804, DOI 10.1091/mbc.E08-08-0886; Camp AH, 2008, MOL MICROBIOL, V69, P402, DOI 10.1111/j.1365-2958.2008.06289.x; Camp AH, 2009, GENE DEV, V23, P1014, DOI 10.1101/gad.1781709; Chiang WC, 2008, BIOCHEMISTRY-US, V47, P8775, DOI 10.1021/bi800633d; Doan T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000566; Du Plessis DJF, 2011, BBA-BIOMEMBRANES, V1808, P851, DOI 10.1016/j.bbamem.2010.08.016; Dunschede B, 2011, J BIOL CHEM, V286, P35187, DOI 10.1074/jbc.M111.250746; ERRINGTON J, 1992, J GEN MICROBIOL, V138, P2609, DOI 10.1099/00221287-138-12-2609; Geng YP, 2014, J BACTERIOL, V196, P1318, DOI 10.1128/JB.01084-13; Glick BS, 1996, PROTEIN SCI, V5, P2651, DOI 10.1002/pro.5560051229; GueroutFleury AM, 1996, GENE, V180, P57, DOI 10.1016/S0378-1119(96)00404-0; HENNER DJ, 1990, METHOD ENZYMOL, V185, P223; Henriques AO, 1998, J BACTERIOL, V180, P2285, DOI 10.1128/JB.180.9.2285-2291.1998; HENRIQUES AO, 1995, J BACTERIOL, V177, P3394, DOI 10.1128/jb.177.12.3394-3406.1995; Hilbert DW, 2004, MICROBIOL MOL BIOL R, V68, P234, DOI 10.1128/MMBR.68.2.234-262.2004; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; ILLING N, 1991, MOL MICROBIOL, V5, P1927, DOI 10.1111/j.1365-2958.1991.tb00816.x; Jefferies KC, 2008, J BIOL CHEM, V283, P4512, DOI 10.1074/jbc.M707144200; Kellner EM, 1996, MOL MICROBIOL, V21, P913, DOI 10.1046/j.1365-2958.1996.461408.x; Klenner C, 2012, J BIOL CHEM, V287, P3769, DOI 10.1074/jbc.M111.307223; Kohler R, 2009, MOL CELL, V34, P344, DOI 10.1016/j.molcel.2009.04.019; Koide K, 2007, J BIOL CHEM, V282, P4553, DOI 10.1074/jbc.M607339200; Kroos L, 1999, MOL MICROBIOL, V31, P1285, DOI 10.1046/j.1365-2958.1999.01214.x; Kruger V, 2012, J BIOL CHEM, V287, P33314, DOI 10.1074/jbc.M112.387563; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lotz M, 2008, J MOL BIOL, V375, P901, DOI 10.1016/j.jmb.2007.10.089; Meisner J, 2008, P NATL ACAD SCI USA, V105, P15100, DOI 10.1073/pnas.0806301105; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Murakami T, 2002, J BACTERIOL, V184, P1998, DOI 10.1128/JB.184.7.1998-2004.2002; Nargang FE, 2002, J BIOL CHEM, V277, P12846, DOI 10.1074/jbc.M112099200; Natale P, 2008, BBA-BIOMEMBRANES, V1778, P1735, DOI 10.1016/j.bbamem.2007.07.015; Neale EJ, 2007, J BIOL CHEM, V282, P37597, DOI 10.1074/jbc.M706437200; Nouwen N, 2002, MOL MICROBIOL, V44, P1397, DOI 10.1046/j.1365-2958.2002.02972.x; Oliver DC, 2008, J BIOL CHEM, V283, P5208, DOI 10.1074/jbc.M708936200; Piggot PJ, 2004, CURR OPIN MICROBIOL, V7, P579, DOI 10.1016/j.mib.2004.10.001; Pogliano J, 1999, MOL MICROBIOL, V31, P1149, DOI 10.1046/j.1365-2958.1999.01255.x; Ravaud S, 2008, J BIOL CHEM, V283, P9350, DOI 10.1074/jbc.M710493200; Reif S, 2005, J MOL BIOL, V354, P520, DOI 10.1016/j.jmb.2005.09.054; Rubio A, 2005, J BACTERIOL, V187, P5000, DOI 10.1128/JB.187.14.5000-5002.2005; Rudner DZ, 2001, DEV CELL, V1, P733, DOI 10.1016/S1534-5807(01)00094-6; RUTLEDGE T, 1992, EMBO J, V11, P3245, DOI 10.1002/j.1460-2075.1992.tb05402.x; Saller MJ, 2012, BIOL CHEM, V393, P1279, DOI 10.1515/hsz-2012-0199; Saller MJ, 2009, J BACTERIOL, V191, P6749, DOI 10.1128/JB.00853-09; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Serrano M, 2003, J BACTERIOL, V185, P3905, DOI 10.1128/JB.185.13.3905-3917.2003; Serrano M, 2008, J BACTERIOL, V190, P7786, DOI 10.1128/JB.00715-08; SETLOW B, 1991, J BACTERIOL, V173, P6270, DOI 10.1128/jb.173.19.6270-6278.1991; Sousa VL, 2003, J BIOL CHEM, V278, P7624, DOI 10.1074/jbc.M209325200; Stragier P, 1996, ANNU REV GENET, V30, P297, DOI 10.1146/annurev.genet.30.1.297; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tjalsma H, 2003, J BIOL CHEM, V278, P15622, DOI 10.1074/jbc.M301205200; Tjalsma H, 2000, MICROBIOL MOL BIOL R, V64, P515, DOI 10.1128/MMBR.64.3.515-547.2000; van der Does C, 2003, METHOD ENZYMOL, V372, P86; van der Laan M, 2001, EMBO REP, V2, P519, DOI 10.1093/embo-reports/kve106; von Heijne G, 2011, BIOCHEM SOC T, V39, P747, DOI 10.1042/BST0390747; Wang P, 2011, BBA-BIOMEMBRANES, V1808, P866, DOI 10.1016/j.bbamem.2010.08.014; Yuan J, 2007, J BACTERIOL, V189, P8961, DOI 10.1128/JB.01365-07	61	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e99811	10.1371/journal.pone.0099811	http://dx.doi.org/10.1371/journal.pone.0099811			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133632	gold, Green Published, Green Submitted			2022-12-25	WOS:000341302700001
J	Dal Monte, O; Noble, PL; Turchi, J; Cummins, A; Averbeck, BB				Dal Monte, Olga; Noble, Pamela L.; Turchi, Janita; Cummins, Alex; Averbeck, Bruno B.			CSF and Blood Oxytocin Concentration Changes following Intranasal Delivery in Macaque	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; PLASMA OXYTOCIN; SPINAL-CORD; BRAIN; VASOPRESSIN; NASAL; RADIOIMMUNOASSAY; PATHWAYS; BEHAVIOR; RHYTHM	Oxytocin (OT) in the central nervous system (CNS) influences social cognition and behavior, making it a candidate for treating clinical disorders such as schizophrenia and autism. Intranasal administration has been proposed as a possible route of delivery to the CNS for molecules like OT. While intranasal administration of OT influences social cognition and behavior, it is not well established whether this is an effective means for delivering OT to CNS targets. We administered OT or its vehicle (saline) to 15 primates (Macaca mulatta), using either intranasal spray or a nebulizer, and measured OT concentration changes in the cerebral spinal fluid (CSF) and in blood. All subjects received both delivery methods and both drug conditions. Baseline samples of blood and CSF were taken immediately before drug administration. Blood was collected every 10 minutes after administration for 40 minutes and CSF was collected once post-delivery, at the 40 minutes time point. We found that intranasal administration of exogenous OT increased concentrations in both CSF and plasma compared to saline. Both delivery methods resulted in similar elevations of OT concentration in CSF, while the changes in plasma OT concentration were greater after nasal spray compared to nebulizer. In conclusion our study provides evidence that both nebulizer and nasal spray OT administration can elevate CSF OT levels.	[Dal Monte, Olga; Noble, Pamela L.; Turchi, Janita; Cummins, Alex; Averbeck, Bruno B.] NIH, NIMH, Neuropsychol Lab, Bethesda, MD 20892 USA; [Dal Monte, Olga] Univ Turin, Dept Neuropsychol, Turin, Italy	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of Turin	Averbeck, BB (corresponding author), NIH, NIMH, Neuropsychol Lab, Bldg 10, Bethesda, MD 20892 USA.	averbeckbb@mail.nih.gov	Dal Monte, Olga/P-3759-2018	Dal Monte, Olga/0000-0002-7823-4769	Intramural Research Program of the NIMH/NIH/DHHS; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002928] Funding Source: NIH RePORTER	Intramural Research Program of the NIMH/NIH/DHHS; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by the Intramural Research Program of the NIMH/NIH/DHHS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMICO JA, 1990, J CLIN ENDOCR METAB, V71, P1531, DOI 10.1210/jcem-71-6-1531; AMICO JA, 1983, J CLIN ENDOCR METAB, V57, P947, DOI 10.1210/jcem-57-5-947; Appenrodt E, 1998, PHYSIOL BEHAV, V64, P543, DOI 10.1016/S0031-9384(98)00119-X; ARTMAN HG, 1982, J NEUROSCI, V2, P598; Born J, 2002, NAT NEUROSCI, V5, P514, DOI 10.1038/nn849; Bosch OJ, 2005, J NEUROSCI, V25, P6807, DOI 10.1523/JNEUROSCI.1342-05.2005; BOYD NRH, 1972, J ENDOCRINOL, V52, P59, DOI 10.1677/joe.0.0520059; Burri A, 2008, PSYCHONEUROENDOCRINO, V33, P591, DOI 10.1016/j.psyneuen.2008.01.014; Chang SWC, 2012, P NATL ACAD SCI USA, V109, P959, DOI 10.1073/pnas.1114621109; Chen Xue-Qing, 1998, J Alzheimers Dis, V1, P35; Clark CL, 2013, PSYCHONEUROENDOCRINO, V38, P1208, DOI 10.1016/j.psyneuen.2012.10.017; Devarajan K, 2004, NEUROSCI LETT, V367, P144, DOI 10.1016/j.neulet.2004.05.112; Dhanda D.S., 2005, DRUG DELIV TECHNOL, V5, P64; ERMISCH A, 1985, J CEREBR BLOOD F MET, V5, P350, DOI 10.1038/jcbfm.1985.49; Evans S, 2011, PSYCHOL MED, V41, P1471, DOI 10.1017/S0033291710001960; Gamer M, 2010, P NATL ACAD SCI USA, V107, P9400, DOI 10.1073/pnas.1000985107; Gossen A, 2012, NEUROPEPTIDES, V46, P211, DOI 10.1016/j.npep.2012.07.001; Green LA, 2001, BIOL PSYCHIAT, V50, P609, DOI 10.1016/S0006-3223(01)01139-8; Guastella AJ, 2013, PSYCHONEUROENDOCRINO, V38, P612, DOI 10.1016/j.psyneuen.2012.11.019; Guastella AJ, 2010, BIOL PSYCHIAT, V67, P692, DOI 10.1016/j.biopsych.2009.09.020; Heinrichs M, 2009, FRONT NEUROENDOCRIN, V30, P548, DOI 10.1016/j.yfrne.2009.05.005; Illum L, 2003, J CONTROL RELEASE, V87, P187, DOI 10.1016/S0168-3659(02)00363-2; Insel T R, 2001, Prog Brain Res, V133, P59; Jokinen J, 2012, PSYCHONEUROENDOCRINO, V37, P482, DOI 10.1016/j.psyneuen.2011.07.016; Kagerbauer SM, 2013, J NEUROENDOCRINOL, V25, P668, DOI 10.1111/jne.12038; Kirsch P, 2005, J NEUROSCI, V25, P11489, DOI 10.1523/JNEUROSCI.3984-05.2005; Lee R, 2009, PSYCHONEUROENDOCRINO, V34, P1567, DOI 10.1016/j.psyneuen.2009.06.002; Martinez-Lorenzan G, 2008, PAIN, V140, P265, DOI 10.1016/j.pain.2008.08.015; McCullough ME, 2013, NEUROSCI BIOBEHAV R, V37, P1485, DOI 10.1016/j.neubiorev.2013.04.018; MEISENBERG G, 1983, LIFE SCI, V32, P2611, DOI 10.1016/0024-3205(83)90352-1; Modi ME, 2014, PSYCHONEUROENDOCRINO, V45, P49, DOI 10.1016/j.psyneuen.2014.02.011; Neumann ID, 2013, PSYCHONEUROENDOCRINO, V38, P1985, DOI 10.1016/j.psyneuen.2013.03.003; Parker KJ, 2010, BEHAV NEUROSCI, V124, P428, DOI 10.1037/a0019576; Parr LA, 2013, PSYCHONEUROENDOCRINO, V38, P1748, DOI 10.1016/j.psyneuen.2013.02.011; Rimmele U, 2009, J NEUROSCI, V29, P38, DOI 10.1523/JNEUROSCI.4260-08.2009; ROBINSON ICAF, 1993, ANN NY ACAD SCI, V689, P269; Robinson KJ, 2014, J NEUROSCI METH, V226, P73, DOI 10.1016/j.jneumeth.2014.01.019; SECKL JR, 1987, J ENDOCRINOL, V114, P477, DOI 10.1677/joe.0.1140477; Singer T, 2008, EMOTION, V8, P781, DOI 10.1037/a0014195; Stoop R, 2012, NEURON, V76, P142, DOI 10.1016/j.neuron.2012.09.025; Striepens N, 2013, SCI REPORTS, P3; Szeto A, 2011, PSYCHOSOM MED, V73, P393, DOI 10.1097/PSY.0b013e31821df0c2; Thorne RG, 2004, NEUROSCIENCE, V127, P481, DOI 10.1016/j.neuroscience.2004.05.029; THORNE RG, 1995, BRAIN RES, V692, P278, DOI 10.1016/0006-8993(95)00637-6; Weisman O, 2013, PSYCHONEUROENDOCRINO, V38, P694, DOI 10.1016/j.psyneuen.2012.08.011; William H, 2002, DRUG DELIV TECHNOL, V2, P46; Winslow JT, 2003, NEUROPSYCHOPHARMACOL, V28, P910, DOI 10.1038/sj.npp.1300128	48	128	131	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e103677	10.1371/journal.pone.0103677	http://dx.doi.org/10.1371/journal.pone.0103677			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133536	gold, Green Published, Green Submitted			2022-12-25	WOS:000341302700015
J	Donders, TH; Hagemans, K; Dekker, SC; de Weger, LA; de Klerk, P; Wagner-Cremer, F				Donders, Timme H.; Hagemans, Kimberley; Dekker, Stefan C.; de Weger, Letty A.; de Klerk, Pim; Wagner-Cremer, Friederike			Region-Specific Sensitivity of Anemophilous Pollen Deposition to Temperature and Precipitation	PLOS ONE			English	Article							CLIMATE-CHANGE; BETULA-PAPYRIFERA; SHOOT DEVELOPMENT; ACCUMULATION RATES; RECORD; ALNUS; VARIABILITY; NITROGEN; FOREST; PINUS	Understanding relations between climate and pollen production is important for several societal and ecological challenges, importantly pollen forecasting for pollinosis treatment, forensic studies, global change biology, and high-resolution palaeoecological studies of past vegetation and climate fluctuations. For these purposes, we investigate the role of climate variables on annual-scale variations in pollen influx, test the regional consistency of observed patterns, and evaluate the potential to reconstruct high-frequency signals from sediment archives. A 43-year pollen-trap record from the Netherlands is used to investigate relations between annual pollen influx, climate variables (monthly and seasonal temperature and precipitation values), and the North Atlantic Oscillation climate index. Spearman rank correlation analysis shows that specifically in Alnus, Betula, Corylus, Fraxinus, Quercus and Plantago both temperature in the year prior to (T-1), as well as in the growing season (T), are highly significant factors (T-April r(s) between 0.30 [P<0.05[ and 0.58 [P<0.0001]; TJuli-1 rs between 0.32 [P<0.05[and 0.56 [P<0.0001]) in the annual pollen influx of wind-pollinated plants. Total annual pollen prediction models based on multiple climate variables yield R-2 between 0.38 and 0.62 (P<0.0001). The effect of precipitation is minimal. A second trapping station in the SE Netherlands, shows consistent trends and annual variability, suggesting the climate factors are regionally relevant. Summer temperature is thought to influence the formation of reproductive structures, while temperature during the flowering season influences pollen release. This study provides a first predictive model for seasonal pollen forecasting, and also aides forensic studies. Furthermore, variations in pollen accumulation rates from a sub-fossil peat deposit are comparable with the pollen trap data. This suggests that high frequency variability pollen records from natural archives reflect annual past climate variability, and can be used in palaeoecological and -climatological studies to bridge between population- and species-scale responses to climate forcing.	[Donders, Timme H.; Hagemans, Kimberley; Wagner-Cremer, Friederike] Univ Utrecht, Fac Geosci, Dept Phys Geog, Lab Palaeobotany & Palynol, Utrecht, Netherlands; [Hagemans, Kimberley; Dekker, Stefan C.] Univ Utrecht, Fac Geosci, Copernicus Inst, Dept Environm Sci, Utrecht, Netherlands; [de Weger, Letty A.] Leiden Univ, Med Ctr, Dept Pulmonol, Leiden, Netherlands; [de Klerk, Pim] Staatliches Museum Naturkunde Karlsruhe, Bot Sect, Karlsruhe, Germany	Utrecht University; Utrecht University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Donders, TH (corresponding author), Univ Utrecht, Fac Geosci, Dept Phys Geog, Lab Palaeobotany & Palynol, Utrecht, Netherlands.	t.h.donders@uu.nl	Dekker, Stefan/F-5581-2013; de Weger, Letty/GLN-7644-2022; Wagner-Cremer, Friederike/B-4225-2009	Dekker, Stefan/0000-0001-7764-2464; Wagner-Cremer, Friederike/0000-0002-8119-3558; Donders, Timme/0000-0003-4698-3463; de Weger, Letty/0000-0002-9067-7407; de Klerk, Pim/0000-0003-3099-9399	Utrecht University; Leiden University Medical Centre	Utrecht University; Leiden University Medical Centre	This work is supported by Utrecht University and Leiden University Medical Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN S T, 1980, Grana, V19, P47; Autio J, 2004, GRANA, V43, P31, DOI 10.1080/00173130310017409; Barnekow L, 2007, J QUATERNARY SCI, V22, P653, DOI 10.1002/jqs.1096; Beggs PJ, 2004, CLIN EXP ALLERGY, V34, P1507, DOI 10.1111/j.1365-2222.2004.02061.x; Bobbink R, 2010, ECOL APPL, V20, P30, DOI 10.1890/08-1140.1; Brewer S, 2007, ENCY QUATERNARY SCI, P2, DOI DOI 10.1016/B0-44-452747-8/00177-0; CAESAR JC, 1984, CAN J BOT, V62, P1708, DOI 10.1139/b84-231; Dahl uO., 1996, AEROBIOLOGIA, V12, P97, DOI [10.1007/BF02446601, DOI 10.1007/BF02446601]; Detandt M., 2000, AEROBIOLOGIA, V16, P55, DOI [10.1023/A:1007619724282, DOI 10.1023/A:1007619724282]; Donders TH, 2013, GEOPHYS RES LETT, V40, P5776, DOI 10.1002/2013GL058038; Emberlin J, 2007, INT J BIOMETEOROL, V51, P181, DOI 10.1007/s00484-006-0059-2; Finsinger W, 2013, J QUATERNARY SCI, V28, P152, DOI 10.1002/jqs.2598; Garcia-Mozo H, 2001, ISRAEL J PLANT SCI, V49, P41, DOI 10.1092/JR25-EB31-9JTG-WTD6; GREEN D, 1988, J ECOL, V76, P790, DOI 10.2307/2260574; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hicks S, 2001, REV PALAEOBOT PALYNO, V117, P1, DOI 10.1016/S0034-6667(01)00074-4; HIRST JM, 1952, ANN APPL BIOL, V39, P257, DOI 10.1111/j.1744-7348.1952.tb00904.x; Hurrell JW, 1997, CLIMATIC CHANGE, V36, P301, DOI 10.1023/A:1005314315270; Jato V, 2004, GRANA, V43, P217, DOI 10.1080/00173130410016274; Joosten H, 2002, REV PALAEOBOT PALYNO, V122, P29, DOI 10.1016/S0034-6667(02)00090-8; Kasprzyk I, 2009, INT J BIOMETEOROL, V53, P345, DOI 10.1007/s00484-009-0221-8; KNAAP WO, 2010, VEG HIST ARCHAEOBOT, V19, P285, DOI DOI 10.1007/S00334-010-0250-6; Kuoppamaa M, 2009, J QUATERNARY SCI, V24, P513, DOI 10.1002/jqs.1276; LAU TC, 1993, AM J BOT, V80, P763, DOI 10.2307/2445596; MACDONALD AD, 1983, CAN J BOT, V61, P3049, DOI 10.1139/b83-342; MACDONALD AD, 1984, CAN J BOT, V62, P437, DOI 10.1139/b84-066; MCVEAN DN, 1955, J ECOL, V43, P46, DOI 10.2307/2257118; Nielsen AB, 2010, VEG HIST ARCHAEOBOT, V19, P309, DOI 10.1007/s00334-010-0253-3; Ranta H, 2005, INT J BIOMETEOROL, V49, P146, DOI 10.1007/s00484-004-0228-0; Ranta H, 2008, FOREST ECOL MANAG, V255, P643, DOI 10.1016/j.foreco.2007.09.040; Rasmussen Alix, 2002, Aerobiologia, V18, P253, DOI 10.1023/A:1021321615254; Rodriguez-Rajo FJ, 2004, ANN AGR ENV MED, V11, P35; ROGERS CA, 1993, REV PALAEOBOT PALYNO, V79, P133, DOI 10.1016/0034-6667(93)90043-T; Shea KM, 2008, J ALLERGY CLIN IMMUN, V122, P443, DOI 10.1016/j.jaci.2008.06.032; Sjogren P, 2006, HOLOCENE, V16, P277, DOI 10.1191/0959683606hl924rp; Spieksma F. Th. M., 2003, Aerobiologia, V19, P171, DOI 10.1023/B:AERO.0000006528.37447.15; SPIEKSMA FTM, 1995, GRANA, V34, P51, DOI 10.1080/00173139509429033; SPIEKSMA FTM, 1989, GRANA, V28, P25, DOI 10.1080/00173138909431009; Spieksma FTM., 1998, AEROBIOLOGIA, V14, P347, DOI [10.1007/BF02694304, DOI 10.1007/BF02694304, 10.1007/bf02694304]; ter Braak C.J.F., 2002, CANOCO REFERENCE MAN, P500; Tyler G, 2001, ANN BOT-LONDON, V87, P623, DOI 10.1006/anbo.2001.1383; Van der Meijden R., 2005, HEUKELS FLORA NEDERL; Van Vliet AJH, 2002, INT J CLIMATOL, V22, P1757, DOI 10.1002/joc.820; Wagner F, 1996, P NATL ACAD SCI USA, V93, P11705, DOI 10.1073/pnas.93.21.11705; Walsh KAJ, 2008, J FORENSIC SCI, V53, P1053, DOI 10.1111/j.1556-4029.2008.00802.x; Ziello C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034076; Ziska LH, 2000, AUST J PLANT PHYSIOL, V27, P893; 2012, N ATLANTIC OSCILLATI; 2014, NETHERLANDS PHENOLOG	49	12	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e104774	10.1371/journal.pone.0104774	http://dx.doi.org/10.1371/journal.pone.0104774			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133631	Green Published, gold, Green Submitted			2022-12-25	WOS:000341302700041
J	Qi, QR; Xie, QZ; Liu, XL; Zhou, Y				Qi, Qian-Rong; Xie, Qing-Zhen; Liu, Xue-Li; Zhou, Yun			Osteopontin Is Expressed in the Mouse Uterus during Early Pregnancy and Promotes Mouse Blastocyst Attachment and Invasion In Vitro	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; ALPHA-V-BETA-3 INTEGRIN; CONCEPTUS ATTACHMENT; EMBRYO IMPLANTATION; PLACENTAL INTERFACE; ADHESION MOLECULES; TISSUE INHIBITOR; GENE-EXPRESSION; UP-REGULATION; ENDOMETRIUM	Embryo implantation into the maternal uterus is a decisive step for successful mammalian pregnancy. Osteopontin (OPN) is a member of the small integrin-binding ligand N-linked glycoprotein family and participates in cell adhesion and invasion. In this study, we showed that Opn mRNA levels are up-regulated in the mouse uterus on day 4 and at the implantation sites on days 5 and 8 of pregnancy. Immunohistochemistry localized the OPN protein to the glandular epithelium on day 4 and to the decidual zone on day 8 of pregnancy. OPN mRNA and proteins are induced by in vivo and in vitro decidualization. OPN expression in the endometrial stromal cells is regulated by progesterone, a key regulator during decidualization. As a secreted protein, the protein level of OPN in the uterine cavity is enriched on day 4, and in vitro embryo culturing has indicated that OPN can facilitate blastocyst hatching and adhesion. Knockdown of OPN attenuates the adhesion and invasion of blastocysts in mouse endometrial stromal cells by suppressing the expression and enzymatic activity of matrix metalloproteinase-9 in the trophoblast. Our data indicated that OPN expression in the mouse uterus during early pregnancy is essential for blastocyst hatching and adhesion and that the knockdown of OPN in mouse endometrial stroma cells could lead to a restrained in vitro trophoblast invasion.	[Qi, Qian-Rong; Xie, Qing-Zhen; Zhou, Yun] Wuhan Univ, Renmin Hosp, Ctr Reprod Med, Wuhan 430072, Peoples R China; [Liu, Xue-Li] Wuhan Univ, Coll Med, Wuhan 430072, Peoples R China	Wuhan University; Wuhan University	Xie, QZ (corresponding author), Wuhan Univ, Renmin Hosp, Ctr Reprod Med, Wuhan 430072, Peoples R China.	qingzhenxie@hotmail.com	Qi, Qian-Rong/AAV-7553-2020	Qi, Qian-Rong/0000-0003-0276-7187	Chinese National Natural Science Foundation [30670233]; Natural Science of Hubei Province Foundation [2012FKB04447]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Natural Science of Hubei Province Foundation	This work was supported by Chinese National Natural Science Foundation grants (No. 30670233), Natural Science of Hubei Province Foundation grants (No. 2012FKB04447). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnihotri R, 2001, J BIOL CHEM, V276, P28261, DOI 10.1074/jbc.M103608200; Anacker J, 2011, MOL HUM REPROD, V17, P637, DOI 10.1093/molehr/gar033; Bai SX, 2005, REPRODUCTION, V129, P103, DOI 10.1530/rep.1.00283; Casals G, 2012, HUM REPROD, V27, P805, DOI 10.1093/humrep/der432; Chaen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048933; Chen L, 2007, REPRODUCTION, V133, P405, DOI 10.1530/rep.1.01020; Chen YJ, 2009, J CELL PHYSIOL, V221, P98, DOI 10.1002/jcp.21835; Dahiya S, 2011, J IMMUNOL, V187, P2723, DOI 10.4049/jimmunol.1101342; DeMayo FJ, 2002, ANN NY ACAD SCI, V955, P48, DOI 10.1111/j.1749-6632.2002.tb02765.x; Desai B, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-18; Elbehery MM, 2011, CLIN LAB, V57, P953; Erikson DW, 2007, REPRODUCTION, V133, P909, DOI 10.1530/REP-06-0228; Estella C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030508; Feng ZH, 2011, FASEB J, V25, P2245, DOI 10.1096/fj.10-180166; Filant J, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.113.107631; Fluhr H, 2008, FERTIL STERIL, V90, P1384, DOI [10.1016/j.fertnstert.2007.07.1357, 10.1016/j.fertnstert.2007.08.023]; Fonseca BM, 2012, REPROD BIOL, V12, P97, DOI 10.1016/S1642-431X(12)60080-1; Franchi A, 2008, MOL HUM REPROD, V14, P413, DOI 10.1093/molehr/gan029; Garlow JE, 2002, BIOL REPROD, V66, P718, DOI 10.1095/biolreprod66.3.718; Garmy-Susini B, 2013, P NATL ACAD SCI USA, V110, P9042, DOI 10.1073/pnas.1219603110; Herington JL, 2007, REPRODUCTION, V133, P1213, DOI 10.1530/REP-07-0085; Hirota Y, 2010, J CLIN INVEST, V120, P803, DOI 10.1172/JCI40051; Ho HT, 2012, FERTIL STERIL, V97, P974, DOI 10.1016/j.fertnstert.2012.01.116; Johnson GA, 2003, BIOL REPROD, V69, P1458, DOI 10.1095/biolreprod.103.020651; Johnson GA, 2003, BIOL REPROD, V69, P92, DOI 10.1095/biolreprod.102.013573; Johnson GA, 2001, BIOL REPROD, V65, P820, DOI 10.1095/biolreprod65.3.820; Juengel E, 2013, EXP BIOL MED MAYWOOD; Kaitu'u TJ, 2005, BIOL REPROD, V73, P672, DOI 10.1095/biolreprod.105.042473; Kaloglu C, 2010, TISSUE CELL, V42, P301, DOI 10.1016/j.tice.2010.07.004; Koizumi M, 2010, HUM REPROD, V25, P192, DOI 10.1093/humrep/dep370; Kumar V, 2010, CANCER RES, V70, P10381, DOI 10.1158/0008-5472.CAN-10-1470; Lee KM, 2013, ACTA BIOMATER, V9, P5600, DOI 10.1016/j.actbio.2012.10.036; Lei W, 2012, J BIOL CHEM, V287, P15174, DOI 10.1074/jbc.M111.308023; Liu Qian, 2012, Zhonghua Nan Ke Xue, V18, P446; Martinez-Conejero JA, 2011, FERTIL STERIL, V96, P943, DOI 10.1016/j.fertnstert.2011.07.1088; Menkhorst E, 2009, BIOL REPROD, V80, P920, DOI 10.1095/biolreprod.108.073601; Paria BC, 1999, DEVELOPMENT, V126, P1997; Solberg H, 2003, DEVELOPMENT, V130, P4439, DOI 10.1242/dev.00642; Sun XF, 2013, MOL ENDOCRINOL, V27, P1492, DOI 10.1210/me.2013-1086; Tawfeek MA, 2012, BMC WOMENS HEALTH, V12, DOI 10.1186/1472-6874-12-10; Wan PC, 2011, REPROD DOMEST ANIM, V46, P840, DOI 10.1111/j.1439-0531.2011.01752.x; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Wang HB, 2003, FERTIL STERIL, V80, P736, DOI 10.1016/S0015-0282(03)00782-9; Wasik AM, 2013, SCI REP-UK, V3, DOI [10.1038/srep01400, 10.1038/srep02007]; Weintraub AS, 2004, PEDIATR RES, V55, P419, DOI 10.1203/01.PDR.0000112034.98387.B2; White CA, 2007, P NATL ACAD SCI USA, V104, P19357, DOI 10.1073/pnas.0710110104; White FJ, 2006, REPRODUCTION, V132, P919, DOI 10.1530/REP-06-0068; Whiteside EJ, 2001, BIOL REPROD, V64, P1331, DOI 10.1095/biolreprod64.5.1331; Xie QZ, 2013, INT J MOL SCI, V14, P14504, DOI 10.3390/ijms140714504; Yong-feng Cui, 2011, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V33, P210, DOI 10.3881/j.issn.1000-503X.2011.02.022; Zhang S, 2013, MOL ASPECTS MED, V34, P939, DOI 10.1016/j.mam.2012.12.011; Zhao YL, 2010, FERTIL STERIL, V94, P2264, DOI 10.1016/j.fertnstert.2010.01.068; Zhu FX, 2012, GLYCOCONJUGATE J, V29, P347, DOI 10.1007/s10719-012-9426-x	53	20	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e104955	10.1371/journal.pone.0104955	http://dx.doi.org/10.1371/journal.pone.0104955			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133541	Green Published, Green Submitted, gold			2022-12-25	WOS:000341302700055
J	Wang, Y; Tian, Y; Ding, Y; Wang, JC; Yan, S; Zhou, L; Xie, HY; Chen, H; Li, H; Zhang, JH; Zhao, JC; Zheng, SS				Wang, Yan; Tian, Yang; Ding, Yuan; Wang, Jingcheng; Yan, Sheng; Zhou, Lin; Xie, Haiyang; Chen, Hui; Li, Hui; Zhang, Jinhua; Zhao, Jiacong; Zheng, Shusen			MiR-152 May Silence Translation of CaMK II and Induce Spontaneous Immune Tolerance in Mouse Liver Transplantation	PLOS ONE			English	Article							REGULATORY T-CELLS; SPONTANEOUS ACCEPTANCE; OPERATIONAL TOLERANCE; PERIPHERAL-BLOOD; DENDRITIC CELLS; NONCODING RNAS; MICRORNAS; PROLIFERATION; ALLOGRAFTS; GENE	Spontaneous immune tolerance in mouse liver transplantation has always been a hotspot in transplantation-immune research. Recent studies revealed that regulatory T cells (Tregs), hepatic satellite cells and Kupffer cells play a potential role in spontaneous immune tolerance, however the precise mechanism of spontaneous immune tolerance is still undefined. By using Microarray Chips, we investigated different immune regulatory factors to decipher critical mechanisms of spontaneous tolerance after mouse liver transplantation. Allogeneic (C57BL/6-C3H) and syngeneic (C3H-C3H) liver transplantation were performed by 6-8 weeks old male C57BL/6 and C3H mice. Graft samples (N = 4 each group) were collected from 8 weeks post-operation mice. 11 differentially expressed miRNAs in allogeneic grafts (Allografts) vs. syngeneic grafts (Syngrafts) were identified using Agilent Mouse miRNA Chips. It was revealed that 185 genes were modified by the 11 miRNAs, furthermore, within the 185 target genes, 11 of them were tightly correlated with immune regulation after Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis and Genbank data cross-comparison. Verified by real-time PCR and western blot, our results indicated that mRNA expression levels of IL-6 and TAB2 were respectively down regulated following miR-142-3p and miR-155 augment. In addition, increased miR-152 just silenced mRNA of CaMK II and down-regulated translation of CaMK II in tolerated liver grafts, which may play a critical role in immune regulation and spontaneous tolerance induction of mouse liver transplantation.	[Wang, Yan; Tian, Yang; Wang, Jingcheng; Zhou, Lin; Xie, Haiyang; Chen, Hui; Li, Hui; Zhang, Jinhua; Zhao, Jiacong] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Key Lab Combined Multiorgan Transplantat,Minist P, Hangzhou 310003, Zhejiang, Peoples R China; [Ding, Yuan; Yan, Sheng; Zheng, Shusen] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Div Hepatobiliary & Pancreat Surg, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Zheng, SS (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Div Hepatobiliary & Pancreat Surg, Hangzhou 310003, Zhejiang, Peoples R China.	shusenzheng@zju.edu.cn			National High Technology Research and Development Program of China (863 program) [2012AA020501-2]; National Natural Science Foundation of China [81372626]; Natural Science Foundation of Zhejiang Province, China [LQ13H030001]	National High Technology Research and Development Program of China (863 program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province, China(Natural Science Foundation of Zhejiang Province)	This work was supported by: 1. National High Technology Research and Development Program of China (863 program. No. 2012AA020501-2); 2. National Natural Science Foundation of China ( Grant No. 81372626); 3. Natural Science Foundation of Zhejiang Province, China (LQ13H030001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimova T, 2012, AM J TRANSPLANT, V12, P3449, DOI 10.1111/j.1600-6143.2012.04269.x; Pons JA, 2011, GASTROENT HEPAT-BARC, V34, P155, DOI 10.1016/j.gastrohep.2010.11.007; Calmus Y, 2009, PRESSE MED, V38, P1307, DOI 10.1016/j.lpm.2009.06.004; Chan CK, 2012, TRANSPLANTATION, V94, P132, DOI 10.1097/TP.0b013e31825940a4; Charles R, 2013, TRANSPLANTATION, V96, P17, DOI 10.1097/TP.0b013e318294caae; Danger R, 2012, J AM SOC NEPHROL, V23, P597, DOI 10.1681/ASN.2011060543; Demetris AJ, 2013, CURR OPIN ORGAN TRAN, V18, P345, DOI 10.1097/MOT.0b013e3283615d48; Diehl L, 2008, HEPATOLOGY, V47, P296, DOI 10.1002/hep.21965; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Fei BJ, 2012, ONCOL RES, V20, P557, DOI 10.3727/096504013X13775486749254; Harris A, 2010, AM J TRANSPLANT, V10, P713, DOI 10.1111/j.1600-6143.2010.03032.x; Ho PC, 2011, FASEB J, V25, P1758, DOI 10.1096/fj.10-179267; Kurowska-Stolarska M, 2011, P NATL ACAD SCI USA, V108, P11193, DOI 10.1073/pnas.1019536108; Le Luduec JB, 2008, AM J TRANSPLANT, V8, P2297, DOI 10.1111/j.1600-6143.2008.02398.x; Li W, 2008, AM J TRANSPLANT, V8, P1639, DOI 10.1111/j.1600-6143.2008.02300.x; Li W, 2005, AM J TRANSPLANT, V5, P978, DOI 10.1111/j.1600-6143.2005.00823.x; Liu Li-Feng, 2012, Shengli Xuebao, V64, P101; Liu XG, 2010, J IMMUNOL, V185, P7244, DOI 10.4049/jimmunol.1001573; Malmhall C, 2013, J ALLERGY CLIN IMMUN; Mas VR, 2013, AM J TRANSPLANT, V13, P11, DOI 10.1111/j.1600-6143.2012.04313.x; Miroux C, 2012, TRANSPLANTATION, V94, P123, DOI 10.1097/TP.0b013e3182590d8f; Morita M, 2010, AM J TRANSPLANT, V10, P40, DOI 10.1111/j.1600-6143.2009.02859.x; Muangchan C, 2013, CLIN EXP RHEUMATOL, V31, pS122; Myrvang Helene, 2012, Nat Rev Nephrol, V8, P194, DOI 10.1038/nrneph.2012.32; Neyrinck A, 2013, CURR OPIN ANESTHESIO, V26, P382, DOI 10.1097/ACO.0b013e328360dc87; Norris S, 2001, TRANSPLANTATION, V71, P711, DOI 10.1097/00007890-200103270-00003; Onoe T, 2005, J IMMUNOL, V175, P139, DOI 10.4049/jimmunol.175.1.139; Ori D, 2013, J IMMUNOL, V190, P4037, DOI 10.4049/jimmunol.1300173; Otto G, 2013, DIGEST DIS, V31, P164, DOI 10.1159/000347213; Pons JA, 2008, TRANSPLANTATION, V86, P1370, DOI 10.1097/TP.0b013e318188d3e6; QIAN S, 1991, TRANSPLANT P, V23, P705; Rajalingham Sakthiswary, 2012, Inflammation & Allergy Drug Targets, V11, P262; Shalev I, 2012, LIVER TRANSPLANT, V18, P761, DOI 10.1002/lt.23458; Song GS, 2010, HEPATOLOGY, V51, P1735, DOI 10.1002/hep.23547; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Steger U, 2006, TRANSPLANTATION, V82, P1202, DOI 10.1097/01.tp.0000235913.58337.b4; Sun YP, 2011, BLOOD, V117, P6172, DOI 10.1182/blood-2010-12-325647; Terlou A, 2012, J INVEST DERMATOL, V132, P658, DOI 10.1038/jid.2011.369; THAI NL, 1995, TRANSPL P, V27, P509; Veit TD, 2009, TRANSPL IMMUNOL, V20, P229, DOI 10.1016/j.trim.2008.11.001; Wang P, 2012, J IMMUNOL, V189, P211, DOI 10.4049/jimmunol.1200609; Xu CL, 2013, J BIOL CHEM, V288, P11074, DOI 10.1074/jbc.M112.414862; Yan ZY, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks395; Ye Y, 2013, AM J TRANSPLANT, V13, P569, DOI 10.1111/ajt.12088; Zhao GJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074782; Zheng XG, 2013, CANCER LETT, V329, P146, DOI 10.1016/j.canlet.2012.10.026; Zhu C, 2013, PROSTATE, V73, P1082, DOI 10.1002/pros.22656	47	7	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105096	10.1371/journal.pone.0105096	http://dx.doi.org/10.1371/journal.pone.0105096			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133393	Green Published, gold, Green Submitted			2022-12-25	WOS:000341302700069
J	Yang, W; Yao, Y; Yang, YQ; Lu, FT; Li, L; Wang, YH; Nakajima, T; Tsuneyama, K; Ridgway, WM; Gershwin, ME; Lian, ZX				Yang, Wei; Yao, Yuan; Yang, Yan-Qing; Lu, Fang-Ting; Li, Liang; Wang, Yin-Hu; Nakajima, Takahiko; Tsuneyama, Koichi; Ridgway, William M.; Gershwin, M. Eric; Lian, Zhe-Xiong			Differential Modulation by IL-17A of Cholangitis versus Colitis in IL-2R alpha Deleted Mice	PLOS ONE			English	Article							PRIMARY BILIARY-CIRRHOSIS; T-CELLS; IFN-GAMMA; DISEASE; LIVER; INFLAMMATION; IL-23; IMMUNOBIOLOGY; PATHOGENESIS; NEUTROPHILS	IFN-gamma is a signature Th1 cell associated cytokine critical for the inflammatory response in autoimmunity with both proinflammatory and potentially protective functions. IL-17A is the hallmark of T helper 17 (Th17) cell subsets, produced by gamma delta T, CD8+ T, NK and NKT cells. We have taken advantage of our colony of IL-2R alpha(-/-) mice that spontaneously develop both autoimmune cholangitis and inflammatory bowel disease. In this model CD8+ T cells mediate biliary ductular damage, whereas CD4+ T cells mediate induction of colon-specific autoimmunity. Importantly, IL-2R alpha(-/-) mice have high levels of interferon gamma (IFN-gamma), and interleukin-17A (IL-17A). We produced unique double deletions of mice that were either IL-17A(-/-) IL-2R alpha(-/-) or IFN-gamma(-/-) IL-2R alpha(-/-) to specifically address the precise role of these two cytokines in the natural history of autoimmune cholangitis and colitis. Of note, deletion of IL-17A in IL-2R alpha(-/-) mice led to more severe liver inflammation, but ameliorated colitis. In contrast, there were no significant changes in the immunopathology of double knock-out IFN-gamma(-/-) IL-2R alpha(-/-) mice, compared to single knock-out IL-2R alpha(-/-) mice with respect to cholangitis or colitis. Furthermore, there was a significant increase in pathogenetic CD8+ T cells in the liver of IL-17A(-/-) IL-2R alpha(-/-) mice. Our data suggest that while IL-17A plays a protective role in autoimmune cholangitis, it has a pro-inflammatory role in inflammatory bowel disease. These data take on particular significance in the potential use of anti-IL-17A therapy in humans with primary biliary cirrhosis.	[Yang, Wei; Yao, Yuan; Yang, Yan-Qing; Lu, Fang-Ting; Li, Liang; Wang, Yin-Hu; Lian, Zhe-Xiong] Univ Sci & Technol China, Sch Life Sci & Med Ctr, Inst Immunol, Liver Immunol Lab, Hefei 230026, Peoples R China; [Yang, Wei; Yao, Yuan; Yang, Yan-Qing; Lu, Fang-Ting; Li, Liang; Wang, Yin-Hu; Lian, Zhe-Xiong] Univ Sci & Technol China, Sch Life Sci & Med Ctr, CAS Key Lab Innate Immun & Chron Dis, Liver Immunol Lab, Hefei 230026, Peoples R China; [Nakajima, Takahiko; Tsuneyama, Koichi] Toyama Univ, Grad Sch Med & Pharmaceut Sci Res, Dept Diagnost Pathol, Toyama 930, Japan; [Ridgway, William M.] Univ Cincinnati, Div Immunol Allergy & Rheumatol, Cincinnati, OH USA; [Gershwin, M. Eric] Univ Calif Davis, Sch Med, Div Rheumatol Allergy & Clin Immunol, Davis, CA 95616 USA; [Lian, Zhe-Xiong] Innovat Ctr Cell Biol, Hefei Natl Lab Phys Sci Microscale, Hefei, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; University of Toyama; University System of Ohio; University of Cincinnati; University of California System; University of California Davis	Gershwin, ME (corresponding author), Univ Calif Davis, Sch Med, Div Rheumatol Allergy & Clin Immunol, Davis, CA 95616 USA.	megershwin@ucdavis.edu; zxlian1@ustc.edu.cn	Yang, w/AAN-3388-2020; Li, Liang/L-7803-2018	Li, Liang/0000-0003-0745-2571; Tsuneyama, Koichi/0000-0002-0670-9868	National Basic Research Program of China (973 Program) [2010CB945300, 2013CB944900]; National Natural Science Foundation of China [30972738, 31021061, 81130058]; Hundred Talents Program of the Chinese Academy of Sciences	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hundred Talents Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	Financial support provided by the National Basic Research Program of China (973 Program-2010CB945300, 2013CB944900), the National Natural Science Foundation of China (30972738, 31021061, 81130058), and the Hundred Talents Program of the Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando Y, 2012, HEPATOLOGY, V56, P1418, DOI 10.1002/hep.25803; Cupedo T, 2009, NAT IMMUNOL, V10, P66, DOI 10.1038/ni.1668; Elson CO, 2007, GASTROENTEROLOGY, V132, P2359, DOI 10.1053/j.gastro.2007.03.104; Gaffen Sarah L, 2009, Curr Rheumatol Rep, V11, P365; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Ge J, 2010, J CLIN IMMUNOL, V30, P60, DOI 10.1007/s10875-009-9328-2; Harada K, 2009, CLIN EXP IMMUNOL, V157, P261, DOI 10.1111/j.1365-2249.2009.03947.x; He DG, 2006, J IMMUNOL, V177, P6852, DOI 10.4049/jimmunol.177.10.6852; Hirschfield GM, 2013, ANNU REV PATHOL-MECH, V8, P303, DOI 10.1146/annurev-pathol-020712-164014; Hsu W, 2009, HEPATOLOGY, V49, P133, DOI 10.1002/hep.22591; Kamanaka M, 2011, J EXP MED, V208, P1027, DOI 10.1084/jem.20102149; Lafdil F, 2010, CELL MOL IMMUNOL, V7, P250, DOI 10.1038/cmi.2010.5; Lafdil F, 2009, GASTROENTEROLOGY, V137, P2125, DOI 10.1053/j.gastro.2009.08.004; Lan RYZ, 2009, J AUTOIMMUN, V32, P43, DOI 10.1016/j.jaut.2008.11.001; Langrish CL, 2004, IMMUNOL REV, V202, P96, DOI 10.1111/j.0105-2896.2004.00214.x; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lee KA, 2008, CELL IMMUNOL, V251, P50, DOI 10.1016/j.cellimm.2008.03.004; Lemmers A, 2009, HEPATOLOGY, V49, P646, DOI 10.1002/hep.22680; Lian ZX, 2003, J IMMUNOL, V170, P2323, DOI 10.4049/jimmunol.170.5.2323; O'Connor W, 2010, NAT IMMUNOL, V11, P471, DOI 10.1038/ni.1882; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; Ogawa A, 2004, CLIN IMMUNOL, V110, P55, DOI 10.1016/j.clim.2003.09.013; Shin HCK, 1998, CYTOKINE, V10, P841, DOI 10.1006/cyto.1998.0375; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; van den Berg WB, 2009, NAT REV RHEUMATOL, V5, P549, DOI 10.1038/nrrheum.2009.179; Wakabayashi K, 2006, HEPATOLOGY, V44, P1240, DOI 10.1002/hep.21385; WILLERFORD DM, 1995, IMMUNITY, V3, P521, DOI 10.1016/1074-7613(95)90180-9; Yi TS, 2008, BLOOD, V112, P2101, DOI 10.1182/blood-2007-12-126987; Zhang JY, 2010, HEPATOLOGY, V51, P81, DOI 10.1002/hep.23273; Zhang JW, 2007, J CLIN INVEST, V117, P871, DOI 10.1172/JCI31860; Zhang Z, 2006, INFLAMM BOWEL DIS, V12, P382, DOI 10.1097/01.MIB.0000218764.06959.91; Zhou RB, 2007, J IMMUNOL, V178, P4548, DOI 10.4049/jimmunol.178.7.4548	32	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105351	10.1371/journal.pone.0105351	http://dx.doi.org/10.1371/journal.pone.0105351			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133396	gold, Green Published, Green Submitted			2022-12-25	WOS:000341302700101
J	Cardoso, C; Charnikhova, T; Jamil, M; Delaux, PM; Verstappen, F; Amini, M; Lauressergues, D; Ruyter-Spira, C; Bouwmeester, H				Cardoso, Catarina; Charnikhova, Tatsiana; Jamil, Muhammad; Delaux, Pierre-Marc; Verstappen, Francel; Amini, Maryam; Lauressergues, Dominique; Ruyter-Spira, Carolien; Bouwmeester, Harro			Differential Activity of Striga hermonthica Seed Germination Stimulants and Gigaspora rosea Hyphal Branching Factors in Rice and Their Contribution to Underground Communication	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; STRIGOLACTONE PRODUCTION; STRUCTURAL REQUIREMENTS; PHOSPHORUS DEFICIENCY; PHOSPHATE DEFICIENCY; GESNERIOIDES SEEDS; PARASITIC PLANTS; ROOT PARASITES; RED-CLOVER; INHIBITION	Strigolactones (SLs) trigger germination of parasitic plant seeds and hyphal branching of symbiotic arbuscular mycorrhizal (AM) fungi. There is extensive structural variation in SLs and plants usually produce blends of different SLs. The structural variation among natural SLs has been shown to impact their biological activity as hyphal branching and parasitic plant seed germination stimulants. In this study, rice root exudates were fractioned by HPLC. The resulting fractions were analyzed by MRM-LC-MS to investigate the presence of SLs and tested using bioassays to assess their Striga hermonthica seed germination and Gigaspora rosea hyphal branching stimulatory activities. A substantial number of active fractions were revealed often with very different effect on seed germination and hyphal branching. Fractions containing (-)-orobanchol and ent-2'-epi-5-deoxystrigol contributed little to the induction of S. hermonthica seed germination but strongly stimulated AM fungal hyphal branching. Three SLs in one fraction, putative methoxy-5-deoxystrigol isomers, had moderate seed germination and hyphal branching inducing activity. Two fractions contained strong germination stimulants but displayed only modest hyphal branching activity. We provide evidence that these stimulants are likely SLs although no SL-representative masses could be detected using MRM-LC-MS. Our results show that seed germination and hyphal branching are induced to very different extents by the various SLs (or other stimulants) present in rice root exudates. We propose that the development of rice varieties with different SL composition is a promising strategy to reduce parasitic plant infestation while maintaining symbiosis with AM fungi.	[Cardoso, Catarina; Charnikhova, Tatsiana; Jamil, Muhammad; Verstappen, Francel; Amini, Maryam; Ruyter-Spira, Carolien; Bouwmeester, Harro] Wageningen Univ, Lab Plant Physiol, NL-6700 AP Wageningen, Netherlands; [Delaux, Pierre-Marc; Lauressergues, Dominique] Univ Toulouse, Unite Mixte Rech UMR 5546, Lab Rech Sci Vegetales, Castanet Tolosan, France; [Delaux, Pierre-Marc; Lauressergues, Dominique] CNRS, Unite Mixte Rech UMR 5546, Lab Rech Sci Vegetales, Castanet Tolosan, France; [Verstappen, Francel; Bouwmeester, Harro] Ctr Biosyst Genom, Wageningen, Netherlands; [Ruyter-Spira, Carolien] Plant Res Int, Wageningen, Netherlands	Wageningen University & Research; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Centre for BioSystems Genomics	Bouwmeester, H (corresponding author), Wageningen Univ, Lab Plant Physiol, NL-6700 AP Wageningen, Netherlands.	harro.bouwmeester@wur.nl	Jamil, Muhammad/M-8923-2015; Cardoso, Catarina/M-7570-2017; Bouwmeester, Harro J/C-1414-2008	Jamil, Muhammad/0000-0003-0221-518X; Cardoso, Catarina/0000-0003-3323-4447; Delaux, Pierre-Marc/0000-0002-6211-157X; Bouwmeester, Harro/0000-0003-0907-2732	The Netherlands Organization for Scientific Research [865.06.002, 834.08.001]; Centre for Biosystems Genomics, a part of the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research	The Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Centre for Biosystems Genomics, a part of the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research	This work was financed by The Netherlands Organization for Scientific Research with VICI grant nr 865.06.002 and Equipment grant nr 834.08.001, attributed to HB, and co-financed by the Centre for Biosystems Genomics, a part of the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research, attributed to HB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama K, 2005, NATURE, V435, P824, DOI 10.1038/nature03608; Akiyama K, 2010, PLANT CELL PHYSIOL, V51, P1104, DOI 10.1093/pcp/pcq058; Alder A, 2012, SCIENCE, V335, P1348, DOI 10.1126/science.1218094; Awad AA, 2006, PLANT GROWTH REGUL, V48, P221, DOI 10.1007/s10725-006-0009-3; Besserer A, 2006, PLOS BIOL, V4, P1239, DOI 10.1371/journal.pbio.0040226; Boyer FD, 2012, PLANT PHYSIOL, V159, P1524, DOI 10.1104/pp.112.195826; Buee M, 2000, MOL PLANT MICROBE IN, V13, P693, DOI 10.1094/MPMI.2000.13.6.693; Cardoso C, 2011, PLANT SCI, V180, P414, DOI 10.1016/j.plantsci.2010.11.007; Gomez-Roldan V, 2008, NATURE, V455, P189, DOI 10.1038/nature07271; Gurney AL, 1999, NEW PHYTOL, V143, P573, DOI 10.1046/j.1469-8137.1999.00467.x; Jamil M, 2011, WEED RES, V51, P373, DOI 10.1111/j.1365-3180.2011.00847.x; Jamil M, 2012, PLANTA, V235, P473, DOI 10.1007/s00425-011-1520-y; Jamil M, 2011, NEW PHYTOL, V192, P964, DOI 10.1111/j.1469-8137.2011.03850.x; Kapulnik Y, 2011, PLANTA, V233, P209, DOI 10.1007/s00425-010-1310-y; Kohlen W, 2012, NEW PHYTOL, V196, P535, DOI 10.1111/j.1469-8137.2012.04265.x; Kohlen W, 2011, PLANT PHYSIOL, V155, P974, DOI 10.1104/pp.110.164640; Koltai H, 2011, NEW PHYTOL, V190, P545, DOI 10.1111/j.1469-8137.2011.03678.x; Lopez-Raez JA, 2008, NEW PHYTOL, V178, P863, DOI 10.1111/j.1469-8137.2008.02406.x; Matusova R, 2005, PLANT PHYSIOL, V139, P920, DOI 10.1104/pp.105.061382; Matusova R, 2006, WAG UR FRON, V16, P39; Motonami N, 2013, PHYTOCHEMISTRY, V93, P41, DOI 10.1016/j.phytochem.2013.02.017; Nadal M, 2013, CURR OPIN PLANT BIOL, V16, P473, DOI 10.1016/j.pbi.2013.06.005; Nomura S, 2013, PLANT CELL REP, V32, P829, DOI 10.1007/s00299-013-1429-y; Parker C, 2009, PEST MANAG SCI, V65, P453, DOI 10.1002/ps.1713; Ruyter-Spira C, 2011, PLANT PHYSIOL, V155, P721, DOI 10.1104/pp.110.166645; Sato D, 2003, J AGR FOOD CHEM, V51, P1162, DOI 10.1021/jf025997z; Scholes JD, 2008, CURR OPIN PLANT BIOL, V11, P180, DOI 10.1016/j.pbi.2008.02.004; Seto Y, 2014, P NATL ACAD SCI USA, V111, P1640, DOI 10.1073/pnas.1314805111; Ueno K, 2011, J AGR FOOD CHEM, V59, P10485, DOI 10.1021/jf2024193; Umehara M, 2008, NATURE, V455, P195, DOI 10.1038/nature07272; Umehara M, 2010, PLANT CELL PHYSIOL, V51, P1118, DOI 10.1093/pcp/pcq084; Xie X, 2007, J AGR FOOD CHEM, V55, P8067, DOI 10.1021/jf0715121; Xie XN, 2013, MOL PLANT, V6, P153, DOI 10.1093/mp/sss139; Yoneyama K, 2007, PLANTA, V227, P125, DOI 10.1007/s00425-007-0600-5; Yoneyama K, 2007, PLANTA, V225, P1031, DOI 10.1007/s00425-006-0410-1; Yoneyama K, 2009, PEST MANAG SCI, V65, P467, DOI 10.1002/ps.1726; Zwanenburg B, 2013, MOL PLANT, V6, P38, DOI 10.1093/mp/sss141; Zwanenburg B, 2009, PEST MANAG SCI, V65, P478, DOI 10.1002/ps.1706	38	11	12	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104201	10.1371/journal.pone.0104201	http://dx.doi.org/10.1371/journal.pone.0104201			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126953	Green Published, gold, Green Submitted			2022-12-25	WOS:000340879300017
J	Ju, ZL; Chavan, SS; Antoine, DJ; Dancho, M; Tsaava, T; Li, JH; Lu, B; Levine, YA; Stiegler, A; Tamari, Y; Al-Abed, Y; Roth, J; Tracey, KJ; Yang, H				Ju, Zhongliang; Chavan, Sangeeta S.; Antoine, Daniel J.; Dancho, Meghan; Tsaava, Tea; Li, Jianhua; Lu, Ben; Levine, Yaakov A.; Stiegler, Andrew; Tamari, Yehuda; Al-Abed, Yousef; Roth, Jesse; Tracey, Kevin J.; Yang, Huan			Sequestering HMGB1 via DNA-Conjugated Beads Ameliorates Murine Colitis	PLOS ONE			English	Article							MOBILITY GROUP BOX-1; INFLAMMATORY-BOWEL-DISEASE; ULCERATIVE-COLITIS; CYTOKINE ACTIVITY; PROTEIN HMGB1; APOPTOSIS; ACTIVATION; AFFINITY; CYSTEINE; ANTIBODY	Inflammatory bowel disease (IBD) is chronic inflammation of the gastrointestinal tract that affects millions of people worldwide. Although the etiology of IBD is not clear, it is known that products from stressed cells and enteric microbes promote intestinal inflammation. High mobility group box 1 (HMGB1), originally identified as a nuclear DNA binding protein, is a cytokine-like protein mediator implicated in infection, sterile injury, autoimmune disease, and IBD. Elevated levels of HMGB1 have been detected in inflamed human intestinal tissues and in feces of IBD patients and mouse models of colitis. Neutralizing HMGB1 activity by administration of anti-HMGB1 antibodies or HMGB1-specific antagonist improves clinical outcomes in animal models of colitis. Since HMGB1 binds to DNA with high affinity, here we developed a novel strategy to sequester HMGB1 using DNA immobilized on sepharose beads. Screening of DNA-bead constructs revealed that B2 beads, one linear form of DNA conjugated beads, bind HMGB1 with high affinity, capture HMGB1 ex vivo from endotoxin-stimulated RAW 264.7 cell supernatant and from feces of mice with colitis. Oral administration of B2 DNA beads significantly improved body weight, reduced colon injury, and suppressed colonic and circulating cytokine levels in mice with spontaneous colitis (IL-10 knockout) and with dextran sulfate sodium-induced colitis. Thus, DNA beads reduce inflammation by sequestering HMGB1 and may have therapeutic potential for the treatment of IBD.	[Ju, Zhongliang; Chavan, Sangeeta S.; Dancho, Meghan; Tsaava, Tea; Li, Jianhua; Lu, Ben; Roth, Jesse; Tracey, Kevin J.; Yang, Huan] Feinstein Inst Med Res, Lab Biomed Sci, Manhasset, NY 11030 USA; [Antoine, Daniel J.] Univ Liverpool, Dept Mol & Clin Pharmacol, Inst Translat Med, MRC Ctr Drug Safety Sci, Liverpool L69 3BX, Merseyside, England; [Levine, Yaakov A.] SetPoint Med Corp, Valencia, Spain; [Stiegler, Andrew; Tamari, Yehuda] Circulatory Technol Inc, Oyster Bay, NY USA; [Al-Abed, Yousef] Feinstein Inst Med Res, Manhasset, NY USA	Northwell Health; University of Liverpool; Northwell Health	Yang, H (corresponding author), Feinstein Inst Med Res, Lab Biomed Sci, Manhasset, NY 11030 USA.	hyang@nshs.edu	Lu, Ben/AAN-1068-2021; Levine, Yaakov/AAA-2578-2020	Lu, Ben/0000-0002-8597-0406; Levine, Yaakov/0000-0002-3313-6858; Tracey, Kevin J/0000-0003-1884-6314	National Institutes of Health [GM098446, GM062508]; Wellcome Trust, UK; SetPoint Medical Corporation; Circulatory Technology Inc; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098446, R01GM062508] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust, UK(Wellcome Trust); SetPoint Medical Corporation; Circulatory Technology Inc; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study is supported, in part, by grants from the National Institutes of Health (GM098446 to HY and GM062508 to KJT) and from Wellcome Trust, UK (to DJA). Yaakov A. Levine received salary from SetPoint Medical Corporation, and Andrew Stiegler and Yehuda Tamari received salary from Circulatory Technology Inc to fund part of this study. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323; Andrassy M, 2008, CIRCULATION, V117, P3216, DOI 10.1161/CIRCULATIONAHA.108.769331; Antoine DJ, 2014, MOL MED, V20, P135, DOI 10.2119/molmed.2014.00022; Antoine DJ, 2012, J HEPATOL, V56, P1070, DOI 10.1016/j.jhep.2011.12.019; Antoine DJ, 2010, MOL MED, V16, P479, DOI 10.2119/molmed.2010.00126; BIANCHI ME, 1988, EMBO J, V7, P843, DOI 10.1002/j.1460-2075.1988.tb02883.x; Bianchi ME, 1998, AM J HUM GENET, V63, P1573, DOI 10.1086/302170; Bonaldi T, 2003, EMBO J, V22, P5551, DOI 10.1093/emboj/cdg516; Chockalingam PS, 2001, MOL BIOTECHNOL, V19, P189, DOI 10.1385/MB:19:2:189; Dave SH, 2009, J LEUKOCYTE BIOL, V86, P633, DOI 10.1189/jlb.1008662; GARLAND CF, 1981, GASTROENTEROLOGY, V81, P1115; Graff LA, 2011, INFLAMM BOWEL DIS, V17, P1882, DOI 10.1002/ibd.21580; Graff LA, 2009, AM J GASTROENTEROL, V104, P2959, DOI 10.1038/ajg.2009.529; Hill DA, 1997, NUCLEIC ACIDS RES, V25, P3523, DOI 10.1093/nar/25.17.3523; Hubbard WJ, 2005, SHOCK, V24, P52, DOI 10.1097/01.shk.0000191414.94461.7e; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Li JH, 2004, J IMMUNOL METHODS, V289, P211, DOI 10.1016/j.jim.2004.04.019; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lix LM, 2008, INFLAMM BOWEL DIS, V14, P1575, DOI 10.1002/ibd.20511; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Lu B, 2014, P NATL ACAD SCI USA, V111, P3068, DOI 10.1073/pnas.1316925111; Lu B, 2012, NATURE, V488, P670, DOI 10.1038/nature11290; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Macanovic M, 1997, CLIN EXP IMMUNOL, V108, P220, DOI 10.1046/j.1365-2249.1997.3571249.x; Madsen SM, 2001, AM J GASTROENTEROL, V96, P1807, DOI 10.1016/S0002-9270(01)02438-8; Maeda S, 2007, BIOCHEM BIOPH RES CO, V360, P394, DOI 10.1016/j.bbrc.2007.06.065; Magro F, 2010, BIODRUGS, V24, P1, DOI 10.2165/11586300-000000000-00000; Matta R, 2012, AM J PHYSIOL-GASTR L, V302, pG1322, DOI 10.1152/ajpgi.00018.2012; Musumeci D, 2011, MOL BIOSYST, V7, P1742, DOI 10.1039/c1mb05009e; Nikolaus S, 2003, GUT, V52, P1286, DOI 10.1136/gut.52.9.1286; Ombrellino M, 1999, LANCET, V354, P1446, DOI 10.1016/S0140-6736(99)02658-6; Palone F, 2014, INFLAMM BOWEL DIS, V20, P1448, DOI 10.1097/MIB.0000000000000113; Qin SX, 2006, J EXP MED, V203, P1637, DOI 10.1084/jem.20052203; Sappington PL, 2002, GASTROENTEROLOGY, V123, P790, DOI 10.1053/gast.2002.35391; Sartor RB, 2010, GASTROENTEROLOGY, V139, P1816, DOI 10.1053/j.gastro.2010.10.036; Siiman O, 2001, J COLLOID INTERF SCI, V234, P44, DOI 10.1006/jcis.2000.7279; Stros M, 2010, BBA-GENE REGUL MECH, V1799, P101, DOI 10.1016/j.bbagrm.2009.09.008; Sunden-Cullberg J, 2005, CRIT CARE MED, V33, P564, DOI [10.1097/01.CCM.0000155991.88802.4D, 10.1097/01.ccm.0000155991.88802.4D]; Vitali R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066527; Vitali R, 2011, AM J GASTROENTEROL, V106, P2029, DOI 10.1038/ajg.2011.231; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Webb M, 2001, J MOL BIOL, V309, P79, DOI 10.1006/jmbi.2001.4667; Wirtz S, 2005, J CLIN INVEST, V115, P586, DOI 10.1172/JCI200524518; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yanai H, 2011, P NATL ACAD SCI USA, V108, P11542, DOI 10.1073/pnas.1108535108; Yang H, 2013, J LEUKOCYTE BIOL, V93, P865, DOI 10.1189/jlb.1212662; Yang H, 2012, MOL MED, V18, P250, DOI 10.2119/molmed.2011.00389; Yang HA, 2010, P NATL ACAD SCI USA, V107, P11942, DOI 10.1073/pnas.1003893107; Yang H, 2010, BBA-GENE REGUL MECH, V1799, P149, DOI 10.1016/j.bbagrm.2009.11.019; Yang RK, 2006, MOL MED, V12, P105, DOI 10.2119/2006-00010.Yang	51	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e103992	10.1371/journal.pone.0103992	http://dx.doi.org/10.1371/journal.pone.0103992			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127031	Green Published, Green Submitted, gold			2022-12-25	WOS:000340879300010
J	Wang, T; Yang, JJ; Han, RH; Ji, XM; Wu, BQ; Han, L; Luo, C; Fan, JJ; Zhu, BL; Ni, CH				Wang, Ting; Yang, Jingjin; Han, Ruhui; Ji, Xiaoming; Wu, Baiqun; Han, Lei; Luo, Chen; Fan, Jingjing; Zhu, Baoli; Ni, Chunhui			Polymorphisms in SPARC and Coal Workers' Pneumoconiosis Risk in a Chinese Population	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; FIBROBLASTS; UPDATE; INJURY; MICE	Background: The SPARC is a crucial matricellular protein and may influence the course of various diseases like tumor metastasis and fibrosis. In the present study, we investigated the association between the potential functional polymorphisms in SPA Methods: Five potentially functional polymorphisms (rs1059279, rs1059829, rs1053411, rs2304052 and rs4958281) in SPARC were genotyped and analyzed in a case-control study including 697 CWP cases and 694 controls. The genotyping was used by the TaqMan method with the ABI 7900HT Real Time PCR system. Results: Our results revealed that three SNPs (rs1059279, rs1059829, rs1053411) were significantly associated with increased risk of CWP under an additive model (OR = 1.35, 95%CI = 1.06-1.71, P = 0.015 for rs1059279; OR = 1.20, 95%CI = 1.03-1.39, P = 0.021 for rs1059829; OR = 1.31, 95%CI = 1.03-1.65, P = 0.025 for rs1053411). In the stratification analysis, significant associations were observed between each of these three SNPs and patients with 0-20 pack-years of smoking (OR = 1.73, 95%CI = 1.21-2.45 for rs1059279; OR = 1.48, 95%CI = 1.07-2.05 for rs105982; OR = 1.58, 95%CI = 1.13-2.22 for rs1053411). Furthermore, the association between rs1059279 and CWP risk remained significant among subjects with over 27 years of exposure (OR = 1.27, 95%CI = 1.03-1.56, P = 0.023). In the combined analysis of these five polymorphisms, individuals with multiple risk alleles had a higher risk of CWP (Ptrend = 0.015). Conclusion: Our results indicate that three functional SPARC SNPs are associated with an increased risk of CWP in a Chinese population. Further functional research and validation studies with diverse populations are warranted to confirm our findings.	[Wang, Ting; Yang, Jingjin; Han, Ruhui; Ji, Xiaoming; Wu, Baiqun; Han, Lei; Luo, Chen; Fan, Jingjing; Ni, Chunhui] Nanjing Med Univ, Sch Publ Hlth, Dept Occupat Med & Environm Hlth, Nanjing, Jiangsu, Peoples R China; [Zhu, Baoli] Jiangsu Prov Ctr Dis Prevent & Control, Inst Occupat Dis Prevent, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Ni, CH (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Dept Occupat Med & Environm Hlth, Nanjing, Jiangsu, Peoples R China.	chni@njmu.edu.cn	wang, tingting/AAK-2640-2020		National Natural Science Foundation of China [81273044]; Academic Program Development of Jiangsu Higher Education Institutions[PAPD]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Academic Program Development of Jiangsu Higher Education Institutions[PAPD]	This study was partly supported by the National Natural Science Foundation of China (81273044) and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions[PAPD]. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpers CE, 2002, KIDNEY INT, V62, P2073, DOI 10.1046/j.1523-1755.2002.00680.x; Bradshaw AD, 2001, J CLIN INVEST, V107, P1049, DOI 10.1172/JCI12939; Bradshaw AD, 2010, AM J PHYSIOL-HEART C, V298, pH614, DOI 10.1152/ajpheart.00474.2009; Chang W, 2010, J BIOL CHEM, V285, P8196, DOI 10.1074/jbc.M109.025684; Chen WH, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001206; Homma S, 2012, RESPIROLOGY, V17, P467, DOI 10.1111/j.1440-1843.2012.02132.x; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; KUHN C, 1995, AM J PATHOL, V147, P1759; Liu YJ, 2006, J BONE MINER RES, V21, P1511, DOI 10.1359/JBMR.051002; Nawrot TS, 2008, AM J RESP CRIT CARE, V177, P696, DOI 10.1164/rccm.200801-116UP; Sangaletti S, 2008, CANCER RES, V68, P9050, DOI 10.1158/0008-5472.CAN-08-1327; Sangaletti S, 2011, AM J PATHOL, V179, P3000, DOI 10.1016/j.ajpath.2011.08.027; Savani RC, 2000, AM J PHYSIOL-LUNG C, V279, pL743, DOI 10.1152/ajplung.2000.279.4.L743; Shi Q, 2007, ONCOGENE, V26, P4084, DOI 10.1038/sj.onc.1210181; Shibata S, 2013, FIBROGENESIS TISSUE, V6, DOI 10.1186/1755-1536-6-6; Strandjord TP, 1999, AM J PHYSIOL-LUNG C, V277, pL628, DOI 10.1152/ajplung.1999.277.3.L628; Trombetta-Esilva Jessica, 2012, Open Rheumatol J, V6, P146, DOI 10.2174/1874312901206010146; Wang JC, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2973; Wang ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022624; Wang ML, 2010, J HUM GENET, V55, P13, DOI 10.1038/jhg.2009.112; Zhang HP, 2000, GENET EPIDEMIOL, V19, P323, DOI 10.1002/1098-2272(200012)19:4<323::AID-GEPI4>3.0.CO;2-5; Zhou XD, 2005, ARTHRITIS RHEUM-US, V52, P257, DOI 10.1002/art.20785	22	5	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105226	10.1371/journal.pone.0105226	http://dx.doi.org/10.1371/journal.pone.0105226			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126876	Green Published, gold, Green Submitted			2022-12-25	WOS:000340879300096
J	Andersson, T; Ahlbom, A; Magnusson, C; Carlsson, S				Andersson, Tomas; Ahlbom, Anders; Magnusson, Cecilia; Carlsson, Sofia			Prevalence and Incidence of Diabetes in Stockholm County 1990-2010	PLOS ONE			English	Article							NORTHERN SWEDEN MONICA; FAVORABLE TRENDS; FOLLOW-UP; POPULATION; MORTALITY; METAANALYSIS; REGRESSION; REGISTER; RISK	Background: Diabetes is on the rise in the western world, but data from Scandinavia are inconsistent with indications of stable or even reverse trends. To shed new light on this issue, we investigated diabetes trends in Stockholm County 1990-2010, taking into account trends in risk factors and mortality. Methods: We used data from a large population-based quadrennial public health survey conducted between 1990 and 2010 in Stockholm County (similar to 2.1 million inhabitants), supplemented with data from national registers. The age-standardized prevalence and incidence rates of diabetes and related risk factors 1990-2010 were estimated in adult inhabitants. We also modelled the influence of potential risk factors on the diabetes trends and estimated the life time risk of diabetes. Results: The prevalence of diabetes was 4.6% (95% confidence interval (CI); 4.5-4.8%) in 2010 compared to 2.8% (95% CI; 2.3-3.5%) in 1990. Between 1990 and 2002 the prevalence rose annually by 3.8% (95% CI; 2.1-5.5). Incidence rates showed a similar pattern and rose by 3.0% (95% CI; 0.3-5.7%) annually 1990-2002. The rising incidence was mainly attributable to increasing prevalence of overweight/obesity, which rose by 46% during the observation period. In 2010, the lifetime risk of adult onset diabetes was 28% (95% CI; 26-31%) in men and 19% (95% CI; 17-21%) in women. Conclusions: Diabetes rates have been increasing in Stockholm over the last decades, both in terms of incidence and prevalence, and this development is most likely the result of increasing overweight and obesity in the population.	[Andersson, Tomas; Ahlbom, Anders; Carlsson, Sofia] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Andersson, Tomas; Ahlbom, Anders] Stockholm Cty Council, Ctr Occupat & Environm Med, Stockholm, Sweden; [Magnusson, Cecilia] Stockholm Cty Council, Ctr Epidemiol & Community Med, Stockholm, Sweden; [Magnusson, Cecilia] Karolinska Inst, Dept Publ Hlth Sci, S-10401 Stockholm, Sweden	Karolinska Institutet; Stockholm County Council; Stockholm County Council; Karolinska Institutet	Carlsson, S (corresponding author), Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden.	Sofia.carlsson@ki.se		Magnusson, Cecilia/0000-0002-8567-6725; carlsson, sofia/0000-0002-9497-2331				Abdullah A, 2010, DIABETES RES CLIN PR, V89, P309, DOI 10.1016/j.diabres.2010.04.012; Ainetdin T, 2001, 20017 STOCKH COUNT C; [Anonymous], 2011, REP STOCKH COUNT COU; [Anonymous], 2005, GUID ATC CLASS DDD A; Caman OK, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-893; Carstensen B, 2008, DIABETOLOGIA, V51, P2187, DOI 10.1007/s00125-008-1156-z; Dahlquist GG, 2011, DIABETES CARE, V34, P1754, DOI 10.2337/dc11-0056; Davison AC, 1997, CAMBRIDGE SERIES STA; Eliasson M, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-32; Eriksson M, 2011, J INTERN MED, V269, P219, DOI 10.1111/j.1365-2796.2010.02312.x; Evans JMM, 2007, DIABETOLOGIA, V50, P729, DOI 10.1007/s00125-006-0585-9; Gudbjornsdottir S, 2011, NATL DIABETES REGIST; Hardoon SL, 2010, DIABETES CARE, V33, P1494, DOI 10.2337/dc09-2295; International Diabetes Federation, 2013, IDF DIABETES ATLAS; Jansson SPO, 2007, DIABETOLOGIA, V50, P703, DOI 10.1007/s00125-007-0593-4; Jansson SPO, 2010, DIABETES CARE, V33, P551, DOI 10.2337/dc09-0680; Lilja M, 2013, DIABETIC MED, V30, P1054, DOI 10.1111/dme.12208; Lindahl B, 2010, GLOBAL HEALTH ACTION, V3, DOI 10.3402/gha.v3i0.5222; Gonzalez ELM, 2009, J EPIDEMIOL COMMUN H, V63, P332, DOI 10.1136/jech.2008.080382; MIDTHJELL K, 1992, J EPIDEMIOL COMMUN H, V46, P537, DOI 10.1136/jech.46.5.537; PRENTICE RL, 1978, BIOMETRICS, V34, P57, DOI 10.2307/2529588; Rautio A, 2005, J INTERN MED, V258, P369, DOI 10.1111/j.1365-2796.2005.01552.x; Rautio A, 2008, STROKE, V39, P3137, DOI 10.1161/STROKEAHA.107.504100; Ringborg A, 2008, DIABETIC MED, V25, P1178, DOI 10.1111/j.1464-5491.2008.02541.x; Svensson AC, 2013, INT J EPIDEMIOL, V42, P1263, DOI 10.1093/ije/dys126; Swedish National Board of Health and Welfare, OFF STAT SWED MYOC I; van Houwelingen HC, 2002, STAT MED, V21, P589, DOI 10.1002/sim.1040; Wettermark B, 2007, PHARMACOEPIDEM DR S, V16, P726, DOI 10.1002/pds.1294; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654	29	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104033	10.1371/journal.pone.0104033	http://dx.doi.org/10.1371/journal.pone.0104033			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121976	Green Published, Green Submitted, gold			2022-12-25	WOS:000341017000025
J	Campos, MR; Rodrigues, ARS; Silva, WM; Silva, TBM; Silva, VRF; Guedes, RNC; Siqueira, HAA				Campos, Mateus R.; Rodrigues, Agna Rita S.; Silva, Wellington M.; Silva, Tadeu Barbosa M.; Silva, Vitoria Regina F.; Guedes, Raul Narciso C.; Siqueira, Herbert Alvaro A.			Spinosad and the Tomato Borer Tuta absoluta: A Bioinsecticide, an Invasive Pest Threat, and High Insecticide Resistance	PLOS ONE			English	Article							DIAMONDBACK MOTH LEPIDOPTERA; MEYRICK LEPIDOPTERA; BACILLUS-THURINGIENSIS; POPULATIONS; MANAGEMENT; IDENTIFICATION; INHERITANCE; STABILITY; ABAMECTIN; SYNERGISM	The introduction of an agricultural pest species into a new environment is a potential threat to agroecosystems of the invaded area. The phytosanitary concern is even greater if the introduced pest's phenotype expresses traits that will impair the management of that species. The invasive tomato borer, Tuta absoluta (Meyrick) (Lepidoptera: Gelechiidae), is one such species and the characterization of the insecticide resistance prevailing in the area of origin is important to guide management efforts in new areas of introduction. The spinosad is one the main insecticides currently used in Brazil for control of the tomato borer; Brazil is the likely source of the introduction of the tomato borer into Europe. For this reason, spinosad resistance in Brazilian populations of this species was characterized. Spinosad resistance has been reported in Brazilian field populations of this pest species, and one resistant population that was used in this study was subjected to an additional seven generations of selection for spinosad resistance reaching levels over 180,000-fold. Inheritance studies indicated that spinosad resistance is monogenic, incompletely recessive and autosomal with high heritability (h(2) = 0.71). Spinosad resistance was unstable without selection pressure with a negative rate of change in the resistance level (= -0.51) indicating an associated adaptive cost. Esterases and cytochrome P450-dependent monooxygenases titration decreased with spinosad selection, indicating that these detoxification enzymes are not the underlying resistance mechanism. Furthermore, the cross-resistance spectrum was restricted to the insecticide spinetoram, another spinosyn, suggesting that altered target site may be the mechanism involved. Therefore, the suspension of spinosyn use against the tomato borer would be a useful component in spinosad resistance management for this species. Spinosad use against this species in introduced areas should be carefully monitored to prevent rapid selection of high levels of resistance and the potential for its spread to new areas.	[Campos, Mateus R.; Rodrigues, Agna Rita S.; Silva, Wellington M.; Silva, Tadeu Barbosa M.; Silva, Vitoria Regina F.; Siqueira, Herbert Alvaro A.] Univ Fed Rural Pernambuco, Dept Agron Entomol, Recife, PE, Brazil; [Guedes, Raul Narciso C.] Univ Fed Vicosa, Dept Entomol, Vicosa, MG, Brazil	Universidade Federal Rural de Pernambuco (UFRPE); Universidade Federal de Vicosa	Siqueira, HAA (corresponding author), Univ Fed Rural Pernambuco, Dept Agron Entomol, Recife, PE, Brazil.	siqueira@depa.ufrpe.br	Guedes, Raul Narciso Carvalho/L-3924-2013; Campos, Mateus Ribeiro de/G-9828-2012; Siqueira, Herbert A. A./C-6062-2013	Guedes, Raul Narciso Carvalho/0000-0001-6229-7549; Campos, Mateus Ribeiro de/0000-0001-9317-3215; Siqueira, Herbert A. A./0000-0002-8802-8977	National Council of Scientific and Technological Development [CNPq-484240/2011-0]; CAPES Foundation; Insecticide Resistance Action Committee - Brazilian Section (IRAC-BR)	National Council of Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES Foundation(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Insecticide Resistance Action Committee - Brazilian Section (IRAC-BR)	The financial support provided by the National Council of Scientific and Technological Development (CNPq-484240/2011-0) (HAAS), CAPES Foundation (MRC), and the Insecticide Resistance Action Committee - Brazilian Section (IRAC-BR) (HAAS) was greatly appreciated and acknowledged here. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, CROP PROTECTION PROD, DOI DOI 10.1021/BK-2007-0947.CH007; Biondi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076548; BRATTSTEN LB, 1986, SCIENCE, V231, P1255, DOI 10.1126/science.231.4743.1255; Campos MR, 2013, THESIS U FEDERAL RUR; Cifuentes D, 2011, PEST MANAG SCI, V67, P1155, DOI 10.1002/ps.2166; Coustau C, 2000, TRENDS ECOL EVOL, V15, P378, DOI 10.1016/S0169-5347(00)01929-7; Desneux N, 2011, J PEST SCI, V84, P403, DOI 10.1007/s10340-011-0398-6; Desneux N, 2010, J PEST SCI, V83, P197, DOI 10.1007/s10340-010-0321-6; Falconer D. S., 1996, Introduction to quantitative genetics.; Ferguson JS, 2004, J ECON ENTOMOL, V97, P112, DOI 10.1603/0022-0493-97.1.112; Georghiou GP., 1972, ANNU REV ECOL EVOL S, V3, P133, DOI DOI 10.1146/ANNUREV.ES.03.110172.001025; Gontijo PC, 2013, ANN APPL BIOL, V162, P50, DOI 10.1111/aab.12000; Guedes R. N. C., 2012, CAB Reviews, V7, P1, DOI 10.1079/PAVSNNR20127055; Guedes R. N. C., 2012, Bulletin OEPP, V42, P211, DOI 10.1111/epp.2557; Guedes RNC, 2006, PHYSIOL ENTOMOL, V31, P30, DOI 10.1111/j.1365-3032.2005.00479.x; Haack RA, 2010, ANNU REV ENTOMOL, V55, P521, DOI 10.1146/annurev-ento-112408-085427; Haddi K, 2012, INSECT BIOCHEM MOLEC, V42, P506, DOI 10.1016/j.ibmb.2012.03.008; Hartl :D. L, 2000, PRIMER POPULATION GE; Heckel DG, 2012, SCIENCE, V337, P1613, DOI 10.1126/science.1226994; IRAC [Insecticide Resistance Action Committee], 2014, 022 IRAC; LANDE R, 1981, GENETICS, V99, P541; LeOra-Software, 2005, POLO PLUS POLO WIND; Lietti MMM, 2005, NEOTROP ENTOMOL, V34, P113, DOI 10.1590/S1519-566X2005000100016; MAPA, 2014, MAN GAR QUAL AN; NETTER KJ, 1964, J PHARMACOL EXP THER, V146, P61; Olson L. J., 2006, Agricultural and Resource Economics Review, V35, P178; Puinean AM, 2013, J NEUROCHEM, V124, P590, DOI 10.1111/jnc.12029; Ragsdale DW, 2011, ANNU REV ENTOMOL, V56, P375, DOI 10.1146/annurev-ento-120709-144755; Reyes M, 2012, PESTIC BIOCHEM PHYS, V102, P45, DOI 10.1016/j.pestbp.2011.10.008; Robertson J.L., 2007, BIOASSAYS ARTHROPODS, V2nd; Roditakis E, 2013, PEST MANAG SCI, V69, P834, DOI 10.1002/ps.3442; Roditakis E, 2013, PEST MANAG SCI, V69, P217, DOI 10.1002/ps.3404; Salazar E. R., 2001, Agricultura Tecnica, V61, P429; Salazar ER, 1997, SIMIENTE, V67, P8; Salgado VL, 2004, J INSECT PHYSIOL, V50, P867, DOI 10.1016/j.jinsphys.2004.07.007; Salgado VL., 2005, COMP MOLEC INSECT SC, V6, P137, DOI [10.1016/B0-44-451924-6/00078-8, DOI 10.1016/B0-44-451924-6/00078-8]; SAS Institute, 2008, SAS STAT US VERS; Sayyed AH, 2000, PEST MANAG SCI, V56, P743, DOI 10.1002/1526-4998(200009)56:9<743::AID-PS195>3.0.CO;2-8; Sayyed AH, 2008, J ECON ENTOMOL, V101, P1658, DOI 10.1603/0022-0493(2008)101[1658:GBAPCO]2.0.CO;2; Silva GA, 2011, PEST MANAG SCI, V67, P913, DOI 10.1002/ps.2131; Siqueira H. A. A., 2000, Agricultural and Forest Entomology, V2, P147, DOI 10.1046/j.1461-9563.2000.00062.x; Siqueira HAA, 2000, J APPL ENTOMOL, V124, P233, DOI 10.1046/j.1439-0418.2000.00470.x; Siqueira HAA, 2001, INT J PEST MANAGE, V47, P247, DOI 10.1080/09670870110044634; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Sokal R. R., 2012, BIOMETRY; Sparks TC, 2012, PESTIC BIOCHEM PHYS, V102, P1, DOI 10.1016/j.pestbp.2011.11.004; STONE BF, 1968, B WORLD HEALTH ORGAN, V38, P325; Suinaga FA, 2004, PESQUI AGROPECU BRAS, V39, P645, DOI 10.1590/S0100-204X2004000700005; TABASHNIK BE, 1990, J ECON ENTOMOL, V83, P1671, DOI 10.1093/jee/83.5.1671; VANASPEREN K, 1962, J INSECT PHYSIOL, V8, P401, DOI 10.1016/0022-1910(62)90074-4; Wang D, 2010, PHYTOPARASITICA, V38, P103, DOI 10.1007/s12600-009-0077-9; Watson GB, 2010, INSECT BIOCHEM MOLEC, V40, P376, DOI 10.1016/j.ibmb.2009.11.004; Whalon ME, 2008, GLOBAL PESTICIDE RES, P208; Zhao JZ, 2002, J ECON ENTOMOL, V95, P430, DOI 10.1603/0022-0493-95.2.430	54	75	81	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e103235	10.1371/journal.pone.0103235	http://dx.doi.org/10.1371/journal.pone.0103235			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122089	Green Published, Green Submitted, gold			2022-12-25	WOS:000341017000012
J	Gajecki, M; Berman, AH; Sinadinovic, K; Andersson, C; Ljotsson, B; Hedman, E; Ruck, C; Lindefors, N				Gajecki, Mikael; Berman, Anne H.; Sinadinovic, Kristina; Andersson, Claes; Ljotsson, Brjann; Hedman, Erik; Ruck, Christian; Lindefors, Nils			Effects of Baseline Problematic Alcohol and Drug Use on Internet-Based Cognitive Behavioral Therapy Outcomes for Depression, Panic Disorder and Social Anxiety Disorder	PLOS ONE			English	Article							NATIONAL EPIDEMIOLOGIC SURVEY; SUBSTANCE USE DISORDERS; PSYCHIATRIC COMORBIDITY; CIGARETTE-SMOKING; SELF-MEDICATION; DSM-IV; DEPENDENCE; SCALE; PAPER; MOOD	Purpose: Patients' problematic substance use prevalence and effects were explored in relation to internet-based cognitive behavioral therapy (ICBT) outcomes for depression, panic disorder and social anxiety disorder. Methods: At baseline and treatment conclusion, 1601 ICBT patients were assessed with self-rated measures for alcohol and drug use (AUDIT/DUDIT), depressive symptoms (MADRS-S), panic disorder symptoms (PDSS-SR) and social anxiety symptoms (LSAS-SR). Results: Problematic substance use (AUDIT >= 8 for men, >= 6 for women; DUDIT >= 1) occurred among 32.4% of the patients; 24.1% only alcohol, 4.6% only drugs, and 3.7% combined alcohol and drug use. Hazardous alcohol use and probable alcohol dependence negatively affected panic disorder outcomes, and hazardous drug use led to worse social anxiety outcomes. Depression outcomes were not affected by substance use. Treatment adherence was negatively affected by problematic drug use among men and 25-34 year olds; combined substance use negatively affected adherence for women and 35-64 year olds. Conclusion: Problematic substance use does not preclude ICBT treatment but can worsen outcomes, particularly problematic alcohol use for panic disorder patients and hazardous drug use for social anxiety patients. ICBT clinicians should exercise particular caution when treating men and younger patients with problematic drug use, and women or older patients with combined substance use.	[Gajecki, Mikael; Berman, Anne H.; Sinadinovic, Kristina; Andersson, Claes] Karolinska Inst, Dept Clin Neurosci, Ctr Psychiat Res, Stockholm, Sweden; [Berman, Anne H.; Sinadinovic, Kristina] Stockholm Ctr Dependency Disorders, Stockholm, Sweden; [Andersson, Claes] Malmo Univ, Dept Criminol, Malmo, Sweden; [Andersson, Claes] Lund Univ, Dept Clin Sci, Div Psychiat, Lund, Sweden; [Ljotsson, Brjann; Hedman, Erik] Karolinska Inst, Dept Clin Neurosci, Div Psychol, Stockholm, Sweden; [Ruck, Christian; Lindefors, Nils] Karolinska Inst, Dept Clin Neurosci, Div Psychiat, Stockholm, Sweden	Karolinska Institutet; Malmo University; Lund University; Karolinska Institutet; Karolinska Institutet	Gajecki, M (corresponding author), Karolinska Inst, Dept Clin Neurosci, Ctr Psychiat Res, Stockholm, Sweden.	mikael.gajecki@ki.se	Berman, Anne H/C-4636-2011	Berman, Anne H/0000-0002-7709-0230; Hedman-Lagerlof, Erik/0000-0002-7939-9848; Ruck, Christian/0000-0002-8742-0168; Ljotsson, Brjann/0000-0001-8086-1668; Gajecki, Mikael/0000-0002-0987-9010	Stockholm Center for Dependency Disorders; Psychiatry Southwest; Vinnova [2009-00192]	Stockholm Center for Dependency Disorders; Psychiatry Southwest; Vinnova(Vinnova)	This study was funded by the Stockholm Center for Dependency Disorders (http://www.slso.sll.se/SLPOtemplates/SLPOPage1____6639.aspx), Psychiatry Southwest (http://www.slso.sll.se/slpotemplates/slpopage1____4432.aspx) and Vinnova (http://www.vinnova.se/), grant number 2009-00192. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1987, DIAGN STAT MAN MENT; Andersson G., 2007, PSYCHIATRY, V2, P9; Babor TF., 2001, ALCOHOL USE DISORDER; Bergman H, 2002, ALCOHOL ALCOHOLISM, V37, P245, DOI 10.1093/alcalc/37.3.245; Berman AH, 2005, EUR ADDICT RES, V11, P22, DOI 10.1159/000081413; Boden JM, 2010, BRIT J PSYCHIAT, V196, P440, DOI 10.1192/bjp.bp.109.065912; Bolton J, 2006, J NERV MENT DIS, V194, P818, DOI 10.1097/01.nmd.0000244481.63148.98; Bolton JM, 2009, J AFFECT DISORDERS, V115, P367, DOI 10.1016/j.jad.2008.10.003; Bruce SE, 2005, AM J PSYCHIAT, V162, P1179, DOI 10.1176/appi.ajp.162.6.1179; Buckner JD, 2008, DEPRESS ANXIETY, V25, P1028, DOI 10.1002/da.20442; Carlbring P, 2007, COMPUT HUM BEHAV, V23, P1421, DOI 10.1016/j.chb.2005.05.002; Clark D. M., 1995, SOCIAL PHOBIA DIAGNO; Cruce G, 2007, NORD J PSYCHIAT, V61, P92, DOI 10.1080/08039480701226062; Cuijpers P, 2010, PSYCHOL MED, V40, P1943, DOI 10.1017/S0033291710000772; Eberhard S, 2009, SOC PSYCH PSYCH EPID, V44, P1013, DOI 10.1007/s00127-009-0023-7; Eskildsen A, 2010, NORD J PSYCHIAT, V64, P94, DOI 10.3109/08039480903426929; Fergusson DM, 2009, ARCH GEN PSYCHIAT, V66, P260, DOI 10.1001/archgenpsychiatry.2008.543; Furukawa TA, 2009, DEPRESS ANXIETY, V26, P922, DOI 10.1002/da.20532; Gainsbury S, 2011, CLIN PSYCHOL REV, V31, P490, DOI 10.1016/j.cpr.2010.11.007; Grant BF, 2004, ARCH GEN PSYCHIAT, V61, P807, DOI 10.1001/archpsyc.61.8.807; Harrison L., 1997, VALIDITY SELF REPORT; Hedman E, 2013, ACTA PSYCHIAT SCAND, V128, P457, DOI 10.1111/acps.12079; Hedman E, 2014, J AFFECT DISORDERS, V155, P49, DOI 10.1016/j.jad.2013.10.023; Hedman E, 2010, COMPUT HUM BEHAV, V26, P736, DOI 10.1016/j.chb.2010.01.010; Houck PR, 2002, DEPRESS ANXIETY, V15, P183, DOI 10.1002/da.10049; Howell D, 2002, STAT METHODS PSYCHOL; John U, 2004, DRUG ALCOHOL DEPEN, V76, P287, DOI 10.1016/j.drugalcdep.2004.06.004; JONES SH, 1995, BRIT J PSYCHIAT, V166, P654, DOI 10.1192/bjp.166.5.654; Kallmen H, 2011, NORD STUD ALCOHOL DR, V28, P123; Kenneson A, 2013, DRUG ALCOHOL DEPEN, V133, P338, DOI 10.1016/j.drugalcdep.2013.06.011; KHANTZIAN EJ, 1985, AM J PSYCHIAT, V142, P1259; Kim T, 2003, DHA GUIDE EFFECTIVE; Kushner MG, 2000, CLIN PSYCHOL REV, V20, P149, DOI 10.1016/S0272-7358(99)00027-6; Liebowitz M R, 1987, Mod Probl Pharmacopsychiatry, V22, P141; McEvoy PM, 2008, J ANXIETY DISORD, V22, P1087, DOI 10.1016/j.janxdis.2007.11.007; Mennin DS, 2002, J ANXIETY DISORD, V16, P661, DOI 10.1016/S0887-6185(02)00134-2; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Murphy JM, 2003, AM J PSYCHIAT, V160, P1663, DOI 10.1176/appi.ajp.160.9.1663; REGIER DA, 1990, JAMA-J AM MED ASSOC, V264, P2511; Riper H, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1713; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schneier FR, 2010, PSYCHOL MED, V40, P977, DOI 10.1017/S0033291709991231; Shear MK, 1997, AM J PSYCHIAT, V154, P1571, DOI 10.1176/ajp.154.11.1571; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Sinadinovic K, 2011, DRUG ALCOHOL DEPEN, V114, P55, DOI 10.1016/j.drugalcdep.2010.09.004; Sinadinovic K, 2010, ADDICT BEHAV, V35, P464, DOI 10.1016/j.addbeh.2009.12.021; Stockwell T, 2004, ADDICTION, V99, P1024, DOI 10.1111/j.1360-0443.2004.00815.x; Svanborg P, 2003, NORD J PSYCHIAT, V57, P291, DOI 10.1080/08039480307281; SVANBORG P, 1994, ACTA PSYCHIAT SCAND, V89, P21, DOI 10.1111/j.1600-0447.1994.tb01480.x; Titov N, 2011, CURR OPIN PSYCHIATR, V24, P18, DOI 10.1097/YCO.0b013e32833ed18f; Wang YC, 2005, J ADOLESCENT HEALTH, V37, P289, DOI 10.1016/j.jadohealth.2005.03.017; Wilsnack RW, 2009, ADDICTION, V104, P1487, DOI 10.1111/j.1360-0443.2009.02696.x; Zimmermann P, 2003, PSYCHOL MED, V33, P1211, DOI 10.1017/S0033291703008158	53	8	8	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104615	10.1371/journal.pone.0104615	http://dx.doi.org/10.1371/journal.pone.0104615			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO0QT	25122509	Green Published, Green Submitted, gold			2022-12-25	WOS:000341017000049
J	Lago, BV; Mello, FC; Kramvis, A; Niel, C; Gomes, SA				Lago, Barbara V.; Mello, Francisco C.; Kramvis, Anna; Niel, Christian; Gomes, Selma A.			Hepatitis B Virus Subgenotype A1: Evolutionary Relationships between Brazilian, African and Asian Isolates	PLOS ONE			English	Article							LIVER-DISEASE PATIENTS; HBV GENOTYPE F; MOLECULAR CHARACTERIZATION; PHYLOGENETIC ANALYSIS; GENETIC-VARIABILITY; NATURAL-HISTORY; HIGH PREVALENCE; SOUTH-AFRICA; MUTATIONS; SUBTYPE	Brazil is a country of low hepatitis B virus (HBV) endemicity in which the genotype A of HBV (HBV/A) is the most prevalent. The complete nucleotide sequences of 26 HBV/A isolates, originating from eight Brazilian states, were determined. All were adw2. Twenty-three belonged to subgenotype A1 and three to A2. By phylogenetic analysis, it was shown that all the 23 HBV/A1 isolates clustered together with isolates from Bangladesh, India, Japan, Nepal, the Philippines and United Arab Emirates, but not with those of Congo, Kenya, Malawi, Rwanda, South Africa, Tanzania, Uganda and Zimbabwe. Four amino acid residues in the polymerase (His138 in the terminal protein domain, Pro18 and His90 in the spacer, and Ser109 in the reverse transcriptase), and one (Phe17) in the precore region, predominated in Latin American and Asian HBV/A1 isolates, but were rarely encountered in African isolates, with the exception of those from Somalia. Specific variations of two adjacent amino acids in the C-terminal domain of the HBx protein, namely Ala146 and Pro147, were found in all the Brazilian, but rarely in the other HBV/A1 isolates. By Bayesian analysis, the existence of an 'Asian-American' clade within subgenotype A1 was supported by a posterior probability value of 0.996. The close relatedness of the Brazilian, Asian and Somalian isolates suggests that the HBV/A1 strains predominant in Brazil did not originate from the five million slaves who were imported from Central and Western Africa from 1551 to 1840, but rather from the 300-400,000 captives forcibly removed from southeast Africa at the middle of the 19th century.	[Lago, Barbara V.; Mello, Francisco C.; Niel, Christian; Gomes, Selma A.] Fiocruz MS, Inst Oswaldo Cruz, Mol Virol Lab, BR-21045900 Rio De Janeiro, Brazil; [Kramvis, Anna] Univ Witwatersrand, Fac Hlth Sci, Sch Clin Med, Hepatitis Virus Div Res Programme,Dept Internal M, Johannesburg, South Africa	Fundacao Oswaldo Cruz; University of Witwatersrand	Gomes, SA (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Mol Virol Lab, BR-21045900 Rio De Janeiro, Brazil.	selma@ioc.fiocruz.br	gomes, selma A/D-2762-2015; Niel, Christian/G-3712-2013	Kramvis, Anna/0000-0001-6006-3765; Gomes, Selma/0000-0003-0233-3370	Oswaldo Cruz Institute, Rio de Janeiro, Brazil; University of the Witwatersrand, Johannesburg, South Africa	Oswaldo Cruz Institute, Rio de Janeiro, Brazil; University of the Witwatersrand, Johannesburg, South Africa	The authors thank Dr Gonzalo Bello for help in the phylogeographic analysis and Drs Natalia M. Araujo, Ana R. Motta-Castro and Caroline C. Soares for valuable comments. BVL received a doctoral fellowship in the context of cooperation between the Oswaldo Cruz Institute, Rio de Janeiro, Brazil, and the University of the Witwatersrand, Johannesburg, South Africa. The DNA Sequencing Platform PDTIS/FIOCRUZ is acknowledged for performing nucleotide sequencing.	Alvarado-Mora MV, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-415; Andernach IE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081690; Andernach IE, 2009, EMERG INFECT DIS, V15, P1222, DOI 10.3201/eid1508.081642; Andernach IE, 2009, REV MED VIROL, V19, P231, DOI 10.1002/rmv.618; Araujo NM, 2004, ARCH VIROL, V149, P1383, DOI 10.1007/s00705-003-0269-4; ARBOLEDA M, 1995, T ROY SOC TROP MED H, V89, P481, DOI 10.1016/0035-9203(95)90074-8; Beachey R., 1976, SLAVE TRADE E AFRICA; Bertolini DA, 2012, INFECT GENET EVOL, V12, P1295, DOI 10.1016/j.meegid.2012.04.009; Bottecchia M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-11; Bowyer SM, 1997, J GEN VIROL, V78, P1719, DOI 10.1099/0022-1317-78-7-1719; Brazilian Ministry of Health, 2010, EST PREV BAS POP INF; Brichler S, 2013, J GEN VIROL, V94, P2318, DOI 10.1099/vir.0.055459-0; Casey JL, 1996, J INFECT DIS, V174, P920, DOI 10.1093/infdis/174.5.920; Datta S, 2008, VIROLOGY, V382, P190, DOI 10.1016/j.virol.2008.09.007; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Souto FJD, 2007, REV SOC BRAS MED TRO, V40, P18, DOI 10.1590/S0037-86822007000100004; Eltis D., 2010, ATLAS TRANSATLANTIC; Crispim MAE, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-94; Barros LMF, 2014, INFECT GENET EVOL, V24, P68, DOI 10.1016/j.meegid.2014.03.007; Freitas SZ, 2014, BRAZ J INFECT DIS, V18, P473, DOI 10.1016/j.bjid.2014.01.005; Goncalves VF, 2008, HUM HERED, V65, P23, DOI 10.1159/000106059; Gopalakrishnan D, 2013, WORLD J GASTROENTERO, V19, P9294, DOI 10.3748/wjg.v19.i48.9294; GUNTHER S, 1995, J VIROL, V69, P5437; Hadziyannis SJ, 2011, J HEPATOL, V55, P183, DOI 10.1016/j.jhep.2010.12.030; Hannoun C, 2005, J GEN VIROL, V86, P2163, DOI 10.1099/vir.0.80972-0; Hannoun C, 2000, J GEN VIROL, V81, P75, DOI 10.1099/0022-1317-81-1-75; Hubschen JM, 2011, CLIN MICROBIOL INFEC, V17, P88, DOI 10.1111/j.1469-0691.2010.03205.x; Huy TTT, 2008, J VIROL, V82, P5657, DOI 10.1128/JVI.02556-07; Kay A, 2007, VIRUS RES, V127, P164, DOI 10.1016/j.virusres.2007.02.021; Kramvis A, 2005, J VIRAL HEPATITIS, V12, P456, DOI 10.1111/j.1365-2893.2005.00624.x; Kramvis A, 2002, J GEN VIROL, V83, P835, DOI 10.1099/0022-1317-83-4-835; Kramvis A, 2008, J MED VIROL, V80, P27, DOI 10.1002/jmv.21049; Kramvis A, 2013, ANTIVIR THER, V18, P513, DOI 10.3851/IMP2657; Kurbanov F, 2005, J GEN VIROL, V86, P2047, DOI 10.1099/vir.0.80922-0; Kwange SO, 2013, VIRUS GENES, V47, P448, DOI 10.1007/s11262-013-0976-1; Lago BV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092223; Lazarevic I, 2014, WORLD J GASTROENTERO, V20, P7653, DOI 10.3748/wjg.v20.i24.7653; Makondo E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046345; Marciano S, 2013, ANTIVIR THER, V18, P485, DOI 10.3851/IMP2604; Matos MAD, 2009, T ROY SOC TROP MED H, V103, P899, DOI 10.1016/j.trstmh.2009.01.013; Mello FCA, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-103; Motta-Castro A, 2008, ARCH VIROL, V153, P2197, DOI 10.1007/s00705-008-0237-0; Moura IF, 2013, INFECT GENET EVOL, V14, P195, DOI 10.1016/j.meegid.2012.11.022; Ochwoto M, 2013, INFECT GENET EVOL, V20, P103, DOI 10.1016/j.meegid.2013.08.013; OKAMOTO H, 1987, JPN J EXP MED, V57, P231; Olinger CM, 2006, J GEN VIROL, V87, P1163, DOI 10.1099/vir.0.81614-0; ORITO E, 1989, P NATL ACAD SCI USA, V86, P7059, DOI 10.1073/pnas.86.18.7059; Paraskevis D, 2013, HEPATOLOGY, V57, P908, DOI 10.1002/hep.26079; Pourkarim MR, 2011, CLIN MICROBIOL INFEC, V17, P947, DOI 10.1111/j.1469-0691.2010.03374.x; Pourkarim MR, 2010, J CLIN VIROL, V47, P356, DOI 10.1016/j.jcv.2010.01.015; Pourkarim MR, 2010, J CLIN VIROL, V47, P93, DOI 10.1016/j.jcv.2009.09.032; Santos AO, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-315; Tanaka Y, 2004, HEPATOLOGY, V40, P747, DOI 10.1002/hep.20365; Tanwar Sudeep, 2012, Curr Gastroenterol Rep, V14, P37, DOI 10.1007/s11894-011-0233-5; Tatematsu K, 2009, J VIROL, V83, P10538, DOI 10.1128/JVI.00462-09; Valente F, 2010, MEM I OSWALDO CRUZ, V105, P970, DOI 10.1590/S0074-02762010000800004; Viana S, 2005, AM J TROP MED HYG, V73, P808, DOI 10.4269/ajtmh.2005.73.808; Zhou Y, 2007, J MOL EVOL, V65, P197, DOI 10.1007/s00239-007-0054-1	58	29	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e105317	10.1371/journal.pone.0105317	http://dx.doi.org/10.1371/journal.pone.0105317			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122004	gold, Green Published, Green Submitted			2022-12-25	WOS:000341017000116
J	Malikova, J; Camats, N; Fernandez-Cancio, M; Heath, K; Gonzalez, I; Caimari, M; del Campo, M; Albisu, M; Kolouskova, S; Audi, L; Fluck, CE				Malikova, Jana; Camats, Nuria; Fernandez-Cancio, Monica; Heath, Karen; Gonzalez, Isabel; Caimari, Maria; del Campo, Miguel; Albisu, Marian; Kolouskova, Stanislava; Audi, Laura; Flueck, Christa E.			Human NR5A1/SF-1 Mutations Show Decreased Activity on BDNF (Brain-Derived Neurotrophic Factor), an Important Regulator of Energy Balance: Testing Impact of Novel SF-1 Mutations Beyond Steroidogenesis	PLOS ONE			English	Article							ORPHAN NUCLEAR RECEPTOR; CHAIN-CLEAVAGE ENZYME; FACTOR-I SF-1; SEX DEVELOPMENT; GENE; EXPRESSION; DIFFERENTIATION; TRANSCRIPTION; DISORDERS; BEHAVIOR	Context: Human NR5A1/SF-1 mutations cause 46,XY disorder of sex development (DSD) with broad phenotypic variability, and rarely cause adrenal insufficiency although SF-1 is an important transcription factor for many genes involved in steroidogenesis. In addition, the Sf-1 knockout mouse develops obesity with age. Obesity might be mediated through Sf-1 regulating activity of brain-derived neurotrophic factor (BDNF), an important regulator of energy balance in the ventromedial hypothalamus. Objective: To characterize novel SF-1 gene variants in 4 families, clinical, genetic and functional studies were performed with respect to steroidogenesis and energy balance. Patients: 5 patients with 46,XY DSD were found to harbor NR5A1/SF-1 mutations including 2 novel variations. One patient harboring a novel mutation also suffered from adrenal insufficiency. Methods: SF-1 mutations were studied in cell systems (HEK293, JEG3) for impact on transcription of genes involved in steroidogenesis (CYP11A1, CYP17A1, HSD3B2) and in energy balance (BDNF). BDNF regulation by SF-1 was studied by promoter assays (JEG3). Results: Two novel NR5A1/SF-1 mutations (Glu7Stop, His408Profs*159) were confirmed. Glu7Stop is the 4th reported SF-1 mutation causing DSD and adrenal insufficiency. In vitro studies revealed that transcription of the BDNF gene is regulated by SF-1, and that mutant SF-1 decreased BDNF promoter activation (similar to steroid enzyme promoters). However, clinical data from 16 subjects carrying SF-1 mutations showed normal birth weight and BMI. Conclusions: Glu7Stop and His408Profs*159 are novel SF-1 mutations identified in patients with 46,XY DSD and adrenal insufficiency (Glu7Stop). In vitro, SF-1 mutations affect not only steroidogenesis but also transcription of BDNF which is involved in energy balance. However, in contrast to mice, consequences on weight were not found in humans with SF-1 mutations.	[Malikova, Jana; Kolouskova, Stanislava] Charles Univ Prague, Fac Med 2, Dept Pediat, Prague, Czech Republic; [Malikova, Jana; Kolouskova, Stanislava] Univ Hosp Motol, Prague, Czech Republic; [Malikova, Jana; Camats, Nuria; Flueck, Christa E.] Univ Childrens Hosp Bern, Dept Pediat, Bern, Switzerland; [Malikova, Jana; Camats, Nuria; Flueck, Christa E.] Univ Childrens Hosp Bern, Dept Clin Res, Bern, Switzerland; [Fernandez-Cancio, Monica; Albisu, Marian; Audi, Laura] Autonomous Univ Barcelona, CIBERER, Vall Hebron Res Inst VHIR, Barcelona, Spain; [Heath, Karen] Univ Autonoma Madrid, IdiPAZ, Inst Med & Mol Genet INGEMM, Hosp Univ La Paz, Madrid, Spain; [Gonzalez, Isabel] Univ Autonoma Madrid, IdiPAZ, Pediat Endocrinol Serv, Hosp Univ La Paz, Madrid, Spain; [Caimari, Maria] Son Espases Univ Hosp, Palma De Mallorca, Spain; [del Campo, Miguel] Hosp Valle De Hebron, Barcelona, Spain	Charles University Prague; Motol University Hospital; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Autonomous University of Madrid; Hospital Universitario La Paz; Autonomous University of Madrid; Hospital Universitario La Paz; Hospital Universitari Son Espases; Hospital Universitari Vall d'Hebron	Fluck, CE (corresponding author), Charles Univ Prague, Fac Med 2, Dept Pediat, Prague, Czech Republic.	christa.flueck@dkf.unibe.ch	Camats, Nuria/K-8326-2017; Heath, Karen Elise/K-7760-2014; Heath, K. E./ABG-4658-2020	Camats, Nuria/0000-0002-4863-8201; Heath, Karen Elise/0000-0002-5816-7044; Heath, K. E./0000-0002-5816-7044; Flueck, Christa/0000-0002-4568-5504; Fernandez Cancio, Monica/0000-0003-1872-3488	Swiss National Science Foundation [320030-146127]; Instituto de Salud Carlos III, Madrid, Spain CIBERER [U-712]; AGAUR (University and Research Management and Evaluation Agency), Barcelona, Spain [2009SGR31]; ESPE (European Society of Pediatric Endocrinology); Novo Nordisk A/S	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Instituto de Salud Carlos III, Madrid, Spain CIBERER; AGAUR (University and Research Management and Evaluation Agency), Barcelona, Spain(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); ESPE (European Society of Pediatric Endocrinology); Novo Nordisk A/S(Novo Nordisk)	This work was supported by grants of the Swiss National Science Foundation (320030-146127) to CEF, the Instituto de Salud Carlos III, Madrid, Spain CIBERER U-712 to MFC and the AGAUR (University and Research Management and Evaluation Agency), Barcelona, Spain (2009SGR31) to LA, and by ESPE (European Society of Pediatric Endocrinology) Research Fellowship grants to JM and NC (sponsored by Novo Nordisk A/S). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achermann JC, 1999, NAT GENET, V22, P125, DOI 10.1038/9629; Achermann JC, 2002, J CLIN ENDOCR METAB, V87, P1829, DOI 10.1210/jc.87.4.1829; Adamovic T, 2012, SEX DEV, V6, P292, DOI 10.1159/000343782; Allali S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024117; Bashamboo A, 2010, AM J HUM GENET, V87, P505, DOI 10.1016/j.ajhg.2010.09.009; Biason-Lauber A, 2000, AM J HUM GENET, V67, P1563, DOI 10.1086/316893; Camats N, 2012, J CLIN ENDOCR METAB, V97, pE1294, DOI 10.1210/jc.2011-3169; Ciaccio M, 2012, HORM RES PAEDIAT, V78, P119, DOI 10.1159/000338346; Ferraz-de-Souza B, 2011, MOL CELL ENDOCRINOL, V336, P198, DOI 10.1016/j.mce.2010.11.006; Fluck CE, 2004, MOL ENDOCRINOL, V18, P1144, DOI 10.1210/me.2003-0342; Gray J, 2006, DANCING TIMES, V96, P55; Halvorson LM, 1996, J BIOL CHEM, V271, P6645, DOI 10.1074/jbc.271.12.6645; Han JC, 2008, NEW ENGL J MED, V359, P918, DOI 10.1056/NEJMoa0801119; Hoivik EA, 2010, MOL CELL ENDOCRINOL, V315, P27, DOI 10.1016/j.mce.2009.07.003; Huang NW, 2000, J BIOL CHEM, V275, P2852, DOI 10.1074/jbc.275.4.2852; IKEDA Y, 1995, MOL ENDOCRINOL, V9, P478, DOI 10.1210/me.9.4.478; Jacobs SBR, 2003, MOL ENDOCRINOL, V17, P1470, DOI 10.1210/me.2002-0286; Kernie SG, 2000, EMBO J, V19, P1290, DOI 10.1093/emboj/19.6.1290; Kim Kwang Young, 2011, Algae, V26, P1, DOI 10.4490/algae.2011.26.1.001; Kohler B, 2008, HUM MUTAT, V29, P59, DOI 10.1002/humu.20588; Kohjima M, 2010, ENDOCRINOLOGY, V151, P1532, DOI 10.1210/en.2009-1196; LALA DS, 1992, MOL ENDOCRINOL, V6, P1249, DOI 10.1210/me.6.8.1249; Lin L, 2008, SEX DEV, V2, P200, DOI 10.1159/000152036; Lourenco D, 2009, NEW ENGL J MED, V360, P1200, DOI 10.1056/NEJMoa0806228; Majdic G, 2002, ENDOCRINOLOGY, V143, P607, DOI 10.1210/en.143.2.607; Morohashi K, 1999, BLOOD, V93, P1586; Patel MV, 2001, J INVEST DERMATOL, V117, P1559, DOI 10.1046/j.0022-202x.2001.01587.x; Pruunsild P, 2007, GENOMICS, V90, P397, DOI 10.1016/j.ygeno.2007.05.004; Ramayya MS, 1997, J CLIN ENDOCR METAB, V82, P1799, DOI 10.1210/jc.82.6.1799; Rios M, 2001, MOL ENDOCRINOL, V15, P1748, DOI 10.1210/me.15.10.1748; Rios M, 2013, TRENDS NEUROSCI, V36, P83, DOI 10.1016/j.tins.2012.12.009; SADOVSKY Y, 1995, P NATL ACAD SCI USA, V92, P10939, DOI 10.1073/pnas.92.24.10939; Sarafoglou K, 2012, J CLIN ENDOCR METAB, V97, P2292, DOI 10.1210/jc.2012-2178; Schimmer BP, 2010, MOL ENDOCRINOL, V24, P1322, DOI 10.1210/me.2009-0519; Stranahan AM, 2011, NEUROENDOCRINOLOGY, V93, P58, DOI 10.1159/000322808; TAKETO M, 1995, GENOMICS, V25, P565, DOI 10.1016/0888-7543(95)80059-U; Tran PV, 2006, J COMP NEUROL, V498, P637, DOI 10.1002/cne.21070; Tran PV, 2003, MOL CELL NEUROSCI, V22, P441, DOI 10.1016/S1044-7431(03)00027-7; Unger TJ, 2007, J NEUROSCI, V27, P14265, DOI 10.1523/JNEUROSCI.3308-07.2007; Zhao LP, 2001, DEVELOPMENT, V128, P147	40	11	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104838	10.1371/journal.pone.0104838	http://dx.doi.org/10.1371/journal.pone.0104838			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122490	gold, Green Published, Green Submitted			2022-12-25	WOS:000341017000063
J	Bahitham, W; Liao, XP; Peng, F; Bamforth, F; Chan, A; Mason, A; Stone, B; Stothard, P; Sergi, C				Bahitham, Wesam; Liao, Xiaoping; Peng, Fred; Bamforth, Fiona; Chan, Alicia; Mason, Andrew; Stone, Bradley; Stothard, Paul; Sergi, Consolato			Mitochondriome and Cholangiocellular Carcinoma	PLOS ONE			English	Article							DNA G10398A POLYMORPHISM; D-LOOP; HEPATOCELLULAR-CARCINOMA; SOMATIC MUTATIONS; BREAST-CANCER; COPY NUMBER; RISK; ASSOCIATION; EXPRESSION; FREQUENCY	Cholangiocellular carcinoma (CCA) of the liver was the target of more interest, recently, due mainly to its increased incidence and possible association to new environmental factors. Somatic mitochondrial DNA (mtDNA) mutations have been found in several cancers. Some of these malignancies contain changes of mtDNA, which are not or, very rarely, found in the mtDNA databases. In terms of evolutionary genetics and oncology, these data are extremely interesting and may be considered a sign of poor fitness, which may conduct in some way to different cellular processes, including carcinogenesis. MitoChip analysis is a strong tool for investigations in experimental oncology and was carried out on three CCA cell lines (HuCCT1, Huh-28 and OZ) with different outcome in human and a Papova-immortalized normal hepatocyte cell line (THLE-3). Real time quantitative PCR, western blot analysis, transmission electron microscopy, confocal laser microscopy, and metabolic assays including L-Lactate and NAD(+)/NADH assays were meticulously used to identify mtDNA copy number, oxidative phosphorylation (OXPHOS) content, ultrastructural morphology, mitochondrial membrane potential (Delta Psi(m)), and differential composition of metabolites, respectively. Among 102 mtDNA changes observed in the CCA cell lines, 28 were non-synonymous coding region alterations resulting in an amino acid change. Thirty-eight were synonymous and 30 involved ribosomal RNA (rRNA) and transfer RNA (tRNA) regions. We found three new heteroplasmic mutations in two CCA cell lines (HuCCT1 and Huh-28). Interestingly, mtDNA copy number was decreased in all three CCA cell lines, while complexes I and III were decreased with depolarization of mitochondria. L-Lactate and NAD+/NADH assays were increased in all three CCA cell lines. MtDNA alterations seem to be a common event in CCA. This is the first study using MitoChip analysis with comprehensive metabolic studies in CCA cell lines potentially creating a platform for future studies on the interactions between normal and neoplastic cells.	[Bahitham, Wesam; Bamforth, Fiona; Sergi, Consolato] Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB, Canada; [Liao, Xiaoping; Peng, Fred; Stothard, Paul] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Chan, Alicia] Univ Alberta, Dept Genet, Edmonton, AB T6G 2E9, Canada; [Mason, Andrew] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Sergi, Consolato] Univ Alberta, Dept Pediat, Edmonton, AB, Canada; [Stone, Bradley] Benaroya Res Inst, Seattle, WA USA	University of Alberta; University of Alberta; University of Alberta; University of Alberta; University of Alberta; Benaroya Research Institute	Sergi, C (corresponding author), Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB, Canada.	sergi@ualberta.ca	Sergi, Consolato/A-1126-2009; Mason, Andrew/D-2938-2013	Mason, Andrew/0000-0002-0470-9522; Sergi, Consolato/0000-0002-2779-7879	Ministry of Higher Education in Saudi Arabia through the Saudi Cultural Bureau, Ottawa, Ontario, Canada	Ministry of Higher Education in Saudi Arabia through the Saudi Cultural Bureau, Ottawa, Ontario, Canada	The authors thank the Ministry of Higher Education in Saudi Arabia for providing the MSc student (W. B.) scholarship and support through the Saudi Cultural Bureau, Ottawa, Ontario, Canada. The authors also thank the University of Alberta for intramural funding to the principal investigator (CS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuetabh Y, 2011, ANN CLIN LAB SCI, V41, P217; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Al-Bahrani R, 2013, ANN CLIN LAB SCI, V43, P195; Cai W, 2008, J GENET GENOMICS, V35, P649, DOI 10.1016/S1673-8527(08)60086-7; Calhoun ES, 2003, AM J PATHOL, V163, P1255, DOI 10.1016/S0002-9440(10)63485-2; Chatterjee A, 2006, ONCOGENE, V25, P4663, DOI 10.1038/sj.onc.1209604; Chatterjee A, 2011, CANCER PREV RES, V4, P638, DOI 10.1158/1940-6207.CAPR-10-0326; CURI R, 1988, BIOCHEM J, V250, P383, DOI 10.1042/bj2500383; Cutler DJ, 2001, GENOME RES, V11, P1913, DOI 10.1101/gr.197201; Darvishi K, 2007, CANCER LETT, V249, P249, DOI 10.1016/j.canlet.2006.09.005; Endo I, 2008, ANN SURG, V248, P84, DOI 10.1097/SLA.0b013e318176c4d3; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gatto M, 2010, DIGEST LIVER DIS, V42, P253, DOI 10.1016/j.dld.2009.12.008; Grant JR, 2011, BIOINFORMATICS, V27, P2300, DOI 10.1093/bioinformatics/btr372; Heddi A, 1996, BBA-MOL BASIS DIS, V1316, P203, DOI 10.1016/0925-4439(96)00026-9; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; HOMMA S, 1987, Gastroenterologia Japonica, V22, P474; Jakupciak JP, 2006, CURR OPIN MOL THER, V8, P500; Kim MM, 2004, CLIN CANCER RES, V10, P8512, DOI 10.1158/1078-0432.CCR-04-0734; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Komar AA, 2007, SCIENCE, V315, P466, DOI 10.1126/science.1138239; Kothiyal P, 2009, CURR PROTOC HUM GENE, V7; Lee HC, 2005, ANN NY ACAD SCI, V1042, P109, DOI 10.1196/annals.1338.011; Lee HC, 2004, MUTAT RES-FUND MOL M, V547, P71, DOI 10.1016/j.mrfmmm.2003.12.011; Lu JX, 2009, CELL RES, V19, P802, DOI 10.1038/cr.2009.69; Maitra A, 2006, BEST PRACT RES CL GA, V20, P211, DOI 10.1016/j.bpg.2005.10.002; Mambo E, 2005, INT J CANCER, V116, P920, DOI 10.1002/ijc.21110; Maximo V, 2002, AM J PATHOL, V160, P1857, DOI 10.1016/S0002-9440(10)61132-7; Mims MP, 2006, CANCER RES, V66, P1880, DOI 10.1158/0008-5472.CAN-05-3774; MIYAGIWA M, 1989, IN VITRO CELL DEV B, V25, P503; Nomoto S, 2002, CLIN CANCER RES, V8, P481; Ohashi Y, 2004, GYNECOL ONCOL, V93, P54, DOI 10.1016/j.ygyno.2004.01.019; Prasad GN, 2006, INT J CARDIOL, V109, P432, DOI 10.1016/j.ijcard.2005.07.065; Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927; Schapira AHV, 2002, J INHERIT METAB DIS, V25, P207, DOI 10.1023/A:1015629912477; Sui GP, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-73; Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3; Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435; Wallace DC, 1999, GENE, V238, P211, DOI 10.1016/S0378-1119(99)00295-4; Wang Y, 2006, BRIT J CANCER, V95, P1087, DOI 10.1038/sj.bjc.6603377; Wang Y, 2005, GYNECOL ONCOL, V98, P104, DOI 10.1016/j.ygyno.2005.04.015; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; WICE BM, 1981, J BIOL CHEM, V256, P7812; Wu CW, 2005, GENE CHROMOSOME CANC, V44, P19, DOI 10.1002/gcc.20213; Xing JL, 2008, JNCI-J NATL CANCER I, V100, P1104, DOI 10.1093/jnci/djn213; Yin PH, 2004, BRIT J CANCER, V90, P2390, DOI 10.1038/sj.bjc.6601838; Zhang RX, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-130; Zhou SY, 2007, P NATL ACAD SCI USA, V104, P7540, DOI 10.1073/pnas.0610818104	48	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e104694	10.1371/journal.pone.0104694	http://dx.doi.org/10.1371/journal.pone.0104694			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137133	Green Published, Green Submitted, gold			2022-12-25	WOS:000340742100042
J	Onslow, ACE; Jones, MW; Bogacz, R				Onslow, Angela C. E.; Jones, Matthew W.; Bogacz, Rafal			A Canonical Circuit for Generating Phase-Amplitude Coupling	PLOS ONE			English	Article							GAMMA-BAND SYNCHRONIZATION; NEURONAL OSCILLATIONS; HIPPOCAMPAL THETA; PYRAMIDAL CELLS; PREFRONTAL CORTEX; MEDIAL SEPTUM; POTENTIAL OSCILLATIONS; GLUTAMATERGIC INPUTS; WORKING-MEMORY; DIAGONAL BAND	Phase amplitude coupling' (PAC) in oscillatory neural activity describes a phenomenon whereby the amplitude of higher frequency activity is modulated by the phase of lower frequency activity. Such coupled oscillatory activity - also referred to as 'cross-frequency coupling' or 'nested rhythms' - has been shown to occur in a number of brain regions and at behaviorally relevant time points during cognitive tasks; this suggests functional relevance, but the circuit mechanisms of PAC generation remain unclear. In this paper we present a model of a canonical circuit for generating PAC activity, showing how interconnected excitatory and inhibitory neural populations can be periodically shifted in to and out of oscillatory firing patterns by afferent drive, hence generating higher frequency oscillations phase-locked to a lower frequency, oscillating input signal. Since many brain regions contain mutually connected excitatory-inhibitory populations receiving oscillatory input, the simplicity of the mechanism generating PAC in such networks may explain the ubiquity of PAC across diverse neural systems and behaviors. Analytic treatment of this circuit as a nonlinear dynamical system demonstrates how connection strengths and inputs to the populations can be varied in order to change the extent and nature of PAC activity, importantly which phase of the lower frequency rhythm the higher frequency activity is locked to. Consequently, this model can inform attempts to associate distinct types of PAC with different network topologies and physiologies in real data.	[Onslow, Angela C. E.] Univ Bristol, Bristol Ctr Complex Sci, Bristol, Avon, England; [Onslow, Angela C. E.] Boston Univ, Dept Psychol, Ctr Memory & Brain, Boston, MA 02215 USA; [Jones, Matthew W.] Univ Bristol, Sch Physiol & Pharmacol, Bristol, Avon, England; [Bogacz, Rafal] Univ Bristol, Dept Comp Sci, Bristol, Avon, England; [Bogacz, Rafal] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England; [Bogacz, Rafal] Univ Oxford, Dept Pharmacol, MRC, Anat Neuropharmacol Unit, Oxford OX1 3QT, England	University of Bristol; Boston University; University of Bristol; University of Bristol; University of Oxford; University of Oxford	Onslow, ACE (corresponding author), Univ Bristol, Bristol Ctr Complex Sci, Queens Bldg, Bristol, Avon, England.	aonslow@googlemail.com		Jones, Matthew/0000-0001-5396-3108	EPSRC [EP/E501214/1]; MRC [G1002064]; MRC; Medical Research Council [G1002064] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	ACEO was supported by EPSRC grant EP/E501214/1. MWJ was supported by MRC grant number G1002064. RB was supported by the MRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMIT DJ, 1991, NETWORK-COMP NEURAL, V2, P259, DOI 10.1088/0954-898X/2/3/003; Axmacher N, 2010, P NATL ACAD SCI USA, V107, P3228, DOI 10.1073/pnas.0911531107; Belluscio MA, 2012, J NEUROSCI, V32, P423, DOI 10.1523/JNEUROSCI.4122-11.2012; Bland BH, 2001, BEHAV BRAIN RES, V127, P119, DOI 10.1016/S0166-4328(01)00358-8; Bland BH, 2006, HIPPOCAMPUS, V16, P673, DOI 10.1002/hipo.20210; Borgers C, 2003, NEURAL COMPUT, V15, P509, DOI 10.1162/089976603321192059; Borgers C, 2008, P NATL ACAD SCI USA, V105, P18023, DOI 10.1073/pnas.0809511105; BORISYUK RM, 1992, BIOL CYBERN, V66, P319, DOI 10.1007/BF00203668; BRAGIN A, 1995, J NEUROSCI, V15, P47; Brandon MP, 2011, SCIENCE, V332, P595, DOI 10.1126/science.1201652; Brunel N, 2006, NEURAL COMPUT, V18, P1066, DOI 10.1162/neco.2006.18.5.1066; Brunel N, 2008, CHAOS, V18, DOI 10.1063/1.2779858; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Buzsaki G, 2003, NEUROSCIENCE, V116, P201, DOI 10.1016/S0306-4522(02)00669-3; Buzsaki G., 2006, RHYTHMS BRAIN; Buzsaki G, 2012, ANNU REV NEUROSCI, V35, P203, DOI 10.1146/annurev-neuro-062111-150444; Buzsaki G, 2010, NEURON, V68, P362, DOI 10.1016/j.neuron.2010.09.023; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Canolty RT, 2010, TRENDS COGN SCI, V14, P506, DOI 10.1016/j.tics.2010.09.001; Chrobak JJ, 1998, J NEUROSCI, V18, P388; Cobb SR, 2005, J PHYSIOL-LONDON, V562, P81, DOI 10.1113/jphysiol.2004.076539; Cohen M, 2009, SOUTHERN HUMAN REV, V43, P21; Cohen MX, 2009, J COGNITIVE NEUROSCI, V21, P390, DOI 10.1162/jocn.2008.21020; Colgin LL, 2009, NATURE, V462, P353, DOI 10.1038/nature08573; Deschenes M, 2012, CURR OPIN NEUROBIOL, V22, P243, DOI 10.1016/j.conb.2011.11.013; Deshmukh SS, 2010, J NEUROPHYSIOL, V104, P994, DOI 10.1152/jn.01141.2009; Doedel E. J., 1997, AUTO 97 CONTINUATION; Doesburg SM, 2012, BRAIN RES, V1431, P77, DOI 10.1016/j.brainres.2011.11.005; DUTAR P, 1995, PHYSIOL REV, V75, P393, DOI 10.1152/physrev.1995.75.2.393; Ehrlichman RS, 2009, NEUROSCIENCE, V158, P705, DOI 10.1016/j.neuroscience.2008.10.031; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Engel AK, 2001, TRENDS COGN SCI, V5, P16, DOI 10.1016/S1364-6613(00)01568-0; ERMENTROUT B, 1994, NEURAL COMPUT, V6, P679, DOI 10.1162/neco.1994.6.4.679; Ermentrout GB, 1998, P NATL ACAD SCI USA, V95, P1259, DOI 10.1073/pnas.95.3.1259; Feldmeyer D, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00024; Fellin T, 2006, PHYSIOLOGY, V21, P208, DOI 10.1152/physiol.00161.2005; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; GAYKEMA RPA, 1990, J COMP NEUROL, V293, P103, DOI 10.1002/cne.902930109; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; Greene R, 2001, HIPPOCAMPUS, V11, P569, DOI 10.1002/hipo.1072.abs; Hamada Y, 1999, NEUROSCIENCE, V88, P667, DOI 10.1016/S0306-4522(98)00468-0; Henny P, 2008, EUR J NEUROSCI, V27, P654, DOI 10.1111/j.1460-9568.2008.06029.x; Hoover WB, 2007, BRAIN STRUCT FUNCT, V212, P149, DOI 10.1007/s00429-007-0150-4; Hoppensteadt F. C., 1997, APPL MATH SCI, V126; Huh CYL, 2010, J NEUROSCI, V30, P15951, DOI 10.1523/JNEUROSCI.3663-10.2010; ISHIZUKA N, 1990, J COMP NEUROL, V295, P580, DOI 10.1002/cne.902950407; Jensen O, 2002, EUR J NEUROSCI, V15, P1395, DOI 10.1046/j.1460-9568.2002.01975.x; Jensen O, 1996, LEARN MEMORY, V3, P279, DOI 10.1101/lm.3.2-3.279; Kendrick KM, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-55; Kepecs A, 2006, CHEM SENSES, V31, P167, DOI 10.1093/chemsce/bjj016; Kopell N, 2010, SPR SER COMPUT NEURO, V5, P423, DOI 10.1007/978-1-4419-0996-1_15; Kopell N, 2004, P NATL ACAD SCI USA, V101, P15482, DOI 10.1073/pnas.0406343101; Lakatos P, 2005, J NEUROPHYSIOL, V94, P1904, DOI 10.1152/jn.00263.2005; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Lazarewicz MT, 2010, J COGNITIVE NEUROSCI, V22, P1452, DOI 10.1162/jocn.2009.21305; LISMAN JE, 1995, SCIENCE, V267, P1512, DOI 10.1126/science.7878473; Lisman J, 2008, SCHIZOPHRENIA BULL, V34, P974, DOI 10.1093/schbul/sbn060; Mormann F, 2005, HIPPOCAMPUS, V15, P890, DOI 10.1002/hipo.20117; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Onslow ACE, 2012, THESIS U BRISTOL UK; Osipova D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003990; Palva JM, 2005, J NEUROSCI, V25, P3962, DOI 10.1523/JNEUROSCI.4250-04.2005; Palva S, 2007, TRENDS NEUROSCI, V30, P150, DOI 10.1016/j.tins.2007.02.001; Palva S, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00204; Pastoll H, 2013, NEURON, V77, P141, DOI 10.1016/j.neuron.2012.11.032; Pavlides A, 2012, EUR J NEUROSCI, V36, P2229, DOI 10.1111/j.1460-9568.2012.08105.x; Rinzel J, 2008, ACTIVITY PATTERNS SL; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Roopun AK, 2008, FRONT NEUROSCI-SWITZ, V2, P145, DOI 10.3389/neuro.01.034.2008; Roxin A, 2006, PROG THEOR PHYS SUPP, P68, DOI 10.1143/PTPS.161.68; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; Schack B, 2002, INT J PSYCHOPHYSIOL, V44, P143, DOI 10.1016/S0167-8760(01)00199-4; Scheffer-Teixeira R, 2012, CEREB CORTEX, V22, P2404, DOI 10.1093/cercor/bhr319; Scheffzuk C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028489; Shearkhani O, 2013, NEUROBIOL LEARN MEM, V100, P117, DOI 10.1016/j.nlm.2012.12.014; Silberberg G, 2005, TRENDS NEUROSCI, V28, P541, DOI 10.1016/j.tins.2005.08.004; Singer W, 2006, ANN NY ACAD SCI, V929, P123; Sirota A, 2008, NEURON, V60, P683, DOI 10.1016/j.neuron.2008.09.014; SOLTESZ I, 1993, J NEUROPHYSIOL, V70, P97, DOI 10.1152/jn.1993.70.1.97; Spaak E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045688; STEWART M, 1989, J NEUROPHYSIOL, V61, P982, DOI 10.1152/jn.1989.61.5.982; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; Strogatz SH., 2001, NONLINEAR DYNAMICS C; STUMPF C, 1965, ELECTROEN CLIN NEURO, V18, P477, DOI 10.1016/0013-4694(65)90128-8; Takacs VT, 2012, HIPPOCAMPUS, V22, P1379, DOI 10.1002/hipo.20974; Thierry AM, 2000, HIPPOCAMPUS, V10, P411, DOI 10.1002/1098-1063(2000)10:4<411::AID-HIPO7>3.0.CO;2-A; Tort ABL, 2010, J NEUROPHYSIOL, V104, P1195, DOI 10.1152/jn.00106.2010; Tort ABL, 2009, P NATL ACAD SCI USA, V106, P20942, DOI 10.1073/pnas.0911331106; Tort ABL, 2008, P NATL ACAD SCI USA, V105, P20517, DOI 10.1073/pnas.0810524105; Traub RD, 1997, J COMPUT NEUROSCI, V4, P141, DOI 10.1023/A:1008839312043; VanRullen R, 2003, TRENDS COGN SCI, V7, P207, DOI 10.1016/S1364-6613(03)00095-0; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Voytek B, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00191; Wallace E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014804; Wang HX, 2008, P NATL ACAD SCI USA, V105, P16791, DOI 10.1073/pnas.0804318105; Wang XJ, 1996, J NEUROSCI, V16, P6402; White JA, 2000, P NATL ACAD SCI USA, V97, P8128, DOI 10.1073/pnas.100124097; Whittington MA, 2000, INT J PSYCHOPHYSIOL, V38, P315, DOI 10.1016/S0167-8760(00)00173-2; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; WILSON HR, 1972, BIOPHYS J, V12, P1, DOI 10.1016/S0006-3495(72)86068-5; Wilson MT, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002560; Womelsdorf T, 2006, NATURE, V439, P733, DOI 10.1038/nature04258; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]; Wulff P, 2009, P NATL ACAD SCI USA, V106, P3561, DOI 10.1073/pnas.0813176106; Yoder RM, 2005, HIPPOCAMPUS, V15, P381, DOI 10.1002/hipo.20062; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252; Zhang XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036472	107	44	44	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e102591	10.1371/journal.pone.0102591	http://dx.doi.org/10.1371/journal.pone.0102591			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136855	gold, Green Published			2022-12-25	WOS:000340742100002
J	Zielonka, M; Krishnan, RK; Swiercz, JM; Offermanns, S				Zielonka, Matthias; Krishnan, Ramesh K.; Swiercz, Jakub M.; Offermanns, Stefan			The I kappa B Kinase Complex Is Required for Plexin-B-Mediated Activation of RhoA	PLOS ONE			English	Article							SIGNALING PATHWAYS; SEMAPHORIN 4D; RECEPTOR PLEXIN-B1; TUMOR ANGIOGENESIS; CANCER METASTASIS; MELANOMA-CELLS; IKK-ALPHA; PROTEINS; GROWTH; TRANSMEMBRANE	Plexins are widely expressed transmembrane proteins that mediate the cellular effects of semaphorins. The molecular mechanisms of plexin-mediated signal transduction are still poorly understood. Here we show that signalling via B-family plexins leading to the activation of the small GTPase RhoA requires activation of the I kappa B kinase (IKK)-complex. In contrast, plexin-B-dependent regulation of R-Ras activity is not affected by IKK activity. This regulation of plexin signalling depends on the kinase activity of the IKK-complex, but is independent of NF-kappa B activation. We confirm that the IKK-complex is active in tumour cells and osteoblasts, and we demonstrate that plexin-B-dependent tumour cell invasiveness and regulation of osteoblast differentiation require an active IKK-complex. This study identifies a novel, NF-kappa B-independent function of the IKK-complex and shows that IKK directs plexin-B signalling to the activation of RhoA.	[Zielonka, Matthias; Krishnan, Ramesh K.; Swiercz, Jakub M.; Offermanns, Stefan] Max Planck Inst Heart & Lung Res, Dept Pharmacol, Bad Nauheim, Germany; [Zielonka, Matthias] Heidelberg Univ, Inst Pharmacol, Heidelberg, Germany; [Offermanns, Stefan] Goethe Univ Frankfurt, Fac Med, D-60054 Frankfurt, Germany	Max Planck Society; Ruprecht Karls University Heidelberg; Goethe University Frankfurt	Swiercz, JM (corresponding author), Max Planck Inst Heart & Lung Res, Dept Pharmacol, Bad Nauheim, Germany.	Jakub.Swiercz@mpi-bn.mpg.de; Stefan.Offermanns@mpi-bn.mpg.de	Offermanns, Stefan/L-3313-2017	Offermanns, Stefan/0000-0001-8676-6805				Arkan MC, 2011, CURR TOP MICROBIOL, V349, P159, DOI 10.1007/82_2010_97; Artigiani S, 2004, EMBO REP, V5, P710, DOI 10.1038/sj.embor.7400189; Aurandt J, 2002, P NATL ACAD SCI USA, V99, P12085, DOI 10.1073/pnas.142433199; Basile JR, 2004, CANCER RES, V64, P5212, DOI 10.1158/0008-5472.CAN-04-0126; Bollrath J, 2009, EMBO REP, V10, P1314, DOI 10.1038/embor.2009.243; Chariot A, 2009, TRENDS CELL BIOL, V19, P404, DOI 10.1016/j.tcb.2009.05.006; Deng SH, 2007, J NEUROSCI, V27, P6333, DOI 10.1523/JNEUROSCI.5381-06.2007; Descargues P, 2008, P NATL ACAD SCI USA, V105, P2487, DOI 10.1073/pnas.0712044105; Devalaraja MN, 1999, CANCER RES, V59, P1372; Diarra D, 2007, NAT MED, V13, P156, DOI 10.1038/nm1538; Fukuhara S, 2001, ONCOGENE, V20, P1661, DOI 10.1038/sj.onc.1204182; Furuyama T, 1996, J BIOL CHEM, V271, P33376, DOI 10.1074/jbc.271.52.33376; Gareus R, 2007, NAT CELL BIOL, V9, P461, DOI 10.1038/ncb1560; Gasparian AV, 2002, J CELL SCI, V115, P141; Giordano S, 2002, NAT CELL BIOL, V4, P720, DOI 10.1038/ncb843; Gupta SC, 2010, J BIOL CHEM, V285, P35406, DOI 10.1074/jbc.M110.161984; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; Hinz M, 2014, EMBO REP, V15, P46, DOI 10.1002/embr.201337983; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Ishikawa K, 1997, DNA Res, V4, P307, DOI 10.1093/dnares/4.5.307; Jackson-Bernitsas DG, 2007, ONCOGENE, V26, P1385, DOI 10.1038/sj.onc.1209945; Jain G, 2012, NEOPLASIA, V14, P178, DOI 10.1593/neo.111444; Kameyama T, 1996, BIOCHEM BIOPH RES CO, V226, P524, DOI 10.1006/bbrc.1996.1388; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kishore N, 2003, J BIOL CHEM, V278, P32861, DOI 10.1074/jbc.M211439200; Kumar A, 2001, J BIOL CHEM, V276, P2668, DOI 10.1074/jbc.M008356200; Lee DF, 2007, CELL, V130, P440, DOI 10.1016/j.cell.2007.05.058; Lee SH, 2004, P NATL ACAD SCI USA, V101, P17416, DOI 10.1073/pnas.0408061101; Liu BG, 2008, CANCER CELL, V14, P212, DOI 10.1016/j.ccr.2008.07.017; Liu F, 2012, IMMUNOL REV, V246, P239, DOI 10.1111/j.1600-065X.2012.01107.x; Liu S, 2012, J INTERF CYTOK RES, V32, P152, DOI 10.1089/jir.2011.0107; Maestrini E, 1996, P NATL ACAD SCI USA, V93, P674, DOI 10.1073/pnas.93.2.674; Maier V, 2011, MOL CELL NEUROSCI, V46, P419, DOI 10.1016/j.mcn.2010.11.005; Masuda K, 2004, GENES CELLS, V9, P821, DOI 10.1111/j.1365-2443.2004.00766.x; Matsumoto T, 2011, BONE, V48, P129, DOI 10.1016/j.bone.2010.05.036; May MJ, 2000, SCIENCE, V289, P1550, DOI 10.1126/science.289.5484.1550; Negishi-Koga T, 2011, NAT MED, V17, P1473, DOI 10.1038/nm.2489; Neufeld G, 2008, NAT REV CANCER, V8, P632, DOI 10.1038/nrc2404; Ochiai Takanori, 2008, J Med Dent Sci, V55, P49; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Oinuma I, 2004, SCIENCE, V305, P862, DOI 10.1126/science.1097545; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; Perrot V, 2002, J BIOL CHEM, V277, P43115, DOI 10.1074/jbc.M206005200; Ren XD, 2000, METHOD ENZYMOL, V325, P264; Saito Y, 2009, EMBO REP, V10, P614, DOI 10.1038/embor.2009.63; Scheidereit C, 2006, ONCOGENE, V25, P6685, DOI 10.1038/sj.onc.1209934; Shih VFS, 2011, CELL RES, V21, P86, DOI 10.1038/cr.2010.161; Sil AK, 2004, NATURE, V428, P660, DOI 10.1038/nature02421; Suzuki K, 2008, NAT IMMUNOL, V9, P17, DOI 10.1038/ni1553; Swiercz JM, 2008, J BIOL CHEM, V283, P1893, DOI 10.1074/jbc.M706822200; Swiercz JM, 2009, MOL CELL BIOL, V29, P6321, DOI 10.1128/MCB.00103-09; Swiercz JM, 2004, J CELL BIOL, V165, P869, DOI 10.1083/jcb.200312094; Swiercz JM, 2002, NEURON, V35, P51, DOI 10.1016/S0896-6273(02)00750-X; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Tamagnone L, 2012, CANCER CELL, V22, P145, DOI 10.1016/j.ccr.2012.06.031; Tan W, 2011, NATURE, V470, P548, DOI 10.1038/nature09707; Tran TS, 2007, ANNU REV CELL DEV BI, V23, P263, DOI 10.1146/annurev.cellbio.22.010605.093554; van Triest Miranda, 2004, Methods Mol Biol, V250, P97; Wang YX, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002636; Worzfeld T, 2012, J CLIN INVEST, V122, P1296, DOI 10.1172/JCI60568; Xiang SY, 2013, BBA-MOL CELL BIOL L, V1831, P213, DOI 10.1016/j.bbalip.2012.09.004; Yang JM, 2001, CANCER RES, V61, P4901; Yang YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025826; Yeh PY, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-53; Yukawa K, 2010, INT J MOL MED, V26, P39, DOI 10.3892/ijmm_00000432	67	2	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105661	10.1371/journal.pone.0105661	http://dx.doi.org/10.1371/journal.pone.0105661			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137062	Green Published, Green Submitted, gold			2022-12-25	WOS:000340742100113
J	Nanjappa, D; Audic, S; Romac, S; Kooistra, WHCF; Zingone, A				Nanjappa, Deepak; Audic, Stephane; Romac, Sarah; Kooistra, Wiebe H. C. F.; Zingone, Adriana			Assessment of Species Diversity and Distribution of an Ancient Diatom Lineage Using a DNA Metabarcoding Approach	PLOS ONE			English	Article							GENUS SKELETONEMA BACILLARIOPHYCEAE; RIBOSOMAL-RNA; PHYLOGENETIC ANALYSES; COMPLEX BACILLARIOPHYCEAE; LEPTOCYLINDRUS-DANICUS; CHAETOCEROS-SOCIALIS; REVEALS; BIOGEOGRAPHY; ENVIRONMENT; MORPHOLOGY	Background: Continuous efforts to estimate actual diversity and to trace the species distribution and ranges in the natural environments have gone in equal pace with advancements of the technologies in the study of microbial species diversity from microscopic observations to DNA-based barcoding. DNA metabarcoding based on Next Generation Sequencing (NGS) constitutes the latest advancement in these efforts. Here we use NGS data from different sites to investigate the geographic range of six species of the diatom family Leptocylindraceae and to identify possible new taxa within the family. Methodology/Principal Findings: We analysed the V4 and V9 regions of the nuclear-encoded SSU rDNA gene region in the NGS database of the European ERA-Biodiversa project BioMarKs, collected in plankton and sediments at six coastal sites in European coastal waters, as well as environmental sequences from the NCBI database. All species known in the family Leptocylindraceae were detected in both datasets, but the much larger Illumina V9 dataset showed a higher species coverage at the various sites than the 454 V4 dataset. Sequences identical or similar to the references of Leptocylindrus aporus, L. convexus, L. danicus/hargravesii and Tenuicylindrus belgicus were found in the Mediterranean Sea, North Atlantic Ocean and Black Sea as well as at locations outside Europe. Instead, sequences identical or close to that of L. minimus were found in the North Atlantic Ocean and the Black Sea but not in the Mediterranean Sea, while sequences belonging to a yet undescribed taxon were encountered only in Oslo Fjord and Baffin Bay. Conclusions/Significance: Identification of Leptocylindraceae species in NGS datasets has expanded our knowledge of the species biogeographic distribution and of the overall diversity of this diatom family. Individual species appear to be widespread, but not all of them are found everywhere. Despite the sequencing depth allowed by NGS and the wide geographic area covered by this study, the diversity of this ancient diatom family appears to be low, at least at the level of the marker used in this study.	[Nanjappa, Deepak; Kooistra, Wiebe H. C. F.; Zingone, Adriana] Stn Zool Anton Dohrn, Naples, Italy; [Audic, Stephane; Romac, Sarah] Univ Sorbonne, UPMC, CNRS, EPEP,UMR,Stn Biol Roscoff, Roscoff, France	Stazione Zoologica Anton Dohrn di Napoli; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Nanjappa, D (corresponding author), Stn Zool Anton Dohrn, Naples, Italy.	depac.n@gmail.com; zingone@szn.it	Zingone, Adriana/E-4518-2010; Nanjappa, Deepak/AAX-2176-2020	Zingone, Adriana/0000-0001-5946-6532; Audic, Stephane/0000-0001-6193-4374; Kooistra, Wiebe/0000-0002-8641-9739	SZN-Open University PhD program; Progetto Premiale MetaTrac [Bando 21/2012]	SZN-Open University PhD program; Progetto Premiale MetaTrac	D. Nanjappa was supported by the SZN-Open University PhD program and by the Progetto Premiale MetaTrac (Bando 21/2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alix B, 2012, NUCLEIC ACIDS RES, V40, pW573, DOI 10.1093/nar/gks485; Amaral-Zettler LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006372; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Baas Becking L.G.M., 1934, GEOBIOLOGIE INLEIDIN; Berney C, 2013, ISME J, V7, P2387, DOI 10.1038/ismej.2013.116; Bittner L, 2013, MOL ECOL, V22, P87, DOI 10.1111/mec.12108; Case RJ, 2007, APPL ENVIRON MICROB, V73, P278, DOI 10.1128/AEM.01177-06; Degerlund M, 2012, J PLANKTON RES, V34, P416, DOI 10.1093/plankt/fbs004; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Edgcomb V, 2011, ISME J, V5, P1344, DOI 10.1038/ismej.2011.6; Egge E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074371; Fenchel T, 2006, PHILOS T R SOC B, V361, P1965, DOI 10.1098/rstb.2006.1924; FRENCH FW, 1985, J PHYCOL, V21, P477; FRENCH FW, 1986, J PHYCOL, V22, P411, DOI 10.1111/j.1529-8817.1986.tb02482.x; Gilbert JA, 2009, ENVIRON MICROBIOL, V11, P3132, DOI 10.1111/j.1462-2920.2009.02017.x; Gran HH, 1915, PLANKTON PRODUCTION; Guillou L, 2013, NUCLEIC ACIDS RES, V41, pD597, DOI 10.1093/nar/gks1160; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Hargraves P.E., 1990, NOVA HEDWIGIA S, V100, P47; HARGRAVES PE, 1976, J PHYCOL, V12, P118, DOI 10.1111/j.1529-8817.1976.tb02838.x; HILLIS DM, 1992, J HERED, V83, P189, DOI 10.1093/oxfordjournals.jhered.a111190; Huseby S, 2012, EUR J PHYCOL, V47, P480, DOI 10.1080/09670262.2012.741714; Huson D. H., 2012, SYSTEMATIC BIOL; Karsenti E, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001177; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kooistra WHCF, 2008, PROTIST, V159, P177, DOI 10.1016/j.protis.2007.09.004; Logares R, 2012, ISME J, V6, P1823, DOI 10.1038/ismej.2012.36; Lovejoy C, 2006, APPL ENVIRON MICROB, V72, P3085, DOI 10.1128/AEM.72.5.3085-3095.2006; Lundholm N, 2006, J PHYCOL, V42, P464, DOI 10.1111/j.1529-8817.2006.00211.x; Mann DG, 2013, J EUKARYOT MICROBIOL, V60, P414, DOI 10.1111/jeu.12047; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; McDonald SM, 2007, AQUAT MICROB ECOL, V50, P75, DOI 10.3354/ame01148; Meunier A, 1915, MICROPLANKTON MER FL; Montresor M, 2013, MAR ECOL PROG SER, V484, P79, DOI 10.3354/meps10236; Nanjappa D, 2014, MAR DRUGS, V12, P368, DOI 10.3390/md12010368; Nanjappa D, 2013, J PHYCOL, V49, P917, DOI 10.1111/jpy.12102; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Potvin M, 2009, J EUKARYOT MICROBIOL, V56, P174, DOI 10.1111/j.1550-7408.2008.00386.x; Proshkina-Lavrenko AI, 1955, DIATOMOVYE VODOROSIL; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Sarno D, 2005, J PHYCOL, V41, P151, DOI 10.1111/j.1529-8817.2005.04067.x; Sarno D, 2007, J PHYCOL, V43, P156, DOI 10.1111/j.1529-8817.2006.00305.x; Shirokawa Y, 2012, EUR J PHYCOL, V47, P245, DOI 10.1080/09670262.2012.697580; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stoeck T, 2003, APPL ENVIRON MICROB, V69, P2657, DOI 10.1128/AEM.69.5.2657-2663.2003; Stoeck T, 2010, MOL ECOL, V19, P21, DOI 10.1111/j.1365-294X.2009.04480.x; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Telford RJ, 2006, SCIENCE, V312, P1015, DOI 10.1126/science.1125669; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Whitaker RJ, 2003, SCIENCE, V301, P976, DOI 10.1126/science.1086909	50	32	33	2	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e103810	10.1371/journal.pone.0103810	http://dx.doi.org/10.1371/journal.pone.0103810			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133638	Green Published, Green Submitted, gold			2022-12-25	WOS:000341302700017
J	Tabata-Imai, A; Inoue, R; Mori, H				Tabata-Imai, Ayako; Inoue, Ran; Mori, Hisashi			Increased Sensitivity to Inflammatory Pain Induced by Subcutaneous Formalin Injection in Serine Racemase Knock-Out Mice	PLOS ONE			English	Article							D-ASPARTATE RECEPTOR; LONG-TERM POTENTIATION; C-FOS EXPRESSION; SPINAL-CORD; DORSAL-HORN; CENTRAL SENSITIZATION; NMDA-RECEPTORS; ACTIVATION; GLUTAMATE; GLYCINE	D-Serine, an endogenous coagonist of the N-methyl-D-aspartate receptor (NMDAR), is widely distributed in the central nervous system and is synthesized from L-serine by serine racemase (SR). NMDAR plays an important role in pain processing including central sensitization that eventually causes hyperalgesia. To elucidate the roles of D-serine and SR in pain transmission, we evaluated the behavioral changes and spinal nociceptive processing induced by formalin using SR knock-out (KO) mice. We found that SR is mainly distributed in lamina II of the dorsal horn of the spinal cord in wild-type (WT) mice. Although the formalin injected subcutaneously induced the biphasic pain response of licking in SR-KO and WT mice, the time spent on licking was significantly longer in the SR-KO mice during the second phase of the formalin test. The number of neurons immunopositive for c-Fos and phosphorylated extracellular signal-regulated kinase (p-ERK), which are molecular pain markers, in laminae I-II of the ipsilateral dorsal horn was significantly larger in the SR-KO mice. Immunohistochemical staining revealed that the distribution of SR changed from being broad to being concentrated in cell bodies after the formalin injection. On the other hand, the expression level of the cytosolic SR in the ipsilateral dorsal horn significantly decreased. Oral administration of 10 mM D-serine in drinking water for one week cancelled the difference in pain behaviors between WT and SR-KO mice in phase 2 of the formalin test. These findings demonstrate that the SR-KO mice showed increased sensitivity to inflammatory pain and the WT mice showed translocation of SR and decreased SR expression levels after the formalin injection, which suggest a novel antinociceptive mechanism via SR indicating an important role of D-serine in pain transmission.	[Tabata-Imai, Ayako; Inoue, Ran; Mori, Hisashi] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Mol Neurosci, Toyama 930, Japan	University of Toyama	Mori, H (corresponding author), Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Mol Neurosci, Toyama 930, Japan.	hmori@med.u-toyama.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [25293059]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research (B) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (Grant No. 25293059; URL: http://www.mext.go.j/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi S, 2003, SCIENCE, V300, P2094, DOI 10.1126/science.1083970; Balan L, 2009, P NATL ACAD SCI USA, V106, P7589, DOI 10.1073/pnas.0809442106; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Basu AC, 2009, MOL PSYCHIATR, V14, P719, DOI 10.1038/mp.2008.130; Boyce S, 1999, NEUROPHARMACOLOGY, V38, P611, DOI 10.1016/S0028-3908(98)00218-4; Cornelio AM, 2011, BRAIN RES, V1415, P56, DOI 10.1016/j.brainres.2011.07.058; DUBUISSON D, 1977, PAIN, V4, P161, DOI 10.1016/0304-3959(77)90130-0; Dumin E, 2006, J BIOL CHEM, V281, P20291, DOI 10.1074/jbc.M601971200; Fukuda T, 2006, ANESTH ANALG, V102, P811, DOI 10.1213/01.ane.0000197690.19075.bd; Fukuda T, 2009, ANESTH ANALG, V109, P1318, DOI 10.1213/ane.0b013e3181b0fe05; Gao Yong-Jing, 2009, Open Pain J, V2, P11; Ghilardi JR, 2004, J NEUROSCI, V24, P2727, DOI 10.1523/JNEUROSCI.5054-03.2004; Gong NA, 2011, J PHARMACOL EXP THER, V336, P282, DOI 10.1124/jpet.110.172353; Harris JA, 1998, BRAIN RES BULL, V45, P1, DOI 10.1016/S0361-9230(97)00277-3; HASHIMOTO A, 1993, J NEUROCHEM, V60, P783, DOI 10.1111/j.1471-4159.1993.tb03219.x; HUNSKAAR S, 1985, J NEUROSCI METH, V14, P69, DOI 10.1016/0165-0270(85)90116-5; HUNSKAAR S, 1987, PAIN, V30, P103, DOI 10.1016/0304-3959(87)90088-1; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Inoue R, 2014, J INVEST DERMATOL, V134, P1618, DOI 10.1038/jid.2014.22; Inoue R, 2008, J NEUROSCI, V28, P14486, DOI 10.1523/JNEUROSCI.5034-08.2008; Ji RR, 1999, NAT NEUROSCI, V2, P1114, DOI 10.1038/16040; Ji RR, 2002, J NEUROSCI, V22, P478, DOI 10.1523/JNEUROSCI.22-02-00478.2002; Kim Y, 2012, PAIN, V153, P1022, DOI 10.1016/j.pain.2012.02.003; KLECKNER NW, 1988, SCIENCE, V241, P835, DOI 10.1126/science.2841759; KOLHEKAR R, 1994, NEUROSCIENCE, V63, P925, DOI 10.1016/0306-4522(94)90560-6; Kovacs G, 2004, NEUROPHARMACOLOGY, V46, P23, DOI 10.1016/S0028-3908(03)00339-3; Labrie V, 2009, HUM MOL GENET, V18, P3227, DOI 10.1093/hmg/ddp261; Laskowski K, 2011, CAN J ANESTH, V58, P911, DOI 10.1007/s12630-011-9560-0; Latremoliere A, 2009, J PAIN, V10, P895, DOI 10.1016/j.jpain.2009.06.012; Lorenzo LE, 2008, J COMP NEUROL, V508, P592, DOI 10.1002/cne.21691; Lu JM, 2012, BRIT J PHARMACOL, V165, P1941, DOI 10.1111/j.1476-5381.2011.01680.x; Malmberg AB, 2003, PAIN, V101, P109, DOI 10.1016/S0304-3959(02)00303-2; MALMBERG AB, 1992, J PHARMACOL EXP THER, V263, P136; MATSUI T, 1995, J NEUROCHEM, V65, P454; Merrill AW, 2006, ANESTH ANALG, V103, P478, DOI 10.1213/01.ane.0000223847.50233.1b; Miya K, 2008, J COMP NEUROL, V510, P641, DOI 10.1002/cne.21822; Miyoshi Y, 2011, J CHROMATOGR B, V879, P3184, DOI 10.1016/j.jchromb.2010.08.024; MORI H, 1995, NEUROPHARMACOLOGY, V34, P1219, DOI 10.1016/0028-3908(95)00109-J; Mori H, 2010, CHEM BIODIVERS, V7, P1573, DOI 10.1002/cbdv.200900293; Mothet JP, 2006, AGING CELL, V5, P267, DOI 10.1111/j.1474-9726.2006.00216.x; Mothet JP, 2000, P NATL ACAD SCI USA, V97, P4926, DOI 10.1073/pnas.97.9.4926; Mustafa AK, 2007, P NATL ACAD SCI USA, V104, P2950, DOI 10.1073/pnas.0611620104; Muth-Selbach U, 2009, EUR J PHARMACOL, V613, P68, DOI 10.1016/j.ejphar.2009.04.043; Nagy GG, 2004, EUR J NEUROSCI, V20, P3301, DOI 10.1111/j.1460-9568.2004.03798.x; Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051; Pedersen LM, 2008, ACTA PHYSIOL, V192, P421, DOI 10.1111/j.1748-1716.2007.01756.x; Perissin L, 2004, PAIN, V110, P250, DOI 10.1016/j.pain.2004.03.039; Polgar E, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-4; ROSLAND JH, 1991, PAIN, V45, P211, DOI 10.1016/0304-3959(91)90190-9; Sandkuhler J, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-9; Sasabe J, 2007, EMBO J, V26, P4149, DOI 10.1038/sj.emboj.7601840; SCHELL MJ, 1995, P NATL ACAD SCI USA, V92, P3948, DOI 10.1073/pnas.92.9.3948; Seo YJ, 2006, BRAIN RES BULL, V71, P279, DOI 10.1016/j.brainresbull.2006.09.012; Snyder SH, 2000, NEUROCHEM RES, V25, P553, DOI 10.1023/A:1007586314648; Svensson CI, 2006, FEBS LETT, V580, P6629, DOI 10.1016/j.febslet.2006.11.012; Turpin FR, 2011, NEUROBIOL AGING, V32, P1495, DOI 10.1016/j.neurobiolaging.2009.09.001; Wake K, 2001, NEUROSCI LETT, V297, P25, DOI 10.1016/S0304-3940(00)01658-X; WATANABE M, 1994, J COMP NEUROL, V345, P314, DOI 10.1002/cne.903450212; WHEELERACETO H, 1990, PAIN, V40, P229, DOI 10.1016/0304-3959(90)90073-M; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P13409, DOI 10.1073/pnas.96.23.13409; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P721, DOI 10.1073/pnas.96.2.721; WOOLF CJ, 1983, NATURE, V306, P686, DOI 10.1038/306686a0; WOOLF CJ, 1991, PAIN, V44, P293, DOI 10.1016/0304-3959(91)90100-C; Yang YL, 2003, P NATL ACAD SCI USA, V100, P15194, DOI 10.1073/pnas.2431073100; Yoon MH, 1999, ANESTH ANALG, V89, P434, DOI 10.1097/00000539-199908000-00034; Zhao WJ, 2008, CELL MOL NEUROBIOL, V28, P581, DOI 10.1007/s10571-007-9200-y; Zylka MJ, 2005, NEURON, V45, P17, DOI 10.1016/j.neuron.2004.12.015	67	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105282	10.1371/journal.pone.0105282	http://dx.doi.org/10.1371/journal.pone.0105282			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133605	Green Submitted, gold, Green Published			2022-12-25	WOS:000341302700097
J	Duraes, C; Moreira, CS; Alvelos, I; Mendes, A; Santos, LR; Machado, JC; Melo, M; Esteves, C; Neves, C; Sobrinho-Simoes, M; Soares, P				Duraes, Cecilia; Moreira, Carla S.; Alvelos, Ines; Mendes, Adelia; Santos, Liliana R.; Machado, Jose Carlos; Melo, Miguel; Esteves, Cesar; Neves, Celestino; Sobrinho-Simoes, Manuel; Soares, Paula			Polymorphisms in the TNFA and IL6 Genes Represent Risk Factors for Autoimmune Thyroid Disease	PLOS ONE			English	Article							INTERLEUKIN-1 RECEPTOR ANTAGONIST; INTERFERON-GAMMA RECEPTOR; FACTOR-ALPHA PROMOTER; GRAVES-DISEASE; T-CELLS; CHINESE PATIENTS; IFN-GAMMA; ASSOCIATION; SUSCEPTIBILITY; OPHTHALMOPATHY	Background: Autoimmune thyroid disease (AITD) comprises diseases including Hashimoto's thyroiditis and Graves' disease, both characterized by reactivity to autoantigens causing, respectively, inflammatory destruction and autoimmune stimulation of the thyroid-stimulating hormone receptor. AITD is the most common thyroid disease and the leading form of autoimmune disease in women. Cytokines are key regulators of the immune and inflammatory responses; therefore, genetic variants at cytokine-encoding genes are potential risk factors for AITD. Methods: Polymorphisms in the IL6-174 G/C (rs1800795), TNFA-308 G/A (rs1800629), IL1B-511 C/T (rs16944), and IFNGR1-56 T/C (rs2234711) genes were assessed in a case-control study comprising 420 Hashimoto's thyroiditis patients, 111 Graves' disease patients and 735 unrelated controls from Portugal. Genetic variants were discriminated by real-time PCR using TaqMan SNP genotyping assays. Results: A significant association was found between the allele A in TNFA-308 G/A and Hashimoto's thyroiditis, both in the dominant (OR = 1.82, CI = 1.37-2.43, p-value = 4.4x10(-5)) and log-additive (OR = 1.64, CI = 1.28-2.10, p-value = 8.2x10(-5)) models. The allele C in IL6-174 G/C is also associated with Hashimoto's thyroiditis, however, only retained significance after multiple testing correction in the log-additive model (OR = 1.28, CI = 1.06-1.54, p-value = 8.9x10(-3)). The group with Graves' disease also registered a higher frequency of the allele A in TNFA-308 G/A compared with controls both in the dominant (OR = 1.85, CI = 1.19-2.87, p-value = 7.0x10(-3)) and log-additive (OR = 1.69, CI = 1.17-2.44, p-value = 6.6x10(-3)) models. The risk for Hashimoto's thyroiditis and Graves' disease increases with the number of risk alleles (OR for two risk alleles is, respectively, 2.27 and 2.59). Conclusions: This study reports significant associations of genetic variants in TNFA and IL6 with the risk for AITD, highlighting the relevance of polymorphisms in inflammation-related genes in the etiopathogenesis of AITD.	[Duraes, Cecilia; Moreira, Carla S.; Alvelos, Ines; Mendes, Adelia; Machado, Jose Carlos; Melo, Miguel; Sobrinho-Simoes, Manuel; Soares, Paula] Univ Porto IPATIMUP, Inst Mol Pathol & Immunol, Oporto, Portugal; [Moreira, Carla S.; Santos, Liliana R.; Machado, Jose Carlos; Neves, Celestino; Sobrinho-Simoes, Manuel; Soares, Paula] Univ Porto, Fac Med, P-4100 Oporto, Portugal; [Santos, Liliana R.] Univ Coimbra, Fac Med, Coimbra, Portugal; [Melo, Miguel] Univ & Hosp Ctr Coimbra, Dept Diabet Endocrinol & Metab, Coimbra, Portugal; [Melo, Miguel] Univ Coimbra, Fac Med, Unit Endocrinol, Coimbra, Portugal; [Esteves, Cesar; Neves, Celestino] Hosp Sao Joao, Dept Endocrinol, Oporto, Portugal; [Sobrinho-Simoes, Manuel; Soares, Paula] Univ Porto, Fac Med, Dept Pathol & Oncol, P-4100 Oporto, Portugal	Universidade do Porto; Universidade do Porto; Universidade de Coimbra; Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); Universidade de Coimbra; Sao Joao Hospital; Universidade do Porto	Soares, P (corresponding author), Univ Porto IPATIMUP, Inst Mol Pathol & Immunol, Oporto, Portugal.	psoares@ipatimup.pt	Soares, Paula/B-6054-2008; Durães, Cecília/I-2117-2013; Sobrinho-Simões, Manuel/J-8290-2013; Santos, Liliana R/T-3316-2019; Machado, Jose Carlos/C-5907-2009; Duraes, Cecilia/AAY-8903-2021; Melo, Miguel/L-2106-2014	Soares, Paula/0000-0001-9607-6998; Durães, Cecília/0000-0001-9282-0708; Machado, Jose Carlos/0000-0003-4741-8415; Duraes, Cecilia/0000-0001-9282-0708; Neves, Celestino/0000-0002-9575-5902; Mendes, Adelia/0000-0001-6636-0453; Sobrinho-Simoes, Manuel/0000-0003-1613-1235; Melo, Miguel/0000-0002-8365-1380	IPG-UP (Investigacao Cientifica na Pre-Graduacao-Universidade do Porto) grant; Caixa Geral de Depositos; BII grant from the Portuguese Foundation for Science and Technology (FCT); FCT [SFRH/BPD/62974/2009]; Portuguese Foundation for Science and Technology (FCT)	IPG-UP (Investigacao Cientifica na Pre-Graduacao-Universidade do Porto) grant; Caixa Geral de Depositos; BII grant from the Portuguese Foundation for Science and Technology (FCT); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology)	This study was supported by an IPG-UP (Investigacao Cientifica na Pre-Graduacao-Universidade do Porto) grant (with financial support from Caixa Geral de Depositos). Carla Moreira was the recipient of a BII grant from the Portuguese Foundation for Science and Technology (FCT). Cecilia Duraes is supported by an FCT grant (SFRH/BPD/62974/2009). IPATIMUP is an Associate Laboratory of the Portuguese Ministry of Science, Technology and Higher Education and is partially supported by the Portuguese Foundation for Science and Technology (FCT URL: http://www.fct.pt). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anvari M, 2010, ENDOCRINE, V37, P344, DOI 10.1007/s12020-010-9311-y; Aust G, 1996, CLIN EXP IMMUNOL, V105, P148, DOI 10.1046/j.1365-2249.1996.d01-726.x; Barbieri M, 2005, EXP GERONTOL, V40, P599, DOI 10.1016/j.exger.2005.05.004; Bednarczuk T, 2004, AUTOIMMUNITY, V37, P223, DOI 10.1080/0891693042000193320; Belfer I, 2010, INT J STROKE, V5, P145, DOI 10.1111/j.1747-4949.2010.00422.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berkovic MC, 2007, EXP MOL PATHOL, V83, P474, DOI 10.1016/j.yexmp.2007.08.018; BIOQUE G, 1995, CLIN EXP IMMUNOL, V102, P379; Bougacha-Elleuch N, 2004, J AUTOIMMUN, V23, P75, DOI 10.1016/j.jaut.2004.03.011; Canedo P, 2008, GUT, V57, P1504, DOI 10.1136/gut.2007.143578; Caturegli P, 2007, CURR OPIN RHEUMATOL, V19, P44, DOI 10.1097/BOR.0b013e3280113d1a; Chen PL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016635; Chen RH, 2005, INT J IMMUNOGENET, V32, P343, DOI 10.1111/j.1744-313X.2005.00536.x; Chen RH, 2005, J CLIN LAB ANAL, V19, P133, DOI 10.1002/jcla.20067; Chen RH, 2006, J CLIN LAB ANAL, V20, P260, DOI 10.1002/jcla.20152; Chu X, 2011, NAT GENET, V43, P897, DOI 10.1038/ng.898; Cooke GS, 2001, NAT REV GENET, V2, P967, DOI 10.1038/35103577; Eriksson N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034442; Fukutani T, 2004, THYROID, V14, P93, DOI 10.1089/105072504322880328; Ganesh BB, 2011, J INTERF CYTOK RES, V31, P721, DOI 10.1089/jir.2011.0049; Gonzalez JR, 2007, BIOINFORMATICS, V23, P644, DOI 10.1093/bioinformatics/btm025; Gu LQ, 2010, CLIN BIOCHEM, V43, P223, DOI 10.1016/j.clinbiochem.2009.08.012; Horie I, 2011, ENDOCRINOLOGY, V152, P4448, DOI 10.1210/en.2011-1356; Huber A, 2008, ENDOCR REV, V29, P697, DOI 10.1210/er.2008-0015; Hunt PJ, 2001, CLIN ENDOCRINOL, V55, P491, DOI 10.1046/j.1365-2265.2001.01356.x; Inoue N, 2011, CLIN EXP IMMUNOL, V163, P318, DOI 10.1111/j.1365-2249.2010.04306.x; Jager J, 2010, DIABETES, V59, P61, DOI 10.2337/db09-0470; Kallen KJ, 2002, BBA-MOL CELL RES, V1592, P323, DOI 10.1016/S0167-4889(02)00325-7; Kammoun-krichen M, 2008, ANN HUM BIOL, V35, P656, DOI 10.1080/03014460802477939; Khalilzadeh O, 2010, ANN ENDOCRINOL-PARIS, V71, P281, DOI 10.1016/j.ando.2010.01.005; Khalilzadeh O, 2009, CLIN EXP OPHTHALMOL, V37, P614, DOI 10.1111/j.1442-9071.2009.02093.x; Kissonerghis A M, 1989, Autoimmunity, V4, P255, DOI 10.3109/08916938909014702; Kroeger KM, 1997, MOL IMMUNOL, V34, P391, DOI 10.1016/S0161-5890(97)00052-7; Kula D, 2001, FOLIA HISTOCHEM CYTO, V39, P77; Kutluturk F, 2013, ENDOCR METAB IMMUNE, V13, P163, DOI 10.2174/18715303113139990001; Larsen P R KHM, 2003, WILLIAMS TXB ENDOCRI; Li N, 2008, CLIN BIOCHEM, V41, P881, DOI 10.1016/j.clinbiochem.2008.04.014; Liu N, 2010, HUM IMMUNOL, V71, P397, DOI 10.1016/j.humimm.2010.01.023; Liu YH, 2010, INVEST OPHTH VIS SCI, V51, P6238, DOI 10.1167/iovs.09-4965; Marinou I, 2009, ANN RHEUM DIS, V68, P1494, DOI 10.1136/ard.2008.090001; Matsuno H, 2002, RHEUMATOLOGY, V41, P329, DOI 10.1093/rheumatology/41.3.329; Menconi F, 2008, P NATL ACAD SCI USA, V105, P14034, DOI 10.1073/pnas.0806584105; Menconi F, 2008, DIAGNOSTIC CRITERIA IN AUTOIMMUNE DISEASES, P231, DOI 10.1007/978-1-60327-285-8_44; O'Sullivan BJ, 2006, J IMMUNOL, V176, P7278, DOI 10.4049/jimmunol.176.12.7278; Papanas N, 2006, CYTOKINE, V35, P166, DOI 10.1016/j.cyto.2006.07.017; Ramos E, 2004, ANN EPIDEMIOL, V14, P437, DOI 10.1016/j.annepidem.2003.09.013; Ruggeri RM, 2009, J ENDOCRINOL INVEST, V32, P465, DOI [10.3275/6104, 10.1007/BF03346487]; Ruggeri RM, 2006, HISTOL HISTOPATHOL, V21, P249, DOI 10.14670/HH-21.249; SCHEURICH P, 1987, J IMMUNOL, V138, P1786; Shiau MY, 2007, CLIN BIOCHEM, V40, P213, DOI 10.1016/j.clinbiochem.2006.11.009; Simmonds MJ, 2004, GENES IMMUN, V5, P267, DOI 10.1038/sj.gene.6364066; SINHA AA, 1990, SCIENCE, V248, P1380, DOI 10.1126/science.1972595; Slattery ML, 2011, CARCINOGENESIS, V32, P1660, DOI 10.1093/carcin/bgr189; Tomer Y, 2010, THYROID, V20, P715, DOI 10.1089/thy.2010.1644; Tsai LJ, 2009, RHEUMATOL INT, V29, P1001, DOI 10.1007/s00296-009-0900-0; Utiger R., 2000, WERNER INGBARS THYRO, P721; Vangsted AJ, 2009, HAEMATOL-HEMATOL J, V94, P1274, DOI 10.3324/haematol.2008.004572; WEETMAN AP, 1990, J ENDOCRINOL, V127, P357, DOI 10.1677/joe.0.1270357; Wilson AG, 1997, P NATL ACAD SCI USA, V94, P3195, DOI 10.1073/pnas.94.7.3195	59	28	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105492	10.1371/journal.pone.0105492	http://dx.doi.org/10.1371/journal.pone.0105492			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127106	Green Published, gold, Green Submitted			2022-12-25	WOS:000340879300115
J	Forde, BM; Ben Zakour, NL; Stanton-Cook, M; Phan, MD; Totsika, M; Peters, KM; Chan, KG; Schembri, MA; Upton, M; Beatson, SA				Forde, Brian M.; Ben Zakour, Nouri L.; Stanton-Cook, Mitchell; Phan, Minh-Duy; Totsika, Makrina; Peters, Kate M.; Chan, Kok Gan; Schembri, Mark A.; Upton, Mathew; Beatson, Scott A.			The Complete Genome Sequence of Escherichia coli EC958: A High Quality Reference Sequence for the Globally Disseminated Multidrug Resistant E. coli O25b:H4-ST131 Clone	PLOS ONE			English	Article							BETA-LACTAMASE; STRAINS; ASSEMBLIES; COMMENSAL; ALGORITHMS; SELECTION; ISLANDS; GENES	Escherichia coli ST131 is now recognised as a leading contributor to urinary tract and bloodstream infections in both community and clinical settings. Here we present the complete, annotated genome of E. coli EC958, which was isolated from the urine of a patient presenting with a urinary tract infection in the Northwest region of England and represents the most well characterised ST131 strain. Sequencing was carried out using the Pacific Biosciences platform, which provided sufficient depth and read-length to produce a complete genome without the need for other technologies. The discovery of spurious contigs within the assembly that correspond to site-specific inversions in the tail fibre regions of prophages demonstrates the potential for this technology to reveal dynamic evolutionary mechanisms. E. coli EC958 belongs to the major subgroup of ST131 strains that produce the CTX-M-15 extended spectrum beta-lactamase, are fluoroquinolone resistant and encode the fimH30 type 1 fimbrial adhesin. This subgroup includes the Indian strain NA114 and the North American strain JJ1886. A comparison of the genomes of EC958, JJ1886 and NA114 revealed that differences in the arrangement of genomic islands, prophages and other repetitive elements in the NA114 genome are not biologically relevant and are due to misassembly. The availability of a high quality uropathogenic E. coli ST131 genome provides a reference for understanding this multidrug resistant pathogen and will facilitate novel functional, comparative and clinical studies of the E. coli ST131 clonal lineage.	[Forde, Brian M.; Ben Zakour, Nouri L.; Stanton-Cook, Mitchell; Phan, Minh-Duy; Totsika, Makrina; Peters, Kate M.; Schembri, Mark A.; Beatson, Scott A.] Univ Queensland, Australian Infect Dis Res Ctr, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia; [Chan, Kok Gan] Univ Malaya, Fac Sci, Inst Biol Sci, Div Genet & Mol Biol, Kuala Lumpur, Malaysia; [Upton, Mathew] Plymouth Univ Peninsula Sch Med & Dent, Plymouth, Devon, England	University of Queensland; Universiti Malaya	Beatson, SA (corresponding author), Univ Queensland, Australian Infect Dis Res Ctr, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia.	s.beatson@uq.edu.au	Schembri, Mark A/C-7262-2009; Beatson, Scott/B-6985-2013; Upton, Mathew/J-7514-2019; Phan, Minh-Duy/I-9147-2012; Forde, Brian/GLQ-9491-2022; ZAKOUR, Nouri L BEN/B-9338-2011; Chan, Kok Gan/B-8347-2010; Totsika, Makrina/A-8993-2011	Schembri, Mark A/0000-0003-4863-9260; Beatson, Scott/0000-0002-1806-3283; Upton, Mathew/0000-0003-4287-6396; Phan, Minh-Duy/0000-0002-3426-1044; Forde, Brian/0000-0002-2264-4785; ZAKOUR, Nouri L BEN/0000-0002-6949-1755; Chan, Kok Gan/0000-0002-1883-1115; Totsika, Makrina/0000-0003-2468-0293	Australian National Health and Medical Research Council [APP1012076, APP1067455]; University of Malaya HIR Grant (UM-MOHE HIR Grant) [UM.C/625/1/HIR/MOHE/CHAN/14/1]; Australian Research Council (ARC) [FT100100662]; ARC Discovery Early Career Researcher Award [DE130101169]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); University of Malaya HIR Grant (UM-MOHE HIR Grant); Australian Research Council (ARC)(Australian Research Council); ARC Discovery Early Career Researcher Award(Australian Research Council)	This work was supported by grants from the Australian National Health and Medical Research Council to MAS and SAB (APP1012076 and APP1067455) and a University of Malaya HIR Grant to KGC (UM-MOHE HIR Grant UM.C/625/1/HIR/MOHE/CHAN/14/1). MAS is supported by an Australian Research Council (ARC) Future Fellowship (FT100100662). MT is supported by an ARC Discovery Early Career Researcher Award (DE130101169). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Andersen PS, 2013, GENOME ANNOUNCEMENTS, V1; Avasthi TS, 2011, J BACTERIOL, V193, P4272, DOI 10.1128/JB.05413-11; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Carver T, 2008, BIOINFORMATICS, V24, P2672, DOI 10.1093/bioinformatics/btn529; Chen SL, 2006, P NATL ACAD SCI USA, V103, P5977, DOI 10.1073/pnas.0600938103; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/nmeth.2474, 10.1038/NMETH.2474]; Coque TM, 2008, EMERG INFECT DIS, V14, P195, DOI 10.3201/eid1402.070350; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; David M, 2011, BIOINFORMATICS, V27, P1011, DOI 10.1093/bioinformatics/btr046; Dobrindt U, 2002, INFECT IMMUN, V70, P6365, DOI 10.1128/IAI.70.11.6365-6372.2002; English AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041444; Ferenci T, 2009, J BACTERIOL, V191, P4025, DOI 10.1128/JB.00118-09; Fisher CR, 2009, INFECT IMMUN, V77, P1992, DOI 10.1128/IAI.00064-09; Floyd RV, 2012, J INFECT DIS, V206, P1589, DOI 10.1093/infdis/jis554; Gardner SN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081760; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hayashi K, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100049; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; IIDA S, 1987, MOL GEN GENET, V208, P464, DOI 10.1007/BF00328140; IIDA S, 1986, CELL, V45, P71, DOI 10.1016/0092-8674(86)90539-8; Johnson JR, 2010, CLIN INFECT DIS, V51, P286, DOI 10.1086/653932; Johnson TJ, 2007, J BACTERIOL, V189, P3228, DOI 10.1128/JB.01726-06; Kingsford C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-21; Korlach J, 2010, METHOD ENZYMOL, V472, P431, DOI 10.1016/S0076-6879(10)72001-2; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lau SH, 2008, J ANTIMICROB CHEMOTH, V62, P1241, DOI 10.1093/jac/dkn380; Lau SH, 2008, J CLIN MICROBIOL, V46, P1076, DOI 10.1128/JCM.02065-07; Lloyd AL, 2007, J BACTERIOL, V189, P3532, DOI 10.1128/JB.01744-06; Phan MD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003834; Nagarajan N, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-242; Nicolas-Chanoine MH, 2008, J ANTIMICROB CHEMOTH, V61, P273, DOI 10.1093/jac/dkm464; Oshima K, 2008, DNA RES, V15, P375, DOI 10.1093/dnares/dsn026; Otto TD, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1268; Paul S, 2013, J BACTERIOL, V195, P231, DOI 10.1128/JB.01524-12; Peirano G, 2010, INT J ANTIMICROB AG, V35, P316, DOI 10.1016/j.ijantimicag.2009.11.003; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Petty NK, 2014, P NATL ACAD SCI USA, V111, P5694, DOI 10.1073/pnas.1322678111; Phillippy AM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r55; Price L. B., 2013, MBIO, V4, DOI DOI 10.1128/MBIO.00377-13; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; Ricker N, 2012, GENOMICS, V100, P167, DOI 10.1016/j.ygeno.2012.06.009; Salzberg SL, 2012, GENOME RES, V22, P557, DOI 10.1101/gr.131383.111; SANDMEIER H, 1994, MOL MICROBIOL, V12, P343, DOI 10.1111/j.1365-2958.1994.tb01023.x; Shi H, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-83; Sullivan MJ, 2011, BIOINFORMATICS, V27, P1009, DOI 10.1093/bioinformatics/btr039; Toh H, 2010, J BACTERIOL, V192, P1165, DOI 10.1128/JB.01543-09; Totsika M, 2013, J INFECT DIS, V208, P921, DOI 10.1093/infdis/jit245; Totsika M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026578; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	52	74	75	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104400	10.1371/journal.pone.0104400	http://dx.doi.org/10.1371/journal.pone.0104400			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126841	Green Published, gold			2022-12-25	WOS:000340879300024
J	Hurtado, S; Guisbert, KSK; Sontheimer, EJ				Hurtado, Sara; Guisbert, Karen S. Kim; Sontheimer, Erik J.			SPO24 Is a Transcriptionally Dynamic, Small ORF-Encoding Locus Required for Efficient Sporulation in Saccharomyces cerevisiae	PLOS ONE			English	Article							MEIOTIC GENE-EXPRESSION; NONCODING RNA EXPRESSION; TRANSLATIONAL CONTROL; BUDDING YEAST; PHENOTYPIC ANALYSIS; DEFICIENT MUTANTS; SPORE FORMATION; IN-VIVO; MEIOSIS; PROGRAM	In Saccharomyces cerevisiae, meiosis and sporulation are highly regulated responses that are driven in part by changes in RNA expression. Alternative mRNA forms with extended 5' UTRs are atypical in S. cerevisiae, and 5' extensions with upstream open reading frames (uORFs) are even more unusual. Here we characterize the gene YPR036W-A, now renamed SPO24, which encodes a very small (67-amino-acid) protein. This gene gives rise to two mRNA forms: a shorter form throughout meiosis and a longer, 5'-extended form in mid-late meiosis. The latter form includes a uORF for a 14-amino-acid peptide (Spo24(u14)). Deletion of the downstream ORF (dORF) leads to sporulation defects and the appearance of pseudohyphae-like projections. Experiments with luciferase reporters indicate that the uORF does not downregulate dORF translation. The protein encoded by the dORF (Spo24(d67)) localizes to the prospore membrane and is differentially phosphorylated during meiosis. Transcription of the 5'-extended mRNA in mid-meiosis depends upon the presence of two middle sporulation elements (MSEs). Removal of the MSEs severely inhibits the mid-meiotic appearance of the 5'-extended mRNA and limits the ability of plasmid-borne SPO24 to rescue the sporulation defect of a spo24 Delta mutant, suggesting that the 5'-extended mRNA is functionally important. These results reveal Spo24(d67) as a sporulation-related factor that is encoded by a transcriptionally dynamic, uORF-containing locus.	[Hurtado, Sara; Guisbert, Karen S. Kim; Sontheimer, Erik J.] Northwestern Univ, Dept Mol Biosci, Evanston, IL USA	Northwestern University	Sontheimer, EJ (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, RNA Therapeut Inst, Worcester, MA 01605 USA.	erik.sontheimer@umassmed.edu		Sontheimer, Erik/0000-0002-0881-0310; Kim Guisbert, Karen/0000-0001-9907-9502	American Cancer Society; Chicago Biomedical Consortium; The Searle Funds at the Chicago Community Trust; National Institutes of Health (NIH) [R01GM093769]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093769] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Chicago Biomedical Consortium; The Searle Funds at the Chicago Community Trust; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a fellowship from the American Cancer Society to KSKG; by a grant from the Chicago Biomedical Consortium (with support from The Searle Funds at the Chicago Community Trust) to EJS; and by a grant from the National Institutes of Health (NIH) (R01GM093769) to EJS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque CP, 2008, MOL CELL PROTEOMICS, V7, P1389, DOI 10.1074/mcp.M700468-MCP200; Bajgier BK, 2001, MOL BIOL CELL, V12, P1611, DOI 10.1091/mbc.12.6.1611; Benjamin KR, 2003, GENE DEV, V17, P1524, DOI 10.1101/gad.1101503; Brar GA, 2012, SCIENCE, V335, P552, DOI 10.1126/science.1215110; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Chu S, 1998, MOL CELL, V1, P685, DOI 10.1016/S1097-2765(00)80068-4; Clancy MJ, 1998, CURR BIOL, V8, pR461, DOI 10.1016/S0960-9822(98)70293-3; Deutschbauer AM, 2002, P NATL ACAD SCI USA, V99, P15530, DOI 10.1073/pnas.202604399; EATON NR, 1954, J BACTERIOL, V68, P110, DOI 10.1128/JB.68.1.110-116.1954; Enyenihi AH, 2003, GENETICS, V163, P47; ESPOSITO MS, 1969, GENETICS, V61, P79; ESPOSITO MS, 1969, J BACTERIOL, V100, P180, DOI 10.1128/JB.100.1.180-186.1969; FAST D, 1973, J BACTERIOL, V116, P925, DOI 10.1128/JB.116.2.925-930.1973; FREESE EB, 1982, J BACTERIOL, V149, P840, DOI 10.1128/JB.149.3.840-851.1982; Gancedo JM, 2001, FEMS MICROBIOL REV, V25, P107, DOI 10.1016/S0168-6445(00)00056-5; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Gruhler A, 2005, MOL CELL PROTEOMICS, V4, P310, DOI 10.1074/mcp.M400219-MCP200; Guisbert KSK, 2012, RNA, V18, P1142, DOI 10.1261/rna.030510.111; Gurevich V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011005; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; HINNEBUSCH AG, 1993, MOL MICROBIOL, V10, P215, DOI 10.1111/j.1365-2958.1993.tb01947.x; Huber A, 2009, GENE DEV, V23, P1929, DOI 10.1101/gad.532109; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Jungbluth M, 2012, EUKARYOT CELL, V11, P1021, DOI 10.1128/EC.05240-11; Kervestin S, 2012, NAT REV MOL CELL BIO, V13, P700, DOI 10.1038/nrm3454; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Lardenois A, 2011, P NATL ACAD SCI USA, V108, P1058, DOI 10.1073/pnas.1016459108; LAW DTS, 1988, MOL CELL BIOL, V8, P912, DOI 10.1128/MCB.8.2.912; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lynn R R, 1970, J Cell Biol, V44, P688, DOI 10.1083/jcb.44.3.688; Marston AL, 2004, SCIENCE, V303, P1367, DOI 10.1126/science.1094220; MITCHELL AP, 1994, MICROBIOL REV, V58, P56, DOI 10.1128/MMBR.58.1.56-70.1994; Miura F, 2001, FEBS LETT, V505, P103, DOI 10.1016/S0014-5793(01)02792-2; MOENS PB, 1971, CAN J MICROBIOL, V17, P507, DOI 10.1139/m71-084; MUELLER PP, 1986, CELL, V45, P201, DOI 10.1016/0092-8674(86)90384-3; NEIGEBORN L, 1991, GENE DEV, V5, P533, DOI 10.1101/gad.5.4.533; Neiman AM, 2011, GENETICS, V189, P737, DOI 10.1534/genetics.111.127126; Neiman AM, 2005, MICROBIOL MOL BIOL R, V69, P565, DOI 10.1128/MMBR.69.4.565-584.2005; Neiman AM, 1998, J CELL BIOL, V140, P29, DOI 10.1083/jcb.140.1.29; Ozsarac N, 1997, MOL CELL BIOL, V17, P1152, DOI 10.1128/MCB.17.3.1152; PARK HD, 1992, NUCLEIC ACIDS RES, V20, P1909, DOI 10.1093/nar/20.8.1909; Park JS, 2012, J CELL SCI, V125, P3004, DOI 10.1242/jcs.105114; PATEL PV, 1972, J APPL BACTERIOL, V35, P63, DOI 10.1111/j.1365-2672.1972.tb03674.x; Pierce M, 2003, MOL CELL BIOL, V23, P4814, DOI 10.1128/MCB.23.14.4814-4825.2003; Rabitsch KP, 2001, CURR BIOL, V11, P1001, DOI 10.1016/S0960-9822(01)00274-3; Rajkowitsch L, 2004, J MOL BIOL, V335, P71, DOI 10.1016/j.jmb.2003.10.049; Shoemaker DD, 1996, NAT GENET, V14, P450, DOI 10.1038/ng1296-450; Smolka MB, 2007, P NATL ACAD SCI USA, V104, P10364, DOI 10.1073/pnas.0701622104; STRICH R, 1994, GENE DEV, V8, P796, DOI 10.1101/gad.8.7.796; Suda Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007184; Vershon AK, 2000, CURR OPIN CELL BIOL, V12, P334, DOI 10.1016/S0955-0674(00)00104-6; Wethmar K, 2010, GENE DEV, V24, P15, DOI 10.1101/gad.557910; Yang HJ, 2008, J CELL BIOL, V183, P1089, DOI 10.1083/jcb.200809178; ZUBENKO GS, 1981, GENETICS, V97, P45	54	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105058	10.1371/journal.pone.0105058	http://dx.doi.org/10.1371/journal.pone.0105058			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127041	gold, Green Submitted, Green Published			2022-12-25	WOS:000340879300074
J	Weise, FJ; Stratford, KJ; van Vuuren, RJ				Weise, Florian J.; Stratford, Ken J.; van Vuuren, Rudolf J.			Financial Costs of Large Carnivore Translocations - Accounting for Conservation	PLOS ONE			English	Article							LIVESTOCK; WOLF; PREDATION; TOOL; DEPREDATION; CONFLICTS; PAYMENTS; LEOPARDS; AREA; DOGS	Human-carnivore conflict continues to present a major conservation challenge around the world. Translocation of large carnivores is widely implemented but remains strongly debated, in part because of a lack of cost transparency. We report detailed translocation costs for three large carnivore species in Namibia and across different translocation scenarios. We consider the effect of various parameters and factors on costs and translocation success. Total translocation cost for 30 individuals in 22 events was $80,681 (US Dollars). Median translocation cost per individual was $2,393, and $2,669 per event. Median cost per cheetah was $2,760 (n = 23), and $2,108 per leopard (n = 6). One hyaena was translocated at a cost of $1,672. Tracking technology was the single biggest cost element (56%), followed by captive holding and feeding. Soft releases, prolonged captivity and orphaned individuals also increased case-specific costs. A substantial proportion (65.4%) of the total translocation cost was successfully recovered from public interest groups. Less than half the translocations were confirmed successes (44.4%, 3 unknown) with a strong species bias. Four leopards (66.7%) were successfully translocated but only eight of the 20 cheetahs (40.0%) with known outcome met these strict criteria. None of the five habituated cheetahs was translocated successfully, nor was the hyaena. We introduce the concept of Individual Conservation Cost (ICC) and define it as the cost of one successfully translocated individual adjusted by costs of unsuccessful events of the same species. The median ICC for cheetah was $6,898 and $3,140 for leopard. Translocations are costly, but we demonstrate that they are not inherently more expensive than other strategies currently employed in non-lethal carnivore conflict management. We conclude that translocation should be one available option for conserving large carnivores, but needs to be critically evaluated on a case-by-case basis.	[Weise, Florian J.; van Vuuren, Rudolf J.] N Aan Ku Se Res Programme, Res Dept, Windhoek, Khomas, Namibia; [Stratford, Ken J.] Ongava Res Ctr, Res Dept, Outjo, Kunene, Namibia		Weise, FJ (corresponding author), N Aan Ku Se Res Programme, Res Dept, Windhoek, Khomas, Namibia.	florian.weise@gmail.com			National Geographic Big Cats Initiative [B10-11]; Land Rover South Africa; Chester Zoo; Colchester Zoo; Sea World and Busch Gardens; Idea Wild; Sirtrack; SPOTS Foundation; Namibian Wildlife Conservation Trust (UK); West Midland Safari Park; Ongava Game Reserve; Zoological Society of Philadelphia	National Geographic Big Cats Initiative; Land Rover South Africa; Chester Zoo; Colchester Zoo; Sea World and Busch Gardens; Idea Wild; Sirtrack; SPOTS Foundation; Namibian Wildlife Conservation Trust (UK); West Midland Safari Park; Ongava Game Reserve; Zoological Society of Philadelphia	This study was supported by grants (either financially or in-kind) from the National Geographic Big Cats Initiative (grant number: B10-11), Land Rover South Africa, Chester Zoo, Colchester Zoo, Sea World and Busch Gardens, Idea Wild, Sirtrack as well as SPOTS Foundation. Carnivore research at Ongava Research Center is funded by charitable donations from The Namibian Wildlife Conservation Trust (UK), West Midland Safari Park, the directors of Ongava Game Reserve, and the Zoological Society of Philadelphia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwala M, 2010, BIOL CONSERV, V143, P2945, DOI 10.1016/j.biocon.2010.05.003; Andelt WF, 2000, J RANGE MANAGE, V53, P259, DOI 10.2307/4003429; Andelt WF, 1984, GREAT PLAINS WILDL D; Athreya V, 2011, CONSERV BIOL, V25, P133, DOI 10.1111/j.1523-1739.2010.01599.x; Bangs EE, 1996, WILDLIFE SOC B, V24, P402; BELDEN RC, 1993, J WILDLIFE MANAGE, V57, P388, DOI 10.2307/3809438; Boitani L, 2010, WILDLIFE RES, V37, P722, DOI 10.1071/WR10029; Bradley EH, 2005, CONSERV BIOL, V19, P1498, DOI 10.1111/j.1523-1739.2005.00102.x; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Buk K., 2010, Africa Insight, V39, P212; Cobb S., 1981, P181; Corff S, 2005, CARNIVORE DAMAGE PRE, V9, P24; Craven S, 1998, WILDLIFE SOC B, V26, P171; Dickman AJ, 2011, P NATL ACAD SCI USA, V108, P13937, DOI 10.1073/pnas.1012972108; Fischer J, 2000, BIOL CONSERV, V96, P1, DOI 10.1016/S0006-3207(00)00048-3; Fonturbel FE, 2011, WILDLIFE BIOL, V17, P217, DOI 10.2981/10-091; Goodrich JM, 2005, ORYX, V39, P454, DOI 10.1017/S0030605305001146; Green J, 1989, 4 E WILDL DAM CONTR; Gusset M., 2009, REINTRODUCTION TOP O, P307; Gusset M, 2008, J APPL ECOL, V45, P100, DOI 10.1111/j.1365-2664.2007.01357.x; Hamilton P. H., 1981, LEOPARD PANTHERA PAR; Hayward MW, 2007, AFR J ECOL, V45, P103, DOI 10.1111/j.1365-2028.2006.00673.x; Hotte M, 2001, CARNIVORE DAMAGE PRE, V3, P6; Houser A, 2011, S AFR J WILDL RES, V41, P11, DOI 10.3957/056.041.0111; Hunter Luke, 2009, Cat News, V51, P28; Johnson S, 2010, ECOL MODEL, V221, P641, DOI 10.1016/j.ecolmodel.2009.11.012; Jule KR, 2008, BIOL CONSERV, V141, P355, DOI 10.1016/j.biocon.2007.11.007; Lindsey PA, 2005, CONSERV BIOL, V19, P1205, DOI 10.1111/j.1523-1739.2005.00088.x; Lindsey PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052458; Linkie M, 2007, ORYX, V41, P415, DOI 10.1017/S0030605307041415; Linklater WL, 2011, J APPL ECOL, V48, P493, DOI 10.1111/j.1365-2664.2011.01960.x; Linnell JDC, 1997, BIODIVERS CONSERV, V6, P1245, DOI 10.1023/B:BIOC.0000034011.05412.cd; Linnell JDC, 2003, CARNIVORE DAMAGE PRE, V6, P11; Maclennan SD, 2009, BIOL CONSERV, V142, P2419, DOI 10.1016/j.biocon.2008.12.003; Marker L, 2005, CARNIVORE DAMAGE PRE, V8, P28; Marker L, 2000, CARNIVORE DAMAGE PRE, V2, P7; Marker LL, 2005, S AFR J WILDL RES, V35, P105; Marker LL, 2002, THESIS U OXFORD OXFO; MARKERKRAUS L, 1994, ENVIRON CONSERV, V21, P369, DOI 10.1017/S0376892900033750; Marnewick Kelly, 2009, P282, DOI 10.1002/9781444312034.ch13; Marsh H, 2007, CONSERV BIOL, V21, P387, DOI 10.1111/j.1523-1739.2006.00589.x; Martin-Lopez B, 2008, CONSERV BIOL, V22, P624, DOI 10.1111/j.1523-1739.2008.00921.x; Massei G, 2010, WILDLIFE RES, V37, P428, DOI 10.1071/WR08179; McManus JS, 2015, ORYX, V49, P687, DOI 10.1017/S0030605313001610; Metrick A, 1996, LAND ECON, V72, P1, DOI 10.2307/3147153; Miller B, 1999, ANIM CONSERV, V2, P59, DOI 10.1111/j.1469-1795.1999.tb00049.x; Naughton-Treves L, 2003, CONSERV BIOL, V17, P1500, DOI 10.1111/j.1523-1739.2003.00060.x; Nelson Fred, 2009, Human Dimensions of Wildlife, V14, P381, DOI 10.1080/10871200903045228; Ogada MO, 2003, CONSERV BIOL, V17, P1521, DOI 10.1111/j.1523-1739.2003.00061.x; Purchase G.K., 1998, THESIS U ZIMBABWE HA; R Core Team, 2021, R LANG ENV STAT COMP; RABINOWITZ AR, 1986, WILDLIFE SOC B, V14, P170; Ribeiro S, 2005, CARNIVORE DAMAGE PRE, V9, P27; Riley SJ., 1994, URSUS, V9, P567, DOI [10.2307/3872745, DOI 10.2307/3872745]; Rust NA, 2012, PREDATOR FRIENDLY FA; Ruth TK, 1998, J WILDLIFE MANAGE, V62, P1264, DOI 10.2307/3801990; Schumann M, 2006, S AFR J WILDL RES, V36, P173; Shogren JF, 1999, CONSERV BIOL, V13, P1257, DOI 10.1046/j.1523-1739.1999.98414.x; SKINNER JD, 1987, J ZOOL, V212, P350, DOI 10.1111/j.1469-7998.1987.tb05996.x; SPARKS DN, 1973, ROY STAT SOC C-APP, V22, P126, DOI 10.2307/2346321; STANDER PE, 1990, S AFR J WILDL RES, V20, P37; Stander PE, 1997, P S LIONS LEOP GAM R; Stoynov E, 2005, CARNIVORE DAMAGE PRE, V9, P19; Walton MT, 1989, 4 E WILDL DAM CONTR; Weilenmann M, 2010, WILDLIFE RES, V37, P702, DOI 10.1071/WR10013; Wolf CM, 1996, CONSERV BIOL, V10, P1142, DOI 10.1046/j.1523-1739.1996.10041142.x; Woodroffe R, 2007, BIODIVERS CONSERV, V16, P1245, DOI 10.1007/s10531-006-9124-8; Woodroffe Rosie, 1997, P58; Zabel A, 2008, CONSERV BIOL, V22, P247, DOI 10.1111/j.1523-1739.2008.00898.x	69	34	35	2	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105042	10.1371/journal.pone.0105042	http://dx.doi.org/10.1371/journal.pone.0105042			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126849	gold, Green Published, Green Submitted			2022-12-25	WOS:000340879300072
J	Yuen, JWF; Chung, GTY; Lun, SWM; Cheung, CCM; To, KF; Lo, KW				Yuen, Jessie Wai-Fong; Chung, Grace Tin-Yun; Lun, Samantha Wei-Man; Cheung, Chartia Ching-Mei; To, Ka-Fai; Lo, Kwok-Wai			Epigenetic Inactivation of Inositol polyphosphate 4-phosphatase B (INPP4B), a Regulator of PI3K/AKT Signaling Pathway in EBV-Associated Nasopharyngeal Carcinoma	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; CONSTITUTIVE ACTIVATION; PROTEIN; PTEN; IDENTIFICATION; TRANSFORMATION; ESTABLISHMENT; EXPRESSION; RASSF1A; TARGET	Nasopharyngeal carcinoma (NPC) is a common viral-associated neoplasm in which multiple signaling cascades are interfered with by Epstein-Bar virus (EBV) latent proteins and various genetic alterations. Aside from the previously reported PIK3CA amplification, we examined the role of INPP4B, a negative regulator of the PI3K/AKT signaling pathway in the development of NPC. By RT-PCR and Western blotting, we revealed that the expression of INPP4B was down-regulated in all five established EBV-positive tumor lines. While INPP4B was consistently expressed in normal nasopharyngeal epithelial cells, downregulation of INPP4B was found in 32/65 (49.2%) of primary tumors by immunohistochemistry. Furthermore, our study also demonstrated the hypermethylation of the 5'CpG island of INPP4B in the tumors in which INPP4B transcription was downregulated. Notably, the re-expression of INPP4B was detected in the NPC cells treated with the demethylation agent (5-aza-2'deoxycytidine). Our study showed that promoter hypermethylation was the major mechanism for transcriptional silencing of INPP4B in NPC. Furthermore, restoration of INPP4B expression significantly suppressed PI3K/AKT downstream signals in the NPC C666-1 cells. In vivo growth inhibition was clearly demonstrated in the tumor cells stably expressing INPP4B. The findings indicate that epigenetic inactivation of INPP4B is one of the key mechanisms in activating PI3K/AKT signaling cascade and playing a role in the tumorigenesis of NPC.	[Yuen, Jessie Wai-Fong; Chung, Grace Tin-Yun; Lun, Samantha Wei-Man; Cheung, Chartia Ching-Mei; To, Ka-Fai; Lo, Kwok-Wai] Chinese Univ Hong Kong, Dept Anat & Cellular Pathol, State Key Lab Oncol South China, Hong Kong, Hong Kong, Peoples R China; [To, Ka-Fai; Lo, Kwok-Wai] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; State Key Lab Oncology South China; Chinese University of Hong Kong	Lo, KW (corresponding author), Chinese Univ Hong Kong, Dept Anat & Cellular Pathol, State Key Lab Oncol South China, Hong Kong, Hong Kong, Peoples R China.	kwlo@cuhk.edu.hk		Lo, Kwok Wai/0000-0002-3488-6124	Li Ka Shing Institute of Health Science; Hong Kong Research Grant Council [471610, T12-401/13-R]	Li Ka Shing Institute of Health Science; Hong Kong Research Grant Council(Hong Kong Research Grants Council)	This work was supported by Li Ka Shing Institute of Health Science and Hong Kong Research Grant Council (471610 and T12-401/13-R). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki M, 2001, P NATL ACAD SCI USA, V98, P136, DOI 10.1073/pnas.011528498; Bertucci MC, 2013, ANN NY ACAD SCI, V1280, P1, DOI 10.1111/nyas.12036; Chalhoub N, 2009, ANNU REV PATHOL-MECH, V4, P127, DOI 10.1146/annurev.pathol.4.110807.092311; Cheung ST, 1999, INT J CANCER, V83, P121, DOI 10.1002/(SICI)1097-0215(19990924)83:1<121::AID-IJC21>3.0.CO;2-F; Chou CC, 2009, MED ONCOL, V26, P322, DOI 10.1007/s12032-008-9124-5; Chow LSN, 2004, INT J CANCER, V109, P839, DOI 10.1002/ijc.20079; Chung GTY, 2013, J PATHOL, V231, P311, DOI 10.1002/path.4239; Dawson CW, 2012, SEMIN CANCER BIOL, V22, P144, DOI 10.1016/j.semcancer.2012.01.004; Dawson CW, 2003, J BIOL CHEM, V278, P3694, DOI 10.1074/jbc.M209840200; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Fedele CG, 2010, P NATL ACAD SCI USA, V107, P22231, DOI 10.1073/pnas.1015245107; Ferron M, 2006, GENE, V376, P152, DOI 10.1016/j.gene.2006.02.022; Fukuda M, 2007, J VIROL, V81, P9299, DOI 10.1128/JVI.00537-07; Gewinner C, 2009, CANCER CELL, V16, P115, DOI 10.1016/j.ccr.2009.06.006; Hodgson MC, 2011, CANCER RES, V71, P572, DOI 10.1158/0008-5472.CAN-10-2314; HUANG DP, 1980, INT J CANCER, V26, P127, DOI 10.1002/ijc.2910260202; Kwong J, 2002, CLIN CANCER RES, V8, P467; Kwong J, 2007, GENE CHROMOSOME CANC, V46, P171, DOI 10.1002/gcc.20398; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Lo KW, 2004, CANCER CELL, V5, P423, DOI 10.1016/S1535-6108(04)00119-9; Lo KW, 2001, CANCER RES, V61, P3877; Lo KW, 2012, SEMIN CANCER BIOL, V22, P79, DOI 10.1016/j.semcancer.2011.12.011; Ma K, 2008, CELL SIGNAL, V20, P684, DOI 10.1016/j.cellsig.2007.12.004; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Morrison JA, 2004, CANCER RES, V64, P5251, DOI 10.1158/0008-5472.CAN-04-0538; Nave BT, 1999, BIOCHEM J, V344, P427, DOI 10.1042/0264-6021:3440427; Or YYY, 2010, J PATHOL, V220, P97, DOI 10.1002/path.2609; Or YYY, 2006, INT J CANCER, V118, P1065, DOI 10.1002/ijc.21444; Perez-Lorenzo R, 2014, J INVEST DERMATOL, V134, P1359, DOI 10.1038/jid.2013.511; Shu XS, 2013, CARCINOGENESIS, V34, P1984, DOI 10.1093/carcin/bgt165; Song LB, 2009, J CLIN INVEST, V119, P3626, DOI 10.1172/JCI39374; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Tsao SW, 2012, SEMIN CANCER BIOL, V22, P137, DOI 10.1016/j.semcancer.2012.02.004; Tsao SW, 2002, BBA-MOL CELL RES, V1590, P150, DOI 10.1016/S0167-4889(02)00208-2; Vazquez F, 2000, BBA-REV CANCER, V1470, pM21, DOI 10.1016/S0304-419X(99)00032-3; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zhang LY, 2013, CARCINOGENESIS, V34, P454, DOI 10.1093/carcin/bgs346	37	23	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105163	10.1371/journal.pone.0105163	http://dx.doi.org/10.1371/journal.pone.0105163			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126743	Green Published, Green Submitted, gold			2022-12-25	WOS:000340879300087
J	Iacopino, F; Angelucci, C; Piacentini, R; Biamonte, F; Mangiola, A; Maira, G; Grassi, C; Sica, G				Iacopino, Fortunata; Angelucci, Cristiana; Piacentini, Roberto; Biamonte, Filippo; Mangiola, Annunziato; Maira, Giulio; Grassi, Claudio; Sica, Gigliola			Isolation of Cancer Stem Cells from Three Human Glioblastoma Cell Lines: Characterization of Two Selected Clones	PLOS ONE			English	Article							MARKER CD133; EXPRESSION; TUMORS; CHEMOSENSITIVITY; IDENTIFICATION; HETEROGENEITY; MULTIFORME; CHANNELS; MODELS; NESTIN	Cancer stem cells (CSC) were isolated via a non-adherent neurosphere assay from three glioma cell lines: LI, U87, and U373. Using a clonal assay, two clones (D2 and F11) were selected from spheres derived from LI cells and were characterized for the: expression of stem cell markers (CD133, Nestin, Musashi-1 and Sox2); proliferation; differentiation capability (determined by the expression of GalC, beta III-Tubulin and GFAP); Ca2+ signaling and tumorigenicity in nude mice. Both D2 and F11 clones expressed higher levels of all stem cell markers with respect to the parental cell line. Clones grew more slowly than LI cells with a two-fold increase in duplication time. Markers of differentiation (beta III-Tubulin and GFAP) were expressed at high levels in both LI cells and in neurospheres. The expression of Nestin, Sox2, and beta III-Tubulin was down-regulated in D2 and F11 when cultured in serum-containing medium, whereas Musashi-1 was increased. In this condition, duplication time of D2 and F11 increased without reaching that of LI cells. D2, F11 and parental cells did not express voltage-dependent Ca2+-channels but they exhibited increased intracellular Ca2+ levels in response to ATP. These Ca2+ signals were larger in LI cells and in spheres cultured in serum-containing medium, while they were smaller in serum-free medium. The ATP treatment did not affect cell proliferation. Both D2 and F11 induced the appearance of tumors when ortotopically injected in athymic nude mice at a density 50-fold lower than that of LI cells. All these data indicate that both clones have characteristics of CSC and share the same stemness properties. The findings regarding the expression of differentiation markers and Ca2+-channels show that both clones are unable to reach the terminal differentiation. Both D2 and F11 might represent a good model to improve the knowledge on CSC in glioblastoma and to identify new therapeutic approaches.	[Iacopino, Fortunata; Angelucci, Cristiana; Biamonte, Filippo; Sica, Gigliola] Univ Cattolica Sacro Cuore, Sch Med, Inst Histol & Embryol, I-00168 Rome, Italy; [Piacentini, Roberto; Grassi, Claudio] Univ Cattolica Sacro Cuore, Sch Med, Inst Human Physiol, I-00168 Rome, Italy; [Mangiola, Annunziato; Maira, Giulio] Univ Cattolica Sacro Cuore, Sch Med, Inst Neurosurg, I-00168 Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Iacopino, F (corresponding author), Univ Cattolica Sacro Cuore, Sch Med, Inst Histol & Embryol, I-00168 Rome, Italy.	iaco.forty@rm.unicatt.it	Grassi, Claudio/C-3188-2017; Biamonte, Filippo/AAU-7545-2021; Piacentini, Roberto/K-7526-2016	Grassi, Claudio/0000-0001-7253-1685; Biamonte, Filippo/0000-0003-1327-7642; Piacentini, Roberto/0000-0003-4215-1643	French government; Rennes University Hospital; European Research Council [290901]	French government; Rennes University Hospital; European Research Council(European Research Council (ERC)European Commission)	This work has received a French government support granted to the CominLabs excellence laboratory and managed by the National Research Agency in the "Investing for the Future'' program under reference ANR-10-LABX-07-01. It was also supported by the Rennes University Hospital (COREC Project named conneXion, 2012-14). We also thank the European Research Council for the ERC-2011-ADG - Grant Agreement No 290901 - Acronym "NEUCOD''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Binda Elena, 2012, Front Biosci (Schol Ed), V4, P1235; Bleau AM, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/3-4/E27; Brescia P, 2012, J ONCOL, V2012, DOI 10.1155/2012/376894; Butt AM, 2011, SEMIN CELL DEV BIOL, V22, P205, DOI 10.1016/j.semcdb.2011.02.023; Calloni R, 2013, STEM CELLS DEV, V22, P1455, DOI 10.1089/scd.2012.0637; Canazza A, 2011, CANCER BIOL THER, V12, P629, DOI 10.4161/cbt.12.7.16862; Chow EKH, 2013, JALA-J LAB AUTOM, V18, P6, DOI 10.1177/2211068212454739; Cruz M H, 2012, ISRN Oncol, V2012, P392647, DOI 10.5402/2012/392647; D'Ascenzo M, 2006, EUR J NEUROSCI, V23, P935, DOI 10.1111/j.1460-9568.2006.04628.x; Denysenko T, 2010, CELL BIOCHEM FUNCT, V28, P343, DOI 10.1002/cbf.1666; Ellis P, 2004, DEV NEUROSCI-BASEL, V26, P148, DOI 10.1159/000082134; Feng X, 2012, MOL MED REP, V6, P1117, DOI 10.3892/mmr.2012.1040; Fukaya R, 2010, CANCER LETT, V291, P150, DOI 10.1016/j.canlet.2009.10.010; Gedye Craig, 2013, Methods Mol Biol, V946, P181, DOI 10.1007/978-1-62703-128-8_12; Gilbert CA, 2009, J CELL BIOCHEM, V108, P1031, DOI 10.1002/jcb.22350; Gunther HS, 2008, ONCOGENE, V27, P2897, DOI 10.1038/sj.onc.1210949; He H, 2012, J CLIN NEUROSCI, V19, P121, DOI 10.1016/j.jocn.2011.07.026; Hong X, 2012, INT J ONCOL, V41, P1693, DOI 10.3892/ijo.2012.1592; Huszthy PC, 2012, NEURO-ONCOLOGY, V14, P979, DOI 10.1093/neuonc/nos135; Iglesias-Rozas JR, 2005, HISTOL HISTOPATHOL, V20, P351, DOI 10.14670/HH-20.351; Irollo E, 2013, AM J TRANSL RES, V5, P563; Jin F, 2008, CANCER INVEST, V26, P338, DOI 10.1080/07357900701788064; Jin X, 2013, BIOCHEM BIOPH RES CO, V433, P496, DOI 10.1016/j.bbrc.2013.03.021; Johannessen TCA, 2009, NEUROPATH APPL NEURO, V35, P380, DOI [10.1111/j.1365-2990.2009.01008.x, 10.1111/j.1365-2990.2008.01008.x]; Katsetos CD, 2011, ANTI-CANCER AGENT ME, V11, P719; Keysar SB, 2010, MOL CANCER THER, V9, P2450, DOI 10.1158/1535-7163.MCT-10-0530; Kolenda J, 2011, J NEURO-ONCOL, V103, P43, DOI 10.1007/s11060-010-0357-8; Kondo T, 2004, P NATL ACAD SCI USA, V101, P781, DOI 10.1073/pnas.0307618100; Kong BH, 2013, CHILD NERV SYST, V29, P217, DOI 10.1007/s00381-012-1964-9; Ledur PF, 2012, PURINERG SIGNAL, V8, P39, DOI 10.1007/s11302-011-9252-9; Li Z, 2013, EXP HEMATOL ONCOL, V2, DOI 10.1186/2162-3619-2-17; Liu QH, 2009, J NEURO-ONCOL, V94, P1, DOI 10.1007/s11060-009-9919-z; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; MacNicol MC, 2011, CELL CYCLE, V10, P39, DOI 10.4161/cc.10.1.14388; Mellodew K, 2004, DEV BRAIN RES, V151, P13, DOI 10.1016/j.devbrainres.2004.03.018; Molenaar R. J., 2011, ISRN NEUROL, V2011, DOI DOI 10.5402/2011/590249; Nickerson PEB, 2011, EXP EYE RES, V92, P344, DOI 10.1016/j.exer.2011.02.002; Pallini R, 2011, CANCER-AM CANCER SOC, V117, P162, DOI 10.1002/cncr.25581; Pavon LF, 2012, EINSTEIN-SAO PAULO, V10, P197, DOI 10.1590/S1679-45082012000200013; Peng CG, 2012, J NEUROSCI, V32, P13292, DOI 10.1523/JNEUROSCI.2124-12.2012; Pointer KB, 2014, NEUROCHEM INT, V71, P1, DOI 10.1016/j.neuint.2014.03.005; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Qiang L, 2009, CANCER LETT, V279, P13, DOI 10.1016/j.canlet.2009.01.016; Ramasamy S, 2013, ARCH BIOCHEM BIOPHYS, V534, P71, DOI 10.1016/j.abb.2013.02.004; Resende RR, 2007, NEUROSCIENCE, V146, P1169, DOI 10.1016/j.neuroscience.2007.02.041; Romaguera-Ros M, 2012, STEM CELL REV REP, V8, P288, DOI 10.1007/s12015-011-9283-1; Sakakibara S, 1997, J NEUROSCI, V17, P8300; Sampetrean O, 2013, BRAIN TUMOR PATHOL, V30, P209, DOI 10.1007/s10014-013-0141-5; SAVARESE A, 1992, EXP BRAIN RES, V89, P408; Shibata M, 2013, BIOESSAYS, V35, P253, DOI 10.1002/bies.201200101; Singh SK, 2003, CANCER RES, V63, P5821; Swayne LA, 2012, CHANNELS, V6, P69, DOI 10.4161/chan.19721; Tirino V, 2013, FASEB J, V27, P13, DOI 10.1096/fj.12-218222; van Staveren WCG, 2009, BBA-REV CANCER, V1795, P92, DOI 10.1016/j.bbcan.2008.12.004; Wakimoto H, 2012, NEURO-ONCOLOGY, V14, P132, DOI 10.1093/neuonc/nor195; Wan Y, 2012, CHIN J CANCER, V31, P207, DOI 10.5732/cjc.011.10336; Wolanczyk M, 2010, FOLIA NEUROPATHOL, V48, P27; Xu ZY, 2013, ULTRASONICS, V53, P232, DOI 10.1016/j.ultras.2012.06.005; Yu SC, 2008, CANCER LETT, V265, P124, DOI 10.1016/j.canlet.2008.02.010; Zeppernick F, 2008, CLIN CANCER RES, V14, P123, DOI 10.1158/1078-0432.CCR-07-0932; Zhou ZM, 2011, CANCER BIOTHER RADIO, V26, P77, DOI 10.1089/cbr.2010.0857; ZUPI G, 1988, J NEURO-ONCOL, V6, P169, DOI 10.1007/BF02327393	62	49	50	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e105166	10.1371/journal.pone.0105166	http://dx.doi.org/10.1371/journal.pone.0105166			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121761	Green Published, Green Submitted, gold			2022-12-25	WOS:000341017000101
J	Khankhet, J; Vanderwolf, KJ; McAlpine, DF; McBurney, S; Overy, DP; Slavic, D; Xu, JP				Khankhet, Jordan; Vanderwolf, Karen J.; McAlpine, Donald F.; McBurney, Scott; Overy, David P.; Slavic, Durda; Xu, Jianping			Clonal Expansion of the Pseudogymnoascus destructans Genotype in North America Is Accompanied by Significant Variation in Phenotypic Expression	PLOS ONE			English	Article							WHITE-NOSE SYNDROME; CRYPTOCOCCUS-NEOFORMANS; GEOMYCES-DESTRUCTANS; ASPERGILLUS-FUMIGATUS; SUSCEPTIBILITY; PENICILLIUM; MYCOTOXINS; VIRULENCE; DROPLETS; MELANIN	Pseudogymnoascus destructans is the causative agent of an emerging infectious disease that threatens populations of several North American bat species. The fungal disease was first observed in 2006 and has since caused the death of nearly six million bats. The disease, commonly known as white-nose syndrome, is characterized by a cutaneous infection with P. destructans causing erosions and ulcers in the skin of nose, ears and/or wings of bats. Previous studies based on sequences from eight loci have found that isolates of P. destructans from bats in the US all belong to one multilocus genotype. Using the same multilocus sequence typing method, we found that isolates from eastern and central Canada also had the same genotype as those from the US, consistent with the clonal expansion of P. destructans into Canada. However, our PCR fingerprinting revealed that among the 112 North American isolates we analyzed, three, all from Canada, showed minor genetic variation. Furthermore, we found significant variations among isolates in mycelial growth rate; the production of mycelial exudates; and pigment production and diffusion into agar media. These phenotypic differences were influenced by culture medium and incubation temperature, indicating significant variation in environmental condition - dependent phenotypic expression among isolates of the clonal P. destructans genotype in North America.	[Khankhet, Jordan; Xu, Jianping] McMaster Univ, Dept Biol, Hamilton, ON, Canada; [Vanderwolf, Karen J.; McAlpine, Donald F.] New Brunswick Museum, New Brunswick, NJ USA; [Vanderwolf, Karen J.] Canadian Wildlife Fed, Kanata, ON, Canada; [McBurney, Scott] Univ Prince Edward Isl, Atlantic Vet Coll, Dept Pathol & Microbiol, Canadian Cooperat Wildlife Hlth Ctr, Charlottetown, PE C1A 4P3, Canada; [Overy, David P.] Univ Prince Edward Isl, Dept Chem, Charlottetown, PE C1A 4P3, Canada; [Overy, David P.] Univ Prince Edward Isl, Atlantic Vet Coll, Dept Pathol & Microbiol, Charlottetown, PE C1A 4P3, Canada; [Slavic, Durda] Univ Prince Edward Isl, Duffy Res Ctr, Nautilus Biosci Canada Inc, Charlottetown, PE C1A 4P3, Canada; [Slavic, Durda] Univ Guelph, Hlth Anim Lab, Lab Serv, Guelph, ON N1G 2W1, Canada	McMaster University; University of Prince Edward Island; University of Prince Edward Island; University of Prince Edward Island; University of Prince Edward Island; University of Guelph	Xu, JP (corresponding author), McMaster Univ, Dept Biol, Hamilton, ON, Canada.	jpxu@mcmaster.ca	Vanderwolf, Karen/AAI-6010-2020	Vanderwolf, Karen/0000-0003-0963-3093; Overy, David/0000-0003-3107-4777	Ontario Graduate Scholarship; Natural Sciences and Engineering Research Coincil (NSERC) of Canada [5-31998-2010]; Canadian Cooperative Wildlife Health Centre, Atlantic Region	Ontario Graduate Scholarship(Ontario Graduate Scholarship); Natural Sciences and Engineering Research Coincil (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Cooperative Wildlife Health Centre, Atlantic Region	This research was supported by the Ontario Graduate Scholarship and the Natural Sciences and Engineering Research Coincil (NSERC) of Canada (5-31998-2010). Funds in support of the field collection and initial culturing of P. destructans in New Brunswick were provided to DFM and KJV by the New Brunswick Environmental Trust Fund, New Brunswick Wildlife Trust Fund, New Brunswick Department of Natural Resources, National Speleological Society WNS Rapid Response Fund, and Parks Canada. The Canadian Cooperative Wildlife Health Centre, Atlantic Region provided funding for bat necropsies and fungal culture of Nova Scotia and Prince Edward Island samples. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; Canadian Cooperative Wildlife Health Centre, 2013, BAT WHIT NOS SYNDR C; Chaturvedi V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010783; COLOTELO N, 1978, CAN J MICROBIOL, V24, P1173, DOI 10.1139/m78-191; Ehinger MO, 2012, NEW PHYTOL, V196, P853, DOI 10.1111/j.1469-8137.2012.04278.x; Foster J, 2012, 5 ANN WHIT NOS SYNDR; Frick WF, 2010, SCIENCE, V329, P679, DOI 10.1126/science.1188594; Frisvad JC, 2004, STUD MYCOL, P201; Froschauer A, 2012, US FISH WILDL SERV, P1; Gareis M, 2007, MYCOPATHOLOGIA, V163, P207, DOI 10.1007/s11046-007-9003-1; Gargas A, 2009, MYCOTAXON, V108, P147, DOI 10.5248/108.147; Grovel O, 2003, TOXICON, V42, P297, DOI 10.1016/S0041-0101(03)00146-6; Hutwimmer S, 2010, MYCOLOGIA, V102, P1, DOI 10.3852/09-079; Jahn B, 1997, INFECT IMMUN, V65, P5110, DOI 10.1128/IAI.65.12.5110-5117.1997; Jarne P, 1996, TRENDS ECOL EVOL, V11, P424, DOI 10.1016/0169-5347(96)10049-5; JENNINGS DH, 1991, MYCOL RES, V95, P883, DOI 10.1016/S0953-7562(09)80054-3; KWONCHUNG KJ, 1986, INFECT IMMUN, V51, P218, DOI 10.1128/IAI.51.1.218-223.1986; Lopez-Otin C, 2008, J BIOL CHEM, V283, P30433, DOI 10.1074/jbc.R800035200; Martinkova N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013853; MCPHEE WJ, 1977, CAN J BOT, V55, P358, DOI 10.1139/b77-045; Meteyer CU, 2009, J VET DIAGN INVEST, V21, P411, DOI 10.1177/104063870902100401; Minnis AM, 2013, FUNGAL BIOL-UK, V117, P638, DOI 10.1016/j.funbio.2013.07.001; Pringle A, 2002, TRENDS MICROBIOL, V10, P474, DOI 10.1016/S0966-842X(02)02447-2; Puechmaille SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019167; Rachowicz LJ, 2005, CONSERV BIOL, V19, P1441, DOI 10.1111/j.1523-1739.2005.00255.x; Rajkumar SS, 2011, EMERG INFECT DIS, V17, P1273, DOI 10.3201/eid1707.102056; Raudabaugh DB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078300; Ren P, 2012, EMERG INFECT DIS, V18, P883, DOI 10.3201/eid1805.111711; Rosas AL, 1997, FEMS MICROBIOL LETT, V153, P265, DOI 10.1016/S0378-1097(97)00239-5; Rosas AL, 2001, MYCOPATHOLOGIA, V151, P53, DOI 10.1023/A:1010977107089; Singh RS, 2012, RAPIDLY EVOLVING GENES AND GENETIC SYSTEMS, P1; Swofford DL, PHYLOGENETIC ANAL US; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Turner Gregory G., 2011, Bat Research News, V52, P13; Verant ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046280; WANG YL, 1994, APPL ENVIRON MICROB, V60, P3864, DOI 10.1128/AEM.60.10.3864-3866.1994; WANG YL, 1995, INFECT IMMUN, V63, P3131, DOI 10.1128/IAI.63.8.3131-3136.1995; Warnecke L, 2012, P NATL ACAD SCI USA, P1; Wibbelt G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074105	39	23	23	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104684	10.1371/journal.pone.0104684	http://dx.doi.org/10.1371/journal.pone.0104684			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122221	Green Published, Green Submitted, gold			2022-12-25	WOS:000341017000055
J	York, EM; Butler, CJ; Lord, WD				York, Emily M.; Butler, Christopher J.; Lord, Wayne D.			Global Decline in Suitable Habitat for Angiostrongylus (= Parastrongylus) cantonensis: The Role of Climate Change	PLOS ONE			English	Article							ECOLOGICAL NICHE MODELS; NEURAL ANGIOSTRONGYLOSIS; EOSINOPHILIC MENINGITIS; GEOGRAPHIC-DISTRIBUTION; CHANGE IMPACTS; DENGUE-FEVER; MALARIA; DISEASE; DISTRIBUTIONS; RISK	Climate change is implicated in the alteration of the ranges of species worldwide. Such shifts in species distributions may introduce parasites/pathogens, hosts, and vectors associated with disease to new areas. The parasite Angiostrongylus (= Parastrongylus) cantonensis is an invasive species that causes eosinophilic meningitis in humans and neurological abnormalities in domestic/wild animals. Although native to southeastern Asia, A. cantonensis has now been reported from more than 30 countries worldwide. Given the health risks, it is important to describe areas with potentially favorable climate for the establishment of A. cantonensis, as well as areas where this pathogen might become established in the future. We used the program Maxent to develop an ecological niche model for A. cantonensis based on 86 localities obtained from published literature. We then modeled areas of potential A. cantonensis distribution as well as areas projected to have suitable climatic conditions under four Representative Concentration Pathways (RCP) scenarios by the 2050s and the 2070s. The best model contained three bioclimatic variables: mean diurnal temperature range, minimum temperature of coldest month and precipitation of warmest quarter. Potentially suitable habitat for A. cantonensis was located worldwide in tropical and subtropical regions. Under all climate change RCP scenarios, the center of the projected distribution shifted away from the equator at a rate of 68-152 km per decade. However, the extent of areas with highly suitable habitat (>50%) declined by 10.66-15.66% by the 2050s and 13.11-16.11% by the 2070s. These results conflict with previous studies, which have generally found that the prevalence of tropical pathogens will increase during the 21st century. Moreover, it is likely that A. cantonensis will continue to expand its current range in the near future due to introductions and host expansion, whereas climate change will reduce the total geographic area of most suitable climatic conditions during the coming decades.	[York, Emily M.; Lord, Wayne D.] Univ Cent Oklahoma, W Roger Webb Forens Sci Inst, Edmond, OK 73034 USA; [York, Emily M.; Butler, Christopher J.; Lord, Wayne D.] Univ Cent Oklahoma, Dept Biol, Edmond, OK USA	University of Central Oklahoma; University of Central Oklahoma	York, EM (corresponding author), Univ Cent Oklahoma, W Roger Webb Forens Sci Inst, Edmond, OK 73034 USA.	eyork@ou.edu			University of Central Oklahoma Office of Research and Grants	University of Central Oklahoma Office of Research and Grants	Funding for this project was provided by the University of Central Oklahoma Office of Research and Grants. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouma MJ, 1997, TROP MED INT HEALTH, V2, P1122, DOI 10.1046/j.1365-3156.1997.d01-210.x; Bouma MJ, 1996, TROP MED INT HEALTH, V1, P86, DOI 10.1046/j.1365-3156.1996.d01-7.x; Butler CJ, 2003, IBIS, V145, P484, DOI 10.1046/j.1474-919X.2003.00193.x; Chen H. T., 1935, Annales de Parasitologie Paris, V13, P312; Chikweto A, 2009, VET PARASITOL, V162, P160, DOI 10.1016/j.vetpar.2009.02.020; Costa J, 2002, AM J TROP MED HYG, V67, P516, DOI 10.4269/ajtmh.2002.67.516; Curriero FC, 2001, AM J PUBLIC HEALTH, V91, P1194; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Duffy MS, 2004, EMERG INFECT DIS, V10, P2207, DOI 10.3201/eid1012.040319; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Epstein PR, 2000, SCI AM, V283, P50, DOI 10.1038/scientificamerican0800-50; Gonzalez C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000585; Hales S, 2002, LANCET, V360, P830, DOI 10.1016/S0140-6736(02)09964-6; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Higgins DP, 1997, AUST VET J, V75, P564, DOI 10.1111/j.1751-0813.1997.tb14194.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Houghton J. T., 2001, CLIMATE CHANGE 2001; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; Intergovernmental Panel on Climate Change, 2007, 4 INT PAN CLIM CHANG; Jones CC, 2010, ECOL APPL, V20, P311, DOI 10.1890/08-2261.1; Kim DY, 2002, J PARASITOL, V88, P1024, DOI 10.1645/0022-3395(2002)088[1024:PACNEI]2.0.CO;2; KLIKS MM, 1992, SOC SCI MED, V34, P199, DOI 10.1016/0277-9536(92)90097-A; Kutz SJ, 2005, P ROY SOC B-BIOL SCI, V272, P2571, DOI 10.1098/rspb.2005.3285; Kutz SJ, 2009, VET PARASITOL, V163, P217, DOI 10.1016/j.vetpar.2009.06.008; Lafferty KD, 2009, ECOLOGY, V90, P888, DOI 10.1890/08-0079.1; Lai CH, 2007, AM J TROP MED HYG, V76, P399, DOI 10.4269/ajtmh.2007.76.399; Lal A, 2013, TRENDS PARASITOL, V29, P83, DOI 10.1016/j.pt.2012.10.005; Levine RS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000176; Levine RS, 2004, AM J TROP MED HYG, V70, P105, DOI 10.4269/ajtmh.2004.70.105; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Lv S, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000368; MARTENS WJM, 1995, ENVIRON HEALTH PERSP, V103, P458, DOI 10.2307/3432584; MASON KV, 1987, AUST VET J, V64, P201, DOI 10.1111/j.1751-0813.1987.tb15181.x; McArthur R.H., 1972, GEOGRAPHICAL ECOLOGY; MCKENZIE RA, 1978, AUST VET J, V54, P86, DOI 10.1111/j.1751-0813.1978.tb00354.x; Monks DJ, 2005, J AVIAN MED SURG, V19, P289, DOI 10.1647/2004-024.1; Morgan UM, 2000, INT J PARASITOL, V30, P1407, DOI 10.1016/S0020-7519(00)00129-6; NEW D, 1995, NEW ENGL J MED, V332, P1105, DOI 10.1056/NEJM199504203321619; Panackel C, 2006, Indian J Med Microbiol, V24, P220; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Patz JA, 1998, ENVIRON HEALTH PERSP, V106, P147, DOI 10.1289/ehp.98106147; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Peterson AT, 2003, INT J PARASITOL, V33, P919, DOI 10.1016/S0020-7519(03)00094-8; Peterson AT, 2004, EMERG INFECT DIS, V10, P40, DOI 10.3201/eid1001.030125; Phillips S.J., 2004, P 21 INT C MACH LEAR, P655, DOI [DOI 10.1145/1015330.1015412, 10.1145/1015330.1015412]; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Poulin R, 2006, PARASITOLOGY, V132, P143, DOI 10.1017/S0031182005008693; Qvarnstrom Y, 2007, APPL ENVIRON MICROB, V73, P1415, DOI 10.1128/AEM.01968-06; RADOMYOS P, 1992, Southeast Asian Journal of Tropical Medicine and Public Health, V23, P167; Ramirez J, 2008, HIGH RESOLUTION STAT; Reed KD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002034; SMITH G, 1990, PARASITOLOGY, V101, P309, DOI 10.1017/S003118200006337X; So HC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001230; Tanser FC, 2003, LANCET, V362, P1792, DOI 10.1016/S0140-6736(03)14898-2; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Townsend Peterson A., 2005, U S Forest Service General Technical Report PSW, V191, P1201; Wang QP, 2008, LANCET INFECT DIS, V8, P621, DOI 10.1016/S1473-3099(08)70229-9; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Woodruff RE, 2002, EPIDEMIOLOGY, V13, P384, DOI 10.1097/00001648-200207000-00005; WRIGHT JD, 1991, AUST VET J, V68, P58, DOI 10.1111/j.1751-0813.1991.tb03131.x	60	25	26	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e103831	10.1371/journal.pone.0103831	http://dx.doi.org/10.1371/journal.pone.0103831			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122457	Green Published, gold, Green Submitted			2022-12-25	WOS:000341017000021
J	Kitazume, S; Imamaki, R; Kurimoto, A; Ogawa, K; Kato, M; Yamaguchi, Y; Tanaka, K; Ishida, H; Ando, H; Kiso, M; Hashii, N; Kawasaki, N; Taniguchi, N				Kitazume, Shinobu; Imamaki, Rie; Kurimoto, Ayako; Ogawa, Kazuko; Kato, Masaki; Yamaguchi, Yoshiki; Tanaka, Katsunori; Ishida, Hideharu; Ando, Hiromune; Kiso, Makoto; Hashii, Noritaka; Kawasaki, Nana; Taniguchi, Naoyuki			Interaction of Platelet Endothelial Cell Adhesion Molecule (PECAM) with alpha 2,6-Sialylated Glycan Regulates Its Cell Surface Residency and Anti-apoptotic Role	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Cell Adhesion; Endothelial Cell; Lectin; Sialic Acid	N-GLYCOLYLNEURAMINIC ACID; HEPARIN-LIKE MOLECULES; GROWTH-FACTOR; ACETYLNEURAMINIC ACID; SIGNAL-TRANSDUCTION; CD22 LIGANDS; IN-VIVO; RECEPTOR; ANGIOGENESIS; IDENTIFICATION	Background:N-Glycan 2,6-sialylation regulates the cell surface residency of an anti-apoptotic molecule, platelet endothelial cell adhesion molecule (PECAM). Results: An 2,6-sialylated oligosaccharide inhibited the homophilic PECAM interaction and a cluster-type 2,6-sialyl N-glycan probe bound to PECAM-immobilized beads. Conclusion: PECAM is a weak sialic acid binding lectin. Significance: There is a possibility of using a glycan-based method to modulate angiogenesis. The luminal sides of vascular endothelial cells are heavily covered with a so-called glycocalyx, but the precise role of the endothelial glycocalyx remains unclear. Our previous study showed that N-glycan 2,6-sialylation regulates the cell surface residency of an anti-apoptotic molecule, platelet endothelial cell adhesion molecule (PECAM), as well as the sensitivity of endothelial cells toward apoptotic stimuli. As PECAM itself was shown to be modified with biantennary N-glycans having 2,6-sialic acid, we expected that PECAM would possess lectin-like activity toward 2,6-sialic acid to ensure its homophilic interaction. To verify this, a series of oligosaccharides were initially added to observe their inhibitory effects on the homophilic PECAM interaction in vitro. We found that a longer 2,6-sialylated oligosaccharide exhibited strong inhibitory activity. Furthermore, we found that a cluster-type 2,6-sialyl N-glycan probe specifically bound to PECAM-immobilized beads. Moreover, the addition of the 2,6-sialylated oligosaccharide to endothelial cells enhanced the internalization of PECAM as well as the sensitivity to apoptotic stimuli. Collectively, these findings suggest that PECAM is a sialic acid binding lectin and that this binding property supports endothelial cell survival. Notably, our findings that 2,6-sialylated glycans influenced the susceptibility to endothelial cell apoptosis shed light on the possibility of using a glycan-based method to modulate angiogenesis.	[Kitazume, Shinobu; Imamaki, Rie; Kurimoto, Ayako; Ogawa, Kazuko; Taniguchi, Naoyuki] RIKEN, Global Res Cluster, Max Planck Joint Res Ctr, Dis Glyc Team, Wako, Saitama 3510198, Japan; [Kato, Masaki; Yamaguchi, Yoshiki] RIKEN, Global Res Cluster, Max Planck Joint Res Ctr, Struct Glycobiol Team, Wako, Saitama 3510198, Japan; [Tanaka, Katsunori] RIKEN, Biofunct Synthet Chem Lab, Wako, Saitama 3510198, Japan; [Ishida, Hideharu; Ando, Hiromune; Kiso, Makoto] Gifu Univ, Dept Appl Bioorgan Chem, Gifu 5011193, Japan; [Ando, Hiromune; Kiso, Makoto] Kyoto Univ, Inst Integrated Cell Mat Sci WPI iCeMS, Kyoto 6068501, Japan; [Hashii, Noritaka; Kawasaki, Nana] Natl Inst Hlth Sci, Div Biol Chem & Biol, Tokyo 1588501, Japan	RIKEN; RIKEN; RIKEN; Gifu University; Kyoto University; National Institute of Health Sciences - Japan	Kitazume, S (corresponding author), RIKEN, Global Res Cluster, Max Planck Joint Res Ctr, Dis Glyc Team, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	shinobuk@riken.jp	Yamaguchi, Yoshiki/N-5246-2015; Katsunori, Tanaka/AAJ-3284-2020; Taniguchi, Naoyuki/A-7086-2016; Tanaka, Katsunori/N-5072-2015; Taniguchi, Naoyuki/I-4182-2014; Ando, Hiromune/J-8294-2017	Yamaguchi, Yoshiki/0000-0003-0100-5439; Tanaka, Katsunori/0000-0001-6932-4802; Taniguchi, Naoyuki/0000-0001-5889-5968; Ando, Hiromune/0000-0002-0551-0830	Systems Glycobiology Research Project; RIKEN; Ministry of Education Science, Sports and Culture of Japan; Mitsubishi Foundation; Grants-in-Aid for Scientific Research [25460054] Funding Source: KAKEN	Systems Glycobiology Research Project; RIKEN; Ministry of Education Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mitsubishi Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Systems Glycobiology Research Project and from the strategic programs for R&D of RIKEN (to N. T.), a grant-in-aid for Scientific Research from the Ministry of Education Science, Sports and Culture of Japan (to N. T. and S. K.), and a grant from the Mitsubishi Foundation (to S. K.).	Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Cao GY, 2009, AM J PATHOL, V175, P903, DOI 10.2353/ajpath.2009.090206; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; Chen ZM, 2009, ARTERIOSCL THROM VAS, V29, P1067, DOI 10.1161/ATVBAHA.109.186692; Collins BE, 2004, P NATL ACAD SCI USA, V101, P6104, DOI 10.1073/pnas.0400851101; Croci DO, 2014, CELL, V156, P744, DOI 10.1016/j.cell.2014.01.043; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; DeLisser H, 2010, P NATL ACAD SCI USA, V107, P18616, DOI 10.1073/pnas.1004654107; Fu JX, 2008, J CLIN INVEST, V118, P3725, DOI 10.1172/JCI36077; Fukunaga K, 2003, J CARBOHYD CHEM, V22, P919, DOI 10.1081/CAR-120026602; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Gao CJ, 2003, BLOOD, V102, P169, DOI 10.1182/blood-2003-01-0003; Geyer H, 1999, GLYCOBIOLOGY, V9, P915, DOI 10.1093/glycob/9.9.915; GITAYGOREN H, 1992, J BIOL CHEM, V267, P6093; Grewal PK, 2008, NAT MED, V14, P648, DOI 10.1038/nm1760; Halaby DM, 1999, PROTEIN ENG, V12, P563, DOI 10.1093/protein/12.7.563; HANASAKI K, 1994, J BIOL CHEM, V269, P10637; HANASAKI K, 1995, J BIOL CHEM, V270, P7533, DOI 10.1074/jbc.270.13.7533; Hayakawa T, 2001, P NATL ACAD SCI USA, V98, P11399, DOI 10.1073/pnas.191268198; Iozzo RV, 2001, J CLIN INVEST, V108, P349, DOI 10.1172/JCI13738; KAWANO T, 1995, J BIOL CHEM, V270, P16458, DOI 10.1074/jbc.270.27.16458; Kitazume S, 2010, J BIOL CHEM, V285, P6515, DOI 10.1074/jbc.M109.073106; Lapierre F, 1996, GLYCOBIOLOGY, V6, P355, DOI 10.1093/glycob/6.3.355; Lee RT, 2000, GLYCOCONJUGATE J, V17, P543, DOI 10.1023/A:1011070425430; Lundquist JJ, 2002, CHEM REV, V102, P555, DOI 10.1021/cr000418f; Mamdouh Z, 2003, NATURE, V421, P748, DOI 10.1038/nature01300; NAKAGAWA H, 1995, ANAL BIOCHEM, V226, P130, DOI 10.1006/abio.1995.1200; Nakamura K, 2002, GLYCOBIOLOGY, V12, P209, DOI 10.1093/glycob/12.3.209; Newman PJ, 2003, ARTERIOSCL THROM VAS, V23, P953, DOI 10.1161/01.ATV.0000071347.69358.D9; Nitschke L, 1999, J EXP MED, V189, P1513, DOI 10.1084/jem.189.9.1513; Osawa M, 2002, J CELL BIOL, V158, P773, DOI 10.1083/jcb.200205049; Park S, 2010, AM J PHYSIOL-CELL PH, V299, pC1468, DOI 10.1152/ajpcell.00246.2010; Pham T, 2009, BLOOD, V114, P5225, DOI 10.1182/blood-2009-05-220400; Presta M, 2003, CURR PHARM DESIGN, V9, P553, DOI 10.2174/1381612033391379; Rolny C, 2002, J BIOL CHEM, V277, P19315, DOI 10.1074/jbc.M111805200; ROSEN SD, 1989, J IMMUNOL, V142, P1895; Sorensen AL, 2009, BLOOD, V114, P1645, DOI 10.1182/blood-2009-01-199414; Stupack DG, 2001, J CELL BIOL, V155, P459, DOI 10.1083/jcb.200106070; Suzuki T, 2006, BIOCHEM J, V400, P33, DOI 10.1042/BJ20060945; TAKAHASHI N, 1995, ANAL BIOCHEM, V226, P139, DOI 10.1006/abio.1995.1201; Tanaka K, 2010, ANGEW CHEM INT EDIT, V49, P8195, DOI 10.1002/anie.201000892; Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952; Walker JA, 2008, IMMUNOLOGY, V123, P314, DOI 10.1111/j.1365-2567.2007.02752.x; Wang YC, 2010, P NATL ACAD SCI USA, V107, P9228, DOI 10.1073/pnas.0914004107; Woodfin A, 2007, ARTERIOSCL THROM VAS, V27, P2514, DOI 10.1161/ATVBAHA.107.151456; Wuhrer M, 2006, RAPID COMMUN MASS SP, V20, P1747, DOI 10.1002/rcm.2509; Yasukawa Z, 2006, GLYCOBIOLOGY, V16, P651, DOI 10.1093/glycob/cwj112; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W	48	22	22	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27604	27613		10.1074/jbc.M114.563585	http://dx.doi.org/10.1074/jbc.M114.563585			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25135639	Green Published, hybrid			2022-12-25	WOS:000342852800021
J	Qu, F; Zheng, SJ; Liu, S; Wu, CS; Duan, ZP; Zhang, JL				Qu, Feng; Zheng, Su-Jun; Liu, Shuang; Wu, Cai-Sheng; Duan, Zhong-Ping; Zhang, Jin-Lan			Serum Sphingolipids Reflect the Severity of Chronic HBV Infection and Predict the Mortality of HBV-Acute-on-Chronic Liver Failure	PLOS ONE			English	Article							CHRONIC HEPATITIS-B; DISEASE SCORING SYSTEM; ACIDIC SPHINGOMYELINASE; INHIBITION; PROGNOSIS; FULMINANT; CELLS; MODEL	Patients with HBV-acute-on-chronic liver failure (HBV-ACLF) have high mortality and frequently require liver transplantation; few reliable prognostic markers are available. As a class of functional lipids, sphingolipids are extensively involved in the process of HBV infection. However, their role in chronic HBV infection remains unknown. The aim of this study was to determine the serum sphingolipid profile in a population of patients with chronic HBV infection, paying special attention to exploring novel prognostic markers in HBV-ACLF. High performance liquid chromatography tandem mass spectrometry was used to examine the levels of 41 sphingolipids in 156 serum samples prospectively collected from two independent cohorts. The training and validation cohorts comprised 20 and 28 healthy controls (CTRL), 29 and 23 patients with chronic hepatitis B (CHB), and 30 and 26 patients with HBV-ACLF, respectively. Biometric analysis was used to evaluate the association between sphingolipid levels and disease stages. Multivariate analysis revealed difference of sphingolipid profiles between CHB and HBV-ACLF was more drastic than that between CTRL and CHB, which indicated that serum sphingolipid levels were more likely to associate with the progression HBV-ACLF rather than CHB. Furthermore, a 3-month mortality evaluation of HBV-ACLF patients showed that dhCer(d18:0/24:0) was significantly higher in survivors than in non-survivors (including deceased patients and those undergoing liver transplantation, p<0.05), and showed a prognostic performance similar to that of the MELD score. The serum sphingolipid composition varies between CTRL and chronic HBV infection patients. In addition, dhCer(d18:0/24:0) may be a useful prognostic indicator for the early prediction of HBV-ACLF.	[Qu, Feng; Wu, Cai-Sheng; Zhang, Jin-Lan] Chinese Acad Med Sci, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R China; [Qu, Feng; Wu, Cai-Sheng; Zhang, Jin-Lan] Peking Union Med Coll, Beijing 100021, Peoples R China; [Zheng, Su-Jun; Liu, Shuang; Duan, Zhong-Ping] Capital Med Univ, Beijing YouAn Hosp, Artificial Liver Ctr, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Capital Medical University	Duan, ZP (corresponding author), Capital Med Univ, Beijing YouAn Hosp, Artificial Liver Ctr, Beijing, Peoples R China.	duan2517@163.com; zhjl@imm.ac.cn	Wu, Caisheng/AAT-2701-2021; Qu, Feng/L-6355-2013	Qu, Feng/0000-0002-3812-0732	Ministry of Science and Technology of People's Republic of China [2012ZX09301002-006]; National Science and Technology Key Project on "Major Infectious Diseases such as HIV/AIDS, Viral Hepatitis Prevention and Treatment" [2012ZX10002004-006, 2012ZX10004904-003-001, 2013ZX10002002-006-001]; Beijing Municipal Natural Science Foundation [7102085]; Beijing Municipal Science & Technology Commission [Z131107002213019]; High Technical Personnel Training Item in Beijing Health System [2011-3-083]	Ministry of Science and Technology of People's Republic of China(Ministry of Science and Technology, China); National Science and Technology Key Project on "Major Infectious Diseases such as HIV/AIDS, Viral Hepatitis Prevention and Treatment"; Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation); Beijing Municipal Science & Technology Commission(Beijing Municipal Science & Technology Commission); High Technical Personnel Training Item in Beijing Health System	The work was supported by Ministry of Science and Technology of People's Republic of China (2012ZX09301002-006), National Science and Technology Key Project on "Major Infectious Diseases such as HIV/AIDS, Viral Hepatitis Prevention and Treatment" (2012ZX10002004-006, 2012ZX10004904-003-001, 2013ZX10002002-006-001), Beijing Municipal Natural Science Foundation (7102085), Beijing Municipal Science & Technology Commission (No. Z131107002213019); and High Technical Personnel Training Item in Beijing Health System (2011-3-083). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizaki H, 2008, J VIROL, V82, P5715, DOI 10.1128/JVI.02530-07; Bertoletti A, 1997, GASTROENTEROLOGY, V112, P193, DOI 10.1016/S0016-5085(97)70235-X; Brice SE, 2011, ADV EXP MED BIOL, V721, P1, DOI 10.1007/978-1-4614-0650-1_1; Chatzakos V, 2012, BIOCHEM PHARMACOL, V84, P712, DOI 10.1016/j.bcp.2012.06.009; Chinese Society of Hepatology Chinese Medical Association, 2005, Zhonghua Gan Zang Bing Za Zhi, V13, P881; Cicognani C, 1997, ARCH INTERN MED, V157, P792, DOI 10.1001/archinte.157.7.792; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Diamond DL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000719; Dudley JT, 2010, GASTROENTEROLOGY, V139, P735, DOI 10.1053/j.gastro.2010.07.024; Eriksson L., 2013, MULTI MEGAVARIATE DA; Freeman RB, 2002, LIVER TRANSPLANT, V8, P851, DOI 10.1053/jlts.2002.35927; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Garg H, 2012, DIGEST LIVER DIS, V44, P166, DOI 10.1016/j.dld.2011.08.029; Jalan R, 2002, BLOOD PURIFICAT, V20, P252, DOI 10.1159/000047017; Jalan R, 2012, J HEPATOL, V57, P1336, DOI 10.1016/j.jhep.2012.06.026; Jia W., 2009, MED METABONOMICS; Liver Failure and Artificial Liver Group Chinese Society of Infectious Diseases Chinese Medical Association, 2006, Zhonghua Gan Zang Bing Za Zhi, V14, P643; Llacuna L, 2006, HEPATOLOGY, V44, P561, DOI 10.1002/hep.21285; Lorizate M, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004820; Malagarie-Cazenave Sophie, 2002, Expert Rev Mol Med, V4, P1, DOI 10.1017/S146239940200546X; Malhi H, 2006, HEPATOLOGY, V43, pS31, DOI 10.1002/hep.21062; Mari M, 2007, LIVER INT, V27, P440, DOI 10.1111/j.1478-3231.2007.01475.x; Marrero J, 2003, AM J RESP CRIT CARE, V168, P1421, DOI 10.1164/rccm.200303-361UP; Merrill AH, 2011, CHEM REV, V111, P6387, DOI 10.1021/cr2002917; Merrill AH, 2009, J LIPID RES, V50, pS97, DOI 10.1194/jlr.R800073-JLR200; Moles A, 2010, AM J PATHOL, V177, P1214, DOI 10.2353/ajpath.2010.091257; Morales A, 2012, ANTI-CANCER AGENT ME, V12, P364, DOI 10.2174/187152012800228689; Organization WH, 2012, WHO FACT SHEET 204 D; Ozasa A, 2006, HEPATOLOGY, V44, P326, DOI 10.1002/hep.21249; Qu F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052454; Sarin SK, 2009, HEPATOL INT, V3, P269, DOI 10.1007/s12072-008-9106-x; Seijo S, 2013, AM J GASTROENTEROL; Sun QF, 2009, J VIRAL HEPATITIS, V16, P464, DOI 10.1111/j.1365-2893.2008.01046.x; Sun WY, 2012, J ALLERGY, V2012, P1; Tagaram HRS, 2011, GUT, V60, P695, DOI 10.1136/gut.2010.216671; Tatematsu K, 2011, J MED VIROL, V83, P587, DOI 10.1002/jmv.21970; Trygg J, 2002, J CHEMOMETR, V16, P119, DOI 10.1002/cem.695; Umehara T, 2006, BIOCHEM BIOPH RES CO, V346, P67, DOI 10.1016/j.bbrc.2006.05.085; Wu XX, 2012, BIOCHEM PHARMACOL, V84, P1164, DOI 10.1016/j.bcp.2012.08.006; Yu JW, 2008, J GASTROEN HEPATOL, V23, P1242, DOI 10.1111/j.1440-1746.2008.05484.x; Zheng YB, 2012, CLIN INVEST MED, V35, pE75	41	18	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e104988	10.1371/journal.pone.0104988	http://dx.doi.org/10.1371/journal.pone.0104988			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136927	Green Published, gold, Green Submitted			2022-12-25	WOS:000340742100057
J	Wilder, JR; Wegener, DT; David, MZ; Macal, C; Daum, R; Lauderdale, DS				Wilder, Jocelyn R.; Wegener, Duane T.; David, Michael Z.; Macal, Charles; Daum, Robert; Lauderdale, Diane S.			A National Survey of Skin Infections, Care Behaviors and MRSA Knowledge in the United States	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; SOFT-TISSUE INFECTIONS; EMERGENCY-DEPARTMENT; SURVEILLANCE	A nationally representative sample of approximately 2000 individuals was surveyed to assess SSTI infections over their lifetime and then prospectively over six-months. Knowledge of MRSA, future likelihood to self-treat a SSTI and self-care behaviors was also queried. Chi square tests, linear and multinomial regression were used for analysis. About 50% of those with a reported history of a SSTI typical of MRSA had sought medical treatment. MRSA knowledge was low: 28% of respondents could describe MRSA. Use of protective self-care behaviors that may reduce transmission, such as covering a lesion, differed with knowledge of MRSA and socio-demographics. Those reporting a history of a MRSA-like SSTI were more likely to respond that they would self-treat than those without such a history (OR 2.05 95% CI 1.40, 3.01; p<0.001). Since half of respondents reported not seeking care for past lesions, incidence determined from clinical encounters would greatly underestimate true incidence. MRSA knowledge was not associated with seeking medical care, but was associated with self-care practices that may decrease transmission.	[Wilder, Jocelyn R.; David, Michael Z.; Macal, Charles; Daum, Robert; Lauderdale, Diane S.] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; [Wegener, Duane T.] Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA; [Macal, Charles] Argonne Natl Lab, Decis & Informat Sci Div, Argonne, IL 60439 USA	University of Chicago; University System of Ohio; Ohio State University; United States Department of Energy (DOE); Argonne National Laboratory	Wilder, JR (corresponding author), Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA.	jwilder@uchicago.edu	David, Michael Z./X-6737-2019	David, Michael Z./0000-0002-1926-7800	Time-Sharing Experiments for the Social Sciences program (TESS; National Science Foundation) [0818839]; National Institute of General Medical Sciences (NIGMS) [U01 Gm087729 MIDAS]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI095361] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM087729] Funding Source: NIH RePORTER	Time-Sharing Experiments for the Social Sciences program (TESS; National Science Foundation); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The survey was supported by Time-Sharing Experiments for the Social Sciences program (TESS; National Science Foundation Grant 0818839; J. Freese and P. S. Visser, principal investigators). Analysis was supported by the National Institute of General Medical Sciences (NIGMS) U01 Gm087729 MIDAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cenizal MJ, 2007, ANTIMICROB AGENTS CH, V51, P2628, DOI 10.1128/AAC.00206-07; Chen AE, 2006, PEDIATR EMERG CARE, V22, P717, DOI 10.1097/01.pec.0000236832.23947.a0; Dukic VM, 2011, EMERG INFECT DIS, V17, P1068, DOI [10.3201/eid1706.101451, 10.3201/eid/1706.101451]; Edelsberg J, 2009, EMERG INFECT DIS, V15, P1516, DOI 10.3201/eid1509.081228; Hahn W, 2009, J PUBLIC HEALTH MAN, V15, P150, DOI 10.1097/01.PHH.0000346013.74522.f8; Hersh AL, 2008, ARCH INTERN MED, V168, P1585, DOI 10.1001/archinte.168.14.1585; Kaplan SL, 2005, CLIN INFECT DIS, V40, P1785, DOI 10.1086/430312; Kirby JB, 2010, MAIN REASON NOT HAVI; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Purcell K, 2005, ARCH PEDIAT ADOL MED, V159, P980, DOI 10.1001/archpedi.159.10.980; Talan DA, 2011, CLIN INFECT DIS, V53, P144, DOI 10.1093/cid/cir308	12	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e104277	10.1371/journal.pone.0104277	http://dx.doi.org/10.1371/journal.pone.0104277			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137061	gold, Green Submitted, Green Published			2022-12-25	WOS:000340742100023
J	Xia, EH; Jiang, JJ; Huang, H; Zhang, LP; Zhang, HB; Gao, LZ				Xia, En-Hua; Jiang, Jian-Jun; Huang, Hui; Zhang, Li-Ping; Zhang, Hai-Bin; Gao, Li-Zhi			Transcriptome Analysis of the Oil-Rich Tea Plant, Camellia oleifera, Reveals Candidate Genes Related to Lipid Metabolism	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; SNP DISCOVERY; MICROSATELLITE MARKERS; SSR-MARKERS; ANNOTATION; GENERATION; PROTEIN; DUPLICATION; BLAST2GO; MODEL	Background: Rapidly driven by the need for developing sustainable sources of nutritionally important fatty acids and the rising concerns about environmental impacts after using fossil oil, oil-plants have received increasing awareness nowadays. As an important oil-rich plant in China, Camellia oleifera has played a vital role in providing nutritional applications, biofuel productions and chemical feedstocks. However, the lack of C. oleifera genome sequences and little genetic information have largely hampered the urgent needs for efficient utilization of the abundant germplasms towards modern breeding efforts of this woody oil-plant. Results: Here, using the 454 GS-FLX sequencing platform, we generated approximately 600,000 RNA-Seq reads from four tissues of C. oleifera. These reads were trimmed and assembled into 104,842 non-redundant putative transcripts with a total length of similar to 38.9 Mb, representing more than 218-fold of all the C. oleifera sequences currently deposited in the GenBank (as of March 2014). Based on the BLAST similarity searches, nearly 42.6% transcripts could be annotated with known genes, conserved domains, or Gene Ontology (GO) terms. Comparisons with the cultivated tea tree, C. sinensis, identified 3,022 pairs of orthologs, of which 211 exhibited the evidence under positive selection. Pathway analysis detected the majority of genes potentially related to lipid metabolism. Evolutionary analysis of omega-6 fatty acid desaturase (FAD2) genes among 20 oil-plants unexpectedly suggests that a parallel evolution may occur between C. oleifera and Olea oleifera. Additionally, more than 2,300 simple sequence repeats (SSRs) and 20,200 single-nucleotide polymorphisms (SNPs) were detected in the C. oleifera transcriptome. Conclusions: The generated transcriptome represents a considerable increase in the number of sequences deposited in the public databases, providing an unprecedented opportunity to discover all related-genes associated with lipid metabolic pathway in C. oleifera. It will greatly enhance the generation of new varieties of C. oleifera with increased yields and high quality.	[Xia, En-Hua; Jiang, Jian-Jun; Huang, Hui; Zhang, Li-Ping; Zhang, Hai-Bin; Gao, Li-Zhi] Chinese Acad Sci, Kunming Inst Bot, Plant Germplasm & Genom Ctr, Germplasm Bank Wild Species, Kunming, Peoples R China; [Xia, En-Hua; Zhang, Hai-Bin] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Gao, LZ (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Plant Germplasm & Genom Ctr, Germplasm Bank Wild Species, Kunming, Peoples R China.	Lgao@mail.kib.ac.cn	Xia, Enhua/AAV-4999-2021; , 夏恩华/ABD-9329-2020	Xia, Enhua/0000-0003-3411-9117; Jiang, Jianjun/0000-0003-2637-0782	National Science Foundation of China [U0936603]; Key Project of Natural Science Foundation of Yunnan Province [2008CC016]; Top Talent Program of Yunnan Province [20080A009]; Frontier Grant of Kunming Institute of Botany, CAS [672705232515]; Hundred Talents Program of the Chinese Academy of Sciences (CAS); Chinese Academy of Science [KSCX2-YW-N-029]; Kunming Institute of Botany, CAS	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of Natural Science Foundation of Yunnan Province; Top Talent Program of Yunnan Province; Frontier Grant of Kunming Institute of Botany, CAS; Hundred Talents Program of the Chinese Academy of Sciences (CAS); Chinese Academy of Science(Chinese Academy of Sciences); Kunming Institute of Botany, CAS(Chinese Academy of Sciences)	This work was supported by National Science Foundation of China (U0936603), Key Project of Natural Science Foundation of Yunnan Province (2008CC016), Top Talent Program of Yunnan Province (20080A009), Frontier Grant of Kunming Institute of Botany, CAS (672705232515), the Hundred Talents Program of the Chinese Academy of Sciences (CAS), a grant from the Chinese Academy of Science (KSCX2-YW-N-029), and a start-up grant from Kunming Institute of Botany, CAS to L.-Z. Gao. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barbazuk WB, 2007, PLANT J, V51, P910, DOI 10.1111/j.1365-313X.2007.03193.x; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bellin D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-555; Blanca J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-104; Broun P, 1998, SCIENCE, V282, P1315, DOI 10.1126/science.282.5392.1315; Chen Y.H., 2007, PHYSIOCHEMICAL PROPE; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Cheung F, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-272; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Costa GGL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-462; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; Dalquen DA, 2013, GENOME BIOL EVOL, V5, P1800, DOI 10.1093/gbe/evt132; Drobak BK, 2002, TRENDS PLANT SCI, V7, P132, DOI 10.1016/S1360-1385(01)02213-0; Dugail I, 2007, CELL MOL LIFE SCI, V64, P2452, DOI 10.1007/s00018-007-7277-6; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emrich SJ, 2007, GENOME RES, V17, P69, DOI 10.1101/gr.5145806; Feussner I, 2002, ANNU REV PLANT BIOL, V53, P275, DOI 10.1146/annurev.arplant.53.100301.135248; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Gao J. Y., 1993, International Camellia Journal, V25, P53; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; He Shanan, 1982, American Camellia Yearbook 1982, P104; Hou R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021560; Hudson ME, 2008, MOL ECOL RESOUR, V8, P3, DOI 10.1111/j.1471-8286.2007.02019.x; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Kong Q, 2006, MOL ECOL NOTES, V6, P1234, DOI 10.1111/j.1471-8286.2006.01500.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Ma JL, 2011, J VERBRAUCH LEBENSM, V6, P9, DOI 10.1007/s00003-010-0581-3; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; MURPHY DJ, 1990, PROG LIPID RES, V29, P299; Niu SH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-263; OHLROGGE JB, 1994, PLANT PHYSIOL, V104, P821, DOI 10.1104/pp.104.3.821; Rismani-Yazdi H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-148; SHANKLIN J, 1994, BIOCHEMISTRY-US, V33, P12787, DOI 10.1021/bi00209a009; Sharma RK, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-53; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; Shi CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-131; Shi J, 2013, PLANT SYST EVOL, V299, P1387, DOI 10.1007/s00606-013-0814-x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Trick M, 2009, PLANT BIOTECHNOL J, V7, P334, DOI 10.1111/j.1467-7652.2008.00396.x; van Oeveren J, 2009, METHODS MOL BIOL, V578, P73, DOI 10.1007/978-1-60327-411-1_4; Varshney RK, 2002, CELL MOL BIOL LETT, V7, P537; Wall PK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-347; Wang JT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-96; Wang XC, 2012, MOL BIOL REP, V39, P6825, DOI 10.1007/s11033-012-1507-1; Wang XW, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-529; Wen Q, 2012, AM J BOT, V99, pE203, DOI 10.3732/ajb.1100486; Wu HL, 2013, PLANT MOL BIOL REP, V31, P524, DOI 10.1007/s11105-012-0519-2; Xia L. F., 1993, American Camellia Yearbook., P12; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yu Y., 1999, J NAT RESOUR, V2, P123, DOI [10.1017/S0266078400010713, DOI 10.1017/S0266078400010713]; Zhang D., 2006, ACTA HORTIC, V769, P43, DOI DOI 10.17660/ACTAH0RTIC.2008.769.3; Zhang HK, 2012, NUCLEIC ACIDS RES, V40, pW569, DOI 10.1093/nar/gks576; Zhang L, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-329	59	54	64	8	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e104150	10.1371/journal.pone.0104150	http://dx.doi.org/10.1371/journal.pone.0104150			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136805	Green Published, Green Submitted, gold			2022-12-25	WOS:000340742100018
J	Bryan, MS; Argos, M; Pierce, B; Tong, L; Rakibuz-Zaman, M; Ahmed, A; Rahman, M; Islam, T; Yunus, M; Parvez, F; Roy, S; Jasmine, F; Baron, JA; Kibriya, MG; Ahsan, H				Bryan, Molly Scannell; Argos, Maria; Pierce, Brandon; Tong, Lin; Rakibuz-Zaman, Muhammad; Ahmed, Alauddin; Rahman, Mahfuzar; Islam, Tariqul; Yunus, Muhammad; Parvez, Faruque; Roy, Shantanu; Jasmine, Farzana; Baron, John A.; Kibriya, Muhammad G.; Ahsan, Habibul			Genome-Wide Association Studies and Heritability Estimates of Body Mass Index Related Phenotypes in Bangladeshi Adults	PLOS ONE			English	Article							QT INTERVAL DURATION; COMMON VARIANTS; AFRICAN-AMERICANS; ASIAN POPULATIONS; GENETIC-VARIANTS; MORTALITY RISK; WEIGHT CHANGE; MIXED-MODEL; OVERWEIGHT; OBESITY	Many health outcomes are influenced by a person's body mass index, as well as by the trajectory of body mass index through a lifetime. Although previous research has established that body mass index related traits are influenced by genetics, the relationship between these traits and genetics has not been well characterized in people of South Asian ancestry. To begin to characterize this relationship, we analyzed the association between common genetic variation and five phenotypes related to body mass index in a population-based sample of 5,354 Bangladeshi adults. We discovered a significant association between SNV rs347313 (intron of NOS1AP) and change in body mass index in women over two years. In a linear mixed-model, the G allele was associated with an increase of 0.25 kg/m(2) in body mass index over two years (p-value of 2.3.10(-8)). We also estimated the heritability of these phenotypes from our genotype data. We found significant estimates of heritability for all of the body mass index-related phenotypes. Our study evaluated the genetic determinants of body mass index related phenotypes for the first time in South Asians. The results suggest that these phenotypes are heritable and some of this heritability is driven by variation that differs from those previously reported. We also provide evidence that the genetic etiology of body mass index related traits may differ by ancestry, sex, and environment, and consequently that these factors should be considered when assessing the genetic determinants of the risk of body mass index-related disease.	[Bryan, Molly Scannell; Argos, Maria; Pierce, Brandon; Tong, Lin; Roy, Shantanu; Jasmine, Farzana; Kibriya, Muhammad G.; Ahsan, Habibul] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; [Rakibuz-Zaman, Muhammad; Ahmed, Alauddin; Rahman, Mahfuzar; Islam, Tariqul] UChicago Res Bangladesh, Dhaka, Bangladesh; [Yunus, Muhammad] Int Ctr Diarrhoeal Dis Res, Dhaka 1000, Bangladesh; [Parvez, Faruque] Columbia Univ, Dept Environm Hlth Sci, New York, NY USA; [Baron, John A.] Univ N Carolina, Dept Med, Chapel Hill, NC USA	University of Chicago; International Centre for Diarrhoeal Disease Research (ICDDR); Columbia University; University of North Carolina; University of North Carolina Chapel Hill	Ahsan, H (corresponding author), Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA.	habib@uchicago.edu		Pierce, Brandon/0000-0002-7829-952X; Scannell Bryan, Molly/0000-0003-1030-3155; Yunus, Mohammed/0000-0003-1116-4978	National Institute of Health [RO1CA107431, P42ES10349]; Nancy Mollin Michael endowment; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES009089, P42ES010349] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nancy Mollin Michael endowment; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institute of Health (http://www.nih.gov/) grant numbers RO1CA107431, and P42ES10349 to HA, and the Nancy Mollin Michael endowment to MSB (http://www.bsd.uchicago.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KF, 2014, AM J EPIDEMIOL, V179, P135, DOI 10.1093/aje/kwt254; Adams KF, 2013, AM J EPIDEMIOLOGY; Ahsan H, 2006, J EXPO SCI ENV EPID, V16, P191, DOI 10.1038/sj.jea.7500449; Argos M, 2013, EUR J CLIN INVEST, V43, P579, DOI 10.1111/eci.12085; Arking DE, 2006, NAT GENET, V38, P644, DOI 10.1038/ng1790; Balarajan Y, 2009, J NUTR, V139, P2139, DOI 10.3945/jn.109.112029; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Berndt SI, 2013, NAT GENET, V45, P501, DOI 10.1038/ng.2606; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Comuzzie AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051954; de Mutsert R, 2014, AM J EPIDEMIOLOGY; Deurenberg P, 2002, Obes Rev, V3, P141, DOI 10.1046/j.1467-789X.2002.00065.x; Elks Cathy E, 2012, Front Endocrinol (Lausanne), V3, P29, DOI 10.3389/fendo.2012.00029; Flegal KM, 2007, JAMA-J AM MED ASSOC, V298, P2028, DOI 10.1001/jama.298.17.2028; Fox CS, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S18; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Jacqmin-Gadda H, 2007, COMPUT STAT DATA AN, V51, P5142, DOI 10.1016/j.csda.2006.05.021; Jaffrey SR, 1998, NEURON, V20, P115, DOI 10.1016/S0896-6273(00)80439-0; Jee SH, 2006, NEW ENGL J MED, V355, P779, DOI 10.1056/NEJMoa054017; Koh-Banerjee P, 2004, AM J EPIDEMIOL, V159, P1150, DOI 10.1093/aje/kwh167; Kuller LH, 1999, AM J EPIDEMIOL, V149, P515; Lenz M, 2009, DTSCH ARZTEBL INT, V106, P641, DOI 10.3238/arztebl.2009.0641; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Marroni F, 2009, CIRC-CARDIOVASC GENE, V2, P322, DOI 10.1161/CIRCGENETICS.108.833806; Meigs JB, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S16; Monda KL, 2013, NAT GENET, V45, P690, DOI 10.1038/ng.2608; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; Nan C, 2012, EUR J EPIDEMIOL, V27, P247, DOI 10.1007/s10654-012-9678-6; Newton-Cheh C, 2009, NAT GENET, V41, P399, DOI 10.1038/ng.364; Ng MCY, 2012, OBESITY, V20, P622, DOI 10.1038/oby.2011.154; Okada Y, 2012, NAT GENET, V44, P302, DOI 10.1038/ng.1086; Pfeufer A, 2009, NAT GENET, V41, P407, DOI 10.1038/ng.362; Pierce BL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002522; Pierce BL, 2010, INT J EPIDEMIOL, V39, P1037, DOI 10.1093/ije/dyp364; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Sauvaget C, 2008, INT J EPIDEMIOL, V37, P990, DOI 10.1093/ije/dyn059; Smemo S, 2014, NATURE; Smith JG, 2012, CIRC-CARDIOVASC GENE, V5, P647, DOI 10.1161/CIRCGENETICS.112.962787; Speakman JR, 2008, OBESITY, V16, P1961, DOI 10.1038/oby.2008.318; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Tsugane S, 2002, INT J OBESITY, V26, P529, DOI 10.1038/sj.ijo.0801961; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang KS, 2012, GENE, V500, P80, DOI 10.1016/j.gene.2012.03.046; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zaitlen N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003520; Zheng W, 2011, NEW ENGL J MED, V364, P719, DOI 10.1056/NEJMoa1010679; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310	52	10	10	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105062	10.1371/journal.pone.0105062	http://dx.doi.org/10.1371/journal.pone.0105062			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133637	gold, Green Submitted, Green Published			2022-12-25	WOS:000341302700065
J	Gomes, S; Marques, PI; Matthiesen, R; Seixas, S				Gomes, Silvia; Marques, Patricia I.; Matthiesen, Rune; Seixas, Susana			Adaptive Evolution and Divergence of SERPINB3: A Young Duplicate in Great Apes	PLOS ONE			English	Article							CARCINOMA ANTIGEN 1; COPY NUMBER VARIATION; REACTIVE-SITE LOOP; PROTEINASE-INHIBITOR; POSITIVE SELECTION; CYSTEINE PROTEASES; GENE; SERINE; CELLS; EXPRESSION	A series of duplication events led to an expansion of clade B Serine Protease Inhibitors (SERPIN), currently displaying a large repertoire of functions in vertebrates. Accordingly, the recent duplicates SERPINB3 and B4 located in human 18q21.3 SERPIN cluster control the activity of different cysteine and serine proteases, respectively. Here, we aim to assess SERPINB3 and B4 coevolution with their target proteases in order to understand the evolutionary forces shaping the accelerated divergence of these duplicates. Phylogenetic analysis of primate sequences placed the duplication event in a Hominoidae ancestor (similar to 30 Mya) and the emergence of SERPINB3 in Homininae (similar to 9 Mya). We detected evidence of strong positive selection throughout SERPINB4/B3 primate tree and target proteases, cathepsin L2 (CTSL2) and G (CTSG) and chymase (CMA1). Specifically, in the Homininae clade a perfect match was observed between the adaptive evolution of SERPINB3 and cathepsin S (CTSS) and most of sites under positive selection were located at the inhibitor/protease interface. Altogether our results seem to favour a coevolution hypothesis for SERPINB3, CTSS and CTSL2 and for SERPINB4 and CTSG and CMA1. A scenario of an accelerated evolution driven by host-pathogen interactions is also possible since SERPINB3/B4 are potent inhibitors of exogenous proteases, released by infectious agents. Finally, similar patterns of expression and the sharing of many regulatory motifs suggest neofunctionalization as the best fitted model of the functional divergence of SERPINB3 and B4 duplicates.	[Gomes, Silvia; Marques, Patricia I.; Seixas, Susana] Univ Porto IPATIMUP, Inst Mol Pathol & Immunol, Oporto, Portugal; [Marques, Patricia I.] Univ Porto, Inst Biomed Sci Abel Salazar ICBAS, P-4100 Oporto, Portugal; [Matthiesen, Rune] Natl Hlth Inst Doutor Ricardo Jorge INSA, Lisbon, Portugal	Universidade do Porto; Universidade do Porto; Instituto Nacional de Saude Dr. Ricardo Jorge	Gomes, S (corresponding author), Univ Porto IPATIMUP, Inst Mol Pathol & Immunol, Oporto, Portugal.	silviap@ipatimup.pt; sseixas@ipatimup.pt	Matthiesen, Rune/AAF-2167-2020; Marques, Patricia Isabel/J-9983-2019; Seixas, Susana/I-5084-2013	Matthiesen, Rune/0000-0002-6353-2616; Marques, Patricia Isabel/0000-0001-6050-628X; Seixas, Susana/0000-0002-7035-7422; Gomes, Silvia/0000-0002-4881-7808	Portuguese Foundation for Science and Technology (FCT) - European Social Funds (COMPETE-FEDER); Portuguese Ministry of Education and Science (POPH-QREN) [SFRH/BPD/77646/2011, SFRH/BD/68940/2010, PTDC/BEXGMG/0242/2012]; FCT	Portuguese Foundation for Science and Technology (FCT) - European Social Funds (COMPETE-FEDER); Portuguese Ministry of Education and Science (POPH-QREN); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by the Portuguese Foundation for Science and Technology (FCT), financed by the European Social Funds (COMPETE-FEDER) and national funds of the Portuguese Ministry of Education and Science (POPH-QREN) fellowship to SFRH/BPD/77646/2011 S. G., SFRH/BD/68940/2010 to P. I. M. and grant PTDC/BEXGMG/0242/2012 to S. S. IPATIMUP is an Associated Laboratory of the Portuguese Ministry of Education and Science and is partially supported by FCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khunaizi M, 2002, BIOCHEMISTRY-US, V41, P3189, DOI 10.1021/bi015999x; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Ashton-Rickardt PG, 2013, IMMUNOL LETT, V152, P65, DOI 10.1016/j.imlet.2013.04.004; Askew DJ, 2004, GENOMICS, V84, P166, DOI 10.1016/j.ygeno.2004.01.014; Askew YS, 2001, J BIOL CHEM, V276, P49320, DOI 10.1074/jbc.M108879200; Atchley WR, 2001, MOL BIOL EVOL, V18, P1502, DOI 10.1093/oxfordjournals.molbev.a003936; Bartuski AJ, 1997, GENOMICS, V43, P321, DOI 10.1006/geno.1997.4827; Benarafa C, 2005, P NATL ACAD SCI USA, V102, P11367, DOI 10.1073/pnas.0502934102; Bird PI, 1999, IMMUNOL CELL BIOL, V77, P47, DOI 10.1046/j.1440-1711.1999.00787.x; Brunetti-Pierri N, 2008, NAT GENET, V40, P1466, DOI 10.1038/ng.279; Cataltepe S, 2000, J HISTOCHEM CYTOCHEM, V48, P113, DOI 10.1177/002215540004800112; Christeller JT, 2005, FEBS J, V272, P5710, DOI 10.1111/j.1742-4658.2005.04975.x; da Fonseca RR, 2010, FEBS LETT, V584, P469, DOI 10.1016/j.febslet.2009.12.022; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Dumas L, 2007, GENOME RES, V17, P1266, DOI 10.1101/gr.6557307; EVANS E, 1995, GENOMICS, V28, P235, DOI 10.1006/geno.1995.1136; Eyre HJ, 1996, GENOMICS, V37, P406, DOI 10.1006/geno.1996.0580; Force A, 1999, GENETICS, V151, P1531; Forni D, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004189; Gatto M, 2013, CLIN REV ALLERG IMMU, V45, P267, DOI 10.1007/s12016-013-8353-3; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Gooptu B, 2000, P NATL ACAD SCI USA, V97, P67, DOI 10.1073/pnas.97.1.67; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Han K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002388; Han MV, 2009, GENOME RES, V19, P859, DOI 10.1101/gr.085951.108; Hao ZJ, 2012, INT J NANOMED, V7, P827, DOI 10.2147/IJN.S27803; Hardwick RJ, 2011, HUM MUTAT, V32, P743, DOI 10.1002/humu.21491; Hashimoto K, 2005, TUMOR BIOL, V26, P165, DOI 10.1159/000086949; HILL RE, 1987, NATURE, V326, P96, DOI 10.1038/326096a0; Hsing LC, 2005, IMMUNOL REV, V207, P229, DOI 10.1111/j.0105-2896.2005.00310.x; Huber R, 2012, CELL SIGNAL, V24, P1287, DOI 10.1016/j.cellsig.2012.02.007; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Innan H, 2010, NAT REV GENET, V11, P97, DOI 10.1038/nrg2689; Iskow RC, 2012, TRENDS GENET, V28, P245, DOI 10.1016/j.tig.2012.03.002; Izuhara K, 2008, CELL MOL LIFE SCI, V65, P2541, DOI 10.1007/s00018-008-8049-7; Johnson ME, 2001, NATURE, V413, P514, DOI 10.1038/35097067; Johnston IMP, 2000, ONCOGENE, V19, P5348, DOI 10.1038/sj.onc.1203927; Kaiserman D, 2010, CELL DEATH DIFFER, V17, P586, DOI 10.1038/cdd.2009.169; Kanaji S, 2007, FEBS LETT, V581, P4260, DOI 10.1016/j.febslet.2007.07.072; Kantyka T, 2011, BIOL CHEM, V392, P483, DOI 10.1515/BC.2011.044; Karaca E, 2010, MOL CELL PROTEOMICS, V9, P1784, DOI 10.1074/mcp.M000051-MCP201; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li WH, 2005, TRENDS GENET, V21, P602, DOI 10.1016/j.tig.2005.08.006; Luke C, 2000, BIOCHEMISTRY-US, V39, P7081, DOI 10.1021/bi000050g; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Marques PI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066889; Niu AL, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-298; Ohno S., 1970, P1; OHTA T, 1994, J MOL EVOL, V39, P614, DOI 10.1007/BF00160406; Perry GH, 2008, GENOME RES, V18, P1698, DOI 10.1101/gr.082016.108; PONTISSO P, 1991, J HEPATOL, V12, P203, DOI 10.1016/0168-8278(91)90939-9; Puente XS, 2003, NAT REV GENET, V4, P544, DOI 10.1038/nrg1111; Ruvoletto MG, 2004, J GEN VIROL, V85, P621, DOI 10.1099/vir.0.19130-0; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sawyer SL, 2007, PLOS PATHOG, V3, P1918, DOI 10.1371/journal.ppat.0030197; Schick C, 1998, P NATL ACAD SCI USA, V95, P13465, DOI 10.1073/pnas.95.23.13465; Schick C, 1998, BIOCHEMISTRY-US, V37, P5258, DOI 10.1021/bi972521d; Schick C, 1997, J BIOL CHEM, V272, P1849, DOI 10.1074/jbc.272.3.1849; Schrodinger L., 2020, PYMOL; Schwartz S, 2003, NUCLEIC ACIDS RES, V31, P3518, DOI 10.1093/nar/gkg579; Seixas S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032518; Silverman GA, 2004, CELL MOL LIFE SCI, V61, P301, DOI 10.1007/s00018-003-3240-3; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; Song KJ, 2012, KOREAN J PARASITOL, V50, P1, DOI 10.3347/kjp.2012.50.1.1; Suminami Y, 2000, BRIT J CANCER, V82, P981, DOI 10.1054/bjoc.1999.1028; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ullman E, 2011, MOL CELL BIOL, V31, P2902, DOI 10.1128/MCB.05452-11; Vidalino L, 2012, EXP BIOL MED, V237, P793, DOI 10.1258/ebm.2012.012024; Vidalino L, 2009, AUTOIMMUN REV, V9, P108, DOI 10.1016/j.autrev.2009.03.011; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang M, 2000, NAT MED, V6, P196, DOI 10.1038/72303; Zhang SSM, 2005, EXP EYE RES, V81, P103, DOI 10.1016/j.exer.2005.01.016	75	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e104935	10.1371/journal.pone.0104935	http://dx.doi.org/10.1371/journal.pone.0104935			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133778	Green Published, gold, Green Submitted			2022-12-25	WOS:000341302700052
J	Lo, HY; Hsiang, CY; Li, TC; Li, CC; Huang, HC; Chen, JC; Ho, TY				Lo, Hsin-Yi; Hsiang, Chien-Yun; Li, Tsai-Chung; Li, Chia-Cheng; Huang, Hui-Chi; Chen, Jaw-Chyun; Ho, Tin-Yun			A Novel Glycated Hemoglobin A1c-Lowering Traditional Chinese Medicinal Formula, Identified by Translational Medicine Study	PLOS ONE			English	Article							OPHIOPOGON-JAPONICUS; GLUCOSE-HOMEOSTASIS; MOMORDICA-CHARANTIA; PANAX-GINSENG; DOUBLE-BLIND; INSULIN; EFFICACY; DIET; POLYSACCHARIDE; ASSOCIATION	Diabetes is a chronic metabolic disorder that has a significant impact on the health care system. The reduction of glycated hemoglobin A1c is highly associated with the improvements of glycemic control and diabetic complications. In this study, we identified a traditional Chinese medicinal formula with a HbA1c-lowering potential from clinical evidences. By surveying 9,973 diabetic patients enrolled in Taiwan Diabetic Care Management Program, we found that Chu-Yeh-Shih-Kao-Tang (CYSKT) significantly reduced HbA1c values in diabetic patients. CYSKT reduced the levels of HbA1c and fasting blood glucose, and stimulated the blood glucose clearance in type 2 diabetic mice. CYSKT affected the expressions of genes associated with insulin signaling pathway, increased the amount of phosphorylated insulin receptor in cells and tissues, and stimulated the translocation of glucose transporter 4. Moreover, CYSKT affected the expressions of genes related to diabetic complications, improved the levels of renal function indexes, and increased the survival rate of diabetic mice. In conclusion, this was a translational medicine study that applied a "bedside-to-bench'' approach to identify a novel HbA1c-lowering formula. Our findings suggested that oral administration of CYSKT affected insulin signaling pathway, decreased HbA1c and blood glucose levels, and consequently reduced mortality rate in type 2 diabetic mice.	[Lo, Hsin-Yi; Ho, Tin-Yun] China Med Univ, Grad Inst Chinese Med, Taichung, Taiwan; [Hsiang, Chien-Yun] China Med Univ, Dept Microbiol, Taichung, Taiwan; [Li, Tsai-Chung] China Med Univ, Grad Inst Biostat, Taichung, Taiwan; [Li, Chia-Cheng] China Med Univ, Grad Inst Canc Biol, Taichung, Taiwan; [Huang, Hui-Chi] China Med Univ, Dept Chinese Pharmaceut Sci & Chinese Med Resourc, Taichung, Taiwan; [Chen, Jaw-Chyun] Da Yeh Univ, Dept Med Bot & Healthcare, Changhua, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; Da Yeh University	Ho, TY (corresponding author), China Med Univ, Grad Inst Chinese Med, Taichung, Taiwan.	cyhsiang@mail.cmu.edu.tw	Ho, Tin-Yun/O-3889-2015; Hsiang, Chien-Yun/O-3853-2015; Li, Tsai-Chung/P-2052-2015	Li, Tsai-Chung/0000-0002-3346-7462	National Research Program for Biopharmaceuticals [NSC101-2325-B-039-007, NSC102-2325-B-039-007, MOST103-2325-B-039-002]; Ministry of Science and Technology [NSC101-2320-B-039-034-MY3, NSC101-3114-Y-466-002, NSC102-2632-B-039-001-MY3, MOST103-2815-C-039-044-B]; Council of Agriculture [103AS-14.3.2-ST-a1]; China Medical University [CMU101-S-21, CMU101-AWARD-09, CMU102-NSC-04, CMU103-SR-44]; CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan	National Research Program for Biopharmaceuticals; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Council of Agriculture; China Medical University(China Medical University); CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan	This work was supported by grants from National Research Program for Biopharmaceuticals (NSC101-2325-B-039-007, NSC102-2325-B-039-007, and MOST103-2325-B-039-002), Ministry of Science and Technology (NSC101-2320-B-039-034-MY3, NSC101-3114-Y-466-002, NSC102-2632-B-039-001-MY3, and MOST103-2815-C-039-044-B), Council of Agriculture (103AS-14.3.2-ST-a1), China Medical University (CMU101-S-21, CMU101-AWARD-09, CMU102-NSC-04, and CMU103-SR-44), and CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2012, EXPERT OPIN PHARMACO, V13, P1797, DOI 10.1517/14656566.2012.705829; Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc12-s064, 10.2337/dc10-S062, 10.2337/dc13-S067, 10.2337/dc11-S062]; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; BUNN HF, 1978, SCIENCE, V200, P21, DOI 10.1126/science.635569; BUNN HF, 1976, J CLIN INVEST, V57, P1652, DOI 10.1172/JCI108436; Buts JP, 1997, AM J PHYSIOL-GASTR L, V273, pG217, DOI 10.1152/ajpgi.1997.273.1.G217; Chang CT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031808; Chen XM, 2013, CARBOHYD POLYM, V94, P378, DOI 10.1016/j.carbpol.2013.01.037; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Frass M, 2012, OCHSNER J, V12, P45; Gallwitz B, 2012, LANCET, V380, P475, DOI 10.1016/S0140-6736(12)60691-6; GHANNAM N, 1986, HORM RES, V24, P288, DOI 10.1159/000180569; Hu FB, 2011, DIABETES CARE, V34, P1249, DOI 10.2337/dc11-0442; Kamble SM, 1996, J RES AYURVEDA SIDDH, VXVII, P77; Kilpatrick ES, 2008, J CLIN PATHOL, V61, P977, DOI 10.1136/jcp.2007.054304; LEATHERDALE BA, 1981, BRIT MED J, V282, P1823, DOI 10.1136/bmj.282.6279.1823; Li CC, 2012, BIOMEDICINE-TAIWAN, V2, P10, DOI 10.1016/j.biomed.2012.02.002; Liu Z, 2013, J ETHNOPHARMACOL, V145, P233, DOI 10.1016/j.jep.2012.10.058; Lo HY, 2013, J AGR FOOD CHEM, V61, P2461, DOI 10.1021/jf3042402; Luo J, 1998, METABOLISM, V47, P663, DOI 10.1016/S0026-0495(98)90027-0; Mae T, 2003, J NUTR, V133, P3369, DOI 10.1093/jn/133.11.3369; Mu J, 2006, DIABETES, V55, P1695, DOI 10.2337/db05-1602; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Powers A. C., 2012, HARRISONS PRINCIPLES, P2275; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; SHANMUGASUNDARAM ERB, 1990, J ETHNOPHARMACOL, V30, P281, DOI 10.1016/0378-8741(90)90107-5; SOTANIEMI EA, 1995, DIABETES CARE, V18, P1373, DOI 10.2337/diacare.18.10.1373; Stein SA, 2013, EXPERT OPIN DRUG SAF, V12, P153, DOI 10.1517/14740338.2013.752813; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Vuksan V, 2008, NUTR METAB CARDIOVAS, V18, P46, DOI 10.1016/j.numecd.2006.04.003; Wang LY, 2012, J ETHNOPHARMACOL, V143, P347, DOI 10.1016/j.jep.2012.06.050; Yeh GY, 2003, DIABETES CARE, V26, P1277, DOI 10.2337/diacare.26.4.1277; Zhang XP, 2010, DIABETES CARE, V33, P1665, DOI 10.2337/dc09-1939; Zhao HL, 2012, DIABETES, V61, P933, DOI 10.2337/db11-1164	37	9	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e104650	10.1371/journal.pone.0104650	http://dx.doi.org/10.1371/journal.pone.0104650			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133699	Green Submitted, Green Published, gold			2022-12-25	WOS:000341302700035
J	van Hooff, ML; van Loon, J; van Limbeek, J; de Kleuver, M				van Hooff, Miranda L.; van Loon, Jan; van Limbeek, Jacques; de Kleuver, Marinus			The Nijmegen Decision Tool for Chronic Low Back Pain. Development of a Clinical Decision Tool for Secondary or Tertiary Spine Care Specialists	PLOS ONE			English	Article							LUMBAR DISC SURGERY; START BACK; PROGNOSTIC-FACTORS; SCREENING TOOL; RED FLAGS; DISABILITY; MANAGEMENT; PREDICTORS; FEAR; REHABILITATION	Background: In Western Europe, low back pain has the greatest burden of all diseases. When back pain persists, different medical specialists are involved and a lack of consensus exists among these specialists for medical decision-making in Chronic Low Back Pain (CLBP). Objective: To develop a decision tool for secondary or tertiary spine care specialists to decide which patients with CLBP should be seen by a spine surgeon or by other non-surgical medical specialists. Methods: A Delphi study was performed to identify indicators predicting the outcome of interventions. In the preparatory stage evidence from international guidelines and literature were summarized. Eligible studies were reviews and longitudinal studies. Inclusion criteria: surgical or non-surgical interventions and persistence of complaints, CLBP-patients aged 18-65 years, reported baseline measures of predictive indicators, and one or more reported outcomes had to assess functional status, quality of life, pain intensity, employment status or a composite score. Subsequently, a three-round Delphi procedure, to reach consensus on candidate indicators, was performed among a multidisciplinary panel of 29 CLBP-professionals (>five years CLBP-experience). The pre-set threshold for general agreement was >= 70%. The final indicator set was used to develop a clinical decision tool. Results: A draft list with 53 candidate indicators (38 with conclusive evidence and 15 with inconclusive evidence) was included for the Delphi study. Consensus was reached to include 47 indicators. A first version of the decision tool was developed, consisting of a web-based screening questionnaire and a provisional decision algorithm. Conclusions: This is the first clinical decision tool based on current scientific evidence and formal multidisciplinary consensus that helps referring the patient for consultation to a spine surgeon or a non-surgical spine care specialist. We expect that this tool considerably helps in clinical decision-making spine care, thereby improving efficient use of scarce sources and the outcomes of spinal interventions.	[van Hooff, Miranda L.] Sint Maartensklin, Dept Res, Nijmegen, Netherlands; [van Loon, Jan; de Kleuver, Marinus] Sint Maartenskliniek, Dept Orthoped, Nijmegen, Netherlands; [van Limbeek, Jacques] Achmea Hlth Insurance Co, Zeist, Netherlands; [de Kleuver, Marinus] Vrije Univ Amsterdam Med Ctr, Dept Orthoped, Amsterdam, Netherlands	Sint Maartens Clinic; Sint Maartens Clinic; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	van Hooff, ML (corresponding author), Sint Maartensklin, Dept Res, Nijmegen, Netherlands.	m.vanhooff@maartenskliniek.nl	van Hooff, Miranda L./A-4872-2019; de Kleuver, Marinus/A-1203-2016	de Kleuver, Marinus/0000-0002-3506-1212				Aalto TJ, 2006, SPINE, V31, pE648, DOI 10.1097/01.brs.0000231727.88477.da; Airaksinen O, 2006, EUR SPINE J, V15, pS192, DOI 10.1007/s00586-006-1072-1; Apeldoorn A, 2013, FYSIOPRAXIS, V04, P32; Athiviraham A, 2011, SPINE J, V11, P613, DOI 10.1016/j.spinee.2011.03.008; Atlas SJ, 2005, SPINE, V30, P936, DOI 10.1097/01.brs.0000158953.57966.c0; Bederman SS, 2010, SPINE J, V10, P728, DOI 10.1016/j.spinee.2010.05.008; Boulkedid R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020476; Brox JI, 2010, ANN RHEUM DIS, V69, P1643, DOI 10.1136/ard.2009.108902; Bruyere O, 2012, ARCH PUBLIC HEALTH, V70, DOI 10.1186/0778-7367-70-12; Carreon LY, 2009, SPINE, V34, P725, DOI 10.1097/BRS.0b013e318198cae4; CBO Kwaliteitsinstituut voor de Gezondheidszorg, 2009, KET ASP LAG RUGP; CBO Kwaliteitsinstituut voor de Gezondheidszorg, 2009, KET ASP LAG RUGP; Celestin J, 2009, PAIN MED, V10, P639, DOI 10.1111/j.1526-4637.2009.00632.x; Centeno CJ, 2004, SPINE, V29, P1392, DOI 10.1097/01.BRS.0000128771.48789.FB; Chavannes AW, 2005, HUISARTS WET, V48, P113; Chou R, 2010, JAMA-J AM MED ASSOC, V303, P1295, DOI 10.1001/jama.2010.344; Chou R, 2009, SPINE, V34, P1066, DOI 10.1097/BRS.0b013e3181a1390d; Soriano JC, 2010, EUR SPINE J, V19, P1841, DOI [10.1007/s00586.010.1284.2, 10.1007/s00586-010-1284-2]; Cohen SP, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2718; Costa LDM, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3829; Dagenais S, 2008, SPINE J, V8, P8, DOI 10.1016/j.spinee.2007.10.005; Dalkey NC, 1969, DELPHI METHOD EXPT S; den Boer JJ, 2006, PAIN, V123, P45, DOI 10.1016/j.pain.2006.02.008; Downie A, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7095; Fairbank J, 2005, BMJ-BRIT MED J, V330, P1233, DOI 10.1136/bmj.38441.620417.8F; Fairbank J, 2011, SPINE, V36, pS19, DOI 10.1097/BRS.0b013e31822ef72c; Flink IK, 2010, EUR J PAIN, V14, P887, DOI 10.1016/j.ejpain.2010.02.003; Fourney DR, 2011, SPINE, V36, pS1, DOI 10.1097/BRS.0b013e31822f0a0d; Freburger JK, 2009, ARCH INTERN MED, V169, P251, DOI 10.1001/archinternmed.2008.543; Fritzell P, 2006, EUR SPINE J, V15, pS57, DOI 10.1007/s00586-005-1051-y; FRYMOYER JW, 1992, CLIN ORTHOP RELAT R, P101; Gheldof ELM, 2010, EUR J PAIN, V14, DOI 10.1016/j.ejpain.2010.01.003; Glassman SD, 2011, SPINE J, V11, P1108, DOI 10.1016/j.spinee.2011.11.016; Goubert L, 2004, PAIN, V107, P234, DOI 10.1016/j.pain.2003.11.005; Grotle M, 2010, PAIN, V151, P790, DOI 10.1016/j.pain.2010.09.014; Haldeman S, 2008, SPINE J, V8, P1, DOI 10.1016/j.spinee.2007.10.009; Hall H, 2008, CLIN EVID; Harms MC, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-236; Hasenbring M, 1998, Curr Opin Anaesthesiol, V11, P553, DOI 10.1097/00001503-199810000-00018; Hasenbring MI, 2009, EUR J PAIN, V13, P620, DOI 10.1016/j.ejpain.2008.11.001; Hasenbring MI, 2006, EUR J PAIN, V10, P701, DOI 10.1016/j.ejpain.2005.11.004; Heitz CAM, 2009, EUR SPINE J, V18, P1829, DOI 10.1007/s00586-009-1083-9; Henschke N, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008686.pub2; Henschke N, 2012, EUR SPINE J, V21, P375, DOI 10.1007/s00586-011-2023-z; Hill JC, 2011, LANCET, V378, P1560, DOI 10.1016/S0140-6736(11)60937-9; Jacobs WCH, 2013, BEST PRACT RES CL RH, V27, P673, DOI 10.1016/j.berh.2013.09.009; Jensen OK, 2010, SPINE J, V10, P659, DOI 10.1016/j.spinee.2010.03.026; Johansson AC, 2010, DISABIL REHABIL, V32, P521, DOI 10.3109/09638280903177243; Kamper SJ, 2010, BEST PRACT RES CL RH, V24, P181, DOI 10.1016/j.berh.2009.11.003; Koes BW, 2006, BMJ-BRIT MED J, V332, P1430, DOI 10.1136/bmj.332.7555.1430; Koes BW, 2010, EUR SPINE J, V19, P2075, DOI 10.1007/s00586-010-1502-y; Kongsted A, 2011, CHIROPR MAN THER, V19, DOI 10.1186/2045-709X-19-10; Lambeek LC, 2011, SPINE, V36, P1050, DOI 10.1097/BRS.0b013e3181e70488; Linstone A., 2002, DELPHI METHOD TECHNI; Linton SJ, 2000, SPINE, V25, P1148, DOI 10.1097/00007632-200005010-00017; Main CJ, 2002, BMJ-BRIT MED J, V325, P534, DOI 10.1136/bmj.325.7363.534; Martel MO, 2010, PAIN, V151, P330, DOI 10.1016/j.pain.2010.07.004; McCormick JD, 2013, J AM ACAD ORTHOP SUR, V21, P99, DOI 10.5435/JAAOS-21-02-99; Meijer R, 2003, INT J REHABIL RES, V26, P265, DOI 10.1097/00004356-200312000-00003; Melloh M, 2009, INT ORTHOP, V33, P301, DOI 10.1007/s00264-008-0707-8; Costa LDM, 2011, EUR J PAIN, V15, P213, DOI 10.1016/j.ejpain.2010.06.014; Mirza SK, 2007, SPINE, V32, P816, DOI 10.1097/01.brs.0000259225.37454.38; Morso L, 2011, EUR SPINE J, V20, P2166, DOI 10.1007/s00586-011-1911-6; Murphy E., 1998, HEALTH TECHNOL ASSES, V2, pI, DOI [DOI 10.3310/HTA2030, 10.3310/hta2030]; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; NICE (National Institute for Health and Clinical Excellence), 2009, LOW BACK PAIN EARL M, P88; Oxford Centre for Evidence-based Medicine Levels of Evidence, 2009, LEV EV; Pearson A, 2012, SPINE, V37, P1791, DOI 10.1097/BRS.0b013e3182634b04; Peters ML, 2005, PAIN, V113, P45, DOI 10.1016/j.pain.2004.09.033; Picavet HSJ, 2003, PAIN, V102, P167, DOI 10.1016/S0304-3959(02)00372-X; Pincus Tamar, 2002, Spine (Phila Pa 1976), V27, pE109, DOI 10.1097/00007632-200203010-00017; Rihn JA, 2009, AM J MED QUAL, V24, p4S, DOI 10.1177/1062860609349214; Rudwaleit M, 2004, Z RHEUMATOL, V63, P193, DOI 10.1007/s00393-004-0629-9; Sanden B, 2011, SPINE, V36, P1059, DOI 10.1097/BRS.0b013e3181e92b36; Sinikallio S, 2010, DISABIL REHABIL, V32, P462, DOI 10.3109/09638280903171477; Smeets RJEM, 2006, J PAIN, V7, P261, DOI 10.1016/j.jpain.2005.10.011; Stromqvist B, 2013, EUR SPINE J, V22, P953, DOI 10.1007/s00586-013-2758-9; Susan H, 2002, AM J EPIDEMIOL, V156, P1028, DOI 10.1093/aje/kwf136; Swinkels-Meewisse IEJ, 2006, SPINE, V31, P658, DOI 10.1097/01.brs.0000203709.65384.9d; Trief PM, 2006, SPINE, V31, P823, DOI 10.1097/01.brs.0000206362.03950.5b; Truchon M, 2001, DISABIL REHABIL, V23, P758, DOI 10.1080/09638280110061744; Turk DC, 2005, CLIN J PAIN, V21, P44, DOI 10.1097/00002508-200501000-00006; Underwood M, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7432; van der Hulst M, 2005, SPINE, V30, P813, DOI 10.1097/01.brs.0000157414.47713.78; van Hooff ML, 2011, START BACK SCREENING; van Middelkoop M, 2011, EUR SPINE J, V20, P19, DOI 10.1007/s00586-010-1518-3; van Tulder M, 2011, EUR SPINE J, V20, P999, DOI 10.1007/s00586-011-1885-4; VonKorff M, 1996, SPINE, V21, P2833, DOI 10.1097/00007632-199612150-00004; Wand BM, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-11; Weiner BK, 2008, SPINE, V33, P219, DOI 10.1097/BRS.0b013e3181604572; Wessels T, 2006, EUR SPINE J, V15, P1633, DOI 10.1007/s00586-006-0073-4; Wideman TH, 2009, PAIN, V145, P45, DOI 10.1016/j.pain.2009.04.022; Willems PC, 2013, SPINE J, V13, P99, DOI 10.1016/j.spinee.2012.10.001; Williams CM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008643.pub2; Woby SR, 2004, EUR J PAIN, V8, P201, DOI 10.1016/j.ejpain.2003.08.002	95	33	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e104226	10.1371/journal.pone.0104226	http://dx.doi.org/10.1371/journal.pone.0104226			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133645	gold, Green Published			2022-12-25	WOS:000341302700025
J	Cera, N; Di Pierro, ED; Ferretti, A; Tartaro, A; Romani, GL; Perrucci, MG				Cera, Nicoletta; Di Pierro, Ezio Domenico; Ferretti, Antonio; Tartaro, Armando; Romani, Gian Luca; Perrucci, Mauro Gianni			Brain Networks during Free Viewing of Complex Erotic Movie: New Insights on Psychogenic Erectile Dysfunction	PLOS ONE			English	Article							RESTING-STATE NETWORKS; VISUAL SEXUAL STIMULI; DEFAULT MODE NETWORK; FUNCTIONAL CONNECTIVITY; DISTINCT COMPONENTS; AROUSAL; FMRI; ACTIVATION; HEALTHY; SELF	Psychogenic erectile dysfunction (ED) is defined as a male sexual dysfunction characterized by a persistent or recurrent inability to attain adequate penile erection due predominantly or exclusively to psychological or interpersonal factors. Previous fMRI studies were based on the common occurrence in the male sexual behaviour represented by the sexual arousal and penile erection related to viewing of erotic movies. However, there is no experimental evidence of altered brain networks in psychogenic ED patients (EDp). Some studies showed that fMRI activity collected during non sexual movie viewing can be analyzed in a reliable manner with independent component analysis (ICA) and that the resulting brain networks are consistent with previous resting state neuroimaging studies. In the present study, we investigated the modification of the brain networks in EDp compared to healthy controls (HC), using whole-brain fMRI during free viewing of an erotic video clip. Sixteen EDp and nineteen HC were recruited after RigiScan evaluation, psychiatric, and general medical evaluations. The performed ICA showed that visual network (VN), default-mode network (DMN), fronto-parietal network (FPN) and salience network (SN) were spatially consistent across EDp and HC. However, between-group differences in functional connectivity were observed in the DMN and in the SN. In the DMN, EDp showed decreased connectivity values in the inferior parietal lobes, posterior cingulate cortex and medial prefrontal cortex, whereas in the SN decreased and increased connectivity was observed in the right insula and in the anterior cingulate cortex respectively. The decreased levels of intrinsic functional connectivity principally involved the subsystem of DMN relevant for the self relevant mental simulation that concerns remembering of past experiences, thinking to the future and conceiving the viewpoint of the other's actions. Moreover, the between group differences in the SN nodes suggested a decreased recognition of autonomical and sexual arousal changes in EDp.	[Cera, Nicoletta; Ferretti, Antonio; Tartaro, Armando; Romani, Gian Luca; Perrucci, Mauro Gianni] Univ G dAnnunzio, Dept Neurosci Imaging & Clin Sci, Chieti, Italy; [Cera, Nicoletta; Ferretti, Antonio; Tartaro, Armando; Romani, Gian Luca; Perrucci, Mauro Gianni] ITAB Inst Adv Biomed Technol, Chieti, Italy; [Di Pierro, Ezio Domenico] Limmacolata Hosp Celano, Div Urol, Celano, Italy; [Di Pierro, Ezio Domenico] Univ Cattolica Sacro Cuore, I-00168 Rome, Italy	G d'Annunzio University of Chieti-Pescara; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Cera, N (corresponding author), Univ G dAnnunzio, Dept Neurosci Imaging & Clin Sci, Chieti, Italy.	n.cera@unich.it	tartaro, armando at/K-2184-2016; Perrucci, Mauro Gianni/J-8446-2016	tartaro, armando at/0000-0003-0095-2792; Perrucci, Mauro Gianni/0000-0002-5725-1623; FERRETTI, Antonio/0000-0002-8459-0129; Cera, Nicoletta/0000-0002-2702-8789				Abler B, 2011, NEUROPSYCHOPHARMACOL, V36, P1837, DOI 10.1038/npp.2011.66; Arnow BA, 2002, BRAIN, V125, P1014, DOI 10.1093/brain/awf108; Aziz Q, 2000, J CLIN NEUROPHYSIOL, V17, P604, DOI 10.1097/00004691-200011000-00006; Beauregard M, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-18-j0001.2001; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Bocher M, 2001, NEUROIMAGE, V14, P105, DOI 10.1006/nimg.2001.0794; Bordier C, 2013, NEUROIMAGE, V67, P213, DOI 10.1016/j.neuroimage.2012.11.031; Borg C, 2014, SOC COGN AFFECT NEUR, V9, P158, DOI 10.1093/scan/nss117; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; Cera N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039118; Cera N, 2012, J SEX MED, V9, P1602, DOI 10.1111/j.1743-6109.2012.02719.x; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Critchley HD, 2000, J PHYSIOL-LONDON, V523, P259, DOI 10.1111/j.1469-7793.2000.t01-1-00259.x; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; Decety J, 1996, COGNITIVE BRAIN RES, V3, P87, DOI 10.1016/0926-6410(95)00033-X; Derogatis LR, 1977, SCL 90R MANUAL 1 SCO; Esposito F, 2005, NEUROIMAGE, V25, P193, DOI 10.1016/j.neuroimage.2004.10.042; Felician O, 2003, NEUROPSYCHOLOGIA, V41, P1307, DOI 10.1016/S0028-3932(03)00046-0; Ferretti A, 2005, NEUROIMAGE, V26, P1086, DOI 10.1016/j.neuroimage.2005.03.025; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Fossati P, 2004, NEUROIMAGE, V22, P1596, DOI 10.1016/j.neuroimage.2004.03.034; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fransson P, 2008, NEUROIMAGE, V42, P1178, DOI 10.1016/j.neuroimage.2008.05.059; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Georgiadis JR, 2010, NEUROIMAGE, V50, P208, DOI 10.1016/j.neuroimage.2009.12.034; Greicius M, 2008, CURR OPIN NEUROL, V21, P424, DOI 10.1097/WCO.0b013e328306f2c5; HAJNAL JV, 1994, MAGNET RESON MED, V31, P283, DOI 10.1002/mrm.1910310307; Hamann S, 2004, NAT NEUROSCI, V7, P411, DOI 10.1038/nn1208; Hasson U, 2004, SCIENCE, V303, P1634, DOI 10.1126/science.1089506; Holstege G, 2003, J NEUROSCI, V23, P9185; HOON EF, 1976, ARCH SEX BEHAV, V5, P291, DOI 10.1007/BF01542081; Hoon EF, 1986, SEXUALITY RELATED ME; Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722; Karama S, 2002, HUM BRAIN MAPP, V16, P1, DOI 10.1002/hbm.10014; Kim TH, 2013, J SEX MED, V10, P1001, DOI 10.1111/jsm.12057; Koukounas E, 1997, AUST J PSYCHOL, V49, P1, DOI 10.1080/00049539708259843; Laird AR, 2009, J NEUROSCI, V29, P14496, DOI 10.1523/JNEUROSCI.4004-09.2009; Leutmezer F, 1999, NEUROLOGY, V52, P1188, DOI 10.1212/WNL.52.6.1188; Liao W, 2010, NEUROIMAGE, V52, P1549, DOI 10.1016/j.neuroimage.2010.05.010; Liotti M, 2001, P NATL ACAD SCI USA, V98, P2035, DOI 10.1073/pnas.98.4.2035; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Mantini D, 2009, NEUROIMAGE, V44, P265, DOI 10.1016/j.neuroimage.2008.08.019; Montorsi F, 2003, INT J IMPOT RES, V15, P203, DOI 10.1038/sj.ijir.3900999; Moulier V, 2006, NEUROIMAGE, V33, P689, DOI 10.1016/j.neuroimage.2006.06.037; Mouras H, 2003, NEUROIMAGE, V20, P855, DOI 10.1016/S1053-8119(03)00408-7; Pamilo S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042000; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Redoute J, 2000, HUM BRAIN MAPP, V11, P162, DOI 10.1002/1097-0193(200011)11:3<162::AID-HBM30>3.0.CO;2-A; Rosen RC, 1997, UROLOGY, V49, P822, DOI 10.1016/S0090-4295(97)00238-0; Rosen RC, 2001, UROL CLIN N AM, V28, P269, DOI 10.1016/S0094-0143(05)70137-3; Ruby P, 2003, EUR J NEUROSCI, V17, P2475, DOI 10.1046/j.1460-9568.2003.02673.x; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Shamloul R, 2013, LANCET, V381, P153, DOI 10.1016/S0140-6736(12)60520-0; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Shulman GL, 1997, HUM BRAIN MAPP, V5, P317, DOI 10.1002/(SICI)1097-0193(1997)5:4<317::AID-HBM19>3.0.CO;2-A; Spielberger C. D., 1970, SELF EVALUATION QUES; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Stoleru S, 1999, ARCH SEX BEHAV, V28, P1, DOI 10.1023/A:1018733420467; Talairach J., 1988, COPLANAR STEREOTAXIC; Walter M, 2008, NEUROIMAGE, V40, P1482, DOI 10.1016/j.neuroimage.2008.01.040; Weissenbacher A, 2009, NEUROIMAGE, V47, P1408, DOI 10.1016/j.neuroimage.2009.05.005; Wespes E, 2005, GUIDELINES ERECTILE; Xu J, 2007, NEUROPSYCHOPHARMACOL, V32, P1421, DOI 10.1038/sj.npp.1301272	67	32	39	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105336	10.1371/journal.pone.0105336	http://dx.doi.org/10.1371/journal.pone.0105336			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126947	Green Published, Green Submitted, gold			2022-12-25	WOS:000340879300105
J	Pan, C; Hu, YW; Li, J; Wang, ZY; Huang, JJ; Zhang, SZ; Ding, L				Pan, Chi; Hu, Yiwang; Li, Jun; Wang, Zhaoyi; Huang, Jianjin; Zhang, Suzhan; Ding, Ling			Estrogen Receptor-alpha 36 Is Involved in Pterostilbene-Induced Apoptosis and Anti-Proliferation in In Vitro and In Vivo Breast Cancer	PLOS ONE			English	Article							ER-ALPHA; RECEPTOR-ALPHA; VARIANT; ER-ALPHA-36; RESVERATROL; RESISTANCE; CELLS; TRANSDUCTION; INHIBITION; EXPRESSION	Pterostilbene (trans-3,5-dimethoxy-49-hudroxystilbene) is an antioxidant primarily found in blueberries. It also inhibits breast cancer regardless of conventional estrogen receptor (ER-alpha 66) status by inducing both caspase-dependent and caspase-independent apoptosis. However, the pterostilbene-induced apoptosis rate in ER-alpha 66-negative breast cancer cells is much higher than that in ER-alpha 66-positive breast cancer cells. ER-alpha 36, a variant of ER-alpha 66, is widely expressed in ER-alpha 66-negative breast cancer, and its high expression mediates the resistance of ER-alpha 66-positive breast cancer patients to tamoxifen therapy. The aim of the present study is to determine the relationship between the antiproliferation activity of pterostilbene and ER-alpha 36 expression in breast cancer cells. Methyl-thiazolyl-tetrazolium (MTT) assay, apoptosis analysis, and an orthotropic xenograft mouse model were used to examine the effects of pterostilbene on breast cancer cells. The expressions of ER-alpha 36 and caspase 3, the activation of ERK and Akt were also studied through RT-PCR, western blot analysis, and immunohistochemical (IHC) staining. ER-alpha 36 knockdown was found to desensitize ER-alpha 66-negative breast cancer cells to pterostilbene treatment both in vitro and in vivo, and high ER-alpha 36 expression promotes pterostilbene-induced apoptosis in breast cancer cells. Western blot analysis data indicate that MAPK/ERK and PI3K/Akt signaling in breast cancer cells with high ER-alpha 36 expression are mediated by ER-alpha 36, and are inhibited by pterostilbene. These results suggest that ER-alpha 36 is a therapeutic target in ER-alpha 36-positive breast cancer, and pterostilbene is an inhibitor that targets ER-alpha 36 in the personalized therapy against ER-alpha 36-positive breast cancer.	[Pan, Chi; Zhang, Suzhan] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Inst Canc, Hangzhou 310003, Zhejiang, Peoples R China; [Hu, Yiwang] Wenzhou Med Univ, Affiliated Hosp 1, Dept Surg Oncol, Wenzhou, Zhejiang, Peoples R China; [Li, Jun] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Surg Oncol, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Zhaoyi] Creighton Univ, Sch Med, Dept Med Microbiol & Immunol, Omaha, NE USA; [Huang, Jianjin; Ding, Ling] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Med Oncol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Creighton University; Zhejiang University	Ding, L (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Med Oncol, Hangzhou 310003, Zhejiang, Peoples R China.	zrsj@zju.edu.cn; lingding@zju.edu.cn	Pan, Chi/GRR-6330-2022		LD's Zhejiang qianjiang talents project [2011R10029]; Zhejiang medicine scientific research fund projects [2010ZB073]; SZZ's National Natural Science Foundation of China [81102012, 91229104]	LD's Zhejiang qianjiang talents project; Zhejiang medicine scientific research fund projects; SZZ's National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from LD's Zhejiang qianjiang talents project (No. 2011R10029), and Zhejiang medicine scientific research fund projects (No. 2010ZB073) URL: www.zjnsf.gov.cn SZZ's National Natural Science Foundation of China (No. 81102012, No. 91229104). URL: www.nsfc.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Ali S, 2002, NAT REV CANCER, V2, P101, DOI 10.1038/nrc721; Alosi JA, 2010, J SURG RES, V161, P195, DOI 10.1016/j.jss.2009.07.027; Brisdelli F, 2009, CURR DRUG METAB, V10, P530, DOI 10.2174/138920009789375423; Carlson RW, 2009, J NATL COMPR CANC NE, V7, P122, DOI 10.6004/jnccn.2009.0012; Chakraborty A, 2010, TOXICOL IN VITRO, V24, P1215, DOI 10.1016/j.tiv.2010.02.007; Chen RJ, 2012, J AGR FOOD CHEM, V60, P11533, DOI 10.1021/jf302778a; Chen RJ, 2010, MOL NUTR FOOD RES, V54, P1819, DOI 10.1002/mnfr.201000067; Clarke R, 2003, ONCOGENE, V22, P7316, DOI 10.1038/sj.onc.1206937; DeSantis C, 2014, CA-CANCER J CLIN, V64, P52, DOI 10.3322/caac.21203; Dufourny B, 1997, J BIOL CHEM, V272, P31163, DOI 10.1074/jbc.272.49.31163; FISHER B, 1988, J CLIN ONCOL, V6, P1076, DOI 10.1200/JCO.1988.6.7.1076; Jordan NJ, 2004, BREAST CANCER RES TR, V87, P167, DOI 10.1023/B:BREA.0000041623.21338.47; Kang LG, 2010, J CELL MOL MED, V14, P1485, DOI 10.1111/j.1582-4934.2009.00877.x; Kang LG, 2010, MOL ENDOCRINOL, V24, P709, DOI 10.1210/me.2009-0317; KINNE DW, 1987, ARCH SURG-CHICAGO, V122, P1303; LANGCAKE P, 1977, EXPERIENTIA, V33, P151, DOI 10.1007/BF02124034; Lee LMJ, 2008, ANTICANCER RES, V28, P479; Li GL, 2013, MOL ONCOL, V7, P611, DOI 10.1016/j.molonc.2013.02.001; Lin HS, 2009, BIOMED CHROMATOGR, V23, P1308, DOI 10.1002/bmc.1254; Lin SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009013; Lin SL, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-102; McCormack D, 2012, J SURG RES, V173, pE53, DOI 10.1016/j.jss.2011.09.054; Mena S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044524; Moon D, 2013, J SURG RES, V180, P208, DOI 10.1016/j.jss.2012.04.027; Narayanan NK, 2009, INT J CANCER, V125, P1, DOI 10.1002/ijc.24336; Ohshiro K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030725; Pan MH, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nep093; Pan MH, 2009, CARCINOGENESIS, V30, P1234, DOI 10.1093/carcin/bgp121; Pelekanou V, 2012, STEROIDS, V77, P928, DOI 10.1016/j.steroids.2011.12.016; Rimando AM, 2004, J AGR FOOD CHEM, V52, P4713, DOI 10.1021/jf040095e; Roupe KA, 2006, CURR CLIN PHARMACOL, V1, P81, DOI 10.2174/157488406775268246; Shi L, 2009, J CLIN ONCOL, V27, P3423, DOI 10.1200/JCO.2008.17.2254; Smigal C, 2006, CA-CANCER J CLIN, V56, P168, DOI 10.3322/canjclin.56.3.168; Tu BB, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.04.015; Wang YS, 2012, AM J TRANSL RES, V4, P44; Wang ZY, 2006, P NATL ACAD SCI USA, V103, P9063, DOI 10.1073/pnas.0603339103; Zhang J, 2012, STEROIDS, V77, P666, DOI 10.1016/j.steroids.2012.02.013; Zhang XT, 2011, ONCOGENE, V30, P770, DOI 10.1038/onc.2010.458; Zou Y, 2009, FEBS LETT, V583, P1368, DOI 10.1016/j.febslet.2009.03.047	40	25	29	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104459	10.1371/journal.pone.0104459	http://dx.doi.org/10.1371/journal.pone.0104459			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127034	Green Published, gold, Green Submitted			2022-12-25	WOS:000340879300026
J	Brown, HH; Borchelt, DR				Brown, Hilda H.; Borchelt, David R.			Analysis of Mutant SOD1 Electrophoretic Mobility by Blue Native Gel Electrophoresis; Evidence for Soluble Multimeric Assemblies	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; SUPEROXIDE-DISMUTASE 1; MOTOR-NEURON DEGENERATION; MOLECULAR-WEIGHT COMPLEXES; MONOMER-MISFOLDED SOD1; COPPER-BINDING-SITE; ALPHA-B-CRYSTALLIN; TRANSGENIC MICE; FAMILIAL ALS; WILD-TYPE	Mutations in superoxide dismutase 1 (SOD1) cause familial forms of amyotrophic lateral sclerosis (fALS). Disease causing mutations have diverse consequences on the activity and half-life of the protein, ranging from complete inactivity and short half-life to full activity and long-half-life. Uniformly, disease causing mutations induce the protein to misfold and aggregate and such aggregation tendencies are readily visualized by over-expression of the proteins in cultured cells. In the present study we have investigated the potential of using immunoblotting of proteins separated by Blue-Native gel electrophoresis (BNGE) as a means to identify soluble multimeric forms of mutant protein. We find that over-expressed wild-type human SOD1 (hSOD1) is generally not prone to form soluble high molecular weight entities that can be separated by BNGE. For ALS mutant SOD1, we observe that for all mutants examined (A4V, G37R, G85R, G93A, and L126Z), immunoblots of BN-gels separating protein solubilized by digitonin demonstrated varied amounts of high molecular weight immunoreactive entities. These entities lacked reactivity to ubiquitin and were partially dissociated by reducing agents. With the exception of the G93A mutant, these entities were not reactive to the C4F6 conformational antibody. Collectively, these data demonstrate that BNGE can be used to assess the formation of soluble multimeric assemblies of mutant SOD1.	[Brown, Hilda H.; Borchelt, David R.] Univ Florida, Coll Med,McKnight Brain Inst, Ctr Translat Res Neurodegenerat Dis,Dept Neurosci, SantaFe HealthCare Alzheimers Dis Res Ctr, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Borchelt, DR (corresponding author), Univ Florida, Coll Med,McKnight Brain Inst, Ctr Translat Res Neurodegenerat Dis,Dept Neurosci, SantaFe HealthCare Alzheimers Dis Res Ctr, Gainesville, FL 32611 USA.	drb1@ufl.edu			National Institute of Neurological Disorders and Stroke [P01 NS049134]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS049134] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institute of Neurological Disorders and Stroke - Grant number P01 NS049134. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayers J, 2014, J NEUROCHEM, V128, P305, DOI 10.1111/jnc.12451; Ayers JI, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-55; BORCHELT DR, 1994, P NATL ACAD SCI USA, V91, P8292, DOI 10.1073/pnas.91.17.8292; Bosco DA, 2010, NAT NEUROSCI, V13, P1396, DOI 10.1038/nn.2660; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Choi JS, 2004, BIOCHEM BIOPH RES CO, V321, P574, DOI 10.1016/j.bbrc.2004.07.010; Elam JS, 2003, NAT STRUCT BIOL, V10, P461, DOI 10.1038/nsb935; FRIDOVICH I, 1974, ADV ENZYMOL RAMB, V41, P35; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hayward LJ, 2002, J BIOL CHEM, V277, P15923, DOI 10.1074/jbc.M112087200; Jain MR, 2008, PROTEOM CLIN APPL, V2, P670, DOI 10.1002/prca.200780023; Johnston JA, 2000, P NATL ACAD SCI USA, V97, P12571, DOI 10.1073/pnas.220417997; Jonsson PA, 2006, J NEUROPATH EXP NEUR, V65, P1126, DOI 10.1097/01.jnen.0000248545.36046.3c; Jonsson PA, 2004, BRAIN, V127, P73, DOI 10.1093/brain/awh005; Karch CM, 2008, J BIOL CHEM, V283, P13528, DOI 10.1074/jbc.M800564200; Karch CM, 2010, ARCH BIOCHEM BIOPHYS, V503, P175, DOI 10.1016/j.abb.2010.07.027; Karch CM, 2010, J NEUROCHEM, V113, P1092, DOI 10.1111/j.1471-4159.2010.06572.x; Karch CM, 2009, P NATL ACAD SCI USA, V106, P7774, DOI 10.1073/pnas.0902505106; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; NISHIDA CR, 1994, P NATL ACAD SCI USA, V91, P9906, DOI 10.1073/pnas.91.21.9906; Ogihara NL, 1996, BIOCHEMISTRY-US, V35, P2316, DOI 10.1021/bi951930b; Okado-Matsumoto A, 2002, P NATL ACAD SCI USA, V99, P9010, DOI 10.1073/pnas.132260399; PARGE HE, 1992, P NATL ACAD SCI USA, V89, P6109, DOI 10.1073/pnas.89.13.6109; Prudencio M, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-77; Prudencio M, 2009, HUM MOL GENET, V18, P3217, DOI 10.1093/hmg/ddp260; Rakhit R, 2007, NAT MED, V13, P754, DOI 10.1038/nm1559; Ratovitski T, 1999, HUM MOL GENET, V8, P1451, DOI 10.1093/hmg/8.8.1451; Roberts BLT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047838; Rodriguez JA, 2005, P NATL ACAD SCI USA, V102, P10516, DOI 10.1073/pnas.0502515102; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Seetharaman SV, 2010, BIOCHEMISTRY-US, V49, P5714, DOI 10.1021/bi100314n; Shi YH, 2012, PROTEIN SCI, V21, P1197, DOI 10.1002/pro.2107; Shinder GA, 2001, J BIOL CHEM, V276, P12791, DOI 10.1074/jbc.M010759200; Urushitani M, 2007, P NATL ACAD SCI USA, V104, P2495, DOI 10.1073/pnas.0606201104; Wang J, 2003, HUM MOL GENET, V12, P2753, DOI 10.1093/hmg/ddg312; Wang J, 2005, HUM MOL GENET, V14, P2335, DOI 10.1093/hmg/ddi236; Wang J, 2002, NEUROBIOL DIS, V10, P128, DOI 10.1006/nbdi.2002.0498; Wang J, 2002, NEUROBIOL DIS, V9, P139, DOI 10.1006/nbdi.2001.0471; Wang J, 2009, P NATL ACAD SCI USA, V106, P1392, DOI 10.1073/pnas.0813045106; Watanabe Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003497; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Zetterstrom P, 2007, P NATL ACAD SCI USA, V104, P14157, DOI 10.1073/pnas.0700477104; Zetterstrom P, 2013, NEUROMOL MED, V15, P147, DOI 10.1007/s12017-012-8204-z; Zetterstrom P, 2011, J BIOL CHEM, V286, P20130, DOI 10.1074/jbc.M111.218842; Zhang FJ, 2006, BBA-GEN SUBJECTS, V1760, P404, DOI 10.1016/j.bbagen.2005.11.024; Zhang FJ, 2007, J BIOL CHEM, V282, P16691, DOI 10.1074/jbc.M609743200	48	5	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104583	10.1371/journal.pone.0104583	http://dx.doi.org/10.1371/journal.pone.0104583			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121776	Green Published, gold, Green Submitted			2022-12-25	WOS:000341017000045
J	Yang, SS; Murphy, RL; Morishige, DT; Klein, PE; Rooney, WL; Mullet, JE				Yang, Shanshan; Murphy, Rebecca L.; Morishige, Daryl T.; Klein, Patricia E.; Rooney, William L.; Mullet, John E.			Sorghum Phytochrome B Inhibits Flowering in Long Days by Activating Expression of SbPRR37 and SbGHD7, Repressors of SbEHD1, SbCN8 and SbCN12	PLOS ONE			English	Article							PSEUDO-RESPONSE-REGULATOR; PHOTOPERIOD SENSITIVITY; NATURAL VARIATION; ARABIDOPSIS; GENE; LIGHT; PROTEIN; TIME; CONSTANS; GROWTH	Light signaling by phytochrome B in long days inhibits flowering in sorghum by increasing expression of the long day floral repressors PSEUDORESPONSE REGULATOR PROTEIN (SbPRR37, Ma1) and GRAIN NUMBER, PLANT HEIGHT AND HEADING DATE 7 (SbGHD7, Ma6). SbPRR37 and SbGHD7 RNA abundance peaks in the morning and in the evening of long days through coordinate regulation by light and output from the circadian clock. 58 M, a phytochrome B deficient (phyB-1, ma3(R)) genotype, flowered similar to 60 days earlier than 100 M (PHYB, Ma3) in long days and similar to 11 days earlier in short days. Populations derived from 58 M (Ma1, ma3(R), Ma5, ma6) and R. 07007 (Ma1, Ma3, ma5, Ma6) varied in flowering time due to QTL aligned to PHYB/phyB-1 (Ma3), Ma5, and GHD7/ghd7-1 (Ma6). PHYC was proposed as a candidate gene for Ma5 based on alignment and allelic variation. PHYB and Ma5 (PHYC) were epistatic to Ma1 and Ma6 and progeny recessive for either gene flowered early in long days. Light signaling mediated by PhyB was required for high expression of the floral repressors SbPRR37 and SbGHD7 during the evening of long days. In 100 M (PHYB) the floral activators SbEHD1, SbCN8 and SbCN12 were repressed in long days and de-repressed in short days. In 58 M (phyB-1) these genes were highly expressed in long and short days. Furthermore, SbCN15, the ortholog of rice Hd3a (FT), is expressed at low levels in 100 M but at high levels in 58 M (phyB-1) regardless of day length, indicating that PhyB regulation of SbCN15 expression may modify flowering time in a photoperiod-insensitive manner.	[Yang, Shanshan; Murphy, Rebecca L.; Morishige, Daryl T.; Mullet, John E.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Klein, Patricia E.] Texas A&M Univ, Dept Hort Sci, College Stn, TX 77843 USA; [Klein, Patricia E.] Texas A&M Univ, Inst Plant Genom & Biotechnol, College Stn, TX USA; [Rooney, William L.] Texas A&M Univ, Dept Soil & Crop Sci, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Mullet, JE (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	jmullet@neo.tamu.edu	Yang, Shanshan/G-9513-2018	Murphy, Rebecca/0000-0002-1156-4560	Pioneer Hi-Bred International, Inc.; Ceres Inc.; Perry Adkisson Chair in Agricultural Biology	Pioneer Hi-Bred International, Inc.; Ceres Inc.; Perry Adkisson Chair in Agricultural Biology	This research was supported by Pioneer Hi-Bred International, Inc., Ceres Inc., and the Perry Adkisson Chair in Agricultural Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres F, 2012, NAT REV GENET, V13, P627, DOI 10.1038/nrg3291; [Anonymous], 1974, SORGHUM IMPROVEMENT; Balasubramanian S, 2006, NAT GENET, V38, P711, DOI 10.1038/ng1818; Beales J, 2007, THEOR APPL GENET, V115, P721, DOI 10.1007/s00122-007-0603-4; Bookout Angie L, 2003, Nucl Recept Signal, V1, pe012; Childs KL, 1997, PLANT PHYSIOL, V113, P611, DOI 10.1104/pp.113.2.611; CHURCHILL GA, 1994, GENETICS, V138, P963; Clack T, 2009, PLANT CELL, V21, P786, DOI 10.1105/tpc.108.065227; Danilevskaya ON, 2008, PLANT PHYSIOL, V146, P250, DOI 10.1104/pp.107.109538; Distelfeld A, 2010, MOL GENET GENOMICS, V283, P223, DOI 10.1007/s00438-009-0510-2; Doi K, 2004, GENE DEV, V18, P926, DOI 10.1101/gad.1189604; Franklin KA, 2010, J EXP BOT, V61, P11, DOI 10.1093/jxb/erp304; Greenup A, 2009, ANN BOT-LONDON, V103, P1165, DOI 10.1093/aob/mcp063; Hanumappa M, 1999, PLANT PHYSIOL, V119, P1033, DOI 10.1104/pp.119.3.1033; Imaizumi T, 2005, SCIENCE, V309, P293, DOI 10.1126/science.1110586; Imaizumi T, 2010, CURR OPIN PLANT BIOL, V13, P83, DOI 10.1016/j.pbi.2009.09.007; Itoh H, 2010, NAT GENET, V42, P635, DOI 10.1038/ng.606; Izawa T, 2002, GENE DEV, V16, P2006, DOI 10.1101/gad.999202; Jiao YL, 2007, NAT REV GENET, V8, P217, DOI 10.1038/nrg2049; Kami C, 2010, CURR TOP DEV BIOL, V91, P29, DOI 10.1016/S0070-2153(10)91002-8; Koo BH, 2013, MOL PLANT, V6, P1877, DOI 10.1093/mp/sst088; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Leivar P, 2011, TRENDS PLANT SCI, V16, P19, DOI 10.1016/j.tplants.2010.08.003; Mace ES, 2013, THEOR APPL GENET, V126, P1377, DOI 10.1007/s00122-013-2059-z; Meng X, 2011, PLANT CELL, V23, P942, DOI 10.1105/tpc.110.081406; Monte E, 2003, PLANT CELL, V15, P1962, DOI 10.1105/tpc.012971; Morgan PW, 2000, WILEY SERIES CROP SC, P240; Morishige DT, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-448; Murphy RL, 2011, P NATL ACAD SCI USA, V108, P16469, DOI 10.1073/pnas.1106212108; Murphy RL, 2014, PLANT GENOM IN PRESS; Nagatani A, 2010, CURR OPIN PLANT BIOL, V13, P565, DOI 10.1016/j.pbi.2010.07.002; Nakamichi N, 2010, PLANT CELL, V22, P594, DOI 10.1105/tpc.109.072892; Nozue K, 2007, NATURE, V448, P358, DOI 10.1038/nature05946; Olson SN, 2012, BIOFUEL BIOPROD BIOR, V6, P640, DOI 10.1002/bbb.1357; Osugi A, 2011, PLANT PHYSIOL, V157, P1128, DOI 10.1104/pp.111.181792; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pruneda-Paz JL, 2010, TRENDS PLANT SCI, V15, P259, DOI 10.1016/j.tplants.2010.03.003; QUAIL PH, 1994, PLANT CELL, V6, P468, DOI 10.1105/tpc.6.4.468; Robson F, 2001, PLANT J, V28, P619, DOI 10.1046/j.1365-313x.2001.01163.x; Rooney WL, 2007, BIOFUEL BIOPROD BIOR, V1, P147, DOI 10.1002/bbb.15; Rooney WL, 1999, CROP SCI, V39, P397, DOI 10.2135/cropsci1999.0011183X0039000200016x; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Srikanth A, 2011, CELL MOL LIFE SCI, V68, P2013, DOI 10.1007/s00018-011-0673-y; Takano M, 2005, PLANT CELL, V17, P3311, DOI 10.1105/tpc.105.035899; Tamaki S, 2007, SCIENCE, V316, P1033, DOI 10.1126/science.1141753; Tsuji H, 2011, CURR OPIN PLANT BIOL, V14, P45, DOI 10.1016/j.pbi.2010.08.016; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; Turner A, 2005, SCIENCE, V310, P1031, DOI 10.1126/science.1117619; Vigouroux Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019563; Wang S, 2012, WINDOWS QTL CARTOGRA; Welch SM, 2004, MOD GEN NETW CONTR T, P1; Yan LL, 2004, SCIENCE, V303, P1640, DOI 10.1126/science.1094305; Yang SS, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-148; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473	54	39	44	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e105352	10.1371/journal.pone.0105352	http://dx.doi.org/10.1371/journal.pone.0105352			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122453	Green Published, gold, Green Submitted			2022-12-25	WOS:000341017000118
J	Ramnath, R; Foster, RR; Qiu, Y; Cope, G; Butler, MJ; Salmon, AH; Mathieson, PW; Coward, RJ; Welsh, GI; Satchell, SC				Ramnath, Raina; Foster, Rebecca R.; Qiu, Yan; Cope, George; Butler, Matthew J.; Salmon, Andrew H.; Mathieson, Peter W.; Coward, Richard J.; Welsh, Gavin I.; Satchell, Simon C.			Matrix metalloproteinase 9-mediated shedding of syndecan 4 in response to tumor necrosis factor alpha : a contributor to endothelial cell glycocalyx dysfunction	FASEB JOURNAL			English	Article						heparan sulfate; microvascular permeability	HEPARAN-SULFATE PROTEOGLYCANS; DIABETIC-NEPHROPATHY; GLOMERULAR ENDOTHELIUM; GENE-EXPRESSION; ALBUMINURIA; SULODEXIDE; BARRIER; TNF; MICROALBUMINURIA; MECHANISM	The endothelial surface glycocalyx is a hydrated mesh in which proteoglycans are prominent. It is damaged in diseases associated with elevated levels of tumor necrosis factor (TNF-). We investigated the mechanism of TNF--induced disruption of the glomerular endothelial glycocalyx. We used conditionally immortalized human glomerular endothelial cells (GEnCs), quantitative PCR arrays, Western blotting, immunoprecipitation, immunofluorescence, and dot blots to examine the effects of TNF-. TNF- induced syndecan 4 (SDC4) mRNA up-regulation by 2.5-fold, whereas cell surface SDC4 and heparan sulfate (HS) were reduced by 36 and 30%, respectively, and SDC4 and sulfated glycosaminoglycan in the culture medium were increased by 52 and 65%, respectively, indicating TNF--induced shedding. Small interfering (siRNA) knockdown of SDC4 (by 52%) caused a corresponding loss of cell surface HS of similar magnitude (38%), and immunoprecipitation demonstrated that SDC4 and HS are shed as intact proteoglycan ectodomains. All of the effects of TNF- on SDC4 and HS were abrogated by the metalloproteinase (MMP) inhibitor batimastat. Also abrogated was the associated 37% increase in albumin passage across GEnC monolayers. Specific MMP9 knockdown by siRNA similarly blocked TNF- effects. SDC4 is the predominant HS proteoglycan in the GEnC glycocalyx. TNF--induced MMP9-mediated shedding of SDC4 is likely to contribute to the endothelial glycocalyx disruption observed in diabetes and inflammatory states.Ramnath, R., Foster, R. R., Qiu, Y., Cope, G., Butler, M. J., Salmon, A. H., Mathieson, P. W., Coward, R. J., Welsh, G. I., Satchell, S. C. Matrix metalloproteinase 9-mediated shedding of syndecan 4 in response to tumor necrosis factor : a contributor to endothelial cell glycocalyx dysfunction.	[Ramnath, Raina; Foster, Rebecca R.; Qiu, Yan; Cope, George; Butler, Matthew J.; Salmon, Andrew H.; Mathieson, Peter W.; Coward, Richard J.; Welsh, Gavin I.; Satchell, Simon C.] Univ Bristol, Sch Clin Sci, Acad Renal Unit, Bristol, Avon, England	University of Bristol	Satchell, SC (corresponding author), Acad Renal Unit, Dorothy Hodgkin Bldg,Whitson St, Bristol BS1 3NY, Avon, England.	s.c.satchell@bristol.ac.uk	Foster, Rebecca/GSM-6886-2022; Ramnath, Raina/AAO-1180-2020; Foster, Becky/ABC-4433-2020	Foster, Rebecca/0000-0002-9645-1476; Welsh, Gavin Iain/0000-0002-2148-6658; Coward, Richard/0000-0001-6183-2546; Butler, Matthew/0000-0002-9814-8008; Ramnath, Raina/0000-0001-8472-5081	Diabetes UK [10/0004003]; British Heart Foundation Basic Science Intermediate Research Fellowship [FS/10/017/28249]; MRC [MR/K010492/1, G0802829] Funding Source: UKRI; British Heart Foundation [PG/12/51/29705, FS/10/017/28249] Funding Source: researchfish; Kidney Research UK [ST5/2012, RP45/2013] Funding Source: researchfish; Medical Research Council [G0802829, MR/K010492/1] Funding Source: researchfish	Diabetes UK(Diabetes UK); British Heart Foundation Basic Science Intermediate Research Fellowship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Kidney Research UK(Kidney Research UK (KRUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors are grateful to Amy Russell (Academic Renal Unit, University of Bristol) for her technical assistance with the isolation of human GEnCs and Dr. Donald Fraser (Institute of Nephrology, Cardiff University, Cadiff, UK) for assistance with running the TEDAs. The work was funded by a Diabetes UK project grant (10/0004003). R.R.F. was supported by a British Heart Foundation Basic Science Intermediate Research Fellowship (FS/10/017/28249). The authors declare no conflicts of interest.	Adembri C, 2011, CRIT CARE, V15, DOI 10.1186/cc10559; Bass MD, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.264pe18; Bjornson A, 2005, AM J PHYSIOL-RENAL, V288, pF748, DOI 10.1152/ajprenal.00202.2004; Granqvist ABR, 2006, AM J PHYSIOL-RENAL, V291, pF722, DOI 10.1152/ajprenal.00433.2005; Blouza S, 2010, J NEPHROL, V23, P415; Broekhuizen LN, 2010, DIABETOLOGIA, V53, P2646, DOI 10.1007/s00125-010-1910-x; Brule S, 2006, GLYCOBIOLOGY, V16, P488, DOI 10.1093/glycob/cwj098; Chappell D, 2009, CARDIOVASC RES, V83, P388, DOI 10.1093/cvr/cvp097; Chappell D, 2009, BASIC RES CARDIOL, V104, P78, DOI 10.1007/s00395-008-0749-5; Chen SJ, 2010, KIDNEY INT, V78, P1088, DOI 10.1038/ki.2010.136; Couchman JR, 2010, ANNU REV CELL DEV BI, V26, P89, DOI 10.1146/annurev-cellbio-100109-104126; Fan QL, 2003, KIDNEY INT, V64, P1978, DOI 10.1046/j.1523-1755.2003.00312.x; Foster RR, 2013, AM J PATHOL, V183, P604, DOI 10.1016/j.ajpath.2013.04.019; Friedl J, 2002, BLOOD, V100, P1334, DOI 10.1182/blood.V100.4.1334.h81602001334_1334_1339; GAMBARO G, 1992, KIDNEY INT, V42, P285, DOI 10.1038/ki.1992.288; Gharagozlian S, 2009, BMC CLIN PATHOL, V9, DOI 10.1186/1472-6890-9-7; Gil N, 2012, DIABETES, V61, P208, DOI 10.2337/db11-1024; Haraldsson B, 2008, PHYSIOL REV, V88, P451, DOI 10.1152/physrev.00055.2006; Henry CBS, 2000, AM J PHYSIOL-HEART C, V279, pH2815, DOI 10.1152/ajpheart.2000.279.6.H2815; Jeansson M, 2006, DIABETOLOGIA, V49, P2200, DOI 10.1007/s00125-006-0319-z; Jensen JS, 2000, HYPERTENSION, V35, P898, DOI 10.1161/01.HYP.35.4.898; Karon J, 2007, BLOOD PURIFICAT, V25, P510, DOI 10.1159/000113011; KIM CW, 1994, MOL BIOL CELL, V5, P797, DOI 10.1091/mbc.5.7.797; Lassalle P, 1996, J BIOL CHEM, V271, P20458, DOI 10.1074/jbc.271.34.20458; Levick JR, 2010, CARDIOVASC RES, V87, P198, DOI 10.1093/cvr/cvq062; Manon-Jensen T, 2010, FEBS J, V277, P3876, DOI 10.1111/j.1742-4658.2010.07798.x; Fernandez-Real JM, 2012, ACTA DIABETOL, V49, P301, DOI 10.1007/s00592-011-0349-y; Masola V, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-213; Multhaupt HAB, 2009, J PHYSIOL PHARMACOL, V60, P31; Nair S, 2008, J NEPHROL, V21, P400; Navarro JF, 2005, KIDNEY INT, V68, P98; Navarro-Gonzalez JF, 2008, J AM SOC NEPHROL, V19, P433, DOI 10.1681/ASN.2007091048; Navarro-Gonzalez JF, 2009, CYTOKINE GROWTH F R, V20, P165, DOI 10.1016/j.cytogfr.2009.02.005; Nieuwdorp M, 2006, DIABETES, V55, P1127, DOI 10.2337/diabetes.55.04.06.db05-1619; Ostrowski SR, 2013, CRIT CARE, V17, DOI 10.1186/cc12532; Pruessmeyer J, 2010, J BIOL CHEM, V285, P555, DOI 10.1074/jbc.M109.059394; Pyke C, 1997, NEPHRON, V77, P461, DOI 10.1159/000190325; Ramani VC, 2012, J BIOL CHEM, V287, P9952, DOI 10.1074/jbc.M111.330803; Reitsma S, 2007, PFLUG ARCH EUR J PHY, V454, P345, DOI 10.1007/s00424-007-0212-8; Rops AL, 2007, KIDNEY INT, V72, P1204, DOI 10.1038/sj.ki.5002514; Salmon AHJ, 2012, J PATHOL, V226, P562, DOI 10.1002/path.3964; Satchell SC, 2008, DIABETOLOGIA, V51, P714, DOI 10.1007/s00125-008-0961-8; Satchell SC, 2006, KIDNEY INT, V69, P1633, DOI 10.1038/sj.ki.5000277; Satchell SC, 2004, J AM SOC NEPHROL, V15, P566, DOI 10.1097/01.ASN.0000115397.22519.03; Satchell S, 2013, NAT REV NEPHROL, V9, P717, DOI 10.1038/nrneph.2013.197; Satchell SC, 2012, KIDNEY INT, V82, P949, DOI 10.1038/ki.2012.258; Sato T, 2003, J BIOL CHEM, V278, P3063, DOI 10.1074/jbc.M208886200; Satoh M, 2010, MICROCIRCULATION, V17, P103, DOI 10.1111/j.1549-8719.2009.00010.x; Schalkwijk CG, 2005, CLIN SCI, V109, P143, DOI 10.1042/CS20050025; Singh A, 2011, AM J PHYSIOL-RENAL, V300, pF40, DOI 10.1152/ajprenal.00103.2010; Singh A, 2007, J AM SOC NEPHROL, V18, P2885, DOI 10.1681/ASN.2007010119; Singh A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055852; Strand ME, 2013, FEBS J, V280, P2228, DOI 10.1111/febs.12161; Sulikowska B, 2006, AM J NEPHROL, V26, P621, DOI 10.1159/000098195; Tamsma JT, 1996, NEPHROL DIAL TRANSPL, V11, P182; Tan XH, 2012, AM J PHYSIOL-LUNG C, V302, P1700, DOI 10.1152/ajplung.00167.2011; Weinbaum S, 2007, ANNU REV BIOMED ENG, V9, P121, DOI 10.1146/annurev.bioeng.9.060906.151959; Zhang YF, 1999, J BIOL CHEM, V274, P14786, DOI 10.1074/jbc.274.21.14786	58	78	80	0	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2014	28	11					4686	4699		10.1096/fj.14-252221	http://dx.doi.org/10.1096/fj.14-252221			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AS1OU	25122554				2022-12-25	WOS:000344050900010
J	Sheng, YQ; Li, W; Zhu, F; Liu, KD; Chen, HY; Yao, K; Reddy, K; Lim, DY; Oi, NM; Li, HT; Peng, C; Ma, WY; Bode, AM; Dong, ZM; Dong, ZG				Sheng, Yuqiao; Li, Wei; Zhu, Feng; Liu, Kangdong; Chen, Hanyong; Yao, Ke; Reddy, Kanamata; Lim, Do Young; Oi, Naomi; Li, Haitao; Peng, Cong; Ma, Wei-Ya; Bode, Ann M.; Dong, Ziming; Dong, Zigang			3,6,2 ',4 ',5 '-Pentahydroxyflavone, an Orally Bioavailable Multiple Protein Kinase Inhibitor, Overcomes Gefitinib Resistance in Non-small Cell Lung Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADVANCED SOLID TUMORS; I PI3K INHIBITOR; AURORA-B-KINASE; PHASE-I; ACQUIRED-RESISTANCE; MET AMPLIFICATION; GROWTH; MUTATION; OVEREXPRESSION; EXPRESSION	Non-small cell lung cancer (NSCLC) is the most lethal cancer, causing more than 150,000 deaths in the United States in 2013. The receptor tyrosine kinase inhibitors such as gefitinib are not perfect clinical therapeutic agents for NSCLC treatment due to primary or acquired tyrosine kinase inhibitor resistance. Herein, 3,6,2',4',5'-pentahydroxyflavone (36245-PHF) was identified as a multiple kinase inhibitor for NSCLC treatment based on the computational screening of a natural products database. 36245-PHF was shown to inhibit PI3K and Aurora A and B kinases and overcome gefitinib-resistant NSCLC growth. Our data clearly showed that 36245-PHF markedly inhibited anchorage-independent growth of gefitinib-resistant NSCLC cell lines and exerted a substantial chemotherapeutic effect following oral administration in a gefitinib-resistant NSCLC xenograft model. The evidence from three different subsequent methodological approaches, in vitro, ex vivo, and in vivo, all confirmed that 36245-PHF as a multiple protein kinase inhibitor. Overall, we identified 36245-PHF as a multiple protein kinase inhibitor and as a novel therapeutic agent to overcome gefitinib-resistant NSCLC growth, which could provide a new option for clinical NSCLC oral treatment.	[Sheng, Yuqiao; Li, Wei; Zhu, Feng; Liu, Kangdong; Chen, Hanyong; Yao, Ke; Reddy, Kanamata; Lim, Do Young; Oi, Naomi; Li, Haitao; Peng, Cong; Ma, Wei-Ya; Bode, Ann M.; Dong, Zigang] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA; [Sheng, Yuqiao; Liu, Kangdong; Dong, Ziming] Zhengzhou Univ, Basic Med Coll, Dept Physiol & Pathophysiol, Zhengzhou 450001, Henan, Peoples R China; [Sheng, Yuqiao] Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou 450001, Henan, Peoples R China; [Li, Wei] Cent S Univ, Xiangya Sch Med, Canc Res Inst, Changsha 410078, Hunan, Peoples R China; [Peng, Cong] Cent S Univ, Xiangya Hosp, Changsha 410078, Hunan, Peoples R China	University of Minnesota System; Zhengzhou University; Zhengzhou University; Central South University; Central South University	Dong, ZM (corresponding author), Zhengzhou Univ, 100 Kexue Rd, Zhengzhou 450001, Henan, Peoples R China.	Dongzm@zzu.edu.cn; zgdong@hi.umn.edu	Sheng, Yuqiao/AAT-7522-2020; ZHU, Feng/C-1303-2010	Sheng, Yuqiao/0000-0002-7528-7187; Zhu, Feng/0000-0003-1172-0102	Hormel Foundation; United Soybean Board; National Institutes of Health [CA1661011, CA172457, R37 C081064, CA027502, ES016548]; NATIONAL CANCER INSTITUTE [R21CA172457, P01CA027502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016548] Funding Source: NIH RePORTER	Hormel Foundation; United Soybean Board; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by The Hormel Foundation, United Soybean Board, and National Institutes of Health Grants CA1661011, CA172457, R37 C081064, CA027502, and ES016548.	Bendell JC, 2012, J CLIN ONCOL, V30, P282, DOI 10.1200/JCO.2011.36.1360; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Calderon-Montano JM, 2011, MINI-REV MED CHEM, V11, P298, DOI 10.2174/138955711795305335; Carvajal RD, 2006, CLIN CANCER RES, V12, P6869, DOI 10.1158/1078-0432.CCR-06-1405; Dar AA, 2010, MOL CANCER THER, V9, P268, DOI 10.1158/1535-7163.MCT-09-0765; DeSantis CE, 2014, CA-CANCER J CLIN, V64, P252, DOI 10.3322/caac.21235; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Engelman JA, 2006, J CLIN INVEST, V116, P2695, DOI 10.1172/JCI28656; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Hong DS, 2012, CLIN CANCER RES, V18, P4173, DOI 10.1158/1078-0432.CCR-12-0714; Jackman D, 2010, J CLIN ONCOL, V28, P357, DOI 10.1200/JCO.2009.24.7049; Kamei H, 1996, CANCER BIOTHER RADIO, V11, P193, DOI 10.1089/cbr.1996.11.193; Kawano O, 2006, LUNG CANCER, V54, P209, DOI 10.1016/j.lungcan.2006.07.006; Li H, 2011, ADV MED SCI-POLAND, V56, P275, DOI 10.2478/v10039-011-0043-x; Li X, 2012, CARCINOGENESIS, V33, P2548, DOI 10.1093/carcin/bgs283; Liu MM, 2012, EUR J MED CHEM, V52, P33, DOI 10.1016/j.ejmech.2012.03.002; Lo Iacono M, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-100; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Ogawa E, 2008, ANN SURG ONCOL, V15, P547, DOI 10.1245/s10434-007-9653-8; Osaki M, 2004, APOPTOSIS, V9, P667, DOI 10.1023/B:APPT.0000045801.15585.dd; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Reck M, 2013, LANCET, V382, P709, DOI 10.1016/S0140-6736(13)61502-0; Shapiro GI, 2014, CLIN CANCER RES, V20, P233, DOI 10.1158/1078-0432.CCR-13-1777; Smith SL, 2005, BRIT J CANCER, V93, P719, DOI 10.1038/sj.bjc.6602779; Turke AB, 2010, CANCER CELL, V17, P77, DOI 10.1016/j.ccr.2009.11.022; Vischioni B, 2006, MOL CANCER THER, V5, P2905, DOI 10.1158/1535-7163.MCT-06-0301; Wheeler DL, 2010, NAT REV CLIN ONCOL, V7, P493, DOI 10.1038/nrclinonc.2010.97; Wu CC, 2011, BIOCHEM BIOPH RES CO, V405, P168, DOI 10.1016/j.bbrc.2011.01.001; Xie H, 2013, CANCER RES, V73, P716, DOI 10.1158/0008-5472.CAN-12-2784	29	16	17	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28192	28201		10.1074/jbc.M114.593475	http://dx.doi.org/10.1074/jbc.M114.593475			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25122774	Green Published, hybrid			2022-12-25	WOS:000343765400016
J	Abais, JM; Xia, M; Li, GB; Chen, Y; Conley, SM; Gehr, TWB; Boini, KM; Li, PL				Abais, Justine M.; Xia, Min; Li, Guangbi; Chen, Yang; Conley, Sabena M.; Gehr, Todd W. B.; Boini, Krishna M.; Li, Pin-Lan			Nod-like Receptor Protein 3 (NLRP3) Inflammasome Activation and Podocyte Injury via Thioredoxin-Interacting Protein (TXNIP) during Hyperhomocysteinemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-CHANNEL BLOCKERS; GLOMERULAR SCLEROSIS; OXIDATIVE STRESS; NADPH OXIDASE; CELL-DEATH; FOLIC-ACID; ER STRESS; EXPRESSION; DAMAGE; GENE	NADPH oxidase-derived reactive oxygen species (ROS) have been reported to activate NLRP3 inflammasomes resulting in podocyte and glomerular injury during hyperhomocysteinemia (hHcys). However, the mechanism by which the inflammasome senses ROS is still unknown in podocytes upon hHcys stimulation. The current study explored whether thioredoxin-interacting protein (TXNIP), an endogenous inhibitor of the antioxidant thioredoxin and ROS sensor, mediates hHcys-induced NLRP3 inflammasome activation and consequent glomerular injury. In cultured podocytes, size exclusion chromatography and confocal microscopy showed that inhibition of TXNIP by siRNA or verapamil prevented Hcys-induced TXNIP protein recruitment to form NLRP3 inflammasomes and abolished Hcys-induced increases in caspase-1 activity and IL-1 beta production. TXNIP inhibition protected podocytes from injury as shown by normal expression levels of podocyte markers, podocin and desmin. In vivo, adult C57BL/6J male mice were fed a folate-free diet for 4 weeks to induce hHcys, and TXNIP was inhibited by verapamil (1 mg/ml in drinking water) or by local microbubble-ultrasound TXNIP shRNA transfection. Evidenced by immunofluorescence and co-immunoprecipitation studies, glomerular inflammasome formation and TXNIP binding to NLRP3 were markedly increased in mice with hHcys but not in TXNIP shRNA-transfected mice or those receiving verapamil. Furthermore, TXNIP inhibition significantly reduced caspase-1 activity and IL-1 beta production in glomeruli of mice with hHcys. Correspondingly, TXNIP shRNA transfection and verapamil attenuated hHcys-induced proteinuria, albuminuria, glomerular damage, and podocyte injury. In conclusion, our results demonstrate that TXNIP binding to NLRP3 is a key signaling mechanism necessary for hHcys-induced NLRP3 inflammasome formation and activation and subsequent glomerular injury.	[Abais, Justine M.; Xia, Min; Li, Guangbi; Chen, Yang; Conley, Sabena M.; Boini, Krishna M.; Li, Pin-Lan] Virginia Commonwealth Univ, Sch Med, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA; [Gehr, Todd W. B.] Virginia Commonwealth Univ, Sch Med, Dept Internal Med, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University	Abais, JM (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Pharmacol & Toxicol, 410 N 12th St, Richmond, VA 23298 USA.	pli@vcu.edu			National Institutes of Health [DK54927, HL075316, HL57244, 1F31AG043289-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057244, R01HL075316, R29HL057244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG043289] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by Grants DK54927, HL075316, and HL57244 (to P.-L. L.) and 1F31AG043289-01 (to J. M. A.) from the National Institutes of Health.	Abais JM, 2014, FREE RADICAL BIO MED, V67, P211, DOI 10.1016/j.freeradbiomed.2013.10.009; Abais JM, 2013, ANTIOXID REDOX SIGN, V18, P1537, DOI 10.1089/ars.2012.4666; Advani A, 2009, J AM SOC NEPHROL, V20, P730, DOI 10.1681/ASN.2008020142; Al-Gayyar MMH, 2011, BRIT J PHARMACOL, V164, P170, DOI 10.1111/j.1476-5381.2011.01336.x; Bakker PJ, 2014, KIDNEY INT, V85, P1112, DOI 10.1038/ki.2013.503; Benko S, 2008, CYTOKINE, V43, P368, DOI 10.1016/j.cyto.2008.07.013; Boini KM, 2014, BBA-MOL CELL RES, V1843, P836, DOI 10.1016/j.bbamcr.2014.01.033; Boini KM, 2011, AM J PATHOL, V179, P2210, DOI 10.1016/j.ajpath.2011.07.019; Brough D, 2003, J IMMUNOL, V170, P3029, DOI 10.4049/jimmunol.170.6.3029; Cao L, 2013, MICROVASC RES, V89, P146, DOI 10.1016/j.mvr.2013.07.002; Cha-Molstad H, 2012, MOL PHARMACOL, V82, P541, DOI 10.1124/mol.112.078253; Chen JQ, 2009, AM J PHYSIOL-ENDOC M, V296, pE1133, DOI 10.1152/ajpendo.90944.2008; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; FLOEGE J, 1992, LAB INVEST, V67, P486; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HARRIS DCH, 1987, KIDNEY INT, V31, P41, DOI 10.1038/ki.1987.6; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Joles JA, 2000, J AM SOC NEPHROL, V11, P669, DOI 10.1681/ASN.V114669; Kalani A, 2014, J MOL NEUROSCI, V52, P202, DOI 10.1007/s12031-013-0122-5; Kang DH, 2003, CURR OPIN NEPHROL HY, V12, P43, DOI 10.1097/00041552-200301000-00008; Kawachi H, 2006, NEPHROLOGY, V11, P274, DOI 10.1111/j.1440-1797.2006.00583.x; Lerner AG, 2012, CELL METAB, V16, P250, DOI 10.1016/j.cmet.2012.07.007; Li NJ, 2002, HYPERTENSION, V39, P443, DOI 10.1161/hy02t2.102992; Li XN, 2009, BIOCHEM BIOPH RES CO, V381, P660, DOI 10.1016/j.bbrc.2009.02.132; Martinon F, 2005, TRENDS IMMUNOL, V26, P447, DOI 10.1016/j.it.2005.06.004; Martinon F, 2004, CURR BIOL, V14, P1929, DOI 10.1016/j.cub.2004.10.027; Minn AH, 2005, BIOCHEM BIOPH RES CO, V336, P770, DOI 10.1016/j.bbrc.2005.08.161; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Nilsson K, 2007, DEMENT GERIATR COGN, V23, P321, DOI 10.1159/000100927; O'Connor W, 2003, J IMMUNOL, V171, P6329, DOI 10.4049/jimmunol.171.12.6329; Oslowski CM, 2012, CELL METAB, V16, P265, DOI 10.1016/j.cmet.2012.07.005; Overley-Adamson B, 2014, CANCER BIOL THER, V15, P452, DOI 10.4161/cbt.27820; PELAYO JC, 1988, AM J PHYSIOL, V254, pF425, DOI 10.1152/ajprenal.1988.254.3.F425; Petrilli V, 2007, JOINT BONE SPINE, V74, P571, DOI 10.1016/j.jbspin.2007.04.004; RAIJ L, 1984, KIDNEY INT, V26, P137, DOI 10.1038/ki.1984.147; Schwartz EJ, 2001, J AM SOC NEPHROL, V12, P1677, DOI 10.1681/ASN.V1281677; Sen U, 2010, AM J NEPHROL, V31, P442, DOI 10.1159/000296717; Shah A, 2013, J BIOL CHEM, V288, P6835, DOI 10.1074/jbc.M112.419101; Srinivasula SM, 2002, J BIOL CHEM, V277, P21119, DOI 10.1074/jbc.C200179200; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; Xiong J, 2013, J CELL MOL MED, V17, P1598, DOI 10.1111/jcmm.12173; Xu GL, 2012, DIABETES, V61, P848, DOI 10.2337/db11-0955; Yang F, 2014, J CEREBR BLOOD F MET, V34, P660, DOI 10.1038/jcbfm.2013.242; Yi F, 2006, KIDNEY INT, V70, P88, DOI 10.1038/sj.ki.5001517; Yin Y, 2013, FRONT BIOSCI-LANDMRK, V18, P638, DOI 10.2741/4127; Zhang AY, 2004, MICROVASC RES, V67, P159, DOI 10.1016/j.mvr.2003.11.001; Zhang C, 2012, HYPERTENSION, V60, P154, DOI 10.1161/HYPERTENSIONAHA.111.189688; Zhang C, 2011, PFLUG ARCH EUR J PHY, V462, P455, DOI 10.1007/s00424-011-0981-y; Zhang C, 2010, BBA-MOL CELL RES, V1803, P482, DOI 10.1016/j.bbamcr.2009.12.006; Zhang C, 2010, FREE RADICAL BIO MED, V48, P1109, DOI 10.1016/j.freeradbiomed.2010.01.029; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	51	103	110	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					27159	27168		10.1074/jbc.M114.567537	http://dx.doi.org/10.1074/jbc.M114.567537			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25138219	Green Published, hybrid			2022-12-25	WOS:000342853900041
J	Schommer, NN; Muto, J; Nizet, V; Gallo, RL				Schommer, Nina N.; Muto, Jun; Nizet, Victor; Gallo, Richard L.			Hyaluronan Breakdown Contributes to Immune Defense against Group A Streptococcus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOFT-TISSUE INFECTIONS; ACID CAPSULE; CD44; SKIN; RECEPTOR; ACTIVATION; ATTACHMENT; VIRULENCE; DISEASE; FORMS	Group A Streptococcus (GAS) commonly infects human skin and occasionally causes severe and life-threatening invasive diseases. The hyaluronan (HA) capsule of GAS has been proposed to protect GAS from host defense by mimicking endogenous HA, a large and abundant glycosaminoglycan in the skin. However, HA is degraded during tissue injury, and the functions of short-chain HA that is generated during infection have not been studied. To examine the impact of the molecular mass of HA on GAS infection, we established infection models in vitro and in vivo in which the size of HA was defined by enzymatic digestion or custom synthesis. We discovered that conversion of high molecular mass HA to low molecular mass HA facilitated GAS phagocytosis by macrophages and limited the severity of infection in mice. In contrast, native high molecular mass HA significantly impaired internalization by macrophages and increased GAS survival in murine blood. Thus, our data demonstrate that GAS virulence can be influenced by the size of HA derived from both the bacterium and host and suggest that high molecular mass HA facilitates GAS deep tissue infections, whereas the generation of short-chain HA can be protective.	[Schommer, Nina N.; Muto, Jun; Gallo, Richard L.] Univ Calif San Diego, Dept Med, Div Dermatol, La Jolla, CA 92093 USA; [Nizet, Victor; Gallo, Richard L.] Univ Calif San Diego, Dept Pediat, Div Pharmacol & Drug Discovery, La Jolla, CA 92093 USA; [Nizet, Victor] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Gallo, RL (corresponding author), Univ Calif San Diego, Dept Med, Div Dermatol, La Jolla, CA 92093 USA.	rgallo@ucsd.edu	Nizet, Victor/AAF-3190-2019; Gallo, Richard L/A-8931-2009	Gallo, Richard L/0000-0002-1401-7861; Nizet, Victor/0000-0003-3847-0422	National Institutes of Health Grants [P01HL057345, P01HL107150]; Deutsche Forschungsgemeinschaft Grant [SCHO1340]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057345, P01HL107150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077780, R01AI083358] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft Grant(German Research Foundation (DFG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants P01HL057345 and P01HL107150 (to R. L. G.). This work was also supported Deutsche Forschungsgemeinschaft Grant SCHO1340 (to N. N. S.).	Betschel SD, 1998, INFECT IMMUN, V66, P1671, DOI 10.1128/IAI.66.4.1671-1679.1998; Cogen AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008557; Cole JN, 2011, NAT REV MICROBIOL, V9, P724, DOI 10.1038/nrmicro2648; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Cywes C, 2001, NATURE, V414, P648, DOI 10.1038/414648a; Dicker KT, 2014, ACTA BIOMATER, V10, P1558, DOI 10.1016/j.actbio.2013.12.019; DiNubile MJ, 2004, J ANTIMICROB CHEMOTH, V53, P37, DOI 10.1093/jac/dkh202; Giordano Philip, 2007, Ther Clin Risk Manag, V3, P309, DOI 10.2147/tcrm.2007.3.2.309; HEESEMANN J, 1985, J CLIN MICROBIOL, V22, P168, DOI 10.1128/JCM.22.2.168-175.1985; Hill DR, 2013, J BIOL CHEM, V288, P29090, DOI 10.1074/jbc.M113.468629; Hollands A, 2010, J INFECT DIS, V202, P11, DOI 10.1086/653124; Jackson DG, 2009, IMMUNOL REV, V230, P216, DOI 10.1111/j.1600-065X.2009.00803.x; Kothapalli D, 2008, J BIOL CHEM, V283, P31823, DOI 10.1074/jbc.M802934200; LAURENT TC, 1992, FASEB J, V6, P2397, DOI 10.1096/fasebj.6.7.1563592; Lin JN, 2011, J CLIN MICROBIOL, V49, P3632, DOI 10.1128/JCM.00531-11; Midwood KS, 2004, INT J BIOCHEM CELL B, V36, P1031, DOI 10.1016/j.biocel.2003.12.003; Muto J, 2014, J CLIN INVEST, V124, P1309, DOI 10.1172/JCI67947; Nathwani D, 2009, INT J ANTIMICROB AG, V34, pS24, DOI 10.1016/S0924-8579(09)70546-1; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; Scheibner KA, 2006, J IMMUNOL, V177, P1272, DOI 10.4049/jimmunol.177.2.1272; Schommer NN, 2011, INFECT IMMUN, V79, P2267, DOI 10.1128/IAI.01142-10; Schrager HM, 1998, J CLIN INVEST, V101, P1708, DOI 10.1172/JCI2121; Scott JE, 1999, P NATL ACAD SCI USA, V96, P4850, DOI 10.1073/pnas.96.9.4850; Slevin M, 2007, MATRIX BIOL, V26, P58, DOI 10.1016/j.matbio.2006.08.261; Tammi MI, 2002, J BIOL CHEM, V277, P4581, DOI 10.1074/jbc.R100037200; TAMMI R, 1988, J INVEST DERMATOL, V90, P412, DOI 10.1111/1523-1747.ep12456530; Taylor KR, 2007, J BIOL CHEM, V282, P18265, DOI 10.1074/jbc.M606352200; Vachon E, 2006, BLOOD, V107, P4149, DOI 10.1182/blood-2005-09-3808; WESSELS MR, 1991, P NATL ACAD SCI USA, V88, P8317, DOI 10.1073/pnas.88.19.8317; WHITNACK E, 1981, INFECT IMMUN, V31, P985, DOI 10.1128/IAI.31.3.985-991.1981; Yang CX, 2012, J BIOL CHEM, V287, P43094, DOI 10.1074/jbc.M112.349209	31	26	26	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					26914	26921		10.1074/jbc.M114.575621	http://dx.doi.org/10.1074/jbc.M114.575621			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25122767	Green Published, hybrid			2022-12-25	WOS:000342853900022
J	Xu, JY; You, D; Leng, PQ; Ye, BC				Xu, Jun-Yu; You, Di; Leng, Pei-Qiang; Ye, Bang-Ce			Allosteric Regulation of a Protein Acetyltransferase in Micromonospora aurantiaca by the Amino Acids Cysteine and Arginine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYL-COA SYNTHETASE; KINASE-HOMOSERINE DEHYDROGENASE; LYSINE ACETYLATION; ESCHERICHIA-COLI; ASPARTATE KINASE; ARABIDOPSIS-THALIANA; BACILLUS-SUBTILIS; ACT DOMAIN; ENZYMES; METABOLISM	ACT domains (amino acid-binding domains) are linked to a wide range of metabolic enzymes that are regulated by amino acid concentration. Seventy proteins with ACT-GCN5-related N-acetyltransferase (GNAT) domain organization were found in actinomycetales. In this study, we investigate the ACT-containing GNAT acetyltransferase, Micau_1670 (MaKat), from Micromonospora aurantiaca ATCC 27029. Arginine and cysteine were identified as ligands by monitoring the conformational changes that occur upon amino acids binding to the ACT domain in the MaKat protein using FRET assay. It was found that MaKat is an amino acid-regulated protein acetyltransferase, whereas arginine and cysteine stimulated the activity of MaKat with regard to acetylation of acetyl-CoA synthetase (Micau_0428). Our research reveals the biochemical characterization of a protein acetyltransferase that contains a fusion of a GNAT domain with an ACT domain and provides a novel signaling pathway for regulating cellular protein acetylation. These findings indicate that acetylation of proteins and acetyltransferase activity may be tightly linked to cellular concentrations of some amino acids in actinomycetales.	[Xu, Jun-Yu; You, Di; Leng, Pei-Qiang; Ye, Bang-Ce] E China Univ Sci & Technol, Lab Biosyst & Microanal, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China	East China University of Science & Technology	Ye, BC (corresponding author), E China Univ Sci & Technol, Lab Biosyst & Microanal, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China.	bcye@ecust.edu.cn	xu, junyu/AAR-6286-2021	Xu, Jun-Yu/0000-0002-1403-9200	China National Science Foundation [21276079]; Chinese Ministry of Education Grant Specialized Research Fund for the Doctoral Program [20120074110009]; National Key Technologies RD Program [2014AA021502, 2007AA02Z331]; Fundamental Research Funds for the Central Universities; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R34AA021502] Funding Source: NIH RePORTER	China National Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Education Grant Specialized Research Fund for the Doctoral Program; National Key Technologies RD Program(National Key Technology R&D Program); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by China National Science Foundation Grant 21276079, Chinese Ministry of Education Grant Specialized Research Fund for the Doctoral Program 20120074110009, National Key Technologies R&D Program Grants 2014AA021502 and 2007AA02Z331, and grants from the Fundamental Research Funds for the Central Universities.	Aravind L, 1999, J MOL BIOL, V287, P1023, DOI 10.1006/jmbi.1999.2653; Berndsen CE, 2005, METHODS, V36, P321, DOI 10.1016/j.ymeth.2005.03.002; Caldara M, 2008, J BIOL CHEM, V283, P6347, DOI 10.1074/jbc.M705884200; Castano-Cerezo S, 2011, MOL MICROBIOL, V82, P1110, DOI 10.1111/j.1365-2958.2011.07873.x; COSTREJEAN JM, 1977, J BIOL CHEM, V252, P5332; Crosby HA, 2012, J BIOL CHEM, V287, P15590, DOI 10.1074/jbc.M112.352104; Curien G, 2005, J BIOL CHEM, V280, P41178, DOI 10.1074/jbc.M509324200; Curien G, 2007, FEBS J, V274, P164, DOI 10.1111/j.1742-4658.2006.05573.x; Friedmann DR, 2013, FEBS J, V280, P5570, DOI 10.1111/febs.12373; Gardner JG, 2008, J BACTERIOL, V190, P5132, DOI 10.1128/JB.00340-08; Grant GA, 2006, J BIOL CHEM, V281, P33825, DOI 10.1074/jbc.R600024200; GRUNDY FJ, 1994, J BACTERIOL, V176, P4527, DOI 10.1128/JB.176.15.4527-4533.1994; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Henriksen P, 2012, MOL CELL PROTEOMICS, V11, P1510, DOI 10.1074/mcp.M112.017251; Hirsch AM, 2010, SOIL BIOL BIOCHEM, V42, P536, DOI 10.1016/j.soilbio.2009.11.023; Kim D, 2013, PROTEOMICS, V13, P1726, DOI 10.1002/pmic.201200001; Kim Y, 2000, ANAL BIOCHEM, V280, P308, DOI 10.1006/abio.2000.4546; Lee DW, 2013, PROTEOMICS, V13, P2278, DOI 10.1002/pmic.201200072; Liberles JS, 2005, AMINO ACIDS, V28, P1, DOI 10.1007/s00726-004-0152-y; Mas-Droux C, 2006, PLANT CELL, V18, P1681, DOI 10.1105/tpc.105.040451; NAGY PL, 1995, J BACTERIOL, V177, P1292, DOI 10.1128/jb.177.5.1292-1298.1995; Nambi S, 2013, J BIOL CHEM, V288, P14114, DOI 10.1074/jbc.M113.463992; Nambi S, 2010, J BIOL CHEM, V285, P24313, DOI 10.1074/jbc.M110.118398; Okanishi H, 2013, J PROTEOME RES, V12, P3952, DOI 10.1021/pr400245k; Paris S, 2003, J BIOL CHEM, V278, P5361, DOI 10.1074/jbc.M207379200; Paris S, 2002, PROTEIN EXPRES PURIF, V24, P105, DOI 10.1006/prep.2001.1539; Park S, 2003, J BACTERIOL, V185, P1942, DOI 10.1128/JB.185.6.1942-1950.2003; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; Starai VJ, 2004, J MOL BIOL, V340, P1005, DOI 10.1016/j.jmb.2004.05.010; Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650; Tanner KG, 2000, J BIOL CHEM, V275, P22048, DOI 10.1074/jbc.M002893200; Tucker AC, 2013, MOL MICROBIOL, V87, P152, DOI 10.1111/mmi.12088; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Xu H, 2011, BIOCHEMISTRY-US, V50, P5883, DOI 10.1021/bi200156t; You D, 2014, J BACTERIOL, V196, P3169, DOI 10.1128/JB.01961-14; Zhang C, 2013, APPL MICROBIOL BIOT, V97, P8307, DOI 10.1007/s00253-013-5121-5; Zhang JM, 2009, MOL CELL PROTEOMICS, V8, P215, DOI 10.1074/mcp.M800187-MCP200; Zhang K, 2013, J PROTEOME RES, V12, P844, DOI 10.1021/pr300912q	38	20	21	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					27034	27045		10.1074/jbc.M114.579078	http://dx.doi.org/10.1074/jbc.M114.579078			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25124041	Green Published, hybrid			2022-12-25	WOS:000342853900031
J	Mustafa, AS				Mustafa, Abu S.			Characterization of a Cross-Reactive, Immunodominant and HLA-Promiscuous Epitope of Mycobacterium tuberculosis-Specific Major Antigenic Protein PPE68	PLOS ONE			English	Article							T-CELL EPITOPES; BLOOD MONONUCLEAR-CELLS; DR BINDING PREDICTION; HUMAN TH1 CELLS; GENOMIC REGIONS; BOVIS BCG; IMMUNE-RESPONSES; HEALTHY-SUBJECTS; SECRETED ANTIGEN; CALMETTE-GUERIN	PPE68 (Rv3873), a major antignic protein encoded by Mycobacteriun tuberculosis-specific genomic region of difference (RD)1, is a strong stimulator of peripheral blood mononuclear cells (PBMCs) obtained from tuberculosis patients and Mycobacterium bovis bacillus Calmette Guerin (BCG)-vaccianted healthy subjects in T helper (Th)1 cell assays, i.e. antigen-induced proliferation and interferon-gamma (IFN-gamma) secretion. To confirm the antigen-specific recognition of PPE68 by T cells in IFN-gamma assays, antigen-induced human T-cell lines were established from PBMCs of M. Bovis BCG-vaccinated and HLA-heterogeneous healthy subjects and tested with peptide pools of RD1 proteins. The results showed that PPE68 was recognized by antigen-specific T-cell lines from HLA-heteregeneous subjects. To further identify the immunodominant and HLA-promiscuous Th1-1 cell epitopes present in PPE68, 24 synthetic peptides covering the sequence of PPE68 were indivdually analyzed for HLA-DR binding prediction analysis and tested with PBMCs from M. bovis BCG-vaccinated and HLA-heterogeuous healthy subjects in IFN-gamma assays. The results identified the peptide P9, i.e. aa 121-VLTATNFFGINTIPIALTEM-DYFIR-145, as an immunodominant and HLA-DR promiscuous peptide of PPE68. Furthermore, by using deletion peptides, the immunodominant and HLA-DR promiscuous core sequence was mapped to aa 127-FFGINTIPIA-136. Interestingly, the core sequence is present in several PPE proteins of M. tuberculosis, and conserved in all sequenced strains/species of M. tuberculosis and M. tuberculosis complex, and several other pathogenic mycobacterial species, including M. leprae and M. avium-intracellulalae complex. These results suggest that the peptide aa 121-145 may be exploited as a peptide-based vaccine candidate against tuberculosis and other mycobacterial diseases.	Kuwait Univ, Dept Microbiol, Fac Med, Safat, Kuwait	Kuwait University	Mustafa, AS (corresponding author), Kuwait Univ, Dept Microbiol, Fac Med, Safat, Kuwait.	abusalim@hsc.edu.kw			Kuwait University Research Sector [MI01/10, SRUL02/13]	Kuwait University Research Sector	This study was supported by Kuwait University Research Sector grants MI01/10 and SRUL02/13. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Attiyah R, 2008, INFECT IMMUN, V76, P4190, DOI 10.1128/IAI.00199-08; Al-Attiyah R, 2004, SCAND J IMMUNOL, V59, P16, DOI 10.1111/j.0300-9475.2004.01349.x; Al-Attiyah R, 2003, INFECT IMMUN, V71, P1953, DOI 10.1128/IAI.71.4.1953-1960.2003; Al-Attiyah R, 2003, FEMS IMMUNOL MED MIC, V38, P249, DOI 10.1016/S0928-8244(03)00166-4; Al-Attiyah RJ, 2009, CLIN EXP IMMUNOL, V158, P64, DOI 10.1111/j.1365-2249.2009.04000.x; Al-Attiyah R, 2010, FEMS IMMUNOL MED MIC, V59, P177, DOI 10.1111/j.1574-695X.2010.00677.x; Al-Khodari NY, 2011, CLIN VACCINE IMMUNOL, V18, P477, DOI 10.1128/CVI.00405-10; Amoudy HA, 2006, MED PRIN PRACT, V15, P137, DOI 10.1159/000090919; Aoshi T, 2008, INFECT IMMUN, V76, P1565, DOI 10.1128/IAI.01381-07; Bhasin M, 2007, J BIOSCIENCES, V32, P31, DOI 10.1007/s12038-007-0004-5; Bruns H, 2009, J CLIN INVEST, V119, P1167, DOI 10.1172/JCI38482; Caccamo N, 2003, CLIN EXP IMMUNOL, V133, P260, DOI 10.1046/j.1365-2249.2003.02201.x; Demissie A, 2004, J IMMUNOL, V172, P6938, DOI 10.4049/jimmunol.172.11.6938; Dheda K, 2009, CURR OPIN PULM MED, V15, P188, DOI 10.1097/MCP.0b013e32832a0adc; Dimitrov I, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/705821; Du G, 2010, J IMMUNOL, V185, P3940, DOI 10.4049/jimmunol.1001222; Gordon SV, 1999, MOL MICROBIOL, V32, P643, DOI 10.1046/j.1365-2958.1999.01383.x; Gupta SK, 2011, INFECT GENET EVOL, V11, P308, DOI 10.1016/j.meegid.2010.10.013; Lalvani A, 2001, J INFECT DIS, V183, P469, DOI 10.1086/318081; LAUNOIS P, 1994, INFECT IMMUN, V62, P3679, DOI 10.1128/IAI.62.9.3679-3687.1994; Lonnroth K, 2008, SEMIN RESP CRIT CARE, V29, P481, DOI 10.1055/s-0028-1085700; Mustafa A. S., 2001, Current Pharmaceutical Biotechnology, V2, P157, DOI 10.2174/1389201013378707; Mustafa AS, 2009, SCAND J IMMUNOL, V69, P213, DOI 10.1111/j.1365-3083.2008.02221.x; Mustafa AS, 2008, CLIN VACCINE IMMUNOL, V15, P916, DOI 10.1128/CVI.00056-08; Mustafa AS, 2008, MED PRIN PRACT, V17, P325, DOI 10.1159/000129614; Mustafa AS, 2011, CLIN VACCINE IMMUNOL, V18, P1752, DOI 10.1128/CVI.05260-11; Mustafa AS, 2011, MICROBIOL IMMUNOL, V55, P267, DOI 10.1111/j.1348-0421.2011.00307.x; Mustafa A, 2010, KUWAIT MED J, V42, P98; Mustafa AS, 2010, MED PRIN PRACT, V19, P122, DOI 10.1159/000273073; Mustafa AS, 2009, EXPERT REV VACCINES, V8, P1309, DOI [10.1586/erv.09.93, 10.1586/ERV.09.93]; Mustafa AS, 2009, MED PRIN PRACT, V18, P385, DOI 10.1159/000226293; Mustafa AS, 2006, TUBERCULOSIS, V86, P115, DOI 10.1016/j.tube.2005.05.001; Mustafa AS, 2005, MED PRIN PRACT, V14, P140, DOI 10.1159/000084629; MUSTAFA AS, 1993, VACCINE, V11, P1108, DOI 10.1016/0264-410X(93)90070-E; MUSTAFA AS, 1988, INT J LEPROSY, V56, P265; Mustafa AS, 2003, SCAND J IMMUNOL, V57, P125, DOI 10.1046/j.1365-3083.2003.01204.x; Mustafa AS, 2000, HUM IMMUNOL, V61, P166, DOI 10.1016/S0198-8859(99)00137-8; Mustafa AS, 2000, CLIN INFECT DIS, V30, pS201, DOI 10.1086/313862; Nielsen Morten, 2010, Immunome Res, V6, P9, DOI 10.1186/1745-7580-6-9; Nielsen M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-296; OFTUNG F, 1988, J IMMUNOL, V141, P2749; Okkels LM, 2003, INFECT IMMUN, V71, P6116, DOI 10.1128/IAI.71.11.6116-6123.2003; Ravn P, 2005, CLIN DIAGN LAB IMMUN, V12, P491, DOI 10.1128/CDLI.12.4.491-496.2005; SILVER RF, 1995, J IMMUNOL, V154, P4665; Singh H, 2003, BIOINFORMATICS, V19, P1009, DOI 10.1093/bioinformatics/btg108; Singh H, 2001, BIOINFORMATICS, V17, P1236, DOI 10.1093/bioinformatics/17.12.1236; Storla DG, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-60; Walzl G, 2011, NAT REV IMMUNOL, V11, P343, DOI 10.1038/nri2960; Wang P, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000048; World Health Organization, 2010, WHOHTMTB20107	50	11	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e103679	10.1371/journal.pone.0103679	http://dx.doi.org/10.1371/journal.pone.0103679			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136958	Green Submitted, Green Published, gold			2022-12-25	WOS:000340742100012
J	Raeven, RHM; Brummelman, J; Pennings, JLA; Nijst, OEM; Kuipers, B; Blok, LER; Helm, K; van Riet, E; Jiskoot, W; van Els, CACM; Han, WGH; Kersten, GFA; Metz, B				Raeven, Rene H. M.; Brummelman, Jolanda; Pennings, Jeroen L. A.; Nijst, Olaf E. M.; Kuipers, Betsy; Blok, Laura E. R.; Helm, Kina; van Riet, Elly; Jiskoot, Wim; van Els, Cecile A. C. M.; Han, Wanda G. H.; Kersten, Gideon F. A.; Metz, Bernard			Molecular Signatures of the Evolving Immune Response in Mice following a Bordetella pertussis Infection	PLOS ONE			English	Article							OUTER-MEMBRANE VESICLES; CELL-MEDIATED-IMMUNITY; T-CELLS; RESPIRATORY-INFECTION; DENDRITIC CELLS; CUTTING EDGE; NEUTROPHIL RECRUITMENT; INNATE RESISTANCE; MURINE MODEL; WHOLE-CELL	Worldwide resurgence of pertussis necessitates the need for improvement of pertussis vaccines and vaccination strategies. Since natural infections induce a longer-lasting immunity than vaccinations, detailed knowledge of the immune responses following natural infection can provide important clues for such improvement. The purpose was to elucidate the kinetics of the protective immune response evolving after experimental Bordetella pertussis (B. pertussis) infection in mice. Data were collected from (i) individual analyses, i.e. microarray, flow cytometry, multiplex immunoassays, and bacterial clearance; (ii) twelve time points during the infection; and (iii) different tissues involved in the immune responses, i.e. lungs, spleen and blood. Combined data revealed detailed insight in molecular and cellular sequence of events connecting different phases (innate, bridging and adaptive) of the immune response following the infection. We detected a prolonged acute phase response, broad pathogen recognition, and early gene signatures of subsequent T-cell recruitment in the lungs. Activation of particular transcription factors and specific cell markers provided insight into the time course of the transition from innate towards adaptive immune responses, which resulted in a broad spectrum of systemic antibody subclasses and splenic Th1/Th17 memory cells against B. pertussis. In addition, signatures preceding the local generation of Th1 and Th17 cells as well as IgA in the lungs, considered key elements in protection against B. pertussis, were established. In conclusion, molecular and cellular immunological processes in response to live B. pertussis infection were unraveled, which may provide guidance in selecting new vaccine candidates that should evoke local and prolonged protective immune responses.	[Raeven, Rene H. M.; Nijst, Olaf E. M.; Blok, Laura E. R.; van Riet, Elly; Kersten, Gideon F. A.; Metz, Bernard] Intravacc, Bilthoven, Netherlands; [Raeven, Rene H. M.; Jiskoot, Wim; Kersten, Gideon F. A.] Leiden Acad Ctr Drug Res, Div Drug Delivery Technol, Leiden, Netherlands; [Brummelman, Jolanda; Kuipers, Betsy; Helm, Kina; van Els, Cecile A. C. M.; Han, Wanda G. H.] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands; [Pennings, Jeroen L. A.] Natl Inst Publ Hlth & Environm RIVM, Ctr Hlth Protect GZB, Bilthoven, Netherlands	Netherlands National Institute for Public Health & the Environment; Netherlands National Institute for Public Health & the Environment	Raeven, RHM (corresponding author), Intravacc, Bilthoven, Netherlands.	Rene.raeven@intravacc.nl	Brummelman, Jolanda/F-5701-2019; Blok, Laura/D-7767-2018; van Riet, Elly/V-2921-2018; Raeven, René/AAV-2461-2020; Jiskoot, Wim/A-6877-2016	Brummelman, Jolanda/0000-0003-3581-4816; Blok, Laura/0000-0002-5196-1448; Raeven, René/0000-0002-1063-271X; Jiskoot, Wim/0000-0002-1012-3456; Pennings, Jeroen L.A./0000-0002-9188-6358				Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Alcaide P, 2012, J IMMUNOL, V188, P1421, DOI 10.4049/jimmunol.1101647; Andreasen C, 2008, INFECT IMMUN, V76, P5139, DOI 10.1128/IAI.00895-08; Aoki N, 2004, INFECT IMMUN, V72, P2477, DOI 10.1128/IAI.72.5.2477-2483.2004; Asagiri M, 2008, SCIENCE, V319, P624, DOI 10.1126/science.1150110; Ausiello CM, 1997, INFECT IMMUN, V65, P2168, DOI 10.1128/IAI.65.6.2168-2174.1997; Banus HA, 2006, INFECT IMMUN, V74, P2596, DOI 10.1128/IAI.74.5.2596-2605.2006; Banus S, 2007, IMMUNOGENETICS, V59, P555, DOI 10.1007/s00251-007-0227-5; Barbic J, 1997, INFECT IMMUN, V65, P4904, DOI 10.1128/IAI.65.12.4904-4908.1997; Bart MJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-627; Baxter R, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4249; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Borrego F, 2013, BLOOD, V121, P1951, DOI 10.1182/blood-2012-09-435057; Boyd AP, 2005, J IMMUNOL, V175, P730, DOI 10.4049/jimmunol.175.2.730; BOZIC CR, 1995, J IMMUNOL, V154, P6048; Brandes M, 2013, CELL, V154, P197, DOI 10.1016/j.cell.2013.06.013; Burkhardt AM, 2012, J IMMUNOL, V188, P6399, DOI 10.4049/jimmunol.1102903; Canthaboo C, 2000, VACCINE, V19, P637, DOI 10.1016/S0264-410X(00)00253-X; Carbonetti NH, 2007, CURR OPIN PHARMACOL, V7, P272, DOI 10.1016/j.coph.2006.12.004; Carotta S, 2010, IMMUNOL REV, V238, P63, DOI 10.1111/j.1600-065X.2010.00955.x; Celentano LP, 2005, PEDIATR INFECT DIS J, V24, P761, DOI 10.1097/01.inf.0000177282.53500.77; Cherry JD, 2012, NEW ENGL J MED, V367, P785, DOI 10.1056/NEJMp1209051; Clark GJ, 2009, TRENDS IMMUNOL, V30, P209, DOI 10.1016/j.it.2009.02.003; Clark-Lewis I, 2003, J BIOL CHEM, V278, P289, DOI 10.1074/jbc.M209470200; Dela Cruz CS, 2012, CELL HOST MICROBE, V12, P34, DOI 10.1016/j.chom.2012.05.017; den Dunnen J, 2009, CANCER IMMUNOL IMMUN, V58, P1149, DOI 10.1007/s00262-008-0615-1; Dirix V, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/795958; Doi T, 2012, BIOCHEM BIOPH RES CO, V425, P918, DOI 10.1016/j.bbrc.2012.08.010; Ellis TN, 2010, MICROBIOL MOL BIOL R, V74, P81, DOI 10.1128/MMBR.00031-09; Evans SE, 2010, ANNU REV PHYSIOL, V72, P413, DOI 10.1146/annurev-physiol-021909-135909; Fedele G, 2011, J IMMUNOL, V186, P5388, DOI 10.4049/jimmunol.1003765; Flak TA, 2000, INFECT IMMUN, V68, P1235, DOI 10.1128/IAI.68.3.1235-1242.2000; Furman D, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.15; GERMANN T, 1995, EUR J IMMUNOL, V25, P823, DOI 10.1002/eji.1830250329; Gianchecchi E, 2013, AUTOIMMUN REV; Gibbings D, 2009, J LEUKOCYTE BIOL, V86, P251, DOI 10.1189/jlb.0109040; Hamerman JA, 2006, J IMMUNOL, V177, P2051, DOI 10.4049/jimmunol.177.4.2051; Hellwig SMM, 2001, INFECT IMMUN, V69, P4846, DOI 10.1128/IAI.69.8.4846-4850.2001; Hendrikx LH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027681; Hijnen M, 2005, PROTEIN EXPRES PURIF, V41, P106, DOI 10.1016/j.pep.2005.01.014; Hozbor D, 1999, CURR MICROBIOL, V38, P273, DOI 10.1007/PL00006801; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ito T, 2011, EXP CELL RES, V317, P613, DOI 10.1016/j.yexcr.2010.12.018; Jaffar Z, 2009, J IMMUNOL, V182, P4507, DOI 10.4049/jimmunol.0900237; Jeyaseelan S, 2005, AM J RESP CELL MOL, V32, P531, DOI 10.1165/rcmb.2005-0063OC; JOSE PJ, 1994, J EXP MED, V179, P881, DOI 10.1084/jem.179.3.881; Kaetzel CS, 2005, IMMUNOL REV, V206, P83, DOI 10.1111/j.0105-2896.2005.00278.x; Khader SA, 2009, MUCOSAL IMMUNOL, V2, P403, DOI 10.1038/mi.2009.100; Kikutani H, 2003, NAT REV IMMUNOL, V3, P159, DOI 10.1038/nri1003; Kirimanjeswara GS, 2005, J CLIN INVEST, V115, P3594, DOI 10.1172/JCI24609; Kirimanjeswara GS, 2003, INFECT IMMUN, V71, P1719, DOI 10.1128/IAI.71.4.1719-1724.2003; Kohrgruber N, 2004, J IMMUNOL, V173, P6592, DOI 10.4049/jimmunol.173.11.6592; Kretzschmar M, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000291; Kuehn MJ, 2005, GENE DEV, V19, P2645, DOI 10.1101/gad.1299905; Kuwabara T, 2009, J IMMUNOL, V183, P2513, DOI 10.4049/jimmunol.0800729; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; Leef M, 2000, J EXP MED, V191, P1841, DOI 10.1084/jem.191.11.1841; Liang SC, 2007, J IMMUNOL, V179, P7791, DOI 10.4049/jimmunol.179.11.7791; Liao F, 1999, J IMMUNOL, V162, P186; Male V, 2012, TRENDS IMMUNOL, V33, P98, DOI 10.1016/j.it.2011.10.002; Mann PB, 2004, J INFECT DIS, V189, P833, DOI 10.1086/381898; Marquis JF, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002097; Mattoo S, 2005, CLIN MICROBIOL REV, V18, P326, DOI 10.1128/CMR.18.2.326-382.2005; McGuirk P, 1998, EUR J IMMUNOL, V28, P153, DOI 10.1002/(SICI)1521-4141(199801)28:01<153::AID-IMMU153>3.3.CO;2-R; McGuirk P, 2002, J EXP MED, V195, P221, DOI 10.1084/jem.20011288; Mielcarek N, 2006, PLOS PATHOG, V2, P662, DOI 10.1371/journal.ppat.0020065; Mills KHG, 1998, INFECT IMMUN, V66, P594, DOI 10.1128/IAI.66.2.594-602.1998; MILLS KHG, 1993, INFECT IMMUN, V61, P399, DOI 10.1128/IAI.61.2.399-410.1993; Mitsdoerffer M, 2010, P NATL ACAD SCI USA, V107, P14292, DOI 10.1073/pnas.1009234107; Miyagawa F, 2012, P NATL ACAD SCI USA, V109, P12123, DOI 10.1073/pnas.1201453109; Miyake K, 2000, J ENDOTOXIN RES, V6, P389, DOI 10.1179/096805100101532324; Molinero LL, 2012, P NATL ACAD SCI USA, V109, P18529, DOI 10.1073/pnas.1204557109; Mooi FR, 2014, EPIDEMIOL INFECT, V142, P685, DOI 10.1017/S0950268813000071; Moreno G, 2013, MICROBES INFECT; Nakano-Yokomizo T, 2011, J EXP MED, V208, P1661, DOI 10.1084/jem.20101623; Nimmerjahn F, 2007, ADV IMMUNOL, V96, P179, DOI 10.1016/S0065-2776(07)96005-8; Nishida M, 2010, J BIOL CHEM, V285, P15268, DOI 10.1074/jbc.M109.076232; Nishimura J, 2008, J IMMUNOL, V180, P4032, DOI 10.4049/jimmunol.180.6.4032; Nitschke L, 2005, CURR OPIN IMMUNOL, V17, P290, DOI 10.1016/j.coi.2005.03.005; Norderhaug IN, 1999, CRIT REV IMMUNOL, V19, P481; Nowak EC, 2009, J EXP MED, V206, P1653, DOI 10.1084/jem.20090246; Pennings JLA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018866; Perry AK, 2005, CELL RES, V15, P407, DOI 10.1038/sj.cr.7290309; Pisabarro MT, 2006, J IMMUNOL, V176, P2069, DOI 10.4049/jimmunol.176.4.2069; Powlesland AS, 2006, J BIOL CHEM, V281, P20440, DOI 10.1074/jbc.M601925200; Raychaudhuri S, 2000, Pac Symp Biocomput, P455; Reibman J, 2003, AM J RESP CELL MOL, V28, P648, DOI 10.1165/rcmb.2002-0095OC; Roberts AW, 2005, GROWTH FACTORS, V23, P33, DOI 10.1080/08977190500055836; Rodriguez ME, 2001, J IMMUNOL, V167, P6545, DOI 10.4049/jimmunol.167.11.6545; Ross PJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003264; Ryan M, 1997, J INFECT DIS, V175, P1246, DOI 10.1086/593682; Saiga H, 2008, J IMMUNOL, V181, P8521, DOI 10.4049/jimmunol.181.12.8521; Sallusto F, 1997, SCIENCE, V277, P2005, DOI 10.1126/science.277.5334.2005; SCHMITT E, 1990, EUR J IMMUNOL, V20, P1709, DOI 10.1002/eji.1830200813; Schroll A, 2012, EUR J IMMUNOL, V42, P3346, DOI 10.1002/eji.201142351; Shin DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027384; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; Stenger RM, 2011, CLIN VACCINE IMMUNOL, V18, P595, DOI 10.1128/CVI.00061-10; Stoeckle C, 2009, EXP HEMATOL, V37, P266, DOI 10.1016/j.exphem.2008.10.011; Takagi H, 2011, IMMUNITY, V35, P958, DOI 10.1016/j.immuni.2011.10.014; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Tam VC, 2013, CELL, V154, P213, DOI 10.1016/j.cell.2013.05.052; Turkistany SA, 2011, ARCH IMMUNOL THER EX, V59, P431, DOI 10.1007/s00005-011-0147-9; van der Ark AAJ, 2012, EXPERT REV VACCINES, V11, P1121, DOI [10.1586/ERV.12.83, 10.1586/erv.12.83]; van Kooyk Y, 2008, BIOCHEM SOC T, V36, P1478, DOI 10.1042/BST0361478; Vandebriel RJ, 2003, MICROB PATHOGENESIS, V35, P19, DOI 10.1016/S0882-4010(03)00087-1; Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038/ni.1659; VERWEY WF, 1949, J BACTERIOL, V58, P127, DOI 10.1128/JB.58.2.127-134.1949; Vukman KV, 2013, J LEUKOC BIOL; Warfel JM, 2013, MUCOSAL IMMUNOL, V6, P787, DOI 10.1038/mi.2012.117; Warfel JM, 2014, P NATL ACAD SCI USA, V111, P787, DOI 10.1073/pnas.1314688110; Wendelboe Aaron M, 2005, Pediatr Infect Dis J, V24, pS58, DOI 10.1097/01.inf.0000160914.59160.41; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Zollinger WD, 2010, VACCINE; Zurita E, 2013, INFECT IMMUN, V81, P2371, DOI 10.1128/IAI.00336-13	117	31	31	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e104548	10.1371/journal.pone.0104548	http://dx.doi.org/10.1371/journal.pone.0104548			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137043	Green Published, gold, Green Submitted			2022-12-25	WOS:000340742100040
J	Zhang, HX; Yu, Q; Huang, YX; Zheng, W; Tian, Y; Song, YT; Li, GD; Zhou, DW				Zhang, Hongxiang; Yu, Qiang; Huang, Yingxin; Zheng, Wei; Tian, Yu; Song, Yantao; Li, Guangdi; Zhou, Daowei			Germination Shifts of C-3 and C-4 Species under Simulated Global Warming Scenario	PLOS ONE			English	Article							CARBON-ISOTOPE COMPOSITION; DIURNAL TEMPERATURE-RANGE; CLIMATE-CHANGE; ALTERNATING TEMPERATURE; MINIMUM TEMPERATURE; ELEVATED CO2; GRASSLANDS; ECOSYSTEM; SALINITY; IMPACTS	Research efforts around the world have been increasingly devoted to investigating changes in C-3 and C-4 species' abundance or distribution with global warming, as they provide important insight into carbon fluxes and linked biogeochemical cycles. However, changes in the early life stage (e. g. germination) of C-3 and C-4 species in response to global warming, particularly with respect to asymmetric warming, have received less attention. We investigated germination percentage and rate of C-3 and C-4 species under asymmetric (+3/+6 degrees C at day/night) and symmetric warming (+5/+5 degrees C at day/night), simulated by alternating temperatures. A thermal time model was used to calculate germination base temperature and thermal time constant. Two additional alternating temperature regimes were used to test temperature metrics effect. The germination percentage and rate increased continuously for C-4 species, but increased and then decreased with temperature for C-3 species under both symmetric and asymmetric warming. Compared to asymmetric warming, symmetric warming significantly overestimated the speed of germination percentage change with temperature for C-4 species. Among the temperature metrics (minimum, maximum, diurnal temperature range and average temperature), maximum temperature was most correlated with germination of C-4 species. Our results indicate that global warming may favour germination of C-4 species, at least for the C-4 species studied in this work. The divergent effects of asymmetric and symmetric warming on plant germination also deserve more attention in future studies.	[Zhang, Hongxiang; Huang, Yingxin; Li, Guangdi; Zhou, Daowei] Chinese Acad Sci, Northeast Inst Geog & Agroecol, Changchun, Peoples R China; [Yu, Qiang] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China; [Zheng, Wei; Li, Guangdi] Graham Ctr Agr Innovat, Wagga Wagga, NSW, Australia; [Tian, Yu] Jilin Agr Univ, Anim Sci & Technol Coll, Changchun, Peoples R China; [Song, Yantao] Dalian Nationalities Univ, Coll Environm & Resources, Dalian, Peoples R China	Chinese Academy of Sciences; Northeast Institute of Geography & Agroecology, CAS; Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Jilin Agricultural University; Dalian Minzu University	Zhou, DW (corresponding author), Chinese Acad Sci, Northeast Inst Geog & Agroecol, Changchun, Peoples R China.	zhoudaowei@iga.ac.cn	Zhang, Hongxiang/GMW-5541-2022; Yu, Qiang/E-2097-2011; Li, Guangdi/B-8515-2011	Yu, Qiang/0000-0002-5480-0623; Li, Guangdi/0000-0002-4841-3803	National Natural Science Foundation of China [41330640]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research has been supported by the National Natural Science Foundation of China (41330640). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Asab MS, 2001, BIODIVERS CONSERV, V10, P597, DOI 10.1023/A:1016667125469; Alward RD, 1999, SCIENCE, V283, P229, DOI 10.1126/science.283.5399.229; Aronson EL, 2009, AGR FOREST METEOROL, V149, P1791, DOI 10.1016/j.agrformet.2009.06.007; Auerswald K, 2009, BIOGEOSCIENCES, V6, P795, DOI 10.5194/bg-6-795-2009; Bai WM, 2012, BIOGEOSCIENCES, V9, P375, DOI 10.5194/bg-9-375-2012; Beier C, 2004, ECOSYSTEMS, V7, P583, DOI 10.1007/s10021-004-0178-8; Bremond L, 2012, GLOBAL CHANGE BIOL, V18, P2324, DOI 10.1111/j.1365-2486.2012.02690.x; Collatz GJ, 1998, OECOLOGIA, V114, P441, DOI 10.1007/s004420050468; Collins SL, 2010, J ARID ENVIRON, V74, P611, DOI 10.1016/j.jaridenv.2009.10.005; De Frenne P, 2011, GLOBAL CHANGE BIOL, V17, P3240, DOI 10.1111/j.1365-2486.2011.02449.x; Easterling DR, 1997, SCIENCE, V277, P364, DOI 10.1126/science.277.5324.364; Ekstam B, 1999, SEED SCI RES, V9, P165, DOI 10.1017/S0960258599000185; ELLIS RH, 1994, ANN BOT-LONDON, V74, P519, DOI 10.1006/anbo.1994.1149; Falster D. S., 2006, SMATR STANDARDISED M; Garcia-Huidobro J, 1982, J EXPT BOTANY, V33, P287; GARCIAHUIDOBRO J, 1982, J EXP BOT, V33, P297, DOI 10.1093/jxb/33.2.297; Gordo O, 2010, GLOBAL CHANGE BIOL, V16, P1082, DOI 10.1111/j.1365-2486.2009.02084.x; Gul B, 1999, CAN J BOT, V77, P240, DOI 10.1139/cjb-77-2-240; HATTERSLEY PW, 1983, OECOLOGIA, V57, P113, DOI 10.1007/BF00379569; He JS, 2005, INT J PLANT SCI, V166, P615, DOI 10.1086/430196; Hovenden MJ, 2008, GLOBAL CHANGE BIOL, V14, P1633, DOI 10.1111/j.1365-2486.2008.01597.x; KARL TR, 1993, B AM METEOROL SOC, V74, P1007, DOI 10.1175/1520-0477(1993)074<1007:ANPORG>2.0.CO;2; Khan MA, 2000, J ARID ENVIRON, V45, P207, DOI 10.1006/jare.2000.0640; Khan MA, 1996, ANN BOT-LONDON, V78, P547, DOI 10.1006/anbo.1996.0159; Liu BH, 2004, J CLIMATE, V17, P4453, DOI 10.1175/3230.1; Lobell DB, 2007, AGRON J, V99, P469, DOI 10.2134/agronj2006.0209; Luo YQ, 2007, ANNU REV ECOL EVOL S, V38, P683, DOI 10.1146/annurev.ecolsys.38.091206.095808; Markus B, 2004, AQUAT BOT, V79, P15; Paruelo JM, 1996, ECOL APPL, V6, P1212, DOI 10.2307/2269602; Phillips CL, 2011, GLOBAL CHANGE BIOL, V17, P3263, DOI 10.1111/j.1365-2486.2011.02483.x; Qiu J, 2006, SEED SCI RES, V16, P261, DOI 10.1017/SSR2006258; Sage RF, 2003, PHOTOSYNTH RES, V77, P209, DOI 10.1023/A:1025882003661; Sun DL, 2014, IEEE GEOSCI REMOTE S, V11, P1524, DOI 10.1109/LGRS.2014.2298371; Thorpe J, 2008, CAN J SOIL SCI, V88, P595, DOI 10.4141/CJSS07094; Trudgill DL, 2000, NEW PHYTOL, V145, P107, DOI 10.1046/j.1469-8137.2000.00554.x; von Fischer JC, 2008, GLOBAL CHANGE BIOL, V14, P1141, DOI 10.1111/j.1365-2486.2008.01552.x; Vose RS, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024379; Wan SQ, 2009, ECOLOGY, V90, P2700, DOI 10.1890/08-2026.1; Wang WQ, 2009, J EXP BOT, V60, P3397, DOI 10.1093/jxb/erp178; Winslow JC, 2003, ECOL MODEL, V163, P153, DOI 10.1016/S0304-3800(02)00415-5; Wittmer MHOM, 2010, GLOBAL CHANGE BIOL, V16, P605, DOI 10.1111/j.1365-2486.2009.02033.x; Xia JY, 2014, NAT GEOSCI, V7, P173, DOI [10.1038/ngeo2093, 10.1038/NGEO2093]; Zavaleta ES, 2003, P NATL ACAD SCI USA, V100, P9892, DOI 10.1073/pnas.1732012100; Zhang H, 2007, SEED SCI TECHNOL, V35, P291, DOI 10.15258/sst.2007.35.2.05; Zhang H., 2008, THESIS	45	8	10	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105139	10.1371/journal.pone.0105139	http://dx.doi.org/10.1371/journal.pone.0105139			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137138	Green Submitted, gold, Green Published			2022-12-25	WOS:000340742100069
J	de Gouw, D; de Jonge, MI; Hermans, PWM; Wessels, HJCT; Zomer, A; Berends, A; Pratt, C; Berbers, GA; Mooi, FR; Diavatopoulos, DA				de Gouw, Daan; de Jonge, Marien I.; Hermans, Peter W. M.; Wessels, Hans J. C. T.; Zomer, Aldert; Berends, Alinda; Pratt, Catherine; Berbers, Guy A.; Mooi, Frits R.; Diavatopoulos, Dimitri A.			Proteomics-Identified Bvg-Activated Autotransporters Protect against Bordetella pertussis in a Mouse Model	PLOS ONE			English	Article							ADENYLATE-CYCLASE TOXIN; DISEASE BURDEN; IMMUNITY; PERTACTIN; CELLS; COLONIZATION; PHAGOCYTOSIS; VACCINATION; EXPRESSION; MATURATION	Pertussis is a highly infectious respiratory disease of humans caused by the bacterium Bordetella pertussis. Despite high vaccination coverage, pertussis has re-emerged globally. Causes for the re-emergence of pertussis include limited duration of protection conferred by acellular pertussis vaccines (aP) and pathogen adaptation. Pathogen adaptations involve antigenic divergence with vaccine strains, the emergence of strains which show enhanced in vitro expression of a number of virulence-associated genes and of strains that do not express pertactin, an important aP component. Clearly, the identification of more effective B. pertussis vaccine antigens is of utmost importance. To identify novel antigens, we used proteomics to identify B. pertussis proteins regulated by the master virulence regulatory system BvgAS in vitro. Five candidates proteins were selected and it was confirmed that they were also expressed in the lungs of naive mice seven days after infection. The five proteins were expressed in recombinant form, adjuvanted with alum and used to immunize mice as stand-alone antigens. Subsequent respiratory challenge showed that immunization with the autotransporters Vag8 and SphB1 significantly reduced bacterial load in the lungs. Whilst these antigens induced strong opsonizing antibody responses, we found that none of the tested alum-adjuvanted vaccines - including a three-component aP - reduced bacterial load in the nasopharynx, suggesting that alternative immunological responses may be required for efficient bacterial clearance from the nasopharynx.	[de Gouw, Daan; de Jonge, Marien I.; Hermans, Peter W. M.; Zomer, Aldert; Berends, Alinda; Mooi, Frits R.; Diavatopoulos, Dimitri A.] Radboud Univ Nijmegen, Med Ctr, Dept Pediat, Lab Pediat Infect Dis, NL-6525 ED Nijmegen, Netherlands; [de Gouw, Daan; de Jonge, Marien I.; Hermans, Peter W. M.; Zomer, Aldert; Berends, Alinda; Mooi, Frits R.; Diavatopoulos, Dimitri A.] Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, Lab Med Immunol, NL-6525 ED Nijmegen, Netherlands; [Wessels, Hans J. C. T.] Radboud Univ Nijmegen, Med Ctr, Radboud Prote Ctr, Nijmegen Ctr Mitochondrial Disorders,Dept Lab Med, NL-6525 ED Nijmegen, Netherlands; [Berbers, Guy A.; Mooi, Frits R.] Natl Inst Publ Hlth & Environm, RIVM, Netherlands Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands; [Pratt, Catherine] Publ Hlth England, Ctr Emergency Preparedness & Response, Salisbury, Wilts, England	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Netherlands National Institute for Public Health & the Environment; Public Health England	Diavatopoulos, DA (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Pediat, Lab Pediat Infect Dis, NL-6525 ED Nijmegen, Netherlands.	dimitri.diavatopoulos@radboudumc.nl	de Jonge, Marien I./P-5869-2015; Diavatopoulos, Dimitri A/L-4269-2015; Hermans, Peter W.M./H-8042-2014; Pratt, Catherine/AAD-6118-2022; Mooi, prof.F.R./L-4528-2015; Wessels, Hans J/P-6248-2015	de Jonge, Marien I./0000-0003-2812-5895; Diavatopoulos, Dimitri A/0000-0001-7065-7807; Pratt, Catherine/0000-0001-6132-2570; Wessels, Hans J/0000-0001-5957-3127; Zomer, Aldert/0000-0002-0758-5190	Netherlands Organization of Scientific Research (ZonMw) [125020001]	Netherlands Organization of Scientific Research (ZonMw)(Netherlands Organization for Scientific Research (NWO)Netherlands Organization for Health Research and Development)	D.d.G. is supported by Grant 125020001 from the Netherlands Organization of Scientific Research (ZonMw). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdillahi H, 1988, J Med Microbiol, V26, P177; Barkoff AM, 2012, CLIN VACCINE IMMUNOL, V19, P1703, DOI 10.1128/CVI.00367-12; Bart MJ, 2014, MBIO, V5, DOI 10.1128/mBio.01074-14; Bart MJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-627; Bisgard KM, 2004, PEDIATR INFECT DIS J, V23, P985, DOI 10.1097/01.inf.0000145263.37198.2b; Boulton Jacqueline, 2013, Br J Nurs, V22, P1046; Campbell P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035874; Coutte L, 2003, MOL MICROBIOL, V49, P529, DOI 10.1046/j.1365-2958.2003.03573.x; Cron LE, 2011, INFECT IMMUN, V79, P3697, DOI 10.1128/IAI.01383-10; de Gouw D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084523; de Gouw D, 2011, FEMS MICROBIOL REV, V35, P441, DOI 10.1111/j.1574-6976.2010.00257.x; de Greeff SC, 2010, CLIN INFECT DIS, V50, P1339, DOI 10.1086/652281; de Greeff SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014183; Decker KB, 2012, MICROBIOL-SGM, V158, P1665, DOI 10.1099/mic.0.058941-0; Dunne A, 2010, J IMMUNOL, V185, P1711, DOI 10.4049/jimmunol.1000105; Fedele G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008734; Higgins SC, 2006, J IMMUNOL, V177, P7980, DOI 10.4049/jimmunol.177.11.7980; Hijnen M, 2005, PROTEIN EXPRES PURIF, V41, P106, DOI 10.1016/j.pep.2005.01.014; Hyams C, 2010, INFECT IMMUN, V78, P704, DOI 10.1128/IAI.00881-09; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Kim JH, 2009, J IMMUNOL, V183, P3294, DOI 10.4049/jimmunol.0900398; King AJ, 2008, BMC GENOMICS, V9, P1, DOI 10.1186/1471-2164-9-311; Kirimanjeswara GS, 2003, INFECT IMMUN, V71, P1719, DOI 10.1128/IAI.71.4.1719-1724.2003; Kowalzik F, 2007, PEDIATR INFECT DIS J, V26, P238, DOI 10.1097/01.inf.0000256750.07118.ee; Lam C, 2014, EMERG INFECT DIS, V20, P626, DOI 10.3201/eid2004.131478; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu YJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000159; Malley R, 2005, P NATL ACAD SCI USA, V102, P4848, DOI 10.1073/pnas.0501254102; Marr N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020585; Mazar J, 2006, MOL MICROBIOL, V62, P641, DOI 10.1111/j.1365-2958.2006.05392.x; McConnell MJ, 2011, PROTEIN EXPRES PURIF, V77, P98, DOI 10.1016/j.pep.2010.11.019; MELTON AR, 1993, INFECT IMMUN, V61, P807, DOI 10.1128/IAI.61.3.807-815.1993; Mobberley-Schuman PS, 2005, INFECT IMMUN, V73, P7317, DOI 10.1128/IAI.73.11.7317-7323.2005; Mooi FR, 2014, EPIDEMIOL INFECT, V142, P685, DOI 10.1017/S0950268813000071; Mooi FR, 2009, EMERG INFECT DIS, V15, P1206, DOI 10.3201/eid1508.081511; Neo YL, 2010, MICROBES INFECT, V12, P238, DOI 10.1016/j.micinf.2009.12.002; NURMINEN M, 1992, MOL MICROBIOL, V6, P2499; Otsuka N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031985; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Pawloski LC, 2013, CLIN VACCINE IMMUNOL; Polewicz M, 2013, VACCINE, V31, P3148, DOI 10.1016/j.vaccine.2013.05.008; ROBERTS M, 1992, VACCINE, V10, P43, DOI 10.1016/0264-410X(92)90418-J; Ross PJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003264; STEVENS TL, 1988, NATURE, V334, P255, DOI 10.1038/334255a0; Sukumar N, 2009, INFECT IMMUN, V77, P885, DOI 10.1128/IAI.01076-08; Thalen M, 1999, J BIOTECHNOL, V75, P147, DOI 10.1016/S0168-1656(99)00155-8; Trzcinski K, 2008, INFECT IMMUN, V76, P2678, DOI 10.1128/IAI.00141-08; Tsou CC, 2010, MOL CELL PROTEOMICS, V9, P131, DOI 10.1074/mcp.M900177-MCP200; van der Maas NAT, 2013, VACCINE, V31, P4541, DOI 10.1016/j.vaccine.2013.07.060; van Gent M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046407; Warfel JM, 2013, MUCOSAL IMMUNOL, V6, P787, DOI 10.1038/mi.2012.117; Warfel JM, 2013, P NATL ACAD SCI US; Witt MA, 2012, CLIN INFECT DIS, V54, P1730, DOI 10.1093/cid/cis287; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Zhang Z, 2009, J CLIN INVEST, V119, P1899, DOI 10.1172/JCI36731	55	33	33	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105011	10.1371/journal.pone.0105011	http://dx.doi.org/10.1371/journal.pone.0105011			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133400	Green Published, gold			2022-12-25	WOS:000341302700061
J	Hidalgo-Galiana, A; Monge, M; Biron, DG; Canals, F; Ribera, I; Cieslak, A				Hidalgo-Galiana, Amparo; Monge, Marta; Biron, David G.; Canals, Francesc; Ribera, Ignacio; Cieslak, Alexandra			Reproducibility and Consistency of Proteomic Experiments on Natural Populations of a Non-Model Aquatic Insect	PLOS ONE			English	Article							THERMAL TOLERANCE; BRUNNEUS GROUP; HUMAN PLASMA; RESPONSES; PROTEINS; ECOLOGY; STRESS; COLEOPTERA; PHYSIOLOGY	Population proteomics has a great potential to address evolutionary and ecological questions, but its use in wild populations of non-model organisms is hampered by uncontrolled sources of variation. Here we compare the response to temperature extremes of two geographically distant populations of a diving beetle species (Agabus ramblae) using 2-D DIGE. After one week of acclimation in the laboratory under standard conditions, a third of the specimens of each population were placed at either 4 or 27 degrees C for 12 h, with another third left as a control. We then compared the protein expression level of three replicated samples of 2-3 specimens for each treatment. Within each population, variation between replicated samples of the same treatment was always lower than variation between treatments, except for some control samples that retained a wider range of expression levels. The two populations had a similar response, without significant differences in the number of protein spots over-or under-expressed in the pairwise comparisons between treatments. We identified exemplary proteins among those differently expressed between treatments, which proved to be proteins known to be related to thermal response or stress. Overall, our results indicate that specimens collected in the wild are suitable for proteomic analyses, as the additional sources of variation were not enough to mask the consistency and reproducibility of the response to the temperature treatments.	[Hidalgo-Galiana, Amparo; Ribera, Ignacio; Cieslak, Alexandra] Univ Pompeu Fabra, CSIC, Inst Evolutionary Biol, Anim Biodivers & Evolut Program, Barcelona, Spain; [Monge, Marta; Canals, Francesc] VHIO, Barcelona, Spain; [Biron, David G.] Univ Blaise Pascal, Equipe Interact Hotes Parasites, UMR CNRS 6023, Lab Microorganismes Genome & Environm, Aubiere, France	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; Vall d'Hebron Institut d'Oncologia (VHIO); Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA)	Hidalgo-Galiana, A (corresponding author), Univ Pompeu Fabra, CSIC, Inst Evolutionary Biol, Anim Biodivers & Evolut Program, Barcelona, Spain.	hg.amparo@gmail.com; A.Cieslak@gmx.net	Monge, Marta/I-3667-2015; Ribera, Ignacio/K-2909-2017	Monge, Marta/0000-0002-9839-4903; Ribera, Ignacio/0000-0002-2791-7615	Spanish government through I+D+i programme [CGL2007-61665, CGL2010-15755]	Spanish government through I+D+i programme	This work was funded by the Spanish government through the I+D+i programme, grants CGL2007-61665 and CGL2010-15755. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angilletta MJ, 2002, J THERM BIOL, V27, P249, DOI 10.1016/S0306-4565(01)00094-8; Bale JS, 2002, PHILOS T R SOC B, V357, P849, DOI 10.1098/rstb.2002.1074; Barrett J, 2005, INT J PARASITOL, V35, P543, DOI 10.1016/j.ijpara.2005.01.013; Biron DG, 2006, PROTEOMICS, V6, P1712, DOI 10.1002/pmic.200500423; Bowler K, 2008, BIOL REV, V83, P339, DOI 10.1111/j.1469-185X.2008.00046.x; Calosi P, 2008, J BIOGEOGR, V35, P295, DOI 10.1111/j.1365-2699.2007.01787.x; Chevalier F, 2004, PROTEOMICS, V4, P1372, DOI 10.1002/pmic.200300750; Cheviron ZA, 2008, MOL ECOL, V17, P4556, DOI 10.1111/j.1365-294X.2008.03942.x; Cieslak A, 2009, ECOSISTEMAS, V18, P34; Cieslak A, 2007, ELECTROPHORESIS, V28, P535, DOI 10.1002/elps.200600620; Corzett TH, 2006, J PROTEOME RES, V5, P2611, DOI 10.1021/pr060100p; Dahlhoff EP, 2007, J BIOSCIENCES, V32, P477, DOI 10.1007/s12038-007-0047-7; Diz AP, 2012, MOL ECOL, V21, P1060, DOI 10.1111/j.1365-294X.2011.05426.x; Diz AP, 2009, ELECTROPHORESIS, V30, P2967, DOI 10.1002/elps.200900210; Dowd WW, 2012, INTEGR COMP BIOL, V52, P705, DOI 10.1093/icb/ics093; Excoffier L, 2009, ANNU REV ECOL EVOL S, V40, P481, DOI 10.1146/annurev.ecolsys.39.110707.173414; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; Hidalgo-Galiana A, 2014, BMC EVOL BI IN PRESS; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Jorge I, 2005, PROTEOMICS, V5, P222, DOI 10.1002/pmic.200400893; Karp NA, 2009, PROTEOMICS, V9, P388, DOI 10.1002/pmic.200800485; Karr TL, 2008, HEREDITY, V100, P200, DOI 10.1038/sj.hdy.6801008; Kostal V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004546; McMullen DC, 2010, PHYSIOL BIOCHEM ZOOL, V83, P677, DOI 10.1086/653489; Millan A., 1997, Latissimus, V9, P2; Millan A, 2001, COLEOPTS BULL, V55, P107, DOI 10.1649/0010-065X(2001)055[0107:TAGBGW]2.0.CO;2; Mimura M, 2010, J EVOLUTION BIOL, V23, P249, DOI 10.1111/j.1420-9101.2009.01910.x; Molloy MP, 2003, PROTEOMICS, V3, P1912, DOI 10.1002/pmic.200300534; Monge M, 2009, CARCINOGENESIS, V30, P1288, DOI 10.1093/carcin/bgp119; Nedelkov D, 2004, ANAL CHEM, V76, P1733, DOI 10.1021/ac035105+; Parker R, 2006, J EXP BOT, V57, P1109, DOI 10.1093/jxb/erj134; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pedersen KS, 2010, HEREDITY, V104, P125, DOI 10.1038/hdy.2009.132; Rider MH, 2011, J INSECT PHYSIOL, V57, P1453, DOI 10.1016/j.jinsphys.2011.07.006; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Sanchez-Fernandez Aragon P, 2012, PLOS ONE, DOI [10.1371/journal.pone.0048163, DOI 10.1371/J0URNAL.P0NE.0048163]; SAS Institute Inc, 2007, JMP US GUID; Serafini L, 2011, COMP BIOCHEM PHYS D, V6, P322, DOI 10.1016/j.cbd.2011.07.002; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Spicer J. I., 1999, PHYSL DIVERSITY ITS; Storey KB, 2012, CAN J ZOOL, V90, P456, DOI 10.1139/Z2012-011; Thiellement H, 1999, ELECTROPHORESIS, V20, P2013, DOI 10.1002/(SICI)1522-2683(19990701)20:10&lt;2013::AID-ELPS2013&gt;3.0.CO;2-#; Valledor L, 2011, J PROTEOMICS, V74, P1, DOI 10.1016/j.jprot.2010.07.007; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Whitehead A, 2012, J EXP BIOL, V215, P884, DOI 10.1242/jeb.058735	46	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e104734	10.1371/journal.pone.0104734	http://dx.doi.org/10.1371/journal.pone.0104734			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133588	gold, Green Published, Green Submitted			2022-12-25	WOS:000341302700040
J	Joers, V; Dilley, K; Rahman, S; Jones, C; Shultz, J; Simmons, H; Emborg, ME				Joers, Valerie; Dilley, Kristine; Rahman, Shahrose; Jones, Corinne; Shultz, Jeanette; Simmons, Heather; Emborg, Marina E.			Cardiac Sympathetic Denervation in 6-OHDA-Treated Nonhuman Primates	PLOS ONE			English	Article							ALPHA-SYNUCLEIN EXPRESSION; AUTONOMIC NERVOUS-SYSTEM; RAT ADRENAL-MEDULLA; PARKINSONS-DISEASE; SUBSTANTIA-NIGRA; ORTHOSTATIC HYPOTENSION; LEWY-BODY; C-11 HYDROXYEPHEDRINE; MIBG SCINTIGRAPHY; 6-HYDROXYDOPAMINE	Cardiac sympathetic neurodegeneration and dysautonomia affect patients with sporadic and familial Parkinson's disease (PD) and are currently proposed as prodromal signs of PD. We have recently developed a nonhuman primate model of cardiac dysautonomia by iv 6-hydroxydopamine (6-OHDA). Our in vivo findings included decreased cardiac uptake of a sympathetic radioligand and circulating catecholamines; here we report the postmortem characterization of the model. Ten adult rhesus monkeys (5-17 yrs old) were used in this study. Five animals received 6-OHDA (50 mg/kg iv) and five were age-matched controls. Three months post-neurotoxin the animals were euthanized; hearts and adrenal glands were processed for immunohistochemistry. Quantification of immunoreactivity (ir) of stainings was performed by an investigator blind to the treatment group using NIH ImageJ software (for cardiac bundles and adrenals, area above threshold and optical density) and MBF StereoInvestigator (for cardiac fibers, area fraction fractionator probe). Sympathetic cardiac nerve bundle analysis and fiber area density showed a significant reduction in global cardiac tyrosine hydroxylase-ir (TH; catecholaminergic marker) in 6-OHDA animals compared to controls. Quantification of protein gene protein 9.5 (pan-neuronal marker) positive cardiac fibers showed a significant deficit in 6-OHDA monkeys compared to controls and correlated with TH-ir fiber area. Semi-quantitative evaluation of human leukocyte antigen-ir (inflammatory marker) and nitrotyrosine-ir (oxidative stress marker) did not show significant changes 3 months post-neurotoxin. Cardiac nerve bundle alpha-synuclein-ir (presynaptic protein) was reduced (trend) in 6-OHDA treated monkeys; insoluble proteinase-K resistant alpha-synuclein (typical of PD pathology) was not observed. In the adrenal medulla, 6-OHDA monkeys had significantly reduced TH-ir and aminoacid decarboxylase-ir. Our results confirm that systemic 6-OHDA dosing to nonhuman primates induces cardiac sympathetic neurodegeneration and loss of catecholaminergic enzymes in the adrenal medulla, and suggests that this model can be used as a platform to evaluate disease-modifying strategies aiming to induce peripheral neuroprotection.	[Joers, Valerie; Dilley, Kristine; Rahman, Shahrose; Jones, Corinne; Shultz, Jeanette; Simmons, Heather; Emborg, Marina E.] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Preclin Parkinsons Res Program, Madison, WI 53706 USA; [Joers, Valerie; Jones, Corinne; Emborg, Marina E.] Univ Wisconsin, Neurosci Training Program, Madison, WI 53706 USA; [Jones, Corinne] Univ Wisconsin, Commun Sci & Disorders Training Program, Madison, WI USA; [Shultz, Jeanette; Emborg, Marina E.] Univ Wisconsin, Cellular & Mol Pathol Training Program, Madison, WI USA; [Emborg, Marina E.] Univ Wisconsin, Dept Med Phys, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Emborg, ME (corresponding author), Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Preclin Parkinsons Res Program, Madison, WI 53706 USA.	emborg@primate.wisc.edu	Joers, Valerie/S-2455-2019; Jones, Corinne/K-7775-2019	Joers, Valerie/0000-0001-6743-6587; Rahman, Shahrose/0000-0003-3138-2518	WNPRC NIH [P51RR000167, R21NS084158, R01HD15433]; UW NIH-CTSA; Graduate School of the University of Wisconsin, Madison; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD015433] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000167] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS084158] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011106] Funding Source: NIH RePORTER	WNPRC NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UW NIH-CTSA; Graduate School of the University of Wisconsin, Madison; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the WNPRC NIH base grant P51RR000167, R21NS084158, R01HD15433, UW NIH-CTSA pilot project award, and awards from the Graduate School of the University of Wisconsin, Madison. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA H, 1989, BRAIN RES, V489, P247, DOI 10.1016/0006-8993(89)90857-3; ALLMAN KC, 1993, J AM COLL CARDIOL, V22, P1425, DOI 10.1016/0735-1097(93)90553-D; Amino T, 2005, BRAIN PATHOL, V15, P29, DOI 10.1111/j.1750-3639.2005.tb00097.x; Amino T, 2008, NEUROSCI RES, V60, P314, DOI 10.1016/j.neures.2007.11.011; Arbab A S, 1996, Ann Nucl Med, V10, P211; Beach TG, 2010, ACTA NEUROPATHOL, V119, P689, DOI 10.1007/s00401-010-0664-3; Beyer K, 2008, NEUROGENETICS, V9, P163, DOI 10.1007/s10048-008-0124-6; Braak H, 2004, CELL TISSUE RES, V318, P121, DOI 10.1007/s00441-004-0956-9; Buob A, 2010, CLIN RES CARDIOL, V99, P701, DOI 10.1007/s00392-010-0170-6; Cao JM, 2000, CIRC RES, V86, P816, DOI 10.1161/01.RES.86.7.816; CARMICHAEL SW, 1988, NEW ENGL J MED, V318, P254; Carvey PM, 2005, EUR J NEUROSCI, V22, P1158, DOI 10.1111/j.1460-9568.2005.04281.x; Cicchetti F, 2002, EUR J NEUROSCI, V15, P991, DOI 10.1046/j.1460-9568.2002.01938.x; Courbon F, 2003, MOVEMENT DISORD, V18, P890, DOI 10.1002/mds.10461; DAY INM, 1987, FEBS LETT, V210, P157, DOI 10.1016/0014-5793(87)81327-3; Emborg ME, 2007, ILAR J, V48, P339, DOI 10.1093/ilar.48.4.339; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Fumimura Y, 2007, J NEUROPATH EXP NEUR, V66, P354, DOI 10.1097/nen.0b013e3180517454; GAUTHIER P, 1972, CIRC RES, V31, P207, DOI 10.1161/01.RES.31.2.207; Ghebremedhin E, 2009, ACTA NEUROPATHOL, V118, P777, DOI 10.1007/s00401-009-0596-y; Goldstein DS, 2007, NEUROLOGY, V69, P1580, DOI 10.1212/01.wnl.0000268696.57912.64; Goldstein DS, 2007, CLIN AUTON RES, V17, P118, DOI 10.1007/s10286-007-0396-1; Goldstein DS, 2005, HYPERTENSION, V46, P1333, DOI 10.1161/01.HYP.0000188052.69549.e4; Goldstein DS, 2002, NEUROLOGY, V58, P1247, DOI 10.1212/WNL.58.8.1247; Goldstein DS, 2000, ANN INTERN MED, V133, P338, DOI 10.7326/0003-4819-133-5-200009050-00009; GOLDSTEIN DS, 1991, J HYPERTENS, V9, P417, DOI 10.1097/00004872-199105000-00005; Goldstein DS, 2003, J PHARMACOL EXP THER, V306, P855, DOI 10.1124/jpet.103.051714; Goldstein DS, 2003, NEUROLOGY, V60, P1327, DOI 10.1212/01.WNL.0000058766.46428.F3; Gonera EG, 1997, MOVEMENT DISORD, V12, P871, DOI 10.1002/mds.870120607; Hattori N, 1996, J NUCL MED, V37, P1985; Henze C, 2005, BRAIN RES, V1052, P97, DOI 10.1016/j.brainres.2005.06.020; Iwanaga K, 1999, NEUROLOGY, V52, P1269, DOI 10.1212/WNL.52.6.1269; JACKSON P, 1985, J NEUROCHEM, V45, P185, DOI 10.1111/j.1471-4159.1985.tb05491.x; JACKSONLEWIS V, 1995, NEURODEGENERATION, V4, P257, DOI 10.1016/1055-8330(95)90015-2; Joers V, 2014, AM J NUCL MED MOLEC, V4, P125; Joers V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035371; KAST A, 1994, LAB ANIM, V28, P80, DOI 10.1258/002367794781065834; Kawano H, 2003, HEART VESSELS, V18, P32, DOI 10.1007/s003800300005; Kawasaki T, 2007, J PHARMACOL EXP THER, V322, P274, DOI 10.1124/jpet.106.119206; KENT C, 1989, J ANAT, V166, P213; Kippenberger AG, 1999, J NEUROCHEM, V73, P1024, DOI 10.1046/j.1471-4159.1999.0731024.x; KOSTRZEWA RM, 1974, PHARMACOL REV, V26, P199; Kowall NW, 2000, NEUROREPORT, V11, P211, DOI 10.1097/00001756-200001170-00041; Kujawa K, 2000, ARCH NEUROL-CHICAGO, V57, P1461, DOI 10.1001/archneur.57.10.1461; KUMAR R, 1995, J NEUROCHEM, V64, P1703; LAVERTY R, 1965, BRIT J PHARM CHEMOTH, V24, P549, DOI 10.1111/j.1476-5381.1965.tb01745.x; Li ST, 2002, ANN NEUROL, V52, P220, DOI 10.1002/ana.10236; MAJEED SK, 1980, LAB ANIM, V14, P363, DOI 10.1258/002367780781071166; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; Mathias CJ, 1998, CLIN NEUROSCI, V5, P153; McGeer PL, 2004, ANN NY ACAD SCI, V1035, P104, DOI 10.1196/annals.1332.007; Miller AD, 2009, VET PATHOL, V46, P1221, DOI 10.1354/vp.09-VP-0022-M-FL; Mitsui J, 2006, J NEUROL SCI, V243, P101, DOI 10.1016/j.jns.2005.11.034; Muhlfeld C, 2010, J APPL PHYSIOL, V108, P1402, DOI 10.1152/japplphysiol.01013.2009; Navarro-Otano J, 2013, PARKINSONISM RELAT D, V19, P27, DOI 10.1016/j.parkreldis.2012.07.005; Orimo S, 2011, NEUROPATH APPL NEURO, V37, P791, DOI 10.1111/j.1365-2990.2011.01194.x; Orimo S, 2002, J NEUROL NEUROSUR PS, V73, P776, DOI 10.1136/jnnp.73.6.776; PERUMAL AS, 1992, BRAIN RES BULL, V29, P699, DOI 10.1016/0361-9230(92)90142-K; PORTER CC, 1963, J PHARMACOL EXP THER, V140, P308; PORTER CC, 1965, J PHARMACOL EXP THER, V150, P17; Purisai MG, 2005, NEUROBIOL DIS, V20, P898, DOI 10.1016/j.nbd.2005.05.028; Raffel DM, 2006, J NUCL MED, V47, P1490; Ruiz-Martinez J, 2011, MOVEMENT DISORD, V26, P2026, DOI 10.1002/mds.23773; SACHS C, 1975, BRAIN RES, V99, P277, DOI 10.1016/0006-8993(75)90029-3; Savica R, 2010, ARCH NEUROL-CHICAGO, V67, P798, DOI 10.1001/archneurol.2010.135; SENARD JM, 1993, CLIN NEUROPHARMACOL, V16, P70, DOI 10.1097/00002826-199302000-00008; Sharabi Y, 2008, MOVEMENT DISORD, V23, P1725, DOI 10.1002/mds.22226; Siderowf A, 2012, MOVEMENT DISORD, V27, P608, DOI 10.1002/mds.24954; SISSON JC, 1987, J NUCL MED, V28, P1620; SKELTONSTROUD PN, 1985, VET PATHOL, V22, P141, DOI 10.1177/030098588502200208; SKENE JHP, 1989, J CELL BIOL, V108, P613, DOI 10.1083/jcb.108.2.613; Smith WW, 2005, J NEUROSCI, V25, P5544, DOI 10.1523/JNEUROSCI.0482-05.2005; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; STODDARD SL, 1989, EXP NEUROL, V104, P218, DOI 10.1016/0014-4886(89)90032-0; Swanson CR, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-91; Tolosa E, 2007, PARKINSONISM RELAT D, V13, pS2, DOI 10.1016/j.parkreldis.2007.06.007; Tompkins MM, 2003, BRAIN RES, V984, P233, DOI 10.1016/S0006-8993(03)03040-3; TRANZER JP, 1973, EXPERIENTIA, V29, P314, DOI 10.1007/BF01926498; Vila M, 2000, J NEUROCHEM, V74, P721, DOI 10.1046/j.1471-4159.2000.740721.x; Wakabayashi K, 1997, EUR NEUROL, V38, P2, DOI 10.1159/000113469; WAKABAYASHI K, 1993, ADV NEUROL, V60, P609; Wakabayashi K, 2007, NEUROPATHOLOGY, V27, P494, DOI 10.1111/j.1440-1789.2007.00803.x; Wong KK, 2012, RADIOLOGY, V265, P240, DOI 10.1148/radiol.12112723	83	25	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e104850	10.1371/journal.pone.0104850	http://dx.doi.org/10.1371/journal.pone.0104850			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133405	Green Submitted, gold, Green Published			2022-12-25	WOS:000341302700045
J	Pinzon, JHC; Beach-Letendre, J; Weil, E; Mydlarz, LD				Pinzon, Jorge H.; Beach-Letendre, Joshuah; Weil, Ernesto; Mydlarz, Laura D.			Relationship between Phylogeny and Immunity Suggests Older Caribbean Coral Lineages Are More Resistant to Disease	PLOS ONE			English	Article							WHITE PLAGUE DISEASE; LIFE-HISTORY STRATEGIES; ROQUES-NATIONAL-PARK; CLIMATE-CHANGE; SCLERACTINIAN CORALS; ECOLOGICAL IMMUNOLOGY; REACTIVE OXYGEN; INNATE IMMUNITY; BAND DISEASE; REEF CORALS	Diseases affect coral species fitness and contribute significantly to the deterioration of coral reefs. The increase in frequency and severity of disease outbreaks has made evaluating and determining coral resistance a priority. Phylogenetic patterns in immunity and disease can provide important insight to how corals may respond to current and future environmental and/or biologically induced diseases. The purpose of this study was to determine if immunity, number of diseases and disease prevalence show a phylogenetic signal among Caribbean corals. We characterized the constitutive levels of six distinct innate immune traits in 14 Caribbean coral species and tested for the presence of a phylogenetic signal on each trait. Results indicate that constitutive levels of some individual immune related processes (i.e. melanin concentration, peroxidase and inhibition of bacterial growth), as well as their combination show a phylogenetic signal. Additionally, both the number of diseases affecting each species and disease prevalence (as measures of disease burden) show a significant phylogenetic signal. The phylogenetic signal of immune related processes, combined with estimates of species divergence times, indicates that among the studied species, those belonging to older lineages tend to resist/fight infections better than more recently diverged coral lineages. This result, combined with the increasing stressful conditions on corals in the Caribbean, suggest that future reefs in the region will likely be dominated by older lineages while modern species may face local population declines and/or geographic extinction.	[Pinzon, Jorge H.; Beach-Letendre, Joshuah; Mydlarz, Laura D.] Univ Texas Arlington, Dept Biol, Arlington, TX 76019 USA; [Weil, Ernesto] Univ Puerto Rico, Dept Marine Sci, Mayaguez, PR 00709 USA	University of Texas System; University of Texas Arlington; University of Puerto Rico; University of Puerto Rico Mayaguez	Pinzon, JHC (corresponding author), Univ Texas Arlington, Dept Biol, Arlington, TX 76019 USA.	pinzon@uta.edu	Weil, Ernesto/AAI-3591-2020; Weil, Ernesto/ABF-1290-2020; Pinzon, Jorge/C-7277-2011	Weil, Ernesto/0000-0001-5275-1584; Pinzon, Jorge/0000-0002-3330-8226	NSF grant IOS [1017458, 1017510]; NSF [OCE -1105143]; NSF grant OCE-PRF [1225163]; Division Of Integrative Organismal Systems [1017510] Funding Source: National Science Foundation	NSF grant IOS; NSF(National Science Foundation (NSF)); NSF grant OCE-PRF; Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding was provided by NSF grant IOS # 1017458 to L. D. M., NSF grant IOS # 1017510 and OCE -1105143 to E. W., and NSF grant OCE-PRF # 1225163 to J.H.P.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouheif E, 1999, EVOL ECOL RES, V1, P895; [Anonymous], MICROB ECOL; [Anonymous], BEAST IS CROSS PLATF; [Anonymous], 2005, CARIBBEAN MARINE BIO; [Anonymous], B INVESTIG MAR COSTE; [Anonymous], BIOLOGY; [Anonymous], ENTOMOL EXP APPL; Ardia DR, 2012, FUNCT ECOL, V26, P732, DOI 10.1111/j.1365-2435.2012.01989.x; Aronson RB, 2001, HYDROBIOLOGIA, V460, P25, DOI 10.1023/A:1013103928980; Arregoitia LDV, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1092; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Baums IB, 2006, ECOL MONOGR, V76, P503, DOI 10.1890/0012-9615(2006)076[0503:GVICSI]2.0.CO;2; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Bogdan C, 2000, CURR OPIN IMMUNOL, V12, P64, DOI 10.1016/S0952-7915(99)00052-7; Boughton RK, 2011, FUNCT ECOL, V25, P81, DOI 10.1111/j.1365-2435.2010.01817.x; Budd AF, 2012, ZOOL J LINN SOC-LOND, V166, P465, DOI 10.1111/j.1096-3642.2012.00855.x; Bulmer MS, 2004, MOL BIOL EVOL, V21, P2256, DOI 10.1093/molbev/msh236; Cairns Stephen D., 1999, Atoll Research Bulletin, V459, P1; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Cervino JM, 2008, J APPL MICROBIOL, V105, P1658, DOI 10.1111/j.1365-2672.2008.03871.x; Cervino JM, 2004, APPL ENVIRON MICROB, V70, P6855, DOI 10.1128/AEM.70.11.6855-6864.2004; Christensen BM, 2005, TRENDS PARASITOL, V21, P192, DOI 10.1016/j.pt.2005.02.007; Croquer A, 2005, CARIBB J SCI, V41, P815; Croquer A, 2003, REV BIOL TROP, V51, P167; Croquer A, 2003, REV BIOL TROP, V51, P39; Croquer A, 2009, DIS AQUAT ORGAN, V87, P33, DOI 10.3354/dao02164; Darling ES, 2012, ECOL LETT, V15, P1378, DOI 10.1111/j.1461-0248.2012.01861.x; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Diaz M, 2011, CORAL REEFS, V30, P73, DOI 10.1007/s00338-010-0668-4; DRUMMOND AJ, 2009, GENEIOUS V4 8; Fukami H, 2004, NATURE, V427, P832, DOI 10.1038/nature02339; Fukami H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003222; Garcia A, 2003, REV BIOL TROP, V51, P173; Garzon-Ferreira J, 2001, HYDROBIOLOGIA, V460, P65, DOI 10.1023/A:1013133818360; Ghosh J, 2011, DEV COMP IMMUNOL, V35, P959, DOI 10.1016/j.dci.2010.12.009; Gilbert GS, 2007, P NATL ACAD SCI USA, V104, P4979, DOI 10.1073/pnas.0607968104; GITTLEMAN JL, 1990, SYST ZOOL, V39, P227, DOI 10.2307/2992183; GLADFELTER WB, 1982, B MAR SCI, V32, P639; Gochfeld DJ, 2008, MAR ECOL PROG SER, V362, P119, DOI 10.3354/meps07418; Harrison PL, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P59, DOI 10.1007/978-94-007-0114-4_6; Harvell D, 2007, OCEANOGRAPHY, V20, P172, DOI 10.5670/oceanog.2007.91; Harvell D, 2009, ECOLOGY, V90, P912, DOI 10.1890/08-0616.1; Hawley DM, 2011, FUNCT ECOL, V25, P48, DOI 10.1111/j.1365-2435.2010.01753.x; Hemmrich G, 2007, TRENDS IMMUNOL, V28, P449, DOI 10.1016/j.it.2007.08.003; Hoi-Leitner M, 2001, BEHAV ECOL SOCIOBIOL, V49, P333, DOI 10.1007/s002650000310; Huang DW, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-37; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Hughes TP, 2000, ECOLOGY, V81, P2250, DOI 10.1890/0012-9658(2000)081[2250:RFLHAL]2.0.CO;2; Kaczmarsky LT, 2005, CARIBB J SCI, V41, P124; Krasnov BR, 2011, ECOGRAPHY, V34, P114, DOI 10.1111/j.1600-0587.2010.06502.x; LaJeunesse TC, 2003, LIMNOL OCEANOGR, V48, P2046, DOI 10.4319/lo.2003.48.5.2046; Lee KA, 2008, J ANIM ECOL, V77, P356, DOI 10.1111/j.1365-2656.2007.01347.x; Lewis JB, 1997, MAR POLLUT BULL, V34, P622, DOI 10.1016/S0025-326X(96)00184-1; Loker ES, 2004, IMMUNOL REV, V198, P10, DOI 10.1111/j.0105-2896.2004.0117.x; Ma ZP, 2010, FISH SHELLFISH IMMUN, V28, P187, DOI 10.1016/j.fsi.2009.10.019; Magor BG, 2001, DEV COMP IMMUNOL, V25, P651, DOI 10.1016/S0145-305X(01)00029-5; McClanahan T. R., 2009, V205, P121; McGinty ES, 2012, MICROB ECOL, V64, P1000, DOI 10.1007/s00248-012-0085-z; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Miller J, 2009, CORAL REEFS, V28, P925, DOI 10.1007/s00338-009-0531-7; Millet S, 2007, DEV COMP IMMUNOL, V31, P188, DOI 10.1016/j.dci.2006.05.013; MURPHY PM, 1993, CELL, V72, P823, DOI 10.1016/0092-8674(93)90571-7; MUTHIGA NA, 1987, BIOL BULL-US, V173, P539, DOI 10.2307/1541699; Mydlarz LD, 2011, COMP BIOCHEM PHYS A, V159, P372, DOI 10.1016/j.cbpa.2011.03.029; Mydlarz LD, 2010, J EXP BIOL, V213, P934, DOI 10.1242/jeb.037580; Mydlarz LD, 2009, DIS AQUAT ORGAN, V87, P67, DOI 10.3354/dao02088; Navas-Camacho R, 2010, REV BIOL TROP, V58, P95; Norris K, 2000, BEHAV ECOL, V11, P19, DOI 10.1093/beheco/11.1.19; Palmer CV, 2012, P ROY SOC B-BIOL SCI, V279, P4106, DOI 10.1098/rspb.2012.1477; Palmer CV, 2011, J EXP BIOL, V214, P4240, DOI 10.1242/jeb.061267; Palmer CV, 2010, FASEB J, V24, P1935, DOI 10.1096/fj.09-152447; Previtali MA, 2012, OIKOS, V121, P1483, DOI 10.1111/j.1600-0706.2012.020215.x; Reusch TBH, 2005, P NATL ACAD SCI USA, V102, P2826, DOI 10.1073/pnas.0500008102; Richards MH, 2000, MOL BIOL EVOL, V17, P146, DOI 10.1093/oxfordjournals.molbev.a026227; Roder C, 2014, MOL ECOL, V23, P965, DOI 10.1111/mec.12638; Roder C, 2014, ISME J, V8, P31, DOI 10.1038/ismej.2013.127; Romano SL, 1997, J MOL EVOL, V45, P397, DOI 10.1007/PL00006245; Romano SL, 2000, B MAR SCI, V67, P1043; Romano SL, 1996, SCIENCE, V271, P640, DOI 10.1126/science.271.5249.640; Santavy DL, 2001, HYDROBIOLOGIA, V460, P39, DOI 10.1023/A:1013194422440; Satake H, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00034; Schulenburg H, 2009, PHILOS T R SOC B, V364, P3, DOI 10.1098/rstb.2008.0249; Stolarski J, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-316; Sutherland KP, 2004, MAR ECOL PROG SER, V266, P273, DOI 10.3354/meps266273; Tella JL, 2002, P ROY SOC B-BIOL SCI, V269, P1059, DOI 10.1098/rspb.2001.1951; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tieleman BI, 2005, P ROY SOC B-BIOL SCI, V272, P1715, DOI 10.1098/rspb.2005.3155; Veizer J, 2000, NATURE, V408, P698, DOI 10.1038/35047044; Vidal-Dupiol J, 2011, J BIOL CHEM, V286, P22688, DOI 10.1074/jbc.M110.216358; Vidal-Dupiol J, 2011, J EXP BIOL, V214, P1533, DOI 10.1242/jeb.053165; Voss JD, 2006, DIS AQUAT ORGAN, V69, P33, DOI 10.3354/dao069033; Wang DD, 2012, CELL STRESS CHAPERON, V17, P423, DOI 10.1007/s12192-011-0317-z; Ward JR, 2006, DIS AQUAT ORGAN, V69, P23, DOI 10.3354/dao069023; Weil E, 2004, CORAL HEALTH AND DISEASE, P35; Weil E, 2006, DIS AQUAT ORGAN, V69, P1, DOI 10.3354/dao069001; Weil E, 2009, CARIBB J SCI, V45, P221; Weil E, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P465, DOI 10.1007/978-94-007-0114-4_27	98	23	23	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e104787	10.1371/journal.pone.0104787	http://dx.doi.org/10.1371/journal.pone.0104787			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133685	Green Published, Green Submitted, gold			2022-12-25	WOS:000341302700042
J	Purohit, P; Perez-Branguli, F; Prots, I; Borger, E; Gunn-Moore, F; Welzel, O; Loy, K; Wenzel, EM; Gromer, TW; Brachs, S; Holzer, M; Buslei, R; Fritsch, K; Regensburger, M; Bohm, KJ; Winner, B; Mielenz, D				Purohit, Pavitra; Perez-Branguli, Francesc; Prots, Iryna; Borger, Eva; Gunn-Moore, Frank; Welzel, Oliver; Loy, Kristina; Wenzel, Eva Maria; Groemer, Teja W.; Brachs, Sebastian; Holzer, Max; Buslei, Rolf; Fritsch, Kristin; Regensburger, Martin; Boehm, Konrad J.; Winner, Beate; Mielenz, Dirk			The Ca2+ Sensor Protein Swiprosin-1/EFhd2 Is Present in Neurites and Involved in Kinesin-Mediated Transport in Neurons	PLOS ONE			English	Article							BINDING ADAPTER PROTEINS; ALZHEIMERS-DISEASE; SYNAPTIC VESICLES; EF-HAND; TAU; STAGE; SYNAPTOPHYSIN; DYNAMICS; EFHD2; MICE	Swiprosin-1/EFhd2 (EFhd2) is a cytoskeletal Ca2+ sensor protein strongly expressed in the brain. It has been shown to interact with mutant tau, which can promote neurodegeneration, but nothing is known about the physiological function of EFhd2 in the nervous system. To elucidate this question, we analyzed EFhd2(-/-)/lacZ reporter mice and showed that lacZ was strongly expressed in the cortex, the dentate gyrus, the CA1 and CA2 regions of the hippocampus, the thalamus, and the olfactory bulb. Immunohistochemistry and western blotting confirmed this pattern and revealed expression of EFhd2 during neuronal maturation. In cortical neurons, EFhd2 was detected in neurites marked by MAP2 and co-localized with pre- and post-synaptic markers. Approximately one third of EFhd2 associated with a biochemically isolated synaptosome preparation. There, EFhd2 was mostly confined to the cytosolic and plasma membrane fractions. Both synaptic endocytosis and exocytosis in primary hippocampal EFhd2(-/-) neurons were unaltered but transport of synaptophysin-GFP containing vesicles was enhanced in EFhd2(-/-) primary hippocampal neurons, and notably, EFhd2 inhibited kinesin mediated microtubule gliding. Therefore, we found that EFhd2 is a neuronal protein that interferes with kinesin-mediated transport.	[Purohit, Pavitra; Brachs, Sebastian; Fritsch, Kristin; Mielenz, Dirk] Univ Klinikum Erlangen, Dept Internal Med 3, Div Mol Immunol, Erlangen, Germany; [Purohit, Pavitra; Perez-Branguli, Francesc; Prots, Iryna; Brachs, Sebastian; Fritsch, Kristin; Regensburger, Martin; Winner, Beate; Mielenz, Dirk] Univ Erlangen Nurnberg, D-91054 Erlangen, Germany; [Perez-Branguli, Francesc; Prots, Iryna; Winner, Beate] Univ Klinikum Erlangen, IZKF Nachwuchsgrp 3, Erlangen, Germany; [Borger, Eva; Gunn-Moore, Frank] Univ St Andrews, Sch Biol Med & Biol Sci Bldg, St Andrews, Fife, Scotland; [Welzel, Oliver; Loy, Kristina; Wenzel, Eva Maria; Groemer, Teja W.] Univ Erlangen Nurnberg, Dept Psychiat, D-91054 Erlangen, Germany; [Holzer, Max] Univ Leipzig, Paul Flechsig Inst Brain Res, D-04109 Leipzig, Germany; [Holzer, Max] Leibniz Inst Age Res, Jena, Germany; [Buslei, Rolf] Univ Erlangen Nurnberg, Inst Neuropathol, D-91054 Erlangen, Germany; [Regensburger, Martin] Univ Erlangen Nurnberg, Dept Neurol, D-91054 Erlangen, Germany; [Boehm, Konrad J.] Fritz Lipmann Inst, Mol Motors Lab, Jena, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of St Andrews; University of Erlangen Nuremberg; Leipzig University; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); University of Erlangen Nuremberg; University of Erlangen Nuremberg; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI)	Mielenz, D (corresponding author), Univ Klinikum Erlangen, Dept Internal Med 3, Div Mol Immunol, Erlangen, Germany.	dmielenz@molmed.uni-erlangen.de	Winner, Beate/K-3730-2012; Regensburger, Martin/AAI-2311-2020; Winner, Beate/O-8213-2019; Holzer, Max/A-1729-2008; Prots, Iryna/O-7982-2018; Borger, Eva/H-5999-2013	Winner, Beate/0000-0002-6909-0564; Regensburger, Martin/0000-0002-2172-7386; Winner, Beate/0000-0002-6909-0564; Holzer, Max/0000-0003-1754-9932; Prots, Iryna/0000-0001-9561-0909; Borger, Eva/0000-0003-4965-2969; Brachs, Sebastian/0000-0002-6336-3939; Gunn-Moore, Francis James/0000-0003-3422-3387; Wenzel, Eva Maria/0000-0002-5561-3344	German Science Foundation (Deutsche Forschungsgemeinschaft, DFG) [FOR832]; German Federal Ministry of Education and Research [01GQ113]; Bavarian Ministry of Sciences, Research and the Arts; Interdisciplinary Center for Clinical Research (IZKF, Universitatsklinikum Erlangen) [E8]; ELAN Fonds (Universitatsklinikum Erlangen) [11.08.19.1]; Alzheimer's Research UK; Alzheimers Research UK [ART-PG2009-3] Funding Source: researchfish	German Science Foundation (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Bavarian Ministry of Sciences, Research and the Arts; Interdisciplinary Center for Clinical Research (IZKF, Universitatsklinikum Erlangen); ELAN Fonds (Universitatsklinikum Erlangen); Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK))	This work was supported by grants from the German Science Foundation (Deutsche Forschungsgemeinschaft, DFG; FOR832, to DM), the German Federal Ministry of Education and Research (01GQ113; to BW), the Bavarian Ministry of Sciences, Research and the Arts in the framework of the Bavarian Molecular Biosystems Reseach Network, the Interdisciplinary Center for Clinical Research (IZKF, Universitatsklinikum Erlangen; E8, to DM; NIII, to BW; Lab rotation to MR), the ELAN Fonds (Universitatsklinikum Erlangen; 11.08.19.1, to IP), and the Alzheimer's Research UK (EB, FGM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpar A, 2012, CELL SIGNAL, V24, P378, DOI 10.1016/j.cellsig.2011.09.028; Avramidou A, 2007, CELL DEATH DIFFER, V14, P1936, DOI 10.1038/sj.cdd.4402206; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Bohm KJ, 2008, CELL BIOL INT, V32, P588, DOI 10.1016/j.cellbi.2007.12.001; Bohm KJ, 1997, CELL MOTIL CYTOSKEL, V37, P226, DOI 10.1002/(SICI)1097-0169(1997)37:3<226::AID-CM4>3.0.CO;2-4; Brachs S, 2014, EUR J IMMUNOL, V44, P3206, DOI 10.1002/eji.201444479; Brachs Sebastian, 2013, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, V32, P237, DOI 10.1089/mab.2013.0014; BRADY ST, 1984, NATURE, V310, P56, DOI 10.1038/310056a0; Buslei R, 2007, ACTA NEUROPATHOL, V113, P585, DOI 10.1007/s00401-006-0184-3; Conde C, 2009, NAT REV NEUROSCI, V10, P319, DOI 10.1038/nrn2631; Da Silva JS, 2005, NAT NEUROSCI, V8, P606, DOI 10.1038/nn1442; Dima AA, 2011, CYTOM PART A, V79A, P545, DOI 10.1002/cyto.a.21079; Dixit R, 2008, SCIENCE, V319, P1086, DOI 10.1126/science.1152993; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Dutting S, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-2; ESHKIND LG, 1995, CELL TISSUE RES, V282, P423, DOI 10.1007/s004410050493; Ferrer-Acosta Y, 2013, J NEUROCHEM, V125, P921, DOI 10.1111/jnc.12155; Ferrer-Acosta Y, 2013, PROTEIN PEPTIDE LETT, V20, P573; Guruharsha KG, 2011, CELL, V147, P690, DOI 10.1016/j.cell.2011.08.047; Hagen S, 2012, CELL CALCIUM, V51, P411, DOI 10.1016/j.ceca.2012.01.004; Hornbruch-Freitag C, 2011, J CELL SCI, V124, P3266, DOI 10.1242/jcs.083907; Hubner K, 2002, INT REV CYTOL, V214, P103; Huh YH, 2013, CELL MOL LIFE SCI, V70, P4841, DOI 10.1007/s00018-013-1447-5; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Kalchishkova N, 2008, J MOL BIOL, V382, P127, DOI 10.1016/j.jmb.2008.06.092; Kroczek C, 2010, J IMMUNOL, V184, P3665, DOI 10.4049/jimmunol.0903642; Kwon MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071626; McMahon HT, 1996, P NATL ACAD SCI USA, V93, P4760, DOI 10.1073/pnas.93.10.4760; Meixner A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.001172; Mielenz D, 2005, J IMMUNOL, V174, P3508, DOI 10.4049/jimmunol.174.6.3508; Millecamps S, 2013, NAT REV NEUROSCI, V14, P161, DOI 10.1038/nrn3380; Perez-Branguli F, 2014, HUM MOL GENET; Perlson E, 2010, TRENDS NEUROSCI, V33, P335, DOI 10.1016/j.tins.2010.03.006; Prots I, 2003, CELL BIOL INT, V27, P251, DOI 10.1016/S1065-6995(02)00313-X; Ribchester RR, 2009, CURR OPIN PHARMACOL, V9, P297, DOI 10.1016/j.coph.2009.03.006; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Sudhof TC, 2012, NEURON, V75, P11, DOI 10.1016/j.neuron.2012.06.012; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; Vega IE, 2008, J NEUROCHEM, V106, P96, DOI 10.1111/j.1471-4159.2008.05339.x; Waites CL, 2011, TRENDS NEUROSCI, V34, P326, DOI 10.1016/j.tins.2011.03.004; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; Welzel O, 2011, EUR BIOPHYS J BIOPHY, V40, P1061, DOI 10.1007/s00249-011-0722-3; Wigge P, 1998, TRENDS NEUROSCI, V21, P339, DOI 10.1016/S0166-2236(98)01264-8; Yuan A, 2008, J NEUROSCI, V28, P1682, DOI 10.1523/JNEUROSCI.5242-07.2008	44	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e103976	10.1371/journal.pone.0103976	http://dx.doi.org/10.1371/journal.pone.0103976			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133820	Green Published, gold, Green Submitted			2022-12-25	WOS:000341302700020
J	Tengroth, L; Arebro, J; Georen, SK; Winqvist, O; Cardell, LO				Tengroth, Lotta; Arebro, Julia; Georen, Susanna Kumlien; Winqvist, Ola; Cardell, Lars-Olaf			Deprived TLR9 Expression in Apparently Healthy Nasal Mucosa Might Trigger Polyp-Growth in Chronic Rhinosinusitis Patients	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-9; CPG DNA; CELLS; INFLAMMATION; OLIGODEOXYNUCLEOTIDE; TOLL-LIKE-RECEPTOR-9; ACTIVATION; CYTOKINES; DISEASES; NOSE	Background: The origin of nasal polyps in chronic rhinosinusitis is unknown, but the role of viral infections in polyp growth is clinically well established. Toll-like receptors (TLRs) have recently emerged as key players in our local airway defense against microbes. Among these, TLR9 has gained special interest in viral diseases. Many studies on chronic rhinosinusitis with nasal polyps (CRSwNP) compare polyp tissue with nasal mucosa from polyp-free individuals. Knowledge about changes in the turbinate tissue bordering the polyp tissue is limited. Objectives: To analyse the role of TLR9 mediated microbial defense in tissue bordering the polyp. Methods: Nasal polyps and turbinate tissue from 11 patients with CRSwNP and turbinate tissue from 11 healthy controls in total were used. Five biopsies from either group were analysed immediately with flow cytometry regarding receptor expression and 6 biopsies were used for in vitro stimulation with a TLR9 agonist, CpG. Cytokine release was analysed using Luminex. Eight patients with CRSwNP in total were intranasally challenged with CpG/placebo 24 hours before surgery and the biopsies were collected and analysed as above. Results: TLR9 expression was detected on turbinate epithelial cells from healthy controls and polyp epithelial cells from patients, whereas TLR9 was absent in turbinate epithelial cells from patients. CpG stimulation increased the percentage cells expressing TLR9 and decreased percentage cells expressing VEGFR2 in turbinate tissue from patients. After CpG stimulation the elevated levels of IL-6, G-CSF and MIP-1 beta in the turbinate tissue from patients were reduced towards the levels demonstrated in healthy controls. Conclusion: Defects in the TLR9 mediated microbial defense in the mucosa adjacent to the anatomic origin of the polyp might explain virus induced polyp growth. CpG stimulation decreased VEGFR2, suggesting a role for CpG in polyp formation. The focus on turbinate tissue in patients with CRSwNP opens new perspectives in CRSwNP-research.	[Tengroth, Lotta; Arebro, Julia; Georen, Susanna Kumlien; Cardell, Lars-Olaf] Karolinska Inst, Dept Clin Sci Intervent & Technol, Div Ear Nose & Throat Dis, Stockholm, Sweden; [Winqvist, Ola] Karolinska Inst, Dept Med, Unit Translat Immunol, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Cardell, LO (corresponding author), Karolinska Inst, Dept Clin Sci Intervent & Technol, Div Ear Nose & Throat Dis, Stockholm, Sweden.	lars-olaf.cardell@ki.se		Kumlien Georen, Susanna/0000-0001-7292-9255; Arebro, Julia/0000-0002-2584-0941; winqvist, Ola/0000-0003-0842-4441	Swedish Medical Research Council [2011-3357]	Swedish Medical Research Council(Swedish Medical Research Council (SMRC))	Swedish Medical Research Council (Grant number: 2011-3357; http://www.vr.se/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachert C, 2007, ALLERGOLOGIE, V30, P155; Bachert C, 2009, ALLERGY, V64, P520, DOI 10.1111/j.1398-9995.2009.01964.x; Beisswenger C, 2006, J IMMUNOL, V177, P1833, DOI 10.4049/jimmunol.177.3.1833; Bernstein JM, 2004, OTOLARYNG HEAD NECK, V130, P526, DOI 10.1016/j.otohns.2003.12.022; Bhattacharyya N, 2001, AM J RHINOL, V15, P169, DOI 10.2500/105065801779954184; Bobic S, 2014, ALLERGY, V69, P237, DOI 10.1111/all.12277; Cho GS, 2013, J CLIN MICROBIOL, V51, P979, DOI 10.1128/JCM.02806-12; CONNOLLY DT, 1989, J CLIN INVEST, V84, P1470, DOI 10.1172/JCI114322; Coste A, 2000, EUR RESPIR J, V15, P367, DOI 10.1034/j.1399-3003.2000.15b24.x; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Fransson M, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-17; Gong J, 2013, AM J OTOLARYNGOL; Gwaltney JM, 1996, CLIN INFECT DIS, V23, P1209, DOI 10.1093/clinids/23.6.1209; Hartmann G, 1999, P NATL ACAD SCI USA, V96, P9305, DOI 10.1073/pnas.96.16.9305; Hayashi F, 2003, BLOOD, V102, P2660, DOI 10.1182/blood-2003-04-1078; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Kadowaki N, 2001, J IMMUNOL, V166, P2291, DOI 10.4049/jimmunol.166.4.2291; Kern RC, 2008, AM J RHINOL, V22, P549, DOI 10.2500/ajr.2008.22.3228; Kirtsreesakul V, 2006, ARCH OTOLARYNGOL, V132, P1102, DOI 10.1001/archotol.132.10.1102; Klinman DM, 2004, NAT REV IMMUNOL, V4, P248, DOI 10.1038/nri1329; Kodama S, 2006, LARYNGOSCOPE, V116, P331, DOI 10.1097/01.mlg.0000194222.93067.f7; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Krieg Arthur M, 2007, Proc Am Thorac Soc, V4, P289, DOI 10.1513/pats.200701-021AW; Lane AP, 2006, AM J RHINOL, V20, P138, DOI 10.1177/194589240602000203; LARSEN PL, 1992, LARYNGOSCOPE, V102, P670, DOI 10.1288/00005537-199206000-00013; Lee HS, 2009, AM J RESP CRIT CARE, V180, P1056, DOI 10.1164/rccm.200905-0740OC; Leigh R, 2008, J ALLERGY CLIN IMMUN, V121, P1238, DOI 10.1016/j.jaci.2008.01.067; Li J, 2004, AM J PHYSIOL-LUNG C, V287, pL552, DOI 10.1152/ajplung.00436.2003; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Mansson A, 2009, ALLERGY, V64, P1292, DOI 10.1111/j.1398-9995.2009.02012.x; Meltzer EO, 2004, OTOLARYNG HEAD NECK, V131, pS1, DOI 10.1016/j.otohns.2004.09.067; Norlander T, 1996, LARYNGOSCOPE, V106, P196, DOI 10.1097/00005537-199602000-00017; Pandey S, 2006, IMMUNOL CELL BIOL, V84, P333, DOI 10.1111/j.1440-1711.2006.01444.x; Park SK, 2009, LARYNGOSCOPE, V119, P409, DOI 10.1002/lary.20085; PEDERSEN M, 1983, EUR J RESPIR DIS, V64, P355; Ramanathan M, 2007, AM J RHINOL, V21, P110, DOI 10.2500/ajr.2007.21.2997; Ramanathan M, 2008, AM J RHINOL, V22, P115, DOI 10.2500/ajr.2008.22.3136; Scavuzzo MC, 2005, BIOMED PHARMACOTHER, V59, P323, DOI 10.1016/j.biopha.2004.11.010; Simon HU, 1997, J IMMUNOL, V158, P3902; Takeshita F, 2001, J IMMUNOL, V167, P3555, DOI 10.4049/jimmunol.167.7.3555; Tan L, 2009, AM J RHINOL ALLERGY, V23, P123, DOI 10.2500/ajra.2009.23.3279; Tengroth L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098239; Van Crombruggen K, 2011, J ALLERGY CLIN IMMUN, V128, P728, DOI 10.1016/j.jaci.2011.07.049; Van Zele T, 2006, ALLERGY, V61, P1280, DOI 10.1111/j.1398-9995.2006.01225.x; Wang Cheng-shuo, 2003, Zhonghua Er Bi Yan Hou Ke Za Zhi, V38, P243; Wang XD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039875; Wu CC, 2012, AM J OTOLARYNG, V33, P14, DOI 10.1016/j.amjoto.2010.12.001; Yamazaki Y, 2006, MOL DIVERS, V10, P515, DOI 10.1007/s11030-006-9027-3; Zhang N, 2008, J ALLERGY CLIN IMMUN, V122, P961, DOI 10.1016/j.jaci.2008.07.008	49	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105618	10.1371/journal.pone.0105618	http://dx.doi.org/10.1371/journal.pone.0105618			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133733	gold, Green Submitted, Green Published			2022-12-25	WOS:000341302700123
J	Wang, F; McShea, WJ; Wang, DJ; Li, S; Zhao, Q; Wang, H; Lu, Z				Wang, Fang; McShea, William J.; Wang, Dajun; Li, Sheng; Zhao, Qing; Wang, Hao; Lu, Zhi			Evaluating Landscape Options for Corridor Restoration between Giant Panda Reserves	PLOS ONE			English	Article							FOPING-NATURE-RESERVE; WOLONG NATURE-RESERVE; HABITAT SUITABILITY; MINSHAN MOUNTAINS; CONSERVATION; SCENARIO; MODELS; FOREST; CHINA; CONNECTIVITY	The establishment of corridors can offset the negative effects of habitat fragmentation by connecting isolated habitat patches. However, the practical value of corridor planning is minimal if corridor identification is not based on reliable quantitative information about species-environment relationships. An example of this need for quantitative information is planning for giant panda conservation. Although the species has been the focus of intense conservation efforts for decades, most corridor projects remain hypothetical due to the lack of reliable quantitative researches at an appropriate spatial scale. In this paper, we evaluated a framework for giant panda forest corridor planning. We linked our field survey data with satellite imagery, and conducted species occupancy modelling to examine the habitat use of giant panda within the potential corridor area. We then conducted least-cost and circuit models to identify potential paths of dispersal across the landscape, and compared the predicted cost under current conditions and alternative conservation management options considered during corridor planning. We found that due to giant panda's association with areas of low elevation and flat terrain, human infrastructures in the same area have resulted in corridor fragmentation. We then identified areas with high potential to function as movement corridors, and our analysis of alternative conservation scenarios showed that both forest/bamboo restoration and automobile tunnel construction would significantly improve the effectiveness of corridor, while residence relocation would not significantly improve corridor effectiveness in comparison with the current condition. The framework has general value in any conservation activities that anticipate improving habitat connectivity in human modified landscapes. Specifically, our study suggested that, in this landscape, automobile tunnels are the best means to remove current barriers to giant panda movements caused by anthropogenic interferences.	[Wang, Fang; McShea, William J.] Natl Zool Pk, Smithsonian Conservat Biol Inst, Front Royal, VA 22630 USA; [Wang, Fang; Wang, Dajun; Li, Sheng; Wang, Hao; Lu, Zhi] Peking Univ, Sch Life Sci, Beijing 100871, Peoples R China; [Zhao, Qing] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO USA	Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Peking University; Colorado State University	Wang, F (corresponding author), Natl Zool Pk, Smithsonian Conservat Biol Inst, Front Royal, VA 22630 USA.	wangf@si.edu	Wang, Fang/AIC-7698-2022; Zhao, Qing/K-3486-2015	Zhao, Qing/0000-0003-2759-1114; Wang, Fang/0000-0002-3922-5851; McShea, William/0000-0002-8102-0200	Ocean Park Conservation Foundation, Hong Kong (OPCFHK); Conservation International (CI)	Ocean Park Conservation Foundation, Hong Kong (OPCFHK); Conservation International (CI)	This research was funded by Ocean Park Conservation Foundation, Hong Kong (OPCFHK, www.opcf.org.hk) and Conservation International (CI, www.conservation.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaensen F, 2003, LANDSCAPE URBAN PLAN, V64, P233, DOI 10.1016/S0169-2046(02)00242-6; ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; [Anonymous], 2004, WORLDCLIM INTERPOLAT; ASTER G, 2011, VALIDATION TEAM 2009; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Chetkiewicz CLB, 2009, J APPL ECOL, V46, P1036, DOI 10.1111/j.1365-2664.2009.01686.x; China's Ministry of Forestry & WWF, 1989, COMPR REP CHIN GIANT; Corlatti L, 2009, CONSERV BIOL, V23, P548, DOI 10.1111/j.1523-1739.2008.01162.x; Dang HS, 2010, FOREST ECOL MANAG, V259, P547, DOI 10.1016/j.foreco.2009.11.011; Downes SJ, 1997, CONSERV BIOL, V11, P718, DOI 10.1046/j.1523-1739.1997.96094.x; Erb PL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042574; ESRI, 2013, 10 2 DESKT HELP; Feng TT, 2009, J WILDLIFE MANAGE, V73, P852, DOI 10.2193/2008-186; Fiske IJ, 2011, J STAT SOFTW, V43, P1; Hines, 2017, OCCUPANCY ESTIMATION; Huck M, 2010, ACTA THERIOL, V55, P177, DOI 10.4098/j.at.0001-7051.114.2009; Huijser MP, 2009, ECOL SOC, V14; Koen EL, 2012, LANDSCAPE ECOL, V27, P29, DOI 10.1007/s10980-011-9675-2; LaPoint S, 2013, LANDSCAPE ECOL, V28, P1615, DOI 10.1007/s10980-013-9910-0; Li HL, 2010, ECOL MODEL, V221, P944, DOI 10.1016/j.ecolmodel.2009.12.006; Li S, 2010, IBIS, V152, P299, DOI 10.1111/j.1474-919X.2009.00989.x; Liu JG, 2001, SCIENCE, V292, P98, DOI 10.1126/science.1058104; Liu XH, 2005, J WILDLIFE MANAGE, V69, P1623, DOI 10.2193/0022-541X(2005)69[1623:GPHSIF]2.0.CO;2; Liu XH, 2002, J WILDLIFE MANAGE, V66, P1179, DOI 10.2307/3802951; Loucks CJ, 2001, SCIENCE, V294, P1465, DOI 10.1126/science.1064710; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; McRae B., 2009, CIRCUITSCAPE USER GU; McShea WJ, 2014, ENVIRON CONSERV, V41, P93, DOI 10.1017/S0376892913000581; McShea WJ, 2008, HUMAN WILDLIFE INTER, V76; Muchoney D, 2000, INT J REMOTE SENS, V21, P1115, DOI 10.1080/014311600210100; Olsson MPO, 2008, LANDSCAPE URBAN PLAN, V85, P133, DOI 10.1016/j.landurbplan.2007.10.006; Pan W., 2001, OPPORTUNITY GIANT PA; Peterson GD, 2003, CONSERV BIOL, V17, P358, DOI 10.1046/j.1523-1739.2003.01491.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Postma TJBM, 2005, TECHNOL FORECAST SOC, V72, P161, DOI 10.1016/j.techfore.2003.11.005; Qi DW, 2012, INTEGR ZOOL, V7, P165, DOI 10.1111/j.1749-4877.2012.00281.x; Rogers S, 2006, POPUL ENVIRON, V28, P41, DOI 10.1007/s11111-007-0033-x; Sawyer SC, 2011, J APPL ECOL, V48, P668, DOI 10.1111/j.1365-2664.2011.01970.x; Shen GZ, 2008, CONSERV BIOL, V22, P1144, DOI 10.1111/j.1523-1739.2008.01038.x; Songer Melissa, 2012, International Journal of Ecology, P1; State Forestry Administration, 2006, 3 NAT SURV REP GIANT; Swaisgood RR, 2010, BIOL LETTERS, V6, P143, DOI 10.1098/rsbl.2009.0786; Thompson JR, 2012, BIOSCIENCE, V62, P367, DOI 10.1525/bio.2012.62.4.8; Tuan Mu M-N, 2012, SPATIOTEMPORAL DYNAM; Wang Q, 2006, FOREST CHRON, V82, P31, DOI 10.5558/tfc82031-1; Wang XZ, 2009, ECOL RES, V24, P1101, DOI 10.1007/s11284-009-0589-2; Wang Xuezhi, 2008, Acta Ecologica Sinica, V28, P821; Wang ZM, 2010, AMBIO, V39, P443, DOI 10.1007/s13280-010-0054-z; Wu PF, 2010, PROCEDIA ENVIRON SCI, V2, P111, DOI 10.1016/j.proenv.2010.10.015; Wu X, 2010, SHAANXI FOREST SCI T, V2, P5, DOI DOI 10.1088/1748-6041/5/4/044105; Yeh ET, 2009, GEOFORUM, V40, P884, DOI 10.1016/j.geoforum.2009.06.004; Yin KP, 2006, INTEGR ZOOL, V1, P170, DOI 10.1111/j.1749-4877.2006.00032.x; Zeller KA, 2012, LANDSCAPE ECOL, V27, P777, DOI 10.1007/s10980-012-9737-0; [曾治高 ZENG Zhi-gao], 2009, [西北林学院学报, Journal of Northwest Forestry College], V24, P88; Zhang PC, 2000, SCIENCE, V288, P2135, DOI 10.1126/science.288.5474.2135; Zhang ZJ, 2011, BIOL LETTERS, V7, P403, DOI 10.1098/rsbl.2010.1081; Zhen Cao, 2012, 2012 International Conference on Civil Engineering and Urban Planning (CEUP 2012). Proceedings, P56; Zhi-ming B, 2006, J CENTRAL U NATL PHI, V1, P004; Zhu LF, 2011, MOL ECOL, V20, P1122, DOI 10.1111/j.1365-294X.2011.04999.x; Zhu LF, 2010, CONSERV BIOL, V24, P1299, DOI 10.1111/j.1523-1739.2010.01499.x	60	39	48	2	165	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105086	10.1371/journal.pone.0105086	http://dx.doi.org/10.1371/journal.pone.0105086			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133757	Green Published, gold, Green Submitted			2022-12-25	WOS:000341302700067
J	Engi, SA; Cruz, FC; Leao, RM; Spolidorio, LC; Planeta, CS; Crestani, CC				Engi, Sheila A.; Cruz, Fabio C.; Leao, Rodrigo M.; Spolidorio, Luis C.; Planeta, Cleopatra S.; Crestani, Carlos C.			Cardiovascular Complications following Chronic Treatment with Cocaine and Testosterone in Adolescent Rats	PLOS ONE			English	Article							CONDITIONED PLACE PREFERENCE; ANABOLIC-ANDROGENIC STEROIDS; CORONARY-HEART-DISEASE; DRUG-USE; UNANESTHETIZED RATS; BAROREFLEX FUNCTION; BLOOD-PRESSURE; UNITED-STATES; ADULT RATS; BRAIN	Concomitant use of anabolic androgenic steroids and cocaine has increased in the last years. However, the effects of chronic exposure to these substances during adolescence on cardiovascular function are unknown. Here, we investigated the effects of treatment for 10 consecutive days with testosterone and cocaine alone or in combination on basal cardiovascular parameters, baroreflex activity, hemodynamic responses to vasoactive agents, and cardiac morphology in adolescent rats. Administration of testosterone alone increased arterial pressure, reduced heart rate (HR), and exacerbated the tachycardiac baroreflex response. Cocaine-treated animals showed resting bradycardia without changes in arterial pressure and baroreflex activity. Combined treatment with testosterone and cocaine did not affect baseline arterial pressure and HR, but reduced baroreflex-mediated tachycardia. None of the treatments affected arterial pressure response to either vasoconstrictor or vasodilator agents. Also, heart to body ratio and left and right ventricular wall thickness were not modified by drug treatments. However, histological analysis of left ventricular sections of animals subjected to treatment with testosterone and cocaine alone and combined showed a greater spacing between cardiac muscle fibers, dilated blood vessels, and fibrosis. These data show important cardiovascular changes following treatment with testosterone in adolescent rats. However, the results suggest that exposure to cocaine alone or combined with testosterone during adolescence minimally affect cardiovascular function.	[Engi, Sheila A.; Planeta, Cleopatra S.; Crestani, Carlos C.] UNESP, Sch Pharmaceut Sci, Dept Nat Act Principles & Toxicol, Pharmacol Lab, Araraquara, SP, Brazil; [Engi, Sheila A.; Planeta, Cleopatra S.; Crestani, Carlos C.] UNESP, Grad Program Physiol Sci, Joint UFSCar, Sao Carlos, SP, Brazil; [Cruz, Fabio C.; Leao, Rodrigo M.] NIDA, Behav Neurosci Branch, Intramural Res Program, US NIH,Dept Hlth & Human Serv, Baltimore, MD USA; [Spolidorio, Luis C.] UNESP, Sch Dent Araraquara, Dept Physiol & Pathol, Araraquara, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); Universidade Estadual Paulista	Crestani, CC (corresponding author), UNESP, Sch Pharmaceut Sci, Dept Nat Act Principles & Toxicol, Pharmacol Lab, Araraquara, SP, Brazil.	cccrestani@yahoo.com.br	ENGI, SHEILA A/O-2141-2013; Spolidorio, Luís Carlos/G-1857-2012; Crestani, Carlos C/E-4161-2012; Planeta, Cleopatra/Z-5255-2019; Scavone, Cristoforo/C-1580-2012; Leao, Rodrigo/J-4400-2015	ENGI, SHEILA A/0000-0002-5025-0177; Spolidorio, Luís Carlos/0000-0002-0592-542X; Crestani, Carlos C/0000-0002-1942-858X; Planeta, Cleopatra/0000-0002-1378-6327; Scavone, Cristoforo/0000-0002-1206-0882; Leao, Rodrigo/0000-0001-9865-7649	Sao Paulo Research Foundation (FAPESP) [2010/16192-8, 2012/14376-0, 2012/50549-6]; PADC-School of Pharmaceutical Sciences-Sao Paulo State University	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); PADC-School of Pharmaceutical Sciences-Sao Paulo State University	This work was supported by Sao Paulo Research Foundation (FAPESP) grant#2010/16192-8, 2012/14376-0 and 2012/50549-6; and PADC-School of Pharmaceutical Sciences-Sao Paulo State University. CSP is a CNPq research fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achar S, 2010, AM J CARDIOL, V106, P893, DOI 10.1016/j.amjcard.2010.05.013; ANTHONY JC, 1995, DRUG ALCOHOL DEPEN, V40, P9, DOI 10.1016/0376-8716(95)01194-3; Aquaro GD, 2011, HEART, V97, P2056, DOI 10.1136/hrt.2011.226977; Badanich KA, 2008, DEV PSYCHOBIOL, V50, P127, DOI 10.1002/dev.20252; Badanich KA, 2006, EUR J PHARMACOL, V550, P95, DOI 10.1016/j.ejphar.2006.08.034; Beutel A, 2005, J STEROID BIOCHEM, V93, P43, DOI 10.1016/j.jsbmb.2004.11.003; Beveridge TJR, 2004, NEUROSCI LETT, V370, P201, DOI 10.1016/j.neulet.2004.08.021; Brecklin CS, 1998, AM J HYPERTENS, V11, P1279, DOI 10.1016/S0895-7061(98)00135-6; Casey BJ, 2008, DEV REV, V28, P62, DOI [10.1016/j.dr.2007.08.003, 10.1196/annals.1440.010]; Chambers RA, 2003, AM J PSYCHIAT, V160, P1041, DOI 10.1176/appi.ajp.160.6.1041; Chocyk A, 2006, BRAIN RES, V1090, P58, DOI 10.1016/j.brainres.2006.03.045; Coimbra LS, 2014, J CLIN PERIODONTOL, V41, P295, DOI 10.1111/jcpe.12203; COLLINS R, 1990, LANCET, V335, P827, DOI 10.1016/0140-6736(90)90944-Z; Crestani CC, 2011, EUR J PHARMACOL, V670, P527, DOI 10.1016/j.ejphar.2011.09.030; Crestani CC, 2010, NEUROSCI RES, V67, P317, DOI 10.1016/j.neures.2010.05.001; Cruz FC, 2013, NEUROSCIENCE, V253, P29, DOI 10.1016/j.neuroscience.2013.08.034; Cruz FC, 2012, J PSYCHOPHARMACOL, V26, P1366, DOI 10.1177/0269881112453210; DeWit DJ, 1997, HEALTH EDUC BEHAV, V24, P746, DOI 10.1177/109019819702400609; DURANT RH, 1993, NEW ENGL J MED, V328, P922, DOI 10.1056/NEJM199304013281304; DURANT RH, 1995, PEDIATRICS, V96, P23; DYER AR, 1980, AM J EPIDEMIOL, V112, P736, DOI 10.1093/oxfordjournals.aje.a113046; Engi SA, 2012, J CARDIOVASC PHARM, V59, P231, DOI 10.1097/FJC.0b013e31823cc58b; Fanton L, 2009, EXP TOXICOL PATHOL, V61, P317, DOI 10.1016/j.etp.2008.09.007; Goldstein RA, 2009, SEMIN DIAGN PATHOL, V26, P10, DOI 10.1053/j.semdp.2008.12.001; Grant BF, 1997, J STUD ALCOHOL, V58, P464, DOI 10.15288/jsa.1997.58.464; Grassi G, 2006, PROG CARDIOVASC DIS, V48, P407, DOI 10.1016/j.pcad.2006.03.002; Grassi G, 2004, CURR PHARM DESIGN, V10, P3579, DOI 10.2174/1381612043382756; Hassan AF, 2013, INT J HEALTH SCI-IJH, V7, P47, DOI 10.12816/0006020; HEAD GA, 1987, J AUTONOM NERV SYST, V21, P203, DOI 10.1016/0165-1838(87)90023-3; Honzikova N, 2009, PHYSIOL RES, V58, P605, DOI 10.33549/physiolres.931700; Johansson-Steensland P, 2002, EUR J NEUROSCI, V15, P539, DOI 10.1046/j.0953-816x.2001.01877.x; Kandel D, 1997, DRUG ALCOHOL DEPEN, V44, P11, DOI 10.1016/S0376-8716(96)01315-4; KLONER RA, 1992, CIRCULATION, V85, P407, DOI 10.1161/01.CIR.85.2.407; Lattanzio FA, 2005, CARDIOVASC TOXICOL, V5, P377, DOI 10.1385/CT:5:4:377; Macey DJ, 2004, PSYCHOPHARMACOLOGY, V172, P384, DOI 10.1007/s00213-003-1676-7; Maraj S, 2010, CLIN CARDIOL, V33, P264, DOI 10.1002/clc.20746; McCormick CM, 2010, BRAIN COGNITION, V72, P73, DOI 10.1016/j.bandc.2009.06.003; Olivares EL, 2014, PHYSIOL BEHAV, V126, P15, DOI 10.1016/j.physbeh.2013.12.006; Palatini P, 1997, J HUM HYPERTENS, V11, pS19; Phillis BD, 2000, EUR J PHARMACOL, V398, P263, DOI 10.1016/S0014-2999(00)00294-6; Reboussin BA, 2006, NEUROPSYCHOPHARMACOL, V31, P2055, DOI 10.1038/sj.npp.1301037; Riezzo I, 2011, MINI-REV MED CHEM, V11, P409, DOI 10.2174/138955711795445862; Romero Vecchione E, 2002, ACTA CIENT VENEZ, V53, P225; Rosa F, 2005, PHARMACOLOGY, V75, P5, DOI 10.1159/000085771; Salas-Ramirez KY, 2008, HORM BEHAV, V53, P378, DOI 10.1016/j.yhbeh.2007.11.004; Schramm-Sapyta NL, 2009, PSYCHOPHARMACOLOGY, V206, P1, DOI 10.1007/s00213-009-1585-5; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Sullivan ML, 1998, PROG CARDIOVASC DIS, V41, P1, DOI 10.1016/S0033-0620(98)80019-4; Tang EHC, 2010, PFLUG ARCH EUR J PHY, V459, P995, DOI 10.1007/s00424-010-0786-4; Tella SR, 1999, EUR J PHARMACOL, V383, P57, DOI 10.1016/S0014-2999(99)00582-8; Tirelli E, 2003, NEUROSCI BIOBEHAV R, V27, P163, DOI 10.1016/S0149-7634(03)00018-6; Togna GI, 2003, THROMB RES, V109, P195, DOI 10.1016/S0049-3848(03)00184-1; TSENG YT, 1994, FUND APPL TOXICOL, V22, P113, DOI 10.1006/faat.1994.1014; van Amsterdam J, 2010, REGUL TOXICOL PHARM, V57, P117, DOI 10.1016/j.yrtph.2010.02.001; Wong WC, 2013, J NEUROSCI, V33, P4913, DOI 10.1523/JNEUROSCI.1371-12.2013; Zombeck JA, 2009, PSYCHOPHARMACOLOGY, V201, P589, DOI 10.1007/s00213-008-1327-0	56	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e105172	10.1371/journal.pone.0105172	http://dx.doi.org/10.1371/journal.pone.0105172			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121974	Green Submitted, Green Published, gold			2022-12-25	WOS:000341017000102
J	Obanda, V; Omondi, GP; Chiyo, PI				Obanda, Vincent; Omondi, George Paul; Chiyo, Patrick Ilukol			The Influence of Body Mass Index, Age and Sex on Inflammatory Disease Risk in Semi-Captive Chimpanzees	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; C-REACTIVE PROTEIN; PLATELET-DERIVED MICROPARTICLES; SERUM CLINICAL-CHEMISTRY; TUMOR-NECROSIS-FACTOR; BLOOD-CELL COUNT; LYMPHOCYTE RATIO; CAPTIVE CHIMPANZEES; CALORIC RESTRICTION; GENDER-DIFFERENCES	Obesity and ageing are emerging issues in the management of captive primates, including Chimpanzees, Pan troglodytes. Studies on humans show that obesity and old age can independently increase the risk of inflammatory-associated diseases indicated by elevated levels of pro-inflammatory cells and proteins in the blood of older or obese compared to levels in younger or non-obese individuals. In humans, sex can influence the outcomes of these risks. Health management of these problems in chimpanzee populations requires an understanding of similarities and differences of factors influencing inflammatory disease risks in humans and in chimpanzees. We examined the relationship between age, sex and Body Mass Index (BMI) with hematological biomarkers of inflammatory disease risk established for humans which include the neutrophil to lymphocyte ratio (NLR), and neutrophil, white blood cell (WBC), platelet microparticle and platelet counts. We found that higher values of NLR, neutrophil count and platelet microparticle count were associated with higher BMI values and older age indicating increased inflammation risk in these groups; a similar pattern to humans. There was a strong sex by age interaction on inflammation risk, with older males more at risk than older females. In contrast to human studies, total WBC count was not influenced by BMI, but like humans, WBC and platelet counts were lower in older individuals compared to younger individuals. Our findings are similar to those of humans and suggest that further insight on managing chimpanzees can be gained from extensive studies of ageing and obesity in humans. We suggest that managing BMI should be an integral part of health management in captive chimpanzee populations in order to partially reduce the risk of diseases associated with inflammation. These results also highlight parallels in inflammation risk between humans and chimpanzees and have implications for understanding the evolution of inflammation related diseases in apes.	[Obanda, Vincent] Kenya Wildlife Serv, Vet Serv Dept, Nairobi, Kenya; [Obanda, Vincent; Omondi, George Paul] Univ Nairobi, Fac Vet Med, Nairobi, Kenya; [Omondi, George Paul] Ol Pejeta Conservancy, Nanyuki, Kenya; [Chiyo, Patrick Ilukol] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Chiyo, Patrick Ilukol] Duke Univ, Dept Biol, Durham, NC USA	University of Nairobi; University of Notre Dame; Duke University	Chiyo, PI (corresponding author), Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.	pchiyo@gmail.com		Omondi, George/0000-0003-2041-4457	Arcus Foundation US [10OC-32]	Arcus Foundation US	Funding for the health examinations and laboratory analysis of blood samples was provided by the Arcus Foundation US grant number 10OC-32. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Rodriguez L, 2012, CELL IMMUNOL, V273, P124, DOI 10.1016/j.cellimm.2012.01.001; Amat JA, 2007, ECOL RES, V22, P282, DOI 10.1007/s11284-006-0022-z; Bauer SA, 2012, LAB ANIM-UK, V46, P193, DOI 10.1258/la.2012.011120; Bauer SA, 2011, COMPARATIVE MED, V61, P514; BERCOVITCH FB, 1992, HORM BEHAV, V26, P272, DOI 10.1016/0018-506X(92)90047-Y; Berkley KJ, 2006, AM J PHYSIOL-REG I, V291, pR241, DOI 10.1152/ajpregu.00287.2006; Biino G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054289; Bodkin NL, 2003, J GERONTOL A-BIOL, V58, P212; Broughton G, 2006, PLAST RECONSTR SURG, V117, p12S, DOI 10.1097/01.prs.0000225430.42531.c2; Bruunsgaard H, 2003, IMMUNOL ALLERGY CLIN, V23, P15, DOI 10.1016/S0889-8561(02)00056-5; Buyukkaya E, 2014, CLIN APPL THROMB-HEM, V20, P159, DOI 10.1177/1076029612459675; Cartier A, 2009, METABOLISM, V58, P1452, DOI 10.1016/j.metabol.2009.04.025; Casimir GJA, 2010, SHOCK, V34, P23, DOI 10.1097/SHK.0b013e3181ce2c3d; Casimir GJA, 2010, SHOCK, V33, P258, DOI 10.1097/SHK.0b013e3181b2b36b; Chakravarti A, 2009, LAB INVEST, V89, P1084, DOI 10.1038/labinvest.2009.74; Charles LE, 2007, OBESITY, V15, P2846, DOI 10.1038/oby.2007.338; Chung HY, 2009, AGEING RES REV, V8, P18, DOI 10.1016/j.arr.2008.07.002; Cohen S, 2012, P NATL ACAD SCI USA, V109, P5995, DOI 10.1073/pnas.1118355109; Colman RJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4557; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Danese A, 2012, PHYSIOL BEHAV, V106, P29, DOI 10.1016/j.physbeh.2011.08.019; Das UN, 2001, NUTRITION, V17, P953, DOI 10.1016/S0899-9007(01)00672-4; Davis AK, 2008, FUNCT ECOL, V22, P760, DOI 10.1111/j.1365-2435.2008.01467.x; Dayal S, 2013, CIRCULATION, V127, P1308, DOI 10.1161/CIRCULATIONAHA.112.000966; Dinarello CA, 2000, CHEST, V118, P503, DOI 10.1378/chest.118.2.503; Diodato MD, 2001, CYTOKINE, V14, P162, DOI 10.1006/cyto.2001.0861; Dixon JB, 2006, OBES SURG, V16, P251, DOI 10.1381/096089206776116453; Duarte D, 2013, ALLERGY, V68, P1073, DOI 10.1111/all.12190; El Kebir D, 2010, THESCIENTIFICWORLDJO, V10, P1731, DOI 10.1100/tsw.2010.169; Ely JJ, 2013, ZOO BIOL, V32, P79, DOI 10.1002/zoo.21044; Enoch S., 2005, SURGERY, V23, P37, DOI DOI 10.1016/J.MPSUR.2007.11.005; Farhangi MA, 2013, J HEALTH POPUL NUTR, V31, P58; Ferrucci L, 2005, BLOOD, V105, P2294, DOI 10.1182/blood-2004-07-2599; Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003; Gersh BJ, 2010, EUR HEART J, V31, P642, DOI 10.1093/eurheartj/ehq030; Gilbert-Diamond D, 2012, NUTR METAB CARDIOVAS, V22, P244, DOI 10.1016/j.numecd.2010.06.001; Go AS, 2014, CIRCULATION, V129, P399, DOI 10.1161/01.cir.0000442015.53336.12; Goodchild Sarah, 2008, IZN International Zoo News, V55, P353; Guthrie GJK, 2013, CRIT REV ONCOL HEMAT, V88, P218, DOI 10.1016/j.critrevonc.2013.03.010; Herndon JG, 2001, COMPARATIVE MED, V51, P60; Ho JE, 2005, J WOMENS HEALTH, V14, P117, DOI 10.1089/jwh.2005.14.117; Horstman LL, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-10; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Howell S, 2003, COMPARATIVE MED, V53, P413; Ihrig M, 2001, COMPARATIVE MED, V51, P30; Imtiaz Fauzia, 2012, Int Arch Med, V5, P2, DOI 10.1186/1755-7682-5-2; Jayachandran M, 2011, J CARDIOVASC TRANSL, V4, P811, DOI 10.1007/s12265-011-9296-9; Jousilahti P, 1999, CIRCULATION, V99, P1165, DOI 10.1161/01.cir.99.9.1165; Kastman EK, 2012, J NEUROSCI, V32, P11897, DOI 10.1523/JNEUROSCI.2553-12.2012; Kaya H, 2014, CLIN APPL THROMB-HEM, V20, P221, DOI 10.1177/1076029613499821; Kern PA, 2001, AM J PHYSIOL-ENDOC M, V280, pE745; Koenig W, 1999, CIRCULATION, V99, P237, DOI 10.1161/01.CIR.99.2.237; Kubota K, 1991, Nihon Ronen Igakkai Zasshi, V28, P509; Lammey ML, 2008, J AM ASSOC LAB ANIM, V47, P56; Lefevre N, 2012, SHOCK, V38, P37, DOI 10.1097/SHK.0b013e3182571e46; LERNER DJ, 1986, AM HEART J, V111, P383, DOI 10.1016/0002-8703(86)90155-9; Li W, 2013, AGEING RES REV, V12, P1005, DOI 10.1016/j.arr.2013.05.006; Licastro Federico, 2005, Immun Ageing, V2, P8; Liu ZJ, 2010, ENCY EYE, P99; Martin ASG, 2006, AM J CLIN NUTR, V83, p461S, DOI 10.1093/ajcn/83.2.461s; Michaud M, 2013, J AM MED DIR ASSOC, V14, P877, DOI 10.1016/j.jamda.2013.05.009; Milagro FI, 2006, OBESITY, V14, P1118, DOI 10.1038/oby.2006.128; Morrell CN, 2014, BLOOD, V123, P2759, DOI 10.1182/blood-2013-11-462432; Murakami T, 2007, THROMB RES, V119, P45, DOI 10.1016/j.thromres.2005.12.013; Nicoletti A, 1999, CARDIOVASC RES, V41, P532, DOI 10.1016/S0008-6363(98)00305-8; Nunamaker EA, 2012, COMPARATIVE MED, V62, P131; Nunez J, 2008, AM J CARDIOL, V101, P747, DOI 10.1016/j.amjcard.2007.11.004; Obanda V, 2012, AFR J ECOL, V50, P60, DOI 10.1111/j.1365-2028.2011.01294.x; Ogawa K, 2008, IMMUN AGEING, V5, P135; Okyay GU, 2013, RENAL FAILURE, V35, P29, DOI 10.3109/0886022X.2012.734429; Park CS, 2010, AM J CARDIOL, V105, P1284, DOI 10.1016/j.amjcard.2009.12.045; Pennell LM, 2012, J AUTOIMMUN, V38, pJ282, DOI 10.1016/j.jaut.2011.11.013; Robinson DP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002149; Sampson AP, 2000, CLIN EXP ALLERGY, V30, P22; Sarkar D, 2006, CANCER LETT, V236, P13, DOI 10.1016/j.canlet.2005.04.009; Schwitzer C, 2001, ZOO BIOL, V20, P261, DOI 10.1002/zoo.1026; Segal JB, 2006, ANN EPIDEMIOL, V16, P123, DOI 10.1016/j.annepidem.2005.06.052; Seiler BM, 2009, J MED PRIMATOL, V38, P51, DOI 10.1111/j.1600-0684.2008.00307.x; Shaw AC, 2013, NAT REV IMMUNOL, V13, P875, DOI 10.1038/nri3547; Shaw AC, 2011, AGEING RES REV, V10, P346, DOI 10.1016/j.arr.2010.10.007; Sherwood Edward R, 2004, Best Pract Res Clin Anaesthesiol, V18, P385, DOI 10.1016/j.bpa.2003.12.002; Shiga S, 1990, Rinsho Byori, V38, P93; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Stowe RP, 2010, J GERONTOL A-BIOL, V65, P429, DOI 10.1093/gerona/glp198; Thavanati PKR, 2008, J GERONTOL A-BIOL, V63, P360, DOI 10.1093/gerona/63.4.360; Ueba T, 2008, THROMB HAEMOSTASIS, V100, P280, DOI 10.1160/TH07-11-0668; Ueba T, 2010, THROMB RES, V125, pE329, DOI 10.1016/j.thromres.2010.03.004; Uzenbaeva L.B., 2013, ADV GERONTOL, V3, P61; Varol E, 2013, ANGIOLOGY; Vasto S, 2007, MECH AGEING DEV, V128, P83, DOI 10.1016/j.mad.2006.11.015; Videan EN, 2008, AM J PRIMATOL, V70, P327, DOI 10.1002/ajp.20494; Videan EN, 2007, ZOO BIOL, V26, P93, DOI 10.1002/zoo.20122; Visser M, 1999, JAMA-J AM MED ASSOC, V282, P2131, DOI 10.1001/jama.282.22.2131; Visser M, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.1.e13; Wang R, 2011, INT J SPORTS MED, V32, P982, DOI 10.1055/s-0031-1283185; Warnberg J, 2006, AM J CLIN NUTR, V84, P505; Watkins LR, 1995, PAIN, V63, P289, DOI 10.1016/0304-3959(95)00186-7; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Weiss EP, 2011, AM J PHYSIOL-HEART C, V301, pH1205, DOI 10.1152/ajpheart.00685.2011; Willette AA, 2012, DIABETES, V61, P1036, DOI 10.2337/db11-1187; Wisse BE, 2004, J AM SOC NEPHROL, V15, P2792, DOI 10.1097/01.ASN.0000141966.69934.21; Xu JZ, 2010, MECH AGEING DEV, V131, P487, DOI 10.1016/j.mad.2010.04.007; Yang Y, 2011, J GERONTOL A-BIOL, V66, P493, DOI 10.1093/gerona/glr003; Zahorec R, 2001, Bratisl Lek Listy, V102, P5; Zhang RX, 2010, HYPERTENSION, V55, P953, DOI 10.1161/HYPERTENSIONAHA.109.140608; Zihlman A, 2004, P NATL ACAD SCI USA, V101, P10541, DOI 10.1073/pnas.0402635101; Zihlman AL, 2007, J ZOOL, V273, P63, DOI 10.1111/j.1469-7998.2007.00301.x	107	19	19	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104602	10.1371/journal.pone.0104602	http://dx.doi.org/10.1371/journal.pone.0104602			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121995	Green Published, gold			2022-12-25	WOS:000341017000046
J	Regina, VR; Lokanathan, AR; Modrzynski, JJ; Sutherland, DS; Meyer, RL				Regina, Viduthalai R.; Lokanathan, Arcot R.; Modrzynski, Jakub J.; Sutherland, Duncan S.; Meyer, Rikke L.			Surface Physicochemistry and Ionic Strength Affects eDNA's Role in Bacterial Adhesion to Abiotic Surfaces	PLOS ONE			English	Article							BIOFILM FORMATION; EXTRACELLULAR DNA; SUSPENDED PARTICLES; ORGANIC-MATTER; STAPHYLOCOCCUS-XYLOSUS; SUBSTRATUM SURFACES; PLASMID DNA; IV PILI; FORCES; CHARGE	Extracellular DNA (eDNA) is an important structural component of biofilms formed by many bacteria, but few reports have focused on its role in initial cell adhesion. The aim of this study was to investigate the role of eDNA in bacterial adhesion to abiotic surfaces, and determine to which extent eDNA-mediated adhesion depends on the physicochemical properties of the surface and surrounding liquid. We investigated eDNA alteration of cell surface hydrophobicity and zeta potential, and subsequently quantified the effect of eDNA on the adhesion of Staphylococcus xylosus to glass surfaces functionalised with different chemistries resulting in variable hydrophobicity and charge. Cell adhesion experiments were carried out at three different ionic strengths. Removal of eDNA from S. xylosus cells by DNase treatment did not alter the zeta potential, but rendered the cells more hydrophilic. DNase treatment impaired adhesion of cells to glass surfaces, but the adhesive properties of S. xylosus were regained within 30 minutes if DNase was not continuously present, implying a continuous release of eDNA in the culture. Removal of eDNA lowered the adhesion of S. xylosus to all surfaces chemistries tested, but not at all ionic strengths. No effect was seen on glass surfaces and carboxyl-functionalised surfaces at high ionic strength, and a reverse effect occurred on amine-functionalised surfaces at low ionic strength. However, eDNA promoted adhesion of cells to hydrophobic surfaces irrespective of the ionic strength. The adhesive properties of eDNA in mediating initial adhesion of S. xylosus is thus highly versatile, but also dependent on the physicochemical properties of the surface and ionic strength of the surrounding medium.	[Regina, Viduthalai R.; Lokanathan, Arcot R.; Modrzynski, Jakub J.; Sutherland, Duncan S.; Meyer, Rikke L.] Interdisciplinary Nanosci Ctr iNANO, Aarhus C, Denmark; [Meyer, Rikke L.] Aarhus Univ, Dept Biosci, Aarhus C, Denmark; [Lokanathan, Arcot R.] Aalto Univ, Dept Forest Prod Technol, Aalto, Finland; [Modrzynski, Jakub J.] Univ Copenhagen, Dept Plant & Environm Sci, Frederiksberg C, Denmark	Aarhus University; Aarhus University; Aalto University; University of Copenhagen	Meyer, RL (corresponding author), Interdisciplinary Nanosci Ctr iNANO, Aarhus C, Denmark.	rikke.meyer@inano.au.dk	Meyer, Rikke Louise/AAB-5377-2021; Modrzynski, Jakub/C-5667-2015; Sutherland, Duncan S/E-4385-2010	Meyer, Rikke Louise/0000-0002-6485-5134; Modrzynski, Jakub/0000-0001-6297-5741; Sutherland, Duncan S/0000-0002-5045-9915	Danish Strategic Research Council [2106-07-0013]; Alfa Laval; Lundbeck Foundation; Carlsberg Foundation; Lundbeck Foundation [R44-2009-4427] Funding Source: researchfish	Danish Strategic Research Council(Danske Strategiske Forskningsrad (DSF)); Alfa Laval; Lundbeck Foundation(Lundbeckfonden); Carlsberg Foundation(Carlsberg Foundation); Lundbeck Foundation(Lundbeckfonden)	The authors gratefully acknowledge the Danish Strategic Research Council (Grant No. 2106-07-0013), Alfa Laval, the Lundbeck Foundation, and the Carlsberg Foundation for funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee I, 2011, ADV MATER, V23, P690, DOI 10.1002/adma.201001215; Barken KB, 2008, ENVIRON MICROBIOL, V10, P2331, DOI 10.1111/j.1462-2920.2008.01658.x; BECKETT R, 1990, COLLOID SURFACE, V44, P35, DOI 10.1016/0166-6622(90)80185-7; Boks NP, 2008, MICROBIOL-SGM, V154, P3122, DOI 10.1099/mic.0.2008/018622-0; Busscher HJ, 2008, APPL ENVIRON MICROB, V74, P2559, DOI 10.1128/AEM.02839-07; BUSSCHER HJ, 1984, APPL ENVIRON MICROB, V48, P980, DOI 10.1128/AEM.48.5.980-983.1984; Callow Maureen E., 2002, Biologist (London), V49, P10; Cebula TA, 2011, MICROBIAL FORENSICS, 2ND EDITION, P29, DOI 10.1016/B978-0-12-382006-8.00003-7; Chen Y, 2011, APPL ENVIRON MICROB, V77, P5065, DOI 10.1128/AEM.00502-11; Corbett JCW, 2012, COLLOID SURFACE A, V396, P169, DOI 10.1016/j.colsurfa.2011.12.065; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Das T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058299; Das T, 2011, LANGMUIR, V27, P10113, DOI 10.1021/la202013m; Das T, 2011, SOFT MATTER, V7, P2927, DOI 10.1039/c0sm01142h; Das T, 2010, APPL ENVIRON MICROB, V76, P3405, DOI 10.1128/AEM.03119-09; Fletcher M., 1991, BIOFOULING, V4, P129, DOI [10.1080/08927019109378203, DOI 10.1080/08927019109378203]; Fredheim EGA, 2009, J CLIN MICROBIOL, V47, P1172, DOI 10.1128/JCM.01891-08; Goodman SD, 2011, MUCOSAL IMMUNOL, V4, P625, DOI 10.1038/mi.2011.27; Granhall U, 2010, J IND MICROBIOL BIOT, V37, P1061, DOI 10.1007/s10295-010-0754-1; Harmsen M, 2010, APPL ENVIRON MICROB, V76, P2271, DOI 10.1128/AEM.02361-09; Heijstra BD, 2009, ANTON LEEUW INT J G, V95, P343, DOI 10.1007/s10482-009-9320-0; Hermansson M, 1999, COLLOID SURFACE B, V14, P105, DOI 10.1016/S0927-7765(99)00029-6; HUNTER KA, 1982, LIMNOL OCEANOGR, V27, P322, DOI 10.4319/lo.1982.27.2.0322; HUNTER KA, 1979, NATURE, V282, P823, DOI 10.1038/282823a0; Huub HMR, 1995, COLLOIDS SURFACES B, V4; Jurcisek JA, 2007, J BACTERIOL, V189, P3868, DOI 10.1128/JB.01935-06; Lappann M, 2010, MOL MICROBIOL, V75, P1355, DOI 10.1111/j.1365-2958.2010.07054.x; Lata S, 2011, J CORROSION SCI ENG, V14; Liu Y, 2009, BIOFOULING, V25, P241, DOI 10.1080/08927010802713414; Lyubchenko YL, 2011, MICRON, V42, P196, DOI 10.1016/j.micron.2010.08.011; Mackey-Lawrence NM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-61; Mann EE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005822; Marchand S, 2012, COMPR REV FOOD SCI F, V11, P133, DOI 10.1111/j.1541-4337.2011.00183.x; Marino M, 2011, J APPL MICROBIOL, V110, P550, DOI 10.1111/j.1365-2672.2010.04909.x; Moschetti G, 1997, SYST APPL MICROBIOL, V20, P432, DOI 10.1016/S0723-2020(97)80012-4; Nguyen TH, 2007, ENVIRON SCI TECHNOL, V41, P5370, DOI 10.1021/es070425m; Nur A, 2013, J APPL MICROBIOLOGY; Perreten V, 1998, SYST APPL MICROBIOL, V21, P113, DOI 10.1016/S0723-2020(98)80014-3; Qin ZQ, 2007, MICROBIOL-SGM, V153, P2083, DOI 10.1099/mic.0.2007/006031-0; Reid G, 1999, INT J ANTIMICROB AG, V11, P223, DOI 10.1016/S0924-8579(99)00020-5; Rice KC, 2007, P NATL ACAD SCI USA, V104, P8113, DOI 10.1073/pnas.0610226104; Roberts AP, 2010, EXPERT REV ANTI-INFE, V8, P1441, DOI [10.1586/eri.10.106, 10.1586/ERI.10.106]; Robinson H, 2000, NUCLEIC ACIDS RES, V28, P1760, DOI 10.1093/nar/28.8.1760; ROMANOWSKI G, 1991, APPL ENVIRON MICROB, V57, P1057, DOI 10.1128/AEM.57.4.1057-1061.1991; Seu KJ, 2007, BIOPHYS J, V92, P2445, DOI 10.1529/biophysj.106.099721; Sondergaard AK, 2002, INT J FOOD MICROBIOL, V75, P99, DOI 10.1016/S0168-1605(01)00729-2; Stoodley P, 2011, CURR ORTHOP PRACT, V22, P558, DOI 10.1097/BCO.0b013e318230efcf; Van Houdt R, 2010, J APPL MICROBIOL, V109, P1117, DOI 10.1111/j.1365-2672.2010.04756.x; VANLOOSDRECHT MCM, 1989, MICROBIAL ECOL, V17, P1, DOI 10.1007/BF02025589; VANLOOSDRECHT MCM, 1990, AQUAT SCI, V52, P103, DOI 10.1007/BF00878244; VANOSS CJ, 1995, COLLOID SURFACE B, V5, P91, DOI 10.1016/0927-7765(95)01217-7; VernozyRozand C, 1996, INT J FOOD MICROBIOL, V30, P271, DOI 10.1016/0168-1605(96)00952-X; Weiss L, 1972, PROGR SURFACE SCI, V1, P355; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Zita A, 1997, APPL ENVIRON MICROB, V63, P1168, DOI 10.1128/AEM.63.3.1168-1170.1997	55	20	22	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e105033	10.1371/journal.pone.0105033	http://dx.doi.org/10.1371/journal.pone.0105033			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122477	Green Published, gold, Green Submitted			2022-12-25	WOS:000341017000091
J	Mehnert, CS; Rampelt, H; Gebert, M; Oeljeklaus, S; Schrempp, SG; Kochbeck, L; Guiard, B; Warscheid, B; van der Laan, M				Mehnert, Carola S.; Rampelt, Heike; Gebert, Michael; Oeljeklaus, Silke; Schrempp, Sandra G.; Kochbeck, Lioba; Guiard, Bernard; Warscheid, Bettina; van der Laan, Martin			The Mitochondrial ADP/ATP Carrier Associates with the Inner Membrane Presequence Translocase in a Stoichiometric Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY-CHAIN; PROTEIN IMPORT; OXIDATIVE-PHOSPHORYLATION; SUPERCOMPLEX ORGANIZATION; YEAST MITOCHONDRIA; TIM23 MACHINERY; CONTACT SITES; ATP SYNTHASE; COMPLEX; MOTOR	The majority of mitochondrial proteins are synthesized with amino-terminal signal sequences. The presequence translocase of the inner membrane (TIM23 complex) mediates the import of these preproteins. The essential TIM23 core complex closely cooperates with partner protein complexes like the presequence translocase-associated import motor and the respiratory chain. The inner mitochondrial membrane also contains a large number of metabolite carriers, but their association with preprotein translocases has been controversial. We performed a comprehensive analysis of the TIM23 interactome based on stable isotope labeling with amino acids in cell culture. Subsequent biochemical studies on identified partner proteins showed that the mitochondrial ADP/ATP carrier associates with the membrane-embedded core of the TIM23 complex in a stoichiometric manner, revealing an unexpected connection of mitochondrial protein biogenesis to metabolite transport. Our data indicate that direct TIM23-AAC coupling may support preprotein import into mitochondria when respiratory activity is low.	[Mehnert, Carola S.; Rampelt, Heike; Gebert, Michael; Schrempp, Sandra G.; Kochbeck, Lioba; van der Laan, Martin] Univ Freiburg, ZBMZ, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany; [Mehnert, Carola S.; Gebert, Michael; Schrempp, Sandra G.] Univ Freiburg, Fak Biol, D-79104 Freiburg, Germany; [Oeljeklaus, Silke; Warscheid, Bettina] Univ Freiburg, Fak Biol, Inst Biol 2, D-79104 Freiburg, Germany; [Oeljeklaus, Silke; Warscheid, Bettina; van der Laan, Martin] Univ Freiburg, BIOSS Ctr Biol Signaling Studies, D-79104 Freiburg, Germany; [Guiard, Bernard] CNRS, Ctr Genet Mol, F-91190 Gif Sur Yvette, France	University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	van der Laan, M (corresponding author), Univ Freiburg, ZBMZ, Inst Biochem & Mol Biol, Stefan Meier Str 17, D-79104 Freiburg, Germany.	martin.van.der.laan@biochemie.uni-freiburg.de		van der Laan, Martin/0000-0003-0789-9912; Rampelt, Heike/0000-0002-5458-5652; Warscheid, Bettina/0000-0001-5096-1975	Deutsche Forschungsgemeinschaft [Sonderforschungsbereich 746]; Excellence Initiative of the German Federal and State Governments [EXC 294 BIOSS]; Peter and Traudl Engelhorn Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Initiative of the German Federal and State Governments; Peter and Traudl Engelhorn Foundation	This work was supported by the Deutsche Forschungsgemeinschaft, Sonderforschungsbereich 746; by the Excellence Initiative of the German Federal and State Governments (EXC 294 BIOSS); and by a postdoctoral fellowship of the Peter and Traudl Engelhorn Foundation (to H. R.).	Bohnert M, 2010, CURR BIOL, V20, P1227, DOI 10.1016/j.cub.2010.05.058; Castegna A, 2010, J BIOL CHEM, V285, P17359, DOI 10.1074/jbc.M109.097188; Chacinska A, 2003, EMBO J, V22, P5370, DOI 10.1093/emboj/cdg532; Chacinska A, 2005, CELL, V120, P817, DOI 10.1016/j.cell.2005.01.011; Chacinska A, 2010, MOL CELL BIOL, V30, P307, DOI 10.1128/MCB.00749-09; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Claypool SM, 2008, J CELL BIOL, V182, P937, DOI 10.1083/jcb.200801152; Dienhart MK, 2008, MOL BIOL CELL, V19, P3934, DOI 10.1091/mbc.E08-04-0402; Dolezal P, 2006, SCIENCE, V313, P314, DOI 10.1126/science.1127895; Dudek J, 2013, BBA-MOL CELL RES, V1833, P274, DOI 10.1016/j.bbamcr.2012.05.028; Endo T, 2009, BIOL CHEM, V390, P723, DOI 10.1515/BC.2009.087; Ferramosca A, 2013, BBA-MOL CELL RES, V1833, P494, DOI 10.1016/j.bbamcr.2012.11.014; Gebert M, 2012, J CELL BIOL, V197, P595, DOI 10.1083/jcb.201110047; Geissler A, 2002, CELL, V111, P507, DOI 10.1016/S0092-8674(02)01073-5; Gilkerson RW, 2003, FEBS LETT, V546, P355, DOI 10.1016/S0014-5793(03)00633-1; Giraud MF, 1997, EUR J BIOCHEM, V245, P813, DOI 10.1111/j.1432-1033.1997.00813.x; Gold VAM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5129; Habib SJ, 2007, METHOD CELL BIOL, V80, P761, DOI 10.1016/S0091-679X(06)80035-X; Hess DC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000407; Hutu DP, 2008, MOL BIOL CELL, V19, P2642, DOI 10.1091/mbc.E07-12-1226; Ieva R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3853; Klingenberg M, 2008, BBA-BIOMEMBRANES, V1778, P1978, DOI 10.1016/j.bbamem.2008.04.011; Krayl M, 2007, MOL CELL BIOL, V27, P411, DOI 10.1128/MCB.01391-06; Kunji ERS, 2010, BBA-BIOENERGETICS, V1797, P817, DOI 10.1016/j.bbabio.2010.03.023; Meisinger Chris, 2006, Methods Mol Biol, V313, P33; Mick DU, 2012, CELL, V151, P1528, DOI 10.1016/j.cell.2012.11.053; Mokranjac D, 2005, J BIOL CHEM, V280, P23437, DOI 10.1074/jbc.C500135200; Mokranjac D, 2010, BBA-BIOENERGETICS, V1797, P1045, DOI 10.1016/j.bbabio.2010.01.026; Nury H, 2006, ANNU REV BIOCHEM, V75, P713, DOI 10.1146/annurev.biochem.75.103004.142747; Ohlmeier S, 2004, J BIOL CHEM, V279, P3956, DOI 10.1074/jbc.M310160200; Palmieri L, 2000, BBA-BIOENERGETICS, V1459, P363, DOI 10.1016/S0005-2728(00)00173-0; PFANNER N, 1987, CELL, V49, P815, DOI 10.1016/0092-8674(87)90619-2; Pfanner N, 2014, J CELL BIOL, V204, P1083, DOI 10.1083/jcb.201401006; Rehling P, 2004, NAT REV MOL CELL BIO, V5, P519, DOI 10.1038/nrm1426; Reif S, 2005, J MOL BIOL, V354, P520, DOI 10.1016/j.jmb.2005.09.054; Saddar S, 2008, J BIOL CHEM, V283, P6677, DOI 10.1074/jbc.M708440200; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schmidt O, 2011, CELL, V144, P227, DOI 10.1016/j.cell.2010.12.015; Stoldt S, 2012, MOL BIOL CELL, V23, P2292, DOI 10.1091/mbc.E11-06-0538; STUART RA, 1994, EUR J BIOCHEM, V220, P9, DOI 10.1111/j.1432-1033.1994.tb18593.x; Stuart RA, 2009, METHOD ENZYMOL, V456, P191, DOI 10.1016/S0076-6879(08)04411-X; Stuart RA, 2008, J BIOENERG BIOMEMBR, V40, P411, DOI 10.1007/s10863-008-9168-4; Traba J, 2009, MITOCHONDRION, V9, P79, DOI 10.1016/j.mito.2009.01.001; van der Laan M, 2007, NAT CELL BIOL, V9, P1152, DOI 10.1038/ncb1635; van der Laan M, 2006, CURR BIOL, V16, P2271, DOI 10.1016/j.cub.2006.10.025; Vogtle FN, 2009, CELL, V139, P428, DOI 10.1016/j.cell.2009.07.045; Vogel F, 2006, J CELL BIOL, V175, P237, DOI 10.1083/jcb.200605138; Vukotic M, 2012, CELL METAB, V15, P336, DOI 10.1016/j.cmet.2012.01.016; WACHTER C, 1992, EMBO J, V11, P4787, DOI 10.1002/j.1460-2075.1992.tb05584.x; Wiedemann N, 2007, J CELL BIOL, V179, P1115, DOI 10.1083/jcb.200709087; Wittig I, 2009, BBA-BIOENERGETICS, V1787, P672, DOI 10.1016/j.bbabio.2008.12.016; Wurm CA, 2006, FEBS LETT, V580, P5628, DOI 10.1016/j.febslet.2006.09.012	52	23	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					27352	27362		10.1074/jbc.M114.556498	http://dx.doi.org/10.1074/jbc.M114.556498			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25124039	Green Published, hybrid			2022-12-25	WOS:000342853900055
J	Goetstouwers, T; Van Poucke, M; Coppieters, W; Nguyen, VU; Melkebeek, V; Coddens, A; Van Steendam, K; Deforce, D; Cox, E; Peelman, LJ				Goetstouwers, Tiphanie; Van Poucke, Mario; Coppieters, Wouter; Van Ut Nguyen; Melkebeek, Vesna; Coddens, Annelies; Van Steendam, Katleen; Deforce, Dieter; Cox, Eric; Peelman, Luc J.			Refined Candidate Region for F4ab/ac Enterotoxigenic Escherichia coli Susceptibility Situated Proximal to MUC13 in Pigs	PLOS ONE			English	Article							INTESTINAL RECEPTOR; PURIFIED F4; DIARRHEA; IDENTIFICATION; ASSOCIATION; ADHESION; LINKAGE; K88; POLYMORPHISMS; INHERITANCE	F4 enterotoxigenic Escherichia coli (F4 ETEC) are an important cause of diarrhea in neonatal and newly-weaned pigs. Based on the predicted differential O-glycosylation patterns of the 2 MUC13 variants (MUC13A and MUC13B) in F4ac ETEC susceptible and F4ac ETEC resistant pigs, the MUC13 gene was recently proposed as the causal gene for F4ac ETEC susceptibility. Because the absence of MUC13 on Western blot from brush border membrane vesicles of F4ab/acR(+) pigs and the absence of F4ac attachment to immunoprecipitated MUC13 could not support this hypothesis, a new GWAS study was performed using 52 non-adhesive and 68 strong adhesive pigs for F4ab/ac ETEC originating from 5 Belgian farms. A refined candidate region (chr13: 144,810,100-144,993,222) for F4ab/ac ETEC susceptibility was identified with MUC13 adjacent to the distal part of the region. This candidate region lacks annotated genes and contains a sequence gap based on the sequence of the porcine GenomeBuild 10.2. We hypothesize that a porcine orphan gene or trans-acting element present in the identified candidate region has an effect on the glycosylation of F4 binding proteins and therefore determines the F4ab/ac ETEC susceptibility in pigs.	[Goetstouwers, Tiphanie; Van Poucke, Mario; Peelman, Luc J.] Univ Ghent, Fac Vet Med, Lab Anim Genet, B-9000 Ghent, Belgium; [Coppieters, Wouter] Univ Liege B34, Unit Anim Genom, GIGA R, Liege, Sart Tilman, Belgium; [Coppieters, Wouter] Univ Liege B34, Fac Vet Med, Liege, Sart Tilman, Belgium; [Van Ut Nguyen; Melkebeek, Vesna; Coddens, Annelies; Cox, Eric] Univ Ghent, Fac Vet Med, Immunol Lab, Merelbeke, Belgium; [Van Steendam, Katleen; Deforce, Dieter] Univ Ghent, Fac Pharmaceut Sci, Lab Pharmaceut Biotechnol, B-9000 Ghent, Belgium	Ghent University; University of Liege; University of Liege; Ghent University; Ghent University	Peelman, LJ (corresponding author), Univ Ghent, Fac Vet Med, Lab Anim Genet, B-9000 Ghent, Belgium.	Luc.Peelman@UGent.be	Coppieters, Wouter/AAF-5030-2021; Deforce, Dieter LD/J-4725-2013	Coppieters, Wouter/0000-0001-8109-7825; Deforce, Dieter LD/0000-0002-0635-661X; Van Poucke, Mario/0000-0002-4316-8984; Nguyen, Ut/0000-0002-3354-6419; Cox, Eric/0000-0003-4281-2990	Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT Vlaanderen) [080524]	Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This research was funded by an agricultural research grant (IWT-LO project 080524) of the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT Vlaanderen). (http://www.iwt.be/). Authors: E. Cox, L. Peelman, D. Deforce, V.U. Nguyen, T. Goetstouwers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; BIJLSMA IGW, 1987, VET RES COMMUN, V11, P509, DOI 10.1007/BF00396368; Coddens A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023309; COX E, 1993, VET MICROBIOL, V34, P7, DOI 10.1016/0378-1135(93)90003-P; Dupuis MC, 2011, MAMM GENOME, V22, P613, DOI 10.1007/s00335-011-9337-3; EDFORSLILJA I, 1995, ANIM GENET, V26, P237, DOI 10.1111/j.1365-2052.1995.tb03250.x; ERICKSON AK, 1992, INFECT IMMUN, V60, P983, DOI 10.1128/IAI.60.3.983-988.1992; Fairbrother John M., 2005, Animal Health Research Reviews, V6, P17, DOI 10.1079/AHR2005105; Fang XD, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-16; GIBBONS RA, 1977, THEOR APPL GENET, V51, P65, DOI 10.1007/BF00299479; Grange PA, 1996, INFECT IMMUN, V64, P606, DOI 10.1128/IAI.64.2.606-610.1996; Grange PA, 1999, INFECT IMMUN, V67, P165, DOI 10.1128/IAI.67.1.165-172.1999; GUERIN G, 1993, ANIM GENET, V24, P393, DOI 10.1111/j.1365-2052.1993.tb00347.x; Jorgensen C.B., 2004, International application published under the patent cooperation treaty (PCT), Patent No. [PCT/DK2003/000807, 2003000807]; Jorgensen CB, 2003, CYTOGENET GENOME RES, V102, P157, DOI 10.1159/000075742; Jorgensen CB, 2004, Patent No. [WO2004/048606A2, 2004048606A2]; Li HJ, 2008, ASIAN AUSTRAL J ANIM, V21, P489, DOI 10.5713/ajas.2008.70464; Li Yuhua, 2007, Journal of Genetics and Genomics, V34, P591, DOI 10.1016/S1673-8527(07)60067-8; Liu Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036949, 10.1371/journal.pone.0032127, 10.1371/journal.pone.0040003, 10.1186/1746-1596-7-49]; Melkebeek V, 2012, MUCOSAL IMMUNOL, V5, P635, DOI 10.1038/mi.2012.37; Nguyen VU, 2013, VET IMMUNOL IMMUNOP, V152, P93, DOI 10.1016/j.vetimm.2012.09.015; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Python P, 2002, ANIM GENET, V33, P441, DOI 10.1046/j.1365-2052.2002.00915.x; Rampoldi A, 2013, APPROACH GENE CONTRO; Rampoldi A, 2011, MAMM GENOME, V22, P122, DOI 10.1007/s00335-010-9305-3; Rasschaert K, 2007, VET MICROBIOL, V123, P249, DOI 10.1016/j.vetmic.2007.02.017; Ren J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044573; Schroyen M, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-70; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; Van den Broeck W, 1999, VACCINE, V17, P2020, DOI 10.1016/S0264-410X(98)00406-X; Van den Broeck W, 1999, VET MICROBIOL, V68, P255, DOI 10.1016/S0378-1135(99)00076-0; Van Poucke M, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-13; Wang J, 2006, ASIAN AUSTRAL J ANIM, V19, P1342, DOI 10.5713/ajas.2006.1342; Wang Y, 2007, J ANIM BREED GENET, V124, P225, DOI 10.1111/j.1439-0388.2007.00664.x; Williams SJ, 2001, J BIOL CHEM, V276, P18327, DOI 10.1074/jbc.M008850200; Yan XM, 2009, J MED MICROBIOL, V58, P1112, DOI 10.1099/jmm.0.009803-0; Zhang B, 2008, ANIM GENET, V39, P258, DOI 10.1111/j.1365-2052.2008.01721.x; Zhang WP, 2007, VET MICROBIOL, V123, P145, DOI 10.1016/j.vetmic.2007.02.018; Zhang X, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002828	40	20	22	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105013	10.1371/journal.pone.0105013	http://dx.doi.org/10.1371/journal.pone.0105013			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137053	Green Published, Green Submitted, gold			2022-12-25	WOS:000340742100059
J	Li, Q; Liu, XM; Gibbs, RA; Boerwinkle, E; Polychronakos, C; Qu, HQ				Li, Quan; Liu, Xiaoming; Gibbs, Richard A.; Boerwinkle, Eric; Polychronakos, Constantin; Qu, Hui-Qi			Gene-Specific Function Prediction for Non-Synonymous Mutations in Monogenic Diabetes Genes	PLOS ONE			English	Article							GLUCOKINASE MUTATIONS; INSULIN-SECRETION; BETA-CELLS; DATABASE; DISEASE; GLUCOSE; IDENTIFICATION; SENSITIVITY; EXPRESSION; DIAGNOSIS	The rapid progress of genomic technologies has been providing new opportunities to address the need of maturity-onset diabetes of the young (MODY) molecular diagnosis. However, whether a new mutation causes MODY can be questionable. A number of in silico methods have been developed to predict functional effects of rare human mutations. The purpose of this study is to compare the performance of different bioinformatics methods in the functional prediction of nonsynonymous mutations in each MODY gene, and provides reference matrices to assist the molecular diagnosis of MODY. Our study showed that the prediction scores by different methods of the diabetes mutations were highly correlated, but were more complimentary than replacement to each other. The available in silico methods for the prediction of diabetes mutations had varied performances across different genes. Applying gene-specific thresholds defined by this study may be able to increase the performance of in silico prediction of disease-causing mutations.	[Li, Quan; Polychronakos, Constantin] McGill Univ, Montreal Childrens Hosp, Ctr Hlth, Endocrine Genet Lab, Montreal, PQ H3H 1P3, Canada; [Liu, Xiaoming; Boerwinkle, Eric; Qu, Hui-Qi] Univ Texas Houston, Sch Publ Hlth, Ctr Human Genet, Div Epidemiol Human Genet & Environm Sci, Houston, TX USA; [Gibbs, Richard A.; Boerwinkle, Eric] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Gibbs, Richard A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	McGill University; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Baylor College of Medicine; Baylor College of Medicine	Liu, XM (corresponding author), McGill Univ, Montreal Childrens Hosp, Ctr Hlth, Endocrine Genet Lab, Montreal, PQ H3H 1P3, Canada.	Xiaoming.Liu@uth.tmc.edu; huiqi.qu@uth.tmc.edu	Liu, Xiaoming/C-2743-2008; Qu, Hui-Qi/B-4719-2009; Li, Quan/B-3605-2009	Liu, Xiaoming/0000-0001-8285-5528; Qu, Hui-Qi/0000-0001-9317-4488; 	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273] Funding Source: NIH RePORTER; NHGRI NIH HHS [U54 HG003273] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; American Diabetes Association, 2007, Diabetes Care, V30 Suppl 1, pS4; Ashcroft FM, 1998, TRENDS NEUROSCI, V21, P288, DOI 10.1016/S0166-2236(98)01225-9; ASHCROFT FM, 1989, PROG BIOPHYS MOL BIO, V54, P87, DOI 10.1016/0079-6107(89)90013-8; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Borowiec M, 2009, P NATL ACAD SCI USA, V106, P14460, DOI 10.1073/pnas.0906474106; Capriotti E, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S3-S2; Chun S, 2009, GENOME RES, V19, P1553, DOI 10.1101/gr.092619.109; Colombo C, 2008, J CLIN INVEST, V118, P2148, DOI 10.1172/JCI33777; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; Dong C, COMP FUNCTIONA UNPUB; Edghill EL, 2010, REV ENDOCR METAB DIS, V11, P193, DOI 10.1007/s11154-010-9149-x; Ellard S, 2008, DIABETOLOGIA, V51, P546, DOI 10.1007/s00125-008-0942-y; Ellard S, 2000, DIABETOLOGIA, V43, P250, DOI 10.1007/s001250050038; Fajans SS, 2001, NEW ENGL J MED, V345, P971, DOI 10.1056/NEJMra002168; Feigerlova E, 2006, EUR J PEDIATR, V165, P446, DOI 10.1007/s00431-006-0106-3; Frayling TM, 2001, DIABETES, V50, pS94, DOI 10.2337/diabetes.50.2007.S94; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Garber M, 2009, BIOINFORMATICS, V25, pI54, DOI 10.1093/bioinformatics/btp190; Gonzalez-Perez A, 2011, AM J HUM GENET, V88, P440, DOI 10.1016/j.ajhg.2011.03.004; HANEDA M, 1983, P NATL ACAD SCI-BIOL, V80, P6366, DOI 10.1073/pnas.80.20.6366; Johansen MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068370; Liu XM, 2013, HUM MUTAT, V34, pE2393, DOI 10.1002/humu.22376; Liu XM, 2011, HUM MUTAT, V32, P894, DOI 10.1002/humu.21517; Malecki MT, 1999, NAT GENET, V23, P323, DOI 10.1038/15500; Martin D, 2008, DIABETES CARE, V31, P1321, DOI 10.2337/dc07-2017; MATSCHINSKY FM, 1990, DIABETES, V39, P647, DOI 10.2337/diabetes.39.6.647; Menzel R, 1998, DIABETIC MED, V15, P816, DOI 10.1002/(SICI)1096-9136(199810)15:10<816::AID-DIA714>3.0.CO;2-P; Miura A, 2006, J BIOL CHEM, V281, P5246, DOI 10.1074/jbc.M507496200; Morrison AC, 2013, NATURE, V201, P3; Neve B, 2005, P NATL ACAD SCI USA, V102, P4807, DOI 10.1073/pnas.0409177102; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Pearson ER, 2000, DIABETIC MED, V17, P543, DOI 10.1046/j.1464-5491.2000.00305.x; Plengvidhya N, 2007, J CLIN ENDOCR METAB, V92, P2821, DOI 10.1210/jc.2006-1927; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Qu HQ, 2012, AM SOC HUM GEN 2012; Qu HQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021041; Raeder H, 2006, NAT GENET, V38, P54, DOI 10.1038/ng1708; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Shepherd M, 2009, DIABETIC MED, V26, P437, DOI 10.1111/j.1464-5491.2009.02690.x; Shields BM, 2012, DIABETOLOGIA, V55, P1265, DOI 10.1007/s00125-011-2418-8; Shihab HA, 2013, BIOINFORMATICS, V29, P1504, DOI 10.1093/bioinformatics/btt182; Stenson PD, 2003, HUM MUTAT, V21, P577, DOI 10.1002/humu.10212; Stoy J, 2007, P NATL ACAD SCI USA, V104, P15040, DOI 10.1073/pnas.0707291104; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Thomas H, 2001, HUM MOL GENET, V10, P2089, DOI 10.1093/hmg/10.19.2089; Thusberg J, 2011, HUM MUTAT, V32, P358, DOI 10.1002/humu.21445; Thusberg J, 2009, HUM MUTAT, V30, P703, DOI 10.1002/humu.20938; Velho G, 2004, MATURITY ONSET DIABE; Wang L, 2004, ENDOCRINOLOGY, V145, P3941, DOI 10.1210/en.2004-0281; Wang LL, 2011, BASIC CLIN PHARMACOL, V108, P94, DOI 10.1111/j.1742-7843.2010.00627.x; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184	55	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e104452	10.1371/journal.pone.0104452	http://dx.doi.org/10.1371/journal.pone.0104452			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136813	gold, Green Submitted, Green Published			2022-12-25	WOS:000340742100036
J	Wang, L; Xiao, Y; Ping, YY; Li, J; Zhao, HY; Li, F; Hu, J; Zhang, HY; Deng, YL; Tian, JW; Li, X				Wang, Li; Xiao, Yun; Ping, Yanyan; Li, Jing; Zhao, Hongying; Li, Feng; Hu, Jing; Zhang, Hongyi; Deng, Yulan; Tian, Jiawei; Li, Xia			Integrating Multi-Omics for Uncovering the Architecture of Cross-Talking Pathways in Breast Cancer	PLOS ONE			English	Article							DNA METHYLATION; GROWTH-FACTOR; MOLECULAR-MECHANISMS; SIGNALING PATHWAYS; CELL-SURVIVAL; IV COLLAGEN; GENES; EXPRESSION; NETWORK; DISEASE	Cross-talk among abnormal pathways widely occurs in human cancer and generally leads to insensitivity to cancer treatment. Moreover, alterations in the abnormal pathways are not limited to single molecular level. Therefore, we proposed a strategy that integrates a large number of biological sources at multiple levels for systematic identification of cross-talk among risk pathways in cancer by random walk on protein interaction network. We applied the method to multi-Omics breast cancer data from The Cancer Genome Atlas (TCGA), including somatic mutation, DNA copy number, DNA methylation and gene expression profiles. We identified close cross-talk among many known cancer-related pathways with complex change patterns. Furthermore, we identified key genes (linkers) bridging these cross-talks and showed that these genes carried out consistent biological functions with the linked cross-talking pathways. Through identification of leader genes in each pathway, the architecture of cross-talking pathways was built. Notably, we observed that linkers cooperated with leaders to form the fundamentation of cross-talk of pathways which play core roles in deterioration of breast cancer. As an example, we observed that KRAS showed a direct connection to numerous cancer-related pathways, such as MAPK signaling pathway, suggesting that it may be a central communication hub. In summary, we offer an effective way to characterize complex cross-talk among disease pathways, which can be applied to other diseases and provide useful information for the treatment of cancer.	[Wang, Li; Xiao, Yun; Ping, Yanyan; Zhao, Hongying; Li, Feng; Hu, Jing; Zhang, Hongyi; Deng, Yulan; Li, Xia] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China; [Tian, Jiawei] Harbin Med Univ, Affiliated Hosp 2, Dept Ultrason Med, Harbin, Peoples R China; [Li, Jing] Heilongjiang Univ Chinese Med, Affiliated Hosp 1, Dept Ultrason Med, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University; Heilongjiang University of Chinese Medicine	Tian, JW (corresponding author), Harbin Med Univ, Affiliated Hosp 2, Dept Ultrason Med, Harbin, Peoples R China.	jwtian2004@yahoo.com.cn; lixia@hrbmu.edu.cn	Xiao, Yun/A-8359-2013; li, xia/HHZ-7468-2022; Hu, Jing/GPC-4486-2022; Hu, Jing/AAT-8707-2021	Hu, Jing/0000-0002-5996-4889; Hu, Jing/0000-0002-5996-4889; Deng, Yulan/0000-0003-0269-3931; Zhang, Hongyi/0000-0003-3408-2959; Ping, Yanyan/0000-0002-1810-1200	National High Technology Research and Development Program of China [863 Program] [2014AA021102]; National Program on Key Basic Research Project [973 Program] [2014CB910504]; National Natural Science Foundation of China [91129710, 61073136, 31200997, 61170154, 81070946]; National Science Foundation of Heilongjiang Province [C201207, H0906]; Key Laboratory of Cardiovascular Medicine Research (Harbin Medical University), Ministry of Education; Undergraduate Innovation Funds of Harbin Medical University [YJSCX2012-210HLJ]	National High Technology Research and Development Program of China [863 Program](National High Technology Research and Development Program of China); National Program on Key Basic Research Project [973 Program](National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation of Heilongjiang Province; Key Laboratory of Cardiovascular Medicine Research (Harbin Medical University), Ministry of Education; Undergraduate Innovation Funds of Harbin Medical University	This work was supported in part by the National High Technology Research and Development Program of China [863 Program, Grant Nos. 2014AA021102], the National Program on Key Basic Research Project [973 Program, Grant Nos. 2014CB910504], the National Natural Science Foundation of China [Grant Nos. 91129710, 61073136, 31200997, 61170154, and 81070946], the National Science Foundation of Heilongjiang Province (Grant Nos. C201207 and H0906), Key Laboratory of Cardiovascular Medicine Research (Harbin Medical University), Ministry of Education and the Undergraduate Innovation Funds of Harbin Medical University [Grant Nos. YJSCX2012-210HLJ]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anan K, 1996, SURGERY, V119, P333, DOI 10.1016/S0039-6060(96)80120-6; Ballif BA, 2001, CELL GROWTH DIFFER, V12, P397; Basuyaux JP, 1997, J BIOL CHEM, V272, P26188, DOI 10.1074/jbc.272.42.26188; Bazzoun D, 2013, PHARMACOL THERAPEUT, V138, P418, DOI 10.1016/j.pharmthera.2013.02.004; Bernards R, 2012, CELL, V151, P465, DOI 10.1016/j.cell.2012.10.014; Boulay PL, 2008, J BIOL CHEM, V283, P36425, DOI 10.1074/jbc.M803603200; Carr HS, 2013, MOL CELL BIOL, V33, P2773, DOI 10.1128/MCB.00175-13; Chang HH, 2011, IEEE ENG MED BIO, P6849, DOI 10.1109/IEMBS.2011.6091689; Chang ZL, 2010, INFLAMM RES, V59, P791, DOI 10.1007/s00011-010-0208-2; Chari R, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-67; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; De Carvalho DD, 2012, CANCER CELL, V21, P655, DOI 10.1016/j.ccr.2012.03.045; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Fousteri M, 2008, CELL RES, V18, P73, DOI 10.1038/cr.2008.6; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hanash S, 2004, NAT REV CANCER, V4, P638, DOI 10.1038/nrc1414; Hebestreit K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039148; Holm K, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2590; Karinen S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018636; Key TJ, 2010, LANCET ONCOL, V11, P530, DOI 10.1016/S1470-2045(10)70095-4; Kim D, 2012, J BIOMED INFORM, V45, P1191, DOI 10.1016/j.jbi.2012.07.008; Kim JH, 2013, INT J ONCOL, V42, P1257, DOI 10.3892/ijo.2013.1803; Kobayashi Y, 2011, GENOME RES, V21, P1017, DOI 10.1101/gr.119487.110; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Kranenburg O, 2005, BBA-REV CANCER, V1756, P81, DOI 10.1016/j.bbcan.2005.10.001; Lee M, 2004, ONCOGENE, V23, P865, DOI 10.1038/sj.onc.1207223; Li CQ, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt161; Li Y, 2008, BIOINFORMATICS, V24, P1442, DOI 10.1093/bioinformatics/btn200; Logue JS, 2012, GENE DEV, V26, P641, DOI 10.1101/gad.186965.112; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Mosca E, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-76; Muggerud AA, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2466; Muller FL, 2012, NATURE, V488, P337, DOI 10.1038/nature11331; Nakano S, 1999, LAB INVEST, V79, P281; Navlakha S, 2010, BIOINFORMATICS, V26, P1057, DOI 10.1093/bioinformatics/btq076; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Pitteri SJ, 2011, CANCER RES, V71, P5090, DOI 10.1158/0008-5472.CAN-11-0568; Saadatmand S, 2013, BRIT J SURG, V100, P252, DOI 10.1002/bjs.8980; Senchenko VN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015612; Setty M, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.37; Shah N, 2010, NAT REV CANCER, V10, P361, DOI 10.1038/nrc2826; Shenker N, 2012, BRIT J CANCER, V106, P248, DOI 10.1038/bjc.2011.550; Shishido SN, 2012, CLIN IMMUNOL, V144, P142, DOI 10.1016/j.clim.2012.06.002; Sun ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017490; Tang WL, 2013, EURASIP J BIOINFORM, DOI 10.1186/1687-4153-2013-2; Tanjore H, 2006, AM J PATHOL, V168, P715, DOI 10.2353/ajpath.2006.051321; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Wang XJ, 2011, BRIEF FUNCT GENOMICS, V10, P280, DOI 10.1093/bfgp/elr024; Weigel MT, 2013, ANN ONCOL, V24, P126, DOI 10.1093/annonc/mds240; Xiao Y, 2012, NUCLEIC ACIDS RES, V40, P7653, DOI 10.1093/nar/gks538; Xiao Y, 2011, GENOMICS, V98, P64, DOI 10.1016/j.ygeno.2011.04.001; Zhu JK, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/781235; Zografos G, 2013, PHARMACOGENOMICS, V14, P5, DOI [10.2217/pgs.12.189, 10.2217/PGS.12.189]	53	20	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e104282	10.1371/journal.pone.0104282	http://dx.doi.org/10.1371/journal.pone.0104282			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137136	Green Published, Green Submitted, gold			2022-12-25	WOS:000340742100024
J	Xu, F; Wang, XT; Feng, Y; Huang, W; Wang, W; Li, L; Fang, XD; Que, HY; Zhang, GF				Xu, Fei; Wang, Xiaotong; Feng, Yue; Huang, Wen; Wang, Wei; Li, Li; Fang, Xiaodong; Que, Huayong; Zhang, Guofan			Identification of Conserved and Novel MicroRNAs in the Pacific Oyster Crassostrea gigas by Deep Sequencing	PLOS ONE			English	Article							EVOLUTION; GENES; MIRNAS; METABOLISM; EXPRESSION; MIRBASE; STRESS	MicroRNAs (miRNAs) play important roles in regulatory processes in various organisms. To date many studies have been performed in the investigation of miRNAs of numerous bilaterians, but limited numbers of miRNAs have been identified in the few species belonging to the clade Lophotrochozoa. In the current study, deep sequencing was conducted to identify the miRNAs of Crassostrea gigas (Lophotrochozoa) at a genomic scale, using 21 libraries that included different developmental stages and adult organs. A total of 100 hairpin precursor loci were predicted to encode miRNAs. Of these, 19 precursors (pre-miRNA) were novel in the oyster. As many as 53 (53%) miRNAs were distributed in clusters and 49 (49%) precursors were intragenic, which suggests two important biogenetic sources of miRNAs. Different developmental stages were characterized with specific miRNA expression patterns that highlighted regulatory variation along a temporal axis. Conserved miRNAs were expressed universally throughout different stages and organs, whereas novel miRNAs tended to be more specific and may be related to the determination of the novel body plan. Furthermore, we developed an index named the miRNA profile age index (miRPAI) to integrate the evolutionary age and expression levels of miRNAs during a particular developmental stage. We found that the swimming stages were characterized by the youngest miRPAIs. Indeed, the large-scale expression of novel miRNAs indicated the importance of these stages during development, particularly from organogenetic and evolutionary perspectives. Some potentially important miRNAs were identified for further study through significant changes between expression patterns in different developmental events, such as metamorphosis. This study broadened the knowledge of miRNAs in animals and indicated the presence of sophisticated miRNA regulatory networks related to the biological processes in lophotrochozoans.	[Xu, Fei; Wang, Xiaotong; Huang, Wen; Wang, Wei; Li, Li; Que, Huayong; Zhang, Guofan] Chinese Acad Sci, Inst Oceanol, Natl & Local Joint Engn Lab Ecol Mariculture, Qingdao, Peoples R China; [Feng, Yue; Fang, Xiaodong] BGI Tech, Shenzhen, Peoples R China; [Huang, Wen] Grad Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Beijing Genomics Institute (BGI); Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, GF (corresponding author), Chinese Acad Sci, Inst Oceanol, Natl & Local Joint Engn Lab Ecol Mariculture, Qingdao, Peoples R China.	gzhang@qdio.ac.cn	huang, wen/GXW-0661-2022; Fang, Xiaodong/K-6743-2018; Xu, Fei/A-1736-2012	Fang, Xiaodong/0000-0001-7061-3337; Xu, Fei/0000-0002-0981-8429	National Basic Research Program of China (973 Program) [2010CB126401]; National High Technology Research and Development Program (863 program) [2012AA10A405]; National Natural Science Foundation of China [40730845]; Modern Agro-industry Technology Research System [CARS-48]; Taishan Scholar and Scholar Climbing Programs of Shandong; Natural Science Foundation of Shandong Province [ZR2010DQ024]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National High Technology Research and Development Program (863 program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Modern Agro-industry Technology Research System; Taishan Scholar and Scholar Climbing Programs of Shandong; Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	This work was funded by the National Basic Research Program of China (973 Program, 2010CB126401), National High Technology Research and Development Program (863 program, 2012AA10A405), National Natural Science Foundation of China (40730845), Modern Agro-industry Technology Research System (CARS-48), the Taishan Scholar and Scholar Climbing Programs of Shandong and Natural Science Foundation of Shandong Province under Grant ZR2010DQ024. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Behura SK, 2007, INSECT BIOCHEM MOLEC, V37, P3, DOI 10.1016/j.ibmb.2006.10.006; Berezikov E, 2006, NAT GENET, V38, pS2, DOI 10.1038/ng1794; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Brown Miguel, 2013, Frontiers in Genetics, V4, P145, DOI 10.3389/fgene.2013.00145; Campo-Paysaa F, 2011, EVOL DEV, V13, P15, DOI 10.1111/j.1525-142X.2010.00452.x; Chapman EJ, 2007, NAT REV GENET, V8, P884, DOI 10.1038/nrg2179; Chen C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031426; Chen X, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r78; Christodoulou F, 2010, NATURE, V463, P1084, DOI 10.1038/nature08744; Davalos A, 2011, P NATL ACAD SCI USA, V108, P9232, DOI 10.1073/pnas.1102281108; Domazet-Loso T, 2007, TRENDS GENET, V23, P533, DOI 10.1016/j.tig.2007.08.014; Domazet-Loso T, 2010, NATURE, V468, P815, DOI 10.1038/nature09632; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Genard B, 2012, GENE, V499, P70, DOI 10.1016/j.gene.2012.02.021; Gerin I, 2010, J BIOL CHEM, V285, P33652, DOI 10.1074/jbc.M110.152090; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hadfield MG, 2001, AM ZOOL, V41, P1123, DOI 10.1668/0003-1569(2001)041[1123:MCAMAC]2.0.CO;2; Hansen TB, 2011, RNA BIOL, V8, P378, DOI 10.4161/rna.8.3.14333; HE L, 2004, NAT REV GENET, V5, P522; Huan P, 2012, J PROTEOMICS, V75, P3855, DOI 10.1016/j.jprot.2012.04.051; Huang J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008206; Jiao Y, 2014, MAR BIOTECHNOL, V16, P54, DOI 10.1007/s10126-013-9528-x; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lund AH, 2010, CELL DEATH DIFFER, V17, P209, DOI 10.1038/cdd.2009.58; Marco A, 2012, RNA BIOL, V9, P242, DOI 10.4161/rna.19160; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Najafi-Shoushtari SH, 2010, SCIENCE, V328, P1566, DOI 10.1126/science.1189123; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Seitz H, 2009, CURR BIOL, V19, P870, DOI 10.1016/j.cub.2009.03.059; Slack J.M.W., 2012, ESSENTIAL DEV BIOL; Sokol NS, 2008, GENE DEV, V22, P1591, DOI 10.1101/gad.1671708; Tanzer A, 2004, J MOL BIOL, V339, P327, DOI 10.1016/j.jmb.2004.03.065; Tarver JE, 2013, MOL BIOL EVOL, V30, P2369, DOI 10.1093/molbev/mst133; Tarver JE, 2012, BIOESSAYS, V34, P857, DOI 10.1002/bies.201200055; Tsutsumi A, 2011, NAT STRUCT MOL BIOL, V18, P1153, DOI 10.1038/nsmb.2125; Voronezhskaya EE, 2003, J COMP NEUROL, V455, P299, DOI 10.1002/cne.10488; Wheeler BM, 2009, EVOL DEV, V11, P50, DOI 10.1111/j.1525-142X.2008.00302.x; Winter AD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-4; Xiao ZD, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks821; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413; Zhang LF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000716; Zhang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004677	48	25	27	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e104371	10.1371/journal.pone.0104371	http://dx.doi.org/10.1371/journal.pone.0104371			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137038	Green Published, Green Submitted, gold			2022-12-25	WOS:000340742100031
J	Loreto, RG; Elliot, SL; Freitas, MLR; Pereira, TM; Hughes, DP				Loreto, Raquel G.; Elliot, Simon L.; Freitas, Mayara L. R.; Pereira, Thairine M.; Hughes, David P.			Long-Term Disease Dynamics for a Specialized Parasite of Ant Societies: A Field Study	PLOS ONE			English	Article							PHORID PARASITOIDS; HYMENOPTERA; LIFE; NECROPHORESIS; EXPRESSION; ECOLOGY; FOOD	Many studies have investigated how social insects behave when a parasite is introduced into their colonies. These studies have been conducted in the laboratory, and we still have a limited understanding of the dynamics of ant-parasite interactions under natural conditions. Here we consider a specialized parasite of ant societies (Ophiocordyceps camponoti-rufipedis infecting Camponotus rufipes) within a rainforest. We first established that the parasite is unable to develop to transmission stage when introduced within the host nest. Secondly, we surveyed all colonies in the studied area and recorded 100% prevalence at the colony level (all colonies were infected). Finally, we conducted a long-term detailed census of parasite pressure, by mapping the position of infected dead ants and foraging trails (future hosts) in the immediate vicinity of the colonies over 20 months. We report new dead infected ants for all the months we conducted the census - at an average of 14.5 cadavers/month/colony. Based on the low infection rate, the absence of colony collapse or complete recovery of the colonies, we suggest that this parasite represents a chronic infection in the ant societies. We also proposed a "terminal host model of transmission'' that links the age-related polyethism to the persistence of a parasitic infection.	[Loreto, Raquel G.; Hughes, David P.] Penn State Univ, Ctr Infect Dis Dynam, Dept Entomol, University Pk, PA 16802 USA; [Loreto, Raquel G.; Elliot, Simon L.; Freitas, Mayara L. R.; Pereira, Thairine M.] Univ Fed Vicosa, Dept Entomol, Vicosa, MG, Brazil; [Hughes, David P.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Universidade Federal de Vicosa; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Loreto, RG (corresponding author), Penn State Univ, Ctr Infect Dis Dynam, Dept Entomol, University Pk, PA 16802 USA.	rzg148@psu.edu; dph14@psu.edu	Carvalho, Claudine/J-6347-2014; Mendes-Pereira, Thairine/GZA-5363-2022; Elliot, Simon Luke/A-5557-2013	Elliot, Simon Luke/0000-0002-7469-2949; Mendes Pereira, Thairine/0000-0002-3707-9790	CAPES-Brazil [6203/10-8]; CNPq-Brazil; Federal University of Vicosa; Pennsylvania State University	CAPES-Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq-Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Federal University of Vicosa; Pennsylvania State University	This work was supported by CAPES-Brazil (project # 6203/10-8), CNPq-Brazil, Federal University of Vicosa, and Pennsylvania State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036352; Andersen SB, 2009, AM NAT, V174, P424, DOI 10.1086/603640; Banik Sarmistha, 2010, Proceedings of the Zoological Society (Calcutta), V63, P87; Beattie AJ, 2003, PLANT ANIMAL INTERAC, P211; Bos N, 2012, J EVOLUTION BIOL, V25, P324; Bourke A. F., 1995, SOCIAL EVOLUTION ANT; Camazine S., 2001, SELF ORG BIOLOGICAL, DOI DOI 10.1515/9780691212920; Chapuisat M, 2007, P ROY SOC B-BIOL SCI, V274, P2013, DOI 10.1098/rspb.2007.0531; Choe DH, 2009, P NATL ACAD SCI USA, V106, P8251, DOI 10.1073/pnas.0901270106; Cremer S, 2007, CURR BIOL, V17, pR693, DOI 10.1016/j.cub.2007.06.008; Diez L, 2012, NATURWISSENSCHAFTEN, V99, P833, DOI 10.1007/s00114-012-0965-6; Diez L, 2011, ANIM BEHAV, V81, P1171, DOI 10.1016/j.anbehav.2011.02.026; Elizalde L, 2012, J INSECT SCI, V12, DOI 10.1673/031.012.13501; Elliot SL, 2010, ECOLOGY, V91, P65, DOI 10.1890/09-0424.1; Evans HC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017024; EVANS HC, 1982, T BRIT MYCOL SOC, V79, P431, DOI 10.1016/S0007-1536(82)80037-5; Folgarait PJ, 1999, ECOL ENTOMOL, V24, P163, DOI 10.1046/j.1365-2311.1999.00180.x; Gordon DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050472; Hamilton C, 2011, BIOL LETTERS, V7, P89, DOI 10.1098/rsbl.2010.0466; Heinze J, 2010, CURR BIOL, V20, P249, DOI 10.1016/j.cub.2009.12.031; Holldobler B., 1990, pi; Holldobler B, 2008, SUPERORGANISM BEAUTY; Hughes David P., 2011, BMC Ecology, V11, P13, DOI 10.1186/1472-6785-11-13; Hughes DP, 2008, TRENDS ECOL EVOL, V23, P672, DOI 10.1016/j.tree.2008.07.011; Hunt JH, 1983, SOCIAL INSECTS TROPI, P97; JAFFE K, 1984, INSECT SOC, V31, P302, DOI 10.1007/BF02223614; Jones JC, 2007, ADV INSECT PHYSIOL, V33, P153, DOI 10.1016/S0065-2806(06)33003-2; Josens RB, 2000, J INSECT PHYSIOL, V46, P1103, DOI 10.1016/S0022-1910(99)00220-6; Karesh WB, 2012, LANCET, V380, P1936, DOI 10.1016/S0140-6736(12)61678-X; Konrad M, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001300; Loreto RG, 2013, NATURWISSENSCHAFTEN, V100, P957, DOI 10.1007/s00114-013-1096-4; Marikovsky P. I., 1962, Insectes Sociaux Paris, V9, P173, DOI 10.1007/BF02224263; NONACS P, 1991, ECOL ENTOMOL, V16, P73, DOI 10.1111/j.1365-2311.1991.tb00194.x; Oliveira Júnior José Carlos de, 2005, Rev. Árvore, V29, P9, DOI 10.1590/S0100-67622005000100002; ORR MR, 1992, BEHAV ECOL SOCIOBIOL, V30, P395; Pontoppidan MB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004835; Reber A, 2011, J EVOLUTION BIOL, V24, P954, DOI 10.1111/j.1420-9101.2011.02230.x; Reber A, 2008, ECOL LETT, V11, P682, DOI 10.1111/j.1461-0248.2008.01177.x; Rosengaus RB, 1998, BEHAV ECOL SOCIOBIOL, V44, P125, DOI 10.1007/s002650050523; Sakakibara N, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003321; Schmid-Hempel P., 1998, Parasites in social insects.; SCHMIDHEMPEL P, 1984, INSECT SOC, V31, P345, DOI 10.1007/BF02223652; TRANIELLO JFA, 1987, INSECT SOC, V34, P118, DOI 10.1007/BF02223830; TRANIELLO JFA, 1991, BEHAV ECOL SOCIOBIOL, V29, P283, DOI 10.1007/BF00163986; Wilson E.O., 1971, INSECT SOC; WILSON EDWARD O., 1958, PSYCHE, V65, P108, DOI 10.1155/1958/69391; ZIMMERMANN G, 1993, PESTIC SCI, V37, P375, DOI 10.1002/ps.2780370410	47	34	34	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e103516	10.1371/journal.pone.0103516	http://dx.doi.org/10.1371/journal.pone.0103516			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133749	Green Published, gold, Green Submitted			2022-12-25	WOS:000341302700011
J	Tett, AJ; Karunakaran, R; Poole, PS				Tett, Adrian J.; Karunakaran, Ramakrishnan; Poole, Philip S.			Characterisation of SalRAB a Salicylic Acid Inducible Positively Regulated Efflux System of Rhizobium leguminosarum bv viciae 3841	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; ROOT-NODULES; RESISTANCE; NODULATION; PATHOGEN; VECTORS; PUMP; IDENTIFICATION; REQUIREMENT; SELECTION	Salicylic acid is an important signalling molecule in plant-microbe defence and symbiosis. We analysed the transcriptional responses of the nitrogen fixing plant symbiont, Rhizobium leguminosarum bv viciae 3841 to salicylic acid. Two MFS-type multicomponent efflux systems were induced in response to salicylic acid, rmrAB and the hitherto undescribed system salRAB. Based on sequence similarity salA and salB encode a membrane fusion and inner membrane protein respectively. salAB are positively regulated by the LysR regulator SalR. Disruption of salA significantly increased the sensitivity of the mutant to salicylic acid, while disruption of rmrA did not. A salA/rmrA double mutation did not have increased sensitivity relative to the salA mutant. Pea plants nodulated by salA or rmrA strains did not have altered nodule number or nitrogen fixation rates, consistent with weak expression of salA in the rhizosphere and in nodule bacteria. However, BLAST analysis revealed seventeen putative efflux systems in Rlv3841 and several of these were highly differentially expressed during rhizosphere colonisation, host infection and bacteroid differentiation. This suggests they have an integral role in symbiosis with host plants.	[Tett, Adrian J.; Karunakaran, Ramakrishnan] John Innes Ctr, Dept Mol Microbiol, Norwich, Norfolk, England; [Poole, Philip S.] Univ Oxford, Dept Plant Sci, Oxford, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Oxford	Poole, PS (corresponding author), Univ Oxford, Dept Plant Sci, S Parks Rd, Oxford, England.	philip.poole@plants.ox.ac.uk		Ramakrishnan, Karunakaran/0000-0002-6450-1299; Tett, Adrian/0000-0003-3141-3943	Biotechnology and Biological Sciences Research Council UK [BB/F004753/1]; BBSRC [BB/F004753/1, BBS/E/J/000C0642] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F004753/1, BBS/E/J/000C0642] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council UK grant no BB/F004753/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez ME, 2000, PLANT MOL BIOL, V44, P429, DOI 10.1023/A:1026561029533; BERINGER JE, 1974, J GEN MICROBIOL, V84, P188; BUCHANANWOLLASTON V, 1979, J GEN MICROBIOL, V112, P135, DOI 10.1099/00221287-112-1-135; Burse A, 2004, MOL PLANT MICROBE IN, V17, P43, DOI 10.1094/MPMI.2004.17.1.43; Chen ZX, 2009, PLANT SIGNAL BEHAV, V4, P493, DOI 10.4161/psb.4.6.8392; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Eda S, 2011, APPL ENVIRON MICROB, V77, P2855, DOI 10.1128/AEM.02858-10; FIGURSKI DH, 1979, J MOL BIOL, V133, P295, DOI 10.1016/0022-2836(79)90395-4; Gonzalez-Pasayo R, 2000, MOL PLANT MICROBE IN, V13, P572, DOI 10.1094/MPMI.2000.13.5.572; JOHNSTON AWB, 1975, J GEN MICROBIOL, V87, P343, DOI 10.1099/00221287-87-2-343; Karunakaran R, 2005, MICROBIOL-SGM, V151, P3249, DOI 10.1099/mic.0.28311-0; Karunakaran R, 2009, J BACTERIOL, V191, P4002, DOI 10.1128/JB.00165-09; Koronakis V, 2004, ANNU REV BIOCHEM, V73, P467, DOI 10.1146/annurev.biochem.73.011303.074104; Lindemann A, 2010, FEMS MICROBIOL LETT, V312, P184, DOI 10.1111/j.1574-6968.2010.02115.x; Mandal SM, 2010, PLANT SIGNAL BEHAV, V5, P359, DOI 10.4161/psb.5.4.10871; Minagawa S, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-70; Paulsen IT, 2003, CURR OPIN MICROBIOL, V6, P446, DOI 10.1016/j.mib.2003.08.005; POOLE PS, 1994, MICROBIOL-SGM, V140, P2787, DOI 10.1099/00221287-140-10-2787; POOLE PS, 1994, MICROBIOL-SGM, V140, P2797, DOI 10.1099/00221287-140-10-2797; Prell J, 2002, MICROBIOL-SGM, V148, P615, DOI 10.1099/00221287-148-2-615; PRENTKI P, 1984, GENE, V29, P303, DOI 10.1016/0378-1119(84)90059-3; QUANDT J, 1993, GENE, V127, P15, DOI 10.1016/0378-1119(93)90611-6; Ramachandran VK, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r106; Saier MH, 2001, SEMIN CELL DEV BIOL, V12, P205, DOI 10.1006/scdb.2000.0246; Sambrook J, 2001, MOL CLONING LAB MANU; Sato T, 2002, SOIL SCI PLANT NUTR, V48, P413, DOI 10.1080/00380768.2002.10409219; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Shulaev V, 1997, NATURE, V385, P718, DOI 10.1038/385718a0; Soto MJ, 2006, MICROBIOL-SGM, V152, P3167, DOI 10.1099/mic.0.29112-0; Stacey G, 2006, PLANT PHYSIOL, V141, P1473, DOI 10.1104/pp.106.080986; Stoitsova SO, 2008, APPL ENVIRON MICROB, V74, P3387, DOI 10.1128/AEM.02866-07; TRINICK MJ, 1976, NEW PHYTOL, V77, P359, DOI 10.1111/j.1469-8137.1976.tb01525.x; van Spronsen PC, 2003, MOL PLANT MICROBE IN, V16, P83, DOI 10.1094/MPMI.2003.16.1.83; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; Young JPW, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r34	35	6	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e103647	10.1371/journal.pone.0103647	http://dx.doi.org/10.1371/journal.pone.0103647			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133394	Green Published, gold, Green Submitted			2022-12-25	WOS:000341302700013
J	Xu, XL; Jaeger, ER; Wang, XX; Lagler-Ferrez, E; Batalov, S; Mathis, NL; Wiltshire, T; Walker, JR; Cooke, MP; Sauer, K; Huang, YH				Xu, Xiaolu; Jaeger, Emily R.; Wang, Xinxin; Lagler-Ferrez, Erica; Batalov, Serge; Mathis, Nancy L.; Wiltshire, Tim; Walker, John R.; Cooke, Michael P.; Sauer, Karsten; Huang, Yina H.			Mst1 Directs Myosin IIa Partitioning of Low and Higher Affinity Integrins during T Cell Migration	PLOS ONE			English	Article							LYMPHOCYTE MIGRATION; ADHESION; LFA-1; ACTIVATION; MOTILITY; POLARIZATION; PROLIFERATION; TRAFFICKING; CROSSTALK; POLARITY	Chemokines promote T cell migration by transmitting signals that induce T cell polarization and integrin activation and adhesion. Mst1 kinase is a key signal mediator required for both of these processes; however, its molecular mechanism remains unclear. Here, we present a mouse model in which Mst1 function is disrupted by a hypomorphic mutation. Microscopic analysis of Mst1-deficient CD4 T cells revealed a necessary role for Mst1 in controlling the localization and activity of Myosin IIa, a molecular motor that moves along actin filaments. Using affinity specific LFA-1 antibodies, we identified a requirement for Myosin IIa-dependent contraction in the precise spatial distribution of low and higher affinity LFA-1 on the membrane of migrating T cells. Mst1 deficiency or Myosin inhibition resulted in multipolar cells, difficulties in uropod detachment and mis-localization of low affinity LFA-1. Thus, Mst1 regulates Myosin IIa dynamics to organize high and low affinity LFA-1 to the anterior and posterior membrane during T cell migration.	[Xu, Xiaolu; Jaeger, Emily R.; Wang, Xinxin; Mathis, Nancy L.; Huang, Yina H.] Washington Univ, Dept Pathol & Immunol, St Louis, MO USA; [Lagler-Ferrez, Erica; Batalov, Serge; Walker, John R.; Cooke, Michael P.] Novartis Res Fdn, Genom Inst, San Diego, CA USA; [Wiltshire, Tim] Univ N Carolina, Eshelman Sch Pharm, Div Pharmacotherapy & Expt Therapeut, Chapel Hill, NC USA; [Sauer, Karsten] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Huang, Yina H.] Geisel Sch Med Dartmouth, Dept Pathol, Lebanon, NH USA; [Huang, Yina H.] Geisel Sch Med Dartmouth, Dept Microbiol Immunol, Lebanon, NH USA	Washington University (WUSTL); Novartis; University of North Carolina; University of North Carolina Chapel Hill; Scripps Research Institute; Dartmouth College; Dartmouth College	Sauer, K (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	ksauer@scripps.edu; yina.h.huang@dartmouth.edu	Wang, Xin/AAN-8435-2021	Wang, Xin/0000-0002-4457-7376; Huang, Yina/0000-0002-0125-9351; Batalov, Sergey/0000-0002-0925-0554	Leukemia and Lymphoma Society Scholar Award [1440-11]; NIH [AI070845, GM100785, AI089805]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070845, R01AI089805] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100785] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society Scholar Award(Leukemia and Lymphoma Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by The Leukemia and Lymphoma Society Scholar Award 1440-11 to K. S. and by NIH grants AI070845 and GM100785 to K.S. and AI089805 to Y.H.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahpour H, 2012, BLOOD, V119, P3450, DOI 10.1182/blood-2011-09-378158; Calderwood DA, 2013, NAT REV MOL CELL BIO, V14, P503, DOI 10.1038/nrm3624; Chen YL, 2009, CANCER RES, V69, P3713, DOI 10.1158/0008-5472.CAN-08-2515; Crequer A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044010; Dong YL, 2009, J IMMUNOL, V183, P3865, DOI 10.4049/jimmunol.0900678; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Dustin ML, 2008, IMMUNOL REV, V221, P77, DOI 10.1111/j.1600-065X.2008.00589.x; Even-Ram S, 2007, NAT CELL BIOL, V9, P299, DOI 10.1038/ncb1540; Giannone G, 2007, CELL, V128, P561, DOI 10.1016/j.cell.2006.12.039; Hogg N, 2011, NAT REV IMMUNOL, V11, P416, DOI 10.1038/nri2986; Hoyne GF, 2006, IMMUNOL REV, V210, P27, DOI 10.1111/j.0105-2896.2006.00363.x; Huang YH, 2006, ADV EXP MED BIOL, V584, P245; Huse M, 2013, IMMUNOL REV, V256, P95, DOI 10.1111/imr.12116; Jacobelli J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075151; Jacobelli J, 2010, NAT IMMUNOL, V11, P953, DOI 10.1038/ni.1936; Jacobelli J, 2009, J IMMUNOL, V182, P2041, DOI 10.4049/jimmunol.0803267; Katagiri K, 2006, NAT IMMUNOL, V7, P919, DOI 10.1038/ni1374; Katagiri K, 2009, EMBO J, V28, P1319, DOI 10.1038/emboj.2009.82; Kinashi T, 2005, NAT REV IMMUNOL, V5, P546, DOI 10.1038/nri1646; Kliche S, 2012, BLOOD, V119, P777, DOI 10.1182/blood-2011-06-362269; Ku CJ, 2012, CELL, V149, P1073, DOI 10.1016/j.cell.2012.03.044; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Lammermann T, 2009, CURR OPIN CELL BIOL, V21, P636, DOI 10.1016/j.ceb.2009.05.003; Liu X, 2013, P NATL ACAD SCI USA, V110, P11976, DOI 10.1073/pnas.1306180110; Manly KF, 2001, MAMM GENOME, V12, P930, DOI 10.1007/s00335-001-1016-3; Masopust D, 2013, NAT REV IMMUNOL, V13, P309, DOI 10.1038/nri3442; Morin NA, 2008, J EXP MED, V205, P195, DOI 10.1084/jem.20071543; Mou F, 2012, J EXP MED, V209, P741, DOI 10.1084/jem.20111692; Nehme NT, 2012, BLOOD, V119, P3458, DOI 10.1182/blood-2011-09-378364; Overstreet MG, 2013, NAT IMMUNOL, V14, P949, DOI 10.1038/ni.2682; Pletcher MT, 2004, PLOS BIOL, V2, P2159, DOI 10.1371/journal.pbio.0020393; Sanchez-Madrid F, 1999, EMBO J, V18, P501, DOI 10.1093/emboj/18.3.501; Smith A, 2005, J CELL BIOL, V170, P141, DOI 10.1083/jcb.200412032; Smith A, 2003, J CELL SCI, V116, P3123, DOI 10.1242/jcs.00606; Smith A, 2007, IMMUNOL REV, V218, P135, DOI 10.1111/j.1600-065X.2007.00537.x; Soriano SF, 2011, J IMMUNOL, V187, P2356, DOI 10.4049/jimmunol.1100935; Stanley P, 2008, EMBO J, V27, P62, DOI 10.1038/sj.emboj.7601959; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Ueda Y, 2012, PROC IUTAM, V5, P3, DOI 10.1016/j.piutam.2012.06.002; Vicente-Manzanares M, 2011, J CELL BIOL, V193, P381, DOI 10.1083/jcb.201012159; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; Wang Y, 2009, J BIOL CHEM, V284, P12645, DOI 10.1074/jbc.M807207200; Wiltshire T, 2003, P NATL ACAD SCI USA, V100, P3380, DOI 10.1073/pnas.0130101100; Woolf E, 2007, NAT IMMUNOL, V8, P1076, DOI 10.1038/ni1499; Yi J, 2012, MOL BIOL CELL, V23, P834, DOI 10.1091/mbc.E11-08-0731; Zhou DW, 2008, P NATL ACAD SCI USA, V105, P20321, DOI 10.1073/pnas.0810773105	48	15	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105561	10.1371/journal.pone.0105561	http://dx.doi.org/10.1371/journal.pone.0105561			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133611	Green Submitted, Green Published, gold			2022-12-25	WOS:000341302700121
J	Canal, D; Serrano, D; Potti, J				Canal, David; Serrano, David; Potti, Jaime			Exploring Heterozygosity-Survival Correlations in a Wild Songbird Population: Contrasting Effects between Juvenile and Adult Stages	PLOS ONE			English	Article							FLYCATCHERS FICEDULA-HYPOLEUCA; FITNESS CORRELATIONS; INBREEDING DEPRESSION; MULTILOCUS HETEROZYGOSITY; LINKAGE DISEQUILIBRIUM; PIED FLYCATCHER; MATE CHOICE; AGE; MICROSATELLITES; DISPERSAL	The relationship between genetic diversity and fitness, a major issue in evolutionary and conservation biology, is expected to be stronger in traits affected by many loci and those directly influencing fitness. Here we explore the influence of heterozygosity measured at 15 neutral markers on individual survival, one of the most important parameters determining individual fitness. We followed individual survival up to recruitment and during subsequent adult life of 863 fledgling pied flycatchers born in two consecutive breeding seasons. Mark-recapture analyses showed that individual heterozygosity did not influence juvenile or adult survival. In contrast, the genetic relatedness of parents was negatively associated with the offspring's survival during the adult life, but this effect was not apparent in the juvenile (from fledgling to recruitment) stage. Stochastic factors experienced during the first year of life in this long-distance migratory species may have swamped a relationship between heterozygosity and survival up to recruitment.	[Canal, David; Potti, Jaime] CSIC, Dept Evolutionary Ecol, Donana Biol Stn, E-41080 Seville, Spain; [Serrano, David] CSIC, Dept Conservat Biol, Donana Biol Stn, E-41080 Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Canal, D (corresponding author), CSIC, Dept Evolutionary Ecol, Donana Biol Stn, E-41080 Seville, Spain.	davidcanal@ebd.csic.es	Canal, David/E-4401-2013; Serrano, David/B-5352-2013; Potti, Jaime/H-3113-2019	Canal, David/0000-0003-2875-2987; Serrano, David/0000-0001-6205-386X; Potti, Jaime/0000-0002-2284-0022	Spanish Government [PAC05-006-2, CGL2009-10652, CGL2011-29694]; Ministry of Education and Science [I3P-BDP2005]	Spanish Government(Spanish GovernmentEuropean Commission); Ministry of Education and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by projects PAC05-006-2, CGL2009-10652 and CGL2011-29694 from the Spanish Government. DC was supported by a grant from the Ministry of Education and Science (I3P-BDP2005), and also thanks Paola Laiolo for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abercrombie LG, 2009, MOL ECOL RESOUR, V9, P1375, DOI 10.1111/j.1755-0998.2009.02746.x; Acevedo-Whitehouse K, 2006, MOL ECOL, V15, P1973, DOI 10.1111/j.1365-294X.2006.02903.x; Aparicio JM, 2006, MOL ECOL, V15, P4659, DOI 10.1111/j.1365-294X.2006.03111.x; Armbruster P, 2005, HEREDITY, V95, P235, DOI 10.1038/sj.hdy.6800721; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Balakrishnan CN, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-29; Balloux F, 2004, MOL ECOL, V13, P3021, DOI 10.1111/j.1365-294X.2004.02318.x; Brouwer L, 2007, MOL ECOL, V16, P3134, DOI 10.1111/j.1365-294X.2007.03370.x; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Camacho C, 2013, ECOL EVOL, V3, P4841, DOI 10.1002/ece3.563; Canal D, 2012, BEHAV ECOL SOCIOBIOL, V66, P67, DOI 10.1007/s00265-011-1253-8; Canal D, 2011, BEHAVIOUR, V148, P691, DOI 10.1163/000579511X573917; Chapman JR, 2011, J EVOLUTION BIOL, V24, P1715, DOI 10.1111/j.1420-9101.2011.02295.x; Chapman JR, 2009, MOL ECOL, V18, P2746, DOI 10.1111/j.1365-294X.2009.04247.x; Charlesworth B, 1996, P NATL ACAD SCI USA, V93, P6140, DOI 10.1073/pnas.93.12.6140; Charlesworth B, 1999, GENET RES, V74, P329, DOI 10.1017/S0016672399004152; CHARLESWORTH D, 1987, ANNU REV ECOL SYST, V18, P237, DOI 10.1146/annurev.ecolsys.18.1.237; Chernetsov Nikita, 2009, Avian Ecology and Behaviour, V16, P11; Choquet R, 2009, ECOGRAPHY, V32, P1071, DOI 10.1111/j.1600-0587.2009.05968.x; Cohas A, 2009, MOL ECOL, V18, P1491, DOI 10.1111/j.1365-294X.2009.04116.x; Coltman DW, 2003, EVOLUTION, V57, P971, DOI 10.1111/j.0014-3820.2003.tb00309.x; Coulson TN, 1998, P ROY SOC B-BIOL SCI, V265, P489, DOI 10.1098/rspb.1998.0321; Da Silva A, 2009, EVOLUTION, V63, P403, DOI 10.1111/j.1558-5646.2008.00542.x; David P, 1998, HEREDITY, V80, P531, DOI 10.1046/j.1365-2540.1998.00393.x; David P, 2007, MOL ECOL, V16, P2474, DOI 10.1111/j.1365-294X.2007.03330.x; Dawson E, 2002, NATURE, V418, P544, DOI 10.1038/nature00864; Eeva T, 2006, BIOL LETT-UK, V2, P298, DOI 10.1098/rsbl.2006.0443; Ellegren H, 1996, P ROY SOC B-BIOL SCI, V263, P1635, DOI 10.1098/rspb.1996.0239; Escobar JS, 2008, GENETICS, V180, P1593, DOI 10.1534/genetics.108.092718; Foerster K, 2003, NATURE, V425, P714, DOI 10.1038/nature01969; Forstmeier W, 2012, MOL ECOL, V21, P3237, DOI 10.1111/j.1365-294X.2012.05593.x; Gillingham MAF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081118; Grueber CE, 2010, CONSERV BIOL, V24, P1617, DOI 10.1111/j.1523-1739.2010.01549.x; Hansson B, 2001, P ROY SOC B-BIOL SCI, V268, P1287, DOI 10.1098/rspb.2001.1640; Hansson B, 2002, MOL ECOL, V11, P2467, DOI 10.1046/j.1365-294X.2002.01644.x; Harrison XA, 2011, MOL ECOL, V20, P4786, DOI 10.1111/j.1365-294X.2011.05283.x; Hedrick PW, 2000, ANNU REV ECOL SYST, V31, P139, DOI 10.1146/annurev.ecolsys.31.1.139; Houle D, 1996, GENETICS, V143, P1467; Huk T, 2006, P R SOC B, V273, P1681, DOI 10.1098/rspb.2006.3485; Jarne P, 1996, TRENDS ECOL EVOL, V11, P424, DOI 10.1016/0169-5347(96)10049-5; Jensen H, 2007, MOL ECOL, V16, P4066, DOI 10.1111/j.1365-294X.2007.03452.x; Kalbfleisch J.D., 2002, STAT ANAL FAILURE TI; Kalinowski ST, 2006, MOL ECOL NOTES, V6, P576, DOI 10.1111/j.1471-8286.2006.01256.x; Keller L, 2002, CONSERV BIOL, V17, P19, DOI DOI 10.1016/S0169-5347(02)02489-8; Kempenaers B, 2007, ADV STUD BEHAV, V37, P189, DOI 10.1016/S0065-3454(07)37005-8; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Leder EH, 2008, MOL ECOL RESOUR, V8, P874, DOI 10.1111/j.1755-0998.2008.02096.x; Lesbarreres D, 2005, MOL ECOL, V14, P311, DOI 10.1111/j.1365-294X.2004.02394.x; Lundberg A, 1992, PIED FLYCATCHER; Lynch M., 1998, GENETICS ANAL QUANTI; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Martin TE, 1995, J APPL STAT, V22, P863, DOI 10.1080/02664769524676; Miller JM, 2014, HEREDITY, V112, P240, DOI 10.1038/hdy.2013.99; MONTALVO S, 1992, ORNIS SCAND, V23, P491, DOI 10.2307/3676681; Olano-Marin J, 2011, EVOLUTION, V65, P3175, DOI 10.1111/j.1558-5646.2011.01369.x; Olano-Marin J, 2011, MOL ECOL, V20, P4028, DOI 10.1111/j.1365-294X.2011.05177.x; POTTI J, 1991, ORNIS SCAND, V22, P45, DOI 10.2307/3676620; POTTI J, 1991, ARDEA, V79, P419; Potti J, 2013, J EVOLUTION BIOL, V26, P1445, DOI 10.1111/jeb.12145; Price T, 1998, MATERNAL EFFECTS AS ADAPTATIONS, P202; Ralls K., 1986, P35; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Richardson DS, 2004, EVOLUTION, V58, P2037, DOI 10.1111/j.0014-3820.2004.tb00488.x; Rijks JM, 2008, HEREDITY, V100, P587, DOI 10.1038/hdy.2008.18; Ryder TB, 2010, BEHAV ECOL, V21, P203, DOI 10.1093/beheco/arp176; Sandercock BK, 2006, J WILDLIFE MANAGE, V70, P1504, DOI 10.2193/0022-541X(2006)70[1504:EODPFL]2.0.CO;2; Skalski J, 1993, TESTING SIGNIFICANCE, P9; Slate J, 2004, HEREDITY, V93, P255, DOI 10.1038/sj.hdy.6800485; Szulkin M, 2007, J EVOLUTION BIOL, V20, P1531, DOI 10.1111/j.1420-9101.2007.01325.x; Szulkin M, 2010, EVOLUTION, V64, P1202, DOI 10.1111/j.1558-5646.2010.00966.x; Taylor SS, 2010, MOL ECOL, V19, P4454, DOI 10.1111/j.1365-294X.2010.04824.x; Von Hardenberg A, 2007, MOL ECOL, V16, P1969, DOI 10.1111/j.1365-294X.2006.03221.x; Wetzel DP, 2012, MOL ECOL, V21, P406, DOI 10.1111/j.1365-294X.2011.05380.x; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Williams B. K., 2002, ANAL MANAGEMENT ANIM	76	12	12	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e105020	10.1371/journal.pone.0105020	http://dx.doi.org/10.1371/journal.pone.0105020			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122217	Green Published, gold			2022-12-25	WOS:000341017000090
J	Xia, XM; Yu, YX; Weidmann, M; Pan, YJ; Yan, SL; Wang, YJ				Xia, Xiaoming; Yu, Yongxin; Weidmann, Manfred; Pan, Yingjie; Yan, Shuling; Wang, Yongjie			Rapid Detection of Shrimp White Spot Syndrome Virus by Real Time, Isothermal Recombinase Polymerase Amplification Assay	PLOS ONE			English	Article							CRAB SCYLLA-SERRATA; ENVELOPE PROTEIN; MONOCLONAL-ANTIBODY; HISTORIC EMERGENCE; PENAEID SHRIMP; PCR ASSAY; WSSV; DNA; PATHOGENS; INFECTION	White spot syndrome virus (WSSV) causes large economic losses to the shrimp aquaculture industry, and thus far there are no efficient therapeutic treatments available against this lethal virus. In this study, we present the development of a novel real time isothermal recombinase polymerase amplification (RPA) assay for WSSV detection on a small ESEQuant Tube Scanner device. The RPA sensitivity, specificity and rapidity were evaluated by using a plasmid standard as well as viral and shrimp genomic DNAs. Compared with qPCR, the RPA assay revealed more satisfactory performance. It reached a detection limit up to 10 molecules in 95% of cases as determined by probit analysis of 8 independent experiments within 6.41 +/- 0.17 min at 39 degrees C. Consequently, this rapid RPA method has great application potential for field use or point of care diagnostics.	[Xia, Xiaoming; Yu, Yongxin; Pan, Yingjie; Yan, Shuling; Wang, Yongjie] Minist Agr, Lab Qual & Safety Risk Assessment Aquat Prod Stor, Shanghai, Peoples R China; [Xia, Xiaoming; Yu, Yongxin; Pan, Yingjie; Yan, Shuling; Wang, Yongjie] Shanghai Engn Res Ctr Aquat Prod Proc & Preservat, Shanghai, Peoples R China; [Xia, Xiaoming; Yu, Yongxin; Pan, Yingjie; Yan, Shuling; Wang, Yongjie] Shanghai Ocean Univ, Coll Food Sci & Technol, Shanghai, Peoples R China; [Weidmann, Manfred] Univ Stirling, Inst Aquaculture, Stirling FK9 4LA, Scotland; [Yan, Shuling] Univ Gottingen, Inst Biochem & Mol Cell Biol, D-37073 Gottingen, Germany	Ministry of Agriculture & Rural Affairs; Shanghai Ocean University; University of Stirling; University of Gottingen	Wang, YJ (corresponding author), Minist Agr, Lab Qual & Safety Risk Assessment Aquat Prod Stor, Shanghai, Peoples R China.	yjwang@shou.edu.cn	Weidmann, Manfred/G-1817-2015	Weidmann, Manfred/0000-0002-7063-7491; Wang, Yongjie/0000-0002-7209-585X	National Natural Science Foundation of China [41376135]; Doctoral Fund of Ministry of Education of China [20133104110006]; Innovation Program of Shanghai Municipal Education Commission, China [14ZZ144]; Construction Program of Shanghai Committee of Science and Technology, China [11DZ2280300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Fund of Ministry of Education of China(Ministry of Education, China); Innovation Program of Shanghai Municipal Education Commission, China(Innovation Program of Shanghai Municipal Education Commission); Construction Program of Shanghai Committee of Science and Technology, China	This work was supported by the National Natural Science Foundation of China (No. 41376135), Doctoral Fund of Ministry of Education of China (20133104110006), Innovation Program of Shanghai Municipal Education Commission (14ZZ144), China, and Construction Program of Shanghai Committee of Science and Technology (11DZ2280300), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez AM, 2004, ANNU REV PHYTOPATHOL, V42, P339, DOI 10.1146/annurev.phyto.42.040803.140329; Briese T, 2005, EMERG INFECT DIS, V11, P310, DOI 10.3201/eid1102.040492; Chaivisuthangkura Parin, 2004, ScienceAsia, V30, P359, DOI 10.2306/scienceasia1513-1874.2004.30.359; Chaivisuthangkura P, 2010, AQUACULTURE, V299, P15, DOI 10.1016/j.aquaculture.2009.12.005; Chen LL, 2000, DIS AQUAT ORGAN, V40, P157, DOI 10.3354/dao040157; Chou HY, 1995, DIS AQUAT ORGAN, V23, P165, DOI 10.3354/dao023165; Chou PH, 2011, J VIROL METHODS, V173, P67, DOI 10.1016/j.jviromet.2011.01.009; Euler M, 2013, J CLIN MICROBIOL, V51, P1110, DOI 10.1128/JCM.02704-12; Euler M, 2012, J CLIN VIROL, V54, P308, DOI 10.1016/j.jcv.2012.05.006; Euler M, 2012, J CLIN MICROBIOL, V50, P2234, DOI 10.1128/JCM.06504-11; Flegel TW, 2012, J INVERTEBR PATHOL, V110, P166, DOI 10.1016/j.jip.2012.03.004; Hou Chong-lin, 2011, Virologica Sinica, V26, P260, DOI 10.1007/s12250-011-3202-0; INOUYE K, 1994, FISH PATHOL, V29, P149, DOI 10.3147/jsfp.29.149; Jang IK, 2009, AQUACULTURE, V287, P40, DOI 10.1016/j.aquaculture.2008.10.038; Jaroenrama W, 2009, MOL CELL PROBE, V23, P65, DOI 10.1016/j.mcp.2008.12.003; Kiatpathomchai W, 2005, J VIROL METHODS, V130, P79, DOI 10.1016/j.jviromet.2005.06.006; King AM, 2012, 9 REPORT INT COMMITT, P770; Leu JH, 2009, CURR TOP MICROBIOL, V328, P197; Lightner DV, 2012, J INVERTEBR PATHOL, V110, P174, DOI 10.1016/j.jip.2012.03.006; Lo CF, 1996, DIS AQUAT ORGAN, V27, P215, DOI 10.3354/dao027215; Lutz S, 2010, LAB CHIP, V10, P887, DOI 10.1039/b921140c; Mekata T, 2009, LETT APPL MICROBIOL, V48, P25, DOI 10.1111/j.1472-765X.2008.02479.x; Mendoza-Cano F, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-186; Meng XH, 2010, AQUACULTURE, V310, P32, DOI 10.1016/j.aquaculture.2010.10.010; Mrotzek G, 2010, J VIROL METHODS, V168, P262, DOI 10.1016/j.jviromet.2010.05.010; Nadala ECB, 2000, J VIROL METHODS, V84, P175, DOI 10.1016/S0166-0934(99)00140-8; Natividad KDT, 2008, J VIROL METHODS, V149, P28, DOI 10.1016/j.jviromet.2008.01.013; Piepenburg O, 2006, PLOS BIOL, V4, P1115, DOI 10.1371/journal.pbio.0040204; Samanman S, 2011, J VIROL METHODS, V173, P75, DOI 10.1016/j.jviromet.2011.01.010; Sanchez-Paz A, 2010, VET RES, V41, DOI 10.1051/vetres/2010015; Seetang-Nun Y, 2013, MOL CELL PROBE, V27, P71, DOI 10.1016/j.mcp.2012.11.005; Shih Hsiu-Hui, 2004, Taiwania, V49, P159; Supamattaya K, 1998, DIS AQUAT ORGAN, V32, P79, DOI 10.3354/dao032079; Tsai YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045278; Tsai YL, 2012, J VIROL METHODS, V181, P134, DOI 10.1016/j.jviromet.2012.01.017; van Hulten MCW, 2000, VIROLOGY, V266, P227, DOI 10.1006/viro.1999.0088; Wonteerasupaya C, 1995, DIS AQUAT ORGAN, V21, P69; Yi GH, 2004, J BIOCHEM MOL BIOL, V37, P726; You ZO, 2002, DIS AQUAT ORGAN, V51, P77, DOI 10.3354/dao051077	39	58	77	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104667	10.1371/journal.pone.0104667	http://dx.doi.org/10.1371/journal.pone.0104667			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121957	Green Published, Green Submitted, gold			2022-12-25	WOS:000341017000053
J	Barton, KM; Archin, NM; Keedy, KS; Espeseth, AS; Zhang, YL; Gale, J; Wagner, FF; Holson, EB; Margolis, DM				Barton, Kirston M.; Archin, Nancie M.; Keedy, Kara S.; Espeseth, Amy S.; Zhang, Yan-ling; Gale, Jennifer; Wagner, Florence F.; Holson, Edward B.; Margolis, David M.			Selective HDAC Inhibition for the Disruption of Latent HIV-1 Infection	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CD4(+) T-CELLS; NF-KAPPA-B; HISTONE DEACETYLASE INHIBITORS; LONG TERMINAL REPEAT; EXPRESSION; RECRUITMENT; ESTABLISHMENT; THERAPY; IDENTIFICATION	Selective histone deacetylase (HDAC) inhibitors have emerged as a potential anti-latency therapy for persistent human immunodeficiency virus type 1 (HIV-1) infection. We utilized a combination of small molecule inhibitors and short hairpin (sh) RNA-mediated gene knockdown strategies to delineate the key HDAC(s) to be targeted for selective induction of latent HIV-1 expression. Individual depletion of HDAC3 significantly induced expression from the HIV-1 promoter in the 2D10 latency cell line model. However, depletion of HDAC1 or 22 alone or in combination did not significantly induce HIV-1 expression. Co-depletion of HDAC2 and 23 resulted in a significant increase in expression from the HIV-1 promoter. Furthermore, concurrent knockdown of HDAC1, 22, and 23 resulted in a significant increase in expression from the HIV-1 promoter. Using small molecule HDAC inhibitors of differing selectivity to ablate the residual HDAC activity that remained after (sh) RNA depletion, the effect of depletion of HDAC3 was further enhanced. Enzymatic inhibition of HDAC3 with the selective small-molecule inhibitor BRD3308 activated HIV-1 transcription in the 2D10 cell line. Furthermore, ex vivo exposure to BRD3308 induced outgrowth of HIV-1 from resting CD4+ T cells isolated from antiretroviral-treated, aviremic HIV+ patients. Taken together these findings suggest that HDAC3 is an essential target to disrupt HIV-1 latency, and inhibition of HDAC2 may also contribute to the effort to purge and eradicate latent HIV-1 infection.	[Barton, Kirston M.; Keedy, Kara S.; Margolis, David M.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27514 USA; [Archin, Nancie M.; Margolis, David M.] Univ N Carolina, Dept Med, Chapel Hill, NC USA; [Margolis, David M.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Espeseth, Amy S.] Merck Res Labs, Dept Antiviral Res, West Point, PA USA; [Zhang, Yan-ling; Gale, Jennifer; Wagner, Florence F.; Holson, Edward B.] Broad Inst Massachusetts Inst Technol & Harvard U, Stanley Ctr Psychiat Res, Cambridge, MA USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Merck & Company; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Margolis, DM (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27514 USA.	dmargo@med.unc.edu		Barton, Kirston/0000-0002-0410-4849	National Institutes of Health to the UNC TRaCS Institute [DA030156, RR024383]; National Institutes of Health to the UNC Center for AIDS Research; James B. Pendleton Charitable Trust; UNC Virology training grant [T32AI007419]; Stanley Medical Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410, T32AI007419] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA030156] Funding Source: NIH RePORTER	National Institutes of Health to the UNC TRaCS Institute; National Institutes of Health to the UNC Center for AIDS Research; James B. Pendleton Charitable Trust; UNC Virology training grant; Stanley Medical Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by the National Institutes of Health's Grants DA030156 to D. M. M., RR024383 to the UNC TRaCS Institute, AI50410 to the UNC Center for AIDS Research, and an equipment grant from the James B. Pendleton Charitable Trust. K. M. B. was supported by the UNC Virology training grant T32AI007419. BRD3308 compound design, synthesis, and characterization were funded by the Stanley Medical Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. Materials from both the Broad Institute and Merck Research Laboratories will be made available, subject to the standard terms of materials transfer agreements in force at each entity.	Archin N, 2012, NATURE; Archin NM, 2009, AIDS, V23, P1799, DOI 10.1097/QAD.0b013e32832ec1dc; Archin NM, 2009, AIDS RES HUM RETROV, V25, P207, DOI 10.1089/aid.2008.0191; Banerjee C, 2012, J LEUKOCYTE BIOL, V92, P1147, DOI 10.1189/jlb.0312165; Boehm D, 2013, CELL CYCLE, V12, P452, DOI 10.4161/cc.23309; Choudhary SK, 2008, J INFECT DIS, V197, P1162, DOI 10.1086/529525; Chun TW, 1998, P NATL ACAD SCI USA, V95, P8869, DOI 10.1073/pnas.95.15.8869; Coull JJ, 2000, J VIROL, V74, P6790, DOI 10.1128/JVI.74.15.6790-6799.2000; Duverger A, 2009, J VIROL, V83, P3078, DOI 10.1128/JVI.02058-08; Edelstein LC, 2009, AIDS RES HUM RETROV, V25, P883, DOI 10.1089/aid.2008.0294; Ferguson BS, 2013, P NATL ACAD SCI USA, V110, P9806, DOI 10.1073/pnas.1301509110; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; GANCHI PA, 1992, MOL BIOL CELL, V3, P1339, DOI 10.1091/mbc.3.12.1339; Garriga J, 1998, ONCOGENE, V17, P3093, DOI 10.1038/sj.onc.1202548; Gregoretti IV, 2004, J MOL BIOL, V338, P17, DOI 10.1016/j.jmb.2004.02.006; Guenther MG, 2001, MOL CELL BIOL, V21, P6091, DOI 10.1128/MCB.21.18.6091-6101.2001; Hanley TM, 2011, J VIROL, V85, P10834, DOI 10.1128/JVI.00789-11; Hayakawa T, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/129383; Huber K, 2011, J BIOL CHEM, V286, P22211, DOI 10.1074/jbc.M110.180224; Jiang GC, 2007, J VIROL, V81, P10914, DOI 10.1128/JVI.01208-07; Jordan A, 2003, EMBO J, V22, P1868, DOI 10.1093/emboj/cdg188; Katragadda M, 2006, J MED CHEM, V49, P4616, DOI 10.1021/jm0603419; Keedy KS, 2009, J VIROL, V83, P4749, DOI 10.1128/JVI.02585-08; Kutsch O, 2002, J VIROL, V76, P8776, DOI 10.1128/JVI.76.17.8776-8786.2002; Lassen K, 2004, TRENDS MOL MED, V10, P525, DOI 10.1016/j.molmed.2004.09.006; Lusic M, 2003, EMBO J, V22, P6550, DOI 10.1093/emboj/cdg631; Marban C, 2007, EMBO J, V26, P412, DOI 10.1038/sj.emboj.7601516; Okamura H, 2000, MOL CELL, V6, P539, DOI 10.1016/S1097-2765(00)00053-8; Pearson R, 2008, J VIROL, V82, P12291, DOI 10.1128/JVI.01383-08; Poleshko A, 2008, J VIROL, V82, P2313, DOI 10.1128/JVI.01882-07; Reuse S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006093; Savarino A, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-52; Spina CA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003834; Swiggard WJ, 2005, J VIROL, V79, P14179, DOI 10.1128/JVI.79.22.14179-14188.2005; Tyagi M, 2007, EMBO J, V26, P4985, DOI 10.1038/sj.emboj.7601928; *UNAIDS, 2008, 2008 REP GLOB AIDS E; Verhoeven D, 2008, J VIROL, V82, P4016, DOI 10.1128/JVI.02164-07; Williams SA, 2006, EMBO J, V25, P139, DOI 10.1038/sj.emboj.7600900; Williams SA, 2007, J VIROL, V81, P6043, DOI 10.1128/JVI.02074-06; Wood TE, 2010, MOL CANCER THER, V9, P246, DOI 10.1158/1535-7163.MCT-09-0495; Yang WM, 1997, J BIOL CHEM, V272, P28001, DOI 10.1074/jbc.272.44.28001; Ylisastigui L, 2004, AIDS, V18, P1101, DOI 10.1097/00002030-200405210-00003	43	51	55	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e102684	10.1371/journal.pone.0102684	http://dx.doi.org/10.1371/journal.pone.0102684			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136952	Green Submitted, Green Published, gold			2022-12-25	WOS:000340742100003
J	Lonati, PA; Brembilla, NC; Montanari, E; Fontao, L; Gabrielli, A; Vettori, S; Valentini, G; Laffitte, E; Kaya, G; Meroni, PL; Chizzolini, C				Lonati, Paola Adele; Brembilla, Nicolo Costantino; Montanari, Elisa; Fontao, Lionel; Gabrielli, Armando; Vettori, Serena; Valentini, Gabriele; Laffitte, Emmanuel; Kaya, Gurkan; Meroni, Pier-Luigi; Chizzolini, Carlo			High IL-17E and Low IL-17C Dermal Expression Identifies a Fibrosis-Specific Motif Common to Morphea and Systemic Sclerosis	PLOS ONE			English	Article							SCLERODERMA; CELLS; TH17; FIBROBLASTS; DISEASE; CYTOKINES; FAMILY; IL-25; TH2; INTERLEUKIN-17A	Background: High interleukin (IL)-17A levels are characteristically found in the skin of systemic sclerosis (SSc) individuals. Our aim was to investigate whether the dermal expression of IL-17A and related IL-17 family members (i.e. IL-17C, IL-17E and IL-17F) could distinguish fibrotic from healthy skin and could show similarities in SSc and morphea, two disorders with presumed distinct pathogenesis, but characterized by skin fibrosis. Methods: Biopsies were obtained from the involved skin of 14 SSc, 5 morphea and 8 healthy donors (HD) undergoing plastic surgery. Immunohistochemistry/immunofluorescence techniques were coupled to a semi-automated imaging quantification approach to determine the presence of the IL-17 family members in the skin. The in vitro effects induced by the IL-17 family members on fibroblasts from normal and SSc individuals were assessed by ELISA and RIA. Results: Positive cells for each of the IL-17 isoforms investigated were present in the dermis of all the individuals tested, though with variable frequencies. SSc individuals had increased frequency of IL-17A+ (p = 0.0237) and decreased frequency of IL-17F+ (p = 0.0127) and IL-17C+ cells (p = 0.0008) when compared to HD. Similarly, morphea individuals had less frequent IL-17C+ cells (p = 0.0186) in their skin but showed similar number of IL-17A+ and IL-17F+ cells when compared to HD. Finally, IL-17E+ cells were more numerous in morphea (p = 0.0109) and tended to be more frequent in SSc than in HD. Fibroblast production of IL-6, MMP-1 and MCP-1 was enhanced in a dose-dependent manner in the presence of IL-17E and IL-17F, but not in the presence of IL-17C. None of the cytokine tested had significant effect on type I collagen production. Of interest, in SSc the frequency of both IL-17A and IL-17F positive cells increased with disease duration. Conclusions: The frequency of IL-17A and IL-17F distinguish SSc to morphea individuals while dermal expression of IL-17C (low) and IL-17E (high) identifies a fibrosis-specific motif. The specific IL-17C/IL-17E cytokine combination may thus play a role in the development of fibrosis.	[Lonati, Paola Adele; Brembilla, Nicolo Costantino; Montanari, Elisa; Fontao, Lionel; Laffitte, Emmanuel; Kaya, Gurkan; Chizzolini, Carlo] Univ Hosp, Geneva, Switzerland; [Lonati, Paola Adele; Brembilla, Nicolo Costantino; Montanari, Elisa; Fontao, Lionel; Laffitte, Emmanuel; Kaya, Gurkan; Chizzolini, Carlo] Univ Geneva, Sch Med, CH-1211 Geneva, Switzerland; [Lonati, Paola Adele; Meroni, Pier-Luigi] IRCSS Ist Auxol Italiano, Expt Lab Immunol & Rheumatol Researches, Milan, Italy; [Gabrielli, Armando] Inst Clin Med, Ancona, Italy; [Vettori, Serena; Valentini, Gabriele] Univ Naples Federico II, Dept Clin & Expt Med, Naples, Italy; [Meroni, Pier-Luigi] Univ Milan, Div Rheumatol, Dept Clin Sci & Community Hlth, Milan, Italy	University of Geneva; University of Geneva; IRCCS Istituto Auxologico Italiano; University of Naples Federico II; University of Milan	Chizzolini, C (corresponding author), Univ Hosp, Geneva, Switzerland.	carlo.chizzolini@unige.ch	Gabrielli, Armando/AAC-3173-2019; Lonati, Paola Adele/AAA-6270-2020; Chizzolini, Carlo/V-4847-2019; Lionel, Fontao/AGN-3640-2022; meroni, pier luigi/K-8473-2016; Vettori, Serena/A-8641-2016	Lonati, Paola Adele/0000-0002-7987-9497; meroni, pier luigi/0000-0002-3394-1451; Vettori, Serena/0000-0001-5617-9829; Fontao, Lionel/0000-0002-5950-564X; VALENTINI, Gabriele/0000-0002-7852-9137	Swiss National Science Foundation [310030_140791]; Hans Wilsdorf foundation; Ricerca Corrente IRCCS Istituto Auxologico Italiano, Italy	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Hans Wilsdorf foundation; Ricerca Corrente IRCCS Istituto Auxologico Italiano, Italy	Work supported in part by grant 310030_140791 from the Swiss National Science Foundation and the Hans Wilsdorf foundation to CC. PL and PLM were supported by a grant from Ricerca Corrente IRCCS Istituto Auxologico Italiano, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2008, J RHEUMATOL, V35, P515; Aggarwal S, 2002, J LEUKOCYTE BIOL, V71, P1; Brembilla NC, 2013, EUR CYTOKINE NETW; Brembilla NC, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4334; Chang SH, 2011, IMMUNITY, V35, P611, DOI 10.1016/j.immuni.2011.09.010; Chizzolini C, 2003, ARTHRITIS RHEUM-US, V48, P2593, DOI 10.1002/art.11129; Chizzolini C, 2011, AUTOIMMUN REV, V10, P276, DOI 10.1016/j.autrev.2010.09.016; Chung L, 2006, CLIN DERMATOL, V24, P374, DOI 10.1016/j.clindermatol.2006.07.004; Cortez DM, 2007, AM J PHYSIOL-HEART C, V293, pH3356, DOI 10.1152/ajpheart.00928.2007; Dharamsi JW, 2013, JAMA DERMATOL, V149, P1159, DOI 10.1001/jamadermatol.2013.4207; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Fossiez F, 1996, J EXP MED, V183, P2593, DOI 10.1084/jem.183.6.2593; Gabrielli A, 2009, NEW ENGL J MED, V360, P1989, DOI 10.1056/NEJMra0806188; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Gasse P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023185; Gomez-Rodriguez J, 2009, IMMUNITY, V31, P587, DOI 10.1016/j.immuni.2009.07.009; Gregory LG, 2013, THORAX, V68, P82, DOI 10.1136/thoraxjnl-2012-202003; Hams E, 2014, P NATL ACAD SCI USA, V111, P367, DOI 10.1073/pnas.1315854111; Hayashi H, 2013, INFLAMMATION, V36, P830, DOI 10.1007/s10753-013-9609-z; Kurasawa K, 2000, ARTHRITIS RHEUM-US, V43, P2455, DOI 10.1002/1529-0131(200011)43:11<2455::AID-ANR12>3.0.CO;2-K; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; LEROY EC, 1988, J RHEUMATOL, V15, P202; Limpers A, 2014, EXPERT REV CLIN IMMU, V10, P231, DOI 10.1586/1744666X.2014.872561; Meier FMP, 2012, ANN RHEUM DIS, V71, P1355, DOI 10.1136/annrheumdis-2011-200742; Meloni F, 2009, CLIN EXP RHEUMATOL, V27, P765; Mi S, 2011, J IMMUNOL, V187, P3003, DOI 10.4049/jimmunol.1004081; Nakashima T, 2012, J IMMUNOL; Okamoto Y, 2012, ARTHRITIS RHEUM-US, V64, P3726, DOI 10.1002/art.34643; Pappu R, 2012, TRENDS IMMUNOL, V33, P343, DOI 10.1016/j.it.2012.02.008; Radstake TRDJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005903; Steen VD, 1996, SYSTEMIC SCLEROSIS, P51; Torres JE, 1998, AM J DERMATOPATH, V20, P242, DOI 10.1097/00000372-199806000-00003; Truchetet ME, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3486; Truchetet ME, 2013, ARTHRITIS RHEUM; Wilson M, 2010, J PETROL, V51, P1, DOI 10.1093/petrology/egp099; Wright JF, 2007, J BIOL CHEM, V282, P13447, DOI 10.1074/jbc.M700499200; Yaqub A, 2013, RHEUM DIS CLIN N AM, V39, P347, DOI 10.1016/j.rdc.2013.02.013; YOO ZB, 1995, J IMMUNOL, V155, P5483	38	33	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105008	10.1371/journal.pone.0105008	http://dx.doi.org/10.1371/journal.pone.0105008			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136988	gold, Green Published, Green Submitted			2022-12-25	WOS:000340742100058
J	Turrientes, MC; Gonzalez-Alba, JM; del Campo, R; Baquero, MR; Canton, R; Baquero, F; Galan, JC				Turrientes, Maria-Carmen; Gonzalez-Alba, Jose-Maria; del Campo, Rosa; Baquero, Maria-Rosario; Canton, Rafael; Baquero, Fernando; Carlos Galan, Juan			Recombination Blurs Phylogenetic Groups Routine Assignment in Escherichia coli: Setting the Record Straight	PLOS ONE			English	Article							COMMENSAL; PCR; IDENTIFICATION; POPULATIONS; DIVERSITY; EBURST	The characterization of population structures plays a main role for understanding outbreaks and the dynamics of bacterial spreading. In Escherichia coli, the widely used combination of multiplex-PCR scheme together with goeBURST has some limitations. The purpose of this study is to show that the combination of different phylogenetic approaches based on concatenated sequences of MLST genes results in a more precise assignment of E. coli phylogenetic groups, complete understanding of population structure and reconstruction of ancestral clones. A collection of 80 Escherichia coli strains of different origins was analyzed following the Clermont and Doumith's multiplex-PCR schemes. Doumith's multiplex-PCR showed only 1.7% of misassignment, whereas Clermont's-2000 protocol reached 14.0%, although the discrepancies reached 30% and 38.7% respectively when recombinant C, F and E phylogroups were considered. Therefore, correct phylogroup attribution is highly variable and depends on the clonal composition of the sample. As far as population structure of these E. coli strains, including 48 E. coli genomes from GenBank, goeBURST provides a quite dispersed population structure; whereas NeighborNet approach reveals a complex population structure. MLST-based eBURST can infer different founder genotypes, for instance ST23/ST88 could be detected as the founder genotypes for STC23; however, phylogenetic reconstructions might suggest ST410 as the ancestor clone and several evolutionary trajectories with different founders. To improve our routine understanding of E. coli molecular epidemiology, we propose a strategy based on three successive steps; first, to discriminate three main groups A/B1/C, D/F/E and B2 following Doumith's protocol; second, visualization of population structure based on MLST genes according to goeBURST, using NeighborNet to establish more complex relationships among STs; and third, to perform, a cost-free characterization of evolutionary trajectories in variants emerging along the clonal expansion using parsimony methods of phylogenetic analysis.	[Turrientes, Maria-Carmen; Gonzalez-Alba, Jose-Maria; del Campo, Rosa; Canton, Rafael; Baquero, Fernando; Carlos Galan, Juan] Hosp Univ Ramon y Cajal, Inst Ramon y Cajal Invest Sanitaria IRYCIS, Microbiol Serv, Madrid, Spain; [Turrientes, Maria-Carmen; Gonzalez-Alba, Jose-Maria; Baquero, Fernando; Carlos Galan, Juan] CIBER Epidemiol & Salud Publ, Madrid, Spain; [del Campo, Rosa; Canton, Rafael] Red Espanola Invest Enfermedades Infecciosas REIP, Madrid, Spain; [Baquero, Maria-Rosario] Univ Alfonso X El Sabio, Madrid, Spain	Hospital Universitario Ramon y Cajal; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Universidad Alfonso X el Sabio (UAX)	Baquero, F (corresponding author), Hosp Univ Ramon y Cajal, Inst Ramon y Cajal Invest Sanitaria IRYCIS, Microbiol Serv, Madrid, Spain.	baquero@bitmailer.net; juancarlos.galan@salud.madrid.org	CANTON, RAFAEL/ABF-6353-2020; del Campo, Rosa/M-9628-2013	Canton, Rafael/0000-0003-1675-3173; Baquero Artigao, Maria Rosario/0000-0001-8825-1696; del Campo, Rosa/0000-0003-1147-7923	European Union [EvoTAR-FP7-Health-2011-282004]; Regional Government of Madrid in Spain [PROMT-S2010/BMD2414]	European Union(European Commission); Regional Government of Madrid in Spain	MCT PhD is supported by the European Union (EvoTAR-FP7-Health-2011-282004) and JMGA is supported by a fellowship from the Regional Government of Madrid in Spain (PROMT-S2010/BMD2414). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baquero F, 2013, MBIO, V4, DOI 10.1128/mBio.00066-13; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; Clermont O, 2013, ENV MICROBIOL REP, V5, P58, DOI 10.1111/1758-2229.12019; Clermont O, 2011, ENVIRON MICROBIOL, V13, P2468, DOI 10.1111/j.1462-2920.2011.02519.x; Didelot X, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-256; Dobrindt U, 2004, NAT REV MICROBIOL, V2, P414, DOI 10.1038/nrmicro884; Doumith M, 2012, J CLIN MICROBIOL, V50, P3108, DOI 10.1128/JCM.01468-12; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Escobar-Paramo P, 2004, APPL ENVIRON MICROB, V70, P5698, DOI 10.1128/AEM.70.9.5698-5700.2004; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Francisco AP, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-152; Gonzalez-Gonzalez A, 2013, INFECT GENET EVOL, V13, P187, DOI 10.1016/j.meegid.2012.09.003; Gordon DM, 2008, ENVIRON MICROBIOL, V10, P2484, DOI 10.1111/j.1462-2920.2008.01669.x; Homeier T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010877; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jain R, 1999, P NATL ACAD SCI USA, V96, P3801, DOI 10.1073/pnas.96.7.3801; Jaureguy F, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-560; Lawrence JG, 2002, TRENDS MICROBIOL, V10, P1, DOI 10.1016/S0966-842X(01)02282-X; Lemaitre C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074423; Lescat M, 2013, ENV MICROBIOL REP, V5, P49, DOI 10.1111/j.1758-2229.2012.00374.x; Maiden MCJ, 2013, NAT REV MICROBIOL, V11, P728, DOI 10.1038/nrmicro3093; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Mau B, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r44; Mendonca N, 2011, J CLIN MICROBIOL, V49, P3105, DOI 10.1128/JCM.00585-11; Moissenet D, 2010, J CLIN MICROBIOL, V48, P2459, DOI 10.1128/JCM.00529-10; Molina-Lopez J, 2011, J INFECT DEV COUNTR, V5, P840, DOI 10.3855/jidc.1703; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; del Castillo BR, 2011, ENFERM INFEC MICR CL, V29, P785, DOI 10.1016/j.eimc.2011.07.004; Smati M, 2013, APPL ENVIRON MICROB, V79, P5005, DOI 10.1128/AEM.01423-13; Smet A, 2010, MICROB DRUG RESIST, V16, P129, DOI 10.1089/mdr.2009.0132; Tenaillon O, 2010, NAT REV MICROBIOL, V8, P207, DOI 10.1038/nrmicro2298; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Vos M, 2009, ISME J, V3, P199, DOI 10.1038/ismej.2008.93; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x	35	23	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105395	10.1371/journal.pone.0105395	http://dx.doi.org/10.1371/journal.pone.0105395			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137251	Green Published, gold, Green Submitted			2022-12-25	WOS:000340742100088
J	Dinakaran, V; Rathinavel, A; Pushpanathan, M; Sivakumar, R; Gunasekaran, P; Rajendhran, J				Dinakaran, Vasudevan; Rathinavel, Andiappan; Pushpanathan, Muthuirulan; Sivakumar, Ramamoorthy; Gunasekaran, Paramasamy; Rajendhran, Jeyaprakash			Elevated Levels of Circulating DNA in Cardiovascular Disease Patients: Metagenomic Profiling of Microbiome in the Circulation	PLOS ONE			English	Article							CELL-FREE DNA; CORONARY-HEART-DISEASE; RIBOSOMAL-RNA GENE; CAROTID ATHEROSCLEROSIS; PROGNOSTIC MARKER; SEQUENCE-ANALYSIS; BACTERIAL-DNA; HUMAN VIRUSES; HUMAN BLOOD; WEB SERVER	Cardiovascular diseases (CVDs) are the leading cause of death worldwide. An expanding body of evidence supports the role of human microbiome in the establishment of CVDs and, this has gained much attention recently. This work was aimed to study the circulating human microbiome in CVD patients and healthy subjects. The levels of circulating cell free DNA (circDNA) was higher in CVD patients (n = 80) than in healthy controls (n = 40). More specifically, the relative levels of circulating bacterial DNA and the ratio of 16S rRNA/beta-globin gene copy numbers were higher in the circulation of CVD patients than healthy individuals. In addition, we found a higher circulating microbial diversity in CVD patients (n = 3) in comparison to healthy individuals (n = 3) by deep shotgun sequencing. At the phylum level, we observed a dominance of Actinobacteria in CVD patients, followed by Proteobacteria, in contrast to that in healthy controls, where Proteobacteria was predominantly enriched, followed by Actinobacteria. The circulating virome in CVD patients was enriched with bacteriophages with a preponderance of Propionibacterium phages, followed by Pseudomonas phages and Rhizobium phages in contrast to that in healthy individuals, where a relatively greater abundance of eukaryotic viruses dominated by Lymphocystis virus (LCV) and Torque Teno viruses (TTV) was observed. Thus, the release of bacterial and viral DNA elements in the circulation could play a major role leading to elevated circDNA levels in CVD patients. The increased circDNA levels could be either the cause or consequence of CVD incidence, which needs to be explored further.	[Dinakaran, Vasudevan; Pushpanathan, Muthuirulan; Sivakumar, Ramamoorthy; Gunasekaran, Paramasamy; Rajendhran, Jeyaprakash] Madurai Kamaraj Univ, Ctr Excellence Genom Sci, Sch Biol Sci, Dept Genet, Madurai 625021, Tamil Nadu, India; [Rathinavel, Andiappan] Madurai Med Coll, Dept Cardiothorac Surg, Madurai, Tamil Nadu, India; [Rathinavel, Andiappan] Govt Rajaji Hosp, Madurai, Tamil Nadu, India	Madurai Kamaraj University; Madurai Medical College	Rajendhran, J (corresponding author), Madurai Kamaraj Univ, Ctr Excellence Genom Sci, Sch Biol Sci, Dept Genet, Madurai 625021, Tamil Nadu, India.	jrajendhran@gmail.com	Rajendhran, Jeyaprakash/ABD-3893-2020; Vasudevan, Dinakaran/AAE-1954-2020; Pushpanathan, Muthuirulan/K-7302-2019	Vasudevan, Dinakaran/0000-0003-0593-370X; Pushpanathan, Muthuirulan/0000-0001-6240-3073; Rajendhran, Jeyaprakash/0000-0002-1898-1607	Department of Biotechnology, New Delhi [/PR13253GBD/27/237/2009]	Department of Biotechnology, New Delhi(Department of Biotechnology (DBT) India)	The study was financially supported by the Department of Biotechnology, New Delhi (No./PR13253GBD/27/237/2009 & 11-12-2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SJ, 1996, NUCLEIC ACIDS RES, V24, P2623, DOI 10.1093/nar/24.13.2623; Amar J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054461; Angiuoli SV, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-356; Angly FE, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000593; Arahitiyawa NB, 2009, CLIN MICROBIOL REV, V22, P46, DOI [10.1128/CMR.00028-08, DOI 10.1128/CMR.00028-08]; Atamaniuk J, 2004, CLIN CHEM, V50, P1668, DOI 10.1373/clinchem.2004.034553; Bernardin F, 2010, TRANSFUSION, V50, P2474, DOI 10.1111/j.1537-2995.2010.02699.x; Chakravorty S, 2007, J MICROBIOL METH, V69, P330, DOI 10.1016/j.mimet.2007.02.005; Chevreux B., 2005, THESIS; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Cui M, 2013, CARDIOLOGY, V124, P76, DOI 10.1159/000345855; Destouni A, 2009, ACTA CARDIOL, V64, P51, DOI 10.2143/AC.64.1.2034362; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Foulongne V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038499; Frances R, 2007, CLIN EXP IMMUNOL, V150, P230, DOI 10.1111/j.1365-2249.2007.03494.x; Fryer JF, 2007, TRANSFUSION, V47, P1054, DOI 10.1111/j.1537-2995.2007.01235.x; Garg N, 2005, INT J CARDIOL, V98, P253, DOI 10.1016/j.ijcard.2003.10.043; Gorski A, 2006, FEMS IMMUNOL MED MIC, V46, P313, DOI 10.1111/j.1574-695X.2006.00044.x; Groesdonk HV, 2013, J THORAC CARDIOV SUR, V145, P1603, DOI 10.1016/j.jtcvs.2012.11.022; Handley SA, 2012, CELL, V151, P253, DOI 10.1016/j.cell.2012.09.024; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Holdenrieder S, 2005, CLIN CHEM, V51, P1544, DOI 10.1373/clinchem.2005.049320; Huang CH, 2012, RESUSCITATION, V83, P213, DOI 10.1016/j.resuscitation.2011.07.039; LEON SA, 1977, CANCER RES, V37, P646; Li SK, 2012, CLIN MICROBIOL INFEC, V18, P1126, DOI 10.1111/j.1469-0691.2011.03690.x; Lo YMD, 2000, CLIN CHEM, V46, P319; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; Lorusso R, 2014, ANN THORAC SURG, V97, P2219, DOI 10.1016/j.athoracsur.2014.01.029; Merlini E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018580; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Mizrahi-Man O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053608; Moriyama K, 2008, MICROBIOL IMMUNOL, V52, P375, DOI 10.1111/j.1348-0421.2008.00048.x; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Nerheim PL, 2004, AM J PATHOL, V164, P589, DOI 10.1016/S0002-9440(10)63148-3; Nikkari S, 2001, J CLIN MICROBIOL, V39, P1956, DOI 10.1128/JCM.39.5.1956-1959.2001; Ott SJ, 2006, CIRCULATION, V113, P929, DOI 10.1161/CIRCULATIONAHA.105.579979; Pedersen KK, 2014, J ACQ IMMUN DEF SYND, V64, P425, DOI [10.1097/QAI.0b013e31 829f919d, DOI 10.1097/QAI.0B013E31_829F919D]; Popgeorgiev N, 2013, J INFECT DIS, V208, P1042, DOI 10.1093/infdis/jit292; Pussinen PJ, 2005, ARTERIOSCL THROM VAS, V25, P833, DOI 10.1161/01.ATV.0000157982.69663.59; Quiros P, 2014, ANTIMICROB AGENTS CH, V58, P606, DOI 10.1128/AAC.01684-13; Rainer TH, 2003, CLIN CHEM, V49, P562, DOI 10.1373/49.4.562; Rainer TH, 2006, CLIN CHIM ACTA, V368, P110, DOI 10.1016/j.cca.2005.12.021; Rajendhran J, 2013, INT J CARDIOL, V168, P5118, DOI 10.1016/j.ijcard.2013.07.232; Renko J, 2013, EUR J DERMATOL, V23, P53, DOI 10.1684/ejd.2012.1908; Reyes A, 2012, NAT REV MICROBIOL, V10, P607, DOI 10.1038/nrmicro2853; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; Roux S, 2011, BIOINFORMATICS, V27, P3074, DOI 10.1093/bioinformatics/btr519; Saey TH, 2014, SCI NEWS, V185, P18, DOI [10.1002/scin.5591850115, DOI 10.1002/SCIN.5591850115]; Sandek A, 2007, J AM COLL CARDIOL, V50, P1561, DOI 10.1016/j.jacc.2007.07.016; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sekirov I, 2006, NAT MED, V12, P736, DOI 10.1038/nm0706-736; Shimony Avi, 2010, Acute Card Care, V12, P109, DOI 10.3109/17482941.2010.513732; Sparks AB, 2012, PRENATAL DIAG, V32, P3, DOI 10.1002/pd.2922; TAN EM, 1966, J CLIN INVEST, V45, P1732, DOI 10.1172/JCI105479; Tang P, 2010, FUTURE MICROBIOL, V5, P177, DOI [10.2217/fmb.09.120, 10.2217/FMB.09.120]; VANLEEUWEN PAM, 1994, GUT, V35, pS28, DOI 10.1136/gut.35.1_Suppl.S28; Veloso TR, 2011, INFECT IMMUN, V79, P2006, DOI 10.1128/IAI.01208-10; Wang ZN, 2014, EUR HEART J, V35, P904, DOI 10.1093/eurheartj/ehu002; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Wiedermann CJ, 1999, J AM COLL CARDIOL, V34, P1975, DOI 10.1016/S0735-1097(99)00448-9; Wommack KE, 2012, STAND GENOMIC SCI, V6, P421, DOI 10.4056/sigs.2945050; Wu ST, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-444	62	114	116	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105221	10.1371/journal.pone.0105221	http://dx.doi.org/10.1371/journal.pone.0105221			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133738	Green Published, Green Submitted, gold			2022-12-25	WOS:000341302700091
J	Jorgensen, BP; Hansen, JT; Krych, L; Larsen, C; Klein, AB; Nielsen, DS; Josefsen, K; Hansen, AK; Sorensen, DB				Jorgensen, Bettina Pyndt; Hansen, Julie Torpe; Krych, Lukasz; Larsen, Christian; Klein, Anders Bue; Nielsen, Dennis Sandris; Josefsen, Knud; Hansen, Axel Kornerup; Sorensen, Dorte Bratbo			A Possible Link between Food and Mood: Dietary Impact on Gut Microbiota and Behavior in BALB/c Mice	PLOS ONE			English	Article							INTESTINAL MICROBIOTA; NEUROTROPHIC FACTOR; HIGH-FAT; MAJOR DEPRESSION; ANIMAL-MODELS; BRAIN; MEMORY; ANXIETY	Major depressive disorder is a debilitating disease in the Western World. A western diet high in saturated fat and refined sugar seems to play an important part in disease development. Therefore, this study is aimed at investigating whether saturated fat or sucrose predisposes mice to develop behavioral symptoms which can be interpreted as depression-like, and the possible influence of the gut microbiota (GM) in this. Fourty-two mice were randomly assigned to one of three experimental diets, a high-fat, a high-sucrose or a control diet for thirteen weeks. Mice on high-fat diet gained more weight (p = 0.00009), displayed significantly less burrowing behavior than the control mice (p = 0.034), and showed decreased memory in the Morris water maze test compared to mice on high-sucrose diet (p = 0.031). Mice on high-sucrose diet burrowed less goal-oriented, showed greater latency to first bout of immobility in the forced swim test when compared to control mice (p = 0.039) and high-fat fed mice (p = 0.013), and displayed less anxiety than mice on high-fat diet in the triple test (p = 0.009). Behavioral changes were accompanied by a significant change in GM composition of mice fed a high-fat diet, while no difference between diet groups was observed for sucrose preferences, LPS, cholesterol, HbA1c, BDNF and the cytokines IL-1 alpha, IL-1 beta, IL-6, IL-10, IL-12(p70), IL-17 and TNF-alpha. A series of correlations was found between GM, behavior, BDNF and inflammatory mediators. In conclusion, the study shows that dietary fat and sucrose affect behavior, sometimes in opposite directions, and suggests a possible association between GM and behavior.	[Jorgensen, Bettina Pyndt; Hansen, Julie Torpe; Larsen, Christian; Hansen, Axel Kornerup; Sorensen, Dorte Bratbo] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Sect Expt Anim Models, Frederiksberg C, Denmark; [Klein, Anders Bue] Rigshosp, Neurobiol Res Unit, DK-2100 Copenhagen, Denmark; [Krych, Lukasz; Nielsen, Dennis Sandris] Univ Copenhagen, Fac Sci, Dept Food Sci, Frederiksberg C, Denmark; [Josefsen, Knud] Rigshosp, Bartholin Inst, DK-2100 Copenhagen, Denmark	University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen	Jorgensen, BP (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Sect Expt Anim Models, Frederiksberg C, Denmark.	bmp@sund.ku.dk	Nielsen, Dennis/A-9769-2015; Krych, Luaksz/F-4446-2015	Nielsen, Dennis/0000-0001-8121-1114; Krych, Luaksz/0000-0003-3224-1346; Sorensen, Dorte Bratbo/0000-0002-6144-1710; Klein, Anders Bue/0000-0002-0236-3089				Abildgaard A, 2010, INT J NEUROPSYCHOPH, V13, P142; Alesci S, 2005, BIOL PSYCHIAT, V57, p124S; Amar J, 2008, AM J CLIN NUTR, V87, P1219, DOI 10.1093/ajcn/87.5.1219; Anisman H, 2005, CURR PHARM DESIGN, V11, P963, DOI 10.2174/1381612053381701; Bendtsen KMB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046231; Bercik P, 2011, GASTROENTEROLOGY, V141, P599, DOI 10.1053/j.gastro.2011.04.052; Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108; Cani PD, 2009, CURR OPIN PHARMACOL, V9, P737, DOI 10.1016/j.coph.2009.06.016; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Collins SM, 2013, CURR OPIN MICROBIOL, V16, P240, DOI 10.1016/j.mib.2013.06.004; de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015; Deussing J.M., 2006, DRUG DISCO TODAY DIS, V3, P375, DOI [DOI 10.1016/J.DDM0D.2006.11.003, 10.1016/J.DDMOD.2006.11.003, DOI 10.1016/J.DDMOD.2006.11.003]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Fraser LM, 2010, PSYCHOPHARMACOLOGY, V211, P99, DOI 10.1007/s00213-010-1873-0; Frazer A, 2005, NEUROSCI BIOBEHAV R, V29, P515, DOI 10.1016/j.neubiorev.2005.03.006; Gaykema RPA, 2004, BRAIN BEHAV IMMUN, V18, P238, DOI 10.1016/j.bbi.2003.08.002; Granholm AC, 2008, J ALZHEIMERS DIS, V14, P133; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Hrncir T, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-65; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; Hufeldt MR, 2010, COMPARATIVE MED, V60, P336; Isingrini E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010404; Karege F, 2002, PSYCHIAT RES, V109, P143, DOI 10.1016/S0165-1781(02)00005-7; Kesslak JP, 1998, BEHAV NEUROSCI, V112, P1012, DOI 10.1037/0735-7044.112.4.1012; Lauritsen LFS, 2010, SCAND J LAB ANIM SCI, V37, P43; Lee BH, 2010, PSYCHIAT INVEST, V7, P231, DOI 10.4306/pi.2010.7.4.231; Li W, 2009, PHYSIOL BEHAV, V96, P557, DOI 10.1016/j.physbeh.2008.12.004; Lopresti AL, 2013, J AFFECT DISORDERS, V148, P12, DOI 10.1016/j.jad.2013.01.014; Maniam J, 2010, BEHAV BRAIN RES, V208, P72, DOI 10.1016/j.bbr.2009.11.005; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Molteni R, 2002, NEUROSCIENCE, V112, P803, DOI 10.1016/S0306-4522(02)00123-9; Ohland CL, 2013, PSYCHONEUROENDOCRINO, V38, P1738, DOI 10.1016/j.psyneuen.2013.02.008; Pistell PJ, 2010, J NEUROIMMUNOL, V219, P25, DOI 10.1016/j.jneuroim.2009.11.010; Rune I, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/319321; Salaj R, 2013, SCI WORLD J, DOI 10.1155/2013/135142; Schreurs BG, 2010, NEUROSCI BIOBEHAV R, V34, P1366, DOI 10.1016/j.neubiorev.2010.04.010; Sudo N, 2004, J PHYSIOL-LONDON, V558, P263, DOI 10.1113/jphysiol.2004.063388; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; van den Bogert B, 2013, THESIS, P1; van den Bogert B, 2013, FEMS MICROBIOL ECOL, V85, P376, DOI 10.1111/1574-6941.12127; WEST AP, 1990, PROG NEURO-PSYCHOPH, V14, P863, DOI 10.1016/0278-5846(90)90073-P; Wong ML, 2001, NAT REV NEUROSCI, V2, P343, DOI 10.1038/35072566; Zoetendal EG, 2012, ISME J, V6, P1415, DOI 10.1038/ismej.2011.212	43	98	100	2	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e103398	10.1371/journal.pone.0103398	http://dx.doi.org/10.1371/journal.pone.0103398			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133574	gold, Green Submitted, Green Published			2022-12-25	WOS:000341302700008
J	Loizidou, MA; Neophytou, I; Papamichael, D; Kountourakis, P; Vassiliou, V; Marcou, Y; Kakouri, E; Ioannidis, G; Philippou, C; Spanou, E; Tanteles, GA; Anastasiadou, V; Hadjisavvas, A; Kyriacou, K				Loizidou, Maria A.; Neophytou, Ioanna; Papamichael, Demetris; Kountourakis, Panteleimon; Vassiliou, Vassilios; Marcou, Yiola; Kakouri, Eleni; Ioannidis, Georgios; Philippou, Chrystalla; Spanou, Elena; Tanteles, George A.; Anastasiadou, Violetta; Hadjisavvas, Andreas; Kyriacou, Kyriacos			The Mutational Spectrum of Lynch Syndrome in Cyprus	PLOS ONE			English	Article							NONPOLYPOSIS COLORECTAL-CANCER; FOUNDER MUTATION; HEREDITARY; FAMILIES; RISK; MSH2; HNPCC; GENE; MLH1; PREDISPOSITION	Lynch syndrome is the most common form of hereditary colorectal cancer and is caused by germline mutations in the mismatch repair (MMR) genes MLH1, MSH2, MSH6 and PMS2. Mutation carriers have an increased lifetime risk of developing colorectal cancer as well as other extracolonic tumours. The aim of the current study was to evaluate the frequency and distribution of mutations in the MLH1, MSH2 and MSH6 genes within a cohort of Cypriot families that fulfilled the revised Bethesda guidelines. The study cohort included 77 patients who fulfilled at least one of the revised Bethesda guidelines. Mutational analysis revealed the presence of 4 pathogenic mutations, 3 in the MLH1 gene and 1 in the MSH2 gene, in 5 unrelated individuals. It is noted that out of the 4 pathogenic mutations detected, one is novel (c.1610delG in exon 14 of the MLH1) and has been detected for the first time in the Cypriot population. Overall, the pathogenic mutation detection rate in our patient cohort was 7%. This percentage is relatively low but could be explained by the fact that the sole criterion for genetic screening was compliance to the revised Bethesda guidelines. Larger numbers of Lynch syndrome families and screening of the two additional predisposition genes, PMS2 and EPCAM, are needed in order to decipher the full spectrum of mutations associated with Lynch syndrome predisposition in Cyprus.	[Loizidou, Maria A.; Neophytou, Ioanna; Hadjisavvas, Andreas; Kyriacou, Kyriacos] Cyprus Inst Neurol & Genet, Dept Electron Microscopy Mol Pathol, Nicosia, Cyprus; [Papamichael, Demetris; Kountourakis, Panteleimon; Vassiliou, Vassilios; Marcou, Yiola; Kakouri, Eleni] Bank Cyprus Oncol Ctr, Dept Med & Radiat Oncol, Nicosia, Cyprus; [Ioannidis, Georgios] Nicosia Gen Hosp, Dept Oncol, Nicosia, Cyprus; [Philippou, Chrystalla] Limassol Gen Hosp, Dept Oncol, Limassol, Cyprus; [Spanou, Elena; Tanteles, George A.; Anastasiadou, Violetta] Makarios III Hosp, Dept Clin Genet, Nicosia, Cyprus; [Spanou, Elena; Tanteles, George A.; Anastasiadou, Violetta] Cyprus Inst Neurol & Genet, Nicosia, Cyprus		Hadjisavvas, A (corresponding author), Cyprus Inst Neurol & Genet, Dept Electron Microscopy Mol Pathol, Nicosia, Cyprus.	ahsavvas@cing.ac.cy; kyriacos@cing.ac.cy	Loizidou, Maria A/C-6607-2009; Tanteles, George/H-6190-2012	Tanteles, George/0000-0002-8117-9852				Aarnio M, 1995, INT J CANCER, V64, P430, DOI 10.1002/ijc.2910640613; Boland CR, 2010, GASTROENTEROLOGY, V138, P2197, DOI [10.1053/j.gastro.2010.04.024, DOI 10.1053/J.GASTRO.2010.04.024]; Bonadona V, 2011, JAMA-J AM MED ASSOC, V305, P2304, DOI 10.1001/jama.2011.743; de la Chapelle A, 2004, NAT REV CANCER, V4, P769, DOI 10.1038/nrc1453; Domingo E, 2004, J MED GENET, V41, P664, DOI 10.1136/jmg.2004.020651; Dunlop MG, 1997, HUM MOL GENET, V6, P105, DOI 10.1093/hmg/6.1.105; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Foulkes WD, 2002, AM J HUM GENET, V71, P1395, DOI 10.1086/345075; HAMILTON SR, 1995, NEW ENGL J MED, V332, P839, DOI 10.1056/NEJM199503303321302; Hampel H, 2005, GASTROENTEROLOGY, V129, P415, DOI 10.1053/j.gastro.2005.05.011; Hampel H, 2010, J NATL COMPR CANC NE, V8, P597, DOI 10.6004/jnccn.2010.0044; Jarvinen HJ, 2009, J CLIN ONCOL, V27, P4793, DOI 10.1200/JCO.2009.23.7784; Jarvinen HJ, 2000, GASTROENTEROLOGY, V118, P829, DOI 10.1016/S0016-5085(00)70168-5; Jasperson KW, 2010, GASTROENTEROLOGY, V138, P2044, DOI 10.1053/j.gastro.2010.01.054; Jenkins MA, 2006, CLIN GASTROENTEROL H, V4, P489, DOI 10.1016/j.cgh.2006.01.002; Ligtenberg MJL, 2009, NAT GENET, V41, P112, DOI 10.1038/ng.283; Lindor NM, 2005, JAMA-J AM MED ASSOC, V293, P1979, DOI 10.1001/jama.293.16.1979; Lynch HT, 2003, NEW ENGL J MED, V348, P919, DOI 10.1056/NEJMra012242; Mangold E, 2005, INT J CANCER, V116, P692, DOI 10.1002/ijc.20863; Palomaki GE, 2009, GENET MED, V11, P42, DOI 10.1097/GIM.0b013e31818fa2db; Peltomaki P, 1997, GASTROENTEROLOGY, V113, P1146, DOI 10.1053/gast.1997.v113.pm9322509; Pinheiro M, 2011, GENET MED, V13, P895, DOI 10.1097/GIM.0b013e31821dd525; Plazzer JP, 2013, FAM CANCER, V12, P175, DOI 10.1007/s10689-013-9616-0; Quehenberger F, 2005, J MED GENET, V42, P491, DOI 10.1136/jmg.2004.024299; RodriguezBigas MA, 1997, J NATL CANCER I, V89, P1758, DOI 10.1093/jnci/89.23.1758; Steinke V, 2013, INT J CANC J INT DU; Stigliano V, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/1756-9966-33-1; Stoffel E, 2009, GASTROENTEROLOGY, V137, P1621, DOI 10.1053/j.gastro.2009.07.039; Syngal S, 1999, JAMA-J AM MED ASSOC, V282, P247, DOI 10.1001/jama.282.3.247; Tavtigian SV, 2006, J MED GENET, V43, P295, DOI 10.1136/jmg.2005.033878; Thompson BA, 2014, NAT GENET, V46, P107, DOI 10.1038/ng.2854; Umar A, 2004, J NATL CANCER I, V96, P261, DOI 10.1093/jnci/djh034; Vasen HFA, 1999, GASTROENTEROLOGY, V116, P1453, DOI 10.1016/S0016-5085(99)70510-X; VASEN HFA, 1991, DIS COLON RECTUM, V34, P424, DOI 10.1007/BF02053699; Wagner A, 2003, AM J HUM GENET, V72, P1088, DOI 10.1086/373963	35	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105501	10.1371/journal.pone.0105501	http://dx.doi.org/10.1371/journal.pone.0105501			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133505	Green Submitted, gold, Green Published			2022-12-25	WOS:000341302700118
J	Bruner-Tran, KL; Ding, TB; Yeoman, KB; Archibong, A; Arosh, JA; Osteen, KG				Bruner-Tran, Kaylon L.; Ding, Tianbing; Yeoman, Kallie B.; Archibong, Anthony; Arosh, Joe A.; Osteen, Kevin G.			Developmental Exposure of Mice to Dioxin Promotes Transgenerational Testicular Inflammation and an Increased Risk of Preterm Birth in Unexposed Mating Partners	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; REPRODUCTIVE DISEASE; SEMEN QUALITY; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN EXPOSURE; AH RECEPTOR; INHERITANCE; CELL; INFERTILITY; ASSOCIATION; DISRUPTION	TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin, commonly known as dioxin) is a ubiquitous environmental contaminant and known endocrine disruptor. Using a mouse model, we previously found that adult female mice exposed in utero to TCDD (F1 generation) as well as multiple subsequent generations (F2-F4) exhibited reduced fertility and an increased incidence of spontaneous preterm birth. Additional studies revealed that male F1 mice with a similar in utero/developmental TCDD exposure also exhibited diminished fertility and conferred an increased risk of preterm birth to their unexposed mating partners. Herein, we extend these previous observations, reporting that reduced fertility in male F1 mice is linked to testicular inflammation which coincides with apoptosis of developing spermatocytes, sub-fertility and an increased risk of preterm birth in their unexposed mating partners. Significantly, in the absence of additional toxicant exposure, testicular inflammation and reduced fertility persisted in F2 and F3 males and their control mating partners also frequently exhibited spontaneous preterm birth. Although a steady, global decline in male fertility has been noted over the last few decades, the reasons for these changes have not been firmly established. Likewise, the PTB rate in the U. S. and other countries has paralleled industrial development, suggesting a possible relationship between environmental toxicant exposure and adverse pregnancy outcomes. Most current clinical strategies to prevent preterm birth are focused solely on the mother and have yielded limited benefits. In contrast, our studies strongly suggest that the preconception testicular health of the father is a critical determinant of pregnancy outcomes in mice. Future clinical studies should examine the potential contribution of the male to gestation length in women and whether efforts to reduce the incidence of preterm birth should be initiated in both parents prior to pregnancy.	[Bruner-Tran, Kaylon L.; Ding, Tianbing; Yeoman, Kallie B.; Osteen, Kevin G.] Vanderbilt Univ, Sch Med, Dept Obstet & Gynecol, Womens Reprod Hlth Res Ctr, Nashville, TN 37212 USA; [Osteen, Kevin G.] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA; [Archibong, Anthony] Meharry Med Coll, Dept Physiol, Nashville, TN 37208 USA; [Arosh, Joe A.] Texas A&M Univ, Coll Vet Med, Dept Vet Integrat Biosci, College Stn, TX 77843 USA	Vanderbilt University; Vanderbilt University; Meharry Medical College; Texas A&M University System; Texas A&M University College Station	Bruner-Tran, KL (corresponding author), Vanderbilt Univ, Sch Med, Dept Obstet & Gynecol, Womens Reprod Hlth Res Ctr, Nashville, TN 37212 USA.	kaylon.bruner-tran@vanderbilt.edu; kevin.osteen@vanderbilt.edu			National Institute for Environmental Health Sciences [ES14942]; Vanderbilt University School of Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD028934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014942] Funding Source: NIH RePORTER	National Institute for Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Vanderbilt University School of Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institute for Environmental Health Sciences (www.niehs.nih.gov) #ES14942 to KBT and KGO, and Vanderbilt University School of Medicine (http://www.mc.vanderbilt.edu/) to KBT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott BD, 1999, TOXICOL APPL PHARM, V155, P62, DOI 10.1006/taap.1998.8601; Aitken RJ, 2014, REPRODUCTION, V147, pS1, DOI 10.1530/REP-13-0399; Amer Soc Reprod Med, 2013, FERTIL STERIL, V100, P931, DOI 10.1016/j.fertnstert.2013.08.043; Archibong AE, 2012, REPROD TOXICOL, V34, P635, DOI 10.1016/j.reprotox.2012.09.003; Baba T, 2008, SEX DEV, V2, P1, DOI 10.1159/000117714; BARTON SC, 1984, NATURE, V311, P374, DOI 10.1038/311374a0; Bidgoli SA, 2011, SCI TOTAL ENVIRON, V409, P3267, DOI 10.1016/j.scitotenv.2011.03.024; Bouskine A, 2009, ENVIRON HEALTH PERSP, V117, P1053, DOI 10.1289/ehp.0800367; Bruner-Tran KL, 2012, CURR OBSTET GYNECOL, V1, P116, DOI 10.1007/s13669-012-0014-7; Bruner-Tran KL, 2011, BIOL REPROD, V84, P106, DOI 10.1095/biolreprod.110.086744; Bruner-Tran KL, 2011, REPROD TOXICOL, V31, P344, DOI 10.1016/j.reprotox.2010.10.003; Busbee PB, 2013, NUTR REV, V71, P353, DOI 10.1111/nure.12024; Candela S, 2013, EPIDEMIOLOGY, V24, P863, DOI 10.1097/EDE.0b013e3182a712f1; CARLSEN E, 1992, BRIT MED J, V305, P609, DOI 10.1136/bmj.305.6854.609; Dickie M.M., 1975, BIOL LAB MOUSE, P25; Ding TB, 2011, REPROD TOXICOL, V31, P351, DOI 10.1016/j.reprotox.2010.11.003; Esakky P, 2012, REPROD TOXICOL, V34, P665, DOI 10.1016/j.reprotox.2012.10.005; Eskenazi B, 2010, EPIDEMIOLOGY, V21, P224, DOI 10.1097/EDE.0b013e3181cb8b95; Filler R., 1993, MALE REPROD TOXICOLO, P334, DOI DOI 10.1016/B978-0-12-461207-5.50025-0; Fisch H, 2008, UROL CLIN N AM, V35, P137, DOI 10.1016/j.ucl.2008.01.001; Golas A, 2011, REPROD BIOL, V11, P250, DOI 10.1016/S1642-431X(12)60070-9; Guerrero-Bosagna C, 2012, MOL CELL ENDOCRINOL, V354, P3, DOI 10.1016/j.mce.2011.10.004; Hansen DA, 2014, BIOL REPROD, V90, P1; Harris RM, 2012, MATURITAS, V72, P108, DOI 10.1016/j.maturitas.2012.03.002; Heindel JJ, 2006, SEMIN REPROD MED, V24, P168, DOI 10.1055/s-2006-944423; Houben ML, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006572; Jones KM, 2009, INT J ENV RES PUB HE, V6, P1124, DOI 10.3390/ijerph6031124; KAJII T, 1977, NATURE, V268, P633, DOI 10.1038/268633a0; Kretzschmar G, 2010, MOL CELL ENDOCRINOL, V321, P253, DOI 10.1016/j.mce.2010.02.018; Lawrence BP, 2013, SEMIN IMMUNOPATHOL, V35, P615, DOI 10.1007/s00281-013-0395-3; Locke PA, 2011, ALTEX-ALTERN ANIM EX, V28, P266, DOI 10.14573/altex.2011.4.266; Manikkam M, 2012, REPROD TOXICOL, V34, P708, DOI 10.1016/j.reprotox.2012.08.010; Manikkam M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046249; McConaha ME, 2011, REPRODUCTION, V142, P235, DOI 10.1530/REP-11-0070; Mocarelli P, 2008, ENVIRON HEALTH PERSP, V116, P70, DOI 10.1289/ehp.10399; Mocarelli P, 2011, ENVIRON HEALTH PERSP, V119, P713, DOI 10.1289/ehp.1002134; Morimoto H, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095307; Nayyar T, 2007, REPROD TOXICOL, V23, P326, DOI 10.1016/j.reprotox.2006.09.007; Perez Cecilia V, 2013, Spermatogenesis, V3, pe23870; Pflieger-Bruss S, 2004, ANDROLOGIA, V36, P337, DOI 10.1111/j.1439-0272.2004.00641.x; Pham H, 2010, PANCREAS, V39, P332, DOI 10.1097/MPA.0b013e3181baecbe; Rier S, 2002, TOXICOL SCI, V70, P161, DOI 10.1093/toxsci/70.2.161; Roizen JD, 2008, MOL ENDOCRINOL, V22, P105, DOI 10.1210/me.2007-0178; Rolland M, 2013, HUM REPROD, V28, P462, DOI 10.1093/humrep/des415; Roman BL, 1998, TOXICOL APPL PHARM, V150, P228, DOI 10.1006/taap.1998.8388; SAFE SH, 1994, CRIT REV TOXICOL, V24, P87, DOI 10.3109/10408449409049308; Sharma R, 2013, REPROD BIOL ENDOCRIN, V11, P1, DOI DOI 10.1186/1477-7827-11-66; Straub RH, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4484; Swan SH, 1997, ENVIRON HEALTH PERSP, V105, P1228; Thoma ME, 2013, FERTIL STERIL, V99, P1324, DOI 10.1016/j.fertnstert.2012.11.037; Tiano HF, 2002, CANCER RES, V62, P3395; Tracey R, 2013, REPROD TOXICOL, V36, P104, DOI 10.1016/j.reprotox.2012.11.011; Vested A, 2013, ENVIRON HEALTH PERSP, V121, P453, DOI 10.1289/ehp.1205118; Vogel CFA, 2003, J BIOCHEM MOL TOXIC, V17, P305, DOI 10.1002/jbt.10096; Walter A, 2010, CLIN CANCER RES, V16, P3562, DOI 10.1158/1078-0432.CCR-09-3136; Wang HB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003320; Wang X, 2013, P NATL ACAD SCI USA, V110, P10705, DOI 10.1073/pnas.1308998110; Wang Y, 2002, COMPUTER ENG, P15; Wilson MP, 2012, J OCCUP ENVIRON HYG, V9, pD87, DOI 10.1080/15459624.2012.677802	60	43	44	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105084	10.1371/journal.pone.0105084	http://dx.doi.org/10.1371/journal.pone.0105084			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127480	Green Published, Green Submitted, gold			2022-12-25	WOS:000340879300078
J	Can, H; Doskaya, M; Ajzenberg, D; Ozdemir, HG; Caner, A; Iz, SG; Doskaya, AD; Atalay, E; Cetinkaya, C; Urgen, S; Karacali, S; Un, C; Darde, ML; Guruz, Y				Can, Huseyin; Doskaya, Mert; Ajzenberg, Daniel; Ozdemir, H. Gokhan; Caner, Ayse; Iz, Sultan Gulce; Doskaya, Aysu Degirmenci; Atalay, Esra; Cetinkaya, Cagdas; Urgen, Saygun; Karacali, Sabire; Un, Cemal; Darde, Marie-Laure; Guruz, Yuksel			Genetic Characterization of Toxoplasma gondii Isolates and Toxoplasmosis Seroprevalence in Stray Cats of Izmir, Turkey	PLOS ONE			English	Article							FREE-RANGE CHICKENS; CONGENITAL TOXOPLASMOSIS; TISSUE DISTRIBUTION; SOUTH-AMERICA; GENOTYPE; PREVALENCE; DIVERSITY; ANIMALS; ANTIBODIES; INFECTION	Currently, some Toxoplasma gondii genotypes are being associated with serious clinical presentations. A recent report showing the Africa 1 genotype in two local congenital toxoplasmosis cases acquired in Turkey formed the basis of this study because atypical Africa 1 genotype is most frequently detected in animals and patients from sub-Saharan Africa. Since stray cats are considered as the linkage between wild life and urban life in T. gondii transmission, the present study aimed to isolate and characterize T. gondii strains circulating in stray cats of Izmir (Western Turkey). A secondary objective was to determine toxoplasmosis seroprevalence in this cat population. Tissues obtained from 100 deceased stray cats were bioassayed and isolated strains were genotyped using 15 microsatellite markers. In addition, toxoplasmosis seroprevalence was analyzed in 1121 cat sera collected from several large veterinary clinics in Izmir. Among the 22 isolates, 19 were Type II (86.3%), two were Type III (9%) and one was Africa 1 genotype (4.5%). The overall seropositivity rates in cats were 42-48% and 33.4-34.4% according to IFA and ELISA, respectively. Seroprevalence in deceased cats was significantly higher than in healthy cats (P = 0.0033). Finding both the major clonal Type II lineage together with the Type III lineage also found in Middle East, and an atypical genotype, Africa 1 appears consistent with the specific geographic location of Turkey between three continents and raises the possibility of transportation of these strains between continents through trade routes or long distance migratory birds. In addition, the first large study of toxoplasma seroprevalence in a stray cat population was also reported. The relatively high seropositivity rates and the variety of T. gondii genotypes confirm the local stray cat population as a risk factor for human toxoplasmosis in Izmir.	[Can, Huseyin; Atalay, Esra; Karacali, Sabire; Un, Cemal] Ege Univ, Fac Sci, Dept Mol Biol, Bornova, Turkey; [Doskaya, Mert; Caner, Ayse; Doskaya, Aysu Degirmenci; Guruz, Yuksel] Ege Univ, Sch Med, Dept Parasitol, Bornova, Turkey; [Ajzenberg, Daniel; Darde, Marie-Laure] Ctr Hosp Univ Dupuytren, Ctr Natl Reference, Toxoplasmose Toxoplasma Biol Resource Ctr, Limoges, France; [Ajzenberg, Daniel; Darde, Marie-Laure] Univ Limoges, Fac Med, Lab Parasitol Mycol, INSERM UMR 1094, Limoges, France; [Ozdemir, H. Gokhan; Cetinkaya, Cagdas; Urgen, Saygun] Municipal Izmir, Dept Vet Affairs, Izmir, Turkey; [Iz, Sultan Gulce] Ege Univ, Fac Engn, Dept Bioengn, Bornova, Turkey	Ege University; Ege University; CHU Limoges; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Limoges; Izmir Metropolitan Municipality; Ege University	Doskaya, M (corresponding author), Ege Univ, Sch Med, Dept Parasitol, Bornova, Turkey.	mert.doskaya@ege.edu.tr	Iz, Gulce/C-4174-2013; Can, Hüseyin/J-2987-2019; ün, cemal/AAH-3099-2020; Caner, Ayse/AAG-8982-2019; Can, Hüseyin/AAG-3152-2020; Degirmenci, Aysu/DET-8805-2022; Doskaya, Mert/W-4682-2017	Caner, Ayse/0000-0003-3058-9971; Can, Hüseyin/0000-0001-9633-9786; Doskaya, Mert/0000-0001-6868-008X; Gulce Iz, Sultan/0000-0002-9275-6272; Ajzenberg, Daniel/0000-0002-5357-3318	Scientific Research Projects Branch Directorate of Ege University, Turkey [2010-TIP-091, 2011-TIP-034]	Scientific Research Projects Branch Directorate of Ege University, Turkey(Ege University)	This study was supported by the grants given by the Scientific Research Projects Branch Directorate of Ege University, Turkey (Grant No: 2010-TIP-091 and 2011-TIP-034) to Y.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajzenberg D, 2002, J INFECT DIS, V186, P684, DOI 10.1086/342663; Ajzenberg D, 2010, J CLIN MICROBIOL, V48, P4641, DOI 10.1128/JCM.01152-10; Ajzenberg D, 2009, J INFECT DIS, V199, P1155, DOI 10.1086/597477; Al-Kappany YM, 2010, J PARASITOL, V96, P1115, DOI 10.1645/GE-2554.1; Al-Kappany YM, 2010, J PARASITOL, V96, P1112, DOI 10.1645/GE-2608.1; Altintas Nazmiye, 1997, Journal of the Egyptian Society of Parasitology, V27, P439; Babur C, 1998, TURKIYE KLINIKLERI J, V14, P55; Bontell IL, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r53; Cassaing S, 2006, J CLIN MICROBIOL, V44, P720, DOI 10.1128/JCM.44.3.720-724.2006; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Darde ML, 2008, PARASITE, V15, P366, DOI 10.1051/parasite/2008153366; Degirmenci A, 2011, EXP PARASITOL, V128, P1, DOI 10.1016/j.exppara.2011.01.019; Delhaes L, 2010, PRENATAL DIAG, V30, P902, DOI 10.1002/pd.2563; Doskaya M, 2013, PARASITOL INT, V62, P471, DOI 10.1016/j.parint.2013.06.008; Dubey JP, 2008, J PARASITOL, V94, P68, DOI 10.1645/GE-1362.1; Dubey JP, 2007, VET PARASITOL, V145, P352, DOI 10.1016/j.vetpar.2006.12.016; Dubey JP, 2006, VET PARASITOL, V141, P42, DOI 10.1016/j.vetpar.2006.04.037; Dubey JP, 2006, VET PARASITOL, V140, P76, DOI 10.1016/j.vetpar.2006.03.023; Dubey JP, 2013, J PARASITOL, V99, P56, DOI 10.1645/GE-3229.1; Dubey JP, 2010, VET PARASITOL, V172, P195, DOI 10.1016/j.vetpar.2010.05.013; Dubey JP, 2010, J PARASITOL, V96, P709, DOI 10.1645/GE-2425.1; Dubey JP, 2004, J PARASITOL, V90, P721, DOI 10.1645/GE-382R; Elmore SA, 2010, TRENDS PARASITOL, V26, P190, DOI 10.1016/j.pt.2010.01.009; Ertug S, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-66; Herrmann DC, 2010, INT J PARASITOL, V40, P285, DOI 10.1016/j.ijpara.2009.08.001; Karatepe B, 2008, ITAL J ANIM SCI, V7, P113; Khan A, 2011, INT J PARASITOL, V41, P645, DOI 10.1016/j.ijpara.2011.01.005; Lappin MR, 2010, TOP COMPANION ANIM M, V25, P136, DOI 10.1053/j.tcam.2010.07.002; Liang L, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006916; Mercier A, 2011, INFECT GENET EVOL, V11, P1378, DOI 10.1016/j.meegid.2011.05.003; Mercier A, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000876; Ozkan AT, 2008, J PARASITOL, V94, P817, DOI 10.1645/GE-1401.1; Pena HFJ, 2008, INT J PARASITOL, V38, P561, DOI 10.1016/j.ijpara.2007.09.004; Qian WF, 2012, VET PARASITOL, V187, P408, DOI 10.1016/j.vetpar.2012.01.026; Rajendran C, 2012, INFECT GENET EVOL, V12, P359, DOI 10.1016/j.meegid.2011.12.010; Salant H, 2009, VET PARASITOL, V159, P24, DOI 10.1016/j.vetpar.2008.10.011; Sibley LD, 2009, PHILOS T R SOC B, V364, P2749, DOI 10.1098/rstb.2009.0087; Su CL, 2012, P NATL ACAD SCI USA, V109, P5844, DOI 10.1073/pnas.1203190109; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; Wang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053483; Zhou YZ, 2013, VET PARASITOL, V193, P270, DOI 10.1016/j.vetpar.2012.11.031; Zia-Ali N, 2007, PARASITOL RES, V101, P111, DOI 10.1007/s00436-007-0461-7	42	27	28	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104930	10.1371/journal.pone.0104930	http://dx.doi.org/10.1371/journal.pone.0104930			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127360	Green Submitted, gold, Green Published			2022-12-25	WOS:000340879300061
J	Cordier, C; Boutimah, F; Bourdeloux, M; Dupuy, F; Met, E; Alberti, P; Loll, F; Chassaing, G; Burlina, F; Saison-Behmoaras, TE				Cordier, Celine; Boutimah, Fatima; Bourdeloux, Mathilde; Dupuy, Florian; Met, Elisabeth; Alberti, Patrizia; Loll, Francois; Chassaing, Gerard; Burlina, Fabienne; Saison-Behmoaras, Tula Ester			Delivery of Antisense Peptide Nucleic Acids to Cells by Conjugation with Small Arginine-Rich Cell-Penetrating Peptide (R/W)9	PLOS ONE			English	Article							SPLICE-REDIRECTING ACTIVITY; INTRACELLULAR DELIVERY; ENDOCYTIC PATHWAYS; MASS-SPECTROMETRY; PNA; OLIGONUCLEOTIDES; INTERNALIZATION; CHLOROQUINE; EXPRESSION; TRYPTOPHAN	Peptide nucleic acids (PNAs) are very attractive antisense and antigene agents, but these molecules are not passively taken into cells. Here, using a functional cell assay and fluorescent-based methods, we investigated cell uptake and antisense activity of a tridecamer PNA that targets the HIV-1 polypurine tract sequence delivered using the arginine-rich (R/W)9 peptide (RRWWRRWRR). At micromolar concentrations, without use of any transfection agents, almost 80% inhibition of the target gene expression was obtained with the conjugate in the presence of the endosomolytic agent chloroquine. We show that chloroquine not only induced escape from endosomes but also enhanced the cellular uptake of the conjugate. Mechanistic studies revealed that (R/W)9-PNA conjugates were internalized via pinocytosis. Replacement of arginines with lysines reduced the uptake of the conjugate by six-fold, resulting in the abolition of intracellular target inhibition. Our results show that the arginines play a crucial role in the conjugate uptake and antisense activity. To determine whether specificity of the interactions of arginines with cell surface proteoglycans result in the internalization, we used flow cytometry to examine uptake of arginine-and lysine-rich conjugates in wild-type CHO-K1 and proteoglycan-deficient A745 cells. The uptake of both conjugates was decreased by four fold in CHO-745 cells; therefore proteoglycans promote internalization of cationic peptides, irrespective of the chemical nature of their positive charges. Our results show that arginine-rich cell-penetrating peptides, especially (R/W)9, are a promising tool for PNA internalization.	[Cordier, Celine; Boutimah, Fatima; Bourdeloux, Mathilde; Dupuy, Florian; Met, Elisabeth; Alberti, Patrizia; Loll, Francois; Saison-Behmoaras, Tula Ester] Museum Natl Hist Nat, F-75231 Paris, France; [Cordier, Celine; Boutimah, Fatima; Bourdeloux, Mathilde; Dupuy, Florian; Met, Elisabeth; Alberti, Patrizia; Loll, Francois; Saison-Behmoaras, Tula Ester] INSERM, U1154, Paris, France; [Cordier, Celine; Boutimah, Fatima; Bourdeloux, Mathilde; Dupuy, Florian; Met, Elisabeth; Alberti, Patrizia; Loll, Francois; Saison-Behmoaras, Tula Ester] CNRS, UMR 7196, Paris, France; [Chassaing, Gerard; Burlina, Fabienne] Univ Paris 06, Lab BioMol, Paris, France; [Chassaing, Gerard; Burlina, Fabienne] CNRS, UMR 7203, Paris, France; [Chassaing, Gerard; Burlina, Fabienne] Ecole Normale Super, Dept Chim, ENS, UMR 7203, F-75231 Paris, France	Museum National d'Histoire Naturelle (MNHN); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN)	Saison-Behmoaras, TE (corresponding author), Museum Natl Hist Nat, F-75231 Paris, France.	tula@mnhn.fr		Burlina, Fabienne/0000-0002-6042-680X; Alberti, Patrizia/0000-0002-5231-3768	French Ministry for Research	French Ministry for Research(Ministry of Research, France)	C. C. and F. B. were recipients of a PhD fellowship from the French Ministry for Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abes S, 2006, J CONTROL RELEASE, V110, P595, DOI 10.1016/j.jconrel.2005.10.026; Abes S, 2007, NUCLEIC ACIDS RES, V35, P4495, DOI 10.1093/nar/gkm418; Amand HL, 2008, BIOCHEM BIOPH RES CO, V371, P621, DOI 10.1016/j.bbrc.2008.04.039; Amand HL, 2012, BBA-BIOMEMBRANES, V1818, P2669, DOI 10.1016/j.bbamem.2012.06.006; Aubry S, 2010, BBA-BIOMEMBRANES, V1798, P2182, DOI 10.1016/j.bbamem.2009.11.011; Aubry S, 2009, FASEB J, V23, P2956, DOI 10.1096/fj.08-127563; Bechara C, 2013, FASEB J, V27, P738, DOI 10.1096/fj.12-216176; Bendifallah N, 2006, BIOCONJUGATE CHEM, V17, P750, DOI 10.1021/bc050283q; Berthault N, 2011, CANCER GENE THER, V18, P695, DOI 10.1038/cgt.2011.39; Boutimah-Hamoudi F, 2007, NUCLEIC ACIDS RES, V35, P3907, DOI 10.1093/nar/gkm374; Briceno E, 2007, SURG NEUROL, V67, P388, DOI 10.1016/j.surneu.2006.08.080; Burlina F, 2005, ANGEW CHEM INT EDIT, V44, P4244, DOI 10.1002/anie.200500477; de Chaumont F, 2012, NAT METHODS, V9, P690, DOI [10.1038/NMETH.2075, 10.1038/nmeth.2075]; Dean DA, 2000, ADV DRUG DELIVER REV, V44, P81, DOI 10.1016/S0169-409X(00)00087-9; Delaroche D, 2007, ANAL CHEM, V79, P1932, DOI 10.1021/ac061108l; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Drin G, 2003, J BIOL CHEM, V278, P31192, DOI 10.1074/jbc.M303938200; El-Andaloussi S, 2006, J GENE MED, V8, P1262, DOI 10.1002/jgm.950; Erbacher P, 1996, EXP CELL RES, V225, P186, DOI 10.1006/excr.1996.0169; Fabani MM, 2010, NUCLEIC ACIDS RES, V38, P4466, DOI 10.1093/nar/gkq160; Franco CRC, 2001, BRAZ J MED BIOL RES, V34, P971, DOI 10.1590/S0100-879X2001000800001; Hassane FS, 2009, BIOCONJUGATE CHEM, V20, P1523, DOI 10.1021/bc900075p; Ivanova GD, 2008, NUCLEIC ACIDS RES, V36, P6418, DOI 10.1093/nar/gkn671; Kang SH, 1998, BIOCHEMISTRY-US, V37, P6235, DOI 10.1021/bi980300h; Khalil IA, 2006, PHARMACOL REV, V58, P32, DOI 10.1124/pr.58.1.8; Koppelhus U, 2002, ANTISENSE NUCLEIC A, V12, P51, DOI 10.1089/108729002760070795; Koppelhus U, 2008, BIOCONJUGATE CHEM, V19, P1526, DOI 10.1021/bc800068h; Lebleu B, 2008, ADV DRUG DELIVER REV, V60, P517, DOI 10.1016/j.addr.2007.09.002; Lecosnier S, 2011, FASEB J, V25, P2201, DOI 10.1096/fj.10-169540; Liu AP, 2010, J CELL BIOL, V191, P1381, DOI 10.1083/jcb.201008117; Lundin KE, 2006, ADV GENET, V56, P1, DOI 10.1016/S0065-2660(06)56001-8; Madani Fatemeh, 2011, J Biophys, V2011, P414729, DOI 10.1155/2011/414729; Marlin F, 2010, CHEMBIOCHEM, V11, P1493, DOI 10.1002/cbic.201000138; Mousavi SA, 2004, BIOCHEM J, V377, P1, DOI 10.1042/BJ20031000; Nakase I, 2004, MOL THER, V10, P1011, DOI 10.1016/j.ymthe.2004.08.010; Nielsen PE, 2010, CHEM BIODIVERS, V7, P786, DOI 10.1002/cbdv.201000005; Richard JP, 2003, J BIOL CHEM, V278, P585, DOI 10.1074/jbc.M209548200; Rogers FA, 2012, MOL THER, V20, P109, DOI 10.1038/mt.2011.163; Rydberg HA, 2012, BIOCHEMISTRY-US, V51, P5531, DOI 10.1021/bi300454k; Saleh AF, 2010, BIOCONJUGATE CHEM, V21, P1902, DOI 10.1021/bc100275r; Shiraishi T, 2005, CHEM BIOL, V12, P923, DOI 10.1016/j.chembiol.2005.06.009; Shiraishi Takehiko, 2011, Artif DNA PNA XNA, V2, P90; Torres AG, 2012, NUCLEIC ACIDS RES, V40, P2152, DOI 10.1093/nar/gkr885; Vercauteren D, 2010, MOL THER, V18, P561, DOI 10.1038/mt.2009.281; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; Wu RP, 2007, NUCLEIC ACIDS RES, V35, P5182, DOI 10.1093/nar/gkm478	46	22	23	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104999	10.1371/journal.pone.0104999	http://dx.doi.org/10.1371/journal.pone.0104999			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127364	Green Published, gold, Green Submitted			2022-12-25	WOS:000340879300069
J	Halliez, S; Jaumain, E; Huor, A; Douet, JY; Lugan, S; Cassard, H; Lacroux, C; Beringue, V; Andreoletti, O; Vilette, D				Halliez, Sophie; Jaumain, Emilie; Huor, Alvina; Douet, Jean-Yves; Lugan, Severine; Cassard, Herve; Lacroux, Caroline; Beringue, Vincent; Andreoletti, Olivier; Vilette, Didier			White Blood Cell-Based Detection of Asymptomatic Scrapie Infection by Ex Vivo Assays	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHY; PRION INFECTIVITY; VARIANT; TRANSFUSION; COMPONENTS; PROTEIN; SHEEP; PRPSC; VCJD	Prion transmission can occur by blood transfusion in human variant Creutzfeldt-Jakob disease and in experimental animal models, including sheep. Screening of blood and its derivatives for the presence of prions became therefore a major public health issue. As infectious titer in blood is reportedly low, highly sensitive and robust methods are required to detect prions in blood and blood derived products. The objectives of this study were to compare different methods - in vitro, ex vivo and in vivo assays - to detect prion infectivity in cells prepared from blood samples obtained from scrapie infected sheep at different time points of the disease. Protein misfolding cyclic amplification (PMCA) and bioassays in transgenic mice expressing the ovine prion protein were the most efficient methods to identify infected animals at any time of the disease (asymptomatic to terminally-ill stages). However scrapie cell and cerebellar organotypic slice culture assays designed to replicate ovine prions in culture also allowed detection of prion infectivity in blood cells from asymptomatic sheep. These findings confirm that white blood cells are appropriate targets for preclinical detection and introduce ex vivo tools to detect blood infectivity during the asymptomatic stage of the disease.	[Halliez, Sophie; Jaumain, Emilie; Beringue, Vincent] INRA, UR892, Jouy En Josas, France; [Huor, Alvina; Douet, Jean-Yves; Lugan, Severine; Cassard, Herve; Lacroux, Caroline; Andreoletti, Olivier; Vilette, Didier] Ecole Natl Vet Toulouse, UMR INRA ENVT 1225, Toulouse, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse	Vilette, D (corresponding author), Ecole Natl Vet Toulouse, UMR INRA ENVT 1225, Toulouse, France.	d.vilette@envt.fr	Halliez, Sophie/ABA-1356-2020; DOUET, Jean Yves/F-8208-2011	Halliez, Sophie/0000-0002-6173-9752; DOUET, Jean Yves/0000-0002-0426-4957	DIM Malinf (Paris, France) [110208]; Alliance Biosecure Foundation (SafeCJD project); EU FP7 project "PRIORITY''; CONCOTSA	DIM Malinf (Paris, France); Alliance Biosecure Foundation (SafeCJD project); EU FP7 project "PRIORITY''; CONCOTSA	This work was supported by grants from DIM Malinf (Paris, France, grant no. 110208), the Alliance Biosecure Foundation (SafeCJD project), the EU FP7 project "PRIORITY'' and CONCOTSA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreoletti O, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002782; Andreoletti O, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001285; Arellano-Anaya ZE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020563; Atarashi R, 2008, NAT METHODS, V5, P211, DOI 10.1038/nmeth0308-211; Beringue V, 2012, SCIENCE, V335, P472, DOI 10.1126/science.1215659; Bishop MT, 2013, BRAIN, V136, P1139, DOI 10.1093/brain/awt032; Bons N, 2002, TRANSFUSION, V42, P513, DOI 10.1046/j.1537-2995.2002.00098.x; Brown P, 1999, TRANSFUSION, V39, P1169, DOI 10.1046/j.1537-2995.1999.39111169.x; Brown P, 1998, TRANSFUSION, V38, P810, DOI 10.1046/j.1537-2995.1998.38998408999.x; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Cervenakova L, 2003, TRANSFUSION, V43, P1687, DOI 10.1046/j.0041-1132.2003.00586.x; Dassanayake RP, 2012, J GEN VIROL, V93, P1127, DOI 10.1099/vir.0.039032-0; Douet JY, 2014, EMERG INFECT DIS, V20, P114, DOI 10.3201/eid2001.130353; Edgeworth JA, 2011, LANCET, V377, P487, DOI 10.1016/S0140-6736(10)62308-2; Falsig J, 2008, NAT PROTOC, V3, P555, DOI 10.1038/nprot.2008.13; Feraudet C, 2005, J BIOL CHEM, V280, P11247, DOI 10.1074/jbc.M407006200; Gill ON, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5675; Holada K, 2002, J VIROL, V76, P4649, DOI 10.1128/JVI.76.9.4649-4650.2002; Houston F, 2000, LANCET, V356, P999, DOI 10.1016/S0140-6736(00)02719-7; Houston F, 2008, BLOOD, V112, P4739, DOI 10.1182/blood-2008-04-152520; Hunter N, 2002, J GEN VIROL, V83, P2897, DOI 10.1099/0022-1317-83-11-2897; Johnson CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035383; Kanu N, 2002, CURR BIOL, V12, P523, DOI 10.1016/S0960-9822(02)00722-4; Klohn PC, 2003, P NATL ACAD SCI USA, V100, P11666, DOI 10.1073/pnas.1834432100; Lacroux C, 2012, J VIROL, V86, P2056, DOI 10.1128/JVI.06532-11; Le Dur A, 2005, P NATL ACAD SCI USA, V102, P16031, DOI 10.1073/pnas.0502296102; Llewelyn CA, 2004, LANCET, V363, P417, DOI 10.1016/S0140-6736(04)15486-X; Makarava N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1730; Mathiason CK, 2006, SCIENCE, V314, P133, DOI 10.1126/science.1132661; Mathiason CK, 2010, J VIROL, V84, P5097, DOI 10.1128/JVI.02169-09; McCutcheon S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023169; Moudjou M, 2014, MBIO, V5, DOI 10.1128/mBio.00829-13; Orru CD, 2011, MBIO, V2, DOI 10.1128/mBio.00078-11; Paquet S, 2007, J GEN VIROL, V88, P706, DOI 10.1099/vir.0.82336-0; Peden AH, 2004, LANCET, V364, P527, DOI 10.1016/S0140-6736(04)16811-6; Rubenstein R, 2010, J GEN VIROL, V91, P1883, DOI 10.1099/vir.0.020164-0; Segarra C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069632; Tattum MH, 2010, TRANSFUSION, V50, P996, DOI 10.1111/j.1537-2995.2010.02595.x; Wilham JM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001217; Wroe SJ, 2006, LANCET, V368, P2061, DOI 10.1016/S0140-6736(06)69835-8	41	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104287	10.1371/journal.pone.0104287	http://dx.doi.org/10.1371/journal.pone.0104287			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122456	Green Published, gold, Green Submitted			2022-12-25	WOS:000341017000034
J	Rafalowska, J; Sulejczak, D; Chrapusta, SJ; Gadamski, R; Dziewulska, D				Rafalowska, Janina; Sulejczak, Dorota; Chrapusta, Stanislaw J.; Gadamski, Roman; Dziewulska, Dorota			Diverse Expression of Selected SMN Complex Proteins in Humans with Sporadic Amyotrophic Lateral Sclerosis and in a Transgenic Rat Model of Familial Form of the Disease	PLOS ONE			English	Article							SURVIVAL MOTOR-NEURON; SOD1; COMPONENT; IDENTIFICATION; GEMIN2	Background and Objective: There is circumstantial evidence linking sporadic amyotrophic lateral sclerosis (ALS) cases to a malfunction or deficit of a multimeric SMN complex that scrutinizes cellular RNAs; the core of this complex is survival motor neuron (SMN, or gemin 1) protein. We intended to verify this hypothesis by comparing the expression of both SMN and several other functionally associated gemins in the anterior horn motoneurons of patients who died of sporadic ALS (sALS), of transgenic rats with overexpression of the mutated human superoxide dismutase 1 gene (SOD1(G93A)) that represent a model of familial ALS (fALS), and of the respective controls. Methods: Using archival material of paraffin blocks with samples of human and rat spinal cords, immunohistochemical reactions with antibodies against SMN and gemins 2, 3, and 4 were performed and assessed by light microscopy. Results: The expression of SMN and all other studied gemins was observed in motoneurons of sALS patients, fALS rats, and in all controls, although the intensity varied. The immunolabeling was most intense in sALS patients with relatively fast disease course, and decreased with increasing disease duration in both the human sALS and rat fALS material. Irrespective of the disease stage, sALS material showed no or very low gemin 2 immunoreactivity, while clear gemin 2 immnoreactivity was observed in all fALS rats and control material. Conclusion: The deficient expression of gemin 2 in spinal cord motoneurons in human sALS may lead to a dysfunction and loss of neuroprotective action of the SMN complex.	[Rafalowska, Janina; Gadamski, Roman; Dziewulska, Dorota] Polish Acad Sci, Mossakowski Med Res Ctr, Dept Expt & Clin Neuropathol, Warsaw, Poland; [Sulejczak, Dorota; Chrapusta, Stanislaw J.] Polish Acad Sci, Mossakowski Med Res Ctr, Dept Expt Pharmacol, Warsaw, Poland; [Dziewulska, Dorota] Med Univ Warsaw, Dept Neurol, Warsaw, Poland	Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences; Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences; Medical University of Warsaw	Sulejczak, D (corresponding author), Polish Acad Sci, Mossakowski Med Res Ctr, Dept Expt & Clin Neuropathol, Warsaw, Poland.	dsulejczak@imdik.pan.pl	Chrapusta, Stanisław/GLS-1363-2022; Chrapusta, Stanisław/AAA-3076-2020; Dziewulska, Dorota/M-5336-2018	Dziewulska, Dorota/0000-0003-3491-9819; Chrapusta, Stanislaw Jonatan/0000-0001-5219-8993; Sulejczak, Dorota/0000-0002-1697-8164	Ministry of Science and Higher Education of Poland [NN 401 014 640]; Mossakowski Research Institute Polish Academy of Science	Ministry of Science and Higher Education of Poland(Ministry of Science and Higher Education, Poland); Mossakowski Research Institute Polish Academy of Science	This study was supported by grant #NN 401 014 640 from the Ministry of Science and Higher Education of Poland and by statutory funds from the Mossakowski Research Institute Polish Academy of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baccon J, 2002, J BIOL CHEM, V277, P31957, DOI 10.1074/jbc.M203478200; Battle DJ, 2006, COLD SPRING HARB SYM, V71, P313, DOI 10.1101/sqb.2006.71.001; Charroux B, 2000, J CELL BIOL, V148, P1177, DOI 10.1083/jcb.148.6.1177; Charroux B, 1999, J CELL BIOL, V147, P1181, DOI 10.1083/jcb.147.6.1181; Corcia P, 2009, AMYOTROPH LATERAL SC, V10, P436, DOI 10.3109/17482960902759162; Feng WQ, 2005, HUM MOL GENET, V14, P1605, DOI 10.1093/hmg/ddi168; Fidzianska A, 2006, FOLIA NEUROPATHOL, V44, P175; Gertz B, 2012, J NEUROPATH EXP NEUR, V71, P162, DOI 10.1097/NEN.0b013e318244b635; Hao LT, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-28; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; Jablonka S, 2002, P NATL ACAD SCI USA, V99, P10126, DOI 10.1073/pnas.152318699; Kirby J, 2005, BRAIN, V128, P1686, DOI 10.1093/brain/awh503; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Ogawa C, 2007, J BIOL CHEM, V282, P11122, DOI 10.1074/jbc.M609297200; Otter S, 2007, J BIOL CHEM, V282, P5825, DOI 10.1074/jbc.M608528200; Rafalowska J, 2006, FOLIA NEUROPATHOL, V44, P162; Rafalowska J, 2012, FOLIA NEUROPATHOL, V50, P390, DOI 10.5114/fn.2012.32373; Rafalowska J, 2011, FOLIA NEUROPATHOL, V49, P301; Shpargel KB, 2005, P NATL ACAD SCI USA, V102, P17372, DOI 10.1073/pnas.0508947102; Turner BJ, 2014, NEUROBIOL AGING, V35, P906, DOI 10.1016/j.neurobiolaging.2013.09.030; Yamazaki T, 2012, CELL REP, V2, P799, DOI 10.1016/j.celrep.2012.08.025; Zhang HL, 2006, J NEUROSCI, V26, P8622, DOI 10.1523/JNEUROSCI.3967-05.2006	22	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104614	10.1371/journal.pone.0104614	http://dx.doi.org/10.1371/journal.pone.0104614			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122454	gold, Green Submitted, Green Published			2022-12-25	WOS:000341017000048
J	West, PT; Li, Q; Ji, LX; Eichten, SR; Song, JW; Vaughn, MW; Schmitz, RJ; Springer, NM				West, Patrick T.; Li, Qing; Ji, Lexiang; Eichten, Steven R.; Song, Jawon; Vaughn, Matthew W.; Schmitz, Robert J.; Springer, Nathan M.			Genomic Distribution of H3K9me2 and DNA Methylation in a Maize Genome	PLOS ONE			English	Article							GENE ENRICHMENT; MESSENGER-RNA; ARABIDOPSIS; WIDE; HETEROCHROMATIN; LIBRARIES; EPIGENOME; REGIONS; METHYLTRANSFERASES; VARIABILITY	DNA methylation and dimethylation of lysine 9 of histone H3 (H3K9me2) are two chromatin modifications that can be associated with gene expression or recombination rate. The maize genome provides a complex landscape of interspersed genes and transposons. The genome-wide distribution of DNA methylation and H3K9me2 were investigated in seedling tissue for the maize inbred B73 and compared to patterns of these modifications observed in Arabidopsis thaliana. Most maize transposons are highly enriched for DNA methylation in CG and CHG contexts and for H3K9me2. In contrast to findings in Arabidopsis, maize CHH levels in transposons are generally low but some sub-families of transposons are enriched for CHH methylation and these families exhibit low levels of H3K9me2. The profile of modifications over genes reveals that DNA methylation and H3K9me2 is quite low near the beginning and end of genes. Although elevated CG and CHG methylation are found within gene bodies, CHH and H3K9me2 remain low. Maize has much higher levels of CHG methylation within gene bodies than observed in Arabidopsis and this is partially attributable to the presence of transposons within introns for some maize genes. These transposons are associated with high levels of CHG methylation and H3K9me2 but do not appear to prevent transcriptional elongation. Although the general trend is for a strong depletion of H3K9me2 and CHG near the transcription start site there are some putative genes that have high levels of these chromatin modifications. This study provides a clear view of the relationship between DNA methylation and H3K9me2 in the maize genome and how the distribution of these modifications is shaped by the interplay of genes and transposons.	[West, Patrick T.; Li, Qing; Eichten, Steven R.; Springer, Nathan M.] Univ Minnesota, Dept Plant Biol, St Paul, MN 55108 USA; [Ji, Lexiang; Schmitz, Robert J.] Univ Georgia, Dept Genet, Athens, GA 30602 USA; [Ji, Lexiang] Univ Georgia, Inst Bioinformat, Athens, GA 30602 USA; [Song, Jawon; Vaughn, Matthew W.] Univ Texas Austin, Texas Adv Comp Ctr, Austin, TX 78712 USA	University of Minnesota System; University of Minnesota Twin Cities; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University of Texas System; University of Texas Austin	Springer, NM (corresponding author), Univ Minnesota, Dept Plant Biol, St Paul, MN 55108 USA.	springer@umn.edu	Song, Jawon/AAA-4318-2020; Schmitz, Robert/AAY-7659-2020	Song, Jawon/0000-0002-9916-3816; Schmitz, Robert/0000-0001-7538-6663; Eichten, Steven/0000-0003-2268-395X; Vaughn, Matthew/0000-0002-1384-4283	National Science Foundation [IOS-1237931, DBI-0735191, IOS-1339194]; University of Georgia; Direct For Biological Sciences [1237931] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); University of Georgia; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The research was supported by a grant from the National Science Foundation (IOS-1237931) to MWV and NMS. This work also used resources or cyberinfrastructure provided by iPlant Collaborative. The iPlant Collaborative is funded by a grant from the National Science Foundation (DBI-0735191; www.iplantcollaborative.org). Start-up funds from the University of Georgia and a research grant from the National Science Foundation (IOS-1339194) to RJS supported aspects of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartee L, 2001, GENE DEV, V15, P1753, DOI 10.1101/gad.905701; Baucom RS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000732; BENNETZEN JL, 1994, GENOME, V37, P565, DOI 10.1139/g94-081; Cao XF, 2000, P NATL ACAD SCI USA, V97, P4979, DOI 10.1073/pnas.97.9.4979; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Du JM, 2012, CELL, V151, P167, DOI 10.1016/j.cell.2012.07.034; Eichten SR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002372; Eichten SR, 2013, PLANT CELL, V25, P2783, DOI 10.1105/tpc.113.114793; Eichten SR, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003127; Emberton J, 2005, GENOME RES, V15, P1441, DOI 10.1101/gr.3362105; Gent JI, 2012, NUCLEIC ACIDS RES, V40, P1550, DOI 10.1093/nar/gkr862; Haring M, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-11; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jin WW, 2008, CHROMOSOME RES, V16, P1203, DOI 10.1007/s10577-008-1269-8; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Law JA, 2013, NATURE, V498, P385, DOI 10.1038/nature12178; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Messing J, 2006, CURR OPIN PLANT BIOL, V9, P157, DOI 10.1016/j.pbi.2006.01.009; Palmer LE, 2003, SCIENCE, V302, P2115, DOI 10.1126/science.1091265; Papa CM, 2001, PLANT CELL, V13, P1919, DOI 10.1105/tpc.13.8.1919; Parkin IAP, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-6-r77; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rabinowicz PD, 2003, CURR OPIN PLANT BIOL, V6, P150, DOI 10.1016/S1369-5266(03)00008-6; Regulski M, 2013, GENOME RES, V23, P1651, DOI 10.1101/gr.153510.112; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; SanMiguel P, 1996, SCIENCE, V274, P765, DOI 10.1126/science.274.5288.765; Saze H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3301; Schmitz RJ, 2013, GENOME RES, V23, P1663, DOI 10.1101/gr.152538.112; Schmitz RJ, 2011, SCIENCE, V334, P369, DOI 10.1126/science.1212959; Schnable JC, 2012, GENOME BIOL EVOL, V4, P265, DOI 10.1093/gbe/evs009; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Schultz MD, 2012, TRENDS GENET, V28, P583, DOI 10.1016/j.tig.2012.10.012; Sekhon RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061005; Shi JH, 2006, GENETICS, V173, P1571, DOI 10.1534/genetics.106.056853; Springer NM, 2009, MAYDICA, V54, P417; Stroud H, 2014, NAT STRUCT MOL BIOL, V21, P64, DOI 10.1038/nsmb.2735; Stroud H, 2013, CELL, V152, P352, DOI 10.1016/j.cell.2012.10.054; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; VONGS A, 1993, SCIENCE, V260, P1926, DOI 10.1126/science.8316832; Wang XF, 2009, PLANT CELL, V21, P1053, DOI 10.1105/tpc.109.065714; Whitelaw CA, 2003, SCIENCE, V302, P2118, DOI 10.1126/science.1090047; Yuan YN, 2002, GENOME RES, V12, P1345, DOI 10.1101/gr.185902; Zemach A, 2013, CELL, V153, P193, DOI 10.1016/j.cell.2013.02.033; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zhou JL, 2010, PLANT MOL BIOL, V72, P585, DOI 10.1007/s11103-009-9594-7	48	87	88	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e105267	10.1371/journal.pone.0105267	http://dx.doi.org/10.1371/journal.pone.0105267			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122127	Green Published, gold, Green Submitted			2022-12-25	WOS:000341017000110
J	Arif, M; Wei, JS; Zhang, Q; Liu, F; Basurto-Islas, G; Grundke-Iqbal, I; Iqbal, K				Arif, Mohammad; Wei, Jianshe; Zhang, Qi; Liu, Fei; Basurto-Islas, Gustavo; Grundke-Iqbal, Inge; Iqbal, Khalid			Cytoplasmic Retention of Protein Phosphatase 2A Inhibitor 2 (I-2(PP2A)) Induces Alzheimer-like Abnormal Hyperphosphorylation of Tau	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer Disease; Ca2+; Calmodulin-dependent Protein Kinase (CaMK); Protein Serine; Threonine Phosphatase (PSP); Serine; Threonine Protein Kinase; Tau Protein (Tau)	AMYLOID PRECURSOR PROTEIN; CATALYTIC SUBUNIT; NEUROFIBRILLARY DEGENERATION; NUCLEAR-LOCALIZATION; CELL-PROLIFERATION; PHOSPHORYLATED-TAU; DISEASE BRAIN; DOWN-SYNDROME; SET; MICROTUBULES	Background: In Alzheimer brain, I-2(PP2A) is translocated from the neuronal nucleus to the cytoplasm and promotes abnormal hyperphosphorylation of Tau. Results: Inactivation of nuclear localization signal (NLS) causes retention of I-2(PP2A) in the cell cytoplasm, where it promotes Tau hyperphosphorylation by affecting PP2A signaling. Conclusion: Retention of I-2(PP2A) in cell cytoplasm results in Tau hyperphosphorylation. Significance: The study provides potential tools for investigating Tau-based therapeutics. Abnormal hyperphosphorylation of Tau leads to the formation of neurofibrillary tangles, a hallmark of Alzheimer disease (AD), and related tauopathies. The phosphorylation of Tau is regulated by protein phosphatase 2A (PP2A), which in turn is modulated by endogenous inhibitor 2 (I-2(PP2A)). In AD brain, I-2(PP2A) is translocated from neuronal nucleus to cytoplasm, where it inhibits PP2A activity and promotes abnormal phosphorylation of Tau. Here we describe the identification of a potential nuclear localization signal (NLS) in the C-terminal region of I-2(PP2A) containing a conserved basic motif, (RKR181)-R-179, which is sufficient for directing its nuclear localization. The current study further presents an inducible cell model (Tet-Off system) of AD-type abnormal hyperphosphorylation of Tau by expressing I-2(PP2A) in which the NLS was inactivated by (RKR181)-R-179 AAA along with (KR169)-K-168 AA mutations. In this model, the mutant NLS (mNLS)-I-2(PP2A) (I(2)(PP2A)AA-AAA) was retained in the cell cytoplasm, where it physically interacted with PP2A and inhibited its activity. Inhibition of PP2A was associated with the abnormal hyperphosphorylation of Tau, which resulted in microtubule network instability and neurite outgrowth impairment. Expression of mNLS-I-2(PP2A) activated CAMKII and GSK-3, which are Tau kinases regulated by PP2A. The immunoprecipitation experiments showed the direct interaction of I-2(PP2A) with PP2A and GSK-3 but not with CAMKII. Thus, the cell model provides insights into the nature of the potential NLS and the mechanistic relationship between I-2(PP2A)-induced inhibition of PP2A and hyperphosphorylation of Tau that can be utilized to develop drugs preventing Tau pathology.	[Arif, Mohammad; Wei, Jianshe; Zhang, Qi; Liu, Fei; Basurto-Islas, Gustavo; Grundke-Iqbal, Inge; Iqbal, Khalid] New York State Inst Basic Res Dev Disabil, Dept Neurochem, Staten Isl, NY 10314 USA	Institute for Basic Research in Developmental Disabilities	Iqbal, K (corresponding author), New York State Inst Basic Res Dev Disabil, Dept Neurochem, Inge Grundke Iqbal Res Floor,1050 Forest Hill Rd, Staten Isl, NY 10314 USA.	khalid.iqbal.ibr@gmail.com		Basurto-Islas, Gustavo/0000-0002-9401-140X	National Institutes of Health, NIA [AG019158]; New York State Office of People with Developmental Disabilities; NATIONAL INSTITUTE ON AGING [R01AG019158] Funding Source: NIH RePORTER	National Institutes of Health, NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); New York State Office of People with Developmental Disabilities; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health, NIA, Grant AG019158. This work was also supported by the New York State Office of People with Developmental Disabilities.	ALAFUZOFF I, 1987, ACTA NEUROPATHOL, V74, P209, DOI 10.1007/BF00688184; Alonso AD, 1997, P NATL ACAD SCI USA, V94, P298, DOI 10.1073/pnas.94.1.298; Alonso AD, 1996, NAT MED, V2, P783, DOI 10.1038/nm0796-783; ALONSO AD, 1994, P NATL ACAD SCI USA, V91, P5562, DOI 10.1073/pnas.91.12.5562; Alonso AD, 2001, P NATL ACAD SCI USA, V98, P6923, DOI 10.1073/pnas.121119298; Alonso AD, 2010, J BIOL CHEM, V285, P30851, DOI 10.1074/jbc.M110.110957; Alonso AD, 2006, P NATL ACAD SCI USA, V103, P8864, DOI 10.1073/pnas.0603214103; Arnaud L, 2011, FEBS LETT, V585, P2653, DOI 10.1016/j.febslet.2011.07.020; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; Basurto-Islas G, 2013, J BIOL CHEM, V288, P17495, DOI 10.1074/jbc.M112.446070; Bennecib M, 2001, FEBS LETT, V490, P15, DOI 10.1016/S0014-5793(01)02127-5; Blanchard J, 2010, ACTA NEUROPATHOL, V120, P605, DOI 10.1007/s00401-010-0734-6; Bolognin S, 2012, ACTA NEUROPATHOL, V123, P133, DOI 10.1007/s00401-011-0908-x; Canela N, 2003, J BIOL CHEM, V278, P1158, DOI 10.1074/jbc.M207497200; CHEN J, 1992, SCIENCE, V257, P1261, DOI 10.1126/science.1325671; Chen S, 2008, J BIOL CHEM, V283, P10513, DOI 10.1074/jbc.M709852200; Chohan MO, 2006, FEBS LETT, V580, P3973, DOI 10.1016/j.febslet.2006.06.021; Compagnone NA, 2000, MOL ENDOCRINOL, V14, P875, DOI 10.1210/me.14.6.875; DREWES G, 1992, EMBO J, V11, P2131, DOI 10.1002/j.1460-2075.1992.tb05272.x; Facchinetti P, 2014, NEUROBIOL AGING, V35, P958, DOI 10.1016/j.neurobiolaging.2013.08.039; FAVRE B, 1994, J BIOL CHEM, V269, P16311; Fukukawa C, 2005, INT J ONCOL, V26, P751; Goedert M, 2010, TRENDS NEUROSCI, V33, P317, DOI 10.1016/j.tins.2010.04.003; GONG CX, 1995, J NEUROCHEM, V65, P732, DOI 10.1046/j.1471-4159.1995.65020732.x; Gong CX, 1996, BRAIN RES, V741, P95, DOI 10.1016/S0006-8993(96)00904-3; Gong CX, 2005, J NEURAL TRANSM, V112, P813, DOI 10.1007/s00702-004-0221-0; GONG CX, 1993, J NEUROCHEM, V61, P921, DOI 10.1111/j.1471-4159.1993.tb03603.x; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Hernandez F, 2010, MOL CELL BIOCHEM, V344, P211, DOI 10.1007/s11010-010-0544-0; Iijima K, 2010, HUM MOL GENET, V19, P2947, DOI 10.1093/hmg/ddq200; Iqbal K, 2005, ACTA NEUROPATHOL, V109, P25, DOI 10.1007/s00401-004-0951-y; Iqbal K, 1998, NEUROBIOL AGING, V19, pS124; Iqbal K, 2009, ACTA NEUROPATHOL, V118, P53, DOI 10.1007/s00401-009-0486-3; Jeganathan S, 2008, J BIOL CHEM, V283, P32066, DOI 10.1074/jbc.M805300200; Katayose Y, 2000, J BIOL CHEM, V275, P9209, DOI 10.1074/jbc.275.13.9209; KOPKE E, 1993, J BIOL CHEM, V268, P24374; Lam BD, 2013, FEBS LETT, V587, P111, DOI 10.1016/j.febslet.2012.11.013; Li B, 2007, ACTA NEUROPATHOL, V113, P501, DOI 10.1007/s00401-007-0207-8; LI M, 1995, BIOCHEMISTRY-US, V34, P1988, DOI 10.1021/bi00006a020; Li M, 1996, J BIOL CHEM, V271, P11059, DOI 10.1074/jbc.271.19.11059; Liu F, 2005, EUR J NEUROSCI, V22, P1942, DOI 10.1111/j.1460-9568.2005.04391.x; Liu F, 2004, P NATL ACAD SCI USA, V101, P10804, DOI 10.1073/pnas.0400348101; Liu GP, 2008, NEUROBIOL AGING, V29, P1348, DOI 10.1016/j.neurobiolaging.2007.03.012; Luo M, 2004, TRAFFIC, V5, P847, DOI 10.1111/j.1600-0854.2004.00227.x; Madeira A, 2005, FASEB J, V19, P1905, DOI 10.1096/fj.05-3839fje; Mandelkow E, 2007, BRAIN PATHOL, V17, P83, DOI 10.1111/j.1750-3639.2007.00053.x; Pei JJ, 2003, AM J PATHOL, V163, P845, DOI 10.1016/S0002-9440(10)63445-1; Polydoro M, 2009, J NEUROSCI, V29, P10741, DOI 10.1523/JNEUROSCI.1065-09.2009; Qian W, 2010, J ALZHEIMERS DIS, V19, P1221, DOI [10.3233/JAD-2009-1317, 10.3233/JAD-2010-1317]; Qu DB, 2007, J NEUROCHEM, V103, P408, DOI 10.1111/j.1471-4159.2007.04747.x; Sayas CL, 2002, BBA-MOL CELL BIOL L, V1582, P144, DOI 10.1016/S1388-1981(02)00149-X; Seo SB, 2001, CELL, V104, P119, DOI 10.1016/S0092-8674(01)00196-9; SEUBERT P, 1995, J BIOL CHEM, V270, P18917, DOI 10.1074/jbc.270.32.18917; Shi JH, 2008, J BIOL CHEM, V283, P28660, DOI 10.1074/jbc.M802645200; Shin KS, 1999, J CELL BIOCHEM, V74, P119, DOI 10.1002/(SICI)1097-4644(19990701)74:1<119::AID-JCB13>3.0.CO;2-7; Singh TJ, 1996, FEBS LETT, V387, P145, DOI 10.1016/0014-5793(96)00485-1; SINGH TJ, 1995, FEBS LETT, V358, P4, DOI 10.1016/0014-5793(94)01383-C; Sironi JJ, 1998, FEBS LETT, V436, P471, DOI 10.1016/S0014-5793(98)01185-5; Small SA, 2008, NEURON, V60, P534, DOI 10.1016/j.neuron.2008.11.007; Sobral LM, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-32; Sontag JM, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00016; Sun XY, 2012, J BIOL CHEM, V287, P11174, DOI 10.1074/jbc.M111.309070; Tanimukai H, 2005, AM J PATHOL, V166, P1761, DOI 10.1016/S0002-9440(10)62486-8; Tatebayashi Y, 1999, J NEUROSCI, V19, P5245; ten Klooster JP, 2007, EMBO J, V26, P336, DOI 10.1038/sj.emboj.7601518; Tsujio I, 2005, FEBS LETT, V579, P363, DOI 10.1016/j.febslet.2004.11.097; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Wang JZ, 2007, EUR J NEUROSCI, V25, P59, DOI 10.1111/j.1460-9568.2006.05226.x; Wang XC, 2014, ACTA NEUROPATHOL, V127, P243, DOI 10.1007/s00401-013-1175-9; Wang XC, 2010, FASEB J, V24, P4420, DOI 10.1096/fj.10-158477; Yu G, 2013, NEUROBIOL AGING, V34, P1748, DOI 10.1016/j.neurobiolaging.2012.12.025; Yu XX, 2001, MOL BIOL CELL, V12, P185, DOI 10.1091/mbc.12.1.185; Zhu LQ, 2010, J NEUROSCI, V30, P3839, DOI 10.1523/JNEUROSCI.5174-09.2010	73	50	52	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27677	27691		10.1074/jbc.M114.565358	http://dx.doi.org/10.1074/jbc.M114.565358			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25128526	Green Published, hybrid			2022-12-25	WOS:000342852800027
J	Foulcer, SJ; Nelson, CM; Quintero, MV; Kuberan, B; Larkin, J; Dours-Zimmermann, MT; Zimmermann, DR; Apte, SS				Foulcer, Simon J.; Nelson, Courtney M.; Quintero, Maritza V.; Kuberan, Balagurunathan; Larkin, Jonathan; Dours-Zimmermann, Maria T.; Zimmermann, Dieter R.; Apte, Suneel S.			Determinants of Versican-V1 Proteoglycan Processing by the Metalloproteinase ADAMTS5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ADAMTS; Chondroitin Sulfate; Extracellular Matrix; Glycosaminoglycan; Metalloprotease; Proteoglycan; Proteolytic Enzyme; Aggrecanase; Blocking Antibody; Versican	CREST CELL-MIGRATION; SMOOTH-MUSCLE-CELLS; EXTRACELLULAR-MATRIX; PROTEOLYTIC CLEAVAGE; AGGRECANASE-1 ADAMTS-4; NONCATALYTIC DOMAINS; CHONDROITIN SULFATE; ARTICULAR-CARTILAGE; CRYSTAL-STRUCTURES; MULTIPLE DOMAINS	Background: The mechanisms of versican proteolysis by ADAMTS proteases are unknown. Results: The ADAMTS5 ancillary domain and specific chondroitin sulfate chains of versican are required for proteolysis. Conclusion: Docking between the ADAMTS5 ancillary domain and CS chains is a major mechanism underlying versican proteolysis. Proteolysis by ADAMTS1 has a similar requirement for GAG chains. Significance: The findings suggest strategies for blocking versican cleavage. Proteolysis of the Glu(441)-Ala(442) bond in the glycosaminoglycan (GAG) domain of the versican-V1 variant by a disintegrin-like and metalloproteinase domain with thrombospondin type 1 motif (ADAMTS) proteases is required for proper embryo morphogenesis. However, the processing mechanism and the possibility of additional ADAMTS-cleaved processing sites are unknown. We demonstrate here that if Glu(441) is mutated, ADAMTS5 cleaves inefficiently at a proximate upstream site but normally does not cleave elsewhere within the GAG domain. Chondroitin sulfate (CS) modification of versican is a prerequisite for cleavage at the Glu(441)-Ala(442) site, as demonstrated by reduced processing of CS-deficient or chondroitinase ABC-treated versican-V1. Site-directed mutagenesis identified the N-terminal CS attachment sites Ser(507) and Ser(525) as essential for processing of the Glu(441)-Ala(442) bond by ADAMTS5. A construct including only these two GAG chains, but not downstream GAG attachment sites, was cleaved efficiently. Therefore, CS chain attachment to Ser(507) and Ser(525) is necessary and sufficient for versican proteolysis by ADAMTS5. Mutagenesis of Glu(441) and an antibody to a peptide spanning Thr(432)-Gly(445) (i.e. containing the scissile bond) reduced versican-V1 processing. ADAMTS5 lacking the C-terminal ancillary domain did not cleave versican, and an ADAMTS5 ancillary domain construct bound versican-V1 via the CS chains. We conclude that docking of ADAMTS5 with two N-terminal GAG chains of versican-V1 via its ancillary domain is required for versican processing at Glu(441)-Ala(442). V1 proteolysis by ADAMTS1 demonstrated a similar requirement for the N-terminal GAG chains and Glu(441). Therefore, versican cleavage can be inhibited substantially by mutation of Glu(441), Ser(507), and Ser(525) or by an antibody to the region of the scissile bond.	[Foulcer, Simon J.; Nelson, Courtney M.; Apte, Suneel S.] Cleveland Clin, Dept Biomed Engn, Lerner Res Inst, Cleveland, OH 44195 USA; [Quintero, Maritza V.; Kuberan, Balagurunathan] Univ Utah, Hlth Sci Ctr, Dept Med Chem, Salt Lake City, UT 84112 USA; [Quintero, Maritza V.; Kuberan, Balagurunathan] Univ Utah, Hlth Sci Ctr, Dept Bioengn, Salt Lake City, UT 84112 USA; [Larkin, Jonathan] GlaxoSmithKline, Expt Med Unit, King Of Prussia, PA 19406 USA; [Dours-Zimmermann, Maria T.; Zimmermann, Dieter R.] Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland	Cleveland Clinic Foundation; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; GlaxoSmithKline; University of Zurich; University Zurich Hospital	Apte, SS (corresponding author), Cleveland Clin, Dept Biomed Engn, ND20,9500 Euclid Ave, Cleveland, OH 44195 USA.	aptes@ccf.org		Larkin, Jonathan/0000-0002-1202-9287; Balagurunathan, Kuberan/0000-0001-9203-8118; Quintero, Maritza/0000-0001-8879-7867; Apte, Suneel/0000-0001-8441-1226	National Institutes of Health Program of Excellence in Glycoscience Awards [P01 HL-107147, P01 HL-107152]; Sabrina's Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107147, P01HL107152] Funding Source: NIH RePORTER	National Institutes of Health Program of Excellence in Glycoscience Awards; Sabrina's Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Program of Excellence in Glycoscience Awards P01 HL-107147 (to S. S. A.) and P01 HL-107152 (to B. K.) and by funding from Sabrina's Foundation (to S. A.).	Akiyama M, 2009, P NATL ACAD SCI USA, V106, P19274, DOI 10.1073/pnas.0909755106; Aspberg A, 1999, J BIOL CHEM, V274, P20444, DOI 10.1074/jbc.274.29.20444; ASPBERG A, 1995, P NATL ACAD SCI USA, V92, P10590, DOI 10.1073/pnas.92.23.10590; Bai XM, 1999, J BIOL CHEM, V274, P13017, DOI 10.1074/jbc.274.19.13017; BodeLesniewska B, 1996, J HISTOCHEM CYTOCHEM, V44, P303, DOI 10.1177/44.4.8601689; Brown HM, 2006, DEV BIOL, V300, P699, DOI 10.1016/j.ydbio.2006.10.012; Brown HM, 2010, BIOL REPROD, V83, P549, DOI 10.1095/biolreprod.110.084434; Cattaruzza S, 2002, J BIOL CHEM, V277, P47626, DOI 10.1074/jbc.M206521200; Choocheep K, 2010, J BIOL CHEM, V285, P21114, DOI 10.1074/jbc.M109.096479; Dancevic CM, 2013, J BIOL CHEM, V288, P37267, DOI 10.1074/jbc.M112.418624; DOURSZIMMERMANN MT, 1994, J BIOL CHEM, V269, P32992; Dupuis LE, 2013, J MOL CELL CARDIOL, V60, P50, DOI 10.1016/j.yjmcc.2013.03.010; Dupuis LE, 2011, DEV BIOL, V357, P152, DOI 10.1016/j.ydbio.2011.06.041; Dutt S, 2006, J BIOL CHEM, V281, P12123, DOI 10.1074/jbc.M510834200; Dutt S, 2011, J NEUROSCI, V31, P5262, DOI 10.1523/JNEUROSCI.4897-10.2011; Enomoto H, 2010, DEVELOPMENT, V137, P4029, DOI 10.1242/dev.050591; Evanko SP, 1999, ARTERIOSCL THROM VAS, V19, P1004, DOI 10.1161/01.ATV.19.4.1004; Fosang AJ, 2008, NAT CLIN PRACT RHEUM, V4, P420, DOI 10.1038/ncprheum0841; Fushimi K, 2008, J BIOL CHEM, V283, P6706, DOI 10.1074/jbc.M708647200; Gao DC, 2012, CANCER RES, V72, P1384, DOI 10.1158/0008-5472.CAN-11-2905; Gendron C, 2007, J BIOL CHEM, V282, P18294, DOI 10.1074/jbc.M701523200; Hattori N, 2011, J BIOL CHEM, V286, P34298, DOI 10.1074/jbc.M111.254938; Henderson DJ, 1998, CIRC RES, V83, P523, DOI 10.1161/01.RES.83.5.523; Hering TM, 1997, ARCH BIOCHEM BIOPHYS, V345, P259, DOI 10.1006/abbi.1997.0261; ILIC MZ, 1992, ARCH BIOCHEM BIOPHYS, V294, P115, DOI 10.1016/0003-9861(92)90144-L; Isogai Z, 2002, J BIOL CHEM, V277, P4565, DOI 10.1074/jbc.M110583200; Kashiwagi M, 2004, J BIOL CHEM, V279, P10109, DOI 10.1074/jbc.M312123200; Kern CB, 2006, DEV DYNAM, V235, P2238, DOI 10.1002/dvdy.20838; Kern CB, 2010, MATRIX BIOL, V29, P304, DOI 10.1016/j.matbio.2010.01.005; Kischel P, 2010, INT J CANCER, V126, P640, DOI 10.1002/ijc.24812; Kuno K, 1998, J BIOL CHEM, V273, P13912, DOI 10.1074/jbc.273.22.13912; LANDOLT RM, 1995, DEVELOPMENT, V121, P2303; Lark MW, 1997, J CLIN INVEST, V100, P93, DOI 10.1172/JCI119526; LEBARON RG, 1992, J BIOL CHEM, V267, P10003; Lemire JM, 1999, ARTERIOSCL THROM VAS, V19, P1630, DOI 10.1161/01.ATV.19.7.1630; Longpre JM, 2009, INT J BIOCHEM CELL B, V41, P1116, DOI 10.1016/j.biocel.2008.10.008; Longpre JM, 2004, J BIOL CHEM, V279, P33237, DOI 10.1074/jbc.M313151200; Matsumoto K, 2003, J BIOL CHEM, V278, P41205, DOI 10.1074/jbc.M305060200; Matsumoto K, 2006, J BIOL CHEM, V281, P18257, DOI 10.1074/jbc.M510330200; Matthews RT, 2000, J BIOL CHEM, V275, P22695, DOI 10.1074/jbc.M909764199; McCulloch DR, 2009, DEV CELL, V17, P687, DOI 10.1016/j.devcel.2009.09.008; Miwa HE, 2006, MATRIX BIOL, V25, P534, DOI 10.1016/j.matbio.2006.07.004; Mjaatvedt CH, 1998, DEV BIOL, V202, P56, DOI 10.1006/dbio.1998.9001; Mosyak L, 2008, PROTEIN SCI, V17, P16, DOI 10.1110/ps.073287008; Munteanu SE, 2002, MATRIX BIOL, V21, P429, DOI 10.1016/S0945-053X(02)00034-3; Nandadasa S, 2014, MATRIX BIOL, V35, P34, DOI 10.1016/j.matbio.2014.01.005; Perissinotto D, 2000, DEVELOPMENT, V127, P2823; Ricciardelli C, 2009, CANCER METAST REV, V28, P233, DOI 10.1007/s10555-009-9182-y; Rodriguez-Manzaneque JC, 2002, BIOCHEM BIOPH RES CO, V293, P501; Russell DL, 2003, J BIOL CHEM, V278, P42330, DOI 10.1074/jbc.M300519200; Sandy JD, 2001, J BIOL CHEM, V276, P13372, DOI 10.1074/jbc.M009737200; Schmalfeldt M, 2000, J CELL SCI, V113, P807; Shi SL, 2004, J BIOL CHEM, V279, P12060, DOI 10.1074/jbc.M310091200; SHINOMURA T, 1993, J BIOL CHEM, V268, P14461; Silver DL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000003; Snow HE, 2005, ANAT REC PART A, V282A, P95, DOI 10.1002/ar.a.20151; Somerville RPT, 2003, J BIOL CHEM, V278, P9503, DOI 10.1074/jbc.M211009200; Stankunas K, 2008, DEV CELL, V14, P298, DOI 10.1016/j.devcel.2007.11.018; Tortorella M, 2000, J BIOL CHEM, V275, P25791, DOI 10.1074/jbc.M001065200; Tortorella MD, 2000, J BIOL CHEM, V275, P18566, DOI 10.1074/jbc.M909383199; Viapiano MS, 2008, J NEURO-ONCOL, V88, P261, DOI 10.1007/s11060-008-9575-8; Victor XV, 2009, J BIOL CHEM, V284, P25842, DOI 10.1074/jbc.M109.043208; Williams DR, 2005, BIOCHEM BIOPH RES CO, V334, P960, DOI 10.1016/j.bbrc.2005.06.189; Yamaguchi Y, 2000, CELL MOL LIFE SCI, V57, P276, DOI 10.1007/PL00000690; Yang BL, 2003, LIFE SCI, V73, P3399, DOI 10.1016/j.lfs.2003.06.018; Yee AJ, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1751; Zheng XL, 2013, J THROMB HAEMOST, V11, P11, DOI 10.1111/jth.12221; Zheng XL, 2010, HAEMATOL-HEMATOL J, V95, P1555, DOI 10.3324/haematol.2009.019299; ZIMMERMANN DR, 1989, EMBO J, V8, P2975, DOI 10.1002/j.1460-2075.1989.tb08447.x; ZIMMERMANN DR, 1994, J CELL BIOL, V124, P817, DOI 10.1083/jcb.124.5.817	70	37	37	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27859	27873		10.1074/jbc.M114.573287	http://dx.doi.org/10.1074/jbc.M114.573287			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25122765	hybrid, Green Accepted, Green Published			2022-12-25	WOS:000342852800042
J	Worth, AJ; Basu, SS; Snyder, NW; Mesaros, C; Blair, IA				Worth, Andrew J.; Basu, Sankha S.; Snyder, Nathaniel W.; Mesaros, Clementina; Blair, Ian A.			Inhibition of Neuronal Cell Mitochondrial Complex I with Rotenone Increases Lipid beta-Oxidation, Supporting Acetyl-Coenzyme A Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARKINSONS-DISEASE; REDUCTIVE CARBOXYLATION; DOPAMINERGIC-NEURONS; FAT UPTAKE; METABOLISM; DYSFUNCTION; STRESS; GLUTAMINE; SPECTROMETRY; GROWTH	Rotenone is a naturally occurring mitochondrial complex I inhibitor with a known association with parkinsonian phenotypes in both human populations and rodent models. Despite these findings, a clear mechanistic link between rotenone exposure and neuronal damage remains to be determined. Here, we report alterations to lipid metabolism in SH-SY5Y neuroblastoma cells exposed to rotenone. The absolute levels of acetylCoA were found to be maintained despite a significant decrease in glucose-derived acetyl-CoA. Furthermore, palmitoyl-CoA levels were maintained, whereas the levels of many of the medium- chain acyl-CoA species were significantly reduced. Additionally, using isotopologue analysis, we found that beta-oxidation of fatty acids with varying chain lengths helped maintain acetylCoA levels. Rotenone also induced increased glutamine utilization for lipogenesis, in part through reductive carboxylation, as has been found previously in other cell types. Finally, palmitoylcarnitine levels were increased in response to rotenone, indicating an increase in fatty acid import. Taken together, these findings show that alterations to lipid and glutamine metabolism play an important compensatory role in response to complex I inhibition by rotenone.	[Blair, Ian A.] Univ Penn, Ctr Canc Pharmacol, Philadelphia, PA 19104 USA; Univ Penn, Ctr Excellence Environm Toxicol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Blair, IA (corresponding author), Univ Penn, Ctr Canc Pharmacol, 854 BRB 2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.	ianblair@mail.med.upenn.edu		Snyder, Nathaniel/0000-0001-5643-8747	National Institutes of Health Grants [P30ES013508, T32GM008076, T32ES019851]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES019851, P30ES013508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008076] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P30ES013508, T32GM008076, and T32ES019851.	Basu SS, 2012, NAT PROTOC, V7, P1, DOI 10.1038/nprot.2011.421; Basu SS, 2011, CHEM RES TOXICOL, V24, P1630, DOI 10.1021/tx200366j; Basu SS, 2011, ANAL CHEM, V83, P1363, DOI 10.1021/ac1027353; BEAL MF, 1992, ANN NEUROL, V31, P119, DOI 10.1002/ana.410310202; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Cannon JR, 2009, NEUROBIOL DIS, V34, P279, DOI 10.1016/j.nbd.2009.01.016; Chassain C, 2005, EXP NEUROL, V191, P276, DOI 10.1016/j.expneurol.2004.09.017; Daye D, 2012, SEMIN CELL DEV BIOL, V23, P362, DOI 10.1016/j.semcdb.2012.02.002; DeBerardinis RJ, 2010, ONCOGENE, V29, P313, DOI 10.1038/onc.2009.358; DESROSIERS C, 1994, J BIOL CHEM, V269, P27179; Du QQ, 2015, J CHROMATOGR SCI, V53, P79, DOI 10.1093/chromsci/bmu022; Emadi A, 2014, EXP HEMATOL, V42, P247, DOI 10.1016/j.exphem.2013.12.001; Exner N, 2012, EMBO J, V31, P3038, DOI 10.1038/emboj.2012.170; Fan J, 2013, J BIOL CHEM, V288, P31363, DOI 10.1074/jbc.M113.502740; Gameiro PA, 2013, J BIOL CHEM, V288, P12967, DOI 10.1074/jbc.M112.396796; HARTLEY A, 1994, J NEUROCHEM, V63, P1987; Hauser DN, 2013, NEUROBIOL DIS, V51, P35, DOI 10.1016/j.nbd.2012.10.011; Henchcliffe C, 2008, ANN NY ACAD SCI, V1147, P206, DOI 10.1196/annals.1427.037; Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483; Kamphorst JJ, 2013, P NATL ACAD SCI USA, V110, P8882, DOI 10.1073/pnas.1307237110; Kim KY, 2012, CURR OPIN LIPIDOL, V23, P201, DOI 10.1097/MOL.0b013e328352dc5d; Kim KY, 2011, J CLIN INVEST, V121, P3701, DOI 10.1172/JCI44736; Lee SH, 2007, METHOD ENZYMOL, V433, P159, DOI 10.1016/S0076-6879(07)33009-7; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; Lowther J, 2012, BIOCHEM SOC T, V40, P547, DOI 10.1042/BST20110769; Mally J, 1997, J NEUROL SCI, V151, P159, DOI 10.1016/S0022-510X(97)00119-6; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Mullen AR, 2012, NATURE, V481, P385, DOI 10.1038/nature10642; Newman JC, 2012, J BIOL CHEM, V287, P42436, DOI 10.1074/jbc.R112.404863; Pickrell AM, 2013, MOL CELL NEUROSCI, V55, P87, DOI 10.1016/j.mcn.2012.08.002; Pieczenik SR, 2007, EXP MOL PATHOL, V83, P84, DOI 10.1016/j.yexmp.2006.09.008; Plaitakis A, 2000, J NEUROL, V247, P25, DOI 10.1007/PL00007757; Reitman ZJ, 2014, J BIOL CHEM, V289, P23318, DOI 10.1074/jbc.M114.575183; Shamoto-Nagai M, 2003, J NEUROSCI RES, V74, P589, DOI 10.1002/jnr.10777; Singh G, 2000, ANAL CHEM, V72, P3007, DOI 10.1021/ac000374a; Snyder NW, 2013, JOVE-J VIS EXP, DOI 10.3791/50433; Subramaniam SR, 2013, PROG NEUROBIOL, V106, P17, DOI 10.1016/j.pneurobio.2013.04.004; Tanner CM, 2011, ENVIRON HEALTH PERSP, V119, P866, DOI 10.1289/ehp.1002839; Taylor JM, 2013, NEUROCHEM INT, V62, P803, DOI 10.1016/j.neuint.2012.12.016; Varcin M, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/624925; Weber CA, 2006, ANN PHARMACOTHER, V40, P935, DOI 10.1345/aph.1G551; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Xie HR, 2010, CHINESE MED J-PEKING, V123, P1086, DOI 10.3760/cma.j.issn.0366-6999.2010.08.021; Zhang GF, 2011, J BIOL CHEM, V286, P23631, DOI 10.1074/jbc.R110.171405; Zhang ZH, 2011, NAT CHEM BIOL, V7, P58, DOI [10.1038/nchembio.495, 10.1038/NCHEMBIO.495]; Zhou C, 2008, ANN NY ACAD SCI, V1147, P93, DOI 10.1196/annals.1427.023	46	32	32	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					26895	26903		10.1074/jbc.M114.591354	http://dx.doi.org/10.1074/jbc.M114.591354			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25122772	Green Published, hybrid			2022-12-25	WOS:000342853900020
J	Amacher, JF; Zhao, RZ; Spaller, MR; Madden, DR				Amacher, Jeanine F.; Zhao, Ruizhi; Spaller, Mark R.; Madden, Dean R.			Chemically Modified Peptide Scaffolds Target the CFTR-Associated Ligand PDZ Domain	PLOS ONE			English	Article							PROTEIN INTERACTIONS; BINDING; INHIBITORS; SELECTIVITY; AFFINITY; DESIGN; PSD-95	PDZ domains are protein-protein interaction modules that coordinate multiple signaling and trafficking pathways in the cell and that include active therapeutic targets for diseases such as cancer, cystic fibrosis, and addiction. Our previous work characterized a PDZ interaction that restricts the apical membrane half-life of the cystic fibrosis transmembrane conductance regulator (CFTR). Using iterative cycles of peptide-array and solution-binding analysis, we targeted the PDZ domain of the CFTR-Associated Ligand (CAL), and showed that an engineered peptide inhibitor rescues cell-surface expression of the most common CFTR disease mutation Delta F508. Here, we present a series of scaffolds containing chemically modifiable side chains at all non-motif positions along the CAL PDZ domain binding cleft. Concordant equilibrium dissociation constants were determined in parallel by fluorescence polarization, isothermal titration calorimetry, and surface plasmon resonance techniques, confirming robust affinity for each scaffold and revealing an enthalpically driven mode of inhibitor binding. Structural studies demonstrate a conserved binding mode for each peptide, opening the possibility of combinatorial modification. Finally, we diversified one of our peptide scaffolds with halogenated substituents that yielded modest increases in binding affinity. Overall, this work validates our approach and provides a stereochemical foundation for further CAL inhibitor design and screening.	[Amacher, Jeanine F.; Madden, Dean R.] Geisel Sch Med Dartmouth, Dept Biochem, Hanover, NH 03755 USA; [Zhao, Ruizhi; Spaller, Mark R.] Dartmouth Coll, Dept Chem, Hanover, NH 03755 USA; [Zhao, Ruizhi; Spaller, Mark R.] Dartmouth Hitchcock Med Ctr, Norris Cotton Canc Ctr, Lebanon, NH 03766 USA; [Spaller, Mark R.] Geisel Sch Med Dartmouth, Dept Pharmacol & Toxicol, Hanover, NH USA	Dartmouth College; Dartmouth College; Dartmouth College; Norris Cotton Cancer Center; Dartmouth College	Madden, DR (corresponding author), Geisel Sch Med Dartmouth, Dept Biochem, Hanover, NH 03755 USA.	drm0001@dartmouth.edu			National Institutes of Health (NIH) [R01-DK101541, P30-GM106394, T32-DK007301, R01-CA150190]; Hitchcock Foundation; Program Project Grant (PPG; NATIONAL CANCER INSTITUTE [P30CA023108, R01CA150190] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK101541, T32DK007301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM106394] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hitchcock Foundation; Program Project Grant (PPG; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH): http://grants.nih.gov/grants/oer.htm, 1. R01-DK101541 to DRM, 2. P30-GM106394 to DRM, 3. T32-DK007301 to JFA, 4. R01-CA150190 to MRS, and The Hitchcock Foundation: http://med.dartmouth-hitchcock.org/hitchcock_foundation.html, Program Project Grant (PPG) to DRM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Amacher JF, 2014, STRUCTURE, V22, P82, DOI 10.1016/j.str.2013.09.019; Amacher JF, 2013, J BIOL CHEM, V288, P5114, DOI 10.1074/jbc.M112.401588; Amacher JF, 2011, ACTA CRYSTALLOGR F, V67, P600, DOI 10.1107/S1744309111009985; Bach A, 2011, J MED CHEM, V54, P1333, DOI 10.1021/jm1013924; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen XS, 2007, ASSAY DRUG DEV TECHN, V5, P769, DOI 10.1089/adt.2007.092; Craik DJ, 2013, CHEM BIOL DRUG DES, V81, P136, DOI 10.1111/cbdd.12055; Cushing PR, 2008, BIOCHEMISTRY-US, V47, P10084, DOI 10.1021/bi8003928; Cushing PR, 2010, ANGEW CHEM INT EDIT, V49, P9907, DOI 10.1002/anie.201005585; Davey NE, 2012, MOL BIOSYST, V8, P268, DOI 10.1039/c1mb05231d; DeLano WL., 2020, PYMOL MOL GRAPHICS S; Dev KK, 2004, NAT REV DRUG DISCOV, V3, P1047, DOI 10.1038/nrd1578; Drew K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067051; Feng J, 1998, PDB VALIDATION SERVE; Higueruelo AP, 2013, CURR OPIN PHARMACOL, V13, P791, DOI 10.1016/j.coph.2013.05.009; Kundu R, 2012, ANGEW CHEM INT EDIT, V51, P7217, DOI 10.1002/anie.201202291; Li T, 2004, BIOORG MED CHEM LETT, V14, P1385, DOI 10.1016/j.bmcl.2003.09.103; Lim IA, 2002, J BIOL CHEM, V277, P21697, DOI 10.1074/jbc.M112339200; Lohan S, 2013, MINI-REV MED CHEM, V13, P1073, DOI 10.2174/1389557511313070010; Memic A, 2008, CHEMBIOCHEM, V9, P2793, DOI 10.1002/cbic.200800572; Patra CR, 2012, ACS CHEM BIOL, V7, P770, DOI 10.1021/cb200536r; Piserchio A, 2004, CHEM BIOL, V11, P469, DOI 10.1016/j.chembiol.2004.03.013; Reina J, 2002, NAT STRUCT BIOL, V9, P621, DOI 10.1038/nsb815; Roberts KE, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002477; Saff EB, 1997, MATH INTELL, V19, P5, DOI 10.1007/BF03024331; Saro D, 2007, BIOCHEMISTRY-US, V46, P6340, DOI 10.1021/bi062088k; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Thorsen TS, 2010, P NATL ACAD SCI USA, V107, P413, DOI 10.1073/pnas.0902225107; Udugamasooriya DG, 2008, CHEMBIOCHEM, V9, P1587, DOI 10.1002/cbic.200800126; Vouilleme L, 2010, ANGEW CHEM INT EDIT, V49, P9912, DOI 10.1002/anie.201005575; Whitby LR, 2012, ACCOUNTS CHEM RES, V45, P1698, DOI 10.1021/ar300025n; Wolde M, 2007, J BIOL CHEM, V282, P8099, DOI 10.1074/jbc.M611049200; Yan XJ, 2009, J MOL BIOL, V392, P967, DOI 10.1016/j.jmb.2009.07.060; Zhang YN, 2009, NAT CHEM BIOL, V5, P217, DOI 10.1038/nchembio.152; Zhao R, 2012, THESIS DARTMOUTH COL, P128; Zhou SY, 1999, PROG BIOPHYS MOL BIO, V71, P359, DOI 10.1016/S0079-6107(98)00045-5	39	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e103650	10.1371/journal.pone.0103650	http://dx.doi.org/10.1371/journal.pone.0103650			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136860	Green Published, Green Submitted, gold			2022-12-25	WOS:000340742100011
J	Makarevic, J; Rutz, J; Juengel, E; Kaulfuss, S; Reiter, M; Tsaur, I; Bartsch, G; Haferkamp, A; Blaheta, RA				Makarevic, Jasmina; Rutz, Jochen; Juengel, Eva; Kaulfuss, Silke; Reiter, Michael; Tsaur, Igor; Bartsch, Georg; Haferkamp, Axel; Blaheta, Roman A.			Amygdalin Blocks Bladder Cancer Cell Growth In Vitro by Diminishing Cyclin A and cdk2	PLOS ONE			English	Article							P27(KIP1) EXPRESSION; ACTIVATION; APOPTOSIS; LAETRILE; COMPLEMENTARY; DOXORUBICIN; CARCINOMA; SURVIVAL; KINASES; PATHWAY	Amygdalin, a natural compound, has been used by many cancer patients as an alternative approach to treat their illness. However, whether or not this substance truly exerts an anti-tumor effect has never been settled. An in vitro study was initiated to investigate the influence of amygdalin (1.25-10 mg/ml) on the growth of a panel of bladder cancer cell lines (UMUC-3, RT112 and TCCSUP). Tumor growth, proliferation, clonal growth and cell cycle progression were investigated. The cell cycle regulating proteins cdk1, cdk2, cdk4, cyclin A, cyclin B, cyclin D1, p19, p27 as well as the mammalian target of rapamycin (mTOR) related signals phosphoAkt, phosphoRaptor and phosphoRictor were examined. Amygdalin dose-dependently reduced growth and proliferation in all three bladder cancer cell lines, reflected in a significant delay in cell cycle progression and G0/G1 arrest. Molecular evaluation revealed diminished phosphoAkt, phosphoRictor and loss of Cdk and cyclin components. Since the most outstanding effects of amygdalin were observed on the cdk2-cyclin A axis, siRNA knock down studies were carried out, revealing a positive correlation between cdk2/cyclin A expression level and tumor growth. Amygdalin, therefore, may block tumor growth by down-modulating cdk2 and cyclin A. In vivo investigation must follow to assess amygdalin's practical value as an anti-tumor drug.	[Makarevic, Jasmina; Rutz, Jochen; Juengel, Eva; Reiter, Michael; Tsaur, Igor; Bartsch, Georg; Haferkamp, Axel; Blaheta, Roman A.] Goethe Univ Hosp, Dept Urol, Frankfurt, Germany; [Kaulfuss, Silke] Univ Med Ctr Gottingen, Inst Human Genet, Gottingen, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Gottingen	Blaheta, RA (corresponding author), Goethe Univ Hosp, Dept Urol, Frankfurt, Germany.	Blaheta@em.uni-frankfurt.de	Tsaur, Igor/ACG-6445-2022	Tsaur, Igor/0000-0001-5107-3523; Kaulfuss, Silke/0000-0003-2577-9711	Brigitta und Norbert Muth Stiftung; Freunde und Forderer der Goethe-Universitat Frankfurt; RAB	Brigitta und Norbert Muth Stiftung; Freunde und Forderer der Goethe-Universitat Frankfurt; RAB	This work was supported by the "Brigitta und Norbert Muth Stiftung'' (http://www.muth-stiftung.de) and the "Freunde und Forderer der Goethe-Universitat Frankfurt'' (http://www2.uni-frankfurt.de). The funding was received by RAB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blaveri E, 2005, CLIN CANCER RES, V11, P4044, DOI 10.1158/1078-0432.CCR-04-2409; Boss DS, 2010, ANN ONCOL, V21, P884, DOI 10.1093/annonc/mdp377; Calderaro J, 2014, INT J CANCER, V134, P1776, DOI 10.1002/ijc.28518; Canavese M, 2012, CANCER BIOL THER, V13, P451, DOI 10.4161/cbt.19589; Chang HK, 2006, BIOL PHARM BULL, V29, P1597, DOI 10.1248/bpb.29.1597; Chen Y, 2013, IMMUNOPHARM IMMUNOT, V35, P43, DOI 10.3109/08923973.2012.738688; Citrin DL, 2012, ONCOLOGIST, V17, P607, DOI 10.1634/theoncologist.2011-0468; Edwards BK, 2010, CANCER-AM CANCER SOC, V116, P544, DOI 10.1002/cncr.24760; Gillett J, 2012, J ALTERN COMPLEM MED, V18, P1014, DOI 10.1089/acm.2011.0334; Gogolin S, 2013, CELL CYCLE, V12, P1091, DOI 10.4161/cc.24091; Gupta S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081081; Huebner J, 2014, ANTICANCER RES, V34, P943; Juengel E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053100; Kaufman DS, 2009, LANCET, V374, P239, DOI 10.1016/S0140-6736(09)60491-8; Kwon HY, 2003, ARCH PHARM RES, V26, P157, DOI 10.1007/BF02976663; Liang PI, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-611; Lohberger B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066300; Lotan Y, 2013, EUR UROL, V64, P465, DOI 10.1016/j.eururo.2013.03.043; Merrick KA, 2008, MOL CELL, V32, P662, DOI 10.1016/j.molcel.2008.10.022; Milazzo S, 2007, SUPPORT CARE CANCER, V15, P583, DOI 10.1007/s00520-006-0168-9; Mirmiranpour H, 2012, INDIAN J PATHOL MICR, V55, P211, DOI 10.4103/0377-4929.97874; MOERTEL CG, 1982, NEW ENGL J MED, V306, P201, DOI 10.1056/NEJM198201283060403; Moss Ralph W, 2005, Integr Cancer Ther, V4, P65, DOI 10.1177/1534735404273918; Mundhenk J, 2011, ONCOL LETT, V2, P1089, DOI 10.3892/ol.2011.374; NEWELL GR, 1980, CANCER TREAT REP, V64, P363; Pantazis E, 2011, J BUON, V16, P323; Park HJ, 2005, WORLD J GASTROENTERO, V11, P5156; Pitts TM, 2014, PHARMACOL THERAPEUT, V142, P258, DOI 10.1016/j.pharmthera.2013.12.010; Populo H, 2012, INT J MOL SCI, V13, P1886, DOI 10.3390/ijms13021886; Rabbani F, 2007, BJU INT, V100, P259, DOI 10.1111/j.1464-410X.2007.06927.x; See WL, 2010, CELL CYCLE, V9, P1562, DOI 10.4161/cc.9.8.11259; Tang YX, 2009, MOL CANCER THER, V8, P458, DOI 10.1158/1535-7163.MCT-08-0885; Tsaur I, 2011, CANCER LETT, V313, P84, DOI 10.1016/j.canlet.2011.08.026; von der Maase H, 2005, J CLIN ONCOL, V23, P4602, DOI 10.1200/JCO.2005.07.757; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Wu X, 2014, ONCOGENE, V33, P1506, DOI 10.1038/onc.2013.108	36	48	56	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105590	10.1371/journal.pone.0105590	http://dx.doi.org/10.1371/journal.pone.0105590			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136960	Green Published, gold			2022-12-25	WOS:000340742100111
J	Sun, PS; Wahbi, S; Tsonev, T; Haworth, M; Liu, SR; Centritto, M				Sun, Pengsen; Wahbi, Said; Tsonev, Tsonko; Haworth, Matthew; Liu, Shirong; Centritto, Mauro			On the Use of Leaf Spectral Indices to Assess Water Status and Photosynthetic Limitations in Olea europaea L. during Water-Stress and Recovery	PLOS ONE			English	Article							PHOTOCHEMICAL REFLECTANCE INDEX; CARBON-ISOTOPE DISCRIMINATION; GAS-EXCHANGE; DROUGHT STRESS; USE EFFICIENCY; DIFFUSIONAL LIMITATIONS; MESOPHYLL CONDUCTANCE; PHYSIOLOGICAL STATUS; ISOPRENE EMISSION; OLIVE	Diffusional limitations to photosynthesis, relative water content (RWC), pigment concentrations and their association with reflectance indices were studied in olive (Olea europaea) saplings subjected to water-stress and re-watering. RWC decreased sharply as drought progressed. Following rewatering, RWC gradually increased to pre-stress values. Photosynthesis (A), stomatal conductance (g(s)), mesophyll conductance (g(m)), total conductance (g(t)), photochemical reflectance index (PRI), water index (WI) and relative depth index (RDI) closely followed RWC. In contrast, carotenoid concentration, the carotenoid to chlorophyll ratio, water content reflectance index (WCRI) and structural independent pigment index (SIPI) showed an opposite trend to that of RWC. Photosynthesis scaled linearly with leaf conductance to CO2; however, A measured under non-photorespiratory conditions (A(1%O2)) was approximately two times greater than A measured at 21% [O-2], indicating that photorespiration likely increased in response to drought. A(1%O2) also significantly correlated with leaf conductance parameters. These relationships were apparent in saturation type curves, indicating that under non-photorespiratory conditions, CO2 conductance was not the major limitations to A. PRI was significant correlated with RWC. PRI was also very sensitive to pigment concentrations and photosynthesis, and significantly tracked all CO2 conductance parameters. WI, RDI and WCRI were all significantly correlated with RWC, and most notably to leaf transpiration. Overall, PRI correlated more closely with carotenoid concentration than SIPI; whereas WI tracked leaf transpiration more effectively than RDI and WCRI. This study clearly demonstrates that PRI and WI can be used for the fast detection of physiological traits of olive trees subjected to water-stress.	[Sun, Pengsen; Liu, Shirong] Chinese Acad Forestry, Inst Forest Ecol Environm & Protect, Beijing, Peoples R China; [Wahbi, Said] Univ Cadi Ayyad, Fac Sci Semlalia, Lab Biotechnol & Physiol Vegetale, Marrakech, Morocco; [Tsonev, Tsonko] Bulgarian Acad Sci, Inst Plant Physiol & Genet, Sofia, Bulgaria; [Haworth, Matthew; Centritto, Mauro] CNR, Trees & Timber Inst, Florence, Italy	Chinese Academy of Forestry; Research Institute of Forest Ecology, Environment and Protection, CAF; Cadi Ayyad University of Marrakech; Bulgarian Academy of Sciences; Consiglio Nazionale delle Ricerche (CNR); Istituto per la Valorizzazione del Legno e delle Specie Arboree (IVALSA-CNR)	Centritto, M (corresponding author), CNR, Trees & Timber Inst, Florence, Italy.	mauro.centritto@cnr.it	Tsonev, Tsonko/AAC-3949-2019; Tsonev, Tsonko/A-7469-2008; Haworth, Matthew/B-7817-2013	Tsonev, Tsonko/0000-0003-0165-7269; Sun, Pengsen/0000-0002-0099-4661; Haworth, Matthew/0000-0002-3225-6620; WAHBI, Said/0000-0002-3066-5586	National Natural Science Foundation of China [31290223]; Key Laboratory of Forest Ecology and Environment of State Forestry Administration of China; Ministero dellIstruzione dellUniversit della Ricerca of Italy	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory of Forest Ecology and Environment of State Forestry Administration of China; Ministero dellIstruzione dellUniversit della Ricerca of Italy(Ministry of Education, Universities and Research (MIUR))	Financial support was provided by the National Natural Science Foundation of China (Grant No. 31290223), the Key Laboratory of Forest Ecology and Environment of State Forestry Administration of China, and the Ministero dellIstruzione dellUniversit della Ricerca of Italy: PRIN 2010-2011 PRO-ROOT and Progetto Premiale 2012 Aqua. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aganchich B, 2009, TREE PHYSIOL, V29, P685, DOI 10.1093/treephys/tpp012; ARP WJ, 1991, PLANT CELL ENVIRON, V14, P869, DOI 10.1111/j.1365-3040.1991.tb01450.x; Brilli F, 2013, J EXP BOT, V64, P519, DOI 10.1093/jxb/ers353; Centritto M, 2005, AGR ECOSYST ENVIRON, V106, P303, DOI 10.1016/j.agee.2004.10.016; Centritto M, 2003, PLANT CELL ENVIRON, V26, P585, DOI 10.1046/j.1365-3040.2003.00993.x; Centritto M, 1999, TREE PHYSIOL, V19, P799; Centritto M, 2011, TREE PHYSIOL, V31, P275, DOI 10.1093/treephys/tpq112; Centritto M, 2011, ECOL STUD-ANAL SYNTH, V212, P31, DOI 10.1007/978-90-481-9834-4_3; Centritto M, 2009, J EXP BOT, V60, P2325, DOI 10.1093/jxb/erp123; Dai AG, 2011, WIRES CLIM CHANGE, V2, P45, DOI 10.1002/wcc.81; Demmig-Adams B, 2000, NATURE, V403, P371, DOI 10.1038/35000315; Diaz-Espejo A, 2007, PLANT CELL ENVIRON, V30, P922, DOI 10.1111/j.1365-3040.2007.001686.x; Dobrowski SZ, 2005, REMOTE SENS ENVIRON, V97, P403, DOI 10.1016/j.rse.2005.05.006; Fereres E, 2011, J EXP BOT, V62, P4079, DOI 10.1093/jxb/err165; Filella I, 2009, INT J REMOTE SENS, V30, P4443, DOI 10.1080/01431160802575661; Flexas J, 2007, J EXP BOT, V58, P1533, DOI 10.1093/jxb/erm027; Flexas J, 2008, PLANT CELL ENVIRON, V31, P602, DOI 10.1111/j.1365-3040.2007.01757.x; Flexas J, 2013, PHOTOSYNTH RES, V117, P45, DOI 10.1007/s11120-013-9844-z; GAMON JA, 1992, REMOTE SENS ENVIRON, V41, P35, DOI 10.1016/0034-4257(92)90059-S; Garbulsky MF, 2011, REMOTE SENS ENVIRON, V115, P281, DOI 10.1016/j.rse.2010.08.023; Guan XQ, 2004, PHOTOSYNTHETICA, V42, P31, DOI 10.1023/B:PHOT.0000040566.55149.52; Guo JM, 2004, FUNCT PLANT BIOL, V31, P255, DOI 10.1071/FP03185; Gutierrez M, 2010, J EXP BOT, V61, P3291, DOI 10.1093/jxb/erq156; ISMAIL AM, 1994, AUST J PLANT PHYSIOL, V21, P23, DOI 10.1071/PP9940023; Lawlor DW, 2002, PLANT CELL ENVIRON, V25, P275, DOI 10.1046/j.0016-8025.2001.00814.x; Loreto F, 2008, PLANT BIOSYST, V142, P154, DOI 10.1080/11263500701872937; Magnani F, 1996, PLANTA, V199, P296, DOI 10.1007/BF00196572; Marino G, 2014, ENVIRON EXP BOT, V99, P43, DOI 10.1016/j.envexpbot.2013.10.008; Moriana A, 2002, PLANT CELL ENVIRON, V25, P395, DOI 10.1046/j.0016-8025.2001.00822.x; Ollinger SV, 2011, NEW PHYTOL, V189, P375, DOI 10.1111/j.1469-8137.2010.03536.x; Osorio J, 2012, FUNCT PLANT BIOL, V39, P588, DOI 10.1071/FP11284; Penuelas J, 1998, TRENDS PLANT SCI, V3, P151, DOI 10.1016/S1360-1385(98)01213-8; PENUELAS J, 1995, NEW PHYTOL, V131, P291, DOI 10.1111/j.1469-8137.1995.tb03064.x; Ripullone F, 2011, FUNCT PLANT BIOL, V38, P177, DOI 10.1071/FP10078; Rodeghiero M, 2007, PLANT CELL ENVIRON, V30, P1006, DOI 10.1111/j.1365-3040.2007.001689.x; Sage RF, 2013, PLANT BIOLOGY, V15, P624, DOI 10.1111/plb.12024; Sarlikioti V, 2010, ANN APPL BIOL, V157, P81, DOI 10.1111/j.1744-7348.2010.00411.x; Serrano L, 2010, AGR ECOSYST ENVIRON, V139, P490, DOI 10.1016/j.agee.2010.09.007; Sims DA, 2002, REMOTE SENS ENVIRON, V81, P337, DOI 10.1016/S0034-4257(02)00010-X; Suarez L, 2008, REMOTE SENS ENVIRON, V112, P560, DOI 10.1016/j.rse.2007.05.009; Sun P, 2008, INT J REMOTE SENS, V29, P1725, DOI 10.1080/01431160701373754; Tsonev T, 2014, INT J AGRIC BIOL, V16, P335; WELLBURN AR, 1994, J PLANT PHYSIOL, V144, P307, DOI 10.1016/S0176-1617(11)81192-2; Wingler A, 1999, PLANT CELL ENVIRON, V22, P361, DOI 10.1046/j.1365-3040.1999.00410.x	44	34	37	3	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105165	10.1371/journal.pone.0105165	http://dx.doi.org/10.1371/journal.pone.0105165			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136798	Green Published, gold			2022-12-25	WOS:000340742100072
J	Li, QL; Li, M; Ma, L; Li, WZ; Wu, XH; Richards, J; Fu, GX; Xu, W; Bythwood, T; Li, X; Wang, JX; Song, Q				Li, Qiling; Li, Min; Ma, Li; Li, Wenzhi; Wu, Xuehong; Richards, Jendai; Fu, Guoxing; Xu, Wei; Bythwood, Tameka; Li, Xu; Wang, Jianxin; Song, Qing			A Method to Evaluate Genome-Wide Methylation in Archival Formalin-Fixed, Paraffin-Embedded Ovarian Epithelial Cells	PLOS ONE			English	Article							NUCLEIC-ACIDS; GENE-EXPRESSION; DNA METHYLATION; MESSENGER-RNA; EXTRACTION; TISSUE; PCR; AMPLIFICATION; CANCER; ASSAY	Background: The use of DNA from archival formalin and paraffin embedded (FFPE) tissue for genetic and epigenetic analyses may be problematic, since the DNA is often degraded and only limited amounts may be available. Thus, it is currently not known whether genome-wide methylation can be reliably assessed in DNA from archival FFPE tissue. Methodology/Principal Findings: Ovarian tissues, which were obtained and formalin-fixed and paraffin-embedded in either 1999 or 2011, were sectioned and stained with hematoxylin-eosin (H&E). Epithelial cells were captured by laser micro dissection, and their DNA subjected to whole genomic bisulfite conversion, whole genomic polymerase chain reaction (PCR) amplification, and purification. Sequencing and software analyses were performed to identify the extent of genomic methylation. We observed that 31.7% of sequence reads from the DNA in the 1999 archival FFPE tissue, and 70.6% of the reads from the 2011 sample, could be matched with the genome. Methylation rates of CpG on the Watson and Crick strands were 32.2% and 45.5%, respectively, in the 1999 sample, and 65.1% and 42.7% in the 2011 sample. Conclusions/Significance: We have developed an efficient method that allows DNA methylation to be assessed in archival FFPE tissue samples.	[Li, Qiling; Li, Xu; Song, Qing] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Xian 710049, Shaanxi, Peoples R China; [Li, Qiling; Ma, Li; Li, Wenzhi; Richards, Jendai; Fu, Guoxing; Xu, Wei; Bythwood, Tameka; Song, Qing] Morehouse Sch Med, Cardiovasc Res Inst, Atlanta, GA 30310 USA; [Li, Min; Wu, Xuehong; Wang, Jianxin] Cent South Univ, Sch Informat Sci & Engn, Changsha, Hunan, Peoples R China	Xi'an Jiaotong University; Morehouse School of Medicine; Central South University	Li, QL (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Xian 710049, Shaanxi, Peoples R China.	liqilinglady@163.com; qsong@msm.edu	Wang, Jianxin/V-2800-2018; LI, MIN/U-3131-2018; wang, jian/GVS-0711-2022; Ma, Li/AIF-3892-2022	Wang, Jianxin/0000-0003-1516-0480; LI, MIN/0000-0002-0188-1394; wu, xuehong/0000-0003-4861-5648; Li, Qiling/0000-0003-3763-4456	National Institutes of Health [HL003676, RR014758, RR003034]; American Heart Association [09GRNT2300003]; Baltimore Research Enhancement Award Program in Stroke and the Baltimore Geriatrics Research, Education, and Clinical Center of the Department of Veterans Affairs; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR014758] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [S21MD000101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Baltimore Research Enhancement Award Program in Stroke and the Baltimore Geriatrics Research, Education, and Clinical Center of the Department of Veterans Affairs; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by National Institutes of Health grants [HL003676, RR014758, RR003034]; American Heart Association grant [09GRNT2300003]; and in part by the Baltimore Research Enhancement Award Program in Stroke and the Baltimore Geriatrics Research, Education, and Clinical Center of the Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avila L, 2010, PLACENTA, V31, P1070, DOI 10.1016/j.placenta.2010.09.011; Balic M, 2009, J MOL DIAGN, V11, P102, DOI 10.2353/jmoldx.2009.080109; Bonin S, 2005, J CLIN PATHOL, V58, P313, DOI 10.1136/jcp.2004.016477; Bonin S, 2010, VIRCHOWS ARCH, V457, P309, DOI 10.1007/s00428-010-0917-5; Bosso M, 2011, METHODS MOL BIOL, V724, P161, DOI 10.1007/978-1-61779-055-3_11; Butte AJ, 2001, PHYSIOL GENOMICS, V7, P95, DOI 10.1152/physiolgenomics.2001.7.2.95; Chu TY, 2002, INT J GYNECOL CANCER, V12, P171, DOI 10.1046/j.1525-1438.2002.01085.x; Chun J, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-101; Chung JY, 2012, ANAL BIOCHEM, V425, P128, DOI 10.1016/j.ab.2012.03.012; Clark SJ, 2006, NAT PROTOC, V1, P2353, DOI 10.1038/nprot.2006.324; Eisenberg E, 2013, TRENDS GENET, V29, P569, DOI 10.1016/j.tig.2013.05.010; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Feldman M Y, 1973, Prog Nucleic Acid Res Mol Biol, V13, P1, DOI 10.1016/S0079-6603(08)60099-9; Fraga ME, 2002, BIOTECHNIQUES, V33, P632, DOI 10.2144/02333rv01; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Fu GX, 2008, APOPTOSIS, V13, P1291, DOI 10.1007/s10495-008-0259-9; Fu GX, 2011, BIOCHEMISTRY-US, V50, P6292, DOI 10.1021/bi200831a; Fu GX, 2010, BIOCHEMISTRY-US, V49, P8535, DOI 10.1021/bi1005865; Gagnon JF, 2010, EXP MOL PATHOL, V88, P184, DOI 10.1016/j.yexmp.2009.09.020; Gilbert MTP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000537; Gu H, 2010, NAT METHODS, V7, P133, DOI 10.1038/nmeth.1414; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hewitt SM, 2008, ARCH PATHOL LAB MED, V132, P1929, DOI 10.1043/1543-2165-132.12.1929; Irahara N, 2010, J MOL DIAGN, V12, P177, DOI 10.2353/jmoldx.2010.090106; Killian JK, 2009, CANCER RES, V69, P758, DOI 10.1158/0008-5472.CAN-08-2984; Kitazawa S, 2000, LAB INVEST, V80, P275, DOI 10.1038/labinvest.3780031; Klopfleisch R, 2011, HISTOL HISTOPATHOL, V26, P797, DOI 10.14670/HH-26.797; Kristensen LS, 2009, CLIN CHEM, V55, P1471, DOI 10.1373/clinchem.2008.121962; LARGEY JS, 1993, CANCER, V71, P1933, DOI 10.1002/1097-0142(19930315)71:6<1933::AID-CNCR2820710602>3.0.CO;2-D; Lehmann U, 2001, METHODS, V25, P409, DOI 10.1006/meth.2001.1263; LEONARD S, 1993, BIOL PSYCHIAT, V33, P456, DOI 10.1016/0006-3223(93)90174-C; Lewis F, 2001, J PATHOL, V195, P66, DOI 10.1002/1096-9896(200109)195:1<66::AID-PATH921>3.0.CO;2-F; Li QL, 2014, TRANSGENIC RES, V23, P341, DOI 10.1007/s11248-013-9773-9; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Ma L, 2010, NAT METHODS, V7, P299, DOI [10.1038/NMETH.1443, 10.1038/nmeth.1443]; Okello JBA, 2010, ANAL BIOCHEM, V400, P110, DOI 10.1016/j.ab.2010.01.014; Pavelic J, 1996, NEOPLASMA, V43, P75; Poljak M, 2000, PFLUG ARCH EUR J PHY, V439, pR42, DOI 10.1007/s004240000085; Rao WN, 2013, NAT METHODS, V10, P6, DOI 10.1038/nmeth.2308; Santos MCLG, 2008, PATHOL RES PRACT, V204, P633, DOI 10.1016/j.prp.2008.04.005; Shi SR, 2004, HISTOCHEM CELL BIOL, V122, P211, DOI 10.1007/s00418-004-0693-x; Spencer DH, 2013, J MOL DIAGN, V15, P623, DOI 10.1016/j.jmoldx.2013.05.004; Vaught Jimmie, 2011, Journal of the National Cancer Institute Monographs, P24, DOI 10.1093/jncimonographs/lgr009; Wang LT, 1996, J CLIN PATHOL-CL MOL, V49, pM176; Wu L, 2002, APPL IMMUNOHISTO M M, V10, P269, DOI 10.1097/00022744-200209000-00015; Yuan H, 2010, BIOCHEMISTRY-US, V49, P9542, DOI 10.1021/bi101420w	46	7	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e104481	10.1371/journal.pone.0104481	http://dx.doi.org/10.1371/journal.pone.0104481			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133528	gold, Green Submitted, Green Published			2022-12-25	WOS:000341302700031
J	Park, JH; Seo, JH; Wee, HJ; Vo, TTL; Lee, EJ; Choi, H; Cha, JH; Ahn, BJ; Shin, MW; Bae, SJ; Kim, KW				Park, Ji-Hyeon; Seo, Ji Hae; Wee, Hee-Jun; Vo, Tam Thuy Lu; Lee, Eun Ji; Choi, Hoon; Cha, Jong-Ho; Ahn, Bum Ju; Shin, Min Wook; Bae, Sung-Jin; Kim, Kyu-Won			Nuclear Translocation of hARD1 Contributes to Proper Cell Cycle Progression	PLOS ONE			English	Article							ARREST-DEFECTIVE-1 PROTEIN; ACETYLTRANSFERASE COMPLEX; BREAST-CANCER; ARD1 GENE; ACETYLATION; EXPRESSION; PROLIFERATION; TUMORIGENESIS; STABILITY; HYPOXIA	Arrest defective 1 (ARD1) is an acetyltransferase that is highly conserved across organisms, from yeasts to humans. The high homology and widespread expression of ARD1 across multiple species and tissues signify that it serves a fundamental role in cells. Human ARD1 (hARD1) has been suggested to be involved in diverse biological processes, and its role in cell proliferation and cancer development has been recently drawing attention. However, the subcellular localization of ARD1 and its relevance to cellular function remain largely unknown. Here, we have demonstrated that hARD1 is imported to the nuclei of proliferating cells, especially during S phase. Nuclear localization signal (NLS)-deleted hARD1 (hARD1 Delta N), which can no longer access the nucleus, resulted in cell morphology changes and cellular growth impairment. Notably, hARD1 Delta N-expressing cells showed alterations in the cell cycle and the expression levels of cell cycle regulators compared to hARD1 wild-type cells. Furthermore, these effects were rescued when the nuclear import of hARD1 was restored by exogenous NLS. Our results show that hARD1 nuclear translocation mediated by NLS is required for cell cycle progression, thereby contributing to proper cell proliferation.	[Park, Ji-Hyeon; Seo, Ji Hae; Wee, Hee-Jun; Vo, Tam Thuy Lu; Lee, Eun Ji; Choi, Hoon; Cha, Jong-Ho; Ahn, Bum Ju; Shin, Min Wook; Bae, Sung-Jin; Kim, Kyu-Won] Seoul Natl Univ, Coll Pharm, SNU Harvard NeuroVascular Protect Res Ctr, Seoul, South Korea; [Park, Ji-Hyeon; Seo, Ji Hae; Wee, Hee-Jun; Vo, Tam Thuy Lu; Lee, Eun Ji; Choi, Hoon; Cha, Jong-Ho; Ahn, Bum Ju; Shin, Min Wook; Bae, Sung-Jin; Kim, Kyu-Won] Seoul Natl Univ, Pharmaceut Sci Res Inst, Seoul, South Korea; [Kim, Kyu-Won] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Dept Mol Med & Biopharmaceut Sci, Seoul, South Korea; [Kim, Kyu-Won] Seoul Natl Univ, Coll Pharm, Coll Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Kim, KW (corresponding author), Seoul Natl Univ, Coll Pharm, SNU Harvard NeuroVascular Protect Res Ctr, Seoul, South Korea.	qwonkim@snu.ac.kr	Bae, Sung-Jin/AAX-9144-2021; Kim, Kyu Won/AAJ-7213-2020; shin, minwook/HGA-4297-2022	Bae, Sung-Jin/0000-0001-8975-0876	Global Research Laboratory Program [2011-0021874]; Global Core Research Center (GCRC) Program [2011-0030001]; National Research Foundation (NRF) - Ministry of Science, ICT and Future Planning (MSIP) [2013-036038]; Basic Science Research Program through the NRF of Korea - Ministry of Education [2013R1A1A2058956]	Global Research Laboratory Program; Global Core Research Center (GCRC) Program; National Research Foundation (NRF) - Ministry of Science, ICT and Future Planning (MSIP); Basic Science Research Program through the NRF of Korea - Ministry of Education	This research was supported by the Global Research Laboratory Program (2011-0021874), Global Core Research Center (GCRC) Program (2011-0030001), National Research Foundation (NRF) grant (2013-036038) funded by the Ministry of Science, ICT and Future Planning (MSIP), and Basic Science Research Program through the NRF of Korea funded by the Ministry of Education (2013R1A1A2058956). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnesen T, 2005, THYROID, V15, P1131, DOI 10.1089/thy.2005.15.1131; Arnesen T, 2005, BIOCHEM J, V386, P433, DOI 10.1042/BJ20041071; Bilton R, 2005, J BIOL CHEM, V280, P31132, DOI 10.1074/jbc.M504482200; Chun KH, 2007, BIOCHEM BIOPH RES CO, V353, P18, DOI 10.1016/j.bbrc.2006.11.131; Hua KT, 2011, CANCER CELL, V19, P218, DOI 10.1016/j.ccr.2010.11.010; Jeong JW, 2002, CELL, V111, P709, DOI 10.1016/S0092-8674(02)01085-1; Kim SH, 2006, BIOCHEM BIOPH RES CO, V340, P422, DOI 10.1016/j.bbrc.2005.12.018; Kuo HP, 2010, AM J TRANSL RES, V2, P56; Kuo HP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000590; Lee MN, 2010, J NATL CANCER I, V102, P426, DOI 10.1093/jnci/djq026; Lim JH, 2006, CANCER RES, V66, P10677, DOI 10.1158/0008-5472.CAN-06-3171; Liszczak G, 2013, NAT STRUCT MOL BIOL, V20, P1098, DOI 10.1038/nsmb.2636; Ohkawa N, 2008, GENES CELLS, V13, P1171, DOI 10.1111/j.1365-2443.2008.01235.x; Park J, 2012, BIOCHEM BIOPH RES CO, V422, P291, DOI 10.1016/j.bbrc.2012.04.150; Seo JH, 2010, CANCER RES, V70, P4422, DOI 10.1158/0008-5472.CAN-09-3258; Sugiura N, 2003, J BIOL CHEM, V278, P40113, DOI 10.1074/jbc.M301218200; Wang ZH, 2011, ASIAN PAC J CANCER P, V12, P1973; Wang ZH, 2012, P NATL ACAD SCI USA, V109, P3053, DOI 10.1073/pnas.1113356109; WHITEWAY M, 1987, MOL CELL BIOL, V7, P3713, DOI 10.1128/MCB.7.10.3713; WHITEWAY M, 1985, CELL, V43, P483, DOI 10.1016/0092-8674(85)90178-3; Xu HY, 2012, CARCINOGENESIS, V33, P1193, DOI 10.1093/carcin/bgs144; Yu M, 2009, CANCER INVEST, V27, P978, DOI 10.3109/07357900902769723	22	8	8	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105185	10.1371/journal.pone.0105185	http://dx.doi.org/10.1371/journal.pone.0105185			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133627	gold, Green Published, Green Submitted			2022-12-25	WOS:000341302700081
J	Zhao, CZ; Xu, J; Li, Q; Li, S; Wang, P; Xiang, FN				Zhao, Cuizhu; Xu, Jin; Li, Qiang; Li, Shuo; Wang, Peng; Xiang, Fengning			Cloning and Characterization of a Phragmites australis Phytochelatin Synthase (PaPCS) and Achieving Cd Tolerance in Tall Fescue	PLOS ONE			English	Article							GAMMA-GLUTAMYLCYSTEINE SYNTHETASE; HEAVY-METALS POLLUTION; HETEROLOGOUS EXPRESSION; CADMIUM ACCUMULATION; HYPER-ACCUMULATOR; ESCHERICHIA-COLI; GENE FAMILY; ARABIDOPSIS; PLANTS; OVEREXPRESSION	The production of phytochelatins (PCs) provides an important means for plants to achieve tolerance to cadmium (Cd) toxicity. A reed gene encoding PC synthase (PaPCS) was isolated and its function tested through its heterologous expression in a strain of yeast sensitive to Cd. Subsequently, the Cd sensitive and high biomass accumulating species tall fescue was transformed either with PaPCS or PaGCS (a glutamyl cysteine synthetase gene of reed) on their own (single transformants), or with both genes together in the same transgene cassette (double transformant). The single and double transformants showed greater Cd tolerance and accumulated more Cd and PC than wild type plants, and their Cd leaf/root ratio content was higher. The ranking in terms of Cd and PC content for the various transgenic lines was double transformants>PaGCS single transformants>PaPCS single transformants>wild type. Thus PaGCS appears to exert a greater influence than PaPCS over PC synthesis and Cd tolerance/accumulation. The double transformant has interesting potential for phytoremediation.	[Zhao, Cuizhu; Li, Qiang; Li, Shuo; Wang, Peng; Xiang, Fengning] Shandong Univ, Sch Life Sci, Key Lab Plant Cell Engn & Germplasm Innovat, Jinan, Shandong, Peoples R China; [Zhao, Cuizhu] Northwest A&F Univ, Coll Agron, Yangling, Shanxi, Peoples R China; [Xu, Jin] Chinese Acad Sci, Ctr Agr Resources Res, Inst Genet & Dev Biol, Key Lab Agr Water Resources, Shijiazhuang, Peoples R China	Shandong University; Northwest A&F University - China; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Xiang, FN (corresponding author), Shandong Univ, Sch Life Sci, Key Lab Plant Cell Engn & Germplasm Innovat, Jinan, Shandong, Peoples R China.	xfn0990@sdu.edu.cn	WANG, Peng/GSN-5263-2022		Key Projects in the National Science & Technology Pillar Program in the 12th Five year Plan of China [2011BAI06B01]; National Natural Science Foundation of China [30970243]; International technology cooperation project of Shandong Province of China [2011176]; Science & Technology Plan of Shandong Province [2009GG10002001]; Chinese Natural Education Ministry Doctor Station Foundation Fellowship [913111006]	Key Projects in the National Science & Technology Pillar Program in the 12th Five year Plan of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International technology cooperation project of Shandong Province of China; Science & Technology Plan of Shandong Province; Chinese Natural Education Ministry Doctor Station Foundation Fellowship	This research was supported by Key Projects in the National Science & Technology Pillar Program in the 12th Five year Plan of China (grant no. 2011BAI06B01), the National Natural Science Foundation of China (grant no. 30970243), International technology cooperation project of Shandong Province of China (grant no. 2011176), Science & Technology Plan of Shandong Province (grant 2009GG10002001) and the Chinese Natural Education Ministry Doctor Station Foundation Fellowship (grant no. 913111006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett LE, 2003, J ENVIRON QUAL, V32, P432, DOI 10.2134/jeq2003.0432; Bhargava A, 2012, J ENVIRON MANAGE, V105, P103, DOI 10.1016/j.jenvman.2012.04.002; Bonanno G, 2010, ECOL INDIC, V10, P639, DOI 10.1016/j.ecolind.2009.11.002; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunetti P, 2011, J EXP BOT, V62, P5509, DOI 10.1093/jxb/err228; Buege J A, 1978, Methods Enzymol, V52, P302; Cassina L, 2011, INT J PHYTOREMEDIAT, V13, P90, DOI 10.1080/15226514.2011.568538; Chaurasia N, 2008, BIOCHEM BIOPH RES CO, V376, P225, DOI 10.1016/j.bbrc.2008.08.129; Clemens S, 1999, EMBO J, V18, P3325, DOI 10.1093/emboj/18.12.3325; Cobbett CS, 2000, PLANT PHYSIOL, V123, P825, DOI 10.1104/pp.123.3.825; Dhankher OP, 2002, NAT BIOTECHNOL, V20, P1140, DOI 10.1038/nbt747; Ding Teng-da, 2012, Yingyong Shengtai Xuebao, V23, P857; Doyle J.J., 1990, FOCUS, V12, P13, DOI DOI 10.2307/2419362; Ellis JK, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-61; Gasic K, 2007, PLANT MOL BIOL, V64, P361, DOI 10.1007/s11103-007-9158-7; Gendre D, 2007, PLANT J, V49, P1, DOI 10.1111/j.1365-313X.2006.02937.x; Gisbert C, 2003, BIOCHEM BIOPH RES CO, V303, P440, DOI 10.1016/S0006-291X(03)00349-8; Gong JM, 2003, P NATL ACAD SCI USA, V100, P10118, DOI 10.1073/pnas.1734072100; Guo JB, 2012, J HAZARD MATER, V199, P309, DOI 10.1016/j.jhazmat.2011.11.008; Guo Xing-liang, 2012, Yingyong Shengtai Xuebao, V23, P798; Gupta M, 1998, CHEMOSPHERE, V37, P785, DOI 10.1016/S0045-6535(98)00073-3; Hirata K, 2005, J BIOSCI BIOENG, V100, P593, DOI 10.1263/jbb.100.593; Huang J, 2009, WASTE MANAGE RES, V27, P668, DOI 10.1177/0734242X09103835; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Lee S, 2003, PLANT PHYSIOL, V131, P656, DOI 10.1104/pp.014118; Li YJ, 2004, PLANT CELL PHYSIOL, V45, P1787, DOI 10.1093/pcp/pch202; Li YJ, 2006, PLANT PHYSIOL, V141, P288, DOI 10.1104/pp.105.074815; Liu ZL, 2012, APPL BIOCHEM BIOTECH, V166, P722, DOI 10.1007/s12010-011-9461-2; Meyer CL, 2011, PLANTA, V234, P83, DOI 10.1007/s00425-011-1378-z; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Noctor G, 1996, PLANT PHYSIOL, V112, P1071, DOI 10.1104/pp.112.3.1071; Olguin EJ, 2012, NEW BIOTECHNOL, V30, P3, DOI 10.1016/j.nbt.2012.05.020; Osaki Y, 2008, BIOSCI BIOTECH BIOCH, V72, P3306, DOI 10.1271/bbb.80505; Pal R, 2010, APPL BIOCHEM BIOTECH, V160, P945, DOI 10.1007/s12010-009-8565-4; Peterson AG, 2006, PLANT PHYSIOL BIOCH, V44, P885, DOI 10.1016/j.plaphy.2006.10.021; Pomponi M, 2006, PLANTA, V223, P180, DOI 10.1007/s00425-005-0073-3; Salt DE, 1998, ANNU REV PLANT PHYS, V49, P643, DOI 10.1146/annurev.arplant.49.1.643; Scebba F, 2006, BIOL PLANTARUM, V50, P688, DOI 10.1007/s10535-006-0107-0; Seth CS, 2012, INT J PHYTOREMEDIAT, V14, P1, DOI 10.1080/15226514.2011.555799; Shukla D, 2013, PROTOPLASMA, V250, P1263, DOI 10.1007/s00709-013-0508-9; Shukla D, 2013, BIOCHEM BIOPH RES CO, V434, P664, DOI 10.1016/j.bbrc.2013.03.138; Shukla D, 2012, PLANT CELL REP, V31, P1687, DOI 10.1007/s00299-012-1283-3; Singh S, 2008, BIOTECHNOL BIOENG, V99, P333, DOI 10.1002/bit.21577; Suresh B, 2004, CRIT REV BIOTECHNOL, V24, P97, DOI 10.1080/07388550490493627; Tu S, 2004, ENVIRON EXP BOT, V51, P121, DOI 10.1016/j.envexpbot.2003.08.003; Vatamaniuk OK, 1999, P NATL ACAD SCI USA, V96, P7110, DOI 10.1073/pnas.96.12.7110; Vitoria AP, 2001, PHYTOCHEMISTRY, V57, P701, DOI 10.1016/S0031-9422(01)00130-3; Wang FJ, 2012, ACTA BIOCH BIOPH SIN, V44, P886, DOI 10.1093/abbs/gms073; Wawrzynska A, 2005, ACTA BIOCHIM POL, V52, P109; Wawrzynski A, 2006, J EXP BOT, V57, P2173, DOI 10.1093/jxb/erj176; Wu G, 2010, J HAZARD MATER, V174, P1, DOI 10.1016/j.jhazmat.2009.09.113; Yong X, 2014, LETT APPL MICROBIOL, V58, P255, DOI 10.1111/lam.12185; Zhang ZC, 2010, PLANT CELL ENVIRON, V33, P1248, DOI 10.1111/j.1365-3040.2010.02144.x; Zhao CZ, 2010, PLANT CELL ENVIRON, V33, P877, DOI 10.1111/j.1365-3040.2009.02113.x; Zitka O, 2011, J HAZARD MATER, V192, P794, DOI 10.1016/j.jhazmat.2011.05.088	55	23	24	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e103771	10.1371/journal.pone.0103771	http://dx.doi.org/10.1371/journal.pone.0103771			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133575	Green Published, Green Submitted, gold			2022-12-25	WOS:000341302700016
J	Heul, AMV; Gakhar, L; Piper, RC; Subramanian, R				Heul, Aaron M. Ver; Gakhar, Lokesh; Piper, Robert C.; Subramanian, Ramaswamy			Crystal Structure of a Complex of NOD1 CARD and Ubiquitin	PLOS ONE			English	Article							POLYUBIQUITIN CHAINS; RIG-I; RECOGNITION; ACTIVATION; PROTEIN; INNATE; DOMAIN; PEPTIDOGLYCAN; PATHWAY; BINDING	The Caspase Recruitment Domain (CARD) from the innate immune receptor NOD1 was crystallized with Ubiquitin (Ub). NOD1 CARD was present as a helix-swapped homodimer similar to other structures of NOD1 CARD, and Ub monomers formed a homodimer similar in conformation to Lys48-linked di-Ub. The interaction between NOD1 CARD and Ub in the crystal was mediated by novel binding sites on each molecule. Comparisons of these sites to previously identified interaction surfaces on both molecules were made along with discussion of their potential functional significance.	[Heul, Aaron M. Ver; Piper, Robert C.] Univ Iowa, Iowa City, IA USA; [Heul, Aaron M. Ver; Gakhar, Lokesh; Subramanian, Ramaswamy] Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA; [Gakhar, Lokesh] Carver Coll Med, Prot Crystallog Facil, Iowa City, IA USA; [Subramanian, Ramaswamy] Inst Stem Cell Biol & Regenerat Med, Bangalore, Karnataka, India	University of Iowa; University of Iowa; Department of Biotechnology (DBT) India; Institute for Stem Cell Biology & Regenerative Medicine - inStem	Subramanian, R (corresponding author), Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA.	ramas@instem.res.in	Gakhar, Lokesh/P-8356-2019; Subramanian, Ramaswamy/Q-8671-2019; Gakhar, Lokesh/F-2113-2010	Gakhar, Lokesh/0000-0002-3319-1902; Subramanian, Ramaswamy/0000-0002-6709-190X; Gakhar, Lokesh/0000-0002-3319-1902; Piper, Robert/0000-0001-9995-5699; Ver Heul, Aaron/0000-0003-3386-8351	Department of Science and Technology, Government of India; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007337] Funding Source: NIH RePORTER	Department of Science and Technology, Government of India(Department of Science & Technology (India)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	RS was funded by a grant from the Department of Science and Technology, Government of India. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; [Anonymous], PYMOL MOL GRAPH SYST; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Bosanac I, 2010, MOL CELL, V40, P548, DOI 10.1016/j.molcel.2010.10.009; Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450; Boyle JP, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00317; Cardenas I, 2011, J IMMUNOL, V187, P980, DOI 10.4049/jimmunol.1100578; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Chin KH, 2007, PROTEINS, V69, P665, DOI 10.1002/prot.21501; Clarke TB, 2010, NAT MED, V16, P228, DOI 10.1038/nm.2087; Coussens NP, 2007, BIOCHEM BIOPH RES CO, V353, P1, DOI 10.1016/j.bbrc.2006.11.122; Eddins MJ, 2007, J MOL BIOL, V367, P204, DOI 10.1016/j.jmb.2006.12.065; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Heul AMV, 2013, J BIOL CHEM, V288, P6890, DOI 10.1074/jbc.M112.413781; Hysi P, 2005, HUM MOL GENET, V14, P935, DOI 10.1093/hmg/ddi087; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Inohara N, 2000, J BIOL CHEM, V275, P27823; Inohara N, 1999, J BIOL CHEM, V274, P14560, DOI 10.1074/jbc.274.21.14560; Jiang XM, 2012, IMMUNITY, V36, P959, DOI 10.1016/j.immuni.2012.03.022; Kane LA, 2014, J CELL BIOL, V205, P143, DOI 10.1083/jcb.201402104; Kazlauskaite A, 2014, BIOCHEM J, V460, P127, DOI 10.1042/BJ20140334; Koyano F, 2014, NATURE, V510, P162, DOI 10.1038/nature13392; Li X, 2001, FEBS LETT, V507, P169, DOI 10.1016/S0014-5793(01)02954-4; Liu SQ, 2011, CELL RES, V21, P6, DOI 10.1038/cr.2010.170; Liu X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024227; Lo YC, 2009, MOL CELL, V33, P602, DOI 10.1016/j.molcel.2009.01.012; Maignan S, 1998, J MOL BIOL, V282, P359, DOI 10.1006/jmbi.1998.2002; Malynn BA, 2010, IMMUNITY, V33, P843, DOI 10.1016/j.immuni.2010.12.007; Manon F, 2007, J MOL BIOL, V365, P160, DOI 10.1016/j.jmb.2006.09.067; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Pashkova N, 2010, MOL CELL, V40, P433, DOI 10.1016/j.molcel.2010.10.018; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Pierce BG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024657; Qureshi Insaf A, 2009, BMC Res Notes, V2, P251, DOI 10.1186/1756-0500-2-251; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Sato Y, 2011, P NATL ACAD SCI USA, V108, P20520, DOI 10.1073/pnas.1109088108; Schertzer JD, 2011, DIABETES, V60, P2206, DOI 10.2337/db11-0004; Sloper-Mould KE, 2001, J BIOL CHEM, V276, P30483, DOI 10.1074/jbc.M103248200; Srimathi T, 2008, BIOCHEMISTRY-US, V47, P1319, DOI 10.1021/bi7016602; Teo H, 2004, J BIOL CHEM, V279, P28689, DOI 10.1074/jbc.M400023200; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; TSAO DHH, 1991, BIOCHEMISTRY-US, V30, P4565, DOI 10.1021/bi00232a029; Varadan R, 2002, J MOL BIOL, V324, P637, DOI 10.1016/S0022-2836(02)01198-1; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029; Zhu XY, 2003, J BIOL CHEM, V278, P2008, DOI 10.1074/jbc.M210103200	50	12	13	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104017	10.1371/journal.pone.0104017	http://dx.doi.org/10.1371/journal.pone.0104017			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127239	gold, Green Submitted, Green Published			2022-12-25	WOS:000340879300012
J	Nakajima, EC; Laymon, C; Oborski, M; Hou, WZ; Wang, L; Grandis, JR; Ferris, RL; Mountz, JM; Van Houten, B				Nakajima, Erica C.; Laymon, Charles; Oborski, Matthew; Hou, Weizhou; Wang, Lin; Grandis, Jennifer R.; Ferris, Robert L.; Mountz, James M.; Van Houten, Bennett			Quantifying Metabolic Heterogeneity in Head and Neck Tumors in Real Time: 2-DG Uptake Is Highest in Hypoxic Tumor Regions	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; SQUAMOUS-CELL CARCINOMAS; GLUCOSE-METABOLISM; CAIX; MICROENVIRONMENT; HIF-1-ALPHA; OXYGENATION; PERFORMANCE; METASTASIS; CANCERS	Purpose: Intratumoral metabolic heterogeneity may increase the likelihood of treatment failure due to the presence of a subset of resistant tumor cells. Using a head and neck squamous cell carcinoma (HNSCC) xenograft model and a real-time fluorescence imaging approach, we tested the hypothesis that tumors are metabolically heterogeneous, and that tumor hypoxia alters patterns of glucose uptake within the tumor. Experimental Design: Cal33 cells were grown as xenograft tumors (n = 16) in nude mice after identification of this cell line's metabolic response to hypoxia. Tumor uptake of fluorescent markers identifying hypoxia, glucose import, or vascularity was imaged simultaneously using fluorescent molecular tomography. The variability of intratumoral 2-deoxyglucose (IR800-2-DG) concentration was used to assess tumor metabolic heterogeneity, which was further investigated using immunohistochemistry for expression of key metabolic enzymes. HNSCC tumors in patients were assessed for intratumoral variability of F-18-fluorodeoxyglucose (F-18-FDG) uptake in clinical PET scans. Results: IR800-2-DG uptake in hypoxic regions of Cal33 tumors was 2.04 times higher compared to the whole tumor (p = 0.0001). IR800-2-DG uptake in tumors containing hypoxic regions was more heterogeneous as compared to tumors lacking a hypoxic signal. Immunohistochemistry staining for HIF-1 alpha, carbonic anhydrase 9, and ATP synthase subunit 5 beta confirmed xenograft metabolic heterogeneity. We detected heterogeneous F-18-FDG uptake within patient HNSCC tumors, and the degree of heterogeneity varied amongst tumors. Conclusion: Hypoxia is associated with increased intratumoral metabolic heterogeneity. F-18-FDG PET scans may be used to stratify patients according to the metabolic heterogeneity within their tumors, which could be an indicator of prognosis.	[Nakajima, Erica C.] Univ Pittsburgh, Phys Scientist Training Program, Pittsburgh, PA USA; [Nakajima, Erica C.] Howard Hughes Med Inst, Bethesda, MD 20817 USA; [Nakajima, Erica C.; Van Houten, Bennett] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA; [Laymon, Charles] Univ Pittsburgh, Sch Med, Dept Radiol, Pittsburgh, PA USA; [Hou, Weizhou] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA USA; [Wang, Lin] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA USA; [Grandis, Jennifer R.; Ferris, Robert L.] Univ Pittsburgh, Sch Med, Dept Otolaryngol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Howard Hughes Medical Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Van Houten, B (corresponding author), Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA.	vanhoutenb@upmc.edu	Van Houten, Bennett/K-2284-2019		Howard Hughes Medical Institute; National Institutes of Health [U01CA140230, R01CA077308, P30CA047904]; Pennsylvania Commonwealth Universal Research Enhancement; NATIONAL CANCER INSTITUTE [U01CA140230, P30CA047904, P50CA097190, R01CA077308] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Commonwealth Universal Research Enhancement; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Howard Hughes Medical Institute Medical Fellow (ECN), National Institutes of Health U01CA140230 (JMM), P50CA097190 (JRG & RLF), R01CA077308 (JRG) P30CA047904 (BVH), Pennsylvania Commonwealth Universal Research Enhancement (BVH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayer C, 2012, INT J RADIAT ONCOL, V84, pE409, DOI 10.1016/j.ijrobp.2012.04.033; Bettinardi V, 2004, EUR J NUCL MED MOL I, V31, P867, DOI 10.1007/s00259-003-1444-2; Davnall F, 2012, INSIGHTS IMAGING, V3, P573, DOI 10.1007/s13244-012-0196-6; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; DEVREESE K, 1993, EUR J CLIN CHEM CLIN, V31, P829; Dewhirst MW, 2008, NAT REV CANCER, V8, P425, DOI 10.1038/nrc2397; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; GIOANNI J, 1988, EUR J CANCER CLIN ON, V24, P1445, DOI 10.1016/0277-5379(88)90335-5; Hatt M, 2011, J NUCL MED, V52, P1690, DOI 10.2967/jnumed.111.092767; Hoogsteen IJ, 2007, HEAD NECK-J SCI SPEC, V29, P591, DOI 10.1002/hed.20543; Kappler M, 2008, STRAHLENTHER ONKOL, V184, P393, DOI 10.1007/s00066-008-1813-7; Kidd EA, 2008, CLIN CANCER RES, V14, P5236, DOI 10.1158/1078-0432.CCR-07-5252; Kovar JL, 2009, ANAL BIOCHEM, V384, P254, DOI 10.1016/j.ab.2008.09.050; Liao SR, 2012, EUR J NUCL MED MOL I, V39, P27, DOI 10.1007/s00259-011-1934-6; Marusyk A, 2013, SCIENCE, V339, P528, DOI 10.1126/science.1234415; Matsumoto S, 2010, CANCER RES, V70, P10019, DOI 10.1158/0008-5472.CAN-10-2821; Mayer A, 2005, CLIN CANCER RES, V11, P7220, DOI 10.1158/1078-0432.CCR-05-0869; Nahrendorf M, 2007, CIRC RES, V100, P1218, DOI 10.1161/01.RES.0000265064.46075.31; Nakajima EC, 2013, MOL CARCINOGEN, V52, P329, DOI 10.1002/mc.21863; Nieman KM, 2011, NAT MED, V17, P1498, DOI 10.1038/nm.2492; Nordsmark M, 2005, RADIOTHER ONCOL, V77, P18, DOI 10.1016/j.radonc.2005.06.038; Qian W, 2012, J CELL SCI, V125, P5745, DOI 10.1242/jcs.109769; Qian W, 2010, METHODS, V51, P452, DOI 10.1016/j.ymeth.2010.03.006; Rademakers SE, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-167; Rajendran JG, 2004, CLIN CANCER RES, V10, P2245, DOI 10.1158/1078-0432.CCR-0688-3; Rajendran JG, 2006, CLIN CANCER RES, V12, P5435, DOI 10.1158/1078-0432.CCR-05-1773; Robey IF, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/485196; Sano D, 2009, HEAD NECK ONCOL, V1, DOI 10.1186/1758-3284-1-32; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; Soret M, 2007, J NUCL MED, V48, P932, DOI 10.2967/jnumed.106.035774; Swiderek H, 2008, J BIOTECHNOL, V134, P103, DOI 10.1016/j.jbiotec.2008.01.001; Tang DL, 2011, CELL METAB, V13, P701, DOI 10.1016/j.cmet.2011.04.008; Thorwarth D, 2006, RADIOTHERAPY ONCOLOG, V80; Troost EGC, 2005, RADIOTHER ONCOL, V76, P194, DOI 10.1016/j.radonc.2005.06.031; Tseng JC, 2012, MOL IMAGING BIOL, V14, P553, DOI 10.1007/s11307-012-0545-3; van Velden FHP, 2011, EUR J NUCL MED MOL I, V38, P1636, DOI 10.1007/s00259-011-1845-6; Wheeler SE, 2010, ONCOGENE, V29, P5135, DOI 10.1038/onc.2009.279; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Xie BW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031875; YOKOI T, 1988, Tumor Research, V23, P43; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; Zhang QB, 2010, INT J CANCER, V126, P2534, DOI 10.1002/ijc.24979; Zhou HL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008051; Ziebart T, 2011, J CANCER RES CLIN, V137, P193, DOI 10.1007/s00432-010-0875-y	44	24	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e102452	10.1371/journal.pone.0102452	http://dx.doi.org/10.1371/journal.pone.0102452			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127378	Green Published, gold, Green Accepted			2022-12-25	WOS:000340879300005
J	Simon, TE; Le Cointe, R; Delarue, P; Morliere, S; Montfort, F; Herve, MR; Poggi, S				Simon, Thomas E.; Le Cointe, Ronan; Delarue, Patrick; Morliere, Stephanie; Montfort, Francoise; Herve, Maxime R.; Poggi, Sylvain			Interplay between Parasitism and Host Ontogenic Resistance in the Epidemiology of the Soil-Borne Plant Pathogen Rhizoctonia solani	PLOS ONE			English	Article							INOCULUM DENSITY; DISEASE; TRANSMISSION; CARBON; INVASION; BEHAVIOR; GROWTH; FUNGI	Spread of soil-borne fungal plant pathogens is mainly driven by the amount of resources the pathogen is able to capture and exploit should it behave either as a saprotroph or a parasite. Despite their importance in understanding the fungal spread in agricultural ecosystems, experimental data related to exploitation of infected host plants by the pathogen remain scarce. Using Rhizoctonia solani / Raphanus sativus as a model pathosystem, we have obtained evidence on the link between ontogenic resistance of a tuberizing host and (i) its susceptibility to the pathogen and (ii) after infection, the ability of the fungus to spread in soil. Based on a highly replicable experimental system, we first show that infection success strongly depends on the host phenological stage. The nature of the disease symptoms abruptly changes depending on whether infection occurred before or after host tuberization, switching from damping-off to necrosis respectively. Our investigations also demonstrate that fungal spread in soil still depends on the host phenological stage at the moment of infection. High, medium, or low spread occurred when infection was respectively before, during, or after the tuberization process. Implications for crop protection are discussed.	[Simon, Thomas E.; Le Cointe, Ronan; Delarue, Patrick; Morliere, Stephanie; Montfort, Francoise; Herve, Maxime R.; Poggi, Sylvain] INRA UMR 1349 IGEPP, Le Rheu, France	INRAE	Poggi, S (corresponding author), INRA UMR 1349 IGEPP, Le Rheu, France.	sylvain.poggi@rennes.inra.fr		POGGI, Sylvain/0000-0003-3051-5091	French National Research Agency through SYSBIOTEL [ANR-08_STRA-14]; INRA "Plant Health & the Environment" Division	French National Research Agency through SYSBIOTEL(French National Research Agency (ANR)); INRA "Plant Health & the Environment" Division	This research was supported by the French National Research Agency (http://www.agence-nationale-recherche.fr) through funding of the SYSBIOTEL project referenced ANR-08_STRA-14. (SP TES FM RLC). Part of this research was also supported by the INRA "Plant Health & the Environment" Division (http://www.spe.inra.fr/). (SP FM RLC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anees M, 2010, SOIL BIOL BIOCHEM, V42, P1661, DOI 10.1016/j.soilbio.2010.05.013; Bailey DJ, 2000, NEW PHYTOL, V146, P535, DOI 10.1046/j.1469-8137.2000.00660.x; CASTRO C, 1988, PHYTOPATHOLOGY, V78, P1287, DOI 10.1094/Phyto-78-1287; CHRISTIAS C, 1973, PHYTOPATHOLOGY, V63, P602, DOI 10.1094/Phyto-63-602; Cunniffe NJ, 2008, FUNGAL ECOL, V1, P133, DOI 10.1016/j.funeco.2008.10.007; Ferreira IED, 2013, ECOL INFORM, V14, P53, DOI 10.1016/j.ecoinf.2012.11.005; Deacon JW., 1980, INTRO MODERN MYCOLOG; Dordas C, 2008, AGRON SUSTAIN DEV, V28, P33, DOI 10.1051/agro:2007051; Ficke A, 2002, PHYTOPATHOLOGY, V92, P671, DOI 10.1094/PHYTO.2002.92.6.671; Garrett SD, 1970, BIOL ROOT INFECT FUN; Gibson GJ, 1999, P ROY SOC B-BIOL SCI, V266, P1743, DOI 10.1098/rspb.1999.0841; Gilligan CA, 1997, NEW PHYTOL, V135, P475, DOI 10.1046/j.1469-8137.1997.00673.x; Hack H, 1992, NACHRICHTENBLATT DTS, V44, P265; Jacobs H, 2004, MYCOL RES, V108, P453, DOI 10.1017/S0953756204009840; Kleczkowski A, 1997, P ROY SOC B-BIOL SCI, V264, P979, DOI 10.1098/rspb.1997.0135; Lamour A, 2000, IMA J MATH APPL MED, V17, P329, DOI 10.1093/imamci/17.4.329; Leclerc M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086568; Ludlam JJ, 2012, J R SOC INTERFACE, V9, P949, DOI 10.1098/rsif.2011.0506; Otten W, 2004, NEW PHYTOL, V162, P231, DOI 10.1111/j.1469-8137.2004.01011.x; Otten W, 2005, ECOLOGY, V86, P1948, DOI 10.1890/04-1122; Otten W, 2003, ECOLOGY, V84, P3232, DOI 10.1890/02-0564; PAPAVIZAS G, 1961, PHYTOPATHOLOGY, V51, P693; PAUSTIAN K, 1987, SOIL BIOL BIOCHEM, V19, P613, DOI 10.1016/0038-0717(87)90107-6; PITT D, 1964, ANN APPL BIOL, V54, P231, DOI 10.1111/j.1744-7348.1964.tb01187.x; Poggi S, 2013, PHYTOPATHOLOGY, V103, P1012, DOI 10.1094/PHYTO-02-13-0033-R; Poggi S, 2013, PHYTOPATHOLOGY; Schroeder KL, 2008, PHYTOPATHOLOGY, V98, P304, DOI 10.1094/PHYTO-98-3-0304; SNEH B, 1966, PHYTOPATHOLOGY, V56, P74; Sneh B., 1996, RHIZOCTONIA SPECIES; Stacey AJ, 2001, NEW PHYTOL, V150, P169, DOI 10.1046/j.1469-8137.2001.00082.x; Tamm L, 2010, EUR J PLANT PATHOL, V127, P465, DOI 10.1007/s10658-010-9612-2; Whalen MC, 2005, MOL PLANT PATHOL, V6, P347, DOI [10.1111/j.1364-3703.2005.00286.x, 10.1111/J.1364-3703.2005.00286.X]; Zakaria AJ, 2002, FEMS MICROBIOL ECOL, V40, P135, DOI 10.1111/j.1574-6941.2002.tb00945.x	33	28	29	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105159	10.1371/journal.pone.0105159	http://dx.doi.org/10.1371/journal.pone.0105159			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127238	Green Submitted, Green Published, gold			2022-12-25	WOS:000340879300084
J	Bjerknes, S; Skogseid, IM; Saehle, T; Dietrichs, E; Toft, M				Bjerknes, Silje; Skogseid, Inger Marie; Saehle, Terje; Dietrichs, Espen; Toft, Mathias			Surgical Site Infections after Deep Brain Stimulation Surgery: Frequency, Characteristics and Management in a 10-Year Period	PLOS ONE			English	Article							HARDWARE-RELATED INFECTIONS; SMALL-COLONY VARIANTS; OF-THE-LITERATURE; STAPHYLOCOCCUS-AUREUS; SINGLE-CENTER; DEVICE INFECTIONS; BIOFILM; COMPLICATIONS; IMPLANTATION; EFFICACY	Background/Aims: Deep brain stimulation (DBS) implant infection is a feared complication, as it is difficult to manage and leads to increased patient morbidity. We wanted to assess the frequency and possible risk factors of DBS related infections at our centre. In the purpose of evaluating treatment options, we also analyzed treatment, and the clinical and microbiological characteristics of the infections. Methods: Electronic medical records of all patients undergoing DBS surgery at our centre, from 2001 through 2010, were retrospectively reviewed. Results: Of the 588 procedures performed 33 (5.6%) led to an infection. Some patients underwent several procedures, thus 32 out of totally 368 patients (8.7%), and 19 out of 285 patients (6.7%) who received primary lead implantation, developed an infection. Most infections (52%) developed within the first month and 79% within three months. In the majority of the infections (79%) hardware removal was performed. Staphylococcus aureus infections were the most frequent (36%), and more likely to have earlier onset, pus formation, a more aggressive development and lead to hardware removal. No risk factors were identified. Conclusions: Our results indicate that infections with more severe symptoms and growth of staphylococcus aureus should be treated with local hardware removal and antibiotic therapy. In other infections, an initial trial of antibiotic treatment could be considered. New knowledge about the microbiology of DBS related infections may lead to more effective antimicrobial treatment.	[Bjerknes, Silje; Skogseid, Inger Marie; Dietrichs, Espen; Toft, Mathias] Oslo Univ Hosp, Dept Neurol, Oslo, Norway; [Saehle, Terje] Oslo Univ Hosp, Dept Neurosurg, Oslo, Norway; [Dietrichs, Espen] Univ Oslo, Fac Med, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo	Bjerknes, S (corresponding author), Oslo Univ Hosp, Dept Neurol, Oslo, Norway.	sbbjsk@ous-hf.no	Dietrichs, Espen/AAB-4573-2021; Toft, Mathias/AAY-5212-2021	Bjerknes, Silje/0000-0003-2672-2397; Saehle, Terje/0000-0003-0518-0357; Toft, Mathias/0000-0002-6723-6865	Research Council of Norway; South-Eastern Norway Regional Health Authority	Research Council of Norway(Research Council of Norway); South-Eastern Norway Regional Health Authority	The study has been supported by the Research Council of Norway (http://www.forskningsradet.no/en/Home_page/1177315753906) and the South-Eastern Norway Regional Health Authority (http://www.helse-sorost.no/fagfolk/forskning/Sider/side.aspx?utm_source=alias&utm_medium=url&utm_campaig = nhn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RJ, 2012, NEUROSCI BIOBEHAV R, V36, P1920, DOI 10.1016/j.neubiorev.2012.06.001; Baddour LM, 2010, CIRCULATION, V121, P458, DOI 10.1161/CIRCULATIONAHA.109.192665; Bhatia R, 2011, BRIT J NEUROSURG, V25, P625, DOI 10.3109/02688697.2011.566384; Bhatia S, 2010, STEREOT FUNCT NEUROS, V88, P147, DOI 10.1159/000303528; Blomstedt P, 2012, STEREOT FUNCT NEUROS, V90, P92, DOI 10.1159/000335712; Bode LGM, 2010, NEW ENGL J MED, V362, P9, DOI 10.1056/NEJMoa0808939; Brooks JL, 2012, ADV APPL MICROBIOL, V81, P63, DOI 10.1016/B978-0-12-394382-8.00002-2; Costerton JW, 2005, INT J ARTIF ORGANS, V28, P1062, DOI 10.1177/039139880502801103; Cutting K, 1994, Nurs Times, V90, P62; Cutting K, 1994, NURS TIMES, V90, P62; Cutting Keith F, 2004, Br J Community Nurs, V9, pS6; Elstrom P, 2012, J HOSP INFECT, V80, P36, DOI 10.1016/j.jhin.2011.10.004; Falowski S, 2012, STEREOT FUNCT NEUROS, V90, P173, DOI 10.1159/000338254; Fenoy AJ, 2012, J NEUROSURG, V116, P1324, DOI 10.3171/2012.1.JNS111798; Gandhi T, 2012, INFECT DIS CLIN N AM, V26, P57, DOI 10.1016/j.idc.2011.09.001; Gorgulho A, 2009, J NEUROSURG, V110, P239, DOI 10.3171/2008.6.17603; Kiedrowski MR, 2011, ANN NY ACAD SCI, V1241, P104, DOI 10.1111/j.1749-6632.2011.06281.x; Mangram AJ, 1999, AM J INFECT CONTROL, V27, P97, DOI 10.1016/S0196-6553(99)70088-X; Pepper J, 2013, STEREOT FUNCT NEUROS, V91, P56, DOI 10.1159/000343202; Piacentino M, 2011, ACTA NEUROCHIR, V153, P2337, DOI 10.1007/s00701-011-1130-2; Sievert DM, 2013, INFECT CONT HOSP EP, V34, P1, DOI 10.1086/668770; Sillay KA, 2008, NEUROSURGERY, V62, P360, DOI 10.1227/01.neu.0000316002.03765.33; Skogseid IM, 2012, EUR J NEUROL, V19, P610, DOI 10.1111/j.1468-1331.2011.03591.x; Stenehjem E, 2012, INFECT DIS CLIN N AM, V26, P89, DOI 10.1016/j.idc.2011.09.006; Taghva AS, 2013, WORLD NEUROSURG, V80, DOI 10.1016/j.wneu.2012.10.068; Thompson A, 2012, INT REV NEUROBIOL, V107, P253, DOI 10.1016/B978-0-12-404706-8.00014-0; Toba FA, 2011, J THORAC CARDIOV SUR, V141, P1259, DOI 10.1016/j.jtcvs.2010.07.016; Toft M, 2011, MOVEMENT DISORD, V26, P1931, DOI 10.1002/mds.23817; Voges J, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.081232; Von Eiff C, 2007, INT J ARTIF ORGANS, V30, P778, DOI 10.1177/039139880703000906; von Eiff C, 2008, INT J ANTIMICROB AG, V31, P507, DOI 10.1016/j.ijantimicag.2007.10.026	31	89	89	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e105288	10.1371/journal.pone.0105288	http://dx.doi.org/10.1371/journal.pone.0105288			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122445	Green Published, Green Submitted, gold			2022-12-25	WOS:000341017000111
J	Hillary, FG; Rajtmajer, SM; Roman, CA; Medaglia, JD; Slocomb-Dluzen, JE; Calhoun, VD; Good, DC; Wylie, GR				Hillary, Frank G.; Rajtmajer, Sarah M.; Roman, Cristina A.; Medaglia, John D.; Slocomb-Dluzen, Julia E.; Calhoun, Vincent D.; Good, David C.; Wylie, Glenn R.			The Rich Get Richer: Brain Injury Elicits Hyperconnectivity in Core Subnetworks	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; WORKING-MEMORY DYSFUNCTION; GRAPH-THEORETICAL ANALYSIS; FUNCTIONAL MRI DATA; DEFAULT MODE; LOW-FREQUENCY; CONNECTIVITY; NETWORKS; DEFICITS; MILD	There remains much unknown about how large-scale neural networks accommodate neurological disruption, such as moderate and severe traumatic brain injury (TBI). A primary goal in this study was to examine the alterations in network topology occurring during the first year of recovery following TBI. To do so we examined 21 individuals with moderate and severe TBI at 3 and 6 months after resolution of posttraumatic amnesia and 15 age- and education-matched healthy adults using functional MRI and graph theoretical analyses. There were two central hypotheses in this study: 1) physical disruption results in increased functional connectivity, or hyperconnectivity, and 2) hyperconnectivity occurs in regions typically observed to be the most highly connected cortical hubs, or the "rich club". The current findings generally support the hyperconnectivity hypothesis showing that during the first year of recovery after TBI, neural networks show increased connectivity, and this change is disproportionately represented in brain regions belonging to the brain's core subnetworks. The selective increases in connectivity observed here are consistent with the preferential attachment model underlying scale-free network development. This study is the largest of its kind and provides the unique opportunity to examine how neural systems adapt to significant neurological disruption during the first year after injury.	[Hillary, Frank G.; Roman, Cristina A.; Medaglia, John D.] Penn State Univ, Dept Psychol, University Pk, PA 16802 USA; [Rajtmajer, Sarah M.] Penn State Univ, Dept Math, University Pk, PA 16802 USA; [Slocomb-Dluzen, Julia E.; Good, David C.] Hershey Med Ctr, Dept Neurol, Hershey, PA USA; [Calhoun, Vincent D.] Mind Res Network, Albuquerque, NM USA; [Wylie, Glenn R.] Kessler Fdn Res Ctr, W Orange, NJ USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Lovelace Respiratory Research Institute; Kessler Institute for Rehabilitation	Hillary, FG (corresponding author), Penn State Univ, Dept Psychol, University Pk, PA 16802 USA.	fhillary@psu.edu; gwylie@kesslerfoundation.org	Hillary, Frank/AAN-8622-2021		New Jersey Commission for Brain Injury Research [09.001.BIR1]; Social Sciences Research Institute at Pennsylvania State University in University Park, Pennsylvania	New Jersey Commission for Brain Injury Research; Social Sciences Research Institute at Pennsylvania State University in University Park, Pennsylvania	This work was funded in part by the New Jersey Commission for Brain Injury Research (09.001.BIR1) and the Social Sciences Research Institute at Pennsylvania State University in University Park, Pennsylvania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Elseoud A, 2010, HUM BRAIN MAPP, V31, P1207, DOI 10.1002/hbm.20929; Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Allen EA, 2012, NEUROIMAGE, V59, P4141, DOI 10.1016/j.neuroimage.2011.10.010; Allen EA, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00002; [Anonymous], [No title captured]; Army Individual Test Battery, 1990, MAN DIR SCOR; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bassett DS, 2011, P NATL ACAD SCI USA, V108, P7641, DOI 10.1073/pnas.1018985108; Benedict RHB, 2008, MULT SCLER J, V14, P940, DOI 10.1177/1352458508090923; Bigler ED, 2001, J HEAD TRAUMA REHAB, V16, P117, DOI 10.1097/00001199-200104000-00003; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Bouilleret V, 2009, J NEUROTRAUM, V26, P1999, DOI 10.1089/neu.2009.0943; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Caeyenberghs K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00726; Caeyenberghs K, 2012, BRAIN, V135, P1293, DOI 10.1093/brain/aws048; Calhoun VD, 2001, HUM BRAIN MAPP, V13, P43, DOI 10.1002/hbm.1024; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Calhoun Vince D, 2012, IEEE Rev Biomed Eng, V5, P60, DOI 10.1109/RBME.2012.2211076; Calhoun VD, 2009, NEUROIMAGE, V45, pS163, DOI 10.1016/j.neuroimage.2008.10.057; Castellanos NP, 2011, NEUROIMAGE, V55, P1189, DOI 10.1016/j.neuroimage.2010.12.046; Castellanos NP, 2010, BRAIN, V133, P2365, DOI 10.1093/brain/awq174; Cayley A, 1875, BER DTSCH CHEM GES, V8, P1056; Cole MW, 2010, NEUROIMAGE, V49, P3132, DOI 10.1016/j.neuroimage.2009.11.001; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; DeLuca J, 2000, ARCH PHYS MED REHAB, V81, P1327, DOI 10.1053/apmr.2000.9390; Di Perri C, 2013, NEUROLOGY, V81, P1417, DOI 10.1212/WNL.0b013e3182a43b78; Du Y, 2014, P ORG HUM BRAIN MAPP; English SW, 2013, NEUROCRIT CARE, V18, P131, DOI 10.1007/s12028-012-9748-3; Erhardt EB, 2011, HUM BRAIN MAPP, V32, P2075, DOI 10.1002/hbm.21170; Fujiwara E, 2008, NEUROPSYCHOLOGIA, V46, P461, DOI 10.1016/j.neuropsychologia.2007.08.027; GAZZANIGA MS, 1984, BRAIN, V107, P145, DOI 10.1093/brain/107.1.145; GAZZANIGA MS, 1979, BRAIN, V102, P805, DOI 10.1093/brain/102.4.805; Harriger L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046497; Hilgetag CC, 2000, PHILOS T ROY SOC B, V355, P91, DOI 10.1098/rstb.2000.0551; Hillary FG, 2007, CLIN NEUROPSYCHOL, V21, P58, DOI 10.1080/13854040601064542; Hillary FG, 2011, INT J PSYCHOPHYSIOL, V82, P115, DOI 10.1016/j.ijpsycho.2011.03.011; Hillary FG, 2014, NEUROPSYCHOLOGY; Hillary FG, 2008, J INT NEUROPSYCH SOC, V14, P526, DOI 10.1017/S1355617708080788; Hillary FG, 2006, HUM BRAIN MAPP, V27, P837, DOI 10.1002/hbm.20226; Hillary FG, 2011, BRAIN, V134, P1555, DOI 10.1093/brain/awr043; Hillary FG, 2010, BRAIN IMAGING BEHAV, V4, P141, DOI 10.1007/s11682-010-9094-z; JENSEN AR, 1966, ACTA PSYCHOL, V25, P36, DOI 10.1016/0001-6918(66)90004-7; Jimenez N, 2013, PEDIATRICS, V131, pE1850, DOI 10.1542/peds.2012-3354; Jones NC, 2008, J NEUROTRAUM, V25, P1367, DOI 10.1089/neu.2008.0641; Jourdan C, 2013, BRAIN INJURY, V27, P1000, DOI 10.3109/02699052.2013.794971; Kelly RE, 2010, J NEUROSCI METH, V189, P233, DOI 10.1016/j.jneumeth.2010.03.028; KIRCHNER WK, 1958, J EXP PSYCHOL, V55, P352, DOI 10.1037/h0043688; Kiviniemi V, 2009, HUM BRAIN MAPP, V30, P3865, DOI 10.1002/hbm.20813; Kouloulas EJ, 2013, INT J REHABIL RES, V36, P260, DOI 10.1097/MRR.0b013e32835fd99a; Leech R, 2012, J NEUROSCI, V32, P215, DOI 10.1523/JNEUROSCI.3689-11.2012; Liang X, 2013, P NATL ACAD SCI USA, V110, P1929, DOI 10.1073/pnas.1214900110; Lin QH, 2010, HUM BRAIN MAPP, V31, P1076, DOI 10.1002/hbm.20919; Liu YR, 2010, J NUCL MED, V51, P1788, DOI 10.2967/jnumed.110.078626; Madigan NK, 2000, J HEAD TRAUMA REHAB, V15, P943, DOI 10.1097/00001199-200006000-00007; Mantini D, 2011, J NEUROSCI, V31, P12954, DOI 10.1523/JNEUROSCI.2318-11.2011; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McCauley SR, 2013, J NEUROTRAUM, V30, P1506, DOI 10.1089/neu.2013.2925; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; Medaglia JD, 2012, HUM BRAIN MAPP, V33, P979, DOI 10.1002/hbm.21264; Micheloyannis S, 2006, NEUROSCI LETT, V402, P273, DOI 10.1016/j.neulet.2006.04.006; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Palacios EM, 2013, JAMA NEUROL, P1; Pandit AS, 2013, NEUROLOGY, V80, P1826, DOI 10.1212/WNL.0b013e3182929f38; Pouratian Nader, 2003, Neurosurg Focus, V15, pE2; Radford K, 2013, BRAIN INJURY, V27, P507, DOI 10.3109/02699052.2013.766929; Reitan RM, 1985, HALSTEAD REITAN NEUR; Scott J., 2000, SOCIAL STRUCTURE, V2nd; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Sheline YI, 2013, BIOL PSYCHIAT, V74, P340, DOI 10.1016/j.biopsych.2012.11.028; Shimamura M, 2005, NEUROSCIENCE, V131, P87, DOI 10.1016/j.neuroscience.2004.10.041; Shultz SR, 2013, EPILEPSIA, V54, P1240, DOI 10.1111/epi.12223; Sidlauskaite J, 2014, NEUROIMAGE; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Sporns O, 2011, ANN NY ACAD SCI, V1224, P109, DOI 10.1111/j.1749-6632.2010.05888.x; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stam CJ, 2004, NEUROSCI LETT, V355, P25, DOI 10.1016/j.neulet.2003.10.063; Stibick DL, 2001, J NEUROTRAUM, V18, P303, DOI 10.1089/08977150151070955; Strigel RM, 2005, AM J NEURORADIOL, V26, P578; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Sylvester J, 1878, NATURE, V17, P284, DOI [10.1038/017284a0, DOI 10.1038/017284A0]; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; TEASDALE G, 1974, LANCET, V2, P81; Trenerry M. R., 1989, PROFESSIONAL MANUAL; Turner GR, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00009; Vakhtin AA, 2013, BRAIN INJURY, V27, P1304, DOI 10.3109/02699052.2013.823561; van den Heuvel MP, 2012, P NATL ACAD SCI USA, V109, P11372, DOI 10.1073/pnas.1203593109; Vul E, 2012, NEUROIMAGE, V62, P945, DOI 10.1016/j.neuroimage.2012.01.027; Walker WC, 2013, CEPHALALGIA, V33, P998, DOI 10.1177/0333102413482197; Wechsler D, 1997, ADM SCORING MANUAL; Wu HM, 2004, NEUROSURGERY, V55, P1306, DOI 10.1227/01.NEU.0000143028.08719.42; Xu JS, 2013, NEUROIMAGE, V79, P62, DOI 10.1016/j.neuroimage.2013.04.038; Ystad Martin A, 2009, BMC Med Imaging, V9, P17, DOI 10.1186/1471-2342-9-17; Yu QB, 2013, SCHIZOPHR RES, V143, P165, DOI 10.1016/j.schres.2012.11.001; Yu QB, 2011, FRONT SYST NEUROSCI, V5, DOI [10.3389/fnsys.2011.00007, 10.3389/fnsys.2011.00103]	97	92	92	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104021	10.1371/journal.pone.0104021	http://dx.doi.org/10.1371/journal.pone.0104021			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121760	Green Published, Green Submitted, gold			2022-12-25	WOS:000341017000024
J	Lien, GS; Wu, MS; Bien, MY; Chen, CH; Lin, CH; Chen, BC				Lien, Gi-Shih; Wu, Ming-Shun; Bien, Mauo-Ying; Chen, Chien-Hsin; Lin, Chien-Huang; Chen, Bing-Chang			Epidermal Growth Factor Stimulates Nuclear Factor-kappa B Activation and Heme Oxygenase-1 Expression via c-Src, NADPH Oxidase, PI3K, and Akt in Human Colon Cancer Cells	PLOS ONE			English	Article							LUNG EPITHELIAL-CELLS; COLORECTAL-CANCER; REACTIVE OXYGEN; ENDOTHELIAL-CELLS; FACTOR RECEPTOR; TRANSCRIPTION FACTOR; MEDIATED APOPTOSIS; GENE-EXPRESSION; PATHWAYS; KINASE	Previous report showed that epidermal growth factor (EGF) promotes tumor progression. Several studies demonstrated that growth factors can induce heme oxygenase (HO)-1 expression, protect against cellular injury and cancer cell proliferation. In this study, we investigated the involvement of the c-Src, NADPH oxidase, reactive oxygen species (ROS), PI3K/Akt, and NF-kappa B signaling pathways in EGF-induced HO-1 expression in human HT-29 colon cancer cells. Treatment of HT-29 cells with EGF caused HO-1 to be expressed in concentration-and time-dependent manners. Treatment of HT-29 cells with AG1478 (an EGF receptor (EGFR) inhibitor), small interfering RNA of EGFR (EGFR siRNA), a dominant negative mutant of c-Src (c-Src DN), DPI (an NADPH oxidase inhibitor), glutathione (an ROS inhibitor), LY294002 (a PI3K inhibitor), and an Akt DN inhibited EGF-induced HO-1 expression. Stimulation of cells with EGF caused an increase in c-Src phosphorylation at Tyr406 in a time-dependent manner. Treatment of HT-29 cells with EGF induced an increase in p47(phox) translocation from the cytosol to membranes. The EGF-induced ROS production was inhibited by DPI. Stimulation of cells with EGF resulted in an increase in Akt phosphorylation at Ser473, which was inhibited by c-Src DN, DPI, and LY 294002. Moreover, treatment of HT-29 cells with a dominant negative mutant of I kappa B (I kappa B alpha M) inhibited EGF-induced HO-1 expression. Stimulation of cells with EGF induced p65 translocation from the cytosol to nuclei. Treatment of HT-29 cells with EGF induced an increase in kappa B-luciferase activity, which was inhibited by a c-Src DN, LY 294002, and an Akt DN. Furthermore, EGF-induced colon cancer cell proliferation was inhibited by Sn(IV) protoporphyrin-IX (snPP, an HO-1 inhibitor). Taken together, these results suggest that the c-Src, NADPH oxidase, PI3K, and Akt signaling pathways play important roles in EGF-induced NF-kappa B activation and HO-1 expression in HT-29 cells. Moreover, overexpression of HO-1 mediates EGF-induced colon cancer cell proliferation.	[Lien, Gi-Shih; Wu, Ming-Shun] Taipei Med Univ, Wan Fang Hosp, Dept Internal Med, Div Gastroenterol, Taipei, Taiwan; [Wu, Ming-Shun] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Bien, Mauo-Ying; Chen, Bing-Chang] Taipei Med Univ, Coll Med, Sch Resp Therapy, Taipei, Taiwan; [Bien, Mauo-Ying] Taipei Med Univ Hosp, Dept Internal Med, Div Pulm Med, Taipei, Taiwan; [Chen, Chien-Hsin] Taipei Med Univ, Wan Fang Hosp, Dept Surg, Div Colorectal Surg, Taipei, Taiwan; [Lin, Chien-Huang] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan	Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University	Chen, BC (corresponding author), Taipei Med Univ, Coll Med, Sch Resp Therapy, Taipei, Taiwan.	bcchen@tmu.edu.tw		Lin, Chien-Huang/0000-0002-0916-8737	Taipei Medical University-Wan Fang Hospital [101TMU-WFH-02-1, 102TMU-WFH-01-1, 103TMU-WFH-02-1]	Taipei Medical University-Wan Fang Hospital	This study was supported by grants (101TMU-WFH-02-1, 102TMU-WFH-01-1, and 103TMU-WFH-02-1) from Taipei Medical University-Wan Fang Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham NG, 2003, J CELL BIOCHEM, V90, P1098, DOI 10.1002/jcb.10736; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Becker JC, 2007, SCAND J GASTROENTERO, V42, P852, DOI 10.1080/00365520701192383; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Biswas DK, 2000, P NATL ACAD SCI USA, V97, P8542, DOI 10.1073/pnas.97.15.8542; Brady RRW, 2011, CARCINOGENESIS, V32, P1069, DOI 10.1093/carcin/bgr077; Brouard S, 2002, J BIOL CHEM, V277, P17950, DOI 10.1074/jbc.M108317200; Brunton VG, 1997, ONCOGENE, V14, P283, DOI 10.1038/sj.onc.1200827; Chan TO, 1999, ANNU REV BIOCHEM, V68, P965, DOI 10.1146/annurev.biochem.68.1.965; Chen JZ, 2014, CLIN COLORECTAL CANC, V13, P5, DOI 10.1016/j.clcc.2013.10.003; Dal-Cim T, 2012, NEUROCHEM INT, V61, P397, DOI 10.1016/j.neuint.2012.05.021; Fang J, 2004, APOPTOSIS, V9, P27, DOI 10.1023/B:APPT.0000012119.83734.4e; Feliers D, 2006, AM J PHYSIOL-RENAL, V290, pF927, DOI 10.1152/ajprenal.00331.2005; Furfaro AL, 2013, BIOCHIM BIOPHYS ACTA, V1842, P613; Gialeli C, 2013, INVEST NEW DRUG, V31, P516, DOI 10.1007/s10637-012-9875-x; He MH, 2013, INVEST OPHTH VIS SCI, V54, P4092, DOI 10.1167/iovs.13-12004; Kuroda H, 2010, LUNG CANCER, V67, P31, DOI 10.1016/j.lungcan.2009.03.015; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Larsson SC, 2006, INT J CANCER, V119, P2657, DOI 10.1002/ijc.22170; LAVROVSKY Y, 1994, P NATL ACAD SCI USA, V91, P5987, DOI 10.1073/pnas.91.13.5987; Lee HY, 2010, INT J ONCOL, V36, P941, DOI 10.3892/ijo_00000573; Lee HJ, 2008, J ORAL PATHOL MED, V37, P278, DOI 10.1111/j.1600-0714.2007.00616.x; Li DY, 2013, INVEST OPHTH VIS SCI, V54, P5661, DOI 10.1167/iovs.13-12473; Li M, 2005, WORLD J GASTROENTERO, V11, P4685, DOI 10.3748/wjg.v11.i30.4685; Lin CC, 2007, EUR J PHARMACOL, V560, P101, DOI 10.1016/j.ejphar.2007.01.025; Lin CH, 2006, J IMMUNOL, V177, P3427, DOI 10.4049/jimmunol.177.5.3427; Liu JF, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3815; MAINES MD, 1986, J BIOL CHEM, V261, P411; Garcia-Martinez JM, 2010, CELL SIGNAL, V22, P415, DOI 10.1016/j.cellsig.2009.10.013; Do MT, 2013, TOXICOL APPL PHARM, V271, P229, DOI 10.1016/j.taap.2013.05.010; Montezano AC, 2008, ARTERIOSCL THROM VAS, V28, P1511, DOI 10.1161/ATVBAHA.108.168021; Park HS, 2004, MOL CELL BIOL, V24, P4384, DOI 10.1128/MCB.24.10.4384-4394.2004; Qi WT, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-219; Ramana KV, 2010, MOL CANCER THER, V9, P813, DOI 10.1158/1535-7163.MCT-09-0795; Regmi SC, 2014, FREE RADICAL BIO MED, V69, P377, DOI 10.1016/j.freeradbiomed.2014.02.003; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V331, P1, DOI 10.1016/j.bbrc.2005.03.012; Ryter SW, 2002, ANTIOXID REDOX SIGN, V4, P625, DOI 10.1089/15230860260220120; Ryter SW, 2002, ANTIOXID REDOX SIGN, V4, P587, DOI 10.1089/15230860260220085; Shih RH, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-104; Singh MM, 2012, CANCER-AM CANCER SOC, V118, P3433, DOI 10.1002/cncr.26621; Takeya R, 2003, J BIOL CHEM, V278, P25234, DOI 10.1074/jbc.M212856200; Tesoriere L., 2013, BR J NUTR, P1; Tsai JR, 2012, CELL ONCOL, V35, P461, DOI 10.1007/s13402-012-0105-5; Was H, 2010, CURR DRUG TARGETS, V11, P1551, DOI 10.2174/1389450111009011551; Yamaoka-Tojo M, 2004, CIRC RES, V95, P276, DOI 10.1161/01.RES.0000136522.58649.60; Yarom N, 2011, DISCOV MED, V11, P95; Zheng S, 2013, CELL PHYSIOL BIOCHEM, V32, P972, DOI 10.1159/000354500; Zhou SY, 1997, P NATL ACAD SCI USA, V94, P11345, DOI 10.1073/pnas.94.21.11345	50	43	43	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104891	10.1371/journal.pone.0104891	http://dx.doi.org/10.1371/journal.pone.0104891			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122478	Green Published, gold, Green Submitted			2022-12-25	WOS:000341017000070
J	Yi, CR; Allen, JE; Russo, B; Lee, SY; Heindl, JE; Baxt, LA; Herrera, BB; Kahoud, E; MacBeath, G; Goldberg, MB				Yi, Chae-ryun; Allen, John E.; Russo, Brian; Lee, Soo Young; Heindl, Jason E.; Baxt, Leigh A.; Herrera, Bobby Brooke; Kahoud, Emily; MacBeath, Gavin; Goldberg, Marcia B.			Systematic Analysis of Bacterial Effector-Postsynaptic Density 95/Disc Large/Zonula Occludens-1 (PDZ) Domain Interactions Demonstrates Shigella OspE Protein Promotes Protein Kinase C Activation via PDLIM Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Pathogenesis; PDZ Domain; Protein Kinase C (PKC); Protein-Protein Interaction; Secretion; Type III Secretion System (T3SS); OspE; PDLIM Proteins; Shigella	III SECRETION SYSTEM; ENTEROPATHOGENIC ESCHERICHIA-COLI; VIRULENCE FACTOR NLEA; LIM DOMAINS; HOST-CELLS; BINDING; EXPRESSION; TARGETS; PHOSPHORYLATION; JUNCTIONS	Background: PDZ domains provide specificity in protein-protein interactions in eukaryotic systems. Results:Shigella OspE, which is delivered into human cells during infection, binds PDLIM7 via a PDZ interaction and contributes to activation of PKC. Conclusion: During infection, OspE contributes to activation of PKC through PDZ-mediated binding to PDLIM7. Significance: PDZ interactions likely contribute to pathogenesis of several bacterial pathogens. Diseases caused by many Gram-negative bacterial pathogens depend on the activities of bacterial effector proteins that are delivered into eukaryotic cells via specialized secretion systems. Effector protein function largely depends on specific subcellular targeting and specific interactions with cellular ligands. PDZ domains are common domains that serve to provide specificity in protein-protein interactions in eukaryotic systems. We show that putative PDZ-binding motifs are significantly enriched among effector proteins delivered into mammalian cells by certain bacterial pathogens. We use PDZ domain microarrays to identify candidate interaction partners of the Shigella flexneri effector proteins OspE1 and OspE2, which contain putative PDZ-binding motifs. We demonstrate in vitro and in cells that OspE proteins interact with PDLIM7, a member of the PDLIM family of proteins, which contain a PDZ domain and one or more LIM domains, protein interaction domains that participate in a wide variety of functions, including activation of isoforms of protein kinase C (PKC). We demonstrate that activation of PKC during S. flexneri infection is attenuated in the absence of PDLIM7 or OspE proteins and that the OspE PDZ-binding motif is required for wild-type levels of PKC activation. These results are consistent with a model in which binding of OspE to PDLIM7 during infection regulates the activity of PKC isoforms that bind to the PDLIM7 LIM domain.	[Yi, Chae-ryun; Russo, Brian; Baxt, Leigh A.; Herrera, Bobby Brooke; Kahoud, Emily; Goldberg, Marcia B.] Massachusetts Gen Hosp, Div Infect Dis, Cambridge, MA 02139 USA; [Allen, John E.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Lee, Soo Young] Harvard Univ, Sch Med, Program Immunol, Boston, MA 02115 USA; [Russo, Brian; Heindl, Jason E.; Goldberg, Marcia B.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [MacBeath, Gavin] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Goldberg, MB (corresponding author), Massachusetts Gen Hosp, Div Infect Dis, Cambridge, MA 02139 USA.	marcia.goldberg@mgh.harvard.edu	Goldberg, Marcia/U-8604-2019	Herrera, Bobby Brooke/0000-0002-2438-6716; Baxt, Leigh/0000-0001-8286-3907; Allen, John/0000-0001-5005-5139; Lee, Soo Young/0000-0003-1524-836X; MacBeath, Gavin/0000-0003-2585-6772; Heindl, Jason/0000-0003-3919-8045	National Institutes of Health [F32 AI092967, R01 AI081724]; American Heart Association [09POST2260574]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081724, T32AI007061, F32AI092967] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants F32 AI092967 (to L. A. B.) and R01 AI081724 (to M. B. G.). G. M. and J. E. A. are employees and stockholders of Merrimack Pharmaceuticals, Inc.; Supported by American Heart Association Postdoctoral Fellowship 09POST2260574.	Alto NM, 2006, CELL, V124, P133, DOI 10.1016/j.cell.2005.10.031; Ashida H, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003409; Burstein D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000508; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Defilippi P, 1997, J BIOL CHEM, V272, P21726, DOI 10.1074/jbc.272.35.21726; Dewoody R, 2011, MOL MICROBIOL, V79, P1445, DOI 10.1111/j.1365-2958.2011.07534.x; Elkins JM, 2010, PROTEIN SCI, V19, P731, DOI 10.1002/pro.349; Farhadi A, 2006, J PHARMACOL EXP THER, V316, P1, DOI 10.1124/jpet.105.085449; Fukumatsu M, 2012, CELL HOST MICROBE, V11, P325, DOI 10.1016/j.chom.2012.03.001; Gardiol D, 2012, FEBS J, V279, P3529, DOI 10.1111/j.1742-4658.2012.08685.x; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GRAFF JM, 1989, J BIOL CHEM, V264, P21818; Heindl JE, 2010, INFECT IMMUN, V78, P193, DOI 10.1128/IAI.00252-09; Javier RT, 2011, J VIROL, V85, P11544, DOI 10.1128/JVI.05410-11; Kaushansky A, 2010, NAT PROTOC, V5, P773, DOI 10.1038/nprot.2010.36; Kim J, 2007, CELL HOST MICROBE, V2, P160, DOI 10.1016/j.chom.2007.07.010; Kim M, 2009, NATURE, V459, P578, DOI 10.1038/nature07952; Kotaka M, 1999, J CELL BIOCHEM, V72, P279, DOI 10.1002/(SICI)1097-4644(19990201)72:2<279::AID-JCB12>3.0.CO;2-7; Kuroda S, 1996, J BIOL CHEM, V271, P31029, DOI 10.1074/jbc.271.49.31029; LABIGNEROUSSEL AF, 1984, INFECT IMMUN, V46, P251, DOI 10.1128/IAI.46.1.251-259.1984; LABREC EH, 1964, J BACTERIOL, V88, P1503, DOI 10.1128/JB.88.5.1503-1518.1964; Lee SF, 2008, CELL MICROBIOL, V10, P499, DOI [10.1111/j.1462-5822.2007.01065x, 10.1111/j.1462-5822.2007.01065.x]; Liu YS, 2002, J BONE MINER RES, V17, P406, DOI 10.1359/jbmr.2002.17.3.406; Loughran G, 2005, MOL BIOL CELL, V16, P1811, DOI 10.1091/mbc.E04-12-1052; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; Matsumoto H, 2009, CURR OPIN MICROBIOL, V12, P94, DOI 10.1016/j.mib.2008.12.005; Maturana AD, 2011, CELL SIGNAL, V23, P928, DOI 10.1016/j.cellsig.2011.01.021; McGhie EJ, 2009, CURR OPIN MICROBIOL, V12, P117, DOI 10.1016/j.mib.2008.12.001; Miura M, 2006, INFECT IMMUN, V74, P2587, DOI 10.1128/IAI.74.5.2587-2595.2006; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; Nourry Claire, 2003, Sci STKE, V2003, pRE7; Radhakrishnan P, 2007, BBA-GEN SUBJECTS, V1770, P884, DOI 10.1016/j.bbagen.2007.01.019; Schlumberger MC, 2005, P NATL ACAD SCI USA, V102, P12548, DOI 10.1073/pnas.0503407102; Schmitz AM, 2009, NAT METHODS, V6, P500, DOI 10.1038/nmeth.1337; Simpson N, 2006, MOL MICROBIOL, V60, P349, DOI 10.1111/j.1365-2958.2006.05109.x; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Thanabalasuriar A, 2010, CELL MICROBIOL, V12, P31, DOI 10.1111/j.1462-5822.2009.01376.x; Tobe T, 2006, P NATL ACAD SCI USA, V103, P14941, DOI 10.1073/pnas.0604891103; Watarai M, 1997, J EXP MED, V185, P281, DOI 10.1084/jem.185.2.281; Winnen B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002178; Zheng Q, 2007, BIOL CELL, V99, P489, DOI 10.1042/BC20060126	42	9	10	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2014	289	43					30101	30113		10.1074/jbc.M114.595868	http://dx.doi.org/10.1074/jbc.M114.595868			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS6JU	25124035	Green Published, hybrid			2022-12-25	WOS:000344370800050
J	Kim, PY; Vu, TT; Leslie, BA; Stafford, AR; Fredenburgh, JC; Weitz, JI				Kim, Paul Y.; Vu, Trang T.; Leslie, Beverly A.; Stafford, Alan R.; Fredenburgh, James C.; Weitz, Jeffrey I.			Reduced Plasminogen Binding and Delayed Activation Render gamma '-Fibrin More Resistant to Lysis than gamma(A)-Fibrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Kinetics; Fibrinogen; Fibrinolysis; Plasminogen; Tissue Plasminogen Activator (tPA); -Fibrinogen	HIGH-AFFINITY INTERACTION; MYOCARDIAL-INFARCTION; PLASMA-FIBRINOGEN; FACTOR-XIII; CARDIOVASCULAR-DISEASE; SPLICE VARIANT; CLOT STRUCTURE; THROMBIN; TISSUE; INHIBITION	Background: When compared with degradation of the predominant (A)-fibrin, lysis of variant -fibrin is delayed. Results: Thrombin-mediated fibrinopeptide B release is slower from -fibrinogen than from (A)-fibrinogen, resulting in delayed binding and activation of plasminogen. Conclusion: Delayed plasmin generation renders -fibrin resistant to lysis. Significance: The association between slower clotting and delayed lysis highlights the links between coagulation and fibrinolysis. Fibrin (Fn) clots formed from -fibrinogen (-Fg), a variant with an elongated -chain, are resistant to lysis when compared with clots formed from the predominant (A)-Fg, a finding previously attributed to differences in clot structure due to delayed thrombin-mediated fibrinopeptide (FP) B release or impaired cross-linking by factor XIIIa. We investigated whether slower lysis of -Fn reflects delayed plasminogen (Pg) binding and/or activation by tissue plasminogen activator (tPA), reduced plasmin-mediated proteolysis of -Fn, and/or altered cross-linking. Clots formed from -Fg lysed more slowly than those formed from (A)-Fg when lysis was initiated with tPA/Pg when FPA and FPB were both released, but not when lysis was initiated with plasmin, or when only FPA was released. Pg bound to -Fn with an association rate constant 22% lower than that to (A)-Fn, and the lag time for initiation of Pg activation by tPA was longer with -Fn than with (A)-Fn. Once initiated, however, Pg activation kinetics were similar. Factor XIIIa had similar effects on clots formed from both Fg isoforms. Therefore, slower lysis of -Fn clots reflects delayed FPB release, which results in delayed binding and activation of Pg. When clots were formed from Fg mixtures containing more than 20% -Fg, the upper limit of the normal level, the delay in lysis was magnified. These data suggest that circulating levels of -Fg modulate the susceptibility of clots to lysis by slowing Pg activation by tPA and provide another example of the intimate connections between coagulation and fibrinolysis.	[Kim, Paul Y.; Leslie, Beverly A.; Stafford, Alan R.; Fredenburgh, James C.; Weitz, Jeffrey I.] McMaster Univ, Dept Med, Hamilton, ON L8S 4L8, Canada; [Vu, Trang T.; Weitz, Jeffrey I.] McMaster Univ, Dept Biomed Sci, Hamilton, ON L8S 4L8, Canada; [Weitz, Jeffrey I.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8S 4L8, Canada; [Kim, Paul Y.; Vu, Trang T.; Leslie, Beverly A.; Stafford, Alan R.; Fredenburgh, James C.; Weitz, Jeffrey I.] Thrombosis & Atherosclerosis Res Inst, Hamilton, ON L8L 2X2, Canada	McMaster University; McMaster University; McMaster University; McMaster University	Weitz, JI (corresponding author), Thrombosis & Atherosclerosis Res Inst, 237 Barton St East, Hamilton, ON L8L 2X2, Canada.	weitzj@taari.ca	Kim, Paul/GYV-3258-2022; Weitz, Jeffrey/AAD-1929-2019	Kim, Paul/0000-0003-0943-4924; Weitz, Jeffrey/0000-0002-1092-7550	Canadian Institutes of Health Research [MOP3992, MOP102735, CTP 79846]; Heart and Stroke Foundation of Ontario; Ontario Research and Development Challenge Fund; Canadian Institutes of Health Research Fellowship; National Sciences and Engineering Research Council of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Ontario Research and Development Challenge Fund(General Electric); Canadian Institutes of Health Research Fellowship(Canadian Institutes of Health Research (CIHR)); National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	The work was supported in part by Canadian Institutes of Health Research Grants MOP3992, MOP102735, and CTP 79846, the Heart and Stroke Foundation of Ontario, and the Ontario Research and Development Challenge Fund.; The recipient of a Canadian Institutes of Health Research Fellowship.; The recipient of a National Sciences and Engineering Research Council of Canada Award.	Allan P, 2012, J THROMB HAEMOST, V10, P1072, DOI 10.1111/j.1538-7836.2012.04717.x; Ariens RAS, 2002, BLOOD, V100, P743, DOI 10.1182/blood.V100.3.743; CASTELLINO FJ, 1981, METHOD ENZYMOL, V80, P365; Chan HH, 2012, BIOCHEMISTRY-US, V51, P7964, DOI 10.1021/bi301046b; Cheung EYL, 2008, STROKE, V39, P1033, DOI 10.1161/STROKEAHA.107.495499; Collet JP, 2004, ARTERIOSCL THROM VAS, V24, P382, DOI 10.1161/01.ATV.0000109748.77727.3e; Cooper AV, 2003, BLOOD, V102, P535, DOI 10.1182/blood-2002-10-3150; Danesh J, 1998, JAMA-J AM MED ASSOC, V279, P1477, DOI 10.1001/jama.279.18.1477; de Willige SU, 2005, BLOOD, V106, P4176, DOI 10.1182/blood-2005-05-2180; Dejouvencel T, 2010, BLOOD, V115, P2048, DOI 10.1182/blood-2009-06-228817; Doolittle RF, 2006, BIOCHEMISTRY-US, V45, P2657, DOI 10.1021/bi0524767; Falls LA, 1997, J BIOL CHEM, V272, P14251, DOI 10.1074/jbc.272.22.14251; Fredenburgh JC, 2008, J BIOL CHEM, V283, P2470, DOI 10.1074/jbc.M707710200; Gersh KC, 2009, THROMB RES, V124, P356, DOI 10.1016/j.thromres.2008.11.016; Hethershaw EL, 2014, J THROMB HAEMOST, V12, P197, DOI 10.1111/jth.12455; Horrevoets AJG, 1997, J BIOL CHEM, V272, P2183; Horrevoets AJG, 1997, J BIOL CHEM, V272, P2176; HOYLAERTS M, 1982, J BIOL CHEM, V257, P2912; Kim PY, 2007, J THROMB HAEMOST, V5, P1250, DOI 10.1111/j.1538-7836.2007.02426.x; Kim PY, 2012, J BIOL CHEM, V287, P4652, DOI 10.1074/jbc.M111.317719; Lovely RS, 2010, CLIN CHEM, V56, P781, DOI 10.1373/clinchem.2009.138347; Lovely RS, 2002, THROMB HAEMOSTASIS, V88, P26; Ma J, 1999, J AM COLL CARDIOL, V33, P1347, DOI 10.1016/S0735-1097(99)00007-8; Mannila MN, 2007, J THROMB HAEMOST, V5, P766, DOI 10.1111/j.1538-7836.2007.02406.x; Maresca G, 1999, ARTERIOSCL THROM VAS, V19, P1368, DOI 10.1161/01.ATV.19.6.1368; Meh DA, 1996, J BIOL CHEM, V271, P23121, DOI 10.1074/jbc.271.38.23121; Mosesson MW, 2005, J THROMB HAEMOST, V3, P1894, DOI 10.1111/j.1538-7836.2005.01365.x; Pieters M, 2013, BLOOD, V121, P3254, DOI 10.1182/blood-2012-12-471482; Pospisil CH, 2003, J BIOL CHEM, V278, P21584, DOI 10.1074/jbc.M300545200; Schneider M, 2004, J BIOL CHEM, V279, P13333, DOI 10.1074/jbc.M313164200; Senis YA, 2006, BBA-PROTEINS PROTEOM, V1764, P863, DOI 10.1016/j.bbapap.2006.03.004; Siebenlist KR, 1996, BIOCHEMISTRY-US, V35, P10448, DOI 10.1021/bi9606206; Stewart RJ, 1998, J BIOL CHEM, V273, P18292, DOI 10.1074/jbc.273.29.18292; SUENSON E, 1990, J BIOL CHEM, V265, P22228; Tribouilloy C, 1998, AM J CARDIOL, V81, P321, DOI 10.1016/S0002-9149(97)00900-4; Tsurupa G, 2001, BIOCHEMISTRY-US, V40, P801, DOI 10.1021/bi001789t; Vu TT, 2013, J BIOL CHEM, V288, P16862, DOI 10.1074/jbc.M113.464750; Vu TT, 2011, J BIOL CHEM, V286, P30314, DOI 10.1074/jbc.M111.253831; Walker JB, 1999, J BIOL CHEM, V274, P5201, DOI 10.1074/jbc.274.8.5201; Wolberg AS, 2012, CURR OPIN HEMATOL, V19, P349, DOI 10.1097/MOH.0b013e32835673c2; YE J, 1994, J BIOL CHEM, V269, P17965	41	7	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27494	27503		10.1074/jbc.M114.588640	http://dx.doi.org/10.1074/jbc.M114.588640			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25128532	hybrid, Green Published			2022-12-25	WOS:000342852800012
J	Rharass, T; Lemcke, H; Lantow, M; Kuznetsov, SA; Weiss, DG; Panakova, D				Rharass, Tareck; Lemcke, Heiko; Lantow, Margareta; Kuznetsov, Sergei A.; Weiss, Dieter G.; Panakova, Daniela			Ca2+-mediated Mitochondrial Reactive Oxygen Species Metabolism Augments Wnt/beta-Catenin Pathway Activation to Facilitate Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium Signaling; Mitochondrial Metabolism; Reactive Oxygen Species (ROS); Redox Signaling; Wnt Pathway; Dishevelled; Human Neural Progenitor Cells; Nucleoredoxin	INTRACELLULAR CALCIUM; SIGNALING PATHWAY; GROWTH-FACTOR; CA2+ RELEASE; MECHANISMS; INCREASE; PATTERNS; FRET; POOL; ROS	Background: Dissociation of the Wnt/-catenin pathway effector Dishevelled from its complex with nucleoredoxin is a redox-sensitive process, yet the ROS sources remain elusive. Results: Mitochondrial Ca2+ influx stimulates endogenous ROS production and mediates Wnt/-catenin pathway activity. Conclusion: Ca2+-mediated ROS production modulates the signaling efficiency of the Wnt/-catenin pathway. Significance: Metabolic states influence fundamental and developmental signaling to drive cell differentiation. Emerging evidence suggests that reactive oxygen species (ROS) can stimulate the Wnt/-catenin pathway in a number of cellular processes. However, potential sources of endogenous ROS have not been thoroughly explored. Here, we show that growth factor depletion in human neural progenitor cells induces ROS production in mitochondria. Elevated ROS levels augment activation of Wnt/-catenin signaling that regulates neural differentiation. We find that growth factor depletion stimulates the release of Ca2+ from the endoplasmic reticulum stores. Ca2+ subsequently accumulates in the mitochondria and triggers ROS production. The inhibition of mitochondrial Ca2+ uptake with simultaneous growth factor depletion prevents the rise in ROS metabolism. Moreover, low ROS levels block the dissociation of the Wnt effector Dishevelled from nucleoredoxin. Attenuation of the response amplitudes of pathway effectors delays the onset of the Wnt/-catenin pathway activation and results in markedly impaired neuronal differentiation. Our findings reveal Ca2+-mediated ROS metabolic cues that fine-tune the efficiency of cell differentiation by modulating the extent of the Wnt/-catenin signaling output.	[Rharass, Tareck; Panakova, Daniela] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Rharass, Tareck; Lemcke, Heiko; Lantow, Margareta; Weiss, Dieter G.] Univ Rostock, Inst Biol Sci, D-18059 Rostock, Germany; [Rharass, Tareck; Lemcke, Heiko; Kuznetsov, Sergei A.; Weiss, Dieter G.] Univ Rostock, Live Cell Imaging Ctr, D-18059 Rostock, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Rostock; University of Rostock	Panakova, D (corresponding author), Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13125 Berlin, Germany.	daniela.panakova@mdc-berlin.de	Lantow, Margareta/A-1797-2017; Lemcke, Heiko/ABI-1979-2020	Panakova, Daniela/0000-0002-8739-6225; Rharass, Tareck/0000-0001-9406-1776	Helmholtz Association Young Investigator Groups program; Marie Curie Career Integration Grant; German Research Foundation as part of the Research Training School 1387 dIEM oSiRiS (Rostock, Germany)	Helmholtz Association Young Investigator Groups program; Marie Curie Career Integration Grant; German Research Foundation as part of the Research Training School 1387 dIEM oSiRiS (Rostock, Germany)	This work was supported by the Helmholtz Association Young Investigator Groups program to D. P., by Marie Curie Career Integration Grant to D. P., and by the German Research Foundation as part of the Research Training School 1387 dIEM oSiRiS (Rostock, Germany) to D. G. W.	Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Buckman JF, 2001, J NEUROSCI METH, V104, P165, DOI 10.1016/S0165-0270(00)00340-X; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; De A, 2011, ACTA BIOCH BIOPH SIN, V43, P745, DOI 10.1093/abbs/gmr079; Dickinson BC, 2011, NAT CHEM BIOL, V7, P106, DOI 10.1038/NCHEMBIO.497; Donato R, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-36; Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Funato Y, 2006, NAT CELL BIOL, V8, P501, DOI 10.1038/ncb1405; Funato Y, 2010, CURR BIOL, V20, P1945, DOI 10.1016/j.cub.2010.09.065; Gao C, 2010, CELL SIGNAL, V22, P717, DOI 10.1016/j.cellsig.2009.11.021; Gerencser AA, 2005, BIOPHYS J, V88, P698, DOI 10.1529/biophysj.104.050062; Halliwell B, 2003, FEBS LETT, V540, P3, DOI 10.1016/S0014-5793(03)00235-7; Hirabayashi Y, 2004, DEVELOPMENT, V131, P2791, DOI 10.1242/dev.01165; Hofer A. M., 1999, IMAGING LIVING CELLS, P53; Hoffrogge R, 2006, PROTEOMICS, V6, P1833, DOI 10.1002/pmic.200500556; HORWITZ LD, 1995, J MOL CELL CARDIOL, V27, P909, DOI 10.1016/0022-2828(95)90041-1; Hubner R, 2010, BIOCHEM BIOPH RES CO, V400, P358, DOI 10.1016/j.bbrc.2010.08.066; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kajla S, 2012, FASEB J, V26, P2049, DOI 10.1096/fj.11-196360; Kalyanaraman B, 2012, FREE RADICAL BIO MED, V52, P1, DOI 10.1016/j.freeradbiomed.2011.09.030; Kim HY, 2011, J NEUROSCI, V31, P12982, DOI 10.1523/JNEUROSCI.3093-11.2011; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Lajas AI, 1998, BIOCHEM PHARMACOL, V55, P903, DOI 10.1016/S0006-2952(97)00546-7; Lee WT, 2002, NEUROSCIENCE, V112, P707, DOI 10.1016/S0306-4522(02)00097-0; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Love NR, 2013, NAT CELL BIOL, V15, P222, DOI 10.1038/ncb2659; MACCIONI RB, 1995, PHYSIOL REV, V75, P835, DOI 10.1152/physrev.1995.75.4.835; Mallilankaraman K, 2012, NAT CELL BIOL, V14, P1336, DOI 10.1038/ncb2622; Mazemondet O, 2011, CELL MOL BIOL LETT, V16, P515, DOI 10.2478/s11658-011-0021-0; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Mosimann C, 2009, NAT REV MOL CELL BIO, V10, P276, DOI 10.1038/nrm2654; Mussmann C, 2014, STEM CELLS DEV, V23, P1328, DOI 10.1089/scd.2013.0557; Novo E, 2012, J PATHOL, V226, P588, DOI 10.1002/path.3005; Ohno A, 2009, J PHARMACOL SCI, V110, P78, DOI 10.1254/jphs.09037FP; Panakova D, 2010, NATURE, V466, P874, DOI 10.1038/nature09249; Park MK, 2000, EMBO J, V19, P5729, DOI 10.1093/emboj/19.21.5729; Petrosillo G, 2004, J BIOL CHEM, V279, P53103, DOI 10.1074/jbc.M407500200; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pietraszewska-Bogiel A, 2011, J MICROSC-OXFORD, V241, P111, DOI 10.1111/j.1365-2818.2010.03437.x; Poenie Martin, 2006, P1; PROFROCK A, 1991, BIOCHEM BIOPH RES CO, V180, P900, DOI 10.1016/S0006-291X(05)81150-7; Sandieson L, 2014, STEM CELLS DEV, V23, P1037, DOI 10.1089/scd.2014.0010; Satin J, 2008, STEM CELLS, V26, P1961, DOI 10.1634/stemcells.2007-0591; Spagnuolo G, 2006, BIOMATERIALS, V27, P1803, DOI 10.1016/j.biomaterials.2005.10.022; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Tsuang Yang-Hwei, 2006, J Orthop Surg Res, V1, P7, DOI 10.1186/1749-799X-1-7; UEDA N, 1992, AM J PHYSIOL, V263, pF214, DOI 10.1152/ajprenal.1992.263.2.F214; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; van Rheenen J, 2004, BIOPHYS J, V86, P2517, DOI 10.1016/S0006-3495(04)74307-6; Wallrabe H, 2005, CURR OPIN BIOTECH, V16, P19, DOI 10.1016/j.copbio.2004.12.002; Wen JWH, 2012, CELL SIGNAL, V24, P2337, DOI 10.1016/j.cellsig.2012.07.024	52	66	69	4	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27937	27951		10.1074/jbc.M114.573519	http://dx.doi.org/10.1074/jbc.M114.573519			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25124032	hybrid, Green Accepted, Green Published			2022-12-25	WOS:000342852800048
J	Zhang, ZL; Wu, J; Lin, W; Wang, J; Yan, H; Zhao, W; Ma, J; Ding, JP; Zhang, P; Zhao, GP				Zhang, Zilong; Wu, Jian; Lin, Wei; Wang, Jin; Yan, Han; Zhao, Wei; Ma, Jun; Ding, Jianping; Zhang, Peng; Zhao, Guo-Ping			Subdomain II of alpha-Isopropylmalate Synthase Is Essential for Activity INFERRING A MECHANISM OF FEEDBACK INHIBITION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allosteric Regulation; Cooperativity; Enzyme Catalysis; Enzyme Structure; Protein Conformation; Catalytic Module; Feedback Inhibition	TERMINAL REGULATORY DOMAIN; MYCOBACTERIUM-TUBERCULOSIS; LEPTOSPIRA-INTERROGANS; SALMONELLA-TYPHIMURIUM; SUBSTRATE-SPECIFICITY; CITRAMALATE SYNTHASE; HOMOCITRATE SYNTHASE; CRYSTAL-STRUCTURE; MOLECULAR-BASIS; LEUCINE OPERON	Background: Isopropylmalate synthases (IPMSs) with and without a regulatory domain were found. Results: IPMS subdomain II is essential for activities and likely involved in acetyl-CoA binding-mediated conformation transition. Conclusion: The N-terminal domain and the two subdomains comprise the complete and independently functional catalytic module of IPMS. Significance: The IPMS catalytic module was defined and characterized, which inferred a probable feedback inhibition mechanism. The committed step of leucine biosynthesis, converting acetyl-CoA and -ketoisovalerate into -isopropylmalate, is catalyzed by -isopropylmalate synthase (IPMS), an allosteric enzyme subjected to feedback inhibition by the end product l-leucine. We characterized the short form IPMS from Leptospira biflexa (LbIPMS2), which exhibits a catalytic activity comparable with that of the long form IPMS (LbIPMS1) and has a similar N-terminal domain followed by subdomain I and subdomain II but lacks the whole C-terminal regulatory domain. We found that partial deletion of the regulatory domain of LbIPMS1 resulted in a loss of about 50% of the catalytic activity; however, when the regulatory domain was deleted up to Arg-385, producing a protein that is almost equivalent to the intact LbIPMS2, about 90% of the activity was maintained. Moreover, in LbIPMS2 or LbIPMS1, further deletion of several residues from the C terminus of subdomain II significantly impaired or completely abolished the catalytic activity, respectively. These results define a complete and independently functional catalytic module of IPMS consisting of both the N-terminal domain and the two subdomains. Structural comparison of LbIPMS2 and the Mycobacterium tuberculosis IPMS revealed two different conformations of subdomain II that likely represent two substrate-binding states related to cooperative catalysis. The biochemical and structural analyses together with the previously published hydrogen-deuterium exchange data led us to propose a conformation transition mechanism for feedback inhibition mediated by subdomains I and II that might associated with alteration of the binding affinity toward acetyl-CoA.	[Ma, Jun; Zhang, Peng; Zhao, Guo-Ping] Chinese Acad Sci, Key Lab Synthet Biol, Shanghai 200032, Peoples R China; [Zhang, Peng] Chinese Acad Sci, Natl Key Lab Plant Mol Genet, Inst Plant Physiol & Ecol, Shanghai Inst Biol Sci, Shanghai 200032, Peoples R China; [Wu, Jian; Ding, Jianping] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China; [Zhao, Wei; Zhao, Guo-Ping] Fudan Univ, Shanghai Med Coll, Key Lab Med Mol Virol, Minist Educ, Shanghai 200433, Peoples R China; [Zhao, Wei; Zhao, Guo-Ping] Fudan Univ, Shanghai Med Coll, Key Lab Med Mol Virol, Minist Hlth, Shanghai 200433, Peoples R China; [Zhao, Wei; Zhao, Guo-Ping] Fudan Univ, Sch Life Sci, Dept Microbiol & Microbial Engn, Shanghai 200433, Peoples R China; [Zhao, Guo-Ping] Chinese Natl Human Genome Ctr, Shanghai Minist Sci & Technol, Key Lab Hlth & Dis Genom, Shanghai 201203, Peoples R China; [Zhao, Guo-Ping] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Microbiol, Shatin, Hong Kong, Peoples R China; [Zhao, Guo-Ping] Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Shatin, Hong Kong, Peoples R China; [Zhang, Zilong] Shanghai Entry Exit Inspect & Quarantine Bur, Shanghai Int Travel Healthcare Ctr, Shanghai 200335, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Fudan University; Fudan University; Fudan University; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital	Ding, JP (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China.	jpding@sibs.ac.cn; pengzhang01@sibs.ac.cn; gpzhao@sibs.ac.cn		Zhao, Wei/0000-0002-2422-8398; ding, jian ping/0000-0001-7029-7346	National Basic Research Program of China [2012CB721102]; National Nature Science Foundation of China [31322016, 31170690, 31121001, 30830002]; "Special Talent" Program of the Shanghai Institutes for Biological Sciences [2012OHTP]; National Key Laboratory of Plant Molecular Genetics, Institute of Plant Physiology and Ecology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences	National Basic Research Program of China(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); "Special Talent" Program of the Shanghai Institutes for Biological Sciences; National Key Laboratory of Plant Molecular Genetics, Institute of Plant Physiology and Ecology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences	This work was supported by National Basic Research Program of China Grant 2012CB721102; National Nature Science Foundation of China Grants 31322016, 31170690, 31121001, and 30830002; and "Special Talent" Program Grant 2012OHTP of the Shanghai Institutes for Biological Sciences and The National Key Laboratory of Plant Molecular Genetics, Institute of Plant Physiology and Ecology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Bulfer SL, 2010, J BIOL CHEM, V285, P10446, DOI 10.1074/jbc.M109.094383; Bulfer SL, 2009, J BIOL CHEM, V284, P35769, DOI 10.1074/jbc.M109.046821; BURNS RO, 1966, J BACTERIOL, V91, P1570, DOI 10.1128/JB.91.4.1570-1576.1966; Casey AK, 2013, BIOCHEMISTRY-US, V52, P6737, DOI 10.1021/bi401186v; Cavalieri D, 1999, MOL GEN GENET, V261, P152, DOI 10.1007/s004380050952; Chanchaem W, 2002, TUBERCULOSIS, V82, P1, DOI 10.1054/tube.2001.0314; de Carvalho LPS, 2005, J AM CHEM SOC, V127, P10004, DOI 10.1021/ja052513h; de Carvalho LPS, 2006, BIOCHEMISTRY-US, V45, P8988, DOI 10.1021/bi0606602; de Carvalho LPS, 2006, ARCH BIOCHEM BIOPHYS, V451, P141, DOI 10.1016/j.abb.2006.03.030; de Carvalho LPS, 2009, BIOCHEMISTRY-US, V48, P1996, DOI 10.1021/bi801707t; de Kraker JW, 2007, PLANT PHYSIOL, V143, P970, DOI 10.1104/pp.106.085555; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frantom PA, 2009, BIOCHEMISTRY-US, V48, P7457, DOI 10.1021/bi900851q; GODON JJ, 1992, J BACTERIOL, V174, P6580, DOI 10.1128/JB.174.20.6580-6589.1992; Huisman FHA, 2013, BIOCHEM BIOPH RES CO, V433, P249, DOI 10.1016/j.bbrc.2013.02.092; Huisman FHA, 2012, BIOCHEMISTRY-US, V51, P2289, DOI 10.1021/bi201717j; Huisman FHA, 2010, BIOCHEM BIOPH RES CO, V393, P168, DOI 10.1016/j.bbrc.2010.01.114; KOHLHAW G, 1969, J BIOL CHEM, V244, P2218; Koon N, 2004, P NATL ACAD SCI USA, V101, P8295, DOI 10.1073/pnas.0400820101; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; LEARY TR, 1972, J BIOL CHEM, V247, P1089; Ma J, 2008, BIOCHEM J, V415, P45, DOI 10.1042/BJ20080242; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Picardeau M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001607; Ren SX, 2003, NATURE, V422, P888, DOI 10.1038/nature01597; Singh K, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-39; SOMERS JM, 1973, J BACTERIOL, V113, P1268, DOI 10.1128/JB.113.3.1268-1272.1973; SOPER TS, 1976, ARCH BIOCHEM BIOPHYS, V173, P362, DOI 10.1016/0003-9861(76)90271-X; Stols Lucy, 2004, Journal of Structural and Functional Genomics, V5, P95, DOI 10.1023/B:JSFG.0000029196.87615.6e; Swain JF, 2006, CURR OPIN STRUC BIOL, V16, P102, DOI 10.1016/j.sbi.2006.01.003; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P1872, DOI 10.1107/S090744499901029X; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Tsai CJ, 1999, PROTEIN SCI, V8, P1181, DOI 10.1110/ps.8.6.1181; ULM EH, 1972, J BACTERIOL, V110, P1118, DOI 10.1128/JB.110.3.1118-1126.1972; WEBSTER RE, 1965, BIOCHEMISTRY-US, V4, P2319, DOI 10.1021/bi00887a009; WIEGEL J, 1977, ARCH MICROBIOL, V114, P203, DOI 10.1007/BF00446863; WIEGEL J, 1977, ARCH MICROBIOL, V112, P239, DOI 10.1007/BF00413087; WIEGEL J, 1977, ARCH MICROBIOL, V112, P247, DOI 10.1007/BF00413088; Zhang P, 2009, BIOCHEM J, V421, P133, DOI 10.1042/BJ20090336	41	12	17	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27966	27978		10.1074/jbc.M114.559716	http://dx.doi.org/10.1074/jbc.M114.559716			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25128527	hybrid, Green Published			2022-12-25	WOS:000342852800050
J	Okumura, M; Kadokura, H; Hashimoto, S; Yutani, K; Kanemura, S; Hikima, T; Hidaka, Y; Ito, L; Shiba, K; Masui, S; Imai, D; Imaoka, S; Yamaguchi, H; Inaba, K				Okumura, Masaki; Kadokura, Hiroshi; Hashimoto, Shoko; Yutani, Katsuhide; Kanemura, Shingo; Hikima, Takaaki; Hidaka, Yuji; Ito, Len; Shiba, Kohei; Masui, Shoji; Imai, Daiki; Imaoka, Susumu; Yamaguchi, Hiroshi; Inaba, Kenji			Inhibition of the Functional Interplay between Endoplasmic Reticulum (ER) Oxidoreduclin-1 alpha (Ero1 alpha) and Protein-disulfide Isomerase (PDI) by the Endocrine Disruptor Bisphenol A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEROXIREDOXIN IV; BINDING-SITE; FAMILY; DOMAIN; SCATTERING; EXPOSURE; IDENTIFICATION; THIOREDOXIN; MECHANISMS; EXPRESSION	Bisphenol A (BPA) is an endocrine disruptor that may have adverse effects on human health. We recently isolated protein-disulfide isomerase (PDI) as a BPA-binding protein from rat brain homogenates and found that BPA markedly inhibited PDI activity. To elucidate mechanisms of this inhibition, detailed structural, biophysical, and functional analyses of PDI were performed in the presence of BPA. BPA binding to PDI induced significant rearrangement of the N-terminal thioredoxin domain of PDI, resulting in more compact overall structure. This conformational change led to closure of the substrate-binding pocket in b' domain, preventing PDI from binding to unfolded proteins. The b' domain also plays an essential role in the interplay between PDI and ER oxidoreduclin 1 alpha (Ero1 alpha), a flavoenzyme responsible for reoxidation of PDI. We show that BPA inhibited Ero1 alpha-catalyzed PDI oxidation presumably by inhibiting the interaction between the b' domain of PDI and Ero1 alpha; the phenol groups of BPA probably compete with a highly conserved tryptophan residue, located in the protruding beta-hairpin of Ero1 alpha, for binding to PDI. Consistently, BPA slowed down the reoxidation of PDI and caused the reduction of PDI in HeLa cells, indicating that BPA has a great impact on the redox homeostasis of PDI within cells. However, BPA had no effect on the interaction between PDI and peroxiredoxin-4 (Prx4), another PDI family oxidase, suggesting that the interaction between Prx4 and PDI is different from that of Ero1 alpha and PDI. These results indicate that BPA, a widely distributed and potentially harmful chemical, inhibits Ero1-PDI-mediated disulfide bond formation.	[Okumura, Masaki; Hashimoto, Shoko; Kanemura, Shingo; Ito, Len; Imai, Daiki; Imaoka, Susumu; Yamaguchi, Hiroshi] Kwansei Gakuin Univ, Sch Sci & Technol, Sanda, Hyogo 6691337, Japan; [Okumura, Masaki; Masui, Shoji; Inaba, Kenji] Kyushu Univ, Med Inst Bioregulat, Div Prot Chem, Higashi Ku, Fukuoka 8128582, Japan; [Okumura, Masaki; Yutani, Katsuhide; Kanemura, Shingo; Hikima, Takaaki; Yamaguchi, Hiroshi] RIKEN, RIKEN SPring Ctr 8, Sayo, Hyogo 6795148, Japan; [Okumura, Masaki; Hidaka, Yuji] Kinki Univ, Sch Fac Sci & Engn, Higashiosaka, Osaka 5778502, Japan; [Shiba, Kohei] Sysmex Corp, ProCube Business Div, Nishi Ku, Kobe, Hyogo 6512241, Japan; [Okumura, Masaki; Kadokura, Hiroshi; Kanemura, Shingo; Masui, Shoji; Inaba, Kenji] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, Sendai, Miyagi 9808577, Japan	Kwansei Gakuin University; Kyushu University; RIKEN; Kindai University (Kinki University); Sysmex Corporation; Tohoku University	Okumura, M (corresponding author), Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, Katahira 2-1-1, Sendai, Miyagi 9808577, Japan.	okmasaki@mail.tagen.tohoku.ac.jp; hiroshi@kwansei.ac.jp; kinaba@tagen.tohoku.ac.jp	okumura, masaki/AAO-3454-2020; Kadokura, Hiroshi/AAE-1645-2019	okumura, masaki/0000-0001-8130-2470; Kanemura, Shingo/0000-0002-7012-8179; Kadokura, Hiroshi/0000-0001-7308-7141; HIDAKA, YUJI/0000-0002-3131-2619; Inaba, Kenji/0000-0001-8229-0467	Next Generation World-leading Researchers program (MEXT)	Next Generation World-leading Researchers program (MEXT)	This work was supported by funding from the Next Generation World-leading Researchers program (MEXT) (to K. I.), by a grant-in-aid for scientific research (B) (to S. I.), by a grant-in-aid for scientific research (C) (to H. Y. and H. K.), by a grant-in-aid for scientific research on innovative areas (to K. I. and H. K.), and by a grant-in-aid for Japan Society for the Promotion of Science fellows (to M. O., S. H., and S. M.).	[Anonymous], 1956, J POLYM SCI, DOI DOI 10.1002/POL.1956.120199326; Araki K, 2013, J CELL BIOL, V202, P861, DOI 10.1083/jcb.201303027; Araki K, 2012, ANTIOXID REDOX SIGN, V16, P790, DOI 10.1089/ars.2011.4418; Asahi J, 2010, LIFE SCI, V87, P431, DOI 10.1016/j.lfs.2010.08.007; Bindhumol V, 2003, TOXICOLOGY, V188, P117, DOI 10.1016/S0300-483X(03)00056-8; Bulleid NJ, 2011, TRENDS BIOCHEM SCI, V36, P485, DOI 10.1016/j.tibs.2011.05.004; Byrne LJ, 2009, BIOCHEM J, V423, P209, DOI 10.1042/BJ20090565; Cao ZB, 2014, J BIOL CHEM, V289, P5490, DOI 10.1074/jbc.M113.529305; EDMAN JC, 1985, NATURE, V317, P267, DOI 10.1038/317267a0; Fagin D, 2012, NATURE, V490, P462, DOI 10.1038/490462a; Fujisawa T, 2000, J APPL CRYSTALLOGR, V33, P797, DOI 10.1107/S002188980000131X; Hashimoto S, 2012, ACTA CRYSTALLOGR F, V68, P476, DOI 10.1107/S1744309112007439; Hashimoto S, 2012, CHEM RES TOXICOL, V25, P656, DOI 10.1021/tx200374s; Hashimoto S, 2012, J BIOCHEM, V151, P35, DOI 10.1093/jb/mvr122; Hiroi T, 2006, ENDOCRINOLOGY, V147, P2773, DOI 10.1210/en.2005-1235; Imaoka S, 2007, BIOL PHARM BULL, V30, P371, DOI 10.1248/bpb.30.371; Inaba K, 2010, EMBO J, V29, P3330, DOI 10.1038/emboj.2010.222; Jenkins S, 2011, ENVIRON HEALTH PERSP, V119, P1604, DOI 10.1289/ehp.1103850; Kadokura H, 2013, BIOCHEM BIOPH RES CO, V440, P245, DOI 10.1016/j.bbrc.2013.09.063; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kidani T, 2010, J ATHEROSCLER THROMB, V17, P834, DOI 10.5551/jat.4051; Klappa P, 1998, EMBO J, V17, P927, DOI 10.1093/emboj/17.4.927; Kojima R., 2013, ELS, DOI [10.1002/9780470015902.a0024169, DOI 10.1002/9780470015902.A0024169]; Kojima R, 2014, STRUCTURE, V22, P431, DOI 10.1016/j.str.2013.12.013; Masui S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.231357; Narayan M, 2012, FEBS J, V279, P2272, DOI 10.1111/j.1742-4658.2012.08636.x; Nguyen VD, 2008, J MOL BIOL, V383, P1144, DOI 10.1016/j.jmb.2008.08.085; Obata T, 2000, NEUROSCI LETT, V296, P41, DOI 10.1016/S0304-3940(00)01619-0; Okumura M., 2014, CURR PROTOC PROTEIN, V76; Okumura M, 2012, FEBS LETT, V586, P3926, DOI 10.1016/j.febslet.2012.09.031; Okumura M, 2012, FEBS J, V279, P2283, DOI 10.1111/j.1742-4658.2012.08596.x; Okumura M, 2011, FEBS J, V278, P1137, DOI 10.1111/j.1742-4658.2011.08039.x; Papaconstantinou AD, 2001, TOXICOL SCI, V63, P173, DOI 10.1093/toxsci/63.2.173; Pirneskoski A, 2001, J BIOL CHEM, V276, P11287, DOI 10.1074/jbc.M010656200; Plotnikov V, 2002, ASSAY DRUG DEV TECHN, V1, P83, DOI 10.1089/154065802761001338; PRIVALOV PL, 1974, J MOL BIOL, V86, P665, DOI 10.1016/0022-2836(74)90188-0; Ramming T, 2012, ANTIOXID REDOX SIGN, V16, P1109, DOI 10.1089/ars.2011.4475; Sato Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep02456; Sato Y, 2012, FEBS J, V279, P2262, DOI 10.1111/j.1742-4658.2012.08593.x; SCHELLMAN JA, 1976, BIOPOLYMERS, V15, P999, DOI 10.1002/bip.1976.360150513; SCHELLMAN JA, 1975, BIOPOLYMERS, V14, P999, DOI 10.1002/bip.1975.360140509; Shao F, 2000, J BIOL CHEM, V275, P13349, DOI 10.1074/jbc.275.18.13349; Shiba K, 2010, ANAL SCI, V26, P659, DOI 10.2116/analsci.26.659; SVERGUN DI, 1991, J APPL CRYSTALLOGR, V24, P485, DOI 10.1107/S0021889891001280; Tabuchi Y, 2006, BIOCHEM BIOPH RES CO, V345, P1044, DOI 10.1016/j.bbrc.2006.04.177; Tavender TJ, 2010, EMBO J, V29, P4185, DOI 10.1038/emboj.2010.273; Tavender TJ, 2010, ANTIOXID REDOX SIGN, V13, P1177, DOI 10.1089/ars.2010.3230; Tian G, 2006, CELL, V124, P61, DOI 10.1016/j.cell.2005.10.044; Tian G, 2008, J BIOL CHEM, V283, P33630, DOI 10.1074/jbc.M806026200; Vandenberg LN, 2007, REPROD TOXICOL, V24, P139, DOI 10.1016/j.reprotox.2007.07.010; WALKER KW, 1995, BIOCHEMISTRY-US, V34, P13642, DOI 10.1021/bi00041a045; Wang C, 2013, ANTIOXID REDOX SIGN, V19, P44, DOI 10.1089/ars.2012.4630; WEISSMAN JS, 1993, NATURE, V365, P185, DOI 10.1038/365185a0; WEISSMAN JS, 1995, NAT STRUCT BIOL, V2, P1123, DOI 10.1038/nsb1295-1123; WEISSMAN JS, 1991, SCIENCE, V253, P1386, DOI 10.1126/science.1716783; Wijesekara N, 2010, J BIOL CHEM, V285, P33623, DOI 10.1074/jbc.M109.085084	56	30	32	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					27004	27018		10.1074/jbc.M114.564104	http://dx.doi.org/10.1074/jbc.M114.564104			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25122773	Green Published, hybrid			2022-12-25	WOS:000342853900029
J	Mc Sharry, J; Baxter, A; Wallace, LM; Kenton, A; Turner, A; French, DP				Mc Sharry, Jennifer; Baxter, Alison; Wallace, Louise M.; Kenton, Anthony; Turner, Andrew; French, David P.			Delay in Seeking Medical Help following Transient Ischemic Attack (TIA) or "Mini-Stroke": A Qualitative Study	PLOS ONE			English	Article							HEALTH-CARE PROFESSIONALS; URGENT TREATMENT; RISK; EXPRESS	Background: Prompt treatment following Transient Ischemic Attack (TIA) can reduce the risk of subsequent stroke and disability. However, many patients delay in making contact with medical services. This study aimed to explore TIA patients' accounts of delay between symptom onset and contacting medical services including how decisions to contact services were made and the factors discussed in relation to delay. Methods: Twenty interviews were conducted with TIA patients in England. Using a previous systematic review as an initial framework, interview data were organised into categories of symptom recognition, presence of others and type of care sought. A thematic analysis was then conducted to explore descriptions of care-seeking relevant to each category. Results: Delay in contacting medical services varied from less than an hour to eight days. Awareness of typical stroke symptoms could lead to urgent action when more severe TIA symptoms were present but could lead to delay when experienced symptoms were less severe. The role of friends and family varied widely from deciding on and enacting care-seeking decisions to simply providing transport to the GP practice. When family or friends played a greater role, and both made and enacted care-seeking decisions, delays were often shorter, even when patients themselves failed to identify symptoms. Healthcare professionals also impacted on patients' care-seeking with greater delays in seeking further care for the same episode described when patients perceived a lack of urgency during initial healthcare interactions. Conclusions: This study provides new information on patients' decisions to contact medical services following TIA and identifies overlapping factors that can lead to delay in receiving appropriate treatment. While recognition of symptoms may contribute to delay in contacting medical services, additional factors, including full responsibility being taken by others and initial healthcare interactions, can over-ride or undermine the importance of patients' own identification of TIA.	[Mc Sharry, Jennifer] Natl Univ Ireland, Sch Psychol, Hlth Behav Change Res Grp, Galway, Ireland; [Baxter, Alison; Wallace, Louise M.; Turner, Andrew] Coventry Univ, Appl Res Ctr Hlth & Lifestyle Intervent, Coventry, W Midlands, England; [Kenton, Anthony] Univ Hosp Coventry & Warwickshire NHS Trust, Coventry, W Midlands, England; [French, David P.] Univ Manchester, Manchester Ctr Hlth Psychol, Manchester, Lancs, England	Ollscoil na Gaillimhe-University of Galway; Coventry University; University of Warwick; University of Manchester	Mc Sharry, J (corresponding author), Natl Univ Ireland, Sch Psychol, Hlth Behav Change Res Grp, Galway, Ireland.	jenny.mcsharry@nuigalway.ie	French, David P/K-7283-2012	French, David P/0000-0002-7663-7804; Mc Sharry, Jennifer/0000-0001-5459-1588; Turner, Andrew/0000-0001-6538-4242	Coventry and Warwickshire Cardiovascular Network	Coventry and Warwickshire Cardiovascular Network	The research was funded by the Coventry and Warwickshire Cardiovascular Network (http://www.coventryandwarwickshirecardiovascularnetwork.nhs.uk/Home). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers GW, 2002, NEW ENGL J MED, V347, P1713, DOI 10.1056/NEJMsb020987; ANDERSEN BL, 1995, BRIT J SOC PSYCHOL, V34, P33, DOI 10.1111/j.2044-8309.1995.tb01047.x; Braun V., 2006, MAY, V3, P77, DOI 10.1191/1478088706qp063oa; CHAMBERLAIN K, 2004, RES METHODS CLIN HLT, V0005, P00069; Dombrowski SU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039852; Easton JD, 2009, STROKE, V40, P2276, DOI 10.1161/STROKEAHA.108.192218; French DP, 2005, SOC SCI MED, V60, P1411, DOI 10.1016/j.socscimed.2004.08.008; French DP, 2014, PRINCIPLES CONCEPTS; Furie KL, 2011, STROKE, V42, P227, DOI 10.1161/STR.0b013e3181f7d043; Giles MF, 2007, LANCET NEUROL, V6, P1063, DOI 10.1016/S1474-4422(07)70274-0; Giles MF, 2006, STROKE, V37, P1254, DOI 10.1161/01.STR.0000217388.57851.62; Horne R, 2000, HEART, V83, P388, DOI 10.1136/heart.83.4.388; Johnston SC, 2003, NEUROLOGY, V60, P1429, DOI 10.1212/01.WNL.0000063309.41867.0F; Kamara Stania, 2012, Prim Health Care Res Dev, V13, P165, DOI 10.1017/S146342361100051X; Kirkpatrick S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066351; Lavallee PC, 2007, LANCET NEUROL, V6, P953, DOI 10.1016/S1474-4422(07)70248-X; Luengo-Fernandez R, 2009, LANCET NEUROL, V8, P235, DOI 10.1016/S1474-4422(09)70019-5; Mackintosh JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046124; Macleod U, 2009, BRIT J CANCER, V101, pS92, DOI 10.1038/sj.bjc.6605398; Robinson TG, 2013, EMERG MED J, V30, P467, DOI 10.1136/emermed-2012-201471; Rothwell PM, 2007, LANCET, V370, P1432, DOI 10.1016/S0140-6736(07)61448-2; Scott SE, 2013, BRIT J HEALTH PSYCH, V18, P45, DOI 10.1111/j.2044-8287.2012.02077.x; Sprigg N, 2009, J NEUROL NEUROSUR PS, V80, P871, DOI 10.1136/jnnp.2008.167924; Wu CM, 2007, ARCH INTERN MED, V167, P2417, DOI 10.1001/archinte.167.22.2417	24	10	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e104434	10.1371/journal.pone.0104434	http://dx.doi.org/10.1371/journal.pone.0104434			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137185	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000340742100034
J	Adam, M; Imboden, M; Boes, E; Schaffner, E; Kunzli, N; Phuleria, HC; Kronenberg, F; Gaspoz, JM; Carballo, D; Probst-Hensch, N				Adam, Martin; Imboden, Medea; Boes, Eva; Schaffner, Emmanuel; Kuenzli, Nino; Phuleria, Harish Chandra; Kronenberg, Florian; Gaspoz, Jean-Michel; Carballo, David; Probst-Hensch, Nicole			Modifying Effect of a Common Polymorphism in the Interleukin-6 Promoter on the Relationship between Long-Term Exposure to Traffic-Related Particulate Matter and Heart Rate Variability	PLOS ONE			English	Article							PLASMA IL-6 LEVELS; AIR-POLLUTION; CARDIOVASCULAR-DISEASE; SYSTEMIC INFLAMMATION; LUNG-DISEASES; SWISS COHORT; RISK-FACTORS; GENE; ASSOCIATION; MORTALITY	Background: Exposure to particulate matter (PM) has been associated with an increase in many inflammatory markers, including interleukin 6 (IL6). Air pollution exposure has also been suggested to induce an imbalance in the autonomic nervous system (ANS), such as a decrease in heart rate variability (HRV). In this study we aimed to investigate the modifying effect of polymorphisms in a major proinflammatory marker gene, interleukin 6 (IL6), on the relationship between long-term exposure to traffic-related PM10 (TPM10) and HRV. Methods: For this cross-sectional study we analysed 1552 participants of the SAPALDIA cohort aged 50 years and older. Included were persons with valid genotype data, who underwent ambulatory 24-hr electrocardiogram monitoring, and reported on medical history and lifestyle. Main effects of annual average TPM10 and IL6 gene variants (rs1800795; rs2069827; rs2069840; rs10242595) on HRV indices and their interaction with average annual exposure to TPM10 were tested, applying a multivariable mixed linear model. Results: No overall association of TPM10 on HRV was found. Carriers of two proinflammatory G-alleles of the functional IL6 - 174 G/C (rs1800795) polymorphism exhibited lower HRV. An inverse association between a 1 mu g/m(3) increment in yearly averaged TPM10 and HRV was restricted to GG genotypes at this locus with a standard deviation of normal-to-normal intervals (SDNN) (GG-carriers: -1.8%; 95% confidence interval -3.5 to 0.01; p(interaction(additive)) = 0.028); and low frequency power (LF) (GG-carriers: -5.7%; 95% CI: -10.4 to 20.8; p(interaction(dominant)) = 0.049). Conclusions: Our results are consistent with the hypothesis that traffic-related air pollution decreases heart rate variability through inflammatory mechanisms.	[Adam, Martin; Imboden, Medea; Boes, Eva; Schaffner, Emmanuel; Kuenzli, Nino; Phuleria, Harish Chandra; Probst-Hensch, Nicole] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Adam, Martin; Imboden, Medea; Boes, Eva; Schaffner, Emmanuel; Kuenzli, Nino; Phuleria, Harish Chandra; Probst-Hensch, Nicole] Univ Basel, Basel, Switzerland; [Boes, Eva; Kronenberg, Florian] Med Univ Innsbruck, Dept Med Genet Mol & Clin Pharmacol, Div Genet Epidemiol, A-6020 Innsbruck, Austria; [Gaspoz, Jean-Michel] Univ Hosp, Dept Community Med Primary Care & Emergency Med, Geneva, Switzerland; [Carballo, David] Univ Hosp, Dept Internal Med Specialties, Geneva, Switzerland	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Medical University of Innsbruck; University of Geneva; University of Geneva	Adam, M (corresponding author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.	martin.adam@unibas.ch	Kronenberg, Florian/B-1736-2008; Kuenzli, Nino/F-7195-2014	Kronenberg, Florian/0000-0003-2229-1120; Kuenzli, Nino/0000-0001-8360-080X	Swiss National Science Foundation [33CSCO-108796, 3247BO-104283, 3247BO-104288, 3247BO-104284, 3247-065896, 3100-059302, 3200-052720, 3200-042532, 4026-028099]; Federal Office for Forest, Environment and Landscape; Federal Office of Public Health; Federal Office of Roads and Transport; canton's government of Aargau; canton's government of Basel-Stadt; canton's government of Basel-Land; canton's government of Geneva; canton's government of Luzern; canton's government of Ticino; canton's government of Valais; canton's government of Zurich; Swiss Lung League; canton's Lung League of Basel Stadt/Basel Landschaft; canton's Lung League of Geneva; canton's Lung League of Ticino; canton's Lung League of Valais; canton's Lung League of Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Federal Office for Forest, Environment and Landscape; Federal Office of Public Health; Federal Office of Roads and Transport; canton's government of Aargau; canton's government of Basel-Stadt; canton's government of Basel-Land; canton's government of Geneva; canton's government of Luzern; canton's government of Ticino; canton's government of Valais; canton's government of Zurich; Swiss Lung League; canton's Lung League of Basel Stadt/Basel Landschaft; canton's Lung League of Geneva; canton's Lung League of Ticino; canton's Lung League of Valais; canton's Lung League of Zurich	This work was supported by the Swiss National Science Foundation (grant numbers 33CSCO-108796, 3247BO-104283, 3247BO-104288, 3247BO-104284, 3247-065896, 3100-059302, 3200-052720, 3200-042532, 4026-028099), the Federal Office for Forest, Environment and Landscape, the Federal Office of Public Health, the Federal Office of Roads and Transport, the canton's government of Aargau, Basel-Stadt, Basel-Land, Geneva, Luzern, Ticino, Valais and Zurich, the Swiss Lung League and the canton's Lung League of Basel Stadt/Basel Landschaft, Geneva, Ticino, Valais and Zurich. No form of payment was given to any of the authors to produce the manuscript. The study received funding through peer-reviewed grants and donations from non-profit organizations as listed above. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann-Liebrich U, 2005, SOZ PRAVENTIV MED, V50, P245, DOI 10.1007/s00038-005-4075-5; Adam M, 2012, ENVIRON INT, V48, P9, DOI 10.1016/j.envint.2012.06.016; Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; BIGGER JT, 1993, J AM COLL CARDIOL, V21, P729, DOI 10.1016/0735-1097(93)90106-B; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Brull DJ, 2001, ARTERIOSCL THROM VAS, V21, P1458, DOI 10.1161/hq0901.094280; Chan KHK, 2011, CLIN CHEM, V57, P317, DOI 10.1373/clinchem.2010.154526; Danesh J, 2008, PLOS MED, V5, P600, DOI 10.1371/journal.pmed.0050078; Dekker JM, 2000, CIRCULATION, V102, P1239, DOI 10.1161/01.CIR.102.11.1239; Delfino RJ, 2010, EPIDEMIOLOGY, V21, P892, DOI 10.1097/EDE.0b013e3181f20e6c; Delfino RJ, 2009, ENVIRON HEALTH PERSP, V117, P1232, DOI [10.1289/journla.ehp.0800194, 10.1289/ehp.0800194]; Dietrich DF, 2008, ENVIRON HEALTH PERSP, V116, P1357, DOI 10.1289/ehp.11377; Dietrich DF, 2006, EUROPACE, V8, P521, DOI 10.1093/europace/eul063; *EL NASOPA, 1996, CIRCULATION, V93, P1043; Fishman D, 1998, J CLIN INVEST, V102, P1369, DOI 10.1172/JCI2629; Haensel A, 2008, PSYCHONEUROENDOCRINO, V33, P1305, DOI 10.1016/j.psyneuen.2008.08.007; Hulkkonen J, 2001, RHEUMATOLOGY, V40, P656, DOI 10.1093/rheumatology/40.6.656; Hulkkonen J, 2009, ATHEROSCLEROSIS, V203, P454, DOI 10.1016/j.atherosclerosis.2008.07.014; Humphries SE, 2001, EUR HEART J, V22, P2243, DOI 10.1053/euhj.2001.2678; Imboden M, 2006, Clin Mol Allergy, V4, P9, DOI 10.1186/1476-7961-4-9; Kaptoge S, 2014, EUR HEART J, V35, P578, DOI 10.1093/eurheartj/eht367; Kelberman D, 2004, BBA-MOL BASIS DIS, V1688, P160, DOI 10.1016/j.bbadis.2003.11.010; KLEIGER RE, 1987, AM J CARDIOL, V59, P256, DOI 10.1016/0002-9149(87)90795-8; Kormann MSD, 2005, AM J RESP CRIT CARE, V171, P1358, DOI 10.1164/rccm.200410-1312OC; Kunzli N, 2009, THORAX, V64, P664, DOI 10.1136/thx.2008.110031; Lalouschek W, 2006, CLIN CHEM LAB MED, V44, P918, DOI 10.1515/CCLM.2006.165; Lampert R, 2008, AM HEART J, V156, DOI 10.1016/j.ahj.2008.07.009; Lee JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034218; Lieb DC, 2012, EXP DIABETES RES, DOI 10.1155/2012/878760; Link MS, 2010, CURR OPIN CARDIOL, V25, P16, DOI 10.1097/HCO.0b013e32833358cd; Liu LJS, 2007, ENVIRON HEALTH PERSP, V115, P1638, DOI 10.1289/ehp.10177; Ljungman P, 2009, THROMB RES, V124, P57, DOI 10.1016/j.thromres.2008.10.009; Luttmann-Gibson H, 2010, OCCUP ENVIRON MED, V67, P625, DOI 10.1136/oem.2009.050625; Martin BW, 1997, SOZ PRAVENTIV MED, V42, P67, DOI 10.1007/BF01318136; Mayosi BM, 2005, STROKE, V36, P2215, DOI 10.1161/01.STR.0000182254.47941.96; Mills NL, 2011, HEART, V97, P544, DOI 10.1136/hrt.2010.199042; Nolan J, 1998, CIRCULATION, V98, P1510, DOI 10.1161/01.CIR.98.15.1510; Park SK, 2006, CIRCULATION, V114, P2798, DOI 10.1161/CIRCULATIONAHA.106.643197; Pieters N, 2012, HEART, V98, P1127, DOI 10.1136/heartjnl-2011-301505; Pope CA, 2004, ENVIRON HEALTH PERSP, V112, P339, DOI 10.1289/ehp.6588; Probst-Hensch NM, 2008, ENVIRON HEALTH PERSP, V116, P1494, DOI 10.1289/ehp.11402; Ren CZ, 2010, EPIDEMIOLOGY, V21, P198, DOI 10.1097/EDE.0b013e3181cc8bfc; Riikola A, 2009, ATHEROSCLEROSIS, V207, P466, DOI 10.1016/j.atherosclerosis.2009.06.004; Ruckerl R, 2007, ENVIRON HEALTH PERSP, V115, P1072, DOI 10.1289/ehp.10021; Sie MPS, 2008, VASC HEALTH RISK MAN, V4, P863; Sie MPS, 2006, ARTERIOSCL THROM VAS, V26, P212, DOI 10.1161/01.ATV.0000194099.65024.17; Zanobetti A, 2011, PROG CARDIOVASC DIS, V53, P344, DOI 10.1016/j.pcad.2011.01.001	47	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e104978	10.1371/journal.pone.0104978	http://dx.doi.org/10.1371/journal.pone.0104978			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133672	gold, Green Published, Green Accepted			2022-12-25	WOS:000341302700058
J	Fariello, MI; Servin, B; Tosser-Klopp, G; Rupp, R; Moreno, C; San Cristobal, M; Boitard, S				Fariello, Maria-Ines; Servin, Bertrand; Tosser-Klopp, Gwenola; Rupp, Rachel; Moreno, Carole; San Cristobal, Magali; Boitard, Simon		Int Sheep Genomics Consortium	Selection Signatures in Worldwide Sheep Populations	PLOS ONE			English	Article							HOLSTEIN CATTLE; ARTIFICIAL SELECTION; MISSENSE MUTATION; GENOTYPE DATA; ADULT HEIGHT; COAT COLOR; GENE; GENOME; BREEDS; RECEPTOR	The diversity of populations in domestic species offers great opportunities to study genome response to selection. The recently published Sheep HapMap dataset is a great example of characterization of the world wide genetic diversity in sheep. In this study, we re-analyzed the Sheep HapMap dataset to identify selection signatures in worldwide sheep populations. Compared to previous analyses, we made use of statistical methods that (i) take account of the hierarchical structure of sheep populations, (ii) make use of linkage disequilibrium information and (iii) focus specifically on either recent or older selection signatures. We show that this allows pinpointing several new selection signatures in the sheep genome and distinguishing those related to modern breeding objectives and to earlier post-domestication constraints. The newly identified regions, together with the ones previously identified, reveal the extensive genome response to selection on morphology, color and adaptation to new environments.	[Fariello, Maria-Ines; Servin, Bertrand; Tosser-Klopp, Gwenola; Rupp, Rachel; Moreno, Carole; San Cristobal, Magali] INRA, Genet Physiol & Syst Elevage, F-31326 Castanet Tolosan, France; [Fariello, Maria-Ines; Servin, Bertrand; Tosser-Klopp, Gwenola; Rupp, Rachel; Moreno, Carole; San Cristobal, Magali] Ecole Natl Vet Toulouse, Castanet Tolosan, France; [Fariello, Maria-Ines; Servin, Bertrand; Tosser-Klopp, Gwenola; Rupp, Rachel; Moreno, Carole; San Cristobal, Magali] Ecole Natl Super Agron Toulouse, Castanet Tolosan, France; [Fariello, Maria-Ines] Univ Republica, Inst Matamat & Estadist Prof Ing Rafael Laguardia, Fac Ingn, Montevideo, Uruguay; [Fariello, Maria-Ines] Inst Pasteur, Bioinformat Unit, Montevideo, Uruguay; Www Sheephapmap Org, Geneva, Switzerland; [Boitard, Simon] INRA, Genet Anim & Biol Integrat, Jouy En Josas, France; [Boitard, Simon] AgroParisTech, Jouy En Josas, France; [Boitard, Simon] Museum Natl Hist Nat, Origine Struct & Evolut Biodivers, F-75231 Paris, France; [Boitard, Simon] Ecole Prat Hautes Etud, Paris, France; [Boitard, Simon] CNRS, Paris, France	INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite de Toulouse; Institut National Polytechnique de Toulouse; Universidad de la Republica, Uruguay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Centre National de la Recherche Scientifique (CNRS)	Boitard, S (corresponding author), INRA, Genet Anim & Biol Integrat, Jouy En Josas, France.	sboitard@mnhn.fr	Hayes, Ben J/L-3308-2016; Kijas, James W/A-4656-2011; Calvo, Jorge H/E-5240-2016; Simianer, Henner/A-6574-2015; Cemal, Ibrahim/AAC-2783-2020; D'ANDREA, Mariasilvia/AAQ-9396-2020; Arranz, Juan-Jose/H-1225-2015; D'Andrea, Mariasilvia/E-5760-2012; Barendse, William J/D-8608-2011; Slate, Jon/D-2925-2012; McEwan, John/A-1143-2008; Servin, Bertrand/B-2206-2008; Coltman, David/A-4453-2012; Miltiadou, Despoina/E-2204-2016	Hayes, Ben J/0000-0002-5606-3970; Kijas, James W/0000-0002-1417-8278; Calvo, Jorge H/0000-0001-9513-0219; Simianer, Henner/0000-0002-7551-3797; Arranz, Juan-Jose/0000-0001-9058-131X; D'Andrea, Mariasilvia/0000-0002-8932-4057; Barendse, William J/0000-0002-5464-0658; Slate, Jon/0000-0003-3356-5123; McEwan, John/0000-0003-4801-6207; Servin, Bertrand/0000-0001-5141-0913; Carta, Antonello/0000-0003-0534-4876; MacHugh, David/0000-0002-8112-4704; PILLA, Fabio/0000-0002-1781-994X; TOSSER-KLOPP, GWENOLA/0000-0003-0550-4673; ciani, elena/0000-0001-5673-0975; Rupp, Rachel/0000-0003-3375-5816; Coltman, David/0000-0002-1268-2307; Drogemuller, Cord/0000-0001-9773-522X; Lenstra, Johannes A./0000-0003-1745-7739; Hanotte, Olivier/0000-0002-2877-4767; Banos, Georgios/0000-0002-7674-858X; Pardeshi, Varsha/0000-0001-7753-9897; Fariello, Maria Ines/0000-0002-3337-1209; Heaton, Michael/0000-0003-1386-1208; Cemal, Ibrahim/0000-0002-4069-4815; Miltiadou, Despoina/0000-0002-5940-3520				Akey JM, 2010, P NATL ACAD SCI USA, V107, P1160, DOI 10.1073/pnas.0909918107; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Andersson L, 2012, J INTERN MED, V271, P1, DOI 10.1111/j.1365-2796.2011.02450.x; Balasse Marie, 2007, Anthropozoologica, V42, P71; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Becker D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008689; Bidinost F, 2008, SMALL RUMINANT RES, V74, P113, DOI 10.1016/j.smallrumres.2007.04.005; Bierne N, 2013, MOL ECOL, V22, P2061, DOI 10.1111/mec.12241; Bongiorni S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050137; Bonhomme M, 2010, GENETICS, V186, P241, DOI 10.1534/genetics.104.117275; Cadieu E, 2009, SCIENCE, V326, P150, DOI 10.1126/science.1177808; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Cohen-Zinder M, 2005, GENOME RES, V15, P936, DOI 10.1101/gr.3806705; Dominik S, 2012, ANIM GENET, V43, P468, DOI 10.1111/j.1365-2052.2011.02271.x; Druet T, 2013, ANIM GENET, V44, P758, DOI 10.1111/age.12073; Eberlein A, 2009, GENETICS, V183, P951, DOI 10.1534/genetics.109.106476; Excoffier L, 2009, HEREDITY, V103, P285, DOI 10.1038/hdy.2009.74; Fariello MI, 2013, GENETICS, V193, P929, DOI 10.1534/genetics.112.147231; Fleming-Waddell JN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007399; Garcia-Gamez E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021158; Gunther T, 2013, GENETICS, V195, P205, DOI 10.1534/genetics.113.152462; Hauswirth R, 2012, PLOS GENET, V8, P404, DOI 10.1371/journal.pgen.1002653; Heaton MP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002467; Housley DJE, 2006, ANIM GENET, V37, P309, DOI 10.1111/j.1365-2052.2006.01448.x; Jacobs LC, 2013, HUM GENET, V132, P147, DOI 10.1007/s00439-012-1232-9; Joerg H, 1996, MAMM GENOME, V7, P317, DOI 10.1007/s003359900090; Johnston SE, 2011, MOL ECOL, V20, P2555, DOI 10.1111/j.1365-294X.2011.05076.x; Kijas JW, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001258; Kijas JW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004668; KLUNGLAND H, 1995, MAMM GENOME, V6, P636, DOI 10.1007/BF00352371; Kuijper S, 2005, DEV BIOL, V285, P533, DOI 10.1016/j.ydbio.2005.06.017; LEWONTIN RC, 1973, GENETICS, V74, P175; Lin JY, 2007, NATURE, V445, P843, DOI 10.1038/nature05660; Linnen CR, 2013, SCIENCE, V339, P1312, DOI 10.1126/science.1233213; Makvandi-Nejad S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039929; Mancini G, 2014, MOL BIOL REP, V41, P957, DOI 10.1007/s11033-013-2940-5; Moradi MH, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-10; Nakao N, 2008, NATURE, V452, P317, DOI 10.1038/nature06738; Noguchi K, 2010, J PHARMACOL SCI, V112, P89, DOI 10.1254/jphs.09254FP; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Person AD, 2010, DEV DYNAM, V239, P327, DOI 10.1002/dvdy.22156; Pintus E, 2013, ANIM GENET; Pritchard JK, 2000, GENETICS, V155, P945; Qu SM, 1998, DEVELOPMENT, V125, P2711; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Rincon G, 2012, J DAIRY RES, V79, P66, DOI 10.1017/S002202991100080X; Rothammer S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-908; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Stattin EL, 2010, AM J HUM GENET, V86, P126, DOI 10.1016/j.ajhg.2009.12.018; Stickens D, 2005, DEVELOPMENT, V132, P5055, DOI 10.1242/dev.02088; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tompson SW, 2009, AM J HUM GENET, V84, P72, DOI 10.1016/j.ajhg.2008.12.001; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Yang TL, 2010, ANN HUM GENET, V74, P11, DOI 10.1111/j.1469-1809.2009.00555.x; Zeder MA, 2008, P NATL ACAD SCI USA, V105, P11597, DOI 10.1073/pnas.0801317105; Zhang LF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065942	57	100	106	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e103813	10.1371/journal.pone.0103813	http://dx.doi.org/10.1371/journal.pone.0103813			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126940	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000340879300009
J	Marchant, HK; Lavik, G; Holtappels, M; Kuypers, MMM				Marchant, Hannah K.; Lavik, Gaute; Holtappels, Moritz; Kuypers, Marcel M. M.			The Fate of Nitrate in Intertidal Permeable Sediments	PLOS ONE			English	Article							CONTINENTAL-SHELF; ATLANTIC BIGHT; MINERALIZATION RATES; NITROGEN REMOVAL; NUTRIENT FLUXES; AMMONIUM DNRA; DENITRIFICATION; REDUCTION; SEA; TRANSPORT	Coastal zones act as a sink for riverine and atmospheric nitrogen inputs and thereby buffer the open ocean from the effects of anthropogenic activity. Recently, microbial activity in sandy permeable sediments has been identified as a dominant source of N-loss in coastal zones, namely through denitrification. Some of the highest coastal denitrification rates measured so far occur within the intertidal permeable sediments of the eutrophied Wadden Sea. Still, denitrification alone can often account for only half of the substantial nitrate (NO3-) consumption. Therefore, to investigate alternative NO3- sinks such as dissimilatory nitrate reduction to ammonium (DNRA), intracellular nitrate storage by eukaryotes and isotope equilibration effects we carried out (NO3-)-N-15 amendment experiments. By considering all of these sinks in combination, we could quantify the fate of the (NO3-)-N-15 added to the sediment. Denitrification was the dominant nitrate sink (50-75%), while DNRA, which recycles N to the environment accounted for 10-20% of NO3- consumption. Intriguingly, we also observed that between 20 and 40% of (NO3-)-N-15 added to the incubations entered an intracellular pool of NO3- and was subsequently respired when nitrate became limiting. Eukaryotes were responsible for a large proportion of intracellular nitrate storage, and it could be shown through inhibition experiments that at least a third of the stored nitrate was subsequently also respired by eukaryotes. The environmental significance of the intracellular nitrate pool was confirmed by in situ measurements which revealed that intracellular storage can accumulate nitrate at concentrations six fold higher than the surrounding porewater. This intracellular pool is so far not considered when modeling N-loss from intertidal permeable sediments; however it can act as a reservoir for nitrate during low tide. Consequently, nitrate respiration supported by intracellular nitrate storage can add an additional 20% to previous nitrate reduction estimates in intertidal sediments, further increasing their contribution to N-loss.	[Marchant, Hannah K.; Lavik, Gaute; Holtappels, Moritz; Kuypers, Marcel M. M.] Max Planck Inst Marine Microbiol, Bremen, Germany	Max Planck Society	Marchant, HK (corresponding author), Max Planck Inst Marine Microbiol, Bremen, Germany.	hmarchan@mpi-bremen.de	Holtappels, Moritz/ABC-7901-2020	Marchant, Hannah/0000-0002-1482-9165; Holtappels, Moritz/0000-0003-3682-1903	Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	This research was funded by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	ADMIRAAL W, 1987, MAR ECOL PROG SER, V40, P267, DOI 10.3354/meps040267; Al-Raei AM, 2009, OCEAN DYNAM, V59, P351, DOI 10.1007/s10236-009-0186-5; An SM, 2002, MAR ECOL PROG SER, V237, P41, DOI 10.3354/meps237041; Billerbeck M, 2006, MAR ECOL PROG SER, V326, P61, DOI 10.3354/meps326061; Billerbeck M, 2006, MAR ECOL PROG SER, V316, P35, DOI 10.3354/meps316035; Boer SI, 2009, BIOGEOSCIENCES, V6, P1149; Bonin P, 1998, HYDROBIOLOGIA, V389, P169, DOI 10.1023/A:1003585115481; Boyer EW, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002537; BRAMAN RS, 1989, ANAL CHEM, V61, P2715, DOI 10.1021/ac00199a007; Canfield DE, 2005, ADV MAR BIOL, V48, P313; Chipman L, 2012, CONT SHELF RES, V45, P116, DOI 10.1016/j.csr.2012.06.010; Christensen PB, 2000, AQUAT MICROB ECOL, V21, P73, DOI 10.3354/ame021073; Cook PLM, 2006, LIMNOL OCEANOGR-METH, V4, P294, DOI 10.4319/lom.2006.4.294; Cook PLM, 2004, MAR ECOL PROG SER, V280, P39, DOI 10.3354/meps280039; Dahnke K, 2012, BIOGEOSCIENCES, V9, P4059, DOI 10.5194/bg-9-4059-2012; de Beer D, 2005, LIMNOL OCEANOGR, V50, P113, DOI 10.4319/lo.2005.50.1.0113; Deek A, 2013, MAR ECOL PROG SER, V493, P9, DOI 10.3354/meps10514; Deek A, 2012, BIOGEOCHEMISTRY, V108, P467, DOI 10.1007/s10533-011-9611-1; Dong LF, 2011, LIMNOL OCEANOGR, V56, P279, DOI 10.4319/lo.2011.56.1.0279; Ehrenhauss S, 2004, MAR ECOL PROG SER, V271, P99, DOI 10.3354/meps271099; Ehrenhauss S, 2004, CONT SHELF RES, V24, P721, DOI 10.1016/j.csr.2004.01.002; Emery K.O., 1968, AAPG BULL, V52, P445, DOI 10.1306/5D25C2E7-16C1-11D7-8645000102C1865D; FeuilletGirard M, 1997, AQUAT LIVING RESOUR, V10, P49, DOI 10.1051/alr:1997005; FOSSING H, 1995, NATURE, V374, P713, DOI 10.1038/374713a0; Fussel J, 2012, ISME J, V6, P1200, DOI 10.1038/ismej.2011.178; FUHRMAN JA, 1984, SCIENCE, V224, P1257, DOI 10.1126/science.224.4654.1257; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Gao H, 2012, LIMNOL OCEANOGR, V57, P185, DOI 10.4319/lo.2012.57.1.0185; Gao H, 2010, ISME J, V4, P417, DOI 10.1038/ismej.2009.127; Garcia-Robledo E, 2010, MAR ECOL PROG SER, V403, P155, DOI 10.3354/meps08470; Gardner WS, 2006, LIMNOL OCEANOGR, V51, P558, DOI 10.4319/lo.2006.51.1_part_2.0558; Glud RN, 2008, MAR BIOL RES, V4, P243, DOI 10.1080/17451000801888726; Goineau A, 2011, J SEA RES, V65, P58, DOI 10.1016/j.seares.2010.07.007; Grasshoff K, 1999, DETERMINATION NUTR M, P159; Grippo MA, 2010, CONT SHELF RES, V30, P456, DOI 10.1016/j.csr.2009.12.015; Grosskopf T, 2012, NATURE, V488, P361, DOI 10.1038/nature11338; Gruber N., 2004, OCEAN CARBON CYCLE C, VIV, P97, DOI [10.1007/978-1-4020-2087-2_4, DOI 10.1007/978-1-4020-2087-2_4]; Gruber N, 2008, NATURE, V451, P293, DOI 10.1038/nature06592; Hall POJ, 1992, RAPID; Heisterkamp IM, 2012, MAR ECOL PROG SER, V445, P181, DOI 10.3354/meps09464; Hillebrand H, 1999, J PHYCOL, V35, P403, DOI 10.1046/j.1529-8817.1999.3520403.x; Hogslund S, 2008, NITRATE STORAGE ADAP; Holtappels M, 2011, METHOD ENZYMOL, V486, P223, DOI [10.1016/S0076-6879(11)86010-6, 10.1016/B978-0-12-381294-0.00010-9]; Huettel M, 2000, LIMNOL OCEANOGR, V45, P534, DOI 10.4319/lo.2000.45.3.0534; Huettel M, 2003, HYDROBIOLOGIA, V494, P231, DOI 10.1023/A:1025426601773; Jahnke RA, 2000, CONT SHELF RES, V20, P109, DOI 10.1016/S0278-4343(99)00063-1; Jantti H, 2012, AMBIO, V41, P161, DOI 10.1007/s13280-011-0233-6; Kamp A, 2011, P NATL ACAD SCI USA, V108, P5649, DOI 10.1073/pnas.1015744108; Kelso BHL, 1997, APPL ENVIRON MICROB, V63, P4679, DOI 10.1128/AEM.63.12.4679-4685.1997; KING D, 1987, FEMS MICROBIOL ECOL, V45, P15, DOI 10.1111/j.1574-6968.1987.tb02333.x; Koop-Jakobsen K, 2010, LIMNOL OCEANOGR, V55, P789, DOI 10.4319/lo.2009.55.2.0789; Laursen AE, 2002, CONT SHELF RES, V22, P1397, DOI 10.1016/S0278-4343(02)00008-0; Lomas MW, 2000, J PHYCOL, V36, P903, DOI 10.1046/j.1529-8817.2000.99029.x; LOMSTEIN E, 1990, MAR ECOL PROG SER, V61, P97, DOI 10.3354/meps061097; McHatton SC, 1996, APPL ENVIRON MICROB, V62, P954, DOI 10.1128/AEM.62.3.954-958.1996; Pina-Ochoa E, 2010, P NATL ACAD SCI USA, V107, P1148, DOI 10.1073/pnas.0908440107; Polerecky L, 2005, LIMNOL OCEANOGR-METH, V3, P75, DOI 10.4319/lom.2005.3.75; Preisler A, 2007, ISME J, V1, P341, DOI 10.1038/ismej.2007.50; Rao AMF, 2008, CONT SHELF RES, V28, P602, DOI 10.1016/j.csr.2007.11.007; REVSBECH NP, 1989, LIMNOL OCEANOGR, V34, P474, DOI 10.4319/lo.1989.34.2.0474; Risgaard-Petersen N, 2006, NATURE, V443, P93, DOI 10.1038/nature05070; Rusch A, 2003, FEMS MICROBIOL ECOL, V44, P89, DOI 10.1111/j.1574-6941.2003.tb01093.x; Santos IR, 2012, ESTUAR COAST SHELF S, V98, P1, DOI 10.1016/j.ecss.2011.10.024; Sayama M, 2001, APPL ENVIRON MICROB, V67, P3481, DOI 10.1128/AEM.67.8.3481-3487.2001; Seeberg-Elverfeldt J, 2005, LIMNOL OCEANOGR-METH, V3, P361, DOI 10.4319/lom.2005.3.361; Seitzinger S, 2006, ECOL APPL, V16, P2064, DOI 10.1890/1051-0761(2006)016[2064:DALAWA]2.0.CO;2; Sokoll S, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00395; Song G., 2013, BIOGEOSCIENCES, V10, P4671, DOI DOI 10.5194/BGD-10-4671-2013; SORENSEN J, 1978, APPL ENVIRON MICROB, V35, P301; Stief Peter, 2013, PLoS One, V8, pe73257, DOI 10.1371/journal.pone.0073257; Strohm TO, 2007, APPL ENVIRON MICROB, V73, P1420, DOI 10.1128/AEM.02508-06; Thamdrup B, 2002, APPL ENVIRON MICROB, V68, P1312, DOI 10.1128/AEM.68.3.1312-1318.2002; Thamdrup B, 2012, ANNU REV ECOL EVOL S, V43, P407, DOI 10.1146/annurev-ecolsys-102710-145048; Trimmer M, 2009, LIMNOL OCEANOGR, V54, P577, DOI 10.4319/lo.2009.54.2.0577; van Beusekom JEE, 2005, HELGOLAND MAR RES, V59, P45, DOI 10.1007/s10152-004-0206-2; van Beusekom JEE, 2001, WADDEN SEA SPECIFIC; Warembourg F. R, 1993, NITROGEN ISOTOPE TEC, P157; Werner U, 2006, LIMNOL OCEANOGR, V51, P2549, DOI 10.4319/lo.2006.51.6.2549	78	52	52	1	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104517	10.1371/journal.pone.0104517	http://dx.doi.org/10.1371/journal.pone.0104517			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127459	Green Submitted, Green Published, gold			2022-12-25	WOS:000340879300030
J	Ohm, IK; Alfsnes, K; Olsen, MB; Ranheim, T; Sandanger, O; Dahl, TB; Aukrust, P; Finsen, AV; Yndestad, A; Vinge, LE				Ohm, Ingrid Kristine; Alfsnes, Katrine; Olsen, Maria Belland; Ranheim, Trine; Sandanger, Oystein; Dahl, Tuva Borresdatter; Aukrust, Pal; Finsen, Alexandra Vanessa; Yndestad, Arne; Vinge, Leif Erik			Toll-Like Receptor 9 Mediated Responses in Cardiac Fibroblasts	PLOS ONE			English	Article							NF-KAPPA-B; HEART-FAILURE; BACTERIAL-DNA; MYOCARDIAL-INFARCTION; PATHOGEN RECOGNITION; MITOCHONDRIAL-DNA; INNATE IMMUNITY; IN-VITRO; INFLAMMATION; TOLL-LIKE-RECEPTOR-9	Altered cardiac Toll-like receptor 9 (TLR9) signaling is important in several experimental cardiovascular disorders. These studies have predominantly focused on cardiac myocytes or the heart as a whole. Cardiac fibroblasts have recently been attributed increasing significance in mediating inflammatory signaling. However, putative TLR9-signaling through cardiac fibroblasts remains non-investigated. Thus, our aim was to explore TLR9-signaling in cardiac fibroblasts and investigate the consequence of such receptor activity on classical cardiac fibroblast cellular functions. Cultivated murine cardiac fibroblasts were stimulated with different TLR9 agonists (CpG A, B and C) and assayed for the secretion of inflammatory cytokines (tumor necrosis factor alpha [TNF alpha], CXCL2 and interferon alpha/beta). Expression of functional cardiac fibroblast TLR9 was proven as stimulation with CpG B and -C caused significant CXCL2 and TNF alpha-release. These responses were TLR9-specific as complete inhibition of receptor-stimulated responses was achieved by co-treatment with a TLR9-antagonist (ODN 2088) or chloroquine diphosphate. TLR9-stimulated responses were also found more potent in cardiac fibroblasts when compared with classical innate immune cells. Stimulation of cardiac fibroblasts TLR9 was also found to attenuate migration and proliferation, but did not influence myofibroblast differentiation in vitro. Finally, results from in vivo TLR9-stimulation with subsequent fractionation of specific cardiac cell-types (cardiac myocytes, CD45+ cells, CD31+ cells and cardiac fibroblast-enriched cell-fractions) corroborated our in vitro data and provided evidence of differentiated cell-specific cardiac responses. Thus, we conclude that cardiac fibroblast may constitute a significant TLR9 responder cell within the myocardium and, further, that such receptor activity may impact important cardiac fibroblast cellular functions.	[Ohm, Ingrid Kristine; Alfsnes, Katrine; Olsen, Maria Belland; Ranheim, Trine; Sandanger, Oystein; Dahl, Tuva Borresdatter; Aukrust, Pal; Finsen, Alexandra Vanessa; Yndestad, Arne; Vinge, Leif Erik] Oslo Univ Hosp, Rikshosp, Internal Med Res Inst, Oslo, Norway; [Ohm, Ingrid Kristine; Dahl, Tuva Borresdatter; Aukrust, Pal; Yndestad, Arne] Univ Oslo, Fac Med, Oslo, Norway; [Ohm, Ingrid Kristine; Olsen, Maria Belland; Ranheim, Trine; Sandanger, Oystein; Finsen, Alexandra Vanessa; Yndestad, Arne; Vinge, Leif Erik] Univ Oslo, Ctr Heart Failure Res, Oslo, Norway; [Aukrust, Pal] Oslo Univ Hosp, Rikshosp, Sect Clin Immunol & Infect Dis, Oslo, Norway; [Aukrust, Pal; Yndestad, Arne] Univ Oslo, KG Jebsen Inflammatory Res Ctr, Oslo, Norway; [Finsen, Alexandra Vanessa; Vinge, Leif Erik] Oslo Univ Hosp, Rikshosp, Dept Cardiol, Oslo, Norway; [Vinge, Leif Erik] Univ Oslo, KG Jebsen Cardiac Res Ctr, Oslo, Norway	University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; National Hospital Norway; University of Oslo	Ohm, IK (corresponding author), Oslo Univ Hosp, Rikshosp, Internal Med Res Inst, Oslo, Norway.	Ingrid.Kristine.Ohm@rr-research.no	Olsen, Maria/GXA-1825-2022; Olsen, Maria Belland/GQP-4485-2022	Sandanger, Oystein/0000-0001-7475-7362; Dahl, Tuva/0000-0001-7818-9411	University of Oslo; Center for Heart Failure Research; The South-Eastern Norway Regional Health Authority (Helse Sor-Ost)	University of Oslo; Center for Heart Failure Research; The South-Eastern Norway Regional Health Authority (Helse Sor-Ost)	This work was supported by the University of Oslo; Center for Heart Failure Research; and The South-Eastern Norway Regional Health Authority (Helse Sor-Ost); http://www.helse-sorost.no/Sider/side.aspx, http://www.heartfailure.no/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Arumugam TV, 2009, SHOCK, V32, P4, DOI 10.1097/SHK.0b013e318193e333; Baudino TA, 2006, AM J PHYSIOL-HEART C, V291, pH1015, DOI 10.1152/ajpheart.00023.2006; Bliksoen M, 2012, INT J CARDIOL, V158, P132, DOI 10.1016/j.ijcard.2012.04.047; Boyd JH, 2006, CARDIOVASC RES, V72, P384, DOI 10.1016/j.cardiores.2006.09.011; Chen W, 2013, BBA-MOL CELL RES, V1833, P945, DOI 10.1016/j.bbamcr.2012.08.023; Haas T, 2008, IMMUNITY, V28, P315, DOI 10.1016/j.immuni.2008.01.013; Hagemann T, 2008, J EXP MED, V205, P1261, DOI 10.1084/jem.20080108; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Heymans S, 2009, EUR J HEART FAIL, V11, P119, DOI 10.1093/eurjhf/hfn043; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Knuefermann P, 2008, CARDIOVASC RES, V78, P26, DOI 10.1093/cvr/cvn011; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Krug A, 2001, EUR J IMMUNOL, V31, P2154, DOI 10.1002/1521-4141(200107)31:7<2154::AID-IMMU2154>3.0.CO;2-U; Lievens D, 2012, EUR HEART J; Marshall JD, 2005, DNA CELL BIOL, V24, P63, DOI 10.1089/dna.2005.24.63; Mathur S, 2011, SHOCK, V36, P478, DOI 10.1097/SHK.0b013e31822d6442; Medzhitov R, 2000, NEW ENGL J MED, V343, P338, DOI 10.1056/NEJM200008033430506; Meneghin A, 2008, HISTOCHEM CELL BIOL, V130, P979, DOI 10.1007/s00418-008-0466-z; Merrell MA, 2006, MOL CANCER RES, V4, P437, DOI 10.1158/1541-7786.MCR-06-0007; Miles K, 2012, P NATL ACAD SCI USA, V109, P887, DOI 10.1073/pnas.1109173109; Oka T, 2012, NATURE, V485, P251, DOI 10.1038/nature10992; Pagni PP, 2010, AUTOIMMUNITY, V43, P275, DOI 10.3109/08916930903509056; Porter KE, 2009, PHARMACOL THERAPEUT, V123, P255, DOI 10.1016/j.pharmthera.2009.05.002; Raake PW, 2008, CIRC RES, V103, P413, DOI 10.1161/CIRCRESAHA.107.168336; Velten M, 2012, CARDIOVASC RES; Vollmer J, 2004, EUR J IMMUNOL, V34, P251, DOI 10.1002/eji.200324032; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	28	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104398	10.1371/journal.pone.0104398	http://dx.doi.org/10.1371/journal.pone.0104398			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126740	Green Submitted, Green Published, gold			2022-12-25	WOS:000340879300023
J	Takahashi, H; Sai, K; Saito, Y; Kaniwa, N; Matsumura, Y; Hamaguchi, T; Shimada, Y; Ohtsu, A; Yoshino, T; Doi, T; Okuda, H; Ichinohe, R; Takahashi, A; Doi, A; Odaka, Y; Okuyama, M; Saijo, N; Sawada, J; Sakamoto, H; Yoshida, T				Takahashi, Hiro; Sai, Kimie; Saito, Yoshiro; Kaniwa, Nahoko; Matsumura, Yasuhiro; Hamaguchi, Tetsuya; Shimada, Yasuhiro; Ohtsu, Atsushi; Yoshino, Takayuki; Doi, Toshihiko; Okuda, Haruhiro; Ichinohe, Risa; Takahashi, Anna; Doi, Ayano; Odaka, Yoko; Okuyama, Misuzu; Saijo, Nagahiro; Sawada, Jun-ichi; Sakamoto, Hiromi; Yoshida, Teruhiko			Application of a Combination of a Knowledge-Based Algorithm and 2-Stage Screening to Hypothesis-Free Genomic Data on Irinotecan-Treated Patients for Identification of a Candidate Single Nucleotide Polymorphism Related to an Adverse Effect	PLOS ONE			English	Article							ADAPTIVE RESONANCE THEORY; CELL LUNG-CANCER; BOOSTED FUZZY CLASSIFIER; GENE-EXPRESSION ANALYSIS; MESSENGER-RNA STABILITY; ACTIVE METABOLITE SN-38; SWEEP OPERATOR METHOD; PART FILTERING METHOD; SOFT-TISSUE SARCOMAS; ARABIDOPSIS-THALIANA	Interindividual variation in a drug response among patients is known to cause serious problems in medicine. Genomic information has been proposed as the basis for "personalized" health care. The genome-wide association study (GWAS) is a powerful technique for examining single nucleotide polymorphisms (SNPs) and their relationship with drug response variation; however, when using only GWAS, it often happens that no useful SNPs are identified due to multiple testing problems. Therefore, in a previous study, we proposed a combined method consisting of a knowledge-based algorithm, 2 stages of screening, and a permutation test for identifying SNPs. In the present study, we applied this method to a pharmacogenomics study where 109,365 SNPs were genotyped using Illumina Human-1 BeadChip in 168 cancer patients treated with irinotecan chemotherapy. We identified the SNP rs9351963 in potassium voltage-gated channel subfamily KQT member 5 (KCNQ5) as a candidate factor related to incidence of irinotecan-induced diarrhea. The p value for rs9351963 was 3.31x10(-5) in Fisher's exact test and 0.0289 in the permutation test (when multiple testing problems were corrected). Additionally, rs9351963 was clearly superior to the clinical parameters and the model involving rs9351963 showed sensitivity of 77.8% and specificity of 57.6% in the evaluation by means of logistic regression. Recent studies showed that KCNQ4 and KCNQ5 genes encode members of the M channel expressed in gastrointestinal smooth muscle and suggested that these genes are associated with irritable bowel syndrome and similar peristalsis diseases. These results suggest that rs9351963 in KCNQ5 is a possible predictive factor of incidence of diarrhea in cancer patients treated with irinotecan chemotherapy and for selecting chemotherapy regimens, such as irinotecan alone or a combination of irinotecan with a KCNQ5 opener. Nonetheless, clinical importance of rs9351963 should be further elucidated.	[Takahashi, Hiro] Chiba Univ, Grad Sch Hort, Matsudo, Chiba, Japan; [Takahashi, Hiro; Takahashi, Anna] Chubu Univ, Plant Biol Res Ctr, Kasugai, Aichi 487, Japan; [Takahashi, Hiro; Ichinohe, Risa; Doi, Ayano; Odaka, Yoko; Okuyama, Misuzu; Sakamoto, Hiromi; Yoshida, Teruhiko] Natl Canc Ctr, Res Inst, Div Genet, Tokyo 104, Japan; [Sai, Kimie; Saito, Yoshiro; Kaniwa, Nahoko; Okuda, Haruhiro] Natl Inst Hlth Sci, Div Med Safety Sci, Tokyo, Japan; [Matsumura, Yasuhiro] Natl Canc Ctr Hosp East, Res Ctr Innovat Oncol, Div Dev Therapeut, Kashiwa, Chiba, Japan; [Hamaguchi, Tetsuya; Shimada, Yasuhiro] Natl Canc Ctr, Gastrointestinal Med Oncol Div, Tokyo, Japan; [Ohtsu, Atsushi; Yoshino, Takayuki; Doi, Toshihiko] Natl Canc Ctr Hosp East, Dept Gastrointestinal Oncol, Kashiwa, Chiba, Japan; [Ichinohe, Risa; Doi, Ayano] Chiba Univ, Fac Hort, Matsudo, Chiba 271, Japan; [Saijo, Nagahiro] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan; [Sawada, Jun-ichi] Natl Inst Hlth Sci, Div Funct Biochem & Genom, Tokyo, Japan	Chiba University; Chubu University; National Cancer Center - Japan; National Institute of Health Sciences - Japan; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; Chiba University; National Cancer Center - Japan; National Institute of Health Sciences - Japan	Takahashi, H (corresponding author), Chiba Univ, Grad Sch Hort, Matsudo, Chiba, Japan.	hiro.takahashi@chiba-u.jp	Matsumura, Yasuhiro/N-4472-2016; Takahashi, Hiro/E-6746-2013	Takahashi, Hiro/0000-0002-8230-9524; Matsumura, Yasuhiro/0000-0003-4331-8177	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) [21710211, 24710222, 26114703]; Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation [NIBIO ID10-41]; Futaba Electronics Memorial Foundation; Research Foundation for the Electrotechnology of Chubu; Nakajima Foundation; Grants-in-Aid for Scientific Research [26114703] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation; Futaba Electronics Memorial Foundation; Research Foundation for the Electrotechnology of Chubu(Research Foundation for the Electrotechnology of Chubu); Nakajima Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT): Grants-in-Aid for Scientific Research for Young Scientists (B) (nos. 21710211 and 24710222 to H. T.) and Grant-in-Aid for Scientific Research on Innovative Areas (no. 26114703 to H. T.). This work was also supported by the Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation (NIBIO ID10-41), the Futaba Electronics Memorial Foundation, the Research Foundation for the Electrotechnology of Chubu, and the Nakajima Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Ando Y, 2000, CANCER RES, V60, P6921; Benjamini Y., 1995, J ROYAL STAT SOC B, V57, P298; Blandizzi C, 2001, BRIT J PHARMACOL, V132, P73, DOI 10.1038/sj.bjp.0703766; Brown DA, 2009, BRIT J PHARMACOL, V156, P1185, DOI 10.1111/j.1476-5381.2009.00111.x; Capon F, 2004, HUM MOL GENET, V13, P2361, DOI 10.1093/hmg/ddh273; Cavaliere S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062445; Chiba Y, 2013, PLANT CELL PHYSIOL, V54, P180, DOI 10.1093/pcp/pcs164; Ciotti M, 1999, BIOCHEM BIOPH RES CO, V260, P199, DOI 10.1006/bbrc.1999.0453; de Jong FA, 2007, CLIN PHARMACOL THER, V81, P42, DOI 10.1038/sj.clpt.6100019; de Jong FA, 2004, CLIN CANCER RES, V10, P5889, DOI 10.1158/1078-0432.CCR-04-0144; Delmas P, 2005, NAT REV NEUROSCI, V6, P850, DOI 10.1038/nrn1785; Efferth T, 2005, PHARMACOL THERAPEUT, V107, P155, DOI 10.1016/j.pharmthera.2005.02.005; Evans WE, 2003, NEW ENGL J MED, V348, P538, DOI 10.1056/NEJMra020526; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; Gagne JF, 2002, MOL PHARMACOL, V62, P608, DOI 10.1124/mol.62.3.608; Haaz MC, 1998, CANCER RES, V58, P468; Han JY, 2008, LUNG CANCER, V59, P69, DOI 10.1016/j.lungcan.2007.07.019; Han JY, 2009, LUNG CANCER, V63, P115, DOI 10.1016/j.lungcan.2007.12.003; Han JY, 2006, J CLIN ONCOL, V24, P2237, DOI 10.1200/JCO.2005.03.0239; Hyatt JL, 2005, CHEM-BIOL INTERACT, V157, P247, DOI 10.1016/j.cbi.2005.10.033; Ichihara S, 2007, INT J CANCER, V120, P1239, DOI 10.1002/ijc.22513; Ingelman-Sundberg M, 2008, NEW ENGL J MED, V358, P637, DOI 10.1056/NEJMe0708842; Innocenti F, 2004, J CLIN ONCOL, V22, P1382, DOI 10.1200/JCO.2004.07.173; Iwasaki M, 2013, DEVELOPMENT, V140, P1958, DOI 10.1242/dev.085365; Iyer L., 2002, Pharmacogenomics Journal, V2, P43, DOI 10.1038/sj.tpj.6500072; Iyer L, 1998, J CLIN INVEST, V101, P847, DOI 10.1172/JCI915; Jada SR, 2007, CANCER SCI, V98, P1461, DOI 10.1111/j.1349-7006.2007.00541.x; Jepps TA, 2009, AM J PHYSIOL-GASTR L, V297, pG107, DOI 10.1152/ajpgi.00057.2009; Kawamura T, 2008, J BIOSCI BIOENG, V105, P81, DOI 10.1263/jbb.105.81; KAWATO Y, 1993, J PHARM PHARMACOL, V45, P444, DOI 10.1111/j.2042-7158.1993.tb05573.x; Kojima S, 2011, PLANT CELL PHYSIOL, V52, P1259, DOI 10.1093/pcp/pcr083; Kotooka N, 2013, INT J CARDIOL, V167, P1068, DOI 10.1016/j.ijcard.2012.10.066; Kuhn JG, 1998, ONCOLOGY-NY, V12, P39; Ma F, 2009, LUNG CANCER, V66, P114, DOI 10.1016/j.lungcan.2008.12.025; Mathijssen RHJ, 2003, CLIN CANCER RES, V9, P3246; Matsuo N, 2009, PLANT BIOTECHNOL-NAR, V26, P385, DOI 10.5511/plantbiotechnology.26.385; Miceli F, 2008, CURR OPIN PHARMACOL, V8, P65, DOI 10.1016/j.coph.2007.10.003; Michael M, 2006, J CLIN ONCOL, V24, P4228, DOI 10.1200/JCO.2005.04.8496; Minami H, 2007, PHARMACOGENET GENOM, V17, P497, DOI 10.1097/FPC.0b013e328014341f; Nackley AG, 2006, SCIENCE, V314, P1930, DOI 10.1126/science.1131262; Nakagawa A, 2012, PLANT MOL BIOL, V79, P569, DOI 10.1007/s11103-012-9929-7; Nakayama R, 2007, MODERN PATHOL, V20, P749, DOI 10.1038/modpathol.3800794; Nielsen KB, 2007, AM J HUM GENET, V80, P416, DOI 10.1086/511992; Nozawa T, 2005, DRUG METAB DISPOS, V33, P434, DOI 10.1124/dmd.104.001909; Perez C, 2010, NEUROSCI LETT, V468, P238, DOI 10.1016/j.neulet.2009.11.004; Pitman EJG, 1938, BIOMETRIKA, V29, P322, DOI 10.1093/biomet/29.3-4.322; Raida M, 2001, CLIN CANCER RES, V7, P2832; Sai K, 2006, ANN HUM GENET, V70, P605, DOI 10.1111/j.1469-1809.2006.00260.x; Sai K, 2003, PHARMACOGENETICS, V13, P741, DOI 10.1097/00008571-200312000-00005; Sai K, 2008, CANCER CHEMOTH PHARM, V62, P529, DOI 10.1007/s00280-007-0634-1; Sai K, 2008, CANCER LETT, V261, P165, DOI 10.1016/j.canlet.2007.11.009; Sai K, 2010, CANCER CHEMOTH PHARM, V66, P95, DOI 10.1007/s00280-009-1138-y; Sakamoto Y., 1986, AKAIKE INFORM CRITER; Sano M, 2010, INT J ONCOL, V36, P321, DOI 10.3892/ijo_00000503; Sato Y, 2009, PHARMACOGENOMICS J, V9, P137, DOI 10.1038/tpj.2008.17; Sauna ZE, 2007, CANCER RES, V67, P9609, DOI 10.1158/0008-5472.CAN-07-2377; Schwake M, 2003, EMBO REP, V4, P76, DOI 10.1038/sj.embor.embor715; Seo S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076960; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Slatter JG, 1997, DRUG METAB DISPOS, V25, P1157; Sparreboom A, 2003, DRUG RESIST UPDATE, V6, P71, DOI 10.1016/S1368-7646(03)00005-0; Spasovski V, 2013, J APPL GENET, V54, P21, DOI 10.1007/s13353-012-0125-x; Takahashi H, 2004, J BIOSCI BIOENG, V98, P193, DOI 10.1263/jbb.98.193; Takahashi H, 2003, J BIOSCI BIOENG, V96, P154, DOI 10.1263/jbb.96.154; Takahashi H, 2005, BIOINFORMATICS, V21, P179, DOI 10.1093/bioinformatics/bth473; Takahashi H, 2006, J BIOSCI BIOENG, V101, P137, DOI 10.1263/jbb.101.137; Takahashi H, 2005, J CHEM ENG JPN, V38, P763, DOI 10.1252/jcej.38.763; Takahashi H, 2008, J BIOSCI BIOENG, V106, P587, DOI 10.1263/jbb.106.587; Takahashi H, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-399; Takahashi H, 2007, BIOCHEM ENG J, V33, P100, DOI 10.1016/j.bej.2006.08.004; Takahashi H, 2006, J BIOSCI BIOENG, V102, P46, DOI 10.1263/jbb.102.46; Takahashi H, 2006, BIOINFORMATICS, V22, P1662, DOI 10.1093/bioinformatics/btl156; Takahashi H, 2013, J BIOSCI BIOENG, V116, P768, DOI 10.1016/j.jbiosc.2013.05.021; Takahashi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078250; Takahashi H, 2013, PLANT CELL PHYSIOL, V54, P418, DOI 10.1093/pcp/pct027; Takahashi H, 2012, BIOINFORMATICS, V28, P2231, DOI 10.1093/bioinformatics/bts303; Takahashi H, 2006, J CHEM ENG JPN, V39, P767, DOI 10.1252/jcej.39.767; Takakura A, 2012, ONCOL LETT, V3, P520, DOI 10.3892/ol.2011.519; Takane H, 2007, THER DRUG MONIT, V29, P666, DOI 10.1097/FTD.0b013e3181357364; van Kuilenburg ABP, 2001, CLIN CANCER RES, V7, P1149; Xiang XQ, 2006, PHARMACOGENET GENOM, V16, P683, DOI 10.1097/01.fpc.0000230420.05221.71; Xue GG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032870; Yajima I, 2012, AM J CANCER RES, V2, P322; Yamamoto M, 2008, ONCOL REP, V20, P727, DOI 10.3892/or_00000066; Yang XX, 2005, CURR MED CHEM, V12, P1343, DOI 10.2174/0929867054020972; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Yoshida T, 2010, CANCER SCI, V101, P1582, DOI 10.1111/j.1349-7006.2010.01590.x; Yoshimura K, 2011, PLANT CELL PHYSIOL, V52, P1786, DOI 10.1093/pcp/pcr115; Zhou QY, 2005, BRIT J CLIN PHARMACO, V59, P415, DOI 10.1111/j.1365-2125.2004.02330.x	90	5	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105160	10.1371/journal.pone.0105160	http://dx.doi.org/10.1371/journal.pone.0105160			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127363	gold, Green Published, Green Submitted			2022-12-25	WOS:000340879300085
J	Yang, F; Zhao, JF; Shou, QY; Huang, XJ; Chen, G; Yang, KB; Zhang, SG; Lv, BD; Fu, HY				Yang, Fan; Zhao, Jian F.; Shou, Qi Y.; Huang, Xiao J.; Chen, Gang; Yang, Ke B.; Zhang, Shi G.; Lv, Bo D.; Fu, Hui Y.			Phenotypic Modulation of Corpus Cavernosum Smooth Muscle Cells in a Rat Model of Cavernous Neurectomy	PLOS ONE			English	Article							ERECTILE DYSFUNCTION; RADICAL PROSTATECTOMY; MOLECULAR-MECHANISMS; NERVE ABLATION; FIBROSIS; DIFFERENTIATION; PROLIFERATION; NEUROTOMY; HYPOXIA	Background: Patients undergoing radical prostatectomy (RP) are at high risk for erectile dysfunction (ED) due to potential cavernous nerve (CN) damage during surgery. Penile hypoxia after RP is thought to significantly contribute to ED pathogenesis. Aim: We previously showed that corpora cavernosum smooth muscle cells (CCSMCs) undergo phenotypic modulation under hypoxic conditions in vitro. Here, we studied such changes in an in vivo post-RP ED model by investigating CCSMCs in bilateral cavernous neurectomy (BCN) rats. Methods: Sprague-Dawley rats underwent sham (n = 12) or BCN (n = 12) surgery. After 12 weeks, they were injected with apomorphine to determine erectile function. The penile tissues were harvested and assessed for fibrosis using Masson trichrome staining and for molecular markers of phenotypic modulation using immunohistochemistry and western blotting. CCSMC morphological structure was evaluated by hematoxylin-eosin (H&E) staining and transmission electron microscopy (TEM). Results: Erectile function was significantly lower in BCN rats than in sham rats. BCN increased hypoxia-inducible factor-1 alpha and collagen protein expression in corpora cavernous tissue. H&E staining and TEM showed that CCSMCs in BCN rats underwent hypertrophy and showed rough endoplasmic reticulum formation. The expression of CCSMC phenotypic markers, such as smooth muscle alpha-actin, smooth muscle myosin heavy chain, and desmin, was markedly lower, whereas vimentin protein expression was significantly higher in BCN rats than in control rats. Conclusions: CCSMCs undergo phenotype modulation in rats with cavernous neurectomy. The results have unveiled physiological transformations that occur at the cellular and molecular levels and have helped characterize CN injury-induced ED.	[Yang, Fan; Zhao, Jian F.; Huang, Xiao J.; Chen, Gang; Yang, Ke B.; Zhang, Shi G.; Lv, Bo D.] Zhejiang Chinese Med Univ, Affiliated Hosp 2, Dept Urol, Hangzhou, Zhejiang, Peoples R China; [Shou, Qi Y.] Zhejiang Chinese Med Univ, Lab Anim Res Ctr, Hangzhou, Zhejiang, Peoples R China; [Fu, Hui Y.] Zhejiang Chinese Med Univ, Clin Med Coll 2, Cent Lab, Hangzhou, Zhejiang, Peoples R China; [Lv, Bo D.; Fu, Hui Y.] Zhejiang Prov Key Lab Tradit Chinese Med, Androl Lab Integrat Chinese & Western Med, Hangzhou, Zhejiang, Peoples R China	Zhejiang Chinese Medical University; Zhejiang Chinese Medical University; Zhejiang Chinese Medical University	Lv, BD (corresponding author), Zhejiang Chinese Med Univ, Affiliated Hosp 2, Dept Urol, Hangzhou, Zhejiang, Peoples R China.	lbd168@126.com; fhy131@126.com	fu, huiying/GZG-2399-2022		 [WKJ2010-2-020];  [2009ZA009];  [Y2111167]	; ; 	This work was supported by the following: WKJ2010-2-020 (http://www.zjwst.gov.cn/), 2009ZA009 (http://zgj.zjtcm.net/), and Y2111167 (http://www.zjnsf.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asada H, 2005, J VASC SURG, V42, P772, DOI 10.1016/j.jvs.2005.05.046; CHAMLEYCAMPBELL J, 1979, PHYSIOL REV, V59, P1, DOI 10.1152/physrev.1979.59.1.1; Ferrini MG, 2009, J SEX MED, V6, P415, DOI 10.1111/j.1743-6109.2008.01105.x; Halayko AJ, 2001, J APPL PHYSIOL, V90, P358, DOI 10.1152/jappl.2001.90.1.358; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; HEDIN U, 1987, DIFFERENTIATION, V33, P239, DOI 10.1111/j.1432-0436.1987.tb01563.x; Hu WL, 2004, ASIAN J ANDROL, V6, P111; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Leungwattanakij S, 2003, J ANDROL, V24, P239; Li FF, 2012, J IMMUNOL, V189, P3159, DOI 10.4049/jimmunol.1200197; Liu K, 2012, J ANDROL, V33, P1186, DOI 10.2164/jandrol.112.016642; Magheli A, 2009, NAT REV UROL, V6, P415, DOI 10.1038/nrurol.2009.126; Meng MV, 2003, J UROLOGY, V170, P2279, DOI 10.1097/01.ju.0000094190.46523.b2; Mericskay M, 2000, DEV BIOL, V226, P192, DOI 10.1006/dbio.2000.9865; Meuleman EJH, 2003, EUR UROL, V43, P95, DOI 10.1016/S0302-2838(02)00546-8; Montorsi F, 1997, J UROLOGY, V158, P1408, DOI 10.1016/S0022-5347(01)64227-7; Moreland RB, 1998, INT J IMPOT RES, V10, P113, DOI 10.1038/sj.ijir.3900328; Nehra A, 1996, J UROLOGY, V156, P1320, DOI 10.1016/S0022-5347(01)65578-2; Orr AW, 2009, ARTERIOSCL THROM VAS, V29, P225, DOI 10.1161/ATVBAHA.108.178749; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; OWENS GK, 1995, PHYSIOL REV, V75, P487; Prakash YS, 2013, AM J PHYSIOL-LUNG C, V305, pL912, DOI 10.1152/ajplung.00259.2013; Thakar RG, 2009, BIOPHYS J, V96, P3423, DOI 10.1016/j.bpj.2008.11.074; Vignozzi L, 2006, J SEX MED, V3, P419, DOI 10.1111/j.1743-6109.2006.00208.x; Wei AY, 2012, INT J IMPOT RES, V24, P196, DOI 10.1038/ijir.2012.16; Welliver RC, 2014, J SEX MED, V11, P1071, DOI 10.1111/jsm.12445; Zhang XH, 2002, CHINESE MED J-PEKING, V115, P1179	27	17	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105186	10.1371/journal.pone.0105186	http://dx.doi.org/10.1371/journal.pone.0105186			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127037	Green Published, Green Submitted, gold			2022-12-25	WOS:000340879300090
J	Joo, YB; Bang, SY; Kim, TH; Shim, SC; Lee, S; Joo, KB; Kim, JH; Min, HJ; Rahman, P; Inman, RD				Joo, Young Bin; Bang, So-Young; Kim, Tae-Hwan; Shim, Seung-Cheol; Lee, Seunghun; Joo, Kyung Bin; Kim, Jong Heon; Min, Hye Joon; Rahman, Proton; Inman, Robert D.			Bone Morphogenetic Protein 6 Polymorphisms Are Associated with Radiographic Progression in Ankylosing Spondylitis	PLOS ONE			English	Article							GENETIC POLYMORPHISMS; DISEASE SEVERITY; CLINICAL-TRIALS; DAMAGE; SPONDYLOARTHRITIS; SUSCEPTIBILITY; SYNDESMOPHYTES; RISK; SPONDYLARTHRITIS; IDENTIFICATION	Background and Object: Nearly 25 genetic loci associated with susceptibility to ankylosing spondylitis (AS) have been identified by several large studies. However, there have been limited studies to identify the genes associated with radiographic severity of the disease. Thus we investigated which genes involved in bone formation pathways might be associated with radiographic severity in AS. Methods: A total of 417 Korean AS patients were classified into two groups based on the radiographic severity as defined by the modified Stoke' Ankylosing Spondylitis Spinal Score (mSASSS) system. Severe AS was defined by the presence of syndesmophytes and/or fusion in the lumbar or cervical spine (n = 195). Mild AS was defined by the absence of any syndesmophyte or fusion (n = 170). A total of 251 single nucleotide polymorphisms (SNPs) within 52 genes related to bone formation were selected and genotyped. Odds ratios (OR) and 95% confidence interval (95% CI) were analysed by multivariate logistic regression controlling for age at onset of symptoms, sex, disease duration, and smoking status as covariates. Results: We identified new loci of bone morphogenetic protein 6 (BMP6) associated with radiographic severity in patients with AS that passed false discovery rate threshold. Two SNPs in BMP6 were significantly associated with radiologic severity [rs270378 (OR 1.97, p = 6.74x10(-4)) and rs1235192 [OR 1.92, p = 1.17x10(-3)]) adjusted by covariates. Conclusion: This is the first study to demonstrate that BMP6 is associated with radiographic severity in AS, supporting the role wingless-type like/BMP pathway on radiographic progression in AS.	[Joo, Young Bin; Bang, So-Young; Kim, Tae-Hwan] Hanyang Univ, Hosp Rheumat Dis, Dept Rheumatol, Seoul 133791, South Korea; [Shim, Seung-Cheol] Chungnam Natl Univ Hosp, Daejeon Rheumatoid & Degenerat Arthrit Ctr, Div Rheumatol, Taejon, South Korea; [Lee, Seunghun; Joo, Kyung Bin] Hanyang Univ, Hosp Rheumat Dis, Dept Radiol, Seoul 133791, South Korea; [Kim, Jong Heon] Hanyang Univ, Hosp Rheumat Dis, Dept Orthoped, Seoul 133791, South Korea; [Min, Hye Joon] Cornell Univ, Dept Anthropol, Ithaca, NY USA; [Rahman, Proton] Mem Univ Newfoundland, St Clares Mercy Hosp, Dept Rheumatol, St John, NF, Canada; [Inman, Robert D.] Univ Toronto, Toronto Western Hosp, Div Rheumatol, Toronto, ON M5T 2S8, Canada	Hanyang University; Chungnam National University; Chungnam National University Hospital; Hanyang University; Hanyang University; Cornell University; Memorial University Newfoundland; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Kim, TH (corresponding author), Hanyang Univ, Hosp Rheumat Dis, Dept Rheumatol, Seoul 133791, South Korea.	thkim@hanyang.ac.kr		Shim, Seung cheol/0000-0002-3199-359X; Inman, Robert/0000-0002-4750-1422				Appel H, 2009, ARTHRITIS RHEUM-US, V60, P3257, DOI 10.1002/art.24888; Ashley-Koch AE, 2008, BLOOD, V111, P5721, DOI 10.1182/blood-2007-02-074849; Baldwin C, 2005, BLOOD, V106, P372, DOI 10.1182/blood-2005-02-0548; Bandarian F, 2013, LIPIDS, V48, P1207, DOI 10.1007/s11745-013-3847-6; Baraliakos X, 2007, ANN RHEUM DIS, V66, P910, DOI 10.1136/ard.2006.066415; Baraliakos X, 2009, J RHEUMATOL, V36, P997, DOI 10.3899/jrheum.080871; Bartolome N, 2012, RHEUMATOLOGY, V51, P1471, DOI 10.1093/rheumatology/kes056; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bobacz K, 2003, ARTHRITIS RHEUM-US, V48, P2501, DOI 10.1002/art.11248; Brophy S, 2004, J RHEUMATOL, V31, P1775; Brown MA, 2008, RHEUMATOLOGY, V47, P132, DOI 10.1093/rheumatology/kem269; Brown MA, 1997, ARTHRITIS RHEUM, V40, P1823, DOI 10.1002/art.1780401015; CARETTE S, 1983, ARTHRITIS RHEUM, V26, P186, DOI 10.1002/art.1780260210; Carter S, 2012, THER ADV MUSCULOSKEL, V4, P293, DOI 10.1177/1759720X12444175; Chen HA, 2011, SEMIN ARTHRITIS RHEU, V40, P552, DOI 10.1016/j.semarthrit.2010.07.008; Chen HA, 2010, J RHEUMATOL, V37, P2126, DOI 10.3899/jrheum.100200; Cortes A, 2013, NAT GENET, V45, P730, DOI 10.1038/ng.2667; Creemers MCW, 2005, ANN RHEUM DIS, V64, P127, DOI 10.1136/ard.2004.020503; Dougados M, 2012, ARTHRIT CARE RES, V64, P290, DOI 10.1002/acr.20671; Edmondson AC, 2011, CIRC-CARDIOVASC GENE, V4, P145, DOI 10.1161/CIRCGENETICS.110.957563; GITELMAN SE, 1994, J CELL BIOL, V126, P1595, DOI 10.1083/jcb.126.6.1595; Hall BK, 2000, BIOESSAYS, V22, P138, DOI 10.1002/(SICI)1521-1878(200002)22:2<138::AID-BIES5>3.3.CO;2-W; Haroon N, 2012, ARTHRITIS RHEUM-US, V64, P1119, DOI 10.1002/art.33430; Heiland GR, 2012, ANN RHEUM DIS, V71, P572, DOI 10.1136/annrheumdis-2011-200216; Jane JA, 2002, MOL THER, V6, P464, DOI 10.1006/mthe.2002.0691; Khan MA, 2002, BEST PRACT RES CL RH, V16, P675, DOI 10.1053/BERH.2002.0243; Kroon F, 2012, ANN RHEUM DIS, V71, P1623, DOI 10.1136/annrheumdis-2012-201370; Lian ZJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061527; Lories RJU, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2642; Lories RJU, 2005, J CLIN INVEST, V115, P1571, DOI 10.1172/JCI23738; Macsai CE, 2008, J CELL PHYSIOL, V215, P578, DOI 10.1002/jcp.21342; Maksymowych WP, 2007, ARTHRITIS RHEUM-US, V56, P1846, DOI 10.1002/art.22589; Park MC, 2008, SCAND J RHEUMATOL, V37, P200, DOI 10.1080/03009740701774941; Pimentel-Santos FM, 2012, J RHEUMATOL, V39, P131, DOI 10.3899/jrheum.110681; Poddubnyy D, 2012, ARTHRITIS RHEUM-US, V64, P1388, DOI 10.1002/art.33465; Ramiro S, 2014, ANN RHEUM DIS; Schett G, 2010, BEST PRACT RES CL RH, V24, P363, DOI 10.1016/j.berh.2010.01.005; Seo JS, 2005, RHEUMATOLOGY, V44, P1299, DOI 10.1093/rheumatology/kei013; Slattery ML, 2013, INT J CANCER, V132, P2928, DOI 10.1002/ijc.27960; Szczypiorska M, 2011, RHEUMATOLOGY, V50, P1969, DOI 10.1093/rheumatology/ker229; Ulug P, 2009, ANN HEMATOL, V88, P803, DOI 10.1007/s00277-008-0659-5; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; van der Heijde D, 2008, ARTHRITIS RHEUM-US, V58, P1324, DOI 10.1002/art.23471; van der Heijde D, 2005, J RHEUMATOL, V32, P2048; van der Heijde D, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2794; van Tubergen A, 2012, ANN RHEUM DIS, V71, P518, DOI 10.1136/annrheumdis-2011-200411; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361; Wanders AJB, 2004, ARTHRITIS RHEUM-US, V50, P2622, DOI 10.1002/art.20446; Wang CM, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3855; Ward MM, 2009, ARTHRIT RHEUM-ARTHR, V61, P859, DOI 10.1002/art.24585	50	16	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104966	10.1371/journal.pone.0104966	http://dx.doi.org/10.1371/journal.pone.0104966			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121767	Green Submitted, Green Published, gold			2022-12-25	WOS:000341017000080
J	Mathur, A; Abd Elmageed, ZY; Liu, XC; Kostochka, ML; Zhang, HT; Abdel-Mageed, AB; Mondal, D				Mathur, Aditi; Abd Elmageed, Zakaria Y.; Liu, Xichun; Kostochka, Mikhail L.; Zhang, Haitao; Abdel-Mageed, Asim B.; Mondal, Debasis			Subverting ER-Stress towards Apoptosis by Nelfinavir and Curcumin Coexposure Augments Docetaxel Efficacy in Castration Resistant Prostate Cancer Cells	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM-STRESS; HIV-1 PROTEASE INHIBITOR; IN-VITRO; AKT PHOSPHORYLATION; DOWN-REGULATION; GROWTH ARREST; COMBINATION; TRIB3; GRP78; SENSITIZATION	Despite its side-effects, docetaxel (DTX) remains a first-line treatment against castration resistant prostate cancer (CRPC). Therefore, strategies to increase its anti-tumor efficacy and decrease its side effects are critically needed. Targeting of the constitutive endoplasmic reticulum (ER) stress in cancer cells is being investigated as a chemosensitization approach. We hypothesized that the simultaneous induction of ER-stress and suppression of PI3K/AKT survival pathway will be a more effective approach. In a CRPC cell line, C4-2B, we observed significant (p<0.005) enhancement of DTX-induced cytotoxicity following coexposure to thapsigargin and an AKT-inhibitor. However, since these two agents are not clinically approved, we investigated whether a combination of nelfinavir (NFR) and curcumin (CUR), known to target both these metabolic pathways, can similarly increase DTX cytotoxicity in CRPC cells. Within 24 hrs post-exposure to physiologic concentrations of NFR (5 mM) and CUR (5 mM) a significantly (p<0.005) enhanced cytotoxicity was evident with low concentration of DTX (10 nM). This 3-drug combination rapidly increased apoptosis in aggressive C4-2B cells, but not in RWPE-1 cells or in primary prostate epithelial cells (PrEC). Comparative molecular studies revealed that this 3-drug combination caused a more pronounced suppression of phosphorylated-AKT and higher induction in phosphorylated-eIF2 alpha in C4-2B cells, as compared to RWPE-1 cells. Acute exposure (3-9 hrs) to this 3-drug combination intensified ER-stress induced pro-apoptotic markers, i.e. ATF4, CHOP, and TRIB3. At much lower concentrations, chronic (3 wks) exposures to these three agents drastically reduced colony forming units (CFU) by C4-2B cells. In vivo studies using mice containing C4-2B tumor xenografts showed significant (p<0.05) enhancement of DTX's (10 mg/kg) anti-tumor efficacy following coexposure to NFR (20 mg/kg) & CUR (100 mg/kg). Immunohistochemical (IHC) analyses of tumor sections indicated decreased Ki-67 staining and increased TUNEL intensity in mice exposed to the 3-drug combination. Therefore, subverting ER-stress towards apoptosis using adjuvant therapy with NFR and CUR can chemosensitize the CRPC cells to DTX therapy.	[Mathur, Aditi; Mondal, Debasis] Tulane Univ, Sch Med, Dept Pharmacol, New Orleans, LA 70112 USA; [Abd Elmageed, Zakaria Y.; Abdel-Mageed, Asim B.] Tulane Univ, Sch Med, Dept Urol, New Orleans, LA 70112 USA; [Liu, Xichun; Zhang, Haitao] Tulane Univ, Sch Med, Dept Pathol, New Orleans, LA 70112 USA; [Kostochka, Mikhail L.] Tulane Univ, Sch Med, Peptide Res Labs, New Orleans, LA 70112 USA	Tulane University; Tulane University; Tulane University; Tulane University	Mondal, D (corresponding author), Tulane Univ, Sch Med, Dept Pharmacol, New Orleans, LA 70112 USA.	dmondal@tulane.edu	Elmageed, Zakaria Y Abd/O-3456-2018	Elmageed, Zakaria Y Abd/0000-0003-4031-0348; Abdel-Mageed, Asim/0000-0001-8590-783X	Department of Defense [PC080811, PC081598]; Louisiana Cancer Research Consortium (LCRC)	Department of Defense(United States Department of Defense); Louisiana Cancer Research Consortium (LCRC)	These studies were supported by grants from the Department of Defense, to D.M. (#PC080811) and to A.B.A. (#PC081598), and funds from the Louisiana Cancer Research Consortium (LCRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand P, 2008, CANCER LETT, V267, P133, DOI 10.1016/j.canlet.2008.03.025; [Anonymous], 2003, METH MOL B; Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; Baril Jean-Guy, 2003, Can J Infect Dis, V14, P201; Basile V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053664; Bernstein WB, 2008, CURR OPIN HIV AIDS, V3, P666, DOI 10.1097/COH.0b013e328313915d; Bruning A, 2011, METHOD ENZYMOL, V491, P127, DOI 10.1016/B978-0-12-385928-0.00008-0; Bruning A, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-19; Chen TC, 2011, CANCER LETT, V302, P100, DOI 10.1016/j.canlet.2010.11.008; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Daneshmand S, 2007, HUM PATHOL, V38, P1547, DOI 10.1016/j.humpath.2007.03.014; DYKES DJ, 1995, INVEST NEW DRUG, V13, P1, DOI 10.1007/BF02614214; Funk MB, 1999, AIDS, V13, P1653, DOI 10.1097/00002030-199909100-00008; Galsky MD, 2010, ANN ONCOL, V21, P2135, DOI 10.1093/annonc/mdq050; Gills J, 2007, CLIN CANCER RES, V13, P5183, DOI 10.1158/1078-0432.CCR-07-0161; Gupta AK, 2007, NEOPLASIA, V9, P271, DOI 10.1593/neo.07124; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; He HN, 2010, CANCER LETT, V295, P38, DOI 10.1016/j.canlet.2010.02.011; Healy SJM, 2009, EUR J PHARMACOL, V625, P234, DOI 10.1016/j.ejphar.2009.06.064; Higano CS, 2011, UROL ONCOL-SEMIN ORI, V29, pS1, DOI 10.1016/j.urolonc.2011.08.013; Hirota Morihiko, 2006, Journal of Toxicological Sciences, V31, P149, DOI 10.2131/jts.31.149; Ikezoe T, 2004, CANCER RES, V64, P7426, DOI 10.1158/0008-5472.CAN-03-2677; Jensen Mette Munk, 2008, BMC Med Imaging, V8, P16, DOI 10.1186/1471-2342-8-16; Kosaka T, 2011, J UROLOGY, V185, P2376, DOI 10.1016/j.juro.2011.02.016; Lee HK, 2008, NEURO-ONCOLOGY, V10, P236, DOI 10.1215/15228517-2008-006; Lin SS, 2008, CANCER LETT, V272, P77, DOI 10.1016/j.canlet.2008.06.031; Liu CF, 2013, PROSTATE, V73, P418, DOI 10.1002/pros.22583; Ma YJ, 2004, NAT REV CANCER, V4, P966, DOI 10.1038/nrc1505; Mhaidat N, 2008, APOPTOSIS, V13, P1505, DOI 10.1007/s10495-008-0276-8; Morgan D M, 1998, Methods Mol Biol, V79, P179; Musende AG, 2010, PROSTATE, V70, P1437, DOI 10.1002/pros.21179; Nicoletti-Carvalho JE, 2010, J ENDOCRINOL, V206, P183, DOI 10.1677/JOE-09-0356; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Pai VB, 1999, ANN PHARMACOTHER, V33, P325, DOI 10.1345/aph.18089; Pan MH, 1999, DRUG METAB DISPOS, V27, P486; Prudente S, 2012, ENDOCR REV, V33, P526, DOI 10.1210/er.2011-1042; Qian B, 2008, J ENDOCRINOL, V199, P407, DOI 10.1677/JOE-08-0331; Qian DZ, 2010, PROSTATE, V70, P433, DOI 10.1002/pros.21077; Schonthal Axel H, 2012, Front Biosci (Schol Ed), V4, P412; Schwarze SR, 2008, PROSTATE, V68, P1615, DOI 10.1002/pros.20828; Schwarzer R, 2006, CELL SIGNAL, V18, P899, DOI 10.1016/j.cellsig.2005.08.002; Shim JS, 2012, JNCI-J NATL CANCER I, V104, P1576, DOI 10.1093/jnci/djs396; SHIMIZU K, 2012, PRIMATE RES, V28, P1, DOI DOI 10.2354/psj.28.008; Shishodia S, 2007, CURR PROB CANCER, V31, P243, DOI 10.1016/j.currproblcancer.2007.04.001; Tan SS, 2011, J PATHOL, V223, P81, DOI 10.1002/path.2795; Tang YX, 2011, NEOPLASIA, V13, P108, DOI 10.1593/neo.101092; Wang L, 2009, MOL PHARMACOL, V76, P1238, DOI 10.1124/mol.109.059105; Woo JH, 2003, CARCINOGENESIS, V24, P1199, DOI 10.1093/carcin/bgg082; WU HC, 1994, INT J CANCER, V57, P406, DOI 10.1002/ijc.2910570319; Wu Y, 2009, CANCER BIOL THER, V8, P146, DOI 10.4161/cbt.8.2.7087; Yang Y, 2005, CANCER SCI, V96, P425, DOI 10.1111/j.1349-7006.2005.00063.x; Yang Y, 2006, BRIT J CANCER, V95, P1653, DOI 10.1038/sj.bjc.6603435; Yap TA, 2011, NAT REV CLIN ONCOL, V8, P597, DOI 10.1038/nrclinonc.2011.117; Yin HT, 2012, ACTA BIOCH BIOPH SIN, V44, P147, DOI 10.1093/abbs/gmr106; Yung HW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017894; Zhang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080071	56	42	44	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e103109	10.1371/journal.pone.0103109	http://dx.doi.org/10.1371/journal.pone.0103109			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121735	Green Published, gold			2022-12-25	WOS:000341017000010
J	Smith, BN; Burton, LJ; Henderson, V; Randle, DD; Morton, DJ; Smith, BA; Taliaferro-Smith, L; Nagappan, P; Yates, C; Zayzafoon, M; Chung, LWK; Odero-Marah, VA				Smith, Bethany N.; Burton, Liza J.; Henderson, Veronica; Randle, Diandra D.; Morton, Derrick J.; Smith, Basil A.; Taliaferro-Smith, Latonia; Nagappan, Peri; Yates, Clayton; Zayzafoon, Majd; Chung, Leland W. K.; Odero-Marah, Valerie A.			Snail Promotes Epithelial Mesenchymal Transition in Breast Cancer Cells in Part via Activation of Nuclear ERK2	PLOS ONE			English	Article							PROSTATE-CANCER; TRANSCRIPTION FACTORS; EXPRESSION; PHOSPHORYLATION; PATHWAY; RESISTANCE; MAPK; LOCALIZATION; PROGRESSION; INHIBITOR	Snail transcription factor is up-regulated in several cancers and associated with increased tumor migration and invasion via induction of epithelial-to-mesenchymal transition (EMT). MAPK (ERK1/2) signaling regulates cellular processes including cell motility, adhesion, and invasion. We investigated the regulation of ERK1/2 by Snail in breast cancer cells. ERK1/2 activity (p-ERK) was higher in breast cancer patient tissue as compared to normal tissue. Snail and p-ERK were increased in several breast cancer cell lines as compared to normal mammary epithelial cells. Snail knockdown in MDA-MB-231 and T47-D breast cancer cells decreased or re-localized p-ERK from the nuclear compartment to the cytoplasm. Snail overexpression in MCF-7 breast cancer cells induced EMT, increased cell migration, decreased cell adhesion and also increased tumorigenicity. Snail induced nuclear translocation of p-ERK, and the activation of its subcellular downstream effector, Elk-1. Inhibiting MAPK activity with UO126 or knockdown of ERK2 isoform with siRNA in MCF-7 Snail cells reverted EMT induced by Snail as shown by decreased Snail and vimentin expression, decreased cell migration and increased cell adhesion. Overall, our data suggest that ERK2 isoform activation by Snail in aggressive breast cancer cells leads to EMT associated with increased cell migration and decreased cell adhesion. This regulation is enhanced by positive feedback regulation of Snail by ERK2. Therefore, therapeutic targeting of ERK2 isoform may be beneficial for breast cancer.	[Smith, Bethany N.; Burton, Liza J.; Henderson, Veronica; Randle, Diandra D.; Morton, Derrick J.; Smith, Basil A.; Nagappan, Peri; Odero-Marah, Valerie A.] Clark Atlanta Univ, Ctr Canc Res & Therapeut Dev, Atlanta, GA 30314 USA; [Smith, Bethany N.; Burton, Liza J.; Henderson, Veronica; Randle, Diandra D.; Morton, Derrick J.; Smith, Basil A.; Nagappan, Peri; Odero-Marah, Valerie A.] Clark Atlanta Univ, Dept Biol Sci, Atlanta, GA 30314 USA; [Taliaferro-Smith, Latonia] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA; [Taliaferro-Smith, Latonia] Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA 30322 USA; [Yates, Clayton] Tuskegee Univ, Dept Biol, Tuskegee, AL 36088 USA; [Yates, Clayton] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Chung, Leland W. K.] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Dept Med, Urooncol Res Program, Los Angeles, CA 90048 USA	Clark Atlanta University; Clark Atlanta University; Emory University; Emory University; Tuskegee University; University of Alabama System; University of Alabama Birmingham; Cedars Sinai Medical Center	Odero-Marah, VA (corresponding author), Clark Atlanta Univ, Ctr Canc Res & Therapeut Dev, Atlanta, GA 30314 USA.	vodero_marah@cau.edu	Smith, Bethany/GYT-9168-2022		NIH grants [P20MD002285-01, G12RR003062-22]; NATIONAL CANCER INSTITUTE [P01CA098912, U54CA118623, U54CA118948] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003062] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007590, P20MD002285] Funding Source: NIH RePORTER	NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This study was supported by NIH grants P20MD002285-01 (VOM) and G12RR003062-22. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aceves-Luquero CI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006124; American Cancer Society, 2012, BREAST CANC FACTS FI; Aziz SW, 2013, BREAST CANC METASTAS, P47; Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Chen HM, 2009, CANCER RES, V69, P9228, DOI 10.1158/0008-5472.CAN-09-1950; Du C, 2010, CANCER RES, V70, P7810, DOI 10.1158/0008-5472.CAN-09-4481; Franco DL, 2010, J CELL SCI, V123, P3467, DOI 10.1242/jcs.068692; Hsu YL, 2013, ONCOGENE, V32, P4436, DOI 10.1038/onc.2012.444; Kuo HT, 2013, POL J PATHOL, V64, P163, DOI 10.5114/PJP.2013.38132; Lacroix M, 2004, ONCOL REP, V12, P701; Lee S, 2007, GYNECOL ONCOL, V104, P338, DOI 10.1016/j.ygyno.2006.08.040; Martinez-Estrada OM, 2006, BIOCHEM J, V394, P449, DOI 10.1042/BJ20050591; Mazzucchelli C, 2002, NEURON, V34, P807, DOI 10.1016/S0896-6273(02)00716-X; Neal CL, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-336; Neal CL, 2011, CELL ADHES MIGR, V5, P249, DOI 10.4161/cam.5.3.15618; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Normanno N, 2006, J CELL PHYSIOL, V207, P420, DOI 10.1002/jcp.20588; Ohkubo T, 2004, J CELL SCI, V117, P1675, DOI 10.1242/jcs.01004; Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374; Rinehart J, 2004, J CLIN ONCOL, V22, P4456, DOI 10.1200/JCO.2004.01.185; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Sebolt-Leopold JS, 1999, NAT MED, V5, P810, DOI 10.1038/10533; Shukla A, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-314; Silvers AL, 2003, NEOPLASIA, V5, P319, DOI 10.1016/S1476-5586(03)80025-8; Smith AP, 2009, ONCOGENE, V28, P422, DOI 10.1038/onc.2008.395; Smith BN, 2012, CELL ADHES MIGR, V6, P433, DOI 10.4161/cam.21687; Smith ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009295; Svensson S, 2005, ONCOGENE, V24, P4370, DOI 10.1038/sj.onc.1208626; Vantaggiato Chiara, 2006, J Biol, V5, P14, DOI 10.1186/jbiol38; Vega S, 2004, GENE DEV, V18, P1131, DOI 10.1101/gad.294104; von Thun A, 2012, J CELL SCI, V125, P1465, DOI 10.1242/jcs.092916; Whyte J, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2361; Wortzel Inbal, 2011, Genes Cancer, V2, P195, DOI 10.1177/1947601911407328; Yamasaki H, 2005, GENES CELLS, V10, P455, DOI 10.1111/j.1365-2443.2005.00850.x; Yang ZB, 2005, CANCER RES, V65, P3179, DOI 10.1158/0008-5472.CAN-04-3480; Yook JI, 2005, J BIOL CHEM, V280, P11740, DOI 10.1074/jbc.M413878200; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	38	80	87	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104987	10.1371/journal.pone.0104987	http://dx.doi.org/10.1371/journal.pone.0104987			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122124	Green Published, Green Submitted, gold			2022-12-25	WOS:000341017000082
J	Salanova, M; Gelfi, C; Moriggi, M; Vasso, M; Vigano, A; Minafra, L; Bonifacio, G; Schiffl, G; Gutsmann, M; Felsenberg, D; Cerretelli, P; Blottner, D				Salanova, Michele; Gelfi, Cecilia; Moriggi, Manuela; Vasso, Michele; Vigano, Agnese; Minafra, Luigi; Bonifacio, Gaetano; Schiffl, Gudrun; Gutsmann, Martina; Felsenberg, Dieter; Cerretelli, Paolo; Blottner, Dieter			Disuse deterioration of human skeletal muscle challenged by resistive exercise superimposed with vibration: evidence from structural and proteomic analysis	FASEB JOURNAL			English	Article						bed rest; atrophy; ultrastructure; countermeasures; protein expression	FOCAL ADHESION KINASE; HEAVY-CHAIN ISOFORMS; TERM BED REST; TENASCIN-C; SHORTENING VELOCITY; FAST HINDLIMB; FIBERS; EXPRESSION; RAT; PROTEIN	In the present bed rest (BR) study, 23 volunteers were randomized into 3 subgroups: 60 d BR control (Ctr); BR with resistive exercise (RE; lower-limb load); and resistive vibration exercise (RVE; RE with superimposed vibration). The aim was to analyze by confocal and electron microscopy the effects of vibration on myofibril and filament integrity in soleus (Sol) and vastus lateralis (VL) muscle; differential proteomics of contractile, cytoskeletal, and costameric proteins (TN-C, ROCK1, and FAK); and expression of PGC1 and atrophy-related master genes MuRF1 and MuRF2. RVE (but not RE) preserved myofiber size and phenotype in Sol and VL by overexpressing MYBPC1 (42%, P0.01), WDR1 (39%, P0.01), sarcosin (84%, P0.01), and CKM (20%, P0.01) and prevented myofibrillar ultrastructural damage as detectable by MuRF1 expression. In Sol, cytoskeletal and contractile proteins were normalized by RVE, and TN-C increased (59%, P0.01); the latter also with RE (108%, P0.01). In VL, the outcomes of both RVE (acting on sarcosin and desmin) and RE (by way of troponinT-slow and MYL2) were similar. RVE appears to be a highly efficient countermeasure protocol against muscle atrophy and ultrastructural and molecular dysregulation induced by chronic disuse.Salanova, M., Gelfi, C., Moriggi, M., Vasso, M., Vigan, A., Minafra, L., Bonifacio, G., Schiffl, G., Gutsmann, M., Felsenberg, D., Cerretelli, P., Blottner, D. Disuse deterioration of human skeletal muscle challenged by resistive exercise superimposed with vibration: evidence from structural and proteomic analysis.	[Salanova, Michele; Schiffl, Gudrun; Gutsmann, Martina; Blottner, Dieter] Charite, Inst Anat, Neuromuscular Grp, Ctr Space Med Berlin, D-10115 Berlin, Germany; [Felsenberg, Dieter] Charite, Ctr Muscle & Bone Res ZMK, D-10115 Berlin, Germany; [Gelfi, Cecilia; Moriggi, Manuela; Vigano, Agnese] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy; [Gelfi, Cecilia; Vasso, Michele; Cerretelli, Paolo] CNR, Inst Bioimaging & Mol Physiol, Segrate, Italy; [Gelfi, Cecilia] Ist Ricovero & Cura Carattere Sci IRCCS Policlin, San Donato Milanese, Italy; [Vasso, Michele; Minafra, Luigi] CNR Lab Tecnol Oncol LATO, Inst Bioimaging & Mol Physiol, Cefalu, Italy; [Bonifacio, Gaetano] Univ Lausanne, Dept Pharmacol & Toxicol, Lausanne, Switzerland	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Milan; Consiglio Nazionale delle Ricerche (CNR); IRCCS Policlinico San Donato; University of Lausanne	Salanova, M (corresponding author), Charite, Neuromuscular Grp, Campus Charite Mitte,Philippstr 12, D-10115 Berlin, Germany.	michele.salanova@charite.de; cecilia.gelfi@unimi.it	Minafra, L/AFR-1042-2022; MORIGGI, MANUELA/AAB-5477-2021; Gelfi, Cecilia/L-1490-2016	Minafra, L/0000-0003-3112-4519; MORIGGI, MANUELA/0000-0002-4718-0307; Gelfi, Cecilia/0000-0002-2996-6912; Blottner, Dieter/0000-0003-0355-3340; VASSO, MICHELE/0000-0003-0431-0981	European Space Agency (ESA) [14431/02/NL/SH2]; German Aerospace Center (DER) [50WB0821, 50WB0720]; Fondo per gli Investimenti della Ricerca di Base (FIRB) [RBRN07BMCF]; Agenzia Spaziale Italiana (ASI); Telethon [GGP11082]; FP7-BIO-NMD project [241665]	European Space Agency (ESA)(European Space Agency); German Aerospace Center (DER); Fondo per gli Investimenti della Ricerca di Base (FIRB)(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); Agenzia Spaziale Italiana (ASI)(Agenzia Spaziale Italiana (ASI)); Telethon(Fondazione Telethon); FP7-BIO-NMD project	The Second Berlin Bed Rest Study (BBR-2) was supported by grant 14431/02/NL/SH2 from the European Space Agency (ESA) and German Aerospace Center (DER), grant 50WB0821 (D.B.), and grant 50WB0720 (D.F.). The authors thank D. L. Belavy for his help as BBR-2 study coordinator; Ms. Petra Schrade for the technical support during the ultrastuctural analysis; S. Krasnici and J. Fakler (Traumatology Unit, Charite Campus Benjamin Franklin, Berlin, Germany) for excellence in muscle biopsy sampling; and Andrew Clarke for the language editorial work. Anti-MuRF2 antibodies were a kind gift of C. Krone and S. Labeit (Mannheim University, Mannheim, Germany). BBR-2 was also sponsored by Novotec Medical GmbH (Pforzheim, Germany) and Charite Universitatsmedizin Berlin. Special thanks to the volunteers and the staff of the Radiology Department and all the enthusiastic :members participating in BBR-2. Proteomics and mechanotransduction assessment were carried out at die University of Milan by the node of The Italian Human Proteomic Network, coordinated by C.G. and financially supported by Fondo per gli Investimenti della Ricerca di Base (FIRB; grant. RBRN07BMCF to CC.), Agenzia Spaziale Italiana (ASI; to P.C.), Telethon (grant GGP11082 to C.G.), and the FP7-BIO-NMD project (grant 241665 to C.G.).	Adams GR, 2003, J APPL PHYSIOL, V95, P2185, DOI 10.1152/japplphysiol.00346.2003; Andersen JL, 1999, J APPL PHYSIOL, V86, P455, DOI 10.1152/jappl.1999.86.2.455; Baldwin KM, 1996, MED SCI SPORT EXER, V28, P983, DOI 10.1097/00005768-199608000-00008; BAR A, 1988, FEBS LETT, V235, P153, DOI 10.1016/0014-5793(88)81253-5; Belavy DL, 2010, J MUSCULOSKEL NEURON, V10, P207; Benjamini Y, 2000, J EDUC BEHAV STAT, V25, P60, DOI 10.2307/1165312; Bershadsky AD, 2003, ANNU REV CELL DEV BI, V19, P677, DOI 10.1146/annurev.cellbio.19.111301.153011; BETTO DD, 1986, BIOCHEM BIOPH RES CO, V138, P981, DOI 10.1016/S0006-291X(86)80592-7; Blottner D, 2006, EUR J APPL PHYSIOL, V97, P261, DOI 10.1007/s00421-006-0160-6; Booth FW, 1997, INT J SPORTS MED, V18, pS265, DOI 10.1055/s-2007-972723; BOTTINELLI R, 1994, J MUSCLE RES CELL M, V15, P413, DOI 10.1007/BF00122115; Caiozzo VJ, 1996, J APPL PHYSIOL, V80, P1503, DOI 10.1152/jappl.1996.80.5.1503; CHIQUETEHRISMANN R, 1994, J CELL BIOL, V127, P2093, DOI 10.1083/jcb.127.6.2093; Cochrane DJ, 2009, MUSCLE NERVE, V40, P420, DOI 10.1002/mus.21330; Durieux AC, 2007, BIOCHEM SOC T, V35, P1312, DOI 10.1042/BST0351312; EDGERTON VR, 1995, J APPL PHYSIOL, V78, P1733, DOI 10.1152/jappl.1995.78.5.1733; Ervasti JM, 2003, J BIOL CHEM, V278, P13591, DOI 10.1074/jbc.R200021200; Fluck M, 2002, J EXP BIOL, V205, P2337; Fluck M, 2008, P NATL ACAD SCI USA, V105, P13662, DOI 10.1073/pnas.0805365105; GRANIT R, 1956, ACTA PHYSIOL SCAND, V37, P114, DOI 10.1111/j.1748-1716.1956.tb01347.x; Ito K, 2004, HYPERTENSION, V43, P156, DOI 10.1161/01.HYP.0000114602.82140.a4; Jarvinen TAH, 2003, J CELL SCI, V116, P857, DOI 10.1242/jcs.00303; Leger B, 2006, J PHYSIOL-LONDON, V576, P923, DOI 10.1113/jphysiol.2006.116715; LEUNG T, 1995, J BIOL CHEM, V270, P29051, DOI 10.1074/jbc.270.49.29051; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Mackey AL, 2011, FASEB J, V25, P1943, DOI 10.1096/fj.10-176487; Marouga R, 2005, ANAL BIOANAL CHEM, V382, P669, DOI 10.1007/s00216-005-3126-3; Midwood KS, 2009, J CELL COMMUN SIGNAL, V3, P287, DOI 10.1007/s12079-009-0075-1; Moriggi M, 2010, PROTEOMICS, V10, P3756, DOI 10.1002/pmic.200900817; Pasini E, 2012, EXP GERONTOL, V47, P23, DOI 10.1016/j.exger.2011.10.003; Quach NL, 2006, DEV BIOL, V293, P38, DOI 10.1016/j.ydbio.2005.12.040; Rittweger J, 2010, BONE, V46, P137, DOI 10.1016/j.bone.2009.08.051; Salanova M, 2008, J ANAT, V212, P306, DOI 10.1111/j.1469-7580.2008.00854.x; Salanova M, 2008, HISTOCHEM CELL BIOL, V130, P105, DOI 10.1007/s00418-008-0399-6; Salanova M, 2011, FASEB J, V25, P4312, DOI 10.1096/fj.11-186049; Salanova M, 2009, HISTOCHEM CELL BIOL, V132, P383, DOI 10.1007/s00418-009-0624-y; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Schenck U, 1996, ACTA CYTOL, V40, P73; SCHIAFFINO S, 1989, J MUSCLE RES CELL M, V10, P197, DOI 10.1007/BF01739810; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Schuenke MD, 2009, EUR J APPL PHYSIOL, V106, P885, DOI 10.1007/s00421-009-1091-9; Smith Temple F., 2008, V48, P20, DOI 10.1007/978-0-387-09595-0_3; TERMIN A, 1989, EUR J BIOCHEM, V186, P749, DOI 10.1111/j.1432-1033.1989.tb15269.x; Traon APL, 2007, EUR J APPL PHYSIOL, V101, P143, DOI 10.1007/s00421-007-0474-z; Trappe S, 2004, J PHYSIOL-LONDON, V557, P501, DOI 10.1113/jphysiol.2004.062166; Vigano A, 2011, PROTEOMICS, V11, P4202, DOI 10.1002/pmic.201000804; Viswanathan S, 2006, NAT PROTOC, V1, P1351, DOI 10.1038/nprot.2006.234; Widrick JJ, 1997, AM J PHYSIOL-CELL PH, V273, pC1690	48	34	36	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2014	28	11					4748	4763		10.1096/fj.14-252825	http://dx.doi.org/10.1096/fj.14-252825			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AS1OU	25122557				2022-12-25	WOS:000344050900015
J	Gupta, S; Yeeles, JTP; Marians, KJ				Gupta, Sankalp; Yeeles, Joseph T. P.; Marians, Kenneth J.			Regression of Replication Forks Stalled by Leading-strand Template Damage II-REGRESSION BY RecA IS INHIBITED BY SSB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING-PROTEIN; PROMOTED BRANCH MIGRATION; ESCHERICHIA-COLI; IN-VITRO; GENETIC-RECOMBINATION; HOLLIDAY JUNCTIONS; RUVC PROTEIN; INITIATION; REPLISOME; REPAIR	Stalled replication forks are sites of chromosome breakage and the formation of toxic recombination intermediates that undermine genomic stability. Thus, replication fork repair and reactivation are essential processes. Among the many models of replication fork reactivation is one that invokes fork regression catalyzed by the strand exchange protein RecA as an intermediate in the processing of the stalled fork. We have investigated the replication fork regression activity of RecA using a reconstituted DNA replication system where the replisome is stalled by collision with leading-strand template damage. We find that RecA is unable to regress the stalled fork in the presence of the replisome and SSB. If the replication proteins are removed from the stalled fork, RecA will catalyze net regression as long as the Okazaki fragments are sealed. RecA-generated Holliday junctions can be detected by RuvC cleavage, although this is not a robust reaction. On the other hand, extensive branch migration by RecA, where a completely unwound product consisting of the paired nascent leading and lagging strands is produced, is observed under conditions where RuvC activity is suppressed. This branch migration reaction is inhibited by SSB, possibly accounting for the failure of RecA to generate products in the presence of the replication proteins. Interestingly, we find that the RecA-RuvC reaction is supported to differing extents, depending on the template damage; templates carrying a cyclopyrimidine dimer elicit more RecA-RuvC product than those carrying a synthetic abasic site. This difference could be ascribed to a higher affinity of RecA binding to DNAs carrying a thymidine dimer than to those with an abasic site.	[Gupta, Sankalp; Yeeles, Joseph T. P.; Marians, Kenneth J.] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Marians, KJ (corresponding author), Mem Sloan Kettering Canc Ctr, Program Mol Biol, 1275 York Ave, New York, NY 10065 USA.	kmarians@sloankettering.edu	Gupta, Sankalp/M-1907-2014	Yeeles, Joseph/0000-0002-2255-2119	National Institutes of Health [GM34557]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034557, R37GM034557] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM34557 (to K. J. M.).	ASAI T, 1993, EMBO J, V12, P3287, DOI 10.1002/j.1460-2075.1993.tb05998.x; Atkinson J, 2009, NUCLEIC ACIDS RES, V37, P3475, DOI 10.1093/nar/gkp244; BENSON FE, 1994, J BIOL CHEM, V269, P5195; BOBST EV, 1985, FEBS LETT, V181, P133, DOI 10.1016/0014-5793(85)81128-5; CASSUTO E, 1980, P NATL ACAD SCI-BIOL, V77, P3962, DOI 10.1073/pnas.77.7.3962; Chow KH, 2004, J BIOL CHEM, V279, P3492, DOI 10.1074/jbc.M311012200; CONNOLLY B, 1991, P NATL ACAD SCI USA, V88, P6063, DOI 10.1073/pnas.88.14.6063; Courcelle J, 2001, GENETICS, V158, P41; Courcelle J, 2003, SCIENCE, V299, P1064, DOI 10.1126/science.1081328; COX MM, 1983, J BIOL CHEM, V258, P2577; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; COX MM, 1981, P NATL ACAD SCI-BIOL, V78, P6018, DOI 10.1073/pnas.78.10.6018; Ferrari ME, 1997, BIOPHYS CHEM, V64, P235, DOI 10.1016/S0301-4622(96)02223-5; Gabbai CB, 2010, DNA REPAIR, V9, P202, DOI 10.1016/j.dnarep.2009.12.009; Gupta S, 2014, J BIOL CHEM, V289, P28376, DOI 10.1074/jbc.M114.587881; HAHN TR, 1988, J BIOL CHEM, V263, P7431; Heller RC, 2005, MOL CELL, V17, P733, DOI 10.1016/j.molcel.2005.01.019; Indiani C, 2013, P NATL ACAD SCI USA, V110, P5410, DOI 10.1073/pnas.1303301110; Kogoma T, 1996, CELL, V85, P625, DOI 10.1016/S0092-8674(00)81229-5; KOWALCZYKOWSKI SC, 1987, J MOL BIOL, V193, P81, DOI 10.1016/0022-2836(87)90629-2; KOWALCZYKOWSKI SC, 1987, J MOL BIOL, V193, P97, DOI 10.1016/0022-2836(87)90630-9; Kowalczykowski SC, 2000, TRENDS BIOCHEM SCI, V25, P156, DOI 10.1016/S0968-0004(00)01569-3; Kurth I, 2013, NATURE, V496, P119, DOI 10.1038/nature11988; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; Lusetti SL, 2002, ANNU REV BIOCHEM, V71, P71, DOI 10.1146/annurev.biochem.71.083101.133940; MASAI H, 1994, EMBO J, V13, P5338, DOI 10.1002/j.1460-2075.1994.tb06868.x; MCENTEE K, 1979, P NATL ACAD SCI USA, V76, P2615, DOI 10.1073/pnas.76.6.2615; McGlynn P, 2002, NAT REV MOL CELL BIO, V3, P859, DOI 10.1038/nrm951; McInerney P, 2007, J BIOL CHEM, V282, P25903, DOI 10.1074/jbc.M703777200; Michel B, 2004, P NATL ACAD SCI USA, V101, P12783, DOI 10.1073/pnas.0401586101; Michel B, 2007, DNA REPAIR, V6, P967, DOI 10.1016/j.dnarep.2007.02.016; Morimatsu K, 2003, MOL CELL, V11, P1337, DOI 10.1016/S1097-2765(03)00188-6; Robu ME, 2001, P NATL ACAD SCI USA, V98, P8211, DOI 10.1073/pnas.131022698; ROSENBERG M, 1990, J BIOL CHEM, V265, P20641; Rothstein R, 2000, GENE DEV, V14, P1; Seigneur M, 2000, MOL MICROBIOL, V38, P565, DOI 10.1046/j.1365-2958.2000.02152.x; SHAH R, 1994, CELL, V79, P853, DOI 10.1016/0092-8674(94)90074-4; SHIBATA T, 1979, P NATL ACAD SCI USA, V76, P5100, DOI 10.1073/pnas.76.10.5100; Sommer S, 1998, MOL MICROBIOL, V28, P281, DOI 10.1046/j.1365-2958.1998.00803.x; Stohl EA, 2003, J BIOL CHEM, V278, P2278, DOI 10.1074/jbc.M210496200; TSANEVA IR, 1992, CELL, V69, P1171, DOI 10.1016/0092-8674(92)90638-S; UMEZU K, 1993, P NATL ACAD SCI USA, V90, P3875, DOI 10.1073/pnas.90.9.3875; WEST SC, 1984, CELL, V37, P683, DOI 10.1016/0092-8674(84)90401-X; WEST SC, 1981, P NATL ACAD SCI-BIOL, V78, P6149, DOI 10.1073/pnas.78.10.6149; WEST SC, 1982, MOL GEN GENET, V186, P333, DOI 10.1007/BF00729451; WHITBY MC, 1994, EMBO J, V13, P5220, DOI 10.1002/j.1460-2075.1994.tb06853.x; WU CA, 1992, J BIOL CHEM, V267, P4030; Yeeles JTP, 2013, MOL CELL, V52, P855, DOI 10.1016/j.molcel.2013.10.020; Yeeles JTP, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012815; Yeeles JTP, 2011, SCIENCE, V334, P235, DOI 10.1126/science.1209111	50	12	12	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28388	28398		10.1074/jbc.M114.587907	http://dx.doi.org/10.1074/jbc.M114.587907			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25138217	Green Published, hybrid			2022-12-25	WOS:000343765400032
J	Kidwell, MA; Chan, JM; Doudna, JA				Kidwell, Mary Anne; Chan, Jessica M.; Doudna, Jennifer A.			Evolutionarily Conserved Roles of the Dicer Helicase Domain in Regulating RNA Interference Processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR RIG-I; STRUCTURAL BASIS; DROSOPHILA DICER-1; RECOGNITION; PROTEINS; ACCUMULATION; ACTIVATION; INSIGHTS; BINDING; GENES	The enzyme Dicer generates 21-25 nucleotide RNAs that target specific mRNAs for silencing during RNA interference and related pathways. Although their active sites and RNA binding regions are functionally conserved, the helicase domains have distinct activities in the context of different Dicer enzymes. To examine the evolutionary origins of Dicer helicase functions, we investigated two related Dicer enzymes from the thermophilic fungus Sporotrichum thermophile. RNA cleavage assays showed that S. thermophile Dicer-1 (StDicer-1) can process hairpin precursor microRNAs, whereas StDicer-2 can only cleave linear double-stranded RNAs. Furthermore, only StDicer-2 possesses robust ATP hydrolytic activity in the presence of double-stranded RNA. Deletion of the StDicer-2 helicase domain increases both StDicer-2 cleavage activity and affinity for hairpin RNA. Notably, both StDicer-1 and StDicer-2 could complement the distantly related yeast Schizosaccharomyces pombe lacking its endogenous Dicer gene but only in their full-length forms, underscoring the importance of the helicase domain. These results suggest an in vivo regulatory function for the helicase domain that may be conserved from fungi to humans.	[Kidwell, Mary Anne; Chan, Jessica M.; Doudna, Jennifer A.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Doudna, JA (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, 731 Stanley Hall,MS 3220, Berkeley, CA 94720 USA.	doudna@berkeley.edu			National Institutes of Health [5R01GM073794]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073794] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R01GM073794.	Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Bazzini AA, 2012, SCIENCE, V336, P233, DOI 10.1126/science.1215704; Beeson WT, 2011, APPL ENVIRON MICROB, V77, P650, DOI 10.1128/AEM.01922-10; Catalanotto C, 2004, MOL CELL BIOL, V24, P2536, DOI 10.1128/MCB.24.6.2536-2545.2004; Cenik ES, 2011, MOL CELL, V42, P172, DOI 10.1016/j.molcel.2011.03.002; Cerutti H, 2006, CURR GENET, V50, P81, DOI 10.1007/s00294-006-0078-x; Chakravarthy S, 2010, J MOL BIOL, V404, P392, DOI 10.1016/j.jmb.2010.09.030; Civril F, 2011, EMBO REP, V12, P1127, DOI 10.1038/embor.2011.190; de Jong D, 2009, MOL BIOL EVOL, V26, P1333, DOI 10.1093/molbev/msp042; De N, 2013, MOL CELL, V50, P344, DOI 10.1016/j.molcel.2013.04.001; Djuranovic S, 2012, SCIENCE, V336, P237, DOI 10.1126/science.1215691; FerreDAmare AR, 1996, NUCLEIC ACIDS RES, V24, P977, DOI 10.1093/nar/24.5.977; Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335; Gee P, 2008, J BIOL CHEM, V283, P9488, DOI 10.1074/jbc.M706777200; Jiang FG, 2011, NATURE, V479, P423, DOI 10.1038/nature10537; Kadotani N, 2004, J BIOL CHEM, V279, P44467, DOI 10.1074/jbc.M408259200; Kowalinski E, 2011, CELL, V147, P423, DOI 10.1016/j.cell.2011.09.039; Lau PW, 2012, NAT STRUCT MOL BIOL, V19, P436, DOI 10.1038/nsmb.2268; Lee HC, 2010, MOL CELL, V38, P803, DOI 10.1016/j.molcel.2010.04.005; Lee HY, 2012, RNA, V18, P2012, DOI 10.1261/rna.035501.112; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Lindner K, 2002, MOL BIOL CELL, V13, P435, DOI 10.1091/mbc.01-11-0537; Luo DH, 2011, CELL, V147, P409, DOI 10.1016/j.cell.2011.09.023; Ma E, 2008, J MOL BIOL, V380, P237, DOI 10.1016/j.jmb.2008.05.005; Ma EB, 2012, J MOL BIOL, V422, P466, DOI 10.1016/j.jmb.2012.06.009; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; Moran Y, 2013, MOL BIOL EVOL, V30, P2541, DOI 10.1093/molbev/mst159; Mukherjee K, 2013, MOL BIOL EVOL, V30, P627, DOI 10.1093/molbev/mss263; Provost P, 2002, P NATL ACAD SCI USA, V99, P16648, DOI 10.1073/pnas.212633199; Sasaki T, 2007, GENE, V396, P312, DOI 10.1016/j.gene.2007.04.001; Taylor DW, 2013, NAT STRUCT MOL BIOL, V20, P662, DOI 10.1038/nsmb.2564; Tsutsumi A, 2011, NAT STRUCT MOL BIOL, V18, P1153, DOI 10.1038/nsmb.2125; Welker NC, 2010, RNA, V16, P893, DOI 10.1261/rna.2122010; Wilson RC, 2013, ANNU REV BIOPHYS, V42, P217, DOI 10.1146/annurev-biophys-083012-130404; Zhang HD, 2004, CELL, V118, P57, DOI 10.1016/j.cell.2004.06.017	35	10	10	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28352	28362		10.1074/jbc.M114.589051	http://dx.doi.org/10.1074/jbc.M114.589051			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25135636	Green Published, hybrid			2022-12-25	WOS:000343765400029
J	Laflamme, G; Tremblay-Boudreault, T; Roy, MA; Andersen, P; Bonneil, E; Atchia, K; Thibault, P; D'Amours, D; Kwok, BH				Laflamme, Guillaume; Tremblay-Boudreault, Thierry; Roy, Marc-Andre; Andersen, Parker; Bonneil, Eric; Atchia, Kaleem; Thibault, Pierre; D'Amours, Damien; Kwok, Benjamin H.			Structural Maintenance of Chromosome (SMC) Proteins Link Microtubule Stability to Genome Integrity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Division; Chromosomes; Microtubule; Mitosis; Mitotic Spindle; SMC Proteins	KINESIN; CONDENSIN; DNA; TUBULIN; YEAST; KINETOCHORE; MITOSIS; SPINDLE; COMPLEX; IDENTIFICATION	Background: SMC proteins organize chromosome architecture, whereas microtubules form the structural framework for chromosome movement in mitosis. Results: SMC proteins bind to and stabilize microtubules to promote proper mitotic spindle formation. Conclusion: SMC proteins can provide a functional link between microtubules and DNA to ensure faithful chromosome segregation. Significance: SMC-microtubule interactions are essential to establish a robust system for maintaining genome integrity. Structural maintenance of chromosome (SMC) proteins are key organizers of chromosome architecture and are essential for genome integrity. They act by binding to chromatin and connecting distinct parts of chromosomes together. Interestingly, their potential role in providing connections between chromatin and the mitotic spindle has not been explored. Here, we show that yeast SMC proteins bind directly to microtubules and can provide a functional link between microtubules and DNA. We mapped the microtubule-binding region of Smc5 and generated a mutant with impaired microtubule binding activity. This mutant is viable in yeast but exhibited a cold-specific conditional lethality associated with mitotic arrest, aberrant spindle structures, and chromosome segregation defects. In an in vitro reconstitution assay, this Smc5 mutant also showed a compromised ability to protect microtubules from cold-induced depolymerization. Collectively, these findings demonstrate that SMC proteins can bind to and stabilize microtubules and that SMC-microtubule interactions are essential to establish a robust system to maintain genome integrity.	[Laflamme, Guillaume; Tremblay-Boudreault, Thierry; Andersen, Parker; Atchia, Kaleem; Kwok, Benjamin H.] Univ Montreal, Stn Ctr Ville, Inst Res Immunol & Canc, Chem Biol Cell Div Lab, Montreal, PQ H3C 3J7, Canada; [Laflamme, Guillaume; Roy, Marc-Andre; D'Amours, Damien] Univ Montreal, Stn Ctr Ville, Inst Res Immunol & Canc, Lab Cell Cycle Regulat & Chromosome Struct, Montreal, PQ H3C 3J7, Canada; [Bonneil, Eric; Thibault, Pierre] Univ Montreal, Stn Ctr Ville, Inst Res Immunol & Canc, Lab Prote & Bioanalyt Mass Spectrometry, Montreal, PQ H3C 3J7, Canada; [Thibault, Pierre] Univ Montreal, Stn Ctr Ville, Dept Chem, Montreal, PQ H3C 3J7, Canada; [D'Amours, Damien] Univ Montreal, Stn Ctr Ville, Dept Pathol & Cellular Biol, Montreal, PQ H3C 3J7, Canada; [Kwok, Benjamin H.] Univ Montreal, Stn Ctr Ville, Dept Med, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	D'Amours, D (corresponding author), Univ Montreal, Stn Ctr Ville, Inst Res Immunol & Canc, Lab Cell Cycle Regulat & Chromosome Struct, Montreal, PQ H3C 3J7, Canada.	damien.damours@umontreal.ca; benjamin.kwok@umontreal.ca		Laflamme, Guillaume/0000-0002-9083-4572	Canadian Institutes of Health Research (CIHR) [MOP-82912, MOP-97928]; Canadian Cancer Society Research Institute [020304]; Fonds de Recherche du Quebec en Sante [22131]; Natural Sciences and Engineering Research Council; Canadian Center of Excellence in Commercialization and Research (CECR); Canada Foundation for Innovation; Fonds de Recherche Sante (FRQS); Fonds Perseverance (IRIC, Universite de Montreal); FRQS	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Fonds de Recherche du Quebec en Sante(Fonds de la Recherche en Sante du Quebec); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Center of Excellence in Commercialization and Research (CECR); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Fonds de Recherche Sante (FRQS); Fonds Perseverance (IRIC, Universite de Montreal); FRQS	This work was supported by Canadian Institutes of Health Research (CIHR) Grants MOP-82912 (to D. D.) and MOP-97928 (to B. H. K.), Canadian Cancer Society Research Institute Grant 020304 (to D. D.), Fonds de Recherche du Quebec en Sante Grant 22131 (to B. H. K.), and the Natural Sciences and Engineering Research Council (to P. T.). The Institute for Research in Immunology and Cancer (IRIC) is supported in part by the Canadian Center of Excellence in Commercialization and Research (CECR), the Canada Foundation for Innovation, and Fonds de Recherche Sante (FRQS).; Supported by a graduate scholarship from the Fonds Perseverance (IRIC, Universite de Montreal).; Supported by a Ph.D. scholarship from FRQS.	Akhmedov AT, 1998, J BIOL CHEM, V273, P24088, DOI 10.1074/jbc.273.37.24088; Akiyoshi B, 2009, GENE DEV, V23, P2887, DOI 10.1101/gad.1865909; Antonio C, 2000, CELL, V102, P425, DOI 10.1016/S0092-8674(00)00048-9; Arora K, 2014, J MOL BIOL, V426, P2997, DOI 10.1016/j.jmb.2014.05.030; Bazile F, 2010, CELL CYCLE, V9, P3243, DOI 10.4161/cc.9.16.12620; BROACH JR, 1986, CELL, V44, P3, DOI 10.1016/0092-8674(86)90477-0; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Chiu A, 2004, J BIOL CHEM, V279, P26233, DOI 10.1074/jbc.M402439200; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Crevel IMTC, 1996, J MOL BIOL, V257, P66, DOI 10.1006/jmbi.1996.0147; De Piccoli G, 2009, CHROMOSOME RES, V17, P251, DOI 10.1007/s10577-008-9016-8; Desai A, 1999, CELL, V96, P69, DOI 10.1016/S0092-8674(00)80960-5; ELINSON RP, 1985, DEV BIOL, V109, P224, DOI 10.1016/0012-1606(85)90362-8; Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473; Funabiki H, 2000, CELL, V102, P411, DOI 10.1016/S0092-8674(00)00047-7; Gache V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009248; GARD DL, 1987, J CELL BIOL, V105, P2191, DOI 10.1083/jcb.105.5.2191; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Hayashi I, 2003, J BIOL CHEM, V278, P36430, DOI 10.1074/jbc.M305773200; HEIDEMANN SR, 1975, J CELL BIOL, V67, P105, DOI 10.1083/jcb.67.1.105; Helenius J, 2006, NATURE, V441, P115, DOI 10.1038/nature04736; HILLER G, 1978, CELL, V14, P795, DOI 10.1016/0092-8674(78)90335-5; Hirano T, 2006, NAT REV MOL CELL BIO, V7, P311, DOI 10.1038/nrm1909; Hirano T, 2012, GENE DEV, V26, P1659, DOI 10.1101/gad.194746.112; HOYT MA, 1991, CELL, V66, P507, DOI 10.1016/0092-8674(81)90014-3; HUFFAKER TC, 1988, J CELL BIOL, V106, P1997, DOI 10.1083/jcb.106.6.1997; JARVIK J, 1975, P NATL ACAD SCI USA, V72, P2738, DOI 10.1073/pnas.72.7.2738; JOHNSON KA, 1977, J MOL BIOL, V117, P1, DOI 10.1016/0022-2836(77)90020-1; Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850; Kapitein LC, 2008, J CELL BIOL, V182, P421, DOI 10.1083/jcb.200801145; Kegel A, 2010, COLD SH Q B, V75, P179, DOI 10.1101/sqb.2010.75.047; Kinoshita K, 2002, TRENDS CELL BIOL, V12, P267, DOI 10.1016/S0962-8924(02)02295-X; Kwok BH, 2004, CURR BIOL, V14, P1783, DOI 10.1016/j.cub.2004.09.052; Lee YM, 2001, BIOCHEM J, V360, P549, DOI 10.1042/0264-6021:3600549; LI R, 1991, CELL, V66, P519, DOI 10.1016/0092-8674(81)90015-5; Lindroos HB, 2006, MOL CELL, V22, P755, DOI 10.1016/j.molcel.2006.05.014; Mack GJ, 2001, P NATL ACAD SCI USA, V98, P14434, DOI 10.1073/pnas.261371298; Nakazawa N, 2008, J CELL BIOL, V180, P1115, DOI 10.1083/jcb.200708170; Okada Y, 2000, P NATL ACAD SCI USA, V97, P640, DOI 10.1073/pnas.97.2.640; Ono T, 2004, MOL BIOL CELL, V15, P3296, DOI 10.1091/mbc.E04-03-0242; Pebernard S, 2008, EMBO J, V27, P3011, DOI 10.1038/emboj.2008.220; Ramey VH, 2011, MOL BIOL CELL, V22, P457, DOI 10.1091/mbc.E10-10-0841; Ratsima H, 2011, P NATL ACAD SCI USA, V108, pE914, DOI 10.1073/pnas.1106448108; REIJO RA, 1994, MOL BIOL CELL, V5, P29, DOI 10.1091/mbc.5.1.29; RIEDER CL, 1981, CHROMOSOMA, V84, P145, DOI 10.1007/BF00293368; Rossio V, 2010, J CELL BIOL, V191, P981, DOI 10.1083/jcb.201007025; Roy MA, 2011, CELL CYCLE, V10, P690, DOI 10.4161/cc.10.4.14860; SALMON ED, 1980, J CELL BIOL, V85, P853, DOI 10.1083/jcb.85.3.853; Sauer G, 2005, MOL CELL PROTEOMICS, V4, P35, DOI 10.1074/mcp.M400158-MCP200; Skop AR, 2004, SCIENCE, V305, P61, DOI 10.1126/science.1097931; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Solinet S, 2013, J CELL BIOL, V202, P251, DOI 10.1083/jcb.201304052; St-Pierre J, 2009, MOL CELL, V34, P416, DOI 10.1016/j.molcel.2009.04.013; Stephens AD, 2011, J CELL BIOL, V193, P1167, DOI 10.1083/jcb.201103138; Tirnauer JS, 2000, J CELL BIOL, V149, P761, DOI 10.1083/jcb.149.4.761; Torres-Rosell J, 2005, NAT CELL BIOL, V7, P412, DOI 10.1038/ncb1239; VALE RD, 1985, CELL, V42, P39, DOI 10.1016/S0092-8674(85)80099-4; Weinger JS, 2011, CURR BIOL, V21, P154, DOI 10.1016/j.cub.2010.12.038; Woehlke G, 1997, CELL, V90, P207, DOI 10.1016/S0092-8674(00)80329-3; Yoshimura SH, 2002, CURR BIOL, V12, P508, DOI 10.1016/S0960-9822(02)00719-4	61	12	12	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27418	27431		10.1074/jbc.M114.569608	http://dx.doi.org/10.1074/jbc.M114.569608			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25135640	hybrid, Green Published			2022-12-25	WOS:000342852800006
J	Petersson, ME; Obreja, O; Lampert, A; Carr, RW; Schmelz, M; Fransen, E				Petersson, Marcus E.; Obreja, Otilia; Lampert, Angelika; Carr, Richard W.; Schmelz, Martin; Fransen, Erik			Differential Axonal Conduction Patterns of Mechano-Sensitive and Mechano-Insensitive Nociceptors - A Combined Experimental and Modelling Study	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; INNERVATING HUMAN SKIN; C-NOCICEPTORS; SODIUM-CHANNELS; FIBERS; PAIN; NEURONS; IDENTIFICATION; EXCITABILITY; CURRENTS	Cutaneous pain sensations are mediated largely by C-nociceptors consisting of both mechano-sensitive (CM) and mechano-insensitive (CMi) fibres that can be distinguished from one another according to their characteristic axonal properties. In healthy skin and relative to CMi fibres, CM fibres show a higher initial conduction velocity, less activity-dependent conduction velocity slowing, and less prominent post-spike supernormality. However, after sensitization with nerve growth factor, the electrical signature of CMi fibres changes towards a profile similar to that of CM fibres. Here we take a combined experimental and modelling approach to examine the molecular basis of such alterations to the excitation thresholds. Changes in electrical activation thresholds and activity-dependent slowing were examined in vivo using single-fibre recordings of CM and CMi fibres in domestic pigs following NGF application. Using computational modelling, we investigated which axonal mechanisms contribute most to the electrophysiological differences between the fibre classes. Simulations of axonal conduction suggest that the differences between CMi and CM fibres are strongly influenced by the densities of the delayed rectifier potassium channel (Kdr), the voltage-gated sodium channels Na(V)1.7 and Na(V)1.8, and the Na+/K+-ATPase. Specifically, the CM fibre profile required less K-dr and Na(V)1.8 in combination with more Na(V)1.7 and Na+/ K(+)AT-Pase. The difference between CM and CMi fibres is thus likely to reflect a relative rather than an absolute difference in protein expression. In support of this, it was possible to replicate the experimental reduction of the ADS pattern of CMi nociceptors towards a CM-like pattern following intradermal injection of nerve growth factor by decreasing the contribution of Kdr (by 50%), increasing the Na+/K+-ATPase (by 10%), and reducing the branch length from 2 cm to 1 cm. The findings highlight key molecules that potentially contribute to the NGF-induced switch in nociceptors phenotype, in particular NaV1.7 which has already been identified clinically as a principal contributor to chronic pain states such as inherited erythromelalgia.	[Petersson, Marcus E.; Fransen, Erik] KTH Royal Inst Technol, Sch Comp Sci & Commun, Stockholm, Sweden; [Petersson, Marcus E.; Fransen, Erik] KTH Royal Inst Technol, Stockholm Brain Inst, Stockholm, Sweden; [Obreja, Otilia; Carr, Richard W.; Schmelz, Martin] Heidelberg Univ, Univ Med Mannheim, Dept Anaesthesiol, Mannheim, Germany; [Lampert, Angelika] Univ Erlangen Nurnberg, Inst Physiol & Pathophysiol, D-91054 Erlangen, Germany	Royal Institute of Technology; Royal Institute of Technology; Ruprecht Karls University Heidelberg; University of Erlangen Nuremberg	Fransen, E (corresponding author), KTH Royal Inst Technol, Sch Comp Sci & Commun, Stockholm, Sweden.	erikf@csc.kth.se	Lampert, Angelika/F-7198-2010; Schmelz, Martin/A-9327-2013; Carr, Richard/AAE-9188-2020; Carr, Richard/GSD-4859-2022	Lampert, Angelika/0000-0001-6319-6272; Schmelz, Martin/0000-0002-9736-7241; Carr, Richard/0000-0001-8617-9133; Obreja, Otilia/0000-0002-0230-7538	Swedish Research council [VR 621-2007-4223]; Pain Excellence Consortium Baden-Wurttemberg, Germany; IASP grant; Astra-Zeneca R&D Sodertalje, Sweden	Swedish Research council(Swedish Research CouncilEuropean Commission); Pain Excellence Consortium Baden-Wurttemberg, Germany; IASP grant; Astra-Zeneca R&D Sodertalje, Sweden(AstraZeneca)	This study was funded by the Swedish Research council, VR 621-2007-4223, http://www.vr.se/; the Pain Excellence Consortium Baden-Wurttemberg, Germany; and the IASP grant to OO, http://www.iasp-pain.org/. Research funding was received from Astra-Zeneca R&D Sodertalje, Sweden, http://www.astrazeneca.se/home/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bostock H, 2003, J PHYSIOL-LONDON, V553, P649, DOI 10.1113/jphysiol.2003.046342; Choi JS, 2011, J NEUROPHYSIOL, V106, P3173, DOI 10.1152/jn.00100.2011; Diss JKJ, 2008, MOL CELL NEUROSCI, V37, P537, DOI 10.1016/j.mcn.2007.12.002; Fjell J, 1999, J NEUROPHYSIOL, V81, P803, DOI 10.1152/jn.1999.81.2.803; Gould HJ, 2000, BRAIN RES, V854, P19, DOI 10.1016/S0006-8993(99)02216-7; Handwerker HO, 2010, PAIN, V148, P355, DOI 10.1016/j.pain.2009.12.012; HODGKIN AL, 1952, COLD SPRING HARB SYM, V17, P43, DOI 10.1101/SQB.1952.017.01.007; INOUE N, 1988, J NEUROCHEM, V50, P230, DOI 10.1111/j.1471-4159.1988.tb13254.x; Jia ZF, 2008, J GEN PHYSIOL, V131, P575, DOI 10.1085/jgp.200709924; Kleggetveit IP, 2012, PAIN, V153, P2040, DOI 10.1016/j.pain.2012.05.017; MEYER RA, 1988, BRAIN RES, V441, P81, DOI 10.1016/0006-8993(88)91385-6; Obreja O, 2011, PAIN, V152, P2138, DOI 10.1016/j.pain.2011.05.021; Obreja O, 2011, PAIN, V152, P1856, DOI 10.1016/j.pain.2011.04.002; Obreja O, 2010, PAIN, V148, P59, DOI 10.1016/j.pain.2009.10.006; Orstavik K, 2003, BRAIN, V126, P567, DOI 10.1093/brain/awg060; Orstavik K, 2006, J NEUROSCI, V26, P11287, DOI 10.1523/JNEUROSCI.2659-06.2006; Sarkar AX, 2012, J PHYSIOL-LONDON, V590, P2555, DOI 10.1113/jphysiol.2011.223313; Schmelz M, 2000, BRAIN, V123, P560, DOI 10.1093/brain/123.3.560; SCHMELZ M, 1995, EXP BRAIN RES, V104, P331; Schmelz M, 2000, NEUROREPORT, V11, P645, DOI 10.1097/00001756-200002280-00041; SCHMIDT R, 1995, J NEUROSCI, V15, P333; Schmidt R, 2002, J NEUROPHYSIOL, V88, P1859, DOI 10.1152/jn.2002.88.4.1859; Schmidt R, 2000, NEUROSCIENCE, V98, P793, DOI 10.1016/S0306-4522(00)00189-5; Serra J, 1999, J PHYSIOL-LONDON, V515, P799, DOI 10.1111/j.1469-7793.1999.799ab.x; Serra J, 2011, PAIN; Tigerholm J, 2013, J NEUROPHYSIOL; TOREBJORK HE, 1974, BRAIN RES, V67, P387, DOI 10.1016/0006-8993(74)90489-2; Waxman SG, 2011, NATURE, V472, P173, DOI 10.1038/472173a; Weidner C, 1999, J NEUROSCI, V19, P10184; Weidner C, 2000, J PHYSIOL-LONDON, V527, P185, DOI 10.1111/j.1469-7793.2000.00185.x; Weidner C, 2003, J PHYSIOL-LONDON, V547, P931, DOI 10.1113/jphysiol.2002.028712; Weidner C, 2002, J NEUROSCI, V22, P6704; Zhang YH, 2004, NEUROSCI LETT, V366, P187, DOI 10.1016/j.neulet.2004.05.042; Zhu ZR, 2009, NEUROSIGNALS, V17, P181, DOI 10.1159/000209279	34	16	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e103556	10.1371/journal.pone.0103556	http://dx.doi.org/10.1371/journal.pone.0103556			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136824	gold, Green Published, Green Submitted			2022-12-25	WOS:000340742100010
J	de Oliveira, AR; Colombo, AC; Muthuraju, S; Almada, RC; Brandao, ML				de Oliveira, Amanda Ribeiro; Colombo, Ana Caroline; Muthuraju, Sangu; Almada, Rafael Carvalho; Brandao, Marcus Lira			Dopamine D-2-Like Receptors Modulate Unconditioned Fear: Role of the Inferior Colliculus	PLOS ONE			English	Article							ELEVATED PLUS-MAZE; GABAERGIC NIGROCOLLICULAR PATHWAYS; NUCLEUS-ACCUMBENS DOPAMINE; VENTRAL TEGMENTAL AREA; EVOKED-POTENTIALS; CONDITIONED FEAR; MIDBRAIN TECTUM; EXTRACELLULAR DOPAMINE; ELECTRICAL-STIMULATION; DEFENSIVE BEHAVIOR	Background: A reduction of dopamine release or D-2 receptor blockade in the terminal fields of the mesolimbic system clearly reduces conditioned fear. Injections of haloperidol, a preferential D-2 receptor antagonist, into the inferior colliculus (IC) enhance the processing of unconditioned aversive information. However, a clear characterization of the interplay of D-2 receptors in the mediation of unconditioned and conditioned fear is still lacking. Methods: The present study investigated the effects of intra-IC injections of the D-2 receptor-selective antagonist sulpiride on behavior in the elevated plus maze (EPM), auditory-evoked potentials (AEPs) to loud sounds recorded from the IC, fear-potentiated startle (FPS), and conditioned freezing. Results: Intra-IC injections of sulpiride caused clear proaversive effects in the EPM and enhanced AEPs induced by loud auditory stimuli. Intra-IC sulpiride administration did not affect FPS or conditioned freezing. Conclusions: Dopamine D-2-like receptors of the inferior colliculus play a role in the modulation of unconditioned aversive information but not in the fear-potentiated startle response.	[de Oliveira, Amanda Ribeiro; Colombo, Ana Caroline; Muthuraju, Sangu; Almada, Rafael Carvalho; Brandao, Marcus Lira] Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Lab Neuropsicofarmacol, Ribeirao Preto, SP, Brazil; [de Oliveira, Amanda Ribeiro; Colombo, Ana Caroline; Muthuraju, Sangu; Almada, Rafael Carvalho; Brandao, Marcus Lira] INeC, Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo	Brandao, ML (corresponding author), Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Lab Neuropsicofarmacol, Ribeirao Preto, SP, Brazil.	mbrandao@usp.br	SANGU, MUTHURAJU/C-3200-2011; SANGU, MUTHURAJU/AAY-8060-2020; MUTHURAJU, SANGU/B-2742-2018; Colombo, Ana Caroline/J-5412-2015; Almada, Rafael C/G-9555-2012; Brandao, Marcus L/C-5657-2012	SANGU, MUTHURAJU/0000-0002-7949-2110; MUTHURAJU, SANGU/0000-0002-7949-2110; Colombo, Ana Caroline/0000-0002-6547-0340; Almada, Rafael C/0000-0003-3215-7435; Brandao, Marcus L/0000-0001-7437-2382; Ribeiro de Oliveira, Amanda/0000-0002-8457-7338	FAPESP [11/00041-3]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by FAPESP (Proc. no. 11/00041-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANISMAN H, 1991, ANIMAL MODELS PSYCHI, V2, P1; Anseloni VZ, 1997, BEHAV PHARMACOL, V8, P533, DOI 10.1097/00008877-199711000-00011; Anstrom KK, 2009, NEUROSCIENCE, V161, P3, DOI 10.1016/j.neuroscience.2009.03.023; Aparicio MA, 2010, NEUROSCIENCE, V166, P653, DOI 10.1016/j.neuroscience.2009.12.074; Baas JMP, 2006, BIOL PSYCHIAT, V59, P588, DOI 10.1016/j.biopsych.2005.09.009; BIGGIO G, 1990, PHARMACOL THERAPEUT, V48, P121, DOI 10.1016/0163-7258(90)90077-F; Borelli KG, 2008, HORM BEHAV, V53, P40, DOI 10.1016/j.yhbeh.2007.08.013; Brandao ML, 2005, NEUROSCI BIOBEHAV R, V29, P1299, DOI 10.1016/j.neubiorev.2005.04.013; Brandao ML, 1999, NEUROSCI BIOBEHAV R, V23, P863, DOI 10.1016/S0149-7634(99)00038-X; BRANDAO ML, 1982, PHARMACOL BIOCHEM BE, V16, P397, DOI 10.1016/0091-3057(82)90441-5; BRANDAO ML, 1993, BEHAV BRAIN RES, V58, P49, DOI 10.1016/0166-4328(93)90089-9; BRANDAO ML, 1988, PHYSIOL BEHAV, V44, P361, DOI 10.1016/0031-9384(88)90038-8; BRANDAO ML, 1994, NEUROSCI BIOBEHAV R, V18, P339, DOI 10.1016/0149-7634(94)90047-7; Brandao ML, 2001, PHYSIOL BEHAV, V72, P365, DOI 10.1016/S0031-9384(00)00418-2; Cabral A, 2009, NEUROSCIENCE, V161, P707, DOI 10.1016/j.neuroscience.2009.03.073; CARDOSO SH, 1992, BEHAV PHARMACOL, V3, P489; CARDOSO SH, 1994, BEHAV BRAIN RES, V63, P17, DOI 10.1016/0166-4328(94)90046-9; Casseday JH, 1996, BRAIN BEHAV EVOLUT, V47, P311, DOI 10.1159/000113249; Castellan-Baldan L, 2006, J CHEM NEUROANAT, V32, P1, DOI 10.1016/j.jchemneu.2006.05.002; Castilho VM, 2001, PSYCHOPHARMACOLOGY, V155, P154, DOI 10.1007/s002130100697; COIMBRA NC, 1993, BEHAV BRAIN RES, V59, P131, DOI 10.1016/0166-4328(93)90159-N; Colombo AC, 2013, BEHAV BRAIN RES, V257, P201, DOI 10.1016/j.bbr.2013.10.002; COVEY E, 1987, J COMP NEUROL, V263, P179, DOI 10.1002/cne.902630203; Cuadra G, 2000, BRAIN RES BULL, V52, P413, DOI 10.1016/S0361-9230(00)00278-1; Datla KP, 2002, EUR J NEUROSCI, V16, P1987, DOI 10.1046/j.1460-9568.2002.02249.x; David AS, 1996, NEUROREPORT, V7, P932, DOI 10.1097/00001756-199603220-00021; de Oliveira AR, 2013, EUR NEUROPSYCHOPHARM, V23, P379, DOI 10.1016/j.euroneuro.2012.05.007; de Oliveira AR, 2006, PHARMACOL BIOCHEM BE, V84, P102, DOI 10.1016/j.pbb.2006.04.012; de Oliveira AR, 2011, NEUROBIOL LEARN MEM, V95, P37, DOI 10.1016/j.nlm.2010.10.005; de Oliveira AR, 2009, BEHAV BRAIN RES, V199, P271, DOI 10.1016/j.bbr.2008.12.004; Caetano KAD, 2013, BEHAV PHARMACOL, V24, P264, DOI 10.1097/FBP.0b013e32836356c4; Del Cano GG, 2006, J COMP NEUROL, V499, P716, DOI 10.1002/cne.21107; Espejo EF, 1999, NEUROSCIENCE, V88, P609, DOI 10.1016/S0306-4522(98)00258-9; FADDA F, 1978, LIFE SCI, V23, P2219, DOI 10.1016/0024-3205(78)90207-2; FAINGOLD CL, 1989, HEARING RES, V40, P127, DOI 10.1016/0378-5955(89)90106-8; FEENSTRA MGP, 1995, NEUROSCI LETT, V189, P81, DOI 10.1016/0304-3940(95)11456-7; Ferreira-Netto C, 2007, EXP NEUROL, V204, P693, DOI 10.1016/j.expneurol.2006.12.023; Garcia AMB, 2005, PHYSIOL BEHAV, V85, P440, DOI 10.1016/j.physbeh.2005.04.027; Gomez-Nieto R, 2014, BRAIN STRUC IN PRESS; HALL RD, 1967, J NEUROPHYSIOL, V30, P893, DOI 10.1152/jn.1967.30.4.893; Hurd YL, 2001, J CHEM NEUROANAT, V22, P127, DOI 10.1016/S0891-0618(01)00122-3; LEDOUX JE, 1984, J NEUROSCI, V4, P683; Li Y, 1998, HEARING RES, V121, P1, DOI 10.1016/S0378-5955(98)00066-5; LONG KJ, 1984, ARCH NEUROL-CHICAGO, V41, P1109, DOI 10.1001/archneur.1984.04050210111028; Lopez DE, 1999, J COMP NEUROL, V415, P160; Maisonnette SS, 1996, BRAIN RES BULL, V40, P93, DOI 10.1016/0361-9230(95)02136-1; Marinelli S, 2005, NEUROPSYCHOPHARMACOL, V30, P864, DOI 10.1038/sj.npp.1300615; Martinez RCR, 2008, NEUROSCI LETT, V446, P112, DOI 10.1016/j.neulet.2008.09.057; MASINO T, 1993, J NEUROSCI, V13, P351; MCCULLOUGH LD, 1992, PSYCHOPHARMACOLOGY, V109, P379, DOI 10.1007/BF02245888; McNaughton N, 2004, NEUROSCI BIOBEHAV R, V28, P285, DOI 10.1016/j.neubiorev.2004.03.005; Melo LL, 2010, BRAIN RES, V1349, P41, DOI 10.1016/j.brainres.2010.06.020; MORIIZUMI T, 1991, EXP BRAIN RES, V87, P223; Morrow BA, 1999, NEUROSCIENCE, V92, P553, DOI 10.1016/S0306-4522(99)00014-7; Muthuraju S, 2014, NEUROSCIENCE, V261, P195, DOI 10.1016/j.neuroscience.2013.11.063; MYERS RD, 1966, PHYSIOL BEHAV, V1, P171, DOI 10.1016/0031-9384(66)90064-3; Nobre MJ, 2004, BRAIN RES, V999, P124, DOI 10.1016/j.brainres.2003.12.001; Nobre MJ, 2003, HEARING RES, V184, P82, DOI [10.1016/S0378-5955(03)00231-4, 10.1016/S0378-5955(03)00231 -4]; OLAZABAL UE, 1989, J COMP NEUROL, V282, P98, DOI 10.1002/cne.902820108; Pandossio JE, 1999, PSYCHOPHARMACOLOGY, V142, P360, DOI 10.1007/s002130050900; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Reis FLV, 2004, PHARMACOL BIOCHEM BE, V79, P359, DOI 10.1016/j.pbb.2004.08.006; RODGERS RJ, 1994, PHARMACOL BIOCHEM BE, V49, P985, DOI 10.1016/0091-3057(94)90253-4; Salamone JD, 1996, J NEUROSCI METH, V64, P137, DOI 10.1016/0165-0270(95)00125-5; SALAMONE JD, 1994, BEHAV BRAIN RES, V61, P117, DOI 10.1016/0166-4328(94)90153-8; Sandner G, 2002, BEHAV BRAIN RES, V128, P161, DOI 10.1016/S0166-4328(01)00273-X; SCHMITT P, 1986, BEHAV BRAIN RES, V22, P181, DOI 10.1016/0166-4328(86)90039-2; SZCZEPANIAK WS, 1995, NEUROSCI LETT, V196, P77, DOI 10.1016/0304-3940(95)11851-M; Tidey JW, 1996, BRAIN RES, V721, P140, DOI 10.1016/0006-8993(96)00159-X; Young AMJ, 2004, J NEUROSCI METH, V138, P57, DOI 10.1016/j.jneumeth.2004.03.003	71	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e104228	10.1371/journal.pone.0104228	http://dx.doi.org/10.1371/journal.pone.0104228			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133693	Green Submitted, Green Published, gold			2022-12-25	WOS:000341302700026
J	Mahdavi, S; Kuyucak, S				Mahdavi, Somayeh; Kuyucak, Serdar			Molecular Dynamics Study of Binding of mu-Conotoxin GIIIA to the Voltage-Gated Sodium Channel Na(v)1.4	PLOS ONE			English	Article							FREE-ENERGY SIMULATIONS; KV1 POTASSIUM CHANNELS; SELECTIVITY FILTER; CRYSTAL-STRUCTURE; OUTER VESTIBULE; ION-CHANNEL; CYSTEINE MUTAGENESIS; NA+; PORE; SITE	Homology models of mammalian voltage-gated sodium (Na-v) channels based on the crystal structures of the bacterial counterparts are needed to interpret the functional data on sodium channels and understand how they operate. Such models would also be invaluable in structure-based design of therapeutics for diseases involving sodium channels such as chronic pain and heart diseases. Here we construct a homology model for the pore domain of the Na(v)1.4 channel and use the functional data for the binding of mu-conotoxin GIIIA to Na(v)1.4 to validate the model. The initial poses for the Na(v)1.4-GIIIA complex are obtained using the HADDOCK protein docking program, which are then refined in molecular dynamics simulations. The binding mode for the final complex is shown to be in broad agreement with the available mutagenesis data. The standard binding free energy, determined from the potential of mean force calculations, is also in good agreement with the experimental value. Because the pore domains of Na(v)1 channels are highly homologous, the model constructed for Na(v)1.4 will provide an excellent template for other Na(v)1 channels.	[Mahdavi, Somayeh; Kuyucak, Serdar] Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia	University of Sydney	Kuyucak, S (corresponding author), Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia.	serdar@physics.usyd.edu.au	Kuyucak, Serdar/AAH-8417-2021	Kuyucak, Serdar/0000-0003-4315-9532				Amaral C, 2012, P NATL ACAD SCI USA, V109, P21336, DOI 10.1073/pnas.1218087109; Ashcroft F. M., 2000, ION CHANNELS DIS CHA; BACKX PH, 1992, SCIENCE, V257, P248, DOI 10.1126/science.1321496; Bastug T, 2006, BIOPHYS J, V90, P3941, DOI 10.1529/biophysj.105.074633; Bastug T, 2009, BIOPHYS J, V96, P4006, DOI 10.1016/j.bpj.2009.02.041; Becker S, 1992, ACTION DERIVATIVE; Carnevale V, 2011, J PHYS CHEM LETT, V2, P2504, DOI 10.1021/jz2011379; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Chahine M, 1998, BIOPHYS J, V75, P236, DOI 10.1016/S0006-3495(98)77510-1; Chakrabarti N, 2013, P NATL ACAD SCI USA, V110, P11331, DOI 10.1073/pnas.1309452110; Chang NS, 1998, BIOCHEMISTRY-US, V37, P4407, DOI 10.1021/bi9724927; Chen PC, 2012, TOXINS, V4, P110, DOI 10.3390/toxins4020110; Chen PC, 2011, BIOPHYS J, V100, P2466, DOI 10.1016/j.bpj.2011.03.052; Chen PC, 2009, BIOPHYS J, V96, P2577, DOI 10.1016/j.bpj.2008.12.3952; Chen R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093267; Chen R, 2012, BIOPHYS J, V102, P483, DOI 10.1016/j.bpj.2011.12.041; Choudhary G, 2007, CHANNELS, V1, P344, DOI 10.4161/chan.5112; Corry B, 2012, J AM CHEM SOC, V134, P1840, DOI 10.1021/ja210020h; CRUZ LJ, 1985, J BIOL CHEM, V260, P9280; Cummins TR, 2002, MOL PHARMACOL, V61, P1192, DOI 10.1124/mol.61.5.1192; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Dudley SC, 2000, J GEN PHYSIOL, V116, P679, DOI 10.1085/jgp.116.5.679; Dudley SC, 1995, BIOPHYS J, V69, P1657, DOI 10.1016/S0006-3495(95)80045-7; Dutertre S, 2010, J BIOL CHEM, V285, P13315, DOI 10.1074/jbc.R109.076596; Fozzard HA, 2010, MAR DRUGS, V8, P219, DOI 10.3390/md8020219; French RJ, 2004, CURR MED CHEM, V11, P3053, DOI 10.2174/0929867043363866; Furini S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002476; Hille B., 2001, IONIC CHANNELS EXCIT, P814; Hui KY, 2002, J GEN PHYSIOL, V119, P45, DOI 10.1085/jgp.119.1.45; Ke S, 2013, BIOCHEM BIOPH RES CO, V430, P1272, DOI 10.1016/j.bbrc.2012.12.055; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; LANCELIN JM, 1991, BIOCHEMISTRY-US, V30, P6908, DOI 10.1021/bi00242a014; Li RA, 2004, TOXICON, V44, P117, DOI 10.1016/j.toxicon.2004.03.028; Li RA, 2002, FEBS LETT, V511, P159, DOI 10.1016/S0014-5793(01)03316-6; Li RA, 1997, BIOPHYS J, V73, P1874, DOI 10.1016/S0006-3495(97)78218-3; Li RA, 2001, J BIOL CHEM, V276, P11072, DOI 10.1074/jbc.M010862200; Mahdavi S, 2013, BIOCHEMISTRY-US, V52, P1631, DOI 10.1021/bi301257p; McCusker EC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2077; Norton RS, 2010, MOLECULES, V15, P2825, DOI 10.3390/molecules15042825; OHIZUMI Y, 1986, J PHARMACOL EXP THER, V239, P243; OTT KH, 1991, FEBS LETT, V278, P160, DOI 10.1016/0014-5793(91)80107-E; Payandeh J, 2012, NATURE, V486, P135, DOI 10.1038/nature11077; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Pennington MW, 2012, FEBS LETT, V586, P3996, DOI 10.1016/j.febslet.2012.09.038; PerezGarcia MT, 1996, P NATL ACAD SCI USA, V93, P300, DOI 10.1073/pnas.93.1.300; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Qiu H, 2012, BBA-BIOMEMBRANES, V1818, P2529, DOI 10.1016/j.bbamem.2012.06.003; Raju SG, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003090; Rashid MH, 2014, SCI REP-UK, V4, DOI 10.1038/srep04509; Rashid MH, 2014, J PHYS CHEM B, V118, P707, DOI 10.1021/jp410950h; Rashid MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078712; Rashid MH, 2012, J PHYS CHEM B, V116, P4812, DOI 10.1021/jp300639x; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sato C, 2001, NATURE, V409, P1047, DOI 10.1038/35059098; SATO K, 1991, J BIOL CHEM, V266, P16989; Shaya D, 2014, J MOL BIOL, V426, P467, DOI 10.1016/j.jmb.2013.10.010; Stock L, 2013, J PHYS CHEM B, V117, P3782, DOI 10.1021/jp401403b; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; Terlau H, 2004, PHYSIOL REV, V84, P41, DOI 10.1152/physrev.00020.2003; TERLAU H, 1991, FEBS LETT, V293, P93, DOI 10.1016/0014-5793(91)81159-6; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tikhonov DB, 2012, MOL PHARMACOL, V82, P97, DOI 10.1124/mol.112.078212; Twede VD, 2009, IDRUGS, V12, P231; Ulmschneider MB, 2013, P NATL ACAD SCI USA, V110, P6364, DOI 10.1073/pnas.1214667110; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; WAKAMATSU K, 1992, BIOCHEMISTRY-US, V31, P12577, DOI 10.1021/bi00165a006; Wilson MJ, 2011, P NATL ACAD SCI USA, V108, P10302, DOI 10.1073/pnas.1107027108; Xia MD, 2013, BIOPHYS J, V104, P2401, DOI 10.1016/j.bpj.2013.04.035; Xue T, 2003, BIOPHYS J, V85, P2299, DOI 10.1016/S0006-3495(03)74654-2; Yarov-Yarovoy V, 2012, P NATL ACAD SCI USA, V109, pE93, DOI 10.1073/pnas.1118434109; Zhang X, 2013, CELL RES, V23, P409, DOI 10.1038/cr.2012.173; Zhang X, 2012, NATURE, V486, P130, DOI 10.1038/nature11054	74	19	19	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105300	10.1371/journal.pone.0105300	http://dx.doi.org/10.1371/journal.pone.0105300			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133704	gold, Green Published, Green Submitted			2022-12-25	WOS:000341302700099
J	Moussa, M; Goldberg, SN; Kumar, G; Sawant, RR; Levchenko, T; Torchilin, VP; Ahmed, M				Moussa, Marwan; Goldberg, S. Nahum; Kumar, Gaurav; Sawant, Rupa R.; Levchenko, Tatyana; Torchilin, Vladimir P.; Ahmed, Muneeb			Nanodrug-Enhanced Radiofrequency Tumor Ablation: Effect of Micellar or Liposomal Carrier on Drug Delivery and Treatment Efficacy	PLOS ONE			English	Article							COLORECTAL LIVER METASTASES; THERMAL ABLATION; DOXORUBICIN ACCUMULATION; MODEL; ADJUVANT; CANCER; COAGULATION; DESTRUCTION; COMBINATION; CARCINOMA	Purpose: To determine the effect of different drug-loaded nanocarriers (micelles and liposomes) on delivery and treatment efficacy for radiofrequency ablation (RFA) combined with nanodrugs. Materials/Methods: Fischer 344 rats were used (n = 196). First, single subcutaneous R3230 tumors or normal liver underwent RFA followed by immediate administration of IV fluorescent beads (20, 100, and 500 nm), with fluorescent intensity measured at 4-24 hr. Next, to study carrier type on drug efficiency, RFA was combined with micellar (20 nm) or liposomal (100 nm) preparations of doxorubicin (Dox; targeting HIF-1 alpha) or quercetin (Qu; targeting HSP70). Animals received RFA alone, RFA with Lipo-Dox or Mic-Dox (1 mg IV, 15 min post-RFA), and RFA with Lipo-Qu or Mic-Qu given 24 hr pre- or 15 min post-RFA (0.3 mg IV). Tumor coagulation and HIF-1 alpha orHSP70 expression were assessed 24 hr post-RFA. Third, the effect of RFA combined with IV Lipo-Dox, Mic-Dox, Lipo-Qu, or Mic-Qu (15 min post-RFA) compared to RFA alone on tumor growth and animal endpoint survival was evaluated. Finally, drug uptake was compared between RFA/Lipo-Dox and RFA/Mic-Dox at 4-72 hr. Results: Smaller 20 nm beads had greater deposition and deeper tissue penetration in both tumor (100 nm/500 nm) and liver (100 nm) (p < 0.05). Mic-Dox and Mic-Qu suppressed periablational HIF-1 alpha or HSP70 rim thickness more than liposomal preparations (p < 0.05). RFA/Mic-Dox had greater early (4 hr) intratumoral doxorubicin, but RFA/Lipo-Dox had progressively higher intratumoral doxorubicin at 24-72 hr post-RFA (p < 0.04). No difference in tumor growth and survival was seen between RFA/Lipo-Qu and RFA/Mic-Qu. Yet, RFA/Lipo-Dox led to greater animal endpoint survival compared to RFA/Mic-Dox (p < 0.03). Conclusion: With RF ablation, smaller particle micelles have superior penetration and more effective local molecular modulation. However, larger long-circulating liposomal carriers can result in greater intratumoral drug accumulation over time and reduced tumor growth. Accordingly, different carriers provide specific advantages, which should be considered when formulating optimal combination therapies.	[Moussa, Marwan; Goldberg, S. Nahum; Kumar, Gaurav; Ahmed, Muneeb] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Radiol,Lab Minimally Invas Tumor Therapies, Boston, MA 02115 USA; [Goldberg, S. Nahum] Hadassah Hebrew Univ, Med Ctr, Dept Radiol, Div Image Guided Therapy & Intervent Oncol, Jerusalem, Israel; [Sawant, Rupa R.; Levchenko, Tatyana; Torchilin, Vladimir P.] Northeastern Univ, Dept Pharmaceut Sci, Boston, MA 02115 USA; [Sawant, Rupa R.; Levchenko, Tatyana; Torchilin, Vladimir P.] Northeastern Univ, Ctr Pharmaceut Biotechnol & Nanomed, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Hebrew University of Jerusalem; Hadassah University Medical Center; Northeastern University; Northeastern University	Ahmed, M (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Radiol,Lab Minimally Invas Tumor Therapies, Boston, MA 02115 USA.	mahmed@bidmc.harvard.edu	Ahmed, Muneeb/X-8479-2018; Goldberg, S. Nahum/AAV-4526-2020		National Cancer Institute, National Institutes of Health, Bethesda, MD [R01CA133114, R01 CA100045, CCNE 1U54CA151881-01]; Harvard Medical Faculty Physicians Faculty Radiology Foundation; Israel Science Foundation; NATIONAL CANCER INSTITUTE [U54CA151881, R01CA133114, R01CA100045] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health, Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Harvard Medical Faculty Physicians Faculty Radiology Foundation; Israel Science Foundation(Israel Science Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Cancer Institute, National Institutes of Health, Bethesda, MD (R01CA133114, R01 CA100045, and CCNE 1U54CA151881-01), Harvard Medical Faculty Physicians Faculty Radiology Foundation, and the Israel Science Foundation. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Ahmed M, 2005, J VASC INTERV RADIOL, V16, P1365, DOI 10.1097/01.RVI.0000175324.63304.25; Ahmed M, 2004, INT J HYPERTHER, V20, P781, DOI 10.1080/02656730410001711655; Ahmed M, 2003, CANCER RES, V63, P6327; Ahmed M, 2012, CHEM PHYS LIPIDS; Ahmed M, 2011, RADIOLOGY, V258, P351, DOI 10.1148/radiol.10081634; Andriyanov AV, 2014, PLOS ONE IN PRESS; D'Ippolito G, 2003, RADIOLOGY, V228, P112, DOI 10.1148/radiol.2281020358; de Smet M, 2013, INVEST RADIOL, V48, P395, DOI 10.1097/RLI.0b013e3182806940; Gasselhuber A, 2012, INT J HYPERTHER, V28, P337, DOI 10.3109/02656736.2012.677930; Goldberg SN, 2002, AM J ROENTGENOL, V179, P93, DOI 10.2214/ajr.179.1.1790093; Goldberg SN, 2002, RADIOLOGY, V222, P797, DOI 10.1148/radiol.2223010861; Hamano N, 2014, BIOL PHARM BULL, V37, P174, DOI 10.1248/bpb.b13-00605; Kong J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037266; Lencioni R, 2005, RADIOLOGY, V234, P961, DOI 10.1148/radiol.2343040350; Lukyanov AN, 2002, PHARMACEUT RES, V19, P1424, DOI 10.1023/A:1020488012264; Monsky WL, 2002, RADIOLOGY, V224, P823, DOI 10.1148/radiol.2243011421; Nijkamp MW, 2009, ANN SURG, V249, P814, DOI 10.1097/SLA.0b013e3181a38ef5; Nikfarjam M, 2006, SURGERY, V139, P73, DOI 10.1016/j.surg.2005.07.030; Perche F, 2012, CANCER BIOL THER, V13, P1205, DOI 10.4161/cbt.21353; Poff JA, 2008, RADIOLOGY, V248, P485, DOI 10.1148/radiol.2482071674; Poon RTP, 2011, FUTURE ONCOL, V7, P937, DOI [10.2217/fon.11.73, 10.2217/FON.11.73]; Poon RTP, 2009, EXPERT OPIN PHARMACO, V10, P333, DOI [10.1517/14656560802677874 , 10.1517/14656560802677874]; Potter AJ, 2002, CARCINOGENESIS, V23, P389, DOI 10.1093/carcin/23.3.389; Rapoport N, 2012, INT J HYPERTHER, V28, P374, DOI 10.3109/02656736.2012.665567; Sawant RR, 2011, METHODS MOL BIOL, V751, P357, DOI 10.1007/978-1-61779-151-2_23; Sofocleous CT, 2008, RADIOLOGY, V249, P364, DOI 10.1148/radiol.2491071752; Sofocleous CT, 2013, ANN SURG ONCOL; Solazzo SA, 2010, RADIOLOGY, V255, P62, DOI 10.1148/radiol.09091196; Soundararajan A, 2011, RADIOLOGY, V261, P813, DOI 10.1148/radiol.11110361; Theriault JR, 2006, J IMMUNOL, V177, P8604, DOI 10.4049/jimmunol.177.12.8604; Tsukioka Y, 2002, JPN J CANCER RES, V93, P1145, DOI 10.1111/j.1349-7006.2002.tb01217.x; Weissig V, 1998, PHARMACEUT RES, V15, P1552, DOI 10.1023/A:1011951016118; Wood BJ, 2012, J VASC INTERV RADIOL, V23, P248, DOI 10.1016/j.jvir.2011.10.018; Yamazaki Y, 2006, BIOL PHARM BULL, V29, P1999, DOI 10.1248/bpb.29.1999; Yang W, 2012, J CONTROL RELEASE; Yang W, 2011, INT J HYPERTHER, V27, P527, DOI 10.3109/02656736.2011.582474; Yang W, 2010, RADIOLOGY, V257, P685, DOI 10.1148/radiol.10100500	37	21	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e102727	10.1371/journal.pone.0102727	http://dx.doi.org/10.1371/journal.pone.0102727			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133740	Green Published, Green Submitted, gold			2022-12-25	WOS:000341302700003
J	Kataoka, H; Kono, H; Patel, Z; Rock, KL				Kataoka, Hiroshi; Kono, Hajime; Patel, Zubin; Rock, Kenneth L.			Evaluation of the Contribution of Multiple DAMPs and DAMP Receptors in Cell Death-Induced Sterile Inflammatory Responses	PLOS ONE			English	Article							PROTEASE-ACTIVATED RECEPTORS; ISCHEMIA-REPERFUSION INJURY; INDUCED LIVER-INJURY; DYING CELLS; PARACELLULAR PERMEABILITY; COMPLEMENT ACTIVATION; RAT-LIVER; MICE; DANGER; INNATE	When cells die by necrosis in vivo they stimulate an inflammatory response. It is thought that this response is triggered when the injured cells expose proinflammatory molecules, collectively referred to as damage associated molecular patterns (DAMPs), which are recognized by cells or soluble molecules of the innate or adaptive immune system. Several putative DAMPs and/or their receptors have been identified, but whether and how much they participate in responses in vivo is incompletely understood, and they have not previously been compared side-by-side in the same models. This study focuses on evaluating the contribution of multiple mechanisms that have been proposed to or potentially could participate in cell death-induced inflammation: The third component of complement (C3), ATP (and its receptor P2X7), antibodies, the C-type lectin receptor Mincle (Clec4e), and protease-activated receptor 2 (PAR2). We investigate the role of these factors in cell death-induced inflammation to dead cells in the peritoneum and acetaminophen-induced liver damage. We find that mice deficient in antibody, C3 or PAR2 have impaired inflammatory responses to dying cells. In contrast there was no reduction in inflammation to cell death in the peritoneum or liver of mice that genetically lack Mincle, the P2X7 receptor or that were treated with apyrase to deplete ATP. These results indicate that antibody, complement and PAR2 contribute to cell death-induced inflammation but that Mincle and ATP-P2X7 receptor are not required for this response in at least 2 different in vivo models.	[Kataoka, Hiroshi; Patel, Zubin; Rock, Kenneth L.] UMass Med Sch, Dept Pathol, Worcester, MA 01655 USA; [Kono, Hajime] Teikyo Univ, Sch Med, Dept Internal Med, Tokyo 173, Japan	University of Massachusetts System; University of Massachusetts Worcester; Teikyo University	Rock, KL (corresponding author), UMass Med Sch, Dept Pathol, Worcester, MA 01655 USA.	Kenneth.rock@umassmed.edu	Kataoka, Hiroshi/AAR-1444-2020	Kataoka, Hiroshi/0000-0002-2502-8304; Kono, Hajime/0000-0002-4578-8677	NIH; Diabetes Endocrinology Research Center [DK32520]; Ministry of Health, Labor and Welfare; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Naito Foundation; Bristol-Myers Squibb; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM063483] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [26670411] Funding Source: KAKEN	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetes Endocrinology Research Center; Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Naito Foundation(Naito Memorial Foundation); Bristol-Myers Squibb(Bristol-Myers Squibb); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the NIH to KLR and core resources supported by the Diabetes Endocrinology Research Center grant DK32520 were also used. H. Kono is supported by a Grant for Research on Intractable Diseases from the Ministry of Health, Labor and Welfare and Grant-in-Aid (C) and Grant-in-Aid for Scientific Research on Innovative Areas for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. H. Kono is also supported by grants from The Naito Foundation and Bristol-Myers Squibb. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Cenac N, 2004, J PHYSIOL-LONDON, V558, P913, DOI 10.1113/jphysiol.2004.061721; Cenac N, 2003, J IMMUNOL, V170, P4296, DOI 10.4049/jimmunol.170.8.4296; Cenac N, 2002, AM J PATHOL, V161, P1903, DOI 10.1016/S0002-9440(10)64466-5; Chen CJ, 2007, NAT MED, V13, P851, DOI 10.1038/nm1603; Diepenhorst GMP, 2009, ANN SURG, V249, P889, DOI 10.1097/SLA.0b013e3181a38f45; Eigenbrod T, 2008, J IMMUNOL, V181, P8194, DOI 10.4049/jimmunol.181.12.8194; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; FEARON DT, 1983, ANNU REV IMMUNOL, V1, P243, DOI 10.1146/annurev.iy.01.040183.001331; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; Haas T, 2008, IMMUNITY, V28, P315, DOI 10.1016/j.immuni.2008.01.013; HILL JH, 1971, J EXP MED, V133, P885, DOI 10.1084/jem.133.4.885; Hinson Jack A, 2010, Handb Exp Pharmacol, P369, DOI 10.1007/978-3-642-00663-0_12; Holt MP, 2008, J LEUKOCYTE BIOL, V84, P1410, DOI 10.1189/jlb.0308173; Huber-Lang M, 2006, NAT MED, V12, P682, DOI 10.1038/nm1419; Imaeda AB, 2009, J CLIN INVEST, V119, P305, DOI 10.1172/JCI35958; KAMIIKE W, 1982, J BIOCHEM-TOKYO, V91, P1349, DOI 10.1093/oxfordjournals.jbchem.a133822; Kanevets U, 2009, J IMMUNOL, V182, P1912, DOI 10.4049/jimmunol.0803777; Kim SJ, 2002, J EXP MED, V196, P655, DOI 10.1084/jem.20020542; Kohl J, 2006, IMMUNOL RES, V34, P157, DOI 10.1385/IR:34:2:157; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Kono H, 2010, J CLIN INVEST, V120, P1939, DOI 10.1172/JCI40124; Kono H, 2010, J IMMUNOL, V184, P4470, DOI 10.4049/jimmunol.0902485; Li L, 2008, KIDNEY INT, V74, P1526, DOI 10.1038/ki.2008.500; MAJNO G, 1995, AM J PATHOL, V146, P3; MAJNO G, 1960, VIRCHOWS ARCH A, V333, P421, DOI 10.1007/BF00955327; Majno G., 2004, CELLS TISSUES DIS PR; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Masubuchi Y, 2005, J HEPATOL, V42, P110, DOI 10.1016/j.jhep.2004.09.015; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.immunol.12.1.991; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; PAGE AR, 1958, AM J PATHOL, V34, P645; PINCKARD RN, 1980, J CLIN INVEST, V66, P1050, DOI 10.1172/JCI109933; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Rock KL, 2008, ANNU REV PATHOL-MECH, V3, P99, DOI 10.1146/annurev.pathmechdis.3.121806.151456; Rock KL, 2011, IMMUNOL REV, V243, P191, DOI 10.1111/j.1600-065X.2011.01040.x; Rock KL, 2010, ANNU REV IMMUNOL, V28, P321, DOI 10.1146/annurev-immunol-030409-101311; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Schmidlin F, 2002, J IMMUNOL, V169, P5315, DOI 10.4049/jimmunol.169.9.5315; Shpacovitch V, 2008, J LEUKOCYTE BIOL, V83, P1309, DOI 10.1189/jlb.0108001; Shpacovitch V, 2007, TRENDS IMMUNOL, V28, P541, DOI 10.1016/j.it.2007.09.001; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Vendemiale G, 1996, BIOCHEM PHARMACOL, V52, P1147, DOI 10.1016/0006-2952(96)00414-5; Weiser MR, 1996, J EXP MED, V183, P2343, DOI 10.1084/jem.183.5.2343; Wells CA, 2008, J IMMUNOL, V180, P7404, DOI 10.4049/jimmunol.180.11.7404; WESSELS MR, 1995, P NATL ACAD SCI USA, V92, P11490, DOI 10.1073/pnas.92.25.11490; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651; Zhang M, 2006, J EXP MED, V203, P141, DOI 10.1084/jem.20050390	50	39	43	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104741	10.1371/journal.pone.0104741	http://dx.doi.org/10.1371/journal.pone.0104741			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127469	Green Published, gold, Green Submitted			2022-12-25	WOS:000340879300046
J	Lau, SC; Lim, HN; Basri, M; Masoumi, HRF; Tajudin, AA; Huang, NM; Pandikumar, A; Chia, CH; Andou, Y				Lau, Siaw Cheng; Lim, Hong Ngee; Basri, Mahiran; Masoumi, Hamid Reza Fard; Tajudin, Asilah Ahmad; Huang, Nay Ming; Pandikumar, Alagarsamy; Chia, Chi Hua; Andou, Yoshito			Enhanced Biocatalytic Esterification with Lipase-Immobilized Chitosan/Graphene Oxide Beads	PLOS ONE			English	Article							CANDIDA-RUGOSA LIPASE; CHITOSAN; OPTIMIZATION; SUPPORT	In this work, lipase from Candida rugosa was immobilized onto chitosan/graphene oxide beads. This was to provide an enzyme-immobilizing carrier with excellent enzyme immobilization activity for an enzyme group requiring hydrophilicity on the immobilizing carrier. In addition, this work involved a process for the preparation of an enzymatically active product insoluble in a reaction medium consisting of lauric acid and oleyl alcohol as reactants and hexane as a solvent. This product enabled the stability of the enzyme under the working conditions and allowed the enzyme to be readily isolated from the support. In particular, this meant that an enzymatic reaction could be stopped by the simple mechanical separation of the "insoluble'' enzyme from the reaction medium. Chitosan was incorporated with graphene oxide because the latter was able to enhance the physical strength of the chitosan beads by its superior mechanical integrity and low thermal conductivity. The X-ray diffraction pattern showed that the graphene oxide was successfully embedded within the structure of the chitosan. Further, the lipase incorporation on the beads was confirmed by a thermo-gravimetric analysis. The lipase immobilization on the beads involved the functionalization with coupling agents, N-hydroxysulfosuccinimide sodium (NHS) and 1-ethyl-(3-dimethylaminopropyl) carbodiimide (EDC), and it possessed a high enzyme activity of 64 U. The overall esterification conversion of the prepared product was 78% at 60 degrees C, and it attained conversions of 98% and 88% with commercially available lipozyme and novozyme, respectively, under similar experimental conditions.	[Lau, Siaw Cheng; Lim, Hong Ngee; Basri, Mahiran; Masoumi, Hamid Reza Fard] Univ Putra Malaysia, Fac Sci, Dept Chem, Serdang 43400, Selangor, Malaysia; [Lim, Hong Ngee] Univ Putra Malaysia, Inst Adv Technol, Serdang 43400, Selangor, Malaysia; [Basri, Mahiran] Univ Putra Malaysia, Inst Biosci, Lab Mol Biomed, Serdang 43400, Selangor, Malaysia; [Tajudin, Asilah Ahmad] Univ Putra Malaysia, Fac Biotechnol & Biomol Sci, Serdang 43400, Selangor, Malaysia; [Huang, Nay Ming; Pandikumar, Alagarsamy] Univ Malaya, Dept Phys, Fac Sci, Low Dimens Mat Res Ctr, Kuala Lumpur 59100, Malaysia; [Chia, Chi Hua] Univ Kebangsaan Malaysia, Fac Sci & Technol, Sch Appl Phys, Bangi 43600, Selangor, Malaysia; [Andou, Yoshito] Kyushu Inst Technol, Ecotown Collaborat Res & Dev Ctr Environm & Recyc, Fukuoka, Japan	Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Malaya; Universiti Kebangsaan Malaysia; Kyushu Institute of Technology	Lim, HN (corresponding author), Univ Putra Malaysia, Fac Sci, Dept Chem, Serdang 43400, Selangor, Malaysia.	janet_limhn@yahoo.com	Chia, Chin-hua/I-7261-2013; Huang, NM/C-2423-2009; Alagarsamy, Pandikumar/AAG-4582-2019; Lim, HN/C-4927-2011; Alagarsamy, Pandikumar/D-6811-2011	Chia, Chin-hua/0000-0002-5269-4070; Alagarsamy, Pandikumar/0000-0002-8804-5195; Lim, HN/0000-0003-2436-8953; Alagarsamy, Pandikumar/0000-0002-8804-5195	Ministry of Higher Education [FRGS/1/2012/ST05/UPM/02/3, UM.C/625/1/HIR/MOHE/SC/21]	Ministry of Higher Education(Science and Technology Development Fund (STDF)Ministry of Higher Education & Scientific Research (MHESR))	This research work was supported by the Fundamental Research Grant Scheme (FRGS/1/2012/ST05/UPM/02/3) and a High Impact Research Grant (UM.C/625/1/HIR/MOHE/SC/21) from the Ministry of Higher Education. The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	Aghabarari B, 2014, J TAIWAN INST CHEM E, V45, P1468, DOI 10.1016/j.jtice.2014.03.006; Arena B.J., 1981, US Pat, Patent No. [4274980, 4,274,980]; Basri M, 2013, J MOL CATAL B-ENZYM, V85-86, P214, DOI 10.1016/j.molcatb.2012.09.013; Belhaj-Ben Romdhane I, 2011, J MOL CATAL B-ENZYM, V68, P230, DOI 10.1016/j.molcatb.2010.11.010; Betigeri SS, 2002, BIOMATERIALS, V23, P3627, DOI 10.1016/S0142-9612(02)00095-9; Cabrera Z, 2009, J MOL CATAL B-ENZYM, V57, P171, DOI 10.1016/j.molcatb.2008.08.012; Chiou SH, 2004, BIOMATERIALS, V25, P197, DOI 10.1016/S0142-9612(03)00482-4; Foresti ML, 2007, ENZYME MICROB TECH, V40, P769, DOI 10.1016/j.enzmictec.2006.06.009; Glasser W.G., 1998, Patent No. [WO/1998/041546, 1998041546]; Gunawan E.R., 2004, J OLEO SCI, V53, P471, DOI [10.5650/jos.53.471, DOI 10.5650/JOS.53.471, DOI 10.5650/jos.53.471]; Haigh KF, 2014, CHEM ENG RES DES, V92, P713, DOI 10.1016/j.cherd.2014.01.006; Hernandez-Martin E, 2009, J AGR FOOD CHEM, V57, P701, DOI 10.1021/jf802017x; Huang NM, 2011, INT J NANOMED, V6, P3443, DOI 10.2147/IJN.S26812; Huang XJ, 2007, EUR POLYM J, V43, P3710, DOI 10.1016/j.eurpolymj.2007.06.010; Hung TC, 2003, J MOL CATAL B-ENZYM, V26, P69, DOI 10.1016/S1381-1177(03)00167-X; Juan C, 2014, NEW BIOTECHNOLOGY; Kawamura Y, 1996, United States Patent, Patent No. 5508185; Kuo CH, 2012, CARBOHYD POLYM, V87, P2538, DOI 10.1016/j.carbpol.2011.11.026; KWON DY, 1986, J AM OIL CHEM SOC, V63, P89, DOI 10.1007/BF02676129; Kyzas GZ, 2014, MATER LETT, V128, P46, DOI 10.1016/j.matlet.2014.04.129; Lee DG, 2009, J MOL CATAL B-ENZYM, V57, P62, DOI 10.1016/j.molcatb.2008.06.017; Leuba, 1978, [No title captured], Patent No. [4 094 743, 4094743]; Lim HN, 2012, J NON-CRYST SOLIDS, V358, P525, DOI 10.1016/j.jnoncrysol.2011.11.007; Lu XX, 2012, J AGR FOOD CHEM, V60, P9273, DOI 10.1021/jf303096c; Mizuki T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066528; Orrego CE, 2010, CARBOHYD POLYM, V79, P9, DOI 10.1016/j.carbpol.2009.06.015; Pires-Cabral P, 2010, BIOCHEM ENG J, V48, P246, DOI 10.1016/j.bej.2009.10.021; Raghavendra T, 2013, BIORESOURCE TECHNOL, V140, P103, DOI 10.1016/j.biortech.2013.04.071; Rao RAK, 2014, J ENVIRON CHEM ENG, V2, P199, DOI 10.1016/j.jece.2013.12.011; Stergiou PY, 2013, BIOTECHNOL ADV, V31, P1846, DOI 10.1016/j.biotechadv.2013.08.006; Wang J., 2010, Pat, Patent No. [WO 2010065121 A1, 2010065121, WO/2010/065121]; Wang JQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043478; Weber N, 2001, J AGR FOOD CHEM, V49, P5210, DOI 10.1021/jf0107407; Won K, 2005, PROCESS BIOCHEM, V40, P2149, DOI 10.1016/j.procbio.2004.08.014; Xie WL, 2012, BIOMASS BIOENERG, V36, P373, DOI 10.1016/j.biombioe.2011.11.006; Xu J, 2006, J MEMBRANE SCI, V281, P410, DOI 10.1016/j.memsci.2006.04.009; Ye P, 2006, BIOMATERIALS, V27, P4169, DOI 10.1016/j.biomaterials.2006.03.027; Yi SS, 2009, J MOL CATAL B-ENZYM, V57, P123, DOI 10.1016/j.molcatb.2008.08.002; Zang LM, 2014, IND ENG CHEM RES, V53, P3448, DOI 10.1021/ie404072s	39	23	24	2	133	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104695	10.1371/journal.pone.0104695	http://dx.doi.org/10.1371/journal.pone.0104695			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127038	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000340879300042
J	Tsai, JZ; Peng, SJ; Chen, YW; Wang, KW; Li, CH; Wang, JY; Chen, CJ; Lin, HJ; Smith, EE; Wu, HK; Sung, SF; Yeh, PS; Hsin, YL				Tsai, Jang-Zern; Peng, Syu-Jyun; Chen, Yu-Wei; Wang, Kuo-Wei; Li, Chen-Hua; Wang, Jing-Yi; Chen, Chi-Jen; Lin, Huey-Juan; Smith, Eric Edward; Wu, Hsiao-Kuang; Sung, Sheng-Feng; Yeh, Poh-Shiow; Hsin, Yue-Loong			Automated Segmentation and Quantification of White Matter Hyperintensities in Acute Ischemic Stroke Patients with Cerebral Infarction	PLOS ONE			English	Article							SMALL VESSEL DISEASE; MULTIPLE-SCLEROSIS LESIONS; MR FLAIR IMAGES; PROBABILISTIC SEGMENTATION; INTRACEREBRAL HEMORRHAGE; AMYLOID ANGIOPATHY; REGISTRATION; RELIABILITY; PROGRESSION; PREDICTORS	White matter hyperintensities (WMHs) of presumed vascular origin are common in ageing population, especially in patients with acute cerebral infarction and the volume has been reported to be associated with mental impairment and the risk of hemorrhage from antithrombotic agents. WMHs delineation can be computerized to minimize human bias. However, the presence of cerebral infarcts greatly degrades the accuracy of WMHs detection and thus limits the application of computerized delineation to patients with acute cerebral infarction. We propose a computer-assisted segmentation method to depict WMHs in the presence of cerebral infarcts in combined T1-weighted, fluid attenuation inversion recovery, and diffusion-weighted magnetic resonance imaging (MRI). The proposed method detects WMHs by empirical threshold and atlas information, with subtraction of white matter voxels affected by acute infarction. The method was derived using MRI from 25 hemispheres with WMHs only and 13 hemispheres with both WMHs and cerebral infarcts. Similarity index (SI) and correlation were utilized to assess the agreement between the new automated method and a gold standard visually guided semi-automated method done by an expert rater. The proposed WMHs segmentation approach produced average SI, sensitivity and specificity of 83.142 +/- 11.742, 84.154 +/- 16.086 and 99.988 +/- 0.029% with WMHs only and of 68.826 +/- 14.036, 74.381 +/- 18.473 and 99.956 +/- 0.054% with both WMHs and cerebral infarcts in the derivation cohort. The performance of the proposed method with an external validation cohort was also highly consistent with that of the experienced rater.	[Tsai, Jang-Zern; Peng, Syu-Jyun; Wang, Kuo-Wei] Natl Cent Univ, Dept Elect Engn, Jhongli, Taoyuan County, Taiwan; [Chen, Yu-Wei; Wu, Hsiao-Kuang] Natl Cent Univ, Dept Comp Sci & Informat Engn, Jhongli, Taoyuan County, Taiwan; [Chen, Yu-Wei; Li, Chen-Hua; Wang, Jing-Yi] Landseed Hosp, Dept Neurol, Pingzhen City, Taoyuan County, Taiwan; [Chen, Yu-Wei; Li, Chen-Hua] Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan; [Wang, Kuo-Wei] Landseed Hosp, Dept Med Imaging, Pingzhen City, Taoyuan County, Taiwan; [Chen, Chi-Jen] Taipei Med Univ, Shuang Ho Hosp, Dept Radiol, New Taipei City, Taiwan; [Lin, Huey-Juan; Yeh, Poh-Shiow] Chi Mei Med Ctr, Dept Neurol, Tainan, Taiwan; [Smith, Eric Edward] Univ Calgary, Dept Clin Neurosci Radiol & Community Hlth Sci, Calgary, AB, Canada; [Sung, Sheng-Feng] Chia Yi Christian Hosp, Ditmanson Med Fdn, Dept Internal Med, Div Neurol, Chiayi, Taiwan; [Hsin, Yue-Loong] Chung Shan Med Univ, Dept Neurol, Taichung, Taiwan; [Hsin, Yue-Loong] Chung Shan Med Univ Hosp, Taichung, Taiwan; [Hsin, Yue-Loong] Natl Chiao Tung Univ, Biomed Elect Translat Res Ctr, Hsinchu, Taiwan	National Central University; National Central University; National Taiwan University; National Taiwan University Hospital; Taipei Medical University; Chi Mei Hospital; University of Calgary; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; National Yang Ming Chiao Tung University	Chen, YW (corresponding author), Natl Cent Univ, Dept Comp Sci & Informat Engn, Jhongli, Taoyuan County, Taiwan.	yuwchen@gmail.com	Smith, Eric E/C-5443-2012; WANG, JINGYI/GSJ-1241-2022; wang, jing/GRS-7509-2022	Smith, Eric E/0000-0003-3956-1668; 	Annual National Central University [NCU/LSH-100-A-006]; Landseed Hospital Joint R & D Project, Taiwan; National Science Council, Taiwan [NSC 101-2221-E-008-015-MY3]	Annual National Central University; Landseed Hospital Joint R & D Project, Taiwan; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	The study is supported by a grant (NCU/LSH-100-A-006) from 2011 Annual National Central University and Landseed Hospital Joint R & D Project, Taiwan and in part by a grant (NSC 101-2221-E-008-015-MY3) from the National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Admiraal-Behloul F, 2005, NEUROIMAGE, V28, P607, DOI 10.1016/j.neuroimage.2005.06.061; Altaf N, 2008, RADIOLOGY, V248, P202, DOI 10.1148/radiol.2481070300; Anbeek P, 2005, NEUROIMAGE, V27, P795, DOI 10.1016/j.neuroimage.2005.05.046; Anbeek P, 2004, NEUROIMAGE, V21, P1037, DOI 10.1016/j.neuroimage.2003.10.012; Anbeek P, 2004, MED IMAGE ANAL, V8, P205, DOI 10.1016/j.media.2004.06.019; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; BARTKO JJ, 1991, SCHIZOPHRENIA BULL, V17, P483, DOI 10.1093/schbul/17.3.483; Beare R, 2009, NEUROIMAGE, V47, P199, DOI 10.1016/j.neuroimage.2009.03.055; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1177/096228029900800204; Chen YW, 2006, NEUROLOGY, V67, P83, DOI 10.1212/01.wnl.0000223613.57229.24; Debette S, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3666; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Dyrby TB, 2008, NEUROIMAGE, V41, P335, DOI 10.1016/j.neuroimage.2008.02.024; Geremia E, 2011, NEUROIMAGE, V57, P378, DOI 10.1016/j.neuroimage.2011.03.080; Gouw AA, 2008, CEREBROVASC DIS, V25, P247, DOI 10.1159/000113863; Gurol ME, 2006, NEUROLOGY, V66, P23, DOI 10.1212/01.wnl.0000191403.95453.6a; Hsieh FI, 2010, CIRCULATION, V122, P1116, DOI 10.1161/CIRCULATIONAHA.110.936526; Huppertz HJ, 2008, EPILEPSIA, V49, P772, DOI 10.1111/j.1528-1167.2007.01436.x; Huppertz HJ, 2005, EPILEPSY RES, V67, P35, DOI 10.1016/j.eplepsyres.2005.07.009; Khayati R, 2008, COMPUT BIOL MED, V38, P379, DOI 10.1016/j.compbiomed.2007.12.005; Khayati R, 2008, COMPUT MED IMAG GRAP, V32, P124, DOI 10.1016/j.compmedimag.2007.10.003; Kloppel S, 2011, NEUROIMAGE, V57, P416, DOI 10.1016/j.neuroimage.2011.04.053; Longstreth WT, 2005, STROKE, V36, P56, DOI 10.1161/01.STR.0000149625.99732.69; Maes F, 1997, IEEE T MED IMAGING, V16, P187, DOI 10.1109/42.563664; Maillard P, 2008, NEURORADIOLOGY, V50, P31, DOI 10.1007/s00234-007-0312-3; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.4.390; Pantoni L, 2002, STROKE, V33, P2827, DOI 10.1161/01.STR.0000038424.70926.5E; Poels MMF, 2012, STROKE, V43, P2637, DOI 10.1161/STROKEAHA.111.642264; Schmahmann JD, 2008, ANN NY ACAD SCI, V1142, P266, DOI 10.1196/annals.1444.017; Schmidt P, 2012, NEUROIMAGE, V59, P3774, DOI 10.1016/j.neuroimage.2011.11.032; Schoonheim MM, 2014, HUM BRAIN MAPP, V35, P2348, DOI 10.1002/hbm.22332; Schulz UG, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000261; Shi L, 2013, J NEUROSCI METH, V213, P138, DOI 10.1016/j.jneumeth.2012.12.014; Shiee N, 2010, NEUROIMAGE, V49, P1524, DOI 10.1016/j.neuroimage.2009.09.005; Smith EE, 2004, NEUROLOGY, V63, P1606, DOI 10.1212/01.WNL.0000142966.22886.20; Smith EE, 2010, STROKE, V41, pS139, DOI 10.1161/STROKEAHA.110.596056; Smith EE, 2010, STROKE, V41, P1933, DOI 10.1161/STROKEAHA.110.579078; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Tsai JZ, 2014, BIOMED RES INT, V2014; van Straaten ECW, 2006, STROKE, V37, P836, DOI 10.1161/01.STR.0000202585.26325.74; Wahlund LO, 2001, STROKE, V32, P1318, DOI 10.1161/01.STR.32.6.1318; Wardlaw JM, 2013, LANCET NEUROL, V12, P822, DOI 10.1016/S1474-4422(13)70124-8; Weinstein G, 2013, STROKE, V44, P2787, DOI 10.1161/STROKEAHA.113.000947; ZIJDENBOS AP, 1994, IEEE T MED IMAGING, V13, P716, DOI 10.1109/42.363096	45	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104011	10.1371/journal.pone.0104011	http://dx.doi.org/10.1371/journal.pone.0104011			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127120	Green Submitted, Green Published, gold			2022-12-25	WOS:000340879300011
J	Edele, F; Dudda, JC; Bachtanian, E; Jakob, T; Pircher, H; Martin, SF				Edele, Fanny; Dudda, Jan C.; Bachtanian, Eva; Jakob, Thilo; Pircher, Hanspeter; Martin, Stefan F.			Efficiency of Dendritic Cell Vaccination against B16 Melanoma Depends on the Immunization Route	PLOS ONE			English	Article							CD8 T-CELLS; HOMING RECEPTOR PATTERNS; CANCER-IMMUNOTHERAPY; IMMUNE-RESPONSES; VIRAL-INFECTION; LYMPH-NODES; IN-VIVO; BYSTANDER ACTIVATION; TUMOR-IMMUNOTHERAPY; ANTIGEN	Dendritic cells (DC) presenting tumor antigens are crucial to induce potent T cell-mediated anti-tumor immune responses. Therefore DC-based cancer vaccines have been established for therapy, however clinical outcomes are often poor and need improvement. Using a mouse model of B16 melanoma, we found that the route of preventive DC vaccination critically determined tumor control. While repeated DC vaccination did not show an impact of the route of DC application on the prevention of tumor growth, a single DC vaccination revealed that both the imprinting of skin homing receptors and an enhanced proliferation state of effector T cells was seen only upon intracutaneous but not intravenous or intraperitoneal immunization. Tumor growth was prevented only by intracutaneous DC vaccination. Our results indicate that under suboptimal conditions the route of DC vaccination crucially determines the efficiency of tumor defense. DC-based strategies for immunotherapy of cancer should take into account the immunization route in order to optimize tissue targeting of tumor antigen specific T cells.	[Edele, Fanny; Dudda, Jan C.; Bachtanian, Eva; Jakob, Thilo; Martin, Stefan F.] Univ Freiburg, Med Ctr, Dept Dermatol, Allergy Res Grp, Freiburg, Germany; [Pircher, Hanspeter] Univ Freiburg, Med Ctr, Inst Med Microbiol & Hyg, Freiburg, Germany	University of Freiburg; University of Freiburg	Martin, SF (corresponding author), Univ Freiburg, Med Ctr, Dept Dermatol, Allergy Res Grp, Freiburg, Germany.	stefan.martin@uniklinik-freiburg.de			Deutsche Forschungsgemeinschaft (DFG) [MA1567/8-1, ED203/2-1]; Forschungskommission der Medizinischen Fakultat, Medical Center - University of Freiburg	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Forschungskommission der Medizinischen Fakultat, Medical Center - University of Freiburg	This work was supported by a grant from the Deutsche Forschungsgemeinschaft (DFG) MA1567/8-1 (S. F. M. and F. E.) & ED203/2-1 (F. E.) and a grant from the Forschungskommission der Medizinischen Fakultat, Medical Center - University of Freiburg (S. F. M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abastado JP, 2012, CANCER RES, V72, P2159, DOI 10.1158/0008-5472.CAN-11-3538; Bar JJ, 2008, IMMUNITY, V28, P859, DOI 10.1016/j.immuni.2008.04.010; Bousso P, 2003, NAT IMMUNOL, V4, P579, DOI 10.1038/ni928; Brinkman CC, 2008, J IMMUNOL, V181, P1814, DOI 10.4049/jimmunol.181.3.1814; Butz EA, 1998, IMMUNITY, V8, P167, DOI 10.1016/S1074-7613(00)80469-0; Calzascia T, 2005, IMMUNITY, V22, P175, DOI 10.1016/j.immuni.2004.12.008; de Vries IJM, 2003, CLIN CANCER RES, V9, P5091; Dhodapkar MV, 2000, J CLIN INVEST, V105, pR9, DOI 10.1172/JCI9051; Dhodapkar MV, 1999, J CLIN INVEST, V104, P173, DOI 10.1172/JCI6909; Dudda JC, 2005, EUR J IMMUNOL, V35, P1056, DOI 10.1002/eji.200425817; Dudda JC, 2004, TRENDS IMMUNOL, V25, P417, DOI 10.1016/j.it.2004.05.008; Dudda JC, 2004, J IMMUNOL, V172, P857, DOI 10.4049/jimmunol.172.2.857; Edele F, 2008, J IMMUNOL, V181, P3745, DOI 10.4049/jimmunol.181.6.3745; Fong L, 2001, J IMMUNOL, V166, P4254, DOI 10.4049/jimmunol.166.6.4254; Fong L, 2001, P NATL ACAD SCI USA, V98, P8809, DOI 10.1073/pnas.141226398; Frankenberger B, 2012, EUR J CELL BIOL, V91, P53, DOI 10.1016/j.ejcb.2011.01.012; Grover A, 2006, CLIN CANCER RES, V12, P5801, DOI 10.1158/1078-0432.CCR-05-2421; Hammerschmidt SI, 2008, J EXP MED, V205, P2483, DOI 10.1084/jem.20080039; Hsu FJ, 1996, NAT MED, V2, P52, DOI 10.1038/nm0196-52; Kalinski P, 2013, EXPERT REV VACCINES, V12, P285, DOI [10.1586/erv.13.22, 10.1586/ERV.13.22]; KYBURZ D, 1993, EUR J IMMUNOL, V23, P1956, DOI 10.1002/eji.1830230834; Martin-Fontecha A, 2003, J EXP MED, V198, P615, DOI 10.1084/jem.20030448; Masopust D, 2004, J IMMUNOL, V172, P4875, DOI 10.4049/jimmunol.172.8.4875; Molenaar R, 2009, J IMMUNOL, V183, P6395, DOI 10.4049/jimmunol.0900311; Morse MA, 2009, EXPERT OPIN BIOL TH, V9, P331, DOI 10.1517/14712590802715756 ; Moutsopoulos NM, 2008, CURR OPIN IMMUNOL, V20, P234, DOI 10.1016/j.coi.2008.04.003; Mullins DW, 2006, J IMMUNOL, V176, P4535, DOI 10.4049/jimmunol.176.8.4535; Mullins DW, 2003, J EXP MED, V198, P1023, DOI 10.1084/jem.20021348; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Murali-Krishna K, 1998, ADV EXP MED BIOL, V452, P123; Nestle FO, 1998, NAT MED, V4, P328, DOI 10.1038/nm0398-328; Ohl L, 2004, IMMUNITY, V21, P279, DOI 10.1016/j.immuni.2004.06.014; Palucka K, 2012, NAT REV CANCER, V12, P265, DOI 10.1038/nrc3258; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Prevost-Blondel A, 1998, J IMMUNOL, V161, P2187; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; Sheasley-O'Neill SL, 2007, J IMMUNOL, V178, P1512, DOI 10.4049/jimmunol.178.3.1512; Sims RB, 2012, VACCINE, V30, P4394, DOI 10.1016/j.vaccine.2011.11.058; Thurner B, 1999, J EXP MED, V190, P1669, DOI 10.1084/jem.190.11.1669; Timmerman JM, 2002, BLOOD, V99, P1517, DOI 10.1182/blood.V99.5.1517; Xu GS, 2008, J CANCER RES CLIN, V134, P1043, DOI 10.1007/s00432-008-0393-3; Yoneyama H, 2005, INT J HEMATOL, V81, P204, DOI 10.1532/IJH97.04164; Zimmermann C, 1996, J EXP MED, V183, P1367, DOI 10.1084/jem.183.4.1367; Zitvogel L, 1996, J EXP MED, V183, P87, DOI 10.1084/jem.183.1.87	44	14	14	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e105266	10.1371/journal.pone.0105266	http://dx.doi.org/10.1371/journal.pone.0105266			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121970	Green Published, gold, Green Submitted			2022-12-25	WOS:000341017000109
J	Oynebraten, I; Hinkula, J; Fredriksen, AB; Bogen, B				Oynebraten, Inger; Hinkula, Jorma; Fredriksen, Agnete B.; Bogen, Bjarne			Increased Generation of HIV-1 gp120-Reactive CD8(+) T Cells by a DNA Vaccine Construct Encoding the Chemokine CCL3	PLOS ONE			English	Article							TARGETING DENDRITIC CELLS; IMMUNE-RESPONSE; IN-VIVO; TUMOR-ANTIGEN; ANTIBODY; FUSION; EXPRESSION; RECEPTORS; MOLECULES; MOUSE	DNA vaccines based on subunits from pathogens have several advantages over other vaccine strategies. DNA vaccines can easily be modified, they show good safety profiles, are stable and inexpensive to produce, and the immune response can be focused to the antigen of interest. However, the immunogenicity of DNA vaccines which is generally quite low needs to be improved. Electroporation and co-delivery of genetically encoded immune adjuvants are two strategies aiming at increasing the efficacy of DNA vaccines. Here, we have examined whether targeting to antigen-presenting cells (APC) could increase the immune response to surface envelope glycoprotein (Env) gp120 from Human Immunodeficiency Virus type 1 (HIV- 1). To target APC, we utilized a homodimeric vaccine format denoted vaccibody, which enables covalent fusion of gp120 to molecules that can target APC. Two molecules were tested for their efficiency as targeting units: the antibody-derived single chain Fragment variable (scFv) specific for the major histocompatilibility complex (MHC) class II I-E molecules, and the CC chemokine ligand 3 (CCL3). The vaccines were delivered as DNA into muscle of mice with or without electroporation. Targeting of gp120 to MHC class II molecules induced antibodies that neutralized HIV-1 and that persisted for more than a year after one single immunization with electroporation. Targeting by CCL3 significantly increased the number of HIV-1 gp120-reactive CD8(+) T cells compared to non-targeted vaccines and gp120 delivered alone in the absence of electroporation. The data suggest that chemokines are promising molecular adjuvants because small amounts can attract immune cells and promote immune responses without advanced equipment such as electroporation.	[Oynebraten, Inger; Fredriksen, Agnete B.; Bogen, Bjarne] Univ Oslo, Dept Immunol, Oslo, Norway; [Oynebraten, Inger; Fredriksen, Agnete B.; Bogen, Bjarne] Oslo Univ Hosp, Rikshosp, Oslo, Norway; [Oynebraten, Inger; Fredriksen, Agnete B.; Bogen, Bjarne] Univ Oslo, Ctr Immune Regulat, Oslo, Norway; [Hinkula, Jorma] Linkoping Univ, Dept Clin & Expt Med, Div Mol Virol, Linkoping, Sweden; [Bogen, Bjarne] Univ Oslo, KG Jebsen Ctr Res Influenza Vaccines, Oslo, Norway	University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; Linkoping University; University of Oslo	Oynebraten, I (corresponding author), Oslo Univ Hosp, Rikshosp, Dept Pathol, Oslo, Norway.	inger.oynebraten@rr-research.no; bjarne.bogen@medisin.uio.no	Hinkula, Jorma/P-6849-2018; Øynebråten, Inger/W-3369-2019	Øynebråten, Inger/0000-0001-8914-5676	Research Council of Norway; Odd Fellow	Research Council of Norway(Research Council of Norway); Odd Fellow	The study was supported by grants from the Research Council of Norway and Odd Fellow (http://www.oddfellow.no/). The funders had no role in study design, data collection or analyses, decision to publish, or preparation of the manuscript.	Aliberti J, 2000, NAT IMMUNOL, V1, P83, DOI 10.1038/76957; Altfeld M, 2011, NAT REV IMMUNOL, V11, P176, DOI 10.1038/nri2935; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Barouch DH, 2002, J IMMUNOL, V168, P562, DOI 10.4049/jimmunol.168.2.562; Bergman PJ, 2006, VACCINE, V24, P4582, DOI 10.1016/j.vaccine.2005.08.027; Biragyn A, 2002, BLOOD, V100, P1153, DOI 10.1182/blood-2002-01-0086; Biragyn A, 1999, NAT BIOTECHNOL, V17, P253, DOI 10.1038/6995; Biragyn A, 2007, J IMMUNOL, V179, P1381, DOI 10.4049/jimmunol.179.2.1381; Borroni EM, 2010, PHARMACOL THERAPEUT, V127, P1, DOI 10.1016/j.pharmthera.2010.04.006; BROLIDEN PA, 1990, J VIROL, V64, P936, DOI 10.1128/JVI.64.2.936-940.1990; CARAYANNIOTIS G, 1987, NATURE, V327, P59, DOI 10.1038/327059a0; Charmoy M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000755; Cheong C, 2010, BLOOD, V116, P3828, DOI 10.1182/blood-2010-06-288068; Coban C, 2013, HUM VACC IMMUNOTHER, V9, P2216, DOI 10.4161/hv.25893; Cohn L, 2013, J EXP MED, V210, P1049, DOI 10.1084/jem.20121251; Compeer EB, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00037; Cruz LJ, 2012, NANOMEDICINE-UK, V7, P1591, DOI [10.2217/NNM.12.131, 10.2217/nnm.12.131]; D'Ambrosio D, 2003, J IMMUNOL METHODS, V273, P3, DOI 10.1016/S0022-1759(02)00414-3; Davis BS, 2001, J VIROL, V75, P4040, DOI 10.1128/JVI.75.9.4040-4047.2001; Ferraro B, 2011, CLIN INFECT DIS, V53, P296, DOI 10.1093/cid/cir334; Flingai S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00354; Fredriksen AB, 2006, MOL THER, V13, P776, DOI 10.1016/j.ymthe.2005.10.019; Fredriksen AB, 2007, BLOOD, V110, P1797, DOI 10.1182/blood-2006-06-032938; Froyland M, 2011, EUR J HAEMATOL, V86, P385, DOI 10.1111/j.1600-0609.2011.01590.x; Garver KA, 2005, DIS AQUAT ORGAN, V64, P13, DOI 10.3354/dao064013; Grodeland G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080008; Grodeland G, 2013, J IMMUNOL, V191, P3221, DOI 10.4049/jimmunol.1300504; Heath WR, 2013, NAT IMMUNOL, V14, P978, DOI 10.1038/ni.2680; Iwasaki A, 1997, J IMMUNOL, V158, P4591; Joffre OP, 2012, NAT REV IMMUNOL, V12, P557, DOI 10.1038/nri3254; Karpus WJ, 1997, J IMMUNOL, V158, P4129; KAWAMURA H, 1986, J IMMUNOL, V136, P58; Kew O, 2002, SCIENCE, V296, P356, DOI 10.1126/science.1068284; Kim JJ, 1997, J IMMUNOL, V158, P816; Kreutz M, 2013, BLOOD, V121, P2836, DOI 10.1182/blood-2012-09-452078; Liu MA, 2011, IMMUNOL REV, V239, P62, DOI 10.1111/j.1600-065X.2010.00980.x; Liu WL, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002295; Mack M, 2001, J IMMUNOL, V166, P4697, DOI 10.4049/jimmunol.166.7.4697; MALISSEN M, 1984, CELL, V37, P1101, DOI 10.1016/0092-8674(84)90444-6; Maurer M, 2004, INT J BIOCHEM CELL B, V36, P1882, DOI 10.1016/j.biocel.2003.10.019; McKay PF, 2004, EUR J IMMUNOL, V34, P1011, DOI 10.1002/eji.200324840; McMichael AJ, 2014, NAT IMMUNOL, V15, P319, DOI 10.1038/ni.2844; Menten P, 2002, CYTOKINE GROWTH F R, V13, P455, DOI 10.1016/S1359-6101(02)00045-X; Nchinda G, 2008, J CLIN INVEST, V118, P1427, DOI 10.1172/JCI34224; NEUBERGER MS, 1981, P NATL ACAD SCI-BIOL, V78, P1138, DOI 10.1073/pnas.78.2.1138; Norderhaug L, 1997, J IMMUNOL METHODS, V204, P77, DOI 10.1016/S0022-1759(97)00034-3; Oynebraten I, 2012, SCAND J IMMUNOL; OZATO K, 1980, J IMMUNOL, V124, P533; Peng BW, 2007, VACCINE, V25, P2064, DOI 10.1016/j.vaccine.2006.11.042; Qin H, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/860160; Qin L, 2007, J VIROL, V81, P10606, DOI 10.1128/JVI.01000-07; Roos AK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007226; Ruffini PA, 2010, VACCINE, V29, P191, DOI 10.1016/j.vaccine.2010.10.057; Santra S, 2000, J IMMUNOL, V165, P6791, DOI 10.4049/jimmunol.165.12.6791; Sardesai NY, 2011, CURR OPIN IMMUNOL, V23, P421, DOI 10.1016/j.coi.2011.03.008; Schiavo R, 2006, BLOOD, V107, P4597, DOI 10.1182/blood-2005-08-3207; Schiffner T, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-72; Schjetne KW, 2007, J IMMUNOL, V178, P4169, DOI 10.4049/jimmunol.178.7.4169; Smed-Sorensen A, 2013, ADV EXP MED BIOL, V762, P263, DOI 10.1007/978-1-4614-4433-6_10; Snider DP, 1997, IMMUNOLOGY, V90, P323, DOI 10.1111/j.1365-2567.1997.00323.x; Song RJ, 2007, MOL THER, V15, P1007, DOI 10.1038/mt.sj.6300129; Spang HCL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045393; Steinman RM, 2012, ANNU REV IMMUNOL, V30, P1, DOI 10.1146/annurev-immunol-100311-102839; Stephenson KE, 2013, IMMUNOL REV, V254, P295, DOI 10.1111/imr.12073; Tacken PJ, 2011, SEMIN IMMUNOL, V23, P12, DOI 10.1016/j.smim.2011.01.001; TAKAHASHI H, 1992, SCIENCE, V255, P333, DOI 10.1126/science.1372448; Trumpfheller C, 2006, J EXP MED, V203, P607, DOI 10.1084/jem.20052005; Viola A, 2008, ANNU REV PHARMACOL, V48, P171, DOI 10.1146/annurev.pharmtox.48.121806.154841; XIANG ZQ, 1995, IMMUNITY, V2, P129, DOI 10.1016/S1074-7613(95)80001-8	69	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104814	10.1371/journal.pone.0104814	http://dx.doi.org/10.1371/journal.pone.0104814			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122197	Green Submitted, Green Published, gold			2022-12-25	WOS:000341017000062
J	Srivastava, A; Sinha, S				Srivastava, Ashutosh; Sinha, Somdatta			Thermostability of In Vitro Evolved Bacillus subtilis Lipase A: A Network and Dynamics Perspective	PLOS ONE			English	Article							PROTEIN THERMAL-STABILITY; MOLECULAR-DYNAMICS; DIRECTED EVOLUTION; STRUCTURAL BASIS; HYDROGEN-BONDS; RESIDUES	Proteins in thermophilic organisms remain stable and function optimally at high temperatures. Owing to their important applicability in many industrial processes, such thermostable proteins have been studied extensively, and several structural factors attributed to their enhanced stability. How these factors render the emergent property of thermostability to proteins, even in situations where no significant changes occur in their three-dimensional structures in comparison to their mesophilic counter-parts, has remained an intriguing question. In this study we treat Lipase A from Bacillus subtilis and its six thermostable mutants in a unified manner and address the problem with a combined complex network-based analysis and molecular dynamic studies to find commonality in their properties. The Protein Contact Networks (PCN) of the wild-type and six mutant Lipase A structures developed at a mesoscopic scale were analyzed at global network and local node (residue) level using network parameters and community structure analysis. The comparative PCN analysis of all proteins pointed towards important role of specific residues in the enhanced thermostability. Network analysis results were corroborated with finer-scale molecular dynamics simulations at both room and high temperatures. Our results show that this combined approach at two scales can uncover small but important changes in the local conformations that add up to stabilize the protein structure in thermostable mutants, even when overall conformation differences among them are negligible. Our analysis not only supports the experimentally determined stabilizing factors, but also unveils the important role of contacts, distributed throughout the protein, that lead to thermostability. We propose that this combined mesoscopic-network and fine-grained molecular dynamics approach is a convenient and useful scheme not only to study allosteric changes leading to protein stability in the face of negligible over-all conformational changes due to mutations, but also in other molecular networks where change in function does not accompany significant change in the network structure.	[Srivastava, Ashutosh] Ctr Cellular & Mol Biol, CSIR, Hyderabad, Andhra Pradesh, India; [Sinha, Somdatta] Indian Inst Sci Educ & Res Mohali, Manauli, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Indian Institute of Science Education & Research (IISER) - Mohali	Sinha, S (corresponding author), Indian Inst Sci Educ & Res Mohali, Manauli, India.	ssinha@iisermohali.ac.in		Srivastava, Ashutosh/0000-0001-9820-720X	CSIR India; DST India	CSIR India(Council of Scientific & Industrial Research (CSIR) - India); DST India(Department of Science & Technology (India))	AS acknowledges financial support from CSIR India. SS thanks DST India for the JC Bose Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya P, 2004, J MOL BIOL, V341, P1271, DOI 10.1016/j.jmb.2004.06.059; Ahmad S, 2008, J MOL BIOL, V381, P324, DOI 10.1016/j.jmb.2008.05.063; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Babu MM, 2012, SCIENCE, V337, P1460, DOI 10.1126/science.1228775; Bagler G, 2005, PHYSICA A, V346, P27, DOI 10.1016/j.physa.2004.08.046; Bagler G, 2007, BIOINFORMATICS, V23, P1760, DOI 10.1093/bioinformatics/btm257; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Cavallo L, 2003, NUCLEIC ACIDS RES, V31, P3364, DOI 10.1093/nar/gkg601; Chan CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021624; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Csardi N., 2006, INT J COMP SYST, V1695, P1; Day R, 2002, J MOL BIOL, V322, P189, DOI 10.1016/S0022-2836(02)00672-1; del Sol A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r92; del Sol A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100063; Development Core Team R, 2010, R FDN STAT COMPUT, V1, P409; Di Paola L, 2013, CHEM REV, V113, P1598, DOI 10.1021/cr3002356; Duan Y, 1998, SCIENCE, V282, P740, DOI 10.1126/science.282.5389.740; Essman U, 1995, J CHEM PHYS, V102, P31; Facchiano AM, 1999, PROTEIN ENG, V12, P893, DOI 10.1093/oxfordjournals.protein.a029825; Giver L, 1998, P NATL ACAD SCI USA, V95, P12809, DOI 10.1073/pnas.95.22.12809; Gonzalez-Blasco G, 2000, J BIOL CHEM, V275, P13708, DOI 10.1074/jbc.275.18.13708; Gromiha MM, 2013, PROTEINS, V81, P715, DOI 10.1002/prot.24232; Gromiha MM, 2004, PROG BIOPHYS MOL BIO, V86, P235, DOI 10.1016/j.pbiomolbio.2003.09.003; Haliloglu T, 1997, PHYS REV LETT, V79, P3090, DOI 10.1103/PhysRevLett.79.3090; Haney P, 1997, PROTEINS, V28, P117, DOI 10.1002/(SICI)1097-0134(199705)28:1<117::AID-PROT12>3.0.CO;2-M; Hansia P, 2009, MOL BIOSYST, V5, P1860, DOI 10.1039/b903807h; Hashem Y, 2009, METHODS, V47, P187, DOI 10.1016/j.ymeth.2008.09.020; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kamal MZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035188; Kamal MZ, 2011, J MOL BIOL, V413, P726, DOI 10.1016/j.jmb.2011.09.002; Krissinel E, 2005, LECT NOTES COMPUT SC, V3695, P67; Kumar S, 2002, CHEMBIOCHEM, V3, P604, DOI 10.1002/1439-7633(20020703)3:7<604::AID-CBIC604>3.0.CO;2-X; Kumar S, 2000, PROTEIN ENG, V13, P179, DOI 10.1093/protein/13.3.179; Lehmann M, 2001, CURR OPIN BIOTECH, V12, P371, DOI 10.1016/S0958-1669(00)00229-9; Lehmann M, 2000, BBA-PROTEIN STRUCT M, V1543, P408, DOI 10.1016/S0167-4838(00)00238-7; Liszka MJ, 2012, ANNU REV CHEM BIOMOL, V3, P77, DOI 10.1146/annurev-chembioeng-061010-114239; Matsumura I, 1999, PROTEIN SCI, V8, P731; MATSUMURA M, 1989, NATURE, V342, P291, DOI 10.1038/342291a0; NICHOLSON H, 1988, NATURE, V336, P651, DOI 10.1038/336651a0; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; PJURA P, 1993, PROTEIN SCI, V2, P2226, DOI 10.1002/pro.5560021222; Polyansky AA, 2004, RUSS J BIOORG CHEM+, V30, P421, DOI 10.1023/B:RUBI.0000043784.51859.41; Pouderoyen G, 2001, J MOL BIOL, V309, P215; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Purmonen M, 2007, PROTEIN ENG DES SEL, V20, P551, DOI 10.1093/protein/gzm056; Russell RJM, 1997, BIOCHEMISTRY-US, V36, P9983, DOI 10.1021/bi9705321; Salminen T, 1996, PROTEIN SCI, V5, P1014; Stephens DE, 2007, J BIOTECHNOL, V127, P348, DOI 10.1016/j.jbiotec.2006.06.015; Szilagyi A, 2000, STRUCTURE, V8, P493, DOI 10.1016/S0969-2126(00)00133-7; Tsai CJ, 2008, J MOL BIOL, V378, P1, DOI 10.1016/j.jmb.2008.02.034; Vogt G, 1997, FOLD DES, V2, pS40, DOI 10.1016/S1359-0278(97)00062-X; Vogt G, 1997, J MOL BIOL, V269, P631, DOI 10.1006/jmbi.1997.1042; Watanabe K, 1998, J MOL CATAL B-ENZYM, V4, P167, DOI 10.1016/S1381-1177(97)00031-3; WATANABE K, 1994, EUR J BIOCHEM, V226, P277, DOI 10.1111/j.1432-1033.1994.tb20051.x; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Zhao HM, 1999, PROTEIN ENG, V12, P47, DOI 10.1093/protein/12.1.47	59	20	24	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e102856	10.1371/journal.pone.0102856	http://dx.doi.org/10.1371/journal.pone.0102856			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122499	Green Published, Green Submitted, gold			2022-12-25	WOS:000341017000007
J	Yang, GX; Xu, YY; Fan, YP; Wang, J; Chen, XL; Zhang, YD; Wu, JH				Yang, Guang-xia; Xu, Yu-yin; Fan, Ya-ping; Wang, Jing; Chen, Xiao-lan; Zhang, Yi-de; Wu, Jian-hua			A Maladaptive Role for EP4 Receptors in Mouse Mesangial Cells	PLOS ONE			English	Article							PROSTAGLANDIN E-2; PROSTANOID RECEPTORS; CYCLOOXYGENASE-2; EXPRESSION; INHIBITION; ACTIVATION; SYNTHASE; INJURY	Roles of the prostaglandin E2 E-prostanoid 4 receptor (EP4) on extracellular matrix (ECM) accumulation induced by TGF-beta 1 in mouse glomerular mesangial cells (GMCs) remain unknown. Previously, we have identified that TGF-beta 1 stimulates the expression of FN and Col I in mouse GMCs. Here we asked whether stimulation of EP4 receptors would exacerbate renal fibrosis associated with enhanced glomerular ECM accumulation. We generated EP4(Flox/Flox) and EP4(+/-) mice, cultured primary WT, EP4(Flox/Flox) and EP4(+/-) GMCs, AD-EP4 transfected WT GMCs (EP4 overexpression) and AD-Cre transfected EP4(Flox/Flox) GMCs (EP4 deleted). We found that TGF-beta 1-induced cAMP and PGE2 synthesis decreased in EP4 deleted GMCs and increased in EP4 overexpressed GMCs. Elevated EP4 expression in GMCs augmented the coupling of TGF-beta 1 to FN, Col I expression and COX2/PGE2 signaling, while TGF-beta 1 induced FN, Col I expression and COX2/PGE2 signaling were down-regulated in EP4 deficiency GMCs. 8 weeks after 5/6 nephrectomy (Nx), WT and EP4(+/-) mice exhibited markedly increased accumulation of ECM compared with sham-operated controls. Albuminuria, blood urea nitrogen and creatinine (BUN and Cr) concentrations were significantly increased in WT mice as compared to those of EP4(+/-) mice. Urine osmotic pressure was dramatically decreased after 5/6 Nx surgery in WT mice as compared to EP4(+/-) mice. The pathological changes in kidney of EP4(+/-) mice was markedly alleviated compared with WT mice. Immunohistochemical analysis showed significant reductions of Col I and FN in the kidney of EP4(+/-) mice compared with WT mice. Collectively, this investigation established EP4 as a potent mediator of the pro-TGF-beta 1 activities elicited by COX2/PGE2 in mice GMCs. Our findings suggested that prostaglandin E2, acting via EP4 receptors contributed to accumulation of ECM in GMCs and promoted renal fibrosis.	[Yang, Guang-xia; Xu, Yu-yin; Fan, Ya-ping; Chen, Xiao-lan; Zhang, Yi-de; Wu, Jian-hua] Nantong Univ, Affiliated Hosp, Dept Nephrol, Nantong, Jiangsu, Peoples R China; [Yang, Guang-xia] Jiangnan Univ, Wuxi Peoples Hosp 4, Affiliated Hosp, Dept Rheumatol, Wuxi, Jiangsu, Peoples R China; [Wang, Jing] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China	Nantong University; Jiangnan University; Shanghai Jiao Tong University	Chen, XL (corresponding author), Nantong Univ, Affiliated Hosp, Dept Nephrol, Nantong, Jiangsu, Peoples R China.	chenxl8448@sina.com			National Natural Science Fundation of China [81170656]; Jiangsu Basic Research Program [BK2008185]; Science Foundation of Nantong City, Jiangsu province, China [HS2011021]	National Natural Science Fundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Basic Research Program; Science Foundation of Nantong City, Jiangsu province, China	This research was supported by fundings from: National Natural Science Fundation of China (No. 81170656), Jiangsu Basic Research Program (BK2008185) and the Science Foundation of Nantong City, Jiangsu province, China (No. HS2011021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boor P, 2012, KIDNEY INT, V82, P132, DOI 10.1038/ki.2012.125; Breyer MD, 2000, AM J PHYSIOL-RENAL, V279, pF12, DOI 10.1152/ajprenal.2000.279.1.F12; Cheng HF, 2007, J AM SOC NEPHROL, V18, P551, DOI 10.1681/ASN.2006090990; Das F, 2010, FEBS LETT, V584, P4268, DOI 10.1016/j.febslet.2010.09.010; Fujino H, 2002, J BIOL CHEM, V277, P2614, DOI 10.1074/jbc.M109440200; Fujino H, 2003, J BIOL CHEM, V278, P12151, DOI 10.1074/jbc.M212665200; FUNK CD, 1993, J BIOL CHEM, V268, P26767; Gilbert RD, 2009, KIDNEY INT, V75, P415, DOI 10.1038/ki.2008.573; Heeg MHJ, 2005, KIDNEY INT, V68, P96, DOI 10.1111/j.1523-1755.2005.00384.x; Jo YI, 2007, NEPHRON EXP NEPHROL, V107, P87, DOI 10.1159/000108653; Jung GS, 2009, J AM SOC NEPHROL, V20, P2162, DOI 10.1681/ASN.2008121232; Kotnik P, 2005, AM J PHYSIOL-RENAL, V288, pF1053, DOI 10.1152/ajprenal.00114.2004; Kudo I, 2005, J BIOCHEM MOL BIOL, V38, P633; Lopez-Novoa JM, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-13; Morath R, 1999, J AM SOC NEPHROL, V10, P1851; Nabrdalik K, 2013, ARCH MED SCI, V9, P230, DOI 10.5114/aoms.2013.34418; Nguyen MT, 2002, J IMMUNOL, V169, P4586, DOI 10.4049/jimmunol.169.8.4586; Raymond C, 2013, T AM CLIN CLIMAT ASS, V124, P139; Sankaran D, 2007, AM J PHYSIOL-RENAL, V293, pF821, DOI 10.1152/ajprenal.00257.2006; Schnaper HW, 2009, FRONT BIOSCI-LANDMRK, V14, P2448, DOI 10.2741/3389; Stitt-Cavanagh EM, 2010, J AM SOC NEPHROL, V21, P1678, DOI 10.1681/ASN.2009121234; Vancheri C, 2004, TRENDS IMMUNOL, V25, P40, DOI 10.1016/j.it.2003.11.001; Vukicevic S, 2006, KIDNEY INT, V70, P1099, DOI 10.1038/sj.ki.5001715; Wahab NA, 2002, J AM SOC NEPHROL, V13, P2437, DOI 10.1097/01.ASN.0000031828.58276.02; Wang JL, 2000, KIDNEY INT, V57, P2334, DOI 10.1046/j.1523-1755.2000.00093.x; Yamamoto E, 2010, HISTOL HISTOPATHOL, V25, P995, DOI 10.14670/HH-25.995; Zeisberg M, 2006, PLOS MED, V3, P535, DOI 10.1371/journal.pmed.0030100	27	11	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104091	10.1371/journal.pone.0104091	http://dx.doi.org/10.1371/journal.pone.0104091			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122504	Green Published, Green Submitted, gold			2022-12-25	WOS:000341017000028
J	Paul, BT; Blanchard, Z; Ridgway, M; ElShamy, WM				Paul, B. T.; Blanchard, Z.; Ridgway, M.; ElShamy, W. M.			BRCA1-IRIS inactivation sensitizes ovarian tumors to cisplatin	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; CYCLIN D1 EXPRESSION; PHOSPHATIDYLINOSITOL 3-KINASE; ANOIKIS RESISTANCE; CLINICAL ACTIVITY; GROWTH-FACTORS; CANCER; TRKB; OVEREXPRESSION; PROMOTES	Ovarian cancer is the first in mortalities among gynecologic cancers in the United States, often due to late diagnosis and/or acquired platinum-resistant recurrences. This study investigates whether BRCA1-IRIS is a novel treatment target for ovarian cancers and in platinum-resistant recurrences. Here we show that more than half of the ovarian cancer samples analyzed showed BRCA1-IRIS and survivin overexpression and lacked nuclear FOXO3a expression. Normal ovarian epithelial cells overexpressing BRCA1-IRIS formed metastasis in mice when injected in the peritoneal cavity, whereas aggressive ovarian cancer cell lines failed to form tumors or metastases in mice when BRCA1-IRIS was silenced in them. We show that BRCA1-IRIS activates two autocrine signaling loops, brain-derived neurotrophic factor/tyrosine kinase B receptor (BDNF/TrkB) and neuregulin 1 (NRG1)/ErbB2. These loops are involved in anoikis resistance and metastasis promotion. These loops operate in several ovarian cancer cell lines, and BRCA1-IRIS silencing or inactivation using a novel inhibitory peptide renders both non-functional and promoted cell death. In a mouse xenograft model, BRCA1-IRIS inactivation using this novel inhibitory peptide resulted in significant reduction in ovarian tumor growth. More importantly, this treatment sensitized ovarian tumors to low cisplatin concentrations. Taken together, these data strongly suggest that BRCA1-IRIS and/or BDNF/TrkB and NRG1/ErbB2 could serve as rational therapeutic targets for advanced ovarian cancers.	[Paul, B. T.; Blanchard, Z.; ElShamy, W. M.] Univ Mississippi, Med Ctr, Inst Canc, Jackson, MS 39216 USA; [Paul, B. T.; Blanchard, Z.; ElShamy, W. M.] Univ Mississippi, Med Ctr, Dept Biochem, Jackson, MS 39216 USA; [Ridgway, M.] Univ Mississippi, Med Ctr, Dept Obstet & Gynecol, Jackson, MS 39216 USA	University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center	ElShamy, WM (corresponding author), Univ Mississippi, Med Ctr, Inst Canc, 2500 North State St,G651,G362, Jackson, MS 39216 USA.	welshamy@umc.edu	ElShamy, Wael M./L-1090-2018; ElShamy, Wael/AAF-2867-2019					Alcantara S, 1997, J NEUROSCI, V17, P3623; Auersperg N, 2013, GYNECOL ONCOL, V130, P246, DOI 10.1016/j.ygyno.2013.03.021; Banerjee S, 2009, ONCOLOGIST, V14, P706, DOI 10.1634/theoncologist.2009-0013; BIRLING MC, 1995, CURR OPIN CELL BIOL, V7, P878, DOI 10.1016/0955-0674(95)80073-5; Blank SV, 2010, GYNECOL ONCOL, V119, P451, DOI 10.1016/j.ygyno.2010.08.008; Brader S, 2004, TUMORI J, V90, P2, DOI 10.1177/030089160409000102; Chandarlapaty S, 2011, CANCER CELL, V19, P58, DOI 10.1016/j.ccr.2010.10.031; Chen LF, 2013, INT J GYNECOL CANCER, V23, P256, DOI 10.1097/IGC.0b013e31827ad2b8; Chock K, 2010, ONCOGENE, V29, P5274, DOI 10.1038/onc.2010.262; Chock KL, 2010, CANCER RES, V70, P8782, DOI 10.1158/0008-5472.CAN-10-1352; Choudhury KR, 2010, J HISTOCHEM CYTOCHEM, V58, P95, DOI 10.1369/jhc.2009.953554; Douma S, 2004, NATURE, V430, P1034, DOI 10.1038/nature02765; ElShamy WM, 2004, NAT CELL BIOL, V6, P954, DOI 10.1038/ncb1171; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Felsher DW, 2008, APMIS, V116, P629, DOI 10.1111/j.1600-0463.2008.01037.x; Geiger TR, 2007, CANCER RES, V67, P6221, DOI 10.1158/0008-5472.CAN-07-0121; Gordon MS, 2006, J CLIN ONCOL, V24, P4324, DOI 10.1200/JCO.2005.05.4221; Hao L, 2007, INT J CANCER, V121, P39, DOI 10.1002/ijc.22597; Hondermarck H, 2012, CYTOKINE GROWTH F R, V23, P357, DOI 10.1016/j.cytogfr.2012.06.004; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; Huang HJ, 2011, BBA-MOL CELL RES, V1813, P1961, DOI 10.1016/j.bbamcr.2011.01.007; Jiang L, 2013, ONCOL LETT, P51605; Jungbluth S, 1997, DEVELOPMENT, V124, P1877; Kim H, 2004, J BIOL CHEM, V279, P33538, DOI 10.1074/jbc.M404115200; Kupferman ME, 2010, ONCOGENE, V29, P2047, DOI 10.1038/onc.2009.486; Lafky JM, 2008, BBA-REV CANCER, V1785, P232, DOI 10.1016/j.bbcan.2008.01.001; Liguang Z., 2007, Experimental Oncology, V29, P121; Liu AX, 1998, CANCER RES, V58, P2973; Makhija S, 2010, J CLIN ONCOL, V28, P1215, DOI 10.1200/JCO.2009.22.3354; MASANA Y, 1993, J NEUROSCI RES, V35, P468, DOI 10.1002/jnr.490350503; Matheny RW, 2009, BIOCHEM BIOPH RES CO, V389, P117, DOI 10.1016/j.bbrc.2009.08.101; Matsuo K, 2010, EXPERT OPIN INV DRUG, V19, P1339, DOI 10.1517/13543784.2010.515585; McCormick F, 2011, J SURG ONCOL, V103, P464, DOI 10.1002/jso.21749; Monsalve M, 2011, CURR DRUG TARGETS, V12, P1322, DOI 10.2174/138945011796150307; Nakuci E, 2006, EXP CELL RES, V312, P3120, DOI 10.1016/j.yexcr.2006.06.021; OHANLAN KA, 1995, GYNECOL ONCOL, V59, P200; Okamura K, 2012, LUNG CANCER, V78, P100, DOI 10.1016/j.lungcan.2012.07.011; Page C, 2000, ANTICANCER RES, V20, P407; Pece S, 1999, J BIOL CHEM, V274, P19347, DOI 10.1074/jbc.274.27.19347; Ponnusamy MP, 2010, ONCOGENE, V29, P5741, DOI 10.1038/onc.2010.309; Puehringer D, 2013, NAT NEUROSCI, V16, P407, DOI 10.1038/nn.3333; Ricci A, 2010, GROWTH FACTORS, V28, P221, DOI 10.3109/08977191003677402; Santo EE, 2013, CANCER RES, V73, P2189, DOI 10.1158/0008-5472.CAN-12-3767; Sergina NV, 2007, NATURE, V445, P437, DOI 10.1038/nature05474; Sheng Q, 2010, CANCER CELL, V17, P298, DOI 10.1016/j.ccr.2009.12.047; Shimizu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034102; Siwak DR, 2010, J ONCOL, V2010, DOI 10.1155/2010/568938; Smit MA, 2011, ONCOGENE, V30, P3735, DOI 10.1038/onc.2011.96; Smit MA, 2009, MOL CELL BIOL, V29, P3722, DOI 10.1128/MCB.01164-08; Tanner B, 2006, J CLIN ONCOL, V24, P4317, DOI 10.1200/JCO.2005.04.8397; Torti D, 2011, EMBO MOL MED, V3, P623, DOI 10.1002/emmm.201100176; Ween MP, 2011, INT J MOL SCI, V12, P1009, DOI 10.3390/ijms12021009; Wendel HG, 2004, NATURE, V428, P332, DOI 10.1038/nature02369; Weng DH, 2009, CANCER LETT, V273, P257, DOI 10.1016/j.canlet.2008.08.027; Yang J, 2004, CELL; Yang JY, 2008, NAT CELL BIOL, V10, P138, DOI 10.1038/ncb1676; Yarden Y, 2001, EUR J CANCER, V37, pS3; Yu XH, 2008, CANCER SCI, V99, P543, DOI 10.1111/j.1349-7006.2007.00722.x; Yu YJ, 2010, APMIS, V118, P188, DOI 10.1111/j.1600-0463.2009.02577.x; Yue W, 2010, REGUL PEPTIDES, V180, P33; Zhang HY, 2009, EUR J OBSTET GYN R B, V146, P81, DOI 10.1016/j.ejogrb.2009.04.035; Zheng WP, 2011, TUMORI, V97, P756, DOI 10.1700/1018.11093	62	26	30	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 4	2015	34	23					3036	3052		10.1038/onc.2014.237	http://dx.doi.org/10.1038/onc.2014.237			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CK3EX	25132263				2022-12-25	WOS:000356100500009
J	Kuzynski, M; Goss, M; Bottini, M; Yadav, MC; Mobley, C; Winters, T; Poliard, A; Kellermann, O; Lee, B; Millan, JL; Napierala, D				Kuzynski, Maria; Goss, Morgan; Bottini, Massimo; Yadav, Manisha C.; Mobley, Callie; Winters, Tony; Poliard, Anne; Kellermann, Odile; Lee, Brendan; Millan, Jose Luis; Napierala, Dobrawa			Dual Role of the Trps1 Transcription Factor in Dentin Mineralization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Biomineralization; Dentin; Differentiation; Extracellular Matrix; Gene Expression; Trps1; Odontoblast	MATRIX VESICLES; TRICHORHINOPHALANGEAL SYNDROME; DENTINOGENESIS IMPERFECTA; HYPOPHOSPHATEMIC RICKETS; ALKALINE-PHOSPHATASE; SKELETAL MINERALIZATION; BONE MINERALIZATION; TOOTH DEVELOPMENT; VITAMIN-D; EXPRESSION	Background: Regulation of dentin mineralization at the gene expression level is poorly understood. Results: Trps1 supports expression of osteogenic genes Alpl, Phospho1, Runx2, and Sp7 in preodontoblastic cells, and in mature cells Trps1 represses phosphate metabolism genes Phex and Vdr. Conclusion: The role of Trps1 in mineralization depends on odontoblastic differentiation stage. Significance: These findings provide insights into regulation of odontoblastic maturation and function. TRPS1 (tricho-rhino-phalangeal syndrome) is a unique GATA-type transcription factor that acts as a transcriptional repressor. TRPS1 deficiency and dysregulated TRPS1 expression result in skeletal and dental abnormalities implicating TRPS1 in endochondral bone formation and tooth development. Moreover, patients with tricho-rhino-phalangeal syndrome frequently present with low bone mass indicating TRPS1 involvement in bone homeostasis. In addition, our previous data demonstrated accelerated mineralization of the perichondrium in Trps1 mutant mice and impaired dentin mineralization in Col1a1-Trps1 transgenic mice, implicating Trps1 in the mineralization process. To understand the role of Trps1 in the differentiation and function of cells producing mineralized matrix, we used a preodontoblastic cell line as a model of dentin mineralization. We generated both Trps1-deficient and Trps1-overexpressing stable cell lines and analyzed the progression of mineralization by alkaline phosphatase and alizarin red staining. As predicted, based on our previous in vivo data, delayed and decreased mineralization of Trps1-overexpressing odontoblastic cells was observed when compared with control cells. This was associated with down-regulation of genes regulating phosphate homeostasis. Interestingly, Trps1-deficient cells lost the ability to mineralize and demonstrated decreased expression of several genes critical for initiating the mineralization process, including Alpl and Phospho1. Based on these data, we have concluded that Trps1 serves two critical and context-dependent functions in odontoblast-regulated mineralization as follows: 1) Trps1 is required for odontoblast maturation by supporting expression of genes crucial for initiating the mineralization process, and 2) Trps1 represses the function of mature cells and, consequently, restricts the extent of extracellular matrix mineralization.	[Kuzynski, Maria; Goss, Morgan; Mobley, Callie; Winters, Tony; Napierala, Dobrawa] Univ Alabama Birmingham, Sch Dent, Dept Oral & Maxillofacial Surg, Inst Oral Hlth Res, Birmingham, AL 35294 USA; [Bottini, Massimo; Yadav, Manisha C.; Millan, Jose Luis] Sanford Burnham Med Res Inst, Sanford Childrens Hlth Res Ctr, La Jolla, CA 92037 USA; [Bottini, Massimo] Univ Roma Tor Vergata, Dept Expt Med & Surg, I-00133 Rome, Italy; [Poliard, Anne] Univ Paris 05, UFR Odontol EA2496, F-92120 Montrouge, France; [Kellermann, Odile] Univ Paris 05, Ctr Univ St Peres, INSERM UMR S 1124, F-75270 Paris 06, France; [Lee, Brendan] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Lee, Brendan] Howard Hughes Med Inst, Houston, TX 77030 USA	University of Alabama System; University of Alabama Birmingham; Sanford Burnham Prebys Medical Discovery Institute; University of Rome Tor Vergata; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Baylor College of Medicine; Howard Hughes Medical Institute	Napierala, D (corresponding author), Univ Alabama Birmingham, Sch Dent, Dept Oral & Maxillofacial Surg, 707 SDB,1919 7th Ave South, Birmingham, AL 35294 USA.	dobrawan@uab.edu		Napierala, Dobrawa/0000-0002-7383-1011; Bottini, Massimo/0000-0001-9237-8972	National Institutes of Health, NIDCR [R01DE023083]; NIAMS [T90DE022736, DE12889, R01AR53102]; University of Alabama at Birmingham Center for Metabolic Bone Disease; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE012889, T90DE022736, R01DE023083] Funding Source: NIH RePORTER	National Institutes of Health, NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); University of Alabama at Birmingham Center for Metabolic Bone Disease; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DE023083 from NIDCR (to D. N.), T90DE022736 (to M. K.), DE12889 and R01AR53102 from NIAMS (to J. L. M.). This work was also supported by a grant from University of Alabama at Birmingham Center for Metabolic Bone Disease (to D. N.).	Addison WN, 2007, J BIOL CHEM, V282, P15872, DOI 10.1074/jbc.M701116200; Anderson HC, 2005, FRONT BIOSCI-LANDMRK, V10, P822, DOI 10.2741/1576; Balcerzak M, 2008, PROTEOMICS, V8, P192, DOI 10.1002/pmic.200700612; Barron MJ, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-31; Bergwitz C, 2012, ADV EXP MED BIOL, V728, P41, DOI 10.1007/978-1-4614-0887-1_3; Boukpessi T, 2006, CALCIFIED TISSUE INT, V79, P294, DOI 10.1007/s00223-006-0182-4; Chaussain-Miller C, 2007, ORAL DIS, V13, P482, DOI 10.1111/j.1601-0825.2006.01326.x; Ciancaglini P, 2010, J BONE MINER RES, V25, P716, DOI 10.1359/jbmr.091023; Fantauzzo KA, 2008, HUM MOL GENET, V17, P3539, DOI 10.1093/hmg/ddn247; Fantauzzo KA, 2012, DEVELOPMENT, V139, P203, DOI 10.1242/dev.069971; Foster BL, 2013, J BONE MINER RES, V28, P271, DOI 10.1002/jbmr.1767; Garces-Ortiz M, 2013, MED ORAL PATOL ORAL, V18, pE537, DOI 10.4317/medoral.18650; George A, 2008, CHEM REV, V108, P4670, DOI 10.1021/cr0782729; Goldberg M, 2002, CONNECT TISSUE RES, V43, P482, DOI 10.1080/03008200290000817; Goldberg Michel, 2011, Front Biosci (Elite Ed), V3, P711, DOI 10.2741/e281; Golub EE, 2011, SEMIN IMMUNOPATHOL, V33, P409, DOI 10.1007/s00281-010-0230-z; Golub EE, 2009, BBA-GEN SUBJECTS, V1790, P1592, DOI 10.1016/j.bbagen.2009.09.006; Gorski JP, 2011, FRONT BIOSCI-LANDMRK, V16, P2598, DOI 10.2741/3875; Harmey D, 2004, AM J PATHOL, V164, P1199, DOI 10.1016/S0002-9440(10)63208-7; Hessle L, 2002, P NATL ACAD SCI USA, V99, P9445, DOI 10.1073/pnas.142063399; Huang BZ, 2008, EUR J ORAL SCI, V116, P104, DOI 10.1111/j.1600-0722.2008.00522.x; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; James MJ, 2006, J BONE MINER RES, V21, P1034, DOI 10.1359/JBMR.060413; Johnson K, 2003, J BONE MINER RES, V18, P994, DOI 10.1359/jbmr.2003.18.6.994; Kantaputra P, 2008, J DENT RES, V87, P1027, DOI 10.1177/154405910808701102; KATCHBURIAN E, 1973, J ANAT, V116, P285; Kim JW, 2007, J DENT RES, V86, P392, DOI 10.1177/154405910708600502; Kirsch T, 1997, J CELL BIOL, V137, P1149, DOI 10.1083/jcb.137.5.1149; Kunath M, 2002, MECH DEVELOP, V119, pS117, DOI 10.1016/S0925-4773(03)00103-5; Lacerda-Pinheiro S, 2012, EUR CELLS MATER, V23, P371, DOI 10.22203/eCM.v023a29; Liu H, 2010, J DENT RES, V89, P1373, DOI 10.1177/0022034510379017; MacDougall M, 2006, AM J MED GENET A, V140A, P2536, DOI 10.1002/ajmg.a.31359; Malik TH, 2001, EMBO J, V20, P1715, DOI 10.1093/emboj/20.7.1715; Massa LF, 2005, HISTOCHEM CELL BIOL, V124, P197, DOI 10.1007/s00418-005-0009-9; McKee MD, 2013, J DENT RES, V92, P721, DOI 10.1177/0022034513490958; McKee MD, 2013, PERIODONTOL 2000, V63, P102, DOI 10.1111/prd.12029; Millan JL, 2013, CALCIFIED TISSUE INT, V93, P299, DOI 10.1007/s00223-012-9672-8; Momeni P, 2000, NAT GENET, V24, P71, DOI 10.1038/71717; Napierala D, 2008, HUM MOL GENET, V17, P2244, DOI 10.1093/hmg/ddn125; Napierala D, 2012, J BONE MINER RES, V27, P1735, DOI 10.1002/jbmr.1636; Piscopo DM, 2009, J BIOL CHEM, V284, P31690, DOI 10.1074/jbc.M109.052316; Polewski MD, 2010, BONE, V46, P81, DOI 10.1016/j.bone.2009.08.055; Priam F, 2005, ARCH ORAL BIOL, V50, P271, DOI 10.1016/j.archoralbio.2004.10.007; Rafaelsen SH, 2013, J BONE MINER RES, V28, P1378, DOI 10.1002/jbmr.1850; Salmon B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056749; Souza MA, 2010, CLINICS, V65, P1023, DOI 10.1590/S1807-59322010001000017; Sreenath T, 2003, J BIOL CHEM, V278, P24874, DOI 10.1074/jbc.M303908200; Stewart AJ, 2006, BONE, V39, P1000, DOI 10.1016/j.bone.2006.05.014; Stratmann U, 1996, CELL TISSUE RES, V284, P223, DOI 10.1007/s004410050582; Street SE, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-80; Suemoto H, 2007, DEV BIOL, V312, P572, DOI 10.1016/j.ydbio.2007.10.001; Suzuki H, 2008, ANAT REC, V291, P183, DOI 10.1002/ar.20630; Takano Y, 2000, BONE, V26, P333, DOI 10.1016/S8756-3282(00)00243-X; Thompson DL, 2002, J BONE MINER RES, V17, P311, DOI 10.1359/jbmr.2002.17.2.311; van den Bos T, 2005, J DENT RES, V84, P1021, DOI 10.1177/154405910508401110; Verdelis K, 2007, BONE, V40, P1399, DOI 10.1016/j.bone.2006.12.061; Vital SO, 2012, BONE, V50, P989, DOI 10.1016/j.bone.2012.01.010; Wuelling M, 2009, DEV BIOL, V328, P40, DOI 10.1016/j.ydbio.2009.01.012; Yadav MC, 2011, J BONE MINER RES, V26, P286, DOI 10.1002/jbmr.195; Ye L, 2004, J BIOL CHEM, V279, P19141, DOI 10.1074/jbc.M400490200; Yoshiko Y, 2007, BONE, V40, P1565, DOI 10.1016/j.bone.2007.01.017; Zhang XM, 2007, ARCH ORAL BIOL, V52, P1172, DOI 10.1016/j.archoralbio.2007.06.010	62	14	14	3	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27481	27493		10.1074/jbc.M114.550129	http://dx.doi.org/10.1074/jbc.M114.550129			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25128529	Green Published, hybrid			2022-12-25	WOS:000342852800011
J	Fueller, E; Schaefer, D; Fischer, U; Krell, PFI; Stanulla, M; Borkhardt, A; Slany, RK				Fueller, Elisa; Schaefer, Daniel; Fischer, Ute; Krell, Pina F. I.; Stanulla, Martin; Borkhardt, Arndt; Slany, Robert K.			Genomic Inverse PCR for Exploration of Ligated Breakpoints (GIPFEL), a New Method to Detect Translocations in Leukemia	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; MLL BREAKPOINTS; AIEOP-BFM; CLUSTER; GENE; REARRANGEMENTS; ELEMENTS; FUSION; REGION; CELL	Here we present a novel method "Genomic inverse PCR for exploration of ligated breakpoints" (GIPFEL) that allows the sensitive detection of recurrent chromosomal translocations. This technique utilizes limited amounts of DNA as starting material and relies on PCR based quantification of unique DNA sequences that are created by circular ligation of restricted genomic DNA from translocation bearing cells. Because the complete potential breakpoint region is interrogated, a prior knowledge of the individual, specific interchromosomal fusion site is not required. We validated GIPFEL for the five most common gene fusions associated with childhood leukemia (MLL-AF4, MLL-AF9, MLL-ENL, ETV6-RUNX1, and TCF3-PBX1). A workflow of restriction digest, purification, ligation, removal of linear fragments and precipitation enriching for circular DNA was developed. GIPFEL allowed detection of translocation specific signature sequences down to a 10(-4) dilution which is close to the theoretical limit. In a blinded proof-of-principle study utilizing DNA from cell lines and 144 children with B-precursor-ALL associated translocations this method was 100% specific with no false positive results. Sensitivity was 83%, 65%, and 24% for t(4;11), t(9;11) and t(11;19) respectively. Translocation t(12;21) was correctly detected in 64% and t(1;19) in 39% of the cases. In contrast to other methods, the characteristics of GIPFEL make it particularly attractive for prospective studies.	[Fueller, Elisa; Slany, Robert K.] Univ Erlangen Nurnberg, Dept Genet, D-91054 Erlangen, Germany; [Schaefer, Daniel; Fischer, Ute; Krell, Pina F. I.; Borkhardt, Arndt] Univ Dusseldorf, Fac Med, Dept Pediat Oncol Hematol & Clin Immunol, Univ Childrens Hosp, Dusseldorf, Germany; [Stanulla, Martin] Hannover Med Sch, Dept Pediat Hematol & Oncol, Hannover, Germany	University of Erlangen Nuremberg; Heinrich Heine University Dusseldorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Hannover Medical School	Borkhardt, A (corresponding author), Univ Dusseldorf, Fac Med, Dept Pediat Oncol Hematol & Clin Immunol, Univ Childrens Hosp, Dusseldorf, Germany.	arndt.borkhardt@med.uni-duesseldorf.de; robert.slany@fau.de	Stanulla, Martin/N-4674-2017	Stanulla, Martin/0000-0002-3834-0727	German Ministry for Radiation Protection (Bundesministerium fur Strahlenschutz, BfS) [3612S70019]	German Ministry for Radiation Protection (Bundesministerium fur Strahlenschutz, BfS)	This research was funded by a grant of the German Ministry for Radiation Protection (Bundesministerium fur Strahlenschutz, BfS) grant number 3612S70019. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao Y, 2000, GENE CHROMOSOME CANC, V27, P412, DOI 10.1002/(SICI)1098-2264(200004)27:4<412::AID-GCC11>3.0.CO;2-X; Cimino G, 1997, CANCER RES, V57, P2879; Conter V, 2010, BLOOD, V115, P3206, DOI 10.1182/blood-2009-10-248146; Emerenciano M, 2013, BRIT J HAEMATOL, V161, P224, DOI 10.1111/bjh.12250; Felix CA, 1997, BLOOD, V90, P4679, DOI 10.1182/blood.V90.12.4679.4679_4679_4686; Ghosh S, 2013, LEUKEMIA, V27, P1745, DOI 10.1038/leu.2013.1; Kibbe WA, 2007, NUCLEIC ACIDS RES, V35, pW43, DOI 10.1093/nar/gkm234; KOBAYASHI H, 1993, BLOOD, V82, P547; Langer T, 2003, GENE CHROMOSOME CANC, V36, P393, DOI 10.1002/gcc.10167; Lausten-Thomsen U, 2008, EUR J HAEMATOL, V81, P161, DOI 10.1111/j.1600-0609.2008.01091.x; Lausten-Thomsen U, 2011, BLOOD, V117, P186, DOI 10.1182/blood-2010-05-282764; Megonigal MD, 1997, P NATL ACAD SCI USA, V94, P11583, DOI 10.1073/pnas.94.21.11583; Meyer C, 2005, P NATL ACAD SCI USA, V102, P449, DOI 10.1073/pnas.0406994102; Mori H, 2002, P NATL ACAD SCI USA, V99, P8242, DOI 10.1073/pnas.112218799; Pui CH, 2011, J CLIN ONCOL, V29, P551, DOI 10.1200/JCO.2010.30.7405; Rodic N, 2013, MOBILE DNA-UK, V4, DOI 10.1186/1759-8753-4-22; Rowley JD, 2013, SCIENCE, V340, P1412, DOI 10.1126/science.1241318; Schrappe M, 2011, BLOOD, V118, P2077, DOI 10.1182/blood-2011-03-338707; Stanulla M, 1997, MOL CELL BIOL, V17, P4070, DOI 10.1128/MCB.17.7.4070; Thandla SP, 1999, BLOOD, V93, P293, DOI 10.1182/blood.V93.1.293.401k37_293_299; van der Burg M, 1999, LEUKEMIA, V13, P2107, DOI 10.1038/sj.leu.2401595; von Goessel H, 2009, LEUKEMIA RES, V33, P1082, DOI 10.1016/j.leukres.2008.11.001; Wiemels JL, 2002, P NATL ACAD SCI USA, V99, P15101, DOI 10.1073/pnas.222481199; Wiemels JL, 2008, CANCER RES, V68, P9935, DOI 10.1158/0008-5472.CAN-08-2139	24	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e104419	10.1371/journal.pone.0104419	http://dx.doi.org/10.1371/journal.pone.0104419			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137060	Green Submitted, Green Published, gold			2022-12-25	WOS:000340742100032
J	Hofman, R; de Bekker-Grob, EW; Richardus, JH; de Koning, HJ; van Ballegooijen, M; Korfage, IJ				Hofman, Robine; de Bekker-Grob, Esther W.; Richardus, Jan Hendrik; de Koning, Harry J.; van Ballegooijen, Marjolein; Korfage, Ida J.			Have Preferences of Girls Changed Almost 3 Years after the Much Debated Start of the HPV Vaccination Program in the Netherlands? A Discrete Choice Experiment	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; WILLINGNESS-TO-PAY; HEALTH-CARE; EFFICACY; COHORT; WOMEN; RISK	Objectives: To assess how girls' preferences have changed almost 3 years after the much debated start of the human papillomavirus (HPV) vaccination program. Methods: A discrete choice experiment (DCE) was conducted among girls aged 11-15 years who were invited, or were not yet invited, to get vaccinated. A panel latent class model was used to determine girls' preferences for vaccination based on five characteristics: degree of protection against cervical cancer; duration of protection; risk of mild side-effects; age of vaccination; and the number of required doses of the vaccine. Results: The response rate was 85% (500/592). Most girls preferred vaccination at age 14 years (instead of at age 9 years) and a 2-dose scheme (instead of the current 3-dose scheme). Girls were willing to trade-off 7% (CI: 3.2% to 10.8%) of the degree of protection to have 10% less risk of mild side-effects, and 4% (CI: 1.2% to 5.9%) to receive 2 doses instead of 3 doses. Latent class analyses showed that there was preference heterogeneity among girls, i.e., higher educated girls and HPV vaccinated girls had a higher probability to opt for HPV vaccination at a higher age than lower educated girls or non-vaccinated girls. Conclusions: Three years after the start of HPV vaccination program the risk of mild side-effects and age at vaccination seem to have become less important. For the Dutch national immunization program, we recommend not to lower the current target age of 12 years. A 2-dose scheme may result in a higher uptake and we recommend that if this scheme is introduced, it needs to receive adequate publicity.	[Hofman, Robine; de Bekker-Grob, Esther W.; Richardus, Jan Hendrik; de Koning, Harry J.; van Ballegooijen, Marjolein; Korfage, Ida J.] Erasmus MC Univ Med Ctr Rotterdam, Dept Publ Hlth, Rotterdam, Netherlands; [Richardus, Jan Hendrik] Municipal Publ Hlth Serv Rotterdam Rijnmond, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Hofman, R (corresponding author), Erasmus MC Univ Med Ctr Rotterdam, Dept Publ Hlth, Rotterdam, Netherlands.	r.hofman@erasmusmc.nl	Richardus, Jan Hendrik/AAE-1278-2021; de+Koning, Harry/AAF-9062-2019	Richardus, Jan Hendrik/0000-0003-0564-6313; de+Koning, Harry/0000-0003-4682-3646	Dutch Cancer Society [EMCR 2009-4561]	Dutch Cancer Society(KWF Kankerbestrijding)	This study was funded by the Dutch Cancer Society (no. EMCR 2009-4561). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishop AJ, 2004, BJOG-INT J OBSTET GY, V111, P775, DOI 10.1111/j.1471-0528.2004.00197.x; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Brown DS, 2010, VACCINE, V28, P1702, DOI 10.1016/j.vaccine.2009.12.024; Centers for Disease Control and Prevention, 2013, WHAT AR RISKS THIS V; Centers for Disease Control and Prevention, 2014, POSS SID EFF VACC; de Bekker-Grob EW, 2013, BRIT J CANCER, V108, P533, DOI 10.1038/bjc.2013.5; de Bekker-Grob EW, 2012, HEALTH ECON, V21, P145, DOI 10.1002/hec.1697; de Bekker-Grob EW, 2010, VACCINE, V28, P6692, DOI 10.1016/j.vaccine.2010.08.001; de Hoogh PAAM, 2011, IMMUNIZATION COVERAG; Hensher D., 2005, APPL CHOICE ANAL PRI, DOI 10.1017/CBO9780511610356; Herbild L, 2009, VALUE HEALTH, V12, P560, DOI 10.1111/j.1524-4733.2008.00465.x; Hole AR, 2007, HEALTH ECON, V16, P827, DOI 10.1002/hec.1197; Johnson FR, 2013, VALUE HEALTH, V16, P3, DOI 10.1016/j.jval.2012.08.2223; KOUTSKY LA, 1992, NEW ENGL J MED, V327, P1272, DOI 10.1056/NEJM199210293271804; Kreimer AR, 2011, JNCI-J NATL CANCER I, V103, P1444, DOI 10.1093/jnci/djr319; Lancsar E, 2008, PHARMACOECONOMICS, V26, P661, DOI 10.2165/00019053-200826080-00004; Lancsar E, 2006, HEALTH ECON, V15, P797, DOI 10.1002/hec.1104; Munoz N, 2004, INT J CANCER, V111, P278, DOI 10.1002/ijc.20244; Oteng B, 2011, SEX TRANSM INFECT, V87, P52, DOI 10.1136/sti.2009.041392; Phillips Kathryn A, 2006, Prev Chronic Dis, V3, pA75; Puthanakit T, 2013, IMMUNE RESPONSES 2 D; RIVM, 2014, VOORT 1 PRIK MIND TE; Roteli-Martins CM, 2012, HUM VACC IMMUNOTHER, V8, DOI 10.4161/hv.18865; Ryan M, 2004, BMJ-BRIT MED J, V328, P360, DOI 10.1136/bmj.328.7436.360; Ryan M, 2009, HEALTH ECON, V18, P321, DOI 10.1002/hec.1369; Serrano B, 2012, INFECT AGENTS CANCER, V7, DOI 10.1186/1750-9378-7-38; Swait J., 1994, J RETAIL CONSUM SERV, V1, P77, DOI [10.1016/0969-6989(94)90002-7, DOI 10.1016/0969-6989(94)90002-7]; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Winer RL, 2003, AM J EPIDEMIOL, V157, P218, DOI 10.1093/aje/kwf180; Woodman CBJ, 2001, LANCET, V357, P1831, DOI 10.1016/S0140-6736(00)04956-4; Zwakhals S, 2012, HPV COHORT 1998 INTE	31	18	18	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e104772	10.1371/journal.pone.0104772	http://dx.doi.org/10.1371/journal.pone.0104772			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN6XM	25136919	Green Published, gold, Green Submitted			2022-12-25	WOS:000340742100047
J	Liu, XW; Long, ZW; Cai, H; Huang, H; Shi, YQ; Wang, YN				Liu, Xiaowen; Long, Ziwen; Cai, Hong; Huang, Hua; Shi, Yingqiang; Wang, Yanong			Analysis of Lymph Node Metastasis Correlation with Prognosis in Patients with T2 Gastric Cancer	PLOS ONE			English	Article							ADENOCARCINOMA	Purpose: To investigate the correlated factors for lymph node metastasis and prognosis for patients with T2 gastric cancer. Methods: A total of 442 patients with T2 gastric cancer who underwent gastrectomy from January 1996 to December 2009 were evaluated. The clinicopathological parameters were analyzed for lymph node metastasis and prognosis, including gender, age, tumor size, tumor location, histological type, depth of invasion, vascular tumor emboli, nervous invasion, resection type, and pathological stage. Results: The rate of lymph node metastasis was 45.9%. Univariate analysis showed that depth of invasion, tumor size, and vascular tumor emboli were associated with lymph node metastasis. Logistic regression demonstrated that depth of invasion, tumor size, and vascular tumor emboli were independently predictive factors for lymph node metastasis. The 5-year survival rate was 64.0%. Multivariate analysis showed that tumor size, tumor location, resection type, and pathological stage were independent prognostic factors. Based on tumor size, there were significant differences of 5-year survival between small size tumor (<6 cm) and large size tumor (>= 6 cm) according to stage IIA (P = 0.006). Based on tumor location, there were significant differences of 5-year survival among different tumor location according to stage IB. Based on resection type, there were significant differences of overall 5-year survival between curative surgery and palliative surgery according to stage IIB (P = 0.015) and IIIA (P = 0.001). Conclusion: Depth of invasion, tumor size, and vascular tumor emboli were independently predictive factors for lymph node metastasis. Tumor size, tumor location, resection type, and pathological stage were independent prognostic factors.	[Liu, Xiaowen; Long, Ziwen; Cai, Hong; Huang, Hua; Shi, Yingqiang; Wang, Yanong] Fudan Univ, Shanghai Canc Ctr, Dept Gastr Canc & Soft Tissue Sarcoma, Shanghai 200433, Peoples R China; [Liu, Xiaowen; Long, Ziwen; Cai, Hong; Huang, Hua; Shi, Yingqiang; Wang, Yanong] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Wang, YN (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Gastr Canc & Soft Tissue Sarcoma, Shanghai 200433, Peoples R China.	wangyn1111@hotmail.com						ADACHI Y, 1994, GUT, V35, P1368, DOI 10.1136/gut.35.10.1368; Baiocchi GL, 2010, ANN SURG, V252, P70, DOI 10.1097/SLA.0b013e3181e4585e; Dicken BJ, 2005, ANN SURG, V241, P27, DOI 10.1097/01.sla.0000149300.28588.23; Gammerer G, 2012, ANTICANCER RES, V32, P1839; Hsu JT, 2013, EJSO-EUR J SURG ONC, V39, P1287, DOI 10.1016/j.ejso.2013.07.183; Kim DY, 2006, WORLD J GASTROENTERO, V12, P1182, DOI 10.3748/wjg.v12.i8.1182; Kim Jin-Pok, 1998, Gastric Cancer, V1, P125, DOI 10.1007/s101200050006; KIM JP, 1994, WORLD J SURG, V18, P872, DOI 10.1007/BF00299091; Lim MS, 2011, J GASTROINTEST SURG, V15, P1783, DOI 10.1007/s11605-011-1624-5; Liu XW, 2009, ANN SURG ONCOL, V16, P1875, DOI 10.1245/s10434-009-0449-x; Lu J, 2013, SURG ONCOL, V22, P167, DOI 10.1016/j.suronc.2013.05.002; MARUYAMA K, 1987, SCAND J GASTROENTERO, V22, P63, DOI 10.3109/00365528709091021; Nitti D, 2009, BRIT J SURG, V96, P398, DOI 10.1002/bjs.6487; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Qiu MZ, 2011, TUMOR BIOL, V32, P489, DOI 10.1007/s13277-010-0142-5; Shibata A, 2006, CANC EPIDEMIOLOGY PR, P707; Shou ZX, 2012, ANN SURG, V256, P1014, DOI 10.1097/SLA.0b013e3182592f56; Siewert JR, 1998, ANN SURG, V228, P449, DOI 10.1097/00000658-199810000-00002; Tang HL, 2013, CLIN CANCER RES, V19, P5602, DOI 10.1158/1078-0432.CCR-13-1326; Wu CY, 2002, HEPATO-GASTROENTEROL, V49, P1465; Yamashita H, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-147	21	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105112	10.1371/journal.pone.0105112	http://dx.doi.org/10.1371/journal.pone.0105112			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136920	Green Published, Green Submitted, gold			2022-12-25	WOS:000340742100065
J	Sachdev, PS; Mohan, A; Cannon, E; Crawford, JD; Silberstein, P; Cook, R; Coyne, T; Silburn, PA				Sachdev, Perminder S.; Mohan, Adith; Cannon, Elisabeth; Crawford, John D.; Silberstein, Paul; Cook, Raymond; Coyne, Terrence; Silburn, Peter A.			Deep Brain Stimulation of the Antero-Medial Globus Pallidus Interna for Tourette Syndrome	PLOS ONE			English	Review							THALAMIC-STIMULATION; SCALE; PALLIDOTOMY; NUCLEUS	Background: We have previously reported the results of Deep Brain Stimulation (DBS) of the antero-medial globus pallidus interna (GPi) for severe Tourette Syndrome (TS) in 11 patients. We extend this case series to 17 patients and a longer follow-up to a maximum of 46 months. Methods: 17 patients (14 male; mean age 29.1 years, range 17-51 years) with severe and medically intractable TS were implanted with Medtronic quadripolar electrodes bilaterally in the antero-medial GPi. The primary outcome measure was the Yale Global Tic Severity Scale (YGTSS). Secondary outcome measures included the Yale-Brown Obsessive Compulsive Scale, Hamilton Depression Rating Scale, Gilles de la Tourette Quality of Life Scale and Global Assessment of Functioning. Follow up was at one month, three months and finally at a mean 24.1 months (range 8-46 months) following surgery. Results: Overall, there was a 48.3% reduction in motor tics and a 41.3% reduction in phonic tics at one month, and this improvement was maintained at final follow-up. 12 out of 17 (70.6%) patients had a>50% reduction in YGTSS score at final follow up. Only 8 patients required ongoing pharmacotherapy for tics post-surgery. Patients improved significantly on all secondary measures. Adverse consequences included lead breakage in 4 patients, infection (1), transient anxiety (2), dizziness (1), poor balance (1) and worsening of stuttering (1). Conclusions: This case series provides further support that antero-medial GPi DBS is an effective and well tolerated treatment for a subgroup of severe TS, with benefits sustained up to 4 years.	[Sachdev, Perminder S.; Mohan, Adith; Cannon, Elisabeth] Prince Wales Hosp, Inst Neuropsychiat, Randwick, NSW 2031, Australia; [Sachdev, Perminder S.; Mohan, Adith; Crawford, John D.] Univ New S Wales, Sch Psychiat, Ctr Hlth Brain Ageing, Sydney, NSW, Australia; [Silberstein, Paul; Cook, Raymond] North Shore Private Hosp, Sydney, NSW, Australia; [Coyne, Terrence; Silburn, Peter A.] Univ Queensland, Clin Res Ctr, Herston, Qld, Australia; [Coyne, Terrence; Silburn, Peter A.] St Andrews War Mem Hosp, Spring Hill, Qld, Australia	University of New South Wales Sydney; University of Queensland	Sachdev, PS (corresponding author), Prince Wales Hosp, Inst Neuropsychiat, Randwick, NSW 2031, Australia.	p.sachdev@unsw.edu.au	Sachdev, Perminder/ABC-1137-2020	Sachdev, Perminder/0000-0002-9595-3220	University of New South Wales (UNSW) Australia & Prince of Wales Hospital; Prince of Wales Hospital; UNSW Australia; North Shore Private Hospital; University of Queensland; St. Andrew's War Memorial Hospital; National Health and Medical Research Council of Australia Program [401162]; NSW Institute of Psychiatry Training Fellowship	University of New South Wales (UNSW) Australia & Prince of Wales Hospital; Prince of Wales Hospital(Chinese University of Hong Kong); UNSW Australia; North Shore Private Hospital; University of Queensland(University of Queensland); St. Andrew's War Memorial Hospital; National Health and Medical Research Council of Australia Program(National Health and Medical Research Council (NHMRC) of Australia); NSW Institute of Psychiatry Training Fellowship	Employment: PSS and AM - University of New South Wales (UNSW) Australia & Prince of Wales Hospital; EC - Prince of Wales Hospital; JDC - UNSW Australia; PS and RC - North Shore Private Hospital; TC and PAS - University of Queensland and St. Andrew's War Memorial Hospital. Grants: PSS and AM - National Health and Medical Research Council of Australia Program Grant (no. 401162); EC - NSW Institute of Psychiatry Training Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermans L, 2011, BRAIN, V134, P832, DOI 10.1093/brain/awq380; Cannon E, 2012, AM J PSYCHIAT, V169, P860, DOI 10.1176/appi.ajp.2012.11101583; Cavanna AE, 2008, NEUROLOGY, V71, P1410, DOI 10.1212/01.wnl.0000327890.02893.61; Cook RJ, 1998, J CLIN NEUROSCI, V5, P20, DOI 10.1016/S0967-5868(98)90196-5; Denys D, 2010, ARCH GEN PSYCHIAT, V67, P1061, DOI 10.1001/archgenpsychiatry.2010.122; GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1006; Greenberg BD, 2010, MOL PSYCHIATR, V15, P64, DOI 10.1038/mp.2008.55; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hariz MI, 2010, EUR J NEUROSCI, V32, P1128, DOI 10.1111/j.1460-9568.2010.07415.x; Holtzheimer PE, 2012, ARCH GEN PSYCHIAT, V69, P150, DOI 10.1001/archgenpsychiatry.2011.1456; JONES SH, 1995, BRIT J PSYCHIAT, V166, P654, DOI 10.1192/bjp.166.5.654; Kennedy SH, 2011, AM J PSYCHIAT, V168, P502, DOI 10.1176/appi.ajp.2010.10081187; LAITINEN LV, 1992, STEREOT FUNCT NEUROS, V58, P14, DOI 10.1159/000098965; LECKMAN JF, 1989, J AM ACAD CHILD PSY, V28, P566, DOI 10.1097/00004583-198907000-00015; Martinez-Fernandez R, 2011, MOVEMENT DISORD, V26, P1922, DOI 10.1002/mds.23734; Massano J, 2013, J NEUROL, V260, P2417, DOI 10.1007/s00415-013-7049-1; Motlagh MG, 2013, TREMOR OTHER HYPERKI, P3; Muller-Vahl KR, 2013, NEUROSCI BIOBEHAV R, V37, P1178, DOI 10.1016/j.neubiorev.2012.09.012; Nebel A, 2009, J NEURAL TRANSM, V116, P167, DOI 10.1007/s00702-008-0173-x; Porta M, 2012, ACTA NEUROCHIR, V154, P2029, DOI 10.1007/s00701-012-1497-8; Schaltenbrand G., 1977, ATLAS STEREOTAXY HUM; Servello D, 2010, NEUROMODULATION, V13, P187, DOI 10.1111/j.1525-1403.2009.00253.x; Starr PA, 2002, J NEUROSURG, V97, P370, DOI 10.3171/jns.2002.97.2.0370; Toft M, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-44; Welter ML, 2008, ARCH NEUROL-CHICAGO, V65, P952, DOI 10.1001/archneur.65.7.952	25	50	52	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e104926	10.1371/journal.pone.0104926	http://dx.doi.org/10.1371/journal.pone.0104926			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136825	Green Published, gold, Green Submitted			2022-12-25	WOS:000340742100055
J	Suzuki, C; Kawazuma, K; Horita, S; Terada, T; Tanokura, M; Okada, K; Yamane, H; Nojiri, H				Suzuki, Chiho; Kawazuma, Kohei; Horita, Shoichiro; Terada, Tohru; Tanokura, Masaru; Okada, Kazunori; Yamane, Hisakazu; Nojiri, Hideaki			Oligomerization Mechanisms of an H-NS Family Protein, Pmr, Encoded on the Plasmid pCAR1 Provide a Molecular Basis for Functions of H-NS Family Members	PLOS ONE			English	Article							HORIZONTALLY ACQUIRED DNA; ESCHERICHIA-COLI; DIMERIZATION DOMAIN; PSEUDOMONAS-PUTIDA; SELF-ASSOCIATION; GENE-EXPRESSION; FOREIGN DNA; BINDING; MVAT; FOLD	Enterobacterial H-NS-like proteins and Pseudomonas MvaT-like proteins share low homology at the amino acid sequence level, but both can function as xenogeneic silencers and are included in the H-NS family of proteins. H-NS family members have dimerization/oligomerization and DNA-binding domains connected by a flexible linker and form large nucleoprotein complexes using both domains. Pmr, an MvaT-like protein encoded on the IncP-7 carbazole-degradative plasmid pCAR1, is a key regulator of an interaction between pCAR1 and its host Pseudomonas putida KT2440. KT2440 has two transcribed genes that encode the MvaT-like proteins TurA and TurB. Our previous transcriptome analyses suggested that the functions of Pmr, TurA and TurB are non-equivalent, although the detailed underlying mechanisms remain unclear. In this study, we focused on the protein-protein interactions of Pmr, and assessed the homo-oligomerization capacity of various substituted and truncated Pmr derivatives by protein-protein cross-linking analysis. Six of the seven residues identified as important for homo-oligomerization in Pmr were located near the N-terminus, and the putative flexible linker or the region near that was not involved in homo-oligomerization, suggesting that Pmr homo-oligomerization is different from that of enterobacterial H-NS and that the functional mechanism differs between H-NS-like and MvaT-like proteins. In addition, we assessed homo- and hetero-oligomerization of Pmr by surface plasmon resonance analysis and found that the coupling ratio of TurB-Pmr oligomers is smaller than that of Pmr-Pmr or TurA-Pmr oligomers. These results raised the possibility that composition of the hetero-oligomers of Pmr, TurA, and TurB could explain why the different gene sets were affected by either pmr, turA, or turB disruption in our previous studies.	[Suzuki, Chiho; Kawazuma, Kohei; Okada, Kazunori; Yamane, Hisakazu; Nojiri, Hideaki] Univ Tokyo, Biotechnol Res Ctr, Tokyo, Japan; [Horita, Shoichiro; Tanokura, Masaru] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo, Japan; [Terada, Tohru; Nojiri, Hideaki] Univ Tokyo, Grad Sch Agr & Life Sci, Agr Bioinformat Res Unit, Tokyo, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Nojiri, H (corresponding author), Univ Tokyo, Biotechnol Res Ctr, Tokyo, Japan.	anojiri@mail.ecc.u-tokyo.ac.jp	Terada, Tohru/W-2956-2019	Terada, Tohru/0000-0002-7091-0646; Nojiri, Hideaki/0000-0003-3091-8691; Suzuki-Minakuchi, Chiho/0000-0001-6622-1955; Tanokura, Masaru/0000-0001-5072-2480	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology of Japan [24380043]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	CS was supported by research fellowships from the Japan Society for the Promotion of Science for Young Scientists. This work was supported in part by a Grant-in-Aid for Scientific Research (24380043) (to HN) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali SS, 2012, CURR OPIN MICROBIOL, V15, P175, DOI 10.1016/j.mib.2011.12.014; Arold ST, 2010, P NATL ACAD SCI USA, V107, P15728, DOI 10.1073/pnas.1006966107; Banos RC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000513; Bloch V, 2003, NAT STRUCT BIOL, V10, P212, DOI 10.1038/nsb904; Bouffartigues E, 2007, NAT STRUCT MOL BIOL, V14, P441, DOI 10.1038/nsmb1233; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Castang S, 2012, J BACTERIOL, V194, P5101, DOI 10.1128/JB.00932-12; Castang S, 2010, MOL MICROBIOL, V78, P916, DOI 10.1111/j.1365-2958.2010.07378.x; Castang S, 2008, P NATL ACAD SCI USA, V105, P18947, DOI 10.1073/pnas.0808215105; Cerdan R, 2003, J MOL BIOL, V334, P179, DOI 10.1016/j.jmb.2003.09.051; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Dillon SC, 2010, MOL MICROBIOL, V76, P1250, DOI 10.1111/j.1365-2958.2010.07173.x; Dorman CJ, 2009, FRONT BIOSCI-LANDMRK, V14, P4103, DOI 10.2741/3515; Dorman CJ, 2004, NAT REV MICROBIOL, V2, P391, DOI 10.1038/nrmicro883; Doyle M, 2007, SCIENCE, V315, P251, DOI 10.1126/science.1137550; Esposito D, 2002, J MOL BIOL, V324, P841, DOI 10.1016/S0022-2836(02)01141-5; Fang FC, 2008, CURR OPIN MICROBIOL, V11, P113, DOI 10.1016/j.mib.2008.02.011; Fernandez-de-Alba C, 2013, J MOL BIOL, V425, P2347, DOI 10.1016/j.jmb.2013.03.006; Grainger DC, 2006, NUCLEIC ACIDS RES, V34, P4642, DOI 10.1093/nar/gkl542; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Lang B, 2007, NUCLEIC ACIDS RES, V35, P6330, DOI 10.1093/nar/gkm712; Leonard PG, 2009, MOL MICROBIOL, V73, P165, DOI 10.1111/j.1365-2958.2009.06754.x; Lim CJ, 2012, NUCLEIC ACIDS RES, V40, P3316, DOI 10.1093/nar/gkr1247; Lobley A, 2009, BIOINFORMATICS, V25, P1761, DOI 10.1093/bioinformatics/btp302; Lucchini S, 2006, PLOS PATHOG, V2, P746, DOI 10.1371/journal.ppat.0020081; Lucchini S, 2009, MOL MICROBIOL, V74, P1169, DOI 10.1111/j.1365-2958.2009.06929.x; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Navarre WW, 2006, SCIENCE, V313, P236, DOI 10.1126/science.1128794; Nojiri H, 2013, CURR OPIN BIOTECH, V24, P423, DOI 10.1016/j.copbio.2012.09.014; Nojiri H, 2012, BIOSCI BIOTECH BIOCH, V76, P1, DOI 10.1271/bbb.110620; Oshima T, 2006, DNA RES, V13, P141, DOI 10.1093/dnares/dsl009; Renzi F, 2010, ENVIRON MICROBIOL, V12, P254, DOI 10.1111/j.1462-2920.2009.02064.x; Rescalli E, 2004, J BIOL CHEM, V279, P7777, DOI 10.1074/jbc.M310580200; Rimsky S, 2004, CURR OPIN MICROBIOL, V7, P109, DOI 10.1016/j.mib.2004.02.001; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Sette M, 2009, J BIOL CHEM, V284, P30453, DOI 10.1074/jbc.M109.044313; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; SHI XL, 1994, J BACTERIOL, V176, P6769, DOI 10.1128/JB.176.21.6769-6775.1994; Shindo H, 1999, FEBS LETT, V455, P63, DOI 10.1016/S0014-5793(99)00862-5; Sonden B, 1996, EMBO J, V15, P4970, DOI 10.1002/j.1460-2075.1996.tb00877.x; Suzuki C, 2011, BIOSCI BIOTECH BIOCH, V75, P711, DOI 10.1271/bbb.100841; Takeda T., 2011, INT J EVOL BIOL; Tendeng C, 2003, TRENDS MICROBIOL, V11, P511, DOI 10.1016/j.tim.2003.09.005; Tendeng C, 2003, MICROBIOL-SGM, V149, P3047, DOI 10.1099/mic.0.C0125-0; Ueguchi C, 1996, J MOL BIOL, V263, P149, DOI 10.1006/jmbi.1996.0566; Vallet-Gely I, 2005, P NATL ACAD SCI USA, V102, P11082, DOI 10.1073/pnas.0502663102; Wiedenbeck J, 2011, FEMS MICROBIOL REV, V35, P957, DOI 10.1111/j.1574-6976.2011.00292.x; Yun CS, 2010, J BACTERIOL, V192, P4720, DOI 10.1128/JB.00591-10; Yuste L, 2006, ENVIRON MICROBIOL, V8, P165, DOI 10.1111/j.1462-2920.2005.00890.x	50	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105656	10.1371/journal.pone.0105656	http://dx.doi.org/10.1371/journal.pone.0105656			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137042	Green Published, Green Submitted, gold			2022-12-25	WOS:000340742100112
J	Wei, M; Yu, R; Deutsch, SC				Wei, Meng; Yu, Run; Deutsch, Stephen C.			Insignificant Medium-Term Vitamin D Status Change after 25-Hydroxyvitamin D Testing in a Large Managed Care Population	PLOS ONE			English	Article							CROSS-SECTIONAL SURVEY; D DEFICIENCY; GENERAL-PRACTITIONERS; PRESCRIBING SUNSHINE; SUPPLEMENTATION; INSUFFICIENCY; PREVENTION; FRACTURES; ADULTS	Objectives: To examine the clinical utility of 25-hydroxyvitamin D (25(OH)D) testing in achieving medium-term vitamin D (VD) sufficiency in a managed care population. Methods: Retrospective study of a continuously-enrolled patient population in a 3-year period between 2011 and 2013. Primary outcome was VD status at similar to 1 year after 25(OH)D testing. Patient demographics, comorbidities, medications, and 25(OH)D test results were gathered from relevant databases and multivariate logistic regression analysis used to study the risk factors of persistent VD deficiency or insufficiency. Results: Of 22,784 patients, 7533 (females 69.3%) did 14,563 25(OH)D tests, with an estimated cost of $582,520. Of the 7533 patients, 1126 had another 25(OH)D test at 300-400 days after the first one. Based on the two test results, 234 patients (20.8%) maintained sufficient 25(OH)D levels; 132 (11.7%) turned from VD-sufficient into VD-insufficient or -deficient; 538 (47.8%) remained VD-insufficient or -deficient, and only 222 (19.7%) improved to be VD-sufficient. Overall, only 8.0% more patients were VD-sufficient at similar to 1 year after 25(OH)D testing. Only younger age and higher BMI were independent risk factors for persistent low 25(OH)D levels and high-dose VD use was not associated with achieving VD sufficiency. Conclusions: 25(OH)D testing only benefits a small portion of patients thus lacks clinical utility in achieving VD sufficiency in the medium term but incurs a significant cost. A practical strategy to treat VD deficiency or insufficiency is needed; without it, 25(OH)D testing adds little value to most patients' health and should be used with discretion.	[Wei, Meng; Deutsch, Stephen C.] Cedars Sinai Med Care Fdn, Beverly Hills, CA USA; [Yu, Run] Cedars Sinai Med Ctr, Div Endocrinol, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center	Yu, R (corresponding author), Cedars Sinai Med Ctr, Div Endocrinol, Los Angeles, CA 90048 USA.	run.yu@cshs.org						Basit S, 2013, BRIT J BIOMED SCI, V70, P161, DOI 10.1080/09674845.2013.11669951; Bilinski KL, 2012, MED J AUSTRALIA, V197, P90, DOI 10.5694/mja12.10561; Bischoff-Ferrari HA, 2012, NEW ENGL J MED, V367, P40, DOI 10.1056/NEJMoa1109617; Bonevski B, 2012, INT J CANCER, V130, P2138, DOI 10.1002/ijc.26225; Drincic A, 2013, J CLIN ENDOCR METAB, V98, P4845, DOI 10.1210/jc.2012-4103; Forrest KYZ, 2011, NUTR RES, V31, P48, DOI 10.1016/j.nutres.2010.12.001; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; IOM, 2011, DIETARY REFERENCE IN; Jackson RD, 2006, NEW ENGL J MED, V354, P669, DOI 10.1056/NEJMoa055218; Lee P, 2009, AM J MED, V122, P1056, DOI 10.1016/j.amjmed.2009.06.008; Looker AC, 2008, AM J CLIN NUTR, V88, P1519, DOI 10.3945/ajcn.2008.26182; Pietras SM, 2009, ARCH INTERN MED, V169, P1806, DOI 10.1001/archinternmed.2009.361; Reeder AI, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-85; Reid IR, 2014, LANCET, V383, P146, DOI 10.1016/S0140-6736(13)61647-5; Rosen CJ, 2011, NEW ENGL J MED, V364, P248, DOI 10.1056/NEJMcp1009570; Sanders KM, 2010, JAMA-J AM MED ASSOC, V303, P1815, DOI 10.1001/jama.2010.594; Sattar N, 2012, LANCET, V379, P95, DOI 10.1016/S0140-6736(11)61816-3; Stratton-Loeffler MJ, 2012, J MANAGE CARE PHARM, V18, P497, DOI 10.18553/jmcp.2012.18.7.497; Vogt TM, 2004, AM J MANAG CARE, V10, P643; Yu R, 2014, SOUTH MED J, V107, P218, DOI 10.1097/SMJ.0000000000000094	21	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105571	10.1371/journal.pone.0105571	http://dx.doi.org/10.1371/journal.pone.0105571			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136806	Green Published, gold, Green Submitted			2022-12-25	WOS:000340742100108
J	Wylie, SJ; Li, H; Saqib, M; Jones, MGK				Wylie, Stephen J.; Li, Hua; Saqib, Muhammad; Jones, Michael G. K.			The Global Trade in Fresh Produce and the Vagility of Plant Viruses: A Case Study in Garlic	PLOS ONE			English	Article							SEQUENCE; RNA; POTYVIRUS; HOMOLOGY	As cuisine becomes globalized, large volumes of fresh produce are traded internationally. The potential exists for pathogens infecting fresh produce to hitchhike to new locations and perhaps to establish there. It is difficult to identify them using traditional methods if pathogens are novel, scarce, and/or unexpected. In an attempt to overcome this limitation, we used high-throughput sequencing technology as a means of detecting all RNA viruses infecting garlic (Allium sativum L.) bulbs imported into Australia from China, the USA, Mexico, Argentina and Spain, and those growing in Australia. Bulbs tested were grown over multiple vegetative generations and all were stably infected with one or more viruses, including two species not previously recorded in Australia. Present in various combinations from 10 garlic bulbs were 41 virus isolates representing potyviruses (Onion yellow dwarf virus, Leek yellow stripe virus), carlaviruses (Shallot latent virus, Garlic common latent virus) and allexiviruses (Garlic virus A, B, C, D, and X), for which 19 complete and 22 partial genome sequences were obtained, including the first complete genome sequences of two isolates of GarVD. The most genetically distinct isolates of GarVA and GarVX described so far were identified from Mexico and Argentina, and possible scenarios explaining this are presented. The complete genome sequence of an isolate of the potexvirus Asparagus virus 3 (AV3) was obtained in Australia from wild garlic (A. vineale L.), a naturalized weed. This is first time AV3 has been identified from wild garlic and the first time it has been identified beyond China and Japan. The need for routine generic diagnosis and appropriate legislation to address the risks to primary production and wild plant communities from pathogens spread through the international trade in fresh produce is discussed.	[Wylie, Stephen J.; Li, Hua; Jones, Michael G. K.] Murdoch Univ, Sch Vet & Life Sci, Western Australian State Agr Biotechnol Ctr, Plant Virol Grp, Perth, WA, Australia; [Saqib, Muhammad] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Plant Gene Regulat Res Grp, Tsukuba, Ibaraki, Japan	Murdoch University; National Institute of Advanced Industrial Science & Technology (AIST)	Wylie, SJ (corresponding author), Murdoch Univ, Sch Vet & Life Sci, Western Australian State Agr Biotechnol Ctr, Plant Virol Grp, Perth, WA, Australia.	s.wylie@murdoch.edu.au	Jones, Michael G.K./M-5932-2013; Wylie, Stephen/M-5910-2013	Jones, Michael G.K./0000-0001-5002-0227; Li, Hua/0000-0002-0973-5762; Wylie, Stephen/0000-0002-5639-7460				Adams IP, 2009, MOL PLANT PATHOL, V10, P537, DOI [10.1111/J.1364-3703.2009.00545.X, 10.1111/j.1364-3703.2009.00545.x]; Adams MJ, 2004, ARCH VIROL, V149, P1045, DOI [10.1007/s00705-003-0304-0, 10.1007/s00705-004-0304-0]; [Anonymous], 2013, COMMODITY 070320 GAR; BARTON JOHN H., 2010, EVOLUTION TRADE REGI; Bratlie MS, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-1; Chen J, 2004, ARCH VIROL, V149, P435, DOI 10.1007/s00705-003-0234-2; Chen J, 2002, ARCH VIROL, V147, P683, DOI 10.1007/s007050200018; Conci VC, 2010, J PHYTOPATHOL, V158, P186, DOI 10.1111/j.1439-0434.2009.01601.x; FUJISAWA I, 1986, Annals of the Phytopathological Society of Japan, V52, P193, DOI 10.3186/jjphytopath.52.193; Hagen C, 2012, ARCH VIROL, V157, P907, DOI 10.1007/s00705-012-1253-7; Hagen C, 2011, ARCH VIROL, V156, P1209, DOI 10.1007/s00705-011-0979-y; Hashimoto M, 2008, ARCH VIROL, V153, P219, DOI 10.1007/s00705-007-1052-8; Hirschegger P, 2010, MOL PHYLOGENET EVOL, V54, P488, DOI 10.1016/j.ympev.2009.08.030; Ipek M, 2006, GENOME, V49, P1246, DOI 10.1139/G06-092; King A. M. Q, 2012, VIRUS TAXONOMY; Loebenstein G, 2012, VIRUSES POTATO VIRUS, P210; MORRIS TJ, 1979, PHYTOPATHOLOGY, V69, P854, DOI 10.1094/Phyto-69-854; Parsons W.T., 2001, NOXIOUS WEEDS AUSTR, Vsecond; Pu YY, 2011, J VIROL, V85, P2975, DOI 10.1128/JVI.02147-10; Rivlin RS, 2001, J NUTR, V131, p951S, DOI 10.1093/jn/131.3.951S; Espino HS, 2012, GENETIC DIVERSITY IN PLANTS, P479; Stannard D., 1993, AM HOLOCAUST CONQUES; Symons M, 2007, ONE CONTINUOUS PICNI; Sztuba-Solinska J, 2011, ANNU REV PHYTOPATHOL, V49, P415, DOI 10.1146/annurev-phyto-072910-095351; Uyttendaele M, 2014, GLOBAL SAFETY FRESH, V33; Valverde RA., 2007, PLANT VIRUSES, V1, P116; Wylie SJ, 2012, AUSTRALAS PLANT DIS, V7, P23, DOI 10.1007/s13314-011-0038-2; Wylie SJ, 2012, ARCH VIROL, V157, P1471, DOI 10.1007/s00705-012-1319-6; Wylie SJ, 2012, ARCH VIROL, V157, P271, DOI 10.1007/s00705-011-1166-x; Zohary D, 1988, DOMESTICATION PLANTS, P249	30	36	37	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105044	10.1371/journal.pone.0105044	http://dx.doi.org/10.1371/journal.pone.0105044			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133543	Green Published, gold			2022-12-25	WOS:000341302700063
J	Garcia, G; Rios, N; Gutierrrez, V; Varela, JG; Fernandez, CB; Pardo, BG; Portela, PM				Garcia, Graciela; Rios, Nestor; Gutierrrez, Veronica; Guerra Varela, Jorge; Bouza Fernandez, Carmen; Gomez Pardo, Belen; Martinez Portela, Paulino			Promiscuous Speciation with Gene Flow in Silverside Fish Genus Odontesthes (Atheriniformes, Atherinopsidae) from South Western Atlantic Ocean Basins	PLOS ONE			English	Article							POPULATION-GROWTH; BONARIENSIS VALENCIENNES; PRESBYTER CUVIER; TELEOSTEI; SOFTWARE; INFERENCE; WINDOWS; MARINE; BRAZIL; MODEL	The present paper integrates phylogenetic and population genetics analyses based on mitochondrial and nuclear molecular markers in silversides, genus Odontesthes, from a non-sampled area in the SW Atlantic Ocean to address species discrimination and to define Managements Units for sustainable conservation. All phylogenetic analyses based on the COI mitochondrial gene were consistent to support the monophyly of the genus Odontesthes and to include O. argentinensis, O. perugiae-humensis and some O. bonariensis haplotypes in a basal polytomy conforming a major derivative clade. Microsatellites data revealed somewhat higher genetic variability values in the O. argentinensis-perugia populations than in O. bonariensis and O. perugia-humensis taxa. Contrasting population genetics structuring emerged from mitochondrial and microsatellites analyses in these taxa. Whereas mitochondrial data supported two major groups (O. argentinensis-perugiahumensis vs. O. bonariensis-perugiae-humensis populations), microsatellite data detected three major genetic entities represented by O. bonariensis, O. perugiae-humensis and an admixture of populations belonging to O. argentinensis-perugiae respectively. Therefore, the star COI polytomy in the tree topology involving these taxa could be interpreted by several hypothetic scenarios such as the existence of shared ancestral polymorphisms, incomplete lineage sorting in a radiating speciation process and/or reticulation events. Present findings support that promiscuous and recent contact between incipient species sharing asymmetric gene flow exchanges, blurs taxa boundaries yielding complicated taxonomy and Management Units delimitation in silverside genus Odontesthes from SW Atlantic Ocean basins.	[Garcia, Graciela; Rios, Nestor; Gutierrrez, Veronica] UdelaR, Fac Ciencias, Secc Genet Evolut, Montevideo, Uruguay; [Guerra Varela, Jorge; Bouza Fernandez, Carmen; Gomez Pardo, Belen; Martinez Portela, Paulino] Univ Santiago de Compostela, Fac Vet, Dept Genet, Lugo, Spain	Universidad de la Republica, Uruguay; Universidade de Santiago de Compostela	Garcia, G (corresponding author), UdelaR, Fac Ciencias, Secc Genet Evolut, Montevideo, Uruguay.	ggarcia@fcien.edu.uy	PARDO, BELEN G./K-9652-2014; Martínez, Paulino/K-8636-2014; Gómez, ACUIGEN/ABD-5337-2020	PARDO, BELEN G./0000-0003-3548-6306; Martínez, Paulino/0000-0001-8438-9305; Rios, Nestor/0000-0002-0669-7668; Gutierrez Coppetti, Veronica/0000-0002-6627-0519; Guerra-Varela, Jorge/0000-0002-8365-7125	Agencia Nacional de Investigacion e Inovacion (ANII) of Uruguay [Fondo Maria Vinas_2009_1_2793, FMV_2009_1_2793_Project]	Agencia Nacional de Investigacion e Inovacion (ANII) of Uruguay	This research received financial support from the project Fondo Maria Vinas_2009_1_2793 (FMV_2009_1_2793_Project) granted by the Agencia Nacional de Investigacion e Inovacion (ANII) of Uruguay. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; [Anonymous], UDELAR REV FACULTAD; BAMBER RN, 1988, J FISH BIOL, V33, P17, DOI 10.1111/j.1095-8649.1988.tb05554.x; BAMBER RN, 1985, BIOL J LINN SOC, V25, P61, DOI 10.1111/j.1095-8312.1985.tb00386.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beheregaray LB, 2002, P ROY SOC B-BIOL SCI, V269, P65, DOI 10.1098/rspb.2001.1838; Beheregaray LB, 2001, MOL ECOL, V10, P2849, DOI 10.1046/j.1365-294X.2001.t01-1-01406.x; Beheregaray LB, 2000, COPEIA, P441; Bemvenuti MA, 2006, BIOCELL, V30, P111; Bemvenuti MA, 2002, REVTA BRAS ZOOL CURI, V19, P239; Bemvenuti Marlise de Azevedo, 1997, Atlantica, V19, P113; Bonferroni C., 1936, PUBBL R 1 SUPER SCI, V8, P3; Campos H, 1984, SERIE ZOOLOGIA, V13, P71; Carnevia D, 2008, PLAN NACL DESARROLLO; CREECH S, 1991, J FISH BIOL, V39, P807, DOI 10.1111/j.1095-8649.1991.tb04410.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dyer BS, 2006, BIOCELL, V30, P69; Dyer BS, 1998, PHYLOGENY CLASSIFICA; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Froese R, 2012, SPECIES ODONTESTHES; Fu YX, 1997, GENETICS, V147, P915; Goudet J., 2001, FSTAT PROGRAM ESTIMA; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; HARPENDING HC, 1994, HUM BIOL, V66, P591; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Heras S, 2011, CR BIOL, V334, P273, DOI 10.1016/j.crvi.2011.03.004; Hey J, 2007, P NATL ACAD SCI USA, V104, P2785, DOI 10.1073/pnas.0611164104; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; KIMURA M, 1964, GENETICS, V49, P725; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Koshimizu E., 2009, MOL ECOL RESOUR, V9, P1460; Langella O., 1999, POPULATIONS 1 2 28; Liedloff A. C., 1999, MANTEL NONPARAMETRIC; Malabarba Luiz R., 2002, Ichthyological Exploration of Freshwaters, V13, P257; MANTEL N, 1967, CANCER RES, V27, P209; MCDADE LA, 1992, EVOLUTION, V46, P1329, DOI 10.1111/j.1558-5646.1992.tb01127.x; MEDRANO JF, 1990, BIOTECHNIQUES, V8, P43; Miranda LA, 2005, AQUAC RES, V36, P1473, DOI 10.1111/j.1365-2109.2005.01357.x; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; Nei M., 1987, MOL EVOLUTIONARY GEN; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; POTTER IC, 1986, HYDROBIOLOGIA, V139, P23, DOI 10.1007/BF00770239; Pritchard JK, 2000, GENETICS, V155, P945; Rambaut A, 2009, TRACER V 1 5; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; SPRECHMANN P, 1978, Zitteliana, V4, P3; Strussmann CA, 1997, J EXP ZOOL, V278, P167, DOI 10.1002/(SICI)1097-010X(19970615)278:3&lt;167::AID-JEZ6&gt;3.0.CO;2-M; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tejedor D., 2001, FUNDAMENTOS BIOL EC; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tombari AD, 2005, REV CHIL HIST NAT, V78, P623; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Zardi GI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019402	63	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104659	10.1371/journal.pone.0104659	http://dx.doi.org/10.1371/journal.pone.0104659			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126842	Green Submitted, Green Published, gold			2022-12-25	WOS:000340879300040
J	Lou, PH; Lucchinetti, E; Zhang, LY; Affolter, A; Gandhi, M; Hersberger, M; Warren, BE; Lemieux, H; Sobhi, HF; Clanachan, AS; Zaugg, M				Lou, Phing-How; Lucchinetti, Eliana; Zhang, Liyan; Affolter, Andreas; Gandhi, Manoj; Hersberger, Martin; Warren, Blair E.; Lemieux, Helene; Sobhi, Hany F.; Clanachan, Alexander S.; Zaugg, Michael			Loss of Intralipid (R)- but Not Sevoflurane-Mediated Cardioprotection in Early Type-2 Diabetic Hearts of Fructose-Fed Rats: Importance of ROS Signaling	PLOS ONE			English	Article							CYTOCHROME-C-OXIDASE; FATTY-ACID OXIDATION; IN-VIVO; MITOCHONDRIAL; ISOFLURANE; REPERFUSION; SUPEROXIDE; ISCHEMIA; ISCHAEMIA/REPERFUSION; MYOCARDIUM	Background: Insulin resistance and early type-2 diabetes are highly prevalent. However, it is unknown whether Intralipid (R) and sevoflurane protect the early diabetic heart against ischemia-reperfusion injury. Methods: Early type-2 diabetic hearts from Sprague-Dawley rats fed for 6 weeks with fructose were exposed to 15 min of ischemia and 30 min of reperfusion. Intralipid (R) (1%) was administered at the onset of reperfusion. Peri-ischemic sevoflurane (2 vol.-%) served as alternative protection strategy. Recovery of left ventricular function was recorded and the activation of Akt and ERK 1/2 was monitored. Mitochondrial function was assessed by high-resolution respirometry and mitochondrial ROS production was measured by Amplex Red and aconitase activity assays. Acylcarnitine tissue content was measured and concentration-response curves of complex IV inhibition by palmitoylcarnitine were obtained. Results: Intralipid (R) did not exert protection in early diabetic hearts, while sevoflurane improved functional recovery. Sevoflurane protection was abolished by concomitant administration of the ROS scavenger N-2-mercaptopropionyl glycine. Sevoflurane, but not Intralipid (R) produced protective ROS during reperfusion, which activated Akt. Intralipid (R) failed to inhibit respiratory complex IV, while sevoflurane inhibited complex I. Early diabetic hearts exhibited reduced carnitine-palmitoyl-transferase-1 activity, but palmitoylcarnitine could not rescue protection and enhance postischemic functional recovery. Cardiac mitochondria from early diabetic rats exhibited an increased content of subunit IV-2 of respiratory complex IV and of uncoupling protein-3. Conclusions: Early type-2 diabetic hearts lose complex IV-mediated protection by Intralipid (R) potentially due to a switch in complex IV subunit expression and increased mitochondrial uncoupling, but are amenable to complex I-mediated sevoflurane protection.	[Lou, Phing-How] Univ Alberta, Cardiovasc Res Ctr, Edmonton, AB, Canada; [Lucchinetti, Eliana; Zhang, Liyan; Zaugg, Michael] Univ Alberta, Dept Anesthesiol & Pain Med, Edmonton, AB, Canada; [Affolter, Andreas; Hersberger, Martin] Univ Childrens Hosp Zurich, Dept Clin Chem, Zurich, Switzerland; [Gandhi, Manoj; Clanachan, Alexander S.] Univ Alberta, Dept Pharmacol, Edmonton, AB, Canada; [Warren, Blair E.; Lemieux, Helene] Univ Alberta, Edmonton, AB, Canada; [Sobhi, Hany F.] Coppin State Univ, Coppin Ctr Organ Synth, Baltimore, MD USA	University of Alberta; University of Alberta; University Children's Hospital Zurich; University of Alberta; University of Alberta; University System of Maryland; Coppin State University	Zaugg, M (corresponding author), Univ Alberta, Dept Anesthesiol & Pain Med, Edmonton, AB, Canada.	michael.zaugg@ualberta.ca	Zaugg, Michael/G-4287-2016; Zhang, Li/GWM-7501-2022	Lucchinetti, Eliana/0000-0003-3338-1279; Hersberger, Martin/0000-0002-4472-329X; Zaugg, Michael/0000-0002-2016-8973; lemieux, Helene/0000-0002-8864-6062	Heart and Stroke Foundation of Alberta; Northwest Territories; Canadian Institutes of Health Research [MOP115055]; Natural Sciences and Engineering Research Council of Canada; Mazankowski Alberta Heart Institute, Edmonton, Canada; "Bourse pour apprentis-chercheurs" from the Campus Saint-Jean of the University of Alberta, Edmonton, Canada; Nunavut (Canada)	Heart and Stroke Foundation of Alberta; Northwest Territories; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Mazankowski Alberta Heart Institute, Edmonton, Canada; "Bourse pour apprentis-chercheurs" from the Campus Saint-Jean of the University of Alberta, Edmonton, Canada; Nunavut (Canada)	The study was supported by grants from the Heart and Stroke Foundation of Alberta, Northwest Territories, and Nunavut (Canada), and the Canadian Institutes of Health Research (MOP115055), a discovery grant from the Natural Sciences and Engineering Research Council of Canada, and a grant from the Mazankowski Alberta Heart Institute, Edmonton, Canada. BEW was supported by a "Bourse pour apprentis-chercheurs" from the Campus Saint-Jean of the University of Alberta, Edmonton, Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT RD, 1988, JAMA-J AM MED ASSOC, V260, P3456, DOI 10.1001/jama.260.23.3456; Agarwal B, 2014, BBA-BIOENERGETICS, V1837, P354, DOI 10.1016/j.bbabio.2013.11.006; Boudina S, 2005, CIRCULATION, V112, P2686, DOI 10.1161/CIRCULATIONAHA.105.554360; Bourens M, 2013, ANTIOXID REDOX SIGN, V19, P1940, DOI 10.1089/ars.2012.4847; Burwell LS, 2009, J MOL CELL CARDIOL, V46, P804, DOI 10.1016/j.yjmcc.2009.02.026; Cacho J, 2008, AM J PHYSIOL-ENDOC M, V295, pE1269, DOI 10.1152/ajpendo.90207.2008; Cline GW, 2001, J BIOL CHEM, V276, P20240, DOI 10.1074/jbc.M102540200; DAI S, 1995, J PHARMACOL TOX MET, V33, P101, DOI 10.1016/1056-8719(94)00063-A; De Hert SG, 2004, ANESTHESIOLOGY, V101, P299, DOI 10.1097/00000542-200408000-00009; Deyhimy DI, 2007, ANESTH ANALG, V105, P316, DOI 10.1213/01.ane.0000267524.71445.e7; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; Franks NP, 1996, ANESTHESIOLOGY, V84, P716, DOI 10.1097/00000542-199603000-00027; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Gardner PR, 2002, METHOD ENZYMOL, V349, P9, DOI 10.1016/S0076-6879(02)49317-2; Gonsolin D, 2007, MOL CELL BIOCHEM, V295, P217, DOI 10.1007/s11010-006-9291-7; Hanley PJ, 2002, J PHYSIOL-LONDON, V544, P687, DOI 10.1113/jphysiol.2002.025015; Harmancey R, 2013, FASEB J, V27, P3966, DOI 10.1096/fj.13-234914; Herlitz J, 1996, DIABETES CARE, V19, P698, DOI 10.2337/diacare.19.7.698; Hirata N, 2011, ANESTHESIOLOGY, V115, P531, DOI 10.1097/ALN.0b013e31822a2316; Hiser C, 2013, BIOCHEMISTRY-US, V52, P1385, DOI 10.1021/bi3014505; Huttemann M, 2007, FEBS J, V274, P5737, DOI 10.1111/j.1742-4658.2007.06093.x; Huhn R, 2010, NUTR METAB CARDIOVAS, V20, P706, DOI 10.1016/j.numecd.2009.06.010; Huisamen B, 2003, MOL CELL BIOCHEM, V249, P31, DOI 10.1023/A:1024749614222; Hulver MW, 2005, CELL METAB, V2, P251, DOI 10.1016/j.cmet.2005.09.002; Kadenbach B, 2000, FREE RADICAL BIO MED, V29, P211, DOI 10.1016/S0891-5849(00)00305-1; Kevin LG, 2003, ANESTH ANALG, V96, P949, DOI 10.1213/01.ANE.0000052515.25465.35; Lemoine S, 2010, DIABETES METAB, V36, P21, DOI 10.1016/j.diabet.2009.06.006; Li JY, 2012, ANESTHESIOLOGY, V117, P836, DOI 10.1097/ALN.0b013e3182655e73; Liu JJ, 2013, ANTIOXID REDOX SIGN, V19, P1916, DOI 10.1089/ars.2012.4589; Lloyd-Jones D, 2010, CIRCULATION, V121, P948, DOI 10.1161/CIRCULATIONAHA.109.192666; Lou PH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087205; Lou PH, 2013, CARDIOVASC RES, V97, P251, DOI 10.1093/cvr/cvs323; Lowenstein JM, 1969, METHOD ENZYMOL, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; Makino A, 2011, AM J PHYSIOL-REG I, V300, pR1296, DOI 10.1152/ajpregu.00437.2010; Malingriaux EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077786; Morel S, 2003, CLIN EXP PHARMACOL P, V30, P446, DOI 10.1046/j.1440-1681.2003.03858.x; Morrish NJ, 2001, DIABETOLOGIA, V44, pS14, DOI 10.1007/PL00002934; Mullenheim J, 2002, ANESTHESIOLOGY, V96, P934; Muravyeva M, 2014, ANESTHESIOLOGY, V120, P870, DOI 10.1097/ALN.0000000000000107; Murphy MP, 2003, J BIOL CHEM, V278, P48534, DOI 10.1074/jbc.M308529200; Rahman S, 2011, ANESTHESIOLOGY, V115, P242, DOI 10.1097/ALN.0b013e318223b8b9; Samuel VT, 2011, TRENDS ENDOCRIN MET, V22, P60, DOI 10.1016/j.tem.2010.10.003; Saotome M, 2009, AM J PHYSIOL-HEART C, V296, pH1125, DOI 10.1152/ajpheart.00436.2008; Sedlic F, 2009, ANESTH ANALG, V109, P405, DOI 10.1213/ane.0b013e3181a93ad9; Sharpe M, 1997, BIOCHEM CELL BIOL, V75, P71, DOI 10.1139/bcb-75-1-71; Srinivasan S, 2012, FREE RADICAL BIO MED, V53, P1252, DOI 10.1016/j.freeradbiomed.2012.07.021; Stewart JM, 2000, BIOCHEM CELL BIOL, V78, P675, DOI 10.1139/bcb-78-6-675; Tanaka K, 2002, AM J PHYSIOL-HEART C, V282, pH2018, DOI 10.1152/ajpheart.01130.2001; Toime LJ, 2010, FREE RADICAL BIO MED, V49, P606, DOI 10.1016/j.freeradbiomed.2010.05.010; Tsutsumi YM, 2007, LIFE SCI, V81, P1223, DOI 10.1016/j.lfs.2007.08.031; Wang LG, 2010, ANESTHESIOLOGY, V113, P541, DOI 10.1097/ALN.0b013e3181e2c1a1; WINKLER E, 1994, J BIOL CHEM, V269, P2508; Zaugg M, 2012, ANESTHESIOLOGY, V116, P648, DOI 10.1097/ALN.0b013e318247225a; Zhou MJ, 1997, ANAL BIOCHEM, V253, P162, DOI 10.1006/abio.1997.2391	55	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104971	10.1371/journal.pone.0104971	http://dx.doi.org/10.1371/journal.pone.0104971			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127027	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000340879300066
J	Nakagawa, K; Sawada, N; Hirota, Y; Uchino, Y; Suhara, Y; Hasegawa, T; Amizuka, N; Okamoto, T; Tsugawa, N; Kamao, M; Funahashi, N; Okano, T				Nakagawa, Kimie; Sawada, Natsumi; Hirota, Yoshihisa; Uchino, Yuri; Suhara, Yoshitomo; Hasegawa, Tomoka; Amizuka, Norio; Okamoto, Tadashi; Tsugawa, Naoko; Kamao, Maya; Funahashi, Nobuaki; Okano, Toshio			Vitamin K-2 Biosynthetic Enzyme, UBIAD1 Is Essential for Embryonic Development of Mice	PLOS ONE			English	Article							MENAQUINONE-4 VITAMIN-K-2; PHYLLOQUINONE VITAMIN-K-1; CARCINOMA-CELLS; COENZYME Q(10); TARGET GENES; CHOLESTEROL; TERE1; PRENYLTRANSFERASE; PURESORB-Q(TM)40; ACCUMULATION	UbiA prenyltransferase domain containing 1 (UBIAD1) is a novel vitamin K-2 biosynthetic enzyme screened and identified from the human genome database. UBIAD1 has recently been shown to catalyse the biosynthesis of Coenzyme Q10 (CoQ10) in zebrafish and human cells. To investigate the function of UBIAD1 in vivo, we attempted to generate mice lacking Ubiad1, a homolog of human UBIAD1, by gene targeting. Ubiad1-deficient (Ubiad1(-/-)) mouse embryos failed to survive beyond embryonic day 7.5, exhibiting small-sized body and gastrulation arrest. Ubiad1(-/-) embryonic stem (ES) cells failed to synthesize vitamin K-2 but were able to synthesize CoQ9, similar to wild-type ES cells. Ubiad1(+/-) mice developed normally, exhibiting normal growth and fertility. Vitamin K-2 tissue levels and synthesis activity were approximately half of those in the wild-type, whereas CoQ9 tissue levels and synthesis activity were similar to those in the wild-type. Similarly, UBIAD1 expression and vitamin K-2 synthesis activity of mouse embryonic fibroblasts prepared from Ubiad1(+/-) E15.5 embryos were approximately half of those in the wild-type, whereas CoQ9 levels and synthesis activity were similar to those in the wildtype. Ubiad1(-/-) mouse embryos failed to be rescued, but their embryonic lifespans were extended to term by oral administration of MK-4 or CoQ10 to pregnant Ubiad1(+/-) mice. These results suggest that UBIAD1 is responsible for vitamin K-2 synthesis but may not be responsible for CoQ9 synthesis in mice. We propose that UBIAD1 plays a pivotal role in embryonic development by synthesizing vitamin K-2, but may have additional functions beyond the biosynthesis of vitamin K-2.	[Nakagawa, Kimie; Sawada, Natsumi; Hirota, Yoshihisa; Uchino, Yuri; Tsugawa, Naoko; Kamao, Maya; Funahashi, Nobuaki; Okano, Toshio] Kobe Pharmaceut Univ, Dept Hygien Sci, Kobe, Hyogo 658, Japan; [Suhara, Yoshitomo] Shibaura Inst Technol, Dept Biosci & Engn, Saitama, Japan; [Hasegawa, Tomoka; Amizuka, Norio] Hokkaido Univ, Grad Sch Dent Med, Div Oral Hlth Sci, Sapporo, Hokkaido 060, Japan; [Okamoto, Tadashi] Kobe Gakuin Univ, Fac Pharmaceut Sci, Dept Hlth Sci & Social Pharm, Kobe, Hyogo, Japan	Kobe Pharmaceutical University; Shibaura Institute of Technology; Hokkaido University; Kobe Gakuin University	Nakagawa, K (corresponding author), Kobe Pharmaceut Univ, Dept Hygien Sci, Kobe, Hyogo 658, Japan.	nakagawa@kobepharma-u.ac.jp; t-okano@kobepharma-u.ac.jp	Funahashi, Nobuaki/ABF-1529-2021; Hirota, Yoshihisa/R-6741-2019	Funahashi, Nobuaki/0000-0003-0888-1060; Hirota, Yoshihisa/0000-0002-6462-9479; Suhara, Yoshitomo/0000-0002-4770-2910	JSPS [23390022, 23790110]; Naito Foundation;  [24-7941]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Naito Foundation(Naito Memorial Foundation); 	This work was supported in part by a Grant-in-aid for Scientific Research (B) [grant number 23390022] to TO, a Grant-in-aid for Scientific Research (Young Scientists-B) [grant number 23790110] to KN from JSPS, the Naito Foundation Subsidy for Female Researchers after Maternity Leave to KN from the Naito Foundation and a Grant-in-aid for JSPS Fellows [grant number 24-7941] to YH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma K, 2009, ENDOCR J, V56, P843, DOI 10.1507/endocrj.K09E-108; Fredericks WJ, 2013, ONCOTARGET, V4, P1075, DOI 10.18632/oncotarget.1103; Fredericks WJ, 2013, J CELL BIOCHEM, V114, P2170, DOI 10.1002/jcb.24567; Fredericks WJ, 2013, INT J ONCOL, V43, P638, DOI 10.3892/ijo.2013.1985; Fredericks WJ, 2011, DNA CELL BIOL, V30, P851, DOI 10.1089/dna.2011.1315; Furie B, 1999, BLOOD, V93, P1798, DOI 10.1182/blood.V93.6.1798.406k22_1798_1808; Gaynor PM, 1996, ARTERIOSCL THROM VAS, V16, P992, DOI 10.1161/01.ATV.16.8.992; Hegarty JM, 2013, DEVELOPMENT, V140, P1713, DOI 10.1242/dev.093112; Hirota Y, 2013, J BIOL CHEM, V288, P33071, DOI 10.1074/jbc.M113.477356; Ichikawa T, 2007, J MOL ENDOCRINOL, V39, P239, DOI 10.1677/JME-07-0048; Ichikawa T, 2006, J BIOL CHEM, V281, P16927, DOI 10.1074/jbc.M600896200; Iwaki T, 2010, J THROMB HAEMOST, V8, P2341, DOI 10.1111/j.1538-7836.2010.03995.x; LAWITTS JA, 1993, METHOD ENZYMOL, V225, P153; McGarvey TW, 2003, PROSTATE, V54, P144, DOI 10.1002/pros.10174; Mugoni V, 2013, NAT PROTOC, V8, P2337, DOI 10.1038/nprot.2013.139; Mugoni V, 2013, CELL, V152, P504, DOI 10.1016/j.cell.2013.01.013; NAKAGATA N, 1992, EXP ANIM TOKYO, V41, P387, DOI 10.1538/expanim1978.41.3_387; Nakagawa K, 2010, NATURE, V468, P117, DOI 10.1038/nature09464; Nakao K, 1997, EXP ANIM TOKYO, V46, P231, DOI 10.1538/expanim.46.231; Nickerson ML, 2013, HUM MUTAT, V34, P317, DOI 10.1002/humu.22230; Nickerson ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010760; Nukui K, 2007, J NUTR SCI VITAMINOL, V53, P187, DOI 10.3177/jnsv.53.187; Nukui K, 2008, BIOFACTORS, V32, P209, DOI 10.1002/biof.5520320125; Okano T, 2008, J BIOL CHEM, V283, P11270, DOI 10.1074/jbc.M702971200; Orr A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000685; QUINN P, 1985, FERTIL STERIL, V44, P493; Robertson E. J., 1987, TERATOCARCINOMAS EMB; Sato Y, 2005, BONE, V36, P61, DOI 10.1016/j.bone.2004.09.018; Stanley TB, 1998, BIOCHEMISTRY-US, V37, P13262, DOI 10.1021/bi981031y; Suhara Y, 2009, BIOORG MED CHEM LETT, V19, P1054, DOI 10.1016/j.bmcl.2009.01.021; Tabb MM, 2003, J BIOL CHEM, V278, P43919, DOI 10.1074/jbc.M303136200; Teshima K, 2005, ANAL BIOCHEM, V338, P12, DOI 10.1016/j.ab.2004.12.007; Vos M, 2012, SCIENCE, V336, P1306, DOI 10.1126/science.1218632; Wang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072015; Yanagawa Y, 1999, TRANSGENIC RES, V8, P215, DOI 10.1023/A:1008914020843; Yoda Y., 1971, JAPANESE J ANIM REPR, V16, P147, DOI [DOI 10.1262/JRD1955.16.147, 10.1262/jrd1955.16.147]; Zu YG, 2006, J SEP SCI, V29, P1607, DOI 10.1002/jssc.200600047	37	28	32	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104078	10.1371/journal.pone.0104078	http://dx.doi.org/10.1371/journal.pone.0104078			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127365	Green Published, Green Submitted, gold			2022-12-25	WOS:000340879300013
J	Proenca, DN; Fonseca, L; Powers, TO; Abrantes, IMO; Morais, PV				Proenca, Diogo Neves; Fonseca, Luis; Powers, Thomas O.; Abrantes, Isabel M. O.; Morais, Paula V.			Diversity of Bacteria Carried by Pinewood Nematode in USA and Phylogenetic Comparison with Isolates from Other Countries	PLOS ONE			English	Article							DRAFT GENOME SEQUENCE; BURSAPHELENCHUS-XYLOPHILUS; WOOD NEMATODE; WILT DISEASE; PATHOGENICITY; ENDOPHYTES; DATABASE	Pine wilt disease (PWD) is native to North America and has spread to Asia and Europe. Lately, mutualistic relationship has been suggested between the pinewood nematode (PWN), Bursaphelenchus xylophilus the causal nematode agent of PWD, and bacteria. In countries where PWN occurs, nematodes from diseased trees were reported to carry bacteria from several genera. However no data exists for the United States. The objective of this study was to evaluate the diversity of the bacterial community carried by B. xylophilus, isolated from different Pinus spp. with PWD in Nebraska, United States. The bacteria carried by PWN belonged to Gammaproteobacteria (79.9%), Betaproteobacteria (11.7%), Bacilli (5.0%), Alphaproteobacteria (1.7%) and Flavobacteriia (1.7%). Strains from the genera Chryseobacterium and Pigmentiphaga were found associated with the nematode for the first time. These results were compared to results from similar studies conducted from other countries of three continents in order to assess the diversity of bacteria with associated with PWN. The isolates from the United States, Portugal and China belonged to 25 different genera and only strains from the genus Pseudomonas were found in nematodes from all countries. The strains from China were closely related to P. fluorescens and the strains isolated from Portugal and USA were phylogenetically related to P. mohnii and P. lutea. Nematodes from the different countries are associated with bacteria of different species, not supporting a relationship between PWN with a particular bacterial species. Moreover, the diversity of the bacteria carried by the pinewood nematode seems to be related to the geographic area and the Pinus species. The roles these bacteria play within the pine trees or when associated with the nematodes, might be independent of the presence of the nematode in the tree and only related on the bacteria's relationship with the tree.	[Proenca, Diogo Neves; Fonseca, Luis; Abrantes, Isabel M. O.; Morais, Paula V.] Univ Coimbra, IMAR CMA, Coimbra, Portugal; [Powers, Thomas O.] Univ Nebraska, Dept Plant Pathol, Lincoln, NE 68583 USA; [Abrantes, Isabel M. O.; Morais, Paula V.] Univ Coimbra, FCTUC, Dept Life Sci, Coimbra, Portugal	Universidade de Coimbra; University of Nebraska System; University of Nebraska Lincoln; Universidade de Coimbra	Morais, PV (corresponding author), Univ Coimbra, IMAR CMA, Coimbra, Portugal.	pvmorais@ci.uc.pt	Abrantes, Isabel/CAG-1426-2022; Morais, Paula Vasconcelos/C-9756-2014; Proença, Diogo Neves/K-1801-2015	Abrantes, Isabel/0000-0002-8761-2151; Morais, Paula Vasconcelos/0000-0002-1939-6389; Proença, Diogo Neves/0000-0002-1284-9082; Fonseca, Luis/0000-0001-7405-8916	FEDER through the Programa Operacional Factores de Competitividade - COMPETE; Fundacao para a Ciencia e a Tecnologia (FCT), Portugal [PTDC/AGR-CFL/115373/2009]; FCT [SFRH/BD/61311/2009]	FEDER through the Programa Operacional Factores de Competitividade - COMPETE; Fundacao para a Ciencia e a Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was financial supported by FEDER funds through the Programa Operacional Factores de Competitividade - COMPETE and by national funds through the Fundacao para a Ciencia e a Tecnologia (FCT), Portugal, under the project PTDC/AGR-CFL/115373/2009. DNP was supported by FCT, graduate fellowship SFRH/BD/61311/2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashelford KE, 2006, APPL ENVIRON MICROB, V72, P5734, DOI 10.1128/AEM.00556-06; Castagnone C, 2005, EUR J PLANT PATHOL, V112, P191, DOI 10.1007/s10658-004-0580-2; El-Hadad ME, 2011, BRAZ J MICROBIOL, V42, P105, DOI 10.1590/S1517-83822011000100014; *EPPO OEPP, 2009, B OEPP EPPO, V39, P344; Evans H. F., 1996, Bulletin OEPP, V26, P199, DOI 10.1111/j.1365-2338.1996.tb00594.x; Guo QQ, 2007, J NEMATOL, V39, P243; Han ZM, 2003, J PHYTOPATHOL, V151, P683, DOI 10.1046/j.1439-0434.2003.00790.x; Higgins D. F., 1999, Sustainability of pine forests in relation to pine wilt and decline. Proceedings of International Symposium, Tokyo, Japan, 27-28 October, 1998, P23; Jones JT, 2008, MOL PLANT PATHOL, V9, P357, DOI 10.1111/J.1364-3703.2007.00461.X; JUKES T H, 1969, P21; Kawazu K, 1996, BIOSCI BIOTECH BIOCH, V60, P1413, DOI 10.1271/bbb.60.1413; Kikuchi T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002219; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; Kwon HR, 2010, PEST MANAG SCI, V66, P634, DOI 10.1002/ps.1920; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; NICKLE WR, 1981, J NEMATOL, V13, P385; OKU H, 1980, NATURWISSENSCHAFTEN, V67, P198, DOI 10.1007/BF01086307; Paiva G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079705; Paracer S, 2000, SYMBIOSIS INTRO BIOL, V2nd; PETRINI O, 1991, MICROBIAL ECOLOGY LE, P179, DOI DOI 10.1007/978-1-4612-3168-4_9; Proenca DN, 2012, J BACTERIOL, V194, P4789, DOI 10.1128/JB.01116-12; Proenca DN, 2012, J BACTERIOL, V194, P3764, DOI 10.1128/JB.00670-12; Proenca DN, 2011, BACTERIA ARCHAEA COM; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; RAINEY FA, 1992, SYST APPL MICROBIOL, V15, P197, DOI 10.1016/S0723-2020(11)80092-5; Ribeiro B, 2012, FOREST PATHOL, V42, P521, DOI 10.1111/efp.12010; Rodrigues JM, 2008, PINE WILT DISEASE: A WORLDWIDE THREAT TO FOREST ECOSYSTEMS, P5, DOI 10.1007/978-1-4020-8455-3_1; Roriz M, 2011, EXP PARASITOL, V128, P357, DOI 10.1016/j.exppara.2011.04.008; Rosenblueth M, 2006, MOL PLANT MICROBE IN, V19, P827, DOI 10.1094/MPMI-19-0827; Ryan RP, 2008, FEMS MICROBIOL LETT, V278, P1, DOI 10.1111/j.1574-6968.2007.00918.x; Ryan RP, 2009, NAT REV MICROBIOL, V7, P514, DOI 10.1038/nrmicro2163; Scholl EH, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-6-r39; Scholl EH, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-9; Sniezko RA, 2006, CAN J PLANT PATHOL, V28, pS270, DOI 10.1080/07060660609507384; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tian Xueliang, 2010, Weishengwu Xuebao, V50, P909; Toth Agnes, 2011, Acta Biologica Szegediensis, V55, P213; Van den Brink PJ, 1999, ENVIRON TOXICOL CHEM, V18, P138, DOI [10.1897/1551-5028(1999)018&lt;0138:PRCAOT&gt;2.3.CO;2, 10.1002/etc.5620180207]; Vicente CSL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046661; Vicente CSL, 2011, ANTON LEEUW INT J G, V100, P477, DOI 10.1007/s10482-011-9602-1; Wu XQ, 2013, INT J BIOL SCI, V9, P34, DOI 10.7150/ijbs.5071; Zhao BG, 2005, FOREST PATHOL, V35, P339, DOI 10.1111/j.1439-0329.2005.00417.x; Zhao BG, 2003, NEMATOLOGY, V5, P899, DOI 10.1163/156854103773040817; Zhao BG, 2009, J NEMATOL, V41, P11; Zhu LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038095	46	14	15	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105190	10.1371/journal.pone.0105190	http://dx.doi.org/10.1371/journal.pone.0105190			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127255	Green Published, gold			2022-12-25	WOS:000340879300092
J	Liu, Q; Liu, H; Wen, J; Peterson, PM				Liu, Qing; Liu, Huan; Wen, Jun; Peterson, Paul M.			Infrageneric Phylogeny and Temporal Divergence of Sorghum (Andropogoneae, Poaceae) Based on Low-Copy Nuclear and Plastid Sequences	PLOS ONE			English	Article							PHOSPHOENOLPYRUVATE CARBOXYLASE; ALLOTETRAPLOID ORIGIN; CHLOROPLAST GENOME; CLIMATIC-CHANGE; EVOLUTIONARY; PLANT; GENE; DIVERSIFICATION; MIOCENE; GRASSES	The infrageneric phylogeny and temporal divergence of Sorghum were explored in the present study. Sequence data of two low-copy nuclear (LCN) genes, phosphoenolpyruvate carboxylase 4 (Pepc4) and granule-bound starch synthase I (GBSSI), from 79 accessions of Sorghum plus Cleistachne sorghoides together with those from outgroups were used for maximum likelihood (ML) and Bayesian inference (BI) analyses. Bayesian dating based on three plastid DNA markers (ndhA intron, rpl32-trnL, and rps16 intron) was used to estimate the ages of major diversification events in Sorghum. The monophyly of Sorghum plus Cleistachne sorghoides (with the latter nested within Sorghum) was strongly supported by the Pepc4 data using BI analysis, and the monophyly of Sorghum was strongly supported by GBSSI data using both ML and BI analyses. Sorghum was divided into three clades in the Pepc4, GBSSI, and plastid phylograms: the subg. Sorghum lineage; the subg. Parasorghum and Stiposorghum lineage; and the subg. Chaetosorghum and Heterosorghum lineage. Two LCN homoeologous loci of Cleistachne sorghoides were first discovered in the same accession. Sorghum arundinaceum, S. bicolor, S. x drummondii, S. propinquum, and S. virgatum were closely related to S. x almum in the Pepc4, GBSSI, and plastid phylograms, suggesting that they may be potential genome donors to S. almum. Multiple LCN and plastid allelic variants have been identified in S. halepense of subg. Sorghum. The crown ages of Sorghum plus Cleistachne sorghoides and subg. Sorghum are estimated to be 12.7 million years ago (Mya) and 8.6 Mya, respectively. Molecular results support the recognition of three distinct subgenera in Sorghum: subg. Chaetosorghum with two sections, each with a single species, subg. Parasorghum with 17 species, and subg. Sorghum with nine species and we also provide a new nomenclatural combination, Sorghum sorghoides.	[Liu, Qing; Liu, Huan] Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China; [Liu, Huan] Univ Chinese Acad Sci, Beijing, Peoples R China; [Wen, Jun; Peterson, Paul M.] Smithsonian Inst, Natl Museum Nat Hist, Dept Bot, Washington, DC 20560 USA	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Smithsonian Institution; Smithsonian National Museum of Natural History	Liu, Q (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China.	liuqing@scib.ac.cn; peterson@si.edu	Peterson, Paul M./S-9572-2019	Peterson, Paul M./0000-0001-9405-5528; Liu, Qing/0000-0003-2712-6028	National Natural Science Foundation of China [31270275, 31310103023]; Special Basic Research Foundation of Ministry of Science and Technology of the People's Republic of China [2013FY112100]; Key Laboratory of Plant Resources Conservation and Sustainable Utilization, South China Botanical Garden, CAS [201212ZS]; 42nd Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry [2011-1139]; Laboratories of Analytical Biology of the National Museum of Natural History, Smithsonian Institution	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Basic Research Foundation of Ministry of Science and Technology of the People's Republic of China; Key Laboratory of Plant Resources Conservation and Sustainable Utilization, South China Botanical Garden, CAS(Chinese Academy of Sciences); 42nd Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry; Laboratories of Analytical Biology of the National Museum of Natural History, Smithsonian Institution	This work was supported by the National Natural Science Foundation of China (31270275, 31310103023), the Special Basic Research Foundation of Ministry of Science and Technology of the People's Republic of China (2013FY112100), the Key Project of Key Laboratory of Plant Resources Conservation and Sustainable Utilization, South China Botanical Garden, CAS (201212ZS), the 42nd Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry (2011-1139), and the Laboratories of Analytical Biology of the National Museum of Natural History, Smithsonian Institution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHSAN SMN, 1994, ANN MO BOT GARD, V81, P775, DOI 10.2307/2399922; Baltisberger M., 2010, TAXON, V59, P1298; BHATTI A. G., 1960, Journal of Heredity, V51, P107; Bolnick DI, 2007, ANNU REV ECOL EVOL S, V38, P459, DOI 10.1146/annurev.ecolsys.38.091206.095804; Brassac J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033808; CELARIER ROBERT P., 1958, CYTOLOGIA [TOKYO], V23, P395, DOI 10.1508/cytologia.23.395; CELARIER ROBERT P., 1956, CYTOLOGIA, V21, P272, DOI 10.1508/cytologia.21.272; Cerling TE, 1997, NATURE, V389, P153, DOI 10.1038/38229; Chen S.L., 2006, FLORA CHINA, V22, P602; Christin PA, 2008, CURR BIOL, V18, P37, DOI 10.1016/j.cub.2007.11.058; Clayton W. D., 2006, GRASSBASE ONLINE WOR; CLAYTON WD, 1982, FLORA TROPICAL E AFR, P320; Clayton WD, 1986, KEW B ADDIT SER, V13, P320; Cronn R, 2004, NEW PHYTOL, V161, P133, DOI [10.1111/j.1469-8137.2004.00947.x, 10.1046/j.1469-8137.2003.00947.x]; DEWET JMJ, 1978, AM J BOT, V65, P477, DOI 10.2307/2442706; DEWET JMJ, 1967, EVOLUTION, V21, P787, DOI 10.1111/j.1558-5646.1967.tb03434.x; Dillon SL, 2007, PLANT SYST EVOL, V268, P29, DOI 10.1007/s00606-007-0571-9; Dillon SL, 2004, PLANT SYST EVOL, V249, P233, DOI 10.1007/s00606-004-0210-7; Dillon SL, 2001, PLANT SYST EVOL, V230, P97, DOI 10.1007/s006060170007; Doggett H., 1976, Evolution of crop plants., P112; DOGGETT J, 1970, SORGHUM; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; DUVALL MR, 1990, SYST BOT, V15, P472, DOI 10.2307/2419363; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edwards EJ, 2010, SCIENCE, V328, P587, DOI 10.1126/science.1177216; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Finarelli JA, 2010, P ROY SOC B-BIOL SCI, V277, P2721, DOI 10.1098/rspb.2010.0348; Fortune PM, 2007, MOL PHYLOGENET EVOL, V43, P1040, DOI 10.1016/j.ympev.2006.11.018; Fujita MK, 2010, EVOLUTION, V64, P2293, DOI 10.1111/j.1558-5646.2010.00993.x; Gaut BS, 1997, P NATL ACAD SCI USA, V94, P6809, DOI 10.1073/pnas.94.13.6809; Gelman A., 1992, STAT SCI, V7, P457, DOI [DOI 10.1214/SS/1177011136, 10.1214/ss/1177011136]; Grusz AL, 2009, AM J BOT, V96, P1636, DOI 10.3732/ajb.0900019; GU MH, 1984, J HERED, V75, P196, DOI 10.1093/oxfordjournals.jhered.a109911; Guiraud R, 2005, J AFR EARTH SCI, V43, P83, DOI 10.1016/j.jafrearsci.2005.07.017; HARLAN J R, 1971, Taxon, V20, P509, DOI 10.2307/1218252; HARTLEY W., 1958, AUSTRALIAN JOUR BOT, V6, P116, DOI 10.1071/BT9580116; Hata S, 1998, PLANT J, V13, P267, DOI 10.1046/j.1365-313X.1998.00022.x; HIRAISHI A, 1995, J FERMENT BIOENG, V79, P523, DOI 10.1016/0922-338X(95)94742-A; Ho SYW, 2009, SYST BIOL, V58, P367, DOI 10.1093/sysbio/syp035; House L.R., 1985, GUIDE SORGHUM BREEDI; Jacobs BF, 1999, ANN MO BOT GARD, V86, P590, DOI 10.2307/2666186; Janis CM, 2000, P NATL ACAD SCI USA, V97, P7899, DOI 10.1073/pnas.97.14.7899; Jiang Bin, 2011, Journal of Tropical and Subtropical Botany, V19, P195; Kellogg E. A., 2000, Grasses: systematics and evolution., P149; Keng Y. L., 1939, SINENSIA, V10, P274; KNOBLOCH I W, 1972, Taxon, V21, P97, DOI 10.2307/1219229; Knobloch I.W., 1968, CHECK LIST CROSSES G; Laerdal T, 2002, PALAEOGEOGR PALAEOCL, V187, P213, DOI 10.1016/S0031-0182(02)00478-9; LAZARIDES M, 1991, Australian Systematic Botany, V4, P591, DOI 10.1071/SB9910591; LEPINIEC L, 1994, PLANT SCI, V99, P111, DOI 10.1016/0168-9452(94)90168-6; Li FW, 2012, SYST BOT, V37, P845, DOI 10.1600/036364412X656626; LI N, 2009, THESIS ZHEJIANG NORM; Liao Fang, 2009, Yichuan, V31, P523, DOI 10.3724/SP.J.1005.2009.00523; Linder HP, 2005, ANNU REV ECOL EVOL S, V36, P107, DOI 10.1146/annurev.ecolsys.36.102403.135635; Liu Huan, 2014, Journal of Tropical and Subtropical Botany, V22, P1; Liu Q, 2011, PLANT ECOL, V212, P1733, DOI 10.1007/s11258-011-9946-7; Liu Q, 2011, ANN BOT-LONDON, V108, P1287, DOI 10.1093/aob/mcr231; LU QS, 2006, CROPS THEIR WILD REL, P360; Mahelka V, 2010, MOL BIOL EVOL, V27, P1370, DOI 10.1093/molbev/msq021; Martin HA, 2006, J ARID ENVIRON, V66, P533, DOI 10.1016/j.jaridenv.2006.01.009; MARTIN JH, 1959, HDB PFLANZENZUCHTUNG, V2, P565; Mason-Gamer RJ, 1998, MOL BIOL EVOL, V15, P1658, DOI 10.1093/oxfordjournals.molbev.a025893; Mathews S, 2002, INT J PLANT SCI, V163, P441, DOI 10.1086/339155; MORDEN CW, 1990, THEOR APPL GENET, V80, P296, DOI 10.1007/BF00210063; NAMBUDIRI EMV, 1978, NATURE, V276, P816, DOI 10.1038/276816a0; Ness RW, 2011, MOL BIOL EVOL, V28, P3009, DOI 10.1093/molbev/msr119; Ng'uni D, 2010, ANN BOT-LONDON, V105, P471, DOI 10.1093/aob/mcp305; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; PATERSON AH, 1995, P NATL ACAD SCI USA, V92, P6127, DOI 10.1073/pnas.92.13.6127; Paterson AH, 2004, P NATL ACAD SCI USA, V101, P9903, DOI 10.1073/pnas.0307901101; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Peterson PM, 2010, MOL PHYLOGENET EVOL, V55, P580, DOI 10.1016/j.ympev.2010.01.018; Phillips S, 1995, FLORA ETHIOPIA ERITR; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Price HJ, 2005, ANN BOT-LONDON, V95, P219, DOI 10.1093/aob/mci015; REDDI VR, 1970, GENETICA, V41, P321, DOI 10.1007/BF00958915; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rota-Stabelli O, 2008, MOL PHYLOGENET EVOL, V48, P103, DOI 10.1016/j.ympev.2008.03.033; Rothfels CJ, 2014, SYST BIOL, V63, P31, DOI 10.1093/sysbio/syt058; RUSSELLSMITH J, 1995, KAKADU NATURAL CULTU, P94; Sepulchre P, 2006, SCIENCE, V313, P1419, DOI 10.1126/science.1129158; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; SNOWDEN J. D., 1955, JOUR LINN SOC [BOT], V55, P191; Soreng RJ, 2014, WORLD WIDE PHYLOGENE; Spangler R, 1999, SYST BOT, V24, P267, DOI 10.2307/2419552; Spangler RE, 2003, AUST SYST BOT, V16, P279, DOI 10.1071/SB01006; STENHOUSE JW, 1997, BIODIVERSITY TRUST C, P292; Stromberg CAE, 2005, P NATL ACAD SCI USA, V102, P11980, DOI 10.1073/pnas.0505700102; SUN Y, 1994, THEOR APPL GENET, V89, P26, DOI 10.1007/BF00226978; Swezey CS, 2009, J AFR EARTH SCI, V53, P89, DOI 10.1016/j.jafrearsci.2008.08.001; Swigonova Z, 2004, GENOME RES, V14, P1916, DOI 10.1101/gr.2332504; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; TANG H, 1988, THEOR APPL GENET, V76, P277; Udall JA, 2005, GENETICS, V169, P967, DOI 10.1534/genetics.104.033209; VAHIDY AA, 1987, ANN MO BOT GARD, V74, P432, DOI 10.2307/2399415; VANOOSTERHOUT SAM, 1992, THESIS U ZIMBABWE; Vicentini A, 2008, GLOBAL CHANGE BIOL, V14, P2963, DOI 10.1111/j.1365-2486.2008.01688.x; Voje KL, 2009, MOL ECOL, V18, P93, DOI 10.1111/j.1365-294X.2008.04002.x; Wheeler MC, 2005, S-P B ENVIRON SCI, P125, DOI 10.1007/3-540-27250-X_5; WHISTLER DP, 1992, GEOL SOC AM BULL, V104, P644, DOI 10.1130/0016-7606(1992)104<0644:MBABOT>2.3.CO;2; Winkler IS, 2009, P NATL ACAD SCI USA, V106, P18103, DOI 10.1073/pnas.0904852106; WU T-P, 1990, Cytologia (Tokyo), V55, P141, DOI 10.1508/cytologia.55.141; WU TP, 1993, J HERED, V84, P484, DOI 10.1093/oxfordjournals.jhered.a111377; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zhang N, 2012, NEW PHYTOL, V195, P923, DOI 10.1111/j.1469-8137.2012.04212.x; Zhang Y, 2014, TURK J BOT, V38, P665, DOI 10.3906/bot-1308-27; Zimmer EA, 2012, MOL PHYLOGENET EVOL, V65, P774, DOI 10.1016/j.ympev.2012.07.015; Zwickl D., 2006, GARLI GENETIC ALGORI	108	16	17	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104933	10.1371/journal.pone.0104933	http://dx.doi.org/10.1371/journal.pone.0104933			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122516	Green Published, Green Submitted, gold			2022-12-25	WOS:000341017000077
J	Rojas-Caraballo, J; Lopez-Aban, J; del Villar, LP; Vizcaino, C; Vicente, B; Fernandez-Soto, P; del Olmo, E; Patarroyo, MA; Muro, A				Rojas-Caraballo, Jose; Lopez-Aban, Julio; Perez del Villar, Luis; Vizcaino, Carolina; Vicente, Belen; Fernandez-Soto, Pedro; del Olmo, Esther; Alfonso Patarroyo, Manuel; Muro, Antonio			In Vitro and In Vivo Studies for Assessing the Immune Response and Protection-Inducing Ability Conferred by Fasciola hepatica-Derived Synthetic Peptides Containing B- and T-Cell Epitopes	PLOS ONE			English	Article							CATHEPSIN-L PROTEINASES; SCHISTOSOMA-MANSONI; HELMINTH INFECTION; VACCINE ADJUVANTS; SHEEP; CATTLE; FLUKE; ANTIGENS; ANTIBODY; MICE	Fasciolosis is considered the most widespread trematode disease affecting grazing animals around the world; it is currently recognised by the World Health Organisation as an emergent human pathogen. Triclabendazole is still the most effective drug against this disease; however, resistant strains have appeared and developing an effective vaccine against this disease has increasingly become a priority. Several bioinformatics tools were here used for predicting B- and T-cell epitopes according to the available data for Fasciola hepatica protein amino acid sequences. BALB/c mice were immunised with the synthetic peptides by using the ADAD vaccination system and several immune response parameters were measured (antibody titres, cytokine levels, T-cell populations) to evaluate their ability to elicit an immune response. Based on the immunogenicity results so obtained, seven peptides were selected to assess their protection-inducing ability against experimental infection with F. hepatica metacercariae. Twenty-four B- or T-epitope-containing peptides were predicted and chemically synthesised. Immunisation of mice with peptides so-called B1, B2, B5, B6, T14, T15 and T16 induced high levels of total IgG, IgG1 and IgG2a (p<0.05) and a mixed Th1/Th2/Th17/Treg immune response, according to IFN-gamma, IL-4, IL-17 and IL-10 levels, accompanied by increased CD62L(+) T-cell populations. A high level of protection was obtained in mice vaccinated with peptides B2, B5, B6 and T15 formulated in the ADAD vaccination system with the AA0029 immunomodulator. The bioinformatics approach used in the present study led to the identification of seven peptides as vaccine candidates against the infection caused by Fasciola hepatica (a liver-fluke trematode). However, vaccine efficacy must be evaluated in other host species, including those having veterinary importance.	[Rojas-Caraballo, Jose; Lopez-Aban, Julio; Perez del Villar, Luis; Vicente, Belen; Fernandez-Soto, Pedro; Muro, Antonio] Univ Salamanca IBSAL CIETUS, Trop Dis Res Ctr, Parasite & Mol Immunol Lab, Salamanca, Spain; [Rojas-Caraballo, Jose; Vizcaino, Carolina; Alfonso Patarroyo, Manuel] Fdn Inst Inmunol Colombia FIDIC, Mol Biol & Immunol Dept, Bogota, Colombia; [del Olmo, Esther] Univ Salamanca IBSAL CIETUS, Trop Dis Res Ctr, Dept Pharmaceut Chem, Salamanca, Spain; [Alfonso Patarroyo, Manuel] Univ Rosario, Sch Med & Hlth Sci, Dept Basic Sci, Bogota, Colombia	Universidad del Rosario	Muro, A (corresponding author), Univ Salamanca IBSAL CIETUS, Trop Dis Res Ctr, Parasite & Mol Immunol Lab, Salamanca, Spain.	ama@usal.es	Patarroyo, Manuel A/I-8046-2016; del Olmo, Esther/L-5803-2014; López-Abán, Julio/B-3557-2015	Patarroyo, Manuel A/0000-0002-4751-2500; del Olmo, Esther/0000-0002-3965-3290; López-Abán, Julio/0000-0001-8509-0727; Muro, Antonio/0000-0003-0244-4740	Fundacion Ramon Areces (Madrid, Spain) [XV-2010-2013]	Fundacion Ramon Areces (Madrid, Spain)	This study was supported by Fundacion Ramon Areces (Madrid, Spain). Reference: XV-2010-2013 (www.fundacionareces.es). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnello D, 2003, J CLIN IMMUNOL, V23, P147, DOI 10.1023/A:1023381027062; Arnon R, 2003, INT IMMUNOPHARMACOL, V3, P1195, DOI 10.1016/S1567-5769(03)00016-X; Arnon R, 2000, IMMUNOLOGY, V101, P555, DOI 10.1046/j.1365-2567.2000.00139.x; Artis D, 1999, J EXP MED, V190, P953, DOI 10.1084/jem.190.7.953; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bustamante JM, 2008, NAT MED, V14, P542, DOI 10.1038/nm1744; Caoili SEC, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/910524; Cardoso FC, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000308; Dalton JP, 1996, INFECT IMMUN, V64, P5066, DOI 10.1128/IAI.64.12.5066-5074.1996; Dalton JP, 2003, INT J PARASITOL, V33, P1173, DOI 10.1016/S0020-7519(03)00171-1; de Aluja AS, 2005, VACCINE, V23, P4062, DOI 10.1016/j.vaccine.2004.11.076; De Groot AS, 2006, DRUG DISCOV TODAY, V11, P203, DOI 10.1016/S1359-6446(05)03720-7; De Groot AS, 2004, METHODS, V34, P425, DOI 10.1016/j.ymeth.2004.06.004; del Olmo E, 2006, BIOORG MED CHEM LETT, V16, P6091, DOI 10.1016/j.bmcl.2006.08.113; Deleage G, 2001, COMPUT BIOL MED, V31, P259, DOI 10.1016/S0010-4825(01)00008-7; Espino AM, 2005, EXP PARASITOL, V110, P374, DOI 10.1016/j.exppara.2005.03.029; Espino AM, 2010, VET PARASITOL, V169, P82, DOI 10.1016/j.vetpar.2009.12.018; Fairweather I, 2011, VET PARASITOL, V180, P133, DOI 10.1016/j.vetpar.2011.05.034; Farias LP, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000597; Flynn RJ, 2008, INT J PARASITOL, V38, P1673, DOI 10.1016/j.ijpara.2008.05.008; Gause WC, 2003, TRENDS IMMUNOL, V24, P269, DOI 10.1016/S1471-4906(03)00101-7; HAGAN P, 1993, PARASITE IMMUNOL, V15, P1, DOI 10.1111/j.1365-3024.1993.tb00565.x; Hans Dhiraj, 2006, Med Chem, V2, P627; Harmsen MM, 2004, INT J PARASITOL, V34, P675, DOI 10.1016/j.ijpara.2003.12.011; HAROUN EM, 1986, VET PARASITOL, V20, P63, DOI 10.1016/0304-4017(86)90093-2; Hillyer GV, 2005, J HELMINTHOL, V79, P241, DOI 10.1079/JOH2005304; HOUGHTEN RA, 1985, P NATL ACAD SCI USA, V82, P5131, DOI 10.1073/pnas.82.15.5131; Hoyle DV, 2003, PARASITE IMMUNOL, V25, P221, DOI 10.1046/j.1365-3024.2003.00627.x; Jayaraj R, 2009, VET PARASITOL, V160, P230, DOI 10.1016/j.vetpar.2008.10.099; Jezek J, 2008, BIOPOLYMERS, V90, P349, DOI 10.1002/bip.20788; Kaplan R M, 2001, Vet Ther, V2, P40; Kensil CR, 1996, CRIT REV THER DRUG, V13, P1; Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2; Lopez-Aban J, 2007, J PARASITOL, V93, P428, DOI 10.1645/GE-838R1.1; Madhumathi J, 2010, VACCINE, V28, P5038, DOI 10.1016/j.vaccine.2010.05.012; Martinez-Fernandez AR, 2004, VET PARASITOL, V126, P287, DOI 10.1016/j.vetpar.2004.07.023; Mas-Coma S, 2005, J HELMINTHOL, V79, P207, DOI 10.1079/JOH2005296; Mas-Coma S, 2009, VET PARASITOL, V163, P264, DOI 10.1016/j.vetpar.2009.03.024; McCole DF, 1999, PARASITE IMMUNOL, V21, P1, DOI 10.1046/j.1365-3024.1999.00188.x; McGonigle L, 2008, INT J PARASITOL, V38, P149, DOI 10.1016/j.ijpara.2007.10.007; McManus DP, 2006, PARASITOLOGY, V133, pS43, DOI 10.1017/S0031182006001806; MERRIFIELD RB, 1969, ADV ENZYMOL RAMB, V32, P221; Mulcahy G, 1999, RES VET SCI, V67, P27, DOI 10.1053/rvsc.1998.0270; Mulcahy G, 1998, VACCINE, V16, P932, DOI 10.1016/S0264-410X(97)00289-2; Negrao-Correa Deborah, 2001, Revista do Instituto de Medicina Tropical de Sao Paulo, V43, P291, DOI 10.1590/S0036-46652001000500011; Patarroyo ME, 2008, J CELL MOL MED, V12, P1915, DOI 10.1111/j.1582-4934.2008.00174.x; Piacenza L, 1999, INFECT IMMUN, V67, P1954; Prowse RK, 2002, PARASITE IMMUNOL, V24, P57, DOI 10.1046/j.0141-9838.2001.00438.x; Purcell AW, 2007, NAT REV DRUG DISCOV, V6, P404, DOI 10.1038/nrd2224; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Read AJ, 2009, VACCINE, V27, P1024, DOI 10.1016/j.vaccine.2008.11.096; Robinson K, 1995, IMMUNOLOGY, V86, P495; Rutitzky LI, 2009, EUR J IMMUNOL, V39, P2470, DOI 10.1002/eji.200939325; Sette A, 2010, IMMUNITY, V33, P530, DOI 10.1016/j.immuni.2010.09.017; Singh M, 1999, NAT BIOTECHNOL, V17, P1075, DOI 10.1038/15058; Taylor MD, 2012, TRENDS IMMUNOL, V33, P181, DOI 10.1016/j.it.2012.01.001; Totte P, 2010, DEV COMP IMMUNOL, V34, P177, DOI 10.1016/j.dci.2009.09.005; Vilar MM, 2003, VACCINE, V22, P137, DOI 10.1016/S0264-410X(03)00300-1; Villa-Mancera A, 2012, VET J, V194, P108, DOI 10.1016/j.tvjl.2012.03.003; Vlieghe P, 2010, DRUG DISCOV TODAY, V15, P40, DOI 10.1016/j.drudis.2009.10.009; Wedrychowicz H, 2007, VET PARASITOL, V147, P77, DOI 10.1016/j.vetpar.2007.03.023; World Health Organization (WHO), 2011, IN EST GLOB BURD FOO; Zaph C, 2004, NAT MED, V10, P1104, DOI 10.1038/nm1108; ZIMMERMAN GL, 1983, J PARASITOL, V69, P473, DOI 10.2307/3281356	64	23	23	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e105323	10.1371/journal.pone.0105323	http://dx.doi.org/10.1371/journal.pone.0105323			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122166	Green Published, Green Submitted, gold			2022-12-25	WOS:000341017000117
J	Williams, CML; Cheah, ESG; Malkin, J; Patel, H; Otu, J; Mlaga, K; Sutherland, JS; Antonio, M; Perera, N; Woltmann, G; Haldar, P; Garton, NJ; Barer, MR				Williams, Caroline M. L.; Cheah, Eddy S. G.; Malkin, Joanne; Patel, Hemu; Otu, Jacob; Mlaga, Kodjovi; Sutherland, Jayne S.; Antonio, Martin; Perera, Nelun; Woltmann, Gerrit; Haldar, Pranabashis; Garton, Natalie J.; Barer, Michael R.			Face Mask Sampling for the Detection of Mycobacterium tuberculosis in Expelled Aerosols	PLOS ONE			English	Article							AIRBORNE TRANSMISSION; PULMONARY TUBERCULOSIS; INFECTION; VARIABILITY; RESISTANCE; BACILLI	Background: Although tuberculosis is transmitted by the airborne route, direct information on the natural output of bacilli into air by source cases is very limited. We sought to address this through sampling of expelled aerosols in face masks that were subsequently analyzed for mycobacterial contamination. Methods: In series 1, 17 smear microscopy positive patients wore standard surgical face masks once or twice for periods between 10 minutes and 5 hours; mycobacterial contamination was detected using a bacteriophage assay. In series 2, 19 patients with suspected tuberculosis were studied in Leicester UK and 10 patients with at least one positive smear were studied in The Gambia. These subjects wore one FFP30 mask modified to contain a gelatin filter for one hour; this was subsequently analyzed by the Xpert MTB/RIF system. Results: In series 1, the bacteriophage assay detected live mycobacteria in 11/17 patients with wearing times between 10 and 120 minutes. Variation was seen in mask positivity and the level of contamination detected in multiple samples from the same patient. Two patients had non-tuberculous mycobacterial infections. In series 2, 13/20 patients with pulmonary tuberculosis produced positive masks and 0/9 patients with extrapulmonary or non-tuberculous diagnoses were mask positive. Overall, 65% of patients with confirmed pulmonary mycobacterial infection gave positive masks and this included 3/6 patients who received diagnostic bronchoalveolar lavages. Conclusion: Mask sampling provides a simple means of assessing mycobacterial output in non-sputum expectorant. The approach shows potential for application to the study of airborne transmission and to diagnosis.	[Williams, Caroline M. L.; Cheah, Eddy S. G.; Malkin, Joanne; Haldar, Pranabashis; Garton, Natalie J.; Barer, Michael R.] Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England; [Malkin, Joanne; Patel, Hemu; Perera, Nelun; Barer, Michael R.] Univ Hosp Leicester NHS Trust, Dept Clin Microbiol, Leicester, Leics, England; [Otu, Jacob; Mlaga, Kodjovi; Sutherland, Jayne S.; Antonio, Martin] MRC Unit, Banjul, Gambia; [Woltmann, Gerrit; Haldar, Pranabashis] Glenfield Hosp, Dept Resp Med, Leicester, Leics, England; [Haldar, Pranabashis] Glenfield Hosp, Resp Biomed Res Unit, Natl Inst Hlth Res, Leicester, Leics, England	University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; University of London; London School of Hygiene & Tropical Medicine; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital	Barer, MR (corresponding author), Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England.	mrb19@le.ac.uk	Mlaga, Kodjovi D./AAL-3472-2020; Cheah, Eddy Seong Guan/T-1754-2017	Cheah, Eddy Seong Guan/0000-0002-4555-167X; Woltmann, Gerrit/0000-0002-9253-6034; Sutherland, Jayne/0000-0002-7083-4997; Haldar, Pranabashis/0000-0002-1572-5421; Barer, Michael/0000-0002-0377-3100	Henry Smith Charity; Edith Murphy Foundation; Medical Research Council [MC_UP_A900_1122, MC_U190071468, G0300403] Funding Source: researchfish; MRC [MC_UP_A900_1122, MC_U190071468, G0300403] Funding Source: UKRI	Henry Smith Charity; Edith Murphy Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	MRB and ESGC received funding from the Henry Smith Charity (www.henrysmithcharity.org.uk) and the Edith Murphy Foundation (www.edithmurphy.co.uk). CMLW held a UK National Institute for Health Research Academic Clinical Fellowship (www.nihr.ac.uk) during this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkerman OW, 2013, J CLIN MICROBIOL, V51, P3505, DOI 10.1128/JCM.00843-13; Behr MA, 1999, LANCET, V353, P444, DOI 10.1016/S0140-6736(98)03406-0; Boston LN, 1901, J AMER MED ASSOC, V37, P685; Bridges CB, 2003, CLIN INFECT DIS, V37, P1094, DOI 10.1086/378292; Cheah ESG, 2010, J MOL DIAGN, V12, P250, DOI 10.2353/jmoldx.2010.090030; Dharmadhikari AS, 2011, TUBERCULOSIS, V91, P329, DOI 10.1016/j.tube.2011.03.002; Escombe AR, 2007, CLIN INFECT DIS, V44, P1349, DOI 10.1086/515397; FEIGIN RD, 1982, NEW ENGL J MED, V307, P1255, DOI 10.1056/NEJM198211113072007; Fennelly KP, 2007, CLIN INFECT DIS, V44, P1358, DOI 10.1086/516617; Fennelly KP, 2012, AM J RESP CRIT CARE, V186, P450, DOI 10.1164/rccm.201203-0444OC; Fennelly KP, 2004, AM J RESP CRIT CARE, V169, P604, DOI 10.1164/rccm.200308-1101OC; Friedrich SO, 2013, LANCET RESP MED, V1, P462, DOI 10.1016/S2213-2600(13)70119-X; Garton NJ, 2008, PLOS MED, V5, P634, DOI 10.1371/journal.pmed.0050075; Helb D, 2010, J CLIN MICROBIOL, V48, P229, DOI 10.1128/JCM.01463-09; Hernandez-Garduno E, 2004, THORAX, V59, P286, DOI 10.1136/thx.2003.011759; Huynh KN, 2008, CLIN INFECT DIS, V46, P93, DOI 10.1086/523000; Jones-Lopez EC, 2013, AM J RESP CRIT CARE, V187, P1007, DOI 10.1164/rccm.201208-1422OC; Mole R, 2007, J MED MICROBIOL, V56, P1334, DOI 10.1099/jmm.0.46936-0; Mukamolova GV, 2010, AM J RESP CRIT CARE, V181, P174, DOI 10.1164/rccm.200905-0661OC; Parsons LM, 2011, CLIN MICROBIOL REV, V24, P314, DOI 10.1128/CMR.00059-10; RILEY RL, 1959, AM J HYG, V70, P185, DOI 10.1093/oxfordjournals.aje.a120069; Roy CJ, 2004, NEW ENGL J MED, V350, P1710, DOI 10.1056/NEJMp048051; Sepkowitz KA, 1996, CLIN INFECT DIS, V23, P954, DOI 10.1093/clinids/23.5.954; STEINBERG P, 1969, AM J EPIDEMIOL, V89, P62, DOI 10.1093/oxfordjournals.aje.a120916; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Wurie Fatima, 2013, F1000Res, V2, P14, DOI 10.12688/f1000research.2-14.v1	26	16	16	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104921	10.1371/journal.pone.0104921	http://dx.doi.org/10.1371/journal.pone.0104921			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122163	Green Published, Green Submitted, gold			2022-12-25	WOS:000341017000075
J	Sergeeva, OA; Tran, MT; Haase-Pettingell, C; King, JA				Sergeeva, Oksana A.; Tran, Meme T.; Haase-Pettingell, Cameron; King, Jonathan A.			Biochemical Characterization of Mutants in Chaperonin Proteins CCT4 and CCT5 Associated with Hereditary Sensory Neuropathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; Crystallin; Molecular Chaperone; Protein Folding; Protein Stability; CCT; TRiC; Chaperonin; Complex Assembly; Neuropathy	GAMMA-D-CRYSTALLIN; SPASTIC PARAPLEGIA SPG13; HUNTINGTONS-DISEASE; IN-VITRO; MOLECULAR CHAPERONES; SUBUNIT; MUTATION; AGGREGATION; GENE; FLUORESCENCE	Background: Point mutations in two genes encoding chaperonin subunits have been implicated in neuropathies. Results: CCT4 and CCT5 proteins carrying these mutations were expressed in bacteria and investigated for their biochemical defects. Conclusion: H147R CCT5 is faulty in chaperoning function, whereas C450Y CCT4 may be defective in protein stability. Significance: These biochemical defects may be the source of these neuropathies in patients. Hereditary sensory neuropathies are a class of disorders marked by degeneration of the nerve fibers in the sensory periphery neurons. Recently, two mutations were identified in the subunits of the eukaryotic cytosolic chaperonin TRiC, a protein machine responsible for folding actin and tubulin in the cell. C450Y CCT4 was identified in a stock of Sprague-Dawley rats, whereas H147R CCT5 was found in a human Moroccan family. As with many genetically identified mutations associated with neuropathies, the underlying molecular basis of the mutants was not defined. We investigated the biochemical properties of these mutants using an expression system in Escherichia coli that produces homo-oligomeric rings of CCT4 and CCT5. Full-length versions of both mutant protein chains were expressed in E. coli at levels approaching that of the WT chains. Sucrose gradient centrifugation revealed chaperonin-sized complexes of both WT and mutant chaperonins, but with reduced recovery of C450Y CCT4 soluble subunits. Electron microscopy of negatively stained samples of C450Y CCT4 revealed few ring-shaped species, whereas WT CCT4, H147R CCT5, and WT CCT5 revealed similar ring structures. CCT5 complexes were assayed for their ability to suppress aggregation of and refold the model substrate d-crystallin, suppress aggregation of mutant huntingtin, and refold the physiological substrate -actin in vitro. H147R CCT5 was not as efficient in chaperoning these substrates as WT CCT5. The subtle effects of these mutations are consistent with the homozygous disease phenotype, in which most functions are carried out during development and adulthood, but some selective function is lost or reduced.	[Sergeeva, Oksana A.; Tran, Meme T.; Haase-Pettingell, Cameron; King, Jonathan A.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	King, JA (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave,68-330, Cambridge, MA 02139 USA.	jaking@mit.edu		Sergeeva, Oksana/0000-0002-4830-0518	National Science Foundation [NSF-007031]; NATIONAL EYE INSTITUTE [R01EY015834, PN2EY016525] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank Dr. Chengbiao Wu for helpful discussions, Koning Shen and Dr. Judith Frydman for the mHtt plasmid, and Drs. Emily Sontag and Leslie Thompson for mHtt protocol suggestions. We thank the Biophysical Instrumentation Facility for the Study of Complex Macromolecular Systems (supported by National Science Foundation Grant NSF-007031).	Abe Y, 2009, J BIOL CHEM, V284, P14939, DOI 10.1074/jbc.M900097200; Acosta-Sampson L, 2010, J MOL BIOL, V401, P134, DOI 10.1016/j.jmb.2010.05.067; Arrasate M, 2012, EXP NEUROL, V238, P1, DOI 10.1016/j.expneurol.2011.12.013; Auer-Grumbach M, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-7; Bates GP, 2005, NAT REV GENET, V6, P766, DOI 10.1038/nrg1686; Bouhouche A, 2006, J MED GENET, V43, P441, DOI 10.1136/jmg.2005.039230; Bross P, 2008, J BIOL CHEM, V283, P15694, DOI 10.1074/jbc.M800548200; CAVANAGH NPC, 1979, BRAIN, V102, P79, DOI 10.1093/brain/102.1.79; Chen JJ, 2006, BIOCHEMISTRY-US, V45, P11552, DOI 10.1021/bi060988v; Clabough Erin B. D., 2013, Yale Journal of Biology and Medicine, V86, P217; Flaugh SL, 2006, J BIOL CHEM, V281, P30782, DOI 10.1074/jbc.M603882200; Flaugh SL, 2005, PROTEIN SCI, V14, P2030, DOI 10.1110/ps.051460505; Flaugh SL, 2005, PROTEIN SCI, V14, P571, DOI 10.1110/ps.041111405; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Hagiwara Hiroki, 2004, Breast Cancer, V11, P82, DOI 10.1007/BF02968008; Hansen JJ, 2002, AM J HUM GENET, V70, P1328, DOI 10.1086/339935; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Knee KM, 2013, CELL STRESS CHAPERON, V18, P137, DOI 10.1007/s12192-012-0357-z; Knee KM, 2011, PROTEIN SCI, V20, P30, DOI 10.1002/pro.531; Kong FR, 2011, PROTEIN SCI, V20, P513, DOI 10.1002/pro.583; Kosinski-Collins MS, 2004, PROTEIN SCI, V13, P2223, DOI 10.1110/ps.04627004; Kosinski-Collins MS, 2003, PROTEIN SCI, V12, P480, DOI 10.1110/ps.0225503; Lee MJ, 2003, HUM MOL GENET, V12, P1917, DOI 10.1093/hmg/ddg198; Llorca O, 1999, NATURE, V402, P693, DOI 10.1038/45294; Lundin VF, 2010, TRENDS BIOCHEM SCI, V35, P288, DOI 10.1016/j.tibs.2009.12.007; Machida K, 2012, PROTEIN EXPRES PURIF, V82, P61, DOI 10.1016/j.pep.2011.11.010; Moreau KL, 2009, J BIOL CHEM, V284, P33285, DOI 10.1074/jbc.M109.031344; Pappenberger G, 2006, J MOL BIOL, V360, P484, DOI 10.1016/j.jmb.2006.05.003; Reissmann S, 2007, NAT STRUCT MOL BIOL, V14, P432, DOI 10.1038/nsmb1236; Rotthier A, 2009, BRAIN, V132, P2699, DOI 10.1093/brain/awp198; Sergeeva OA, 2014, PROTEIN SCI, V23, P693, DOI 10.1002/pro.2452; Sergeeva OA, 2013, J BIOL CHEM, V288, P17734, DOI 10.1074/jbc.M112.443929; Shahmoradian SH, 2013, ELIFE, V2, DOI 10.7554/eLife.00710; Sontag EM, 2013, P NATL ACAD SCI USA, V110, P3077, DOI 10.1073/pnas.1222663110; Tam S, 2006, NAT CELL BIOL, V8, P1155, DOI 10.1038/ncb1477; Tam S, 2009, NAT STRUCT MOL BIOL, V16, P1279, DOI 10.1038/nsmb.1700; THOMAS PK, 1994, BRAIN, V117, P651, DOI 10.1093/brain/117.4.651; Timmerman V, 2013, EXP NEUROL, V246, P14, DOI 10.1016/j.expneurol.2012.01.010; Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1; Wetzel R, 2012, J MOL BIOL, V421, P466, DOI 10.1016/j.jmb.2012.01.030	40	18	18	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27470	27480		10.1074/jbc.M114.576033	http://dx.doi.org/10.1074/jbc.M114.576033			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25124038	Green Published, hybrid			2022-12-25	WOS:000342852800010
J	Jeon, JW; Ha, UH; Paek, SH				Jeon, Jin-Woo; Ha, Un-Hwan; Paek, Se-Hwan			In Vitro Inflammation Inhibition Model Based on Semi-Continuous Toll-Like Receptor Biosensing	PLOS ONE			English	Article							NF-KAPPA-B; ENERGY-TRANSFER; CELL-LINES; SALICYLATE; ACTIVATION; ASPIRIN; EXPRESSION; DISEASE; MACROPHAGES; RESONANCE	In A chemical inhibition model of inflammation is proposed by semi-continuous monitoring the density of toll-like receptor 1 (TLR1) expressed on mammalian cells following bacterial infection to investigate an in vivo-mimicked drug screening system. The inflammation was induced by adding bacterial lysate (e.g., Pseudomonas aeruginosa) to a mammalian cell culture (e.g., A549 cell line). The TLR1 density on the same cells was immunochemically monitored up to three cycles under optimized cyclic bacterial stimulation-and-restoration conditions. The assay was carried out by adopting a cell-compatible immunoanalytical procedure and signal generation method. Signal intensity relative to the background control obtained without stimulation was employed to plot the standard curve for inflammation. To suppress the inflammatory response, sodium salicylate, which inhibits nuclear factor-kappa B activity, was used to prepare the standard curve for anti-inflammation. Such measurement of differential TLR densities was used as a biosensing approach discriminating the anti-inflammatory substance from the non-effector, which was simulated by using caffeic acid phenethyl ester and acetaminophen as the two components, respectively. As the same cells exposed to repetitive bacterial stimulation were semi-continuously monitored, the efficacy and toxicity of the inhibitors may further be determined regarding persistency against time. Therefore, this semi-continuous biosensing model could be appropriate as a substitute for animal-based experimentation during drug screening prior to pre-clinical tests.	[Jeon, Jin-Woo; Paek, Se-Hwan] Korea Univ, Dept Bio Microsyst Technol, Seoul, South Korea; [Ha, Un-Hwan; Paek, Se-Hwan] Korea Univ, Dept Biotechnol & Bioinformat, Sejong, South Korea	Korea University; Korea University	Paek, SH (corresponding author), Korea Univ, Dept Bio Microsyst Technol, Seoul, South Korea.	shpaek@korea.ac.kr	Ha, Un-Hwan/ABH-8017-2020	Ha, Un-Hwan/0000-0001-9182-7000	Converging Research Center Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning, Korea [2013K000249]; BK21 plus program of the Ministry of Education, Korea	Converging Research Center Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning, Korea; BK21 plus program of the Ministry of Education, Korea	This research was supported by the Converging Research Center Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning, Korea (No. 2013K000249). This work was also supported by the BK21 plus program of the Ministry of Education, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellosillo B, 1998, BLOOD, V92, P1406, DOI 10.1182/blood.V92.4.1406.416k17_1406_1414; Catella-Lawson F, 2001, NEW ENGL J MED, V345, P1809, DOI 10.1056/NEJMoa003199; Cho IH, 2012, ANAL CHEM, V84, P9713, DOI 10.1021/ac300668y; Chyka PA, 2007, CLIN TOXICOL, V45, P95, DOI 10.1080/15563650600907140; COLLINS T, 1995, FASEB J, V9, P899, DOI 10.1096/fasebj.9.10.7542214; Cugno M, 2000, CLIN SCI, V99, P461, DOI 10.1042/CS20000095; de Lara LGV, 2003, AM J PHYSIOL-LUNG C, V285, pL899, DOI 10.1152/ajplung.00082.2003; Ehlers M, 2007, TRENDS IMMUNOL, V28, P74, DOI 10.1016/j.it.2006.12.006; Ferrero-Miliani L, 2007, CLIN EXP IMMUNOL, V147, P227, DOI 10.1111/j.1365-2249.2006.03261.x; FITZPATRICK FA, 1980, PROSTAGLANDINS, V19, P917, DOI 10.1016/0090-6980(80)90126-4; Ghaemmaghami AM, 2012, DRUG DISCOV TODAY, V17, P173, DOI 10.1016/j.drudis.2011.10.029; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Gosai SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015460; GRANSTROM E, 1980, PROSTAG OTH LIPID M, V19, P933, DOI 10.1016/0090-6980(80)90127-6; Hennessy EJ, 2010, NAT REV DRUG DISCOV, V9, P293, DOI 10.1038/nrd3203; Hertzberg RP, 2000, CURR OPIN CHEM BIOL, V4, P445, DOI 10.1016/S1367-5931(00)00110-1; Hinz B, 2008, FASEB J, V22, P383, DOI 10.1096/fj.07-8506com; HogenEsch H, 2012, J CONTROL RELEASE, V164, P183, DOI 10.1016/j.jconrel.2012.02.031; Huh D, 2010, SCIENCE, V328, P1662, DOI 10.1126/science.1188302; Huttunen K, 2003, ENVIRON HEALTH PERSP, V111, P85, DOI 10.1289/ehp.5478; Intahphuak S, 2004, J ETHNOPHARMACOL, V90, P69, DOI 10.1016/j.jep.2003.09.026; Irazoqui JE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000982; Jeon JW, 2014, SCI REP UK IN PRESS; Kaplan AP, 2002, J ALLERGY CLIN IMMUN, V109, P195, DOI 10.1067/mai.2002.121316; KOPP E, 1994, SCIENCE, V265, P956, DOI 10.1126/science.8052854; Lan T, 2007, P NATL ACAD SCI USA, V104, P13750, DOI 10.1073/pnas.0706059104; Leung MCK, 2008, TOXICOL SCI, V106, P5, DOI 10.1093/toxsci/kfn121; Liu QJ, 2014, CHEM REV, V114, P6423, DOI 10.1021/cr2003129; MARGOLIUS HS, 1995, HYPERTENSION, V26, P221, DOI 10.1161/01.HYP.26.2.221; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Meneghin A, 2007, J CLIN INVEST, V117, P530, DOI 10.1172/JCI30595; Mousavi SA, 2004, BIOCHEM J, V377, P1, DOI 10.1042/BJ20031000; Natarajan K, 1996, P NATL ACAD SCI USA, V93, P9090, DOI 10.1073/pnas.93.17.9090; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Ospelt C, 2010, INT J BIOCHEM CELL B, V42, P495, DOI 10.1016/j.biocel.2009.10.010; Panter G, 2009, CURR OPIN MOL THER, V11, P133; Prado GN, 2002, J CELL PHYSIOL, V193, P275, DOI 10.1002/jcp.10175; PRESCOTT LF, 1982, BRIT MED J, V285, P1383, DOI 10.1136/bmj.285.6352.1383; RAYMOND P, 1995, J IMMUNOL METHODS, V180, P247, DOI 10.1016/0022-1759(94)00320-V; Sabourin T, 2002, AM J PHYSIOL-HEART C, V283, pH227, DOI 10.1152/ajpheart.00978.2001; SCHEINMAN RI, 1995, SCIENCE, V270, P283, DOI 10.1126/science.270.5234.283; Seabrook GR, 1997, NEUROPHARMACOLOGY, V36, P1009, DOI 10.1016/S0028-3908(97)00065-8; Shin HS, 2013, PATHOG DIS, V69, P149, DOI 10.1111/2049-632X.12074; Shin HS, 2011, CURR MICROBIOL, V63, P138, DOI 10.1007/s00284-011-9959-4; Singh AK, 2013, J IMMUNOTOXICOL, V10, P141, DOI 10.3109/1547691X.2012.700653; SNYDER DS, 1976, PROSTAGLANDINS, V11, P631, DOI 10.1016/0090-6980(76)90066-6; Stamme C, 2000, AM J RESP CELL MOL, V23, P772, DOI 10.1165/ajrcmb.23.6.4083; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; Tian H, 2007, BRIT J PHARMACOL, V150, P321, DOI 10.1038/sj.bjp.0706988; Vandooren J, 2013, CRIT REV BIOCHEM MOL, V48, P222, DOI 10.3109/10409238.2013.770819; VANE JR, 1971, NATURE-NEW BIOL, V231, P232, DOI 10.1038/newbio231232a0; Verstrepen L, 2008, CELL MOL LIFE SCI, V65, P2964, DOI 10.1007/s00018-008-8064-8; Weiss U, 2008, NATURE, V454, P427, DOI 10.1038/454427a; Wu SH, 2013, SMALL, V9, P3532, DOI 10.1002/smll.201203125; Xu Z, 2012, J INFLAMM-LOND, V9, DOI 10.1186/1476-9255-9-2; Yin MJ, 1998, NATURE, V396, P77, DOI 10.1038/23948	56	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105212	10.1371/journal.pone.0105212	http://dx.doi.org/10.1371/journal.pone.0105212			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136864	Green Published, Green Submitted, gold			2022-12-25	WOS:000340742100074
J	Molina-Navarro, MM; Trivino, JC; Martinez-Dolz, L; Lago, F; Gonzalez-Juanatey, JR; Portoles, M; Rivera, M				Micaela Molina-Navarro, Maria; Carlos Trivino, Juan; Martinez-Dolz, Luis; Lago, Francisca; Ramon Gonzalez-Juanatey, Jose; Portoles, Manuel; Rivera, Miguel			Functional Networks of Nucleocytoplasmic Transport-Related Genes Differentiate Ischemic and Dilated Cardiomyopathies. A New Therapeutic Opportunity	PLOS ONE			English	Article							RAN-BINDING PROTEIN-3; NF-KAPPA-B; HEART-FAILURE; RNA-SEQ; NUCLEAR IMPORT; CLINICAL-IMPLICATIONS; EXPRESSION; PYK2; PHOSPHORYLATION; QUANTIFICATION	Heart failure provokes alterations in the expression of nucleocytoplasmic transport-related genes. To elucidate the nucleocytoplasmic transport-linked functional network underlying the two major causes of heart failure, ischemic cardiomyopathy (ICM) and dilated cardiomyopathy (DCM), we examined global transcriptome profiles of left ventricular myocardium tissue samples from 31 patients (ICM, n = 10; DCM, n = 13) undergoing heart transplantation and control donors (CNT, n = 8) using RNA-Sequencing and GeneMANIA. Comparative profiling of ICM versus control and DCM versus control showed 1081 and 2440 differentially expressed genes, respectively (>1.29-fold; P<0.05). GeneMANIA revealed differentially regulated functional networks specific to ICM and DCM. In comparison with CNT, differential expression was seen in 9 and 12 nucleocytoplasmic transport-related genes in ICM and DCM groups, respectively. DDX3X, KPNA2, and PTK2B were related to ICM, while SMURF2, NUP153, IPO5, RANBP3, NOXA1, and RHOJ were involved in DCM pathogenesis. Furthermore, the two pathologies shared 6 altered genes: XPO1, ARL4, NFKB2, FHL3, RANBP2, and RHOU showing an identical trend in expression in both ICM and DCM. Notably, the core of the derived functional networks composed of nucleocytoplasmic transport-related genes (XPO1, RANBP2, NUP153, IPO5, KPNA2, and RANBP3) branched into several pathways with downregulated genes. Moreover, we identified genes whose expression levels correlated with left ventricular mass index and left ventricular function parameters in HF patients. Collectively, our study provides a clear distinction between the two pathologies at the transcriptome level and opens up new possibilities to search for appropriate therapeutic targets for ICM and DCM.	[Micaela Molina-Navarro, Maria; Portoles, Manuel; Rivera, Miguel] Hosp La Fe, Hlth Res Inst, Cardiocirculatory Unit, E-46009 Valencia, Spain; [Carlos Trivino, Juan] Sistemas Genom, Valencia, Spain; [Martinez-Dolz, Luis] La Fe Univ Hosp, Dept Cardiol, Heart Failure & Transplantat Unit, Valencia, Spain; [Lago, Francisca; Ramon Gonzalez-Juanatey, Jose] Univ Clin Hosp, Dept Cardiol, Cellular & Mol Cardiol Res Unit, Santiago De Compostela, Spain; [Lago, Francisca; Ramon Gonzalez-Juanatey, Jose] Univ Clin Hosp, Inst Biomed Res, Santiago De Compostela, Spain	Hospital Universitari i Politecnic La Fe; Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela	Rivera, M (corresponding author), Hosp La Fe, Hlth Res Inst, Cardiocirculatory Unit, E-46009 Valencia, Spain.	miguelrivera492@gmail.com	PORTOLES, MANUEL/B-4789-2009; Dolz, Luis Martinez/X-4627-2018	PORTOLES, MANUEL/0000-0002-4415-7160; Dolz, Luis Martinez/0000-0001-5145-8191; , Micaela/0000-0002-2103-0351; Gonzalez Juanatey, Jose Ramon/0000-0001-9681-3388	National Institute of Health "Fondo de Investigaciones Sanitarias del Instituto de Salud Carlos III'' [RD12/0042/0003]; FIS Project [PI10/00275]	National Institute of Health "Fondo de Investigaciones Sanitarias del Instituto de Salud Carlos III''; FIS Project	This work was supported by grants from the National Institute of Health "Fondo de Investigaciones Sanitarias del Instituto de Salud Carlos III'' [RD12/0042/0003; FIS Project PI10/00275]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambasta RK, 2006, FREE RADICAL BIO MED, V41, P193, DOI 10.1016/j.freeradbiomed.2005.12.035; Auerbach SS, 2010, TOXICOL PATHOL, V38, P923, DOI 10.1177/0192623310382864; Balan M, 2011, CELL STRESS CHAPERON, V16, P105, DOI 10.1007/s12192-010-0217-7; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Chao HW, 2012, NUCLEIC ACIDS RES, V40, P8484, DOI 10.1093/nar/gks598; Cohn JN, 2000, J AM COLL CARDIOL, V35, P569, DOI 10.1016/S0735-1097(99)00630-0; Cortes R, 2010, CARDIOVASC RES, V85, P464, DOI 10.1093/cvr/cvp336; Dominguez D, 2003, MOL CELL BIOL, V23, P5078, DOI 10.1128/MCB.23.14.5078-5089.2003; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/NMETH.1613, 10.1038/nmeth.1613]; Giubbini R, 2009, EUR J NUCL MED MOL I, V36, P2068, DOI 10.1007/s00259-009-1246-2; GRIMM S, 1993, BIOCHEM J, V290, P297, DOI 10.1042/bj2900297; Hart DL, 2008, J MOL CELL CARDIOL, V45, P93, DOI 10.1016/j.yjmcc.2008.04.002; Heidkamp MC, 2005, AM J PHYSIOL-CELL PH, V289, pC471, DOI 10.1152/ajpcell.00130.2005; Ho H, 2012, CANCER RES, V72, P5516, DOI 10.1158/0008-5472.CAN-12-0775; Itoh S, 2007, CURR OPIN CELL BIOL, V19, P176, DOI 10.1016/j.ceb.2007.02.015; Kelley JB, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-63; Kim T, 2014, MOL CELLS, V37, P81, DOI 10.14348/molcells.2014.2337; Lang D, 2011, AM J PHYSIOL-HEART C, V301, pH975, DOI 10.1152/ajpheart.00241.2011; Lassegue B, 2010, ARTERIOSCL THROM VAS, V30, P653, DOI 10.1161/ATVBAHA.108.181610; Lee JH, 2011, CIRC RES, V109, P1332, DOI 10.1161/CIRCRESAHA.111.249433; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lindsay ME, 2001, J CELL BIOL, V153, P1391, DOI 10.1083/jcb.153.7.1391; Ling SZ, 2004, AM J PHYSIOL-CELL PH, V287, pC698, DOI 10.1152/ajpcell.00030.2004; Lonn P, 2009, CELL RES, V19, P21, DOI 10.1038/cr.2008.308; Macrae Duncan J, 2007, Proc Am Thorac Soc, V4, P176, DOI 10.1513/pats.200701-011GC; McMurray JJ, 2000, HEART, V83, P596, DOI 10.1136/heart.83.5.596; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Molina-Navarro MM, 2013, INT J CARDIOL, V168, P2837, DOI 10.1016/j.ijcard.2013.03.192; Nemergut ME, 2002, J BIOL CHEM, V277, P17385, DOI 10.1074/jbc.c100620200; Niu XL, 2010, CIRCULATION, V121, P549, DOI 10.1161/CIRCULATIONAHA.109.908319; PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rouleau JL, 1993, J AM COLL CARDIOL, V22, P390, DOI 10.1016/0735-1097(93)90042-Y; Sakabe NJ, 2012, HUM MOL GENET, V21, P2194, DOI 10.1093/hmg/dds034; Song HK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035552; Soto-Rifo R, 2013, NUCLEIC ACIDS RES, V41, P6286, DOI 10.1093/nar/gkt306; Steijger T, 2013, NAT METHODS, V10, P1177, DOI [10.1038/nmeth.2714, 10.1038/NMETH.2714]; Sturchler E, 2013, BBA-MOL CELL RES, V1833, P583, DOI 10.1016/j.bbamcr.2012.10.023; Sun MN, 2011, BBA-MOL CELL RES, V1813, P438, DOI 10.1016/j.bbamcr.2011.01.003; Tarazon E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048957; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Weis K, 1996, EMBO J, V15, P1818, DOI 10.1002/j.1460-2075.1996.tb00531.x; Yedavalli VSRK, 2004, CELL, V119, P381, DOI 10.1016/j.cell.2004.09.029; Young JC, 2011, FASEB J, V25, P3958, DOI 10.1096/fj.10-176941; Yuan L, 2011, BLOOD, V118, P1145, DOI 10.1182/blood-2010-10-315275; Zuberi K, 2013, NUCLEIC ACIDS RES, V41, pW115, DOI 10.1093/nar/gkt533	50	20	20	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e104709	10.1371/journal.pone.0104709	http://dx.doi.org/10.1371/journal.pone.0104709			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137373	Green Published, gold, Green Submitted			2022-12-25	WOS:000340742100044
J	Sauter, KA; Pridans, C; Sehgal, A; Bain, CC; Scott, C; Moffat, L; Rojo, R; Stutchfield, BM; Davies, CL; Donaldson, DS; Renault, K; McColl, BW; Mowat, AM; Serrels, A; Frame, MC; Mabbott, NA; Hume, DA				Sauter, Kristin A.; Pridans, Clare; Sehgal, Anuj; Bain, Calum C.; Scott, Charlotte; Moffat, Lindsey; Rojo, Rocio; Stutchfield, Ben M.; Davies, Claire L.; Donaldson, David S.; Renault, Kathleen; McColl, Barry W.; Mowat, Alan M.; Serrels, Alan; Frame, Margaret C.; Mabbott, Neil A.; Hume, David A.			The MacBlue Binary Transgene (csf1r-gal4VP16/UAS-ECFP) Provides a Novel Marker for Visualisation of Subsets of Monocytes, Macrophages and Dendritic Cells and Responsiveness to CSF1 Administration	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; MONONUCLEAR PHAGOCYTE SYSTEM; ISOLATED LYMPHOID FOLLICLES; INTESTINAL LAMINA PROPRIA; HEMATOPOIETIC STEM-CELLS; FACTOR-I CSF-1; FACTOR-1 RECEPTOR; T-CELLS; IMMUNOHISTOCHEMICAL LOCALIZATION; DIFFERENTIAL TRANSCRIPTION	The MacBlue transgenic mouse uses the Csf1r promoter and first intron to drive expression of gal4-VP16, which in turn drives a cointegrated gal4-responsive UAS-ECFP cassette. The Csf1r promoter region used contains a deletion of a 150 bp conserved region covering trophoblast and osteoclast-specific transcription start sites. In this study, we examined expression of the transgene in embryos and adult mice. In embryos, ECFP was expressed in the large majority of macrophages derived from the yolk sac, and as the liver became a major site of monocytopoiesis. In adults, ECFP was detected at high levels in both Ly6C(+) and Ly6C(-) monocytes and distinguished them from Ly6C(+), F4/80(+), CSF1R(+) immature myeloid cells in peripheral blood. ECFP was also detected in the large majority of microglia and Langerhans cells. However, expression was lost from the majority of tissue macrophages, including Kupffer cells in the liver and F4/80(+) macrophages of the lung, kidney, spleen and intestine. The small numbers of positive cells isolated from the liver resembled blood monocytes. In the gut, ECFP+ cells were identified primarily as classical dendritic cells or blood monocytes in disaggregated cell preparations. Immunohistochemistry showed large numbers of ECFP+ cells in the Peyer's patch and isolated lymphoid follicles. The MacBlue transgene was used to investigate the effect of treatment with CSF1-Fc, a form of the growth factor with longer half-life and efficacy. CSF1-Fc massively expanded both the immature myeloid cell (ECFP-) and Ly6C(+) monocyte populations, but had a smaller effect on Ly6C(-) monocytes. There were proportional increases in ECFP+ cells detected in lung and liver, consistent with monocyte infiltration, but no generation of ECFP+ Kupffer cells. In the gut, there was selective infiltration of large numbers of cells into the lamina propria and Peyer's patches. We discuss the use of the MacBlue transgene as a marker of monocyte/macrophage/dendritic cell differentiation.	[Sauter, Kristin A.; Pridans, Clare; Sehgal, Anuj; Moffat, Lindsey; Rojo, Rocio; Davies, Claire L.; Donaldson, David S.; Renault, Kathleen; McColl, Barry W.; Mabbott, Neil A.; Hume, David A.] Univ Edinburgh, Roslin Inst, Easter Bush, Midlothian, Scotland; [Sauter, Kristin A.; Pridans, Clare; Sehgal, Anuj; Moffat, Lindsey; Rojo, Rocio; Davies, Claire L.; Donaldson, David S.; Renault, Kathleen; McColl, Barry W.; Mabbott, Neil A.; Hume, David A.] Univ Edinburgh, Royal Dick Sch Vet Studies, Easter Bush, Midlothian, Scotland; [Bain, Calum C.; Scott, Charlotte; Mowat, Alan M.] Univ Glasgow, Ctr Immunobiol, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland; [Stutchfield, Ben M.] Univ Edinburgh, MRC Ctr Inflammat Res, Queens Med Res Inst, Edinburgh, Midlothian, Scotland; [Serrels, Alan; Frame, Margaret C.] Univ Edinburgh, Edinburgh Canc Res Ctr, Edinburgh, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; University of Glasgow; University of Edinburgh; University of Edinburgh	Hume, DA (corresponding author), Univ Edinburgh, Roslin Inst, Easter Bush, Midlothian, Scotland.	David.hume@roslin.ed.ac.uk	Mowat, Allan M/H-7932-2016; Rojo, Rocio/S-7515-2018; Pridans, Clare/AAF-9953-2020; Mabbott, Neil/AAF-8777-2020; Scott, Charlotte/K-3563-2014	Mowat, Allan M/0000-0001-9389-3079; Rojo, Rocio/0000-0001-9686-3377; Pridans, Clare/0000-0001-9423-557X; Mabbott, Neil/0000-0001-7395-1796; Frame, Margaret/0000-0001-5882-1942; Sehgal, Anuj/0000-0002-5210-1730; Donaldson, David/0000-0002-8523-7853; Bain, Calum/0000-0001-8884-327X; McColl, Barry W/0000-0002-0521-9656; Hume, David/0000-0002-2615-1478; Sauter, Kristin/0000-0002-8721-3222; Scott, Charlotte/0000-0003-4914-6580	Biotechnology and Biological Sciences Research Council (BBSRC); BBSRC doctoral training studentship [BB/J01666X/1]; Cancer Research UK [C157/A15703]; BBSRC [BB/J014672/1]; Biotechnology and Biological Sciences Research Council [BBS/E/D/20221657, BB/J014672/1, BBS/E/D/20251969] Funding Source: researchfish; Cancer Research UK [15703] Funding Source: researchfish; Medical Research Council [G0901193, MR/L003384/1] Funding Source: researchfish; BBSRC [BBS/E/D/20251969, BBS/E/D/20221657] Funding Source: UKRI; MRC [G0901193, MR/L003384/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC doctoral training studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding provided by Biotechnology and Biological Sciences Research Council (BBSRC). http://www.bbsrc.ac.uk/home/home.aspx. AS was supported by a BBSRC doctoral training studentship (BB/J01666X/1); DSD and NAM were supported by project funding from the BBSRC (BB/J014672/1). 338CPC R41310 CD, 338CPC RA2025 BM, Darwin Trust of Edinburgh PhD scholarship - KR, Medical Research Council, http://www.mrc.ac.uk/, MRC 338CPC RA2613 BM, Cancer Research UK (program grant C157/A15703). http://www.cancerresearchuk.org/AS,MSF. The author(s) received no specific funding for this work: KAS, CP, LM, RR, BMS, AMM, DAH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcora D, 2013, STEM CELL RES, V10, P203, DOI 10.1016/j.scr.2012.12.001; Alexander KA, 2011, J BONE MINER RES, V26, P1517, DOI 10.1002/jbmr.354; Alikhan MA, 2011, AM J PATHOL, V179, P1243, DOI 10.1016/j.ajpath.2011.05.037; Bain CC, 2013, MUCOSAL IMMUNOL, V6, P498, DOI 10.1038/mi.2012.89; Bain CC, 2012, IMMUNOBIOLOGY, V217, P643, DOI 10.1016/j.imbio.2011.11.004; BARTOCCI A, 1987, P NATL ACAD SCI USA, V84, P6179, DOI 10.1073/pnas.84.17.6179; Behringer R, 2014, MANIPULATING MOUSE E, V4; Bertrand JY, 2005, BLOOD, V106, P3004, DOI 10.1182/blood-2005-02-0461; Biermann H, 1999, J LEUKOCYTE BIOL, V65, P217, DOI 10.1002/jlb.65.2.217; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; Canel M, 2010, CANCER RES, V70, P9413, DOI 10.1158/0008-5472.CAN-10-1454; CECCHINI MG, 1994, DEVELOPMENT, V120, P1357; Cerovic V, 2013, MUCOSAL IMMUNOL, V6, P104, DOI 10.1038/mi.2012.53; Chitu V, 2006, CURR OPIN IMMUNOL, V18, P39, DOI 10.1016/j.coi.2005.11.006; Chorro L, 2009, J EXP MED, V206, P3089, DOI 10.1084/jem.20091586; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; FAVOT P, 1995, ONCOGENE, V11, P1371; Follows GA, 2003, NUCLEIC ACIDS RES, V31, P5805, DOI 10.1093/nar/gkg804; Fries PN, 2011, CELL TISSUE RES, V343, P33, DOI 10.1007/s00441-010-1030-4; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756; Gow DJ, 2012, CYTOKINE, V60, P793, DOI 10.1016/j.cyto.2012.08.008; Gow DJ, 2014, MOLTHERAPY UNPUB; Grondin B, 2007, MOL CELL BIOL, V27, P2919, DOI 10.1128/MCB.00936-06; Hadis U, 2011, IMMUNITY, V34, P237, DOI 10.1016/j.immuni.2011.01.016; Hamada H, 2002, J IMMUNOL, V168, P57, DOI 10.4049/jimmunol.168.1.57; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hettinger J, 2013, NAT IMMUNOL, V14, P821, DOI 10.1038/ni.2638; Himes SR, 2006, J IMMUNOL, V176, P2219, DOI 10.4049/jimmunol.176.4.2219; Himes SR, 2005, ONCOGENE, V24, P5278, DOI 10.1038/sj.onc.1208657; Hoeffel G, 2012, J EXP MED; Hume DA, 2008, MUCOSAL IMMUNOL, V1, P432, DOI 10.1038/mi.2008.36; Hume DA, 2006, CURR OPIN IMMUNOL, V18, P49, DOI 10.1016/j.coi.2005.11.008; HUME DA, 1988, J IMMUNOL, V141, P3405; HUME DA, 1983, J CELL BIOL, V97, P253, DOI 10.1083/jcb.97.1.253; Hume DA, 2002, J LEUKOCYTE BIOL, V72, P621; Hume DA, 2012, BLOOD, V119, P1810, DOI 10.1182/blood-2011-09-379214; Jacquelin S, 2013, BLOOD; Jang MH, 2006, J IMMUNOL, V176, P803, DOI 10.4049/jimmunol.176.2.803; Jenkins SJ, 2013, JEXPMED IN PRESS; LEE SH, 1985, J EXP MED, V161, P475, DOI 10.1084/jem.161.3.475; Lin HH, 2005, J EXP MED, V201, P1615, DOI 10.1084/jem.20042307; Lorenz RG, 2004, ANN NY ACAD SCI, V1029, P44, DOI 10.1196/annals.1309.006; Luo J, 2013, J EXP MED, V210, P157, DOI 10.1084/jem.20120412; MacDonald KPA, 2010, BLOOD, V116, P3955, DOI 10.1182/blood-2010-02-266296; MacDonald KPA, 2005, J IMMUNOL, V175, P1399, DOI 10.4049/jimmunol.175.3.1399; Menke J, 2009, J CLIN INVEST, V119, P2330, DOI 10.1172/JCI39087; Mooney JE, 2010, AM J PATHOL, V176, P369, DOI 10.2353/ajpath.2010.090545; Mossadegh-Keller N, 2013, NATURE, V497, P239, DOI 10.1038/nature12026; Nagaraj S, 2013, J IMMUNOL, V191, P17, DOI 10.4049/jimmunol.1300654; Nandi S, 2012, DEV BIOL, V367, P100, DOI 10.1016/j.ydbio.2012.03.026; Ovchinnikov DA, 2008, J LEUKOCYTE BIOL, V83, P430, DOI 10.1189/jlb.0807585; Ovchinnikov DA, 2010, J LEUKOCYTE BIOL, V87, P815, DOI 10.1189/jlb.0809557; PAVLI P, 1990, IMMUNOLOGY, V70, P40; PERRY VH, 1985, NEUROSCIENCE, V15, P313, DOI 10.1016/0306-4522(85)90215-5; Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528; Sasmono RT, 2007, J LEUKOCYTE BIOL, V82, P111, DOI 10.1189/jlb.1206713; Sasmono RT, 2003, BLOOD, V101, P1155, DOI 10.1182/blood-2002-02-0569; Satpathy AT, 2013, NAT IMMUNOL, V14, P937, DOI 10.1038/ni.2679; Satpathy AT, 2012, NAT IMMUNOL, V13, P1145, DOI 10.1038/ni.2467; Satpathy AT, 2012, J EXP MED, V209, P1135, DOI 10.1084/jem.20120030; Sauter KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054935; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Serrels A, 2012, INT J CANCER, V131, P287, DOI 10.1002/ijc.26351; STACEY KJ, 1995, MOL CELL BIOL, V15, P3430; Tagoh H, 2002, GENE DEV, V16, P1721, DOI 10.1101/gad.222002; Tamoutounour S, 2012, EUR J IMMUNOL, V42, P3150, DOI 10.1002/eji.201242847; ULICH TR, 1990, BLOOD, V75, P846; van Zuylen WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015723; VISVADER J, 1989, MOL CELL BIOL, V9, P1336, DOI 10.1128/MCB.9.3.1336; Wang YM, 2012, NAT IMMUNOL, V13, P753, DOI 10.1038/ni.2360; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001	74	44	44	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105429	10.1371/journal.pone.0105429	http://dx.doi.org/10.1371/journal.pone.0105429			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137049	Green Published, Green Accepted, gold			2022-12-25	WOS:000340742100094
J	Zhussupova, A; Hayashida, T; Takahashi, M; Miyao, K; Okazaki, H; Jinno, H; Kitagawa, Y				Zhussupova, Aisulu; Hayashida, Tetsu; Takahashi, Maiko; Miyao, Kazuhiro; Okazaki, Hiroshi; Jinno, Hiromitsu; Kitagawa, Yuko			An E2F1-HOXB9 Transcriptional Circuit Is Associated with Breast Cancer Progression	PLOS ONE			English	Article							TUMOR-GROWTH; FACTOR E2F-1; HOMEODOMAIN PROTEIN; KINASE 4/6; EXPRESSION; HOXB9; PROGNOSIS; CARCINOMA; ACTIVATION; GENES	Homeobox B9 (HOXB9), a member of the homeobox gene family, is overexpressed in breast cancer and promotes tumor progression and metastasis by stimulating epithelial-to-mesenchymal transition and angiogenesis within the tumor microenvironment. HOXB9 activates the TGF beta-ATM axis, leading to checkpoint activation and DNA repair, which engenders radioresistance in breast cancer cells. Despite detailed reports of the role of HOXB9 in breast cancer, the factors that regulate HOXB9 transcription have not been extensively examined. Here we uncover an underlying mechanism that may suggest novel targeting strategies for breast cancer treatment. To identify a transcription factor binding site (TFBS) in the HOXB9 promoter region, a dual luciferase reporter assay was conducted. Protein candidates that may directly attach to a TFBS of HOXB9 were examined by Q-PCR, electrophoretic mobility shift assay (EMSA), chromatin immunoprecipitation (ChIP), and mutation analysis. A HOXB9 promoter region from -404 to -392 was identified as TFBS, and E2F1 was a potential binding candidate in this region. The induction of HOXB9 expression by E2F1 was observed by Q-PCR in several breast cancer cell lines overexpressing E2F1. The stimulatory effect of E2F1 on HOXB9 transcription and its ability to bind the TFBS were confirmed by luciferase, EMSA and ChIP assay. Immunohistochemical analysis of 139 breast cancer tissue samples revealed a significant correlation between E2F1 and HOXB9 expression (p<0.001). Furthermore, a CDK4/6 inhibitor suppressed E2F1 expression and also reduced expression of HOXB9 and its downstream target genes. Our in vitro analysis identified the TFBS of the HOXB9 promoter region and suggested that E2F1 is a direct regulator of HOXB9 expression; these data support the strong correlation we found between E2F1 and HOXB9 in clinical breast cancer samples. These results suggest that targeting the E2F1/HOXB9 axis may be a novel strategy for the control or prevention of cancer progression and metastasis.	[Zhussupova, Aisulu; Hayashida, Tetsu; Takahashi, Maiko; Miyao, Kazuhiro; Okazaki, Hiroshi; Jinno, Hiromitsu; Kitagawa, Yuko] Keio Univ, Sch Med, Dept Surg, Tokyo 160, Japan	Keio University	Hayashida, T (corresponding author), Keio Univ, Sch Med, Dept Surg, Tokyo 160, Japan.	tetsu@z7.keio.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [25293292, 25461997, 25861163]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan Grants-in-Aid for Scientific Research (Grant NOS. #25293292, #25461997, and #25861163). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2006, ONCOL REP, V15, P797; Alinari L, 2012, CLIN CANCER RES, V18, P4600, DOI 10.1158/1078-0432.CCR-12-0839; Ansari KI, 2011, BIOCHEMISTRY-US, V50, P3517, DOI 10.1021/bi102037t; Black AR, 1999, GENE, V237, P281, DOI 10.1016/S0378-1119(99)00305-4; BONCINELLI E, 1991, TRENDS GENET, V7, P329, DOI 10.1016/0168-9525(91)90423-N; Boncinelli E, 1997, CURR OPIN GENET DEV, V7, P331, DOI 10.1016/S0959-437X(97)80146-3; Bramis J, 2004, ANTICANCER RES, V24, P3041; Chiba N, 2012, P NATL ACAD SCI USA, V109, P2760, DOI 10.1073/pnas.1018867108; Daftary GS, 2006, ENDOCR REV, V27, P331, DOI 10.1210/er.2005-0018; Ebihara Y, 2004, DIS ESOPHAGUS, V17, P150, DOI 10.1111/j.1442-2050.2004.00393.x; Evangelou K, 2008, J CLIN PATHOL, V61, P601, DOI 10.1136/jcp.2007.050963; FAIELLA A, 1994, P NATL ACAD SCI USA, V91, P5335, DOI 10.1073/pnas.91.12.5335; Finn RS, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2419; Finn RS Crown JP, 2012, CAN RES S3, V72; Flagiello D, 1997, FEBS LETT, V415, P263, DOI 10.1016/S0014-5793(97)01118-6; Fry DW, 2004, MOL CANCER THER, V3, P1427; Gonzalez-Angulo AM, 2007, ADV EXP MED BIOL, V608, P1; Gorgoulis VG, 2002, J PATHOL, V198, P142, DOI 10.1002/path.1121; Greer JM, 2000, NATURE, V403, P661, DOI 10.1038/35001077; Han SH, 2003, BREAST CANC RES TREA, V82, P6; Hayashida T, 2010, P NATL ACAD SCI USA, V107, P1100, DOI 10.1073/pnas.0912710107; Hoshino Y, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-102; Huang K, 2014, CHINESE J CANCER RES, V26, P72, DOI 10.3978/j.issn.1000-9604.2014.01.11; Jin K, 2012, P NATL ACAD SCI USA, V109, P2736, DOI 10.1073/pnas.1018859108; Kwon MJ, 2010, ANN SURG ONCOL, V17, P564, DOI 10.1245/s10434-009-0767-z; Lechner JF, 2001, RADIAT RES, V155, P235, DOI 10.1667/0033-7587(2001)155[0235:PCDTMA]2.0.CO;2; Lee J, 2008, CLIN CANCER RES, V14, P82, DOI 10.1158/1078-0432.CCR-07-0612; Mega S, 2005, DIS ESOPHAGUS, V18, P109, DOI 10.1111/j.1442-2050.2005.00463.x; Nguyen DX, 2009, CELL, V138, P51, DOI 10.1016/j.cell.2009.04.030; Oyama T, 2005, ANTICANCER RES, V25, P1193; Palaiologou M, 2012, VIRCHOWS ARCH, V460, P439, DOI 10.1007/s00428-012-1220-4; Phillips AC, 2001, APOPTOSIS, V6, P173, DOI 10.1023/A:1011332625740; Rubin E, 2007, CANCER RES, V67, P1527, DOI 10.1158/0008-5472.CAN-06-4283; Seki H, 2012, ANN SURG ONCOL, V19, P1831, DOI 10.1245/s10434-012-2295-5; Shrestha B, 2012, FEBS J, V279, P3715, DOI 10.1111/j.1742-4658.2012.08733.x; Stavnes HT, 2013, GYNECOL ONCOL, V129, P358, DOI 10.1016/j.ygyno.2013.02.021; Stevaux O, 2002, CURR OPIN CELL BIOL, V14, P684, DOI 10.1016/S0955-0674(02)00388-5; Wu XY, 2006, CANCER RES, V66, P9527, DOI 10.1158/0008-5472.CAN-05-4470; Wyllie AH, 2002, J PATHOL, V198, P139, DOI 10.1002/path.1238; Yamazaki K, 2003, PATHOL RES PRACT, V199, P23, DOI 10.1078/0344-0338-00348; Zacharatos P, 2004, J PATHOL, V203, P744, DOI 10.1002/path.1582	41	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105285	10.1371/journal.pone.0105285	http://dx.doi.org/10.1371/journal.pone.0105285			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136922	Green Published, gold			2022-12-25	WOS:000340742100083
J	Firacative, C; Duan, S; Meyer, W				Firacative, Carolina; Duan, Shuyao; Meyer, Wieland			Galleria mellonella Model Identifies Highly Virulent Strains among All Major Molecular Types of Cryptococcus gattii	PLOS ONE			English	Article							EMERGING FUNGAL PATHOGEN; CANDIDA-ALBICANS MUTANTS; GENETIC DIVERSITY; SEROTYPE-C; NEOFORMANS; INFECTION; SUSCEPTIBILITY; EPIDEMIOLOGY; OUTBREAK; ORIGIN	Cryptococcosis is mainly caused by Cryptococcus neoformans. However, the number of cases due to C. gattii is increasing, affecting mainly immunocompetent hosts. C. gattii is divided into four major molecular types, VGI to VGIV, which differ in their host range, epidemiology, antifungal susceptibility and geographic distribution. Besides studies on the Vancouver Island outbreak strains, which showed that the subtype VGIIa is highly virulent compared to the subtype VGIIb, little is known about the virulence of the other major molecular types. To elucidate the virulence potential of the major molecular types of C. gattii, Galleria mellonella larvae were inoculated with ten globally selected strains per molecular type. Survival rates were recorded and known virulence factors were studied. One VGII, one VGIII and one VGIV strain were more virulent (p<0.05) than the highly virulent Vancouver Island outbreak strain VGIIa (CDCR265), 11 (four VGI, two VGII, four VGIII and one VGIV) had similar virulence (p>0.05), 21 (five VGI, five VGII, four VGIII and seven VGIV) were less virulent (p<0.05) while one strain of each molecular type were avirulent. Cell and capsule size of all strains increased markedly during larvae infection (p<0.001). No differences in growth rate at 37 degrees C were observed. Melanin synthesis was directly related with the level of virulence: more virulent strains produced more melanin than less virulent strains (p<0.05). The results indicate that all C. gattii major molecular types exhibit a range of virulence, with some strains having the potential to be more virulent. The study highlights the necessity to further investigate the genetic background of more and less virulent strains in order to recognize critical features, other than the known virulence factors (capsule, melanin and growth at mammalian body temperature), that maybe crucial for the development and progression of cryptococcosis.	[Firacative, Carolina; Duan, Shuyao; Meyer, Wieland] Univ Sydney, Westmead Hosp, Sydney Med Sch,Westmead Millennium Inst,Mol Mycol, Ctr Infect Dis & Microbiol,Marie Bashir Inst Infe, Sydney, NSW 2006, Australia; [Firacative, Carolina] Inst Nacl Salud, Microbiol Grp, Bogota, Colombia	University of Sydney; Westmead Institute for Medical Research; Instituto Nacional de Salud (Colombia)	Meyer, W (corresponding author), Univ Sydney, Westmead Hosp, Sydney Med Sch,Westmead Millennium Inst,Mol Mycol, Ctr Infect Dis & Microbiol,Marie Bashir Inst Infe, Sydney, NSW 2006, Australia.	wieland.meyer@sydney.edu.au	Meyer, Wieland/G-1204-2015; Firacative, Carolina/ABB-9942-2021	Meyer, Wieland/0000-0001-9933-8340; Firacative, Carolina/0000-0001-7547-5172	NHMRC [APP1031943]; COLCIENCIAS Colombia	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); COLCIENCIAS Colombia(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	This study was supported by an NH&MRC project grant # APP1031943 to WM. Carolina Firacative was supported by a PhD scholarship "Becas Francisco Jose de Caldas" from COLCIENCIAS Colombia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boekhout T, 2001, MICROBIOL-UK, V147, P891, DOI 10.1099/00221287-147-4-891; Bovers M, 2008, REV IBEROAM MICOL, V25, pS4, DOI 10.1016/S1130-1406(08)70019-6; Brennan M, 2002, FEMS IMMUNOL MED MIC, V34, P153, DOI 10.1111/j.1574-695X.2002.tb00617.x; Byrnes EJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000850; Byrnes EJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002205; Byrnes EJ, 2011, MICROBES INFECT, V13, P895, DOI 10.1016/j.micinf.2011.05.009; Byrnes EJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005851; Capilla J, 2006, MED MYCOL, V44, P601, DOI 10.1080/13693780600810040; Carriconde F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016936; Olivares LRC, 2009, MED MYCOL, V47, P713, DOI 10.3109/13693780802559031; Chayakulkeeree M, 2006, INFECT DIS CLIN N AM, V20, P507, DOI 10.1016/j.idc.2006.07.001; Chen S, 2000, CLIN INFECT DIS, V31, P499, DOI 10.1086/313992; Chen YL, 2013, G3-GENES GENOM GENET, V3, P527, DOI 10.1534/g3.112.004242; Chong HS, 2010, J CLIN MICROBIOL, V48, P4115, DOI 10.1128/JCM.01271-10; Cogliati M, 2012, MYCOSES, V55, P262, DOI 10.1111/j.1439-0507.2011.02082.x; Dunphy GB, 2003, CAN J MICROBIOL, V49, P514, DOI 10.1139/W03-064; Escandon P, 2006, FEMS YEAST RES, V6, P625, DOI 10.1111/j.1567-1364.2006.00055.x; Feldmesser M, 2001, MICROBIOL-SGM, V147, P2355, DOI 10.1099/00221287-147-8-2355; Firacative C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037566; Fraser JA, 2005, NATURE, V437, P1360, DOI 10.1038/nature04220; Garcia-Rodas R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024485; Garcia-Solache MA, 2013, MBIO, V4, DOI 10.1128/mBio.00100-13; Halliday CL, 1999, J CLIN MICROBIOL, V37, P2920, DOI 10.1128/JCM.37.9.2920-2926.1999; Heitman J, 2011, CRYPTOCOCCUS: FROM HUMAN PATHOGEN TO MODEL YEAST, P1; Jackson JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004224; Kidd SE, 2004, P NATL ACAD SCI USA, V101, P17258, DOI 10.1073/pnas.0402981101; Krockenberger MB, 2010, MYCOPATHOLOGIA, V170, P315, DOI 10.1007/s11046-010-9328-z; Litvintseva AP, 2005, J INFECT DIS, V192, P888, DOI 10.1086/432486; Lockhart SR, 2012, DIAGN MICR INFEC DIS, V73, P144, DOI 10.1016/j.diagmicrobio.2012.02.018; Loperena-Alvarez Y, 2010, MYCOPATHOLOGIA, V170, P279, DOI 10.1007/s11046-010-9296-3; McClelland EE, 2006, INFECT IMMUN, V74, P1500, DOI 10.1128/IAI.74.3.1500-1504.2006; Meyer W, 1999, ELECTROPHORESIS, V20, P1790, DOI 10.1002/(SICI)1522-2683(19990101)20:8&lt;1790::AID-ELPS1790&gt;3.0.CO;2-2; Meyer W, 2003, EMERG INFECT DIS, V9, P189; Meyer W, 2009, MED MYCOL, V47, P561, DOI 10.1080/13693780902953886; Mylonakis E, 2005, INFECT IMMUN, V73, P3842, DOI 10.1128/IAI.73.7.3842-3850.2005; Ngamskulrungroj P, 2011, CLIN MICROBIOL INFEC, V17, P251, DOI 10.1111/j.1469-0691.2010.03222.x; Ngamskulrungroj P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005862; Posteraro B, 2012, J CLIN MICROBIOL, V50, P2472, DOI 10.1128/JCM.00737-12; Pukkila-Worley R, 2005, EUKARYOT CELL, V4, P190, DOI 10.1128/EC.4.1.190-201.2005; Sabiiti Wilber, 2012, Int J Microbiol, V2012, P626745, DOI 10.1155/2012/626745; Scorzoni L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060047; Sellers B, 2012, AM J MED SCI, V343, P510, DOI 10.1097/MAJ.0b013e3182464bc7; Steenbergen JN, 2003, MICROBES INFECT, V5, P667, DOI 10.1016/S1286-4579(03)00092-3; Sukroongreung S, 1996, MYCOPATHOLOGIA, V135, P75, DOI 10.1007/BF00436454; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson GR, 2014, INFECT IMMUN, V82, P3058, DOI 10.1128/IAI.01805-14; Trilles L, 2012, MED MYCOL, V50, P328, DOI 10.3109/13693786.2011.602126; Voelz K, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003771; Walraven CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028625; Zaragoza O, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000945; Zaragoza Oscar, 2004, Biol Proced Online, V6, P10, DOI 10.1251/bpo68	51	40	41	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105076	10.1371/journal.pone.0105076	http://dx.doi.org/10.1371/journal.pone.0105076			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133687	Green Published, Green Submitted, gold			2022-12-25	WOS:000341302700066
J	Gevaert, E; Dolle, L; Billiet, T; Dubruel, P; van Grunsven, L; van Apeldoorn, A; Cornelissen, R				Gevaert, Elien; Dolle, Laurent; Billiet, Thomas; Dubruel, Peter; van Grunsven, Leo; van Apeldoorn, Aart; Cornelissen, Ria			High Throughput Micro-Well Generation of Hepatocyte Micro-Aggregates for Tissue Engineering	PLOS ONE			English	Article							CELL-LADEN MICROGELS; E-CADHERIN; SPHEROIDS; LIVER; SIZE; CONSTRUCTS; VIABILITY; CULTURES	The main challenge in hepatic tissue engineering is the fast dedifferentiation of primary hepatocytes in vitro. One successful approach to maintain hepatocyte phenotype on the longer term is the cultivation of cells as aggregates. This paper demonstrates the use of an agarose micro-well chip for the high throughput generation of hepatocyte aggregates, uniform in size. In our study we observed that aggregation of hepatocytes had a beneficial effect on the expression of certain hepatocyte specific markers. Moreover we observed that the beneficial effect was dependent on the aggregate dimensions, indicating that aggregate parameters should be carefully considered. In a second part of the study, the selected aggregates were immobilized by encapsulation in methacrylamide-modified gelatin. Phenotype evaluations revealed that a stable hepatocyte phenotype could be maintained during 21 days when encapsulated in the hydrogel. In conclusion we have demonstrated the beneficial use of micro-well chips for hepatocyte aggregation and the size-dependent effects on hepatocyte phenotype. We also pointed out that methacrylamide-modified gelatin is suitable for the encapsulation of these aggregates.	[Gevaert, Elien; Cornelissen, Ria] Univ Ghent, Tissue Engn Grp, B-9000 Ghent, Belgium; [Dolle, Laurent; van Grunsven, Leo] Vrije Univ Brussels, Liver cell Biol Lab, Brussels, Belgium; [Billiet, Thomas; Dubruel, Peter] Univ Ghent, Polymer Chem & Biomat Res Grp, B-9000 Ghent, Belgium; [van Apeldoorn, Aart] Univ Twente, Dept Dev Bioengn, NL-7500 AE Enschede, Netherlands	Ghent University; Vrije Universiteit Brussel; Ghent University; University of Twente	Cornelissen, R (corresponding author), Univ Ghent, Tissue Engn Grp, B-9000 Ghent, Belgium.	Ria.Cornelissen@UGent.be	van Apeldoorn, Aart/AAP-5433-2021; van Grunsven, Leo/E-5839-2010	van Apeldoorn, Aart/0000-0002-2940-5699; van Grunsven, Leo/0000-0002-0990-7034; Dubruel, Peter/0000-0002-5928-7726	IWT_SBO Grant from the 'Agentschap voor Innovatie door Wetenschap en Technologie' [090066 HepStem]; Interuniversity Attraction Poles (IAP) - phase VII (Federal Science Policy -BELSPO) [P7/47, 10/2012-09/2017]; Brustem: Impulse program - Brustem (Brussels Government) [2011-IP-LS-104, 06/2011-05/2014]	IWT_SBO Grant from the 'Agentschap voor Innovatie door Wetenschap en Technologie'; Interuniversity Attraction Poles (IAP) - phase VII (Federal Science Policy -BELSPO); Brustem: Impulse program - Brustem (Brussels Government)	This work was supported by the IWT_SBO Grant 090066 HepStem from the 'Agentschap voor Innovatie door Wetenschap en Technologie'. LD and LvG: Interuniversity Attraction Poles (IAP) - phase VII - contract P7/47 (Federal Science Policy -BELSPO) (10/2012-09/2017); Brustem: Impulse program 2011-IP-LS-104 - Brustem (Brussels Government) (06/2011-05/2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. port not to have conflicts of interest and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asthana A, 2012, DRUG DISCOV TODAY, V17, P810, DOI 10.1016/j.drudis.2012.03.004; Billiet T, 2013, MACROMOL BIOSCI; Billiet T, 2014, BIOMATERIALS, V35, P49, DOI 10.1016/j.biomaterials.2013.09.078; Brophy CM, 2009, HEPATOLOGY, V49, P578, DOI 10.1002/hep.22674; Du YA, 2008, P NATL ACAD SCI USA, V105, P9522, DOI 10.1073/pnas.0801866105; Du Y, 2008, CELL MOL BIOENG, V1, P157, DOI 10.1007/s12195-008-0020-z; Fukuda J, 2005, TISSUE ENG, V11, P1254, DOI 10.1089/ten.2005.11.1254; Glicklis R, 2004, BIOTECHNOL BIOENG, V86, P672, DOI 10.1002/bit.20086; Goncalves LA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-169; Jindal R, 2010, TISSUE ENG C; Lin RZ, 2006, CELL TISSUE RES, V324, P411, DOI 10.1007/s00441-005-0148-2; Luebke-Wheeler JL, 2009, CELL TRANSPLANT, V18, P1281, DOI 10.3727/096368909X474258; Mei Y, 2010, J BIOTECHNOL, V150, P438, DOI 10.1016/j.jbiotec.2010.09.953; Miranda JP, 2010, TISSUE ENG PART C-ME, V16, P1223, DOI [10.1089/ten.tec.2009.0784, 10.1089/ten.TEC.2009.0784]; Mironov V, 2009, BIOMATERIALS, V30, P2164, DOI 10.1016/j.biomaterials.2008.12.084; Nichol JW, 2009, SOFT MATTER, V5, P1312, DOI 10.1039/b814285h; Pang Y, 2012, BIOFABRICATION, V4, DOI 10.1088/1758-5082/4/4/045004; Ramaiahgari S.C., 2014, ARCH TOXICOL; Rivron NC, 2012, P NATL ACAD SCI USA, V109, P6886, DOI 10.1073/pnas.1201626109; Rivron NC, 2009, BIOMATERIALS, V30, P4851, DOI 10.1016/j.biomaterials.2009.06.037; Shulman Maria, 2013, Methods Mol Biol, V945, P287, DOI 10.1007/978-1-62703-125-7_17; Spijker HS, 2013, DIABETES, V62, P2471, DOI 10.2337/db12-1001; Taguchi T, 2011, J MATER SCI-MATER M, V22, P2357, DOI 10.1007/s10856-011-4414-4; Uygun BE, 2013, CURR OPIN BIOTECH, V24, P893, DOI 10.1016/j.copbio.2013.05.008; van Zijl F, 2010, WORLD J HEPATOL, V2, P1, DOI 10.4254/wjh.v2.i1.1; Wang XH, 2006, TISSUE ENG, V12, P83, DOI 10.1089/ten.2006.12.83; Wong SF, 2011, BIOMATERIALS, V32, P8087, DOI 10.1016/j.biomaterials.2011.07.028	27	35	36	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105171	10.1371/journal.pone.0105171	http://dx.doi.org/10.1371/journal.pone.0105171			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133500	Green Published, gold, Green Submitted			2022-12-25	WOS:000341302700078
J	Hartung, V; Prell, T; Gaser, C; Turner, MR; Tietz, F; Ilse, B; Bokemeyer, M; Witte, OW; Grosskreutz, J				Hartung, Viktor; Prell, Tino; Gaser, Christian; Turner, Martin R.; Tietz, Florian; Ilse, Benjamin; Bokemeyer, Martin; Witte, Otto W.; Grosskreutz, Julian			Voxel-Based MRI Intensitometry Reveals Extent of Cerebral White Matter Pathology in Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							BRAIN ATROPHY; HEXANUCLEOTIDE REPEAT; WHOLE-BRAIN; MORPHOMETRY; ALS; DEGENERATION; INVOLVEMENT; PROGRESSION; ACTIVATION; C9ORF72	Amyotrophic lateral sclerosis (ALS) is characterized by progressive loss of upper and lower motor neurons. Advanced MRI techniques such as diffusion tensor imaging have shown great potential in capturing a common white matter pathology. However the sensitivity is variable and diffusion tensor imaging is not yet applicable to the routine clinical environment. Voxel-based morphometry (VBM) has revealed grey matter changes in ALS, but the bias-reducing algorithms inherent to traditional VBM are not optimized for the assessment of the white matter changes. We have developed a novel approach to white matter analysis, namely voxel-based intensitometry (VBI). High resolution T1-weighted MRI was acquired at 1.5 Tesla in 30 ALS patients and 37 age-matched healthy controls. VBI analysis at the group level revealed widespread white matter intensity increases in the corticospinal tracts, corpus callosum, sub-central, frontal and occipital white matter tracts and cerebellum. VBI results correlated with disease severity (ALSFRS-R) and patterns of cerebral involvement differed between bulbar- and limb-onset. VBI would be easily translatable to the routine clinical environment, and once optimized for individual analysis offers significant biomarker potential in ALS.	[Hartung, Viktor; Prell, Tino; Tietz, Florian; Witte, Otto W.; Grosskreutz, Julian] Univ Hosp Jena, Hans Berger Dept Neurol, Jena, Germany; [Gaser, Christian] Univ Hosp Jena, Dept Psychiat & Psychotherapy, Jena, Germany; [Bokemeyer, Martin] Univ Hosp Jena, Dept Radiol, Neuroradiol Sect, Jena, Germany; [Turner, Martin R.] Univ Oxford, Nuffield Dept Clin Neurosci, Oxford, England; [Witte, Otto W.] Univ Hosp Jena, CSCC, Jena, Germany; [Ilse, Benjamin] Univ Med Ctr, Dept Palliat Med, Gottingen, Germany	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; University of Oxford; Friedrich Schiller University of Jena; University of Gottingen	Prell, T (corresponding author), Univ Hosp Jena, Hans Berger Dept Neurol, Jena, Germany.	tino.prell@med.uni-jena.de	Grosskreutz, Julian/G-2293-2010; Gaser, Christian/F-5103-2010; Witte, Otto/P-4127-2018; Prell, Tino/AAE-5492-2020	Grosskreutz, Julian/0000-0001-9525-1424; Gaser, Christian/0000-0002-9940-099X; Witte, Otto/0000-0003-2101-4105; Prell, Tino/0000-0002-6423-3108; Hartung, Viktor/0000-0002-6273-9172; Turner, Martin/0000-0003-0267-3180	German Bundesministerium fur Bildung und Forschung (BMBF) grant SOPHIA; BMBF grant PYRAMID; BMBF; Medical Research Council [MR/K01014X/1] Funding Source: researchfish; Motor Neurone Disease Association [Turner/Jan13/944-795] Funding Source: researchfish; MRC [MR/K01014X/1] Funding Source: UKRI	German Bundesministerium fur Bildung und Forschung (BMBF) grant SOPHIA(Federal Ministry of Education & Research (BMBF)); BMBF grant PYRAMID; BMBF(Federal Ministry of Education & Research (BMBF)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Motor Neurone Disease Association; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This project is supported by the German Bundesministerium fur Bildung und Forschung (BMBF) grant SOPHIA to JG under the aegis of the EU Joint Programme - Neurodegenerative Disease Research (JPND - www.jpnd.eu) and a BMBF grant PYRAMID to JG in the framework of the ERANET E-RARE program (www.e-rare.eu). This study was undertaken in cooperation with the BMBF funded MND-NET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosta F, 2007, HUM BRAIN MAPP, V28, P1430, DOI 10.1002/hbm.20364; Agosta F, 2009, AMYOTROPH LATERAL SC, V10, P168, DOI 10.1080/17482960802603841; Ashburner J, 1997, NEUROIMAGE, V6, P209, DOI 10.1006/nimg.1997.0290; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Bede P, 2013, J NEUROL NEUROSUR PS, V84, P766, DOI 10.1136/jnnp-2012-302674; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Canu E, 2011, AM J NEURORADIOL, V32, P1307, DOI 10.3174/ajnr.A2469; Chen ZY, 2010, AMYOTROPH LATERAL SC, V11, P549, DOI 10.3109/17482968.2010.516265; Chio A, 2011, J NEUROL NEUROSUR PS, V82, P740, DOI 10.1136/jnnp.2010.235952; Ciccarelli O, 2009, HUM BRAIN MAPP, V30, P615, DOI 10.1002/hbm.20527; Cistaro A, 2012, EUR J NUCL MED MOL I, V39, P251, DOI 10.1007/s00259-011-1979-6; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Ding XQ, 2011, AMYOTROPH LATERAL SC, V12, P406, DOI 10.3109/17482968.2011.597402; Douaud G, 2011, BRAIN, V134, P3467, DOI 10.1093/brain/awr279; Ellis CM, 2001, NEUROLOGY, V57, P1571, DOI 10.1212/WNL.57.9.1571; Evans MC, 2013, MOL CELL NEUROSCI, V53, P34, DOI 10.1016/j.mcn.2012.10.008; Filippini N, 2010, NEUROLOGY, V75, P1645, DOI 10.1212/WNL.0b013e3181fb84d1; Grosskreutz J, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-17; Hall ED, 1998, GLIA, V23, P249, DOI 10.1002/(SICI)1098-1136(199807)23:3<249::AID-GLIA7>3.0.CO;2-#; Kassubek J, 2005, AMYOTROPH LATERAL SC, V6, P213, DOI 10.1080/14660820510038538; Kassubek J, 2005, J CLIN NEUROSCI, V12, P588, DOI 10.1016/j.jocn.2004.07.020; Keil C, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-141; Kolind S, 2013, AMYOTROPH LAT SCL FR, V14, P562, DOI 10.3109/21678421.2013.794843; Menke RAL, 2012, ARCH NEUROL-CHICAGO, V69, P1493, DOI 10.1001/archneurol.2012.1122; Mezzapesa DM, 2007, AM J NEURORADIOL, V28, P255; Miller KL, 2011, NEUROIMAGE, V57, P167, DOI 10.1016/j.neuroimage.2011.03.070; Phukan J, 2012, J NEUROL NEUROSUR PS, V83, P102, DOI 10.1136/jnnp-2011-300188; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Rose S, 2012, NEUROIMAGE, V59, P2661, DOI 10.1016/j.neuroimage.2011.08.054; SMITH MC, 1960, J NEUROL NEUROSUR PS, V23, P269, DOI 10.1136/jnnp.23.4.269; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Swash M, 2012, J NEUROL NEUROSUR PS, V83, P659, DOI 10.1136/jnnp-2012-302315; Turner MR, 2012, BIOMARK MED, V6, P319, DOI [10.2217/BMM.12.26, 10.2217/bmm.12.26]; Turner MR, 2011, LANCET NEUROL, V10, P400, DOI 10.1016/S1474-4422(11)70049-7; Turner MR, 2009, LANCET NEUROL, V8, P94, DOI 10.1016/S1474-4422(08)70293-X; Turner MR, 2004, NEUROBIOL DIS, V15, P601, DOI 10.1016/j.nbd.2003.12.012	37	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e104894	10.1371/journal.pone.0104894	http://dx.doi.org/10.1371/journal.pone.0104894			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133577	Green Published, gold, Green Submitted			2022-12-25	WOS:000341302700048
J	Pedrazzi, M; Nash, B; Meucci, O; Brandimarti, R				Pedrazzi, Manuela; Nash, Bradley; Meucci, Olimpia; Brandimarti, Renato			Molecular Features Contributing to Virus-Independent Intracellular Localization and Dynamic Behavior of the Herpesvirus Transport Protein U(S)9	PLOS ONE			English	Article							FAST AXONAL-TRANSPORT; II MEMBRANE-PROTEIN; PSEUDORABIES VIRUS; ANTEROGRADE TRANSPORT; ORGANELLE TRANSPORT; ENVELOPE PROTEIN; NERVOUS-SYSTEM; IN-VITRO; HIPPOCAMPAL-NEURONS; CYTOPLASMIC DYNEIN	Reaching the right destination is of vital importance for molecules, proteins, organelles, and cargoes. Thus, intracellular traffic is continuously controlled and regulated by several proteins taking part in the process. Viruses exploit this machinery, and viral proteins regulating intracellular transport have been identified as they represent valuable tools to understand and possibly direct molecules targeting and delivery. Deciphering the molecular features of viral proteins contributing to (or determining) this dynamic phenotype can eventually lead to a virus-independent approach to control cellular transport and delivery. From this virus-independent perspective we looked at U(S)9, a virion component of Herpes Simplex Virus involved in anterograde transport of the virus inside neurons of the infected host. As the natural cargo of U(S)9-related vesicles is the virus (or its parts), defining its autonomous, virus-independent role in vesicles transport represents a prerequisite to make U(S)9 a valuable molecular tool to study and possibly direct cellular transport. To assess the extent of this autonomous role in vesicles transport, we analyzed U(S)9 behavior in the absence of viral infection. Based on our studies, Us9 behavior appears similar in different cell types; however, as expected, the data we obtained in neurons best represent the virus-independent properties of U(S)9. In these primary cells, transfected U(S)9 mostly recapitulates the behavior of U(S)9 expressed from the viral genome. Additionally, ablation of two major phosphorylation sites (i.e. Y32Y33 and S34ES36) have no effect on protein incorporation on vesicles and on its localization on both proximal and distal regions of the cells. These results support the idea that, while U(S)9 post-translational modification may be important to regulate cargo loading and, consequently, virion export and delivery, no additional viral functions are required for U(S)9 role in intracellular transport.	[Pedrazzi, Manuela; Brandimarti, Renato] Univ Bologna, Dept Pharm & Biotechnol, Bologna, Italy; [Nash, Bradley; Meucci, Olimpia; Brandimarti, Renato] Drexel Univ, Coll Med, Dept Physiol & Pharmacol, Philadelphia, PA 19104 USA; [Meucci, Olimpia] Drexel Univ, Coll Med, Dept Microbiol & Immunol, Philadelphia, PA 19104 USA	University of Bologna; Drexel University; Drexel University	Meucci, O (corresponding author), Drexel Univ, Coll Med, Dept Physiol & Pharmacol, Philadelphia, PA 19104 USA.	omeucci@drexelmed.edu; renato.brandimarti@unibo.it		BRANDIMARTI, RENATO/0000-0003-3078-9009	National Institutes of Health (NIH) [DA15014, DA 32444]; NATIONAL CANCER INSTITUTE [P30CA056036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH097623] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015014, R01DA032444] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was partially supported by the National Institutes of Health (NIH), grants DA15014 and DA 32444 to OM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brandimarti R, 1997, P NATL ACAD SCI USA, V94, P13973, DOI 10.1073/pnas.94.25.13973; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Brideau AD, 2000, J VIROL, V74, P4549, DOI 10.1128/JVI.74.10.4549-4561.2000; Brideau AD, 1999, J VIROL, V73, P4372, DOI 10.1128/JVI.73.5.4372-4384.1999; Brideau AD, 1998, J VIROL, V72, P4560, DOI 10.1128/JVI.72.6.4560-4570.1998; Brideau AD, 2000, J VIROL, V74, P834, DOI 10.1128/JVI.74.2.834-845.2000; Butchi NB, 2007, J NEUROVIROL, V13, P384, DOI 10.1080/13550280701375433; CAILLEAU R, 1974, J NATL CANCER I, V53, P661, DOI 10.1093/jnci/53.3.661; Ch'ng TH, 2005, J VIROL, V79, P10875, DOI 10.1128/JVI.79.17.10875-10889.2005; Chowdhury SI, 2011, VET MICROBIOL, V152, P270, DOI 10.1016/j.vetmic.2011.05.012; Chowdhury SI, 2002, J VIROL, V76, P3839, DOI 10.1128/JVI.76.8.3839-3851.2002; Coller KE, 2008, TRAFFIC, V9, P1458, DOI 10.1111/j.1600-0854.2008.00782.x; DAIKOKU T, 1994, J GEN VIROL, V75, P2065, DOI 10.1099/0022-1317-75-8-2065; Deacon SW, 2003, J CELL BIOL, V160, P297, DOI 10.1083/jcb.200210066; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Enquist LW, 2002, VET MICROBIOL, V86, P5, DOI 10.1016/S0378-1135(01)00486-2; Feierbach B, 2007, J VIROL, V81, P6846, DOI 10.1128/JVI.00069-07; Fournier HN, 2005, MOL BIOL CELL, V16, P1859, DOI 10.1091/mbc.E04-08-0744; FRAME MC, 1986, VIROLOGY, V150, P321, DOI 10.1016/0042-6822(86)90297-7; FRUH K, 1995, NATURE, V375, P415, DOI 10.1038/375415a0; Greber UF, 2006, CELL, V124, P741, DOI 10.1016/j.cell.2006.02.018; Gross SP, 2002, J CELL BIOL, V156, P715, DOI 10.1083/jcb.200109047; HILL A, 1995, NATURE, V375, P411, DOI 10.1038/375411a0; Hirokawa N, 1996, TRENDS CELL BIOL, V6, P135, DOI 10.1016/0962-8924(96)10003-9; Hirokawa N, 1998, CURR OPIN CELL BIOL, V10, P60, DOI 10.1016/S0955-0674(98)80087-2; Ibiricu I, 2013, CELL MICROBIOL, V15, P285, DOI 10.1111/cmi.12093; Kato A, 2005, J VIROL, V79, P9325, DOI 10.1128/JVI.79.14.9325-9331.2005; Kato A, 2008, J VIROL, V82, P6172, DOI 10.1128/JVI.00044-08; Kramer T, 2012, CELL HOST MICROBE, V12, P806, DOI 10.1016/j.chom.2012.10.013; Kratchmarov R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058776; LANDAU NR, 1992, J VIROL, V66, P5110, DOI 10.1128/JVI.66.8.5110-5113.1992; LaVail JH, 2007, NEUROSCIENCE, V146, P974, DOI 10.1016/j.neuroscience.2007.02.010; Lee GE, 2006, J VIROL, V80, P4264, DOI 10.1128/JVI.80.9.4264-4275.2006; Lyman MG, 2008, J VIROL, V82, P10308, DOI 10.1128/JVI.01204-08; Lyman MG, 2007, J VIROL, V81, P11363, DOI 10.1128/JVI.01281-07; Lyman MG, 2009, J VIROL, V83, P6978, DOI 10.1128/JVI.00598-09; Lyman MG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000065; Martin M, 1999, MOL BIOL CELL, V10, P3717, DOI 10.1091/mbc.10.11.3717; MCGEOCH DJ, 1985, J MOL BIOL, V181, P1, DOI 10.1016/0022-2836(85)90320-1; McGraw HM, 2009, J VIROL, V83, P8315, DOI 10.1128/JVI.00633-09; Miranda-Saksena M, 2000, J VIROL, V74, P1827, DOI 10.1128/JVI.74.4.1827-1839.2000; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Nascimento R, 2012, PROTOPLASMA, V249, P519, DOI 10.1007/s00709-011-0327-9; Nguyen ML, 2005, VIROLOGY, V336, P274, DOI 10.1016/j.virol.2005.03.026; Pautke C, 2004, ANTICANCER RES, V24, P3743; Polcicova K, 2005, P NATL ACAD SCI USA, V102, P11462, DOI 10.1073/pnas.0503230102; ROIZMAN B, 2001, FIELDS VIROLOGY, V2, P2399; SADOUL K, 1995, J CELL BIOL, V128, P1019, DOI 10.1083/jcb.128.6.1019; Sengupta R, 2009, J NEUROSCI, V29, P2534, DOI 10.1523/JNEUROSCI.5865-08.2009; Snyder A, 2008, J VIROL, V82, P10613, DOI 10.1128/JVI.01241-08; Taylor MP, 2012, MBIO, V3, DOI 10.1128/mBio.00063-12; Tomishima MJ, 2001, J CELL BIOL, V154, P741, DOI 10.1083/jcb.200011146; WatermanStorer CM, 1997, P NATL ACAD SCI USA, V94, P12180, DOI 10.1073/pnas.94.22.12180	53	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e104634	10.1371/journal.pone.0104634	http://dx.doi.org/10.1371/journal.pone.0104634			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133647	gold, Green Published, Green Submitted			2022-12-25	WOS:000341302700034
J	Ata-Ul-Karim, ST; Yao, X; Liu, XJ; Cao, WX; Zhu, Y				Ata-Ul-Karim, Syed Tahir; Yao, Xia; Liu, Xiaojun; Cao, Weixing; Zhu, Yan			Determination of Critical Nitrogen Dilution Curve Based on Stem Dry Matter in Rice	PLOS ONE			English	Article							NUTRITION INDEX; MANAGEMENT; YIELD; ACCUMULATION; BIOMASS; CORN	Plant analysis is a very promising diagnostic tool for assessment of crop nitrogen (N) requirements in perspectives of cost effective and environment friendly agriculture. Diagnosing N nutritional status of rice crop through plant analysis will give insights into optimizing N requirements of future crops. The present study was aimed to develop a new methodology for determining the critical nitrogen (N-c) dilution curve based on stem dry matter (S-DM) and to assess its suitability to estimate the level of N nutrition for rice (Oryza sativa L.) in east China. Three field experiments with varied N rates (0-360 kg N ha(-1)) using three Japonica rice hybrids, Lingxiangyou-18, Wuxiangjing-14 and Wuyunjing were conducted in Jiangsu province of east China. S-DM and stem N concentration (SNC) were determined during vegetative stage for growth analysis. A N-c dilution curve based on S-DM was described by the equation (N-c = 2.17W(-0.27) with W being S-DM in t ha(-1)), when S-DM ranged from 0.88 to 7.94 t ha(-1). However, for S-DM, < 0.88 t h(-1), the constant critical value N-c = 1.76% S-DM was applied. The curve was dually validated for N-limiting and non-N-limiting growth conditions. The N nutrition index (NNI) and accumulated N deficit (N-and) of stem ranged from 0.57 to 1.06 and 51.1 to -7.07 kg N ha(-1), respectively, during key growth stages under varied N rates in 2010 and 2011. The values of Delta N derived from either NNI or N-and could be used as references for N dressing management during rice growth. Our results demonstrated that the present curve well differentiated the conditions of limiting and non-limiting N nutrition in rice crop. The S-DM based N-c dilution curve can be adopted as an alternate and novel approach for evaluating plant N status to support N fertilization decision during the vegetative growth of Japonica rice in east China.	[Ata-Ul-Karim, Syed Tahir; Yao, Xia; Liu, Xiaojun; Cao, Weixing; Zhu, Yan] Nanjing Agr Univ, Natl Engn & Technol Ctr Informat Agr, Jiangsu Key Lab Informat Agr, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Zhu, Y (corresponding author), Nanjing Agr Univ, Natl Engn & Technol Ctr Informat Agr, Jiangsu Key Lab Informat Agr, Nanjing, Jiangsu, Peoples R China.	yanzhu@njau.edu.cn	Ata-Ul-Karim, Syed Tahir/AAB-6257-2020; Zhu, Yan/AAK-6927-2020; Ata-Ul-Karim, Syed Tahir/F-7468-2017	Ata-Ul-Karim, Syed Tahir/0000-0001-5233-4502; Zhu, Yan/0000-0002-8912-3888; Ata-Ul-Karim, Syed Tahir/0000-0001-5233-4502; Yao, Xia/0000-0002-1093-1736	National High-Tech Research and Development Program of China (863 Program) [2011AA100703]; Special Program for Agriculture Science and Technology from Ministry of Agriculture in China [201303109]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Science and Technology Support Plan of Jiangsu Province [BE2011351, BE2012302]	National High-Tech Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Special Program for Agriculture Science and Technology from Ministry of Agriculture in China; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Science and Technology Support Plan of Jiangsu Province	This work was supported by grants from the National High-Tech Research and Development Program of China (863 Program) (2011AA100703), Special Program for Agriculture Science and Technology from Ministry of Agriculture in China (201303109), Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), and Science and Technology Support Plan of Jiangsu Province (BE2011351, BE2012302). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	de Oliveira ECA, 2013, J PLANT NUTR SOIL SC, V176, P712, DOI 10.1002/jpln.201200133; de Oliveira ECA, 2010, REV BRAS CIENC SOLO, V34, P1343, DOI 10.1590/S0100-06832010000400031; Ata-Ul-Karim ST, 2014, FIELD CROP RES, V167, P76, DOI 10.1016/j.fcr.2014.07.010; Ata-Ul-Karim ST, 2013, FIELD CROP RES, V149, P149, DOI 10.1016/j.fcr.2013.03.012; Belanger G, 2000, PLANT SOIL, V219, P177, DOI 10.1023/A:1004749828745; Cabangon RJ, 2011, FIELD CROP RES, V121, P136, DOI 10.1016/j.fcr.2010.12.002; Chen J, 2011, AGR ECOSYST ENVIRON, V142, P195, DOI 10.1016/j.agee.2011.05.005; Confalonieri R, 2011, J AGR SCI-CAMBRIDGE, V149, P633, DOI 10.1017/S0021859611000177; Debaeke P, 2006, J PLANT NUTR, V29, P75, DOI 10.1080/01904160500416471; Gayler S, 2002, GEODERMA, V105, P367, DOI 10.1016/S0016-7061(01)00113-6; Ghosh M, 2004, J AGR SCI, V142, P183, DOI 10.1017/S002185960400423X; Hahn WS, 1997, STAT METHODS AGR LIF; Islam M. A., 2008, Journal of Agriculture & Rural Development (Gazipur), V6, P7; Jaggard KW, 2009, J AGR SCI-CAMBRIDGE, V147, P287, DOI 10.1017/S0021859609008478; JUSTES E, 1994, ANN BOT-LONDON, V74, P397, DOI 10.1006/anbo.1994.1133; Kage H, 2002, PLANT SOIL, V246, P201, DOI 10.1023/A:1020627723616; Lemaire G, 2008, EUR J AGRON, V28, P614, DOI 10.1016/j.eja.2008.01.005; Lin FF, 2010, COMPUT ELECTRON AGR, V71, pS60, DOI 10.1016/j.compag.2009.09.006; Shan YuHua, 2001, Journal of Yangzhou University, Natural Science Edition, V4, P42; Sheehy JE, 1998, FIELD CROP RES, V59, P31, DOI 10.1016/S0378-4290(98)00105-1; SMEAL D, 1994, COMMUN SOIL SCI PLAN, V25, P1495, DOI 10.1080/00103629409369130; Vouillot MO, 1998, AGRONOMIE, V18, P117, DOI 10.1051/agro:19980202; Wang W, 2012, J INTEGR AGR, V11, P2001, DOI 10.1016/S2095-3119(12)60457-2; Yao X, 2014, EUR J AGRON, V55, P20, DOI 10.1016/j.eja.2013.12.004; Ying JF, 1998, FIELD CROP RES, V57, P71, DOI 10.1016/S0378-4290(98)00077-X; Yoshida H, 2006, FIELD CROP RES, V97, P337, DOI 10.1016/j.fcr.2005.11.004; Yue SC, 2012, AGRON J, V104, P523, DOI 10.2134/agronj2011.0258; Zhao B, 2014, AGRON J, V106, P379, DOI 10.2134/agronj2013.0213; Ziadi N, 2008, AGRON J, V100, P271, DOI 10.2134/agronj2007.0059; Ziadi N, 2010, AGRON J, V102, P241, DOI 10.2134/agronj2009.0266; Ziadi N, 2009, AGRON J, V101, P947, DOI 10.2134/agronj2008.0172x	31	26	34	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104540	10.1371/journal.pone.0104540	http://dx.doi.org/10.1371/journal.pone.0104540			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127042	Green Published, Green Submitted, gold			2022-12-25	WOS:000340879300034
J	Mi, SF; Jia, XJ; Wang, JZ; Qiao, WB; Peng, XW; Han, YJ				Mi, Shuofu; Jia, Xiaojing; Wang, Jinzhi; Qiao, Weibo; Peng, Xiaowei; Han, Yejun			Biochemical Characterization of Two Thermostable Xylanolytic Enzymes Encoded by a Gene Cluster of Caldicellulosiruptor owensensis	PLOS ONE			English	Article							GH39 BETA-XYLOSIDASE; THERMOANAEROBACTERIUM-SACCHAROLYTICUM; STRUCTURAL INSIGHTS; ESCHERICHIA-COLI; PLANT BIOMASS; FAMILY 10; XYLANASE; CLONING; EXPRESSION; OVEREXPRESSION	The xylanolytic extremely thermophilic bacterium Caldicellulosiruptor owensensis provides a promising platform for xylan utilization. In the present study, two novel xylanolytic enzymes, GH10 endo-beta-1,4-xylanase (Coxyn A) and GH39 beta-1,4-xylosidase (Coxyl A) encoded in one gene cluster of C. owensensis were heterogeneously expressed and biochemically characterized. The optimum temperature of the two xylanlytic enzymes was 75 degrees C, and the respective optimum pH for Coxyn A and Coxyl A was 7.0 and 5.0. The difference of Coxyn A and Coxyl A in solution was existing as monomer and homodimer respectively, it was also observed in predicted secondary structure. Under optimum condition, the catalytic efficiency (k(cat)/K-m) of Coxyn A was 366 mg ml(-1) s(-1) on beechwood xylan, and the catalytic efficiency (k(cat)/K-m) of Coxyl A was 2253 mM(-1) s(-1) on pNP-beta-D-xylopyranoside. Coxyn A degraded xylan to oligosaccharides, which were converted to monomer by Coxyl A. The two intracellular enzymes might be responsible for xylooligosaccharides utilization in C. owensensis, also provide a potential way for xylan degradation in vitro.	[Mi, Shuofu; Jia, Xiaojing; Qiao, Weibo; Peng, Xiaowei; Han, Yejun] Chinese Acad Sci, Inst Proc Engn, Natl Key Lab Biochem Engn, Beijing, Peoples R China; [Wang, Jinzhi] Chinese Acad Agr Sci, Inst Agrofood Sci & Technol, Beijing 100193, Peoples R China; [Qiao, Weibo] Shenyang Agr Univ, Shenyang 110161, Peoples R China	Chinese Academy of Sciences; Institute of Process Engineering, CAS; Chinese Academy of Agricultural Sciences; Shenyang Agricultural University	Han, YJ (corresponding author), Chinese Acad Sci, Inst Proc Engn, Natl Key Lab Biochem Engn, Beijing, Peoples R China.	yejunhan09@gmail.com	Han, Yejun/AAC-7411-2019		National High Technology Research and Development Program of China (863 Project) [2014AA021905]	National High Technology Research and Development Program of China (863 Project)(National High Technology Research and Development Program of China)	YH received funding from National High Technology Research and Development Program of China (863 Project), grant number is 2014AA021905. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2009, APPL MICROBIOL BIOT, V84, P19, DOI 10.1007/s00253-009-2079-4; Beg QK, 2001, APPL MICROBIOL BIOT, V56, P326, DOI 10.1007/s002530100704; BLAKENEY AB, 1980, J SCI FOOD AGR, V31, P889, DOI 10.1002/jsfa.2740310905; Blumer-Schuette SE, 2008, CURR OPIN BIOTECH, V19, P210, DOI 10.1016/j.copbio.2008.04.007; Blumer-Schuette SE, 2012, J BACTERIOL, V194, P4015, DOI 10.1128/JB.00266-12; Blumer-Schuette SE, 2011, J BACTERIOL, V193, P1483, DOI 10.1128/JB.01515-10; Blumer-Schuette SE, 2010, APPL ENVIRON MICROB, V76, P8084, DOI 10.1128/AEM.01400-10; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bravman T, 2001, FEBS LETT, V495, P39, DOI 10.1016/S0014-5793(01)02360-2; Correa JM, 2012, APPL BIOCHEM BIOTECH, V168, P2218, DOI 10.1007/s12010-012-9931-1; Deutschmann R, 2012, BIOTECHNOL ADV, V30, P1627, DOI 10.1016/j.biotechadv.2012.07.001; Dwivedi PP, 1996, APPL MICROBIOL BIOT, V45, P86, DOI 10.1007/s002530050653; Ebringerova A, 2005, ADV POLYM SCI, V186, P1, DOI 10.1007/b136816; FUKUMURA M, 1995, BIOSCI BIOTECH BIOCH, V59, P40, DOI 10.1271/bbb.59.40; Gallardo O, 2010, J BIOL CHEM, V285, P2721, DOI 10.1074/jbc.M109.064394; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Han YJ, 2012, J BIOL CHEM, V287, P34946, DOI 10.1074/jbc.M112.391532; Huang CY, 1998, INT J SYST BACTERIOL, V48, P91, DOI 10.1099/00207713-48-1-91; LEE YE, 1993, APPL ENVIRON MICROB, V59, P3134, DOI 10.1128/AEM.59.9.3134-3137.1993; LUTHI E, 1990, APPL ENVIRON MICROB, V56, P2677; MORIYAMA H, 1987, EUR J BIOCHEM, V166, P539, DOI 10.1111/j.1432-1033.1987.tb13547.x; Morris DD, 1999, EXTREMOPHILES, V3, P103, DOI 10.1007/s007920050105; Ochs M, 2013, J MOL CATAL B-ENZYM, V96, P21, DOI 10.1016/j.molcatb.2013.06.001; Polizeli MLTM, 2005, APPL MICROBIOL BIOT, V67, P577, DOI 10.1007/s00253-005-1904-7; Rizzatti ACS, 2001, J IND MICROBIOL BIOT, V26, P156, DOI 10.1038/sj.jim.7000107; Sa-Pereira P, 2003, MOL BIOTECHNOL, V24, P257, DOI 10.1385/MB:24:3:257; Shao WL, 2011, APPL ENVIRON MICROB, V77, P719, DOI 10.1128/AEM.01511-10; Shi H, 2014, BIOTECHNOL LETT, V36, P587, DOI 10.1007/s10529-013-1392-2; Shi H, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-27; Su XY, 2013, APPL ENVIRON MICROB, V79, P1481, DOI 10.1128/AEM.03265-12; Takahashi Y, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-447; VanFossen AL, 2011, BIOTECHNOL BIOENG, V108, P1559, DOI 10.1002/bit.23093; Verma D, 2012, BIORESOURCE TECHNOL, V117, P360, DOI 10.1016/j.biortech.2012.04.034; Viborg AH, 2013, AMB EXPRESS, V3, DOI 10.1186/2191-0855-3-56; Wongwisansri S, 2013, BIORESOURCE TECHNOL, V132, P410, DOI 10.1016/j.biortech.2012.11.117; Yang JK, 2004, J MOL BIOL, V335, P155, DOI 10.1016/j.jmb.2003.10.026; Yang XZ, 2014, FOOD CHEM, V148, P381, DOI 10.1016/j.foodchem.2013.10.062; Yeoman CJ, 2010, ADV APPL MICROBIOL, V70, P1, DOI 10.1016/S0065-2164(10)70001-0; Ying Y, 2013, ENZYME MICROB TECH, V53, P194, DOI 10.1016/j.enzmictec.2013.04.004; Zverlov V, 1996, APPL MICROBIOL BIOT, V45, P245, DOI 10.1007/s002530050678	40	20	23	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105264	10.1371/journal.pone.0105264	http://dx.doi.org/10.1371/journal.pone.0105264			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127169	Green Published, gold, Green Submitted			2022-12-25	WOS:000340879300099
J	Ohm, IK; Gao, E; Olsen, MB; Alfsnes, K; Bliksoen, M; Ogaard, J; Ranheim, T; Nymo, SH; Holmen, YD; Aukrust, P; Yndestad, A; Vinge, LE				Ohm, Ingrid Kristine; Gao, Erhe; Olsen, Maria Belland; Alfsnes, Katrine; Bliksoen, Marte; Ogaard, Jonas; Ranheim, Trine; Nymo, Stale Haugset; Holmen, Yangchen Dhondup; Aukrust, Pal; Yndestad, Arne; Vinge, Leif Erik			Toll-Like Receptor 9-Activation during Onset of Myocardial Ischemia Does Not Influence Infarct Extension	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; INJURY; EXPRESSION	Aim: Myocardial infarction (MI) remains a major cause of death and disability worldwide, despite available reperfusion therapies. Inflammatory signaling is considered nodal in defining final infarct size. Activation of the innate immune receptor toll-like receptors (TLR) 9 prior to ischemia and reperfusion (I/R) reduces infarct size, but the consequence of TLR9 activation timed to the onset of ischemia is not known. Methods and Results: The TLR9-agonist; CpG B was injected i.p. in C57BL/6 mice immediately after induction of ischemia (30 minutes). Final infarct size, as well as area-at-risk, was measured after 24 hours of reperfusion. CpG B injection resulted in a significant increase in circulating granulocytes and monocytes both in sham and I/R mice. Paradoxically, clear evidence of reduced cardiac infiltration of both monocytes and granulocytes could be demonstrated in I/R mice treated with CpG B (immunocytochemistry, myeloperoxidase activity and mRNA expression patterns). In addition, systemic TLR9 activation elicited significant alterations of cardiac inflammatory genes. Despite these biochemical and cellular changes, there was no difference in infarct size between vehicle and CpG B treated I/R mice. Conclusion: Systemic TLR9-stimulation upon onset of ischemia and subsequent reperfusion does not alter final infarct size despite causing clear alterations of both systemic and cardiac inflammatory parameters. Our results question the clinical usefulness of TLR9 activation during cardiac I/R.	[Ohm, Ingrid Kristine; Olsen, Maria Belland; Alfsnes, Katrine; Bliksoen, Marte; Ogaard, Jonas; Ranheim, Trine; Nymo, Stale Haugset; Holmen, Yangchen Dhondup; Aukrust, Pal; Yndestad, Arne; Vinge, Leif Erik] Oslo Univ Hosp, Rikshosp, Internal Med Res Inst, Oslo, Norway; [Ohm, Ingrid Kristine; Nymo, Stale Haugset; Aukrust, Pal; Yndestad, Arne] Univ Oslo, Fac Med, Oslo, Norway; [Ohm, Ingrid Kristine; Olsen, Maria Belland; Bliksoen, Marte; Ranheim, Trine; Nymo, Stale Haugset; Holmen, Yangchen Dhondup; Yndestad, Arne; Vinge, Leif Erik] Univ Oslo, Ctr Heart Failure Res, Oslo, Norway; [Gao, Erhe] Temple Univ, Sch Med, Ctr Translat Med, Philadelphia, PA USA; [Aukrust, Pal] Oslo Univ Hosp, Rikshosp, Sect Clin Immunol & Infect Dis, Oslo, Norway; [Aukrust, Pal; Yndestad, Arne] Univ Oslo, KG Jebsen Inflammatory Res Ctr, Oslo, Norway; [Vinge, Leif Erik] Oslo Univ Hosp, Rikshosp, Dept Cardiol, Oslo, Norway; [Vinge, Leif Erik] Univ Oslo, KG Jebsen Cardiac Res Ctr, Oslo, Norway	University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; National Hospital Norway; University of Oslo	Ohm, IK (corresponding author), Oslo Univ Hosp, Rikshosp, Internal Med Res Inst, Oslo, Norway.	Ingrid.Kristine.Ohm@rr-research.no	Olsen, Maria/GXA-1825-2022; Olsen, Maria Belland/GQP-4485-2022	Ogaard, Jonas/0000-0001-9194-5939	University of Oslo; Center for Heart Failure Research; The South-Eastern Norway Regional Health Authority (Helse Sor-Ost)	University of Oslo; Center for Heart Failure Research; The South-Eastern Norway Regional Health Authority (Helse Sor-Ost)	This work was supported by the University of Oslo; and Center for Heart Failure Research; and The South-Eastern Norway Regional Health Authority (Helse Sor-Ost), http://www.helse-sorost.no/Sider/side.aspx, http://www.heartfailure.no/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arslan F, 2011, NAT REV CARDIOL, V8, P292, DOI 10.1038/nrcardio.2011.38; Arumugam TV, 2009, SHOCK, V32, P4, DOI 10.1097/SHK.0b013e318193e333; Bliksoen M, 2012, INT J CARDIOL, V158, P132, DOI 10.1016/j.ijcard.2012.04.047; Cao ZJ, 2013, BBA-MOL BASIS DIS, V1832, P96, DOI 10.1016/j.bbadis.2012.08.008; Damas JK, 2000, CARDIOVASC RES, V47, P778, DOI 10.1016/S0008-6363(00)00142-5; Filep JG, 1997, CIRCULATION, V96, P295; Frangogiannis NG, 2012, CIRC RES, V110, P159, DOI 10.1161/CIRCRESAHA.111.243162; Gao E, 2007, AM J PHYSIOL-HEART C, V293, pH60, DOI 10.1152/ajpheart.00227.2007; Gao E, 2010, CIRC RES, V107, P1445, DOI 10.1161/CIRCRESAHA.110.223925; Hausenloy DJ, 2013, J CLIN INVEST, V123, P92, DOI 10.1172/JCI62874; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Markowski P, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0376-7; Mersmann J, 2010, CRIT CARE MED, V38, P903, DOI 10.1097/CCM.0b013e3181ce50e6; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Oka T, 2012, NATURE, V485, P251, DOI 10.1038/nature10992; Swirski FK, 2013, SCIENCE, V339, P161, DOI 10.1126/science.1230719; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Timmers L, 2012, CARDIOVASC RES, V94, P276, DOI 10.1093/cvr/cvs018; Wang E, 2011, ANESTHESIOLOGY, V114, P603, DOI 10.1097/ALN.0b013e31820a4d5b; WILLIAMS FM, 1994, BRIT J PHARMACOL, V111, P1123, DOI 10.1111/j.1476-5381.1994.tb14861.x; Xia Ying, 2007, Inflammation & Allergy Drug Targets, V6, P101; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Zouggari Y, 2013, NAT MED, V19, P1273, DOI 10.1038/nm.3284	24	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104407	10.1371/journal.pone.0104407	http://dx.doi.org/10.1371/journal.pone.0104407			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126943	Green Published, Green Submitted, gold			2022-12-25	WOS:000340879300025
J	Thompson, CE; Biesmeijer, JC; Allnutt, TR; Pietravalle, S; Budge, GE				Thompson, Catherine E.; Biesmeijer, Jacobus C.; Allnutt, Theodore R.; Pietravalle, Stephane; Budge, Giles E.			Parasite Pressures on Feral Honey Bees (Apis mellifera sp.)	PLOS ONE			English	Article							VARROA-DESTRUCTOR; GENE-EXPRESSION; PCR; COLONIES; VIRUS; ADAPTATIONS; RESISTANCE; BRAIN; MITES	Feral honey bee populations have been reported to be in decline due to the spread of Varroa destructor, an ectoparasitic mite that when left uncontrolled leads to virus build-up and colony death. While pests and diseases are known causes of large-scale managed honey bee colony losses, no studies to date have considered the wider pathogen burden in feral colonies, primarily due to the difficulty in locating and sampling colonies, which often nest in inaccessible locations such as church spires and tree tops. In addition, little is known about the provenance of feral colonies and whether they represent a reservoir of Varroa tolerant material that could be used in apiculture. Samples of forager bees were collected from paired feral and managed honey bee colonies and screened for the presence of ten honey bee pathogens and pests using qPCR. Prevalence and quantity was similar between the two groups for the majority of pathogens, however feral honey bees contained a significantly higher level of deformed wing virus than managed honey bee colonies. An assessment of the honey bee race was completed for each colony using three measures of wing venation. There were no apparent differences in wing morphometry between feral and managed colonies, suggesting feral colonies could simply be escapees from the managed population. Interestingly, managed honey bee colonies not treated for Varroa showed similar, potentially lethal levels of deformed wing virus to that of feral colonies. The potential for such findings to explain the large fall in the feral population and the wider context of the importance of feral colonies as potential pathogen reservoirs is discussed.	[Thompson, Catherine E.; Biesmeijer, Jacobus C.] Univ Leeds, Leeds, W Yorkshire, England; [Allnutt, Theodore R.; Pietravalle, Stephane; Budge, Giles E.] Food & Environm Res Agcy, York, N Yorkshire, England	University of Leeds; Food & Environment Research Agency	Thompson, CE (corresponding author), Univ Leeds, Woodhouse Lane, Leeds, W Yorkshire, England.	fbsct@leeds.ac.uk		Biesmeijer, Koos/0000-0003-0328-0573	BBSRC [BB/D526488/1]; Defra; NERC; Scottish Government; Wellcome Trust, under the Insect Pollinator Initiative [BB/I000801/1]; BBSRC [BB/I000801/1, BB/I025220/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I025220/1, BB/I000801/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Defra(Department for Environment, Food & Rural Affairs (DEFRA)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Scottish Government; Wellcome Trust, under the Insect Pollinator Initiative(Wellcome Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	CET was funded as part of a 4 year BBSRC PhD (Grant BB/D526488/1)(http://www.bbsrc.ac.uk/funding/studentships). GEB was funded by a grant from BBSRC, Defra, NERC, the Scottish Government, and the Wellcome Trust, under the Insect Pollinator Initiative (Grants BB/I000801/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], BIOGEOGRAPHY TAXONOM, DOI DOI 10.1007/978-3-642-72649-1; BAILEY L, 1981, ANN APPL BIOL, V97, P109, DOI 10.1111/j.1744-7348.1981.tb02999.x; Bailey L., 1961, AM BEE J, V101, P89; Belloy L, 2007, APIDOLOGIE, V38, P136, DOI [10.1051/apido:2006069, 10.1051/apido:2007039]; Boecking O, 2008, J VERBRAUCH LEBENSM, V3, P221, DOI 10.1007/s00003-008-0331-y; Bouga M, 2011, J APICULT RES, V50, P51, DOI 10.3896/IBRA.1.50.1.06; Budge G, 2010, INVESTIGATING HONEY, P1; Budge GE, 2014, PLOS ONE IN PRESS; Budge GE, 2010, J INVERTEBR PATHOL, V105, P164, DOI 10.1016/j.jip.2010.06.004; Buchler R, 2010, APIDOLOGIE, V41, P393, DOI 10.1051/apido/2010011; Carreck NL, 2002, APIACTA, V37, P33; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Chantawannakul P, 2006, J INVERTEBR PATHOL, V91, P69, DOI 10.1016/j.jip.2005.11.001; de Miranda JR, 2010, J INVERTEBR PATHOL, V103, pS48, DOI 10.1016/j.jip.2009.06.012; de Miranda JR, 2010, J GEN VIROL, V91, P2524, DOI 10.1099/vir.0.022434-0; DEFRA, 2013, BEES OTH POLL THEIR; Dietemann V, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.1.09; Doebler SA, 2000, BIOSCIENCE, V50, P738, DOI 10.1641/0006-3568(2000)050[0738:TRAFOT]2.0.CO;2; Edwards P, 2007, MORPHPLOTV2 2; Evison SEF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030641; Fries I, 2001, APIDOLOGIE, V32, P199, DOI 10.1051/apido:2001122; Genersch E, 2010, APIDOLOGIE, V41, P332, DOI 10.1051/apido/2010014; Genersch E, 2010, APPL MICROBIOL BIOT, V87, P87, DOI 10.1007/s00253-010-2573-8; Green DM, 2000, HEREDITY, V85, P450, DOI 10.1046/j.1365-2540.2000.00788.x; Highfield AC, 2009, APPL ENVIRON MICROB, V75, P7212, DOI 10.1128/AEM.02227-09; Hollander M., 1973, NONPARAMETRIC STAT M; Iqbal J, 2007, P R SOC B, V274, P1517, DOI 10.1098/rspb.2007.0022; Kerstes NAG, 2014, INSECT SCI, V21, P401, DOI 10.1111/1744-7917.12064; Le Conte Y, 2007, APIDOLOGIE, V38, P566, DOI 10.1051/apido:2007040; Le Conte Y, 2010, APIDOLOGIE, V41, P353, DOI 10.1051/apido/2010017; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Locke B, 2012, ECOL EVOL, V2, P1144, DOI 10.1002/ece3.248; Locke B, 2011, APIDOLOGIE, V42, P533, DOI 10.1007/s13592-011-0029-5; Lourenco AP, 2008, APIDOLOGIE, V39, P372, DOI 10.1051/apido:2008015; Martin SJ, 2012, SCIENCE, V336, P1304, DOI 10.1126/science.1220941; MORITZ RFA, 1991, J APICULT RES, V30, P54, DOI 10.1080/00218839.1991.11101234; Paxton RJ, 2007, APIDOLOGIE, V38, P558, DOI 10.1051/apido:2007037; RATNIEKS FLW, 1989, ECOL ENTOMOL, V14, P475, DOI 10.1111/j.1365-2311.1989.tb00951.x; Ratti C, 2004, J VIROL METHODS, V122, P95, DOI 10.1016/j.jviromet.2004.08.013; Rosenkranz P, 2010, J INVERTEBR PATHOL, V103, pS96, DOI 10.1016/j.jip.2009.07.016; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seeley TD, 2007, APIDOLOGIE, V38, P19, DOI 10.1051/apido:2006055; Taylor MA, 2007, NEW ZEAL J CROP HORT, V35, P313, DOI 10.1080/01140670709510197; Thompson C.E., 2010, BEE CRAFT, V92, P22; Tofilski A, 2004, J INSECT SCI, V4, DOI [10.1093/JIS/4.1.17, 10.1093/jis/4.1.17]; Tofilski A, 2008, APIDOLOGIE, V39, P558, DOI 10.1051/apido:2008037; Toma DP, 2000, P NATL ACAD SCI USA, V97, P6914, DOI 10.1073/pnas.97.12.6914; Villa JD, 2008, J ECON ENTOMOL, V101, P1756, DOI 10.1603/0022-0493-101.6.1756; VSNInternational, 2011, GENSTAT WINDOWS; Wallner K., 2003, Pesticide Outlook, V14, P80, DOI 10.1039/b301510f; Yamazaki Y, 2006, FEBS LETT, V580, P2667, DOI 10.1016/j.febslet.2006.04.016	51	34	34	0	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105164	10.1371/journal.pone.0105164	http://dx.doi.org/10.1371/journal.pone.0105164			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126840	Green Published, gold, Green Submitted			2022-12-25	WOS:000340879300088
J	Yan, J; Zhang, L; Xu, JS; Sultana, N; Hu, J; Cai, XQ; Li, J; Xu, PX; Cai, CL				Yan, Jianyun; Zhang, Lu; Xu, Jinshu; Sultana, Nishat; Hu, Jun; Cai, Xiaoqiang; Li, Jun; Xu, Pin-Xian; Cai, Chen-Leng			Smad4 Regulates Ureteral Smooth Muscle Cell Differentiation during Mouse Embryogenesis	PLOS ONE			English	Article							TGF-BETA SUPERFAMILY; NEURAL CREST CELLS; URINARY-TRACT; URETEROPELVIC JUNCTION; VASCULAR DEVELOPMENT; SIGNAL-TRANSDUCTION; EXPRESSION; TBX18; MESENCHYME; MYOCARDIN	Proper formation of ureteral smooth muscle cells (SMCs) during embryogenesis is essential for ureter peristalsis that propels urine from the kidney to the bladder in mammals. Currently the molecular factors that regulate differentiation of ureteral mesenchymal cells into SMCs are incompletely understood. A recent study has reported that Smad4 deficiency reduces the number of ureteral SMCs. However, its precise role in the ureteral smooth muscle development remains largely unknown. Here, we used Tbx18:Cre knock-in mouse line to delete Smad4 to examine its requirement in the development of ureteral mesenchyme and SMC differentiation. We found that mice with specific deletion of Smad4 in Tbx18-expressing ureteral mesenchyme exhibited hydroureter and hydronephrosis at embryonic day (E) 16.5, and the mutant mesenchymal cells failed to differentiate into SMCs with increased apoptosis and decreased proliferation. Molecular markers for SMCs including alpha smooth muscle actin (alpha-SMA) and smooth muscle myosin heavy chain (SM-MHC) were absent in the mutant ureters. Moreover, disruption of Smad4 significantly reduced the expression of genes, including Sox9, Tbx18 and Myocardin associated with SMC differentiation. These findings suggest that Smad4 is essential for initiating the SMC differentiation program during ureter development.	[Yan, Jianyun; Zhang, Lu; Xu, Jinshu; Sultana, Nishat; Hu, Jun; Cai, Xiaoqiang; Li, Jun; Xu, Pin-Xian; Cai, Chen-Leng] Icahn Sch Med Mt Sinai, Dept Dev & Regenerat Biol, Mindich Child Hlth & Dev Inst, New York, NY 10029 USA; [Yan, Jianyun; Zhang, Lu; Xu, Jinshu; Sultana, Nishat; Hu, Jun; Cai, Xiaoqiang; Li, Jun; Xu, Pin-Xian; Cai, Chen-Leng] Icahn Sch Med Mt Sinai, Black Family Stem Cell Inst, New York, NY 10029 USA; [Xu, Jinshu; Li, Jun; Xu, Pin-Xian] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Yan, Jianyun] Southern Med Univ, Dept Histol & Embryol, Guangzhou, Guangdong, Peoples R China	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Southern Medical University - China	Cai, CL (corresponding author), Icahn Sch Med Mt Sinai, Dept Dev & Regenerat Biol, Mindich Child Hlth & Dev Inst, New York, NY 10029 USA.	chenleng.cai@mssm.edu	Yan, Jianyun/AAX-4510-2020; Xu, Jinshu/Q-3879-2017	Yan, Jianyun/0000-0002-6962-1169; Xu, Jinshu/0000-0002-6287-5633	NHLBI [1R01HL095810, 1K02HL094688]; American Heart Association [0855808D]; March of Dimes Foundation [5-FY07-642]; NIDDK [R01 DK064640]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K02HL094688, R01HL095810] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); March of Dimes Foundation(March of Dimes); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study is supported by grants to C.L.C. from the NHLBI (1R01HL095810 and 1K02HL094688), the American Heart Association (0855808D) and the March of Dimes Foundation (5-FY07-642), and grant to P-X. X. from the NIDDK (R01 DK064640). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airik R, 2007, KIDNEY INT, V72, P1459, DOI 10.1038/sj.ki.5002589; Airik R, 2006, J CLIN INVEST, V116, P663, DOI 10.1172/JCI26027; Airik R, 2010, HUM MOL GENET, V19, P4918, DOI 10.1093/hmg/ddq426; Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Akiyama H, 2004, P NATL ACAD SCI USA, V101, P6502, DOI 10.1073/pnas.0401711101; Benazet JD, 2012, DEVELOPMENT, V139, P4250, DOI 10.1242/dev.084822; Bohnenpoll T, 2013, DEV BIOL, V380, P25, DOI 10.1016/j.ydbio.2013.04.036; Brenner-Anantharam A, 2007, DEVELOPMENT, V134, P1967, DOI 10.1242/dev.004234; Bush KT, 2004, DEV BIOL, V266, P285, DOI 10.1016/j.ydbio.2003.10.023; Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; Cai XQ, 2013, DEVELOPMENT, V140, P3176, DOI 10.1242/dev.092502; Caubit X, 2008, DEVELOPMENT, V135, P3301, DOI 10.1242/dev.022442; Chang CP, 2004, J CLIN INVEST, V113, P1051, DOI 10.1172/JCI200420049; Chen F, 2009, PEDIATR NEPHROL, V24, P1621, DOI 10.1007/s00467-008-1072-y; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Deng FM, 2001, P NATL ACAD SCI USA, V98, P154, DOI 10.1073/pnas.98.1.154; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Grisanti L, 2013, J INVEST DERMATOL, V133, P344, DOI 10.1038/jid.2012.329; Huang JH, 2008, J CLIN INVEST, V118, P515, DOI [10.1172/JC133304, 10.1172/JCI33304]; Huang JH, 2009, P NATL ACAD SCI USA, V106, P18734, DOI 10.1073/pnas.0910749106; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; Kang H, 2012, J BIOL CHEM, V287, P3976, DOI 10.1074/jbc.M111.303156; Kawabata M, 1999, J BIOCHEM, V125, P9, DOI 10.1093/oxfordjournals.jbchem.a022273; Ko SO, 2007, DEV BIOL, V312, P435, DOI 10.1016/j.ydbio.2007.09.050; Kraus F, 2001, MECH DEVELOP, V100, P83, DOI 10.1016/S0925-4773(00)00494-9; Liu ZP, 2005, DEV CELL, V9, P261, DOI 10.1016/j.devcel.2005.05.017; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mao X, 2012, ARTERIOSCL THROM VAS, V32, P2171, DOI 10.1161/ATVBAHA.112.253872; Martin E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063721; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Miyazaki Y, 2003, KIDNEY INT, V63, P835, DOI 10.1046/j.1523-1755.2003.00834.x; Miyazaki Y, 2000, J CLIN INVEST, V105, P863, DOI 10.1172/JCI8256; Nie XG, 2008, DEV BIOL, V316, P417, DOI 10.1016/j.ydbio.2008.02.006; Nie XG, 2010, DEVELOPMENT, V137, P755, DOI 10.1242/dev.045757; OWENS GK, 1995, PHYSIOL REV, V75, P487; Pope JC, 1999, J AM SOC NEPHROL, V10, P2018; Pritchett J, 2011, TRENDS MOL MED, V17, P166, DOI 10.1016/j.molmed.2010.12.001; Qi X, 2007, DEV BIOL, V311, P136, DOI 10.1016/j.ydbio.2007.08.022; Raphel L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044052; Song LY, 2007, CIRC RES, V101, P277, DOI 10.1161/CIRCRESAHA.107.155630; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; Tripathi P, 2012, J AM SOC NEPHROL, V23, P618, DOI 10.1681/ASN.2011060566; Trowe MO, 2012, DEVELOPMENT, V139, P3099, DOI 10.1242/dev.077388; Wang GJ, 2009, J UROLOGY, V181, P401, DOI 10.1016/j.juro.2008.08.117; Wang YQ, 2009, GENESIS, V47, P409, DOI 10.1002/dvg.20515; Wang ZG, 2003, P NATL ACAD SCI USA, V100, P7129, DOI 10.1073/pnas.1232341100; Wilkinson D. G., 1998, SITU HYBRIDIZATION P; Woolf AS, 2013, J AM SOC NEPHROL, V24, P19, DOI 10.1681/ASN.2012020127; Xu JY, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032554, 10.1371/journal.pone.0038665]; Yang X, 2002, GENESIS, V32, P80, DOI 10.1002/gene.10029; Yu J, 2002, DEVELOPMENT, V129, P5301; Zhou YX, 2003, J BIOL CHEM, V278, P42313, DOI 10.1074/jbc.M308287200	53	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104503	10.1371/journal.pone.0104503	http://dx.doi.org/10.1371/journal.pone.0104503			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127126	Green Published, Green Submitted, gold			2022-12-25	WOS:000340879300027
J	Dyson, RM; Palliser, HK; Latter, JL; Chwatko, G; Glowacki, R; Wright, IMR				Dyson, Rebecca M.; Palliser, Hannah K.; Latter, Joanna L.; Chwatko, Grazyna; Glowacki, Rafal; Wright, Ian M. R.			A Role for H2S in the Microcirculation of Newborns: The Major Metabolite of H2S (Thiosulphate) Is Increased in Preterm Infants	PLOS ONE			English	Article							HYDROGEN-SULFIDE; BLOOD-FLOW; CREATININE EXCRETION; NITRIC-OXIDE; 1ST YEAR; MEDIATOR; RAT; INHIBITION; INDICATOR; APOPTOSIS	Excessive vasodilatation during the perinatal period is associated with cardiorespiratory instability in preterm neonates. Little evidence of the mechanisms controlling microvascular tone during circulatory transition exists. We hypothesised that hydrogen sulphide (H2S), an important regulator of microvascular reactivity and central cardiac function in adults and animal models, may contribute to the vasodilatation observed in preterm newborns. Term and preterm neonates (24-43 weeks gestational age) were studied. Peripheral microvascular blood flow was assessed by laser Doppler. Thiosulphate, a urinary metabolite of H2S, was determined by high performance liquid chromatography as a measure of 24 hr total body H2S turnover for the first 3 days of postnatal life. H2S turnover was greatest in very preterm infants and decreased with increasing gestational age (p = 0.0001). H2S turnover was stable across the first 72 hrs of life in older neonates. In very preterm neonates, H2S turnover increased significantly from day 1 to 3 ( p = 0.0001); and males had higher H2S turnover than females (p = 0.04). A significant relationship between microvascular blood flow and H2S turnover was observed on day 2 of postnatal life (p = 0.0004). H2S may play a role in maintaining microvascular tone in the perinatal period. Neonates at the greatest risk of microvascular dysfunction characterised by inappropriate peripheral vasodilatation - very preterm male neonates - are also the neonates with highest levels of total body H2S turnover suggesting that overproduction of this gasotransmitter may contribute to microvascular dysfunction in preterms. Potentially, H2S is a target to selectively control microvascular tone in the circulation of newborns.	[Dyson, Rebecca M.; Palliser, Hannah K.; Latter, Joanna L.; Wright, Ian M. R.] Mothers & Babies Res Ctr, Hunter Med Res Inst, New Lambton Hts, NSW, Australia; [Dyson, Rebecca M.; Wright, Ian M. R.] Univ Newcastle, Sch Med & Publ Hlth, Discipline Paediat & Child Hlth, Callaghan, NSW 2308, Australia; [Dyson, Rebecca M.; Wright, Ian M. R.] Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW, Australia; [Dyson, Rebecca M.; Wright, Ian M. R.] Univ Wollongong, Grad Sch Med, Wollongong, NSW, Australia; [Palliser, Hannah K.] Univ Newcastle, Sch Biomed Sci & Pharm, Callaghan, NSW 2308, Australia; [Latter, Joanna L.] Univ Newcastle, Sch Med & Publ Hlth, Discipline Publ Hlth, Callaghan, NSW 2308, Australia; [Chwatko, Grazyna; Glowacki, Rafal] Univ Lodz, Fac Chem, Dept Environm Chem, PL-90131 Lodz, Poland; [Wright, Ian M. R.] John Hunter Childrens Hosp, Kaleidoscope Neonatal Intens Care Unit, New Lambton Hts, NSW, Australia	Hunter Medical Research Institute; University of Newcastle; University of Newcastle; University of Wollongong; University of Wollongong; University of Newcastle; University of Newcastle; University of Lodz	Wright, IMR (corresponding author), Mothers & Babies Res Ctr, Hunter Med Res Inst, New Lambton Hts, NSW, Australia.	iwright@uow.edu.au	Chwatko, Grażyna/R-8757-2016	Glowacki, Rafal/0000-0003-0071-1470; Palliser, Hannah/0000-0001-5783-9737; Dyson, Rebecca/0000-0003-2319-6897; Latter, Joanna/0000-0002-8499-0069; Chwatko, Grazyna/0000-0001-9247-5131; Wright, Ian/0000-0001-5337-0134	National Health and Medical Research Council [569285]; John Hunter Hospital Charitable Trust; Hunter Children's Research Foundation; University of Lodz	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); John Hunter Hospital Charitable Trust; Hunter Children's Research Foundation; University of Lodz	This study was funded by a National Health and Medical Research Council Project Grant awarded to IMRW (ID#569285; https://www.nhmrc.gov.au/) and John Hunter Hospital Charitable Trust Project Grants awarded to IMRW, HKP and RMD. RMD was supported by the Hunter Children's Research Foundation. The HPLC work performed by GC and RG was supported by the University of Lodz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba-Alejandre I, 2013, INT J PEDIAT, V2013, DOI 10.1155/2013/768784; Amey M, 2008, PEDIATR CRIT CARE ME, V9, P76, DOI 10.1097/01.PCC.0000298550.29453.7D; APPLEGARTH DA, 1975, CLIN CHIM ACTA, V64, P83, DOI 10.1016/0009-8981(75)90148-5; APPLEGARTH DA, 1968, CLIN CHIM ACTA, V22, P131, DOI 10.1016/0009-8981(68)90348-3; Baragatti B, 2013, AM J PHYSIOL-HEART C, V304, pH927, DOI 10.1152/ajpheart.00718.2012; BEAUCHAMP RO, 1984, CRC CR REV TOXICOL, V13, P25, DOI 10.3109/10408448409029321; Bhatia M, 2005, BRIT J PHARMACOL, V145, P141, DOI 10.1038/sj.bjp.0706186; Bhatia M, 2012, SCIENTIFICA, V2012, P12; Bhutani V. K., 1997, SEMINARS PERINATOLOG, V2, P1; Chiku T, 2009, J BIOL CHEM, V284, P11601, DOI 10.1074/jbc.M808026200; Chwatko G, 2009, TALANTA, V79, P229, DOI 10.1016/j.talanta.2009.03.040; Clifton VL, 2010, PLACENTA, V31, pS33, DOI 10.1016/j.placenta.2009.11.010; Collin M, 2005, SHOCK, V24, P595, DOI 10.1097/01.shk.0000188328.59770.25; Collin M, 2005, BRIT J PHARMACOL, V146, P498, DOI 10.1038/sj.bjp.0706367; Dasgupta SJ, 2003, ARCH DIS CHILD-FETAL, V88, pF450, DOI 10.1136/fn.88.6.F450; Du Junbao, 2003, Beijing Da Xue Xue Bao Yi Xue Ban, V35, P102; Dyson RM, 2012, PEDIATR RES, V71, P20, DOI 10.1038/pr.2011.9; Elder DE, 1999, J PAEDIATR CHILD H, V35, P145, DOI 10.1046/j.1440-1754.1999.00308.x; Elrod JW, 2007, P NATL ACAD SCI USA, V104, P15560, DOI 10.1073/pnas.0705891104; Evans N, 2002, ARCH DIS CHILD-FETAL, V87, P181; Hille ETM, 2007, PEDIATRICS, V120, pE587, DOI 10.1542/peds.2006-2407; Ji Y, 2008, EUR J PHARMACOL, V587, P1, DOI 10.1016/j.ejphar.2008.03.044; Jiang Hai-long, 2005, Di Yi Jun Yi Da Xue Xue Bao, V25, P951; Kage S, 1997, INT J LEGAL MED, V110, P220, DOI 10.1007/s004140050071; KANGAS J, 1987, CLIN CHIM ACTA, V164, P7, DOI 10.1016/0009-8981(87)90101-X; Kent AL, 2012, PEDIATRICS, V129, P124, DOI 10.1542/peds.2011-1578; Kimura H, 2005, ANTIOXID REDOX SIGN, V7, P795, DOI 10.1089/ars.2005.7.795; Kubli S, 2000, J CARDIOVASC PHARM, V36, P640, DOI 10.1097/00005344-200011000-00014; Leffler CW, 2011, AM J PHYSIOL-HEART C, V300, pH440, DOI 10.1152/ajpheart.00722.2010; Levonen AL, 2000, BIOCHEM J, V347, P291, DOI 10.1042/0264-6021:3470291; Li L, 2005, FASEB J, V19, P1196, DOI 10.1096/fj.04-3583fje; Martin JA, 2007, CELL MOL BIOL NOIS S, V53; Minamishima S, 2009, CIRCULATION, V120, P888, DOI 10.1161/CIRCULATIONAHA.108.833491; Mok YYP, 2004, BRIT J PHARMACOL, V143, P881, DOI 10.1038/sj.bjp.0706014; Olson KR, 2006, J EXP BIOL, V209, P4011, DOI 10.1242/jeb.02480; Pan TT, 2006, J MOL CELL CARDIOL, V40, P119, DOI 10.1016/j.yjmcc.2005.10.003; Picker JD, 1993, HOMOCYSTINURIA CAUSE; Ritter JM, 2010, BRIT J CLIN PHARMACO, V69, P573, DOI 10.1111/j.1365-2125.2010.03690.x; Saukkonen K, 2010, SHOCK, V34, P558, DOI 10.1097/SHK.0b013e3181e14de9; Seri I, 2001, PEDIATRICS, V107, P1070, DOI 10.1542/peds.107.5.1070; Shaul PW, 1997, SEMIN PERINATOL, V21, P381, DOI 10.1016/S0146-0005(97)80004-3; Sodha NR, 2008, EUR J CARDIO-THORAC, V33, P906, DOI 10.1016/j.ejcts.2008.01.047; Stark MJ, 2008, ARCH DIS CHILD-FETAL, V93, pF271, DOI 10.1136/adc.2007.123539; Stark MJ, 2011, J MATERN-FETAL NEO M, V24, P1215, DOI 10.3109/14767058.2011.569618; Stark MJ, 2009, PEDIATRICS, V124, P277, DOI 10.1542/peds.2008-0877; Stark MJ, 2008, PEDIATR RES, V63, P415, DOI 10.1203/01.pdr.0000304937.38669.63; Toombs CF, 2010, BRIT J CLIN PHARMACO, V69, P626, DOI 10.1111/j.1365-2125.2010.03636.x; Wang R, 2002, FASEB J, V16, P1792, DOI 10.1096/fj.02-0211hyp; Wen YD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053147; Yao LL, 2010, AM J PHYSIOL-HEART C, V298, pH1310, DOI 10.1152/ajpheart.00339.2009; Zhang HL, 2006, AM J PHYSIOL-LUNG C, V290, pL1193, DOI 10.1152/ajplung.00489.2005; Zhang L, 2010, MOL MED, V16, P417, DOI 10.2119/molmed.2010.00027; ZLOTKIN SH, 1982, PEDIATR RES, V16, P65; Zoccali C, 2009, NEPHROL DIAL TRANSPL, V24, P1394, DOI 10.1093/ndt/gfp053	54	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e105085	10.1371/journal.pone.0105085	http://dx.doi.org/10.1371/journal.pone.0105085			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121737	Green Submitted, gold, Green Published			2022-12-25	WOS:000341017000094
J	Rangaswamy, US; O'Flaherty, BM; Speck, SH				Rangaswamy, Udaya S.; O'Flaherty, Brigid M.; Speck, Samuel H.			Tyrosine 129 of the Murine Gammaherpesvirus M2 Protein Is Critical for M2 Function In Vivo	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; SARCOMA-ASSOCIATED HERPESVIRUS; B-CELLS; KAPOSIS-SARCOMA; LATENT MEMBRANE-PROTEIN-1; VIRAL INTERLEUKIN-10; DENDRITIC CELLS; IL-10; INFECTION; GENE	A common strategy shared by all known gammaherpesviruses is their ability to establish a latent infection in lymphocytes - predominantly in B cells. In immunocompromised patients, such as transplant recipients or AIDS patients, gammaherpesvirus infections can lead to the development of lymphoproliferative disease and lymphoid malignancies. The human gamma-herpesviruses, EBV and KSHV, encode proteins that are capable of modulating the host immune signaling machinery, thereby subverting host immune responses. Murine gamma-herpesvirus 68 (MHV68) infection of laboratory strains of mice has proven to be useful small-animal model that shares important pathogenic strategies with the human gamma-herpesviruses. The MHV68 M2 protein is known to manipulate B cell signaling and, dependent on route and dose of virus inoculation, plays a role in both the establishment of latency and virus reactivation. M2 contains two tyrosines that are targets for phosphorylation, and have been shown to interact with the B cell signaling machinery. Here we describe in vitro and in vivo studies of M2 mutants which reveals that while both tyrosines Y120 and Y129 are required for M2 induction of IL-10 expression from primary murine B cells in vitro, only Y129 is critical for reactivation from latency and plasma cell differentiation in vivo.	[Rangaswamy, Udaya S.; O'Flaherty, Brigid M.] Emory Univ, Sch Med, Microbiol & Mol Genet Grad Program, Atlanta, GA 30322 USA; [Rangaswamy, Udaya S.; O'Flaherty, Brigid M.; Speck, Samuel H.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Speck, Samuel H.] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University	Speck, SH (corresponding author), Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.	sspeck@emory.edu	Speck, Samuel/L-5893-2019		National Institutes of Health (NIH) [R01 AI058057]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058057] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded by grant number R01 AI058057 from the National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton E, 2011, ANNU REV IMMUNOL, V29, P351, DOI 10.1146/annurev-immunol-072710-081639; CARSETTI R, 1995, J EXP MED, V181, P2129, DOI 10.1084/jem.181.6.2129; Collins CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033230; Collins CM, 2009, J VIROL, V83, P6484, DOI 10.1128/JVI.00297-09; de Miranda MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001654; de Miranda MP, 2013, J BIOL CHEM, V288, P3858, DOI 10.1074/jbc.M112.439810; DeZalia M, 2008, J VIROL, V82, P7411, DOI 10.1128/JVI.00651-08; Ding YZ, 2003, J IMMUNOL, V170, P1383, DOI 10.4049/jimmunol.170.3.1383; FINBLOOM DS, 1995, J IMMUNOL, V155, P1079; Flano E, 2000, J IMMUNOL, V165, P1074, DOI 10.4049/jimmunol.165.2.1074; Ganem D, 2006, ANNU REV PATHOL-MECH, V1, P273, DOI 10.1146/annurev.pathol.1.110304.100133; Herskowitz J, 2005, J VIROL, V79, P2261, DOI 10.1128/JVI.79.4.2261-2273.2005; Herskowitz JH, 2008, J VIROL, V82, P3295, DOI 10.1128/JVI.02234-07; Hornef MW, 1997, CLIN DIAGN LAB IMMUN, V4, P545, DOI 10.1128/CDLI.4.5.545-549.1997; Jacoby MA, 2002, J VIROL, V76, P1790, DOI 10.1128/JVI.76.4.1790-1801.2002; Kotenko SV, 2000, P NATL ACAD SCI USA, V97, P1695, DOI 10.1073/pnas.97.4.1695; Krutzik PO, 2005, J IMMUNOL, V175, P2366, DOI 10.4049/jimmunol.175.4.2366; Lagunoff M, 1999, P NATL ACAD SCI USA, V96, P5704, DOI 10.1073/pnas.96.10.5704; Lambert SL, 2007, J IMMUNOL, V179, P8225, DOI 10.4049/jimmunol.179.12.8225; Liang XZ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000677; Madureira PA, 2005, J BIOL CHEM, V280, P37310, DOI 10.1074/jbc.M507478200; MIYAZAKI I, 1993, J EXP MED, V178, P439, DOI 10.1084/jem.178.2.439; MOORE KW, 1990, SCIENCE, V248, P1230, DOI 10.1126/science.2161559; Ouyang P, 2014, J GEN VIROL, V95, P245, DOI 10.1099/vir.0.058966-0; Punjabi AS, 2007, J VIROL, V81, P2449, DOI 10.1128/JVI.01769-06; Rangaswamy US, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003858; Rodrigues L, 2006, J VIROL, V80, P6123, DOI 10.1128/JVI.02700-05; Santarelli R, 2014, SCI REP-UK, V4, DOI 10.1038/srep04241; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Shair KHY, 2007, PLOS PATHOG, V3, P1669, DOI 10.1371/journal.ppat.0030166; Siegel AM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000039; Siegel AM, 2010, J VIROL, V84, P674, DOI 10.1128/JVI.01306-09; Spencer JV, 2002, J VIROL, V76, P1285, DOI 10.1128/JVI.76.3.1285-1292.2002; Stinski MF, 2007, HUMAN HERPESVIRUSES: BIOLOGY, THERAPY, AND IMMUNOPROPHYLAXIS, P241; STUART AD, 1995, ONCOGENE, V11, P1711; Virgin HW, 1999, J VIROL, V73, P2321, DOI 10.1128/JVI.73.3.2321-2332.1999; Virgin HW, 1997, J VIROL, V71, P5894, DOI 10.1128/JVI.71.8.5894-5904.1997; Vockerodt M, 2001, VIROLOGY, V280, P183, DOI 10.1006/viro.2000.0768; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Weck KE, 1996, J VIROL, V70, P6775, DOI 10.1128/JVI.70.10.6775-6780.1996; Weck KE, 1999, J VIROL, V73, P4651, DOI 10.1128/JVI.73.6.4651-4661.1999; Weck KE, 1999, J VIROL, V73, P3273, DOI 10.1128/JVI.73.4.3273-3283.1999; Wehinger J, 1996, FEBS LETT, V394, P365, DOI 10.1016/0014-5793(96)00990-8; Welte T, 1999, SCIENCE, V283, P222, DOI 10.1126/science.283.5399.222; Willer DO, 2003, J VIROL, V77, P8310, DOI 10.1128/JVI.77.15.8310-8321.2003; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452	46	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e105197	10.1371/journal.pone.0105197	http://dx.doi.org/10.1371/journal.pone.0105197			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122496	Green Submitted, Green Published, gold			2022-12-25	WOS:000341017000105
J	Xu, Y; Wen, X; Wen, LS; Wu, LY; Deng, NY; Chou, KC				Xu, Yan; Wen, Xin; Wen, Li-Shu; Wu, Ling-Yun; Deng, Nai-Yang; Chou, Kuo-Chen			iNitro-Tyr: Prediction of Nitrotyrosine Sites in Proteins with General Pseudo Amino Acid Composition	PLOS ONE			English	Article							SECONDARY STRUCTURE-CONTENT; LABEL LEARNING CLASSIFIER; CHOUS PSEAAC FORMULATION; PROTEASE CLEAVAGE SITES; S-NITROSYLATION SITES; SUBCELLULAR-LOCALIZATION; SIGNAL PEPTIDES; STRUCTURAL CLASSES; MULTIPLE SITES; PHYSICOCHEMICAL PROPERTIES	Nitrotyrosine is one of the post-translational modifications (PTMs) in proteins that occurs when their tyrosine residue is nitrated. Compared with healthy people, a remarkably increased level of nitrotyrosine is detected in those suffering from rheumatoid arthritis, septic shock, and coeliac disease. Given an uncharacterized protein sequence that contains many tyrosine residues, which one of them can be nitrated and which one cannot? This is a challenging problem, not only directly related to in-depth understanding the PTM's mechanism but also to the nitrotyrosine-based drug development. Particularly, with the avalanche of protein sequences generated in the postgenomic age, it is highly desired to develop a high throughput tool in this regard. Here, a new predictor called "iNitro-Tyr'' was developed by incorporating the position-specific dipeptide propensity into the general pseudo amino acid composition for discriminating the nitrotyrosine sites from non-nitrotyrosine sites in proteins. It was demonstrated via the rigorous jackknife tests that the new predictor not only can yield higher success rate but also is much more stable and less noisy. A web-server for iNitro-Tyr is accessible to the public at http://app.aporc.org/iNitro-Tyr/. For the convenience of most experimental scientists, we have further provided a protocol of step-by-step guide, by which users can easily get their desired results without the need to follow the complicated mathematics that were presented in this paper just for the integrity of its development process. It has not escaped our notice that the approach presented here can be also used to deal with the other PTM sites in proteins.	[Xu, Yan; Wen, Xin] Univ Sci & Technol Beijing, Dept Informat & Comp Sci, Beijing 100083, Peoples R China; [Wen, Li-Shu] Liaoning Shiyou Univ, Coll Sci, Fushun, Peoples R China; [Wu, Ling-Yun] Chinese Acad Sci, Acad Math & Syst Sci, Inst Appl Math, Beijing, Peoples R China; [Deng, Nai-Yang] China Agr Univ, Coll Sci, Beijing 100094, Peoples R China; [Chou, Kuo-Chen] King Abdulaziz Univ, CEGMR, Jeddah 21413, Saudi Arabia; [Chou, Kuo-Chen] Gordon Life Sci Inst, Boston, MA USA	University of Science & Technology Beijing; Liaoning Petrochemical University; Chinese Academy of Sciences; Academy of Mathematics & System Sciences, CAS; China Agricultural University; King Abdulaziz University; Gordon Life Science Institute	Xu, Y (corresponding author), Univ Sci & Technol Beijing, Dept Informat & Comp Sci, Beijing 100083, Peoples R China.	xuyan@ustb.edu.cn	Wu, Ling-Yun/C-4222-2008; Chou, Kuo-Chen/A-8340-2009	Wu, Ling-Yun/0000-0001-9487-0215; Xu, Yan/0000-0001-9462-580X	National Natural Science Foundation of China [11301024, 11371365, 11101029, 31201002, 11071013]; National Natural Science Foundation of China [11301024, 11371365, 11101029, 31201002, 11071013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National Natural Science Foundation of China (No. 11301024, No. 11371365, No. 11101029, No. 31201002, No. 11071013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abello N, 2009, J PROTEOME RES, V8, P3222, DOI 10.1021/pr900039c; Cao DS, 2013, BIOINFORMATICS, V29, P960, DOI 10.1093/bioinformatics/btt072; Casoni F, 2005, J BIOL CHEM, V280, P16295, DOI 10.1074/jbc.M413111200; Chen W, 2014, ANAL BIOCHEM, V462, P76, DOI 10.1016/j.ab.2014.06.022; Chen W, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/623149; Chen W, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1450; Chen W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047843; Chen YK, 2013, J THEOR BIOL, V318, P1, DOI 10.1016/j.jtbi.2012.10.033; CHOU JJ, 1993, BIOPOLYMERS, V33, P1405, DOI 10.1002/bip.360330910; Chou KC, 2005, BIOINFORMATICS, V21, P10, DOI 10.1093/bioinformatics/bth466; Chou KC, 1996, ANAL BIOCHEM, V233, P1, DOI 10.1006/abio.1996.0001; Chou KC, 2002, CURR PROTEIN PEPT SC, V3, P615, DOI 10.2174/1389203023380468; Chou KC, 2001, PEPTIDES, V22, P1973, DOI 10.1016/S0196-9781(01)00540-X; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; CHOU KC, 1995, PROTEIN SCI, V4, P1365, DOI 10.1002/pro.5560040712; Chou KC, 2001, PROTEINS, V42, P136, DOI 10.1002/1097-0134(20010101)42:1<136::AID-PROT130>3.0.CO;2-F; CHOU KC, 1993, J BIOL CHEM, V268, P16938; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; Chou KC, 2001, PROTEIN ENG, V14, P75, DOI 10.1093/protein/14.2.75; Chou KC, 1999, J PROTEIN CHEM, V18, P473, DOI 10.1023/A:1020696810938; Chou KC, 2009, NAT SCI, V2, P63, DOI DOI 10.4236/NS.2009.12011; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Chou KC, 2007, ANAL BIOCHEM, V370, P1, DOI 10.1016/j.ab.2007.07.006; Chou KC, 2007, BIOCHEM BIOPH RES CO, V357, P633, DOI 10.1016/j.bbrc.2007.03.162; Chou KC, 2006, J PROTEOME RES, V5, P1888, DOI 10.1021/pr060167c; Chou KC, 2012, MOL BIOSYST, V8, P629, DOI 10.1039/c1mb05420a; Chou KC, 2013, MOL BIOSYST, V9, P1092, DOI 10.1039/c3mb25555g; Chou KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018258; Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024; Dekker F. F, 2012, CURR PROTOC PROTEIN; Ding H, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/286419; Du PF, 2014, INT J MOL SCI, V15, P3495, DOI 10.3390/ijms15033495; Du PF, 2012, ANAL BIOCHEM, V425, P117, DOI 10.1016/j.ab.2012.03.015; Fan YN, 2014, INT J MOL SCI, V15, P4915, DOI 10.3390/ijms15034915; Feeney M. B., 2013, ANTIOXID REDOX SIGNA; Feng KY, 2005, BIOCHEM BIOPH RES CO, V334, P213, DOI 10.1016/j.bbrc.2005.06.075; Feng PM, 2013, ANAL BIOCHEM, V442, P118, DOI 10.1016/j.ab.2013.05.024; Georgiou D.N., 2013, OPEN BIOINF J, V7, P41, DOI DOI 10.2174/1875036201307010041; Ghesquiere B, 2009, MOL CELL PROTEOMICS, V8, P2642, DOI 10.1074/mcp.M900259-MCP200; Guo SH, 2014, BIOINFORMATICS, V30, P1522, DOI 10.1093/bioinformatics/btu083; Hajisharifi Z, 2014, J THEOR BIOL, V341, P34, DOI 10.1016/j.jtbi.2013.08.037; Huang C, 2013, J THEOR BIOL, V335, P205, DOI 10.1016/j.jtbi.2013.06.034; Jarmula A, 2013, J COMPUT AID MOL DES, V27, P45, DOI 10.1007/s10822-012-9624-4; Jia CZ, 2014, INT J MOL SCI, V15, P10410, DOI 10.3390/ijms150610410; Jiang Y, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/287019; Kandaswamy KK, 2011, J THEOR BIOL, V270, P56, DOI 10.1016/j.jtbi.2010.10.037; Khosravian M, 2013, PROTEIN PEPTIDE LETT, V20, P180, DOI 10.2174/092986613804725307; Kong L, 2014, J THEOR BIOL, V344, P12, DOI 10.1016/j.jtbi.2013.11.021; LIN SX, 2013, J BIOMED SCI JBISE, V6, P435, DOI DOI 10.4236/JBISE.2013.64054; Lin WZ, 2013, MOL BIOSYST, V9, P634, DOI 10.1039/c3mb25466f; Liu B, 2014, BIOINFORMATICS, V30, P472, DOI 10.1093/bioinformatics/btt709; Liu WM, 1999, PROTEIN ENG, V12, P1041, DOI 10.1093/protein/12.12.1041; Liu ZX, 2011, MOL BIOSYST, V7, P1197, DOI 10.1039/c0mb00279h; Mei SY, 2012, J THEOR BIOL, V310, P80, DOI 10.1016/j.jtbi.2012.06.028; Mei SY, 2012, J THEOR BIOL, V293, P121, DOI 10.1016/j.jtbi.2011.10.015; Min JL, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/701317; Mohabatkar H, 2013, MED CHEM, V9, P133, DOI 10.2174/157340613804488341; Mohabatkar H, 2011, J THEOR BIOL, V281, P18, DOI 10.1016/j.jtbi.2011.04.017; Mohammad Beigi Majid, 2011, J Struct Funct Genomics, V12, P191, DOI 10.1007/s10969-011-9120-4; Nanni L, 2012, IEEE ACM T COMPUT BI, V9, P467, DOI 10.1109/TCBB.2011.117; Qiu WR, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/947416; Qiu WR, 2014, INT J MOL SCI, V15, P1746, DOI 10.3390/ijms15021746; Sahu SS, 2010, COMPUT BIOL CHEM, V34, P320, DOI 10.1016/j.compbiolchem.2010.09.002; Shen HB, 2005, BIOCHEM BIOPH RES CO, V334, P577, DOI 10.1016/j.bbrc.2005.06.128; Shen HB, 2009, ANAL BIOCHEM, V394, P269, DOI 10.1016/j.ab.2009.07.046; Sun XY, 2012, MOL BIOSYST, V8, P3178, DOI 10.1039/c2mb25280e; Wang M, 2005, J THEOR BIOL, V232, P7, DOI 10.1016/j.jtbi.2004.07.023; Wu ZC, 2011, MOL BIOSYST, V7, P3287, DOI 10.1039/c1mb05232b; Xiao X, 2013, J THEOR BIOL, V337, P71, DOI 10.1016/j.jtbi.2013.08.013; Xiao X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072234; Xiao X, 2013, ANAL BIOCHEM, V436, P168, DOI 10.1016/j.ab.2013.01.019; Xiao X, 2011, J THEOR BIOL, V284, P42, DOI 10.1016/j.jtbi.2011.06.005; Xu Y, 2014, INT J MOL SCI, V15, P7594, DOI 10.3390/ijms15057594; Xu Y, 2013, PEERJ, V1, DOI 10.7717/peerj.171; Xu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055844; Zhan XQ, 2008, MOL CELL PROTEOMICS, V7, P864, DOI 10.1074/mcp.M700417-MCP200; Zia-ur-Rehman, 2012, PROTEIN PEPTIDE LETT, V19, P890	77	222	223	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e105018	10.1371/journal.pone.0105018	http://dx.doi.org/10.1371/journal.pone.0105018			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121969	Green Submitted, Green Published, gold			2022-12-25	WOS:000341017000088
J	Wu, JN; Yan, SZ; Zhao, JL; Ye, YY				Wu, Jianing; Yan, Shaoze; Zhao, Jieliang; Ye, Yuying			Barbs Facilitate the Helical Penetration of Honeybee (Apis mellifera ligustica) Stingers	PLOS ONE			English	Article							OVIPOSITOR; HYMENOPTERA; INSECTA; WASPS	The stinger is a very small and efficient device that allows honeybees to perform two main physiological activities: repelling enemies and laying eggs for reproduction. In this study, we explored the specific characteristics of stinger penetration, where we focused on its movements and the effects of it microstructure. The stingers of Italian honeybees (Apis mellifera ligustica) were grouped and fixed onto four types of cubic substrates, before pressing into different substrates. The morphological characteristics of the stinger cross-sections were analyzed before and after penetration by microscopy. Our findings suggest that the honeybee stinger undergoes helical and clockwise rotation during penetration. We also found that the helical penetration of the stinger is associated directly with the spiral distribution of the barbs, thereby confirming that stinger penetration involves an advanced microstructure rather than a simple needle-like apparatus. These results provide new insights into the mechanism of honeybee stinger penetration.	[Wu, Jianing; Yan, Shaoze; Zhao, Jieliang; Ye, Yuying] Tsinghua Univ, Dept Mech Engn, State Key Lab Tribol, Div Intelligent & Biomech Syst, Beijing 100084, Peoples R China	Tsinghua University	Yan, SZ (corresponding author), Tsinghua Univ, Dept Mech Engn, State Key Lab Tribol, Div Intelligent & Biomech Syst, Beijing 100084, Peoples R China.	yansz@mail.tsinghua.edu.cn	Zhao, Jieliang/B-1872-2016; Yan, Shaoze/M-1707-2015; yan, shaoze/X-5768-2019; Yu, GH/H-4968-2013	Zhao, Jieliang/0000-0001-6879-0537; Yan, Shaoze/0000-0003-2578-6831; Yu, GH/0000-0002-5699-779X	Research Project of the State Key Laboratory of Tribology [SKLT11B03]	Research Project of the State Key Laboratory of Tribology	This work was funded by the Research Project of the State Key Laboratory of Tribology under Contract no. SKLT11B03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyagi S, 2008, SENSOR ACTUAT A-PHYS, V143, P20, DOI 10.1016/j.sna.2007.06.007; Brown PE, 1998, J INSECT PHYSIOL, V44, P1017, DOI 10.1016/S0022-1910(98)00072-9; Cardinal S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021086; Choo YM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010393; Dade H.A., 1994, ANATOMY DISSECTION H; Duan JJ, 2000, J INSECT BEHAV, V13, P175, DOI 10.1023/A:1007780029320; Frasson L, 2010, P I MECH ENG H, V224, P775, DOI 10.1243/09544119JEIM663; Gao Y, 2007, J SPACECRAFT ROCKETS, V44, P703, DOI 10.2514/1.23025; Izumi H, 2011, SENSOR ACTUAT A-PHYS, V165, P115, DOI 10.1016/j.sna.2010.02.010; Klowden MJ, 2013, PHYSIOLOGICAL SYSTEMS IN INSECTS, 3RD EDITION, P1; Kong XQ, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.011910; Rahman MH, 1998, ZOOL SCR, V27, P333, DOI 10.1111/j.1463-6409.1998.tb00465.x; Robbins CR., 2002, CHEM PHYS BEHAV HUMA, V4th ed.; Schilthuizen M, 1998, SYST ENTOMOL, V23, P253, DOI 10.1046/j.1365-3113.1998.00049.x; Snodgrass R.E., 1956, ANATOMY HONEY BEE; Srinivasan MV, 2000, SCIENCE, V287, P851, DOI 10.1126/science.287.5454.851; Tautz J., 2008, BUZZ BEES BIOL SUPER; van Dooremalen C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036285; Vilhelmsen L, 2001, ZOOMORPHOLOGY, V121, P63, DOI 10.1007/s004350100046; Visscher PK, 1996, LANCET, V348, P301, DOI 10.1016/S0140-6736(96)01367-0; Winston M. L. L., 1991, BIOL HONEY BEE; WU E, 1994, EXP MECH, V34, P93, DOI 10.1007/BF02325705	22	35	35	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103823	10.1371/journal.pone.0103823	http://dx.doi.org/10.1371/journal.pone.0103823			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25137372	Green Published, gold, Green Submitted			2022-12-25	WOS:000339812700058
J	Wu, CC; Tsai, TH; Chang, C; Lee, TT; Lin, C; Cheng, IHJ; Sun, MC; Chuang, YJ; Chen, BS				Wu, Chia-Chou; Tsai, Tsung-Han; Chang, Chieh; Lee, Tian-Thai; Lin, Che; Cheng, Irene Han-Juo; Sun, Mu-Chien; Chuang, Yung-Jen; Chen, Bor-Sen			On the Crucial Cerebellar Wound Healing-Related Pathways and Their Cross-Talks after Traumatic Brain Injury in Danio rerio	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; ZEBRAFISH MODEL; CELL-MIGRATION; IMMUNE-SYSTEM; REGENERATION; NEUROTRANSMITTERS; NEUROGENESIS; CANNABINOIDS; PATHOGENESIS; MECHANISMS	Upon injury, the direct damage and the subsequent secondary injury in the brain often result in chronic neurological disorders. Due to multifactorial nature of secondary injury and subsequent complex cellular responses, much of the underlying mechanisms are unclear. This study used an adult zebrafish cerebellum injury model to investigate the phenotypes and the secondary injury responses for recovery mechanisms of injured brain. Using the time course microarray analysis, a candidate protein-protein interaction (PPI) network was refined as cerebellar wound healing PPI network by dynamic modeling and big data mining. Pathway enrichment and ontological analysis were incorporated into the refined network to highlight the main molecular scheme of cerebellar wound healing. Several significant pathways, including chemokine, Phosphatidylinositide 3-kinases, and axon guidance signaling pathway and their cross-talks through PI3K, PAK2, and PLXNA3 were identified to coordinate for neurogenesis and angiogenesis, which are essential for the restoration of the injured brain. Our finding provides an insight into the molecular restoration mechanisms after traumatic brain injury, and open up new opportunity to devise the treatment for traumatic brain injury in human.	[Wu, Chia-Chou; Tsai, Tsung-Han; Lin, Che; Chen, Bor-Sen] Natl Tsing Hua Univ, Deptartment Elect Engn, Hsinchu, Taiwan; [Chang, Chieh; Lee, Tian-Thai; Chuang, Yung-Jen] Natl Tsing Hua Univ, Deptartment Med Sci, Hsinchu, Taiwan; [Chang, Chieh; Lee, Tian-Thai; Chuang, Yung-Jen] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan; [Cheng, Irene Han-Juo] Natl Yang Ming Univ, Inst Brain Sci, Taipei 112, Taiwan; [Sun, Mu-Chien] Changhua Christian Hosp, Stroke Ctr, Changhua, Taiwan; [Sun, Mu-Chien] Changhua Christian Hosp, Deptartment Neurol, Changhua, Taiwan	National Tsing Hua University; National Tsing Hua University; National Tsing Hua University; National Yang Ming Chiao Tung University; Changhua Christian Hospital; Changhua Christian Hospital	Chen, BS (corresponding author), Natl Tsing Hua Univ, Deptartment Elect Engn, Hsinchu, Taiwan.	bschen@ee.nthu.edu.tw	Wu, Chia-Chou/L-1058-2013; Chen, Bor-Sen/D-9114-2017; Hsu, Yuan-Man/K-7074-2015	Wu, Chia-Chou/0000-0002-4009-6858; Chang, Jia-Hao/0000-0001-7843-2688; Chang, Chiung-Hung/0000-0001-6917-4875; Hsu, Yuan-Man/0000-0002-4575-7475	National Science Council of Taiwan, R.O.C. [NSC 102-2745-E-007-001-ASP]	National Science Council of Taiwan, R.O.C.(Ministry of Science and Technology, Taiwan)	The work was supported by the National Science Council of Taiwan, R.O.C. [NSC 102-2745-E-007-001-ASP]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antos CL, 2010, ADV EXP MED BIOL, V695, P184, DOI 10.1007/978-1-4419-7037-4_13; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Basu S, 2000, J NEUROIMMUNOL, V102, P113, DOI 10.1016/S0165-5728(99)00176-9; Berg DA, 2013, DEVELOPMENT, V140, P2548, DOI 10.1242/dev.088005; BLALOCK JE, 1992, CHEM IMMUNOL, V52, P1; Bradford Y, 2011, NUCLEIC ACIDS RES, V39, pD822, DOI 10.1093/nar/gkq1077; Cameron DA, 2005, MOL VIS, V11, P775; Chen BS, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-46; Craig Sonya E L, 2008, J Ocul Biol Dis Infor, V1, P73, DOI 10.1007/s12177-008-9011-5; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Feala JD, 2013, J NEUROTRAUM, V30, P1101, DOI 10.1089/neu.2012.2631; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Guingab-Cagmat JD, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00061; Guo Y, 2011, NEUROSCIENCE, V172, P329, DOI 10.1016/j.neuroscience.2010.10.026; Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559; Hui SP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084212; Jiang W, 2005, J CLIN INVEST, V115, P3104, DOI 10.1172/JCI25509; Kalueff AV, 2013, ZEBRAFISH, V10, P70, DOI 10.1089/zeb.2012.0861; Kishimoto N, 2012, DIS MODEL MECH, V5, P200, DOI 10.1242/dmm.007336; Kizil C, 2012, DEV NEUROBIOL, V72, P429, DOI 10.1002/dneu.20918; Kyritsis N, 2012, SCIENCE, V338, P1353, DOI 10.1126/science.1228773; Levin ED, 2009, FRONT NEUROSCI, P293; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lukacs NW, 2001, NAT REV IMMUNOL, V1, P108, DOI 10.1038/35100503; Martins RAP, 2008, BRAIN RES, V1192, P37, DOI 10.1016/j.brainres.2007.04.076; McCurley AT, 2010, J EXP NEUROSCI, V4, P17; Mechoulam R, 2002, TRENDS MOL MED, V8, P58, DOI 10.1016/S1471-4914(02)02276-1; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Neselius S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033606; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Postlethwait J, 1999, METHOD CELL BIOL, V60, P149; Qin Z, 2009, P NATL ACAD SCI USA, V106, P9310, DOI 10.1073/pnas.0811186106; Qiu YH, 1996, ADV NEUROIMMUNOL, V6, P223, DOI 10.1016/S0960-5428(96)00018-6; Rajaram MVS, 2006, J IMMUNOL, V177, P6317, DOI 10.4049/jimmunol.177.9.6317; Ridley AJ, 2001, J CELL SCI, V114, P2713; Shohami E, 2011, BRIT J PHARMACOL, V163, P1402, DOI 10.1111/j.1476-5381.2011.01343.x; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Stadelmann WK, 1998, AM J SURG, V176, p39S, DOI 10.1016/S0002-9610(98)00184-6; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Tanaka EM, 2009, NAT REV NEUROSCI, V10, P713, DOI 10.1038/nrn2707; Vicente-Manzanares M, 2002, INT REV CYTOL, V216, P233; Wang YC, 2010, BMC SYST BIOL, V4, DOI [10.1186/1752-0509-4-S2-S1, 10.1186/1752-0509-4-20]; Webster JI, 2002, ANNU REV IMMUNOL, V20, P125, DOI 10.1146/annurev.immunol.20.082401.104914; Yang SK, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-19	49	16	18	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e97902	10.1371/journal.pone.0097902	http://dx.doi.org/10.1371/journal.pone.0097902			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926785	gold, Green Submitted, Green Published			2022-12-25	WOS:000338278100009
J	Wang, J; Qin, TQ; Chen, JR; Li, YL; Wang, L; Huang, H; Li, J				Wang, Ji; Qin, Tianqiang; Chen, Jianrong; Li, Yulin; Wang, Ling; Huang, He; Li, Jing			Hyperuricemia and Risk of Incident Hypertension: A Systematic Review and Meta-Analysis of Observational Studies	PLOS ONE			English	Article							SERUM URIC-ACID; MUSCLE-CELL-PROLIFERATION; BLOOD-PRESSURE; PREDICTORS; CHINESE; PATHOGENESIS; ASSOCIATION; COHORT; LEVEL; BIAS	Background: Observational studies of the relationship between hyperuricemia and the incidence of hypertension are controversial. We conducted a systematic review and meta-analysis to assess the association and consistency between uric acid levels and the risk of hypertension development. Methods: We searched MEDLINE, EMBASE, CBM (Chinese Biomedicine Database) through September 2013 and reference lists of retrieved studies to identify cohort studies and nested case-control studies with uric acid levels as exposure and incident hypertension as outcome variables. Two reviewers independently extracted data and assessed study quality using Newcastle-Ottawa Scale. Extracted information included study design, population, definition of hyperuricemia and hypertension, number of incident hypertension, effect sizes, and adjusted confounders. Pooled relative risks (RRs) and corresponding 95% confidence intervals (CIs) for the association between hyperuricemia and risk of hypertension were calculated using a random-effects model. Results: We included 25 studies with 97,824 participants assessing the association between uric acid and incident hypertension in our meta-analysis. The quality of included studies is moderate to high. Random-effects meta-analysis showed that hyperuricemia was associated with a higher risk of incident hypertension, regardless of whether the effect size was adjusted or not, whether the data were categorical or continuous as 1 SD/1 mg/dl increase in uric acid level (unadjusted: RR=1.73, 95% CI 1.46 similar to 2.06 for categorical data, RR=1.22, 95% CI 1.03 similar to 1.45 for a 1 SD increase; adjusted: RR=1.48, 95% CI 1.33 similar to 1.65 for categorical data, RR=1.15, 95% CI 1.06 similar to 1.26 for a 1 mg/dl increase), and the risk is consistent in subgroup analyses and have a dose-response relationship. Conclusions: Hyperuricemia may modestly increase the risk of hypertension incidence, consistent with a dose-response relationship.	[Wang, Ji; Qin, Tianqiang; Chen, Jianrong; Li, Jing] Sichuan Univ, West China Hosp, Dept Evidence Based Med & Clin Epidemiol, Chengdu 610064, Peoples R China; [Li, Yulin] Chengdu Univ, TCM, Affiliated Hosp 2, Chengdu, Peoples R China; [Wang, Ling] Mianyang Peoples Hosp, Dept Cardiol, Mianyang City, Peoples R China; [Huang, He] Sichuan Univ, West China Hosp, Dept Cardiol, Chengdu 610064, Peoples R China	Sichuan University; Chengdu University; Sichuan University	Li, J (corresponding author), Sichuan Univ, West China Hosp, Dept Evidence Based Med & Clin Epidemiol, Chengdu 610064, Peoples R China.	lijing68@hotmail.com		Norback, Dan/0000-0002-5174-6668; Li, Jing/0000-0003-1191-9971				Chien KL, 2011, J HUM HYPERTENS, V25, P294, DOI 10.1038/jhh.2010.63; Corry DB, 2008, J HYPERTENS, V26, P269, DOI 10.1097/HJH.0b013e3282f240bf; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Duval S, 2000, J AM STAT ASSOC, V95, P89, DOI 10.2307/2669529; Dyer AR, 1999, J HUM HYPERTENS, V13, P13, DOI 10.1038/sj.jhh.1000740; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; Feig DI, 2008, JAMA-J AM MED ASSOC, V300, P924, DOI 10.1001/jama.300.8.924; Feig DI, 2004, KIDNEY INT, V66, P281, DOI 10.1111/j.1523-1755.2004.00729.x; FESSEL WJ, 1980, AM J MED, V68, P401, DOI 10.1016/0002-9343(80)90111-4; Forman JP, 2007, J AM SOC NEPHROL, V18, P287, DOI 10.1681/ASN.2006080865; Forman JP, 2009, ARCH INTERN MED, V169, P155, DOI 10.1001/archinternmed.2008.521; Gaffo AL, 2013, ANN RHEUM DIS, V72, P1321, DOI 10.1136/annrheumdis-2012-201916; Grayson PC, 2011, ARTHRIT CARE RES, V63, P102, DOI 10.1002/acr.20344; GREENLAND S, 1987, EPIDEMIOL REV, V9, P1; HUNT SC, 1991, HYPERTENSION, V17, P969, DOI 10.1161/01.HYP.17.6.969; Imazu M, 2001, HYPERTENS RES, V24, P531, DOI 10.1291/hypres.24.531; Johnson RJ, 2005, HYPERTENSION, V45, P18, DOI 10.1161/01.HYP.0000150785.39055.e8; Johnson RJ, 2005, AM J HYPERTENS, V18, P431, DOI 10.1016/j.amjhyper.2004.08.035; JOSSA F, 1994, J HUM HYPERTENS, V8, P677; KAHN HA, 1972, AM HEART J, V84, P171, DOI 10.1016/0002-8703(72)90331-6; Kang DH, 2005, J AM SOC NEPHROL, V16, P3553, DOI 10.1681/ASN.2005050572; Khosla UM, 2005, KIDNEY INT, V67, P1739, DOI 10.1111/j.1523-1755.2005.00273.x; Krishnan E, 2007, HYPERTENSION, V49, P298, DOI 10.1161/01.HYP.0000254480.64564.b6; Mahomed F.-A., 1879, LANCET, V113, P399; Mazzali M, 2001, HYPERTENSION, V38, P1101, DOI 10.1161/hy1101.092839; Mellen PB, 2006, HYPERTENSION, V48, P1037, DOI 10.1161/01.HYP.0000249768.26560.66; Moher David, 2009, BMJ, V339, pb2535, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Nagahama K, 2004, HYPERTENS RES, V27, P835, DOI 10.1291/hypres.27.835; Nakanishi N, 2003, EUR J EPIDEMIOL, V18, P523, DOI 10.1023/A:1024600905574; Nakanishi N, 1998, J HYPERTENS, V16, P753, DOI 10.1097/00004872-199816060-00006; Perlstein TS, 2006, HYPERTENSION, V48, P1031, DOI 10.1161/01.HYP.0000248752.08807.4c; RAO GN, 1991, J BIOL CHEM, V266, P8604; Sanchez-Lozada LG, 2005, KIDNEY INT, V67, P237, DOI 10.1111/j.1523-1755.2005.00074.x; SELBY JV, 1990, AM J EPIDEMIOL, V131, P1017, DOI 10.1093/oxfordjournals.aje.a115593; Shankar A, 2006, J HUM HYPERTENS, V20, P937, DOI 10.1038/sj.jhh.1002095; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Sundstrom J, 2005, HYPERTENSION, V45, P28, DOI 10.1161/01.HYP.0000150784.92944.9a; Taniguchi Y, 2001, J HYPERTENS, V19, P1209, DOI 10.1097/00004872-200107000-00005; Watanabe S, 2002, HYPERTENSION, V40, P355, DOI 10.1161/01.HYP.0000028589.66335.AA; Wells GA., NEWCASTLE OTTAWA SCA; [吴云涛 Wu Yuntao], 2010, [中华高血压杂志, Chinese Journal of Hypertension], V18, P545; Yang T, 2012, METABOLISM, V61, P1747, DOI 10.1016/j.metabol.2012.05.006; Yeh CJ, 2001, J FORMOS MED ASSOC, V100, P668; Zhang H, 2001, CHIN J HYPERTENS, V9, P160; Zhang WL, 2009, CLIN CHEM, V55, P2026, DOI 10.1373/clinchem.2009.124891	46	167	189	5	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e114259	10.1371/journal.pone.0114259	http://dx.doi.org/10.1371/journal.pone.0114259			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437867	gold, Green Submitted, Green Published			2022-12-25	WOS:000347114900134
J	Thompson, MB; Tangen, JM				Thompson, Matthew B.; Tangen, Jason M.			The Nature of Expertise in Fingerprint Matching: Experts Can Do a Lot with a Little	PLOS ONE			English	Article							DECISION-MAKING; INFORMATION; IDENTIFICATION; RECOGNITION; ERROR	Expert decision making often seems impressive, even miraculous. People with genuine expertise in a particular domain can perform quickly and accurately, and with little information. In the series of experiments presented here, we manipulate the amount of "information'' available to a group of experts whose job it is to identify the source of crime scene fingerprints. In Experiment 1, we reduced the amount of information available to experts by inverting fingerprint pairs and adding visual noise. There was no evidence for an inversion effect-experts were just as accurate for inverted prints as they were for upright prints-but expert performance with artificially noisy prints was impressive. In Experiment 2, we separated matching and nonmatching print pairs in time. Experts were conservative, but they were still able to discriminate pairs of fingerprints that were separated by five-seconds, even though the task was quite different from their everyday experience. In Experiment 3, we separated the print pairs further in time to test the long-term memory of experts compared to novices. Long-term recognition memory for experts and novices was the same, with both performing around chance. In Experiment 4, we presented pairs of fingerprints quickly to experts and novices in a matching task. Experts were more accurate than novices, particularly for similar nonmatching pairs, and experts were generally more accurate when they had more time. It is clear that experts can match prints accurately when there is reduced visual information, reduced opportunity for direct comparison, and reduced time to engage in deliberate reasoning. These findings suggest that non-analytic processing accounts for a substantial portion of the variance in expert fingerprint matching accuracy. Our conclusion is at odds with general wisdom in fingerprint identification practice and formal training, and at odds with the claims and explanations that are offered in court during expert testimony.	[Thompson, Matthew B.; Tangen, Jason M.] Univ Queensland, Sch Psychol, St Lucia, Qld, Australia	University of Queensland	Thompson, MB (corresponding author), Univ Queensland, Sch Psychol, St Lucia, Qld, Australia.	mbthompson@gmail.com; jtangen@psy.uq.edu.au	Thompson, Matthew/J-9922-2012; Tangen, Jason/ABH-8577-2020	Thompson, Matthew/0000-0002-5649-1203; Tangen, Jason/0000-0002-0649-2566; Poulsen, Mette Homann/0000-0003-2162-3007; Tarnow, Lise/0000-0002-8735-966X; Feidenhansl, Robert/0000-0002-7963-3649; Mathiesen, Joachim/0000-0002-5621-5487	Australian Research Council Linkage Grant to Tangen [LP120100063]; Fulbright Scholarship; Villum Fonden [00007172] Funding Source: researchfish	Australian Research Council Linkage Grant to Tangen(Australian Research Council); Fulbright Scholarship; Villum Fonden(Villum Fonden)	This research was supported by an Australian Research Council Linkage Grant to Tangen (LP120100063; www.arc.gov.au; see The Forensic Reasoning Project at ForensicReasoning. com), and a Fulbright Scholarship to Thompson (www.fulbright.com.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERNETHY B, 1991, INT J SPORT PSYCHOL, V22, P189; [Anonymous], 2009, STRENGTHENING FORENS; BARROWS HS, 1982, CLIN INVEST MED, V5, P49; Barton JJS, 2006, PERCEPTION, V35, P1089, DOI 10.1068/p5547; Brooks L, 1987, EMORY S COGNITION 1, P141; Brooks LR, 2005, CAN J EXP PSYCHOL, V59, P62, DOI 10.1037/h0087462; BROOKS LR, 1978, NON ANALYTIC CONCEPT; BUSEY T, 2011, J FORENSIC IDENTIF, V60, P61; Busey TA, 2005, VISION RES, V45, P431, DOI 10.1016/j.visres.2004.08.021; Busey TA, 2010, PSYCHON B REV, V17, P155, DOI 10.3758/PBR.17.2.155; CAMPBELL A, 2011, THE FINGERPRINT INQU, P790; Cole SA, 2009, LP R, V8, P233, DOI DOI 10.1093/LPR/MGP016; Cole SA, 2005, J CRIM LAW CRIM, V95, P985; Cowan N, 2008, PROG BRAIN RES, V169, P323, DOI 10.1016/S0079-6123(07)00020-9; DEGROOT AD, 1978, THOUGHT AND CHOICE I; Dodson CS, 1997, MEM COGNITION, V25, P129, DOI 10.3758/BF03201107; Dror I.E., 2006, J FORENSIC IDENTIFIC, V56, P600, DOI DOI 10.1016/S1355-0306(98)72118-5; Dror IE, 2006, FORENSIC SCI INT, V156, P74, DOI 10.1016/j.forsciint.2005.10.017; Dror IE, 2011, FORENSIC SCI INT, V208, P10, DOI 10.1016/j.forsciint.2010.10.013; Edmond G, 2015, LAW PROBAB RISK, V14, P1, DOI [10.1093/lpr/mgu018, 10.1093/lpr/mgt011]; ERICSSON KA, 1993, PSYCHOL REV, V100, P363, DOI 10.1037/0033-295X.100.3.363; Ericsson KA, 1996, ANNU REV PSYCHOL, V47, P273, DOI 10.1146/annurev.psych.47.1.273; ERICSSON KA, 1991, TOWARD A GENERAL THE; Evans KK, 2013, PSYCHON B REV, V20, P1170, DOI 10.3758/s13423-013-0459-3; Evans KK, 2011, PSYCHOL SCI, V22, P739, DOI 10.1177/0956797611407930; Evans KK, 2011, ATTEN PERCEPT PSYCHO, V73, P30, DOI 10.3758/s13414-010-0022-5; *FED BUR INV, 1984, THE SCIENCE OF FINGE; Gauthier I, 1997, VISION RES, V37, P1673, DOI 10.1016/S0042-6989(96)00286-6; Gobet F, 2006, CAMBRIDGE HANDBOOK OF EXPERTISE AND EXPERT PERFORMANCE, P523; Greene MR, 2009, COGNITIVE PSYCHOL, V58, P137, DOI 10.1016/j.cogpsych.2008.06.001; HENRY ER, 1900, CLASSIFICATION AND U; Hughson AL, 2001, AUST J PSYCHOL, V53, P103, DOI 10.1080/00049530108255130; INTRAUB H, 1981, J EXP PSYCHOL HUMAN, V7, P604, DOI 10.1037/0096-1523.7.3.604; Joubert OR, 2007, VISION RES, V47, P3286, DOI 10.1016/j.visres.2007.09.013; Kahneman D., 2011, THINKING FAST AND SL; Kahneman D, 2009, AM PSYCHOL, V64, P515, DOI 10.1037/a0016755; Kassin SM, 2013, J APPL RES MEM COGN, V2, P42, DOI 10.1016/j.jarmac.2013.01.001; KLEIN GA, 1998, SOURCES OF POWER; Loftus EF, 2004, SCIENCE, V304, P959; Medin DL., 1989, ADV PSYCHOL HUMAN IN, P189, DOI [10.4324/9781315807768-13, DOI 10.4324/9781315807768-13]; Mnookin JL, 2011, UCLA LAW REV, V58, P725; MYLESWORSLEY M, 1988, J EXP PSYCHOL LEARN, V14, P553, DOI 10.1037/0278-7393.14.3.553; NISBETT RE, 1977, PSYCHOL REV, V84, P231, DOI 10.1037/0033-295X.84.3.231; Norman GR, 2010, MED EDUC, V44, P94, DOI 10.1111/j.1365-2923.2009.03507.x; Norman GR, 1997, ADV HEALTH SCI EDUC, V2, P173, DOI 10.1023/A:1009784330364; NORMAN GR, 1989, ARCH DERMATOL, V125, P1063, DOI 10.1001/archderm.125.8.1063; POTTER MC, 1975, NATURE, V253, P437, DOI 10.1038/253437a0; Rossion Bruno, 2002, Behav Cogn Neurosci Rev, V1, P63, DOI 10.1177/1534582302001001004; Saks MJ, 2005, SCIENCE, V309, P892, DOI 10.1126/science.1111565; SEARSTON RA, PUTTING BIAS INTO CO; Spinney L, 2010, NATURE, V464, P344, DOI 10.1038/464344a; Tangen JM, 2011, PSYCHOL SCI, V22, P995, DOI 10.1177/0956797611414729; Thompson MB, 2014, LAW HUMAN BEHAV, V38, P84, DOI 10.1037/lhb0000051; Thompson MB, 2013, J FORENSIC SCI, V58, P1519, DOI 10.1111/1556-4029.12203; Ulery BT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032800; Ulery BT, 2011, P NATL ACAD SCI USA, V108, P7733, DOI 10.1073/pnas.1018707108; Vokey JR, 2009, Q J EXP PSYCHOL, V62, P1023, DOI 10.1080/17470210802372987; Wilson T., 2002, STRANGERS TO OURSELV	58	51	51	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e114759	10.1371/journal.pone.0114759	http://dx.doi.org/10.1371/journal.pone.0114759			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX9IA	25122138	gold, Green Submitted, Green Published			2022-12-25	WOS:000347215600026
J	You, ZQ; Chen, MX; Yang, S; Zhou, ZK; Qin, P				You, Zhiqi; Chen, Mingxi; Yang, Sen; Zhou, Zongkui; Qin, Ping			Childhood Adversity, Recent Life Stressors and Suicidal Behavior in Chinese College Students	PLOS ONE			English	Article							EVENTS; ABUSE; RISK; ADOLESCENCE; IDEATION; GENDER; WOMEN	Background: Although the independent effects of childhood adversities and of recent negative events on suicidality have been well-documented, the combinative role of childhood and recent adversities on risk for suicidality is still underexplored, especially in the context of Chinese culture and in consideration of specific types of negative events. Method: 5989 students, randomly sampled from six universities in central China, completed the online survey for this study. Suicidal behavior, life adversity during childhood and stressful events in recent school life were assessed with designed questionnaires. Results: Students experiencing recent stressful life events more often reported an experience of life adversity during childhood. While recent stressful life events and childhood life adversity both were associated with an increased risk for suicidal behavior, the two exposures presented conjunctively and acted interactively to increase the risk. There was noticeable variation of effects associated with specific childhood life adversities, and sexual abuse, poor parental relationship, divorce of parents and loss of a parent were among the adversities associated with the highest increased risk. Recent conflicts with classmates, poor school performance and rupture of romantic relationships were the recent school life stressors associated with the highest increased risk. Conclusions: Childhood adversity and recent school life stressors had a combinative role in predicting suicidality of young people studying in Chinese colleges. Unhappy family life during childhood and recent interpersonal conflicts in school were the most important predictors of suicidality in this population.	[You, Zhiqi; Chen, Mingxi; Yang, Sen; Zhou, Zongkui] Minist Educ, Key Lab Adolescent Cyberpsychol & Behav CCNU, Wuhan, Peoples R China; [You, Zhiqi; Chen, Mingxi; Yang, Sen; Zhou, Zongkui] Cent China Normal Univ, Sch Psychol, Wuhan, Peoples R China; [Qin, Ping] Univ Aarhus, Natl Ctr Register Based Res, Aarhus, Denmark; [Qin, Ping] Univ Oslo, Natl Ctr Suicide Res & Prevent, Inst Clin Med, Oslo, Norway	Central China Normal University; Aarhus University; University of Oslo	Zhou, ZK (corresponding author), Minist Educ, Key Lab Adolescent Cyberpsychol & Behav CCNU, Wuhan, Peoples R China.	zhouzk@mail.ccnu.edu.cn	; Park, Cheol-Young/C-6690-2018	You, Zhiqi/0000-0002-2140-5870; Park, Cheol-Young/0000-0002-9415-9965; Yang, Soo Jin/0000-0001-7892-7648	Key Project of International Cooperation from the Chinese Ministry of Science and Technology [2010DFA31790]; Major Program of National Social Science Foundation of P.R. China [11ZD151]; Excellent doctoral dissertation cultivation grant from Central China Normal University [2013YBZD05]	Key Project of International Cooperation from the Chinese Ministry of Science and Technology; Major Program of National Social Science Foundation of P.R. China; Excellent doctoral dissertation cultivation grant from Central China Normal University	This work was funded by Key Project of International Cooperation from the Chinese Ministry of Science and Technology [project number: 2010DFA31790], Major Program of National Social Science Foundation of P.R. China [project number: 11&ZD151] and Excellent doctoral dissertation cultivation grant from Central China Normal University [project number: 2013YBZD05]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman BP, 2004, DEV PSYCHOL, V40, P367, DOI 10.1037/0012-1649.40.3.367; Bedi S, 2011, SUICIDE LIFE-THREAT, V41, P406, DOI 10.1111/j.1943-278X.2011.00040.x; Buchmann AF, 2012, PRAX KINDERPSYCHOL K, V61, P32, DOI 10.13109/prkk.2012.61.1.32; Cupina D, 2009, AUSTRALAS PSYCHIATRY, V17, P233, DOI 10.1080/10398560802680746; Frederick J, 2008, CHILD FAM SOC WORK, V13, P300, DOI 10.1111/j.1365-2206.2008.00554.x; Galera C, 2008, ACTA PSYCHIAT SCAND, V118, P480, DOI 10.1111/j.1600-0447.2008.01262.x; Grover KE, 2009, J CLIN PSYCHOL, V65, P1281, DOI 10.1002/jclp.20632; Hawton K, 2001, PSYCHOL MED, V31, P827, DOI 10.1017/S0033291701003993; Hawton K, 2000, BRIT J PSYCHIAT, V177, P484, DOI 10.1192/bjp.177.6.484; HILL EM, 1994, ETHOL SOCIOBIOL, V15, P323, DOI 10.1016/0162-3095(94)90006-X; Vazquez JJ, 2010, J COMMUNITY APPL SOC, V20, P288, DOI 10.1002/casp.1036; Kleiman EM, 2012, J AFFECT DISORDERS, V143, P236, DOI 10.1016/j.jad.2012.05.014; Kwok SYCL, 2011, NURS RES, V60, P422, DOI 10.1097/NNR.0b013e31823585d6; Moscicki Eve K., 1994, Annals of Epidemiology, V4, P152; Pedersen NL, 2010, EUR PSYCHIAT, V25, P264, DOI 10.1016/j.eurpsy.2009.12.008; Phillips MR, 2002, LANCET, V359, P835, DOI 10.1016/S0140-6736(02)07954-0; Pompili M, 2009, J HEADACHE PAIN, V10, P283, DOI 10.1007/s10194-009-0134-2; Sarchiapone A, 2009, EUR PSYCHIAT, V24, P57, DOI 10.1016/j.eurpsy.2008.07.005; Sfoggia A, 2008, CRISIS, V29, P154, DOI 10.1027/0227-5910.29.3.154; Singh S, 2012, ASIAN J PSYCHIATR, V5, P154, DOI 10.1016/j.ajp.2012.02.024; Skopp NA, 2011, J SOC CLIN PSYCHOL, V30, P361, DOI 10.1521/jscp.2011.30.4.361; Spokas M, 2009, J TRAUMA STRESS, V22, P467, DOI 10.1002/jts.20438; Sundin M, 2011, SUBST USE MISUSE, V46, P1690, DOI 10.3109/10826084.2011.605414; Tang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017977; Van Heeringen K, 2000, CRISIS, V21, p192a, DOI [10.1201/b12215-7, DOI 10.1201/B12215-7]; Van Orden KA, 2010, PSYCHOL REV, V117, P575, DOI 10.1037/a0018697; Violato C., 2004, INDIVID DIFFER RES, V2, P162; Wang YQ, 2012, PSYCHIAT ANN, V42, P101, DOI 10.3928/00485713-20120217-07; Yen S, 2009, ACTA PSYCHIAT SCAND, V120, P222, DOI 10.1111/j.1600-0447.2009.01366.x; Zhang J, 2006, DEATH STUD, V30, P259, DOI 10.1080/07481180500493443; Zhang J, 2012, J AFFECT DISORDERS, V140, P161, DOI 10.1016/j.jad.2012.01.010	31	37	39	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e86672	10.1371/journal.pone.0086672	http://dx.doi.org/10.1371/journal.pone.0086672			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE0TC	25133775	Green Published, gold, Green Submitted			2022-12-25	WOS:000333678100001
J	Tang, YN; Li, X; Yao, YF; Ferguson, DK; Li, CS				Tang, Ye-Na; Li, Xiao; Yao, Yi-Feng; Ferguson, David Kay; Li, Cheng-Sen			Environmental Reconstruction of Tuyoq in the Fifth Century and Its Bearing on Buddhism in Turpan, Xinjiang, China	PLOS ONE			English	Article							YANGHAI TOMBS; POLLEN; L.; QUATERNARY; PLATEAU; UPLIFT; BP	The Thousand Buddha Grottoes of Tuyoq, Turpan, Xinjiang, China were once a famous Buddhist temple along the ancient Silk Road which was first constructed in the Fifth Century (A.D.). Although archaeological researches about the Grottoes have been undertaken for over a century, the ancient environment has remained enigmatic. Based on seven clay samples from the Grottoes' adobes, pollen and leaf epidermis were analyzed to decipher the vegetation and climate of Fifth Century Turpan, and the environmental landscape was reconstructed in three dimensions. The results suggest that temperate steppe vegetation dominated the Tuyoq region under a warmer and wetter environment with more moderate seasonality than today, as the ancient mean annual temperature was 15.3 degrees C, the mean annual precipitation was approximately 1000 mm and the temperature difference between coldest and warmest months was 24 degrees C using Co-existence Approach. Taken in the context of wheat and grape cultivation as shown by pollen of Vitis and leaf epidermis of Triticum, we infer that the Tuyoq region was an oasis with booming Buddhism in the Fifth Century, which was probably encouraged by a 1 degrees C warmer temperature with an abundant water supply compared to the coeval world that experienced the 1.4 k BP cooling event.	[Tang, Ye-Na; Yao, Yi-Feng; Ferguson, David Kay; Li, Cheng-Sen] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China; [Li, Xiao] Renmin Univ China, Sch Chinese Class, Beijing, Peoples R China; [Ferguson, David Kay] Univ Vienna, Dept Paleontol, Vienna, Austria	Chinese Academy of Sciences; Institute of Botany, CAS; Renmin University of China; University of Vienna	Yao, YF (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China.	yaoyf@ibcas.ac.cn; lics@ibcas.ac.cn		Rajwa, Bartek/0000-0001-7540-8236; Bhunia, Arun/0000-0003-3640-1554; Bae, Euiwon/0000-0001-6095-3223	China National Key Basic Research Program [2014CB954201]	China National Key Basic Research Program(National Basic Research Program of China)	This research was supported by China National Key Basic Research Program (2014CB954201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdirahman H, 2009, J CHINA HYDROL, V29, P50; Andersen TS, 1972, GRANA, V12, P79, DOI 10.1080/00173137209428830; Anjum Perveen, 2006, World Applied Sciences Journal, V1, P60; [Anonymous], LAND CLIM DAT CHIN 1; Bond G, 1997, SCIENCE, V278, P1257, DOI 10.1126/science.278.5341.1257; Cai LB, 1995, ACTA BOT BOREAL OCCI, V15, P323; [罗传秀 LUO Chuanxiu], 2007, [干旱区地理, Arid Land Geography], V30, P536; Chen S.L., 1993, MICROMORPHOLOGICAL A; Chen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045137; Cheng J., 2006, HOLOCENE VEGETATION, P283; DRIESSEN MNBM, 1989, GRANA, V28, P115, DOI 10.1080/00173138909429962; Editorial office, 2007, CHIN CULT HERIT, P80; Editorial office, 2012, HIST REF, V22, P24; ELLIS R P, 1979, Bothalia, V12, P641; Fan ZL, 1995, ARID ZONE RES S, V12, P308; Ferguson DK, 2007, CR PALEVOL, V6, P423, DOI 10.1016/j.crpv.2007.09.018; [葛全胜 Ge Quansheng], 2002, [第四纪研究, Quaternary Sciences], V22, P166; IBCAS (Institute of Botany the Chinese Academy of Sciences), 1976, SPOR PTER PHYT SIN; IDBMC, 1983, LAND CLIM DAT CHIN 2, p[4, 126]; IDBMC (Information Department of Beijing Meteorological Center), 1983, LAND CLIM DAT CHIN 6; IDBMC (INFORMATION DEPARTMENT OF BEIJING METEOROLOGICAL CENTER), 1984, LAND CLIM DAT CHIN 3; IDBMC (Information Department of Beijing Meteorological Center), 1984, LAND CLIM DAT CHIN 4, V4-6, P99; IDBMC (INFORMATION DEPARTMENT OF BEIJING METEOROLOGICAL CENTER), 1984, LAND CLIM DAT CHIN 5; JAT (Joint Archaeological Team of Research Center for Frontier Archaeology of the Institute of Archaeology Chinese Academy of Social Sciences and Academia Turfanica and Kizil Research Institute), 2011, ARCHAEOLOGY, V7, P27; JAT (Joint Archaeological Team of Research Center for Frontier Archaeology of the Institute of Archaeology Chinese Academy of Social Sciences and Academia Turfanica and Kizil Research Institute), 2012, ARCHAEOLOGY, P7; Jiang H, 2007, J PALAEOGEOGR, V5, P551; Jiang HE, 2007, J ETHNOPHARMACOL, V113, P409, DOI 10.1016/j.jep.2007.06.020; Jiang HE, 2006, J ETHNOPHARMACOL, V108, P414, DOI 10.1016/j.jep.2006.05.034; Jiang HE, 2007, J ARCHAEOL SCI, V34, P167, DOI 10.1016/j.jas.2006.04.003; Jiang HE, 2009, J ARCHAEOL SCI, V36, P1458, DOI 10.1016/j.jas.2009.02.010; Klementz Dmitriy A., 1899, NACHRICHTEN KAISERLI; Le Coq VA, 1913, CHOSTSCHO; Li JF, 1985, P QUAT XINJ AR AR, P1; Li JJ, 1999, CHINESE SCI BULL, V44, P2117, DOI 10.1007/BF03182692; LI WY, 1998, QUATERNARY VEGETATIO; Li X., 1993, ARID LAND GEOGRAPHY, V16, P63; Li XQ, 1999, ACTA BOT SIN, V41, P782; Lin M, 1996, CULT RELIC, V12, P54; Lin XL, 2008, THESIS SHANDONG NORM; Luo CX, 2008, ARID LAND GEOGR, V28, P272; Ma QingWen, 2005, Bulletin of Botanical Research, V25, P307; Ma YX, 2004, B BOT RES, V24; [毛礼米 MAO Limi], 2011, [微体古生物学报, Acta Micropalaeontologica Sinica], V28, P169; Moberg A, 2005, NATURE, V433, P613, DOI 10.1038/nature03265; Mokushiki K, 1999, XIYU KAO GU TU PU; Moore P.D., 1991, BLACKWELL SCI PUBLI; Mosbrugger V, 1997, PALAEOGEOGR PALAEOCL, V134, P61, DOI 10.1016/S0031-0182(96)00154-X; PAGE J S, 1978, Kew Bulletin, V32, P313, DOI 10.2307/4117102; Pan W, 2003, URANIUM GEOL, V19, P332; Qiu ZW, 2012, ECON BOT, V66, P255, DOI 10.1007/s12231-012-9204-5; [舒强 SHU Qiang], 2007, [干旱区资源与环境, Journal of Arid Land Resources and Environment], V21, P95; The editorial board of Chinese Frescoes Corpus, 1995, CORP CHIN ART CLASS; Wang F.X., 1995, POLLEN FLORA CHINA; Wang S, 2000, GAOCHANG HIST TRANSP, P85; Weng Cheng-Yu, 1993, Acta Botanica Sinica, V35, P69; Wu Z. Y., 1999, SEED PLANTS CHINA; Xi Y.Z., 1994, YUSHANIA, V11, P119; Xie XM, 1994, J INN MONG NORM U NA, V1, P53; Yan S., 1991, ARID LAND GEOGR, V14, P1; Yan S, 1989, ARID ZONE RES, V6, P26; Yao YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039780; Zhang DF, 2000, ENVIRON GEOL, V39, P1352, DOI 10.1007/s002540000174; Zhang H, 2003, J ARID ENVIRON, V55, P545, DOI 10.1016/S0140-1963(02)00283-5; Zhao Y, 2012, HOLOCENE, V22, P1385, DOI 10.1177/0959683612449762; Zhong Wei, 2001, Arid Land Geography, V24, P212; Zhou XJ, 1989, J ARID REGIONS RES, V1, P9; 蔡联炳, 1996, 西北植物学报, V16, P65	67	40	43	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86363	10.1371/journal.pone.0086363	http://dx.doi.org/10.1371/journal.pone.0086363			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301BI	25136836	Green Published, gold, Green Submitted			2022-12-25	WOS:000330507300057
J	Thomsen, M; Hernandez-Garcia, A; Mathiesen, J; Poulsen, M; Sorensen, DN; Tarnow, L; Feidenhansl, R				Thomsen, Maria; Hernandez-Garcia, Anier; Mathiesen, Joachim; Poulsen, Mette; Sorensen, Dan N.; Tarnow, Lise; Feidenhansl, Robert			Model Study of the Pressure Build-Up during Subcutaneous Injection	PLOS ONE			English	Article							INSULIN; INFUSION; TISSUE	In this study we estimate the subcutaneous tissue counter pressure during drug infusion from a series of injections of insulin in type 2 diabetic patients using a non-invasive method. We construct a model for the pressure evolution in subcutaneous tissue based on mass continuity and the flow laws of a porous medium. For equivalent injection forces we measure the change in the infusion rate between injections in air at atmospheric pressure and in tissue. From a best fit with our model, we then determine the flow permeability as well as the bulk modulus of the tissue, estimated to be of the order 10(-11) - 10(-10) m(2) and 10(5) Pa, respectively. The permeability is in good agreement with reported values for adipose porcine tissue. We suggest our model as a general way to estimate the pressure build-up in tissue during subcutaneous injection.	[Thomsen, Maria; Hernandez-Garcia, Anier; Mathiesen, Joachim; Feidenhansl, Robert] Univ Copenhagen, Niels Bohr Inst, DK-2100 Copenhagen, Denmark; [Thomsen, Maria; Poulsen, Mette; Sorensen, Dan N.] Novo Nordisk AS, Hillerod, Denmark; [Tarnow, Lise] Nordsjae llands Hosp, Hillerod, Denmark; [Tarnow, Lise] Aarhus Univ Hosp, Klin Epidemiol Afdeling, DK-8000 Aarhus, Denmark; [Tarnow, Lise] Steno Diabet Ctr AS, Gentofte, Denmark	University of Copenhagen; Niels Bohr Institute; Novo Nordisk; Aarhus University; Steno Diabetes Center	Thomsen, M (corresponding author), Univ Copenhagen, Niels Bohr Inst, Blegdamsvej 17, DK-2100 Copenhagen, Denmark.	mariath@fys.ku.dk	Thompson, Matthew/J-9922-2012; Tangen, Jason/ABH-8577-2020	Thompson, Matthew/0000-0002-5649-1203; Tangen, Jason/0000-0002-0649-2566; Poulsen, Mette Homann/0000-0003-2162-3007; Tarnow, Lise/0000-0002-8735-966X; Feidenhansl, Robert/0000-0002-7963-3649; Mathiesen, Joachim/0000-0002-5621-5487	Villum Fonden [00007172] Funding Source: researchfish	Villum Fonden(Villum Fonden)		Agache PG, 2004, MEASURING SKIN; AUKLAND K, 1993, PHYSIOL REV, V73, P1, DOI 10.1152/physrev.1993.73.1.1; Comley KSC, 2010, THESIS U CAMBRIDGE E; Darcy H., 1856, FONTAINES PUBLIQUE V, DOI [10.2307/1467138, DOI 10.2307/1467138]; De Coninck C, 2010, J DIABETES, V2, P168, DOI 10.1111/j.1753-0407.2010.00077.x; Gentile S, 2011, ACTA DIABETOL, V48, P121, DOI 10.1007/s00592-009-0172-x; Heinemann L, 2013, DIABETES TECHNOL THE, V15, pS48, DOI 10.1089/dia.2013.1506; Holstein A, 2010, EXPERT OPIN DRUG SAF, V9, P225, DOI 10.1517/14740330903496402; Johansson UB, 2005, DIABETES CARE, V28, P2025, DOI 10.2337/diacare.28.8.2025; Johnsen O, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.011301; MCGILL R, 1978, AM STAT, V32, P12, DOI 10.2307/2683468; Milan G, 2010, J CLIN ENDOCR METAB, V95, P3126, DOI 10.1210/jc.2009-2773; Omar Magdy A, 2011, BMC Res Notes, V4, P290, DOI 10.1186/1756-0500-4-290; Patte C, 2013, DIABETES TECHNOL THE, V15, P289, DOI 10.1089/dia.2012.0319; Pearson Teresa L, 2010, J Diabetes Sci Technol, V4, P522; Peteiro-Gonzalez D, 2011, DIABETES RES CLIN PR, V91, pE61, DOI 10.1016/j.diabres.2010.11.026; SPIEGELMAN M, 1993, J FLUID MECH, V247, P17, DOI 10.1017/S0022112093000369; STRANDEN E, 1982, MICROVASC RES, V24, P241, DOI 10.1016/0026-2862(82)90015-2; Strauss K, 2002, PRACT DIABETES INT, V19, P71, DOI 10.1002/pdi.314; Thomsen M, 2012, PHYS MED BIOL, V57, P7191, DOI 10.1088/0031-9155/57/21/7191; Vardar B, 2007, DIABETES RES CLIN PR, V77, P231, DOI 10.1016/j.diabres.2006.12.023; Wang H.F., 2000, PRI SER GEO; Wielandt JO, 2011, EXPERT OPIN DRUG DEL, V8, P1271, DOI 10.1517/17425247.2011.615308; Wiig H, 2003, ACTA ANAESTH SCAND, V47, P111, DOI 10.1034/j.1399-6576.2003.00050.x	24	51	51	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104054	10.1371/journal.pone.0104054	http://dx.doi.org/10.1371/journal.pone.0104054			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122138	Green Published, gold			2022-12-25	WOS:000341017000026
J	Wu, CH; Chen, LS; Yen, MF; Chiu, YH; Fann, CY; Chen, HH; Pan, SL				Wu, Chueh-Hung; Chen, Li-Sheng; Yen, Ming-Fang; Chiu, Yueh-Hsia; Fann, Ching-Yuan; Chen, Hsiu-Hsi; Pan, Shin-Liang			Does Non-Central Nervous System Tuberculosis Increase the Risk of Ischemic Stroke? A Population-Based Propensity Score-Matched Follow-Up Study	PLOS ONE			English	Article							CAROTID ATHEROSCLEROSIS; CHRONIC INFECTIONS; CIGARETTE-SMOKING; HEALTH-INSURANCE; PREVALENCE; TAIWAN; SEX; AGE	Background: Previous studies on the association between tuberculosis and the risk of developing ischemic stroke have generated inconsistent results. We therefore performed a population-based, propensity score-matched longitudinal follow-up study to investigate whether contracting non-central nervous system (CNS) tuberculosis leads to an increased risk of ischemic stroke. Methods: We used a logistic regression model that includes age, sex, pre-existing comorbidities and socioeconomic status as covariates to compute the propensity score. A total of 5804 persons with at least three ambulatory visits in 2001 with the principal diagnosis of non-CNS tuberculosis were enrolled in the tuberculosis group. The non-tuberculosis group consisted of 5804, propensity score-matched subjects without tuberculosis. The three-year ischemic stroke-free survival rates for these 2 groups were estimated using the Kaplan-Meier method. The stratified Cox proportional hazards regression was used to estimate the effect of tuberculosis on the occurrence of ischemic stroke. Results: During three-year follow-up, 176 subjects in the tuberculosis group (3.0%) and 207 in the non-tuberculosis group (3.6%) had ischemic stroke. The hazard ratio for developing ischemic stroke in the tuberculosis group was 0.92 compared to the non-tuberculosis group (95% confidence interval: 0.73-1.14, P = 0.4299). Conclusions: Non-CNS tuberculosis does not increase the risk of subsequent ischemic stroke.	[Wu, Chueh-Hung; Pan, Shin-Liang] Natl Taiwan Univ Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Wu, Chueh-Hung; Pan, Shin-Liang] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Chen, Li-Sheng; Yen, Ming-Fang] Taipei Med Univ, Coll Oral Med, Sch Oral Hyg, Taipei, Taiwan; [Chiu, Yueh-Hsia] Chang Gung Univ, Dept & Grad Inst Hlth Care Management, Taoyuan, Taiwan; [Fann, Ching-Yuan] Kainan Univ, Dept Nutr & Hlth Sci, Taoyuan, Taiwan; [Chen, Hsiu-Hsi] Natl Taiwan Univ, Coll Publ Hlth, Ctr Biostat Consultat, Taipei 10764, Taiwan; [Chen, Hsiu-Hsi] Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Epidemiol, Div Biostat, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; Taipei Medical University; Chang Gung University; Nan Kai University Technology; National Taiwan University; National Taiwan University	Pan, SL (corresponding author), Natl Taiwan Univ Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan.	panslcb@gmail.com		Chen, Hsiu-Hsi/0000-0002-5799-6705; Chiu, Sherry Yueh-Hsia/0000-0002-7207-7088; PAN, SHIN-LIANG/0000-0001-6451-4666; WU, CHUEH-HUNG/0000-0002-3979-3541	Department of Health, Executive Yuan, Republic of China [DOH93-TD-M-113-030, DOH94-TD-M-113-004, DOH95-TD-M-113-002]	Department of Health, Executive Yuan, Republic of China	This study was supported by grants DOH93-TD-M-113-030, DOH94-TD-M-113-004, and DOH95-TD-M-113-002 from the Department of Health, Executive Yuan, Republic of China. This study used the complete National Health Insurance Research Database provided by the Bureau of National Health Insurance, Department of Health. The interpretation and conclusions contained in this study do not necessarily represent those of the Department of Health, Executive Yuan, Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcavi L, 2004, ARCH INTERN MED, V164, P2206, DOI 10.1001/archinte.164.20.2206; Asplund K, 2009, STROKE, V40, P2319, DOI 10.1161/STROKEAHA.109.547869; Byberg S, 2012, EUR RESPIR J, V40, P1289, DOI 10.1183/09031936.00039612; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; DAVIS PH, 1987, ANN NEUROL, V22, P319, DOI 10.1002/ana.410220307; De Silva DA, 2009, J NEUROL SCI, V285, P118, DOI 10.1016/j.jns.2009.06.013; Dobler CC, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000666; Elkind MSV, 2006, STROKE, V37, P790, DOI 10.1161/01.STR.0000202624.89869.e9; Engstrom G, 2001, STROKE, V32, P1098, DOI 10.1161/01.STR.32.5.1098; Espinola-Klein C, 2002, STROKE, V33, P2581, DOI 10.1161/01.STR.0000034789.82859.A4; Faurholt-Jepsen D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024215; Giral P, 2007, ATHEROSCLEROSIS, V190, P150, DOI 10.1016/j.atherosclerosis.2006.01.008; Hagiwara Noriko, 2007, J Stroke Cerebrovasc Dis, V16, P145, DOI 10.1016/j.jstrokecerebrovasdis.2007.02.001; Holmes CB, 1998, INT J TUBERC LUNG D, V2, P96; Hsieh FY, 2000, CONTROL CLIN TRIALS, V21, P552, DOI 10.1016/S0197-2456(00)00104-5; Huang YP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068314; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Kalayoglu MV, 2002, JAMA-J AM MED ASSOC, V288, P2724, DOI 10.1001/jama.288.21.2724; Kiechl S, 2001, CIRCULATION, V103, P1064, DOI 10.1161/01.CIR.103.8.1064; Kiechl S, 2002, STROKE, V33, P2170, DOI 10.1161/01.STR.0000027209.59821.98; Lin HC, 2007, J URBAN HEALTH, V84, P604, DOI 10.1007/s11524-007-9195-1; Lin HC, 2010, NEUROLOGY, V74, P792, DOI 10.1212/WNL.0b013e3181d31e5c; Liu CY., 2006, J HLTH MANAGEMENT, V4, P1, DOI DOI 10.29805/JHM.200606.0001; McNamee R, 2005, OCCUP ENVIRON MED, V62, P500, DOI 10.1136/oem.2002.001115; Mori T, 2010, INFECT DIS CLIN N AM, V24, P751, DOI 10.1016/j.idc.2010.04.011; Parsons L.S., 2004, PERFORMING 1 N CASE; Prasad A, 2002, CIRCULATION, V106, P184, DOI 10.1161/01.CIR.0000021125.83697.21; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Schneeweiss S, 2000, INT J EPIDEMIOL, V29, P891, DOI 10.1093/ije/29.5.891; Sheu JJ, 2010, STROKE, V41, P244, DOI 10.1161/STROKEAHA.109.567735; Simons LA, 1998, STROKE, V29, P1341, DOI 10.1161/01.STR.29.7.1341; Viswanathan V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041367; Wang JM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-292; Wen CP, 2008, ANN INTERN MED, V148, P258, DOI 10.7326/0003-4819-148-4-200802190-00004; WHO, 2009, GLOB TUB CONTR EP ST, P6; WOLF PA, 1985, STROKE, V16, P359, DOI 10.1161/01.STR.16.3.359; Wu CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049343	38	20	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e98158	10.1371/journal.pone.0098158	http://dx.doi.org/10.1371/journal.pone.0098158			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25133789	Green Published, Green Submitted, gold			2022-12-25	WOS:000339558100001
